Citrus Sinensis ID: 045798
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 1008 | 2.2.26 [Sep-21-2011] | |||||||
| C0LGP4 | 1010 | Probable LRR receptor-lik | yes | no | 0.958 | 0.956 | 0.465 | 0.0 | |
| Q9SD62 | 1025 | Putative receptor-like pr | no | no | 0.960 | 0.944 | 0.462 | 0.0 | |
| C0LGT6 | 1031 | LRR receptor-like serine/ | no | no | 0.961 | 0.939 | 0.428 | 0.0 | |
| Q9FL28 | 1173 | LRR receptor-like serine/ | no | no | 0.876 | 0.753 | 0.345 | 1e-135 | |
| Q9FIZ3 | 1252 | LRR receptor-like serine/ | no | no | 0.885 | 0.713 | 0.331 | 1e-128 | |
| Q9ZUI0 | 980 | Putative leucine-rich rep | no | no | 0.841 | 0.865 | 0.349 | 1e-128 | |
| C0LGQ5 | 1249 | LRR receptor-like serine/ | no | no | 0.900 | 0.726 | 0.330 | 1e-127 | |
| Q9M2Z1 | 1002 | Leucine-rich repeat recep | no | no | 0.867 | 0.872 | 0.341 | 1e-122 | |
| O49545 | 1003 | Leucine-rich repeat recep | no | no | 0.865 | 0.869 | 0.340 | 1e-120 | |
| Q9SHI2 | 1101 | Leucine-rich repeat recep | no | no | 0.892 | 0.817 | 0.329 | 1e-120 |
| >sp|C0LGP4|Y3475_ARATH Probable LRR receptor-like serine/threonine-protein kinase At3g47570 OS=Arabidopsis thaliana GN=At3g47570 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 838 bits (2164), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 463/994 (46%), Positives = 643/994 (64%), Gaps = 28/994 (2%)
Query: 10 EDGDRAALQAFKSMIAHEPQGILNSWNDSRHFCEWEGITCGRRHRRVTALDLMSKSLSGS 69
++ DR AL FKS ++ + + +L+SWN S C W+G+TCGR+++RVT L+L L G
Sbjct: 22 DETDRQALLQFKSQVSEDKRVVLSSWNHSFPLCNWKGVTCGRKNKRVTHLELGRLQLGGV 81
Query: 70 LSPHLGNLSFLREINLSNNTIQGEIPPEFGRLFRLEALFLSNNSLVGKIPANLSYCSRLT 129
+SP +GNLSFL ++L N G IP E G+L RLE L + N L G IP L CSRL
Sbjct: 82 ISPSIGNLSFLVSLDLYENFFGGTIPQEVGQLSRLEYLDMGINYLRGPIPLGLYNCSRLL 141
Query: 130 VLCIEYNKLQGRIPLEFVSLSKLKDLSLAKNKLTGGIPPFLGNLTSLEVLSLAGNSFGRN 189
L ++ N+L G +P E SL+ L L+L N + G +P LGNLT LE L+L+ N+
Sbjct: 142 NLRLDSNRLGGSVPSELGSLTNLVQLNLYGNNMRGKLPTSLGNLTLLEQLALSHNNLEGE 201
Query: 190 IPDSLGQLKQLKILAIGGNNLSGPIPPSIYNLSFLVVFSVSHNQIHGSLPPSLGLLLPNL 249
IP + QL Q+ L + NN SG PP++YNLS L + + +N G L P LG+LLPNL
Sbjct: 202 IPSDVAQLTQIWSLQLVANNFSGVFPPALYNLSSLKLLGIGYNHFSGRLRPDLGILLPNL 261
Query: 250 KFFQIHHNFFSGSIPISLSNASKLEHIEIANNNFSGKLSVNFGGMKNLSLLNLQFSNLGS 309
F + N+F+GSIP +LSN S LE + + NN +G + FG + NL LL L ++LGS
Sbjct: 262 LSFNMGGNYFTGSIPTTLSNISTLERLGMNENNLTGSIPT-FGNVPNLKLLFLHTNSLGS 320
Query: 310 GESDEMGFMNSLTNCSKLRVLSLGGNQFRGALPHSIANLSSQLQILILSSNQFYGSIPLG 369
S ++ F+ SLTNC++L L +G N+ G LP SIANLS++L L L GSIP
Sbjct: 321 DSSRDLEFLTSLTNCTQLETLGIGRNRLGGDLPISIANLSAKLVTLDLGGTLISGSIPYD 380
Query: 370 IGNLVDLYLLGMVENQFTGAIPKEMGKLQKLQGLDFSGNHFSGEIPSSLGNLSSLYEVFF 429
IGNL++L L + +N +G +P +GKL L+ L N SG IP+ +GN++ L +
Sbjct: 381 IGNLINLQKLILDQNMLSGPLPTSLGKLLNLRYLSLFSNRLSGGIPAFIGNMTMLETLDL 440
Query: 430 NNNNLSGVIPFSLGNLKRLAFLEMSGNELSGTIPEDIFNISYLSNSLNLARNHLVGIIPP 489
+NN G++P SLGN L L + N+L+GTIP +I I L L+++ N L+G +P
Sbjct: 441 SNNGFEGIVPTSLGNCSHLLELWIGDNKLNGTIPLEIMKIQQLLR-LDMSGNSLIGSLPQ 499
Query: 490 RIGNLRALRSFDVSNNDLSGEIPIELGHCSSLEEIYLAGNLFHGSIPSFFNALKGVQKID 549
IG L+ L + + +N LSG++P LG+C ++E ++L GNLF+G IP L GV+++D
Sbjct: 500 DIGALQNLGTLSLGDNKLSGKLPQTLGNCLTMESLFLEGNLFYGDIPD-LKGLVGVKEVD 558
Query: 550 LSRNNLSGQIPIFLEALS-LEYLNLSFNDFEGKIPAKGIFANASAISVVGCNRLCGGIPE 608
LS N+LSG IP + + S LEYLNLSFN+ EGK+P KGIF NA+ +S+VG N LCGGI
Sbjct: 559 LSNNDLSGSIPEYFASFSKLEYLNLSFNNLEGKVPVKGIFENATTVSIVGNNDLCGGIMG 618
Query: 609 LQLPKC-TESKSSSQKISRRLKIII----SAITAFSGFFMVSFFILYWHKWRRGPSRLPS 663
QL C +++ S +K S RLK ++ IT FM S +++ K ++
Sbjct: 619 FQLKPCLSQAPSVVKKHSSRLKKVVIGVSVGITLLLLLFMASVTLIWLRKRKKNKETNNP 678
Query: 664 RPMMRKAL-PKMSYKSLLKATNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCE 722
P + L K+SY L ATNGFSS++++G GSFG VYK L + VVA+KV+N+Q
Sbjct: 679 TPSTLEVLHEKISYGDLRNATNGFSSSNMVGSGSFGTVYKALLLTEKKVVAVKVLNMQRR 738
Query: 723 GASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAV 782
GA KSFMAEC++LK+IRHRNLVK++T+CSSIDFQGN+F+A++YE+MPNGSL+ WLHP V
Sbjct: 739 GAMKSFMAECESLKDIRHRNLVKLLTACSSIDFQGNEFRALIYEFMPNGSLDMWLHPEEV 798
Query: 783 PKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGD 842
+ + LTLL+R++IAIDVAS LDYLH HC EPI HCDLKPSN+LLD+DL+ H+ D
Sbjct: 799 EEIHRPSR-TLTLLERLNIAIDVASVLDYLHVHCHEPIAHCDLKPSNVLLDDDLTAHVSD 857
Query: 843 FGLAR----FHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT 898
FGLAR F +E + LSS+ GV+GTIGY APEYG+G + S NGDVYS+GILLLEM T
Sbjct: 858 FGLARLLLKFDEESFFNQLSSA-GVRGTIGYAAPEYGVGGQPSINGDVYSFGILLLEMFT 916
Query: 899 AKKPTDVMFEGDLNLHNFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLE 958
K+PT+ +F G+ L+++ + ALP +++DIV DE IL ++ G +E
Sbjct: 917 GKRPTNELFGGNFTLNSYTKSALPERILDIV------DESILHIG-----LRVGF-PVVE 964
Query: 959 CLISMVKIGVACSMESPQDRMNMTNVVHELQSVK 992
CL + ++G+ C ESP +R+ + VV EL S++
Sbjct: 965 CLTMVFEVGLRCCEESPMNRLATSIVVKELISIR 998
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9SD62|Y3471_ARATH Putative receptor-like protein kinase At3g47110 OS=Arabidopsis thaliana GN=At3g47110 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 753 bits (1944), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 460/995 (46%), Positives = 620/995 (62%), Gaps = 27/995 (2%)
Query: 10 EDGDRAALQAFKSMIAHEPQGILNSWNDSRHFCEWEGITCGRRHRRVTALDLMSKSLSGS 69
E+ D+ AL FKS ++ + +L SWNDS C W G+ CG +HRRVT +DL L+G
Sbjct: 37 EETDKQALLEFKSQVSETSRVVLGSWNDSLPLCSWTGVKCGLKHRRVTGVDLGGLKLTGV 96
Query: 70 LSPHLGNLSFLREINLSNNTIQGEIPPEFGRLFRLEALFLSNNSLVGKIPANLSYCSRLT 129
+SP +GNLSFLR +NL++N G IP E G LFRL+ L +SNN G IP LS CS L+
Sbjct: 97 VSPFVGNLSFLRSLNLADNFFHGAIPSEVGNLFRLQYLNMSNNLFGGVIPVVLSNCSSLS 156
Query: 130 VLCIEYNKLQGRIPLEFVSLSKLKDLSLAKNKLTGGIPPFLGNLTSLEVLSLAGNSFGRN 189
L + N L+ +PLEF SLSKL LSL +N LTG P LGNLTSL++L N
Sbjct: 157 TLDLSSNHLEQGVPLEFGSLSKLVLLSLGRNNLTGKFPASLGNLTSLQMLDFIYNQIEGE 216
Query: 190 IPDSLGQLKQLKILAIGGNNLSGPIPPSIYNLSFLVVFSVSHNQIHGSLPPSLGLLLPNL 249
IP + +LKQ+ I N +G PP IYNLS L+ S++ N G+L P G LLPNL
Sbjct: 217 IPGDIARLKQMIFFRIALNKFNGVFPPPIYNLSSLIFLSITGNSFSGTLRPDFGSLLPNL 276
Query: 250 KFFQIHHNFFSGSIPISLSNASKLEHIEIANNNFSGKLSVNFGGMKNLSLLNLQFSNLGS 309
+ + N F+G+IP +LSN S L ++I +N+ +GK+ ++FG ++NL LL L ++LG+
Sbjct: 277 QILYMGINSFTGTIPETLSNISSLRQLDIPSNHLTGKIPLSFGRLQNLLLLGLNNNSLGN 336
Query: 310 GESDEMGFMNSLTNCSKLRVLSLGGNQFRGALPHSIANLSSQLQILILSSNQFYGSIPLG 369
S ++ F+ +LTNCS+L+ L++G N+ G LP IANLS+QL L L N GSIP G
Sbjct: 337 YSSGDLDFLGALTNCSQLQYLNVGFNKLGGQLPVFIANLSTQLTELSLGGNLISGSIPHG 396
Query: 370 IGNLVDLYLLGMVENQFTGAIPKEMGKLQKLQGLDFSGNHFSGEIPSSLGNLSSLYEVFF 429
IGNLV L L + EN TG +P +G+L +L+ + N SGEIPSSLGN+S L ++
Sbjct: 397 IGNLVSLQTLDLGENLLTGKLPPSLGELSELRKVLLYSNGLSGEIPSSLGNISGLTYLYL 456
Query: 430 NNNNLSGVIPFSLGNLKRLAFLEMSGNELSGTIPEDIFNISYLSNSLNLARNHLVGIIPP 489
NN+ G IP SLG+ L L + N+L+G+IP ++ + L LN++ N LVG +
Sbjct: 457 LNNSFEGSIPSSLGSCSYLLDLNLGTNKLNGSIPHELMELPSLV-VLNVSFNLLVGPLRQ 515
Query: 490 RIGNLRALRSFDVSNNDLSGEIPIELGHCSSLEEIYLAGNLFHGSIPSFFNALKGVQKID 549
IG L+ L + DVS N LSG+IP L +C SLE + L GN F G IP L G++ +D
Sbjct: 516 DIGKLKFLLALDVSYNKLSGQIPQTLANCLSLEFLLLQGNSFVGPIPD-IRGLTGLRFLD 574
Query: 550 LSRNNLSGQIPIFLEALS-LEYLNLSFNDFEGKIPAKGIFANASAISVVGCNRLCGGIPE 608
LS+NNLSG IP ++ S L+ LNLS N+F+G +P +G+F N SA+SV G LCGGIP
Sbjct: 575 LSKNNLSGTIPEYMANFSKLQNLNLSLNNFDGAVPTEGVFRNTSAMSVFGNINLCGGIPS 634
Query: 609 LQLPKCT-ESKSSSQKISRRLKIIISAITAFSGFFMVSFFILYWHKWRRGPSRLPSRPMM 667
LQL C+ E + + + I +SA+ A + L W+K R R +
Sbjct: 635 LQLQPCSVELPRRHSSVRKIITICVSAVMAALLLLCLCVVYLCWYKLRVKSVRANNNEND 694
Query: 668 RKALP------KMSYKSLLKATNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC 721
R P K+SY L K T GFSS++LIG G+FG V+KG L VAIKV+NL
Sbjct: 695 RSFSPVKSFYEKISYDELYKTTGGFSSSNLIGSGNFGAVFKGFLGSKNKAVAIKVLNLCK 754
Query: 722 EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHA 781
GA+KSF+AEC+AL IRHRNLVK++T CSS DF+GNDF+A+VYE+MPNG+L+ WLHP
Sbjct: 755 RGAAKSFIAECEALGGIRHRNLVKLVTICSSSDFEGNDFRALVYEFMPNGNLDMWLHPDE 814
Query: 782 VPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIG 841
+ + L L R++IAIDVASAL YLH +C PI HCD+KPSNILLD DL+ H+
Sbjct: 815 IEETGNPSR-TLGLFARLNIAIDVASALVYLHTYCHNPIAHCDIKPSNILLDKDLTAHVS 873
Query: 842 DFGLARFHQEVSNSTLS---SSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT 898
DFGLA+ + T SS GV+GTIGY APEYG+G S GDVYS+GI+LLE+ T
Sbjct: 874 DFGLAQLLLKFDRDTFHIQFSSAGVRGTIGYAAPEYGMGGHPSIMGDVYSFGIVLLEIFT 933
Query: 899 AKKPTDVMFEGDLNLHNFARMAL-PNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRL 957
K+PT+ +F L LH+F + AL Q +DI DE IL R + +
Sbjct: 934 GKRPTNKLFVDGLTLHSFTKSALQKRQALDIT------DETIL------RGAYAQHFNMV 981
Query: 958 ECLISMVKIGVACSMESPQDRMNMTNVVHELQSVK 992
ECL + ++GV+CS ESP +R++M + +L S++
Sbjct: 982 ECLTLVFRVGVSCSEESPVNRISMAEAISKLVSIR 1016
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGT6|EFR_ARATH LRR receptor-like serine/threonine-protein kinase EFR OS=Arabidopsis thaliana GN=EFR PE=1 SV=1 | Back alignment and function description |
|---|
Score = 745 bits (1923), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 434/1014 (42%), Positives = 611/1014 (60%), Gaps = 45/1014 (4%)
Query: 11 DGDRAALQAFKSMIA-HEPQGILNSWNDSRHFCEWEGITCGRRHRRVTALDLMSKSLSGS 69
+ D AL FKS ++ + + +L SWN S FC W G+TCGRR RV +L+L L+G
Sbjct: 29 ETDMQALLEFKSQVSENNKREVLASWNHSSPFCNWIGVTCGRRRERVISLNLGGFKLTGV 88
Query: 70 LSPHLGNLSFLREINLSNNTIQGEIPPEFGRLFRLEALFLSNNSLVGKIPANLSYCSRLT 129
+SP +GNLSFLR +NL++N+ IP + GRLFRL+ L +S N L G+IP++LS CSRL+
Sbjct: 89 ISPSIGNLSFLRLLNLADNSFGSTIPQKVGRLFRLQYLNMSYNLLEGRIPSSLSNCSRLS 148
Query: 130 VLCIEYNKLQGRIPLEFVSLSKLKDLSLAKNKLTGGIPPFLGNLTSLEVLSLAGNSFGRN 189
+ + N L +P E SLSKL L L+KN LTG P LGNLTSL+ L A N
Sbjct: 149 TVDLSSNHLGHGVPSELGSLSKLAILDLSKNNLTGNFPASLGNLTSLQKLDFAYNQMRGE 208
Query: 190 IPDSLGQLKQLKILAIGGNNLSGPIPPSIYNLSFLVVFSVSHNQIHGSLPPSLGLLLPNL 249
IPD + +L Q+ I N+ SG PP++YN+S L S++ N G+L G LLPNL
Sbjct: 209 IPDEVARLTQMVFFQIALNSFSGGFPPALYNISSLESLSLADNSFSGNLRADFGYLLPNL 268
Query: 250 KFFQIHHNFFSGSIPISLSNASKLEHIEIANNNFSGKLSVNFGGMKNLSLLNLQFSNLGS 309
+ + N F+G+IP +L+N S LE +I++N SG + ++FG ++NL L ++ ++LG+
Sbjct: 269 RRLLLGTNQFTGAIPKTLANISSLERFDISSNYLSGSIPLSFGKLRNLWWLGIRNNSLGN 328
Query: 310 GESDEMGFMNSLTNCSKLRVLSLGGNQFRGALPHSIANLSSQLQILILSSNQFYGSIPLG 369
S + F+ ++ NC++L L +G N+ G LP SIANLS+ L L L N G+IP
Sbjct: 329 NSSSGLEFIGAVANCTQLEYLDVGYNRLGGELPASIANLSTTLTSLFLGQNLISGTIPHD 388
Query: 370 IGNLVDLYLLGMVENQFTGAIPKEMGKLQKLQGLDFSGNHFSGEIPSSLGNLSSLYEVFF 429
IGNLV L L + N +G +P GKL LQ +D N SGEIPS GN++ L ++
Sbjct: 389 IGNLVSLQELSLETNMLSGELPVSFGKLLNLQVVDLYSNAISGEIPSYFGNMTRLQKLHL 448
Query: 430 NNNNLSGVIPFSLGNLKRLAFLEMSGNELSGTIPEDIFNISYLSNSLNLARNHLVGIIPP 489
N+N+ G IP SLG + L L M N L+GTIP++I I L+ ++L+ N L G P
Sbjct: 449 NSNSFHGRIPQSLGRCRYLLDLWMDTNRLNGTIPQEILQIPSLA-YIDLSNNFLTGHFPE 507
Query: 490 RIGNLRALRSFDVSNNDLSGEIPIELGHCSSLEEIYLAGNLFHGSIPSFFNALKGVQKID 549
+G L L S N LSG++P +G C S+E +++ GN F G+IP + L ++ +D
Sbjct: 508 EVGKLELLVGLGASYNKLSGKMPQAIGGCLSMEFLFMQGNSFDGAIPD-ISRLVSLKNVD 566
Query: 550 LSRNNLSGQIPIFLEAL-SLEYLNLSFNDFEGKIPAKGIFANASAISVVGCNRLCGGIPE 608
S NNLSG+IP +L +L SL LNLS N FEG++P G+F NA+A+SV G +CGG+ E
Sbjct: 567 FSNNNLSGRIPRYLASLPSLRNLNLSMNKFEGRVPTTGVFRNATAVSVFGNTNICGGVRE 626
Query: 609 LQLPKCTESKSSSQK--ISRRLKIIISAITAFSGFFMVSFFI-LYWHKWRR--------G 657
+QL C S ++ +S R K++ + ++ L W R+
Sbjct: 627 MQLKPCIVQASPRKRKPLSVRKKVVSGICIGIASLLLIIIVASLCWFMKRKKKNNASDGN 686
Query: 658 PSRLPSRPMMRKALPKMSYKSLLKATNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVI 717
PS + M + K+SY+ L AT+ FSST+LIG G+FG V+KG L + +VA+KV+
Sbjct: 687 PSDSTTLGMFHE---KVSYEELHSATSRFSSTNLIGSGNFGNVFKGLLGPENKLVAVKVL 743
Query: 718 NLQCEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWL 777
NL GA+KSFMAEC+ K IRHRNLVK+IT CSS+D +GNDF+A+VYE+MP GSL+ WL
Sbjct: 744 NLLKHGATKSFMAECETFKGIRHRNLVKLITVCSSLDSEGNDFRALVYEFMPKGSLDMWL 803
Query: 778 HPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLS 837
+ +R + LT ++++IAIDVASAL+YLH HC +P+ HCD+KPSNILLD+DL+
Sbjct: 804 QLEDL-ERVNDHSRSLTPAEKLNIAIDVASALEYLHVHCHDPVAHCDIKPSNILLDDDLT 862
Query: 838 GHIGDFGLARFHQEVSNSTL---SSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLL 894
H+ DFGLA+ + + SS GV+GTIGY APEYG+G + S GDVYS+GILLL
Sbjct: 863 AHVSDFGLAQLLYKYDRESFLNQFSSAGVRGTIGYAAPEYGMGGQPSIQGDVYSFGILLL 922
Query: 895 EMVTAKKPTDVMFEGDLNLHNFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGIN 954
EM + KKPTD F GD NLH++ + L C G N
Sbjct: 923 EMFSGKKPTDESFAGDYNLHSYTKSILSG----------------------CTS-SGGSN 959
Query: 955 SRLECLISMVKIGVACSMESPQDRMNMTNVVHELQSVKNILLELETVFNKQTEN 1008
+ E L ++++G+ CS E P+DRM V EL S+++ +T + +
Sbjct: 960 AIDEGLRLVLQVGIKCSEEYPRDRMRTDEAVRELISIRSKFFSSKTTITESPRD 1013
|
Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of elongation factor Tu (EF-Tu), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Reduces transformation by Rhizobium radiobacter probably by inducing plant defense during the interaction. Binding to the effector AvrPto1 from P.syringae blocks the downstream plant immune response. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FL28|FLS2_ARATH LRR receptor-like serine/threonine-protein kinase FLS2 OS=Arabidopsis thaliana GN=FLS2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 483 bits (1242), Expect = e-135, Method: Compositional matrix adjust.
Identities = 344/997 (34%), Positives = 518/997 (51%), Gaps = 113/997 (11%)
Query: 66 LSGSLSPHLGNLSFLREINLSNNTIQGEIPPEFGRLFRLEALFLSNNSLVGKIPANLSYC 125
L+GS+ +G L+ L +++LS N + G+IP +FG L L++L L+ N L G IPA + C
Sbjct: 204 LTGSIPVSIGTLANLTDLDLSGNQLTGKIPRDFGNLLNLQSLVLTENLLEGDIPAEIGNC 263
Query: 126 SRLTVLCIEYNKLQGRIPLEFVSLSKLKDLSLAKNKLTGGIPPFLGNLTSLEVLSLAGNS 185
S L L + N+L G+IP E +L +L+ L + KNKLT IP L LT L L L+ N
Sbjct: 264 SSLVQLELYDNQLTGKIPAELGNLVQLQALRIYKNKLTSSIPSSLFRLTQLTHLGLSENH 323
Query: 186 FGRNIPDSLGQLKQLKILAIGGNNLSGPIPPSIYNLSFLVVFSVSHNQIHGSLPPSLGLL 245
I + +G L+ L++L + NN +G P SI NL L V +V N I G LP LG L
Sbjct: 324 LVGPISEEIGFLESLEVLTLHSNNFTGEFPQSITNLRNLTVLTVGFNNISGELPADLG-L 382
Query: 246 LPNLKFFQIHHNFFSGSIPISLSNASKLEHIEIANNNFSGKLSVNFGGMKNLSLLNLQFS 305
L NL+ H N +G IP S+SN + L+ +++++N +G++ FG M NL F
Sbjct: 383 LTNLRNLSAHDNLLTGPIPSSISNCTGLKLLDLSHNQMTGEIPRGFGRM------NLTFI 436
Query: 306 NLG----SGESDEMGFMNSLTNCSKLRVLSLGGNQFRGALPHSIANLSSQLQILILSSNQ 361
++G +GE + + NCS L LS+ N G L I L +L+IL +S N
Sbjct: 437 SIGRNHFTGE-----IPDDIFNCSNLETLSVADNNLTGTLKPLIGKL-QKLRILQVSYNS 490
Query: 362 FYGSIPLGIGNLVDLYLLGMVENQFTGAIPKEMGKLQKLQG------------------- 402
G IP IGNL DL +L + N FTG IP+EM L LQG
Sbjct: 491 LTGPIPREIGNLKDLNILYLHSNGFTGRIPREMSNLTLLQGLRMYSNDLEGPIPEEMFDM 550
Query: 403 -----LDFSGNHFSGEIPSSLGNLSSLYEVFFNNNNLSGVIPFSLGNLKRLAFLEMSGNE 457
LD S N FSG+IP+ L SL + N +G IP SL +L L ++S N
Sbjct: 551 KLLSVLDLSNNKFSGQIPALFSKLESLTYLSLQGNKFNGSIPASLKSLSLLNTFDISDNL 610
Query: 458 LSGTIPEDIF-NISYLSNSLNLARNHLVGIIPPRIGNLRALRSFDVSNNDLSGEIPIELG 516
L+GTIP ++ ++ + LN + N L G IP +G L ++ D+SNN SG IP L
Sbjct: 611 LTGTIPGELLASLKNMQLYLNFSNNLLTGTIPKELGKLEMVQEIDLSNNLFSGSIPRSLQ 670
Query: 517 HCSSL---------------EEIY----------LAGNLFHGSIPSFFNALKGVQKIDLS 551
C ++ +E++ L+ N F G IP F + + +DLS
Sbjct: 671 ACKNVFTLDFSQNNLSGHIPDEVFQGMDMIISLNLSRNSFSGEIPQSFGNMTHLVSLDLS 730
Query: 552 RNNLSGQIPIFLEALS-LEYLNLSFNDFEGKIPAKGIFANASAISVVGCNRLCGGIPELQ 610
NNL+G+IP L LS L++L L+ N+ +G +P G+F N +A ++G LCG L+
Sbjct: 731 SNNLTGEIPESLANLSTLKHLKLASNNLKGHVPESGVFKNINASDLMGNTDLCGSKKPLK 790
Query: 611 LPKCTESKSSSQKISRRLKIIISAITAFSGFFMVSFFILYWHKW--------RRGPSRLP 662
CT + SS S+R ++I+ + + + +V +L S LP
Sbjct: 791 --PCTIKQKSSH-FSKRTRVILIILGSAAALLLVLLLVLILTCCKKKEKKIENSSESSLP 847
Query: 663 SRPMMRKALPKMSYKSLLKATNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQ-- 720
K L + K L +AT+ F+S ++IG S VYKG L EDG V+A+KV+NL+
Sbjct: 848 DLDSALK-LKRFEPKELEQATDSFNSANIIGSSSLSTVYKGQL-EDGTVIAVKVLNLKEF 905
Query: 721 CEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPH 780
+ K F E K L ++HRNLVK++ ++ KA+V +M NG+LE +H
Sbjct: 906 SAESDKWFYTEAKTLSQLKHRNLVKIL----GFAWESGKTKALVLPFMENGNLEDTIHGS 961
Query: 781 AVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHI 840
A P +LL++I + + +AS +DYLH PI+HCDLKP+NILLD+D H+
Sbjct: 962 AAPIG--------SLLEKIDLCVHIASGIDYLHSGYGFPIVHCDLKPANILLDSDRVAHV 1013
Query: 841 GDFGLAR---FHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMV 897
DFG AR F ++ ST +S+ +GTIGY APE+ +V+T DV+S+GI+++E++
Sbjct: 1014 SDFGTARILGFRED--GSTTASTSAFEGTIGYLAPEFAYMRKVTTKADVFSFGIIMMELM 1071
Query: 898 TAKKPTDVMFEG--DLNLHNFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINS 955
T ++PT + E D+ L ++ N +V + D E+ S ++
Sbjct: 1072 TKQRPTSLNDEDSQDMTLRQLVEKSIGNGRKGMVRVL---DMELGDSIVSLKQE------ 1122
Query: 956 RLECLISMVKIGVACSMESPQDRMNMTNVVHELQSVK 992
E + +K+ + C+ P+DR +M ++ L ++
Sbjct: 1123 --EAIEDFLKLCLFCTSSRPEDRPDMNEILTHLMKLR 1157
|
Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of flagellin (flg22), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Flagellin-binding to the receptor is the first step to initiate the innate immune MAP kinase signaling cascade (MEKK1, MKK4/MKK5 and MPK3/MPK6), resulting in enhanced resistance against pathogens. Binding to the effector AvrPto1 from Pseudomonas syringae blocks the downstream plant immune response. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FIZ3|GSO2_ARATH LRR receptor-like serine/threonine-protein kinase GSO2 OS=Arabidopsis thaliana GN=GSO2 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 461 bits (1186), Expect = e-128, Method: Compositional matrix adjust.
Identities = 338/1019 (33%), Positives = 521/1019 (51%), Gaps = 126/1019 (12%)
Query: 52 RHRRVTALDLMSKSLSGSLSPHLGNLSFLREINLSNNTIQGEIPPEFGRLFRLEALFLSN 111
R + + L+L S SG + LG+L ++ +NL N +QG IP L L+ L LS+
Sbjct: 238 RLKNLQTLNLGDNSFSGEIPSQLGDLVSIQYLNLIGNQLQGLIPKRLTELANLQTLDLSS 297
Query: 112 NSLVGKIPANLSYCSRLTVLCIEYNKLQGRIPLEFVSL-SKLKDLSLAKNKLTGGIPPFL 170
N+L G I ++L L + N+L G +P S + LK L L++ +L+G IP +
Sbjct: 298 NNLTGVIHEEFWRMNQLEFLVLAKNRLSGSLPKTICSNNTSLKQLFLSETQLSGEIPAEI 357
Query: 171 GNLTSLEVLSLAGNSFGRNIPDSLGQLKQLKILAIGGNNLSGPIPPSIYNLSFLVVFSVS 230
N SL++L L+ N+ IPDSL QL +L L + N+L G + SI NL+ L F++
Sbjct: 358 SNCQSLKLLDLSNNTLTGQIPDSLFQLVELTNLYLNNNSLEGTLSSSISNLTNLQEFTLY 417
Query: 231 HNQIHGSLPPSLGLLLPNLKFFQIHHNFFSGSIPISLSNASKLEHIEIANNNFSGKLSVN 290
HN + G +P +G L L+ ++ N FSG +P+ + N ++L+ I+ N SG++ +
Sbjct: 418 HNNLEGKVPKEIGFL-GKLEIMYLYENRFSGEMPVEIGNCTRLQEIDWYGNRLSGEIPSS 476
Query: 291 FGGMKNLSLLNLQFSNLGSGESDEMGFM-NSLTNCSKLRVLSLGGNQFRGALPHSIANLS 349
G +K+L+ L+L+ E++ +G + SL NC ++ V+ L NQ G++P S L+
Sbjct: 477 IGRLKDLTRLHLR-------ENELVGNIPASLGNCHQMTVIDLADNQLSGSIPSSFGFLT 529
Query: 350 SQLQILI-----------------------LSSNQFYGSI-------------------- 366
+ +I SSN+F GSI
Sbjct: 530 ALELFMIYNNSLQGNLPDSLINLKNLTRINFSSNKFNGSISPLCGSSSYLSFDVTENGFE 589
Query: 367 ---PLGIGNLVDLYLLGMVENQFTGAIPKEMGKLQKLQGLDFSGNHFSGEIPSSLGNLSS 423
PL +G +L L + +NQFTG IP+ GK+ +L LD S N SG IP LG
Sbjct: 590 GDIPLELGKSTNLDRLRLGKNQFTGRIPRTFGKISELSLLDISRNSLSGIIPVELGLCKK 649
Query: 424 LYEVFFNNNNLSGVIPFSLGNLKRLAFLEMS------------------------GNELS 459
L + NNN LSGVIP LG L L L++S GN L+
Sbjct: 650 LTHIDLNNNYLSGVIPTWLGKLPLLGELKLSSNKFVGSLPTEIFSLTNILTLFLDGNSLN 709
Query: 460 GTIPEDIFNISYLSNSLNLARNHLVGIIPPRIGNLRALRSFDVSNNDLSGEIPIELGHCS 519
G+IP++I N+ L N+LNL N L G +P IG L L +S N L+GEIP+E+G
Sbjct: 710 GSIPQEIGNLQAL-NALNLEENQLSGPLPSTIGKLSKLFELRLSRNALTGEIPVEIGQLQ 768
Query: 520 SLEE-IYLAGNLFHGSIPSFFNALKGVQKIDLSRNNLSGQIPIFL-EALSLEYLNLSFND 577
L+ + L+ N F G IPS + L ++ +DLS N L G++P + + SL YLNLS+N+
Sbjct: 769 DLQSALDLSYNNFTGRIPSTISTLPKLESLDLSHNQLVGEVPGQIGDMKSLGYLNLSYNN 828
Query: 578 FEGKIPAKGIFANASAISVVGCNRLCGGIPELQLPKCTESKSSSQK-ISRRLKIIISAIT 636
EGK+ K F+ A + VG LCG L C + S +Q+ +S + +IISAI+
Sbjct: 829 LEGKL--KKQFSRWQADAFVGNAGLCGS----PLSHCNRAGSKNQRSLSPKTVVIISAIS 882
Query: 637 AFSGF-FMVSFFILYWH------KWRRGPSRLPSRPMMRKALPKMS---------YKSLL 680
+ + MV IL++ K RG + S P S + ++
Sbjct: 883 SLAAIALMVLVIILFFKQNHDLFKKVRGGNSAFSSNSSSSQAPLFSNGGAKSDIKWDDIM 942
Query: 681 KATNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGAS-KSFMAECKALKNIR 739
+AT+ + +IG G G VYK L ++G +A+K I + + S KSF E K L IR
Sbjct: 943 EATHYLNEEFMIGSGGSGKVYKAEL-KNGETIAVKKILWKDDLMSNKSFNREVKTLGTIR 1001
Query: 740 HRNLVKVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRI 799
HR+LVK++ CSS + + ++YEYM NGS+ WLH + K+ KE+ L R+
Sbjct: 1002 HRHLVKLMGYCSS---KADGLNLLIYEYMANGSVWDWLHANENTKK-KEV---LGWETRL 1054
Query: 800 SIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSS 859
IA+ +A ++YLH+ C PI+H D+K SN+LLD+++ H+GDFGLA+ ++ S
Sbjct: 1055 KIALGLAQGVEYLHYDCVPPIVHRDIKSSNVLLDSNIEAHLGDFGLAKILTGNYDTNTES 1114
Query: 860 SVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARM 919
+ G+ GY APEY + + DVYS GI+L+E+VT K PT+ MF+ + ++ +
Sbjct: 1115 NTMFAGSYGYIAPEYAYSLKATEKSDVYSMGIVLMEIVTGKMPTEAMFDEETDMVRWVET 1174
Query: 920 ALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDR 978
L P E+++ S +++ + E +++I + C+ PQ+R
Sbjct: 1175 VLD------TPPGSEAREKLIDS-----ELKSLLPCEEEAAYQVLEIALQCTKSYPQER 1222
|
Together with GSO1, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Involved in the nuclear division phase of megagametogenesis. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZUI0|Y2241_ARATH Putative leucine-rich repeat receptor-like serine/threonine-protein kinase At2g24130 OS=Arabidopsis thaliana GN=At2g24130 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 461 bits (1186), Expect = e-128, Method: Compositional matrix adjust.
Identities = 323/925 (34%), Positives = 503/925 (54%), Gaps = 77/925 (8%)
Query: 125 CSRLTVLCIEYN----KLQGRIPLEFVSLSKLKDLSLAKNKLTGGIPPFLGNL-TSLEVL 179
C++ + IE + L G I +L+ L L L++N G IPP +G+L +L+ L
Sbjct: 61 CNKESTQVIELDISGRDLGGEISPSIANLTGLTVLDLSRNFFVGKIPPEIGSLHETLKQL 120
Query: 180 SLAGNSFGRNIPDSLGQLKQLKILAIGGNNLSGPIPPSIY---NLSFLVVFSVSHNQIHG 236
SL+ N NIP LG L +L L +G N L+G IP ++ + S L +S+N + G
Sbjct: 121 SLSENLLHGNIPQELGLLNRLVYLDLGSNRLNGSIPVQLFCNGSSSSLQYIDLSNNSLTG 180
Query: 237 SLPPSLGLLLPNLKFFQIHHNFFSGSIPISLSNASKLEHIEIANNNFSGKL-SVNFGGMK 295
+P + L L+F + N +G++P SLSN++ L+ +++ +N SG+L S M
Sbjct: 181 EIPLNYHCHLKELRFLLLWSNKLTGTVPSSLSNSTNLKWMDLESNMLSGELPSQVISKMP 240
Query: 296 NLSLLNLQFSNLGS--GESDEMGFMNSLTNCSKLRVLSLGGNQFRGALPHSIANLSSQLQ 353
L L L +++ S ++ F SL N S L+ L L GN G + S+ +LS L
Sbjct: 241 QLQFLYLSYNHFVSHNNNTNLEPFFASLANSSDLQELELAGNSLGGEITSSVRHLSVNLV 300
Query: 354 ILILSSNQFYGSIPLGIGNLVDLYLLGMVENQFTGAIPKEMGKLQKLQGLDFSGNHFSGE 413
+ L N+ +GSIP I NL++L LL + N +G IP+E+ KL KL+ + S NH +GE
Sbjct: 301 QIHLDQNRIHGSIPPEISNLLNLTLLNLSSNLLSGPIPRELCKLSKLERVYLSNNHLTGE 360
Query: 414 IPSSLGNLSSLYEVFFNNNNLSGVIPFSLGNLKRLAFLEMSGNELSGTIP---------- 463
IP LG++ L + + NNLSG IP S GNL +L L + GN LSGT+P
Sbjct: 361 IPMELGDIPRLGLLDVSRNNLSGSIPDSFGNLSQLRRLLLYGNHLSGTVPQSLGKCINLE 420
Query: 464 ---------------EDIFNISYLSNSLNLARNHLVGIIPPRIGNLRALRSFDVSNNDLS 508
E + N+ L LNL+ NHL G IP + + + S D+S+N+LS
Sbjct: 421 ILDLSHNNLTGTIPVEVVSNLRNLKLYLNLSSNHLSGPIPLELSKMDMVLSVDLSSNELS 480
Query: 509 GEIPIELGHCSSLEEIYLAGNLFHGSIPSFFNALKGVQKIDLSRNNLSGQI-PIFLEALS 567
G+IP +LG C +LE + L+ N F ++PS L ++++D+S N L+G I P F ++ +
Sbjct: 481 GKIPPQLGSCIALEHLNLSRNGFSSTLPSSLGQLPYLKELDVSFNRLTGAIPPSFQQSST 540
Query: 568 LEYLNLSFNDFEGKIPAKGIFANASAISVVGCNRLCGGIPELQLPKCTESKSSSQKISRR 627
L++LN SFN G + KG F+ + S +G + LCG I +Q K + K S +
Sbjct: 541 LKHLNFSFNLLSGNVSDKGSFSKLTIESFLGDSLLCGSIKGMQACK-KKHKYPSVLLPVL 599
Query: 628 LKIIISAITAFSGFFMVSF------FILYWHKWRRGPSRLPSRPMMRKALPKMSYKSLLK 681
L +I + + G+ +V +Y + + + P++SY+ L+
Sbjct: 600 LSLIATPVLCVFGYPLVQRSRFGKNLTVYAKEEVEDEEK---QNQNDPKYPRISYQQLIA 656
Query: 682 ATNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCE-GASKSFMAECKALKNIRH 740
AT GF+++ LIG G FG VYKG L + VA+KV++ + S SF EC+ LK RH
Sbjct: 657 ATGGFNASSLIGSGRFGHVYKGVL-RNNTKVAVKVLDPKTALEFSGSFKRECQILKRTRH 715
Query: 741 RNLVKVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRIS 800
RNL+++IT+CS F A+V MPNGSLE+ L+P ++ L L+Q ++
Sbjct: 716 RNLIRIITTCSK-----PGFNALVLPLMPNGSLERHLYPGEYSSKN------LDLIQLVN 764
Query: 801 IAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSS 860
I DVA + YLHH+ ++HCDLKPSNILLD++++ + DFG++R Q V T+S+
Sbjct: 765 ICSDVAEGIAYLHHYSPVKVVHCDLKPSNILLDDEMTALVTDFGISRLVQGVE-ETVSTD 823
Query: 861 VGVK---------GTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDL 911
V G++GY APEYG+G ST+GDVYS+G+LLLE+V+ ++PTDV+
Sbjct: 824 DSVSFGSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVSGRRPTDVLVNEGS 883
Query: 912 NLHNFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACS 971
+LH F + P+ + I++ L + +KC ++ E ++ M+++G+ C+
Sbjct: 884 SLHEFMKSHYPDSLEGIIEQALSRWKP-QGKPEKCEKLWR------EVILEMIELGLVCT 936
Query: 972 MESPQDRMNMTNVVHELQSVKNILL 996
+P R +M +V HE+ +K L
Sbjct: 937 QYNPSTRPDMLDVAHEMGRLKEYLF 961
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGQ5|GSO1_ARATH LRR receptor-like serine/threonine-protein kinase GSO1 OS=Arabidopsis thaliana GN=GSO1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 457 bits (1175), Expect = e-127, Method: Compositional matrix adjust.
Identities = 325/982 (33%), Positives = 494/982 (50%), Gaps = 74/982 (7%)
Query: 56 VTALDLMSKSLSGSLSPHLGNLSFLREINLSNNTIQGEIPPEF-GRLFRLEALFLSNNSL 114
+ LDL + +L+G + N+S L ++ L+NN + G +P LE L LS L
Sbjct: 289 LQTLDLSANNLTGEIPEEFWNMSQLLDLVLANNHLSGSLPKSICSNNTNLEQLVLSGTQL 348
Query: 115 VGKIPANLSYCSRLTVLCIEYNKLQGRIPLEFVSLSKLKDLSLAKNKLTGGIPPFLGNLT 174
G+IP LS C L L + N L G IP L +L DL L N L G + P + NLT
Sbjct: 349 SGEIPVELSKCQSLKQLDLSNNSLAGSIPEALFELVELTDLYLHNNTLEGTLSPSISNLT 408
Query: 175 SLEVLSLAGNSFGRNIPDSLGQLKQLKILAIGGNNLSGPIPPSIYNLSFLVVFSVSHNQI 234
+L+ L L N+ +P + L++L++L + N SG IP I N + L + + N
Sbjct: 409 NLQWLVLYHNNLEGKLPKEISALRKLEVLFLYENRFSGEIPQEIGNCTSLKMIDMFGNHF 468
Query: 235 HGSLPPSLGLLLPNLKFFQIHHNFFSGSIPISLSNASKLEHIEIANNNFSGKLSVNFGGM 294
G +PPS+G L L + N G +P SL N +L +++A+N SG + +FG +
Sbjct: 469 EGEIPPSIGRL-KELNLLHLRQNELVGGLPASLGNCHQLNILDLADNQLSGSIPSSFGFL 527
Query: 295 KNLSLLNLQFSNLGSGESDEM-----------------GFMNSLTNCSKLRVLSLGGNQF 337
K L L L ++L D + G ++ L S + N F
Sbjct: 528 KGLEQLMLYNNSLQGNLPDSLISLRNLTRINLSHNRLNGTIHPLCGSSSYLSFDVTNNGF 587
Query: 338 RGALPHSIANLSSQLQILILSSNQFYGSIPLGIGNLVDLYLLGMVENQFTGAIPKEMGKL 397
+P + N S L L L NQ G IP +G + +L LL M N TG IP ++
Sbjct: 588 EDEIPLELGN-SQNLDRLRLGKNQLTGKIPWTLGKIRELSLLDMSSNALTGTIPLQLVLC 646
Query: 398 QKLQGLDFSGNHFSGEIPSSLGNLSSLYEVFFNNNNLSGVIPFSLGNLKRLAFLEMSGNE 457
+KL +D + N SG IP LG LS L E+ ++N +P L N +L L + GN
Sbjct: 647 KKLTHIDLNNNFLSGPIPPWLGKLSQLGELKLSSNQFVESLPTELFNCTKLLVLSLDGNS 706
Query: 458 LSGTIPEDIFNISYLSNSLNLARNHLVGIIPPRIGNLRALRSFDVSNNDLSGEIPIELGH 517
L+G+IP++I N+ L N LNL +N G +P +G L L +S N L+GEIP+E+G
Sbjct: 707 LNGSIPQEIGNLGAL-NVLNLDKNQFSGSLPQAMGKLSKLYELRLSRNSLTGEIPVEIGQ 765
Query: 518 CSSLEE-IYLAGNLFHGSIPSFFNALKGVQKIDLSRNNLSGQIPIFL-EALSLEYLNLSF 575
L+ + L+ N F G IPS L ++ +DLS N L+G++P + + SL YLN+SF
Sbjct: 766 LQDLQSALDLSYNNFTGDIPSTIGTLSKLETLDLSHNQLTGEVPGSVGDMKSLGYLNVSF 825
Query: 576 NDFEGKIPAKGIFANASAISVVGCNRLCGGIPELQLPKCTESKSSS--QKISRRLKIIIS 633
N+ GK+ K F+ A S +G LCG L +C +S++ Q +S R +IIS
Sbjct: 826 NNLGGKL--KKQFSRWPADSFLGNTGLCGS----PLSRCNRVRSNNKQQGLSARSVVIIS 879
Query: 634 AITAFSGFFMVSFFILYWHKWRRG-----------------PSRLPSRPMMRKALPK--M 674
AI+A + ++ I + K R S+ +P+ R K +
Sbjct: 880 AISALTAIGLMILVIALFFKQRHDFFKKVGHGSTAYTSSSSSSQATHKPLFRNGASKSDI 939
Query: 675 SYKSLLKATNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGAS-KSFMAECK 733
++ +++AT+ S +IG G G VYK L E+G VA+K I + + S KSF E K
Sbjct: 940 RWEDIMEATHNLSEEFMIGSGGSGKVYKAEL-ENGETVAVKKILWKDDLMSNKSFSREVK 998
Query: 734 ALKNIRHRNLVKVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKL 793
L IRHR+LVK++ CSS + ++YEYM NGS+ WLH P +K+ ++ L
Sbjct: 999 TLGRIRHRHLVKLMGYCSS---KSEGLNLLIYEYMKNGSIWDWLHEDK-PVLEKKKKL-L 1053
Query: 794 TLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVS 853
R+ IA+ +A ++YLHH C PI+H D+K SN+LLD+++ H+GDFGLA+ E
Sbjct: 1054 DWEARLRIAVGLAQGVEYLHHDCVPPIVHRDIKSSNVLLDSNMEAHLGDFGLAKVLTENC 1113
Query: 854 NSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNL 913
++ S+ + GY APEY + + DVYS GI+L+E+VT K PTD +F +
Sbjct: 1114 DTNTDSNTWFACSYGYIAPEYAYSLKATEKSDVYSMGIVLMEIVTGKMPTDSVFGAE--- 1170
Query: 914 HNFARMALPNQVMDIVDPILRNDEEILASTDKC--RRMQTGINSRLECLISMVKIGVACS 971
MD+V + + E ++ DK +++ + + +++I + C+
Sbjct: 1171 ------------MDMVRWVETHLEVAGSARDKLIDPKLKPLLPFEEDAACQVLEIALQCT 1218
Query: 972 MESPQDRMNMTNVVHELQSVKN 993
SPQ+R + L V N
Sbjct: 1219 KTSPQERPSSRQACDSLLHVYN 1240
|
Together with GSO2, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9M2Z1|BAME2_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase BAM2 OS=Arabidopsis thaliana GN=BAM2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 441 bits (1133), Expect = e-122, Method: Compositional matrix adjust.
Identities = 312/913 (34%), Positives = 470/913 (51%), Gaps = 39/913 (4%)
Query: 4 FQVAALEDGDRAALQAFKSMIAHEPQGILNSWNDSRHFCEWEGITCGRRHRRVTALDLMS 63
F VA A L S E +L SWN S FC W G+TC R VT+LDL
Sbjct: 19 FTVAKPITELHALLSLKSSFTIDEHSPLLTSWNLSTTFCSWTGVTCDVSLRHVTSLDLSG 78
Query: 64 KSLSGSLSPHLGNLSFLREINLSNNTIQGEIPPEFGRLFRLEALFLSNNSLVGKIPANLS 123
+LSG+LS + +L L+ ++L+ N I G IPP+ L+ L L LSNN G P LS
Sbjct: 79 LNLSGTLSSDVAHLPLLQNLSLAANQISGPIPPQISNLYELRHLNLSNNVFNGSFPDELS 138
Query: 124 Y-CSRLTVLCIEYNKLQGRIPLEFVSLSKLKDLSLAKNKLTGGIPPFLGNLTSLEVLSLA 182
L VL + N L G +P+ +L++L+ L L N +G IP G LE L+++
Sbjct: 139 SGLVNLRVLDLYNNNLTGDLPVSLTNLTQLRHLHLGGNYFSGKIPATYGTWPVLEYLAVS 198
Query: 183 GNSFGRNIPDSLGQLKQLKILAIG-GNNLSGPIPPSIYNLSFLVVFSVSHNQIHGSLPPS 241
GN IP +G L L+ L IG N +PP I NLS LV F ++ + G +PP
Sbjct: 199 GNELTGKIPPEIGNLTTLRELYIGYYNAFENGLPPEIGNLSELVRFDAANCGLTGEIPPE 258
Query: 242 LGLLLP-NLKFFQIHHNFFSGSIPISLSNASKLEHIEIANNNFSGKLSVNFGGMKNLSLL 300
+G L + F Q+ N F+G+I L S L+ ++++NN F+G++ +F +KNL+LL
Sbjct: 259 IGKLQKLDTLFLQV--NAFTGTITQELGLISSLKSMDLSNNMFTGEIPTSFSQLKNLTLL 316
Query: 301 NLQFSNLGSGESDEMGFMNSLTNCSKLRVLSLGGNQFRGALPHSIANLSSQLQILILSSN 360
NL + L + +G M +L VL L N F G++P + + +L IL LSSN
Sbjct: 317 NLFRNKLYGAIPEFIGEM------PELEVLQLWENNFTGSIPQKLGE-NGRLVILDLSSN 369
Query: 361 QFYGSIPLGIGNLVDLYLLGMVENQFTGAIPKEMGKLQKLQGLDFSGNHFSGEIPSSLGN 420
+ G++P + + L L + N G+IP +GK + L + N +G IP L
Sbjct: 370 KLTGTLPPNMCSGNRLMTLITLGNFLFGSIPDSLGKCESLTRIRMGENFLNGSIPKELFG 429
Query: 421 LSSLYEVFFNNNNLSGVIPFSLGNLK-RLAFLEMSGNELSGTIPEDIFNISYLSNSLNLA 479
L L +V +N L+G +P S G + L + +S N+LSG++P I N+S + L L
Sbjct: 430 LPKLSQVELQDNYLTGELPISGGGVSGDLGQISLSNNQLSGSLPAAIGNLSGVQKLL-LD 488
Query: 480 RNHLVGIIPPRIGNLRALRSFDVSNNDLSGEIPIELGHCSSLEEIYLAGNLFHGSIPSFF 539
N G IPP IG L+ L D S+N SG I E+ C L + L+ N G IP+
Sbjct: 489 GNKFSGSIPPEIGRLQQLSKLDFSHNLFSGRIAPEISRCKLLTFVDLSRNELSGDIPNEL 548
Query: 540 NALKGVQKIDLSRNNLSGQIPIFLEAL-SLEYLNLSFNDFEGKIPAKGIFANASAISVVG 598
+K + ++LSRN+L G IP+ + ++ SL ++ S+N+ G +P+ G F+ + S VG
Sbjct: 549 TGMKILNYLNLSRNHLVGSIPVTIASMQSLTSVDFSYNNLSGLVPSTGQFSYFNYTSFVG 608
Query: 599 CNRLCGGIPELQLPKCTESKSSSQKISRRLKIIISAITAFSGFFMVSFFILYWHKWRRGP 658
+ LCG P L +S + +S K+++ F I+ R
Sbjct: 609 NSHLCG--PYLGPCGKGTHQSHVKPLSATTKLLLVLGLLFCSMVFAIVAIIKARSLRNAS 666
Query: 659 SRLPSRPMMRKALPKMSYKSLLKATNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVIN 718
++ A ++ + + + ++IG G G VYKG + + G +VA+K +
Sbjct: 667 E---AKAWRLTAFQRLDF-TCDDVLDSLKEDNIIGKGGAGIVYKGTMPK-GDLVAVKRLA 721
Query: 719 LQCEGASKS--FMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKAIVYEYMPNGSLEKW 776
G+S F AE + L IRHR++V+++ CS+ ++ +VYEYMPNGSL +
Sbjct: 722 TMSHGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSN-----HETNLLVYEYMPNGSLGEV 776
Query: 777 LHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDL 836
LH K+ + R IA++ A L YLHH C I+H D+K +NILLD++
Sbjct: 777 LH----GKKGGHLHWN----TRYKIALEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSNF 828
Query: 837 SGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEM 896
H+ DFGLA+F Q+ S S++ G+ GY APEY +V DVYS+G++LLE+
Sbjct: 829 EAHVADFGLAKFLQDSGTSECMSAIA--GSYGYIAPEYAYTLKVDEKSDVYSFGVVLLEL 886
Query: 897 VTAKKPTDVMFEG 909
+T KKP +G
Sbjct: 887 ITGKKPVGEFGDG 899
|
Necessary for male gametophyte development, as well as ovule specification and function. Involved in cell-cell communication process required during early anther development, and regulating cell division and differentiation to organize cell layers. Required for the development of high-ordered vascular strands within the leaf and a correlated control of leaf shape, size and symmetry. May regulate the CLV1-dependent CLV3-mediated signaling in meristems maintenance. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O49545|BAME1_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase BAM1 OS=Arabidopsis thaliana GN=BAM1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 434 bits (1117), Expect = e-120, Method: Compositional matrix adjust.
Identities = 311/913 (34%), Positives = 473/913 (51%), Gaps = 41/913 (4%)
Query: 32 LNSWNDSRHFCEWEGITCGRRHRRVTALDLMSKSLSGSLSPHLGNLSFLREINLSNNTIQ 91
L+SW S FC W G+TC R VT+LDL +LSG+LSP + +L L+ ++L+ N I
Sbjct: 47 LSSWKVSTSFCTWIGVTCDVSRRHVTSLDLSGLNLSGTLSPDVSHLRLLQNLSLAENLIS 106
Query: 92 GEIPPEFGRLFRLEALFLSNNSLVGKIPANLSY-CSRLTVLCIEYNKLQGRIPLEFVSLS 150
G IPPE L L L LSNN G P +S L VL + N L G +P+ +L+
Sbjct: 107 GPIPPEISSLSGLRHLNLSNNVFNGSFPDEISSGLVNLRVLDVYNNNLTGDLPVSVTNLT 166
Query: 151 KLKDLSLAKNKLTGGIPPFLGNLTSLEVLSLAGNSFGRNIPDSLGQLKQLKILAIG-GNN 209
+L+ L L N G IPP G+ +E L+++GN IP +G L L+ L IG N
Sbjct: 167 QLRHLHLGGNYFAGKIPPSYGSWPVIEYLAVSGNELVGKIPPEIGNLTTLRELYIGYYNA 226
Query: 210 LSGPIPPSIYNLSFLVVFSVSHNQIHGSLPPSLGLLLP-NLKFFQIHHNFFSGSIPISLS 268
+PP I NLS LV F ++ + G +PP +G L + F Q+ N FSG + L
Sbjct: 227 FEDGLPPEIGNLSELVRFDGANCGLTGEIPPEIGKLQKLDTLFLQV--NVFSGPLTWELG 284
Query: 269 NASKLEHIEIANNNFSGKLSVNFGGMKNLSLLNLQFSNLGSGESDEMGFMNSLTNCSKLR 328
S L+ ++++NN F+G++ +F +KNL+LLNL F N GE E + + +L
Sbjct: 285 TLSSLKSMDLSNNMFTGEIPASFAELKNLTLLNL-FRNKLHGEIPEF-----IGDLPELE 338
Query: 329 VLSLGGNQFRGALPHSIANLSSQLQILILSSNQFYGSIPLGIGNLVDLYLLGMVENQFTG 388
VL L N F G++P + + +L ++ LSSN+ G++P + + L L + N G
Sbjct: 339 VLQLWENNFTGSIPQKLGE-NGKLNLVDLSSNKLTGTLPPNMCSGNKLETLITLGNFLFG 397
Query: 389 AIPKEMGKLQKLQGLDFSGNHFSGEIPSSLGNLSSLYEVFFNNNNLSGVIPFSLGNLKRL 448
+IP +GK + L + N +G IP L L L +V +N LSG +P + G L
Sbjct: 398 SIPDSLGKCESLTRIRMGENFLNGSIPKGLFGLPKLTQVELQDNYLSGELPVAGGVSVNL 457
Query: 449 AFLEMSGNELSGTIPEDIFNISYLSNSLNLARNHLVGIIPPRIGNLRALRSFDVSNNDLS 508
+ +S N+LSG +P I N + + L L N G IP +G L+ L D S+N S
Sbjct: 458 GQISLSNNQLSGPLPPAIGNFTGVQKLL-LDGNKFQGPIPSEVGKLQQLSKIDFSHNLFS 516
Query: 509 GEIPIELGHCSSLEEIYLAGNLFHGSIPSFFNALKGVQKIDLSRNNLSGQIPIFLEAL-S 567
G I E+ C L + L+ N G IP+ A+K + ++LSRN+L G IP + ++ S
Sbjct: 517 GRIAPEISRCKLLTFVDLSRNELSGEIPNEITAMKILNYLNLSRNHLVGSIPGSISSMQS 576
Query: 568 LEYLNLSFNDFEGKIPAKGIFANASAISVVGCNRLCG---GIPELQLPKCTESKSSSQKI 624
L L+ S+N+ G +P G F+ + S +G LCG G + + K S +
Sbjct: 577 LTSLDFSYNNLSGLVPGTGQFSYFNYTSFLGNPDLCGPYLGPCKDGVAKGGHQSHSKGPL 636
Query: 625 SRRLKIIISAITAFSGFFMVSFFILYWHKWRRGPSRLPSRPMMRKALPKMSYKSLLKATN 684
S +K+++ ++F ++ K R SR A ++ + + +
Sbjct: 637 SASMKLLLVLGLLVCS---IAFAVVAIIKARSLKKASESRAWRLTAFQRLDF-TCDDVLD 692
Query: 685 GFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKS--FMAECKALKNIRHRN 742
++IG G G VYKG + +G +VA+K + G+S F AE + L IRHR+
Sbjct: 693 SLKEDNIIGKGGAGIVYKGVM-PNGDLVAVKRLAAMSRGSSHDHGFNAEIQTLGRIRHRH 751
Query: 743 LVKVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIA 802
+V+++ CS+ ++ +VYEYMPNGSL + LH K+ + R IA
Sbjct: 752 IVRLLGFCSN-----HETNLLVYEYMPNGSLGEVLH----GKKGGHLHWD----TRYKIA 798
Query: 803 IDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVG 862
++ A L YLHH C I+H D+K +NILLD++ H+ DFGLA+F Q+ S S++
Sbjct: 799 LEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSNFEAHVADFGLAKFLQDSGTSECMSAIA 858
Query: 863 VKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMALP 922
G+ GY APEY +V DVYS+G++LLE+VT +KP +G + +M
Sbjct: 859 --GSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELVTGRKPVGEFGDGVDIVQWVRKMTDS 916
Query: 923 NQ--VMDIVDPIL 933
N+ V+ ++DP L
Sbjct: 917 NKDSVLKVLDPRL 929
|
Necessary for male gametophyte development, as well as ovule specification and function. Involved in cell-cell communication process required during early anther development, and regulating cell division and differentiation to organize cell layers. Required for the development of high-ordered vascular strands within the leaf and a correlated control of leaf shape, size and symmetry. May regulate the CLV1-dependent CLV3-mediated signaling in meristems maintenance. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SHI2|Y1723_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase At1g17230 OS=Arabidopsis thaliana GN=At1g17230 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 432 bits (1110), Expect = e-120, Method: Compositional matrix adjust.
Identities = 319/967 (32%), Positives = 486/967 (50%), Gaps = 67/967 (6%)
Query: 59 LDLMSKSLSGSLSPHLGNLSFLREINLSNNTIQGEIPPEFGRLFRLEALFLSNNSLVGKI 118
L L L GS+ +GNLS L+E+ + +N + G IPP +L +L + N G I
Sbjct: 144 LYLCENYLFGSIPRQIGNLSSLQELVIYSNNLTGVIPPSMAKLRQLRIIRAGRNGFSGVI 203
Query: 119 PANLSYCSRLTVLCIEYNKLQGRIPLEFVSLSKLKDLSLAKNKLTGGIPPFLGNLTSLEV 178
P+ +S C L VL + N L+G +P + L L DL L +N+L+G IPP +GN++ LEV
Sbjct: 204 PSEISGCESLKVLGLAENLLEGSLPKQLEKLQNLTDLILWQNRLSGEIPPSVGNISRLEV 263
Query: 179 LSLAGNSFGRNIPDSLGQLKQLKILAIGGNNLSGPIPPSIYNLSFLVVFSVSHNQIHGSL 238
L+L N F +IP +G+L ++K L + N L+G IP I NL S NQ+ G +
Sbjct: 264 LALHENYFTGSIPREIGKLTKMKRLYLYTNQLTGEIPREIGNLIDAAEIDFSENQLTGFI 323
Query: 239 PPSLGLLLPNLKFFQIHHNFFSGSIPISLSNASKLEHIEIANNNFSGKLSVNFGGMKNLS 298
P G +L NLK + N G IP L + LE ++++ N +G + + L
Sbjct: 324 PKEFGHIL-NLKLLHLFENILLGPIPRELGELTLLEKLDLSINRLNGTIPQELQFLPYLV 382
Query: 299 LLNLQFSNLGSGESDEMGFM----------NSLTN------C--SKLRVLSLGGNQFRGA 340
L L + L +GF NSL+ C L +LSLG N+ G
Sbjct: 383 DLQLFDNQLEGKIPPLIGFYSNFSVLDMSANSLSGPIPAHFCRFQTLILLSLGSNKLSGN 442
Query: 341 LPHSIANLSSQLQILILSSNQFYGSIPLGIGNLVDLYLLGMVENQFTGAIPKEMGKLQKL 400
+P + S L L+L NQ GS+P+ + NL +L L + +N +G I ++GKL+ L
Sbjct: 443 IPRDLKTCKS-LTKLMLGDNQLTGSLPIELFNLQNLTALELHQNWLSGNISADLGKLKNL 501
Query: 401 QGLDFSGNHFSGEIPSSLGNLSSLYEVFFNNNNLSGVIPFSLGNLKRLAFLEMSGNELSG 460
+ L + N+F+GEIP +GNL+ + ++N L+G IP LG+ + L++SGN+ SG
Sbjct: 502 ERLRLANNNFTGEIPPEIGNLTKIVGFNISSNQLTGHIPKELGSCVTIQRLDLSGNKFSG 561
Query: 461 TIPEDIFNISYLSNSLNLARNHLVGIIPPRIGNLRALRSFDVSNNDLSGEIPIELGHCSS 520
I +++ + YL L L+ N L G IP G+L L + N LS IP+ELG +S
Sbjct: 562 YIAQELGQLVYLE-ILRLSDNRLTGEIPHSFGDLTRLMELQLGGNLLSENIPVELGKLTS 620
Query: 521 LE-EIYLAGNLFHGSIPSFFNALKGVQKIDLSRNNLSGQIPIFL-EALSLEYLNLSFNDF 578
L+ + ++ N G+IP L+ ++ + L+ N LSG+IP + +SL N+S N+
Sbjct: 621 LQISLNISHNNLSGTIPDSLGNLQMLEILYLNDNKLSGEIPASIGNLMSLLICNISNNNL 680
Query: 579 EGKIPAKGIFANASAISVVGCNRLCGGIPELQLPKCTESKSSSQKI---SRRLKIIISAI 635
G +P +F + + G + LC P S S + S+R KI+
Sbjct: 681 VGTVPDTAVFQRMDSSNFAGNHGLCNSQRSHCQPLVPHSDSKLNWLINGSQRQKILTITC 740
Query: 636 TAFSGFFMVSFFILYWHKWRRGPSRLP----SRP--MMRKALPK--MSYKSLLKATNGFS 687
F+++F L W RR P+ + ++P M PK +Y+ L+ AT FS
Sbjct: 741 IVIGSVFLITFLGLCWTIKRREPAFVALEDQTKPDVMDSYYFPKKGFTYQGLVDATRNFS 800
Query: 688 STHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASK--SFMAECKALKNIRHRNLVK 745
++G G+ G VYK + G V+A+K +N + EGAS SF AE L IRHRN+VK
Sbjct: 801 EDVVLGRGACGTVYKAEMS-GGEVIAVKKLNSRGEGASSDNSFRAEISTLGKIRHRNIVK 859
Query: 746 VITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDV 805
+ C + N ++YEYM GSL + L + E L R IA+
Sbjct: 860 LYGFC----YHQNS-NLLLYEYMSKGSLGEQL-------QRGEKNCLLDWNARYRIALGA 907
Query: 806 ASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKG 865
A L YLHH C+ I+H D+K +NILLD H+GDFGLA+ + S S V G
Sbjct: 908 AEGLCYLHHDCRPQIVHRDIKSNNILLDERFQAHVGDFGLAKL---IDLSYSKSMSAVAG 964
Query: 866 TIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMALPNQV 925
+ GY APEY +V+ D+YS+G++LLE++T K P + +G +L N+ R ++ N +
Sbjct: 965 SYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKPPVQPLEQGG-DLVNWVRRSIRNMI 1023
Query: 926 MDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVV 985
P + + L + DK + + ++KI + C+ SP R M VV
Sbjct: 1024 -----PTIEMFDARLDTNDKRTVHEMSL---------VLKIALFCTSNSPASRPTMREVV 1069
Query: 986 HELQSVK 992
+ +
Sbjct: 1070 AMITEAR 1076
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 1008 | ||||||
| 359482058 | 1040 | PREDICTED: probable LRR receptor-like se | 0.986 | 0.955 | 0.535 | 0.0 | |
| 147853780 | 1904 | hypothetical protein VITISV_030954 [Viti | 0.976 | 0.516 | 0.538 | 0.0 | |
| 224115346 | 1017 | predicted protein [Populus trichocarpa] | 0.961 | 0.952 | 0.541 | 0.0 | |
| 224141953 | 1026 | predicted protein [Populus trichocarpa] | 0.964 | 0.947 | 0.540 | 0.0 | |
| 224090977 | 1034 | predicted protein [Populus trichocarpa] | 0.974 | 0.949 | 0.516 | 0.0 | |
| 224127492 | 1022 | predicted protein [Populus trichocarpa] | 0.980 | 0.966 | 0.509 | 0.0 | |
| 224097752 | 1025 | predicted protein [Populus trichocarpa] | 0.977 | 0.960 | 0.518 | 0.0 | |
| 359486510 | 965 | PREDICTED: probable LRR receptor-like se | 0.938 | 0.980 | 0.530 | 0.0 | |
| 224097750 | 1023 | predicted protein [Populus trichocarpa] | 0.975 | 0.960 | 0.515 | 0.0 | |
| 255577438 | 1028 | receptor-kinase, putative [Ricinus commu | 0.975 | 0.956 | 0.507 | 0.0 |
| >gi|359482058|ref|XP_002274540.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1028 bits (2657), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 538/1004 (53%), Positives = 688/1004 (68%), Gaps = 10/1004 (0%)
Query: 11 DGDRAALQAFKSMIAHEPQGILNSWNDSRHFCEWEGITCGRRHRRVTALDLMSKSLSGSL 70
+ DR AL A K+ I +P GI SWNDS HFC W G+TCG RH+RV L+L S L GSL
Sbjct: 38 ETDRLALLAIKAQITQDPLGITTSWNDSVHFCNWTGVTCGHRHQRVNTLNLNSLHLVGSL 97
Query: 71 SPHLGNLSFLREINLSNNTIQGEIPPEFGRLFRLEALFLSNNSLVGKIPANLSYCSRLTV 130
SP +GNL+FL +NL N G+IP E GRL RL AL L+NNS G+IPANLS CS L
Sbjct: 98 SPSIGNLTFLTGLNLELNNFHGQIPQELGRLSRLRALNLTNNSFSGEIPANLSRCSNLVY 157
Query: 131 LCIEYNKLQGRIPLEFVSLSKLKDLSLAKNKLTGGIPPFLGNLTSLEVLSLAGNSFGRNI 190
+ +N L GRIP S K+ + L N LTG +P LGNLTS++ LS A N +I
Sbjct: 158 FRLGFNNLIGRIPSWLGSYPKVVRMQLHYNNLTGPVPDSLGNLTSIKSLSFAVNHLEGSI 217
Query: 191 PDSLGQLKQLKILAIGGNNLSGPIPPSIYNLSFLVVFSVSHNQIHGSLPPSLGLLLPNLK 250
P +LGQL+ L+ + +G N SG IP S+YN+S L VFS+ +N+++GSLP L LPNL+
Sbjct: 218 PQALGQLQTLEFMGLGMNGFSGIIPSSVYNMSSLEVFSLPYNKLYGSLPWDLAFTLPNLQ 277
Query: 251 FFQIHHNFFSGSIPISLSNASKLEHIEIANNNFSGKLSVNFGGMKNLSLLNLQFSNLGSG 310
I +N F+GS+P SLSNAS L +I +NF+GK+S++FGGM NL L L + LG G
Sbjct: 278 VLNIGNNDFTGSLPSSLSNASNLLEFDITMSNFTGKVSIDFGGMPNLWGLFLASNPLGKG 337
Query: 311 ESDEMGFMNSLTNCSKLRVLSLGGNQFRGALPHSIANLSSQLQILILSSNQFYGSIPLGI 370
E+D++ F+NSL C L+VL L G+QF G LP+SIANLS+QL L L +NQ G+IP GI
Sbjct: 338 EADDLSFLNSLMKCRALKVLDLSGSQFGGVLPNSIANLSTQLMKLKLDNNQLSGTIPPGI 397
Query: 371 GNLVDLYLLGMVENQFTGAIPKEMGKLQKLQGLDFSGNHFSGEIPSSLGNLSSLYEVFFN 430
GNLV+L L + N FTG+IP +G LQ L +D S N SG IPSSLGN++ LY +
Sbjct: 398 GNLVNLTDLILANNDFTGSIPVLIGNLQMLGRIDLSRNQLSGHIPSSLGNITRLYSLHLQ 457
Query: 431 NNNLSGVIPFSLGNLKRLAFLEMSGNELSGTIPEDIFNISYLSNSLNLARNHLVGIIPPR 490
NN+LSG IP S GNL L L++S N L+GTIPE + ++ L+ SLNLARN L G++P
Sbjct: 458 NNHLSGKIPSSFGNLLYLQELDLSYNSLNGTIPEKVMDLVSLTISLNLARNQLTGLLPSE 517
Query: 491 IGNLRALRSFDVSNNDLSGEIPIELGHCSSLEEIYLAGNLFHGSIPSFFNALKGVQKIDL 550
+ L+ L DVS N LSGEIP LG C +LE +++ GN F GSIP F +L+G+ +DL
Sbjct: 518 VRKLKNLGHLDVSENKLSGEIPDGLGSCLTLEHLHMEGNFFKGSIPPSFISLRGLLDLDL 577
Query: 551 SRNNLSGQIPIFLEALSLEYLNLSFNDFEGKIPAKGIFANASAISVVGCNRLCGGIPELQ 610
SRNNLSGQIP FL+ LSL LNLSFN+FEG++P KG+F NA++ SV G N+LCGGIPEL
Sbjct: 578 SRNNLSGQIPEFLQQLSLSNLNLSFNNFEGQLPTKGVFNNATSTSVAGNNKLCGGIPELH 637
Query: 611 LPKCTESKSSSQKISRRLKIIISAITAFSGFFMVSFFILYWHKWRRGPSRLPSRPMM--R 668
LP C +K + + R LK++I +T F G ++ +L ++ RR R PS+ +
Sbjct: 638 LPACPVTKPKTGESKRGLKLMIGLLTGFLGLVLI-MSLLVINRLRR-VKREPSQTSASSK 695
Query: 669 KALPKMSYKSLLKATNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSF 728
+ +SY L KAT GFSS +LIG G FG VYKG L +D VVA+KVI L GA KSF
Sbjct: 696 DLILNVSYDGLFKATGGFSSANLIGTGGFGSVYKGILGQDETVVAVKVIQLHQRGAVKSF 755
Query: 729 MAECKALKNIRHRNLVKVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKE 788
AEC+AL+NIRHRNLVKV+T+CSS+D+QGNDFKA+VYE+MPNGSLE WLHP P +
Sbjct: 756 KAECEALRNIRHRNLVKVLTTCSSVDYQGNDFKALVYEFMPNGSLENWLHPVPTPDEIND 815
Query: 789 IEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARF 848
+ L+L QR++IAIDVASALDYLHHHC +PI+HCDLKPSNILLDND++ H+GDFGLARF
Sbjct: 816 VLRILSLPQRLNIAIDVASALDYLHHHCHKPIVHCDLKPSNILLDNDMTAHVGDFGLARF 875
Query: 849 HQEV---SNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDV 905
E S+ + SSS+G+KGTIGY APEYG+G++VS GD YSYGILLLEM T K+PT+
Sbjct: 876 IPEAAGRSHPSQSSSIGLKGTIGYAAPEYGMGTKVSALGDTYSYGILLLEMFTGKRPTES 935
Query: 906 MFEGDLNLHNFARMALPNQVMDIVDPIL---RNDEEILASTDKCRRMQTGINSRLECLIS 962
MF LNLHNF +MALP ++ DI+DP EE + D ECLIS
Sbjct: 936 MFSDQLNLHNFVKMALPERIADIIDPFFLSSEAKEEETTAADSSNLAHMKREKMHECLIS 995
Query: 963 MVKIGVACSMESPQDRMNMTNVVHELQSVKNILLELETVFNKQT 1006
+++IGV+CS+ESP++RM +T + ELQ ++ ILL F T
Sbjct: 996 ILRIGVSCSLESPRERMAITEAIKELQLIRKILLGNGVSFGAST 1039
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147853780|emb|CAN83822.1| hypothetical protein VITISV_030954 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1025 bits (2649), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 535/994 (53%), Positives = 685/994 (68%), Gaps = 10/994 (1%)
Query: 11 DGDRAALQAFKSMIAHEPQGILNSWNDSRHFCEWEGITCGRRHRRVTALDLMSKSLSGSL 70
+ DR AL A K+ I +P GI SWNDS HFC W G+TCG RH+RV L+L S L GSL
Sbjct: 69 ETDRLALLAIKAQITQDPLGITTSWNDSVHFCNWTGVTCGHRHQRVNTLNLSSLHLVGSL 128
Query: 71 SPHLGNLSFLREINLSNNTIQGEIPPEFGRLFRLEALFLSNNSLVGKIPANLSYCSRLTV 130
SP +GNL+FL +NL N G+IP E GRL RL AL L+NNS G+IPANLS CS L
Sbjct: 129 SPSIGNLTFLTGLNLELNNFHGQIPQELGRLSRLRALNLTNNSFSGEIPANLSRCSNLVY 188
Query: 131 LCIEYNKLQGRIPLEFVSLSKLKDLSLAKNKLTGGIPPFLGNLTSLEVLSLAGNSFGRNI 190
+ +N L GRIP S K+ + L N LTG +P LGNLTS++ LS A N +I
Sbjct: 189 FRLGFNNLIGRIPSWLGSYPKVVRMQLHYNNLTGPVPDSLGNLTSIKSLSFAVNHLEGSI 248
Query: 191 PDSLGQLKQLKILAIGGNNLSGPIPPSIYNLSFLVVFSVSHNQIHGSLPPSLGLLLPNLK 250
P +LGQL+ L+ + +G N SG IP S+YN+S L VFS+ +N+++GSLP L LPNL+
Sbjct: 249 PQALGQLQTLEFMGLGMNGFSGIIPSSVYNMSSLEVFSLPYNKLYGSLPWDLAFTLPNLQ 308
Query: 251 FFQIHHNFFSGSIPISLSNASKLEHIEIANNNFSGKLSVNFGGMKNLSLLNLQFSNLGSG 310
I +N F+G +P SLSNAS L +I +NF+GK+S++FGGM NL L L + LG G
Sbjct: 309 VLNIGNNDFTGPLPSSLSNASNLLEFDITMSNFTGKVSIDFGGMPNLWGLFLASNPLGKG 368
Query: 311 ESDEMGFMNSLTNCSKLRVLSLGGNQFRGALPHSIANLSSQLQILILSSNQFYGSIPLGI 370
E+D++ F+NSL C L+VL L G+QF G LP+SIANLS+QL L L +NQ G+IP GI
Sbjct: 369 EADDLSFLNSLMKCRALKVLDLSGSQFGGVLPNSIANLSTQLMKLKLDNNQLSGTIPPGI 428
Query: 371 GNLVDLYLLGMVENQFTGAIPKEMGKLQKLQGLDFSGNHFSGEIPSSLGNLSSLYEVFFN 430
GNLV+L L + N FTG+IP +G LQ L +D S N SG IPSSLGN++ LY +
Sbjct: 429 GNLVNLTDLILANNDFTGSIPVLIGNLQMLGRIDLSRNQLSGHIPSSLGNITRLYSLHLQ 488
Query: 431 NNNLSGVIPFSLGNLKRLAFLEMSGNELSGTIPEDIFNISYLSNSLNLARNHLVGIIPPR 490
NN+LSG IP S GNL L L++S N L+GTIPE + ++ L+ SLNLARN L G++P
Sbjct: 489 NNHLSGKIPSSFGNLLYLQELDLSYNSLNGTIPEKVMDLVSLTISLNLARNQLTGLLPSE 548
Query: 491 IGNLRALRSFDVSNNDLSGEIPIELGHCSSLEEIYLAGNLFHGSIPSFFNALKGVQKIDL 550
+ L+ L DVS N LSGEIP LG C +LE +++ GN F GSIP F +L+G+ +DL
Sbjct: 549 VRKLKNLGHLDVSENKLSGEIPDGLGSCLTLEHLHMEGNFFKGSIPPSFISLRGLLDLDL 608
Query: 551 SRNNLSGQIPIFLEALSLEYLNLSFNDFEGKIPAKGIFANASAISVVGCNRLCGGIPELQ 610
SRNNLSGQIP FL+ LSL LNLSFN+FEG++P KG+F NA++ SV G N+LCGGIPEL
Sbjct: 609 SRNNLSGQIPEFLQQLSLSNLNLSFNNFEGQLPTKGVFNNATSTSVAGNNKLCGGIPELH 668
Query: 611 LPKCTESKSSSQKISRRLKIIISAITAFSGFFMVSFFILYWHKWRRGPSRLPSRPMM--R 668
LP C +K + + R LK++I +T F G ++ +L ++ RR R PS+ +
Sbjct: 669 LPACPVTKPKTGESKRGLKLMIGLLTGFLGLVLI-MSLLVINRLRR-VKREPSQTSASSK 726
Query: 669 KALPKMSYKSLLKATNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSF 728
+ +SY L KAT GFSS +LIG G FG VYKG L +D VVA+KVI L GA KSF
Sbjct: 727 DLILNVSYDGLFKATGGFSSANLIGTGGFGSVYKGXLGQDETVVAVKVIQLHQRGAVKSF 786
Query: 729 MAECKALKNIRHRNLVKVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKE 788
AEC+AL+NIRHRNLVKV+T+CSS+D+QGNDFKA+VYE+MPNGSLE WLHP P +
Sbjct: 787 KAECEALRNIRHRNLVKVLTTCSSVDYQGNDFKALVYEFMPNGSLENWLHPVPTPDEIND 846
Query: 789 IEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARF 848
+ L+L QR++IAIDVASALDYLHHHC +PI+HCDLKPSNILLDND++ H+GDFGLARF
Sbjct: 847 VLRILSLPQRLNIAIDVASALDYLHHHCHKPIVHCDLKPSNILLDNDMTAHVGDFGLARF 906
Query: 849 HQEV---SNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDV 905
E S+ + SSS+G+KGTIGY APEYG+G++VS GD YSYGILLLEM T K+PT+
Sbjct: 907 IPEAAGRSHPSQSSSIGLKGTIGYAAPEYGMGTKVSALGDTYSYGILLLEMFTGKRPTES 966
Query: 906 MFEGDLNLHNFARMALPNQVMDIVDPIL---RNDEEILASTDKCRRMQTGINSRLECLIS 962
MF LNLHNF +MALP ++ DI+DP EE + D ECLIS
Sbjct: 967 MFSDQLNLHNFVKMALPERIADIIDPFFLSSEAKEEETTAADSSNLAHMKREKMHECLIS 1026
Query: 963 MVKIGVACSMESPQDRMNMTNVVHELQSVKNILL 996
+++IGV+CS+ESP++RM +T + ELQ ++ ILL
Sbjct: 1027 ILRIGVSCSLESPRERMAITEAIKELQLIRKILL 1060
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224115346|ref|XP_002317009.1| predicted protein [Populus trichocarpa] gi|222860074|gb|EEE97621.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1015 bits (2625), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 537/992 (54%), Positives = 701/992 (70%), Gaps = 23/992 (2%)
Query: 13 DRAALQAFKSMIAHEPQGILNSWNDSRHFCEWEGITCGRRHRRVTALDLMSKSLSGSLSP 72
DR AL FKS I H+PQ I SWNDS HFC+W+G+ CGRRH RVT L L S L GS+SP
Sbjct: 39 DRLALLDFKSKIIHDPQNIFGSWNDSLHFCQWQGVRCGRRHERVTVLKLESSGLVGSISP 98
Query: 73 HLGNLSFLREINLSNNTIQGEIPPEFGRLFRLEALFLSNNSLVGKIPANLSYCSRLTVLC 132
LGNLSFL ++LSNNT+QG+IP GRLFRL+ L L+NNS VG+IP NLS+CS+L L
Sbjct: 99 ALGNLSFLWGLDLSNNTLQGKIPDGLGRLFRLQILVLNNNSFVGEIPGNLSHCSKLDYLG 158
Query: 133 IEYNKLQGRIPLEFVSLSKLKDLSLAKNKLTGGIPPFLGNLTSLEVLSLAGNSFGRNIPD 192
+ N L G+IP E VSLSKL+ L + KN L+G IPPF+GNLTSL +S A N+F IPD
Sbjct: 159 LASNNLVGKIPAELVSLSKLEKLVIHKNNLSGAIPPFIGNLTSLNSISAAANNFQGRIPD 218
Query: 193 SLGQLKQLKILAIGGNNLSGPIPPSIYNLSFLVVFSVSHNQIHGSLPPSLGLLLPNLKFF 252
+LGQLK L+ L +G N LSG IP IYNLS L + S+S NQ+ G LP +G+ LPNL++
Sbjct: 219 TLGQLKNLESLGLGTNFLSGTIPLPIYNLSTLSILSLSENQLQGYLPSDIGVSLPNLQYI 278
Query: 253 QIHHNFFSGSIPISLSNASKLEHIEIANNNFSGKLSVNFGGMKNLSLLNLQFSNLGSGES 312
QI N FSGSIP+S+SN+S L+ +E +N+FSGKLSVNFGG+K+L++++L F+ +GSGE
Sbjct: 279 QIRANQFSGSIPLSISNSSNLQVLEAGDNSFSGKLSVNFGGLKHLAVVSLSFNKMGSGEP 338
Query: 313 DEMGFMNSLTNCSKLRVLSLGGNQFRGALPHSIANLSSQLQILILSSNQFYGSIPLGIGN 372
E+ F++SL NC+ L + + GN F G LP+S+ NLS+ L L L NQ +G I GIGN
Sbjct: 339 GELSFLDSLINCTSLYAIDIVGNHFEGMLPNSLGNLSTGLTFLGLGQNQLFGGIHSGIGN 398
Query: 373 LVDLYLLGMVENQFTGAIPKEMGKLQKLQGLDFSGNHFSGEIPSSLGNLSSLYEVFFNNN 432
L++L LG+ NQ +G IP ++GKL+ LQ S N SG IPSS+GNL+ L E N
Sbjct: 399 LINLNTLGLEFNQLSGPIPLDIGKLRMLQRFSLSYNRLSGHIPSSIGNLTLLLEFDLQGN 458
Query: 433 NLSGVIPFSLGNLKRLAFLEMSGNELSGTIPEDIFNISYLSNSLNLARNHLVGIIPPRIG 492
L G IP S+GN ++L L +S N LSG P+++F IS LS SL+L++N+ G +P IG
Sbjct: 459 QLQGTIPSSIGNCQKLLLLHLSRNNLSGNAPKELFAISSLSVSLDLSQNYFNGSLPSEIG 518
Query: 493 NLRALRSFDVSNNDLSGEIPIELGHCSSLEEIYLAGNLFHGSIPSFFNALKGVQKIDLSR 552
+L++L +VS N+ SGEIP L C+SLE +Y+ N F GSIPS F+ L+G+QK+DLS
Sbjct: 519 SLKSLAKLNVSYNEFSGEIPSTLASCTSLEYLYMQHNFFQGSIPSSFSTLRGIQKLDLSH 578
Query: 553 NNLSGQIPIFLEALSLEYLNLSFNDFEGKIPAKGIFANASAISVVGCNRLCGGIPELQLP 612
NNLSGQIP FL+ +L LNLSFNDFEG++P KG F NA+AISV G +LCGGI EL+LP
Sbjct: 579 NNLSGQIPKFLDTFALLTLNLSFNDFEGEVPTKGAFGNATAISVDGNKKLCGGISELKLP 638
Query: 613 KCTESKSSSQKISRRLKIIISAITAFSGFFMVSFFILYWHKWRRGPSRLPSRPMMRKALP 672
KC KS KI L ++++ F G +VSF +LY + +R S +++ LP
Sbjct: 639 KCNFKKSKKWKIPLWLILLLTIACGFLGVAVVSFVLLYLSRRKR--KEQSSELSLKEPLP 696
Query: 673 KMSYKSLLKATNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAEC 732
K+SY+ LLKATNGFSS +LIG G FG VY+G LD+D VVAIKV+NLQ GASKSF+AEC
Sbjct: 697 KVSYEMLLKATNGFSSDNLIGEGGFGSVYRGILDQDDTVVAIKVLNLQTRGASKSFVAEC 756
Query: 733 KALKNIRHRNLVKVITSCSSIDFQGNDFKAIVYEYMPNGS---LEKWLHPHAVPKRDKEI 789
+AL+N+RHRNL+K+ITSCSS+DFQGN+FKA+VYE+MPNGS LEKWL+ H
Sbjct: 757 EALRNVRHRNLLKIITSCSSVDFQGNEFKALVYEFMPNGSLEILEKWLYSH--------- 807
Query: 790 EIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFH 849
L LLQR++I IDVASAL+YLHH ++HCDLKPSNILLD ++ H+ DFG+A+
Sbjct: 808 NYFLDLLQRLNIMIDVASALEYLHHGNATLVVHCDLKPSNILLDENMVAHVSDFGIAKLL 867
Query: 850 QEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEG 909
E + T + ++ T+GY APEYGLGS+VS GD+YSYGI LLEM+T K+PTD MFEG
Sbjct: 868 GEGHSITQTMTL---ATVGYMAPEYGLGSQVSIYGDIYSYGIPLLEMITRKRPTDNMFEG 924
Query: 910 DLNLHNFARMALPNQVMDIVDPILRNDEEILA------STDKCRRMQTGINSRLECLISM 963
LNLH FARMALP QV++IVDP L + + A S + I + +EC+ S+
Sbjct: 925 TLNLHGFARMALPEQVLNIVDPSLLSSGNVKAGRMSNTSLENPTSSSGEIGTLVECVTSL 984
Query: 964 VKIGVACSMESPQDRMNMTNVVHELQSVKNIL 995
++IG++CS E P+DR+ + + + EL S++ IL
Sbjct: 985 IQIGLSCSRELPRDRLEINHAITELCSIRKIL 1016
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224141953|ref|XP_002324325.1| predicted protein [Populus trichocarpa] gi|222865759|gb|EEF02890.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 987 bits (2551), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 535/989 (54%), Positives = 681/989 (68%), Gaps = 17/989 (1%)
Query: 11 DGDRAALQAFKSMIAHEPQGILNSWNDSRHFCEWEGITCGRRHRRVTALDLMSKSLSGSL 70
+ D AL AFK+ I L+SWNDS FC W GITCGRRH RV ++L+ + L+G+L
Sbjct: 31 ETDYEALLAFKAKIQDPHSNTLSSWNDSLDFCNWPGITCGRRHGRVRIINLVDQKLAGTL 90
Query: 71 SPHLGNLSFLREINLSNNTIQGEIPPEFGRLFRLEALFLSNNSLVGKIPANLSYCSRLTV 130
SP++GN+SFLREI L+NNTI GEIPPE GRL RL L L+NNS+ GKIPANLS CS L
Sbjct: 91 SPYVGNISFLREIRLANNTIHGEIPPEVGRLLRLRVLMLTNNSIEGKIPANLSGCSSLAE 150
Query: 131 LCIEYNKLQGRIPLEFVSLSKLKDLSLAKNKLTGGIPPFLGNLTSLEVLSLAGNSFGRNI 190
L I+ NKL G IP E LSKL LS +N L G IP +GNLTSLE LSL N I
Sbjct: 151 LYIDRNKLGGEIPTELGFLSKLTILSFRQNNLLGKIPHSIGNLTSLESLSLKRNVLEGTI 210
Query: 191 PDSLGQLKQLKILAIGGNNLSGPIPPSIYNLSFLVVFSVSHNQIHGSLPPSLGLLLPNLK 250
PDSLG+LK+L L +G N LSG IPPS+YNLS + F + N GSLP +LGL P+L+
Sbjct: 211 PDSLGRLKRLTSLLLGENKLSGFIPPSLYNLSLITTFYLGGNGFRGSLPSNLGLSFPHLQ 270
Query: 251 FFQIHHNFFSGSIPISLSNASKLEHIEIANNNFSGKLSVNFGGMKNLSLLNLQFSNLGSG 310
+ + N FSG IP SL+NAS+L+ + N+ +GK+ FG + +LS L+ +NLG+G
Sbjct: 271 WLALWQNQFSGPIPGSLTNASELQIVSFTYNSLTGKIPDIFGKLHHLSGLHFGSNNLGTG 330
Query: 311 ESDEMGFMNSLTNCSKLRVLSLGGNQFRGALPHSIANLSSQLQILILSSNQFYGSIPLGI 370
DEM F+ SLTNCS L+V+S+ N+ G+LP ++ NLS+ + LS N G IP GI
Sbjct: 331 GDDEMAFLASLTNCSMLKVVSINNNRLEGSLPITVGNLSTYMVYFGLSGNHIVGRIPSGI 390
Query: 371 GNLVDLYLLGMVENQFTGAIPKEMGKLQKLQGLDFSGNHFSGEIPSSLGNLSSLYEVFFN 430
GNLV+L L M N FTG IP G L+KL+ N SG+IPSSLGNLS L ++ +
Sbjct: 391 GNLVNLTFLYMDRNHFTGEIPTSFGNLRKLEQFSLFSNRLSGKIPSSLGNLSLLSVLYLD 450
Query: 431 NNNLSGVIPFSLGNLKRLAFLEMSGNELSGTIPEDIFNISYLSNSLNLARNHLVGIIPPR 490
+N L IP SLG K L L +S L+G+IPE +F S + SLNL+ N G +P
Sbjct: 451 DNKLKDTIPASLGGCKNLVSLGLSRKNLNGSIPEQLFGTSSVLFSLNLSHNQFTGSLPST 510
Query: 491 IGNLRALRSFDVSNNDLSGEIPIELGHCSSLEEIYLAGNLFHGSIPSFFNALKGVQKIDL 550
IG+L+ L DVS N LSGEIP G C+SLE +++ N F GSIPS F++L+G+Q +DL
Sbjct: 511 IGSLKGLSELDVSWNMLSGEIPTSFGGCTSLEVLHMEDNFFQGSIPSSFSSLRGIQFLDL 570
Query: 551 SRNNLSGQIPIFLEALSLEYLNLSFNDFEGKIPAKGIFANASAISVVGCNRLCGGIPELQ 610
S NNLSGQ+P FL + LNLS+N+FEG++P KG+F N SA+SVVG ++LCGGI EL
Sbjct: 571 SCNNLSGQLPNFLVTIPFISLNLSYNNFEGEVPRKGVFTNESAVSVVGNDKLCGGILELH 630
Query: 611 LPKCTESKSSSQKISR-RLKIIISAITAFSGFFMVSFFILYWHKWRRGPSRLPSRPMMRK 669
LP+C + K+S + + I+ A G VS F+ W K +R S ++++
Sbjct: 631 LPECPNKEPKKTKMSHLQYLLAITIPCALVGAITVSSFLFCWFKKKR--KEHSSDTLLKE 688
Query: 670 ALPKMSYKSLLKATNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFM 729
+ P++SY+ L KAT+GFS+T+LIGVGSF VYKG +DEDG +VAIKV+NLQ GASKSF
Sbjct: 689 SFPQISYERLFKATDGFSTTNLIGVGSFSSVYKGRIDEDGTLVAIKVLNLQRRGASKSFK 748
Query: 730 AECKALKNIRHRNLVKVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEI 789
EC+AL+NIRHRNLVK+ITSCSSIDFQGN+FKA+VYEYMP GSLEKWLHP D++I
Sbjct: 749 DECEALRNIRHRNLVKIITSCSSIDFQGNNFKALVYEYMPKGSLEKWLHPTQETHDDQQI 808
Query: 790 E--IKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLAR 847
+ LL+RI+IAIDVA+ALDYLHHHC PI+HCD+KPSNILLD D+ GH+GDFGLAR
Sbjct: 809 NQVQRPNLLERINIAIDVAAALDYLHHHCHSPIIHCDVKPSNILLDKDMIGHLGDFGLAR 868
Query: 848 FHQEVSNSTL-SSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVM 906
QE S +L SSS G+KGT GY APEYG G EVS +GDVYSYGILLLEM+T K+P D
Sbjct: 869 IFQEFSEPSLESSSAGIKGTTGYAAPEYGQGREVSIDGDVYSYGILLLEMMTGKRPIDDT 928
Query: 907 FEGDLNLHNFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKI 966
FE LNLH FA+MALP+ V++I DP+L ++ + + M+ ECL S+VKI
Sbjct: 929 FEKGLNLHMFAKMALPDHVIEITDPVLLSERHL----ENAASME-------ECLTSLVKI 977
Query: 967 GVACSMESPQDRMNMTNVVHELQSVKNIL 995
GVACSM+SP+DRM+M+ VV EL V++
Sbjct: 978 GVACSMDSPRDRMDMSRVVRELLMVRDTF 1006
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224090977|ref|XP_002309132.1| predicted protein [Populus trichocarpa] gi|222855108|gb|EEE92655.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 971 bits (2510), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 515/998 (51%), Positives = 698/998 (69%), Gaps = 16/998 (1%)
Query: 11 DGDRAALQAFKSMIAHEPQGILNSWNDSRHFCEWEGITCGRRHRRVTALDLMSKSLSGSL 70
+ D AL A K+ I +P G+++SWNDS HFC W GI CG H+RV L+L L GSL
Sbjct: 36 ETDHLALLAIKAQIKLDPLGLMSSWNDSLHFCNWGGIICGNLHQRVITLNLSHYGLVGSL 95
Query: 71 SPHLGNLSFLREINLSNNTIQGEIPPEFGRLFRLEALFLSNNSLVGKIPANLSYCSRLTV 130
SP +GN+SFLR I+L N GEIP E GRL RL+ + SNNS G+IPANLS CS L +
Sbjct: 96 SPQIGNMSFLRGISLEQNYFHGEIPQEIGRLDRLKYINFSNNSFSGEIPANLSGCSSLLM 155
Query: 131 LCIEYNKLQGRIPLEFVSLSKLKDLSLAKNKLTGGIPPFLGNLTSLEVLSLAGNSFGRNI 190
L + +NKL G+IP + SL KL+ + L N L G +P LGN++S+ LSL+ N+F +I
Sbjct: 156 LRLGFNKLTGQIPYQLGSLQKLERVQLHYNNLNGSVPDSLGNISSVRSLSLSVNNFEGSI 215
Query: 191 PDSLGQLKQLKILAIGGNNLSGPIPPSIYNLSFLVVFSVSHNQIHGSLPPSLGLLLPNLK 250
PD+LG+LK L L +G NNLSG IPP+I+NLS L+VF++ +NQ+HG+LP LGL LPNL+
Sbjct: 216 PDALGRLKTLNFLGLGLNNLSGMIPPTIFNLSSLIVFTLPYNQLHGTLPSDLGLTLPNLQ 275
Query: 251 FFQIHHNFFSGSIPISLSNASKLEHIEIANNNFSGKLSVNFGGMKNLSLLNLQFSNLGSG 310
I HNFFSG +P+S+SNAS L ++I +NF+ K++++FGG+ NL L L + LG G
Sbjct: 276 VLNIGHNFFSGPLPVSISNASNLLELDIDTSNFT-KVTIDFGGLPNLWSLALSSNPLGKG 334
Query: 311 ESDEMGFMNSLTNCSKLRVLSLGGNQFRGALPHSIANLSSQLQILILSSNQFYGSIPLGI 370
E+D++ F++SLT C LR+L L + F G +P SI NLS+QL +L L NQ GSIP I
Sbjct: 335 EADDLSFIDSLTKCRNLRLLDLSNSHFGGVIPDSIGNLSTQLFLLKLRGNQLSGSIPTVI 394
Query: 371 GNLVDLYLLGMVENQFTGAIPKEMGKLQKLQGLDFSGNHFSGEIPSSLGNLSSLYEVFFN 430
NL++L L + +N +G+IP +G L+ LQ LD S N SG IPSSLGN++ L+E
Sbjct: 395 ENLLNLAELTVEKNYLSGSIPSVLGNLKMLQRLDLSENKLSGLIPSSLGNITQLFEFHLQ 454
Query: 431 NNNLSGVIPFSLGNLKRLAFLEMSGNELSGTIPEDIFNISYLSNSLNLARNHLVGIIPPR 490
N + G IP S GNLK L L++S N LSGTIP+++ +S L+ SLNLA+N L G +PP
Sbjct: 455 KNQIMGSIPSSFGNLKYLQNLDLSQNLLSGTIPKEVMGLSSLTISLNLAQNQLTGPLPPE 514
Query: 491 IGNLRALRSFDVSNNDLSGEIPIELGHCSSLEEIYLAGNLFHGSIPSFFNALKGVQKIDL 550
NL L DVS N L G+IP LG C +LE++++ GN F G+IP F++L+G++ +DL
Sbjct: 515 AQNLMNLGYLDVSENKLYGQIPSSLGSCVTLEKLHMQGNFFEGAIPPSFSSLRGLRDMDL 574
Query: 551 SRNNLSGQIPIFLEALSLEYLNLSFNDFEGKIPAKGIFANASAISVVGCNRLCGGIPELQ 610
SRNNLSGQIP FL+ L+L LNLSFN FEG++P +G F NA+AIS+ G RLCGGIP+L+
Sbjct: 575 SRNNLSGQIPQFLKRLALISLNLSFNHFEGEVPREGAFLNATAISLSGNKRLCGGIPQLK 634
Query: 611 LPKCTESKSSSQKISRRLKIIISAITAF--SGFFMVSFFILYWHKWRRGPSRLPSRPMMR 668
LP+C ++S + K SRR+K++I+ +T F M I K R S S +
Sbjct: 635 LPRCVVNRSKNGKTSRRVKLMIAILTPLLVLVFVMSILVINRLRKKNRQSSLASSLSSKQ 694
Query: 669 KALPKMSYKSLLKATNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSF 728
+ L K+SY++L KAT GFSS +LIG GSFG VY+G LD + VVA+KV+ ++ KSF
Sbjct: 695 ELLLKVSYRNLHKATAGFSSANLIGAGSFGSVYRGILDPNETVVAVKVLFMRQRKTLKSF 754
Query: 729 MAECKALKNIRHRNLVKVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKR--- 785
MAEC+ LKNIRHRNLVK++T+CSS+DFQGNDFKA+VYE+MPNG+LE WL H+ P+
Sbjct: 755 MAECEILKNIRHRNLVKILTACSSVDFQGNDFKALVYEFMPNGTLESWL--HSFPRTNGI 812
Query: 786 DKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGL 845
+++++I L+ QR++IAIDVA+AL+YLH+ C +P++HCDLKPSN+LLDND++ H+GDFGL
Sbjct: 813 NEDLKI-LSFHQRLNIAIDVAAALNYLHYQCHKPVVHCDLKPSNVLLDNDMTAHVGDFGL 871
Query: 846 ARFHQEV---SNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKP 902
ARF +E S+ SSSVG+KGT+GY APEYG+GS+ S NGDVYSYGILLLEM T K+P
Sbjct: 872 ARFIEEAINPSHRNESSSVGLKGTVGYAAPEYGMGSKPSMNGDVYSYGILLLEMFTGKRP 931
Query: 903 TDVMFEGDLNLHNFARMALPNQVMDIVDPILRNDEEILAST----DKCRRMQTGINSRLE 958
TD MF L+LHNF + ALP+Q+ ++VDP+ E + R Q + E
Sbjct: 932 TDDMFHDGLDLHNFVKTALPDQISEVVDPLFVTGGEGDEEETGHLENRTRGQIKKDQMQE 991
Query: 959 CLISMVKIGVACSMESPQDRMNMTNVVHELQSVKNILL 996
LI++++IG+ACS+ES +R N+ +V+ ELQ+V+ L
Sbjct: 992 SLIAILRIGIACSVESINERKNVKDVLTELQNVRRFFL 1029
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224127492|ref|XP_002329291.1| predicted protein [Populus trichocarpa] gi|222870745|gb|EEF07876.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 968 bits (2502), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 507/996 (50%), Positives = 683/996 (68%), Gaps = 8/996 (0%)
Query: 4 FQVAALEDGDRAALQAFKSMIAHEPQGILNSWNDSRHFCEWEGITCGRRHRRVTALDLMS 63
F + + D+ +L FK+ I +P G L+SWN+S FC+W G+TCGRRH+RV LDL S
Sbjct: 26 FSIYGGNETDKLSLLTFKAQITGDPLGKLSSWNESSQFCQWSGVTCGRRHQRVVELDLHS 85
Query: 64 KSLSGSLSPHLGNLSFLREINLSNNTIQGEIPPEFGRLFRLEALFLSNNSLVGKIPANLS 123
L GSLSPH+GNLSFLR +NL+NN++ IP E GRLFRLE L L NN+ G IPAN+S
Sbjct: 86 YQLVGSLSPHIGNLSFLRILNLANNSLSLYIPQELGRLFRLEELVLRNNTFDGGIPANIS 145
Query: 124 YCSRLTVLCIEYNKLQGRIPLEFVSLSKLKDLSLAKNKLTGGIPPFLGNLTSLEVLSLAG 183
C+ L +L L G++P E LSKL+ L++ N G IP GNL+++ + +
Sbjct: 146 RCANLRILDFSRGNLTGKLPAELGLLSKLQVLTIELNNFVGEIPYSFGNLSAINAIYGSI 205
Query: 184 NSFGRNIPDSLGQLKQLKILAIGGNNLSGPIPPSIYNLSFLVVFSVSHNQIHGSLPPSLG 243
N+ +IP+ GQLK+LKIL++G NNLSG IPPSI+NLS L + S NQ++GSLP +LG
Sbjct: 206 NNLEGSIPNVFGQLKRLKILSLGANNLSGMIPPSIFNLSSLTLLSFPVNQLYGSLPHTLG 265
Query: 244 LLLPNLKFFQIHHNFFSGSIPISLSNASKLEHIEIANNNFSGKLSVNFGGMKNLSLLNLQ 303
L LPNL+ F IH N F G IP + SNAS L +I +NNF+GK+ +L +L +
Sbjct: 266 LTLPNLQVFNIHTNQFGGLIPATFSNASNLLSFQIGSNNFNGKVPP-LSSSHDLQVLGVG 324
Query: 304 FSNLGSGESDEMGFMNSLT-NCSKLRVLSLGGNQFRGALPHSIANLSSQLQILILSSNQF 362
+NLG GE++++ F+ L N + L L N F G LP ++N S++L + + NQ
Sbjct: 325 DNNLGKGENNDLNFVYPLANNMTSLEALDTSDNNFGGVLPEIVSNFSTKLMKMTFARNQI 384
Query: 363 YGSIPLGIGNLVDLYLLGMVENQFTGAIPKEMGKLQKLQGLDFSGNHFSGEIPSSLGNLS 422
GSIP IGNL++L LG+ NQ TG IP MGKLQKL L +GN SG IPSS+GN++
Sbjct: 385 RGSIPTQIGNLINLEALGLETNQLTGMIPSSMGKLQKLSDLFLNGNKISGMIPSSMGNMT 444
Query: 423 SLYEVFFNNNNLSGVIPFSLGNLKRLAFLEMSGNELSGTIPEDIFNISYLSNSLNLARNH 482
SL V NNL G IP SLGN ++L L +S N LSG IP+++ +I LS L L+ N
Sbjct: 445 SLGRVNMRLNNLEGSIPPSLGNWQKLLSLALSQNNLSGPIPKELVSIPSLSMYLVLSENE 504
Query: 483 LVGIIPPRIGNLRALRSFDVSNNDLSGEIPIELGHCSSLEEIYLAGNLFHGSIPSFFNAL 542
L G +P + L L DVS N SGEIP LG C SLE ++L N G IP ++L
Sbjct: 505 LTGSLPIEMEKLVNLGYLDVSKNRFSGEIPKSLGSCVSLESLHLEENFLQGPIPITLSSL 564
Query: 543 KGVQKIDLSRNNLSGQIPIFLEALS-LEYLNLSFNDFEGKIPAKGIFANASAISVVGCNR 601
+ +Q+++LS NNL+GQIP FLE LE LNLSFNDFEG++P +G F N SAIS+ G +
Sbjct: 565 RAIQELNLSYNNLTGQIPEFLEDFKLLESLNLSFNDFEGEVPVQGAFQNTSAISIFGNKK 624
Query: 602 LCGGIPELQLPKCTESKSSSQKISRRLKIIISAITAFSGFFMVSFFILYWHKWRRGPSRL 661
LCGGIP+L L +C S+ ++ K +L II ++ F G ++ F+L++ ++
Sbjct: 625 LCGGIPQLNLTRCPSSEPTNSKSPTKLIWIIGSVCGFLGVILIISFLLFYCFRKKKDKPA 684
Query: 662 PSRPMMRKALPKMSYKSLLKATNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC 721
S+P + + P+++Y+ LL AT+GFSS +LIG GSFG V+KG L D IVVA+KV+NL
Sbjct: 685 ASQPSLETSFPRVAYEDLLGATDGFSSANLIGEGSFGSVFKGILGPDKIVVAVKVLNLLR 744
Query: 722 EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHA 781
+GASKSFMAEC+ALK+IRHRNLVK++T+CSSIDFQGNDFKA+VYE+M NG+LE+WLHP
Sbjct: 745 KGASKSFMAECEALKSIRHRNLVKLLTTCSSIDFQGNDFKALVYEFMVNGNLEEWLHP-- 802
Query: 782 VPKRDKEIEIK-LTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHI 840
V D+ K L L+ R++IAI +ASAL+YLHH CQ PI+HCDLKPSNILLD +++ H+
Sbjct: 803 VQTSDEANGPKALDLMHRLNIAIHMASALNYLHHDCQMPIIHCDLKPSNILLDTNMTAHV 862
Query: 841 GDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAK 900
GDFGLARFH E SN T SSVG+KGTIGY APEYG+G +VST GDVYSYGILLLEM T K
Sbjct: 863 GDFGLARFHSEASNQT--SSVGLKGTIGYAAPEYGIGGKVSTYGDVYSYGILLLEMFTGK 920
Query: 901 KPTDVMFEGDLNLHNFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECL 960
+P D MF+ LNLH++A+MALP++++++VDP+L + + S+D+ G + CL
Sbjct: 921 RPVDGMFKDGLNLHSYAKMALPDRIVEVVDPLLVREIRSVNSSDEMGMYHIGPHEISACL 980
Query: 961 ISMVKIGVACSMESPQDRMNMTNVVHELQSVKNILL 996
++++K+GVACS+E P++RM++ +VV EL +K+ LL
Sbjct: 981 MTIIKMGVACSVELPRERMDIGDVVTELNRIKDTLL 1016
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224097752|ref|XP_002311067.1| predicted protein [Populus trichocarpa] gi|222850887|gb|EEE88434.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 964 bits (2492), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 515/994 (51%), Positives = 676/994 (68%), Gaps = 9/994 (0%)
Query: 11 DGDRAALQAFKSMIAHEPQGILNSWNDSRHFCEWEGITCGRRHRRVTALDLMSKSLSGSL 70
+ DR +L A KS I ++P G+L+SWN+S HFC+W G+ CG+RHRRV +DL S L GSL
Sbjct: 33 ETDRLSLLALKSQITNDPFGMLSSWNESLHFCDWSGVICGKRHRRVVEIDLHSAQLVGSL 92
Query: 71 SPHLGNLSFLREINLSNNTIQGEIPPEFGRLFRLEALFLSNNSLVGKIPANLSYCSRLTV 130
SPH+GNLSFLR + L NN IP E G LFRL L L NN+ GKIP N+S+CS L +
Sbjct: 93 SPHIGNLSFLRILKLENNRFSHNIPQELGHLFRLRMLSLENNTFDGKIPVNISHCSNLLI 152
Query: 131 LCIEYNKLQGRIPLEFVSLSKLKDLSLAKNKLTGGIPPFLGNLTSLEVLSLAGNSFGRNI 190
L + N L G++P+E SLSKL+ N L GGIP GNL+++ + AGN I
Sbjct: 153 LSLSGNNLTGKLPIELGSLSKLQVFFFQFNYLVGGIPSSFGNLSAIIQIFGAGNYLQGGI 212
Query: 191 PDSLGQLKQLKILAIGGNNLSGPIPPSIYNLSFLVVFSVSHNQIHGSLPPSLGLLLPNLK 250
P+S+GQLK LK + G NN++G IPPSIYNLS L+ F+V NQ+HG+LPP LGL LPNL+
Sbjct: 213 PNSIGQLKSLKSFSFGRNNMTGMIPPSIYNLSSLMRFAVPVNQLHGNLPPDLGLTLPNLE 272
Query: 251 FFQIHHNFFSGSIPISLSNASKLEHIEIANNNFSGKLSVNFGGMKNLSLLNLQFSNLGSG 310
+ N FSGSIP + SNAS + IE++NNN +G++ + + L L + + LG+G
Sbjct: 273 ILLMSFNRFSGSIPPTFSNASTIAVIELSNNNLTGRVP-DLSSLSKLRWLIVDVNYLGNG 331
Query: 311 ESDEMGFMNSLTNCSKLRVLSLGGNQFRGALPHSIANLSSQLQILILSSNQFYGSIPLGI 370
D++ F+ L N + L LS+ N F G LP I+N S L+ + NQ GSIP GI
Sbjct: 332 NDDDLSFLPPLANKTSLEELSINDNNFGGLLPKIISNFSENLKRMTFGRNQIRGSIPSGI 391
Query: 371 GNLVDLYLLGMVENQFTGAIPKEMGKLQKLQGLDFSGNHFSGEIPSSLGNLSSLYEVFFN 430
GNL+ L LG+ NQ TG IP +GKLQ L L GN SG IPSS+GN++SL EV+ +
Sbjct: 392 GNLIGLDTLGLEMNQLTGVIPNSIGKLQNLGVLALGGNKISGNIPSSMGNITSLLEVYLS 451
Query: 431 NNNLSGVIPFSLGNLKRLAFLEMSGNELSGTIPEDIFNISYLSNSLNLARNHLVGIIPPR 490
NNL G IP SLGN + L L + N LSG+IP+++ +I S L L+ N L G +P
Sbjct: 452 ANNLQGRIPSSLGNCQNLLILHLDQNNLSGSIPKEVISIPSSSRILVLSENQLTGSLPLE 511
Query: 491 IGNLRALRSFDVSNNDLSGEIPIELGHCSSLEEIYLAGNLFHGSIPSFFNALKGVQKIDL 550
+G L L F++S+N LSGEIP LG C SLE +Y+ GNLF G IP ++L+ +Q ++L
Sbjct: 512 VGKLANLGYFNLSHNRLSGEIPRTLGSCVSLEFLYMEGNLFQGPIPESLSSLRALQILNL 571
Query: 551 SRNNLSGQIPIFLEALS-LEYLNLSFNDFEGKIPAKGIFANASAISVVGCNRLCGGIPEL 609
S NNLSG+IP FL L L L+LSFN+ EG++P +GIFA AS S++G +LCGG+P+L
Sbjct: 572 SHNNLSGEIPKFLAELKLLTSLDLSFNNLEGEVPVQGIFARASGFSMLGNKKLCGGMPQL 631
Query: 610 QLPKCTESKSSSQKISRRLKIIISAITAFSGFFMVSFFILYWHKWRRGPSRLPSRPMMRK 669
L +CT KS K S +LK+II+ F G +V ++L++ + SR S
Sbjct: 632 NLSRCTSKKSRKLKSSTKLKLIIAIPCGFVGIILVVSYMLFFF-LKEKKSRPASGSPWES 690
Query: 670 ALPKMSYKSLLKATNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFM 729
+++Y+ LL+ATNGFS +LIG GSFG VYKG L DG VA+KV NL EGASKSFM
Sbjct: 691 TFQRVAYEDLLQATNGFSPANLIGAGSFGSVYKGILRSDGAAVAVKVFNLLREGASKSFM 750
Query: 730 AECKALKNIRHRNLVKVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEI 789
AEC AL NIRHRNLVKV+T+CS IDFQGNDFKA+VYE+M NGSLE+WLHP + +
Sbjct: 751 AECAALINIRHRNLVKVLTACSGIDFQGNDFKALVYEFMVNGSLEEWLHPAQI-SDEAHR 809
Query: 790 EIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFH 849
L+LLQR++IAIDVASALDYLH+HCQ I+HCDLKPSN+LLD DL+ H+GDFGLAR
Sbjct: 810 RRDLSLLQRLNIAIDVASALDYLHNHCQIAIVHCDLKPSNVLLDGDLTAHVGDFGLARLL 869
Query: 850 QEVSNSTL---SSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVM 906
+ S+ +SS+G+KGTIGY APEYGLGSEVS GDVYSYGILLLE+ T ++PTD +
Sbjct: 870 PQASHQLCLDQTSSIGLKGTIGYAAPEYGLGSEVSPYGDVYSYGILLLEVFTGRRPTDGL 929
Query: 907 FEGDLNLHNFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKI 966
F+ LNLHNFA+ ALP V +++DP+L + E S D RRM + I + +ECL ++VK+
Sbjct: 930 FKDGLNLHNFAKTALPISVAEVLDPVLVTEAE-ETSGDASRRM-SHIGNHMECLAAIVKV 987
Query: 967 GVACSMESPQDRMNMTNVVHELQSVKNILLELET 1000
GVACS E P++RM +++V EL+ +++ILL +T
Sbjct: 988 GVACSAEFPRERMEISSVAVELRRIRHILLGPQT 1021
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359486510|ref|XP_002271317.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like, partial [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 964 bits (2491), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 507/955 (53%), Positives = 675/955 (70%), Gaps = 9/955 (0%)
Query: 46 GITCGRRHRRVTALDLMSKSLSGSLSPHLGNLSFLREINLSNNTIQGEIPPEFGRLFRLE 105
G+ CGRRH+RVT LDL S+ L GS+SPH+GNLSFLR + L N EIPPE G L RL+
Sbjct: 1 GVKCGRRHQRVTMLDLQSQKLVGSISPHIGNLSFLRVLQLEENGFNHEIPPEIGHLRRLQ 60
Query: 106 ALFLSNNSLVGKIPANLSYCSRLTVLCIEYNKLQGRIPLEFVSLSKLKDLSLAKNKLTGG 165
LFLSNNSL G+IPANLS CS+L + + +N+L G+IP E SLSKL+ L + N L+GG
Sbjct: 61 MLFLSNNSLSGEIPANLSSCSKLMYIYVGWNRLVGKIPAELGSLSKLQYLFIHANSLSGG 120
Query: 166 IPPFLGNLTSLEVLSLAGNSFGRNIPDSLGQLKQLKILAIGGNNLSGPIPPSIYNLSFLV 225
IP GNL+SLE LS N+ IP SL QL L +A+ N LSG IPPS+ NLS L+
Sbjct: 121 IPRSFGNLSSLERLSATQNNIVGTIPASLFQLITLTHVALNANGLSGTIPPSLSNLSSLI 180
Query: 226 VFSVSHNQIHGSLPPSLGLLLPNLKFFQIHHNFFSGSIPISLSNASKLEHIEIANNNFSG 285
F+VS N +HG+LP +LG+ LPNL+ + N F+GSIP+SLSNAS LE+ NN +G
Sbjct: 181 FFAVSFNHLHGNLPSNLGITLPNLQDLSLSGNRFTGSIPVSLSNASNLEYFSCNGNNLTG 240
Query: 286 KLSVNFGGMKNLSLLNLQFSNLGSGESDEMGFMNSLTNCSKLRVLSLGGNQFRGALPHSI 345
K+ + ++ L ++ +NLG+GE +++GF++SLTN S L VL+L N F G LP SI
Sbjct: 241 KVP-SLEKLQRLHFFSVTSNNLGNGEIEDLGFLSSLTNVSNLEVLALNVNNFGGVLPESI 299
Query: 346 ANLSSQLQILILSSNQFYGSIPLGIGNLVDLYLLGMVENQFTGAIPKEMGKLQKLQGLDF 405
N S++L L+L N+ GSIP GIGNLV L L M ENQ +G+IP ++GKLQ L+ L
Sbjct: 300 GNWSTKLATLLLDGNKIGGSIPAGIGNLVSLERLEMWENQLSGSIPVDIGKLQNLRVLML 359
Query: 406 SGNHFSGEIPSSLGNLSSLYEVFFNNNNLSGVIPFSLGNLKRLAFLEMSGNELSGTIPED 465
N SG +PSSLGNL +L ++ N G IP SLG + L FL++S N LSGTIP
Sbjct: 360 IKNKLSGILPSSLGNLENLIQLVLGRNYFQGKIPSSLGKCQNLLFLDLSLNNLSGTIPPQ 419
Query: 466 IFNISYLSNSLNLARNHLVGIIPPRIGNLRALRSFDVSNNDLSGEIPIELGHCSSLEEIY 525
+ ++S LS SL+++ N L G +P +GNL+ L DVSNN LSG IP +G C+SLE +
Sbjct: 420 VVSLSSLSISLDISDNRLTGALPIEVGNLKNLGVLDVSNNMLSGGIPSSVGSCTSLEYLS 479
Query: 526 LAGNLFHGSIPSFFNALKGVQKIDLSRNNLSGQIPIFLEALSLEYLNLSFNDFEGKIPAK 585
+ GN F GSIPS F++L+G++ +DLS NNLSG+IP FL+ + + +NLS+NDFEG +P +
Sbjct: 480 MKGNFFQGSIPSSFSSLRGIRILDLSHNNLSGKIPEFLQDIHFQLVNLSYNDFEGILPTE 539
Query: 586 GIFANASAISVVGCNRLCGGIPELQLPKCTESKSSSQKISRRLKIIISAITAFSGFFMV- 644
G+F N SA S++G ++LCGGIPE QLPKC + + +S LKIII+ ++ V
Sbjct: 540 GVFKNVSATSIMGNSKLCGGIPEFQLPKCNLQEPKKRGLSLALKIIIATVSGLLAITCVL 599
Query: 645 SFFILYWHKWRRGPSRLPSRPMMRKALPKMSYKSLLKATNGFSSTHLIGVGSFGCVYKGA 704
SF I W + ++G P+ K+L K+SY+SLL+AT+GFSS++LIGVGSFG VYKG
Sbjct: 600 SFLIFLWLRKKKGE---PASSSSEKSLLKVSYQSLLRATDGFSSSNLIGVGSFGSVYKGI 656
Query: 705 LDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKAIV 764
LD DG +A+KV+NL +GASKSF+AEC+AL+NIRHRNLVKV+T+CS +D+QGNDFKA+V
Sbjct: 657 LDHDGTAIAVKVLNLLRKGASKSFIAECEALRNIRHRNLVKVLTACSGVDYQGNDFKAVV 716
Query: 765 YEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCD 824
YE+M NGSLE+WLHP KL LQR++IAIDVA ALDYLHH CQ PI+HCD
Sbjct: 717 YEFMVNGSLEQWLHPTPTTAEASAPPRKLNFLQRLNIAIDVACALDYLHHQCQTPIVHCD 776
Query: 825 LKPSNILLDNDLSGHIGDFGLARFHQEVSNST---LSSSVGVKGTIGYTAPEYGLGSEVS 881
LKPSN+LLD +++GH+GDFG+A+F E + SSS+G++GTIGY APEYG+GSEVS
Sbjct: 777 LKPSNVLLDTEMTGHVGDFGIAKFLPEAATRVPEIQSSSIGIRGTIGYAAPEYGMGSEVS 836
Query: 882 TNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMALPNQVMDIVDPILRNDEEILA 941
T+GDVYS+GILLLEM T K+PT+ MF+ LN+HNF + A+P +V +I DP+L + +
Sbjct: 837 TSGDVYSFGILLLEMFTGKRPTEDMFKDSLNIHNFVKTAVPERVAEIADPVLLQEGVEMD 896
Query: 942 STDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHELQSVKNILL 996
+T RRM + +++ ECLIS+ IG+ACS E P++R N+T+ EL SV++I L
Sbjct: 897 NTTSQRRMASSHDAQ-ECLISIFGIGLACSAELPRERKNITDAAAELNSVRDIFL 950
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224097750|ref|XP_002311066.1| predicted protein [Populus trichocarpa] gi|222850886|gb|EEE88433.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 962 bits (2488), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 513/995 (51%), Positives = 681/995 (68%), Gaps = 12/995 (1%)
Query: 11 DGDRAALQAFKSMIAHEPQGILNSWNDSRHFCEWEGITCGRRHRRVTALDLMSKSLSGSL 70
+ DR +L AFK+ I+ +P G L+SWN+S HFCEW G+ CGR+HRRV LDL S L+GSL
Sbjct: 32 ETDRLSLLAFKTQIS-DPLGKLSSWNESLHFCEWSGVICGRKHRRVVELDLHSSQLAGSL 90
Query: 71 SPHLGNLSFLREINLSNNTIQGEIPPEFGRLFRLEALFLSNNSLVGKIPANLSYCSRLTV 130
SPH+GNLSFLR +NL N+ IP E GRLFR++ L L NN+ G+IP N+S C+ L
Sbjct: 91 SPHIGNLSFLRILNLEKNSFSYLIPQELGRLFRIQELSLGNNTFSGEIPVNISRCTNLLS 150
Query: 131 LCIEYNKLQGRIPLEFVSLSKLKDLSLAKNKLTGGIPPFLGNLTSLEVLSLAGNSFGRNI 190
+ + N L G++P EF SLSKL+ L+ +N L G IPP GNL+ L+++ N+ I
Sbjct: 151 IGLASNNLTGKLPAEFGSLSKLQVLNFQRNHLFGEIPPSYGNLSELQIIRGVRNNLQGGI 210
Query: 191 PDSLGQLKQLKILAIGGNNLSGPIPPSIYNLSFLVVFSVSHNQIHGSLPPSLGLLLPNLK 250
PDS+GQLK+L G N+LSG IP SIYN+S LV FS NQ++G LPP LGL LPNL
Sbjct: 211 PDSIGQLKRLADFTFGVNSLSGTIPSSIYNMSSLVRFSAPLNQLYGILPPELGLTLPNLD 270
Query: 251 FFQIHHNFFSGSIPISLSNASKLEHIEIANNNFSGKLSVNFGGMKNLSLLNLQFSNLGSG 310
F I N F G IP +LSNASK+ +++ NN+F+GK+ + G+ NL L L F+NLG+
Sbjct: 271 TFNILSNQFRGLIPSTLSNASKISDLQLRNNSFTGKVP-SLAGLHNLQRLVLNFNNLGNN 329
Query: 311 ESDEMGFMNSLTNCSKLRVLSLGGNQFRGALPHSIANLSSQLQILILSSNQFYGSIPLGI 370
E D++GF+ L N + L +L++ N F G LP + N S++L+I+I+ N GSIP I
Sbjct: 330 EDDDLGFLYPLANTTSLEILAINHNNFGGVLPEIVCNFSTKLRIMIIGENNLRGSIPTEI 389
Query: 371 GNLVDLYLLGMVENQFTGAIPKEMGKLQKLQGLDFSGNHFSGEIPSSLGNLSSLYEVFFN 430
G L+ L LG+ NQ TG IP +GKLQ+L + +GN SG IPSSLGN++SL EV+F
Sbjct: 390 GKLIGLDTLGLELNQLTGIIPSSIGKLQRLGVFNINGNKISGNIPSSLGNITSLLEVYFF 449
Query: 431 NNNLSGVIPFSLGNLKRLAFLEMSGNELSGTIPEDIFNISYLSNSLNLARNHLVGIIPPR 490
NNL G IP SLGN + L L + N LSG+IP+++ IS LS L+LA N L+G +P
Sbjct: 450 ANNLQGRIPSSLGNCQNLLMLRLDQNNLSGSIPKEVLGISSLSMYLDLAENQLIGPLPSE 509
Query: 491 IGNLRALRSFDVSNNDLSGEIPIELGHCSSLEEIYLAGNLFHGSIPSFFNALKGVQKIDL 550
+G L L +V N LSGEIP L C SLE + L N F GSIP ++L+ +Q ++L
Sbjct: 510 VGKLVHLGGLNVYKNRLSGEIPGILSSCVSLEHLNLGPNFFQGSIPESLSSLRALQILNL 569
Query: 551 SRNNLSGQIPIFLEALS-LEYLNLSFNDFEGKIPAKGIFANASAISVVGCNRLCGGIPEL 609
S NNLSG+IP FL L L+LSFN+ EG++P +G+FA AS S++G +LCGG P+L
Sbjct: 570 SHNNLSGKIPKFLAEFKLLTSLDLSFNNLEGEVPVQGVFARASGFSMLGNKKLCGGRPQL 629
Query: 610 QLPKCTESKSSSQKISRRLKIIISAITAFSG-FFMVSFFILYWHKWRRGPSRLPSRPMMR 668
L +CT KS K S ++K+II+ F G +VS+ + + K ++ SR S
Sbjct: 630 NLSRCTSKKSRKLKSSTKMKLIIAIPCGFVGIILLVSYMLFFLLKEKK--SRPASGSPWE 687
Query: 669 KALPKMSYKSLLKATNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSF 728
+++Y+ LL+AT GFS +LIG GSFG VYKG L DG VA+KV NL EGASKSF
Sbjct: 688 STFQRVAYEDLLQATKGFSPANLIGAGSFGSVYKGILRSDGAAVAVKVFNLLREGASKSF 747
Query: 729 MAECKALKNIRHRNLVKVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKE 788
MAEC AL NIRHRNLVKV+T+CS IDFQGNDFKA+VYE+M NGSLE+WLHP + +
Sbjct: 748 MAECAALINIRHRNLVKVLTACSGIDFQGNDFKALVYEFMVNGSLEEWLHPVQISD-EAH 806
Query: 789 IEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARF 848
+ L+LLQR++IAIDVASALDYLH+HCQ + HCDLKPSN+LLD D++ H+GDFGLAR
Sbjct: 807 VRRDLSLLQRLNIAIDVASALDYLHNHCQIAVAHCDLKPSNVLLDGDMTAHVGDFGLARL 866
Query: 849 HQEVSNSTL---SSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDV 905
+ S+ +SS+G+KGTIGY APEYGLGSEVS GDVYSYGILLLE+ T ++PT+
Sbjct: 867 LPQASHQLCLDQTSSIGLKGTIGYAAPEYGLGSEVSPYGDVYSYGILLLEVFTGRRPTNG 926
Query: 906 MFEGDLNLHNFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVK 965
+F+ LNLHNFA+ ALP V +++DP+L + E S D RRM + I + +ECL ++VK
Sbjct: 927 LFKDGLNLHNFAKTALPISVAEVLDPVLVTEAE-ETSGDASRRM-SHIGNHMECLAAIVK 984
Query: 966 IGVACSMESPQDRMNMTNVVHELQSVKNILLELET 1000
+GVACS E P++RM +++V EL+ +++ILL +T
Sbjct: 985 VGVACSAEFPRERMEISSVAVELRRIRHILLGPQT 1019
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255577438|ref|XP_002529598.1| receptor-kinase, putative [Ricinus communis] gi|223530931|gb|EEF32790.1| receptor-kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 962 bits (2486), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 505/995 (50%), Positives = 684/995 (68%), Gaps = 12/995 (1%)
Query: 11 DGDRAALQAFKSMIAHEPQGILNSWNDSRHFCEWEGITCGRRHRRVTALDLMSKSLSGSL 70
+ DR +L AFK+ I +P IL+SWN+S HFC+W GITCG RH+RV +DL S LSGSL
Sbjct: 33 ETDRLSLLAFKAHITDDPLHILSSWNESLHFCKWSGITCGSRHQRVIEIDLESSRLSGSL 92
Query: 71 SPHLGNLSFLREINLSNNTIQGEIPPEFGRLFRLEALFLSNNSLVGKIPANLSYCSRLTV 130
+ +GNLSFLR +NL NN++ IP E GRLFRL L L NS G+IP N+SYCS L
Sbjct: 93 TAFIGNLSFLRVLNLQNNSLSHYIPQEIGRLFRLRTLILRRNSFSGEIPVNISYCSNLLT 152
Query: 131 LCIEYNKLQGRIPLEFVSLSKLKDLSLAKNKLTGGIPPFLGNLTSLEVLSLAGNSFGRNI 190
L + N L G++P E SLSKL+ N LTG I P NL+SLE++ N+F I
Sbjct: 153 LRLGRNNLTGKLPAELKSLSKLQMFEFEINYLTGEISPSFSNLSSLEIIYGTRNNFHGEI 212
Query: 191 PDSLGQLKQLKILAIGGNNLSGPIPPSIYNLSFLVVFSVSHNQIHGSLPPSLGLLLPNLK 250
P+S+GQLK L+ ++GG+N SG IPPSI+NLS L + SV NQ+HG+LPP LG LP L+
Sbjct: 213 PNSIGQLKSLQTFSLGGSNFSGVIPPSIFNLSSLTILSVPINQLHGNLPPDLGQSLPKLE 272
Query: 251 FFQIHHNFFSGSIPISLSNASKLEHIEIANNNFSGKLSVNFGGMKNLSLLNLQFSNLGSG 310
+++ N FSGSIP ++SNAS L ++++ NNF+GK+ + + NLS + + +NLG+G
Sbjct: 273 VLRLYANKFSGSIPPTISNASNLVALDVSQNNFTGKVP-SLARLHNLSYIGIHKNNLGNG 331
Query: 311 ESDEMGFMNSLTNCSKLRVLSLGGNQFRGALPHSIANLSSQLQILILSSNQFYGSIPLGI 370
E D++ F+ +L N + L +L++ N G LP ++N S++L + N+ G IP I
Sbjct: 332 EDDDLSFLYTLANNTNLEILAITENNLGGVLPEMLSNFSTKLVHMAFGRNKIRGRIPSEI 391
Query: 371 GNLVDLYLLGMVENQFTGAIPKEMGKLQKLQGLDFSGNHFSGEIPSSLGNLSSLYEVFFN 430
NL+ L LG N+ TG+IP +GKL+ L L + N+ SG IPSSLGN++SL +
Sbjct: 392 DNLIRLEALGFERNELTGSIPSSLGKLKNLIKLYLNDNNISGSIPSSLGNITSLSTISLK 451
Query: 431 NNNLSGVIPFSLGNLKRLAFLEMSGNELSGTIPEDIFNISYLSNSLNLARNHLVGIIPPR 490
NNL G IP SLGN +++ +++S N LSGTIP+++ +I LS SL+L+ N G +P
Sbjct: 452 VNNLEGSIPSSLGNCQQMLLMDLSRNNLSGTIPKELISIPSLSISLDLSENQFTGSLPME 511
Query: 491 IGNLRALRSFDVSNNDLSGEIPIELGHCSSLEEIYLAGNLFHGSIPSFFNALKGVQKIDL 550
+G L L DVS N LSGEIP LG C+ LE +YL GN F G+IP ++L+G+ ++L
Sbjct: 512 VGGLVNLGYLDVSKNKLSGEIPKSLGSCTRLETLYLQGNAFQGTIPVSLSSLRGINDLNL 571
Query: 551 SRNNLSGQIP-IFLEALSLEYLNLSFNDFEGKIPAKGIFANASAISVVGCNRLCGGIPEL 609
S NNL+GQIP F E SLE L+LS+NDFEG++PA+G+F NASA S+ G LCGGIPE+
Sbjct: 572 SHNNLTGQIPNFFAEFKSLEKLDLSYNDFEGEVPAEGVFKNASAFSISGNKNLCGGIPEI 631
Query: 610 QLPKCTESKSSSQKISRRLKIII--SAITAFSGFFMVSFFILYWHKWRRGPSRLPSRPMM 667
LP+CT +KS K S +L++II + + S + K R+ ++ S +
Sbjct: 632 NLPRCTLNKSMKPKTSHKLRLIIVVACCGVVGVLLLTSALLFCCLKMRK--NKEASGSSL 689
Query: 668 RKALPKMSYKSLLKATNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKS 727
K+SY++LLKAT+GFSS +LIG GSFG VYKG L D ++A+KV+NLQ +GAS+S
Sbjct: 690 DIFFQKVSYQNLLKATDGFSSANLIGAGSFGSVYKGILAPDETIIAVKVLNLQHKGASRS 749
Query: 728 FMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDK 787
FM EC+AL N+RHRNLVKV+T+CSS DF+ NDFKA+VYEYM NGSLE+WLHP P +D+
Sbjct: 750 FMTECQALANVRHRNLVKVLTACSSSDFEENDFKALVYEYMVNGSLEEWLHPTQNPDQDQ 809
Query: 788 EIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLAR 847
I L+L++R+SI+IDVASALDYLH+ CQ P++HCDLKPSNILLD+D++ H+GDFGLAR
Sbjct: 810 PPRI-LSLIERLSISIDVASALDYLHNQCQVPVVHCDLKPSNILLDSDMTAHVGDFGLAR 868
Query: 848 FH-QEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVM 906
F +S+ SSS+G++GT+GY APEYG+GS+VST GDVY+YGILLLE+ T KKPTD M
Sbjct: 869 FLIAAPHHSSPSSSIGIRGTVGYAAPEYGMGSDVSTYGDVYTYGILLLELFTGKKPTDAM 928
Query: 907 FEGDLNLHNFARMALPNQVMDIVDPIL--RNDEEILASTDKCRRMQTGI--NSRLECLIS 962
F+ LNLH A+MA+P+++ DP L DE AS T I + L CL S
Sbjct: 929 FKDGLNLHILAKMAMPDRLALAADPFLLITEDEGTSASATSASHRITCIARDKVLGCLNS 988
Query: 963 MVKIGVACSMESPQDRMNMTNVVHELQSVKNILLE 997
++KIGV CS ESP+DRM++++V +EL ++NILLE
Sbjct: 989 ILKIGVDCSAESPRDRMDISDVANELVRIRNILLE 1023
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 1008 | ||||||
| UNIPROTKB|Q40640 | 1025 | Xa21 "Receptor kinase-like pro | 0.958 | 0.942 | 0.449 | 2.1e-210 | |
| TAIR|locus:2079142 | 1010 | AT3G47570 [Arabidopsis thalian | 0.958 | 0.956 | 0.438 | 1.2e-209 | |
| TAIR|locus:2075631 | 1009 | AT3G47090 [Arabidopsis thalian | 0.959 | 0.958 | 0.431 | 8.8e-205 | |
| TAIR|locus:2075661 | 1025 | AT3G47110 [Arabidopsis thalian | 0.960 | 0.944 | 0.430 | 7.3e-201 | |
| TAIR|locus:2079157 | 1011 | AT3G47580 [Arabidopsis thalian | 0.955 | 0.952 | 0.417 | 1.4e-199 | |
| TAIR|locus:2149922 | 1031 | EFR "EF-TU receptor" [Arabidop | 0.958 | 0.936 | 0.405 | 6.9e-189 | |
| UNIPROTKB|O24435 | 813 | O24435 "Receptor kinase-like p | 0.707 | 0.876 | 0.404 | 2.4e-138 | |
| TAIR|locus:2170483 | 1173 | FLS2 "FLAGELLIN-SENSITIVE 2" [ | 0.888 | 0.763 | 0.322 | 9.1e-116 | |
| TAIR|locus:2047525 | 980 | AT2G24130 [Arabidopsis thalian | 0.857 | 0.881 | 0.328 | 2.2e-114 | |
| TAIR|locus:2005540 | 999 | HAE "HAESA" [Arabidopsis thali | 0.840 | 0.847 | 0.334 | 2.4e-110 |
| UNIPROTKB|Q40640 Xa21 "Receptor kinase-like protein" [Oryza sativa (taxid:4530)] | Back alignment and assigned GO terms |
|---|
Score = 2034 (721.1 bits), Expect = 2.1e-210, P = 2.1e-210
Identities = 449/999 (44%), Positives = 605/999 (60%)
Query: 12 GDRAALQAFKSMIAHEPQGILNSWNDSRH--FCEWEGITCGRRHRR----VTALDLMSKS 65
GD AL +FKS + ++ L SWN S H C W G+ CGRR RR V L L S +
Sbjct: 31 GDELALLSFKSSLLYQGGQSLASWNTSGHGQHCTWVGVVCGRRRRRHPHRVVKLLLRSSN 90
Query: 66 LSGSLSPHLGNLSFLREINLSNNTIQGEIPPEFGRLFRLEALFLSNNSLVGKIPANLSYC 125
LSG +SP LGNLSFLRE++L +N + GEIPPE RL RL+ L LS+NS+ G IPA + C
Sbjct: 91 LSGIISPSLGNLSFLRELDLGDNYLSGEIPPELSRLSRLQLLELSDNSIQGSIPAAIGAC 150
Query: 126 SRLTVLCIEYNKLQGRIPLEF-VXXXXXXXXXXXXXXXTGGIPPFLGNLTSLEVLSLAGN 184
++LT L + +N+L+G IP E +G IP LGNLTSL+ L+ N
Sbjct: 151 TKLTSLDLSHNQLRGMIPREIGASLKHLSNLYLYKNGLSGEIPSALGNLTSLQEFDLSFN 210
Query: 185 SFGRNIPDSLGQLKQLKILAIGGNNLSGPIPPSIYNLSFLVVFSVSHNQIHXXXXXXXXX 244
IP SLGQL L + +G NNLSG IP SI+NLS L FSV N++
Sbjct: 211 RLSGAIPSSLGQLSSLLTMNLGQNNLSGMIPNSIWNLSSLRAFSVRENKLGGMIPTNAFK 270
Query: 245 XXXNLKFFQIHHNFFSGSIPISLSNASKLEHIEIANNNFSGKLSVNFGGMKXXXXXXXXX 304
L+ + N F G IP S++NAS L I+I N FSG ++ FG ++
Sbjct: 271 TLHLLEVIDMGTNRFHGKIPASVANASHLTVIQIYGNLFSGIITSGFGRLRNLTELYLWR 330
Query: 305 XXXXXGESDEMGFMNSLTNCSKLRVLSLGGNQFRGALPHSIAXXXXXXXXXXXXXXXFYG 364
E D+ GF++ LTNCSKL+ L+LG N G LP+S + G
Sbjct: 331 NLFQTREQDDWGFISDLTNCSKLQTLNLGENNLGGVLPNSFSNLSTSLSFLALELNKITG 390
Query: 365 SIPLGIGNLVDLYLLGMVENQFTGAIPKEMGKLQKLQGLDFSGNHFSGEIPSSLGNLSSL 424
SIP IGNL+ L L + N F G++P +G+L+ L L N+ SG IP ++GNL+ L
Sbjct: 391 SIPKDIGNLIGLQHLYLCNNNFRGSLPSSLGRLKNLGILLAYENNLSGSIPLAIGNLTEL 450
Query: 425 YEVFFNNNNLSGVIPFSLGNLKRLAFLEMSGNELSGTIPEDIFNISYLSNSLNLARNHLV 484
+ N SG IP++L NL L L +S N LSG IP ++FNI LS +N+++N+L
Sbjct: 451 NILLLGTNKFSGWIPYTLSNLTNLLSLGLSTNNLSGPIPSELFNIQTLSIMINVSKNNLE 510
Query: 485 GIIPPRIGNLRALRSFDVSNNDLSGEIPIELGHCSSLEEIYLAGNLFHGSIPSFFNALKG 544
G IP IG+L+ L F +N LSG+IP LG C L +YL NL GSIPS LKG
Sbjct: 511 GSIPQEIGHLKNLVEFHAESNRLSGKIPNTLGDCQLLRYLYLQNNLLSGSIPSALGQLKG 570
Query: 545 VQKIDLSRNNLSGQIPIFLEALS-LEYLNLSFNDFEGKIPAKGIFANASAISVVGCNRLC 603
++ +DLS NNLSGQIP L ++ L LNLSFN F G++P G FA AS IS+ G +LC
Sbjct: 571 LETLDLSSNNLSGQIPTSLADITMLHSLNLSFNSFVGEVPTIGAFAAASGISIQGNAKLC 630
Query: 604 GGIPELQLPKCTESKSSSQKISRRLKIIISAITAFSGFFMVSFFILY-WHKWRRGPSRLP 662
GGIP+L LP+C + +K L I +S A + + S ++L WHK R P
Sbjct: 631 GGIPDLHLPRCCPLLEN-RKHFPVLPISVSLAAALA--ILSSLYLLITWHK--RTKKGAP 685
Query: 663 SRPMMRKALPKMSYKSLLKATNGFSSTHLIGVGSFGCVYKGALD-EDGIVVAIKVINLQC 721
SR M K P +SY L+KAT+GF+ T+L+G GSFG VYKG L+ +D VA+KV+ L+
Sbjct: 686 SRTSM-KGHPLVSYSQLVKATDGFAPTNLLGSGSFGSVYKGKLNIQDH--VAVKVLKLEN 742
Query: 722 EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHA 781
A KSF AEC+AL+N+RHRNLVK++T CSSID +GNDFKAIVY++MPNGSLE W+HP
Sbjct: 743 PKALKSFTAECEALRNMRHRNLVKIVTICSSIDNRGNDFKAIVYDFMPNGSLEDWIHPET 802
Query: 782 VPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIG 841
+ D+ L L +R++I +DVA ALDYLH H EP++HCD+K SN+LLD+D+ H+G
Sbjct: 803 NDQADQR---HLNLHRRVTILLDVACALDYLHRHGPEPVVHCDIKSSNVLLDSDMVAHVG 859
Query: 842 DFGLARFHQEVSN--STLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTA 899
DFGLAR + ++ +SS+G GTIGY APEYG+G ST+GD+YSYGIL+LE+VT
Sbjct: 860 DFGLARILVDGTSLIQQSTSSMGFIGTIGYAAPEYGVGLIASTHGDIYSYGILVLEIVTG 919
Query: 900 KKPTDVMFEGDLNLHNFARMALPNQVMDIVDP-ILRNDEEILASTDK--CRRMQTGINSR 956
K+PTD F DL L + + L +V D+VD ++ + E L ST+ CRR+
Sbjct: 920 KRPTDSTFRPDLGLRQYVELGLHGRVTDVVDTKLILDSENWLNSTNNSPCRRIT------ 973
Query: 957 LECLISMVKIGVACSMESPQDRMNMTNVVHELQSVKNIL 995
EC++ ++++G++CS E P R +++ EL ++K L
Sbjct: 974 -ECIVWLLRLGLSCSQELPSSRTPTGDIIDELNAIKQNL 1011
|
|
| TAIR|locus:2079142 AT3G47570 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2027 (718.6 bits), Expect = 1.2e-209, P = 1.2e-209
Identities = 436/994 (43%), Positives = 608/994 (61%)
Query: 10 EDGDRAALQAFKSMIAHEPQGILNSWNDSRHFCEWEGITCGRRHRRVTALDLMSKSLSGS 69
++ DR AL FKS ++ + + +L+SWN S C W+G+TCGR+++RVT L+L L G
Sbjct: 22 DETDRQALLQFKSQVSEDKRVVLSSWNHSFPLCNWKGVTCGRKNKRVTHLELGRLQLGGV 81
Query: 70 LSPHLGNLSFLREINLSNNTIQGEIPPEFGRLFRLEALFLSNNSLVGKIPANLSYCSRLT 129
+SP +GNLSFL ++L N G IP E G+L RLE L + N L G IP L CSRL
Sbjct: 82 ISPSIGNLSFLVSLDLYENFFGGTIPQEVGQLSRLEYLDMGINYLRGPIPLGLYNCSRLL 141
Query: 130 VLCIEYNKLQGRIPLEFVXXXXXXXXXXXXXXXTGGIPPFLGNLTSLEVLSLAGNSFGRN 189
L ++ N+L G +P E G +P LGNLT LE L+L+ N+
Sbjct: 142 NLRLDSNRLGGSVPSELGSLTNLVQLNLYGNNMRGKLPTSLGNLTLLEQLALSHNNLEGE 201
Query: 190 IPDSLGQLKQLKILAIGGNNLSGPIPPSIYNLSFLVVFSVSHNQIHXXXXXXXXXXXXNL 249
IP + QL Q+ L + NN SG PP++YNLS L + + +N NL
Sbjct: 202 IPSDVAQLTQIWSLQLVANNFSGVFPPALYNLSSLKLLGIGYNHFSGRLRPDLGILLPNL 261
Query: 250 KFFQIHHNFFSGSIPISLSNASKLEHIEIANNNFSGKLSVNFGGMKXXXXXXXXXXXXXX 309
F + N+F+GSIP +LSN S LE + + NN +G + FG +
Sbjct: 262 LSFNMGGNYFTGSIPTTLSNISTLERLGMNENNLTGSIPT-FGNVPNLKLLFLHTNSLGS 320
Query: 310 GESDEMGFMNSLTNCSKLRVLSLGGNQFRGALPHSIAXXXXXXXXXXXXXXXFYGSIPLG 369
S ++ F+ SLTNC++L L +G N+ G LP SIA GSIP
Sbjct: 321 DSSRDLEFLTSLTNCTQLETLGIGRNRLGGDLPISIANLSAKLVTLDLGGTLISGSIPYD 380
Query: 370 IGNLVDLYLLGMVENQFTGAIPKEMGKLQKLQGLDFSGNHFSGEIPSSLGNLSSLYEVFF 429
IGNL++L L + +N +G +P +GKL L+ L N SG IP+ +GN++ L +
Sbjct: 381 IGNLINLQKLILDQNMLSGPLPTSLGKLLNLRYLSLFSNRLSGGIPAFIGNMTMLETLDL 440
Query: 430 NNNNLSGVIPFSLGNLKRLAFLEMSGNELSGTIPEDIFNISYLSNSLNLARNHLVGIIPP 489
+NN G++P SLGN L L + N+L+GTIP +I I L L+++ N L+G +P
Sbjct: 441 SNNGFEGIVPTSLGNCSHLLELWIGDNKLNGTIPLEIMKIQQLLR-LDMSGNSLIGSLPQ 499
Query: 490 RIGNLRALRSFDVSNNDLSGEIPIELGHCSSLEEIYLAGNLFHGSIPSFFNALKGVQKID 549
IG L+ L + + +N LSG++P LG+C ++E ++L GNLF+G IP L GV+++D
Sbjct: 500 DIGALQNLGTLSLGDNKLSGKLPQTLGNCLTMESLFLEGNLFYGDIPDL-KGLVGVKEVD 558
Query: 550 LSRNNLSGQIPIFLEALS-LEYLNLSFNDFEGKIPAKGIFANASAISVVGCNRLCGGIPE 608
LS N+LSG IP + + S LEYLNLSFN+ EGK+P KGIF NA+ +S+VG N LCGGI
Sbjct: 559 LSNNDLSGSIPEYFASFSKLEYLNLSFNNLEGKVPVKGIFENATTVSIVGNNDLCGGIMG 618
Query: 609 LQLPKC-TESKSSSQKISRRLK-IIISA---ITAFSGFFMVSFFILYWHKWRRGPSRLPS 663
QL C +++ S +K S RLK ++I IT FM S +++ K ++
Sbjct: 619 FQLKPCLSQAPSVVKKHSSRLKKVVIGVSVGITLLLLLFMASVTLIWLRKRKKNKETNNP 678
Query: 664 RPMMRKAL-PKMSYKSLLKATNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCE 722
P + L K+SY L ATNGFSS++++G GSFG VYK L + VVA+KV+N+Q
Sbjct: 679 TPSTLEVLHEKISYGDLRNATNGFSSSNMVGSGSFGTVYKALLLTEKKVVAVKVLNMQRR 738
Query: 723 GASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAV 782
GA KSFMAEC++LK+IRHRNLVK++T+CSSIDFQGN+F+A++YE+MPNGSL+ WLHP V
Sbjct: 739 GAMKSFMAECESLKDIRHRNLVKLLTACSSIDFQGNEFRALIYEFMPNGSLDMWLHPEEV 798
Query: 783 PKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGD 842
+ + LTLL+R++IAIDVAS LDYLH HC EPI HCDLKPSN+LLD+DL+ H+ D
Sbjct: 799 EEIHRPSRT-LTLLERLNIAIDVASVLDYLHVHCHEPIAHCDLKPSNVLLDDDLTAHVSD 857
Query: 843 FGLAR----FHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT 898
FGLAR F +E + LSS+ GV+GTIGY APEYG+G + S NGDVYS+GILLLEM T
Sbjct: 858 FGLARLLLKFDEESFFNQLSSA-GVRGTIGYAAPEYGVGGQPSINGDVYSFGILLLEMFT 916
Query: 899 AKKPTDVMFEGDLNLHNFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLE 958
K+PT+ +F G+ L+++ + ALP +++DIVD E IL ++ G +E
Sbjct: 917 GKRPTNELFGGNFTLNSYTKSALPERILDIVD------ESILHIG-----LRVGFPV-VE 964
Query: 959 CLISMVKIGVACSMESPQDRMNMTNVVHELQSVK 992
CL + ++G+ C ESP +R+ + VV EL S++
Sbjct: 965 CLTMVFEVGLRCCEESPMNRLATSIVVKELISIR 998
|
|
| TAIR|locus:2075631 AT3G47090 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1981 (702.4 bits), Expect = 8.8e-205, P = 8.8e-205
Identities = 428/992 (43%), Positives = 593/992 (59%)
Query: 10 EDGDRAALQAFKSMIAHEPQGILNSWNDSRHFCEWEGITCGRRHRRVTALDLMSKSLSGS 69
++ DR AL KS ++ + L++WN+S C W+ + CGR+H+RVT LDL L G
Sbjct: 22 DESDRQALLEIKSQVSESKRDALSAWNNSFPLCSWKWVRCGRKHKRVTRLDLGGLQLGGV 81
Query: 70 LSPHLGNLSFLREINLSNNTIQGEIPPEFGRLFRLEALFLSNNSLVGKIPANLSYCSRLT 129
+SP +GNLSFL ++LSNN+ G IP E G LFRL+ L + N L G+IPA+LS CSRL
Sbjct: 82 ISPSIGNLSFLIYLDLSNNSFGGTIPQEMGNLFRLKYLAVGFNYLEGEIPASLSNCSRLL 141
Query: 130 VLCIEYNKLQGRIPLEFVXXXXXXXXXXXXXXXTGGIPPFLGNLTSLEVLSLAGNSFGRN 189
L + N L +P E G P F+ NLTSL VL+L N
Sbjct: 142 YLDLFSNNLGDGVPSELGSLRKLLYLYLGLNDLKGKFPVFIRNLTSLIVLNLGYNHLEGE 201
Query: 190 IPDSLGQLKQLKILAIGGNNLSGPIPPSIYNLSFLVVFSVSHNQIHXXXXXXXXXXXXNL 249
IPD + L Q+ L + NN SG PP+ YNLS L + N N+
Sbjct: 202 IPDDIAMLSQMVSLTLTMNNFSGVFPPAFYNLSSLENLYLLGNGFSGNLKPDFGNLLPNI 261
Query: 250 KFFQIHHNFFSGSIPISLSNASKLEHIEIANNNFSGKLSVNFGGMKXXXXXXXXXXXXXX 309
+H NF +G+IP +L+N S LE I N +G +S NFG ++
Sbjct: 262 HELSLHGNFLTGAIPTTLANISTLEMFGIGKNRMTGSISPNFGKLENLHYLELANNSLGS 321
Query: 310 GESDEMGFMNSLTNCSKLRVLSLGGNQFRGALPHSIAXXXXXXXXXXXXXXXFYGSIPLG 369
++ F+++LTNCS L LS+ N+ GALP SI YGSIP
Sbjct: 322 YSFGDLAFLDALTNCSHLHGLSVSYNRLGGALPTSIVNMSTELTVLNLKGNLIYGSIPHD 381
Query: 370 IGNLVDLYLLGMVENQFTGAIPKEMGKLQKLQGLDFSGNHFSGEIPSSLGNLSSLYEVFF 429
IGNL+ L L + +N TG +P +G L L L N FSGEIPS +GNL+ L +++
Sbjct: 382 IGNLIGLQSLLLADNLLTGPLPTSLGNLVGLGELILFSNRFSGEIPSFIGNLTQLVKLYL 441
Query: 430 NNNNLSGVIPFSLGNLKRLAFLEMSGNELSGTIPEDIFNISYLSNSLNLARNHLVGIIPP 489
+NN+ G++P SLG+ + L++ N+L+GTIP++I I L + LN+ N L G +P
Sbjct: 442 SNNSFEGIVPPSLGDCSHMLDLQIGYNKLNGTIPKEIMQIPTLVH-LNMESNSLSGSLPN 500
Query: 490 RIGNLRALRSFDVSNNDLSGEIPIELGHCSSLEEIYLAGNLFHGSIPSFFNALKGVQKID 549
IG L+ L + NN+LSG +P LG C S+E IYL N F G+IP L GV+ +D
Sbjct: 501 DIGRLQNLVELLLGNNNLSGHLPQTLGKCLSMEVIYLQENHFDGTIPDI-KGLMGVKNVD 559
Query: 550 LSRNNLSGQIPIFLEALS-LEYLNLSFNDFEGKIPAKGIFANASAISVVGCNRLCGGIPE 608
LS NNLSG I + E S LEYLNLS N+FEG++P +GIF NA+ +SV G LCG I E
Sbjct: 560 LSNNNLSGSISEYFENFSKLEYLNLSDNNFEGRVPTEGIFQNATLVSVFGNKNLCGSIKE 619
Query: 609 LQLPKC-TESKSSSQKISRRLKIIISAITAFSGFFMVSFFI-LYWHKWRRGPSRLP-SRP 665
L+L C ++ + LK + ++ ++ F + L W K R+ ++ S P
Sbjct: 620 LKLKPCIAQAPPVETRHPSLLKKVAIGVSVGIALLLLLFIVSLSWFKKRKNNQKINNSAP 679
Query: 666 MMRKAL-PKMSYKSLLKATNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGA 724
+ K+SY L AT+GFSS++++G GSFG V+K L + +VA+KV+N+Q GA
Sbjct: 680 FTLEIFHEKLSYGDLRNATDGFSSSNIVGSGSFGTVFKALLQTENKIVAVKVLNMQRRGA 739
Query: 725 SKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPK 784
KSFMAEC++LK+IRHRNLVK++T+C+SIDFQGN+F+A++YE+MPNGSL+KWLHP V +
Sbjct: 740 MKSFMAECESLKDIRHRNLVKLLTACASIDFQGNEFRALIYEFMPNGSLDKWLHPEEVEE 799
Query: 785 RDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFG 844
+ LTLL+R++IAIDVAS LDYLH HC EPI HCDLKPSNILLD+DL+ H+ DFG
Sbjct: 800 IHRPSRT-LTLLERLNIAIDVASVLDYLHVHCHEPIAHCDLKPSNILLDDDLTAHVSDFG 858
Query: 845 LAR----FHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAK 900
LAR F QE + LSS+ GV+GTIGY APEYG+G + S +GDVYS+G+L+LEM T K
Sbjct: 859 LARLLLKFDQESFFNQLSSA-GVRGTIGYAAPEYGMGGQPSIHGDVYSFGVLVLEMFTGK 917
Query: 901 KPTDVMFEGDLNLHNFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECL 960
+PT+ +F G+ L+++ + ALP +V+DI D + IL S ++ G LECL
Sbjct: 918 RPTNELFGGNFTLNSYTKAALPERVLDIAD------KSILHSG-----LRVGFPV-LECL 965
Query: 961 ISMVKIGVACSMESPQDRMNMTNVVHELQSVK 992
++ +G+ C ESP +R+ + EL S++
Sbjct: 966 KGILDVGLRCCEESPLNRLATSEAAKELISIR 997
|
|
| TAIR|locus:2075661 AT3G47110 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1944 (689.4 bits), Expect = 7.3e-201, P = 7.3e-201
Identities = 428/995 (43%), Positives = 582/995 (58%)
Query: 10 EDGDRAALQAFKSMIAHEPQGILNSWNDSRHFCEWEGITCGRRHRRVTALDLMSKSLSGS 69
E+ D+ AL FKS ++ + +L SWNDS C W G+ CG +HRRVT +DL L+G
Sbjct: 37 EETDKQALLEFKSQVSETSRVVLGSWNDSLPLCSWTGVKCGLKHRRVTGVDLGGLKLTGV 96
Query: 70 LSPHLGNLSFLREINLSNNTIQGEIPPEFGRLFRLEALFLSNNSLVGKIPANLSYCSRLT 129
+SP +GNLSFLR +NL++N G IP E G LFRL+ L +SNN G IP LS CS L+
Sbjct: 97 VSPFVGNLSFLRSLNLADNFFHGAIPSEVGNLFRLQYLNMSNNLFGGVIPVVLSNCSSLS 156
Query: 130 VLCIEYNKLQGRIPLEFVXXXXXXXXXXXXXXXTGGIPPFLGNLTSLEVLSLAGNSFGRN 189
L + N L+ +PLEF TG P LGNLTSL++L N
Sbjct: 157 TLDLSSNHLEQGVPLEFGSLSKLVLLSLGRNNLTGKFPASLGNLTSLQMLDFIYNQIEGE 216
Query: 190 IPDSLGQLKQLKILAIGGNNLSGPIPPSIYNLSFLVVFSVSHNQIHXXXXXXXXXXXXNL 249
IP + +LKQ+ I N +G PP IYNLS L+ S++ N NL
Sbjct: 217 IPGDIARLKQMIFFRIALNKFNGVFPPPIYNLSSLIFLSITGNSFSGTLRPDFGSLLPNL 276
Query: 250 KFFQIHHNFFSGSIPISLSNASKLEHIEIANNNFSGKLSVNFGGMKXXXXXXXXXXXXXX 309
+ + N F+G+IP +LSN S L ++I +N+ +GK+ ++FG ++
Sbjct: 277 QILYMGINSFTGTIPETLSNISSLRQLDIPSNHLTGKIPLSFGRLQNLLLLGLNNNSLGN 336
Query: 310 GESDEMGFMNSLTNCSKLRVLSLGGNQFRGALPHSIAXXXXXXXXXXXXXXXFYGSIPLG 369
S ++ F+ +LTNCS+L+ L++G N+ G LP IA GSIP G
Sbjct: 337 YSSGDLDFLGALTNCSQLQYLNVGFNKLGGQLPVFIANLSTQLTELSLGGNLISGSIPHG 396
Query: 370 IGNLVDLYLLGMVENQFTGAIPKEMGKLQKLQGLDFSGNHFSGEIPSSLGNLSSLYEVFF 429
IGNLV L L + EN TG +P +G+L +L+ + N SGEIPSSLGN+S L ++
Sbjct: 397 IGNLVSLQTLDLGENLLTGKLPPSLGELSELRKVLLYSNGLSGEIPSSLGNISGLTYLYL 456
Query: 430 NNNNLSGVIPFSLGNLKRLAFLEMSGNELSGTIPEDIFNISYLSNSLNLARNHLVGIIPP 489
NN+ G IP SLG+ L L + N+L+G+IP ++ + L LN++ N LVG +
Sbjct: 457 LNNSFEGSIPSSLGSCSYLLDLNLGTNKLNGSIPHELMELPSLV-VLNVSFNLLVGPLRQ 515
Query: 490 RIGNLRALRSFDVSNNDLSGEIPIELGHCSSLEEIYLAGNLFHGSIPSFFNALKGVQKID 549
IG L+ L + DVS N LSG+IP L +C SLE + L GN F G IP L G++ +D
Sbjct: 516 DIGKLKFLLALDVSYNKLSGQIPQTLANCLSLEFLLLQGNSFVGPIPDI-RGLTGLRFLD 574
Query: 550 LSRNNLSGQIPIFLEALS-LEYLNLSFNDFEGKIPAKGIFANASAISVVGCNRLCGGIPE 608
LS+NNLSG IP ++ S L+ LNLS N+F+G +P +G+F N SA+SV G LCGGIP
Sbjct: 575 LSKNNLSGTIPEYMANFSKLQNLNLSLNNFDGAVPTEGVFRNTSAMSVFGNINLCGGIPS 634
Query: 609 LQLPKCT-ESKSSSQKISRRLKIIISAITAFSGFFMVSFFILYWHKWRRGPSRLPSRPMM 667
LQL C+ E + + + I +SA+ A + L W+K R R +
Sbjct: 635 LQLQPCSVELPRRHSSVRKIITICVSAVMAALLLLCLCVVYLCWYKLRVKSVRANNNEND 694
Query: 668 RKALP------KMSYKSLLKATNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC 721
R P K+SY L K T GFSS++LIG G+FG V+KG L VAIKV+NL
Sbjct: 695 RSFSPVKSFYEKISYDELYKTTGGFSSSNLIGSGNFGAVFKGFLGSKNKAVAIKVLNLCK 754
Query: 722 EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHA 781
GA+KSF+AEC+AL IRHRNLVK++T CSS DF+GNDF+A+VYE+MPNG+L+ WLHP
Sbjct: 755 RGAAKSFIAECEALGGIRHRNLVKLVTICSSSDFEGNDFRALVYEFMPNGNLDMWLHPDE 814
Query: 782 VPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIG 841
+ + L L R++IAIDVASAL YLH +C PI HCD+KPSNILLD DL+ H+
Sbjct: 815 IEETGNPSRT-LGLFARLNIAIDVASALVYLHTYCHNPIAHCDIKPSNILLDKDLTAHVS 873
Query: 842 DFGLARFHQEVSNSTLS---SSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT 898
DFGLA+ + T SS GV+GTIGY APEYG+G S GDVYS+GI+LLE+ T
Sbjct: 874 DFGLAQLLLKFDRDTFHIQFSSAGVRGTIGYAAPEYGMGGHPSIMGDVYSFGIVLLEIFT 933
Query: 899 AKKPTDVMFEGDLNLHNFARMALPN-QVMDIVDPILRNDEEILASTDKCRRMQTGINSRL 957
K+PT+ +F L LH+F + AL Q +DI D E IL R + +
Sbjct: 934 GKRPTNKLFVDGLTLHSFTKSALQKRQALDITD------ETIL------RGAYAQHFNMV 981
Query: 958 ECLISMVKIGVACSMESPQDRMNMTNVVHELQSVK 992
ECL + ++GV+CS ESP +R++M + +L S++
Sbjct: 982 ECLTLVFRVGVSCSEESPVNRISMAEAISKLVSIR 1016
|
|
| TAIR|locus:2079157 AT3G47580 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1932 (685.2 bits), Expect = 1.4e-199, P = 1.4e-199
Identities = 417/998 (41%), Positives = 601/998 (60%)
Query: 10 EDGDRAALQAFKSMIAHEPQGILNSWNDSRHFCEWEGITCGRRHRRVTALDLMSKSLSGS 69
++ DR AL FKS ++ + +L+SWN+S C W+ +TCGR+H+RVT L+L L G
Sbjct: 22 DETDRQALLEFKSQVSEGKRDVLSSWNNSFPLCNWKWVTCGRKHKRVTHLNLGGLQLGGI 81
Query: 70 LSPHLGNLSFLREINLSNNTIQGEIPPEFGRLFRLEALFLSNNSLVGKIPANLSYCSRLT 129
+SP +GN+SFL ++LS+N G IP E G LFRLE L+++ NSL G IPA LS CSRL
Sbjct: 82 VSPSIGNVSFLISLDLSDNAFGGIIPREVGNLFRLEHLYMAFNSLEGGIPATLSNCSRLL 141
Query: 130 VLCIEYNKLQGRIPLEFVXXXXXXXXXXXXXXXTGGIPPFLGNLTSLEVLSLAGNSFGRN 189
L + N L+ +P E G +P LGNLTSL+ L N+
Sbjct: 142 NLDLYSNPLRQGVPSELGSLTKLVILDLGRNNLKGKLPRSLGNLTSLKSLGFTDNNIEGE 201
Query: 190 IPDSLGQLKQLKILAIGGNNLSGPIPPSIYNLSFLVVFSVSHNQIHXXXXXXXXXXXXNL 249
+PD L +L Q+ L + N G PP+IYNLS L + + N+
Sbjct: 202 VPDELARLSQMVGLGLSMNKFFGVFPPAIYNLSALEDLFLFGSGFSGSLKPDFGNLLPNI 261
Query: 250 KFFQIHHNFFSGSIPISLSNASKLEHIEIANNNFSGKLSVNFGGMKXXXXXXXXXXXXXX 309
+ + N G+IP +LSN S L+ I N +G + NFG +
Sbjct: 262 RELNLGENDLVGAIPTTLSNISTLQKFGINKNMMTGGIYPNFGKVPSLQYLDLSENPLGS 321
Query: 310 GESDEMGFMNSLTNCSKLRVLSLGGNQFRGALPHSIAXXXXXXXXXXXXXXXFYGSIPLG 369
++ F++SLTNC+ L++LS+G + GALP SIA F+GSIP
Sbjct: 322 YTFGDLEFIDSLTNCTHLQLLSVGYTRLGGALPTSIANMSTELISLNLIGNHFFGSIPQD 381
Query: 370 IGNLVDLYLLGMVENQFTGAIPKEMGKLQKLQGLDFSGNHFSGEIPSSLGNLSSLYEVFF 429
IGNL+ L L + +N TG +P +GKL +L L N SGEIPS +GNL+ L ++
Sbjct: 382 IGNLIGLQRLQLGKNMLTGPLPTSLGKLLRLGLLSLYSNRMSGEIPSFIGNLTQLEILYL 441
Query: 430 NNNNLSGVIPFSLGNLKRLAFLEMSGNELSGTIPEDIFNISYLSNSLNLARNHLVGIIPP 489
+NN+ G++P SLG + L + N+L+GTIP++I I L N L++ N L G +P
Sbjct: 442 SNNSFEGIVPPSLGKCSHMLDLRIGYNKLNGTIPKEIMQIPTLVN-LSMEGNSLSGSLPN 500
Query: 490 RIGNLRALRSFDVSNNDLSGEIPIELGHCSSLEEIYLAGNLFHGSIPSFFNALKGVQKID 549
IG+L+ L + NN SG +P LG+C ++E+++L GN F G+IP+ L GV+++D
Sbjct: 501 DIGSLQNLVKLSLENNKFSGHLPQTLGNCLAMEQLFLQGNSFDGAIPNI-RGLMGVRRVD 559
Query: 550 LSRNNLSGQIPIFLEALS-LEYLNLSFNDFEGKIPAKGIFANASAISVVGCNRLCGGIPE 608
LS N+LSG IP + S LEYLNLS N+F GK+P+KG F N++ + V G LCGGI +
Sbjct: 560 LSNNDLSGSIPEYFANFSKLEYLNLSINNFTGKVPSKGNFQNSTIVFVFGNKNLCGGIKD 619
Query: 609 LQLPKC------TESKSSSQKISRRLKIIISAITAFSGFFMVSFFILYWHKWRRGPSR-- 660
L+L C E+K SS +++ I++S A +++ +L W + RR +
Sbjct: 620 LKLKPCLAQEPPVETKHSSHL--KKVAILVSIGIALLLLLVIASMVLCWFRKRRKNQQTN 677
Query: 661 --LPSRPMMRKALPKMSYKSLLKATNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVIN 718
+PS+ + K+SY L ATNGFSS++++G GSFG V+K L + +VA+KV+N
Sbjct: 678 NLVPSK--LEIFHEKISYGDLRNATNGFSSSNMVGSGSFGTVFKALLPTESKIVAVKVLN 735
Query: 719 LQCEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLH 778
+Q GA KSFMAEC++LK+ RHRNLVK++T+C+S DFQGN+F+A++YEY+PNGS++ WLH
Sbjct: 736 MQRRGAMKSFMAECESLKDTRHRNLVKLLTACASTDFQGNEFRALIYEYLPNGSVDMWLH 795
Query: 779 PHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSG 838
P V + + LTLL+R++I IDVAS LDYLH HC EPI HCDLKPSN+LL++DL+
Sbjct: 796 PEEVEEIRRPPRT-LTLLERLNIVIDVASVLDYLHVHCHEPIAHCDLKPSNVLLEDDLTA 854
Query: 839 HIGDFGLAR----FHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLL 894
H+ DFGLAR F +E + LSS+ GV+GTIGY APEYG+G + S +GDVYS+G+LLL
Sbjct: 855 HVSDFGLARLLLKFDKESFLNQLSSA-GVRGTIGYAAPEYGMGGQPSIHGDVYSFGVLLL 913
Query: 895 EMVTAKKPTDVMFEGDLNLHNFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGIN 954
EM T K+PTD +F G+L LH++ ++ALP +V +I D + IL ++ G
Sbjct: 914 EMFTGKRPTDELFGGNLTLHSYTKLALPEKVFEIAD------KAILHIG-----LRVGFR 962
Query: 955 SRLECLISMVKIGVACSMESPQDRMNMTNVVHELQSVK 992
+ ECL ++++G+ C E P +R+ + V EL S++
Sbjct: 963 TA-ECLTLVLEVGLRCCEEYPTNRLATSEVAKELISIR 999
|
|
| TAIR|locus:2149922 EFR "EF-TU receptor" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1831 (649.6 bits), Expect = 6.9e-189, P = 6.9e-189
Identities = 408/1005 (40%), Positives = 576/1005 (57%)
Query: 13 DRAALQAFKSMIA-HEPQGILNSWNDSRHFCEWEGITCGRRHRRVTALDLMSKSLSGSLS 71
D AL FKS ++ + + +L SWN S FC W G+TCGRR RV +L+L L+G +S
Sbjct: 31 DMQALLEFKSQVSENNKREVLASWNHSSPFCNWIGVTCGRRRERVISLNLGGFKLTGVIS 90
Query: 72 PHLGNLSFLREINLSNNTIQGEIPPEFGRLFRLEALFLSNNSLVGKIPANLSYCSRLTVL 131
P +GNLSFLR +NL++N+ IP + GRLFRL+ L +S N L G+IP++LS CSRL+ +
Sbjct: 91 PSIGNLSFLRLLNLADNSFGSTIPQKVGRLFRLQYLNMSYNLLEGRIPSSLSNCSRLSTV 150
Query: 132 CIEYNKLQGRIPLEFVXXXXXXXXXXXXXXXTGGIPPFLGNLTSLEVLSLAGNSFGRNIP 191
+ N L +P E TG P LGNLTSL+ L A N IP
Sbjct: 151 DLSSNHLGHGVPSELGSLSKLAILDLSKNNLTGNFPASLGNLTSLQKLDFAYNQMRGEIP 210
Query: 192 DSLGQLKQLKILAIGGNNLSGPIPPSIYNLSFLVVFSVSHNQIHXXXXXXXXXXXXNLKF 251
D + +L Q+ I N+ SG PP++YN+S L S++ N NL+
Sbjct: 211 DEVARLTQMVFFQIALNSFSGGFPPALYNISSLESLSLADNSFSGNLRADFGYLLPNLRR 270
Query: 252 FQIHHNFFSGSIPISLSNASKLEHIEIANNNFSGKLSVNFGGMKXXXXXXXXXXXXXXGE 311
+ N F+G+IP +L+N S LE +I++N SG + ++FG ++
Sbjct: 271 LLLGTNQFTGAIPKTLANISSLERFDISSNYLSGSIPLSFGKLRNLWWLGIRNNSLGNNS 330
Query: 312 SDEMGFMNSLTNCSKLRVLSLGGNQFRGALPHSIAXXXXXXXXXXXXXXXFYGSIPLGIG 371
S + F+ ++ NC++L L +G N+ G LP SIA G+IP IG
Sbjct: 331 SSGLEFIGAVANCTQLEYLDVGYNRLGGELPASIANLSTTLTSLFLGQNLISGTIPHDIG 390
Query: 372 NLVDLYLLGMVENQFTGAIPKEMGKLQKLQGLDFSGNHFSGEIPSSLGNLSSLYEVFFNN 431
NLV L L + N +G +P GKL LQ +D N SGEIPS GN++ L ++ N+
Sbjct: 391 NLVSLQELSLETNMLSGELPVSFGKLLNLQVVDLYSNAISGEIPSYFGNMTRLQKLHLNS 450
Query: 432 NNLSGVIPFSLGNLKRLAFLEMSGNELSGTIPEDIFNISYLSNSLNLARNHLVGIIPPRI 491
N+ G IP SLG + L L M N L+GTIP++I I L+ ++L+ N L G P +
Sbjct: 451 NSFHGRIPQSLGRCRYLLDLWMDTNRLNGTIPQEILQIPSLAY-IDLSNNFLTGHFPEEV 509
Query: 492 GNLRALRSFDVSNNDLSGEIPIELGHCSSLEEIYLAGNLFHGSIPSFFNALKGVQKIDLS 551
G L L S N LSG++P +G C S+E +++ GN F G+IP + L ++ +D S
Sbjct: 510 GKLELLVGLGASYNKLSGKMPQAIGGCLSMEFLFMQGNSFDGAIPDI-SRLVSLKNVDFS 568
Query: 552 RNNLSGQIPIFLEAL-SLEYLNLSFNDFEGKIPAKGIFANASAISVVGCNRLCGGIPELQ 610
NNLSG+IP +L +L SL LNLS N FEG++P G+F NA+A+SV G +CGG+ E+Q
Sbjct: 569 NNNLSGRIPRYLASLPSLRNLNLSMNKFEGRVPTTGVFRNATAVSVFGNTNICGGVREMQ 628
Query: 611 LPKCTESKSSSQK--ISRRLKIIISAITAFSGFFMVSFFI-LYWHKWRRGPSRLPS-RPM 666
L C S ++ +S R K++ + ++ L W R+ + P
Sbjct: 629 LKPCIVQASPRKRKPLSVRKKVVSGICIGIASLLLIIIVASLCWFMKRKKKNNASDGNPS 688
Query: 667 MRKAL----PKMSYKSLLKATNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCE 722
L K+SY+ L AT+ FSST+LIG G+FG V+KG L + +VA+KV+NL
Sbjct: 689 DSTTLGMFHEKVSYEELHSATSRFSSTNLIGSGNFGNVFKGLLGPENKLVAVKVLNLLKH 748
Query: 723 GASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAV 782
GA+KSFMAEC+ K IRHRNLVK+IT CSS+D +GNDF+A+VYE+MP GSL+ WL +
Sbjct: 749 GATKSFMAECETFKGIRHRNLVKLITVCSSLDSEGNDFRALVYEFMPKGSLDMWLQLEDL 808
Query: 783 PKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGD 842
+R + LT ++++IAIDVASAL+YLH HC +P+ HCD+KPSNILLD+DL+ H+ D
Sbjct: 809 -ERVNDHSRSLTPAEKLNIAIDVASALEYLHVHCHDPVAHCDIKPSNILLDDDLTAHVSD 867
Query: 843 FGLARF-HQEVSNSTLS--SSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTA 899
FGLA+ ++ S L+ SS GV+GTIGY APEYG+G + S GDVYS+GILLLEM +
Sbjct: 868 FGLAQLLYKYDRESFLNQFSSAGVRGTIGYAAPEYGMGGQPSIQGDVYSFGILLLEMFSG 927
Query: 900 KKPTDVMFEGDLNLHNFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLEC 959
KKPTD F GD NLH++ + IL+ C G N+ E
Sbjct: 928 KKPTDESFAGDYNLHSYTK-------------------SILSG---CTS-SGGSNAIDEG 964
Query: 960 LISMVKIGVACSMESPQDRMNMTNVVHELQSVKNILLELETVFNK 1004
L ++++G+ CS E P+DRM V EL S+++ +T +
Sbjct: 965 LRLVLQVGIKCSEEYPRDRMRTDEAVRELISIRSKFFSSKTTITE 1009
|
|
| UNIPROTKB|O24435 O24435 "Receptor kinase-like protein" [Oryza sativa (taxid:4530)] | Back alignment and assigned GO terms |
|---|
Score = 1354 (481.7 bits), Expect = 2.4e-138, P = 2.4e-138
Identities = 293/724 (40%), Positives = 409/724 (56%)
Query: 82 EINLSNNTIQGEIPPEFGRLFRLEALFLSNNSLVGKIPANLSYCSRLTVLCIEYNKLQGR 141
++ L ++ + G I P G L L L LS+N L GKIP LS SRL L + +N L G
Sbjct: 82 KLRLRSSNLAGIISPSLGNLSFLRTLQLSDNHLSGKIPQELSRLSRLQQLVLNFNSLSGE 141
Query: 142 IPLEFVXXXXXXXXXXXXXXXTGGIPPFLGNLTSLEVLSLAGNSFGRNIPDSLGQLKQLK 201
IP +G IP LG LT L L+LA N+ +IP S GQL++L
Sbjct: 142 IPAALGNLTSLSVLELTNNTLSGAIPSSLGKLTGLTDLALAENTLSGSIPSSFGQLRRLS 201
Query: 202 ILAIGGNNLSGPIPPSIYNLSFLVVFSVSHNQIHXXXXXXXXXXXXNLKFFQIHHNFFSG 261
L++ NNLSG IP I+N+S L +F V N++ +L+ +++N F G
Sbjct: 202 FLSLAFNNLSGAIPDPIWNISSLTIFEVISNKLSGTLPTNAFSNLPSLQEVYMYYNQFHG 261
Query: 262 SIPISLSNASKLEHIEIANNNFSGKLSVNFGGMKXXXXXXXXXXXXXXGESDEMGFMNSL 321
IP S+ NAS + I N+FSG + G M+ E+++ FM +L
Sbjct: 262 RIPASIGNASNISIFTIGLNSFSGVVPPEIGRMRNLQRLELPETLSEAEETNDWKFMTAL 321
Query: 322 TNCSKLRVLSLGGNQFRGALPHSIAXXXXXXXXXXXXXXXFYGSIPLGIGNLVDLYLLGM 381
TNCS L+ + LGG +F G LP S++ GS+P IGNLV+L L +
Sbjct: 322 TNCSNLQEVELGGCKFGGVLPDSVSNLSSSLVSLSIRDNKISGSLPRDIGNLVNLQYLSL 381
Query: 382 VENQFTGAIPKEMGKLQKLQGLDFSGNHFSGEIPSSLGNLSSLYEVFFNNNNLSGVIPFS 441
N TG++P KL+ L+ L N G +P ++GNL+ L + N G IP +
Sbjct: 382 ANNSLTGSLPSSFSKLKNLRRLTVDNNKLIGSLPLTIGNLTQLTNMEVQFNAFGGTIPST 441
Query: 442 LGNLKRLAFLEMSGNELSGTIPEDIFNISYLSNSLNLARNHLVGIIPPRIGNLRALRSFD 501
LGNL +L + + N G IP +IF+I LS L+++ N+L G IP IG L+ + F
Sbjct: 442 LGNLTKLFQINLGHNNFIGQIPIEIFSIPALSEILDVSHNNLEGSIPKEIGKLKNIVEFH 501
Query: 502 VSNNDLSGEIPIELGHCSSLEEIYLAGNLFHGSIPSFFNALKGVQKIDLSRNNLSGQIPI 561
+N LSGE P +G C L+ ++L N +GSIP LKG+ +DLS NNLSGQIP+
Sbjct: 502 ADSNKLSGENPSTIGECQLLQHLFLQNNFLNGSIPIALTQLKGLDTLDLSGNNLSGQIPM 561
Query: 562 FLEALSLEY-LNLSFNDFEGKIPAKGIFANASAISVVGCNRLCGGIPELQLPKCTESKSS 620
L + L + LNLSFN F G++P G+FANAS I + G +CGGIPEL LP C+
Sbjct: 562 SLGDMPLLHSLNLSFNSFHGEVPTNGVFANASEIYIQGNAHICGGIPELHLPTCSLKSRK 621
Query: 621 SQKISRRLKIIISAITAFSGFFMVSFFILYWHKWRRGPSRLPSRPMMRKALPKMSYKSLL 680
+K L +++ + + F + + +L HK R+ +P+ M+ P ++YK L+
Sbjct: 622 KKKHQILLLVVVICLVSTLAVFSLLYMLLTCHKRRK--KEVPATTSMQ-GHPMITYKQLV 678
Query: 681 KATNGFSSTHLIGVGSFGCVYKGALD-EDGIV---VAIKVINLQCEGASKSFMAECKALK 736
KAT+GFSS+HL+G GSFG VYKG D +DG + VA++V+ L+ A KSF AEC+ L+
Sbjct: 679 KATDGFSSSHLLGSGSFGSVYKGEFDSQDGEITSLVAVRVLKLETPKALKSFTAECETLR 738
Query: 737 NIRHRNLVKVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLL 796
N RHRNLVK++T CSSID +GNDFKAIVY++MPNGSLE WLHP D+ + LTL
Sbjct: 739 NTRHRNLVKIVTICSSIDNRGNDFKAIVYDFMPNGSLEDWLHPET---NDQAEQRHLTLH 795
Query: 797 QRIS 800
QR+S
Sbjct: 796 QRVS 799
|
|
| TAIR|locus:2170483 FLS2 "FLAGELLIN-SENSITIVE 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1141 (406.7 bits), Expect = 9.1e-116, P = 9.1e-116
Identities = 307/953 (32%), Positives = 483/953 (50%)
Query: 58 ALDLMSKSLSGSLSPHLGNLSFLREINLSNNTIQGEIPPEFGRLFRLEALFLSNNSLVGK 117
+L L L G + +GN S L ++ L +N + G+IP E G L +L+AL + N L
Sbjct: 244 SLVLTENLLEGDIPAEIGNCSSLVQLELYDNQLTGKIPAELGNLVQLQALRIYKNKLTSS 303
Query: 118 IPANLSYCSRLTVLCIEYNKLQGRIPLEFVXXXXXXXXXXXXXXXTGGIPPFLGNLTSLE 177
IP++L ++LT L + N L G I E TG P + NL +L
Sbjct: 304 IPSSLFRLTQLTHLGLSENHLVGPISEEIGFLESLEVLTLHSNNFTGEFPQSITNLRNLT 363
Query: 178 VLSLAGNSFGRNIPDSLGQLKQLKILAIGGNNLSGPIPPSIYNLSFLVVFSVSHNQIHXX 237
VL++ N+ +P LG L L+ L+ N L+GPIP SI N + L + +SHNQ+
Sbjct: 364 VLTVGFNNISGELPADLGLLTNLRNLSAHDNLLTGPIPSSISNCTGLKLLDLSHNQM--T 421
Query: 238 XXXXXXXXXXNLKFFQIHHNFFSGSIPISLSNASKLEHIEIANNNFSGKLSVNFGGMKXX 297
NL F I N F+G IP + N S LE + +A+NN +G L G ++
Sbjct: 422 GEIPRGFGRMNLTFISIGRNHFTGEIPDDIFNCSNLETLSVADNNLTGTLKPLIGKLQKL 481
Query: 298 XXXXXXXXXXXXGESDEMGFMNSLTNCSKLRVLSLGGNQFRGALPHSIAXXXXXXXXXXX 357
E+G N L +L L N F G +P ++
Sbjct: 482 RILQVSYNSLTGPIPREIG------NLKDLNILYLHSNGFTGRIPREMSNLTLLQGLRMY 535
Query: 358 XXXXFYGSIPLGIGNLVDLYLLGMVENQFTGAIPKEMGKLQKLQGLDFSGNHFSGEIPSS 417
G IP + ++ L +L + N+F+G IP KL+ L L GN F+G IP+S
Sbjct: 536 SND-LEGPIPEEMFDMKLLSVLDLSNNKFSGQIPALFSKLESLTYLSLQGNKFNGSIPAS 594
Query: 418 LGNLSSLYEVFFNNNNLSGVIPFSL-GNLKRLA-FLEMSGNELSGTIPEDIFNISYLSNS 475
L +LS L ++N L+G IP L +LK + +L S N L+GTIP+++ + +
Sbjct: 595 LKSLSLLNTFDISDNLLTGTIPGELLASLKNMQLYLNFSNNLLTGTIPKELGKLEMVQE- 653
Query: 476 LNLARNHLVGIIPPRIGNLRALRSFDVSNNDLSGEIPIELGH-CSSLEEIYLAGNLFHGS 534
++L+ N G IP + + + + D S N+LSG IP E+ + + L+ N F G
Sbjct: 654 IDLSNNLFSGSIPRSLQACKNVFTLDFSQNNLSGHIPDEVFQGMDMIISLNLSRNSFSGE 713
Query: 535 IPSFFNALKGVQKIDLSRNNLSGQIPIFLEALS-LEYLNLSFNDFEGKIPAKGIFANASA 593
IP F + + +DLS NNL+G+IP L LS L++L L+ N+ +G +P G+F N +A
Sbjct: 714 IPQSFGNMTHLVSLDLSSNNLTGEIPESLANLSTLKHLKLASNNLKGHVPESGVFKNINA 773
Query: 594 ISVVGCNRLCGGIPELQLPKCTESKSSSQKISRRLKIIISAITAFSGFFMVSFFILYWHK 653
++G LCG L+ P CT + SS S+R ++I+ + + + +V +L
Sbjct: 774 SDLMGNTDLCGSKKPLK-P-CTIKQKSSH-FSKRTRVILIILGSAAALLLVLLLVLILTC 830
Query: 654 WRRGPSRLP-----SRPMMRKALPKMSY--KSLLKATNGFSSTHLIGVGSFGCVYKGALD 706
++ ++ S P + AL + K L +AT+ F+S ++IG S VYKG L
Sbjct: 831 CKKKEKKIENSSESSLPDLDSALKLKRFEPKELEQATDSFNSANIIGSSSLSTVYKGQL- 889
Query: 707 EDGIVVAIKVINLQCEGAS--KSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKAIV 764
EDG V+A+KV+NL+ A K F E K L ++HRNLVK++ ++ KA+V
Sbjct: 890 EDGTVIAVKVLNLKEFSAESDKWFYTEAKTLSQLKHRNLVKIL----GFAWESGKTKALV 945
Query: 765 YEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCD 824
+M NG+LE +H A P +LL++I + + +AS +DYLH PI+HCD
Sbjct: 946 LPFMENGNLEDTIHGSAAPIG--------SLLEKIDLCVHIASGIDYLHSGYGFPIVHCD 997
Query: 825 LKPSNILLDNDLSGHIGDFGLAR---FHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVS 881
LKP+NILLD+D H+ DFG AR F ++ ST +S+ +GTIGY APE+ +V+
Sbjct: 998 LKPANILLDSDRVAHVSDFGTARILGFRED--GSTTASTSAFEGTIGYLAPEFAYMRKVT 1055
Query: 882 TNGDVYSYGILLLEMVTAKKPTDVMFEG--DLNLHNFARMALPNQVMDIVDPILRNDEEI 939
T DV+S+GI+++E++T ++PT + E D+ L ++ N +V + D E+
Sbjct: 1056 TKADVFSFGIIMMELMTKQRPTSLNDEDSQDMTLRQLVEKSIGNGRKGMVRVL---DMEL 1112
Query: 940 LASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHELQSVK 992
S ++ E + +K+ + C+ P+DR +M ++ L ++
Sbjct: 1113 GDSIVSLKQE--------EAIEDFLKLCLFCTSSRPEDRPDMNEILTHLMKLR 1157
|
|
| TAIR|locus:2047525 AT2G24130 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1128 (402.1 bits), Expect = 2.2e-114, P = 2.2e-114
Identities = 301/915 (32%), Positives = 470/915 (51%)
Query: 107 LFLSNNSLVGKIPANLSYCSRLTVLCIEYNKLQGRIPLEFVXXXXXXXXXXXXXXXT-GG 165
L +S L G+I +++ + LTVL + N G+IP E G
Sbjct: 71 LDISGRDLGGEISPSIANLTGLTVLDLSRNFFVGKIPPEIGSLHETLKQLSLSENLLHGN 130
Query: 166 IPPFLGNLTSLEVLSLAGNSFGRNIPDSL---GQLKQLKILAIGGNNLSGPIPPSIY--- 219
IP LG L L L L N +IP L G L+ + + N+L+G IP + +
Sbjct: 131 IPQELGLLNRLVYLDLGSNRLNGSIPVQLFCNGSSSSLQYIDLSNNSLTGEIPLNYHCHL 190
Query: 220 -NLSFLVVFSVSHNQIHXXXXXXXXXXXXNLKFFQIHHNFFSGSIPIS-LSNASKLEHIE 277
L FL+++S N++ NLK+ + N SG +P +S +L+ +
Sbjct: 191 KELRFLLLWS---NKL-TGTVPSSLSNSTNLKWMDLESNMLSGELPSQVISKMPQLQFLY 246
Query: 278 IANNNF-SGKLSVNFGGM-KXXXXXXXXXXXXXXGESDEMGFMNSLTNCS-KLRVLSLGG 334
++ N+F S + N G S +S+ + S L + L
Sbjct: 247 LSYNHFVSHNNNTNLEPFFASLANSSDLQELELAGNSLGGEITSSVRHLSVNLVQIHLDQ 306
Query: 335 NQFRGALPHSIAXXXXXXXXXXXXXXXFYGSIPLGIGNLVDLYLLGMVENQFTGAIPKEM 394
N+ G++P I+ G IP + L L + + N TG IP E+
Sbjct: 307 NRIHGSIPPEISNLLNLTLLNLSSNL-LSGPIPRELCKLSKLERVYLSNNHLTGEIPMEL 365
Query: 395 GKLQKLQGLDFSGNHFSGEIPSSLGNLSSLYEVFFNNNNLSGVIPFSLGNLKRLAFLEMS 454
G + +L LD S N+ SG IP S GNLS L + N+LSG +P SLG L L++S
Sbjct: 366 GDIPRLGLLDVSRNNLSGSIPDSFGNLSQLRRLLLYGNHLSGTVPQSLGKCINLEILDLS 425
Query: 455 GNELSGTIP-EDIFNISYLSNSLNLARNHLVGIIPPRIGNLRALRSFDVSNNDLSGEIPI 513
N L+GTIP E + N+ L LNL+ NHL G IP + + + S D+S+N+LSG+IP
Sbjct: 426 HNNLTGTIPVEVVSNLRNLKLYLNLSSNHLSGPIPLELSKMDMVLSVDLSSNELSGKIPP 485
Query: 514 ELGHCSSLEEIYLAGNLFHGSIPSFFNALKGVQKIDLSRNNLSGQIP-IFLEALSLEYLN 572
+LG C +LE + L+ N F ++PS L ++++D+S N L+G IP F ++ +L++LN
Sbjct: 486 QLGSCIALEHLNLSRNGFSSTLPSSLGQLPYLKELDVSFNRLTGAIPPSFQQSSTLKHLN 545
Query: 573 LSFNDFEGKIPAKGIFANASAISVVGCNRLCGGIPELQLPKCTESKSSSQKISRRLKIII 632
SFN G + KG F+ + S +G + LCG I +Q K + K S + L +I
Sbjct: 546 FSFNLLSGNVSDKGSFSKLTIESFLGDSLLCGSIKGMQACK-KKHKYPSVLLPVLLSLIA 604
Query: 633 SAITAFSGFFMV--SFFILYWHKWRRGPSRLPSRPMMRKA-LPKMSYKSLLKATNGFSST 689
+ + G+ +V S F + + + P++SY+ L+ AT GF+++
Sbjct: 605 TPVLCVFGYPLVQRSRFGKNLTVYAKEEVEDEEKQNQNDPKYPRISYQQLIAATGGFNAS 664
Query: 690 HLIGVGSFGCVYKGALDEDGIVVAIKVINLQCE-GASKSFMAECKALKNIRHRNLVKVIT 748
LIG G FG VYKG L + VA+KV++ + S SF EC+ LK RHRNL+++IT
Sbjct: 665 SLIGSGRFGHVYKGVL-RNNTKVAVKVLDPKTALEFSGSFKRECQILKRTRHRNLIRIIT 723
Query: 749 SCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASA 808
+CS G F A+V MPNGSLE+ L+P ++ L L+Q ++I DVA
Sbjct: 724 TCSK---PG--FNALVLPLMPNGSLERHLYPGEYSSKN------LDLIQLVNICSDVAEG 772
Query: 809 LDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNS-------TLSSSV 861
+ YLHH+ ++HCDLKPSNILLD++++ + DFG++R Q V + + S+
Sbjct: 773 IAYLHHYSPVKVVHCDLKPSNILLDDEMTALVTDFGISRLVQGVEETVSTDDSVSFGSTD 832
Query: 862 GVK-GTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMA 920
G+ G++GY APEYG+G ST+GDVYS+G+LLLE+V+ ++PTDV+ +LH F +
Sbjct: 833 GLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVSGRRPTDVLVNEGSSLHEFMKSH 892
Query: 921 LPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMN 980
P+ + I++ L + +KC ++ E ++ M+++G+ C+ +P R +
Sbjct: 893 YPDSLEGIIEQALSRWKP-QGKPEKCEKLWR------EVILEMIELGLVCTQYNPSTRPD 945
Query: 981 MTNVVHELQSVKNIL 995
M +V HE+ +K L
Sbjct: 946 MLDVAHEMGRLKEYL 960
|
|
| TAIR|locus:2005540 HAE "HAESA" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1056 (376.8 bits), Expect = 2.4e-110, Sum P(2) = 2.4e-110
Identities = 299/894 (33%), Positives = 436/894 (48%)
Query: 27 EPQGILNSWNDSRHF--CEWEGITCGRRHRRVTALDLMSKSLSGSLSPHLGNLSFLREIN 84
+P L+SW+D+ C+W G++C V ++DL S L G L +L L ++
Sbjct: 37 DPAQSLSSWSDNNDVTPCKWLGVSCDATSN-VVSVDLSSFMLVGPFPSILCHLPSLHSLS 95
Query: 85 LSNNTIQGEIPPE-FGRLFRLEALFLSNNSLVGKIPANLSY-CSRLTVLCIEYNKLQGRI 142
L NN+I G + + F L +L LS N LVG IP +L + L L I N L I
Sbjct: 96 LYNNSINGSLSADDFDTCHNLISLDLSENLLVGSIPKSLPFNLPNLKFLEISGNNLSDTI 155
Query: 143 PLEFVXXXXXXXXXXXXXXXTGGIPPFLGNLTSLEVLSLAGNSFGRN-IPDSLGQLKQLK 201
P F +G IP LGN+T+L+ L LA N F + IP LG L +L+
Sbjct: 156 PSSFGEFRKLESLNLAGNFLSGTIPASLGNVTTLKELKLAYNLFSPSQIPSQLGNLTELQ 215
Query: 202 ILAIGGNNLSGPIPPSIYNLSFLVVFSVSHNQIHXXXXXXXXXXXXNLKFFQIHHNFFSG 261
+L + G NL GPIPPS+ L+ LV ++ NQ+ ++ ++ +N FSG
Sbjct: 216 VLWLAGCNLVGPIPPSLSRLTSLVNLDLTFNQL-TGSIPSWITQLKTVEQIELFNNSFSG 274
Query: 262 SIPISLSNASKLEHIEIANNNFSGKLSVNFGGMKXXXXXXXXXXXXXXGESDEMGFMNSL 321
+P S+ N + L+ + + N +GK+ N + G E S+
Sbjct: 275 ELPESMGNMTTLKRFDASMNKLTGKIPDNLNLLNLESLNLFENMLE--GPLPE-----SI 327
Query: 322 TNCSKLRVLSLGGNQFRGALPHSIAXXXXXXXXXXXXXXXFYGSIPLGIGNLVDLYLLGM 381
T L L L N+ G LP + F G IP + L L +
Sbjct: 328 TRSKTLSELKLFNNRLTGVLPSQLGANSPLQYVDLSYNR-FSGEIPANVCGEGKLEYLIL 386
Query: 382 VENQFTGAIPKEMGKLQKLQGLDFSGNHFSGEIPSSLGNLSSLYEVFFNNNNLSGVIPFS 441
++N F+G I +GK + L + S N SG+IP L L + ++N+ +G IP +
Sbjct: 387 IDNSFSGEISNNLGKCKSLTRVRLSNNKLSGQIPHGFWGLPRLSLLELSDNSFTGSIPKT 446
Query: 442 LGNLKRLAFLEMSGNELSGTIPEDIFNISYLSNSLNLARNHLVGIIPPRIGNLRALRSFD 501
+ K L+ L +S N SG+IP +I +++ + ++ A N G IP + L+ L D
Sbjct: 447 IIGAKNLSNLRISKNRFSGSIPNEIGSLNGIIE-ISGAENDFSGEIPESLVKLKQLSRLD 505
Query: 502 VSNNDLSGEIPIELGHCSSLEEIYLAGNLFHGSIPSFFNALKGVQKIDLSRNNLSGQIPI 561
+S N LSGEIP EL +L E+ LA N G IP L + +DLS N SG+IP+
Sbjct: 506 LSKNQLSGEIPRELRGWKNLNELNLANNHLSGEIPKEVGILPVLNYLDLSSNQFSGEIPL 565
Query: 562 FLEALSLEYLNLSFNDFEGKIPAKGIFANAS-AISVVGCNRLCGGIPELQLPKCTESKSS 620
L+ L L LNLS+N GKIP ++AN A +G LC + L K T SK+
Sbjct: 566 ELQNLKLNVLNLSYNHLSGKIPP--LYANKIYAHDFIGNPGLCVDLDGL-CRKITRSKNI 622
Query: 621 SQKISRRLKIIISAITAFSGFFMVSFFILYWHKWRRGPSRLPSRPMMRKALPKMSYKSLL 680
+++ + G M FI K R S + R + K+ + S
Sbjct: 623 GYVWILLTIFLLAGLVFVVGIVM---FIAKCRKLRALKSSTLAASKWR-SFHKLHF-SEH 677
Query: 681 KATNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEG-----ASKS-----FMA 730
+ + ++IG GS G VYK L G VVA+K +N +G +S S F A
Sbjct: 678 EIADCLDEKNVIGFGSSGKVYKVEL-RGGEVVAVKKLNKSVKGGDDEYSSDSLNRDVFAA 736
Query: 731 ECKALKNIRHRNLVKVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIE 790
E + L IRH+++V++ CSS D K +VYEYMPNGSL LH D++
Sbjct: 737 EVETLGTIRHKSIVRLWCCCSS-----GDCKLLVYEYMPNGSLADVLHG------DRKGG 785
Query: 791 IKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQ 850
+ L +R+ IA+D A L YLHH C PI+H D+K SNILLD+D + DFG+A+ Q
Sbjct: 786 VVLGWPERLRIALDAAEGLSYLHHDCVPPIVHRDVKSSNILLDSDYGAKVADFGIAKVGQ 845
Query: 851 EVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTD 904
+ T + G+ G+ GY APEY V+ D+YS+G++LLE+VT K+PTD
Sbjct: 846 MSGSKTPEAMSGIAGSCGYIAPEYVYTLRVNEKSDIYSFGVVLLELVTGKQPTD 899
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| C0LGP4 | Y3475_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.4657 | 0.9583 | 0.9564 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.921 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | gw1.XVIII.1848.1 | hypothetical protein (976 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 1008 | |||
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-128 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 5e-45 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-42 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 6e-41 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-36 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 3e-36 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 5e-36 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-34 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-34 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-30 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-29 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 6e-28 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 8e-28 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 1e-26 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 4e-26 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 8e-26 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-25 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 7e-25 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 8e-25 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 4e-24 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 4e-24 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-23 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-23 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 8e-23 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 3e-22 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 3e-22 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 8e-22 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 9e-22 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 1e-21 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 4e-21 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 4e-21 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-20 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 1e-20 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-20 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 3e-20 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 5e-20 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 5e-20 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 6e-20 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 7e-20 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 9e-20 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 9e-20 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-19 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 3e-19 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 3e-19 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 4e-19 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 4e-19 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 1e-18 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-18 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-18 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 1e-18 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-18 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-18 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-18 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 4e-18 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 5e-18 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 6e-18 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 6e-18 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 7e-18 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 1e-17 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 2e-17 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-17 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 3e-17 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 3e-17 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 3e-17 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 3e-17 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 4e-17 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 4e-17 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 6e-17 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 8e-17 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 8e-17 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-16 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 1e-16 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-16 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-16 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-16 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-16 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 2e-16 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-16 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 3e-16 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 3e-16 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 4e-16 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 4e-16 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 5e-16 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 6e-16 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 6e-16 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 1e-15 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-15 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-15 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 1e-15 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-15 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-15 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-15 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-15 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 4e-15 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 5e-15 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 5e-15 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 8e-15 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 8e-15 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-14 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 1e-14 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 1e-14 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-14 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-14 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-14 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 3e-14 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 3e-14 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 4e-14 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 5e-14 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 6e-14 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 6e-14 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 8e-14 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 1e-13 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-13 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-13 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-13 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 1e-13 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 1e-13 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 1e-13 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-13 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-13 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 2e-13 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-13 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-13 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 3e-13 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 3e-13 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 4e-13 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 4e-13 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 4e-13 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 5e-13 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 6e-13 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 9e-13 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 9e-13 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 9e-13 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 9e-13 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 9e-13 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 1e-12 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-12 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-12 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-12 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-12 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-12 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-12 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-12 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-12 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 3e-12 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 3e-12 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 3e-12 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 4e-12 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 4e-12 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 4e-12 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 5e-12 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 6e-12 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 6e-12 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 6e-12 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 9e-12 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 9e-12 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 1e-11 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-11 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 2e-11 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-11 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-11 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-11 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-11 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-11 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 4e-11 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 4e-11 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 4e-11 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 5e-11 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 5e-11 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 5e-11 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 7e-11 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 7e-11 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 8e-11 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 9e-11 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 9e-11 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 9e-11 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 9e-11 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 1e-10 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 1e-10 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 1e-10 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 1e-10 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-10 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 1e-10 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-10 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 2e-10 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-10 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-10 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-10 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-10 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 3e-10 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 3e-10 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 3e-10 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 3e-10 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 3e-10 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 4e-10 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 4e-10 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 4e-10 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 5e-10 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 5e-10 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 6e-10 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 7e-10 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 7e-10 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 7e-10 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 7e-10 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 7e-10 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 8e-10 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 9e-10 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 9e-10 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 1e-09 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 1e-09 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 1e-09 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 1e-09 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 1e-09 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 1e-09 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-09 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-09 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 2e-09 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 2e-09 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 2e-09 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 3e-09 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 3e-09 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 3e-09 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 3e-09 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 3e-09 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 3e-09 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 4e-09 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 4e-09 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 5e-09 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 5e-09 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 5e-09 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 6e-09 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 6e-09 | |
| pfam08263 | 42 | pfam08263, LRRNT_2, Leucine rich repeat N-terminal | 7e-09 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 7e-09 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 8e-09 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 9e-09 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-08 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-08 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-08 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-08 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-08 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-08 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 3e-08 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 3e-08 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 3e-08 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 3e-08 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 3e-08 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 4e-08 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 4e-08 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 4e-08 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 4e-08 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 4e-08 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 4e-08 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 5e-08 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 6e-08 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 7e-08 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 8e-08 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 9e-08 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 9e-08 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 9e-08 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 9e-08 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 1e-07 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-07 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 1e-07 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 2e-07 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 2e-07 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 3e-07 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 3e-07 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 3e-07 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 4e-07 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 4e-07 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 4e-07 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 6e-07 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 6e-07 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 7e-07 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 7e-07 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 9e-07 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-06 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 1e-06 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 2e-06 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 2e-06 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 2e-06 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-06 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-06 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 3e-06 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 3e-06 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 3e-06 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 4e-06 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 4e-06 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 4e-06 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 5e-06 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 6e-06 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 7e-06 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 7e-06 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 8e-06 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 1e-05 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 1e-05 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 1e-05 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-05 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-05 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-05 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 4e-05 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 4e-05 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 5e-05 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 6e-05 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 7e-05 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 7e-05 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-04 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 1e-04 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 3e-04 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 4e-04 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 6e-04 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 6e-04 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 6e-04 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 0.001 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 0.001 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.002 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.002 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.002 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 0.002 | |
| PLN03210 | 1153 | PLN03210, PLN03210, Resistant to P | 0.002 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 0.003 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.003 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 0.003 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 0.003 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 413 bits (1063), Expect = e-128
Identities = 310/992 (31%), Positives = 482/992 (48%), Gaps = 91/992 (9%)
Query: 17 LQAFKSMIAHEPQGILNSWNDSRHFCEWEGITCGRRHRRVTALDLMSKSLSGSLSPHLGN 76
L +FKS I ++P L++WN S C W+GITC RV ++DL K++SG +S +
Sbjct: 34 LLSFKSSI-NDPLKYLSNWNSSADVCLWQGITC-NNSSRVVSIDLSGKNISGKISSAIFR 91
Query: 77 LSFLREINLSNNTIQGEIPPE-FGRLFRLEALFLSNNSLVGKIPANLSYCSRLTVLCIEY 135
L +++ INLSNN + G IP + F L L LSNN+ G IP L L +
Sbjct: 92 LPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPRGSIPN--LETLDLSN 149
Query: 136 NKLQGRIPLEFVSLSKLKDLSLAKNKLTGGIPPFLGNLTSLEVLSLAGNSFGRNIPDSLG 195
N L G IP + S S LK L L N L G IP L NLTSLE L+LA N IP LG
Sbjct: 150 NMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELG 209
Query: 196 QLKQLKILAIGGNNLSGPIPPSIYNLSFLVVFSVSHNQIHGSLPPSLGLLLPNLKFFQIH 255
Q+K LK + +G NNLSG IP I L+ L + +N + G +P SLG L NL++ ++
Sbjct: 210 QMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNL-KNLQYLFLY 268
Query: 256 HNFFSGSIPISLSNASKLEHIEIANNNFSGKLSVNFGGMKNLSLLNLQFSNLGSGESDEM 315
N SG IP S+ + KL +++++N+ SG++ ++NL +L+L FSN +G+
Sbjct: 269 QNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHL-FSNNFTGKIPV- 326
Query: 316 GFMNSLTNCSKLRVLSLGGNQFRGALPHSIANLSSQ--LQILILSSNQFYGSIPLGIGNL 373
+LT+ +L+VL L N+F G +P NL L +L LS+N G IP G+ +
Sbjct: 327 ----ALTSLPRLQVLQLWSNKFSGEIP---KNLGKHNNLTVLDLSTNNLTGEIPEGLCSS 379
Query: 374 VDLYLLGMVENQFTGAIPKEMGKLQKLQGLDFSGNHFSGEIPSSLGNLSSLYEVFFNNNN 433
+L+ L + N G IPK +G + L+ + N FSGE+PS L +Y + +NNN
Sbjct: 380 GNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNN 439
Query: 434 LSGVIPFSLGNLKRLAFLEMSGNELSGTIPEDIFNISYLSNSLNLARNHLVGIIPPRIGN 493
L G I ++ L L ++ N+ G +P D F L N L+L+RN G +P ++G+
Sbjct: 440 LQGRINSRKWDMPSLQMLSLARNKFFGGLP-DSFGSKRLEN-LDLSRNQFSGAVPRKLGS 497
Query: 494 LRALRSFDVSNNDLSGEIPIELGHCSSLEEIYLAGNLFHGSIPSFFNALKGVQKIDLSRN 553
L L +S N LSGEIP EL C L + L+ N G IP+ F+ + + ++DLS+N
Sbjct: 498 LSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQN 557
Query: 554 NLSGQIPIFLEAL-SLEYLNLSFNDFEGKIPAKGIFANASAISVVGCNRLCGGIPELQLP 612
LSG+IP L + SL +N+S N G +P+ G F +A +V G LCGG LP
Sbjct: 558 QLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLP 617
Query: 613 KCTESKSSSQKISRRLKIIISAITAFSGFFMVSFFILYWHKWRRGPSRLPSRPMMR---- 668
C + K I + AF +V+F ++ RG + L + +
Sbjct: 618 PCKRVR----KTPSWWFYITCTLGAFLVLALVAFGFVF----IRGRNNLELKRVENEDGT 669
Query: 669 --------KALPKMSYKSLLKATNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQ 720
K ++ +L + ++I G G YKG ++G+ +K IN
Sbjct: 670 WELQFFDSKVSKSITINDILSSLK---EENVISRGKKGASYKGKSIKNGMQFVVKEIN-D 725
Query: 721 CEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPH 780
S +A+ + ++H N+VK+I C S +++EY+
Sbjct: 726 VNSIPSSEIAD---MGKLQHPNIVKLIGLCRS-----EKGAYLIHEYIEG---------- 767
Query: 781 AVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHI 840
K E+ L+ +R IAI +A AL +LH C ++ +L P I++D H+
Sbjct: 768 ---KNLSEVLRNLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHL 824
Query: 841 GDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAK 900
L L + + Y APE +++ D+Y +G++L+E++T K
Sbjct: 825 -RLSLP--------GLLCTDTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGK 875
Query: 901 KPTDVMFEGDLNLHNFARMALPNQVMDI-VDPILRNDEEILASTDKCRRMQTGINSRLEC 959
P D F ++ +AR + +D+ +DP +R D +N
Sbjct: 876 SPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGD--------------VSVNQNE-- 919
Query: 960 LISMVKIGVACSMESPQDRMNMTNVVHELQSV 991
++ ++ + + C+ P R +V+ L+S
Sbjct: 920 IVEVMNLALHCTATDPTARPCANDVLKTLESA 951
|
Length = 968 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 161 bits (410), Expect = 5e-45
Identities = 68/214 (31%), Positives = 102/214 (47%), Gaps = 26/214 (12%)
Query: 692 IGVGSFGCVYKGALDEDGIVVAIKVINLQ-CEGASKSFMAECKALKNIRHRNLVKVITSC 750
+G G FG VY + G VAIK+I + + + E + LK + H N+VK+
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 751 SSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALD 810
+ +V EY GSL+ L KE E KL+ + + I + + L+
Sbjct: 61 ED-----ENHLYLVMEYCEGGSLKDLL---------KENEGKLSEDEILRILLQILEGLE 106
Query: 811 YLHHHCQEPILHCDLKPSNILLDNDLSGH--IGDFGLARFHQEVSNSTLSSSVGVKGTIG 868
YLH + I+H DLKP NILLD+D +G + DFGL++ + + + GT
Sbjct: 107 YLHSN---GIIHRDLKPENILLDSD-NGKVKLADFGLSKLLTSDKSLLKT----IVGTPA 158
Query: 869 YTAPEYGLG-SEVSTNGDVYSYGILLLEMVTAKK 901
Y APE LG S D++S G++L E+ K
Sbjct: 159 YMAPEVLLGKGYYSEKSDIWSLGVILYELPELKD 192
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 154 bits (393), Expect = 2e-42
Identities = 80/227 (35%), Positives = 107/227 (47%), Gaps = 32/227 (14%)
Query: 691 LIGVGSFGCVYKGALDEDGIVVAIKVINLQ-CEGASKSFMAECKALKNIRHRNLVKVITS 749
+G GSFG VY + G +VAIKVI + + + + E K LK ++H N+V++
Sbjct: 6 KLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYDV 65
Query: 750 CSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASAL 809
F+ D +V EY G L L R E E + + SAL
Sbjct: 66 -----FEDEDKLYLVMEYCEGGDLFDLLKKR---GRLSEDEAR-------FYLRQILSAL 110
Query: 810 DYLHHHCQEPILHCDLKPSNILLDNDLSGH--IGDFGLARFHQEVSNSTLSSSVGVKGTI 867
+YLH I+H DLKP NILLD D GH + DFGLAR L++ V GT
Sbjct: 111 EYLHSKG---IVHRDLKPENILLDED--GHVKLADFGLARQLD--PGEKLTTFV---GTP 160
Query: 868 GYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLH 914
Y APE LG D++S G++L E++T K P F GD L
Sbjct: 161 EYMAPEVLLGKGYGKAVDIWSLGVILYELLTGKPP----FPGDDQLL 203
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 151 bits (383), Expect = 6e-41
Identities = 72/214 (33%), Positives = 109/214 (50%), Gaps = 25/214 (11%)
Query: 692 IGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASK--SFMAECKALKNIRHRNLVKVITS 749
+G GSFG VYK G +VA+K++ + E + K + E + L+ + H N+V++I +
Sbjct: 7 LGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDA 66
Query: 750 CSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASAL 809
F+ D +V EY G L +L L+ + IA+ + L
Sbjct: 67 -----FEDKDHLYLVMEYCEGGDLFDYLSRG----------GPLSEDEAKKIALQILRGL 111
Query: 810 DYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGY 869
+YLH + I+H DLKP NILLD + I DFGLA+ S+S+L++ V GT Y
Sbjct: 112 EYLHSN---GIIHRDLKPENILLDENGVVKIADFGLAKKL-LKSSSSLTTFV---GTPWY 164
Query: 870 TAPE-YGLGSEVSTNGDVYSYGILLLEMVTAKKP 902
APE G+ DV+S G++L E++T K P
Sbjct: 165 MAPEVLLGGNGYGPKVDVWSLGVILYELLTGKPP 198
|
Length = 260 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 138 bits (349), Expect = 2e-36
Identities = 80/303 (26%), Positives = 132/303 (43%), Gaps = 57/303 (18%)
Query: 692 IGVGSFGCVYKGALDEDG----IVVAIKVINLQC-EGASKSFMAECKALKNIRHRNLVKV 746
+G G+FG VYKG L G + VA+K + E + F+ E + ++ + H N+VK+
Sbjct: 7 LGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVKL 66
Query: 747 ITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVA 806
+ C+ + IV EYMP G L +L + R KE+ +L +S A+ +A
Sbjct: 67 LGVCTE---EEPLM--IVMEYMPGGDLLDYLRKN----RPKEL----SLSDLLSFALQIA 113
Query: 807 SALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGT 866
++YL +H DL N L+ +L I DFGL+R ++ + G K
Sbjct: 114 RGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSR---DLYDDDYYKVKGGKLP 167
Query: 867 IGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT-AKKPTDVMFEGDLNLHNFARMALPNQV 925
I + APE + ++ DV+S+G+LL E+ T ++P M
Sbjct: 168 IRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGM------------------- 208
Query: 926 MDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVV 985
++ E+L K R+ C + K+ + C E P+DR + +V
Sbjct: 209 ---------SNAEVLEYLKKGYRLP----KPPNCPPELYKLMLQCWAEDPEDRPTFSELV 255
Query: 986 HEL 988
L
Sbjct: 256 EIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 137 bits (348), Expect = 3e-36
Identities = 77/303 (25%), Positives = 129/303 (42%), Gaps = 58/303 (19%)
Query: 692 IGVGSFGCVYKGALDEDG----IVVAIKVINLQC-EGASKSFMAECKALKNIRHRNLVKV 746
+G G+FG VYKG L G + VA+K + E + F+ E + ++ + H N+VK+
Sbjct: 7 LGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVKL 66
Query: 747 ITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVA 806
+ C+ + + IV EYM G L +L + KL+L +S A+ +A
Sbjct: 67 LGVCTE---EEPLY--IVMEYMEGGDLLSYLRKNRP---------KLSLSDLLSFALQIA 112
Query: 807 SALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGT 866
++YL +H DL N L+ +L I DFGL+R ++ + G K
Sbjct: 113 RGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSR---DLYDDDYYRKRGGKLP 166
Query: 867 IGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT-AKKPTDVMFEGDLNLHNFARMALPNQV 925
I + APE + ++ DV+S+G+LL E+ T ++P M
Sbjct: 167 IRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGM------------------- 207
Query: 926 MDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVV 985
++EE+L R+ C + + + C E P+DR + +V
Sbjct: 208 ---------SNEEVLEYLKNGYRLP----QPPNCPPELYDLMLQCWAEDPEDRPTFSELV 254
Query: 986 HEL 988
L
Sbjct: 255 EIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 136 bits (346), Expect = 5e-36
Identities = 68/217 (31%), Positives = 103/217 (47%), Gaps = 25/217 (11%)
Query: 692 IGVGSFGCVYKGAL----DEDGIVVAIKVINLQC-EGASKSFMAECKALKNIRHRNLVKV 746
+G G+FG VYKG L + VA+K + E + F+ E +K + H N+V++
Sbjct: 7 LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66
Query: 747 ITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVA 806
+ C+ QG IV EYMP G L +L H KLTL + +A+ +A
Sbjct: 67 LGVCT----QGEPLY-IVTEYMPGGDLLDFLRKH---------GEKLTLKDLLQMALQIA 112
Query: 807 SALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGT 866
++YL +H DL N L+ +L I DFGL+R E G K
Sbjct: 113 KGMEYLESK---NFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYR--KRGGGKLP 167
Query: 867 IGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT-AKKP 902
I + APE + ++ DV+S+G+LL E+ T ++P
Sbjct: 168 IKWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGEQP 204
|
Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 132 bits (335), Expect = 2e-34
Identities = 81/311 (26%), Positives = 128/311 (41%), Gaps = 64/311 (20%)
Query: 692 IGVGSFGCVYKGAL---DEDGIVVAIKVINLQCEGASKS----FMAECKALKNIRHRNLV 744
+G G+FG VYKG L D VA+K + E AS+ F+ E + +K + H N+V
Sbjct: 3 LGEGAFGEVYKGKLKGKDGKTTEVAVKTL---KEDASEEERKDFLKEARVMKKLGHPNVV 59
Query: 745 KVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAID 804
+++ C+ + + +V EYM G L +L P + L+L +S AI
Sbjct: 60 RLLGVCTE---EEPLY--LVLEYMEGGDLLDYLRKSR-PVFPSPEKSTLSLKDLLSFAIQ 113
Query: 805 VASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVK 864
+A ++YL +H DL N L+ DL I DFGL+R K
Sbjct: 114 IAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVY-------DDDYYRK 163
Query: 865 GTIG-----YTAPEYGLGSEVSTNGDVYSYGILLLEMVT-AKKPTDVMFEGDLNLHNFAR 918
T G + APE ++ DV+S+G+LL E+ T P + G
Sbjct: 164 KTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATP----YPG--------- 210
Query: 919 MALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDR 978
L N+ E+L K R+ C + ++ ++C P+DR
Sbjct: 211 --LSNE-------------EVLEYLRKGYRLPKPEY----CPDELYELMLSCWQLDPEDR 251
Query: 979 MNMTNVVHELQ 989
+ +V L+
Sbjct: 252 PTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 132 bits (334), Expect = 2e-34
Identities = 62/215 (28%), Positives = 100/215 (46%), Gaps = 20/215 (9%)
Query: 690 HLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGA--SKSFMAECKALKNIRHRNLVKVI 747
L+G GSFG VY + G ++A+K + L + ++ E + L +++H N+V+
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 748 TSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVAS 807
S + + I EY+ GSL L + E I+ Q +
Sbjct: 66 GSERDEE---KNTLNIFLEYVSGGSLSSLLKKF---GKLPEPVIRKYTRQ-------ILE 112
Query: 808 ALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTI 867
L YLH + I+H D+K +NIL+D+D + DFG A+ ++ + S V+GT
Sbjct: 113 GLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGS--VRGTP 167
Query: 868 GYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKP 902
+ APE G E D++S G ++EM T K P
Sbjct: 168 YWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPP 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 2e-30
Identities = 77/214 (35%), Positives = 107/214 (50%), Gaps = 24/214 (11%)
Query: 691 LIGVGSFGCVYKGALDEDGIVVAIKVINLQ--CEGASKSFMAECKALKNIRHRNLVKVIT 748
LIG G+FG VYKG E G VAIK I+L+ E A KS M E LKN++H N+VK I
Sbjct: 7 LIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIG 66
Query: 749 SCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASA 808
S + +D I+ EY NGSL + + E + + + Q V
Sbjct: 67 S-----IETSDSLYIILEYAENGSLRQIIKKFG---PFPESLVAVYVYQ-------VLQG 111
Query: 809 LDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIG 868
L YLH ++ ++H D+K +NIL D + DFG+A +VS S V GT
Sbjct: 112 LAYLH---EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDAS----VVGTPY 164
Query: 869 YTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKP 902
+ APE S ST D++S G ++E++T P
Sbjct: 165 WMAPEVIEMSGASTASDIWSLGCTVIELLTGNPP 198
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 117 bits (297), Expect = 2e-29
Identities = 80/263 (30%), Positives = 119/263 (45%), Gaps = 40/263 (15%)
Query: 691 LIGVGSFGCVYKGALDEDGIVVAIKVINLQC--EGASKSFMAECKALKNIRHRNLVKVIT 748
IG GSFG VY DG + +K I+L E + + E K LK + H N++K
Sbjct: 7 QIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYE 66
Query: 749 SCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASA 808
S F+ IV EY G L + + K+ K+ Q + + + A
Sbjct: 67 S-----FEEKGKLCIVMEYADGGDLSQKI------KKQKKEGKPFPEEQILDWFVQLCLA 115
Query: 809 LDYLHHHCQEPILHCDLKPSNILLDNDLSGHI--GDFGLARFHQEVSNSTLSSSVGVKGT 866
L YLH ILH D+KP NI L ++ G + GDFG+++ V +ST+ + V GT
Sbjct: 116 LKYLH---SRKILHRDIKPQNIFLTSN--GLVKLGDFGISK----VLSSTVDLAKTVVGT 166
Query: 867 IGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARM------- 919
Y +PE + D++S G +L E+ T K P FEG+ NL A
Sbjct: 167 PYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHP----FEGE-NLLELALKILKGQYP 221
Query: 920 ALPNQV----MDIVDPILRNDEE 938
+P+Q ++V +L+ D E
Sbjct: 222 PIPSQYSSELRNLVSSLLQKDPE 244
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 6e-28
Identities = 73/232 (31%), Positives = 117/232 (50%), Gaps = 38/232 (16%)
Query: 692 IGVGSFGCVYKGALDEDGIVVAIKVINLQCE--GASKSFMAECKALKNIRHRNLVK---V 746
IG G++G VYK + G +VA+K I ++ E G + + E K L+ +RH N+V+ +
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEI 66
Query: 747 ITSCSSIDFQGNDFKAIVYEYMP---NGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAI 803
+TS +G+ + +V+EYM G L+ P E+K T Q
Sbjct: 67 VTSKG----KGSIY--MVFEYMDHDLTGLLD---SP----------EVKFTESQIKCYMK 107
Query: 804 DVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGV 863
+ L YLH + ILH D+K SNIL++ND + DFGLAR + + +++ ++ V +
Sbjct: 108 QLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRV-I 163
Query: 864 KGTIGYTAPEYGLGSEVSTNG-DVYSYGILLLEMVTAKKPTDVMFEGDLNLH 914
T+ Y PE LG+ D++S G +L E+ KP +F+G L
Sbjct: 164 --TLWYRPPELLLGATRYGPEVDMWSVGCILAELFL-GKP---IFQGSTELE 209
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 8e-28
Identities = 65/212 (30%), Positives = 97/212 (45%), Gaps = 24/212 (11%)
Query: 692 IGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSCS 751
IG G FG VYK G VAIKVI L+ + + + E + LK +H N+VK S
Sbjct: 8 IGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGS-- 65
Query: 752 SIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDY 811
+ D IV E+ GSL+ L + E +I + ++ L+Y
Sbjct: 66 ---YLKKDELWIVMEFCSGGSLKDLLKST--NQTLTESQIAY-------VCKELLKGLEY 113
Query: 812 LHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLA-RFHQEVSNSTLSSSVGVKGTIGYT 870
LH + I+H D+K +NILL +D + DFGL+ + + +T+ GT +
Sbjct: 114 LHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMV------GTPYWM 164
Query: 871 APEYGLGSEVSTNGDVYSYGILLLEMVTAKKP 902
APE G D++S GI +E+ K P
Sbjct: 165 APEVINGKPYDYKADIWSLGITAIELAEGKPP 196
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 71/207 (34%), Positives = 108/207 (52%), Gaps = 28/207 (13%)
Query: 691 LIGVGSFGCVYKGALDEDGIVVAIKVINLQCEG-ASKSFMAECKALKNIRHRNLVKVITS 749
IG G FG V G D G VA+K L+ + A+++F+AE + +RH NLV+++
Sbjct: 13 TIGKGEFGDVMLG--DYRGQKVAVK--CLKDDSTAAQAFLAEASVMTTLRHPNLVQLL-- 66
Query: 750 CSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASAL 809
+ QGN IV EYM GSL +L R + + +TL Q++ A+DV +
Sbjct: 67 --GVVLQGNPL-YIVTEYMAKGSLVDYL-------RSRGRAV-ITLAQQLGFALDVCEGM 115
Query: 810 DYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGY 869
+YL ++ +H DL N+L+ DL + DFGLA+ ++ G K + +
Sbjct: 116 EYLE---EKNFVHRDLAARNVLVSEDLVAKVSDFGLAK------EASQGQDSG-KLPVKW 165
Query: 870 TAPEYGLGSEVSTNGDVYSYGILLLEM 896
TAPE + ST DV+S+GILL E+
Sbjct: 166 TAPEALREKKFSTKSDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 4e-26
Identities = 80/232 (34%), Positives = 113/232 (48%), Gaps = 37/232 (15%)
Query: 686 FSSTHLIGVGSFGCVYKGALD-EDGIVVAIKVINL--QCEGASKSFMAECKALKNIRHRN 742
+ +G G++G VYK A D + G +VA+K I L + EG + + E LK ++H N
Sbjct: 1 YEKLEKLGEGTYGVVYK-ARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPN 59
Query: 743 LVK---VITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRI 799
+VK VI + + +V+EY L+K+L P IK + Q +
Sbjct: 60 IVKLLDVIHTERKL--------YLVFEYCDM-DLKKYLDKRPGPL--SPNLIKSIMYQLL 108
Query: 800 SIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSS 859
L Y H H ILH DLKP NIL++ D + DFGLAR + T +
Sbjct: 109 R-------GLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFG-IPLRTYTH 157
Query: 860 SVGVKGTIGYTAPEYGLGSEV-STNGDVYSYGILLLEMVTAKKPTDVMFEGD 910
V V T+ Y APE LGS+ ST D++S G + EM+T KP +F GD
Sbjct: 158 EV-V--TLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMIT-GKP---LFPGD 202
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 8e-26
Identities = 72/221 (32%), Positives = 106/221 (47%), Gaps = 24/221 (10%)
Query: 692 IGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSCS 751
+G G FG V++G L ++ + VAIK++ + F E +ALK +RH++L+ + CS
Sbjct: 14 LGSGYFGEVWEG-LWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCS 72
Query: 752 SIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDY 811
+ I+ E M GSL +L R E L + I +A VA + Y
Sbjct: 73 -----VGEPVYIITELMEKGSLLAFL-------RSPE-GQVLPVASLIDMACQVAEGMAY 119
Query: 812 LHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTA 871
L ++ +H DL NIL+ DL + DFGLAR +E + + K +TA
Sbjct: 120 LE---EQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYK----WTA 172
Query: 872 PEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLN 912
PE ST DV+S+GILL EM T + V + G N
Sbjct: 173 PEAASHGTFSTKSDVWSFGILLYEMFTYGQ---VPYPGMNN 210
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 1e-25
Identities = 65/214 (30%), Positives = 106/214 (49%), Gaps = 29/214 (13%)
Query: 692 IGVGSFGCVYKGALDEDG---IVVAIKVINLQC-EGASKSFMAECKALKNIRHRNLVK-- 745
IG G FG V +G L G I VAIK + + F+ E + H N+++
Sbjct: 12 IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLE 71
Query: 746 -VITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAID 804
V+T + I+ EYM NGSL+K+L + + K T+ Q + +
Sbjct: 72 GVVTKSRPV--------MIITEYMENGSLDKFLREN---------DGKFTVGQLVGMLRG 114
Query: 805 VASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVK 864
+AS + YL +H DL NIL++++L + DFGL+R E S +T ++ G K
Sbjct: 115 IASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSR-RLEDSEATYTTKGG-K 169
Query: 865 GTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT 898
I +TAPE + ++ DV+S+GI++ E+++
Sbjct: 170 IPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 7e-25
Identities = 71/218 (32%), Positives = 103/218 (47%), Gaps = 30/218 (13%)
Query: 687 SSTHL---IGVGSFGCVYKGALDEDGIV-VAIKVINLQCEGA--SKSFMAECKALKNIRH 740
S L +G G FG V+ G + G VA+K + G ++F+ E + +K +RH
Sbjct: 6 ESLKLERKLGAGQFGEVWMGTWN--GTTKVAVKTLK---PGTMSPEAFLQEAQIMKKLRH 60
Query: 741 RNLVKVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRIS 800
LV++ CS + IV EYM GSL +L + E KL L Q +
Sbjct: 61 DKLVQLYAVCS----EEEPI-YIVTEYMSKGSLLDFL-------KSGE-GKKLRLPQLVD 107
Query: 801 IAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSS 860
+A +A + YL +H DL NIL+ +L I DFGLAR + + ++
Sbjct: 108 MAAQIAEGMAYLE---SRNYIHRDLAARNILVGENLVCKIADFGLARL---IEDDEYTAR 161
Query: 861 VGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT 898
G K I +TAPE + DV+S+GILL E+VT
Sbjct: 162 EGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 8e-25
Identities = 83/287 (28%), Positives = 121/287 (42%), Gaps = 52/287 (18%)
Query: 692 IGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSCS 751
+G G FG V++G L + VA+K + K F+AE + +K +RH L+++ C+
Sbjct: 14 LGAGQFGEVWEG-LWNNTTPVAVKTLKPGTMDP-KDFLAEAQIMKKLRHPKLIQLYAVCT 71
Query: 752 SIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDY 811
+ IV E M GSL ++L +KL Q I +A VAS + Y
Sbjct: 72 L-----EEPIYIVTELMKYGSLLEYLQ------GGAGRALKLP--QLIDMAAQVASGMAY 118
Query: 812 LHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTA 871
L +H DL N+L+ + + DFGLAR +E + G K I +TA
Sbjct: 119 LEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKE---DIYEAREGAKFPIKWTA 172
Query: 872 PEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMALPNQVMDIVDP 931
PE L + S DV+S+GILL E+VT + RM P
Sbjct: 173 PEAALYNRFSIKSDVWSFGILLTEIVT-----------------YGRMPYPGM------- 208
Query: 932 ILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDR 978
+ E+L D+ RM C + I + C E P DR
Sbjct: 209 ---TNAEVLQQVDQGYRMPCPPG----CPKELYDIMLDCWKEDPDDR 248
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 105 bits (262), Expect = 4e-24
Identities = 71/222 (31%), Positives = 105/222 (47%), Gaps = 28/222 (12%)
Query: 691 LIGVGSFGCVYKGALDEDGIVVAIKVINLQ---CEGASKSFMAECKALKNIRH-RNLVKV 746
+G GSFG VY D +VA+KV+ + + F+ E + L ++ H N+VK+
Sbjct: 7 KLGEGSFGEVYLA---RDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKL 63
Query: 747 ITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVA 806
FQ +V EY+ GSLE L + L+ + + I +
Sbjct: 64 YDF-----FQDEGSLYLVMEYVDGGSLEDLLKKI-------GRKGPLSESEALFILAQIL 111
Query: 807 SALDYLHHHCQEPILHCDLKPSNILLD-NDLSGHIGDFGLARF--HQEVSNSTLSSSVGV 863
SAL+YLH I+H D+KP NILLD + + DFGLA+ ++S +
Sbjct: 112 SALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTS 168
Query: 864 KGTIGYTAPEYGLGSE---VSTNGDVYSYGILLLEMVTAKKP 902
GT GY APE LG S++ D++S GI L E++T P
Sbjct: 169 VGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPP 210
|
Length = 384 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 4e-24
Identities = 70/212 (33%), Positives = 100/212 (47%), Gaps = 26/212 (12%)
Query: 692 IGVGSFGCVYKGALDEDGIVVAIKVINLQCEGA--SKSFMAECKALKNIRHRNLVKVITS 749
+G G FG V+ G I VAIK+I EGA F+ E K + + H NLV++
Sbjct: 12 LGSGQFGVVHLGKW-RGKIDVAIKMIR---EGAMSEDDFIEEAKVMMKLSHPNLVQLYGV 67
Query: 750 CSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASAL 809
C+ Q F IV EYM NG L +L + K LL + DV A+
Sbjct: 68 CTK---QRPIF--IVTEYMANGCLLNYL------RERKGKLGTEWLL---DMCSDVCEAM 113
Query: 810 DYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGY 869
+YL + +H DL N L+ D + DFGLAR+ V + +SS G K + +
Sbjct: 114 EYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARY---VLDDQYTSSQGTKFPVKW 167
Query: 870 TAPEYGLGSEVSTNGDVYSYGILLLEMVTAKK 901
PE S S+ DV+S+G+L+ E+ + K
Sbjct: 168 APPEVFDYSRFSSKSDVWSFGVLMWEVFSEGK 199
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 71/216 (32%), Positives = 95/216 (43%), Gaps = 29/216 (13%)
Query: 692 IGVGSFGCVYKGALDEDGIVVAIKVIN---LQCEGASKSFMAECKALKNIRHRNLVKVIT 748
+G GSFG V + G + A+KV+ + + + E L I H +VK
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVK--L 58
Query: 749 SCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASA 808
+ FQ + +V EY P G L L R E + A ++ A
Sbjct: 59 HYA---FQTEEKLYLVLEYAPGGELFSHLSKE---GRFSEERARF-------YAAEIVLA 105
Query: 809 LDYLHHHCQEPILHCDLKPSNILLDNDLSGHI--GDFGLARFHQEVSNSTLSSSVGVKGT 866
L+YLH I++ DLKP NILLD D GHI DFGLA+ S ++ G T
Sbjct: 106 LEYLH---SLGIIYRDLKPENILLDAD--GHIKLTDFGLAK-ELSSEGSRTNTFCG---T 156
Query: 867 IGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKP 902
Y APE LG D +S G+LL EM+T K P
Sbjct: 157 PEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPP 192
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 72/262 (27%), Positives = 111/262 (42%), Gaps = 29/262 (11%)
Query: 692 IGVGSFGCVYKGAL----DEDGIVVAIKVINLQCEGASKS-FMAECKALKNIRHRNLVKV 746
+G G FG V D G VA+K +N E +S F E + L+ + H N+VK
Sbjct: 12 LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKY 71
Query: 747 ITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVA 806
C G ++ EY+P+GSL +L H ++ L + + + +
Sbjct: 72 KGVCEK---PGGRSLRLIMEYLPSGSLRDYLQRHRD---------QINLKRLLLFSSQIC 119
Query: 807 SALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGT 866
+DYL + +H DL NIL++++ I DFGLA+ E + G +
Sbjct: 120 KGMDYLG---SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPG-ESP 175
Query: 867 IGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMALPNQVM 926
I + APE S+ S+ DV+S+G+ L E+ T P+ F RM Q
Sbjct: 176 IFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQS------PPAEFLRMIGIAQGQ 229
Query: 927 DIVDPILR--NDEEILASTDKC 946
IV +L + E L C
Sbjct: 230 MIVTRLLELLKEGERLPRPPSC 251
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 98.8 bits (247), Expect = 8e-23
Identities = 67/221 (30%), Positives = 102/221 (46%), Gaps = 36/221 (16%)
Query: 690 HLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGAS-KSFMAECKALKNIRHRNLVKVIT 748
++G GS G VYK G + A+K I++ + K + E K L++ +VK
Sbjct: 7 KVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVK--- 63
Query: 749 SCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEI-EIKLTLLQRISIAIDVAS 807
C ++ + +IV EYM GSL L K+ +I E L IA +
Sbjct: 64 -CYGAFYKEGEI-SIVLEYMDGGSLADLL------KKVGKIPEPVLAY-----IARQILK 110
Query: 808 ALDYLH--HHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVK- 864
LDYLH H I+H D+KPSN+L+++ I DFG+++ L +++
Sbjct: 111 GLDYLHTKRH----IIHRDIKPSNLLINSKGEVKIADFGISK--------VLENTLDQCN 158
Query: 865 ---GTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKP 902
GT+ Y +PE G S D++S G+ LLE K P
Sbjct: 159 TFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFP 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 97.2 bits (242), Expect = 3e-22
Identities = 59/209 (28%), Positives = 107/209 (51%), Gaps = 20/209 (9%)
Query: 690 HLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITS 749
H +G G +G VY+G + + VA+K + + + F+ E +K I+H NLV+++
Sbjct: 12 HKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 70
Query: 750 CSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASAL 809
C+ + F I+ E+M G+L +L + +++ + LL +A ++SA+
Sbjct: 71 CT----REPPF-YIITEFMTYGNLLDYLR-----ECNRQEVNAVVLLY---MATQISSAM 117
Query: 810 DYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGY 869
+YL ++ +H DL N L+ + + DFGL+R T ++ G K I +
Sbjct: 118 EYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG---DTYTAHAGAKFPIKW 171
Query: 870 TAPEYGLGSEVSTNGDVYSYGILLLEMVT 898
TAPE ++ S DV+++G+LL E+ T
Sbjct: 172 TAPESLAYNKFSIKSDVWAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 97.5 bits (243), Expect = 3e-22
Identities = 73/226 (32%), Positives = 111/226 (49%), Gaps = 29/226 (12%)
Query: 692 IGVGSFGCVYKGAL-----DEDGIVVAIKVINLQC-EGASKSFMAECKALKNIRHRNLVK 745
+G G+FG V+ G + D +VA+K + A K F E + L N +H N+VK
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 746 VITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPH----AVPKRDKEIEIKLTLLQRISI 801
C+ +G D +V+EYM +G L K+L H A K +LTL Q + I
Sbjct: 73 FYGVCT----EG-DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQI 127
Query: 802 AIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSV 861
A+ +AS + YL + +H DL N L+ DL IGDFG++R +V +
Sbjct: 128 AVQIASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSR---DVYTTDYYR-- 179
Query: 862 GVKGT----IGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT-AKKP 902
V G I + PE + + +T DV+S+G++L E+ T K+P
Sbjct: 180 -VGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 95.9 bits (239), Expect = 8e-22
Identities = 65/219 (29%), Positives = 104/219 (47%), Gaps = 25/219 (11%)
Query: 690 HLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMA---ECKALKNIRHRNLVKV 746
+ IG G+FG VY + G ++A+K I +Q + K+ E K L+ ++H NLVK
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQ-DNDPKTIKEIADEMKVLELLKHPNLVK- 63
Query: 747 ITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVA 806
++ I EY G+LE+ L I +++ ++ +
Sbjct: 64 ---YYGVEVHREKV-YIFMEYCSGGTLEELLE-------HGRIL-DEHVIRVYTLQL--L 109
Query: 807 SALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGT 866
L YLH H I+H D+KP+NI LD++ +GDFG A + + + + GT
Sbjct: 110 EGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGT 166
Query: 867 IGYTAPEYGLGSEVSTNG---DVYSYGILLLEMVTAKKP 902
Y APE G + +G D++S G ++LEM T K+P
Sbjct: 167 PAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRP 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 95.7 bits (238), Expect = 9e-22
Identities = 66/220 (30%), Positives = 105/220 (47%), Gaps = 35/220 (15%)
Query: 692 IGVGSFGCV----YKGALDEDGIVVAIKVINLQCEGA--SKSFMAECKALKNIRHRNLVK 745
+G G FG V ++G D VAIK+I EG+ F+ E K + + H LV+
Sbjct: 12 LGTGQFGVVKYGKWRGQYD-----VAIKMIK---EGSMSEDEFIEEAKVMMKLSHEKLVQ 63
Query: 746 VITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDV 805
+ C+ Q + IV EYM NG L +L +E + Q + + DV
Sbjct: 64 LYGVCTK---QRPIY--IVTEYMSNGCLLNYL---------REHGKRFQPSQLLEMCKDV 109
Query: 806 ASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKG 865
+ YL +H DL N L+D+ + DFGL+R+ V + +SSVG K
Sbjct: 110 CEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRY---VLDDEYTSSVGSKF 163
Query: 866 TIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT-AKKPTD 904
+ ++ PE L S+ S+ DV+++G+L+ E+ + K P +
Sbjct: 164 PVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYE 203
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 95.0 bits (236), Expect = 1e-21
Identities = 62/205 (30%), Positives = 104/205 (50%), Gaps = 28/205 (13%)
Query: 692 IGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSCS 751
IG G FG V +G + G VA+K N++C+ +++F+ E + + H+NLV+++
Sbjct: 14 IGEGEFGAVLQG--EYTGQKVAVK--NIKCDVTAQAFLEETAVMTKLHHKNLVRLL---G 66
Query: 752 SIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDY 811
I G IV E M G+L +L ++++Q + ++DVA ++Y
Sbjct: 67 VILHNG---LYIVMELMSKGNLVNFLRTRG--------RALVSVIQLLQFSLDVAEGMEY 115
Query: 812 LHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTA 871
L + ++H DL NIL+ D + DFGLAR +++ + VK +TA
Sbjct: 116 LE---SKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSK---LPVK----WTA 165
Query: 872 PEYGLGSEVSTNGDVYSYGILLLEM 896
PE + S+ DV+SYG+LL E+
Sbjct: 166 PEALKHKKFSSKSDVWSYGVLLWEV 190
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 94.6 bits (236), Expect = 4e-21
Identities = 61/213 (28%), Positives = 93/213 (43%), Gaps = 24/213 (11%)
Query: 686 FSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVK 745
+ + IG G+ G VYK G VAIK + L+ + E +K+ +H N+V
Sbjct: 21 YKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIIN-EILIMKDCKHPNIVD 79
Query: 746 VITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDV 805
S + D +V EYM GSL + + V + +I + +V
Sbjct: 80 YYDS-----YLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIA---------YVCREV 125
Query: 806 ASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGL-ARFHQEVSNSTLSSSVGVK 864
L+YLH + ++H D+K NILL D S + DFG A+ +E S V
Sbjct: 126 LQGLEYLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRN-----SVV 177
Query: 865 GTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMV 897
GT + APE + D++S GI+ +EM
Sbjct: 178 GTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMA 210
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 93.5 bits (233), Expect = 4e-21
Identities = 64/218 (29%), Positives = 100/218 (45%), Gaps = 34/218 (15%)
Query: 692 IGVGSFGCVYKGALDEDGIVVAIKVINLQ-C--EGASKSFMAECKALKNIRHRNLVKVIT 748
IG G+FG V + + A+K +N Q C +G+ ++ + E + L+ + H LV +
Sbjct: 8 IGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWY 67
Query: 749 SCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASA 808
S FQ + +V + + G L ++ V + E ++K ++ A
Sbjct: 68 S-----FQDEENMYLVVDLLLGGDL-RYHLSQKV--KFSEEQVKF-------WICEIVLA 112
Query: 809 LDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIG 868
L+YLH I+H D+KP NILLD HI DF +A +V+ TL + GT G
Sbjct: 113 LEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIAT---KVTPDTL--TTSTSGTPG 164
Query: 869 YTAPE----YGLGSEVSTNGDVYSYGILLLEMVTAKKP 902
Y APE G V D +S G+ E + K+P
Sbjct: 165 YMAPEVLCRQGYSVAV----DWWSLGVTAYECLRGKRP 198
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 92.6 bits (230), Expect = 1e-20
Identities = 79/293 (26%), Positives = 132/293 (45%), Gaps = 65/293 (22%)
Query: 692 IGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVK---VIT 748
+G G FG V+ G VAIK + Q + ++F+AE +K ++H LV+ V+T
Sbjct: 14 LGAGQFGEVWMG-YYNGHTKVAIKSLK-QGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT 71
Query: 749 SCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASA 808
+ I+ EYM NGSL +L K + I++ + L I +A +A
Sbjct: 72 ---------QEPIYIITEYMENGSLVDFL------KTPEGIKLTINKL--IDMAAQIAEG 114
Query: 809 LDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIG 868
+ ++ ++ +H DL+ +NIL+ L I DFGLAR + ++ ++ G K I
Sbjct: 115 MAFIE---RKNYIHRDLRAANILVSETLCCKIADFGLARL---IEDNEYTAREGAKFPIK 168
Query: 869 YTAPE---YGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMALPNQV 925
+TAPE YG + DV+S+GILL E+VT + R+ P
Sbjct: 169 WTAPEAINYGT---FTIKSDVWSFGILLTEIVT-----------------YGRIPYPG-- 206
Query: 926 MDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDR 978
+ E++ + ++ RM N C + ++ C E P++R
Sbjct: 207 --------MTNPEVIQNLERGYRMPRPDN----CPEELYELMRLCWKEKPEER 247
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 92.6 bits (230), Expect = 1e-20
Identities = 64/216 (29%), Positives = 114/216 (52%), Gaps = 28/216 (12%)
Query: 691 LIGVGSFGCVYKGALDEDG---IVVAIKVINL-QCEGASKSFMAECKALKNIRHRNLVK- 745
+IG G FG V +G L G I VAIK + E + F++E + H N++
Sbjct: 11 VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 746 --VITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAI 803
V+T + I+ E+M NG+L+ +L ++ + + T++Q + +
Sbjct: 71 EGVVTKSRPV--------MIITEFMENGALDSFL---------RQNDGQFTVIQLVGMLR 113
Query: 804 DVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQE-VSNSTLSSSVG 862
+A+ + YL + +H DL NIL++++L + DFGL+RF ++ S+ T +SS+G
Sbjct: 114 GIAAGMKYL---SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLG 170
Query: 863 VKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT 898
K I +TAPE + ++ DV+SYGI++ E+++
Sbjct: 171 GKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS 206
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 91.6 bits (228), Expect = 2e-20
Identities = 66/219 (30%), Positives = 99/219 (45%), Gaps = 29/219 (13%)
Query: 692 IGVGSFGCVYKGALDEDGIVVAIKVINL-QCEGASKSFMAECKALKNIRHRNLVKVITSC 750
IGVG+ VY + VAIK I+L +C+ + E +A+ H N+VK TS
Sbjct: 9 IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTS- 67
Query: 751 SSIDFQGNDFKAIVYEYMPNGSLEKWLH--PHAVPKRDKEIEIKLTLLQRISIAIDVASA 808
F D +V Y+ GSL L + P+ + I T+L+ +V
Sbjct: 68 ----FVVGDELWLVMPYLSGGSL---LDIMKSSYPRGGLDEAIIATVLK------EVLKG 114
Query: 809 LDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIG 868
L+YLH + Q +H D+K NILL D S I DFG++ + + T GT
Sbjct: 115 LEYLHSNGQ---IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPC 171
Query: 869 YTAPE-----YGLGSEVSTNGDVYSYGILLLEMVTAKKP 902
+ APE +G + D++S+GI +E+ T P
Sbjct: 172 WMAPEVMEQVHGYDFKA----DIWSFGITAIELATGAAP 206
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 91.5 bits (228), Expect = 3e-20
Identities = 73/275 (26%), Positives = 114/275 (41%), Gaps = 51/275 (18%)
Query: 691 LIGVGSFGCVYKGALDEDGIVVAIKVIN---LQCEGASKSFMAECKAL-KNIRHRNLVKV 746
+IG GSF V E AIK+++ L E K E + L + H ++K+
Sbjct: 8 IIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKL 67
Query: 747 ITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVA 806
+ FQ + V EY PNG L +++ + ++ K T A ++
Sbjct: 68 YYT-----FQDEENLYFVLEYAPNGELLQYIRKY------GSLDEKCTRF----YAAEIL 112
Query: 807 SALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARF-------HQEVSNSTLSS 859
AL+YLH + I+H DLKP NILLD D+ I DFG A+ ++T
Sbjct: 113 LALEYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNID 169
Query: 860 SVGVK---------GTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGD 910
S K GT Y +PE + D+++ G ++ +M+T K P F G
Sbjct: 170 SQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP----FRGS 225
Query: 911 LNLHNFAR-MAL--------PNQVMDIVDPILRND 936
F + + L P D+++ +L D
Sbjct: 226 NEYLTFQKILKLEYSFPPNFPPDAKDLIEKLLVLD 260
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 5e-20
Identities = 66/215 (30%), Positives = 108/215 (50%), Gaps = 30/215 (13%)
Query: 692 IGVGSFGCVYKGALDEDGIVVAIKVINLQC-EGASKSFMAECKALKNIRHRNLVK---VI 747
+G G++ VYKG G +VA+K I+L EG + + E +K ++H N+V+ VI
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVI 67
Query: 748 TSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVAS 807
+ + + +V+EYM + L+K++ H V L S +
Sbjct: 68 HTENKL--------MLVFEYM-DKDLKKYMDTHGVRG-------ALDPNTVKSFTYQLLK 111
Query: 808 ALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLAR-FHQEVSNSTLSSSVGVKGT 866
+ + H + +LH DLKP N+L++ + DFGLAR F V +T S+ V T
Sbjct: 112 GIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPV--NTFSNEV---VT 163
Query: 867 IGYTAPEYGLGSEV-STNGDVYSYGILLLEMVTAK 900
+ Y AP+ LGS ST+ D++S G ++ EM+T +
Sbjct: 164 LWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.2 bits (227), Expect = 5e-20
Identities = 72/233 (30%), Positives = 112/233 (48%), Gaps = 50/233 (21%)
Query: 692 IGVGSFGCVYKGALDEDGIVVAIKVINLQC--EGASKSFMAECKALKNIRHRNLVK---V 746
IG G++G VYK G +VA+K I L+ EG + + E LK + H N+V+ V
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDV 66
Query: 747 ITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVA 806
+ S + + +V+E++ + L+K++ + D + IK L Q +
Sbjct: 67 VHSENKL--------YLVFEFL-DLDLKKYMDSSPLTGLDPPL-IKSYLYQLLQ------ 110
Query: 807 SALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLAR--------FHQEVSNSTLS 858
+ Y H H +LH DLKP N+L+D + + + DFGLAR + EV
Sbjct: 111 -GIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVV----- 161
Query: 859 SSVGVKGTIGYTAPEYGLGS-EVSTNGDVYSYGILLLEMVTAKKPTDVMFEGD 910
T+ Y APE LGS + ST D++S G + EMV ++P +F GD
Sbjct: 162 -------TLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVN-RRP---LFPGD 203
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 90.4 bits (224), Expect = 6e-20
Identities = 80/287 (27%), Positives = 130/287 (45%), Gaps = 53/287 (18%)
Query: 692 IGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSCS 751
+G G FG V+ G + + VA+K + + +SF+ E + +K +RH LV++ S
Sbjct: 14 LGNGQFGEVWMGTWNGN-TKVAVKTLK-PGTMSPESFLEEAQIMKKLRHDKLVQLYAVVS 71
Query: 752 SIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDY 811
IV EYM GSL +L +D E L L + +A VA+ + Y
Sbjct: 72 EEPIY------IVTEYMSKGSLLDFL-------KDGEGR-ALKLPNLVDMAAQVAAGMAY 117
Query: 812 LHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTA 871
+ + +H DL+ +NIL+ + L I DFGLAR + ++ ++ G K I +TA
Sbjct: 118 IE---RMNYIHRDLRSANILVGDGLVCKIADFGLARL---IEDNEYTARQGAKFPIKWTA 171
Query: 872 PEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMALPNQVMDIVDP 931
PE L + DV+S+GILL E+VT R+ P
Sbjct: 172 PEAALYGRFTIKSDVWSFGILLTELVTK-----------------GRVPYPGM------- 207
Query: 932 ILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDR 978
N+ E+L ++ RM +C IS+ ++ + C + P++R
Sbjct: 208 ---NNREVLEQVERGYRMPC----PQDCPISLHELMLQCWKKDPEER 247
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 90.2 bits (224), Expect = 7e-20
Identities = 70/224 (31%), Positives = 102/224 (45%), Gaps = 41/224 (18%)
Query: 691 LIGVGSFGCVYKGALDEDGIVVAIKVINL-----QCEGASKSFMAECKALKNIRHRNLVK 745
L+G GSFG VY+G +DG A+K ++L + A K E L ++H N+V+
Sbjct: 7 LLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66
Query: 746 VITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDV 805
+ + D I E +P GSL K L + E I+L Q +
Sbjct: 67 YLGTERE-----EDNLYIFLELVPGGSLAKLLKKYGSF---PEPVIRLYTRQ-------I 111
Query: 806 ASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKG 865
L+YLH +H D+K +NIL+D + + DFG+A+ Q V S S KG
Sbjct: 112 LLGLEYLH---DRNTVHRDIKGANILVDTNGVVKLADFGMAK--QVVEFSFAKS---FKG 163
Query: 866 TIGYTAPE-------YGLGSEVSTNGDVYSYGILLLEMVTAKKP 902
+ + APE YGL + D++S G +LEM T K P
Sbjct: 164 SPYWMAPEVIAQQGGYGLAA------DIWSLGCTVLEMATGKPP 201
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 90.7 bits (226), Expect = 9e-20
Identities = 68/215 (31%), Positives = 101/215 (46%), Gaps = 34/215 (15%)
Query: 690 HLIGVGSFGCVYKGALDEDGIVVAIKVINLQ-----CEGASKSFMAECKALKNIRHRN-- 742
+G G++ VYK E G +VAIK I L +G + + + E K L+ ++H N
Sbjct: 6 KKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNII 65
Query: 743 -LVKVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISI 801
L+ V S+I+ +V+E+M LEK + +DK I LT S
Sbjct: 66 GLLDVFGHKSNIN--------LVFEFME-TDLEKVI-------KDKSI--VLTPADIKSY 107
Query: 802 AIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSV 861
+ L+YLH + ILH DLKP+N+L+ +D + DFGLAR N ++ V
Sbjct: 108 MLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGS-PNRKMTHQV 163
Query: 862 GVKGTIGYTAPEYGLGSEVSTNG-DVYSYGILLLE 895
T Y APE G+ G D++S G + E
Sbjct: 164 ---VTRWYRAPELLFGARHYGVGVDMWSVGCIFAE 195
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 9e-20
Identities = 66/207 (31%), Positives = 103/207 (49%), Gaps = 26/207 (12%)
Query: 690 HLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITS 749
IG G FG V G D G VA+K I + + +++F+AE + +RH NLV+++
Sbjct: 12 QTIGKGEFGDVMLG--DYRGNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGV 67
Query: 750 CSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASAL 809
++ +G + IV EYM GSL +L + +K +L DV A+
Sbjct: 68 I--VEEKGGLY--IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSL--------DVCEAM 115
Query: 810 DYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGY 869
+YL + +H DL N+L+ D + DFGL + E S++ + + VK +
Sbjct: 116 EYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTK---EASSTQDTGKLPVK----W 165
Query: 870 TAPEYGLGSEVSTNGDVYSYGILLLEM 896
TAPE + ST DV+S+GILL E+
Sbjct: 166 TAPEALREKKFSTKSDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 89.4 bits (222), Expect = 1e-19
Identities = 70/213 (32%), Positives = 101/213 (47%), Gaps = 29/213 (13%)
Query: 691 LIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASK-SFMAECKALKNIRHRNLVKVITS 749
IG G+FG VYKG L + VA+K K F+ E + LK H N+VK+I
Sbjct: 2 KIGKGNFGDVYKGVL-KGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGV 60
Query: 750 CSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASAL 809
C IV E +P GSL +L R K+ LT+ + + +++D A+ +
Sbjct: 61 CVQ-----KQPIYIVMELVPGGSLLTFL-------RKKKNR--LTVKKLLQMSLDAAAGM 106
Query: 810 DYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGT-IG 868
+YL +H DL N L+ + I DFG++R E + S G+K I
Sbjct: 107 EYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSR---EEEGGIYTVSDGLKQIPIK 160
Query: 869 YTAPE---YGLGSEVSTNGDVYSYGILLLEMVT 898
+TAPE YG ++ DV+SYGILL E +
Sbjct: 161 WTAPEALNYG---RYTSESDVWSYGILLWETFS 190
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 88.9 bits (221), Expect = 3e-19
Identities = 64/208 (30%), Positives = 94/208 (45%), Gaps = 24/208 (11%)
Query: 692 IGVGSFGCVYKGALDEDGIVVAIKVINLQ--CEGASKSFMAECKALKNIRHRNLVKVITS 749
IG G+ G V+K E G VA+K + L+ G + E KAL+ +H +VK++
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLL-- 65
Query: 750 CSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASAL 809
+ G+ F +V EYMP L + L ++ E L Q S + +
Sbjct: 66 --DVFPHGSGF-VLVMEYMP-SDLSEVL---------RDEERPLPEAQVKSYMRMLLKGV 112
Query: 810 DYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGY 869
Y+H I+H DLKP+N+L+ D I DFGLAR E S V T Y
Sbjct: 113 AYMH---ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQV---ATRWY 166
Query: 870 TAPEYGLGSEVSTNG-DVYSYGILLLEM 896
APE G+ G D+++ G + E+
Sbjct: 167 RAPELLYGARKYDPGVDLWAVGCIFAEL 194
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 3e-19
Identities = 75/229 (32%), Positives = 113/229 (49%), Gaps = 30/229 (13%)
Query: 686 FSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINL--QCEGASKSFMAECKALKNIRHRNL 743
F IG G++G VYK G VVA+K I L + EG + + E LK + H N+
Sbjct: 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 61
Query: 744 VKVITSCSSIDFQGNDFKA-IVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIA 802
VK++ D + K +V+E++ + L+K++ A P I L L++ S
Sbjct: 62 VKLL------DVIHTENKLYLVFEFL-HQDLKKFMD--ASPLS----GIPLPLIK--SYL 106
Query: 803 IDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVG 862
+ L + H H +LH DLKP N+L++ + + + DFGLAR V T + V
Sbjct: 107 FQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG-VPVRTYTHEV- 161
Query: 863 VKGTIGYTAPEYGLGSEV-STNGDVYSYGILLLEMVTAKKPTDVMFEGD 910
T+ Y APE LG + ST D++S G + EMVT + +F GD
Sbjct: 162 --VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR----ALFPGD 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 88.1 bits (218), Expect = 4e-19
Identities = 65/217 (29%), Positives = 111/217 (51%), Gaps = 32/217 (14%)
Query: 691 LIGVGSFGCVYKGALDEDG---IVVAIKVINL-QCEGASKSFMAECKALKNIRHRNLVK- 745
+IG G FG V++G L G + VAIK + E + F++E + H N+++
Sbjct: 12 VIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRL 71
Query: 746 --VITSCSSIDFQGNDFK--AIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISI 801
V+T FK I+ EYM NG+L+K+L RD + E + Q + +
Sbjct: 72 EGVVTK----------FKPAMIITEYMENGALDKYL-------RDHDGE--FSSYQLVGM 112
Query: 802 AIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSV 861
+A+ + YL +H DL NIL++++L + DFGL+R ++ T ++S
Sbjct: 113 LRGIAAGMKYL---SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTS- 168
Query: 862 GVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT 898
G K I +TAPE + ++ DV+S+GI++ E+++
Sbjct: 169 GGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMS 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 4e-19
Identities = 65/207 (31%), Positives = 102/207 (49%), Gaps = 22/207 (10%)
Query: 692 IGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSCS 751
+G G FG V+ G + VAIK + + ++F+ E + +K +RH LV++ S
Sbjct: 14 LGQGCFGEVWMGTWN-GTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 71
Query: 752 SIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDY 811
IV EYM GSL +L E+ L L Q + +A +AS + Y
Sbjct: 72 EEPIY------IVTEYMSKGSLLDFL--------KGEMGKYLRLPQLVDMAAQIASGMAY 117
Query: 812 LHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTA 871
+ + +H DL+ +NIL+ +L + DFGLAR + ++ ++ G K I +TA
Sbjct: 118 VE---RMNYVHRDLRAANILVGENLVCKVADFGLARL---IEDNEYTARQGAKFPIKWTA 171
Query: 872 PEYGLGSEVSTNGDVYSYGILLLEMVT 898
PE L + DV+S+GILL E+ T
Sbjct: 172 PEAALYGRFTIKSDVWSFGILLTELTT 198
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 86.9 bits (215), Expect = 1e-18
Identities = 64/215 (29%), Positives = 106/215 (49%), Gaps = 28/215 (13%)
Query: 691 LIGVGSFGCVYKGALDEDG---IVVAIKVINL-QCEGASKSFMAECKALKNIRHRNLVK- 745
+IG G FG V G L G I VAIK + E + F++E + H N++
Sbjct: 11 VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 746 --VITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAI 803
V+T + IV EYM NGSL+ +L H + + T++Q + +
Sbjct: 71 EGVVTKSKPV--------MIVTEYMENGSLDAFLRKH---------DGQFTVIQLVGMLR 113
Query: 804 DVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGV 863
+AS + YL +H DL NIL++++L + DFGL+R ++ + ++ G
Sbjct: 114 GIASGMKYL---SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTR-GG 169
Query: 864 KGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT 898
K I +TAPE + ++ DV+SYGI++ E+++
Sbjct: 170 KIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 86.6 bits (215), Expect = 1e-18
Identities = 68/216 (31%), Positives = 105/216 (48%), Gaps = 31/216 (14%)
Query: 692 IGVGSFGCVYKGALDEDGIVVAIKVINLQCEGA-SKSFMAECKALKNIRHRNLVKVITSC 750
+G G+ G V K G ++A+K I L+ A K + E L +V +
Sbjct: 9 LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAF 68
Query: 751 SSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIE--IKLTLLQRISIAIDVASA 808
+ D +I EYM GSL+K L KE++ I +L +I++A V
Sbjct: 69 ----YNNGDI-SICMEYMDGGSLDKIL---------KEVQGRIPERILGKIAVA--VLKG 112
Query: 809 LDYLHHHCQEPILHCDLKPSNILLDNDLSGHIG--DFGLARFHQEVSNSTLSSSVGVKGT 866
L YLH + I+H D+KPSNIL+++ G I DFG++ ++ NS + VG T
Sbjct: 113 LTYLHE--KHKIIHRDVKPSNILVNS--RGQIKLCDFGVSG---QLVNSLAKTFVG---T 162
Query: 867 IGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKP 902
Y APE G++ S D++S G+ L+E+ T + P
Sbjct: 163 SSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFP 198
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.0 bits (216), Expect = 1e-18
Identities = 67/215 (31%), Positives = 100/215 (46%), Gaps = 35/215 (16%)
Query: 692 IGVGSFGCVYKGALDEDGIVVAIKVINL--QCEGASKSFMAECKALKNIRHRNLVKVITS 749
IG G++G VYK G +VAIK I L + EG K+ + E K LK + H N++K++
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLL-- 64
Query: 750 CSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIE-IKLTLLQRISIAIDVASA 808
+ D +V+E+M + L K + + I+ LLQ
Sbjct: 65 --DVFRHKGDL-YLVFEFM-DTDLYKLIKDRQRGLPESLIKSYLYQLLQ----------G 110
Query: 809 LDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVK---- 864
L + H H ILH DLKP N+L++ + + DFGLAR + S V
Sbjct: 111 LAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLAR--------SFGSPVRPYTHYV 159
Query: 865 GTIGYTAPEYGLGSEV-STNGDVYSYGILLLEMVT 898
T Y APE LG + ST D++S G + E+++
Sbjct: 160 VTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLS 194
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 86.6 bits (215), Expect = 1e-18
Identities = 65/223 (29%), Positives = 102/223 (45%), Gaps = 27/223 (12%)
Query: 692 IGVGSFGCVYKGAL-----DEDGIVVAIKVINLQCEGASKS----FMAECKALKNIRHRN 742
+G GSFG VY+G E VAIK +N E AS F+ E +K +
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVN---ENASMRERIEFLNEASVMKEFNCHH 70
Query: 743 LVKVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIA 802
+V+++ S G +V E M G L+ +L + TL + I +A
Sbjct: 71 VVRLLGVVS----TGQP-TLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMA 125
Query: 803 IDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVG 862
++A + YL + +H DL N ++ DL+ IGDFG+ R ++ + G
Sbjct: 126 AEIADGMAYLA---AKKFVHRDLAARNCMVAEDLTVKIGDFGMTR---DIYETDYYRKGG 179
Query: 863 VKGT--IGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT-AKKP 902
KG + + APE +T DV+S+G++L EM T A++P
Sbjct: 180 -KGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQP 221
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 86.1 bits (214), Expect = 2e-18
Identities = 59/220 (26%), Positives = 94/220 (42%), Gaps = 27/220 (12%)
Query: 692 IGVGSFGCVYKGALDEDGIVVAIKVINLQ--CEGASKSFMAECKALKNIRHRNLVK---- 745
IG GSFG V K DG ++ K I+ E + ++E L+ ++H N+V+
Sbjct: 8 IGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDR 67
Query: 746 -VITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAID 804
+ S ++ IV EY G L + + ++ K+ + I
Sbjct: 68 IIDRSNQTL--------YIVMEYCEGGDLAQLI------QKCKKERKYIEEEFIWRILTQ 113
Query: 805 VASALDYLHH--HCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVG 862
+ AL H+ +LH DLKP+NI LD + + +GDFGLA+ +S + V
Sbjct: 114 LLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGH-DSSFAKTYV- 171
Query: 863 VKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKP 902
GT Y +PE D++S G L+ E+ P
Sbjct: 172 --GTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPP 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 85.8 bits (213), Expect = 2e-18
Identities = 69/220 (31%), Positives = 99/220 (45%), Gaps = 29/220 (13%)
Query: 692 IGVGSFGCVYKGALDEDGIVVAIKVIN---LQCEGASKSFMAECKALKNIRHRNLVKVIT 748
I G++G V+ G + AIKVI + + + E L + +VK+
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60
Query: 749 SCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASA 808
S FQG +V EY+P G L L V D+++ RI IA ++ A
Sbjct: 61 S-----FQGKKNLYLVMEYLPGGDLASLLE--NVGSLDEDV-------ARIYIA-EIVLA 105
Query: 809 LDYLHHHCQEPILHCDLKPSNILLDNDLSGHI--GDFGLARF----HQEVSNSTLSSSVG 862
L+YLH + I+H DLKP NIL+D++ GH+ DFGL++ Q N
Sbjct: 106 LEYLHSN---GIIHRDLKPDNILIDSN--GHLKLTDFGLSKVGLVRRQINLNDDEKEDKR 160
Query: 863 VKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKP 902
+ GT Y APE LG S D +S G +L E + P
Sbjct: 161 IVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPP 200
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 85.9 bits (213), Expect = 2e-18
Identities = 70/236 (29%), Positives = 109/236 (46%), Gaps = 26/236 (11%)
Query: 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVI---NLQCEGASKSFMAECKALKNIR 739
F IG G F VYK DG VVA+K + + A + + E LK +
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 740 HRNLVKVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRI 799
H N++K + S F N+ IV E G L + + H K+ K + + T+ +
Sbjct: 61 HPNVIKYLAS-----FIENNELNIVLELADAGDLSR-MIKHF--KKQKRLIPERTIWKYF 112
Query: 800 SIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSS 859
+ + SAL+++H I+H D+KP+N+ + +GD GL RF S+ T ++
Sbjct: 113 ---VQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRF---FSSKTTAA 163
Query: 860 SVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGD-LNLH 914
V GT Y +PE + + D++S G LL EM + P F GD +NL+
Sbjct: 164 HSLV-GTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP----FYGDKMNLY 214
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 86.4 bits (215), Expect = 4e-18
Identities = 71/223 (31%), Positives = 100/223 (44%), Gaps = 34/223 (15%)
Query: 689 THLIGVGSFGCVYKGALDED-GIVVAIKVINL--QCEGASKSFMAECKALKNIRHRNLVK 745
IG G++G V A+D+ G VAIK I+ +K + E K L+++RH N++
Sbjct: 5 LKPIGSGAYGVVCS-AVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIG 63
Query: 746 ---VITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIA 802
++ S DF ND IV E M L K + LT
Sbjct: 64 LLDILRPPSPEDF--NDV-YIVTELMET-DLHKVIKS----------PQPLTDDHIQYFL 109
Query: 803 IDVASALDYLH--HHCQEPILHCDLKPSNILLDNDLSGHIGDFGLAR--FHQEVSNSTLS 858
+ L YLH + ++H DLKPSNIL++++ I DFGLAR E L+
Sbjct: 110 YQILRGLKYLHSAN-----VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLT 164
Query: 859 SSVGVKGTIGYTAPEYGLGSEVSTNG-DVYSYGILLLEMVTAK 900
V V T Y APE L S T D++S G + E++T K
Sbjct: 165 EYV-V--TRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 5e-18
Identities = 67/224 (29%), Positives = 111/224 (49%), Gaps = 24/224 (10%)
Query: 692 IGVGSFGCV-----YKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKV 746
+G G+FG V Y + +D ++VA+K + A K F E + L N++H ++VK
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72
Query: 747 ITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHA------VPKRDKEIEIKLTLLQRIS 800
C D +V+EYM +G L K+L H V + ++ + +L L Q +
Sbjct: 73 YGVCGD-----GDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLH 127
Query: 801 IAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSS 860
IA +AS + YL + +H DL N L+ +L IGDFG++R +V ++
Sbjct: 128 IASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR---DVYSTDYYRV 181
Query: 861 VG-VKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT-AKKP 902
G I + PE + + +T DV+S+G++L E+ T K+P
Sbjct: 182 GGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 225
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 6e-18
Identities = 61/219 (27%), Positives = 96/219 (43%), Gaps = 22/219 (10%)
Query: 686 FSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKS-FMAECKALKNIRHRNLV 744
+ LIG G++G VY+G G VVA+K+INL S E L +R
Sbjct: 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPP 62
Query: 745 KVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAID 804
+ S +G I+ EY GS+ + + ++ + I+ L+
Sbjct: 63 NITKYYGSY-LKGPRL-WIIMEYAEGGSVRTLMKAGPIAEKYISVIIREVLV-------- 112
Query: 805 VASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVK 864
AL Y+H ++H D+K +NIL+ N + + DFG+A ++ ++ S V
Sbjct: 113 ---ALKYIHK---VGVIHRDIKAANILVTNTGNVKLCDFGVA---ALLNQNSSKRSTFV- 162
Query: 865 GTIGYTAPEYGL-GSEVSTNGDVYSYGILLLEMVTAKKP 902
GT + APE G T D++S GI + EM T P
Sbjct: 163 GTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPP 201
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 6e-18
Identities = 65/224 (29%), Positives = 96/224 (42%), Gaps = 26/224 (11%)
Query: 692 IGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAEC----KALKNIRHRNLVKVI 747
IG GSFG V+K D V A+K I+L ++ E + L + +++
Sbjct: 8 IGKGSFGVVFKVVRKADKRVYAMKQIDLS--KMNRREREEAIDEARVLAKLDSSYIIRYY 65
Query: 748 TSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVAS 807
S F IV EY NG L K L + L Q I +
Sbjct: 66 ES-----FLDKGKLNIVMEYAENGDLHKLLK--------MQRGRPLPEDQVWRFFIQILL 112
Query: 808 ALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTI 867
L +LH + ILH D+K N+ LD + IGD G+A+ +S++T ++ V GT
Sbjct: 113 GLAHLH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKL---LSDNTNFANTIV-GTP 165
Query: 868 GYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDL 911
Y +PE + DV++ G++L E T K P D +G L
Sbjct: 166 YYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGAL 209
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 7e-18
Identities = 70/214 (32%), Positives = 99/214 (46%), Gaps = 27/214 (12%)
Query: 692 IGVGSFGCV----YKGALDEDGIVVAIKVINLQCEGASKS-FMAECKALKNIRHRNLVKV 746
+G G FG V Y A D G +VA+K + +C + S + E LK + H N+VK
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71
Query: 747 ITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVA 806
CS QG ++ EY+P GSL +L H KL L Q + A +
Sbjct: 72 KGCCSE---QGGKGLQLIMEYVPLGSLRDYLPKH-----------KLNLAQLLLFAQQIC 117
Query: 807 SALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGT 866
+ YLH + +H DL N+LLDND IGDFGLA+ V V G
Sbjct: 118 EGMAYLH---SQHYIHRDLAARNVLLDNDRLVKIGDFGLAK---AVPEGHEYYRVREDGD 171
Query: 867 --IGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT 898
+ + A E ++ S DV+S+G+ L E++T
Sbjct: 172 SPVFWYAVECLKENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 84.0 bits (207), Expect = 1e-17
Identities = 71/222 (31%), Positives = 110/222 (49%), Gaps = 23/222 (10%)
Query: 692 IGVGSFGCV-----YKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKV 746
+G G+FG V Y ++D I+VA+K + + A K F E + L N++H ++VK
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72
Query: 747 ITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPH---AVPKRDKEIEIKLTLLQRISIAI 803
C D +V+EYM +G L K+L H AV + +LT Q + IA
Sbjct: 73 YGVCVE-----GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQ 127
Query: 804 DVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGV 863
+A+ + YL + +H DL N L+ +L IGDFG++R +V ST VG
Sbjct: 128 QIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSR---DVY-STDYYRVGG 180
Query: 864 KGT--IGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT-AKKP 902
I + PE + + +T DV+S G++L E+ T K+P
Sbjct: 181 HTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 222
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 2e-17
Identities = 72/208 (34%), Positives = 103/208 (49%), Gaps = 26/208 (12%)
Query: 691 LIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASK-SFMAECKALKNIRHRNLVKVITS 749
L+G G+FG V+KG L +D VA+K K F++E + LK H N+VK+I
Sbjct: 2 LLGKGNFGEVFKGTL-KDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGV 60
Query: 750 CSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASAL 809
C+ IV E +P G +L R K+ E+K Q + A+D A+ +
Sbjct: 61 CTQ-----RQPIYIVMELVPGGDFLSFL-------RKKKDELKTK--QLVKFALDAAAGM 106
Query: 810 DYLH-HHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGT-I 867
YL +C +H DL N L+ + I DFG++R QE + + SS G+K I
Sbjct: 107 AYLESKNC----IHRDLAARNCLVGENNVLKISDFGMSR--QE--DDGIYSSSGLKQIPI 158
Query: 868 GYTAPEYGLGSEVSTNGDVYSYGILLLE 895
+TAPE S+ DV+SYGILL E
Sbjct: 159 KWTAPEALNYGRYSSESDVWSYGILLWE 186
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 2e-17
Identities = 64/224 (28%), Positives = 113/224 (50%), Gaps = 25/224 (11%)
Query: 692 IGVGSFGCVYKGAL-----DEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKV 746
+G G+FG V+ ++D ++VA+K + E A + F E + L ++H+++V+
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 747 ITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHA----VPKRDKEIEI-KLTLLQRISI 801
C+ +V+EYM +G L ++L H + +++ +LTL Q ++I
Sbjct: 73 YGVCTE-----GRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAI 127
Query: 802 AIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSV 861
A +AS + YL +H DL N L+ L IGDFG++R ++ ST V
Sbjct: 128 ASQIASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSR---DIY-STDYYRV 180
Query: 862 GVKGT--IGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT-AKKP 902
G + I + PE L + +T D++S+G++L E+ T K+P
Sbjct: 181 GGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 3e-17
Identities = 64/220 (29%), Positives = 95/220 (43%), Gaps = 32/220 (14%)
Query: 691 LIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSC 750
++G G++G VY + +AIK I + + E ++HRN+V+ + S
Sbjct: 15 VLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSD 74
Query: 751 SSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALD 810
S N F I E +P GSL L P +D E I Q + L
Sbjct: 75 SE-----NGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQ-------ILEGLK 122
Query: 811 YLHHHCQEPILHCDLKPSNILLDNDLSG--HIGDFGLARFHQEVSNSTLSSSVGVKGTIG 868
YLH I+H D+K N+L+ N SG I DFG ++ ++ T + GT+
Sbjct: 123 YLH---DNQIVHRDIKGDNVLV-NTYSGVVKISDFGTSKRLAGINPCTET----FTGTLQ 174
Query: 869 YTAPEY------GLGSEVSTNGDVYSYGILLLEMVTAKKP 902
Y APE G G+ D++S G ++EM T K P
Sbjct: 175 YMAPEVIDKGPRGYGAP----ADIWSLGCTIVEMATGKPP 210
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 3e-17
Identities = 67/208 (32%), Positives = 103/208 (49%), Gaps = 24/208 (11%)
Query: 692 IGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSCS 751
+G G FG V+ G + VAIK + ++F+ E + +K +RH LV + S
Sbjct: 14 LGQGCFGEVWMGTWN-GTTKVAIKTLK-PGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVS 71
Query: 752 SIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIK-LTLLQRISIAIDVASALD 810
IV E+M GSL +L KE + K L L Q + +A +A +
Sbjct: 72 EEPIY------IVTEFMGKGSLLDFL---------KEGDGKYLKLPQLVDMAAQIADGMA 116
Query: 811 YLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYT 870
Y+ + +H DL+ +NIL+ ++L I DFGLAR + ++ ++ G K I +T
Sbjct: 117 YIE---RMNYIHRDLRAANILVGDNLVCKIADFGLARL---IEDNEYTARQGAKFPIKWT 170
Query: 871 APEYGLGSEVSTNGDVYSYGILLLEMVT 898
APE L + DV+S+GILL E+VT
Sbjct: 171 APEAALYGRFTIKSDVWSFGILLTELVT 198
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.1 bits (206), Expect = 3e-17
Identities = 67/211 (31%), Positives = 99/211 (46%), Gaps = 22/211 (10%)
Query: 691 LIGVGSFGCVYKGALDEDGIVVAIKVINLQC--EGASKSFMAECKALKNIR---HRNLVK 745
IG G++G VYK G VA+K + + EG S + E LK + H N+V+
Sbjct: 6 EIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVR 65
Query: 746 VITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDV 805
++ C +V+E++ + L +L P E IK + Q +
Sbjct: 66 LLDVCHGPRTDRELKLTLVFEHV-DQDLATYLSKCPKPGLPPET-IKDLMRQ-------L 116
Query: 806 ASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKG 865
+D+LH H I+H DLKP NIL+ +D I DFGLAR + L+S V V
Sbjct: 117 LRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIYSF--EMALTSVV-V-- 168
Query: 866 TIGYTAPEYGLGSEVSTNGDVYSYGILLLEM 896
T+ Y APE L S +T D++S G + E+
Sbjct: 169 TLWYRAPEVLLQSSYATPVDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 82.8 bits (205), Expect = 3e-17
Identities = 73/245 (29%), Positives = 118/245 (48%), Gaps = 43/245 (17%)
Query: 686 FSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCE--GASKSFMAECKALKNIRHRNL 743
++ IG G++G VYKG + G +VA+K I L+ E G + + E LK ++H N+
Sbjct: 2 YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNI 61
Query: 744 VKVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAI 803
V + + Q + +++E++ + L+K+L ++PK + ++ +L S
Sbjct: 62 VCLQ----DVLMQESRL-YLIFEFL-SMDLKKYLD--SLPK-GQYMDAELVK----SYLY 108
Query: 804 DVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLAR--------FHQEVSNS 855
+ + + H +LH DLKP N+L+DN + DFGLAR + EV
Sbjct: 109 QILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVV-- 163
Query: 856 TLSSSVGVKGTIGYTAPEYGLGSE-VSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLH 914
T+ Y APE LGS ST D++S G + EM T KKP +F GD +
Sbjct: 164 ----------TLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMAT-KKP---LFHGDSEID 209
Query: 915 NFARM 919
R+
Sbjct: 210 QLFRI 214
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 4e-17
Identities = 68/224 (30%), Positives = 109/224 (48%), Gaps = 29/224 (12%)
Query: 692 IGVGSFGCVYKGALDEDGIVVAIKVINLQCEGA--SKSFMAECKALKNIRHRNLVKVITS 749
+G G FG V+ G I VAIK IN EGA + F+ E K + + H LV++
Sbjct: 12 LGSGQFGVVHLGKWRAQ-IKVAIKAIN---EGAMSEEDFIEEAKVMMKLSHPKLVQLYGV 67
Query: 750 CSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASAL 809
C+ Q + IV E+M NG L +L R ++ ++ +L +S+ DV +
Sbjct: 68 CTQ---QKPLY--IVTEFMENGCLLNYL-------RQRQGKLSKDML--LSMCQDVCEGM 113
Query: 810 DYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGY 869
+YL + +H DL N L+ + + DFG+ R+ V + +SS G K + +
Sbjct: 114 EYLE---RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRY---VLDDEYTSSSGAKFPVKW 167
Query: 870 TAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNL 913
+ PE S+ S+ DV+S+G+L+ E+ T K + FE N
Sbjct: 168 SPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGK---MPFEKKSNY 208
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 4e-17
Identities = 77/299 (25%), Positives = 131/299 (43%), Gaps = 57/299 (19%)
Query: 692 IGVGSFGCVYKGALDEDGIVVAIKVINLQCEGA--SKSFMAECKALKNIRHRNLVKVITS 749
IG G FG V+ G E VAIK I EGA + F+ E + + + H LV++
Sbjct: 12 IGSGQFGLVWLGYWLEKR-KVAIKTIR---EGAMSEEDFIEEAQVMMKLSHPKLVQLYGV 67
Query: 750 CSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASAL 809
C+ +V+E+M +G L +L + + + TLL + +DV +
Sbjct: 68 CTE-----RSPICLVFEFMEHGCLSDYL------RAQRGKFSQETLLG---MCLDVCEGM 113
Query: 810 DYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGY 869
YL ++H DL N L+ + + DFG+ RF V + +SS G K + +
Sbjct: 114 AYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRF---VLDDQYTSSTGTKFPVKW 167
Query: 870 TAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMALPNQVMDIV 929
++PE S+ S+ DV+S+G+L+ E V EG N
Sbjct: 168 SSPEVFSFSKYSSKSDVWSFGVLMWE---------VFSEGKTPYEN-------------- 204
Query: 930 DPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHEL 988
R++ E++ + + R+ RL S+ ++ C E P+DR + + ++H+L
Sbjct: 205 ----RSNSEVVETINAGFRL---YKPRL-ASQSVYELMQHCWKERPEDRPSFSLLLHQL 255
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 81.5 bits (202), Expect = 6e-17
Identities = 65/224 (29%), Positives = 92/224 (41%), Gaps = 29/224 (12%)
Query: 691 LIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSC 750
+G GS+G VYK E G VVAIKV+ + E + + E LK +VK S
Sbjct: 10 KLGEGSYGSVYKAIHKETGQVVAIKVVPV--EEDLQEIIKEISILKQCDSPYIVKYYGS- 66
Query: 751 SSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALD 810
+ N IV EY GS+ + K E EI L Q L+
Sbjct: 67 ----YFKNTDLWIVMEYCGAGSVSDIM--KITNKTLTEEEIAAILYQ-------TLKGLE 113
Query: 811 YLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYT 870
YLH + +H D+K NILL+ + + DFG++ T++ V GT +
Sbjct: 114 YLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVS----GQLTDTMAKRNTVIGTPFWM 166
Query: 871 APEYGLGSEVSTNGDVYSYGILLLEMVTAK------KPTDVMFE 908
APE + D++S GI +EM K P +F
Sbjct: 167 APEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFM 210
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 8e-17
Identities = 61/225 (27%), Positives = 106/225 (47%), Gaps = 38/225 (16%)
Query: 692 IGVGSFGCVYKGAL-----DEDGIVVAIKVINLQCEGASKS-FMAECKALKNIRHRNLVK 745
+G G+FG VYKG L VAIK + E + F E + + +++H N+V
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 746 VITSCSSIDFQGNDFKAIVYEYMPNGSLEKWL---HPHAVP---KRDKEIEIKLTLLQRI 799
++ C+ +++EY+ +G L ++L PH+ D+ ++ L +
Sbjct: 73 LLGVCTK-----EQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFL 127
Query: 800 SIAIDVASALDYL--HHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLAR------FHQE 851
IAI +A+ ++YL HH H DL N L+ L+ I DFGL+R +++
Sbjct: 128 HIAIQIAAGMEYLSSHHFV-----HRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRV 182
Query: 852 VSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEM 896
S S L + + PE L + +T D++S+G++L E+
Sbjct: 183 QSKSLLP--------VRWMPPEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 8e-17
Identities = 71/296 (23%), Positives = 113/296 (38%), Gaps = 65/296 (21%)
Query: 692 IGVGSFGCVYKGALDEDG---IVVAIKVINLQCEGASKS-FMAECKALKNIRHRNLVKVI 747
+G G+FG V KG + VA+K + + A K F+ E + + H +V++I
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 748 TSCSSIDFQGNDFKAIVYEYMPNGSLEKWL--HPHAVPKRDKEIEIKLTLLQRISIAIDV 805
C +G +V E P G L K+L ++K Q V
Sbjct: 63 GVC-----KGEPL-MLVMELAPLGPLLKYLKKRREI-----PVSDLKELAHQ-------V 104
Query: 806 ASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKG 865
A + YL + +H DL N+LL N I DFG++R + ++ +
Sbjct: 105 AMGMAYLE---SKHFVHRDLAARNVLLVNRHQAKISDFGMSR-ALGAGSDYYRATTAGRW 160
Query: 866 TIGYTAPE---YGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMALP 922
+ + APE YG + S+ DV+SYG+ L E F+ A P
Sbjct: 161 PLKWYAPECINYG---KFSSKSDVWSYGVTLWEA-------------------FSYGAKP 198
Query: 923 NQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDR 978
M E++A + R+ EC + I ++C P+DR
Sbjct: 199 YGEM--------KGAEVIAMLESGERL----PRPEECPQEIYSIMLSCWKYRPEDR 242
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 1e-16
Identities = 83/279 (29%), Positives = 120/279 (43%), Gaps = 47/279 (16%)
Query: 685 GFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINL--QCEGASKSFMAECKALKNIRHRN 742
F +G GS+G VYK D A+K ++L + + + E + L ++ H N
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 743 LVKVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRD-KEIEIKLTLLQRISI 801
++ + +D GN IV EY P G L K + ++ E EI I
Sbjct: 61 IISY--KEAFLD--GNKL-CIVMEYAPFGDLSKAISKRKKKRKLIPEQEI-------WRI 108
Query: 802 AIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSV 861
I + L LH ++ ILH DLK +NILL + IGD G+++ V ++ +
Sbjct: 109 FIQLLRGLQALH---EQKILHRDLKSANILLVANDLVKIGDLGISK----VLKKNMAKT- 160
Query: 862 GVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEG----DLNL---- 913
GT Y APE G S D++S G LL EM T P FE DL
Sbjct: 161 -QIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPP----FEARSMQDLRYKVQR 215
Query: 914 -------HNFARMALPNQV--MDIVDPILR-NDEEILAS 942
+++ L N + M V P LR N ++ILAS
Sbjct: 216 GKYPPIPPIYSQ-DLQNFIRSMLQVKPKLRPNCDKILAS 253
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 1e-16
Identities = 79/256 (30%), Positives = 114/256 (44%), Gaps = 59/256 (23%)
Query: 692 IGVGSFGCVYKGALDEDGIVVAIKVINLQCE--GASKSFMAECKALKNIRHRNLVK---V 746
IG G++G VYK +A+K I L+ E G + + E LK ++H N+V+ V
Sbjct: 10 IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDV 69
Query: 747 ITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVA 806
+ S + +V+EY+ + L+K H + P K + T L +I
Sbjct: 70 VHSEKRL--------YLVFEYL-DLDLKK--HMDSSPDFAKNPRLIKTYLYQI------L 112
Query: 807 SALDYLHHHCQEPILHCDLKPSNILLD---NDLSGHIGDFGLAR--------FHQEVSNS 855
+ Y H H +LH DLKP N+L+D N L + DFGLAR F EV
Sbjct: 113 RGIAYCHSH---RVLHRDLKPQNLLIDRRTNALK--LADFGLARAFGIPVRTFTHEVV-- 165
Query: 856 TLSSSVGVKGTIGYTAPEYGLGS-EVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLH 914
T+ Y APE LGS ST D++S G + EMV +KP +F GD +
Sbjct: 166 ----------TLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVN-QKP---LFPGDSEID 211
Query: 915 N----FARMALPNQVM 926
F + PN+
Sbjct: 212 ELFKIFRILGTPNEET 227
|
Length = 294 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 81.1 bits (201), Expect = 1e-16
Identities = 67/215 (31%), Positives = 95/215 (44%), Gaps = 40/215 (18%)
Query: 692 IGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKS---FMAECKALKNIRHRNLVKVIT 748
+G GSFG V G A+K+++ K + E + L++IRH LV +
Sbjct: 9 LGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYG 68
Query: 749 SCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASA 808
S FQ + +V EY+P G L L ++ + A V A
Sbjct: 69 S-----FQDDSNLYLVMEYVPGGELFSHL------RKSGRFPEPVARF----YAAQVVLA 113
Query: 809 LDYLHHHCQEPILHCDLKPSNILLDNDLSGHI--GDFGLARFHQEVSNSTLSSSVGVKGT 866
L+YLH I++ DLKP N+LLD+D G+I DFG A+ V T + GT
Sbjct: 114 LEYLHS---LDIVYRDLKPENLLLDSD--GYIKITDFGFAKR---VKGRTYTLC----GT 161
Query: 867 IGYTAPEY----GLGSEVSTNGDVYSYGILLLEMV 897
Y APE G G V D ++ GIL+ EM+
Sbjct: 162 PEYLAPEIILSKGYGKAV----DWWALGILIYEML 192
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 2e-16
Identities = 68/223 (30%), Positives = 100/223 (44%), Gaps = 52/223 (23%)
Query: 692 IGVGSFGCVYKGALDEDGIVVAIKVINLQC-EGASKSFMAECKALKNIRHRNLV---KVI 747
+G GS+ VYKG G +VA+K I L+ EGA + + E LK+++H N+V +I
Sbjct: 13 LGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDII 72
Query: 748 TSCSSIDFQGNDFKAIVYEYM-----------PNGSLEKWLHPHAVPKRDKEIEIKLTLL 796
+ ++ V+EY+ G L H V +L L
Sbjct: 73 HTKKTLTL--------VFEYLDTDLKQYMDDCGGG-----LSMHNV---------RLFLF 110
Query: 797 QRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNST 856
Q + L Y H +LH DLKP N+L+ + DFGLAR + V + T
Sbjct: 111 QLL-------RGLAYCHQ---RRVLHRDLKPQNLLISERGELKLADFGLAR-AKSVPSKT 159
Query: 857 LSSSVGVKGTIGYTAPEYGLGS-EVSTNGDVYSYGILLLEMVT 898
S+ V T+ Y P+ LGS E ST+ D++ G + EM T
Sbjct: 160 YSNEV---VTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMAT 199
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 2e-16
Identities = 40/81 (49%), Positives = 58/81 (71%)
Query: 138 LQGRIPLEFVSLSKLKDLSLAKNKLTGGIPPFLGNLTSLEVLSLAGNSFGRNIPDSLGQL 197
L+G IP + L L+ ++L+ N + G IPP LG++TSLEVL L+ NSF +IP+SLGQL
Sbjct: 430 LRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQL 489
Query: 198 KQLKILAIGGNNLSGPIPPSI 218
L+IL + GN+LSG +P ++
Sbjct: 490 TSLRILNLNGNSLSGRVPAAL 510
|
Length = 623 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 2e-16
Identities = 74/224 (33%), Positives = 112/224 (50%), Gaps = 35/224 (15%)
Query: 691 LIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKS----FMAECKALKNI-RHRNLVK 745
+IG G+FG V K + +DG+ + + ++ E ASK F E + L + H N++
Sbjct: 14 VIGEGNFGQVLKARIKKDGLRMDAAIKRMK-EYASKDDHRDFAGELEVLCKLGHHPNIIN 72
Query: 746 VITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEI------KLTLLQRI 799
++ +C + +G + AI EY P+G+L +L V + D I L+ Q +
Sbjct: 73 LLGAC---EHRGYLYLAI--EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 127
Query: 800 SIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSS 859
A DVA +DYL Q+ +H DL NIL+ + I DFGL+R QEV
Sbjct: 128 HFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR-GQEVY------ 177
Query: 860 SVGVKGTIG-----YTAPEYGLGSEVSTNGDVYSYGILLLEMVT 898
VK T+G + A E S +TN DV+SYG+LL E+V+
Sbjct: 178 ---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 2e-16
Identities = 69/224 (30%), Positives = 108/224 (48%), Gaps = 26/224 (11%)
Query: 692 IGVGSFGCVYKGALDEDGIVVAIKVINLQC--EGASKSFMAECKALKNIR---HRNLVKV 746
IGVG++G VYK G VA+K + +Q +G S + E LK + H N+V++
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67
Query: 747 ITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVA 806
+ C++ +V+E++ + L +L VP E L+++
Sbjct: 68 MDVCATSRTDRETKVTLVFEHV-DQDLRTYLD--KVPPPGLPAETIKDLMRQF------L 118
Query: 807 SALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGT 866
LD+LH +C I+H DLKP NIL+ + + DFGLAR + S + V T
Sbjct: 119 RGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIY-----SCQMALTPVVVT 170
Query: 867 IGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGD 910
+ Y APE L S +T D++S G + EM +KP +F G+
Sbjct: 171 LWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKP---LFCGN 210
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 2e-16
Identities = 68/225 (30%), Positives = 110/225 (48%), Gaps = 32/225 (14%)
Query: 691 LIGVGSFGCVYK-GALDEDGIVVAIKVINLQ-------CEGASKSF---MAECKALK-NI 738
+G G+FGCVYK + ++A+K IN+ KS ++E +K +
Sbjct: 7 HLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQL 66
Query: 739 RHRNLVKVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQR 798
RH N+V+ + F ND IV + + L + H +++ ++ + + R
Sbjct: 67 RHPNIVRYYKT-----FLENDRLYIVMDLIEGAPLGE--HFNSLKEKKQRFTEE-----R 114
Query: 799 I-SIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTL 857
I +I + + AL YLH ++ I+H DL P+NI+L D I DFGLA+ Q+ S L
Sbjct: 115 IWNIFVQMVLALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFGLAK--QKQPESKL 170
Query: 858 SSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKP 902
+S V GTI Y+ PE DV+++G +L +M T + P
Sbjct: 171 TSVV---GTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPP 212
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 3e-16
Identities = 71/229 (31%), Positives = 108/229 (47%), Gaps = 43/229 (18%)
Query: 691 LIGVGSFGCVYKG-ALDEDG-----IVVAIKVINLQCEGAS----KSFMAECKALKNIRH 740
+G G+FG VY+G A D G I VA+K + +GA+ K F+ E + N H
Sbjct: 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLR---KGATDQEKKEFLKEAHLMSNFNH 58
Query: 741 RNLVKVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRIS 800
N+VK++ C N+ + I+ E M G L +L V + + LTL + +
Sbjct: 59 PNIVKLLGVCLL-----NEPQYIIMELMEGGDLLSYLRDARVERFGPPL---LTLKELLD 110
Query: 801 IAIDVASALDYLHHHCQEPILHCDLKPSNILL-----DNDLSGHIGDFGLAR------FH 849
I +DVA YL Q +H DL N L+ D D IGDFGLAR ++
Sbjct: 111 ICLDVAKGCVYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYY 167
Query: 850 QEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT 898
++ L + + APE L + +T DV+S+G+L+ E++T
Sbjct: 168 RKEGEGLLP--------VRWMAPESLLDGKFTTQSDVWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.1 bits (198), Expect = 3e-16
Identities = 61/224 (27%), Positives = 97/224 (43%), Gaps = 36/224 (16%)
Query: 684 NGFSSTHLIGVGSFGCVYKGALDEDGIVVAIK--VINLQCEGASKSFMAECKALKNIRHR 741
N + ++G G++G V K G +VAIK + E K+ + E K L+ +RH
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHE 60
Query: 742 NLVKVITSCSSIDFQGNDFKAIVYEYMPNGSLE------KWLHPHAVPKRDKEIEIKLTL 795
N+V + + +G + +V+EY+ LE L P AV + +
Sbjct: 61 NIVNLKEAFRR---KGRLY--LVFEYVERTLLELLEASPGGLPPDAV---------RSYI 106
Query: 796 LQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNS 855
Q + A+ Y H H I+H D+KP NIL+ + DFG AR + S
Sbjct: 107 WQ-------LLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARPAS 156
Query: 856 TLSSSVGVKGTIGYTAPEYGLGS-EVSTNGDVYSYGILLLEMVT 898
L+ V T Y APE +G DV++ G ++ E++
Sbjct: 157 PLTDYV---ATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLD 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 4e-16
Identities = 61/226 (26%), Positives = 109/226 (48%), Gaps = 36/226 (15%)
Query: 691 LIGVGSFGCVYKGALDEDGIVVAIKVINL----------QCEGASKSFMAECKALKNIRH 740
LIG G++G VY G ++A+K + L + + K+ +E + LK++ H
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 741 RNLVKVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRIS 800
N+V+ + ++ +I EY+P GS+ L + R +E ++ Q
Sbjct: 68 LNIVQYL-GFE----TTEEYLSIFLEYVPGGSIGSCLRTYG---RFEEQLVRFFTEQ--- 116
Query: 801 IAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSS 860
V L YLH + ILH DLK N+L+D D I DFG+++ ++ ++ +
Sbjct: 117 ----VLEGLAYLH---SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDN--DQN 167
Query: 861 VGVKGTIGYTAPE----YGLGSEVSTNGDVYSYGILLLEMVTAKKP 902
+ ++G++ + APE Y G S D++S G ++LEM ++P
Sbjct: 168 MSMQGSVFWMAPEVIHSYSQG--YSAKVDIWSLGCVVLEMFAGRRP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 4e-16
Identities = 78/243 (32%), Positives = 116/243 (47%), Gaps = 42/243 (17%)
Query: 686 FSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINL--QCEGASKSFMAECKALKNIRHRNL 743
F IG G++G VYK + G +VA+K + L + EG + + E K L+ + HRN+
Sbjct: 9 FDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNI 68
Query: 744 VK----VITSCSSIDF---QGNDFKAIVYEYMPN---GSLEKWLHPHAVPKRDKEIEIKL 793
V V ++DF +G + +V+EYM + G LE L V + I+
Sbjct: 69 VNLKEIVTDKQDALDFKKDKGAFY--LVFEYMDHDLMGLLESGL----VHFSEDHIK--- 119
Query: 794 TLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHI--GDFGLARFHQE 851
S + L+Y H ++ LH D+K SNILL+N G I DFGLAR +
Sbjct: 120 ------SFMKQLLEGLNYCH---KKNFLHRDIKCSNILLNN--KGQIKLADFGLARLYNS 168
Query: 852 VSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNG-DVYSYGILLLEMVTAKKPTDVMFEGD 910
+ ++ V T+ Y PE LG E DV+S G +L E+ T KKP +F+ +
Sbjct: 169 EESRPYTNKV---ITLWYRPPELLLGEERYGPAIDVWSCGCILGELFT-KKP---IFQAN 221
Query: 911 LNL 913
L
Sbjct: 222 QEL 224
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 5e-16
Identities = 58/219 (26%), Positives = 98/219 (44%), Gaps = 26/219 (11%)
Query: 692 IGVGSFGCVYKGALDEDG----IVVAIKVI-NLQCEGASKSFMAECKALKNIRHRNLVKV 746
+G G+FG VYKG +G I VAIKV+ A+K + E + ++ H ++V++
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 747 ITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVA 806
+ C S Q ++ + MP G L ++ H +D + ++ + +A
Sbjct: 75 LGICLSSQVQ------LITQLMPLGCLLDYVRNH----KD-----NIGSQYLLNWCVQIA 119
Query: 807 SALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGT 866
+ YL ++H DL N+L+ I DFGLA+ + G K
Sbjct: 120 KGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAE--GGKVP 174
Query: 867 IGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT-AKKPTD 904
I + A E L + DV+SYG+ + E++T KP +
Sbjct: 175 IKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYE 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 6e-16
Identities = 64/214 (29%), Positives = 106/214 (49%), Gaps = 36/214 (16%)
Query: 692 IGVGSFGCVYKGALDEDGIVVAIKVINLQCE-GASKSFMAECKALKNIRHRNLV---KVI 747
+G GS+ VYKG +G +VA+KVI+++ E G + + E LK ++H N+V +I
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDII 72
Query: 748 TSCSSIDFQGNDFKAIVYEYM---PNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAID 804
+ ++ F + +YM P G LHP+ ++L + Q +
Sbjct: 73 HTKETLTFVFEYMHTDLAQYMIQHPGG-----LHPY---------NVRLFMFQLLR---- 114
Query: 805 VASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVK 864
L Y+H + ILH DLKP N+L+ + DFGLAR + + + T SS V
Sbjct: 115 ---GLAYIHG---QHILHRDLKPQNLLISYLGELKLADFGLAR-AKSIPSQTYSSEV--- 164
Query: 865 GTIGYTAPEYGLGS-EVSTNGDVYSYGILLLEMV 897
T+ Y P+ LG+ + S+ D++ G + +EM+
Sbjct: 165 VTLWYRPPDVLLGATDYSSALDIWGAGCIFIEML 198
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 6e-16
Identities = 68/250 (27%), Positives = 111/250 (44%), Gaps = 25/250 (10%)
Query: 691 LIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGAS-----KSFMAECKALKNIRHRNLVK 745
L+G G+FG VY + G +A+K + + + E + LKN++H +V+
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQ 68
Query: 746 VITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDV 805
C D +I EYMP GS++ L + + T+ ++ + I
Sbjct: 69 YY-GCLRDDET----LSIFMEYMPGGSVKDQLKAYGA--------LTETVTRKYTRQI-- 113
Query: 806 ASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKG 865
++YLH + I+H D+K +NIL D+ + +GDFG ++ Q + +S V G
Sbjct: 114 LEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMK-SVTG 169
Query: 866 TIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMALPNQV 925
T + +PE G DV+S G ++EM+T K P FE + A Q+
Sbjct: 170 TPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPW-AEFEAMAAIFKIATQPTNPQL 228
Query: 926 MDIVDPILRN 935
V P RN
Sbjct: 229 PSHVSPDARN 238
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.9 bits (195), Expect = 1e-15
Identities = 69/247 (27%), Positives = 99/247 (40%), Gaps = 50/247 (20%)
Query: 692 IGVGSFGCVYKGALDE--DGIVVAIKVI---NLQCEGASKSFMAECKALKNIRHRNLVKV 746
IG G++G VYK DG AIK Q G S+S E L+ ++H N+V +
Sbjct: 8 IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSL 67
Query: 747 ITSCSS---------IDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQ 797
+ D+ +D I+ K+ H A +K L Q
Sbjct: 68 VEVFLEHADKSVYLLFDYAEHDLWQII----------KF-HRQAKRVSIPPSMVKSLLWQ 116
Query: 798 RISIAIDVASALDYLHHHCQEPILHCDLKPSNILL--DNDLSG--HIGDFGLARFHQEVS 853
+ + + YLH +LH DLKP+NIL+ + G IGD GLAR
Sbjct: 117 -------ILNGVHYLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPL 166
Query: 854 NSTLSSSVGVKGTIGYTAPEYGLGSEVSTNG-DVYSYGILLLEMVT---------AKKPT 903
L+ V TI Y APE LG+ T D+++ G + E++T AK
Sbjct: 167 KP-LADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKK 225
Query: 904 DVMFEGD 910
F+ D
Sbjct: 226 SNPFQRD 232
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 1e-15
Identities = 74/257 (28%), Positives = 121/257 (47%), Gaps = 34/257 (13%)
Query: 692 IGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVK---VIT 748
+G G FG V+ G + + VA+K + + ++F+ E +K ++H LV+ V+T
Sbjct: 14 LGAGQFGEVWMGYYN-NSTKVAVKTLK-PGTMSVQAFLEEANLMKTLQHDKLVRLYAVVT 71
Query: 749 SCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASA 808
I I+ EYM GSL +L K D+ ++ L L I + +A
Sbjct: 72 KEEPI--------YIITEYMAKGSLLDFL------KSDEGGKVLLPKL--IDFSAQIAEG 115
Query: 809 LDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIG 868
+ Y+ ++ +H DL+ +N+L+ L I DFGLAR + ++ ++ G K I
Sbjct: 116 MAYIE---RKNYIHRDLRAANVLVSESLMCKIADFGLARV---IEDNEYTAREGAKFPIK 169
Query: 869 YTAPEYGLGSEVSTNGDVYSYGILLLEMVT-AKKPTDVMFEGDL--NLHNFARMA----L 921
+TAPE + DV+S+GILL E+VT K P M D+ L RM
Sbjct: 170 WTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMENC 229
Query: 922 PNQVMDIVDPILRNDEE 938
P+++ DI+ + E
Sbjct: 230 PDELYDIMKTCWKEKAE 246
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.0 bits (193), Expect = 1e-15
Identities = 64/226 (28%), Positives = 96/226 (42%), Gaps = 40/226 (17%)
Query: 686 FSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASK---------SFMAECKALK 736
F+ IG GSFG VYK VVAIKVI+L E A F+++C++
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDL--EEAEDEIEDIQQEIQFLSQCRSP- 59
Query: 737 NIRHRNLVKVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLL 796
+ K S F I+ EY GS L P + E I
Sbjct: 60 -----YITKYYGS-----FLKGSKLWIIMEYCGGGSCLDLLKPG----KLDETYIA---- 101
Query: 797 QRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNST 856
I +V L+YLH +E +H D+K +NILL + + DFG++ +++++
Sbjct: 102 ---FILREVLLGLEYLH---EEGKIHRDIKAANILLSEEGDVKLADFGVS---GQLTSTM 152
Query: 857 LSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKP 902
+ V GT + APE S D++S GI +E+ + P
Sbjct: 153 SKRNTFV-GTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPP 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 1e-15
Identities = 63/225 (28%), Positives = 107/225 (47%), Gaps = 30/225 (13%)
Query: 686 FSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQ--CEGASKSFMAECKALKNIRHRNL 743
+ ++G G+FG V+ D +V IK I ++ + + EC+ LK + H N+
Sbjct: 2 YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNI 61
Query: 744 VKVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQ---RIS 800
++ + F + IV EY P G+L +++ KR + + T+L +I
Sbjct: 62 IEYYEN-----FLEDKALMIVMEYAPGGTLAEYIQ-----KRCNSLLDEDTILHFFVQIL 111
Query: 801 IAIDVASALDYLHHHCQEPILHCDLKPSNILLD-NDLSGHIGDFGLARFHQEVSNSTLSS 859
+A LHH + ILH DLK NILLD + + IGDFG+++ S+ S
Sbjct: 112 LA---------LHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKIL-----SSKSK 157
Query: 860 SVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTD 904
+ V GT Y +PE G + D+++ G +L E+ + K+ +
Sbjct: 158 AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFE 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 2e-15
Identities = 65/223 (29%), Positives = 106/223 (47%), Gaps = 33/223 (14%)
Query: 691 LIGVGSFGCVYKGALDEDG--IVVAIKVIN-LQCEGASKSFMAECKALKNI-RHRNLVKV 746
+IG G+FG V + + +DG + AIK++ E + F E + L + H N++ +
Sbjct: 9 VIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINL 68
Query: 747 ITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIK------LTLLQRIS 800
+ +C + + I EY P G+L +L V + D + LT Q +
Sbjct: 69 LGAC-----ENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQ 123
Query: 801 IAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSS 860
A DVA+ + YL ++ +H DL N+L+ +L+ I DFGL+R
Sbjct: 124 FASDVATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSR----------GEE 170
Query: 861 VGVKGTIG-----YTAPEYGLGSEVSTNGDVYSYGILLLEMVT 898
V VK T+G + A E S +T DV+S+G+LL E+V+
Sbjct: 171 VYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 77.8 bits (192), Expect = 2e-15
Identities = 64/225 (28%), Positives = 105/225 (46%), Gaps = 29/225 (12%)
Query: 690 HLIGVGSFGCVYKGAL-----DEDGIVVAIKVINLQC-EGASKSFMAECKALKNI-RHRN 742
+G G+FG V K + VA+K++ E ++E + +K I +H+N
Sbjct: 18 KPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 77
Query: 743 LVKVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPH------AVPKRDKEIEIKLTLL 796
++ ++ C+ +G + +V EY +G+L +L A P + E LT
Sbjct: 78 IINLLGVCTQ---EGPLY--VVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQK 132
Query: 797 QRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLAR--FHQEVSN 854
+S A VA +++L + +H DL N+L+ D I DFGLAR H +
Sbjct: 133 DLVSFAYQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYR 189
Query: 855 STLSSSVGVKGTIGYTAPEYGLGSEVSTN-GDVYSYGILLLEMVT 898
T + + VK + APE L V T+ DV+S+G+LL E+ T
Sbjct: 190 KTTNGRLPVK----WMAPE-ALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 2e-15
Identities = 70/211 (33%), Positives = 108/211 (51%), Gaps = 30/211 (14%)
Query: 692 IGVGSFGCVYKGALDEDGIVVAIKVINLQCE-GASKSFMAECKALKNIRHRNLV---KVI 747
+G GS+ VYKG +G +VA+KVI LQ E G + + E LK ++H N+V +I
Sbjct: 13 LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDII 72
Query: 748 TSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVAS 807
+ ++ +V+EY+ + L +++ H P +KL L Q +
Sbjct: 73 HTKETL--------TLVFEYV-HTDLCQYMDKH--PGGLHPENVKLFLFQLLR------- 114
Query: 808 ALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTI 867
L Y+H Q ILH DLKP N+L+ + + DFGLAR + V + T S+ V T+
Sbjct: 115 GLSYIH---QRYILHRDLKPQNLLISDTGELKLADFGLAR-AKSVPSHTYSNEV---VTL 167
Query: 868 GYTAPEYGLGS-EVSTNGDVYSYGILLLEMV 897
Y P+ LGS E ST D++ G + +EM+
Sbjct: 168 WYRPPDVLLGSTEYSTCLDMWGVGCIFVEMI 198
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 77.3 bits (191), Expect = 2e-15
Identities = 69/225 (30%), Positives = 107/225 (47%), Gaps = 41/225 (18%)
Query: 695 GSFGCVYKGALDEDGIVVAIKVINL--QCEGASKSFMAECKALKNIRHRNLVKV--ITSC 750
G++G VY+ + G +VA+K + + + EG + + E L ++H N+V V +
Sbjct: 16 GTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVG 75
Query: 751 SSID--FQGNDFKAIVYEYMPN---GSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDV 805
S++D + +V EY+ + +E P E+K +LQ +
Sbjct: 76 SNLDKIY-------MVMEYVEHDLKSLMETMKQPFLQS------EVKCLMLQ-------L 115
Query: 806 ASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKG 865
S + +LH + ILH DLK SN+LL+N I DFGLAR + V
Sbjct: 116 LSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVV---- 168
Query: 866 TIGYTAPEYGLG-SEVSTNGDVYSYGILLLEMVTAKKPTDVMFEG 909
T+ Y APE LG E ST D++S G + E++T KKP +F G
Sbjct: 169 TLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLT-KKP---LFPG 209
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 4e-15
Identities = 69/237 (29%), Positives = 111/237 (46%), Gaps = 33/237 (13%)
Query: 692 IGVGSFGCVYKGA-LDEDGIVVAIKVINLQC--EGASKSFMAECKALKNIR---HRNLVK 745
IG G++G V+K L G VA+K + +Q EG S + E L+++ H N+V+
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 746 VITSCSSIDFQGNDFKAIVYEYMPNG---SLEKWLHPHAVPKRDKEIEIKLTLLQRISIA 802
+ C+ +V+E++ L+K P + K++ LL+
Sbjct: 69 LFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDM--MFQLLR----- 121
Query: 803 IDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVG 862
LD+LH H ++H DLKP NIL+ + + DFGLAR + S +SV
Sbjct: 122 -----GLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSVV 170
Query: 863 VKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARM 919
V T+ Y APE L S +T D++S G + EM +KP +F G ++ ++
Sbjct: 171 V--TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKP---LFRGSSDVDQLGKI 221
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 5e-15
Identities = 65/227 (28%), Positives = 107/227 (47%), Gaps = 37/227 (16%)
Query: 691 LIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGAS---------KSFMAECKALKNIRHR 741
LIG GSFG VY G G ++A+K + L AS + E LK ++H
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 742 NLVKVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPH-AVPKRDKEIEIKLTLLQRIS 800
N+V+ + S D I EY+P GS+ L+ + A + ++ L
Sbjct: 67 NIVQYLGSSLD-----ADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQIL----- 116
Query: 801 IAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSS 860
L+YLH I+H D+K +NIL+DN I DFG+++ ++ ++LS+
Sbjct: 117 ------KGLNYLH---NRGIIHRDIKGANILVDNKGGIKISDFGISK---KLEANSLSTK 164
Query: 861 VG-----VKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKP 902
++G++ + APE + + D++S G L++EM+T K P
Sbjct: 165 TNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 5e-15
Identities = 61/212 (28%), Positives = 104/212 (49%), Gaps = 21/212 (9%)
Query: 692 IGVGSFG----CVYKGALDEDGIVVAIKVINLQCEGA-SKSFMAECKALKNIRHRNLVKV 746
+G G FG C Y D G VA+K + + G E + L+N+ H N+VK
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71
Query: 747 ITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVA 806
C+ + GN K I+ E++P+GSL+++L P+ +I +K Q++ A+ +
Sbjct: 72 KGICT--EDGGNGIKLIM-EFLPSGSLKEYL-----PRNKNKINLK----QQLKYAVQIC 119
Query: 807 SALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGT 866
+DYL +H DL N+L++++ IGDFGL + E + +
Sbjct: 120 KGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTK-AIETDKEYYTVKDDLDSP 175
Query: 867 IGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT 898
+ + APE + S+ DV+S+G+ L E++T
Sbjct: 176 VFWYAPECLIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 8e-15
Identities = 68/225 (30%), Positives = 100/225 (44%), Gaps = 37/225 (16%)
Query: 686 FSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCE--GASKSFMAECKALKNIRHRNL 743
F + IG G++G VY+ G +VA+K + + E G S + E L N+RH N+
Sbjct: 9 FEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNI 68
Query: 744 V---KVITSCSSIDFQGNDFKAI--VYEYMPN--GSLEKWLHPHAVPKRDKEIEIKLTLL 796
V +V+ G +I V EY SL +P E ++K +L
Sbjct: 69 VELKEVV--------VGKHLDSIFLVMEYCEQDLASLLD-----NMPTPFSESQVKCLML 115
Query: 797 QRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNST 856
Q + L YLH + I+H DLK SN+LL + I DFGLAR + +
Sbjct: 116 Q-------LLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPM 165
Query: 857 LSSSVGVKGTIGYTAPEYGLGSEVSTNG-DVYSYGILLLEMVTAK 900
V T+ Y APE LG T D+++ G +L E++ K
Sbjct: 166 TPKVV----TLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.6 bits (187), Expect = 8e-15
Identities = 68/220 (30%), Positives = 98/220 (44%), Gaps = 41/220 (18%)
Query: 692 IGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSF--MAEC------KALKNI-RHRN 742
+G G+FG VY E G +VAIK + K F EC K+L+ + H N
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKMK-------KKFYSWEECMNLREVKSLRKLNEHPN 59
Query: 743 LVKVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIA 802
+VK+ F+ ND V+EYM G+L + L K E I+ + Q
Sbjct: 60 IVKLKEV-----FRENDELYFVFEYM-EGNLYQ-LMKDRKGKPFSESVIRSIIYQ----- 107
Query: 803 IDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEV-SNSTLSSSV 861
+ L ++H H H DLKP N+L+ I DFGLAR E+ S + V
Sbjct: 108 --ILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAR---EIRSRPPYTDYV 159
Query: 862 GVKGTIGYTAPEYGLGSEV-STNGDVYSYGILLLEMVTAK 900
T Y APE L S S+ D+++ G ++ E+ T +
Sbjct: 160 ---STRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 75.8 bits (187), Expect = 1e-14
Identities = 72/259 (27%), Positives = 108/259 (41%), Gaps = 52/259 (20%)
Query: 692 IGVGSFGCVYKGALDEDGIVVAIKVINL--QCEGASKSFMAECKALKNIRHRNLVKVITS 749
+G G+FG VYK + G VVA+K I + + +G + + E K LK ++H N+V +I
Sbjct: 16 LGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDM 75
Query: 750 CSSIDFQGNDFKAIVYEYMP------NGSLE----KWLHPHAVPKRDKEIEIKLTLLQRI 799
+ + VY P +G LE K IK +LQ
Sbjct: 76 AVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQ----------IKCYMLQ-- 123
Query: 800 SIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSS 859
+ ++YLH + ILH D+K +NIL+DN I DFGLAR +
Sbjct: 124 -----LLEGINYLH---ENHILHRDIKAANILIDNQGILKIADFGLARPYDG--PPPNPK 173
Query: 860 SVGVKGTIGYT---------APEYGLG-SEVSTNGDVYSYGILLLEMVTAKKPTDVMFEG 909
G GT YT PE LG +T D++ G + EM T ++P + +G
Sbjct: 174 GGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFT-RRP---ILQG 229
Query: 910 DLNLHN----FARMALPNQ 924
++ F P +
Sbjct: 230 KSDIDQLHLIFKLCGTPTE 248
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.6 bits (184), Expect = 1e-14
Identities = 67/231 (29%), Positives = 99/231 (42%), Gaps = 41/231 (17%)
Query: 692 IGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSCS 751
IG G++G VYK G +VAIKVI L+ + E LK RH N+V S
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGS-- 68
Query: 752 SIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDY 811
+ D IV EY GSL+ L+ LQ + + L Y
Sbjct: 69 ---YLRRDKLWIVMEYCGGGSLQDIYQ---------VTRGPLSELQIAYVCRETLKGLAY 116
Query: 812 LHHHCQEPILHCDLKPSNILLDNDLSGHI--GDFGLARFHQEVSNSTLSSSVGVKGTIGY 869
LH + +H D+K +NILL D G + DFG++ +++ T++ GT +
Sbjct: 117 LH---ETGKIHRDIKGANILLTED--GDVKLADFGVS---AQLTA-TIAKRKSFIGTPYW 167
Query: 870 TAPEYGLGSEVSTNG------DVYSYGILLLEMVTAKKPTDVMFEGDLNLH 914
APE + V G D+++ GI +E+ + P MF +LH
Sbjct: 168 MAPEV---AAVERKGGYDGKCDIWALGITAIELAELQPP---MF----DLH 208
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 1e-14
Identities = 63/245 (25%), Positives = 109/245 (44%), Gaps = 36/245 (14%)
Query: 691 LIGVGSFGCVYKGA---LDEDGIVVAIKVINLQCEGASKS-FMAECKALKNIRHRNLVKV 746
IG G FG VY+G + + I VA+K + + F+ E ++ H ++VK+
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72
Query: 747 ITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVA 806
I + + IV E P G L +L + +K L L I + ++
Sbjct: 73 IGVIT------ENPVWIVMELAPLGELRSYL------QVNKY---SLDLASLILYSYQLS 117
Query: 807 SALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGT 866
+AL YL + +H D+ N+L+ + +GDFGL+R+ ++ S +S G K
Sbjct: 118 TALAYLE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLED--ESYYKASKG-KLP 171
Query: 867 IGYTAPEYGLGSEVSTNGDVYSYGILLLE-MVTAKKPTDVMFEGDLN------LHNFARM 919
I + APE ++ DV+ +G+ + E ++ KP F+G N + N R+
Sbjct: 172 IKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKP----FQGVKNNDVIGRIENGERL 227
Query: 920 ALPNQ 924
+P
Sbjct: 228 PMPPN 232
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 2e-14
Identities = 67/218 (30%), Positives = 102/218 (46%), Gaps = 30/218 (13%)
Query: 692 IGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSCS 751
+G G+FG VYK E G++ A KVI+ + E + +M E L + H N+VK++
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLL---D 69
Query: 752 SIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDY 811
+ ++ N + I+ E+ G+++ + E+E LT Q + AL+Y
Sbjct: 70 AFYYENNLW--ILIEFCAGGAVDAVM---------LELERPLTEPQIRVVCKQTLEALNY 118
Query: 812 LHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNS-TLSSSVGVKGTIGYT 870
LH + I+H DLK NIL D GD LA F N+ T+ GT +
Sbjct: 119 LH---ENKIIHRDLKAGNILFTLD-----GDIKLADFGVSAKNTRTIQRRDSFIGTPYWM 170
Query: 871 APEYGLGSEVSTN------GDVYSYGILLLEMVTAKKP 902
APE + E S + DV+S GI L+EM + P
Sbjct: 171 APEVVM-CETSKDRPYDYKADVWSLGITLIEMAQIEPP 207
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 2e-14
Identities = 66/211 (31%), Positives = 99/211 (46%), Gaps = 32/211 (15%)
Query: 692 IGVGSFGCVYKGALDEDGIVVAIKVI--NLQCEGASKSFMAECKALKNIRHRNLVKVITS 749
IG G+FG V+ G L D VA+K L + +K F+ E + LK H N+V++I
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAK-FLQEARILKQYSHPNIVRLIGV 61
Query: 750 CSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASAL 809
C+ Q IV E + G +L + KE+ I + + A+ +
Sbjct: 62 CT----QKQPI-YIVMELVQGGDFLTFLRTEGPRLKVKEL---------IQMVENAAAGM 107
Query: 810 DYLH-HHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGT-I 867
+YL HC +H DL N L+ I DFG++R E + +S+ G+K +
Sbjct: 108 EYLESKHC----IHRDLAARNCLVTEKNVLKISDFGMSR---EEEDGVYASTGGMKQIPV 160
Query: 868 GYTAPE---YGLGSEVSTNGDVYSYGILLLE 895
+TAPE YG S+ DV+S+GILL E
Sbjct: 161 KWTAPEALNYG---RYSSESDVWSFGILLWE 188
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 3e-14
Identities = 61/195 (31%), Positives = 83/195 (42%), Gaps = 32/195 (16%)
Query: 476 LNLARNHLVGIIPPRIGNLRALRSFDVSNNDLSGEIPIELGHCSSLEEIYLAGNLFHGSI 535
L L L G IP I LR L+S ++S N + G IP LG +SLE + L+ N F+GSI
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 536 PSFFNALKGVQKIDLSRNNLSGQIPIFLEALSLEYLNLSFNDFEGKIPAKGIFANASAIS 595
P L ++ ++L+ N+LSG++P L L + +F D G
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAG--------------- 527
Query: 596 VVGCNRLCGGIPELQLPKCTESKSSSQKISRRLKIIISAITAFSGFFMVSFFILYWHKWR 655
LC GIP L C S KI I AF F+V + +W R
Sbjct: 528 ------LC-GIP--GLRACGPHLSVGAKIG----IAFGVSVAF--LFLVICAMCWWK--R 570
Query: 656 RGPSRLPSRPMMRKA 670
R R R+A
Sbjct: 571 RQNILRAQRIAAREA 585
|
Length = 623 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 3e-14
Identities = 71/224 (31%), Positives = 103/224 (45%), Gaps = 29/224 (12%)
Query: 686 FSSTHLI-----GVGSFG----CVYKGALDEDGIVVAIKVINLQCEGAS--KSFMAECKA 734
F HL G G+FG C Y D G VVA+K LQ A + F E +
Sbjct: 1 FEERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVK--KLQHSTAEHLRDFEREIEI 58
Query: 735 LKNIRHRNLVKVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLT 794
LK+++H N+VK C S G +V EY+P GSL +L H R++ KL
Sbjct: 59 LKSLQHDNIVKYKGVCYS---AGRRNLRLVMEYLPYGSLRDYLQKH----RERLDHRKLL 111
Query: 795 LLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSN 854
L A + ++YL + +H DL NIL++++ IGDFGL + +
Sbjct: 112 LY-----ASQICKGMEYLG---SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKE 163
Query: 855 STLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT 898
G + I + APE S+ S DV+S+G++L E+ T
Sbjct: 164 YYKVREPG-ESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 3e-14
Identities = 70/233 (30%), Positives = 115/233 (49%), Gaps = 29/233 (12%)
Query: 679 LLKATNGFSSTHLIGVGSFGCVYKGALDEDG----IVVAIKVINLQCEG--ASKSFMAEC 732
+LK T ++G G+FG VYKG +G I VAIK++N + G A+ FM E
Sbjct: 3 ILKETE-LKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILN-ETTGPKANVEFMDEA 60
Query: 733 KALKNIRHRNLVKVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIK 792
+ ++ H +LV+++ C S Q +V + MP+G L ++H H +D I
Sbjct: 61 LIMASMDHPHLVRLLGVCLSPTIQ------LVTQLMPHGCLLDYVHEH----KDN---IG 107
Query: 793 LTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEV 852
LL ++ + +A + YL + ++H DL N+L+ + I DFGLAR +
Sbjct: 108 SQLL--LNWCVQIAKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLE-- 160
Query: 853 SNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT-AKKPTD 904
+ ++ G K I + A E + + DV+SYG+ + E++T KP D
Sbjct: 161 GDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.6 bits (184), Expect = 4e-14
Identities = 66/245 (26%), Positives = 95/245 (38%), Gaps = 54/245 (22%)
Query: 684 NGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVIN-----LQCEGASKSFMAECKALKNI 738
+ F +IG G+FG V+ + G V A+KV+ + + AE L +
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQ--IAHVRAERDILADA 58
Query: 739 RHRNLVKVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQR 798
+VK+ S FQ + +V EYMP G L L V + R
Sbjct: 59 DSPWIVKLYYS-----FQDEEHLYLVMEYMPGGDLMNLLIRKDV------FPEETA---R 104
Query: 799 ISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHI--GDFGLA----RFHQEV 852
IA ++ ALD +H + +H D+KP NIL+D D GHI DFGL +
Sbjct: 105 FYIA-ELVLALDSVH---KLGFIHRDIKPDNILIDAD--GHIKLADFGLCKKMNKAKDRE 158
Query: 853 SNSTLSSSVG---------------------VKGTIGYTAPEYGLGSEVSTNGDVYSYGI 891
S ++ GT Y APE G+ D +S G+
Sbjct: 159 YYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGV 218
Query: 892 LLLEM 896
+L EM
Sbjct: 219 ILYEM 223
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 73.2 bits (179), Expect = 5e-14
Identities = 67/223 (30%), Positives = 105/223 (47%), Gaps = 33/223 (14%)
Query: 691 LIGVGSFGCVYKGALDEDGIVV--AIKVIN-LQCEGASKSFMAECKALKNI-RHRNLVKV 746
+IG G+FG V K + +DG+ + AIK + + + F E + L + H N++ +
Sbjct: 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 61
Query: 747 ITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRD----KEIEIKLTLLQR--IS 800
+ +C + + + EY P+G+L +L V + D TL + +
Sbjct: 62 LGAC-----EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 116
Query: 801 IAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSS 860
A DVA +DYL Q+ +H DL NIL+ + I DFGL+R
Sbjct: 117 FAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR----------GQE 163
Query: 861 VGVKGTIG-----YTAPEYGLGSEVSTNGDVYSYGILLLEMVT 898
V VK T+G + A E S +TN DV+SYG+LL E+V+
Sbjct: 164 VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 6e-14
Identities = 36/85 (42%), Positives = 52/85 (61%)
Query: 379 LGMVENQFTGAIPKEMGKLQKLQGLDFSGNHFSGEIPSSLGNLSSLYEVFFNNNNLSGVI 438
LG+ G IP ++ KL+ LQ ++ SGN G IP SLG+++SL + + N+ +G I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 439 PFSLGNLKRLAFLEMSGNELSGTIP 463
P SLG L L L ++GN LSG +P
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVP 507
|
Length = 623 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 6e-14
Identities = 65/217 (29%), Positives = 95/217 (43%), Gaps = 28/217 (12%)
Query: 692 IGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSCS 751
+G G+FG VYK E G + A KVI + E + +M E + L H +VK++ +
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGA-- 77
Query: 752 SIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDY 811
F + I+ E+ P G+++ + E++ LT Q I + AL Y
Sbjct: 78 ---FYWDGKLWIMIEFCPGGAVDAIM---------LELDRGLTEPQIQVICRQMLEALQY 125
Query: 812 LHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSN-STLSSSVGVKGTIGYT 870
LH I+H DLK N+LL D GD LA F N TL GT +
Sbjct: 126 LH---SMKIIHRDLKAGNVLLTLD-----GDIKLADFGVSAKNVKTLQRRDSFIGTPYWM 177
Query: 871 APEYGL-----GSEVSTNGDVYSYGILLLEMVTAKKP 902
APE + + D++S GI L+EM + P
Sbjct: 178 APEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPP 214
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 8e-14
Identities = 69/223 (30%), Positives = 106/223 (47%), Gaps = 34/223 (15%)
Query: 692 IGVGSFGCVYKGALDEDGIVVAIKVINLQC-EGASKSFMAECKALKNIRHRNLVK---VI 747
+G G++ V+KG +VA+K I L+ EGA + + E LKN++H N+V +I
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII 72
Query: 748 TSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVAS 807
+ + +V+EY+ + L+++L ++I + L R
Sbjct: 73 HTERCL--------TLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLR--------- 114
Query: 808 ALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTI 867
L Y H ILH DLKP N+L++ + DFGLAR + V T S+ V T+
Sbjct: 115 GLSYCHK---RKILHRDLKPQNLLINEKGELKLADFGLAR-AKSVPTKTYSNEV---VTL 167
Query: 868 GYTAPEYGLGS-EVSTNGDVYSYGILLLEMVTAKKPTDVMFEG 909
Y P+ LGS E ST D++ G +L EM T + MF G
Sbjct: 168 WYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRP----MFPG 206
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 1e-13
Identities = 60/212 (28%), Positives = 92/212 (43%), Gaps = 17/212 (8%)
Query: 692 IGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMA--ECKALKNIRHRNLVKVITS 749
IG G+FG V+K + +VA+K + ++ E A E K L+ ++H N+V +I
Sbjct: 20 IGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 79
Query: 750 CSSIDFQGNDFKAIVYEYMP--NGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVAS 807
C + N +K Y L L V + EIK + + +
Sbjct: 80 CRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNV--KFTLSEIKKVMKM-------LLN 130
Query: 808 ALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTI 867
L Y+H + ILH D+K +NIL+ D + DFGLAR NS + T+
Sbjct: 131 GLYYIH---RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTL 187
Query: 868 GYTAPEYGLGS-EVSTNGDVYSYGILLLEMVT 898
Y PE LG + D++ G ++ EM T
Sbjct: 188 WYRPPELLLGERDYGPPIDMWGAGCIMAEMWT 219
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 73.0 bits (180), Expect = 1e-13
Identities = 79/240 (32%), Positives = 112/240 (46%), Gaps = 61/240 (25%)
Query: 692 IGVGSFGCVYKGALDED-GIVVAIKVI-----NLQCEGASKSFMAECKALKNIR-HRNLV 744
+G G++G V+K A+D VVA+K I N A ++F E L+ + H N+V
Sbjct: 15 LGKGAYGIVWK-AIDRRTKEVVALKKIFDAFRNAT--DAQRTFR-EIMFLQELGDHPNIV 70
Query: 745 KVITSCSSIDFQGNDFKA-------IVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQ 797
K++ N KA +V+EYM E LH AV I+ +L+
Sbjct: 71 KLL----------NVIKAENDKDIYLVFEYM-----ETDLH--AV--------IRANILE 105
Query: 798 RI---SIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLAR----FHQ 850
+ I + AL Y+H ++H DLKPSNILL++D + DFGLAR +
Sbjct: 106 DVHKRYIMYQLLKALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEE 162
Query: 851 EVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNG-DVYSYGILLLEMVTAKKPTDVMFEG 909
N L+ V T Y APE LGS T G D++S G +L EM+ K +F G
Sbjct: 163 NPENPVLTDYV---ATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKP----LFPG 215
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 1e-13
Identities = 75/232 (32%), Positives = 100/232 (43%), Gaps = 35/232 (15%)
Query: 692 IGVGSFGCVYKGALDEDGIVVAIKVIN---LQCEGASKSFMAECKAL-KNIRHRNLVKVI 747
IG GSFG V DG A+KV+ + + K MAE L KN++H LV +
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 748 TSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVAS 807
S FQ D V +Y+ G L L + E + A ++AS
Sbjct: 63 YS-----FQTADKLYFVLDYVNGGELFFHLQRE---RSFPEPRARF-------YAAEIAS 107
Query: 808 ALDYLHHHCQEPILHCDLKPSNILLDNDLSGHI--GDFGLARFHQEVSNSTLSSSVGVKG 865
AL YLH I++ DLKP NILLD+ GH+ DFGL + E S +T + G
Sbjct: 108 ALGYLH---SLNIIYRDLKPENILLDSQ--GHVVLTDFGLCKEGIEHSKTTSTFC----G 158
Query: 866 TIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKP-----TDVMFEGDLN 912
T Y APE D + G +L EM+ P T M++ LN
Sbjct: 159 TPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILN 210
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 1e-13
Identities = 57/214 (26%), Positives = 89/214 (41%), Gaps = 24/214 (11%)
Query: 692 IGVGSFGCVYKGALDEDGIVVAIKVIN---LQCEGASKSFMAECKALKNIRHRNLVKVIT 748
+G G FG V + G + A K ++ L+ + + E K L+ + R +V
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIV---- 56
Query: 749 SCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASA 808
+ F+ D +V M G L+ ++ P + + I A +
Sbjct: 57 -SLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEA--------RAIFYAAQIICG 107
Query: 809 LDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIG 868
L++LH Q I++ DLKP N+LLD+ + I D GLA V G GT G
Sbjct: 108 LEHLH---QRRIVYRDLKPENVLLDDHGNVRISDLGLA-----VELKGGKKIKGRAGTPG 159
Query: 869 YTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKP 902
Y APE G + D ++ G L EM+ + P
Sbjct: 160 YMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 1e-13
Identities = 54/217 (24%), Positives = 101/217 (46%), Gaps = 21/217 (9%)
Query: 691 LIGVGSFGCVYKGALD-EDGIVVAIKVINLQCEGASKS----FMAECKALKNIRHRNLVK 745
++G G FG V +G L +DG + + V ++ + + S F++E +K+ H N++K
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65
Query: 746 VITSC-SSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAID 804
+I C + Q ++ +M +G L H + R + KL L + +D
Sbjct: 66 LIGVCFEASSLQKIPKPMVILPFMKHGDL----HSFLLYSRLGGLPEKLPLQTLLKFMVD 121
Query: 805 VASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLAR--FHQEVSNSTLSSSVG 862
+A ++YL +H DL N +L D++ + DFGL++ + + + +
Sbjct: 122 IALGMEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMP 178
Query: 863 VKGTIGYTAPEYGLGSEVST-NGDVYSYGILLLEMVT 898
VK + A E L V T DV+++G+ + E+ T
Sbjct: 179 VK----WIAIE-SLADRVYTSKSDVWAFGVTMWEIAT 210
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 1e-13
Identities = 75/312 (24%), Positives = 123/312 (39%), Gaps = 63/312 (20%)
Query: 692 IGVGSFGCVYKG-----ALDEDGIVVAIKVINLQCEGASKS-FMAECKALKNIRHRNLVK 745
+G G+FG VY+G D + VA+K + C +S F+ E + H+N+V+
Sbjct: 14 LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVR 73
Query: 746 VITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDV 805
+I + F+ + I+ E M G L+ +L P+ ++ LT+ + A DV
Sbjct: 74 LI----GVSFERLP-RFILLELMAGGDLKSFLR-ENRPRPERPSS--LTMKDLLFCARDV 125
Query: 806 ASALDYLHHHCQEPILHCDLKPSNILLDNDLSGH---IGDFGLARFHQEVSNSTLSSSVG 862
A YL + +H D+ N LL G I DFG+AR +S
Sbjct: 126 AKGCKYLE---ENHFIHRDIAARNCLLTCKGPGRVAKIADFGMAR-------DIYRASYY 175
Query: 863 VKG-----TIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFA 917
KG I + PE L ++ DV+S+G+LL E+ +
Sbjct: 176 RKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFS-----------------LG 218
Query: 918 RMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQD 977
M P + N E + T R ++ C + +I C +P+D
Sbjct: 219 YMPYPGR---------TNQEVMEFVTGGGR-----LDPPKGCPGPVYRIMTDCWQHTPED 264
Query: 978 RMNMTNVVHELQ 989
R N ++ +Q
Sbjct: 265 RPNFATILERIQ 276
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 1e-13
Identities = 68/224 (30%), Positives = 93/224 (41%), Gaps = 43/224 (19%)
Query: 692 IGVGSFGCVYKGALDEDGIVVAIKVINLQCEGA-SKSFMAECKALKNIRHRNLVKVITSC 750
+G G+ G V K L G++ A+K I K + E + K+ + +VK +
Sbjct: 9 LGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAF 68
Query: 751 -----SSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRIS----- 800
SSI I EY GSL+ ++ K+ K+ RI
Sbjct: 69 LDESSSSI--------GIAMEYCEGGSLD------SIYKKVKK------RGGRIGEKVLG 108
Query: 801 -IAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSS 859
IA V L YLH I+H D+KPSNILL + DFG VS ++S
Sbjct: 109 KIAESVLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFG-------VSGELVNS 158
Query: 860 SVGV-KGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKP 902
G GT Y APE G S DV+S G+ LLE+ + P
Sbjct: 159 LAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFP 202
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 1e-13
Identities = 66/227 (29%), Positives = 99/227 (43%), Gaps = 40/227 (17%)
Query: 686 FSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSF---MAECKALKNIRHRN 742
F+ IG GSFG VY VVAIK ++ + +++ + + E + L+ +RH N
Sbjct: 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76
Query: 743 LVKVITSCSSIDFQGNDFKA----IVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQR 798
+I+++G + +V EY GS L H P ++ EI
Sbjct: 77 ---------TIEYKGCYLREHTAWLVMEYCL-GSASDILEVHKKPLQEVEIA-------- 118
Query: 799 ISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLS 858
+I L YLH H + +H D+K NILL + + DFG S S +S
Sbjct: 119 -AICHGALQGLAYLHSHER---IHRDIKAGNILLTEPGTVKLADFG--------SASLVS 166
Query: 859 SSVGVKGTIGYTAPEYGLG-SEVSTNG--DVYSYGILLLEMVTAKKP 902
+ GT + APE L E +G DV+S GI +E+ K P
Sbjct: 167 PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 2e-13
Identities = 63/231 (27%), Positives = 108/231 (46%), Gaps = 26/231 (11%)
Query: 692 IGVGSFGCVYKGALDEDGIVVAIK---VINLQCEGASKSFMAECKALKNIRHRNLVKVIT 748
IG G F VY+ DG+ VA+K + +L A + E LK + H N++K
Sbjct: 10 IGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYA 69
Query: 749 SCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASA 808
S F ++ IV E G L + + K+ K + + T+ + + + SA
Sbjct: 70 S-----FIEDNELNIVLELADAGDLSRMIKHF---KKQKRLIPEKTVWKYF---VQLCSA 118
Query: 809 LDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIG 868
L+++H ++H D+KP+N+ + +GD GL RF +S +++ + GT
Sbjct: 119 LEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFF----SSKTTAAHSLVGTPY 171
Query: 869 YTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGD-LNLHNFAR 918
Y +PE + + D++S G LL EM + P F GD +NL++ +
Sbjct: 172 YMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP----FYGDKMNLYSLCK 218
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 2e-13
Identities = 59/220 (26%), Positives = 100/220 (45%), Gaps = 31/220 (14%)
Query: 691 LIGVGSFGCVYKGALDEDG---IVVAIKVINLQCEGASK-SFMAECKALKNIRHRNLVK- 745
++G G FG + +G L + VAI + C + F+AE L H N+V+
Sbjct: 12 ILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRL 71
Query: 746 --VITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAI 803
VIT +++ IV EYM NG+L+ +L H E +L Q + +
Sbjct: 72 EGVITRGNTM--------MIVTEYMSNGALDSFLRKH---------EGQLVAGQLMGMLP 114
Query: 804 DVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGV 863
+AS + YL + +H L +L+++DL I F QE + + +++
Sbjct: 115 GLASGMKYL---SEMGYVHKGLAAHKVLVNSDLVCKISGFRRL---QEDKSEAIYTTMSG 168
Query: 864 KGTIGYTAPEYGLGSEVSTNGDVYSYGILLLE-MVTAKKP 902
K + + APE S+ DV+S+GI++ E M ++P
Sbjct: 169 KSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 2e-13
Identities = 61/231 (26%), Positives = 101/231 (43%), Gaps = 38/231 (16%)
Query: 692 IGVGSFG--CVYKGALDEDGIVVAIKVINLQ--CEGASKSFMAECKALKNIRHRNLVKVI 747
+G G+FG +Y+ ED +V K +NL E + + E L ++H N++
Sbjct: 8 LGKGAFGEATLYRRT--EDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYY 65
Query: 748 TSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQR---ISIAID 804
F ++ I EY G+L DK + K L + +
Sbjct: 66 NH-----FMDDNTLLIEMEYANGGTLY-----------DKIVRQKGQLFEEEMVLWYLFQ 109
Query: 805 VASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVK 864
+ SA+ Y+H + ILH D+K NI L +GDFG+++ + S S + V
Sbjct: 110 IVSAVSYIH---KAGILHRDIKTLNIFLTKAGLIKLGDFGISK----ILGSEYSMAETVV 162
Query: 865 GTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGD--LNL 913
GT Y +PE G + + D+++ G +L E++T K+ F+ LNL
Sbjct: 163 GTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKR----TFDATNPLNL 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 3e-13
Identities = 38/104 (36%), Positives = 53/104 (50%), Gaps = 4/104 (3%)
Query: 44 WEGITCG----RRHRRVTALDLMSKSLSGSLSPHLGNLSFLREINLSNNTIQGEIPPEFG 99
W G C + + L L ++ L G + + L L+ INLS N+I+G IPP G
Sbjct: 404 WSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLG 463
Query: 100 RLFRLEALFLSNNSLVGKIPANLSYCSRLTVLCIEYNKLQGRIP 143
+ LE L LS NS G IP +L + L +L + N L GR+P
Sbjct: 464 SITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVP 507
|
Length = 623 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 3e-13
Identities = 68/235 (28%), Positives = 102/235 (43%), Gaps = 36/235 (15%)
Query: 691 LIGVGSFGCVYKGALDEDGIVVAIKVIN---LQCEGASKSFMAECKALKNIRHRNLVKVI 747
LIG G G VY VA+K I + K F+ E K ++ H +V V
Sbjct: 9 LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVY 68
Query: 748 TSCSSIDFQGNDFKAIVYEYMP---NGSLEKWLHPHAVPKRD---KEIEIKLTLLQRISI 801
+ CS D VY MP +L+ L +V +++ KE+ K ++ +SI
Sbjct: 69 SICSDGD--------PVYYTMPYIEGYTLKSLLK--SVWQKESLSKELAEKTSVGAFLSI 118
Query: 802 AIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSV 861
+ + ++Y+H + +LH DLKP NILL I D+G A F + L V
Sbjct: 119 FHKICATIEYVH---SKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDV 175
Query: 862 GVK--------------GTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKP 902
+ GT Y APE LG S + D+Y+ G++L +M+T P
Sbjct: 176 DERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFP 230
|
Length = 932 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 3e-13
Identities = 67/233 (28%), Positives = 109/233 (46%), Gaps = 48/233 (20%)
Query: 692 IGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMA-ECKALKNIRHRNLVKVITSC 750
IG G+ G VYK G + A+KVI E + + E + L+++ H N+VK C
Sbjct: 82 IGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVK----C 137
Query: 751 SSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALD 810
+ + + ++ E+M GSLE E L + R + S +
Sbjct: 138 HDMFDHNGEIQ-VLLEFMDGGSLEGTHIAD---------EQFLADVAR-----QILSGIA 182
Query: 811 YLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTL---SSSVGVKGTI 867
YLH + I+H D+KPSN+L+++ + I DFG++R + T+ +SSV GTI
Sbjct: 183 YLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSR----ILAQTMDPCNSSV---GTI 232
Query: 868 GYTAPEYGLGSEVSTN----------GDVYSYGILLLEMVTAKKPTDVMFEGD 910
Y +PE ++T+ GD++S G+ +LE + P V +GD
Sbjct: 233 AYMSPE-----RINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGD 280
|
Length = 353 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 4e-13
Identities = 61/216 (28%), Positives = 103/216 (47%), Gaps = 20/216 (9%)
Query: 691 LIGVGSFGCVYKGAL-DEDG--IVVAIKVINLQCE-GASKSFMAECKALKNIRHRNLVKV 746
+IG G FGCVY G L D DG I A+K +N + + F+ E +K+ H N++ +
Sbjct: 2 VIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSL 61
Query: 747 ITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVA 806
+ C + +G+ +V YM +G L ++ + T+ I + VA
Sbjct: 62 LGIC--LPSEGSPL--VVLPYMKHGDLRNFIRS---ETHNP------TVKDLIGFGLQVA 108
Query: 807 SALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGT 866
++YL + +H DL N +LD + + DFGLAR + ++ + G K
Sbjct: 109 KGMEYL---ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLP 165
Query: 867 IGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKP 902
+ + A E + +T DV+S+G+LL E++T P
Sbjct: 166 VKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 201
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 4e-13
Identities = 64/271 (23%), Positives = 103/271 (38%), Gaps = 65/271 (23%)
Query: 692 IGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSCS 751
I G+FG VY G AIKV+ KS M + N++ + +I S
Sbjct: 4 ISKGAFGSVYLAKKRSTGDYFAIKVL-------KKSDMIAKNQVTNVKAERAIMMIQGES 56
Query: 752 SI------DFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRI------ 799
FQ D+ +V EY+ G +L++ +
Sbjct: 57 PYVAKLYYSFQSKDYLYLVMEYLNGGDCA-------------------SLIKTLGGLPED 97
Query: 800 ---SIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHI--GDFGLARFHQEVSN 854
+V ++ LH Q I+H D+KP N+L+D +GH+ DFGL+R E
Sbjct: 98 WAKQYIAEVVLGVEDLH---QRGIIHRDIKPENLLIDQ--TGHLKLTDFGLSRNGLE--- 149
Query: 855 STLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKP-----TDVMFE- 908
+ GT Y APE LG D +S G ++ E + P D +F+
Sbjct: 150 -----NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDN 204
Query: 909 ---GDLNLHNFARMALPNQVMDIVDPILRND 936
+N + + +D+++ +L D
Sbjct: 205 ILSRRINWPEEVKEFCSPEAVDLINRLLCMD 235
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 4e-13
Identities = 73/288 (25%), Positives = 124/288 (43%), Gaps = 55/288 (19%)
Query: 692 IGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSCS 751
+G G FG V+ ++ VA+K + +F+AE +K ++H LVK+ +
Sbjct: 14 LGAGQFGEVWMATYNKH-TKVAVKTMKPGSMSVE-AFLAEANVMKTLQHDKLVKLHAVVT 71
Query: 752 SIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDY 811
I+ E+M GSL +L K D+ + L L I + +A + +
Sbjct: 72 KEPIY------IITEFMAKGSLLDFL------KSDEGSKQPLPKL--IDFSAQIAEGMAF 117
Query: 812 LHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTA 871
+ Q +H DL+ +NIL+ L I DFGLAR + ++ ++ G K I +TA
Sbjct: 118 IE---QRNYIHRDLRAANILVSASLVCKIADFGLARV---IEDNEYTAREGAKFPIKWTA 171
Query: 872 PEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMALPNQVMDIVDP 931
PE + DV+S+GILL+E+VT + R+ P
Sbjct: 172 PEAINFGSFTIKSDVWSFGILLMEIVT-----------------YGRIPYPGM------- 207
Query: 932 ILRNDEEILASTDKCRRMQTGINSRLE-CLISMVKIGVACSMESPQDR 978
++ E++ + ++ RM R E C + I + C P++R
Sbjct: 208 ---SNPEVIRALERGYRMP-----RPENCPEELYNIMMRCWKNRPEER 247
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 5e-13
Identities = 64/223 (28%), Positives = 105/223 (47%), Gaps = 43/223 (19%)
Query: 692 IGVGSFGCVYKGALDEDGIVVAIKVINLQ--CEGASKSFMAECKALKNIRHRNLVKVITS 749
IG G++G V+K E +VA+K + L EG S + E LK ++H+N+V++
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLY-- 65
Query: 750 CSSIDFQGNDFK-AIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASA 808
D +D K +V+EY + L+K+ D EI +K + Q +
Sbjct: 66 ----DVLHSDKKLTLVFEYC-DQDLKKYFD-SCNGDIDPEI-VKSFMFQLLK-------G 111
Query: 809 LDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLAR--------FHQEVSNSTLSSS 860
L + H H +LH DLKP N+L++ + + DFGLAR + EV
Sbjct: 112 LAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVV------- 161
Query: 861 VGVKGTIGYTAPEYGLGSEV-STNGDVYSYGILLLEMVTAKKP 902
T+ Y P+ G+++ ST+ D++S G + E+ A +P
Sbjct: 162 -----TLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 6e-13
Identities = 40/112 (35%), Positives = 64/112 (57%), Gaps = 4/112 (3%)
Query: 330 LSLGGNQFRGALPHSIANLSSQLQILILSSNQFYGSIPLGIGNLVDLYLLGMVENQFTGA 389
L L RG +P+ I+ L LQ + LS N G+IP +G++ L +L + N F G+
Sbjct: 423 LGLDNQGLRGFIPNDISKLR-HLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGS 481
Query: 390 IPKEMGKLQKLQGLDFSGNHFSGEIPSSLGNLSSLYEVFFNNNNLSGV--IP 439
IP+ +G+L L+ L+ +GN SG +P++LG L+ FN + +G+ IP
Sbjct: 482 IPESLGQLTSLRILNLNGNSLSGRVPAALGGR-LLHRASFNFTDNAGLCGIP 532
|
Length = 623 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 9e-13
Identities = 64/219 (29%), Positives = 99/219 (45%), Gaps = 43/219 (19%)
Query: 692 IGVGSFGCVYKGALDEDGIVVAIKVINLQCE-GASKSFMAECKALKNIRHRNLVKVITSC 750
+G G+ G VYK ++A+KVI L K M+E ++++ C
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSE------------LEILYKC 56
Query: 751 SS---IDFQGNDFK----AIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAI 803
S I F G F +I E+M GSL+ + +P+ +L RI++A
Sbjct: 57 DSPYIIGFYGAFFVENRISICTEFMDGGSLDVY---RKIPEH---------VLGRIAVA- 103
Query: 804 DVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGV 863
V L YL ILH D+KPSN+L++ + DFG++ ++ NS + VG
Sbjct: 104 -VVKGLTYL---WSLKILHRDVKPSNMLVNTRGQVKLCDFGVST---QLVNSIAKTYVG- 155
Query: 864 KGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKP 902
T Y APE G + + DV+S GI +E+ + P
Sbjct: 156 --TNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFP 192
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 9e-13
Identities = 66/221 (29%), Positives = 107/221 (48%), Gaps = 44/221 (19%)
Query: 692 IGVGSFGCVYKGALDEDGIVVAIKVINLQCE-GASKSFMAECKALKNIRHRNLVK---VI 747
+G G++ VYKG +VA+K I L+ E GA + + E LK+++H N+V +I
Sbjct: 14 LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII 73
Query: 748 TSCSSIDFQGNDFKAIVYEYMPNGSLEKWL-------HPHAVPKRDKEIEIKLTLLQRIS 800
+ S+ +V+EY+ + L+++L + H V KL L Q +
Sbjct: 74 HTEKSL--------TLVFEYL-DKDLKQYLDDCGNSINMHNV---------KLFLFQLLR 115
Query: 801 IAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSS 860
L+Y H + +LH DLKP N+L++ + DFGLAR + + T S+
Sbjct: 116 -------GLNYCH---RRKVLHRDLKPQNLLINERGELKLADFGLAR-AKSIPTKTYSNE 164
Query: 861 VGVKGTIGYTAPEYGLGS-EVSTNGDVYSYGILLLEMVTAK 900
V T+ Y P+ LGS + ST D++ G + EM T +
Sbjct: 165 V---VTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 9e-13
Identities = 68/219 (31%), Positives = 108/219 (49%), Gaps = 38/219 (17%)
Query: 692 IGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECK-ALKNIRHRNLVKVITSC 750
+G G+ G V K G+++A K+I+L E K A++N R L KV+ C
Sbjct: 9 LGAGNGGVVTKVLHRPSGLIMARKLIHL-----------EIKPAIRNQIIREL-KVLHEC 56
Query: 751 SS---IDFQGNDFK----AIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAI 803
+S + F G + +I E+M GSL+ V K+ I + L +ISIA
Sbjct: 57 NSPYIVGFYGAFYSDGEISICMEHMDGGSLD------QVLKKAGRIPENI--LGKISIA- 107
Query: 804 DVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGV 863
V L YL + I+H D+KPSNIL+++ + DFG++ ++ +S +S VG
Sbjct: 108 -VLRGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVS---GQLIDSMANSFVG- 160
Query: 864 KGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKP 902
T Y +PE G+ + D++S G+ L+EM + P
Sbjct: 161 --TRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYP 197
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 9e-13
Identities = 60/215 (27%), Positives = 93/215 (43%), Gaps = 29/215 (13%)
Query: 691 LIGVGSFGCVYKGALDEDG----IVVAIKVINLQCEGASKSFMA---ECKALKNIRHRNL 743
L+G G FG V+KG +G I VAIK I Q ++F A+ ++ H +
Sbjct: 14 LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTI--QDRSGRQTFQEITDHMLAMGSLDHAYI 71
Query: 744 VKVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAI 803
V+++ C Q +V + P GSL + H RD L + ++ +
Sbjct: 72 VRLLGICPGASLQ------LVTQLSPLGSLLDHVRQH----RDS-----LDPQRLLNWCV 116
Query: 804 DVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGV 863
+A + YL H ++H +L NILL +D I DFG+A S
Sbjct: 117 QIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSE--H 171
Query: 864 KGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT 898
K I + A E L + DV+SYG+ + EM++
Sbjct: 172 KTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 9e-13
Identities = 64/223 (28%), Positives = 105/223 (47%), Gaps = 27/223 (12%)
Query: 692 IGVGSFGCVYKGAL-----DEDGIVVAIKVINLQCEGASK----SFMAECKALKNIRHRN 742
+G GSFG VY+G DE VAIK +N E AS F+ E +K +
Sbjct: 14 LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVN---EAASMRERIEFLNEASVMKEFNCHH 70
Query: 743 LVKVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIA 802
+V+++ S QG ++ E M G L+ +L + ++ +L + I +A
Sbjct: 71 VVRLLGVVS----QGQP-TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMA 125
Query: 803 IDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVG 862
++A + YL+ + +H DL N ++ D + IGDFG+ R E T G
Sbjct: 126 GEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE----TDYYRKG 178
Query: 863 VKG--TIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT-AKKP 902
KG + + +PE +T DV+S+G++L E+ T A++P
Sbjct: 179 GKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP 221
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 1e-12
Identities = 56/223 (25%), Positives = 101/223 (45%), Gaps = 33/223 (14%)
Query: 691 LIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGAS------KSFMAECKALKNIRHRNLV 744
+G G+F Y+ + G ++A+K + +S ++ E + + + H +++
Sbjct: 7 QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66
Query: 745 KVI-TSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAI 803
+++ +C F + E+M GS+ L + K I LL+
Sbjct: 67 RMLGATCEDSHFN------LFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLR------ 114
Query: 804 DVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGH---IGDFGLA-RFHQEVSNSTLSS 859
L YLH + I+H D+K +N+L+D+ +G I DFG A R + + +
Sbjct: 115 ----GLSYLH---ENQIIHRDVKGANLLIDS--TGQRLRIADFGAAARLAAKGTGAGEFQ 165
Query: 860 SVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKP 902
+ GTI + APE G + + DV+S G +++EM TAK P
Sbjct: 166 GQLL-GTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 1e-12
Identities = 63/230 (27%), Positives = 107/230 (46%), Gaps = 41/230 (17%)
Query: 692 IGVGSFGCVYKG---ALDED----GIVVAIKVINLQCEGASKSF---MAECKALKNI-RH 740
+G G FG V +D+D + VA+K+ L+ + K ++E + +K I +H
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKM--LKDDATDKDLSDLVSEMEMMKMIGKH 77
Query: 741 RNLVKVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRD------KEIEIKLT 794
+N++ ++ +C+ Q +V EY G+L ++L P D K E +LT
Sbjct: 78 KNIINLLGACT----QDGPLYVLV-EYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLT 132
Query: 795 LLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLAR------F 848
+S A VA ++YL + +H DL N+L+ D I DFGLAR +
Sbjct: 133 FKDLVSCAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDY 189
Query: 849 HQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT 898
+++ +N L + + APE + DV+S+G+LL E+ T
Sbjct: 190 YKKTTNGRLP--------VKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 68.8 bits (169), Expect = 1e-12
Identities = 61/221 (27%), Positives = 93/221 (42%), Gaps = 40/221 (18%)
Query: 692 IGVGSFGCVYKGALDEDGIVVAIKVIN---LQCEGASKSFMAECKALKNIRHRNLVKVIT 748
+GVG FG V + A+K + + G + +E + L+ H +VK+
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 749 SCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASA 808
+ F+ + ++ EY G L L D+ R IA V A
Sbjct: 61 T-----FKDKKYIYMLMEYCLGGELWTILRDRG--LFDEY-------TARFYIAC-VVLA 105
Query: 809 LDYLHHHCQEPILHCDLKPSNILLDNDLSGHI--GDFGLARFHQEVSNSTLSSSVGVK-- 864
+YLH+ I++ DLKP N+LLD+ +G++ DFG A+ G K
Sbjct: 106 FEYLHNR---GIIYRDLKPENLLLDS--NGYVKLVDFGFAK----------KLKSGQKTW 150
Query: 865 ---GTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKP 902
GT Y APE L + D +S GILL E++T + P
Sbjct: 151 TFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPP 191
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 2e-12
Identities = 58/215 (26%), Positives = 90/215 (41%), Gaps = 28/215 (13%)
Query: 691 LIGVGSFGCVYKGALDEDG---IVVAIKVI-NLQCEGASKSFMAECKALKNIRHRNLVK- 745
+G GSFG V +G G I VA+K + + + F+ E + ++ H NL++
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61
Query: 746 --VITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAI 803
V+ + + +V E P GSL L A+ ++ L ++ I
Sbjct: 62 YGVVLTHPLM---------MVTELAPLGSLLDRLRKDALG------HFLISTLCDYAVQI 106
Query: 804 DVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGV 863
A+ + YL + +H DL NILL +D IGDFGL R + +
Sbjct: 107 --ANGMRYLE---SKRFIHRDLAARNILLASDDKVKIGDFGLMR-ALPQNEDHYVMEEHL 160
Query: 864 KGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT 898
K + APE S DV+ +G+ L EM T
Sbjct: 161 KVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFT 195
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 2e-12
Identities = 71/232 (30%), Positives = 102/232 (43%), Gaps = 36/232 (15%)
Query: 692 IGVGSFGCVYKGALDEDGIVVAIKVINL-----QCEGASKSFMAECKALKNIRHRNLVKV 746
IG GSFG +Y D IK I+L + + ASK E L ++H N+V
Sbjct: 8 IGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKK---EVILLAKMKHPNIVTF 64
Query: 747 ITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLH-PHAVPKRDKEIEIKLTLLQRISIAIDV 805
S FQ N IV EY G L K ++ V + +I +S + +
Sbjct: 65 FAS-----FQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQI---------LSWFVQI 110
Query: 806 ASALDYLHHHCQEPILHCDLKPSNILLD-NDLSGHIGDFGLARFHQEVSNSTLSSSVGVK 864
+ L ++H ILH D+K NI L N + +GDFG+AR N ++ +
Sbjct: 111 SLGLKHIH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIAR----QLNDSMELAYTCV 163
Query: 865 GTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNF 916
GT Y +PE + D++S G +L E+ T K P FEG+ NLH
Sbjct: 164 GTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHP----FEGN-NLHQL 210
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 61/219 (27%), Positives = 102/219 (46%), Gaps = 23/219 (10%)
Query: 692 IGVGSFGCVYKGA--LDEDGIVVAIKVINLQCEGASK-SFMAECKALKNIRHRNLVKVIT 748
+G G+FGCV KG + + I VAIKV+ + E + + M E + + + + +V++I
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62
Query: 749 SCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASA 808
C + +V E G L K+L K+D+ +T+ + + V+
Sbjct: 63 VCEAEALM------LVMEMASGGPLNKFL----SGKKDE-----ITVSNVVELMHQVSMG 107
Query: 809 LDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIG 868
+ YL + +H DL N+LL N I DFGL++ + + S G K +
Sbjct: 108 MKYLE---GKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAG-KWPLK 163
Query: 869 YTAPEYGLGSEVSTNGDVYSYGILLLEMVT-AKKPTDVM 906
+ APE + S+ DV+SYGI + E + +KP M
Sbjct: 164 WYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKM 202
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 2e-12
Identities = 59/228 (25%), Positives = 104/228 (45%), Gaps = 38/228 (16%)
Query: 692 IGVGSFGCVYK----GAL-DEDGIVVAIKVINLQCEGAS----KSFMAECKALKNIRHRN 742
IG G+FG V++ G L E +VA+K++ E AS F E + H N
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLK---EEASADMQADFQREAALMAEFDHPN 69
Query: 743 LVKVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLH---PHAVPKRDKEIE--------- 790
+VK++ C+ G +++EYM G L ++L P A
Sbjct: 70 IVKLLGVCA----VGKPM-CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNP 124
Query: 791 IKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLAR--F 848
+ L+ +++ IA VA+ + YL + +H DL N L+ ++ I DFGL+R +
Sbjct: 125 LPLSCTEQLCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIY 181
Query: 849 HQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEM 896
+ ++ + ++ I + PE + +T DV++YG++L E+
Sbjct: 182 SADYYKASENDAI----PIRWMPPESIFYNRYTTESDVWAYGVVLWEI 225
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 2e-12
Identities = 67/229 (29%), Positives = 105/229 (45%), Gaps = 41/229 (17%)
Query: 691 LIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGAS---KSFMAECKALKNIRHRNLVKVI 747
L+G GS+G V K E G +VAIK L+ E K M E + LK +RH NLV +I
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKF-LESEDDKMVKKIAMREIRMLKQLRHENLVNLI 66
Query: 748 TSCSSIDFQGNDFKAIVYEYMPNGSLEKWLH-PHAVPKRDKEIEIKLTLLQRISIAIDVA 806
F+ +V+E++ + L+ P+ + E ++ L Q +
Sbjct: 67 EV-----FRRKKRLYLVFEFVDHTVLDDLEKYPNGL----DESRVRKYLFQ-------IL 110
Query: 807 SALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVK-- 864
+++ H H I+H D+KP NIL+ + DFG AR TL++ V
Sbjct: 111 RGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFAR--------TLAAPGEVYTD 159
Query: 865 --GTIGYTAPEYGLG-SEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGD 910
T Y APE +G ++ D+++ G L+ EM+T + +F GD
Sbjct: 160 YVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTG----EPLFPGD 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 2e-12
Identities = 66/218 (30%), Positives = 96/218 (44%), Gaps = 30/218 (13%)
Query: 692 IGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSCS 751
+G G+FG VYK E G+ A K+I ++ E + FM E L +H N+V + +
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 752 SIDFQGNDFKA-IVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALD 810
+ K I+ E+ G+L+ + E+E LT Q + + AL+
Sbjct: 73 ------YENKLWILIEFCDGGALDSIM---------LELERGLTEPQIRYVCRQMLEALN 117
Query: 811 YLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSN-STLSSSVGVKGTIGY 869
+LH H ++H DLK NILL D GD LA F N STL GT +
Sbjct: 118 FLHSH---KVIHRDLKAGNILLTLD-----GDVKLADFGVSAKNKSTLQKRDTFIGTPYW 169
Query: 870 TAPEYGLGSEVSTN-----GDVYSYGILLLEMVTAKKP 902
APE N D++S GI L+E+ + P
Sbjct: 170 MAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPP 207
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 3e-12
Identities = 61/211 (28%), Positives = 93/211 (44%), Gaps = 23/211 (10%)
Query: 692 IGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSCS 751
IG G+ G VY G VAIK +NLQ + + + E ++ +H N+V + S
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDS-- 84
Query: 752 SIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDY 811
+ D +V EY+ GSL D E + Q ++ + AL++
Sbjct: 85 ---YLVGDELWVVMEYLAGGSLT-----------DVVTETCMDEGQIAAVCRECLQALEF 130
Query: 812 LHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTA 871
LH ++H D+K NILL D S + DFG F +++ S V GT + A
Sbjct: 131 LH---SNQVIHRDIKSDNILLGMDGSVKLTDFG---FCAQITPEQSKRSTMV-GTPYWMA 183
Query: 872 PEYGLGSEVSTNGDVYSYGILLLEMVTAKKP 902
PE D++S GI+ +EMV + P
Sbjct: 184 PEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 3e-12
Identities = 67/224 (29%), Positives = 105/224 (46%), Gaps = 36/224 (16%)
Query: 686 FSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVK 745
F+ IG GSFG VYKG + VVAIK+I+L+ AE +++I+ +
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLE--------EAE-DEIEDIQQE--IT 54
Query: 746 VITSCSS---IDFQGNDFKA----IVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQR 798
V++ C S + G+ K I+ EY+ GS L P P + I T+L+
Sbjct: 55 VLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLKPG--PLEETYIA---TILRE 109
Query: 799 ISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLS 858
I LDYLH E +H D+K +N+LL + DFG+A +++++ +
Sbjct: 110 I------LKGLDYLH---SERKIHRDIKAANVLLSEQGDVKLADFGVA---GQLTDTQIK 157
Query: 859 SSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKP 902
+ V GT + APE S D++S GI +E+ + P
Sbjct: 158 RNTFV-GTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 3e-12
Identities = 55/232 (23%), Positives = 104/232 (44%), Gaps = 42/232 (18%)
Query: 685 GFSSTHLIGVGSFGCVYKGAL-DEDGIV---VAIKVINLQCEGASKS----FMAECKALK 736
+ + L+ G+FG ++ G L DE V +K + + AS+ + E L
Sbjct: 7 RVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVK---DHASEIQVTLLLQESCLLY 63
Query: 737 NIRHRNLVKVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIK---- 792
+ H+N++ ++ C + + ++Y YM G+L+ +L ++ + E
Sbjct: 64 GLSHQNILPILHVC----IEDGEPPFVLYPYMNWGNLKLFL------QQCRLGEANNPQA 113
Query: 793 LTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLAR----- 847
L+ Q + +AI +A + YLH ++H D+ N ++D +L I D L+R
Sbjct: 114 LSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDNALSRDLFPM 170
Query: 848 -FHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT 898
+H N + + A E + E S+ DV+S+G+LL E++T
Sbjct: 171 DYHCLGDNENRP--------VKWMALESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 4e-12
Identities = 63/224 (28%), Positives = 105/224 (46%), Gaps = 36/224 (16%)
Query: 686 FSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVK 745
F+ IG GSFG V+KG + VVAIK+I+L+ AE +++I+ +
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLE--------EAE-DEIEDIQQE--IT 54
Query: 746 VITSCSS---IDFQGNDFKA----IVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQR 798
V++ C S + G+ K I+ EY+ GS L P + + Q
Sbjct: 55 VLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDET-----------QI 103
Query: 799 ISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLS 858
+I ++ LDYLH E +H D+K +N+LL + DFG+A +++++ +
Sbjct: 104 ATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVA---GQLTDTQIK 157
Query: 859 SSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKP 902
+ V GT + APE S + D++S GI +E+ + P
Sbjct: 158 RNTFV-GTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 4e-12
Identities = 65/224 (29%), Positives = 111/224 (49%), Gaps = 36/224 (16%)
Query: 686 FSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVK 745
F +G G+ G V+K + G+++A K+I+L+ + A++N R L +
Sbjct: 7 FEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIK----------PAIRNQIIREL-Q 55
Query: 746 VITSCSS---IDFQGNDFK----AIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQR 798
V+ C+S + F G + +I E+M GSL++ L K I +L +
Sbjct: 56 VLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL--------KKAGRIPEQILGK 107
Query: 799 ISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLS 858
+SIA V L YL + I+H D+KPSNIL+++ + DFG++ ++ +S +
Sbjct: 108 VSIA--VIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS---GQLIDSMAN 160
Query: 859 SSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKP 902
S VG + Y +PE G+ S D++S G+ L+EM + P
Sbjct: 161 SFVGTRS---YMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYP 201
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 4e-12
Identities = 60/217 (27%), Positives = 96/217 (44%), Gaps = 22/217 (10%)
Query: 691 LIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKS-----FMAECKALKNIRHRNLVK 745
L+G G+FG VY + G +A K + E S E + LKN++H +V+
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQ 68
Query: 746 VITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDV 805
+ + I EYMP GS++ L + + +L+ +S
Sbjct: 69 YY---GCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMS----- 120
Query: 806 ASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKG 865
YLH + I+H D+K +NIL D+ + +GDFG ++ Q + S + V G
Sbjct: 121 -----YLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSG-TGIRSVTG 171
Query: 866 TIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKP 902
T + +PE G DV+S G ++EM+T K P
Sbjct: 172 TPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 5e-12
Identities = 67/228 (29%), Positives = 108/228 (47%), Gaps = 36/228 (15%)
Query: 686 FSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVK 745
F+ IG GSFG V+KG + VVAIK+I+L+ AE +++I+ +
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLE--------EAE-DEIEDIQQE--IT 54
Query: 746 VITSCSS---IDFQGNDFKA----IVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQR 798
V++ C S + G+ K I+ EY+ GS L A P + +I T+L+
Sbjct: 55 VLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLL--RAGPFDEFQIA---TMLKE 109
Query: 799 ISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLS 858
I LDYLH E +H D+K +N+LL + DFG+A +++++ +
Sbjct: 110 I------LKGLDYLH---SEKKIHRDIKAANVLLSEQGDVKLADFGVA---GQLTDTQIK 157
Query: 859 SSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVM 906
+ V GT + APE S + D++S GI +E+ + P M
Sbjct: 158 RNTFV-GTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDM 204
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 6e-12
Identities = 67/248 (27%), Positives = 108/248 (43%), Gaps = 38/248 (15%)
Query: 692 IGVGSFGCVYKGALDEDGIVVAIKVINLQC--EGASKSFMAECKALKNIRHRN-LVKVIT 748
IG G++G VYK G +VA+K L+ EG + + E L+ + +V+++
Sbjct: 9 IGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLD 68
Query: 749 SCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASA 808
+ G +V+EY+ + L+K++ + R + ++ + A
Sbjct: 69 VEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSN---GRGPGRPLPAKTIKSFMYQLLKGVA 124
Query: 809 LDYLHHHCQEPILHCDLKPSNILLDNDLSG-HIGDFGLARFHQEVSNSTLSSSVGVKG-- 865
+ H H ++H DLKP N+L+D I D GL R + S+ VK
Sbjct: 125 --HCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLGLGR----------AFSIPVKSYT 169
Query: 866 ----TIGYTAPEYGLGS-EVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLN----LHNF 916
T+ Y APE LGS ST D++S G + EM K+P +F GD LH F
Sbjct: 170 HEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSR-KQP---LFPGDSELQQLLHIF 225
Query: 917 ARMALPNQ 924
+ P +
Sbjct: 226 KLLGTPTE 233
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 6e-12
Identities = 66/220 (30%), Positives = 102/220 (46%), Gaps = 28/220 (12%)
Query: 691 LIGVGSFGCVYKGALDEDGIVVAIKVINLQ--CEGASKSFMA-EC--KALKNIRHRNLVK 745
L+G G+FG VY + G +A+K + + SK A EC + LKN+RH +V+
Sbjct: 9 LLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQ 68
Query: 746 VITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDV 805
C D + +I EYMP GS++ L + + +LQ +S
Sbjct: 69 YY-GCLR-DPEEKKL-SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVS----- 120
Query: 806 ASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVK- 864
YLH + I+H D+K +NIL D+ + +GDFG ++ Q + S G+K
Sbjct: 121 -----YLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTIC----MSGTGIKS 168
Query: 865 --GTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKP 902
GT + +PE G DV+S ++EM+T K P
Sbjct: 169 VTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 6e-12
Identities = 38/98 (38%), Positives = 55/98 (56%), Gaps = 7/98 (7%)
Query: 805 VASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVK 864
+ S L++LH Q I++ DLKP N+LLDND + I D GLA ++ + T G
Sbjct: 106 IISGLEHLH---QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKT----KGYA 158
Query: 865 GTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKP 902
GT G+ APE G E + D ++ G+ L EM+ A+ P
Sbjct: 159 GTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGP 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 66.6 bits (163), Expect = 9e-12
Identities = 79/301 (26%), Positives = 119/301 (39%), Gaps = 74/301 (24%)
Query: 686 FSSTHL-----IGVGSFGCVYKGALDEDGIVVAIKVINLQCEGAS-KSFMAECKALKNIR 739
F++ L IG G+FG V K G ++A+K I + K + + + R
Sbjct: 1 FTAEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVM--R 58
Query: 740 HRNLVKVITSCSSIDFQGNDFKA----IVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTL 795
+ ++ F G F+ I E M + SL+K + + I
Sbjct: 59 SSDCPYIVK------FYGALFREGDCWICMELM-DISLDK-FYKYVYEVLKSVIP----- 105
Query: 796 LQRI--SIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIG--DFGLARFHQE 851
+ I IA+ AL+YL + I+H D+KPSNILL D +G+I DFG++ Q
Sbjct: 106 -EEILGKIAVATVKALNYLKEELK--IIHRDVKPSNILL--DRNGNIKLCDFGIS--GQL 158
Query: 852 VSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNG--------DVYSYGILLLEMVTAKKPT 903
V + + G + Y APE + + DV+S GI L E+ T K P
Sbjct: 159 VDSIAKTRDAGCR---PYMAPE-----RIDPSARDGYDVRSDVWSLGITLYEVATGKFPY 210
Query: 904 DVMFEGDLNLHNFARMALPNQVMDIVD---PILRNDEEILASTDKCRRMQTGINSRLECL 960
++ +Q+ +V PIL N EE S IN CL
Sbjct: 211 P------------KWNSVFDQLTQVVKGDPPILSNSEEREFSP----SFVNFINL---CL 251
Query: 961 I 961
I
Sbjct: 252 I 252
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 9e-12
Identities = 68/220 (30%), Positives = 112/220 (50%), Gaps = 13/220 (5%)
Query: 369 GIGNLVDLYLLGMVE---NQFTGAIPKEMGKLQKLQGLDFSGNHFSGEIPSSLGNL-SSL 424
G NL++L L ++ N+ I E+ +L L LD N+ + +IP +G L S+L
Sbjct: 85 GSENLLNLLPLPSLDLNLNRLRSNIS-ELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNL 142
Query: 425 YEVFFNNNNLSGVIPFSLGNLKRLAFLEMSGNELSGTIPEDIFNISYLSNSLNLARNHLV 484
E+ ++N + +P L NL L L++S N+LS +P+ + N+S L+N L+L+ N +
Sbjct: 143 KELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNN-LDLSGNKI- 198
Query: 485 GIIPPRIGNLRALRSFDVSNNDLSGEIPIELGHCSSLEEIYLAGNLFHGSIPSFFNALKG 544
+PP I L AL D+SNN + E+ L + +L + L+ N +P L
Sbjct: 199 SDLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKL-EDLPESIGNLSN 256
Query: 545 VQKIDLSRNNLSGQIPIFLEALSLEYLNLSFNDFEGKIPA 584
++ +DLS N +S I +L L+LS N +P
Sbjct: 257 LETLDLSNNQIS-SISSLGSLTNLRELDLSGNSLSNALPL 295
|
Length = 394 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 1e-11
Identities = 58/225 (25%), Positives = 105/225 (46%), Gaps = 34/225 (15%)
Query: 692 IGVGSFGCVYKGAL-----DEDGIVVAIKVINLQCEGA-SKSFMAECKALKNIRHRNLVK 745
+G FG VYKG L E VAIK + + EG + F E ++H N+V
Sbjct: 13 LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVC 72
Query: 746 VITSCSSIDFQGNDFKAIVYEYMPNGSLEKWL---HPHA-VPKRDKEIEIKLTL--LQRI 799
++ + ++++ Y + L ++L PH+ V D + +K TL +
Sbjct: 73 LLGVVTK-----EQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFV 127
Query: 800 SIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLAR------FHQEVS 853
I +A+ +++L H ++H DL N+L+ + L+ I D GL R +++ +
Sbjct: 128 HIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMG 184
Query: 854 NSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT 898
NS L I + +PE + + S + D++SYG++L E+ +
Sbjct: 185 NSLLP--------IRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 1e-11
Identities = 57/228 (25%), Positives = 105/228 (46%), Gaps = 37/228 (16%)
Query: 692 IGVGSFGCVYKG---ALDED----GIVVAIKVI-NLQCEGASKSFMAECKALKNI-RHRN 742
+G G FG V +D+D + VA+K++ + E ++E + +K I +H+N
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82
Query: 743 LVKVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEI------KLTLL 796
++ ++ +C+ Q IV EY G+L ++L P + +I ++T
Sbjct: 83 IINLLGACT----QDGPLYVIV-EYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFK 137
Query: 797 QRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLAR------FHQ 850
+S VA ++YL + +H DL N+L+ + I DFGLAR +++
Sbjct: 138 DLVSCTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYK 194
Query: 851 EVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT 898
+ +N L + + APE + DV+S+G+L+ E+ T
Sbjct: 195 KTTNGRLP--------VKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 2e-11
Identities = 65/208 (31%), Positives = 99/208 (47%), Gaps = 13/208 (6%)
Query: 319 NSLTNCSKLRVLSLGGNQFRGALPHSIANLSSQLQILILSSNQFYGSIPLGIGNLVDLYL 378
+ L + L L L N +P I L S L+ L LS N+ S+P + NL +L
Sbjct: 110 SELLELTNLTSLDLDNNNI-TDIPPLIGLLKSNLKELDLSDNK-IESLPSPLRNLPNLKN 167
Query: 379 LGMVENQFTGAIPKEMGKLQKLQGLDFSGNHFSGEIPSSLGNLSSLYEVFFNNNNLSGVI 438
L + N + +PK + L L LD SGN S ++P + LS+L E+ +NN++ ++
Sbjct: 168 LDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSIIELL 225
Query: 439 PFSLGNLKRLAFLEMSGNEL--SGTIPEDIFNISYLSNSLNLARNHLVGIIPPRIGNLRA 496
SL NLK L+ LE+S N+L ++ N+ L S N +G+L
Sbjct: 226 S-SLSNLKNLSGLELSNNKLEDLPESIGNLSNLETLDLSNNQ------ISSISSLGSLTN 278
Query: 497 LRSFDVSNNDLSGEIPIELGHCSSLEEI 524
LR D+S N LS +P+ LE +
Sbjct: 279 LRELDLSGNSLSNALPLIALLLLLLELL 306
|
Length = 394 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 2e-11
Identities = 54/170 (31%), Positives = 75/170 (44%), Gaps = 42/170 (24%)
Query: 692 IGVGSFGCVYKGALDEDGIVVAIK---------VINLQCEGASKSFMAECKALKNIRHRN 742
IG GS+G V+K E G +VAIK VI K + E + LK ++H N
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIK-------KIALREIRMLKQLKHPN 61
Query: 743 LVKVITSCSSIDFQGNDFKAIVYEYMPN---GSLEKWLHPHAVPKRDKEIEIKLTLLQRI 799
LV +I F+ +V+EY + LEK +P VP E IK
Sbjct: 62 LVNLIEV-----FRRKRKLHLVFEYCDHTVLNELEK--NPRGVP----EHLIK------- 103
Query: 800 SIAIDVASALDYLH-HHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARF 848
I A+++ H H+C +H D+KP NIL+ + DFG AR
Sbjct: 104 KIIWQTLQAVNFCHKHNC----IHRDVKPENILITKQGQIKLCDFGFARI 149
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 2e-11
Identities = 65/228 (28%), Positives = 95/228 (41%), Gaps = 38/228 (16%)
Query: 691 LIGVGSFGCVYKGALDEDGIVVAIKVIN----LQCEGASKSFMAECKALKNIRHRNLVKV 746
++G GSFG V L + A+KV+ LQ + + M E + L +
Sbjct: 2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDV-ECTMTEKRVLALAGKHPFLTQ 60
Query: 747 ITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVA 806
+ SC FQ D V EY+ G L H + D+ + A ++
Sbjct: 61 LHSC----FQTKDRLFFVMEYVNGGDL--MFHIQRSGRFDEP--------RARFYAAEIV 106
Query: 807 SALDYLHHHCQEPILHCDLKPSNILLDNDLSGH--IGDFGLAR--FHQEVSNSTLSSSVG 862
L +LH I++ DLK N+LLD++ GH I DFG+ + V+ ST
Sbjct: 107 LGLQFLHER---GIIYRDLKLDNVLLDSE--GHIKIADFGMCKEGILGGVTTSTFC---- 157
Query: 863 VKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGD 910
GT Y APE D ++ G+LL EM+ + P FEGD
Sbjct: 158 --GTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSP----FEGD 199
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 2e-11
Identities = 65/218 (29%), Positives = 110/218 (50%), Gaps = 36/218 (16%)
Query: 692 IGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSCS 751
+G G+ G V K G+++A K+I+L+ + A++N R L +V+ C+
Sbjct: 13 LGAGNGGVVTKVQHKPSGLIMARKLIHLEIK----------PAIRNQIIREL-QVLHECN 61
Query: 752 S---IDFQGNDFK----AIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAID 804
S + F G + +I E+M GSL++ L K K I ++ L ++SIA
Sbjct: 62 SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL------KEAKRIPEEI--LGKVSIA-- 111
Query: 805 VASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVK 864
V L YL Q I+H D+KPSNIL+++ + DFG++ ++ +S +S VG +
Sbjct: 112 VLRGLAYLREKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVS---GQLIDSMANSFVGTR 166
Query: 865 GTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKP 902
Y +PE G+ S D++S G+ L+E+ + P
Sbjct: 167 S---YMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 2e-11
Identities = 65/212 (30%), Positives = 94/212 (44%), Gaps = 24/212 (11%)
Query: 692 IGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKS---FMAECKALKNIRHRNLVKVIT 748
IG GSFG EDG IK IN+ + + K E L N++H N+V+
Sbjct: 8 IGEGSFGKAILVKSKEDGKQYVIKEINI-SKMSPKEREESRKEVAVLSNMKHPNIVQYQE 66
Query: 749 SCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASA 808
S F+ N IV +Y G L K K + + + Q + + + A
Sbjct: 67 S-----FEENGNLYIVMDYCEGGDLYK--------KINAQRGVLFPEDQILDWFVQICLA 113
Query: 809 LDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIG 868
L ++H ILH D+K NI L D + +GDFG+AR V NST+ + GT
Sbjct: 114 LKHVH---DRKILHRDIKSQNIFLTKDGTIKLGDFGIAR----VLNSTVELARTCIGTPY 166
Query: 869 YTAPEYGLGSEVSTNGDVYSYGILLLEMVTAK 900
Y +PE + D+++ G +L EM T K
Sbjct: 167 YLSPEICENRPYNNKSDIWALGCVLYEMCTLK 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 3e-11
Identities = 35/92 (38%), Positives = 51/92 (55%)
Query: 104 LEALFLSNNSLVGKIPANLSYCSRLTVLCIEYNKLQGRIPLEFVSLSKLKDLSLAKNKLT 163
++ L L N L G IP ++S L + + N ++G IP S++ L+ L L+ N
Sbjct: 420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFN 479
Query: 164 GGIPPFLGNLTSLEVLSLAGNSFGRNIPDSLG 195
G IP LG LTSL +L+L GNS +P +LG
Sbjct: 480 GSIPESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 4e-11
Identities = 68/227 (29%), Positives = 94/227 (41%), Gaps = 40/227 (17%)
Query: 686 FSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINL---QCEGASKSFMAECKALKNIRHRN 742
F H IG GSFG VY VVA+K ++ Q + + E K L+ ++H N
Sbjct: 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPN 82
Query: 743 LVKVITSCSSIDFQGNDFKA----IVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQR 798
+I+++G K +V EY GS L H P ++ EI
Sbjct: 83 ---------TIEYKGCYLKEHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIA-------- 124
Query: 799 ISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLS 858
+I L YLH H ++H D+K NILL + DFG S S S
Sbjct: 125 -AITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFG--------SASKSS 172
Query: 859 SSVGVKGTIGYTAPEYGLG-SEVSTNG--DVYSYGILLLEMVTAKKP 902
+ GT + APE L E +G DV+S GI +E+ K P
Sbjct: 173 PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 219
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 4e-11
Identities = 76/267 (28%), Positives = 114/267 (42%), Gaps = 43/267 (16%)
Query: 692 IGVGSFGCVYKGALDED-GIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKV--IT 748
+G GS G V+ A+D D VA+K I L + K + E K ++ + H N+VKV +
Sbjct: 13 LGCGSNGLVFS-AVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVL 71
Query: 749 SCSSIDFQ---GNDFKA----IVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISI 801
S D G+ + IV EYM L L + E +L + Q +
Sbjct: 72 GPSGSDLTEDVGSLTELNSVYIVQEYM-ETDLANVLEQGPLS----EEHARLFMYQLLR- 125
Query: 802 AIDVASALDYLHHHCQEPILHCDLKPSNILLD-NDLSGHIGDFGLARF-HQEVSNST-LS 858
L Y+H +LH DLKP+N+ ++ DL IGDFGLAR S+ LS
Sbjct: 126 ------GLKYIH---SANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLS 176
Query: 859 SSVGVKGTIGYTAPEYGLGSEVSTNG-DVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFA 917
+ K Y +P L T D+++ G + EM+T K +F G H
Sbjct: 177 EGLVTK---WYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK----PLFAGA---HELE 226
Query: 918 RMALPNQVMDIVDPILRNDEEILASTD 944
+M L +++ V + D L +
Sbjct: 227 QMQL---ILESVPVVREEDRNELLNVI 250
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 4e-11
Identities = 62/224 (27%), Positives = 98/224 (43%), Gaps = 46/224 (20%)
Query: 691 LIGVGSFGCVYKGALDEDGIVVAIK------VINLQCEGASKSFMAECKALKNIRHRNLV 744
+G G+FG V+ A+K VI L+ E + E + LK + H ++
Sbjct: 8 TVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHN---EKRVLKEVSHPFII 64
Query: 745 KVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAID 804
++ + D F ++ EY+P G L +L + + + A +
Sbjct: 65 RLF--WTEHD---QRFLYMLMEYVPGGELFSYLRNSG----------RFSNSTGLFYASE 109
Query: 805 VASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHI--GDFGLARFHQEVSNSTLSSSVG 862
+ AL+YLH I++ DLKP NILLD + GHI DFG A+ ++ + T +
Sbjct: 110 IVCALEYLHSK---EIVYRDLKPENILLDKE--GHIKLTDFGFAK---KLRDRTWT---- 157
Query: 863 VKGTIGYTAPEY----GLGSEVSTNGDVYSYGILLLEMVTAKKP 902
+ GT Y APE G V D ++ GIL+ EM+ P
Sbjct: 158 LCGTPEYLAPEVIQSKGHNKAV----DWWALGILIYEMLVGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 5e-11
Identities = 73/246 (29%), Positives = 109/246 (44%), Gaps = 47/246 (19%)
Query: 692 IGVGSFGCVYKGALDEDGIVVAIKVIN--LQCEGASKSFMAECKALKNIRHRN---LVKV 746
+G G++G V G VAIK + Q E +K E + LK+++H N L+ V
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDV 82
Query: 747 ITSCSSIDFQGNDFKAIVYEYMP--NGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAID 804
T S+D + +DF Y MP L K + K +K E ++ L
Sbjct: 83 FTPDLSLD-RFHDF----YLVMPFMGTDLGKLM------KHEKLSEDRIQFL-----VYQ 126
Query: 805 VASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVK 864
+ L Y+H I+H DLKP N+ ++ D I DFGLAR T S G
Sbjct: 127 MLKGLKYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR-------QTDSEMTGYV 176
Query: 865 GTIGYTAPEYGLG-SEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMALPN 923
T Y APE L + D++S G ++ EM+T K +F+G +L +
Sbjct: 177 VTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKP----LFKGHDHL---------D 223
Query: 924 QVMDIV 929
Q+M+I+
Sbjct: 224 QLMEIM 229
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 65.0 bits (159), Expect = 5e-11
Identities = 65/225 (28%), Positives = 92/225 (40%), Gaps = 50/225 (22%)
Query: 692 IGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMA---------ECKALKNIRHRN 742
IG G++G V G VAIK I +F E K L++ +H N
Sbjct: 13 IGSGAYGVVCSAIDTRSGKKVAIKKI-------PHAFDVPTLAKRTLRELKILRHFKHDN 65
Query: 743 LVKVITSCSSIDFQGNDFKAI--VYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRIS 800
++ + G DFK + V + M + L +H P ++ I L L R
Sbjct: 66 IIAIRDILRP---PGADFKDVYVVMDLMES-DLHHIIHSDQ-PLTEEHIRYFLYQLLR-- 118
Query: 801 IAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSS 860
L Y+H ++H DLKPSN+L++ D IGDFG+AR SS
Sbjct: 119 -------GLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMAR-------GLSSSP 161
Query: 861 VGVKG-------TIGYTAPEYGLGS-EVSTNGDVYSYGILLLEMV 897
K T Y APE L E +T D++S G + EM+
Sbjct: 162 TEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEML 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 65.0 bits (159), Expect = 5e-11
Identities = 67/230 (29%), Positives = 96/230 (41%), Gaps = 44/230 (19%)
Query: 692 IGVGSFGCVYKGALDEDGIVVAIKVIN--LQCEGASKSFMAECKALKNIRHRN---LVKV 746
+G G++G V + G VAIK ++ Q +K E + LK++ H N L+ V
Sbjct: 23 VGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDV 82
Query: 747 ITSCSSI-DFQGNDFKAIVYEYMP--NGSLEKWLHPHAVPKRDK--EIEIKLTLLQRISI 801
T SS+ DFQ VY L + + K K + I+ + Q +
Sbjct: 83 FTPASSLEDFQD------VYLVTHLMGADL------NNIVKCQKLSDDHIQFLVYQILR- 129
Query: 802 AIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSV 861
L Y+H I+H DLKPSNI ++ D I DFGLAR T
Sbjct: 130 ------GLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLAR-------HTDDEMT 173
Query: 862 GVKGTIGYTAPEYGLGSEVSTNG-DVYSYGILLLEMVTAKKPTDVMFEGD 910
G T Y APE L D++S G ++ E++T K +F G
Sbjct: 174 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK----TLFPGS 219
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 7e-11
Identities = 36/111 (32%), Positives = 56/111 (50%), Gaps = 12/111 (10%)
Query: 430 NNNNLSGVIPFSLGNLKRLAFLEMSGNELSGTIPEDIFNISYLSNSLNLARNHLVGIIPP 489
+N L G IP + L+ L + +SGN + G IP + +I+ L L+L+ N G IP
Sbjct: 426 DNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLE-VLDLSYNSFNGSIPE 484
Query: 490 RIGNLRALRSFDVSNNDLSGEIPIELGHCSSLEEIYLAGNLFHGSIPSFFN 540
+G L +LR +++ N LSG +P LG G L H + +F +
Sbjct: 485 SLGQLTSLRILNLNGNSLSGRVPAALG-----------GRLLHRASFNFTD 524
|
Length = 623 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 64.0 bits (155), Expect = 7e-11
Identities = 61/211 (28%), Positives = 94/211 (44%), Gaps = 23/211 (10%)
Query: 692 IGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSCS 751
IG G+ G VY G VAIK +NLQ + + + E ++ ++ N+V + S
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS-- 84
Query: 752 SIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDY 811
+ D +V EY+ GSL D E + Q ++ + ALD+
Sbjct: 85 ---YLVGDELWVVMEYLAGGSLT-----------DVVTETCMDEGQIAAVCRECLQALDF 130
Query: 812 LHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTA 871
LH + ++H D+K NILL D S + DFG F +++ S V GT + A
Sbjct: 131 LHSN---QVIHRDIKSDNILLGMDGSVKLTDFG---FCAQITPEQSKRSTMV-GTPYWMA 183
Query: 872 PEYGLGSEVSTNGDVYSYGILLLEMVTAKKP 902
PE D++S GI+ +EMV + P
Sbjct: 184 PEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 8e-11
Identities = 62/224 (27%), Positives = 102/224 (45%), Gaps = 29/224 (12%)
Query: 692 IGVGSFGCVYKG---ALDED--GIVVAIKVINLQCEGASKSF---MAECKALKNI-RHRN 742
+G G FG V LD++ V + V L+ + K ++E + +K I +H+N
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 743 LVKVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVP------KRDKEIEIKLTLL 796
++ ++ +C+ Q IV EY G+L ++L P + E +L+
Sbjct: 86 IINLLGACT----QDGPLYVIV-EYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFK 140
Query: 797 QRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLAR--FHQEVSN 854
+S A VA ++YL + +H DL N+L+ D I DFGLAR H +
Sbjct: 141 DLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 197
Query: 855 STLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT 898
T + + VK + APE + DV+S+G+LL E+ T
Sbjct: 198 KTTNGRLPVK----WMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 9e-11
Identities = 34/80 (42%), Positives = 45/80 (56%)
Query: 364 GSIPLGIGNLVDLYLLGMVENQFTGAIPKEMGKLQKLQGLDFSGNHFSGEIPSSLGNLSS 423
G IP I L L + + N G IP +G + L+ LD S N F+G IP SLG L+S
Sbjct: 432 GFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTS 491
Query: 424 LYEVFFNNNNLSGVIPFSLG 443
L + N N+LSG +P +LG
Sbjct: 492 LRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 9e-11
Identities = 28/78 (35%), Positives = 51/78 (65%), Gaps = 1/78 (1%)
Query: 190 IPDSLGQLKQLKILAIGGNNLSGPIPPSIYNLSFLVVFSVSHNQIHGSLPPSLGLLLPNL 249
IP+ + +L+ L+ + + GN++ G IPPS+ +++ L V +S+N +GS+P SLG L +L
Sbjct: 434 IPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLG-QLTSL 492
Query: 250 KFFQIHHNFFSGSIPISL 267
+ ++ N SG +P +L
Sbjct: 493 RILNLNGNSLSGRVPAAL 510
|
Length = 623 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 9e-11
Identities = 71/288 (24%), Positives = 127/288 (44%), Gaps = 42/288 (14%)
Query: 692 IGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSCS 751
IG GS G V G VA+K+++L+ + + E +++ +H+N+V++ S
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY- 87
Query: 752 SIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDY 811
G + ++ E++ G+L D + +L Q ++ V AL Y
Sbjct: 88 ---LVGEELWVLM-EFLQGGALT-----------DIVSQTRLNEEQIATVCESVLQALCY 132
Query: 812 LHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTA 871
LH + ++H D+K +ILL D + DFG F ++S V GT + A
Sbjct: 133 LH---SQGVIHRDIKSDSILLTLDGRVKLSDFG---FCAQISKDVPKRKSLV-GTPYWMA 185
Query: 872 PEYGLGSEVSTNGDVYSYGILLLEMVTAKKP--TDVMFEGDLNLHNFARMALPNQVMDIV 929
PE + T D++S GI+++EMV + P +D + L + L N +
Sbjct: 186 PEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKN--AHKI 243
Query: 930 DPILRNDEEILASTDKCRR------------MQTGINSRLECLISMVK 965
P+LR+ E + + + R +QTG+ ECL+ +++
Sbjct: 244 SPVLRDFLERMLTREPQERATAQELLDHPFLLQTGLP---ECLVPLIQ 288
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.2 bits (157), Expect = 9e-11
Identities = 63/231 (27%), Positives = 94/231 (40%), Gaps = 46/231 (19%)
Query: 686 FSSTHLIGVGSFGCVYKGALDEDGIVVAIKVI-----NLQCEGASKSFMAECKALKNIRH 740
+ + IG G++G V G+ VAIK I C+ + E K L+ +H
Sbjct: 7 YQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRT----LREIKILRRFKH 62
Query: 741 RNLVKVITSCSSIDFQGNDFKA--IVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQR 798
N++ ++ F+ F IV E M L+ KL Q
Sbjct: 63 ENIIGILDIIRPPSFE--SFNDVYIVQELMETD-----LY-------------KLIKTQH 102
Query: 799 IS------IAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFH--Q 850
+S + L Y+H +LH DLKPSN+LL+ + I DFGLAR +
Sbjct: 103 LSNDHIQYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPE 159
Query: 851 EVSNSTLSSSVGVKGTIGYTAPEYGLGS-EVSTNGDVYSYGILLLEMVTAK 900
L+ V T Y APE L S + D++S G +L EM++ +
Sbjct: 160 HDHTGFLTEYV---ATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-10
Identities = 59/217 (27%), Positives = 97/217 (44%), Gaps = 22/217 (10%)
Query: 691 LIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKS-----FMAECKALKNIRHRNLVK 745
L+G G+FG VY + G +A+K + E S E + LKN+ H +V+
Sbjct: 9 LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68
Query: 746 VITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDV 805
D +I E+MP GS++ L + + + +L+ +S
Sbjct: 69 YYGCLR--DPMERTL-SIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVS----- 120
Query: 806 ASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKG 865
YLH + I+H D+K +NIL D+ + +GDFG ++ Q + S + V G
Sbjct: 121 -----YLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSG-TGMKSVTG 171
Query: 866 TIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKP 902
T + +PE G D++S G ++EM+T K P
Sbjct: 172 TPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 1e-10
Identities = 61/214 (28%), Positives = 104/214 (48%), Gaps = 30/214 (14%)
Query: 692 IGVGSFGCVYKGALDEDGIVVAIKVINLQCE-GASKSFMAECKALKNIRHRNLVK---VI 747
+G G++ V+KG +VA+K I L+ E GA + + E LK+++H N+V ++
Sbjct: 14 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIV 73
Query: 748 TSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVAS 807
+ S+ +V+EY+ + L++++ ++I L + R
Sbjct: 74 HTDKSL--------TLVFEYL-DKDLKQYMDDCGNIMSMHNVKIFLYQILR--------- 115
Query: 808 ALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTI 867
L Y H + +LH DLKP N+L++ + DFGLAR + V T S+ V T+
Sbjct: 116 GLAYCH---RRKVLHRDLKPQNLLINERGELKLADFGLAR-AKSVPTKTYSNEV---VTL 168
Query: 868 GYTAPEYGLG-SEVSTNGDVYSYGILLLEMVTAK 900
Y P+ LG SE ST D++ G + EM + +
Sbjct: 169 WYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 1e-10
Identities = 60/232 (25%), Positives = 106/232 (45%), Gaps = 27/232 (11%)
Query: 679 LLKATNGFSSTHLIGVGSFGCVYKGALDEDG----IVVAIKVI-NLQCEGASKSFMAECK 733
+LK T F ++G G+FG VYKG +G I VAIK + A+K + E
Sbjct: 3 ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 61
Query: 734 ALKNIRHRNLVKVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKL 793
+ ++ + ++ +++ C + Q ++ + MP G L ++ H +D L
Sbjct: 62 VMASVDNPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREH----KDNIGSQYL 111
Query: 794 TLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVS 853
++ + +A ++YL + ++H DL N+L+ I DFGLA+ +
Sbjct: 112 -----LNWCVQIAKGMNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG--A 161
Query: 854 NSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT-AKKPTD 904
+ + G K I + A E L + DV+SYG+ + E++T KP D
Sbjct: 162 DEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 1e-10
Identities = 67/233 (28%), Positives = 104/233 (44%), Gaps = 38/233 (16%)
Query: 686 FSSTHLIGVGSFGCVYKGALDEDGIVVAIKVIN--LQCEGASKSFMAECKALKNIRHRN- 742
+ + IG G+ G V G VAIK ++ Q +K E +K + H+N
Sbjct: 18 YQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNI 77
Query: 743 --LVKVITSCSSIDFQGNDFKA--IVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQR 798
L+ V T S++ +F+ +V E M + +L V + D + E R
Sbjct: 78 IGLLNVFTPQKSLE----EFQDVYLVMELM-DANL------CQVIQMDLDHE-------R 119
Query: 799 ISIAI-DVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTL 857
+S + + + +LH I+H DLKPSNI++ +D + I DFGLAR S +
Sbjct: 120 MSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFM 173
Query: 858 SSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGD 910
+ V T Y APE LG N D++S G ++ EM+ V+F G
Sbjct: 174 MTPYVV--TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGT----VLFPGT 220
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 62/226 (27%), Positives = 104/226 (46%), Gaps = 26/226 (11%)
Query: 692 IGVGSFGCVYKGALDEDGIVVAIK---VINLQCEGASKSFMAECKALKNIRHRNLVKVIT 748
IG G F VY+ D VA+K + + A + + E LK + H N++K +
Sbjct: 10 IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLD 69
Query: 749 SCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASA 808
S F ++ IV E G L + + K+ K + + T+ + + + SA
Sbjct: 70 S-----FIEDNELNIVLELADAGDLSQMIKYF---KKQKRLIPERTVWKYF---VQLCSA 118
Query: 809 LDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIG 868
++++H ++H D+KP+N+ + +GD GL RF S +T + S + GT
Sbjct: 119 VEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS--SKTTAAHS--LVGTPY 171
Query: 869 YTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGD-LNL 913
Y +PE + + D++S G LL EM + P F GD +NL
Sbjct: 172 YMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP----FYGDKMNL 213
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 1e-10
Identities = 69/231 (29%), Positives = 103/231 (44%), Gaps = 37/231 (16%)
Query: 686 FSSTHLIGVGSFGCVYKGALDEDGIVVAIKVIN--LQCEGASKSFMAECKALKNIRHRN- 742
++S +G G++G V G VAIK ++ Q E +K E LK+++H N
Sbjct: 17 YTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENV 76
Query: 743 --LVKVITSCSSID-FQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRI 799
L+ V TS S D FQ DF +V YM L+K + E +++ + Q +
Sbjct: 77 IGLLDVFTSAVSGDEFQ--DF-YLVMPYMQT-DLQKIMGHPL-----SEDKVQYLVYQML 127
Query: 800 SIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSS 859
L Y+H I+H DLKP N+ ++ D I DFGLAR +
Sbjct: 128 C-------GLKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLAR-------HADAE 170
Query: 860 SVGVKGTIGYTAPEYGLG-SEVSTNGDVYSYGILLLEMVTAKKPTDVMFEG 909
G T Y APE L + D++S G ++ EM+T K +F+G
Sbjct: 171 MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK----TLFKG 217
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 2e-10
Identities = 61/211 (28%), Positives = 95/211 (45%), Gaps = 23/211 (10%)
Query: 692 IGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSCS 751
IG G+ G V+ G VAIK INLQ + + + E +K +++ N+V + S
Sbjct: 27 IGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDS-- 84
Query: 752 SIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDY 811
F D +V EY+ GSL D E + Q ++ + AL++
Sbjct: 85 ---FLVGDELFVVMEYLAGGSLT-----------DVVTETCMDEAQIAAVCRECLQALEF 130
Query: 812 LHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTA 871
LH + ++H D+K N+LL D S + DFG F +++ S V GT + A
Sbjct: 131 LHAN---QVIHRDIKSDNVLLGMDGSVKLTDFG---FCAQITPEQSKRSTMV-GTPYWMA 183
Query: 872 PEYGLGSEVSTNGDVYSYGILLLEMVTAKKP 902
PE D++S GI+ +EMV + P
Sbjct: 184 PEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 75/319 (23%), Positives = 126/319 (39%), Gaps = 59/319 (18%)
Query: 679 LLKATNGFSSTHLIGVGSFGCVYKGALDEDG----IVVAIKVINLQCE-GASKSFMAECK 733
+LK T ++G G+FG VYKG DG I VAIKV+ A+K + E
Sbjct: 3 ILKETE-LKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAY 61
Query: 734 ALKNIRHRNLVKVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKL 793
+ + + +++ C + Q +V + MP G L ++ + +D+ +
Sbjct: 62 VMAGVGSPYVCRLLGICLTSTVQ------LVTQLMPYGCLLDYVREN----KDR-----I 106
Query: 794 TLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVS 853
++ + +A + YL + ++H DL N+L+ + I DFGLAR
Sbjct: 107 GSQDLLNWCVQIAKGMSYLE---EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLD--I 161
Query: 854 NSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT-AKKPTDVMFEGDLN 912
+ T + G K I + A E L + DV+SYG+ + E++T KP D +
Sbjct: 162 DETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGI------ 215
Query: 913 LHNFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSM 972
+I D + +K R+ C I + I V C M
Sbjct: 216 -----------PAREIPDLL-----------EKGERLPQPPI----CTIDVYMIMVKCWM 249
Query: 973 ESPQDRMNMTNVVHELQSV 991
+ R +V E +
Sbjct: 250 IDSECRPRFRELVDEFSRM 268
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 56/225 (24%), Positives = 102/225 (45%), Gaps = 34/225 (15%)
Query: 692 IGVGSFGCVYKGALDEDGI----VVAIKVI-NLQCEGASKSFMAECKALKNIRHRNLVKV 746
+G +FG +YKG L G+ +VAIK + ++ F E + + H N+V +
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72
Query: 747 ITSCSSIDFQGNDFKAIVYEYMPNGSLEKWL---HPHA----VPKRDKEIEIKLTLLQRI 799
+ + +++EY+ G L ++L PH+ D ++ L +
Sbjct: 73 LGVVTQ-----EQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFL 127
Query: 800 SIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLAR------FHQEVS 853
IAI +A+ ++YL H +H DL NIL+ L I D GL+R +++
Sbjct: 128 HIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQP 184
Query: 854 NSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT 898
S L I + PE + + S++ D++S+G++L E+ +
Sbjct: 185 KSLLP--------IRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 65/230 (28%), Positives = 102/230 (44%), Gaps = 36/230 (15%)
Query: 692 IGVGSFGCVYKG-ALDEDGI----VVAIKVINLQCEGASKS----FMAECKALKNIRHRN 742
+G G FG V K A G VA+K++ E AS S ++E LK + H +
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLK---ENASSSELRDLLSEFNLLKQVNHPH 64
Query: 743 LVKVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLH------PHAVPKR--------DKE 788
++K+ +CS + ++ EY GSL +L P + D
Sbjct: 65 VIKLYGACSQ-----DGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNP 119
Query: 789 IEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARF 848
E LT+ IS A ++ + YL + ++H DL N+L+ I DFGL+R
Sbjct: 120 DERALTMGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRD 176
Query: 849 HQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT 898
E +S + S G + + + A E +T DV+S+G+LL E+VT
Sbjct: 177 VYE-EDSYVKRSKG-RIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 2e-10
Identities = 66/227 (29%), Positives = 103/227 (45%), Gaps = 32/227 (14%)
Query: 691 LIGVGSFGCVYKGALDEDGIVVAIKVINLQ--CEGASKSFMAECKALKNIRHRNLVKVIT 748
++G G+ G V DG A+KV++++ E AE L N ++VK
Sbjct: 39 VLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVK--- 95
Query: 749 SCSSIDFQGNDFK--------AIVYEYMPNGSLEKWLHPHAVPKRD-KEIEIKLTLLQRI 799
C DF D + A+V +Y G L + + A R +E E L +Q
Sbjct: 96 -CHE-DFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQ-- 151
Query: 800 SIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSS 859
L +HH + ++H D+K +NILL ++ +GDFG ++ + +T+S
Sbjct: 152 --------VLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMY----AATVSD 199
Query: 860 SVGVK--GTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTD 904
VG GT Y APE S D++S G+LL E++T K+P D
Sbjct: 200 DVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFD 246
|
Length = 496 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 2e-10
Identities = 49/214 (22%), Positives = 103/214 (48%), Gaps = 18/214 (8%)
Query: 692 IGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKS----FMAECKALKNIRHRNLVKVI 747
+G G FG V +G L++D ++ + V ++ ++S F++E +K H N++++I
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 748 TSC-SSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVA 806
C +++ +G ++ +M +G L H + R + L + D+A
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDL----HSFLLYSRLGDCPQYLPTQMLVKFMTDIA 122
Query: 807 SALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLAR--FHQEVSNSTLSSSVGVK 864
S ++YL + +H DL N +L+ +++ + DFGL++ ++ + + + VK
Sbjct: 123 SGMEYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVK 179
Query: 865 GTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT 898
+ A E +T DV+S+G+ + E+ T
Sbjct: 180 ----WIAIESLADRVYTTKSDVWSFGVTMWEIAT 209
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 3e-10
Identities = 61/226 (26%), Positives = 103/226 (45%), Gaps = 39/226 (17%)
Query: 691 LIGVGSFGCVYKGALDEDGIVVAIKVINLQ------CEGASKSFMAECKALKNIRHRNLV 744
++G G++G VY G L G ++A+K + L E + E LK+++H N+V
Sbjct: 7 VLGKGAYGTVYCG-LTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 745 KVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLH-----PHAVPKR-DKEIEIKLTLLQR 798
+ + +C N +I E++P GS+ L+ P V + K+I L
Sbjct: 66 QYLGTC----LDDNTI-SIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQI------LDG 114
Query: 799 ISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLS 858
++ YLH++C ++H D+K +N++L + + DFG AR V
Sbjct: 115 VA----------YLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTH 161
Query: 859 SSV--GVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKP 902
S++ + GT + APE S D++S G + EM T K P
Sbjct: 162 SNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPP 207
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 3e-10
Identities = 65/246 (26%), Positives = 106/246 (43%), Gaps = 29/246 (11%)
Query: 692 IGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSCS 751
IG GS G V G VA+K ++L+ + + E +++ H N+V + S
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNS-- 87
Query: 752 SIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDY 811
+ D +V E++ G+L D ++ Q ++ + V AL Y
Sbjct: 88 ---YLVGDELWVVMEFLEGGALT-----------DIVTHTRMNEEQIATVCLSVLRALSY 133
Query: 812 LHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGL-ARFHQEVSNSTLSSSVGVKGTIGYT 870
LH + ++H D+K +ILL +D + DFG A+ +EV + GT +
Sbjct: 134 LH---NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRK-----SLVGTPYWM 185
Query: 871 APEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMALPNQVMDI-- 928
APE T D++S GI+++EM+ + P E L R LP +V D
Sbjct: 186 APEVISRLPYGTEVDIWSLGIMVIEMIDGEPP--YFNEPPLQAMRRIRDNLPPRVKDSHK 243
Query: 929 VDPILR 934
V +LR
Sbjct: 244 VSSVLR 249
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 3e-10
Identities = 55/199 (27%), Positives = 88/199 (44%), Gaps = 28/199 (14%)
Query: 712 VAIKVI-NLQCEGAS--KSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKAIVYEYM 768
VAIK++ E F E + H N+V ++ S + V+EY+
Sbjct: 6 VAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEA----PPGLLFAVFEYV 61
Query: 769 PNGSLEKWLHPH-AVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKP 827
P +L + L A+P E +LQ LD L + I+H DLKP
Sbjct: 62 PGRTLREVLAADGALPA----GETGRLMLQ----------VLDALACAHNQGIVHRDLKP 107
Query: 828 SNILLD-NDLSGH--IGDFGLARF---HQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVS 881
NI++ + H + DFG+ ++ +TL+ + V GT Y APE G V+
Sbjct: 108 QNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVT 167
Query: 882 TNGDVYSYGILLLEMVTAK 900
N D+Y++G++ LE +T +
Sbjct: 168 PNSDLYAWGLIFLECLTGQ 186
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 3e-10
Identities = 68/264 (25%), Positives = 117/264 (44%), Gaps = 37/264 (14%)
Query: 692 IGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSCS 751
IG GS G V + G +VA+K ++L+ + + E +++ +H N+V++ S
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNS-- 85
Query: 752 SIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDY 811
+ D +V E++ G+L D ++ Q ++ + V AL
Sbjct: 86 ---YLVGDELWVVMEFLEGGALT-----------DIVTHTRMNEEQIAAVCLAVLKALSV 131
Query: 812 LHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGL-ARFHQEVSNSTLSSSVGVKGTIGYT 870
LH + ++H D+K +ILL +D + DFG A+ +EV + GT +
Sbjct: 132 LH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRK-----SLVGTPYWM 183
Query: 871 APE----YGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMALPNQVM 926
APE G EV D++S GI+++EMV + P E L R LP ++
Sbjct: 184 APELISRLPYGPEV----DIWSLGIMVIEMVDGEPP--YFNEPPLKAMKMIRDNLPPKLK 237
Query: 927 DI--VDPILRNDEEILASTDKCRR 948
++ V P L+ + L D +R
Sbjct: 238 NLHKVSPSLKGFLDRLLVRDPAQR 261
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 3e-10
Identities = 62/230 (26%), Positives = 104/230 (45%), Gaps = 41/230 (17%)
Query: 692 IGVGSFGCVYKG---ALDED----GIVVAIKVINLQCEGASKSF---MAECKALKNI-RH 740
+G G FG V + +D+ + VA+K+ L+ K ++E + +K I +H
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKM--LKDNATDKDLADLISEMELMKLIGKH 77
Query: 741 RNLVKVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEI------KLT 794
+N++ ++ C+ Q IV EY G+L ++L P D +I +L+
Sbjct: 78 KNIINLLGVCT----QEGPLYVIV-EYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLS 132
Query: 795 LLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLAR------F 848
+S A VA ++YL +H DL N+L+ D I DFGLAR +
Sbjct: 133 FKDLVSCAYQVARGMEYLE---SRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDY 189
Query: 849 HQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT 898
+++ SN L + + APE + DV+S+GIL+ E+ T
Sbjct: 190 YKKTSNGRLP--------VKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 4e-10
Identities = 72/262 (27%), Positives = 105/262 (40%), Gaps = 50/262 (19%)
Query: 686 FSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINL---QCEGASKSFMAECKALKNIRHRN 742
FS IG GSFG VY + VVAIK ++ Q + + E + L+ +RH N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 743 LVKVITSCSSIDFQGNDFKA----IVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQR 798
+I ++G + +V EY GS L H P ++ EI
Sbjct: 77 ---------TIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIA-------- 118
Query: 799 ISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLS 858
++ L YLH H ++H D+K NILL +GDFG S S ++
Sbjct: 119 -AVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFG--------SASIMA 166
Query: 859 SSVGVKGTIGYTAPEYGLG-SEVSTNG--DVYSYGILLLEMVTAKKPTDVMFEGDLNLHN 915
+ GT + APE L E +G DV+S GI +E+ K P L N
Sbjct: 167 PANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP----------LFN 216
Query: 916 FARMALPNQVMDIVDPILRNDE 937
M+ + P L++
Sbjct: 217 MNAMSALYHIAQNESPALQSGH 238
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 4e-10
Identities = 54/221 (24%), Positives = 103/221 (46%), Gaps = 19/221 (8%)
Query: 686 FSSTHLIGVGSFGCVYKGAL---DEDGIVVAIKVI--NLQCEGASKSFMAECKALKNIRH 740
F+ ++G G FG V + L D VA+K++ ++ + F+ E +K H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 741 RNLVKVI-TSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRI 799
N++K+I S S ++ +M +G L H + R E L L +
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDL----HTFLLMSRIGEEPFTLPLQTLV 116
Query: 800 SIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLAR--FHQEVSNSTL 857
ID+AS ++YL + +H DL N +L+ +++ + DFGL++ + +
Sbjct: 117 RFMIDIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGC 173
Query: 858 SSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT 898
+S + VK + A E + +T+ DV+++G+ + E++T
Sbjct: 174 ASKLPVK----WLALESLADNVYTTHSDVWAFGVTMWEIMT 210
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 4e-10
Identities = 56/211 (26%), Positives = 95/211 (45%), Gaps = 23/211 (10%)
Query: 692 IGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSCS 751
IG GS G V G VA+K ++L+ + + E +++ +H N+V++ +S
Sbjct: 27 IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSS-- 84
Query: 752 SIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDY 811
+ D +V E++ G+L D ++ Q ++ + V AL +
Sbjct: 85 ---YLVGDELWVVMEFLEGGALT-----------DIVTHTRMNEEQIATVCLAVLKALSF 130
Query: 812 LHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTA 871
LH ++H D+K +ILL +D + DFG F +VS V GT + A
Sbjct: 131 LHAQ---GVIHRDIKSDSILLTSDGRVKLSDFG---FCAQVSKEVPRRKSLV-GTPYWMA 183
Query: 872 PEYGLGSEVSTNGDVYSYGILLLEMVTAKKP 902
PE T D++S GI+++EMV + P
Sbjct: 184 PEVISRLPYGTEVDIWSLGIMVIEMVDGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 5e-10
Identities = 71/235 (30%), Positives = 99/235 (42%), Gaps = 39/235 (16%)
Query: 691 LIGVGSFGCVYKGALDEDGIVVAIKVINLQC---EGASKSFMAECKAL-KNIRHRNLVKV 746
+IG GSFG V DG A+KV+ + + MAE L KN++H LV +
Sbjct: 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL 61
Query: 747 ITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVA 806
S FQ + V +Y+ G L + H + E + A +VA
Sbjct: 62 HYS-----FQTAEKLYFVLDYVNGGEL--FFHLQR-ERCFLEPRARF-------YAAEVA 106
Query: 807 SALDYLHHHCQEPILHCDLKPSNILLDNDLSGHI--GDFGLAR--FHQEVSNSTLSSSVG 862
SA+ YLH I++ DLKP NILLD+ GH+ DFGL + E + ST
Sbjct: 107 SAIGYLH---SLNIIYRDLKPENILLDS--QGHVVLTDFGLCKEGVEPEETTSTFC---- 157
Query: 863 VKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKP-----TDVMFEGDLN 912
GT Y APE D + G +L EM+ P M++ L+
Sbjct: 158 --GTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILH 210
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 5e-10
Identities = 60/233 (25%), Positives = 101/233 (43%), Gaps = 38/233 (16%)
Query: 686 FSSTHLI---GVGSFGCVYKGALDEDGIVVAIKVINLQC-EGASKSFMAECKALKNIRHR 741
F HL G+ F D ++VA+K++ + A F+ E K + +++
Sbjct: 18 FGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNP 77
Query: 742 NLVKVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRIS- 800
N+++++ C S +D ++ EYM NG L ++L +EIE T I
Sbjct: 78 NIIRLLGVCVS-----DDPLCMITEYMENGDLNQFL-------SQREIESTFTHANNIPS 125
Query: 801 --------IAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEV 852
+A+ +AS + YL +H DL N L+ N + I DFG++R
Sbjct: 126 VSIANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSR----- 177
Query: 853 SNSTLSSSVGVKG----TIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKK 901
N ++G I + A E L + +T DV+++G+ L EM T K
Sbjct: 178 -NLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCK 229
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.1 bits (149), Expect = 6e-10
Identities = 67/247 (27%), Positives = 97/247 (39%), Gaps = 53/247 (21%)
Query: 679 LLKATNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNI 738
L T F +IG G++G VYK + G +VAIK++++ E + E L+
Sbjct: 1 LPDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDII-EDEEEEIKEEYNILRKY 59
Query: 739 -RHRNLVKVITSCSSIDFQGNDFKA----------IVYEYMPNGS---LEKWLHPHAVPK 784
H N+ F G K +V E GS L K L K
Sbjct: 60 SNHPNIA---------TFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGL--RKKGK 108
Query: 785 RDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFG 844
R KE I I + L YLH + ++H D+K NILL + + DFG
Sbjct: 109 RLKEEWIAY-------ILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFG 158
Query: 845 LARFHQEVSNSTLSSSVGVKGT-IG---YTAPE-----YGLGSEVSTNGDVYSYGILLLE 895
++ L S++G + T IG + APE + DV+S GI +E
Sbjct: 159 VSA--------QLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIE 210
Query: 896 MVTAKKP 902
+ K P
Sbjct: 211 LADGKPP 217
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 7e-10
Identities = 40/108 (37%), Positives = 58/108 (53%), Gaps = 15/108 (13%)
Query: 804 DVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIG--DFGLARFHQEVSNSTLSSSV 861
++A ALD+LH I++ DLKP NILLD + GHI DFGL++ + S
Sbjct: 106 ELALALDHLH---SLGIIYRDLKPENILLDEE--GHIKLTDFGLSKESIDHEKKAYSFC- 159
Query: 862 GVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEG 909
GT+ Y APE + + D +S+G+L+ EM+T P F+G
Sbjct: 160 ---GTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLP----FQG 200
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 7e-10
Identities = 55/218 (25%), Positives = 98/218 (44%), Gaps = 31/218 (14%)
Query: 692 IGVGSFGCVYKGALDEDGIVVAIKVINLQCEGA---SKSFMAECKALKNIRHRNLVKVIT 748
IG G FG V G ++ + V L+ + F+ E + ++++H NL++ +
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62
Query: 749 SCSS-IDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVAS 807
C+ + +V E+ P G L+ +L ++ + + T LQR+ A ++A
Sbjct: 63 QCTEVTPY------LLVMEFCPLGDLKGYLRSC---RKAELMTPDPTTLQRM--ACEIAL 111
Query: 808 ALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTI 867
L +LH + +H DL N LL DL+ IGD+GL+ H + + + +
Sbjct: 112 GLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLS--HNKYKEDYYVTPDQLWVPL 166
Query: 868 GYTAPEYGLGSEVSTN---------GDVYSYGILLLEM 896
+ APE L EV N +V+S G+ + E+
Sbjct: 167 RWIAPE--LVDEVHGNLLVVDQTKESNVWSLGVTIWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 7e-10
Identities = 60/237 (25%), Positives = 101/237 (42%), Gaps = 50/237 (21%)
Query: 692 IGVGSFGCVYKGALDE-DGIVVAIKVINLQCEGA-----SKSFMAEC----------KAL 735
+G G++G V K A D G +VAIK + + E + + + C K +
Sbjct: 17 LGEGTYGKVEK-AYDTLTGKIVAIKKVKI-IEISNDVTKDRQLVGMCGIHFTTLRELKIM 74
Query: 736 KNIRHRNLVKVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTL 795
I+H N++ ++ + DF +V + M L+K + + +I+LT
Sbjct: 75 NEIKHENIMGLVDV-----YVEGDFINLVMDIM-ASDLKKVV----------DRKIRLTE 118
Query: 796 LQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLAR-------- 847
Q I + + + L+ LH +H DL P+NI +++ I DFGLAR
Sbjct: 119 SQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYS 175
Query: 848 ---FHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNG-DVYSYGILLLEMVTAK 900
E + V T+ Y APE +G+E D++S G + E++T K
Sbjct: 176 DTLSKDETMQRREEMTSKVV-TLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 7e-10
Identities = 63/225 (28%), Positives = 101/225 (44%), Gaps = 26/225 (11%)
Query: 691 LIGVGSFGCVYKGALDEDGIVVAIKVIN----LQCEGASKSFMAECKALKNIRHRNLVKV 746
++G GSFG V L E G + A+KV+ LQ + + M E + L R+ +
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQ-DDDVECTMTEKRILSLARNHPFLTQ 60
Query: 747 ITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVA 806
+ C FQ D V E++ G L H + D+ + A ++
Sbjct: 61 LYCC----FQTPDRLFFVMEFVNGGDL--MFHIQKSRRFDEA--------RARFYAAEIT 106
Query: 807 SALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGT 866
SAL +LH + I++ DLK N+LLD++ + DFG+ + + + N +S+ GT
Sbjct: 107 SALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCK--EGIFNGKTTSTFC--GT 159
Query: 867 IGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDL 911
Y APE + D ++ G+LL EM+ P + E DL
Sbjct: 160 PDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDL 204
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 7e-10
Identities = 62/216 (28%), Positives = 102/216 (47%), Gaps = 32/216 (14%)
Query: 692 IGVGSFGCVYKGALDEDGIVVAIKVINLQCEGA-SKSFMAECKALKNIRHRNLVKVITSC 750
+G G+ G V K G V+A KV+++ + + K + E + + R +V +
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGA- 71
Query: 751 SSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALD 810
F + + E+M GSL++ K I + +L +I++A V L
Sbjct: 72 ----FLNENNICMCMEFMDCGSLDRIYK--------KGGPIPVEILGKIAVA--VVEGLT 117
Query: 811 YLH--HHCQEPILHCDLKPSNILLDNDLSGHIG--DFGLARFHQEVSNSTLSSSVGVKGT 866
YL+ H I+H D+KPSNIL+++ G I DFG++ E+ NS + VG T
Sbjct: 118 YLYNVHR----IMHRDIKPSNILVNS--RGQIKLCDFGVS---GELINSIADTFVG---T 165
Query: 867 IGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKP 902
Y +PE G + + DV+S GI ++E+ K P
Sbjct: 166 STYMSPERIQGGKYTVKSDVWSLGISIIELALGKFP 201
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 8e-10
Identities = 63/223 (28%), Positives = 105/223 (47%), Gaps = 27/223 (12%)
Query: 692 IGVGSFGCVYKG-ALD----EDGIVVAIKVINLQCEGASK----SFMAECKALKNIRHRN 742
+G GSFG VY+G A D E VA+K +N E AS F+ E +K +
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVN---ESASLRERIEFLNEASVMKGFTCHH 70
Query: 743 LVKVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIA 802
+V+++ S +V E M +G L+ +L + TL + I +A
Sbjct: 71 VVRLLGVVSK-----GQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMA 125
Query: 803 IDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVG 862
++A + YL+ + +H DL N ++ +D + IGDFG+ R E T G
Sbjct: 126 AEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYE----TDYYRKG 178
Query: 863 VKG--TIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT-AKKP 902
KG + + APE +T+ D++S+G++L E+ + A++P
Sbjct: 179 GKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQP 221
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 60.9 bits (147), Expect = 9e-10
Identities = 68/227 (29%), Positives = 97/227 (42%), Gaps = 40/227 (17%)
Query: 686 FSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSF---MAECKALKNIRHRN 742
F+ IG GSFG VY VVAIK ++ + +++ + + E K L+ I+H N
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 743 LVKVITSCSSIDFQGNDFKA----IVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQR 798
SI+++G + +V EY GS L H P ++ EI
Sbjct: 87 ---------SIEYKGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIA-------- 128
Query: 799 ISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLS 858
+I L YLH H ++H D+K NILL + DFG S S S
Sbjct: 129 -AITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFG--------SASIAS 176
Query: 859 SSVGVKGTIGYTAPEYGLG-SEVSTNG--DVYSYGILLLEMVTAKKP 902
+ GT + APE L E +G DV+S GI +E+ K P
Sbjct: 177 PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 223
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 9e-10
Identities = 63/231 (27%), Positives = 97/231 (41%), Gaps = 25/231 (10%)
Query: 685 GFSSTHLIGVGSFGCV--YKGALDEDGIVVAIKVIN--LQCEGASKSFMAECKALKNIR- 739
+ +G G++G V + A + VAIK I + +K + E K L++ R
Sbjct: 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRG 60
Query: 740 HRNLVKVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRI 799
H+N+ + I F GN + +YE + L + + P D +
Sbjct: 61 HKNITCLYDM--DIVFPGNFNELYLYEELMEADLHQIIRS-GQPLTDAHFQ--------- 108
Query: 800 SIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSS 859
S + L Y+H +LH DLKP N+L++ D I DFGLAR E
Sbjct: 109 SFIYQILCGLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGF 165
Query: 860 SVGVKGTIGYTAPEYGLG-SEVSTNGDVYSYGILLLEMVTAKKPTDVMFEG 909
T Y APE L + DV+S G +L E++ +KP +F+G
Sbjct: 166 MTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELL-GRKP---VFKG 212
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 1e-09
Identities = 69/218 (31%), Positives = 97/218 (44%), Gaps = 30/218 (13%)
Query: 691 LIGVGSFGCVYKGALDEDGIVVAIKVINLQC---EGASKSFMAECKAL-KNIRHRNLVKV 746
+IG GSFG V DG A+KV+ + K MAE L KN++H LV +
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 747 ITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVA 806
S FQ + V +++ G L + H + + E + R A ++A
Sbjct: 62 HYS-----FQTTEKLYFVLDFVNGGEL--FFH---LQRERSFPEPR----ARFYAA-EIA 106
Query: 807 SALDYLHHHCQEPILHCDLKPSNILLDNDLSGHI--GDFGLARFHQEVSNSTLSSSVGVK 864
SAL YLH I++ DLKP NILLD+ GH+ DFGL + S++T +
Sbjct: 107 SALGYLH---SINIVYRDLKPENILLDS--QGHVVLTDFGLCKEGIAQSDTTTTFC---- 157
Query: 865 GTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKP 902
GT Y APE D + G +L EM+ P
Sbjct: 158 GTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-09
Identities = 38/101 (37%), Positives = 52/101 (51%), Gaps = 8/101 (7%)
Query: 802 AIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSV 861
A ++ L+ LH QE I++ DLKP NILLD+ I D GLA E T+ V
Sbjct: 108 AAEICCGLEDLH---QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPE--GQTIKGRV 162
Query: 862 GVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKP 902
GT+GY APE + + D ++ G LL EM+ + P
Sbjct: 163 ---GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 1e-09
Identities = 62/224 (27%), Positives = 95/224 (42%), Gaps = 36/224 (16%)
Query: 692 IGVGSFGCVYKGALDEDGIVVAIKVIN---LQCEGASKSFMAECKALKNIRHRNLVKVIT 748
+G G +G V+ + G +VA+K + L + + E L + LVK++
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68
Query: 749 SCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASA 808
+ FQ +++ + EY+P G L+ V D R +A ++ A
Sbjct: 69 A-----FQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDH---------ARFYMA-EMFEA 113
Query: 809 LDYLHHHCQEPILHCDLKPSNILLDNDLSGHI--GDFGLARFHQEVSNSTLSSSVGVKGT 866
+D LH + +H DLKP N L+D SGHI DFGL++ +NS V G+
Sbjct: 114 VDALH---ELGYIHRDLKPENFLIDA--SGHIKLTDFGLSKGIVTYANS-------VVGS 161
Query: 867 IGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGD 910
Y APE G D +S G +L E + P F G
Sbjct: 162 PDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPP----FSGS 201
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 1e-09
Identities = 62/219 (28%), Positives = 100/219 (45%), Gaps = 35/219 (15%)
Query: 692 IGVGSFGCVYKG---ALDEDGIV--VAIKVINLQCEGASK-SFMAECKALKNI-RHRNLV 744
+G G+FG V + L + V VA+K++ + + + M+E K + ++ H N+V
Sbjct: 43 LGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIV 102
Query: 745 KVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAID 804
++ +C+ G ++ EY G L +L ++ E LTL +S +
Sbjct: 103 NLLGACTI---GGPIL--VITEYCCYGDLLNFLR--------RKRESFLTLEDLLSFSYQ 149
Query: 805 VASALDYL-HHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGV 863
VA + +L +C +H DL N+LL + I DFGLAR SN V
Sbjct: 150 VAKGMAFLASKNC----IHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYV------V 199
Query: 864 KGT----IGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT 898
KG + + APE + DV+SYGILL E+ +
Sbjct: 200 KGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 1e-09
Identities = 58/211 (27%), Positives = 94/211 (44%), Gaps = 23/211 (10%)
Query: 692 IGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSCS 751
IG G+ G VY G VAI+ +NLQ + + + E ++ ++ N+V + S
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS-- 85
Query: 752 SIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDY 811
+ D +V EY+ GSL D E + Q ++ + AL++
Sbjct: 86 ---YLVGDELWVVMEYLAGGSLT-----------DVVTETCMDEGQIAAVCRECLQALEF 131
Query: 812 LHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTA 871
LH + ++H D+K NILL D S + DFG F +++ S V GT + A
Sbjct: 132 LHSN---QVIHRDIKSDNILLGMDGSVKLTDFG---FCAQITPEQSKRSTMV-GTPYWMA 184
Query: 872 PEYGLGSEVSTNGDVYSYGILLLEMVTAKKP 902
PE D++S GI+ +EM+ + P
Sbjct: 185 PEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 1e-09
Identities = 72/320 (22%), Positives = 133/320 (41%), Gaps = 65/320 (20%)
Query: 686 FSSTHL-----IGVGSFGCVY----KGALDEDG-IVVAIKVINLQCEGASKS-FMAECKA 734
F ++L +G G FG V+ KG +E G +V +K + + +S F E
Sbjct: 2 FPRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDM 61
Query: 735 LKNIRHRNLVKVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLT 794
+ + H+N+V+++ C + ++ EY G L+++L K +K L+
Sbjct: 62 FRKLSHKNVVRLLGLCREAEPH-----YMILEYTDLGDLKQFLRATK-SKDEKLKPPPLS 115
Query: 795 LLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSN 854
Q++++ +A +D+L + +H DL N L+ + + L++ +V N
Sbjct: 116 TKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSK---DVYN 169
Query: 855 STLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLH 914
S + + APE + ST DV+S+G+L+ E+
Sbjct: 170 SEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEV------------------ 211
Query: 915 NFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLE------CLISMVKIGV 968
F + LP + +DEE+L R+Q G +LE C + K+
Sbjct: 212 -FTQGELPFYGL--------SDEEVLN------RLQAG---KLELPVPEGCPSRLYKLMT 253
Query: 969 ACSMESPQDRMNMTNVVHEL 988
C +P+DR + + +V L
Sbjct: 254 RCWAVNPKDRPSFSELVSAL 273
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 2e-09
Identities = 71/259 (27%), Positives = 118/259 (45%), Gaps = 47/259 (18%)
Query: 692 IGVGSFGCVYKGALDED-GIVVAIKVIN--LQCEGASKSFMAECKALKNIRHRNLVKVIT 748
IG G+ G V A D GI VA+K ++ Q + +K E LK + H+N++ ++
Sbjct: 29 IGSGAQGIVC-AAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLN 87
Query: 749 SCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAID--VA 806
+ P SLE++ + V + + L Q I + +D
Sbjct: 88 V-----------------FTPQKSLEEFQDVYLVMEL-----MDANLCQVIHMELDHERM 125
Query: 807 SALDY-----LHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSV 861
S L Y + H I+H DLKPSNI++ +D + I DFGLAR +N ++ V
Sbjct: 126 SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TACTNFMMTPYV 183
Query: 862 GVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFAR--- 918
+ Y APE LG N D++S G ++ E+V V+F+G ++ + +
Sbjct: 184 VTR---YYRAPEVILGMGYKENVDIWSVGCIMGELVKGS----VIFQGTDHIDQWNKVIE 236
Query: 919 -MALPN-QVMDIVDPILRN 935
+ P+ + M+ + P +RN
Sbjct: 237 QLGTPSAEFMNRLQPTVRN 255
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 60.5 bits (146), Expect = 2e-09
Identities = 62/215 (28%), Positives = 94/215 (43%), Gaps = 25/215 (11%)
Query: 691 LIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSF---MAECKALKNIRHRNLVKVI 747
L+G G+FG V G A+K++ + A + E + LKN RH L +
Sbjct: 2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLK 61
Query: 748 TSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVAS 807
S FQ D V EY+ G L L V D+ R A ++ S
Sbjct: 62 YS-----FQTKDRLCFVMEYVNGGELFFHLSRERVFSEDR---------TRFYGA-EIVS 106
Query: 808 ALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTI 867
ALDYLH I++ DLK N++LD D I DFGL + + ++++ + GT
Sbjct: 107 ALDYLH---SGKIVYRDLKLENLMLDKDGHIKITDFGLCK--EGITDAATMKTFC--GTP 159
Query: 868 GYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKP 902
Y APE ++ D + G+++ EM+ + P
Sbjct: 160 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 2e-09
Identities = 79/258 (30%), Positives = 114/258 (44%), Gaps = 37/258 (14%)
Query: 691 LIGVGSFGCVYKGALDEDGIVVAIKVINLQC---EGASKSFMAECKAL-KNIRHRNLVKV 746
+IG GSFG V + A+KV+ + + K M+E L KN++H LV +
Sbjct: 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61
Query: 747 ITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISI-AIDV 805
S FQ D V +Y+ G L L +R++ L R A ++
Sbjct: 62 HFS-----FQTADKLYFVLDYINGGELFYHL------QRER-----CFLEPRARFYAAEI 105
Query: 806 ASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHI--GDFGLARFHQEVSNSTLSSSVGV 863
ASAL YLH I++ DLKP NILLD+ GHI DFGL + + E N T S+
Sbjct: 106 ASALGYLH---SLNIVYRDLKPENILLDS--QGHIVLTDFGLCKENIE-HNGTTSTFC-- 157
Query: 864 KGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKP-----TDVMFEGDLNLHNFAR 918
GT Y APE D + G +L EM+ P T M++ LN +
Sbjct: 158 -GTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLK 216
Query: 919 MALPNQVMDIVDPILRND 936
+ N +++ +L+ D
Sbjct: 217 PNITNSARHLLEGLLQKD 234
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 2e-09
Identities = 55/225 (24%), Positives = 107/225 (47%), Gaps = 33/225 (14%)
Query: 692 IGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASK---SFMAECKALKNIRHRNLVKVIT 748
IG G FG V + D V + V L+ +SK F+ + + ++H N+++ +
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62
Query: 749 SC-SSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVAS 807
C +I + +V+EY G L+ +L +R+ ++ LLQR+ A ++A+
Sbjct: 63 QCVEAIPY------LLVFEYCELGDLKSYLSQEQWHRRNSQL----LLLQRM--ACEIAA 110
Query: 808 ALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGL--ARFHQEVSNSTLSSSVGVKG 865
+ ++H H LH DL N L +DL+ +GD+G+ +R+ ++ + V ++
Sbjct: 111 GVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLR- 166
Query: 866 TIGYTAPEYG-------LGSEVSTNGDVYSYGILLLEMV-TAKKP 902
+ APE + +E + +V++ G+ L E+ A +P
Sbjct: 167 ---WLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQP 208
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 2e-09
Identities = 61/230 (26%), Positives = 101/230 (43%), Gaps = 34/230 (14%)
Query: 691 LIGVGSFGCVYKGALDEDGIV---VAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVI 747
LIG G FGCVY+ D + K+ NL+ E + + E NI + + +
Sbjct: 19 LIGCGGFGCVYETQCASDHCINNQAVAKIENLENE----TIVMETLVYNNIYDIDKIALW 74
Query: 748 TSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRI-------- 799
+ +ID G + +Y GS ++ + +K +E + +RI
Sbjct: 75 KNIHNIDHLG------IPKYYGCGSFKRCRMYYRFILLEKLVENTKEIFKRIKCKNKKLI 128
Query: 800 -SIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARF------HQEV 852
+I D+ + L+Y+H H I H D+KP NI++D + G+I D+G+A H E
Sbjct: 129 KNIMKDMLTTLEYIHEH---GISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEY 185
Query: 853 SNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKP 902
S +GT+ Y + G+ V+ GD+ S G +L+ K P
Sbjct: 186 SKEQKDLH---RGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLP 232
|
Length = 294 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 3e-09
Identities = 56/219 (25%), Positives = 92/219 (42%), Gaps = 27/219 (12%)
Query: 692 IGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASK---SFMAECKALKNIRHRNLVKVIT 748
IG G FG V G + V L+ F+ E + + + H N+++ +
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 749 SC-SSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVAS 807
C SI + +V E+ P G L+ +L + + +LQR+ A +VAS
Sbjct: 63 QCIESIPY------LLVLEFCPLGDLKNYLRSNRGMVAQMA---QKDVLQRM--ACEVAS 111
Query: 808 ALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTI 867
L +LH Q +H DL N L DLS IGD+GLA ++ + +
Sbjct: 112 GLLWLH---QADFIHSDLALRNCQLTADLSVKIGDYGLA--LEQYPEDYYITKDCHAVPL 166
Query: 868 GYTAPEYG-------LGSEVSTNGDVYSYGILLLEMVTA 899
+ APE L + + +++S G+ + E+ TA
Sbjct: 167 RWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTA 205
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 3e-09
Identities = 56/256 (21%), Positives = 107/256 (41%), Gaps = 36/256 (14%)
Query: 685 GFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLV 744
G++ + GS G V+ V +K+ G + + E L+N+ H +++
Sbjct: 67 GYTVIKTLTPGSEGRVFVATKPGQPDPVVLKI------GQKGTTLIEAMLLQNVNHPSVI 120
Query: 745 KVITSCSSIDFQGNDFKAIVYEYMP--NGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIA 802
++ + S AI +P + L +L KR + + I Q + I
Sbjct: 121 RMKDTLVS--------GAITCMVLPHYSSDLYTYL-----TKRSRPLPID----QALIIE 163
Query: 803 IDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVG 862
+ L YLH I+H D+K NI +++ IGD G A+F + +G
Sbjct: 164 KQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQF-----PVVAPAFLG 215
Query: 863 VKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMALP 922
+ GT+ APE + ++ D++S GI+L EM+ P+ + + + +
Sbjct: 216 LAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAY--PSTIFEDPPSTPEEYVKSC-H 272
Query: 923 NQVMDIVDPILRNDEE 938
+ ++ I+ + + EE
Sbjct: 273 SHLLKIISTLKVHPEE 288
|
Length = 357 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 3e-09
Identities = 47/159 (29%), Positives = 75/159 (47%), Gaps = 27/159 (16%)
Query: 755 FQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISI-AIDVASALDYLH 813
FQ + V EY+ G L H + + D R A ++ L +LH
Sbjct: 65 FQTKEHLFFVMEYLNGGDL--MFHIQSSGRFD---------EARARFYAAEIICGLQFLH 113
Query: 814 HHCQEPILHCDLKPSNILLDNDLSGHI--GDFGLARFHQEVSNSTLSSSVGVKGTIGYTA 871
++ I++ DLK N+LLD D GHI DFG+ + + ++ +S+ GT Y A
Sbjct: 114 ---KKGIIYRDLKLDNVLLDKD--GHIKIADFGMCK--ENMNGEGKASTFC--GTPDYIA 164
Query: 872 PEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGD 910
PE G + + + D +S+G+LL EM+ + P F G+
Sbjct: 165 PEILKGQKYNESVDWWSFGVLLYEMLIGQSP----FHGE 199
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 3e-09
Identities = 64/225 (28%), Positives = 96/225 (42%), Gaps = 44/225 (19%)
Query: 691 LIGVGSFGCVYKGALDEDGIVVAIKVI---------NLQCEGASKSFMAECKALK-NIRH 740
++G GSFG V+ L AIK + +++C M E + L H
Sbjct: 2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECT------MVEKRVLSLAWEH 55
Query: 741 RNLVKVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRIS 800
L + + FQ + V EY+ G L H + K D L R +
Sbjct: 56 PFLTHLYCT-----FQTKENLFFVMEYLNGGDL--MFHIQSCHKFD---------LPRAT 99
Query: 801 I-AIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQ--EVSNSTL 857
A ++ L +LH + I++ DLK NILLD D I DFG+ + + + T
Sbjct: 100 FYAAEIICGLQFLH---SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTF 156
Query: 858 SSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKP 902
GT Y APE LG + +T+ D +S+G+LL EM+ + P
Sbjct: 157 C------GTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 3e-09
Identities = 64/229 (27%), Positives = 100/229 (43%), Gaps = 51/229 (22%)
Query: 692 IGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSCS 751
IG G+FG VY+ + + A+KV+ + K +A+ + I RN I +
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVL------SKKEIVAKKEVAHTIGERN----ILVRT 50
Query: 752 SID-----------FQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRIS 800
+D FQ + +V +YM G L L D+ +
Sbjct: 51 LLDESPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDR---------AKFY 101
Query: 801 IAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIG--DFGLARFHQEVSNSTLS 858
IA ++ AL++LH + I++ DLKP NILLD GHI DFGL++ ++++ +
Sbjct: 102 IA-ELVLALEHLHKY---DIVYRDLKPENILLDAT--GHIALCDFGLSK--ANLTDNKTT 153
Query: 859 SSVGVKGTIGYTAPEY-----GLGSEVSTNGDVYSYGILLLEMVTAKKP 902
++ GT Y APE G V D +S G+L+ EM P
Sbjct: 154 NTFC--GTTEYLAPEVLLDEKGYTKHV----DFWSLGVLVFEMCCGWSP 196
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 3e-09
Identities = 57/216 (26%), Positives = 102/216 (47%), Gaps = 25/216 (11%)
Query: 684 NGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVI--NLQCEGASKSFMAECKALKNIRHR 741
N F ++G G++G V K E +VAIK + + E ++ + E K L+ ++
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE 60
Query: 742 NLVKVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWL-HPHAVPKRDKEIEIKLTLLQRIS 800
N+V++ + F+ +V+EY+ LE P+ VP +++ + Q I
Sbjct: 61 NIVELKEA-----FRRRGKLYLVFEYVEKNMLELLEEMPNGVPPE----KVRSYIYQLIK 111
Query: 801 IAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSS 860
A+ + H + I+H D+KP N+L+ ++ + DFG AR E SN+ +
Sbjct: 112 -------AIHWCH---KNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEY 161
Query: 861 VGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEM 896
V + Y +PE LG+ D++S G +L E+
Sbjct: 162 VATR---WYRSPELLLGAPYGKAVDMWSVGCILGEL 194
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 4e-09
Identities = 67/223 (30%), Positives = 103/223 (46%), Gaps = 30/223 (13%)
Query: 692 IGVGSFGCVYKGALDEDGIVVAIK-VINL-QCEGASKSFMAECKALKNIRHRNLVKV--I 747
IG G+FG V+ DG VA+K + N+ Q + K E K L +H N++ I
Sbjct: 8 IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDI 67
Query: 748 TSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAV-PKRDKEIEIKLTLLQRISIAIDVA 806
ID F+ I Y+ ++ LH V P+ +K+ L Q +
Sbjct: 68 LQPPHIDP----FEEI---YVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQ-------IL 113
Query: 807 SALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGT 866
L YLH ILH D+KP N+L++++ I DFGLAR +E S + V T
Sbjct: 114 RGLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARV-EEPDESKHMTQEVV--T 167
Query: 867 IGYTAPEYGLGSEVSTNG-DVYSYGILLLEMVTAKKPTDVMFE 908
Y APE +GS T+ D++S G + E++ + ++F+
Sbjct: 168 QYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRR----ILFQ 206
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 4e-09
Identities = 60/223 (26%), Positives = 89/223 (39%), Gaps = 46/223 (20%)
Query: 692 IGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKS---FMAECKALKNIRHRNLVKVIT 748
+G GSFG V G AIK + + K E L + H +V ++
Sbjct: 26 LGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMC 85
Query: 749 SCSSIDFQGNDFKAIVYEYMPNGSLEKWLH-----PHAVPKRDKEIEIKLTLLQRISIAI 803
S FQ + + E++ G L L P+ V K
Sbjct: 86 S-----FQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAK---------------FYHA 125
Query: 804 DVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGV 863
++ A +YLH + I++ DLKP N+LLDN + DFG A+ +V + T + +
Sbjct: 126 ELVLAFEYLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAK---KVPDRTFT----L 175
Query: 864 KGTIGYTAPEY----GLGSEVSTNGDVYSYGILLLEMVTAKKP 902
GT Y APE G G V D ++ G+LL E + P
Sbjct: 176 CGTPEYLAPEVIQSKGHGKAV----DWWTMGVLLYEFIAGYPP 214
|
Length = 329 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 5e-09
Identities = 72/272 (26%), Positives = 110/272 (40%), Gaps = 59/272 (21%)
Query: 678 SLLKATNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVI--NLQCEGASKSFMAECKAL 735
++ + TN + +G+G+FG V G VAIK I +K E K L
Sbjct: 4 TVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLL 63
Query: 736 KNIRHRNLVKV----ITSCSSIDF----QGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDK 787
K++RH N++ + I+ I F G D + + + LEK
Sbjct: 64 KHLRHENIISLSDIFISPLEDIYFVTELLGTDLHRL----LTSRPLEKQF---------- 109
Query: 788 EIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLAR 847
I+ L Q + L Y+H ++H DLKPSNIL++ + I DFGLAR
Sbjct: 110 ---IQYFLYQ-------ILRGLKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLAR 156
Query: 848 FHQEVSNSTLSSSVGVKGTIGYTAPEYGL-----GSEVSTNGDVYSYGILLLEMVTAKKP 902
G T Y APE L EV D++S G + EM+ K
Sbjct: 157 IQD-------PQMTGYVSTRYYRAPEIMLTWQKYDVEV----DIWSAGCIFAEMLEGKP- 204
Query: 903 TDVMFEGDLNLHNFARMA--LPNQVMDIVDPI 932
+F G +++ F+ + L D+++ I
Sbjct: 205 ---LFPGKDHVNQFSIITDLLGTPPDDVINTI 233
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 58.9 bits (143), Expect = 5e-09
Identities = 68/231 (29%), Positives = 96/231 (41%), Gaps = 35/231 (15%)
Query: 692 IGVGSFGCVYKGALDEDGIVVAIKVINLQCEGA--SKSFMAECKALKNIRHRNLVKVITS 749
IG G++G V E VAIK I + +K + E K L+++ H N++ +
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDI 72
Query: 750 CSSIDFQGNDFKA--IVYEYMPNGSLEKWLHP---HAVPKRDKEIEIKLTLLQRISIAID 804
F IVYE M LH + D + L L R
Sbjct: 73 MPPP--HREAFNDVYIVYELMDTD-----LHQIIRSSQTLSDDHCQYFLYQLLR------ 119
Query: 805 VASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVK 864
L Y+H +LH DLKPSN+LL+ + I DFGLAR ++
Sbjct: 120 ---GLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLAR----TTSEKGDFMTEYV 169
Query: 865 GTIGYTAPEYGLG-SEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLH 914
T Y APE L SE +T DV+S G + E++ +KP +F G +H
Sbjct: 170 VTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLG-RKP---LFPGKDYVH 216
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 5e-09
Identities = 69/221 (31%), Positives = 100/221 (45%), Gaps = 33/221 (14%)
Query: 691 LIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKS--FMAECKALKNIRHRNLVKV-- 746
+IG GS+G V G VAIK IN E S + + E K L+ +RH ++V++
Sbjct: 7 VIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKH 66
Query: 747 ITSCSSIDFQGNDFKAI--VYEYMPNGSLEKWLHPHAVPKRDKEI---EIKLTLLQRISI 801
I S +FK I V+E M E LH V K + ++ + L Q +
Sbjct: 67 IMLPPS----RREFKDIYVVFELM-----ESDLH--QVIKANDDLTPEHHQFFLYQLLR- 114
Query: 802 AIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSV 861
AL Y+H + H DLKP NIL + D I DFGLAR + + + +
Sbjct: 115 ------ALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD 165
Query: 862 GVKGTIGYTAPEY--GLGSEVSTNGDVYSYGILLLEMVTAK 900
V T Y APE S+ + D++S G + E++T K
Sbjct: 166 YV-ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.4 bits (142), Expect = 6e-09
Identities = 69/248 (27%), Positives = 96/248 (38%), Gaps = 60/248 (24%)
Query: 691 LIGVGSFGCVYKGALDEDGIVVAIKVINLQC---EGASKSFMAECKALKNIRHRNLVKVI 747
L+G G G V+ L G + A+KV++ + K + E + L + H L +
Sbjct: 8 LLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLY 67
Query: 748 TSCSSIDFQGNDFKAIVYEYMPNGSLEKWL--HPHAVPKRDKEIEIKLTLLQRISIAIDV 805
S FQ + +V +Y P G L + L P K E + A +V
Sbjct: 68 AS-----FQTETYLCLVMDYCPGGELFRLLQRQPG---KCLSEEVARF-------YAAEV 112
Query: 806 ASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHI--GDFGLA----------------- 846
AL+YLH I++ DLKP NILL GHI DF L+
Sbjct: 113 LLALEYLH---LLGIVYRDLKPENILLHES--GHIMLSDFDLSKQSDVEPPPVSKALRKG 167
Query: 847 ---RFHQEVSNSTLSSSVGVK-----GTIGYTAPE----YGLGSEVSTNGDVYSYGILLL 894
+ + T S + GT Y APE G GS V D ++ GILL
Sbjct: 168 SRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAV----DWWTLGILLY 223
Query: 895 EMVTAKKP 902
EM+ P
Sbjct: 224 EMLYGTTP 231
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 6e-09
Identities = 64/238 (26%), Positives = 104/238 (43%), Gaps = 52/238 (21%)
Query: 692 IGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSCS 751
+G G++G V K G ++A+K I + R L+ + S
Sbjct: 9 LGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQ-------------KRLLMDLDISMR 55
Query: 752 SID------FQGNDFKA----IVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISI 801
S+D F G F+ I E M + SL+K + DK + I +L +I
Sbjct: 56 SVDCPYTVTFYGALFREGDVWICMEVM-DTSLDK-FYKKVY---DKGLTIPEDILGKI-- 108
Query: 802 AIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSV 861
A+ + AL+YLH + ++H D+KPSN+L++ + + DFG++ L SV
Sbjct: 109 AVSIVKALEYLHS--KLSVIHRDVKPSNVLINRNGQVKLCDFGIS--------GYLVDSV 158
Query: 862 GVKGTIG---YTAPEYGLGSEVSTNG-----DVYSYGILLLEMVTAKKPTD---VMFE 908
G Y APE + E++ G DV+S GI ++E+ T + P D F+
Sbjct: 159 AKTIDAGCKPYMAPER-INPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQ 215
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|219766 pfam08263, LRRNT_2, Leucine rich repeat N-terminal domain | Back alignment and domain information |
|---|
Score = 51.9 bits (125), Expect = 7e-09
Identities = 20/40 (50%), Positives = 25/40 (62%), Gaps = 1/40 (2%)
Query: 11 DGDRAALQAFKSMIAHEPQGILNSWNDS-RHFCEWEGITC 49
+ DR AL AFKS + +P G L+SWN S C W G+TC
Sbjct: 2 NDDRDALLAFKSSLNGDPSGALSSWNPSSSDPCSWTGVTC 41
|
Leucine Rich Repeats pfam00560 are short sequence motifs present in a number of proteins with diverse functions and cellular locations. Leucine Rich Repeats are often flanked by cysteine rich domains. This domain is often found at the N-terminus of tandem leucine rich repeats. Length = 42 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 7e-09
Identities = 63/213 (29%), Positives = 95/213 (44%), Gaps = 25/213 (11%)
Query: 692 IGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKA--LKNIRHRNLVKVITS 749
+G GS+G V DG IK +NL+ + AE +A L ++H N+V S
Sbjct: 8 VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRES 67
Query: 750 CSSIDFQGND-FKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTL-LQRISIAIDVAS 807
++G D IV + G L L KE + KL Q + + +A
Sbjct: 68 -----WEGEDGLLYIVMGFCEGGDLYHKL---------KEQKGKLLPENQVVEWFVQIAM 113
Query: 808 ALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTI 867
AL YLH ++ ILH DLK N+ L +GD G+AR + + ++S+ + GT
Sbjct: 114 ALQYLH---EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLE--NQCDMAST--LIGTP 166
Query: 868 GYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAK 900
Y +PE + DV++ G + EM T K
Sbjct: 167 YYMSPELFSNKPYNYKSDVWALGCCVYEMATLK 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 8e-09
Identities = 71/269 (26%), Positives = 114/269 (42%), Gaps = 37/269 (13%)
Query: 691 LIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITS- 749
+IG G FG VY + G + A+K C + M + + L + R ++ ++++
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMK-----CLDKKRIKMKQGETLA-LNERIMLSLVSTG 54
Query: 750 ------CSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAI 803
C + F D + + M G L L H V +KE+ A
Sbjct: 55 DCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFS-EKEMRF---------YAT 104
Query: 804 DVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGV 863
++ L+++H+ +++ DLKP+NILLD I D GLA + S +SV
Sbjct: 105 EIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLA---CDFSKKKPHASV-- 156
Query: 864 KGTIGYTAPE-YGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMALP 922
GT GY APE G+ ++ D +S G +L +++ P D H RM L
Sbjct: 157 -GTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD--KHEIDRMTLT 213
Query: 923 NQVM--DIVDPILRNDEEILASTDKCRRM 949
V D P L++ E L D +R+
Sbjct: 214 VNVELPDSFSPELKSLLEGLLQRDVSKRL 242
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 9e-09
Identities = 65/227 (28%), Positives = 99/227 (43%), Gaps = 30/227 (13%)
Query: 691 LIGVGSFGCVYKGALDEDGIVVAIKVIN----LQCEGASKSFMAECKALKNIRHRNLVKV 746
++G GSFG V L V AIKV+ LQ + + M E + L +
Sbjct: 2 VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCT-MTEKRILALAAKHPFLTA 60
Query: 747 ITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVA 806
+ C FQ D V EY+ G L + + K E + A +V
Sbjct: 61 LHCC----FQTKDRLFFVMEYVNGGDLM-----FQIQRSRKFDEPRSRFY-----AAEVT 106
Query: 807 SALDYLHHHCQEPILHCDLKPSNILLDNDLSGH--IGDFGLARFHQEVSNSTLSSSVGVK 864
AL +LH H +++ DLK NILLD + GH + DFG+ + + + N +++
Sbjct: 107 LALMFLHRH---GVIYRDLKLDNILLDAE--GHCKLADFGMCK--EGILNGVTTTTFC-- 157
Query: 865 GTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDL 911
GT Y APE E + D ++ G+L+ EM+ + P + E DL
Sbjct: 158 GTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDL 204
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 1e-08
Identities = 67/230 (29%), Positives = 99/230 (43%), Gaps = 38/230 (16%)
Query: 691 LIGVGSFGCVYKGALDEDGIVVAIK-----VINLQCEGASKSFMAECKALKNIRHRNLVK 745
L+G G+FG V G A+K VI + E A + E + L+N RH L
Sbjct: 2 LLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHT--LTESRVLQNTRHPFLTA 59
Query: 746 VITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDV 805
+ S FQ +D V EY G L L V D+ R A ++
Sbjct: 60 LKYS-----FQTHDRLCFVMEYANGGELFFHLSRERVFSEDR---------ARFYGA-EI 104
Query: 806 ASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHI--GDFGLARFHQEVSNSTLSSSVGV 863
SAL YLH +++ DLK N++LD D GHI DFGL + + +S+ +
Sbjct: 105 VSALGYLH---SCDVVYRDLKLENLMLDKD--GHIKITDFGLCK--EGISDGATMKTFC- 156
Query: 864 KGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKP-----TDVMFE 908
GT Y APE ++ D + G+++ EM+ + P + +FE
Sbjct: 157 -GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFE 205
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 1e-08
Identities = 54/220 (24%), Positives = 93/220 (42%), Gaps = 24/220 (10%)
Query: 686 FSSTHLIGVGSFGCVYKGALDEDGIVVAIKVIN---LQCEGASKSFMAECKALKNIRHRN 742
F ++G G FG V + G + A K + ++ + E + L+ + +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 743 LVKVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIA 802
+V + + ++ D +V M G L+ ++ P ++E + + A
Sbjct: 62 VVNLAYA-----YETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEE--------RALFYA 108
Query: 803 IDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVG 862
++ L+ LH +E ++ DLKP NILLD+ I D GLA V S G
Sbjct: 109 AEILCGLEDLH---RENTVYRDLKPENILLDDYGHIRISDLGLA-----VKIPEGESIRG 160
Query: 863 VKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKP 902
GT+GY APE + + D + G L+ EM+ + P
Sbjct: 161 RVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 1e-08
Identities = 39/103 (37%), Positives = 53/103 (51%), Gaps = 12/103 (11%)
Query: 802 AIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGH--IGDFGLARFHQEVSNSTLSS 859
A ++ L+ LH +E I++ DLKP NILLD+ GH I D GLA E T+
Sbjct: 108 AAEITCGLEDLH---RERIVYRDLKPENILLDD--YGHIRISDLGLAVEIPE--GETIRG 160
Query: 860 SVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKP 902
V GT+GY APE + + D + G L+ EM+ K P
Sbjct: 161 RV---GTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 2e-08
Identities = 34/94 (36%), Positives = 52/94 (55%), Gaps = 3/94 (3%)
Query: 202 ILAIGGNN--LSGPIPPSIYNLSFLVVFSVSHNQIHGSLPPSLGLLLPNLKFFQIHHNFF 259
I +G +N L G IP I L L ++S N I G++PPSLG + +L+ + +N F
Sbjct: 420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSI-TSLEVLDLSYNSF 478
Query: 260 SGSIPISLSNASKLEHIEIANNNFSGKLSVNFGG 293
+GSIP SL + L + + N+ SG++ GG
Sbjct: 479 NGSIPESLGQLTSLRILNLNGNSLSGRVPAALGG 512
|
Length = 623 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 2e-08
Identities = 63/242 (26%), Positives = 115/242 (47%), Gaps = 39/242 (16%)
Query: 686 FSSTHLIGVGSFGCVY---KGALDEDGIVVAIKVIN----LQCEGASKSFMAECKALKNI 738
F ++G G++G V+ K + + G + A+KV+ +Q ++ E + L++I
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 61
Query: 739 RHRNLVKVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPK-RDKEIEIKLTLLQ 797
R + + FQ + ++ +Y+ G L H + R KE E+++ +
Sbjct: 62 RQSPFLVTLHYA----FQTDTKLHLILDYINGGEL----FTHLSQRERFKEQEVQIYSGE 113
Query: 798 RISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHI--GDFGLAR-FHQEVSN 854
+ AL++LH + I++ D+K NILLD++ GH+ DFGL++ FH++
Sbjct: 114 -------IVLALEHLH---KLGIIYRDIKLENILLDSN--GHVVLTDFGLSKEFHEDEVE 161
Query: 855 STLSSSVGVKGTIGYTAPEYGLGSEVSTNG--DVYSYGILLLEMVTAKKPTDVMFEGDLN 912
S GTI Y AP+ G + + D +S G+L+ E++T P V +G+ N
Sbjct: 162 RAYS----FCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTV--DGEKN 215
Query: 913 LH 914
Sbjct: 216 SQ 217
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 2e-08
Identities = 63/237 (26%), Positives = 99/237 (41%), Gaps = 40/237 (16%)
Query: 686 FSSTHLIGVGSFGCVYKGALDEDGIVVAIKVI---------NLQCEGASKSFMAECKALK 736
F+ ++G GSFG V + AIK++ +++C M E + L
Sbjct: 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECT------MVEKRVLA 55
Query: 737 NIRHRNLVKVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLL 796
+ + SC FQ D V EY+ G L H V K +
Sbjct: 56 LQDKPPFLTQLHSC----FQTVDRLYFVMEYVNGGDL--MYHIQQVGKFKEP-------- 101
Query: 797 QRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFH--QEVSN 854
Q + A +++ L +LH + I++ DLK N++LD++ I DFG+ + H V+
Sbjct: 102 QAVFYAAEISVGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTT 158
Query: 855 STLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDL 911
T GT Y APE + D ++YG+LL EM+ + P D E +L
Sbjct: 159 RTFC------GTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDEL 209
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 3e-08
Identities = 76/271 (28%), Positives = 116/271 (42%), Gaps = 41/271 (15%)
Query: 691 LIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITS- 749
+IG G FG VY + G + A+K C + M + + L + R ++ ++++
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMK-----CLDKKRIKMKQGETLA-LNERIMLSLVSTG 54
Query: 750 ------CSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAI 803
C S F D + + + M G L L H V E E++ A
Sbjct: 55 DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGV---FSEAEMRF-------YAA 104
Query: 804 DVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGH--IGDFGLARFHQEVSNSTLSSSV 861
++ L+++H+ +++ DLKP+NILLD GH I D GLA + S +SV
Sbjct: 105 EIILGLEHMHNRF---VVYRDLKPANILLDE--HGHVRISDLGLA---CDFSKKKPHASV 156
Query: 862 GVKGTIGYTAPE-YGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMA 920
GT GY APE G ++ D +S G +L +++ P D H RM
Sbjct: 157 ---GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD--KHEIDRMT 211
Query: 921 LPNQVM--DIVDPILRNDEEILASTDKCRRM 949
L V D P LR+ E L D RR+
Sbjct: 212 LTMAVELPDSFSPELRSLLEGLLQRDVNRRL 242
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 3e-08
Identities = 59/229 (25%), Positives = 99/229 (43%), Gaps = 34/229 (14%)
Query: 686 FSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVK 745
F IG G++G VYK G + AIKVI L+ E +K+ +H N+V
Sbjct: 11 FELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVA 70
Query: 746 VITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDV 805
S + D I E+ GSL+ H + L+ Q ++ +
Sbjct: 71 YFGS-----YLRRDKLWICMEFCGGGSLQDIYH----------VTGPLSESQIAYVSRET 115
Query: 806 ASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKG 865
L YLH + +H D+K +NILL ++ + DFG++ +++ +T++ G
Sbjct: 116 LQGLYYLHSKGK---MHRDIKGANILLTDNGHVKLADFGVS---AQIT-ATIAKRKSFIG 168
Query: 866 TIGYTAPEYGLGSEVSTNG------DVYSYGILLLEMVTAKKPTDVMFE 908
T + APE + V G D+++ GI +E+ + P MF+
Sbjct: 169 TPYWMAPEV---AAVERKGGYNQLCDIWAVGITAIELAELQPP---MFD 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 3e-08
Identities = 65/224 (29%), Positives = 103/224 (45%), Gaps = 39/224 (17%)
Query: 692 IGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSCS 751
+G G++G VYK G+ +A+K I L+ + + F L +I H+ + I
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESK--FNQIIMEL-DILHKAVSPYI---- 61
Query: 752 SIDFQGNDF-KAIVY---EYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVAS 807
+DF G F + VY EYM GSL+K + E +L+RI+ A V
Sbjct: 62 -VDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPE-----DVLRRITYA--VVK 113
Query: 808 ALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTI 867
L +L + I+H D+KP+N+L++ + + DFG++ L +S+ K I
Sbjct: 114 GLKFLKE--EHNIIHRDVKPTNVLVNGNGQVKLCDFGVS--------GNLVASLA-KTNI 162
Query: 868 G---YTAPEYGLGSEVSTNG------DVYSYGILLLEMVTAKKP 902
G Y APE + N DV+S G+ +LEM + P
Sbjct: 163 GCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYP 206
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 3e-08
Identities = 57/215 (26%), Positives = 93/215 (43%), Gaps = 25/215 (11%)
Query: 691 LIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSF---MAECKALKNIRHRNLVKVI 747
L+G G+FG V G A+K++ + A + E + L+N RH L +
Sbjct: 2 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 61
Query: 748 TSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVAS 807
+ FQ +D V EY G L L V ++ R A ++ S
Sbjct: 62 YA-----FQTHDRLCFVMEYANGGELFFHLSRERVFTEER---------ARFYGA-EIVS 106
Query: 808 ALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTI 867
AL+YLH +++ D+K N++LD D I DFGL + + +S+ + GT
Sbjct: 107 ALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFC--GTP 159
Query: 868 GYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKP 902
Y APE ++ D + G+++ EM+ + P
Sbjct: 160 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 3e-08
Identities = 54/162 (33%), Positives = 82/162 (50%), Gaps = 27/162 (16%)
Query: 692 IGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFM----AECKALKNIRHRNLVKVI 747
I G+FG VY G + + A+KV+ + + +K+ + AE AL + +V +
Sbjct: 12 ISRGAFGKVYLGRKKNNSKLYAVKVVK-KADMINKNMVHQVQAERDALALSKSPFIVHLY 70
Query: 748 TSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVAS 807
S Q + +V EY+ G ++ LH + D+E+ +K IS +VA
Sbjct: 71 YS-----LQSANNVYLVMEYLIGGDVKSLLHIYGY--FDEEMAVKY-----IS---EVAL 115
Query: 808 ALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIG--DFGLAR 847
ALDYLH H I+H DLKP N+L+ N GHI DFGL++
Sbjct: 116 ALDYLHRH---GIIHRDLKPDNMLISN--EGHIKLTDFGLSK 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 4e-08
Identities = 74/271 (27%), Positives = 119/271 (43%), Gaps = 64/271 (23%)
Query: 691 LIGVGSFGCVY---KGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNI----RHRNL 743
++G G +G V+ K + G + A+KV+ ++ A KA +NI +H +
Sbjct: 3 VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFI 62
Query: 744 VKVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAI 803
V +I + FQ ++ EY+ G L L+R I +
Sbjct: 63 VDLIYA-----FQTGGKLYLILEYLSGGEL-------------------FMHLEREGIFM 98
Query: 804 -DVAS--------ALDYLHHHCQEPILHCDLKPSNILLDNDLSGHI--GDFGLARFHQEV 852
D A AL++LH Q+ I++ DLKP NILLD GH+ DFGL + + +
Sbjct: 99 EDTACFYLSEISLALEHLH---QQGIIYRDLKPENILLDA--QGHVKLTDFGLCK--ESI 151
Query: 853 SNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTA---------KKPT 903
T++ + GTI Y APE + S D +S G L+ +M+T KK
Sbjct: 152 HEGTVTHTFC--GTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTI 209
Query: 904 DVMFEGDLNLHNFARMALPNQVMDIVDPILR 934
D + +G LNL + L + D++ +L+
Sbjct: 210 DKILKGKLNLPPY----LTPEARDLLKKLLK 236
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 4e-08
Identities = 34/105 (32%), Positives = 57/105 (54%), Gaps = 9/105 (8%)
Query: 793 LTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEV 852
L L Q ++A + SA+DY+H E I+H D+K N+L++ +GDFG A F +
Sbjct: 257 LGLAQVTAVARQLLSAIDYIH---GEGIIHRDIKTENVLVNGPEDICLGDFGAACFAR-- 311
Query: 853 SNSTLSSSV--GVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLE 895
+ S+ G+ GT+ APE G + + D++S G+++ E
Sbjct: 312 --GSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 4e-08
Identities = 60/229 (26%), Positives = 98/229 (42%), Gaps = 40/229 (17%)
Query: 691 LIGVGSFGCVYKGALDEDGIVVAIKVI---------NLQCEGASKSFMAECKALKNIRHR 741
++G GSFG V L G A+K + +++C K +A + H
Sbjct: 2 VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTH- 60
Query: 742 NLVKVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISI 801
C+ FQ + V E++ G L + +DK + L +
Sbjct: 61 ------LYCT---FQTKEHLFFVMEFLNGGDLMFHI-------QDKG---RFDLYRATFY 101
Query: 802 AIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSV 861
A ++ L +LH + I++ DLK N++LD D I DFG+ + + V +S+
Sbjct: 102 AAEIVCGLQFLH---SKGIIYRDLKLDNVMLDRDGHIKIADFGMCK--ENVFGDNRASTF 156
Query: 862 GVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGD 910
GT Y APE G + + + D +S+G+LL EM+ + P F GD
Sbjct: 157 C--GTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSP----FHGD 199
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 4e-08
Identities = 62/233 (26%), Positives = 90/233 (38%), Gaps = 49/233 (21%)
Query: 692 IGVGSFGCVYKGALDEDGIVVAIKVI------------NLQCEGASKSFMAECKALKNIR 739
+G G FG V + G + AIK + +L CE + F R
Sbjct: 7 LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCE--KRIFETANSE----R 60
Query: 740 HRNLVKVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRI 799
H LV + +C FQ D V EY G L +H + + +
Sbjct: 61 HPFLVNLF-AC----FQTEDHVCFVMEYAAGGDLMMHIHTDVFSEP-----------RAV 104
Query: 800 SIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGH--IGDFGLARFHQEVSNSTL 857
A V L YLH + I++ DLK N+LLD + G I DFGL + + T
Sbjct: 105 FYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTE--GFVKIADFGLCKEGMGFGDRTS 159
Query: 858 SSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGD 910
+ GT + APE + + D + G+L+ EM+ + P F GD
Sbjct: 160 TFC----GTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESP----FPGD 204
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 4e-08
Identities = 58/223 (26%), Positives = 95/223 (42%), Gaps = 34/223 (15%)
Query: 692 IGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSCS 751
+G G++G VYK G + A+K+I L+ E +K +H N+V S
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGS-- 74
Query: 752 SIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDY 811
+ + I EY GSL+ H + L+ LQ + + L Y
Sbjct: 75 ---YLSREKLWICMEYCGGGSLQDIYH----------VTGPLSELQIAYVCRETLQGLAY 121
Query: 812 LHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTA 871
LH + +H D+K +NILL ++ + DFG+A +T++ GT + A
Sbjct: 122 LHSKGK---MHRDIKGANILLTDNGDVKLADFGVA----AKITATIAKRKSFIGTPYWMA 174
Query: 872 PEYGLGSEVSTNG------DVYSYGILLLEMVTAKKPTDVMFE 908
PE + V NG D+++ GI +E+ + P MF+
Sbjct: 175 PEV---AAVEKNGGYNQLCDIWAVGITAIELAELQPP---MFD 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 55.9 bits (134), Expect = 4e-08
Identities = 66/231 (28%), Positives = 101/231 (43%), Gaps = 48/231 (20%)
Query: 692 IGVGSFGCV---YKGALDEDGIVVAIKVIN--LQCEGASKSFMAECKALKNIRHRNLVKV 746
IG G+ G V Y LD + VAIK ++ Q + +K E +K + H+N++ +
Sbjct: 25 IGSGAQGIVCAAYDAVLDRN---VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISL 81
Query: 747 ITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVA 806
+ + P SLE++ + V + + L Q I + +D
Sbjct: 82 LNV-----------------FTPQKSLEEFQDVYLVMEL-----MDANLCQVIQMELD-H 118
Query: 807 SALDYL--------HHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLS 858
+ YL H I+H DLKPSNI++ +D + I DFGLAR S +
Sbjct: 119 ERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMM 175
Query: 859 SSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEG 909
+ V T Y APE LG N D++S G ++ EMV K ++F G
Sbjct: 176 TPYVV--TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK----ILFPG 220
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 5e-08
Identities = 63/229 (27%), Positives = 106/229 (46%), Gaps = 35/229 (15%)
Query: 686 FSSTHLIGVGSFGCVY---KGALDEDGIVVAIKVIN----LQCEGASKSFMAECKALKNI 738
F ++G G++G V+ K + G + A+KV+ +Q ++ E + L+ +
Sbjct: 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAV 61
Query: 739 RHRN-LVKVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQ 797
R LV + + FQ + ++ +Y+ G L L+ + E E+
Sbjct: 62 RRCPFLVTLHYA-----FQTDTKLHLILDYVNGGELFTHLYQR---EHFTESEV------ 107
Query: 798 RISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHI--GDFGLARFHQEVSNS 855
R+ IA ++ ALD+LH Q I++ D+K NILLD++ GH+ DFGL++ E
Sbjct: 108 RVYIA-EIVLALDHLH---QLGIIYRDIKLENILLDSE--GHVVLTDFGLSK---EFLAE 158
Query: 856 TLSSSVGVKGTIGYTAPEYGLGSEVSTNG--DVYSYGILLLEMVTAKKP 902
+ GTI Y APE G + D +S G+L E++T P
Sbjct: 159 EEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 6e-08
Identities = 63/211 (29%), Positives = 94/211 (44%), Gaps = 26/211 (12%)
Query: 692 IGVGSFGCVY----KGALDEDGIVVAIKVINLQCEGASKSFMA--ECKALKNIRHRNLVK 745
+G GSFG VY K A+ E+ + V +K I + +++ A E + L + H +VK
Sbjct: 8 LGKGSFGTVYLVKDKKAVAEERLKV-LKEIPVGELNPNETVQANQEAQLLSKLDHPAIVK 66
Query: 746 VITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDV 805
S F D I+ EY L+ L K L+ Q I +
Sbjct: 67 FHAS-----FLERDAFCIITEYCEGRDLDCKLEEL------KHTGKTLSENQVCEWFIQL 115
Query: 806 ASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKG 865
+ Y+H Q ILH DLK NI L N+L IGDFG++R + + L+++ G
Sbjct: 116 LLGVHYMH---QRRILHRDLKAKNIFLKNNLL-KIGDFGVSRLL--MGSCDLATT--FTG 167
Query: 866 TIGYTAPEYGLGSEVSTNGDVYSYGILLLEM 896
T Y +PE + D++S G +L EM
Sbjct: 168 TPYYMSPEALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 7e-08
Identities = 52/196 (26%), Positives = 90/196 (45%), Gaps = 26/196 (13%)
Query: 712 VAIKVINLQC---EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKAIVYEYM 768
VA+KV L+ + A + F+ E K L + N+ +++ C+ + ++ EYM
Sbjct: 49 VAVKV--LRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTV-----DPPLCMIMEYM 101
Query: 769 PNGSLEKWLHPHAVPKRDKEIEIKLTLLQR--ISIAIDVASALDYLHHHCQEPILHCDLK 826
NG L ++L H V + +L + +A +AS + YL +H DL
Sbjct: 102 ENGDLNQFLQKH-VAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLA 157
Query: 827 PSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGT----IGYTAPEYGLGSEVST 882
N L+ + + I DFG++R N S V+G I + A E L + +T
Sbjct: 158 TRNCLVGKNYTIKIADFGMSR------NLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTT 211
Query: 883 NGDVYSYGILLLEMVT 898
DV+++G+ L E++T
Sbjct: 212 KSDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 8e-08
Identities = 37/118 (31%), Positives = 64/118 (54%), Gaps = 12/118 (10%)
Query: 802 AIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIG--DFGLARFHQEVSNSTLSS 859
A ++ AL++LH + I++ DLK N+LLD D GHI D+G+ + ++T +
Sbjct: 102 AAEICIALNFLH---ERGIIYRDLKLDNVLLDAD--GHIKLTDYGMCKEGLGPGDTTSTF 156
Query: 860 SVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEG-DLNLHNF 916
GT Y APE G E + D ++ G+L+ EM+ + P D++ + D+N ++
Sbjct: 157 C----GTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDY 210
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 9e-08
Identities = 60/215 (27%), Positives = 94/215 (43%), Gaps = 24/215 (11%)
Query: 691 LIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSF---MAECKALKNIRHRNLVKVI 747
L+G G+FG V G A+K++ + A + E + L+N RH L +
Sbjct: 2 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 61
Query: 748 TSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVAS 807
S FQ +D V EY G L L V D+ R A ++ S
Sbjct: 62 YS-----FQTHDRLCFVMEYANGGELFFHLSRERVFSEDR---------ARFYGA-EIVS 106
Query: 808 ALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTI 867
ALDYLH ++ +++ DLK N++LD D I DFGL + + + + + GT
Sbjct: 107 ALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTFC--GTP 160
Query: 868 GYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKP 902
Y APE ++ D + G+++ EM+ + P
Sbjct: 161 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 9e-08
Identities = 60/245 (24%), Positives = 103/245 (42%), Gaps = 31/245 (12%)
Query: 669 KALPKMSYKSLLKATNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSF 728
++L + +L F ++G G++G VYKG + G + AIKV+++ E +
Sbjct: 1 RSLDDIDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-EDEEEEI 59
Query: 729 MAECKALKNI-RHRNLVKVITSCSSIDFQGNDFKA-IVYEYMPNGSLEKWLHPHAVPKRD 786
E LK HRN+ + G+D + +V E+ GS+ + K
Sbjct: 60 KLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLV------KNT 113
Query: 787 KEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLA 846
K +K + I ++ L +LH H ++H D+K N+LL + + DFG++
Sbjct: 114 KGNALKEDWIAYIC--REILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVS 168
Query: 847 RFHQEVSNSTLSSSVGVK----GTIGYTAPEY-----GLGSEVSTNGDVYSYGILLLEMV 897
+ L +VG + GT + APE + D++S GI +EM
Sbjct: 169 --------AQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMA 220
Query: 898 TAKKP 902
P
Sbjct: 221 EGAPP 225
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 9e-08
Identities = 37/97 (38%), Positives = 52/97 (53%), Gaps = 11/97 (11%)
Query: 808 ALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIG--DFGLARFHQEVSNSTLSSSVGVKG 865
AL+ LH + +++ DLKP NILLD GHI DFGL + + + + T + G
Sbjct: 105 ALENLH---KFNVIYRDLKPENILLD--YQGHIALCDFGLCKLNMKDDDKTNTFC----G 155
Query: 866 TIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKP 902
T Y APE LG + D ++ G+LL EM+T P
Sbjct: 156 TPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPP 192
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 9e-08
Identities = 66/241 (27%), Positives = 101/241 (41%), Gaps = 62/241 (25%)
Query: 686 FSSTHLIGVGSFGCVY----KGALDEDGIVVAIKVI---------NLQCEGASKSFMAEC 732
F+ ++G GSFG V KG DE + AIK++ +++C M E
Sbjct: 2 FNFLMVLGKGSFGKVMLAERKGT-DE---LYAIKILKKDVIIQDDDVECT------MVEK 51
Query: 733 KALKNIRHRNLVKVITSCSSIDFQGNDFKAIVYEYMPNGSLE-------KWLHPHAVPKR 785
+ L + + SC FQ D V EY+ G L K+ PHAV
Sbjct: 52 RVLALPGKPPFLTQLHSC----FQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAV--- 104
Query: 786 DKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGH--IGDF 843
A ++A L +LH + I++ DLK N++LD + GH I DF
Sbjct: 105 --------------FYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDAE--GHIKIADF 145
Query: 844 GLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPT 903
G+ + + +T + GT Y APE + D +++G+LL EM+ + P
Sbjct: 146 GMCKENIFGGKTTRTFC----GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPF 201
Query: 904 D 904
D
Sbjct: 202 D 202
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 1e-07
Identities = 52/192 (27%), Positives = 83/192 (43%), Gaps = 18/192 (9%)
Query: 712 VAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKAIVYEYMPNG 771
V K + L E + +E L H +VK DF+ +D ++ EY G
Sbjct: 96 VVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFD-----DFKSDDKLLLIMEYGSGG 150
Query: 772 SLEKWLHPHAVPKRD-KEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNI 830
L K + +E E+ L Q + ALD +H ++H DLK +NI
Sbjct: 151 DLNKQIKQRLKEHLPFQEYEVGLLFYQ-------IVLALDEVHSRK---MMHRDLKSANI 200
Query: 831 LLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYG 890
L +GDFG ++ + + + ++SS GT Y APE S D++S G
Sbjct: 201 FLMPTGIIKLGDFGFSKQYSDSVSLDVASSFC--GTPYYLAPELWERKRYSKKADMWSLG 258
Query: 891 ILLLEMVTAKKP 902
++L E++T +P
Sbjct: 259 VILYELLTLHRP 270
|
Length = 478 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 53.9 bits (130), Expect = 1e-07
Identities = 35/108 (32%), Positives = 52/108 (48%), Gaps = 15/108 (13%)
Query: 801 IAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIG--DFGLARFHQEVSNSTLS 858
+ + + AL YL + ++H D+KPSNILL D SG++ DFG++ + T S
Sbjct: 119 MTVAIVKALHYLKE--KHGVIHRDVKPSNILL--DASGNVKLCDFGISGRLVDSKAKTRS 174
Query: 859 SSVGVKGTIGYTAPEY----GLGSEVSTNGDVYSYGILLLEMVTAKKP 902
G Y APE + DV+S GI L+E+ T + P
Sbjct: 175 -----AGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFP 217
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 1e-07
Identities = 49/188 (26%), Positives = 81/188 (43%), Gaps = 25/188 (13%)
Query: 723 GASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAV 782
G E L+ I H +++++ + F N F ++ +P + L+ +
Sbjct: 125 GQRGGTATEAHILRAINHPSIIQLKGT-----FTYNKFTCLI---LPRYKTD--LYCYLA 174
Query: 783 PKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGD 842
KR + + ++I V A+ YLH + I+H D+K NI +++ +GD
Sbjct: 175 AKR------NIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGD 225
Query: 843 FGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKP 902
FG A F ++ + G GTI APE D++S GI+L EM T
Sbjct: 226 FGAACFPVDI---NANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH-- 280
Query: 903 TDVMFEGD 910
D +FE D
Sbjct: 281 -DSLFEKD 287
|
Length = 391 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 2e-07
Identities = 59/215 (27%), Positives = 107/215 (49%), Gaps = 28/215 (13%)
Query: 690 HLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITS 749
++IG GSFG VY+ + VAIK + + ++ + +KN+ H N++ +
Sbjct: 72 NIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLI----MKNLNHINIIFLKDY 127
Query: 750 CSSIDFQGND---FKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVA 806
+ F+ N+ F +V E++P ++ K++ +A + + + + L L + +
Sbjct: 128 YYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYA--RNNHALPLFLVKL----YSYQLC 180
Query: 807 SALDYLHHHCQEPILHCDLKPSNILLD-NDLSGHIGDFGLAR--FHQEVSNSTLSSSVGV 863
AL Y+H + I H DLKP N+L+D N + + DFG A+ + S S + S
Sbjct: 181 RALAYIH---SKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRF-- 235
Query: 864 KGTIGYTAPEYGLGS-EVSTNGDVYSYGILLLEMV 897
Y APE LG+ +T+ D++S G ++ EM+
Sbjct: 236 -----YRAPELMLGATNYTTHIDLWSLGCIIAEMI 265
|
Length = 440 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 2e-07
Identities = 66/234 (28%), Positives = 102/234 (43%), Gaps = 54/234 (23%)
Query: 692 IGVGSFGCV---YKGALDEDGIVVAIKVIN--LQCEGASKSFMAECKALKNIRHRNLVKV 746
IG G+ G V Y L+ + VAIK ++ Q + +K E +K + H+N++ +
Sbjct: 32 IGSGAQGIVCAAYDAILERN---VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGL 88
Query: 747 ITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKL---TLLQRISIAI 803
+ + P SLE++ +D I ++L L Q I + +
Sbjct: 89 LNV-----------------FTPQKSLEEF--------QDVYIVMELMDANLCQVIQMEL 123
Query: 804 DVASALDYL--------HHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNS 855
D + YL H I+H DLKPSNI++ +D + I DFGLAR S
Sbjct: 124 D-HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTS 179
Query: 856 TLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEG 909
+ + V T Y APE LG N D++S G ++ EM+ V+F G
Sbjct: 180 FMMTPYVV--TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG----VLFPG 227
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 3e-07
Identities = 61/229 (26%), Positives = 92/229 (40%), Gaps = 31/229 (13%)
Query: 684 NGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASK--SFMAECKALKNIRHR 741
F L+G G FG V G + A+KV+ A + SF E ++I
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEE---ERDILSI 57
Query: 742 NLVKVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISI 801
+ I FQ D +V EY P G L L+ + + + L + +
Sbjct: 58 SNSPWIPQLQYA-FQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLA---ELVL 113
Query: 802 AIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHI--GDFGLARFHQEVSNSTLSS 859
AI + Y+H D+KP N+L+D +GHI DFG A + +N ++S
Sbjct: 114 AIHSVHQMGYVHR---------DIKPENVLIDR--TGHIKLADFGSAA--RLTANKMVNS 160
Query: 860 SVGVKGTIGYTAPEYGLGSEVSTNG------DVYSYGILLLEMVTAKKP 902
+ V GT Y APE G D +S G++ EM+ + P
Sbjct: 161 KLPV-GTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSP 208
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 3e-07
Identities = 52/204 (25%), Positives = 93/204 (45%), Gaps = 32/204 (15%)
Query: 710 IVVAIKVINLQC-EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKAIVYEYM 768
++VA+K++ + A F+ E K L ++ N+++++ C D ++ EYM
Sbjct: 47 LLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVD-----EDPLCMITEYM 101
Query: 769 PNGSLEKWLHPH-----------AVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQ 817
NG L ++L H AVP I + L + +A+ +AS + YL
Sbjct: 102 ENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSL--LHVALQIASGMKYL---SS 156
Query: 818 EPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKG----TIGYTAPE 873
+H DL N L+ +L+ I DFG++R N ++G I + A E
Sbjct: 157 LNFVHRDLATRNCLVGENLTIKIADFGMSR------NLYAGDYYRIQGRAVLPIRWMAWE 210
Query: 874 YGLGSEVSTNGDVYSYGILLLEMV 897
L + +T DV+++G+ L E++
Sbjct: 211 CILMGKFTTASDVWAFGVTLWEIL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 3e-07
Identities = 58/222 (26%), Positives = 97/222 (43%), Gaps = 28/222 (12%)
Query: 686 FSSTHLIGVGSFGCVYKGALDEDGIVVAIKVIN---LQCEGASKSFMAECKALKNIRHRN 742
F ++G G FG V + G + A K + ++ + E + L+ + R
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61
Query: 743 LVKVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIA 802
+V + + ++ D +V M G L+ ++ P D++ + I A
Sbjct: 62 VVSL-----AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQ--------RAIFYA 108
Query: 803 IDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGH--IGDFGLARFHQEVSNSTLSSS 860
++ L+ L +E I++ DLKP NILLD+ GH I D GLA Q T+
Sbjct: 109 AELCCGLEDLQ---RERIVYRDLKPENILLDD--RGHIRISDLGLAV--QIPEGETVRGR 161
Query: 861 VGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKP 902
V GT+GY APE + + + D + G L+ EM+ + P
Sbjct: 162 V---GTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 4e-07
Identities = 26/69 (37%), Positives = 43/69 (62%)
Query: 54 RRVTALDLMSKSLSGSLSPHLGNLSFLREINLSNNTIQGEIPPEFGRLFRLEALFLSNNS 113
R + +++L S+ G++ P LG+++ L ++LS N+ G IP G+L L L L+ NS
Sbjct: 442 RHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNS 501
Query: 114 LVGKIPANL 122
L G++PA L
Sbjct: 502 LSGRVPAAL 510
|
Length = 623 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 4e-07
Identities = 55/238 (23%), Positives = 100/238 (42%), Gaps = 27/238 (11%)
Query: 692 IGVGSFGCVYKGALDEDGI--VVAIKVINLQCEGAS--KSFMAECKALKNIRHRNLVKVI 747
+G G+FG V KG VA+K++ + + E ++ + + +V++I
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 748 TSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVAS 807
C + + +V E G L K+L +++K + K + V+
Sbjct: 63 GICEAESWM------LVMELAELGPLNKFL------QKNKHVTEK----NITELVHQVSM 106
Query: 808 ALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTI 867
+ YL +H DL N+LL I DFGL++ N + + G K +
Sbjct: 107 GMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHG-KWPV 162
Query: 868 GYTAPEYGLGSEVSTNGDVYSYGILLLEMVT-AKKPTDVMFEGDLN--LHNFARMALP 922
+ APE + S+ DV+S+G+L+ E + +KP M ++ + + RM P
Sbjct: 163 KWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECP 220
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 52.8 bits (126), Expect = 4e-07
Identities = 71/254 (27%), Positives = 110/254 (43%), Gaps = 31/254 (12%)
Query: 686 FSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVK 745
F +IG G+FG V L V A+K++N + E ++ A + +++ +
Sbjct: 3 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILN-KWEMLKRAETACFREERDVLVNGDNQ 61
Query: 746 VITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDV 805
IT+ FQ + +V +Y G L L R E + L + + IAID
Sbjct: 62 WITTLHYA-FQDENNLYLVMDYYVGGDLLTLLS--KFEDRLPEDMARFYLAEMV-IAIDS 117
Query: 806 ASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHI--GDFGLARFHQEVSNSTLSSSVGV 863
L Y+H D+KP NIL+ D++GHI DFG + + + T+ SSV V
Sbjct: 118 VHQLHYVHR---------DIKPDNILM--DMNGHIRLADFGSCL--KLMEDGTVQSSVAV 164
Query: 864 KGTIGYTAPEYGLGSE-----VSTNGDVYSYGILLLEMVTAKKP--TDVMFE--GDLNLH 914
GT Y +PE E D +S G+ + EM+ + P + + E G + H
Sbjct: 165 -GTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNH 223
Query: 915 NFARMALPNQVMDI 928
R P QV D+
Sbjct: 224 K-ERFQFPAQVTDV 236
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 6e-07
Identities = 53/208 (25%), Positives = 81/208 (38%), Gaps = 32/208 (15%)
Query: 697 FGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQ 756
F C G DE V +K + K+ E LK I HR ++ +I +
Sbjct: 109 FVCTKHG--DEQRKKVIVKAVT-----GGKTPGREIDILKTISHRAIINLIHAYR----- 156
Query: 757 GNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIK--LTLLQRISIAIDVASALDYLHH 814
+K+ V MP + + + ++ L L Q I+I + AL YLH
Sbjct: 157 ---WKSTVCMVMPKYKCDLFTY----------VDRSGPLPLEQAITIQRRLLEALAYLH- 202
Query: 815 HCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEY 874
I+H D+K NI LD + +GDFG A ++ G GT+ +PE
Sbjct: 203 --GRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDT--PQCYGWSGTLETNSPEL 258
Query: 875 GLGSEVSTNGDVYSYGILLLEMVTAKKP 902
D++S G++L EM
Sbjct: 259 LALDPYCAKTDIWSAGLVLFEMSVKNVT 286
|
Length = 392 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 6e-07
Identities = 49/198 (24%), Positives = 94/198 (47%), Gaps = 22/198 (11%)
Query: 708 DGIVVAIKVINLQC-EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKAIVYE 766
++VA+K++ + A F+ E K + ++ N+++++ C + +D ++ E
Sbjct: 45 QPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCIT-----SDPLCMITE 99
Query: 767 YMPNGSLEKWLHPHAVPKRDKEIEIKLTL--LQRISIAIDVASALDYLHHHCQEPILHCD 824
YM NG L ++L H P+ E +T+ I +A +AS + YL +H D
Sbjct: 100 YMENGDLNQFLSRHE-PQEAAEKADVVTISYSTLIFMATQIASGMKYLS---SLNFVHRD 155
Query: 825 LKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKG----TIGYTAPEYGLGSEV 880
L N L+ + + I DFG++R N ++G I + + E L +
Sbjct: 156 LATRNCLVGKNYTIKIADFGMSR------NLYSGDYYRIQGRAVLPIRWMSWESILLGKF 209
Query: 881 STNGDVYSYGILLLEMVT 898
+T DV+++G+ L E++T
Sbjct: 210 TTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 7e-07
Identities = 34/109 (31%), Positives = 59/109 (54%), Gaps = 11/109 (10%)
Query: 804 DVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIG--DFGLARFHQEVSNSTLSSSV 861
+++ AL+YLH + I++ DLK N+LLD++ GHI D+G+ + ++T
Sbjct: 104 EISLALNYLH---ERGIIYRDLKLDNVLLDSE--GHIKLTDYGMCKEGLRPGDTT----S 154
Query: 862 GVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGD 910
GT Y APE G + + D ++ G+L+ EM+ + P D++ D
Sbjct: 155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSD 203
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 7e-07
Identities = 68/264 (25%), Positives = 102/264 (38%), Gaps = 71/264 (26%)
Query: 684 NGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNI---RH 740
+ F S +IG G+FG V + G + A+K + + E K +A +A ++I
Sbjct: 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKL-RKSEMLEKEQVAHVRAERDILAEAD 59
Query: 741 RNLVKVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIE------IKLT 794
V V S FQ ++ ++ EY+P G + L K+D E I T
Sbjct: 60 NPWV-VKLYYS---FQDENYLYLIMEYLPGGDMMTLLM-----KKDTFTEEETRFYIAET 110
Query: 795 LLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHI--GDFGLA----RF 848
+L AID L Y+H D+KP N+LLD GHI DFGL +
Sbjct: 111 IL-----AIDSIHKLGYIHR---------DIKPDNLLLDAK--GHIKLSDFGLCTGLKKS 154
Query: 849 H----------------QEVSNSTLSSS--------------VGVKGTIGYTAPEYGLGS 878
H + + +SS GT Y APE L +
Sbjct: 155 HRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQT 214
Query: 879 EVSTNGDVYSYGILLLEMVTAKKP 902
+ D +S G+++ EM+ P
Sbjct: 215 GYNKECDWWSLGVIMYEMLVGYPP 238
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 9e-07
Identities = 57/230 (24%), Positives = 102/230 (44%), Gaps = 30/230 (13%)
Query: 677 KSLLKATNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVIN--LQCEGASKSFMAECKA 734
K++ + + + +G G++G V + G+ VA+K ++ Q +K E +
Sbjct: 10 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 69
Query: 735 LKNIRHRN---LVKVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEI 791
LK+++H N L+ V T S++ + ND Y+ + L+ ++ + +
Sbjct: 70 LKHMKHENVIGLLDVFTPARSLE-EFNDV------YLVTHLMGADLNNIVKCQKLTDDHV 122
Query: 792 KLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQE 851
+ + Q + L Y+H I+H DLKPSN+ ++ D I DFGLAR
Sbjct: 123 QFLIYQ-------ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---- 168
Query: 852 VSNSTLSSSVGVKGTIGYTAPEYGLG-SEVSTNGDVYSYGILLLEMVTAK 900
T G T Y APE L + D++S G ++ E++T +
Sbjct: 169 ---HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 1e-06
Identities = 66/244 (27%), Positives = 110/244 (45%), Gaps = 48/244 (19%)
Query: 686 FSSTHLIGVGSFGCVY---KGALDEDGIVVAIKVIN----LQCEGASKSFMAECKALKNI 738
F ++G G++G V+ K + G + A+KV+ +Q + E L+++
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHV 61
Query: 739 RHRNLVKVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRD--KEIEIKLTLL 796
R + + FQ ++ +Y+ G + L+ +RD E E++
Sbjct: 62 RQSPFLVTLHYA----FQTEAKLHLILDYVSGGEMFTHLY-----QRDNFSEDEVRF--- 109
Query: 797 QRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHI--GDFGLAR-FHQEVS 853
+ ++ AL++LH + I++ D+K NILLD++ GH+ DFGL++ F E
Sbjct: 110 ----YSGEIILALEHLH---KLGIVYRDIKLENILLDSE--GHVVLTDFGLSKEFLSEEK 160
Query: 854 NSTLSSSVGVKGTIGYTAPEY-----GLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFE 908
T S GTI Y APE G G V D +S GIL+ E++T P E
Sbjct: 161 ERTYSFC----GTIEYMAPEIIRGKGGHGKAV----DWWSLGILIFELLTGASP--FTLE 210
Query: 909 GDLN 912
G+ N
Sbjct: 211 GERN 214
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 50.7 bits (122), Expect = 1e-06
Identities = 53/229 (23%), Positives = 94/229 (41%), Gaps = 63/229 (27%)
Query: 692 IGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASK-SFMAECKALKNIR-HRNLVKVI-- 747
IG G+F V K + G AIK + + + + + E +AL+ + H N++++I
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEV 66
Query: 748 -----TSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIA 802
T ++ F+ D +YE + +P E +K + Q +
Sbjct: 67 LFDRKTGRLALVFELMDMN--LYELIKG-------RKRPLP----EKRVKSYMYQLLK-- 111
Query: 803 IDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVG 862
+LD++H + I H D+KP NIL+ +D+ + DFG R +
Sbjct: 112 -----SLDHMHRN---GIFHRDIKPENILIKDDI-LKLADFGSCR------------GIY 150
Query: 863 VKG-------TIGYTAPEYGLGSEVSTNG------DVYSYGILLLEMVT 898
K T Y APE L T+G D+++ G + E+++
Sbjct: 151 SKPPYTEYISTRWYRAPECLL-----TDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 2e-06
Identities = 64/227 (28%), Positives = 96/227 (42%), Gaps = 16/227 (7%)
Query: 142 IPLEFVSLSKLKDLSLAKNKLTGGIPPFLGNLTSLEVLSLAGNSFGRNIPDSLGQLKQLK 201
++L L L L N+L I L LT+L L L N+ P LK
Sbjct: 85 GSENLLNLLPLPSLDLNLNRLRSNISE-LLELTNLTSLDLDNNNITDIPPLIGLLKSNLK 143
Query: 202 ILAIGGNNLSGPIPPSIYNLSFLVVFSVSHNQIHGSLPPSLGLLLPNLKFFQIHHNFFSG 261
L + N + +P + NL L +S N + LP L L NL + N S
Sbjct: 144 ELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLS-NLSNLNNLDLSGNKIS- 199
Query: 262 SIPISLSNASKLEHIEIANNNFSGKLSVNFGGMKNLSLLNLQFSNLGSGESDEMGFMNSL 321
+P + S LE ++++NN+ +L + +KNLS L L + L S+
Sbjct: 200 DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKL-------EDLPESI 251
Query: 322 TNCSKLRVLSLGGNQFRGALPHSIANLSSQLQILILSSNQFYGSIPL 368
N S L L L NQ + S+ +L++ L+ L LS N ++PL
Sbjct: 252 GNLSNLETLDLSNNQ--ISSISSLGSLTN-LRELDLSGNSLSNALPL 295
|
Length = 394 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 2e-06
Identities = 73/282 (25%), Positives = 127/282 (45%), Gaps = 36/282 (12%)
Query: 686 FSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVK 745
F +IG G+FG V + + A+K++N + E ++ A + +N+ +
Sbjct: 3 FEIIKVIGRGAFGEVAVVKMKHTERIYAMKILN-KWEMLKRAETACFREERNVLVNGDCQ 61
Query: 746 VITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTL-LQRISIAID 804
IT+ FQ ++ +V +Y G L L + E +L + R IA +
Sbjct: 62 WITTLHYA-FQDENYLYLVMDYYVGGDLLTLL---------SKFEDRLPEDMARFYIA-E 110
Query: 805 VASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHI--GDFGLARFHQEVSNSTLSSSVG 862
+ A+ +H Q +H D+KP N+LL D++GHI DFG + + T+ SSV
Sbjct: 111 MVLAIHSIH---QLHYVHRDIKPDNVLL--DMNGHIRLADFGSCL--KMNQDGTVQSSVA 163
Query: 863 VKGTIGYTAPEY------GLGSEVSTNGDVYSYGILLLEMVTAKKP--TDVMFE--GDLN 912
V GT Y +PE G+G + D +S G+ + EM+ + P + + E G +
Sbjct: 164 V-GTPDYISPEILQAMEDGMG-KYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM 221
Query: 913 LHNFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGIN 954
H R P+ + D+ + + ++ S ++ R Q GI
Sbjct: 222 NHE-ERFQFPSHITDVSEEAKDLIQRLICSRER-RLGQNGIE 261
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 50.4 bits (121), Expect = 2e-06
Identities = 45/159 (28%), Positives = 69/159 (43%), Gaps = 22/159 (13%)
Query: 74 LGNLSFLREINLSNNTIQGEIPPEFGRLFR---LEALFLSNNSLVGKIPANLSYCS---- 126
L L+E++LS+N + + L R L+ L L+NN L G L
Sbjct: 77 LTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGL-GDRGLRLLAKGLKDL 135
Query: 127 --RLTVLCIEYNKLQGR----IPLEFVSLSKLKDLSLAKNKLTG-GIP---PFLGNLTSL 176
L L + N+L+G + + LK+L+LA N + GI L +L
Sbjct: 136 PPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNL 195
Query: 177 EVLSLAGNSF----GRNIPDSLGQLKQLKILAIGGNNLS 211
EVL L N + ++L LK L++L +G NNL+
Sbjct: 196 EVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLT 234
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 50.1 bits (119), Expect = 2e-06
Identities = 59/228 (25%), Positives = 97/228 (42%), Gaps = 31/228 (13%)
Query: 686 FSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNI-RHRNLV 744
F L+G G++G VYKG + G + AIKV+++ + + E LK HRN+
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD-EEEEIKQEINMLKKYSHHRNIA 66
Query: 745 KVITSCSSIDFQGNDFKA-IVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAI 803
+ + G D + +V E+ GS+ + K K +K + I
Sbjct: 67 TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLI------KNTKGNTLKEEWIA--YICR 118
Query: 804 DVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGV 863
++ L +LH H ++H D+K N+LL + + DFG++ + L +VG
Sbjct: 119 EILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVS--------AQLDRTVGR 167
Query: 864 K----GTIGYTAPEYGLGSE-----VSTNGDVYSYGILLLEMVTAKKP 902
+ GT + APE E D++S GI +EM P
Sbjct: 168 RNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP 215
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 2e-06
Identities = 32/107 (29%), Positives = 60/107 (56%), Gaps = 11/107 (10%)
Query: 802 AIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIG--DFGLARFHQEVSNSTLSS 859
+ +++ AL++LH + I++ DLK N+LLD + GHI D+G+ + + + +S
Sbjct: 102 SAEISLALNFLH---ERGIIYRDLKLDNVLLDAE--GHIKLTDYGMCK--EGIRPGDTTS 154
Query: 860 SVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVM 906
+ GT Y APE G + + D ++ G+L+ EM+ + P D++
Sbjct: 155 TFC--GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIV 199
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 3e-06
Identities = 63/262 (24%), Positives = 106/262 (40%), Gaps = 66/262 (25%)
Query: 686 FSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRN--- 742
F IG+G+FG V + + A+K + + + ++ A KA ++I
Sbjct: 3 FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLR-KADVLMRNQAAHVKAERDILAEADNE 61
Query: 743 -LVKVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISI 801
+VK+ S FQ D V +Y+P G + L + + D L R I
Sbjct: 62 WVVKLYYS-----FQDKDNLYFVMDYIPGGDMMSLLIRLGIFEED---------LARFYI 107
Query: 802 AIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIG--DFGL---------ARFHQ 850
A ++ A++ +H + +H D+KP NIL+D D GHI DFGL ++++Q
Sbjct: 108 A-ELTCAIESVH---KMGFIHRDIKPDNILIDRD--GHIKLTDFGLCTGFRWTHDSKYYQ 161
Query: 851 EVSNSTLSS----------------SVGVK--------------GTIGYTAPEYGLGSEV 880
+ + S + + GT Y APE L +
Sbjct: 162 KGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGY 221
Query: 881 STNGDVYSYGILLLEMVTAKKP 902
+ D +S G++L EM+ + P
Sbjct: 222 TQLCDWWSVGVILYEMLVGQPP 243
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 3e-06
Identities = 44/173 (25%), Positives = 77/173 (44%), Gaps = 27/173 (15%)
Query: 731 ECKALKNIRHRNLVKVITSCSSIDF-----QGNDFKAIVYEYMPNGSLEKWLHPHAVPKR 785
E AL + H N++K+ S Q DF +Y +M + + + W +
Sbjct: 213 EILALGRLNHENILKIEEILRSEANTYMITQKYDFD--LYSFMYDEAFD-W--------K 261
Query: 786 DKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGL 845
D+ + L Q +I + A++Y+H + ++H D+K NI L+ D +GDFG
Sbjct: 262 DRPL-----LKQTRAIMKQLLCAVEYIH---DKKLIHRDIKLENIFLNCDGKIVLGDFGT 313
Query: 846 ARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT 898
A + G GT+ +PE G D++S G++LL+M++
Sbjct: 314 A---MPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 3e-06
Identities = 42/152 (27%), Positives = 63/152 (41%), Gaps = 21/152 (13%)
Query: 755 FQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHH 814
FQ + + +V EYMP G L + + VP++ + +V ALD +H
Sbjct: 112 FQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKF-----------YTAEVVLALDAIH- 159
Query: 815 HCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEY 874
++H D+KP N+LLD + DFG E ++V GT Y +PE
Sbjct: 160 --SMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAV---GTPDYISPEV 214
Query: 875 ----GLGSEVSTNGDVYSYGILLLEMVTAKKP 902
G D +S G+ L EM+ P
Sbjct: 215 LKSQGGDGYYGRECDWWSVGVFLFEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 4e-06
Identities = 65/252 (25%), Positives = 108/252 (42%), Gaps = 36/252 (14%)
Query: 662 PSRPMMRKALPKMSYKSLLKATNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC 721
P M + +SL T+ + IG G++G VYK +DG + A+K+++
Sbjct: 6 PYNSSM------LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILD-PI 58
Query: 722 EGASKSFMAECKALKNI-RHRNLVKVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWL--- 777
+ AE L+++ H N+VK F G +KA + + G L WL
Sbjct: 59 SDVDEEIEAEYNILQSLPNHPNVVK---------FYGMFYKA---DKLVGGQL--WLVLE 104
Query: 778 --HPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDND 835
+ +V + K + I L I+ + AL L H I+H D+K +NILL +
Sbjct: 105 LCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTE 164
Query: 836 LSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEY-----GLGSEVSTNGDVYSYG 890
+ DFG++ +++++ L + V GT + APE DV+S G
Sbjct: 165 GGVKLVDFGVS---AQLTSTRLRRNTSV-GTPFWMAPEVIACEQQYDYSYDARCDVWSLG 220
Query: 891 ILLLEMVTAKKP 902
I +E+ P
Sbjct: 221 ITAIELGDGDPP 232
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 4e-06
Identities = 46/179 (25%), Positives = 80/179 (44%), Gaps = 28/179 (15%)
Query: 684 NGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRN- 742
F + +IG G+FG V + G + A+K + L+ E K +A KA +++ +
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTL-LKSEMFKKDQLAHVKAERDVLAESD 59
Query: 743 ---LVKVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRI 799
+V + S FQ + ++ E++P G L L + D + +
Sbjct: 60 SPWVVSLYYS-----FQDAQYLYLIMEFLPGGDLMTMLIKYDTFSED----VTRFYMAEC 110
Query: 800 SIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHI--GDFGLAR-FHQEVSNS 855
+AI+ L ++H D+KP NIL+D GHI DFGL+ FH++ ++
Sbjct: 111 VLAIEAVHKLGFIHR---------DIKPDNILIDRG--GHIKLSDFGLSTGFHKQHDSA 158
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 4e-06
Identities = 39/101 (38%), Positives = 53/101 (52%), Gaps = 14/101 (13%)
Query: 802 AIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQ--EVSNSTLSS 859
A ++ ALD LH +E I+ DL P+NILLD+ GHI L F + EV +S
Sbjct: 91 AAEMVVALDALH---REGIVCRDLNPNNILLDD--RGHIQ---LTYFSRWSEVEDSCDGE 142
Query: 860 SVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAK 900
+V Y APE G SE + D +S G +L E++T K
Sbjct: 143 AVENM----YCAPEVGGISEETEACDWWSLGAILFELLTGK 179
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 5e-06
Identities = 46/154 (29%), Positives = 67/154 (43%), Gaps = 25/154 (16%)
Query: 755 FQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHH 814
FQ + + +V EYMP G L + + +P++ R A +V ALD +H
Sbjct: 112 FQDDKYLYMVMEYMPGGDLVNLMSNYDIPEK----------WARFYTA-EVVLALDAIHS 160
Query: 815 HCQEPILHCDLKPSNILLDNDLSGHI--GDFGLARFHQEVSNSTLSSSVGVKGTIGYTAP 872
+H D+KP N+LLD SGH+ DFG + +N + V GT Y +P
Sbjct: 161 M---GFIHRDVKPDNMLLDK--SGHLKLADFGTCM--KMDANGMVRCDTAV-GTPDYISP 212
Query: 873 EY----GLGSEVSTNGDVYSYGILLLEMVTAKKP 902
E G D +S G+ L EM+ P
Sbjct: 213 EVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 6e-06
Identities = 46/154 (29%), Positives = 66/154 (42%), Gaps = 25/154 (16%)
Query: 755 FQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHH 814
FQ + + +V EYMP G L + + VP++ R A +V ALD +H
Sbjct: 112 FQDDRYLYMVMEYMPGGDLVNLMSNYDVPEK----------WARFYTA-EVVLALDAIH- 159
Query: 815 HCQEPILHCDLKPSNILLDNDLSGH--IGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAP 872
+H D+KP N+LLD SGH + DFG + ++V GT Y +P
Sbjct: 160 --SMGFIHRDVKPDNMLLDK--SGHLKLADFGTCMKMNKEGMVRCDTAV---GTPDYISP 212
Query: 873 EY----GLGSEVSTNGDVYSYGILLLEMVTAKKP 902
E G D +S G+ L EM+ P
Sbjct: 213 EVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 7e-06
Identities = 63/223 (28%), Positives = 101/223 (45%), Gaps = 32/223 (14%)
Query: 692 IGVGSFGCVYK-----GALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKV 746
+G G++G VYK G D D A+K I + G S S E L+ ++H N++
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRD---YALKQI--EGTGISMSACREIALLRELKHPNVI-- 61
Query: 747 ITSCSSIDFQGNDFKA-IVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDV 805
S + D K ++++Y + L + H K +K+ ++L S+ +
Sbjct: 62 --SLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKK-PVQLPRGMVKSLLYQI 117
Query: 806 ASALDYLHHHCQEPILHCDLKPSNILL--DNDLSGH--IGDFGLARFHQEVSNSTLSSSV 861
+ YLH + +LH DLKP+NIL+ + G I D G AR NS L
Sbjct: 118 LDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLF----NSPLKPLA 170
Query: 862 G---VKGTIGYTAPEYGLGSEVSTNG-DVYSYGILLLEMVTAK 900
V T Y APE LG+ T D+++ G + E++T++
Sbjct: 171 DLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 7e-06
Identities = 38/116 (32%), Positives = 55/116 (47%), Gaps = 15/116 (12%)
Query: 786 DKEIEIKLTLLQRISIAIDVASALDYL-HHHCQEPILHCDLKPSNILLDNDLSGHIGDFG 844
D E L L + + VA +D+L +C +H D+ N+LL + I DFG
Sbjct: 202 DTEDSWPLDLDDLLRFSSQVAQGMDFLASKNC----IHRDVAARNVLLTDGRVAKICDFG 257
Query: 845 LARFHQEVSNSTLSSSVGVKGT----IGYTAPEYGLGSEVSTNGDVYSYGILLLEM 896
LAR ++ N S+ VKG + + APE + DV+SYGILL E+
Sbjct: 258 LAR---DIMN---DSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEI 307
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 8e-06
Identities = 63/232 (27%), Positives = 95/232 (40%), Gaps = 42/232 (18%)
Query: 686 FSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVK 745
F +IG G+FG V + G V A+K++N K M + R V
Sbjct: 3 FEILKVIGRGAFGEVAVVKMKNTGQVYAMKILN-------KWEMLKRAETACFREERDVL 55
Query: 746 VITSCSSID-----FQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEI--EIKLTLLQR 798
V I FQ + +V +Y G L L K + + ++ L
Sbjct: 56 VNGDRRWITNLHYAFQDENNLYLVMDYYVGGDLLTLL-----SKFEDRLPEDMARFYLAE 110
Query: 799 ISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHI--GDFGLARFHQEVSNST 856
+ +AID L Y+H D+KP N+LL D +GHI DFG + +++ T
Sbjct: 111 MVLAIDSVHQLGYVHR---------DIKPDNVLL--DKNGHIRLADFGSCL--RLLADGT 157
Query: 857 LSSSVGVKGTIGYTAPEY------GLGSEVSTNGDVYSYGILLLEMVTAKKP 902
+ S+V V GT Y +PE G G D +S G+ + EM+ + P
Sbjct: 158 VQSNVAV-GTPDYISPEILQAMEDGKGR-YGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 1e-05
Identities = 52/198 (26%), Positives = 78/198 (39%), Gaps = 39/198 (19%)
Query: 793 LTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEV 852
LTL IS + VA +++L +H DL NILL + I DFGLAR
Sbjct: 170 LTLEDLISYSFQVARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLAR--DIY 224
Query: 853 SNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLN 912
+ + + + APE +T DV+S+G+LL E+
Sbjct: 225 KDPDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEI---------------- 268
Query: 913 LHNFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRL--ECLISMVKIGVAC 970
F+ A P P ++ DEE CRR++ G R + I + C
Sbjct: 269 ---FSLGASPY-------PGVQIDEEF------CRRLKEGTRMRAPEYATPEIYSIMLDC 312
Query: 971 SMESPQDRMNMTNVVHEL 988
+P+DR + +V L
Sbjct: 313 WHNNPEDRPTFSELVEIL 330
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 1e-05
Identities = 55/219 (25%), Positives = 102/219 (46%), Gaps = 24/219 (10%)
Query: 692 IGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSCS 751
+G G++G VYK + + ++ G S S E L+ ++H N++ +
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIAL----Q 64
Query: 752 SIDFQGNDFKA-IVYEYMPNGSLEKWLHPHAVPKRDKE-IEIKLTLLQRISIAIDVASAL 809
+ +D K ++++Y + L + H K +K+ +++ ++++ S+ + +
Sbjct: 65 KVFLSHSDRKVWLLFDYAEH-DLWHIIKFHRASKANKKPMQLPRSMVK--SLLYQILDGI 121
Query: 810 DYLHHHCQEPILHCDLKPSNILL--DNDLSGH--IGDFGLARFHQEVSNSTLSSSVG--- 862
YLH + +LH DLKP+NIL+ + G I D G AR NS L
Sbjct: 122 HYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLF----NSPLKPLADLDP 174
Query: 863 VKGTIGYTAPEYGLGSEVSTNG-DVYSYGILLLEMVTAK 900
V T Y APE LG+ T D+++ G + E++T++
Sbjct: 175 VVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 1e-05
Identities = 63/238 (26%), Positives = 99/238 (41%), Gaps = 48/238 (20%)
Query: 686 FSSTHLIGVGSFGCVY----KGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHR 741
F+ ++G GSFG V KG + I + K + +Q + + M E + L
Sbjct: 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECT-MVEKRVLALSGKP 60
Query: 742 NLVKVITSCSSIDFQGNDFKAIVYEYMPNGSLE-------KWLHPHAVPKRDKEIEIKLT 794
+ + SC FQ D V EY+ G L ++ PHAV
Sbjct: 61 PFLTQLHSC----FQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAV------------ 104
Query: 795 LLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLAR--FHQEV 852
A ++A L +LH + I++ DLK N++LD++ I DFG+ + V
Sbjct: 105 -----FYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGV 156
Query: 853 SNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGD 910
+ T GT Y APE + D +++G+LL EM+ + P FEG+
Sbjct: 157 TTKTFC------GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP----FEGE 204
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 2e-05
Identities = 54/213 (25%), Positives = 90/213 (42%), Gaps = 21/213 (9%)
Query: 691 LIGVGSFGCVYKGALDEDGIVVAIKVINL-QCEGASKSFMAECKALKNIRHRNLVKVITS 749
++G GSFG A+K I L + A + E L ++H N+V S
Sbjct: 7 VVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKES 66
Query: 750 CSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASAL 809
F+ + IV EY G L + + + ++ + T+LQ + + +
Sbjct: 67 -----FEADGHLYIVMEYCDGGDLMQ-----KIKLQRGKLFPEDTILQWF---VQMCLGV 113
Query: 810 DYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGY 869
++H ++ +LH D+K NI L + +GDFG AR + S + + GT Y
Sbjct: 114 QHIH---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSAR----LLTSPGAYACTYVGTPYY 166
Query: 870 TAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKP 902
PE + D++S G +L E+ T K P
Sbjct: 167 VPPEIWENMPYNNKSDIWSLGCILYELCTLKHP 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 2e-05
Identities = 55/225 (24%), Positives = 96/225 (42%), Gaps = 34/225 (15%)
Query: 692 IGVGSFGCVYKGALDEDGIVVAIKVIN--LQCEGASKSFMAECKALKNIRHRN---LVKV 746
+G G++G V VA+K ++ Q ++ E + LK+++H N L+ V
Sbjct: 23 VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDV 82
Query: 747 ITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVA 806
T +SI+ +F + Y+ + L+ ++ + ++ + Q +
Sbjct: 83 FTPATSIE----NFNEV---YLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLR------ 129
Query: 807 SALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGT 866
L Y+H I+H DLKPSN+ ++ D I DFGLAR G T
Sbjct: 130 -GLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLAR-------QADDEMTGYVAT 178
Query: 867 IGYTAPEYGLG-SEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGD 910
Y APE L + D++S G ++ E++ K +F G+
Sbjct: 179 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK----ALFPGN 219
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 2e-05
Identities = 55/214 (25%), Positives = 93/214 (43%), Gaps = 24/214 (11%)
Query: 692 IGVGSFGCVYKGALDEDGIVVAIKVIN---LQCEGASKSFMAECKALKNIRHRNLVKVIT 748
+G G FG V + G + A K ++ L+ + K + E + L+ + +V +
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 749 SCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASA 808
+ F+ +V M G L+ H + V +R E+E + +I+ I
Sbjct: 61 A-----FESKTHLCLVMSLMNGGDLK--YHIYNVGERGLEMERVIHYSAQITCGI----- 108
Query: 809 LDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIG 868
LH H + I++ D+KP N+LLD+ + + D GLA ++ T + GT G
Sbjct: 109 ---LHLHSMD-IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRA-----GTNG 159
Query: 869 YTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKP 902
Y APE S D ++ G + EMV + P
Sbjct: 160 YMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 4e-05
Identities = 38/108 (35%), Positives = 53/108 (49%), Gaps = 9/108 (8%)
Query: 793 LTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLAR--FHQ 850
LT L +S VA +++L + +H DL N+LL I DFGLAR H
Sbjct: 234 LTTLDLLSFTYQVARGMEFL---ASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHD 290
Query: 851 EVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT 898
S S+ + VK + APE + +T DV+SYGILL E+ +
Sbjct: 291 SNYVSKGSTFLPVK----WMAPESIFDNLYTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 4e-05
Identities = 38/114 (33%), Positives = 55/114 (48%), Gaps = 13/114 (11%)
Query: 787 KEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLA 846
+E E+ L +S + VA + +L + +H DL NILL + I DFGLA
Sbjct: 205 EEDELALDTEDLLSFSYQVAKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLA 261
Query: 847 RFHQEVSNSTLSSSVGVKGT----IGYTAPEYGLGSEVSTNGDVYSYGILLLEM 896
R ++ N S+ VKG + + APE + DV+SYGILL E+
Sbjct: 262 R---DIRN---DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEI 309
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 5e-05
Identities = 60/255 (23%), Positives = 105/255 (41%), Gaps = 60/255 (23%)
Query: 686 FSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIR-HRNLV 744
F S +IG G+FG V + G V A+K++ K+ M E + + +IR R+++
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHVYAMKILR-------KADMLEKEQVGHIRAERDIL 55
Query: 745 KVITSCSSI----DFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDK--EIEIKLTLLQR 798
S + FQ ++ E++P G + L K+D E E + + +
Sbjct: 56 VEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLM-----KKDTLTEEETQFYIAET 110
Query: 799 ISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGL---------ARFH 849
+ +AID L ++H D+KP N+LLD+ + DFGL F+
Sbjct: 111 V-LAIDSIHQLGFIHR---------DIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFY 160
Query: 850 QEVSNSTLSS----------------------SVGVKGTIGYTAPEYGLGSEVSTNGDVY 887
+ +++S S + GT Y APE + + + D +
Sbjct: 161 RNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWW 220
Query: 888 SYGILLLEMVTAKKP 902
S G+++ EM+ P
Sbjct: 221 SLGVIMYEMLIGYPP 235
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 6e-05
Identities = 48/159 (30%), Positives = 67/159 (42%), Gaps = 44/159 (27%)
Query: 808 ALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIG--DFGLARF------------HQEVS 853
AL+YLH++ I+H DLKP N+L+ + GHI DFGL++ H E
Sbjct: 113 ALEYLHNY---GIVHRDLKPDNLLITS--MGHIKLTDFGLSKIGLMSLTTNLYEGHIEKD 167
Query: 854 NSTLSSSVGVKGTIGYTAPEY----GLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEG 909
V GT Y APE G G V D ++ GI+L E + P F G
Sbjct: 168 TREFLDK-QVCGTPEYIAPEVILRQGYGKPV----DWWAMGIILYEFLVGCVP----FFG 218
Query: 910 DLNLHNFARM------------ALPNQVMDIVDPILRND 936
D F ++ ALP D++ +LR +
Sbjct: 219 DTPEELFGQVISDDIEWPEGDEALPADAQDLISRLLRQN 257
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 7e-05
Identities = 58/257 (22%), Positives = 103/257 (40%), Gaps = 64/257 (24%)
Query: 686 FSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVK 745
F S +IG G+FG V + G + A+K++ K+ M E + + +IR +
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHIYAMKILR-------KADMLEKEQVAHIRAERDIL 55
Query: 746 VITSCSSI-----DFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRD--KEIEIKLTLLQR 798
V + + FQ ++ E++P G + L K+D E + + +
Sbjct: 56 VEADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLM-----KKDTLSEEATQFYIAET 110
Query: 799 ISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHI--GDFGL---------AR 847
+ +AID L ++H D+KP N+LLD GH+ DFGL
Sbjct: 111 V-LAIDAIHQLGFIHR---------DIKPDNLLLDA--KGHVKLSDFGLCTGLKKAHRTE 158
Query: 848 FHQEVSNSTLSS----------------------SVGVKGTIGYTAPEYGLGSEVSTNGD 885
F++ ++++ S + GT Y APE + + + D
Sbjct: 159 FYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCD 218
Query: 886 VYSYGILLLEMVTAKKP 902
+S G+++ EM+ P
Sbjct: 219 WWSLGVIMYEMLIGYPP 235
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 7e-05
Identities = 58/220 (26%), Positives = 95/220 (43%), Gaps = 20/220 (9%)
Query: 689 THLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIR-HRNLVKVI 747
IG G++G V+K ++G A+K+++ + AE LK + H N+VK
Sbjct: 23 IETIGKGTYGKVFKVLNKKNGSKAAVKILD-PIHDIDEEIEAEYNILKALSDHPNVVKFY 81
Query: 748 TSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVAS 807
D + D +V E GS+ + KR + +E + IA +
Sbjct: 82 GMYYKKDVKNGDQLWLVLELCNGGSVTDLVK--GFLKRGERMEEPI-------IAYILHE 132
Query: 808 ALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTI 867
AL L H +H D+K +NILL + + DFG++ +++++ L + V GT
Sbjct: 133 ALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVS---AQLTSTRLRRNTSV-GTP 188
Query: 868 GYTAPEY-----GLGSEVSTNGDVYSYGILLLEMVTAKKP 902
+ APE L S DV+S GI +E+ P
Sbjct: 189 FWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPP 228
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 1e-04
Identities = 22/85 (25%), Positives = 44/85 (51%), Gaps = 6/85 (7%)
Query: 261 GSIPISLSNASKLEHIEIANNNFSGKLSVNFGGMKNLSLLNLQFSNLGSGESDEMGFMNS 320
G IP +S L+ I ++ N+ G + + G + +L +L+L +++ + +G + S
Sbjct: 432 GFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTS 491
Query: 321 LTNCSKLRVLSLGGNQFRGALPHSI 345
LR+L+L GN G +P ++
Sbjct: 492 ------LRILNLNGNSLSGRVPAAL 510
|
Length = 623 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 1e-04
Identities = 66/266 (24%), Positives = 111/266 (41%), Gaps = 70/266 (26%)
Query: 686 FSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNI----RHR 741
F +G+G+FG V + + A+K + + + +++ +A KA ++I +
Sbjct: 3 FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKK-DVLNRNQVAHVKAERDILAEADNE 61
Query: 742 NLVKVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISI 801
+VK+ S FQ D V +Y+P G + L +E+ +L R I
Sbjct: 62 WVVKLYYS-----FQDKDNLYFVMDYIPGGDMMSLL---------IRMEVFPEVLARFYI 107
Query: 802 AIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIG--DFGL---------ARFHQ 850
A ++ A++ +H + +H D+KP NIL+ DL GHI DFGL ++++Q
Sbjct: 108 A-ELTLAIESVH---KMGFIHRDIKPDNILI--DLDGHIKLTDFGLCTGFRWTHNSKYYQ 161
Query: 851 -----------------EVSN-------STLSSSV----------GVKGTIGYTAPEYGL 876
+VSN TL + GT Y APE L
Sbjct: 162 KGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLL 221
Query: 877 GSEVSTNGDVYSYGILLLEMVTAKKP 902
+ D +S G++L EM+ + P
Sbjct: 222 RKGYTQLCDWWSVGVILFEMLVGQPP 247
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 43.7 bits (104), Expect = 3e-04
Identities = 42/179 (23%), Positives = 76/179 (42%), Gaps = 35/179 (19%)
Query: 740 HRNLVKVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRI 799
+ N +K+ S +++ ++ +Y+ +G L L E KL+ +
Sbjct: 68 NPNFIKLYYSVTTLKGH-----VLIMDYIKDGDLFDLLK----------KEGKLSEAEVK 112
Query: 800 SIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSG-HIGDFGLARFHQEVSNSTLS 858
I + AL+ LH H I+H D+K N+L D ++ D+GL +
Sbjct: 113 KIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCK----------- 158
Query: 859 SSVGVK----GTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNL 913
+G GT+ Y +PE G + D ++ G+L E++T K P + +L+L
Sbjct: 159 -IIGTPSCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDL 216
|
Length = 267 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 43.1 bits (102), Expect = 4e-04
Identities = 45/157 (28%), Positives = 65/157 (41%), Gaps = 24/157 (15%)
Query: 691 LIGVGSFG--CVYKGALDEDGIVVAIKVINLQ-CEGASKSFM-AECKALKNIRHRNLVKV 746
LIG V+ +VA+K INL C + E + ++H N++
Sbjct: 5 LIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPY 64
Query: 747 ITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVA 806
+TS F + +V M GS E L H P+ E+ I L DV
Sbjct: 65 VTS-----FIVDSELYVVSPLMAYGSCEDLLKTH-FPEGLPELAIAFILK-------DVL 111
Query: 807 SALDYLHHHCQEPILHCDLKPSNILLDND----LSGH 839
+ALDY+H + +H +K S+ILL D LSG
Sbjct: 112 NALDYIHS---KGFIHRSVKASHILLSGDGKVVLSGL 145
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 6e-04
Identities = 64/272 (23%), Positives = 103/272 (37%), Gaps = 82/272 (30%)
Query: 686 FSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNI----RHR 741
F +G+G+FG V + + A+K + + + ++ +A KA ++I +
Sbjct: 3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKK-DVLLRNQVAHVKAERDILAEADNE 61
Query: 742 NLVKVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISI 801
+V++ S FQ D V +Y+P G + L + D L R I
Sbjct: 62 WVVRLYYS-----FQDKDNLYFVMDYIPGGDMMSLLIRMGIFPED---------LARFYI 107
Query: 802 AIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIG--DFGL-------------- 845
A ++ A++ +H + +H D+KP NIL+D D GHI DFGL
Sbjct: 108 A-ELTCAVESVH---KMGFIHRDIKPDNILIDRD--GHIKLTDFGLCTGFRWTHDSKYYQ 161
Query: 846 -----------------------------------ARFHQEVSNSTLSSSVGVKGTIGYT 870
AR HQ +L GT Y
Sbjct: 162 SGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLV------GTPNYI 215
Query: 871 APEYGLGSEVSTNGDVYSYGILLLEMVTAKKP 902
APE L + + D +S G++L EM+ + P
Sbjct: 216 APEVLLRTGYTQLCDWWSVGVILYEMLVGQPP 247
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 6e-04
Identities = 42/146 (28%), Positives = 66/146 (45%), Gaps = 9/146 (6%)
Query: 793 LTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEV 852
L+ + + + VA+ +++L + +H DL N+L+ I DFGLAR
Sbjct: 236 LSYMDLVGFSYQVANGMEFL---ASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRD 292
Query: 853 SNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT---AKKPTDVMFEG 909
SN S + + + APE + +T DV+S+GILL E+ T P M E
Sbjct: 293 SNYISKGSTFLP--LKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQ 350
Query: 910 DLN-LHNFARMALPNQVMDIVDPILR 934
N + RMA P D + I++
Sbjct: 351 FYNAIKRGYRMAKPAHASDEIYEIMQ 376
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 6e-04
Identities = 63/238 (26%), Positives = 94/238 (39%), Gaps = 44/238 (18%)
Query: 673 KMSYKSLLKATNGFSSTHLIGVGSFGCV----YKGALDEDGIVVAIKVINLQCEGASKS- 727
KM Y+ F+ +G GSFG V YK +ED VAIK + + +
Sbjct: 26 KMKYED-------FNFIRTLGTGSFGRVILATYK---NEDFPPVAIKRFE-KSKIIKQKQ 74
Query: 728 ---FMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPK 784
+E K L I H V + S F+ + +V E++ G +L +
Sbjct: 75 VDHVFSERKILNYINHPFCVNLYGS-----FKDESYLYLVLEFVIGGEFFTFL------R 123
Query: 785 RDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFG 844
R+K + I + +YL I++ DLKP N+LLD D + DFG
Sbjct: 124 RNKRFPNDVGCFYAAQIVL----IFEYLQ---SLNIVYRDLKPENLLLDKDGFIKMTDFG 176
Query: 845 LARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKP 902
A+ + TL GT Y APE L D ++ GI + E++ P
Sbjct: 177 FAKV-VDTRTYTLC------GTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPP 227
|
Length = 340 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 0.001
Identities = 55/226 (24%), Positives = 95/226 (42%), Gaps = 47/226 (20%)
Query: 690 HLIGVGSFGCVYKGAL----DEDG------IVVAIKVINLQCEGASKSFMAECKALKNIR 739
HL G G+F +YKG L D D + V +KV+ S +F + +
Sbjct: 2 HL-GQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLG-SDHRDSLAFFETASLMSQLS 59
Query: 740 HRNLVKVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRI 799
H++LVK+ C + +V EY+ G L+ +LH ++L ++
Sbjct: 60 HKHLVKLYGVCVRDENI------MVEEYVKFGPLDVFLHREKNN---------VSLHWKL 104
Query: 800 SIAIDVASALDYLHHHCQEPILHCDLKPSNILL---DNDLSG----HIGDFGLARFHQEV 852
+A +ASAL YL + ++H ++ NIL+ + + D G+
Sbjct: 105 DVAKQLASALHYLE---DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI----- 156
Query: 853 SNSTLSSSVGVKGTIGYTAPEY--GLGSEVSTNGDVYSYGILLLEM 896
+ LS V+ I + APE + ++ D +S+G LLE+
Sbjct: 157 --TVLSREERVE-RIPWIAPECIRNGQASLTIAADKWSFGTTLLEI 199
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 0.001
Identities = 35/161 (21%), Positives = 63/161 (39%), Gaps = 30/161 (18%)
Query: 691 LIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLV--KVIT 748
L+ G VY L +K+ + +GA E L+ + + L KV+
Sbjct: 5 LLKGGLTNRVYL--LGTKDEDYVLKINPSREKGAD--REREVAILQLLARKGLPVPKVLA 60
Query: 749 SCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASA 808
S S + ++ E++ +L++ ++ ++ IA +A
Sbjct: 61 SGESDGWS-----YLLMEWIEGETLDE-----------------VSEEEKEDIAEQLAEL 98
Query: 809 LDYLHHHCQEPILHCDLKPSNILLDND-LSGHIGDFGLARF 848
L LH + H DL P NIL+D+ + G I D+ A +
Sbjct: 99 LAKLHQLPLLVLCHGDLHPGNILVDDGKILGII-DWEYAGY 138
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 37.5 bits (88), Expect = 0.002
Identities = 19/60 (31%), Positives = 29/60 (48%), Gaps = 1/60 (1%)
Query: 520 SLEEIYLAGNLFHGSIPSFFNALKGVQKIDLSRNNLSGQIPIFLEAL-SLEYLNLSFNDF 578
+L+ + L+ N F L ++ +DLS NNL+ P L SL L+LS N+
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 37.5 bits (88), Expect = 0.002
Identities = 18/60 (30%), Positives = 29/60 (48%)
Query: 399 KLQGLDFSGNHFSGEIPSSLGNLSSLYEVFFNNNNLSGVIPFSLGNLKRLAFLEMSGNEL 458
L+ LD S N + + L +L + + NNL+ + P + L L L++SGN L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 36.8 bits (86), Expect = 0.002
Identities = 24/61 (39%), Positives = 34/61 (55%), Gaps = 2/61 (3%)
Query: 151 KLKDLSLAKNKLTGGIPP-FLGNLTSLEVLSLAGNSFGRNIPDSLGQLKQLKILAIGGNN 209
LK L L+ N+LT IP L +L+VL L+GN+ P++ L L+ L + GNN
Sbjct: 1 NLKSLDLSNNRLTV-IPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNN 59
Query: 210 L 210
L
Sbjct: 60 L 60
|
Length = 60 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 0.002
Identities = 49/198 (24%), Positives = 74/198 (37%), Gaps = 39/198 (19%)
Query: 793 LTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEV 852
LTL I + VA +++L +H DL NILL + I DFGLAR
Sbjct: 176 LTLEDLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLAR--DIY 230
Query: 853 SNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLN 912
+ + + + APE + DV+S+G+LL E+
Sbjct: 231 KDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI---------------- 274
Query: 913 LHNFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLIS--MVKIGVAC 970
F+ A P P ++ DEE CRR++ G R + M + + C
Sbjct: 275 ---FSLGASPY-------PGVKIDEEF------CRRLKEGTRMRAPDYTTPEMYQTMLDC 318
Query: 971 SMESPQDRMNMTNVVHEL 988
P R + +V L
Sbjct: 319 WHGEPSQRPTFSELVEHL 336
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|215633 PLN03210, PLN03210, Resistant to P | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 0.002
Identities = 79/333 (23%), Positives = 133/333 (39%), Gaps = 67/333 (20%)
Query: 77 LSFLREINLSNNTIQGEIPPEFGRLFRLEALFLSNNSLVGKIPANLSYCSRLTVLCIEYN 136
L+ LR I+L + EIP + LE L LS+ S + ++P+++ Y
Sbjct: 633 LTGLRNIDLRGSKNLKEIP-DLSMATNLETLKLSDCSSLVELPSSIQY------------ 679
Query: 137 KLQGRIPLEFVSLSKLKDLSLAKNKLTGGIPPFLGNLTSLEVLSLAGNSFGRNIPDSLGQ 196
L+KL+DL +++ + +P + NL SL L+L+G S ++ PD
Sbjct: 680 ------------LNKLEDLDMSRCENLEILPTGI-NLKSLYRLNLSGCSRLKSFPDISTN 726
Query: 197 LKQLKILAIGGNNLSGPIPPSIYNLSFLVVFSVSHNQIHGS---LPPSLGLLLPNLKFFQ 253
+ L + + + NL L++ + ++ L P + +L P+L
Sbjct: 727 ISWLDLDETAIEEFPSNLR--LENLDELILCEMKSEKLWERVQPLTPLMTMLSPSLTRLF 784
Query: 254 IHHNFFSGSIPISLSNASKLEHIEIANNNFSGKLSVNFGGMKNLSLLNLQFSNLGSGESD 313
+ +P S+ N KLEH+EI N NL L NL S ES
Sbjct: 785 LSDIPSLVELPSSIQNLHKLEHLEIEN-------------CINLETLPTGI-NLESLESL 830
Query: 314 EMGFMNSLTNCSKLRVLSLGGNQFRGALPHSIANLSSQLQILILSSNQFYGSIPLGIGNL 373
+ L+ CS+LR + ++S+ + L LS +P I
Sbjct: 831 D------LSGCSRLR---------------TFPDISTNISDLNLSRTGIE-EVPWWIEKF 868
Query: 374 VDLYLLGMVENQFTGAIPKEMGKLQKLQGLDFS 406
+L L M + + KL+ L+ +DFS
Sbjct: 869 SNLSFLDMNGCNNLQRVSLNISKLKHLETVDFS 901
|
syringae 6; Provisional. Length = 1153 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 0.003
Identities = 22/65 (33%), Positives = 36/65 (55%), Gaps = 1/65 (1%)
Query: 56 VTALDLMSKSLSGSLSPHLGNLSFLREINLSNNTIQGEIPPEFG-RLFRLEALFLSNNSL 114
+ LDL S +GS+ LG L+ LR +NL+ N++ G +P G RL + ++N+
Sbjct: 468 LEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAG 527
Query: 115 VGKIP 119
+ IP
Sbjct: 528 LCGIP 532
|
Length = 623 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 36.8 bits (86), Expect = 0.003
Identities = 20/60 (33%), Positives = 25/60 (41%)
Query: 103 RLEALFLSNNSLVGKIPANLSYCSRLTVLCIEYNKLQGRIPLEFVSLSKLKDLSLAKNKL 162
L++L LSNN L L VL + N L P F L L+ L L+ N L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.3 bits (96), Expect = 0.003
Identities = 50/205 (24%), Positives = 89/205 (43%), Gaps = 39/205 (19%)
Query: 722 EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHP-H 780
E + E ++ ++H+N+V+ I + + N I+ E+ G L + + +
Sbjct: 53 EREKSQLVIEVNVMRELKHKNIVRYIDRFLN---KANQKLYILMEFCDAGDLSRNIQKCY 109
Query: 781 AVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEP----ILHCDLKPSNILLD--- 833
+ + +E I + I + AL Y H+ P +LH DLKP NI L
Sbjct: 110 KMFGKIEEHAI-------VDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGI 162
Query: 834 ----------NDLSGH----IGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSE 879
N+L+G IGDFGL++ + +++ S GT Y +PE L
Sbjct: 163 RHIGKITAQANNLNGRPIAKIGDFGLSK---NIGIESMAHS--CVGTPYYWSPELLLHET 217
Query: 880 VSTN--GDVYSYGILLLEMVTAKKP 902
S + D+++ G ++ E+ + K P
Sbjct: 218 KSYDDKSDMWALGCIIYELCSGKTP 242
|
Length = 1021 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.003
Identities = 61/270 (22%), Positives = 105/270 (38%), Gaps = 74/270 (27%)
Query: 691 LIGVGSFGCVYKGAL-----DEDGIVVAIKVINLQCEGAS----KSFMAECKALKNI-RH 740
++G G+FG V + + VA+K++ EGA+ K+ M+E K L +I H
Sbjct: 14 VLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLK---EGATASEHKALMSELKILIHIGNH 70
Query: 741 RNLVKVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHA---VPKRDKEIEIK----- 792
N+V ++ +C+ + N ++ E+ G+L +L P R+K + +
Sbjct: 71 LNVVNLLGACT----KPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRA 126
Query: 793 --------------------------------------------LTLLQRISIAIDVASA 808
LT+ I + VA
Sbjct: 127 MVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARG 186
Query: 809 LDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIG 868
+++L +H DL NILL + I DFGLAR + + S + +
Sbjct: 187 MEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP--LK 241
Query: 869 YTAPEYGLGSEVSTNGDVYSYGILLLEMVT 898
+ APE +T DV+S+G+LL E+ +
Sbjct: 242 WMAPESIFDKVYTTQSDVWSFGVLLWEIFS 271
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 1008 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.98 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.98 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.98 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.98 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.97 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.97 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.97 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.97 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.96 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.96 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.96 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.96 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.96 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.96 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.95 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.95 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.95 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.95 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.95 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.95 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.94 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.93 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.93 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.93 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.92 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.91 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.9 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.9 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.89 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.89 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.89 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.88 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.88 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.87 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.87 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.87 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.87 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.83 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.83 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.82 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.82 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.82 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.81 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.8 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.78 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.78 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.77 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.76 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.76 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.76 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.74 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.73 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.73 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.72 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.71 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.71 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.68 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.64 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.63 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.63 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.62 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.61 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.54 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.54 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.53 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.53 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.5 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.49 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.46 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.4 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.39 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.36 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.35 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.35 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.26 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.2 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.2 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.2 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.2 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 99.08 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 99.08 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.08 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.05 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.05 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.03 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.03 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.02 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.02 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.0 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.0 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.0 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.98 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.98 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.94 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.9 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.88 | |
| PF08263 | 43 | LRRNT_2: Leucine rich repeat N-terminal domain; In | 98.88 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.85 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.81 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.78 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.76 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.75 | |
| KOG2982 | 418 | consensus Uncharacterized conserved protein [Funct | 98.75 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.74 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.58 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.53 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.53 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.49 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.47 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.46 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-115 Score=1108.10 Aligned_cols=922 Identities=32% Similarity=0.514 Sum_probs=784.8
Q ss_pred ccCChhhHHHHHHHHHhhccCCCCCCCCCCCCCCCCcccceEEcCCCCeEEEEeccccCCCCccCcCccCCccCCeeeec
Q 045798 7 AALEDGDRAALQAFKSMIAHEPQGILNSWNDSRHFCEWEGITCGRRHRRVTALDLMSKSLSGSLSPHLGNLSFLREINLS 86 (1008)
Q Consensus 7 ~~~~~~~~~~l~~~k~~~~~~~~~~~~~w~~~~~~c~w~gv~c~~~~~~v~~l~l~~~~l~~~l~~~l~~l~~L~~L~L~ 86 (1008)
+..+++|++||++||+++. +|.+.+.+|+..++||.|.||+|+. ..+|+.|||++++++|.++..+..+++|++|+|+
T Consensus 24 ~~~~~~~~~~l~~~~~~~~-~~~~~~~~w~~~~~~c~w~gv~c~~-~~~v~~L~L~~~~i~~~~~~~~~~l~~L~~L~Ls 101 (968)
T PLN00113 24 SMLHAEELELLLSFKSSIN-DPLKYLSNWNSSADVCLWQGITCNN-SSRVVSIDLSGKNISGKISSAIFRLPYIQTINLS 101 (968)
T ss_pred cCCCHHHHHHHHHHHHhCC-CCcccCCCCCCCCCCCcCcceecCC-CCcEEEEEecCCCccccCChHHhCCCCCCEEECC
Confidence 4558899999999999995 7888889999888999999999974 4689999999999999999999999999999999
Q ss_pred CCCCCCCCCcccc-CCCCCCEEEccCCCCCCccCcccccCcCcceEeeeccccccCCCccccccCCCCeeecccccCCCC
Q 045798 87 NNTIQGEIPPEFG-RLFRLEALFLSNNSLVGKIPANLSYCSRLTVLCIEYNKLQGRIPLEFVSLSKLKDLSLAKNKLTGG 165 (1008)
Q Consensus 87 ~n~~~~~~p~~~~-~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~ 165 (1008)
+|++++.+|..+. .+.+|++|+|++|.+++.+|. +.+++|++|+|++|.+++.+|..++++++|++|+|++|.+.+.
T Consensus 102 ~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~--~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~ 179 (968)
T PLN00113 102 NNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGK 179 (968)
T ss_pred CCccCCcCChHHhccCCCCCEEECcCCccccccCc--cccCCCCEEECcCCcccccCChHHhcCCCCCEEECccCccccc
Confidence 9999988988765 999999999999999988886 5689999999999999999999999999999999999999999
Q ss_pred CCCCCccccccchhhcccccCCCCCCccccCCCCCcEEEecCCcccccCCccccCCCCcceeccccccccccCChhhhhc
Q 045798 166 IPPFLGNLTSLEVLSLAGNSFGRNIPDSLGQLKQLKILAIGGNNLSGPIPPSIYNLSFLVVFSVSHNQIHGSLPPSLGLL 245 (1008)
Q Consensus 166 ~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~~~lp~~~~~~ 245 (1008)
+|..++++++|++|+|++|.+.+.+|..++.+++|+.|+|++|.+++.+|..+.++++|++|++++|.+.+.+|..+..
T Consensus 180 ~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~- 258 (968)
T PLN00113 180 IPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGN- 258 (968)
T ss_pred CChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccCCcCChhHhcCCCCCEEECcCceeccccChhHhC-
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999888887654
Q ss_pred CCCCcEEEeccccCCCCCCcccccCCCCceeecccccccccccccccCCCcccccccccccCCCCCCCcccccccccccC
Q 045798 246 LPNLKFFQIHHNFFSGSIPISLSNASKLEHIEIANNNFSGKLSVNFGGMKNLSLLNLQFSNLGSGESDEMGFMNSLTNCS 325 (1008)
Q Consensus 246 l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~l~ 325 (1008)
+++|++|+|++|.+.+.+|..+.++++|++|++++|.+.+..|..+..+++|+.|++++|.+.... +..+..++
T Consensus 259 l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~------~~~~~~l~ 332 (968)
T PLN00113 259 LKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKI------PVALTSLP 332 (968)
T ss_pred CCCCCEEECcCCeeeccCchhHhhccCcCEEECcCCeeccCCChhHcCCCCCcEEECCCCccCCcC------ChhHhcCC
Confidence 899999999999999999999999999999999999999999999999999999999999987533 34678899
Q ss_pred CCcEEEecCCcCCccCChhhhhhcccceeeeeccccccCCCCCccccccccceEEecCccccCCcchhccCCCCCceEEc
Q 045798 326 KLRVLSLGGNQFRGALPHSIANLSSQLQILILSSNQFYGSIPLGIGNLVDLYLLGMVENQFTGAIPKEMGKLQKLQGLDF 405 (1008)
Q Consensus 326 ~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 405 (1008)
+|+.|++++|++.+.+|..+..+. +|+.|++++|++++.+|..+..+.+|+.|++++|++.+.+|..+..+++|+.|+|
T Consensus 333 ~L~~L~L~~n~l~~~~p~~l~~~~-~L~~L~Ls~n~l~~~~p~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L 411 (968)
T PLN00113 333 RLQVLQLWSNKFSGEIPKNLGKHN-NLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRL 411 (968)
T ss_pred CCCEEECcCCCCcCcCChHHhCCC-CCcEEECCCCeeEeeCChhHhCcCCCCEEECcCCEecccCCHHHhCCCCCCEEEC
Confidence 999999999999999999998886 5999999999999999999999999999999999999999999999999999999
Q ss_pred cCCcccccccccccCCCCcceeeccccccccccCCCCcCCCcccEeecccccccCCcchhhhhhhhhhhhhcccCccccC
Q 045798 406 SGNHFSGEIPSSLGNLSSLYEVFFNNNNLSGVIPFSLGNLKRLAFLEMSGNELSGTIPEDIFNISYLSNSLNLARNHLVG 485 (1008)
Q Consensus 406 s~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~lp~~~~~~~~~~~~L~L~~N~l~~ 485 (1008)
++|++++.+|..+..++.|+.|++++|.+++.+|..+..+++|+.|+|++|++.|.+|..+. ...++.|+|++|++++
T Consensus 412 ~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~~--~~~L~~L~ls~n~l~~ 489 (968)
T PLN00113 412 QDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFG--SKRLENLDLSRNQFSG 489 (968)
T ss_pred cCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCceeeeecCcccc--cccceEEECcCCccCC
Confidence 99999999999999999999999999999999999999999999999999999998887653 2456889999999999
Q ss_pred CCcccccccccccccccccccccCCCCcccccccccceeeccCcccccchhhhhhccccccEEecCCCcccccccCc-cc
Q 045798 486 IIPPRIGNLRALRSFDVSNNDLSGEIPIELGHCSSLEEIYLAGNLFHGSIPSFFNALKGVQKIDLSRNNLSGQIPIF-LE 564 (1008)
Q Consensus 486 ~~p~~~~~l~~L~~Ldls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~-~~ 564 (1008)
.+|..+..+++|+.|+|++|.+++.+|..++.+++|++|+|++|.++|.+|..|..+++|+.|||++|+++|.+|.. ..
T Consensus 490 ~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~ 569 (968)
T PLN00113 490 AVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGN 569 (968)
T ss_pred ccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999987 66
Q ss_pred ccccceeecccCcccccCCCCcccCCcccceeccCCccCCCCCCCCCCCCCCCCCCcccccceeeeeehhHHHHHHHHHH
Q 045798 565 ALSLEYLNLSFNDFEGKIPAKGIFANASAISVVGCNRLCGGIPELQLPKCTESKSSSQKISRRLKIIISAITAFSGFFMV 644 (1008)
Q Consensus 565 ~~~L~~L~l~~N~l~g~~p~~~~~~~~~~~~~~~n~~l~g~~~~~~~~~~~~~~~s~~~~~~~~~iii~~~~~~~~~~~~ 644 (1008)
+.+|+.|++++|+++|.+|..+++.++...++.||+.+||..+....++|.... +...+..+++.+++++++++++
T Consensus 570 l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~~~~c~~~~----~~~~~~~~~~~~~~~~~~~~~~ 645 (968)
T PLN00113 570 VESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKRVR----KTPSWWFYITCTLGAFLVLALV 645 (968)
T ss_pred CcccCEEeccCCcceeeCCCcchhcccChhhhcCCccccCCccccCCCCCcccc----ccceeeeehhHHHHHHHHHHHH
Confidence 778999999999999999999999999999999999999987766666664321 1112223333333333333333
Q ss_pred HHHHhhhhhcccCC-CCCCCchh-hh------hcCCCCCHHHHHHHhcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEE
Q 045798 645 SFFILYWHKWRRGP-SRLPSRPM-MR------KALPKMSYKSLLKATNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKV 716 (1008)
Q Consensus 645 ~~~~~~~~~~~~~~-~~~~~~~~-~~------~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~ 716 (1008)
++++++++++++.. .+...... .. .....++++++ ...|...+.||+|+||.||+|++..+++.||||+
T Consensus 646 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~ 722 (968)
T PLN00113 646 AFGFVFIRGRNNLELKRVENEDGTWELQFFDSKVSKSITINDI---LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKE 722 (968)
T ss_pred HHHHHHHHhhhcccccccccccccccccccccccchhhhHHHH---HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEE
Confidence 33333333322111 11110000 00 00112233333 3567888999999999999999988999999999
Q ss_pred eccccchhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceEEEEEeccCCCChhcccccCCCCCCCcccccccCHH
Q 045798 717 INLQCEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLL 796 (1008)
Q Consensus 717 ~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~ 796 (1008)
++.... ...+|++++++++||||++++++|. +++..++||||+++|+|.++++ .++|.
T Consensus 723 ~~~~~~----~~~~~~~~l~~l~HpnIv~~~~~~~-----~~~~~~lv~Ey~~~g~L~~~l~-------------~l~~~ 780 (968)
T PLN00113 723 INDVNS----IPSSEIADMGKLQHPNIVKLIGLCR-----SEKGAYLIHEYIEGKNLSEVLR-------------NLSWE 780 (968)
T ss_pred ccCCcc----ccHHHHHHHhhCCCCCcceEEEEEE-----cCCCCEEEEeCCCCCcHHHHHh-------------cCCHH
Confidence 864322 2235688999999999999999964 3456899999999999999985 47899
Q ss_pred HHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEcccCcccccccccCccccccccccccccccCccccC
Q 045798 797 QRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGL 876 (1008)
Q Consensus 797 ~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 876 (1008)
++..|+.||++|++|||+++.++|+||||||+||+++.++.+++. ||.+...... ....+|..|+|||++.
T Consensus 781 ~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~--------~~~~~t~~y~aPE~~~ 851 (968)
T PLN00113 781 RRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD--------TKCFISSAYVAPETRE 851 (968)
T ss_pred HHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC--------CCccccccccCccccc
Confidence 999999999999999997656799999999999999999888875 6655432111 1224789999999999
Q ss_pred CCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCcc-hhhhhcccccCchHHhhhhhhhhhccccchh
Q 045798 877 GSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMALPNQ-VMDIVDPILRNDEEILASTDKCRRMQTGINS 955 (1008)
Q Consensus 877 ~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~ 955 (1008)
+..++.++|||||||++|||++|+.||+...........|.+...... ...++|+.+.... ..
T Consensus 852 ~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------------~~ 915 (968)
T PLN00113 852 TKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDV----------------SV 915 (968)
T ss_pred CCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCC----------------Cc
Confidence 999999999999999999999999999765555555666665444322 3334444432211 11
Q ss_pred HHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHHHHHHHHHH
Q 045798 956 RLECLISMVKIGVACSMESPQDRMNMTNVVHELQSVKNILL 996 (1008)
Q Consensus 956 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~i~~~~~ 996 (1008)
..++..++.+++.+||+.||++||||+||+++|+++.....
T Consensus 916 ~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~~ 956 (968)
T PLN00113 916 NQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSSS 956 (968)
T ss_pred cHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhcccc
Confidence 23455678999999999999999999999999998866433
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-60 Score=603.55 Aligned_cols=518 Identities=34% Similarity=0.528 Sum_probs=479.2
Q ss_pred ccCCeeeecCCCCCCCCCccccCCCCCCEEEccCCCCCCccCcccc-cCcCcceEeeeccccccCCCccccccCCCCeee
Q 045798 78 SFLREINLSNNTIQGEIPPEFGRLFRLEALFLSNNSLVGKIPANLS-YCSRLTVLCIEYNKLQGRIPLEFVSLSKLKDLS 156 (1008)
Q Consensus 78 ~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~-~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~ 156 (1008)
..++.|+|++|++++.+|..|..+++|++|+|++|++++.+|..+. .+++|++|+|++|++++.+|. +.+++|++|+
T Consensus 69 ~~v~~L~L~~~~i~~~~~~~~~~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~--~~l~~L~~L~ 146 (968)
T PLN00113 69 SRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETLD 146 (968)
T ss_pred CcEEEEEecCCCccccCChHHhCCCCCCEEECCCCccCCcCChHHhccCCCCCEEECcCCccccccCc--cccCCCCEEE
Confidence 3689999999999999999999999999999999999998998765 999999999999999988886 4689999999
Q ss_pred cccccCCCCCCCCCccccccchhhcccccCCCCCCccccCCCCCcEEEecCCcccccCCccccCCCCcceeccccccccc
Q 045798 157 LAKNKLTGGIPPFLGNLTSLEVLSLAGNSFGRNIPDSLGQLKQLKILAIGGNNLSGPIPPSIYNLSFLVVFSVSHNQIHG 236 (1008)
Q Consensus 157 L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~~ 236 (1008)
|++|.+++.+|..++++++|++|+|++|.+.+.+|..|+.+++|++|+|++|.+++.+|..+.++++|+.|++++|.+.+
T Consensus 147 Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~ 226 (968)
T PLN00113 147 LSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSG 226 (968)
T ss_pred CcCCcccccCChHHhcCCCCCEEECccCcccccCChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccCC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999998
Q ss_pred cCChhhhhcCCCCcEEEeccccCCCCCCcccccCCCCceeecccccccccccccccCCCcccccccccccCCCCCCCccc
Q 045798 237 SLPPSLGLLLPNLKFFQIHHNFFSGSIPISLSNASKLEHIEIANNNFSGKLSVNFGGMKNLSLLNLQFSNLGSGESDEMG 316 (1008)
Q Consensus 237 ~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~ 316 (1008)
.+|..+.. +++|++|+|++|.+.+.+|..+.++++|++|++++|++.+..|..+..+++|+.|++++|++...
T Consensus 227 ~~p~~l~~-l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~------ 299 (968)
T PLN00113 227 EIPYEIGG-LTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGE------ 299 (968)
T ss_pred cCChhHhc-CCCCCEEECcCceeccccChhHhCCCCCCEEECcCCeeeccCchhHhhccCcCEEECcCCeeccC------
Confidence 89987754 89999999999999999999999999999999999999999999999999999999999988643
Q ss_pred ccccccccCCCcEEEecCCcCCccCChhhhhhcccceeeeeccccccCCCCCccccccccceEEecCccccCCcchhccC
Q 045798 317 FMNSLTNCSKLRVLSLGGNQFRGALPHSIANLSSQLQILILSSNQFYGSIPLGIGNLVDLYLLGMVENQFTGAIPKEMGK 396 (1008)
Q Consensus 317 ~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~ 396 (1008)
++..+..+++|+.|++++|.+.+.+|..+..+. +|+.|++++|.+++.+|..++.+++|+.|++++|++.+.+|..+..
T Consensus 300 ~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~-~L~~L~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~~ 378 (968)
T PLN00113 300 IPELVIQLQNLEILHLFSNNFTGKIPVALTSLP-RLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCS 378 (968)
T ss_pred CChhHcCCCCCcEEECCCCccCCcCChhHhcCC-CCCEEECcCCCCcCcCChHHhCCCCCcEEECCCCeeEeeCChhHhC
Confidence 234678899999999999999999999999887 5999999999999999999999999999999999999999999999
Q ss_pred CCCCceEEccCCcccccccccccCCCCcceeeccccccccccCCCCcCCCcccEeecccccccCCcchhhhhhhhhhhhh
Q 045798 397 LQKLQGLDFSGNHFSGEIPSSLGNLSSLYEVFFNNNNLSGVIPFSLGNLKRLAFLEMSGNELSGTIPEDIFNISYLSNSL 476 (1008)
Q Consensus 397 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~lp~~~~~~~~~~~~L 476 (1008)
+++|+.|++++|++.+.+|..+..+++|+.|++++|.+++..|..|.++++|+.|++++|++++.+|..+..... ++.|
T Consensus 379 ~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~-L~~L 457 (968)
T PLN00113 379 SGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPS-LQML 457 (968)
T ss_pred cCCCCEEECcCCEecccCCHHHhCCCCCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCC-CcEE
Confidence 999999999999999999999999999999999999999999999999999999999999999988887766544 5789
Q ss_pred cccCccccCCCcccccccccccccccccccccCCCCcccccccccceeeccCcccccchhhhhhccccccEEecCCCccc
Q 045798 477 NLARNHLVGIIPPRIGNLRALRSFDVSNNDLSGEIPIELGHCSSLEEIYLAGNLFHGSIPSFFNALKGVQKIDLSRNNLS 556 (1008)
Q Consensus 477 ~L~~N~l~~~~p~~~~~l~~L~~Ldls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~ 556 (1008)
+|++|++.+.+|..++ .++|+.||+++|++++.+|..+..+++|++|+|++|++.+.+|..+..+++|+.|+|++|+++
T Consensus 458 ~L~~n~~~~~~p~~~~-~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 536 (968)
T PLN00113 458 SLARNKFFGGLPDSFG-SKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLS 536 (968)
T ss_pred ECcCceeeeecCcccc-cccceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCccc
Confidence 9999999999998764 589999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccCc-ccccccceeecccCcccccCCCC-cccCCcccceeccCCccCCCCCC
Q 045798 557 GQIPIF-LEALSLEYLNLSFNDFEGKIPAK-GIFANASAISVVGCNRLCGGIPE 608 (1008)
Q Consensus 557 ~~~p~~-~~~~~L~~L~l~~N~l~g~~p~~-~~~~~~~~~~~~~n~~l~g~~~~ 608 (1008)
|.+|.. ..+.+|+.|+|++|+++|.+|.. ..+..+..+.+.+| .+.|.+|.
T Consensus 537 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N-~l~~~~p~ 589 (968)
T PLN00113 537 GQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHN-HLHGSLPS 589 (968)
T ss_pred ccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEeccCC-cceeeCCC
Confidence 999987 67889999999999999999975 23445555555655 46666664
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-47 Score=416.01 Aligned_cols=290 Identities=40% Similarity=0.712 Sum_probs=241.0
Q ss_pred cCCCCCHHHHHHHhcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccchhhHHHHHHHHHHhhcCCCCceeeeec
Q 045798 670 ALPKMSYKSLLKATNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITS 749 (1008)
Q Consensus 670 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~ 749 (1008)
....|+++++..||++|...+.||+|+||.||+|... +|+.||||++.........+|.+|+.++.+++|||+|+++||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~-~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGy 139 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLS-DGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGY 139 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEEC-CCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEE
Confidence 4667999999999999999999999999999999996 669999998876543314559999999999999999999999
Q ss_pred cccccccCCceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCC
Q 045798 750 CSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSN 829 (1008)
Q Consensus 750 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~N 829 (1008)
|.+ .+++.++|||||++|+|.++++..... .++|.++++||.++|+||+|||+.+++.||||||||+|
T Consensus 140 C~e----~~~~~~LVYEym~nGsL~d~L~~~~~~--------~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssN 207 (361)
T KOG1187|consen 140 CLE----GGEHRLLVYEYMPNGSLEDHLHGKKGE--------PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSN 207 (361)
T ss_pred Eec----CCceEEEEEEccCCCCHHHHhCCCCCC--------CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHH
Confidence 863 222689999999999999999876421 67999999999999999999999888889999999999
Q ss_pred eeecCCCCeEEcccCccccccc-ccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccc-
Q 045798 830 ILLDNDLSGHIGDFGLARFHQE-VSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMF- 907 (1008)
Q Consensus 830 Ill~~~~~~kL~Dfg~a~~~~~-~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~- 907 (1008)
||+|+++++||+|||+|+.... ...... ...||.+|+|||++..+..+.|+|||||||++.|++||+.|.+...
T Consensus 208 ILLD~~~~aKlsDFGLa~~~~~~~~~~~~----~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~ 283 (361)
T KOG1187|consen 208 ILLDEDFNAKLSDFGLAKLGPEGDTSVST----TVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRP 283 (361)
T ss_pred eeECCCCCEEccCccCcccCCccccceee----ecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCC
Confidence 9999999999999999975543 211111 0059999999999999999999999999999999999999887543
Q ss_pred cCCccHHHHHHhhCCc-chhhhhcccccC-chHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHH
Q 045798 908 EGDLNLHNFARMALPN-QVMDIVDPILRN-DEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVV 985 (1008)
Q Consensus 908 ~~~~~~~~~~~~~~~~-~~~~~~d~~l~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl 985 (1008)
.....+..|+...+.. .+.+++|+.+.. ... ..++..++..++.+|++.+|.+||+|.||+
T Consensus 284 ~~~~~l~~w~~~~~~~~~~~eiiD~~l~~~~~~-----------------~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv 346 (361)
T KOG1187|consen 284 RGELSLVEWAKPLLEEGKLREIVDPRLKEGEYP-----------------DEKEVKKLAELALRCLRPDPKERPTMSQVV 346 (361)
T ss_pred cccccHHHHHHHHHHCcchhheeCCCccCCCCC-----------------hHHHHHHHHHHHHHHcCcCCCcCcCHHHHH
Confidence 3344577776555544 588889988762 211 014566689999999999999999999999
Q ss_pred HHHHHHHH
Q 045798 986 HELQSVKN 993 (1008)
Q Consensus 986 ~~L~~i~~ 993 (1008)
++|+.+..
T Consensus 347 ~~L~~~~~ 354 (361)
T KOG1187|consen 347 KELEGILS 354 (361)
T ss_pred HHHHhhcc
Confidence 99965543
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-46 Score=379.19 Aligned_cols=253 Identities=25% Similarity=0.350 Sum_probs=210.2
Q ss_pred CCCCceEeeccCeeEEEEEEcCCCeEEEEEEecccc-chhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCc-eEEE
Q 045798 686 FSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC-EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGND-FKAI 763 (1008)
Q Consensus 686 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~-~~~l 763 (1008)
.+..+.||+|..|+||+++++.+++.+|+|++.... +...+++.+|++++++.+||+||.++|+| ..+. ..+|
T Consensus 81 le~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF-----~~~~~~isI 155 (364)
T KOG0581|consen 81 LERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAF-----YSNGEEISI 155 (364)
T ss_pred hhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEE-----EeCCceEEe
Confidence 345688999999999999999999999999996543 45567899999999999999999999995 4444 5999
Q ss_pred EEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEccc
Q 045798 764 VYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDF 843 (1008)
Q Consensus 764 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 843 (1008)
+||||++|+|++++...+ ++++...-+|+.++++||.|||+. .+||||||||+|||+...|++|||||
T Consensus 156 ~mEYMDgGSLd~~~k~~g----------~i~E~~L~~ia~~VL~GL~YLh~~--~~IIHRDIKPsNlLvNskGeVKicDF 223 (364)
T KOG0581|consen 156 CMEYMDGGSLDDILKRVG----------RIPEPVLGKIARAVLRGLSYLHEE--RKIIHRDIKPSNLLVNSKGEVKICDF 223 (364)
T ss_pred ehhhcCCCCHHHHHhhcC----------CCCHHHHHHHHHHHHHHHHHHhhc--cCeeeccCCHHHeeeccCCCEEeccc
Confidence 999999999999998664 799999999999999999999963 39999999999999999999999999
Q ss_pred CcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCc
Q 045798 844 GLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMALPN 923 (1008)
Q Consensus 844 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~~~~~ 923 (1008)
|.+..+.... ....+||..|||||.+.+..|+.++||||||++++|+++|+.||....+. +.
T Consensus 224 GVS~~lvnS~------a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~------------~~ 285 (364)
T KOG0581|consen 224 GVSGILVNSI------ANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPP------------YL 285 (364)
T ss_pred cccHHhhhhh------cccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCC------------CC
Confidence 9998775541 23467999999999999999999999999999999999999998753111 11
Q ss_pred chhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 045798 924 QVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHE 987 (1008)
Q Consensus 924 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 987 (1008)
...++++..+.+.+ +..+. ..+++++..++..|++.||.+|||++|+++.
T Consensus 286 ~~~~Ll~~Iv~~pp-------------P~lP~-~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 286 DIFELLCAIVDEPP-------------PRLPE-GEFSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred CHHHHHHHHhcCCC-------------CCCCc-ccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 23333333333222 11111 1477889999999999999999999999874
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-45 Score=375.14 Aligned_cols=200 Identities=34% Similarity=0.543 Sum_probs=181.0
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccc--cchhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCce
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQ--CEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDF 760 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 760 (1008)
..+|...+.||+|+||+||+|+++.++..||||.+... .....+.+..|+.+++.++|||||++++++ ..+++
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~-----~~~~~ 83 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCI-----EDDDF 83 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEE-----ecCCe
Confidence 46788999999999999999999999999999999755 455667889999999999999999999994 56678
Q ss_pred EEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCC-----
Q 045798 761 KAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDND----- 835 (1008)
Q Consensus 761 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~----- 835 (1008)
.|+|||||.||+|.+|++..+ .+++..++.++.|||.||++||+. +||||||||+|||++..
T Consensus 84 i~lVMEyC~gGDLs~yi~~~~----------~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~ 150 (429)
T KOG0595|consen 84 IYLVMEYCNGGDLSDYIRRRG----------RLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDT 150 (429)
T ss_pred EEEEEEeCCCCCHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCC
Confidence 999999999999999999876 789999999999999999999997 99999999999999764
Q ss_pred -CCeEEcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCc
Q 045798 836 -LSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDV 905 (1008)
Q Consensus 836 -~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~ 905 (1008)
-.+||+|||+|+........ ...+|++.|||||++...+|+.|+|+||+|+++|++++|+.||+.
T Consensus 151 ~~~LKIADFGfAR~L~~~~~a-----~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a 216 (429)
T KOG0595|consen 151 SPVLKIADFGFARFLQPGSMA-----ETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDA 216 (429)
T ss_pred CceEEecccchhhhCCchhHH-----HHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccc
Confidence 45799999999988754322 346799999999999999999999999999999999999999974
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-44 Score=389.42 Aligned_cols=258 Identities=34% Similarity=0.509 Sum_probs=206.6
Q ss_pred CCCceEeeccCeeEEEEEEcCCCeE-EEEEEeccccch--hhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceEEE
Q 045798 687 SSTHLIGVGSFGCVYKGALDEDGIV-VAIKVINLQCEG--ASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKAI 763 (1008)
Q Consensus 687 ~~~~~lg~G~~g~Vy~~~~~~~~~~-vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 763 (1008)
.+.+.||+|+||+||+|.++ |+. ||||++...... ..+.|.+|+.+|.+++|||||+++|+|.... ...++
T Consensus 44 ~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~----~~~~i 117 (362)
T KOG0192|consen 44 PIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPP----GSLCI 117 (362)
T ss_pred hhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC----CceEE
Confidence 34466999999999999994 555 999999754322 2568999999999999999999999986422 15899
Q ss_pred EEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCC-ceeccCCCCCeeecCCC-CeEEc
Q 045798 764 VYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEP-ILHCDLKPSNILLDNDL-SGHIG 841 (1008)
Q Consensus 764 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~-ivH~Dlkp~NIll~~~~-~~kL~ 841 (1008)
||||+++|+|.++++... ...+++..++.|+.|||+||.|||+. + ||||||||+|||++.++ ++||+
T Consensus 118 VtEy~~~GsL~~~l~~~~--------~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~ 186 (362)
T KOG0192|consen 118 VTEYMPGGSLSVLLHKKR--------KRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIA 186 (362)
T ss_pred EEEeCCCCcHHHHHhhcc--------cCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEEC
Confidence 999999999999998741 11899999999999999999999998 6 99999999999999997 99999
Q ss_pred ccCcccccccccCccccccccccccccccCccccC--CCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHh
Q 045798 842 DFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGL--GSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARM 919 (1008)
Q Consensus 842 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~ 919 (1008)
|||+++...... .......||+.|||||++. ...|+.|+||||||+++|||+||+.||...............
T Consensus 187 DFGlsr~~~~~~----~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~- 261 (362)
T KOG0192|consen 187 DFGLSREKVISK----TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVG- 261 (362)
T ss_pred CCccceeecccc----ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhc-
Confidence 999998655432 1122256999999999999 569999999999999999999999999754321100000000
Q ss_pred hCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHHHHHHHHHH
Q 045798 920 ALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHELQSVKNILL 996 (1008)
Q Consensus 920 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~i~~~~~ 996 (1008)
..++.++ ..++..+..+|.+||+.||..||++.|++..|+.+.....
T Consensus 262 ----------------------------~~Rp~~p--~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~ 308 (362)
T KOG0192|consen 262 ----------------------------GLRPPIP--KECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHIS 308 (362)
T ss_pred ----------------------------CCCCCCC--ccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhc
Confidence 0011111 1267778999999999999999999999999999877644
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-44 Score=388.63 Aligned_cols=248 Identities=25% Similarity=0.354 Sum_probs=210.6
Q ss_pred cCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEecc---ccchhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCce
Q 045798 684 NGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINL---QCEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDF 760 (1008)
Q Consensus 684 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 760 (1008)
.+|...+.||+|||+.||++++..+|+.||+|++.. ..+...+.+.+|+++.++++|||||+++++ |++.++
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~-----FEDs~n 92 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHF-----FEDSNN 92 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeE-----eecCCc
Confidence 569999999999999999999988999999999974 345667889999999999999999999999 788999
Q ss_pred EEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEE
Q 045798 761 KAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHI 840 (1008)
Q Consensus 761 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 840 (1008)
+|||.|+|+.++|..+++..+ ++++.+++.+++||+.||.|||++ +|+|||||..|+|++++.++||
T Consensus 93 VYivLELC~~~sL~el~Krrk----------~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKI 159 (592)
T KOG0575|consen 93 VYIVLELCHRGSLMELLKRRK----------PLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKI 159 (592)
T ss_pred eEEEEEecCCccHHHHHHhcC----------CCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEe
Confidence 999999999999999998554 899999999999999999999998 9999999999999999999999
Q ss_pred cccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHhh
Q 045798 841 GDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMA 920 (1008)
Q Consensus 841 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~~ 920 (1008)
+|||+|.....+... ..+.+||+.|+|||++.....+..+||||+|||+|-|++|++||+..
T Consensus 160 gDFGLAt~le~~~Er----k~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk-------------- 221 (592)
T KOG0575|consen 160 GDFGLATQLEYDGER----KKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETK-------------- 221 (592)
T ss_pred cccceeeeecCcccc----cceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccc--------------
Confidence 999999987655333 23467999999999999999999999999999999999999998742
Q ss_pred CCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 921 LPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 921 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
.+.+.+++.-..++ .++. ..+.+-.++|.++|+.||.+|||+++|+.
T Consensus 222 ---~vkety~~Ik~~~Y----------~~P~------~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 222 ---TVKETYNKIKLNEY----------SMPS------HLSAEAKDLIRKLLRPNPSERPSLDEVLD 268 (592)
T ss_pred ---hHHHHHHHHHhcCc----------cccc------ccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 11111111111111 0111 23344589999999999999999999985
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=372.49 Aligned_cols=253 Identities=25% Similarity=0.314 Sum_probs=206.1
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccc-------hhhHHHHHHHHHHhhcCCCCceeeeeccccccc
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCE-------GASKSFMAECKALKNIRHRNLVKVITSCSSIDF 755 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 755 (1008)
.+.|.+.+.||+|+||.|-+|..+.+|+.||||+++...- ......++|+++|++++||+||+++++ +
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~-----f 245 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDF-----F 245 (475)
T ss_pred cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeee-----e
Confidence 4568889999999999999999999999999999974321 122346899999999999999999999 6
Q ss_pred cCCceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCC
Q 045798 756 QGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDND 835 (1008)
Q Consensus 756 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~ 835 (1008)
+.++..||||||++||+|.+++-.++ .+.+.....+++|++.|+.|||++ ||+||||||+|||+..+
T Consensus 246 ~~~ds~YmVlE~v~GGeLfd~vv~nk----------~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~ 312 (475)
T KOG0615|consen 246 EVPDSSYMVLEYVEGGELFDKVVANK----------YLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSND 312 (475)
T ss_pred ecCCceEEEEEEecCccHHHHHHhcc----------ccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccC
Confidence 77778999999999999999998776 577778899999999999999998 99999999999999765
Q ss_pred ---CCeEEcccCcccccccccCccccccccccccccccCccccCCCCC---CcccchhhHHHHHHHHHhCCCCCCccccC
Q 045798 836 ---LSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEV---STNGDVYSYGILLLEMVTAKKPTDVMFEG 909 (1008)
Q Consensus 836 ---~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~sDvwslG~vl~elltG~~pf~~~~~~ 909 (1008)
..+||+|||+|+..+... .+.+.+||+.|.|||++.+..+ ..++|+||+||++|-+++|.+||......
T Consensus 313 ~e~~llKItDFGlAK~~g~~s-----fm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~ 387 (475)
T KOG0615|consen 313 AEDCLLKITDFGLAKVSGEGS-----FMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTD 387 (475)
T ss_pred CcceEEEecccchhhccccce-----ehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCC
Confidence 788999999999765322 2345789999999999887643 34889999999999999999999765433
Q ss_pred CccHHHHHHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 910 DLNLHNFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 910 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
........+..+.. .-+.+.+..++-.++|.+|+..||++|||++|+++
T Consensus 388 ~sl~eQI~~G~y~f----------------------------~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 388 PSLKEQILKGRYAF----------------------------GPLQWDRISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred ccHHHHHhcCcccc----------------------------cChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 22222221111111 11124467777899999999999999999999986
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-44 Score=383.90 Aligned_cols=255 Identities=32% Similarity=0.487 Sum_probs=209.0
Q ss_pred CCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccchhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceEEEEE
Q 045798 686 FSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKAIVY 765 (1008)
Q Consensus 686 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 765 (1008)
++.++.||+|.||+||.|.+. ....||+|.++.. ....+.|.+|+++|++++|++||+++|+|.. ++.+||||
T Consensus 208 l~l~~~LG~G~FG~V~~g~~~-~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~-----~~piyIVt 280 (468)
T KOG0197|consen 208 LKLIRELGSGQFGEVWLGKWN-GSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTK-----QEPIYIVT 280 (468)
T ss_pred HHHHHHhcCCccceEEEEEEc-CCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEec-----CCceEEEE
Confidence 455688999999999999995 4458999999865 3445789999999999999999999999853 33699999
Q ss_pred eccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEcccCc
Q 045798 766 EYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGL 845 (1008)
Q Consensus 766 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~ 845 (1008)
|||+.|+|.+|++..... .+...+.+.++.|||+|++||+++ ++|||||.++||||+++..+||+|||+
T Consensus 281 E~m~~GsLl~yLr~~~~~--------~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGL 349 (468)
T KOG0197|consen 281 EYMPKGSLLDYLRTREGG--------LLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGL 349 (468)
T ss_pred EecccCcHHHHhhhcCCC--------ccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEccccc
Confidence 999999999999873322 788999999999999999999998 999999999999999999999999999
Q ss_pred ccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCccccCCccHHHHHHhhCCcc
Q 045798 846 ARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT-AKKPTDVMFEGDLNLHNFARMALPNQ 924 (1008)
Q Consensus 846 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~ 924 (1008)
|+...++ ......+..-+..|.|||++..+.++.|||||||||+||||+| |+.||.....
T Consensus 350 Ar~~~d~---~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn---------------- 410 (468)
T KOG0197|consen 350 ARLIGDD---EYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSN---------------- 410 (468)
T ss_pred ccccCCC---ceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCH----------------
Confidence 9944332 2222333446789999999999999999999999999999999 8888764311
Q ss_pred hhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHHHHHHH
Q 045798 925 VMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHELQSVKN 993 (1008)
Q Consensus 925 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~i~~ 993 (1008)
.+....++...+++.+. .||.+++++|..||+.+|++|||++.+...++.+..
T Consensus 411 ------------~ev~~~le~GyRlp~P~----~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~ 463 (468)
T KOG0197|consen 411 ------------EEVLELLERGYRLPRPE----GCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFT 463 (468)
T ss_pred ------------HHHHHHHhccCcCCCCC----CCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhh
Confidence 11112223334444433 488899999999999999999999998888887654
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-45 Score=355.96 Aligned_cols=262 Identities=26% Similarity=0.351 Sum_probs=208.1
Q ss_pred cCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccc--cchhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceE
Q 045798 684 NGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQ--CEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFK 761 (1008)
Q Consensus 684 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 761 (1008)
.+|++.++||+|+||+||+++...+|..||.|.++.. +..+.++...|+.++++++|||||+++++-. .++....
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f---~~~~evl 95 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSF---IEDNEVL 95 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhh---hccchhh
Confidence 3578889999999999999999999999999999854 3455678999999999999999999998522 2333448
Q ss_pred EEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCC-ceeccCCCCCeeecCCCCeEE
Q 045798 762 AIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEP-ILHCDLKPSNILLDNDLSGHI 840 (1008)
Q Consensus 762 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~-ivH~Dlkp~NIll~~~~~~kL 840 (1008)
+||||+|.+|+|.+.++.-+... ..+++..+++++.|++.||.++|+..+++ |+||||||.||+++.+|.+||
T Consensus 96 nivmE~c~~GDLsqmIk~~K~qk------r~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKL 169 (375)
T KOG0591|consen 96 NIVMELCDAGDLSQMIKHFKKQK------RLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKL 169 (375)
T ss_pred HHHHHhhcccCHHHHHHHHHhcc------ccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceee
Confidence 99999999999999997654332 27999999999999999999999943222 889999999999999999999
Q ss_pred cccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHhh
Q 045798 841 GDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMA 920 (1008)
Q Consensus 841 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~~ 920 (1008)
+|||+++.+...... ....+|||.||+||.+.+.+|+.||||||+||++|||+.-++||... ++....+
T Consensus 170 GDfGL~r~l~s~~tf----A~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~-----n~~~L~~-- 238 (375)
T KOG0591|consen 170 GDFGLGRFLSSKTTF----AHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD-----NLLSLCK-- 238 (375)
T ss_pred ccchhHhHhcchhHH----HHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc-----cHHHHHH--
Confidence 999999987654433 34578999999999999999999999999999999999999998642 1111111
Q ss_pred CCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHHH
Q 045798 921 LPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHELQ 989 (1008)
Q Consensus 921 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 989 (1008)
+.-..+. + +. +..-.+..+..++..|+..||+.||+...++..+.
T Consensus 239 ----------KI~qgd~------------~-~~-p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~ 283 (375)
T KOG0591|consen 239 ----------KIEQGDY------------P-PL-PDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQ 283 (375)
T ss_pred ----------HHHcCCC------------C-CC-cHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHH
Confidence 0000000 0 00 12346677899999999999999998655554443
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-43 Score=347.49 Aligned_cols=286 Identities=20% Similarity=0.229 Sum_probs=208.8
Q ss_pred cCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEecccc--chhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceE
Q 045798 684 NGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC--EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFK 761 (1008)
Q Consensus 684 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 761 (1008)
+.|+...++|+|+||.||+++++.+|+.||||++.... +...+-.++|++++++++|+|+|.++++ |......
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEV-----Frrkrkl 76 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEV-----FRRKRKL 76 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHH-----HHhccee
Confidence 46888899999999999999999999999999997432 3445678999999999999999999999 5667779
Q ss_pred EEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEc
Q 045798 762 AIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIG 841 (1008)
Q Consensus 762 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 841 (1008)
++|+|||+. ++.+-+..... .++...+.+++.|++.|+.|+|++ ++|||||||+|||++.+|.+|||
T Consensus 77 hLVFE~~dh-TvL~eLe~~p~---------G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLC 143 (396)
T KOG0593|consen 77 HLVFEYCDH-TVLHELERYPN---------GVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLC 143 (396)
T ss_pred EEEeeecch-HHHHHHHhccC---------CCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEec
Confidence 999999966 55444544432 578899999999999999999998 99999999999999999999999
Q ss_pred ccCcccccccccCccccccccccccccccCccccCC-CCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHH-Hh
Q 045798 842 DFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLG-SEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFA-RM 919 (1008)
Q Consensus 842 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~-~~ 919 (1008)
|||+|+.+....+. .+..+.|.+|+|||.+.+ .+|++.+||||+||++.||++|.+-|....+-|..+.... -.
T Consensus 144 DFGFAR~L~~pgd~----YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG 219 (396)
T KOG0593|consen 144 DFGFARTLSAPGDN----YTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLG 219 (396)
T ss_pred cchhhHhhcCCcch----hhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHc
Confidence 99999987643322 234568999999999888 6899999999999999999999998865433222211111 01
Q ss_pred hCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH--HHHHHHHH
Q 045798 920 ALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH--ELQSVKNI 994 (1008)
Q Consensus 920 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~--~L~~i~~~ 994 (1008)
.+.+....+....-.... ..+.+...+.+-.........-+.+++..|++.||++|++.+|++. ..+.+.+.
T Consensus 220 ~L~prhq~iF~~N~~F~G---v~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~~~er 293 (396)
T KOG0593|consen 220 NLIPRHQSIFSSNPFFHG---VRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDGFIER 293 (396)
T ss_pred ccCHHHHHHhccCCceee---eecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHHHHHH
Confidence 112222222211000000 0000000000001111234456899999999999999999999986 24444433
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-45 Score=374.91 Aligned_cols=442 Identities=27% Similarity=0.422 Sum_probs=314.4
Q ss_pred eEEEEeccccCCCCccCcCccCCccCCeeeecCCCCCCCCCccccCCCCCCEEEccCCCCCCccCcccccCcCcceEeee
Q 045798 55 RVTALDLMSKSLSGSLSPHLGNLSFLREINLSNNTIQGEIPPEFGRLFRLEALFLSNNSLVGKIPANLSYCSRLTVLCIE 134 (1008)
Q Consensus 55 ~v~~l~l~~~~l~~~l~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls 134 (1008)
..+.+++.+|.++ .+|++++.+..++.|+.++|+++ .+|+.+..+.+|..|+.++|.+. .+|+.++.+..|..|+..
T Consensus 69 ~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~l~~s~n~~~-el~~~i~~~~~l~dl~~~ 145 (565)
T KOG0472|consen 69 CLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLS-ELPEQIGSLISLVKLDCSSNELK-ELPDSIGRLLDLEDLDAT 145 (565)
T ss_pred ceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHh-hccHHHhhhhhhhhhhcccccee-ecCchHHHHhhhhhhhcc
Confidence 4667777777777 67778888888888888888877 77778888888888888888887 777778888888888888
Q ss_pred ccccccCCCccccccCCCCeeecccccCCCCCCCCCccccccchhhcccccCCCCCCccccCCCCCcEEEecCCcccccC
Q 045798 135 YNKLQGRIPLEFVSLSKLKDLSLAKNKLTGGIPPFLGNLTSLEVLSLAGNSFGRNIPDSLGQLKQLKILAIGGNNLSGPI 214 (1008)
Q Consensus 135 ~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~ 214 (1008)
+|+++ ..|+.+.++.+|..|++.+|+++ ..|+..-+++.|++||+..|-+ +.+|..++.+.+|..|+|.+|.|. ..
T Consensus 146 ~N~i~-slp~~~~~~~~l~~l~~~~n~l~-~l~~~~i~m~~L~~ld~~~N~L-~tlP~~lg~l~~L~~LyL~~Nki~-~l 221 (565)
T KOG0472|consen 146 NNQIS-SLPEDMVNLSKLSKLDLEGNKLK-ALPENHIAMKRLKHLDCNSNLL-ETLPPELGGLESLELLYLRRNKIR-FL 221 (565)
T ss_pred ccccc-cCchHHHHHHHHHHhhccccchh-hCCHHHHHHHHHHhcccchhhh-hcCChhhcchhhhHHHHhhhcccc-cC
Confidence 88887 67777777888888888888888 4455555588888888888888 667888899999999999999988 45
Q ss_pred CccccCCCCcceeccccccccccCChhhhhcCCCCcEEEeccccCCCCCCcccccCCCCceeecccccccccccccccCC
Q 045798 215 PPSIYNLSFLVVFSVSHNQIHGSLPPSLGLLLPNLKFFQIHHNFFSGSIPISLSNASKLEHIEIANNNFSGKLSVNFGGM 294 (1008)
Q Consensus 215 ~~~~~~l~~L~~L~ls~N~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l 294 (1008)
| .|.+++.|.+|+++.|+|. .+|....+.++++..|||..|+++ ..|+.++-+.+|++||+++|.|++ .|..+++|
T Consensus 222 P-ef~gcs~L~Elh~g~N~i~-~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clLrsL~rLDlSNN~is~-Lp~sLgnl 297 (565)
T KOG0472|consen 222 P-EFPGCSLLKELHVGENQIE-MLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLLRSLERLDLSNNDISS-LPYSLGNL 297 (565)
T ss_pred C-CCCccHHHHHHHhcccHHH-hhHHHHhcccccceeeeccccccc-cCchHHHHhhhhhhhcccCCcccc-CCcccccc
Confidence 6 7888899999999999998 889998888999999999999998 789999999999999999999984 56788888
Q ss_pred CcccccccccccCCCCCCC-----------------------------------cccccccccccCCCcEEEecCCcCCc
Q 045798 295 KNLSLLNLQFSNLGSGESD-----------------------------------EMGFMNSLTNCSKLRVLSLGGNQFRG 339 (1008)
Q Consensus 295 ~~L~~L~L~~n~l~~~~~~-----------------------------------~~~~~~~l~~l~~L~~L~Ls~N~l~~ 339 (1008)
+|+.|-+.+|.+.++..+ ....+.....+.+.+.|++++-+++
T Consensus 298 -hL~~L~leGNPlrTiRr~ii~~gT~~vLKyLrs~~~~dglS~se~~~e~~~t~~~~~~~~~~~~i~tkiL~~s~~qlt- 375 (565)
T KOG0472|consen 298 -HLKFLALEGNPLRTIRREIISKGTQEVLKYLRSKIKDDGLSQSEGGTETAMTLPSESFPDIYAIITTKILDVSDKQLT- 375 (565)
T ss_pred -eeeehhhcCCchHHHHHHHHcccHHHHHHHHHHhhccCCCCCCcccccccCCCCCCcccchhhhhhhhhhcccccccc-
Confidence 888888888887432110 0011112233445555555555555
Q ss_pred cCChhhhhhcc--cceeeeeccccccCCCCCccccccccceEEecCccccCCcchhccCCCCCceEEccCCccccccccc
Q 045798 340 ALPHSIANLSS--QLQILILSSNQFYGSIPLGIGNLVDLYLLGMVENQFTGAIPKEMGKLQKLQGLDFSGNHFSGEIPSS 417 (1008)
Q Consensus 340 ~~p~~~~~l~~--~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~ 417 (1008)
.+|+.++.... -.+..+++.|++. ++|..+..+..+... +++++|.+. .+|..
T Consensus 376 ~VPdEVfea~~~~~Vt~VnfskNqL~-elPk~L~~lkelvT~-----------------------l~lsnn~is-fv~~~ 430 (565)
T KOG0472|consen 376 LVPDEVFEAAKSEIVTSVNFSKNQLC-ELPKRLVELKELVTD-----------------------LVLSNNKIS-FVPLE 430 (565)
T ss_pred cCCHHHHHHhhhcceEEEecccchHh-hhhhhhHHHHHHHHH-----------------------HHhhcCccc-cchHH
Confidence 55555444321 1445555555555 445444444433322 233333333 55555
Q ss_pred ccCCCCcceeeccccccccccCCCCcCCCcccEeecccccccCCcchhhhhhhhhhhhhcccCccccCCCcccccccccc
Q 045798 418 LGNLSSLYEVFFNNNNLSGVIPFSLGNLKRLAFLEMSGNELSGTIPEDIFNISYLSNSLNLARNHLVGIIPPRIGNLRAL 497 (1008)
Q Consensus 418 ~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~lp~~~~~~~~~~~~L~L~~N~l~~~~p~~~~~l~~L 497 (1008)
++.+++|..|+|++|-+. .+|..++.+..|+.||+|.|+|. .+|+.++....+ +.+-.++|++...-|+.+.++.+|
T Consensus 431 l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~l-Etllas~nqi~~vd~~~l~nm~nL 507 (565)
T KOG0472|consen 431 LSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFR-MLPECLYELQTL-ETLLASNNQIGSVDPSGLKNMRNL 507 (565)
T ss_pred HHhhhcceeeecccchhh-hcchhhhhhhhhheecccccccc-cchHHHhhHHHH-HHHHhccccccccChHHhhhhhhc
Confidence 555555556666555555 56777777778888888888887 677766655443 344445566665555557777888
Q ss_pred cccccccccccCCCCcccccccccceeeccCcccccchhhhh
Q 045798 498 RSFDVSNNDLSGEIPIELGHCSSLEEIYLAGNLFHGSIPSFF 539 (1008)
Q Consensus 498 ~~Ldls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~ 539 (1008)
..|||.+|.+. .+|+.+++|++|++|+|+||+|+ .++..+
T Consensus 508 ~tLDL~nNdlq-~IPp~LgnmtnL~hLeL~gNpfr-~Pr~~i 547 (565)
T KOG0472|consen 508 TTLDLQNNDLQ-QIPPILGNMTNLRHLELDGNPFR-QPRHQI 547 (565)
T ss_pred ceeccCCCchh-hCChhhccccceeEEEecCCccC-CCHHHH
Confidence 88888888887 77777777777777777777777 444443
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-42 Score=352.34 Aligned_cols=201 Identities=33% Similarity=0.455 Sum_probs=182.5
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEecccc---chhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCc
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC---EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGND 759 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 759 (1008)
.++|++.++||+|+||+||.++.+.+++.||+|+++... ..+.+...+|..++.+++||.||+++.. |++++
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ys-----FQt~~ 98 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYS-----FQTEE 98 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEe-----cccCC
Confidence 567999999999999999999999999999999997442 3456788999999999999999999988 78999
Q ss_pred eEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeE
Q 045798 760 FKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGH 839 (1008)
Q Consensus 760 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 839 (1008)
..|+|+||+.||.|..++++.+ .+++..++-++..|+.||.|||+. +|||||+||+|||+|.+|+++
T Consensus 99 kLylVld~~~GGeLf~hL~~eg----------~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~ 165 (357)
T KOG0598|consen 99 KLYLVLDYLNGGELFYHLQREG----------RFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIK 165 (357)
T ss_pred eEEEEEeccCCccHHHHHHhcC----------CcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEE
Confidence 9999999999999999998776 899999999999999999999997 999999999999999999999
Q ss_pred EcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCc
Q 045798 840 IGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDV 905 (1008)
Q Consensus 840 L~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~ 905 (1008)
|+|||+++........ +.+++||+.|||||++.+..|+.++|.||+|+++|||++|.+||..
T Consensus 166 LtDFgL~k~~~~~~~~----t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~ 227 (357)
T KOG0598|consen 166 LTDFGLCKEDLKDGDA----TRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYA 227 (357)
T ss_pred EeccccchhcccCCCc----cccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcC
Confidence 9999999854443322 2347899999999999999999999999999999999999999974
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-42 Score=384.71 Aligned_cols=269 Identities=25% Similarity=0.420 Sum_probs=215.1
Q ss_pred cCCCCCceEeeccCeeEEEEEEc-----CCCeEEEEEEeccccch-hhHHHHHHHHHHhhcCCCCceeeeeccccccccC
Q 045798 684 NGFSSTHLIGVGSFGCVYKGALD-----EDGIVVAIKVINLQCEG-ASKSFMAECKALKNIRHRNLVKVITSCSSIDFQG 757 (1008)
Q Consensus 684 ~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 757 (1008)
.+....+.||+|+||+||+|+.. ++...||||.++...+. ...+|++|++++..++|||||+++|+|. .
T Consensus 486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~-----~ 560 (774)
T KOG1026|consen 486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCR-----E 560 (774)
T ss_pred hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEc-----c
Confidence 34556788999999999999884 34468999999977665 7789999999999999999999999985 4
Q ss_pred CceEEEEEeccCCCChhcccccCCCCCCCc----ccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeec
Q 045798 758 NDFKAIVYEYMPNGSLEKWLHPHAVPKRDK----EIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLD 833 (1008)
Q Consensus 758 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~----~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~ 833 (1008)
++..|+|+|||..|||.+|+..+....... +...+++..+.+.||.|||.||+||-++ .+|||||..+|+||.
T Consensus 561 ~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVg 637 (774)
T KOG1026|consen 561 GDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVG 637 (774)
T ss_pred CCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceec
Confidence 666999999999999999998765432211 1133599999999999999999999998 999999999999999
Q ss_pred CCCCeEEcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCccccCCcc
Q 045798 834 NDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT-AKKPTDVMFEGDLN 912 (1008)
Q Consensus 834 ~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-G~~pf~~~~~~~~~ 912 (1008)
++..|||+|||+++..-..+- +.....-.-.++|||||.+..++||.+|||||||||+||+++ |+.||.....++
T Consensus 638 e~l~VKIsDfGLsRdiYssDY--Yk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~E-- 713 (774)
T KOG1026|consen 638 ENLVVKISDFGLSRDIYSSDY--YKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQE-- 713 (774)
T ss_pred cceEEEecccccchhhhhhhh--hcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHH--
Confidence 999999999999984432221 111112335789999999999999999999999999999999 899986432211
Q ss_pred HHHHHHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHHHHHH
Q 045798 913 LHNFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHELQSVK 992 (1008)
Q Consensus 913 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~i~ 992 (1008)
+.+.+ ...+ -.+..+.||.+++.||..||+.+|++||+++||-.+|+..-
T Consensus 714 ------------VIe~i--------------~~g~----lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~ 763 (774)
T KOG1026|consen 714 ------------VIECI--------------RAGQ----LLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWA 763 (774)
T ss_pred ------------HHHHH--------------HcCC----cccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHH
Confidence 00000 0000 12234568999999999999999999999999999999875
Q ss_pred HH
Q 045798 993 NI 994 (1008)
Q Consensus 993 ~~ 994 (1008)
..
T Consensus 764 ~~ 765 (774)
T KOG1026|consen 764 QA 765 (774)
T ss_pred hc
Confidence 54
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-42 Score=363.10 Aligned_cols=256 Identities=28% Similarity=0.375 Sum_probs=211.5
Q ss_pred HHHhcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccc---cchhhHHHHHHHHHHhhc-CCCCceeeeeccccccc
Q 045798 680 LKATNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQ---CEGASKSFMAECKALKNI-RHRNLVKVITSCSSIDF 755 (1008)
Q Consensus 680 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 755 (1008)
.+..++|.+.+.||+|+|++||+|+.+.+++.||||++... .+...+.+..|-.+|.+| +||.|++++.. |
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~T-----F 143 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFT-----F 143 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEE-----e
Confidence 34467899999999999999999999999999999999633 234446678899999999 99999999988 7
Q ss_pred cCCceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCC
Q 045798 756 QGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDND 835 (1008)
Q Consensus 756 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~ 835 (1008)
+++...|+|+||+++|+|.++|++.+ .+++..++.++.||+.||+|||++ |||||||||+|||+|++
T Consensus 144 QD~~sLYFvLe~A~nGdll~~i~K~G----------sfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~d 210 (604)
T KOG0592|consen 144 QDEESLYFVLEYAPNGDLLDLIKKYG----------SFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKD 210 (604)
T ss_pred ecccceEEEEEecCCCcHHHHHHHhC----------cchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCC
Confidence 88889999999999999999999876 799999999999999999999998 99999999999999999
Q ss_pred CCeEEcccCcccccccccCc---------cccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCcc
Q 045798 836 LSGHIGDFGLARFHQEVSNS---------TLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVM 906 (1008)
Q Consensus 836 ~~~kL~Dfg~a~~~~~~~~~---------~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~ 906 (1008)
+++||+|||.|+.+.+.... .......++||..|.+||++.....++.+|+|+|||++|+|+.|.+||...
T Consensus 211 mhikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~ 290 (604)
T KOG0592|consen 211 GHIKITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAA 290 (604)
T ss_pred CcEEEeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccc
Confidence 99999999999987654332 111124578999999999999999999999999999999999999999753
Q ss_pred ccCCccHHHHHHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 907 FEGDLNLHNFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 907 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
.+ +..+- .+++- ...+++. .++...+|+.+.+..||.+|+|++||.+
T Consensus 291 Ne----yliFq---------kI~~l--------------~y~fp~~------fp~~a~dLv~KLLv~dp~~Rlt~~qIk~ 337 (604)
T KOG0592|consen 291 NE----YLIFQ---------KIQAL--------------DYEFPEG------FPEDARDLIKKLLVRDPSDRLTSQQIKA 337 (604)
T ss_pred cH----HHHHH---------HHHHh--------------cccCCCC------CCHHHHHHHHHHHccCccccccHHHHhh
Confidence 22 11110 11110 0112222 2345689999999999999999988766
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=363.65 Aligned_cols=274 Identities=21% Similarity=0.244 Sum_probs=207.3
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccchhh-HHHHHHHHHHhhcC-CCCceeeeeccccccccCCc-
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGAS-KSFMAECKALKNIR-HRNLVKVITSCSSIDFQGND- 759 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~-~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~- 759 (1008)
.++|.++++||.|.||.||+|+..++++.||||.++..-.... -.-.+|++.+++++ ||||+++.+++. +.+
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~-----d~~~ 83 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIR-----DNDR 83 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhh-----ccCc
Confidence 5689999999999999999999999999999999985543332 34578999999998 999999999953 334
Q ss_pred eEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeE
Q 045798 760 FKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGH 839 (1008)
Q Consensus 760 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 839 (1008)
..++||||| ..+|++.++.... .+++..++.|+.||++||+|+|++ |+.|||+||+|||+.....+|
T Consensus 84 ~L~fVfE~M-d~NLYqLmK~R~r---------~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iK 150 (538)
T KOG0661|consen 84 ILYFVFEFM-DCNLYQLMKDRNR---------LFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIK 150 (538)
T ss_pred eEeeeHHhh-hhhHHHHHhhcCC---------cCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeE
Confidence 899999999 7799999987632 899999999999999999999998 999999999999999999999
Q ss_pred EcccCcccccccccCccccccccccccccccCccccC-CCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHH
Q 045798 840 IGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGL-GSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFAR 918 (1008)
Q Consensus 840 L~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~ 918 (1008)
|+|||+|+.+...... +..+.|.+|+|||++. .+.|+.+.||||+|||++|+.+-++.|....+-|..+.. ..
T Consensus 151 iaDFGLARev~SkpPY-----TeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KI-c~ 224 (538)
T KOG0661|consen 151 IADFGLAREVRSKPPY-----TEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKI-CE 224 (538)
T ss_pred ecccccccccccCCCc-----chhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHH-HH
Confidence 9999999977654433 3456899999999865 467899999999999999999999988755443322211 11
Q ss_pred hhCCcchhhhhcccccCchHHhhhhhhhhhccccch-----hHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 045798 919 MALPNQVMDIVDPILRNDEEILASTDKCRRMQTGIN-----SRLECLISMVKIGVACSMESPQDRMNMTNVVHE 987 (1008)
Q Consensus 919 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 987 (1008)
....+...++.. ........ .-+++...+ -...++.+..+++.+|+++||.+||||+|.++.
T Consensus 225 VLGtP~~~~~~e-----g~~La~~m--nf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 225 VLGTPDKDSWPE-----GYNLASAM--NFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HhCCCccccchh-----HHHHHHHh--ccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 111111000000 00000000 000110000 011366778999999999999999999999863
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-44 Score=369.83 Aligned_cols=477 Identities=24% Similarity=0.349 Sum_probs=347.2
Q ss_pred CccCCeeeecCCCCCCCCCccccCCCCCCEEEccCCCCCCccCcccccCcCcceEeeeccccccCCCccccccCCCCeee
Q 045798 77 LSFLREINLSNNTIQGEIPPEFGRLFRLEALFLSNNSLVGKIPANLSYCSRLTVLCIEYNKLQGRIPLEFVSLSKLKDLS 156 (1008)
Q Consensus 77 l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~ 156 (1008)
-..|+.|.+++|+++ .+.+.+.++..|.+|++++|+++ ..|.+++.+..++.|+.++|+++ .+|+.++++.+|++|+
T Consensus 44 qv~l~~lils~N~l~-~l~~dl~nL~~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~l~ 120 (565)
T KOG0472|consen 44 QVDLQKLILSHNDLE-VLREDLKNLACLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLS-ELPEQIGSLISLVKLD 120 (565)
T ss_pred hcchhhhhhccCchh-hccHhhhcccceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHh-hccHHHhhhhhhhhhh
Confidence 345666777777766 45555666666666666666666 55666666666666666666666 5666666666666666
Q ss_pred cccccCCCCCCCCCccccccchhhcccccCCCCCCccccCCCCCcEEEecCCcccccCCccccCCCCcceeccccccccc
Q 045798 157 LAKNKLTGGIPPFLGNLTSLEVLSLAGNSFGRNIPDSLGQLKQLKILAIGGNNLSGPIPPSIYNLSFLVVFSVSHNQIHG 236 (1008)
Q Consensus 157 L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~~ 236 (1008)
++.|.+. .+|+.++.+..|+.|+..+|+++ ..|.++..+.+|..|++.+|+++
T Consensus 121 ~s~n~~~-el~~~i~~~~~l~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~------------------------- 173 (565)
T KOG0472|consen 121 CSSNELK-ELPDSIGRLLDLEDLDATNNQIS-SLPEDMVNLSKLSKLDLEGNKLK------------------------- 173 (565)
T ss_pred cccccee-ecCchHHHHhhhhhhhccccccc-cCchHHHHHHHHHHhhccccchh-------------------------
Confidence 6666666 55555666666666666666652 34444444444444454444444
Q ss_pred cCChhhhhcCCCCcEEEeccccCCCCCCcccccCCCCceeecccccccccccccccCCCcccccccccccCCCCCCCccc
Q 045798 237 SLPPSLGLLLPNLKFFQIHHNFFSGSIPISLSNASKLEHIEIANNNFSGKLSVNFGGMKNLSLLNLQFSNLGSGESDEMG 316 (1008)
Q Consensus 237 ~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~ 316 (1008)
.+|+.... ++.|++||..+|-+. .+|..++.+.+|+.|++.+|+|... | .|.++..|++++++.|+|..++..
T Consensus 174 ~l~~~~i~-m~~L~~ld~~~N~L~-tlP~~lg~l~~L~~LyL~~Nki~~l-P-ef~gcs~L~Elh~g~N~i~~lpae--- 246 (565)
T KOG0472|consen 174 ALPENHIA-MKRLKHLDCNSNLLE-TLPPELGGLESLELLYLRRNKIRFL-P-EFPGCSLLKELHVGENQIEMLPAE--- 246 (565)
T ss_pred hCCHHHHH-HHHHHhcccchhhhh-cCChhhcchhhhHHHHhhhcccccC-C-CCCccHHHHHHHhcccHHHhhHHH---
Confidence 34443333 555555555555555 5666677777777888888877743 3 677888888888888887766533
Q ss_pred ccccccccCCCcEEEecCCcCCccCChhhhhhcccceeeeeccccccCCCCCccccccccceEEecCccccCCcchhccC
Q 045798 317 FMNSLTNCSKLRVLSLGGNQFRGALPHSIANLSSQLQILILSSNQFYGSIPLGIGNLVDLYLLGMVENQFTGAIPKEMGK 396 (1008)
Q Consensus 317 ~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~ 396 (1008)
...++.++.+|||..|+++ .+|+.++-+. +|++||+|+|.|+ .+|..++++ .|+.|.+.+|.+..+..+-+..
T Consensus 247 ---~~~~L~~l~vLDLRdNklk-e~Pde~clLr-sL~rLDlSNN~is-~Lp~sLgnl-hL~~L~leGNPlrTiRr~ii~~ 319 (565)
T KOG0472|consen 247 ---HLKHLNSLLVLDLRDNKLK-EVPDEICLLR-SLERLDLSNNDIS-SLPYSLGNL-HLKFLALEGNPLRTIRREIISK 319 (565)
T ss_pred ---Hhcccccceeeeccccccc-cCchHHHHhh-hhhhhcccCCccc-cCCcccccc-eeeehhhcCCchHHHHHHHHcc
Confidence 5668889999999999999 8999999886 4999999999999 788899999 9999999999987543333322
Q ss_pred CC--CCceEE-------ccCCccc----cc----ccccccCCCCcceeeccccccccccCCCCcCCCc---ccEeecccc
Q 045798 397 LQ--KLQGLD-------FSGNHFS----GE----IPSSLGNLSSLYEVFFNNNNLSGVIPFSLGNLKR---LAFLEMSGN 456 (1008)
Q Consensus 397 l~--~L~~L~-------Ls~N~l~----~~----~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~---L~~L~Ls~N 456 (1008)
-+ -|++|. +|.-+=. +. .-.....+.+.+.|+++.-+++ .+|.....-.. ....+++.|
T Consensus 320 gT~~vLKyLrs~~~~dglS~se~~~e~~~t~~~~~~~~~~~~i~tkiL~~s~~qlt-~VPdEVfea~~~~~Vt~VnfskN 398 (565)
T KOG0472|consen 320 GTQEVLKYLRSKIKDDGLSQSEGGTETAMTLPSESFPDIYAIITTKILDVSDKQLT-LVPDEVFEAAKSEIVTSVNFSKN 398 (565)
T ss_pred cHHHHHHHHHHhhccCCCCCCcccccccCCCCCCcccchhhhhhhhhhcccccccc-cCCHHHHHHhhhcceEEEecccc
Confidence 11 022221 1111100 01 1112345667889999999998 45554433333 788999999
Q ss_pred cccCCcchhhhhhhhhhhhhcccCccccCCCcccccccccccccccccccccCCCCcccccccccceeeccCcccccchh
Q 045798 457 ELSGTIPEDIFNISYLSNSLNLARNHLVGIIPPRIGNLRALRSFDVSNNDLSGEIPIELGHCSSLEEIYLAGNLFHGSIP 536 (1008)
Q Consensus 457 ~l~~~lp~~~~~~~~~~~~L~L~~N~l~~~~p~~~~~l~~L~~Ldls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p 536 (1008)
++. ++|.++.....+...+.+++|.+. .+|..++.+++|..|+|++|.+. .+|.+++.+..|++|+++.|+|. .+|
T Consensus 399 qL~-elPk~L~~lkelvT~l~lsnn~is-fv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr-~lP 474 (565)
T KOG0472|consen 399 QLC-ELPKRLVELKELVTDLVLSNNKIS-FVPLELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFR-MLP 474 (565)
T ss_pred hHh-hhhhhhHHHHHHHHHHHhhcCccc-cchHHHHhhhcceeeecccchhh-hcchhhhhhhhhheecccccccc-cch
Confidence 998 899999999998888889888886 78999999999999999999998 89999999999999999999999 899
Q ss_pred hhhhccccccEEecCCCcccccccCc-ccccccceeecccCcccccCCCCcccCCcccceeccCCcc
Q 045798 537 SFFNALKGVQKIDLSRNNLSGQIPIF-LEALSLEYLNLSFNDFEGKIPAKGIFANASAISVVGCNRL 602 (1008)
Q Consensus 537 ~~~~~l~~L~~L~ls~N~l~~~~p~~-~~~~~L~~L~l~~N~l~g~~p~~~~~~~~~~~~~~~n~~l 602 (1008)
..+..+..|+.+-.++|++....|.. ..+.+|.+|||.+|.++..+|..+...++..+-+.|||+-
T Consensus 475 ~~~y~lq~lEtllas~nqi~~vd~~~l~nm~nL~tLDL~nNdlq~IPp~LgnmtnL~hLeL~gNpfr 541 (565)
T KOG0472|consen 475 ECLYELQTLETLLASNNQIGSVDPSGLKNMRNLTTLDLQNNDLQQIPPILGNMTNLRHLELDGNPFR 541 (565)
T ss_pred HHHhhHHHHHHHHhccccccccChHHhhhhhhcceeccCCCchhhCChhhccccceeEEEecCCccC
Confidence 99999999999999999999777764 5667899999999999999998888999999888998653
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-42 Score=378.04 Aligned_cols=267 Identities=26% Similarity=0.469 Sum_probs=223.2
Q ss_pred CCCCCceEeeccCeeEEEEEEcCCC---eEEEEEEecccc-chhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCce
Q 045798 685 GFSSTHLIGVGSFGCVYKGALDEDG---IVVAIKVINLQC-EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDF 760 (1008)
Q Consensus 685 ~y~~~~~lg~G~~g~Vy~~~~~~~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 760 (1008)
...+.++||.|.||+||+|+.+..| ..||||.++... ++...+|..|+.||.++.||||+++.|+ ......
T Consensus 630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGV-----VTks~P 704 (996)
T KOG0196|consen 630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGV-----VTKSKP 704 (996)
T ss_pred heEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEE-----EecCce
Confidence 3467789999999999999997655 579999999654 4566789999999999999999999999 566778
Q ss_pred EEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEE
Q 045798 761 KAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHI 840 (1008)
Q Consensus 761 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 840 (1008)
.+||+|||++|+|+.|++.+.. ++++.+...++++||.|++||-+. ++|||||.++|||++.+..+|+
T Consensus 705 vMIiTEyMENGsLDsFLR~~DG---------qftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsnLvCKV 772 (996)
T KOG0196|consen 705 VMIITEYMENGSLDSFLRQNDG---------QFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILVNSNLVCKV 772 (996)
T ss_pred eEEEhhhhhCCcHHHHHhhcCC---------ceEeehHHHHHHHHHHHhHHHhhc---CchhhhhhhhheeeccceEEEe
Confidence 9999999999999999987753 789999999999999999999998 9999999999999999999999
Q ss_pred cccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCccccCCccHHHHHHh
Q 045798 841 GDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT-AKKPTDVMFEGDLNLHNFARM 919 (1008)
Q Consensus 841 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-G~~pf~~~~~~~~~~~~~~~~ 919 (1008)
+|||+++.++++....+. ..+-.-+.+|.|||.+..+.+|.+|||||||+|+||.++ |.+||.++...
T Consensus 773 sDFGLSRvledd~~~~yt-t~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQ---------- 841 (996)
T KOG0196|consen 773 SDFGLSRVLEDDPEAAYT-TLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ---------- 841 (996)
T ss_pred ccccceeecccCCCcccc-ccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchH----------
Confidence 999999988766533322 233345689999999999999999999999999999887 99998654221
Q ss_pred hCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHHHHHHHHHHHHH
Q 045798 920 ALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHELQSVKNILLELE 999 (1008)
Q Consensus 920 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~i~~~~~~~~ 999 (1008)
+.+..+++..++++ ..+||..|.+||..||+.|-.+||++.+|+..|+++-..=..++
T Consensus 842 ------------------dVIkaIe~gyRLPp----PmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~SLk 899 (996)
T KOG0196|consen 842 ------------------DVIKAIEQGYRLPP----PMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPNSLK 899 (996)
T ss_pred ------------------HHHHHHHhccCCCC----CCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCchhhc
Confidence 12222333344443 34689999999999999999999999999999999865544444
Q ss_pred Hh
Q 045798 1000 TV 1001 (1008)
Q Consensus 1000 ~~ 1001 (1008)
+.
T Consensus 900 ~~ 901 (996)
T KOG0196|consen 900 TI 901 (996)
T ss_pred cc
Confidence 43
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=357.46 Aligned_cols=280 Identities=26% Similarity=0.327 Sum_probs=211.2
Q ss_pred cCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEecccc--chhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceE
Q 045798 684 NGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC--EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFK 761 (1008)
Q Consensus 684 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 761 (1008)
+.|+.+++||+|.||.||+|++..+|+.||+|+++... ++......+||.||+++.||||+++.+.... ......
T Consensus 117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~---~~~~si 193 (560)
T KOG0600|consen 117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTS---KLSGSI 193 (560)
T ss_pred HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEe---cCCceE
Confidence 35677789999999999999999999999999998665 4555678899999999999999999998543 234679
Q ss_pred EEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEc
Q 045798 762 AIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIG 841 (1008)
Q Consensus 762 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 841 (1008)
|+|+|||++ +|..++.... .++++.++..+++|++.||+|+|++ ||+|||||.+|||||.+|.+||+
T Consensus 194 YlVFeYMdh-DL~GLl~~p~---------vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKia 260 (560)
T KOG0600|consen 194 YLVFEYMDH-DLSGLLSSPG---------VKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIA 260 (560)
T ss_pred EEEEecccc-hhhhhhcCCC---------cccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEec
Confidence 999999955 9998887643 2899999999999999999999998 99999999999999999999999
Q ss_pred ccCcccccccccCccccccccccccccccCccccCCC-CCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHhh
Q 045798 842 DFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGS-EVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMA 920 (1008)
Q Consensus 842 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~~ 920 (1008)
|||+|+++....... .+..+.|.+|+|||.+.|. .|+.++|+||.|||+.||++|++.|....+ -..++...+..
T Consensus 261 DFGLAr~y~~~~~~~---~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tE-veQl~kIfklc 336 (560)
T KOG0600|consen 261 DFGLARFYTPSGSAP---YTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTE-VEQLHKIFKLC 336 (560)
T ss_pred cccceeeccCCCCcc---cccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccH-HHHHHHHHHHh
Confidence 999999876655433 4456789999999998875 799999999999999999999999865322 12233333333
Q ss_pred CCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 921 LPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 921 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
..+....|-...+-......+.....+++.+ .....+....+|+..+|..||.+|.||.++++
T Consensus 337 GSP~e~~W~~~kLP~~~~~kp~~~y~r~l~E---~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 337 GSPTEDYWPVSKLPHATIFKPQQPYKRRLRE---TFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred CCCChhccccccCCcccccCCCCcccchHHH---HhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 3222111111011100000000000001111 01234455689999999999999999999875
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-41 Score=361.00 Aligned_cols=251 Identities=24% Similarity=0.325 Sum_probs=212.6
Q ss_pred cCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccchhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceEEE
Q 045798 684 NGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKAI 763 (1008)
Q Consensus 684 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 763 (1008)
..|...++||+|+.|.||.|....+++.||||++........+-+.+|+.+|+..+|+|||++++.+ ..++..|+
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sy-----lv~deLWV 347 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSY-----LVGDELWV 347 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHh-----cccceeEE
Confidence 4577889999999999999999999999999999988777778899999999999999999999984 44577999
Q ss_pred EEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEccc
Q 045798 764 VYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDF 843 (1008)
Q Consensus 764 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 843 (1008)
|||||+||+|.+.+... .+++.++..|++++++||+|||.+ ||+|||||.+|||++.+|.+||+||
T Consensus 348 VMEym~ggsLTDvVt~~-----------~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDF 413 (550)
T KOG0578|consen 348 VMEYMEGGSLTDVVTKT-----------RMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDF 413 (550)
T ss_pred EEeecCCCchhhhhhcc-----------cccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeee
Confidence 99999999999999765 689999999999999999999998 9999999999999999999999999
Q ss_pred CcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCc
Q 045798 844 GLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMALPN 923 (1008)
Q Consensus 844 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~~~~~ 923 (1008)
|++..+...... ....+||+.|||||+.....|++|+||||||++++||+-|++||-. +. .+......
T Consensus 414 GFcaqi~~~~~K----R~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYln--E~--PlrAlyLI---- 481 (550)
T KOG0578|consen 414 GFCAQISEEQSK----RSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLN--EN--PLRALYLI---- 481 (550)
T ss_pred eeeeccccccCc----cccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccC--CC--hHHHHHHH----
Confidence 999877654432 3446799999999999999999999999999999999999999852 11 11111100
Q ss_pred chhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 045798 924 QVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHE 987 (1008)
Q Consensus 924 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 987 (1008)
+.+-.+.+......+..+.+++.+||+.||++||+|.|+++.
T Consensus 482 ----------------------a~ng~P~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 482 ----------------------ATNGTPKLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred ----------------------hhcCCCCcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 011112222334567789999999999999999999999873
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-41 Score=352.30 Aligned_cols=260 Identities=29% Similarity=0.427 Sum_probs=203.2
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccchhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceEE
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKA 762 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 762 (1008)
..+|...+.||+|+||+||++....+|+.+|||.+........+.+.+|++++++++|||||+++|.... .....++
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~---~~~~~~~ 92 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSS---RENDEYN 92 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCcccc---ccCeeeE
Confidence 3457778999999999999999988899999999976543336779999999999999999999997321 1113689
Q ss_pred EEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecC-CCCeEEc
Q 045798 763 IVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDN-DLSGHIG 841 (1008)
Q Consensus 763 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kL~ 841 (1008)
++|||+++|+|.+++...+. ++++..++.+.+||++||+|||++ |||||||||+|||++. ++.+||+
T Consensus 93 i~mEy~~~GsL~~~~~~~g~---------~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~Kla 160 (313)
T KOG0198|consen 93 IFMEYAPGGSLSDLIKRYGG---------KLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLA 160 (313)
T ss_pred eeeeccCCCcHHHHHHHcCC---------CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEec
Confidence 99999999999999987652 589999999999999999999997 9999999999999999 7999999
Q ss_pred ccCcccccccccCccccccccccccccccCccccCCC-CCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHhh
Q 045798 842 DFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGS-EVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMA 920 (1008)
Q Consensus 842 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~~ 920 (1008)
|||.++.... ............||+.|||||++..+ ...+++||||+||++.||+||++||....+.. .......
T Consensus 161 DFG~a~~~~~-~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~---~~~~~ig 236 (313)
T KOG0198|consen 161 DFGLAKKLES-KGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEA---EALLLIG 236 (313)
T ss_pred cCcccccccc-ccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchH---HHHHHHh
Confidence 9999987664 11122223346799999999999853 34469999999999999999999987431100 0000000
Q ss_pred CCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHH
Q 045798 921 LPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHEL 988 (1008)
Q Consensus 921 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 988 (1008)
.... .+.++ ...+.+..+++..|+..||++||||+|+++.-
T Consensus 237 ~~~~-------------------------~P~ip--~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hp 277 (313)
T KOG0198|consen 237 REDS-------------------------LPEIP--DSLSDEAKDFLRKCFKRDPEKRPTAEELLEHP 277 (313)
T ss_pred ccCC-------------------------CCCCC--cccCHHHHHHHHHHhhcCcccCcCHHHHhhCh
Confidence 0000 00011 12445568999999999999999999999864
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=321.38 Aligned_cols=275 Identities=24% Similarity=0.302 Sum_probs=209.6
Q ss_pred cCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEecccc--chhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceE
Q 045798 684 NGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC--EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFK 761 (1008)
Q Consensus 684 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 761 (1008)
.+|...+++|+|.||.||+|++.++|+.||||+++... ++......+|++.++.++|+||+.++++ |...+..
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~-----F~~~~~l 76 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDV-----FPHKSNL 76 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhh-----ccCCCce
Confidence 46888899999999999999999999999999998542 3345678999999999999999999999 6777789
Q ss_pred EEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEc
Q 045798 762 AIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIG 841 (1008)
Q Consensus 762 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 841 (1008)
.+|+||| ..+|+..++.... .++..++..++.++++|++|+|+. .|+||||||.|+|++++|.+||+
T Consensus 77 ~lVfEfm-~tdLe~vIkd~~i---------~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiA 143 (318)
T KOG0659|consen 77 SLVFEFM-PTDLEVVIKDKNI---------ILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIA 143 (318)
T ss_pred EEEEEec-cccHHHHhccccc---------ccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEee
Confidence 9999999 5699999986642 789999999999999999999997 99999999999999999999999
Q ss_pred ccCcccccccccCccccccccccccccccCccccCCC-CCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHhh
Q 045798 842 DFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGS-EVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMA 920 (1008)
Q Consensus 842 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~~ 920 (1008)
|||+|+.+........ ..+-|.+|+|||.+.|. .|+..+||||.||++.||+-|.+-|....+- +.+....+..
T Consensus 144 DFGLAr~f~~p~~~~~----~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDi-dQL~~If~~L 218 (318)
T KOG0659|consen 144 DFGLARFFGSPNRIQT----HQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDI-DQLSKIFRAL 218 (318)
T ss_pred cccchhccCCCCcccc----cceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchH-HHHHHHHHHc
Confidence 9999998876544332 23679999999998875 6999999999999999999988766432221 1222222222
Q ss_pred CCcchhhhhcccccCchHHhhhhhhhhhccccch--hHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 045798 921 LPNQVMDIVDPILRNDEEILASTDKCRRMQTGIN--SRLECLISMVKIGVACSMESPQDRMNMTNVVHE 987 (1008)
Q Consensus 921 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 987 (1008)
..+...++-+-.--.++ .+.+..+.+.. .-..++.+..+++..++..||.+|+|+.|+++.
T Consensus 219 GTP~~~~WP~~~~lpdY------~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 219 GTPTPDQWPEMTSLPDY------VKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred CCCCcccCccccccccH------HHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 22221111111100111 11111111100 112455566999999999999999999998864
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=342.70 Aligned_cols=265 Identities=25% Similarity=0.325 Sum_probs=209.8
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccc-hhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceE
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCE-GASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFK 761 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 761 (1008)
.+.|++.+.||.|..++||+|+....++.||||++..+.- ...+.+++|+..|+.++||||++++.. |..+...
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~s-----Fvv~~~L 99 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCS-----FVVDSEL 99 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEE-----EEeccee
Confidence 4679999999999999999999999999999999985433 335889999999999999999999988 6777889
Q ss_pred EEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEc
Q 045798 762 AIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIG 841 (1008)
Q Consensus 762 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 841 (1008)
|+||.||.+|++.+.++..... .+.+..+..|++++++||.|||.+ |.||||||+.||||+.+|.+||+
T Consensus 100 WvVmpfMa~GS~ldIik~~~~~--------Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLa 168 (516)
T KOG0582|consen 100 WVVMPFMAGGSLLDIIKTYYPD--------GLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLA 168 (516)
T ss_pred EEeehhhcCCcHHHHHHHHccc--------cccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEc
Confidence 9999999999999999866533 589999999999999999999998 99999999999999999999999
Q ss_pred ccCcccccccccCccccccccccccccccCccccCC--CCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHh
Q 045798 842 DFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLG--SEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARM 919 (1008)
Q Consensus 842 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~ 919 (1008)
|||.+..+-+............+||+.|||||++.. ..|+.|+||||||++..|+.+|..||.....-.....
T Consensus 169 dFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~----- 243 (516)
T KOG0582|consen 169 DFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLL----- 243 (516)
T ss_pred CceeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHH-----
Confidence 999987665544322222255689999999999543 4699999999999999999999999974322111000
Q ss_pred hCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 920 ALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 920 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
.+........-..+.. .........+.+++..|++.||.+||||+++++
T Consensus 244 tLqn~pp~~~t~~~~~------------------d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 244 TLQNDPPTLLTSGLDK------------------DEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred HhcCCCCCcccccCCh------------------HHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 0111100000000000 011234557899999999999999999999986
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-41 Score=361.36 Aligned_cols=266 Identities=29% Similarity=0.431 Sum_probs=210.6
Q ss_pred HhcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEecccc--chhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCc
Q 045798 682 ATNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC--EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGND 759 (1008)
Q Consensus 682 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 759 (1008)
..+...+.+.||+|+||+||+|+|-+ .||||+++... +...+.|++|+.++++-+|.||+-+.|+|.. +.
T Consensus 390 p~~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~-----p~ 461 (678)
T KOG0193|consen 390 PPEEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMN-----PP 461 (678)
T ss_pred CHHHhhccceeccccccceeeccccc---ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcC-----Cc
Confidence 34456678899999999999999954 59999998554 3456789999999999999999999999753 23
Q ss_pred eEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeE
Q 045798 760 FKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGH 839 (1008)
Q Consensus 760 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 839 (1008)
..||+.+|+|-+|+.+++-... +++..+.+.||.|||+|+.|||.. +|||||+|..|||+.+++.||
T Consensus 462 -~AIiTqwCeGsSLY~hlHv~et---------kfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVk 528 (678)
T KOG0193|consen 462 -LAIITQWCEGSSLYTHLHVQET---------KFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVK 528 (678)
T ss_pred -eeeeehhccCchhhhhccchhh---------hhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEE
Confidence 4999999999999999986642 799999999999999999999996 999999999999999999999
Q ss_pred EcccCcccccccccCccccccccccccccccCccccCCC---CCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHH
Q 045798 840 IGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGS---EVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNF 916 (1008)
Q Consensus 840 L~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~ 916 (1008)
|+|||++.......... ......|...|||||++... +|++++||||||+|+|||++|..||..... +..+-..
T Consensus 529 IgDFGLatvk~~w~g~~--q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~-dqIifmV 605 (678)
T KOG0193|consen 529 IGDFGLATVKTRWSGEQ--QLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNR-DQIIFMV 605 (678)
T ss_pred Eecccceeeeeeecccc--ccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCCh-hheEEEe
Confidence 99999998654432211 12234488899999998754 689999999999999999999999973211 1100000
Q ss_pred HHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHHHHHHHHHH
Q 045798 917 ARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHELQSVKNILL 996 (1008)
Q Consensus 917 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~i~~~~~ 996 (1008)
.+. ..++........++.++.+|+..||..++++||.+.+|+..|+.+.....
T Consensus 606 GrG---------------------------~l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~~p 658 (678)
T KOG0193|consen 606 GRG---------------------------YLMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPSLP 658 (678)
T ss_pred ccc---------------------------ccCccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhccc
Confidence 000 01111112234678899999999999999999999999999988876544
Q ss_pred HH
Q 045798 997 EL 998 (1008)
Q Consensus 997 ~~ 998 (1008)
++
T Consensus 659 ki 660 (678)
T KOG0193|consen 659 KI 660 (678)
T ss_pred cc
Confidence 43
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=360.44 Aligned_cols=368 Identities=23% Similarity=0.240 Sum_probs=224.1
Q ss_pred CCEEEccCCCCCCccCcccccCcCcceEeeeccccccCCCccccccCCCCeeecccccCCCCCCCCCccccccchhhccc
Q 045798 104 LEALFLSNNSLVGKIPANLSYCSRLTVLCIEYNKLQGRIPLEFVSLSKLKDLSLAKNKLTGGIPPFLGNLTSLEVLSLAG 183 (1008)
Q Consensus 104 L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~ 183 (1008)
-+.||+++|.++..-+..|.++++|+.++|.+|.++ .+|...+...+|+.|+|.+|.|+..-.+.+..++.|+.|||+.
T Consensus 80 t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~L~~N~I~sv~se~L~~l~alrslDLSr 158 (873)
T KOG4194|consen 80 TQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLDLRHNLISSVTSEELSALPALRSLDLSR 158 (873)
T ss_pred eeeeeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccccccceeEEeeeccccccccHHHHHhHhhhhhhhhhh
Confidence 344666666666665666666666666666666666 5665555556677777777777766666677777777777777
Q ss_pred ccCCCCCCccccCCCCCcEEEecCCcccccCCccccCCCCcceeccccccccccCChhhhhcCCCCcEEEeccccCCCCC
Q 045798 184 NSFGRNIPDSLGQLKQLKILAIGGNNLSGPIPPSIYNLSFLVVFSVSHNQIHGSLPPSLGLLLPNLKFFQIHHNFFSGSI 263 (1008)
Q Consensus 184 n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~ 263 (1008)
|.|+......|..-.++++|+|++|+|+......|.++.+|..|.|+.|+++ .+|...|+.++.|+.|+|..|+|.-..
T Consensus 159 N~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrit-tLp~r~Fk~L~~L~~LdLnrN~irive 237 (873)
T KOG4194|consen 159 NLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRIT-TLPQRSFKRLPKLESLDLNRNRIRIVE 237 (873)
T ss_pred chhhcccCCCCCCCCCceEEeeccccccccccccccccchheeeecccCccc-ccCHHHhhhcchhhhhhccccceeeeh
Confidence 7776666666777677777777777777777777777777777777777776 677766666666666666666665333
Q ss_pred CcccccCCCCceeecccccccccccccccCCCcccccccccccCCCCCCCcccccccccccCCCcEEEecCCcCCccCCh
Q 045798 264 PISLSNASKLEHIEIANNNFSGKLSVNFGGMKNLSLLNLQFSNLGSGESDEMGFMNSLTNCSKLRVLSLGGNQFRGALPH 343 (1008)
Q Consensus 264 p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~ 343 (1008)
--.|..+++|+.|.|.+|.|.......|.+|.++++|+|..|+++.+..+ .+.++++
T Consensus 238 ~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g------~lfgLt~----------------- 294 (873)
T KOG4194|consen 238 GLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEG------WLFGLTS----------------- 294 (873)
T ss_pred hhhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhhcc------cccccch-----------------
Confidence 44555666666666666666655555555555555555555555544433 3334444
Q ss_pred hhhhhcccceeeeeccccccCCCCCccccccccceEEecCccccCCcchhccCCCCCceEEccCCcccccccccccCCCC
Q 045798 344 SIANLSSQLQILILSSNQFYGSIPLGIGNLVDLYLLGMVENQFTGAIPKEMGKLQKLQGLDFSGNHFSGEIPSSLGNLSS 423 (1008)
Q Consensus 344 ~~~~l~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 423 (1008)
|+.|+||+|.|...-++.+.-.++|++|+|++|+|+...+..|..|..|++|+|++|++...-...|..+++
T Consensus 295 --------L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lss 366 (873)
T KOG4194|consen 295 --------LEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSS 366 (873)
T ss_pred --------hhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhh
Confidence 444444444444444444444444555555555554444444555555555555555554333344455555
Q ss_pred cceeeccccccccccC---CCCcCCCcccEeecccccccCCcchhhhhhhhhhhhhcccCccccCCCccccccccccccc
Q 045798 424 LYEVFFNNNNLSGVIP---FSLGNLKRLAFLEMSGNELSGTIPEDIFNISYLSNSLNLARNHLVGIIPPRIGNLRALRSF 500 (1008)
Q Consensus 424 L~~L~l~~N~l~~~~p---~~~~~l~~L~~L~Ls~N~l~~~lp~~~~~~~~~~~~L~L~~N~l~~~~p~~~~~l~~L~~L 500 (1008)
|++|+|++|.|+..+- ..|..|++|+.|+|.+|++. .||...|.....++.|||.+|.|..+-|++|..+ .|+.|
T Consensus 367 L~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk-~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m-~Lk~L 444 (873)
T KOG4194|consen 367 LHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLK-SIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPM-ELKEL 444 (873)
T ss_pred hhhhcCcCCeEEEEEecchhhhccchhhhheeecCceee-ecchhhhccCcccceecCCCCcceeecccccccc-hhhhh
Confidence 5555555555554432 23555666666666666665 5666666666666666666666666778888887 78777
Q ss_pred cccccc
Q 045798 501 DVSNND 506 (1008)
Q Consensus 501 dls~N~ 506 (1008)
-++.-.
T Consensus 445 v~nSss 450 (873)
T KOG4194|consen 445 VMNSSS 450 (873)
T ss_pred hhcccc
Confidence 765433
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=359.07 Aligned_cols=251 Identities=27% Similarity=0.368 Sum_probs=204.2
Q ss_pred HHhcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccc----cc-hhhHHHHHHHHHHhhcC-CCCceeeeecccccc
Q 045798 681 KATNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQ----CE-GASKSFMAECKALKNIR-HRNLVKVITSCSSID 754 (1008)
Q Consensus 681 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~-~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~ 754 (1008)
...++|.+.+.||+|+||+|+.|.+..+++.||+|++... .. ...+.+.+|+.++++++ ||||++++++
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev----- 88 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEV----- 88 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEE-----
Confidence 3467899999999999999999999989999999987643 12 33556779999999998 9999999999
Q ss_pred ccCCceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecC
Q 045798 755 FQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDN 834 (1008)
Q Consensus 755 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~ 834 (1008)
+......++||||+.+|+|.+++...+ ++.+..++.++.|++.|++|+|++ ||+||||||+||+++.
T Consensus 89 ~~t~~~~~ivmEy~~gGdL~~~i~~~g----------~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~ 155 (370)
T KOG0583|consen 89 FATPTKIYIVMEYCSGGDLFDYIVNKG----------RLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDG 155 (370)
T ss_pred EecCCeEEEEEEecCCccHHHHHHHcC----------CCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecC
Confidence 566667999999999999999998854 788999999999999999999998 9999999999999999
Q ss_pred C-CCeEEcccCcccccccccCccccccccccccccccCccccCCCC-CC-cccchhhHHHHHHHHHhCCCCCCccccCCc
Q 045798 835 D-LSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSE-VS-TNGDVYSYGILLLEMVTAKKPTDVMFEGDL 911 (1008)
Q Consensus 835 ~-~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~sDvwslG~vl~elltG~~pf~~~~~~~~ 911 (1008)
+ +++||+|||++....... ......+||+.|+|||++.+.. |+ .++||||+||++|.|++|+.||+..
T Consensus 156 ~~~~~Kl~DFG~s~~~~~~~----~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~----- 226 (370)
T KOG0583|consen 156 NEGNLKLSDFGLSAISPGED----GLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDS----- 226 (370)
T ss_pred CCCCEEEeccccccccCCCC----CcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCc-----
Confidence 9 999999999999774111 1223467999999999999977 75 7899999999999999999999851
Q ss_pred cHHHHHHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHH
Q 045798 912 NLHNFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVV 985 (1008)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl 985 (1008)
......+. ..... ..++.... +.++..++.+|+..||.+|+|+.||+
T Consensus 227 ~~~~l~~k------------i~~~~--------------~~~p~~~~-S~~~~~Li~~mL~~~P~~R~t~~~i~ 273 (370)
T KOG0583|consen 227 NVPNLYRK------------IRKGE--------------FKIPSYLL-SPEARSLIEKMLVPDPSTRITLLEIL 273 (370)
T ss_pred cHHHHHHH------------HhcCC--------------ccCCCCcC-CHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 11111111 00000 00111111 45678999999999999999999998
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=352.11 Aligned_cols=247 Identities=32% Similarity=0.446 Sum_probs=209.7
Q ss_pred cCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEecccc--chhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceE
Q 045798 684 NGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC--EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFK 761 (1008)
Q Consensus 684 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 761 (1008)
++|.+.+.||+|+||.||||+.+.+.+.||+|.+.+.. +++.+.+.+|++++++++||||+.++++ |+...+.
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~es-----fEt~~~~ 76 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLES-----FETSAHL 76 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHh-----hcccceE
Confidence 57889999999999999999999999999999997543 4556789999999999999999999999 6788889
Q ss_pred EEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEc
Q 045798 762 AIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIG 841 (1008)
Q Consensus 762 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 841 (1008)
|+|+||+.| +|..++...+ .++++.++.++.|++.||.|||+. +|.|||+||+||+++.++.+|+|
T Consensus 77 ~vVte~a~g-~L~~il~~d~----------~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~Klc 142 (808)
T KOG0597|consen 77 WVVTEYAVG-DLFTILEQDG----------KLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLC 142 (808)
T ss_pred EEEehhhhh-hHHHHHHhcc----------CCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeec
Confidence 999999955 9999998765 899999999999999999999998 99999999999999999999999
Q ss_pred ccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHhhC
Q 045798 842 DFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMAL 921 (1008)
Q Consensus 842 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~~~ 921 (1008)
|||+|+.+..... ....+.||+.|||||...+++|+..+|.||+||++||+++|++||...
T Consensus 143 dFg~Ar~m~~~t~----vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~--------------- 203 (808)
T KOG0597|consen 143 DFGLARAMSTNTS----VLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR--------------- 203 (808)
T ss_pred hhhhhhhcccCce----eeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH---------------
Confidence 9999997655322 234567999999999999999999999999999999999999998632
Q ss_pred CcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 922 PNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 922 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
.+..++...+.+.. .........+..++...+..||.+|.|..+++.
T Consensus 204 --si~~Lv~~I~~d~v----------------~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 204 --SITQLVKSILKDPV----------------KPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred --HHHHHHHHHhcCCC----------------CCcccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence 12222222222211 011245667889999999999999999999876
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=319.72 Aligned_cols=274 Identities=18% Similarity=0.236 Sum_probs=219.7
Q ss_pred HhcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccchhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceE
Q 045798 682 ATNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFK 761 (1008)
Q Consensus 682 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 761 (1008)
..++|++.+.+|+|||+.||.++.-.+++.||+|++.....+..+..++|++..++++|||++++++++....-+.....
T Consensus 19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~ 98 (302)
T KOG2345|consen 19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA 98 (302)
T ss_pred cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence 35789999999999999999999988999999999988877788899999999999999999999999876655667789
Q ss_pred EEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEc
Q 045798 762 AIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIG 841 (1008)
Q Consensus 762 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 841 (1008)
|++++|+..|+|.+.+......+ ..+++.+++.|+.+|++||++||+. .++++||||||.||++++++.+++.
T Consensus 99 yll~Pyy~~Gsl~d~i~~~k~kg------~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~ 171 (302)
T KOG2345|consen 99 YLLLPYYKRGSLLDEIERLKIKG------NFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLM 171 (302)
T ss_pred EEEeehhccccHHHHHHHHhhcC------CccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEE
Confidence 99999999999999998765432 2789999999999999999999997 3359999999999999999999999
Q ss_pred ccCcccccccccC-----ccccccccccccccccCccccC---CCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccH
Q 045798 842 DFGLARFHQEVSN-----STLSSSVGVKGTIGYTAPEYGL---GSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNL 913 (1008)
Q Consensus 842 Dfg~a~~~~~~~~-----~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~ 913 (1008)
|||.+....-.-. ...........|..|+|||.+. +...++++|||||||++|+|+.|..||+...+...++
T Consensus 172 D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSl 251 (302)
T KOG2345|consen 172 DLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSL 251 (302)
T ss_pred eccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeE
Confidence 9999975432211 1111122345899999999865 3457899999999999999999999998665432222
Q ss_pred HHHHHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHHHHH
Q 045798 914 HNFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHELQSV 991 (1008)
Q Consensus 914 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~i 991 (1008)
.-.+. .+. ..+ +.....++.+.+++..|++.||.+||++.+++..++.+
T Consensus 252 aLAv~-----------n~q--------------~s~----P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L 300 (302)
T KOG2345|consen 252 ALAVQ-----------NAQ--------------ISI----PNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL 300 (302)
T ss_pred EEeee-----------ccc--------------ccc----CCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence 11100 000 000 11112567789999999999999999999999988764
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=336.80 Aligned_cols=274 Identities=25% Similarity=0.370 Sum_probs=216.2
Q ss_pred cCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccchhhHHHHHHHHHHhhc--CCCCceeeeeccccccccCCceE
Q 045798 684 NGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNI--RHRNLVKVITSCSSIDFQGNDFK 761 (1008)
Q Consensus 684 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~~~~~~~~~~~~~~~~~ 761 (1008)
.+..+.+.||+|.||+||+|.+ .|+.||||++.. .+++.+.+|.++++.+ +|+||+.+++.-.. +-..-...
T Consensus 211 rqI~L~e~IGkGRyGEVwrG~w--rGe~VAVKiF~s---rdE~SWfrEtEIYqTvmLRHENILgFIaaD~~-~~gs~TQL 284 (513)
T KOG2052|consen 211 RQIVLQEIIGKGRFGEVWRGRW--RGEDVAVKIFSS---RDERSWFRETEIYQTVMLRHENILGFIAADNK-DNGSWTQL 284 (513)
T ss_pred heeEEEEEecCccccceeeccc--cCCceEEEEecc---cchhhhhhHHHHHHHHHhccchhhhhhhcccc-CCCceEEE
Confidence 4567789999999999999999 589999999963 3456788899998876 99999999987221 11222368
Q ss_pred EEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhh-----CCCCCceeccCCCCCeeecCCC
Q 045798 762 AIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHH-----HCQEPILHCDLKPSNILLDNDL 836 (1008)
Q Consensus 762 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-----~~~~~ivH~Dlkp~NIll~~~~ 836 (1008)
++|++|.+.|||.||+... .++....++++..+|.||+|||- +.++.|+|||||+.||||..++
T Consensus 285 wLvTdYHe~GSL~DyL~r~-----------tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~ 353 (513)
T KOG2052|consen 285 WLVTDYHEHGSLYDYLNRN-----------TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG 353 (513)
T ss_pred EEeeecccCCcHHHHHhhc-----------cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCC
Confidence 9999999999999999875 78999999999999999999995 3467899999999999999999
Q ss_pred CeEEcccCcccccccccCccccccccccccccccCccccCCC------CCCcccchhhHHHHHHHHHhCC----------
Q 045798 837 SGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGS------EVSTNGDVYSYGILLLEMVTAK---------- 900 (1008)
Q Consensus 837 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~sDvwslG~vl~elltG~---------- 900 (1008)
.+.|+|+|+|..+....+.........+||.+|||||++... +....+||||||.|+||++...
T Consensus 354 ~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~ 433 (513)
T KOG2052|consen 354 TCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQ 433 (513)
T ss_pred cEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhc
Confidence 999999999998877766555556667899999999997653 2245789999999999998643
Q ss_pred CCCCccccCCccHHHHHHhhCCcchhhhhcccccCchHHhhhhhhhhhccccch---hHHHHHHHHHHHHhcccCcCCCC
Q 045798 901 KPTDVMFEGDLNLHNFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGIN---SRLECLISMVKIGVACSMESPQD 977 (1008)
Q Consensus 901 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~ 977 (1008)
.||.+....+.+++.+.....- ++.++.++ ...++...+.++|+.||..+|..
T Consensus 434 ~Pyyd~Vp~DPs~eeMrkVVCv------------------------~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~a 489 (513)
T KOG2052|consen 434 LPYYDVVPSDPSFEEMRKVVCV------------------------QKLRPNIPNRWKSDPALRVMAKLMKECWYANPAA 489 (513)
T ss_pred CCcccCCCCCCCHHHHhcceee------------------------cccCCCCCcccccCHHHHHHHHHHHHhhcCCchh
Confidence 4555554444444443322221 22222222 33467788999999999999999
Q ss_pred CCCHHHHHHHHHHHHHHHHHH
Q 045798 978 RMNMTNVVHELQSVKNILLEL 998 (1008)
Q Consensus 978 RPt~~evl~~L~~i~~~~~~~ 998 (1008)
|-||-.+.+.|.++.+..++.
T Consensus 490 RltALriKKtl~~l~~~~ek~ 510 (513)
T KOG2052|consen 490 RLTALRIKKTLAKLSNSDEKI 510 (513)
T ss_pred hhHHHHHHHHHHHHhcChhhh
Confidence 999999999999988754443
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=346.26 Aligned_cols=249 Identities=26% Similarity=0.354 Sum_probs=206.6
Q ss_pred cCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccc-cchhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceEE
Q 045798 684 NGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQ-CEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKA 762 (1008)
Q Consensus 684 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 762 (1008)
..|+..+.||+|+||.||+|.+..+++.||+|++... .+.+.+++++|+.++..++++||.++++. +-.+...+
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygs-----yl~g~~Lw 87 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGS-----YLKGTKLW 87 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhh-----eeecccHH
Confidence 4577789999999999999999999999999999854 34556889999999999999999999998 45566799
Q ss_pred EEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEcc
Q 045798 763 IVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGD 842 (1008)
Q Consensus 763 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 842 (1008)
++||||.||++.+.++... .+++..+..+++++..|+.|||.+ +.+|||||+.||++..+|.+|++|
T Consensus 88 iiMey~~gGsv~~lL~~~~----------~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~D 154 (467)
T KOG0201|consen 88 IIMEYCGGGSVLDLLKSGN----------ILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLAD 154 (467)
T ss_pred HHHHHhcCcchhhhhccCC----------CCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEe
Confidence 9999999999999998764 447777888999999999999998 999999999999999999999999
Q ss_pred cCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHhhCC
Q 045798 843 FGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMALP 922 (1008)
Q Consensus 843 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~~~~ 922 (1008)
||.+..+...... ....+||+.|||||++.+..|+.|+||||||++.+||++|.+|+........ .- .++
T Consensus 155 fgVa~ql~~~~~r----r~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrv--lf----lIp 224 (467)
T KOG0201|consen 155 FGVAGQLTNTVKR----RKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRV--LF----LIP 224 (467)
T ss_pred cceeeeeechhhc----cccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceE--EE----ecc
Confidence 9999876554332 2457899999999999988999999999999999999999999864322100 00 001
Q ss_pred cchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 923 NQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 923 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
.. .++.... .+...+.+++..|++.||+.||+|.++++
T Consensus 225 k~------------------------~PP~L~~--~~S~~~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 225 KS------------------------APPRLDG--DFSPPFKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred CC------------------------CCCcccc--ccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 10 0111111 35566899999999999999999999986
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=344.02 Aligned_cols=206 Identities=25% Similarity=0.369 Sum_probs=181.2
Q ss_pred HhcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEecccc---chhhHHHHHHHHHHhhcCCCCceeeeeccccccccCC
Q 045798 682 ATNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC---EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGN 758 (1008)
Q Consensus 682 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 758 (1008)
..++|.+++.||+|+||+||+|+-+.+|+.+|+|+++... ..+.+.++.|-++|....+|.||+++.. |++.
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYs-----FQD~ 213 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYS-----FQDK 213 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEE-----ecCC
Confidence 4578999999999999999999999999999999998542 3456778999999999999999999988 7899
Q ss_pred ceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCe
Q 045798 759 DFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSG 838 (1008)
Q Consensus 759 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 838 (1008)
++.|+||||++||++..++...+ .+++..++.++.+++.|++.+|+. |+|||||||+|+|||..|++
T Consensus 214 ~~LYLiMEylPGGD~mTLL~~~~----------~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHi 280 (550)
T KOG0605|consen 214 EYLYLIMEYLPGGDMMTLLMRKD----------TLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHI 280 (550)
T ss_pred CeeEEEEEecCCccHHHHHHhcC----------cCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCE
Confidence 99999999999999999998776 799999999999999999999998 99999999999999999999
Q ss_pred EEcccCccccccccc---------------------Cccc----c------------------ccccccccccccCcccc
Q 045798 839 HIGDFGLARFHQEVS---------------------NSTL----S------------------SSVGVKGTIGYTAPEYG 875 (1008)
Q Consensus 839 kL~Dfg~a~~~~~~~---------------------~~~~----~------------------~~~~~~gt~~y~aPE~~ 875 (1008)
||+|||++.-+.... .... . .....+|||.|||||++
T Consensus 281 KLSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVl 360 (550)
T KOG0605|consen 281 KLSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVL 360 (550)
T ss_pred eeccccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHH
Confidence 999999996332100 0000 0 01135799999999999
Q ss_pred CCCCCCcccchhhHHHHHHHHHhCCCCCCc
Q 045798 876 LGSEVSTNGDVYSYGILLLEMVTAKKPTDV 905 (1008)
Q Consensus 876 ~~~~~~~~sDvwslG~vl~elltG~~pf~~ 905 (1008)
.+..|+..+|.||+|||+|||+.|.+||..
T Consensus 361 l~kgY~~~cDwWSLG~ImyEmLvGyPPF~s 390 (550)
T KOG0605|consen 361 LGKGYGKECDWWSLGCIMYEMLVGYPPFCS 390 (550)
T ss_pred hcCCCCccccHHHHHHHHHHHHhCCCCCCC
Confidence 999999999999999999999999999974
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=353.66 Aligned_cols=367 Identities=22% Similarity=0.236 Sum_probs=328.0
Q ss_pred CCeeeecCCCCCCCCCccccCCCCCCEEEccCCCCCCccCcccccCcCcceEeeeccccccCCCccccccCCCCeeeccc
Q 045798 80 LREINLSNNTIQGEIPPEFGRLFRLEALFLSNNSLVGKIPANLSYCSRLTVLCIEYNKLQGRIPLEFVSLSKLKDLSLAK 159 (1008)
Q Consensus 80 L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~ 159 (1008)
-+.|++++|++..+-+..|.++++|++++|.+|.++ .+|...+...+|+.|+|.+|.|+.+-.+++.-++.|+.|||+.
T Consensus 80 t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~L~~N~I~sv~se~L~~l~alrslDLSr 158 (873)
T KOG4194|consen 80 TQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLDLRHNLISSVTSEELSALPALRSLDLSR 158 (873)
T ss_pred eeeeeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccccccceeEEeeeccccccccHHHHHhHhhhhhhhhhh
Confidence 467999999999888889999999999999999999 8998888888899999999999988888999999999999999
Q ss_pred ccCCCCCCCCCccccccchhhcccccCCCCCCccccCCCCCcEEEecCCcccccCCccccCCCCcceeccccccccccCC
Q 045798 160 NKLTGGIPPFLGNLTSLEVLSLAGNSFGRNIPDSLGQLKQLKILAIGGNNLSGPIPPSIYNLSFLVVFSVSHNQIHGSLP 239 (1008)
Q Consensus 160 n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~~~lp 239 (1008)
|.|+.+.-+.|..-.++++|+|++|+|+....+.|..+.+|..|.|++|+++...+..|.+|++|+.|+|..|+|. .+.
T Consensus 159 N~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrittLp~r~Fk~L~~L~~LdLnrN~ir-ive 237 (873)
T KOG4194|consen 159 NLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITTLPQRSFKRLPKLESLDLNRNRIR-IVE 237 (873)
T ss_pred chhhcccCCCCCCCCCceEEeeccccccccccccccccchheeeecccCcccccCHHHhhhcchhhhhhcccccee-eeh
Confidence 9999665567877789999999999999999999999999999999999999888888999999999999999997 666
Q ss_pred hhhhhcCCCCcEEEeccccCCCCCCcccccCCCCceeecccccccccccccccCCCcccccccccccCCCCCCCcccccc
Q 045798 240 PSLGLLLPNLKFFQIHHNFFSGSIPISLSNASKLEHIEIANNNFSGKLSVNFGGMKNLSLLNLQFSNLGSGESDEMGFMN 319 (1008)
Q Consensus 240 ~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~ 319 (1008)
...|.++++|+.|.|..|.+.......|..+.++++|+|+.|++......++.++..|+.|+|++|.|..+..+.+
T Consensus 238 ~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~W---- 313 (873)
T KOG4194|consen 238 GLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSW---- 313 (873)
T ss_pred hhhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhhcccccccchhhhhccchhhhheeecchh----
Confidence 6778889999999999999998888899999999999999999999999999999999999999999999887644
Q ss_pred cccccCCCcEEEecCCcCCccCChhhhhhcccceeeeeccccccCCCCCccccccccceEEecCccccCCcc---hhccC
Q 045798 320 SLTNCSKLRVLSLGGNQFRGALPHSIANLSSQLQILILSSNQFYGSIPLGIGNLVDLYLLGMVENQFTGAIP---KEMGK 396 (1008)
Q Consensus 320 ~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~---~~~~~ 396 (1008)
+-.++|++|+|+.|+|+..-+.+|..+. +|++|+|++|.++..--..|..+++|+.|||++|.|...+- ..|.+
T Consensus 314 --sftqkL~~LdLs~N~i~~l~~~sf~~L~-~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~g 390 (873)
T KOG4194|consen 314 --SFTQKLKELDLSSNRITRLDEGSFRVLS-QLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNG 390 (873)
T ss_pred --hhcccceeEeccccccccCChhHHHHHH-HhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhcc
Confidence 4467899999999999966666777765 69999999999987667789999999999999999987654 45888
Q ss_pred CCCCceEEccCCcccccccccccCCCCcceeeccccccccccCCCCcCCCcccEeecccc
Q 045798 397 LQKLQGLDFSGNHFSGEIPSSLGNLSSLYEVFFNNNNLSGVIPFSLGNLKRLAFLEMSGN 456 (1008)
Q Consensus 397 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N 456 (1008)
|++|+.|+|.+|+|..+.-.+|.++..|++|+|.+|.|..+-|.+|..+ .|+.|-+..-
T Consensus 391 l~~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m-~Lk~Lv~nSs 449 (873)
T KOG4194|consen 391 LPSLRKLRLTGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPM-ELKELVMNSS 449 (873)
T ss_pred chhhhheeecCceeeecchhhhccCcccceecCCCCcceeecccccccc-hhhhhhhccc
Confidence 9999999999999996666789999999999999999999999999999 8988877543
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=321.05 Aligned_cols=199 Identities=30% Similarity=0.391 Sum_probs=180.7
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEecccc---chhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCc
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC---EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGND 759 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 759 (1008)
.++|++.+.||.|+||.|.+++.+.+|..+|+|+++... -...+...+|..+++.+.||.++++++. +.+.+
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t-----~~d~~ 117 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGT-----FKDNS 117 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEe-----eccCC
Confidence 356888999999999999999999999999999997543 2445678899999999999999999998 46777
Q ss_pred eEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeE
Q 045798 760 FKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGH 839 (1008)
Q Consensus 760 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 839 (1008)
+.|+||||++||.|..++++.+ ++++..++.+|.||+.|++|||+. +|++||+||+|||+|.+|.+|
T Consensus 118 ~lymvmeyv~GGElFS~Lrk~~----------rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iK 184 (355)
T KOG0616|consen 118 NLYMVMEYVPGGELFSYLRKSG----------RFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIK 184 (355)
T ss_pred eEEEEEeccCCccHHHHHHhcC----------CCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEE
Confidence 8999999999999999999876 899999999999999999999998 999999999999999999999
Q ss_pred EcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCcc
Q 045798 840 IGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVM 906 (1008)
Q Consensus 840 L~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~ 906 (1008)
|+|||+|+..... ..+.+||+.|+|||++...+|..++|.|||||++|||+.|.+||...
T Consensus 185 itDFGFAK~v~~r-------T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~ 244 (355)
T KOG0616|consen 185 ITDFGFAKRVSGR-------TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDD 244 (355)
T ss_pred EEeccceEEecCc-------EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCC
Confidence 9999999966432 33467999999999999999999999999999999999999999753
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=331.51 Aligned_cols=286 Identities=23% Similarity=0.262 Sum_probs=212.7
Q ss_pred HHhcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEec--cccchhhHHHHHHHHHHhhcCCCCceeeeeccccccccCC
Q 045798 681 KATNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVIN--LQCEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGN 758 (1008)
Q Consensus 681 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~--~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 758 (1008)
.....|...+.||+|+||.|+.|.++.+|+.||||++. .......++..+|+++++.++|+||+.+.++........-
T Consensus 19 ~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f 98 (359)
T KOG0660|consen 19 EIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKF 98 (359)
T ss_pred eccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccc
Confidence 34566777899999999999999999999999999997 5566677889999999999999999999999776444555
Q ss_pred ceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCe
Q 045798 759 DFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSG 838 (1008)
Q Consensus 759 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 838 (1008)
..+|+|+|+| +.+|.+.++... .++...+..++.||++||+|+|+. +|+|||+||.|++++.+...
T Consensus 99 ~DvYiV~elM-etDL~~iik~~~----------~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~l 164 (359)
T KOG0660|consen 99 NDVYLVFELM-ETDLHQIIKSQQ----------DLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDL 164 (359)
T ss_pred ceeEEehhHH-hhHHHHHHHcCc----------cccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCE
Confidence 6799999999 779999998764 589999999999999999999998 99999999999999999999
Q ss_pred EEcccCcccccccccCccccccccccccccccCccccCC-CCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHH
Q 045798 839 HIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLG-SEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFA 917 (1008)
Q Consensus 839 kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~ 917 (1008)
||+|||+|+..... ......+..+.|.+|+|||.+.. ..|+.+.||||+||++.||++|++-|.....- ..+.. .
T Consensus 165 KI~DFGLAR~~~~~--~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v-~Ql~l-I 240 (359)
T KOG0660|consen 165 KICDFGLARYLDKF--FEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYV-HQLQL-I 240 (359)
T ss_pred Eeccccceeecccc--CcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchH-HHHHH-H
Confidence 99999999987654 22223455678999999998654 57999999999999999999999987642111 01111 1
Q ss_pred HhhCCcchhhhhcccccCchHHhhhhhhhhhc-cccc-hhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 918 RMALPNQVMDIVDPILRNDEEILASTDKCRRM-QTGI-NSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 918 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~-~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
....+....+.+.. +..+ ..+.-....... +.++ .........-.+++.+|+..||.+|+|++|+++
T Consensus 241 ~~~lGtP~~e~l~~-i~s~-~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~ 309 (359)
T KOG0660|consen 241 LELLGTPSEEDLQK-IRSE-KARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALA 309 (359)
T ss_pred HHhcCCCCHHHHHH-hccH-HHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence 11111111111110 0000 000000000000 0000 011134445689999999999999999999987
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=336.25 Aligned_cols=280 Identities=26% Similarity=0.353 Sum_probs=207.1
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccchhhHHHHHHHHHHhhc--CCCCceeeeeccccccccCCce
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNI--RHRNLVKVITSCSSIDFQGNDF 760 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~~~~~~~~~~~~~~~~ 760 (1008)
....+..+.||+|+||.||+|.. +++.||||++. ....+.|++|-+|++.. +|+||++++++-...... ...
T Consensus 209 l~pl~l~eli~~Grfg~V~KaqL--~~~~VAVKifp---~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~-~~e 282 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKAQL--DNRLVAVKIFP---EQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTAD-RME 282 (534)
T ss_pred CCchhhHHHhhcCccceeehhhc--cCceeEEEecC---HHHHHHHHhHHHHHhccCccchhHHHhhchhccCCcc-ccc
Confidence 34456678899999999999999 57999999996 44567888998888765 899999999985443322 457
Q ss_pred EEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhC------CCCCceeccCCCCCeeecC
Q 045798 761 KAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHH------CQEPILHCDLKPSNILLDN 834 (1008)
Q Consensus 761 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~------~~~~ivH~Dlkp~NIll~~ 834 (1008)
+++|+||.+.|+|.+|++.+ .++|....+|+..+++||+|||+. ++++|+|||||.+||||.+
T Consensus 283 ywLVt~fh~kGsL~dyL~~n-----------tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~ 351 (534)
T KOG3653|consen 283 YWLVTEFHPKGSLCDYLKAN-----------TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKN 351 (534)
T ss_pred eeEEeeeccCCcHHHHHHhc-----------cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEcc
Confidence 89999999999999999877 799999999999999999999974 3567999999999999999
Q ss_pred CCCeEEcccCcccccccccCccccccccccccccccCccccCCCC------CCcccchhhHHHHHHHHHhCCCCCCc--c
Q 045798 835 DLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSE------VSTNGDVYSYGILLLEMVTAKKPTDV--M 906 (1008)
Q Consensus 835 ~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------~~~~sDvwslG~vl~elltG~~pf~~--~ 906 (1008)
|+++.|+|||+|..+........ ....+||.+|||||++.+.- .-.+.||||+|.|+|||++...-++. .
T Consensus 352 DlTccIaDFGLAl~~~p~~~~~d--~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~v 429 (534)
T KOG3653|consen 352 DLTCCIADFGLALRLEPGKPQGD--THGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPV 429 (534)
T ss_pred CCcEEeeccceeEEecCCCCCcc--hhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCC
Confidence 99999999999998875443332 34478999999999987652 23478999999999999997765431 1
Q ss_pred ccCCccHHHHHHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchh---HHHHHHHHHHHHhcccCcCCCCCCCHHH
Q 045798 907 FEGDLNLHNFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINS---RLECLISMVKIGVACSMESPQDRMNMTN 983 (1008)
Q Consensus 907 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~RPt~~e 983 (1008)
.+-...+..-+ .. +|.+.. +....-..+.++.++. .......+.+.+..||+.||+.|.||.=
T Consensus 430 p~Yqlpfe~ev--G~--------hPt~e~----mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~C 495 (534)
T KOG3653|consen 430 PEYQLPFEAEV--GN--------HPTLEE----MQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGC 495 (534)
T ss_pred CcccCchhHHh--cC--------CCCHHH----HHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHH
Confidence 11111111000 00 111110 0001111111111111 1145667899999999999999999999
Q ss_pred HHHHHHHHHHHH
Q 045798 984 VVHELQSVKNIL 995 (1008)
Q Consensus 984 vl~~L~~i~~~~ 995 (1008)
|.+++..+....
T Consensus 496 v~eR~~~l~~~~ 507 (534)
T KOG3653|consen 496 VEERMAELMMLW 507 (534)
T ss_pred HHHHHHHHhccC
Confidence 999988876543
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=324.36 Aligned_cols=279 Identities=24% Similarity=0.265 Sum_probs=207.7
Q ss_pred cCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccc--hhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceE
Q 045798 684 NGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCE--GASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFK 761 (1008)
Q Consensus 684 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 761 (1008)
+.|+.+..|++|.||.||+|+++.+++.||+|+++...+ +-.-.-.+|+.++.+.+|||||.+-.+... ..-+..
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG---~~~d~i 152 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVG---SNMDKI 152 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEec---ccccee
Confidence 457888999999999999999999999999999986543 223457899999999999999999888543 233559
Q ss_pred EEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEc
Q 045798 762 AIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIG 841 (1008)
Q Consensus 762 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 841 (1008)
|+|||||+. +|...+...+. ++...++..++.|+++|++|||++ .|+|||+||+|+|+...|.+||+
T Consensus 153 y~VMe~~Eh-DLksl~d~m~q---------~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKia 219 (419)
T KOG0663|consen 153 YIVMEYVEH-DLKSLMETMKQ---------PFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIA 219 (419)
T ss_pred eeeHHHHHh-hHHHHHHhccC---------CCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEec
Confidence 999999955 99999987652 789999999999999999999998 99999999999999999999999
Q ss_pred ccCcccccccccCccccccccccccccccCccccCCC-CCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHhh
Q 045798 842 DFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGS-EVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMA 920 (1008)
Q Consensus 842 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~~ 920 (1008)
|||+|+.++... ...+..+-|.+|+|||.+.+. .|+++.|+||+|||+.||+++++.|....+-+.....+....
T Consensus 220 DFGLAR~ygsp~----k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llG 295 (419)
T KOG0663|consen 220 DFGLAREYGSPL----KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLG 295 (419)
T ss_pred ccchhhhhcCCc----ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhC
Confidence 999999887653 234556789999999998875 689999999999999999999999876544333322222222
Q ss_pred CCcchhhhhcccccCchHH---hhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 921 LPNQVMDIVDPILRNDEEI---LASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 921 ~~~~~~~~~d~~l~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
.|.. -+.+.+..-+.. .........++..+.... ..+.=.+++...+..||++|.||+|.++
T Consensus 296 tPte---~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~-lse~g~~Lln~llt~dP~kR~tA~~~L~ 360 (419)
T KOG0663|consen 296 TPSE---AIWPGYSELPAVKKMTFSEHPYNNLRKKFGALS-LSEQGFDLLNKLLTYDPGKRITAEDGLK 360 (419)
T ss_pred CCcc---ccCCCccccchhhccccCCCCchhhhhhccccc-cchhHHHHHHHHhccCccccccHHHhhc
Confidence 2211 000000000000 000000001111111110 2244578999999999999999999875
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-39 Score=357.93 Aligned_cols=271 Identities=25% Similarity=0.373 Sum_probs=205.1
Q ss_pred hcCCCCCceEeeccCeeEEEEEEc-----CCCeEEEEEEecccc-chhhHHHHHHHHHHhhc-CCCCceeeeeccccccc
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALD-----EDGIVVAIKVINLQC-EGASKSFMAECKALKNI-RHRNLVKVITSCSSIDF 755 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 755 (1008)
.++|++.++||+|+||.||+|.+. .+++.||+|+++... ....+.+.+|++++.++ +||||++++++|.
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~---- 81 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACT---- 81 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEec----
Confidence 467999999999999999999752 345789999997443 23456799999999999 8999999999864
Q ss_pred cCCceEEEEEeccCCCChhcccccCCCCCC--------------------------------------------------
Q 045798 756 QGNDFKAIVYEYMPNGSLEKWLHPHAVPKR-------------------------------------------------- 785 (1008)
Q Consensus 756 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~-------------------------------------------------- 785 (1008)
..+...++||||+++|+|.+++........
T Consensus 82 ~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (338)
T cd05102 82 KPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQ 161 (338)
T ss_pred CCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccch
Confidence 334568999999999999999875421100
Q ss_pred --CcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEcccCcccccccccCccccccccc
Q 045798 786 --DKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGV 863 (1008)
Q Consensus 786 --~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~ 863 (1008)
......++++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++......... .....
T Consensus 162 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~--~~~~~ 236 (338)
T cd05102 162 ETDDLWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYV--RKGSA 236 (338)
T ss_pred hccccccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchh--cccCC
Confidence 000012588899999999999999999997 99999999999999999999999999998653322111 11223
Q ss_pred cccccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCccccCCccHHHHHHhhCCcchhhhhcccccCchHHhhh
Q 045798 864 KGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT-AKKPTDVMFEGDLNLHNFARMALPNQVMDIVDPILRNDEEILAS 942 (1008)
Q Consensus 864 ~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 942 (1008)
.++..|+|||++.+..++.++|||||||++|||++ |..||....... .+..... +..
T Consensus 237 ~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~----~~~~~~~--------~~~---------- 294 (338)
T cd05102 237 RLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE----EFCQRLK--------DGT---------- 294 (338)
T ss_pred CCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH----HHHHHHh--------cCC----------
Confidence 46788999999999999999999999999999997 999986432110 0100000 000
Q ss_pred hhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHHHHHHH
Q 045798 943 TDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHELQSVKN 993 (1008)
Q Consensus 943 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~i~~ 993 (1008)
... ....++..+.+++.+||+.||++|||+.|+++.|+++..
T Consensus 295 -----~~~----~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 295 -----RMR----APENATPEIYRIMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred -----CCC----CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 000 001234568999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=344.94 Aligned_cols=252 Identities=24% Similarity=0.400 Sum_probs=205.0
Q ss_pred CCCCCHHHHHHHhcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccchhhHHHHHHHHHHhhcCCCCceeeeecc
Q 045798 671 LPKMSYKSLLKATNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSC 750 (1008)
Q Consensus 671 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 750 (1008)
.=++++++|. ..+-||+|+.|.||+|+. .++.||||+++.- -..+++-+++++||||+.+.|+|
T Consensus 118 ~WeiPFe~Is-------ELeWlGSGaQGAVF~Grl--~netVAVKKV~el-------kETdIKHLRkLkH~NII~FkGVC 181 (904)
T KOG4721|consen 118 LWEIPFEEIS-------ELEWLGSGAQGAVFLGRL--HNETVAVKKVREL-------KETDIKHLRKLKHPNIITFKGVC 181 (904)
T ss_pred hccCCHHHhh-------hhhhhccCcccceeeeec--cCceehhHHHhhh-------hhhhHHHHHhccCcceeeEeeee
Confidence 3345666653 357899999999999999 5789999988532 23577889999999999999998
Q ss_pred ccccccCCceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCe
Q 045798 751 SSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNI 830 (1008)
Q Consensus 751 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NI 830 (1008)
.. ...+|||||||+.|-|...++... +++......|..+||.|+.|||.+ .|||||||.-||
T Consensus 182 tq-----sPcyCIiMEfCa~GqL~~VLka~~----------~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNi 243 (904)
T KOG4721|consen 182 TQ-----SPCYCIIMEFCAQGQLYEVLKAGR----------PITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNI 243 (904)
T ss_pred cC-----CceeEEeeeccccccHHHHHhccC----------ccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCce
Confidence 64 345899999999999999998765 789999999999999999999998 999999999999
Q ss_pred eecCCCCeEEcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCC
Q 045798 831 LLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGD 910 (1008)
Q Consensus 831 ll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~ 910 (1008)
||+.+..+||+|||.++...+.. ....+.||..|||||++...+.++|+||||||||||||+||..||.......
T Consensus 244 LIs~~d~VKIsDFGTS~e~~~~S-----TkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssA 318 (904)
T KOG4721|consen 244 LISYDDVVKISDFGTSKELSDKS-----TKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA 318 (904)
T ss_pred EeeccceEEeccccchHhhhhhh-----hhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhe
Confidence 99999999999999998665432 2334679999999999999999999999999999999999999987432110
Q ss_pred ccHHHHHHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHHHH
Q 045798 911 LNLHNFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHELQS 990 (1008)
Q Consensus 911 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 990 (1008)
. .| ...... | ..+....|++.+.-|++.||+..|..||++.+++..|+-
T Consensus 319 I---Iw--GVGsNs--------L------------------~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldI 367 (904)
T KOG4721|consen 319 I---IW--GVGSNS--------L------------------HLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDI 367 (904)
T ss_pred e---EE--eccCCc--------c------------------cccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhh
Confidence 0 00 000000 0 011123678889999999999999999999999998865
Q ss_pred HH
Q 045798 991 VK 992 (1008)
Q Consensus 991 i~ 992 (1008)
..
T Consensus 368 a~ 369 (904)
T KOG4721|consen 368 AS 369 (904)
T ss_pred cC
Confidence 43
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=333.11 Aligned_cols=262 Identities=25% Similarity=0.320 Sum_probs=203.0
Q ss_pred HHHhcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEecccc--------------chhhHHHHHHHHHHhhcCCCCcee
Q 045798 680 LKATNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC--------------EGASKSFMAECKALKNIRHRNLVK 745 (1008)
Q Consensus 680 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--------------~~~~~~~~~E~~~l~~l~h~niv~ 745 (1008)
.+..+.|++.+.||+|.||.|-+|++..+++.||||++.... ....+...+|+.+|++++|||||+
T Consensus 93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~ 172 (576)
T KOG0585|consen 93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK 172 (576)
T ss_pred ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence 345688999999999999999999999999999999995321 112357999999999999999999
Q ss_pred eeeccccccccCCceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccC
Q 045798 746 VITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDL 825 (1008)
Q Consensus 746 ~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dl 825 (1008)
++++..+ +..+..|+|+|||..|.+...-.... .+++.++++++.+++.||+|||.+ |||||||
T Consensus 173 LiEvLDD---P~s~~~YlVley~s~G~v~w~p~d~~----------els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDI 236 (576)
T KOG0585|consen 173 LIEVLDD---PESDKLYLVLEYCSKGEVKWCPPDKP----------ELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDI 236 (576)
T ss_pred EEEeecC---cccCceEEEEEeccCCccccCCCCcc----------cccHHHHHHHHHHHHHHHHHHHhc---Ceecccc
Confidence 9998543 55678999999998887765432211 389999999999999999999998 9999999
Q ss_pred CCCCeeecCCCCeEEcccCcccccccccCc-cccccccccccccccCccccCCCC----CCcccchhhHHHHHHHHHhCC
Q 045798 826 KPSNILLDNDLSGHIGDFGLARFHQEVSNS-TLSSSVGVKGTIGYTAPEYGLGSE----VSTNGDVYSYGILLLEMVTAK 900 (1008)
Q Consensus 826 kp~NIll~~~~~~kL~Dfg~a~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDvwslG~vl~elltG~ 900 (1008)
||+|+|++++|++||+|||.+......... ....-...+||+.|+|||...++. .+.+.||||+||++|.|+.|+
T Consensus 237 KPsNLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~ 316 (576)
T KOG0585|consen 237 KPSNLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQ 316 (576)
T ss_pred chhheEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhcc
Confidence 999999999999999999999866332111 111122356999999999877632 356889999999999999999
Q ss_pred CCCCccccCCccHHHHHHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCC
Q 045798 901 KPTDVMFEGDLNLHNFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMN 980 (1008)
Q Consensus 901 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt 980 (1008)
.||-..++ .++.++... -+-.++...+..+.+.+++.+++..||++|.+
T Consensus 317 ~PF~~~~~-----------------~~l~~KIvn--------------~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~ 365 (576)
T KOG0585|consen 317 LPFFDDFE-----------------LELFDKIVN--------------DPLEFPENPEINEDLKDLIKRLLEKDPEQRIT 365 (576)
T ss_pred CCcccchH-----------------HHHHHHHhc--------------CcccCCCcccccHHHHHHHHHHhhcChhheee
Confidence 99864322 111111111 01111222345667899999999999999999
Q ss_pred HHHHHHHH
Q 045798 981 MTNVVHEL 988 (1008)
Q Consensus 981 ~~evl~~L 988 (1008)
..+|....
T Consensus 366 l~~ik~Hp 373 (576)
T KOG0585|consen 366 LPDIKLHP 373 (576)
T ss_pred hhhheecc
Confidence 99987654
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=372.64 Aligned_cols=266 Identities=25% Similarity=0.408 Sum_probs=209.8
Q ss_pred CCCCCceEeeccCeeEEEEEEcCC-C----eEEEEEEeccc-cchhhHHHHHHHHHHhhcCCCCceeeeeccccccccCC
Q 045798 685 GFSSTHLIGVGSFGCVYKGALDED-G----IVVAIKVINLQ-CEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGN 758 (1008)
Q Consensus 685 ~y~~~~~lg~G~~g~Vy~~~~~~~-~----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 758 (1008)
..+..+.||+|.||.||.|..... + ..||||.++.. +.+...+|.+|+.+|+.++|||||+++|+|.+ .
T Consensus 693 ~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~-----~ 767 (1025)
T KOG1095|consen 693 NVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLD-----S 767 (1025)
T ss_pred heEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecC-----C
Confidence 345668899999999999998532 2 34899998754 34667899999999999999999999999854 5
Q ss_pred ceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCe
Q 045798 759 DFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSG 838 (1008)
Q Consensus 759 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 838 (1008)
...+|++|||++|+|..|+++.+..... ...++..+.+.++.|||+|+.||++. ++|||||.++|+|+++...|
T Consensus 768 ~~~~i~leyM~gGDL~sflr~~r~~~~~---~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~V 841 (1025)
T KOG1095|consen 768 GPPLILLEYMEGGDLLSFLRESRPAPFQ---PSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVV 841 (1025)
T ss_pred CCcEEEehhcccCcHHHHHHhcccccCC---CCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcE
Confidence 5589999999999999999887543221 33799999999999999999999997 99999999999999999999
Q ss_pred EEcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCccccCCccHHHHH
Q 045798 839 HIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT-AKKPTDVMFEGDLNLHNFA 917 (1008)
Q Consensus 839 kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-G~~pf~~~~~~~~~~~~~~ 917 (1008)
||+|||+|+.+-...-.. ......-...|||||.+..+.++.|+|||||||++||++| |..||......+. ...+
T Consensus 842 KIaDFGlArDiy~~~yyr--~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v-~~~~- 917 (1025)
T KOG1095|consen 842 KIADFGLARDIYDKDYYR--KHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEV-LLDV- 917 (1025)
T ss_pred EEcccchhHhhhhchhee--ccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHH-HHHH-
Confidence 999999999332222111 1111134579999999999999999999999999999999 8888864321110 0000
Q ss_pred HhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHHHHHHHHH
Q 045798 918 RMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHELQSVKNIL 995 (1008)
Q Consensus 918 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~i~~~~ 995 (1008)
....+++ +...|+..++++|..||+.+|++||++..+++++..+.+..
T Consensus 918 --------------------------~~ggRL~----~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~ 965 (1025)
T KOG1095|consen 918 --------------------------LEGGRLD----PPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAA 965 (1025)
T ss_pred --------------------------HhCCccC----CCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhh
Confidence 0001111 12357888999999999999999999999999988887653
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=331.34 Aligned_cols=279 Identities=24% Similarity=0.280 Sum_probs=204.7
Q ss_pred CCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccchhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceEEEE
Q 045798 685 GFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKAIV 764 (1008)
Q Consensus 685 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 764 (1008)
.|...+++|+|+||.||+|...++++.||||++-.+.. --.+|+++|+.+.|||||++..++......+.-+..+|
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 46778999999999999999999999999999864422 33579999999999999999988776443334466799
Q ss_pred EeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCC-CCeEEccc
Q 045798 765 YEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDND-LSGHIGDF 843 (1008)
Q Consensus 765 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kL~Df 843 (1008)
||||+. +|.++++.....+ .+++...++-+.+||.+||+|||+. +|+||||||.|+|+|.+ |.+|||||
T Consensus 101 leymP~-tL~~~~r~~~~~~------~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDF 170 (364)
T KOG0658|consen 101 LEYMPE-TLYRVIRHYTRAN------QRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDF 170 (364)
T ss_pred HHhchH-HHHHHHHHHhhcC------CCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccC
Confidence 999955 9999987521111 1678888999999999999999997 99999999999999976 89999999
Q ss_pred CcccccccccCccccccccccccccccCccccCCC-CCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHhhCC
Q 045798 844 GLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGS-EVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMALP 922 (1008)
Q Consensus 844 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~~~~ 922 (1008)
|.|+......... ....|..|+|||.+.|. .|+.+.||||.|||+.||+-|++-|... .....+....+....
T Consensus 171 GSAK~L~~~epni-----SYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~-s~~dQL~eIik~lG~ 244 (364)
T KOG0658|consen 171 GSAKVLVKGEPNI-----SYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGD-SSVDQLVEIIKVLGT 244 (364)
T ss_pred CcceeeccCCCce-----eEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCC-CHHHHHHHHHHHhCC
Confidence 9999876654433 34589999999998875 7999999999999999999999998652 222333344333332
Q ss_pred cchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 923 NQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 923 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
+...++. .+-....+. ...+.....+..-.....+.+..+++.++++++|.+|.++.|++.
T Consensus 245 Pt~e~I~-~mn~~y~~~--~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~ 305 (364)
T KOG0658|consen 245 PTREDIK-SMNPNYTEF--KFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA 305 (364)
T ss_pred CCHHHHh-hcCcccccc--cCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence 2222211 111000000 000001111000012245667899999999999999999999875
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=346.46 Aligned_cols=249 Identities=25% Similarity=0.344 Sum_probs=209.1
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEecccc---chhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCc
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC---EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGND 759 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 759 (1008)
.+-|+..+.||.|+.|.|-.|++.++|+.+|||++.... +.....+.+|+-+|+.+.||||++++++ ++...
T Consensus 11 iGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydV-----we~~~ 85 (786)
T KOG0588|consen 11 IGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDV-----WENKQ 85 (786)
T ss_pred ccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeee-----eccCc
Confidence 356888999999999999999999999999999997542 2334678999999999999999999999 67888
Q ss_pred eEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeE
Q 045798 760 FKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGH 839 (1008)
Q Consensus 760 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 839 (1008)
++|+|.||+++|-|.+|+-.++ ++++.++.++++||+.|+.|+|.. +|+|||+||+|+|+|..+++|
T Consensus 86 ~lylvlEyv~gGELFdylv~kG----------~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIK 152 (786)
T KOG0588|consen 86 HLYLVLEYVPGGELFDYLVRKG----------PLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIK 152 (786)
T ss_pred eEEEEEEecCCchhHHHHHhhC----------CCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEe
Confidence 9999999999999999998776 899999999999999999999998 999999999999999999999
Q ss_pred EcccCcccccccccCccccccccccccccccCccccCCCCC-CcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHH
Q 045798 840 IGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEV-STNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFAR 918 (1008)
Q Consensus 840 L~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~ 918 (1008)
|+|||+|....++.-- .+.+|++.|.|||++.|.+| +.++||||+|||+|.|+||+.||++ .+++....
T Consensus 153 IADFGMAsLe~~gklL-----eTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdD-----dNir~LLl 222 (786)
T KOG0588|consen 153 IADFGMASLEVPGKLL-----ETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDD-----DNIRVLLL 222 (786)
T ss_pred eeccceeecccCCccc-----cccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCC-----ccHHHHHH
Confidence 9999999865444332 23569999999999999988 4689999999999999999999973 22222221
Q ss_pred hhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 045798 919 MALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHE 987 (1008)
Q Consensus 919 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 987 (1008)
... ++.+ .|+ ..++.+..+|+.+|+..||++|.|++||.+.
T Consensus 223 KV~------------~G~f----------~MP------s~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH 263 (786)
T KOG0588|consen 223 KVQ------------RGVF----------EMP------SNISSEAQDLLRRMLDVDPSTRITTEEILKH 263 (786)
T ss_pred HHH------------cCcc----------cCC------CcCCHHHHHHHHHHhccCccccccHHHHhhC
Confidence 111 1111 111 2345567899999999999999999999874
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=360.70 Aligned_cols=275 Identities=22% Similarity=0.275 Sum_probs=216.6
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccchhhHHHHHHHHHHhhc-CCCCceeeeecccccc-ccC-Cc
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNI-RHRNLVKVITSCSSID-FQG-ND 759 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~-~~~-~~ 759 (1008)
..++++.+.|.+|||+.||.|++...|..||+|++-..++...+.+.+|+++|++| .|+|||.+++...... ... ..
T Consensus 36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~ 115 (738)
T KOG1989|consen 36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVW 115 (738)
T ss_pred CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCcee
Confidence 45678899999999999999999877799999999877788889999999999999 5999999999422221 222 35
Q ss_pred eEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeE
Q 045798 760 FKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGH 839 (1008)
Q Consensus 760 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 839 (1008)
++++.||||++|.|-+++...... .+++.++++|+.|+++|+++||.. +++|||||||.+||||+.+++.|
T Consensus 116 EvllLmEyC~gg~Lvd~mn~Rlq~--------~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~K 186 (738)
T KOG1989|consen 116 EVLLLMEYCKGGSLVDFMNTRLQT--------RLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYK 186 (738)
T ss_pred EEEeehhhccCCcHHHHHHHHHhc--------cCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEE
Confidence 688999999999999999765432 699999999999999999999996 66899999999999999999999
Q ss_pred EcccCcccccccccCcc-----ccccccccccccccCcccc---CCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCc
Q 045798 840 IGDFGLARFHQEVSNST-----LSSSVGVKGTIGYTAPEYG---LGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDL 911 (1008)
Q Consensus 840 L~Dfg~a~~~~~~~~~~-----~~~~~~~~gt~~y~aPE~~---~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~ 911 (1008)
|||||.|.-.-...... .........|+.|+|||++ .+...++|+|||||||+||-|+....||+....
T Consensus 187 LCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~--- 263 (738)
T KOG1989|consen 187 LCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK--- 263 (738)
T ss_pred eCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc---
Confidence 99999997332221100 0011123378999999974 567899999999999999999999999974311
Q ss_pred cHHHHHHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHHHHH
Q 045798 912 NLHNFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHELQSV 991 (1008)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~i 991 (1008)
..+++..+ .++.....+..+.+||+.||+.||.+||++-+|++.+..+
T Consensus 264 --------------laIlng~Y------------------~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l 311 (738)
T KOG1989|consen 264 --------------LAILNGNY------------------SFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFEL 311 (738)
T ss_pred --------------eeEEeccc------------------cCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHH
Confidence 01111110 1111234677789999999999999999999999999998
Q ss_pred HHHHHHHHHh
Q 045798 992 KNILLELETV 1001 (1008)
Q Consensus 992 ~~~~~~~~~~ 1001 (1008)
.+....+...
T Consensus 312 ~~~~~~~~~~ 321 (738)
T KOG1989|consen 312 ANKPCPIPDI 321 (738)
T ss_pred hcCCCCcccc
Confidence 8764444333
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=337.68 Aligned_cols=264 Identities=24% Similarity=0.378 Sum_probs=207.3
Q ss_pred cCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccc-hhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceEE
Q 045798 684 NGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCE-GASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKA 762 (1008)
Q Consensus 684 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 762 (1008)
....++++||+|-||+|.+++.. .+..||||.++.... ....+|.+|+++|.+++||||++++|+|. .++.++
T Consensus 538 s~L~~~ekiGeGqFGEVhLCeve-g~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~-----~DePic 611 (807)
T KOG1094|consen 538 SRLRFKEKIGEGQFGEVHLCEVE-GPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCV-----QDDPLC 611 (807)
T ss_pred hheehhhhhcCcccceeEEEEec-CceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeee-----cCCchH
Confidence 45677899999999999999984 569999999986654 34588999999999999999999999985 355689
Q ss_pred EEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEcc
Q 045798 763 IVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGD 842 (1008)
Q Consensus 763 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 842 (1008)
+|+|||++|+|.+|+..+..+ ........+|+.||+.|++||.+. ++||||+.++|+|++.++++||+|
T Consensus 612 mI~EYmEnGDLnqFl~aheap--------t~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiad 680 (807)
T KOG1094|consen 612 MITEYMENGDLNQFLSAHELP--------TAETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIAD 680 (807)
T ss_pred HHHHHHhcCcHHHHHHhccCc--------ccccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecC
Confidence 999999999999999988644 234556677999999999999998 999999999999999999999999
Q ss_pred cCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHh--CCCCCCccccCCccHHHHHHhh
Q 045798 843 FGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT--AKKPTDVMFEGDLNLHNFARMA 920 (1008)
Q Consensus 843 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt--G~~pf~~~~~~~~~~~~~~~~~ 920 (1008)
||+++-+-..+- .......+-+.+|||||.+..++++.+||||+||+++||+++ ...||....+++ ..+-....
T Consensus 681 fgmsR~lysg~y--y~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~--vven~~~~ 756 (807)
T KOG1094|consen 681 FGMSRNLYSGDY--YRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQ--VVENAGEF 756 (807)
T ss_pred cccccccccCCc--eeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHH--HHHhhhhh
Confidence 999984433222 222334456789999999999999999999999999999876 677886543221 11111111
Q ss_pred CCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHHHHH
Q 045798 921 LPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHELQSV 991 (1008)
Q Consensus 921 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~i 991 (1008)
++.+ . .+.-.....-|+.+++++|.+||+.|-++||+++++..-|++.
T Consensus 757 ~~~~------------~-----------~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 757 FRDQ------------G-----------RQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred cCCC------------C-----------cceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 1111 0 0000111235778899999999999999999999999888653
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-39 Score=326.80 Aligned_cols=249 Identities=24% Similarity=0.341 Sum_probs=206.8
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEecccc---chhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCc
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC---EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGND 759 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 759 (1008)
..+|.+.+.||+|.||.|-+|.....|+.||||.++... +.+.-.+.+|++||+.++||||+.++.+ |+..+
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEV-----FENkd 126 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEV-----FENKD 126 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhh-----hcCCc
Confidence 457889999999999999999998899999999997543 3344568899999999999999999999 78899
Q ss_pred eEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeE
Q 045798 760 FKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGH 839 (1008)
Q Consensus 760 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 839 (1008)
...|||||..+|.|++|+...+ .+++.+++.+++||++|+.|+|.+ ++||||+|.+|||+|.++++|
T Consensus 127 KIvivMEYaS~GeLYDYiSer~----------~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiK 193 (668)
T KOG0611|consen 127 KIVIVMEYASGGELYDYISERG----------SLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIK 193 (668)
T ss_pred eEEEEEEecCCccHHHHHHHhc----------cccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCee
Confidence 9999999999999999998876 899999999999999999999998 999999999999999999999
Q ss_pred EcccCcccccccccCccccccccccccccccCccccCCCCC-CcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHH
Q 045798 840 IGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEV-STNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFAR 918 (1008)
Q Consensus 840 L~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~ 918 (1008)
|+|||++..+....- -..++|++-|.+||+..|.+| ++.+|-||+||++|.++.|..||+.... ...++
T Consensus 194 IADFGLSNly~~~kf-----LqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dh-----k~lvr 263 (668)
T KOG0611|consen 194 IADFGLSNLYADKKF-----LQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDH-----KRLVR 263 (668)
T ss_pred eeccchhhhhccccH-----HHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchH-----HHHHH
Confidence 999999988765432 234679999999999999988 5789999999999999999999974311 11111
Q ss_pred hhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHH
Q 045798 919 MALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHEL 988 (1008)
Q Consensus 919 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 988 (1008)
+.-.+.+ .+ .+.+..-.-+|++|+..+|++|.|+.+|....
T Consensus 264 ------------QIs~GaY------------rE-----P~~PSdA~gLIRwmLmVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 264 ------------QISRGAY------------RE-----PETPSDASGLIRWMLMVNPERRATIEDIASHW 304 (668)
T ss_pred ------------Hhhcccc------------cC-----CCCCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence 1100000 00 01222335788999999999999999998754
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=337.88 Aligned_cols=264 Identities=20% Similarity=0.261 Sum_probs=204.4
Q ss_pred CCCCHHHHHHHhcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccchh---hHHHHHHHHHHhhcCCCCceeeee
Q 045798 672 PKMSYKSLLKATNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGA---SKSFMAECKALKNIRHRNLVKVIT 748 (1008)
Q Consensus 672 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~ 748 (1008)
..++.+++. ......||+|++|.||+|.. +|+.||||+++...... .+.+.+|++++++++||||+++++
T Consensus 13 ~~i~~~~i~-----~~~~~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g 85 (283)
T PHA02988 13 KCIESDDID-----KYTSVLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYG 85 (283)
T ss_pred eecCHHHcC-----CCCCeEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEee
Confidence 344555552 22236799999999999998 68999999997543322 467889999999999999999999
Q ss_pred ccccccccCCceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCC
Q 045798 749 SCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPS 828 (1008)
Q Consensus 749 ~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~ 828 (1008)
++.+. .......++||||+++|+|.+++.... .+++..+..++.|++.|++|||+. .+++||||||+
T Consensus 86 ~~~~~-~~~~~~~~lv~Ey~~~g~L~~~l~~~~----------~~~~~~~~~i~~~i~~~l~~lH~~--~~~~Hrdlkp~ 152 (283)
T PHA02988 86 FIIDI-VDDLPRLSLILEYCTRGYLREVLDKEK----------DLSFKTKLDMAIDCCKGLYNLYKY--TNKPYKNLTSV 152 (283)
T ss_pred eEEec-ccCCCceEEEEEeCCCCcHHHHHhhCC----------CCChhHHHHHHHHHHHHHHHHHhc--CCCCCCcCChh
Confidence 86431 123456899999999999999997653 678899999999999999999973 27889999999
Q ss_pred CeeecCCCCeEEcccCcccccccccCccccccccccccccccCccccCC--CCCCcccchhhHHHHHHHHHhCCCCCCcc
Q 045798 829 NILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLG--SEVSTNGDVYSYGILLLEMVTAKKPTDVM 906 (1008)
Q Consensus 829 NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwslG~vl~elltG~~pf~~~ 906 (1008)
||++++++.+||+|||+++...... ....++..|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 153 nill~~~~~~kl~dfg~~~~~~~~~-------~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~ 225 (283)
T PHA02988 153 SFLVTENYKLKIICHGLEKILSSPP-------FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENL 225 (283)
T ss_pred hEEECCCCcEEEcccchHhhhcccc-------ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCC
Confidence 9999999999999999998653321 12347899999999876 67899999999999999999999998643
Q ss_pred ccCCccHHHHHHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 907 FEGDLNLHNFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 907 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
.. ....... ..... + ... ...++..+.+++.+||+.||++|||++|+++
T Consensus 226 ~~-----~~~~~~i------------~~~~~----------~--~~~--~~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 274 (283)
T PHA02988 226 TT-----KEIYDLI------------INKNN----------S--LKL--PLDCPLEIKCIVEACTSHDSIKRPNIKEILY 274 (283)
T ss_pred CH-----HHHHHHH------------HhcCC----------C--CCC--CCcCcHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 11 0110000 00000 0 000 0134567899999999999999999999999
Q ss_pred HHHHHHH
Q 045798 987 ELQSVKN 993 (1008)
Q Consensus 987 ~L~~i~~ 993 (1008)
.|+.++.
T Consensus 275 ~l~~~~~ 281 (283)
T PHA02988 275 NLSLYKF 281 (283)
T ss_pred HHHHHHh
Confidence 9998764
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=344.94 Aligned_cols=244 Identities=26% Similarity=0.344 Sum_probs=202.1
Q ss_pred HhcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEecccc---chhhHHHHHHHHHHhhc-CCCCceeeeeccccccccC
Q 045798 682 ATNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC---EGASKSFMAECKALKNI-RHRNLVKVITSCSSIDFQG 757 (1008)
Q Consensus 682 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~ 757 (1008)
..++|.+.++||+|+||+|++|..+.+++.||||++++.. .++.+..+.|.+|+... +||.++.++.+ |+.
T Consensus 366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~-----fQT 440 (694)
T KOG0694|consen 366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSC-----FQT 440 (694)
T ss_pred cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccc-----ccc
Confidence 3568999999999999999999999999999999998653 45667889999999888 69999999998 789
Q ss_pred CceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCC
Q 045798 758 NDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLS 837 (1008)
Q Consensus 758 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 837 (1008)
.++.|+||||+.||++..+.+.. .+++..++-++..|+.||.|||++ +|||||||.+|||+|.+|+
T Consensus 441 ~~~l~fvmey~~Ggdm~~~~~~~-----------~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh 506 (694)
T KOG0694|consen 441 KEHLFFVMEYVAGGDLMHHIHTD-----------VFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGH 506 (694)
T ss_pred CCeEEEEEEecCCCcEEEEEecc-----------cccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCc
Confidence 99999999999999966555433 799999999999999999999998 9999999999999999999
Q ss_pred eEEcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHH
Q 045798 838 GHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFA 917 (1008)
Q Consensus 838 ~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~ 917 (1008)
+||+|||+++.--.... .+.+++||+.|||||++.+..|+.++|.|||||++|||+.|..||....++
T Consensus 507 ~kiADFGlcKe~m~~g~----~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEe-------- 574 (694)
T KOG0694|consen 507 VKIADFGLCKEGMGQGD----RTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEE-------- 574 (694)
T ss_pred EEecccccccccCCCCC----ccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHH--------
Confidence 99999999984322222 344678999999999999999999999999999999999999998743222
Q ss_pred HhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCH
Q 045798 918 RMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNM 981 (1008)
Q Consensus 918 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~ 981 (1008)
++.|..+..++. . ..-.+.+.+.++++++..+|++|..+
T Consensus 575 ---------e~FdsI~~d~~~----------y------P~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 575 ---------EVFDSIVNDEVR----------Y------PRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred ---------HHHHHHhcCCCC----------C------CCcccHHHHHHHHHHhccCcccccCC
Confidence 112222211110 0 01234556899999999999999866
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-38 Score=350.41 Aligned_cols=284 Identities=22% Similarity=0.241 Sum_probs=202.5
Q ss_pred CCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccc--cchhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceEE
Q 045798 685 GFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQ--CEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKA 762 (1008)
Q Consensus 685 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 762 (1008)
+|++.+.||+|+||.||+|++..+++.||||+++.. .......+.+|++++++++||||+++++++...........|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 588899999999999999999889999999998743 223345788999999999999999999987544334445689
Q ss_pred EEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEcc
Q 045798 763 IVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGD 842 (1008)
Q Consensus 763 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 842 (1008)
+||||+ +++|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|
T Consensus 81 lv~e~~-~~~L~~~l~~~~----------~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~D 146 (338)
T cd07859 81 VVFELM-ESDLHQVIKAND----------DLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICD 146 (338)
T ss_pred EEEecC-CCCHHHHHHhcc----------cCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEcc
Confidence 999999 579999886543 689999999999999999999998 999999999999999999999999
Q ss_pred cCcccccccccCccccccccccccccccCccccCC--CCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHhh
Q 045798 843 FGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLG--SEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMA 920 (1008)
Q Consensus 843 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~~ 920 (1008)
||+++......... .......||..|+|||++.+ ..++.++|||||||++|||++|+.||...... .... .....
T Consensus 147 fg~~~~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~-~~~~-~~~~~ 223 (338)
T cd07859 147 FGLARVAFNDTPTA-IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVV-HQLD-LITDL 223 (338)
T ss_pred CccccccccccCcc-ccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChH-HHHH-HHHHH
Confidence 99998543322111 11223468999999999765 57899999999999999999999998642110 0011 11111
Q ss_pred CCcchhhhhcccccCchHHhhhhhhhh-hccccch-hHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 045798 921 LPNQVMDIVDPILRNDEEILASTDKCR-RMQTGIN-SRLECLISMVKIGVACSMESPQDRMNMTNVVHE 987 (1008)
Q Consensus 921 ~~~~~~~~~d~~l~~~~~~~~~~~~~~-~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 987 (1008)
................. ........ ..+.... .....+..+.+++.+||+.||++|||++|+++.
T Consensus 224 ~~~~~~~~~~~i~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 224 LGTPSPETISRVRNEKA--RRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred hCCCCHHHHHHhhhhhH--HHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 10000000000000000 00000000 0000000 001234567899999999999999999999863
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=345.46 Aligned_cols=262 Identities=26% Similarity=0.369 Sum_probs=207.6
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCe---E-EEEEEeccc---cchhhHHHHHHHHHHhhcCCCCceeeeeccccccc
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGI---V-VAIKVINLQ---CEGASKSFMAECKALKNIRHRNLVKVITSCSSIDF 755 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~---~-vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 755 (1008)
.++-...++||+|+||.||+|..+..+. . ||||..+.. ......+|++|+++|+.++|||||+++|++
T Consensus 156 H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa----- 230 (474)
T KOG0194|consen 156 HSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVA----- 230 (474)
T ss_pred ccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-----
Confidence 4455566999999999999999964322 3 899999852 356678899999999999999999999995
Q ss_pred cCCceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCC
Q 045798 756 QGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDND 835 (1008)
Q Consensus 756 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~ 835 (1008)
......++|||+|.||+|.+|+++.+. .++..++..++.++|.||+|||+. +++||||.++|+|++.+
T Consensus 231 ~~~~Pl~ivmEl~~gGsL~~~L~k~~~---------~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~ 298 (474)
T KOG0194|consen 231 VLEEPLMLVMELCNGGSLDDYLKKNKK---------SLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKK 298 (474)
T ss_pred cCCCccEEEEEecCCCcHHHHHHhCCC---------CCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCC
Confidence 456679999999999999999987752 589999999999999999999997 99999999999999999
Q ss_pred CCeEEcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCccccCCccHH
Q 045798 836 LSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT-AKKPTDVMFEGDLNLH 914 (1008)
Q Consensus 836 ~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-G~~pf~~~~~~~~~~~ 914 (1008)
+.+||+|||+++.-....... ....-+..|+|||.+..+.|++++|||||||++||+++ |..||...... ...
T Consensus 299 ~~vKISDFGLs~~~~~~~~~~----~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~--~v~ 372 (474)
T KOG0194|consen 299 GVVKISDFGLSRAGSQYVMKK----FLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY--EVK 372 (474)
T ss_pred CeEEeCccccccCCcceeecc----ccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH--HHH
Confidence 999999999997543111111 01135689999999999999999999999999999999 88898643211 011
Q ss_pred HHHHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHHHHHHHH
Q 045798 915 NFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHELQSVKNI 994 (1008)
Q Consensus 915 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~i~~~ 994 (1008)
.++ .. ...+++. ....+..+..++.+||..+|++||||.++.+.++.+...
T Consensus 373 ~kI---------------~~----------~~~r~~~----~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~ 423 (474)
T KOG0194|consen 373 AKI---------------VK----------NGYRMPI----PSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKK 423 (474)
T ss_pred HHH---------------Hh----------cCccCCC----CCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhc
Confidence 110 00 0011111 113566788999999999999999999999999988766
Q ss_pred HH
Q 045798 995 LL 996 (1008)
Q Consensus 995 ~~ 996 (1008)
..
T Consensus 424 ~~ 425 (474)
T KOG0194|consen 424 KE 425 (474)
T ss_pred cc
Confidence 44
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=304.65 Aligned_cols=251 Identities=23% Similarity=0.337 Sum_probs=209.1
Q ss_pred HhcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccc---cchhhHHHHHHHHHHhhcCCCCceeeeeccccccccCC
Q 045798 682 ATNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQ---CEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGN 758 (1008)
Q Consensus 682 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 758 (1008)
+.++|.+.+.||+|.||.||.|+.++++..||+|++... ..+...++.+|+++.+.++||||++++++ |.+.
T Consensus 20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~-----fhd~ 94 (281)
T KOG0580|consen 20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGY-----FHDS 94 (281)
T ss_pred chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhh-----eecc
Confidence 356799999999999999999999999999999998643 23445789999999999999999999999 6788
Q ss_pred ceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCe
Q 045798 759 DFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSG 838 (1008)
Q Consensus 759 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 838 (1008)
...|+++||..+|.+...++..+.. ++++.....+..|+|.|+.|+|.. +|+||||||+|+|++.++..
T Consensus 95 ~riyLilEya~~gel~k~L~~~~~~--------~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~l 163 (281)
T KOG0580|consen 95 KRIYLILEYAPRGELYKDLQEGRMK--------RFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGEL 163 (281)
T ss_pred ceeEEEEEecCCchHHHHHHhcccc--------cccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCe
Confidence 8999999999999999999855432 688889999999999999999996 99999999999999999999
Q ss_pred EEcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHH
Q 045798 839 HIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFAR 918 (1008)
Q Consensus 839 kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~ 918 (1008)
|++|||.+...... .....+||..|.|||+..+..++..+|+|++|++.||++.|.+||+... .+..+.....
T Consensus 164 kiAdfGwsV~~p~~------kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~-~~etYkrI~k 236 (281)
T KOG0580|consen 164 KIADFGWSVHAPSN------KRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS-HSETYKRIRK 236 (281)
T ss_pred eccCCCceeecCCC------CceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh-hHHHHHHHHH
Confidence 99999999854422 1234679999999999999999999999999999999999999997543 1111222111
Q ss_pred hhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 045798 919 MALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHE 987 (1008)
Q Consensus 919 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 987 (1008)
... ..+ ...+....++|.+|+..+|.+|.+..|+++-
T Consensus 237 ~~~-------~~p-------------------------~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 237 VDL-------KFP-------------------------STISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred ccc-------cCC-------------------------cccChhHHHHHHHHhccCccccccHHHHhhh
Confidence 110 000 1244556899999999999999999999874
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=340.93 Aligned_cols=253 Identities=24% Similarity=0.323 Sum_probs=210.5
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEecccc--chhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCce
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC--EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDF 760 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 760 (1008)
.++|..++++|+|+||.++.++++.+++.||+|.+.... +...+...+|+.+++++.|||||.+.+. |..++.
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds-----~~~~~~ 77 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDS-----FEEDGQ 77 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccc-----hhcCCc
Confidence 357899999999999999999999999999999997543 3445578999999999999999999998 455555
Q ss_pred -EEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeE
Q 045798 761 -KAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGH 839 (1008)
Q Consensus 761 -~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 839 (1008)
.+|||+||+||++.+.+...+. ..++++.+..|+.||+.|+.|||+. +|+|||||+.|||++.++.+|
T Consensus 78 ~l~Ivm~Y~eGg~l~~~i~~~k~--------~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~Vk 146 (426)
T KOG0589|consen 78 LLCIVMEYCEGGDLAQLIKEQKG--------VLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVK 146 (426)
T ss_pred eEEEEEeecCCCCHHHHHHHHhh--------ccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCcee
Confidence 9999999999999999987652 2799999999999999999999986 999999999999999999999
Q ss_pred EcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHh
Q 045798 840 IGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARM 919 (1008)
Q Consensus 840 L~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~ 919 (1008)
|+|||+|+........ ....+||+.|++||.+.+.+|..|+||||+||++|||++-+++|....-
T Consensus 147 LgDfGlaK~l~~~~~~----a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m----------- 211 (426)
T KOG0589|consen 147 LGDFGLAKILNPEDSL----ASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNM----------- 211 (426)
T ss_pred ecchhhhhhcCCchhh----hheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccch-----------
Confidence 9999999987765422 2346799999999999999999999999999999999999999874311
Q ss_pred hCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 045798 920 ALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHE 987 (1008)
Q Consensus 920 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 987 (1008)
..++-+...... .+.......++..++..|++.+|..||++.+++.+
T Consensus 212 ------~~Li~ki~~~~~---------------~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 212 ------SELILKINRGLY---------------SPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred ------HHHHHHHhhccC---------------CCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 111111110000 00112355678999999999999999999999987
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=344.74 Aligned_cols=200 Identities=26% Similarity=0.378 Sum_probs=175.3
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEecccc-chhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceE
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC-EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFK 761 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 761 (1008)
.++|++.+.||+|+||.||+|++..++..||+|+++... +...+.+.+|++++++++||||+++++++ ..++..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~ 78 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF-----YSDGEI 78 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEE-----EECCEE
Confidence 468999999999999999999999899999999997543 33456799999999999999999999985 455679
Q ss_pred EEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEc
Q 045798 762 AIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIG 841 (1008)
Q Consensus 762 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 841 (1008)
++||||+++|+|.+++.... .+++..+..++.|++.||+|||+. .+|+||||||+||+++.++.+||+
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~----------~~~~~~~~~~~~~i~~~l~~lH~~--~~ivH~dlkp~Nil~~~~~~~kl~ 146 (331)
T cd06649 79 SICMEHMDGGSLDQVLKEAK----------RIPEEILGKVSIAVLRGLAYLREK--HQIMHRDVKPSNILVNSRGEIKLC 146 (331)
T ss_pred EEEeecCCCCcHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHhhc--CCEEcCCCChhhEEEcCCCcEEEc
Confidence 99999999999999997543 688999999999999999999985 269999999999999999999999
Q ss_pred ccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCc
Q 045798 842 DFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDV 905 (1008)
Q Consensus 842 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~ 905 (1008)
|||++....... .....|+..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 147 Dfg~~~~~~~~~------~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~ 204 (331)
T cd06649 147 DFGVSGQLIDSM------ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPP 204 (331)
T ss_pred cCcccccccccc------cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 999997553321 1224589999999999999999999999999999999999999864
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-38 Score=342.18 Aligned_cols=246 Identities=23% Similarity=0.294 Sum_probs=199.3
Q ss_pred cCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEecccc---chhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCce
Q 045798 684 NGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC---EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDF 760 (1008)
Q Consensus 684 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 760 (1008)
++|++.+.||+|+||.||+|.+..+++.||+|++.... ....+.+.+|++++++++||||++++++ +.+++.
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~-----~~~~~~ 75 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWT-----EHDQRF 75 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhh-----hccCCe
Confidence 47899999999999999999998899999999986432 2334678899999999999999999988 456678
Q ss_pred EEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEE
Q 045798 761 KAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHI 840 (1008)
Q Consensus 761 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 840 (1008)
.++||||+++|+|.+++...+ .+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||
T Consensus 76 ~~lv~e~~~~~~L~~~~~~~~----------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl 142 (291)
T cd05612 76 LYMLMEYVPGGELFSYLRNSG----------RFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKL 142 (291)
T ss_pred EEEEEeCCCCCCHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEE
Confidence 999999999999999997654 688999999999999999999998 9999999999999999999999
Q ss_pred cccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHhh
Q 045798 841 GDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMA 920 (1008)
Q Consensus 841 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~~ 920 (1008)
+|||++....... ....|++.|+|||++.+..++.++|||||||++|||++|+.||...... .....
T Consensus 143 ~Dfg~~~~~~~~~-------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~-----~~~~~- 209 (291)
T cd05612 143 TDFGFAKKLRDRT-------WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPF-----GIYEK- 209 (291)
T ss_pred EecCcchhccCCc-------ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHH-
Confidence 9999998653321 1245899999999999988999999999999999999999998642110 00000
Q ss_pred CCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCC-----HHHHHHH
Q 045798 921 LPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMN-----MTNVVHE 987 (1008)
Q Consensus 921 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~~ 987 (1008)
+..... .++ ...+..+.+++.+||+.||.+||+ ++|+++.
T Consensus 210 -------i~~~~~--------------~~~------~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 210 -------ILAGKL--------------EFP------RHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred -------HHhCCc--------------CCC------ccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 000000 000 012345789999999999999995 8887754
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=336.81 Aligned_cols=252 Identities=23% Similarity=0.296 Sum_probs=198.4
Q ss_pred CCCCCceEeeccCeeEEEEEEcCCCeEEEEEEecccc---chhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceE
Q 045798 685 GFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC---EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFK 761 (1008)
Q Consensus 685 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 761 (1008)
.|+..+.||+|+||.||+|.+..+++.||+|++.... ......+.+|++++++++|++|+++++++ ..++..
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~-----~~~~~~ 75 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAY-----ETKDAL 75 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEE-----ccCCeE
Confidence 3778899999999999999998899999999986432 22334678999999999999999999884 556679
Q ss_pred EEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEc
Q 045798 762 AIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIG 841 (1008)
Q Consensus 762 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 841 (1008)
++||||+++|+|.+++...... .+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+
T Consensus 76 ~lv~e~~~~g~L~~~~~~~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~ 144 (285)
T cd05631 76 CLVLTIMNGGDLKFHIYNMGNP--------GFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRIS 144 (285)
T ss_pred EEEEEecCCCcHHHHHHhhCCC--------CCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEe
Confidence 9999999999999887643211 588999999999999999999997 99999999999999999999999
Q ss_pred ccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHhhC
Q 045798 842 DFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMAL 921 (1008)
Q Consensus 842 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~~~ 921 (1008)
|||++........ .....||..|+|||++.+..++.++|||||||++|||++|+.||........ .....
T Consensus 145 Dfg~~~~~~~~~~-----~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~-~~~~~---- 214 (285)
T cd05631 145 DLGLAVQIPEGET-----VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVK-REEVD---- 214 (285)
T ss_pred eCCCcEEcCCCCe-----ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchh-HHHHH----
Confidence 9999986532211 1234589999999999999999999999999999999999999974322110 00000
Q ss_pred CcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCC-----HHHHHH
Q 045798 922 PNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMN-----MTNVVH 986 (1008)
Q Consensus 922 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~ 986 (1008)
..+.... .......+..+.+++.+||+.||.+||+ ++|+++
T Consensus 215 ---------~~~~~~~---------------~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 215 ---------RRVKEDQ---------------EEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred ---------HHhhccc---------------ccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 0000000 0001123456789999999999999997 777776
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=320.60 Aligned_cols=283 Identities=25% Similarity=0.317 Sum_probs=207.4
Q ss_pred cCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccc--hhhHHHHHHHHHHhhcCCCC-ceeeeecccccc-ccCCc
Q 045798 684 NGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCE--GASKSFMAECKALKNIRHRN-LVKVITSCSSID-FQGND 759 (1008)
Q Consensus 684 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~n-iv~~~~~~~~~~-~~~~~ 759 (1008)
..|..+++||+|.||+||+|+.+.+|+.||+|+++...+ +......+|+.++++++|+| |+++++++.... +....
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 446677889999999999999999999999999986543 46677899999999999999 999999965432 12223
Q ss_pred eEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeE
Q 045798 760 FKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGH 839 (1008)
Q Consensus 760 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 839 (1008)
..++|+||+ .-+|.+|+....... ..++...++.++.||+.||+|||++ +|+||||||+||+|+++|.+|
T Consensus 91 ~l~lvfe~~-d~DL~~ymd~~~~~~------~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lK 160 (323)
T KOG0594|consen 91 KLYLVFEFL-DRDLKKYMDSLPKKP------QGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLK 160 (323)
T ss_pred eEEEEEEee-cccHHHHHHhccccc------cCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEe
Confidence 788999999 679999998765321 1467789999999999999999998 999999999999999999999
Q ss_pred EcccCcccccccccCccccccccccccccccCccccCCC-CCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHH
Q 045798 840 IGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGS-EVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFAR 918 (1008)
Q Consensus 840 L~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~ 918 (1008)
|+|||+|+...-... .....++|.+|+|||++.+. .|+...||||+||+++||+++++-|....+.+.....+..
T Consensus 161 laDFGlAra~~ip~~----~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~ 236 (323)
T KOG0594|consen 161 LADFGLARAFSIPMR----TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRL 236 (323)
T ss_pred eeccchHHHhcCCcc----cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHH
Confidence 999999996543322 23446689999999999887 7899999999999999999999888755442222222211
Q ss_pred hhCCcc-hhhhhcccccCchHHhhhhhhhhhccccchhHH---HHHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 045798 919 MALPNQ-VMDIVDPILRNDEEILASTDKCRRMQTGINSRL---ECLISMVKIGVACSMESPQDRMNMTNVVHE 987 (1008)
Q Consensus 919 ~~~~~~-~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 987 (1008)
...|.. ...-+...-.... .. ...+....-.. .......+++.+|++++|++|.||+.+++.
T Consensus 237 lGtP~e~~Wp~v~~~~~~k~----~f---~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 237 LGTPNEKDWPGVSSLPDYKA----PF---PKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred cCCCCccCCCCccccccccc----cC---cCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 111111 0000000000000 00 00000000000 111356899999999999999999999875
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=340.33 Aligned_cols=275 Identities=24% Similarity=0.350 Sum_probs=199.2
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccc-hhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceE
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCE-GASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFK 761 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 761 (1008)
.++|++.+.||+|+||.||+|....+++.||+|+++.... .....+.+|+.+++.++||||+++++++ ..++..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-----~~~~~~ 78 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDII-----HTKETL 78 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEE-----ecCCeE
Confidence 4689999999999999999999988999999999975432 3345678999999999999999999984 556779
Q ss_pred EEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEc
Q 045798 762 AIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIG 841 (1008)
Q Consensus 762 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 841 (1008)
++||||+ .++|.+++..... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+
T Consensus 79 ~lv~e~~-~~~l~~~~~~~~~---------~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~ 145 (303)
T cd07869 79 TLVFEYV-HTDLCQYMDKHPG---------GLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLA 145 (303)
T ss_pred EEEEECC-CcCHHHHHHhCCC---------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEC
Confidence 9999999 5688888765421 578899999999999999999998 99999999999999999999999
Q ss_pred ccCcccccccccCccccccccccccccccCccccCC-CCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHhh
Q 045798 842 DFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLG-SEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMA 920 (1008)
Q Consensus 842 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~~ 920 (1008)
|||++........ ......+++.|+|||++.+ ..++.++||||+||++|||++|..||.................
T Consensus 146 Dfg~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 221 (303)
T cd07869 146 DFGLARAKSVPSH----TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVL 221 (303)
T ss_pred CCCcceeccCCCc----cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHh
Confidence 9999975432211 1123458899999998765 4578899999999999999999999975322111111111111
Q ss_pred CCcchhhhh----cccccCchHHhhhhhhhhhccccch---hHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 921 LPNQVMDIV----DPILRNDEEILASTDKCRRMQTGIN---SRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 921 ~~~~~~~~~----d~~l~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
.......+. .+...... .. ...+.... .....+..+.+++.+|++.||++|||++|+++
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~--~~-----~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 222 GTPNEDTWPGVHSLPHFKPER--FT-----LYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred CCCChhhccchhhcccccccc--cc-----ccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 000000000 00000000 00 00000000 00012345789999999999999999999986
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=336.98 Aligned_cols=277 Identities=22% Similarity=0.259 Sum_probs=201.5
Q ss_pred cCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEecccc--chhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceE
Q 045798 684 NGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC--EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFK 761 (1008)
Q Consensus 684 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 761 (1008)
++|++.+.||+|+||.||+|++..+++.||+|+++... +...+.+.+|++++++++||||+++++++ ..++..
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~ 75 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAF-----RRRGKL 75 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhE-----ecCCEE
Confidence 47999999999999999999999899999999987432 23356788999999999999999999884 556779
Q ss_pred EEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEc
Q 045798 762 AIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIG 841 (1008)
Q Consensus 762 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 841 (1008)
++||||++++.+..+..... .+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+
T Consensus 76 ~lv~e~~~~~~l~~~~~~~~----------~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~ 142 (287)
T cd07848 76 YLVFEYVEKNMLELLEEMPN----------GVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLC 142 (287)
T ss_pred EEEEecCCCCHHHHHHhcCC----------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEe
Confidence 99999998877765543221 688999999999999999999997 99999999999999999999999
Q ss_pred ccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHh--
Q 045798 842 DFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARM-- 919 (1008)
Q Consensus 842 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~-- 919 (1008)
|||++.......... .....|+..|+|||++.+..++.++||||+||++|||++|+.||......+. .......
T Consensus 143 Dfg~~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~-~~~~~~~~~ 218 (287)
T cd07848 143 DFGFARNLSEGSNAN---YTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQ-LFTIQKVLG 218 (287)
T ss_pred eccCccccccccccc---ccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhhC
Confidence 999998654322211 1234589999999999988899999999999999999999999864322111 1111110
Q ss_pred hCCcchhhhhcccccCchHHhhhhhhhhhcccc--chhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 920 ALPNQVMDIVDPILRNDEEILASTDKCRRMQTG--INSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 920 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
..+........ ..+............... .......+..+.+++.+||+.||++|||++|+++
T Consensus 219 ~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 219 PLPAEQMKLFY----SNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred CCCHHHHHhhh----ccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 01111000000 000000000000000000 0001124567899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=335.79 Aligned_cols=279 Identities=25% Similarity=0.338 Sum_probs=199.6
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEecccc-chhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceE
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC-EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFK 761 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 761 (1008)
.++|++.+.||+|+||.||+|....+++.||+|+++... ......+.+|++++++++||||+++++++ ..++..
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-----~~~~~~ 78 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII-----HTERCL 78 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEE-----cCCCeE
Confidence 357999999999999999999998899999999997443 23345788999999999999999999984 456679
Q ss_pred EEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEc
Q 045798 762 AIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIG 841 (1008)
Q Consensus 762 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 841 (1008)
++||||++ ++|.+++..... .+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+
T Consensus 79 ~lv~e~~~-~~l~~~l~~~~~---------~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~ 145 (288)
T cd07871 79 TLVFEYLD-SDLKQYLDNCGN---------LMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLA 145 (288)
T ss_pred EEEEeCCC-cCHHHHHHhcCC---------CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEC
Confidence 99999996 599998865431 578899999999999999999997 99999999999999999999999
Q ss_pred ccCcccccccccCccccccccccccccccCccccCC-CCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHhh
Q 045798 842 DFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLG-SEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMA 920 (1008)
Q Consensus 842 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~~ 920 (1008)
|||+++........ .....+++.|+|||++.+ ..++.++||||+||++|||++|+.||......+ ........
T Consensus 146 DfG~~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~-~~~~~~~~- 219 (288)
T cd07871 146 DFGLARAKSVPTKT----YSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKE-ELHLIFRL- 219 (288)
T ss_pred cCcceeeccCCCcc----ccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHH-
Confidence 99999754322211 123457999999998865 568999999999999999999999986432111 11111111
Q ss_pred CCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 921 LPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 921 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
......+..... ....+.........+..+..........+..+++.+|++.||.+|||++|+++
T Consensus 220 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 220 LGTPTEETWPGI-TSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred hCCCChHHhhcc-ccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 110000000000 00000000000000000000000122345789999999999999999999974
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=345.53 Aligned_cols=254 Identities=20% Similarity=0.286 Sum_probs=202.5
Q ss_pred cCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEecccc---chhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCce
Q 045798 684 NGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC---EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDF 760 (1008)
Q Consensus 684 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 760 (1008)
++|++.+.||+|+||.||+|++..+++.||+|+++... ......+.+|++++..++||||+++++++ ..++.
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~-----~~~~~ 75 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAF-----QDDEY 75 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEE-----EcCCE
Confidence 46899999999999999999998889999999997432 23446788999999999999999999884 56678
Q ss_pred EEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEE
Q 045798 761 KAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHI 840 (1008)
Q Consensus 761 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 840 (1008)
.|+||||+++|+|.+++.... .+++..++.++.||+.||+|||+. +|+||||||+||+++.++.+||
T Consensus 76 ~~lv~e~~~g~~L~~~l~~~~----------~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL 142 (333)
T cd05600 76 LYLAMEYVPGGDFRTLLNNLG----------VLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKL 142 (333)
T ss_pred EEEEEeCCCCCCHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEE
Confidence 999999999999999997543 688999999999999999999998 9999999999999999999999
Q ss_pred cccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHhh
Q 045798 841 GDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMA 920 (1008)
Q Consensus 841 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~~ 920 (1008)
+|||++..... ......||+.|+|||++.+..++.++|||||||++|||++|..||......+ .......
T Consensus 143 ~Dfg~a~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~-~~~~i~~-- 212 (333)
T cd05600 143 TDFGLSKGIVT-------YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNE-TWENLKY-- 212 (333)
T ss_pred EeCcCCccccc-------ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHH-HHHHHHh--
Confidence 99999975533 1223458999999999999999999999999999999999999986421110 0000000
Q ss_pred CCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 045798 921 LPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHE 987 (1008)
Q Consensus 921 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 987 (1008)
.... ... +.........+.++.+++.+||+.+|.+||+++|+++.
T Consensus 213 ~~~~----~~~------------------~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 213 WKET----LQR------------------PVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred cccc----ccC------------------CCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 0000 000 00000011245567899999999999999999999864
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=337.59 Aligned_cols=271 Identities=21% Similarity=0.342 Sum_probs=200.1
Q ss_pred cCCCCCceEeeccCeeEEEEEEcC----------------CCeEEEEEEecccc-chhhHHHHHHHHHHhhcCCCCceee
Q 045798 684 NGFSSTHLIGVGSFGCVYKGALDE----------------DGIVVAIKVINLQC-EGASKSFMAECKALKNIRHRNLVKV 746 (1008)
Q Consensus 684 ~~y~~~~~lg~G~~g~Vy~~~~~~----------------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~ 746 (1008)
++|++.++||+|+||.||+|.+.. ++..||+|+++... ......+.+|++++.+++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 578999999999999999998632 34579999987543 2345679999999999999999999
Q ss_pred eeccccccccCCceEEEEEeccCCCChhcccccCCCCCCC---------cccccccCHHHHHHHHHHHHHHHHHHhhCCC
Q 045798 747 ITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRD---------KEIEIKLTLLQRISIAIDVASALDYLHHHCQ 817 (1008)
Q Consensus 747 ~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~---------~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ 817 (1008)
++++ ...+..++||||+++|+|.+++......... ......+++..+..++.||+.||+|||+.
T Consensus 85 ~~~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~-- 157 (304)
T cd05096 85 LGVC-----VDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL-- 157 (304)
T ss_pred EEEE-----ecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC--
Confidence 9995 3456689999999999999998654321110 11123578899999999999999999998
Q ss_pred CCceeccCCCCCeeecCCCCeEEcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHH
Q 045798 818 EPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMV 897 (1008)
Q Consensus 818 ~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ell 897 (1008)
+|+||||||+||+++.++.+||+|||+++......... ......++..|+|||++.+..++.++||||||+++|||+
T Consensus 158 -~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~ 234 (304)
T cd05096 158 -NFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYR--IQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEIL 234 (304)
T ss_pred -CccccCcchhheEEcCCccEEECCCccceecccCceeE--ecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHH
Confidence 99999999999999999999999999997553322211 122234578999999998889999999999999999998
Q ss_pred h--CCCCCCccccCCccHHHHHHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCC
Q 045798 898 T--AKKPTDVMFEGDLNLHNFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESP 975 (1008)
Q Consensus 898 t--G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP 975 (1008)
+ |..||...... ........ ......... .......++..+.+++.+||+.||
T Consensus 235 ~~~~~~p~~~~~~~--~~~~~~~~--------~~~~~~~~~---------------~~~~~~~~~~~~~~li~~cl~~~p 289 (304)
T cd05096 235 MLCKEQPYGELTDE--QVIENAGE--------FFRDQGRQV---------------YLFRPPPCPQGLYELMLQCWSRDC 289 (304)
T ss_pred HccCCCCCCcCCHH--HHHHHHHH--------Hhhhccccc---------------cccCCCCCCHHHHHHHHHHccCCc
Confidence 7 45666532111 00000000 000000000 000011245678999999999999
Q ss_pred CCCCCHHHHHHHHH
Q 045798 976 QDRMNMTNVVHELQ 989 (1008)
Q Consensus 976 ~~RPt~~evl~~L~ 989 (1008)
++|||+.||.+.|+
T Consensus 290 ~~RPs~~~i~~~l~ 303 (304)
T cd05096 290 RERPSFSDIHAFLT 303 (304)
T ss_pred hhCcCHHHHHHHHh
Confidence 99999999998875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=343.29 Aligned_cols=242 Identities=24% Similarity=0.308 Sum_probs=194.4
Q ss_pred ceEeeccCeeEEEEEEcCCCeEEEEEEecccc---chhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceEEEEEe
Q 045798 690 HLIGVGSFGCVYKGALDEDGIVVAIKVINLQC---EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKAIVYE 766 (1008)
Q Consensus 690 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 766 (1008)
+.||+|+||.||+|....+|+.||+|+++... ......+.+|++++++++||||++++++ +..++..++|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~-----~~~~~~~~lv~e 75 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYS-----FQTHDRLCFVME 75 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEE-----EEcCCEEEEEEe
Confidence 46999999999999998899999999997432 2334568899999999999999999988 456678999999
Q ss_pred ccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEcccCcc
Q 045798 767 YMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLA 846 (1008)
Q Consensus 767 ~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a 846 (1008)
|+++|+|.+++.... .+++.++..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 76 ~~~~~~L~~~l~~~~----------~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a 142 (323)
T cd05571 76 YANGGELFFHLSRER----------VFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLC 142 (323)
T ss_pred CCCCCcHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCC
Confidence 999999999987654 689999999999999999999998 9999999999999999999999999998
Q ss_pred cccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCcchh
Q 045798 847 RFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMALPNQVM 926 (1008)
Q Consensus 847 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 926 (1008)
+....... ......||+.|+|||++.+..++.++||||+||++|||++|+.||..... ........
T Consensus 143 ~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~-----~~~~~~~~----- 208 (323)
T cd05571 143 KEGISDGA----TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-----EKLFELIL----- 208 (323)
T ss_pred cccccCCC----cccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCH-----HHHHHHHH-----
Confidence 74322111 12234589999999999999999999999999999999999999863211 00000000
Q ss_pred hhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCC-----CHHHHHH
Q 045798 927 DIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRM-----NMTNVVH 986 (1008)
Q Consensus 927 ~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~ 986 (1008)
.... .++ ...+.++.+++.+||+.||++|| ++.++++
T Consensus 209 -------~~~~----------~~p------~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 209 -------MEEI----------RFP------RTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred -------cCCC----------CCC------CCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 0000 000 12345678999999999999999 7888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=346.72 Aligned_cols=268 Identities=24% Similarity=0.352 Sum_probs=203.1
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcC-----CCeEEEEEEecccc-chhhHHHHHHHHHHhhc-CCCCceeeeeccccccc
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDE-----DGIVVAIKVINLQC-EGASKSFMAECKALKNI-RHRNLVKVITSCSSIDF 755 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 755 (1008)
.++|++.+.||+|+||.||+|++.. +++.||+|+++... ....+.+.+|+++++.+ +|+||++++++|
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~----- 111 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGAC----- 111 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEe-----
Confidence 4578999999999999999998643 33579999997543 33456789999999999 899999999985
Q ss_pred cCCceEEEEEeccCCCChhcccccCCCCC---------------------------------------------------
Q 045798 756 QGNDFKAIVYEYMPNGSLEKWLHPHAVPK--------------------------------------------------- 784 (1008)
Q Consensus 756 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~--------------------------------------------------- 784 (1008)
...+..++||||+++|+|.+++.......
T Consensus 112 ~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (374)
T cd05106 112 THGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSS 191 (374)
T ss_pred cCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccc
Confidence 44567899999999999999986432100
Q ss_pred ---------CCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEcccCcccccccccCc
Q 045798 785 ---------RDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNS 855 (1008)
Q Consensus 785 ---------~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~ 855 (1008)
.......++++.+++.++.||+.||+|||+. +|+||||||+||++++++.+||+|||+++........
T Consensus 192 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~ 268 (374)
T cd05106 192 SQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNY 268 (374)
T ss_pred cccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcce
Confidence 0001123588999999999999999999997 9999999999999999999999999999765433221
Q ss_pred cccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCccccCCccHHHHHHhhCCcchhhhhccccc
Q 045798 856 TLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT-AKKPTDVMFEGDLNLHNFARMALPNQVMDIVDPILR 934 (1008)
Q Consensus 856 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 934 (1008)
. ......++..|+|||++.+..++.++|||||||++|||++ |+.||....... ......... ..
T Consensus 269 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~-~~~~~~~~~------------~~ 333 (374)
T cd05106 269 V--VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS-KFYKMVKRG------------YQ 333 (374)
T ss_pred e--eccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH-HHHHHHHcc------------cC
Confidence 1 1112335678999999988899999999999999999997 999986432111 011110000 00
Q ss_pred CchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHHHHH
Q 045798 935 NDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHELQSV 991 (1008)
Q Consensus 935 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~i 991 (1008)
. .. ....+.++.+++.+||+.||++|||+.+|++.|+++
T Consensus 334 ~----------------~~--~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~ 372 (374)
T cd05106 334 M----------------SR--PDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQ 372 (374)
T ss_pred c----------------cC--CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 0 00 001245689999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=344.96 Aligned_cols=246 Identities=23% Similarity=0.282 Sum_probs=198.7
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEecccc---chhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCc
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC---EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGND 759 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 759 (1008)
.++|++.+.||+|+||.||+|++..+++.||+|+++... ....+.+.+|+.++++++||||++++++ +.+++
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~-----~~~~~ 91 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCS-----FQDEN 91 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEE-----EEcCC
Confidence 357899999999999999999999899999999987432 2334678999999999999999999998 45667
Q ss_pred eEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeE
Q 045798 760 FKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGH 839 (1008)
Q Consensus 760 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 839 (1008)
..++||||+++|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+|
T Consensus 92 ~~~lv~e~~~~~~L~~~l~~~~----------~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~k 158 (329)
T PTZ00263 92 RVYFLLEFVVGGELFTHLRKAG----------RFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVK 158 (329)
T ss_pred EEEEEEcCCCCChHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEE
Confidence 8999999999999999987653 678899999999999999999998 999999999999999999999
Q ss_pred EcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHh
Q 045798 840 IGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARM 919 (1008)
Q Consensus 840 L~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~ 919 (1008)
|+|||+++...... ....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ...+ ..
T Consensus 159 l~Dfg~~~~~~~~~-------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~----~~~~-~~ 226 (329)
T PTZ00263 159 VTDFGFAKKVPDRT-------FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP----FRIY-EK 226 (329)
T ss_pred EeeccCceEcCCCc-------ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCH----HHHH-HH
Confidence 99999998653321 124589999999999999999999999999999999999999853211 1000 00
Q ss_pred hCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCC-----HHHHHH
Q 045798 920 ALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMN-----MTNVVH 986 (1008)
Q Consensus 920 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~ 986 (1008)
+....+ .++. ..+..+.+++.+||+.||.+||+ +++++.
T Consensus 227 --------i~~~~~--------------~~p~------~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 270 (329)
T PTZ00263 227 --------ILAGRL--------------KFPN------WFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKN 270 (329)
T ss_pred --------HhcCCc--------------CCCC------CCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 000000 0000 12345789999999999999997 566664
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=304.15 Aligned_cols=253 Identities=21% Similarity=0.343 Sum_probs=205.8
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccc--------hhhHHHHHHHHHHhhc-CCCCceeeeeccccc
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCE--------GASKSFMAECKALKNI-RHRNLVKVITSCSSI 753 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~ 753 (1008)
-+.|...+.+|.|..++|-++..+++|..+|+|++..... ...+.-.+|+.|++++ .||+|+++.++
T Consensus 16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~---- 91 (411)
T KOG0599|consen 16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDV---- 91 (411)
T ss_pred HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeee----
Confidence 4568888999999999999999999999999999863321 1234567899999998 89999999999
Q ss_pred cccCCceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeec
Q 045798 754 DFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLD 833 (1008)
Q Consensus 754 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~ 833 (1008)
++.+.+.++|+|.|+.|.|.+|+.... .+++...++|++|+..|++|||.. .|||||+||+|||++
T Consensus 92 -yes~sF~FlVFdl~prGELFDyLts~V----------tlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILld 157 (411)
T KOG0599|consen 92 -YESDAFVFLVFDLMPRGELFDYLTSKV----------TLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLD 157 (411)
T ss_pred -ccCcchhhhhhhhcccchHHHHhhhhe----------eecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeec
Confidence 456666999999999999999998764 799999999999999999999998 999999999999999
Q ss_pred CCCCeEEcccCcccccccccCccccccccccccccccCccccCC------CCCCcccchhhHHHHHHHHHhCCCCCCccc
Q 045798 834 NDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLG------SEVSTNGDVYSYGILLLEMVTAKKPTDVMF 907 (1008)
Q Consensus 834 ~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~sDvwslG~vl~elltG~~pf~~~~ 907 (1008)
++.++||+|||+|+.+.....- ...+||++|.|||.+.. ..|+..+|+||+||++|.++.|.+||.-.
T Consensus 158 dn~~i~isDFGFa~~l~~GekL-----relCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHR- 231 (411)
T KOG0599|consen 158 DNMNIKISDFGFACQLEPGEKL-----RELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHR- 231 (411)
T ss_pred cccceEEeccceeeccCCchhH-----HHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHH-
Confidence 9999999999999987665433 23679999999998754 25788999999999999999999998521
Q ss_pred cCCccHHHHHHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 045798 908 EGDLNLHNFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHE 987 (1008)
Q Consensus 908 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 987 (1008)
... -++.-...+ +++-..+.+.+.+....+++.+|++.||.+|.|++|+++.
T Consensus 232 -----------kQm-----lMLR~ImeG------------kyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaH 283 (411)
T KOG0599|consen 232 -----------KQM-----LMLRMIMEG------------KYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAH 283 (411)
T ss_pred -----------HHH-----HHHHHHHhc------------ccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence 100 000000111 1111223455677788999999999999999999999863
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-37 Score=334.48 Aligned_cols=279 Identities=24% Similarity=0.295 Sum_probs=200.0
Q ss_pred cCCCCCceEeeccCeeEEEEEEcC-CCeEEEEEEecccc--chhhHHHHHHHHHHhhc---CCCCceeeeeccccccccC
Q 045798 684 NGFSSTHLIGVGSFGCVYKGALDE-DGIVVAIKVINLQC--EGASKSFMAECKALKNI---RHRNLVKVITSCSSIDFQG 757 (1008)
Q Consensus 684 ~~y~~~~~lg~G~~g~Vy~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~~~~~~ 757 (1008)
++|++.+.||+|+||.||+|++.. +++.||+|+++... ......+.+|+.+++.+ .||||++++++|.......
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 479999999999999999999853 56889999987432 22334567788777766 6999999999976544455
Q ss_pred CceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCC
Q 045798 758 NDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLS 837 (1008)
Q Consensus 758 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 837 (1008)
....++||||++ ++|.+++...... .+++..+..++.||+.||+|||+. +|+||||||+||+++.++.
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~~--------~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~ 148 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPEP--------GVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQ 148 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCCC--------CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCC
Confidence 667899999995 6999998654321 588999999999999999999997 9999999999999999999
Q ss_pred eEEcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHH
Q 045798 838 GHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFA 917 (1008)
Q Consensus 838 ~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~ 917 (1008)
+||+|||+++...... ......||+.|+|||++.+..++.++|||||||++|||++|++||......+ ......
T Consensus 149 ~kl~Dfg~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~-~~~~i~ 222 (290)
T cd07862 149 IKLADFGLARIYSFQM-----ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD-QLGKIL 222 (290)
T ss_pred EEEccccceEeccCCc-----ccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHH-HHHHHH
Confidence 9999999998654321 1223458999999999988899999999999999999999999987432211 111111
Q ss_pred HhhCCcchhhhhcccccCchHHhhhhhhhhhccccch-hHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 918 RMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGIN-SRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 918 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
.........++.. .... +.... . ........ .....+..+.+++.+|++.||++|||+.|+++
T Consensus 223 ~~~~~~~~~~~~~-~~~~-~~~~~--~--~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 223 DVIGLPGEEDWPR-DVAL-PRQAF--H--SKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred HHhCCCChhhchh-hhcc-cchhc--c--CCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 1110000000000 0000 00000 0 00000000 01124556789999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=345.57 Aligned_cols=267 Identities=25% Similarity=0.343 Sum_probs=202.4
Q ss_pred hcCCCCCceEeeccCeeEEEEEE-----cCCCeEEEEEEecccc-chhhHHHHHHHHHHhhc-CCCCceeeeeccccccc
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGAL-----DEDGIVVAIKVINLQC-EGASKSFMAECKALKNI-RHRNLVKVITSCSSIDF 755 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~-----~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 755 (1008)
.++|++.+.||+|+||.||+|.+ ..++..||||+++... ....+.+.+|+++++.+ +||||++++++|
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~----- 108 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGAC----- 108 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeee-----
Confidence 34689999999999999999974 2356789999997432 33456789999999999 899999999995
Q ss_pred cCCceEEEEEeccCCCChhcccccCCCCCCC-------------------------------------------------
Q 045798 756 QGNDFKAIVYEYMPNGSLEKWLHPHAVPKRD------------------------------------------------- 786 (1008)
Q Consensus 756 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~------------------------------------------------- 786 (1008)
..++..++||||+++|+|.+++.........
T Consensus 109 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 188 (375)
T cd05104 109 TVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRS 188 (375)
T ss_pred ccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccc
Confidence 4556689999999999999998653210000
Q ss_pred ----------------cccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEcccCcccccc
Q 045798 787 ----------------KEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQ 850 (1008)
Q Consensus 787 ----------------~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~ 850 (1008)
......+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~ 265 (375)
T cd05104 189 VRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIR 265 (375)
T ss_pred cccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceecc
Confidence 00112578999999999999999999997 99999999999999999999999999998654
Q ss_pred cccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCccccCCccHHHHHHhhCCcchhhhh
Q 045798 851 EVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT-AKKPTDVMFEGDLNLHNFARMALPNQVMDIV 929 (1008)
Q Consensus 851 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 929 (1008)
....... .....++..|+|||++.+..++.++|||||||++|||++ |..||....... ..... +
T Consensus 266 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~-~~~~~------------~ 330 (375)
T cd05104 266 NDSNYVV--KGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS-KFYKM------------I 330 (375)
T ss_pred Ccccccc--cCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH-HHHHH------------H
Confidence 3322111 112335678999999999999999999999999999998 888886432111 11111 0
Q ss_pred cccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHHHH
Q 045798 930 DPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHELQS 990 (1008)
Q Consensus 930 d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 990 (1008)
...... .. ....+.++.+++.+||+.||++|||+.||++.|++
T Consensus 331 ~~~~~~----------------~~--~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~ 373 (375)
T cd05104 331 KEGYRM----------------LS--PECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ 373 (375)
T ss_pred HhCccC----------------CC--CCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence 000000 00 00124568999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-39 Score=306.97 Aligned_cols=252 Identities=20% Similarity=0.285 Sum_probs=201.6
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccc--cchhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCce
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQ--CEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDF 760 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 760 (1008)
.+.|++.+.||+|.|+.||++....+|+.+|+|++... .....+.+.+|++|-+.++||||+++.+. .....+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~t-----i~~~~~ 84 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS-----IQEESF 84 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhh-----hcccce
Confidence 46788889999999999999999999999999998632 23456789999999999999999999998 566777
Q ss_pred EEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecC---CCC
Q 045798 761 KAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDN---DLS 837 (1008)
Q Consensus 761 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~~ 837 (1008)
.|+|+|+|.|++|..-+-... .+++..+-..+.||++||.|+|.+ +|||||+||+|+++.. .--
T Consensus 85 ~ylvFe~m~G~dl~~eIV~R~----------~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~ 151 (355)
T KOG0033|consen 85 HYLVFDLVTGGELFEDIVARE----------FYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAA 151 (355)
T ss_pred eEEEEecccchHHHHHHHHHH----------HHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCc
Confidence 999999999999975553321 678889999999999999999998 9999999999999943 346
Q ss_pred eEEcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHH
Q 045798 838 GHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFA 917 (1008)
Q Consensus 838 ~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~ 917 (1008)
+||+|||+|...... ....+.+||++|||||+....+|+..+|||+.||++|-++.|++||...... ..++...
T Consensus 152 vKL~~FGvAi~l~~g-----~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~-rlye~I~ 225 (355)
T KOG0033|consen 152 VKLADFGLAIEVNDG-----EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH-RLYEQIK 225 (355)
T ss_pred eeecccceEEEeCCc-----cccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHH-HHHHHHh
Confidence 799999999877622 2245678999999999999999999999999999999999999998742111 0111111
Q ss_pred HhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 918 RMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 918 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
.... .+ +.+.+....++-.+++++|+..||++|.|+.|.+.
T Consensus 226 ----------------~g~y----------d~--~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 226 ----------------AGAY----------DY--PSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred ----------------cccc----------CC--CCcccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence 1110 00 01112234556689999999999999999999875
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=331.25 Aligned_cols=257 Identities=26% Similarity=0.423 Sum_probs=211.0
Q ss_pred CCCCCceEeeccCeeEEEEEEcC----CCeEEEEEEecccc-chhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCc
Q 045798 685 GFSSTHLIGVGSFGCVYKGALDE----DGIVVAIKVINLQC-EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGND 759 (1008)
Q Consensus 685 ~y~~~~~lg~G~~g~Vy~~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 759 (1008)
.....++||+|.||.||+|.... ..-.||||..+.+. .+..+.|..|+-+|+.+.||||++++|+|.+ .
T Consensus 390 ~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e------~ 463 (974)
T KOG4257|consen 390 LITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE------Q 463 (974)
T ss_pred hccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec------c
Confidence 34556789999999999999842 22468999998643 4567889999999999999999999999864 3
Q ss_pred eEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeE
Q 045798 760 FKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGH 839 (1008)
Q Consensus 760 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 839 (1008)
..|||||.++.|.|..|++.++. .++......++.||+.||+|||+. ..|||||..+|||+.....+|
T Consensus 464 P~WivmEL~~~GELr~yLq~nk~---------sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVK 531 (974)
T KOG4257|consen 464 PMWIVMELAPLGELREYLQQNKD---------SLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVK 531 (974)
T ss_pred ceeEEEecccchhHHHHHHhccc---------cchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceee
Confidence 48999999999999999987753 788999999999999999999996 999999999999999999999
Q ss_pred EcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCccccCCccHHHHHH
Q 045798 840 IGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT-AKKPTDVMFEGDLNLHNFAR 918 (1008)
Q Consensus 840 L~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-G~~pf~~~~~~~~~~~~~~~ 918 (1008)
|+|||+++.+++..-.. .....-+..|||||.+.-++++.+||||-|||++||++. |..||......+..
T Consensus 532 LaDFGLSR~~ed~~yYk---aS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI------ 602 (974)
T KOG4257|consen 532 LADFGLSRYLEDDAYYK---ASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVI------ 602 (974)
T ss_pred ecccchhhhccccchhh---ccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceE------
Confidence 99999999886654322 223346789999999999999999999999999999987 99998754322210
Q ss_pred hhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHHHHHHHH
Q 045798 919 MALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHELQSVKNI 994 (1008)
Q Consensus 919 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~i~~~ 994 (1008)
.. ++...+. +....||..++.++.+||++||.+||++.|+...|+.+..+
T Consensus 603 -----------~~-----------iEnGeRl----P~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~qe 652 (974)
T KOG4257|consen 603 -----------GH-----------IENGERL----PCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQE 652 (974)
T ss_pred -----------EE-----------ecCCCCC----CCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHHH
Confidence 00 0001111 12346888999999999999999999999999999998765
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=366.44 Aligned_cols=482 Identities=25% Similarity=0.334 Sum_probs=329.2
Q ss_pred EEeccccCCCCccCcCccCCccCCeeeecCCCCCCCCCccccCCCCCCEEEccCCCCCCccCcccccCcCcceEeeeccc
Q 045798 58 ALDLMSKSLSGSLSPHLGNLSFLREINLSNNTIQGEIPPEFGRLFRLEALFLSNNSLVGKIPANLSYCSRLTVLCIEYNK 137 (1008)
Q Consensus 58 ~l~l~~~~l~~~l~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~ 137 (1008)
.+|+++..++ .||..+..-..|+.|+++.|-+-...-+.+.+..+|+.|||++|+++ ..|..+..+.+|+.|+++.|-
T Consensus 2 ~vd~s~~~l~-~ip~~i~~~~~~~~ln~~~N~~l~~pl~~~~~~v~L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~ 79 (1081)
T KOG0618|consen 2 HVDASDEQLE-LIPEQILNNEALQILNLRRNSLLSRPLEFVEKRVKLKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNY 79 (1081)
T ss_pred CcccccccCc-ccchhhccHHHHHhhhccccccccCchHHhhheeeeEEeeccccccc-cCCchhhhHHHHhhcccchhh
Confidence 3577777777 68888877778999999998876333344556666999999999998 889999999999999999999
Q ss_pred cccCCCccccccCCCCeeecccccCCCCCCCCCccccccchhhcccccCCCCCCccccCCCCCcEEEecCCcccccCCcc
Q 045798 138 LQGRIPLEFVSLSKLKDLSLAKNKLTGGIPPFLGNLTSLEVLSLAGNSFGRNIPDSLGQLKQLKILAIGGNNLSGPIPPS 217 (1008)
Q Consensus 138 l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~ 217 (1008)
|. ..|.+..++.+|++|.|.+|++. ..|..+..+.+|+.|+++.|++ +..|..+..++.+..+..++|......+
T Consensus 80 i~-~vp~s~~~~~~l~~lnL~~n~l~-~lP~~~~~lknl~~LdlS~N~f-~~~Pl~i~~lt~~~~~~~s~N~~~~~lg-- 154 (1081)
T KOG0618|consen 80 IR-SVPSSCSNMRNLQYLNLKNNRLQ-SLPASISELKNLQYLDLSFNHF-GPIPLVIEVLTAEEELAASNNEKIQRLG-- 154 (1081)
T ss_pred Hh-hCchhhhhhhcchhheeccchhh-cCchhHHhhhcccccccchhcc-CCCchhHHhhhHHHHHhhhcchhhhhhc--
Confidence 98 67888888999999999999998 8898999999999999999998 6788888888888889988883222222
Q ss_pred ccCCCCcceeccccccccccCChhhhhcCCCCc-EEEeccccCCCCCCcccccCCCCceeecccccccccccccccCCCc
Q 045798 218 IYNLSFLVVFSVSHNQIHGSLPPSLGLLLPNLK-FFQIHHNFFSGSIPISLSNASKLEHIEIANNNFSGKLSVNFGGMKN 296 (1008)
Q Consensus 218 ~~~l~~L~~L~ls~N~l~~~lp~~~~~~l~~L~-~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~ 296 (1008)
... ++.++|..|.+.+.++..+. +++ .|+|.+|.+. -..+.++.+|+.|.+..|++....- ..++
T Consensus 155 --~~~-ik~~~l~~n~l~~~~~~~i~----~l~~~ldLr~N~~~---~~dls~~~~l~~l~c~rn~ls~l~~----~g~~ 220 (1081)
T KOG0618|consen 155 --QTS-IKKLDLRLNVLGGSFLIDIY----NLTHQLDLRYNEME---VLDLSNLANLEVLHCERNQLSELEI----SGPS 220 (1081)
T ss_pred --ccc-chhhhhhhhhcccchhcchh----hhheeeecccchhh---hhhhhhccchhhhhhhhcccceEEe----cCcc
Confidence 222 77788888887776666543 333 4888888776 2345677777888888777764322 2356
Q ss_pred ccccccccccCCCCCCCcccccccccccCCCcEEEecCCcCCccCChhhhhhcccceeeeeccccccCCCCCcccccccc
Q 045798 297 LSLLNLQFSNLGSGESDEMGFMNSLTNCSKLRVLSLGGNQFRGALPHSIANLSSQLQILILSSNQFYGSIPLGIGNLVDL 376 (1008)
Q Consensus 297 L~~L~L~~n~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~Ls~N~l~~~~p~~~~~l~~L 376 (1008)
|+.|+.++|.+...... .--.+|+++++++|+++ .+|+++..+. +|+.|+..+|.++ .+|..+..+.+|
T Consensus 221 l~~L~a~~n~l~~~~~~--------p~p~nl~~~dis~n~l~-~lp~wi~~~~-nle~l~~n~N~l~-~lp~ri~~~~~L 289 (1081)
T KOG0618|consen 221 LTALYADHNPLTTLDVH--------PVPLNLQYLDISHNNLS-NLPEWIGACA-NLEALNANHNRLV-ALPLRISRITSL 289 (1081)
T ss_pred hheeeeccCcceeeccc--------cccccceeeecchhhhh-cchHHHHhcc-cceEecccchhHH-hhHHHHhhhhhH
Confidence 66777777766633221 11235667777777776 5666666665 4777777777775 666667777777
Q ss_pred ceEEecCccccCCcchhccCCCCCceEEccCCccccccccc-ccCCC-CcceeeccccccccccCCCCcCCCcccEeecc
Q 045798 377 YLLGMVENQFTGAIPKEMGKLQKLQGLDFSGNHFSGEIPSS-LGNLS-SLYEVFFNNNNLSGVIPFSLGNLKRLAFLEMS 454 (1008)
Q Consensus 377 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~-~~~l~-~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls 454 (1008)
+.|....|.+. .+|.....++.|++|||..|+|. ..|+. +.-+. +|..|+.+.|.+....-..=..+..|+.|++.
T Consensus 290 ~~l~~~~nel~-yip~~le~~~sL~tLdL~~N~L~-~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~Lyla 367 (1081)
T KOG0618|consen 290 VSLSAAYNELE-YIPPFLEGLKSLRTLDLQSNNLP-SLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLA 367 (1081)
T ss_pred HHHHhhhhhhh-hCCCcccccceeeeeeehhcccc-ccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHh
Confidence 77777777776 55566666677777777777776 34432 33332 25566666666653221122234567777777
Q ss_pred cccccCCcchhhhhhhhhhhhhcccCccccCCCcccccccccccccccccccccCCCCcccccccccceeeccCcccccc
Q 045798 455 GNELSGTIPEDIFNISYLSNSLNLARNHLVGIIPPRIGNLRALRSFDVSNNDLSGEIPIELGHCSSLEEIYLAGNLFHGS 534 (1008)
Q Consensus 455 ~N~l~~~lp~~~~~~~~~~~~L~L~~N~l~~~~p~~~~~l~~L~~Ldls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 534 (1008)
+|.|+...-+-+... ..++.|+|++|+|.......+.++..|+.|+||+|+++ .+|.++.++..|++|...+|+|. .
T Consensus 368 nN~Ltd~c~p~l~~~-~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~ 444 (1081)
T KOG0618|consen 368 NNHLTDSCFPVLVNF-KHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-S 444 (1081)
T ss_pred cCcccccchhhhccc-cceeeeeecccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-e
Confidence 777764332222222 23366777777776433344566777777777777776 67777777777777777777777 5
Q ss_pred hhhhhhccccccEEecCCCccccc-ccCcccccccceeecccCc
Q 045798 535 IPSFFNALKGVQKIDLSRNNLSGQ-IPIFLEALSLEYLNLSFND 577 (1008)
Q Consensus 535 ~p~~~~~l~~L~~L~ls~N~l~~~-~p~~~~~~~L~~L~l~~N~ 577 (1008)
.| .+..+++|+.+|+|.|+|+.. +|.-.....|++|||++|.
T Consensus 445 fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~ 487 (1081)
T KOG0618|consen 445 FP-ELAQLPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNT 487 (1081)
T ss_pred ch-hhhhcCcceEEecccchhhhhhhhhhCCCcccceeeccCCc
Confidence 66 667777777777777777753 3333333567777777775
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-37 Score=339.49 Aligned_cols=200 Identities=26% Similarity=0.399 Sum_probs=174.6
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEecccc-chhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceE
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC-EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFK 761 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 761 (1008)
.++|++.++||+|+||.||+|.+..+++.||+|+++... ......+.+|+++++.++||||++++++| ..+++.
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~ 78 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF-----YSDGEI 78 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEE-----EECCEE
Confidence 468999999999999999999998899999999987542 33456799999999999999999999995 456679
Q ss_pred EEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEc
Q 045798 762 AIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIG 841 (1008)
Q Consensus 762 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 841 (1008)
++||||+++|+|.+++.... .+++..+..++.|++.|++|||+. .+|+||||||+||+++.++.+||+
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~----------~~~~~~~~~~~~~l~~~l~~lH~~--~~ivH~dlkp~Nili~~~~~~kL~ 146 (333)
T cd06650 79 SICMEHMDGGSLDQVLKKAG----------RIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLC 146 (333)
T ss_pred EEEEecCCCCcHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCChhhEEEcCCCCEEEe
Confidence 99999999999999997543 678899999999999999999974 279999999999999999999999
Q ss_pred ccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCc
Q 045798 842 DFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDV 905 (1008)
Q Consensus 842 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~ 905 (1008)
|||++....... .....|+..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 147 Dfg~~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~ 204 (333)
T cd06650 147 DFGVSGQLIDSM------ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPP 204 (333)
T ss_pred eCCcchhhhhhc------cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 999997543321 1223589999999999988899999999999999999999999864
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=330.36 Aligned_cols=257 Identities=23% Similarity=0.393 Sum_probs=201.5
Q ss_pred hcCCCCCceEeeccCeeEEEEEEc---CCCeEEEEEEecccc-chhhHHHHHHHHHHhhcCCCCceeeeeccccccccCC
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALD---EDGIVVAIKVINLQC-EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGN 758 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 758 (1008)
.++|++.+.||+|+||.||+|.+. ..+..||+|+++... ......+.+|+.++++++||||+++++++ ..+
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~ 78 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVI-----TRG 78 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEE-----ecC
Confidence 356889999999999999999874 346789999997543 23446789999999999999999999985 455
Q ss_pred ceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCe
Q 045798 759 DFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSG 838 (1008)
Q Consensus 759 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 838 (1008)
+..++||||+++|+|.+++..... .+++.+++.++.|++.||+|||+. +++||||||+||+++.++.+
T Consensus 79 ~~~~lv~e~~~~~~L~~~l~~~~~---------~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~ 146 (266)
T cd05064 79 NTMMIVTEYMSNGALDSFLRKHEG---------QLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVC 146 (266)
T ss_pred CCcEEEEEeCCCCcHHHHHHhCCC---------CCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcE
Confidence 679999999999999999875421 689999999999999999999998 99999999999999999999
Q ss_pred EEcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCccccCCccHHHHH
Q 045798 839 HIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT-AKKPTDVMFEGDLNLHNFA 917 (1008)
Q Consensus 839 kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-G~~pf~~~~~~~~~~~~~~ 917 (1008)
|++|||.+........ .......++..|+|||.+.+..++.++|||||||++||+++ |..||...... ...
T Consensus 147 ~l~dfg~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~-----~~~ 218 (266)
T cd05064 147 KISGFRRLQEDKSEAI---YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ-----DVI 218 (266)
T ss_pred EECCCcccccccccch---hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH-----HHH
Confidence 9999998764322111 11112235678999999999999999999999999999875 99998643111 000
Q ss_pred HhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHHHHH
Q 045798 918 RMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHELQSV 991 (1008)
Q Consensus 918 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~i 991 (1008)
.. ..+. ...+ ....++..+.+++.+||+.+|.+||+++|+.+.|+++
T Consensus 219 ~~--------~~~~---------------~~~~----~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 219 KA--------VEDG---------------FRLP----APRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred HH--------HHCC---------------CCCC----CCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 00 0000 0000 0113456689999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=343.17 Aligned_cols=273 Identities=21% Similarity=0.265 Sum_probs=199.9
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccchhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceEE
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKA 762 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 762 (1008)
.++|++.+.||+|+||.||+|.+..+++.||+|+.. ...+.+|++++++++||||+++++++ ..+...+
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~-----~~~~~~~ 159 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTF-----TYNKFTC 159 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEE-----EECCeeE
Confidence 357999999999999999999999999999999753 23578899999999999999999984 4566789
Q ss_pred EEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEcc
Q 045798 763 IVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGD 842 (1008)
Q Consensus 763 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 842 (1008)
+|+|++ .++|..++.... .+++..++.++.||+.||+|||+. +|+||||||+||+++.++.+||+|
T Consensus 160 lv~e~~-~~~L~~~l~~~~----------~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~D 225 (391)
T PHA03212 160 LILPRY-KTDLYCYLAAKR----------NIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGD 225 (391)
T ss_pred EEEecC-CCCHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEe
Confidence 999999 578988886543 678999999999999999999997 999999999999999999999999
Q ss_pred cCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCC------ccHHHH
Q 045798 843 FGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGD------LNLHNF 916 (1008)
Q Consensus 843 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~------~~~~~~ 916 (1008)
||+|+........ ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+ ..+...
T Consensus 226 FG~a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i 302 (391)
T PHA03212 226 FGAACFPVDINAN---KYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLI 302 (391)
T ss_pred CCccccccccccc---ccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHH
Confidence 9999754322211 1223569999999999999899999999999999999999998864321111 111111
Q ss_pred HHhhC------CcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 917 ARMAL------PNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 917 ~~~~~------~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
..... +......++..... ............+........+.++.+++.+||+.||++||||+|+++
T Consensus 303 ~~~~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 303 IRRSGTHPNEFPIDAQANLDEIYIG---LAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred HHHhcCChhhcCcchhHHHHHHHHH---HHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 11110 00000000000000 000000000000111112345678999999999999999999999985
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=366.06 Aligned_cols=486 Identities=26% Similarity=0.306 Sum_probs=397.6
Q ss_pred eEEEEeccccCCCCccCcCccCCccCCeeeecCCCCCCCCCccccCCCCCCEEEccCCCCCCccCcccccCcCcceEeee
Q 045798 55 RVTALDLMSKSLSGSLSPHLGNLSFLREINLSNNTIQGEIPPEFGRLFRLEALFLSNNSLVGKIPANLSYCSRLTVLCIE 134 (1008)
Q Consensus 55 ~v~~l~l~~~~l~~~l~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls 134 (1008)
.++.|++..|.+-.-.-+.+..-..|+.|+|++|.+. ..|..+..+.+|+.|+++.|.|. ..|.+.+++.+|++|.|.
T Consensus 22 ~~~~ln~~~N~~l~~pl~~~~~~v~L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~i~-~vp~s~~~~~~l~~lnL~ 99 (1081)
T KOG0618|consen 22 ALQILNLRRNSLLSRPLEFVEKRVKLKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNYIR-SVPSSCSNMRNLQYLNLK 99 (1081)
T ss_pred HHHhhhccccccccCchHHhhheeeeEEeeccccccc-cCCchhhhHHHHhhcccchhhHh-hCchhhhhhhcchhheec
Confidence 3777888887665322344555556999999999998 88999999999999999999999 888999999999999999
Q ss_pred ccccccCCCccccccCCCCeeecccccCCCCCCCCCccccccchhhcccccCCCCCCccccCCCCCcEEEecCCcccccC
Q 045798 135 YNKLQGRIPLEFVSLSKLKDLSLAKNKLTGGIPPFLGNLTSLEVLSLAGNSFGRNIPDSLGQLKQLKILAIGGNNLSGPI 214 (1008)
Q Consensus 135 ~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~ 214 (1008)
.|.+. ..|.++..+++|+.|+++.|++. .+|..+..++.++.+..++|.... .++... ++.+++..|.+.+.+
T Consensus 100 ~n~l~-~lP~~~~~lknl~~LdlS~N~f~-~~Pl~i~~lt~~~~~~~s~N~~~~----~lg~~~-ik~~~l~~n~l~~~~ 172 (1081)
T KOG0618|consen 100 NNRLQ-SLPASISELKNLQYLDLSFNHFG-PIPLVIEVLTAEEELAASNNEKIQ----RLGQTS-IKKLDLRLNVLGGSF 172 (1081)
T ss_pred cchhh-cCchhHHhhhcccccccchhccC-CCchhHHhhhHHHHHhhhcchhhh----hhcccc-chhhhhhhhhcccch
Confidence 99998 89999999999999999999999 889999999999999999993222 233333 889999999999888
Q ss_pred CccccCCCCcceeccccccccccCChhhhhcCCCCcEEEeccccCCCCCCcccccCCCCceeecccccccccccccccCC
Q 045798 215 PPSIYNLSFLVVFSVSHNQIHGSLPPSLGLLLPNLKFFQIHHNFFSGSIPISLSNASKLEHIEIANNNFSGKLSVNFGGM 294 (1008)
Q Consensus 215 ~~~~~~l~~L~~L~ls~N~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l 294 (1008)
+..+..++. .|+|.+|.+. ... ...+++|+.|....|++... --..++|+.|+.+.|.+....+ -.--
T Consensus 173 ~~~i~~l~~--~ldLr~N~~~-~~d---ls~~~~l~~l~c~rn~ls~l----~~~g~~l~~L~a~~n~l~~~~~--~p~p 240 (1081)
T KOG0618|consen 173 LIDIYNLTH--QLDLRYNEME-VLD---LSNLANLEVLHCERNQLSEL----EISGPSLTALYADHNPLTTLDV--HPVP 240 (1081)
T ss_pred hcchhhhhe--eeecccchhh-hhh---hhhccchhhhhhhhcccceE----EecCcchheeeeccCcceeecc--cccc
Confidence 888888877 8999999986 222 23368999999999998732 2346789999999999983332 2234
Q ss_pred CcccccccccccCCCCCCCcccccccccccCCCcEEEecCCcCCccCChhhhhhcccceeeeeccccccCCCCCcccccc
Q 045798 295 KNLSLLNLQFSNLGSGESDEMGFMNSLTNCSKLRVLSLGGNQFRGALPHSIANLSSQLQILILSSNQFYGSIPLGIGNLV 374 (1008)
Q Consensus 295 ~~L~~L~L~~n~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~Ls~N~l~~~~p~~~~~l~ 374 (1008)
.+|+++++++|+++.+. +.+..+.+|+.+...+|++. .+|..+.... .|+.|++.+|.+. -+|.....++
T Consensus 241 ~nl~~~dis~n~l~~lp-------~wi~~~~nle~l~~n~N~l~-~lp~ri~~~~-~L~~l~~~~nel~-yip~~le~~~ 310 (1081)
T KOG0618|consen 241 LNLQYLDISHNNLSNLP-------EWIGACANLEALNANHNRLV-ALPLRISRIT-SLVSLSAAYNELE-YIPPFLEGLK 310 (1081)
T ss_pred ccceeeecchhhhhcch-------HHHHhcccceEecccchhHH-hhHHHHhhhh-hHHHHHhhhhhhh-hCCCcccccc
Confidence 68999999999998765 35778999999999999997 8899888887 4999999999998 7888889999
Q ss_pred ccceEEecCccccCCcchhccCCCC-CceEEccCCcccccccccccCCCCcceeeccccccccccCCCCcCCCcccEeec
Q 045798 375 DLYLLGMVENQFTGAIPKEMGKLQK-LQGLDFSGNHFSGEIPSSLGNLSSLYEVFFNNNNLSGVIPFSLGNLKRLAFLEM 453 (1008)
Q Consensus 375 ~L~~L~L~~n~l~~~~~~~~~~l~~-L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L 453 (1008)
+|++|+|..|+|....+..+..+.. |..|+.|.|.+....-..=..++.|+.|++.+|.++...-..+.+...|+.|+|
T Consensus 311 sL~tLdL~~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhL 390 (1081)
T KOG0618|consen 311 SLRTLDLQSNNLPSLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHL 390 (1081)
T ss_pred eeeeeeehhccccccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccccchhhhccccceeeeee
Confidence 9999999999999544444444444 889999999997433223335678999999999999887778999999999999
Q ss_pred ccccccCCcchhhhhhhhhhhhhcccCccccCCCcccccccccccccccccccccCCCCcccccccccceeeccCccccc
Q 045798 454 SGNELSGTIPEDIFNISYLSNSLNLARNHLVGIIPPRIGNLRALRSFDVSNNDLSGEIPIELGHCSSLEEIYLAGNLFHG 533 (1008)
Q Consensus 454 s~N~l~~~lp~~~~~~~~~~~~L~L~~N~l~~~~p~~~~~l~~L~~Ldls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 533 (1008)
++|+|. ++|...+.-...+++|+||+|+|+ .+|+.+..+..|++|...+|++. .+| ++..+++|+.+|+|.|.|+.
T Consensus 391 syNrL~-~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~ 466 (1081)
T KOG0618|consen 391 SYNRLN-SFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLDLSCNNLSE 466 (1081)
T ss_pred cccccc-cCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcceEEecccchhhh
Confidence 999997 899999988888999999999999 78999999999999999999998 888 89999999999999999995
Q ss_pred c-hhhhhhccccccEEecCCCcccccccCc-ccccccceeecccC
Q 045798 534 S-IPSFFNALKGVQKIDLSRNNLSGQIPIF-LEALSLEYLNLSFN 576 (1008)
Q Consensus 534 ~-~p~~~~~l~~L~~L~ls~N~l~~~~p~~-~~~~~L~~L~l~~N 576 (1008)
. +|.... -++|+.|||++|.-.-..-.. ..+.++...+++-|
T Consensus 467 ~~l~~~~p-~p~LkyLdlSGN~~l~~d~~~l~~l~~l~~~~i~~~ 510 (1081)
T KOG0618|consen 467 VTLPEALP-SPNLKYLDLSGNTRLVFDHKTLKVLKSLSQMDITLN 510 (1081)
T ss_pred hhhhhhCC-CcccceeeccCCcccccchhhhHHhhhhhheecccC
Confidence 4 344333 389999999999742111111 22345566666655
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=338.92 Aligned_cols=242 Identities=23% Similarity=0.285 Sum_probs=193.4
Q ss_pred ceEeeccCeeEEEEEEcCCCeEEEEEEecccc---chhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceEEEEEe
Q 045798 690 HLIGVGSFGCVYKGALDEDGIVVAIKVINLQC---EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKAIVYE 766 (1008)
Q Consensus 690 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 766 (1008)
+.||+|+||.||+|+...+|+.||+|+++... ......+.+|+++++.++||||+++++++ ...+..|+|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~-----~~~~~~~lv~E 75 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAF-----QTHDRLCFVME 75 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEE-----ecCCEEEEEEe
Confidence 46999999999999998899999999997432 23445678899999999999999999884 55677999999
Q ss_pred ccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEcccCcc
Q 045798 767 YMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLA 846 (1008)
Q Consensus 767 ~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a 846 (1008)
|+++|+|..++.... .+++..++.++.||+.||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 76 ~~~~~~L~~~l~~~~----------~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~ 142 (323)
T cd05595 76 YANGGELFFHLSRER----------VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLC 142 (323)
T ss_pred CCCCCcHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHh
Confidence 999999998886543 689999999999999999999998 9999999999999999999999999998
Q ss_pred cccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCcchh
Q 045798 847 RFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMALPNQVM 926 (1008)
Q Consensus 847 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 926 (1008)
........ ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ......
T Consensus 143 ~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~-----~~~~~~------ 207 (323)
T cd05595 143 KEGISDGA----TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-----RLFELI------ 207 (323)
T ss_pred ccccCCCC----ccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHH-----HHHHHH------
Confidence 74322111 112345899999999999999999999999999999999999998632110 000000
Q ss_pred hhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCC-----CHHHHHH
Q 045798 927 DIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRM-----NMTNVVH 986 (1008)
Q Consensus 927 ~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~ 986 (1008)
.... ..++ ...+.++.+++.+||+.||.+|| ++.++++
T Consensus 208 --~~~~--------------~~~p------~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 208 --LMEE--------------IRFP------RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred --hcCC--------------CCCC------CCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 0000 0000 12345678999999999999998 7888775
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=338.03 Aligned_cols=240 Identities=25% Similarity=0.304 Sum_probs=191.2
Q ss_pred EeeccCeeEEEEEEcCCCeEEEEEEeccc---cchhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceEEEEEecc
Q 045798 692 IGVGSFGCVYKGALDEDGIVVAIKVINLQ---CEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKAIVYEYM 768 (1008)
Q Consensus 692 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 768 (1008)
||+|+||.||+|.+..+++.||+|+++.. .......+.+|+.++++++||||+++++++ ..++..++||||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~~lv~e~~ 75 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSF-----QSPEKLYLVLAFI 75 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEE-----ecCCeEEEEEcCC
Confidence 69999999999999888999999998643 233456788999999999999999999884 5567799999999
Q ss_pred CCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEcccCcccc
Q 045798 769 PNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARF 848 (1008)
Q Consensus 769 ~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~ 848 (1008)
++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 76 ~~g~L~~~l~~~~----------~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~ 142 (312)
T cd05585 76 NGGELFHHLQREG----------RFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKL 142 (312)
T ss_pred CCCcHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECccccc
Confidence 9999999997543 688999999999999999999997 999999999999999999999999999975
Q ss_pred cccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCcchhhh
Q 045798 849 HQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMALPNQVMDI 928 (1008)
Q Consensus 849 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 928 (1008)
...... ......||+.|+|||++.+..++.++||||+||++|||++|+.||..... ........
T Consensus 143 ~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~-----~~~~~~~~------- 206 (312)
T cd05585 143 NMKDDD----KTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENV-----NEMYRKIL------- 206 (312)
T ss_pred CccCCC----ccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCH-----HHHHHHHH-------
Confidence 432221 12234589999999999999999999999999999999999999863211 11111000
Q ss_pred hcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCH---HHHHH
Q 045798 929 VDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNM---TNVVH 986 (1008)
Q Consensus 929 ~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~---~evl~ 986 (1008)
.... . .....+.++.+++.+||+.||.+||++ .|++.
T Consensus 207 -----~~~~----------~------~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~ 246 (312)
T cd05585 207 -----QEPL----------R------FPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKN 246 (312)
T ss_pred -----cCCC----------C------CCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence 0000 0 001234567899999999999999864 55543
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=338.14 Aligned_cols=243 Identities=25% Similarity=0.328 Sum_probs=194.7
Q ss_pred ceEeeccCeeEEEEEEcCCCeEEEEEEeccc---cchhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceEEEEEe
Q 045798 690 HLIGVGSFGCVYKGALDEDGIVVAIKVINLQ---CEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKAIVYE 766 (1008)
Q Consensus 690 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 766 (1008)
+.||+|+||.||+|++..+++.||+|++... .......+.+|+++++.++||||++++++ +..++..++|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~-----~~~~~~~~lv~E 75 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYS-----FQTKDRLCFVME 75 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEE-----EEcCCEEEEEEe
Confidence 4699999999999999989999999999743 22345678899999999999999999988 456778999999
Q ss_pred ccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEcccCcc
Q 045798 767 YMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLA 846 (1008)
Q Consensus 767 ~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a 846 (1008)
|+++|+|.+++.... .+++.++..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 76 y~~~g~L~~~l~~~~----------~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~ 142 (328)
T cd05593 76 YVNGGELFFHLSRER----------VFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLC 142 (328)
T ss_pred CCCCCCHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCC
Confidence 999999998886543 689999999999999999999998 9999999999999999999999999998
Q ss_pred cccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCcchh
Q 045798 847 RFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMALPNQVM 926 (1008)
Q Consensus 847 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 926 (1008)
+....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..... .......
T Consensus 143 ~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~-----~~~~~~~------ 207 (328)
T cd05593 143 KEGITDAA----TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-----EKLFELI------ 207 (328)
T ss_pred ccCCCccc----ccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCH-----HHHHHHh------
Confidence 75322111 11234589999999999988999999999999999999999999863211 0111000
Q ss_pred hhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCC-----CHHHHHHH
Q 045798 927 DIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRM-----NMTNVVHE 987 (1008)
Q Consensus 927 ~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~ 987 (1008)
..... .++ ...+.++.+++.+||+.||.+|| ++.|+++.
T Consensus 208 ------~~~~~----------~~p------~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 208 ------LMEDI----------KFP------RTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred ------ccCCc----------cCC------CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 00000 000 12344578999999999999997 88888763
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=340.90 Aligned_cols=247 Identities=23% Similarity=0.291 Sum_probs=197.7
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCC-eEEEEEEeccc---cchhhHHHHHHHHHHhhcCCCCceeeeeccccccccCC
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDG-IVVAIKVINLQ---CEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGN 758 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~-~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 758 (1008)
.++|++.+.||+|+||.||+|.+..++ ..||+|++... .....+.+.+|+++++.++||||+++++++ .++
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~-----~~~ 103 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSF-----KDE 103 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEE-----EeC
Confidence 457999999999999999999875544 78999998643 223446788999999999999999999994 556
Q ss_pred ceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCe
Q 045798 759 DFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSG 838 (1008)
Q Consensus 759 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 838 (1008)
+..++||||+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+
T Consensus 104 ~~~~lv~Ey~~~g~L~~~i~~~~----------~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~i 170 (340)
T PTZ00426 104 SYLYLVLEFVIGGEFFTFLRRNK----------RFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFI 170 (340)
T ss_pred CEEEEEEeCCCCCcHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCE
Confidence 77999999999999999997654 688999999999999999999997 99999999999999999999
Q ss_pred EEcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHH
Q 045798 839 HIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFAR 918 (1008)
Q Consensus 839 kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~ 918 (1008)
||+|||++...... .....||+.|+|||++.+..++.++|||||||++|||++|..||..... ...+..
T Consensus 171 kL~DFG~a~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~----~~~~~~ 239 (340)
T PTZ00426 171 KMTDFGFAKVVDTR-------TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEP----LLIYQK 239 (340)
T ss_pred EEecCCCCeecCCC-------cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCH----HHHHHH
Confidence 99999999865321 1234589999999999988899999999999999999999999864211 000000
Q ss_pred hhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCC-----CHHHHHHH
Q 045798 919 MALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRM-----NMTNVVHE 987 (1008)
Q Consensus 919 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~ 987 (1008)
+..... .++. ..+..+.+++.+|++.||++|+ +++|+++.
T Consensus 240 ---------i~~~~~--------------~~p~------~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 240 ---------ILEGII--------------YFPK------FLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred ---------HhcCCC--------------CCCC------CCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 000000 0011 1234468999999999999995 88888764
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=339.53 Aligned_cols=249 Identities=25% Similarity=0.355 Sum_probs=192.9
Q ss_pred cCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccc-hhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceEE
Q 045798 684 NGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCE-GASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKA 762 (1008)
Q Consensus 684 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 762 (1008)
++|+..+.||+|+||.||+|.+..+++.||||++..... ...+.+.+|+++++.++|+||+++++++ ..++..+
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~~ 148 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMF-----DHNGEIQ 148 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEe-----ccCCeEE
Confidence 346678899999999999999988999999999865433 3456789999999999999999999984 5667799
Q ss_pred EEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEcc
Q 045798 763 IVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGD 842 (1008)
Q Consensus 763 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 842 (1008)
+||||+++|+|.+.. ...+..+..++.||+.||+|||+. +|+||||||+||++++++.+||+|
T Consensus 149 lv~e~~~~~~L~~~~--------------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~D 211 (353)
T PLN00034 149 VLLEFMDGGSLEGTH--------------IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIAD 211 (353)
T ss_pred EEEecCCCCcccccc--------------cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcc
Confidence 999999999987542 345677889999999999999998 999999999999999999999999
Q ss_pred cCcccccccccCccccccccccccccccCccccCC-----CCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHH
Q 045798 843 FGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLG-----SEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFA 917 (1008)
Q Consensus 843 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~ 917 (1008)
||+++........ .....||..|+|||++.. ...+.++|||||||++|||++|+.||...... .+....
T Consensus 212 fG~~~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~--~~~~~~ 285 (353)
T PLN00034 212 FGVSRILAQTMDP----CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQG--DWASLM 285 (353)
T ss_pred cccceeccccccc----ccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCc--cHHHHH
Confidence 9999865432211 123458999999998743 23456899999999999999999998732111 111111
Q ss_pred HhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 045798 918 RMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHE 987 (1008)
Q Consensus 918 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 987 (1008)
..... .. .. .....++.++.+++.+||+.||++|||+.|+++.
T Consensus 286 ~~~~~-----------~~--------------~~--~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 286 CAICM-----------SQ--------------PP--EAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred HHHhc-----------cC--------------CC--CCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000 00 00 0011245568999999999999999999999874
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=343.66 Aligned_cols=203 Identities=26% Similarity=0.331 Sum_probs=173.3
Q ss_pred CCCCCceEeeccCeeEEEEEEcCCCeEEEEEEecccc---chhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceE
Q 045798 685 GFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC---EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFK 761 (1008)
Q Consensus 685 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 761 (1008)
.|.+++.||+|+||+||+|++..+++.||+|+++... ....+.+.+|++++++++||||+++++++ .+++..
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~-----~~~~~~ 76 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSF-----QDKDNL 76 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEE-----ecCCEE
Confidence 5888999999999999999999999999999996432 23456789999999999999999999984 566779
Q ss_pred EEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEc
Q 045798 762 AIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIG 841 (1008)
Q Consensus 762 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 841 (1008)
++||||+++|+|.+++.... .+++..++.++.||+.||+|||+. +|+||||||+||+++.++.+||+
T Consensus 77 ~lv~E~~~gg~L~~~l~~~~----------~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~ 143 (381)
T cd05626 77 YFVMDYIPGGDMMSLLIRME----------VFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLT 143 (381)
T ss_pred EEEEecCCCCcHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEe
Confidence 99999999999999987653 688999999999999999999997 99999999999999999999999
Q ss_pred ccCcccccccccCcc-------------------------------------------ccccccccccccccCccccCCC
Q 045798 842 DFGLARFHQEVSNST-------------------------------------------LSSSVGVKGTIGYTAPEYGLGS 878 (1008)
Q Consensus 842 Dfg~a~~~~~~~~~~-------------------------------------------~~~~~~~~gt~~y~aPE~~~~~ 878 (1008)
|||++.......... ........||+.|+|||++.+.
T Consensus 144 DFGl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~ 223 (381)
T cd05626 144 DFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRK 223 (381)
T ss_pred eCcCCcccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCC
Confidence 999986432110000 0001234699999999999988
Q ss_pred CCCcccchhhHHHHHHHHHhCCCCCCc
Q 045798 879 EVSTNGDVYSYGILLLEMVTAKKPTDV 905 (1008)
Q Consensus 879 ~~~~~sDvwslG~vl~elltG~~pf~~ 905 (1008)
.++.++|||||||++|||++|+.||..
T Consensus 224 ~~~~~~DiwSlG~il~elltG~~Pf~~ 250 (381)
T cd05626 224 GYTQLCDWWSVGVILFEMLVGQPPFLA 250 (381)
T ss_pred CCCCccceeehhhHHHHHHhCCCCCcC
Confidence 899999999999999999999999864
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=340.89 Aligned_cols=204 Identities=26% Similarity=0.349 Sum_probs=175.1
Q ss_pred cCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEecccc---chhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCce
Q 045798 684 NGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC---EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDF 760 (1008)
Q Consensus 684 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 760 (1008)
++|++.+.||+|+||+||+|....+++.||+|+++... ......+.+|+.++.+++|++|+++++. +.++..
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~-----~~~~~~ 75 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYS-----FQDKLN 75 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEE-----EecCCe
Confidence 47899999999999999999998899999999997432 2334568899999999999999999998 456678
Q ss_pred EEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEE
Q 045798 761 KAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHI 840 (1008)
Q Consensus 761 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 840 (1008)
.|+||||+++|+|.+++.... .+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~~----------~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL 142 (363)
T cd05628 76 LYLIMEFLPGGDMMTLLMKKD----------TLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKL 142 (363)
T ss_pred EEEEEcCCCCCcHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEE
Confidence 999999999999999997654 689999999999999999999997 9999999999999999999999
Q ss_pred cccCcccccccccCcc-------------------------------ccccccccccccccCccccCCCCCCcccchhhH
Q 045798 841 GDFGLARFHQEVSNST-------------------------------LSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSY 889 (1008)
Q Consensus 841 ~Dfg~a~~~~~~~~~~-------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwsl 889 (1008)
+|||+++......... .......+||+.|+|||++.+..++.++|||||
T Consensus 143 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSl 222 (363)
T cd05628 143 SDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSL 222 (363)
T ss_pred eeccCcccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhh
Confidence 9999997543211000 000123469999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCc
Q 045798 890 GILLLEMVTAKKPTDV 905 (1008)
Q Consensus 890 G~vl~elltG~~pf~~ 905 (1008)
||++|||++|+.||..
T Consensus 223 Gvil~ell~G~~Pf~~ 238 (363)
T cd05628 223 GVIMYEMLIGYPPFCS 238 (363)
T ss_pred HHHHHHHHhCCCCCCC
Confidence 9999999999999864
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=329.60 Aligned_cols=258 Identities=26% Similarity=0.433 Sum_probs=212.0
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccchhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceEE
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKA 762 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 762 (1008)
..+....++||-|.||.||.|.|+.-.-.||||.++.+ ....++|.+|+.+|+.++|||+|+++|+|.. +...|
T Consensus 266 RtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED-tMeveEFLkEAAvMKeikHpNLVqLLGVCT~-----EpPFY 339 (1157)
T KOG4278|consen 266 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTH-----EPPFY 339 (1157)
T ss_pred chheeeeeccCCCcccceeeeeeeccceeeehhhhhhc-chhHHHHHHHHHHHHhhcCccHHHHhhhhcc-----CCCeE
Confidence 34566778999999999999999988889999999754 4567899999999999999999999999864 33489
Q ss_pred EEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEcc
Q 045798 763 IVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGD 842 (1008)
Q Consensus 763 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 842 (1008)
||+|||.+|+|.+|++..... .++....+.++.||+.|++||... ++||||+.++|+|+.++..+|++|
T Consensus 340 IiTEfM~yGNLLdYLRecnr~--------ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvAD 408 (1157)
T KOG4278|consen 340 IITEFMCYGNLLDYLRECNRS--------EVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVAD 408 (1157)
T ss_pred EEEecccCccHHHHHHHhchh--------hcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeec
Confidence 999999999999999877533 577778899999999999999996 999999999999999999999999
Q ss_pred cCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCccccCCccHHHHHHhhC
Q 045798 843 FGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT-AKKPTDVMFEGDLNLHNFARMAL 921 (1008)
Q Consensus 843 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-G~~pf~~~~~~~~~~~~~~~~~~ 921 (1008)
||+++.+..+. +....+..-.+.|.|||-+.-..++.|+|||+|||++||+.| |-.||....-
T Consensus 409 FGLsRlMtgDT---YTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidl------------- 472 (1157)
T KOG4278|consen 409 FGLSRLMTGDT---YTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDL------------- 472 (1157)
T ss_pred cchhhhhcCCc---eecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccH-------------
Confidence 99999876542 222333445789999999988899999999999999999999 7778753210
Q ss_pred CcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHHHHHH
Q 045798 922 PNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHELQSVK 992 (1008)
Q Consensus 922 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~i~ 992 (1008)
.++++++...+ +|.. .+.|++.++++|+.||++.|.+||++.|+-+.++.|-
T Consensus 473 -SqVY~LLEkgy--------------RM~~----PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf 524 (1157)
T KOG4278|consen 473 -SQVYGLLEKGY--------------RMDG----PEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMF 524 (1157)
T ss_pred -HHHHHHHhccc--------------cccC----CCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHh
Confidence 01222222222 2221 2357888999999999999999999999999998763
|
|
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=324.71 Aligned_cols=262 Identities=21% Similarity=0.294 Sum_probs=206.4
Q ss_pred cCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccc---cchhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCce
Q 045798 684 NGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQ---CEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDF 760 (1008)
Q Consensus 684 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 760 (1008)
++|++.+.||+|+||.||+|....+++.||||.++.. .......+.+|+++++.++||||+++++++ ...+.
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~ 76 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSF-----IEDNE 76 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeE-----EECCe
Confidence 5799999999999999999999889999999987632 233445789999999999999999999984 44567
Q ss_pred EEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEE
Q 045798 761 KAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHI 840 (1008)
Q Consensus 761 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 840 (1008)
.++|+||+++++|.+++...... ...+++..+..++.|++.||+|||++ +++||||||+||+++.++.++|
T Consensus 77 ~~~v~e~~~~~~L~~~~~~~~~~------~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l 147 (267)
T cd08228 77 LNIVLELADAGDLSQMIKYFKKQ------KRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKL 147 (267)
T ss_pred EEEEEEecCCCcHHHHHHHhhhc------cCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEE
Confidence 89999999999999888543211 11578899999999999999999997 9999999999999999999999
Q ss_pred cccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHhh
Q 045798 841 GDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMA 920 (1008)
Q Consensus 841 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~~ 920 (1008)
+|||.+......... .....++..|+|||.+.+..++.++||||||+++|||++|+.||...... ...+....
T Consensus 148 ~d~g~~~~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~---~~~~~~~~ 220 (267)
T cd08228 148 GDLGLGRFFSSKTTA----AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN---LFSLCQKI 220 (267)
T ss_pred CccccceeccchhHH----HhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccccc---HHHHHHHH
Confidence 999999865432211 12235888999999998888999999999999999999999998532111 11111100
Q ss_pred CCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHHHHHH
Q 045798 921 LPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHELQSVK 992 (1008)
Q Consensus 921 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~i~ 992 (1008)
.... .+ + ......+..+.+++.+||+.+|.+||++.||++.+++++
T Consensus 221 ~~~~------------------------~~-~-~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 221 EQCD------------------------YP-P-LPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred hcCC------------------------CC-C-CChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 0000 00 0 001234566899999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=343.78 Aligned_cols=204 Identities=26% Similarity=0.377 Sum_probs=174.9
Q ss_pred cCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEecccc---chhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCce
Q 045798 684 NGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC---EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDF 760 (1008)
Q Consensus 684 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 760 (1008)
++|++.+.||+|+||.||+|++..+++.||||+++... ......+.+|+++++.++||||++++++ +.+++.
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~-----~~~~~~ 75 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYS-----FQDENY 75 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEE-----EEcCCe
Confidence 47999999999999999999999899999999997432 2334568899999999999999999998 456778
Q ss_pred EEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEE
Q 045798 761 KAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHI 840 (1008)
Q Consensus 761 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 840 (1008)
.++||||+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||
T Consensus 76 ~~lv~E~~~~g~L~~~l~~~~----------~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl 142 (364)
T cd05599 76 LYLIMEYLPGGDMMTLLMKKD----------TFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKL 142 (364)
T ss_pred EEEEECCCCCcHHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEE
Confidence 999999999999999987543 689999999999999999999998 9999999999999999999999
Q ss_pred cccCcccccccccCccc----------------------------------cccccccccccccCccccCCCCCCcccch
Q 045798 841 GDFGLARFHQEVSNSTL----------------------------------SSSVGVKGTIGYTAPEYGLGSEVSTNGDV 886 (1008)
Q Consensus 841 ~Dfg~a~~~~~~~~~~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDv 886 (1008)
+|||++........... ......+||+.|+|||++.+..++.++||
T Consensus 143 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di 222 (364)
T cd05599 143 SDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDW 222 (364)
T ss_pred eecccceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeee
Confidence 99999875432111000 00112458999999999999899999999
Q ss_pred hhHHHHHHHHHhCCCCCCc
Q 045798 887 YSYGILLLEMVTAKKPTDV 905 (1008)
Q Consensus 887 wslG~vl~elltG~~pf~~ 905 (1008)
|||||++|||++|..||..
T Consensus 223 wSlG~il~el~~G~~Pf~~ 241 (364)
T cd05599 223 WSLGVIMYEMLVGYPPFCS 241 (364)
T ss_pred ecchhHHHHhhcCCCCCCC
Confidence 9999999999999999864
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=328.49 Aligned_cols=265 Identities=23% Similarity=0.409 Sum_probs=204.6
Q ss_pred cCCCCCceEeeccCeeEEEEEEcCCC-----eEEEEEEeccccc-hhhHHHHHHHHHHhhcCCCCceeeeeccccccccC
Q 045798 684 NGFSSTHLIGVGSFGCVYKGALDEDG-----IVVAIKVINLQCE-GASKSFMAECKALKNIRHRNLVKVITSCSSIDFQG 757 (1008)
Q Consensus 684 ~~y~~~~~lg~G~~g~Vy~~~~~~~~-----~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 757 (1008)
++|++.+.||+|+||.||+|.....+ ..||+|.++.... .....+.+|++++++++||||+++++++ ..
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~-----~~ 79 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVC-----TK 79 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEE-----cC
Confidence 46889999999999999999985444 6899999874432 3456789999999999999999999985 44
Q ss_pred CceEEEEEeccCCCChhcccccCCCCCCC------cccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCee
Q 045798 758 NDFKAIVYEYMPNGSLEKWLHPHAVPKRD------KEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNIL 831 (1008)
Q Consensus 758 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~------~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIl 831 (1008)
.+..+++|||+++++|.+++......... ......+++..++.++.|++.||+|||+. +++||||||+||+
T Consensus 80 ~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil 156 (283)
T cd05048 80 EQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCL 156 (283)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEE
Confidence 56689999999999999999764321110 00113688999999999999999999998 9999999999999
Q ss_pred ecCCCCeEEcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCccccCC
Q 045798 832 LDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT-AKKPTDVMFEGD 910 (1008)
Q Consensus 832 l~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-G~~pf~~~~~~~ 910 (1008)
+++++.+||+|||++.......... ......+++.|+|||.+.+..++.++|||||||++|||++ |..||......
T Consensus 157 ~~~~~~~~L~dfg~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~- 233 (283)
T cd05048 157 VGEGLTVKISDFGLSRDIYSADYYR--VQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ- 233 (283)
T ss_pred EcCCCcEEECCCcceeecccccccc--ccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH-
Confidence 9999999999999997543322111 1222346788999999988899999999999999999998 99998643211
Q ss_pred ccHHHHHHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHHHH
Q 045798 911 LNLHNFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHELQS 990 (1008)
Q Consensus 911 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 990 (1008)
... ..+..... . .....++.++.+++.+||+.||++||++.||++.|++
T Consensus 234 ----~~~---------~~i~~~~~----------------~--~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 234 ----EVI---------EMIRSRQL----------------L--PCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred ----HHH---------HHHHcCCc----------------C--CCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 000 00000000 0 0012356778999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=323.03 Aligned_cols=256 Identities=25% Similarity=0.421 Sum_probs=203.2
Q ss_pred cCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccchhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceEEE
Q 045798 684 NGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKAI 763 (1008)
Q Consensus 684 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 763 (1008)
.+|.+.+.||+|+||.||+|.+...++.||+|+++.. ....+.+.+|++++++++|+||++++++| ..++..++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~l 79 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVC-----TREPPFYI 79 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEE-----cCCCCcEE
Confidence 3578889999999999999999888999999998754 33456789999999999999999999985 44566899
Q ss_pred EEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEccc
Q 045798 764 VYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDF 843 (1008)
Q Consensus 764 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 843 (1008)
||||+++++|.+++...... .+++..++.++.|++.||+|||+. +++||||||+||++++++.+||+||
T Consensus 80 v~e~~~~~~L~~~~~~~~~~--------~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df 148 (263)
T cd05052 80 ITEFMTYGNLLDYLRECNRQ--------EVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADF 148 (263)
T ss_pred EEEeCCCCcHHHHHHhCCCC--------CCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCC
Confidence 99999999999998654321 588999999999999999999997 9999999999999999999999999
Q ss_pred CcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCccccCCccHHHHHHhhCC
Q 045798 844 GLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT-AKKPTDVMFEGDLNLHNFARMALP 922 (1008)
Q Consensus 844 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-G~~pf~~~~~~~~~~~~~~~~~~~ 922 (1008)
|.+......... ......++..|+|||.+.+..++.++|||||||++|||++ |..||..... ......
T Consensus 149 ~~~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~-----~~~~~~--- 217 (263)
T cd05052 149 GLSRLMTGDTYT---AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-----SQVYEL--- 217 (263)
T ss_pred ccccccccceee---ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH-----HHHHHH---
Confidence 999865432211 1112234678999999988899999999999999999998 8888753211 111000
Q ss_pred cchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHHHHH
Q 045798 923 NQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHELQSV 991 (1008)
Q Consensus 923 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~i 991 (1008)
+...... . ....++.++.+++.+||+.||++|||+.++++.|+.+
T Consensus 218 ------~~~~~~~----------------~--~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 218 ------LEKGYRM----------------E--RPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred ------HHCCCCC----------------C--CCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 0000000 0 0112356689999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=350.25 Aligned_cols=255 Identities=21% Similarity=0.251 Sum_probs=202.1
Q ss_pred CCCCCceEeeccCeeEEEEEEcCC-CeEEEEEEeccccchhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceEEE
Q 045798 685 GFSSTHLIGVGSFGCVYKGALDED-GIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKAI 763 (1008)
Q Consensus 685 ~y~~~~~lg~G~~g~Vy~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 763 (1008)
.|.+.+.||+|+||.||+|....+ ++.||+|.+..........+.+|+++++.++||||+++++++ ..++..|+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~-----~~~~~~~l 142 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDF-----KSDDKLLL 142 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEE-----EECCEEEE
Confidence 489999999999999999998766 788999987665555566788999999999999999999985 45677999
Q ss_pred EEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEccc
Q 045798 764 VYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDF 843 (1008)
Q Consensus 764 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 843 (1008)
||||+++|+|.+++...... ..++++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+||
T Consensus 143 v~E~~~gg~L~~~l~~~~~~------~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DF 213 (478)
T PTZ00267 143 IMEYGSGGDLNKQIKQRLKE------HLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDF 213 (478)
T ss_pred EEECCCCCCHHHHHHHHHhc------cCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeC
Confidence 99999999999887643211 11688999999999999999999997 9999999999999999999999999
Q ss_pred CcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCc
Q 045798 844 GLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMALPN 923 (1008)
Q Consensus 844 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~~~~~ 923 (1008)
|+++........ .......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ....
T Consensus 214 gla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~-----~~~~------ 280 (478)
T PTZ00267 214 GFSKQYSDSVSL--DVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ-----REIM------ 280 (478)
T ss_pred cCceecCCcccc--ccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH-----HHHH------
Confidence 999865432211 112335689999999999999999999999999999999999999863211 0010
Q ss_pred chhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 045798 924 QVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHE 987 (1008)
Q Consensus 924 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 987 (1008)
...+.... .. .....+.++.+++.+||+.||++||++++++..
T Consensus 281 ------~~~~~~~~---------~~------~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~ 323 (478)
T PTZ00267 281 ------QQVLYGKY---------DP------FPCPVSSGMKALLDPLLSKNPALRPTTQQLLHT 323 (478)
T ss_pred ------HHHHhCCC---------CC------CCccCCHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence 00000000 00 001234567999999999999999999999753
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=327.74 Aligned_cols=279 Identities=25% Similarity=0.293 Sum_probs=200.2
Q ss_pred CCCCCceEeeccCeeEEEEEEcCCCeEEEEEEecccc--chhhHHHHHHHHHHhhc---CCCCceeeeeccccccccCCc
Q 045798 685 GFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC--EGASKSFMAECKALKNI---RHRNLVKVITSCSSIDFQGND 759 (1008)
Q Consensus 685 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~~~~~~~~ 759 (1008)
+|++.+.||+|+||+||+|++..+++.||+|+++... ......+.+|+++++++ +||||+++++++.........
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 5889999999999999999999899999999987432 22234566787777766 799999999987654444566
Q ss_pred eEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeE
Q 045798 760 FKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGH 839 (1008)
Q Consensus 760 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 839 (1008)
..++||||++ ++|.+++...... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+|
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~~~~~--------~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~k 148 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDKVPPP--------GLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVK 148 (288)
T ss_pred eEEEEEcccc-cCHHHHHHhcCCC--------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEE
Confidence 7899999996 5898888654321 589999999999999999999998 999999999999999999999
Q ss_pred EcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHh
Q 045798 840 IGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARM 919 (1008)
Q Consensus 840 L~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~ 919 (1008)
|+|||++........ .....+|..|+|||++.+..++.++||||+||++|||++|++||......+ ........
T Consensus 149 l~dfg~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~-~~~~~~~~ 222 (288)
T cd07863 149 LADFGLARIYSCQMA-----LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD-QLGKIFDL 222 (288)
T ss_pred ECccCccccccCccc-----CCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHH-HHHHHHHH
Confidence 999999986543221 122457899999999998899999999999999999999999986432211 11111111
Q ss_pred hCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 920 ALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 920 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
........+- ........ ... ............+.+..+.+++.+|++.||++|||+.|++.
T Consensus 223 ~~~~~~~~~~-~~~~~~~~---~~~-~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 223 IGLPPEDDWP-RDVTLPRG---AFS-PRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred hCCCChhhCc-cccccccc---ccC-CCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0000000000 00000000 000 00000000011134566789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=311.08 Aligned_cols=248 Identities=25% Similarity=0.337 Sum_probs=207.8
Q ss_pred CCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccchhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceEEEEE
Q 045798 686 FSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKAIVY 765 (1008)
Q Consensus 686 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 765 (1008)
|.++++||+|+||.||+|.++++|+.||||.+... .+.+++.+|+.+|+++..|++|++||.+. .....|+||
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYF-----K~sDLWIVM 107 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYF-----KHSDLWIVM 107 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhc-----cCCceEeeh
Confidence 66789999999999999999999999999998754 44678899999999999999999999853 344589999
Q ss_pred eccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEcccCc
Q 045798 766 EYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGL 845 (1008)
Q Consensus 766 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~ 845 (1008)
|||..|+..+.++.... ++++.++..+++..++||+|||.. .-+|||||+.|||+..+|.+||+|||.
T Consensus 108 EYCGAGSiSDI~R~R~K---------~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGV 175 (502)
T KOG0574|consen 108 EYCGAGSISDIMRARRK---------PLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGV 175 (502)
T ss_pred hhcCCCcHHHHHHHhcC---------CccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccc
Confidence 99999999999976542 799999999999999999999998 889999999999999999999999999
Q ss_pred ccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCcch
Q 045798 846 ARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMALPNQV 925 (1008)
Q Consensus 846 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~ 925 (1008)
|-.+.+... ....+.||+.|||||++..-.|..++||||+|++..||..|++||.+...-.. .+ .+|
T Consensus 176 AGQLTDTMA----KRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRA---IF---MIP--- 242 (502)
T KOG0574|consen 176 AGQLTDTMA----KRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRA---IF---MIP--- 242 (502)
T ss_pred cchhhhhHH----hhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccce---eE---ecc---
Confidence 986654432 23457799999999999999999999999999999999999999875322100 00 001
Q ss_pred hhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 926 MDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 926 ~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
.+.++-+...++.+.++.++++.|+-..|++|-||.++++
T Consensus 243 ---------------------T~PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~ 282 (502)
T KOG0574|consen 243 ---------------------TKPPPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCE 282 (502)
T ss_pred ---------------------CCCCCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence 1112233345567778999999999999999999999876
|
|
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=355.58 Aligned_cols=272 Identities=25% Similarity=0.317 Sum_probs=206.8
Q ss_pred cCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEecccc---chhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCce
Q 045798 684 NGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC---EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDF 760 (1008)
Q Consensus 684 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 760 (1008)
++|++.++||+|+||.||+|.+..+++.||+|+++... +...+++.+|++++++++||||+++++++ .+++.
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~-----~d~~~ 76 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSIC-----SDGDP 76 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEE-----eeCCE
Confidence 57999999999999999999998889999999997432 23356799999999999999999999985 45567
Q ss_pred EEEEEeccCCCChhcccccCCCCC-CCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeE
Q 045798 761 KAIVYEYMPNGSLEKWLHPHAVPK-RDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGH 839 (1008)
Q Consensus 761 ~~lv~e~~~~gsL~~~l~~~~~~~-~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 839 (1008)
.++||||++||+|.+++....... .........++..++.++.||+.||+|||+. +|+||||||+||+++.++.+|
T Consensus 77 lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vK 153 (932)
T PRK13184 77 VYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVV 153 (932)
T ss_pred EEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEE
Confidence 899999999999999986432111 1111223577888999999999999999997 999999999999999999999
Q ss_pred EcccCcccccccccCc--------------cccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCc
Q 045798 840 IGDFGLARFHQEVSNS--------------TLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDV 905 (1008)
Q Consensus 840 L~Dfg~a~~~~~~~~~--------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~ 905 (1008)
|+|||+++........ .........||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 154 LiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~ 233 (932)
T PRK13184 154 ILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRR 233 (932)
T ss_pred EEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCC
Confidence 9999999865221110 00111234699999999999999999999999999999999999999864
Q ss_pred cccCCccHHHHHHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCC-CHHHH
Q 045798 906 MFEGDLNLHNFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRM-NMTNV 984 (1008)
Q Consensus 906 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-t~~ev 984 (1008)
........ ..... .+. ......+.+..+.+++.+|++.||++|| +++++
T Consensus 234 ~~~~ki~~----~~~i~-------------~P~-------------~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeL 283 (932)
T PRK13184 234 KKGRKISY----RDVIL-------------SPI-------------EVAPYREIPPFLSQIAMKALAVDPAERYSSVQEL 283 (932)
T ss_pred cchhhhhh----hhhcc-------------Chh-------------hccccccCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence 21110000 00000 000 0000113456688999999999999995 67777
Q ss_pred HHHHHHHHH
Q 045798 985 VHELQSVKN 993 (1008)
Q Consensus 985 l~~L~~i~~ 993 (1008)
++.|+....
T Consensus 284 l~~Le~~lq 292 (932)
T PRK13184 284 KQDLEPHLQ 292 (932)
T ss_pred HHHHHHHHh
Confidence 777777654
|
|
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=326.68 Aligned_cols=276 Identities=25% Similarity=0.382 Sum_probs=205.3
Q ss_pred cCCCCCceEeeccCeeEEEEEE----cCCCeEEEEEEeccccchhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCc
Q 045798 684 NGFSSTHLIGVGSFGCVYKGAL----DEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGND 759 (1008)
Q Consensus 684 ~~y~~~~~lg~G~~g~Vy~~~~----~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 759 (1008)
.+|++.+.||+|+||.||+|.. ..+++.||+|+++.......+.+.+|++++++++||||+++++++.. .+..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~~~ 80 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYS---AGRR 80 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEcc---CCCC
Confidence 4788999999999999999984 34688999999986656666789999999999999999999998643 3445
Q ss_pred eEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeE
Q 045798 760 FKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGH 839 (1008)
Q Consensus 760 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 839 (1008)
..++||||+++++|.+++..... .+++..++.++.|++.||+|||+. +|+||||||+||++++++.+|
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~---------~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~ 148 (284)
T cd05081 81 NLRLVMEYLPYGSLRDYLQKHRE---------RLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVK 148 (284)
T ss_pred ceEEEEEecCCCCHHHHHHhcCc---------CCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEE
Confidence 68999999999999999865421 588999999999999999999998 999999999999999999999
Q ss_pred EcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHh
Q 045798 840 IGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARM 919 (1008)
Q Consensus 840 L~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~ 919 (1008)
|+|||++........... ......++..|+|||++.+..++.++|||||||++|||++|..|+..... .+...
T Consensus 149 l~dfg~~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~------~~~~~ 221 (284)
T cd05081 149 IGDFGLTKVLPQDKEYYK-VREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPA------EFMRM 221 (284)
T ss_pred ECCCcccccccCCCccee-ecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcch------hhhhh
Confidence 999999986644322111 11112244569999999888899999999999999999999877542211 01100
Q ss_pred hCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHHHHH
Q 045798 920 ALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHELQSV 991 (1008)
Q Consensus 920 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~i 991 (1008)
.............+ .......... +....++.++.+++.+||+.+|++||||.||++.|+.+
T Consensus 222 ~~~~~~~~~~~~~~------~~~~~~~~~~----~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 222 MGNDKQGQMIVYHL------IELLKNNGRL----PAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred cccccccccchHHH------HHHHhcCCcC----CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 00000000000000 0000000000 11123456789999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=333.57 Aligned_cols=270 Identities=25% Similarity=0.355 Sum_probs=203.9
Q ss_pred cCCCCCceEeeccCeeEEEEEEcC-----CCeEEEEEEecccc-chhhHHHHHHHHHHhhc-CCCCceeeeecccccccc
Q 045798 684 NGFSSTHLIGVGSFGCVYKGALDE-----DGIVVAIKVINLQC-EGASKSFMAECKALKNI-RHRNLVKVITSCSSIDFQ 756 (1008)
Q Consensus 684 ~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 756 (1008)
++|++.+.||+|+||.||+|.... +++.||+|+++... ....+.+.+|+.++.++ +|+||++++++|. .
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~----~ 82 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACT----K 82 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEe----c
Confidence 479999999999999999997532 35789999987432 23345688999999999 8999999999874 3
Q ss_pred CCceEEEEEeccCCCChhcccccCCCCCC---------------------------------------------------
Q 045798 757 GNDFKAIVYEYMPNGSLEKWLHPHAVPKR--------------------------------------------------- 785 (1008)
Q Consensus 757 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~--------------------------------------------------- 785 (1008)
.+...++||||+++++|.+++........
T Consensus 83 ~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (337)
T cd05054 83 PGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEG 162 (337)
T ss_pred CCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhh
Confidence 45578999999999999999864321000
Q ss_pred CcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEcccCcccccccccCccccccccccc
Q 045798 786 DKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKG 865 (1008)
Q Consensus 786 ~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~g 865 (1008)
......++++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||++.......... ......+
T Consensus 163 ~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~--~~~~~~~ 237 (337)
T cd05054 163 DELYKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYV--RKGDARL 237 (337)
T ss_pred hHHhhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchh--hccCCCC
Confidence 000012689999999999999999999998 99999999999999999999999999998654322111 1122346
Q ss_pred cccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCccccCCccHHHHHHhhCCcchhhhhcccccCchHHhhhhh
Q 045798 866 TIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT-AKKPTDVMFEGDLNLHNFARMALPNQVMDIVDPILRNDEEILASTD 944 (1008)
Q Consensus 866 t~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~ 944 (1008)
+..|+|||++.+..++.++|||||||++|||++ |..||......+ ....... .. ..
T Consensus 238 ~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~-~~~~~~~----~~--------~~---------- 294 (337)
T cd05054 238 PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE-EFCRRLK----EG--------TR---------- 294 (337)
T ss_pred CccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH-HHHHHHh----cc--------CC----------
Confidence 778999999999999999999999999999998 999986421111 0000000 00 00
Q ss_pred hhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHHHHHHH
Q 045798 945 KCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHELQSVKN 993 (1008)
Q Consensus 945 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~i~~ 993 (1008)
.. .....+.++.+++.+||+.+|++||++.|+++.|+++..
T Consensus 295 ----~~----~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 295 ----MR----APEYATPEIYSIMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred ----CC----CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 00 001234567999999999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=339.48 Aligned_cols=268 Identities=26% Similarity=0.358 Sum_probs=203.7
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcC-----CCeEEEEEEecccc-chhhHHHHHHHHHHhhcC-CCCceeeeeccccccc
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDE-----DGIVVAIKVINLQC-EGASKSFMAECKALKNIR-HRNLVKVITSCSSIDF 755 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~ 755 (1008)
.++|++.++||+|+||.||+|.+.. .+..||||+++... ....+.+.+|+++++++. ||||++++++|
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~----- 110 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGAC----- 110 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEE-----
Confidence 5689999999999999999998742 23579999997543 334567999999999995 99999999995
Q ss_pred cCCceEEEEEeccCCCChhcccccCCCCCCC-------------------------------------------------
Q 045798 756 QGNDFKAIVYEYMPNGSLEKWLHPHAVPKRD------------------------------------------------- 786 (1008)
Q Consensus 756 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~------------------------------------------------- 786 (1008)
...+..++|||||++|+|.+++.........
T Consensus 111 ~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (400)
T cd05105 111 TKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVP 190 (400)
T ss_pred ccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccch
Confidence 4456799999999999999988653210000
Q ss_pred -------------------------------------cccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCC
Q 045798 787 -------------------------------------KEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSN 829 (1008)
Q Consensus 787 -------------------------------------~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~N 829 (1008)
......+++..+..++.||+.||+|||+. +|+||||||+|
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~N 267 (400)
T cd05105 191 MLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARN 267 (400)
T ss_pred hhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHh
Confidence 00012478899999999999999999997 99999999999
Q ss_pred eeecCCCCeEEcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCcccc
Q 045798 830 ILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT-AKKPTDVMFE 908 (1008)
Q Consensus 830 Ill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-G~~pf~~~~~ 908 (1008)
|++++++.+||+|||+++......... ......++..|+|||.+.+..++.++|||||||++|||++ |..||.....
T Consensus 268 ill~~~~~~kL~DfGla~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~ 345 (400)
T cd05105 268 VLLAQGKIVKICDFGLARDIMHDSNYV--SKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIV 345 (400)
T ss_pred EEEeCCCEEEEEeCCcceecccccccc--ccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccch
Confidence 999999999999999998654322211 1122346788999999998899999999999999999997 8999864321
Q ss_pred CCccHHHHHHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHH
Q 045798 909 GDLNLHNFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHEL 988 (1008)
Q Consensus 909 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 988 (1008)
....... .. ... ++ +....++..+.+++.+||+.||++|||+.+|.++|
T Consensus 346 ~~~~~~~-~~------------~~~--------------~~----~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l 394 (400)
T cd05105 346 DSTFYNK-IK------------SGY--------------RM----AKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIV 394 (400)
T ss_pred hHHHHHH-Hh------------cCC--------------CC----CCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHH
Confidence 1100000 00 000 00 00113456789999999999999999999999999
Q ss_pred HHH
Q 045798 989 QSV 991 (1008)
Q Consensus 989 ~~i 991 (1008)
+++
T Consensus 395 ~~l 397 (400)
T cd05105 395 ESL 397 (400)
T ss_pred HHH
Confidence 875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=334.60 Aligned_cols=245 Identities=26% Similarity=0.352 Sum_probs=191.6
Q ss_pred CCCCceEeeccCeeEEEEEEcCCCeEEEEEEecccc---chhhHHHHHHHHHH---hhcCCCCceeeeeccccccccCCc
Q 045798 686 FSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC---EGASKSFMAECKAL---KNIRHRNLVKVITSCSSIDFQGND 759 (1008)
Q Consensus 686 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l---~~l~h~niv~~~~~~~~~~~~~~~ 759 (1008)
|++.+.||+|+||.||+|.+..+++.||||+++... ....+.+.+|++++ +.++||||++++++ +..++
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~-----~~~~~ 75 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFAC-----FQTED 75 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeE-----EEcCC
Confidence 678899999999999999998899999999997432 23345677776665 46689999999998 45667
Q ss_pred eEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeE
Q 045798 760 FKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGH 839 (1008)
Q Consensus 760 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 839 (1008)
..|+||||+++++|..++... .+++..+..++.||+.||+|||+. +|+||||||+||++++++.+|
T Consensus 76 ~~~lv~E~~~~~~L~~~~~~~-----------~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~k 141 (324)
T cd05589 76 HVCFVMEYAAGGDLMMHIHTD-----------VFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVK 141 (324)
T ss_pred EEEEEEcCCCCCcHHHHhhcC-----------CCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEE
Confidence 899999999999999887542 689999999999999999999998 999999999999999999999
Q ss_pred EcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHh
Q 045798 840 IGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARM 919 (1008)
Q Consensus 840 L~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~ 919 (1008)
|+|||+++....... ......|++.|+|||++.+..++.++|||||||++|||++|+.||...... ...
T Consensus 142 L~Dfg~~~~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~-----~~~-- 210 (324)
T cd05589 142 IADFGLCKEGMGFGD----RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEE-----EVF-- 210 (324)
T ss_pred eCcccCCccCCCCCC----cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHH-----HHH--
Confidence 999999874322111 122345899999999999999999999999999999999999998642110 000
Q ss_pred hCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCC-----HHHHHH
Q 045798 920 ALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMN-----MTNVVH 986 (1008)
Q Consensus 920 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~ 986 (1008)
+....... ..+ ...+..+.+++.+||+.||.+||+ +.++++
T Consensus 211 ----------~~i~~~~~----------~~p------~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 211 ----------DSIVNDEV----------RYP------RFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred ----------HHHHhCCC----------CCC------CCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 00000000 000 123455789999999999999994 555544
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=324.74 Aligned_cols=255 Identities=27% Similarity=0.432 Sum_probs=201.9
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccchhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceEE
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKA 762 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 762 (1008)
.++|++.++||+|+||.||+|... +++.||+|.+... ....+.+.+|+.++++++|+||+++++++ ...+..+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~ 77 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPG-TMSVQAFLEEANLMKTLQHDKLVRLYAVV-----TKEEPIY 77 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCC-chhHHHHHHHHHHHHhCCCCCeeeEEEEE-----cCCCCcE
Confidence 357899999999999999999975 6778999998653 33457899999999999999999999884 4566689
Q ss_pred EEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEcc
Q 045798 763 IVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGD 842 (1008)
Q Consensus 763 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 842 (1008)
+||||+++++|.+++...... .+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|
T Consensus 78 lv~e~~~~~~L~~~l~~~~~~--------~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~d 146 (261)
T cd05072 78 IITEYMAKGSLLDFLKSDEGG--------KVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIAD 146 (261)
T ss_pred EEEecCCCCcHHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECC
Confidence 999999999999998754321 678889999999999999999997 999999999999999999999999
Q ss_pred cCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCccccCCccHHHHHHhhC
Q 045798 843 FGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT-AKKPTDVMFEGDLNLHNFARMAL 921 (1008)
Q Consensus 843 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-G~~pf~~~~~~~~~~~~~~~~~~ 921 (1008)
||.+......... ......++..|+|||++.+..++.++|||||||++|+|++ |..||......+ .........
T Consensus 147 fg~~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~--~~~~~~~~~ 221 (261)
T cd05072 147 FGLARVIEDNEYT---AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD--VMSALQRGY 221 (261)
T ss_pred CccceecCCCcee---ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHH--HHHHHHcCC
Confidence 9999865432211 1122335778999999988889999999999999999998 999985321110 000000000
Q ss_pred CcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHHHH
Q 045798 922 PNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHELQS 990 (1008)
Q Consensus 922 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 990 (1008)
.. +.....+.++.+++.+||+.+|++||+++++.+.|+.
T Consensus 222 --------------------------~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 222 --------------------------RM----PRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred --------------------------CC----CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 00 0001234567899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=341.52 Aligned_cols=256 Identities=25% Similarity=0.332 Sum_probs=203.0
Q ss_pred cCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEecccc---chhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCce
Q 045798 684 NGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC---EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDF 760 (1008)
Q Consensus 684 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 760 (1008)
++|.+.+.||+|+||+||+|++..+++.||+|+++... ......+.+|++++..++||||++++++ +.++++
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~-----~~~~~~ 75 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYS-----FQDEEH 75 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhh-----eecCCe
Confidence 47999999999999999999998899999999997432 2445678999999999999999999988 456778
Q ss_pred EEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEE
Q 045798 761 KAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHI 840 (1008)
Q Consensus 761 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 840 (1008)
.++||||+++++|.+++.... .+++..++.++.||+.||+|||+. +|+||||||+||+++.++.+||
T Consensus 76 ~~lv~e~~~~~~L~~~l~~~~----------~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL 142 (350)
T cd05573 76 LYLVMEYMPGGDLMNLLIRKD----------VFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKL 142 (350)
T ss_pred EEEEEcCCCCCCHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEe
Confidence 999999999999999997653 689999999999999999999997 9999999999999999999999
Q ss_pred cccCcccccccccC-------------------------ccccccccccccccccCccccCCCCCCcccchhhHHHHHHH
Q 045798 841 GDFGLARFHQEVSN-------------------------STLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLE 895 (1008)
Q Consensus 841 ~Dfg~a~~~~~~~~-------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~e 895 (1008)
+|||++........ ..........||+.|+|||++.+..++.++|||||||++||
T Consensus 143 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~e 222 (350)
T cd05573 143 ADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYE 222 (350)
T ss_pred ecCCCCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhh
Confidence 99999986544320 00011223458999999999999999999999999999999
Q ss_pred HHhCCCCCCccccCCccHHHHHHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCC
Q 045798 896 MVTAKKPTDVMFEGDLNLHNFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESP 975 (1008)
Q Consensus 896 lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP 975 (1008)
|++|+.||..... ...+..... +. ..+ ..+ .....+.++.+++.+|++ ||
T Consensus 223 ll~g~~Pf~~~~~----~~~~~~i~~------~~-~~~--------------~~p----~~~~~~~~~~~li~~ll~-dp 272 (350)
T cd05573 223 MLYGFPPFYSDTL----QETYNKIIN------WK-ESL--------------RFP----PDPPVSPEAIDLICRLLC-DP 272 (350)
T ss_pred hccCCCCCCCCCH----HHHHHHHhc------cC-Ccc--------------cCC----CCCCCCHHHHHHHHHHcc-Ch
Confidence 9999999864321 000000000 00 000 000 001135567899999997 99
Q ss_pred CCCCC-HHHHHHH
Q 045798 976 QDRMN-MTNVVHE 987 (1008)
Q Consensus 976 ~~RPt-~~evl~~ 987 (1008)
.+||+ ++|+++.
T Consensus 273 ~~R~~s~~~ll~h 285 (350)
T cd05573 273 EDRLGSFEEIKSH 285 (350)
T ss_pred hhcCCCHHHHhcC
Confidence 99999 9999874
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=333.02 Aligned_cols=196 Identities=30% Similarity=0.407 Sum_probs=172.7
Q ss_pred CCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccchhhHHHHHHHHHHhhcC-C-----CCceeeeeccccccccCC
Q 045798 685 GFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIR-H-----RNLVKVITSCSSIDFQGN 758 (1008)
Q Consensus 685 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-----~niv~~~~~~~~~~~~~~ 758 (1008)
+|.+.+.||+|.||.|.+|.+..+++.||||+++.. ..-..+.+.|+.++..++ | -|+|+++++ |...
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~-k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~-----F~fr 260 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK-KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDY-----FYFR 260 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC-hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeec-----cccc
Confidence 789999999999999999999999999999999865 344567788999999996 4 489999999 6788
Q ss_pred ceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCC--C
Q 045798 759 DFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDND--L 836 (1008)
Q Consensus 759 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~--~ 836 (1008)
++.|||+|.+ ..+|+++++.+... .++...++.++.||+.||.+||+. +|||+||||+|||+.+. .
T Consensus 261 ~HlciVfELL-~~NLYellK~n~f~--------Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~ 328 (586)
T KOG0667|consen 261 NHLCIVFELL-STNLYELLKNNKFR--------GLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRS 328 (586)
T ss_pred cceeeeehhh-hhhHHHHHHhcCCC--------CCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcC
Confidence 8999999999 77999999987643 689999999999999999999998 99999999999999643 4
Q ss_pred CeEEcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCc
Q 045798 837 SGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDV 905 (1008)
Q Consensus 837 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~ 905 (1008)
.+||+|||.|+......- ..+.+..|+|||++.|.+|+.+.||||||||++||++|.+.|..
T Consensus 329 ~vKVIDFGSSc~~~q~vy-------tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG 390 (586)
T KOG0667|consen 329 RIKVIDFGSSCFESQRVY-------TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPG 390 (586)
T ss_pred ceeEEecccccccCCcce-------eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCC
Confidence 789999999996544322 34578899999999999999999999999999999999877754
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=350.62 Aligned_cols=266 Identities=23% Similarity=0.286 Sum_probs=205.9
Q ss_pred HHHHhcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccc--cchhhHHHHHHHHHHhhcCCCCceeeeeccccccc-
Q 045798 679 LLKATNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQ--CEGASKSFMAECKALKNIRHRNLVKVITSCSSIDF- 755 (1008)
Q Consensus 679 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~- 755 (1008)
.....++|++.+.||+|+||+||+|.+..+++.||||++... .+.....+.+|+.++..++|+||+++.+.+...+.
T Consensus 27 ~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~ 106 (496)
T PTZ00283 27 AKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPR 106 (496)
T ss_pred ccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceeccccc
Confidence 344567999999999999999999999889999999998643 23445678899999999999999998876543221
Q ss_pred --cCCceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeec
Q 045798 756 --QGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLD 833 (1008)
Q Consensus 756 --~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~ 833 (1008)
......++||||+++|+|.+++...... ...+++..+..++.|++.||+|||+. +|+||||||+||+++
T Consensus 107 ~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~------~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~ 177 (496)
T PTZ00283 107 NPENVLMIALVLDYANAGDLRQEIKSRAKT------NRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLC 177 (496)
T ss_pred CcccceEEEEEEeCCCCCcHHHHHHHhhcc------CCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEe
Confidence 1112478999999999999998654321 12689999999999999999999997 999999999999999
Q ss_pred CCCCeEEcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccH
Q 045798 834 NDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNL 913 (1008)
Q Consensus 834 ~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~ 913 (1008)
.++.+||+|||+++......... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.... .
T Consensus 178 ~~~~vkL~DFGls~~~~~~~~~~--~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~-----~ 250 (496)
T PTZ00283 178 SNGLVKLGDFGFSKMYAATVSDD--VGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN-----M 250 (496)
T ss_pred CCCCEEEEecccCeecccccccc--ccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC-----H
Confidence 99999999999998654322111 1223468999999999999999999999999999999999999986321 1
Q ss_pred HHHHHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 045798 914 HNFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHE 987 (1008)
Q Consensus 914 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 987 (1008)
...... .+.... ..+ ....+.++.+++.+||+.||.+||++.++++.
T Consensus 251 ~~~~~~------------~~~~~~---------~~~------~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 251 EEVMHK------------TLAGRY---------DPL------PPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred HHHHHH------------HhcCCC---------CCC------CCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 111111 000000 000 01234568999999999999999999999763
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=332.52 Aligned_cols=259 Identities=24% Similarity=0.393 Sum_probs=202.6
Q ss_pred cCCCCCceEeeccCeeEEEEEEcCCCe----EEEEEEecccc-chhhHHHHHHHHHHhhcCCCCceeeeeccccccccCC
Q 045798 684 NGFSSTHLIGVGSFGCVYKGALDEDGI----VVAIKVINLQC-EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGN 758 (1008)
Q Consensus 684 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 758 (1008)
.+|++.+.||+|+||.||+|.+..+++ .||+|+++... ....+++.+|+.+++.++||||++++++|..
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~------ 80 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT------ 80 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcC------
Confidence 469999999999999999999865554 48999987443 3445789999999999999999999999743
Q ss_pred ceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCe
Q 045798 759 DFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSG 838 (1008)
Q Consensus 759 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 838 (1008)
+..++|+||+++|+|.+++..... .+++..++.++.||+.||+|||+. +|+||||||+||+++.++.+
T Consensus 81 ~~~~~v~e~~~~g~l~~~l~~~~~---------~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~ 148 (316)
T cd05108 81 STVQLITQLMPFGCLLDYVREHKD---------NIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHV 148 (316)
T ss_pred CCceeeeecCCCCCHHHHHHhccc---------cCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcE
Confidence 236799999999999999976431 578889999999999999999997 99999999999999999999
Q ss_pred EEcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCccccCCccHHHHH
Q 045798 839 HIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT-AKKPTDVMFEGDLNLHNFA 917 (1008)
Q Consensus 839 kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-G~~pf~~~~~~~~~~~~~~ 917 (1008)
||+|||+++.......... .....++..|+|||++.+..++.++|||||||++|||++ |+.||+..... ......
T Consensus 149 kl~DfG~a~~~~~~~~~~~--~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~--~~~~~~ 224 (316)
T cd05108 149 KITDFGLAKLLGADEKEYH--AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--EISSIL 224 (316)
T ss_pred EEccccccccccCCCccee--ccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHH
Confidence 9999999986654322111 112234678999999999999999999999999999998 99998632110 011100
Q ss_pred HhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHHHHHHHH
Q 045798 918 RMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHELQSVKNI 994 (1008)
Q Consensus 918 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~i~~~ 994 (1008)
. ... ..+ ....++..+.+++.+||+.+|.+||++.+++..+.++...
T Consensus 225 ~------------~~~--------------~~~----~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~ 271 (316)
T cd05108 225 E------------KGE--------------RLP----QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 271 (316)
T ss_pred h------------CCC--------------CCC----CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcC
Confidence 0 000 000 0012344578999999999999999999999998877543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=311.35 Aligned_cols=257 Identities=25% Similarity=0.328 Sum_probs=206.5
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEecccc---chhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCc
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC---EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGND 759 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 759 (1008)
.+.|+.++.||.|.-|+||+++.+.++..+|+|++.... .....+.+.|-+|++.+.||.++.+|.. ++.++
T Consensus 76 l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~-----fet~~ 150 (459)
T KOG0610|consen 76 LRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYAS-----FETDK 150 (459)
T ss_pred HHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhhe-----eeccc
Confidence 345677899999999999999999888999999997542 3445678899999999999999999998 67888
Q ss_pred eEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeE
Q 045798 760 FKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGH 839 (1008)
Q Consensus 760 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 839 (1008)
+.|+|||||+||+|....+++... .+++..++.++..++-||+|||-. |||+|||||+||||.++|++.
T Consensus 151 ~~cl~meyCpGGdL~~LrqkQp~~--------~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIM 219 (459)
T KOG0610|consen 151 YSCLVMEYCPGGDLHSLRQKQPGK--------RFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIM 219 (459)
T ss_pred eeEEEEecCCCccHHHHHhhCCCC--------ccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEE
Confidence 899999999999999999876543 799999999999999999999998 999999999999999999999
Q ss_pred EcccCccccccccc---------------------------------C-------------------ccccccccccccc
Q 045798 840 IGDFGLARFHQEVS---------------------------------N-------------------STLSSSVGVKGTI 867 (1008)
Q Consensus 840 L~Dfg~a~~~~~~~---------------------------------~-------------------~~~~~~~~~~gt~ 867 (1008)
|+||.++....... . ........++||.
T Consensus 220 LsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGTh 299 (459)
T KOG0610|consen 220 LSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTH 299 (459)
T ss_pred eeeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCcccccccccc
Confidence 99999885321100 0 0001223467999
Q ss_pred cccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCcchhhhhcccccCchHHhhhhhhhh
Q 045798 868 GYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMALPNQVMDIVDPILRNDEEILASTDKCR 947 (1008)
Q Consensus 868 ~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~ 947 (1008)
.|.|||++.|...+.++|.|+|||++|||+.|..||....... .+..++.+.+.
T Consensus 300 EYlAPEvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~-------------Tl~NIv~~~l~------------- 353 (459)
T KOG0610|consen 300 EYLAPEVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKE-------------TLRNIVGQPLK------------- 353 (459)
T ss_pred ccccceeeecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchh-------------hHHHHhcCCCc-------------
Confidence 9999999999999999999999999999999999987432211 11122211111
Q ss_pred hccccchhHHHHHHHHHHHHhcccCcCCCCCCC----HHHHHH
Q 045798 948 RMQTGINSRLECLISMVKIGVACSMESPQDRMN----MTNVVH 986 (1008)
Q Consensus 948 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt----~~evl~ 986 (1008)
++...+.+....+||++.+..||.+|.. |.||.+
T Consensus 354 -----Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~ 391 (459)
T KOG0610|consen 354 -----FPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKR 391 (459)
T ss_pred -----CCCCCcchhHHHHHHHHHhccChhhhhccccchHHhhc
Confidence 1111134566799999999999999998 777765
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=325.60 Aligned_cols=251 Identities=33% Similarity=0.525 Sum_probs=190.5
Q ss_pred CCceEeeccCeeEEEEEEc----CCCeEEEEEEecccc-chhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceEE
Q 045798 688 STHLIGVGSFGCVYKGALD----EDGIVVAIKVINLQC-EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKA 762 (1008)
Q Consensus 688 ~~~~lg~G~~g~Vy~~~~~----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 762 (1008)
+.+.||.|.||.||+|.+. ..+..|+||+++... ....+.+.+|++.+++++||||++++|+|. ..+..+
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~-----~~~~~~ 77 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCI-----ENEPLF 77 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEE-----SSSSEE
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccc-----cccccc
Confidence 4578999999999999997 346789999996543 334688999999999999999999999975 344489
Q ss_pred EEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEcc
Q 045798 763 IVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGD 842 (1008)
Q Consensus 763 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 842 (1008)
+||||+++|+|.+++...... .+++.++..|+.||+.||+|||+. +++||||+++||++++++.+||+|
T Consensus 78 lv~e~~~~g~L~~~L~~~~~~--------~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~ 146 (259)
T PF07714_consen 78 LVMEYCPGGSLDDYLKSKNKE--------PLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSD 146 (259)
T ss_dssp EEEE--TTEBHHHHHHHTCTT--------TSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEES
T ss_pred ccccccccccccccccccccc--------cccccccccccccccccccccccc---cccccccccccccccccccccccc
Confidence 999999999999999876211 789999999999999999999998 999999999999999999999999
Q ss_pred cCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCccccCCccHHHHHHhhC
Q 045798 843 FGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT-AKKPTDVMFEGDLNLHNFARMAL 921 (1008)
Q Consensus 843 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-G~~pf~~~~~~~~~~~~~~~~~~ 921 (1008)
||++......... ...........|+|||.+.+..++.++||||||+++||+++ |+.||..... ........
T Consensus 147 f~~~~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~-----~~~~~~~~ 219 (259)
T PF07714_consen 147 FGLSRPISEKSKY--KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDN-----EEIIEKLK 219 (259)
T ss_dssp TTTGEETTTSSSE--EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCH-----HHHHHHHH
T ss_pred ccccccccccccc--cccccccccccccccccccccccccccccccccccccccccccccccccccc-----cccccccc
Confidence 9999866222111 11223347789999999988889999999999999999999 6788753311 11111000
Q ss_pred CcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHH
Q 045798 922 PNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHEL 988 (1008)
Q Consensus 922 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 988 (1008)
.. .+.. ....++..+.+++.+||+.||++|||+.+++++|
T Consensus 220 ~~-----------------------~~~~----~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 220 QG-----------------------QRLP----IPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp TT-----------------------EETT----SBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred cc-----------------------ccce----eccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 00 0000 0112455688999999999999999999999886
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=326.18 Aligned_cols=268 Identities=26% Similarity=0.393 Sum_probs=203.0
Q ss_pred CCCCceEeeccCeeEEEEEE----cCCCeEEEEEEeccccc-hhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCce
Q 045798 686 FSSTHLIGVGSFGCVYKGAL----DEDGIVVAIKVINLQCE-GASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDF 760 (1008)
Q Consensus 686 y~~~~~lg~G~~g~Vy~~~~----~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 760 (1008)
|++.+.||+|+||+||++.. ..+++.||+|+++.... .....+.+|++++++++||||++++++|.. .....
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~~~ 82 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSE---QGGKG 82 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEec---CCCce
Confidence 48899999999999988653 34678999999975432 345678899999999999999999998643 33456
Q ss_pred EEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEE
Q 045798 761 KAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHI 840 (1008)
Q Consensus 761 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 840 (1008)
.++||||+++++|.+++... .+++.+++.++.|++.|++|||+. +|+||||||+||++++++.+||
T Consensus 83 ~~lv~e~~~~~~l~~~~~~~-----------~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l 148 (283)
T cd05080 83 LQLIMEYVPLGSLRDYLPKH-----------KLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKI 148 (283)
T ss_pred EEEEecCCCCCCHHHHHHHc-----------CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEE
Confidence 89999999999999998643 689999999999999999999997 9999999999999999999999
Q ss_pred cccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHhh
Q 045798 841 GDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMA 920 (1008)
Q Consensus 841 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~~ 920 (1008)
+|||++........... ......++..|+|||.+.+..++.++||||||+++|||++|+.||...... ........
T Consensus 149 ~dfg~~~~~~~~~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~---~~~~~~~~ 224 (283)
T cd05080 149 GDFGLAKAVPEGHEYYR-VREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKK---FEEMIGPK 224 (283)
T ss_pred eecccccccCCcchhhc-cCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcch---hhhhhccc
Confidence 99999986643222110 111223567799999998888999999999999999999999997543211 00010000
Q ss_pred CCc----chhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHHHHHH
Q 045798 921 LPN----QVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHELQSVK 992 (1008)
Q Consensus 921 ~~~----~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~i~ 992 (1008)
... ...+.++.. ...+ ....++.++.+++.+||+.+|.+|||+++|++.|+++.
T Consensus 225 ~~~~~~~~~~~~~~~~----------------~~~~--~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 225 QGQMTVVRLIELLERG----------------MRLP--CPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred ccccchhhhhhhhhcC----------------CCCC--CCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 000 000111000 0000 11234567899999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=327.07 Aligned_cols=270 Identities=26% Similarity=0.411 Sum_probs=207.9
Q ss_pred cCCCCCceEeeccCeeEEEEEE-----cCCCeEEEEEEeccccchhhHHHHHHHHHHhhcCCCCceeeeeccccccccCC
Q 045798 684 NGFSSTHLIGVGSFGCVYKGAL-----DEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGN 758 (1008)
Q Consensus 684 ~~y~~~~~lg~G~~g~Vy~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 758 (1008)
++|.+.+.||+|+||.||++.. ..++..||+|.+........+.+.+|++++++++||||+++++++ ...
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~ 79 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVC-----VEG 79 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEE-----ecC
Confidence 4688999999999999999985 234567999999766556667899999999999999999999985 445
Q ss_pred ceEEEEEeccCCCChhcccccCCCCCC---CcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCC
Q 045798 759 DFKAIVYEYMPNGSLEKWLHPHAVPKR---DKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDND 835 (1008)
Q Consensus 759 ~~~~lv~e~~~~gsL~~~l~~~~~~~~---~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~ 835 (1008)
+..++||||+++++|.+++........ .......+++.+++.++.|++.||+|||+. +++||||||+||+++++
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~ 156 (288)
T cd05093 80 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGEN 156 (288)
T ss_pred CccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccC
Confidence 678999999999999999975432110 001122589999999999999999999997 99999999999999999
Q ss_pred CCeEEcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCccccCCccHH
Q 045798 836 LSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT-AKKPTDVMFEGDLNLH 914 (1008)
Q Consensus 836 ~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-G~~pf~~~~~~~~~~~ 914 (1008)
+.+||+|||.++........ .......++..|+|||++.+..++.++|||||||++|||++ |..||......+
T Consensus 157 ~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~---- 230 (288)
T cd05093 157 LLVKIGDFGMSRDVYSTDYY--RVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE---- 230 (288)
T ss_pred CcEEeccCCccccccCCcee--ecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH----
Confidence 99999999999855332211 11122335778999999998889999999999999999998 888875332110
Q ss_pred HHHHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHHHHHHHH
Q 045798 915 NFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHELQSVKNI 994 (1008)
Q Consensus 915 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~i~~~ 994 (1008)
......... .. .. ....+.++.+++.+||+.||.+|||+.||.+.|+++...
T Consensus 231 -~~~~i~~~~--------~~-------------~~------~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 231 -VIECITQGR--------VL-------------QR------PRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred -HHHHHHcCC--------cC-------------CC------CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 000000000 00 00 001345689999999999999999999999999998765
Q ss_pred H
Q 045798 995 L 995 (1008)
Q Consensus 995 ~ 995 (1008)
.
T Consensus 283 ~ 283 (288)
T cd05093 283 S 283 (288)
T ss_pred c
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=341.44 Aligned_cols=204 Identities=24% Similarity=0.323 Sum_probs=173.5
Q ss_pred cCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEecccc---chhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCce
Q 045798 684 NGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC---EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDF 760 (1008)
Q Consensus 684 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 760 (1008)
++|++.+.||+|+||.||+|....+++.||||++.... ....+.+.+|++++++++||||++++++ +.++++
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~-----~~~~~~ 75 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYS-----FQDAQY 75 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEE-----EEcCCe
Confidence 47899999999999999999999999999999986431 2334678899999999999999999998 456778
Q ss_pred EEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEE
Q 045798 761 KAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHI 840 (1008)
Q Consensus 761 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 840 (1008)
.|+||||+++|+|.+++.... .+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~~----------~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl 142 (377)
T cd05629 76 LYLIMEFLPGGDLMTMLIKYD----------TFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKL 142 (377)
T ss_pred eEEEEeCCCCCcHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEE
Confidence 999999999999999987543 688999999999999999999998 9999999999999999999999
Q ss_pred cccCcccccccccCcc-----------c--------------------------------cccccccccccccCccccCC
Q 045798 841 GDFGLARFHQEVSNST-----------L--------------------------------SSSVGVKGTIGYTAPEYGLG 877 (1008)
Q Consensus 841 ~Dfg~a~~~~~~~~~~-----------~--------------------------------~~~~~~~gt~~y~aPE~~~~ 877 (1008)
+|||+++.+....... . .......||+.|+|||++.+
T Consensus 143 ~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 222 (377)
T cd05629 143 SDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQ 222 (377)
T ss_pred eecccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHcc
Confidence 9999996432110000 0 00012459999999999999
Q ss_pred CCCCcccchhhHHHHHHHHHhCCCCCCc
Q 045798 878 SEVSTNGDVYSYGILLLEMVTAKKPTDV 905 (1008)
Q Consensus 878 ~~~~~~sDvwslG~vl~elltG~~pf~~ 905 (1008)
..++.++|||||||++|||++|..||..
T Consensus 223 ~~~~~~~DiwSlGvil~elltG~~Pf~~ 250 (377)
T cd05629 223 QGYGQECDWWSLGAIMFECLIGWPPFCS 250 (377)
T ss_pred CCCCCceeeEecchhhhhhhcCCCCCCC
Confidence 8999999999999999999999999864
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-36 Score=319.76 Aligned_cols=251 Identities=26% Similarity=0.408 Sum_probs=197.1
Q ss_pred cCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccchhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceEEE
Q 045798 684 NGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKAI 763 (1008)
Q Consensus 684 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 763 (1008)
++|++.+.||+|+||.||+|.+. ++..+|+|.+... ....+.+.+|++++++++||||+++++++ ...+..++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~i 76 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVC-----TQQKPLYI 76 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEec-cCceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEE-----ccCCCEEE
Confidence 45888999999999999999885 5678999988643 33346789999999999999999999985 44566899
Q ss_pred EEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEccc
Q 045798 764 VYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDF 843 (1008)
Q Consensus 764 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 843 (1008)
||||+++|+|.++++.... .+++..++.++.|++.||+|||+. +|+||||||+||++++++.+||+||
T Consensus 77 v~e~~~~~~L~~~~~~~~~---------~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~ 144 (256)
T cd05114 77 VTEFMENGCLLNYLRQRQG---------KLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDF 144 (256)
T ss_pred EEEcCCCCcHHHHHHhCcc---------CCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCC
Confidence 9999999999999875421 578999999999999999999997 9999999999999999999999999
Q ss_pred CcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCccccCCccHHHHHHhhCC
Q 045798 844 GLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT-AKKPTDVMFEGDLNLHNFARMALP 922 (1008)
Q Consensus 844 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-G~~pf~~~~~~~~~~~~~~~~~~~ 922 (1008)
|.++........ ......++..|+|||++.+..++.++||||||+++|||++ |+.||...... ..........
T Consensus 145 g~~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~--~~~~~i~~~~- 218 (256)
T cd05114 145 GMTRYVLDDEYT---SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNY--EVVEMISRGF- 218 (256)
T ss_pred CCccccCCCcee---ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHHHCCC-
Confidence 999755332211 1122235678999999988889999999999999999999 89998532110 0000000000
Q ss_pred cchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHH
Q 045798 923 NQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHEL 988 (1008)
Q Consensus 923 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 988 (1008)
+ .. .....+.++.+++.+||+.+|++||+++|+++.|
T Consensus 219 --------~-----------------~~----~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 219 --------R-----------------LY----RPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred --------C-----------------CC----CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 0 00 0001234579999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=321.08 Aligned_cols=258 Identities=26% Similarity=0.429 Sum_probs=203.3
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCC---CeEEEEEEecccc-chhhHHHHHHHHHHhhcCCCCceeeeeccccccccCC
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDED---GIVVAIKVINLQC-EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGN 758 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 758 (1008)
.++|++.+.||+|+||.||+|.+... ...||+|+++... ......+.+|+.++++++||||+++++.+ ...
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~ 77 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVV-----TKS 77 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEE-----ecC
Confidence 35789999999999999999998543 4689999987543 33456789999999999999999999984 456
Q ss_pred ceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCe
Q 045798 759 DFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSG 838 (1008)
Q Consensus 759 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 838 (1008)
+..++||||+++++|.+++..... .+++..++.++.|++.|++|||++ +|+||||||+||++++++.+
T Consensus 78 ~~~~iv~e~~~~~~L~~~~~~~~~---------~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~ 145 (266)
T cd05033 78 RPVMIITEYMENGSLDKFLRENDG---------KFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVC 145 (266)
T ss_pred CceEEEEEcCCCCCHHHHHHhccC---------CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCE
Confidence 678999999999999999875431 688999999999999999999997 99999999999999999999
Q ss_pred EEcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCccccCCccHHHHH
Q 045798 839 HIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT-AKKPTDVMFEGDLNLHNFA 917 (1008)
Q Consensus 839 kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-G~~pf~~~~~~~~~~~~~~ 917 (1008)
+|+|||+++.......... .....++..|+|||.+.+..++.++||||||+++|||++ |..||...... ......
T Consensus 146 ~l~dfg~~~~~~~~~~~~~--~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~--~~~~~~ 221 (266)
T cd05033 146 KVSDFGLSRRLEDSEATYT--TKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ--DVIKAV 221 (266)
T ss_pred EECccchhhccccccccee--ccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH--HHHHHH
Confidence 9999999987652221111 112235678999999998899999999999999999998 99998532110 000000
Q ss_pred HhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHHHHH
Q 045798 918 RMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHELQSV 991 (1008)
Q Consensus 918 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~i 991 (1008)
... .. . +....++..+.+++.+||+.+|++||+++||++.|+++
T Consensus 222 ~~~------------~~--------------~----~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 222 EDG------------YR--------------L----PPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred HcC------------CC--------------C----CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 000 00 0 00112455689999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=324.75 Aligned_cols=257 Identities=31% Similarity=0.453 Sum_probs=206.3
Q ss_pred HhcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccchhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceE
Q 045798 682 ATNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFK 761 (1008)
Q Consensus 682 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 761 (1008)
...+|++.++||+|+||.||+|.+.. ++.||+|++..........+.+|+++++.++|+||+++++++ ...+..
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~ 77 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVC-----SVGEPV 77 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeE-----ecCCCe
Confidence 34578999999999999999999975 899999999866555567899999999999999999999985 455678
Q ss_pred EEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEc
Q 045798 762 AIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIG 841 (1008)
Q Consensus 762 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 841 (1008)
++||||+++++|.+++...... .+++.+++.++.|++.|++|||+. +|+||||+|+||++++++.+||+
T Consensus 78 ~lv~e~~~~~~L~~~~~~~~~~--------~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~ 146 (261)
T cd05148 78 YIITELMEKGSLLAFLRSPEGQ--------VLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVA 146 (261)
T ss_pred EEEEeecccCCHHHHHhcCCCC--------CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEc
Confidence 9999999999999999764321 689999999999999999999997 99999999999999999999999
Q ss_pred ccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCccccCCccHHHHHHhh
Q 045798 842 DFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT-AKKPTDVMFEGDLNLHNFARMA 920 (1008)
Q Consensus 842 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-G~~pf~~~~~~~~~~~~~~~~~ 920 (1008)
|||.+......... .....++..|+|||.+.+..++.++||||||+++|+|++ |+.||...... .......
T Consensus 147 d~g~~~~~~~~~~~----~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~--~~~~~~~-- 218 (261)
T cd05148 147 DFGLARLIKEDVYL----SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNH--EVYDQIT-- 218 (261)
T ss_pred cccchhhcCCcccc----ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHH--HHHHHHH--
Confidence 99999865432211 112336778999999988889999999999999999998 89998532110 0000000
Q ss_pred CCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHHHHH
Q 045798 921 LPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHELQSV 991 (1008)
Q Consensus 921 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~i 991 (1008)
.... . +....++..+.+++.+||+.||.+|||++++++.|+.+
T Consensus 219 ----------~~~~----------------~--~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 219 ----------AGYR----------------M--PCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred ----------hCCc----------------C--CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 0000 0 00113456688999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=341.36 Aligned_cols=203 Identities=25% Similarity=0.324 Sum_probs=172.8
Q ss_pred CCCCCceEeeccCeeEEEEEEcCCCeEEEEEEecccc---chhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceE
Q 045798 685 GFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC---EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFK 761 (1008)
Q Consensus 685 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 761 (1008)
.|++++.||+|+||.||+|+...+++.||+|++.... ....+.+.+|++++++++||||+++++++ .+++..
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~-----~~~~~~ 76 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSF-----QDKDNL 76 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEE-----EeCCEE
Confidence 5889999999999999999999899999999987432 23346788999999999999999999984 566789
Q ss_pred EEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEc
Q 045798 762 AIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIG 841 (1008)
Q Consensus 762 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 841 (1008)
|+||||+++|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+
T Consensus 77 ~lv~E~~~gg~L~~~l~~~~----------~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~ 143 (382)
T cd05625 77 YFVMDYIPGGDMMSLLIRMG----------IFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLT 143 (382)
T ss_pred EEEEeCCCCCcHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEe
Confidence 99999999999999987543 678899999999999999999998 99999999999999999999999
Q ss_pred ccCcccccccccCc-------------------------------------------cccccccccccccccCccccCCC
Q 045798 842 DFGLARFHQEVSNS-------------------------------------------TLSSSVGVKGTIGYTAPEYGLGS 878 (1008)
Q Consensus 842 Dfg~a~~~~~~~~~-------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~ 878 (1008)
|||++......... .........||+.|+|||++.+.
T Consensus 144 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~ 223 (382)
T cd05625 144 DFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRT 223 (382)
T ss_pred ECCCCccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCC
Confidence 99997533210000 00001224689999999999999
Q ss_pred CCCcccchhhHHHHHHHHHhCCCCCCc
Q 045798 879 EVSTNGDVYSYGILLLEMVTAKKPTDV 905 (1008)
Q Consensus 879 ~~~~~sDvwslG~vl~elltG~~pf~~ 905 (1008)
.++.++||||+||++|||++|+.||..
T Consensus 224 ~~~~~~DiwSlGvil~elltG~~Pf~~ 250 (382)
T cd05625 224 GYTQLCDWWSVGVILYEMLVGQPPFLA 250 (382)
T ss_pred CCCCeeeEEechHHHHHHHhCCCCCCC
Confidence 999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=331.24 Aligned_cols=241 Identities=24% Similarity=0.333 Sum_probs=188.6
Q ss_pred ceEeeccCeeEEEEEEcCCCeEEEEEEecccc---chhhHHHHHHHHHHhhc-CCCCceeeeeccccccccCCceEEEEE
Q 045798 690 HLIGVGSFGCVYKGALDEDGIVVAIKVINLQC---EGASKSFMAECKALKNI-RHRNLVKVITSCSSIDFQGNDFKAIVY 765 (1008)
Q Consensus 690 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~ 765 (1008)
+.||+|+||.||+|.+..+++.||+|+++... ....+.+..|..++... +||||++++++ +..++..++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~-----~~~~~~~~lv~ 75 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCT-----FQTKEHLFFVM 75 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeE-----EEcCCEEEEEE
Confidence 46999999999999998899999999997432 23344566677777655 89999999988 45567799999
Q ss_pred eccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEcccCc
Q 045798 766 EYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGL 845 (1008)
Q Consensus 766 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~ 845 (1008)
||+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 76 e~~~gg~L~~~~~~~~----------~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~ 142 (316)
T cd05592 76 EYLNGGDLMFHIQSSG----------RFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGM 142 (316)
T ss_pred cCCCCCcHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcC
Confidence 9999999999987543 688999999999999999999997 999999999999999999999999999
Q ss_pred ccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCcch
Q 045798 846 ARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMALPNQV 925 (1008)
Q Consensus 846 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~ 925 (1008)
++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ........
T Consensus 143 a~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~-----~~~~~~i~---- 209 (316)
T cd05592 143 CKENMNGEG----KASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDE-----DELFDSIL---- 209 (316)
T ss_pred CeECCCCCC----ccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCH-----HHHHHHHH----
Confidence 975432221 12234589999999999998999999999999999999999999864211 00100000
Q ss_pred hhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHH-HHH
Q 045798 926 MDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMT-NVV 985 (1008)
Q Consensus 926 ~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~-evl 985 (1008)
... ..++ ...+.++.+++.+||+.||.+||++. +++
T Consensus 210 --------~~~----------~~~~------~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05592 210 --------NDR----------PHFP------RWISKEAKDCLSKLFERDPTKRLGVDGDIR 246 (316)
T ss_pred --------cCC----------CCCC------CCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 000 0000 11334568999999999999999975 443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=336.10 Aligned_cols=244 Identities=24% Similarity=0.312 Sum_probs=193.3
Q ss_pred ceEeeccCeeEEEEEEcCCCeEEEEEEecccc---chhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceEEEEEe
Q 045798 690 HLIGVGSFGCVYKGALDEDGIVVAIKVINLQC---EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKAIVYE 766 (1008)
Q Consensus 690 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 766 (1008)
+.||+|+||.||+|.+..+++.||+|+++... ......+.+|+++++.++||||++++++ +...+..|+|||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~-----~~~~~~~~lv~E 75 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYS-----FQTHDRLCFVME 75 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEE-----EEcCCEEEEEEe
Confidence 46999999999999998899999999997432 2334567889999999999999999988 456678999999
Q ss_pred ccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEcccCcc
Q 045798 767 YMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLA 846 (1008)
Q Consensus 767 ~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a 846 (1008)
|+++|+|..++.... .+++..+..++.||+.||+|||+. ++|+||||||+||+++.++.+||+|||++
T Consensus 76 ~~~~~~L~~~l~~~~----------~l~~~~~~~~~~qi~~aL~~lH~~--~~ivHrDikp~NIll~~~~~~kL~Dfg~~ 143 (325)
T cd05594 76 YANGGELFFHLSRER----------VFSEDRARFYGAEIVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLC 143 (325)
T ss_pred CCCCCcHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCCCCeEEECCCCCEEEecCCCC
Confidence 999999999886543 689999999999999999999972 29999999999999999999999999998
Q ss_pred cccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCcchh
Q 045798 847 RFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMALPNQVM 926 (1008)
Q Consensus 847 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 926 (1008)
+........ .....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ..........
T Consensus 144 ~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~-----~~~~~~i~~~--- 211 (325)
T cd05594 144 KEGIKDGAT----MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-----EKLFELILME--- 211 (325)
T ss_pred eecCCCCcc----cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCH-----HHHHHHHhcC---
Confidence 743222111 1234589999999999999999999999999999999999999853211 0000000000
Q ss_pred hhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCC-----CHHHHHHH
Q 045798 927 DIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRM-----NMTNVVHE 987 (1008)
Q Consensus 927 ~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~ 987 (1008)
. ..++ ...+.++.+++.+||+.||++|+ ++.++++.
T Consensus 212 ---------~----------~~~p------~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 212 ---------E----------IRFP------RTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred ---------C----------CCCC------CCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 0 0000 11344578999999999999996 89988753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=323.23 Aligned_cols=255 Identities=21% Similarity=0.286 Sum_probs=200.3
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccchhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceEE
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKA 762 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 762 (1008)
.++|++.+.||+|+||.||+|....+++.||+|+++.........+.+|+.++++++||||+++++++ ..++..+
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~-----~~~~~~~ 82 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSY-----LSREKLW 82 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEE-----EeCCEEE
Confidence 35799999999999999999999889999999999765445556788999999999999999999985 4556789
Q ss_pred EEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEcc
Q 045798 763 IVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGD 842 (1008)
Q Consensus 763 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 842 (1008)
+||||+++++|.++++... .+++..+..++.|++.|++|||+. +|+|||++|+||+++.++.+||+|
T Consensus 83 iv~e~~~~~~L~~~~~~~~----------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~d 149 (267)
T cd06646 83 ICMEYCGGGSLQDIYHVTG----------PLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLAD 149 (267)
T ss_pred EEEeCCCCCcHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECc
Confidence 9999999999999986543 678999999999999999999997 999999999999999999999999
Q ss_pred cCcccccccccCccccccccccccccccCccccC---CCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHh
Q 045798 843 FGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGL---GSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARM 919 (1008)
Q Consensus 843 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~ 919 (1008)
||++......... .....++..|+|||.+. ...++.++|||||||++|||++|+.||......... ....
T Consensus 150 fg~~~~~~~~~~~----~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~-~~~~-- 222 (267)
T cd06646 150 FGVAAKITATIAK----RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL-FLMS-- 222 (267)
T ss_pred Cccceeecccccc----cCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhh-eeee--
Confidence 9999865432111 12245888999999874 345788999999999999999999998532111000 0000
Q ss_pred hCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 045798 920 ALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHE 987 (1008)
Q Consensus 920 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 987 (1008)
..... ++........+..+.+++.+||+.+|++|||++++++.
T Consensus 223 ----------~~~~~---------------~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 265 (267)
T cd06646 223 ----------KSNFQ---------------PPKLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTH 265 (267)
T ss_pred ----------cCCCC---------------CCCCccccccCHHHHHHHHHHhhCChhhCcCHHHHhcC
Confidence 00000 00000011234568899999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=333.03 Aligned_cols=242 Identities=24% Similarity=0.298 Sum_probs=191.3
Q ss_pred CCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccc---cchhhHHHHHHHHHHhhcCCC-CceeeeeccccccccCCce
Q 045798 685 GFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQ---CEGASKSFMAECKALKNIRHR-NLVKVITSCSSIDFQGNDF 760 (1008)
Q Consensus 685 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~-niv~~~~~~~~~~~~~~~~ 760 (1008)
+|++.+.||+|+||.||+|.+..+++.||+|+++.. .....+.+..|++++..+.|+ +|++++++ +...+.
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~-----~~~~~~ 75 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSC-----FQTMDR 75 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEE-----EEcCCE
Confidence 488899999999999999999888999999999743 234456788899999999765 57778777 455677
Q ss_pred EEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEE
Q 045798 761 KAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHI 840 (1008)
Q Consensus 761 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 840 (1008)
.|+||||+++|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||
T Consensus 76 ~~lv~E~~~~g~L~~~~~~~~----------~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL 142 (324)
T cd05587 76 LYFVMEYVNGGDLMYHIQQVG----------KFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKI 142 (324)
T ss_pred EEEEEcCCCCCcHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEE
Confidence 999999999999999986543 678999999999999999999997 9999999999999999999999
Q ss_pred cccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHhh
Q 045798 841 GDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMA 920 (1008)
Q Consensus 841 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~~ 920 (1008)
+|||++........ ......||+.|+|||++.+..++.++||||+||++|||++|+.||...... .....
T Consensus 143 ~Dfg~~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~-----~~~~~- 212 (324)
T cd05587 143 ADFGMCKENIFGGK----TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED-----ELFQS- 212 (324)
T ss_pred eecCcceecCCCCC----ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH-----HHHHH-
Confidence 99999874322111 112345899999999999999999999999999999999999998643110 00000
Q ss_pred CCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCH
Q 045798 921 LPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNM 981 (1008)
Q Consensus 921 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~ 981 (1008)
+..... .++ ...+.++.+++.+||+.||.+|+++
T Consensus 213 -------i~~~~~--------------~~~------~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 213 -------IMEHNV--------------SYP------KSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred -------HHcCCC--------------CCC------CCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 000000 000 0123457899999999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=324.17 Aligned_cols=253 Identities=25% Similarity=0.288 Sum_probs=198.6
Q ss_pred CCCCCceEeeccCeeEEEEEEcCCCeEEEEEEecccc---chhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceE
Q 045798 685 GFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC---EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFK 761 (1008)
Q Consensus 685 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 761 (1008)
+|++.+.||+|+||+||++.+..+++.||+|++.... ......+.+|++++++++||||+++++++ ..++..
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~ 75 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAY-----ETKDAL 75 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeee-----cCCCeE
Confidence 4788999999999999999998889999999986432 22235678899999999999999999984 455679
Q ss_pred EEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEc
Q 045798 762 AIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIG 841 (1008)
Q Consensus 762 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 841 (1008)
++||||+++|+|.+++...... .+++..+..++.|++.||+|||+. +++||||||+||++++++.++|+
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~ 144 (285)
T cd05605 76 CLVLTLMNGGDLKFHIYNMGNP--------GFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRIS 144 (285)
T ss_pred EEEEeccCCCcHHHHHHhcCcC--------CCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEe
Confidence 9999999999999888643211 689999999999999999999997 99999999999999999999999
Q ss_pred ccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHhhC
Q 045798 842 DFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMAL 921 (1008)
Q Consensus 842 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~~~ 921 (1008)
|||++........ .....|+..|+|||++.+..++.++||||+||++|||++|+.||....... ....... .
T Consensus 145 Dfg~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~-~~~~~~~-~- 216 (285)
T cd05605 145 DLGLAVEIPEGET-----IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKV-KREEVER-R- 216 (285)
T ss_pred eCCCceecCCCCc-----cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhh-HHHHHHH-H-
Confidence 9999986533221 122358999999999998889999999999999999999999986421110 0000000 0
Q ss_pred CcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCC-----CHHHHHHH
Q 045798 922 PNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRM-----NMTNVVHE 987 (1008)
Q Consensus 922 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~ 987 (1008)
+... +. ......+..+.+++.+||+.||++|| +++++++.
T Consensus 217 -------~~~~-----------------~~--~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 217 -------VKED-----------------QE--EYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred -------hhhc-----------------cc--ccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 0000 00 00112455678999999999999999 78888653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=338.45 Aligned_cols=281 Identities=21% Similarity=0.234 Sum_probs=200.4
Q ss_pred CCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccc--cchhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceEE
Q 045798 685 GFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQ--CEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKA 762 (1008)
Q Consensus 685 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 762 (1008)
+|++.+.||+|+||.||+|.+..+++.||+|++... .....+++.+|+++++.++|+||+++++++...........|
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 478899999999999999999889999999998643 223446789999999999999999999986543322223689
Q ss_pred EEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEcc
Q 045798 763 IVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGD 842 (1008)
Q Consensus 763 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 842 (1008)
+||||+. ++|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|
T Consensus 81 lv~e~~~-~~l~~~~~~~~----------~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~D 146 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSPQ----------PLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICD 146 (372)
T ss_pred EEeeccc-cCHHHHHhcCC----------CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEecc
Confidence 9999995 68888775443 689999999999999999999998 999999999999999999999999
Q ss_pred cCcccccccccCccccccccccccccccCccccCCC-CCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHhhC
Q 045798 843 FGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGS-EVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMAL 921 (1008)
Q Consensus 843 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~~~ 921 (1008)
||+++........ ......++..|+|||++.+. .++.++||||+||++|||++|+.||...... ...........
T Consensus 147 fg~a~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~i~~~~g 222 (372)
T cd07853 147 FGLARVEEPDESK---HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPI-QQLDLITDLLG 222 (372)
T ss_pred ccceeecccCccc---cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHH-HHHHHHHHHcC
Confidence 9999865432211 11223578999999998774 4789999999999999999999998643211 11111111111
Q ss_pred CcchhhhhcccccCchHHhhhhhhhhhccccc----hhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 045798 922 PNQVMDIVDPILRNDEEILASTDKCRRMQTGI----NSRLECLISMVKIGVACSMESPQDRMNMTNVVHE 987 (1008)
Q Consensus 922 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 987 (1008)
.....++.. ... ............++.. ....+.+.++.+++.+|++.||++|||+.|+++.
T Consensus 223 ~~~~~~~~~-~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 223 TPSLEAMRS-ACE---GARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred CCCHHHHHH-hhH---HHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 111100000 000 0000000000000000 0011235568899999999999999999999863
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=332.67 Aligned_cols=237 Identities=26% Similarity=0.326 Sum_probs=189.1
Q ss_pred ceEeeccCeeEEEEEEcCCCeEEEEEEeccc---cchhhHHHHHHHHHHhhc-CCCCceeeeeccccccccCCceEEEEE
Q 045798 690 HLIGVGSFGCVYKGALDEDGIVVAIKVINLQ---CEGASKSFMAECKALKNI-RHRNLVKVITSCSSIDFQGNDFKAIVY 765 (1008)
Q Consensus 690 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~ 765 (1008)
+.||+|+||.||+|++..+++.||+|+++.. .....+.+..|.+++..+ +||||++++++ +...+..|+||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~-----~~~~~~~~iv~ 75 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCC-----FQTPDRLFFVM 75 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeE-----EEcCCEEEEEE
Confidence 4699999999999999889999999998743 233456678888888877 79999999998 45667899999
Q ss_pred eccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEcccCc
Q 045798 766 EYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGL 845 (1008)
Q Consensus 766 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~ 845 (1008)
||+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 76 Ey~~~g~L~~~i~~~~----------~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~ 142 (320)
T cd05590 76 EFVNGGDLMFHIQKSR----------RFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGM 142 (320)
T ss_pred cCCCCchHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCC
Confidence 9999999999887654 688999999999999999999997 999999999999999999999999999
Q ss_pred ccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCcch
Q 045798 846 ARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMALPNQV 925 (1008)
Q Consensus 846 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~ 925 (1008)
++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ........
T Consensus 143 ~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~-----~~~~~~i~---- 209 (320)
T cd05590 143 CKEGIFNGK----TTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENE-----DDLFEAIL---- 209 (320)
T ss_pred CeecCcCCC----cccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH-----HHHHHHHh----
Confidence 874322111 12234589999999999998999999999999999999999999864211 01110000
Q ss_pred hhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCH
Q 045798 926 MDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNM 981 (1008)
Q Consensus 926 ~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~ 981 (1008)
.... ..+ ...+.++.+++.+|++.||++||++
T Consensus 210 --------~~~~----------~~~------~~~~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 210 --------NDEV----------VYP------TWLSQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred --------cCCC----------CCC------CCCCHHHHHHHHHHcccCHHHCCCC
Confidence 0000 000 0134457899999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=342.26 Aligned_cols=204 Identities=26% Similarity=0.336 Sum_probs=173.4
Q ss_pred cCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEecccc---chhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCce
Q 045798 684 NGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC---EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDF 760 (1008)
Q Consensus 684 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 760 (1008)
++|++++.||+|+||.||+|+...+++.||+|++.... ......+.+|++++++++|+||+++++. +.+++.
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~-----~~~~~~ 75 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYS-----FQDKDN 75 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEE-----EEcCCE
Confidence 36999999999999999999999899999999986432 2234568899999999999999999998 456778
Q ss_pred EEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEE
Q 045798 761 KAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHI 840 (1008)
Q Consensus 761 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 840 (1008)
.++||||+++|+|.+++...+ .+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||
T Consensus 76 ~~lv~E~~~~g~L~~~i~~~~----------~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL 142 (376)
T cd05598 76 LYFVMDYIPGGDMMSLLIRLG----------IFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKL 142 (376)
T ss_pred EEEEEeCCCCCcHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEE
Confidence 999999999999999997653 678889999999999999999998 9999999999999999999999
Q ss_pred cccCcccccccccCc---------------------------------------cccccccccccccccCccccCCCCCC
Q 045798 841 GDFGLARFHQEVSNS---------------------------------------TLSSSVGVKGTIGYTAPEYGLGSEVS 881 (1008)
Q Consensus 841 ~Dfg~a~~~~~~~~~---------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~ 881 (1008)
+|||+|..+...... .........||+.|+|||++.+..++
T Consensus 143 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 222 (376)
T cd05598 143 TDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYT 222 (376)
T ss_pred EeCCCCccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCC
Confidence 999998533110000 00001134699999999999999999
Q ss_pred cccchhhHHHHHHHHHhCCCCCCc
Q 045798 882 TNGDVYSYGILLLEMVTAKKPTDV 905 (1008)
Q Consensus 882 ~~sDvwslG~vl~elltG~~pf~~ 905 (1008)
.++|||||||++|||++|+.||..
T Consensus 223 ~~~DiwSlGvilyell~G~~Pf~~ 246 (376)
T cd05598 223 QLCDWWSVGVILYEMLVGQPPFLA 246 (376)
T ss_pred cceeeeeccceeeehhhCCCCCCC
Confidence 999999999999999999999864
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=324.64 Aligned_cols=266 Identities=23% Similarity=0.379 Sum_probs=201.7
Q ss_pred HhcCCCCCceEeeccCeeEEEEEEc-----CCCeEEEEEEecccc-chhhHHHHHHHHHHhhcCCCCceeeeeccccccc
Q 045798 682 ATNGFSSTHLIGVGSFGCVYKGALD-----EDGIVVAIKVINLQC-EGASKSFMAECKALKNIRHRNLVKVITSCSSIDF 755 (1008)
Q Consensus 682 ~~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 755 (1008)
+.++|++.+.||+|+||.||+|.+. ..++.||+|+++... ......+.+|+.+++.++||||+++++++
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~----- 78 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV----- 78 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEE-----
Confidence 4578999999999999999999864 235789999986432 23445789999999999999999999985
Q ss_pred cCCceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCC
Q 045798 756 QGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDND 835 (1008)
Q Consensus 756 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~ 835 (1008)
..+...++||||+++++|.+++...............+++..++.++.|++.|++|||+. +++||||||+||+++++
T Consensus 79 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~ 155 (277)
T cd05062 79 SQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAED 155 (277)
T ss_pred cCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCC
Confidence 455678999999999999999875432111111122578889999999999999999997 99999999999999999
Q ss_pred CCeEEcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCccccCCccHH
Q 045798 836 LSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT-AKKPTDVMFEGDLNLH 914 (1008)
Q Consensus 836 ~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-G~~pf~~~~~~~~~~~ 914 (1008)
+.++|+|||++.......... ......++..|+|||++.+..++.++|||||||++|||++ |..||..... .
T Consensus 156 ~~~~l~dfg~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~-----~ 228 (277)
T cd05062 156 FTVKIGDFGMTRDIYETDYYR--KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN-----E 228 (277)
T ss_pred CCEEECCCCCccccCCcceee--cCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH-----H
Confidence 999999999987543322211 1112235788999999998889999999999999999999 6888753211 1
Q ss_pred HHHHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHHH
Q 045798 915 NFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHELQ 989 (1008)
Q Consensus 915 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 989 (1008)
....... ...... ....++..+.+++.+||+.||++|||+.|+++.|+
T Consensus 229 ~~~~~~~--------~~~~~~-------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 229 QVLRFVM--------EGGLLD-------------------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred HHHHHHH--------cCCcCC-------------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 1111000 000000 00123456899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=339.03 Aligned_cols=255 Identities=22% Similarity=0.280 Sum_probs=199.3
Q ss_pred HhcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccc---cchhhHHHHHHHHHHhhcCCCCceeeeeccccccccCC
Q 045798 682 ATNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQ---CEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGN 758 (1008)
Q Consensus 682 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 758 (1008)
..++|++.+.||+|+||.||+|+...+++.||+|+++.. .....+.+.+|+.+++.++||||++++++ +.++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~-----~~~~ 115 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYA-----FQDD 115 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEE-----EecC
Confidence 356799999999999999999999989999999999642 12334567899999999999999999988 4567
Q ss_pred ceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCe
Q 045798 759 DFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSG 838 (1008)
Q Consensus 759 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 838 (1008)
+..++||||+++|+|.+++... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+
T Consensus 116 ~~~~lv~Ey~~gg~L~~~l~~~-----------~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~ 181 (370)
T cd05596 116 KYLYMVMEYMPGGDLVNLMSNY-----------DIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHL 181 (370)
T ss_pred CEEEEEEcCCCCCcHHHHHHhc-----------CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCE
Confidence 7899999999999999998643 578888999999999999999997 99999999999999999999
Q ss_pred EEcccCcccccccccCccccccccccccccccCccccCCC----CCCcccchhhHHHHHHHHHhCCCCCCccccCCccHH
Q 045798 839 HIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGS----EVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLH 914 (1008)
Q Consensus 839 kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~ 914 (1008)
||+|||.+......... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||..... ..
T Consensus 182 kL~DfG~~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~----~~ 254 (370)
T cd05596 182 KLADFGTCMKMDANGMV---RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL----VG 254 (370)
T ss_pred EEEeccceeeccCCCcc---cCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCH----HH
Confidence 99999999865432211 11234589999999987653 478899999999999999999999864211 00
Q ss_pred HHHHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCC--CCCHHHHHHH
Q 045798 915 NFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQD--RMNMTNVVHE 987 (1008)
Q Consensus 915 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~evl~~ 987 (1008)
.+.. +.+.. . ....+.....+.++.+++.+|++.+|++ |||++|+++.
T Consensus 255 ~~~~---------i~~~~----~------------~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 255 TYSK---------IMDHK----N------------SLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred HHHH---------HHcCC----C------------cCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 1100 00000 0 0000011123456789999999999988 9999999764
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=333.04 Aligned_cols=243 Identities=27% Similarity=0.337 Sum_probs=192.3
Q ss_pred ceEeeccCeeEEEEEEcCCCeEEEEEEecccc---chhhHHHHHHHHHHhhc-CCCCceeeeeccccccccCCceEEEEE
Q 045798 690 HLIGVGSFGCVYKGALDEDGIVVAIKVINLQC---EGASKSFMAECKALKNI-RHRNLVKVITSCSSIDFQGNDFKAIVY 765 (1008)
Q Consensus 690 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~ 765 (1008)
+.||+|+||.||+|++..+++.||+|+++... ....+.+..|.+++..+ +||+|++++++ +..++..|+||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~-----~~~~~~~~lv~ 75 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCC-----FQTKDRLFFVM 75 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeE-----EEcCCeEEEEE
Confidence 46999999999999998889999999987432 33445678899998876 89999999998 45667799999
Q ss_pred eccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEcccCc
Q 045798 766 EYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGL 845 (1008)
Q Consensus 766 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~ 845 (1008)
||+++|+|..++.... .+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 76 E~~~~~~L~~~l~~~~----------~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~ 142 (321)
T cd05591 76 EYVNGGDLMFQIQRSR----------KFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGM 142 (321)
T ss_pred eCCCCCcHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeeccc
Confidence 9999999999887553 688999999999999999999998 999999999999999999999999999
Q ss_pred ccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCcch
Q 045798 846 ARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMALPNQV 925 (1008)
Q Consensus 846 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~ 925 (1008)
+......... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...... ....
T Consensus 143 ~~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~-----~~~~------- 206 (321)
T cd05591 143 CKEGILNGVT----TTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNED-----DLFE------- 206 (321)
T ss_pred ceecccCCcc----ccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHH-----HHHH-------
Confidence 8753322111 12345899999999999889999999999999999999999998643211 0000
Q ss_pred hhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCC-------CHHHHHHH
Q 045798 926 MDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRM-------NMTNVVHE 987 (1008)
Q Consensus 926 ~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-------t~~evl~~ 987 (1008)
....... ..+ ...+.++.+++.+||+.||++|| +++++++.
T Consensus 207 -----~i~~~~~----------~~p------~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 207 -----SILHDDV----------LYP------VWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred -----HHHcCCC----------CCC------CCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 0000000 000 01234578999999999999999 77777653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=336.64 Aligned_cols=255 Identities=22% Similarity=0.280 Sum_probs=197.4
Q ss_pred HhcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccc---cchhhHHHHHHHHHHhhcCCCCceeeeeccccccccCC
Q 045798 682 ATNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQ---CEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGN 758 (1008)
Q Consensus 682 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 758 (1008)
..++|++.+.||+|+||.||+|++..+++.||+|++... .....+.+.+|+.+++.++||||++++++ +.++
T Consensus 41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~-----~~~~ 115 (370)
T cd05621 41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCA-----FQDD 115 (370)
T ss_pred CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEE-----EEcC
Confidence 457899999999999999999999989999999998632 12334568899999999999999999998 4567
Q ss_pred ceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCe
Q 045798 759 DFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSG 838 (1008)
Q Consensus 759 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 838 (1008)
+..|+||||+++|+|.+++... .+++..+..++.||+.||+|||+. +|+||||||+|||+++++.+
T Consensus 116 ~~~~lv~Ey~~gg~L~~~l~~~-----------~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~ 181 (370)
T cd05621 116 KYLYMVMEYMPGGDLVNLMSNY-----------DVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHL 181 (370)
T ss_pred CEEEEEEcCCCCCcHHHHHHhc-----------CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCE
Confidence 7899999999999999998643 578889999999999999999998 99999999999999999999
Q ss_pred EEcccCcccccccccCccccccccccccccccCccccCCC----CCCcccchhhHHHHHHHHHhCCCCCCccccCCccHH
Q 045798 839 HIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGS----EVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLH 914 (1008)
Q Consensus 839 kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~ 914 (1008)
||+|||+|......... ......||+.|+|||++.+. .++.++||||+||++|||++|+.||..... ..
T Consensus 182 kL~DFG~a~~~~~~~~~---~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~----~~ 254 (370)
T cd05621 182 KLADFGTCMKMDETGMV---RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSL----VG 254 (370)
T ss_pred EEEecccceecccCCce---ecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCH----HH
Confidence 99999999865432211 11234699999999998654 378899999999999999999999863211 00
Q ss_pred HHHHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCC--CCCHHHHHHH
Q 045798 915 NFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQD--RMNMTNVVHE 987 (1008)
Q Consensus 915 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~evl~~ 987 (1008)
.+. .+.+.... ...+.....+..+.+++..|++.+|.+ |||++|+++.
T Consensus 255 ~~~---------~i~~~~~~----------------~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 255 TYS---------KIMDHKNS----------------LNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred HHH---------HHHhCCcc----------------cCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 110 01100000 000011123455678888899755543 8899998875
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=318.08 Aligned_cols=262 Identities=24% Similarity=0.340 Sum_probs=207.2
Q ss_pred cCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccc---cchhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCce
Q 045798 684 NGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQ---CEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDF 760 (1008)
Q Consensus 684 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 760 (1008)
++|++.+.||+|+||.||+|....+++.||+|.++.. .....+.+.+|++++++++|++++++++++ ..++.
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~-----~~~~~ 76 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASF-----IENNE 76 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeee-----ecCCe
Confidence 5799999999999999999999889999999988632 223456899999999999999999999985 44567
Q ss_pred EEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEE
Q 045798 761 KAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHI 840 (1008)
Q Consensus 761 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 840 (1008)
.++||||+++++|.+++...... ...+++.+++.++.|++.|++|||+. +|+||||+|+||+++.++.++|
T Consensus 77 ~~lv~e~~~~~~L~~~l~~~~~~------~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l 147 (267)
T cd08224 77 LNIVLELADAGDLSRMIKHFKKQ------KRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKL 147 (267)
T ss_pred EEEEEecCCCCCHHHHHHHhccc------CCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEE
Confidence 89999999999999998643211 11688999999999999999999998 9999999999999999999999
Q ss_pred cccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHhh
Q 045798 841 GDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMA 920 (1008)
Q Consensus 841 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~~ 920 (1008)
+|||.+......... .....++..|+|||.+.+..++.++|||||||++|+|++|+.||.... ..........
T Consensus 148 ~d~~~~~~~~~~~~~----~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~~~~~~~~ 220 (267)
T cd08224 148 GDLGLGRFFSSKTTA----AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK---MNLYSLCKKI 220 (267)
T ss_pred eccceeeeccCCCcc----cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCC---ccHHHHHhhh
Confidence 999998755432211 122347889999999988889999999999999999999999985321 1111111000
Q ss_pred CCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHHHHHH
Q 045798 921 LPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHELQSVK 992 (1008)
Q Consensus 921 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~i~ 992 (1008)
. .... +.. .....+..+.+++.+||..+|++|||+.+|+++|+++.
T Consensus 221 ~--------~~~~-----------------~~~-~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 221 E--------KCDY-----------------PPL-PADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred h--------cCCC-----------------CCC-ChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 0 0000 000 01134556889999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=333.46 Aligned_cols=204 Identities=26% Similarity=0.289 Sum_probs=170.6
Q ss_pred HhcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccc--cchhhHHHHHHHHHHhhcCCCCceeeeecccccc-ccCC
Q 045798 682 ATNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQ--CEGASKSFMAECKALKNIRHRNLVKVITSCSSID-FQGN 758 (1008)
Q Consensus 682 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~~ 758 (1008)
..++|++.+.||+|+||.||+|.+..+++.||+|++... .......+.+|+.+++.++||||+++++++.... ....
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 357899999999999999999999889999999998643 2344567889999999999999999999865322 1223
Q ss_pred ceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCe
Q 045798 759 DFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSG 838 (1008)
Q Consensus 759 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 838 (1008)
...|+||||++ +++.+.+.. .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+
T Consensus 99 ~~~~lv~e~~~-~~l~~~~~~------------~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~ 162 (359)
T cd07876 99 QDVYLVMELMD-ANLCQVIHM------------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTL 162 (359)
T ss_pred ceeEEEEeCCC-cCHHHHHhc------------cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCE
Confidence 45799999995 567666532 478888999999999999999998 99999999999999999999
Q ss_pred EEcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCcc
Q 045798 839 HIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVM 906 (1008)
Q Consensus 839 kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~ 906 (1008)
||+|||+++....... .....||..|+|||++.+..++.++||||+||++|+|++|+.||...
T Consensus 163 kl~Dfg~a~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~ 225 (359)
T cd07876 163 KILDFGLARTACTNFM-----MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGT 225 (359)
T ss_pred EEecCCCccccccCcc-----CCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence 9999999975432211 12345899999999999999999999999999999999999999743
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-37 Score=325.57 Aligned_cols=244 Identities=28% Similarity=0.343 Sum_probs=197.4
Q ss_pred CCCCceEeeccCeeEEEEEEcCCCeEEEEEEecccc---chhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceEE
Q 045798 686 FSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC---EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKA 762 (1008)
Q Consensus 686 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 762 (1008)
|.-.+.||.|+||.||-|++..+.+.||||++.... .....++.+|++.+++++|||++.+.||| -.+...|
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCy-----Lre~TaW 102 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCY-----LREHTAW 102 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCccccccee-----eccchHH
Confidence 455688999999999999999999999999997543 33456899999999999999999999995 4455689
Q ss_pred EEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEcc
Q 045798 763 IVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGD 842 (1008)
Q Consensus 763 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 842 (1008)
+||||| -|+-.|.+.-++. ++.+.++..|..+.+.||+|||++ +.||||||+.|||+++.|.|||+|
T Consensus 103 LVMEYC-lGSAsDlleVhkK---------plqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaD 169 (948)
T KOG0577|consen 103 LVMEYC-LGSASDLLEVHKK---------PLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLAD 169 (948)
T ss_pred HHHHHH-hccHHHHHHHHhc---------cchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeecc
Confidence 999999 7799998876643 788999999999999999999998 999999999999999999999999
Q ss_pred cCcccccccccCccccccccccccccccCccccC---CCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHh
Q 045798 843 FGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGL---GSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARM 919 (1008)
Q Consensus 843 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~ 919 (1008)
||.|.+..+. ..++|||.|||||++. .++|+-++||||+|++..|+.-.++|...+.. -..+-+.+.-
T Consensus 170 FGSAsi~~PA--------nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNA-MSALYHIAQN 240 (948)
T KOG0577|consen 170 FGSASIMAPA--------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-MSALYHIAQN 240 (948)
T ss_pred ccchhhcCch--------hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchH-HHHHHHHHhc
Confidence 9999866543 2357999999999875 46899999999999999999999999643211 0000011100
Q ss_pred hCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 920 ALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 920 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
. .|.+ ...+.+..+.+++..|++.-|.+|||.+++++
T Consensus 241 e---------sPtL---------------------qs~eWS~~F~~Fvd~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 241 E---------SPTL---------------------QSNEWSDYFRNFVDSCLQKIPQERPTSEELLK 277 (948)
T ss_pred C---------CCCC---------------------CCchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence 0 0001 12245667899999999999999999998765
|
|
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-36 Score=331.32 Aligned_cols=194 Identities=25% Similarity=0.366 Sum_probs=167.7
Q ss_pred ceEeeccCeeEEEEEEcCCCeEEEEEEecccc---chhhHHHHHHHHHHhhc-CCCCceeeeeccccccccCCceEEEEE
Q 045798 690 HLIGVGSFGCVYKGALDEDGIVVAIKVINLQC---EGASKSFMAECKALKNI-RHRNLVKVITSCSSIDFQGNDFKAIVY 765 (1008)
Q Consensus 690 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~ 765 (1008)
+.||+|+||.||+|.+..+++.||+|+++... ....+.+.+|..++.++ +||||+++++++ ..++..|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~-----~~~~~~~lv~ 75 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCF-----QTESRLFFVI 75 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEE-----EcCCEEEEEE
Confidence 46999999999999999899999999997432 23345688999999998 799999999984 5667799999
Q ss_pred eccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEcccCc
Q 045798 766 EYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGL 845 (1008)
Q Consensus 766 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~ 845 (1008)
||+++|+|.+++.... ++++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 76 e~~~~g~L~~~~~~~~----------~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~ 142 (329)
T cd05588 76 EFVSGGDLMFHMQRQR----------KLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGM 142 (329)
T ss_pred eCCCCCCHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCcc
Confidence 9999999998886543 689999999999999999999997 999999999999999999999999999
Q ss_pred ccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCc
Q 045798 846 ARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDV 905 (1008)
Q Consensus 846 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~ 905 (1008)
++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||+.
T Consensus 143 ~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~ 198 (329)
T cd05588 143 CKEGIRPGD----TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 198 (329)
T ss_pred ccccccCCC----ccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCccc
Confidence 874222111 11234589999999999999999999999999999999999999964
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=314.12 Aligned_cols=248 Identities=21% Similarity=0.291 Sum_probs=206.0
Q ss_pred cCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEecccc--chhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceE
Q 045798 684 NGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC--EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFK 761 (1008)
Q Consensus 684 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 761 (1008)
+=|...+.||+|.|+.|-+|++.-+|+.||||++.... .-....+.+|++.|+.++|||||++|++ .......
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEV-----iDTQTKl 92 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEV-----IDTQTKL 92 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeeh-----hcccceE
Confidence 45888899999999999999998899999999997543 2334678999999999999999999999 5667789
Q ss_pred EEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeec-CCCCeEE
Q 045798 762 AIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLD-NDLSGHI 840 (1008)
Q Consensus 762 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~kL 840 (1008)
|+|+|.-.+|+|.+||.++.. .+.+..+.+++.||+.|+.|+|+. .+||||+||+||.+- .-|-+||
T Consensus 93 yLiLELGD~GDl~DyImKHe~---------Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKL 160 (864)
T KOG4717|consen 93 YLILELGDGGDLFDYIMKHEE---------GLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKL 160 (864)
T ss_pred EEEEEecCCchHHHHHHhhhc---------cccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEe
Confidence 999999999999999987753 689999999999999999999998 999999999998764 5689999
Q ss_pred cccCcccccccccCccccccccccccccccCccccCCCCCC-cccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHh
Q 045798 841 GDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVS-TNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARM 919 (1008)
Q Consensus 841 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~ 919 (1008)
.|||++..+.+.... ...+|+..|-|||++.|..|+ +++||||+||++|-+++|++||....+.+
T Consensus 161 TDFGFSNkf~PG~kL-----~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSE--------- 226 (864)
T KOG4717|consen 161 TDFGFSNKFQPGKKL-----TTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSE--------- 226 (864)
T ss_pred eeccccccCCCcchh-----hcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchh---------
Confidence 999999877655433 335699999999999999886 57899999999999999999997542211
Q ss_pred hCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 920 ALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 920 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
.+..++|-.+. .......++.++|..|+..||++|.+.+||+.
T Consensus 227 ----TLTmImDCKYt--------------------vPshvS~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 227 ----TLTMIMDCKYT--------------------VPSHVSKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred ----hhhhhhccccc--------------------CchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 11222221111 11245677899999999999999999999875
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=318.87 Aligned_cols=255 Identities=32% Similarity=0.467 Sum_probs=201.2
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccchhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceEE
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKA 762 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 762 (1008)
.++|++.+.||+|++|.||+|.+. +++.||+|.++... ...+.+.+|++++++++||||+++++++ ...+..+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~ 77 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVC-----TLEEPIY 77 (261)
T ss_pred hhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEE-----ecCCCee
Confidence 456899999999999999999975 56789999987542 3356789999999999999999999984 4556689
Q ss_pred EEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEcc
Q 045798 763 IVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGD 842 (1008)
Q Consensus 763 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 842 (1008)
+||||+++++|.+++..... ..+++..+..++.|++.|+.|||+. +|+||||||+||++++++.+||+|
T Consensus 78 lv~e~~~~~~L~~~~~~~~~--------~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d 146 (261)
T cd05068 78 IVTELMKYGSLLEYLQGGAG--------RALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVAD 146 (261)
T ss_pred eeeecccCCcHHHHHhccCC--------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECC
Confidence 99999999999999875431 1689999999999999999999997 999999999999999999999999
Q ss_pred cCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCccccCCccHHHHHHhhC
Q 045798 843 FGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT-AKKPTDVMFEGDLNLHNFARMAL 921 (1008)
Q Consensus 843 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-G~~pf~~~~~~~~~~~~~~~~~~ 921 (1008)
||++......... .......+..|+|||++.+..++.++||||||+++|||++ |+.||...... ...
T Consensus 147 fg~~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~----~~~----- 214 (261)
T cd05068 147 FGLARVIKEDIYE---AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNA----EVL----- 214 (261)
T ss_pred cceEEEccCCccc---ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHH----HHH-----
Confidence 9999866532111 1111223468999999998899999999999999999999 99898532110 000
Q ss_pred CcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHHHH
Q 045798 922 PNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHELQS 990 (1008)
Q Consensus 922 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 990 (1008)
..++.... . +.....+..+.+++.+||+.+|.+||+++++++.|+.
T Consensus 215 -----~~~~~~~~--------------~----~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 215 -----QQVDQGYR--------------M----PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred -----HHHHcCCC--------------C----CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 00000000 0 0011234568999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=322.39 Aligned_cols=248 Identities=25% Similarity=0.313 Sum_probs=192.0
Q ss_pred EeeccCeeEEEEEEcCCCeEEEEEEeccccc---hhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceEEEEEecc
Q 045798 692 IGVGSFGCVYKGALDEDGIVVAIKVINLQCE---GASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKAIVYEYM 768 (1008)
Q Consensus 692 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 768 (1008)
||+|+||+||+|.+..+++.||+|++..... ...+.+..|++++++++|+||+++.++ +..+...++||||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~-----~~~~~~~~lv~e~~ 75 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYA-----FQTKTDLCLVMTIM 75 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEE-----EcCCCeEEEEEeCC
Confidence 6999999999999988999999999864321 223567889999999999999999988 45567799999999
Q ss_pred CCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEcccCcccc
Q 045798 769 PNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARF 848 (1008)
Q Consensus 769 ~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~ 848 (1008)
++|+|.+++...... ...+++..++.++.||+.||+|||+. +|+||||||+||+++.++.+||+|||.+..
T Consensus 76 ~~g~L~~~~~~~~~~------~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~ 146 (280)
T cd05608 76 NGGDLRYHIYNVDEE------NPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVE 146 (280)
T ss_pred CCCCHHHHHHhcccc------CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCcccee
Confidence 999999887532211 11689999999999999999999997 999999999999999999999999999976
Q ss_pred cccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCcchhhh
Q 045798 849 HQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMALPNQVMDI 928 (1008)
Q Consensus 849 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 928 (1008)
....... .....||+.|+|||++.+..++.++|||||||++|||++|+.||........ .......
T Consensus 147 ~~~~~~~----~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~-~~~~~~~--------- 212 (280)
T cd05608 147 LKDGQSK----TKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE-NKELKQR--------- 212 (280)
T ss_pred cCCCCcc----ccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchh-HHHHHHh---------
Confidence 5432211 1234589999999999999999999999999999999999999864321110 0000000
Q ss_pred hcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCC-----CHHHHHH
Q 045798 929 VDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRM-----NMTNVVH 986 (1008)
Q Consensus 929 ~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~ 986 (1008)
.... ........+..+.+++.+||+.||++|| +++++++
T Consensus 213 ---~~~~----------------~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 213 ---ILND----------------SVTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred ---hccc----------------CCCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 0000 0000112455678999999999999999 6666665
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=337.03 Aligned_cols=381 Identities=27% Similarity=0.405 Sum_probs=232.8
Q ss_pred CEEEccCCCCC-CccCcccccCcCcceEeeeccccccCCCccccccCCCCeeecccccCCCCCCCCCccccccchhhccc
Q 045798 105 EALFLSNNSLV-GKIPANLSYCSRLTVLCIEYNKLQGRIPLEFVSLSKLKDLSLAKNKLTGGIPPFLGNLTSLEVLSLAG 183 (1008)
Q Consensus 105 ~~L~Ls~n~l~-~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~ 183 (1008)
+-.|+++|.++ +..|..+..+++++.|.|...++. .+|+.++.+.+|++|.+++|++. .+-..+..|+.|+.+.+.+
T Consensus 10 rGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~-~vhGELs~Lp~LRsv~~R~ 87 (1255)
T KOG0444|consen 10 RGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLI-SVHGELSDLPRLRSVIVRD 87 (1255)
T ss_pred ecccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhH-hhhhhhccchhhHHHhhhc
Confidence 33444444444 344555555555555555555555 55666666666666666666665 4455566666666666666
Q ss_pred ccCC-CCCCccccCCCCCcEEEecCCcccccCCccccCCCCcceeccccccccccCChhhhhcCCCCcEEEeccccCCCC
Q 045798 184 NSFG-RNIPDSLGQLKQLKILAIGGNNLSGPIPPSIYNLSFLVVFSVSHNQIHGSLPPSLGLLLPNLKFFQIHHNFFSGS 262 (1008)
Q Consensus 184 n~l~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~ 262 (1008)
|++. .-+|..+-++..|..|||++|+++ ..|..+..-+++..|+||+|+|. +||..+|..+.-|-+|||++|++. .
T Consensus 88 N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~Ie-tIPn~lfinLtDLLfLDLS~NrLe-~ 164 (1255)
T KOG0444|consen 88 NNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIE-TIPNSLFINLTDLLFLDLSNNRLE-M 164 (1255)
T ss_pred cccccCCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccc-cCCchHHHhhHhHhhhccccchhh-h
Confidence 6653 335556666777777777777776 56777777777777777777777 788887777777778888888887 6
Q ss_pred CCcccccCCCCceeecccccccccccccccCCCcccccccccccCCCCCCCcccccccccccCCCcEEEecCCcCC-ccC
Q 045798 263 IPISLSNASKLEHIEIANNNFSGKLSVNFGGMKNLSLLNLQFSNLGSGESDEMGFMNSLTNCSKLRVLSLGGNQFR-GAL 341 (1008)
Q Consensus 263 ~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~-~~~ 341 (1008)
+|..+..+..|++|+|++|.+....-..+. .+++|++|.+++.+-+ .-+
T Consensus 165 LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLP------------------------------smtsL~vLhms~TqRTl~N~ 214 (1255)
T KOG0444|consen 165 LPPQIRRLSMLQTLKLSNNPLNHFQLRQLP------------------------------SMTSLSVLHMSNTQRTLDNI 214 (1255)
T ss_pred cCHHHHHHhhhhhhhcCCChhhHHHHhcCc------------------------------cchhhhhhhcccccchhhcC
Confidence 677777888888888888877643322222 3334444444443321 134
Q ss_pred ChhhhhhcccceeeeeccccccCCCCCccccccccceEEecCccccCCcchhccCCCCCceEEccCCcccccccccccCC
Q 045798 342 PHSIANLSSQLQILILSSNQFYGSIPLGIGNLVDLYLLGMVENQFTGAIPKEMGKLQKLQGLDFSGNHFSGEIPSSLGNL 421 (1008)
Q Consensus 342 p~~~~~l~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l 421 (1008)
|.++..+. +|..+|||.|.+. .+|+++.++++|+.|+|++|+|+ .+.......
T Consensus 215 Ptsld~l~-NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~it-------------------------eL~~~~~~W 267 (1255)
T KOG0444|consen 215 PTSLDDLH-NLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKIT-------------------------ELNMTEGEW 267 (1255)
T ss_pred CCchhhhh-hhhhccccccCCC-cchHHHhhhhhhheeccCcCcee-------------------------eeeccHHHH
Confidence 44444443 3555555555555 44444444444444444444444 333333333
Q ss_pred CCcceeeccccccccccCCCCcCCCcccEeecccccccCCcchhhhhhhhhhhhhcccCccccCCCcccccccccccccc
Q 045798 422 SSLYEVFFNNNNLSGVIPFSLGNLKRLAFLEMSGNELSGTIPEDIFNISYLSNSLNLARNHLVGIIPPRIGNLRALRSFD 501 (1008)
Q Consensus 422 ~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~lp~~~~~~~~~~~~L~L~~N~l~~~~p~~~~~l~~L~~Ld 501 (1008)
.+|+.|+|++|+++ .+|.+++.++.|+.|.+.+|+++ +. -+|..|+.|.+|+.+.
T Consensus 268 ~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~-----------------------Fe-GiPSGIGKL~~Levf~ 322 (1255)
T KOG0444|consen 268 ENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLT-----------------------FE-GIPSGIGKLIQLEVFH 322 (1255)
T ss_pred hhhhhhccccchhc-cchHHHhhhHHHHHHHhccCccc-----------------------cc-CCccchhhhhhhHHHH
Confidence 44444445555544 45555555555555555555554 11 3677777788888888
Q ss_pred cccccccCCCCcccccccccceeeccCcccccchhhhhhccccccEEecCCCcccccccCccc-ccccceeecc
Q 045798 502 VSNNDLSGEIPIELGHCSSLEEIYLAGNLFHGSIPSFFNALKGVQKIDLSRNNLSGQIPIFLE-ALSLEYLNLS 574 (1008)
Q Consensus 502 ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~-~~~L~~L~l~ 574 (1008)
.++|.+. ..|+.++.|..|+.|.|++|++- .+|+.+.-|+.|+.|||..|.----+|.-.+ ...|+.-++.
T Consensus 323 aanN~LE-lVPEglcRC~kL~kL~L~~NrLi-TLPeaIHlL~~l~vLDlreNpnLVMPPKP~da~~~lefYNID 394 (1255)
T KOG0444|consen 323 AANNKLE-LVPEGLCRCVKLQKLKLDHNRLI-TLPEAIHLLPDLKVLDLRENPNLVMPPKPNDARKKLEFYNID 394 (1255)
T ss_pred hhccccc-cCchhhhhhHHHHHhccccccee-echhhhhhcCCcceeeccCCcCccCCCCcchhhhcceeeecc
Confidence 8888887 78888888888888888888887 6888888888888888888865533332222 2345554443
|
|
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=320.86 Aligned_cols=258 Identities=25% Similarity=0.356 Sum_probs=199.2
Q ss_pred cCCCCCceEeeccCeeEEEEEEcCCCe----EEEEEEeccccc-hhhHHHHHHHHHHhhcCCCCceeeeeccccccccCC
Q 045798 684 NGFSSTHLIGVGSFGCVYKGALDEDGI----VVAIKVINLQCE-GASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGN 758 (1008)
Q Consensus 684 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 758 (1008)
++|++.+.||+|+||+||+|.+..+++ .|++|.+..... ....++..|+.+++++.||||+++++++. +
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~------~ 80 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP------G 80 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC------C
Confidence 468889999999999999999876665 477787754322 23457888888999999999999999853 2
Q ss_pred ceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCe
Q 045798 759 DFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSG 838 (1008)
Q Consensus 759 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 838 (1008)
...++++||+++|+|.+++..... .+++..+..|+.||+.||+|||+. +++||||||+||++++++.+
T Consensus 81 ~~~~~i~e~~~~gsL~~~l~~~~~---------~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~ 148 (279)
T cd05111 81 ASLQLVTQLSPLGSLLDHVRQHRD---------SLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIV 148 (279)
T ss_pred CccEEEEEeCCCCcHHHHHHhccc---------CCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcE
Confidence 346889999999999999975431 689999999999999999999997 99999999999999999999
Q ss_pred EEcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCccccCCccHHHHH
Q 045798 839 HIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT-AKKPTDVMFEGDLNLHNFA 917 (1008)
Q Consensus 839 kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-G~~pf~~~~~~~~~~~~~~ 917 (1008)
||+|||.++......... ......++..|+|||++.++.++.++|||||||++||+++ |..||...... ..
T Consensus 149 kl~Dfg~~~~~~~~~~~~--~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~--~~---- 220 (279)
T cd05111 149 QIADFGVADLLYPDDKKY--FYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH--EV---- 220 (279)
T ss_pred EEcCCccceeccCCCccc--ccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHH--HH----
Confidence 999999998654322111 1122446788999999988899999999999999999998 99998643110 00
Q ss_pred HhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHHHHHHH
Q 045798 918 RMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHELQSVKN 993 (1008)
Q Consensus 918 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~i~~ 993 (1008)
.+++.... .... ...++..+.+++.+||..||++|||+.|+++.|..+..
T Consensus 221 --------~~~~~~~~--------------~~~~----~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 221 --------PDLLEKGE--------------RLAQ----PQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR 270 (279)
T ss_pred --------HHHHHCCC--------------cCCC----CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence 01110000 0000 00123456889999999999999999999999888654
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=332.56 Aligned_cols=194 Identities=26% Similarity=0.384 Sum_probs=167.2
Q ss_pred ceEeeccCeeEEEEEEcCCCeEEEEEEeccc---cchhhHHHHHHHHHHhhc-CCCCceeeeeccccccccCCceEEEEE
Q 045798 690 HLIGVGSFGCVYKGALDEDGIVVAIKVINLQ---CEGASKSFMAECKALKNI-RHRNLVKVITSCSSIDFQGNDFKAIVY 765 (1008)
Q Consensus 690 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~ 765 (1008)
+.||+|+||.||+|++..+++.||+|+++.. .....+.+.+|+.++.++ +||||++++++ +..++..++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~-----~~~~~~~~lv~ 75 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSC-----FQTESRLFFVI 75 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeE-----EEeCCEEEEEE
Confidence 4799999999999999989999999999743 223445678899988877 89999999998 45567899999
Q ss_pred eccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEcccCc
Q 045798 766 EYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGL 845 (1008)
Q Consensus 766 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~ 845 (1008)
||+++|+|..++.... .+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 76 E~~~~~~L~~~~~~~~----------~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~ 142 (329)
T cd05618 76 EYVNGGDLMFHMQRQR----------KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGM 142 (329)
T ss_pred eCCCCCCHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCc
Confidence 9999999998886543 689999999999999999999997 999999999999999999999999999
Q ss_pred ccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCc
Q 045798 846 ARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDV 905 (1008)
Q Consensus 846 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~ 905 (1008)
++........ .....||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 143 ~~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~ 198 (329)
T cd05618 143 CKEGLRPGDT----TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 198 (329)
T ss_pred cccccCCCCc----cccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCcc
Confidence 8743221111 1234589999999999999999999999999999999999999963
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=319.91 Aligned_cols=262 Identities=23% Similarity=0.315 Sum_probs=206.0
Q ss_pred cCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEecccc---chhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCce
Q 045798 684 NGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC---EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDF 760 (1008)
Q Consensus 684 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 760 (1008)
++|++.+.||+|+||.||+|....+++.||||.+.... .....++.+|+++++.++|+||+++++++ ..++.
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~~ 76 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASF-----IEDNE 76 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhhee-----EeCCe
Confidence 46888999999999999999998899999999886422 23446788999999999999999999984 45567
Q ss_pred EEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEE
Q 045798 761 KAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHI 840 (1008)
Q Consensus 761 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 840 (1008)
.++||||+++++|.+++...... ...+++..++.++.|++.|++|||++ +++|+||||+||+++.++.++|
T Consensus 77 ~~~v~e~~~~~~L~~~~~~~~~~------~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l 147 (267)
T cd08229 77 LNIVLELADAGDLSRMIKHFKKQ------KRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKL 147 (267)
T ss_pred EEEEEEecCCCCHHHHHHHhhcc------CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEE
Confidence 89999999999999988642211 11689999999999999999999998 9999999999999999999999
Q ss_pred cccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHhh
Q 045798 841 GDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMA 920 (1008)
Q Consensus 841 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~~ 920 (1008)
+|||.+......... .....++..|+|||++.+..++.++||||||+++|+|++|..||...... ........
T Consensus 148 ~dfg~~~~~~~~~~~----~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~~~~~~ 220 (267)
T cd08229 148 GDLGLGRFFSSKTTA----AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN---LYSLCKKI 220 (267)
T ss_pred CcchhhhccccCCcc----cccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch---HHHHhhhh
Confidence 999998765433211 12245889999999998888999999999999999999999998532111 01110000
Q ss_pred CCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHHHHHH
Q 045798 921 LPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHELQSVK 992 (1008)
Q Consensus 921 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~i~ 992 (1008)
.....+ .......+..+.+++.+||+.||.+|||+.+|++.++++.
T Consensus 221 -----~~~~~~---------------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 221 -----EQCDYP---------------------PLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred -----hcCCCC---------------------CCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 000000 0001134567899999999999999999999999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=323.03 Aligned_cols=269 Identities=26% Similarity=0.411 Sum_probs=207.5
Q ss_pred cCCCCCceEeeccCeeEEEEEEc-----CCCeEEEEEEeccccchhhHHHHHHHHHHhhcCCCCceeeeeccccccccCC
Q 045798 684 NGFSSTHLIGVGSFGCVYKGALD-----EDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGN 758 (1008)
Q Consensus 684 ~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 758 (1008)
.+|.+.+.||+|+||.||+|... .++..|++|.++.......+.+.+|++++++++|+||+++++++ ...
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~ 79 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVC-----GDG 79 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEE-----ccC
Confidence 45788899999999999999863 24567999998766555567899999999999999999999995 455
Q ss_pred ceEEEEEeccCCCChhcccccCCCCCC------CcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeee
Q 045798 759 DFKAIVYEYMPNGSLEKWLHPHAVPKR------DKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILL 832 (1008)
Q Consensus 759 ~~~~lv~e~~~~gsL~~~l~~~~~~~~------~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll 832 (1008)
+..++||||+++++|.+++........ .......+++..++.++.||+.|++|||++ +|+||||||+||++
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~ 156 (291)
T cd05094 80 DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLV 156 (291)
T ss_pred CceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEE
Confidence 668999999999999999976532100 001112589999999999999999999997 99999999999999
Q ss_pred cCCCCeEEcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCccccCCc
Q 045798 833 DNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT-AKKPTDVMFEGDL 911 (1008)
Q Consensus 833 ~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-G~~pf~~~~~~~~ 911 (1008)
+.++.+||+|||.+.......... ......++..|+|||++.+..++.++|||||||++|||++ |+.||......
T Consensus 157 ~~~~~~~l~dfg~a~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~-- 232 (291)
T cd05094 157 GANLLVKIGDFGMSRDVYSTDYYR--VGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT-- 232 (291)
T ss_pred ccCCcEEECCCCcccccCCCceee--cCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--
Confidence 999999999999997554322111 1122346788999999998899999999999999999999 99997542111
Q ss_pred cHHHHHHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHHHHH
Q 045798 912 NLHNFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHELQSV 991 (1008)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~i 991 (1008)
.......... ... ....++..+.+++.+||+.||++|||+.+|+++|+++
T Consensus 233 ---~~~~~~~~~~--------~~~-------------------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~ 282 (291)
T cd05094 233 ---EVIECITQGR--------VLE-------------------RPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHAL 282 (291)
T ss_pred ---HHHHHHhCCC--------CCC-------------------CCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHH
Confidence 0000000000 000 0012345689999999999999999999999999998
Q ss_pred HHH
Q 045798 992 KNI 994 (1008)
Q Consensus 992 ~~~ 994 (1008)
.+.
T Consensus 283 ~~~ 285 (291)
T cd05094 283 GKA 285 (291)
T ss_pred Hhh
Confidence 664
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-36 Score=330.75 Aligned_cols=242 Identities=23% Similarity=0.277 Sum_probs=191.5
Q ss_pred CCCCCceEeeccCeeEEEEEEcCCCeEEEEEEecccc---chhhHHHHHHHHHHhhc-CCCCceeeeeccccccccCCce
Q 045798 685 GFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC---EGASKSFMAECKALKNI-RHRNLVKVITSCSSIDFQGNDF 760 (1008)
Q Consensus 685 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~ 760 (1008)
+|.+.+.||+|+||.||+|++..+++.||+|+++... ....+.+..|..++..+ +|++|+++++++ ...+.
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-----~~~~~ 75 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCF-----QTMDR 75 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEE-----ecCCE
Confidence 4888999999999999999998889999999987432 23334577788888877 688899998884 55677
Q ss_pred EEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEE
Q 045798 761 KAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHI 840 (1008)
Q Consensus 761 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 840 (1008)
.++||||+++|+|.+++.... .+++.++..++.||+.||+|||+. +|+||||||+||++++++.+||
T Consensus 76 ~~lv~E~~~~g~L~~~~~~~~----------~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL 142 (323)
T cd05616 76 LYFVMEYVNGGDLMYQIQQVG----------RFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKI 142 (323)
T ss_pred EEEEEcCCCCCCHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEE
Confidence 999999999999999986543 688999999999999999999998 9999999999999999999999
Q ss_pred cccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHhh
Q 045798 841 GDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMA 920 (1008)
Q Consensus 841 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~~ 920 (1008)
+|||+++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .......
T Consensus 143 ~DfG~~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~-~~~~~i~--- 214 (323)
T cd05616 143 ADFGMCKENMWDGV----TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED-ELFQSIM--- 214 (323)
T ss_pred ccCCCceecCCCCC----ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHH-HHHHHHH---
Confidence 99999974322111 112345899999999999999999999999999999999999998642110 0000000
Q ss_pred CCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCH
Q 045798 921 LPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNM 981 (1008)
Q Consensus 921 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~ 981 (1008)
.... .++ ...+.++.+++.+|++.||.+|+++
T Consensus 215 ---------~~~~--------------~~p------~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 215 ---------EHNV--------------AYP------KSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred ---------hCCC--------------CCC------CcCCHHHHHHHHHHcccCHHhcCCC
Confidence 0000 000 1234457899999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=327.49 Aligned_cols=247 Identities=23% Similarity=0.324 Sum_probs=201.4
Q ss_pred eEeeccCeeEEEEEEcCCCeEEEEEEeccccchhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceEEEEEeccCC
Q 045798 691 LIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKAIVYEYMPN 770 (1008)
Q Consensus 691 ~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~ 770 (1008)
+||+|.||+||.|++..+...+|||.+........+-+..|+...++++|.|||+++|.| ..+++.-|.||.++|
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~-----senGf~kIFMEqVPG 656 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSV-----SENGFFKIFMEQVPG 656 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhcc-----CCCCeEEEEeecCCC
Confidence 699999999999999989999999999877777778899999999999999999999995 455678999999999
Q ss_pred CChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeec-CCCCeEEcccCccccc
Q 045798 771 GSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLD-NDLSGHIGDFGLARFH 849 (1008)
Q Consensus 771 gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~kL~Dfg~a~~~ 849 (1008)
|+|.+.++..-.+- +-.+..+-.+.+||++||.|||+. .|||||||-+||||. -.|.+||+|||-++..
T Consensus 657 GSLSsLLrskWGPl-------KDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRL 726 (1226)
T KOG4279|consen 657 GSLSSLLRSKWGPL-------KDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRL 726 (1226)
T ss_pred CcHHHHHHhccCCC-------ccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhh
Confidence 99999998765432 236777888999999999999998 999999999999995 5689999999999877
Q ss_pred ccccCccccccccccccccccCccccCCC--CCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCcchhh
Q 045798 850 QEVSNSTLSSSVGVKGTIGYTAPEYGLGS--EVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMALPNQVMD 927 (1008)
Q Consensus 850 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 927 (1008)
...... +..+.||..|||||++..+ .|+.++|||||||++.||.||++||........ .-
T Consensus 727 AginP~----TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqA--------------AM 788 (1226)
T KOG4279|consen 727 AGINPC----TETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQA--------------AM 788 (1226)
T ss_pred ccCCcc----ccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhH--------------hh
Confidence 544332 3446699999999999775 588999999999999999999999864322111 11
Q ss_pred hhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 928 IVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 928 ~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
+--.+.+..+ + ...+.+.+...+|.+|+.+||.+||+|.++++
T Consensus 789 FkVGmyKvHP--------------~--iPeelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 789 FKVGMYKVHP--------------P--IPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred hhhcceecCC--------------C--CcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 1111111111 1 12456677899999999999999999999875
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-36 Score=330.29 Aligned_cols=243 Identities=24% Similarity=0.306 Sum_probs=191.3
Q ss_pred CceEeeccCeeEEEEEEc---CCCeEEEEEEecccc----chhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceE
Q 045798 689 THLIGVGSFGCVYKGALD---EDGIVVAIKVINLQC----EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFK 761 (1008)
Q Consensus 689 ~~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 761 (1008)
++.||+|+||.||+++.. .+++.||+|+++... ......+.+|+++++.++||||+++++++ ..++..
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~-----~~~~~~ 75 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAF-----QTGGKL 75 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEE-----ecCCeE
Confidence 368999999999999873 467899999987431 23345678999999999999999999884 556679
Q ss_pred EEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEc
Q 045798 762 AIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIG 841 (1008)
Q Consensus 762 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 841 (1008)
|+||||+++++|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~----------~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~ 142 (323)
T cd05584 76 YLILEYLSGGELFMHLEREG----------IFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLT 142 (323)
T ss_pred EEEEeCCCCchHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEe
Confidence 99999999999999987554 678889999999999999999997 99999999999999999999999
Q ss_pred ccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHhhC
Q 045798 842 DFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMAL 921 (1008)
Q Consensus 842 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~~~ 921 (1008)
|||+++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ....
T Consensus 143 Dfg~~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~-----~~~~--- 210 (323)
T cd05584 143 DFGLCKESIHEGT----VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRK-----KTID--- 210 (323)
T ss_pred eCcCCeecccCCC----cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHH-----HHHH---
Confidence 9999874322211 112345899999999999888999999999999999999999998642110 0000
Q ss_pred CcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCC-----CHHHHHH
Q 045798 922 PNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRM-----NMTNVVH 986 (1008)
Q Consensus 922 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~ 986 (1008)
.+..... ..+ ...+..+.+++.+||+.||++|| +++++++
T Consensus 211 -----~~~~~~~--------------~~~------~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 211 -----KILKGKL--------------NLP------PYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred -----HHHcCCC--------------CCC------CCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 0000000 000 11234578999999999999999 7887766
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=331.39 Aligned_cols=252 Identities=23% Similarity=0.290 Sum_probs=195.2
Q ss_pred CCCCCceEeeccCeeEEEEEEc---CCCeEEEEEEeccc----cchhhHHHHHHHHHHhhc-CCCCceeeeecccccccc
Q 045798 685 GFSSTHLIGVGSFGCVYKGALD---EDGIVVAIKVINLQ----CEGASKSFMAECKALKNI-RHRNLVKVITSCSSIDFQ 756 (1008)
Q Consensus 685 ~y~~~~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 756 (1008)
+|++.+.||+|+||.||+|+.. .+++.||+|+++.. .....+.+.+|+++++.+ +|++|++++++ +.
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~-----~~ 75 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYA-----FQ 75 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEE-----Ee
Confidence 4888999999999999998873 46889999998642 123345688999999999 59999999988 45
Q ss_pred CCceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCC
Q 045798 757 GNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDL 836 (1008)
Q Consensus 757 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 836 (1008)
.++..++||||+++|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++
T Consensus 76 ~~~~~~lv~e~~~~g~L~~~l~~~~----------~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~ 142 (332)
T cd05614 76 TEAKLHLILDYVSGGEMFTHLYQRD----------NFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEG 142 (332)
T ss_pred cCCEEEEEEeCCCCCcHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCC
Confidence 6677999999999999999987543 688999999999999999999997 999999999999999999
Q ss_pred CeEEcccCcccccccccCccccccccccccccccCccccCCC-CCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHH
Q 045798 837 SGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGS-EVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHN 915 (1008)
Q Consensus 837 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~ 915 (1008)
.+||+|||+++......... .....||..|+|||++.+. .++.++|||||||++|||++|+.||........ ...
T Consensus 143 ~~kl~DfG~~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~-~~~ 218 (332)
T cd05614 143 HVVLTDFGLSKEFLSEEKER---TYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNT-QSE 218 (332)
T ss_pred CEEEeeCcCCccccccCCCc---cccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCC-HHH
Confidence 99999999998553322211 2234689999999998765 478899999999999999999999864322111 111
Q ss_pred HHHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCC-----CHHHHHH
Q 045798 916 FARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRM-----NMTNVVH 986 (1008)
Q Consensus 916 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~ 986 (1008)
.... .....+ .. ....+..+.+++.+||+.||++|| +++++++
T Consensus 219 ~~~~------------~~~~~~--------------~~--~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 219 VSRR------------ILKCDP--------------PF--PSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred HHHH------------HhcCCC--------------CC--CCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 1100 000000 00 012345578999999999999999 6667765
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-36 Score=329.21 Aligned_cols=241 Identities=25% Similarity=0.350 Sum_probs=189.7
Q ss_pred ceEeeccCeeEEEEEEcCCCeEEEEEEecccc---chhhHHHHHHHHHHhhc-CCCCceeeeeccccccccCCceEEEEE
Q 045798 690 HLIGVGSFGCVYKGALDEDGIVVAIKVINLQC---EGASKSFMAECKALKNI-RHRNLVKVITSCSSIDFQGNDFKAIVY 765 (1008)
Q Consensus 690 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~ 765 (1008)
+.||+|+||.||+|++..+++.||+|+++... ....+.+..|..++... +||+|++++++ +..+++.|+||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~-----~~~~~~~~lv~ 75 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCT-----FQTKEHLFFVM 75 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEE-----EEeCCEEEEEE
Confidence 46999999999999999899999999997432 23345677788888765 89999999998 45667899999
Q ss_pred eccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEcccCc
Q 045798 766 EYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGL 845 (1008)
Q Consensus 766 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~ 845 (1008)
||+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 76 E~~~~g~L~~~i~~~~----------~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~ 142 (316)
T cd05620 76 EFLNGGDLMFHIQDKG----------RFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGM 142 (316)
T ss_pred CCCCCCcHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCC
Confidence 9999999999987543 688999999999999999999998 999999999999999999999999999
Q ss_pred ccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCcch
Q 045798 846 ARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMALPNQV 925 (1008)
Q Consensus 846 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~ 925 (1008)
++....... ......||+.|+|||++.+..++.++||||+||++|||++|+.||...... ..........
T Consensus 143 ~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~--~~~~~~~~~~---- 212 (316)
T cd05620 143 CKENVFGDN----RASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED--ELFESIRVDT---- 212 (316)
T ss_pred CeecccCCC----ceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH--HHHHHHHhCC----
Confidence 874322111 122345899999999999999999999999999999999999998632110 0000000000
Q ss_pred hhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHH-HHH
Q 045798 926 MDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMT-NVV 985 (1008)
Q Consensus 926 ~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~-evl 985 (1008)
+ ..+. ..+.++.+++.+||+.||.+||++. ++.
T Consensus 213 -----~----------------~~~~------~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 213 -----P----------------HYPR------WITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred -----C----------------CCCC------CCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 0 0000 1234578999999999999999985 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-36 Score=329.85 Aligned_cols=242 Identities=23% Similarity=0.294 Sum_probs=192.6
Q ss_pred ceEeeccCeeEEEEEEcCCCeEEEEEEecccc---chhhHHHHHHHHHHhhc-CCCCceeeeeccccccccCCceEEEEE
Q 045798 690 HLIGVGSFGCVYKGALDEDGIVVAIKVINLQC---EGASKSFMAECKALKNI-RHRNLVKVITSCSSIDFQGNDFKAIVY 765 (1008)
Q Consensus 690 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~ 765 (1008)
+.||+|+||.||+|.+..+++.||+|+++... ......+.+|.+++..+ +||||+++++++ ...+..++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~-----~~~~~~~lv~ 75 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCF-----QTKDRLFFVM 75 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEE-----EcCCEEEEEE
Confidence 46999999999999998889999999997432 23445678899999888 799999999984 5667799999
Q ss_pred eccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEcccCc
Q 045798 766 EYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGL 845 (1008)
Q Consensus 766 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~ 845 (1008)
||+++|+|..++.... .+++.++..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+
T Consensus 76 e~~~~~~L~~~~~~~~----------~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~ 142 (318)
T cd05570 76 EYVNGGDLMFHIQRSG----------RFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGM 142 (318)
T ss_pred cCCCCCCHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCC
Confidence 9999999999887553 689999999999999999999997 999999999999999999999999999
Q ss_pred ccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCcch
Q 045798 846 ARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMALPNQV 925 (1008)
Q Consensus 846 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~ 925 (1008)
++........ .....|++.|+|||++.+..++.++|||||||++|+|++|+.||..... .......
T Consensus 143 ~~~~~~~~~~----~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~-----~~~~~~i----- 208 (318)
T cd05570 143 CKEGILGGVT----TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDE-----DELFQSI----- 208 (318)
T ss_pred CeecCcCCCc----ccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCH-----HHHHHHH-----
Confidence 8743221111 1224589999999999999999999999999999999999999863211 0110000
Q ss_pred hhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCH-----HHHHH
Q 045798 926 MDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNM-----TNVVH 986 (1008)
Q Consensus 926 ~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~-----~evl~ 986 (1008)
... .. ..+ ...+..+.+++.+||+.||.+|||+ .++++
T Consensus 209 ---~~~----~~----------~~~------~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 209 ---LED----EV----------RYP------RWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred ---HcC----CC----------CCC------CcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 000 00 000 1234567899999999999999999 77765
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=320.76 Aligned_cols=249 Identities=22% Similarity=0.282 Sum_probs=193.1
Q ss_pred EeeccCeeEEEEEEcCCCeEEEEEEecccc---chhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceEEEEEecc
Q 045798 692 IGVGSFGCVYKGALDEDGIVVAIKVINLQC---EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKAIVYEYM 768 (1008)
Q Consensus 692 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 768 (1008)
||+|+||.||+++...+|+.||+|++.... ......+..|++++++++||||++++++ +..+.+.++||||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~-----~~~~~~~~lv~e~~ 75 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYA-----FESKTHLCLVMSLM 75 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEE-----EecCCeEEEEEecC
Confidence 699999999999998899999999986321 2223456779999999999999999988 45667799999999
Q ss_pred CCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEcccCcccc
Q 045798 769 PNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARF 848 (1008)
Q Consensus 769 ~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~ 848 (1008)
++++|.+++...... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++|+|||++..
T Consensus 76 ~g~~L~~~~~~~~~~--------~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~ 144 (277)
T cd05607 76 NGGDLKYHIYNVGER--------GLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVE 144 (277)
T ss_pred CCCCHHHHHHhcccc--------CCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeee
Confidence 999999888654321 578999999999999999999997 999999999999999999999999999976
Q ss_pred cccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCcchhhh
Q 045798 849 HQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMALPNQVMDI 928 (1008)
Q Consensus 849 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 928 (1008)
...... .....|+..|+|||++.+..++.++||||+||++|||++|+.||....+.. ..........
T Consensus 145 ~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~-~~~~~~~~~~------- 211 (277)
T cd05607 145 LKDGKT-----ITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKV-AKEELKRRTL------- 211 (277)
T ss_pred cCCCce-----eeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchh-hHHHHHHHhh-------
Confidence 543221 122358999999999998889999999999999999999999986432111 1011111000
Q ss_pred hcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHHH
Q 045798 929 VDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHELQ 989 (1008)
Q Consensus 929 ~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 989 (1008)
.... .. .....+.++.+++.+||+.||++||+++|+++...
T Consensus 212 -----~~~~------------~~---~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~ 252 (277)
T cd05607 212 -----EDEV------------KF---EHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPR 252 (277)
T ss_pred -----cccc------------cc---ccccCCHHHHHHHHHHhccCHhhCCCCccchhhhh
Confidence 0000 00 00123455789999999999999999988775443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=324.23 Aligned_cols=251 Identities=23% Similarity=0.284 Sum_probs=202.2
Q ss_pred cCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccchhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceEEE
Q 045798 684 NGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKAI 763 (1008)
Q Consensus 684 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 763 (1008)
.+|++.+.||+|+||.||+|.+..+++.||+|.+........+.+.+|+.+++.++|+||+++++.+ ..+.+.++
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~-----~~~~~~~l 94 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY-----LVGDELWV 94 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEE-----EeCCEEEE
Confidence 5789999999999999999999889999999999866555667899999999999999999999984 44567999
Q ss_pred EEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEccc
Q 045798 764 VYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDF 843 (1008)
Q Consensus 764 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 843 (1008)
||||+++++|.+++... .+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+||
T Consensus 95 v~e~~~~~~L~~~~~~~-----------~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~df 160 (296)
T cd06654 95 VMEYLAGGSLTDVVTET-----------CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDF 160 (296)
T ss_pred eecccCCCCHHHHHHhc-----------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECcc
Confidence 99999999999998643 578889999999999999999998 9999999999999999999999999
Q ss_pred CcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCc
Q 045798 844 GLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMALPN 923 (1008)
Q Consensus 844 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~~~~~ 923 (1008)
|.+......... .....+++.|+|||.+.+..++.++|||||||++|+|++|+.||........ .........
T Consensus 161 g~~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~-~~~~~~~~~-- 233 (296)
T cd06654 161 GFCAQITPEQSK----RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA-LYLIATNGT-- 233 (296)
T ss_pred ccchhccccccc----cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHh-HHHHhcCCC--
Confidence 998754332211 1223588999999999888899999999999999999999999864321110 000000000
Q ss_pred chhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 045798 924 QVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHE 987 (1008)
Q Consensus 924 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 987 (1008)
+. .......+..+.+++.+||..||++|||+.|+++.
T Consensus 234 -------~~--------------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 234 -------PE--------------------LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred -------CC--------------------CCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 00 00011234567899999999999999999999873
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=327.95 Aligned_cols=241 Identities=28% Similarity=0.375 Sum_probs=189.3
Q ss_pred ceEeeccCeeEEEEEEcCCCeEEEEEEecccc---chhhHHHHHHHHHHhhc-CCCCceeeeeccccccccCCceEEEEE
Q 045798 690 HLIGVGSFGCVYKGALDEDGIVVAIKVINLQC---EGASKSFMAECKALKNI-RHRNLVKVITSCSSIDFQGNDFKAIVY 765 (1008)
Q Consensus 690 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~ 765 (1008)
+.||+|+||.||+|++..+++.||+|+++... ....+.+..|..++... +||||+++++++ ..++..++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~-----~~~~~~~lv~ 75 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTF-----QTKENLFFVM 75 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEE-----EeCCEEEEEE
Confidence 46999999999999998889999999997532 23345667788888765 999999999984 5567799999
Q ss_pred eccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEcccCc
Q 045798 766 EYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGL 845 (1008)
Q Consensus 766 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~ 845 (1008)
||+++|+|.+++.... .+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 76 ey~~~g~L~~~l~~~~----------~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~ 142 (316)
T cd05619 76 EYLNGGDLMFHIQSCH----------KFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGM 142 (316)
T ss_pred eCCCCCcHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCc
Confidence 9999999999987543 688899999999999999999998 999999999999999999999999999
Q ss_pred ccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCcch
Q 045798 846 ARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMALPNQV 925 (1008)
Q Consensus 846 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~ 925 (1008)
+........ ......||..|+|||++.+..++.++||||+||++|||++|+.||...... .........
T Consensus 143 ~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~--~~~~~i~~~----- 211 (316)
T cd05619 143 CKENMLGDA----KTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE--ELFQSIRMD----- 211 (316)
T ss_pred ceECCCCCC----ceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhC-----
Confidence 874322111 112345899999999999989999999999999999999999998642110 000000000
Q ss_pred hhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHH-HHH
Q 045798 926 MDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMT-NVV 985 (1008)
Q Consensus 926 ~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~-evl 985 (1008)
.+ ..+ .....++.+++.+||+.||++||++. ++.
T Consensus 212 ----~~----------------~~~------~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05619 212 ----NP----------------CYP------RWLTREAKDILVKLFVREPERRLGVKGDIR 246 (316)
T ss_pred ----CC----------------CCC------ccCCHHHHHHHHHHhccCHhhcCCChHHHH
Confidence 00 000 01234568999999999999999997 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=333.49 Aligned_cols=204 Identities=26% Similarity=0.268 Sum_probs=171.5
Q ss_pred HHhcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccc--cchhhHHHHHHHHHHhhcCCCCceeeeecccccc-ccC
Q 045798 681 KATNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQ--CEGASKSFMAECKALKNIRHRNLVKVITSCSSID-FQG 757 (1008)
Q Consensus 681 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~ 757 (1008)
...++|++.+.||+|+||.||+|.+...++.||+|++... .......+.+|+.+++.++||||+++++++.... ...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 3467899999999999999999999888999999998743 2334567889999999999999999999865322 123
Q ss_pred CceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCC
Q 045798 758 NDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLS 837 (1008)
Q Consensus 758 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 837 (1008)
....++||||++ +++.+++.. .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.
T Consensus 94 ~~~~~lv~e~~~-~~l~~~~~~------------~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~ 157 (355)
T cd07874 94 FQDVYLVMELMD-ANLCQVIQM------------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCT 157 (355)
T ss_pred cceeEEEhhhhc-ccHHHHHhh------------cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCC
Confidence 346799999995 567766632 578889999999999999999998 9999999999999999999
Q ss_pred eEEcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCc
Q 045798 838 GHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDV 905 (1008)
Q Consensus 838 ~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~ 905 (1008)
+||+|||+++....... .....||..|+|||++.+..++.++|||||||++|+|++|+.||..
T Consensus 158 ~kl~Dfg~~~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 220 (355)
T cd07874 158 LKILDFGLARTAGTSFM-----MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPG 220 (355)
T ss_pred EEEeeCcccccCCCccc-----cCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 99999999985433211 1234589999999999998999999999999999999999999864
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=341.81 Aligned_cols=280 Identities=24% Similarity=0.284 Sum_probs=194.9
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccchhhHHHHHHHHHHhhcCCCCceeeeeccccccc---cCCc
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSCSSIDF---QGND 759 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~---~~~~ 759 (1008)
.++|++.+.||+|+||.||+|....+++.||||++... .....+|+.+++.++||||+++++++....+ ....
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~----~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 140 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQD----PQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI 140 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecC----cchHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence 45799999999999999999999888999999988533 2234579999999999999999887543222 2233
Q ss_pred eEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCC-Ce
Q 045798 760 FKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDL-SG 838 (1008)
Q Consensus 760 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~ 838 (1008)
+.++||||++ +++.+++...... ...+++..++.++.||+.||+|||+. +|+||||||+||+++.++ .+
T Consensus 141 ~l~lvmE~~~-~~l~~~~~~~~~~------~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~v 210 (440)
T PTZ00036 141 FLNVVMEFIP-QTVHKYMKHYARN------NHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTL 210 (440)
T ss_pred EEEEEEecCC-ccHHHHHHHHhhc------CCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCce
Confidence 5779999996 5787776532111 11689999999999999999999998 999999999999998664 69
Q ss_pred EEcccCcccccccccCccccccccccccccccCccccCCC-CCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHH
Q 045798 839 HIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGS-EVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFA 917 (1008)
Q Consensus 839 kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~ 917 (1008)
||+|||+|+....... .....||+.|+|||++.+. .++.++|||||||++|||++|.+||......+ ......
T Consensus 211 kL~DFGla~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~-~~~~i~ 284 (440)
T PTZ00036 211 KLCDFGSAKNLLAGQR-----SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVD-QLVRII 284 (440)
T ss_pred eeeccccchhccCCCC-----cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHH
Confidence 9999999986543221 1234589999999987764 68999999999999999999999986432111 111111
Q ss_pred HhhCCcchhh--hhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 045798 918 RMALPNQVMD--IVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHE 987 (1008)
Q Consensus 918 ~~~~~~~~~~--~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 987 (1008)
.....+.... ...+.... ..............+ ....+.++.+++.+||+.||.+|||+.|+++.
T Consensus 285 ~~~~~p~~~~~~~~~~~~~~---~~~~~~~~~~l~~~~--p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h 351 (440)
T PTZ00036 285 QVLGTPTEDQLKEMNPNYAD---IKFPDVKPKDLKKVF--PKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351 (440)
T ss_pred HHhCCCCHHHHHHhchhhhc---ccCCccCchhHHHHh--ccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence 1111110000 00000000 000000000000000 01234578999999999999999999999853
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=322.27 Aligned_cols=265 Identities=29% Similarity=0.430 Sum_probs=204.0
Q ss_pred hcCCCCCceEeeccCeeEEEEEEc-----CCCeEEEEEEeccccch-hhHHHHHHHHHHhhcCCCCceeeeecccccccc
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALD-----EDGIVVAIKVINLQCEG-ASKSFMAECKALKNIRHRNLVKVITSCSSIDFQ 756 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 756 (1008)
.++|.+.+.||+|+||.||+|... .+++.||+|+++..... ..+.+.+|++++++++|+||+++++++ .
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~ 78 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVC-----T 78 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEE-----e
Confidence 346888999999999999999874 23578999999765443 457899999999999999999999995 4
Q ss_pred CCceEEEEEeccCCCChhcccccCCCCCCC----cccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeee
Q 045798 757 GNDFKAIVYEYMPNGSLEKWLHPHAVPKRD----KEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILL 832 (1008)
Q Consensus 757 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~----~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll 832 (1008)
.....++||||+++++|.+++...+..... ......+++.++..++.|++.|++|||+. +++||||||+||++
T Consensus 79 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili 155 (280)
T cd05049 79 EGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLV 155 (280)
T ss_pred cCCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEE
Confidence 456799999999999999999765321100 01123688999999999999999999997 99999999999999
Q ss_pred cCCCCeEEcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCccccCCc
Q 045798 833 DNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT-AKKPTDVMFEGDL 911 (1008)
Q Consensus 833 ~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-G~~pf~~~~~~~~ 911 (1008)
+.++.+||+|||.++......... ......+++.|+|||++.+..++.++|||||||++|||++ |..||......
T Consensus 156 ~~~~~~kl~d~g~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~-- 231 (280)
T cd05049 156 GYDLVVKIGDFGMSRDVYTTDYYR--VGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE-- 231 (280)
T ss_pred cCCCeEEECCcccceecccCccee--cCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHH--
Confidence 999999999999997543322111 1122335788999999999999999999999999999998 99998532111
Q ss_pred cHHHHHHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHHH
Q 045798 912 NLHNFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHELQ 989 (1008)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 989 (1008)
....... ...... .....+..+.+++.+||+.||++||+++||++.|+
T Consensus 232 ~~~~~~~-----------~~~~~~-------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 232 EVIECIT-----------QGRLLQ-------------------RPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred HHHHHHH-----------cCCcCC-------------------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 0000000 000000 00124456899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=316.29 Aligned_cols=249 Identities=26% Similarity=0.385 Sum_probs=194.7
Q ss_pred ceEeeccCeeEEEEEEcCCCeEEEEEEecccc-chhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceEEEEEecc
Q 045798 690 HLIGVGSFGCVYKGALDEDGIVVAIKVINLQC-EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKAIVYEYM 768 (1008)
Q Consensus 690 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 768 (1008)
+.||+|+||.||+|.+..+++.||+|.+.... ......+.+|++++++++||||++++++| ......++||||+
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~lv~e~~ 75 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC-----TQKQPIYIVMELV 75 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEE-----cCCCCeEEEEeec
Confidence 46999999999999998899999999886432 33456799999999999999999999995 4456689999999
Q ss_pred CCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEcccCcccc
Q 045798 769 PNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARF 848 (1008)
Q Consensus 769 ~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~ 848 (1008)
++++|.+++..... .+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||.+..
T Consensus 76 ~~~~L~~~~~~~~~---------~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 143 (252)
T cd05084 76 QGGDFLTFLRTEGP---------RLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSRE 143 (252)
T ss_pred cCCcHHHHHHhCCC---------CCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcc
Confidence 99999999865421 578999999999999999999997 999999999999999999999999999975
Q ss_pred cccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCccccCCccHHHHHHhhCCcchhh
Q 045798 849 HQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT-AKKPTDVMFEGDLNLHNFARMALPNQVMD 927 (1008)
Q Consensus 849 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 927 (1008)
........ .......+..|+|||.+.++.++.++|||||||++|||++ |..||....... . ..
T Consensus 144 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~--~------------~~ 207 (252)
T cd05084 144 EEDGVYAS--TGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQ--T------------RE 207 (252)
T ss_pred cccccccc--cCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHH--H------------HH
Confidence 43221110 0111123567999999998889999999999999999998 888875321100 0 00
Q ss_pred hhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHHH
Q 045798 928 IVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHELQ 989 (1008)
Q Consensus 928 ~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 989 (1008)
.+..... . .....++..+.+++.+||+.+|++|||+.||.+.|+
T Consensus 208 ~~~~~~~----------------~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 208 AIEQGVR----------------L--PCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred HHHcCCC----------------C--CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 0000000 0 001123556899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=318.42 Aligned_cols=265 Identities=22% Similarity=0.389 Sum_probs=201.9
Q ss_pred CCCCceEeeccCeeEEEEEEcCC---CeEEEEEEecccc--chhhHHHHHHHHHHhhcCCCCceeeeeccccccc-cCCc
Q 045798 686 FSSTHLIGVGSFGCVYKGALDED---GIVVAIKVINLQC--EGASKSFMAECKALKNIRHRNLVKVITSCSSIDF-QGND 759 (1008)
Q Consensus 686 y~~~~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~ 759 (1008)
|++.+.||+|+||.||+|....+ +..||+|+++... ......+.+|++.++.++||||+++++++..... ....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 56789999999999999998543 3789999987542 2334679999999999999999999998654332 3334
Q ss_pred eEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeE
Q 045798 760 FKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGH 839 (1008)
Q Consensus 760 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 839 (1008)
..++||||+++|+|..++........ ...+++..++.++.|++.||+|||+. +++||||||+||++++++.+|
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~----~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~k 153 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGL----PEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVC 153 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCC----cccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEE
Confidence 57999999999999999865432111 12689999999999999999999997 999999999999999999999
Q ss_pred EcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCccccCCccHHHHHH
Q 045798 840 IGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT-AKKPTDVMFEGDLNLHNFAR 918 (1008)
Q Consensus 840 L~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-G~~pf~~~~~~~~~~~~~~~ 918 (1008)
|+|||.++......... ......++..|+|||.+.+..++.++|||||||++|||++ |..||...... ....
T Consensus 154 l~dfg~~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~-----~~~~ 226 (273)
T cd05035 154 VADFGLSKKIYSGDYYR--QGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH-----EIYD 226 (273)
T ss_pred ECCccceeecccccccc--ccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH-----HHHH
Confidence 99999998654332211 1111235678999999988889999999999999999999 88887532110 0000
Q ss_pred hhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHHHHH
Q 045798 919 MALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHELQSV 991 (1008)
Q Consensus 919 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~i 991 (1008)
.. ..... ......++.++.+++.+||+.||.+|||+.|+++.|+.+
T Consensus 227 ~~------------~~~~~---------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 227 YL------------RHGNR---------------LKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred HH------------HcCCC---------------CCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 00 00000 000112455689999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=323.83 Aligned_cols=280 Identities=21% Similarity=0.274 Sum_probs=204.2
Q ss_pred cCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEecccc-chhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceEE
Q 045798 684 NGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC-EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKA 762 (1008)
Q Consensus 684 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 762 (1008)
++|++.+.||+|+||.||+|.+..++..||+|.++... .....++.+|++++++++||||+++++++ ..++..+
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~~ 75 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAF-----YSDGEIS 75 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----eeCCEEE
Confidence 46899999999999999999998899999999987542 23346788999999999999999999985 4567799
Q ss_pred EEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEcc
Q 045798 763 IVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGD 842 (1008)
Q Consensus 763 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 842 (1008)
+||||+++++|.+++.... .+++..+..++.|++.||+|||+. .+++||||||+||++++++.+||+|
T Consensus 76 lv~ey~~~~~L~~~l~~~~----------~~~~~~~~~~~~~i~~~l~~lH~~--~~i~H~dl~p~nil~~~~~~~~l~d 143 (308)
T cd06615 76 ICMEHMDGGSLDQVLKKAG----------RIPENILGKISIAVLRGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCD 143 (308)
T ss_pred EEeeccCCCcHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHhh--CCEEECCCChHHEEEecCCcEEEcc
Confidence 9999999999999997653 688999999999999999999973 2899999999999999999999999
Q ss_pred cCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHhhCC
Q 045798 843 FGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMALP 922 (1008)
Q Consensus 843 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~~~~ 922 (1008)
||.+....... .....++..|+|||.+.+..++.++|||||||++|+|++|+.||..... ............
T Consensus 144 fg~~~~~~~~~------~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~--~~~~~~~~~~~~ 215 (308)
T cd06615 144 FGVSGQLIDSM------ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDA--KELEAMFGRPVS 215 (308)
T ss_pred CCCcccccccc------cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcch--hhHHHhhcCccc
Confidence 99987543221 1224588999999999888899999999999999999999999863221 111111110000
Q ss_pred cch-hhhhcc---cccCchHHhh---hhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHH
Q 045798 923 NQV-MDIVDP---ILRNDEEILA---STDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHEL 988 (1008)
Q Consensus 923 ~~~-~~~~d~---~l~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 988 (1008)
... ...... .......... .........++.......+.++.+++.+||+.+|++|||+.||++.-
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~ 288 (308)
T cd06615 216 EGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHP 288 (308)
T ss_pred cccccCCcccccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence 000 000000 0000000000 00000000000001112456789999999999999999999998863
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=330.37 Aligned_cols=282 Identities=18% Similarity=0.211 Sum_probs=200.9
Q ss_pred HHHhcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEecccc--chhhHHHHHHHHHHhhcCCCCceeeeeccccccc-c
Q 045798 680 LKATNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC--EGASKSFMAECKALKNIRHRNLVKVITSCSSIDF-Q 756 (1008)
Q Consensus 680 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~ 756 (1008)
....++|++.+.||+|+||.||+|.+..+++.||||++.... ....+.+.+|++++++++||||+++++++..... .
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07878 11 WEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIE 90 (343)
T ss_pred hhhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccc
Confidence 345678999999999999999999998899999999986432 2234567899999999999999999988643221 2
Q ss_pred CCceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCC
Q 045798 757 GNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDL 836 (1008)
Q Consensus 757 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 836 (1008)
.....|+++|++ +++|.+++... .+++..+..++.||+.||+|||+. +|+||||||+||++++++
T Consensus 91 ~~~~~~~~~~~~-~~~l~~~~~~~-----------~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~ 155 (343)
T cd07878 91 NFNEVYLVTNLM-GADLNNIVKCQ-----------KLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDC 155 (343)
T ss_pred ccCcEEEEeecC-CCCHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCC
Confidence 234578999998 88998887532 689999999999999999999998 999999999999999999
Q ss_pred CeEEcccCcccccccccCccccccccccccccccCccccCC-CCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHH
Q 045798 837 SGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLG-SEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHN 915 (1008)
Q Consensus 837 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~ 915 (1008)
.+||+|||+++..... .....||..|+|||++.+ ..++.++|||||||++|+|++|+.||...... .....
T Consensus 156 ~~kl~Dfg~~~~~~~~-------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~ 227 (343)
T cd07878 156 ELRILDFGLARQADDE-------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYI-DQLKR 227 (343)
T ss_pred CEEEcCCccceecCCC-------cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHH-HHHHH
Confidence 9999999999855332 123458999999999877 56889999999999999999999998642111 11111
Q ss_pred HHHhhCCcchhhhhcccccCchHHhhhhhhhhhccccc--hhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 045798 916 FARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGI--NSRLECLISMVKIGVACSMESPQDRMNMTNVVHE 987 (1008)
Q Consensus 916 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 987 (1008)
+....... ..+........... .........+... .........+.+++.+|++.||.+|||+.|+++.
T Consensus 228 ~~~~~~~~-~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 228 IMEVVGTP-SPEVLKKISSEHAR--KYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred HHHHhCCC-CHHHHHhcchhhHH--HHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 11111000 00111100000000 0000000000000 0000123457899999999999999999999864
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=321.08 Aligned_cols=259 Identities=22% Similarity=0.301 Sum_probs=201.4
Q ss_pred HHhcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccchhhHHHHHHHHHHhhc-CCCCceeeeecccccccc-CC
Q 045798 681 KATNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNI-RHRNLVKVITSCSSIDFQ-GN 758 (1008)
Q Consensus 681 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~-~~ 758 (1008)
.+.+.|++.+.||+|+||.||+|....+++.||+|++.... .....+.+|+.++.++ +|+||+++++++...... ..
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 35678999999999999999999998899999999987543 3446788999999998 799999999997643222 13
Q ss_pred ceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCe
Q 045798 759 DFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSG 838 (1008)
Q Consensus 759 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 838 (1008)
...++||||+++++|.+++..... ..+++..+..++.|++.|++|||+. +|+||||||+||++++++.+
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~~--------~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~ 150 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNTKG--------NTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEV 150 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhccC--------CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCE
Confidence 568999999999999999875432 1688999999999999999999998 99999999999999999999
Q ss_pred EEcccCcccccccccCccccccccccccccccCccccC-----CCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccH
Q 045798 839 HIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGL-----GSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNL 913 (1008)
Q Consensus 839 kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~ 913 (1008)
||+|||++........ ......|+..|+|||++. +..++.++|||||||++|||++|+.||......
T Consensus 151 ~l~Dfg~~~~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~---- 222 (272)
T cd06637 151 KLVDFGVSAQLDRTVG----RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM---- 222 (272)
T ss_pred EEccCCCceecccccc----cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHH----
Confidence 9999999975533221 122345889999999876 335788999999999999999999998632110
Q ss_pred HHHHHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 914 HNFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 914 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
....... ... .+.. .....+.++.+++.+||..+|.+|||+.|+++
T Consensus 223 ~~~~~~~-~~~-----~~~~---------------------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 223 RALFLIP-RNP-----APRL---------------------KSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred HHHHHHh-cCC-----CCCC---------------------CCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 0000000 000 0000 00123456789999999999999999999875
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=316.79 Aligned_cols=255 Identities=29% Similarity=0.451 Sum_probs=199.7
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccchhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceEE
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKA 762 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 762 (1008)
.++|++.++||+|+||.||+|.+.. ...||+|+++... ...+.+.+|++++++++||||+++++.+. .+..+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~-~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~------~~~~~ 76 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS------EEPIY 76 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecC-CceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEEC------CCCcE
Confidence 3569999999999999999998864 4569999987532 23467899999999999999999998732 34479
Q ss_pred EEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEcc
Q 045798 763 IVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGD 842 (1008)
Q Consensus 763 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 842 (1008)
+||||+++|+|.+++..... ..+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|
T Consensus 77 lv~e~~~~~~L~~~~~~~~~--------~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~d 145 (262)
T cd05071 77 IVTEYMSKGSLLDFLKGEMG--------KYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVAD 145 (262)
T ss_pred EEEEcCCCCcHHHHHhhccc--------cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEecc
Confidence 99999999999999975421 1578999999999999999999997 999999999999999999999999
Q ss_pred cCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCccccCCccHHHHHHhhC
Q 045798 843 FGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT-AKKPTDVMFEGDLNLHNFARMAL 921 (1008)
Q Consensus 843 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-G~~pf~~~~~~~~~~~~~~~~~~ 921 (1008)
||.+.......... .....++..|+|||+..+..++.++|||||||++|||++ |..||....... ....
T Consensus 146 fg~~~~~~~~~~~~---~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~-----~~~~-- 215 (262)
T cd05071 146 FGLARLIEDNEYTA---RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-----VLDQ-- 215 (262)
T ss_pred CCceeecccccccc---ccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHH-----HHHH--
Confidence 99997654332111 112336778999999988889999999999999999999 788875321110 0000
Q ss_pred CcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHHHHH
Q 045798 922 PNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHELQSV 991 (1008)
Q Consensus 922 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~i 991 (1008)
..... . .+...+.+..+.+++.+|++.||++||+++++++.|+..
T Consensus 216 -------~~~~~----------------~--~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 216 -------VERGY----------------R--MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred -------HhcCC----------------C--CCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 00000 0 000123556789999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=326.07 Aligned_cols=277 Identities=23% Similarity=0.335 Sum_probs=199.2
Q ss_pred cCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEecccc-chhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceEE
Q 045798 684 NGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC-EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKA 762 (1008)
Q Consensus 684 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 762 (1008)
++|.+.+.||+|+||.||+|.+..+++.||+|+++... ......+.+|++++++++||||+++++++ ..++..+
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~~ 80 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIV-----HTDKSLT 80 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEE-----eeCCeEE
Confidence 57999999999999999999998889999999987543 23345688999999999999999999984 4566799
Q ss_pred EEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEcc
Q 045798 763 IVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGD 842 (1008)
Q Consensus 763 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 842 (1008)
+||||++ ++|.+++..... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|
T Consensus 81 lv~e~~~-~~l~~~~~~~~~---------~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~D 147 (309)
T cd07872 81 LVFEYLD-KDLKQYMDDCGN---------IMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLAD 147 (309)
T ss_pred EEEeCCC-CCHHHHHHhcCC---------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECc
Confidence 9999996 588888765431 578899999999999999999997 999999999999999999999999
Q ss_pred cCcccccccccCccccccccccccccccCccccCC-CCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHhhC
Q 045798 843 FGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLG-SEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMAL 921 (1008)
Q Consensus 843 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~~~ 921 (1008)
||+++........ .....++..|+|||++.+ ..++.++||||+||++|||++|+.||......+ ......+..
T Consensus 148 fg~~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~-~~~~~~~~~- 221 (309)
T cd07872 148 FGLARAKSVPTKT----YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVED-ELHLIFRLL- 221 (309)
T ss_pred cccceecCCCccc----cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHh-
Confidence 9999754332211 122347899999998765 468899999999999999999999986432211 111111111
Q ss_pred CcchhhhhcccccCchHHhhhhhhhh-hccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 922 PNQVMDIVDPILRNDEEILASTDKCR-RMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 922 ~~~~~~~~d~~l~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
.....+........ ... ....... ............+.++.+++.+|++.||.+|||++|+++
T Consensus 222 ~~~~~~~~~~~~~~-~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 222 GTPTEETWPGISSN-DEF-KNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred CCCCHHHHhhhcch-hhh-hhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 10000000000000 000 0000000 000000011124556789999999999999999999987
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=315.44 Aligned_cols=250 Identities=27% Similarity=0.410 Sum_probs=198.6
Q ss_pred cCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccchhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceEEE
Q 045798 684 NGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKAI 763 (1008)
Q Consensus 684 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 763 (1008)
++|++.+.||+|+||.||+|.. .++.||+|.++.. ...+.+.+|+.++++++|++++++++++ +..++..++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~--~~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~----~~~~~~~~l 77 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVI----VEEKGGLYI 77 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEE--cCCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEE----EcCCCceEE
Confidence 4688999999999999999987 4788999998643 3346789999999999999999999874 244566899
Q ss_pred EEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEccc
Q 045798 764 VYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDF 843 (1008)
Q Consensus 764 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 843 (1008)
||||+++++|.+++...... .+++..++.++.|++.||+|||++ +++||||||+||++++++.+||+||
T Consensus 78 v~e~~~~~~L~~~~~~~~~~--------~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df 146 (256)
T cd05082 78 VTEYMAKGSLVDYLRSRGRS--------VLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDF 146 (256)
T ss_pred EEECCCCCcHHHHHHhcCCC--------CCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCC
Confidence 99999999999998754321 578999999999999999999997 9999999999999999999999999
Q ss_pred CcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCccccCCccHHHHHHhhCC
Q 045798 844 GLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT-AKKPTDVMFEGDLNLHNFARMALP 922 (1008)
Q Consensus 844 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-G~~pf~~~~~~~~~~~~~~~~~~~ 922 (1008)
|++........ ...++..|+|||++.+..++.++|||||||++|||++ |+.||.... .......
T Consensus 147 g~~~~~~~~~~-------~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~-----~~~~~~~--- 211 (256)
T cd05082 147 GLTKEASSTQD-------TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP-----LKDVVPR--- 211 (256)
T ss_pred ccceeccccCC-------CCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCC-----HHHHHHH---
Confidence 99875433221 1224678999999988889999999999999999998 999875321 1111100
Q ss_pred cchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHHHHH
Q 045798 923 NQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHELQSV 991 (1008)
Q Consensus 923 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~i 991 (1008)
+..... .. ....++..+.+++.+||+.+|++|||+.++++.|+.+
T Consensus 212 ------~~~~~~----------------~~--~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 212 ------VEKGYK----------------MD--APDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred ------HhcCCC----------------CC--CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 000000 00 0012456689999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=342.83 Aligned_cols=204 Identities=24% Similarity=0.336 Sum_probs=167.0
Q ss_pred HHHHHHhcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccchhhHHHHHHHHHHhhcCC------CCceeeeecc
Q 045798 677 KSLLKATNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRH------RNLVKVITSC 750 (1008)
Q Consensus 677 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h------~niv~~~~~~ 750 (1008)
+++....++|++.++||+|+||+||+|.+..+++.||||+++.. ......+..|+++++.++| .+++++++++
T Consensus 122 ~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~ 200 (467)
T PTZ00284 122 EDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNV-PKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYF 200 (467)
T ss_pred CccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecc-hhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEE
Confidence 34445578899999999999999999999888999999999643 2233456677777777754 4578888775
Q ss_pred ccccccCCceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCe
Q 045798 751 SSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNI 830 (1008)
Q Consensus 751 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NI 830 (1008)
. ....+.|+|||++ +++|.+++.... .+++..+..|+.||+.||+|||+. .+||||||||+||
T Consensus 201 ~----~~~~~~~iv~~~~-g~~l~~~l~~~~----------~l~~~~~~~i~~qi~~aL~yLH~~--~gIiHrDlKP~NI 263 (467)
T PTZ00284 201 Q----NETGHMCIVMPKY-GPCLLDWIMKHG----------PFSHRHLAQIIFQTGVALDYFHTE--LHLMHTDLKPENI 263 (467)
T ss_pred E----cCCceEEEEEecc-CCCHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHhc--CCeecCCCCHHHE
Confidence 3 2345789999998 789999887543 689999999999999999999972 2999999999999
Q ss_pred eecCCC----------------CeEEcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHH
Q 045798 831 LLDNDL----------------SGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLL 894 (1008)
Q Consensus 831 ll~~~~----------------~~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ 894 (1008)
|++.++ .+||+|||.+...... .....||+.|+|||++.+..++.++|||||||++|
T Consensus 264 Ll~~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~~-------~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~ 336 (467)
T PTZ00284 264 LMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDERHS-------RTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIY 336 (467)
T ss_pred EEecCCcccccccccccCCCCceEEECCCCccccCccc-------cccccCCccccCcHHhhcCCCCcHHHHHHHHHHHH
Confidence 998765 4999999988632211 22356899999999999999999999999999999
Q ss_pred HHHhCCCCCCc
Q 045798 895 EMVTAKKPTDV 905 (1008)
Q Consensus 895 elltG~~pf~~ 905 (1008)
||++|+.||+.
T Consensus 337 elltG~~pf~~ 347 (467)
T PTZ00284 337 ELYTGKLLYDT 347 (467)
T ss_pred HHHhCCCCCCC
Confidence 99999999964
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=328.20 Aligned_cols=256 Identities=25% Similarity=0.411 Sum_probs=209.1
Q ss_pred CCCCceEeeccCeeEEEEEEcCCCe----EEEEEEecc-ccchhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCce
Q 045798 686 FSSTHLIGVGSFGCVYKGALDEDGI----VVAIKVINL-QCEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDF 760 (1008)
Q Consensus 686 y~~~~~lg~G~~g~Vy~~~~~~~~~----~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 760 (1008)
.+..++||+|+||+||+|.+...|+ +||+|++.. ...+...++.+|+-+|.++.|||+++++|+|....
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~------ 771 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST------ 771 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch------
Confidence 3456899999999999999965554 689998863 34566788999999999999999999999986432
Q ss_pred EEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEE
Q 045798 761 KAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHI 840 (1008)
Q Consensus 761 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 840 (1008)
..||++|++.|+|.+|++.++. ++.....+.|..|||+||.|||++ ++|||||..+||||.+-..+|+
T Consensus 772 ~qlvtq~mP~G~LlDyvr~hr~---------~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvki 839 (1177)
T KOG1025|consen 772 LQLVTQLMPLGCLLDYVREHRD---------NIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKI 839 (1177)
T ss_pred HHHHHHhcccchHHHHHHHhhc---------cccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEE
Confidence 7899999999999999998764 688889999999999999999998 9999999999999999999999
Q ss_pred cccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCccccCCccHHHHHHh
Q 045798 841 GDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT-AKKPTDVMFEGDLNLHNFARM 919 (1008)
Q Consensus 841 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-G~~pf~~~~~~~~~~~~~~~~ 919 (1008)
.|||+|+....+....... ...-.+.|||-|.+....|+.++|||||||++||++| |..|++....+
T Consensus 840 tdfgla~ll~~d~~ey~~~--~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~---------- 907 (1177)
T KOG1025|consen 840 TDFGLAKLLAPDEKEYSAP--GGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAE---------- 907 (1177)
T ss_pred EecchhhccCccccccccc--ccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHH----------
Confidence 9999999887665543322 2335678999999999999999999999999999999 99998643211
Q ss_pred hCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHHHHHHH
Q 045798 920 ALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHELQSVKN 993 (1008)
Q Consensus 920 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~i~~ 993 (1008)
.+.+++... .+ .+...-++.+++.++.+||..|+..||+|+++..++.++..
T Consensus 908 ----eI~dlle~g--------------eR----LsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ar 959 (1177)
T KOG1025|consen 908 ----EIPDLLEKG--------------ER----LSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMAR 959 (1177)
T ss_pred ----HhhHHHhcc--------------cc----CCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhc
Confidence 011111100 00 11223477889999999999999999999999999887653
|
|
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=317.87 Aligned_cols=250 Identities=25% Similarity=0.327 Sum_probs=197.4
Q ss_pred cCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEecccc-chhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceEE
Q 045798 684 NGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC-EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKA 762 (1008)
Q Consensus 684 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 762 (1008)
++|++.+.||+|+||.||+|.+..+++.||+|++.... ......+.+|++++++++||||+++++++ ..++..+
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~~ 75 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF-----FVENRIS 75 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEE-----EECCEEE
Confidence 36888999999999999999998899999999986542 33456789999999999999999999995 4456789
Q ss_pred EEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEcc
Q 045798 763 IVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGD 842 (1008)
Q Consensus 763 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 842 (1008)
+||||+++++|..+. .+++..+..++.|++.|++|||+. +|+|+||||+||+++.++.++|+|
T Consensus 76 lv~e~~~~~~l~~~~--------------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~d 138 (279)
T cd06619 76 ICTEFMDGGSLDVYR--------------KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCD 138 (279)
T ss_pred EEEecCCCCChHHhh--------------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEee
Confidence 999999999997652 567888999999999999999998 999999999999999999999999
Q ss_pred cCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccH--HHHHHhh
Q 045798 843 FGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNL--HNFARMA 920 (1008)
Q Consensus 843 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~--~~~~~~~ 920 (1008)
||++....... .....++..|+|||++.+..++.++|||||||++|+|++|+.||.......... .......
T Consensus 139 fg~~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 212 (279)
T cd06619 139 FGVSTQLVNSI------AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCI 212 (279)
T ss_pred CCcceeccccc------ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHH
Confidence 99997553321 122458999999999999899999999999999999999999986533221110 0000000
Q ss_pred CCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 045798 921 LPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHE 987 (1008)
Q Consensus 921 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 987 (1008)
.+. .. ... .....+.++.+++.+||+.+|++||+++|+++.
T Consensus 213 --------~~~----~~---------~~~-----~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 213 --------VDE----DP---------PVL-----PVGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred --------hcc----CC---------CCC-----CCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 000 00 000 001234467899999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=331.61 Aligned_cols=253 Identities=20% Similarity=0.239 Sum_probs=198.9
Q ss_pred cCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEecccc---chhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCce
Q 045798 684 NGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC---EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDF 760 (1008)
Q Consensus 684 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 760 (1008)
++|.+.+.||+|+||+||+|....+++.||+|+++... ....+.+.+|+.+++.++|+||+++++++ .+++.
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~-----~~~~~ 75 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAF-----QDKDN 75 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEE-----ecCCe
Confidence 47899999999999999999999899999999997432 23446788999999999999999999884 55677
Q ss_pred EEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEE
Q 045798 761 KAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHI 840 (1008)
Q Consensus 761 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 840 (1008)
.++||||+++|+|.+++..... .+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||
T Consensus 76 ~~lv~e~~~~~~L~~~l~~~~~---------~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL 143 (330)
T cd05601 76 LYLVMEYQPGGDLLSLLNRYED---------QFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKL 143 (330)
T ss_pred EEEEECCCCCCCHHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEe
Confidence 9999999999999999976521 689999999999999999999998 9999999999999999999999
Q ss_pred cccCcccccccccCccccccccccccccccCccccC------CCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHH
Q 045798 841 GDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGL------GSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLH 914 (1008)
Q Consensus 841 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~ 914 (1008)
+|||++......... ......||+.|+|||++. +..++.++|||||||++|||++|+.||..... ..
T Consensus 144 ~Dfg~a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~----~~ 216 (330)
T cd05601 144 ADFGSAARLTANKMV---NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTS----AK 216 (330)
T ss_pred ccCCCCeECCCCCce---eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCH----HH
Confidence 999999865433221 112245899999999976 45678999999999999999999999863211 11
Q ss_pred HHHHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 915 NFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 915 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
.+...... ...+. . +.....+..+.+++..|++ +|.+|||+++++.
T Consensus 217 ~~~~i~~~-------~~~~~--------------~----~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 217 TYNNIMNF-------QRFLK--------------F----PEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred HHHHHHcC-------CCccC--------------C----CCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 11000000 00000 0 0001234557889999998 9999999999885
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=318.14 Aligned_cols=259 Identities=25% Similarity=0.465 Sum_probs=202.3
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCe---EEEEEEecccc-chhhHHHHHHHHHHhhcCCCCceeeeeccccccccCC
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGI---VVAIKVINLQC-EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGN 758 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~---~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 758 (1008)
.++|+..+.||+|+||.||+|....+++ .||+|.++... ....+.+.+|++++++++|+||+++.+++ ...
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~ 78 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVV-----TKF 78 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEE-----ccC
Confidence 3568888999999999999999865543 79999987542 34456799999999999999999999985 455
Q ss_pred ceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCe
Q 045798 759 DFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSG 838 (1008)
Q Consensus 759 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 838 (1008)
+..++||||+++++|.+++..... .+++.++..++.|++.|++|||+. +++||||||+||++++++.+
T Consensus 79 ~~~~lv~e~~~~~~L~~~~~~~~~---------~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~ 146 (268)
T cd05063 79 KPAMIITEYMENGALDKYLRDHDG---------EFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLEC 146 (268)
T ss_pred CCcEEEEEcCCCCCHHHHHHhcCC---------CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcE
Confidence 678999999999999999865421 688999999999999999999998 99999999999999999999
Q ss_pred EEcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCccccCCccHHHHH
Q 045798 839 HIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT-AKKPTDVMFEGDLNLHNFA 917 (1008)
Q Consensus 839 kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-G~~pf~~~~~~~~~~~~~~ 917 (1008)
|++|||++............ ......+..|+|||++.+..++.++|||||||++|||++ |+.||...... ...
T Consensus 147 kl~dfg~~~~~~~~~~~~~~-~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~-----~~~ 220 (268)
T cd05063 147 KVSDFGLSRVLEDDPEGTYT-TSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH-----EVM 220 (268)
T ss_pred EECCCccceeccccccccee-ccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHH-----HHH
Confidence 99999999765433221111 111223567999999988889999999999999999997 99998532110 111
Q ss_pred HhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHHHHH
Q 045798 918 RMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHELQSV 991 (1008)
Q Consensus 918 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~i 991 (1008)
.. +... ...+ ...+++.++.+++.+||+.+|++||++.+|++.|+++
T Consensus 221 ~~---------i~~~--------------~~~~----~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 221 KA---------INDG--------------FRLP----APMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred HH---------HhcC--------------CCCC----CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 00 0000 0000 0113456689999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=318.17 Aligned_cols=265 Identities=22% Similarity=0.404 Sum_probs=200.0
Q ss_pred CCCCceEeeccCeeEEEEEEcCCCe--EEEEEEeccc--cchhhHHHHHHHHHHhhcCCCCceeeeeccccccc-cCCce
Q 045798 686 FSSTHLIGVGSFGCVYKGALDEDGI--VVAIKVINLQ--CEGASKSFMAECKALKNIRHRNLVKVITSCSSIDF-QGNDF 760 (1008)
Q Consensus 686 y~~~~~lg~G~~g~Vy~~~~~~~~~--~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~~ 760 (1008)
|.+.+.||+|+||.||+|.+..+++ .||+|.++.. .....+.+.+|+++++.++|+||++++++|..... .....
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 3567899999999999999876664 6999988743 23445778999999999999999999998753221 22235
Q ss_pred EEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEE
Q 045798 761 KAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHI 840 (1008)
Q Consensus 761 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 840 (1008)
.++||||+++|+|.+++........ ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl 153 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDC----PQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCV 153 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCC----cccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEE
Confidence 7899999999999998753321110 12589999999999999999999997 9999999999999999999999
Q ss_pred cccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCccccCCccHHHHHHh
Q 045798 841 GDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT-AKKPTDVMFEGDLNLHNFARM 919 (1008)
Q Consensus 841 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-G~~pf~~~~~~~~~~~~~~~~ 919 (1008)
+|||+++......... ......+++.|+|||+..+..++.++|||||||++|||++ |+.||..... ........
T Consensus 154 ~Dfg~~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~--~~~~~~~~- 228 (272)
T cd05075 154 ADFGLSKKIYNGDYYR--QGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN--SEIYDYLR- 228 (272)
T ss_pred CCCCcccccCccccee--cCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHHH-
Confidence 9999998654332111 1112235678999999999899999999999999999999 7888753211 00000000
Q ss_pred hCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHHHHH
Q 045798 920 ALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHELQSV 991 (1008)
Q Consensus 920 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~i 991 (1008)
... ..+ ....++..+.+++.+||+.||++|||+.|+++.|+.+
T Consensus 229 --~~~-----------------------~~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 229 --QGN-----------------------RLK----QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred --cCC-----------------------CCC----CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 000 000 0012345679999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=320.17 Aligned_cols=253 Identities=24% Similarity=0.311 Sum_probs=199.5
Q ss_pred cCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccchhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceEEE
Q 045798 684 NGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKAI 763 (1008)
Q Consensus 684 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 763 (1008)
++|++.+.||+|+||.||+|.+..+++.||+|+++.........+.+|+.+++.++||||+++++++ ..++..++
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~-----~~~~~~~l 83 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSY-----LRRDKLWI 83 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEE-----EeCCEEEE
Confidence 4788889999999999999999889999999999866555556788999999999999999999984 55677999
Q ss_pred EEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEccc
Q 045798 764 VYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDF 843 (1008)
Q Consensus 764 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 843 (1008)
||||+++++|.+++...+ .+++.+++.++.|++.|++|||+. +++|+||||+||+++.++.+||+||
T Consensus 84 v~e~~~~~~L~~~~~~~~----------~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~df 150 (267)
T cd06645 84 CMEFCGGGSLQDIYHVTG----------PLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADF 150 (267)
T ss_pred EEeccCCCcHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcc
Confidence 999999999999986543 688999999999999999999998 9999999999999999999999999
Q ss_pred CcccccccccCccccccccccccccccCccccC---CCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHhh
Q 045798 844 GLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGL---GSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMA 920 (1008)
Q Consensus 844 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~~ 920 (1008)
|.+........ ......|+..|+|||++. ...++.++|||||||++|+|++|+.||........ ........
T Consensus 151 g~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~-~~~~~~~~ 225 (267)
T cd06645 151 GVSAQITATIA----KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA-LFLMTKSN 225 (267)
T ss_pred eeeeEccCccc----ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhh-HHhhhccC
Confidence 99875532211 112345899999999874 45688999999999999999999999853221100 00000000
Q ss_pred CCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 921 LPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 921 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
.. .+.. ......+..+.+++.+||+.+|++|||+++|++
T Consensus 226 ~~-------~~~~--------------------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 226 FQ-------PPKL--------------------KDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred CC-------CCcc--------------------cccCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 00 0000 000113345789999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=322.14 Aligned_cols=269 Identities=25% Similarity=0.395 Sum_probs=204.4
Q ss_pred cCCCCCceEeeccCeeEEEEEEcCCCe--EEEEEEeccc-cchhhHHHHHHHHHHhhc-CCCCceeeeeccccccccCCc
Q 045798 684 NGFSSTHLIGVGSFGCVYKGALDEDGI--VVAIKVINLQ-CEGASKSFMAECKALKNI-RHRNLVKVITSCSSIDFQGND 759 (1008)
Q Consensus 684 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~ 759 (1008)
++|++.+.||+|+||.||+|....++. .+++|.++.. .....+.+.+|++++.++ +||||+++++++ ...+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~-----~~~~ 76 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGAC-----ENRG 76 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEE-----ccCC
Confidence 578999999999999999999876654 4788888743 234456789999999999 799999999985 4455
Q ss_pred eEEEEEeccCCCChhcccccCCCCCCC------cccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeec
Q 045798 760 FKAIVYEYMPNGSLEKWLHPHAVPKRD------KEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLD 833 (1008)
Q Consensus 760 ~~~lv~e~~~~gsL~~~l~~~~~~~~~------~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~ 833 (1008)
..++||||+++++|.+++......... ......+++..++.++.|++.|++|||++ +|+||||||+||+++
T Consensus 77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~ 153 (297)
T cd05089 77 YLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVG 153 (297)
T ss_pred cceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEEC
Confidence 689999999999999999764321100 01122588999999999999999999997 999999999999999
Q ss_pred CCCCeEEcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCccccCCcc
Q 045798 834 NDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT-AKKPTDVMFEGDLN 912 (1008)
Q Consensus 834 ~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-G~~pf~~~~~~~~~ 912 (1008)
+++.+||+|||++........ ......+..|+|||++.+..++.++|||||||++|||++ |..||.....
T Consensus 154 ~~~~~kl~dfg~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~---- 224 (297)
T cd05089 154 ENLASKIADFGLSRGEEVYVK-----KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTC---- 224 (297)
T ss_pred CCCeEEECCcCCCccccceec-----cCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH----
Confidence 999999999999864321111 111123567999999988889999999999999999997 9999853211
Q ss_pred HHHHHHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHHHHHH
Q 045798 913 LHNFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHELQSVK 992 (1008)
Q Consensus 913 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~i~ 992 (1008)
...... +..... .. ....++..+.+++.+||+.+|.+|||++++++.|+.+.
T Consensus 225 -~~~~~~---------~~~~~~----------------~~--~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~ 276 (297)
T cd05089 225 -AELYEK---------LPQGYR----------------ME--KPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRML 276 (297)
T ss_pred -HHHHHH---------HhcCCC----------------CC--CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 001000 000000 00 00123456789999999999999999999999999888
Q ss_pred HHHHH
Q 045798 993 NILLE 997 (1008)
Q Consensus 993 ~~~~~ 997 (1008)
+....
T Consensus 277 ~~~~~ 281 (297)
T cd05089 277 EARKA 281 (297)
T ss_pred Hhhcc
Confidence 76543
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=314.29 Aligned_cols=251 Identities=26% Similarity=0.349 Sum_probs=202.1
Q ss_pred CCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccc--cchhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceEE
Q 045798 685 GFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQ--CEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKA 762 (1008)
Q Consensus 685 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 762 (1008)
+|.+.+.||+|++|.||+|....+++.||+|.+... .....+.+.+|++++++++||||+++++++ ..++..+
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~ 75 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESF-----LDKGKLN 75 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeee-----ccCCEEE
Confidence 478889999999999999999889999999998643 234567899999999999999999999984 4556799
Q ss_pred EEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEcc
Q 045798 763 IVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGD 842 (1008)
Q Consensus 763 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 842 (1008)
+||||+++++|.+++..... ..+++..++.++.|++.|+.|||+. +++||||+|+||++++++.++|+|
T Consensus 76 lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~d 144 (256)
T cd08529 76 IVMEYAENGDLHKLLKMQRG--------RPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGD 144 (256)
T ss_pred EEEEeCCCCcHHHHHHHhcC--------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcc
Confidence 99999999999999976421 1688999999999999999999997 999999999999999999999999
Q ss_pred cCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHhhCC
Q 045798 843 FGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMALP 922 (1008)
Q Consensus 843 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~~~~ 922 (1008)
||.+.......... ....++..|+|||+..+..++.++|||||||++|+|++|+.||...... .....
T Consensus 145 f~~~~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----~~~~~--- 212 (256)
T cd08529 145 LGVAKLLSDNTNFA----NTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQG-----ALILK--- 212 (256)
T ss_pred cccceeccCccchh----hccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH-----HHHHH---
Confidence 99998654432211 2235788999999999988999999999999999999999998643210 00000
Q ss_pred cchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 045798 923 NQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHE 987 (1008)
Q Consensus 923 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 987 (1008)
...... +. .....+..+.+++.+||+.+|++||++.++++.
T Consensus 213 -----~~~~~~-----------------~~--~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 213 -----IIRGVF-----------------PP--VSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred -----HHcCCC-----------------CC--CccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 000000 00 001345568999999999999999999999863
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=329.84 Aligned_cols=238 Identities=30% Similarity=0.337 Sum_probs=186.5
Q ss_pred ceEeeccCeeEEEEEEcCCCeEEEEEEecccc---chhhHHHHHHHH-HHhhcCCCCceeeeeccccccccCCceEEEEE
Q 045798 690 HLIGVGSFGCVYKGALDEDGIVVAIKVINLQC---EGASKSFMAECK-ALKNIRHRNLVKVITSCSSIDFQGNDFKAIVY 765 (1008)
Q Consensus 690 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 765 (1008)
+.||+|+||+||+|.+..+|+.||+|++.... ......+..|.. +++.++||||+++++++ ..++..++||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~-----~~~~~~~lv~ 75 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSF-----QTADKLYFVL 75 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEE-----EeCCEEEEEE
Confidence 46999999999999999899999999986432 222344555554 56788999999999884 5667799999
Q ss_pred eccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEcccCc
Q 045798 766 EYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGL 845 (1008)
Q Consensus 766 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~ 845 (1008)
||+++|+|..++.... .+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 76 e~~~~g~L~~~l~~~~----------~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~ 142 (323)
T cd05575 76 DYVNGGELFFHLQRER----------SFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGL 142 (323)
T ss_pred cCCCCCCHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCC
Confidence 9999999999987543 688999999999999999999997 999999999999999999999999999
Q ss_pred ccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCcch
Q 045798 846 ARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMALPNQV 925 (1008)
Q Consensus 846 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~ 925 (1008)
+........ ......||+.|+|||++.+..++.++|||||||++|||++|+.||..... .....
T Consensus 143 ~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~-----~~~~~------- 206 (323)
T cd05575 143 CKEGIEHSK----TTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDT-----AEMYD------- 206 (323)
T ss_pred CcccccCCC----ccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCH-----HHHHH-------
Confidence 874322211 12234589999999999999999999999999999999999999864211 11100
Q ss_pred hhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHH
Q 045798 926 MDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMT 982 (1008)
Q Consensus 926 ~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ 982 (1008)
...... ...+ ...+..+.+++.+|++.||.+||++.
T Consensus 207 -----~i~~~~----------~~~~------~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 207 -----NILNKP----------LRLK------PNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred -----HHHcCC----------CCCC------CCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 000000 0000 11245678999999999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=333.35 Aligned_cols=208 Identities=25% Similarity=0.320 Sum_probs=176.5
Q ss_pred HHHHHHHhcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccc---cchhhHHHHHHHHHHhhcCCCCceeeeecccc
Q 045798 676 YKSLLKATNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQ---CEGASKSFMAECKALKNIRHRNLVKVITSCSS 752 (1008)
Q Consensus 676 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 752 (1008)
..++....++|++.+.||+|+||.||+|++..+++.||+|++... .....+.+.+|+.+++.++||||++++++
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~--- 111 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYA--- 111 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEE---
Confidence 344555668999999999999999999999999999999998632 12334568899999999999999999988
Q ss_pred ccccCCceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeee
Q 045798 753 IDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILL 832 (1008)
Q Consensus 753 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll 832 (1008)
+..++..++||||+++|+|.+++... .+++..+..++.||+.||+|||+. +|+||||||+||++
T Consensus 112 --~~~~~~~~lv~Ey~~gg~L~~~~~~~-----------~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll 175 (371)
T cd05622 112 --FQDDRYLYMVMEYMPGGDLVNLMSNY-----------DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLL 175 (371)
T ss_pred --EEcCCEEEEEEcCCCCCcHHHHHHhc-----------CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEE
Confidence 45667899999999999999998643 578888999999999999999998 99999999999999
Q ss_pred cCCCCeEEcccCcccccccccCccccccccccccccccCccccCCC----CCCcccchhhHHHHHHHHHhCCCCCCc
Q 045798 833 DNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGS----EVSTNGDVYSYGILLLEMVTAKKPTDV 905 (1008)
Q Consensus 833 ~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDvwslG~vl~elltG~~pf~~ 905 (1008)
+.++.+||+|||++......... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||..
T Consensus 176 ~~~~~ikL~DfG~a~~~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~ 249 (371)
T cd05622 176 DKSGHLKLADFGTCMKMNKEGMV---RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA 249 (371)
T ss_pred CCCCCEEEEeCCceeEcCcCCcc---cccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCC
Confidence 99999999999999865432211 11234699999999998654 378899999999999999999999864
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=318.29 Aligned_cols=259 Identities=25% Similarity=0.395 Sum_probs=202.1
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCe----EEEEEEecccc-chhhHHHHHHHHHHhhcCCCCceeeeeccccccccC
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGI----VVAIKVINLQC-EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQG 757 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 757 (1008)
.++|++.++||+|+||+||+|.+..+++ +||+|+++... ....+.+.+|+.+++.++||||++++++|..
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~----- 80 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT----- 80 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-----
Confidence 4578899999999999999999866665 48999987543 3445678999999999999999999998642
Q ss_pred CceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCC
Q 045798 758 NDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLS 837 (1008)
Q Consensus 758 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 837 (1008)
...++++||+++|+|.+++..... .+++..++.++.|++.||+|||+. +|+||||||+||++++++.
T Consensus 81 -~~~~l~~~~~~~g~l~~~l~~~~~---------~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~ 147 (279)
T cd05109 81 -STVQLVTQLMPYGCLLDYVRENKD---------RIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNH 147 (279)
T ss_pred -CCcEEEEEcCCCCCHHHHHhhccC---------CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCc
Confidence 236799999999999999875431 689999999999999999999997 9999999999999999999
Q ss_pred eEEcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCccccCCccHHHH
Q 045798 838 GHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT-AKKPTDVMFEGDLNLHNF 916 (1008)
Q Consensus 838 ~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-G~~pf~~~~~~~~~~~~~ 916 (1008)
+||+|||+++.......... .....++..|+|||...+..++.++|||||||++|||++ |..||...... .....
T Consensus 148 ~kL~dfG~~~~~~~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--~~~~~ 223 (279)
T cd05109 148 VKITDFGLARLLDIDETEYH--ADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAR--EIPDL 223 (279)
T ss_pred EEECCCCceeecccccceee--cCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHH
Confidence 99999999986643322111 112235678999999988899999999999999999998 88888632110 01111
Q ss_pred HHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHHHHHHH
Q 045798 917 ARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHELQSVKN 993 (1008)
Q Consensus 917 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~i~~ 993 (1008)
.. .... .+ ....++..+.+++.+||+.||++||++.|+++.|+.+..
T Consensus 224 ~~------------~~~~--------------~~----~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05109 224 LE------------KGER--------------LP----QPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMAR 270 (279)
T ss_pred HH------------CCCc--------------CC----CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 10 0000 00 001234567899999999999999999999999877654
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=319.72 Aligned_cols=262 Identities=25% Similarity=0.363 Sum_probs=201.1
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcC-----CCeEEEEEEecccc-chhhHHHHHHHHHHhhcCCCCceeeeecccccccc
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDE-----DGIVVAIKVINLQC-EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQ 756 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 756 (1008)
.++|.+.+.||+|+||.||+|.+.. .+..||+|.+.... ......+.+|+.++++++|+||+++++++ .
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~ 79 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVS-----F 79 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----c
Confidence 4679999999999999999999976 67889999887443 33446799999999999999999999985 3
Q ss_pred CCceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCC
Q 045798 757 GNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDL 836 (1008)
Q Consensus 757 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 836 (1008)
+.+..++||||+++++|.+++........ ....+++..++.++.||+.|++|||+. +++||||||+||+++.++
T Consensus 80 ~~~~~~lv~e~~~g~~L~~~i~~~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~ 153 (277)
T cd05036 80 ERLPRFILLELMAGGDLKSFLRENRPRPE---RPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKG 153 (277)
T ss_pred cCCCcEEEEecCCCCCHHHHHHHhCCCCC---CCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccC
Confidence 44567999999999999999976542211 112689999999999999999999997 999999999999998654
Q ss_pred ---CeEEcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCccccCCcc
Q 045798 837 ---SGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT-AKKPTDVMFEGDLN 912 (1008)
Q Consensus 837 ---~~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-G~~pf~~~~~~~~~ 912 (1008)
.+||+|||+++......... .......+..|+|||++.+..++.++|||||||++|||++ |..||......
T Consensus 154 ~~~~~kl~dfg~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~--- 228 (277)
T cd05036 154 PGRVAKIADFGMARDIYRASYYR--KGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ--- 228 (277)
T ss_pred CCcceEeccCccccccCCcccee--cCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH---
Confidence 58999999998653221111 1111224568999999998899999999999999999997 99998632111
Q ss_pred HHHHHHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHHH
Q 045798 913 LHNFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHELQ 989 (1008)
Q Consensus 913 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 989 (1008)
.... .+...... . ....++..+.+++.+||+.+|++|||+.+|++.|+
T Consensus 229 --~~~~---------~~~~~~~~--------------~----~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 229 --EVME---------FVTGGGRL--------------D----PPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred --HHHH---------HHHcCCcC--------------C----CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 0100 00000000 0 00123456889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=322.86 Aligned_cols=269 Identities=27% Similarity=0.429 Sum_probs=203.6
Q ss_pred cCCCCCceEeeccCeeEEEEEEcCCCe--EEEEEEecccc-chhhHHHHHHHHHHhhc-CCCCceeeeeccccccccCCc
Q 045798 684 NGFSSTHLIGVGSFGCVYKGALDEDGI--VVAIKVINLQC-EGASKSFMAECKALKNI-RHRNLVKVITSCSSIDFQGND 759 (1008)
Q Consensus 684 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~--~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~ 759 (1008)
++|++.+.||+|+||.||+|.+..++. .+|+|.++... ......+.+|++++.++ +|+||+++++++ ..++
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~-----~~~~ 81 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGAC-----EHRG 81 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEE-----CCCC
Confidence 568899999999999999999876665 45777766432 33456789999999999 899999999995 4556
Q ss_pred eEEEEEeccCCCChhcccccCCCCCCC------cccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeec
Q 045798 760 FKAIVYEYMPNGSLEKWLHPHAVPKRD------KEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLD 833 (1008)
Q Consensus 760 ~~~lv~e~~~~gsL~~~l~~~~~~~~~------~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~ 833 (1008)
..++||||+++++|.++++........ ......+++.+++.++.|++.|++|||+. +++||||||+||+++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~ 158 (303)
T cd05088 82 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVG 158 (303)
T ss_pred CceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEec
Confidence 799999999999999999755321100 01112689999999999999999999997 999999999999999
Q ss_pred CCCCeEEcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCccccCCcc
Q 045798 834 NDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT-AKKPTDVMFEGDLN 912 (1008)
Q Consensus 834 ~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-G~~pf~~~~~~~~~ 912 (1008)
+++.+||+|||++....... ......++..|+|||++.+..++.++|||||||++|||++ |..||......
T Consensus 159 ~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--- 230 (303)
T cd05088 159 ENYVAKIADFGLSRGQEVYV-----KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA--- 230 (303)
T ss_pred CCCcEEeCccccCcccchhh-----hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChH---
Confidence 99999999999986332111 1111224678999999988889999999999999999998 99998532111
Q ss_pred HHHHHHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHHHHHH
Q 045798 913 LHNFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHELQSVK 992 (1008)
Q Consensus 913 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~i~ 992 (1008)
...... +.. .. .. .....+..+.+++.+||+.+|++||+++++++.++++.
T Consensus 231 --~~~~~~-~~~--------~~--------------~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~ 281 (303)
T cd05088 231 --ELYEKL-PQG--------YR--------------LE----KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 281 (303)
T ss_pred --HHHHHH-hcC--------Cc--------------CC----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 010000 000 00 00 00113446789999999999999999999999999886
Q ss_pred HHHHH
Q 045798 993 NILLE 997 (1008)
Q Consensus 993 ~~~~~ 997 (1008)
+....
T Consensus 282 ~~~~~ 286 (303)
T cd05088 282 EERKT 286 (303)
T ss_pred Hhhhh
Confidence 66543
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=320.71 Aligned_cols=267 Identities=24% Similarity=0.369 Sum_probs=203.3
Q ss_pred CCCCCceEeeccCeeEEEEEEcC-----CCeEEEEEEeccccc-hhhHHHHHHHHHHhhcCCCCceeeeeccccccccCC
Q 045798 685 GFSSTHLIGVGSFGCVYKGALDE-----DGIVVAIKVINLQCE-GASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGN 758 (1008)
Q Consensus 685 ~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 758 (1008)
+|++.+.||+|+||.||+|.... ....||+|.+..... ...+.+.+|+.+++.++||||+++++.| ..+
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~ 75 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGAC-----SQD 75 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEE-----ecC
Confidence 47888999999999999998742 235799998875433 3456799999999999999999999985 445
Q ss_pred ceEEEEEeccCCCChhcccccCCCCCC--------------CcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceecc
Q 045798 759 DFKAIVYEYMPNGSLEKWLHPHAVPKR--------------DKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCD 824 (1008)
Q Consensus 759 ~~~~lv~e~~~~gsL~~~l~~~~~~~~--------------~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~D 824 (1008)
+..++|+||+++++|.+++........ .......+++..++.++.|++.||+|||+. +++|||
T Consensus 76 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~d 152 (290)
T cd05045 76 GPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRD 152 (290)
T ss_pred CCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---Ceehhh
Confidence 668999999999999999865422110 011123689999999999999999999997 999999
Q ss_pred CCCCCeeecCCCCeEEcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCC
Q 045798 825 LKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT-AKKPT 903 (1008)
Q Consensus 825 lkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-G~~pf 903 (1008)
|||+||++++++.+||+|||+++......... ......++..|+|||++.+..++.++||||||+++|||++ |..||
T Consensus 153 ikp~nill~~~~~~kl~dfg~~~~~~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~ 230 (290)
T cd05045 153 LAARNVLVAEGRKMKISDFGLSRDVYEEDSYV--KRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPY 230 (290)
T ss_pred hhhheEEEcCCCcEEeccccccccccCccchh--cccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCC
Confidence 99999999999999999999997553322211 1122335678999999988889999999999999999998 99998
Q ss_pred CccccCCccHHHHHHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHH
Q 045798 904 DVMFEGDLNLHNFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTN 983 (1008)
Q Consensus 904 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 983 (1008)
...... .....+....... ....++.++.+++.+||+.+|++||+++|
T Consensus 231 ~~~~~~--------------~~~~~~~~~~~~~------------------~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~ 278 (290)
T cd05045 231 PGIAPE--------------RLFNLLKTGYRME------------------RPENCSEEMYNLMLTCWKQEPDKRPTFAD 278 (290)
T ss_pred CCCCHH--------------HHHHHHhCCCCCC------------------CCCCCCHHHHHHHHHHccCCcccCCCHHH
Confidence 532110 0111111110000 00123456889999999999999999999
Q ss_pred HHHHHHHHHH
Q 045798 984 VVHELQSVKN 993 (1008)
Q Consensus 984 vl~~L~~i~~ 993 (1008)
+++.|+++-.
T Consensus 279 i~~~l~~~~~ 288 (290)
T cd05045 279 ISKELEKMMV 288 (290)
T ss_pred HHHHHHHHHh
Confidence 9999998754
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=316.64 Aligned_cols=252 Identities=26% Similarity=0.423 Sum_probs=197.1
Q ss_pred cCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccchhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceEEE
Q 045798 684 NGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKAI 763 (1008)
Q Consensus 684 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 763 (1008)
++|++.+.||+|+||.||+|.+. ++..||+|.++.. ....+.+.+|+.++++++||||++++++|. ..+..++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~aik~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~l 76 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEG-SMSEDEFIEEAKVMMKLSHEKLVQLYGVCT-----KQRPIYI 76 (256)
T ss_pred HHeEEeeEecCcccceEEEEEec-CCCcEEEEEcCCC-cccHHHHHHHHHHHhcCCCCCeeeEEEEEc-----cCCCcEE
Confidence 46888999999999999999885 4557999988743 233467899999999999999999999953 4456899
Q ss_pred EEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEccc
Q 045798 764 VYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDF 843 (1008)
Q Consensus 764 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 843 (1008)
||||+++|+|.+++..... .+++.+++.++.||+.||+|||+. +++|+||||+||+++.++.+||+||
T Consensus 77 v~e~~~~~~l~~~i~~~~~---------~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~ 144 (256)
T cd05113 77 VTEYMSNGCLLNYLREHGK---------RFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDF 144 (256)
T ss_pred EEEcCCCCcHHHHHHhcCC---------CCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCC
Confidence 9999999999999875421 578999999999999999999997 9999999999999999999999999
Q ss_pred CcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCccccCCccHHHHHHhhCC
Q 045798 844 GLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT-AKKPTDVMFEGDLNLHNFARMALP 922 (1008)
Q Consensus 844 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-G~~pf~~~~~~~~~~~~~~~~~~~ 922 (1008)
|.++........ ......++..|+|||+..+..++.++|||||||++|||++ |..||......+ ....
T Consensus 145 g~~~~~~~~~~~---~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~-----~~~~--- 213 (256)
T cd05113 145 GLSRYVLDDEYT---SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE-----TVEK--- 213 (256)
T ss_pred ccceecCCCcee---ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH-----HHHH---
Confidence 999755332211 1122335678999999988889999999999999999998 999986321110 0000
Q ss_pred cchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHHH
Q 045798 923 NQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHELQ 989 (1008)
Q Consensus 923 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 989 (1008)
...... .. .....+..+.+++.+||+.+|.+||++.++++.++
T Consensus 214 ---------~~~~~~-----------~~----~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 214 ---------VSQGLR-----------LY----RPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred ---------HhcCCC-----------CC----CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 000000 00 00012456799999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=314.55 Aligned_cols=253 Identities=30% Similarity=0.484 Sum_probs=198.9
Q ss_pred cCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccchhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceEEE
Q 045798 684 NGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKAI 763 (1008)
Q Consensus 684 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 763 (1008)
++|++.+.||+|+||.||+|... ++..||+|.++.... ..+.+.+|+.++++++|++++++++++. ....++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~------~~~~~l 77 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS------EEPIYI 77 (260)
T ss_pred HHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC------CCCcEE
Confidence 47899999999999999999875 667899999875432 3467999999999999999999998742 344789
Q ss_pred EEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEccc
Q 045798 764 VYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDF 843 (1008)
Q Consensus 764 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 843 (1008)
||||+++++|.+++...... .+++.+++.++.|++.||+|||+. +++||||||+||++++++.++|+||
T Consensus 78 v~e~~~~~~L~~~~~~~~~~--------~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~df 146 (260)
T cd05070 78 VTEYMSKGSLLDFLKDGEGR--------ALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADF 146 (260)
T ss_pred EEEecCCCcHHHHHHhcCCC--------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCc
Confidence 99999999999998754321 588999999999999999999998 9999999999999999999999999
Q ss_pred CcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCccccCCccHHHHHHhhCC
Q 045798 844 GLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT-AKKPTDVMFEGDLNLHNFARMALP 922 (1008)
Q Consensus 844 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-G~~pf~~~~~~~~~~~~~~~~~~~ 922 (1008)
|.+.......... .....++..|+|||++.+..++.++||||||+++|||++ |..||...... ....
T Consensus 147 g~~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~-----~~~~---- 214 (260)
T cd05070 147 GLARLIEDNEYTA---RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR-----EVLE---- 214 (260)
T ss_pred eeeeeccCccccc---ccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH-----HHHH----
Confidence 9998654322111 112235678999999988889999999999999999999 88888532110 0000
Q ss_pred cchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHHHH
Q 045798 923 NQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHELQS 990 (1008)
Q Consensus 923 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 990 (1008)
.+..... . +.....+..+.+++.+||..+|.+|||++++.+.|+.
T Consensus 215 -----~~~~~~~--------------~----~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 215 -----QVERGYR--------------M----PCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred -----HHHcCCC--------------C----CCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 0000000 0 0011234568999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=319.84 Aligned_cols=265 Identities=23% Similarity=0.365 Sum_probs=201.0
Q ss_pred cCCCCCceEeeccCeeEEEEEE----cCCCeEEEEEEecccc-chhhHHHHHHHHHHhhcCCCCceeeeeccccccccCC
Q 045798 684 NGFSSTHLIGVGSFGCVYKGAL----DEDGIVVAIKVINLQC-EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGN 758 (1008)
Q Consensus 684 ~~y~~~~~lg~G~~g~Vy~~~~----~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 758 (1008)
++|++.+.||+|+||.||+|.. ...++.||+|.++... ......+.+|++++++++||||+++++++ ..+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-----~~~ 79 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVV-----TQE 79 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEE-----ecC
Confidence 4678889999999999999985 2356789999997433 23346789999999999999999999984 455
Q ss_pred ceEEEEEeccCCCChhcccccCCCCCC-------CcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCee
Q 045798 759 DFKAIVYEYMPNGSLEKWLHPHAVPKR-------DKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNIL 831 (1008)
Q Consensus 759 ~~~~lv~e~~~~gsL~~~l~~~~~~~~-------~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIl 831 (1008)
+..|+||||+++++|.+++........ .......+++.++..++.|++.||+|||+. +++||||||+||+
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nil 156 (283)
T cd05090 80 QPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNIL 156 (283)
T ss_pred CceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEE
Confidence 678999999999999999864321100 001122588999999999999999999997 9999999999999
Q ss_pred ecCCCCeEEcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCccccCC
Q 045798 832 LDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT-AKKPTDVMFEGD 910 (1008)
Q Consensus 832 l~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-G~~pf~~~~~~~ 910 (1008)
+++++.+||+|||+++......... ......++..|+|||++.+..++.++|||||||++|||++ |..||.....
T Consensus 157 i~~~~~~kl~dfg~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~-- 232 (283)
T cd05090 157 IGEQLHVKISDLGLSREIYSADYYR--VQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN-- 232 (283)
T ss_pred EcCCCcEEeccccccccccCCccee--cccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH--
Confidence 9999999999999998654322111 1122335678999999988889999999999999999998 8888753211
Q ss_pred ccHHHHHHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHHHH
Q 045798 911 LNLHNFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHELQS 990 (1008)
Q Consensus 911 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 990 (1008)
............ + +....++.++.+++.+||+.||++||++.+|.+.|.+
T Consensus 233 ~~~~~~~~~~~~----------~--------------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 233 QEVIEMVRKRQL----------L--------------------PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HHHHHHHHcCCc----------C--------------------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 001111100000 0 0011234567899999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=314.71 Aligned_cols=255 Identities=25% Similarity=0.436 Sum_probs=192.5
Q ss_pred ceEeeccCeeEEEEEEcC---CCeEEEEEEeccc-cchhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceEEEEE
Q 045798 690 HLIGVGSFGCVYKGALDE---DGIVVAIKVINLQ-CEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKAIVY 765 (1008)
Q Consensus 690 ~~lg~G~~g~Vy~~~~~~---~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 765 (1008)
+.||+|+||.||+|.+.. .+..||+|++... .....+.+.+|+.+++.++||||++++++|. ..+...++||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~----~~~~~~~lv~ 76 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICL----PSEGSPLVVL 76 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEee----cCCCCcEEEE
Confidence 468999999999998742 3467999998643 2344578899999999999999999999763 3345578999
Q ss_pred eccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEcccCc
Q 045798 766 EYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGL 845 (1008)
Q Consensus 766 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~ 845 (1008)
||+.+|+|.+++..... ..++..+..++.|++.|++|||+. +++||||||+||++++++.+||+|||+
T Consensus 77 e~~~~~~L~~~~~~~~~---------~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~ 144 (262)
T cd05058 77 PYMKHGDLRNFIRSETH---------NPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGL 144 (262)
T ss_pred ecCCCCCHHHHHHhcCC---------CCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccc
Confidence 99999999999875431 457778899999999999999997 999999999999999999999999999
Q ss_pred ccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCC-CCCCccccCCccHHHHHHhhCCcc
Q 045798 846 ARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAK-KPTDVMFEGDLNLHNFARMALPNQ 924 (1008)
Q Consensus 846 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~-~pf~~~~~~~~~~~~~~~~~~~~~ 924 (1008)
++.................++..|+|||.+.+..++.++|||||||++|||++|. +||..... ........
T Consensus 145 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~-----~~~~~~~~--- 216 (262)
T cd05058 145 ARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDS-----FDITVYLL--- 216 (262)
T ss_pred cccccCCcceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCH-----HHHHHHHh---
Confidence 9755332211111112234677899999998888999999999999999999965 45532110 00100000
Q ss_pred hhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHHHHHH
Q 045798 925 VMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHELQSVK 992 (1008)
Q Consensus 925 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~i~ 992 (1008)
.... .. .....+..+.+++.+||+.+|++||++.||++.|+++.
T Consensus 217 ---------~~~~-----------~~----~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 217 ---------QGRR-----------LL----QPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred ---------cCCC-----------CC----CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence 0000 00 00123456889999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=331.76 Aligned_cols=284 Identities=20% Similarity=0.169 Sum_probs=201.9
Q ss_pred HhcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccc--cchhhHHHHHHHHHHhhcCCCCceeeeecccccc-ccCC
Q 045798 682 ATNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQ--CEGASKSFMAECKALKNIRHRNLVKVITSCSSID-FQGN 758 (1008)
Q Consensus 682 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~~ 758 (1008)
..++|++.+.||+|+||.||+|.+...++.||||++... .......+.+|+.+++.++||||+++++++.... ....
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 457899999999999999999999889999999998743 2334567889999999999999999998864322 2333
Q ss_pred ceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCe
Q 045798 759 DFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSG 838 (1008)
Q Consensus 759 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 838 (1008)
...|+||||++ ++|.+++.. .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+
T Consensus 102 ~~~~lv~e~~~-~~l~~~~~~------------~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~ 165 (364)
T cd07875 102 QDVYIVMELMD-ANLCQVIQM------------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTL 165 (364)
T ss_pred CeEEEEEeCCC-CCHHHHHHh------------cCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcE
Confidence 46899999995 577777642 467888999999999999999997 99999999999999999999
Q ss_pred EEcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHH
Q 045798 839 HIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFAR 918 (1008)
Q Consensus 839 kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~ 918 (1008)
||+|||+++....... .....+|..|+|||++.+..++.++|||||||++|||++|+.||...... ..+.....
T Consensus 166 kL~DfG~a~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~-~~~~~~~~ 239 (364)
T cd07875 166 KILDFGLARTAGTSFM-----MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHI-DQWNKVIE 239 (364)
T ss_pred EEEeCCCccccCCCCc-----ccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHH-HHHHHHHH
Confidence 9999999985533211 12245899999999999999999999999999999999999998643211 11111111
Q ss_pred hhCC--cchhhhhcccccCchHHhhhhh--------hhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 045798 919 MALP--NQVMDIVDPILRNDEEILASTD--------KCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHE 987 (1008)
Q Consensus 919 ~~~~--~~~~~~~d~~l~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 987 (1008)
.... ......+.+......+.+.... .....+...........++.+++.+|++.||.+|||+.|+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 240 QLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred hcCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 1000 0011111100000000000000 0000000000111234567899999999999999999999873
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=314.55 Aligned_cols=254 Identities=24% Similarity=0.345 Sum_probs=200.4
Q ss_pred cCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccc-----hhhHHHHHHHHHHhhcCCCCceeeeeccccccccCC
Q 045798 684 NGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCE-----GASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGN 758 (1008)
Q Consensus 684 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 758 (1008)
++|.+.+.||+|++|.||+|....+++.||+|+++.... ...+.+.+|++++++++||||+++++++ ..+
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~ 76 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCL-----RDD 76 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEE-----ccC
Confidence 578999999999999999999988899999999864321 1235688999999999999999999994 455
Q ss_pred ceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCe
Q 045798 759 DFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSG 838 (1008)
Q Consensus 759 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 838 (1008)
+..++|+||+++++|.+++.... .+++..+..++.|++.|++|||+. +++||||+|+||++++++.+
T Consensus 77 ~~~~~v~e~~~~~~l~~~~~~~~----------~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~ 143 (263)
T cd06625 77 ETLSIFMEYMPGGSVKDQLKAYG----------ALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNV 143 (263)
T ss_pred CeEEEEEEECCCCcHHHHHHHhC----------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCE
Confidence 68999999999999999987543 578899999999999999999998 99999999999999999999
Q ss_pred EEcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHH
Q 045798 839 HIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFAR 918 (1008)
Q Consensus 839 kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~ 918 (1008)
+|+|||.++......... .......++..|+|||++.+..++.++||||+|+++|||++|+.||..... ......
T Consensus 144 ~l~dfg~~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~----~~~~~~ 218 (263)
T cd06625 144 KLGDFGASKRLQTICSSG-TGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEA----MAAIFK 218 (263)
T ss_pred EEeecccceecccccccc-ccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccch----HHHHHH
Confidence 999999997554322111 111223478899999999998899999999999999999999999863211 000000
Q ss_pred hhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 045798 919 MALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHE 987 (1008)
Q Consensus 919 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 987 (1008)
...... ... .....+..+.+++.+||+.+|.+|||+.|+++.
T Consensus 219 ~~~~~~-------------------------~~~--~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 219 IATQPT-------------------------NPQ--LPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred HhccCC-------------------------CCC--CCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 000000 000 011234567899999999999999999999863
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=320.34 Aligned_cols=275 Identities=23% Similarity=0.397 Sum_probs=204.0
Q ss_pred cCCCCCceEeeccCeeEEEEEE----cCCCeEEEEEEecccc-chhhHHHHHHHHHHhhcCCCCceeeeeccccccccCC
Q 045798 684 NGFSSTHLIGVGSFGCVYKGAL----DEDGIVVAIKVINLQC-EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGN 758 (1008)
Q Consensus 684 ~~y~~~~~lg~G~~g~Vy~~~~----~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 758 (1008)
.-|++.+.||+|+||.||+|.. ..++..||+|.++... ....+.+.+|+++++.++||||+++.+++.. .++
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~ 80 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTE---DGG 80 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEec---CCC
Confidence 3478899999999999999985 3467899999987543 3345679999999999999999999998643 234
Q ss_pred ceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCe
Q 045798 759 DFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSG 838 (1008)
Q Consensus 759 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 838 (1008)
...++||||+++++|.+++..... .+++..+..++.|++.||+|||+. +++||||||+||+++.++.+
T Consensus 81 ~~~~lv~e~~~g~~L~~~l~~~~~---------~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~ 148 (284)
T cd05079 81 NGIKLIMEFLPSGSLKEYLPRNKN---------KINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQV 148 (284)
T ss_pred CceEEEEEccCCCCHHHHHHhccC---------CCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCE
Confidence 568999999999999999865421 579999999999999999999997 99999999999999999999
Q ss_pred EEcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHH
Q 045798 839 HIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFAR 918 (1008)
Q Consensus 839 kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~ 918 (1008)
||+|||.++......... .......++..|+|||++.+..++.++|||||||++|||++++.|+...... ...
T Consensus 149 ~l~dfg~~~~~~~~~~~~-~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~------~~~ 221 (284)
T cd05079 149 KIGDFGLTKAIETDKEYY-TVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTL------FLK 221 (284)
T ss_pred EECCCccccccccCccce-eecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccch------hhh
Confidence 999999998664432211 1122344677899999998888999999999999999999988775322110 000
Q ss_pred hhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHHHHH
Q 045798 919 MALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHELQSV 991 (1008)
Q Consensus 919 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~i 991 (1008)
...+.......+.. .......... +....++..+.+++.+||+.+|++|||++++++.++.+
T Consensus 222 ~~~~~~~~~~~~~~-------~~~~~~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 222 MIGPTHGQMTVTRL-------VRVLEEGKRL----PRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred hcccccccccHHHH-------HHHHHcCccC----CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 00000000000000 0000000000 01123456789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=326.59 Aligned_cols=243 Identities=25% Similarity=0.317 Sum_probs=191.2
Q ss_pred CCCCCceEeeccCeeEEEEEEcCCCeEEEEEEecccc---chhhHHHHHHHHHHhhcC-CCCceeeeeccccccccCCce
Q 045798 685 GFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC---EGASKSFMAECKALKNIR-HRNLVKVITSCSSIDFQGNDF 760 (1008)
Q Consensus 685 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~ 760 (1008)
+|+..+.||+|+||.||+|.+..+++.||+|+++... ....+.+..|++++..+. |++|+++.++ +...+.
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~-----~~~~~~ 75 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSC-----FQTVDR 75 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeE-----EecCCE
Confidence 4778899999999999999999899999999987432 233456788999998885 5677788877 455677
Q ss_pred EEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEE
Q 045798 761 KAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHI 840 (1008)
Q Consensus 761 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 840 (1008)
.|+||||+++|+|.+++.... .+++.+++.++.|++.||+|||++ +|+||||||+||+++.++.+||
T Consensus 76 ~~lv~Ey~~~g~L~~~i~~~~----------~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL 142 (323)
T cd05615 76 LYFVMEYVNGGDLMYHIQQVG----------KFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKI 142 (323)
T ss_pred EEEEEcCCCCCcHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEE
Confidence 999999999999999986543 689999999999999999999997 9999999999999999999999
Q ss_pred cccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHhh
Q 045798 841 GDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMA 920 (1008)
Q Consensus 841 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~~ 920 (1008)
+|||+++....... ......||+.|+|||++.+..++.++||||+||++|||++|+.||...... ....
T Consensus 143 ~Dfg~~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~-----~~~~-- 211 (323)
T cd05615 143 ADFGMCKEHMVDGV----TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDED-----ELFQ-- 211 (323)
T ss_pred eccccccccCCCCc----cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHH-----HHHH--
Confidence 99999874322211 112345899999999999889999999999999999999999998643110 0000
Q ss_pred CCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHH
Q 045798 921 LPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMT 982 (1008)
Q Consensus 921 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ 982 (1008)
.+..... ..+ ...+.++.+++.+|++.+|.+|+++.
T Consensus 212 ------~i~~~~~--------------~~p------~~~~~~~~~li~~~l~~~p~~R~~~~ 247 (323)
T cd05615 212 ------SIMEHNV--------------SYP------KSLSKEAVSICKGLMTKHPSKRLGCG 247 (323)
T ss_pred ------HHHhCCC--------------CCC------ccCCHHHHHHHHHHcccCHhhCCCCC
Confidence 0000000 000 11234568999999999999999853
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=320.84 Aligned_cols=260 Identities=25% Similarity=0.364 Sum_probs=202.2
Q ss_pred hcCCCCCceEeeccCeeEEEEEE-----cCCCeEEEEEEecccc-chhhHHHHHHHHHHhhc-CCCCceeeeeccccccc
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGAL-----DEDGIVVAIKVINLQC-EGASKSFMAECKALKNI-RHRNLVKVITSCSSIDF 755 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~-----~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 755 (1008)
.++|.+.+.||+|+||.||+|.. ...+..||+|+++... ....+.+.+|+++++++ +||||+++++++
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~----- 108 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGAC----- 108 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEE-----
Confidence 35689999999999999999975 2345689999987543 34456799999999999 799999999985
Q ss_pred cCCceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCC
Q 045798 756 QGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDND 835 (1008)
Q Consensus 756 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~ 835 (1008)
...+..++||||+++|+|.++++..... .+++.++..++.|++.||+|||+. +|+|+||||+||+++.+
T Consensus 109 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~--------~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~ 177 (302)
T cd05055 109 TIGGPILVITEYCCYGDLLNFLRRKRES--------FLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHG 177 (302)
T ss_pred ecCCceEEEEEcCCCCcHHHHHHhCCCC--------CCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCC
Confidence 4455689999999999999998754311 489999999999999999999997 99999999999999999
Q ss_pred CCeEEcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCccccCCccHH
Q 045798 836 LSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT-AKKPTDVMFEGDLNLH 914 (1008)
Q Consensus 836 ~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-G~~pf~~~~~~~~~~~ 914 (1008)
+.+|++|||.++......... ......++..|+|||.+.+..++.++||||+||++|||++ |..||.......
T Consensus 178 ~~~~l~dfg~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~---- 251 (302)
T cd05055 178 KIVKICDFGLARDIMNDSNYV--VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS---- 251 (302)
T ss_pred CeEEECCCcccccccCCCcee--ecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH----
Confidence 999999999998654332211 1112346788999999999899999999999999999998 999986432111
Q ss_pred HHHHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHHHHH
Q 045798 915 NFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHELQSV 991 (1008)
Q Consensus 915 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~i 991 (1008)
.+. ..++..... . .....+.++.+++.+||+.+|++|||+.|+++.|+++
T Consensus 252 ~~~---------~~~~~~~~~----------------~--~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 252 KFY---------KLIKEGYRM----------------A--QPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred HHH---------HHHHcCCcC----------------C--CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 000 000000000 0 0001234689999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=313.62 Aligned_cols=248 Identities=23% Similarity=0.347 Sum_probs=194.1
Q ss_pred eEeeccCeeEEEEEE--cCCCeEEEEEEecccc--chhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceEEEEEe
Q 045798 691 LIGVGSFGCVYKGAL--DEDGIVVAIKVINLQC--EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKAIVYE 766 (1008)
Q Consensus 691 ~lg~G~~g~Vy~~~~--~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 766 (1008)
.||+|+||.||+|.+ ..+++.||+|+++... ....+.+.+|+.+++.+.||||+++++++. ++..++|||
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~------~~~~~lv~e 75 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE------AESWMLVME 75 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc------CCCcEEEEe
Confidence 589999999999975 3467899999987443 234567899999999999999999999853 345689999
Q ss_pred ccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEcccCcc
Q 045798 767 YMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLA 846 (1008)
Q Consensus 767 ~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a 846 (1008)
|+++|+|.+++.... .+++..+..++.|++.|++|||+. +|+||||||+||++++++.+||+|||.+
T Consensus 76 ~~~~~~L~~~l~~~~----------~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~ 142 (257)
T cd05116 76 LAELGPLNKFLQKNK----------HVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLS 142 (257)
T ss_pred cCCCCcHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccc
Confidence 999999999986543 688999999999999999999997 9999999999999999999999999999
Q ss_pred cccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCccccCCccHHHHHHhhCCcch
Q 045798 847 RFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT-AKKPTDVMFEGDLNLHNFARMALPNQV 925 (1008)
Q Consensus 847 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~ 925 (1008)
............ .....++..|+|||.+....++.++|||||||++|||++ |..||...... ......
T Consensus 143 ~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--~~~~~i-------- 211 (257)
T cd05116 143 KALGADENYYKA-KTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN--EVTQMI-------- 211 (257)
T ss_pred cccCCCCCeeee-cCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHH--------
Confidence 865443322111 112234678999999888889999999999999999998 99998643111 011111
Q ss_pred hhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHHHH
Q 045798 926 MDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHELQS 990 (1008)
Q Consensus 926 ~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 990 (1008)
..... ... ...++.++.+++.+||+.||++||++++|++.|+.
T Consensus 212 ----~~~~~------------~~~------~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 212 ----ESGER------------MEC------PQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred ----HCCCC------------CCC------CCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 00000 000 01245568999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=315.09 Aligned_cols=251 Identities=28% Similarity=0.419 Sum_probs=197.0
Q ss_pred cCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccchhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceEEE
Q 045798 684 NGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKAI 763 (1008)
Q Consensus 684 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 763 (1008)
.+|++.+.||+|+||.||+|.+. ++..+|+|++... ......+.+|++++++++||||+++++++ ...+..++
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~l 76 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREG-AMSEDDFIEEAKVMMKLSHPNLVQLYGVC-----TKQRPIFI 76 (256)
T ss_pred HHcchhhhhccCCCceEEEeEec-CCccEEEEEeccC-CCCHHHHHHHHHHHHhCCCCCEEEEEEEE-----cCCCceEE
Confidence 35788999999999999999885 5678999998643 22345788999999999999999999984 45567899
Q ss_pred EEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEccc
Q 045798 764 VYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDF 843 (1008)
Q Consensus 764 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 843 (1008)
||||+++++|.+++..... .+++..++.++.|++.|++|||+. +++||||||+||++++++.+||+||
T Consensus 77 v~e~~~~~~L~~~l~~~~~---------~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~df 144 (256)
T cd05059 77 VTEYMANGCLLNYLRERKG---------KLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDF 144 (256)
T ss_pred EEecCCCCCHHHHHHhccc---------CCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCc
Confidence 9999999999999875431 578999999999999999999998 9999999999999999999999999
Q ss_pred CcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCccccCCccHHHHHHhhCC
Q 045798 844 GLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT-AKKPTDVMFEGDLNLHNFARMALP 922 (1008)
Q Consensus 844 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-G~~pf~~~~~~~~~~~~~~~~~~~ 922 (1008)
|.++......... .....++..|+|||.+.+..++.++||||||+++|||++ |+.||......+ ......
T Consensus 145 g~~~~~~~~~~~~---~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--~~~~~~---- 215 (256)
T cd05059 145 GLARYVLDDQYTS---SQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE--VVESVS---- 215 (256)
T ss_pred ccceecccccccc---cCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHH--HHHHHH----
Confidence 9997654322111 111224568999999998899999999999999999999 788886321110 000000
Q ss_pred cchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHH
Q 045798 923 NQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHEL 988 (1008)
Q Consensus 923 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 988 (1008)
... +.. ....++.++.+++.+||..+|++|||+.|+++.|
T Consensus 216 --------~~~--------------~~~----~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 216 --------AGY--------------RLY----RPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred --------cCC--------------cCC----CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 000 000 0012455689999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=312.54 Aligned_cols=251 Identities=25% Similarity=0.388 Sum_probs=197.0
Q ss_pred ceEeeccCeeEEEEEEcCCC---eEEEEEEeccccc-hhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceEEEEE
Q 045798 690 HLIGVGSFGCVYKGALDEDG---IVVAIKVINLQCE-GASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKAIVY 765 (1008)
Q Consensus 690 ~~lg~G~~g~Vy~~~~~~~~---~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 765 (1008)
++||+|+||.||+|.+...+ ..||+|.++.... ...+.+.+|+++++++.|+||+++++++. .+..++||
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~------~~~~~~v~ 74 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK------GEPLMLVM 74 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc------CCceEEEE
Confidence 46999999999999875444 7899999875433 34567999999999999999999999843 34579999
Q ss_pred eccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEcccCc
Q 045798 766 EYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGL 845 (1008)
Q Consensus 766 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~ 845 (1008)
||+++++|.+++.... .+++..+..++.|++.|++|||+. +++||||||+||+++.++.+||+|||.
T Consensus 75 e~~~~~~L~~~l~~~~----------~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~ 141 (257)
T cd05060 75 ELAPLGPLLKYLKKRR----------EIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGM 141 (257)
T ss_pred EeCCCCcHHHHHHhCC----------CCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccc
Confidence 9999999999997654 578999999999999999999998 999999999999999999999999999
Q ss_pred ccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCccccCCccHHHHHHhhCCcc
Q 045798 846 ARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT-AKKPTDVMFEGDLNLHNFARMALPNQ 924 (1008)
Q Consensus 846 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~ 924 (1008)
++.......... ......++..|+|||...+..++.++|||||||++|||++ |..||..... ...........+
T Consensus 142 ~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~--~~~~~~~~~~~~-- 216 (257)
T cd05060 142 SRALGAGSDYYR-ATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG--AEVIAMLESGER-- 216 (257)
T ss_pred cceeecCCcccc-cccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH--HHHHHHHHcCCc--
Confidence 986644332211 1112224568999999988899999999999999999998 9999864311 111111110000
Q ss_pred hhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHHHHHH
Q 045798 925 VMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHELQSVK 992 (1008)
Q Consensus 925 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~i~ 992 (1008)
. +....++..+.+++.+||..+|.+||++.++++.|+++.
T Consensus 217 ------------------------~----~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 217 ------------------------L----PRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred ------------------------C----CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 0 001123456889999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=327.36 Aligned_cols=271 Identities=23% Similarity=0.346 Sum_probs=202.5
Q ss_pred hcCCCCCceEeeccCeeEEEEEE-----cCCCeEEEEEEecccc-chhhHHHHHHHHHHhhc-CCCCceeeeeccccccc
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGAL-----DEDGIVVAIKVINLQC-EGASKSFMAECKALKNI-RHRNLVKVITSCSSIDF 755 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~-----~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 755 (1008)
.++|++.+.||+|+||.||+|.+ ..+++.||||+++... ......+.+|+.++.++ +||||++++++|.
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~---- 81 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACT---- 81 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceee----
Confidence 35799999999999999999985 2357899999997543 23346788999999999 7899999999864
Q ss_pred cCCceEEEEEeccCCCChhcccccCCCCCC--------------------------------------------------
Q 045798 756 QGNDFKAIVYEYMPNGSLEKWLHPHAVPKR-------------------------------------------------- 785 (1008)
Q Consensus 756 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~-------------------------------------------------- 785 (1008)
..+...++||||+++|+|.+++........
T Consensus 82 ~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (343)
T cd05103 82 KPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDV 161 (343)
T ss_pred cCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccc
Confidence 334568999999999999999865321000
Q ss_pred -------CcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEcccCcccccccccCcccc
Q 045798 786 -------DKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLS 858 (1008)
Q Consensus 786 -------~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~ 858 (1008)
.......+++..+..++.||+.||+|||+. +|+||||||+||++++++.+||+|||++..........
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~-- 236 (343)
T cd05103 162 EEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYV-- 236 (343)
T ss_pred hhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchh--
Confidence 000012478899999999999999999997 99999999999999999999999999998653322111
Q ss_pred ccccccccccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCccccCCccHHHHHHhhCCcchhhhhcccccCch
Q 045798 859 SSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT-AKKPTDVMFEGDLNLHNFARMALPNQVMDIVDPILRNDE 937 (1008)
Q Consensus 859 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 937 (1008)
......++..|+|||++.+..++.++||||||+++|||++ |..||....... . .... +...
T Consensus 237 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-~---~~~~---------~~~~----- 298 (343)
T cd05103 237 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-E---FCRR---------LKEG----- 298 (343)
T ss_pred hcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH-H---HHHH---------Hhcc-----
Confidence 1112335678999999988899999999999999999997 888875321110 0 0000 0000
Q ss_pred HHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHHHHHHH
Q 045798 938 EILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHELQSVKN 993 (1008)
Q Consensus 938 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~i~~ 993 (1008)
.... . ....+.++.+++.+||+.||++|||+.||++.|+.+..
T Consensus 299 ---------~~~~--~--~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 299 ---------TRMR--A--PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred ---------CCCC--C--CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 0000 0 00123457899999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=321.20 Aligned_cols=269 Identities=21% Similarity=0.268 Sum_probs=206.7
Q ss_pred CHHHHHHHhcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccchhhHHHHHHHHHHhhc-CCCCceeeeeccccc
Q 045798 675 SYKSLLKATNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNI-RHRNLVKVITSCSSI 753 (1008)
Q Consensus 675 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~ 753 (1008)
.++++..+.++|++.+.||+|+||.||+|.+..+++.||+|+++.. ......+.+|+.+++++ +||||+++++++...
T Consensus 9 ~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 87 (286)
T cd06638 9 IFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPI-HDIDEEIEAEYNILKALSDHPNVVKFYGMYYKK 87 (286)
T ss_pred EeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccc-cchHHHHHHHHHHHHHHhcCCCeeeeeeeeeec
Confidence 3455666789999999999999999999999889999999998643 23346788999999999 799999999987654
Q ss_pred cccCCceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeec
Q 045798 754 DFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLD 833 (1008)
Q Consensus 754 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~ 833 (1008)
....++..++||||+++++|.+++...... ...+++..+..++.|++.|+.|||+. +++||||||+||+++
T Consensus 88 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~------~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~ 158 (286)
T cd06638 88 DVKNGDQLWLVLELCNGGSVTDLVKGFLKR------GERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLT 158 (286)
T ss_pred ccCCCCeEEEEEeecCCCCHHHHHHHhhcc------CccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEEC
Confidence 445667899999999999999987532111 11688999999999999999999997 999999999999999
Q ss_pred CCCCeEEcccCcccccccccCccccccccccccccccCccccCC-----CCCCcccchhhHHHHHHHHHhCCCCCCcccc
Q 045798 834 NDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLG-----SEVSTNGDVYSYGILLLEMVTAKKPTDVMFE 908 (1008)
Q Consensus 834 ~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwslG~vl~elltG~~pf~~~~~ 908 (1008)
.++.+||+|||.+......... .....|+..|+|||++.. ..++.++||||+||++|||++|+.||.....
T Consensus 159 ~~~~~kl~dfg~~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~ 234 (286)
T cd06638 159 TEGGVKLVDFGVSAQLTSTRLR----RNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHP 234 (286)
T ss_pred CCCCEEEccCCceeecccCCCc----cccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCch
Confidence 9999999999999765432111 122458999999998753 4578899999999999999999999863211
Q ss_pred CCccHHHHHHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 045798 909 GDLNLHNFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHE 987 (1008)
Q Consensus 909 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 987 (1008)
...... .... ..+.. ......+..+.+++.+||+.||++|||+.||++.
T Consensus 235 ----~~~~~~--~~~~----~~~~~--------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 235 ----MRALFK--IPRN----PPPTL--------------------HQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred ----hHHHhh--cccc----CCCcc--------------------cCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 000000 0000 00000 0000123457899999999999999999999874
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=328.71 Aligned_cols=243 Identities=28% Similarity=0.325 Sum_probs=188.0
Q ss_pred ceEeeccCeeEEEEEEcCCCeEEEEEEecccc---chhhHHHHHHHH-HHhhcCCCCceeeeeccccccccCCceEEEEE
Q 045798 690 HLIGVGSFGCVYKGALDEDGIVVAIKVINLQC---EGASKSFMAECK-ALKNIRHRNLVKVITSCSSIDFQGNDFKAIVY 765 (1008)
Q Consensus 690 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 765 (1008)
+.||+|+||.||+|++..+++.||+|++.... ......+..|.. +++.++||||++++++ +..++..++||
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~-----~~~~~~~~lv~ 75 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFS-----FQTADKLYFVL 75 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEE-----EEcCCeEEEEE
Confidence 46999999999999999899999999986432 122234444444 5677899999999988 45667799999
Q ss_pred eccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEcccCc
Q 045798 766 EYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGL 845 (1008)
Q Consensus 766 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~ 845 (1008)
||+++|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 76 e~~~~~~L~~~~~~~~----------~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~ 142 (325)
T cd05602 76 DYINGGELFYHLQRER----------CFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGL 142 (325)
T ss_pred eCCCCCcHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCC
Confidence 9999999999987543 578889999999999999999998 999999999999999999999999999
Q ss_pred ccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCcch
Q 045798 846 ARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMALPNQV 925 (1008)
Q Consensus 846 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~ 925 (1008)
++....... ......||+.|+|||++.+..++.++||||+||++|||++|+.||...... ....
T Consensus 143 a~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-----~~~~------- 206 (325)
T cd05602 143 CKENIEHNG----TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA-----EMYD------- 206 (325)
T ss_pred CcccccCCC----CcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHH-----HHHH-------
Confidence 974322211 122345899999999999999999999999999999999999998632110 0000
Q ss_pred hhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 045798 926 MDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHE 987 (1008)
Q Consensus 926 ~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 987 (1008)
.+...... . ....+..+.+++.+|++.||.+||++.+.+..
T Consensus 207 -~i~~~~~~--------------~------~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ 247 (325)
T cd05602 207 -NILNKPLQ--------------L------KPNITNSARHLLEGLLQKDRTKRLGAKDDFME 247 (325)
T ss_pred -HHHhCCcC--------------C------CCCCCHHHHHHHHHHcccCHHHCCCCCCCHHH
Confidence 00000000 0 01234557899999999999999998855443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=331.29 Aligned_cols=239 Identities=26% Similarity=0.308 Sum_probs=189.6
Q ss_pred ceEeeccCeeEEEEEE---cCCCeEEEEEEeccccc--hhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceEEEE
Q 045798 690 HLIGVGSFGCVYKGAL---DEDGIVVAIKVINLQCE--GASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKAIV 764 (1008)
Q Consensus 690 ~~lg~G~~g~Vy~~~~---~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 764 (1008)
+.||+|+||.||+++. ..+|+.||+|+++.... .....+.+|++++++++||||+++++++ ..++..|+|
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-----~~~~~~~lv 76 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAF-----QTEGKLYLI 76 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEE-----EcCCEEEEE
Confidence 6799999999999886 34789999999974322 2345678899999999999999999984 556779999
Q ss_pred EeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEcccC
Q 045798 765 YEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFG 844 (1008)
Q Consensus 765 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg 844 (1008)
|||+++|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 77 ~e~~~~~~L~~~l~~~~----------~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg 143 (318)
T cd05582 77 LDFLRGGDLFTRLSKEV----------MFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFG 143 (318)
T ss_pred EcCCCCCcHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeecc
Confidence 99999999999986543 689999999999999999999998 99999999999999999999999999
Q ss_pred cccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCcc
Q 045798 845 LARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMALPNQ 924 (1008)
Q Consensus 845 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~~~~~~ 924 (1008)
++......... .....|++.|+|||++.+..++.++|||||||++|||++|+.||..... ......
T Consensus 144 ~~~~~~~~~~~----~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~-----~~~~~~----- 209 (318)
T cd05582 144 LSKESIDHEKK----AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDR-----KETMTM----- 209 (318)
T ss_pred CCcccCCCCCc----eecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCH-----HHHHHH-----
Confidence 99754332111 2234589999999999988899999999999999999999999864211 000000
Q ss_pred hhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHH
Q 045798 925 VMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTN 983 (1008)
Q Consensus 925 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 983 (1008)
+..... .++ ...+..+.+++.+||+.||++||++.+
T Consensus 210 ---i~~~~~--------------~~p------~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 210 ---ILKAKL--------------GMP------QFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred ---HHcCCC--------------CCC------CCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 000000 000 113445789999999999999999665
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=319.64 Aligned_cols=264 Identities=26% Similarity=0.417 Sum_probs=202.7
Q ss_pred cCCCCCceEeeccCeeEEEEEEc-----CCCeEEEEEEeccccchhhHHHHHHHHHHhhcCCCCceeeeeccccccccCC
Q 045798 684 NGFSSTHLIGVGSFGCVYKGALD-----EDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGN 758 (1008)
Q Consensus 684 ~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 758 (1008)
.+|...++||+|+||.||+|... .++..||+|.+..........+.+|++++++++|+||+++++++ ..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~ 79 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVC-----TEG 79 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEE-----ecC
Confidence 46788899999999999999742 35678999998766666677899999999999999999999984 445
Q ss_pred ceEEEEEeccCCCChhcccccCCCCCC-----CcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeec
Q 045798 759 DFKAIVYEYMPNGSLEKWLHPHAVPKR-----DKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLD 833 (1008)
Q Consensus 759 ~~~~lv~e~~~~gsL~~~l~~~~~~~~-----~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~ 833 (1008)
+..++||||+++++|.+++........ .......+++..++.++.|++.|++|||+. +++||||||+||+++
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~ 156 (280)
T cd05092 80 RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVG 156 (280)
T ss_pred CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEc
Confidence 668999999999999999976542110 001112589999999999999999999997 999999999999999
Q ss_pred CCCCeEEcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCccccCCcc
Q 045798 834 NDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT-AKKPTDVMFEGDLN 912 (1008)
Q Consensus 834 ~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-G~~pf~~~~~~~~~ 912 (1008)
+++.+||+|||++.......... ......+++.|+|||.+.+..++.++|||||||++|||++ |..||......+
T Consensus 157 ~~~~~kL~dfg~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~-- 232 (280)
T cd05092 157 QGLVVKIGDFGMSRDIYSTDYYR--VGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTE-- 232 (280)
T ss_pred CCCCEEECCCCceeEcCCCceee--cCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHH--
Confidence 99999999999997543322111 1112235688999999998899999999999999999998 899975321110
Q ss_pred HHHHHHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHHH
Q 045798 913 LHNFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHELQ 989 (1008)
Q Consensus 913 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 989 (1008)
..... . ... .. .....++..+.+++.+||+.||.+||+++||.+.|+
T Consensus 233 ~~~~~------------~---~~~-----------~~----~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 233 AIECI------------T---QGR-----------EL----ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred HHHHH------------H---cCc-----------cC----CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 00000 0 000 00 000124556889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=323.62 Aligned_cols=253 Identities=26% Similarity=0.389 Sum_probs=205.0
Q ss_pred CCCCceEeeccCeeEEEEEEcCC-C--eEEEEEEeccccch-hhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceE
Q 045798 686 FSSTHLIGVGSFGCVYKGALDED-G--IVVAIKVINLQCEG-ASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFK 761 (1008)
Q Consensus 686 y~~~~~lg~G~~g~Vy~~~~~~~-~--~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 761 (1008)
....++||+|.||.|++|.|... | ..||||.++..... ...+|.+|+.+|.+|+|+|++++||+.. +...
T Consensus 112 i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl------~qp~ 185 (1039)
T KOG0199|consen 112 IKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVL------DQPA 185 (1039)
T ss_pred HHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeec------cchh
Confidence 34568899999999999999542 2 46899999876554 6689999999999999999999999943 2557
Q ss_pred EEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEc
Q 045798 762 AIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIG 841 (1008)
Q Consensus 762 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 841 (1008)
.+|||.++.|+|.+.+++.... .+.......++.|||.|+.||.+. ++||||+..+|+++.....+||+
T Consensus 186 mMV~ELaplGSLldrLrka~~~--------~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~ 254 (1039)
T KOG0199|consen 186 MMVFELAPLGSLLDRLRKAKKA--------ILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKIC 254 (1039)
T ss_pred hHHhhhcccchHHHHHhhcccc--------ceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeee
Confidence 8999999999999999873322 688889999999999999999997 99999999999999999999999
Q ss_pred ccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCccccCCccHHHHHHhh
Q 045798 842 DFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT-AKKPTDVMFEGDLNLHNFARMA 920 (1008)
Q Consensus 842 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-G~~pf~~~~~~~~~~~~~~~~~ 920 (1008)
|||+.+.+....+... ......-...|+|||.+....++.+||||+|||++|||++ |..||.....
T Consensus 255 DFGLmRaLg~ned~Yv-m~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g------------ 321 (1039)
T KOG0199|consen 255 DFGLMRALGENEDMYV-MAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRG------------ 321 (1039)
T ss_pred cccceeccCCCCcceE-ecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCH------------
Confidence 9999998877665442 2333446789999999999999999999999999999999 7788753211
Q ss_pred CCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHH
Q 045798 921 LPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHEL 988 (1008)
Q Consensus 921 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 988 (1008)
..+...+|. ..++ +....|+++++++|..||..+|++|||+..|.+.+
T Consensus 322 --~qIL~~iD~--------------~erL----pRPk~csedIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 322 --IQILKNIDA--------------GERL----PRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred --HHHHHhccc--------------cccC----CCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence 112222221 1111 12335889999999999999999999999997544
|
|
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=312.89 Aligned_cols=250 Identities=27% Similarity=0.416 Sum_probs=193.7
Q ss_pred eEeeccCeeEEEEEEc--CCCeEEEEEEeccccc-hhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceEEEEEec
Q 045798 691 LIGVGSFGCVYKGALD--EDGIVVAIKVINLQCE-GASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKAIVYEY 767 (1008)
Q Consensus 691 ~lg~G~~g~Vy~~~~~--~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~ 767 (1008)
.||+|+||.||+|.+. ..+..||+|++..... ...+.+.+|+.++++++||||++++++|. .+..++||||
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~------~~~~~lv~e~ 75 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE------AEALMLVMEM 75 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc------CCCeEEEEEe
Confidence 3899999999999874 3456799999875533 33467999999999999999999999853 2357999999
Q ss_pred cCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEcccCccc
Q 045798 768 MPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLAR 847 (1008)
Q Consensus 768 ~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~ 847 (1008)
+++++|.+++..... .+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||.+.
T Consensus 76 ~~~~~L~~~l~~~~~---------~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~ 143 (257)
T cd05115 76 ASGGPLNKFLSGKKD---------EITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSK 143 (257)
T ss_pred CCCCCHHHHHHhCCC---------CCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccc
Confidence 999999999864321 689999999999999999999997 99999999999999999999999999998
Q ss_pred ccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCccccCCccHHHHHHhhCCcchh
Q 045798 848 FHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT-AKKPTDVMFEGDLNLHNFARMALPNQVM 926 (1008)
Q Consensus 848 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~ 926 (1008)
.......... ......++..|+|||++.+..++.++|||||||++||+++ |..||...... .. .
T Consensus 144 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-----~~---------~ 208 (257)
T cd05115 144 ALGADDSYYK-ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP-----EV---------M 208 (257)
T ss_pred cccCCcccee-ccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHH-----HH---------H
Confidence 5543322111 1111224578999999888889999999999999999996 99998643111 00 0
Q ss_pred hhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHHHHH
Q 045798 927 DIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHELQSV 991 (1008)
Q Consensus 927 ~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~i 991 (1008)
..+..... . . ....++.++.+++.+||+.+|++||++.+|.+.|+.+
T Consensus 209 ~~~~~~~~--------------~--~--~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 209 SFIEQGKR--------------L--D--CPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred HHHHCCCC--------------C--C--CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 00000000 0 0 0012456788999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=318.08 Aligned_cols=265 Identities=25% Similarity=0.358 Sum_probs=202.8
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCC-----CeEEEEEEecccc-chhhHHHHHHHHHHhhcCCCCceeeeecccccccc
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDED-----GIVVAIKVINLQC-EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQ 756 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 756 (1008)
.++|++.+.||+|+||.||+|.+... +..||+|.+.... ......+.+|+.+++.++||||+++++++ .
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~ 79 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVV-----S 79 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEE-----c
Confidence 45788999999999999999998533 3789999987443 24456788999999999999999999995 4
Q ss_pred CCceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCC
Q 045798 757 GNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDL 836 (1008)
Q Consensus 757 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 836 (1008)
.....++||||+++|+|.+++...............+++..++.++.|++.||.|||+. +++||||||+||+++.++
T Consensus 80 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~ 156 (277)
T cd05032 80 TGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDL 156 (277)
T ss_pred CCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCC
Confidence 55678999999999999999975432211101122578999999999999999999997 999999999999999999
Q ss_pred CeEEcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCccccCCccHHH
Q 045798 837 SGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT-AKKPTDVMFEGDLNLHN 915 (1008)
Q Consensus 837 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-G~~pf~~~~~~~~~~~~ 915 (1008)
.+||+|||+++......... ......++..|+|||.+.+..++.++|||||||++||+++ |..||...... ....
T Consensus 157 ~~kl~dfg~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~--~~~~ 232 (277)
T cd05032 157 TVKIGDFGMTRDIYETDYYR--KGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNE--EVLK 232 (277)
T ss_pred CEEECCcccchhhccCcccc--cCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHH--HHHH
Confidence 99999999997554332111 1122346789999999988889999999999999999998 88887532110 0000
Q ss_pred HHHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHHH
Q 045798 916 FARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHELQ 989 (1008)
Q Consensus 916 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 989 (1008)
... +... ... ...++..+.+++.+||+.+|++|||+.|+++.|+
T Consensus 233 ~~~-----------~~~~-------------~~~------~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 233 FVI-----------DGGH-------------LDL------PENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred HHh-----------cCCC-------------CCC------CCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 000 0000 000 0123556899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=322.02 Aligned_cols=269 Identities=24% Similarity=0.401 Sum_probs=204.9
Q ss_pred HhcCCCCCceEeeccCeeEEEEEEcC-----CCeEEEEEEecccc-chhhHHHHHHHHHHhhc-CCCCceeeeecccccc
Q 045798 682 ATNGFSSTHLIGVGSFGCVYKGALDE-----DGIVVAIKVINLQC-EGASKSFMAECKALKNI-RHRNLVKVITSCSSID 754 (1008)
Q Consensus 682 ~~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~ 754 (1008)
..++|++.+.||+|+||.||+|.... ....||+|+++... ......+.+|+++++++ +|+||+++++++
T Consensus 10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~---- 85 (293)
T cd05053 10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVC---- 85 (293)
T ss_pred CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE----
Confidence 35678999999999999999999853 33789999987532 33446789999999999 899999999985
Q ss_pred ccCCceEEEEEeccCCCChhcccccCCCCCCC------cccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCC
Q 045798 755 FQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRD------KEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPS 828 (1008)
Q Consensus 755 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~------~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~ 828 (1008)
..++..++||||+++|+|.++++........ ......+++..++.++.|++.|++|||+. +|+||||||+
T Consensus 86 -~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~ 161 (293)
T cd05053 86 -TQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAAR 161 (293)
T ss_pred -cCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---Ccccccccee
Confidence 4456689999999999999999754311000 01123789999999999999999999997 9999999999
Q ss_pred CeeecCCCCeEEcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCccc
Q 045798 829 NILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT-AKKPTDVMF 907 (1008)
Q Consensus 829 NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-G~~pf~~~~ 907 (1008)
||+++.++.+||+|||.++......... ......++..|+|||++.+..++.++|||||||++||+++ |..||....
T Consensus 162 Nil~~~~~~~kL~Dfg~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~ 239 (293)
T cd05053 162 NVLVTEDHVMKIADFGLARDIHHIDYYR--KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP 239 (293)
T ss_pred eEEEcCCCeEEeCcccccccccccccee--ccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCC
Confidence 9999999999999999998654332111 1112235678999999988889999999999999999997 888875321
Q ss_pred cCCccHHHHHHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 045798 908 EGDLNLHNFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHE 987 (1008)
Q Consensus 908 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 987 (1008)
. ..... .+..... . .....++..+.+++.+||+.||++|||+.|+++.
T Consensus 240 ~-----~~~~~---------~~~~~~~--------------~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~ 287 (293)
T cd05053 240 V-----EELFK---------LLKEGYR--------------M----EKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED 287 (293)
T ss_pred H-----HHHHH---------HHHcCCc--------------C----CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 1 00000 0000000 0 0011234568899999999999999999999999
Q ss_pred HHHHH
Q 045798 988 LQSVK 992 (1008)
Q Consensus 988 L~~i~ 992 (1008)
|+.+.
T Consensus 288 l~~~~ 292 (293)
T cd05053 288 LDRML 292 (293)
T ss_pred HHHhh
Confidence 98763
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=316.72 Aligned_cols=259 Identities=26% Similarity=0.465 Sum_probs=201.6
Q ss_pred cCCCCCceEeeccCeeEEEEEEcCCCe---EEEEEEeccc-cchhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCc
Q 045798 684 NGFSSTHLIGVGSFGCVYKGALDEDGI---VVAIKVINLQ-CEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGND 759 (1008)
Q Consensus 684 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~---~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 759 (1008)
.+|++.+.||+|+||.||+|....+++ .||+|+++.. .+.....|..|+.+++.++||||+++++++ ..+.
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~-----~~~~ 78 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVV-----TKSR 78 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEE-----CCCC
Confidence 357889999999999999999876554 6999998754 234457899999999999999999999984 5566
Q ss_pred eEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeE
Q 045798 760 FKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGH 839 (1008)
Q Consensus 760 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 839 (1008)
..++||||+++++|.+++..... .+++.+++.++.|++.|++|||+. +++||||||+||+++.++.+|
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~k 146 (269)
T cd05065 79 PVMIITEFMENGALDSFLRQNDG---------QFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCK 146 (269)
T ss_pred ceEEEEecCCCCcHHHHHhhCCC---------CCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEE
Confidence 78999999999999999875431 578999999999999999999997 999999999999999999999
Q ss_pred EcccCcccccccccCccc-cccccccccccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCccccCCccHHHHH
Q 045798 840 IGDFGLARFHQEVSNSTL-SSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT-AKKPTDVMFEGDLNLHNFA 917 (1008)
Q Consensus 840 L~Dfg~a~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-G~~pf~~~~~~~~~~~~~~ 917 (1008)
|+|||.+........... ........+..|+|||++.+..++.++|||||||++||+++ |..||...... ......
T Consensus 147 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~--~~~~~i 224 (269)
T cd05065 147 VSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ--DVINAI 224 (269)
T ss_pred ECCCccccccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH--HHHHHH
Confidence 999999976543322111 11111112457999999998899999999999999999886 99998632111 000110
Q ss_pred HhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHHHHH
Q 045798 918 RMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHELQSV 991 (1008)
Q Consensus 918 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~i 991 (1008)
.... +. +...+++..+.+++.+||+.+|.+||++++|+..|+++
T Consensus 225 ~~~~--------------------------~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 225 EQDY--------------------------RL----PPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred HcCC--------------------------cC----CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0000 00 00113455688999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=333.62 Aligned_cols=204 Identities=25% Similarity=0.349 Sum_probs=174.9
Q ss_pred cCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEecccc---chhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCce
Q 045798 684 NGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC---EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDF 760 (1008)
Q Consensus 684 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 760 (1008)
++|++.+.||+|+||.||+|+...+++.||+|+++... ......+.+|+.++..++||+|+++++. +.+++.
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~-----~~~~~~ 75 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYS-----FQDKRN 75 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEE-----EEcCCE
Confidence 46889999999999999999999899999999996432 2334678899999999999999999998 466778
Q ss_pred EEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEE
Q 045798 761 KAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHI 840 (1008)
Q Consensus 761 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 840 (1008)
.++||||+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~~----------~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL 142 (360)
T cd05627 76 LYLIMEFLPGGDMMTLLMKKD----------TLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKL 142 (360)
T ss_pred EEEEEeCCCCccHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEE
Confidence 999999999999999987653 688999999999999999999997 9999999999999999999999
Q ss_pred cccCcccccccccCc-------------------------------cccccccccccccccCccccCCCCCCcccchhhH
Q 045798 841 GDFGLARFHQEVSNS-------------------------------TLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSY 889 (1008)
Q Consensus 841 ~Dfg~a~~~~~~~~~-------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwsl 889 (1008)
+|||++......... ........+||+.|+|||++.+..++.++|||||
T Consensus 143 ~DfG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSl 222 (360)
T cd05627 143 SDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSL 222 (360)
T ss_pred eeccCCcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccc
Confidence 999998754321100 0000123469999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCc
Q 045798 890 GILLLEMVTAKKPTDV 905 (1008)
Q Consensus 890 G~vl~elltG~~pf~~ 905 (1008)
||++|||++|+.||..
T Consensus 223 Gvilyel~tG~~Pf~~ 238 (360)
T cd05627 223 GVIMYEMLIGYPPFCS 238 (360)
T ss_pred cceeeecccCCCCCCC
Confidence 9999999999999864
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=321.59 Aligned_cols=253 Identities=25% Similarity=0.296 Sum_probs=207.5
Q ss_pred HhcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccch---hhHHHHHHHHHHhhcC-CCCceeeeeccccccccC
Q 045798 682 ATNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEG---ASKSFMAECKALKNIR-HRNLVKVITSCSSIDFQG 757 (1008)
Q Consensus 682 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~ 757 (1008)
....|.+.+.||+|.||.||+++.+.+|+.+|+|++...... ..+.+.+|+.+|+++. |||||.++++ +++
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~-----~e~ 107 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDA-----FED 107 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEE-----EEc
Confidence 356799999999999999999999999999999999755432 3468999999999997 9999999999 567
Q ss_pred CceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCC--
Q 045798 758 NDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDND-- 835 (1008)
Q Consensus 758 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-- 835 (1008)
.+..++|||++.||.|.+.+... .+++..+..++.|++.|++|||+. ||+|||+||+|+|+...
T Consensus 108 ~~~~~lvmEL~~GGeLfd~i~~~-----------~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~ 173 (382)
T KOG0032|consen 108 PDSVYLVMELCEGGELFDRIVKK-----------HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDE 173 (382)
T ss_pred CCeEEEEEEecCCchHHHHHHHc-----------cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccC
Confidence 77899999999999999998653 289999999999999999999998 99999999999999533
Q ss_pred --CCeEEcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccH
Q 045798 836 --LSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNL 913 (1008)
Q Consensus 836 --~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~ 913 (1008)
+.+|++|||+|...... ......+||+.|+|||++....|+..+||||+||++|.|++|.+||....+.....
T Consensus 174 ~~~~ik~~DFGla~~~~~~-----~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~ 248 (382)
T KOG0032|consen 174 GSGRIKLIDFGLAKFIKPG-----ERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL 248 (382)
T ss_pred CCCcEEEeeCCCceEccCC-----ceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH
Confidence 57999999999977651 12334679999999999999999999999999999999999999987543221111
Q ss_pred HHHHHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 045798 914 HNFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHE 987 (1008)
Q Consensus 914 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 987 (1008)
......+ ++ ..+.+........+++..|+..||.+|+|+.++++.
T Consensus 249 -~i~~~~~-----~f-----------------------~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 249 -AILRGDF-----DF-----------------------TSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred -HHHcCCC-----CC-----------------------CCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 1110000 00 111233456678999999999999999999999983
|
|
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=314.64 Aligned_cols=251 Identities=22% Similarity=0.283 Sum_probs=200.7
Q ss_pred CCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccc-cchhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceEEE
Q 045798 685 GFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQ-CEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKAI 763 (1008)
Q Consensus 685 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 763 (1008)
+|++.+.||+|+||.||++.+..+++.||+|.++.. .....+.+.+|+.+++.++|+||+++++. +.+++..++
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~-----~~~~~~~~l 75 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKES-----FEADGHLYI 75 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEE-----EEECCEEEE
Confidence 478899999999999999999889999999998643 23455778899999999999999999998 456678999
Q ss_pred EEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEccc
Q 045798 764 VYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDF 843 (1008)
Q Consensus 764 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 843 (1008)
||||+++++|.+++...... .+++..++.++.|++.||.|||++ +|+|+||||+||++++++.++++||
T Consensus 76 v~e~~~~~~l~~~~~~~~~~--------~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~df 144 (255)
T cd08219 76 VMEYCDGGDLMQKIKLQRGK--------LFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDF 144 (255)
T ss_pred EEeeCCCCcHHHHHHhccCC--------CCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEccc
Confidence 99999999999988653321 578899999999999999999998 9999999999999999999999999
Q ss_pred CcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCc
Q 045798 844 GLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMALPN 923 (1008)
Q Consensus 844 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~~~~~ 923 (1008)
|.+......... .....++..|+|||++.+..++.++||||||+++|+|++|..||..... ..........
T Consensus 145 g~~~~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~-----~~~~~~~~~~ 215 (255)
T cd08219 145 GSARLLTSPGAY----ACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSW-----KNLILKVCQG 215 (255)
T ss_pred Ccceeecccccc----cccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCH-----HHHHHHHhcC
Confidence 999765432211 1224588899999999888899999999999999999999999863211 1110000000
Q ss_pred chhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 045798 924 QVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHE 987 (1008)
Q Consensus 924 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 987 (1008)
. .. .. ....+..+.+++.+||+.||++|||+.|++.+
T Consensus 216 ~--------~~-----------------~~--~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 216 S--------YK-----------------PL--PSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred C--------CC-----------------CC--CcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 0 00 00 01234457899999999999999999999865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-35 Score=313.46 Aligned_cols=254 Identities=29% Similarity=0.441 Sum_probs=200.4
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccchhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceEE
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKA 762 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 762 (1008)
.++|++.++||+|+||.||+|... +++.||+|.+.... ...+.+.+|+.++++++|+||+++++++ ..+..+
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~------~~~~~~ 76 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVV------TQEPIY 76 (260)
T ss_pred hHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEE------ccCCcE
Confidence 457899999999999999999975 67889999987542 3346789999999999999999999873 234589
Q ss_pred EEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEcc
Q 045798 763 IVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGD 842 (1008)
Q Consensus 763 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 842 (1008)
+||||+++++|.+++...... .+++.++..++.|++.||+|||+. +++||||||+||++++++.++|+|
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~--------~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~d 145 (260)
T cd05067 77 IITEYMENGSLVDFLKTPEGI--------KLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIAD 145 (260)
T ss_pred EEEEcCCCCCHHHHHHhcCCC--------CCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEcc
Confidence 999999999999998654321 688999999999999999999997 999999999999999999999999
Q ss_pred cCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCccccCCccHHHHHHhhC
Q 045798 843 FGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT-AKKPTDVMFEGDLNLHNFARMAL 921 (1008)
Q Consensus 843 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-G~~pf~~~~~~~~~~~~~~~~~~ 921 (1008)
||.+......... ......++..|+|||++.+..++.++||||||+++||+++ |+.||...... ....
T Consensus 146 fg~~~~~~~~~~~---~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-----~~~~--- 214 (260)
T cd05067 146 FGLARLIEDNEYT---AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNP-----EVIQ--- 214 (260)
T ss_pred CcceeecCCCCcc---cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChH-----HHHH---
Confidence 9999765422211 1112335778999999988889999999999999999999 99998632110 0000
Q ss_pred CcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHHHH
Q 045798 922 PNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHELQS 990 (1008)
Q Consensus 922 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 990 (1008)
.+..... . +.....+.++.+++.+||+.+|++|||++++.+.|+.
T Consensus 215 ------~~~~~~~--------------~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 215 ------NLERGYR--------------M----PRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred ------HHHcCCC--------------C----CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 0000000 0 0001234568999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=329.15 Aligned_cols=243 Identities=29% Similarity=0.314 Sum_probs=188.4
Q ss_pred ceEeeccCeeEEEEEEcCCCeEEEEEEecccc---chhhHHHHHHHH-HHhhcCCCCceeeeeccccccccCCceEEEEE
Q 045798 690 HLIGVGSFGCVYKGALDEDGIVVAIKVINLQC---EGASKSFMAECK-ALKNIRHRNLVKVITSCSSIDFQGNDFKAIVY 765 (1008)
Q Consensus 690 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 765 (1008)
+.||+|+||.||+|.+..+|+.||+|++.... ......+..|.. +++.++||||++++++ +..++..++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~-----~~~~~~~~lv~ 75 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYS-----FQTTEKLYFVL 75 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEE-----EecCCEEEEEE
Confidence 46999999999999999899999999986431 223345556655 4677899999999988 45667899999
Q ss_pred eccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEcccCc
Q 045798 766 EYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGL 845 (1008)
Q Consensus 766 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~ 845 (1008)
||+++|+|..++.... .+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 76 e~~~~~~L~~~l~~~~----------~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~ 142 (325)
T cd05604 76 DFVNGGELFFHLQRER----------SFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGL 142 (325)
T ss_pred cCCCCCCHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCC
Confidence 9999999998886543 689999999999999999999997 999999999999999999999999999
Q ss_pred ccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCcch
Q 045798 846 ARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMALPNQV 925 (1008)
Q Consensus 846 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~ 925 (1008)
++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......
T Consensus 143 ~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~-----~~~~~~------ 207 (325)
T cd05604 143 CKEGIAQSD----TTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDV-----AEMYDN------ 207 (325)
T ss_pred cccCCCCCC----CcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCH-----HHHHHH------
Confidence 874322111 12234589999999999999999999999999999999999999863211 001000
Q ss_pred hhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 045798 926 MDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHE 987 (1008)
Q Consensus 926 ~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 987 (1008)
.....+. ++ ...+..+.+++.+|++.+|.+||++.+.++.
T Consensus 208 --~~~~~~~--------------~~------~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~ 247 (325)
T cd05604 208 --ILHKPLV--------------LR------PGASLTAWSILEELLEKDRQRRLGAKEDFLE 247 (325)
T ss_pred --HHcCCcc--------------CC------CCCCHHHHHHHHHHhccCHHhcCCCCCCHHH
Confidence 0000000 00 0123456899999999999999998644433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-35 Score=311.77 Aligned_cols=251 Identities=29% Similarity=0.450 Sum_probs=201.6
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccchhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceEE
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKA 762 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 762 (1008)
.++|++.+.||+|+||.||+|.. .++.||+|.++.... ..+++.+|+.++++++|+||+++++++ .+.+..+
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~--~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~ 76 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDY--RGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVV-----LQGNPLY 76 (256)
T ss_pred hhhccceeeeecCCCceEEEEEe--cCcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEE-----cCCCCeE
Confidence 45788999999999999999998 478999999976533 567899999999999999999999985 3466789
Q ss_pred EEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEcc
Q 045798 763 IVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGD 842 (1008)
Q Consensus 763 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 842 (1008)
+||||+++++|.+++...... .+++..+..++.|++.|++|||+. +++||||||+||+++.++.+||+|
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~--------~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d 145 (256)
T cd05039 77 IVTEYMAKGSLVDYLRSRGRA--------VITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSD 145 (256)
T ss_pred EEEEecCCCcHHHHHHhcCCC--------CCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEcc
Confidence 999999999999998754321 589999999999999999999998 999999999999999999999999
Q ss_pred cCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCccccCCccHHHHHHhhC
Q 045798 843 FGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT-AKKPTDVMFEGDLNLHNFARMAL 921 (1008)
Q Consensus 843 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-G~~pf~~~~~~~~~~~~~~~~~~ 921 (1008)
||.++....... ....+..|+|||++.+..++.++||||||+++||+++ |..||...... ....
T Consensus 146 ~g~~~~~~~~~~-------~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-----~~~~--- 210 (256)
T cd05039 146 FGLAKEASQGQD-------SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK-----DVVP--- 210 (256)
T ss_pred cccccccccccc-------cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHH-----HHHH---
Confidence 999986532211 1225678999999988889999999999999999997 99998532111 0000
Q ss_pred CcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHHHHH
Q 045798 922 PNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHELQSV 991 (1008)
Q Consensus 922 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~i 991 (1008)
.+..... .. .....+..+.+++.+||+.+|++|||++|++++|+.+
T Consensus 211 ------~~~~~~~----------------~~--~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 211 ------HVEKGYR----------------ME--APEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred ------HHhcCCC----------------CC--CccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 0000000 00 0012356689999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-35 Score=316.61 Aligned_cols=269 Identities=22% Similarity=0.384 Sum_probs=208.0
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcC----CCeEEEEEEecccc-chhhHHHHHHHHHHhhcCCCCceeeeeccccccccC
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDE----DGIVVAIKVINLQC-EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQG 757 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 757 (1008)
.++|++.+.||+|+||.||+|.+.. .+..||+|++.... ....+.+.+|+.++++++|+||+++++++. ..
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~----~~ 80 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCI----ED 80 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe----cC
Confidence 5689999999999999999999864 26889999987442 344567899999999999999999999864 33
Q ss_pred CceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCC
Q 045798 758 NDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLS 837 (1008)
Q Consensus 758 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 837 (1008)
+...++++||+++++|.+++........ .....+++.+++.++.|++.||+|||+. +++||||||+||++++++.
T Consensus 81 ~~~~~~~~~~~~~~~L~~~l~~~~~~~~--~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~ 155 (280)
T cd05043 81 GEPPFVLYPYMNWGNLKLFLQQCRLGEA--NNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQ 155 (280)
T ss_pred CCCCEEEEEcCCCCcHHHHHHhcccccc--ccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCc
Confidence 5668999999999999999876432110 0112689999999999999999999997 9999999999999999999
Q ss_pred eEEcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCccccCCccHHHH
Q 045798 838 GHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT-AKKPTDVMFEGDLNLHNF 916 (1008)
Q Consensus 838 ~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-G~~pf~~~~~~~~~~~~~ 916 (1008)
+||+|||+++.+........ .....++..|+|||++.+..++.++|||||||++||+++ |+.||..... .....+
T Consensus 156 ~kl~d~g~~~~~~~~~~~~~--~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--~~~~~~ 231 (280)
T cd05043 156 VKITDNALSRDLFPMDYHCL--GDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP--FEMAAY 231 (280)
T ss_pred EEECCCCCcccccCCceEEe--CCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH--HHHHHH
Confidence 99999999986543221111 112236778999999988889999999999999999999 9999864211 111111
Q ss_pred HHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHHHHHHHH
Q 045798 917 ARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHELQSVKNI 994 (1008)
Q Consensus 917 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~i~~~ 994 (1008)
..... ... ....++.++.+++.+||+.||++|||+.|+++.|+.+.+.
T Consensus 232 ~~~~~--------------------------~~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 279 (280)
T cd05043 232 LKDGY--------------------------RLA----QPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ 279 (280)
T ss_pred HHcCC--------------------------CCC----CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence 11000 000 0112345689999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=320.07 Aligned_cols=250 Identities=23% Similarity=0.286 Sum_probs=201.9
Q ss_pred cCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccchhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceEEE
Q 045798 684 NGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKAI 763 (1008)
Q Consensus 684 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 763 (1008)
.+|++.+.||.|+||.||+|.+..+++.||+|.+........+.+.+|+.+++.++||||+++++++ ..++..++
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~~~~~l 93 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSF-----LVGDELFV 93 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeE-----ecCceEEE
Confidence 4689999999999999999999889999999999765555567889999999999999999999984 45667999
Q ss_pred EEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEccc
Q 045798 764 VYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDF 843 (1008)
Q Consensus 764 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 843 (1008)
|+||+++++|..++... .+++.++..++.|++.|++|||+. +++||||||+||+++.++.+||+||
T Consensus 94 v~e~~~~~~L~~~~~~~-----------~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~df 159 (296)
T cd06655 94 VMEYLAGGSLTDVVTET-----------CMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDF 159 (296)
T ss_pred EEEecCCCcHHHHHHhc-----------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccC
Confidence 99999999999988643 578999999999999999999998 9999999999999999999999999
Q ss_pred CcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCc
Q 045798 844 GLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMALPN 923 (1008)
Q Consensus 844 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~~~~~ 923 (1008)
|++......... .....++..|+|||.+.+..++.++|||||||++|+|++|+.||........ . .........
T Consensus 160 g~~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~-~-~~~~~~~~~ 233 (296)
T cd06655 160 GFCAQITPEQSK----RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA-L-YLIATNGTP 233 (296)
T ss_pred ccchhccccccc----CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-H-HHHHhcCCc
Confidence 998755432211 1223588899999999888899999999999999999999999864321100 0 000000000
Q ss_pred chhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 924 QVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 924 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
........+..+.+++.+||..||.+|||+.++++
T Consensus 234 ----------------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 234 ----------------------------ELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred ----------------------------ccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 00011123456789999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=325.78 Aligned_cols=248 Identities=25% Similarity=0.377 Sum_probs=197.2
Q ss_pred CCCceEeeccCeeEEEEEEcCCCeEEEEEEec----cccchhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceEE
Q 045798 687 SSTHLIGVGSFGCVYKGALDEDGIVVAIKVIN----LQCEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKA 762 (1008)
Q Consensus 687 ~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~----~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 762 (1008)
+...+||+|+|-+||+|.+..+|..||=-.++ ..++...++|..|+.+++.|+||||++++.++.+ .......
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d---~~n~~in 119 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVD---TDNKTIN 119 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheec---CCCceee
Confidence 34567999999999999998889888733332 2345566899999999999999999999999654 3335688
Q ss_pred EEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecC-CCCeEEc
Q 045798 763 IVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDN-DLSGHIG 841 (1008)
Q Consensus 763 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kL~ 841 (1008)
+|+|.+..|+|..|+++++ ++....+..|++||++||.|||++ .++|+|||||.+||||+. .|.|||+
T Consensus 120 ~iTEL~TSGtLr~Y~kk~~----------~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIG 188 (632)
T KOG0584|consen 120 FITELFTSGTLREYRKKHR----------RVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIG 188 (632)
T ss_pred eeeecccCCcHHHHHHHhc----------cCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeec
Confidence 9999999999999999887 788899999999999999999998 679999999999999975 4999999
Q ss_pred ccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHhhC
Q 045798 842 DFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMAL 921 (1008)
Q Consensus 842 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~~~ 921 (1008)
|+|+|........ ..++|||.|||||++. ..|++.+||||||+++.||+|+..||..-......+........
T Consensus 189 DLGLAtl~r~s~a------ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiK 261 (632)
T KOG0584|consen 189 DLGLATLLRKSHA------KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIK 261 (632)
T ss_pred chhHHHHhhcccc------ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCC
Confidence 9999987654322 2367999999999976 68999999999999999999999998632221111222211112
Q ss_pred CcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 922 PNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 922 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
|..+..+- .+++.++|.+|+.. ..+|||+.|+++
T Consensus 262 P~sl~kV~------------------------------dPevr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 262 PAALSKVK------------------------------DPEVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred HHHhhccC------------------------------CHHHHHHHHHHhcC-chhccCHHHHhh
Confidence 22222211 23468999999999 999999999986
|
|
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-35 Score=313.09 Aligned_cols=254 Identities=26% Similarity=0.346 Sum_probs=203.4
Q ss_pred cCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccchhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceEEE
Q 045798 684 NGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKAI 763 (1008)
Q Consensus 684 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 763 (1008)
++|++.+.||+|+||.||+|....+++.+|+|++........+.+.+|++++++++||||++++++ +..++..++
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~-----~~~~~~~~l 77 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGS-----YLRRDKLWI 77 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEE-----EEeCCEEEE
Confidence 578999999999999999999988889999999986655566789999999999999999999998 455677999
Q ss_pred EEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEccc
Q 045798 764 VYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDF 843 (1008)
Q Consensus 764 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 843 (1008)
+|||+++++|.+++..... .+++.++..++.|++.|++|||++ +++||||+|+||+++.++.+||+||
T Consensus 78 ~~e~~~~~~l~~~~~~~~~---------~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~ 145 (262)
T cd06613 78 VMEYCGGGSLQDIYQVTRG---------PLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADF 145 (262)
T ss_pred EEeCCCCCcHHHHHHhhcc---------CCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECcc
Confidence 9999999999999875421 688999999999999999999998 9999999999999999999999999
Q ss_pred CcccccccccCccccccccccccccccCccccCCC---CCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHhh
Q 045798 844 GLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGS---EVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMA 920 (1008)
Q Consensus 844 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~~ 920 (1008)
|.+......... .....++..|+|||.+.+. .++.++|||||||++|||++|+.||........ ........
T Consensus 146 g~~~~~~~~~~~----~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~-~~~~~~~~ 220 (262)
T cd06613 146 GVSAQLTATIAK----RKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRA-LFLISKSN 220 (262)
T ss_pred ccchhhhhhhhc----cccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHhcc
Confidence 999765432211 1224578899999998776 789999999999999999999999864221100 00000000
Q ss_pred CCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 921 LPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 921 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
.. ... .......+.++.+++.+||..+|.+|||+.+|+.
T Consensus 221 ~~-------~~~--------------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 221 FP-------PPK--------------------LKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred CC-------Ccc--------------------ccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00 000 0011234567899999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=325.35 Aligned_cols=244 Identities=23% Similarity=0.340 Sum_probs=190.3
Q ss_pred ceEeeccCeeEEEEEEcCCCeEEEEEEecccc---chhhHHHHHHHHHHhhc-CCCCceeeeeccccccccCCceEEEEE
Q 045798 690 HLIGVGSFGCVYKGALDEDGIVVAIKVINLQC---EGASKSFMAECKALKNI-RHRNLVKVITSCSSIDFQGNDFKAIVY 765 (1008)
Q Consensus 690 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~ 765 (1008)
+.||+|+||.||+|....+++.||+|+++... ....+.+.+|+.++.++ +||+|++++++ +...+..++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~-----~~~~~~~~lv~ 75 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSC-----FQTTSRLFLVI 75 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEE-----EEeCCEEEEEE
Confidence 47999999999999999899999999997532 23445688999999888 69999999998 45667799999
Q ss_pred eccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEcccCc
Q 045798 766 EYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGL 845 (1008)
Q Consensus 766 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~ 845 (1008)
||+++|+|..++.... .+++..++.++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 76 e~~~~~~L~~~~~~~~----------~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~ 142 (327)
T cd05617 76 EYVNGGDLMFHMQRQR----------KLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGM 142 (327)
T ss_pred eCCCCCcHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEecccc
Confidence 9999999998886543 689999999999999999999997 999999999999999999999999999
Q ss_pred ccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCC-ccHHHHHHhhCCcc
Q 045798 846 ARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGD-LNLHNFARMALPNQ 924 (1008)
Q Consensus 846 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~-~~~~~~~~~~~~~~ 924 (1008)
++........ .....||+.|+|||++.+..++.++|||||||++|||++|+.||....... ..........
T Consensus 143 ~~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~---- 214 (327)
T cd05617 143 CKEGLGPGDT----TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQV---- 214 (327)
T ss_pred ceeccCCCCc----eecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHH----
Confidence 8743221111 123458999999999999999999999999999999999999996432111 1100000000
Q ss_pred hhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHH
Q 045798 925 VMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMT 982 (1008)
Q Consensus 925 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ 982 (1008)
.... ....+ ...+..+.+++.+||+.||++||++.
T Consensus 215 ---~~~~--------------~~~~p------~~~~~~~~~li~~~L~~dP~~R~~~~ 249 (327)
T cd05617 215 ---ILEK--------------PIRIP------RFLSVKASHVLKGFLNKDPKERLGCQ 249 (327)
T ss_pred ---HHhC--------------CCCCC------CCCCHHHHHHHHHHhccCHHHcCCCC
Confidence 0000 00011 11234568999999999999999853
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=329.75 Aligned_cols=269 Identities=23% Similarity=0.327 Sum_probs=202.5
Q ss_pred hcCCCCCceEeeccCeeEEEEEEc-----CCCeEEEEEEecccc-chhhHHHHHHHHHHhhcC-CCCceeeeeccccccc
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALD-----EDGIVVAIKVINLQC-EGASKSFMAECKALKNIR-HRNLVKVITSCSSIDF 755 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~ 755 (1008)
.++|.+.+.||+|+||.||+|.+. ..++.||+|+++... ....+.+.+|++++.++. ||||++++++|.
T Consensus 36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~---- 111 (401)
T cd05107 36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACT---- 111 (401)
T ss_pred HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc----
Confidence 346788899999999999999964 345689999997542 233457899999999997 999999999963
Q ss_pred cCCceEEEEEeccCCCChhcccccCCCCCC--------------------------------------------------
Q 045798 756 QGNDFKAIVYEYMPNGSLEKWLHPHAVPKR-------------------------------------------------- 785 (1008)
Q Consensus 756 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~-------------------------------------------------- 785 (1008)
.....++||||+++|+|.++++..+....
T Consensus 112 -~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (401)
T cd05107 112 -KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYV 190 (401)
T ss_pred -cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCcc
Confidence 44568999999999999999975431000
Q ss_pred --------------------------------------CcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCC
Q 045798 786 --------------------------------------DKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKP 827 (1008)
Q Consensus 786 --------------------------------------~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp 827 (1008)
.......+++..+..++.||+.||+|||+. +++||||||
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp 267 (401)
T cd05107 191 PMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAA 267 (401)
T ss_pred chhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCc
Confidence 000012478888999999999999999997 999999999
Q ss_pred CCeeecCCCCeEEcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCcc
Q 045798 828 SNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT-AKKPTDVM 906 (1008)
Q Consensus 828 ~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-G~~pf~~~ 906 (1008)
+||++++++.+||+|||+++......... ......++..|+|||.+.+..++.++|||||||++|||++ |..||...
T Consensus 268 ~NiLl~~~~~~kL~DfGla~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~ 345 (401)
T cd05107 268 RNVLICEGKLVKICDFGLARDIMRDSNYI--SKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPEL 345 (401)
T ss_pred ceEEEeCCCEEEEEecCcceecccccccc--cCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCC
Confidence 99999999999999999998653322211 1122346788999999988889999999999999999998 88897532
Q ss_pred ccCCccHHHHHHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 907 FEGDLNLHNFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 907 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
...+. .. ..+..... ... ...++.++.+++.+||..+|.+||+++||++
T Consensus 346 ~~~~~----~~---------~~~~~~~~----------------~~~--p~~~~~~l~~li~~cl~~~P~~RPs~~ell~ 394 (401)
T cd05107 346 PMNEQ----FY---------NAIKRGYR----------------MAK--PAHASDEIYEIMQKCWEEKFEIRPDFSQLVH 394 (401)
T ss_pred CchHH----HH---------HHHHcCCC----------------CCC--CCCCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 11100 00 00000000 000 0123456899999999999999999999999
Q ss_pred HHHHHH
Q 045798 987 ELQSVK 992 (1008)
Q Consensus 987 ~L~~i~ 992 (1008)
.|+++.
T Consensus 395 ~L~~~~ 400 (401)
T cd05107 395 LVGDLL 400 (401)
T ss_pred HHHHHh
Confidence 998763
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=313.79 Aligned_cols=259 Identities=24% Similarity=0.309 Sum_probs=199.9
Q ss_pred HHHHhcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccchhhHHHHHHHHHHhhcCCCCceeeeeccccccccCC
Q 045798 679 LLKATNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGN 758 (1008)
Q Consensus 679 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 758 (1008)
++.+++.+.....||+|+||.||+|.+..++..||+|.+........+.+.+|+.++++++|+||+++++++ ..+
T Consensus 3 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~ 77 (268)
T cd06624 3 YEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSD-----SEN 77 (268)
T ss_pred cccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeee-----ccC
Confidence 344566777778999999999999999888999999998766556667899999999999999999999985 455
Q ss_pred ceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecC-CCC
Q 045798 759 DFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDN-DLS 837 (1008)
Q Consensus 759 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~~ 837 (1008)
+..++|+||+++++|.+++...... ...++..+..++.||+.|++|||+. +|+||||||+||+++. ++.
T Consensus 78 ~~~~lv~e~~~~~~L~~~l~~~~~~-------~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~ 147 (268)
T cd06624 78 GFFKIFMEQVPGGSLSALLRSKWGP-------LKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGV 147 (268)
T ss_pred CEEEEEEecCCCCCHHHHHHHhccc-------CCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCe
Confidence 6799999999999999998754211 0227888899999999999999997 9999999999999976 679
Q ss_pred eEEcccCcccccccccCccccccccccccccccCccccCCCC--CCcccchhhHHHHHHHHHhCCCCCCccccCCccHHH
Q 045798 838 GHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSE--VSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHN 915 (1008)
Q Consensus 838 ~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~ 915 (1008)
+||+|||.+......... .....++..|+|||++.+.. ++.++||||||+++|+|++|+.||....... ...
T Consensus 148 ~~l~dfg~~~~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~--~~~ 221 (268)
T cd06624 148 VKISDFGTSKRLAGINPC----TETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQ--AAM 221 (268)
T ss_pred EEEecchhheecccCCCc----cccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChh--hhH
Confidence 999999999755332211 11234789999999986643 7889999999999999999999986321110 000
Q ss_pred HHHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 916 FARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 916 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
+.... ... .+.. ....+.++.+++.+||+.+|.+|||+.|+++
T Consensus 222 ~~~~~------------~~~--------------~~~~--~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 222 FKVGM------------FKI--------------HPEI--PESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred hhhhh------------hcc--------------CCCC--CcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 00000 000 0000 1123456789999999999999999999875
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=349.69 Aligned_cols=261 Identities=22% Similarity=0.271 Sum_probs=200.3
Q ss_pred HHHhcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccc--cchhhHHHHHHHHHHhhcCCCCceeeeeccccccccC
Q 045798 680 LKATNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQ--CEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQG 757 (1008)
Q Consensus 680 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 757 (1008)
....++|.+++.||+|+||+||+|.+..+++.||+|++... .......+..|+.+++.++||||+++++++.. ..
T Consensus 9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~d---e~ 85 (1021)
T PTZ00266 9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLN---KA 85 (1021)
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEe---cC
Confidence 33467899999999999999999999989999999998743 23445678999999999999999999998542 34
Q ss_pred CceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCC----CCCceeccCCCCCeeec
Q 045798 758 NDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHC----QEPILHCDLKPSNILLD 833 (1008)
Q Consensus 758 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~----~~~ivH~Dlkp~NIll~ 833 (1008)
....|+||||+++|+|.+++...... ...+++..++.|+.||+.||+|||+.. .++||||||||+|||++
T Consensus 86 ~~~lyIVMEY~~gGSL~~lL~k~~~~------~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~ 159 (1021)
T PTZ00266 86 NQKLYILMEFCDAGDLSRNIQKCYKM------FGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLS 159 (1021)
T ss_pred CCEEEEEEeCCCCCcHHHHHHHHhhc------cCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEee
Confidence 45789999999999999998653211 116899999999999999999999852 13699999999999996
Q ss_pred C-----------------CCCeEEcccCcccccccccCccccccccccccccccCccccCC--CCCCcccchhhHHHHHH
Q 045798 834 N-----------------DLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLG--SEVSTNGDVYSYGILLL 894 (1008)
Q Consensus 834 ~-----------------~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwslG~vl~ 894 (1008)
. .+.+||+|||++........ .....||+.|+|||++.+ ..++.++|||||||++|
T Consensus 160 s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~-----~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILY 234 (1021)
T PTZ00266 160 TGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESM-----AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIY 234 (1021)
T ss_pred cCccccccccccccccCCCCceEEccCCcccccccccc-----ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHH
Confidence 4 23589999999986543221 123458999999999854 45889999999999999
Q ss_pred HHHhCCCCCCccccCCccHHHHHHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcC
Q 045798 895 EMVTAKKPTDVMFEGDLNLHNFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMES 974 (1008)
Q Consensus 895 elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d 974 (1008)
||++|..||.... ........... .+ .. .....+.++.++|..||+.+
T Consensus 235 ELLTGk~PF~~~~----~~~qli~~lk~-------------~p----------~l-----pi~~~S~eL~dLI~~~L~~d 282 (1021)
T PTZ00266 235 ELCSGKTPFHKAN----NFSQLISELKR-------------GP----------DL-----PIKGKSKELNILIKNLLNLS 282 (1021)
T ss_pred HHHHCCCCCCcCC----cHHHHHHHHhc-------------CC----------CC-----CcCCCCHHHHHHHHHHhcCC
Confidence 9999999986321 11111110000 00 00 00112456889999999999
Q ss_pred CCCCCCHHHHHH
Q 045798 975 PQDRMNMTNVVH 986 (1008)
Q Consensus 975 P~~RPt~~evl~ 986 (1008)
|.+||++.|++.
T Consensus 283 PeeRPSa~QlL~ 294 (1021)
T PTZ00266 283 AKERPSALQCLG 294 (1021)
T ss_pred hhHCcCHHHHhc
Confidence 999999999985
|
|
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=320.35 Aligned_cols=251 Identities=24% Similarity=0.274 Sum_probs=202.3
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccchhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceEE
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKA 762 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 762 (1008)
..+|++.+.||+|+||.||+|....+++.||+|.+........+.+.+|+.+++.++|+||+++++++ ..++..+
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~~~~ 92 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY-----LVGDELW 92 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEE-----ecCCEEE
Confidence 36799999999999999999999889999999999866555667789999999999999999999984 4566799
Q ss_pred EEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEcc
Q 045798 763 IVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGD 842 (1008)
Q Consensus 763 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 842 (1008)
+||||+++++|.+++... .+++.++..++.|++.||.|||+. +++||||||+||+++.++.++|+|
T Consensus 93 lv~e~~~~~~L~~~~~~~-----------~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~D 158 (297)
T cd06656 93 VVMEYLAGGSLTDVVTET-----------CMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTD 158 (297)
T ss_pred EeecccCCCCHHHHHHhC-----------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECc
Confidence 999999999999998643 578889999999999999999997 999999999999999999999999
Q ss_pred cCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHhhCC
Q 045798 843 FGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMALP 922 (1008)
Q Consensus 843 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~~~~ 922 (1008)
||.+......... .....+++.|+|||.+.+..++.++|||||||++|++++|+.||........... ....
T Consensus 159 fg~~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~-~~~~--- 230 (297)
T cd06656 159 FGFCAQITPEQSK----RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL-IATN--- 230 (297)
T ss_pred CccceEccCCccC----cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheee-eccC---
Confidence 9998755332211 1123478899999999888899999999999999999999999863211100000 0000
Q ss_pred cchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 923 NQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 923 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
.. +........+..+.+++.+||+.+|++||+++++++
T Consensus 231 ------------~~--------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 231 ------------GT--------------PELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred ------------CC--------------CCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00 000001123455789999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-38 Score=333.99 Aligned_cols=372 Identities=27% Similarity=0.367 Sum_probs=291.8
Q ss_pred ccCcCcceEeeeccccc-cCCCccccccCCCCeeecccccCCCCCCCCCccccccchhhcccccCCCCCCccccCCCCCc
Q 045798 123 SYCSRLTVLCIEYNKLQ-GRIPLEFVSLSKLKDLSLAKNKLTGGIPPFLGNLTSLEVLSLAGNSFGRNIPDSLGQLKQLK 201 (1008)
Q Consensus 123 ~~l~~L~~L~Ls~n~l~-~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~ 201 (1008)
+-|+-.+-.|+++|.++ +..|.....+++++.|.|...++. .+|+.++.+.+|++|.+++|++. .+...++.++.|+
T Consensus 4 gVLpFVrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~-~vhGELs~Lp~LR 81 (1255)
T KOG0444|consen 4 GVLPFVRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLI-SVHGELSDLPRLR 81 (1255)
T ss_pred cccceeecccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhH-hhhhhhccchhhH
Confidence 44566777899999999 577899999999999999999999 89999999999999999999994 5667788999999
Q ss_pred EEEecCCccc-ccCCccccCCCCcceeccccccccccCChhhhhcCCCCcEEEeccccCCCCCCcccccCCCCceeeccc
Q 045798 202 ILAIGGNNLS-GPIPPSIYNLSFLVVFSVSHNQIHGSLPPSLGLLLPNLKFFQIHHNFFSGSIPISLSNASKLEHIEIAN 280 (1008)
Q Consensus 202 ~L~L~~n~l~-~~~~~~~~~l~~L~~L~ls~N~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~ 280 (1008)
.+.+.+|++. +-+|..+..+..|+.||||+|+++ ..|. .+....++-.|+||+
T Consensus 82 sv~~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~-------------------------~LE~AKn~iVLNLS~ 135 (1255)
T KOG0444|consen 82 SVIVRDNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPT-------------------------NLEYAKNSIVLNLSY 135 (1255)
T ss_pred HHhhhccccccCCCCchhcccccceeeecchhhhh-hcch-------------------------hhhhhcCcEEEEccc
Confidence 9999999886 345667777777777777777776 4444 444445555555555
Q ss_pred ccccccccccccCCCcccccccccccCCCCCCCcccccccccccCCCcEEEecCCcCCccCChhhhhhcccceeeeeccc
Q 045798 281 NNFSGKLSVNFGGMKNLSLLNLQFSNLGSGESDEMGFMNSLTNCSKLRVLSLGGNQFRGALPHSIANLSSQLQILILSSN 360 (1008)
Q Consensus 281 N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~Ls~N 360 (1008)
|+|..+....|. ++..|-.|+||+|++. .+|..+..+. .|++|+||+|
T Consensus 136 N~IetIPn~lfi------------------------------nLtDLLfLDLS~NrLe-~LPPQ~RRL~-~LqtL~Ls~N 183 (1255)
T KOG0444|consen 136 NNIETIPNSLFI------------------------------NLTDLLFLDLSNNRLE-MLPPQIRRLS-MLQTLKLSNN 183 (1255)
T ss_pred CccccCCchHHH------------------------------hhHhHhhhccccchhh-hcCHHHHHHh-hhhhhhcCCC
Confidence 555544333333 3334444555555555 5555555554 4666666666
Q ss_pred cccCCCCCccccccccceEEecCcccc-CCcchhccCCCCCceEEccCCcccccccccccCCCCcceeeccccccccccC
Q 045798 361 QFYGSIPLGIGNLVDLYLLGMVENQFT-GAIPKEMGKLQKLQGLDFSGNHFSGEIPSSLGNLSSLYEVFFNNNNLSGVIP 439 (1008)
Q Consensus 361 ~l~~~~p~~~~~l~~L~~L~L~~n~l~-~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p 439 (1008)
.+.-.--..+..|++|..|++++.+-+ ..+|..+..+.+|..+|||.|.+. .+|+.+.++.+|+.|+|++|+|+ .+.
T Consensus 184 PL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~it-eL~ 261 (1255)
T KOG0444|consen 184 PLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKIT-ELN 261 (1255)
T ss_pred hhhHHHHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCcee-eee
Confidence 654333334556777888888775433 467889999999999999999998 89999999999999999999999 455
Q ss_pred CCCcCCCcccEeecccccccCCcchhhhhhhhhhhhhcccCccccCCCccccccccccccccccccccc-CCCCcccccc
Q 045798 440 FSLGNLKRLAFLEMSGNELSGTIPEDIFNISYLSNSLNLARNHLVGIIPPRIGNLRALRSFDVSNNDLS-GEIPIELGHC 518 (1008)
Q Consensus 440 ~~~~~l~~L~~L~Ls~N~l~~~lp~~~~~~~~~~~~L~L~~N~l~~~~p~~~~~l~~L~~Ldls~N~l~-~~~p~~~~~l 518 (1008)
-..+...+|++|+||.|+++ .+|++++.|+.|+.|.+.+|+++ .-+|..|+.+
T Consensus 262 ~~~~~W~~lEtLNlSrNQLt--------------------------~LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL 315 (1255)
T KOG0444|consen 262 MTEGEWENLETLNLSRNQLT--------------------------VLPDAVCKLTKLTKLYANNNKLTFEGIPSGIGKL 315 (1255)
T ss_pred ccHHHHhhhhhhccccchhc--------------------------cchHHHhhhHHHHHHHhccCcccccCCccchhhh
Confidence 56667778888888888887 78999999999999999999987 3499999999
Q ss_pred cccceeeccCcccccchhhhhhccccccEEecCCCcccccccCcccccccceeecccCcccccCC
Q 045798 519 SSLEEIYLAGNLFHGSIPSFFNALKGVQKIDLSRNNLSGQIPIFLEALSLEYLNLSFNDFEGKIP 583 (1008)
Q Consensus 519 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~L~~L~l~~N~l~g~~p 583 (1008)
.+|+++..++|.+. ..|+.++.+..|+.|.|++|++-..+...--+..|..|||.+|.=---+|
T Consensus 316 ~~Levf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLiTLPeaIHlL~~l~vLDlreNpnLVMPP 379 (1255)
T KOG0444|consen 316 IQLEVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLITLPEAIHLLPDLKVLDLRENPNLVMPP 379 (1255)
T ss_pred hhhHHHHhhccccc-cCchhhhhhHHHHHhcccccceeechhhhhhcCCcceeeccCCcCccCCC
Confidence 99999999999999 89999999999999999999998543333556789999999997555544
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=316.58 Aligned_cols=253 Identities=28% Similarity=0.431 Sum_probs=197.5
Q ss_pred CCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccchhh--HHHHHHHHHHhhcCCCCceeeeeccccccccCCceEEE
Q 045798 686 FSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGAS--KSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKAI 763 (1008)
Q Consensus 686 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~--~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 763 (1008)
|++.+.||+|+||+||+|....+++.||+|++........ ....+|+.++++++||||+++++++ ......++
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~-----~~~~~~~~ 75 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVF-----QDDNYLYI 75 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEE-----EESSEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccc-----cccccccc
Confidence 6678999999999999999999999999999986643332 2345699999999999999999994 44777899
Q ss_pred EEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEccc
Q 045798 764 VYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDF 843 (1008)
Q Consensus 764 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 843 (1008)
||||+++++|.+++.... .+++..+..++.|+++||++||+. +|+||||||+||++++++.++|+||
T Consensus 76 v~~~~~~~~L~~~l~~~~----------~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Df 142 (260)
T PF00069_consen 76 VMEYCPGGSLQDYLQKNK----------PLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDF 142 (260)
T ss_dssp EEEEETTEBHHHHHHHHS----------SBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSG
T ss_pred cccccccccccccccccc----------cccccccccccccccccccccccc---ccccccccccccccccccccccccc
Confidence 999999999999997332 789999999999999999999998 9999999999999999999999999
Q ss_pred CcccccccccCccccccccccccccccCccccC-CCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHhhCC
Q 045798 844 GLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGL-GSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMALP 922 (1008)
Q Consensus 844 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~~~~ 922 (1008)
|.+....... .......++..|+|||++. +..++.++||||+|+++|+|++|..||..... ........
T Consensus 143 g~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~--~~~~~~~~---- 212 (260)
T PF00069_consen 143 GSSVKLSENN----ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNS--DDQLEIIE---- 212 (260)
T ss_dssp TTTEESTSTT----SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSH--HHHHHHHH----
T ss_pred cccccccccc----cccccccccccccccccccccccccccccccccccccccccccccccccccc--hhhhhhhh----
Confidence 9997541111 1122345899999999988 78899999999999999999999999874310 00000000
Q ss_pred cchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 923 NQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 923 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
....... .............+.+++.+||+.||++|||+.++++
T Consensus 213 --------~~~~~~~------------~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 213 --------KILKRPL------------PSSSQQSREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp --------HHHHTHH------------HHHTTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred --------hcccccc------------cccccccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000000 0000000011267899999999999999999999975
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=314.77 Aligned_cols=259 Identities=27% Similarity=0.473 Sum_probs=201.9
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCC---eEEEEEEecccc-chhhHHHHHHHHHHhhcCCCCceeeeeccccccccCC
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDG---IVVAIKVINLQC-EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGN 758 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 758 (1008)
.++|++.+.||+|+||.||+|.+..++ ..||+|.++... ....+.+.+|+.++++++||||+++++++ ..+
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~ 77 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVV-----TKS 77 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEE-----ecC
Confidence 357889999999999999999885333 479999987533 33456899999999999999999999984 455
Q ss_pred ceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCe
Q 045798 759 DFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSG 838 (1008)
Q Consensus 759 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 838 (1008)
+..++||||+++++|.+++..... .+++.++..++.|++.|++|||+. +++||||||+||+++.++.+
T Consensus 78 ~~~~lv~e~~~~~~L~~~~~~~~~---------~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~ 145 (267)
T cd05066 78 KPVMIVTEYMENGSLDAFLRKHDG---------QFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVC 145 (267)
T ss_pred CccEEEEEcCCCCCHHHHHHhcCC---------CCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeE
Confidence 678999999999999999975431 578999999999999999999997 99999999999999999999
Q ss_pred EEcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCccccCCccHHHHH
Q 045798 839 HIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT-AKKPTDVMFEGDLNLHNFA 917 (1008)
Q Consensus 839 kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-G~~pf~~~~~~~~~~~~~~ 917 (1008)
+++|||.+........... ......++..|+|||++.+..++.++||||||+++||+++ |..||......+ .....
T Consensus 146 ~l~dfg~~~~~~~~~~~~~-~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~--~~~~~ 222 (267)
T cd05066 146 KVSDFGLSRVLEDDPEAAY-TTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD--VIKAI 222 (267)
T ss_pred EeCCCCcccccccccceee-ecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH--HHHHH
Confidence 9999999986644322111 1112224568999999998889999999999999999886 999985321100 00000
Q ss_pred HhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHHHHH
Q 045798 918 RMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHELQSV 991 (1008)
Q Consensus 918 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~i 991 (1008)
. +. . +. +....++..+.+++.+||+.+|.+||++.++++.|+++
T Consensus 223 ~-----------~~-~--------------~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 223 E-----------EG-Y--------------RL----PAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred h-----------CC-C--------------cC----CCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 0 00 0 00 00112345678999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=317.24 Aligned_cols=252 Identities=25% Similarity=0.350 Sum_probs=199.3
Q ss_pred cCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccchhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceEEE
Q 045798 684 NGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKAI 763 (1008)
Q Consensus 684 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 763 (1008)
+.|++.+.||+|+||.||+|.+..+++.||+|++........+.+.+|+++++.++|+||+++++++ ..+...++
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~l 86 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAF-----YWDGKLWI 86 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEE-----EeCCeEEE
Confidence 5689999999999999999999888999999999876666678899999999999999999999985 44567999
Q ss_pred EEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEccc
Q 045798 764 VYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDF 843 (1008)
Q Consensus 764 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 843 (1008)
||||+++++|..++..... .+++..+..++.|++.|++|||++ +++||||||+||+++.++.+||+||
T Consensus 87 v~e~~~~~~l~~~~~~~~~---------~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~df 154 (292)
T cd06644 87 MIEFCPGGAVDAIMLELDR---------GLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADF 154 (292)
T ss_pred EEecCCCCcHHHHHHhhcC---------CCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccC
Confidence 9999999999888754321 588999999999999999999998 9999999999999999999999999
Q ss_pred CcccccccccCccccccccccccccccCccccC-----CCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHH
Q 045798 844 GLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGL-----GSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFAR 918 (1008)
Q Consensus 844 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~ 918 (1008)
|.+......... .....++..|+|||++. ...++.++|||||||++|||++|..||..... ......
T Consensus 155 g~~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~----~~~~~~ 226 (292)
T cd06644 155 GVSAKNVKTLQR----RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP----MRVLLK 226 (292)
T ss_pred ccceeccccccc----cceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccH----HHHHHH
Confidence 998753322111 12244788999999874 34578899999999999999999999863211 000000
Q ss_pred hhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 919 MALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 919 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
..... .+ ........+.++.+++.+||+.+|++||+++|+++
T Consensus 227 ~~~~~------~~--------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 227 IAKSE------PP--------------------TLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred HhcCC------Cc--------------------cCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 00000 00 00001123446789999999999999999999976
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-35 Score=316.96 Aligned_cols=266 Identities=21% Similarity=0.282 Sum_probs=205.9
Q ss_pred CCHHHHHHHhcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccchhhHHHHHHHHHHhhc-CCCCceeeeecccc
Q 045798 674 MSYKSLLKATNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNI-RHRNLVKVITSCSS 752 (1008)
Q Consensus 674 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~ 752 (1008)
.++.++....+.|++.+.||+|+||.||+|.+..+++.||+|++... ......+..|+.+++++ +|+||+++++++..
T Consensus 6 ~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 84 (282)
T cd06636 6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-EDEEEEIKLEINMLKKYSHHRNIATYYGAFIK 84 (282)
T ss_pred hhhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC-hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhc
Confidence 45566666778999999999999999999999889999999998654 23446788999999998 79999999998753
Q ss_pred ccc-cCCceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCee
Q 045798 753 IDF-QGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNIL 831 (1008)
Q Consensus 753 ~~~-~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIl 831 (1008)
... ...+..++||||+++|+|.+++...... .+++..+..++.|++.|++|||++ +|+||||+|+||+
T Consensus 85 ~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~--------~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nil 153 (282)
T cd06636 85 KSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGN--------ALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVL 153 (282)
T ss_pred ccccCCCCEEEEEEEeCCCCcHHHHHHHccCC--------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEE
Confidence 221 2356789999999999999998754321 578888999999999999999998 9999999999999
Q ss_pred ecCCCCeEEcccCcccccccccCccccccccccccccccCccccC-----CCCCCcccchhhHHHHHHHHHhCCCCCCcc
Q 045798 832 LDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGL-----GSEVSTNGDVYSYGILLLEMVTAKKPTDVM 906 (1008)
Q Consensus 832 l~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwslG~vl~elltG~~pf~~~ 906 (1008)
+++++.++|+|||.+........ ......|+..|+|||.+. +..++.++|||||||++|||++|+.||...
T Consensus 154 i~~~~~~~l~dfg~~~~~~~~~~----~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~ 229 (282)
T cd06636 154 LTENAEVKLVDFGVSAQLDRTVG----RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDM 229 (282)
T ss_pred ECCCCCEEEeeCcchhhhhcccc----CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCcccc
Confidence 99999999999999875432211 112345889999999875 346788999999999999999999998632
Q ss_pred ccCCccHHHHHHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 907 FEGDLNLHNFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 907 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
.... ...... ....+. .....++..+.+++.+||+.||.+|||+.|+++
T Consensus 230 ~~~~----~~~~~~------~~~~~~---------------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 230 HPMR----ALFLIP------RNPPPK---------------------LKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred CHHh----hhhhHh------hCCCCC---------------------CcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 1100 000000 000000 001124556899999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=318.18 Aligned_cols=271 Identities=22% Similarity=0.356 Sum_probs=201.0
Q ss_pred cCCCCCceEeeccCeeEEEEEEc----------------CCCeEEEEEEecccc-chhhHHHHHHHHHHhhcCCCCceee
Q 045798 684 NGFSSTHLIGVGSFGCVYKGALD----------------EDGIVVAIKVINLQC-EGASKSFMAECKALKNIRHRNLVKV 746 (1008)
Q Consensus 684 ~~y~~~~~lg~G~~g~Vy~~~~~----------------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~ 746 (1008)
++|++.+.||+|+||.||+|... .++..||+|+++... ......+.+|+++++.++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 57999999999999999998643 234579999997543 3345689999999999999999999
Q ss_pred eeccccccccCCceEEEEEeccCCCChhcccccCCCCCCC-cccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccC
Q 045798 747 ITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRD-KEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDL 825 (1008)
Q Consensus 747 ~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~-~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dl 825 (1008)
++++ ..++..++||||+++++|.+++......... ......+++.++..++.|++.|++|||+. +++||||
T Consensus 85 ~~~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl 156 (296)
T cd05095 85 LAVC-----ITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDL 156 (296)
T ss_pred EEEE-----ecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccC
Confidence 9984 4456689999999999999999765432111 11123588899999999999999999998 9999999
Q ss_pred CCCCeeecCCCCeEEcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHh--CCCCC
Q 045798 826 KPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT--AKKPT 903 (1008)
Q Consensus 826 kp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt--G~~pf 903 (1008)
||+||+++.++.++|+|||+++......... ......++..|+|||...++.++.++|||||||++|||++ |..||
T Consensus 157 kp~Nili~~~~~~~l~dfg~~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~ 234 (296)
T cd05095 157 ATRNCLVGKNYTIKIADFGMSRNLYSGDYYR--IQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPY 234 (296)
T ss_pred ChheEEEcCCCCEEeccCcccccccCCccee--ccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCc
Confidence 9999999999999999999997553322111 1112234678999999888889999999999999999998 67787
Q ss_pred CccccCCccHHHHHHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHH
Q 045798 904 DVMFEGDLNLHNFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTN 983 (1008)
Q Consensus 904 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 983 (1008)
......+ ...... ........ .. ..+....++..+.+++.+||+.||.+||++.|
T Consensus 235 ~~~~~~~-~~~~~~---------~~~~~~~~------------~~---~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ 289 (296)
T cd05095 235 SQLSDEQ-VIENTG---------EFFRDQGR------------QV---YLPKPALCPDSLYKLMLSCWRRNAKERPSFQE 289 (296)
T ss_pred cccChHH-HHHHHH---------HHHhhccc------------cc---cCCCCCCCCHHHHHHHHHHcCCCcccCCCHHH
Confidence 5321110 000000 00000000 00 00001124467899999999999999999999
Q ss_pred HHHHHH
Q 045798 984 VVHELQ 989 (1008)
Q Consensus 984 vl~~L~ 989 (1008)
|.+.|+
T Consensus 290 i~~~l~ 295 (296)
T cd05095 290 IHATLL 295 (296)
T ss_pred HHHHHh
Confidence 999886
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-35 Score=318.62 Aligned_cols=269 Identities=24% Similarity=0.276 Sum_probs=206.7
Q ss_pred CCHHHHHHHhcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccchhhHHHHHHHHHHhhc-CCCCceeeeecccc
Q 045798 674 MSYKSLLKATNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNI-RHRNLVKVITSCSS 752 (1008)
Q Consensus 674 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~ 752 (1008)
+...++..+.++|.+.+.||+|+||.||+|....+++.||+|++... ......+.+|+.+++++ +|||++++++++..
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~-~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~ 90 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPI-SDVDEEIEAEYNILQSLPNHPNVVKFYGMFYK 90 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccc-ccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence 34466667789999999999999999999999889999999998643 23346778899999999 89999999999765
Q ss_pred ccccCCceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeee
Q 045798 753 IDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILL 832 (1008)
Q Consensus 753 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll 832 (1008)
.+....+..++||||+++++|.++++..... ...+++..++.++.|++.||+|||+. +++||||||+||++
T Consensus 91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~------~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili 161 (291)
T cd06639 91 ADKLVGGQLWLVLELCNGGSVTELVKGLLIC------GQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILL 161 (291)
T ss_pred ccccCCCeeEEEEEECCCCcHHHHHHHhhhc------CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEE
Confidence 4433456789999999999999988642211 11688999999999999999999997 99999999999999
Q ss_pred cCCCCeEEcccCcccccccccCccccccccccccccccCccccCCC-----CCCcccchhhHHHHHHHHHhCCCCCCccc
Q 045798 833 DNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGS-----EVSTNGDVYSYGILLLEMVTAKKPTDVMF 907 (1008)
Q Consensus 833 ~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~sDvwslG~vl~elltG~~pf~~~~ 907 (1008)
+.++.+||+|||.+......... .....++..|+|||.+... .++.++|||||||++|||++|+.||....
T Consensus 162 ~~~~~~kl~dfg~~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~ 237 (291)
T cd06639 162 TTEGGVKLVDFGVSAQLTSTRLR----RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMH 237 (291)
T ss_pred cCCCCEEEeecccchhccccccc----ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCc
Confidence 99999999999999865432211 1123578999999987543 36889999999999999999999986431
Q ss_pred cCCccHHHHHHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 908 EGDLNLHNFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 908 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
.. .......+.. + +.+ ....+....+.+++.+||+.+|++||++.|+++
T Consensus 238 ~~-~~~~~~~~~~-~--------~~~--------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 238 PV-KTLFKIPRNP-P--------PTL--------------------LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred HH-HHHHHHhcCC-C--------CCC--------------------CcccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 11 0000000000 0 000 001123345889999999999999999999975
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=315.89 Aligned_cols=252 Identities=23% Similarity=0.270 Sum_probs=196.3
Q ss_pred CCCCCceEeeccCeeEEEEEEcCCCeEEEEEEecccc---chhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceE
Q 045798 685 GFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC---EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFK 761 (1008)
Q Consensus 685 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 761 (1008)
.|+..+.||+|+||+||+|.+..+++.||+|++.... ......+.+|++++++++|++|+++.+++ ..++..
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~-----~~~~~~ 75 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAY-----ETKDAL 75 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEE-----ecCCEE
Confidence 3677899999999999999998899999999986432 22335678899999999999999998884 556779
Q ss_pred EEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEc
Q 045798 762 AIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIG 841 (1008)
Q Consensus 762 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 841 (1008)
++||||+++++|.+++...... .+++..+..++.|++.||.|||+. +|+||||||+||++++++.+||+
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~~~--------~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~ 144 (285)
T cd05632 76 CLVLTIMNGGDLKFHIYNMGNP--------GFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRIS 144 (285)
T ss_pred EEEEEeccCccHHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEe
Confidence 9999999999999888644321 689999999999999999999997 99999999999999999999999
Q ss_pred ccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHhhC
Q 045798 842 DFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMAL 921 (1008)
Q Consensus 842 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~~~ 921 (1008)
|||++........ .....|+..|+|||++.+..++.++|||||||++|||++|..||........ ...... ..
T Consensus 145 Dfg~~~~~~~~~~-----~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~-~~~~~~-~~ 217 (285)
T cd05632 145 DLGLAVKIPEGES-----IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVK-REEVDR-RV 217 (285)
T ss_pred cCCcceecCCCCc-----ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHH-hh
Confidence 9999975432211 1234589999999999888999999999999999999999999864311100 000000 00
Q ss_pred CcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCC-----HHHHHH
Q 045798 922 PNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMN-----MTNVVH 986 (1008)
Q Consensus 922 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~ 986 (1008)
..... . .....+..+.+++..||+.||++||+ +.+++.
T Consensus 218 ~~~~~---------------------~------~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 218 LETEE---------------------V------YSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred hcccc---------------------c------cCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence 00000 0 00123445789999999999999999 556555
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-35 Score=317.89 Aligned_cols=268 Identities=22% Similarity=0.351 Sum_probs=201.5
Q ss_pred HhcCCCCCceEeeccCeeEEEEEEc-----CCCeEEEEEEeccccc-hhhHHHHHHHHHHhhcCCCCceeeeeccccccc
Q 045798 682 ATNGFSSTHLIGVGSFGCVYKGALD-----EDGIVVAIKVINLQCE-GASKSFMAECKALKNIRHRNLVKVITSCSSIDF 755 (1008)
Q Consensus 682 ~~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 755 (1008)
..++|++.+.||+|+||.||+|..+ ..+..||+|.++.... .....+.+|+.++++++||||+++++++
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~----- 78 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVV----- 78 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEE-----
Confidence 4578999999999999999999764 2356899998864432 3345688999999999999999999984
Q ss_pred cCCceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCC
Q 045798 756 QGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDND 835 (1008)
Q Consensus 756 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~ 835 (1008)
...+..++||||+++|+|.+++................++..+..++.|++.||+|||+. +|+||||||+||+++++
T Consensus 79 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~ 155 (288)
T cd05061 79 SKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHD 155 (288)
T ss_pred cCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCC
Confidence 445678999999999999999975432111111112567788999999999999999997 99999999999999999
Q ss_pred CCeEEcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCccccCCccHH
Q 045798 836 LSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT-AKKPTDVMFEGDLNLH 914 (1008)
Q Consensus 836 ~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-G~~pf~~~~~~~~~~~ 914 (1008)
+.+||+|||+++.......... .....++..|+|||.+.++.++.++|||||||++|||++ |..||......
T Consensus 156 ~~~~L~Dfg~~~~~~~~~~~~~--~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~----- 228 (288)
T cd05061 156 FTVKIGDFGMTRDIYETDYYRK--GGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE----- 228 (288)
T ss_pred CcEEECcCCccccccccccccc--cCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHH-----
Confidence 9999999999975533221111 112235678999999998899999999999999999998 78887532110
Q ss_pred HHHHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHHHHH
Q 045798 915 NFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHELQSV 991 (1008)
Q Consensus 915 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~i 991 (1008)
...... .+..... ....++..+.+++.+||+.||++|||+.++++.+++.
T Consensus 229 ~~~~~~--------~~~~~~~-------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~ 278 (288)
T cd05061 229 QVLKFV--------MDGGYLD-------------------QPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 278 (288)
T ss_pred HHHHHH--------HcCCCCC-------------------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence 111000 0000000 0012345689999999999999999999999888764
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=316.68 Aligned_cols=275 Identities=25% Similarity=0.388 Sum_probs=207.0
Q ss_pred cCCCCCceEeeccCeeEEEEEEcC----CCeEEEEEEeccccch-hhHHHHHHHHHHhhcCCCCceeeeeccccccccCC
Q 045798 684 NGFSSTHLIGVGSFGCVYKGALDE----DGIVVAIKVINLQCEG-ASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGN 758 (1008)
Q Consensus 684 ~~y~~~~~lg~G~~g~Vy~~~~~~----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 758 (1008)
+.|++.+.||+|+||.||+|.... +++.||+|+++..... ..+.+.+|+++++.+.|+||+++++++.. .++
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~---~~~ 80 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEK---PGG 80 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeec---CCC
Confidence 467888999999999999999743 4789999999865443 46789999999999999999999998643 335
Q ss_pred ceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCe
Q 045798 759 DFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSG 838 (1008)
Q Consensus 759 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 838 (1008)
...++||||+++++|.+++..... .+++..+..++.|++.||+|||+. +++||||||+||+++.++.+
T Consensus 81 ~~~~lv~e~~~~~~l~~~l~~~~~---------~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~ 148 (284)
T cd05038 81 RSLRLIMEYLPSGSLRDYLQRHRD---------QINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLV 148 (284)
T ss_pred CceEEEEecCCCCCHHHHHHhCcc---------ccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCE
Confidence 678999999999999999976531 589999999999999999999997 99999999999999999999
Q ss_pred EEcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHH
Q 045798 839 HIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFAR 918 (1008)
Q Consensus 839 kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~ 918 (1008)
+|+|||.+........... ......++..|+|||...+..++.++||||||+++|||++|+.|+......... +..
T Consensus 149 ~l~dfg~~~~~~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~---~~~ 224 (284)
T cd05038 149 KISDFGLAKVLPEDKDYYY-VKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLR---MIG 224 (284)
T ss_pred EEcccccccccccCCccee-ccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcc---ccc
Confidence 9999999987653322111 111223566799999998889999999999999999999999997543221100 000
Q ss_pred hhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHHHHH
Q 045798 919 MALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHELQSV 991 (1008)
Q Consensus 919 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~i 991 (1008)
..........+...+.. ..+ .+....++.++.+++.+||+.+|++||||.||+++|+.+
T Consensus 225 ~~~~~~~~~~~~~~~~~----------~~~----~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 225 IAQGQMIVTRLLELLKE----------GER----LPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred cccccccHHHHHHHHHc----------CCc----CCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 00000000000000000 000 011123456789999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=317.96 Aligned_cols=271 Identities=22% Similarity=0.361 Sum_probs=198.9
Q ss_pred cCCCCCceEeeccCeeEEEEEEcCC--------------CeEEEEEEecccc-chhhHHHHHHHHHHhhcCCCCceeeee
Q 045798 684 NGFSSTHLIGVGSFGCVYKGALDED--------------GIVVAIKVINLQC-EGASKSFMAECKALKNIRHRNLVKVIT 748 (1008)
Q Consensus 684 ~~y~~~~~lg~G~~g~Vy~~~~~~~--------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~ 748 (1008)
++|++.+.||+|+||.||+|..... ...||+|+++... ......+.+|++++++++|+|++++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 5799999999999999999987432 2358999987542 334567999999999999999999999
Q ss_pred ccccccccCCceEEEEEeccCCCChhcccccCCCCCCC--cccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCC
Q 045798 749 SCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRD--KEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLK 826 (1008)
Q Consensus 749 ~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~--~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlk 826 (1008)
++ ...+..++||||+++++|.+++......... ......+++..++.++.|++.||+|||+. +++|||||
T Consensus 85 ~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlk 156 (295)
T cd05097 85 VC-----VSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLA 156 (295)
T ss_pred EE-----cCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccC
Confidence 95 4556789999999999999998654211100 00111478899999999999999999998 99999999
Q ss_pred CCCeeecCCCCeEEcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHh--CCCCCC
Q 045798 827 PSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT--AKKPTD 904 (1008)
Q Consensus 827 p~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt--G~~pf~ 904 (1008)
|+||++++++.+||+|||++......... .......++..|+|||+..++.++.++|||||||++|+|++ |..||.
T Consensus 157 p~Nill~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~ 234 (295)
T cd05097 157 TRNCLVGNHYTIKIADFGMSRNLYSGDYY--RIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYS 234 (295)
T ss_pred hhhEEEcCCCcEEecccccccccccCcce--eccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCc
Confidence 99999999999999999999754332211 11122345778999999988889999999999999999998 556765
Q ss_pred ccccCCccHHHHHHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHH
Q 045798 905 VMFEGDLNLHNFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNV 984 (1008)
Q Consensus 905 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev 984 (1008)
...... ........ . +..... .. .......+..+.+++.+||+.||++|||+++|
T Consensus 235 ~~~~~~-~~~~~~~~-~--------~~~~~~-------------~~--~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i 289 (295)
T cd05097 235 LLSDEQ-VIENTGEF-F--------RNQGRQ-------------IY--LSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKI 289 (295)
T ss_pred ccChHH-HHHHHHHh-h--------hhcccc-------------cc--CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHH
Confidence 321110 00000000 0 000000 00 00001234568999999999999999999999
Q ss_pred HHHHH
Q 045798 985 VHELQ 989 (1008)
Q Consensus 985 l~~L~ 989 (1008)
++.|+
T Consensus 290 ~~~l~ 294 (295)
T cd05097 290 HHFLR 294 (295)
T ss_pred HHHHh
Confidence 99886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=315.73 Aligned_cols=252 Identities=23% Similarity=0.301 Sum_probs=197.6
Q ss_pred CCCCCceEeeccCeeEEEEEEcCCCeEEEEEEecccc---chhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceE
Q 045798 685 GFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC---EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFK 761 (1008)
Q Consensus 685 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 761 (1008)
.|+..+.||+|+||.||+|.+..+++.||+|.+.... ......+.+|+.++++++|++|+++++.+ ..++..
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~-----~~~~~~ 75 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAY-----ETKDAL 75 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEE-----ecCCEE
Confidence 3677899999999999999999999999999986432 22235678899999999999999999884 455679
Q ss_pred EEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEc
Q 045798 762 AIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIG 841 (1008)
Q Consensus 762 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 841 (1008)
++||||+++++|.+++..... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++|+
T Consensus 76 ~lv~e~~~g~~L~~~l~~~~~--------~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~ 144 (285)
T cd05630 76 CLVLTLMNGGDLKFHIYHMGE--------AGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRIS 144 (285)
T ss_pred EEEEEecCCCcHHHHHHHhcc--------cCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEe
Confidence 999999999999998864332 1588999999999999999999997 99999999999999999999999
Q ss_pred ccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHhhC
Q 045798 842 DFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMAL 921 (1008)
Q Consensus 842 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~~~ 921 (1008)
|||++......... ....|+..|+|||++.+..++.++||||+||++|+|++|+.||....... ......
T Consensus 145 Dfg~~~~~~~~~~~-----~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~-~~~~~~---- 214 (285)
T cd05630 145 DLGLAVHVPEGQTI-----KGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKI-KREEVE---- 214 (285)
T ss_pred eccceeecCCCccc-----cCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccc-hHHHHH----
Confidence 99998754322211 12358999999999999899999999999999999999999986432110 000000
Q ss_pred CcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCC-----HHHHHH
Q 045798 922 PNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMN-----MTNVVH 986 (1008)
Q Consensus 922 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~ 986 (1008)
...+. ... .. ....+.++.+++..||+.||++||| ++|+++
T Consensus 215 -----~~~~~----~~~---------~~------~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 215 -----RLVKE----VQE---------EY------SEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred -----hhhhh----hhh---------hc------CccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 00000 000 00 0123445789999999999999999 788877
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=311.97 Aligned_cols=253 Identities=28% Similarity=0.439 Sum_probs=198.0
Q ss_pred cCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccchhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceEEE
Q 045798 684 NGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKAI 763 (1008)
Q Consensus 684 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 763 (1008)
++|.+.+.||+|++|.||+|.+. .+..||+|++... ....+.+.+|++++++++|+|++++++++. .+..++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~lK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~------~~~~~~ 77 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWN-GTTKVAIKTLKPG-TMMPEAFLQEAQIMKKLRHDKLVPLYAVVS------EEPIYI 77 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEc-CCceEEEEEcccC-CccHHHHHHHHHHHHhCCCCCeeeEEEEEc------CCCcEE
Confidence 46889999999999999999986 4456999988643 233467899999999999999999998742 345789
Q ss_pred EEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEccc
Q 045798 764 VYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDF 843 (1008)
Q Consensus 764 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 843 (1008)
||||+++++|.+++..... ..+++..+..++.|++.||+|||+. +++||||||+||++++++.++|+||
T Consensus 78 v~e~~~~~~L~~~~~~~~~--------~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~df 146 (260)
T cd05069 78 VTEFMGKGSLLDFLKEGDG--------KYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADF 146 (260)
T ss_pred EEEcCCCCCHHHHHhhCCC--------CCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCC
Confidence 9999999999999975431 1578999999999999999999997 9999999999999999999999999
Q ss_pred CcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCccccCCccHHHHHHhhCC
Q 045798 844 GLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT-AKKPTDVMFEGDLNLHNFARMALP 922 (1008)
Q Consensus 844 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-G~~pf~~~~~~~~~~~~~~~~~~~ 922 (1008)
|.+......... ......++..|+|||...+..++.++||||||+++|||++ |..||....... ..........
T Consensus 147 g~~~~~~~~~~~---~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--~~~~~~~~~~ 221 (260)
T cd05069 147 GLARLIEDNEYT---ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE--VLEQVERGYR 221 (260)
T ss_pred ccceEccCCccc---ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHcCCC
Confidence 999765432211 1112236778999999988889999999999999999999 888986421110 0000000000
Q ss_pred cchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHHHH
Q 045798 923 NQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHELQS 990 (1008)
Q Consensus 923 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 990 (1008)
.. .....+..+.+++.+||+.||.+||++++|++.|+.
T Consensus 222 ----------------------------~~--~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 222 ----------------------------MP--CPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred ----------------------------CC--CCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 00 011245568999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=315.51 Aligned_cols=251 Identities=25% Similarity=0.350 Sum_probs=198.0
Q ss_pred CCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccchhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceEEEEE
Q 045798 686 FSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKAIVY 765 (1008)
Q Consensus 686 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 765 (1008)
|++.+.||+|+||.||+|.+..++..+|+|.+........+.+.+|+++++.++||||+++++++ ..++..++||
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~-----~~~~~~~~v~ 81 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF-----YYENNLWILI 81 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEE-----eeCCEEEEEE
Confidence 67788999999999999999888999999999766556667899999999999999999999985 4456789999
Q ss_pred eccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEcccCc
Q 045798 766 EYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGL 845 (1008)
Q Consensus 766 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~ 845 (1008)
||+++++|..++..... ++++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||+
T Consensus 82 e~~~~~~l~~~~~~~~~---------~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~ 149 (282)
T cd06643 82 EFCAGGAVDAVMLELER---------PLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGV 149 (282)
T ss_pred EecCCCcHHHHHHhcCC---------CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEccccc
Confidence 99999999988764321 689999999999999999999997 999999999999999999999999999
Q ss_pred ccccccccCccccccccccccccccCccccC-----CCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHhh
Q 045798 846 ARFHQEVSNSTLSSSVGVKGTIGYTAPEYGL-----GSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMA 920 (1008)
Q Consensus 846 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~~ 920 (1008)
+......... .....++..|+|||++. +..++.++|||||||++|||++|+.||....... .........
T Consensus 150 ~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~-~~~~~~~~~ 224 (282)
T cd06643 150 SAKNTRTIQR----RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMR-VLLKIAKSE 224 (282)
T ss_pred cccccccccc----cccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHH-HHHHHhhcC
Confidence 8754332111 12245889999999874 3457889999999999999999999986421100 000000000
Q ss_pred CCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 045798 921 LPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHE 987 (1008)
Q Consensus 921 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 987 (1008)
.+ . .......+.++.+++.+||+.||.+||+++++++.
T Consensus 225 ~~---------~--------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 225 PP---------T--------------------LAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred CC---------C--------------------CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00 0 00011234567999999999999999999998763
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=324.42 Aligned_cols=284 Identities=23% Similarity=0.236 Sum_probs=204.5
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccc-cchhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceE
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQ-CEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFK 761 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 761 (1008)
.++|++.+.||+|+||.||+|.+..+++.||+|++... .......+.+|+.++++++|+||+++++++....+......
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 57899999999999999999999889999999998643 23345678899999999999999999998766555556678
Q ss_pred EEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEc
Q 045798 762 AIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIG 841 (1008)
Q Consensus 762 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 841 (1008)
++|+||++ +++.+++... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+
T Consensus 84 ~lv~e~~~-~~l~~~~~~~-----------~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~ 148 (336)
T cd07849 84 YIVQELME-TDLYKLIKTQ-----------HLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKIC 148 (336)
T ss_pred EEEehhcc-cCHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEC
Confidence 99999995 5888877543 689999999999999999999998 99999999999999999999999
Q ss_pred ccCcccccccccCccccccccccccccccCccccCC-CCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHhh
Q 045798 842 DFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLG-SEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMA 920 (1008)
Q Consensus 842 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~~ 920 (1008)
|||++........... ......|+..|+|||.+.+ ..++.++||||+||++|+|++|+.||...... .....+....
T Consensus 149 dfg~~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~-~~~~~~~~~~ 226 (336)
T cd07849 149 DFGLARIADPEHDHTG-FLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYL-HQLNLILGVL 226 (336)
T ss_pred cccceeeccccccccC-CcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHc
Confidence 9999986543322111 1223458899999998654 46889999999999999999999998542110 0111111111
Q ss_pred CC---cchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 045798 921 LP---NQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHE 987 (1008)
Q Consensus 921 ~~---~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 987 (1008)
.. +....+.+....... ........ .+........+.++.+++.+||+.||++|||+.|+++.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~---~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 227 GTPSQEDLNCIISLRARNYI---KSLPFKPK-VPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred CCCCHHHHHHhhchhhhhHH---hhcCcCCc-ccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00 111111110000000 00000000 00000011235668999999999999999999999875
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=333.30 Aligned_cols=196 Identities=24% Similarity=0.368 Sum_probs=167.2
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccchhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceEE
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKA 762 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 762 (1008)
..+|.+.+.||+|+||.||+|.+...++.||||... ...+.+|++++++++|+||+++++++ ..++..+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~-----~~~~~~~ 236 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVR-----VVGGLTC 236 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEE-----EECCEEE
Confidence 457999999999999999999999889999999643 23467899999999999999999985 3456689
Q ss_pred EEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEcc
Q 045798 763 IVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGD 842 (1008)
Q Consensus 763 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 842 (1008)
+|||++ .++|.+++..... .+++.+++.|+.||+.||+|||+. +|+||||||+|||++.++.+||+|
T Consensus 237 lv~e~~-~~~L~~~l~~~~~---------~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~D 303 (461)
T PHA03211 237 LVLPKY-RSDLYTYLGARLR---------PLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGD 303 (461)
T ss_pred EEEEcc-CCCHHHHHHhcCC---------CCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcc
Confidence 999999 5799888864321 689999999999999999999997 999999999999999999999999
Q ss_pred cCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCC
Q 045798 843 FGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTD 904 (1008)
Q Consensus 843 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~ 904 (1008)
||+++......... ......||..|+|||++.+..++.++|||||||++|||++|..|+.
T Consensus 304 FGla~~~~~~~~~~--~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf 363 (461)
T PHA03211 304 FGAACFARGSWSTP--FHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLF 363 (461)
T ss_pred cCCceecccccccc--cccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcc
Confidence 99998654322111 1223569999999999999999999999999999999999887653
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=321.53 Aligned_cols=207 Identities=26% Similarity=0.367 Sum_probs=163.9
Q ss_pred CceEeeccCeeEEEEEEc--CCCeEEEEEEeccccchhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceEEEEEe
Q 045798 689 THLIGVGSFGCVYKGALD--EDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKAIVYE 766 (1008)
Q Consensus 689 ~~~lg~G~~g~Vy~~~~~--~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 766 (1008)
.++||+|+||+||+|+.. .+++.||+|+++.. .....+.+|++++++++||||+++++++.. ..+...++|||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~---~~~~~~~lv~e 80 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGT--GISMSACREIALLRELKHPNVISLQKVFLS---HADRKVWLLFD 80 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCC--CCcHHHHHHHHHHHhcCCCCCcceeeeEec---CCCcEEEEEEe
Confidence 468999999999999975 36689999998643 223567899999999999999999988642 34556899999
Q ss_pred ccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeee----cCCCCeEEcc
Q 045798 767 YMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILL----DNDLSGHIGD 842 (1008)
Q Consensus 767 ~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll----~~~~~~kL~D 842 (1008)
|+ +++|.+++........ ......+++..++.++.||+.||+|||+. +|+||||||+||++ +.++.+||+|
T Consensus 81 ~~-~~~l~~~~~~~~~~~~-~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~D 155 (317)
T cd07868 81 YA-EHDLWHIIKFHRASKA-NKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIAD 155 (317)
T ss_pred cc-CCCHHHHHHhcccccc-cCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEee
Confidence 99 5688888764332111 11122689999999999999999999998 99999999999999 4567899999
Q ss_pred cCcccccccccCccccccccccccccccCccccCCC-CCCcccchhhHHHHHHHHHhCCCCCCcc
Q 045798 843 FGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGS-EVSTNGDVYSYGILLLEMVTAKKPTDVM 906 (1008)
Q Consensus 843 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltG~~pf~~~ 906 (1008)
||+|+........ ........+|+.|+|||++.+. .++.++||||+||++|||++|++||...
T Consensus 156 fG~a~~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 156 MGFARLFNSPLKP-LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred cCceeccCCCCcc-ccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 9999865433211 1122335689999999998774 5899999999999999999999999643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=316.71 Aligned_cols=278 Identities=25% Similarity=0.299 Sum_probs=198.0
Q ss_pred CCCCCceEeeccCeeEEEEEEcCCCeEEEEEEecccc--chhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceEE
Q 045798 685 GFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC--EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKA 762 (1008)
Q Consensus 685 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 762 (1008)
+|++.+.||+|++|.||+|....+++.||+|+++... ....+.+.+|+.++++++||||+++++++ ..++..+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~ 75 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVL-----MQESRLY 75 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEE-----eeCCeEE
Confidence 4888999999999999999998889999999987432 23346788999999999999999999994 4567799
Q ss_pred EEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEcc
Q 045798 763 IVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGD 842 (1008)
Q Consensus 763 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 842 (1008)
+||||++ ++|.+++...... ..+++..++.++.|++.||+|||+. +++||||+|+||+++.++.+||+|
T Consensus 76 ~v~e~~~-~~l~~~~~~~~~~-------~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~d 144 (285)
T cd07861 76 LIFEFLS-MDLKKYLDSLPKG-------QYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLAD 144 (285)
T ss_pred EEEecCC-CCHHHHHhcCCCC-------CcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECc
Confidence 9999996 6898888654321 1689999999999999999999997 999999999999999999999999
Q ss_pred cCcccccccccCccccccccccccccccCccccCCC-CCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHhhC
Q 045798 843 FGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGS-EVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMAL 921 (1008)
Q Consensus 843 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~~~ 921 (1008)
||++........ ......+++.|+|||++.+. .++.++|||||||++|+|++|+.||....+.+..... .....
T Consensus 145 fg~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~-~~~~~ 219 (285)
T cd07861 145 FGLARAFGIPVR----VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRI-FRILG 219 (285)
T ss_pred ccceeecCCCcc----cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH-HHHhC
Confidence 999975432211 11223468899999987654 4788999999999999999999998643221111111 00000
Q ss_pred CcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 922 PNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 922 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
... .... +............... ............+.++.+++.+||+.||++|||+.+|++
T Consensus 220 ~~~-~~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 220 TPT-EDVW-PGVTSLPDYKNTFPKW-KKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred CCC-hhhh-hcchhhHHHHhhcccc-CcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 000 0000 0000000000000000 000000001124566789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-35 Score=318.13 Aligned_cols=275 Identities=23% Similarity=0.304 Sum_probs=197.2
Q ss_pred CCCCCceEeeccCeeEEEEEEcCCCeEEEEEEecccc--chhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceEE
Q 045798 685 GFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC--EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKA 762 (1008)
Q Consensus 685 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 762 (1008)
+|++.+.||+|+||.||+|.+..+|+.||+|+++... ......+.+|++++++++||||++++++ +.+....+
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~-----~~~~~~~~ 75 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV-----LHSDKKLT 75 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHH-----hccCCceE
Confidence 4888999999999999999999899999999987432 2234567889999999999999999998 45667799
Q ss_pred EEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEcc
Q 045798 763 IVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGD 842 (1008)
Q Consensus 763 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 842 (1008)
+|+||++ ++|.+++..... .+++..++.++.||++||+|||+. +++||||||+||+++.++.+||+|
T Consensus 76 lv~e~~~-~~l~~~~~~~~~---------~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d 142 (284)
T cd07839 76 LVFEYCD-QDLKKYFDSCNG---------DIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLAD 142 (284)
T ss_pred EEEecCC-CCHHHHHHhcCC---------CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECc
Confidence 9999995 588887764321 689999999999999999999997 999999999999999999999999
Q ss_pred cCcccccccccCccccccccccccccccCccccCCC-CCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHhhC
Q 045798 843 FGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGS-EVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMAL 921 (1008)
Q Consensus 843 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~~~ 921 (1008)
||.++........ .....++..|+|||++.+. .++.++|||||||++|||++|+.|+.........+........
T Consensus 143 fg~~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~ 218 (284)
T cd07839 143 FGLARAFGIPVRC----YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLG 218 (284)
T ss_pred cchhhccCCCCCC----cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhC
Confidence 9999855432211 1223478899999988764 4689999999999999999999986432221111111111111
Q ss_pred Ccchhh--hhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 922 PNQVMD--IVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 922 ~~~~~~--~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
...... .+..... ............+ .......+.++.+++.+||+.||.+|||++|+++
T Consensus 219 ~~~~~~~~~~~~~~~--~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 219 TPTEESWPGVSKLPD--YKPYPMYPATTSL---VNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred CCChHHhHHhhhccc--ccccCCCCCcchh---hhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 100000 0000000 0000000000000 0001124567789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=325.47 Aligned_cols=238 Identities=28% Similarity=0.308 Sum_probs=185.2
Q ss_pred ceEeeccCeeEEEEEEcCCCeEEEEEEecccc---chhhHHHHHHHH-HHhhcCCCCceeeeeccccccccCCceEEEEE
Q 045798 690 HLIGVGSFGCVYKGALDEDGIVVAIKVINLQC---EGASKSFMAECK-ALKNIRHRNLVKVITSCSSIDFQGNDFKAIVY 765 (1008)
Q Consensus 690 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 765 (1008)
+.||+|+||.||+|++..+++.||+|++.... ......+.+|.. +++.++||||+++++++ .+.+..++||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~-----~~~~~~~lv~ 75 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSF-----QTAEKLYFVL 75 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEE-----EcCCEEEEEE
Confidence 46999999999999998899999999986432 222344555554 57888999999999884 5667799999
Q ss_pred eccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEcccCc
Q 045798 766 EYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGL 845 (1008)
Q Consensus 766 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~ 845 (1008)
||+++|+|..++.... .+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 76 e~~~~~~L~~~l~~~~----------~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 142 (321)
T cd05603 76 DYVNGGELFFHLQRER----------CFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGL 142 (321)
T ss_pred cCCCCCCHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCC
Confidence 9999999998886543 678899999999999999999997 999999999999999999999999999
Q ss_pred ccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCcch
Q 045798 846 ARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMALPNQV 925 (1008)
Q Consensus 846 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~ 925 (1008)
++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..... .......
T Consensus 143 ~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-----~~~~~~i----- 208 (321)
T cd05603 143 CKEGVEPEE----TTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDV-----SQMYDNI----- 208 (321)
T ss_pred CccCCCCCC----ccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCH-----HHHHHHH-----
Confidence 874322211 12234589999999999988999999999999999999999999864211 1111000
Q ss_pred hhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHH
Q 045798 926 MDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMT 982 (1008)
Q Consensus 926 ~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ 982 (1008)
..... ..+ .....++.+++.+|++.||.+||++.
T Consensus 209 ---~~~~~--------------~~~------~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 209 ---LHKPL--------------QLP------GGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred ---hcCCC--------------CCC------CCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 00000 000 11234578999999999999999875
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=320.35 Aligned_cols=251 Identities=24% Similarity=0.345 Sum_probs=203.7
Q ss_pred CCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccchhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceEEEE
Q 045798 685 GFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKAIV 764 (1008)
Q Consensus 685 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 764 (1008)
-|.++..||.|+||.||+|..++++-..|.|++....+...++|.-|++|+..+.||+||++++.| ..++..+|+
T Consensus 33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ay-----y~enkLwil 107 (1187)
T KOG0579|consen 33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAY-----YFENKLWIL 107 (1187)
T ss_pred HHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHH-----hccCceEEE
Confidence 356678899999999999999988888899999988888899999999999999999999999984 456779999
Q ss_pred EeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEcccC
Q 045798 765 YEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFG 844 (1008)
Q Consensus 765 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg 844 (1008)
.|||.||-.+..+-.-+. .+++.++.-+++|++.||.|||+. .|||||+|+.|||++-+|.++|+|||
T Consensus 108 iEFC~GGAVDaimlEL~r---------~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFG 175 (1187)
T KOG0579|consen 108 IEFCGGGAVDAIMLELGR---------VLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFG 175 (1187)
T ss_pred EeecCCchHhHHHHHhcc---------ccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeeccc
Confidence 999999999888765432 799999999999999999999998 99999999999999999999999999
Q ss_pred cccccccccCccccccccccccccccCcccc-----CCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHh
Q 045798 845 LARFHQEVSNSTLSSSVGVKGTIGYTAPEYG-----LGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARM 919 (1008)
Q Consensus 845 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~ 919 (1008)
.+..... .......++||++|||||+. ...+|++++||||||+++.||..+.+|-.... ..+....
T Consensus 176 VSAKn~~----t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHheln----pMRVllK- 246 (1187)
T KOG0579|consen 176 VSAKNKS----TRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELN----PMRVLLK- 246 (1187)
T ss_pred ccccchh----HHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccc----hHHHHHH-
Confidence 9864332 22234457899999999985 35689999999999999999999999954221 0111111
Q ss_pred hCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 920 ALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 920 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
..+.++ +-.-........+.+++.+|+..||..||++.++++
T Consensus 247 ------------iaKSeP-------------PTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 247 ------------IAKSEP-------------PTLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred ------------HhhcCC-------------CcccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 011111 111111234556899999999999999999999986
|
|
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=313.08 Aligned_cols=279 Identities=23% Similarity=0.264 Sum_probs=208.2
Q ss_pred cCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccc-hhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceEE
Q 045798 684 NGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCE-GASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKA 762 (1008)
Q Consensus 684 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 762 (1008)
++|...+.||.|++|.||+|.+..+++.||+|++..... .....+.+|++++++++||||++++++|.. ...+..+
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~~~~~~ 77 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLD---ESSSSIG 77 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEc---cCCCeEE
Confidence 468889999999999999999988899999999875432 345679999999999999999999998643 3445689
Q ss_pred EEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEcc
Q 045798 763 IVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGD 842 (1008)
Q Consensus 763 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 842 (1008)
+||||+++++|.+++...... ...+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|
T Consensus 78 lv~e~~~~~~L~~~l~~~~~~------~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d 148 (287)
T cd06621 78 IAMEYCEGGSLDSIYKKVKKR------GGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCD 148 (287)
T ss_pred EEEEecCCCCHHHHHHHHHhc------CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEee
Confidence 999999999999887542211 11678899999999999999999998 999999999999999999999999
Q ss_pred cCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHhhCC
Q 045798 843 FGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMALP 922 (1008)
Q Consensus 843 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~~~~ 922 (1008)
||++........ ....++..|+|||.+.+..++.++||||+||++|+|++|+.||...................
T Consensus 149 fg~~~~~~~~~~------~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 222 (287)
T cd06621 149 FGVSGELVNSLA------GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVN 222 (287)
T ss_pred cccccccccccc------ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhc
Confidence 999875432211 12347889999999988899999999999999999999999987442210111111110000
Q ss_pred cchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH--HHHHHHHHHHHHHH
Q 045798 923 NQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH--ELQSVKNILLELET 1000 (1008)
Q Consensus 923 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~--~L~~i~~~~~~~~~ 1000 (1008)
.. .+.+. .........+..+.+++.+||+.+|.+|||+.|+++ -+.....+...++.
T Consensus 223 ~~-----~~~~~----------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~~~~~~~~~ 281 (287)
T cd06621 223 MP-----NPELK----------------DEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQMKKKVNMAK 281 (287)
T ss_pred CC-----chhhc----------------cCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCccccccccchhhHHH
Confidence 00 00000 000001123556899999999999999999999998 34444443334444
Q ss_pred h
Q 045798 1001 V 1001 (1008)
Q Consensus 1001 ~ 1001 (1008)
.
T Consensus 282 ~ 282 (287)
T cd06621 282 F 282 (287)
T ss_pred H
Confidence 3
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=310.08 Aligned_cols=251 Identities=26% Similarity=0.347 Sum_probs=202.0
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccchhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceEE
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKA 762 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 762 (1008)
.++|++.+.||+|+||.||+|....+++.||+|.++.... .+.+.+|++++++++|+||+++++++ ..+...|
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~-----~~~~~~~ 74 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSY-----FKNTDLW 74 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeee-----ecCCcEE
Confidence 3679999999999999999999987889999999875422 67899999999999999999999984 4557799
Q ss_pred EEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEcc
Q 045798 763 IVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGD 842 (1008)
Q Consensus 763 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 842 (1008)
+++||+++++|.+++..... .+++..+..++.|++.|+.|||+. +++||||+|+||++++++.+||+|
T Consensus 75 l~~e~~~~~~L~~~l~~~~~---------~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~d 142 (256)
T cd06612 75 IVMEYCGAGSVSDIMKITNK---------TLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLAD 142 (256)
T ss_pred EEEecCCCCcHHHHHHhCcc---------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcc
Confidence 99999999999999865331 689999999999999999999998 999999999999999999999999
Q ss_pred cCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHhhCC
Q 045798 843 FGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMALP 922 (1008)
Q Consensus 843 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~~~~ 922 (1008)
||.+......... .....++..|+|||++.+..++.++||||||+++|+|++|+.||........ ... ..
T Consensus 143 fg~~~~~~~~~~~----~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~----~~~--~~ 212 (256)
T cd06612 143 FGVSGQLTDTMAK----RNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRA----IFM--IP 212 (256)
T ss_pred cccchhcccCccc----cccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhh----hhh--hc
Confidence 9999865443211 1223478899999999888999999999999999999999999864321110 000 00
Q ss_pred cchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 923 NQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 923 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
. .. ..........+..+.+++.+||+.||++|||+.||++
T Consensus 213 ~--------~~----------------~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 213 N--------KP----------------PPTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred c--------CC----------------CCCCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 0 00 0000011123456899999999999999999999975
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=317.48 Aligned_cols=272 Identities=22% Similarity=0.347 Sum_probs=202.4
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCC----------------CeEEEEEEecccc-chhhHHHHHHHHHHhhcCCCCcee
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDED----------------GIVVAIKVINLQC-EGASKSFMAECKALKNIRHRNLVK 745 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~----------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~ 745 (1008)
..+|++.+.||+|+||.||+|.+... +..||+|++.... ....+.+.+|++++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 35789999999999999999987543 3568999987543 244568999999999999999999
Q ss_pred eeeccccccccCCceEEEEEeccCCCChhcccccCCCCCCC-cccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceecc
Q 045798 746 VITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRD-KEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCD 824 (1008)
Q Consensus 746 ~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~-~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~D 824 (1008)
++++| ..++..++||||+++++|.+++......... ......+++..++.++.|++.||+|||+. +|+|||
T Consensus 84 ~~~~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~d 155 (296)
T cd05051 84 LLGVC-----TVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRD 155 (296)
T ss_pred EEEEE-----ecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccc
Confidence 99985 4456789999999999999998765421111 11122689999999999999999999997 999999
Q ss_pred CCCCCeeecCCCCeEEcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHh--CCCC
Q 045798 825 LKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT--AKKP 902 (1008)
Q Consensus 825 lkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt--G~~p 902 (1008)
|||+||+++.++.++|+|||.++......... ......++..|+|||++.+..++.++|||||||++|||++ |..|
T Consensus 156 lkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p 233 (296)
T cd05051 156 LATRNCLVGKNYTIKIADFGMSRNLYSSDYYR--VQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQP 233 (296)
T ss_pred cchhceeecCCCceEEccccceeecccCccee--ecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCC
Confidence 99999999999999999999997543322111 1223346788999999988889999999999999999998 6677
Q ss_pred CCccccCCccHHHHHHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHH
Q 045798 903 TDVMFEGDLNLHNFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMT 982 (1008)
Q Consensus 903 f~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ 982 (1008)
|......+ .+........... .....+....++.++.+++.+||+.||++|||+.
T Consensus 234 ~~~~~~~~-~~~~~~~~~~~~~------------------------~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ 288 (296)
T cd05051 234 YEHLTDQQ-VIENAGHFFRDDG------------------------RQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFR 288 (296)
T ss_pred CCCcChHH-HHHHHHhcccccc------------------------ccccCCCccCCCHHHHHHHHHHhccChhcCCCHH
Confidence 65321100 0000000000000 0000000112345789999999999999999999
Q ss_pred HHHHHHH
Q 045798 983 NVVHELQ 989 (1008)
Q Consensus 983 evl~~L~ 989 (1008)
||++.|+
T Consensus 289 el~~~L~ 295 (296)
T cd05051 289 EIHLFLQ 295 (296)
T ss_pred HHHHHhc
Confidence 9998875
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=312.88 Aligned_cols=258 Identities=24% Similarity=0.382 Sum_probs=202.4
Q ss_pred cCCCCCceEeeccCeeEEEEEEcCC---CeEEEEEEecccc-chhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCc
Q 045798 684 NGFSSTHLIGVGSFGCVYKGALDED---GIVVAIKVINLQC-EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGND 759 (1008)
Q Consensus 684 ~~y~~~~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 759 (1008)
++|.+.+.||+|+||.||+|.+... ...||+|...... ....+.+.+|+.++++++||||++++++|.. +
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~------~ 79 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE------N 79 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC------C
Confidence 4688899999999999999987533 3579999987554 3455689999999999999999999998542 3
Q ss_pred eEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeE
Q 045798 760 FKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGH 839 (1008)
Q Consensus 760 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 839 (1008)
..++||||+++|+|.+++..... .+++..++.++.|++.|++|||+. +++||||||+||+++.++.+|
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~ 147 (270)
T cd05056 80 PVWIVMELAPLGELRSYLQVNKY---------SLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVK 147 (270)
T ss_pred CcEEEEEcCCCCcHHHHHHhCCC---------CCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeE
Confidence 46899999999999999975431 579999999999999999999997 999999999999999999999
Q ss_pred EcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCccccCCccHHHHHH
Q 045798 840 IGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT-AKKPTDVMFEGDLNLHNFAR 918 (1008)
Q Consensus 840 L~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-G~~pf~~~~~~~~~~~~~~~ 918 (1008)
|+|||.++......... .....++..|+|||.+....++.++||||||+++||+++ |..||......+. ......
T Consensus 148 l~d~g~~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~-~~~~~~ 223 (270)
T cd05056 148 LGDFGLSRYLEDESYYK---ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDV-IGRIEN 223 (270)
T ss_pred EccCceeeeccccccee---cCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHH-HHHHHc
Confidence 99999998654332111 112234568999999888889999999999999999986 9999864321110 000000
Q ss_pred hhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHHHHHHHH
Q 045798 919 MALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHELQSVKNI 994 (1008)
Q Consensus 919 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~i~~~ 994 (1008)
. .+. +....++..+.+++.+|+..+|.+|||+.++++.|+.+.++
T Consensus 224 ---~------------------------~~~----~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~ 268 (270)
T cd05056 224 ---G------------------------ERL----PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE 268 (270)
T ss_pred ---C------------------------CcC----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 0 000 00112455789999999999999999999999999997764
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=317.25 Aligned_cols=270 Identities=21% Similarity=0.407 Sum_probs=205.6
Q ss_pred hcCCCCCceEeeccCeeEEEEEEc-------CCCeEEEEEEecccc-chhhHHHHHHHHHHhhc-CCCCceeeeeccccc
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALD-------EDGIVVAIKVINLQC-EGASKSFMAECKALKNI-RHRNLVKVITSCSSI 753 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~-------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~ 753 (1008)
.++|.+.+.||+|+||.||+|+.. .++..||+|.++... ....+.+.+|+.+++.+ +||||+++++++
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~--- 90 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC--- 90 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEE---
Confidence 567889999999999999999752 234579999987432 34456799999999999 899999999985
Q ss_pred cccCCceEEEEEeccCCCChhcccccCCCCCCC------cccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCC
Q 045798 754 DFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRD------KEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKP 827 (1008)
Q Consensus 754 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~------~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp 827 (1008)
......++||||+++|+|.+++......... ......+++.++..++.||+.||+|||+. +++||||||
T Consensus 91 --~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp 165 (304)
T cd05101 91 --TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAA 165 (304)
T ss_pred --ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---Ceeeccccc
Confidence 4456789999999999999999765322110 00123688999999999999999999998 999999999
Q ss_pred CCeeecCCCCeEEcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCcc
Q 045798 828 SNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT-AKKPTDVM 906 (1008)
Q Consensus 828 ~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-G~~pf~~~ 906 (1008)
+||++++++.+||+|||.++......... ......++..|+|||++.+..++.++||||||+++|||++ |..||...
T Consensus 166 ~Nili~~~~~~kl~D~g~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~ 243 (304)
T cd05101 166 RNVLVTENNVMKIADFGLARDVNNIDYYK--KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI 243 (304)
T ss_pred ceEEEcCCCcEEECCCccceecccccccc--cccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccC
Confidence 99999999999999999998654332211 1112335678999999988889999999999999999998 77776432
Q ss_pred ccCCccHHHHHHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 907 FEGDLNLHNFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 907 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
. ........... .... ....++..+.+++.+||+.+|.+|||+.|+++
T Consensus 244 ~-----~~~~~~~~~~~-----------------------~~~~----~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~ 291 (304)
T cd05101 244 P-----VEELFKLLKEG-----------------------HRMD----KPANCTNELYMMMRDCWHAIPSHRPTFKQLVE 291 (304)
T ss_pred C-----HHHHHHHHHcC-----------------------CcCC----CCCCCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 1 11111100000 0000 01134566899999999999999999999999
Q ss_pred HHHHHHHH
Q 045798 987 ELQSVKNI 994 (1008)
Q Consensus 987 ~L~~i~~~ 994 (1008)
.|+++...
T Consensus 292 ~l~~~~~~ 299 (304)
T cd05101 292 DLDRILTL 299 (304)
T ss_pred HHHHHHHh
Confidence 99887654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=316.39 Aligned_cols=264 Identities=22% Similarity=0.330 Sum_probs=200.2
Q ss_pred CCCCCceEeeccCeeEEEEEEcC-----CCeEEEEEEeccccc-hhhHHHHHHHHHHhhcCCCCceeeeeccccccccCC
Q 045798 685 GFSSTHLIGVGSFGCVYKGALDE-----DGIVVAIKVINLQCE-GASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGN 758 (1008)
Q Consensus 685 ~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 758 (1008)
+|++.+.||+|+||.||+|.... .++.||+|+++.... ...+.+.+|+.+++.++||||+++++++ ...
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~-----~~~ 80 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVV-----TKE 80 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEE-----cCC
Confidence 47778999999999999998743 357899999975433 2346789999999999999999999985 445
Q ss_pred ceEEEEEeccCCCChhcccccCCCCC------CCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeee
Q 045798 759 DFKAIVYEYMPNGSLEKWLHPHAVPK------RDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILL 832 (1008)
Q Consensus 759 ~~~~lv~e~~~~gsL~~~l~~~~~~~------~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll 832 (1008)
...++++||+++++|.+++....... ........+++..+..++.|++.||+|+|++ +|+||||||+||++
T Consensus 81 ~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~ 157 (283)
T cd05091 81 QPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLV 157 (283)
T ss_pred CceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEe
Confidence 56899999999999999985432110 0011122588999999999999999999997 99999999999999
Q ss_pred cCCCCeEEcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCccccCCc
Q 045798 833 DNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT-AKKPTDVMFEGDL 911 (1008)
Q Consensus 833 ~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-G~~pf~~~~~~~~ 911 (1008)
++++.+||+|||+++......... ......+++.|+|||++.+..++.++|||||||++|||++ |..||.....
T Consensus 158 ~~~~~~kl~Dfg~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~--- 232 (283)
T cd05091 158 FDKLNVKISDLGLFREVYAADYYK--LMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN--- 232 (283)
T ss_pred cCCCceEecccccccccccchhee--eccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH---
Confidence 999999999999988654322111 1122346789999999988889999999999999999998 7778753211
Q ss_pred cHHHHHHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHHHH
Q 045798 912 NLHNFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHELQS 990 (1008)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 990 (1008)
........... .. +....++..+.+++..||+.+|++||+++||+..|+.
T Consensus 233 --~~~~~~i~~~~--------~~-------------------~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 233 --QDVIEMIRNRQ--------VL-------------------PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred --HHHHHHHHcCC--------cC-------------------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 01111000000 00 0011345668999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=316.06 Aligned_cols=254 Identities=25% Similarity=0.364 Sum_probs=201.7
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccchhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceEE
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKA 762 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 762 (1008)
.++|++.+.||.|+||.||+|.+..+++.||+|+++.......+.+.+|++++++++||||+++++.+ ..+...+
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~ 78 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAY-----FYENKLW 78 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEE-----ecCCeEE
Confidence 45789999999999999999999888999999999876566667899999999999999999999984 4566789
Q ss_pred EEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEcc
Q 045798 763 IVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGD 842 (1008)
Q Consensus 763 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 842 (1008)
+||||+++++|.+++..... .+++..++.++.|++.|+.|||+. +|+||||+|+||+++.++.++|+|
T Consensus 79 lv~e~~~~~~L~~~~~~~~~---------~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d 146 (280)
T cd06611 79 ILIEFCDGGALDSIMLELER---------GLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLAD 146 (280)
T ss_pred EEeeccCCCcHHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEcc
Confidence 99999999999999865421 689999999999999999999998 999999999999999999999999
Q ss_pred cCcccccccccCccccccccccccccccCccccC-----CCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHH
Q 045798 843 FGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGL-----GSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFA 917 (1008)
Q Consensus 843 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~ 917 (1008)
||.+......... .....++..|+|||.+. ...++.++||||||+++|||++|+.||...... .......
T Consensus 147 ~g~~~~~~~~~~~----~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~-~~~~~~~ 221 (280)
T cd06611 147 FGVSAKNKSTLQK----RDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM-RVLLKIL 221 (280)
T ss_pred Cccchhhcccccc----cceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH-HHHHHHh
Confidence 9998754332211 12245889999999864 345678999999999999999999998642110 0000000
Q ss_pred HhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 045798 918 RMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHE 987 (1008)
Q Consensus 918 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 987 (1008)
... .+. .......+.++.+++.+||+.+|.+||++.++++.
T Consensus 222 ~~~---------~~~--------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 222 KSE---------PPT--------------------LDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred cCC---------CCC--------------------cCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 000 000 00011234567899999999999999999999875
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=311.41 Aligned_cols=255 Identities=29% Similarity=0.464 Sum_probs=201.4
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccchhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceEE
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKA 762 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 762 (1008)
.++|++.+.||+|+||.||+|... +++.||+|.+... ....+++.+|+.++++++|+||+++++++ ......+
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~ 77 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPG-TMSPEAFLQEAQIMKKLRHDKLVQLYAVC-----SEEEPIY 77 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCC-ccCHHHHHHHHHHHhhCCCCCEeeeeeee-----ecCCceE
Confidence 568999999999999999999985 5688999998754 23346799999999999999999999984 4456689
Q ss_pred EEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEcc
Q 045798 763 IVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGD 842 (1008)
Q Consensus 763 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 842 (1008)
+||||+++++|.+++...... .+++..+..++.|++.|++|||+. +++||||||+||++++++.+||+|
T Consensus 78 ~v~e~~~~~~L~~~i~~~~~~--------~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d 146 (261)
T cd05034 78 IVTEYMSKGSLLDFLKSGEGK--------KLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIAD 146 (261)
T ss_pred EEEeccCCCCHHHHHhccccC--------CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECc
Confidence 999999999999999764321 689999999999999999999998 999999999999999999999999
Q ss_pred cCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCccccCCccHHHHHHhhC
Q 045798 843 FGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT-AKKPTDVMFEGDLNLHNFARMAL 921 (1008)
Q Consensus 843 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-G~~pf~~~~~~~~~~~~~~~~~~ 921 (1008)
||.+......... ......++..|+|||.+.+..++.++||||+|+++|++++ |+.||...... ........
T Consensus 147 ~g~~~~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~-~~~~~~~~--- 219 (261)
T cd05034 147 FGLARLIEDDEYT---AREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR-EVLEQVER--- 219 (261)
T ss_pred cccceeccchhhh---hhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH-HHHHHHHc---
Confidence 9999865432111 1112234678999999998889999999999999999998 99998532110 00000000
Q ss_pred CcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHHHH
Q 045798 922 PNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHELQS 990 (1008)
Q Consensus 922 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 990 (1008)
... .. .....+.++.+++.+|++.+|++||+++++.+.|+.
T Consensus 220 ----------~~~----------------~~--~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 220 ----------GYR----------------MP--RPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred ----------CCC----------------CC--CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 000 00 001224568999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=315.52 Aligned_cols=263 Identities=22% Similarity=0.315 Sum_probs=204.4
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEecccc-chhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceE
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC-EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFK 761 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 761 (1008)
.++|++.+.||+|+||+||+|.+..+++.||+|++.... ....+.+.+|+++++.++||||+++++++ ......
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~ 78 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF-----LNENNI 78 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeE-----ecCCEE
Confidence 356888999999999999999998889999999987543 34457899999999999999999999995 445779
Q ss_pred EEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEc
Q 045798 762 AIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIG 841 (1008)
Q Consensus 762 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 841 (1008)
++||||+++++|.+++...+ .+++..+..++.|++.|+.|||+. .+++||||+|+||++++++.++|+
T Consensus 79 ~lv~e~~~~~~L~~~~~~~~----------~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~ 146 (284)
T cd06620 79 CMCMEFMDCGSLDRIYKKGG----------PIPVEILGKIAVAVVEGLTYLYNV--HRIMHRDIKPSNILVNSRGQIKLC 146 (284)
T ss_pred EEEEecCCCCCHHHHHHhcc----------CCCHHHHHHHHHHHHHHHHHHHHh--cCeeccCCCHHHEEECCCCcEEEc
Confidence 99999999999999986543 688999999999999999999973 389999999999999999999999
Q ss_pred ccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHhhC
Q 045798 842 DFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMAL 921 (1008)
Q Consensus 842 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~~~ 921 (1008)
|||++........ ....|+..|+|||++.+..++.++|||||||++|++++|+.||.......... ..
T Consensus 147 d~gl~~~~~~~~~------~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~------~~ 214 (284)
T cd06620 147 DFGVSGELINSIA------DTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQ------DD 214 (284)
T ss_pred cCCcccchhhhcc------CccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhh------hh
Confidence 9999865422211 12458999999999988889999999999999999999999997543211100 00
Q ss_pred CcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHH
Q 045798 922 PNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHEL 988 (1008)
Q Consensus 922 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 988 (1008)
+....+.+........ +.. ...+.+..+.+++.+||+.||++|||++|+++..
T Consensus 215 ~~~~~~~~~~~~~~~~-------------~~~-~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 215 PMGILDLLQQIVQEPP-------------PRL-PSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred hhHHHHHHHHHhhccC-------------CCC-CchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 0001111111110000 000 0112556789999999999999999999999863
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=314.56 Aligned_cols=275 Identities=22% Similarity=0.273 Sum_probs=200.0
Q ss_pred cCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEecccc--chhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceE
Q 045798 684 NGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC--EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFK 761 (1008)
Q Consensus 684 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 761 (1008)
++|++.+.||+|+||.||+|.+..+++.||+|++.... ....+.+.+|++++++++|+|++++++++ ..+...
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~~~ 75 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVF-----RRKRKL 75 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEE-----eeCCEE
Confidence 47899999999999999999998889999999986432 22345688999999999999999999984 556678
Q ss_pred EEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEc
Q 045798 762 AIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIG 841 (1008)
Q Consensus 762 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 841 (1008)
++||||++++.|..+..... .+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+
T Consensus 76 ~~v~e~~~~~~l~~~~~~~~----------~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~ 142 (286)
T cd07847 76 HLVFEYCDHTVLNELEKNPR----------GVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLC 142 (286)
T ss_pred EEEEeccCccHHHHHHhCCC----------CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEEC
Confidence 99999999988888765432 689999999999999999999997 99999999999999999999999
Q ss_pred ccCcccccccccCccccccccccccccccCccccCC-CCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHhh
Q 045798 842 DFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLG-SEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMA 920 (1008)
Q Consensus 842 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~~ 920 (1008)
|||.+......... .....++..|+|||++.+ ..++.++||||||+++|||++|+.||......+. ........
T Consensus 143 dfg~~~~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~-~~~~~~~~ 217 (286)
T cd07847 143 DFGFARILTGPGDD----YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQ-LYLIRKTL 217 (286)
T ss_pred ccccceecCCCccc----ccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHh
Confidence 99999866443211 112347889999999876 4578999999999999999999999864322111 10110000
Q ss_pred --CCcchhhhhccc--ccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 921 --LPNQVMDIVDPI--LRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 921 --~~~~~~~~~d~~--l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
.........+.. ..... .................+..+.+++.+||+.+|++|||+.|++.
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 218 GDLIPRHQQIFSTNQFFKGLS-----IPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred CCCChHHhhhccccccccccc-----CCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 000000000000 00000 00000000000001123567899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=318.94 Aligned_cols=277 Identities=24% Similarity=0.325 Sum_probs=199.4
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEecccc-chhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceE
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC-EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFK 761 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 761 (1008)
.++|.+.+.||+|+||.||+|.+..+++.||+|.++... ......+.+|+.++++++||||+++++++ ..++..
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~-----~~~~~~ 79 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII-----HTEKSL 79 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEE-----ecCCeE
Confidence 357999999999999999999998889999999987443 33345678999999999999999999994 556679
Q ss_pred EEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEc
Q 045798 762 AIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIG 841 (1008)
Q Consensus 762 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 841 (1008)
++||||++ ++|.+++..... .+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+
T Consensus 80 ~lv~e~~~-~~l~~~l~~~~~---------~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~ 146 (301)
T cd07873 80 TLVFEYLD-KDLKQYLDDCGN---------SINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLA 146 (301)
T ss_pred EEEEeccc-cCHHHHHHhcCC---------CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEEC
Confidence 99999995 699888865421 578899999999999999999998 99999999999999999999999
Q ss_pred ccCcccccccccCccccccccccccccccCccccCCC-CCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHhh
Q 045798 842 DFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGS-EVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMA 920 (1008)
Q Consensus 842 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~~ 920 (1008)
|||++......... .....++..|+|||++.+. .++.++|||||||++|||++|+.||...... ........ .
T Consensus 147 dfg~~~~~~~~~~~----~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~-~~~~~~~~-~ 220 (301)
T cd07873 147 DFGLARAKSIPTKT----YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVE-EQLHFIFR-I 220 (301)
T ss_pred cCcchhccCCCCCc----ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHH-H
Confidence 99999754322211 1123478899999987654 5788999999999999999999998643211 11111111 1
Q ss_pred CCcchhhhhcccccCchHHhhhhhhhhhcccc--chhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 921 LPNQVMDIVDPILRNDEEILASTDKCRRMQTG--INSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 921 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
............+....- .... ....... .......+..+.+++.+|++.||.+|||++|+++
T Consensus 221 ~~~~~~~~~~~~~~~~~~--~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 221 LGTPTEETWPGILSNEEF--KSYN-YPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred cCCCChhhchhhhccccc--cccc-cCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 111000111110000000 0000 0000000 0001123456789999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=329.83 Aligned_cols=275 Identities=20% Similarity=0.226 Sum_probs=198.4
Q ss_pred hcCCCCCceEeeccCeeEEEEEEc--CCCeEEEEEEeccccchhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCce
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALD--EDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDF 760 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~--~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 760 (1008)
..+|.+.+.||+|+||.||+|... ..++.||+|.+... ....+|++++++++||||+++++++ .....
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~-----~~~~~ 160 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAY-----RWKST 160 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeE-----eeCCE
Confidence 357999999999999999999764 34678999988543 3456899999999999999999884 55667
Q ss_pred EEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEE
Q 045798 761 KAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHI 840 (1008)
Q Consensus 761 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 840 (1008)
.++|||++ +++|.+++.... .+++..++.++.||+.||+|||+. +|+||||||+||+++.++.+||
T Consensus 161 ~~lv~e~~-~~~l~~~l~~~~----------~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l 226 (392)
T PHA03207 161 VCMVMPKY-KCDLFTYVDRSG----------PLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVL 226 (392)
T ss_pred EEEEehhc-CCCHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEE
Confidence 99999999 578988884332 789999999999999999999997 9999999999999999999999
Q ss_pred cccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCC--ccHHHHHH
Q 045798 841 GDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGD--LNLHNFAR 918 (1008)
Q Consensus 841 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~--~~~~~~~~ 918 (1008)
+|||+++......... ......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ..+....+
T Consensus 227 ~DfG~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~ 304 (392)
T PHA03207 227 GDFGAACKLDAHPDTP--QCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIR 304 (392)
T ss_pred ccCccccccCcccccc--cccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHH
Confidence 9999997654432211 1223569999999999999999999999999999999999999986432211 11111111
Q ss_pred hhCCcchhhhhcccccCchHHhhhh---hhhhhccccch---hHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 045798 919 MALPNQVMDIVDPILRNDEEILAST---DKCRRMQTGIN---SRLECLISMVKIGVACSMESPQDRMNMTNVVHE 987 (1008)
Q Consensus 919 ~~~~~~~~~~~d~~l~~~~~~~~~~---~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 987 (1008)
...... .++. . .......... ....+.+...+ .....+.++.+++.+|++.||++|||+.|++..
T Consensus 305 ~~~~~~-~~~~-~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 305 CMQVHP-LEFP-Q--NGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred HhccCc-cccC-C--ccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 111000 0000 0 0000000000 00000000000 011234567899999999999999999999874
|
|
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=308.72 Aligned_cols=255 Identities=27% Similarity=0.368 Sum_probs=201.9
Q ss_pred CCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccc--hhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceEE
Q 045798 685 GFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCE--GASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKA 762 (1008)
Q Consensus 685 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 762 (1008)
+|++.+.||+|+||.||+|....+++.||+|+++.... ...+.+.+|++++++++|+||+++++.+ ...+..+
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~-----~~~~~~~ 75 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVE-----VHREKVY 75 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeE-----ecCCEEE
Confidence 58889999999999999999988899999999976544 3567899999999999999999999984 4567799
Q ss_pred EEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEcc
Q 045798 763 IVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGD 842 (1008)
Q Consensus 763 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 842 (1008)
+|+||+++++|.+++.... .+++..+..++.|++.|++|||+. +|+|+||+|+||++++++.+||+|
T Consensus 76 lv~e~~~~~~L~~~~~~~~----------~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d 142 (264)
T cd06626 76 IFMEYCSGGTLEELLEHGR----------ILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGD 142 (264)
T ss_pred EEEecCCCCcHHHHHhhcC----------CCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcc
Confidence 9999999999999987643 578889999999999999999998 999999999999999999999999
Q ss_pred cCcccccccccCccccccccccccccccCccccCCCC---CCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHh
Q 045798 843 FGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSE---VSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARM 919 (1008)
Q Consensus 843 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~ 919 (1008)
||.+..................++..|+|||++.+.. ++.++||||||+++|++++|+.||...... .......
T Consensus 143 ~g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~---~~~~~~~ 219 (264)
T cd06626 143 FGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE---FQIMFHV 219 (264)
T ss_pred cccccccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcch---HHHHHHH
Confidence 9999876543332211112345788999999988766 889999999999999999999998632111 0000000
Q ss_pred hCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 920 ALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 920 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
... ..+..+.....+..+.+++.+||+.+|.+|||+.|++.
T Consensus 220 ~~~--------------------------~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 220 GAG--------------------------HKPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred hcC--------------------------CCCCCCcccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 000 00001111123456789999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=308.41 Aligned_cols=251 Identities=24% Similarity=0.307 Sum_probs=199.7
Q ss_pred CCCCCceEeeccCeeEEEEEEcCCCeEEEEEEecccc--chhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceEE
Q 045798 685 GFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC--EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKA 762 (1008)
Q Consensus 685 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 762 (1008)
+|++.+.||+|++|.||+|.+..+++.||+|++.... ....+.+.+|++++++++|+|++++++.+. ..+...+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~----~~~~~~~ 76 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWE----GEDGLLY 76 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeec----CCCCEEE
Confidence 5889999999999999999998889999999986432 334567899999999999999999988742 2344689
Q ss_pred EEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEcc
Q 045798 763 IVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGD 842 (1008)
Q Consensus 763 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 842 (1008)
+||||+++++|.+++...... .+++.+++.++.|++.|++|||+. +++||||||+||+++.++.++|+|
T Consensus 77 lv~e~~~~~~l~~~l~~~~~~--------~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~d 145 (257)
T cd08223 77 IVMGFCEGGDLYHKLKEQKGK--------LLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGD 145 (257)
T ss_pred EEecccCCCcHHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEec
Confidence 999999999999998753221 589999999999999999999997 999999999999999999999999
Q ss_pred cCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHhhCC
Q 045798 843 FGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMALP 922 (1008)
Q Consensus 843 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~~~~ 922 (1008)
||.+......... .....+++.|+|||++.+..++.++||||+|+++|+|++|+.||..... ........
T Consensus 146 f~~~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~-----~~~~~~~~- 215 (257)
T cd08223 146 LGIARVLENQCDM----ASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDM-----NSLVYRII- 215 (257)
T ss_pred ccceEEecccCCc----cccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH-----HHHHHHHH-
Confidence 9999865432221 2234578999999999998999999999999999999999999863211 11100000
Q ss_pred cchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 923 NQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 923 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
...+. . .....+..+.+++.+||+.||++|||+.++++
T Consensus 216 -------~~~~~-----------------~--~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 253 (257)
T cd08223 216 -------EGKLP-----------------P--MPKDYSPELGELIATMLSKRPEKRPSVKSILR 253 (257)
T ss_pred -------hcCCC-----------------C--CccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 00000 0 01124456889999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=309.39 Aligned_cols=240 Identities=21% Similarity=0.319 Sum_probs=185.1
Q ss_pred ceEeeccCeeEEEEEEcC------------CCeEEEEEEeccccchhhHHHHHHHHHHhhcCCCCceeeeeccccccccC
Q 045798 690 HLIGVGSFGCVYKGALDE------------DGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQG 757 (1008)
Q Consensus 690 ~~lg~G~~g~Vy~~~~~~------------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 757 (1008)
+.||+|+||.||+|.... ....||+|++..........+.+|+.+++.++||||+++++++. .
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~-----~ 75 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCV-----R 75 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEe-----c
Confidence 468999999999998632 22368999987655555668899999999999999999999953 4
Q ss_pred CceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCC
Q 045798 758 NDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLS 837 (1008)
Q Consensus 758 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 837 (1008)
+...++||||+++|+|..++..... .+++..++.++.||+.||+|||+. +|+||||||+||+++.++.
T Consensus 76 ~~~~~lv~e~~~~~~l~~~~~~~~~---------~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~ 143 (262)
T cd05077 76 DVENIMVEEFVEFGPLDLFMHRKSD---------VLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGI 143 (262)
T ss_pred CCCCEEEEecccCCCHHHHHHhcCC---------CCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCc
Confidence 4567999999999999998865421 688999999999999999999997 9999999999999987654
Q ss_pred -------eEEcccCcccccccccCccccccccccccccccCccccC-CCCCCcccchhhHHHHHHHHH-hCCCCCCcccc
Q 045798 838 -------GHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGL-GSEVSTNGDVYSYGILLLEMV-TAKKPTDVMFE 908 (1008)
Q Consensus 838 -------~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDvwslG~vl~ell-tG~~pf~~~~~ 908 (1008)
+|++|||.+...... ....++..|+|||.+. +..++.++|||||||++|||+ +|..||.....
T Consensus 144 ~~~~~~~~~l~d~g~~~~~~~~--------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~ 215 (262)
T cd05077 144 DGECGPFIKLSDPGIPITVLSR--------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTL 215 (262)
T ss_pred cCCCCceeEeCCCCCCccccCc--------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcch
Confidence 899999998754321 1234788999999876 466899999999999999998 57777653210
Q ss_pred CCccHHHHHHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHH
Q 045798 909 GDLNLHNFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHEL 988 (1008)
Q Consensus 909 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 988 (1008)
. ...... ..... . ......++.+++.+||+.||.+||++.+|++.+
T Consensus 216 ~--~~~~~~------------~~~~~--------------~------~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 216 A--EKERFY------------EGQCM--------------L------VTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred h--HHHHHH------------hcCcc--------------C------CCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 0 000000 00000 0 001234578999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=314.61 Aligned_cols=240 Identities=22% Similarity=0.333 Sum_probs=185.9
Q ss_pred ceEeeccCeeEEEEEEcCCCe-------EEEEEEeccccchhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceEE
Q 045798 690 HLIGVGSFGCVYKGALDEDGI-------VVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKA 762 (1008)
Q Consensus 690 ~~lg~G~~g~Vy~~~~~~~~~-------~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 762 (1008)
+.||+|+||.||+|.....+. .||+|++........+.+.+|+.+++.+.||||+++++++ ..++..+
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~-----~~~~~~~ 75 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVC-----VCGDESI 75 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEE-----EeCCCcE
Confidence 469999999999999865443 4888888655445567889999999999999999999995 3455689
Q ss_pred EEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCC-----
Q 045798 763 IVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLS----- 837 (1008)
Q Consensus 763 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~----- 837 (1008)
+||||+++|+|.+++..... .+++..++.++.||+.|++|||+. +|+||||||+||+++.++.
T Consensus 76 lv~e~~~~g~L~~~l~~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~ 143 (258)
T cd05078 76 MVQEYVKFGSLDTYLKKNKN---------LINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGN 143 (258)
T ss_pred EEEecCCCCcHHHHHhcCCC---------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCC
Confidence 99999999999999976532 578899999999999999999997 9999999999999987765
Q ss_pred ---eEEcccCcccccccccCccccccccccccccccCccccCCC-CCCcccchhhHHHHHHHHHhCC-CCCCccccCCcc
Q 045798 838 ---GHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGS-EVSTNGDVYSYGILLLEMVTAK-KPTDVMFEGDLN 912 (1008)
Q Consensus 838 ---~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltG~-~pf~~~~~~~~~ 912 (1008)
++++|||.+...... ....++..|+|||++.+. .++.++|||||||++|||++|. .||..... ..
T Consensus 144 ~~~~~l~d~g~~~~~~~~--------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~-~~- 213 (258)
T cd05078 144 PPFIKLSDPGISITVLPK--------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDS-QK- 213 (258)
T ss_pred CceEEecccccccccCCc--------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccH-HH-
Confidence 599999988654321 123478899999998764 5789999999999999999995 45432110 00
Q ss_pred HHHHHHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHH
Q 045798 913 LHNFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHEL 988 (1008)
Q Consensus 913 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 988 (1008)
.... .... ..++. ....++.+++.+||+.||++|||++++++.|
T Consensus 214 ~~~~------------~~~~--------------~~~~~------~~~~~~~~li~~~l~~~p~~Rps~~~il~~l 257 (258)
T cd05078 214 KLQF------------YEDR--------------HQLPA------PKWTELANLINQCMDYEPDFRPSFRAIIRDL 257 (258)
T ss_pred HHHH------------HHcc--------------ccCCC------CCcHHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 0000 0000 00010 1224578999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=313.18 Aligned_cols=240 Identities=22% Similarity=0.345 Sum_probs=183.8
Q ss_pred eEeeccCeeEEEEEEcC------------------------CCeEEEEEEeccccchhhHHHHHHHHHHhhcCCCCceee
Q 045798 691 LIGVGSFGCVYKGALDE------------------------DGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKV 746 (1008)
Q Consensus 691 ~lg~G~~g~Vy~~~~~~------------------------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 746 (1008)
+||+|+||.||+|.... ....||+|++..........+.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 69999999999998531 124689999875544555678999999999999999999
Q ss_pred eeccccccccCCceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCC
Q 045798 747 ITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLK 826 (1008)
Q Consensus 747 ~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlk 826 (1008)
+++|. .+...++||||+++|+|..++..... .+++..+..++.||++||+|||+. +|+|||||
T Consensus 82 ~~~~~-----~~~~~~lv~ey~~~g~L~~~l~~~~~---------~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlk 144 (274)
T cd05076 82 HGVCV-----RGSENIMVEEFVEHGPLDVCLRKEKG---------RVPVAWKITVAQQLASALSYLEDK---NLVHGNVC 144 (274)
T ss_pred EEEEE-----eCCceEEEEecCCCCcHHHHHHhcCC---------CCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCC
Confidence 99964 44568999999999999999865321 678899999999999999999997 99999999
Q ss_pred CCCeeecCCC-------CeEEcccCcccccccccCccccccccccccccccCccccCC-CCCCcccchhhHHHHHHHHH-
Q 045798 827 PSNILLDNDL-------SGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLG-SEVSTNGDVYSYGILLLEMV- 897 (1008)
Q Consensus 827 p~NIll~~~~-------~~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~ell- 897 (1008)
|+||++++.+ .+|++|||.+....... ...++..|+|||.+.+ ..++.++|||||||++||++
T Consensus 145 p~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~~--------~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~ 216 (274)
T cd05076 145 AKNILLARLGLAEGTSPFIKLSDPGVSFTALSRE--------ERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICF 216 (274)
T ss_pred cccEEEeccCcccCccceeeecCCcccccccccc--------ccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHh
Confidence 9999997643 37999999886432211 1236788999998865 56899999999999999995
Q ss_pred hCCCCCCccccCCccHHHHHHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCC
Q 045798 898 TAKKPTDVMFEGDLNLHNFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQD 977 (1008)
Q Consensus 898 tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~ 977 (1008)
+|+.||....... ...+. ... ..++. .....+.+++.+||+.+|++
T Consensus 217 ~g~~p~~~~~~~~--~~~~~------------~~~--------------~~~~~------~~~~~~~~li~~cl~~~p~~ 262 (274)
T cd05076 217 DGEVPLKERTPSE--KERFY------------EKK--------------HRLPE------PSCKELATLISQCLTYEPTQ 262 (274)
T ss_pred CCCCCccccChHH--HHHHH------------Hhc--------------cCCCC------CCChHHHHHHHHHcccChhh
Confidence 6888876321110 00000 000 00000 11235789999999999999
Q ss_pred CCCHHHHHHHHH
Q 045798 978 RMNMTNVVHELQ 989 (1008)
Q Consensus 978 RPt~~evl~~L~ 989 (1008)
|||+.+|++.|+
T Consensus 263 Rps~~~il~~L~ 274 (274)
T cd05076 263 RPSFRTILRDLT 274 (274)
T ss_pred CcCHHHHHHhhC
Confidence 999999998873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=317.71 Aligned_cols=270 Identities=23% Similarity=0.393 Sum_probs=204.5
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcC-------CCeEEEEEEecccc-chhhHHHHHHHHHHhhc-CCCCceeeeeccccc
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDE-------DGIVVAIKVINLQC-EGASKSFMAECKALKNI-RHRNLVKVITSCSSI 753 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~ 753 (1008)
.++|.+.+.||+|+||.||+|.+.. +...||+|.++... ......+.+|+++++.+ +||||++++++|
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~--- 93 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC--- 93 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEE---
Confidence 3579999999999999999998642 23579999997542 34456788999999999 899999999985
Q ss_pred cccCCceEEEEEeccCCCChhcccccCCCCCCC------cccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCC
Q 045798 754 DFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRD------KEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKP 827 (1008)
Q Consensus 754 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~------~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp 827 (1008)
...+..++||||+++|+|.+++......... ......+++.+++.++.|++.||+|||+. +++||||||
T Consensus 94 --~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp 168 (307)
T cd05098 94 --TQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAA 168 (307)
T ss_pred --ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccH
Confidence 4456689999999999999999765321100 01122589999999999999999999997 999999999
Q ss_pred CCeeecCCCCeEEcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCcc
Q 045798 828 SNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT-AKKPTDVM 906 (1008)
Q Consensus 828 ~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-G~~pf~~~ 906 (1008)
+||+++.++.+||+|||.+.......... ......++..|+|||++.+..++.++|||||||++|||++ |..||...
T Consensus 169 ~Nill~~~~~~kL~dfg~a~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~ 246 (307)
T cd05098 169 RNVLVTEDNVMKIADFGLARDIHHIDYYK--KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV 246 (307)
T ss_pred HheEEcCCCcEEECCCcccccccccchhh--ccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcC
Confidence 99999999999999999997553321111 1111224578999999988889999999999999999998 88887532
Q ss_pred ccCCccHHHHHHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 907 FEGDLNLHNFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 907 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
. ....... +.... .+ .....++.++.+++.+||..+|.+|||+.||++
T Consensus 247 ~-----~~~~~~~---------~~~~~--------------~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~ 294 (307)
T cd05098 247 P-----VEELFKL---------LKEGH--------------RM----DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 294 (307)
T ss_pred C-----HHHHHHH---------HHcCC--------------CC----CCCCcCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 1 1111110 00000 00 001123456889999999999999999999999
Q ss_pred HHHHHHHH
Q 045798 987 ELQSVKNI 994 (1008)
Q Consensus 987 ~L~~i~~~ 994 (1008)
.|+++...
T Consensus 295 ~l~~~~~~ 302 (307)
T cd05098 295 DLDRILAL 302 (307)
T ss_pred HHHHHHHH
Confidence 99998665
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=312.31 Aligned_cols=250 Identities=27% Similarity=0.327 Sum_probs=201.5
Q ss_pred cCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEecccc-chhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceEE
Q 045798 684 NGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC-EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKA 762 (1008)
Q Consensus 684 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 762 (1008)
++|++.+.||.|++|.||+|.+..+++.||+|++.... ......+.+|+++++.++|+||+++++++ .++...+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~ 75 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSF-----LKGSKLW 75 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEE-----EECCeEE
Confidence 46888999999999999999998899999999987543 34456789999999999999999999984 4557799
Q ss_pred EEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEcc
Q 045798 763 IVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGD 842 (1008)
Q Consensus 763 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 842 (1008)
+|+||+++++|.+++... ++++..+..++.|++.|+.|||+. +++||||+|+||++++++.++|+|
T Consensus 76 ~v~e~~~~~~L~~~~~~~-----------~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d 141 (274)
T cd06609 76 IIMEYCGGGSCLDLLKPG-----------KLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLAD 141 (274)
T ss_pred EEEEeeCCCcHHHHHhhc-----------CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcc
Confidence 999999999999998753 578999999999999999999997 999999999999999999999999
Q ss_pred cCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHhhCC
Q 045798 843 FGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMALP 922 (1008)
Q Consensus 843 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~~~~ 922 (1008)
||.+......... .....++..|+|||++.+..++.++|||||||++|+|++|+.||....... .........+
T Consensus 142 ~g~~~~~~~~~~~----~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~--~~~~~~~~~~ 215 (274)
T cd06609 142 FGVSGQLTSTMSK----RNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMR--VLFLIPKNNP 215 (274)
T ss_pred cccceeecccccc----cccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHH--HHHHhhhcCC
Confidence 9999866543211 223457889999999998889999999999999999999999986421100 0000000000
Q ss_pred cchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 045798 923 NQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHE 987 (1008)
Q Consensus 923 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 987 (1008)
+.+ . ....+.++.+++.+||..+|++|||++++++.
T Consensus 216 --------~~~--------------------~-~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 216 --------PSL--------------------E-GNKFSKPFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred --------CCC--------------------c-ccccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 000 0 00134567899999999999999999999763
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=308.11 Aligned_cols=251 Identities=22% Similarity=0.298 Sum_probs=202.4
Q ss_pred CCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccc--cchhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceEE
Q 045798 685 GFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQ--CEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKA 762 (1008)
Q Consensus 685 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 762 (1008)
+|+..+.||.|+||.||.++...+++.||+|.+... .......+.+|++++++++|+||+++++++ .+.+..+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~~~~ 75 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHF-----MDDNTLL 75 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEE-----ecCCeEE
Confidence 588999999999999999999989999999998643 244456789999999999999999999994 4567799
Q ss_pred EEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEcc
Q 045798 763 IVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGD 842 (1008)
Q Consensus 763 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 842 (1008)
+||||+++++|.+++...... .+++.++..++.|++.|++|||+. +++||||+|+||++++++.+||+|
T Consensus 76 ~~~e~~~~~~L~~~~~~~~~~--------~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d 144 (256)
T cd08221 76 IEMEYANGGTLYDKIVRQKGQ--------LFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGD 144 (256)
T ss_pred EEEEecCCCcHHHHHHhcccc--------CCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECc
Confidence 999999999999999754311 689999999999999999999997 999999999999999999999999
Q ss_pred cCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHhhCC
Q 045798 843 FGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMALP 922 (1008)
Q Consensus 843 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~~~~ 922 (1008)
||.+........ ......+++.|+|||...+..++.++||||||+++|||++|..||...... ....
T Consensus 145 ~~~~~~~~~~~~----~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~-----~~~~---- 211 (256)
T cd08221 145 FGISKILGSEYS----MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPL-----NLVV---- 211 (256)
T ss_pred CcceEEcccccc----cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHH-----HHHH----
Confidence 999986543321 122345899999999998888999999999999999999999998632110 0000
Q ss_pred cchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 045798 923 NQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHE 987 (1008)
Q Consensus 923 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 987 (1008)
......... .....+.++.+++.+||+.+|.+||+++|+++.
T Consensus 212 ----~~~~~~~~~-------------------~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 212 ----KIVQGNYTP-------------------VVSVYSSELISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred ----HHHcCCCCC-------------------CccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence 000000000 001234568899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=308.73 Aligned_cols=257 Identities=27% Similarity=0.435 Sum_probs=200.7
Q ss_pred ceEeeccCeeEEEEEEcCC---CeEEEEEEeccccch-hhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceEEEEE
Q 045798 690 HLIGVGSFGCVYKGALDED---GIVVAIKVINLQCEG-ASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKAIVY 765 (1008)
Q Consensus 690 ~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 765 (1008)
+.||+|+||.||+|..... +..||+|+++..... ..+.+.+|+++++.++|+||+++++++. .....++||
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~~~lv~ 75 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCT-----EEEPLYLVL 75 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeec-----CCCceEEEE
Confidence 4699999999999999765 889999999865433 3678999999999999999999999853 466799999
Q ss_pred eccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEcccCc
Q 045798 766 EYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGL 845 (1008)
Q Consensus 766 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~ 845 (1008)
||+++++|.+++....... .......+++.+++.++.|++.||+|||+. +++||||+|+||++++++.+||+|||.
T Consensus 76 e~~~~~~L~~~l~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~ 151 (262)
T cd00192 76 EYMEGGDLLDYLRKSRPVF-PSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGL 151 (262)
T ss_pred EeccCCcHHHHHhhccccc-cccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEccccc
Confidence 9999999999997652110 000012789999999999999999999997 999999999999999999999999999
Q ss_pred ccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCccccCCccHHHHHHhhCCcc
Q 045798 846 ARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT-AKKPTDVMFEGDLNLHNFARMALPNQ 924 (1008)
Q Consensus 846 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~ 924 (1008)
+......... .......++..|+|||.+.+..++.++||||+|+++|||++ |..||..... .......
T Consensus 152 ~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-----~~~~~~~---- 220 (262)
T cd00192 152 SRDVYDDDYY--RKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN-----EEVLEYL---- 220 (262)
T ss_pred cccccccccc--ccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH-----HHHHHHH----
Confidence 9876543321 11223457889999999988889999999999999999999 6899864311 0010000
Q ss_pred hhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHHH
Q 045798 925 VMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHELQ 989 (1008)
Q Consensus 925 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 989 (1008)
.+... ......++.++.+++.+||+.+|.+|||+.|+++.|+
T Consensus 221 ----~~~~~-------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 221 ----RKGYR-------------------LPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred ----HcCCC-------------------CCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 00000 0001123567899999999999999999999998773
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=308.26 Aligned_cols=254 Identities=24% Similarity=0.348 Sum_probs=195.6
Q ss_pred cCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEecccc-----chhhHHHHHHHHHHhhcCCCCceeeeeccccccccCC
Q 045798 684 NGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC-----EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGN 758 (1008)
Q Consensus 684 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 758 (1008)
.+|+..+.||+|+||.||+|.+..+++.||+|++.... ....+.+.+|+.++++++||||+++++++.. ..+
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~ 78 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRD---RAE 78 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEc---CCC
Confidence 47899999999999999999998889999999986432 1234578899999999999999999998542 234
Q ss_pred ceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCe
Q 045798 759 DFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSG 838 (1008)
Q Consensus 759 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 838 (1008)
...++++||+++++|.+++.... .+++..++.++.|++.||+|||+. +|+||||+|+||+++.++.+
T Consensus 79 ~~~~l~~e~~~~~~L~~~l~~~~----------~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~ 145 (266)
T cd06651 79 KTLTIFMEYMPGGSVKDQLKAYG----------ALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNV 145 (266)
T ss_pred CEEEEEEeCCCCCcHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCE
Confidence 56899999999999999987543 578889999999999999999997 99999999999999999999
Q ss_pred EEcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHH
Q 045798 839 HIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFAR 918 (1008)
Q Consensus 839 kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~ 918 (1008)
||+|||++.......... .......++..|+|||++.+..++.++||||+||++|||++|+.||..... ......
T Consensus 146 ~l~dfg~~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~----~~~~~~ 220 (266)
T cd06651 146 KLGDFGASKRLQTICMSG-TGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEA----MAAIFK 220 (266)
T ss_pred EEccCCCccccccccccC-CccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccch----HHHHHH
Confidence 999999997553221111 111223478899999999988899999999999999999999999864211 000000
Q ss_pred hhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 919 MALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 919 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
...... .+ .. .......+.+++ +||..+|++||+++||++
T Consensus 221 ~~~~~~-----~~--------------------~~--~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 221 IATQPT-----NP--------------------QL--PSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred HhcCCC-----CC--------------------CC--chhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 000000 00 00 012234456666 688899999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=312.77 Aligned_cols=259 Identities=24% Similarity=0.422 Sum_probs=203.2
Q ss_pred cCCCCCceEeeccCeeEEEEEEcCCCe----EEEEEEeccccc-hhhHHHHHHHHHHhhcCCCCceeeeeccccccccCC
Q 045798 684 NGFSSTHLIGVGSFGCVYKGALDEDGI----VVAIKVINLQCE-GASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGN 758 (1008)
Q Consensus 684 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 758 (1008)
.+|++.+.||+|+||.||+|.+..+|+ .||+|+...... .....+.+|+.++++++||||++++++|..
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------ 80 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS------ 80 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec------
Confidence 568889999999999999999865554 689998875533 345678999999999999999999998643
Q ss_pred ceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCe
Q 045798 759 DFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSG 838 (1008)
Q Consensus 759 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 838 (1008)
...++||||+++|+|.+++..... .+++..+..++.||+.|++|||++ +++||||||+||+++.++.+
T Consensus 81 ~~~~~v~e~~~~g~L~~~l~~~~~---------~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~ 148 (279)
T cd05057 81 SQVQLITQLMPLGCLLDYVRNHKD---------NIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHV 148 (279)
T ss_pred CceEEEEecCCCCcHHHHHHhccC---------CCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeE
Confidence 568999999999999999876432 588999999999999999999997 99999999999999999999
Q ss_pred EEcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCccccCCccHHHHH
Q 045798 839 HIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT-AKKPTDVMFEGDLNLHNFA 917 (1008)
Q Consensus 839 kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-G~~pf~~~~~~~~~~~~~~ 917 (1008)
||+|||.++.......... .....++..|+|||.+....++.++||||||+++||+++ |+.||..... ..+.
T Consensus 149 kL~dfg~~~~~~~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-----~~~~ 221 (279)
T cd05057 149 KITDFGLAKLLDVDEKEYH--AEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA-----VEIP 221 (279)
T ss_pred EECCCcccccccCccccee--cCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCH-----HHHH
Confidence 9999999986653322111 111224678999999988889999999999999999998 9999864311 1111
Q ss_pred HhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHHHHHHHH
Q 045798 918 RMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHELQSVKNI 994 (1008)
Q Consensus 918 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~i~~~ 994 (1008)
. .+.. .. .. +....++..+.+++.+||..||.+||++.++++.|+++.+.
T Consensus 222 ~---------~~~~---~~-----------~~----~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05057 222 D---------LLEK---GE-----------RL----PQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARD 271 (279)
T ss_pred H---------HHhC---CC-----------CC----CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhC
Confidence 0 0000 00 00 00011334578999999999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=309.63 Aligned_cols=252 Identities=26% Similarity=0.392 Sum_probs=198.6
Q ss_pred CCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccch---------hhHHHHHHHHHHhhcCCCCceeeeeccccccc
Q 045798 685 GFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEG---------ASKSFMAECKALKNIRHRNLVKVITSCSSIDF 755 (1008)
Q Consensus 685 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 755 (1008)
+|.+.+.||+|++|.||+|.+..+++.||+|++...... ..+.+.+|+.++++++||||+++++++
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~----- 75 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSS----- 75 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEE-----
Confidence 478889999999999999999888999999988643221 225688999999999999999999984
Q ss_pred cCCceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCC
Q 045798 756 QGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDND 835 (1008)
Q Consensus 756 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~ 835 (1008)
...+..++||||+++++|.+++.... .+++..+..++.|++.||+|||+. +++||||+|+||+++++
T Consensus 76 ~~~~~~~lv~e~~~~~~L~~~l~~~~----------~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~ 142 (267)
T cd06628 76 LDADHLNIFLEYVPGGSVAALLNNYG----------AFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNK 142 (267)
T ss_pred EeCCccEEEEEecCCCCHHHHHHhcc----------CccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCC
Confidence 45667899999999999999997553 678889999999999999999997 99999999999999999
Q ss_pred CCeEEcccCcccccccccCcc--ccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccH
Q 045798 836 LSGHIGDFGLARFHQEVSNST--LSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNL 913 (1008)
Q Consensus 836 ~~~kL~Dfg~a~~~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~ 913 (1008)
+.+||+|||.++......... ........|+..|+|||.+.+..++.++||||+||++|+|++|+.||..... .
T Consensus 143 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~----~ 218 (267)
T cd06628 143 GGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQ----L 218 (267)
T ss_pred CCEEecccCCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccH----H
Confidence 999999999998665321111 1111123478899999999888899999999999999999999999864211 0
Q ss_pred HHHHHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 914 HNFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 914 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
....... ....+ .. ....+..+.+++.+||+.||.+||++.||++
T Consensus 219 ~~~~~~~------~~~~~--------------------~~--~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 219 QAIFKIG------ENASP--------------------EI--PSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred HHHHHHh------ccCCC--------------------cC--CcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 0000000 00000 00 0123456789999999999999999999976
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=323.01 Aligned_cols=193 Identities=24% Similarity=0.379 Sum_probs=164.3
Q ss_pred HhcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccchhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceE
Q 045798 682 ATNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFK 761 (1008)
Q Consensus 682 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 761 (1008)
...+|++.+.||+|+||.||+|.+..+++.||+|+.... ....|+.++++++||||+++++++ ..+...
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~ 132 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTL-----VSGAIT 132 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheE-----EeCCee
Confidence 346799999999999999999999888899999985422 235699999999999999999985 455678
Q ss_pred EEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEc
Q 045798 762 AIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIG 841 (1008)
Q Consensus 762 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 841 (1008)
++|||++ .++|.+++..... .+++..++.|+.||+.||+|||++ +|+||||||+||+++.++.+||+
T Consensus 133 ~lv~e~~-~~~l~~~l~~~~~---------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~ 199 (357)
T PHA03209 133 CMVLPHY-SSDLYTYLTKRSR---------PLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIG 199 (357)
T ss_pred EEEEEcc-CCcHHHHHHhccC---------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEe
Confidence 9999999 5689888865321 689999999999999999999998 99999999999999999999999
Q ss_pred ccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCC
Q 045798 842 DFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPT 903 (1008)
Q Consensus 842 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf 903 (1008)
|||.++....... .....||..|+|||++.+..++.++|||||||++|||+++..|+
T Consensus 200 DfG~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 200 DLGAAQFPVVAPA-----FLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred cCccccccccCcc-----cccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 9999974322111 12345899999999999999999999999999999999966554
|
|
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=309.78 Aligned_cols=249 Identities=25% Similarity=0.318 Sum_probs=201.2
Q ss_pred cCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEecccc-chhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceEE
Q 045798 684 NGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC-EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKA 762 (1008)
Q Consensus 684 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 762 (1008)
..|+..+.||.|+||.||+|.+..+++.||+|+++... ......+.+|+.+++++.|+||+++++++ .++...+
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~ 78 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY-----LKGTKLW 78 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----EECCEEE
Confidence 35778899999999999999998889999999987542 34557899999999999999999999995 4566799
Q ss_pred EEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEcc
Q 045798 763 IVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGD 842 (1008)
Q Consensus 763 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 842 (1008)
+||||+++++|.+++... ++++.++..++.|++.|++|||+. +++|+||+|+||+++.++.++++|
T Consensus 79 lv~e~~~~~~L~~~i~~~-----------~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~d 144 (277)
T cd06640 79 IIMEYLGGGSALDLLRAG-----------PFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLAD 144 (277)
T ss_pred EEEecCCCCcHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcc
Confidence 999999999999998643 578889999999999999999997 999999999999999999999999
Q ss_pred cCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHhhCC
Q 045798 843 FGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMALP 922 (1008)
Q Consensus 843 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~~~~ 922 (1008)
||.+......... .....++..|+|||++.+..++.++|||||||++|||++|..||........ .
T Consensus 145 fg~~~~~~~~~~~----~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~-----~----- 210 (277)
T cd06640 145 FGVAGQLTDTQIK----RNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRV-----L----- 210 (277)
T ss_pred cccceeccCCccc----cccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhH-----h-----
Confidence 9999765432211 1223478899999999888899999999999999999999999864211100 0
Q ss_pred cchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 045798 923 NQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHE 987 (1008)
Q Consensus 923 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 987 (1008)
..+... . ++ ......+..+.+++.+||+.+|++||++.+++..
T Consensus 211 ----~~~~~~---~-------------~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 211 ----FLIPKN---N-------------PP--TLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred ----hhhhcC---C-------------CC--CCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 000000 0 00 0112356678999999999999999999999775
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=319.61 Aligned_cols=202 Identities=25% Similarity=0.309 Sum_probs=171.7
Q ss_pred cCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccc---cchhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCce
Q 045798 684 NGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQ---CEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDF 760 (1008)
Q Consensus 684 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 760 (1008)
++|++.+.||+|+||.||+|....+++.||+|+++.. .....+.+.+|+.++..++|+||+++++++ ..+++
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~ 75 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAF-----QDENN 75 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEE-----ecCCe
Confidence 4799999999999999999999989999999998642 223345688999999999999999999984 56678
Q ss_pred EEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEE
Q 045798 761 KAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHI 840 (1008)
Q Consensus 761 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 840 (1008)
.|+||||+++|+|.+++..... .+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||
T Consensus 76 ~~lv~e~~~g~~L~~~l~~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl 143 (331)
T cd05597 76 LYLVMDYYVGGDLLTLLSKFED---------RLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRL 143 (331)
T ss_pred EEEEEecCCCCcHHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEE
Confidence 9999999999999999965321 688999999999999999999998 9999999999999999999999
Q ss_pred cccCcccccccccCccccccccccccccccCccccCC-----CCCCcccchhhHHHHHHHHHhCCCCCCc
Q 045798 841 GDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLG-----SEVSTNGDVYSYGILLLEMVTAKKPTDV 905 (1008)
Q Consensus 841 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwslG~vl~elltG~~pf~~ 905 (1008)
+|||++.......... .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||..
T Consensus 144 ~Dfg~~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~ 210 (331)
T cd05597 144 ADFGSCLRLLADGTVQ---SNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYA 210 (331)
T ss_pred EECCceeecCCCCCcc---ccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCC
Confidence 9999987554322111 112358999999999863 4578899999999999999999999863
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=316.62 Aligned_cols=270 Identities=24% Similarity=0.404 Sum_probs=204.0
Q ss_pred cCCCCCceEeeccCeeEEEEEEc-------CCCeEEEEEEecccc-chhhHHHHHHHHHHhhc-CCCCceeeeecccccc
Q 045798 684 NGFSSTHLIGVGSFGCVYKGALD-------EDGIVVAIKVINLQC-EGASKSFMAECKALKNI-RHRNLVKVITSCSSID 754 (1008)
Q Consensus 684 ~~y~~~~~lg~G~~g~Vy~~~~~-------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~ 754 (1008)
++|.+.+.||+|+||.||+|... .....||+|+++... ......+.+|+++++++ +||||++++++|
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~---- 87 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVC---- 87 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEE----
Confidence 57889999999999999999763 234579999987542 33456788999999999 699999999985
Q ss_pred ccCCceEEEEEeccCCCChhcccccCCCCCCC------cccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCC
Q 045798 755 FQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRD------KEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPS 828 (1008)
Q Consensus 755 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~------~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~ 828 (1008)
...+..++||||+++|+|.+++......... ......+++.++..++.|++.||+|||++ +++||||||+
T Consensus 88 -~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~ 163 (314)
T cd05099 88 -TQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAAR 163 (314)
T ss_pred -ccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---Ceeeccccce
Confidence 3455689999999999999999764321100 01123689999999999999999999997 9999999999
Q ss_pred CeeecCCCCeEEcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCccc
Q 045798 829 NILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT-AKKPTDVMF 907 (1008)
Q Consensus 829 NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-G~~pf~~~~ 907 (1008)
||++++++.+||+|||.++.......... .....++..|+|||++.+..++.++|||||||++|||++ |..||....
T Consensus 164 Nill~~~~~~kL~Dfg~~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~ 241 (314)
T cd05099 164 NVLVTEDNVMKIADFGLARGVHDIDYYKK--TSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIP 241 (314)
T ss_pred eEEEcCCCcEEEccccccccccccccccc--cccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCC
Confidence 99999999999999999986543221111 111224567999999988889999999999999999999 888875321
Q ss_pred cCCccHHHHHHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 045798 908 EGDLNLHNFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHE 987 (1008)
Q Consensus 908 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 987 (1008)
. ..... .+... ..+ .....++.++.+++.+||+.+|++|||+.|+++.
T Consensus 242 ~-----~~~~~---------~~~~~--------------~~~----~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~ 289 (314)
T cd05099 242 V-----EELFK---------LLREG--------------HRM----DKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEA 289 (314)
T ss_pred H-----HHHHH---------HHHcC--------------CCC----CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 1 00100 00000 000 0011234567899999999999999999999999
Q ss_pred HHHHHHHH
Q 045798 988 LQSVKNIL 995 (1008)
Q Consensus 988 L~~i~~~~ 995 (1008)
|+++....
T Consensus 290 l~~~~~~~ 297 (314)
T cd05099 290 LDKVLAAV 297 (314)
T ss_pred HHHHHHHh
Confidence 99887653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=312.91 Aligned_cols=253 Identities=23% Similarity=0.293 Sum_probs=195.4
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEecc--ccchhhHHHHHHHHHHhhc-CCCCceeeeeccccccccCCc
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINL--QCEGASKSFMAECKALKNI-RHRNLVKVITSCSSIDFQGND 759 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~ 759 (1008)
...|++.++||+||.+.||++... +.+.||+|++.. .+......|.+|+..+.++ .|.+||++++| ...++
T Consensus 360 g~~Yeilk~iG~GGSSkV~kV~~s-~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DY-----Ev~d~ 433 (677)
T KOG0596|consen 360 GREYEILKQIGSGGSSKVFKVLNS-DKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDY-----EVTDG 433 (677)
T ss_pred cchhhHHHhhcCCCcceeeeeecC-CCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeee-----eccCc
Confidence 346999999999999999999884 667788877653 3345567899999999999 79999999999 56688
Q ss_pred eEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeE
Q 045798 760 FKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGH 839 (1008)
Q Consensus 760 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 839 (1008)
+.|+||||- ..+|..+++..... .+...++.+..||+.|+.++|.+ ||||.||||.|+|+-. |.+|
T Consensus 434 ~lYmvmE~G-d~DL~kiL~k~~~~---------~~~~~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlVk-G~LK 499 (677)
T KOG0596|consen 434 YLYMVMECG-DIDLNKILKKKKSI---------DPDWFLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLVK-GRLK 499 (677)
T ss_pred eEEEEeecc-cccHHHHHHhccCC---------CchHHHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEEe-eeEE
Confidence 899999987 77999999876532 23237889999999999999998 9999999999999864 5999
Q ss_pred EcccCcccccccccCccccccccccccccccCccccCCCC-----------CCcccchhhHHHHHHHHHhCCCCCCcccc
Q 045798 840 IGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSE-----------VSTNGDVYSYGILLLEMVTAKKPTDVMFE 908 (1008)
Q Consensus 840 L~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-----------~~~~sDvwslG~vl~elltG~~pf~~~~~ 908 (1008)
|+|||+|..+..+..... ....+||+.||+||++.... .+++|||||+||++|+|+.|+.||.....
T Consensus 500 LIDFGIA~aI~~DTTsI~--kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n 577 (677)
T KOG0596|consen 500 LIDFGIANAIQPDTTSIV--KDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN 577 (677)
T ss_pred eeeechhcccCcccccee--eccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH
Confidence 999999998876655443 34567999999999876432 56789999999999999999999864211
Q ss_pred CCccHHHHHHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 909 GDLNLHNFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 909 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
. |.+ +..+.++--+-.+ + .++ ...++.++|+.|++.||++|||..|+++
T Consensus 578 ~------~aK------l~aI~~P~~~Ief------------p-~~~----~~~~li~~mK~CL~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 578 Q------IAK------LHAITDPNHEIEF------------P-DIP----ENDELIDVMKCCLARDPKKRWSIPELLQ 626 (677)
T ss_pred H------HHH------HHhhcCCCccccc------------c-CCC----CchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence 0 111 1122222111000 0 001 1122799999999999999999999987
|
|
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=307.27 Aligned_cols=254 Identities=26% Similarity=0.419 Sum_probs=199.7
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccchhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceEE
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKA 762 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 762 (1008)
.++|++.+.||+|+||.||+|.+. .+..||+|.++.. ....+.+.+|++++++++|+||+++.+.+. . ...+
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~-~~~~ 76 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVT-----K-EPIY 76 (260)
T ss_pred ccceeEEeEecCccceEEEEEEec-CCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEc-----C-CCeE
Confidence 467899999999999999999875 5677999988754 334567899999999999999999998853 2 4579
Q ss_pred EEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEcc
Q 045798 763 IVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGD 842 (1008)
Q Consensus 763 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 842 (1008)
+||||+++++|.+++...... .+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~--------~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d 145 (260)
T cd05073 77 IITEFMAKGSLLDFLKSDEGS--------KQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIAD 145 (260)
T ss_pred EEEEeCCCCcHHHHHHhCCcc--------ccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECC
Confidence 999999999999999764321 678899999999999999999997 999999999999999999999999
Q ss_pred cCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCccccCCccHHHHHHhhC
Q 045798 843 FGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT-AKKPTDVMFEGDLNLHNFARMAL 921 (1008)
Q Consensus 843 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-G~~pf~~~~~~~~~~~~~~~~~~ 921 (1008)
||.+......... ......++..|+|||++.+..++.++|||||||++|++++ |..||...... ..........
T Consensus 146 ~~~~~~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~--~~~~~~~~~~ 220 (260)
T cd05073 146 FGLARVIEDNEYT---AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP--EVIRALERGY 220 (260)
T ss_pred CcceeeccCCCcc---cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHH--HHHHHHhCCC
Confidence 9999765432211 1112335678999999988889999999999999999999 89898632110 0000000000
Q ss_pred CcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHHHH
Q 045798 922 PNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHELQS 990 (1008)
Q Consensus 922 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 990 (1008)
. .+.....+.++.+++.+||+.+|++||++.++.+.|+.
T Consensus 221 ~------------------------------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 221 R------------------------------MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred C------------------------------CCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 0 00011234568899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=319.53 Aligned_cols=202 Identities=21% Similarity=0.234 Sum_probs=165.7
Q ss_pred CCceEeec--cCeeEEEEEEcCCCeEEEEEEecccc--chhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceEEE
Q 045798 688 STHLIGVG--SFGCVYKGALDEDGIVVAIKVINLQC--EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKAI 763 (1008)
Q Consensus 688 ~~~~lg~G--~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 763 (1008)
+.++||+| +|++||++..+.+|+.||+|+++... ....+.+.+|+++++.++||||++++++| ..++..++
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~-----~~~~~~~l 76 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATF-----IADNELWV 76 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEE-----EECCEEEE
Confidence 46789999 68999999999999999999997542 23445788899999999999999999985 45667999
Q ss_pred EEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEccc
Q 045798 764 VYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDF 843 (1008)
Q Consensus 764 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 843 (1008)
||||+++|+|.+++..+... .+++..++.++.|++.||+|||+. +|+||||||+||+++.++.++++||
T Consensus 77 v~e~~~~~~l~~~~~~~~~~--------~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~ 145 (327)
T cd08227 77 VTSFMAYGSAKDLICTHFMD--------GMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGL 145 (327)
T ss_pred EEeccCCCcHHHHHHhhccC--------CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEccc
Confidence 99999999999998654321 588999999999999999999997 9999999999999999999999999
Q ss_pred CcccccccccCcc---ccccccccccccccCccccCC--CCCCcccchhhHHHHHHHHHhCCCCCCc
Q 045798 844 GLARFHQEVSNST---LSSSVGVKGTIGYTAPEYGLG--SEVSTNGDVYSYGILLLEMVTAKKPTDV 905 (1008)
Q Consensus 844 g~a~~~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwslG~vl~elltG~~pf~~ 905 (1008)
+.+.......... ........++..|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 212 (327)
T cd08227 146 RSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD 212 (327)
T ss_pred chhhccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 8765332211100 001112346778999999876 4688999999999999999999999974
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=307.33 Aligned_cols=251 Identities=25% Similarity=0.365 Sum_probs=197.2
Q ss_pred ceEeeccCeeEEEEEEcC-CC--eEEEEEEeccccc-hhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceEEEEE
Q 045798 690 HLIGVGSFGCVYKGALDE-DG--IVVAIKVINLQCE-GASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKAIVY 765 (1008)
Q Consensus 690 ~~lg~G~~g~Vy~~~~~~-~~--~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 765 (1008)
+.||+|++|.||+|.+.. .+ ..||+|++..... ...+.+.+|++++++++||||+++++.+. + ...++||
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~-~~~~~v~ 74 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVL-----T-HPLMMVT 74 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEc-----C-CeEEEEE
Confidence 468999999999999854 33 3699999986655 55678999999999999999999999853 3 6689999
Q ss_pred eccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEcccCc
Q 045798 766 EYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGL 845 (1008)
Q Consensus 766 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~ 845 (1008)
||+++++|.+++..... ..+++..++.++.|++.||+|||+. +++||||+|+||+++.++.+||+|||.
T Consensus 75 e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~ 143 (257)
T cd05040 75 ELAPLGSLLDRLRKDAL--------GHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGL 143 (257)
T ss_pred EecCCCcHHHHHHhccc--------ccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEeccccc
Confidence 99999999999976532 1689999999999999999999997 999999999999999999999999999
Q ss_pred ccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCccccCCccHHHHHHhhCCcc
Q 045798 846 ARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT-AKKPTDVMFEGDLNLHNFARMALPNQ 924 (1008)
Q Consensus 846 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~ 924 (1008)
++.......... ......++..|+|||++.+..++.++|||||||++|||++ |..||......+ .........
T Consensus 144 ~~~~~~~~~~~~-~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--~~~~~~~~~--- 217 (257)
T cd05040 144 MRALPQNEDHYV-MEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQ--ILKKIDKEG--- 217 (257)
T ss_pred ccccccccccee-cccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHhcC---
Confidence 987654322111 1122447789999999988899999999999999999998 999985321110 000000000
Q ss_pred hhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHHH
Q 045798 925 VMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHELQ 989 (1008)
Q Consensus 925 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 989 (1008)
.. .......+..+.+++.+||+.+|++|||+.|+++.|.
T Consensus 218 ------~~--------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 218 ------ER--------------------LERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred ------Cc--------------------CCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 00 0000123456899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=320.48 Aligned_cols=285 Identities=21% Similarity=0.252 Sum_probs=205.5
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEecccc--chhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCce
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC--EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDF 760 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 760 (1008)
.++|++.+.||+|+||.||+|....+++.||+|++.... ......+.+|+.++++++||||+++++++.... .....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~~~ 82 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPG-ADFKD 82 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccC-CCCce
Confidence 468999999999999999999999899999999987532 234567788999999999999999998865432 34457
Q ss_pred EEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEE
Q 045798 761 KAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHI 840 (1008)
Q Consensus 761 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 840 (1008)
.++||||+ +++|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+||++++++.+||
T Consensus 83 ~~lv~e~~-~~~l~~~~~~~~----------~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl 148 (334)
T cd07855 83 VYVVMDLM-ESDLHHIIHSDQ----------PLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRI 148 (334)
T ss_pred EEEEEehh-hhhHHHHhccCC----------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEe
Confidence 89999999 469999886543 689999999999999999999997 9999999999999999999999
Q ss_pred cccCcccccccccCccccccccccccccccCccccCC-CCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHh
Q 045798 841 GDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLG-SEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARM 919 (1008)
Q Consensus 841 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~ 919 (1008)
+|||++..................++..|+|||.+.+ ..++.++|||||||++|||++|+.||....... .. .....
T Consensus 149 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~-~~-~~~~~ 226 (334)
T cd07855 149 GDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVH-QL-KLILS 226 (334)
T ss_pred cccccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHH-HH-HHHHH
Confidence 9999997654433222222223468899999998765 468899999999999999999999986431110 11 11111
Q ss_pred hCCcchhhhhcccccCchHHhhhhhhhhhccccch---hHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 045798 920 ALPNQVMDIVDPILRNDEEILASTDKCRRMQTGIN---SRLECLISMVKIGVACSMESPQDRMNMTNVVHE 987 (1008)
Q Consensus 920 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 987 (1008)
..........+......... ..+ ........+ .....+.++.+++.+||+.+|.+|||+++++..
T Consensus 227 ~~g~~~~~~~~~~~~~~~~~--~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 227 VLGSPSEEVLNRIGSDRVRK--YIQ-NLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred HhCCChhHhhhhhchhhHHH--HHh-hcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 11111111111111000000 000 000000000 012346778999999999999999999998874
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=310.26 Aligned_cols=258 Identities=28% Similarity=0.434 Sum_probs=195.0
Q ss_pred ceEeeccCeeEEEEEEcCCCe--EEEEEEecccc-chhhHHHHHHHHHHhhc-CCCCceeeeeccccccccCCceEEEEE
Q 045798 690 HLIGVGSFGCVYKGALDEDGI--VVAIKVINLQC-EGASKSFMAECKALKNI-RHRNLVKVITSCSSIDFQGNDFKAIVY 765 (1008)
Q Consensus 690 ~~lg~G~~g~Vy~~~~~~~~~--~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~ 765 (1008)
+.||+|+||.||+|.+..++. .+|+|.++... ....+.+.+|++++.++ +||||++++++| ...+..++||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~-----~~~~~~~lv~ 75 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGAC-----EHRGYLYLAI 75 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEE-----ecCCCceEEE
Confidence 368999999999999976665 46888887432 34456789999999999 899999999995 3455689999
Q ss_pred eccCCCChhcccccCCCCCCC------cccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeE
Q 045798 766 EYMPNGSLEKWLHPHAVPKRD------KEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGH 839 (1008)
Q Consensus 766 e~~~~gsL~~~l~~~~~~~~~------~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 839 (1008)
||+++|+|.+++......... ......+++.+++.++.|++.|++|||+. +++||||||+||++++++.+|
T Consensus 76 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~k 152 (270)
T cd05047 76 EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAK 152 (270)
T ss_pred EeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEE
Confidence 999999999998764321100 01122588999999999999999999997 999999999999999999999
Q ss_pred EcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCccccCCccHHHHHH
Q 045798 840 IGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT-AKKPTDVMFEGDLNLHNFAR 918 (1008)
Q Consensus 840 L~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-G~~pf~~~~~~~~~~~~~~~ 918 (1008)
++|||++....... .......+..|+|||++.+..++.++|||||||++|||++ |..||..... .....
T Consensus 153 l~dfgl~~~~~~~~-----~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~-----~~~~~ 222 (270)
T cd05047 153 IADFGLSRGQEVYV-----KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC-----AELYE 222 (270)
T ss_pred ECCCCCccccchhh-----hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCH-----HHHHH
Confidence 99999986322111 1111224567999999988889999999999999999997 9999853211 00100
Q ss_pred hhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHHHHHH
Q 045798 919 MALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHELQSVK 992 (1008)
Q Consensus 919 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~i~ 992 (1008)
.. ..... .. .....+.++.+++.+||+.+|.+|||+.|++..|+++.
T Consensus 223 ~~---------~~~~~--------------~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 223 KL---------PQGYR--------------LE----KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred HH---------hCCCC--------------CC----CCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 00 00000 00 00123446789999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-34 Score=306.85 Aligned_cols=254 Identities=23% Similarity=0.295 Sum_probs=196.6
Q ss_pred cCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEecccc-----chhhHHHHHHHHHHhhcCCCCceeeeeccccccccCC
Q 045798 684 NGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC-----EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGN 758 (1008)
Q Consensus 684 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 758 (1008)
++|++.+.||+|+||.||+|.+..+++.||+|++.... ....+.+.+|++++++++||||+++++++.. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~ 78 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRD---PME 78 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEecc---CCC
Confidence 47899999999999999999998889999999886321 1234578899999999999999999998532 223
Q ss_pred ceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCe
Q 045798 759 DFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSG 838 (1008)
Q Consensus 759 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 838 (1008)
...++||||+++++|.+++.... .+++..+..++.|++.||+|||+. +++||||||+||+++.++.+
T Consensus 79 ~~~~~v~e~~~~~~L~~~l~~~~----------~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~ 145 (265)
T cd06652 79 RTLSIFMEHMPGGSIKDQLKSYG----------ALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNV 145 (265)
T ss_pred ceEEEEEEecCCCcHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCE
Confidence 56889999999999999987543 578888999999999999999998 99999999999999999999
Q ss_pred EEcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHH
Q 045798 839 HIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFAR 918 (1008)
Q Consensus 839 kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~ 918 (1008)
+|+|||.+.......... .......++..|+|||++.+..++.++|||||||++|||++|+.||..... ......
T Consensus 146 ~l~Dfg~~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~----~~~~~~ 220 (265)
T cd06652 146 KLGDFGASKRLQTICLSG-TGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEA----MAAIFK 220 (265)
T ss_pred EECcCccccccccccccc-cccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccch----HHHHHH
Confidence 999999998553321111 112224588999999999888899999999999999999999999863211 011100
Q ss_pred hhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 919 MALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 919 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
...... .+ . ........+.+++.+|+. +|++||+++||++
T Consensus 221 ~~~~~~-----~~--------------------~--~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 221 IATQPT-----NP--------------------V--LPPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred HhcCCC-----CC--------------------C--CchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 000000 00 0 011234557788899984 9999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=313.05 Aligned_cols=266 Identities=23% Similarity=0.375 Sum_probs=201.9
Q ss_pred hcCCCCCceEeeccCeeEEEEEEc-----CCCeEEEEEEeccccc-hhhHHHHHHHHHHhhcCCCCceeeeecccccccc
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALD-----EDGIVVAIKVINLQCE-GASKSFMAECKALKNIRHRNLVKVITSCSSIDFQ 756 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 756 (1008)
.++|++.+.||+|+||.||+|.+. .++..||+|+++.... .....+.+|+.+++++.||||++++++| .
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~-----~ 78 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVC-----A 78 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEE-----c
Confidence 467999999999999999999874 2578999999875432 3456799999999999999999999985 3
Q ss_pred CCceEEEEEeccCCCChhcccccCCCCCCCc------------ccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceecc
Q 045798 757 GNDFKAIVYEYMPNGSLEKWLHPHAVPKRDK------------EIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCD 824 (1008)
Q Consensus 757 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~------------~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~D 824 (1008)
.++..++||||+++|+|.+++.......... .....+++.+++.++.|++.||+|||+. +++|||
T Consensus 79 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~d 155 (288)
T cd05050 79 VGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRD 155 (288)
T ss_pred CCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---Ceeccc
Confidence 4556899999999999999997543211100 1112588999999999999999999997 999999
Q ss_pred CCCCCeeecCCCCeEEcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCC
Q 045798 825 LKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT-AKKPT 903 (1008)
Q Consensus 825 lkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-G~~pf 903 (1008)
|||+||++++++.++|+|||.+........... ......+..|+|||.+.+..++.++|||||||++|||++ |..||
T Consensus 156 l~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~ 233 (288)
T cd05050 156 LATRNCLVGENMVVKIADFGLSRNIYSADYYKA--SENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPY 233 (288)
T ss_pred ccHhheEecCCCceEECccccceecccCccccc--cCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCC
Confidence 999999999999999999999875433221111 111234678999999988899999999999999999998 88887
Q ss_pred CccccCCccHHHHHHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHH
Q 045798 904 DVMFEGDLNLHNFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTN 983 (1008)
Q Consensus 904 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 983 (1008)
..... ........... ... .....+.++.+++.+||+.||++|||+.|
T Consensus 234 ~~~~~-----~~~~~~~~~~~--------~~~-------------------~~~~~~~~l~~li~~~l~~~p~~Rpt~~e 281 (288)
T cd05050 234 YGMAH-----EEVIYYVRDGN--------VLS-------------------CPDNCPLELYNLMRLCWSKLPSDRPSFAS 281 (288)
T ss_pred CCCCH-----HHHHHHHhcCC--------CCC-------------------CCCCCCHHHHHHHHHHcccCcccCCCHHH
Confidence 53211 01110000000 000 00123456899999999999999999999
Q ss_pred HHHHHHH
Q 045798 984 VVHELQS 990 (1008)
Q Consensus 984 vl~~L~~ 990 (1008)
+++.|++
T Consensus 282 l~~~l~~ 288 (288)
T cd05050 282 INRILQR 288 (288)
T ss_pred HHHHhhC
Confidence 9999863
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=308.76 Aligned_cols=256 Identities=21% Similarity=0.330 Sum_probs=200.1
Q ss_pred CCCCCceEeeccCeeEEEEEEcCCCeEEEEEEecccc------chhhHHHHHHHHHHhhcCCCCceeeeeccccccccCC
Q 045798 685 GFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC------EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGN 758 (1008)
Q Consensus 685 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 758 (1008)
+|+..+.||+|+||.||+|....+++.||+|+++... ....+.+.+|++++++++|+||+++++++ .++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~ 75 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGAT-----CED 75 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhcee-----ccC
Confidence 4788899999999999999998899999999987432 12346789999999999999999999994 556
Q ss_pred ceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCC-C
Q 045798 759 DFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDL-S 837 (1008)
Q Consensus 759 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~ 837 (1008)
+..++||||+++++|.+++.... ++++..+..++.|++.||+|||+. +++||||+|+||+++.++ .
T Consensus 76 ~~~~~v~e~~~~~~L~~~l~~~~----------~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~ 142 (268)
T cd06630 76 SHFNLFVEWMAGGSVSHLLSKYG----------AFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQR 142 (268)
T ss_pred CeEEEEEeccCCCcHHHHHHHhC----------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCE
Confidence 67999999999999999987543 678999999999999999999998 999999999999998776 5
Q ss_pred eEEcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHH
Q 045798 838 GHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFA 917 (1008)
Q Consensus 838 ~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~ 917 (1008)
+||+|||.+..................++..|+|||.+.+..++.++||||+|+++|+|++|..||........ .....
T Consensus 143 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~-~~~~~ 221 (268)
T cd06630 143 LRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNH-LALIF 221 (268)
T ss_pred EEEcccccccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcch-HHHHH
Confidence 89999999986654322111112234578999999999888899999999999999999999999863211100 00000
Q ss_pred HhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 918 RMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 918 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
...... .. .......+.++.+++.+|++.+|.+|||+.|+++
T Consensus 222 ~~~~~~-------------------------~~--~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 222 KIASAT-------------------------TA--PSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred HHhccC-------------------------CC--CCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 000000 00 0011234566889999999999999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=312.12 Aligned_cols=255 Identities=22% Similarity=0.271 Sum_probs=198.5
Q ss_pred cCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccc-cchhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceEE
Q 045798 684 NGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQ-CEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKA 762 (1008)
Q Consensus 684 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 762 (1008)
++|++.+.||+|+||.||+|.+..+++.||+|.++.. .+.....+.+|++++++++|+||+++++++ ..++..+
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~~ 75 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAF-----FIEGAVY 75 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhhe-----ecCCeEE
Confidence 4688999999999999999999889999999998754 233456789999999999999999999984 4567799
Q ss_pred EEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEcc
Q 045798 763 IVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGD 842 (1008)
Q Consensus 763 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 842 (1008)
+||||+++++|..++...... ..+++..+..++.|++.|+.|||+. .+|+||||||+||+++.++.+||+|
T Consensus 76 lv~e~~~~~~l~~~~~~~~~~-------~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~d 146 (286)
T cd06622 76 MCMEYMDAGSLDKLYAGGVAT-------EGIPEDVLRRITYAVVKGLKFLKEE--HNIIHRDVKPTNVLVNGNGQVKLCD 146 (286)
T ss_pred EEEeecCCCCHHHHHHhcccc-------CCCCHHHHHHHHHHHHHHHHHHHhc--CCEeeCCCCHHHEEECCCCCEEEee
Confidence 999999999999988754211 1689999999999999999999963 3899999999999999999999999
Q ss_pred cCcccccccccCccccccccccccccccCccccCCC------CCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHH
Q 045798 843 FGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGS------EVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNF 916 (1008)
Q Consensus 843 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~ 916 (1008)
||.+........ ....++..|+|||.+.+. .++.++|||||||++|+|++|+.||...... .....
T Consensus 147 fg~~~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~--~~~~~ 218 (286)
T cd06622 147 FGVSGNLVASLA------KTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYA--NIFAQ 218 (286)
T ss_pred cCCcccccCCcc------ccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchh--hHHHH
Confidence 999975532211 123478899999997554 3478999999999999999999998632110 00000
Q ss_pred HHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 045798 917 ARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHE 987 (1008)
Q Consensus 917 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 987 (1008)
.. ...+.. +.. .....+.++.+++.+||+.+|++||++++++..
T Consensus 219 ~~--------~~~~~~-----------------~~~--~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 219 LS--------AIVDGD-----------------PPT--LPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred HH--------HHhhcC-----------------CCC--CCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 00 000000 000 011245667899999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=313.71 Aligned_cols=281 Identities=25% Similarity=0.354 Sum_probs=197.5
Q ss_pred HhcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEecccc-chhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCce
Q 045798 682 ATNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC-EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDF 760 (1008)
Q Consensus 682 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 760 (1008)
++++|++.+.||+|+||.||+|....+++.||+|++.... ......+.+|+++++.++|+||+++++++ ..++.
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~-----~~~~~ 77 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDII-----HTKET 77 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEE-----ecCCe
Confidence 4678999999999999999999998889999999987543 23345678999999999999999999984 45667
Q ss_pred EEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEE
Q 045798 761 KAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHI 840 (1008)
Q Consensus 761 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 840 (1008)
.++||||+. +++.+++..... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||
T Consensus 78 ~~lv~e~~~-~~l~~~~~~~~~---------~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l 144 (291)
T cd07870 78 LTFVFEYMH-TDLAQYMIQHPG---------GLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKL 144 (291)
T ss_pred EEEEEeccc-CCHHHHHHhCCC---------CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEE
Confidence 999999994 788777654321 567888999999999999999998 9999999999999999999999
Q ss_pred cccCcccccccccCccccccccccccccccCccccCCC-CCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHh
Q 045798 841 GDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGS-EVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARM 919 (1008)
Q Consensus 841 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~ 919 (1008)
+|||+++........ .....++..|+|||++.+. .++.++|||||||++|||++|+.||+........+......
T Consensus 145 ~Dfg~~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~ 220 (291)
T cd07870 145 ADFGLARAKSIPSQT----YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTV 220 (291)
T ss_pred eccccccccCCCCCC----CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHH
Confidence 999999754332111 1223478899999998764 57889999999999999999999987432211111111100
Q ss_pred -hCCcc-hhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 920 -ALPNQ-VMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 920 -~~~~~-~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
..+.. ....+...-...++. ........... .......+..+.+++.+|++.||.+|||++|++.
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~-~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 221 LGVPTEDTWPGVSKLPNYKPEW-FLPCKPQQLRV-VWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred cCCCChhhhhhhhhcccccchh-ccccCCcchhh-hccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 00100 000000000000000 00000000000 0000112456789999999999999999999874
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-34 Score=307.51 Aligned_cols=257 Identities=22% Similarity=0.347 Sum_probs=188.2
Q ss_pred ceEeeccCeeEEEEEEcC--CCeEEEEEEeccccc-hhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceEEEEEe
Q 045798 690 HLIGVGSFGCVYKGALDE--DGIVVAIKVINLQCE-GASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKAIVYE 766 (1008)
Q Consensus 690 ~~lg~G~~g~Vy~~~~~~--~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 766 (1008)
+.||+|+||.||+|.... ++..+|+|.++.... .....+.+|+.++++++||||+++++++ .+....++|||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~~lv~e 75 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQC-----TEVTPYLLVME 75 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----cCCCCcEEEEE
Confidence 468999999999998642 446799999875432 3345789999999999999999999985 34456899999
Q ss_pred ccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEcccCcc
Q 045798 767 YMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLA 846 (1008)
Q Consensus 767 ~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a 846 (1008)
|+++|+|.+++....... ....++..+..++.|++.|++|||+. +++||||||+||+++.++.+||+|||.+
T Consensus 76 ~~~~g~L~~~l~~~~~~~-----~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~ 147 (269)
T cd05087 76 FCPLGDLKGYLRSCRKAE-----LMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLS 147 (269)
T ss_pred CCCCCcHHHHHHHhhhcc-----cccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCcccc
Confidence 999999999997543211 11467778889999999999999997 9999999999999999999999999999
Q ss_pred cccccccCccccccccccccccccCccccCCC-------CCCcccchhhHHHHHHHHHh-CCCCCCccccCCccHHHHHH
Q 045798 847 RFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGS-------EVSTNGDVYSYGILLLEMVT-AKKPTDVMFEGDLNLHNFAR 918 (1008)
Q Consensus 847 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~sDvwslG~vl~ellt-G~~pf~~~~~~~~~~~~~~~ 918 (1008)
......... .......++..|+|||++.+. .++.++||||||+++|||++ |+.||......+. ...
T Consensus 148 ~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~--~~~-- 221 (269)
T cd05087 148 HNKYKEDYY--VTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQV--LTY-- 221 (269)
T ss_pred ccccCccee--ecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHH--HHH--
Confidence 754322211 111224477889999987542 35789999999999999996 9999864321110 000
Q ss_pred hhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHHH
Q 045798 919 MALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHELQ 989 (1008)
Q Consensus 919 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 989 (1008)
..........++.+. ...+..+.+++..|| .+|++|||++||+..|+
T Consensus 222 -~~~~~~~~~~~~~~~----------------------~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 222 -TVREQQLKLPKPRLK----------------------LPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred -HhhcccCCCCCCccC----------------------CCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 000000000011000 012345788999999 68999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-35 Score=320.06 Aligned_cols=288 Identities=24% Similarity=0.274 Sum_probs=212.2
Q ss_pred CCCCceEeeccCeeEEEEEEcCCCeEEEEEEecccc-chhhHHHHHHHHHHhhcCCCCceeeeecccccc-ccCCceEEE
Q 045798 686 FSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC-EGASKSFMAECKALKNIRHRNLVKVITSCSSID-FQGNDFKAI 763 (1008)
Q Consensus 686 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~~~~~~l 763 (1008)
+...+.||+|+||.||+|+.+++|+.||||.++... ....+...+|++++++++|+|||+++++-.... .--.....+
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 455678999999999999999999999999998543 355678899999999999999999998832211 111345789
Q ss_pred EEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeec--CCC--CeE
Q 045798 764 VYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLD--NDL--SGH 839 (1008)
Q Consensus 764 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~--~~~--~~k 839 (1008)
|||||.+|||..++..... ...+++.+.+.++.+++.||.|||++ +||||||||.||++- ++| ..|
T Consensus 95 vmEyC~gGsL~~~L~~PEN-------~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyK 164 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLNSPEN-------AYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYK 164 (732)
T ss_pred EEeecCCCcHHHHhcCccc-------ccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEe
Confidence 9999999999999975433 23799999999999999999999998 999999999999983 333 359
Q ss_pred EcccCcccccccccCccccccccccccccccCccccCC-CCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHH-
Q 045798 840 IGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLG-SEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFA- 917 (1008)
Q Consensus 840 L~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~- 917 (1008)
|+|||.|+..++... ....+||..|.+||.+.. +.|+..+|.|||||++|+.+||..||........+.+...
T Consensus 165 LtDfG~Arel~d~s~-----~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~ 239 (732)
T KOG4250|consen 165 LTDFGAARELDDNSL-----FTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWH 239 (732)
T ss_pred eecccccccCCCCCe-----eeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhh
Confidence 999999998776552 345779999999999884 7889999999999999999999999976443322222111
Q ss_pred -HhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCC--CHHHHHHHHHHHHHH
Q 045798 918 -RMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRM--NMTNVVHELQSVKNI 994 (1008)
Q Consensus 918 -~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP--t~~evl~~L~~i~~~ 994 (1008)
....+..+....++...+ ....-..++.+..........+-.++..++.++|.+|- .+.+....+..|.+.
T Consensus 240 ~~tkkp~~v~i~~~~~eNg------pv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~~ 313 (732)
T KOG4250|consen 240 IITKKPSGVAIGAQEEENG------PVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILNL 313 (732)
T ss_pred hhccCCCceeEeeecccCC------ceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHhh
Confidence 111222222111111110 01111222333333334555677888888999999999 777777777776543
|
|
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=311.12 Aligned_cols=262 Identities=23% Similarity=0.292 Sum_probs=203.4
Q ss_pred HHhcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccchhhHHHHHHHHHHhhc-CCCCceeeeeccccccc-cCC
Q 045798 681 KATNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNI-RHRNLVKVITSCSSIDF-QGN 758 (1008)
Q Consensus 681 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~-~~~ 758 (1008)
.++++|++.+.||+|++|.||+|.+..+++.||+|++.... ...+.+.+|+.+++++ .|+||+++++++..... ...
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE-DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc-hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 35689999999999999999999998889999999987553 3456799999999999 79999999999765332 345
Q ss_pred ceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCe
Q 045798 759 DFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSG 838 (1008)
Q Consensus 759 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 838 (1008)
+..++||||+++++|.+++...... ...+++..+..++.|++.||+|||+. +++||||+|+||++++++.+
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~------~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~ 152 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLRKK------GKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEV 152 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHhhc------CCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeE
Confidence 6789999999999999988653211 12689999999999999999999998 99999999999999999999
Q ss_pred EEcccCcccccccccCccccccccccccccccCccccCC-----CCCCcccchhhHHHHHHHHHhCCCCCCccccCCccH
Q 045798 839 HIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLG-----SEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNL 913 (1008)
Q Consensus 839 kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~ 913 (1008)
||+|||.+......... .....++..|+|||++.. ..++.++|||||||++|+|++|+.||......
T Consensus 153 ~l~d~~~~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---- 224 (275)
T cd06608 153 KLVDFGVSAQLDSTLGR----RNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM---- 224 (275)
T ss_pred EECCCccceecccchhh----hcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchH----
Confidence 99999999755432211 123458899999998753 34678999999999999999999998632110
Q ss_pred HHHHHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 914 HNFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 914 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
..... ... .. .+........+.++.+++.+||..||++|||+.|+++
T Consensus 225 ~~~~~---------~~~----~~-------------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 225 RALFK---------IPR----NP-------------PPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred HHHHH---------hhc----cC-------------CCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 00000 000 00 0000011224557889999999999999999999975
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=307.25 Aligned_cols=250 Identities=26% Similarity=0.344 Sum_probs=200.6
Q ss_pred CCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccc--cchhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceEE
Q 045798 685 GFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQ--CEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKA 762 (1008)
Q Consensus 685 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 762 (1008)
+|++.+.||+|+||.||++....+++.||+|++... .....+.+.+|++++++++||||++++++ +...++.+
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~-----~~~~~~~~ 75 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQES-----FEENGNLY 75 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEee-----ecCCCeEE
Confidence 588999999999999999999889999999998643 23345678999999999999999999998 45667899
Q ss_pred EEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEcc
Q 045798 763 IVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGD 842 (1008)
Q Consensus 763 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 842 (1008)
+||||+++++|.+++...... .+++.++..++.|++.|++|||+. +++|+||+|+||+++.++.++++|
T Consensus 76 lv~e~~~~~~l~~~~~~~~~~--------~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d 144 (256)
T cd08218 76 IVMDYCEGGDLYKKINAQRGV--------LFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGD 144 (256)
T ss_pred EEEecCCCCcHHHHHHhccCC--------CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEee
Confidence 999999999999998754321 578899999999999999999997 999999999999999999999999
Q ss_pred cCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHhhCC
Q 045798 843 FGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMALP 922 (1008)
Q Consensus 843 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~~~~ 922 (1008)
||.+......... .....|+..|+|||+..+..++.++|||||||++|+|++|+.||..... ..
T Consensus 145 ~~~~~~~~~~~~~----~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~-----~~------- 208 (256)
T cd08218 145 FGIARVLNSTVEL----ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNM-----KN------- 208 (256)
T ss_pred ccceeecCcchhh----hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCH-----HH-------
Confidence 9999865432211 1123478899999999888899999999999999999999999853210 00
Q ss_pred cchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 923 NQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 923 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
.++..+.... + . .....+.++.+++.+||+.+|.+||++.||++
T Consensus 209 -----~~~~~~~~~~------------~-~--~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 209 -----LVLKIIRGSY------------P-P--VSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred -----HHHHHhcCCC------------C-C--CcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 1111100000 0 0 01123456899999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=316.87 Aligned_cols=206 Identities=26% Similarity=0.373 Sum_probs=163.0
Q ss_pred ceEeeccCeeEEEEEEcC--CCeEEEEEEeccccchhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceEEEEEec
Q 045798 690 HLIGVGSFGCVYKGALDE--DGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKAIVYEY 767 (1008)
Q Consensus 690 ~~lg~G~~g~Vy~~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~ 767 (1008)
.+||+|+||.||+|.... ++..||+|.++.. .....+.+|++++++++||||+++++++.. ..+...++||||
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~---~~~~~~~lv~e~ 81 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGT--GISMSACREIALLRELKHPNVIALQKVFLS---HSDRKVWLLFDY 81 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCC--CCcHHHHHHHHHHHhCCCCCeeeEEEEEec---cCCCeEEEEEee
Confidence 679999999999999753 5578999998643 233567899999999999999999998643 345678999999
Q ss_pred cCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeee----cCCCCeEEccc
Q 045798 768 MPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILL----DNDLSGHIGDF 843 (1008)
Q Consensus 768 ~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll----~~~~~~kL~Df 843 (1008)
++ ++|.+++........ ......+++..++.++.||+.||+|||+. +|+||||||+||++ +.++.+||+||
T Consensus 82 ~~-~~l~~~~~~~~~~~~-~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~Df 156 (317)
T cd07867 82 AE-HDLWHIIKFHRASKA-NKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADM 156 (317)
T ss_pred eC-CcHHHHHHhhhcccc-CCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeec
Confidence 95 588887754322111 11122689999999999999999999997 99999999999999 56679999999
Q ss_pred CcccccccccCccccccccccccccccCccccCCC-CCCcccchhhHHHHHHHHHhCCCCCCcc
Q 045798 844 GLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGS-EVSTNGDVYSYGILLLEMVTAKKPTDVM 906 (1008)
Q Consensus 844 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltG~~pf~~~ 906 (1008)
|+++........ ........+|..|+|||++.+. .++.++|||||||++|||++|++||...
T Consensus 157 G~a~~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 157 GFARLFNSPLKP-LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred cceeccCCCccc-ccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 999866433221 1112334689999999998764 5789999999999999999999999643
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=311.96 Aligned_cols=248 Identities=26% Similarity=0.341 Sum_probs=198.9
Q ss_pred CCCCCceEeeccCeeEEEEEEcCCCeEEEEEEecccc-chhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceEEE
Q 045798 685 GFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC-EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKAI 763 (1008)
Q Consensus 685 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 763 (1008)
.|+..+.||+|+||.||+|.+..+++.||+|.++... ....+.+.+|++++++++||||+++++++ ..++..++
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~l 79 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSY-----LKGTKLWI 79 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhccc-----ccCCceEE
Confidence 4667788999999999999998889999999987442 34456789999999999999999999984 45667999
Q ss_pred EEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEccc
Q 045798 764 VYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDF 843 (1008)
Q Consensus 764 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 843 (1008)
||||+++++|.+++... .+++..+..++.|++.|+.|||+. +++|+||+|+||++++++.++++||
T Consensus 80 v~e~~~~~~L~~~~~~~-----------~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~df 145 (277)
T cd06642 80 IMEYLGGGSALDLLKPG-----------PLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADF 145 (277)
T ss_pred EEEccCCCcHHHHhhcC-----------CCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccc
Confidence 99999999999988642 578899999999999999999997 9999999999999999999999999
Q ss_pred CcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCc
Q 045798 844 GLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMALPN 923 (1008)
Q Consensus 844 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~~~~~ 923 (1008)
|++......... .....++..|+|||++.+..++.++|||||||++|||++|+.||........ ... ...
T Consensus 146 g~~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~--~~~----~~~ 215 (277)
T cd06642 146 GVAGQLTDTQIK----RNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRV--LFL----IPK 215 (277)
T ss_pred cccccccCcchh----hhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhH--Hhh----hhc
Confidence 999765432211 1223478899999999988899999999999999999999999863321100 000 000
Q ss_pred chhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 045798 924 QVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHE 987 (1008)
Q Consensus 924 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 987 (1008)
. ..+. .....+..+.+++.+||+.+|++||++.++++.
T Consensus 216 ~----~~~~----------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 216 N----SPPT----------------------LEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred C----CCCC----------------------CCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 0 0000 001234567899999999999999999999984
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=315.69 Aligned_cols=262 Identities=26% Similarity=0.408 Sum_probs=202.3
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCe----EEEEEEeccccc-hhhHHHHHHHHHHhhcCCCCceeeeeccccccccC
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGI----VVAIKVINLQCE-GASKSFMAECKALKNIRHRNLVKVITSCSSIDFQG 757 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 757 (1008)
.++|+..+.||+|+||.||+|.+..+++ .||+|++..... .....+.+|+.+++.++||||++++++|..
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~----- 80 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLS----- 80 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcC-----
Confidence 3568889999999999999999876665 578898864432 334578999999999999999999998642
Q ss_pred CceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCC
Q 045798 758 NDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLS 837 (1008)
Q Consensus 758 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 837 (1008)
...++|+||+++|+|.+++..... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.
T Consensus 81 -~~~~~v~e~~~~g~l~~~~~~~~~---------~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~ 147 (303)
T cd05110 81 -PTIQLVTQLMPHGCLLDYVHEHKD---------NIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNH 147 (303)
T ss_pred -CCceeeehhcCCCCHHHHHHhccc---------CCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCc
Confidence 235799999999999999875431 578899999999999999999998 9999999999999999999
Q ss_pred eEEcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCccccCCccHHHH
Q 045798 838 GHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT-AKKPTDVMFEGDLNLHNF 916 (1008)
Q Consensus 838 ~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-G~~pf~~~~~~~~~~~~~ 916 (1008)
+||+|||.++......... ......++..|+|||++.+..++.++|||||||++|||++ |+.||..... .....+
T Consensus 148 ~kL~Dfg~~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~--~~~~~~ 223 (303)
T cd05110 148 VKITDFGLARLLEGDEKEY--NADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT--REIPDL 223 (303)
T ss_pred eEEccccccccccCccccc--ccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHH
Confidence 9999999998654332211 1122335778999999988899999999999999999997 8899853211 001111
Q ss_pred HHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHHHHHHHHHH
Q 045798 917 ARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHELQSVKNILL 996 (1008)
Q Consensus 917 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~i~~~~~ 996 (1008)
.. .... .+ ....++..+.+++.+||..+|++||+++++++.++++.+...
T Consensus 224 ~~------------~~~~--------------~~----~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~~ 273 (303)
T cd05110 224 LE------------KGER--------------LP----QPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDPQ 273 (303)
T ss_pred HH------------CCCC--------------CC----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhchh
Confidence 10 0000 00 001123457899999999999999999999999998765543
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=314.68 Aligned_cols=249 Identities=23% Similarity=0.326 Sum_probs=197.6
Q ss_pred CCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccchhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceEEEEE
Q 045798 686 FSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKAIVY 765 (1008)
Q Consensus 686 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 765 (1008)
|.....||+|+||.||++....+++.||||++........+.+.+|+.+++.++|+||+++++.+ ..++..++||
T Consensus 24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~-----~~~~~~~lv~ 98 (292)
T cd06658 24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY-----LVGDELWVVM 98 (292)
T ss_pred HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHhe-----ecCCeEEEEE
Confidence 34456799999999999999888999999998765555667899999999999999999999984 4566799999
Q ss_pred eccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEcccCc
Q 045798 766 EYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGL 845 (1008)
Q Consensus 766 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~ 845 (1008)
||+++++|.+++... .+++.++..++.||+.|++|||+. +|+||||||+||++++++.++|+|||+
T Consensus 99 e~~~~~~L~~~~~~~-----------~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~ 164 (292)
T cd06658 99 EFLEGGALTDIVTHT-----------RMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGF 164 (292)
T ss_pred eCCCCCcHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcc
Confidence 999999999988532 578899999999999999999997 999999999999999999999999999
Q ss_pred ccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCcch
Q 045798 846 ARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMALPNQV 925 (1008)
Q Consensus 846 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~ 925 (1008)
+......... .....++..|+|||...+..++.++||||||+++|||++|+.||..... ...... .
T Consensus 165 ~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~----~~~~~~------~ 230 (292)
T cd06658 165 CAQVSKEVPK----RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPP----LQAMRR------I 230 (292)
T ss_pred hhhccccccc----CceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHH------H
Confidence 8754332211 1224588999999999888899999999999999999999999863211 000000 0
Q ss_pred hhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 045798 926 MDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHE 987 (1008)
Q Consensus 926 ~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 987 (1008)
.....+.+ ......+..+.+++.+||..||.+|||++|+++.
T Consensus 231 ~~~~~~~~--------------------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 231 RDNLPPRV--------------------KDSHKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred HhcCCCcc--------------------ccccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 00000000 0011234467899999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=321.59 Aligned_cols=202 Identities=23% Similarity=0.315 Sum_probs=172.5
Q ss_pred cCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccc---cchhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCce
Q 045798 684 NGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQ---CEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDF 760 (1008)
Q Consensus 684 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 760 (1008)
++|++.+.||+|+||.||++++..+++.||+|++... .......+.+|+.++..++|++|++++++ +.+++.
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~-----~~~~~~ 75 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYA-----FQDENY 75 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEE-----EEcCCE
Confidence 4799999999999999999999889999999998642 12334568889999999999999999998 456778
Q ss_pred EEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEE
Q 045798 761 KAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHI 840 (1008)
Q Consensus 761 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 840 (1008)
.|+||||+++|+|.+++..... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||
T Consensus 76 ~~lv~Ey~~gg~L~~~l~~~~~---------~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl 143 (331)
T cd05624 76 LYLVMDYYVGGDLLTLLSKFED---------RLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRL 143 (331)
T ss_pred EEEEEeCCCCCcHHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEE
Confidence 9999999999999999975321 678999999999999999999997 9999999999999999999999
Q ss_pred cccCcccccccccCccccccccccccccccCccccCC-----CCCCcccchhhHHHHHHHHHhCCCCCCc
Q 045798 841 GDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLG-----SEVSTNGDVYSYGILLLEMVTAKKPTDV 905 (1008)
Q Consensus 841 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwslG~vl~elltG~~pf~~ 905 (1008)
+|||++.......... .....||+.|+|||++.+ +.++.++|||||||++|||++|+.||..
T Consensus 144 ~DfG~a~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~ 210 (331)
T cd05624 144 ADFGSCLKMNQDGTVQ---SSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYA 210 (331)
T ss_pred EeccceeeccCCCcee---eccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccC
Confidence 9999997654322211 122458999999998865 4678899999999999999999999863
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-34 Score=307.73 Aligned_cols=261 Identities=26% Similarity=0.305 Sum_probs=204.3
Q ss_pred cCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEecccc-chhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceEE
Q 045798 684 NGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC-EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKA 762 (1008)
Q Consensus 684 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 762 (1008)
++|++.+.||.|+||+||+|....++..||+|++.... ....+.+.+|+++++.++|+||+++++.+ ..++..+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~ 75 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSF-----VVGDELW 75 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEE-----eeCCEEE
Confidence 47899999999999999999998889999999987432 33567899999999999999999999884 4567799
Q ss_pred EEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEcc
Q 045798 763 IVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGD 842 (1008)
Q Consensus 763 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 842 (1008)
+|||++++++|.+++...... ..+++..+..++.|++.|++|||+. +++||||+|+||++++++.++|+|
T Consensus 76 iv~e~~~~~~l~~~~~~~~~~-------~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~d 145 (267)
T cd06610 76 LVMPYLSGGSLLDIMKSSYPR-------GGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIAD 145 (267)
T ss_pred EEEeccCCCcHHHHHHHhccc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcc
Confidence 999999999999999754321 1689999999999999999999998 999999999999999999999999
Q ss_pred cCcccccccccCccccccccccccccccCccccCCC-CCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHhhC
Q 045798 843 FGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGS-EVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMAL 921 (1008)
Q Consensus 843 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~~~ 921 (1008)
||++..................++..|+|||++... .++.++|||||||++|+|++|+.||....... ........ .
T Consensus 146 f~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~-~~~~~~~~-~ 223 (267)
T cd06610 146 FGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK-VLMLTLQN-D 223 (267)
T ss_pred cchHHHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh-hHHHHhcC-C
Confidence 999986655433221122334588999999998776 78999999999999999999999986432111 01110000 0
Q ss_pred CcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 922 PNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 922 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
+ +.+... ......+..+.+++.+||+.||++|||++++++
T Consensus 224 ~--------~~~~~~-----------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 224 P--------PSLETG-----------------ADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred C--------CCcCCc-----------------cccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 0 000000 001134566789999999999999999999975
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=313.32 Aligned_cols=202 Identities=29% Similarity=0.442 Sum_probs=169.4
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccc-hhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceE
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCE-GASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFK 761 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 761 (1008)
.++|++.+.||+|++|.||+|....+++.||+|.+..... .....+.+|++++++++|+||+++++++ ..++..
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~ 78 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDII-----HTKKTL 78 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEE-----ecCCeE
Confidence 3679999999999999999999988899999999875432 2334577899999999999999999984 566789
Q ss_pred EEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEc
Q 045798 762 AIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIG 841 (1008)
Q Consensus 762 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 841 (1008)
++||||++ ++|.+++..... .+++..++.++.|++.||.|||+. +|+||||||+||+++.++.+||+
T Consensus 79 ~lv~e~~~-~~L~~~~~~~~~---------~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~ 145 (291)
T cd07844 79 TLVFEYLD-TDLKQYMDDCGG---------GLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLA 145 (291)
T ss_pred EEEEecCC-CCHHHHHHhCCC---------CCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEEC
Confidence 99999996 599998865431 578999999999999999999998 99999999999999999999999
Q ss_pred ccCcccccccccCccccccccccccccccCccccCC-CCCCcccchhhHHHHHHHHHhCCCCCCcc
Q 045798 842 DFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLG-SEVSTNGDVYSYGILLLEMVTAKKPTDVM 906 (1008)
Q Consensus 842 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltG~~pf~~~ 906 (1008)
|||.++........ .....++..|+|||++.+ ..++.++||||+|+++|+|++|+.||...
T Consensus 146 dfg~~~~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~ 207 (291)
T cd07844 146 DFGLARAKSVPSKT----YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGS 207 (291)
T ss_pred ccccccccCCCCcc----ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 99998744321111 112236789999998765 45789999999999999999999998643
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=319.20 Aligned_cols=202 Identities=25% Similarity=0.297 Sum_probs=171.1
Q ss_pred cCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccc---cchhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCce
Q 045798 684 NGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQ---CEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDF 760 (1008)
Q Consensus 684 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 760 (1008)
++|++.++||+|+||.||+++...+++.||+|++... .......+.+|+.++..++|++|+++++++ .+++.
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~ 75 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAF-----QDENN 75 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEE-----ecCCE
Confidence 4789999999999999999999888999999998632 123344588899999999999999999884 56677
Q ss_pred EEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEE
Q 045798 761 KAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHI 840 (1008)
Q Consensus 761 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 840 (1008)
.++||||+++|+|.+++..... .+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||
T Consensus 76 ~~lv~ey~~~g~L~~~l~~~~~---------~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL 143 (332)
T cd05623 76 LYLVMDYYVGGDLLTLLSKFED---------RLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRL 143 (332)
T ss_pred EEEEEeccCCCcHHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEE
Confidence 9999999999999999975321 688999999999999999999998 9999999999999999999999
Q ss_pred cccCcccccccccCccccccccccccccccCccccC-----CCCCCcccchhhHHHHHHHHHhCCCCCCc
Q 045798 841 GDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGL-----GSEVSTNGDVYSYGILLLEMVTAKKPTDV 905 (1008)
Q Consensus 841 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwslG~vl~elltG~~pf~~ 905 (1008)
+|||++......... ......||+.|+|||++. ...++.++|||||||++|||++|+.||..
T Consensus 144 ~DfG~a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~ 210 (332)
T cd05623 144 ADFGSCLKLMEDGTV---QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYA 210 (332)
T ss_pred eecchheecccCCcc---eecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCC
Confidence 999999754322211 112245899999999876 34678999999999999999999999863
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=316.13 Aligned_cols=256 Identities=25% Similarity=0.324 Sum_probs=200.3
Q ss_pred cCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccc---hhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCce
Q 045798 684 NGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCE---GASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDF 760 (1008)
Q Consensus 684 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 760 (1008)
++|++.+.||+|+||.||+|....+++.||+|.+..... ...+.+.+|+++++.++|+||+++++.+ ..+..
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~ 75 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASF-----QTETY 75 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeee-----ecCCE
Confidence 368899999999999999999988899999999975432 2446789999999999999999999984 55677
Q ss_pred EEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEE
Q 045798 761 KAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHI 840 (1008)
Q Consensus 761 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 840 (1008)
.++||||+++++|.+++...... .+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|
T Consensus 76 ~~lv~e~~~~~~L~~~~~~~~~~--------~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l 144 (316)
T cd05574 76 LCLVMDYCPGGELFRLLQRQPGK--------CLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIML 144 (316)
T ss_pred EEEEEEecCCCCHHHHHHhCCCC--------ccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEE
Confidence 99999999999999998754321 689999999999999999999998 9999999999999999999999
Q ss_pred cccCcccccccccCccc-------------------------cccccccccccccCccccCCCCCCcccchhhHHHHHHH
Q 045798 841 GDFGLARFHQEVSNSTL-------------------------SSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLE 895 (1008)
Q Consensus 841 ~Dfg~a~~~~~~~~~~~-------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~e 895 (1008)
+|||++........... .......|+..|+|||++.+..++.++||||||+++|+
T Consensus 145 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~ 224 (316)
T cd05574 145 SDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYE 224 (316)
T ss_pred eecchhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHH
Confidence 99999875433211100 01112357889999999998889999999999999999
Q ss_pred HHhCCCCCCccccCCccHHHHHHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCC
Q 045798 896 MVTAKKPTDVMFEGDLNLHNFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESP 975 (1008)
Q Consensus 896 lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP 975 (1008)
|++|+.||...... ..+. ...+... ..+.....+..+.+++.+||+.||
T Consensus 225 l~~g~~pf~~~~~~----~~~~---------~~~~~~~------------------~~~~~~~~~~~~~~li~~~l~~~p 273 (316)
T cd05574 225 MLYGTTPFKGSNRD----ETFS---------NILKKEV------------------TFPGSPPVSSSARDLIRKLLVKDP 273 (316)
T ss_pred HhhCCCCCCCCchH----HHHH---------HHhcCCc------------------cCCCccccCHHHHHHHHHHccCCH
Confidence 99999998633211 0010 0000000 000011245678999999999999
Q ss_pred CCCCC----HHHHHH
Q 045798 976 QDRMN----MTNVVH 986 (1008)
Q Consensus 976 ~~RPt----~~evl~ 986 (1008)
++||| ++|++.
T Consensus 274 ~~R~s~~~~~~~ll~ 288 (316)
T cd05574 274 SKRLGSKRGAAEIKQ 288 (316)
T ss_pred hHCCCchhhHHHHHc
Confidence 99999 666555
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=314.10 Aligned_cols=259 Identities=22% Similarity=0.245 Sum_probs=199.5
Q ss_pred cCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEecccc---chhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCce
Q 045798 684 NGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC---EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDF 760 (1008)
Q Consensus 684 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 760 (1008)
++|++.+.||+|+||.||+|.+..+++.||+|.+.... ....+.+.+|+++++.++||||+++++.+ ..+++
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~ 75 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSF-----ETKRH 75 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEE-----ecCCE
Confidence 46899999999999999999999899999999987542 23345788999999999999999999884 55667
Q ss_pred EEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEE
Q 045798 761 KAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHI 840 (1008)
Q Consensus 761 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 840 (1008)
.++||||+++++|.+++.... .+++..+..++.|++.|++|||+. +++||||||+||+++.++.+||
T Consensus 76 ~~lv~e~~~g~~L~~~l~~~~----------~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l 142 (305)
T cd05609 76 LCMVMEYVEGGDCATLLKNIG----------ALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKL 142 (305)
T ss_pred EEEEEecCCCCcHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEE
Confidence 999999999999999996543 688999999999999999999998 9999999999999999999999
Q ss_pred cccCcccccccccCc-----------cccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccC
Q 045798 841 GDFGLARFHQEVSNS-----------TLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEG 909 (1008)
Q Consensus 841 ~Dfg~a~~~~~~~~~-----------~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~ 909 (1008)
+|||.++........ .........++..|+|||.+.+..++.++|||||||++|||++|..||.....
T Consensus 143 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~- 221 (305)
T cd05609 143 TDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP- 221 (305)
T ss_pred eeCCCccccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-
Confidence 999998742111000 00011123478899999999888899999999999999999999999853211
Q ss_pred CccHHHHHHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHHH
Q 045798 910 DLNLHNFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHELQ 989 (1008)
Q Consensus 910 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 989 (1008)
........... ... +. .....+..+.+++.+||+.||++||++.++.+.|+
T Consensus 222 ----~~~~~~~~~~~---~~~-------------------~~---~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~ 272 (305)
T cd05609 222 ----EELFGQVISDD---IEW-------------------PE---GDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQ 272 (305)
T ss_pred ----HHHHHHHHhcc---cCC-------------------CC---ccccCCHHHHHHHHHHhccChhhccCccCHHHHHh
Confidence 00000000000 000 00 00023456799999999999999999766666554
Q ss_pred H
Q 045798 990 S 990 (1008)
Q Consensus 990 ~ 990 (1008)
.
T Consensus 273 ~ 273 (305)
T cd05609 273 H 273 (305)
T ss_pred C
Confidence 4
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-34 Score=306.62 Aligned_cols=253 Identities=23% Similarity=0.346 Sum_probs=196.7
Q ss_pred CCCCCceEeeccCeeEEEEEEcCCCeEEEEEEecccc------chhhHHHHHHHHHHhhcCCCCceeeeeccccccccCC
Q 045798 685 GFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC------EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGN 758 (1008)
Q Consensus 685 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 758 (1008)
+|++.+.||+|+||+||+|... +++.||+|.++... ......+.+|++++++++|+||++++++| .+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~-~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~ 74 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTN-QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTC-----LDD 74 (265)
T ss_pred CccccceEeccCCeEEEEEEEc-CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEe-----ecC
Confidence 4788999999999999999874 78899999986432 12235688999999999999999999995 445
Q ss_pred ceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCe
Q 045798 759 DFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSG 838 (1008)
Q Consensus 759 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 838 (1008)
+..++||||+++++|.+++.... ++++..+..++.|++.|++|||+. +|+|+||+|+||++++++.+
T Consensus 75 ~~~~lv~e~~~~~~L~~~l~~~~----------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~ 141 (265)
T cd06631 75 NTISIFMEFVPGGSISSILNRFG----------PLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGII 141 (265)
T ss_pred CeEEEEEecCCCCcHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeE
Confidence 77999999999999999997543 678899999999999999999998 99999999999999999999
Q ss_pred EEcccCcccccccccCc--cccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHH
Q 045798 839 HIGDFGLARFHQEVSNS--TLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNF 916 (1008)
Q Consensus 839 kL~Dfg~a~~~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~ 916 (1008)
+|+|||.+......... .........++..|+|||++.+..++.++|||||||++|+|++|+.||...... ...
T Consensus 142 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~----~~~ 217 (265)
T cd06631 142 KLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRL----AAM 217 (265)
T ss_pred EeccchhhHhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChH----HHH
Confidence 99999999754321111 111112345889999999999888999999999999999999999998642110 000
Q ss_pred HHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 917 ARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 917 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
........ . .+. .....+.++.+++.+||+.+|.+||++.|+++
T Consensus 218 ~~~~~~~~---~-~~~----------------------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 218 FYIGAHRG---L-MPR----------------------LPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred HHhhhccC---C-CCC----------------------CCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00000000 0 000 00123456789999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=313.67 Aligned_cols=277 Identities=23% Similarity=0.288 Sum_probs=199.2
Q ss_pred cCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEecccc--chhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceE
Q 045798 684 NGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC--EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFK 761 (1008)
Q Consensus 684 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 761 (1008)
++|++.+.||+|+||.||+|.+..+++.||+|++.... ....+.+.+|+++++.++||||+++++++ ..++..
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~ 75 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVF-----RRKKRL 75 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhc-----ccCCeE
Confidence 46889999999999999999998889999999986432 22356788999999999999999999994 566779
Q ss_pred EEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEc
Q 045798 762 AIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIG 841 (1008)
Q Consensus 762 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 841 (1008)
++||||+++++|..+..... .+++.++..++.|++.|++|||+. +++||||+|+||++++++.++|+
T Consensus 76 ~lv~e~~~~~~l~~~~~~~~----------~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~ 142 (286)
T cd07846 76 YLVFEFVDHTVLDDLEKYPN----------GLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLC 142 (286)
T ss_pred EEEEecCCccHHHHHHhccC----------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEE
Confidence 99999999999988765432 588999999999999999999997 99999999999999999999999
Q ss_pred ccCcccccccccCccccccccccccccccCccccCC-CCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHh-
Q 045798 842 DFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLG-SEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARM- 919 (1008)
Q Consensus 842 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~- 919 (1008)
|||++......... .....++..|+|||++.+ ..++.++||||||+++|||++|++||...... .........
T Consensus 143 dfg~~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~-~~~~~~~~~~ 217 (286)
T cd07846 143 DFGFARTLAAPGEV----YTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDI-DQLYHIIKCL 217 (286)
T ss_pred eeeeeeeccCCccc----cCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchH-HHHHHHHHHh
Confidence 99999765432211 122457899999998765 34788999999999999999999988532111 000111000
Q ss_pred -hCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 920 -ALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 920 -~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
..........+..-........... ............+..+.+++.+||+.+|++||++.++++
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 218 GNLIPRHQEIFQKNPLFAGMRLPEVK---EIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred CCCchhhHHHhccchHhhcccccccc---CcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 0000000000000000000000000 000000001134567899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=347.29 Aligned_cols=257 Identities=27% Similarity=0.324 Sum_probs=205.1
Q ss_pred HhcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccc--hhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCc
Q 045798 682 ATNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCE--GASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGND 759 (1008)
Q Consensus 682 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 759 (1008)
.+-+++....||.|.||.||-|....+|+..|+|.++.+.. ...+...+|..++..++|||+|+++|+ ..+.+
T Consensus 1233 V~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGV-----EvHRe 1307 (1509)
T KOG4645|consen 1233 VTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGV-----EVHRE 1307 (1509)
T ss_pred ceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCce-----eecHH
Confidence 34567778899999999999999999999999999875533 334678899999999999999999999 56677
Q ss_pred eEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeE
Q 045798 760 FKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGH 839 (1008)
Q Consensus 760 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 839 (1008)
..+|.||||++|+|.+.+...+ -.++.....+..|++.|++|||++ |||||||||.||+++.+|.+|
T Consensus 1308 kv~IFMEyC~~GsLa~ll~~gr----------i~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK 1374 (1509)
T KOG4645|consen 1308 KVYIFMEYCEGGSLASLLEHGR----------IEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIK 1374 (1509)
T ss_pred HHHHHHHHhccCcHHHHHHhcc----------hhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEE
Confidence 7899999999999999997664 467777788999999999999998 999999999999999999999
Q ss_pred EcccCcccccccccCccccccccccccccccCccccCCC---CCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHH
Q 045798 840 IGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGS---EVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNF 916 (1008)
Q Consensus 840 L~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~ 916 (1008)
++|||.|..+..........-....||+.|||||++.+. .-..++||||+|||+.||+||++||.....+..-.-+.
T Consensus 1375 ~~DFGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V 1454 (1509)
T KOG4645|consen 1375 YGDFGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHV 1454 (1509)
T ss_pred eecccceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHH
Confidence 999999998766542222333456799999999998764 35678999999999999999999986432221111111
Q ss_pred HHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 045798 917 ARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHE 987 (1008)
Q Consensus 917 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 987 (1008)
+... .++++.. .+.+=.+++..|+..||++|.++.|+++.
T Consensus 1455 ~~gh-----------------------------~Pq~P~~--ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1455 AAGH-----------------------------KPQIPER--LSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred hccC-----------------------------CCCCchh--hhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 1111 1222222 33444789999999999999999877653
|
|
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-34 Score=305.62 Aligned_cols=248 Identities=27% Similarity=0.355 Sum_probs=198.1
Q ss_pred CCCCCceEeeccCeeEEEEEEcCCCeEEEEEEecccc-----chhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCc
Q 045798 685 GFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC-----EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGND 759 (1008)
Q Consensus 685 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 759 (1008)
+|+..+.||+|+||.||+|....+++.||+|++.... ....+.+.+|++++++++|+||+++++++ ..+.
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~ 75 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTE-----REED 75 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeE-----ecCC
Confidence 4778899999999999999998889999999986433 23456789999999999999999999984 4556
Q ss_pred eEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeE
Q 045798 760 FKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGH 839 (1008)
Q Consensus 760 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 839 (1008)
..++|+||+++++|.+++.... .+++..+..++.|++.|++|||+. +++|+||+|+||+++.++.+|
T Consensus 76 ~~~lv~e~~~~~~L~~~~~~~~----------~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~k 142 (258)
T cd06632 76 NLYIFLELVPGGSLAKLLKKYG----------SFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVK 142 (258)
T ss_pred eEEEEEEecCCCcHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEE
Confidence 7899999999999999997543 578999999999999999999998 999999999999999999999
Q ss_pred EcccCcccccccccCccccccccccccccccCccccCCCC-CCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHH
Q 045798 840 IGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSE-VSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFAR 918 (1008)
Q Consensus 840 L~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~ 918 (1008)
|+|||.+....... ......++..|+|||.+.... ++.++|+|||||++|+|++|+.||......+ ....
T Consensus 143 l~d~~~~~~~~~~~-----~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~----~~~~ 213 (258)
T cd06632 143 LADFGMAKQVVEFS-----FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVA----AVFK 213 (258)
T ss_pred EccCccceeccccc-----cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHH----HHHH
Confidence 99999987654332 112345889999999987766 8999999999999999999999986432100 0000
Q ss_pred hhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 919 MALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 919 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
...... . +.. .......+.+++.+||+.+|.+||++.+++.
T Consensus 214 ~~~~~~--------~-----------------~~~--~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 214 IGRSKE--------L-----------------PPI--PDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred HHhccc--------C-----------------CCc--CCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 000000 0 000 0123456789999999999999999999975
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=315.61 Aligned_cols=269 Identities=24% Similarity=0.408 Sum_probs=203.7
Q ss_pred cCCCCCceEeeccCeeEEEEEEcC-------CCeEEEEEEecccc-chhhHHHHHHHHHHhhc-CCCCceeeeecccccc
Q 045798 684 NGFSSTHLIGVGSFGCVYKGALDE-------DGIVVAIKVINLQC-EGASKSFMAECKALKNI-RHRNLVKVITSCSSID 754 (1008)
Q Consensus 684 ~~y~~~~~lg~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~ 754 (1008)
.+|++.+.||+|+||.||+|.+.. .+..||+|+++... ....+.+.+|+++++++ +||||++++++|
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~---- 87 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGAC---- 87 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEE----
Confidence 468999999999999999998632 22478999887543 33456899999999999 899999999985
Q ss_pred ccCCceEEEEEeccCCCChhcccccCCCCCCC------cccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCC
Q 045798 755 FQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRD------KEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPS 828 (1008)
Q Consensus 755 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~------~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~ 828 (1008)
..++..++||||+++|+|.+++......... ......+++.++..++.|++.||+|||+. +++||||||+
T Consensus 88 -~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~ 163 (334)
T cd05100 88 -TQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAAR 163 (334)
T ss_pred -ccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---Ceeccccccc
Confidence 3456689999999999999999764321100 01123688999999999999999999997 9999999999
Q ss_pred CeeecCCCCeEEcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCccc
Q 045798 829 NILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT-AKKPTDVMF 907 (1008)
Q Consensus 829 NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-G~~pf~~~~ 907 (1008)
||++++++.+||+|||.++......... ......++..|+|||++.+..++.++|||||||++|||++ |..||....
T Consensus 164 Nill~~~~~~kL~Dfg~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~ 241 (334)
T cd05100 164 NVLVTEDNVMKIADFGLARDVHNIDYYK--KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP 241 (334)
T ss_pred eEEEcCCCcEEECCcccceecccccccc--cccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCC
Confidence 9999999999999999998654322111 1112234568999999999899999999999999999998 888875321
Q ss_pred cCCccHHHHHHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 045798 908 EGDLNLHNFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHE 987 (1008)
Q Consensus 908 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 987 (1008)
............ . .. ....++.++.+++.+||+.+|++|||+.|+++.
T Consensus 242 -----~~~~~~~~~~~~---------~----------------~~--~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~ 289 (334)
T cd05100 242 -----VEELFKLLKEGH---------R----------------MD--KPANCTHELYMIMRECWHAVPSQRPTFKQLVED 289 (334)
T ss_pred -----HHHHHHHHHcCC---------C----------------CC--CCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 111111000000 0 00 001234568899999999999999999999999
Q ss_pred HHHHHHH
Q 045798 988 LQSVKNI 994 (1008)
Q Consensus 988 L~~i~~~ 994 (1008)
|+++...
T Consensus 290 l~~~~~~ 296 (334)
T cd05100 290 LDRVLTV 296 (334)
T ss_pred HHHHhhh
Confidence 9988743
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-34 Score=304.65 Aligned_cols=247 Identities=30% Similarity=0.421 Sum_probs=192.7
Q ss_pred ceEeeccCeeEEEEEEcCCCeEEEEEEeccccc-hhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceEEEEEecc
Q 045798 690 HLIGVGSFGCVYKGALDEDGIVVAIKVINLQCE-GASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKAIVYEYM 768 (1008)
Q Consensus 690 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 768 (1008)
++||+|+||.||+|... +++.||+|+++.... .....+.+|++++++++||||++++++| ...+..++||||+
T Consensus 1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~lv~e~~ 74 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC-----TQRQPIYIVMELV 74 (250)
T ss_pred CccCCCCCceEEEEEec-CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEE-----ecCCccEEEEECC
Confidence 46899999999999875 788999999875433 3345789999999999999999999985 3445689999999
Q ss_pred CCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEcccCcccc
Q 045798 769 PNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARF 848 (1008)
Q Consensus 769 ~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~ 848 (1008)
++++|.+++..... .+++..+..++.|++.||.|+|+. +++||||||+||+++.++.+||+|||++..
T Consensus 75 ~~~~L~~~~~~~~~---------~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~ 142 (250)
T cd05085 75 PGGDFLSFLRKKKD---------ELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQ 142 (250)
T ss_pred CCCcHHHHHHhcCC---------CCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCcccee
Confidence 99999999865431 578999999999999999999997 999999999999999999999999999975
Q ss_pred cccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCccccCCccHHHHHHhhCCcchhh
Q 045798 849 HQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT-AKKPTDVMFEGDLNLHNFARMALPNQVMD 927 (1008)
Q Consensus 849 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 927 (1008)
....... ......++..|+|||++.+..++.++||||||+++|++++ |..||....... ......
T Consensus 143 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~--~~~~~~--------- 208 (250)
T cd05085 143 EDDGIYS---SSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQ--AREQVE--------- 208 (250)
T ss_pred ccccccc---cCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHH--HHHHHH---------
Confidence 4322111 1111234678999999988889999999999999999998 999985321110 000000
Q ss_pred hhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHHH
Q 045798 928 IVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHELQ 989 (1008)
Q Consensus 928 ~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 989 (1008)
.... . .....++..+.+++.+||+.+|++||++.|++++|.
T Consensus 209 ---~~~~--------------~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 209 ---KGYR--------------M----SCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred ---cCCC--------------C----CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 0000 0 000123456899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-34 Score=304.69 Aligned_cols=251 Identities=25% Similarity=0.434 Sum_probs=196.9
Q ss_pred cCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccchhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceEEE
Q 045798 684 NGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKAI 763 (1008)
Q Consensus 684 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 763 (1008)
.+|++.+.||+|+||.||+|.+. +++.+|+|+++.. ......+.+|++++++++||+++++++++ ......++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~~ 76 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREG-AMSEEDFIEEAQVMMKLSHPKLVQLYGVC-----TERSPICL 76 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCC-CCCHHHHHHHHHHHHhCCCCCeeeEEEEE-----ccCCceEE
Confidence 46888999999999999999885 5778999988643 23346789999999999999999999984 45567899
Q ss_pred EEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEccc
Q 045798 764 VYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDF 843 (1008)
Q Consensus 764 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 843 (1008)
||||+++++|.+++..... .+++..++.++.|++.|++|||+. +++||||||+||+++.++.+||+||
T Consensus 77 v~e~~~~~~L~~~~~~~~~---------~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~ 144 (256)
T cd05112 77 VFEFMEHGCLSDYLRAQRG---------KFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDF 144 (256)
T ss_pred EEEcCCCCcHHHHHHhCcc---------CCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCC
Confidence 9999999999999865431 578999999999999999999998 9999999999999999999999999
Q ss_pred CcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCccccCCccHHHHHHhhCC
Q 045798 844 GLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT-AKKPTDVMFEGDLNLHNFARMALP 922 (1008)
Q Consensus 844 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-G~~pf~~~~~~~~~~~~~~~~~~~ 922 (1008)
|.+......... ......++.+|+|||++.+..++.++||||||+++|||++ |..||...... ......
T Consensus 145 g~~~~~~~~~~~---~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~-----~~~~~~-- 214 (256)
T cd05112 145 GMTRFVLDDQYT---SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS-----EVVETI-- 214 (256)
T ss_pred cceeecccCccc---ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHH-----HHHHHH--
Confidence 999755332111 1112235678999999988889999999999999999998 89998632110 011000
Q ss_pred cchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHH
Q 045798 923 NQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHEL 988 (1008)
Q Consensus 923 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 988 (1008)
...... ..+ ...+..+.+++.+||+.+|++|||+.|+++.|
T Consensus 215 -------~~~~~~-------------~~~-----~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 215 -------NAGFRL-------------YKP-----RLASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred -------hCCCCC-------------CCC-----CCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 000000 000 01235689999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=306.49 Aligned_cols=247 Identities=28% Similarity=0.468 Sum_probs=195.5
Q ss_pred cCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccchhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceEEE
Q 045798 684 NGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKAI 763 (1008)
Q Consensus 684 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 763 (1008)
++|++.+.||+|+||.||+|.. +++.||+|+++.. ...+.+.+|+.++++++|||++++++++.. +..++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~------~~~~~ 75 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCD--VTAQAFLEETAVMTKLHHKNLVRLLGVILH------NGLYI 75 (254)
T ss_pred HHceeeeeeccCCCCceEeccc--CCCceEEEeecCc--chHHHHHHHHHHHHhCCCCCcCeEEEEEcC------CCcEE
Confidence 4688999999999999999975 6888999998643 234678999999999999999999998532 23689
Q ss_pred EEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEccc
Q 045798 764 VYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDF 843 (1008)
Q Consensus 764 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 843 (1008)
||||+++++|.+++...... .+++..+..++.|++.|++|||+. +++||||||+||+++.++.+||+||
T Consensus 76 v~e~~~~~~L~~~l~~~~~~--------~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Df 144 (254)
T cd05083 76 VMELMSKGNLVNFLRTRGRA--------LVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDF 144 (254)
T ss_pred EEECCCCCCHHHHHHhcCcC--------CCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCC
Confidence 99999999999999754321 578999999999999999999997 9999999999999999999999999
Q ss_pred CcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCccccCCccHHHHHHhhCC
Q 045798 844 GLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT-AKKPTDVMFEGDLNLHNFARMALP 922 (1008)
Q Consensus 844 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-G~~pf~~~~~~~~~~~~~~~~~~~ 922 (1008)
|.+........ ....+..|+|||++.+..++.++|||||||++|||++ |+.||...... ...
T Consensus 145 g~~~~~~~~~~-------~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~-----~~~----- 207 (254)
T cd05083 145 GLARVGSMGVD-------NSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLK-----EVK----- 207 (254)
T ss_pred ccceeccccCC-------CCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHH-----HHH-----
Confidence 99975432211 1224578999999988899999999999999999998 89998532110 000
Q ss_pred cchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHHHH
Q 045798 923 NQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHELQS 990 (1008)
Q Consensus 923 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 990 (1008)
..+.... ++. ....++..+.+++.+||+.+|++||+++++++.|+.
T Consensus 208 ----~~~~~~~--------------~~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 208 ----ECVEKGY--------------RME----PPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred ----HHHhCCC--------------CCC----CCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 0000000 000 011245668899999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=311.51 Aligned_cols=251 Identities=24% Similarity=0.276 Sum_probs=202.0
Q ss_pred cCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccchhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceEEE
Q 045798 684 NGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKAI 763 (1008)
Q Consensus 684 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 763 (1008)
++|.+.+.||+|+||.||+|....+++.||+|.+........+.+.+|+.++++++||||+++++.+ ..++..++
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~-----~~~~~~~l 93 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSY-----LVGDELWV 93 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhhee-----eeCCcEEE
Confidence 6799999999999999999998888999999998765555567889999999999999999999985 44567899
Q ss_pred EEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEccc
Q 045798 764 VYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDF 843 (1008)
Q Consensus 764 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 843 (1008)
|+||+++++|.+++... .+++.++..++.|++.|++|||++ +++||||+|+||+++.++.+||+||
T Consensus 94 v~e~~~~~~L~~~~~~~-----------~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~df 159 (293)
T cd06647 94 VMEYLAGGSLTDVVTET-----------CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDF 159 (293)
T ss_pred EEecCCCCcHHHHHhhc-----------CCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccC
Confidence 99999999999998643 578889999999999999999998 9999999999999999999999999
Q ss_pred CcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCc
Q 045798 844 GLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMALPN 923 (1008)
Q Consensus 844 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~~~~~ 923 (1008)
|.+......... .....+++.|+|||.+.+..++.++|||||||++|++++|+.||.......... .... ..
T Consensus 160 g~~~~~~~~~~~----~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~-~~~~--~~- 231 (293)
T cd06647 160 GFCAQITPEQSK----RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-LIAT--NG- 231 (293)
T ss_pred cceecccccccc----cccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhee-ehhc--CC-
Confidence 998755433221 122358889999999988889999999999999999999999986431111000 0000 00
Q ss_pred chhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 045798 924 QVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHE 987 (1008)
Q Consensus 924 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 987 (1008)
.+........+..+.+++.+||+.+|++||++.+++..
T Consensus 232 --------------------------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 232 --------------------------TPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred --------------------------CCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000111234567899999999999999999999875
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=301.36 Aligned_cols=248 Identities=26% Similarity=0.311 Sum_probs=201.8
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccc---cchhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCc
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQ---CEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGND 759 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 759 (1008)
.+.|+.-++||+||||.||-++.+.+|+.||.|.+... .........+|-+++.+++.+.||.+-.+ ++..+
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYA-----feTkd 258 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYA-----FETKD 258 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeee-----ecCCC
Confidence 35678889999999999999999999999999988532 23344567899999999999999998877 67888
Q ss_pred eEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeE
Q 045798 760 FKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGH 839 (1008)
Q Consensus 760 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 839 (1008)
..|+|+..|.||+|.-+|.+.+.+ .+++..++.++.+|+.||++||.+ +||.||+||+|||+|+.|+++
T Consensus 259 ~LClVLtlMNGGDLkfHiyn~g~~--------gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvR 327 (591)
T KOG0986|consen 259 ALCLVLTLMNGGDLKFHIYNHGNP--------GFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVR 327 (591)
T ss_pred ceEEEEEeecCCceeEEeeccCCC--------CCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeE
Confidence 899999999999999999988764 689999999999999999999998 999999999999999999999
Q ss_pred EcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHh
Q 045798 840 IGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARM 919 (1008)
Q Consensus 840 L~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~ 919 (1008)
|+|+|+|..+...... ...+||.+|||||++.+..|+...|.||+||++|||+.|+.||....+..
T Consensus 328 ISDLGLAvei~~g~~~-----~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKv--------- 393 (591)
T KOG0986|consen 328 ISDLGLAVEIPEGKPI-----RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKV--------- 393 (591)
T ss_pred eeccceEEecCCCCcc-----ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhh---------
Confidence 9999999977554322 23479999999999999999999999999999999999999986432211
Q ss_pred hCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCC
Q 045798 920 ALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMN 980 (1008)
Q Consensus 920 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt 980 (1008)
-.+-+|++...+++.. ....+++..++....+..||.+|..
T Consensus 394 -----k~eEvdrr~~~~~~ey---------------~~kFS~eakslc~~LL~Kdp~~RLG 434 (591)
T KOG0986|consen 394 -----KREEVDRRTLEDPEEY---------------SDKFSEEAKSLCEGLLTKDPEKRLG 434 (591)
T ss_pred -----hHHHHHHHHhcchhhc---------------ccccCHHHHHHHHHHHccCHHHhcc
Confidence 1112333333222211 1234455677778888888888863
|
|
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=308.63 Aligned_cols=255 Identities=25% Similarity=0.350 Sum_probs=202.7
Q ss_pred cCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEecccc-chhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceEE
Q 045798 684 NGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC-EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKA 762 (1008)
Q Consensus 684 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 762 (1008)
++|+..+.||+|+||.||+|.+..+++.||+|++.... ....+.+.+|+++++++.||||+++++.+ ..+...+
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~~ 75 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAF-----YNNGDIS 75 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheee-----ecCCEEE
Confidence 46788899999999999999998889999999987553 34456789999999999999999999985 4457799
Q ss_pred EEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhh-CCCCCceeccCCCCCeeecCCCCeEEc
Q 045798 763 IVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHH-HCQEPILHCDLKPSNILLDNDLSGHIG 841 (1008)
Q Consensus 763 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kL~ 841 (1008)
+|+||+++++|.+++.... ..+++..+..++.|++.|++|||+ . +++||||||+||++++++.++|+
T Consensus 76 lv~e~~~~~~L~~~~~~~~---------~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~ 143 (265)
T cd06605 76 ICMEYMDGGSLDKILKEVQ---------GRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLC 143 (265)
T ss_pred EEEEecCCCcHHHHHHHcc---------CCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEe
Confidence 9999999999999987653 168899999999999999999999 7 99999999999999999999999
Q ss_pred ccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHhhC
Q 045798 842 DFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMAL 921 (1008)
Q Consensus 842 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~~~ 921 (1008)
|||.+......... ...++..|+|||.+.+..++.++||||||+++|+|++|+.||...............
T Consensus 144 d~g~~~~~~~~~~~------~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~--- 214 (265)
T cd06605 144 DFGVSGQLVNSLAK------TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQ--- 214 (265)
T ss_pred ecccchhhHHHHhh------cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHH---
Confidence 99998755332111 145788999999999889999999999999999999999998644221111111111
Q ss_pred CcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 045798 922 PNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHE 987 (1008)
Q Consensus 922 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 987 (1008)
....... +.. .....+.++.+++.+||..||++|||+.|++..
T Consensus 215 ---------~~~~~~~-------------~~~-~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 215 ---------YIVNEPP-------------PRL-PSGKFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred ---------HHhcCCC-------------CCC-ChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 1000000 000 011145668999999999999999999999753
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=305.56 Aligned_cols=257 Identities=24% Similarity=0.321 Sum_probs=186.2
Q ss_pred ceEeeccCeeEEEEEEcC--CCeEEEEEEecccc-chhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceEEEEEe
Q 045798 690 HLIGVGSFGCVYKGALDE--DGIVVAIKVINLQC-EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKAIVYE 766 (1008)
Q Consensus 690 ~~lg~G~~g~Vy~~~~~~--~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 766 (1008)
+.||+|+||.||+|.... ....+|+|.+.... ......+.+|+.+++.++|+||+++++.| ......++|||
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~-----~~~~~~~lv~e 75 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQC-----IESIPYLLVLE 75 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEE-----CCCCceEEEEE
Confidence 358999999999997532 34578899876443 23346788999999999999999999985 44566899999
Q ss_pred ccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEcccCcc
Q 045798 767 YMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLA 846 (1008)
Q Consensus 767 ~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a 846 (1008)
|+++|+|.+++....... ....++..+..++.||+.|++|||+. +|+||||||+||++++++.+||+|||++
T Consensus 76 ~~~~g~L~~~l~~~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~ 147 (269)
T cd05042 76 FCPLGDLKNYLRSNRGMV-----AQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLA 147 (269)
T ss_pred eCCCCcHHHHHHhccccc-----cccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccc
Confidence 999999999997654211 01356788899999999999999998 9999999999999999999999999998
Q ss_pred cccccccCccccccccccccccccCccccC-------CCCCCcccchhhHHHHHHHHHh-CCCCCCccccCCccHHHHHH
Q 045798 847 RFHQEVSNSTLSSSVGVKGTIGYTAPEYGL-------GSEVSTNGDVYSYGILLLEMVT-AKKPTDVMFEGDLNLHNFAR 918 (1008)
Q Consensus 847 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~sDvwslG~vl~ellt-G~~pf~~~~~~~~~~~~~~~ 918 (1008)
.......... ......++..|+|||++. ...++.++|||||||++|||++ |..||......+ .......
T Consensus 148 ~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~-~~~~~~~ 224 (269)
T cd05042 148 LEQYPEDYYI--TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ-VLKQVVR 224 (269)
T ss_pred cccccchhee--ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH-HHHHHhh
Confidence 7543221111 112234577899999864 3456889999999999999999 777875321110 0000000
Q ss_pred hhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHHH
Q 045798 919 MALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHELQ 989 (1008)
Q Consensus 919 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 989 (1008)
.....+.++.+ ....+..+.+++..|| .||++|||++||++.|.
T Consensus 225 ----~~~~~~~~~~~----------------------~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 225 ----EQDIKLPKPQL----------------------DLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred ----ccCccCCCCcc----------------------cccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 00000000000 1123455678888999 59999999999999873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=305.78 Aligned_cols=254 Identities=24% Similarity=0.312 Sum_probs=201.5
Q ss_pred CCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccc--cchhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceEE
Q 045798 685 GFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQ--CEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKA 762 (1008)
Q Consensus 685 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 762 (1008)
+|++.+.||.|+||.||+|.+..+++.||+|+++.. .....+.+.+|++++++++|+||+++++++.. ..+...+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~---~~~~~~~ 77 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIID---RSNQTLY 77 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeec---CCCCEEE
Confidence 488899999999999999999889999999998743 23445678899999999999999999987542 3455689
Q ss_pred EEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHh-----hCCCCCceeccCCCCCeeecCCCC
Q 045798 763 IVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLH-----HHCQEPILHCDLKPSNILLDNDLS 837 (1008)
Q Consensus 763 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH-----~~~~~~ivH~Dlkp~NIll~~~~~ 837 (1008)
++|||+++++|.+++...... ..++++..++.++.||+.||+||| +. +++||||+|+||+++.++.
T Consensus 78 ~~~e~~~~~~L~~~l~~~~~~------~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~---~i~h~dl~p~nili~~~~~ 148 (265)
T cd08217 78 IVMEYCEGGDLAQLIQKCKKE------RKYIEEEFIWRILTQLLLALYECHNRSDPGN---TVLHRDLKPANIFLDANNN 148 (265)
T ss_pred EEehhccCCCHHHHHHHHhhc------ccCCCHHHHHHHHHHHHHHHHHHhcCccccC---cceecCCCHHHEEEecCCC
Confidence 999999999999998654211 126899999999999999999999 65 9999999999999999999
Q ss_pred eEEcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHH
Q 045798 838 GHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFA 917 (1008)
Q Consensus 838 ~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~ 917 (1008)
+||+|||.+......... .....++..|+|||++.+..++.++||||||+++|+|++|+.||.... .....
T Consensus 149 ~kl~d~g~~~~~~~~~~~----~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-----~~~~~ 219 (265)
T cd08217 149 VKLGDFGLAKILGHDSSF----AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN-----QLQLA 219 (265)
T ss_pred EEEecccccccccCCccc----ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC-----HHHHH
Confidence 999999999876543321 112358899999999998889999999999999999999999986432 11111
Q ss_pred HhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 918 RMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 918 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
.... ..... . .....+..+.+++.+|++.+|++|||+++|++
T Consensus 220 ~~~~--------~~~~~-----------------~--~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~ 261 (265)
T cd08217 220 SKIK--------EGKFR-----------------R--IPYRYSSELNEVIKSMLNVDPDKRPSTEELLQ 261 (265)
T ss_pred HHHh--------cCCCC-----------------C--CccccCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 1000 00000 0 00123456899999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-34 Score=310.53 Aligned_cols=275 Identities=23% Similarity=0.261 Sum_probs=200.4
Q ss_pred CCCCCceEeeccCeeEEEEEEcCCCeEEEEEEecccc--chhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceEE
Q 045798 685 GFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC--EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKA 762 (1008)
Q Consensus 685 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 762 (1008)
+|++.+.||+|+||.||+|.+..+++.||+|++.... ....+.+.+|+.++++++||||+++++++ ..+...+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~~ 75 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVF-----PHGSGFV 75 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEE-----ecCCeeE
Confidence 5888999999999999999998889999999997543 34456899999999999999999999984 4567799
Q ss_pred EEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEcc
Q 045798 763 IVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGD 842 (1008)
Q Consensus 763 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 842 (1008)
+||||+ +++|.+++..... .+++.+++.++.||+.||+|||+. +++|+||||+||+++.++.++|+|
T Consensus 76 ~v~e~~-~~~L~~~~~~~~~---------~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~d 142 (286)
T cd07832 76 LVMEYM-PSDLSEVLRDEER---------PLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIAD 142 (286)
T ss_pred EEeccc-CCCHHHHHHhcCC---------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEee
Confidence 999999 9999999865431 689999999999999999999998 999999999999999999999999
Q ss_pred cCcccccccccCccccccccccccccccCccccCCC-CCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHhhC
Q 045798 843 FGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGS-EVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMAL 921 (1008)
Q Consensus 843 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~~~ 921 (1008)
||.+......... ......++..|+|||++.+. .++.++||||+|+++|||++|.+||...... ..+........
T Consensus 143 fg~~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~-~~~~~~~~~~~ 218 (286)
T cd07832 143 FGLARLFSEEEPR---LYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDI-EQLAIVFRTLG 218 (286)
T ss_pred eeecccccCCCCC---ccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHH-HHHHHHHHHcC
Confidence 9999866443221 11224588999999998654 4689999999999999999998777532211 11111111000
Q ss_pred CcchhhhhcccccCchHHhh---hhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 922 PNQVMDIVDPILRNDEEILA---STDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 922 ~~~~~~~~d~~l~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
......+ +.+........ .......+. ....+.+..+.+++.+|++.+|.+|||++++++
T Consensus 219 ~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~ 281 (286)
T cd07832 219 TPNEETW--PGLTSLPDYNKITFPESKPIPLE---EIFPDASPEALDLLKGLLVYDPSKRLSAAEALR 281 (286)
T ss_pred CCChHHH--hhccCcchhhcccCCCCCcchHH---HhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 0000000 00000000000 000000000 000123467899999999999999999999975
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-34 Score=303.19 Aligned_cols=248 Identities=29% Similarity=0.430 Sum_probs=194.6
Q ss_pred ceEeeccCeeEEEEEEcCCCeEEEEEEeccccch-hhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceEEEEEecc
Q 045798 690 HLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEG-ASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKAIVYEYM 768 (1008)
Q Consensus 690 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 768 (1008)
++||+|+||.||+|.+.. ++.||+|+++..... ....+.+|+++++++.|+||+++++++ ......++||||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~~v~e~~ 74 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC-----VQKQPIYIVMELV 74 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEE-----ecCCCeEEEEEcC
Confidence 469999999999999975 999999998754333 456899999999999999999999984 4556789999999
Q ss_pred CCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEcccCcccc
Q 045798 769 PNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARF 848 (1008)
Q Consensus 769 ~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~ 848 (1008)
++++|.+++..... .+++..+..++.|++.|++|||++ +++||||+|+||+++.++.+||+|||.+..
T Consensus 75 ~~~~l~~~l~~~~~---------~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~ 142 (251)
T cd05041 75 PGGSLLTFLRKKKN---------RLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRE 142 (251)
T ss_pred CCCcHHHHHHhcCC---------CCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeecccccc
Confidence 99999999865421 578899999999999999999998 999999999999999999999999999985
Q ss_pred cccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCccccCCccHHHHHHhhCCcchhh
Q 045798 849 HQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT-AKKPTDVMFEGDLNLHNFARMALPNQVMD 927 (1008)
Q Consensus 849 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 927 (1008)
........ .......+..|+|||.+.++.++.++|||||||++|||++ |..||...... .......
T Consensus 143 ~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~--~~~~~~~--------- 209 (251)
T cd05041 143 EEGGIYTV--SDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQ--QTRERIE--------- 209 (251)
T ss_pred ccCCccee--ccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHH--HHHHHHh---------
Confidence 54221111 1111224667999999988899999999999999999999 78887533211 0000000
Q ss_pred hhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHHH
Q 045798 928 IVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHELQ 989 (1008)
Q Consensus 928 ~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 989 (1008)
.... .......+.++.+++.+||+.+|.+|||+.|+++.|+
T Consensus 210 ---~~~~------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 210 ---SGYR------------------MPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred ---cCCC------------------CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 0000 0001123456899999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=321.47 Aligned_cols=192 Identities=28% Similarity=0.355 Sum_probs=160.6
Q ss_pred EeeccCeeEEEEEEcCCCeEEEEEEecccc---chhhHHHHHHHHHHhhc---CCCCceeeeeccccccccCCceEEEEE
Q 045798 692 IGVGSFGCVYKGALDEDGIVVAIKVINLQC---EGASKSFMAECKALKNI---RHRNLVKVITSCSSIDFQGNDFKAIVY 765 (1008)
Q Consensus 692 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~~~~~~~~~~~lv~ 765 (1008)
||+|+||+||+|++..+++.||+|++.... ......+..|..++... +||+|++++++ +..++..|+||
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~-----~~~~~~~~lv~ 75 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFS-----FQTDSDLYLVT 75 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEE-----EecCCeEEEEE
Confidence 699999999999998899999999986421 22233455677777665 69999999988 45667799999
Q ss_pred eccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEcccCc
Q 045798 766 EYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGL 845 (1008)
Q Consensus 766 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~ 845 (1008)
||+++|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 76 e~~~~g~L~~~l~~~~----------~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~ 142 (330)
T cd05586 76 DYMSGGELFWHLQKEG----------RFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGL 142 (330)
T ss_pred cCCCCChHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCc
Confidence 9999999999887543 689999999999999999999998 999999999999999999999999999
Q ss_pred ccccccccCccccccccccccccccCccccCCC-CCCcccchhhHHHHHHHHHhCCCCCCc
Q 045798 846 ARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGS-EVSTNGDVYSYGILLLEMVTAKKPTDV 905 (1008)
Q Consensus 846 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltG~~pf~~ 905 (1008)
+......... .....||..|+|||++.+. .++.++||||+||++|||++|+.||..
T Consensus 143 a~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~ 199 (330)
T cd05586 143 SKANLTDNKT----TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYA 199 (330)
T ss_pred CcCCCCCCCC----ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCC
Confidence 8753222111 1234589999999998764 478999999999999999999999864
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=286.15 Aligned_cols=258 Identities=21% Similarity=0.229 Sum_probs=205.4
Q ss_pred HhcCCCCC-ceEeeccCeeEEEEEEcCCCeEEEEEEeccccchhhHHHHHHHHHHhhc-CCCCceeeeeccccccccCCc
Q 045798 682 ATNGFSST-HLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNI-RHRNLVKVITSCSSIDFQGND 759 (1008)
Q Consensus 682 ~~~~y~~~-~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~ 759 (1008)
.+++|++. ++||-|-.|.|..+..+.+++.+|+|++... ...++|++..-.. .|||||.+++++.- .+.+..
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeN-s~~~rk 132 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYEN-SYQGRK 132 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhh-hccCce
Confidence 35666664 5799999999999999999999999998633 4567788766555 79999999999754 356677
Q ss_pred eEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecC---CC
Q 045798 760 FKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDN---DL 836 (1008)
Q Consensus 760 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~ 836 (1008)
...+|||.|+||.|...++.++.. .+++.++-.|++||+.|+.|||+. +|.||||||+|+|.+. +.
T Consensus 133 cLLiVmE~meGGeLfsriq~~g~~--------afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na 201 (400)
T KOG0604|consen 133 CLLIVMECMEGGELFSRIQDRGDQ--------AFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNA 201 (400)
T ss_pred eeEeeeecccchHHHHHHHHcccc--------cchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCc
Confidence 889999999999999999887643 799999999999999999999998 9999999999999964 45
Q ss_pred CeEEcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHH
Q 045798 837 SGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNF 916 (1008)
Q Consensus 837 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~ 916 (1008)
.+||+|||+|+....... ....+.|+.|.|||++....|+..+|+||+||++|-|++|.+||.......
T Consensus 202 ~lKLtDfGFAK~t~~~~~-----L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~a------ 270 (400)
T KOG0604|consen 202 PLKLTDFGFAKETQEPGD-----LMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA------ 270 (400)
T ss_pred ceEecccccccccCCCcc-----ccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCcc------
Confidence 689999999986543222 223457999999999999999999999999999999999999998653311
Q ss_pred HHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 917 ARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 917 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
+++....-+. . ..+.-+.+.+...+++..++|+..++.+|.+|.|+.|++.
T Consensus 271 ----ispgMk~rI~---~------------gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~ 321 (400)
T KOG0604|consen 271 ----ISPGMKRRIR---T------------GQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD 321 (400)
T ss_pred ----CChhHHhHhh---c------------cCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence 1111111110 0 0111123345677888899999999999999999999986
|
|
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=302.11 Aligned_cols=249 Identities=24% Similarity=0.372 Sum_probs=198.5
Q ss_pred CCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccc--cchhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceEE
Q 045798 685 GFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQ--CEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKA 762 (1008)
Q Consensus 685 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 762 (1008)
+|+..+.||+|+||.||+|....+++.||+|++... .......+.+|++++++++|||++++++. +..++..+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~-----~~~~~~~~ 75 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYEN-----FLEDKALM 75 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeee-----EecCCEEE
Confidence 588899999999999999999889999999998643 23445679999999999999999999988 45567799
Q ss_pred EEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCC-CCeEEc
Q 045798 763 IVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDND-LSGHIG 841 (1008)
Q Consensus 763 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kL~ 841 (1008)
+||||+++++|.+++..... ..+++..+..++.|++.|++|||++ +++||||+|+||+++++ +.+||+
T Consensus 76 lv~e~~~~~~L~~~~~~~~~--------~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~ 144 (256)
T cd08220 76 IVMEYAPGGTLAEYIQKRCN--------SLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIG 144 (256)
T ss_pred EEEecCCCCCHHHHHHHhcc--------cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEc
Confidence 99999999999999975431 1588999999999999999999998 99999999999999865 457999
Q ss_pred ccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHhhC
Q 045798 842 DFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMAL 921 (1008)
Q Consensus 842 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~~~ 921 (1008)
|||.+........ .....++..|+|||.+.+..++.++||||||+++|+|++|+.||...... ......
T Consensus 145 d~~~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~-----~~~~~~- 213 (256)
T cd08220 145 DFGISKILSSKSK-----AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLP-----ALVLKI- 213 (256)
T ss_pred cCCCceecCCCcc-----ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchH-----HHHHHH-
Confidence 9999986543321 12245788999999999888999999999999999999999998632110 010000
Q ss_pred CcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 922 PNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 922 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
...... . .....+..+.+++.+||+.+|.+|||+.|++.
T Consensus 214 -------~~~~~~-----------------~--~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 214 -------MSGTFA-----------------P--ISDRYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred -------HhcCCC-----------------C--CCCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 000000 0 00123456789999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=307.18 Aligned_cols=263 Identities=20% Similarity=0.323 Sum_probs=201.3
Q ss_pred cCCCCCceEeeccCeeEEEEEEcC-----CCeEEEEEEeccccch-hhHHHHHHHHHHhhcCCCCceeeeeccccccccC
Q 045798 684 NGFSSTHLIGVGSFGCVYKGALDE-----DGIVVAIKVINLQCEG-ASKSFMAECKALKNIRHRNLVKVITSCSSIDFQG 757 (1008)
Q Consensus 684 ~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 757 (1008)
++|++.+.||+|+||.||+|+.+. +.+.||+|.+...... ..+.+.+|++++++++|+||+++++++ .+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~ 79 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLC-----RE 79 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEE-----CC
Confidence 578899999999999999999743 3467999998754433 457899999999999999999999985 44
Q ss_pred CceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCC
Q 045798 758 NDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLS 837 (1008)
Q Consensus 758 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 837 (1008)
.+..++||||+++|+|.+++......... .....+++..++.++.|++.||+|||+. +|+||||||+||+++.++.
T Consensus 80 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~-~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~ 155 (275)
T cd05046 80 AEPHYMILEYTDLGDLKQFLRATKSKDEK-LKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQRE 155 (275)
T ss_pred CCcceEEEEecCCCcHHHHHHhccccccc-ccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCc
Confidence 56689999999999999999765421111 1112589999999999999999999997 9999999999999999999
Q ss_pred eEEcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCccccCCccHHHH
Q 045798 838 GHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT-AKKPTDVMFEGDLNLHNF 916 (1008)
Q Consensus 838 ~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-G~~pf~~~~~~~~~~~~~ 916 (1008)
++++|||++........ .......++..|+|||.+.+..++.++||||||+++|+|++ |..||...... .....
T Consensus 156 ~~l~~~~~~~~~~~~~~---~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~--~~~~~ 230 (275)
T cd05046 156 VKVSLLSLSKDVYNSEY---YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDE--EVLNR 230 (275)
T ss_pred EEEcccccccccCcccc---cccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchH--HHHHH
Confidence 99999999874432211 11222346788999999888888999999999999999999 77887532111 00000
Q ss_pred HHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHHH
Q 045798 917 ARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHELQ 989 (1008)
Q Consensus 917 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 989 (1008)
.. .... .. .....++..+.+++.+||+.+|.+|||+.|+++.|+
T Consensus 231 ~~-----------~~~~----------------~~--~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 231 LQ-----------AGKL----------------EL--PVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred HH-----------cCCc----------------CC--CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 00 0000 00 001124456899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=334.78 Aligned_cols=261 Identities=28% Similarity=0.355 Sum_probs=193.9
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEecccc-chhhHHHHHHHHHHhhcCCCCceeeeecccccc-------
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC-EGASKSFMAECKALKNIRHRNLVKVITSCSSID------- 754 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------- 754 (1008)
..+|+..+.||+||||.||+++.+-+|+.||||++.... ......+.+|+..+++++|||||+++..+.+..
T Consensus 478 ~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~e 557 (1351)
T KOG1035|consen 478 LNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLE 557 (1351)
T ss_pred hhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccccc
Confidence 456788899999999999999999999999999997553 344567899999999999999999984422110
Q ss_pred ------------------------------------------------cc------------------------------
Q 045798 755 ------------------------------------------------FQ------------------------------ 756 (1008)
Q Consensus 755 ------------------------------------------------~~------------------------------ 756 (1008)
+.
T Consensus 558 i~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e 637 (1351)
T KOG1035|consen 558 IVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSE 637 (1351)
T ss_pred ccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccC
Confidence 00
Q ss_pred -----------------------------CCceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHH
Q 045798 757 -----------------------------GNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVAS 807 (1008)
Q Consensus 757 -----------------------------~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~ 807 (1008)
.....||-||||+...+.++++.+... -.....++++++|++
T Consensus 638 ~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~---------~~~d~~wrLFreIlE 708 (1351)
T KOG1035|consen 638 GSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN---------SQRDEAWRLFREILE 708 (1351)
T ss_pred CccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc---------hhhHHHHHHHHHHHH
Confidence 002357888888887888877665311 146788999999999
Q ss_pred HHHHHhhCCCCCceeccCCCCCeeecCCCCeEEcccCcccccc----c----------ccCccccccccccccccccCcc
Q 045798 808 ALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQ----E----------VSNSTLSSSVGVKGTIGYTAPE 873 (1008)
Q Consensus 808 ~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~----~----------~~~~~~~~~~~~~gt~~y~aPE 873 (1008)
||+|+|++ |||||||||.||+++++..|||+|||+|.... . .........+..+||.-|+|||
T Consensus 709 GLaYIH~~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPE 785 (1351)
T KOG1035|consen 709 GLAYIHDQ---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPE 785 (1351)
T ss_pred HHHHHHhC---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHH
Confidence 99999998 99999999999999999999999999998622 0 0111111334578999999999
Q ss_pred ccCCCC---CCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCcchhhhhcccccCchHHhhhhhhhhhcc
Q 045798 874 YGLGSE---VSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQ 950 (1008)
Q Consensus 874 ~~~~~~---~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~ 950 (1008)
++.+.. |+.|+|+||+|||++||+. ||....+....+.......+|.. .++.++..
T Consensus 786 ll~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~-~~f~~~~~----------------- 844 (1351)
T KOG1035|consen 786 LLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEP-ADFFDPEH----------------- 844 (1351)
T ss_pred HhcccccccccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCC-cccccccc-----------------
Confidence 987654 9999999999999999995 56644443322222222223322 22222211
Q ss_pred ccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 951 TGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 951 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
+.=.++|+++++.||.+||||.|++.
T Consensus 845 ----------~~e~slI~~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 845 ----------PEEASLIRWLLSHDPSKRPTATELLN 870 (1351)
T ss_pred ----------hHHHHHHHHHhcCCCccCCCHHHHhh
Confidence 11268899999999999999999985
|
|
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=307.86 Aligned_cols=254 Identities=21% Similarity=0.287 Sum_probs=192.2
Q ss_pred cCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEecccc-chhhHHHHHHHHH-HhhcCCCCceeeeeccccccccCCceE
Q 045798 684 NGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC-EGASKSFMAECKA-LKNIRHRNLVKVITSCSSIDFQGNDFK 761 (1008)
Q Consensus 684 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~-l~~l~h~niv~~~~~~~~~~~~~~~~~ 761 (1008)
++|++.+.||+|+||.||+|.+..+|+.||+|+++... ......+..|+.+ ++..+||||+++++++ ..++..
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~-----~~~~~~ 75 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGAL-----FREGDV 75 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEE-----ecCCcE
Confidence 47899999999999999999999899999999987542 2233456666665 5666999999999985 345668
Q ss_pred EEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEc
Q 045798 762 AIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIG 841 (1008)
Q Consensus 762 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 841 (1008)
++||||++ |+|.+++....... ..+++..++.++.||+.|++|||++ .+++||||||+||+++.++.+||+
T Consensus 76 ~lv~e~~~-~~l~~~l~~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~--~~i~h~dlkp~nil~~~~~~~kl~ 146 (283)
T cd06617 76 WICMEVMD-TSLDKFYKKVYDKG------LTIPEDILGKIAVSIVKALEYLHSK--LSVIHRDVKPSNVLINRNGQVKLC 146 (283)
T ss_pred EEEhhhhc-ccHHHHHHHhccCC------CCCCHHHHHHHHHHHHHHHHHHhhc--CCeecCCCCHHHEEECCCCCEEEe
Confidence 99999995 78888876432111 2689999999999999999999984 389999999999999999999999
Q ss_pred ccCcccccccccCccccccccccccccccCccccCC----CCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHH
Q 045798 842 DFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLG----SEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFA 917 (1008)
Q Consensus 842 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~ 917 (1008)
|||.+........ .....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||..............
T Consensus 147 dfg~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~ 221 (283)
T cd06617 147 DFGISGYLVDSVA-----KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVV 221 (283)
T ss_pred ecccccccccccc-----cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHH
Confidence 9999986533211 112347889999998765 4568899999999999999999999863211100000000
Q ss_pred HhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 918 RMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 918 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
... .+. . .....+.++.+++.+||+.+|++||+++++++
T Consensus 222 ~~~---------~~~--------------------~-~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 222 EEP---------SPQ--------------------L-PAEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred hcC---------CCC--------------------C-CccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000 000 0 00123556899999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-34 Score=311.64 Aligned_cols=249 Identities=23% Similarity=0.312 Sum_probs=197.0
Q ss_pred CCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccchhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceEEEEE
Q 045798 686 FSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKAIVY 765 (1008)
Q Consensus 686 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 765 (1008)
|.....||+|+||.||+|....+++.||+|++........+.+.+|+.+++.++||||+++++++ ..++..++||
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~-----~~~~~~~iv~ 97 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY-----LVGEELWVLM 97 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhhe-----eeCCeEEEEE
Confidence 33445799999999999999888999999999765555567789999999999999999999984 4567799999
Q ss_pred eccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEcccCc
Q 045798 766 EYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGL 845 (1008)
Q Consensus 766 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~ 845 (1008)
||+++++|.+++... .+++..++.++.|++.||+|||+. +++||||+|+||+++.++.+||+|||+
T Consensus 98 e~~~~~~L~~~~~~~-----------~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~ 163 (297)
T cd06659 98 EFLQGGALTDIVSQT-----------RLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGF 163 (297)
T ss_pred ecCCCCCHHHHHhhc-----------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechh
Confidence 999999999987542 578999999999999999999998 999999999999999999999999999
Q ss_pred ccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCcch
Q 045798 846 ARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMALPNQV 925 (1008)
Q Consensus 846 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~ 925 (1008)
+......... .....++..|+|||++.+..++.++|||||||++|||++|+.||..... ...........
T Consensus 164 ~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~----~~~~~~~~~~~-- 233 (297)
T cd06659 164 CAQISKDVPK----RKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSP----VQAMKRLRDSP-- 233 (297)
T ss_pred Hhhccccccc----ccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHhccC--
Confidence 8754332211 1224588999999999888899999999999999999999999863211 00000000000
Q ss_pred hhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 045798 926 MDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHE 987 (1008)
Q Consensus 926 ~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 987 (1008)
.... ......+..+.+++.+||+.+|++||+++++++.
T Consensus 234 ----~~~~--------------------~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 234 ----PPKL--------------------KNAHKISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred ----CCCc--------------------cccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 0000 0001233457899999999999999999999884
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=311.88 Aligned_cols=210 Identities=28% Similarity=0.388 Sum_probs=171.0
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEecccc--chhhHHHHHHHHHHhhcCCCCceeeeeccccccc---cC
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC--EGASKSFMAECKALKNIRHRNLVKVITSCSSIDF---QG 757 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~---~~ 757 (1008)
.++|++.+.||+|+||.||+|....+++.||||++.... ......+.+|++++++++||||++++++|..... ..
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 457999999999999999999998899999999986432 2223456789999999999999999998765332 23
Q ss_pred CceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCC
Q 045798 758 NDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLS 837 (1008)
Q Consensus 758 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 837 (1008)
....++||||+. +++.+++.... ..+++.+++.++.||+.||+|||++ +++|+||||+||+++.++.
T Consensus 91 ~~~~~lv~e~~~-~~l~~~l~~~~---------~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~ 157 (310)
T cd07865 91 KGSFYLVFEFCE-HDLAGLLSNKN---------VKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGI 157 (310)
T ss_pred CceEEEEEcCCC-cCHHHHHHhcc---------cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCc
Confidence 345799999995 58888875432 1589999999999999999999998 9999999999999999999
Q ss_pred eEEcccCcccccccccCccccccccccccccccCccccCCC-CCCcccchhhHHHHHHHHHhCCCCCCc
Q 045798 838 GHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGS-EVSTNGDVYSYGILLLEMVTAKKPTDV 905 (1008)
Q Consensus 838 ~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltG~~pf~~ 905 (1008)
+||+|||.+..................++..|+|||.+.+. .++.++||||||+++|||++|+.||..
T Consensus 158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~ 226 (310)
T cd07865 158 LKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQG 226 (310)
T ss_pred EEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCC
Confidence 99999999986543322211112234578899999987664 478899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=308.60 Aligned_cols=277 Identities=27% Similarity=0.332 Sum_probs=197.7
Q ss_pred CCCCCceEeeccCeeEEEEEEcCCCeEEEEEEecccc--chhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceEE
Q 045798 685 GFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC--EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKA 762 (1008)
Q Consensus 685 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 762 (1008)
+|+..+.||+|++|.||+|.+..+++.||||+++... ......+.+|++++++++||||+++++++ .+++..+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~~ 75 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVI-----HTENKLY 75 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhc-----ccCCcEE
Confidence 4888999999999999999998899999999987432 22345789999999999999999999984 5567799
Q ss_pred EEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEcc
Q 045798 763 IVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGD 842 (1008)
Q Consensus 763 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 842 (1008)
+||||+. ++|.+++...... .+++..+..++.|++.|++|||+. +++||||+|+||+++.++.+||+|
T Consensus 76 ~v~e~~~-~~l~~~~~~~~~~--------~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~d 143 (284)
T cd07860 76 LVFEFLH-QDLKKFMDASPLS--------GIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLAD 143 (284)
T ss_pred EEeeccc-cCHHHHHHhCCCC--------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEee
Confidence 9999995 6898888654321 689999999999999999999997 999999999999999999999999
Q ss_pred cCcccccccccCccccccccccccccccCccccCCCC-CCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHhhC
Q 045798 843 FGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSE-VSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMAL 921 (1008)
Q Consensus 843 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~~~ 921 (1008)
||.+......... .....++..|+|||++.+.. ++.++|||||||++|||+||+.||....+.+. .........
T Consensus 144 fg~~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~-~~~~~~~~~ 218 (284)
T cd07860 144 FGLARAFGVPVRT----YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ-LFRIFRTLG 218 (284)
T ss_pred ccchhhcccCccc----cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH-HHHHHHHhC
Confidence 9998755332211 11234688999999876644 58899999999999999999999864322111 111111110
Q ss_pred CcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 922 PNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 922 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
... ....+.....++......... ...........+.++.+++.+||+.||++|||++|+++
T Consensus 219 ~~~--~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 219 TPD--EVVWPGVTSLPDYKPSFPKWA-RQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred CCC--hhhhhhhhHHHHHHhhccccc-ccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 000 000000000000000000000 00000000123456789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=309.51 Aligned_cols=245 Identities=26% Similarity=0.325 Sum_probs=198.3
Q ss_pred cCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEecccc---chhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCce
Q 045798 684 NGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC---EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDF 760 (1008)
Q Consensus 684 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 760 (1008)
++|++.+.||+|+||.||+|.+..+++.||+|+++... ....+.+.+|+++++++.||||+++++++ ..++.
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~ 75 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSF-----QDDSN 75 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEE-----EcCCe
Confidence 47899999999999999999998889999999986432 23456789999999999999999999984 55677
Q ss_pred EEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEE
Q 045798 761 KAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHI 840 (1008)
Q Consensus 761 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 840 (1008)
.++||||+++++|.+++.... .+++..+..++.|++.||+|||+. +++||||+|+||+++.++.+||
T Consensus 76 ~~~v~e~~~~~~L~~~~~~~~----------~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl 142 (290)
T cd05580 76 LYLVMEYVPGGELFSHLRKSG----------RFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKI 142 (290)
T ss_pred EEEEEecCCCCCHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEE
Confidence 999999999999999987653 689999999999999999999997 9999999999999999999999
Q ss_pred cccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHhh
Q 045798 841 GDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMA 920 (1008)
Q Consensus 841 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~~ 920 (1008)
+|||++...... .....+++.|+|||.+.+..++.++||||||+++|+|++|+.||..... .......
T Consensus 143 ~dfg~~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~~~- 210 (290)
T cd05580 143 TDFGFAKRVKGR-------TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNP----IQIYEKI- 210 (290)
T ss_pred eeCCCccccCCC-------CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHH-
Confidence 999999865433 1223588999999999888889999999999999999999999863221 0000000
Q ss_pred CCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCC-----CHHHHHH
Q 045798 921 LPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRM-----NMTNVVH 986 (1008)
Q Consensus 921 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~ 986 (1008)
.. ... .++ ...+..+.+++.+||+.||.+|| +++|+++
T Consensus 211 --------~~----~~~----------~~~------~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 211 --------LE----GKV----------RFP------SFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred --------hc----CCc----------cCC------ccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 00 000 000 01245678999999999999999 6666654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=301.76 Aligned_cols=252 Identities=29% Similarity=0.481 Sum_probs=198.6
Q ss_pred CCCCceEeeccCeeEEEEEEcCCC----eEEEEEEeccccch-hhHHHHHHHHHHhhcCCCCceeeeeccccccccCCce
Q 045798 686 FSSTHLIGVGSFGCVYKGALDEDG----IVVAIKVINLQCEG-ASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDF 760 (1008)
Q Consensus 686 y~~~~~lg~G~~g~Vy~~~~~~~~----~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 760 (1008)
+++.+.||.|+||.||+|.+...+ ..||+|+++..... ..+.+.+|++++++++|+||+++++++ ...+.
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~ 75 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVC-----TEEEP 75 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEE-----cCCCe
Confidence 457789999999999999997655 89999999755433 567899999999999999999999985 44467
Q ss_pred EEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEE
Q 045798 761 KAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHI 840 (1008)
Q Consensus 761 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 840 (1008)
.+++|||+++++|.+++...... .+++.++..++.|++.|++|||+. +++||||+|+||+++.++.++|
T Consensus 76 ~~~i~e~~~~~~l~~~~~~~~~~--------~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l 144 (258)
T smart00219 76 LMIVMEYMEGGDLLDYLRKNRPK--------ELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKI 144 (258)
T ss_pred eEEEEeccCCCCHHHHHHhhhhc--------cCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEE
Confidence 99999999999999998764311 289999999999999999999998 9999999999999999999999
Q ss_pred cccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCccccCCccHHHHHHh
Q 045798 841 GDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT-AKKPTDVMFEGDLNLHNFARM 919 (1008)
Q Consensus 841 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-G~~pf~~~~~~~~~~~~~~~~ 919 (1008)
+|||.+........... ....++..|+|||.+.+..++.++||||+|+++|+|++ |..||..... ......
T Consensus 145 ~dfg~~~~~~~~~~~~~---~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~-----~~~~~~ 216 (258)
T smart00219 145 SDFGLSRDLYDDDYYKK---KGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN-----EEVLEY 216 (258)
T ss_pred cccCCceeccccccccc---ccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH-----HHHHHH
Confidence 99999986654422111 11236789999999988889999999999999999998 7788753110 001000
Q ss_pred hCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHH
Q 045798 920 ALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHEL 988 (1008)
Q Consensus 920 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 988 (1008)
. .... .. ......+.++.+++.+|+..||++|||+.|+++.|
T Consensus 217 ~---------~~~~--------------~~----~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 217 L---------KKGY--------------RL----PKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred H---------hcCC--------------CC----CCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 0 0000 00 00012455689999999999999999999998764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=304.23 Aligned_cols=239 Identities=24% Similarity=0.397 Sum_probs=186.9
Q ss_pred ceEeeccCeeEEEEEEcCCC----------eEEEEEEeccccchhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCc
Q 045798 690 HLIGVGSFGCVYKGALDEDG----------IVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGND 759 (1008)
Q Consensus 690 ~~lg~G~~g~Vy~~~~~~~~----------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 759 (1008)
+.||+|+||.||+|.+..++ ..|++|++...... ...+.+|+.++++++||||++++++|.. .
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~ 73 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR------D 73 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec------C
Confidence 46999999999999997655 35888887654333 6789999999999999999999998642 4
Q ss_pred eEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCC---
Q 045798 760 FKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDL--- 836 (1008)
Q Consensus 760 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~--- 836 (1008)
..++||||+++|+|.+++..... .+++..+..++.||+.||+|||+. +|+||||||+||+++.++
T Consensus 74 ~~~lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~ 141 (259)
T cd05037 74 ENIMVEEYVKFGPLDVFLHREKN---------NVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNE 141 (259)
T ss_pred CcEEEEEcCCCCcHHHHHHhhcc---------CCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCcccc
Confidence 46999999999999999976532 578899999999999999999997 999999999999999887
Q ss_pred ----CeEEcccCcccccccccCccccccccccccccccCccccCCC--CCCcccchhhHHHHHHHHHh-CCCCCCccccC
Q 045798 837 ----SGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGS--EVSTNGDVYSYGILLLEMVT-AKKPTDVMFEG 909 (1008)
Q Consensus 837 ----~~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDvwslG~vl~ellt-G~~pf~~~~~~ 909 (1008)
.+||+|||++...... ....++..|+|||++.+. .++.++|||||||++|||++ |..||......
T Consensus 142 ~~~~~~kl~Dfg~a~~~~~~--------~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~ 213 (259)
T cd05037 142 GYVPFIKLSDPGIPITVLSR--------EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSS 213 (259)
T ss_pred CCceeEEeCCCCcccccccc--------cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCch
Confidence 7999999999855331 112367789999998876 78999999999999999999 56676532110
Q ss_pred CccHHHHHHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHHH
Q 045798 910 DLNLHNFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHELQ 989 (1008)
Q Consensus 910 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 989 (1008)
....+.. ... ..+. .....+.+++.+||..+|.+|||+.||++.|+
T Consensus 214 --~~~~~~~-----------~~~---------------~~~~------~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 214 --EKERFYQ-----------DQH---------------RLPM------PDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred --hHHHHHh-----------cCC---------------CCCC------CCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0000000 000 0000 00145789999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=315.35 Aligned_cols=284 Identities=24% Similarity=0.241 Sum_probs=205.4
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccc--cchhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCce
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQ--CEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDF 760 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 760 (1008)
.++|.+.+.||+|+||+||+|.+..+++.||||.++.. .......+.+|+.+++.++|+||+++++++..........
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 46799999999999999999999889999999998743 2333456788999999999999999999866443333356
Q ss_pred EEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEE
Q 045798 761 KAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHI 840 (1008)
Q Consensus 761 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 840 (1008)
.++|+||+ +++|.+++.... ++++..+..++.|++.||.|||+. +++||||||+||+++.++.+||
T Consensus 84 ~~lv~e~~-~~~L~~~~~~~~----------~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL 149 (337)
T cd07858 84 VYIVYELM-DTDLHQIIRSSQ----------TLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKI 149 (337)
T ss_pred EEEEEeCC-CCCHHHHHhcCC----------CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEE
Confidence 89999999 578998886543 689999999999999999999997 9999999999999999999999
Q ss_pred cccCcccccccccCccccccccccccccccCccccCC-CCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHh
Q 045798 841 GDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLG-SEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARM 919 (1008)
Q Consensus 841 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~ 919 (1008)
+|||++......... .....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||..... ..........
T Consensus 150 ~Dfg~~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-~~~~~~~~~~ 224 (337)
T cd07858 150 CDFGLARTTSEKGDF----MTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDY-VHQLKLITEL 224 (337)
T ss_pred CcCccccccCCCccc----ccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCh-HHHHHHHHHH
Confidence 999999865432211 122357889999998765 4688999999999999999999999864211 0111111111
Q ss_pred hCC---cchhhhhcccccCchHHhhhhhhhhhcc-ccc-hhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHH--HHHH
Q 045798 920 ALP---NQVMDIVDPILRNDEEILASTDKCRRMQ-TGI-NSRLECLISMVKIGVACSMESPQDRMNMTNVVHE--LQSV 991 (1008)
Q Consensus 920 ~~~---~~~~~~~d~~l~~~~~~~~~~~~~~~~~-~~~-~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~--L~~i 991 (1008)
..+ .......+..... ........+ ... .....++.++.+++.+||+.+|++|||++|+++. ++.+
T Consensus 225 ~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~ 297 (337)
T cd07858 225 LGSPSEEDLGFIRNEKARR------YIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL 297 (337)
T ss_pred hCCCChHHhhhcCchhhhH------HHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence 000 0000000000000 000000000 000 0112356778999999999999999999999876 5544
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=283.36 Aligned_cols=210 Identities=28% Similarity=0.360 Sum_probs=176.6
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCC----eEEEEEEecccc--chhhHHHHHHHHHHhhcCCCCceeeeecccccccc
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDG----IVVAIKVINLQC--EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQ 756 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~----~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 756 (1008)
...|+.+..||+|.||.||+|....+. +.+|+|.++... .+......+|+..++.++|||++.+..++. .
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl----~ 98 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFL----S 98 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHh----c
Confidence 457999999999999999999664332 379999998553 345677899999999999999999999864 3
Q ss_pred CCceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCC-
Q 045798 757 GNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDND- 835 (1008)
Q Consensus 757 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~- 835 (1008)
.+..+++++||.+. +|...++.+.... ...++...+..|++||+.|+.|||++ =|+|||+||.|||+..+
T Consensus 99 ~d~~v~l~fdYAEh-DL~~II~fHr~~~-----~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdg 169 (438)
T KOG0666|consen 99 HDKKVWLLFDYAEH-DLWHIIKFHRASK-----AKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDG 169 (438)
T ss_pred cCceEEEEehhhhh-hHHHHHHHhccch-----hccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccC
Confidence 36789999999965 9999998776432 23789999999999999999999997 79999999999999877
Q ss_pred ---CCeEEcccCcccccccccCccccccccccccccccCccccCCC-CCCcccchhhHHHHHHHHHhCCCCCCcc
Q 045798 836 ---LSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGS-EVSTNGDVYSYGILLLEMVTAKKPTDVM 906 (1008)
Q Consensus 836 ---~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltG~~pf~~~ 906 (1008)
|.|||+|||+|+.+...-.. ......++-|.+|+|||.+.|. .||++.||||.||++.||+|-++.|...
T Consensus 170 perG~VKIaDlGlaR~~~~plkp-l~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~ 243 (438)
T KOG0666|consen 170 PERGRVKIADLGLARLFNNPLKP-LASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGR 243 (438)
T ss_pred CccCeeEeecccHHHHhhccccc-cccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccch
Confidence 99999999999988765433 2334557789999999998875 6999999999999999999999888653
|
|
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=305.63 Aligned_cols=249 Identities=23% Similarity=0.315 Sum_probs=198.2
Q ss_pred CCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccchhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceEEEE
Q 045798 685 GFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKAIV 764 (1008)
Q Consensus 685 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 764 (1008)
.|...+.||+|++|.||+|....+++.||+|+++.......+.+.+|+.+++.++||||+++++++ ..+++.++|
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~-----~~~~~~~~v 94 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSY-----LVGDELWVV 94 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEE-----EcCCeEEEE
Confidence 355568999999999999999888999999998765455566789999999999999999999984 456778999
Q ss_pred EeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEcccC
Q 045798 765 YEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFG 844 (1008)
Q Consensus 765 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg 844 (1008)
+||+++++|.+++... ++++..+..++.|++.|++|||++ +++||||+|+||+++.++.++|+|||
T Consensus 95 ~e~~~~~~L~~~~~~~-----------~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g 160 (285)
T cd06648 95 MEFLEGGALTDIVTHT-----------RMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFG 160 (285)
T ss_pred EeccCCCCHHHHHHhC-----------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccc
Confidence 9999999999998752 678899999999999999999998 99999999999999999999999999
Q ss_pred cccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCcc
Q 045798 845 LARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMALPNQ 924 (1008)
Q Consensus 845 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~~~~~~ 924 (1008)
.+......... .....|+..|+|||...+..++.++|||||||++|||++|+.||..... ...... ....
T Consensus 161 ~~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~----~~~~~~-~~~~- 230 (285)
T cd06648 161 FCAQVSKEVPR----RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP----LQAMKR-IRDN- 230 (285)
T ss_pred cchhhccCCcc----cccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCH----HHHHHH-HHhc-
Confidence 88754332111 1224588999999999888899999999999999999999999853210 000000 0000
Q ss_pred hhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 925 VMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 925 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
..+.. ......+..+.+++.+||+.+|++|||+.++++
T Consensus 231 ----~~~~~--------------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 231 ----LPPKL--------------------KNLHKVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred ----CCCCC--------------------cccccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 00000 001123456899999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=308.45 Aligned_cols=275 Identities=22% Similarity=0.246 Sum_probs=198.5
Q ss_pred CCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccch-----hhHHHHHHHHHHhhcCCCCceeeeeccccccccCCc
Q 045798 685 GFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEG-----ASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGND 759 (1008)
Q Consensus 685 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 759 (1008)
+|++.+.||+|+||.||+|.+..+++.||+|+++..... ....+..|++++++++|+||+++++++ .+.+
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~ 75 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVF-----GHKS 75 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhhee-----ecCC
Confidence 478889999999999999999888999999999754322 345678899999999999999999995 4467
Q ss_pred eEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeE
Q 045798 760 FKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGH 839 (1008)
Q Consensus 760 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 839 (1008)
..++||||+ +++|.+++..... .+++..++.++.||++||+|||+. +|+||||+|+||+++.++.+|
T Consensus 76 ~~~lv~e~~-~~~L~~~i~~~~~---------~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~ 142 (298)
T cd07841 76 NINLVFEFM-ETDLEKVIKDKSI---------VLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLK 142 (298)
T ss_pred EEEEEEccc-CCCHHHHHhccCC---------CCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEE
Confidence 799999999 9999999975431 589999999999999999999998 999999999999999999999
Q ss_pred EcccCcccccccccCccccccccccccccccCccccCC-CCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHH
Q 045798 840 IGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLG-SEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFAR 918 (1008)
Q Consensus 840 L~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~ 918 (1008)
|+|||++......... .....++..|+|||.+.+ ..++.++|||||||++|||++|.+||...... ........
T Consensus 143 l~dfg~~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~-~~~~~~~~ 217 (298)
T cd07841 143 LADFGLARSFGSPNRK----MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDI-DQLGKIFE 217 (298)
T ss_pred EccceeeeeccCCCcc----ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccH-HHHHHHHH
Confidence 9999999866443211 112346788999998755 45788999999999999999997777532211 11111111
Q ss_pred hhCCcchhhhhcccccCchHHhhhhhhhhhcccc-chhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 045798 919 MALPNQVMDIVDPILRNDEEILASTDKCRRMQTG-INSRLECLISMVKIGVACSMESPQDRMNMTNVVHE 987 (1008)
Q Consensus 919 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 987 (1008)
.........+.+.. . ..... ......... .......+..+.+++.+||+.||++|||++|+++.
T Consensus 218 ~~~~~~~~~~~~~~-~-~~~~~---~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 218 ALGTPTEENWPGVT-S-LPDYV---EFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred HcCCCchhhhhhcc-c-ccccc---cccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 10000000000000 0 00000 000000000 00112345678999999999999999999999873
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=304.88 Aligned_cols=255 Identities=27% Similarity=0.417 Sum_probs=194.6
Q ss_pred ceEeeccCeeEEEEEEcCCC------eEEEEEEecccc-chhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceEE
Q 045798 690 HLIGVGSFGCVYKGALDEDG------IVVAIKVINLQC-EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKA 762 (1008)
Q Consensus 690 ~~lg~G~~g~Vy~~~~~~~~------~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 762 (1008)
+.||+|+||.||+|...... +.||+|.+.... ......+.+|+.+++.++||||++++++| ...+..+
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~ 75 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVC-----LLNEPQY 75 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeee-----cCCCCeE
Confidence 46999999999999985433 689999886442 24456789999999999999999999985 3455689
Q ss_pred EEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCC-----C
Q 045798 763 IVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDL-----S 837 (1008)
Q Consensus 763 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-----~ 837 (1008)
+||||+++++|.+++........ ....+++.+++.++.|++.|++|||+. +++|+||||+||+++.++ .
T Consensus 76 ~v~e~~~~~~L~~~l~~~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~ 149 (269)
T cd05044 76 IIMELMEGGDLLSYLRDARVERF---GPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRV 149 (269)
T ss_pred EEEeccCCCcHHHHHHHhhhccc---CCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcc
Confidence 99999999999999975432110 112578999999999999999999997 999999999999999877 8
Q ss_pred eEEcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCccccCCccHHHH
Q 045798 838 GHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT-AKKPTDVMFEGDLNLHNF 916 (1008)
Q Consensus 838 ~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-G~~pf~~~~~~~~~~~~~ 916 (1008)
++++|||++.......... ......++..|+|||++.++.++.++|||||||++|||++ |..||...... .....
T Consensus 150 ~~l~dfg~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~--~~~~~ 225 (269)
T cd05044 150 VKIGDFGLARDIYKSDYYR--KEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ--EVLQH 225 (269)
T ss_pred eEECCcccccccccccccc--cCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHH--HHHHH
Confidence 9999999997553322111 1122335788999999999999999999999999999998 99998532110 00000
Q ss_pred HHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHHH
Q 045798 917 ARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHELQ 989 (1008)
Q Consensus 917 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 989 (1008)
. +... .+ ......+..+.+++.+||+.+|.+||++++|++.|+
T Consensus 226 ~------------~~~~--------------~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 226 V------------TAGG--------------RL----QKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred H------------hcCC--------------cc----CCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 0 0000 00 001134567899999999999999999999999885
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=305.37 Aligned_cols=249 Identities=27% Similarity=0.374 Sum_probs=197.4
Q ss_pred CCCCCceEeeccCeeEEEEEEcCCCeEEEEEEecccc-chhhHHHHHHHHHHhhcC---CCCceeeeeccccccccCCce
Q 045798 685 GFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC-EGASKSFMAECKALKNIR---HRNLVKVITSCSSIDFQGNDF 760 (1008)
Q Consensus 685 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~~~~ 760 (1008)
.|+..+.||+|+||.||+|.+..+++.||+|+++... ....+.+.+|+.++++++ |||++++++++ ..+..
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~-----~~~~~ 76 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSY-----LKGPR 76 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeee-----eeCCE
Confidence 4778899999999999999998899999999987542 344567889999999996 99999999985 45667
Q ss_pred EEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEE
Q 045798 761 KAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHI 840 (1008)
Q Consensus 761 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 840 (1008)
.++||||+++++|.+++... .+++..++.++.|++.|+.|||+. +++||||+|+||+++.++.++|
T Consensus 77 ~~lv~e~~~~~~L~~~~~~~-----------~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l 142 (277)
T cd06917 77 LWIIMEYAEGGSVRTLMKAG-----------PIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKL 142 (277)
T ss_pred EEEEEecCCCCcHHHHHHcc-----------CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEE
Confidence 89999999999999998643 678999999999999999999997 9999999999999999999999
Q ss_pred cccCcccccccccCccccccccccccccccCccccCCC-CCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHh
Q 045798 841 GDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGS-EVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARM 919 (1008)
Q Consensus 841 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~ 919 (1008)
+|||.+......... .....|+..|+|||.+.++ .++.++|||||||++|+|++|+.||...... ....
T Consensus 143 ~dfg~~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~-----~~~~- 212 (277)
T cd06917 143 CDFGVAALLNQNSSK----RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAF-----RAMM- 212 (277)
T ss_pred ccCCceeecCCCccc----cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChh-----hhhh-
Confidence 999999866543311 1234588999999987654 5688999999999999999999998632110 0000
Q ss_pred hCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 045798 920 ALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHE 987 (1008)
Q Consensus 920 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 987 (1008)
..... ..+.+. ....+.++.+++.+||+.||++||++.|+++.
T Consensus 213 ~~~~~----~~~~~~---------------------~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 213 LIPKS----KPPRLE---------------------DNGYSKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred ccccC----CCCCCC---------------------cccCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 00000 000000 00134568899999999999999999999763
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=302.10 Aligned_cols=253 Identities=26% Similarity=0.370 Sum_probs=204.6
Q ss_pred cCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccc-hhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceEE
Q 045798 684 NGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCE-GASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKA 762 (1008)
Q Consensus 684 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 762 (1008)
++|++.+.||+|++|.||+|.+..+++.||+|++..... .....+.+|++++.+++|+|++++++++ ..++..+
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~ 75 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAF-----YKEGEIS 75 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEE-----ccCCeEE
Confidence 468899999999999999999988899999999876543 4567899999999999999999999984 4557799
Q ss_pred EEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhh-CCCCCceeccCCCCCeeecCCCCeEEc
Q 045798 763 IVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHH-HCQEPILHCDLKPSNILLDNDLSGHIG 841 (1008)
Q Consensus 763 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kL~ 841 (1008)
+||||+++++|.+++.... .+++..+..++.|++.|++|||+ . +++||||+|+||+++.++.++|+
T Consensus 76 lv~e~~~~~~L~~~l~~~~----------~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~ 142 (264)
T cd06623 76 IVLEYMDGGSLADLLKKVG----------KIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIA 142 (264)
T ss_pred EEEEecCCCcHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEc
Confidence 9999999999999997553 78999999999999999999999 7 99999999999999999999999
Q ss_pred ccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHhhC
Q 045798 842 DFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMAL 921 (1008)
Q Consensus 842 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~~~ 921 (1008)
|||.+.......... ....++..|+|||.+.+..++.++||||||+++|+|++|+.||...... ..........
T Consensus 143 df~~~~~~~~~~~~~----~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~--~~~~~~~~~~ 216 (264)
T cd06623 143 DFGISKVLENTLDQC----NTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQP--SFFELMQAIC 216 (264)
T ss_pred cCccceecccCCCcc----cceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccccc--CHHHHHHHHh
Confidence 999998654332221 1234788999999999888999999999999999999999998654220 0111100000
Q ss_pred CcchhhhhcccccCchHHhhhhhhhhhccccchhHHH-HHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 045798 922 PNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLE-CLISMVKIGVACSMESPQDRMNMTNVVHE 987 (1008)
Q Consensus 922 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~li~~cl~~dP~~RPt~~evl~~ 987 (1008)
.... +. .... .+..+.+++.+||..+|++|||+.|+++.
T Consensus 217 ------------~~~~-------------~~--~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 217 ------------DGPP-------------PS--LPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred ------------cCCC-------------CC--CCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 0000 00 0011 45678999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=308.04 Aligned_cols=266 Identities=22% Similarity=0.256 Sum_probs=188.8
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCC---CeEEEEEEeccccchhh-----------HHHHHHHHHHhhcCCCCceeeee
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDED---GIVVAIKVINLQCEGAS-----------KSFMAECKALKNIRHRNLVKVIT 748 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~~~~-----------~~~~~E~~~l~~l~h~niv~~~~ 748 (1008)
.++|++.+.||+|+||.||+|.+..+ +..+|+|+......... .....+...+..+.|++++++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 36899999999999999999998766 66778887543322110 11223344556678999999998
Q ss_pred ccccccccCCceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCC
Q 045798 749 SCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPS 828 (1008)
Q Consensus 749 ~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~ 828 (1008)
++.... ......++++|++ ..++.+.+.... ..++..+..++.|++.||+|||+. +|+||||||+
T Consensus 91 ~~~~~~-~~~~~~~~~~~~~-~~~~~~~~~~~~----------~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~ 155 (294)
T PHA02882 91 CGSFKR-CRMYYRFILLEKL-VENTKEIFKRIK----------CKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPE 155 (294)
T ss_pred eeeEec-CCceEEEEEEehh-ccCHHHHHHhhc----------cCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHH
Confidence 754321 1223467888887 446666654332 356788899999999999999997 9999999999
Q ss_pred CeeecCCCCeEEcccCcccccccccCccc---cccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCc
Q 045798 829 NILLDNDLSGHIGDFGLARFHQEVSNSTL---SSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDV 905 (1008)
Q Consensus 829 NIll~~~~~~kL~Dfg~a~~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~ 905 (1008)
||+++.++.++|+|||+|+.......... .......||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 156 Nill~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~ 235 (294)
T PHA02882 156 NIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKG 235 (294)
T ss_pred HEEEcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCc
Confidence 99999999999999999986643221110 111224599999999999999999999999999999999999999975
Q ss_pred cccCCccHHHHHHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHH
Q 045798 906 MFEGDLNLHNFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVV 985 (1008)
Q Consensus 906 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl 985 (1008)
...... ...... .+++.+...... ....++..+.+++..||+.+|++||++++++
T Consensus 236 ~~~~~~-~~~~~~-------~~~~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~ 290 (294)
T PHA02882 236 FGHNGN-LIHAAK-------CDFIKRLHEGKI-----------------KIKNANKFIYDFIECVTKLSYEEKPDYDALI 290 (294)
T ss_pred cccchH-HHHHhH-------HHHHHHhhhhhh-----------------ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHH
Confidence 421111 111100 011111100000 0112356689999999999999999999999
Q ss_pred HHH
Q 045798 986 HEL 988 (1008)
Q Consensus 986 ~~L 988 (1008)
+.+
T Consensus 291 ~~~ 293 (294)
T PHA02882 291 KIF 293 (294)
T ss_pred Hhh
Confidence 876
|
|
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=303.31 Aligned_cols=255 Identities=24% Similarity=0.392 Sum_probs=196.5
Q ss_pred CCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccc----------hhhHHHHHHHHHHhhcCCCCceeeeecccccc
Q 045798 685 GFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCE----------GASKSFMAECKALKNIRHRNLVKVITSCSSID 754 (1008)
Q Consensus 685 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 754 (1008)
+|.+.+.||+|+||.||+|....+++.||+|.++.... ...+.+.+|+.+++.++|||++++++++
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~---- 77 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFE---- 77 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEe----
Confidence 47788999999999999999988899999998863211 1124678899999999999999999985
Q ss_pred ccCCceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecC
Q 045798 755 FQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDN 834 (1008)
Q Consensus 755 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~ 834 (1008)
...+..++||||+++++|.+++.... .+++..+..++.|++.||.|||+. +++||||+|+||+++.
T Consensus 78 -~~~~~~~lv~e~~~~~~L~~~l~~~~----------~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~ 143 (272)
T cd06629 78 -TTEEYLSIFLEYVPGGSIGSCLRTYG----------RFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDA 143 (272)
T ss_pred -ccCCceEEEEecCCCCcHHHHHhhcc----------CCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcC
Confidence 45567899999999999999987653 688899999999999999999997 9999999999999999
Q ss_pred CCCeEEcccCcccccccccCccccccccccccccccCccccCCCC--CCcccchhhHHHHHHHHHhCCCCCCccccCCcc
Q 045798 835 DLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSE--VSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLN 912 (1008)
Q Consensus 835 ~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~ 912 (1008)
++.++++|||.+.......... ......++..|+|||.+.... ++.++||||||+++||+++|..||.....
T Consensus 144 ~~~~~l~d~~~~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~---- 217 (272)
T cd06629 144 DGICKISDFGISKKSDDIYDND--QNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEA---- 217 (272)
T ss_pred CCeEEEeecccccccccccccc--ccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcch----
Confidence 9999999999997543321111 122345789999999987654 78999999999999999999999853211
Q ss_pred HHHHHHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 913 LHNFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 913 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
......... ...... .+. ....+.+..+.+++.+||+.+|.+|||+++|++
T Consensus 218 ~~~~~~~~~-~~~~~~--------------------~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 218 IAAMFKLGN-KRSAPP--------------------IPP--DVSMNLSPVALDFLNACFTINPDNRPTARELLQ 268 (272)
T ss_pred HHHHHHhhc-cccCCc--------------------CCc--cccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence 111100000 000000 000 001134567899999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=304.51 Aligned_cols=265 Identities=22% Similarity=0.392 Sum_probs=198.5
Q ss_pred CCCCceEeeccCeeEEEEEEcC---CCeEEEEEEecccc--chhhHHHHHHHHHHhhcCCCCceeeeeccccccccC-Cc
Q 045798 686 FSSTHLIGVGSFGCVYKGALDE---DGIVVAIKVINLQC--EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQG-ND 759 (1008)
Q Consensus 686 y~~~~~lg~G~~g~Vy~~~~~~---~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~-~~ 759 (1008)
|.+.+.||+|+||.||+|.+.. +++.||||+++... ....+++.+|++++++++||||+++++++....... ..
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 6678899999999999998643 56899999987542 344567899999999999999999999865322111 12
Q ss_pred eEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeE
Q 045798 760 FKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGH 839 (1008)
Q Consensus 760 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 839 (1008)
..++++||+++|+|.+++........ ...+++..++.++.|++.|++|||+. +|+||||||+||+++.++.+|
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~----~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~k 153 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEE----PFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVC 153 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCC----CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEE
Confidence 35789999999999988754321110 12578899999999999999999997 999999999999999999999
Q ss_pred EcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCccccCCccHHHHHH
Q 045798 840 IGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT-AKKPTDVMFEGDLNLHNFAR 918 (1008)
Q Consensus 840 L~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-G~~pf~~~~~~~~~~~~~~~ 918 (1008)
++|||.++......... ......++..|++||.+.+..++.++|||||||++|||++ |+.||...... .......
T Consensus 154 l~dfg~~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~--~~~~~~~ 229 (273)
T cd05074 154 VADFGLSKKIYSGDYYR--QGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENS--EIYNYLI 229 (273)
T ss_pred ECcccccccccCCccee--cCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHH--HHHHHHH
Confidence 99999998654322111 1112335678999999988889999999999999999999 88887532110 0000000
Q ss_pred hhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHHHHH
Q 045798 919 MALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHELQSV 991 (1008)
Q Consensus 919 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~i 991 (1008)
... .+. .....+..+.+++.+||+.+|++||++.|+++.|+++
T Consensus 230 --~~~--------~~~--------------------~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 230 --KGN--------RLK--------------------QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred --cCC--------cCC--------------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 000 000 0012345689999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=309.14 Aligned_cols=277 Identities=23% Similarity=0.323 Sum_probs=200.7
Q ss_pred cCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEecccc--chhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceE
Q 045798 684 NGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC--EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFK 761 (1008)
Q Consensus 684 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 761 (1008)
++|++.+.||+|+||.||+|.+..+++.||+|+++... ....+.+.+|++++++++|+||+++++++ ..++..
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~ 75 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAF-----RRKGRL 75 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheE-----EECCEE
Confidence 46899999999999999999998889999999987432 33456899999999999999999999995 446679
Q ss_pred EEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEc
Q 045798 762 AIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIG 841 (1008)
Q Consensus 762 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 841 (1008)
++||||++++.+..+..... .+++.++..++.||+.|++|||+. +++||||+|+||++++++.+||+
T Consensus 76 ~iv~e~~~~~~l~~~~~~~~----------~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~ 142 (288)
T cd07833 76 YLVFEYVERTLLELLEASPG----------GLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLC 142 (288)
T ss_pred EEEEecCCCCHHHHHHhcCC----------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEE
Confidence 99999998877766554332 588999999999999999999998 99999999999999999999999
Q ss_pred ccCcccccccccCccccccccccccccccCccccCCC-CCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHh-
Q 045798 842 DFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGS-EVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARM- 919 (1008)
Q Consensus 842 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~- 919 (1008)
|||.+......... ......++..|+|||++.+. .++.++||||||+++|+|++|+.||......+. .......
T Consensus 143 d~g~~~~~~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~-~~~~~~~~ 218 (288)
T cd07833 143 DFGFARALRARPAS---PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQ-LYLIQKCL 218 (288)
T ss_pred eeecccccCCCccc---cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHh
Confidence 99999866543321 11224578899999999888 789999999999999999999999864321110 0000000
Q ss_pred -hCCcchhhhh--cccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 920 -ALPNQVMDIV--DPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 920 -~~~~~~~~~~--d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
..+....... ++...... ........... .......+.++.+++.+||..+|++|||++++++
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 219 GPLPPSHQELFSSNPRFAGVA--FPEPSQPESLE--RRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred CCCCHHHhhhcccCccccccc--cCCCCCcHHHH--HhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 0000000000 00000000 00000000000 0001123677899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=284.77 Aligned_cols=201 Identities=28% Similarity=0.368 Sum_probs=177.5
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEecccc---chhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCc
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC---EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGND 759 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 759 (1008)
.++|...++||+|.||.|-+++.+.+++.||+|+++... ..+...-..|-++++..+||.+..+... |+..+
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYs-----FQt~d 241 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYS-----FQTQD 241 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhh-----hccCc
Confidence 467888999999999999999999999999999998542 3344556789999999999999888766 78889
Q ss_pred eEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeE
Q 045798 760 FKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGH 839 (1008)
Q Consensus 760 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 839 (1008)
+.|+||||..||.|.-++...+ .+++...+.+-..|+.||.|||++ +||.||+|.+|.|+|.+|++|
T Consensus 242 rlCFVMeyanGGeLf~HLsrer----------~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIK 308 (516)
T KOG0690|consen 242 RLCFVMEYANGGELFFHLSRER----------VFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIK 308 (516)
T ss_pred eEEEEEEEccCceEeeehhhhh----------cccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceE
Confidence 9999999999999999987654 788999999999999999999998 999999999999999999999
Q ss_pred EcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCc
Q 045798 840 IGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDV 905 (1008)
Q Consensus 840 L~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~ 905 (1008)
|+|||+++.--... ......+||+.|.|||++....|+.++|.|.+|||+|||++|+.||..
T Consensus 309 itDFGLCKE~I~~g----~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn 370 (516)
T KOG0690|consen 309 ITDFGLCKEEIKYG----DTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYN 370 (516)
T ss_pred eeecccchhccccc----ceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccc
Confidence 99999998432222 223457899999999999999999999999999999999999999974
|
|
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=307.17 Aligned_cols=247 Identities=28% Similarity=0.333 Sum_probs=193.8
Q ss_pred cCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEecccc---chhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCce
Q 045798 684 NGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC---EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDF 760 (1008)
Q Consensus 684 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 760 (1008)
.+|.+.+.||+|+||.||+|....+++.||+|++.... ....+.+.+|+++++.++||||+++.++|. +++.
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~-----~~~~ 89 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYL-----REHT 89 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEE-----eCCe
Confidence 46889999999999999999998889999999986432 233457889999999999999999999953 4566
Q ss_pred EEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEE
Q 045798 761 KAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHI 840 (1008)
Q Consensus 761 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 840 (1008)
.++||||++ |++.+++..... .+++..+..++.|++.||.|||+. +|+||||+|+||+++.++.+||
T Consensus 90 ~~lv~e~~~-g~l~~~~~~~~~---------~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL 156 (307)
T cd06607 90 AWLVMEYCL-GSASDILEVHKK---------PLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKL 156 (307)
T ss_pred EEEEHHhhC-CCHHHHHHHccc---------CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEE
Confidence 899999995 677777654321 688999999999999999999998 9999999999999999999999
Q ss_pred cccCcccccccccCccccccccccccccccCccccC---CCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHH
Q 045798 841 GDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGL---GSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFA 917 (1008)
Q Consensus 841 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~ 917 (1008)
+|||++....... ...++..|+|||++. ...++.++||||||+++|||++|+.||....... ...
T Consensus 157 ~dfg~~~~~~~~~--------~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~----~~~ 224 (307)
T cd06607 157 ADFGSASLVSPAN--------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS----ALY 224 (307)
T ss_pred eecCcceecCCCC--------CccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHH----HHH
Confidence 9999987543221 234788999999874 4568899999999999999999999985321100 000
Q ss_pred HhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 045798 918 RMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHE 987 (1008)
Q Consensus 918 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 987 (1008)
.... . .. +. ......+..+.+++.+||+.+|++||++.+|+..
T Consensus 225 ~~~~-~------------~~-------------~~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 225 HIAQ-N------------DS-------------PT-LSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred HHhc-C------------CC-------------CC-CCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 0000 0 00 00 0011245568999999999999999999999873
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=302.34 Aligned_cols=248 Identities=26% Similarity=0.349 Sum_probs=198.5
Q ss_pred CCCCCceEeeccCeeEEEEEEcCCCeEEEEEEecccc-chhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceEEE
Q 045798 685 GFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC-EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKAI 763 (1008)
Q Consensus 685 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 763 (1008)
-|++.+.||+|+||.||+|.+..+++.||+|++.... ....+.+.+|++++++++||||+++++++ ..++..++
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~~~~~l 79 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY-----LKDTKLWI 79 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEE-----EeCCeEEE
Confidence 3778899999999999999998889999999986432 33446789999999999999999999984 55667999
Q ss_pred EEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEccc
Q 045798 764 VYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDF 843 (1008)
Q Consensus 764 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 843 (1008)
||||+++++|.+++... .+++..+..++.|++.|+.|||+. +++|+||+|+||+++.++.++|+||
T Consensus 80 v~e~~~~~~l~~~i~~~-----------~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~df 145 (277)
T cd06641 80 IMEYLGGGSALDLLEPG-----------PLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADF 145 (277)
T ss_pred EEEeCCCCcHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeec
Confidence 99999999999998643 578999999999999999999997 9999999999999999999999999
Q ss_pred CcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCc
Q 045798 844 GLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMALPN 923 (1008)
Q Consensus 844 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~~~~~ 923 (1008)
|.+......... .....++..|+|||.+.+..++.++|||||||++|+|++|..||...... ..... ...
T Consensus 146 g~~~~~~~~~~~----~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-----~~~~~-~~~ 215 (277)
T cd06641 146 GVAGQLTDTQIK----RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPM-----KVLFL-IPK 215 (277)
T ss_pred ccceecccchhh----hccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchH-----HHHHH-Hhc
Confidence 998755432111 12235788999999998888899999999999999999999998632110 00000 000
Q ss_pred chhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 045798 924 QVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHE 987 (1008)
Q Consensus 924 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 987 (1008)
.. .+. .....+.++.+++.+||+.+|.+||++.++++.
T Consensus 216 ~~----~~~----------------------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 216 NN----PPT----------------------LEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred CC----CCC----------------------CCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 00 000 001234567899999999999999999999984
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=303.27 Aligned_cols=248 Identities=25% Similarity=0.303 Sum_probs=199.6
Q ss_pred CCCCCceEeeccCeeEEEEEEcCCCeEEEEEEecccc---chhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceE
Q 045798 685 GFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC---EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFK 761 (1008)
Q Consensus 685 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 761 (1008)
+|++.+.||.|+||.||+|.+..+++.||+|++.... ....+.+.+|++++++++||||++++++ +.++...
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~-----~~~~~~~ 75 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYS-----FQDEENM 75 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHh-----hcCCCeE
Confidence 5888999999999999999998889999999997432 2445789999999999999999999988 4567789
Q ss_pred EEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEc
Q 045798 762 AIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIG 841 (1008)
Q Consensus 762 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 841 (1008)
++|+||+++++|.+++.... ++++..+..++.|+++||.|||+. +++|+||+|+||++++++.++|+
T Consensus 76 ~lv~e~~~~~~L~~~l~~~~----------~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~ 142 (258)
T cd05578 76 YLVVDLLLGGDLRYHLSQKV----------KFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHIT 142 (258)
T ss_pred EEEEeCCCCCCHHHHHHhcC----------CcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEe
Confidence 99999999999999997553 688999999999999999999998 99999999999999999999999
Q ss_pred ccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHhhC
Q 045798 842 DFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMAL 921 (1008)
Q Consensus 842 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~~~ 921 (1008)
|||.+........ .....++..|+|||.+.+..++.++||||+|+++|+|++|+.||...... ....+.....
T Consensus 143 d~~~~~~~~~~~~-----~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~~~~~~~~~ 215 (258)
T cd05578 143 DFNIATKVTPDTL-----TTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT--IRDQIRAKQE 215 (258)
T ss_pred ecccccccCCCcc-----ccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc--HHHHHHHHhc
Confidence 9999986543321 12244788999999998888999999999999999999999998743221 0111110000
Q ss_pred CcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCH--HHHH
Q 045798 922 PNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNM--TNVV 985 (1008)
Q Consensus 922 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~--~evl 985 (1008)
. ..+. .....+..+.+++.+||+.||.+||++ +|++
T Consensus 216 ---------~-----------------~~~~--~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 216 ---------T-----------------ADVL--YPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred ---------c-----------------cccc--CcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 0 0000 011234678899999999999999999 5554
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-33 Score=307.99 Aligned_cols=210 Identities=28% Similarity=0.383 Sum_probs=171.1
Q ss_pred CCCCCceEeeccCeeEEEEEEcC--CCeEEEEEEecccc---chhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCc
Q 045798 685 GFSSTHLIGVGSFGCVYKGALDE--DGIVVAIKVINLQC---EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGND 759 (1008)
Q Consensus 685 ~y~~~~~lg~G~~g~Vy~~~~~~--~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 759 (1008)
+|++.+.||+|+||.||+|.+.. +++.||+|++.... ....+.+.+|+.++++++||||+++++++.. ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~~ 77 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLE---HADK 77 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeC---CCCc
Confidence 48889999999999999999987 78999999998633 3445678899999999999999999999653 2236
Q ss_pred eEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecC----C
Q 045798 760 FKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDN----D 835 (1008)
Q Consensus 760 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~----~ 835 (1008)
..++||||++ +++.+++....... ...+++..++.++.||+.||+|||+. +|+||||||+||+++. +
T Consensus 78 ~~~lv~e~~~-~~l~~~~~~~~~~~-----~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~ 148 (316)
T cd07842 78 SVYLLFDYAE-HDLWQIIKFHRQAK-----RVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPER 148 (316)
T ss_pred eEEEEEeCCC-cCHHHHHHhhccCC-----CcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCcc
Confidence 7999999995 57777765432211 12688999999999999999999997 9999999999999999 8
Q ss_pred CCeEEcccCcccccccccCccccccccccccccccCccccCCC-CCCcccchhhHHHHHHHHHhCCCCCCccc
Q 045798 836 LSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGS-EVSTNGDVYSYGILLLEMVTAKKPTDVMF 907 (1008)
Q Consensus 836 ~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltG~~pf~~~~ 907 (1008)
+.+||+|||++......... ........++..|+|||++.+. .++.++|||||||++|+|++|+.||....
T Consensus 149 ~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~ 220 (316)
T cd07842 149 GVVKIGDLGLARLFNAPLKP-LADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGRE 220 (316)
T ss_pred ceEEECCCccccccCCCccc-ccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCc
Confidence 99999999999865443221 1112234578999999987664 57899999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=302.79 Aligned_cols=256 Identities=26% Similarity=0.394 Sum_probs=197.8
Q ss_pred CCCCCceEeeccCeeEEEEEEcC-CCeEEEEEEeccc----------cchhhHHHHHHHHHHhh-cCCCCceeeeecccc
Q 045798 685 GFSSTHLIGVGSFGCVYKGALDE-DGIVVAIKVINLQ----------CEGASKSFMAECKALKN-IRHRNLVKVITSCSS 752 (1008)
Q Consensus 685 ~y~~~~~lg~G~~g~Vy~~~~~~-~~~~vavK~~~~~----------~~~~~~~~~~E~~~l~~-l~h~niv~~~~~~~~ 752 (1008)
+|++.+.||+|+||.||+|.+.. .++.+|+|.+... ......++.+|+.++.+ ++||||+++++++
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~-- 78 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTF-- 78 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeE--
Confidence 48889999999999999999976 5789999988532 12233567788888875 6999999999984
Q ss_pred ccccCCceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeee
Q 045798 753 IDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILL 832 (1008)
Q Consensus 753 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll 832 (1008)
..++..++||||+++++|.+++...... ...+++..++.++.|++.|+.|||+. .+++||||+|+||++
T Consensus 79 ---~~~~~~~lv~e~~~~~~l~~~l~~~~~~------~~~~~~~~~~~~~~~l~~~l~~lh~~--~~i~H~dl~~~nil~ 147 (269)
T cd08528 79 ---LENDRLYIVMDLIEGAPLGEHFNSLKEK------KQRFTEERIWNIFVQMVLALRYLHKE--KRIVHRDLTPNNIML 147 (269)
T ss_pred ---ccCCeEEEEEecCCCCcHHHHHHHHHhc------cCCCCHHHHHHHHHHHHHHHHHhccC--CceeecCCCHHHEEE
Confidence 4567799999999999999987542211 11688999999999999999999963 289999999999999
Q ss_pred cCCCCeEEcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCcc
Q 045798 833 DNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLN 912 (1008)
Q Consensus 833 ~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~ 912 (1008)
+.++.+||+|||.+....... ......++..|+|||+..+..++.++||||||+++|+|++|+.||.....
T Consensus 148 ~~~~~~~l~dfg~~~~~~~~~-----~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~---- 218 (269)
T cd08528 148 GEDDKVTITDFGLAKQKQPES-----KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNM---- 218 (269)
T ss_pred CCCCcEEEecccceeeccccc-----ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCH----
Confidence 999999999999998654432 12234588999999999988899999999999999999999999853211
Q ss_pred HHHHHHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHHH
Q 045798 913 LHNFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHELQ 989 (1008)
Q Consensus 913 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 989 (1008)
...... ..+...... .....+..+.+++.+||+.||++||++.||.++++
T Consensus 219 -~~~~~~--------~~~~~~~~~------------------~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 219 -LSLATK--------IVEAVYEPL------------------PEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred -HHHHHH--------HhhccCCcC------------------CcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 001000 000000000 00123456889999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-33 Score=300.00 Aligned_cols=256 Identities=22% Similarity=0.351 Sum_probs=184.0
Q ss_pred ceEeeccCeeEEEEEEcCC--CeEEEEEEecccc-chhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceEEEEEe
Q 045798 690 HLIGVGSFGCVYKGALDED--GIVVAIKVINLQC-EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKAIVYE 766 (1008)
Q Consensus 690 ~~lg~G~~g~Vy~~~~~~~--~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 766 (1008)
+.||+|+||.||+|....+ ...+++|.++... ....+.+.+|+.+++.++||||+++++.|. .....++|||
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~-----~~~~~~lv~e 75 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCV-----EAIPYLLVFE 75 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEec-----CCCccEEEEe
Confidence 3599999999999976422 2456777766433 345678999999999999999999999854 4566899999
Q ss_pred ccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEcccCcc
Q 045798 767 YMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLA 846 (1008)
Q Consensus 767 ~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a 846 (1008)
|+++|+|.+++....... ...++..+..++.||+.||+|||+. +++||||||+||+++.++.+||+|||.+
T Consensus 76 ~~~~~~L~~~l~~~~~~~------~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~ 146 (268)
T cd05086 76 YCELGDLKSYLSQEQWHR------RNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIG 146 (268)
T ss_pred cCCCCcHHHHHHhhhccc------ccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccc
Confidence 999999999997643211 1467778889999999999999997 9999999999999999999999999998
Q ss_pred cccccccCccccccccccccccccCccccCC-------CCCCcccchhhHHHHHHHHHh-CCCCCCccccCCccHHHHHH
Q 045798 847 RFHQEVSNSTLSSSVGVKGTIGYTAPEYGLG-------SEVSTNGDVYSYGILLLEMVT-AKKPTDVMFEGDLNLHNFAR 918 (1008)
Q Consensus 847 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~sDvwslG~vl~ellt-G~~pf~~~~~~~~~~~~~~~ 918 (1008)
........ ........++..|+|||++.. ..++.++|||||||++|||++ |..||..... .....
T Consensus 147 ~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~-----~~~~~ 219 (268)
T cd05086 147 PSRYKEDY--IETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD-----REVLN 219 (268)
T ss_pred cccCcchh--hhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH-----HHHHH
Confidence 64321111 111123457889999998743 245789999999999999997 4667643211 01111
Q ss_pred hhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHHH
Q 045798 919 MALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHELQ 989 (1008)
Q Consensus 919 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 989 (1008)
...........++.+. ......+.+++..|| .+|++||+++||++.|.
T Consensus 220 ~~~~~~~~~~~~~~~~----------------------~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 220 HVIKDQQVKLFKPQLE----------------------LPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred HHHhhcccccCCCccC----------------------CCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 1000111111111111 012345678999999 67999999999998873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=303.13 Aligned_cols=243 Identities=23% Similarity=0.284 Sum_probs=184.8
Q ss_pred eEeeccCeeEEEEEEcCCCeEEEEEEecccc---chhhHHHHHHHHHHhh---cCCCCceeeeeccccccccCCceEEEE
Q 045798 691 LIGVGSFGCVYKGALDEDGIVVAIKVINLQC---EGASKSFMAECKALKN---IRHRNLVKVITSCSSIDFQGNDFKAIV 764 (1008)
Q Consensus 691 ~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~---l~h~niv~~~~~~~~~~~~~~~~~~lv 764 (1008)
.||+|+||.||+|.+..+++.||+|.+.... ......+.+|..+++. ..||+|+.+++++ ..++..++|
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~-----~~~~~~~lv 75 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAF-----HTPDKLCFI 75 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEE-----ecCCeEEEE
Confidence 4899999999999998889999999986432 1222334455544443 4799999998884 455678999
Q ss_pred EeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEcccC
Q 045798 765 YEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFG 844 (1008)
Q Consensus 765 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg 844 (1008)
|||+++++|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||++++++.++|+|||
T Consensus 76 ~e~~~~~~L~~~i~~~~----------~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg 142 (279)
T cd05633 76 LDLMNGGDLHYHLSQHG----------VFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLG 142 (279)
T ss_pred EecCCCCCHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCC
Confidence 99999999999987543 689999999999999999999997 99999999999999999999999999
Q ss_pred cccccccccCccccccccccccccccCccccCC-CCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCc
Q 045798 845 LARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLG-SEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMALPN 923 (1008)
Q Consensus 845 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~~~~~ 923 (1008)
++........ ....|+..|+|||.+.+ ..++.++||||+||++|||++|..||........ .........
T Consensus 143 ~~~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~--~~~~~~~~~- 213 (279)
T cd05633 143 LACDFSKKKP------HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK--HEIDRMTLT- 213 (279)
T ss_pred cceeccccCc------cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCH--HHHHHHhhc-
Confidence 9875432211 12358999999998764 5688999999999999999999999864322111 001000000
Q ss_pred chhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCC-----CHHHHHHH
Q 045798 924 QVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRM-----NMTNVVHE 987 (1008)
Q Consensus 924 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~ 987 (1008)
... ......+.++.+++.+||+.||++|| |++|+++.
T Consensus 214 -----~~~----------------------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 214 -----VNV----------------------ELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred -----CCc----------------------CCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 000 00112345678999999999999999 58888774
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-33 Score=299.74 Aligned_cols=251 Identities=20% Similarity=0.247 Sum_probs=193.7
Q ss_pred HHHHHHHhcCCCCCceE--eeccCeeEEEEEEcCCCeEEEEEEeccccchhhHHHHHHHHHHhhc-CCCCceeeeecccc
Q 045798 676 YKSLLKATNGFSSTHLI--GVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNI-RHRNLVKVITSCSS 752 (1008)
Q Consensus 676 ~~~~~~~~~~y~~~~~l--g~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~ 752 (1008)
..+.....++|.+.+.+ |+|+||.||++....+++.+|+|++........ |+.....+ +||||+++++++
T Consensus 6 ~~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~-- 78 (267)
T PHA03390 6 LSELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSV-- 78 (267)
T ss_pred HHHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEE--
Confidence 34455556788888887 999999999999998999999999864322111 22222222 799999999985
Q ss_pred ccccCCceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeee
Q 045798 753 IDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILL 832 (1008)
Q Consensus 753 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll 832 (1008)
..++..++||||+++++|.+++.... .+++.++..++.|+++|++|||+. +++||||||+||++
T Consensus 79 ---~~~~~~~iv~e~~~~~~L~~~l~~~~----------~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~ 142 (267)
T PHA03390 79 ---TTLKGHVLIMDYIKDGDLFDLLKKEG----------KLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLY 142 (267)
T ss_pred ---ecCCeeEEEEEcCCCCcHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEE
Confidence 44567999999999999999997653 689999999999999999999998 99999999999999
Q ss_pred cCCC-CeEEcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCc
Q 045798 833 DNDL-SGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDL 911 (1008)
Q Consensus 833 ~~~~-~~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~ 911 (1008)
+.++ .++|+|||.+....... ...++..|+|||++.+..++.++||||+||++|||++|+.||....+...
T Consensus 143 ~~~~~~~~l~dfg~~~~~~~~~--------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~ 214 (267)
T PHA03390 143 DRAKDRIYLCDYGLCKIIGTPS--------CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEEL 214 (267)
T ss_pred eCCCCeEEEecCccceecCCCc--------cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchh
Confidence 9988 99999999987553221 13478999999999998999999999999999999999999974433222
Q ss_pred cHHHHHHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCC-HHHHHH
Q 045798 912 NLHNFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMN-MTNVVH 986 (1008)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-~~evl~ 986 (1008)
....+.... .. ..+.....+..+.+++.+||+.+|.+||+ ++|+++
T Consensus 215 ~~~~~~~~~-~~----------------------------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 215 DLESLLKRQ-QK----------------------------KLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred hHHHHHHhh-cc----------------------------cCCcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 112111110 00 00001134556899999999999999996 588874
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-33 Score=312.61 Aligned_cols=284 Identities=21% Similarity=0.196 Sum_probs=202.4
Q ss_pred HhcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccc--cchhhHHHHHHHHHHhhcCCCCceeeeecccccc-ccCC
Q 045798 682 ATNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQ--CEGASKSFMAECKALKNIRHRNLVKVITSCSSID-FQGN 758 (1008)
Q Consensus 682 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~~ 758 (1008)
..++|++.+.||+|+||.||+|.+..+++.||+|++... .......+.+|+.++++++|+||+++++++.... +.+.
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 457899999999999999999999889999999998642 2334456788999999999999999999865322 2333
Q ss_pred ceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCe
Q 045798 759 DFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSG 838 (1008)
Q Consensus 759 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 838 (1008)
...|+||||+ .++|.+++.. .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+
T Consensus 94 ~~~~lv~e~~-~~~l~~~~~~------------~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~ 157 (353)
T cd07850 94 QDVYLVMELM-DANLCQVIQM------------DLDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTL 157 (353)
T ss_pred CcEEEEEecc-CCCHHHHHhh------------cCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCE
Confidence 5689999999 4588887742 367888999999999999999998 99999999999999999999
Q ss_pred EEcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHH
Q 045798 839 HIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFAR 918 (1008)
Q Consensus 839 kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~ 918 (1008)
||+|||.++....... .....++..|+|||.+.+..++.++|||||||++|+|++|+.||...... ..+.....
T Consensus 158 kL~Dfg~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~-~~~~~~~~ 231 (353)
T cd07850 158 KILDFGLARTAGTSFM-----MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHI-DQWNKIIE 231 (353)
T ss_pred EEccCccceeCCCCCC-----CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHH-HHHHHHHH
Confidence 9999999986543211 12234788999999999999999999999999999999999998643111 11111111
Q ss_pred hhC--CcchhhhhcccccCchHHhhh--------hhhhhhccccch-hHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 045798 919 MAL--PNQVMDIVDPILRNDEEILAS--------TDKCRRMQTGIN-SRLECLISMVKIGVACSMESPQDRMNMTNVVHE 987 (1008)
Q Consensus 919 ~~~--~~~~~~~~d~~l~~~~~~~~~--------~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 987 (1008)
... +....+.++............ ......++.... .....+..+.+++.+||+.||++|||+.|+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 232 QLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred hcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 100 001111111111000000000 000000000000 011345668899999999999999999999864
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=307.11 Aligned_cols=280 Identities=24% Similarity=0.281 Sum_probs=198.3
Q ss_pred cCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccc--hhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceE
Q 045798 684 NGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCE--GASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFK 761 (1008)
Q Consensus 684 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 761 (1008)
++|++.+.||+|+||.||+|.+..+++.||+|.++.... .....+.+|+.++++++||||+++++++.. ......
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~---~~~~~~ 81 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVG---SNLDKI 81 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEe---cCCCcE
Confidence 578999999999999999999988899999999974432 233467889999999999999999998542 223679
Q ss_pred EEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEc
Q 045798 762 AIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIG 841 (1008)
Q Consensus 762 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 841 (1008)
++||||++ ++|.+++..... .+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+
T Consensus 82 ~lv~e~~~-~~L~~~~~~~~~---------~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~ 148 (293)
T cd07843 82 YMVMEYVE-HDLKSLMETMKQ---------PFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKIC 148 (293)
T ss_pred EEEehhcC-cCHHHHHHhccC---------CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEe
Confidence 99999996 599988865431 589999999999999999999997 99999999999999999999999
Q ss_pred ccCcccccccccCccccccccccccccccCccccCCC-CCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHhh
Q 045798 842 DFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGS-EVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMA 920 (1008)
Q Consensus 842 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~~ 920 (1008)
|||.+......... .....++..|+|||.+.+. .++.++||||+|+++|+|++|..||......+ .........
T Consensus 149 d~g~~~~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~-~~~~~~~~~ 223 (293)
T cd07843 149 DFGLAREYGSPLKP----YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEID-QLNKIFKLL 223 (293)
T ss_pred ecCceeeccCCccc----cccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHh
Confidence 99999865543211 1223478899999988764 46889999999999999999999986432111 111111110
Q ss_pred CCcc--hhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 921 LPNQ--VMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 921 ~~~~--~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
.... ....... +....................+. ...+..+.+++.+||+.||++|||+.|+++
T Consensus 224 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 224 GTPTEKIWPGFSE-LPGAKKKTFTKYPYNQLRKKFPA-LSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred CCCchHHHHHhhc-cchhcccccccccchhhhccccc-cCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 0000 0000000 00000000000000000000000 013556789999999999999999999975
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-33 Score=303.05 Aligned_cols=253 Identities=25% Similarity=0.329 Sum_probs=203.0
Q ss_pred HhcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccchhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceE
Q 045798 682 ATNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFK 761 (1008)
Q Consensus 682 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 761 (1008)
..+.|+..+.||+|++|.||+|.+..+++.||+|++..... ..+.+.+|++++++++|+|++++++++ ..++..
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~ 90 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSY-----LVGDEL 90 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEE-----EECCEE
Confidence 46678899999999999999999988899999999976544 456789999999999999999999985 445779
Q ss_pred EEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEc
Q 045798 762 AIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIG 841 (1008)
Q Consensus 762 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 841 (1008)
++|+||+++++|.+++.... ..+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++|+
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~---------~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~ 158 (286)
T cd06614 91 WVVMEYMDGGSLTDIITQNF---------VRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLA 158 (286)
T ss_pred EEEEeccCCCcHHHHHHHhc---------cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEEC
Confidence 99999999999999997653 1689999999999999999999997 99999999999999999999999
Q ss_pred ccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHhhC
Q 045798 842 DFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMAL 921 (1008)
Q Consensus 842 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~~~ 921 (1008)
|||.+......... .....++..|+|||++.+..++.++|||||||++|+|++|+.||...... ......
T Consensus 159 d~~~~~~~~~~~~~----~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~----~~~~~~-- 228 (286)
T cd06614 159 DFGFAAQLTKEKSK----RNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPL----RALFLI-- 228 (286)
T ss_pred ccchhhhhccchhh----hccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHH----HHHHHH--
Confidence 99998755432211 12234788999999998888999999999999999999999998632110 000000
Q ss_pred CcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 922 PNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 922 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
..... .........+..+.+++.+||+.+|.+|||+.++++
T Consensus 229 -------~~~~~-----------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 229 -------TTKGI-----------------PPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred -------HhcCC-----------------CCCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 00000 000011124556899999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=303.84 Aligned_cols=245 Identities=28% Similarity=0.336 Sum_probs=192.4
Q ss_pred CCCCceEeeccCeeEEEEEEcCCCeEEEEEEecccc---chhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceEE
Q 045798 686 FSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC---EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKA 762 (1008)
Q Consensus 686 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 762 (1008)
|...+.||+|+||.||+|.+..+++.||+|++.... ......+.+|++++++++|||++++++++ ..++..+
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~~~~~ 101 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCY-----LREHTAW 101 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEE-----eeCCeEE
Confidence 677889999999999999998889999999986432 23345788999999999999999999985 4456689
Q ss_pred EEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEcc
Q 045798 763 IVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGD 842 (1008)
Q Consensus 763 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 842 (1008)
+||||++ |++.+++..... ++++.++..++.|++.|+.|||+. +|+||||+|+||+++.++.+||+|
T Consensus 102 lv~e~~~-g~l~~~~~~~~~---------~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~d 168 (317)
T cd06635 102 LVMEYCL-GSASDLLEVHKK---------PLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLAD 168 (317)
T ss_pred EEEeCCC-CCHHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEec
Confidence 9999995 588777754321 689999999999999999999998 999999999999999999999999
Q ss_pred cCcccccccccCccccccccccccccccCccccC---CCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHh
Q 045798 843 FGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGL---GSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARM 919 (1008)
Q Consensus 843 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~ 919 (1008)
||.+...... ....++..|+|||++. ++.++.++|||||||++|||++|+.||...... .........
T Consensus 169 fg~~~~~~~~--------~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~-~~~~~~~~~ 239 (317)
T cd06635 169 FGSASIASPA--------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-SALYHIAQN 239 (317)
T ss_pred CCCccccCCc--------ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHH-HHHHHHHhc
Confidence 9998754322 1234788999999874 456889999999999999999999997532110 000000000
Q ss_pred hCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 045798 920 ALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHE 987 (1008)
Q Consensus 920 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 987 (1008)
..+. ......+..+.+++.+||+.+|.+||++.++++.
T Consensus 240 ~~~~------------------------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 277 (317)
T cd06635 240 ESPT------------------------------LQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKH 277 (317)
T ss_pred cCCC------------------------------CCCccccHHHHHHHHHHccCCcccCcCHHHHHhC
Confidence 0000 0011234567899999999999999999999984
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-33 Score=297.72 Aligned_cols=254 Identities=24% Similarity=0.292 Sum_probs=197.5
Q ss_pred cCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccc-----cchhhHHHHHHHHHHhhcCCCCceeeeeccccccccCC
Q 045798 684 NGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQ-----CEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGN 758 (1008)
Q Consensus 684 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 758 (1008)
.+|++.+.||+|+||.||+|.+..+++.||+|++... .......+.+|++++++++|+||+++++++.. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~---~~~ 78 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRD---PEE 78 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEc---CCC
Confidence 4789999999999999999999889999999987532 12344678999999999999999999998542 234
Q ss_pred ceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCe
Q 045798 759 DFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSG 838 (1008)
Q Consensus 759 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 838 (1008)
...++|+||+++++|.+++.... .+++..+..++.|++.|++|||+. +++|+||||+||+++.++.+
T Consensus 79 ~~~~~v~e~~~~~~L~~~~~~~~----------~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~ 145 (264)
T cd06653 79 KKLSIFVEYMPGGSIKDQLKAYG----------ALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNV 145 (264)
T ss_pred CEEEEEEEeCCCCcHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCE
Confidence 56889999999999999987543 578889999999999999999998 99999999999999999999
Q ss_pred EEcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHH
Q 045798 839 HIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFAR 918 (1008)
Q Consensus 839 kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~ 918 (1008)
+|+|||.++......... .......++..|+|||++.+..++.++|||||||++|++++|+.||..... ......
T Consensus 146 ~l~dfg~~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~~ 220 (264)
T cd06653 146 KLGDFGASKRIQTICMSG-TGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEA----MAAIFK 220 (264)
T ss_pred EECccccccccccccccC-ccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCH----HHHHHH
Confidence 999999998653321111 111234588999999999888899999999999999999999999863211 110100
Q ss_pred hhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 919 MALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 919 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
..... .++. ........+.+++.+||+ +|..||++.+++.
T Consensus 221 ~~~~~-------------------------~~~~--~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 221 IATQP-------------------------TKPM--LPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred HHcCC-------------------------CCCC--CCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 00000 0000 011234567999999999 5799999998764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-33 Score=298.54 Aligned_cols=250 Identities=26% Similarity=0.324 Sum_probs=198.3
Q ss_pred CCCCCceEeeccCeeEEEEEEcCCCeEEEEEEecccc--chhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceEE
Q 045798 685 GFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC--EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKA 762 (1008)
Q Consensus 685 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 762 (1008)
+|.+.+.||+|+||.||+|....+|..||+|.+.... ....+.+.+|+++++.++|+||+++++.+ ..+...+
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~-----~~~~~~~ 75 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASF-----QENGRLF 75 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhhee-----ccCCeEE
Confidence 5788899999999999999999899999999986432 23456788999999999999999999984 4566799
Q ss_pred EEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCC-CeEEc
Q 045798 763 IVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDL-SGHIG 841 (1008)
Q Consensus 763 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kL~ 841 (1008)
+|+||+++++|.+++...... .+++..+..++.|++.|++|||+. +++|+||||+||++++++ .+|++
T Consensus 76 lv~e~~~~~~L~~~~~~~~~~--------~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~ 144 (257)
T cd08225 76 IVMEYCDGGDLMKRINRQRGV--------LFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLG 144 (257)
T ss_pred EEEecCCCCcHHHHHHhccCC--------CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEec
Confidence 999999999999998754321 578999999999999999999998 999999999999999885 46999
Q ss_pred ccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHhhC
Q 045798 842 DFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMAL 921 (1008)
Q Consensus 842 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~~~ 921 (1008)
|||.+.......... ....|++.|+|||+..+..++.++||||||+++|||++|..||..... ........
T Consensus 145 d~~~~~~~~~~~~~~----~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~ 215 (257)
T cd08225 145 DFGIARQLNDSMELA----YTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNL-----HQLVLKIC 215 (257)
T ss_pred ccccchhccCCcccc----cccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccH-----HHHHHHHh
Confidence 999998654332211 123488999999999888899999999999999999999999863211 11111000
Q ss_pred CcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 922 PNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 922 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
.. ..... ....+..+.+++.+||+.+|++|||+.|+++
T Consensus 216 ~~--------~~~~~-------------------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 216 QG--------YFAPI-------------------SPNFSRDLRSLISQLFKVSPRDRPSITSILK 253 (257)
T ss_pred cc--------cCCCC-------------------CCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 00 00000 0123345789999999999999999999976
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-33 Score=308.50 Aligned_cols=278 Identities=23% Similarity=0.268 Sum_probs=200.9
Q ss_pred HHHHhcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccc--cchhhHHHHHHHHHHhhcCCCCceeeeecccccccc
Q 045798 679 LLKATNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQ--CEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQ 756 (1008)
Q Consensus 679 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 756 (1008)
+...+++|++.+.||+|+||.||+|.+..+++.||+|++... .....+.+.+|++++++++||||+++.+++. .
T Consensus 5 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~----~ 80 (328)
T cd07856 5 VFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFI----S 80 (328)
T ss_pred eeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEe----c
Confidence 345678999999999999999999999889999999988532 2234567889999999999999999999853 2
Q ss_pred CCceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCC
Q 045798 757 GNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDL 836 (1008)
Q Consensus 757 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 836 (1008)
.....++|+||+ +++|.++++.. ++++..+..++.|++.||+|||+. +|+||||+|+||++++++
T Consensus 81 ~~~~~~lv~e~~-~~~L~~~~~~~-----------~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~ 145 (328)
T cd07856 81 PLEDIYFVTELL-GTDLHRLLTSR-----------PLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENC 145 (328)
T ss_pred CCCcEEEEeehh-ccCHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCC
Confidence 345689999999 67898887643 577888899999999999999997 999999999999999999
Q ss_pred CeEEcccCcccccccccCccccccccccccccccCccccCC-CCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHH
Q 045798 837 SGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLG-SEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHN 915 (1008)
Q Consensus 837 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~ 915 (1008)
.+||+|||.+....... ....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||...... .....
T Consensus 146 ~~~l~dfg~~~~~~~~~-------~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~-~~~~~ 217 (328)
T cd07856 146 DLKICDFGLARIQDPQM-------TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHV-NQFSI 217 (328)
T ss_pred CEEeCccccccccCCCc-------CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHH
Confidence 99999999997443211 12347889999998766 56899999999999999999999998643210 00001
Q ss_pred HHHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchh---HHHHHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 045798 916 FARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINS---RLECLISMVKIGVACSMESPQDRMNMTNVVHE 987 (1008)
Q Consensus 916 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 987 (1008)
.. ........++.+........... .. .......+. ....+.++.+++.+||+.+|++|||+++++..
T Consensus 218 ~~-~~~~~~~~~~~~~~~~~~~~~~~--~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 218 IT-DLLGTPPDDVINTICSENTLRFV--QS-LPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred HH-HHhCCCCHHHHHhccchhhHHHH--hh-ccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 11 11111111111111111000000 00 000000000 01235678999999999999999999999765
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=328.04 Aligned_cols=208 Identities=26% Similarity=0.336 Sum_probs=182.8
Q ss_pred HHHHHHhcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEecc---ccchhhHHHHHHHHHHhhcCCCCceeeeeccccc
Q 045798 677 KSLLKATNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINL---QCEGASKSFMAECKALKNIRHRNLVKVITSCSSI 753 (1008)
Q Consensus 677 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 753 (1008)
.++.-..++|.++++||+|+||.|..++.+.+++.||+|++.. -.......|..|-++|..-+.+-|+.+..+
T Consensus 68 ~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyA---- 143 (1317)
T KOG0612|consen 68 KELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYA---- 143 (1317)
T ss_pred HHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHH----
Confidence 3444456789999999999999999999999999999999975 224455679999999999999999999887
Q ss_pred cccCCceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeec
Q 045798 754 DFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLD 833 (1008)
Q Consensus 754 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~ 833 (1008)
|+++.+.|+|||||+||+|-.++.+.. ++++..++.++..|+.||..+|+. |+|||||||+|||+|
T Consensus 144 -FQD~~~LYlVMdY~pGGDlltLlSk~~----------~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld 209 (1317)
T KOG0612|consen 144 -FQDERYLYLVMDYMPGGDLLTLLSKFD----------RLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLD 209 (1317)
T ss_pred -hcCccceEEEEecccCchHHHHHhhcC----------CChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEec
Confidence 789999999999999999999998764 689999999999999999999998 999999999999999
Q ss_pred CCCCeEEcccCcccccccccCccccccccccccccccCccccCC-----CCCCcccchhhHHHHHHHHHhCCCCCCc
Q 045798 834 NDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLG-----SEVSTNGDVYSYGILLLEMVTAKKPTDV 905 (1008)
Q Consensus 834 ~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwslG~vl~elltG~~pf~~ 905 (1008)
..|++||+|||.+..+..++... ....+|||.|++||++.. +.|++.+|.||+||++|||+.|..||..
T Consensus 210 ~~GHikLADFGsClkm~~dG~V~---s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYa 283 (1317)
T KOG0612|consen 210 KSGHIKLADFGSCLKMDADGTVR---SSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYA 283 (1317)
T ss_pred ccCcEeeccchhHHhcCCCCcEE---eccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchH
Confidence 99999999999998776544332 233569999999998752 5789999999999999999999999863
|
|
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=294.89 Aligned_cols=250 Identities=29% Similarity=0.386 Sum_probs=201.8
Q ss_pred CCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccchhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceEEEE
Q 045798 685 GFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKAIV 764 (1008)
Q Consensus 685 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 764 (1008)
+|+..+.||+|++|.||+|.+..+++.||+|++........+.+.+|++++++++|++++++++++ ..+...+++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~l~ 75 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSY-----LKKDELWIV 75 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEE-----ecCCeEEEE
Confidence 478889999999999999999888999999999866555667899999999999999999999984 445678999
Q ss_pred EeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEcccC
Q 045798 765 YEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFG 844 (1008)
Q Consensus 765 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg 844 (1008)
+||+++++|.+++.... ..+++..+..++.|++.|++|||+. +++||||+|+||++++++.++|+|||
T Consensus 76 ~e~~~~~~L~~~~~~~~---------~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~ 143 (253)
T cd05122 76 MEFCSGGSLKDLLKSTN---------QTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFG 143 (253)
T ss_pred EecCCCCcHHHHHhhcC---------CCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecc
Confidence 99999999999987653 1689999999999999999999997 99999999999999999999999999
Q ss_pred cccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCcc
Q 045798 845 LARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMALPNQ 924 (1008)
Q Consensus 845 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~~~~~~ 924 (1008)
.+........ .....++..|+|||.+.+..++.++||||||+++|+|++|+.||...... ........ ..
T Consensus 144 ~~~~~~~~~~-----~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~----~~ 213 (253)
T cd05122 144 LSAQLSDTKA-----RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPM-KALFKIAT----NG 213 (253)
T ss_pred cccccccccc-----ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchH-HHHHHHHh----cC
Confidence 9986654321 12345889999999998888999999999999999999999998632110 00000000 00
Q ss_pred hhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 925 VMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 925 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
. +........+..+.+++.+||+.||++|||+.|+++
T Consensus 214 ~-------------------------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 214 P-------------------------PGLRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred C-------------------------CCcCcccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0 000001112456899999999999999999999875
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=306.38 Aligned_cols=249 Identities=24% Similarity=0.338 Sum_probs=204.2
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccc--hhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCce
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCE--GASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDF 760 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 760 (1008)
...|.+.+.||+|.|+.|.+|.+..++..||||.++...- .....+.+|+++|..++|||||+++.+ .+....
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v-----~~t~~~ 129 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSV-----IETEAT 129 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeee-----eeecce
Confidence 5679999999999999999999999999999999975432 223458999999999999999999999 566777
Q ss_pred EEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEE
Q 045798 761 KAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHI 840 (1008)
Q Consensus 761 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 840 (1008)
.|+||||+.+|.+.+|+.+++ +..+..+..++.|+.+|++|+|+. .|||||||++||+++.+.++||
T Consensus 130 lylV~eya~~ge~~~yl~~~g----------r~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikI 196 (596)
T KOG0586|consen 130 LYLVMEYASGGELFDYLVKHG----------RMKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKI 196 (596)
T ss_pred eEEEEEeccCchhHHHHHhcc----------cchhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceee
Confidence 999999999999999999887 566688999999999999999997 9999999999999999999999
Q ss_pred cccCcccccccccCccccccccccccccccCccccCCCCC-CcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHh
Q 045798 841 GDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEV-STNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARM 919 (1008)
Q Consensus 841 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~ 919 (1008)
+|||++..+..... ....+|++.|.|||++.+..| ++++|+||+|+++|-|+.|..||+...-
T Consensus 197 aDfgfS~~~~~~~~-----lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~l----------- 260 (596)
T KOG0586|consen 197 ADFGFSTFFDYGLM-----LQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNL----------- 260 (596)
T ss_pred eccccceeeccccc-----ccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccc-----------
Confidence 99999998764332 233569999999999998776 6799999999999999999999984311
Q ss_pred hCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 045798 920 ALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHE 987 (1008)
Q Consensus 920 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 987 (1008)
..+-++.+.+.. +++ .-...++.+++++++-.+|.+|++.+++++.
T Consensus 261 ------k~Lr~rvl~gk~----------rIp------~~ms~dce~lLrk~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 261 ------KELRPRVLRGKY----------RIP------FYMSCDCEDLLRKFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred ------ccccchheeeee----------ccc------ceeechhHHHHHHhhccCccccCCHHHhhhh
Confidence 111111111111 000 1123346788999999999999999999874
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-33 Score=306.17 Aligned_cols=280 Identities=25% Similarity=0.283 Sum_probs=197.4
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccc--hhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCce
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCE--GASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDF 760 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 760 (1008)
.++|++.+.||+|+||.||+|.+..+|+.||+|+++.... .....+.+|+.++++++|+||+++++++.. ...+.
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~~~ 82 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVG---KHLDS 82 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEec---CCCCe
Confidence 4679999999999999999999988999999999874432 223456789999999999999999998542 22356
Q ss_pred EEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEE
Q 045798 761 KAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHI 840 (1008)
Q Consensus 761 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 840 (1008)
.++||||++ ++|.+++.... ..+++.++..++.||+.||+|||+. +++||||||+||++++++.+||
T Consensus 83 ~~lv~e~~~-~~l~~~l~~~~---------~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL 149 (309)
T cd07845 83 IFLVMEYCE-QDLASLLDNMP---------TPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKI 149 (309)
T ss_pred EEEEEecCC-CCHHHHHHhcc---------cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEE
Confidence 899999995 58888876532 1689999999999999999999998 9999999999999999999999
Q ss_pred cccCcccccccccCccccccccccccccccCccccCC-CCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHh
Q 045798 841 GDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLG-SEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARM 919 (1008)
Q Consensus 841 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~ 919 (1008)
+|||.+......... .....++..|+|||.+.+ ..++.++||||+||++|||++|+.||......+ .......
T Consensus 150 ~dfg~~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~-~~~~~~~- 223 (309)
T cd07845 150 ADFGLARTYGLPAKP----MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIE-QLDLIIQ- 223 (309)
T ss_pred CccceeeecCCccCC----CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHH-
Confidence 999999866433211 112235788999998865 457899999999999999999999986432111 1111111
Q ss_pred hCCcchhhhhcccccCchHH-hhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 920 ALPNQVMDIVDPILRNDEEI-LASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 920 ~~~~~~~~~~d~~l~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
.......... +.+..-+.. ...... .............+..+.+++.+|++.||++|||++|+++
T Consensus 224 ~~~~~~~~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~ 289 (309)
T cd07845 224 LLGTPNESIW-PGFSDLPLVGKFTLPK-QPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE 289 (309)
T ss_pred hcCCCChhhc-hhhhcccccccccccC-CCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 1100000000 000000000 000000 0000000000113556789999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-33 Score=308.51 Aligned_cols=283 Identities=21% Similarity=0.197 Sum_probs=197.7
Q ss_pred CCCCCceEeeccCeeEEEEEEcCC--CeEEEEEEecccc--chhhHHHHHHHHHHhhc-CCCCceeeeeccccccccCCc
Q 045798 685 GFSSTHLIGVGSFGCVYKGALDED--GIVVAIKVINLQC--EGASKSFMAECKALKNI-RHRNLVKVITSCSSIDFQGND 759 (1008)
Q Consensus 685 ~y~~~~~lg~G~~g~Vy~~~~~~~--~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~ 759 (1008)
+|++.+.||+|+||.||+|..... +..||+|++.... ....+.+.+|+++++++ +||||+++++.+... .....
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~-~~~~~ 79 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVF-PGNFN 79 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeec-cccCC
Confidence 478889999999999999999877 8899999986432 22346788999999999 699999999875421 12335
Q ss_pred eEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeE
Q 045798 760 FKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGH 839 (1008)
Q Consensus 760 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 839 (1008)
..++++||+ +++|.+++.... .+++..++.++.||+.||+|||+. +|+||||||+||+++.++.+|
T Consensus 80 ~~~~~~e~~-~~~L~~~l~~~~----------~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~k 145 (332)
T cd07857 80 ELYLYEELM-EADLHQIIRSGQ----------PLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELK 145 (332)
T ss_pred cEEEEEecc-cCCHHHHHhcCC----------CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEE
Confidence 578999998 479999886543 689999999999999999999997 999999999999999999999
Q ss_pred EcccCcccccccccCccccccccccccccccCccccCC-CCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHH
Q 045798 840 IGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLG-SEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFAR 918 (1008)
Q Consensus 840 L~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~ 918 (1008)
|+|||.++.................|+..|+|||+..+ ..++.++||||+||++|+|++|+.||...... ........
T Consensus 146 l~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~-~~~~~~~~ 224 (332)
T cd07857 146 ICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYV-DQLNQILQ 224 (332)
T ss_pred eCcCCCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHH-HHHHHHHH
Confidence 99999998654432221112233468999999998765 46899999999999999999999998642211 01111111
Q ss_pred hhCCcchhhhhcccccCchHHh-hhhhhhhhccccch-hHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 919 MALPNQVMDIVDPILRNDEEIL-ASTDKCRRMQTGIN-SRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 919 ~~~~~~~~~~~d~~l~~~~~~~-~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
.... ...+.+........... ....... ..... ........+.+++.+|++.||.+|||+.|+++
T Consensus 225 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 225 VLGT-PDEETLSRIGSPKAQNYIRSLPNIP--KKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred HhCC-CCHHHHHhhhhhhHHHHHHhccccC--CcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 1100 00011110000000000 0000000 00000 00112456899999999999999999999875
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-33 Score=302.79 Aligned_cols=245 Identities=23% Similarity=0.321 Sum_probs=195.6
Q ss_pred CceEeeccCeeEEEEEEcCCCeEEEEEEeccccchhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceEEEEEecc
Q 045798 689 THLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKAIVYEYM 768 (1008)
Q Consensus 689 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 768 (1008)
..+||+|+||.||+|....+++.||+|++..........+.+|+.+++.++|+||+++++++ ..++..++||||+
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~~~~~lv~e~~ 99 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY-----LVGDELWVVMEFL 99 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEE-----EeCCEEEEEEecC
Confidence 46799999999999999889999999998765555667799999999999999999999984 5567799999999
Q ss_pred CCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEcccCcccc
Q 045798 769 PNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARF 848 (1008)
Q Consensus 769 ~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~ 848 (1008)
++++|.+++... ++++..+..++.|++.|++|||+. +++||||+|+||++++++.++|+|||.+..
T Consensus 100 ~~~~L~~~~~~~-----------~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~ 165 (292)
T cd06657 100 EGGALTDIVTHT-----------RMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQ 165 (292)
T ss_pred CCCcHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEccccccee
Confidence 999999987533 578899999999999999999998 999999999999999999999999999875
Q ss_pred cccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCcchhhh
Q 045798 849 HQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMALPNQVMDI 928 (1008)
Q Consensus 849 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 928 (1008)
....... .....++..|+|||.+.+..++.++||||+|+++|+|++|..||..... ...........+..
T Consensus 166 ~~~~~~~----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~--~~~~~~~~~~~~~~---- 235 (292)
T cd06657 166 VSKEVPR----RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP--LKAMKMIRDNLPPK---- 235 (292)
T ss_pred ccccccc----ccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHhhCCcc----
Confidence 4332211 1224578999999998888889999999999999999999999863211 00001111011100
Q ss_pred hcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 929 VDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 929 ~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
.......+..+.+++.+||+.+|.+||++.++++
T Consensus 236 ------------------------~~~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 236 ------------------------LKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred ------------------------cCCcccCCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 0001123445789999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-33 Score=303.96 Aligned_cols=284 Identities=21% Similarity=0.245 Sum_probs=198.2
Q ss_pred cCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccc--hhhHHHHHHHHHHhhc-CCCCceeeeeccccccccCCce
Q 045798 684 NGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCE--GASKSFMAECKALKNI-RHRNLVKVITSCSSIDFQGNDF 760 (1008)
Q Consensus 684 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~ 760 (1008)
++|++.+.||+|+||.||+|.+..+++.||+|+++.... .....+.+|+.+++.+ +||||+++++++...+......
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 468999999999999999999988999999999875432 2346788999999999 5699999999865433323345
Q ss_pred EEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecC-CCCeE
Q 045798 761 KAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDN-DLSGH 839 (1008)
Q Consensus 761 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~k 839 (1008)
.|+||||+++ +|.+++...... ....+++..++.++.||+.||+|||+. +|+||||+|+||+++. ++.+|
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~-----~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~k 151 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRG-----PGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLK 151 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhccc-----CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEE
Confidence 7999999964 898888654321 012689999999999999999999997 9999999999999998 88999
Q ss_pred EcccCcccccccccCccccccccccccccccCccccCC-CCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHH
Q 045798 840 IGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLG-SEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFAR 918 (1008)
Q Consensus 840 L~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~ 918 (1008)
|+|||.+......... .....+++.|+|||++.+ ..++.++||||||+++|+|++|..||....+... ......
T Consensus 152 l~dfg~~~~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~-~~~~~~ 226 (295)
T cd07837 152 IADLGLGRAFSIPVKS----YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQ-LLHIFK 226 (295)
T ss_pred EeecccceecCCCccc----cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHH-HHHHHH
Confidence 9999999755332111 112346888999998765 4578999999999999999999999864211111 111111
Q ss_pred hhCCcchhhhhcccccCchHHhhhhhhhhhccccc-hhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 919 MALPNQVMDIVDPILRNDEEILASTDKCRRMQTGI-NSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 919 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
.........+ +....... ........+... ......+.++.+++.+||+.||.+||+++|++.
T Consensus 227 ~~~~~~~~~~--~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 227 LLGTPTEQVW--PGVSKLRD---WHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred HhCCCChhhC--cchhhccc---hhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 0000000000 00000000 000000000000 001134567899999999999999999999875
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-33 Score=309.97 Aligned_cols=286 Identities=22% Similarity=0.275 Sum_probs=200.5
Q ss_pred HhcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccc--cchhhHHHHHHHHHHhhc-CCCCceeeeeccccccccCC
Q 045798 682 ATNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQ--CEGASKSFMAECKALKNI-RHRNLVKVITSCSSIDFQGN 758 (1008)
Q Consensus 682 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~ 758 (1008)
..++|++.+.||+|+||.||+|.+..+++.||+|++... .......+.+|+.+++++ +||||++++++|.. .+.
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~---~~~ 81 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKA---END 81 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeecc---CCC
Confidence 356799999999999999999999888999999988532 223345678899999999 99999999998642 334
Q ss_pred ceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCe
Q 045798 759 DFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSG 838 (1008)
Q Consensus 759 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 838 (1008)
...++||||++ ++|.+++... .+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+
T Consensus 82 ~~~~lv~e~~~-~~L~~~~~~~-----------~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~ 146 (337)
T cd07852 82 KDIYLVFEYME-TDLHAVIRAN-----------ILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRV 146 (337)
T ss_pred ceEEEEecccc-cCHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcE
Confidence 56899999995 6999888643 467888999999999999999997 99999999999999999999
Q ss_pred EEcccCcccccccccCcc-ccccccccccccccCccccCC-CCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHH
Q 045798 839 HIGDFGLARFHQEVSNST-LSSSVGVKGTIGYTAPEYGLG-SEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNF 916 (1008)
Q Consensus 839 kL~Dfg~a~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~ 916 (1008)
||+|||.+.......... ........|+..|+|||.+.+ ..++.++||||||+++|+|++|+.||......+. ....
T Consensus 147 kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~-~~~~ 225 (337)
T cd07852 147 KLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQ-LEKI 225 (337)
T ss_pred EEeeccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHH-HHHH
Confidence 999999998654432210 111223458899999998755 4578899999999999999999999864322111 1111
Q ss_pred HHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 045798 917 ARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHE 987 (1008)
Q Consensus 917 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 987 (1008)
.... ...........-..........................+.++.+++.+||+.||++|||+.++++.
T Consensus 226 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 226 IEVI-GPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHh-CCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 1110 000000000000000000000000000000000011246678999999999999999999999974
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-33 Score=302.50 Aligned_cols=276 Identities=26% Similarity=0.323 Sum_probs=198.8
Q ss_pred CCCCceEeeccCeeEEEEEEcCCCeEEEEEEecccc--chhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceEEE
Q 045798 686 FSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC--EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKAI 763 (1008)
Q Consensus 686 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 763 (1008)
|++.+.||+|+||.||+|....+++.||+|+++... ......+.+|++++++++|+|++++++++... ..+..++
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~---~~~~~~l 77 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSK---GKGSIYM 77 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecC---CCCcEEE
Confidence 678899999999999999998889999999998653 33456788999999999999999999996432 1367999
Q ss_pred EEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEccc
Q 045798 764 VYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDF 843 (1008)
Q Consensus 764 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 843 (1008)
||||++ ++|.+++.... ..+++..++.++.|++.|++|||+. +++|+||+|+||++++++.+||+||
T Consensus 78 v~e~~~-~~l~~~~~~~~---------~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~ 144 (287)
T cd07840 78 VFEYMD-HDLTGLLDSPE---------VKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADF 144 (287)
T ss_pred Eecccc-ccHHHHHhccC---------CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccc
Confidence 999996 58988886542 1689999999999999999999997 9999999999999999999999999
Q ss_pred CcccccccccCccccccccccccccccCccccCC-CCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHhhCC
Q 045798 844 GLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLG-SEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMALP 922 (1008)
Q Consensus 844 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~~~~ 922 (1008)
|.+......... ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...... ............
T Consensus 145 g~~~~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~-~~~~~~~~~~~~ 220 (287)
T cd07840 145 GLARPYTKRNSA---DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTEL-EQLEKIFELCGS 220 (287)
T ss_pred cceeeccCCCcc---cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCC
Confidence 999866543321 1122346788999997765 45789999999999999999999998643221 111111111110
Q ss_pred cchhhh--hcccccCchHHhhhhhhhhhccccchh-HHH-HHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 923 NQVMDI--VDPILRNDEEILASTDKCRRMQTGINS-RLE-CLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 923 ~~~~~~--~d~~l~~~~~~~~~~~~~~~~~~~~~~-~~~-~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
.....+ .... ..... .......+..... ... ++..+.+++.+||+.+|.+||+++++++
T Consensus 221 ~~~~~~~~~~~~-~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 221 PTDENWPGVSKL-PWFEN----LKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred Cchhhccccccc-hhhhh----ccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 000000 0000 00000 0000000000000 001 2667899999999999999999999976
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=299.55 Aligned_cols=278 Identities=24% Similarity=0.276 Sum_probs=199.2
Q ss_pred CCCCceEeeccCeeEEEEEEcCCCeEEEEEEecccc--chhhHHHHHHHHHHhhc---CCCCceeeeeccccccccCCce
Q 045798 686 FSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC--EGASKSFMAECKALKNI---RHRNLVKVITSCSSIDFQGNDF 760 (1008)
Q Consensus 686 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~~~~~~~~~ 760 (1008)
|++.+.||+|+||.||+|.+..+++.||+|+++... ......+.+|+.+++++ .|+|++++++++...+......
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 677899999999999999998789999999997432 22334567788877766 5999999999976544333445
Q ss_pred EEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEE
Q 045798 761 KAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHI 840 (1008)
Q Consensus 761 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 840 (1008)
.+++|||+. ++|.+++...... .+++..++.++.|++.||+|||+. +++|+||+|+||++++++.+||
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~~~~--------~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l 148 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKCPKP--------GLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKI 148 (287)
T ss_pred eEEEehhcc-cCHHHHHHHccCC--------CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEE
Confidence 899999995 5898888654321 589999999999999999999997 9999999999999999999999
Q ss_pred cccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHhh
Q 045798 841 GDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMA 920 (1008)
Q Consensus 841 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~~ 920 (1008)
+|||.+......... ....++..|+|||++.+..++.++|||||||++|||++|..||....+. .....+....
T Consensus 149 ~dfg~~~~~~~~~~~-----~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~-~~~~~~~~~~ 222 (287)
T cd07838 149 ADFGLARIYSFEMAL-----TSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEA-DQLDKIFDVI 222 (287)
T ss_pred eccCcceeccCCccc-----ccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChH-HHHHHHHHHc
Confidence 999999866433211 1234788999999999889999999999999999999999998643221 1122221111
Q ss_pred CCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 921 LPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 921 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
.......+...... .. ... .............+.+..+.+++.+||+.||.+||+++|++.
T Consensus 223 ~~~~~~~~~~~~~~-~~---~~~-~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 223 GLPSEEEWPRNVSL-PR---SSF-PSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred CCCChHhcCCCccc-ch---hhc-ccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 11000000000000 00 000 000000001112245577889999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=301.20 Aligned_cols=278 Identities=24% Similarity=0.307 Sum_probs=198.7
Q ss_pred CCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccc-hhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceEEE
Q 045798 685 GFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCE-GASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKAI 763 (1008)
Q Consensus 685 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 763 (1008)
+|++.+.||.|++|.||+|.+..+|+.||+|+++.... ...+.+.+|++++++++|+||+++++++ ...+..++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~~l 75 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVI-----HTENKLML 75 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeE-----eeCCcEEE
Confidence 58889999999999999999988999999999975432 3346778899999999999999999995 45567899
Q ss_pred EEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEccc
Q 045798 764 VYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDF 843 (1008)
Q Consensus 764 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 843 (1008)
||||++ ++|.+++...... ..+++..+..++.|++.||+|||+. +++||||+|+||++++++.++|+||
T Consensus 76 v~e~~~-~~l~~~~~~~~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~ 144 (284)
T cd07836 76 VFEYMD-KDLKKYMDTHGVR-------GALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADF 144 (284)
T ss_pred EEecCC-ccHHHHHHhcCCC-------CCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeec
Confidence 999996 5898888654321 1689999999999999999999997 9999999999999999999999999
Q ss_pred CcccccccccCccccccccccccccccCccccCCC-CCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHhhCC
Q 045798 844 GLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGS-EVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMALP 922 (1008)
Q Consensus 844 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~~~~ 922 (1008)
|.+......... .....++..|+|||++.+. .++.++|||||||++|+|++|+.||...... ............
T Consensus 145 g~~~~~~~~~~~----~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~-~~~~~~~~~~~~ 219 (284)
T cd07836 145 GLARAFGIPVNT----FSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNE-DQLLKIFRIMGT 219 (284)
T ss_pred chhhhhcCCccc----cccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHHHHhCC
Confidence 999754332111 1123468899999987664 5688999999999999999999998643221 111111111110
Q ss_pred cchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 923 NQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 923 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
..... .. .+...+........ .............+..+.+++.+|++.||.+||+++|+++
T Consensus 220 ~~~~~-~~-~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 220 PTEST-WP-GISQLPEYKPTFPR-YPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred CChhh-HH-HHhcCchhcccccC-CChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00000 00 00000000000000 0000000001134567889999999999999999999875
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-33 Score=301.90 Aligned_cols=276 Identities=26% Similarity=0.328 Sum_probs=197.5
Q ss_pred CCCCceEeeccCeeEEEEEEcCCCeEEEEEEecccc--chhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceEEE
Q 045798 686 FSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC--EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKAI 763 (1008)
Q Consensus 686 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 763 (1008)
|++.+.||+|++|.||+|.+..+|+.||+|++.... ....+.+.+|++++++++|||++++++++ .+++..++
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~-----~~~~~~~i 75 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVV-----HSENKLYL 75 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhhee-----ccCCeEEE
Confidence 678899999999999999998899999999987543 23346788999999999999999999985 45577999
Q ss_pred EEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEccc
Q 045798 764 VYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDF 843 (1008)
Q Consensus 764 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 843 (1008)
||||+ +++|.+++..... ..+++..+..++.|++.||+|||+. +++||||+|+||+++.++.++|+||
T Consensus 76 v~e~~-~~~l~~~~~~~~~--------~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df 143 (283)
T cd07835 76 VFEFL-DLDLKKYMDSSPL--------TGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADF 143 (283)
T ss_pred EEecc-CcCHHHHHhhCCC--------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeec
Confidence 99999 5699999875532 1689999999999999999999997 9999999999999999999999999
Q ss_pred CcccccccccCccccccccccccccccCccccCCC-CCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHhhCC
Q 045798 844 GLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGS-EVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMALP 922 (1008)
Q Consensus 844 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~~~~ 922 (1008)
|.+......... .....++..|+|||++.+. .++.++||||||+++|+|++|+.||....... ......+....
T Consensus 144 ~~~~~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-~~~~~~~~~~~ 218 (283)
T cd07835 144 GLARAFGVPVRT----YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEID-QLFRIFRTLGT 218 (283)
T ss_pred ccccccCCCccc----cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCC
Confidence 999754332111 1123468899999987664 56889999999999999999999986432111 11111111110
Q ss_pred cchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 923 NQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 923 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
..-. ..+.....++......... ...........+..+.+++.+||+.||++|||++|+++
T Consensus 219 ~~~~--~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 219 PDED--VWPGVTSLPDYKPTFPKWA-RQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred CChH--Hhhhhhhchhhhhhccccc-ccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 0000 0000000000000000000 00000001123456889999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-33 Score=308.38 Aligned_cols=291 Identities=24% Similarity=0.239 Sum_probs=207.2
Q ss_pred CCCCCceEeeccCeeEEEEEEcCCCeEEEEEEecccc--chhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceEE
Q 045798 685 GFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC--EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKA 762 (1008)
Q Consensus 685 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 762 (1008)
+|++.+.||+|++|.||+|....+++.||+|++.... ....+.+.+|+.+++.++|+||+++.+++...........|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 5889999999999999999998889999999987543 34456899999999999999999999996543322334689
Q ss_pred EEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEcc
Q 045798 763 IVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGD 842 (1008)
Q Consensus 763 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 842 (1008)
+||||++ ++|.+++.... .+++..++.++.|++.||+|||+. +|+||||||+||+++.++.++|+|
T Consensus 81 lv~e~~~-~~l~~~l~~~~----------~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~d 146 (330)
T cd07834 81 IVTELME-TDLHKVIKSPQ----------PLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICD 146 (330)
T ss_pred EEecchh-hhHHHHHhCCC----------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcc
Confidence 9999996 58988886543 689999999999999999999998 999999999999999999999999
Q ss_pred cCcccccccccCccccccccccccccccCccccCCC-CCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHhhC
Q 045798 843 FGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGS-EVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMAL 921 (1008)
Q Consensus 843 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~~~ 921 (1008)
||.+.......... .......++..|+|||++.+. .++.++||||+|+++|+|++|+.||....... ........ .
T Consensus 147 fg~~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~-~~~~i~~~-~ 223 (330)
T cd07834 147 FGLARGVDPDEDEK-GFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYID-QLNLIVEV-L 223 (330)
T ss_pred cCceEeeccccccc-ccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHH-HHHHHHHh-c
Confidence 99998665432110 112234578899999999887 78999999999999999999999986432211 01111110 0
Q ss_pred CcchhhhhcccccCch-HHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHH--HHHHHH
Q 045798 922 PNQVMDIVDPILRNDE-EILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHE--LQSVKN 993 (1008)
Q Consensus 922 ~~~~~~~~d~~l~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~--L~~i~~ 993 (1008)
.....+.......... ............. ........+..+.+++.+||+.+|.+|||+++++.. +++++.
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~ 297 (330)
T cd07834 224 GTPSEEDLKFITSEKARNYLKSLPKKPKKP-LSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHD 297 (330)
T ss_pred CCCChhHhhhccccchhhHHhhcccCCcch-hHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcc
Confidence 0000000000000000 0000000000000 000011245678999999999999999999999874 555443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-34 Score=276.66 Aligned_cols=252 Identities=22% Similarity=0.286 Sum_probs=194.5
Q ss_pred CCCCCceEeeccCeeEEEEEEcCCCeEEEEEEecccc-chhhHHHHHHHHHHhhc-CCCCceeeeeccccccccCCceEE
Q 045798 685 GFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC-EGASKSFMAECKALKNI-RHRNLVKVITSCSSIDFQGNDFKA 762 (1008)
Q Consensus 685 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~ 762 (1008)
+.+.+..||.|..|.||+++.+.+|..+|||.+.... .++.+++...++++..- .+|.||+.+|+ |..+..++
T Consensus 93 dl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~Gy-----Fi~n~dV~ 167 (391)
T KOG0983|consen 93 DLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGY-----FITNTDVF 167 (391)
T ss_pred HhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeE-----EeeCchHH
Confidence 3455678999999999999999999999999997543 45567788888888776 48999999999 45556688
Q ss_pred EEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEcc
Q 045798 763 IVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGD 842 (1008)
Q Consensus 763 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 842 (1008)
+.||.| ...++.+++.... ++++..+-++...+++||.||.+. .+|+|||+||+|||+|+.|++|+||
T Consensus 168 IcMelM-s~C~ekLlkrik~---------piPE~ilGk~tva~v~AL~YLKeK--H~viHRDvKPSNILlDe~GniKlCD 235 (391)
T KOG0983|consen 168 ICMELM-STCAEKLLKRIKG---------PIPERILGKMTVAIVKALYYLKEK--HGVIHRDVKPSNILLDERGNIKLCD 235 (391)
T ss_pred HHHHHH-HHHHHHHHHHhcC---------CchHHhhhhhHHHHHHHHHHHHHh--cceeecccCccceEEccCCCEEeec
Confidence 999998 5566666655432 688888899999999999999986 5999999999999999999999999
Q ss_pred cCcccccccccCccccccccccccccccCccccCC---CCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHh
Q 045798 843 FGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLG---SEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARM 919 (1008)
Q Consensus 843 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~ 919 (1008)
||++-.+.+... .....|-+.|||||.+.- ..|+.++||||||++++|+.||+.||..-..+-..+.....
T Consensus 236 FGIsGrlvdSkA-----htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln- 309 (391)
T KOG0983|consen 236 FGISGRLVDSKA-----HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLN- 309 (391)
T ss_pred ccccceeecccc-----cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHh-
Confidence 999976654332 233458999999998764 36888999999999999999999998642111111111111
Q ss_pred hCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 045798 920 ALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHE 987 (1008)
Q Consensus 920 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 987 (1008)
..| +.+. .....+..+.+++..|++.|+.+||...++++.
T Consensus 310 ~eP--------P~L~--------------------~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 310 EEP--------PLLP--------------------GHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred cCC--------CCCC--------------------cccCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 000 1111 111245568999999999999999999999873
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-33 Score=297.21 Aligned_cols=244 Identities=23% Similarity=0.271 Sum_probs=187.2
Q ss_pred ceEeeccCeeEEEEEEcCCCeEEEEEEeccccc---hhhHHHHHHHHHHh-hcCCCCceeeeeccccccccCCceEEEEE
Q 045798 690 HLIGVGSFGCVYKGALDEDGIVVAIKVINLQCE---GASKSFMAECKALK-NIRHRNLVKVITSCSSIDFQGNDFKAIVY 765 (1008)
Q Consensus 690 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~-~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 765 (1008)
+.||+|+||.||+|....+++.||+|+++.... .....+..|..++. ..+|+|++++++++ ..++..++|+
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~-----~~~~~~~lv~ 76 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSF-----QSKDYLYLVM 76 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeE-----EcCCeEEEEE
Confidence 569999999999999988899999999864321 12234455555444 45899999999984 4566799999
Q ss_pred eccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEcccCc
Q 045798 766 EYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGL 845 (1008)
Q Consensus 766 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~ 845 (1008)
||+++++|.+++.... .+++..+..++.|++.||.|||+. +++||||+|+||++++++.+||+|||.
T Consensus 77 e~~~~~~L~~~l~~~~----------~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~ 143 (260)
T cd05611 77 EYLNGGDCASLIKTLG----------GLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGL 143 (260)
T ss_pred eccCCCCHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeeccc
Confidence 9999999999987543 688999999999999999999997 999999999999999999999999999
Q ss_pred ccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCcch
Q 045798 846 ARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMALPNQV 925 (1008)
Q Consensus 846 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~ 925 (1008)
+...... ....++..|+|||.+.+..++.++||||||+++|+|++|..||...... ..+....
T Consensus 144 ~~~~~~~--------~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~~~~~~----- 206 (260)
T cd05611 144 SRNGLEN--------KKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPD----AVFDNIL----- 206 (260)
T ss_pred ceecccc--------ccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHH----HHHHHHH-----
Confidence 8754321 1234788999999998888899999999999999999999998632110 0000000
Q ss_pred hhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHH
Q 045798 926 MDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHEL 988 (1008)
Q Consensus 926 ~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 988 (1008)
.... .........++..+.+++.+||+.+|++||++.++.+.+
T Consensus 207 ----~~~~----------------~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l 249 (260)
T cd05611 207 ----SRRI----------------NWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIK 249 (260)
T ss_pred ----hccc----------------CCCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHH
Confidence 0000 000000112456689999999999999999887665544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=307.81 Aligned_cols=285 Identities=22% Similarity=0.245 Sum_probs=199.5
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccc--cchhhHHHHHHHHHHhhcCCCCceeeeeccccccc-cCCc
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQ--CEGASKSFMAECKALKNIRHRNLVKVITSCSSIDF-QGND 759 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~ 759 (1008)
.++|.+.+.||+|+||.||+|.+..+++.||+|+++.. .+.....+.+|++++++++||||+++++++..... ....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 47899999999999999999999888999999998643 22334568899999999999999999998654321 2234
Q ss_pred eEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeE
Q 045798 760 FKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGH 839 (1008)
Q Consensus 760 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 839 (1008)
..++|+||+. .++..+... .+++..+..++.|++.||+|||+. +++||||||+||+++.++.+|
T Consensus 94 ~~~lv~e~~~-~~l~~~~~~------------~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~k 157 (342)
T cd07879 94 DFYLVMPYMQ-TDLQKIMGH------------PLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELK 157 (342)
T ss_pred eEEEEecccc-cCHHHHHcC------------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEE
Confidence 5799999995 477665421 578899999999999999999998 999999999999999999999
Q ss_pred EcccCcccccccccCccccccccccccccccCccccCC-CCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHH
Q 045798 840 IGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLG-SEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFAR 918 (1008)
Q Consensus 840 L~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~ 918 (1008)
|+|||+++..... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||...... ........
T Consensus 158 L~dfg~~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~-~~~~~~~~ 229 (342)
T cd07879 158 ILDFGLARHADAE-------MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL-DQLTQILK 229 (342)
T ss_pred EeeCCCCcCCCCC-------CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHH
Confidence 9999999754321 112347889999999876 46889999999999999999999998642111 01111111
Q ss_pred hhCCcchhhhhcccccCchHHhhhhhhhhhcc-ccch-hHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHH--HHHHHHH
Q 045798 919 MALPNQVMDIVDPILRNDEEILASTDKCRRMQ-TGIN-SRLECLISMVKIGVACSMESPQDRMNMTNVVHE--LQSVKNI 994 (1008)
Q Consensus 919 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~-~~~~-~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~--L~~i~~~ 994 (1008)
. .+.....+.+..-..... .........+ .... .....+..+.+++.+||+.||++||+++|++.. +++++..
T Consensus 230 ~-~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~ 306 (342)
T cd07879 230 V-TGVPGPEFVQKLEDKAAK--SYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDA 306 (342)
T ss_pred h-cCCCCHHHHHHhcccchH--HHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcccc
Confidence 0 000000000000000000 0000000000 0000 001234567899999999999999999999954 6665543
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-33 Score=307.34 Aligned_cols=288 Identities=18% Similarity=0.240 Sum_probs=196.1
Q ss_pred ceEeec--cCeeEEEEEEcCCCeEEEEEEecccc--chhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceEEEEE
Q 045798 690 HLIGVG--SFGCVYKGALDEDGIVVAIKVINLQC--EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKAIVY 765 (1008)
Q Consensus 690 ~~lg~G--~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 765 (1008)
..||+| +||+||+|.+..+|+.||+|++.... ....+.+.+|+.+++.++||||+++++++ ..++..++|+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~-----~~~~~~~~v~ 78 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVF-----TTGSWLWVIS 78 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeE-----ecCCceEEEE
Confidence 346666 89999999998899999999987432 23456789999999999999999999994 4566799999
Q ss_pred eccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEcccCc
Q 045798 766 EYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGL 845 (1008)
Q Consensus 766 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~ 845 (1008)
||+.++++.+++...... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++++||+.
T Consensus 79 e~~~~~~l~~~l~~~~~~--------~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~ 147 (328)
T cd08226 79 PFMAYGSANSLLKTYFPE--------GMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSH 147 (328)
T ss_pred ecccCCCHHHHHHhhccc--------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHH
Confidence 999999999998765321 588999999999999999999997 999999999999999999999999986
Q ss_pred ccccccccCcc---ccccccccccccccCccccCCC--CCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHhh
Q 045798 846 ARFHQEVSNST---LSSSVGVKGTIGYTAPEYGLGS--EVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMA 920 (1008)
Q Consensus 846 a~~~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~~ 920 (1008)
+.......... ........++..|+|||++.+. .++.++||||+||++|||++|+.||.................
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~ 227 (328)
T cd08226 148 LYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPP 227 (328)
T ss_pred HhhhhccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCC
Confidence 64332211110 0001112246679999998764 478999999999999999999999865322111111100000
Q ss_pred C--------CcchhhhhcccccCch---HHhhh---hhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 921 L--------PNQVMDIVDPILRNDE---EILAS---TDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 921 ~--------~~~~~~~~d~~l~~~~---~~~~~---~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
. +.......+....... +.... ...........+....+...+.+++.+||+.||++|||++|+++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~ 307 (328)
T cd08226 228 YSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS 307 (328)
T ss_pred CCCccccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 0 0000000000000000 00000 00000000011122356778999999999999999999999986
Q ss_pred H--HHHHHH
Q 045798 987 E--LQSVKN 993 (1008)
Q Consensus 987 ~--L~~i~~ 993 (1008)
. ++.+++
T Consensus 308 ~~~~~~~~~ 316 (328)
T cd08226 308 HAFFKQVKE 316 (328)
T ss_pred CHHHHHHHH
Confidence 3 444433
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=325.29 Aligned_cols=281 Identities=19% Similarity=0.204 Sum_probs=188.6
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCC-eEEEEE------------------EeccccchhhHHHHHHHHHHhhcCCCCc
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDG-IVVAIK------------------VINLQCEGASKSFMAECKALKNIRHRNL 743 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~-~~vavK------------------~~~~~~~~~~~~~~~E~~~l~~l~h~ni 743 (1008)
.++|++++.||+|+||+||+|..+... ..+++| .+. ........+.+|++++++++||||
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK-AGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh-cchHHHHHHHHHHHHHHhCCCCCc
Confidence 568999999999999999998764322 222222 111 112234568899999999999999
Q ss_pred eeeeeccccccccCCceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceec
Q 045798 744 VKVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHC 823 (1008)
Q Consensus 744 v~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~ 823 (1008)
+++++++ ...+..|+|+|++ ++++.+++....... .......+++.|+.||+.||+|||+. +||||
T Consensus 226 v~l~~~~-----~~~~~~~lv~e~~-~~~l~~~l~~~~~~~-----~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHr 291 (501)
T PHA03210 226 LKIEEIL-----RSEANTYMITQKY-DFDLYSFMYDEAFDW-----KDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHR 291 (501)
T ss_pred CcEeEEE-----EECCeeEEEEecc-ccCHHHHHhhccccc-----cccccHHHHHHHHHHHHHHHHHHHhC---CeecC
Confidence 9999994 4556789999999 568887775432211 01334667889999999999999997 99999
Q ss_pred cCCCCCeeecCCCCeEEcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCC
Q 045798 824 DLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPT 903 (1008)
Q Consensus 824 Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf 903 (1008)
||||+|||++.++.+||+|||+++.+...... ......||..|+|||++.+..++.++|||||||++|||++|..++
T Consensus 292 DLKP~NILl~~~~~vkL~DFGla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p 368 (501)
T PHA03210 292 DIKLENIFLNCDGKIVLGDFGTAMPFEKEREA---FDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCP 368 (501)
T ss_pred CCCHHHEEECCCCCEEEEeCCCceecCccccc---ccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCC
Confidence 99999999999999999999999866433221 122356899999999999999999999999999999999988643
Q ss_pred -CccccC-CccHHHHHHh------hCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCC
Q 045798 904 -DVMFEG-DLNLHNFARM------ALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESP 975 (1008)
Q Consensus 904 -~~~~~~-~~~~~~~~~~------~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP 975 (1008)
...... ...+...... .++.....+.+..-... ........+..-.....+..+.+++.+|++.||
T Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~------~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP 442 (501)
T PHA03210 369 IGDGGGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAE------IDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDW 442 (501)
T ss_pred ccCCCCCHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhh------cccCccchhhHHHhcCCChHHHHHHHHHhccCc
Confidence 321111 1111111110 01111111111000000 000000000000011234557888999999999
Q ss_pred CCCCCHHHHHHH
Q 045798 976 QDRMNMTNVVHE 987 (1008)
Q Consensus 976 ~~RPt~~evl~~ 987 (1008)
++|||+.|+++.
T Consensus 443 ~~Rpsa~elL~h 454 (501)
T PHA03210 443 HLRPGAAELLAL 454 (501)
T ss_pred ccCcCHHHHhhC
Confidence 999999999863
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=255.96 Aligned_cols=196 Identities=28% Similarity=0.460 Sum_probs=169.5
Q ss_pred CCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccc--cchhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceEE
Q 045798 685 GFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQ--CEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKA 762 (1008)
Q Consensus 685 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 762 (1008)
.|...++||+|.||+||+|+.+++++.||+|+++.. +++......+|+-+++.++|.|||+++++ ...+...-
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dv-----lhsdkklt 77 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV-----LHSDKKLT 77 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhh-----hccCceeE
Confidence 466678999999999999999999999999999754 34556789999999999999999999998 57778899
Q ss_pred EEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEcc
Q 045798 763 IVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGD 842 (1008)
Q Consensus 763 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 842 (1008)
+|+||| +.+|..|...... .++.+.++.++.|+++|+.++|++ ++.|||+||.|.+|..+|+.|++|
T Consensus 78 lvfe~c-dqdlkkyfdslng---------~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelklad 144 (292)
T KOG0662|consen 78 LVFEFC-DQDLKKYFDSLNG---------DLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLAD 144 (292)
T ss_pred EeHHHh-hHHHHHHHHhcCC---------cCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecc
Confidence 999999 6699988865432 688999999999999999999998 999999999999999999999999
Q ss_pred cCcccccccccCccccccccccccccccCccccCCCC-CCcccchhhHHHHHHHHHhCCCC
Q 045798 843 FGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSE-VSTNGDVYSYGILLLEMVTAKKP 902 (1008)
Q Consensus 843 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwslG~vl~elltG~~p 902 (1008)
||+|+.++-.. ......+.|.+|++|.++.+.. |+...|+||.||++.|+.....|
T Consensus 145 fglarafgipv----rcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrp 201 (292)
T KOG0662|consen 145 FGLARAFGIPV----RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP 201 (292)
T ss_pred cchhhhcCCce----EeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCC
Confidence 99998665432 2223345799999999998864 78899999999999999985544
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=288.82 Aligned_cols=278 Identities=22% Similarity=0.284 Sum_probs=207.6
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccchhhHHHHHHHHHHhhcC-C-C----Cceeeeecccccccc
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIR-H-R----NLVKVITSCSSIDFQ 756 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-~----niv~~~~~~~~~~~~ 756 (1008)
+++|.++..+|+|.||.|-.+.+.+.+..||||+++.- ....+..+-|+++++++. + | -+|.+.++ |+
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V-~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~w-----Fd 161 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV-DKYREAALIEIEVLQKINESDPNGKFRCVQMRDW-----FD 161 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH-HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehh-----hh
Confidence 67899999999999999999999989999999999754 344566788999999993 2 2 36677677 67
Q ss_pred CCceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecC--
Q 045798 757 GNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDN-- 834 (1008)
Q Consensus 757 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~-- 834 (1008)
..++.|||+|.+ |-|+.+++..+... +++...++.+++|+++++++||+. +++|-|+||+||++.+
T Consensus 162 yrghiCivfell-G~S~~dFlk~N~y~--------~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~ 229 (415)
T KOG0671|consen 162 YRGHICIVFELL-GLSTFDFLKENNYI--------PFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSE 229 (415)
T ss_pred ccCceEEEEecc-ChhHHHHhccCCcc--------ccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccc
Confidence 788899999999 88999999886533 799999999999999999999998 9999999999999831
Q ss_pred ------------------CCCeEEcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHH
Q 045798 835 ------------------DLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEM 896 (1008)
Q Consensus 835 ------------------~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~el 896 (1008)
+..+|++|||.|....... ...+.|..|+|||++.+-.++.++||||+|||++|+
T Consensus 230 ~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h-------s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~El 302 (415)
T KOG0671|consen 230 YFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH-------STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVEL 302 (415)
T ss_pred eEEEeccCCccceeccCCCcceEEEecCCcceeccCc-------ceeeeccccCCchheeccCcCCccCceeeeeEEEEe
Confidence 3457999999998654432 235689999999999999999999999999999999
Q ss_pred HhCCCCCCccccCCccHHHHHHh--hCCcchhhhh------cc-ccc-----CchHHhhhhhhhhhccccchhHHHHHHH
Q 045798 897 VTAKKPTDVMFEGDLNLHNFARM--ALPNQVMDIV------DP-ILR-----NDEEILASTDKCRRMQTGINSRLECLIS 962 (1008)
Q Consensus 897 ltG~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~~------d~-~l~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 962 (1008)
.+|...|..-. ..+.++-+.+. ++|.....-. .. .+. ...+.+...+.|+...........+..+
T Consensus 303 ytG~~LFqtHe-n~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~ 381 (415)
T KOG0671|consen 303 YTGETLFQTHE-NLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQ 381 (415)
T ss_pred eccceecccCC-cHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhH
Confidence 99999876322 11111111111 1222111111 00 000 0000112222233333333344467778
Q ss_pred HHHHHhcccCcCCCCCCCHHHHHH
Q 045798 963 MVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 963 l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
+.+|+++|+..||.+|+|+.|++.
T Consensus 382 LfDLl~~mL~fDP~~RiTl~EAL~ 405 (415)
T KOG0671|consen 382 LFDLLRRMLEFDPARRITLREALS 405 (415)
T ss_pred HHHHHHHHHccCccccccHHHHhc
Confidence 999999999999999999999875
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=304.92 Aligned_cols=258 Identities=25% Similarity=0.285 Sum_probs=191.9
Q ss_pred CCCCCceEeeccCeeEEEEEEcCCCeEEEEEEecccc-chhhHHHHHHHHHHhhcC-CCCceeeeeccccccccCCceEE
Q 045798 685 GFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC-EGASKSFMAECKALKNIR-HRNLVKVITSCSSIDFQGNDFKA 762 (1008)
Q Consensus 685 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~ 762 (1008)
+|...+.||+|+||.||++.+..+++.||+|.+.... ......+.+|+.++.++. |+||+++++++ ..+...+
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~-----~~~~~~~ 79 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGAL-----FREGDCW 79 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEE-----ecCCcEE
Confidence 4566788999999999999999899999999987443 344567899999999995 99999999985 3456689
Q ss_pred EEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEcc
Q 045798 763 IVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGD 842 (1008)
Q Consensus 763 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 842 (1008)
++|||++ +++.++....... ....+++..+..++.|++.||+|||+. .+++||||||+||+++.++.+||+|
T Consensus 80 ~~~e~~~-~~l~~l~~~~~~~-----~~~~l~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~d 151 (288)
T cd06616 80 ICMELMD-ISLDKFYKYVYEV-----LKSVIPEEILGKIAVATVKALNYLKEE--LKIIHRDVKPSNILLDRNGNIKLCD 151 (288)
T ss_pred EEEeccc-CCHHHHHHHHHHh-----hcCCCCHHHHHHHHHHHHHHHHHHhhc--CCeeccCCCHHHEEEccCCcEEEee
Confidence 9999984 5665543211000 011689999999999999999999973 3899999999999999999999999
Q ss_pred cCcccccccccCccccccccccccccccCccccCCC---CCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHh
Q 045798 843 FGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGS---EVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARM 919 (1008)
Q Consensus 843 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~ 919 (1008)
||++......... ....++..|+|||++.+. .++.++||||+||++|||++|+.||..... ..... ..
T Consensus 152 fg~~~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~---~~~~~-~~ 222 (288)
T cd06616 152 FGISGQLVDSIAK-----TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS---VFDQL-TQ 222 (288)
T ss_pred cchhHHhccCCcc-----ccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch---HHHHH-hh
Confidence 9999755332211 123478899999998776 689999999999999999999999863210 00000 00
Q ss_pred hCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 045798 920 ALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHE 987 (1008)
Q Consensus 920 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 987 (1008)
..... .+.+. .. .....+.++.+++.+||+.||++|||++||++.
T Consensus 223 ~~~~~-----~~~~~----------------~~--~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 223 VVKGD-----PPILS----------------NS--EEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred hcCCC-----CCcCC----------------Cc--CCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000 00000 00 001345678999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=294.19 Aligned_cols=254 Identities=25% Similarity=0.370 Sum_probs=202.5
Q ss_pred CCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccc--hhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceEE
Q 045798 685 GFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCE--GASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKA 762 (1008)
Q Consensus 685 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 762 (1008)
+|+..+.||+|++|.||+|....+++.|++|++..... ...+.+.+|++++++++|+||+++++.+... .....+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~---~~~~~~ 77 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDE---EKNTLN 77 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecC---CCCeEE
Confidence 47788999999999999999988899999999975542 4567899999999999999999999985421 126789
Q ss_pred EEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEcc
Q 045798 763 IVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGD 842 (1008)
Q Consensus 763 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 842 (1008)
+|+||+++++|.+++.... .+++..+..++.|++.|++|||+. +++||||+|+||+++.++.++|+|
T Consensus 78 lv~e~~~~~~L~~~~~~~~----------~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d 144 (260)
T cd06606 78 IFLEYVSGGSLSSLLKKFG----------KLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLAD 144 (260)
T ss_pred EEEEecCCCcHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcc
Confidence 9999999999999987653 689999999999999999999997 999999999999999999999999
Q ss_pred cCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHhhCC
Q 045798 843 FGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMALP 922 (1008)
Q Consensus 843 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~~~~ 922 (1008)
||.+......... .......++..|+|||...+..++.++||||||+++|+|++|..||..... ...........
T Consensus 145 ~~~~~~~~~~~~~--~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~~~ 219 (260)
T cd06606 145 FGCAKRLGDIETG--EGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGN---PMAALYKIGSS 219 (260)
T ss_pred cccEEeccccccc--ccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc---hHHHHHhcccc
Confidence 9999866554321 011224588999999999888899999999999999999999999864320 00000000000
Q ss_pred cchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 923 NQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 923 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
... .. .....+..+.+++.+|++.+|.+||++.|++.
T Consensus 220 ~~~-------------------------~~--~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 220 GEP-------------------------PE--IPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred CCC-------------------------cC--CCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 000 00 01123566899999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-33 Score=308.89 Aligned_cols=285 Identities=22% Similarity=0.241 Sum_probs=198.4
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccchhhHHHHHHHHHHhhcCCCCceeeeecccccc--------
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSCSSID-------- 754 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-------- 754 (1008)
..+|.+.+.||.|+||.||+|....+++.||+|++........+.+.+|++++++++||||+++++++....
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 368999999999999999999999899999999997665566678899999999999999999998754322
Q ss_pred -ccCCceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeec
Q 045798 755 -FQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLD 833 (1008)
Q Consensus 755 -~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~ 833 (1008)
+......++||||++ ++|.+++... .+++..++.++.||+.||.|||+. +|+||||||+||+++
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~~~-----------~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~ 148 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLEQG-----------PLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFIN 148 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHHcC-----------CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEc
Confidence 112245799999995 6898887532 578999999999999999999998 999999999999997
Q ss_pred -CCCCeEEcccCcccccccccCccccccccccccccccCccccCC-CCCCcccchhhHHHHHHHHHhCCCCCCccccCCc
Q 045798 834 -NDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLG-SEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDL 911 (1008)
Q Consensus 834 -~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~ 911 (1008)
+++.+|++|||.+........... ......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||........
T Consensus 149 ~~~~~~kl~dfg~~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~ 227 (342)
T cd07854 149 TEDLVLKIGDFGLARIVDPHYSHKG-YLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQ 227 (342)
T ss_pred CCCceEEECCcccceecCCcccccc-ccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 456789999999975533211111 1112347889999997654 5678899999999999999999999964322111
Q ss_pred cHHHHHHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 912 NLHNFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
...... ..+..............+..... .......+..........++.+++.+||+.||.+|||+.|++.
T Consensus 228 -~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 228 -MQLILE-SVPVVREEDRNELLNVIPSFVRN-DGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred -HHHHHH-hcCCCChHHhhhhhhhhhhhhhh-cccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 000100 00100000000000000000000 0000000000001123456789999999999999999999985
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-35 Score=279.57 Aligned_cols=210 Identities=26% Similarity=0.395 Sum_probs=178.2
Q ss_pred cCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEecc--ccchhhHHHHHHHHHHhhcCCCCceeeeecccccccc---CC
Q 045798 684 NGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINL--QCEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQ---GN 758 (1008)
Q Consensus 684 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~---~~ 758 (1008)
+.|....+||+|.||+||+|+.+.+|+.||+|++-. ..++-.....+|++++..++|+|++.+++.|...... +.
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 456667889999999999999999999999987643 3344456789999999999999999999998865432 22
Q ss_pred ceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCe
Q 045798 759 DFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSG 838 (1008)
Q Consensus 759 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 838 (1008)
...|+||.+|+. +|...+.... .+++..++.+++.++..||.|+|.. .|+|||+||.|+||+.+|.+
T Consensus 97 ~t~ylVf~~ceh-DLaGlLsn~~---------vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgil 163 (376)
T KOG0669|consen 97 ATFYLVFDFCEH-DLAGLLSNRK---------VRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGIL 163 (376)
T ss_pred ceeeeeHHHhhh-hHHHHhcCcc---------ccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceE
Confidence 347999999955 8988887653 2789999999999999999999998 99999999999999999999
Q ss_pred EEcccCcccccccccCccccccccccccccccCccccCC-CCCCcccchhhHHHHHHHHHhCCCCCCcc
Q 045798 839 HIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLG-SEVSTNGDVYSYGILLLEMVTAKKPTDVM 906 (1008)
Q Consensus 839 kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltG~~pf~~~ 906 (1008)
||+|||+++.+...........+..+.|.+|++||.+.| +.|+++.|||+.|||+.||++|.+.+...
T Consensus 164 klADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgn 232 (376)
T KOG0669|consen 164 KLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGN 232 (376)
T ss_pred EeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCC
Confidence 999999998776655554445666778999999998877 47999999999999999999999987643
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=306.36 Aligned_cols=286 Identities=20% Similarity=0.262 Sum_probs=203.9
Q ss_pred HHHHHHHhcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEecccc--chhhHHHHHHHHHHhhcCCCCceeeeeccccc
Q 045798 676 YKSLLKATNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC--EGASKSFMAECKALKNIRHRNLVKVITSCSSI 753 (1008)
Q Consensus 676 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 753 (1008)
..++....++|.+.+.||+|+||.||+|.+..+++.||+|+++... ....+.+.+|+.++++++||||+++++++...
T Consensus 9 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~ 88 (345)
T cd07877 9 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 88 (345)
T ss_pred HHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeec
Confidence 3456667899999999999999999999998899999999987432 22346788999999999999999999986532
Q ss_pred c-ccCCceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeee
Q 045798 754 D-FQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILL 832 (1008)
Q Consensus 754 ~-~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll 832 (1008)
. +......+++++++ +++|.+++... .+++..+..++.|++.||+|||+. +|+||||||+||++
T Consensus 89 ~~~~~~~~~~lv~~~~-~~~L~~~~~~~-----------~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll 153 (345)
T cd07877 89 RSLEEFNDVYLVTHLM-GADLNNIVKCQ-----------KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAV 153 (345)
T ss_pred ccccccccEEEEehhc-ccCHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEE
Confidence 2 22334578888887 88998887543 578999999999999999999998 99999999999999
Q ss_pred cCCCCeEEcccCcccccccccCccccccccccccccccCccccCC-CCCCcccchhhHHHHHHHHHhCCCCCCccccCCc
Q 045798 833 DNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLG-SEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDL 911 (1008)
Q Consensus 833 ~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~ 911 (1008)
++++.+||+|||++...... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||...... .
T Consensus 154 ~~~~~~kl~dfg~~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~-~ 225 (345)
T cd07877 154 NEDCELKILDFGLARHTDDE-------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI-D 225 (345)
T ss_pred cCCCCEEEeccccccccccc-------ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-H
Confidence 99999999999999754321 122347889999998766 46788999999999999999999998542211 1
Q ss_pred cHHHHHHhhCCcchhhhhcccccCchHHhhhhhhhhhccc-cch-hHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 045798 912 NLHNFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQT-GIN-SRLECLISMVKIGVACSMESPQDRMNMTNVVHE 987 (1008)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~-~~~-~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 987 (1008)
......+..... ........-.... ..........+. ... .....+..+.+++.+|++.||.+||++.++++.
T Consensus 226 ~~~~~~~~~~~~-~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 226 QLKLILRLVGTP-GAELLKKISSESA--RNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred HHHHHHHHhCCC-CHHHHhhcccHhH--HHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 111111111100 0011100000000 000000000000 000 000134567899999999999999999998864
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=306.41 Aligned_cols=280 Identities=22% Similarity=0.255 Sum_probs=200.1
Q ss_pred HHhcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEecccc--chhhHHHHHHHHHHhhcCCCCceeeeeccccccc-cC
Q 045798 681 KATNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC--EGASKSFMAECKALKNIRHRNLVKVITSCSSIDF-QG 757 (1008)
Q Consensus 681 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~ 757 (1008)
...++|++.+.||+|+||.||+|.+..+++.||||++.... ....+.+.+|++++++++||||+++++++..... ..
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07880 12 EVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDR 91 (343)
T ss_pred ccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccc
Confidence 35678999999999999999999998899999999986432 2334568899999999999999999998643211 11
Q ss_pred CceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCC
Q 045798 758 NDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLS 837 (1008)
Q Consensus 758 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 837 (1008)
....++||||+ +++|.+++... .+++..++.++.|++.||+|||+. +|+||||||+||+++.++.
T Consensus 92 ~~~~~lv~e~~-~~~l~~~~~~~-----------~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~ 156 (343)
T cd07880 92 FHDFYLVMPFM-GTDLGKLMKHE-----------KLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCE 156 (343)
T ss_pred cceEEEEEecC-CCCHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCC
Confidence 23468999999 78999887542 688999999999999999999998 9999999999999999999
Q ss_pred eEEcccCcccccccccCccccccccccccccccCccccCC-CCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHH
Q 045798 838 GHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLG-SEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNF 916 (1008)
Q Consensus 838 ~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~ 916 (1008)
+||+|||++....... ....++..|+|||.+.+ ..++.++||||+||++|++++|+.||...... ......
T Consensus 157 ~kl~dfg~~~~~~~~~-------~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~-~~~~~~ 228 (343)
T cd07880 157 LKILDFGLARQTDSEM-------TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHL-DQLMEI 228 (343)
T ss_pred EEEeecccccccccCc-------cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHH
Confidence 9999999997543321 12347889999998876 45789999999999999999999998643211 011111
Q ss_pred HHhhCCcchhhhhcccccCchHHhhhhhhhhhcccc-c-hhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 917 ARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTG-I-NSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 917 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~-~-~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
...... ...++.......... ..........+. . ......+..+.+++.+|++.||++|||+.++++
T Consensus 229 ~~~~~~-~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~ 297 (343)
T cd07880 229 MKVTGT-PSKEFVQKLQSEDAK--NYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA 297 (343)
T ss_pred HHhcCC-CCHHHHHhhcchhHH--HHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 110000 001111111000000 000000000000 0 001134556889999999999999999999984
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=295.64 Aligned_cols=243 Identities=23% Similarity=0.294 Sum_probs=192.6
Q ss_pred EeeccCeeEEEEEEcCCCeEEEEEEecccc---chhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceEEEEEecc
Q 045798 692 IGVGSFGCVYKGALDEDGIVVAIKVINLQC---EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKAIVYEYM 768 (1008)
Q Consensus 692 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 768 (1008)
||.|++|.||+|.+..+++.||+|++.... ....+.+.+|++++++++||||+++++.+ .++...++||||+
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~lv~e~~ 75 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTF-----KDKKYIYMLMEYC 75 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeE-----EcCCccEEEEecC
Confidence 689999999999998889999999986432 23456799999999999999999999984 5567799999999
Q ss_pred CCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEcccCcccc
Q 045798 769 PNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARF 848 (1008)
Q Consensus 769 ~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~ 848 (1008)
++++|.+++.... .+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||.+..
T Consensus 76 ~~~~L~~~l~~~~----------~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~ 142 (262)
T cd05572 76 LGGELWTILRDRG----------LFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKK 142 (262)
T ss_pred CCCcHHHHHhhcC----------CCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccc
Confidence 9999999997653 578999999999999999999997 999999999999999999999999999986
Q ss_pred cccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCcchhhh
Q 045798 849 HQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMALPNQVMDI 928 (1008)
Q Consensus 849 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 928 (1008)
...... .....++..|+|||.+.+..++.++||||+|+++|+|++|..||....+.. ...... .
T Consensus 143 ~~~~~~-----~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~~~~--------~ 206 (262)
T cd05572 143 LKSGQK-----TWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP---MEIYND--------I 206 (262)
T ss_pred cCcccc-----cccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH---HHHHHH--------H
Confidence 644321 122357889999999888889999999999999999999999986432110 000000 0
Q ss_pred hcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCC-----HHHHHH
Q 045798 929 VDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMN-----MTNVVH 986 (1008)
Q Consensus 929 ~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~ 986 (1008)
.+.. .... .....+.++.+++.+||+.+|++||+ ++|+++
T Consensus 207 ~~~~----------------~~~~--~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 207 LKGN----------------GKLE--FPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred hccC----------------CCCC--CCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 0000 0000 01112556899999999999999999 566554
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=303.77 Aligned_cols=278 Identities=20% Similarity=0.229 Sum_probs=191.4
Q ss_pred cCeeEEEEEEcCCCeEEEEEEeccc--cchhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceEEEEEeccCCCCh
Q 045798 696 SFGCVYKGALDEDGIVVAIKVINLQ--CEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKAIVYEYMPNGSL 773 (1008)
Q Consensus 696 ~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL 773 (1008)
++|.||.++...+++.||+|+++.. .....+.+.+|++++++++|+||++++++ +...+..+++|||+++|+|
T Consensus 12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~-----~~~~~~~~~~~e~~~~~~l 86 (314)
T cd08216 12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTS-----FIVDSELYVVSPLMAYGSC 86 (314)
T ss_pred CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhhe-----eecCCeEEEEEeccCCCCH
Confidence 3455566666558999999999754 33455789999999999999999999998 4556778999999999999
Q ss_pred hcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEcccCccccccccc
Q 045798 774 EKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVS 853 (1008)
Q Consensus 774 ~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~ 853 (1008)
.+++...... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+|++|||.+.......
T Consensus 87 ~~~l~~~~~~--------~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~ 155 (314)
T cd08216 87 EDLLKTHFPE--------GLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHG 155 (314)
T ss_pred HHHHHHhccc--------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeecccc
Confidence 9999754321 578899999999999999999998 99999999999999999999999999987553322
Q ss_pred Cc---cccccccccccccccCccccCC--CCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCcch---
Q 045798 854 NS---TLSSSVGVKGTIGYTAPEYGLG--SEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMALPNQV--- 925 (1008)
Q Consensus 854 ~~---~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~--- 925 (1008)
.. .........++..|+|||++.+ ..++.++|||||||++|||++|+.||........... ......+...
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~-~~~~~~~~~~~~~ 234 (314)
T cd08216 156 KRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLE-KVRGTVPCLLDKS 234 (314)
T ss_pred ccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-HHhccCccccccC
Confidence 11 1111122347788999999866 3588999999999999999999999874322111111 1110000000
Q ss_pred -hhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHH--HHHHH
Q 045798 926 -MDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHE--LQSVK 992 (1008)
Q Consensus 926 -~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~--L~~i~ 992 (1008)
............ ......................++.+++.+||+.||++|||++|+++. +..++
T Consensus 235 ~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~ 302 (314)
T cd08216 235 TYPLYEDSMSQSR--SSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCK 302 (314)
T ss_pred chhhhcCCcCccc--ccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhc
Confidence 000000000000 000000000011111222445678999999999999999999999874 44443
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-32 Score=297.58 Aligned_cols=276 Identities=26% Similarity=0.292 Sum_probs=199.8
Q ss_pred CCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccc--hhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceEEE
Q 045798 686 FSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCE--GASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKAI 763 (1008)
Q Consensus 686 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 763 (1008)
|++.+.||+|++|.||+|....+++.||+|+++.... .....+.+|++++++++|+||+++++++ ..++..++
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~~ 75 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVF-----RHKGDLYL 75 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhh-----ccCCCEEE
Confidence 6778999999999999999988999999999875432 3456788999999999999999999985 45577999
Q ss_pred EEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEccc
Q 045798 764 VYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDF 843 (1008)
Q Consensus 764 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 843 (1008)
|+||++ +++.+++.... ..+++..+..++.|++.||+|||+. +|+||||+|+||+++.++.+||+||
T Consensus 76 v~e~~~-~~l~~~l~~~~---------~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df 142 (283)
T cd05118 76 VFEFMD-TDLYKLIKDRQ---------RGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADF 142 (283)
T ss_pred EEeccC-CCHHHHHHhhc---------ccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeee
Confidence 999996 48888876542 1689999999999999999999998 9999999999999999999999999
Q ss_pred CcccccccccCccccccccccccccccCccccCCC-CCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHhhCC
Q 045798 844 GLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGS-EVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMALP 922 (1008)
Q Consensus 844 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~~~~ 922 (1008)
|.+........ ......++..|+|||.+.+. .++.++||||+|+++|+|++|+.||......+ ........ ..
T Consensus 143 ~~~~~~~~~~~----~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~-~~~~~~~~-~~ 216 (283)
T cd05118 143 GLARSFGSPVR----PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEID-QLFKIFRT-LG 216 (283)
T ss_pred eeeEecCCCcc----cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHH-cC
Confidence 99976644321 11223478899999998776 78999999999999999999999986432111 11111110 00
Q ss_pred cchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 923 NQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 923 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
......................... ...........+.++.+++.+||+.||.+||++.+++.
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 217 TPDPEVWPKFTSLARNYKFSFPKKA-GMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred CCchHhcccchhhhhhhhhhhcccc-ccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 0000000000000000000000000 00000112345778999999999999999999999975
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=301.43 Aligned_cols=283 Identities=24% Similarity=0.304 Sum_probs=200.7
Q ss_pred HHhcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEecccc--chhhHHHHHHHHHHhhcCCCCceeeeecccccc----
Q 045798 681 KATNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC--EGASKSFMAECKALKNIRHRNLVKVITSCSSID---- 754 (1008)
Q Consensus 681 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~---- 754 (1008)
...++|++.+.||+|+||.||+|.+..+++.||+|+++... ......+.+|++++++++||||+++++++....
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 34678999999999999999999998889999999997542 233456788999999999999999999865432
Q ss_pred -ccCCceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeec
Q 045798 755 -FQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLD 833 (1008)
Q Consensus 755 -~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~ 833 (1008)
..+....++|+||+++ ++.+++.... ..+++..++.++.||+.||+|||+. +|+||||||+||+++
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~---------~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~ 150 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESGL---------VHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLN 150 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcCC---------CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEC
Confidence 1223478999999965 7777765432 1689999999999999999999998 999999999999999
Q ss_pred CCCCeEEcccCcccccccccCccccccccccccccccCccccCC-CCCCcccchhhHHHHHHHHHhCCCCCCccccCCcc
Q 045798 834 NDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLG-SEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLN 912 (1008)
Q Consensus 834 ~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~ 912 (1008)
+++.+||+|||.+.......... .....++..|+|||.+.+ ..++.++|||||||++|||++|++||..... ...
T Consensus 151 ~~~~~kl~dfg~~~~~~~~~~~~---~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~-~~~ 226 (302)
T cd07864 151 NKGQIKLADFGLARLYNSEESRP---YTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQE-LAQ 226 (302)
T ss_pred CCCcEEeCcccccccccCCcccc---cccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh-HHH
Confidence 99999999999998654433211 112346788999998765 3578899999999999999999999864211 111
Q ss_pred HHHHHHhhCCcc---hhhhhcccccCchHHhhhhhhhhhccccc-hhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 913 LHNFARMALPNQ---VMDIVDPILRNDEEILASTDKCRRMQTGI-NSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 913 ~~~~~~~~~~~~---~~~~~d~~l~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
............ ...+........ .+......... ......+..+.+++.+||+.||.+|||++++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 227 LELISRLCGSPCPAVWPDVIKLPYFNT------MKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred HHHHHHHhCCCChhhcccccccccccc------cccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 111111111000 000000000000 00000000000 001123567899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=298.20 Aligned_cols=274 Identities=20% Similarity=0.218 Sum_probs=193.3
Q ss_pred CCCCceEeeccCeeEEEEEEcCCCeEEEEEEecccc-chhhHHHHHHHHHHhhc-CCCCceeeeeccccccccCCceEEE
Q 045798 686 FSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC-EGASKSFMAECKALKNI-RHRNLVKVITSCSSIDFQGNDFKAI 763 (1008)
Q Consensus 686 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~l 763 (1008)
|++.+.||+|+||.||+|....+++.||+|+++... ........+|+.++.++ +|+|++++++++.. ...+..++
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~---~~~~~~~l 77 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFD---RKTGRLAL 77 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEec---CCCCcEEE
Confidence 678899999999999999998899999999987532 22233456788999988 49999999999643 22267899
Q ss_pred EEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEccc
Q 045798 764 VYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDF 843 (1008)
Q Consensus 764 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 843 (1008)
||||++ +++.+++..... .+++.+++.++.|++.||+|||+. +++||||+|+||+++. +.+||+||
T Consensus 78 v~e~~~-~~l~~~l~~~~~---------~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~df 143 (282)
T cd07831 78 VFELMD-MNLYELIKGRKR---------PLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADF 143 (282)
T ss_pred EEecCC-ccHHHHHHhccC---------CCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEec
Confidence 999995 588888765321 689999999999999999999997 9999999999999999 99999999
Q ss_pred CcccccccccCccccccccccccccccCccccCC-CCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHhhCC
Q 045798 844 GLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLG-SEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMALP 922 (1008)
Q Consensus 844 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~~~~ 922 (1008)
|.++........ ....++..|+|||++.+ ..++.++||||+||++|||++|..||......+ ..........
T Consensus 144 g~~~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~--~~~~~~~~~~ 216 (282)
T cd07831 144 GSCRGIYSKPPY-----TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELD--QIAKIHDVLG 216 (282)
T ss_pred ccccccccCCCc-----CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHH--HHHHHHHHcC
Confidence 999865432221 12347889999997644 557889999999999999999999986432111 1111111111
Q ss_pred cchhhhhcccccCchHHhhhhhhhhhccccc-hhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 923 NQVMDIVDPILRNDEEILASTDKCRRMQTGI-NSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 923 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
.....+ .......... ............ ......+..+.+++.+||+.+|++|||++++++
T Consensus 217 ~~~~~~-~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 217 TPDAEV-LKKFRKSRHM--NYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred CCCHHH-HHhhcccccc--cccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 100000 0000000000 000000000000 001234678999999999999999999999975
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=298.13 Aligned_cols=242 Identities=24% Similarity=0.307 Sum_probs=188.1
Q ss_pred EeeccCeeEEEEEEcCCCeEEEEEEecccc---chhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceEEEEEecc
Q 045798 692 IGVGSFGCVYKGALDEDGIVVAIKVINLQC---EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKAIVYEYM 768 (1008)
Q Consensus 692 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 768 (1008)
||+|+||+||+|....+|+.||+|++.... ......+.+|++++++++||||+++++++ ...+..|+||||+
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~lv~e~~ 75 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAF-----ETKDDLCLVMTLM 75 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEE-----ecCCeEEEEEecC
Confidence 689999999999998899999999986432 22345678899999999999999999884 5567799999999
Q ss_pred CCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEcccCcccc
Q 045798 769 PNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARF 848 (1008)
Q Consensus 769 ~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~ 848 (1008)
++++|.+++...... .+++..+..++.|++.|+.|||+. +++||||+|+||++++++.+||+|||.+..
T Consensus 76 ~~~~L~~~l~~~~~~--------~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~ 144 (277)
T cd05577 76 NGGDLKYHIYNVGEP--------GFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVE 144 (277)
T ss_pred CCCcHHHHHHHcCcC--------CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhh
Confidence 999999998755421 689999999999999999999997 999999999999999999999999999875
Q ss_pred cccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCcchhhh
Q 045798 849 HQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMALPNQVMDI 928 (1008)
Q Consensus 849 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 928 (1008)
...... .....++..|+|||++.+..++.++||||+||++|+|++|+.||....... .........
T Consensus 145 ~~~~~~-----~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~-------- 210 (277)
T cd05577 145 LKGGKK-----IKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKV-EKEELKRRT-------- 210 (277)
T ss_pred hccCCc-----cccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccc-cHHHHHhcc--------
Confidence 543211 112347889999999988889999999999999999999999986432210 000000000
Q ss_pred hcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHH
Q 045798 929 VDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTN 983 (1008)
Q Consensus 929 ~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 983 (1008)
... + .......+..+.+++.+||+.||.+||+++|
T Consensus 211 ----~~~--------------~--~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~ 245 (277)
T cd05577 211 ----LEM--------------A--VEYPDKFSPEAKDLCEALLQKDPEKRLGCRG 245 (277)
T ss_pred ----ccc--------------c--ccCCccCCHHHHHHHHHHccCChhHccCCCc
Confidence 000 0 0000123456789999999999999994444
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=294.10 Aligned_cols=250 Identities=26% Similarity=0.311 Sum_probs=200.6
Q ss_pred CCCCCceEeeccCeeEEEEEEcCCCeEEEEEEecccc--chhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceEE
Q 045798 685 GFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC--EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKA 762 (1008)
Q Consensus 685 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 762 (1008)
+|++.+.||+|+||.||++.+..+++.||+|++.... ......+.+|+++++.++|+||+++.+++ ......+
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~ 75 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAF-----LDGNKLC 75 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhh-----ccCCEEE
Confidence 5888999999999999999998899999999987432 34456788999999999999999999884 4557799
Q ss_pred EEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEcc
Q 045798 763 IVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGD 842 (1008)
Q Consensus 763 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 842 (1008)
+||||+++++|.+++...... ...+++..++.++.|++.||+|||+. +++||||+|+||++++++.+||+|
T Consensus 76 ~v~e~~~~~~L~~~~~~~~~~------~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d 146 (256)
T cd08530 76 IVMEYAPFGDLSKAISKRKKK------RKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGD 146 (256)
T ss_pred EEehhcCCCCHHHHHHHHHhh------cCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEee
Confidence 999999999999998653211 12689999999999999999999997 999999999999999999999999
Q ss_pred cCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHhhCC
Q 045798 843 FGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMALP 922 (1008)
Q Consensus 843 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~~~~ 922 (1008)
||.+........ ....++..|+|||.+.+..++.++|+||+|+++|||++|+.||...... .......
T Consensus 147 ~g~~~~~~~~~~------~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~--~~~~~~~---- 214 (256)
T cd08530 147 LGISKVLKKNMA------KTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ--DLRYKVQ---- 214 (256)
T ss_pred ccchhhhccCCc------ccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHh----
Confidence 999986654311 1234788999999999988999999999999999999999998643110 0000000
Q ss_pred cchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 923 NQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 923 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
.. .++ . .....+.++.+++.+|++.+|++|||+.|+++
T Consensus 215 -------~~----------------~~~-~--~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 215 -------RG----------------KYP-P--IPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred -------cC----------------CCC-C--CchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 00 000 0 01134566899999999999999999999975
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=279.78 Aligned_cols=275 Identities=21% Similarity=0.299 Sum_probs=212.4
Q ss_pred HHHHHHhcCCCCCceEeeccCeeEEEEEEcCCC-----eEEEEEEeccc-cchhhHHHHHHHHHHhhcCCCCceeeeecc
Q 045798 677 KSLLKATNGFSSTHLIGVGSFGCVYKGALDEDG-----IVVAIKVINLQ-CEGASKSFMAECKALKNIRHRNLVKVITSC 750 (1008)
Q Consensus 677 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~-----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 750 (1008)
+++.....+++....+.+|.||.||+|.+++.. +.|-+|.++.. ++-....+..|.-.+..+.|||+..+.+++
T Consensus 277 ~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ 356 (563)
T KOG1024|consen 277 QELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVS 356 (563)
T ss_pred HhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEE
Confidence 445555567888889999999999999886433 35667777643 334456789999999999999999999997
Q ss_pred ccccccCCceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCe
Q 045798 751 SSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNI 830 (1008)
Q Consensus 751 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NI 830 (1008)
. ++.+..++++.++.-|+|..|+...+.. .......++..+...++.|++.|++|||++ +|||.||.++|.
T Consensus 357 i----e~~~~P~V~y~~~~~gNLK~FL~~Cr~~--~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNC 427 (563)
T KOG1024|consen 357 I----EDYATPFVLYPATGVGNLKSFLQICRGD--DPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNC 427 (563)
T ss_pred e----eccCcceEEEeccCcchHHHHHHHhccC--CCccccchhHHHHHHHHHHHHHHHHHHHhc---Ccccchhhhhcc
Confidence 4 4666788999999999999999855421 122233688889999999999999999998 999999999999
Q ss_pred eecCCCCeEEcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCccccC
Q 045798 831 LLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT-AKKPTDVMFEG 909 (1008)
Q Consensus 831 ll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-G~~pf~~~~~~ 909 (1008)
+||+..++||+|=.+++..-+.+-... ....-.+..||+||.+....|+.++|||||||++|||+| |+.||......
T Consensus 428 vIdd~LqVkltDsaLSRDLFP~DYhcL--GDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPf 505 (563)
T KOG1024|consen 428 VIDDQLQVKLTDSALSRDLFPGDYHCL--GDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPF 505 (563)
T ss_pred eehhheeEEeccchhccccCccccccc--CCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHH
Confidence 999999999999999985543322111 112235779999999999999999999999999999999 88997532110
Q ss_pred CccHHHHHHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHHH
Q 045798 910 DLNLHNFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHELQ 989 (1008)
Q Consensus 910 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 989 (1008)
+...-..+..++..+ ..||.++..+|.-||+.+|++||+++|++.-|.
T Consensus 506 ----------------------------Em~~ylkdGyRlaQP----~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLs 553 (563)
T KOG1024|consen 506 ----------------------------EMEHYLKDGYRLAQP----FNCPDELFTVMACCWALLPEERPSFSQLVICLS 553 (563)
T ss_pred ----------------------------HHHHHHhccceecCC----CCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHH
Confidence 000111112222222 358889999999999999999999999999998
Q ss_pred HHHHH
Q 045798 990 SVKNI 994 (1008)
Q Consensus 990 ~i~~~ 994 (1008)
+....
T Consensus 554 eF~~q 558 (563)
T KOG1024|consen 554 EFHTQ 558 (563)
T ss_pred HHHHH
Confidence 76544
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-33 Score=275.69 Aligned_cols=274 Identities=20% Similarity=0.283 Sum_probs=207.4
Q ss_pred CHHHHHHHhcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccchhhHHHHHHHHHHhhc-CCCCceeeeeccccc
Q 045798 675 SYKSLLKATNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNI-RHRNLVKVITSCSSI 753 (1008)
Q Consensus 675 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~ 753 (1008)
.++|+.+.++ +.||+|+|+.|--+....+|..||||++.+.......++.+|++++... .|+||++++++
T Consensus 74 ~F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLief---- 144 (463)
T KOG0607|consen 74 KFEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEF---- 144 (463)
T ss_pred hHHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHH----
Confidence 4677766654 6799999999999999889999999999988677788999999999999 79999999999
Q ss_pred cccCCceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeec
Q 045798 754 DFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLD 833 (1008)
Q Consensus 754 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~ 833 (1008)
|+++...|+|||-|.||+|..+|++++ .+++.++.++.++|+.||.+||.. ||.|||+||+|||-.
T Consensus 145 -FEdd~~FYLVfEKm~GGplLshI~~~~----------~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~ 210 (463)
T KOG0607|consen 145 -FEDDTRFYLVFEKMRGGPLLSHIQKRK----------HFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCE 210 (463)
T ss_pred -hcccceEEEEEecccCchHHHHHHHhh----------hccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeec
Confidence 788889999999999999999998776 799999999999999999999996 999999999999996
Q ss_pred CCC---CeEEcccCcccccccccCc---cccccccccccccccCccccC-----CCCCCcccchhhHHHHHHHHHhCCCC
Q 045798 834 NDL---SGHIGDFGLARFHQEVSNS---TLSSSVGVKGTIGYTAPEYGL-----GSEVSTNGDVYSYGILLLEMVTAKKP 902 (1008)
Q Consensus 834 ~~~---~~kL~Dfg~a~~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwslG~vl~elltG~~p 902 (1008)
... -+|||||.++.-.....+. ....-...+|+..|||||+.. ...|+.++|.||+|||+|-|++|.+|
T Consensus 211 ~pn~vsPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpP 290 (463)
T KOG0607|consen 211 SPNKVSPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPP 290 (463)
T ss_pred CCCCcCceeeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCC
Confidence 554 4699999888643322211 111223467999999999742 23588999999999999999999999
Q ss_pred CCccccCCccHHHHHHhhCCcc-hhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCH
Q 045798 903 TDVMFEGDLNLHNFARMALPNQ-VMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNM 981 (1008)
Q Consensus 903 f~~~~~~~~~~~~~~~~~~~~~-~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~ 981 (1008)
|...-..+-.+.. ...-.. ...+....-++ .+.-+...+..++.+-.+++...+..|+.+|.++
T Consensus 291 FvG~Cg~dCGWdr---Ge~Cr~CQ~~LFesIQEG------------kYeFPdkdWahIS~eakdlisnLlvrda~~rlsa 355 (463)
T KOG0607|consen 291 FVGHCGADCGWDR---GEVCRVCQNKLFESIQEG------------KYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSA 355 (463)
T ss_pred ccCccCCcCCccC---CCccHHHHHHHHHHHhcc------------CCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhh
Confidence 9754332221110 000000 00111110000 0111112234566677888888899999999999
Q ss_pred HHHHH
Q 045798 982 TNVVH 986 (1008)
Q Consensus 982 ~evl~ 986 (1008)
.+++.
T Consensus 356 ~~vln 360 (463)
T KOG0607|consen 356 AQVLN 360 (463)
T ss_pred hhccC
Confidence 98876
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-32 Score=295.67 Aligned_cols=242 Identities=22% Similarity=0.277 Sum_probs=184.2
Q ss_pred eEeeccCeeEEEEEEcCCCeEEEEEEeccccc---hhhHHHHHHHH---HHhhcCCCCceeeeeccccccccCCceEEEE
Q 045798 691 LIGVGSFGCVYKGALDEDGIVVAIKVINLQCE---GASKSFMAECK---ALKNIRHRNLVKVITSCSSIDFQGNDFKAIV 764 (1008)
Q Consensus 691 ~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~---~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 764 (1008)
.||+|+||.||+|....+++.||+|.+..... .....+..|.. .++...||+|+++.++ +..++..++|
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~-----~~~~~~~~~v 75 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYA-----FHTPDKLSFI 75 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeee-----eecCCEEEEE
Confidence 48999999999999988899999999864321 11223444443 3444579999999988 4556779999
Q ss_pred EeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEcccC
Q 045798 765 YEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFG 844 (1008)
Q Consensus 765 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg 844 (1008)
|||+++++|.+++.... .+++..++.++.|++.|++|||+. +|+||||||+||+++.++.+||+|||
T Consensus 76 ~e~~~g~~L~~~l~~~~----------~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg 142 (278)
T cd05606 76 LDLMNGGDLHYHLSQHG----------VFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLG 142 (278)
T ss_pred EecCCCCcHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCc
Confidence 99999999999886543 689999999999999999999997 99999999999999999999999999
Q ss_pred cccccccccCccccccccccccccccCccccCCC-CCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCc
Q 045798 845 LARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGS-EVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMALPN 923 (1008)
Q Consensus 845 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~~~~~ 923 (1008)
.+....... .....|+..|+|||.+.++ .++.++||||+||++|||++|+.||.......... .......
T Consensus 143 ~~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~--~~~~~~~- 213 (278)
T cd05606 143 LACDFSKKK------PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE--IDRMTLT- 213 (278)
T ss_pred CccccCccC------CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHH--HHHHhhc-
Confidence 987543221 1123589999999998754 68899999999999999999999986432111100 0000000
Q ss_pred chhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCC-----CHHHHHH
Q 045798 924 QVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRM-----NMTNVVH 986 (1008)
Q Consensus 924 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~ 986 (1008)
.+. .. ....+..+.+++.+|+..+|.+|| ++.|+++
T Consensus 214 -----~~~--------------------~~--~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 214 -----MAV--------------------EL--PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred -----cCC--------------------CC--CCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 000 00 011245678999999999999999 9999985
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=297.30 Aligned_cols=248 Identities=26% Similarity=0.354 Sum_probs=193.4
Q ss_pred EeeccCeeEEEEEEcCCCeEEEEEEeccccc---hhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceEEEEEecc
Q 045798 692 IGVGSFGCVYKGALDEDGIVVAIKVINLQCE---GASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKAIVYEYM 768 (1008)
Q Consensus 692 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 768 (1008)
||+|+||.||+|.+..+++.||+|++..... ...+.+.+|++++++++||||+++++. +..+...|+||||+
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~-----~~~~~~~~lv~e~~ 75 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYS-----FQGKKNLYLVMEYL 75 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHh-----eecCcEEEEEEecC
Confidence 6899999999999988899999999875432 345678999999999999999999988 45667799999999
Q ss_pred CCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEcccCcccc
Q 045798 769 PNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARF 848 (1008)
Q Consensus 769 ~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~ 848 (1008)
++++|.+++.... .+++..+..++.|++.||+|||+. +++||||+|+||++++++.++|+|||++..
T Consensus 76 ~~~~L~~~l~~~~----------~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~ 142 (265)
T cd05579 76 PGGDLASLLENVG----------SLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKV 142 (265)
T ss_pred CCCcHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchh
Confidence 9999999997543 689999999999999999999997 999999999999999999999999999875
Q ss_pred cccccCcc----ccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCcc
Q 045798 849 HQEVSNST----LSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMALPNQ 924 (1008)
Q Consensus 849 ~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~~~~~~ 924 (1008)
........ ........++..|+|||...+..++.++||||||+++|++++|..||...... .....
T Consensus 143 ~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~-----~~~~~----- 212 (265)
T cd05579 143 GLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPE-----EIFQN----- 212 (265)
T ss_pred cccCcccccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH-----HHHHH-----
Confidence 43321100 01122345788999999998888999999999999999999999998643210 00000
Q ss_pred hhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHH
Q 045798 925 VMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHEL 988 (1008)
Q Consensus 925 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 988 (1008)
..... .. .+.....+..+.+++.+||+.+|++|||+.++.+.|
T Consensus 213 -------~~~~~------------~~--~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l 255 (265)
T cd05579 213 -------ILNGK------------IE--WPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIK 255 (265)
T ss_pred -------HhcCC------------cC--CCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHh
Confidence 00000 00 000001255679999999999999999996665544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-32 Score=298.98 Aligned_cols=276 Identities=24% Similarity=0.282 Sum_probs=195.6
Q ss_pred cCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEecccc--chhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceE
Q 045798 684 NGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC--EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFK 761 (1008)
Q Consensus 684 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 761 (1008)
++|++.+.||+|++|.||+|.+..+++.||+|++.... ....+.+.+|++++++++||||+++++++ ..++..
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~ 76 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVV-----HSEKRL 76 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEE-----ecCCeE
Confidence 57899999999999999999998899999999986432 23346788999999999999999999994 456779
Q ss_pred EEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecC-CCCeEE
Q 045798 762 AIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDN-DLSGHI 840 (1008)
Q Consensus 762 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kL 840 (1008)
++||||++ +++.+++...... .+++..+..++.||+.||+|||+. +++||||+|+||+++. ++.+||
T Consensus 77 ~lv~e~~~-~~l~~~~~~~~~~--------~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl 144 (294)
T PLN00009 77 YLVFEYLD-LDLKKHMDSSPDF--------AKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKL 144 (294)
T ss_pred EEEEeccc-ccHHHHHHhCCCC--------CcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEE
Confidence 99999995 6888887543311 467888999999999999999997 9999999999999985 567899
Q ss_pred cccCcccccccccCccccccccccccccccCccccCCC-CCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHh
Q 045798 841 GDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGS-EVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARM 919 (1008)
Q Consensus 841 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~ 919 (1008)
+|||++......... .....++..|+|||++.+. .++.++||||+||++|+|++|+.||....+.+.... ....
T Consensus 145 ~dfg~~~~~~~~~~~----~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~-~~~~ 219 (294)
T PLN00009 145 ADFGLARAFGIPVRT----FTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFK-IFRI 219 (294)
T ss_pred cccccccccCCCccc----cccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-HHHH
Confidence 999999754332111 1223478899999987664 578999999999999999999999864322111111 1000
Q ss_pred hCCcchhhhhcccccCchHHhhhhhhhhhccccc--hhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 920 ALPNQVMDIVDPILRNDEEILASTDKCRRMQTGI--NSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 920 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
.........+.. ...+.... ....+.... ......+.++.+++.+|++.+|++||++.++++
T Consensus 220 -~~~~~~~~~~~~-~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 220 -LGTPNEETWPGV-TSLPDYKS---AFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred -hCCCChhhcccc-ccchhhhh---hcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000000000000 00000000 000000000 001123456789999999999999999999986
|
|
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-32 Score=292.16 Aligned_cols=252 Identities=25% Similarity=0.361 Sum_probs=202.1
Q ss_pred CCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccc--hhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceEE
Q 045798 685 GFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCE--GASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKA 762 (1008)
Q Consensus 685 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 762 (1008)
+|.+.+.||+|+||.||+|.+..+++.||+|++..... ...+.+.+|+++++.++|+|++++.+.+ ..++..+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~-----~~~~~~~ 75 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESF-----EEKGKLC 75 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEE-----ecCCEEE
Confidence 58889999999999999999988899999999975433 4566789999999999999999999984 4457799
Q ss_pred EEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEcc
Q 045798 763 IVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGD 842 (1008)
Q Consensus 763 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 842 (1008)
+|+||+++++|.+++...... ...+++..+..++.|++.|++|||+. +++|+||+|+||+++.++.++|+|
T Consensus 76 lv~e~~~~~~L~~~l~~~~~~------~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d 146 (258)
T cd08215 76 IVMEYADGGDLSQKIKKQKKE------GKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGD 146 (258)
T ss_pred EEEEecCCCcHHHHHHHhhcc------CCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECC
Confidence 999999999999998764311 11789999999999999999999998 999999999999999999999999
Q ss_pred cCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHhhCC
Q 045798 843 FGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMALP 922 (1008)
Q Consensus 843 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~~~~ 922 (1008)
||.+........ ......+++.|+|||...+..++.++||||+|+++|+|++|+.||..... .......
T Consensus 147 ~~~~~~~~~~~~----~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~-----~~~~~~~-- 215 (258)
T cd08215 147 FGISKVLSSTVD----LAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENL-----LELALKI-- 215 (258)
T ss_pred ccceeecccCcc----eecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcH-----HHHHHHH--
Confidence 999986544321 11223588899999999888899999999999999999999999863211 1111100
Q ss_pred cchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 923 NQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 923 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
....... . ....+..+.+++.+||..+|++|||+.|+++
T Consensus 216 ------~~~~~~~-------------~------~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 216 ------LKGQYPP-------------I------PSQYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred ------hcCCCCC-------------C------CCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 0000000 0 0023456789999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-32 Score=292.13 Aligned_cols=248 Identities=31% Similarity=0.409 Sum_probs=200.6
Q ss_pred CCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccc--hhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceEE
Q 045798 685 GFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCE--GASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKA 762 (1008)
Q Consensus 685 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 762 (1008)
+|++.+.||+|++|.||+|....+++.||+|.+..... ...+.+.+|++++++++|+|++++++++ ..+...+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~ 75 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSI-----ETSDSLY 75 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEE-----EeCCEEE
Confidence 47889999999999999999988899999999976543 4557899999999999999999999984 4456799
Q ss_pred EEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEcc
Q 045798 763 IVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGD 842 (1008)
Q Consensus 763 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 842 (1008)
+||||+++++|.+++.... .+++..+..++.|++.|+.|||+. +|+||||+|+||+++.++.++|+|
T Consensus 76 ~v~e~~~~~~L~~~~~~~~----------~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d 142 (254)
T cd06627 76 IILEYAENGSLRQIIKKFG----------PFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLAD 142 (254)
T ss_pred EEEecCCCCcHHHHHHhcc----------CCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEec
Confidence 9999999999999987553 789999999999999999999997 999999999999999999999999
Q ss_pred cCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHhhCC
Q 045798 843 FGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMALP 922 (1008)
Q Consensus 843 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~~~~ 922 (1008)
||.+......... .....++..|+|||...+..++.++||||+|+++|+|++|+.||..... .........
T Consensus 143 ~~~~~~~~~~~~~----~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~----~~~~~~~~~- 213 (254)
T cd06627 143 FGVATKLNDVSKD----DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNP----MAALFRIVQ- 213 (254)
T ss_pred cccceecCCCccc----ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccH----HHHHHHHhc-
Confidence 9999866543321 1224578899999998888889999999999999999999999863211 000000000
Q ss_pred cchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 923 NQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 923 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
.. . ... ....+..+.+++.+||..+|++|||+.+++.
T Consensus 214 ~~-------~--------------~~~------~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 214 DD-------H--------------PPL------PEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred cC-------C--------------CCC------CCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 00 0 000 0123456789999999999999999999874
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=302.69 Aligned_cols=286 Identities=24% Similarity=0.274 Sum_probs=198.0
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEecccc--chhhHHHHHHHHHHhhcCCCCceeeeeccccccc---cC
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC--EGASKSFMAECKALKNIRHRNLVKVITSCSSIDF---QG 757 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~---~~ 757 (1008)
.++|++.+.||+|+||.||+|.+..+++.||+|++.... ......+.+|++++++++||||+++++++..... ..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 578999999999999999999998899999999986432 2223467899999999999999999987543221 23
Q ss_pred CceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCC
Q 045798 758 NDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLS 837 (1008)
Q Consensus 758 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 837 (1008)
....++||||+. +++..++.... ..+++..+..++.|+++||+|||+. +|+||||||+||++++++.
T Consensus 87 ~~~~~lv~~~~~-~~l~~~~~~~~---------~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~ 153 (311)
T cd07866 87 RGSVYMVTPYMD-HDLSGLLENPS---------VKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGI 153 (311)
T ss_pred CceEEEEEecCC-cCHHHHHhccc---------cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCC
Confidence 446799999995 57777665432 1689999999999999999999998 9999999999999999999
Q ss_pred eEEcccCcccccccccCccc-------cccccccccccccCccccCCC-CCCcccchhhHHHHHHHHHhCCCCCCccccC
Q 045798 838 GHIGDFGLARFHQEVSNSTL-------SSSVGVKGTIGYTAPEYGLGS-EVSTNGDVYSYGILLLEMVTAKKPTDVMFEG 909 (1008)
Q Consensus 838 ~kL~Dfg~a~~~~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltG~~pf~~~~~~ 909 (1008)
+||+|||++........... .......+++.|+|||.+.+. .++.++|||||||++|||++|++||......
T Consensus 154 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~ 233 (311)
T cd07866 154 LKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDI 233 (311)
T ss_pred EEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHH
Confidence 99999999986543322111 111234578889999987654 5789999999999999999999998643221
Q ss_pred CccHHHHHHhhCCcchhhhhcc-cccCchHHhhhhhhhhhccccch-hHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 910 DLNLHNFARMALPNQVMDIVDP-ILRNDEEILASTDKCRRMQTGIN-SRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 910 ~~~~~~~~~~~~~~~~~~~~d~-~l~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
. ................+.+. .+........ ....+.... ........+.+++.+|++.||++|||+.|++.
T Consensus 234 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 234 D-QLHLIFKLCGTPTEETWPGWRSLPGCEGVHS----FTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred H-HHHHHHHHhCCCChhhchhhhhccccccccc----CCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 1 11111111000000000000 0000000000 000000000 01123356889999999999999999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-32 Score=297.44 Aligned_cols=245 Identities=28% Similarity=0.349 Sum_probs=190.7
Q ss_pred CCCCceEeeccCeeEEEEEEcCCCeEEEEEEecccc---chhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceEE
Q 045798 686 FSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC---EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKA 762 (1008)
Q Consensus 686 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 762 (1008)
|...+.||+|+||.||+|.+..+++.||+|++.... ....+.+.+|+++++.++|||++++++++ .+.+..+
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~~ 97 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCY-----LKEHTAW 97 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEE-----EeCCEEE
Confidence 666788999999999999998899999999986432 23345788999999999999999999995 4556789
Q ss_pred EEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEcc
Q 045798 763 IVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGD 842 (1008)
Q Consensus 763 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 842 (1008)
+||||+. |++.+++..... ++++.++..++.||+.|++|||+. +++||||+|+||+++.++.+||+|
T Consensus 98 lv~e~~~-~~l~~~l~~~~~---------~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~d 164 (313)
T cd06633 98 LVMEYCL-GSASDLLEVHKK---------PLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLAD 164 (313)
T ss_pred EEEecCC-CCHHHHHHhcCC---------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEee
Confidence 9999994 688777754321 688999999999999999999997 999999999999999999999999
Q ss_pred cCcccccccccCccccccccccccccccCccccC---CCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHh
Q 045798 843 FGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGL---GSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARM 919 (1008)
Q Consensus 843 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~ 919 (1008)
||.+...... ....|+..|+|||++. ...++.++|||||||++|+|++|..||........ .......
T Consensus 165 fg~~~~~~~~--------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~-~~~~~~~ 235 (313)
T cd06633 165 FGSASKSSPA--------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-LYHIAQN 235 (313)
T ss_pred cCCCcccCCC--------CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHhc
Confidence 9998643211 1235888999999974 45688899999999999999999999854211000 0000000
Q ss_pred hCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 045798 920 ALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHE 987 (1008)
Q Consensus 920 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 987 (1008)
..+. . .....+..+.+++.+||+.+|.+||++.+++..
T Consensus 236 ~~~~---------~---------------------~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 236 DSPT---------L---------------------QSNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred CCCC---------C---------------------CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000 0 001223457899999999999999999999863
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=298.33 Aligned_cols=252 Identities=27% Similarity=0.378 Sum_probs=200.9
Q ss_pred cCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccc---cchhhHHHHHHHHHHhhcC-CCCceeeeeccccccccCCc
Q 045798 684 NGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQ---CEGASKSFMAECKALKNIR-HRNLVKVITSCSSIDFQGND 759 (1008)
Q Consensus 684 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~ 759 (1008)
++|.+.+.||+|+||.||+|....+++.||+|++... .....+.+.+|+++++++. |+||++++++ +.+++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~-----~~~~~ 75 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYT-----FQDEE 75 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHH-----hcCCc
Confidence 4789999999999999999999889999999998642 2334467889999999998 9999999998 45667
Q ss_pred eEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeE
Q 045798 760 FKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGH 839 (1008)
Q Consensus 760 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 839 (1008)
..++||||+++++|.+++.... .+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++
T Consensus 76 ~~~lv~e~~~~~~L~~~l~~~~----------~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~ 142 (280)
T cd05581 76 NLYFVLEYAPNGELLQYIRKYG----------SLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIK 142 (280)
T ss_pred eEEEEEcCCCCCcHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEE
Confidence 7999999999999999997654 689999999999999999999998 999999999999999999999
Q ss_pred EcccCcccccccccCcc----------------ccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCC
Q 045798 840 IGDFGLARFHQEVSNST----------------LSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPT 903 (1008)
Q Consensus 840 L~Dfg~a~~~~~~~~~~----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf 903 (1008)
++|||.+.......... ........++..|+|||...+..++.++||||||+++|++++|+.||
T Consensus 143 l~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~ 222 (280)
T cd05581 143 ITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPF 222 (280)
T ss_pred ecCCccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCC
Confidence 99999998654432110 01122345789999999988888999999999999999999999998
Q ss_pred CccccCCccHHHHHHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCH--
Q 045798 904 DVMFEGDLNLHNFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNM-- 981 (1008)
Q Consensus 904 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~-- 981 (1008)
..... ...... ..+.. ..+ ....+..+.+++.+||+.+|.+||++
T Consensus 223 ~~~~~----~~~~~~---------~~~~~--------------~~~------~~~~~~~~~~li~~~l~~~p~~R~~~~~ 269 (280)
T cd05581 223 RGSNE----YLTFQK---------ILKLE--------------YSF------PPNFPPDAKDLIEKLLVLDPQDRLGVNE 269 (280)
T ss_pred CCccH----HHHHHH---------HHhcC--------------CCC------CCccCHHHHHHHHHHhcCCHhhCCCccc
Confidence 64321 000000 00000 000 01224567899999999999999999
Q ss_pred --HHHHH
Q 045798 982 --TNVVH 986 (1008)
Q Consensus 982 --~evl~ 986 (1008)
+++++
T Consensus 270 ~~~~ll~ 276 (280)
T cd05581 270 GYDELKA 276 (280)
T ss_pred CHHHHhc
Confidence 66653
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.3e-32 Score=299.29 Aligned_cols=247 Identities=28% Similarity=0.324 Sum_probs=192.3
Q ss_pred CCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccc---cchhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceE
Q 045798 685 GFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQ---CEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFK 761 (1008)
Q Consensus 685 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 761 (1008)
.|...+.||+|+||.||+|++..+++.||+|.+... ......++.+|+++++.++|+|++++.+++. ..+..
T Consensus 16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~ 90 (308)
T cd06634 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYL-----REHTA 90 (308)
T ss_pred HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEE-----cCCee
Confidence 477778999999999999999888999999998642 2233457889999999999999999999853 45678
Q ss_pred EEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEc
Q 045798 762 AIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIG 841 (1008)
Q Consensus 762 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 841 (1008)
++||||+. |++.+++..... .+++.++..++.|++.|+.|||+. +++||||+|+||+++.++.+||+
T Consensus 91 ~lv~e~~~-~~l~~~~~~~~~---------~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~ 157 (308)
T cd06634 91 WLVMEYCL-GSASDLLEVHKK---------PLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLG 157 (308)
T ss_pred EEEEEccC-CCHHHHHHHcCC---------CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEEC
Confidence 99999995 688877754321 578999999999999999999997 99999999999999999999999
Q ss_pred ccCcccccccccCccccccccccccccccCccccC---CCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHH
Q 045798 842 DFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGL---GSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFAR 918 (1008)
Q Consensus 842 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~ 918 (1008)
|||.+...... ....++..|+|||.+. ...++.++|||||||++|+|++|..||...... ........
T Consensus 158 dfg~~~~~~~~--------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-~~~~~~~~ 228 (308)
T cd06634 158 DFGSASIMAPA--------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-SALYHIAQ 228 (308)
T ss_pred CcccceeecCc--------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHH-HHHHHHhh
Confidence 99998754322 1234788999999874 356788999999999999999999997532110 00000000
Q ss_pred hhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHH
Q 045798 919 MALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHEL 988 (1008)
Q Consensus 919 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 988 (1008)
...+ . ......+..+.+++.+||+.+|++||+++++++.-
T Consensus 229 ~~~~-----------------------------~-~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~ 268 (308)
T cd06634 229 NESP-----------------------------A-LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR 268 (308)
T ss_pred cCCC-----------------------------C-cCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCc
Confidence 0000 0 00112445678999999999999999999988753
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.4e-32 Score=305.93 Aligned_cols=279 Identities=21% Similarity=0.260 Sum_probs=199.5
Q ss_pred HhcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccc--cchhhHHHHHHHHHHhhcCCCCceeeeeccccccc-cCC
Q 045798 682 ATNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQ--CEGASKSFMAECKALKNIRHRNLVKVITSCSSIDF-QGN 758 (1008)
Q Consensus 682 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~ 758 (1008)
..++|++.+.||+|++|.||+|.+..+++.||+|++... .....+.+.+|+.++++++|+|++++.+++..... ...
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 467899999999999999999999888999999998643 22334567889999999999999999987543221 222
Q ss_pred ceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCe
Q 045798 759 DFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSG 838 (1008)
Q Consensus 759 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 838 (1008)
...++|+||+ +++|.+++... ++++..+..++.|++.|++|||+. +|+||||+|+||++++++.+
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~~-----------~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~ 157 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKCQ-----------KLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCEL 157 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCE
Confidence 3489999999 77999988642 689999999999999999999997 99999999999999999999
Q ss_pred EEcccCcccccccccCccccccccccccccccCccccCC-CCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHH
Q 045798 839 HIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLG-SEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFA 917 (1008)
Q Consensus 839 kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~ 917 (1008)
||+|||.+...... .....++..|+|||.+.+ ..++.++||||+||++||+++|+.||...... .......
T Consensus 158 kL~dfg~~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~-~~~~~i~ 229 (343)
T cd07851 158 KILDFGLARHTDDE-------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHI-DQLKRIM 229 (343)
T ss_pred EEcccccccccccc-------ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHH
Confidence 99999999865332 122347889999998765 36788999999999999999999998642111 0111111
Q ss_pred HhhCCcchhhhhcccccCchHHhhhhhhhhhc-cccch-hHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 918 RMALPNQVMDIVDPILRNDEEILASTDKCRRM-QTGIN-SRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 918 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~-~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
.. .......+........... ........ +.... .....+.++.+++.+|++.||++|||+.||++
T Consensus 230 ~~-~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 230 NL-VGTPDEELLQKISSESARN--YIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred Hh-cCCCCHHHHhhccchhHHH--HHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 10 0000011111110000000 00000000 00000 00123567899999999999999999999976
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.3e-32 Score=321.93 Aligned_cols=269 Identities=26% Similarity=0.418 Sum_probs=206.7
Q ss_pred cCCCCCceEeeccCeeEEEEEEcC-------CCeEEEEEEecccc-chhhHHHHHHHHHHhhc-CCCCceeeeecccccc
Q 045798 684 NGFSSTHLIGVGSFGCVYKGALDE-------DGIVVAIKVINLQC-EGASKSFMAECKALKNI-RHRNLVKVITSCSSID 754 (1008)
Q Consensus 684 ~~y~~~~~lg~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~ 754 (1008)
++..+.+.+|+|.||.||+|.... ....||||.++... ..+.+.+..|+++|+.+ +|+||+.++|+|..
T Consensus 296 ~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~-- 373 (609)
T KOG0200|consen 296 ENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQ-- 373 (609)
T ss_pred hhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeecc--
Confidence 344566799999999999998631 14679999998543 35567899999999999 69999999999854
Q ss_pred ccCCceEEEEEeccCCCChhcccccCCCCCCCcc----cc--cccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCC
Q 045798 755 FQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKE----IE--IKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPS 828 (1008)
Q Consensus 755 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~----~~--~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~ 828 (1008)
....++|+||++.|+|.+|++..+....... .. ..++..+.+.++.|||.|++||++. ++||||+.++
T Consensus 374 ---~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAaR 447 (609)
T KOG0200|consen 374 ---DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAAR 447 (609)
T ss_pred ---CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---Cccchhhhhh
Confidence 6679999999999999999988761000000 00 2489999999999999999999997 9999999999
Q ss_pred CeeecCCCCeEEcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCccc
Q 045798 829 NILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT-AKKPTDVMF 907 (1008)
Q Consensus 829 NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-G~~pf~~~~ 907 (1008)
|||++++..+||+|||+|+..............+. -...|||||.+....|+.+||||||||++||+++ |..||....
T Consensus 448 NVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~-LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~ 526 (609)
T KOG0200|consen 448 NVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGT-LPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIP 526 (609)
T ss_pred hEEecCCCEEEEccccceeccCCCCceEecCCCCc-cceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCC
Confidence 99999999999999999996554433322211111 3567999999999999999999999999999999 888875311
Q ss_pred cCCccHHHHHHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 045798 908 EGDLNLHNFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHE 987 (1008)
Q Consensus 908 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 987 (1008)
.. ..+.+.+.+ ..++.. ...|+.+++++|+.||+.+|++||++.|+++.
T Consensus 527 ~~-------------~~l~~~l~~--------------G~r~~~----P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~ 575 (609)
T KOG0200|consen 527 PT-------------EELLEFLKE--------------GNRMEQ----PEHCSDEIYDLMKSCWNADPEDRPTFSECVEF 575 (609)
T ss_pred cH-------------HHHHHHHhc--------------CCCCCC----CCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence 00 001111111 111111 22467788999999999999999999999999
Q ss_pred HHHHH
Q 045798 988 LQSVK 992 (1008)
Q Consensus 988 L~~i~ 992 (1008)
++...
T Consensus 576 ~~~~l 580 (609)
T KOG0200|consen 576 FEKHL 580 (609)
T ss_pred HHHHH
Confidence 99854
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.6e-32 Score=295.19 Aligned_cols=271 Identities=24% Similarity=0.269 Sum_probs=194.9
Q ss_pred CCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccc-hhhHHHHHHHHHHhhcC-CCCceeeeeccccccccCCceEEE
Q 045798 686 FSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCE-GASKSFMAECKALKNIR-HRNLVKVITSCSSIDFQGNDFKAI 763 (1008)
Q Consensus 686 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~l 763 (1008)
|++.+.||+|++|+||+|....+++.||+|++..... .......+|+..+++++ |+|++++++++ ..++..++
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~-----~~~~~~~l 75 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVF-----RENDELYF 75 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHh-----hcCCcEEE
Confidence 6788999999999999999988899999999864422 22334567999999998 99999999995 44677999
Q ss_pred EEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEccc
Q 045798 764 VYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDF 843 (1008)
Q Consensus 764 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 843 (1008)
||||+ +|+|.+++..... ..+++.++..++.|++.||.|||+. +++|+||+|+||++++++.++|+||
T Consensus 76 v~e~~-~~~l~~~~~~~~~--------~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~ 143 (283)
T cd07830 76 VFEYM-EGNLYQLMKDRKG--------KPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADF 143 (283)
T ss_pred EEecC-CCCHHHHHHhccc--------ccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeec
Confidence 99999 8899998875431 1689999999999999999999997 9999999999999999999999999
Q ss_pred CcccccccccCccccccccccccccccCccccC-CCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHhhCC
Q 045798 844 GLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGL-GSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMALP 922 (1008)
Q Consensus 844 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~~~~ 922 (1008)
|.+......... ....++..|+|||++. +..++.++||||||+++|||++|+.||......+. .........+
T Consensus 144 ~~~~~~~~~~~~-----~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~-~~~~~~~~~~ 217 (283)
T cd07830 144 GLAREIRSRPPY-----TDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQ-LYKICSVLGT 217 (283)
T ss_pred ccceeccCCCCc-----CCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHH-HHHHHHhcCC
Confidence 999855432211 1234788999999874 44678999999999999999999999864321111 1111110000
Q ss_pred cchhhhh-----cccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 923 NQVMDIV-----DPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 923 ~~~~~~~-----d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
.....+. +........... ...... .....+..+.+++.+||+.||++|||++|++.
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~---~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 218 PTKQDWPEGYKLASKLGFRFPQFA----PTSLHQ---LIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred CChhhhhhHhhhhccccccccccc----cccHHH---HcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 0000000 000000000000 000000 00012466899999999999999999999875
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.1e-32 Score=296.11 Aligned_cols=265 Identities=21% Similarity=0.253 Sum_probs=196.3
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEecccc-chhhHHHHHHHHHHhhc-CCCCceeeeeccccccccCCce
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC-EGASKSFMAECKALKNI-RHRNLVKVITSCSSIDFQGNDF 760 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~ 760 (1008)
.++|++.+.||+|+||.||+|.+..+++.||||+++... ......+..|+.++.+. .||||++++++| ..+..
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~-----~~~~~ 88 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYF-----ITDSD 88 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheee-----ecCCe
Confidence 467899999999999999999998789999999997542 23445667788777766 599999999995 44567
Q ss_pred EEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEE
Q 045798 761 KAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHI 840 (1008)
Q Consensus 761 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 840 (1008)
.++||||+ ++++.+++..... .+++..+..++.|++.|++|||+. .+|+||||+|+||++++++.+||
T Consensus 89 ~~~v~e~~-~~~l~~l~~~~~~---------~l~~~~~~~i~~~i~~~l~~lH~~--~~i~H~dl~p~nill~~~~~~kL 156 (296)
T cd06618 89 VFICMELM-STCLDKLLKRIQG---------PIPEDILGKMTVAIVKALHYLKEK--HGVIHRDVKPSNILLDASGNVKL 156 (296)
T ss_pred EEEEeecc-CcCHHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhh--CCEecCCCcHHHEEEcCCCCEEE
Confidence 99999998 5577777654221 688999999999999999999973 38999999999999999999999
Q ss_pred cccCcccccccccCccccccccccccccccCccccCCCC----CCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHH
Q 045798 841 GDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSE----VSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNF 916 (1008)
Q Consensus 841 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~ 916 (1008)
+|||.+......... ....++..|+|||.+.+.. ++.++||||||+++|+|++|+.||.............
T Consensus 157 ~dfg~~~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~ 231 (296)
T cd06618 157 CDFGISGRLVDSKAK-----TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKI 231 (296)
T ss_pred CccccchhccCCCcc-----cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHH
Confidence 999999755332211 1234788999999987553 7889999999999999999999986321110000000
Q ss_pred HHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHH--HHHHHH
Q 045798 917 ARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHEL--QSVKNI 994 (1008)
Q Consensus 917 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L--~~i~~~ 994 (1008)
...... .++ ....++.++.+++.+||+.||.+||+++++++.- .....+
T Consensus 232 ------------~~~~~~-------------~~~----~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~ 282 (296)
T cd06618 232 ------------LQEEPP-------------SLP----PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYETA 282 (296)
T ss_pred ------------hcCCCC-------------CCC----CCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhccchh
Confidence 000000 000 0002345689999999999999999999998753 333444
Q ss_pred HHHH
Q 045798 995 LLEL 998 (1008)
Q Consensus 995 ~~~~ 998 (1008)
..+.
T Consensus 283 ~~~~ 286 (296)
T cd06618 283 EVDV 286 (296)
T ss_pred HHHH
Confidence 4433
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.1e-32 Score=294.15 Aligned_cols=256 Identities=23% Similarity=0.283 Sum_probs=196.4
Q ss_pred CCCCCceEeeccCeeEEEEEEc---CCCeEEEEEEecccc----chhhHHHHHHHHHHhhc-CCCCceeeeecccccccc
Q 045798 685 GFSSTHLIGVGSFGCVYKGALD---EDGIVVAIKVINLQC----EGASKSFMAECKALKNI-RHRNLVKVITSCSSIDFQ 756 (1008)
Q Consensus 685 ~y~~~~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 756 (1008)
+|++.+.||+|+||.||+|... .+++.||||+++... ....+.+.+|++++.++ +||+|+++++. +.
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~-----~~ 75 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYA-----FQ 75 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhhee-----ee
Confidence 4788899999999999999863 367889999986432 23345788999999999 69999999988 45
Q ss_pred CCceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCC
Q 045798 757 GNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDL 836 (1008)
Q Consensus 757 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 836 (1008)
.+...++||||+++|+|.+++.... .+++..+..++.|+++||+|||+. +++||||+|+||+++.++
T Consensus 76 ~~~~~~lv~e~~~~~~L~~~~~~~~----------~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~ 142 (288)
T cd05583 76 TDTKLHLILDYVNGGELFTHLYQRE----------HFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEG 142 (288)
T ss_pred cCCEEEEEEecCCCCcHHHHHhhcC----------CcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCC
Confidence 6677899999999999999986543 678899999999999999999997 999999999999999999
Q ss_pred CeEEcccCcccccccccCccccccccccccccccCccccCCCC--CCcccchhhHHHHHHHHHhCCCCCCccccCCccHH
Q 045798 837 SGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSE--VSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLH 914 (1008)
Q Consensus 837 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~ 914 (1008)
.++|+|||++.......... .....++..|+|||...+.. .+.++||||||+++|||++|..||...... ....
T Consensus 143 ~~~l~dfg~~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~-~~~~ 218 (288)
T cd05583 143 HVVLTDFGLSKEFLAEEEER---AYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQ-NSQS 218 (288)
T ss_pred CEEEEECccccccccccccc---cccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCccc-chHH
Confidence 99999999987654332111 12234789999999987654 788999999999999999999998532111 0011
Q ss_pred HHHHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHHHH
Q 045798 915 NFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHELQS 990 (1008)
Q Consensus 915 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 990 (1008)
...... ....+ . .....+..+.+++.+||+.||++|||+.++.+.|+.
T Consensus 219 ~~~~~~------------~~~~~--------------~--~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 219 EISRRI------------LKSKP--------------P--FPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred HHHHHH------------HccCC--------------C--CCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 111100 00000 0 011234567899999999999999999888777654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=299.73 Aligned_cols=279 Identities=22% Similarity=0.247 Sum_probs=195.2
Q ss_pred hcCCCC-CceEeeccCeeEEEEEEcCCCeEEEEEEeccccchh--------------hHHHHHHHHHHhhcCCCCceeee
Q 045798 683 TNGFSS-THLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGA--------------SKSFMAECKALKNIRHRNLVKVI 747 (1008)
Q Consensus 683 ~~~y~~-~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~--------------~~~~~~E~~~l~~l~h~niv~~~ 747 (1008)
.++|.. .+.||+|+||.||+|.+..+++.||+|+++...... ...+.+|++++++++|+||++++
T Consensus 7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 86 (335)
T PTZ00024 7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV 86 (335)
T ss_pred ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence 456654 477999999999999998889999999986432211 12578999999999999999999
Q ss_pred eccccccccCCceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCC
Q 045798 748 TSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKP 827 (1008)
Q Consensus 748 ~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp 827 (1008)
+++ ..++..++||||++ |+|.+++.... .+++..+..++.|++.||+|||+. +++||||+|
T Consensus 87 ~~~-----~~~~~~~lv~e~~~-~~l~~~l~~~~----------~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~ 147 (335)
T PTZ00024 87 DVY-----VEGDFINLVMDIMA-SDLKKVVDRKI----------RLTESQVKCILLQILNGLNVLHKW---YFMHRDLSP 147 (335)
T ss_pred EEE-----ecCCcEEEEEeccc-cCHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHhC---CeecccccH
Confidence 984 45667999999995 69999886543 688999999999999999999997 999999999
Q ss_pred CCeeecCCCCeEEcccCcccccccccCc----------cccccccccccccccCccccCCC-CCCcccchhhHHHHHHHH
Q 045798 828 SNILLDNDLSGHIGDFGLARFHQEVSNS----------TLSSSVGVKGTIGYTAPEYGLGS-EVSTNGDVYSYGILLLEM 896 (1008)
Q Consensus 828 ~NIll~~~~~~kL~Dfg~a~~~~~~~~~----------~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~vl~el 896 (1008)
+||+++.++.+||+|||.+......... .........++..|+|||.+.+. .++.++||||+||++|||
T Consensus 148 ~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el 227 (335)
T PTZ00024 148 ANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAEL 227 (335)
T ss_pred HHeEECCCCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHH
Confidence 9999999999999999999865411100 00111123467889999998764 468899999999999999
Q ss_pred HhCCCCCCccccCCccHHHHHHhhCCcchhhhhcccccCchHHhhhhhhhhhccccch-hHHHHHHHHHHHHhcccCcCC
Q 045798 897 VTAKKPTDVMFEGDLNLHNFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGIN-SRLECLISMVKIGVACSMESP 975 (1008)
Q Consensus 897 ltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP 975 (1008)
++|+.||......+ ................+-+..-..... ......+.... .....+.++.+++.+||+.+|
T Consensus 228 ~tg~~p~~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P 301 (335)
T PTZ00024 228 LTGKPLFPGENEID-QLGRIFELLGTPNEDNWPQAKKLPLYT-----EFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNP 301 (335)
T ss_pred HhCCCCCCCCCHHH-HHHHHHHHhCCCchhhCcchhhccccc-----ccCcCCcccHHHhCcCCChHHHHHHHHHcCCCc
Confidence 99999986432211 111111110000000000000000000 00000000000 001234568899999999999
Q ss_pred CCCCCHHHHHH
Q 045798 976 QDRMNMTNVVH 986 (1008)
Q Consensus 976 ~~RPt~~evl~ 986 (1008)
++|||++|++.
T Consensus 302 ~~R~s~~~~l~ 312 (335)
T PTZ00024 302 LERISAKEALK 312 (335)
T ss_pred hhccCHHHHhc
Confidence 99999999986
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=291.94 Aligned_cols=253 Identities=24% Similarity=0.323 Sum_probs=193.8
Q ss_pred CCCCCceEeeccCeeEEEEEEc---CCCeEEEEEEecccc----chhhHHHHHHHHHHhhc-CCCCceeeeecccccccc
Q 045798 685 GFSSTHLIGVGSFGCVYKGALD---EDGIVVAIKVINLQC----EGASKSFMAECKALKNI-RHRNLVKVITSCSSIDFQ 756 (1008)
Q Consensus 685 ~y~~~~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 756 (1008)
+|++.+.||+|+||.||+|... .+|+.||+|+++... ....+.+.+|+++++++ +|++|++++++ +.
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~-----~~ 75 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYA-----FQ 75 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeE-----ee
Confidence 4788999999999999999874 478999999987432 22346788999999999 69999999988 45
Q ss_pred CCceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCC
Q 045798 757 GNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDL 836 (1008)
Q Consensus 757 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 836 (1008)
.+...++||||+++++|.+++.... .+++..+..++.|++.||+|||+. +++||||+|+||+++.++
T Consensus 76 ~~~~~~lv~e~~~~~~L~~~l~~~~----------~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~ 142 (290)
T cd05613 76 TDTKLHLILDYINGGELFTHLSQRE----------RFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNG 142 (290)
T ss_pred cCCeEEEEEecCCCCcHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCC
Confidence 5667899999999999999987543 678899999999999999999997 999999999999999999
Q ss_pred CeEEcccCcccccccccCccccccccccccccccCccccCCC--CCCcccchhhHHHHHHHHHhCCCCCCccccCCccHH
Q 045798 837 SGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGS--EVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLH 914 (1008)
Q Consensus 837 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~ 914 (1008)
.+||+|||++......... ......|+..|+|||.+.+. .++.++||||||+++|+|++|..||...... ....
T Consensus 143 ~~kl~dfg~~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~-~~~~ 218 (290)
T cd05613 143 HVVLTDFGLSKEFHEDEVE---RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEK-NSQA 218 (290)
T ss_pred CEEEeeCccceeccccccc---ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcc-ccHH
Confidence 9999999999765432211 11234588999999998753 4678999999999999999999998632111 1111
Q ss_pred HHHHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCC-----CHHHHHHH
Q 045798 915 NFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRM-----NMTNVVHE 987 (1008)
Q Consensus 915 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~ 987 (1008)
...... ....+ . .....+..+.+++.+||+.||++|| ++++++..
T Consensus 219 ~~~~~~------------~~~~~--------------~--~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 219 EISRRI------------LKSEP--------------P--YPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred HHHHHh------------hccCC--------------C--CCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 111100 00000 0 0012345678999999999999997 67777663
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=291.51 Aligned_cols=273 Identities=27% Similarity=0.310 Sum_probs=198.1
Q ss_pred CCCCceEeeccCeeEEEEEEcCCCeEEEEEEecccc--chhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceEEE
Q 045798 686 FSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC--EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKAI 763 (1008)
Q Consensus 686 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 763 (1008)
|+..+.||+|++|.||+|....+++.||+|++.... +...+.+.+|+.++++++|+|++++++++ ...+..++
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~~~ 75 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVI-----HTERKLYL 75 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhh-----hcCCceEE
Confidence 567789999999999999998889999999998653 33456788999999999999999999985 44577999
Q ss_pred EEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEccc
Q 045798 764 VYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDF 843 (1008)
Q Consensus 764 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 843 (1008)
||||++ ++|.+++.... ..+++..++.++.|++.||+|||+. +|+||||+|+||++++++.+||+||
T Consensus 76 v~e~~~-~~l~~~i~~~~---------~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~ 142 (282)
T cd07829 76 VFEYCD-MDLKKYLDKRP---------GPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADF 142 (282)
T ss_pred EecCcC-cCHHHHHHhhc---------cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecC
Confidence 999996 69999997652 1689999999999999999999998 9999999999999999999999999
Q ss_pred CcccccccccCccccccccccccccccCccccCCC-CCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHhhCC
Q 045798 844 GLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGS-EVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMALP 922 (1008)
Q Consensus 844 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~~~~ 922 (1008)
|.+......... .....++..|+|||.+.+. .++.++|||||||++||+++|+.||...... ............
T Consensus 143 g~~~~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~-~~~~~~~~~~~~ 217 (282)
T cd07829 143 GLARAFGIPLRT----YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEI-DQLFKIFQILGT 217 (282)
T ss_pred CcccccCCCccc----cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHH-HHHHHHHHHhCC
Confidence 999765432211 1123357789999998776 7899999999999999999999998643211 111111111100
Q ss_pred cc--hhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 923 NQ--VMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 923 ~~--~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
.. ............. ...... ...........+..+.+++.+||+.||++||++++++.
T Consensus 218 ~~~~~~~~~~~~~~~~~----~~~~~~-~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 218 PTEESWPGVTKLPDYKP----TFPKFP-PKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred CcHHHHHhhcccccccc----cccccC-ccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 00 0000000000000 000000 00000000122567899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=287.47 Aligned_cols=251 Identities=23% Similarity=0.258 Sum_probs=192.8
Q ss_pred CCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccc-----cchhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCc
Q 045798 685 GFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQ-----CEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGND 759 (1008)
Q Consensus 685 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 759 (1008)
+|.+.+.||+|+||.||+|.+...+..+++|+++.. .......+..|+.+++.++||||+++++++ .+..
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~ 75 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASF-----LERD 75 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHH-----hcCC
Confidence 588899999999999999999766666777776532 123344677899999999999999999984 4456
Q ss_pred eEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeE
Q 045798 760 FKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGH 839 (1008)
Q Consensus 760 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 839 (1008)
..++||||+++++|.+++...... ...+++..++.++.|++.|+.|||+. +++|+||+|+||+++. +.+|
T Consensus 76 ~~~lv~e~~~~~~l~~~~~~~~~~------~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~ 145 (260)
T cd08222 76 AFCIITEYCEGRDLDCKLEELKHT------GKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLK 145 (260)
T ss_pred ceEEEEEeCCCCCHHHHHHHHhhc------ccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEe
Confidence 689999999999999988643211 12689999999999999999999997 9999999999999975 5699
Q ss_pred EcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHh
Q 045798 840 IGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARM 919 (1008)
Q Consensus 840 L~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~ 919 (1008)
|+|||.+......... .....++..|+|||...+..++.++||||||+++|+|++|..||.... .. .....
T Consensus 146 l~d~g~~~~~~~~~~~----~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~----~~-~~~~~ 216 (260)
T cd08222 146 IGDFGVSRLLMGSCDL----ATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN----FL-SVVLR 216 (260)
T ss_pred ecccCceeecCCCccc----ccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc----HH-HHHHH
Confidence 9999999765432221 122347889999999888888999999999999999999999985321 00 01000
Q ss_pred hCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 920 ALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 920 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
..... .+ . .....+.++.+++.+||+.+|++||++.|+++
T Consensus 217 ~~~~~-----~~--------------------~--~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 217 IVEGP-----TP--------------------S--LPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred HHcCC-----CC--------------------C--CcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 00000 00 0 01134567899999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-31 Score=301.30 Aligned_cols=267 Identities=22% Similarity=0.275 Sum_probs=219.1
Q ss_pred CCHHHHHHHhcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccchhhHHHHHHHHHHhhc-CCCCceeeeecccc
Q 045798 674 MSYKSLLKATNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNI-RHRNLVKVITSCSS 752 (1008)
Q Consensus 674 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~ 752 (1008)
..++.+...++.|.+.+.||.|.+|.||++....+++.+|+|+.... .+..++...|.++++.. .|||++.++|++.-
T Consensus 9 ~~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~-~d~deEiE~eynil~~~~~hpnv~~fyg~~~k 87 (953)
T KOG0587|consen 9 IDLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPT-EDEEEEIELEYNMLKKYSHHPNVATFYGAFIK 87 (953)
T ss_pred cchhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCC-ccccHHHHHHHHHHHhccCCCCcceEEEEEEE
Confidence 34445555677899999999999999999999999999999998765 44456788899999888 79999999999888
Q ss_pred ccccCCceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeee
Q 045798 753 IDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILL 832 (1008)
Q Consensus 753 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll 832 (1008)
.+...++..|+|||||.+|+..|+++..... ++.|..+..|++.++.|+.+||.. .++|||||=.|||+
T Consensus 88 ~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~--------rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLL 156 (953)
T KOG0587|consen 88 KDPGNGDQLWLVMEFCGGGSVTDLVKNTKGN--------RLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLL 156 (953)
T ss_pred ecCCCCCeEEEEeeccCCccHHHHHhhhccc--------chhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEE
Confidence 7778889999999999999999999876522 899999999999999999999998 99999999999999
Q ss_pred cCCCCeEEcccCcccccccccCccccccccccccccccCccccCCC-----CCCcccchhhHHHHHHHHHhCCCCCCccc
Q 045798 833 DNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGS-----EVSTNGDVYSYGILLLEMVTAKKPTDVMF 907 (1008)
Q Consensus 833 ~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~sDvwslG~vl~elltG~~pf~~~~ 907 (1008)
+.++.+||+|||.+...+..... ....+||+.|||||++... .|+..+|+||+|++..||.-|.+|+.+..
T Consensus 157 T~e~~VKLvDFGvSaQldsT~gr----RnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmH 232 (953)
T KOG0587|consen 157 TENAEVKLVDFGVSAQLDSTVGR----RNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMH 232 (953)
T ss_pred eccCcEEEeeeeeeeeeeccccc----ccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcc
Confidence 99999999999999876554433 3346799999999998654 46778999999999999999999976432
Q ss_pred cCCccHHHHHHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 908 EGDLNLHNFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 908 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
.- +..+ .-.++.++.......-..++.++|..|+..|.++||++.++++
T Consensus 233 Pm--------raLF----------------------~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 233 PM--------RALF----------------------LIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred hh--------hhhc----------------------cCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 21 0000 0011122222234456778999999999999999999999875
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=320.82 Aligned_cols=147 Identities=31% Similarity=0.440 Sum_probs=131.2
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEecccc---chhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCc
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC---EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGND 759 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 759 (1008)
.++|.+.++||+|+||.||+|.+..+++.||||+++... ......+.+|+.+++.++||||+++++++ ...+
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~-----~~~~ 77 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSL-----QSAN 77 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEE-----EECC
Confidence 468999999999999999999998889999999997432 23346789999999999999999999884 5566
Q ss_pred eEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeE
Q 045798 760 FKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGH 839 (1008)
Q Consensus 760 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 839 (1008)
+.|+||||+++++|.+++.... .+++..++.|+.||+.||+|||+. +||||||||+|||++.++.+|
T Consensus 78 ~~~lVmEy~~g~~L~~li~~~~----------~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vk 144 (669)
T cd05610 78 NVYLVMEYLIGGDVKSLLHIYG----------YFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIK 144 (669)
T ss_pred EEEEEEeCCCCCCHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEE
Confidence 7999999999999999987543 578889999999999999999997 999999999999999999999
Q ss_pred EcccCccc
Q 045798 840 IGDFGLAR 847 (1008)
Q Consensus 840 L~Dfg~a~ 847 (1008)
|+|||+++
T Consensus 145 L~DFGls~ 152 (669)
T cd05610 145 LTDFGLSK 152 (669)
T ss_pred EEeCCCCc
Confidence 99999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-33 Score=274.22 Aligned_cols=255 Identities=26% Similarity=0.274 Sum_probs=190.5
Q ss_pred CceEeeccCeeEEEEEEcCCCeEEEEEEecccc-chhhHHHHHHHHHHhhc-CCCCceeeeeccccccccCCceEEEEEe
Q 045798 689 THLIGVGSFGCVYKGALDEDGIVVAIKVINLQC-EGASKSFMAECKALKNI-RHRNLVKVITSCSSIDFQGNDFKAIVYE 766 (1008)
Q Consensus 689 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~e 766 (1008)
...||.|+||+|++-.+++.|+..|||+++... +.+.+++..|.+...+- +.||||+++|++. . ++..||.||
T Consensus 69 lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F----~-EGdcWiCME 143 (361)
T KOG1006|consen 69 LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALF----S-EGDCWICME 143 (361)
T ss_pred HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhh----c-CCceeeeHH
Confidence 367999999999999999999999999998544 46677888888865554 8999999999964 2 334799999
Q ss_pred ccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEcccCcc
Q 045798 767 YMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLA 846 (1008)
Q Consensus 767 ~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a 846 (1008)
.| ..|++.+-+.-.. .....+++.-.-.|....+.||.||.+. ..|+|||+||+|||++..|.+||||||++
T Consensus 144 LM-d~SlDklYk~vy~-----vq~~~ipE~Ilg~ItvatV~AL~yLK~~--lkiIHRDvKPSNILldr~G~vKLCDFGIc 215 (361)
T KOG1006|consen 144 LM-DISLDKLYKRVYS-----VQKSRIPENILGHITVATVDALDYLKEE--LKIIHRDVKPSNILLDRHGDVKLCDFGIC 215 (361)
T ss_pred HH-hhhHHHHHHHHHH-----HHhccCcHhhhhheeeeehhHHHHHHHH--hhhhhccCChhheEEecCCCEeeecccch
Confidence 99 6687665432110 0112788888889999999999999986 58999999999999999999999999999
Q ss_pred cccccccCccccccccccccccccCccccCCC--CCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCcc
Q 045798 847 RFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGS--EVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMALPNQ 924 (1008)
Q Consensus 847 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~~~~~~ 924 (1008)
-.+.+.-. .+.-.|-..|||||.+... .|+-+|||||+|+++||+.||..||..+.. ......
T Consensus 216 GqLv~SiA-----kT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s----vfeql~------ 280 (361)
T KOG1006|consen 216 GQLVDSIA-----KTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS----VFEQLC------ 280 (361)
T ss_pred HhHHHHHH-----hhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH----HHHHHH------
Confidence 75543322 1223488899999988653 588899999999999999999999864311 111111
Q ss_pred hhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 045798 925 VMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHE 987 (1008)
Q Consensus 925 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 987 (1008)
....+++....... ...+....+.+++..|+..|-.+||...++.+.
T Consensus 281 ------~Vv~gdpp~l~~~~----------~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 281 ------QVVIGDPPILLFDK----------ECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred ------HHHcCCCCeecCcc----------cccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 11111111100000 112356678999999999999999999988763
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-32 Score=287.21 Aligned_cols=245 Identities=25% Similarity=0.347 Sum_probs=193.3
Q ss_pred CceEeeccCeeEEEEEEcCCCeEEEEEEeccc--cchhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceEEEEEe
Q 045798 689 THLIGVGSFGCVYKGALDEDGIVVAIKVINLQ--CEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKAIVYE 766 (1008)
Q Consensus 689 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 766 (1008)
.+.||+|.||+||-|.++.+|+.||||++.+. .......+++|+.|++.+.||.||.+... ++..+..++|||
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M-----~ET~ervFVVME 643 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECM-----FETPERVFVVME 643 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEe-----ecCCceEEEEeh
Confidence 47899999999999999999999999999643 23455789999999999999999999877 577888999999
Q ss_pred ccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCC---CCeEEccc
Q 045798 767 YMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDND---LSGHIGDF 843 (1008)
Q Consensus 767 ~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~---~~~kL~Df 843 (1008)
.+ .|+..+.+-..... ++++.....+..||+.||.|||.. +|||+|+||+|||+... -.+|||||
T Consensus 644 Kl-~GDMLEMILSsEkg--------RL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDF 711 (888)
T KOG4236|consen 644 KL-HGDMLEMILSSEKG--------RLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDF 711 (888)
T ss_pred hh-cchHHHHHHHhhcc--------cchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccc
Confidence 99 66776666443322 789999999999999999999997 99999999999999643 57899999
Q ss_pred CcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCc
Q 045798 844 GLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMALPN 923 (1008)
Q Consensus 844 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~~~~~ 923 (1008)
|+|+++++..- ...++||+.|.|||++....|...-|+||.||++|--++|..||....+-.+.+... .-.+|.
T Consensus 712 GfARiIgEksF-----RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNA-aFMyPp 785 (888)
T KOG4236|consen 712 GFARIIGEKSF-----RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNA-AFMYPP 785 (888)
T ss_pred cceeecchhhh-----hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHHhhcc-ccccCC
Confidence 99998876432 234779999999999999999999999999999999999999986432211111111 111111
Q ss_pred chhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 924 QVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 924 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
.++.++...-+++|...++..-.+|-|.+.-+.
T Consensus 786 ------------------------------~PW~eis~~AidlIn~LLqVkm~kRysvdk~ls 818 (888)
T KOG4236|consen 786 ------------------------------NPWSEISPEAIDLINNLLQVKMRKRYSVDKSLS 818 (888)
T ss_pred ------------------------------CchhhcCHHHHHHHHHHHHHHHHHhcchHhhcc
Confidence 123345555677777777777778877776543
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.8e-32 Score=294.92 Aligned_cols=240 Identities=23% Similarity=0.255 Sum_probs=193.3
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccchhhHHHHHHHHHHhhc-CCCCceeeeeccccccccCCceE
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNI-RHRNLVKVITSCSSIDFQGNDFK 761 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~ 761 (1008)
++.|.....+|.|+|+.|-.+.+..+++..++|++... ..+..+|+.++... +||||+++.+. +.++.+.
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~----~~~~~~e~~~~~~~~~h~niv~~~~v-----~~~~~~~ 391 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR----ADDNQDEIPISLLVRDHPNIVKSHDV-----YEDGKEI 391 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheecccc----ccccccccchhhhhcCCCcceeecce-----ecCCcee
Confidence 55677888899999999999999999999999999654 33455677777666 89999999999 5677889
Q ss_pred EEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeee-cCCCCeEE
Q 045798 762 AIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILL-DNDLSGHI 840 (1008)
Q Consensus 762 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll-~~~~~~kL 840 (1008)
|+|||.+.++-+.+.+...+ ....++..|+.+|+.|+.|||++ ||||||+||+|||+ +..++++|
T Consensus 392 ~~v~e~l~g~ell~ri~~~~-----------~~~~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrl 457 (612)
T KOG0603|consen 392 YLVMELLDGGELLRRIRSKP-----------EFCSEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRL 457 (612)
T ss_pred eeeehhccccHHHHHHHhcc-----------hhHHHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEE
Confidence 99999999998887776543 33367888999999999999997 99999999999999 58899999
Q ss_pred cccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHhh
Q 045798 841 GDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMA 920 (1008)
Q Consensus 841 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~~ 920 (1008)
+|||.++..... ....+-|..|.|||+.....|++++|+||||+++|+|++|+.||.....+ .....+..
T Consensus 458 tyFG~a~~~~~~-------~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~---~ei~~~i~ 527 (612)
T KOG0603|consen 458 TYFGFWSELERS-------CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG---IEIHTRIQ 527 (612)
T ss_pred EEechhhhCchh-------hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch---HHHHHhhc
Confidence 999999876554 12234688999999999999999999999999999999999998753322 11111111
Q ss_pred CCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 921 LPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 921 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
.+. .....+...++++.+|++.||.+||+|.++..
T Consensus 528 ~~~-------------------------------~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 528 MPK-------------------------------FSECVSDEAKDLLQQLLQVDPALRLGADEIGA 562 (612)
T ss_pred CCc-------------------------------cccccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence 110 01234555689999999999999999999865
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-31 Score=282.32 Aligned_cols=237 Identities=30% Similarity=0.344 Sum_probs=190.5
Q ss_pred EeeccCeeEEEEEEcCCCeEEEEEEeccccc---hhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceEEEEEecc
Q 045798 692 IGVGSFGCVYKGALDEDGIVVAIKVINLQCE---GASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKAIVYEYM 768 (1008)
Q Consensus 692 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 768 (1008)
||.|+||.||++....+++.||+|++..... .....+..|++++++++|+||+++++. +..++..++||||+
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~-----~~~~~~~~~v~e~~ 75 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYA-----FQTEEKLYLVLEYA 75 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHH-----eecCCeeEEEEecC
Confidence 6899999999999988899999999875422 245678999999999999999999988 45677899999999
Q ss_pred CCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEcccCcccc
Q 045798 769 PNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARF 848 (1008)
Q Consensus 769 ~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~ 848 (1008)
++++|.+++.... .+++..+..++.|++.|+.|||+. +++|+||+|+||+++.++.++|+|||.+..
T Consensus 76 ~~~~L~~~l~~~~----------~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~ 142 (250)
T cd05123 76 PGGELFSHLSKEG----------RFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKE 142 (250)
T ss_pred CCCcHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCccee
Confidence 9999999997653 678999999999999999999997 999999999999999999999999999986
Q ss_pred cccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCcchhhh
Q 045798 849 HQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMALPNQVMDI 928 (1008)
Q Consensus 849 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 928 (1008)
...... ......++..|+|||...+...+.++|+||||+++|++++|..||..... ........
T Consensus 143 ~~~~~~----~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~-----~~~~~~~~------- 206 (250)
T cd05123 143 LSSEGS----RTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR-----KEIYEKIL------- 206 (250)
T ss_pred cccCCC----cccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH-----HHHHHHHh-------
Confidence 543321 12234578899999999888889999999999999999999999864321 01100000
Q ss_pred hcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHH
Q 045798 929 VDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTN 983 (1008)
Q Consensus 929 ~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 983 (1008)
.... . .....+..+.+++.+||..||++||++.+
T Consensus 207 -~~~~--------------~------~~~~~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 207 -KDPL--------------R------FPEFLSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred -cCCC--------------C------CCCCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence 0000 0 00112456789999999999999999954
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-32 Score=282.59 Aligned_cols=262 Identities=26% Similarity=0.346 Sum_probs=199.3
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccc-------hhhHHHHHHHHHHhhcCCCCceeeeeccccccc
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCE-------GASKSFMAECKALKNIRHRNLVKVITSCSSIDF 755 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 755 (1008)
.++|-...+||+|||++||+|.+....+.||||+-..... .-.+...+|.+|.+.+.||.||++|+++.
T Consensus 462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfs---- 537 (775)
T KOG1151|consen 462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFS---- 537 (775)
T ss_pred HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeee----
Confidence 3568888999999999999999988889999998753321 11245788999999999999999999964
Q ss_pred cCCceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecC-
Q 045798 756 QGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDN- 834 (1008)
Q Consensus 756 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~- 834 (1008)
-+.+..|-|+|||+|.+|+-|++.++ .+++.+++.|+.||+.||.||.+. .++|||-|+||.|||+..
T Consensus 538 lDtdsFCTVLEYceGNDLDFYLKQhk----------lmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~G 606 (775)
T KOG1151|consen 538 LDTDSFCTVLEYCEGNDLDFYLKQHK----------LMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNG 606 (775)
T ss_pred eccccceeeeeecCCCchhHHHHhhh----------hhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecC
Confidence 45667899999999999999999876 789999999999999999999986 678999999999999954
Q ss_pred --CCCeEEcccCcccccccccCcc---ccccccccccccccCccccCCC----CCCcccchhhHHHHHHHHHhCCCCCCc
Q 045798 835 --DLSGHIGDFGLARFHQEVSNST---LSSSVGVKGTIGYTAPEYGLGS----EVSTNGDVYSYGILLLEMVTAKKPTDV 905 (1008)
Q Consensus 835 --~~~~kL~Dfg~a~~~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDvwslG~vl~elltG~~pf~~ 905 (1008)
-|.+||+|||++++++++.... ..-+....||.+|.+||.+.-+ ..+.|+||||+||++|+.+.|+.||..
T Consensus 607 tacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGh 686 (775)
T KOG1151|consen 607 TACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGH 686 (775)
T ss_pred cccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCC
Confidence 4789999999999887654331 1122345699999999986543 468899999999999999999999974
Q ss_pred cccCCccHHHHHHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHH
Q 045798 906 MFEGDLNLHNFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVV 985 (1008)
Q Consensus 906 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl 985 (1008)
.......+..- .++... ...++.-.....+-..+|++|+++.-++|....++.
T Consensus 687 nqsQQdILqeN----------TIlkAt-----------------EVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 687 NQSQQDILQEN----------TILKAT-----------------EVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred chhHHHHHhhh----------chhcce-----------------eccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence 32211111000 000000 000111112334457889999999888888777764
Q ss_pred H
Q 045798 986 H 986 (1008)
Q Consensus 986 ~ 986 (1008)
.
T Consensus 740 ~ 740 (775)
T KOG1151|consen 740 C 740 (775)
T ss_pred c
Confidence 3
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-32 Score=277.41 Aligned_cols=210 Identities=27% Similarity=0.334 Sum_probs=176.5
Q ss_pred CCHHHHHHHhcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEecccc---chhhHHHHHHHHHHhhc-CCCCceeeeec
Q 045798 674 MSYKSLLKATNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC---EGASKSFMAECKALKNI-RHRNLVKVITS 749 (1008)
Q Consensus 674 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~ 749 (1008)
.+-.+..+ ..+|..+.+||+|+||.|.+|..+.+.+.||||+++..- +++.+--+.|-+++... +-|.++++..+
T Consensus 340 ~~~~d~i~-~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHSc 418 (683)
T KOG0696|consen 340 SSKRDRIK-ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSC 418 (683)
T ss_pred CCccccee-ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHH
Confidence 34444333 347999999999999999999999999999999997442 23344556777787776 57788888877
Q ss_pred cccccccCCceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCC
Q 045798 750 CSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSN 829 (1008)
Q Consensus 750 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~N 829 (1008)
|+.-+..|+||||+.||+|--.++.-+ ++.+..+..+|..||-||-+||++ ||+.||+|.+|
T Consensus 419 -----FQTmDRLyFVMEyvnGGDLMyhiQQ~G----------kFKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDN 480 (683)
T KOG0696|consen 419 -----FQTMDRLYFVMEYVNGGDLMYHIQQVG----------KFKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDN 480 (683)
T ss_pred -----hhhhhheeeEEEEecCchhhhHHHHhc----------ccCCchhhhhhHHHHHHhhhhhcC---Ceeeeeccccc
Confidence 677788999999999999998887765 678888999999999999999997 99999999999
Q ss_pred eeecCCCCeEEcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCcc
Q 045798 830 ILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVM 906 (1008)
Q Consensus 830 Ill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~ 906 (1008)
||++.+|++||+|||+++.--.. ...+...+||+.|+|||++...+|+..+|.||+||++|||+.|++||+..
T Consensus 481 vmLd~eGHiKi~DFGmcKEni~~----~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGe 553 (683)
T KOG0696|consen 481 VMLDSEGHIKIADFGMCKENIFD----GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGE 553 (683)
T ss_pred eEeccCCceEeeecccccccccC----CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCC
Confidence 99999999999999999732211 12234578999999999999999999999999999999999999999854
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-31 Score=279.61 Aligned_cols=223 Identities=20% Similarity=0.141 Sum_probs=175.8
Q ss_pred ccCeeEEEEEEcCCCeEEEEEEeccccchhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceEEEEEeccCCCChh
Q 045798 695 GSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKAIVYEYMPNGSLE 774 (1008)
Q Consensus 695 G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~ 774 (1008)
|.+|.||++++..+++.||+|+++... .+.+|...+....||||+++++++ ...+..++||||+++|+|.
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~-----~~~~~~~lv~e~~~~~~L~ 73 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYI-----VSEDSVFLVLQHAEGGKLW 73 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhhe-----ecCCeEEEEEecCCCCCHH
Confidence 899999999999999999999997542 233455555556799999999984 5567799999999999999
Q ss_pred cccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEcccCcccccccccC
Q 045798 775 KWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSN 854 (1008)
Q Consensus 775 ~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~ 854 (1008)
+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++++|||.+.......
T Consensus 74 ~~l~~~~----------~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~- 139 (237)
T cd05576 74 SHISKFL----------NIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC- 139 (237)
T ss_pred HHHHHhc----------CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhcccccc-
Confidence 9986543 588999999999999999999997 99999999999999999999999999886543321
Q ss_pred ccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCcchhhhhccccc
Q 045798 855 STLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMALPNQVMDIVDPILR 934 (1008)
Q Consensus 855 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 934 (1008)
....++..|+|||...+..++.++||||+|+++|||++|+.|+....... . .... +
T Consensus 140 ------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~-----------~----~~~~--~- 195 (237)
T cd05576 140 ------DGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI-----------N----THTT--L- 195 (237)
T ss_pred ------ccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc-----------c----cccc--c-
Confidence 11235778999999988889999999999999999999998864221000 0 0000 0
Q ss_pred CchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHH
Q 045798 935 NDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNV 984 (1008)
Q Consensus 935 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev 984 (1008)
..+ ...+..+.+++.+|++.||++||++.+.
T Consensus 196 -------------~~~------~~~~~~~~~li~~~l~~dp~~R~~~~~~ 226 (237)
T cd05576 196 -------------NIP------EWVSEEARSLLQQLLQFNPTERLGAGVA 226 (237)
T ss_pred -------------CCc------ccCCHHHHHHHHHHccCCHHHhcCCCcc
Confidence 000 1133457899999999999999997433
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=274.58 Aligned_cols=138 Identities=26% Similarity=0.417 Sum_probs=120.4
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccchhhHHHHHHHHHHhhcC--------CCCceeeeecccccc
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIR--------HRNLVKVITSCSSID 754 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--------h~niv~~~~~~~~~~ 754 (1008)
..+|.+.++||-|.|++||+|.+..+.+.||+|+.+.. +.-.+....|++++++++ ..+||++++.|...+
T Consensus 77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG 155 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG 155 (590)
T ss_pred CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC
Confidence 46899999999999999999999999999999999754 455677889999999982 247999999976544
Q ss_pred ccCCceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeec
Q 045798 755 FQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLD 833 (1008)
Q Consensus 755 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~ 833 (1008)
..+.++|+|+|+. |.+|..+|...... .++...+++|++||+.||.|||..| ||||-||||+|||+.
T Consensus 156 -pNG~HVCMVfEvL-GdnLLklI~~s~Yr--------Glpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 156 -PNGQHVCMVFEVL-GDNLLKLIKYSNYR--------GLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLC 222 (590)
T ss_pred -CCCcEEEEEehhh-hhHHHHHHHHhCCC--------CCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeee
Confidence 6778999999999 88999999876543 6899999999999999999999986 999999999999993
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=249.89 Aligned_cols=209 Identities=25% Similarity=0.312 Sum_probs=170.1
Q ss_pred HhcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEecccc-chhhHHHHHHHHHHhhc-CCCCceeeeeccccccccCCc
Q 045798 682 ATNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC-EGASKSFMAECKALKNI-RHRNLVKVITSCSSIDFQGND 759 (1008)
Q Consensus 682 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~ 759 (1008)
..+....+..||+|+||.|-+.++..+|+..|+|.++..- .+..++..+|+++..+. .+|.+|.++|.. ....
T Consensus 44 ~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~-----~reg 118 (282)
T KOG0984|consen 44 PADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGAL-----FREG 118 (282)
T ss_pred chhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhh-----hccc
Confidence 3444555678999999999999999999999999997442 34556788888877665 899999999984 4455
Q ss_pred eEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeE
Q 045798 760 FKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGH 839 (1008)
Q Consensus 760 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 839 (1008)
..++.||.| ..||+.+-++.-.. +..+++..+-+|+..+.+||.|||++ -.++|||+||+|||++.+|++|
T Consensus 119 dvwIcME~M-~tSldkfy~~v~~~------g~~ipE~vlGkIa~Svv~al~~L~~k--L~vIHRDvKPsNiLIn~~GqVK 189 (282)
T KOG0984|consen 119 DVWICMELM-DTSLDKFYRKVLKK------GGTIPEDVLGKIAVSVVHALEFLHSK--LSVIHRDVKPSNILINYDGQVK 189 (282)
T ss_pred cEEEeHHHh-hhhHHHHHHHHHhc------CCcCchHHhhHhHHHHHHHHHHHHHH--hhhhhccCCcceEEEccCCcEE
Confidence 689999999 67888765432211 22789999999999999999999997 5899999999999999999999
Q ss_pred EcccCcccccccccCccccccccccccccccCccccCC----CCCCcccchhhHHHHHHHHHhCCCCCCccccC
Q 045798 840 IGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLG----SEVSTNGDVYSYGILLLEMVTAKKPTDVMFEG 909 (1008)
Q Consensus 840 L~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~sDvwslG~vl~elltG~~pf~~~~~~ 909 (1008)
+||||++-++.+.-.... ..|-..|||||.+.. ..|+-+|||||+|+++.||.+++.||+.....
T Consensus 190 iCDFGIsG~L~dSiAkt~-----daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tp 258 (282)
T KOG0984|consen 190 ICDFGISGYLVDSIAKTM-----DAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTP 258 (282)
T ss_pred EcccccceeehhhhHHHH-----hcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCH
Confidence 999999987755433221 237788999998754 36899999999999999999999999865443
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-30 Score=299.74 Aligned_cols=277 Identities=20% Similarity=0.197 Sum_probs=173.8
Q ss_pred HhcCCCCCceEeeccCeeEEEEEEcCC----CeEEEEEEeccccchhhHHHHHHHHHHhhcCCCCceeeeeccccc-ccc
Q 045798 682 ATNGFSSTHLIGVGSFGCVYKGALDED----GIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSCSSI-DFQ 756 (1008)
Q Consensus 682 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~ 756 (1008)
..++|.+.+.||+|+||.||+|.+..+ +..||+|++..... .+....| .+....+.++..+...+... ...
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 467899999999999999999999877 89999998864322 1212222 11222233333322221111 114
Q ss_pred CCceEEEEEeccCCCChhcccccCCCCCCCc----------ccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCC
Q 045798 757 GNDFKAIVYEYMPNGSLEKWLHPHAVPKRDK----------EIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLK 826 (1008)
Q Consensus 757 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~----------~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlk 826 (1008)
.+...++||||+++++|.+++.......... ..........+..++.||+.||+|||++ +|+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcCC
Confidence 5667899999999999999987543110000 0001123445678999999999999997 99999999
Q ss_pred CCCeeecC-CCCeEEcccCcccccccccCccccccccccccccccCccccCCC----------------------CCCcc
Q 045798 827 PSNILLDN-DLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGS----------------------EVSTN 883 (1008)
Q Consensus 827 p~NIll~~-~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~ 883 (1008)
|+|||++. ++.+||+|||+|+........ ......+++.|+|||.+... .++.+
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~~---~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k 359 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGINY---IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDR 359 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCcccccccccc---CCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCC
Confidence 99999986 579999999999855432221 12234689999999965322 23456
Q ss_pred cchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHhh--CCcchhhh---hcccccCchHHhhhhhhhhhccccchhHHH
Q 045798 884 GDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMA--LPNQVMDI---VDPILRNDEEILASTDKCRRMQTGINSRLE 958 (1008)
Q Consensus 884 sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~~--~~~~~~~~---~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 958 (1008)
+||||+||++|||+++..|++.. ...+.... .......+ +.+.. ..+ ..........
T Consensus 360 ~DVwSlGviL~el~~~~~~~~~~------~~~~~~~l~~~~~~~~~~~~~~~~~~--~~~----------~~~~~~~~d~ 421 (566)
T PLN03225 360 FDIYSAGLIFLQMAFPNLRSDSN------LIQFNRQLKRNDYDLVAWRKLVEPRA--SPD----------LRRGFEVLDL 421 (566)
T ss_pred cccHHHHHHHHHHHhCcCCCchH------HHHHHHHHHhcCCcHHHHHHhhcccc--chh----------hhhhhhhccc
Confidence 79999999999999977765421 11111100 00000000 00000 000 0000000011
Q ss_pred HHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 959 CLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 959 ~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
......+++.+|++.||++|||++|+++
T Consensus 422 ~~~~~~dLi~~mL~~dP~kR~ta~e~L~ 449 (566)
T PLN03225 422 DGGAGWELLKSMMRFKGRQRISAKAALA 449 (566)
T ss_pred cchHHHHHHHHHccCCcccCCCHHHHhC
Confidence 2234568999999999999999999987
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-30 Score=257.87 Aligned_cols=202 Identities=25% Similarity=0.364 Sum_probs=178.4
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccc---cchhhHHHHHHHHHHhhc-CCCCceeeeeccccccccCC
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQ---CEGASKSFMAECKALKNI-RHRNLVKVITSCSSIDFQGN 758 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~ 758 (1008)
.++|...++||+|+|+.|..++.+++.+.||+|+++.. .++..+-.+.|-.+..+. +||.+|.+..+ |+.+
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhsc-----fqte 323 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSC-----FQTE 323 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhh-----hccc
Confidence 56799999999999999999999999999999999843 344455677888888777 89999999988 6788
Q ss_pred ceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCe
Q 045798 759 DFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSG 838 (1008)
Q Consensus 759 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 838 (1008)
...++|.||++||+|--+++..+ +++++.++.+...|.-||.|||++ ||+.||+|.+||++|..|++
T Consensus 324 srlffvieyv~ggdlmfhmqrqr----------klpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghi 390 (593)
T KOG0695|consen 324 SRLFFVIEYVNGGDLMFHMQRQR----------KLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHI 390 (593)
T ss_pred ceEEEEEEEecCcceeeehhhhh----------cCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCce
Confidence 88999999999999988887665 899999999999999999999998 99999999999999999999
Q ss_pred EEcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCcc
Q 045798 839 HIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVM 906 (1008)
Q Consensus 839 kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~ 906 (1008)
||+|||+++.--...+. +...+||+.|+|||++.+..|...+|.|++||+++||+.|+.||+..
T Consensus 391 kltdygmcke~l~~gd~----tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdiv 454 (593)
T KOG0695|consen 391 KLTDYGMCKEGLGPGDT----TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIV 454 (593)
T ss_pred eecccchhhcCCCCCcc----cccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCccee
Confidence 99999999843322222 33477999999999999999999999999999999999999999853
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-30 Score=247.51 Aligned_cols=277 Identities=19% Similarity=0.262 Sum_probs=204.0
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccchhhHHHHHHHHHHhhc-CCCCceeeeeccccccccCCceE
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNI-RHRNLVKVITSCSSIDFQGNDFK 761 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~ 761 (1008)
.++|++++++|+|.|++||.|....+.++++||+++. -..+.+.+|+.+++.+ .||||++++++..+ +.....
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP---VkkkKIkREikIL~nL~gg~NIi~L~DiV~D---p~Sktp 110 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP---VKKKKIKREIKILQNLRGGPNIIKLLDIVKD---PESKTP 110 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeech---HHHHHHHHHHHHHHhccCCCCeeehhhhhcC---ccccCc
Confidence 4689999999999999999999988999999999974 3457789999999999 59999999999765 334457
Q ss_pred EEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCC-CCeEE
Q 045798 762 AIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDND-LSGHI 840 (1008)
Q Consensus 762 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kL 840 (1008)
.+|+||+.+.+....-. .++...++.++.+++.||.|+|+. ||.|||+||.|++||.. -..+|
T Consensus 111 aLiFE~v~n~Dfk~ly~-------------tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrl 174 (338)
T KOG0668|consen 111 SLIFEYVNNTDFKQLYP-------------TLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRL 174 (338)
T ss_pred hhHhhhhccccHHHHhh-------------hhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeee
Confidence 89999998887776653 677788999999999999999998 99999999999999864 56899
Q ss_pred cccCcccccccccCccccccccccccccccCccccCCC-CCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHh
Q 045798 841 GDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGS-EVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARM 919 (1008)
Q Consensus 841 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~ 919 (1008)
+|+|+|..+.+...... .+.+..|.-||.+-.- .|+..-|+|||||++..|+..+.||.........+...+..
T Consensus 175 IDWGLAEFYHp~~eYnV-----RVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakV 249 (338)
T KOG0668|consen 175 IDWGLAEFYHPGKEYNV-----RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKV 249 (338)
T ss_pred eecchHhhcCCCceeee-----eeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHH
Confidence 99999998766544332 3467788999987764 57888999999999999999999985443333444444444
Q ss_pred hCCcchhhhhccc---ccCchHHhhhhhhhhhccccchh--HHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 920 ALPNQVMDIVDPI---LRNDEEILASTDKCRRMQTGINS--RLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 920 ~~~~~~~~~~d~~---l~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
.....+...+++- +....+..........+...+.. ..-..++..+++...++.|-++||||+|.+.
T Consensus 250 LGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 250 LGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred hChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence 3333333222211 11111110000001111111110 0112356689999999999999999999876
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-30 Score=292.04 Aligned_cols=260 Identities=27% Similarity=0.355 Sum_probs=196.6
Q ss_pred CCCceEeeccCee-EEEEEEcCCCeEEEEEEeccccchhhHHHHHHHHHHhhc-CCCCceeeeeccccccccCCceEEEE
Q 045798 687 SSTHLIGVGSFGC-VYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNI-RHRNLVKVITSCSSIDFQGNDFKAIV 764 (1008)
Q Consensus 687 ~~~~~lg~G~~g~-Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv 764 (1008)
...+++|.|+.|+ ||+|.. .|+.||||++- .+-.+..++|+..++.- .|||||++++. ..+..+.||+
T Consensus 512 ~~~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll---~e~~~~A~rEi~lL~eSD~H~NviRyyc~-----E~d~qF~YIa 581 (903)
T KOG1027|consen 512 SPKEILGYGSNGTVVFRGVY--EGREVAVKRLL---EEFFDFAQREIQLLQESDEHPNVIRYYCS-----EQDRQFLYIA 581 (903)
T ss_pred ccHHHcccCCCCcEEEEEee--CCceehHHHHh---hHhHHHHHHHHHHHHhccCCCceEEEEee-----ccCCceEEEE
Confidence 3346789999875 799999 68899999985 33345678999999988 89999999988 5777889999
Q ss_pred EeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecC-----CCCeE
Q 045798 765 YEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDN-----DLSGH 839 (1008)
Q Consensus 765 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~-----~~~~k 839 (1008)
.|.| ..+|.+++..... .. + .......+.++.|+++||++||+. +||||||||.||||+. ..+++
T Consensus 582 lELC-~~sL~dlie~~~~-d~--~---~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~ 651 (903)
T KOG1027|consen 582 LELC-ACSLQDLIESSGL-DV--E---MQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAK 651 (903)
T ss_pred ehHh-hhhHHHHHhcccc-ch--h---hcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEE
Confidence 9999 6799999987511 10 0 111145678899999999999998 9999999999999975 25789
Q ss_pred EcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhC-CCCCCccccCCccHHHHHH
Q 045798 840 IGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTA-KKPTDVMFEGDLNLHNFAR 918 (1008)
Q Consensus 840 L~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG-~~pf~~~~~~~~~~~~~~~ 918 (1008)
|+|||+++........... ..+..||-+|+|||++....-+.++||||+|||+|+.++| .+||+...+.+.++..-..
T Consensus 652 iSDfglsKkl~~~~sS~~r-~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl~~~~ 730 (903)
T KOG1027|consen 652 ISDFGLSKKLAGGKSSFSR-LSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANILTGNY 730 (903)
T ss_pred ecccccccccCCCcchhhc-ccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhhcCcc
Confidence 9999999988766544333 5566799999999999998888899999999999999995 8999865443322211100
Q ss_pred hhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH---------HHH
Q 045798 919 MALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH---------ELQ 989 (1008)
Q Consensus 919 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~---------~L~ 989 (1008)
.+. .+.. ..++ +-.++|.+|++++|..||+|.+|+. +|+
T Consensus 731 --------~L~--~L~~--------------------~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~~ekrL~ 778 (903)
T KOG1027|consen 731 --------TLV--HLEP--------------------LPDC--EAKDLISRMLNPDPQLRPSATDVLNHPLFWDSEKRLS 778 (903)
T ss_pred --------cee--eecc--------------------CchH--HHHHHHHHhcCCCcccCCCHHHHhCCCccCChHHHHH
Confidence 000 0000 0111 4579999999999999999999985 555
Q ss_pred HHHHHHHHHH
Q 045798 990 SVKNILLELE 999 (1008)
Q Consensus 990 ~i~~~~~~~~ 999 (1008)
=+++.-++.|
T Consensus 779 Fl~dvSDRvE 788 (903)
T KOG1027|consen 779 FLRDVSDRVE 788 (903)
T ss_pred HHHhhhhhhh
Confidence 5555555444
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.4e-29 Score=284.86 Aligned_cols=279 Identities=18% Similarity=0.193 Sum_probs=183.5
Q ss_pred HhcCCCCCceEeeccCeeEEEEEEc----------------CCCeEEEEEEeccccchhhHH--------------HHHH
Q 045798 682 ATNGFSSTHLIGVGSFGCVYKGALD----------------EDGIVVAIKVINLQCEGASKS--------------FMAE 731 (1008)
Q Consensus 682 ~~~~y~~~~~lg~G~~g~Vy~~~~~----------------~~~~~vavK~~~~~~~~~~~~--------------~~~E 731 (1008)
..++|.+.++||+|+||.||+|... ..++.||||+++.......++ ...|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 4678999999999999999999752 245689999987543333233 3446
Q ss_pred HHHHhhcCCCCc-----eeeeecccccc---ccCCceEEEEEeccCCCChhcccccCCCCCC--------------Cccc
Q 045798 732 CKALKNIRHRNL-----VKVITSCSSID---FQGNDFKAIVYEYMPNGSLEKWLHPHAVPKR--------------DKEI 789 (1008)
Q Consensus 732 ~~~l~~l~h~ni-----v~~~~~~~~~~---~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~--------------~~~~ 789 (1008)
+.++.+++|.++ ++++++|.... ....+..++||||+++++|.++++....... ....
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777777766554 66777764321 1223568999999999999999875321100 0001
Q ss_pred ccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEcccCcccccccccCccccccccccccccc
Q 045798 790 EIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGY 869 (1008)
Q Consensus 790 ~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y 869 (1008)
...+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.......... .....+++.|
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~---~~~g~~tp~Y 376 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFN---PLYGMLDPRY 376 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCccC---ccccCCCcce
Confidence 12467888999999999999999997 99999999999999999999999999997543321111 1112357899
Q ss_pred cCccccCCCC--------------------C--CcccchhhHHHHHHHHHhCCC-CCCccccCCccHHHHHHhhCCcchh
Q 045798 870 TAPEYGLGSE--------------------V--STNGDVYSYGILLLEMVTAKK-PTDVMFEGDLNLHNFARMALPNQVM 926 (1008)
Q Consensus 870 ~aPE~~~~~~--------------------~--~~~sDvwslG~vl~elltG~~-pf~~~~~~~~~~~~~~~~~~~~~~~ 926 (1008)
+|||.+.... + ..+.||||+||++|+|++|.. ||............ ......
T Consensus 377 ~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~-----~~~~~~ 451 (507)
T PLN03224 377 SPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQ-----YDNDLN 451 (507)
T ss_pred eChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhh-----ccchHH
Confidence 9999875432 1 124799999999999999885 65421100000000 000000
Q ss_pred hhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCC---CCCCCHHHHHH
Q 045798 927 DIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESP---QDRMNMTNVVH 986 (1008)
Q Consensus 927 ~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP---~~RPt~~evl~ 986 (1008)
.+. ... .....++..........+++.+++..+| .+|+|++|+++
T Consensus 452 ~~r--~~~-------------~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~ 499 (507)
T PLN03224 452 RWR--MYK-------------GQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS 499 (507)
T ss_pred HHH--hhc-------------ccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence 000 000 0000111122345567899999998766 68999999975
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-29 Score=266.98 Aligned_cols=239 Identities=30% Similarity=0.360 Sum_probs=190.3
Q ss_pred cCeeEEEEEEcCCCeEEEEEEeccccchh-hHHHHHHHHHHhhcCCCCceeeeeccccccccCCceEEEEEeccCCCChh
Q 045798 696 SFGCVYKGALDEDGIVVAIKVINLQCEGA-SKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKAIVYEYMPNGSLE 774 (1008)
Q Consensus 696 ~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~ 774 (1008)
+||.||+|....+++.||+|++....... .+.+.+|++.+++++|++++++++++. .....++++||+++++|.
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~-----~~~~~~l~~e~~~~~~L~ 75 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFE-----DEDKLYLVMEYCDGGDLF 75 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhhee-----eCCEEEEEEeCCCCCCHH
Confidence 58999999998889999999997654444 678999999999999999999999853 446789999999999999
Q ss_pred cccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEcccCcccccccccC
Q 045798 775 KWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSN 854 (1008)
Q Consensus 775 ~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~ 854 (1008)
+++.... .+++..+..++.+++.++.|||+. +++|+||+|+||++++++.++++|||.+.......
T Consensus 76 ~~~~~~~----------~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~- 141 (244)
T smart00220 76 DLLKKRG----------RLSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG- 141 (244)
T ss_pred HHHHhcc----------CCCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc-
Confidence 9987543 378899999999999999999998 99999999999999999999999999998665432
Q ss_pred ccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCcchhhhhccccc
Q 045798 855 STLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMALPNQVMDIVDPILR 934 (1008)
Q Consensus 855 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 934 (1008)
......++..|+|||...+..++.++||||+|+++|++++|..||....... ........ ....
T Consensus 142 ----~~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~----~~~~~~~~--------~~~~ 205 (244)
T smart00220 142 ----LLTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLL----ELFKKIGK--------PKPP 205 (244)
T ss_pred ----ccccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHH----HHHHHHhc--------cCCC
Confidence 1123457889999999988889999999999999999999999986421110 00000000 0000
Q ss_pred CchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 935 NDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 935 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
........+.++.+++.+||..+|++||++.++++
T Consensus 206 -----------------~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 206 -----------------FPPPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred -----------------CccccccCCHHHHHHHHHHccCCchhccCHHHHhh
Confidence 00000014456899999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7e-31 Score=276.06 Aligned_cols=200 Identities=25% Similarity=0.336 Sum_probs=176.2
Q ss_pred cCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEecc---ccchhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCce
Q 045798 684 NGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINL---QCEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDF 760 (1008)
Q Consensus 684 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 760 (1008)
.+++++..||-||||.|-++........+|+|+++. ......+.+..|-.+|...+.|.||++|.. |.+..+
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrT-----frd~ky 494 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRT-----FRDSKY 494 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHH-----hccchh
Confidence 345667789999999999999865555688888863 334556778899999999999999999988 677888
Q ss_pred EEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEE
Q 045798 761 KAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHI 840 (1008)
Q Consensus 761 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 840 (1008)
+|+.||-|-||.++..++..+ .++...++.++..+++|++|||+. +||.||+||+|.+++.+|-+||
T Consensus 495 vYmLmEaClGGElWTiLrdRg----------~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KL 561 (732)
T KOG0614|consen 495 VYMLMEACLGGELWTILRDRG----------SFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKL 561 (732)
T ss_pred hhhhHHhhcCchhhhhhhhcC----------CcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEE
Confidence 999999999999999998776 788889999999999999999997 9999999999999999999999
Q ss_pred cccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCcc
Q 045798 841 GDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVM 906 (1008)
Q Consensus 841 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~ 906 (1008)
.|||+|+.+..... +.+++||+.|.|||++.....+.++|.||+|+++||+++|.+||...
T Consensus 562 VDFGFAKki~~g~K-----TwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~ 622 (732)
T KOG0614|consen 562 VDFGFAKKIGSGRK-----TWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGV 622 (732)
T ss_pred eehhhHHHhccCCc-----eeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCC
Confidence 99999998765432 34578999999999999999999999999999999999999999743
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-30 Score=252.49 Aligned_cols=202 Identities=26% Similarity=0.331 Sum_probs=167.7
Q ss_pred CCCceEeeccCeeEEEEEEcCCCeEEEEEEeccc--cchhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceEEEE
Q 045798 687 SSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQ--CEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKAIV 764 (1008)
Q Consensus 687 ~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 764 (1008)
+..+.||.|+||.||.+.+..+|+.||+|++... .-...+++.+|++++.-++|.|++..+++........-.+.|+|
T Consensus 56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~ 135 (449)
T KOG0664|consen 56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL 135 (449)
T ss_pred CCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence 4458899999999999999999999999998632 23445789999999999999999998887543332222357889
Q ss_pred EeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEcccC
Q 045798 765 YEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFG 844 (1008)
Q Consensus 765 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg 844 (1008)
+|.| ..+|...+-... .++.+.+.-++.||++||+|||+. +|.||||||.|.++..+...||||||
T Consensus 136 TELm-QSDLHKIIVSPQ----------~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFG 201 (449)
T KOG0664|consen 136 TELM-QSDLHKIIVSPQ----------ALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFG 201 (449)
T ss_pred HHHH-HhhhhheeccCC----------CCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccc
Confidence 9999 668888876443 788889999999999999999998 99999999999999999999999999
Q ss_pred cccccccccCccccccccccccccccCccccCCC-CCCcccchhhHHHHHHHHHhCCCCCCc
Q 045798 845 LARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGS-EVSTNGDVYSYGILLLEMVTAKKPTDV 905 (1008)
Q Consensus 845 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltG~~pf~~ 905 (1008)
+|+..+...... .+..+-|..|+|||++.|. .|+.+.||||.||++.|++..+..|..
T Consensus 202 LARvee~d~~~h---MTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQA 260 (449)
T KOG0664|consen 202 LARTWDQRDRLN---MTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQA 260 (449)
T ss_pred cccccchhhhhh---hHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhc
Confidence 999765443322 2234578999999998875 689999999999999999998888753
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-29 Score=272.26 Aligned_cols=206 Identities=25% Similarity=0.312 Sum_probs=175.7
Q ss_pred cCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEecccc---chhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCce
Q 045798 684 NGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC---EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDF 760 (1008)
Q Consensus 684 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 760 (1008)
.-|..++.||-|+||+|.+++...+...||+|.+++.+ ......++.|-+||.....+-||++|.. |++++.
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyyS-----FQDkdn 703 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYS-----FQDKDN 703 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEE-----eccCCc
Confidence 34777889999999999999998888899999987543 2334568889999999999999999988 789999
Q ss_pred EEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEE
Q 045798 761 KAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHI 840 (1008)
Q Consensus 761 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 840 (1008)
+|+||+|++||++-.++-+.+ -+.+..++.++..+..|+++.|+. |+|||||||+|||||.+|++||
T Consensus 704 LYFVMdYIPGGDmMSLLIrmg----------IFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKL 770 (1034)
T KOG0608|consen 704 LYFVMDYIPGGDMMSLLIRMG----------IFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKL 770 (1034)
T ss_pred eEEEEeccCCccHHHHHHHhc----------cCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceee
Confidence 999999999999999987665 688899999999999999999998 9999999999999999999999
Q ss_pred cccCcccccccccCcccc--------------------------------------ccccccccccccCccccCCCCCCc
Q 045798 841 GDFGLARFHQEVSNSTLS--------------------------------------SSVGVKGTIGYTAPEYGLGSEVST 882 (1008)
Q Consensus 841 ~Dfg~a~~~~~~~~~~~~--------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~ 882 (1008)
+|||++.-+.-..+..++ .....+||+.|+|||++....|+.
T Consensus 771 TDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q 850 (1034)
T KOG0608|consen 771 TDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQ 850 (1034)
T ss_pred eeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccc
Confidence 999999633211111000 011246999999999999999999
Q ss_pred ccchhhHHHHHHHHHhCCCCCCccc
Q 045798 883 NGDVYSYGILLLEMVTAKKPTDVMF 907 (1008)
Q Consensus 883 ~sDvwslG~vl~elltG~~pf~~~~ 907 (1008)
-+|.||.|||+|||+.|++||-...
T Consensus 851 ~cdwws~gvil~em~~g~~pf~~~t 875 (1034)
T KOG0608|consen 851 LCDWWSVGVILYEMLVGQPPFLADT 875 (1034)
T ss_pred cchhhHhhHHHHHHhhCCCCccCCC
Confidence 9999999999999999999997543
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3e-29 Score=268.09 Aligned_cols=200 Identities=24% Similarity=0.346 Sum_probs=173.2
Q ss_pred HHhcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccc--------hhhHHHHHHHHHHhhcC---CCCceeeeec
Q 045798 681 KATNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCE--------GASKSFMAECKALKNIR---HRNLVKVITS 749 (1008)
Q Consensus 681 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~---h~niv~~~~~ 749 (1008)
+...+|...+.+|+|+||.|+.|.++++...|+||.+.+..- ...-.+-.|++||..++ |+||++++++
T Consensus 558 ~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdf 637 (772)
T KOG1152|consen 558 KKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDF 637 (772)
T ss_pred cccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhe
Confidence 344579999999999999999999999999999999864421 11224667999999996 9999999999
Q ss_pred cccccccCCceEEEEEecc-CCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCC
Q 045798 750 CSSIDFQGNDFKAIVYEYM-PNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPS 828 (1008)
Q Consensus 750 ~~~~~~~~~~~~~lv~e~~-~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~ 828 (1008)
|++++++|++||-. ++.+|.+++..++ .+++.++..|++|++.|+++||++ +|||||||-+
T Consensus 638 -----FEddd~yyl~te~hg~gIDLFd~IE~kp----------~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikde 699 (772)
T KOG1152|consen 638 -----FEDDDYYYLETEVHGEGIDLFDFIEFKP----------RMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDE 699 (772)
T ss_pred -----eecCCeeEEEecCCCCCcchhhhhhccC----------ccchHHHHHHHHHHHhcccccccc---Cceecccccc
Confidence 78888999999975 5669999998776 789999999999999999999998 9999999999
Q ss_pred CeeecCCCCeEEcccCcccccccccCccccccccccccccccCccccCCCCC-CcccchhhHHHHHHHHHhCCCCCC
Q 045798 829 NILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEV-STNGDVYSYGILLLEMVTAKKPTD 904 (1008)
Q Consensus 829 NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwslG~vl~elltG~~pf~ 904 (1008)
||.++.+|-+||+|||.|.+..... ...++||.+|.|||++.|..| +..-|||++|+++|.++....||.
T Consensus 700 nvivd~~g~~klidfgsaa~~ksgp------fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 700 NVIVDSNGFVKLIDFGSAAYTKSGP------FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred cEEEecCCeEEEeeccchhhhcCCC------cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 9999999999999999998665432 223579999999999999887 556799999999999999999875
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.4e-29 Score=265.25 Aligned_cols=279 Identities=22% Similarity=0.268 Sum_probs=207.0
Q ss_pred HhcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccchhhHHHHHHHHHHhhcC------CCCceeeeeccccccc
Q 045798 682 ATNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIR------HRNLVKVITSCSSIDF 755 (1008)
Q Consensus 682 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~------h~niv~~~~~~~~~~~ 755 (1008)
.-.+|.+....|+|-|++|.+|.+...|..||||++... +...+.=++|+++|++++ --|+++++-. |
T Consensus 430 LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnN-E~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~-----F 503 (752)
T KOG0670|consen 430 LDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNN-EVMHKTGLKELEILKKLNDADPEDKFHCLRLFRH-----F 503 (752)
T ss_pred hcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecc-hHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHH-----h
Confidence 346899999999999999999999988999999999865 434455678999999994 3478888877 6
Q ss_pred cCCceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCC
Q 045798 756 QGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDND 835 (1008)
Q Consensus 756 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~ 835 (1008)
...++.|+|+|.+ ..+|.+.+++.+.. ..+....+..++.|+.-||..|... +|+|.||||+||||.+.
T Consensus 504 ~hknHLClVFE~L-slNLRevLKKyG~n-------vGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~ 572 (752)
T KOG0670|consen 504 KHKNHLCLVFEPL-SLNLREVLKKYGRN-------VGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNES 572 (752)
T ss_pred hhcceeEEEehhh-hchHHHHHHHhCcc-------cceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccC
Confidence 7788999999998 77999999876543 2678889999999999999999998 99999999999999876
Q ss_pred -CCeEEcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCc-cH
Q 045798 836 -LSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDL-NL 913 (1008)
Q Consensus 836 -~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~-~~ 913 (1008)
..+||||||.|.......-..+ ..+..|.|||++.|-+|+...|+||+||++||+.||+..|......+. .+
T Consensus 573 k~iLKLCDfGSA~~~~eneitPY------LVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl 646 (752)
T KOG0670|consen 573 KNILKLCDFGSASFASENEITPY------LVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRL 646 (752)
T ss_pred cceeeeccCccccccccccccHH------HHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHH
Confidence 4569999999987665443322 356789999999999999999999999999999999998864322111 01
Q ss_pred HHHHHhhCCcch---hhhhcccc--------------------------cCchHHhhhhhhhhhccccchhHHHHHHHHH
Q 045798 914 HNFARMALPNQV---MDIVDPIL--------------------------RNDEEILASTDKCRRMQTGINSRLECLISMV 964 (1008)
Q Consensus 914 ~~~~~~~~~~~~---~~~~d~~l--------------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 964 (1008)
..-....+|..+ ..+.|..+ +........+..+++.+. ........+.
T Consensus 647 ~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~d---eq~~~~~~~r 723 (752)
T KOG0670|consen 647 FMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPD---EQPKIVQQLR 723 (752)
T ss_pred HHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCc---hhHHHHHHHH
Confidence 111111122110 01111111 111122222222222222 2335667789
Q ss_pred HHHhcccCcCCCCCCCHHHHHH
Q 045798 965 KIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 965 ~li~~cl~~dP~~RPt~~evl~ 986 (1008)
+|+..|+..||++|.|..++++
T Consensus 724 dLLdkml~LdP~KRit~nqAL~ 745 (752)
T KOG0670|consen 724 DLLDKMLILDPEKRITVNQALK 745 (752)
T ss_pred HHHHHHhccChhhcCCHHHHhc
Confidence 9999999999999999998875
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.2e-29 Score=270.85 Aligned_cols=254 Identities=23% Similarity=0.311 Sum_probs=203.2
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccchhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceEE
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKA 762 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 762 (1008)
.++|..++.+|.|.||.||+|+++.+++..|+|+++........-.++|+-+++..+||||+.++|.+ ...+..+
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsy-----lr~dklw 88 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSY-----LRRDKLW 88 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhh-----hhhcCcE
Confidence 35788999999999999999999999999999999988777888899999999999999999999984 5566799
Q ss_pred EEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEcc
Q 045798 763 IVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGD 842 (1008)
Q Consensus 763 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 842 (1008)
++||||.+|+|.+.-+-.+ ++++.++..+++..++|++|||+. +-+|||||-.||++++.|.+|++|
T Consensus 89 icMEycgggslQdiy~~Tg----------plselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaD 155 (829)
T KOG0576|consen 89 ICMEYCGGGSLQDIYHVTG----------PLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLAD 155 (829)
T ss_pred EEEEecCCCcccceeeecc----------cchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecc
Confidence 9999999999999877655 899999999999999999999997 889999999999999999999999
Q ss_pred cCcccccccccCccccccccccccccccCcccc---CCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHh
Q 045798 843 FGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYG---LGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARM 919 (1008)
Q Consensus 843 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~---~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~ 919 (1008)
||.+..+...- .....++||+.|||||+. ..+.|...+|||++|+...|+---++|-.+... ....+.-.
T Consensus 156 fgvsaqitati----~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhp---mr~l~LmT 228 (829)
T KOG0576|consen 156 FGVSAQITATI----AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHP---MRALFLMT 228 (829)
T ss_pred cCchhhhhhhh----hhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccch---HHHHHHhh
Confidence 99997654332 233457799999999974 345789999999999999999887777322111 00011000
Q ss_pred hCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 920 ALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 920 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
....+ .+.+++. ..-.+.+-++++.|+..+|++|||++.++.
T Consensus 229 kS~~q-----pp~lkDk--------------------~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 229 KSGFQ-----PPTLKDK--------------------TKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred ccCCC-----CCcccCC--------------------ccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 00000 0111110 123445789999999999999999998765
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3e-28 Score=237.40 Aligned_cols=254 Identities=18% Similarity=0.268 Sum_probs=192.6
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccchhhHHHHHHHHHHhhc-CCCCceeeeeccccccccCCceE
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNI-RHRNLVKVITSCSSIDFQGNDFK 761 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~ 761 (1008)
.+.|.+.+.+|+|.||.+-+++++.+.+.+|+|.++.. ....++|.+|..---.+ .|.||+.-+++. |+..+.+
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~va----Fqt~d~Y 97 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVA----FQTSDAY 97 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHH----hhcCceE
Confidence 34689999999999999999999999999999998754 34567899998665555 699999988774 6778889
Q ss_pred EEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeec--CCCCeE
Q 045798 762 AIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLD--NDLSGH 839 (1008)
Q Consensus 762 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~--~~~~~k 839 (1008)
++++||++.|+|..-+... .+.+.....++.|+++|+.|||+. .+||||||.+||||- +..++|
T Consensus 98 vF~qE~aP~gdL~snv~~~-----------GigE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvK 163 (378)
T KOG1345|consen 98 VFVQEFAPRGDLRSNVEAA-----------GIGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVK 163 (378)
T ss_pred EEeeccCccchhhhhcCcc-----------cccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEE
Confidence 9999999999999988754 477888899999999999999996 999999999999993 345899
Q ss_pred EcccCcccccccccCccccccccccccccccCccccCCC-----CCCcccchhhHHHHHHHHHhCCCCCCccccCCccHH
Q 045798 840 IGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGS-----EVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLH 914 (1008)
Q Consensus 840 L~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~ 914 (1008)
|||||..+..+..... ..-+..|.|||..... ...+.+|||.||+++|.++||+.||....-.+..+.
T Consensus 164 lcDFG~t~k~g~tV~~-------~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~ 236 (378)
T KOG1345|consen 164 LCDFGLTRKVGTTVKY-------LEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYW 236 (378)
T ss_pred eeecccccccCceehh-------hhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHH
Confidence 9999999865433222 2246779999975432 357789999999999999999999985544555555
Q ss_pred HHHHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 045798 915 NFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHE 987 (1008)
Q Consensus 915 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 987 (1008)
.|......... .+ | +.+. ...+...++.++-+..+|++|--..++.++
T Consensus 237 ~~~~w~~rk~~------~~---P---------~~F~-------~fs~~a~r~Fkk~lt~~~~drcki~~~kk~ 284 (378)
T KOG1345|consen 237 EWEQWLKRKNP------AL---P---------KKFN-------PFSEKALRLFKKSLTPRFKDRCKIWTAKKM 284 (378)
T ss_pred HHHHHhcccCc------cC---c---------hhhc-------ccCHHHHHHHHHhcCCcccccchhHHHHHH
Confidence 55433221110 00 0 0011 123445778888899999999555554443
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.8e-28 Score=252.26 Aligned_cols=285 Identities=23% Similarity=0.310 Sum_probs=206.6
Q ss_pred HHHHhcCCCCCceEeeccCeeEEEEEEcC---CCeEEEEEEeccccchhhHHHHHHHHHHhhc-CCCCceeeeecccccc
Q 045798 679 LLKATNGFSSTHLIGVGSFGCVYKGALDE---DGIVVAIKVINLQCEGASKSFMAECKALKNI-RHRNLVKVITSCSSID 754 (1008)
Q Consensus 679 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~ 754 (1008)
+....+.|..+++||+|.|++||+|.+.. ..+.||+|.+... ....++.+|++++..+ .+.||+++.++
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~t--s~p~ri~~El~~L~~~gG~~ni~~~~~~----- 103 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRT--SSPSRILNELEMLYRLGGSDNIIKLNGC----- 103 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccc--cCchHHHHHHHHHHHhccchhhhcchhh-----
Confidence 34456789999999999999999999976 6789999998643 3346789999999999 79999999998
Q ss_pred ccCCceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecC
Q 045798 755 FQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDN 834 (1008)
Q Consensus 755 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~ 834 (1008)
+..++.+++|+||+++....++.. .++..++..+++.+..||+++|+. |||||||||.|++.+.
T Consensus 104 ~rnnd~v~ivlp~~~H~~f~~l~~-------------~l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~ 167 (418)
T KOG1167|consen 104 FRNNDQVAIVLPYFEHDRFRDLYR-------------SLSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNR 167 (418)
T ss_pred hccCCeeEEEecccCccCHHHHHh-------------cCCHHHHHHHHHHHHHHhhhhhcc---CccccCCCcccccccc
Confidence 678889999999999988888875 577889999999999999999998 9999999999999975
Q ss_pred -CCCeEEcccCccccccccc----------------------------------------CccccccccccccccccCcc
Q 045798 835 -DLSGHIGDFGLARFHQEVS----------------------------------------NSTLSSSVGVKGTIGYTAPE 873 (1008)
Q Consensus 835 -~~~~kL~Dfg~a~~~~~~~----------------------------------------~~~~~~~~~~~gt~~y~aPE 873 (1008)
.+.-.|+|||+|...+... +..........||++|+|||
T Consensus 168 ~t~rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPE 247 (418)
T KOG1167|consen 168 RTQRGVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPE 247 (418)
T ss_pred ccCCceEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchH
Confidence 4678999999997221110 00001112356999999999
Q ss_pred ccCCC-CCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCcchh---hhhcc--ccc-----CchHHhhh
Q 045798 874 YGLGS-EVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMALPNQVM---DIVDP--ILR-----NDEEILAS 942 (1008)
Q Consensus 874 ~~~~~-~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~---~~~d~--~l~-----~~~~~~~~ 942 (1008)
++... .-++++||||.||++.-+++++.||.....+-..+.+.+....+..+. ...+. ... ..++.+..
T Consensus 248 vL~k~~~QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~ 327 (418)
T KOG1167|consen 248 VLFRCPRQTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVN 327 (418)
T ss_pred HHhhccCcCCccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhc
Confidence 98764 468899999999999999999999875544444444443332222111 11111 000 11111111
Q ss_pred hhh-----hhhccc----cchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 943 TDK-----CRRMQT----GINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 943 ~~~-----~~~~~~----~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
... |..... ........+..+++++.+|+..||.+|.||+|.++
T Consensus 328 f~s~~~~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALk 380 (418)
T KOG1167|consen 328 FETLHIESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALK 380 (418)
T ss_pred hhccChhhcccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhc
Confidence 111 111111 11112233447899999999999999999999986
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.4e-28 Score=242.72 Aligned_cols=277 Identities=21% Similarity=0.229 Sum_probs=200.7
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccc--cchhhHHHHHHHHHHhhcCCCCceeeeeccccccc-cCCc
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQ--CEGASKSFMAECKALKNIRHRNLVKVITSCSSIDF-QGND 759 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~ 759 (1008)
..+|.-.+.+|.|.- .|..|.+.-.+++||+|++... .....++..+|...+..+.|+||++++.++..... ..-.
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~ 94 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ 94 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence 457777888999998 7888888778999999987532 23445788999999999999999999998654322 2223
Q ss_pred eEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeE
Q 045798 760 FKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGH 839 (1008)
Q Consensus 760 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 839 (1008)
..|+|||+| ..+|.+.+.. .++-..+..|+.|++.|++|||+. ||+|||+||+||++..+..+|
T Consensus 95 e~y~v~e~m-~~nl~~vi~~------------elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lK 158 (369)
T KOG0665|consen 95 EVYLVMELM-DANLCQVILM------------ELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLK 158 (369)
T ss_pred hHHHHHHhh-hhHHHHHHHH------------hcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhhee
Confidence 579999999 7799998872 567788999999999999999998 999999999999999999999
Q ss_pred EcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHh
Q 045798 840 IGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARM 919 (1008)
Q Consensus 840 L~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~ 919 (1008)
|.|||+|+..... ...+..+.|..|+|||++.+..+.+.+||||+||++.||++|+.-|. +...+..|...
T Consensus 159 i~dfg~ar~e~~~-----~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~----g~d~idQ~~ki 229 (369)
T KOG0665|consen 159 ILDFGLARTEDTD-----FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFP----GKDHIDQWNKI 229 (369)
T ss_pred eccchhhcccCcc-----cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEec----CchHHHHHHHH
Confidence 9999999854433 12344668999999999999999999999999999999999998875 22333333221
Q ss_pred h--CCcchhhhhcc---c----ccCchHHhhhhhhhhh-----ccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHH
Q 045798 920 A--LPNQVMDIVDP---I----LRNDEEILASTDKCRR-----MQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVV 985 (1008)
Q Consensus 920 ~--~~~~~~~~~d~---~----l~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl 985 (1008)
. ....-..++++ . .+..++... ...-.. ++.......-......+++.+|+-.||++|-++++++
T Consensus 230 ~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~-~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL 308 (369)
T KOG0665|consen 230 IEQLGTPDPSFMKQLQPTVRNYVENRPQYQA-ISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDAL 308 (369)
T ss_pred HHHhcCCCHHHHHHhhHHHHHHhhcChHhhc-cchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHh
Confidence 1 10001111111 1 111111110 111111 1111111112334568999999999999999999987
Q ss_pred H
Q 045798 986 H 986 (1008)
Q Consensus 986 ~ 986 (1008)
+
T Consensus 309 ~ 309 (369)
T KOG0665|consen 309 R 309 (369)
T ss_pred c
Confidence 6
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.2e-26 Score=236.85 Aligned_cols=211 Identities=30% Similarity=0.485 Sum_probs=180.7
Q ss_pred EeeccCeeEEEEEEcCCCeEEEEEEeccccch-hhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceEEEEEeccCC
Q 045798 692 IGVGSFGCVYKGALDEDGIVVAIKVINLQCEG-ASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKAIVYEYMPN 770 (1008)
Q Consensus 692 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~ 770 (1008)
||+|++|.||++....+++.+++|++...... ..+.+.+|++.++.+.|++++++++++ ......++++|++++
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~-----~~~~~~~~~~e~~~~ 75 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF-----EDENHLYLVMEYCEG 75 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeee-----ecCCeEEEEEecCCC
Confidence 68999999999999777999999999755332 357899999999999999999999994 344678999999998
Q ss_pred CChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecC-CCCeEEcccCccccc
Q 045798 771 GSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDN-DLSGHIGDFGLARFH 849 (1008)
Q Consensus 771 gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kL~Dfg~a~~~ 849 (1008)
++|.+++.... ..+++..+..++.++++++++||+. +++|+||+|.||+++. ++.++|+|||.+...
T Consensus 76 ~~l~~~~~~~~---------~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~ 143 (215)
T cd00180 76 GSLKDLLKENE---------GKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLL 143 (215)
T ss_pred CcHHHHHHhcc---------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEc
Confidence 99999987542 1578999999999999999999998 9999999999999999 899999999999865
Q ss_pred ccccCccccccccccccccccCccccCCC-CCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCcchhhh
Q 045798 850 QEVSNSTLSSSVGVKGTIGYTAPEYGLGS-EVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMALPNQVMDI 928 (1008)
Q Consensus 850 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 928 (1008)
..... ......+...|++||..... .++.++|+|++|++++++
T Consensus 144 ~~~~~----~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-------------------------------- 187 (215)
T cd00180 144 TSDKS----LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-------------------------------- 187 (215)
T ss_pred cCCcc----hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH--------------------------------
Confidence 44321 11223478899999998877 788999999999999999
Q ss_pred hcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 045798 929 VDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHE 987 (1008)
Q Consensus 929 ~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 987 (1008)
..+.+++..|++.+|.+||++.++++.
T Consensus 188 --------------------------------~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 --------------------------------PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred --------------------------------HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 125789999999999999999999864
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.9e-25 Score=234.48 Aligned_cols=199 Identities=32% Similarity=0.448 Sum_probs=171.4
Q ss_pred CCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccch-hhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceEEEE
Q 045798 686 FSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEG-ASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKAIV 764 (1008)
Q Consensus 686 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 764 (1008)
|.+.+.||+|++|.||+|....+++.+|+|.+...... ..+.+.+|++.+++++|+|++++++++ ......+++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~-----~~~~~~~~v 75 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVF-----EDPEPLYLV 75 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeee-----ecCCceEEE
Confidence 56778999999999999999877899999999866554 567899999999999999999999984 344678999
Q ss_pred EeccCCCChhcccccCCCCCCCcccccc-cCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEccc
Q 045798 765 YEYMPNGSLEKWLHPHAVPKRDKEIEIK-LTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDF 843 (1008)
Q Consensus 765 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~-l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 843 (1008)
+||+++++|.+++.... . +++..+..++.+++.++.+||+. +++|+|++|.||+++.++.++|+||
T Consensus 76 ~e~~~~~~L~~~~~~~~----------~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~ 142 (225)
T smart00221 76 MEYCEGGDLFDYLRKKG----------GKLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADF 142 (225)
T ss_pred EeccCCCCHHHHHHhcc----------cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeC
Confidence 99999999999987653 3 78899999999999999999998 9999999999999999999999999
Q ss_pred CcccccccccCccccccccccccccccCcccc-CCCCCCcccchhhHHHHHHHHHhCCCCCCc
Q 045798 844 GLARFHQEVSNSTLSSSVGVKGTIGYTAPEYG-LGSEVSTNGDVYSYGILLLEMVTAKKPTDV 905 (1008)
Q Consensus 844 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~sDvwslG~vl~elltG~~pf~~ 905 (1008)
|.+......... ......++..|++||.. ....++.++|||+||+++|+|++|+.||..
T Consensus 143 g~~~~~~~~~~~---~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 143 GLARFIHRDLAA---LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred ceeeEecCcccc---cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 999866543200 11223477889999998 666788899999999999999999999864
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=5e-28 Score=248.12 Aligned_cols=275 Identities=25% Similarity=0.239 Sum_probs=171.5
Q ss_pred CCeeeecCCCCCCCCCccccCCCCCCEEEccCCCCCCccCcccccCcCcceEeeec-cccccCCCccccccCCCCeeecc
Q 045798 80 LREINLSNNTIQGEIPPEFGRLFRLEALFLSNNSLVGKIPANLSYCSRLTVLCIEY-NKLQGRIPLEFVSLSKLKDLSLA 158 (1008)
Q Consensus 80 L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~-n~l~~~~p~~~~~l~~L~~L~L~ 158 (1008)
-..++|..|+|+.+.|.+|+.+++|+.||||+|+|+.+-|++|..+++|..|-+.+ |+|+......|.+|..|+.|.+.
T Consensus 69 tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~gL~slqrLllN 148 (498)
T KOG4237|consen 69 TVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGAFGGLSSLQRLLLN 148 (498)
T ss_pred ceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhHhhhHHHHHHHhcC
Confidence 46677788888877777788888888888888888877788888888777775555 77886666777888888888888
Q ss_pred cccCCCCCCCCCccccccchhhcccccCCCCCCccccCCCCCcEEEecCCcc------------cccCCccccCCCCcce
Q 045798 159 KNKLTGGIPPFLGNLTSLEVLSLAGNSFGRNIPDSLGQLKQLKILAIGGNNL------------SGPIPPSIYNLSFLVV 226 (1008)
Q Consensus 159 ~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l------------~~~~~~~~~~l~~L~~ 226 (1008)
-|++.-+..+.|..+++|..|.+.+|.+....-.+|..+..++++.+..|.+ ....|..++...-..-
T Consensus 149 an~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdCnL~wla~~~a~~~ietsgarc~~p 228 (498)
T KOG4237|consen 149 ANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDCNLPWLADDLAMNPIETSGARCVSP 228 (498)
T ss_pred hhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccccccccchhhhHHhhchhhcccceecch
Confidence 8888766677778888888888888887554445777888888888777762 1223334444444444
Q ss_pred eccccccccccCChh-hhhcCCCCcEEEeccccCCCCCC-cccccCCCCceeecccccccccccccccCCCccccccccc
Q 045798 227 FSVSHNQIHGSLPPS-LGLLLPNLKFFQIHHNFFSGSIP-ISLSNASKLEHIEIANNNFSGKLSVNFGGMKNLSLLNLQF 304 (1008)
Q Consensus 227 L~ls~N~l~~~lp~~-~~~~l~~L~~L~L~~N~l~~~~p-~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~ 304 (1008)
..|.++++. .++.. +...+..+..=..+.+...+..| ..|..+++|+.|+|++|+|+.+.+.+|.++..+++|.|..
T Consensus 229 ~rl~~~Ri~-q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~ 307 (498)
T KOG4237|consen 229 YRLYYKRIN-QEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTR 307 (498)
T ss_pred HHHHHHHhc-ccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchhhhhhhcchhhhhhhhcCc
Confidence 445555554 22222 22111122111112222222333 3566666666666666666666666666666666666666
Q ss_pred ccCCCCCCCcccccccccccCCCcEEEecCCcCCccCChhhhhhcccceeeeeccccc
Q 045798 305 SNLGSGESDEMGFMNSLTNCSKLRVLSLGGNQFRGALPHSIANLSSQLQILILSSNQF 362 (1008)
Q Consensus 305 n~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~Ls~N~l 362 (1008)
|+|..+... .|.+++.|++|+|.+|+|+..-|..|..+. .|.+|+|-.|.+
T Consensus 308 N~l~~v~~~------~f~~ls~L~tL~L~~N~it~~~~~aF~~~~-~l~~l~l~~Np~ 358 (498)
T KOG4237|consen 308 NKLEFVSSG------MFQGLSGLKTLSLYDNQITTVAPGAFQTLF-SLSTLNLLSNPF 358 (498)
T ss_pred chHHHHHHH------hhhccccceeeeecCCeeEEEecccccccc-eeeeeehccCcc
Confidence 666554433 345555666666666666655555555444 255555555544
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3e-27 Score=242.41 Aligned_cols=441 Identities=21% Similarity=0.208 Sum_probs=224.5
Q ss_pred eeecCCCCCCCCCccccCCCCCCEEEccCCCCCCccCcccccCcCcceEeeeccccccCCCccccccCCCCeeeccc-cc
Q 045798 83 INLSNNTIQGEIPPEFGRLFRLEALFLSNNSLVGKIPANLSYCSRLTVLCIEYNKLQGRIPLEFVSLSKLKDLSLAK-NK 161 (1008)
Q Consensus 83 L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~-n~ 161 (1008)
++-++-.++ .+|..+- ..-.+++|..|+|+...|.+|+.+++|+.||||+|+|+.+-|.+|.++++|..|-+-+ |+
T Consensus 51 VdCr~~GL~-eVP~~LP--~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~Nk 127 (498)
T KOG4237|consen 51 VDCRGKGLT-EVPANLP--PETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNK 127 (498)
T ss_pred EEccCCCcc-cCcccCC--CcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCc
Confidence 455555666 5554432 3456788888888877777888888888888888888888888888888877776655 78
Q ss_pred CCCCCCCCCccccccchhhcccccCCCCCCccccCCCCCcEEEecCCcccccCCccccCCCCcceeccccccccccCChh
Q 045798 162 LTGGIPPFLGNLTSLEVLSLAGNSFGRNIPDSLGQLKQLKILAIGGNNLSGPIPPSIYNLSFLVVFSVSHNQIHGSLPPS 241 (1008)
Q Consensus 162 l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~~~lp~~ 241 (1008)
|+......|++|..|+.|.+.-|++.-...++|..+++|..|.+-+|.+..+--.+|..+..++.+++..|.+.-
T Consensus 128 I~~l~k~~F~gL~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~ic----- 202 (498)
T KOG4237|consen 128 ITDLPKGAFGGLSSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFIC----- 202 (498)
T ss_pred hhhhhhhHhhhHHHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCcccc-----
Confidence 886555678888888888888888877777778888888888888887774444477777777777777776431
Q ss_pred hhhcCCCCcEEEeccccCCCCCCcccccCCCCceeecccccccccccccccCC-CcccccccccccCCCCCCCccccccc
Q 045798 242 LGLLLPNLKFFQIHHNFFSGSIPISLSNASKLEHIEIANNNFSGKLSVNFGGM-KNLSLLNLQFSNLGSGESDEMGFMNS 320 (1008)
Q Consensus 242 ~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l-~~L~~L~L~~n~l~~~~~~~~~~~~~ 320 (1008)
.-+|+++- .+....|.+++......-..+.++++....+..|..- +.+..--.+........ ....
T Consensus 203 ----dCnL~wla----~~~a~~~ietsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~c-----P~~c 269 (498)
T KOG4237|consen 203 ----DCNLPWLA----DDLAMNPIETSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSIC-----PAKC 269 (498)
T ss_pred ----ccccchhh----hHHhhchhhcccceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcC-----hHHH
Confidence 11111110 0001223333444444444455555554444433321 11110000111111111 1112
Q ss_pred ccccCCCcEEEecCCcCCccCChhhhhhcccceeeeeccccccCCCCCccccccccceEEecCccccCCcchhccCCCCC
Q 045798 321 LTNCSKLRVLSLGGNQFRGALPHSIANLSSQLQILILSSNQFYGSIPLGIGNLVDLYLLGMVENQFTGAIPKEMGKLQKL 400 (1008)
Q Consensus 321 l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L 400 (1008)
|..+++|++|+|++|+|++.-+.+|.... .++.|.|..|+|...-...|.++..|+.|+|.+|+|+..-|..|..+..|
T Consensus 270 f~~L~~L~~lnlsnN~i~~i~~~aFe~~a-~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l 348 (498)
T KOG4237|consen 270 FKKLPNLRKLNLSNNKITRIEDGAFEGAA-ELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSL 348 (498)
T ss_pred HhhcccceEeccCCCccchhhhhhhcchh-hhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEeccccccccee
Confidence 33444444444444444433333333333 24444444444432222333333344444444444443333333333344
Q ss_pred ceEEccCCcccccccccccCCCCcceeeccccccccccCCCCcCCCcccEeecccccccC---Ccchhhhhhhhhhhhhc
Q 045798 401 QGLDFSGNHFSGEIPSSLGNLSSLYEVFFNNNNLSGVIPFSLGNLKRLAFLEMSGNELSG---TIPEDIFNISYLSNSLN 477 (1008)
Q Consensus 401 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~---~lp~~~~~~~~~~~~L~ 477 (1008)
.+|+|-.|.+.-. +.+.-|. =.|..+.-.|..| -++-..++.++++.+.+.. ..|+...
T Consensus 349 ~~l~l~~Np~~Cn-----C~l~wl~-~Wlr~~~~~~~~~--Cq~p~~~~~~~~~dv~~~~~~c~~~ee~~---------- 410 (498)
T KOG4237|consen 349 STLNLLSNPFNCN-----CRLAWLG-EWLRKKSVVGNPR--CQSPGFVRQIPISDVAFGDFRCGGPEELG---------- 410 (498)
T ss_pred eeeehccCcccCc-----cchHHHH-HHHhhCCCCCCCC--CCCCchhccccchhccccccccCCccccC----------
Confidence 4443333333200 0000000 0011111111111 1112234455555544431 1111110
Q ss_pred ccCccccCCCcccccccccccc-cccccccccCCCCcccccccccceeeccCcccccchhhhhhccccccEEecCCCccc
Q 045798 478 LARNHLVGIIPPRIGNLRALRS-FDVSNNDLSGEIPIELGHCSSLEEIYLAGNLFHGSIPSFFNALKGVQKIDLSRNNLS 556 (1008)
Q Consensus 478 L~~N~l~~~~p~~~~~l~~L~~-Ldls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~ 556 (1008)
+.-.+.-| ...+-+.+ ..-|++.++ .+|..+- ..-.+|++.+|.++ .+|.. .+..| .+|||+|+++
T Consensus 411 ---~~~s~~cP---~~c~c~~tVvRcSnk~lk-~lp~~iP--~d~telyl~gn~~~-~vp~~--~~~~l-~~dls~n~i~ 477 (498)
T KOG4237|consen 411 ---CLTSSPCP---PPCTCLDTVVRCSNKLLK-LLPRGIP--VDVTELYLDGNAIT-SVPDE--LLRSL-LLDLSNNRIS 477 (498)
T ss_pred ---CCCCCCCC---CCcchhhhhHhhcccchh-hcCCCCC--chhHHHhcccchhc-ccCHH--HHhhh-hcccccCcee
Confidence 00000111 11233333 234445554 6676553 56678888899888 67776 67777 8889999887
Q ss_pred ccccCc-ccccccceeecccC
Q 045798 557 GQIPIF-LEALSLEYLNLSFN 576 (1008)
Q Consensus 557 ~~~p~~-~~~~~L~~L~l~~N 576 (1008)
..--.. .+++.|.+|-||+|
T Consensus 478 ~Lsn~tf~n~tql~tlilsyn 498 (498)
T KOG4237|consen 478 SLSNYTFSNMTQLSTLILSYN 498 (498)
T ss_pred hhhcccccchhhhheeEEecC
Confidence 543322 45666888888776
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.3e-23 Score=267.53 Aligned_cols=344 Identities=23% Similarity=0.235 Sum_probs=182.3
Q ss_pred CccCCccCCeeeecCCC------CCCCCCccccCCC-CCCEEEccCCCCCCccCcccccCcCcceEeeeccccccCCCcc
Q 045798 73 HLGNLSFLREINLSNNT------IQGEIPPEFGRLF-RLEALFLSNNSLVGKIPANLSYCSRLTVLCIEYNKLQGRIPLE 145 (1008)
Q Consensus 73 ~l~~l~~L~~L~L~~n~------~~~~~p~~~~~l~-~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~ 145 (1008)
.+..+.+|+.|.+.++. +...+|+.|..++ +|+.|.+.++.+. .+|..+ ...+|+.|+|++|++. .++..
T Consensus 553 aF~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~-~L~~~ 629 (1153)
T PLN03210 553 AFKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLE-KLWDG 629 (1153)
T ss_pred HHhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCC-CCCCcC-CccCCcEEECcCcccc-ccccc
Confidence 34555555555554332 2223444444442 3555555555554 444444 2455555555555554 34444
Q ss_pred ccccCCCCeeecccccCCCCCCCCCccccccchhhcccccCCCCCCccccCCCCCcEEEecCCcccccCCccccCCCCcc
Q 045798 146 FVSLSKLKDLSLAKNKLTGGIPPFLGNLTSLEVLSLAGNSFGRNIPDSLGQLKQLKILAIGGNNLSGPIPPSIYNLSFLV 225 (1008)
Q Consensus 146 ~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~ 225 (1008)
+..+++|+.|+|++|.....+| .++.+++|+.|+|++|.....+|..+..+++|+.|++++|.....+|..+ ++++|+
T Consensus 630 ~~~l~~Lk~L~Ls~~~~l~~ip-~ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i-~l~sL~ 707 (1153)
T PLN03210 630 VHSLTGLRNIDLRGSKNLKEIP-DLSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI-NLKSLY 707 (1153)
T ss_pred cccCCCCCEEECCCCCCcCcCC-ccccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcC-CCCCCC
Confidence 4555555555555443222333 24445555555555544334445555555555555555543222334333 444555
Q ss_pred eeccccccccccCChhhhhcCCCCcEEEeccccCCCCCCcccccCCCCceeecccccccccccccccCCCcccccccccc
Q 045798 226 VFSVSHNQIHGSLPPSLGLLLPNLKFFQIHHNFFSGSIPISLSNASKLEHIEIANNNFSGKLSVNFGGMKNLSLLNLQFS 305 (1008)
Q Consensus 226 ~L~ls~N~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n 305 (1008)
.|++++|...+.+|.. ..+|+.|+|++|.+. .+|..+ .+++|+.|++..+
T Consensus 708 ~L~Lsgc~~L~~~p~~----~~nL~~L~L~~n~i~-~lP~~~-------------------------~l~~L~~L~l~~~ 757 (1153)
T PLN03210 708 RLNLSGCSRLKSFPDI----STNISWLDLDETAIE-EFPSNL-------------------------RLENLDELILCEM 757 (1153)
T ss_pred EEeCCCCCCccccccc----cCCcCeeecCCCccc-cccccc-------------------------ccccccccccccc
Confidence 5555554433333321 234444444444443 233322 2344444444332
Q ss_pred cCCCCCCCcccc-cccccccCCCcEEEecCCcCCccCChhhhhhcccceeeeeccccccCCCCCccccccccceEEecCc
Q 045798 306 NLGSGESDEMGF-MNSLTNCSKLRVLSLGGNQFRGALPHSIANLSSQLQILILSSNQFYGSIPLGIGNLVDLYLLGMVEN 384 (1008)
Q Consensus 306 ~l~~~~~~~~~~-~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n 384 (1008)
....+....... +......++|+.|+|++|...+.+|..+.++. +|+.|++++|...+.+|..+ ++++|+.|++++|
T Consensus 758 ~~~~l~~~~~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~-~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c 835 (1153)
T PLN03210 758 KSEKLWERVQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLH-KLEHLEIENCINLETLPTGI-NLESLESLDLSGC 835 (1153)
T ss_pred chhhccccccccchhhhhccccchheeCCCCCCccccChhhhCCC-CCCEEECCCCCCcCeeCCCC-CccccCEEECCCC
Confidence 211100000000 00112235677788888776667777777775 48888888775555677665 6778888888877
Q ss_pred cccCCcchhccCCCCCceEEccCCcccccccccccCCCCcceeeccccccccccCCCCcCCCcccEeeccccc
Q 045798 385 QFTGAIPKEMGKLQKLQGLDFSGNHFSGEIPSSLGNLSSLYEVFFNNNNLSGVIPFSLGNLKRLAFLEMSGNE 457 (1008)
Q Consensus 385 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 457 (1008)
.....+|.. .++|+.|+|++|.+. .+|.++..+++|+.|+|++|.-...+|..+..+++|+.|++++|.
T Consensus 836 ~~L~~~p~~---~~nL~~L~Ls~n~i~-~iP~si~~l~~L~~L~L~~C~~L~~l~~~~~~L~~L~~L~l~~C~ 904 (1153)
T PLN03210 836 SRLRTFPDI---STNISDLNLSRTGIE-EVPWWIEKFSNLSFLDMNGCNNLQRVSLNISKLKHLETVDFSDCG 904 (1153)
T ss_pred Ccccccccc---ccccCEeECCCCCCc-cChHHHhcCCCCCEEECCCCCCcCccCcccccccCCCeeecCCCc
Confidence 655455443 356778888888877 677777778888888887744434566677777788888877774
|
syringae 6; Provisional |
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.1e-23 Score=268.39 Aligned_cols=338 Identities=20% Similarity=0.234 Sum_probs=191.5
Q ss_pred ccccccCCCCeeecccccC------CCCCCCCCcccc-ccchhhcccccCCCCCCccccCCCCCcEEEecCCcccccCCc
Q 045798 144 LEFVSLSKLKDLSLAKNKL------TGGIPPFLGNLT-SLEVLSLAGNSFGRNIPDSLGQLKQLKILAIGGNNLSGPIPP 216 (1008)
Q Consensus 144 ~~~~~l~~L~~L~L~~n~l------~~~~~~~~~~l~-~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~ 216 (1008)
.+|.++++|+.|.+..+.. ...+|..|..++ +|+.|.+.+|.+ ..+|..| ...+|+.|+|.+|.+. .++.
T Consensus 552 ~aF~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l-~~lP~~f-~~~~L~~L~L~~s~l~-~L~~ 628 (1153)
T PLN03210 552 NAFKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPL-RCMPSNF-RPENLVKLQMQGSKLE-KLWD 628 (1153)
T ss_pred HHHhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCC-CCCCCcC-CccCCcEEECcCcccc-cccc
Confidence 3445555555555544321 122344444432 355555555555 3344444 3455555555555554 3344
Q ss_pred cccCCCCcceeccccccccccCChhhhhcCCCCcEEEeccccCCCCCCcccccCCCCceeecccccccccccccccCCCc
Q 045798 217 SIYNLSFLVVFSVSHNQIHGSLPPSLGLLLPNLKFFQIHHNFFSGSIPISLSNASKLEHIEIANNNFSGKLSVNFGGMKN 296 (1008)
Q Consensus 217 ~~~~l~~L~~L~ls~N~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~ 296 (1008)
.+..+++|+.|+|++|...+.+|. ...+++|+.|+|++|.....+|..+.++++|+.|++++|......|..+
T Consensus 629 ~~~~l~~Lk~L~Ls~~~~l~~ip~--ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i----- 701 (1153)
T PLN03210 629 GVHSLTGLRNIDLRGSKNLKEIPD--LSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI----- 701 (1153)
T ss_pred ccccCCCCCEEECCCCCCcCcCCc--cccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcC-----
Confidence 455555555555555443334443 2224555555555554444455555555555555555543222222111
Q ss_pred ccccccccccCCCCCCCcccccccccccCCCcEEEecCCcCCccCChhhhhhcccceeeeeccccccCCCCCcccccccc
Q 045798 297 LSLLNLQFSNLGSGESDEMGFMNSLTNCSKLRVLSLGGNQFRGALPHSIANLSSQLQILILSSNQFYGSIPLGIGNLVDL 376 (1008)
Q Consensus 297 L~~L~L~~n~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~Ls~N~l~~~~p~~~~~l~~L 376 (1008)
++++|+.|++++|...+.+|.. ..+|+.|+|++|.+. .+|..+ .+++|
T Consensus 702 --------------------------~l~sL~~L~Lsgc~~L~~~p~~----~~nL~~L~L~~n~i~-~lP~~~-~l~~L 749 (1153)
T PLN03210 702 --------------------------NLKSLYRLNLSGCSRLKSFPDI----STNISWLDLDETAIE-EFPSNL-RLENL 749 (1153)
T ss_pred --------------------------CCCCCCEEeCCCCCCccccccc----cCCcCeeecCCCccc-cccccc-ccccc
Confidence 3456666666666544444432 234677777777765 455544 45666
Q ss_pred ceEEecCcccc-------CCcchhccCCCCCceEEccCCcccccccccccCCCCcceeeccccccccccCCCCcCCCccc
Q 045798 377 YLLGMVENQFT-------GAIPKEMGKLQKLQGLDFSGNHFSGEIPSSLGNLSSLYEVFFNNNNLSGVIPFSLGNLKRLA 449 (1008)
Q Consensus 377 ~~L~L~~n~l~-------~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~ 449 (1008)
+.|++.++... ...+..+...++|+.|+|++|...+.+|..++++++|+.|++++|...+.+|..+ ++++|+
T Consensus 750 ~~L~l~~~~~~~l~~~~~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~ 828 (1153)
T PLN03210 750 DELILCEMKSEKLWERVQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLE 828 (1153)
T ss_pred ccccccccchhhccccccccchhhhhccccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccC
Confidence 66666553321 1122223334677788888877666777777777788888887775555666655 577777
Q ss_pred EeecccccccCCcchhhhhhhhhhhhhcccCccccCCCcccccccccccccccccccccCCCCcccccccccceeeccCc
Q 045798 450 FLEMSGNELSGTIPEDIFNISYLSNSLNLARNHLVGIIPPRIGNLRALRSFDVSNNDLSGEIPIELGHCSSLEEIYLAGN 529 (1008)
Q Consensus 450 ~L~Ls~N~l~~~lp~~~~~~~~~~~~L~L~~N~l~~~~p~~~~~l~~L~~Ldls~N~l~~~~p~~~~~l~~L~~L~L~~N 529 (1008)
.|+|++|.... .+|.. ..+|+.|+|++|.++ .+|.++..+++|++|+|++|
T Consensus 829 ~L~Ls~c~~L~-------------------------~~p~~---~~nL~~L~Ls~n~i~-~iP~si~~l~~L~~L~L~~C 879 (1153)
T PLN03210 829 SLDLSGCSRLR-------------------------TFPDI---STNISDLNLSRTGIE-EVPWWIEKFSNLSFLDMNGC 879 (1153)
T ss_pred EEECCCCCccc-------------------------ccccc---ccccCEeECCCCCCc-cChHHHhcCCCCCEEECCCC
Confidence 77777765432 22221 246777778888777 67777777888888888774
Q ss_pred -ccccchhhhhhccccccEEecCCCc
Q 045798 530 -LFHGSIPSFFNALKGVQKIDLSRNN 554 (1008)
Q Consensus 530 -~l~~~~p~~~~~l~~L~~L~ls~N~ 554 (1008)
+|. .+|..+..++.|+.|++++|.
T Consensus 880 ~~L~-~l~~~~~~L~~L~~L~l~~C~ 904 (1153)
T PLN03210 880 NNLQ-RVSLNISKLKHLETVDFSDCG 904 (1153)
T ss_pred CCcC-ccCcccccccCCCeeecCCCc
Confidence 444 577777777888888887774
|
syringae 6; Provisional |
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=8.5e-24 Score=212.54 Aligned_cols=170 Identities=21% Similarity=0.184 Sum_probs=126.6
Q ss_pred CChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEcccCcccccc
Q 045798 771 GSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQ 850 (1008)
Q Consensus 771 gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~ 850 (1008)
|+|.++++..+. .+++.+++.|+.||+.||+|||++ + ||+||+++.++.+|+ ||.+....
T Consensus 1 GsL~~~l~~~~~---------~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~ 60 (176)
T smart00750 1 VSLADILEVRGR---------PLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKT 60 (176)
T ss_pred CcHHHHHHHhCC---------CCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeec
Confidence 688888875321 689999999999999999999997 4 999999999999999 99998654
Q ss_pred cccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCcchhhhhc
Q 045798 851 EVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMALPNQVMDIVD 930 (1008)
Q Consensus 851 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d 930 (1008)
... ..||+.|+|||++.+..++.++|||||||++|||++|+.||..................
T Consensus 61 ~~~---------~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~--------- 122 (176)
T smart00750 61 PEQ---------SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMP--------- 122 (176)
T ss_pred ccc---------CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhc---------
Confidence 321 14789999999999999999999999999999999999998643221111111111100
Q ss_pred ccccCchHHhhhhhhhhhccccchhHHHHH--HHHHHHHhcccCcCCCCCCCHHHHHHHHHHHHHH
Q 045798 931 PILRNDEEILASTDKCRRMQTGINSRLECL--ISMVKIGVACSMESPQDRMNMTNVVHELQSVKNI 994 (1008)
Q Consensus 931 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~l~~li~~cl~~dP~~RPt~~evl~~L~~i~~~ 994 (1008)
...+. ......... .++.+++.+||+.+|.+||++.|+++.+..+...
T Consensus 123 ---~~~~~-------------~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~~ 172 (176)
T smart00750 123 ---ADDPR-------------DRSNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFAE 172 (176)
T ss_pred ---cCCcc-------------ccccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHHH
Confidence 00000 000011122 2689999999999999999999999998776543
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.4e-24 Score=266.57 Aligned_cols=203 Identities=18% Similarity=0.244 Sum_probs=138.4
Q ss_pred hcCC-CCceeeeecccccc--ccCCceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHh
Q 045798 737 NIRH-RNLVKVITSCSSID--FQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLH 813 (1008)
Q Consensus 737 ~l~h-~niv~~~~~~~~~~--~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH 813 (1008)
.++| +||++++++|.... ....+..+.++||+ +++|.+++.... ..+++.+++.++.||++||+|||
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~---------~~~~~~~~~~i~~qi~~al~~lH 97 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD---------RSVDAFECFHVFRQIVEIVNAAH 97 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc---------ccccHHHHHHHHHHHHHHHHHHH
Confidence 3445 57777777753222 12234567888988 779999996432 16899999999999999999999
Q ss_pred hCCCCCceeccCCCCCeeecC-------------------CCCeEEcccCcccccccccCcc------------cccccc
Q 045798 814 HHCQEPILHCDLKPSNILLDN-------------------DLSGHIGDFGLARFHQEVSNST------------LSSSVG 862 (1008)
Q Consensus 814 ~~~~~~ivH~Dlkp~NIll~~-------------------~~~~kL~Dfg~a~~~~~~~~~~------------~~~~~~ 862 (1008)
++ +|+||||||+|||++. ++.+|++|||+++......... ......
T Consensus 98 ~~---gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (793)
T PLN00181 98 SQ---GIVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQIL 174 (793)
T ss_pred hC---CeeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccc
Confidence 97 9999999999999964 3455666666665322110000 000112
Q ss_pred ccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCcchhhhhcccccCchHHhhh
Q 045798 863 VKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMALPNQVMDIVDPILRNDEEILAS 942 (1008)
Q Consensus 863 ~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 942 (1008)
..||+.|+|||++.+..++.++|||||||++|||++|..|+..... ..........+..
T Consensus 175 ~~gt~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~---~~~~~~~~~~~~~------------------ 233 (793)
T PLN00181 175 AMEMSWYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR---TMSSLRHRVLPPQ------------------ 233 (793)
T ss_pred cCCCcceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH---HHHHHHHhhcChh------------------
Confidence 3578899999999999999999999999999999999888642110 0000000000000
Q ss_pred hhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 943 TDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 943 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
.........+++.+||+.+|.+||+|.|+++
T Consensus 234 -------------~~~~~~~~~~~~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 234 -------------ILLNWPKEASFCLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred -------------hhhcCHHHHHHHHHhCCCChhhCcChHHHhh
Confidence 0011223467888999999999999999975
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.8e-23 Score=242.17 Aligned_cols=261 Identities=28% Similarity=0.382 Sum_probs=134.9
Q ss_pred CcEEEecCCcccccCCccccCCCCcceeccccccccccCChhhhhcCCCCcEEEeccccCCCCCCcccccCCCCceeecc
Q 045798 200 LKILAIGGNNLSGPIPPSIYNLSFLVVFSVSHNQIHGSLPPSLGLLLPNLKFFQIHHNFFSGSIPISLSNASKLEHIEIA 279 (1008)
Q Consensus 200 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~ 279 (1008)
-..|+|++|.++ .+|..+. ++|+.|++++|+++ .+|.. +++|++|+|++|+|+ .+|.. .++|+.|+++
T Consensus 203 ~~~LdLs~~~Lt-sLP~~l~--~~L~~L~L~~N~Lt-~LP~l----p~~Lk~LdLs~N~Lt-sLP~l---p~sL~~L~Ls 270 (788)
T PRK15387 203 NAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPAL----PPELRTLEVSGNQLT-SLPVL---PPGLLELSIF 270 (788)
T ss_pred CcEEEcCCCCCC-cCCcchh--cCCCEEEccCCcCC-CCCCC----CCCCcEEEecCCccC-cccCc---ccccceeecc
Confidence 344555555555 3444443 24555555555555 44431 345555555555555 23321 2345555555
Q ss_pred cccccccccccccCCCcccccccccccCCCCCCCcccccccccccCCCcEEEecCCcCCccCChhhhhhcccceeeeecc
Q 045798 280 NNNFSGKLSVNFGGMKNLSLLNLQFSNLGSGESDEMGFMNSLTNCSKLRVLSLGGNQFRGALPHSIANLSSQLQILILSS 359 (1008)
Q Consensus 280 ~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~Ls~ 359 (1008)
+|.+..+.. . ..+|+.|++++|+++ .+|.. +.+|+.|+|++
T Consensus 271 ~N~L~~Lp~-l---------------------------------p~~L~~L~Ls~N~Lt-~LP~~----p~~L~~LdLS~ 311 (788)
T PRK15387 271 SNPLTHLPA-L---------------------------------PSGLCKLWIFGNQLT-SLPVL----PPGLQELSVSD 311 (788)
T ss_pred CCchhhhhh-c---------------------------------hhhcCEEECcCCccc-ccccc----ccccceeECCC
Confidence 555543211 1 123444555555554 33331 12355556666
Q ss_pred ccccCCCCCccccccccceEEecCccccCCcchhccCCCCCceEEccCCcccccccccccCCCCcceeeccccccccccC
Q 045798 360 NQFYGSIPLGIGNLVDLYLLGMVENQFTGAIPKEMGKLQKLQGLDFSGNHFSGEIPSSLGNLSSLYEVFFNNNNLSGVIP 439 (1008)
Q Consensus 360 N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p 439 (1008)
|+|++ +|... .+|+.|++++|++++ +|.. ..+|+.|+|++|+|+ .+|... .+|+.|++++|+|.+ +|
T Consensus 312 N~L~~-Lp~lp---~~L~~L~Ls~N~L~~-LP~l---p~~Lq~LdLS~N~Ls-~LP~lp---~~L~~L~Ls~N~L~~-LP 378 (788)
T PRK15387 312 NQLAS-LPALP---SELCKLWAYNNQLTS-LPTL---PSGLQELSVSDNQLA-SLPTLP---SELYKLWAYNNRLTS-LP 378 (788)
T ss_pred Ccccc-CCCCc---ccccccccccCcccc-cccc---ccccceEecCCCccC-CCCCCC---cccceehhhcccccc-Cc
Confidence 55552 33321 235555566666653 3321 135777777777776 344432 356666777777763 45
Q ss_pred CCCcCCCcccEeecccccccCCcchhhhhhhhhhhhhcccCccccCCCcccccccccccccccccccccCCCCccccccc
Q 045798 440 FSLGNLKRLAFLEMSGNELSGTIPEDIFNISYLSNSLNLARNHLVGIIPPRIGNLRALRSFDVSNNDLSGEIPIELGHCS 519 (1008)
Q Consensus 440 ~~~~~l~~L~~L~Ls~N~l~~~lp~~~~~~~~~~~~L~L~~N~l~~~~p~~~~~l~~L~~Ldls~N~l~~~~p~~~~~l~ 519 (1008)
.. ..+|+.|+|++|+|+ .+|.. .++|+.|++|+|.|+ .+|.. +.
T Consensus 379 ~l---~~~L~~LdLs~N~Lt-~LP~l----------------------------~s~L~~LdLS~N~Ls-sIP~l---~~ 422 (788)
T PRK15387 379 AL---PSGLKELIVSGNRLT-SLPVL----------------------------PSELKELMVSGNRLT-SLPML---PS 422 (788)
T ss_pred cc---ccccceEEecCCccc-CCCCc----------------------------ccCCCEEEccCCcCC-CCCcc---hh
Confidence 33 245777777777776 23321 124555566666655 34532 23
Q ss_pred ccceeeccCcccccchhhhhhccccccEEecCCCcccccccC
Q 045798 520 SLEEIYLAGNLFHGSIPSFFNALKGVQKIDLSRNNLSGQIPI 561 (1008)
Q Consensus 520 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~ 561 (1008)
+|+.|+|++|+|+ .+|..|+.+++|+.|+|++|+|++.+|.
T Consensus 423 ~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~~ 463 (788)
T PRK15387 423 GLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQ 463 (788)
T ss_pred hhhhhhhccCccc-ccChHHhhccCCCeEECCCCCCCchHHH
Confidence 4555666666665 4566666666666666666666655444
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.1e-23 Score=241.89 Aligned_cols=261 Identities=25% Similarity=0.319 Sum_probs=183.6
Q ss_pred cceeccccccccccCChhhhhcCCCCcEEEeccccCCCCCCcccccCCCCceeecccccccccccccccCCCcccccccc
Q 045798 224 LVVFSVSHNQIHGSLPPSLGLLLPNLKFFQIHHNFFSGSIPISLSNASKLEHIEIANNNFSGKLSVNFGGMKNLSLLNLQ 303 (1008)
Q Consensus 224 L~~L~ls~N~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~ 303 (1008)
-..|+|++|.++ .+|..+. ++|+.|++++|+++. +|.. .+ +|++|+|+
T Consensus 203 ~~~LdLs~~~Lt-sLP~~l~---~~L~~L~L~~N~Lt~-LP~l---p~------------------------~Lk~LdLs 250 (788)
T PRK15387 203 NAVLNVGESGLT-TLPDCLP---AHITTLVIPDNNLTS-LPAL---PP------------------------ELRTLEVS 250 (788)
T ss_pred CcEEEcCCCCCC-cCCcchh---cCCCEEEccCCcCCC-CCCC---CC------------------------CCcEEEec
Confidence 455677777666 5666543 356666666666652 3321 24 44444555
Q ss_pred cccCCCCCCCcccccccccccCCCcEEEecCCcCCccCChhhhhhcccceeeeeccccccCCCCCccccccccceEEecC
Q 045798 304 FSNLGSGESDEMGFMNSLTNCSKLRVLSLGGNQFRGALPHSIANLSSQLQILILSSNQFYGSIPLGIGNLVDLYLLGMVE 383 (1008)
Q Consensus 304 ~n~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~ 383 (1008)
+|+|+.++. ..++|+.|++++|.++ .+|.. ...|+.|++++|+++ .+|.. +++|+.|++++
T Consensus 251 ~N~LtsLP~----------lp~sL~~L~Ls~N~L~-~Lp~l----p~~L~~L~Ls~N~Lt-~LP~~---p~~L~~LdLS~ 311 (788)
T PRK15387 251 GNQLTSLPV----------LPPGLLELSIFSNPLT-HLPAL----PSGLCKLWIFGNQLT-SLPVL---PPGLQELSVSD 311 (788)
T ss_pred CCccCcccC----------cccccceeeccCCchh-hhhhc----hhhcCEEECcCCccc-ccccc---ccccceeECCC
Confidence 454443321 1247788999999988 45543 245899999999998 56653 46899999999
Q ss_pred ccccCCcchhccCCCCCceEEccCCcccccccccccCCCCcceeeccccccccccCCCCcCCCcccEeecccccccCCcc
Q 045798 384 NQFTGAIPKEMGKLQKLQGLDFSGNHFSGEIPSSLGNLSSLYEVFFNNNNLSGVIPFSLGNLKRLAFLEMSGNELSGTIP 463 (1008)
Q Consensus 384 n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~lp 463 (1008)
|+|++ +|.. ..+|+.|++++|+|+ .+|.. ..+|+.|+|++|+|++ +|... .+|+.|++++|+|+ .
T Consensus 312 N~L~~-Lp~l---p~~L~~L~Ls~N~L~-~LP~l---p~~Lq~LdLS~N~Ls~-LP~lp---~~L~~L~Ls~N~L~-~-- 376 (788)
T PRK15387 312 NQLAS-LPAL---PSELCKLWAYNNQLT-SLPTL---PSGLQELSVSDNQLAS-LPTLP---SELYKLWAYNNRLT-S-- 376 (788)
T ss_pred Ccccc-CCCC---cccccccccccCccc-ccccc---ccccceEecCCCccCC-CCCCC---cccceehhhccccc-c--
Confidence 99985 4442 246888999999998 45642 2467888888888884 45432 45667777777776 2
Q ss_pred hhhhhhhhhhhhhcccCccccCCCcccccccccccccccccccccCCCCcccccccccceeeccCcccccchhhhhhccc
Q 045798 464 EDIFNISYLSNSLNLARNHLVGIIPPRIGNLRALRSFDVSNNDLSGEIPIELGHCSSLEEIYLAGNLFHGSIPSFFNALK 543 (1008)
Q Consensus 464 ~~~~~~~~~~~~L~L~~N~l~~~~p~~~~~l~~L~~Ldls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~ 543 (1008)
+|.. ..+|+.|+|++|+|+ .+|.. .++|+.|++++|+|++ +|..+ .
T Consensus 377 -----------------------LP~l---~~~L~~LdLs~N~Lt-~LP~l---~s~L~~LdLS~N~Lss-IP~l~---~ 422 (788)
T PRK15387 377 -----------------------LPAL---PSGLKELIVSGNRLT-SLPVL---PSELKELMVSGNRLTS-LPMLP---S 422 (788)
T ss_pred -----------------------Cccc---ccccceEEecCCccc-CCCCc---ccCCCEEEccCCcCCC-CCcch---h
Confidence 3332 246899999999999 57754 3689999999999994 77643 4
Q ss_pred cccEEecCCCcccccccCc-ccccccceeecccCcccccCCCC
Q 045798 544 GVQKIDLSRNNLSGQIPIF-LEALSLEYLNLSFNDFEGKIPAK 585 (1008)
Q Consensus 544 ~L~~L~ls~N~l~~~~p~~-~~~~~L~~L~l~~N~l~g~~p~~ 585 (1008)
+|+.|+|++|+|+ .+|.. ..+..|+.|+|++|+|+|.+|..
T Consensus 423 ~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~~~ 464 (788)
T PRK15387 423 GLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQA 464 (788)
T ss_pred hhhhhhhccCccc-ccChHHhhccCCCeEECCCCCCCchHHHH
Confidence 6788999999999 56765 67889999999999999988753
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.2e-22 Score=221.48 Aligned_cols=170 Identities=21% Similarity=0.166 Sum_probs=131.5
Q ss_pred HHhcCCCCCceEeeccCeeEEEEEEcC-CCeEEEEEEeccc-----cchhhHHHHHHHHHHhhcCCCCceeeeecccccc
Q 045798 681 KATNGFSSTHLIGVGSFGCVYKGALDE-DGIVVAIKVINLQ-----CEGASKSFMAECKALKNIRHRNLVKVITSCSSID 754 (1008)
Q Consensus 681 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 754 (1008)
...++|.+.+.||+|+||+||+|.+.. +++.||||++... .....+.+.+|++++++++|+|+++.+..+
T Consensus 15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~---- 90 (365)
T PRK09188 15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT---- 90 (365)
T ss_pred cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----
Confidence 346789999999999999999999875 6788899987532 122356799999999999999998533221
Q ss_pred ccCCceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccC-CCCCeeec
Q 045798 755 FQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDL-KPSNILLD 833 (1008)
Q Consensus 755 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dl-kp~NIll~ 833 (1008)
+..|+||||++|++|... .. .. ...++.|+++||+|||+. ||+|||| ||+||+++
T Consensus 91 ----~~~~LVmE~~~G~~L~~~-~~-------------~~---~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~ 146 (365)
T PRK09188 91 ----GKDGLVRGWTEGVPLHLA-RP-------------HG---DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMG 146 (365)
T ss_pred ----CCcEEEEEccCCCCHHHh-Cc-------------cc---hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEc
Confidence 236999999999999632 10 01 146789999999999998 9999999 99999999
Q ss_pred CCCCeEEcccCcccccccccCccc----cccccccccccccCccccCCC
Q 045798 834 NDLSGHIGDFGLARFHQEVSNSTL----SSSVGVKGTIGYTAPEYGLGS 878 (1008)
Q Consensus 834 ~~~~~kL~Dfg~a~~~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~ 878 (1008)
.++.+||+|||+|+.......... .......+++.|+|||++...
T Consensus 147 ~~~~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 147 PDGEAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred CCCCEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 999999999999997654432111 111345688899999987654
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.1e-21 Score=216.28 Aligned_cols=266 Identities=22% Similarity=0.235 Sum_probs=197.3
Q ss_pred CCCCCceEeeccCeeEEEEEEcCCC-eEEEEEEeccccchhhHHHHHHHHHHhhcCC----CCceeeeeccccccccCCc
Q 045798 685 GFSSTHLIGVGSFGCVYKGALDEDG-IVVAIKVINLQCEGASKSFMAECKALKNIRH----RNLVKVITSCSSIDFQGND 759 (1008)
Q Consensus 685 ~y~~~~~lg~G~~g~Vy~~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h----~niv~~~~~~~~~~~~~~~ 759 (1008)
+|.+.+.||+|+||.||.|.+..++ +.+|+|+...........+..|+.++..+.. +++..+++... ..+.
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~----~~~~ 94 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGR----STED 94 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEecc----CCCc
Confidence 7999999999999999999997554 6899998875433333378889999998863 68888888732 4566
Q ss_pred eEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCC----
Q 045798 760 FKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDND---- 835 (1008)
Q Consensus 760 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~---- 835 (1008)
+.++||+.+ |.+|.++....... .++..++..|+.|++.+|+++|+. |++||||||.|+++...
T Consensus 95 ~~~iVM~l~-G~sL~dl~~~~~~~--------~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~ 162 (322)
T KOG1164|consen 95 FNFIVMSLL-GPSLEDLRKRNPPG--------RFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSE 162 (322)
T ss_pred eeEEEEecc-CccHHHHHHhCCCC--------CcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcc
Confidence 789999999 99999988655421 799999999999999999999998 99999999999999765
Q ss_pred -CCeEEcccCccc--ccccccCc---cccc-cccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCcccc
Q 045798 836 -LSGHIGDFGLAR--FHQEVSNS---TLSS-SVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFE 908 (1008)
Q Consensus 836 -~~~kL~Dfg~a~--~~~~~~~~---~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~ 908 (1008)
..+.+.|||+|+ .+...... .... .....||..|+++.+..+...+.+.|+||++.++.|+..|..||.....
T Consensus 163 ~~~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~ 242 (322)
T KOG1164|consen 163 VRTLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEM 242 (322)
T ss_pred cceEEEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccc
Confidence 468999999998 43222221 1111 2345699999999999999999999999999999999999999854322
Q ss_pred CCccHHHHHHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHH
Q 045798 909 GDLNLHNFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHEL 988 (1008)
Q Consensus 909 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 988 (1008)
... ...+........... .....+.++.++...+-..+..++|....+...+
T Consensus 243 ~~~-~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l 294 (322)
T KOG1164|consen 243 TDL-KSKFEKDPRKLLTDR---------------------------FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELL 294 (322)
T ss_pred cch-HHHHHHHhhhhcccc---------------------------ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHH
Confidence 111 111111000000000 0011234456666666668999999999999998
Q ss_pred HHHHHH
Q 045798 989 QSVKNI 994 (1008)
Q Consensus 989 ~~i~~~ 994 (1008)
++....
T Consensus 295 ~~~~~~ 300 (322)
T KOG1164|consen 295 KDVFDS 300 (322)
T ss_pred HHHHHh
Confidence 776554
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.8e-22 Score=236.63 Aligned_cols=336 Identities=21% Similarity=0.299 Sum_probs=186.0
Q ss_pred hccCChhhHHHHHHHHHhhccCCCCCCCC----CCCCCCCCcccc----------------eEEcCCCCeEEEEeccccC
Q 045798 6 VAALEDGDRAALQAFKSMIAHEPQGILNS----WNDSRHFCEWEG----------------ITCGRRHRRVTALDLMSKS 65 (1008)
Q Consensus 6 ~~~~~~~~~~~l~~~k~~~~~~~~~~~~~----w~~~~~~c~w~g----------------v~c~~~~~~v~~l~l~~~~ 65 (1008)
++...++|.+.+++..+.++.. +++.+ |++.+++|-=.. |.|. ...||.+...+..
T Consensus 57 ~~~~~~~~~~~~~~~~~~l~~p--~~~~~~~~~~~~~~~fc~~~~~~~~~l~~~~~~~~~tv~~~--~~~vt~l~~~g~~ 132 (754)
T PRK15370 57 PETASPEEIKSKFECLRMLAFP--AYADNIQYSRGGADQYCILSENSQEILSIVFNTEGYTVEGG--GKSVTYTRVTESE 132 (754)
T ss_pred CCCCCHHHHHHHHHHHHHhcCC--chhhccccccCCCCcccccCCcchhhheeeecCCceEEecC--CCccccccccccc
Confidence 4567789999999999999755 34566 999999996544 4453 3456666655532
Q ss_pred CCCccCcCccCCccCCeeee----cCCCCCCCCC---ccc-----cCCCCCCEEEccCCCCCCccCcccccCcCcceEee
Q 045798 66 LSGSLSPHLGNLSFLREINL----SNNTIQGEIP---PEF-----GRLFRLEALFLSNNSLVGKIPANLSYCSRLTVLCI 133 (1008)
Q Consensus 66 l~~~l~~~l~~l~~L~~L~L----~~n~~~~~~p---~~~-----~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L 133 (1008)
.......+-. .-.+... ..+.-.+..+ .++ +-..+...|+++++.++ .+|..+. ++|+.|+|
T Consensus 133 ~~~~~~~~~~---~~~~~~~w~~w~~~~~~~~~~~r~~a~~r~~~Cl~~~~~~L~L~~~~Lt-sLP~~Ip--~~L~~L~L 206 (754)
T PRK15370 133 QASSASGSKD---AVNYELIWSEWVKEAPAKEAANREEAVQRMRDCLKNNKTELRLKILGLT-TIPACIP--EQITTLIL 206 (754)
T ss_pred ccccCCCCCC---hhhHHHHHHHHHhcCCCCccccHHHHHHHHHhhcccCceEEEeCCCCcC-cCCcccc--cCCcEEEe
Confidence 2211110000 0000000 0000000000 000 11234667777777777 5565543 46777777
Q ss_pred eccccccCCCccccccCCCCeeecccccCCCCCCCCCccccccchhhcccccCCCCCCccccCCCCCcEEEecCCccccc
Q 045798 134 EYNKLQGRIPLEFVSLSKLKDLSLAKNKLTGGIPPFLGNLTSLEVLSLAGNSFGRNIPDSLGQLKQLKILAIGGNNLSGP 213 (1008)
Q Consensus 134 s~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~ 213 (1008)
++|+|+ .+|..+. ++|++|++++|+++ .+|..+. .+|+.|+|++|++. .+|..+. ++|+.|++++|+++ .
T Consensus 207 s~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~Ls~N~L~-~ 276 (754)
T PRK15370 207 DNNELK-SLPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEMELSINRIT-ELPERLP--SALQSLDLFHNKIS-C 276 (754)
T ss_pred cCCCCC-cCChhhc--cCCCEEECCCCccc-cCChhhh--ccccEEECcCCccC-cCChhHh--CCCCEEECcCCccC-c
Confidence 777777 4555443 46777777777777 4555443 36777777777775 4555543 46777777777777 3
Q ss_pred CCccccCCCCcceeccccccccccCChhhhhcCCCCcEEEeccccCCCCCCcccccCCCCceeecccccccccccccccC
Q 045798 214 IPPSIYNLSFLVVFSVSHNQIHGSLPPSLGLLLPNLKFFQIHHNFFSGSIPISLSNASKLEHIEIANNNFSGKLSVNFGG 293 (1008)
Q Consensus 214 ~~~~~~~l~~L~~L~ls~N~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~ 293 (1008)
+|..+. ++|+.|++++|+++ .+|..+. ++|+.|++++|.++. +|..+. ++|+.|++++|.++.+ |..+.
T Consensus 277 LP~~l~--~sL~~L~Ls~N~Lt-~LP~~lp---~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~Lt~L-P~~l~- 345 (754)
T PRK15370 277 LPENLP--EELRYLSVYDNSIR-TLPAHLP---SGITHLNVQSNSLTA-LPETLP--PGLKTLEAGENALTSL-PASLP- 345 (754)
T ss_pred cccccC--CCCcEEECCCCccc-cCcccch---hhHHHHHhcCCcccc-CCcccc--ccceeccccCCccccC-Chhhc-
Confidence 555443 46777778877777 5665442 467778888887773 454332 5677777777777643 22221
Q ss_pred CCcccccccccccCCCCCCCcccccccccccCCCcEEEecCCcCCccCChhhhhhcccceeeeeccccccCCCCCccccc
Q 045798 294 MKNLSLLNLQFSNLGSGESDEMGFMNSLTNCSKLRVLSLGGNQFRGALPHSIANLSSQLQILILSSNQFYGSIPLGIGNL 373 (1008)
Q Consensus 294 l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~Ls~N~l~~~~p~~~~~l 373 (1008)
++| +.|++++|+++ .+|..+. ..|++|+|++|+++ .+|..+.
T Consensus 346 -~sL------------------------------~~L~Ls~N~L~-~LP~~lp---~~L~~LdLs~N~Lt-~LP~~l~-- 387 (754)
T PRK15370 346 -PEL------------------------------QVLDVSKNQIT-VLPETLP---PTITTLDVSRNALT-NLPENLP-- 387 (754)
T ss_pred -Ccc------------------------------cEEECCCCCCC-cCChhhc---CCcCEEECCCCcCC-CCCHhHH--
Confidence 334 44444444444 3333321 13444555555444 2333322
Q ss_pred cccceEEecCccccCCcc----hhccCCCCCceEEccCCccc
Q 045798 374 VDLYLLGMVENQFTGAIP----KEMGKLQKLQGLDFSGNHFS 411 (1008)
Q Consensus 374 ~~L~~L~L~~n~l~~~~~----~~~~~l~~L~~L~Ls~N~l~ 411 (1008)
.+|+.|++++|++. .+| ..+..++++..|+|.+|.++
T Consensus 388 ~sL~~LdLs~N~L~-~LP~sl~~~~~~~~~l~~L~L~~Npls 428 (754)
T PRK15370 388 AALQIMQASRNNLV-RLPESLPHFRGEGPQPTRIIVEYNPFS 428 (754)
T ss_pred HHHHHHhhccCCcc-cCchhHHHHhhcCCCccEEEeeCCCcc
Confidence 13444444444444 222 23344567777777777776
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.4e-23 Score=201.89 Aligned_cols=247 Identities=24% Similarity=0.378 Sum_probs=184.2
Q ss_pred CCCceEeeccCeeEEEEEEcCCCeEEEEEEeccc--cchhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceEEEE
Q 045798 687 SSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQ--CEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKAIV 764 (1008)
Q Consensus 687 ~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 764 (1008)
...-+|.+...|+.|+|++. |..+++|++... .....++|..|.-.++.+.||||++++|.|.. +....++
T Consensus 193 nl~tkl~e~hsgelwrgrwq--gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacns-----ppnlv~i 265 (448)
T KOG0195|consen 193 NLITKLAESHSGELWRGRWQ--GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNS-----PPNLVII 265 (448)
T ss_pred hhhhhhccCCCccccccccc--CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccC-----CCCceEe
Confidence 34567899999999999995 556788887643 23455789999999999999999999999854 4568999
Q ss_pred EeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCce-eccCCCCCeeecCCCCeEEc--
Q 045798 765 YEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPIL-HCDLKPSNILLDNDLSGHIG-- 841 (1008)
Q Consensus 765 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iv-H~Dlkp~NIll~~~~~~kL~-- 841 (1008)
..||+.|+|+..++.... ...+..++.+++.+||+|++|||+. -+++ ---+.+..|++|++.+++|.
T Consensus 266 sq~mp~gslynvlhe~t~--------vvvd~sqav~faldiargmaflhsl--ep~ipr~~lns~hvmidedltarisma 335 (448)
T KOG0195|consen 266 SQYMPFGSLYNVLHEQTS--------VVVDHSQAVRFALDIARGMAFLHSL--EPMIPRFYLNSKHVMIDEDLTARISMA 335 (448)
T ss_pred eeeccchHHHHHHhcCcc--------EEEecchHHHHHHHHHhhHHHHhhc--chhhhhhhcccceEEecchhhhheecc
Confidence 999999999999987652 2678889999999999999999997 2444 34688999999999988873
Q ss_pred ccCcccccccccCccccccccccccccccCccccCCCCC---CcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHH
Q 045798 842 DFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEV---STNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFAR 918 (1008)
Q Consensus 842 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~ 918 (1008)
|--++. ...+..-.+.||+||.+...+- -.++|+|||++++||+.|...||.+...-+-.....
T Consensus 336 d~kfsf-----------qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkia-- 402 (448)
T KOG0195|consen 336 DTKFSF-----------QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIA-- 402 (448)
T ss_pred cceeee-----------eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhh--
Confidence 222211 1112335789999999887654 357899999999999999999987532211100000
Q ss_pred hhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHHHHHH
Q 045798 919 MALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHELQSVK 992 (1008)
Q Consensus 919 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~i~ 992 (1008)
.+-+ ...++++ .+..+.++|.-|+.+||.+||.++.|+-.|+++.
T Consensus 403 -------legl----------------rv~ippg------is~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 403 -------LEGL----------------RVHIPPG------ISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred -------hccc----------------cccCCCC------ccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 0000 0112222 2334678999999999999999999999999874
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=8.1e-22 Score=189.48 Aligned_cols=204 Identities=24% Similarity=0.352 Sum_probs=169.2
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccchhhHHHHHHHHHHhhcCC-CCceeeeeccccccccCCceE
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRH-RNLVKVITSCSSIDFQGNDFK 761 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~~~~~ 761 (1008)
.+.|.++++||+|+||.+|.|....+|+.||||+-+.... ..++..|.++.+.+++ ..|..+..+ ..+..+-
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~--hpqL~yEskvY~iL~~g~GiP~i~~y-----~~e~~yn 86 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK--HPQLLYESKVYRILQGGVGIPHIRHY-----GTEKDYN 86 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC--CcchhHHHHHHHHhccCCCCchhhhh-----ccccccc
Confidence 5689999999999999999999999999999998754322 2467789999999854 556655555 4566678
Q ss_pred EEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCC---CCe
Q 045798 762 AIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDND---LSG 838 (1008)
Q Consensus 762 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~---~~~ 838 (1008)
.+||+.. |.+|++...-... .++..+++-++-|++.-++|+|.+ +++||||||+|+|..-+ ..+
T Consensus 87 vlVMdLL-GPsLEdLfnfC~R---------~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl 153 (341)
T KOG1163|consen 87 VLVMDLL-GPSLEDLFNFCSR---------RFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKL 153 (341)
T ss_pred eeeeecc-CccHHHHHHHHhh---------hhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceE
Confidence 9999999 9999999876542 789999999999999999999998 99999999999999643 467
Q ss_pred EEcccCcccccccccCc---cccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCcc
Q 045798 839 HIGDFGLARFHQEVSNS---TLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVM 906 (1008)
Q Consensus 839 kL~Dfg~a~~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~ 906 (1008)
.++|||+|+.+.+.... .........||.+|.+-.+..+...+.+.|+-|+|.++...-.|..||...
T Consensus 154 ~LIDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQgl 224 (341)
T KOG1163|consen 154 YLIDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGL 224 (341)
T ss_pred EEEeccchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCccccc
Confidence 89999999977654332 223344567999999998888888889999999999999999999999764
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.9e-21 Score=195.65 Aligned_cols=203 Identities=22% Similarity=0.322 Sum_probs=173.6
Q ss_pred cCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccchhhHHHHHHHHHHhhc-CCCCceeeeeccccccccCCceEE
Q 045798 684 NGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNI-RHRNLVKVITSCSSIDFQGNDFKA 762 (1008)
Q Consensus 684 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~ 762 (1008)
-.|++.++||+|+||.++.|..--++++||||.-... .+..++..|.+.++.+ ..+.|..++.+ -+.+.+-.
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk--S~APQLrdEYr~YKlL~g~~GIP~vYYF-----GqeG~~Ni 100 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK--SEAPQLRDEYRTYKLLGGTEGIPQVYYF-----GQEGKYNI 100 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEecccc--CCcchHHHHHHHHHHHcCCCCCCceeee-----ccccchhh
Confidence 4699999999999999999999889999999976533 2345788899999988 67899998877 45666788
Q ss_pred EEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCC-----CC
Q 045798 763 IVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDND-----LS 837 (1008)
Q Consensus 763 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-----~~ 837 (1008)
+|+|.. |.+|+|+..-.+. +++...+..+|.|++.-++|+|++ .+|.|||||+|+||... ..
T Consensus 101 LVidLL-GPSLEDLFD~CgR---------~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~ 167 (449)
T KOG1165|consen 101 LVIDLL-GPSLEDLFDLCGR---------RFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANV 167 (449)
T ss_pred hhhhhh-CcCHHHHHHHhcC---------cccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCce
Confidence 999999 8999999877653 799999999999999999999997 99999999999999643 35
Q ss_pred eEEcccCcccccccccCc---cccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCcc
Q 045798 838 GHIGDFGLARFHQEVSNS---TLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVM 906 (1008)
Q Consensus 838 ~kL~Dfg~a~~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~ 906 (1008)
+.++|||+|+.+.+.... .........||.+||+-....|++-+.+.|.-|+|-|+.+.+.|..||...
T Consensus 168 IhiiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGL 239 (449)
T KOG1165|consen 168 IHIIDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGL 239 (449)
T ss_pred EEEEeccchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccc
Confidence 789999999988765443 222334466999999999999999999999999999999999999999754
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.2e-22 Score=236.83 Aligned_cols=258 Identities=21% Similarity=0.243 Sum_probs=192.7
Q ss_pred CCCceEeeccCeeEEEEEEcCCCeEEEEEEecc-----ccch-hhHHHHHHHHHHhhcCCCCceeeeeccccccccCCce
Q 045798 687 SSTHLIGVGSFGCVYKGALDEDGIVVAIKVINL-----QCEG-ASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDF 760 (1008)
Q Consensus 687 ~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~-----~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 760 (1008)
...+++|.|++|.|+.+......+.++.|.+.. ..+. ....+..|+-+-..+.|+|++..+..+.. ...
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~-----~~~ 395 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQE-----IDG 395 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhh-----ccc
Confidence 345789999999888888766666566665431 1111 11236678888888899999887777433 222
Q ss_pred EEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEE
Q 045798 761 KAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHI 840 (1008)
Q Consensus 761 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 840 (1008)
..-+||||++ +|..++.... .+...++..+++|+..|++|+|+. ||.|||+|++|++++.+|.+||
T Consensus 396 ~~~~mE~~~~-Dlf~~~~~~~----------~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki 461 (601)
T KOG0590|consen 396 ILQSMEYCPY-DLFSLVMSNG----------KLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKI 461 (601)
T ss_pred chhhhhcccH-HHHHHHhccc----------ccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEE
Confidence 3344999999 9999987653 678889999999999999999998 9999999999999999999999
Q ss_pred cccCcccccccccCccccccccccccccccCccccCCCCCCc-ccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHh
Q 045798 841 GDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVST-NGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARM 919 (1008)
Q Consensus 841 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~ 919 (1008)
+|||.+...............+.+|+..|+|||.+.+..|.+ ..||||.|+++..|.+|+.||......+..+ ...
T Consensus 462 ~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~---~~~ 538 (601)
T KOG0590|consen 462 IDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF---KTN 538 (601)
T ss_pred eecCcceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch---hhh
Confidence 999999877665554444566788999999999999999977 5799999999999999999997654443322 000
Q ss_pred hCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 045798 920 ALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHE 987 (1008)
Q Consensus 920 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 987 (1008)
....+. .............+.+...++.+|++.||.+|.|+++|++.
T Consensus 539 ~~~~~~---------------------~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d 585 (601)
T KOG0590|consen 539 NYSDQR---------------------NIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILND 585 (601)
T ss_pred cccccc---------------------ccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhC
Confidence 000000 00001111223566677899999999999999999999863
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=8.5e-21 Score=225.16 Aligned_cols=264 Identities=24% Similarity=0.394 Sum_probs=130.5
Q ss_pred CCcEEEecCCcccccCCccccCCCCcceeccccccccccCChhhhhcCCCCcEEEeccccCCCCCCcccccCCCCceeec
Q 045798 199 QLKILAIGGNNLSGPIPPSIYNLSFLVVFSVSHNQIHGSLPPSLGLLLPNLKFFQIHHNFFSGSIPISLSNASKLEHIEI 278 (1008)
Q Consensus 199 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L 278 (1008)
+...|+++++.++ .+|..+. +.|+.|+|++|+++ .+|..++ ++|++|++++|.++ .+|..+. .+|+.|+|
T Consensus 179 ~~~~L~L~~~~Lt-sLP~~Ip--~~L~~L~Ls~N~Lt-sLP~~l~---~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~L 248 (754)
T PRK15370 179 NKTELRLKILGLT-TIPACIP--EQITTLILDNNELK-SLPENLQ---GNIKTLYANSNQLT-SIPATLP--DTIQEMEL 248 (754)
T ss_pred CceEEEeCCCCcC-cCCcccc--cCCcEEEecCCCCC-cCChhhc---cCCCEEECCCCccc-cCChhhh--ccccEEEC
Confidence 4456777776666 3444332 35666666666666 5555443 35666666666555 3343332 24455555
Q ss_pred ccccccccccccccCCCcccccccccccCCCCCCCcccccccccccCCCcEEEecCCcCCccCChhhhhhcccceeeeec
Q 045798 279 ANNNFSGKLSVNFGGMKNLSLLNLQFSNLGSGESDEMGFMNSLTNCSKLRVLSLGGNQFRGALPHSIANLSSQLQILILS 358 (1008)
Q Consensus 279 ~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~Ls 358 (1008)
++|++..+ |..+. ++|+.|++++|+++ .+|..+. ..|+.|+++
T Consensus 249 s~N~L~~L-P~~l~--------------------------------s~L~~L~Ls~N~L~-~LP~~l~---~sL~~L~Ls 291 (754)
T PRK15370 249 SINRITEL-PERLP--------------------------------SALQSLDLFHNKIS-CLPENLP---EELRYLSVY 291 (754)
T ss_pred cCCccCcC-ChhHh--------------------------------CCCCEEECcCCccC-ccccccC---CCCcEEECC
Confidence 55544421 11110 23445555555554 3444332 135555555
Q ss_pred cccccCCCCCccccccccceEEecCccccCCcchhccCCCCCceEEccCCcccccccccccCCCCcceeecccccccccc
Q 045798 359 SNQFYGSIPLGIGNLVDLYLLGMVENQFTGAIPKEMGKLQKLQGLDFSGNHFSGEIPSSLGNLSSLYEVFFNNNNLSGVI 438 (1008)
Q Consensus 359 ~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~ 438 (1008)
+|+|+ .+|..+. .+|+.|++++|+++. +|..+. ++|+.|++++|.++ .+|..+. ++|+.|++++|+|+ .+
T Consensus 292 ~N~Lt-~LP~~lp--~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~Lt-~LP~~l~--~sL~~L~Ls~N~L~-~L 361 (754)
T PRK15370 292 DNSIR-TLPAHLP--SGITHLNVQSNSLTA-LPETLP--PGLKTLEAGENALT-SLPASLP--PELQVLDVSKNQIT-VL 361 (754)
T ss_pred CCccc-cCcccch--hhHHHHHhcCCcccc-CCcccc--ccceeccccCCccc-cCChhhc--CcccEEECCCCCCC-cC
Confidence 55554 2333221 244445555555442 232221 34555555555554 2343332 34555555555554 23
Q ss_pred CCCCcCCCcccEeecccccccCCcchhhhhhhhhhhhhcccCccccCCCcccccccccccccccccccccCCCCcccc--
Q 045798 439 PFSLGNLKRLAFLEMSGNELSGTIPEDIFNISYLSNSLNLARNHLVGIIPPRIGNLRALRSFDVSNNDLSGEIPIELG-- 516 (1008)
Q Consensus 439 p~~~~~l~~L~~L~Ls~N~l~~~lp~~~~~~~~~~~~L~L~~N~l~~~~p~~~~~l~~L~~Ldls~N~l~~~~p~~~~-- 516 (1008)
|..+. ++|+.|+|++|+|+ .+ |+.+. .+|+.||+++|+|+ .+|..+.
T Consensus 362 P~~lp--~~L~~LdLs~N~Lt-~L-------------------------P~~l~--~sL~~LdLs~N~L~-~LP~sl~~~ 410 (754)
T PRK15370 362 PETLP--PTITTLDVSRNALT-NL-------------------------PENLP--AALQIMQASRNNLV-RLPESLPHF 410 (754)
T ss_pred Chhhc--CCcCEEECCCCcCC-CC-------------------------CHhHH--HHHHHHhhccCCcc-cCchhHHHH
Confidence 33332 34555555555554 33 33332 25667777777776 5555443
Q ss_pred --cccccceeeccCcccccchhhhhhccccccEEecCCCcccc
Q 045798 517 --HCSSLEEIYLAGNLFHGSIPSFFNALKGVQKIDLSRNNLSG 557 (1008)
Q Consensus 517 --~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~ 557 (1008)
.++.+..|+|.+|+|+. ..+.+|+.| ++.|.+.|
T Consensus 411 ~~~~~~l~~L~L~~Npls~------~tl~~L~~L-l~s~~~~g 446 (754)
T PRK15370 411 RGEGPQPTRIIVEYNPFSE------RTIQNMQRL-MSSVGYQG 446 (754)
T ss_pred hhcCCCccEEEeeCCCccH------HHHHHHHHh-hhcccccC
Confidence 34677788888888772 234444455 44555555
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=1e-20 Score=191.12 Aligned_cols=175 Identities=13% Similarity=0.127 Sum_probs=134.3
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccchhhH---H------HHHHHHHHhhcCCCCceeeeeccccc
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASK---S------FMAECKALKNIRHRNLVKVITSCSSI 753 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~---~------~~~E~~~l~~l~h~niv~~~~~~~~~ 753 (1008)
.++|++.+++|.|+||.||++.. ++..+|+|+++........ . +.+|++.+.++.|++|..+.+++...
T Consensus 30 ~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 30 SYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 57899999999999999999765 4668999999754332222 2 68999999999999999998874432
Q ss_pred c---ccCCceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCe
Q 045798 754 D---FQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNI 830 (1008)
Q Consensus 754 ~---~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NI 830 (1008)
. +......++||||++|.+|.++. .++. ....+++.++..+|+. |++|||++|+||
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~--------------~~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Ni 166 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMP--------------EISE----DVKAKIKASIESLHQH---GMVSGDPHKGNF 166 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhh--------------hccH----HHHHHHHHHHHHHHHc---CCccCCCChHHE
Confidence 1 11234689999999999998873 2222 2456999999999998 999999999999
Q ss_pred eecCCCCeEEcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHH
Q 045798 831 LLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMV 897 (1008)
Q Consensus 831 ll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ell 897 (1008)
+++.++ ++++|||............ .+.....+..++|||+||+++....
T Consensus 167 li~~~g-i~liDfg~~~~~~e~~a~d----------------~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 167 IVSKNG-LRIIDLSGKRCTAQRKAKD----------------RIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EEeCCC-EEEEECCCcccccchhhHH----------------HHHHHhHhcccccccceeEeehHHH
Confidence 999988 9999999887553221111 1334445667999999999987664
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=2.3e-20 Score=191.94 Aligned_cols=205 Identities=21% Similarity=0.235 Sum_probs=146.5
Q ss_pred CCCCceeeeecccccc----------------------ccCCceEEEEEeccCCCChhcccccCCCCCCCcccccccCHH
Q 045798 739 RHRNLVKVITSCSSID----------------------FQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLL 796 (1008)
Q Consensus 739 ~h~niv~~~~~~~~~~----------------------~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~ 796 (1008)
+|||||++.+++.+.- ...+...|+||..+ ..+|.+|+... ..+..
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~~-----------~~s~r 341 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWTR-----------HRSYR 341 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhcC-----------CCchH
Confidence 5999999998765331 23344678999998 55999998755 45667
Q ss_pred HHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeee--cCCC--CeEEcccCcccccccccCc--ccccccccccccccc
Q 045798 797 QRISIAIDVASALDYLHHHCQEPILHCDLKPSNILL--DNDL--SGHIGDFGLARFHQEVSNS--TLSSSVGVKGTIGYT 870 (1008)
Q Consensus 797 ~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll--~~~~--~~kL~Dfg~a~~~~~~~~~--~~~~~~~~~gt~~y~ 870 (1008)
...-++.|+++|+.|||++ ||.|||+|++|||+ ++|+ ...++|||++-.-+...-. .........|...-|
T Consensus 342 ~~~~~laQlLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lm 418 (598)
T KOG4158|consen 342 TGRVILAQLLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLM 418 (598)
T ss_pred HHHHHHHHHHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceec
Confidence 7888999999999999998 99999999999999 3443 4589999998643332111 112233455888999
Q ss_pred CccccCCCC------CCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCcchhhhhcccccCchHHhhhhh
Q 045798 871 APEYGLGSE------VSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMALPNQVMDIVDPILRNDEEILASTD 944 (1008)
Q Consensus 871 aPE~~~~~~------~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~ 944 (1008)
|||+....+ -..|+|.|+.|.+.||+++...||....+.....+.+-....|.
T Consensus 419 APEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qLPa--------------------- 477 (598)
T KOG4158|consen 419 APEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQLPA--------------------- 477 (598)
T ss_pred chhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhCCC---------------------
Confidence 999876542 24689999999999999999999975322222222221111111
Q ss_pred hhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHHH
Q 045798 945 KCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHELQ 989 (1008)
Q Consensus 945 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 989 (1008)
+ ...++..+.+++...++.||.+|+++.-....|.
T Consensus 478 ----l------p~~vpp~~rqlV~~lL~r~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 478 ----L------PSRVPPVARQLVFDLLKRDPSKRVSPNIAANVLN 512 (598)
T ss_pred ----C------cccCChHHHHHHHHHhcCCccccCCccHHHhHHH
Confidence 0 1235566789999999999999999877666654
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.1e-20 Score=217.23 Aligned_cols=251 Identities=17% Similarity=0.211 Sum_probs=180.5
Q ss_pred CCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccc-hhhHHHHHHHHH--HhhcCCCCceeeeeccccccccCCceE
Q 045798 685 GFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCE-GASKSFMAECKA--LKNIRHRNLVKVITSCSSIDFQGNDFK 761 (1008)
Q Consensus 685 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~--l~~l~h~niv~~~~~~~~~~~~~~~~~ 761 (1008)
.|...+.||++.|=.|.+|+++ .|. |+||++-...+ -..+.|.++++- ...++|||++++..+ ...+...
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~-eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~-----~~t~kAA 96 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDR-EGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKV-----LVTDKAA 96 (1431)
T ss_pred ceeeecccCchhhhhhhhccCC-Cce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHH-----HHhhHHH
Confidence 5777899999999999999996 454 99999865543 223344443333 445599999998877 4556667
Q ss_pred EEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEc
Q 045798 762 AIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIG 841 (1008)
Q Consensus 762 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 841 (1008)
|+|-+|. .-+|.|.+...+ -+...+.+.|+.|++.|+.-+|+. ||+|||||.+||||+.-..+.|+
T Consensus 97 ylvRqyv-khnLyDRlSTRP----------FL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~Lt 162 (1431)
T KOG1240|consen 97 YLVRQYV-KHNLYDRLSTRP----------FLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLT 162 (1431)
T ss_pred HHHHHHH-hhhhhhhhccch----------HHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhh
Confidence 8999999 559999997664 677888899999999999999998 99999999999999999999999
Q ss_pred ccCcccc--cc--cccCccccccccccccccccCccccCCC----------C-CCcccchhhHHHHHHHHHh-CCCCCCc
Q 045798 842 DFGLARF--HQ--EVSNSTLSSSVGVKGTIGYTAPEYGLGS----------E-VSTNGDVYSYGILLLEMVT-AKKPTDV 905 (1008)
Q Consensus 842 Dfg~a~~--~~--~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------~-~~~~sDvwslG~vl~ellt-G~~pf~~ 905 (1008)
||..-+. ++ +..+......+ ...-..|+|||.+... . .+++.||||+||+++|+++ |++||+-
T Consensus 163 DFAsFKPtYLPeDNPadf~fFFDT-SrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L 241 (1431)
T KOG1240|consen 163 DFASFKPTYLPEDNPADFTFFFDT-SRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL 241 (1431)
T ss_pred cccccCCccCCCCCcccceEEEec-CCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH
Confidence 9977652 11 22222222222 2244579999976441 2 5788999999999999998 6888762
Q ss_pred cccCCccHHHHHHhhCC--cchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHH
Q 045798 906 MFEGDLNLHNFARMALP--NQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTN 983 (1008)
Q Consensus 906 ~~~~~~~~~~~~~~~~~--~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 983 (1008)
. ....+... ......+..+ ....+..++..|++.||.+|.+|++
T Consensus 242 S--------QL~aYr~~~~~~~e~~Le~I--------------------------ed~~~Rnlil~Mi~rdPs~RlSAed 287 (1431)
T KOG1240|consen 242 S--------QLLAYRSGNADDPEQLLEKI--------------------------EDVSLRNLILSMIQRDPSKRLSAED 287 (1431)
T ss_pred H--------HHHhHhccCccCHHHHHHhC--------------------------cCccHHHHHHHHHccCchhccCHHH
Confidence 1 11111110 0011111000 0114689999999999999999999
Q ss_pred HHHHHHHH
Q 045798 984 VVHELQSV 991 (1008)
Q Consensus 984 vl~~L~~i 991 (1008)
.++.-+++
T Consensus 288 yL~~yrG~ 295 (1431)
T KOG1240|consen 288 YLQKYRGL 295 (1431)
T ss_pred HHHhhhcc
Confidence 99886553
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.82 E-value=3.6e-19 Score=199.88 Aligned_cols=262 Identities=28% Similarity=0.365 Sum_probs=194.1
Q ss_pred CCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccch---hhHHHHHHHHHHhhcCCC-CceeeeeccccccccCCceE
Q 045798 686 FSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEG---ASKSFMAECKALKNIRHR-NLVKVITSCSSIDFQGNDFK 761 (1008)
Q Consensus 686 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~-niv~~~~~~~~~~~~~~~~~ 761 (1008)
|.+.+.||.|+||.||++.+. ..+|+|.+...... ....+.+|+.+++.+.|+ +++++.+.+ ......
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~-----~~~~~~ 73 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFF-----QDEGSL 73 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEE-----ecCCEE
Confidence 677889999999999999986 78999998754332 367899999999999888 799999984 344447
Q ss_pred EEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCC-CeEE
Q 045798 762 AIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDL-SGHI 840 (1008)
Q Consensus 762 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kL 840 (1008)
+++++++.++++.+++...... ..+.......++.|++.+++|+|+. +++|||+||+||+++..+ .+++
T Consensus 74 ~~~~~~~~~~~l~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l 143 (384)
T COG0515 74 YLVMEYVDGGSLEDLLKKIGRK-------GPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKL 143 (384)
T ss_pred EEEEecCCCCcHHHHHHhcccc-------cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEE
Confidence 9999999999999777654321 2588899999999999999999998 999999999999999988 7999
Q ss_pred cccCcccccccccCccc--cccccccccccccCccccCC---CCCCcccchhhHHHHHHHHHhCCCCCCccccC--CccH
Q 045798 841 GDFGLARFHQEVSNSTL--SSSVGVKGTIGYTAPEYGLG---SEVSTNGDVYSYGILLLEMVTAKKPTDVMFEG--DLNL 913 (1008)
Q Consensus 841 ~Dfg~a~~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwslG~vl~elltG~~pf~~~~~~--~~~~ 913 (1008)
+|||.+........... .......|+..|+|||.+.+ ..+....|+||+|++++++++|..||...... ....
T Consensus 144 ~dfg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~ 223 (384)
T COG0515 144 IDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQT 223 (384)
T ss_pred eccCcceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHH
Confidence 99999985544332211 12344669999999999887 57888999999999999999999996543221 0011
Q ss_pred HHHHHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 045798 914 HNFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHE 987 (1008)
Q Consensus 914 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 987 (1008)
.......... ...... ..... ......+.+++..|+..+|..|.++.+....
T Consensus 224 ~~~~~~~~~~----~~~~~~----------------~~~~~--~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 224 LKIILELPTP----SLASPL----------------SPSNP--ELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred HHHHHhcCCc----cccccc----------------Ccccc--chhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 1111100000 000000 00000 1223457888999999999999999887765
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.81 E-value=4.6e-20 Score=185.45 Aligned_cols=140 Identities=19% Similarity=0.142 Sum_probs=107.5
Q ss_pred CceEeeccCeeEEEEEEcCCCeEEEEEEeccccch--h-------h-----------------HHHHHHHHHHhhcCCCC
Q 045798 689 THLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEG--A-------S-----------------KSFMAECKALKNIRHRN 742 (1008)
Q Consensus 689 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~-------~-----------------~~~~~E~~~l~~l~h~n 742 (1008)
.+.||+|+||.||+|... +|+.||||+++..... . . ....+|++.+.++.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 468999999999999996 8999999999754211 1 1 12245999999998777
Q ss_pred ceeeeeccccccccCCceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHH-hhCCCCCce
Q 045798 743 LVKVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYL-HHHCQEPIL 821 (1008)
Q Consensus 743 iv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~L-H~~~~~~iv 821 (1008)
+.....+ .. ...++||||++++++........ .++...+..++.|++.+|+|+ |+. ||+
T Consensus 81 v~~p~~~------~~-~~~~iVmE~i~g~~l~~~~~~~~----------~~~~~~~~~i~~qi~~~L~~l~H~~---gii 140 (190)
T cd05147 81 IPCPEPI------LL-KSHVLVMEFIGDDGWAAPRLKDA----------PLSESKARELYLQVIQIMRILYQDC---RLV 140 (190)
T ss_pred CCCCcEE------Ee-cCCEEEEEEeCCCCCcchhhhcC----------CCCHHHHHHHHHHHHHHHHHHHHhC---Ccc
Confidence 6432222 11 11389999998877665432222 678899999999999999999 676 999
Q ss_pred eccCCCCCeeecCCCCeEEcccCcccccc
Q 045798 822 HCDLKPSNILLDNDLSGHIGDFGLARFHQ 850 (1008)
Q Consensus 822 H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~ 850 (1008)
||||||+||+++ ++.++|+|||+|....
T Consensus 141 HrDlkP~NIli~-~~~v~LiDFG~a~~~~ 168 (190)
T cd05147 141 HADLSEYNLLYH-DGKLYIIDVSQSVEHD 168 (190)
T ss_pred cCCCCHHHEEEE-CCcEEEEEccccccCC
Confidence 999999999998 4789999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.80 E-value=4.2e-20 Score=192.28 Aligned_cols=242 Identities=19% Similarity=0.262 Sum_probs=151.9
Q ss_pred CCCCceEeeccCeeEEEEEEcCCCeEEEEEEecccc---chhhHHHHHHHHHHhhcCC----------CCceeeeecccc
Q 045798 686 FSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC---EGASKSFMAECKALKNIRH----------RNLVKVITSCSS 752 (1008)
Q Consensus 686 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h----------~niv~~~~~~~~ 752 (1008)
+...+.||.|+++.||.+.+.++++.+|+|++.... ....+.+++|.-....+.+ -.++..++....
T Consensus 14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i 93 (288)
T PF14531_consen 14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI 93 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence 445678999999999999999999999999986432 2334667777655555322 122222222110
Q ss_pred c---c-c---cCCc-----eEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCc
Q 045798 753 I---D-F---QGND-----FKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPI 820 (1008)
Q Consensus 753 ~---~-~---~~~~-----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i 820 (1008)
. . + .+.. ..+++|+-+ .++|.+++..-...... ...+....+..+..|+++.+++||+. |+
T Consensus 94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~---~~~l~~~arl~lT~Q~I~lvA~Lh~~---Gl 166 (288)
T PF14531_consen 94 PGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQT---HSPLAFAARLSLTVQMIRLVANLHSY---GL 166 (288)
T ss_dssp TTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTT---SHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred cCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccc---cchhHHHHHHHHHHHHHHHHHHHhhc---ce
Confidence 0 0 0 1111 236788888 67898886531110000 11455666777889999999999998 99
Q ss_pred eeccCCCCCeeecCCCCeEEcccCcccccccccCccccccccccccccccCccccCC--------CCCCcccchhhHHHH
Q 045798 821 LHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLG--------SEVSTNGDVYSYGIL 892 (1008)
Q Consensus 821 vH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~sDvwslG~v 892 (1008)
||+||+|+|++++++|.++|+||+.....+..... ...+..|.+||.... ..++.+.|.|++|++
T Consensus 167 VHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~-------~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ 239 (288)
T PF14531_consen 167 VHGDIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC-------SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGIT 239 (288)
T ss_dssp EEST-SGGGEEE-TTS-EEE--GGGEEETTEEEEG-------GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHH
T ss_pred EecccceeeEEEcCCCCEEEcChHHHeecCceeec-------cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHH
Confidence 99999999999999999999999988755432211 124578999997533 247889999999999
Q ss_pred HHHHHhCCCCCCccccCCccHHHHHHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccC
Q 045798 893 LLEMVTAKKPTDVMFEGDLNLHNFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSM 972 (1008)
Q Consensus 893 l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 972 (1008)
+|.|.+|+.||+.......... ....|+ +.++.+.++|..+++
T Consensus 240 ly~lWC~~lPf~~~~~~~~~~~---------------------------~f~~C~----------~~Pe~v~~LI~~lL~ 282 (288)
T PF14531_consen 240 LYSLWCGRLPFGLSSPEADPEW---------------------------DFSRCR----------DMPEPVQFLIRGLLQ 282 (288)
T ss_dssp HHHHHHSS-STCCCGGGSTSGG---------------------------GGTTSS-------------HHHHHHHHHHT-
T ss_pred HHHHHHccCCCCCCCccccccc---------------------------cchhcC----------CcCHHHHHHHHHHcc
Confidence 9999999999975422111000 111222 466778999999999
Q ss_pred cCCCCC
Q 045798 973 ESPQDR 978 (1008)
Q Consensus 973 ~dP~~R 978 (1008)
.+|.+|
T Consensus 283 ~~~~~R 288 (288)
T PF14531_consen 283 RNPEDR 288 (288)
T ss_dssp SSGGGS
T ss_pred CCcccC
Confidence 999988
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.78 E-value=8.7e-19 Score=177.30 Aligned_cols=141 Identities=18% Similarity=0.111 Sum_probs=109.8
Q ss_pred CceEeeccCeeEEEEEEcCCCeEEEEEEeccccchh--------------------------hHHHHHHHHHHhhcCCCC
Q 045798 689 THLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGA--------------------------SKSFMAECKALKNIRHRN 742 (1008)
Q Consensus 689 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~--------------------------~~~~~~E~~~l~~l~h~n 742 (1008)
.+.||+|++|.||+|.+. +|+.||||+++...... ...+..|.+.+.++.|++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 578999999999999987 89999999997542110 123467899999999988
Q ss_pred ceeeeeccccccccCCceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhh-CCCCCce
Q 045798 743 LVKVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHH-HCQEPIL 821 (1008)
Q Consensus 743 iv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~iv 821 (1008)
+.....+.. ...++||||++++++........ +++..++..++.|++.++.++|+ . ||+
T Consensus 81 i~~p~~~~~-------~~~~lVmE~~~g~~~~~~~l~~~----------~~~~~~~~~i~~~l~~~l~~lH~~~---giv 140 (190)
T cd05145 81 VPVPEPILL-------KKNVLVMEFIGDDGSPAPRLKDV----------PLEEEEAEELYEQVVEQMRRLYQEA---GLV 140 (190)
T ss_pred CCCceEEEe-------cCCEEEEEEecCCCchhhhhhhc----------cCCHHHHHHHHHHHHHHHHHHHHhC---CEe
Confidence 744333311 12489999998875543321111 56788899999999999999999 7 999
Q ss_pred eccCCCCCeeecCCCCeEEcccCccccccc
Q 045798 822 HCDLKPSNILLDNDLSGHIGDFGLARFHQE 851 (1008)
Q Consensus 822 H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~ 851 (1008)
||||||+||+++ ++.++|+|||+|.....
T Consensus 141 HrDlkP~NIll~-~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 141 HGDLSEYNILYH-DGKPYIIDVSQAVELDH 169 (190)
T ss_pred cCCCChhhEEEE-CCCEEEEEcccceecCC
Confidence 999999999999 78999999999986543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.2e-18 Score=171.73 Aligned_cols=189 Identities=14% Similarity=0.014 Sum_probs=139.0
Q ss_pred CCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccc----hhhHHHHHHHHHHhhc-CCCCceeeeeccccccccCCceE
Q 045798 687 SSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCE----GASKSFMAECKALKNI-RHRNLVKVITSCSSIDFQGNDFK 761 (1008)
Q Consensus 687 ~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~ 761 (1008)
.+...|++|+||+||.+.. .+.+++.+.+..... -....+.+|+++|+++ +|+++++++++ +..
T Consensus 5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~---------~~~ 73 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW---------DGR 73 (218)
T ss_pred ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE---------cCE
Confidence 4568899999999997766 678888887764422 1123588999999999 45889998875 126
Q ss_pred EEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccC-CCCCeeecCCCCeEE
Q 045798 762 AIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDL-KPSNILLDNDLSGHI 840 (1008)
Q Consensus 762 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dl-kp~NIll~~~~~~kL 840 (1008)
+++|||++|.+|.+.... ....++.|++.+++++|++ ||+|||| ||+||+++.++.++|
T Consensus 74 ~lvmeyI~G~~L~~~~~~-----------------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~L 133 (218)
T PRK12274 74 HLDRSYLAGAAMYQRPPR-----------------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAV 133 (218)
T ss_pred EEEEeeecCccHHhhhhh-----------------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEE
Confidence 899999999888654311 1135788999999999998 9999999 799999999999999
Q ss_pred cccCcccccccccCc----ccc-----ccccccccccccCccccCC--CCCCcccchhhHHHHHHHHHhCCCCCCcc
Q 045798 841 GDFGLARFHQEVSNS----TLS-----SSVGVKGTIGYTAPEYGLG--SEVSTNGDVYSYGILLLEMVTAKKPTDVM 906 (1008)
Q Consensus 841 ~Dfg~a~~~~~~~~~----~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwslG~vl~elltG~~pf~~~ 906 (1008)
+|||+|......... ... ...-...++.|++|+...- ..--.+.+.++-|+-+|.++||+.++...
T Consensus 134 IDFG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~ 210 (218)
T PRK12274 134 IDFQLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED 210 (218)
T ss_pred EECCCceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence 999999855432210 000 0011225777888875322 22225679999999999999999986543
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.5e-20 Score=171.23 Aligned_cols=161 Identities=24% Similarity=0.455 Sum_probs=120.8
Q ss_pred cccccceEEecCccccCCcchhccCCCCCceEEccCCcccccccccccCCCCcceeeccccccccccCCCCcCCCcccEe
Q 045798 372 NLVDLYLLGMVENQFTGAIPKEMGKLQKLQGLDFSGNHFSGEIPSSLGNLSSLYEVFFNNNNLSGVIPFSLGNLKRLAFL 451 (1008)
Q Consensus 372 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L 451 (1008)
++.+++.|.|++|+++ .+|..+..+.+|+.|++++|+|. ..|..++.+++|+.|+++-|++. ..|..|+.++.|+.|
T Consensus 31 ~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levl 107 (264)
T KOG0617|consen 31 NMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVL 107 (264)
T ss_pred chhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhh
Confidence 4555566666666666 56666777788888888888887 77888888888888888888887 788899999999999
Q ss_pred ecccccccCCcchhhhhhhhhhhhhcccCccccCCCcccccccccccccccccccccCCCCcccccccccceeeccCccc
Q 045798 452 EMSGNELSGTIPEDIFNISYLSNSLNLARNHLVGIIPPRIGNLRALRSFDVSNNDLSGEIPIELGHCSSLEEIYLAGNLF 531 (1008)
Q Consensus 452 ~Ls~N~l~~~lp~~~~~~~~~~~~L~L~~N~l~~~~p~~~~~l~~L~~Ldls~N~l~~~~p~~~~~l~~L~~L~L~~N~l 531 (1008)
||++|++.+ ..+|..|-.+..|+.|+|+.|.|. .+|..++++++|+.|.++.|.+
T Consensus 108 dltynnl~e------------------------~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndl 162 (264)
T KOG0617|consen 108 DLTYNNLNE------------------------NSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDL 162 (264)
T ss_pred hcccccccc------------------------ccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCch
Confidence 999999874 145566666677777777777776 6777777777777777777777
Q ss_pred ccchhhhhhccccccEEecCCCcccccccC
Q 045798 532 HGSIPSFFNALKGVQKIDLSRNNLSGQIPI 561 (1008)
Q Consensus 532 ~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~ 561 (1008)
- ++|.+++.+++|+.|.+++|+++-..|.
T Consensus 163 l-~lpkeig~lt~lrelhiqgnrl~vlppe 191 (264)
T KOG0617|consen 163 L-SLPKEIGDLTRLRELHIQGNRLTVLPPE 191 (264)
T ss_pred h-hCcHHHHHHHHHHHHhcccceeeecChh
Confidence 6 6777777777777777777777754443
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.8e-18 Score=191.54 Aligned_cols=218 Identities=26% Similarity=0.405 Sum_probs=161.7
Q ss_pred HhhcCCCCceeeeeccccccccCCceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhh
Q 045798 735 LKNIRHRNLVKVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHH 814 (1008)
Q Consensus 735 l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~ 814 (1008)
|+.+.|.|+.+++|.|.. +...++|.+||..|+|.+.+.... .++++.....+.++|+.||+|+|+
T Consensus 1 l~~l~h~n~~~f~g~~~~-----~~~~~~i~~~c~rGsl~D~i~~~~---------~~~d~~F~~s~~rdi~~Gl~ylh~ 66 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVD-----GPEMIVIWEYCSRGSLLDILSNED---------IKLDYFFILSFIRDISKGLAYLHN 66 (484)
T ss_pred CcccchhhhhhheeeEec-----CCceEEEEeeecCccHHhHHhccc---------cCccHHHHHHHHHHHHHHHHHHhc
Confidence 356789999999999753 366899999999999999998743 278999999999999999999999
Q ss_pred CCCCCc-eeccCCCCCeeecCCCCeEEcccCcccccccccCccccccccccccccccCccccCCC-------CCCcccch
Q 045798 815 HCQEPI-LHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGS-------EVSTNGDV 886 (1008)
Q Consensus 815 ~~~~~i-vH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~sDv 886 (1008)
. +| +|+.+++.|.+++....+|++|||+......... ........-..-|.|||.+.+. ..+.+.||
T Consensus 67 s---~i~~hg~l~s~nClvd~~w~lklt~~Gl~~~~~~~~~--~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdi 141 (484)
T KOG1023|consen 67 S---PIGYHGALKSSNCLVDSRWVLKLTDFGLNSLLEETAE--PEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDI 141 (484)
T ss_pred C---cceeeeeeccccceeeeeEEEEechhhhccccccccc--ccccchhHHHHhccCHHHhcccccccccccccccCCe
Confidence 7 44 9999999999999999999999999987653111 1111222345679999998764 14678999
Q ss_pred hhHHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHH
Q 045798 887 YSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKI 966 (1008)
Q Consensus 887 wslG~vl~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 966 (1008)
||||++++|+++.+.||+........ ...+..... . . ...+++.+....+.++++..+
T Consensus 142 Ys~~ii~~ei~~r~~~~~~~~~~~~~-~eii~~~~~-~----------~----------~~~~rP~i~~~~e~~~~l~~l 199 (484)
T KOG1023|consen 142 YSFGIIMYEILFRSGPFDLRNLVEDP-DEIILRVKK-G----------G----------SNPFRPSIELLNELPPELLLL 199 (484)
T ss_pred ehHHHHHHHHHhccCccccccccCCh-HHHHHHHHh-c----------C----------CCCcCcchhhhhhcchHHHHH
Confidence 99999999999999999864332221 111110000 0 0 011122222222455578999
Q ss_pred HhcccCcCCCCCCCHHHHHHHHHHHHH
Q 045798 967 GVACSMESPQDRMNMTNVVHELQSVKN 993 (1008)
Q Consensus 967 i~~cl~~dP~~RPt~~evl~~L~~i~~ 993 (1008)
+.+||..+|.+||++++|-..++.+..
T Consensus 200 ~~~cw~e~P~~rPs~~~i~~~~~~~~~ 226 (484)
T KOG1023|consen 200 VARCWEEIPEKRPSIEQIRSKLLTINK 226 (484)
T ss_pred HHHhcccChhhCccHHHHHhhhhhhcc
Confidence 999999999999999999988877644
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=4.4e-20 Score=168.27 Aligned_cols=165 Identities=33% Similarity=0.538 Sum_probs=143.6
Q ss_pred CccCCccCCeeeecCCCCCCCCCccccCCCCCCEEEccCCCCCCccCcccccCcCcceEeeeccccccCCCccccccCCC
Q 045798 73 HLGNLSFLREINLSNNTIQGEIPPEFGRLFRLEALFLSNNSLVGKIPANLSYCSRLTVLCIEYNKLQGRIPLEFVSLSKL 152 (1008)
Q Consensus 73 ~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L 152 (1008)
.+..+.+.+.|-||+|+++ .+|+.+..+.+|+.|++++|+|. .+|..++.++.|+.|+++-|++. ..|..|+.++.|
T Consensus 28 gLf~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~l 104 (264)
T KOG0617|consen 28 GLFNMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPAL 104 (264)
T ss_pred cccchhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchh
Confidence 4667788888999999998 77888999999999999999998 88889999999999999999998 889999999999
Q ss_pred CeeecccccCC-CCCCCCCccccccchhhcccccCCCCCCccccCCCCCcEEEecCCcccccCCccccCCCCcceecccc
Q 045798 153 KDLSLAKNKLT-GGIPPFLGNLTSLEVLSLAGNSFGRNIPDSLGQLKQLKILAIGGNNLSGPIPPSIYNLSFLVVFSVSH 231 (1008)
Q Consensus 153 ~~L~L~~n~l~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ls~ 231 (1008)
+.|||..|++. ..+|..|..+..|+.|+|++|.+ ..+|..++++++|+.|.+.+|.+- ..|..++.++.|++|++.+
T Consensus 105 evldltynnl~e~~lpgnff~m~tlralyl~dndf-e~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqg 182 (264)
T KOG0617|consen 105 EVLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDF-EILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQG 182 (264)
T ss_pred hhhhccccccccccCCcchhHHHHHHHHHhcCCCc-ccCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhccc
Confidence 99999988886 46788888899999999999998 678888999999999999999887 6788888899999999999
Q ss_pred ccccccCChhhh
Q 045798 232 NQIHGSLPPSLG 243 (1008)
Q Consensus 232 N~l~~~lp~~~~ 243 (1008)
|+++ .+|+.++
T Consensus 183 nrl~-vlppel~ 193 (264)
T KOG0617|consen 183 NRLT-VLPPELA 193 (264)
T ss_pred ceee-ecChhhh
Confidence 9888 7776654
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.76 E-value=3.1e-18 Score=202.51 Aligned_cols=201 Identities=20% Similarity=0.255 Sum_probs=156.5
Q ss_pred HHHHHhcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccchhhHHHHHHHHHHhhcC---CCCceeeeecccccc
Q 045798 678 SLLKATNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIR---HRNLVKVITSCSSID 754 (1008)
Q Consensus 678 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~ 754 (1008)
+++...+.|.|.+.||+|+||+||+|... +|+.||+|+-+.... .+|.-=.+++.||+ -+.|+.+..+
T Consensus 692 ~~~~~~~~~~I~~e~G~g~y~~vy~a~~~-~~~~~alK~e~P~~~---WEfYI~~q~~~RLk~~~~~~~~~~~~a----- 762 (974)
T KOG1166|consen 692 EFEVGGEKFCISKEIGEGSYGSVYVATHS-NGKLVALKVEKPPNP---WEFYICLQVMERLKPQMLPSIMHISSA----- 762 (974)
T ss_pred eeeecceeEEEEeeeccccceEEEEeecC-CCcEEEEEeecCCCc---eeeeehHHHHHhhchhhhcchHHHHHH-----
Confidence 44455678999999999999999999997 499999999764432 23333334555555 2334444333
Q ss_pred ccCCceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeec-
Q 045798 755 FQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLD- 833 (1008)
Q Consensus 755 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~- 833 (1008)
....+.-++|+||.+.|+|.+++...+ .+++..++.+..|++..+++||.. +||||||||+|+++.
T Consensus 763 ~~~~~~S~lv~ey~~~Gtlld~~N~~~----------~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~ 829 (974)
T KOG1166|consen 763 HVFQNASVLVSEYSPYGTLLDLINTNK----------VMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRR 829 (974)
T ss_pred HccCCcceeeeeccccccHHHhhccCC----------CCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeec
Confidence 233344679999999999999998544 689999999999999999999998 999999999999994
Q ss_pred ------CCCCeEEcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCC
Q 045798 834 ------NDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKP 902 (1008)
Q Consensus 834 ------~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~p 902 (1008)
....++|+|||.+..+.--.+. ..-...++|-.+-.+|+..|+++++++|.|.++.+++.|+.|+..
T Consensus 830 ~~~~~~~~~~l~lIDfG~siDm~lfp~~--~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~ 902 (974)
T KOG1166|consen 830 EICADSDSKGLYLIDFGRSIDMKLFPDG--TKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM 902 (974)
T ss_pred ccCCCCcccceEEEecccceeeeEcCCC--cEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence 2346799999999744332222 122345689999999999999999999999999999999999864
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.1e-17 Score=169.16 Aligned_cols=139 Identities=19% Similarity=0.281 Sum_probs=106.6
Q ss_pred CCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccchhhHHHHHHHHHHhhc-----CCCCceeeeeccccccccCCce-
Q 045798 687 SSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNI-----RHRNLVKVITSCSSIDFQGNDF- 760 (1008)
Q Consensus 687 ~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~~~~~~~~~~~~~~~~- 760 (1008)
.-.+.||+|+||.||. +..++.. +||++........+.+.+|+++++.+ .||||++++|++... .+...
T Consensus 5 ~~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~--~g~g~v 79 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETD--CGTGYV 79 (210)
T ss_pred CCcceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeC--CCCeEE
Confidence 3457899999999995 6556555 69998765455567899999999999 579999999996431 11133
Q ss_pred EEEEEec--cCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHH-HHHhhCCCCCceeccCCCCCeeecC---
Q 045798 761 KAIVYEY--MPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASAL-DYLHHHCQEPILHCDLKPSNILLDN--- 834 (1008)
Q Consensus 761 ~~lv~e~--~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L-~~LH~~~~~~ivH~Dlkp~NIll~~--- 834 (1008)
..+|+|| +.+|+|.+++... .+++. ..++.|++.++ +|||++ +|+||||||+||+++.
T Consensus 80 ~~~I~e~~G~~~~tL~~~l~~~-----------~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~ 143 (210)
T PRK10345 80 YDVIADFDGKPSITLTEFAEQC-----------RYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISE 143 (210)
T ss_pred EEEEecCCCCcchhHHHHHHcc-----------cccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCC
Confidence 3478999 5579999999653 34444 35678888777 999998 9999999999999974
Q ss_pred -CCCeEEcccCcc
Q 045798 835 -DLSGHIGDFGLA 846 (1008)
Q Consensus 835 -~~~~kL~Dfg~a 846 (1008)
++.++|+||+-+
T Consensus 144 ~~~~~~LiDg~G~ 156 (210)
T PRK10345 144 SEVIPVVCDNIGE 156 (210)
T ss_pred CCCcEEEEECCCC
Confidence 347999994433
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.1e-19 Score=199.57 Aligned_cols=288 Identities=18% Similarity=0.217 Sum_probs=148.1
Q ss_pred eeccccccccccCChhhhhcCCCCcEEEeccccCCCC----CCcccccCCCCceeecccccccccccccccCCCcccccc
Q 045798 226 VFSVSHNQIHGSLPPSLGLLLPNLKFFQIHHNFFSGS----IPISLSNASKLEHIEIANNNFSGKLSVNFGGMKNLSLLN 301 (1008)
Q Consensus 226 ~L~ls~N~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~----~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 301 (1008)
.|+|..+.+.+.--..++..+++|+.|++++|.++.. ++..+...++|++|+++++.+.+
T Consensus 2 ~l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~---------------- 65 (319)
T cd00116 2 QLSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGR---------------- 65 (319)
T ss_pred ccccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCC----------------
Confidence 3566666665333333444455566666666665321 23333444445555555544431
Q ss_pred cccccCCCCCCCcccccccccccCCCcEEEecCCcCCccCChhhhhhcc--cceeeeeccccccCCCCCccccccccceE
Q 045798 302 LQFSNLGSGESDEMGFMNSLTNCSKLRVLSLGGNQFRGALPHSIANLSS--QLQILILSSNQFYGSIPLGIGNLVDLYLL 379 (1008)
Q Consensus 302 L~~n~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~--~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 379 (1008)
...........+..+++|+.|++++|.+.+..+..+..+.. +|++|++++|.+++...
T Consensus 66 --------~~~~~~~~~~~l~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~------------ 125 (319)
T cd00116 66 --------IPRGLQSLLQGLTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGL------------ 125 (319)
T ss_pred --------cchHHHHHHHHHHhcCceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHH------------
Confidence 00111111223444556666666666665444444443331 15555555554431000
Q ss_pred EecCccccCCcchhccCC-CCCceEEccCCccccc----ccccccCCCCcceeecccccccc----ccCCCCcCCCcccE
Q 045798 380 GMVENQFTGAIPKEMGKL-QKLQGLDFSGNHFSGE----IPSSLGNLSSLYEVFFNNNNLSG----VIPFSLGNLKRLAF 450 (1008)
Q Consensus 380 ~L~~n~l~~~~~~~~~~l-~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~~----~~p~~~~~l~~L~~ 450 (1008)
..+...+..+ ++|+.|+|++|.+++. ++..+..+.+|++|++++|.+++ .++..+..+++|+.
T Consensus 126 --------~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~ 197 (319)
T cd00116 126 --------RLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEV 197 (319)
T ss_pred --------HHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCE
Confidence 0112233334 5555555555555521 22334445556666666665552 12233444567777
Q ss_pred eecccccccCCcchhhhhhhhhhhhhcccCccccCCCcccccccccccccccccccccCCCCccccc-----ccccceee
Q 045798 451 LEMSGNELSGTIPEDIFNISYLSNSLNLARNHLVGIIPPRIGNLRALRSFDVSNNDLSGEIPIELGH-----CSSLEEIY 525 (1008)
Q Consensus 451 L~Ls~N~l~~~lp~~~~~~~~~~~~L~L~~N~l~~~~p~~~~~l~~L~~Ldls~N~l~~~~p~~~~~-----l~~L~~L~ 525 (1008)
|+|++|.+++.-.. .++..+..+++|++||+++|.+++.....+.. .+.|+.|+
T Consensus 198 L~L~~n~i~~~~~~---------------------~l~~~~~~~~~L~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~ 256 (319)
T cd00116 198 LDLNNNGLTDEGAS---------------------ALAETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLS 256 (319)
T ss_pred EeccCCccChHHHH---------------------HHHHHhcccCCCCEEecCCCcCchHHHHHHHHHHhccCCCceEEE
Confidence 77777776521110 12233455667777777777776432322222 36788888
Q ss_pred ccCcccc----cchhhhhhccccccEEecCCCccccc----ccCccc-c-cccceeecccCcc
Q 045798 526 LAGNLFH----GSIPSFFNALKGVQKIDLSRNNLSGQ----IPIFLE-A-LSLEYLNLSFNDF 578 (1008)
Q Consensus 526 L~~N~l~----~~~p~~~~~l~~L~~L~ls~N~l~~~----~p~~~~-~-~~L~~L~l~~N~l 578 (1008)
+++|.++ ..+...+..+++|+.+|+++|.++.. +..... . ..|+.|++.+|.+
T Consensus 257 l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (319)
T cd00116 257 LSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEEGAQLLAESLLEPGNELESLWVKDDSF 319 (319)
T ss_pred ccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCcHHHHHHHHHHHhhcCCchhhcccCCCCC
Confidence 8888776 23455666677888888888888854 222222 2 3688888887754
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.73 E-value=8.8e-20 Score=202.65 Aligned_cols=258 Identities=22% Similarity=0.243 Sum_probs=120.0
Q ss_pred EeccccCCC-CccCcCccCCccCCeeeecCCCCCCC----CCccccCCCCCCEEEccCCCCCC------ccCcccccCcC
Q 045798 59 LDLMSKSLS-GSLSPHLGNLSFLREINLSNNTIQGE----IPPEFGRLFRLEALFLSNNSLVG------KIPANLSYCSR 127 (1008)
Q Consensus 59 l~l~~~~l~-~~l~~~l~~l~~L~~L~L~~n~~~~~----~p~~~~~l~~L~~L~Ls~n~l~~------~~p~~l~~l~~ 127 (1008)
|+|..+.++ ......+..+..|+.|+++++.++.. ++..+...++|++|+++++.+.+ .++..+..+++
T Consensus 3 l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~~ 82 (319)
T cd00116 3 LSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGCG 82 (319)
T ss_pred cccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcCc
Confidence 556666665 23444455566677777777766422 34445556666677776666552 12334455556
Q ss_pred cceEeeeccccccCCCccccccCC---CCeeecccccCCCCCCCCCccccccchhhcccccCCCCCCccccCC-CCCcEE
Q 045798 128 LTVLCIEYNKLQGRIPLEFVSLSK---LKDLSLAKNKLTGGIPPFLGNLTSLEVLSLAGNSFGRNIPDSLGQL-KQLKIL 203 (1008)
Q Consensus 128 L~~L~Ls~n~l~~~~p~~~~~l~~---L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l-~~L~~L 203 (1008)
|+.|++++|.+.+..+..+..+.+ |++|++++|++++.... .+...+..+ ++|+.|
T Consensus 83 L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~--------------------~l~~~l~~~~~~L~~L 142 (319)
T cd00116 83 LQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLR--------------------LLAKGLKDLPPALEKL 142 (319)
T ss_pred eeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHH--------------------HHHHHHHhCCCCceEE
Confidence 666666666665444444444444 55555555555421110 111222333 444444
Q ss_pred EecCCcccc----cCCccccCCCCcceeccccccccccCChhhh---hcCCCCcEEEeccccCCCC----CCcccccCCC
Q 045798 204 AIGGNNLSG----PIPPSIYNLSFLVVFSVSHNQIHGSLPPSLG---LLLPNLKFFQIHHNFFSGS----IPISLSNASK 272 (1008)
Q Consensus 204 ~L~~n~l~~----~~~~~~~~l~~L~~L~ls~N~l~~~lp~~~~---~~l~~L~~L~L~~N~l~~~----~p~~l~~l~~ 272 (1008)
++++|.+++ .++..+..+.+|+.|++++|.+++.....+. ..+++|+.|+|++|.+.+. ++..+..+++
T Consensus 143 ~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~ 222 (319)
T cd00116 143 VLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKS 222 (319)
T ss_pred EcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCC
Confidence 444444441 1122333344444445544444421111111 1123555555555554422 2233445566
Q ss_pred CceeecccccccccccccccC-----CCcccccccccccCCCCCCCcccccccccccCCCcEEEecCCcCC
Q 045798 273 LEHIEIANNNFSGKLSVNFGG-----MKNLSLLNLQFSNLGSGESDEMGFMNSLTNCSKLRVLSLGGNQFR 338 (1008)
Q Consensus 273 L~~L~L~~N~l~~~~~~~~~~-----l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~ 338 (1008)
|++|++++|.+++.....+.. .++|+.|++++|.+++... ..+...+..+++|+.+++++|.+.
T Consensus 223 L~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~n~i~~~~~--~~l~~~~~~~~~L~~l~l~~N~l~ 291 (319)
T cd00116 223 LEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDITDDGA--KDLAEVLAEKESLLELDLRGNKFG 291 (319)
T ss_pred CCEEecCCCcCchHHHHHHHHHHhccCCCceEEEccCCCCCcHHH--HHHHHHHhcCCCccEEECCCCCCc
Confidence 666666666665432222211 2445555555444432211 111223334455555555555555
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.72 E-value=1.8e-18 Score=190.45 Aligned_cols=186 Identities=26% Similarity=0.304 Sum_probs=155.6
Q ss_pred EeeccCeeEEEEEE---cCCCeEEEEEEeccccc--hhhHHHHHHHHHHhhcC-CCCceeeeeccccccccCCceEEEEE
Q 045798 692 IGVGSFGCVYKGAL---DEDGIVVAIKVINLQCE--GASKSFMAECKALKNIR-HRNLVKVITSCSSIDFQGNDFKAIVY 765 (1008)
Q Consensus 692 lg~G~~g~Vy~~~~---~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~lv~ 765 (1008)
+|+|.||.|++++. ...|+.+|+|+.+.... +.......|..++...+ ||.++++... ++.+...++++
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhya-----fqt~~kl~l~l 76 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYA-----FQTDGKLYLIL 76 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeee-----eccccchhHhh
Confidence 78999999997654 23567899998864432 12225667888888885 9999999887 67778899999
Q ss_pred eccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEcccCc
Q 045798 766 EYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGL 845 (1008)
Q Consensus 766 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~ 845 (1008)
+|..+|.+...+.... .+++.....+...++-+++++|+. +|+|||+|++||+++.+|++++.|||.
T Consensus 77 d~~rgg~lft~l~~~~----------~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfgl 143 (612)
T KOG0603|consen 77 DFLRGGDLFTRLSKEV----------MFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGL 143 (612)
T ss_pred hhcccchhhhccccCC----------chHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchh
Confidence 9999999999887665 677888888999999999999998 999999999999999999999999999
Q ss_pred ccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCc
Q 045798 846 ARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDV 905 (1008)
Q Consensus 846 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~ 905 (1008)
++..-..... +||..|||||++. ....++|.||||++++||+||..||..
T Consensus 144 ske~v~~~~~--------cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~ 193 (612)
T KOG0603|consen 144 SKEAVKEKIA--------CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG 193 (612)
T ss_pred hhHhHhhhhc--------ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence 9855433221 5899999999988 467889999999999999999999864
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.71 E-value=2.3e-18 Score=186.02 Aligned_cols=128 Identities=30% Similarity=0.489 Sum_probs=108.7
Q ss_pred CceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCC
Q 045798 758 NDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLS 837 (1008)
Q Consensus 758 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 837 (1008)
..+.||.|++|+..+|.+|+....... .-++.....++.|++.|++| . +.+|||+||.||+...+..
T Consensus 328 ~~~lyI~Mn~c~~~tledWl~rr~~~e-------~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q 394 (516)
T KOG1033|consen 328 KVYLYIQMNLCEKETLEDWLRRRRTGE-------ERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQ 394 (516)
T ss_pred ccchhhhhhhhhhhhHHHHhhCCCccc-------ccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchh
Confidence 345889999999999999997554332 56788899999999999999 3 9999999999999999999
Q ss_pred eEEcccCcccccccccC--ccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHh
Q 045798 838 GHIGDFGLARFHQEVSN--STLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT 898 (1008)
Q Consensus 838 ~kL~Dfg~a~~~~~~~~--~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt 898 (1008)
+||.|||+......... ......+..+||..||+||.+.+..|+.|+||||||++++|++.
T Consensus 395 ~kIgDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 395 LKIGDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred hhhhhhhheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence 99999999986554431 12223445679999999999999999999999999999999997
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.71 E-value=5.5e-17 Score=168.86 Aligned_cols=143 Identities=18% Similarity=0.113 Sum_probs=111.9
Q ss_pred cCCCCCceEeeccCeeEEEEE-EcCCCeEEEEEEeccccch------------------------hhHHHHHHHHHHhhc
Q 045798 684 NGFSSTHLIGVGSFGCVYKGA-LDEDGIVVAIKVINLQCEG------------------------ASKSFMAECKALKNI 738 (1008)
Q Consensus 684 ~~y~~~~~lg~G~~g~Vy~~~-~~~~~~~vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l 738 (1008)
..|.+.+.||+|+||.||+|. +..+|+.||+|+++..... ....+.+|++.+.++
T Consensus 28 ~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L 107 (237)
T smart00090 28 ILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRL 107 (237)
T ss_pred chHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 358889999999999999998 5568999999998743210 112367899999999
Q ss_pred CCC--CceeeeeccccccccCCceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCC
Q 045798 739 RHR--NLVKVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHC 816 (1008)
Q Consensus 739 ~h~--niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ 816 (1008)
.+. .+.++++. ...++||||++++++..+..... .....++..++.||+.++++||+.
T Consensus 108 ~~~~i~~p~~~~~---------~~~~lV~E~~~g~~L~~~~~~~~----------~~~~~~~~~i~~qi~~~l~~LH~~- 167 (237)
T smart00090 108 YEAGVPVPKPIAW---------RRNVLVMEFIGGDGLPAPRLKDV----------EPEEEEEFELYDDILEEMRKLYKE- 167 (237)
T ss_pred HhcCCCCCeeeEe---------cCceEEEEEecCCcccccccccC----------CcchHHHHHHHHHHHHHHHHHHhc-
Confidence 653 34444432 12489999999988877653222 345566789999999999999998
Q ss_pred CCC-ceeccCCCCCeeecCCCCeEEcccCccccc
Q 045798 817 QEP-ILHCDLKPSNILLDNDLSGHIGDFGLARFH 849 (1008)
Q Consensus 817 ~~~-ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~ 849 (1008)
+ |+||||||+||+++ ++.++|+|||.|...
T Consensus 168 --g~iiH~Dikp~NIli~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 168 --GELVHGDLSEYNILVH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred --CCEEeCCCChhhEEEE-CCCEEEEEChhhhcc
Confidence 8 99999999999999 889999999998744
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.8e-17 Score=189.67 Aligned_cols=169 Identities=27% Similarity=0.345 Sum_probs=125.4
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccchhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceEE
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKA 762 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 762 (1008)
..+|..++.|..|+||.||.++++.+.+.+|+|+=+.. .|++ ||..+.+. .+
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~kiNkq~------------lilR-----nilt~a~n-----------pf 133 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQN------------LILR-----NILTFAGN-----------PF 133 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhcccccc------------hhhh-----ccccccCC-----------cc
Confidence 46789999999999999999999988999999543211 1111 23333322 22
Q ss_pred EEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEcc
Q 045798 763 IVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGD 842 (1008)
Q Consensus 763 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 842 (1008)
.| |+-...++..+ +++.. ++.+++|+|+. +|||||+||+|.+|+.-|++|++|
T Consensus 134 vv------gDc~tllk~~g----------~lPvd--------mvla~Eylh~y---givhrdlkpdnllIT~mGhiKlTD 186 (1205)
T KOG0606|consen 134 VV------GDCATLLKNIG----------PLPVD--------MVLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTD 186 (1205)
T ss_pred ee------chhhhhcccCC----------CCcch--------hhHHhHhhccC---CeecCCCCCCcceeeecccccccc
Confidence 33 44455554433 23332 27899999997 999999999999999999999999
Q ss_pred cCcccccccccC-----------ccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCcc
Q 045798 843 FGLARFHQEVSN-----------STLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVM 906 (1008)
Q Consensus 843 fg~a~~~~~~~~-----------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~ 906 (1008)
||++++...... ........++||+.|+|||++....|+..+|.|++|+++||.+.|+.||...
T Consensus 187 fgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGd 261 (1205)
T KOG0606|consen 187 FGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGD 261 (1205)
T ss_pred hhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCC
Confidence 999974322111 1111223457999999999999999999999999999999999999998643
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.4e-15 Score=155.32 Aligned_cols=143 Identities=27% Similarity=0.204 Sum_probs=110.6
Q ss_pred HHHHhcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccch----------------------hhHHHHHHHHHHh
Q 045798 679 LLKATNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEG----------------------ASKSFMAECKALK 736 (1008)
Q Consensus 679 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~E~~~l~ 736 (1008)
+.....-|.+.+.||+|+||.||+|... +|+.||||+++..... ....+..|..++.
T Consensus 10 ~~~~~~~~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 88 (198)
T cd05144 10 LVKRGVVESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALK 88 (198)
T ss_pred HHHcCchhhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHH
Confidence 3333444888899999999999999885 7999999987643210 1123678899999
Q ss_pred hcCCCC--ceeeeeccccccccCCceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhh
Q 045798 737 NIRHRN--LVKVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHH 814 (1008)
Q Consensus 737 ~l~h~n--iv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~ 814 (1008)
.+.|++ +...++. ...++||||+++++|...... .....++.+++.++.++|+
T Consensus 89 ~l~~~~i~v~~~~~~---------~~~~lv~e~~~g~~L~~~~~~----------------~~~~~~~~~i~~~l~~lh~ 143 (198)
T cd05144 89 ALYEEGFPVPKPIDW---------NRHAVVMEYIDGVELYRVRVL----------------EDPEEVLDEILEEIVKAYK 143 (198)
T ss_pred HHHHcCCCCCceeec---------CCceEEEEEeCCcchhhcccc----------------ccHHHHHHHHHHHHHHHHH
Confidence 987774 4444432 235899999999998765421 2345788999999999999
Q ss_pred CCCCCceeccCCCCCeeecCCCCeEEcccCcccccc
Q 045798 815 HCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQ 850 (1008)
Q Consensus 815 ~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~ 850 (1008)
. +|+||||+|+||++++++.++|+|||.+....
T Consensus 144 ~---gi~H~Dl~p~Nill~~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 144 H---GIIHGDLSEFNILVDDDEKIYIIDWPQMVSTD 176 (198)
T ss_pred C---CCCcCCCCcccEEEcCCCcEEEEECCccccCC
Confidence 7 99999999999999999999999999996443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.63 E-value=1.5e-15 Score=179.16 Aligned_cols=145 Identities=24% Similarity=0.258 Sum_probs=112.0
Q ss_pred CHHHHHHHhcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEec--cccc------hhhHHHHHHHHHHhhcCCCCceee
Q 045798 675 SYKSLLKATNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVIN--LQCE------GASKSFMAECKALKNIRHRNLVKV 746 (1008)
Q Consensus 675 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~--~~~~------~~~~~~~~E~~~l~~l~h~niv~~ 746 (1008)
++.........|...+.||+|+||+||+|.+. +..+++|+.. .... ...+++.+|+++++.++|++++..
T Consensus 324 ~~~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~--~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p 401 (535)
T PRK09605 324 TWIKEEEVKRRKIPDHLIGKGAEADIKKGEYL--GRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTP 401 (535)
T ss_pred eeccccccccccCccceeccCCcEEEEEEeec--CccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCee
Confidence 34444444556678899999999999999884 3344444321 1111 123568899999999999998876
Q ss_pred eeccccccccCCceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCC
Q 045798 747 ITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLK 826 (1008)
Q Consensus 747 ~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlk 826 (1008)
..++. .+...++||||+++++|.+++. ....++.|++.++.|||+. +++|||+|
T Consensus 402 ~~~~~-----~~~~~~lv~E~~~g~~L~~~l~------------------~~~~~~~~i~~~L~~lH~~---giiHrDlk 455 (535)
T PRK09605 402 VIYDV-----DPEEKTIVMEYIGGKDLKDVLE------------------GNPELVRKVGEIVAKLHKA---GIVHGDLT 455 (535)
T ss_pred EEEEE-----eCCCCEEEEEecCCCcHHHHHH------------------HHHHHHHHHHHHHHHHHhC---CCccCCCC
Confidence 65532 2345689999999999998763 3467899999999999998 99999999
Q ss_pred CCCeeecCCCCeEEcccCcccc
Q 045798 827 PSNILLDNDLSGHIGDFGLARF 848 (1008)
Q Consensus 827 p~NIll~~~~~~kL~Dfg~a~~ 848 (1008)
|+||++ .++.++|+|||+++.
T Consensus 456 p~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 456 TSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred hHHEEE-ECCcEEEEeCccccc
Confidence 999999 577999999999974
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.63 E-value=1e-15 Score=158.63 Aligned_cols=134 Identities=23% Similarity=0.308 Sum_probs=109.5
Q ss_pred ceEeeccCeeEEEEEEcCCCeEEEEEEeccccch--------hhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceE
Q 045798 690 HLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEG--------ASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFK 761 (1008)
Q Consensus 690 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 761 (1008)
+.||+|++|.||+|.+ .|..|++|+....... ....+.+|++++..+.|+++.....++ ...+..
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~-----~~~~~~ 74 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYF-----VDPENF 74 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEE-----EeCCCC
Confidence 6799999999999988 6778999986533211 124678899999999998887665553 233457
Q ss_pred EEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEc
Q 045798 762 AIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIG 841 (1008)
Q Consensus 762 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 841 (1008)
++||||++|++|.+++... .. .+..++.+++.++.++|+. +++|||++|.||+++ ++.++++
T Consensus 75 ~lv~e~~~G~~L~~~~~~~-------------~~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~li 136 (211)
T PRK14879 75 IIVMEYIEGEPLKDLINSN-------------GM-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLI 136 (211)
T ss_pred EEEEEEeCCcCHHHHHHhc-------------cH-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEE
Confidence 8999999999999988532 12 7889999999999999997 999999999999999 7899999
Q ss_pred ccCcccc
Q 045798 842 DFGLARF 848 (1008)
Q Consensus 842 Dfg~a~~ 848 (1008)
|||.+..
T Consensus 137 Df~~a~~ 143 (211)
T PRK14879 137 DFGLAEF 143 (211)
T ss_pred ECCcccC
Confidence 9998863
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.62 E-value=1.4e-15 Score=180.82 Aligned_cols=152 Identities=31% Similarity=0.490 Sum_probs=121.4
Q ss_pred ccCChhhHHHHHHHHHhhccCCCCCCCCCCCCCCCC----cccceEEcCC--C--CeEEEEeccccCCCCccCcCccCCc
Q 045798 7 AALEDGDRAALQAFKSMIAHEPQGILNSWNDSRHFC----EWEGITCGRR--H--RRVTALDLMSKSLSGSLSPHLGNLS 78 (1008)
Q Consensus 7 ~~~~~~~~~~l~~~k~~~~~~~~~~~~~w~~~~~~c----~w~gv~c~~~--~--~~v~~l~l~~~~l~~~l~~~l~~l~ 78 (1008)
++..++|.+||++||+++. +|.. .+|.++ +|| .|.||.|... . ..|+.|+|+++.+.|.+|+.++.++
T Consensus 367 ~~t~~~~~~aL~~~k~~~~-~~~~--~~W~g~-~C~p~~~~w~Gv~C~~~~~~~~~~v~~L~L~~n~L~g~ip~~i~~L~ 442 (623)
T PLN03150 367 SKTLLEEVSALQTLKSSLG-LPLR--FGWNGD-PCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKLR 442 (623)
T ss_pred cccCchHHHHHHHHHHhcC-Cccc--CCCCCC-CCCCcccccccceeeccCCCCceEEEEEECCCCCccccCCHHHhCCC
Confidence 3567889999999999985 4432 489754 443 7999999532 1 3588899998888888888888888
Q ss_pred cCCeeeecCCCCCCCCCccccCCCCCCEEEccCCCCCCccCcccccCcCcceEeeeccccccCCCcccccc-CCCCeeec
Q 045798 79 FLREINLSNNTIQGEIPPEFGRLFRLEALFLSNNSLVGKIPANLSYCSRLTVLCIEYNKLQGRIPLEFVSL-SKLKDLSL 157 (1008)
Q Consensus 79 ~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l-~~L~~L~L 157 (1008)
+|+.|+|++|.++|.+|..++.+++|+.|+|++|++++.+|..++++++|++|+|++|+++|.+|..+..+ .++..+++
T Consensus 443 ~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~l~~~~~~~~~l~~ 522 (623)
T PLN03150 443 HLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNF 522 (623)
T ss_pred CCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccccCChHHhhccccCceEEe
Confidence 88889988888888888888888888888888888888888888888888888888888888888877653 45566777
Q ss_pred ccccC
Q 045798 158 AKNKL 162 (1008)
Q Consensus 158 ~~n~l 162 (1008)
.+|..
T Consensus 523 ~~N~~ 527 (623)
T PLN03150 523 TDNAG 527 (623)
T ss_pred cCCcc
Confidence 76653
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.61 E-value=1.1e-15 Score=156.67 Aligned_cols=130 Identities=25% Similarity=0.331 Sum_probs=102.5
Q ss_pred eEeeccCeeEEEEEEcCCCeEEEEEEecccc---c-----hhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceEE
Q 045798 691 LIGVGSFGCVYKGALDEDGIVVAIKVINLQC---E-----GASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKA 762 (1008)
Q Consensus 691 ~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~-----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 762 (1008)
.||+|+||.||+|.+ ++..|++|+..... + ....++.+|++++..+.|+++.....++ ...+..+
T Consensus 1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~-----~~~~~~~ 73 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYD-----VDPDNKT 73 (199)
T ss_pred CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEE-----EECCCCE
Confidence 389999999999996 67889999865321 1 1135678899999999887654333332 1233468
Q ss_pred EEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEcc
Q 045798 763 IVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGD 842 (1008)
Q Consensus 763 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 842 (1008)
+||||++|++|.+++.... . .++.|++.+|+++|+. +++|||++|+||+++ ++.++++|
T Consensus 74 lv~e~~~g~~l~~~~~~~~----------~-------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liD 132 (199)
T TIGR03724 74 IVMEYIEGKPLKDVIEEGN----------D-------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLID 132 (199)
T ss_pred EEEEEECCccHHHHHhhcH----------H-------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEE
Confidence 9999999999998875321 1 7899999999999997 999999999999999 78999999
Q ss_pred cCcccc
Q 045798 843 FGLARF 848 (1008)
Q Consensus 843 fg~a~~ 848 (1008)
||.+..
T Consensus 133 fg~a~~ 138 (199)
T TIGR03724 133 FGLGKY 138 (199)
T ss_pred CCCCcC
Confidence 999874
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.54 E-value=3.1e-14 Score=139.14 Aligned_cols=136 Identities=22% Similarity=0.235 Sum_probs=111.8
Q ss_pred CCceEeeccCeeEEEEEEcCCCeEEEEEEeccccchhhHHHHHHHHHHhhcCC--CCceeeeeccccccccCCceEEEEE
Q 045798 688 STHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRH--RNLVKVITSCSSIDFQGNDFKAIVY 765 (1008)
Q Consensus 688 ~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~~~~~~~lv~ 765 (1008)
+++.||+|.++.||++... +..+++|+...... ...+.+|+.+++.++| ..+++++++. ...+..+++|
T Consensus 2 ~~~~i~~g~~~~v~~~~~~--~~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~-----~~~~~~~~v~ 72 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTK--DEDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASG-----ESDGWSYLLM 72 (155)
T ss_pred cceecccccccceEEEEec--CCeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEc-----CCCCccEEEE
Confidence 4678999999999999984 47899999865433 5678999999999976 5888888773 3446789999
Q ss_pred eccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEcccCc
Q 045798 766 EYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGL 845 (1008)
Q Consensus 766 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~ 845 (1008)
||++++.+..+ +......++.+++.+++++|....++++|||++|+||++++.+.++++|||.
T Consensus 73 e~~~g~~~~~~-----------------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~ 135 (155)
T cd05120 73 EWIEGETLDEV-----------------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEY 135 (155)
T ss_pred EecCCeecccC-----------------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEeccc
Confidence 99988777654 3345677899999999999986445799999999999999989999999999
Q ss_pred cccc
Q 045798 846 ARFH 849 (1008)
Q Consensus 846 a~~~ 849 (1008)
+...
T Consensus 136 ~~~~ 139 (155)
T cd05120 136 AGYG 139 (155)
T ss_pred ccCC
Confidence 8743
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.54 E-value=3e-14 Score=144.53 Aligned_cols=137 Identities=23% Similarity=0.182 Sum_probs=97.6
Q ss_pred CceEeeccCeeEEEEEEcCCCeEEEEEEeccccch--hhHH----------------------HHHHHHHHhhcCCC--C
Q 045798 689 THLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEG--ASKS----------------------FMAECKALKNIRHR--N 742 (1008)
Q Consensus 689 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~----------------------~~~E~~~l~~l~h~--n 742 (1008)
.+.||+|+||+||+|.+. +++.||||+++..... .... ...|.+.+.++.+. .
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 467999999999999986 8999999998743211 1111 13555666665433 2
Q ss_pred ceeeeeccccccccCCceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhh-CCCCCce
Q 045798 743 LVKVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHH-HCQEPIL 821 (1008)
Q Consensus 743 iv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~iv 821 (1008)
+.+.+++ ...++||||++++.+....-... ... .++..++.+++.++.++|. . +|+
T Consensus 81 ~~~~~~~---------~~~~lv~e~~~g~~~~~~~l~~~----------~~~-~~~~~~~~~~~~~l~~lh~~~---~iv 137 (187)
T cd05119 81 VPKPIDL---------NRHVLVMEFIGGDGIPAPRLKDV----------RLL-EDPEELYDQILELMRKLYREA---GLV 137 (187)
T ss_pred CCceEec---------CCCEEEEEEeCCCCccChhhhhh----------hhc-ccHHHHHHHHHHHHHHHhhcc---CcC
Confidence 3444433 12589999998865432111000 011 5678899999999999999 6 999
Q ss_pred eccCCCCCeeecCCCCeEEcccCcccccc
Q 045798 822 HCDLKPSNILLDNDLSGHIGDFGLARFHQ 850 (1008)
Q Consensus 822 H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~ 850 (1008)
||||||+||+++ ++.++++|||.+....
T Consensus 138 H~Dl~p~Nili~-~~~~~liDfg~a~~~~ 165 (187)
T cd05119 138 HGDLSEYNILVD-DGKVYIIDVPQAVEID 165 (187)
T ss_pred cCCCChhhEEEE-CCcEEEEECccccccc
Confidence 999999999999 8899999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.53 E-value=6.6e-16 Score=166.69 Aligned_cols=192 Identities=29% Similarity=0.425 Sum_probs=125.7
Q ss_pred ceeeeeccccccCCCCCccccccccceEEecCccccCCcchhccCCCCCceEEccCCcccccccccccCCCCcceeeccc
Q 045798 352 LQILILSSNQFYGSIPLGIGNLVDLYLLGMVENQFTGAIPKEMGKLQKLQGLDFSGNHFSGEIPSSLGNLSSLYEVFFNN 431 (1008)
Q Consensus 352 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~ 431 (1008)
-...||+.|++. ++|..++.+..|..+.|..|.|. .+|..++.+..|++|||+.|+++ ..|..++.|+ |+.|.+++
T Consensus 77 t~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvli~sN 152 (722)
T KOG0532|consen 77 TVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKVLIVSN 152 (722)
T ss_pred hhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-ceeEEEec
Confidence 345566666666 56666666666666666666666 66666777777777777777776 6666666654 67777777
Q ss_pred cccccccCCCCcCCCcccEeecccccccCCcchhhhhhhhhhhhhcccCccccCCCcccccccccccccccccccccCCC
Q 045798 432 NNLSGVIPFSLGNLKRLAFLEMSGNELSGTIPEDIFNISYLSNSLNLARNHLVGIIPPRIGNLRALRSFDVSNNDLSGEI 511 (1008)
Q Consensus 432 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~lp~~~~~~~~~~~~L~L~~N~l~~~~p~~~~~l~~L~~Ldls~N~l~~~~ 511 (1008)
|+++ .+|..++.+..|..||.|.|.+. ++|..+.....+ +.|++.+|++. .+|+.++.| .|..||+|.|+++ .+
T Consensus 153 Nkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~sl-r~l~vrRn~l~-~lp~El~~L-pLi~lDfScNkis-~i 226 (722)
T KOG0532|consen 153 NKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSL-RDLNVRRNHLE-DLPEELCSL-PLIRLDFSCNKIS-YL 226 (722)
T ss_pred Cccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHH-HHHHHhhhhhh-hCCHHHhCC-ceeeeecccCcee-ec
Confidence 7776 66777777777777777777776 566666555544 35666666665 455555533 4667777777776 67
Q ss_pred CcccccccccceeeccCcccccchhhhhhcccc---ccEEecCCCc
Q 045798 512 PIELGHCSSLEEIYLAGNLFHGSIPSFFNALKG---VQKIDLSRNN 554 (1008)
Q Consensus 512 p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~---L~~L~ls~N~ 554 (1008)
|..|.+|+.|++|-|.+|.|. ++|..++.... -++|+..-++
T Consensus 227 Pv~fr~m~~Lq~l~LenNPLq-SPPAqIC~kGkVHIFKyL~~qA~q 271 (722)
T KOG0532|consen 227 PVDFRKMRHLQVLQLENNPLQ-SPPAQICEKGKVHIFKYLSTQACQ 271 (722)
T ss_pred chhhhhhhhheeeeeccCCCC-CChHHHHhccceeeeeeecchhcc
Confidence 777777777777777777777 56665544332 3445554443
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.53 E-value=1.9e-15 Score=176.68 Aligned_cols=258 Identities=24% Similarity=0.255 Sum_probs=189.1
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcC-CCeEEEEEEecccc--chhhHHHHHHHHHHhhcC-CCCceeeeeccccccccCC
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDE-DGIVVAIKVINLQC--EGASKSFMAECKALKNIR-HRNLVKVITSCSSIDFQGN 758 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~ 758 (1008)
...|.+.+.||+|+|+.|-.+.... ....+|+|.+.... ....+....|..+-..+. |+|++.+++. ....
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~-----~~~~ 93 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEP-----SSSP 93 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCc-----cCCC
Confidence 3467888889999999998887743 33456777665432 334455666888888886 9999999998 5666
Q ss_pred ceEEEEEeccCCCChhccc-ccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHh-hCCCCCceeccCCCCCeeecCCC
Q 045798 759 DFKAIVYEYMPNGSLEKWL-HPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLH-HHCQEPILHCDLKPSNILLDNDL 836 (1008)
Q Consensus 759 ~~~~lv~e~~~~gsL~~~l-~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH-~~~~~~ivH~Dlkp~NIll~~~~ 836 (1008)
+..+++++|..++++.+.+ +.... ..+...+-.++.|+..++.|+| .. ++.|||+||+|.+++..+
T Consensus 94 ~~~~~~~~~s~g~~~f~~i~~~~~~---------~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~ 161 (601)
T KOG0590|consen 94 RSYLLSLSYSDGGSLFSKISHPDST---------GTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESG 161 (601)
T ss_pred cccccccCcccccccccccccCCcc---------CCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCC
Confidence 7799999999999999988 43321 3455567789999999999999 76 999999999999999999
Q ss_pred -CeEEcccCcccccccccCccccccccccc-cccccCccccCCC-CCCcccchhhHHHHHHHHHhCCCCCCccccCCccH
Q 045798 837 -SGHIGDFGLARFHQEVSNSTLSSSVGVKG-TIGYTAPEYGLGS-EVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNL 913 (1008)
Q Consensus 837 -~~kL~Dfg~a~~~~~~~~~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~ 913 (1008)
..+++|||+|..+....+... ......| ++.|+|||...+. ...+..|+||.|+++.-+++|..|++.....+..+
T Consensus 162 ~~l~~~df~~At~~~~~~g~~~-~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~ 240 (601)
T KOG0590|consen 162 SALKIADFGLATAYRNKNGAER-SLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRY 240 (601)
T ss_pred CcccCCCchhhccccccCCcce-eeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccc
Confidence 999999999997766222221 1223457 9999999998874 45678999999999999999999998665544333
Q ss_pred HHHHHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 914 HNFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 914 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
..|......... ...........++..+++..+|..|.+.+++..
T Consensus 241 ~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 241 SSWKSNKGRFTQ----------------------------LPWNSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred eeeccccccccc----------------------------CccccCChhhhhcccccccCCchhccccccccc
Confidence 333322100000 001112233467788888899999999887754
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.50 E-value=1.4e-13 Score=143.77 Aligned_cols=139 Identities=18% Similarity=0.157 Sum_probs=104.9
Q ss_pred ceEe-eccCeeEEEEEEcCCCeEEEEEEecccc-------------chhhHHHHHHHHHHhhcCCCCc--eeeeeccccc
Q 045798 690 HLIG-VGSFGCVYKGALDEDGIVVAIKVINLQC-------------EGASKSFMAECKALKNIRHRNL--VKVITSCSSI 753 (1008)
Q Consensus 690 ~~lg-~G~~g~Vy~~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~E~~~l~~l~h~ni--v~~~~~~~~~ 753 (1008)
..|| .||.|+||.+.. .+..+|||.+.... ......+.+|++++.++.|++| ++.++++...
T Consensus 37 ~~lg~~~g~gtv~~v~~--~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQT--PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred ceeecCCCCccEEEEEe--CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 5687 899999999988 47789999885311 1223568899999999988775 5666653221
Q ss_pred cccCCceEEEEEeccCC-CChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeee
Q 045798 754 DFQGNDFKAIVYEYMPN-GSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILL 832 (1008)
Q Consensus 754 ~~~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll 832 (1008)
.......++|||++++ .+|.+++... .++.. .+.||+.++.+||+. ||+||||||+|||+
T Consensus 115 -~~~~~~~~lV~e~l~G~~~L~~~l~~~-----------~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv 175 (239)
T PRK01723 115 -HGLFYRADILIERIEGARDLVALLQEA-----------PLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILL 175 (239)
T ss_pred -cCcceeeeEEEEecCCCCCHHHHHhcC-----------CCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEE
Confidence 1111234699999997 6898887542 23333 367899999999998 99999999999999
Q ss_pred cCCCCeEEcccCccccc
Q 045798 833 DNDLSGHIGDFGLARFH 849 (1008)
Q Consensus 833 ~~~~~~kL~Dfg~a~~~ 849 (1008)
+.++.++|+|||.+...
T Consensus 176 ~~~~~v~LIDfg~~~~~ 192 (239)
T PRK01723 176 DPDGKFWLIDFDRGELR 192 (239)
T ss_pred cCCCCEEEEECCCcccC
Confidence 99889999999998743
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.49 E-value=5.6e-14 Score=167.25 Aligned_cols=112 Identities=29% Similarity=0.467 Sum_probs=86.5
Q ss_pred cccccccccccccCCCCcccccccccceeeccCcccccchhhhhhccccccEEecCCCcccccccCc-ccccccceeecc
Q 045798 496 ALRSFDVSNNDLSGEIPIELGHCSSLEEIYLAGNLFHGSIPSFFNALKGVQKIDLSRNNLSGQIPIF-LEALSLEYLNLS 574 (1008)
Q Consensus 496 ~L~~Ldls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~-~~~~~L~~L~l~ 574 (1008)
.++.|+|++|.++|.+|..++.+++|+.|+|++|.|+|.+|..++.+++|+.|||++|+++|.+|.. ..+.+|+.|+|+
T Consensus 419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls 498 (623)
T PLN03150 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN 498 (623)
T ss_pred EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence 3677788888888888888888888888888888888888888888888888888888888888776 567778888888
Q ss_pred cCcccccCCCCc--ccCCcccceeccCCccCCCCC
Q 045798 575 FNDFEGKIPAKG--IFANASAISVVGCNRLCGGIP 607 (1008)
Q Consensus 575 ~N~l~g~~p~~~--~~~~~~~~~~~~n~~l~g~~~ 607 (1008)
+|.|+|.+|..- .+.+...+.+.+|+.+||.+.
T Consensus 499 ~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p~ 533 (623)
T PLN03150 499 GNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPG 533 (623)
T ss_pred CCcccccCChHHhhccccCceEEecCCccccCCCC
Confidence 888888888641 223445667889999999643
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.46 E-value=3.4e-15 Score=161.29 Aligned_cols=176 Identities=28% Similarity=0.455 Sum_probs=120.8
Q ss_pred cccccceEEecCccccCCcchhccCCCCCceEEccCCcccccccccccCCCCcceeeccccccccccCCCCcCCCcccEe
Q 045798 372 NLVDLYLLGMVENQFTGAIPKEMGKLQKLQGLDFSGNHFSGEIPSSLGNLSSLYEVFFNNNNLSGVIPFSLGNLKRLAFL 451 (1008)
Q Consensus 372 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L 451 (1008)
.+..-...||+.|++. .+|..++.+..|+.+.|+.|.|. .+|..++++..|..|+|+.|+++ ..|..++.|+ |+.|
T Consensus 73 ~ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvl 148 (722)
T KOG0532|consen 73 DLTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKVL 148 (722)
T ss_pred cccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-ceeE
Confidence 3444456777778877 77777777777888888888877 77777778888888888888877 5676677665 7777
Q ss_pred ecccccccCCcchhhhhhhhhhhhhcccCccccCCCcccccccccccccccccccccCCCCcccccccccceeeccCccc
Q 045798 452 EMSGNELSGTIPEDIFNISYLSNSLNLARNHLVGIIPPRIGNLRALRSFDVSNNDLSGEIPIELGHCSSLEEIYLAGNLF 531 (1008)
Q Consensus 452 ~Ls~N~l~~~lp~~~~~~~~~~~~L~L~~N~l~~~~p~~~~~l~~L~~Ldls~N~l~~~~p~~~~~l~~L~~L~L~~N~l 531 (1008)
-+++|+++ .+|+.+. ....+..|+.+.|.+. .+|..++.+.+|+.|.++.|++. .+|.++. .-.|..||+|.|++
T Consensus 149 i~sNNkl~-~lp~~ig-~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~El~-~LpLi~lDfScNki 223 (722)
T KOG0532|consen 149 IVSNNKLT-SLPEEIG-LLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELC-SLPLIRLDFSCNKI 223 (722)
T ss_pred EEecCccc-cCCcccc-cchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHh-CCceeeeecccCce
Confidence 77888876 6666666 3333345666666666 45566666666666666666666 5666666 33466666666666
Q ss_pred ccchhhhhhccccccEEecCCCcccc
Q 045798 532 HGSIPSFFNALKGVQKIDLSRNNLSG 557 (1008)
Q Consensus 532 ~~~~p~~~~~l~~L~~L~ls~N~l~~ 557 (1008)
+ .||-.|.+|+.|+.|-|.+|.|..
T Consensus 224 s-~iPv~fr~m~~Lq~l~LenNPLqS 248 (722)
T KOG0532|consen 224 S-YLPVDFRKMRHLQVLQLENNPLQS 248 (722)
T ss_pred e-ecchhhhhhhhheeeeeccCCCCC
Confidence 6 566666666666666666666663
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.40 E-value=3.4e-13 Score=136.50 Aligned_cols=161 Identities=25% Similarity=0.374 Sum_probs=122.8
Q ss_pred HhhcCCCCceeeeeccccccccCCceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhh
Q 045798 735 LKNIRHRNLVKVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHH 814 (1008)
Q Consensus 735 l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~ 814 (1008)
+-.+-|.|+|++..++.+..+.+.....+++|||.-|++.+++++.+.. ...+......+|+.||..||.|||+
T Consensus 121 llqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~------~~a~~~~~wkkw~tqIlsal~yLhs 194 (458)
T KOG1266|consen 121 LLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKN------QKALFQKAWKKWCTQILSALSYLHS 194 (458)
T ss_pred HHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHh------hhhhhHHHHHHHHHHHHhhhhhhhc
Confidence 3445799999999998777666777889999999999999999875432 2267788889999999999999999
Q ss_pred CCCCCceeccCCCCCeeecCCCCeEEcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHH
Q 045798 815 HCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLL 894 (1008)
Q Consensus 815 ~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ 894 (1008)
. .+.|+|+++..+-|++..+|-+|++--.-...................+-++|.|||.-.....+.++|||+||+...
T Consensus 195 ~-~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAl 273 (458)
T KOG1266|consen 195 C-DPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCAL 273 (458)
T ss_pred c-CCccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHH
Confidence 5 679999999999999999988887432111111111111111122234678999999877777788999999999999
Q ss_pred HHHhCCCC
Q 045798 895 EMVTAKKP 902 (1008)
Q Consensus 895 elltG~~p 902 (1008)
||..|..-
T Consensus 274 emailEiq 281 (458)
T KOG1266|consen 274 EMAILEIQ 281 (458)
T ss_pred HHHHheec
Confidence 99987754
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.39 E-value=2.8e-13 Score=150.33 Aligned_cols=201 Identities=28% Similarity=0.299 Sum_probs=160.4
Q ss_pred CCCCCceEee--ccCeeEEEEEE--cCCCeEEEEEEec--cccchhhHHHHHHHHHHhhc-CCCCceeeeeccccccccC
Q 045798 685 GFSSTHLIGV--GSFGCVYKGAL--DEDGIVVAIKVIN--LQCEGASKSFMAECKALKNI-RHRNLVKVITSCSSIDFQG 757 (1008)
Q Consensus 685 ~y~~~~~lg~--G~~g~Vy~~~~--~~~~~~vavK~~~--~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~ 757 (1008)
.|.+.+.+|. |.+|.||.+.. ..++..+|+|.-+ ...+....+-.+|+....++ .|++.++.... +++
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~-----~e~ 189 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPA-----WEG 189 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcc-----ccc
Confidence 5677889999 99999999998 8889999999854 33334445556777777777 69999996665 678
Q ss_pred CceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHH----HHHHHhhCCCCCceeccCCCCCeeec
Q 045798 758 NDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVAS----ALDYLHHHCQEPILHCDLKPSNILLD 833 (1008)
Q Consensus 758 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~----~L~~LH~~~~~~ivH~Dlkp~NIll~ 833 (1008)
.+..++-+|++ +.++.++.+.... .++...++.++.+..+ |+.++|+. +++|-|+||.||+..
T Consensus 190 ~~~lfiqtE~~-~~sl~~~~~~~~~---------~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~ 256 (524)
T KOG0601|consen 190 SGILFIQTELC-GESLQSYCHTPCN---------FLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTT 256 (524)
T ss_pred CCcceeeeccc-cchhHHhhhcccc---------cCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecc
Confidence 88899999999 6788888765432 4677778888888888 99999998 999999999999999
Q ss_pred CC-CCeEEcccCcccccccccCcccc-ccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCC
Q 045798 834 ND-LSGHIGDFGLARFHQEVSNSTLS-SSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTD 904 (1008)
Q Consensus 834 ~~-~~~kL~Dfg~a~~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~ 904 (1008)
.+ ...+++|||+...+.+....... ......|...|++||...+ -++.++|||++|.++.+..+|..+..
T Consensus 257 ~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~ 328 (524)
T KOG0601|consen 257 SDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPS 328 (524)
T ss_pred cccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhccccc
Confidence 99 88999999999877665532222 1222257889999998654 67889999999999999999887653
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.36 E-value=3.3e-12 Score=145.19 Aligned_cols=143 Identities=22% Similarity=0.231 Sum_probs=100.6
Q ss_pred CceEeeccCeeEEEEEEcCCCeEEEEEEeccccchhh----------------------------------------HHH
Q 045798 689 THLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGAS----------------------------------------KSF 728 (1008)
Q Consensus 689 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~----------------------------------------~~~ 728 (1008)
.+.||.|++|.||+|+.. +|+.||||+.+....... -+|
T Consensus 122 ~~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf 200 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDL 200 (437)
T ss_pred CcceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCH
Confidence 368999999999999986 899999999864321100 135
Q ss_pred HHHHHHHhhc----CCCCceeeeeccccccccCCceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHH
Q 045798 729 MAECKALKNI----RHRNLVKVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAID 804 (1008)
Q Consensus 729 ~~E~~~l~~l----~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~q 804 (1008)
.+|++.+.++ +|.+-+.+-.++. ......++||||++|++|.++...... .. ....++.+
T Consensus 201 ~~Ea~n~~~~~~~~~~~~~v~vP~v~~----~~~~~~vLvmE~i~G~~L~~~~~~~~~---------~~---~~~~ia~~ 264 (437)
T TIGR01982 201 RREAANASELGENFKNDPGVYVPEVYW----DRTSERVLTMEWIDGIPLSDIAALDEA---------GL---DRKALAEN 264 (437)
T ss_pred HHHHHHHHHHHHhcCCCCCEEeCCEeh----hhcCCceEEEEeECCcccccHHHHHhc---------CC---CHHHHHHH
Confidence 5566666665 2333333333321 223347999999999999987643211 11 23456666
Q ss_pred HHH-HHHHHhhCCCCCceeccCCCCCeeecCCCCeEEcccCccccccc
Q 045798 805 VAS-ALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQE 851 (1008)
Q Consensus 805 i~~-~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~ 851 (1008)
++. .+..+|.. |++|+|++|.||+++.++.++++|||++..+..
T Consensus 265 ~~~~~l~ql~~~---g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 265 LARSFLNQVLRD---GFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred HHHHHHHHHHhC---CceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 665 46788887 999999999999999999999999999986643
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.35 E-value=7.3e-13 Score=151.36 Aligned_cols=199 Identities=32% Similarity=0.514 Sum_probs=112.4
Q ss_pred EEEecCCcCCccCChhhhhhcccceeeeeccccccCCCCCcccccc-ccceEEecCccccCCcchhccCCCCCceEEccC
Q 045798 329 VLSLGGNQFRGALPHSIANLSSQLQILILSSNQFYGSIPLGIGNLV-DLYLLGMVENQFTGAIPKEMGKLQKLQGLDFSG 407 (1008)
Q Consensus 329 ~L~Ls~N~l~~~~p~~~~~l~~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~ 407 (1008)
.+.++.|.+. ..+..+..+. .++.|++.+|.++ .+|.....+. +|+.|++++|.+. .+|..+..+++|+.|++++
T Consensus 97 ~l~~~~~~~~-~~~~~~~~~~-~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~ 172 (394)
T COG4886 97 SLDLNLNRLR-SNISELLELT-NLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSF 172 (394)
T ss_pred eeeccccccc-cCchhhhccc-ceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCC
Confidence 4555555553 1222223322 3666666666665 4444444443 5555555555555 3334455555555555555
Q ss_pred CcccccccccccCCCCcceeeccccccccccCCCCcCCCcccEeecccccccCCcchhhhhhhhhhhhhcccCccccCCC
Q 045798 408 NHFSGEIPSSLGNLSSLYEVFFNNNNLSGVIPFSLGNLKRLAFLEMSGNELSGTIPEDIFNISYLSNSLNLARNHLVGII 487 (1008)
Q Consensus 408 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~lp~~~~~~~~~~~~L~L~~N~l~~~~ 487 (1008)
|++. .+|...+.++.|+.|++++|++. .+|.....+..|++|++++|++ . ..
T Consensus 173 N~l~-~l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~-------------------------~-~~ 224 (394)
T COG4886 173 NDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSI-------------------------I-EL 224 (394)
T ss_pred chhh-hhhhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhcCCcc-------------------------e-ec
Confidence 5555 33433334444444444444444 3333333333344444444432 1 45
Q ss_pred cccccccccccccccccccccCCCCcccccccccceeeccCcccccchhhhhhccccccEEecCCCcccccccCc
Q 045798 488 PPRIGNLRALRSFDVSNNDLSGEIPIELGHCSSLEEIYLAGNLFHGSIPSFFNALKGVQKIDLSRNNLSGQIPIF 562 (1008)
Q Consensus 488 p~~~~~l~~L~~Ldls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~ 562 (1008)
+..+..+.++..|.+++|++. .+|..++.+++|++|++++|+++ .++. ++.+.+|+.||+++|.++..+|..
T Consensus 225 ~~~~~~~~~l~~l~l~~n~~~-~~~~~~~~l~~l~~L~~s~n~i~-~i~~-~~~~~~l~~L~~s~n~~~~~~~~~ 296 (394)
T COG4886 225 LSSLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQIS-SISS-LGSLTNLRELDLSGNSLSNALPLI 296 (394)
T ss_pred chhhhhcccccccccCCceee-eccchhccccccceecccccccc-cccc-ccccCccCEEeccCccccccchhh
Confidence 556677777777778888776 55777777777888888888887 4444 777788888888888887766655
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.35 E-value=6.2e-13 Score=151.97 Aligned_cols=199 Identities=33% Similarity=0.449 Sum_probs=146.3
Q ss_pred eeeeccccccCCCCCccccccccceEEecCccccCCcchhccCCC-CCceEEccCCcccccccccccCCCCcceeecccc
Q 045798 354 ILILSSNQFYGSIPLGIGNLVDLYLLGMVENQFTGAIPKEMGKLQ-KLQGLDFSGNHFSGEIPSSLGNLSSLYEVFFNNN 432 (1008)
Q Consensus 354 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N 432 (1008)
.++++.|.+. .....+..+..+..|++.+|.++ .++.....+. +|+.|++++|++. .+|..+..+++|+.|++++|
T Consensus 97 ~l~~~~~~~~-~~~~~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N 173 (394)
T COG4886 97 SLDLNLNRLR-SNISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFN 173 (394)
T ss_pred eeeccccccc-cCchhhhcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCc
Confidence 4666666664 22333444566667777777766 4555555553 6777777777766 55555666666666666666
Q ss_pred ccccccCCCCcCCCcccEeecccccccCCcchhhhhhhhhhhhhcccCccccCCCcccccccccccccccccccccCCCC
Q 045798 433 NLSGVIPFSLGNLKRLAFLEMSGNELSGTIPEDIFNISYLSNSLNLARNHLVGIIPPRIGNLRALRSFDVSNNDLSGEIP 512 (1008)
Q Consensus 433 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~lp~~~~~~~~~~~~L~L~~N~l~~~~p~~~~~l~~L~~Ldls~N~l~~~~p 512 (1008)
++. .+|...+.+++|+.|++++|+++ .+|..+..+..|+.|++++|.+. .++
T Consensus 174 ~l~-~l~~~~~~~~~L~~L~ls~N~i~--------------------------~l~~~~~~~~~L~~l~~~~N~~~-~~~ 225 (394)
T COG4886 174 DLS-DLPKLLSNLSNLNNLDLSGNKIS--------------------------DLPPEIELLSALEELDLSNNSII-ELL 225 (394)
T ss_pred hhh-hhhhhhhhhhhhhheeccCCccc--------------------------cCchhhhhhhhhhhhhhcCCcce-ecc
Confidence 666 44444445666666666666665 45655566777999999999765 688
Q ss_pred cccccccccceeeccCcccccchhhhhhccccccEEecCCCcccccccCcccccccceeecccCcccccCCCC
Q 045798 513 IELGHCSSLEEIYLAGNLFHGSIPSFFNALKGVQKIDLSRNNLSGQIPIFLEALSLEYLNLSFNDFEGKIPAK 585 (1008)
Q Consensus 513 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~L~~L~l~~N~l~g~~p~~ 585 (1008)
..+.++.++..|.+++|++. .+|..++.++.|+.|++++|+++...+ .....+++.|++++|.+...+|..
T Consensus 226 ~~~~~~~~l~~l~l~~n~~~-~~~~~~~~l~~l~~L~~s~n~i~~i~~-~~~~~~l~~L~~s~n~~~~~~~~~ 296 (394)
T COG4886 226 SSLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQISSISS-LGSLTNLRELDLSGNSLSNALPLI 296 (394)
T ss_pred hhhhhcccccccccCCceee-eccchhccccccceecccccccccccc-ccccCccCEEeccCccccccchhh
Confidence 88999999999999999998 568999999999999999999996544 677789999999999999988865
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.26 E-value=4.6e-11 Score=133.69 Aligned_cols=172 Identities=18% Similarity=0.206 Sum_probs=132.6
Q ss_pred EEEEcCCCeEEEEEEeccccchhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceEEEEEeccCCCChhcccccCC
Q 045798 702 KGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHA 781 (1008)
Q Consensus 702 ~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~ 781 (1008)
.|..+.++.+|.|.+.+.......+...+-++.++.++||+|++++.. ++.++..|+|+|.+. .|..+++
T Consensus 30 ~~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t-----~e~~~~~ylvTErV~--Pl~~~lk--- 99 (690)
T KOG1243|consen 30 DGTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDT-----TEEEGTLYLVTERVR--PLETVLK--- 99 (690)
T ss_pred ccceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhh-----hcccCceEEEeeccc--cHHHHHH---
Confidence 466667889999999887666555678888999999999999999998 566778999999983 5677765
Q ss_pred CCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEcccCcccccccccCccccccc
Q 045798 782 VPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSV 861 (1008)
Q Consensus 782 ~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~ 861 (1008)
.+....+...+.||+.||.+||+. .+++|++|.-+.|+|++.|..||++|.++........ ...
T Consensus 100 ----------~l~~~~v~~Gl~qIl~AL~FL~~d--~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~----~~~ 163 (690)
T KOG1243|consen 100 ----------ELGKEEVCLGLFQILAALSFLNDD--CNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA----PAK 163 (690)
T ss_pred ----------HhHHHHHHHHHHHHHHHHHHHhcc--CCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc----ccc
Confidence 344667788899999999999976 4999999999999999999999999998864433221 011
Q ss_pred cccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCC
Q 045798 862 GVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKK 901 (1008)
Q Consensus 862 ~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~ 901 (1008)
...--..|..|+.+.... -..|.|.|||++||++.|..
T Consensus 164 ~~~~~~s~~~P~~~~~s~--~s~D~~~Lg~li~el~ng~~ 201 (690)
T KOG1243|consen 164 SLYLIESFDDPEEIDPSE--WSIDSWGLGCLIEELFNGSL 201 (690)
T ss_pred cchhhhcccChhhcCccc--cchhhhhHHHHHHHHhCccc
Confidence 112334567777543322 34699999999999999943
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.20 E-value=4.5e-11 Score=137.05 Aligned_cols=148 Identities=18% Similarity=0.185 Sum_probs=98.1
Q ss_pred cCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccchh----------------------------------hH---
Q 045798 684 NGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGA----------------------------------SK--- 726 (1008)
Q Consensus 684 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~----------------------------------~~--- 726 (1008)
..|.. +.||+|++|.||+|+.+.+|+.||||+.+...... .+
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 35766 78999999999999998669999999997442110 11
Q ss_pred ---HHHHHHHHHhhcC----CCCceeeeeccccccccCCceEEEEEeccCCCChhccc--ccCCCCCCCcccccccCHHH
Q 045798 727 ---SFMAECKALKNIR----HRNLVKVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWL--HPHAVPKRDKEIEIKLTLLQ 797 (1008)
Q Consensus 727 ---~~~~E~~~l~~l~----h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l--~~~~~~~~~~~~~~~l~~~~ 797 (1008)
++.+|+..+.++. +...+.+-.++ .+.....++||||++|+.+.++- ...+.. ...+....
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~----~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d------~~~la~~~ 268 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVY----WDYCSETVMVMERMYGIPVSDVAALRAAGTD------MKLLAERG 268 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceee----cccCCCceEEEeeecCccHHhHHHHHhcCCC------HHHHHHHH
Confidence 2445555554442 33333332222 12234578999999999998752 211100 01344444
Q ss_pred HHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCC----CeEEcccCcccccccc
Q 045798 798 RISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDL----SGHIGDFGLARFHQEV 852 (1008)
Q Consensus 798 ~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~----~~kL~Dfg~a~~~~~~ 852 (1008)
+..++.|+. .. |++|+|++|.||+++.++ .++++|||++......
T Consensus 269 v~~~~~Qif-------~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~~ 317 (537)
T PRK04750 269 VEVFFTQVF-------RD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNKE 317 (537)
T ss_pred HHHHHHHHH-------hC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCHH
Confidence 555555554 34 999999999999999888 9999999999876543
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.20 E-value=1.7e-12 Score=136.73 Aligned_cols=208 Identities=20% Similarity=0.174 Sum_probs=89.9
Q ss_pred CCCCCEEEccCCCCCCccC--cccccCcCcceEeeeccccccCCC--ccccccCCCCeeecccccCCCCCCC-CCccccc
Q 045798 101 LFRLEALFLSNNSLVGKIP--ANLSYCSRLTVLCIEYNKLQGRIP--LEFVSLSKLKDLSLAKNKLTGGIPP-FLGNLTS 175 (1008)
Q Consensus 101 l~~L~~L~Ls~n~l~~~~p--~~l~~l~~L~~L~Ls~n~l~~~~p--~~~~~l~~L~~L~L~~n~l~~~~~~-~~~~l~~ 175 (1008)
+.+|+...|.++.+. ..+ .....|++++.||||+|-|...-+ .-...|++|+.|+|+.|++..-... .-..+++
T Consensus 120 ~kkL~~IsLdn~~V~-~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~~ 198 (505)
T KOG3207|consen 120 LKKLREISLDNYRVE-DAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLSH 198 (505)
T ss_pred HHhhhheeecCcccc-ccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhhh
Confidence 444555555554444 111 233344555555555554442211 1223345555555555554411111 1113344
Q ss_pred cchhhcccccCCCCC-CccccCCCCCcEEEecCCcccccCCccccCCCCcceeccccccccccCC-hhhhhcCCCCcEEE
Q 045798 176 LEVLSLAGNSFGRNI-PDSLGQLKQLKILAIGGNNLSGPIPPSIYNLSFLVVFSVSHNQIHGSLP-PSLGLLLPNLKFFQ 253 (1008)
Q Consensus 176 L~~L~L~~n~l~~~~-~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~~~lp-~~~~~~l~~L~~L~ 253 (1008)
|+.|.|+.|.++... -..+..+++|+.|+|..|..-.+.......+..|+.|||++|.+. ..+ ......++.|..|+
T Consensus 199 lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li-~~~~~~~~~~l~~L~~Ln 277 (505)
T KOG3207|consen 199 LKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLI-DFDQGYKVGTLPGLNQLN 277 (505)
T ss_pred hheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCccc-ccccccccccccchhhhh
Confidence 555555555543111 111334455555555555322222223333444555555555544 222 11122244555555
Q ss_pred eccccCCCC-CCcc-----cccCCCCceeeccccccccccc-ccccCCCcccccccccccCCCC
Q 045798 254 IHHNFFSGS-IPIS-----LSNASKLEHIEIANNNFSGKLS-VNFGGMKNLSLLNLQFSNLGSG 310 (1008)
Q Consensus 254 L~~N~l~~~-~p~~-----l~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~n~l~~~ 310 (1008)
++.+.+... .|+. ....++|++|+++.|+|.+... ..+..+++|+.|.+..|.++..
T Consensus 278 ls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~~w~sl~~l~~l~nlk~l~~~~n~ln~e 341 (505)
T KOG3207|consen 278 LSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIRDWRSLNHLRTLENLKHLRITLNYLNKE 341 (505)
T ss_pred ccccCcchhcCCCccchhhhcccccceeeecccCccccccccchhhccchhhhhhccccccccc
Confidence 555554431 1222 2445667777777776653221 2233455555555555555543
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.20 E-value=5.6e-11 Score=118.40 Aligned_cols=130 Identities=18% Similarity=0.081 Sum_probs=96.0
Q ss_pred CceEeeccCeeEEEEEEcCCCeEEEEEEeccccchhhHHHHHHHHHHhhcCCCCce-eeeeccccccccCCceEEEEEec
Q 045798 689 THLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLV-KVITSCSSIDFQGNDFKAIVYEY 767 (1008)
Q Consensus 689 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~~~~~~~~~~~~~~~~~~lv~e~ 767 (1008)
++.++.|.++.||++.. .+..|++|+...... ....+.+|+++++.+.+..++ +++.+. ....++||||
T Consensus 3 ~~~l~~G~~~~vy~~~~--~~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~-------~~~~~lv~e~ 72 (170)
T cd05151 3 ISPLKGGMTNKNYRVEV--ANKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD-------PETGVLITEF 72 (170)
T ss_pred eeecCCcccCceEEEEE--CCeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe-------CCCCeEEEEe
Confidence 46789999999999987 478899999764422 234568899999988654443 444431 1234799999
Q ss_pred cCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCC--CCCceeccCCCCCeeecCCCCeEEcccCc
Q 045798 768 MPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHC--QEPILHCDLKPSNILLDNDLSGHIGDFGL 845 (1008)
Q Consensus 768 ~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~ 845 (1008)
++|.++.+.- . ....++.+++++++.||+.. +.+++|||++|.||+++ ++.++++|||.
T Consensus 73 i~G~~l~~~~--------------~----~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~ 133 (170)
T cd05151 73 IEGSELLTED--------------F----SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEY 133 (170)
T ss_pred cCCCcccccc--------------c----cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccc
Confidence 9998876530 0 11245789999999999972 12359999999999999 66899999998
Q ss_pred cc
Q 045798 846 AR 847 (1008)
Q Consensus 846 a~ 847 (1008)
+.
T Consensus 134 a~ 135 (170)
T cd05151 134 AG 135 (170)
T ss_pred cc
Confidence 86
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.20 E-value=2.1e-10 Score=113.81 Aligned_cols=138 Identities=19% Similarity=0.149 Sum_probs=98.8
Q ss_pred CceEeeccCeeEEEEEEcC------CCeEEEEEEecccc------------c----------hhhHHH----HHHHHHHh
Q 045798 689 THLIGVGSFGCVYKGALDE------DGIVVAIKVINLQC------------E----------GASKSF----MAECKALK 736 (1008)
Q Consensus 689 ~~~lg~G~~g~Vy~~~~~~------~~~~vavK~~~~~~------------~----------~~~~~~----~~E~~~l~ 736 (1008)
...||.|--+.||.|.... .+..+|||+.+... + ...+.+ .+|++.|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 3579999999999998643 35799999985211 0 111223 38999999
Q ss_pred hcC--CCCceeeeeccccccccCCceEEEEEeccCCCChhc-ccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHH-
Q 045798 737 NIR--HRNLVKVITSCSSIDFQGNDFKAIVYEYMPNGSLEK-WLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYL- 812 (1008)
Q Consensus 737 ~l~--h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~L- 812 (1008)
++. .-++.+.+++ ...++||||+.+..+.. .++.. .++..+...+..+++.++..+
T Consensus 82 rl~~~Gv~vP~pi~~---------~~~~lvME~Ig~~~~~~~~Lkd~-----------~~~~~~~~~i~~~i~~~l~~l~ 141 (197)
T cd05146 82 RMQKAGIPCPEVVVL---------KKHVLVMSFIGDDQVPAPKLKDA-----------KLNDEEMKNAYYQVLSMMKQLY 141 (197)
T ss_pred HHHHcCCCCCeEEEe---------cCCEEEEEEcCCCCccchhhhcc-----------ccCHHHHHHHHHHHHHHHHHHH
Confidence 984 3456666654 23689999996643321 11111 344556778889999999999
Q ss_pred hhCCCCCceeccCCCCCeeecCCCCeEEcccCcccccc
Q 045798 813 HHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQ 850 (1008)
Q Consensus 813 H~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~ 850 (1008)
|+. ++||||+++.||+++ ++.+.++|||.|...+
T Consensus 142 H~~---glVHGDLs~~NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 142 KEC---NLVHADLSEYNMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred HhC---CeecCCCCHHHEEEE-CCcEEEEECCCceeCC
Confidence 776 999999999999997 4689999999997554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.08 E-value=1.8e-12 Score=133.09 Aligned_cols=183 Identities=22% Similarity=0.289 Sum_probs=114.3
Q ss_pred CeEEEEeccccCCCC----ccCcCccCCccCCeeeecCCC---CCCCCCc-------cccCCCCCCEEEccCCCCCCccC
Q 045798 54 RRVTALDLMSKSLSG----SLSPHLGNLSFLREINLSNNT---IQGEIPP-------EFGRLFRLEALFLSNNSLVGKIP 119 (1008)
Q Consensus 54 ~~v~~l~l~~~~l~~----~l~~~l~~l~~L~~L~L~~n~---~~~~~p~-------~~~~l~~L~~L~Ls~n~l~~~~p 119 (1008)
..++.++|++|.+.. .+-+.+.+.++|+..++++-- ....+|+ ++..+++|++||||.|-+....+
T Consensus 30 ~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~ftGR~~~Ei~e~L~~l~~aL~~~~~L~~ldLSDNA~G~~g~ 109 (382)
T KOG1909|consen 30 DSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDMFTGRLKDEIPEALKMLSKALLGCPKLQKLDLSDNAFGPKGI 109 (382)
T ss_pred CceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhhhcCCcHHHHHHHHHHHHHHHhcCCceeEeeccccccCccch
Confidence 357889999988864 255667778888888888732 2223443 34556788888888888875555
Q ss_pred ccc----ccCcCcceEeeeccccccCCCcc-------------ccccCCCCeeecccccCCCCC----CCCCccccccch
Q 045798 120 ANL----SYCSRLTVLCIEYNKLQGRIPLE-------------FVSLSKLKDLSLAKNKLTGGI----PPFLGNLTSLEV 178 (1008)
Q Consensus 120 ~~l----~~l~~L~~L~Ls~n~l~~~~p~~-------------~~~l~~L~~L~L~~n~l~~~~----~~~~~~l~~L~~ 178 (1008)
..| ..+..|++|.|.+|.+...--.. .++-++|+++..++|++.... ...|...+.|+.
T Consensus 110 ~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~al~~l~~~kk~~~~~~Lrv~i~~rNrlen~ga~~~A~~~~~~~~lee 189 (382)
T KOG1909|consen 110 RGLEELLSSCTDLEELYLNNCGLGPEAGGRLGRALFELAVNKKAASKPKLRVFICGRNRLENGGATALAEAFQSHPTLEE 189 (382)
T ss_pred HHHHHHHHhccCHHHHhhhcCCCChhHHHHHHHHHHHHHHHhccCCCcceEEEEeeccccccccHHHHHHHHHhccccce
Confidence 543 45678888888888875211111 222356777777777766322 123445566777
Q ss_pred hhcccccCCC----CCCccccCCCCCcEEEecCCcccc----cCCccccCCCCcceeccccccccc
Q 045798 179 LSLAGNSFGR----NIPDSLGQLKQLKILAIGGNNLSG----PIPPSIYNLSFLVVFSVSHNQIHG 236 (1008)
Q Consensus 179 L~L~~n~l~~----~~~~~~~~l~~L~~L~L~~n~l~~----~~~~~~~~l~~L~~L~ls~N~l~~ 236 (1008)
+.++.|.|.. .+..+|.++++|+.|||.+|-++. .+.+.+..+++|+.|++++|.+..
T Consensus 190 vr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~l~dcll~~ 255 (382)
T KOG1909|consen 190 VRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELNLGDCLLEN 255 (382)
T ss_pred EEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchheeeccccccccc
Confidence 7777776631 123346667777777777776652 223455566666666666666653
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.08 E-value=2.3e-12 Score=132.33 Aligned_cols=228 Identities=21% Similarity=0.241 Sum_probs=128.0
Q ss_pred cCcCccCCccCCeeeecCCCCCCC----CCccccCCCCCCEEEccCC---CCCCccCcc-------cccCcCcceEeeec
Q 045798 70 LSPHLGNLSFLREINLSNNTIQGE----IPPEFGRLFRLEALFLSNN---SLVGKIPAN-------LSYCSRLTVLCIEY 135 (1008)
Q Consensus 70 l~~~l~~l~~L~~L~L~~n~~~~~----~p~~~~~l~~L~~L~Ls~n---~l~~~~p~~-------l~~l~~L~~L~Ls~ 135 (1008)
.-+.+..+..+++|+|++|.|... +...+.+.++|+..++|+= ++...+|.+ +..+++|++||||+
T Consensus 22 v~~~~~~~~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~ftGR~~~Ei~e~L~~l~~aL~~~~~L~~ldLSD 101 (382)
T KOG1909|consen 22 VEEELEPMDSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDMFTGRLKDEIPEALKMLSKALLGCPKLQKLDLSD 101 (382)
T ss_pred HHHHhcccCceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhhhcCCcHHHHHHHHHHHHHHHhcCCceeEeeccc
Confidence 344566778899999999988743 4455667788888888873 344556654 34456788888888
Q ss_pred cccccCCCccc----cccCCCCeeecccccCCCCCCCCCccccccchhhcccccCCCCCCccccCCCCCcEEEecCCccc
Q 045798 136 NKLQGRIPLEF----VSLSKLKDLSLAKNKLTGGIPPFLGNLTSLEVLSLAGNSFGRNIPDSLGQLKQLKILAIGGNNLS 211 (1008)
Q Consensus 136 n~l~~~~p~~~----~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~ 211 (1008)
|.|...-+..| .++..|++|+|.+|.+.-..-..++ ..|..|. .|+. ...-++|+.+...+|++.
T Consensus 102 NA~G~~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~--~al~~l~--~~kk-------~~~~~~Lrv~i~~rNrle 170 (382)
T KOG1909|consen 102 NAFGPKGIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLG--RALFELA--VNKK-------AASKPKLRVFICGRNRLE 170 (382)
T ss_pred cccCccchHHHHHHHHhccCHHHHhhhcCCCChhHHHHHH--HHHHHHH--HHhc-------cCCCcceEEEEeeccccc
Confidence 88764444443 3356677777777766521111222 1233333 1111 223346677777777665
Q ss_pred cc----CCccccCCCCcceeccccccccccCC---hhhhhcCCCCcEEEeccccCCC----CCCcccccCCCCceeeccc
Q 045798 212 GP----IPPSIYNLSFLVVFSVSHNQIHGSLP---PSLGLLLPNLKFFQIHHNFFSG----SIPISLSNASKLEHIEIAN 280 (1008)
Q Consensus 212 ~~----~~~~~~~l~~L~~L~ls~N~l~~~lp---~~~~~~l~~L~~L~L~~N~l~~----~~p~~l~~l~~L~~L~L~~ 280 (1008)
.. +...|...+.|+.+.++.|.|...-- ...+..+++|+.|||.+|-++. .+...++.++.|+.|++++
T Consensus 171 n~ga~~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~l~d 250 (382)
T KOG1909|consen 171 NGGATALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELNLGD 250 (382)
T ss_pred cccHHHHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchheeecccc
Confidence 21 22345555666666666666641111 1112335666666666666552 2234555666677777777
Q ss_pred cccccccccccc-----CCCcccccccccccCC
Q 045798 281 NNFSGKLSVNFG-----GMKNLSLLNLQFSNLG 308 (1008)
Q Consensus 281 N~l~~~~~~~~~-----~l~~L~~L~L~~n~l~ 308 (1008)
|.+.......|. ..++|+.|.|.+|.|+
T Consensus 251 cll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt 283 (382)
T KOG1909|consen 251 CLLENEGAIAFVDALKESAPSLEVLELAGNEIT 283 (382)
T ss_pred cccccccHHHHHHHHhccCCCCceeccCcchhH
Confidence 776655444432 2344555555555444
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.08 E-value=7.8e-11 Score=131.09 Aligned_cols=196 Identities=22% Similarity=0.207 Sum_probs=147.0
Q ss_pred hcCCCCCceEeeccCeeEEEEEEc-CCCeEEEEEEeccccchhhH--HHHHHHHHHhhc-CCCCceeeeeccccccccCC
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALD-EDGIVVAIKVINLQCEGASK--SFMAECKALKNI-RHRNLVKVITSCSSIDFQGN 758 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~~vavK~~~~~~~~~~~--~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~ 758 (1008)
..+|..+..||.|.|+.|+....+ .++..|++|........... .-..|+.+...+ .|.++++.... +...
T Consensus 264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~-----W~~~ 338 (524)
T KOG0601|consen 264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSS-----WSQL 338 (524)
T ss_pred cCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCC-----cccc
Confidence 457888999999999999998766 67889999988644333222 235566666666 68888887766 4445
Q ss_pred ceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCC-CC
Q 045798 759 DFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDND-LS 837 (1008)
Q Consensus 759 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~~ 837 (1008)
+..|+=-|||++++....+.-.. .+++..++.+..|++.++.++|+. .++|+|+||+||++..+ +.
T Consensus 339 r~~~ip~e~~~~~s~~l~~~~~~----------~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~ 405 (524)
T KOG0601|consen 339 RQGYIPLEFCEGGSSSLRSVTSQ----------MLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFF 405 (524)
T ss_pred ccccCchhhhcCcchhhhhHHHH----------hcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhh
Confidence 55778899999998887762221 577788899999999999999986 99999999999999886 77
Q ss_pred eEEcccCcccccccccCccccccccccccccc-cCccccCCCCCCcccchhhHHHHHHHHHhCCCC
Q 045798 838 GHIGDFGLARFHQEVSNSTLSSSVGVKGTIGY-TAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKP 902 (1008)
Q Consensus 838 ~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y-~aPE~~~~~~~~~~sDvwslG~vl~elltG~~p 902 (1008)
.+++|||.+..+.-..... ...+..| .+|+......+..++|+||||.-+.|..+|..-
T Consensus 406 ~~~~~~~~~t~~~~~~~~~------~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~l 465 (524)
T KOG0601|consen 406 SKLGDFGCWTRLAFSSGVF------HHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPL 465 (524)
T ss_pred hhccccccccccceecccc------cccccccccchhhccccccccccccccccccccccccCccc
Confidence 8999999986422211111 1123334 355566667788999999999999999998764
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.05 E-value=5.7e-09 Score=110.01 Aligned_cols=278 Identities=13% Similarity=0.073 Sum_probs=170.1
Q ss_pred CCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccchhhHHHHHHHHHHhhc-CCCCceeeeeccc--cccccCCceEEE
Q 045798 687 SSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNI-RHRNLVKVITSCS--SIDFQGNDFKAI 763 (1008)
Q Consensus 687 ~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~--~~~~~~~~~~~l 763 (1008)
...+.||+|+-+.+|-.-. -...+.|+++........+... .|... .||-+-.-+.+=. -.+-.......+
T Consensus 14 ~~gr~LgqGgea~ly~l~e---~~d~VAKIYh~Pppa~~aqk~a---~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGf 87 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGE---VRDQVAKIYHAPPPAAQAQKVA---ELAATPDAPLLNYRVAWPQATLHGGRRGKVIGF 87 (637)
T ss_pred CCCccccCCccceeeecch---hhchhheeecCCCchHHHHHHH---HhccCCCCcchhhhhcccHHHhhCCCccceeEE
Confidence 3457899999999996433 2234678887554433333222 23333 5654433111100 001123333678
Q ss_pred EEeccCCC-ChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEcc
Q 045798 764 VYEYMPNG-SLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGD 842 (1008)
Q Consensus 764 v~e~~~~g-sL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 842 (1008)
+|..+++. ....+........ .-....|...++.++.++.+.+.||.+ |.+-||+.++|+|+++++.+.|.|
T Consensus 88 lmP~v~g~~pI~~~y~p~tRRq----s~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVd 160 (637)
T COG4248 88 LMPKVSGKEPIHMIYSPATRRQ----SYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVD 160 (637)
T ss_pred ecccCCCccchhhhcCchhhcc----cCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEc
Confidence 88887664 2222222111111 111578999999999999999999998 999999999999999999999998
Q ss_pred cCcccccccccCccccccccccccccccCccccC-----CCCCCcccchhhHHHHHHHHHhC-CCCCCccccCCc---cH
Q 045798 843 FGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGL-----GSEVSTNGDVYSYGILLLEMVTA-KKPTDVMFEGDL---NL 913 (1008)
Q Consensus 843 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwslG~vl~elltG-~~pf~~~~~~~~---~~ 913 (1008)
-..-.+...... ....+|...|.+||.-. +..-+...|-|.+|+++++++.| ++||........ .+
T Consensus 161 sDsfqi~~ng~~-----~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~ 235 (637)
T COG4248 161 SDSFQINANGTL-----HLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPL 235 (637)
T ss_pred ccceeeccCCce-----EecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcc
Confidence 655443322211 12345889999999743 34557789999999999999886 999975432111 01
Q ss_pred H-HHHHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCc--CCCCCCCHHHHHHHHHH
Q 045798 914 H-NFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSME--SPQDRMNMTNVVHELQS 990 (1008)
Q Consensus 914 ~-~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~--dP~~RPt~~evl~~L~~ 990 (1008)
+ ..+...+ ...+. .....+-++...+..-.+..+..+..+|+.. .+.-|||++..+..|..
T Consensus 236 E~~Ia~g~f------------~ya~~----~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~a 299 (637)
T COG4248 236 ETDIAHGRF------------AYASD----QRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDA 299 (637)
T ss_pred hhhhhccee------------eechh----ccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHH
Confidence 1 1111111 00000 0001111222233445566778888889865 35689999999999998
Q ss_pred HHHHHHHH
Q 045798 991 VKNILLEL 998 (1008)
Q Consensus 991 i~~~~~~~ 998 (1008)
+.......
T Consensus 300 l~~~L~~C 307 (637)
T COG4248 300 LRQQLKKC 307 (637)
T ss_pred HHHhhhhh
Confidence 88776554
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.05 E-value=8.7e-09 Score=111.74 Aligned_cols=182 Identities=19% Similarity=0.201 Sum_probs=136.6
Q ss_pred cCeeEEEEEEcCCCeEEEEEEeccccchhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceEEEEEeccCC-CChh
Q 045798 696 SFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKAIVYEYMPN-GSLE 774 (1008)
Q Consensus 696 ~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~-gsL~ 774 (1008)
...+.|++...-+|..|++|+++............-+++++++.|+|+|++.+++....| ++...++||+|+++ ++|.
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF-~D~SlvlvYDYyP~s~TL~ 366 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTF-GDLSLVLVYDYYPSSPTLY 366 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhcc-CcceEEEEEecCCCCchHH
Confidence 446889999999999999999965433333344566888999999999999998764433 45568999999876 4676
Q ss_pred cccccCCCCC-----CCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEcccCccccc
Q 045798 775 KWLHPHAVPK-----RDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFH 849 (1008)
Q Consensus 775 ~~l~~~~~~~-----~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~ 849 (1008)
++--...... .........++..+|.++.|+..||.++|+. |+.-+-+.|.+|+++.+.+++|+..|.....
T Consensus 367 d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl 443 (655)
T KOG3741|consen 367 DLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDVL 443 (655)
T ss_pred HHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceeee
Confidence 6543322211 1122234788999999999999999999998 9999999999999999999999888877655
Q ss_pred ccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCC
Q 045798 850 QEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKP 902 (1008)
Q Consensus 850 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~p 902 (1008)
..+... -+.+ -.+-|.=.||.++..|.||..-
T Consensus 444 ~~d~~~------------------~le~---~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 444 QEDPTE------------------PLES---QQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred cCCCCc------------------chhH---HhhhhHHHHHHHHHHHhhcccc
Confidence 443211 1111 2357889999999999999654
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.03 E-value=4.9e-11 Score=119.23 Aligned_cols=206 Identities=20% Similarity=0.243 Sum_probs=118.3
Q ss_pred CCccccCCCCCCEEEccCCCCCCccCcccccCcCcceEeeeccccccCCCccccccCCCCeeecccc-cCCCCCCCCCcc
Q 045798 94 IPPEFGRLFRLEALFLSNNSLVGKIPANLSYCSRLTVLCIEYNKLQGRIPLEFVSLSKLKDLSLAKN-KLTGGIPPFLGN 172 (1008)
Q Consensus 94 ~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n-~l~~~~~~~~~~ 172 (1008)
+|-.+.-+.+|+.+.+|+|.-. .|-+-...=+.|+++......++. .| .+-..+.+..+.-+.- -.+|..-..+..
T Consensus 206 l~f~l~~f~~l~~~~~s~~~~~-~i~~~~~~kptl~t~~v~~s~~~~-~~-~l~pe~~~~D~~~~E~~t~~G~~~~~~dT 282 (490)
T KOG1259|consen 206 LSFNLNAFRNLKTLKFSALSTE-NIVDIELLKPTLQTICVHNTTIQD-VP-SLLPETILADPSGSEPSTSNGSALVSADT 282 (490)
T ss_pred cccchHHhhhhheeeeeccchh-heeceeecCchhheeeeecccccc-cc-cccchhhhcCccCCCCCccCCceEEecch
Confidence 4445556677777777777544 222222333667777777666652 22 1212223332222211 122322233344
Q ss_pred ccccchhhcccccCCCCCCccccCCCCCcEEEecCCcccccCCccccCCCCcceeccccccccccCChhhhhcCCCCcEE
Q 045798 173 LTSLEVLSLAGNSFGRNIPDSLGQLKQLKILAIGGNNLSGPIPPSIYNLSFLVVFSVSHNQIHGSLPPSLGLLLPNLKFF 252 (1008)
Q Consensus 173 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~~~lp~~~~~~l~~L~~L 252 (1008)
...|++|||++|.| ..+.++..-+++++.|++++|.|+.. ..+..+++|+.||||+|.++ .+..+- ..+-+.++|
T Consensus 283 Wq~LtelDLS~N~I-~~iDESvKL~Pkir~L~lS~N~i~~v--~nLa~L~~L~~LDLS~N~Ls-~~~Gwh-~KLGNIKtL 357 (490)
T KOG1259|consen 283 WQELTELDLSGNLI-TQIDESVKLAPKLRRLILSQNRIRTV--QNLAELPQLQLLDLSGNLLA-ECVGWH-LKLGNIKTL 357 (490)
T ss_pred Hhhhhhccccccch-hhhhhhhhhccceeEEeccccceeee--hhhhhcccceEeecccchhH-hhhhhH-hhhcCEeee
Confidence 46788888888888 45666677778888888888888733 23777777888888888776 443322 235566666
Q ss_pred EeccccCCCCCCcccccCCCCceeecccccccccccccccCCCcccccccccccCCCCCCCcccccccccccCCCcEEEe
Q 045798 253 QIHHNFFSGSIPISLSNASKLEHIEIANNNFSGKLSVNFGGMKNLSLLNLQFSNLGSGESDEMGFMNSLTNCSKLRVLSL 332 (1008)
Q Consensus 253 ~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~l~~L~~L~L 332 (1008)
.|+.|.|.. -..+..+-+|..||+++|+|.. .+ -.+++.+++.|+.+.|
T Consensus 358 ~La~N~iE~--LSGL~KLYSLvnLDl~~N~Ie~------------------------ld-----eV~~IG~LPCLE~l~L 406 (490)
T KOG1259|consen 358 KLAQNKIET--LSGLRKLYSLVNLDLSSNQIEE------------------------LD-----EVNHIGNLPCLETLRL 406 (490)
T ss_pred ehhhhhHhh--hhhhHhhhhheeccccccchhh------------------------HH-----HhcccccccHHHHHhh
Confidence 666666652 1233444555555555555542 22 1235667777777777
Q ss_pred cCCcCC
Q 045798 333 GGNQFR 338 (1008)
Q Consensus 333 s~N~l~ 338 (1008)
.+|.+.
T Consensus 407 ~~NPl~ 412 (490)
T KOG1259|consen 407 TGNPLA 412 (490)
T ss_pred cCCCcc
Confidence 888777
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.03 E-value=2.3e-11 Score=128.32 Aligned_cols=161 Identities=18% Similarity=0.219 Sum_probs=69.1
Q ss_pred CCCCcEEEeccccCCCCCC-cccccCCCCceeecccccccccccccccCCCcccccccccccCCCCCCCccccccccccc
Q 045798 246 LPNLKFFQIHHNFFSGSIP-ISLSNASKLEHIEIANNNFSGKLSVNFGGMKNLSLLNLQFSNLGSGESDEMGFMNSLTNC 324 (1008)
Q Consensus 246 l~~L~~L~L~~N~l~~~~p-~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~l 324 (1008)
+.+|+...|.+..+..... .....+++++.|||+.|-+....+. ..-...+
T Consensus 120 ~kkL~~IsLdn~~V~~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v----------------------------~~i~eqL 171 (505)
T KOG3207|consen 120 LKKLREISLDNYRVEDAGIEEYSKILPNVRDLDLSRNLFHNWFPV----------------------------LKIAEQL 171 (505)
T ss_pred HHhhhheeecCccccccchhhhhhhCCcceeecchhhhHHhHHHH----------------------------HHHHHhc
Confidence 4456666666665542111 2344556666666666655433221 1122344
Q ss_pred CCCcEEEecCCcCCccCChhhhhhcccceeeeeccccccC-CCCCccccccccceEEecCccccCCcchhccCCCCCceE
Q 045798 325 SKLRVLSLGGNQFRGALPHSIANLSSQLQILILSSNQFYG-SIPLGIGNLVDLYLLGMVENQFTGAIPKEMGKLQKLQGL 403 (1008)
Q Consensus 325 ~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 403 (1008)
++|+.|+|+.|++.-..........++|+.|.|+.|.++. .+-.....+++|+.|+|..|.....-.....-+..|+.|
T Consensus 172 p~Le~LNls~Nrl~~~~~s~~~~~l~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~L 251 (505)
T KOG3207|consen 172 PSLENLNLSSNRLSNFISSNTTLLLSHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQEL 251 (505)
T ss_pred ccchhcccccccccCCccccchhhhhhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhc
Confidence 4455555555554422222222222344555555554431 011112233444444554443222222233334455555
Q ss_pred EccCCccccccc--ccccCCCCcceeeccccccc
Q 045798 404 DFSGNHFSGEIP--SSLGNLSSLYEVFFNNNNLS 435 (1008)
Q Consensus 404 ~Ls~N~l~~~~p--~~~~~l~~L~~L~l~~N~l~ 435 (1008)
||++|++. ..+ ...+.++.|..|+++.+.+.
T Consensus 252 dLs~N~li-~~~~~~~~~~l~~L~~Lnls~tgi~ 284 (505)
T KOG3207|consen 252 DLSNNNLI-DFDQGYKVGTLPGLNQLNLSSTGIA 284 (505)
T ss_pred cccCCccc-ccccccccccccchhhhhccccCcc
Confidence 55555554 222 22344445555555555444
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.02 E-value=7.8e-11 Score=114.50 Aligned_cols=57 Identities=40% Similarity=0.542 Sum_probs=8.5
Q ss_pred cCCeeeecCCCCCCCCCcccc-CCCCCCEEEccCCCCCCccCcccccCcCcceEeeeccccc
Q 045798 79 FLREINLSNNTIQGEIPPEFG-RLFRLEALFLSNNSLVGKIPANLSYCSRLTVLCIEYNKLQ 139 (1008)
Q Consensus 79 ~L~~L~L~~n~~~~~~p~~~~-~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~ 139 (1008)
.+++|+|.+|.|+ .+. .++ .+.+|+.|+|++|+|+ .++ .+..+++|++|++++|+|+
T Consensus 20 ~~~~L~L~~n~I~-~Ie-~L~~~l~~L~~L~Ls~N~I~-~l~-~l~~L~~L~~L~L~~N~I~ 77 (175)
T PF14580_consen 20 KLRELNLRGNQIS-TIE-NLGATLDKLEVLDLSNNQIT-KLE-GLPGLPRLKTLDLSNNRIS 77 (175)
T ss_dssp ------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS---
T ss_pred ccccccccccccc-ccc-chhhhhcCCCEEECCCCCCc-ccc-CccChhhhhhcccCCCCCC
Confidence 3444555555444 221 232 2444444444444444 221 2333444444444444444
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.02 E-value=5.5e-11 Score=118.88 Aligned_cols=207 Identities=20% Similarity=0.229 Sum_probs=114.1
Q ss_pred ccCcCccCCccCCeeeecCCCCCCCCCccccCCCCCCEEEccCCCCCC---ccCcccccCcCcceEeee-ccccccCCCc
Q 045798 69 SLSPHLGNLSFLREINLSNNTIQGEIPPEFGRLFRLEALFLSNNSLVG---KIPANLSYCSRLTVLCIE-YNKLQGRIPL 144 (1008)
Q Consensus 69 ~l~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~---~~p~~l~~l~~L~~L~Ls-~n~l~~~~p~ 144 (1008)
.+|-.+.-+++|..+.++.+.-. .|-+-...-+.|+++.+.+..++. .+|... +..+.-+ ..-.+|..-.
T Consensus 205 ~l~f~l~~f~~l~~~~~s~~~~~-~i~~~~~~kptl~t~~v~~s~~~~~~~l~pe~~-----~~D~~~~E~~t~~G~~~~ 278 (490)
T KOG1259|consen 205 RLSFNLNAFRNLKTLKFSALSTE-NIVDIELLKPTLQTICVHNTTIQDVPSLLPETI-----LADPSGSEPSTSNGSALV 278 (490)
T ss_pred ccccchHHhhhhheeeeeccchh-heeceeecCchhheeeeecccccccccccchhh-----hcCccCCCCCccCCceEE
Confidence 35567788899999999988655 333333345778888888776652 122211 1100000 0111222222
Q ss_pred cccccCCCCeeecccccCCCCCCCCCccccccchhhcccccCCCCCCccccCCCCCcEEEecCCcccccCCccccCCCCc
Q 045798 145 EFVSLSKLKDLSLAKNKLTGGIPPFLGNLTSLEVLSLAGNSFGRNIPDSLGQLKQLKILAIGGNNLSGPIPPSIYNLSFL 224 (1008)
Q Consensus 145 ~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L 224 (1008)
.+...+.|++|||++|.|+ .+.++..=++.++.|++++|.+... +.+..+++|+.|||++|.++ ....+-..+.+.
T Consensus 279 ~~dTWq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~v--~nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNI 354 (490)
T KOG1259|consen 279 SADTWQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRTV--QNLAELPQLQLLDLSGNLLA-ECVGWHLKLGNI 354 (490)
T ss_pred ecchHhhhhhccccccchh-hhhhhhhhccceeEEeccccceeee--hhhhhcccceEeecccchhH-hhhhhHhhhcCE
Confidence 3333344555555555555 4444454555555555555555322 12555556666666666555 233444455556
Q ss_pred ceeccccccccccCChhhhhcCCCCcEEEeccccCCCC-CCcccccCCCCceeeccccccccccc
Q 045798 225 VVFSVSHNQIHGSLPPSLGLLLPNLKFFQIHHNFFSGS-IPISLSNASKLEHIEIANNNFSGKLS 288 (1008)
Q Consensus 225 ~~L~ls~N~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~-~p~~l~~l~~L~~L~L~~N~l~~~~~ 288 (1008)
+.|.|+.|.|. .+. .+ ..+-+|.+||+++|+|... -...+++++-|+++.|.+|.+.+...
T Consensus 355 KtL~La~N~iE-~LS-GL-~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~vd 416 (490)
T KOG1259|consen 355 KTLKLAQNKIE-TLS-GL-RKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGSVD 416 (490)
T ss_pred eeeehhhhhHh-hhh-hh-HhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccccch
Confidence 66666666554 221 11 1245666666666666532 23467889999999999999986553
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.00 E-value=8.2e-11 Score=134.45 Aligned_cols=247 Identities=25% Similarity=0.263 Sum_probs=132.8
Q ss_pred CCcccccccccccCCCCCCCcccccccccccCCCcEEEecCCcCCccCChhhhhhcccceeeeeccccccCCCCCccccc
Q 045798 294 MKNLSLLNLQFSNLGSGESDEMGFMNSLTNCSKLRVLSLGGNQFRGALPHSIANLSSQLQILILSSNQFYGSIPLGIGNL 373 (1008)
Q Consensus 294 l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~Ls~N~l~~~~p~~~~~l 373 (1008)
+..++.+.++.|.+... .+.+..+++|..|++.+|+|.+ +...+..+. +|++|++++|.|+... .+..+
T Consensus 71 l~~l~~l~l~~n~i~~~-------~~~l~~~~~l~~l~l~~n~i~~-i~~~l~~~~-~L~~L~ls~N~I~~i~--~l~~l 139 (414)
T KOG0531|consen 71 LTSLKELNLRQNLIAKI-------LNHLSKLKSLEALDLYDNKIEK-IENLLSSLV-NLQVLDLSFNKITKLE--GLSTL 139 (414)
T ss_pred hHhHHhhccchhhhhhh-------hcccccccceeeeeccccchhh-cccchhhhh-cchheecccccccccc--chhhc
Confidence 34444444555554431 1235566667777777777763 222233333 4666666666666322 24444
Q ss_pred cccceEEecCccccCCcchhccCCCCCceEEccCCcccccccccccCCCCcceeeccccccccccCCCCcCCCcccEeec
Q 045798 374 VDLYLLGMVENQFTGAIPKEMGKLQKLQGLDFSGNHFSGEIPSSLGNLSSLYEVFFNNNNLSGVIPFSLGNLKRLAFLEM 453 (1008)
Q Consensus 374 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L 453 (1008)
..|+.|++++|.|... ..+..++.|+.+++++|++...-+.....+.+|+.+++.+|.+.. ...+..+..+..+++
T Consensus 140 ~~L~~L~l~~N~i~~~--~~~~~l~~L~~l~l~~n~i~~ie~~~~~~~~~l~~l~l~~n~i~~--i~~~~~~~~l~~~~l 215 (414)
T KOG0531|consen 140 TLLKELNLSGNLISDI--SGLESLKSLKLLDLSYNRIVDIENDELSELISLEELDLGGNSIRE--IEGLDLLKKLVLLSL 215 (414)
T ss_pred cchhhheeccCcchhc--cCCccchhhhcccCCcchhhhhhhhhhhhccchHHHhccCCchhc--ccchHHHHHHHHhhc
Confidence 5566666666666522 233445666666666666653222003445555555555555542 222333344444455
Q ss_pred ccccccCCcchhhhhhhhhhhhhcccCccccCCCcccccccc--cccccccccccccCCCCcccccccccceeeccCccc
Q 045798 454 SGNELSGTIPEDIFNISYLSNSLNLARNHLVGIIPPRIGNLR--ALRSFDVSNNDLSGEIPIELGHCSSLEEIYLAGNLF 531 (1008)
Q Consensus 454 s~N~l~~~lp~~~~~~~~~~~~L~L~~N~l~~~~p~~~~~l~--~L~~Ldls~N~l~~~~p~~~~~l~~L~~L~L~~N~l 531 (1008)
..|+++ ..-+ +..+. .|+.+++++|.+. ..+..+..+..+..|++.+|++
T Consensus 216 ~~n~i~-------------------------~~~~--l~~~~~~~L~~l~l~~n~i~-~~~~~~~~~~~l~~l~~~~n~~ 267 (414)
T KOG0531|consen 216 LDNKIS-------------------------KLEG--LNELVMLHLRELYLSGNRIS-RSPEGLENLKNLPVLDLSSNRI 267 (414)
T ss_pred ccccce-------------------------eccC--cccchhHHHHHHhcccCccc-cccccccccccccccchhhccc
Confidence 555554 2211 11122 3677777777776 4545666677777777777777
Q ss_pred ccchhhhhhccccccEEecCCCccccc---ccC--cccccccceeecccCcccccCCCC
Q 045798 532 HGSIPSFFNALKGVQKIDLSRNNLSGQ---IPI--FLEALSLEYLNLSFNDFEGKIPAK 585 (1008)
Q Consensus 532 ~~~~p~~~~~l~~L~~L~ls~N~l~~~---~p~--~~~~~~L~~L~l~~N~l~g~~p~~ 585 (1008)
... ..+.....+..+.++.|.+... ... ......+..+.+.+|......+..
T Consensus 268 ~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (414)
T KOG0531|consen 268 SNL--EGLERLPKLSELWLNDNKLALSEAISQEYITSAAPTLVTLTLELNPIRKISSLD 324 (414)
T ss_pred ccc--ccccccchHHHhccCcchhcchhhhhccccccccccccccccccCccccccccc
Confidence 632 2244556666777777776632 111 234456788888888777766543
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.00 E-value=5.6e-11 Score=135.76 Aligned_cols=196 Identities=31% Similarity=0.370 Sum_probs=101.5
Q ss_pred CCccCCeeeecCCCCCCCCCccccCCCCCCEEEccCCCCCCccCcccccCcCcceEeeeccccccCCCccccccCCCCee
Q 045798 76 NLSFLREINLSNNTIQGEIPPEFGRLFRLEALFLSNNSLVGKIPANLSYCSRLTVLCIEYNKLQGRIPLEFVSLSKLKDL 155 (1008)
Q Consensus 76 ~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L 155 (1008)
.+..++.+++..|.+. .+-..+..+.+|+.|++.+|+|. .+...+..+++|++|+|++|.|+... .+..++.|+.|
T Consensus 70 ~l~~l~~l~l~~n~i~-~~~~~l~~~~~l~~l~l~~n~i~-~i~~~l~~~~~L~~L~ls~N~I~~i~--~l~~l~~L~~L 145 (414)
T KOG0531|consen 70 SLTSLKELNLRQNLIA-KILNHLSKLKSLEALDLYDNKIE-KIENLLSSLVNLQVLDLSFNKITKLE--GLSTLTLLKEL 145 (414)
T ss_pred HhHhHHhhccchhhhh-hhhcccccccceeeeeccccchh-hcccchhhhhcchheecccccccccc--chhhccchhhh
Confidence 4455555666666665 23334566666666666666666 33333566666666666666666432 23445556666
Q ss_pred ecccccCCCCCCCCCccccccchhhcccccCCCCCC-ccccCCCCCcEEEecCCcccccCCccccCCCCcceeccccccc
Q 045798 156 SLAKNKLTGGIPPFLGNLTSLEVLSLAGNSFGRNIP-DSLGQLKQLKILAIGGNNLSGPIPPSIYNLSFLVVFSVSHNQI 234 (1008)
Q Consensus 156 ~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ls~N~l 234 (1008)
++++|.|+. ...+..++.|+.+++++|++....+ . ...+.+|+.+++.+|.+. ....+..+..+..+++..|.+
T Consensus 146 ~l~~N~i~~--~~~~~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~--~i~~~~~~~~l~~~~l~~n~i 220 (414)
T KOG0531|consen 146 NLSGNLISD--ISGLESLKSLKLLDLSYNRIVDIENDE-LSELISLEELDLGGNSIR--EIEGLDLLKKLVLLSLLDNKI 220 (414)
T ss_pred eeccCcchh--ccCCccchhhhcccCCcchhhhhhhhh-hhhccchHHHhccCCchh--cccchHHHHHHHHhhcccccc
Confidence 666666662 2334446666666666666644333 1 355566666666666664 223344444444445555555
Q ss_pred cccCChhhhhcCC--CCcEEEeccccCCCCCCcccccCCCCceeeccccccc
Q 045798 235 HGSLPPSLGLLLP--NLKFFQIHHNFFSGSIPISLSNASKLEHIEIANNNFS 284 (1008)
Q Consensus 235 ~~~lp~~~~~~l~--~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~ 284 (1008)
+ .+..... +. .|+.+++++|.+. ..+..+..+..+..|++.+|++.
T Consensus 221 ~-~~~~l~~--~~~~~L~~l~l~~n~i~-~~~~~~~~~~~l~~l~~~~n~~~ 268 (414)
T KOG0531|consen 221 S-KLEGLNE--LVMLHLRELYLSGNRIS-RSPEGLENLKNLPVLDLSSNRIS 268 (414)
T ss_pred e-eccCccc--chhHHHHHHhcccCccc-cccccccccccccccchhhcccc
Confidence 4 2211100 11 1445555555554 22233444444455555554444
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.00 E-value=3.8e-10 Score=109.72 Aligned_cols=126 Identities=26% Similarity=0.344 Sum_probs=43.4
Q ss_pred cccccchhhcccccCCCCCCcccc-CCCCCcEEEecCCcccccCCccccCCCCcceeccccccccccCChhhhhcCCCCc
Q 045798 172 NLTSLEVLSLAGNSFGRNIPDSLG-QLKQLKILAIGGNNLSGPIPPSIYNLSFLVVFSVSHNQIHGSLPPSLGLLLPNLK 250 (1008)
Q Consensus 172 ~l~~L~~L~L~~n~l~~~~~~~~~-~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~~~lp~~~~~~l~~L~ 250 (1008)
+...+++|+|.+|+|+.. +.++ .+.+|+.|+|++|.|+.. +.+..++.|+.|++++|+|+ .++..+...+|+|+
T Consensus 17 n~~~~~~L~L~~n~I~~I--e~L~~~l~~L~~L~Ls~N~I~~l--~~l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp~L~ 91 (175)
T PF14580_consen 17 NPVKLRELNLRGNQISTI--ENLGATLDKLEVLDLSNNQITKL--EGLPGLPRLKTLDLSNNRIS-SISEGLDKNLPNLQ 91 (175)
T ss_dssp ---------------------S--TT-TT--EEE-TTS--S----TT----TT--EEE--SS----S-CHHHHHH-TT--
T ss_pred cccccccccccccccccc--cchhhhhcCCCEEECCCCCCccc--cCccChhhhhhcccCCCCCC-ccccchHHhCCcCC
Confidence 344566666666666432 2344 456667777777777643 34666777777777777776 56555544577788
Q ss_pred EEEeccccCCCCC-CcccccCCCCceeeccccccccccc---ccccCCCccccccc
Q 045798 251 FFQIHHNFFSGSI-PISLSNASKLEHIEIANNNFSGKLS---VNFGGMKNLSLLNL 302 (1008)
Q Consensus 251 ~L~L~~N~l~~~~-p~~l~~l~~L~~L~L~~N~l~~~~~---~~~~~l~~L~~L~L 302 (1008)
.|+|++|+|.... -..++.+++|+.|+|.+|.++.... ..+..+|+|+.||-
T Consensus 92 ~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~~~~YR~~vi~~lP~Lk~LD~ 147 (175)
T PF14580_consen 92 ELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVCEKKNYRLFVIYKLPSLKVLDG 147 (175)
T ss_dssp EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGGGSTTHHHHHHHH-TT-SEETT
T ss_pred EEECcCCcCCChHHhHHHHcCCCcceeeccCCcccchhhHHHHHHHHcChhheeCC
Confidence 8888888776422 2466778888888888888875422 11334555555553
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.98 E-value=1.6e-10 Score=134.72 Aligned_cols=208 Identities=25% Similarity=0.302 Sum_probs=149.4
Q ss_pred HHhcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccc---hhhHHHHHHHHHHhhcCCCCceeeeeccccccccC
Q 045798 681 KATNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCE---GASKSFMAECKALKNIRHRNLVKVITSCSSIDFQG 757 (1008)
Q Consensus 681 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 757 (1008)
...+++.+.+.+-+|+++.++.+.-...|...++|+...... ...+....+-.+.-...+|-+++...- +.-
T Consensus 801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s-----~~~ 875 (1205)
T KOG0606|consen 801 SSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPS-----FPC 875 (1205)
T ss_pred CCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCC-----CCC
Confidence 345678888899999999999988877776666666542211 111222222222222344555554433 345
Q ss_pred CceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCC
Q 045798 758 NDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLS 837 (1008)
Q Consensus 758 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 837 (1008)
....++|++|+.+++|...++..+ ..+.+..+.....+..+.+|||.. .+.|||++|.|++...+++
T Consensus 876 rsP~~L~~~~~~~~~~~Skl~~~~----------~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh 942 (1205)
T KOG0606|consen 876 RSPLPLVGHYLNGGDLPSKLHNSG----------CLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGH 942 (1205)
T ss_pred CCCcchhhHHhccCCchhhhhcCC----------CcccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCC
Confidence 566899999999999999988765 344445566677788999999996 6999999999999999999
Q ss_pred eEEcccCccccccccc---------------------------CccccccccccccccccCccccCCCCCCcccchhhHH
Q 045798 838 GHIGDFGLARFHQEVS---------------------------NSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYG 890 (1008)
Q Consensus 838 ~kL~Dfg~a~~~~~~~---------------------------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG 890 (1008)
.+++|||......... ...........+|+.|.+||...+......+|.|+.|
T Consensus 943 ~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g 1022 (1205)
T KOG0606|consen 943 RPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSG 1022 (1205)
T ss_pred cccCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhh
Confidence 9999998433211100 0000123346799999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCcc
Q 045798 891 ILLLEMVTAKKPTDVM 906 (1008)
Q Consensus 891 ~vl~elltG~~pf~~~ 906 (1008)
++++|.++|.+||...
T Consensus 1023 ~~l~e~l~g~pp~na~ 1038 (1205)
T KOG0606|consen 1023 VCLFEVLTGIPPFNAE 1038 (1205)
T ss_pred hhhhhhhcCCCCCCCc
Confidence 9999999999998754
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.98 E-value=4.3e-09 Score=110.02 Aligned_cols=146 Identities=18% Similarity=0.181 Sum_probs=109.0
Q ss_pred CceEeeccCeeEEEEEEcCCCeEEEEEEeccccc-hhhHHHHHHHHHHhhcCC--CCceeeeeccccccccCCceEEEEE
Q 045798 689 THLIGVGSFGCVYKGALDEDGIVVAIKVINLQCE-GASKSFMAECKALKNIRH--RNLVKVITSCSSIDFQGNDFKAIVY 765 (1008)
Q Consensus 689 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~~~~~~~lv~ 765 (1008)
.+.|+.|.++.||++... +|+.+++|+...... .....+.+|+++++.+.+ ..+.+++.++.... ..+..++||
T Consensus 3 ~~~l~~G~~n~~~~v~~~-~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~--~~~~~~~v~ 79 (223)
T cd05154 3 VRQLSGGQSNLTYLLTAG-GGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPS--VLGTPFYVM 79 (223)
T ss_pred ceecCCCccceEEEEEec-CCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCC--ccCCceEEE
Confidence 367899999999999884 468999999764322 134678999999999965 34566776643211 113568999
Q ss_pred eccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCC-----------------------------
Q 045798 766 EYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHC----------------------------- 816 (1008)
Q Consensus 766 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~----------------------------- 816 (1008)
||++|.++.+.+... .++..+...++.++++++++||+..
T Consensus 80 e~i~G~~l~~~~~~~-----------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 148 (223)
T cd05154 80 ERVDGRVLRDRLLRP-----------ELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDA 148 (223)
T ss_pred EEeCCEecCCCCCCC-----------CCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHh
Confidence 999998888765321 4667777788888888888888521
Q ss_pred ------------------------CCCceeccCCCCCeeecC--CCCeEEcccCcccc
Q 045798 817 ------------------------QEPILHCDLKPSNILLDN--DLSGHIGDFGLARF 848 (1008)
Q Consensus 817 ------------------------~~~ivH~Dlkp~NIll~~--~~~~kL~Dfg~a~~ 848 (1008)
...++|+|++|.||+++. ++.+.++||+.+..
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 149 SRTDEPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred hcccccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 245799999999999998 56689999998863
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.94 E-value=4.2e-09 Score=100.09 Aligned_cols=129 Identities=26% Similarity=0.294 Sum_probs=96.0
Q ss_pred ceEeeccCeeEEEEEEcCCCeEEEEEEecccc---c-----hhhHHHHHHHHHHhhcCCC--CceeeeeccccccccCCc
Q 045798 690 HLIGVGSFGCVYKGALDEDGIVVAIKVINLQC---E-----GASKSFMAECKALKNIRHR--NLVKVITSCSSIDFQGND 759 (1008)
Q Consensus 690 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~-----~~~~~~~~E~~~l~~l~h~--niv~~~~~~~~~~~~~~~ 759 (1008)
..+++|+-+.+|.+.+ -|.++++|.-.... + -..++-.+|++++.+++-- +...++++ +++
T Consensus 2 ~~i~~GAEa~i~~~~~--~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dv-------D~~ 72 (204)
T COG3642 2 DLIKQGAEAIIYLTDF--LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDV-------DPD 72 (204)
T ss_pred chhhCCcceeEEeeec--cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEE-------cCC
Confidence 4578999999999977 35557777532211 1 1124678899999988533 33344443 445
Q ss_pred eEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeE
Q 045798 760 FKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGH 839 (1008)
Q Consensus 760 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 839 (1008)
...|+|||.+|..|.+++... ...++..+-.-+.-||.. ||||+|+.++||++..+. +.
T Consensus 73 ~~~I~me~I~G~~lkd~l~~~-----------------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~ 131 (204)
T COG3642 73 NGLIVMEYIEGELLKDALEEA-----------------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IY 131 (204)
T ss_pred CCEEEEEEeCChhHHHHHHhc-----------------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EE
Confidence 578999999999999888643 245777888888999998 999999999999998774 99
Q ss_pred EcccCcccc
Q 045798 840 IGDFGLARF 848 (1008)
Q Consensus 840 L~Dfg~a~~ 848 (1008)
++|||++..
T Consensus 132 ~IDfGLg~~ 140 (204)
T COG3642 132 FIDFGLGEF 140 (204)
T ss_pred EEECCcccc
Confidence 999999973
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.90 E-value=6.5e-09 Score=97.98 Aligned_cols=143 Identities=23% Similarity=0.241 Sum_probs=101.6
Q ss_pred CCceEeeccCeeEEEEEEcCCCeEEEEEEecccc--------chhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCc
Q 045798 688 STHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC--------EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGND 759 (1008)
Q Consensus 688 ~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 759 (1008)
....+-+|+-+.|+++.+ .|+.++||.-.... .-...+..+|++.+.++.--.|.-..-+ +.+..
T Consensus 11 ~l~likQGAEArv~~~~~--~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~-----~~D~~ 83 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF--SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLI-----FIDTY 83 (229)
T ss_pred cceeeeccceeeEeeecc--CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEE-----EEecC
Confidence 567899999999999998 68888887532111 1223578899999998853333221111 22334
Q ss_pred eEEEEEeccCC-CChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCC--
Q 045798 760 FKAIVYEYMPN-GSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDL-- 836 (1008)
Q Consensus 760 ~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-- 836 (1008)
.-.++|||++| .++.+++...-... ........++.+|-+.+.-||.. +|+|||+..+||++..++
T Consensus 84 ~~~i~ME~~~g~~~vk~~i~~~~~~~--------~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~ 152 (229)
T KOG3087|consen 84 GGQIYMEFIDGASTVKDFILSTMEDE--------SEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQ 152 (229)
T ss_pred CCeEEEEeccchhHHHHHHHHHccCc--------ccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCc
Confidence 46799999965 38888887654321 12222367899999999999998 999999999999996553
Q ss_pred -CeEEcccCcccc
Q 045798 837 -SGHIGDFGLARF 848 (1008)
Q Consensus 837 -~~kL~Dfg~a~~ 848 (1008)
.+.++|||++..
T Consensus 153 ~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 153 ITPILIDFGLSSV 165 (229)
T ss_pred CceEEEeecchhc
Confidence 458999999864
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.88 E-value=1.6e-09 Score=131.84 Aligned_cols=104 Identities=28% Similarity=0.350 Sum_probs=47.4
Q ss_pred CCCEEEccCCC--CCCccCcccccCcCcceEeeeccccccCCCccccccCCCCeeecccccCCCCCCCCCccccccchhh
Q 045798 103 RLEALFLSNNS--LVGKIPANLSYCSRLTVLCIEYNKLQGRIPLEFVSLSKLKDLSLAKNKLTGGIPPFLGNLTSLEVLS 180 (1008)
Q Consensus 103 ~L~~L~Ls~n~--l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 180 (1008)
.|++|-+..|. +....+..|..++.|++|||++|.=-+.+|..+++|-+|++|+|++..++ .+|..+++|..|.+|+
T Consensus 546 ~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL~L~~t~I~-~LP~~l~~Lk~L~~Ln 624 (889)
T KOG4658|consen 546 KLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYLDLSDTGIS-HLPSGLGNLKKLIYLN 624 (889)
T ss_pred ccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhcccccCCCcc-ccchHHHHHHhhheec
Confidence 44444444443 22122222444444555555444433444444444445555555544444 4444455555555555
Q ss_pred cccccCCCCCCccccCCCCCcEEEecC
Q 045798 181 LAGNSFGRNIPDSLGQLKQLKILAIGG 207 (1008)
Q Consensus 181 L~~n~l~~~~~~~~~~l~~L~~L~L~~ 207 (1008)
+..+.-...+|.....|++|++|.+-.
T Consensus 625 l~~~~~l~~~~~i~~~L~~Lr~L~l~~ 651 (889)
T KOG4658|consen 625 LEVTGRLESIPGILLELQSLRVLRLPR 651 (889)
T ss_pred cccccccccccchhhhcccccEEEeec
Confidence 544443333344444455555554443
|
|
| >PF08263 LRRNT_2: Leucine rich repeat N-terminal domain; InterPro: IPR013210 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape [] | Back alignment and domain information |
|---|
Probab=98.88 E-value=1.9e-09 Score=78.44 Aligned_cols=41 Identities=46% Similarity=0.998 Sum_probs=32.0
Q ss_pred ChhhHHHHHHHHHhhccCCCCCCCCCCCC--CCCCcccceEEc
Q 045798 10 EDGDRAALQAFKSMIAHEPQGILNSWNDS--RHFCEWEGITCG 50 (1008)
Q Consensus 10 ~~~~~~~l~~~k~~~~~~~~~~~~~w~~~--~~~c~w~gv~c~ 50 (1008)
.++|++||++||+++..+|.+.+.+|+.. .++|+|.||+|+
T Consensus 1 ~~~d~~aLl~~k~~l~~~~~~~l~~W~~~~~~~~C~W~GV~Cd 43 (43)
T PF08263_consen 1 PNQDRQALLAFKKSLNNDPSGVLSSWNPSSDSDPCSWSGVTCD 43 (43)
T ss_dssp -HHHHHHHHHHHHCTT-SC-CCCTT--TT--S-CCCSTTEEE-
T ss_pred CcHHHHHHHHHHHhcccccCcccccCCCcCCCCCeeeccEEeC
Confidence 36899999999999988888999999987 799999999995
|
LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. This domain is often found at the N terminus of tandem leucine rich repeats.; PDB: 3RGZ_A 3RJ0_A 3RIZ_A 3RGX_A 1OGQ_A. |
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.85 E-value=3.1e-09 Score=129.31 Aligned_cols=86 Identities=28% Similarity=0.451 Sum_probs=52.5
Q ss_pred ccCCccCCeeeecCCCCCCCCCccccCCCCCCEEEccCCCCCCccCcccccCcCcceEeeeccccccCCCccccccCCCC
Q 045798 74 LGNLSFLREINLSNNTIQGEIPPEFGRLFRLEALFLSNNSLVGKIPANLSYCSRLTVLCIEYNKLQGRIPLEFVSLSKLK 153 (1008)
Q Consensus 74 l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~ 153 (1008)
+..++.|+.|||++|.=-+.+|.++++|-+|++|+|++..++ .+|..+++|+.|.+|++..+.-...+|..+..|++|+
T Consensus 567 f~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL~L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr 645 (889)
T KOG4658|consen 567 FRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYLDLSDTGIS-HLPSGLGNLKKLIYLNLEVTGRLESIPGILLELQSLR 645 (889)
T ss_pred HhhCcceEEEECCCCCccCcCChHHhhhhhhhcccccCCCcc-ccchHHHHHHhhheeccccccccccccchhhhccccc
Confidence 455666666666665544566666666666666666666666 6666666666666666666655444455555566666
Q ss_pred eeecccc
Q 045798 154 DLSLAKN 160 (1008)
Q Consensus 154 ~L~L~~n 160 (1008)
+|.+...
T Consensus 646 ~L~l~~s 652 (889)
T KOG4658|consen 646 VLRLPRS 652 (889)
T ss_pred EEEeecc
Confidence 6665443
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.81 E-value=2.6e-08 Score=98.70 Aligned_cols=126 Identities=25% Similarity=0.225 Sum_probs=82.8
Q ss_pred eEEEEEEcCCCeEEEEEEecccc-------------c-------------hhhHHHHHHHHHHhhcCCC--Cceeeeecc
Q 045798 699 CVYKGALDEDGIVVAIKVINLQC-------------E-------------GASKSFMAECKALKNIRHR--NLVKVITSC 750 (1008)
Q Consensus 699 ~Vy~~~~~~~~~~vavK~~~~~~-------------~-------------~~~~~~~~E~~~l~~l~h~--niv~~~~~~ 750 (1008)
.||.|... +|..+|+|+.+... . .......+|++.|.++..- ++.+++++.
T Consensus 1 ~Vy~~~~~-~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAIDP-DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEEC-TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEECC-CCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 48999984 78899999975221 0 0113578899999999654 566666551
Q ss_pred ccccccCCceEEEEEeccC--CCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHH-HhhCCCCCceeccCCC
Q 045798 751 SSIDFQGNDFKAIVYEYMP--NGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDY-LHHHCQEPILHCDLKP 827 (1008)
Q Consensus 751 ~~~~~~~~~~~~lv~e~~~--~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~-LH~~~~~~ivH~Dlkp 827 (1008)
..++||||++ |..+..+.. . .++......++.+++..+.. +|+. ||||||+.+
T Consensus 80 ---------~~~ivME~I~~~G~~~~~l~~-~-----------~~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~ 135 (188)
T PF01163_consen 80 ---------RNVIVMEYIGEDGVPLPRLKD-V-----------DLSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSE 135 (188)
T ss_dssp ---------TTEEEEE--EETTEEGGCHHH-C-----------GGGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-ST
T ss_pred ---------CCEEEEEecCCCccchhhHHh-c-----------cccchhHHHHHHHHHHHHHHHHHhc---CceecCCCh
Confidence 2479999997 544544332 1 12234456788888886666 4676 999999999
Q ss_pred CCeeecCCCCeEEcccCcccccc
Q 045798 828 SNILLDNDLSGHIGDFGLARFHQ 850 (1008)
Q Consensus 828 ~NIll~~~~~~kL~Dfg~a~~~~ 850 (1008)
.||+++++ .+.++|||.+....
T Consensus 136 ~NIlv~~~-~~~iIDf~qav~~~ 157 (188)
T PF01163_consen 136 YNILVDDG-KVYIIDFGQAVDSS 157 (188)
T ss_dssp TSEEEETT-CEEE--GTTEEETT
T ss_pred hhEEeecc-eEEEEecCcceecC
Confidence 99999988 99999999987443
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.78 E-value=8.8e-08 Score=101.07 Aligned_cols=146 Identities=16% Similarity=0.044 Sum_probs=100.5
Q ss_pred ceEeeccCeeEEEEEEcCCCeEEEEEEeccccch-----------hhHHHHHHHHHHhhcCCCC--ceeeeecccccccc
Q 045798 690 HLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEG-----------ASKSFMAECKALKNIRHRN--LVKVITSCSSIDFQ 756 (1008)
Q Consensus 690 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~h~n--iv~~~~~~~~~~~~ 756 (1008)
+.+-+.....|+++.. .|+.|.||......-. ....+.+|.+.+.++...+ .++.+++.......
T Consensus 28 e~v~~~~~rrvvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~ 105 (268)
T PRK15123 28 EVFRELEGRRTLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNP 105 (268)
T ss_pred cEEecCCCceEEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCC
Confidence 4555555556778766 6789999977433211 1114788999888883322 23333332211111
Q ss_pred CCceEEEEEeccCCC-ChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecC-
Q 045798 757 GNDFKAIVYEYMPNG-SLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDN- 834 (1008)
Q Consensus 757 ~~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~- 834 (1008)
.....++|||++++. +|.+++...... +.+...+..++.+++..+.-||.. ||+|+|+++.|||++.
T Consensus 106 ~~~~s~LVte~l~~~~sL~~~~~~~~~~--------~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~ 174 (268)
T PRK15123 106 ATRTSFIITEDLAPTISLEDYCADWATN--------PPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLP 174 (268)
T ss_pred ccceeEEEEeeCCCCccHHHHHHhhccc--------CCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEecc
Confidence 134578999999875 898887532111 345667789999999999999998 9999999999999975
Q ss_pred ------CCCeEEcccCcccc
Q 045798 835 ------DLSGHIGDFGLARF 848 (1008)
Q Consensus 835 ------~~~~kL~Dfg~a~~ 848 (1008)
++.+.++||+.+..
T Consensus 175 ~~~~~~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 175 FPGREEDLKLSVIDLHRAQI 194 (268)
T ss_pred ccCCCCCceEEEEECCcccc
Confidence 46889999998863
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.76 E-value=8.1e-09 Score=82.42 Aligned_cols=61 Identities=36% Similarity=0.581 Sum_probs=43.3
Q ss_pred CCCceEEccCCcccccccccccCCCCcceeeccccccccccCCCCcCCCcccEeecccccc
Q 045798 398 QKLQGLDFSGNHFSGEIPSSLGNLSSLYEVFFNNNNLSGVIPFSLGNLKRLAFLEMSGNEL 458 (1008)
Q Consensus 398 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 458 (1008)
++|++|+|++|+++...+..|.++++|++|++++|.+....|..|.++++|++|++++|+|
T Consensus 1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 3566777777777755556677777777777777777766677777777777777777764
|
... |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.75 E-value=5.3e-08 Score=98.38 Aligned_cols=135 Identities=24% Similarity=0.176 Sum_probs=98.0
Q ss_pred CCCCceEeeccCeeEEEEEEcCCCeEEEEEEecccc----------------------chhhHHHHHHHHHHhhcCCC--
Q 045798 686 FSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC----------------------EGASKSFMAECKALKNIRHR-- 741 (1008)
Q Consensus 686 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----------------------~~~~~~~~~E~~~l~~l~h~-- 741 (1008)
+.+..+||-|--+.||.|.+. .|.++|||.=+... .-.....++|.++|.++...
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 445688999999999999986 78999999743111 01123578899999999544
Q ss_pred CceeeeeccccccccCCceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCce
Q 045798 742 NLVKVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPIL 821 (1008)
Q Consensus 742 niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iv 821 (1008)
.+.+.+++ +..++||||++|-.|...- ++....-.++..|+.-+.-.-.. |||
T Consensus 172 ~VP~P~~~---------nRHaVvMe~ieG~eL~~~r---------------~~~en~~~il~~il~~~~~~~~~---GiV 224 (304)
T COG0478 172 KVPKPIAW---------NRHAVVMEYIEGVELYRLR---------------LDVENPDEILDKILEEVRKAYRR---GIV 224 (304)
T ss_pred CCCCcccc---------ccceeeeehcccceeeccc---------------CcccCHHHHHHHHHHHHHHHHHc---Ccc
Confidence 66666655 3478999999886666542 12333344555555555444455 999
Q ss_pred eccCCCCCeeecCCCCeEEcccCcccc
Q 045798 822 HCDLKPSNILLDNDLSGHIGDFGLARF 848 (1008)
Q Consensus 822 H~Dlkp~NIll~~~~~~kL~Dfg~a~~ 848 (1008)
|||+++-||+++++|.+.++||-.+..
T Consensus 225 HGDlSefNIlV~~dg~~~vIDwPQ~v~ 251 (304)
T COG0478 225 HGDLSEFNILVTEDGDIVVIDWPQAVP 251 (304)
T ss_pred ccCCchheEEEecCCCEEEEeCccccc
Confidence 999999999999999999999987753
|
|
| >KOG2982 consensus Uncharacterized conserved protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.75 E-value=1.9e-09 Score=108.21 Aligned_cols=217 Identities=19% Similarity=0.199 Sum_probs=130.0
Q ss_pred cCcCccCCccCCeeeecCCCCCCCC-Cccc-cCCCCCCEEEccCCCCC--CccCcccccCcCcceEeeeccccccCCCcc
Q 045798 70 LSPHLGNLSFLREINLSNNTIQGEI-PPEF-GRLFRLEALFLSNNSLV--GKIPANLSYCSRLTVLCIEYNKLQGRIPLE 145 (1008)
Q Consensus 70 l~~~l~~l~~L~~L~L~~n~~~~~~-p~~~-~~l~~L~~L~Ls~n~l~--~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~ 145 (1008)
-+-.++.+..++.|.+.++.|..+- ...| .....+++|||.+|.|+ ..+-.-+.+|+.|++|+|+.|++...+...
T Consensus 37 s~~~v~s~ra~ellvln~~~id~~gd~~~~~~~~~~v~elDL~~N~iSdWseI~~ile~lP~l~~LNls~N~L~s~I~~l 116 (418)
T KOG2982|consen 37 SYLGVSSLRALELLVLNGSIIDNEGDVMLFGSSVTDVKELDLTGNLISDWSEIGAILEQLPALTTLNLSCNSLSSDIKSL 116 (418)
T ss_pred ceeeeccccchhhheecCCCCCcchhHHHHHHHhhhhhhhhcccchhccHHHHHHHHhcCccceEeeccCCcCCCccccC
Confidence 3444555666777888887776221 1122 24678999999999998 345556778999999999999998544332
Q ss_pred ccccCCCCeeecccccCC-CCCCCCCccccccchhhcccccCCCCCCccccCCCCCcEEEecCCcccccCCc--cccCCC
Q 045798 146 FVSLSKLKDLSLAKNKLT-GGIPPFLGNLTSLEVLSLAGNSFGRNIPDSLGQLKQLKILAIGGNNLSGPIPP--SIYNLS 222 (1008)
Q Consensus 146 ~~~l~~L~~L~L~~n~l~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~--~~~~l~ 222 (1008)
-..+.+|+.|-|.+..+. ...-..+..++.+++|.++.|.+. .+++..|.++..-+. .+..++
T Consensus 117 p~p~~nl~~lVLNgT~L~w~~~~s~l~~lP~vtelHmS~N~~r--------------q~n~Dd~c~e~~s~~v~tlh~~~ 182 (418)
T KOG2982|consen 117 PLPLKNLRVLVLNGTGLSWTQSTSSLDDLPKVTELHMSDNSLR--------------QLNLDDNCIEDWSTEVLTLHQLP 182 (418)
T ss_pred cccccceEEEEEcCCCCChhhhhhhhhcchhhhhhhhccchhh--------------hhccccccccccchhhhhhhcCC
Confidence 245778999999888776 234456678888999999988652 334444444321111 122233
Q ss_pred CcceeccccccccccCChhhhhcCCCCcEEEeccccCCCCC-CcccccCCCCceeecccccccccc-cccccCCCccccc
Q 045798 223 FLVVFSVSHNQIHGSLPPSLGLLLPNLKFFQIHHNFFSGSI-PISLSNASKLEHIEIANNNFSGKL-SVNFGGMKNLSLL 300 (1008)
Q Consensus 223 ~L~~L~ls~N~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~-p~~l~~l~~L~~L~L~~N~l~~~~-~~~~~~l~~L~~L 300 (1008)
.+..+.++-|++. ..+|++..+.+..|.+.... ......++.+-.|+|+.|+|.... ...+.++++|..|
T Consensus 183 c~~~~w~~~~~l~--------r~Fpnv~sv~v~e~PlK~~s~ek~se~~p~~~~LnL~~~~idswasvD~Ln~f~~l~dl 254 (418)
T KOG2982|consen 183 CLEQLWLNKNKLS--------RIFPNVNSVFVCEGPLKTESSEKGSEPFPSLSCLNLGANNIDSWASVDALNGFPQLVDL 254 (418)
T ss_pred cHHHHHHHHHhHH--------hhcccchheeeecCcccchhhcccCCCCCcchhhhhcccccccHHHHHHHcCCchhhee
Confidence 3333444444443 23566666777777665322 223344555556666666665432 2335555666666
Q ss_pred ccccccCC
Q 045798 301 NLQFSNLG 308 (1008)
Q Consensus 301 ~L~~n~l~ 308 (1008)
.+++|.+.
T Consensus 255 Rv~~~Pl~ 262 (418)
T KOG2982|consen 255 RVSENPLS 262 (418)
T ss_pred eccCCccc
Confidence 66655554
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.74 E-value=5.9e-09 Score=83.23 Aligned_cols=61 Identities=34% Similarity=0.474 Sum_probs=48.0
Q ss_pred ccccccccccccccCCCCcccccccccceeeccCcccccchhhhhhccccccEEecCCCcc
Q 045798 495 RALRSFDVSNNDLSGEIPIELGHCSSLEEIYLAGNLFHGSIPSFFNALKGVQKIDLSRNNL 555 (1008)
Q Consensus 495 ~~L~~Ldls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l 555 (1008)
++|+.|++++|+++...+..|..+++|++|++++|.++...|..|..+++|+.|++++|+|
T Consensus 1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 4678888888888855556778888888888888888877777888888888888888865
|
... |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.58 E-value=5.8e-07 Score=89.30 Aligned_cols=142 Identities=17% Similarity=0.151 Sum_probs=104.3
Q ss_pred EeeccCeeEEEEEEcCCCeEEEEEEecccc------chhhHHHHHHHHHHhhcCC--CCceeeeeccccccccCCceEEE
Q 045798 692 IGVGSFGCVYKGALDEDGIVVAIKVINLQC------EGASKSFMAECKALKNIRH--RNLVKVITSCSSIDFQGNDFKAI 763 (1008)
Q Consensus 692 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~~~~~~~l 763 (1008)
-|+||-+.|++... .|+.+-+|+-.... +-....|.+|...+.++.. -.+.+.. ++...........+|
T Consensus 26 ~~rgG~SgV~r~~~--~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~L 102 (216)
T PRK09902 26 YRRNGMSGVQCVER--NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALL 102 (216)
T ss_pred cCCCCcceEEEEEe--CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEE
Confidence 46688899999877 45578888864111 3345689999999999842 2244444 322222233455789
Q ss_pred EEeccCC-CChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCC--eEE
Q 045798 764 VYEYMPN-GSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLS--GHI 840 (1008)
Q Consensus 764 v~e~~~~-gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~--~kL 840 (1008)
|+|-+++ .+|.+++...... +.+......++.+++..++-||+. |+.|+|+.+.||+++.++. +++
T Consensus 103 VTe~L~g~~~L~~~l~~~~~~--------~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~l 171 (216)
T PRK09902 103 VTEDMAGFISIADWYAQHAVS--------PYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGF 171 (216)
T ss_pred EEEeCCCCccHHHHHhcCCcC--------CcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEE
Confidence 9998743 5888887654321 567778889999999999999998 9999999999999986666 899
Q ss_pred cccCccc
Q 045798 841 GDFGLAR 847 (1008)
Q Consensus 841 ~Dfg~a~ 847 (1008)
+||.-++
T Consensus 172 IDlEk~r 178 (216)
T PRK09902 172 LDLEKSR 178 (216)
T ss_pred EEhhccc
Confidence 9998776
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.53 E-value=2.7e-08 Score=112.34 Aligned_cols=98 Identities=22% Similarity=0.427 Sum_probs=77.3
Q ss_pred HHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEcccCcccccccccCccccccc-----cccccccccCccccCC
Q 045798 803 IDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSV-----GVKGTIGYTAPEYGLG 877 (1008)
Q Consensus 803 ~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~-----~~~gt~~y~aPE~~~~ 877 (1008)
.+++.|+.|+|.+ .++||++|.|++|.++..+..||+.|+++.............+. -......|.|||++.+
T Consensus 106 ~~v~dgl~flh~s--Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 106 GNVADGLAFLHRS--AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred hcccchhhhhccC--cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 3455899999987 69999999999999999999999999999765543222111111 1224568999999999
Q ss_pred CCCCcccchhhHHHHHHHHHhCCCC
Q 045798 878 SEVSTNGDVYSYGILLLEMVTAKKP 902 (1008)
Q Consensus 878 ~~~~~~sDvwslG~vl~elltG~~p 902 (1008)
...+.++|+||+||++|.+..|..+
T Consensus 184 ~~~~~~sd~fSlG~li~~i~~~gk~ 208 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLIYTIYNGGKS 208 (700)
T ss_pred ccccccccceeeeeEEEEEecCCcc
Confidence 8889999999999999999955444
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.53 E-value=9.9e-07 Score=87.85 Aligned_cols=142 Identities=18% Similarity=0.178 Sum_probs=97.3
Q ss_pred HhcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccchhhHHH---------HHHHHHHhhc---CCCCceeeeec
Q 045798 682 ATNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSF---------MAECKALKNI---RHRNLVKVITS 749 (1008)
Q Consensus 682 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~---------~~E~~~l~~l---~h~niv~~~~~ 749 (1008)
..++|.+.+++-......|.+... +|+.+++|..+.......+.| .+++....++ .-.....++.+
T Consensus 29 ~~~~~~~~kv~k~~~r~~ValIei--~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~ 106 (229)
T PF06176_consen 29 LDNNYKIIKVFKNTKRNYVALIEI--DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLA 106 (229)
T ss_pred HhCCceEEEeecCCCccEEEEEEE--CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceee
Confidence 346788889998888888887776 789999999875433332222 2333333333 33333343333
Q ss_pred cccccccCCceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCC
Q 045798 750 CSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSN 829 (1008)
Q Consensus 750 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~N 829 (1008)
+....+......++||||++|..|.++.. +++ .++..+++++.-+|+. |++|+|..|.|
T Consensus 107 ~ekk~~~~~~~~~ll~EYIeG~~l~d~~~--------------i~e----~~~~ki~~~ikqlH~~---G~~HGD~hpgN 165 (229)
T PF06176_consen 107 AEKKIFRYTSSYVLLMEYIEGVELNDIED--------------IDE----DLAEKIVEAIKQLHKH---GFYHGDPHPGN 165 (229)
T ss_pred eeeeeccceeEEEEEEEEecCeecccchh--------------cCH----HHHHHHHHHHHHHHHc---CCccCCCCcCc
Confidence 33222333445679999999988877642 222 2556778889999998 99999999999
Q ss_pred eeecCCCCeEEcccCccc
Q 045798 830 ILLDNDLSGHIGDFGLAR 847 (1008)
Q Consensus 830 Ill~~~~~~kL~Dfg~a~ 847 (1008)
++++++ .++++||+..+
T Consensus 166 Flv~~~-~i~iID~~~k~ 182 (229)
T PF06176_consen 166 FLVSNN-GIRIIDTQGKR 182 (229)
T ss_pred EEEECC-cEEEEECcccc
Confidence 999865 59999998765
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.49 E-value=1.4e-09 Score=121.48 Aligned_cols=102 Identities=28% Similarity=0.296 Sum_probs=49.3
Q ss_pred cceEeeeccccccCCCccccccCCCCeeecccccCCCCCCCCCccccccchhhcccccCCCCCCccccCCCCCcEEEecC
Q 045798 128 LTVLCIEYNKLQGRIPLEFVSLSKLKDLSLAKNKLTGGIPPFLGNLTSLEVLSLAGNSFGRNIPDSLGQLKQLKILAIGG 207 (1008)
Q Consensus 128 L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~ 207 (1008)
|.+.+.++|.+. .+..++.=++.|++|+|++|+++.. ..+..+++|++|||+.|.+....--.-.++. |+.|.+++
T Consensus 166 L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v--~~Lr~l~~LkhLDlsyN~L~~vp~l~~~gc~-L~~L~lrn 241 (1096)
T KOG1859|consen 166 LATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKV--DNLRRLPKLKHLDLSYNCLRHVPQLSMVGCK-LQLLNLRN 241 (1096)
T ss_pred HhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhh--HHHHhcccccccccccchhccccccchhhhh-heeeeecc
Confidence 444455555555 4444555555555555555555522 1445555555555555555332222222222 55555555
Q ss_pred CcccccCCccccCCCCcceecccccccc
Q 045798 208 NNLSGPIPPSIYNLSFLVVFSVSHNQIH 235 (1008)
Q Consensus 208 n~l~~~~~~~~~~l~~L~~L~ls~N~l~ 235 (1008)
|.++. -..+.+|.+|+.||+++|-|.
T Consensus 242 N~l~t--L~gie~LksL~~LDlsyNll~ 267 (1096)
T KOG1859|consen 242 NALTT--LRGIENLKSLYGLDLSYNLLS 267 (1096)
T ss_pred cHHHh--hhhHHhhhhhhccchhHhhhh
Confidence 55542 223445555555555555544
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.47 E-value=1.5e-08 Score=90.22 Aligned_cols=60 Identities=22% Similarity=0.375 Sum_probs=38.4
Q ss_pred ccccccccccccccCCCCcccccccccceeeccCcccccchhhhhhccccccEEecCCCccc
Q 045798 495 RALRSFDVSNNDLSGEIPIELGHCSSLEEIYLAGNLFHGSIPSFFNALKGVQKIDLSRNNLS 556 (1008)
Q Consensus 495 ~~L~~Ldls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~ 556 (1008)
+.++.|+|++|.++ .+|.++..++.|+.|+++.|.|. ..|.-|..|.+|-.||..+|.+.
T Consensus 77 ~t~t~lNl~~neis-dvPeE~Aam~aLr~lNl~~N~l~-~~p~vi~~L~~l~~Lds~~na~~ 136 (177)
T KOG4579|consen 77 PTATTLNLANNEIS-DVPEELAAMPALRSLNLRFNPLN-AEPRVIAPLIKLDMLDSPENARA 136 (177)
T ss_pred chhhhhhcchhhhh-hchHHHhhhHHhhhcccccCccc-cchHHHHHHHhHHHhcCCCCccc
Confidence 45666666666666 56666666666666666666666 55565555666666666666655
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.46 E-value=3.8e-09 Score=118.04 Aligned_cols=198 Identities=23% Similarity=0.273 Sum_probs=103.3
Q ss_pred CcCcceEeeeccccccCC-CccccccCCCCeeecccccCCCCCCCCCccc-cccchhhcccccCCCCCCcc-------cc
Q 045798 125 CSRLTVLCIEYNKLQGRI-PLEFVSLSKLKDLSLAKNKLTGGIPPFLGNL-TSLEVLSLAGNSFGRNIPDS-------LG 195 (1008)
Q Consensus 125 l~~L~~L~Ls~n~l~~~~-p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l-~~L~~L~L~~n~l~~~~~~~-------~~ 195 (1008)
+++++.|.+-.-.-.+.. |-.+..+.+|++|.|.++.|.. ...+..+ ..|+.|...+ .+. .+-.. +.
T Consensus 83 lqkt~~lkl~~~pa~~pt~pi~ifpF~sLr~LElrg~~L~~--~~GL~~lr~qLe~LIC~~-Sl~-Al~~v~ascggd~~ 158 (1096)
T KOG1859|consen 83 LQKTKVLKLLPSPARDPTEPISIFPFRSLRVLELRGCDLST--AKGLQELRHQLEKLICHN-SLD-ALRHVFASCGGDIS 158 (1096)
T ss_pred HhhheeeeecccCCCCCCCCceeccccceeeEEecCcchhh--hhhhHHHHHhhhhhhhhc-cHH-HHHHHHHHhccccc
Confidence 455555555544433333 6677788999999999998873 2223222 2455554432 211 01111 11
Q ss_pred C---CCCCcEEEecCCcccccCCccccCCCCcceeccccccccccCChhhhhcCCCCcEEEeccccCCCCCCcccccCCC
Q 045798 196 Q---LKQLKILAIGGNNLSGPIPPSIYNLSFLVVFSVSHNQIHGSLPPSLGLLLPNLKFFQIHHNFFSGSIPISLSNASK 272 (1008)
Q Consensus 196 ~---l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~ 272 (1008)
+ ...|...+.++|.+. ....++.-++.|+.|||++|+++ ... ....++.|++|||++|.+. .+|..--.-.+
T Consensus 159 ns~~Wn~L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~-~v~--~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc~ 233 (1096)
T KOG1859|consen 159 NSPVWNKLATASFSYNRLV-LMDESLQLLPALESLNLSHNKFT-KVD--NLRRLPKLKHLDLSYNCLR-HVPQLSMVGCK 233 (1096)
T ss_pred cchhhhhHhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhh-hhH--HHHhcccccccccccchhc-cccccchhhhh
Confidence 1 124566666677766 44556666666677777777665 222 2233566666666666666 33332222233
Q ss_pred CceeecccccccccccccccCCCcccccccccccCCCCCCCcccccccccccCCCcEEEecCCcCC
Q 045798 273 LEHIEIANNNFSGKLSVNFGGMKNLSLLNLQFSNLGSGESDEMGFMNSLTNCSKLRVLSLGGNQFR 338 (1008)
Q Consensus 273 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~ 338 (1008)
|..|.+++|.++.. ..+.++++|+.||+++|-|..... ...++.+..|+.|+|.+|.+-
T Consensus 234 L~~L~lrnN~l~tL--~gie~LksL~~LDlsyNll~~hse-----L~pLwsLs~L~~L~LeGNPl~ 292 (1096)
T KOG1859|consen 234 LQLLNLRNNALTTL--RGIENLKSLYGLDLSYNLLSEHSE-----LEPLWSLSSLIVLWLEGNPLC 292 (1096)
T ss_pred heeeeecccHHHhh--hhHHhhhhhhccchhHhhhhcchh-----hhHHHHHHHHHHHhhcCCccc
Confidence 66666666665532 223445555555565555543221 123444455555555555554
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 1008 | ||||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 1e-43 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 2e-33 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 1e-43 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 2e-39 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 6e-36 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 3e-34 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 4e-28 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 4e-28 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-23 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 1e-22 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-22 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-22 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 1e-21 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 5e-21 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 5e-21 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-20 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-19 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-19 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-19 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-19 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 3e-19 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 3e-19 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 3e-19 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 4e-19 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 4e-19 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 4e-19 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-17 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-17 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-17 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-17 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-17 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-17 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-17 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 3e-17 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 3e-17 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 3e-17 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 3e-17 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-17 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 3e-17 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 3e-17 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 3e-17 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 3e-17 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 3e-17 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 3e-17 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 3e-17 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 3e-17 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 3e-17 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 3e-17 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 3e-17 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 3e-17 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 3e-17 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-17 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 3e-17 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 3e-17 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 3e-17 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 3e-17 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 3e-17 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 4e-17 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 4e-17 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 4e-17 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-17 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 6e-17 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 7e-17 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 7e-17 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 8e-17 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 9e-17 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 9e-17 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-16 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-16 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 1e-16 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 1e-16 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 1e-16 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-16 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 1e-16 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-16 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 1e-16 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-16 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-16 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-16 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 2e-16 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-16 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-16 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-16 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-16 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-16 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-16 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 3e-16 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 3e-16 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 3e-16 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 3e-16 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 3e-16 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 3e-16 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 3e-16 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 4e-16 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 4e-16 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 4e-16 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 4e-16 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 4e-16 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 6e-16 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 6e-16 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 6e-16 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 6e-16 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 6e-16 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 6e-16 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 7e-16 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 7e-16 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 8e-16 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 8e-16 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 8e-16 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 8e-16 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 8e-16 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 9e-16 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 9e-16 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 1e-15 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-15 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 1e-15 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-15 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-15 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 1e-15 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 1e-15 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 1e-15 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 1e-15 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 1e-15 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-15 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 1e-15 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-15 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 1e-15 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 1e-15 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 1e-15 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 1e-15 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 1e-15 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 1e-15 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-15 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 1e-15 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 1e-15 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-15 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-15 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 1e-15 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-15 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 2e-15 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-15 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-15 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 2e-15 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-15 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-15 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 2e-15 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-15 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-15 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-15 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-15 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-15 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-15 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-15 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-15 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 3e-15 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 3e-15 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 3e-15 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 3e-15 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-15 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 3e-15 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 3e-15 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 3e-15 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 3e-15 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 3e-15 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-15 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 3e-15 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 3e-15 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-15 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-15 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 3e-15 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-15 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 4e-15 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 4e-15 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 4e-15 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 4e-15 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 4e-15 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 4e-15 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-15 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 4e-15 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 4e-15 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 4e-15 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 4e-15 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 4e-15 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 4e-15 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 4e-15 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 4e-15 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 4e-15 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-15 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 4e-15 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 4e-15 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 4e-15 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 4e-15 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 4e-15 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-15 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 5e-15 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 5e-15 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 6e-15 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 6e-15 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 1e-14 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-14 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-14 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-14 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-14 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-14 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-14 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-14 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 3e-14 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-14 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 6e-14 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 6e-14 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 7e-14 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 8e-14 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 8e-14 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 8e-14 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 9e-14 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-13 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-13 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 2e-13 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 2e-13 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 3e-13 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 3e-13 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 4e-13 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-13 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 5e-13 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-13 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 5e-13 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 6e-13 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 6e-13 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 6e-13 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 7e-13 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 8e-13 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 8e-13 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 8e-13 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 8e-13 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 8e-13 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 8e-13 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 8e-13 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-12 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 1e-12 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 1e-12 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 1e-12 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 1e-12 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 1e-12 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-12 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-12 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 2e-12 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-12 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-12 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 3e-12 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 3e-12 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 3e-12 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 3e-12 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 3e-12 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-12 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 3e-12 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 3e-12 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 4e-12 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 4e-12 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 4e-12 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 5e-12 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 5e-12 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 5e-12 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 5e-12 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-12 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 6e-12 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 6e-12 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 6e-12 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-12 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-12 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 6e-12 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 6e-12 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 8e-12 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 8e-12 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 9e-12 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 1e-11 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-11 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-11 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-11 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-11 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-11 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-11 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-11 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-11 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 3e-11 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 3e-11 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 3e-11 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 3e-11 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 3e-11 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-11 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 3e-11 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 3e-11 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-11 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 4e-11 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-11 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 4e-11 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 4e-11 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 4e-11 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 4e-11 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 4e-11 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 4e-11 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 4e-11 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-11 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 5e-11 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 5e-11 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 5e-11 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 5e-11 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-11 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 5e-11 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 5e-11 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 6e-11 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 6e-11 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 6e-11 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 6e-11 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-11 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 6e-11 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 6e-11 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 6e-11 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 6e-11 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 6e-11 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 6e-11 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 6e-11 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 7e-11 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 7e-11 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 8e-11 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 8e-11 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 8e-11 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 8e-11 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 8e-11 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 8e-11 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 8e-11 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 9e-11 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 9e-11 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-10 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 1e-10 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 1e-10 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 1e-10 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-10 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 1e-10 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-10 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-10 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 1e-10 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 2e-10 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-10 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-10 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-10 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-10 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-10 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-10 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-10 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 2e-10 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-10 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-10 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-10 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 2e-10 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 2e-10 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-10 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 2e-10 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 2e-10 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-10 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 3e-10 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 3e-10 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 3e-10 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 3e-10 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-10 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 3e-10 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 3e-10 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 3e-10 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 3e-10 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 3e-10 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 3e-10 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-10 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 3e-10 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-10 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 3e-10 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 3e-10 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 3e-10 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 4e-10 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 4e-10 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 4e-10 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 4e-10 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 4e-10 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 6e-10 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 6e-10 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 6e-10 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 6e-10 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 6e-10 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-10 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 7e-10 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 8e-10 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 8e-10 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 8e-10 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 8e-10 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 8e-10 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 8e-10 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 8e-10 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-10 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-10 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-10 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 9e-10 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-10 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 1e-09 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 1e-09 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-09 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-09 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-09 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-09 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-09 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 1e-09 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-09 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-09 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-09 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-09 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 1e-09 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-09 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-09 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-09 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 1e-09 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 1e-09 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 1e-09 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 1e-09 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-09 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-09 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 1e-09 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-09 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 1e-09 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 1e-09 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 1e-09 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-09 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-09 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-09 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-09 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 2e-09 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 2e-09 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 2e-09 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-09 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-09 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 2e-09 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 2e-09 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 2e-09 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 2e-09 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 2e-09 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 2e-09 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 3e-09 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 3e-09 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 3e-09 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 4e-09 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 4e-09 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 4e-09 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-09 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 4e-09 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 4e-09 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-09 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 4e-09 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 4e-09 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 5e-09 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 5e-09 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 5e-09 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 5e-09 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 5e-09 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 5e-09 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 6e-09 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 6e-09 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 6e-09 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 6e-09 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-09 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 7e-09 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 7e-09 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 8e-09 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 8e-09 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 8e-09 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 9e-09 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-08 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 1e-08 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 1e-08 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 1e-08 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 1e-08 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 1e-08 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 1e-08 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 1e-08 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-08 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 1e-08 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-08 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 1e-08 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-08 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-08 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-08 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 1e-08 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-08 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-08 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 1e-08 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-08 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-08 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 1e-08 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 1e-08 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 1e-08 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 1e-08 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-08 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-08 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-08 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 1e-08 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 2e-08 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 2e-08 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-08 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-08 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-08 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-08 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-08 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 2e-08 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-08 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 2e-08 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-08 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-08 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 2e-08 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-08 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-08 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-08 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 2e-08 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 2e-08 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-08 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 2e-08 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-08 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-08 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-08 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-08 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-08 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-08 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-08 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-08 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-08 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-08 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-08 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 3e-08 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 3e-08 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 3e-08 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 3e-08 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 3e-08 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 3e-08 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 3e-08 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 3e-08 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-08 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 3e-08 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-08 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 4e-08 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 4e-08 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 4e-08 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 4e-08 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 4e-08 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 4e-08 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 4e-08 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 4e-08 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-08 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 4e-08 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-08 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 4e-08 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 5e-08 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 5e-08 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 5e-08 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 5e-08 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 5e-08 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-08 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 5e-08 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 6e-08 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 6e-08 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-08 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 6e-08 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 6e-08 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 7e-08 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 7e-08 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 7e-08 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 7e-08 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-08 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 7e-08 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 7e-08 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 7e-08 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 7e-08 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 8e-08 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 8e-08 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 8e-08 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 8e-08 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 8e-08 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 8e-08 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 8e-08 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 9e-08 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 9e-08 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 9e-08 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 9e-08 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 9e-08 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 9e-08 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 9e-08 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 9e-08 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-07 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 1e-07 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-07 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-07 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-07 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 1e-07 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 1e-07 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-07 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 1e-07 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 1e-07 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-07 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 1e-07 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 1e-07 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 1e-07 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 1e-07 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 1e-07 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 1e-07 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 1e-07 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-07 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 1e-07 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 1e-07 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 1e-07 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 1e-07 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-07 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-07 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-07 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-07 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-07 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-07 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-07 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-07 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-07 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-07 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-07 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-07 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-07 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-07 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-07 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-07 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-07 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-07 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-07 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-07 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-07 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-07 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-07 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-07 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-07 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-07 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-07 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 2e-07 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-07 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-07 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-07 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-07 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-07 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-07 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 2e-07 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-07 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-07 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-07 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-07 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-07 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-07 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 2e-07 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 2e-07 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 2e-07 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-07 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-07 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-07 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-07 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 2e-07 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-07 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-07 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-07 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-07 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-07 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 2e-07 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 2e-07 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-07 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-07 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 2e-07 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-07 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 2e-07 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-07 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-07 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-07 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-07 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 2e-07 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 3e-07 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 3e-07 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 3e-07 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-07 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 3e-07 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 3e-07 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 3e-07 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 3e-07 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 3e-07 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-07 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 3e-07 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 4e-07 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 4e-07 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 4e-07 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 4e-07 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-07 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 4e-07 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 4e-07 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 4e-07 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 4e-07 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 4e-07 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 4e-07 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 4e-07 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 4e-07 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 5e-07 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 5e-07 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 5e-07 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 5e-07 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 5e-07 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 5e-07 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-07 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-07 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 5e-07 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 5e-07 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 5e-07 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 5e-07 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 5e-07 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 5e-07 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 5e-07 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 6e-07 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 6e-07 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 6e-07 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 6e-07 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 6e-07 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 6e-07 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 6e-07 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 6e-07 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 6e-07 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 7e-07 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 8e-07 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 8e-07 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 8e-07 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 9e-07 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 9e-07 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 9e-07 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 9e-07 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 9e-07 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 9e-07 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 9e-07 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-06 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 1e-06 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 1e-06 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 1e-06 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 1e-06 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 1e-06 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 1e-06 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 1e-06 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 1e-06 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 1e-06 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 1e-06 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 1e-06 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 1e-06 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-06 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 1e-06 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 1e-06 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 1e-06 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 1e-06 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 1e-06 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-06 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 1e-06 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 2e-06 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-06 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 2e-06 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-06 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-06 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-06 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-06 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-06 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 2e-06 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 2e-06 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 2e-06 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-06 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 2e-06 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 2e-06 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 2e-06 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-06 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-06 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 2e-06 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 2e-06 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 2e-06 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 2e-06 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-06 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 2e-06 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 3e-06 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 3e-06 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 3e-06 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 3e-06 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 3e-06 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 3e-06 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-06 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 3e-06 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 3e-06 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-06 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-06 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 3e-06 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-06 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 3e-06 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 3e-06 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 3e-06 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 3e-06 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 4e-06 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-06 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-06 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 4e-06 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 4e-06 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 4e-06 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 4e-06 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 4e-06 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 4e-06 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 4e-06 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 4e-06 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 4e-06 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 4e-06 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 5e-06 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 5e-06 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 5e-06 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 5e-06 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 5e-06 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 5e-06 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 5e-06 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 5e-06 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 5e-06 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 5e-06 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 5e-06 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 6e-06 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 6e-06 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 6e-06 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 6e-06 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 6e-06 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 7e-06 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 7e-06 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 7e-06 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 7e-06 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 7e-06 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 7e-06 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 8e-06 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 8e-06 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 9e-06 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 9e-06 | ||
| 2omx_A | 462 | Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX | 1e-05 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-05 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 1e-05 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-05 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 1e-05 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-05 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 1e-05 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 1e-05 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 1e-05 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-05 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 1e-05 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 1e-05 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-05 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-05 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 2e-05 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-05 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-05 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 2e-05 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 2e-05 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 2e-05 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 2e-05 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 2e-05 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-05 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-05 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 2e-05 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 3e-05 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 3e-05 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 3e-05 | ||
| 4hni_A | 296 | Crystal Structure Of Ck1e In Complex With Pf4800567 | 3e-05 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-05 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 4e-05 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 4e-05 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 4e-05 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-05 | ||
| 2omu_A | 462 | Crystal Structure Of Inla G194s+s Y369s/hec1 Comple | 4e-05 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 4e-05 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 4e-05 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 4e-05 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 4e-05 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-05 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-05 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 4e-05 | ||
| 2omt_A | 462 | Crystal Structure Of Inla G194s+sHEC1 COMPLEX Lengt | 4e-05 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 5e-05 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 5e-05 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 5e-05 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 6e-05 | ||
| 1ckj_A | 317 | Casein Kinase I Delta Truncation Mutant Containing | 6e-05 | ||
| 3uys_A | 296 | Crystal Structure Of Apo Human Ck1d Length = 296 | 6e-05 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 7e-05 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-05 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 7e-05 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 7e-05 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 7e-05 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 7e-05 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 7e-05 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 7e-05 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 7e-05 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 8e-05 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 8e-05 | ||
| 2omz_A | 466 | Crystal Structure Of Inla Y369a/hec1 Complex Length | 9e-05 | ||
| 1o6s_A | 466 | Internalin (Listeria Monocytogenes) E-Cadherin (Hum | 1e-04 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-04 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-04 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 1e-04 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 1e-04 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-04 | ||
| 2omv_A | 461 | Crystal Structure Of Inla S192n Y369s/hec1 Complex | 2e-04 | ||
| 2omy_A | 461 | Crystal Structure Of Inla S192n/hec1 Complex Length | 2e-04 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-04 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-04 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 2e-04 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-04 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 2e-04 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-04 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-04 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 3e-04 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 3e-04 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-04 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-04 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 3e-04 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 3e-04 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 3e-04 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-04 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 3e-04 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-04 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-04 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 4e-04 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 4e-04 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 4e-04 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-04 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 4e-04 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 4e-04 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 4e-04 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 4e-04 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 5e-04 | ||
| 2z66_A | 306 | Crystal Structure Of The Vt3 Hybrid Of Human Tlr4 A | 5e-04 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 5e-04 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 5e-04 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 5e-04 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 5e-04 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 5e-04 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 5e-04 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 5e-04 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 5e-04 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 5e-04 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 5e-04 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 5e-04 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 5e-04 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 5e-04 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 5e-04 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 5e-04 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 5e-04 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 6e-04 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 6e-04 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 6e-04 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 6e-04 | ||
| 3fxi_A | 605 | Crystal Structure Of The Human Tlr4-Human Md-2-E.Co | 6e-04 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 6e-04 | ||
| 4g8a_A | 635 | Crystal Structure Of Human Tlr4 Polymorphic Variant | 6e-04 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 7e-04 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 7e-04 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 7e-04 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 7e-04 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 8e-04 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 9e-04 |
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2OMX|A Chain A, Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX Length = 462 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2OMU|A Chain A, Crystal Structure Of Inla G194s+s Y369s/hec1 Complex Length = 462 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2OMT|A Chain A, Crystal Structure Of Inla G194s+sHEC1 COMPLEX Length = 462 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317 | Back alignment and structure |
|
| >pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2OMZ|A Chain A, Crystal Structure Of Inla Y369a/hec1 Complex Length = 466 | Back alignment and structure |
|
| >pdb|1O6S|A Chain A, Internalin (Listeria Monocytogenes) E-Cadherin (Human) Recognition Complex Length = 466 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2OMV|A Chain A, Crystal Structure Of Inla S192n Y369s/hec1 Complex Length = 461 | Back alignment and structure |
|
| >pdb|2OMY|A Chain A, Crystal Structure Of Inla S192n/hec1 Complex Length = 461 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|2Z66|A Chain A, Crystal Structure Of The Vt3 Hybrid Of Human Tlr4 And Hagfish Vlrb.61 Length = 306 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3FXI|A Chain A, Crystal Structure Of The Human Tlr4-Human Md-2-E.Coli Lps Ra Complex Length = 605 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|4G8A|A Chain A, Crystal Structure Of Human Tlr4 Polymorphic Variant D299g And T399i In Complex With Md-2 And Lps Length = 635 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 522 bits (1347), Expect = e-173
Identities = 179/576 (31%), Positives = 270/576 (46%), Gaps = 26/576 (4%)
Query: 59 LDLMSKSLSGSLSPHLGNLSFLREINLSNNTIQGEIPPEFGRLFRLEALFLSNNSLVGKI 118
LD+ S + S + P LG+ S L+ +++S N + G+ L+ L +S+N VG I
Sbjct: 205 LDVSSNNFSTGI-PFLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPI 263
Query: 119 PANLSYCSRLTVLCIEYNKLQGRIPLEFV-SLSKLKDLSLAKNKLTGGIPPFLGNLTSLE 177
P L L + NK G IP + L L L+ N G +PPF G+ + LE
Sbjct: 264 PP--LPLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLE 321
Query: 178 VLSLAGNSFGRNIP-DSLGQLKQLKILAIGGNNLSGPIPPSIYNLSF-LVVFSVSHNQIH 235
L+L+ N+F +P D+L +++ LK+L + N SG +P S+ NLS L+ +S N
Sbjct: 322 SLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFS 381
Query: 236 GSLPPSLG-LLLPNLKFFQIHHNFFSGSIPISLSNASKLEHIEIANNNFSGKLSVNFGGM 294
G + P+L L+ + +N F+G IP +LSN S+L + ++ N SG + + G +
Sbjct: 382 GPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSL 441
Query: 295 KNLSLLNLQFSNLGSGESDEMGFMNSLTNCSKLRVLSLGGNQFRGALPHSIANLSSQLQI 354
L L L + L GE L L L L N G +P ++N ++ L
Sbjct: 442 SKLRDLKLWLNML-EGE-----IPQELMYVKTLETLILDFNDLTGEIPSGLSNCTN-LNW 494
Query: 355 LILSSNQFYGSIPLGIGNLVDLYLLGMVENQFTGAIPKEMGKLQKLQGLDFSGNHFSGEI 414
+ LS+N+ G IP IG L +L +L + N F+G IP E+G + L LD + N F+G I
Sbjct: 495 ISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTI 554
Query: 415 PSSLGNLSSLYEVFFNNNNLSGVIPFSLGNLKRLAFLEMSGN--ELSGTIPEDIFNISYL 472
P+++ S N ++G + N +GN E G E + +S
Sbjct: 555 PAAMFKQSGK----IAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTR 610
Query: 473 SNSLNLARNHLVGIIPPRIGNLRALRSFDVSNNDLSGEIPIELGHCSSLEEIYLAGNLFH 532
N N+ G P N ++ D+S N LSG IP E+G L + L N
Sbjct: 611 -NPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDIS 669
Query: 533 GSIPSFFNALKGVQKIDLSRNNLSGQIPIFLEAL-SLEYLNLSFNDFEGKIPAKGIFANA 591
GSIP L+G+ +DLS N L G+IP + AL L ++LS N+ G IP G F
Sbjct: 670 GSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETF 729
Query: 592 SAISVVGCNRLCGGIPELQLPKCTESKSSSQKISRR 627
+ LCG LP+C S + +R
Sbjct: 730 PPAKFLNNPGLCG----YPLPRCDPSNADGYAHHQR 761
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 487 bits (1255), Expect = e-159
Identities = 174/586 (29%), Positives = 283/586 (48%), Gaps = 36/586 (6%)
Query: 13 DRAALQAFKSMIAHEPQGILNSWNDSRHFCEWEGITCGRRHRRVTALDLMSKSLS---GS 69
+ L +FK ++ + +L W+ +++ C ++G+TC R +VT++DL SK L+ +
Sbjct: 13 EIHQLISFKDVL--PDKNLLPDWSSNKNPCTFDGVTC--RDDKVTSIDLSSKPLNVGFSA 68
Query: 70 LSPHLGNLSFLREINLSNNTIQGEIPPEFGRLFRLEALFLSNNSLVGKIPA--NLSYCSR 127
+S L +L+ L + LSN+ I G + F L +L LS NSL G + +L CS
Sbjct: 69 VSSSLLSLTGLESLFLSNSHINGSV-SGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSG 127
Query: 128 LTVLCIEYNKLQGRIPLE-FVSLSKLKDLSLAKNKLTGGIPP---FLGNLTSLEVLSLAG 183
L L + N L + + L+ L+ L L+ N ++G L+ L+++G
Sbjct: 128 LKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISG 187
Query: 184 NSFGRNIPDSLGQLKQLKILAIGGNNLSGPIPPSIYNLSFLVVFSVSHNQIHGSLPPSLG 243
N ++ + + L+ L + NN S I P + + S L +S N++ G ++
Sbjct: 188 NKISGDVD--VSRCVNLEFLDVSSNNFSTGI-PFLGDCSALQHLDISGNKLSGDFSRAIS 244
Query: 244 LLLPNLKFFQIHHNFFSGSIPISLSNASKLEHIEIANNNFSGKLSVNFGG-MKNLSLLNL 302
LK I N F G IP L+++ +A N F+G++ G L+ L+L
Sbjct: 245 -TCTELKLLNISSNQFVGPIP--PLPLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDL 301
Query: 303 QFSNLGSGESDEMGFMNSLTNCSKLRVLSLGGNQFRGALP-HSIANLSSQLQILILSSNQ 361
++ G +CS L L+L N F G LP ++ + L++L LS N+
Sbjct: 302 SGNHF-YGA-----VPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRG-LKVLDLSFNE 354
Query: 362 FYGSIPLGIGNL-VDLYLLGMVENQFTGAIPKEMGKLQK--LQGLDFSGNHFSGEIPSSL 418
F G +P + NL L L + N F+G I + + K LQ L N F+G+IP +L
Sbjct: 355 FSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTL 414
Query: 419 GNLSSLYEVFFNNNNLSGVIPFSLGNLKRLAFLEMSGNELSGTIPEDIFNISYLSNSLNL 478
N S L + + N LSG IP SLG+L +L L++ N L G IP+++ + L +L L
Sbjct: 415 SNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLE-TLIL 473
Query: 479 ARNHLVGIIPPRIGNLRALRSFDVSNNDLSGEIPIELGHCSSLEEIYLAGNLFHGSIPSF 538
N L G IP + N L +SNN L+GEIP +G +L + L+ N F G+IP+
Sbjct: 474 DFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAE 533
Query: 539 FNALKGVQKIDLSRNNLSGQIPIFLEALSLEYLNLSFNDFEGKIPA 584
+ + +DL+ N +G IP A+ + ++ N GK
Sbjct: 534 LGDCRSLIWLDLNTNLFNGTIP---AAMFKQSGKIAANFIAGKRYV 576
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 334 bits (859), Expect = e-101
Identities = 129/451 (28%), Positives = 202/451 (44%), Gaps = 29/451 (6%)
Query: 171 GNLTSLEVLSLAGNSFGRNIPDSLGQLKQLKILAIGGNNLSGPIPPSIYNLSFLVVFSVS 230
+TS+++ S N + SL L L+ L + ++++G + + L +S
Sbjct: 50 DKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSV-SGFKCSASLTSLDLS 108
Query: 231 HNQIHGSLPPSLGLL-LPNLKFFQIHHNFFSGSIPIS-LSNASKLEHIEIANNNFSGKLS 288
N + G + L LKF + N +S + LE ++++ N+ SG
Sbjct: 109 RNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANV 168
Query: 289 VNF---GGMKNLSLLNLQFSNLGSGESDEMGFMNSLTNCSKLRVLSLGGNQFRGALPHSI 345
V + G L L + + + SG+ ++ C L L + N F +P +
Sbjct: 169 VGWVLSDGCGELKHLAISGNKI-SGDV-------DVSRCVNLEFLDVSSNNFSTGIP-FL 219
Query: 346 ANLSSQLQILILSSNQFYGSIPLGIGNLVDLYLLGMVENQFTGAIPKEMGKLQKLQGLDF 405
+ S+ LQ L +S N+ G I +L LL + NQF G IP L+ LQ L
Sbjct: 220 GDCSA-LQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPL--PLKSLQYLSL 276
Query: 406 SGNHFSGEIPSSL-GNLSSLYEVFFNNNNLSGVIPFSLGNLKRLAFLEMSGNELSGTIPE 464
+ N F+GEIP L G +L + + N+ G +P G+ L L +S N SG +P
Sbjct: 277 AENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPM 336
Query: 465 D-IFNISYLSNSLNLARNHLVGIIPPRIGNLRA-LRSFDVSNNDLSGEIPIELGHC--SS 520
D + + L L+L+ N G +P + NL A L + D+S+N+ SG I L ++
Sbjct: 337 DTLLKMRGLK-VLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNT 395
Query: 521 LEEIYLAGNLFHGSIPSFFNALKGVQKIDLSRNNLSGQIPIFLEALS-LEYLNLSFNDFE 579
L+E+YL N F G IP + + + LS N LSG IP L +LS L L L N E
Sbjct: 396 LQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLE 455
Query: 580 GKIPAKGIFANASAISV--VGCNRLCGGIPE 608
G+IP + + + N L G IP
Sbjct: 456 GEIPQE--LMYVKTLETLILDFNDLTGEIPS 484
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 308 bits (791), Expect = 1e-91
Identities = 113/427 (26%), Positives = 193/427 (45%), Gaps = 25/427 (5%)
Query: 193 SLGQLKQLKILAIGGNNLSGPIPPSIYNLSFLVVFSVSHNQIHGSLPPSLGLLLPNLKFF 252
++ + + + N + S+ +L+ L +S++ I+GS+ +L
Sbjct: 48 RDDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSGFKC--SASLTSL 105
Query: 253 QIHHNFFSGSIP--ISLSNASKLEHIEIANNNFSGKLSV-NFGGMKNLSLLNLQFSNLGS 309
+ N SG + SL + S L+ + +++N V + +L +L+L +++
Sbjct: 106 DLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISG 165
Query: 310 GESDEMGFMNSLTNCSKLRVLSLGGNQFRGALPHSIANLSSQLQILILSSNQFYGSIPLG 369
+ L+ L++ GN+ G + ++ + L+ L +SSN F IP
Sbjct: 166 ANVVGWVLSDGCGE---LKHLAISGNKISGDVD--VSRCVN-LEFLDVSSNNFSTGIPF- 218
Query: 370 IGNLVDLYLLGMVENQFTGAIPKEMGKLQKLQGLDFSGNHFSGEIPSSLGNLSSLYEVFF 429
+G+ L L + N+ +G + + +L+ L+ S N F G IP L SL +
Sbjct: 219 LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPL--PLKSLQYLSL 276
Query: 430 NNNNLSGVIPFSL-GNLKRLAFLEMSGNELSGTIPEDIFNISYLSNSLNLARNHLVGIIP 488
N +G IP L G L L++SGN G +P + S L SL L+ N+ G +P
Sbjct: 277 AENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLE-SLALSSNNFSGELP 335
Query: 489 P-RIGNLRALRSFDVSNNDLSGEIPIELGHCS-SLEEIYLAGNLFHGSIPSFF--NALKG 544
+ +R L+ D+S N+ SGE+P L + S SL + L+ N F G I N
Sbjct: 336 MDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNT 395
Query: 545 VQKIDLSRNNLSGQIPIFLEALS-LEYLNLSFNDFEGKIPAKGIFANASAISVV--GCNR 601
+Q++ L N +G+IP L S L L+LSFN G IP+ + S + + N
Sbjct: 396 LQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSS--LGSLSKLRDLKLWLNM 453
Query: 602 LCGGIPE 608
L G IP+
Sbjct: 454 LEGEIPQ 460
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-25
Identities = 38/130 (29%), Positives = 60/130 (46%), Gaps = 1/130 (0%)
Query: 56 VTALDLMSKSLSGSLSPHLGNLSFLREINLSNNTIQGEIPPEFGRLFRLEALFLSNNSLV 115
++ S+ G SP N + +++S N + G IP E G + L L L +N +
Sbjct: 610 RNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDIS 669
Query: 116 GKIPANLSYCSRLTVLCIEYNKLQGRIPLEFVSLSKLKDLSLAKNKLTGGIPPFLGNLTS 175
G IP + L +L + NKL GRIP +L+ L ++ L+ N L+G I P +G +
Sbjct: 670 GSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPI-PEMGQFET 728
Query: 176 LEVLSLAGNS 185
N
Sbjct: 729 FPPAKFLNNP 738
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 2e-17
Identities = 34/90 (37%), Positives = 49/90 (54%)
Query: 54 RRVTALDLMSKSLSGSLSPHLGNLSFLREINLSNNTIQGEIPPEFGRLFRLEALFLSNNS 113
+ LD+ LSG + +G++ +L +NL +N I G IP E G L L L LS+N
Sbjct: 632 GSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNK 691
Query: 114 LVGKIPANLSYCSRLTVLCIEYNKLQGRIP 143
L G+IP +S + LT + + N L G IP
Sbjct: 692 LDGRIPQAMSALTMLTEIDLSNNNLSGPIP 721
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 63.0 bits (154), Expect = 4e-10
Identities = 21/102 (20%), Positives = 41/102 (40%), Gaps = 2/102 (1%)
Query: 516 GHCSSLEEIYLAGNLFHGSIPSFFNALKGVQKIDLSRNNLSGQIPIFLEALSLEYLNLSF 575
+S++ N+ ++ S +L G++ + LS ++++G + F + SL L+LS
Sbjct: 50 DKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSGFKCSASLTSLDLSR 109
Query: 576 NDFEGKIPAKGIFANASAISV--VGCNRLCGGIPELQLPKCT 615
N G + + S + V N L K
Sbjct: 110 NSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLN 151
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 343 bits (882), Expect = e-106
Identities = 94/585 (16%), Positives = 176/585 (30%), Gaps = 64/585 (10%)
Query: 34 SWNDSRHFCEW---EGITCGRRHRRVTALDLMSKSLSGSLSPHLGNLSFLREINLSNNTI 90
+WN ++ W G++ RVT L L SG + +G L+ L + L ++
Sbjct: 59 NWNFNKELDMWGAQPGVSLNSN-GRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGE 117
Query: 91 QG----EIPPEFGRLFRLEALFLSNNSLVGKIPANLSY--CSRLTVLCIEYNKLQGRIPL 144
+ P E S L CI + Q I
Sbjct: 118 KVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKK 177
Query: 145 EFVSLSKLKDLSLAKNKLTGGIPPFLGNLTSLEVLSLAGNSFGRNIPDSLGQLKQLKILA 204
K + N +T + + LT L + + F + + +
Sbjct: 178 SSRITLKDTQIGQLSNNIT-FVSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEY-- 234
Query: 205 IGGNNLSGPIPPSIYNLSFLVVFSVSHNQIHGSLPPSLGLLLPNLKFFQIHHNFF----- 259
NL L V + LP L LP ++ + N
Sbjct: 235 ---AQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLK-ALPEMQLINVACNRGISGEQ 290
Query: 260 ---SGSIPISLSNASKLEHIEIANNNF-SGKLSVNFGGMKNLSLLNLQFSNLGSGESDEM 315
K++ I I NN + + + MK L +L ++ L
Sbjct: 291 LKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQL-------E 343
Query: 316 GFMNSLTNCSKLRVLSLGGNQFRGALPHSIANLSSQLQILILSSNQFYG-SIPLGIGNLV 374
G + + + KL L+L NQ +P + + Q++ L + N+ ++
Sbjct: 344 GKLPAFGSEIKLASLNLAYNQITE-IPANFCGFTEQVENLSFAHNKLKYIPNIFDAKSVS 402
Query: 375 DLYLLGMVENQFTG-------AIPKEMGKLQKLQGLDFSGNHFSGEIPSSLGNLSSLYEV 427
+ + N+ + K + ++ S N S S L +
Sbjct: 403 VMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSI 462
Query: 428 FFNNNNLSGV-------IPFSLGNLKRLAFLEMSGNELSGTIPEDIF--NISYLSNSLNL 478
N L+ + + N L +++ N+L+ + +D + YL ++L
Sbjct: 463 NLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTK-LSDDFRATTLPYLV-GIDL 520
Query: 479 ARNHLVGIIPPRIGNLRALRSFDVSN------NDLSGEIPIELGHCSSLEEIYLAGNLFH 532
+ N P + N L+ F + N N E P + C SL ++ + N
Sbjct: 521 SYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIR 579
Query: 533 GSIPSFFNALKGVQKIDLSRNNLSGQIP-IFLEALSLEYLNLSFN 576
+ +D+ N + L ++
Sbjct: 580 KVNEKITPNI---SVLDIKDNPNISIDLSYVCPYIEAGMYMLFYD 621
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 283 bits (725), Expect = 9e-84
Identities = 73/511 (14%), Positives = 156/511 (30%), Gaps = 63/511 (12%)
Query: 59 LDLMSKSLSGSLSPHLGNLSFLREINLSNNTIQGEIPPEFGRLFRLEALFLSNNSLVGKI 118
+ S S+ +I +N I + RL +L ++ N+ V +
Sbjct: 164 DCINSDPQQKSIKKSSRITLKDTQIGQLSNNI-TFVSKAVMRLTKLRQFYMGNSPFVAEN 222
Query: 119 PANLSYCSRLTVLCIEYNKLQGRIPLEFVSLSKLKDLSLAKNKLTGGIPPFLGNLTSLEV 178
EY + L++ +L L D+ + +P FL L +++
Sbjct: 223 ICEAWENENS-----EYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQL 277
Query: 179 LSLAGNSF--------GRNIPDSLGQLKQLKILAIGGNNL-SGPIPPSIYNLSFLVVFSV 229
+++A N ++++I+ IG NNL + P+ S+ + L +
Sbjct: 278 INVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLEC 337
Query: 230 SHNQIHGSLPPSLGLLLPNLKFFQIHHNFFSGSIPISLSNASKLEHIEIANNNFSG-KLS 288
+NQ+ G P+ G L + +N + ++E++ A+N
Sbjct: 338 LYNQLEG-KLPAFGSE-IKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLKYIPNI 395
Query: 289 VNFGGMKNLSLLNLQFSNLGSGESDEMGFM-NSLTNCSKLRVLSLGGNQFRGALPHSIAN 347
+ + +S ++ ++ +GS + + + + ++L NQ +
Sbjct: 396 FDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFST 455
Query: 348 LSSQLQILILSSNQFYGSIPLGIGNLVDLYLLGMVENQFTGAIPKEMGKLQKLQGLDFSG 407
S L + L N IP + L +D
Sbjct: 456 GSP-LSSINLMGNML-TEIPKNSLKD----------------ENENFKNTYLLTSIDLRF 497
Query: 408 NHFSGEIPSSL--GNLSSLYEVFFNNNNLSGVIPFSLGNLKRLAFLEMSGNELSGTIPED 465
N + + L L + + N+ S P N L
Sbjct: 498 NKLTK-LSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGF-------------- 541
Query: 466 IFNISYLSNSLNLARNHLVGIIPPRIGNLRALRSFDVSNNDLSGEIPIELGHCSSLEEIY 525
+ N + N + P I +L + +ND+ + ++ ++ +
Sbjct: 542 -----GIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRK-VNEKI--TPNISVLD 593
Query: 526 LAGNLFHGSIPSFFNALKGVQKIDLSRNNLS 556
+ N S+ L +
Sbjct: 594 IKDNPNISIDLSYVCPYIEAGMYMLFYDKTQ 624
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 232 bits (593), Expect = 2e-65
Identities = 74/418 (17%), Positives = 138/418 (33%), Gaps = 40/418 (9%)
Query: 59 LDLMSKSLSGSLSPHLGNLSFLREINLSNNTIQGEIPPEFGRLFRLEALFLSNNSLV--- 115
+ + NL L ++ + N ++P L ++ + ++ N +
Sbjct: 230 ENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGE 289
Query: 116 -----GKIPANLSYCSRLTVLCIEYNKLQ-GRIPLEFVSLSKLKDLSLAKNKLTGGIPPF 169
+ A+ ++ ++ I YN L+ + + KL L N+L G P
Sbjct: 290 QLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEG-KLPA 348
Query: 170 LGNLTSLEVLSLAGNSFGRNIPDSLGQLKQLKILAIGGNNLSG-PIPPSIYNLSFLVVFS 228
G+ L L+LA N + G +Q++ L+ N L P ++S +
Sbjct: 349 FGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLKYIPNIFDAKSVSVMSAID 408
Query: 229 VSHNQIHG-------SLPPSLGLLLPNLKFFQIHHNFFSGSIPISLSNASKLEHIEIANN 281
S+N+I L P+ + N+ + +N S S S L I + N
Sbjct: 409 FSYNEIGSVDGKNFDPLDPTPFKGI-NVSSINLSNNQISKFPKELFSTGSPLSSINLMGN 467
Query: 282 NFSG-------KLSVNFGGMKNLSLLNLQFSNLGSGESDEMGFMNSLTNCSKLRVLSLGG 334
+ + NF L+ ++L+F+ L + SD+ T L + L
Sbjct: 468 MLTEIPKNSLKDENENFKNTYLLTSIDLRFNKL-TKLSDDFRA----TTLPYLVGIDLSY 522
Query: 335 NQFRGALPHSIANLSS-----QLQILILSSNQFYGSIPLGIGNLVDLYLLGMVENQFTGA 389
N F P N S+ N+ P GI L L + N
Sbjct: 523 NSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRK- 580
Query: 390 IPKEMGKLQKLQGLDFSGNHFSGEIPSSLGNLSSLYEVFFNNNNLSGVIPFSLGNLKR 447
+ +++ + LD N S + + + ++KR
Sbjct: 581 VNEKI--TPNISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYDKTQDIRGCDALDIKR 636
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 221 bits (566), Expect = 7e-62
Identities = 75/449 (16%), Positives = 147/449 (32%), Gaps = 56/449 (12%)
Query: 161 KLTGGIPPFLGNLTSLEVLSLAGNSFGRNIPDSLGQLKQLKILAIGGNNLSGPIPPSIYN 220
G N + L + G G SL ++ L++ G SG +P +I
Sbjct: 48 SQQGFGTQPGANWNFNKELDMWGAQPG----VSLNSNGRVTGLSLEGFGASGRVPDAIGQ 103
Query: 221 LSFLVVFSVSHNQIHG----SLPPSLGLLLPNLKFFQIHHNFFSGSIP--ISLSNASKLE 274
L+ L V ++ + P + + + + Q + + + S L
Sbjct: 104 LTELEVLALGSHGEKVNERLFGPKGISANM-SDEQKQKMRMHYQKTFVDYDPREDFSDLI 162
Query: 275 HIEIANNNFSGKLSVNFGGMKNLSLLNLQFSNLGSGESDEMGFMNSLTNCSKLRVLSLGG 334
I ++ + + + + +N+ ++ +KLR +G
Sbjct: 163 KDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITFVSK-------AVMRLTKLRQFYMGN 215
Query: 335 NQFRGALPHSIANLSSQLQILILSSNQFYGSIPLGIGNLVDLYLLGMVENQFTGAIPKEM 394
+ F + Q Y + L NL DL + + +P +
Sbjct: 216 SPFVAENICEAWENEN------SEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFL 269
Query: 395 GKLQKLQGLDFSGNHF--------SGEIPSSLGNLSSLYEVFFNNNNL-SGVIPFSLGNL 445
L ++Q ++ + N + + + ++ NNL + + SL +
Sbjct: 270 KALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKM 329
Query: 446 KRLAFLEMSGNELSGTIPEDIFNISYLSNSLNLARNHLVGIIPPRIGNLRALRSFDVSNN 505
K+L LE N+L G +P + L+ SLNLA N + I G + + ++N
Sbjct: 330 KKLGMLECLYNQLEGKLPA-FGSEIKLA-SLNLAYNQITEIPANFCGFTEQVENLSFAHN 387
Query: 506 DLSGEIP--IELGHCSSLEEIYLAGNLFHGSIPSFFNALKGVQKIDLSRNNLSGQIPIFL 563
L IP + S + I + N + N P
Sbjct: 388 KLK-YIPNIFDAKSVSVMSAIDFSYNEIGS----------------VDGKNFDPLDPTPF 430
Query: 564 EALSLEYLNLSFNDFEGKIPAKGIFANAS 592
+ +++ +NLS N +F+ S
Sbjct: 431 KGINVSSINLSNNQISKFPK--ELFSTGS 457
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 196 bits (500), Expect = 4e-53
Identities = 53/368 (14%), Positives = 111/368 (30%), Gaps = 31/368 (8%)
Query: 252 FQIHHNFFSGSIPISLSNASKLEHIEIANNNFSGKLSVNFGGMKNLSLLNLQFSNLGSGE 311
F + + +SL++ ++ + + SG++ G + L +L L E
Sbjct: 62 FNKELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNE 121
Query: 312 SDEMGFMNSLTNCSKLRVLSLGGNQFRGALPHSIANLS-SQLQILILSSNQFYGSIPLGI 370
++ ++ S L ++S+ SI
Sbjct: 122 RLF--GPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSS 179
Query: 371 GNLVDLYLLGMVENQFTGAIPKEMGKLQKLQGLDFSGNHFSGEIPSSLGNLSSLYEVFFN 430
+ +G + N T + K + +L KL+ + F E +
Sbjct: 180 RITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENS-----E 233
Query: 431 NNNLSGVIPFSLGNLKRLAFLEMSGNELSGTIPEDIFNISYLSNSLNLARNHLVGIIPPR 490
NLK L +E+ +P + + + +N+A N + +
Sbjct: 234 YAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEM-QLINVACNRGISGEQLK 292
Query: 491 IGNLRALRSFDVSNNDLSGEIPIELGHCSSLEEIYLAGN-LFHGSIPSFFNALKGVQKID 549
+ + ++ IY+ N L + + +K + ++
Sbjct: 293 ----------------DDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLE 336
Query: 550 LSRNNLSGQIPIFLEALSLEYLNLSFNDFEGKIPAKGIFANASAISV--VGCNRLCGGIP 607
N L G++P F + L LNL++N IPA + N+L
Sbjct: 337 CLYNQLEGKLPAFGSEIKLASLNLAYNQITE-IPA-NFCGFTEQVENLSFAHNKLKYIPN 394
Query: 608 ELQLPKCT 615
+
Sbjct: 395 IFDAKSVS 402
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 319 bits (820), Expect = 9e-97
Identities = 117/562 (20%), Positives = 202/562 (35%), Gaps = 35/562 (6%)
Query: 51 RRHRRVTALDLMSKSLSGSLSPHLGNLSFLREINLSNNTIQGEIPPEFGRLFRLEALFLS 110
R+ ++T+LD+ ++S L L+ +NL +N + F L L L
Sbjct: 46 TRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLM 105
Query: 111 NNSLVGKIPANLSYCSRLTVLCIEYNKLQGRIPLEFVSLSKLKDLSLAKNKLTGGIPPFL 170
+NS+ L L + +N L V L L++L L+ NK+ L
Sbjct: 106 SNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEEL 165
Query: 171 G--NLTSLEVLSLAGNSFGRNIPDSLGQLKQLKILAIGGNNLSGPIPPSI---YNLSFLV 225
+SL+ L L+ N P + +L L + L + + + +
Sbjct: 166 DIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIR 225
Query: 226 VFSVSHNQIHGSLPPSL-GLLLPNLKFFQIHHNFFSGSIPISLSNASKLEHIEIANNNFS 284
S+S++Q+ + + GL NL + +N + S + +LE+ + NN
Sbjct: 226 NLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQ 285
Query: 285 GKLSVNFGGMKNLSLLNLQFSNLGSGESDEMGFM----NSLTNCSKLRVLSLGGNQFRGA 340
S + G+ N+ LNL+ + S L L++ N G
Sbjct: 286 HLFSHSLHGLFNVRYLNLK-RSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGI 344
Query: 341 LPHSIANLSSQLQILILSSNQFYGSIP-------LGIGNLVDLYLLGMVENQFTGAIPKE 393
+ L + L+ L LS++ L L L L +N+ +
Sbjct: 345 KSNMFTGLIN-LKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNL---TKNKISKIESDA 400
Query: 394 MGKLQKLQGLDFSGNHFSGEIP-SSLGNLSSLYEVFFNNNNLSGVIPFSLGNLKRLAFLE 452
L L+ LD N E+ L +++E++ + N + S + L L
Sbjct: 401 FSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLM 460
Query: 453 MSGNELSGTIPEDIFNISYLSN--SLNLARNHLVGIIPPRIGNLRALRSFDVSNNDLS-- 508
+ L + L N L+L+ N++ I + L L D+ +N+L+
Sbjct: 461 LRRVALKN-VDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARL 519
Query: 509 ------GEIPIELGHCSSLEEIYLAGNLFHGSIPSFFNALKGVQKIDLSRNNLSGQIP-I 561
G L S L + L N F F L ++ IDL NNL+ +
Sbjct: 520 WKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASV 579
Query: 562 FLEALSLEYLNLSFNDFEGKIP 583
F +SL+ LNL N
Sbjct: 580 FNNQVSLKSLNLQKNLITSVEK 601
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 311 bits (799), Expect = 9e-94
Identities = 120/553 (21%), Positives = 211/553 (38%), Gaps = 42/553 (7%)
Query: 59 LDLMSKSLSGSLSPHLGNLSFLREINLSNNTIQGEIPPEFGRLFRLEALFLSNNSLVGKI 118
L LMS S+ + L ++LS+N + +L L+ L LSNN +
Sbjct: 102 LHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALK 161
Query: 119 PANLSYC--SRLTVLCIEYNKLQGRIPLEFVSLSKLKDLSLAKNKLTGGIPPFLG---NL 173
L S L L + N+++ P F ++ +L L L +L + L
Sbjct: 162 SEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELAN 221
Query: 174 TSLEVLSLAGNSFGRNIPDSLGQLK--QLKILAIGGNNLSGPIPPSIYNLSFLVVFSVSH 231
TS+ LSL+ + + LK L +L + NNL+ S L L F + +
Sbjct: 222 TSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEY 281
Query: 232 NQIHGSLPPSLGLLLPNLKFFQIHHNFFSGSI---------PISLSNASKLEHIEIANNN 282
N I SL L N+++ + +F SI S LEH+ + +N+
Sbjct: 282 NNIQHLFSHSLHGL-FNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDND 340
Query: 283 FSGKLSVNFGGMKNLSLLNLQFSNLGSGESDEMGFMNSLTNCSKLRVLSLGGNQFRGALP 342
G S F G+ NL L+L ++ S + SL + S L +L+L N+
Sbjct: 341 IPGIKSNMFTGLINLKYLSLS-NSFTSLRTLTNETFVSLAH-SPLHILNLTKNKISKIES 398
Query: 343 HSIANLSSQLQILILSSNQFYGSIPLG-IGNLVDLYLLGMVENQFTGAIPKEMGKLQKLQ 401
+ + L L++L L N+ + L +++ + + N++ + LQ
Sbjct: 399 DAFSWLGH-LEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQ 457
Query: 402 GLDFSGNHFSG--EIPSSLGNLSSLYEVFFNNNNLSGVIPFSLGNLKRLAFLEMSGNELS 459
L PS L +L + +NNN++ + L L++L L++ N L+
Sbjct: 458 RLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLA 517
Query: 460 GTIPEDIFNISYLSNSLNLARNHLVGIIPPRIGNLRALRSFDVSNNDLSGEIPIELGHCS 519
L ++ G + L L ++ +N
Sbjct: 518 -----------------RLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLF 560
Query: 520 SLEEIYLAGNLFHGSIPSFFNALKGVQKIDLSRNNLSGQIP-IFLEAL-SLEYLNLSFND 577
L+ I L N + S FN ++ ++L +N ++ +F A +L L++ FN
Sbjct: 561 ELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNP 620
Query: 578 FEGKIPAKGIFAN 590
F+ + F N
Sbjct: 621 FDCTCESIAWFVN 633
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 302 bits (776), Expect = 2e-90
Identities = 115/586 (19%), Positives = 211/586 (36%), Gaps = 50/586 (8%)
Query: 59 LDLMSKSLSGSLSPHLGNLSFLREINLSNNTIQGEIPPEFGRLFRLEALFLSNNSLVGKI 118
D L+ + L + + +NL++N ++ F R +L +L + N++
Sbjct: 9 ADCSHLKLT-QVPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLE 65
Query: 119 PANLSYCSRLTVLCIEYNKLQGRIPLEFVSLSKLKDLSLAKNKLTGGIPPFLGNLTSLEV 178
P L VL +++N+L F + L +L L N + +L
Sbjct: 66 PELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLIT 125
Query: 179 LSLAGNSFGRNIPDSLGQLKQLKILAIGGNNLSGPIPPSIY--NLSFLVVFSVSHNQIHG 236
L L+ N + QL+ L+ L + N + + S L +S NQI
Sbjct: 126 LDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKE 185
Query: 237 SLPPSLGLLLPNLKFFQIHHNFFSGSIPISLS---NASKLEHIEIANNNFSGKLSVNFGG 293
P + L +++ S+ L + + ++ ++N+ S + F G
Sbjct: 186 FSPGCFH-AIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLG 244
Query: 294 MK--NLSLLNLQFSNLGSGESDEMGFMNSLTNCSKLRVLSLGGNQFRGALPHSIANLSSQ 351
+K NL++L+L ++NL +D S +L L N + HS+ L +
Sbjct: 245 LKWTNLTMLDLSYNNLNVVGND------SFAWLPQLEYFFLEYNNIQHLFSHSLHGLFN- 297
Query: 352 LQILILSSNQFYGSI---------PLGIGNLVDLYLLGMVENQFTGAIPKEMGKLQKLQG 402
++ L L + SI L L L M +N G L L+
Sbjct: 298 VRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKY 357
Query: 403 LDFSGNHFSGEIPSSLG----NLSSLYEVFFNNNNLSGVIPFSLGNLKRLAFLEMSGNEL 458
L S + S ++ S L+ + N +S + + L L L++ NE+
Sbjct: 358 LSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEI 417
Query: 459 SGTIPEDIFNISYLSN--SLNLARNHLVGIIPPRIGNLRALRSFDVSNNDLSG--EIPIE 514
+ + L N + L+ N + + + +L+ + L P
Sbjct: 418 GQELTGQEW--RGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSP 475
Query: 515 LGHCSSLEEIYLAGNLFHGSIPSFFNALKGVQKIDLSRNNLS--------GQIPIFLEAL 566
+L + L+ N L+ ++ +DL NNL+ G FL+ L
Sbjct: 476 FQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGL 535
Query: 567 S-LEYLNLSFNDFEGKIPAKGIFANASAISV--VGCNRLCGGIPEL 609
S L LNL N F+ +F + + + +G N L +
Sbjct: 536 SHLHILNLESNGFDEIPV--EVFKDLFELKIIDLGLNNLNTLPASV 579
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 247 bits (632), Expect = 2e-70
Identities = 87/482 (18%), Positives = 161/482 (33%), Gaps = 37/482 (7%)
Query: 59 LDLMSKSLSGSLSPHLGNLSFLREINLSNNTIQGEIPPEFG---RLFRLEALFLSNNSLV 115
L+L S + + L + L+N + + + + L LSN+ L
Sbjct: 176 LELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLS 235
Query: 116 GKIPANLSYC--SRLTVLCIEYNKLQGRIPLEFVSLSKLKDLSLAKNKLTGGIPPFLGNL 173
+ LT+L + YN L F L +L+ L N + L L
Sbjct: 236 TTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGL 295
Query: 174 TSLEVLSLAGNSFGRNI---------PDSLGQLKQLKILAIGGNNLSGPIPPSIYNLSFL 224
++ L+L + ++I S LK L+ L + N++ G L L
Sbjct: 296 FNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINL 355
Query: 225 VVFSVSHNQIHGSLPPS---LGLLLPNLKFFQIHHNFFSGSIPISLSNASKLEHIEIANN 281
S+S++ + + L L + N S + S LE +++ N
Sbjct: 356 KYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLN 415
Query: 282 NFSGKLSVN-FGGMKNLSLLNLQFSNLGSGESDEMGFMNSLTNCSKLRVLSLGGNQFRG- 339
+L+ + G++N+ + L ++ NS L+ L L +
Sbjct: 416 EIGQELTGQEWRGLENIFEIYLSYNKYLQLTR------NSFALVPSLQRLMLRRVALKNV 469
Query: 340 -ALPHSIANLSSQLQILILSSNQFYGSIPLGIGNLVDLYLLGMVENQFT--------GAI 390
+ P L + L IL LS+N + L L +L + N G
Sbjct: 470 DSSPSPFQPLRN-LTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGP 528
Query: 391 PKEMGKLQKLQGLDFSGNHFSGEIPSSLGNLSSLYEVFFNNNNLSGVIPFSLGNLKRLAF 450
+ L L L+ N F +L L + NNL+ + N L
Sbjct: 529 IYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKS 588
Query: 451 LEMSGNELSGTIPEDIFNISYLS-NSLNLARNHLVGIIPPRIGNLRALRSFDVSNNDLSG 509
L + N ++ + + +F ++ + L++ N + + + +LS
Sbjct: 589 LNLQKNLITS-VEKKVFGPAFRNLTELDMRFNPFDCTCESIAWFVNWINETHTNIPELSS 647
Query: 510 EI 511
Sbjct: 648 HY 649
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 233 bits (597), Expect = 9e-66
Identities = 82/467 (17%), Positives = 152/467 (32%), Gaps = 57/467 (12%)
Query: 127 RLTVLCIEYNKLQGRIPLEFVSLSKLKDLSLAKNKLTGGIPPFLGNLTSLEVLSLAGNSF 186
V + KL ++P + + + L+L N+L + L L + N+
Sbjct: 5 SHEVADCSHLKLT-QVPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTI 61
Query: 187 GRNIPDSLGQLKQLKILAIGGNNLSGPIPPSIYNLSFLVVFSVSHNQIHGSLPPSLGLLL 246
+ P+ +L LK+L + N LS + + L + N I
Sbjct: 62 SKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQ- 120
Query: 247 PNLKFFQIHHNFFSGSIPISLSNASKLEHIEIANNNFSGKLSVNFGGMKNLSL--LNLQF 304
NL + HN S + + L+ + ++NN S N SL L L
Sbjct: 121 KNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSS 180
Query: 305 SNLGSGESDEMGFMNSLTNCSKLRVLSLGGNQFRGALPHSIANLS--SQLQILILSSNQF 362
+ + +L L L Q +L + + ++ L LS++Q
Sbjct: 181 NQIKEFSP------GCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQL 234
Query: 363 YGSIPLGIGNLVDLYLLGMVENQFTGAIPKEMGKLQKLQGLDFSGNHFSGEIPSSLGNLS 422
+ L K L LD S N+ + S L
Sbjct: 235 STTSNTTFLGL----------------------KWTNLTMLDLSYNNLNVVGNDSFAWLP 272
Query: 423 SLYEVFFNNNNLSGVIPFSLGNLKRLAFLEMSGNELSGTIPEDIFNISYLSNSLNLARNH 482
L F NN+ + SL L + +L + + +++
Sbjct: 273 QLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTK----------------QSISLAS 316
Query: 483 LVGIIPPRIGNLRALRSFDVSNNDLSGEIPIELGHCSSLEEIYLAGNLFHGSIPS---FF 539
L I L+ L ++ +ND+ G +L+ + L+ + + F
Sbjct: 317 LPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFV 376
Query: 540 N-ALKGVQKIDLSRNNLSGQIPIFLEAL-SLEYLNLSFNDFEGKIPA 584
+ A + ++L++N +S L LE L+L N+ ++
Sbjct: 377 SLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTG 423
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 315 bits (809), Expect = 6e-96
Identities = 120/575 (20%), Positives = 202/575 (35%), Gaps = 39/575 (6%)
Query: 56 VTALDLMSKSLSGSLSPHLGNLSFLREINLSNNTIQGEIPPEFGRLFRLEALFLSNNSLV 115
LDL L S + L+ ++LS IQ + L L L L+ N +
Sbjct: 30 TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ 89
Query: 116 GKIPANLSYCSRLTVLCIEYNKLQGRIPLEFVSLSKLKDLSLAKNKLTGG-IPPFLGNLT 174
S S L L L L LK+L++A N + +P + NLT
Sbjct: 90 SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLT 149
Query: 175 SLEVLSLAGNSFGRNIPDSLGQLKQLKI----LAIGGNNLSGPIPPSIYNLSFLVVFSVS 230
+LE L L+ N L L Q+ + L + N ++ I P + L ++
Sbjct: 150 NLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAFKEIRLHKLTLR 208
Query: 231 HNQIHGSLPPSLGLLLPNLKFFQIHHNFFSGSIPISLSNASKLE--------HIEIANNN 282
+N ++ + L L+ ++ F + + S LE +A +
Sbjct: 209 NNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLD 268
Query: 283 FSGKLSVN-FGGMKNLSLLNLQFSNLGSGESDEMGFMNSLTNCSKLRVLSLGGNQFRGAL 341
+ ++ F + N+S +L + + + + L L +F
Sbjct: 269 YYLDDIIDLFNCLTNVSSFSLVSVTIER--------VKDFSYNFGWQHLELVNCKFGQFP 320
Query: 342 PHSIANLSSQLQILILSSNQFYGSIPLGIGNLVDLYLLGMVENQ--FTGAIPKEMGKLQK 399
+ +L L+ G +L L L + N F G +
Sbjct: 321 TLKLKSLKR------LTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTS 374
Query: 400 LQGLDFSGNHFSGEIPSSLGNLSSLYEVFFNNNNLSGVIPFS-LGNLKRLAFLEMSGNEL 458
L+ LD S N + S+ L L + F ++NL + FS +L+ L +L++S
Sbjct: 375 LKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHT 433
Query: 459 SGTIPEDIFNISYLSNSLNLARNHLVGIIPPRI-GNLRALRSFDVSNNDLSGEIPIELGH 517
+S L L +A N P I LR L D+S L P
Sbjct: 434 RVAFNGIFNGLSSLE-VLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNS 492
Query: 518 CSSLEEIYLAGNLFHGSIPSFFNALKGVQKIDLSRNNLSGQIPIFLEAL--SLEYLNLSF 575
SSL+ + ++ N F + L +Q +D S N++ L+ SL +LNL+
Sbjct: 493 LSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQ 552
Query: 576 NDFEGKIPAKGI--FANASAISVVGCNRLCGGIPE 608
NDF + + +V R+ P
Sbjct: 553 NDFACTCEHQSFLQWIKDQRQLLVEVERMECATPS 587
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 283 bits (725), Expect = 5e-84
Identities = 113/548 (20%), Positives = 194/548 (35%), Gaps = 36/548 (6%)
Query: 59 LDLMSKSLSGSLSPHLGNLSFLREINLSNNTIQGEIPPEFGRLFRLEALFLSNNSLVGKI 118
LDL + +LS L + L+ N IQ F L L+ L +L
Sbjct: 57 LDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLE 116
Query: 119 PANLSYCSRLTVLCIEYNKLQG-RIPLEFVSLSKLKDLSLAKNKLTGGIPPFLGNLTSLE 177
+ + L L + +N +Q ++P F +L+ L+ L L+ NK+ L L +
Sbjct: 117 NFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMP 176
Query: 178 V----LSLAGNSFGRNIPDSLGQLKQLKILAIGGNNLSGPIPP-SIYNLSFLVVFSVSHN 232
+ L L+ N P + +++ L L + N S + I L+ L V +
Sbjct: 177 LLNLSLDLSLNPMNFIQPGAFKEIR-LHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLG 235
Query: 233 QI--HGSLPPSLGLLLPNLKFFQIHHN------FFSGSIPISLSNASKLEHIEIANNNFS 284
+ G+L L L I ++ I + + + + +
Sbjct: 236 EFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE 295
Query: 285 GKLSV-NFGGMKNLSLLNLQFSNLGSGESDEM----------GFMNSLTNCSKLRVLSLG 333
G ++L L+N +F + + + G S + L L L
Sbjct: 296 RVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLS 355
Query: 334 GNQ--FRGALPHSIANLSSQLQILILSSNQFYGSIPLGIGNLVDLYLLGMVENQFTGAIP 391
N F+G S +S L+ L LS N + L L L +
Sbjct: 356 RNGLSFKGCCSQSDFGTTS-LKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSE 413
Query: 392 KEM-GKLQKLQGLDFSGNHFSGEIPSSLGNLSSLYEVFFNNNNLSGVI-PFSLGNLKRLA 449
+ L+ L LD S H LSSL + N+ P L+ L
Sbjct: 414 FSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLT 473
Query: 450 FLEMSGNELSGTIPEDIFNISYLSNSLNLARNHLVGIIPPRIGNLRALRSFDVSNNDLSG 509
FL++S +L P ++S L LN++ N+ + L +L+ D S N +
Sbjct: 474 FLDLSQCQLEQLSPTAFNSLSSL-QVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMT 532
Query: 510 EIPIELGHC-SSLEEIYLAGNLFHGSIPS--FFNALKGVQKIDLSRNNLSGQIPIFLEAL 566
EL H SSL + L N F + F +K +++ + + P + +
Sbjct: 533 SKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDKQGM 592
Query: 567 SLEYLNLS 574
+ LN++
Sbjct: 593 PVLSLNIT 600
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 258 bits (660), Expect = 5e-75
Identities = 104/538 (19%), Positives = 182/538 (33%), Gaps = 53/538 (9%)
Query: 109 LSNNSLVGKIPANLSYCSRLTVLCIEYNKLQGRIPLEFVSLSKLKDLSLAKNKLTGGIPP 168
+ KIP NL L + +N L+ F S +L+ L L++ ++
Sbjct: 14 CMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDG 70
Query: 169 FLGNLTSLEVLSLAGNSFGRNIPDSLGQLKQLKILAIGGNNLSGPIPPSIYNLSFLVVFS 228
+L+ L L L GN + L L+ L NL+ I +L L +
Sbjct: 71 AYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELN 130
Query: 229 VSHNQIHGSLPPSLGLLLPNLKFFQIHHNFFSGSIPISLSNAS----------------- 271
V+HN I P L NL+ + N L
Sbjct: 131 VAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN 190
Query: 272 ----------KLEHIEIANNNFSGKLSVN-FGGMKNLSLLNLQFSNLGSGESDEMGFMNS 320
+L + + NN S + G+ L + L + + E ++
Sbjct: 191 FIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSA 250
Query: 321 LTNCSKLRVLSLGGNQ---FRGALPHSIANLSSQLQILILSSNQFYGSIPLGIGNLVDLY 377
L L + + + L++ + L S
Sbjct: 251 LEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTN-VSSFSLVSVTIERVKDF--SYNFGWQ 307
Query: 378 LLGMVENQFTGAIPKEMGKLQKLQGLDFSGNHFSGEIPSSLGNLSSLYEVFFNNNNLS-- 435
L +V +F ++ L++L G S +L SL + + N LS
Sbjct: 308 HLELVNCKFGQFPTLKLKSLKRLTFTSNKGG-----NAFSEVDLPSLEFLDLSRNGLSFK 362
Query: 436 GVIPFSLGNLKRLAFLEMSGNELSGTIPEDIFNISYLSNSLNLARNHLVGIIPPRI-GNL 494
G S L +L++S N + T+ + + L L+ ++L + + +L
Sbjct: 363 GCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLE-HLDFQHSNLKQMSEFSVFLSL 420
Query: 495 RALRSFDVSNNDLSGEIPIELGHCSSLEEIYLAGNLFHGSI-PSFFNALKGVQKIDLSRN 553
R L D+S+ SSLE + +AGN F + P F L+ + +DLS+
Sbjct: 421 RNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQC 480
Query: 554 NLSGQIPIFLEAL-SLEYLNLSFNDFEGKIPAKGIFANASAISVV--GCNRLCGGIPE 608
L P +L SL+ LN+S N+F + +++ V+ N + +
Sbjct: 481 QLEQLSPTAFNSLSSLQVLNMSHNNFFSLDT--FPYKCLNSLQVLDYSLNHIMTSKKQ 536
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 6e-24
Identities = 30/160 (18%), Positives = 61/160 (38%), Gaps = 6/160 (3%)
Query: 426 EVFFNNNNLSGVIPFSLGNLKRLAFLEMSGNELSGTIPEDIFNISYLSNSLNLARNHLVG 485
N + + K L++S N L F+ L L+L+R +
Sbjct: 11 TYQCMELNFYKIPDNLPFSTKN---LDLSFNPLRHLGSYSFFSFPELQ-VLDLSRCEIQT 66
Query: 486 IIPPRIGNLRALRSFDVSNNDLSGEIPIELGHCSSLEEIYLAGNLFHGSIPSFFNALKGV 545
I +L L + ++ N + SSL+++ LK +
Sbjct: 67 IEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTL 126
Query: 546 QKIDLSRNNL-SGQIPIFLEAL-SLEYLNLSFNDFEGKIP 583
++++++ N + S ++P + L +LE+L+LS N +
Sbjct: 127 KELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYC 166
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 5e-11
Identities = 25/123 (20%), Positives = 45/123 (36%), Gaps = 3/123 (2%)
Query: 54 RRVTALDLMSKSLSGSLSPHLGNLSFLREINLSNNTIQGEIPPEFGRLFRLEALFLSNNS 113
R +T LDL L +LS L+ +N+S+N + L L+ L S N
Sbjct: 470 RNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNH 529
Query: 114 LVGKIPANLSYC-SRLTVLCIEYNKLQGRIPLE-FVS-LSKLKDLSLAKNKLTGGIPPFL 170
++ L + S L L + N + F+ + + L + ++ P
Sbjct: 530 IMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDK 589
Query: 171 GNL 173
+
Sbjct: 590 QGM 592
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 303 bits (778), Expect = 3e-95
Identities = 91/307 (29%), Positives = 131/307 (42%), Gaps = 15/307 (4%)
Query: 317 FMNSLTNCSKLR----VLSLGGNQFRGALPHSIANLSSQLQILILSSNQFYGS--IPLGI 370
L N + L + G L + + L LS IP +
Sbjct: 14 IKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYR-VNNLDLSGLNLPKPYPIPSSL 72
Query: 371 GNLVDLYLLGMV-ENQFTGAIPKEMGKLQKLQGLDFSGNHFSGEIPSSLGNLSSLYEVFF 429
NL L L + N G IP + KL +L L + + SG IP L + +L + F
Sbjct: 73 ANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDF 132
Query: 430 NNNNLSGVIPFSLGNLKRLAFLEMSGNELSGTIPEDIFNISYLSNSLNLARNHLVGIIPP 489
+ N LSG +P S+ +L L + GN +SG IP+ + S L S+ ++RN L G IPP
Sbjct: 133 SYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPP 192
Query: 490 RIGNLRALRSFDVSNNDLSGEIPIELGHCSSLEEIYLAGNLFHGSIPSFFNALKGVQKID 549
NL L D+S N L G+ + G + ++I+LA N + K + +D
Sbjct: 193 TFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGL-SKNLNGLD 250
Query: 550 LSRNNLSGQIPIFLEAL-SLEYLNLSFNDFEGKIPAKGIFANASAISVVGCNRLCGGIPE 608
L N + G +P L L L LN+SFN+ G+IP G + LCG
Sbjct: 251 LRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSP-- 308
Query: 609 LQLPKCT 615
LP CT
Sbjct: 309 --LPACT 313
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 265 bits (679), Expect = 5e-81
Identities = 73/299 (24%), Positives = 127/299 (42%), Gaps = 14/299 (4%)
Query: 13 DRAALQAFKSMIAHEPQGILNSWNDSRHFCE--WEGITCGRRHR--RVTALDLMSKSLSG 68
D+ AL K + + L+SW + C W G+ C + RV LDL +L
Sbjct: 7 DKQALLQIKKDLGN--PTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPK 64
Query: 69 S--LSPHLGNLSFLREINLSN-NTIQGEIPPEFGRLFRLEALFLSNNSLVGKIPANLSYC 125
+ L NL +L + + N + G IPP +L +L L++++ ++ G IP LS
Sbjct: 65 PYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQI 124
Query: 126 SRLTVLCIEYNKLQGRIPLEFVSLSKLKDLSLAKNKLTGGIPPFLGNLTSL-EVLSLAGN 184
L L YN L G +P SL L ++ N+++G IP G+ + L ++++ N
Sbjct: 125 KTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRN 184
Query: 185 SFGRNIPDSLGQLKQLKILAIGGNNLSGPIPPSIYNLSFLVVFSVSHNQIHGSLPPSLGL 244
IP + L L + + N L G + ++ N + L +G
Sbjct: 185 RLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDL-GKVG- 241
Query: 245 LLPNLKFFQIHHNFFSGSIPISLSNASKLEHIEIANNNFSGKLSVNFGGMKNLSLLNLQ 303
L NL + +N G++P L+ L + ++ NN G++ G ++ +
Sbjct: 242 LSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYA 299
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 295 bits (756), Expect = 5e-86
Identities = 90/624 (14%), Positives = 191/624 (30%), Gaps = 92/624 (14%)
Query: 13 DRAALQAFKSMI----------AHEPQGILNSWNDSRHFCEWEGITCG--RRHRRVTALD 60
D AL+A + +WN ++ W + RVT L
Sbjct: 270 DYKALKAIWEALDGKNWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDNNGRVTGLS 329
Query: 61 LMSKSLSGSLSPHLGNLSFLREINLSNNTIQGEIPPEFGRLFRLEALFLSNNSLVGKIP- 119
L G + +G L+ L+ ++ ++ + + +
Sbjct: 330 LAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKK 389
Query: 120 ---ANLSYCSRLTVLCIEYNKLQGRIPLEFVSLSKLKDLSLA--KNKLTGGIPPFLGNLT 174
+ +L N+ P++ S LKD + N++T I + LT
Sbjct: 390 MFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITF-ISKAIQRLT 448
Query: 175 SLEVLSLAGNSFG-------------------RNIPDSLGQLKQLKILAIGGNNLSGPIP 215
L+++ A + F N S LK L + + +P
Sbjct: 449 KLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLP 508
Query: 216 PSIYNLSFLVVFSVSHNQIHGSLPPSLGLLLPNLKFFQIHHNFFSGSIPISLSNASKLEH 275
+Y+L L +++ N+ + + K++
Sbjct: 509 DFLYDLPELQSLNIACNRGISAAQLKADW----------------TRLADDEDTGPKIQI 552
Query: 276 IEIANNNFSG-KLSVNFGGMKNLSLLNLQFSNLGSGESDEMGFMNSLTNCSKLRVLSLGG 334
+ NN S + M L LL+ + + + + KL L L
Sbjct: 553 FYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVRH--------LEAFGTNVKLTDLKLDY 604
Query: 335 NQFRGALPHSIANLSSQLQILILSSNQFYGSIP--LGIGNLVDLYLLGMVENQFTGAIPK 392
NQ +P + Q++ L S N+ IP ++ + + N+
Sbjct: 605 NQIEE-IPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGSEGRN 662
Query: 393 -----EMGKLQKLQGLDFSGNHFSGEIPSSLGNLSSLYEVFFNNNNLS-------GVIPF 440
+ K + S N S + + +NN ++
Sbjct: 663 ISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDG 722
Query: 441 SLGNLKRLAFLEMSGNELSGTIPEDIFNISYLS-NSLNLARNHLVGIIPPRIGNLRALRS 499
+ N L +++ N+L+ ++ +D + ++++++ N P + N L++
Sbjct: 723 NYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKA 780
Query: 500 F------DVSNNDLSGEIPIELGHCSSLEEIYLAGNLFHGSIPSFFNALKGVQKIDLSRN 553
F D N + + P + C SL ++ + N + + +D++ N
Sbjct: 781 FGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDI-RKVDE--KLTPQLYILDIADN 837
Query: 554 NL-SGQIPIFLEALSLEYLNLSFN 576
S + + L ++
Sbjct: 838 PNISIDVTSVCPYIEAGMYVLLYD 861
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 246 bits (629), Expect = 9e-69
Identities = 81/488 (16%), Positives = 166/488 (34%), Gaps = 52/488 (10%)
Query: 54 RRVTALDLMSKSLSGSLSPHLGNLSFLREINLSNNTIQG------EIPPEFGRLFRLEAL 107
+R+ DL+ +++ + P + + I+L + I I RL +L+ +
Sbjct: 396 QRLNLSDLLQDAINRN--PEMKPIKKDSRISLKDTQIGNLTNRITFISKAIQRLTKLQII 453
Query: 108 FLSNNSLVGKIPANLSYCSRLTVLCIEYNKLQGRIPLEFVSLSKLKDLSLAKNKLTGGIP 167
+ +N+ +Y K L + +L L D+ L +P
Sbjct: 454 YFANSPFTYDNI-----AVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLP 508
Query: 168 PFLGNLTSLEVLSLAGNSF---------GRNIPDSLGQLKQLKILAIGGNNLSG-PIPPS 217
FL +L L+ L++A N + D +++I +G NNL P S
Sbjct: 509 DFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASAS 568
Query: 218 IYNLSFLVVFSVSHNQIHGSLPPSLGLLLPNLKFFQIHHNFFSGSIPISL-SNASKLEHI 276
+ + L + HN++ + G L ++ +N IP + ++E +
Sbjct: 569 LQKMVKLGLLDCVHNKV--RHLEAFGTN-VKLTDLKLDYNQIE-EIPEDFCAFTDQVEGL 624
Query: 277 EIANNNFSG-KLSVNFGGMKNLSLLNLQFSNLGSGESDEMGFMNSLTNCSKLRVLSLGGN 335
++N N + + ++ ++ + E + ++L N
Sbjct: 625 GFSHNKLKYIPNIFNAKSVYVMGSVDFSYNKI-GSEGRNISCSMDDYKGINASTVTLSYN 683
Query: 336 QFRGALPHSIANLSSQLQILILSSNQF-------YGSIPLGIGNLVDLYLLGMVENQFTG 388
+ + A S + +ILS+N N L + + N+ T
Sbjct: 684 EIQKFPTELFATGSP-ISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLTS 742
Query: 389 AIPKEM--GKLQKLQGLDFSGNHFSGEIPSSLGNLSSL------YEVFFNNNNLSGVIPF 440
+ + L L +D S N FS P+ N S L ++ N + P
Sbjct: 743 -LSDDFRATTLPYLSNMDVSYNCFS-SFPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPT 800
Query: 441 SLGNLKRLAFLEMSGNELSGTIPEDIFNISYLSNSLNLARNHLVGIIPPRIGNLRALRSF 500
+ L L++ N++ + E + L L++A N + I + +
Sbjct: 801 GITTCPSLIQLQIGSNDIR-KVDEKLT--PQL-YILDIADNPNISIDVTSVCPYIEAGMY 856
Query: 501 DVSNNDLS 508
+ +
Sbjct: 857 VLLYDKTQ 864
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 3e-23
Identities = 33/200 (16%), Positives = 67/200 (33%), Gaps = 22/200 (11%)
Query: 52 RHRRVTALDLMSKSLSGSLSPHLGNLSFLREINLSNNTIQ-------GEIPPEFGRLFRL 104
+ + + L + + S + I LSNN + + + L
Sbjct: 671 KGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLL 730
Query: 105 EALFLSNNSLVGKIPANLSYC--SRLTVLCIEYNKLQGRIPLEFVSLSKLKDLSL----- 157
+ L N L + + L+ + + YN P + ++ S+LK +
Sbjct: 731 TTIDLRFNKLTS-LSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRD 788
Query: 158 -AKNKLTGGIPPFLGNLTSLEVLSLAGNSFGRNIPDSLGQLKQLKILAIGGNNL-SGPIP 215
N++ P + SL L + N R + + L QL IL I N S +
Sbjct: 789 AEGNRILRQWPTGITTCPSLIQLQIGSNDI-RKVDEKL--TPQLYILDIADNPNISIDVT 845
Query: 216 PSIYNLSFLVVFSVSHNQIH 235
+ ++ + +++
Sbjct: 846 SVCPYIEAG-MYVLLYDKTQ 864
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 5e-22
Identities = 25/206 (12%), Positives = 66/206 (32%), Gaps = 12/206 (5%)
Query: 384 NQFTGAIPKEMGKLQKLQGLDFSGNHFSGEIPSSLGNLSSLYEVFFNNNNLSGVIPFSLG 443
+ + ++ ++ GL +G G +P ++G L+ L + F ++ +
Sbjct: 309 DMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGD 368
Query: 444 NLKRLAFLEMSGNELSGTIPEDIFNISYLSNSLNLARNHLVG---IIPPRIGNLRALR-- 498
E + + + + N +L ++ + + P + + +L+
Sbjct: 369 EELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDT 428
Query: 499 SFDVSNNDLSGEIPIELGHCSSLEEIYLAGNLFHGSIPSFFNALKGVQKIDLSRNNLSGQ 558
N ++ I + + L+ IY A + F + + +
Sbjct: 429 QIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDW-----EDANSDYAKQYEN 482
Query: 559 IPIFLEAL-SLEYLNLSFNDFEGKIP 583
+ L L + L ++P
Sbjct: 483 EELSWSNLKDLTDVELYNCPNMTQLP 508
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 80.3 bits (198), Expect = 2e-15
Identities = 20/183 (10%), Positives = 49/183 (26%), Gaps = 12/183 (6%)
Query: 408 NHFSGEIPSSLGNLSSLYEVFFNNNNLSGVIPFSLGNLKRLAFLEMSGNELSGTIPEDIF 467
+ + + L N + + G +P ++G L L L + +
Sbjct: 309 DMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETV-SGRLFG 367
Query: 468 NISYLSNSLNLARNHLVGIIPPR-IGNLRALRSFDVSNNDLS-----GEIPIELGHCSSL 521
+ + ++ + + + L D+ + ++ I +
Sbjct: 368 DEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKD 427
Query: 522 EEIYLAGNLFHGSIPSFFNALKGVQKIDLSRNNLSGQIPIFLEALSLEYLNLSFNDFEGK 581
+I N I L +Q I + + + A+ E N +
Sbjct: 428 TQIGNLTNRIT-FISKAIQRLTKLQIIYFANSPFTYDNI----AVDWEDANSDYAKQYEN 482
Query: 582 IPA 584
Sbjct: 483 EEL 485
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 43.7 bits (103), Expect = 3e-04
Identities = 11/84 (13%), Positives = 29/84 (34%), Gaps = 1/84 (1%)
Query: 529 NLFHGSIPSFFNALKGVQKIDLSRNNLSGQIPIFLEALS-LEYLNLSFNDFEGKIPAKGI 587
+++ + V + L+ G++P + L+ L+ L+ + G
Sbjct: 309 DMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGD 368
Query: 588 FANASAISVVGCNRLCGGIPELQL 611
+S +R+ ++ L
Sbjct: 369 EELTPDMSEERKHRIRMHYKKMFL 392
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 279 bits (715), Expect = 1e-82
Identities = 107/538 (19%), Positives = 178/538 (33%), Gaps = 24/538 (4%)
Query: 56 VTALDLMSKSLSGSLSPHLGNLSFLREINLSNNTIQGEIPPEFGRLFRLEALFLSNNSLV 115
L+ L + L L ++L+ I F RL+ L L+ N L+
Sbjct: 35 TECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLI 94
Query: 116 GKIPANLSYCSRLTVLCIEYNKLQGRIPLEFVSLSKLKDLSLAKNKLTGGIPPFLGNLTS 175
LS L L + + + L+ L L N ++ P
Sbjct: 95 FMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEK 154
Query: 176 LEVLSLAGNSFGRNIPDSLGQLKQLKI--LAIGGNNLSGPIPPSIYNLSFLVVFSVSHNQ 233
L+VL N+ + + L+Q L + GN+++G I P ++ + + Q
Sbjct: 155 LKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAG-IEPGAFDSAVFQSLNFGGTQ 213
Query: 234 IHGSLPPSLGLL-LPNLKFFQIHHNFFSGSIPISLSN--ASKLEHIEIANNNFSGKLSVN 290
+ L + +L P +E I + + F S
Sbjct: 214 NLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNT 273
Query: 291 FGGMKNLSLLNLQFSNLGSGESDEMGFMNSLTNCSKLRVLSLGGNQFRGALPHSIANLSS 350
F L L+L ++L + L S L+ L L N+F S +N S
Sbjct: 274 FHCFSGLQELDLTATHLSE-------LPSGLVGLSTLKKLVLSANKFENLCQISASNFPS 326
Query: 351 QLQILILSSNQFYGSIPLG-IGNLVDLYLLGMVENQFT--GAIPKEMGKLQKLQGLDFSG 407
L L + N + G + NL +L L + + ++ L LQ L+ S
Sbjct: 327 -LTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSY 385
Query: 408 NHFSGEIPSSLGNLSSLYEVFFNNNNLSGVIPFS-LGNLKRLAFLEMSGNELSGTIPEDI 466
N + L + L S NL L L +S + L + +
Sbjct: 386 NEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLF 445
Query: 467 FNISYLSNSLNLARNHLVGIIPPRIG---NLRALRSFDVSNNDLSGEIPIELGHCSSLEE 523
+ L LNL NH + L L +S DLS +
Sbjct: 446 DGLPAL-QHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNH 504
Query: 524 IYLAGNLFHGSIPSFFNALKGVQKIDLSRNNLSGQIPIFLEAL-SLEYLNLSFNDFEG 580
+ L+ N S + LKG+ ++L+ N++S +P L L +NL N +
Sbjct: 505 VDLSHNRLTSSSIEALSHLKGIY-LNLASNHISIILPSLLPILSQQRTINLRQNPLDC 561
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 274 bits (704), Expect = 4e-81
Identities = 109/551 (19%), Positives = 184/551 (33%), Gaps = 27/551 (4%)
Query: 59 LDLMSKSLSGSLSPHLGNLSFLREINLSNNTIQGEIPPEFGRLFRLEALFLSNNSLVGKI 118
+ + L+ + L + + S N + F RL L L L+ +
Sbjct: 17 YNCENLGLN-EIPGTL--PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIH 73
Query: 119 PANLSYCSRLTVLCIEYNKLQGRIPLEFVSLSKLKDLSLAKNKLTGGIPPFLGNLTSLEV 178
RL L + N L LK L + ++ L N +LE
Sbjct: 74 EDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLES 133
Query: 179 LSLAGNSFGRNIPDSLGQLKQLKILAIGGNNLSGPIPPSIYNLSFL--VVFSVSHNQIHG 236
L L N ++LK+L N + + +L + +++ N I
Sbjct: 134 LYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDI-A 192
Query: 237 SLPPSLGLLLPNLKFFQIHHNFFSGSIPISLSNAS--KLEHIEIANNNFSGKLSVNFGGM 294
+ P + I L N++ L + + F G+
Sbjct: 193 GIEPGAFDSA-VFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGL 251
Query: 295 KNLSL--LNLQFSNLGSGESDEMGFMNSLTNCSKLRVLSLGGNQFRGALPHSIANLSSQL 352
+S+ +NLQ + S N+ S L+ L L LP + LS+ L
Sbjct: 252 CEMSVESINLQKHYFFNISS------NTFHCFSGLQELDLTATHLS-ELPSGLVGLST-L 303
Query: 353 QILILSSNQFYGSIPLGIGNLVDLYLLGMVENQFTGAIPKEM-GKLQKLQGLDFSGNH-- 409
+ L+LS+N+F + N L L + N + L+ L+ LD S +
Sbjct: 304 KKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIE 363
Query: 410 FSGEIPSSLGNLSSLYEVFFNNNNLSGVIPFSLGNLKRLAFLEMSGNELSGTIPEDIFNI 469
S L NLS L + + N + + +L L+++ L + F
Sbjct: 364 TSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQN 423
Query: 470 SYLSNSLNLARNHLVGIIPPRIGNLRALRSFDVSNNDLSGEIPIE---LGHCSSLEEIYL 526
+L LNL+ + L L AL+ ++ N + L LE + L
Sbjct: 424 LHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVL 483
Query: 527 AGNLFHGSIPSFFNALKGVQKIDLSRNNLSGQIPIFLEALSLEYLNLSFNDFEGKIPAKG 586
+ F +LK + +DLS N L+ L L YLNL+ N +P
Sbjct: 484 SFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIYLNLASNHISIILP--S 541
Query: 587 IFANASAISVV 597
+ S +
Sbjct: 542 LLPILSQQRTI 552
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 234 bits (598), Expect = 2e-66
Identities = 94/530 (17%), Positives = 173/530 (32%), Gaps = 25/530 (4%)
Query: 59 LDLMSKSLSGSLSPHLGNLSFLREINLSNNTIQGEIPPEFGRLFRLEALFLSNNSLVGKI 118
L L + L L L+ + I LE+L+L +N +
Sbjct: 86 LVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIK 145
Query: 119 PANLSYCSRLTVLCIEYNKLQGRIPLEFVSLSKLK--DLSLAKNKLTGGIPPFLGNLTSL 176
+L VL + N + + SL + L+L N + G I P +
Sbjct: 146 LPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAG-IEPGAFDSAVF 204
Query: 177 EVLSLAGNSFGRNIPDSLG--QLKQLKILAIGGNNLSGPIPPSIYNLSF--LVVFSVSHN 232
+ L+ G I L ++ L + + P L + ++ +
Sbjct: 205 QSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKH 264
Query: 233 QIHGSLPPSLGLLLPNLKFFQIHHNFFSGSIPISLSNASKLEHIEIANNNFSGKLSVNFG 292
++ + L+ + S +P L S L+ + ++ N F ++
Sbjct: 265 YFF-NISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISAS 322
Query: 293 GMKNLSLLNLQFSNLGSGESDEMGFMNSLTNCSKLRVLSLGGNQFR--GALPHSIANLSS 350
+L+ L+++ + L N LR L L + + NLS
Sbjct: 323 NFPSLTHLSIKGNTKRLELGT-----GCLENLENLRELDLSHDDIETSDCCNLQLRNLSH 377
Query: 351 QLQILILSSNQFYGSIPLGIGNLVDLYLLGMVENQFTGAIPKE-MGKLQKLQGLDFSGNH 409
LQ L LS N+ L LL + + + L L+ L+ S +
Sbjct: 378 -LQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSL 436
Query: 410 FSGEIPSSLGNLSSLYEVFFNNNNLSGVIPF---SLGNLKRLAFLEMSGNELSGTIPEDI 466
L +L + N+ SL L RL L +S +LS
Sbjct: 437 LDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAF 496
Query: 467 FNISYLSNSLNLARNHLVGIIPPRIGNLRALRSFDVSNNDLSGEIPIELGHCSSLEEIYL 526
++ ++ ++L+ N L + +L+ + ++++N +S +P L S I L
Sbjct: 497 TSLKMMN-HVDLSHNRLTSSSIEALSHLKGIY-LNLASNHISIILPSLLPILSQQRTINL 554
Query: 527 AGNLFHG--SIPSFFNALKGVQKIDLSRNNLSGQIPIFLEALSLEYLNLS 574
N S F K + + + P L + L + LS
Sbjct: 555 RQNPLDCTCSNIYFLEWYKENMQKLEDTEDTLCENPPLLRGVRLSDVTLS 604
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 3e-41
Identities = 66/371 (17%), Positives = 124/371 (33%), Gaps = 57/371 (15%)
Query: 45 EGITCGRRHRRVTALDLMSKSLSGSLSPHLGNLSFLREINLSNNTIQGEIPPEFGRLFRL 104
+ G V +++L S S L+E++L+ + E+P L L
Sbjct: 245 PAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTL 303
Query: 105 EALFLSNNSLVGKIPANLSYCSRLTVLCIEYNKLQGRIPLE-FVSLSKLKDLSLAKNKLT 163
+ L LS N + S LT L I+ N + + +L L++L L+ + +
Sbjct: 304 KKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIE 363
Query: 164 --GGIPPFLGNLTSLEVLSLAGNSFGRNIPDSLGQLKQLKILAIGGNNLSGPIPPSIYNL 221
L NL+ L+ L+L+ N ++ + QL++L +L
Sbjct: 364 TSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELL-----DL----------- 407
Query: 222 SFLVVFSVSHNQIHGSLPPSLGLLLPNLKFFQIHHNFFSGSIPISLSNASKLEHIEIANN 281
+ ++ S L LK + H+ S L+H+ + N
Sbjct: 408 --------AFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGN 459
Query: 282 NFSGKLSVNFGGMKNLSLLNLQFSNLGSGESDEMGFMNSLTNCSKLRVLSLGGNQFRGAL 341
+F NSL +L +L L
Sbjct: 460 HFPKGNIQKT---------------------------NSLQTLGRLEILVLSFCDLSSID 492
Query: 342 PHSIANLSSQLQILILSSNQFYGSIPLGIGNLVDLYLLGMVENQFTGAIPKEMGKLQKLQ 401
H+ +L + + LS N+ S + +L +YL + N + +P + L + +
Sbjct: 493 QHAFTSLKM-MNHVDLSHNRLTSSSIEALSHLKGIYLN-LASNHISIILPSLLPILSQQR 550
Query: 402 GLDFSGNHFSG 412
++ N
Sbjct: 551 TINLRQNPLDC 561
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 9e-25
Identities = 41/211 (19%), Positives = 79/211 (37%), Gaps = 7/211 (3%)
Query: 403 LDFSGNHFSGEIPSSLGNLSSLYEVFFNNNNLSGVIPFSLGNLKRLAFLEMSGNELSGTI 462
+ + EIP +L +S + F+ N L + + L L FL+++ ++
Sbjct: 17 YNCENLGLN-EIPGTL--PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIH 73
Query: 463 PEDIFNISYLSNSLNLARNHLVGIIPPRIGNLRALRSFDVSNNDLSGEIPIELGHCSSLE 522
+ + L ++L L N L+ + + +AL+ +S I L + +LE
Sbjct: 74 EDTFQSQHRL-DTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLE 132
Query: 523 EIYLAGNLFHGSIPSFFNALKGVQKIDLSRNNLSGQIP---IFLEALSLEYLNLSFNDFE 579
+YL N + ++ +D N + L+ + LNL+ ND
Sbjct: 133 SLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIA 192
Query: 580 GKIPAKGIFANASAISVVGCNRLCGGIPELQ 610
G P A +++ G L L+
Sbjct: 193 GIEPGAFDSAVFQSLNFGGTQNLLVIFKGLK 223
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 269 bits (691), Expect = 1e-82
Identities = 96/321 (29%), Positives = 163/321 (50%), Gaps = 38/321 (11%)
Query: 675 SYKSLLKATNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCE-GASKSFMAECK 733
S + L A++ FS+ +++G G FG VYKG L DG +VA+K + + G F E +
Sbjct: 21 SLRELQVASDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQGGELQFQTEVE 79
Query: 734 ALKNIRHRNLVKVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKL 793
+ HRNL+++ C + + +VY YM NGS+ L E + L
Sbjct: 80 MISMAVHRNLLRLRGFCM----TPTE-RLLVYPYMANGSVASCLR------ERPESQPPL 128
Query: 794 TLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVS 853
+R IA+ A L YLH HC I+H D+K +NILLD + +GDFGLA+ +
Sbjct: 129 DWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL-MDYK 187
Query: 854 NSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMF---EGD 910
++ +++ V+GTIG+ APEY + S DV+ YG++LLE++T ++ D+ + D
Sbjct: 188 DTHVTT--AVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDD 245
Query: 911 LNLHNFARMALPN-QVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVA 969
+ L ++ + L ++ +VD L+ + + E + ++++ +
Sbjct: 246 VMLLDWVKGLLKEKKLEALVDVDLQGNYKD------------------EEVEQLIQVALL 287
Query: 970 CSMESPQDRMNMTNVVHELQS 990
C+ SP +R M+ VV L+
Sbjct: 288 CTQSSPMERPKMSEVVRMLEG 308
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 264 bits (677), Expect = 2e-77
Identities = 109/541 (20%), Positives = 190/541 (35%), Gaps = 35/541 (6%)
Query: 56 VTALDLMSKSLSGSLSPHLGNLSFLREINLSNNTIQGEIPPEFGRLFRLEALFLSNNSLV 115
+DL L S N S L+ ++LS I+ + L L L L+ N +
Sbjct: 34 TKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQ 93
Query: 116 GKIPANLSYCSRLTVLCIEYNKLQGRIPLEFVSLSKLKDLSLAKNKLTG-GIPPFLGNLT 174
P + S + L L KL L LK L++A N + +P + NLT
Sbjct: 94 SFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLT 153
Query: 175 SLEVLSLAGNSFGRNIPDSLGQLKQLKI----LAIGGNNLSGPIPPSIYNLSFLVVFSVS 230
+L + L+ N + L L++ L + N + I + L ++
Sbjct: 154 NLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDF-IQDQAFQGIKLHELTLR 212
Query: 231 HNQIHGSLPPSLGLLLPNLKFFQIHHNFFSGSIPISLSNASKLE--------HIEIANNN 282
N ++ + L L ++ F + + S +E + N
Sbjct: 213 GNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTN 272
Query: 283 FSGKLSVNFGGMKNLSLLNLQFSNLGSGESDEMGFMNSLTNCSKLRVLSLGGNQFRGALP 342
V F + N+S ++L ++ + + K + LS+ Q +
Sbjct: 273 DFSDDIVKFHCLANVSAMSLAGVSIKY--------LEDVPKHFKWQSLSIIRCQLKQ--- 321
Query: 343 HSIANLSSQLQILILSSNQFYGSIPLGIGNLVDLYLLGMVENQFT--GAIPKEMGKLQKL 400
+L L+ L L+ N+ GSI L L L + N + G L
Sbjct: 322 FPTLDLPF-LKSLTLTMNK--GSISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSL 378
Query: 401 QGLDFSGNHFSGEIPSSLGNLSSLYEVFFNNNNLSGVIPFS-LGNLKRLAFLEMSGNELS 459
+ LD S N + ++ L L + F ++ L V FS +L++L +L++S
Sbjct: 379 RHLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTK 437
Query: 460 GTIPEDIFNISYLSNSLNLARNHLVGIIPPRI-GNLRALRSFDVSNNDLSGEIPIELGHC 518
++ L N+L +A N + N L D+S L
Sbjct: 438 IDFDGIFLGLTSL-NTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTL 496
Query: 519 SSLEEIYLAGNLFHGSIPSFFNALKGVQKIDLSRNNLSGQIPIFLEAL-SLEYLNLSFND 577
L+ + ++ N S +N L + +D S N + I SL + NL+ N
Sbjct: 497 HRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNS 556
Query: 578 F 578
Sbjct: 557 V 557
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 216 bits (552), Expect = 3e-60
Identities = 100/542 (18%), Positives = 176/542 (32%), Gaps = 53/542 (9%)
Query: 92 GEIPPEFGRLFRLEALFLSNNSLVGKIPANLSYCSRLTVLCIEYNKLQGRIPLEFVSLSK 151
G + P + + + L K+P ++ S + + +N L+ F + S+
Sbjct: 2 GSLNPCIEVVPNIT-YQCMDQKLS-KVPDDIP--SSTKNIDLSFNPLKILKSYSFSNFSE 57
Query: 152 LKDLSLAKNKLTGGIPPFLGNLTSLEVLSLAGNSFGRNIPDSLGQLKQLKILAIGGNNLS 211
L+ L L++ ++ L L L L GN P S L L+ L L+
Sbjct: 58 LQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLA 117
Query: 212 GPIPPSIYNLSFLVVFSVSHNQIHGSLPPSLGLLLPNLKFFQIHHNFFSG---------- 261
I L L +V+HN IH P+ L NL + +N+
Sbjct: 118 SLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLR 177
Query: 262 -----------------SIPISLSNASKLEHIEIANNNFSGKLS----VNFGGMKNLSLL 300
I KL + + N S + N G+ L+
Sbjct: 178 ENPQVNLSLDMSLNPIDFIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLI 237
Query: 301 NLQFSNLGSGESDEMGFMNSLTNCSKLRVLSLGGNQFRGALPHSIANLSSQLQILILSSN 360
+F + + E E M L + + L L++ + + L+
Sbjct: 238 LGEFKDERNLEIFEPSIMEGLCDVTID-EFRLTYTNDFSDDIVKFHCLAN-VSAMSLAGV 295
Query: 361 QFYGSIPLGIGNLVDLYLLGMVENQFTGAIPKEMGKLQKLQGLDFSGNHFSGEIPSSLGN 420
+ L ++ Q P L L+ L + N S I
Sbjct: 296 SI--KYLEDVPKHFKWQSLSIIRCQLKQ-FPT--LDLPFLKSLTLTMNKGS--ISFKKVA 348
Query: 421 LSSLYEVFFNNNNLSGVIP--FSLGNLKRLAFLEMSGNELSGTIPEDIFNISYLSNSLNL 478
L SL + + N LS +S L L++S N + + + L L+
Sbjct: 349 LPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGLEEL-QHLDF 406
Query: 479 ARNHLVGIIPPR-IGNLRALRSFDVSNNDLSGEIPIELGHCSSLEEIYLAGNLFHGSIPS 537
+ L + +L L D+S + + +SL + +AGN F + S
Sbjct: 407 QHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLS 466
Query: 538 -FFNALKGVQKIDLSRNNLSGQIPIFLEAL-SLEYLNLSFNDFEGKIPAKGIFANASAIS 595
F + +DLS+ L + L L+ LN+S N+ + ++S
Sbjct: 467 NVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDS--SHYNQLYSLS 524
Query: 596 VV 597
+
Sbjct: 525 TL 526
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 8e-42
Identities = 69/412 (16%), Positives = 125/412 (30%), Gaps = 50/412 (12%)
Query: 59 LDLMSKSLSGSLSPHLGNLSFLREINLSNNTIQGEIPPE-FGRLFRLEALFLSNNSLVGK 117
LD+ + + L E+ L N I L L L +
Sbjct: 186 LDMSLNPID-FIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDE 244
Query: 118 IPANLSYCSRLTVLC--------IEYNKLQGRIPLEFVSLSKLKDLSLAKNKLTGGIPPF 169
+ S + LC + Y ++F L+ + +SLA +
Sbjct: 245 RNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKY--LED 302
Query: 170 LGNLTSLEVLSLAGNSFGRNIPDSLGQLKQLKILAIGGNNLSGPIPPSIYNLSFLVVFSV 229
+ + LS+ + L LK L + N S I L L +
Sbjct: 303 VPKHFKWQSLSIIRCQLKQF---PTLDLPFLKSLTLTMNKGS--ISFKKVALPSLSYLDL 357
Query: 230 SHNQIHGSLPPSLGLL-LPNLKFFQIHHNFFSGSIPISLSNASKLEHIEIANNNFSGKLS 288
S N + S S L +L+ + N + + +L+H++ ++
Sbjct: 358 SRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTE 416
Query: 289 VN-FGGMKNLSLLNLQFSNLGSGESDEMGFMNSLTNCSKLRVLSLGGNQFRGALPHSIAN 347
+ F ++ L L++ ++N + L L + GN F+ ++
Sbjct: 417 FSAFLSLEKLLYLDISYTNTKIDFDG------IFLGLTSLNTLKMAGNSFKDNTLSNVFA 470
Query: 348 LSSQLQILILSSNQFYGSIPLGIGNLVDLYLLGMVENQFTGAIPKEMGKLQKLQGLDFSG 407
++ L L LS Q L +LQ L+ S
Sbjct: 471 NTTNLTFLDLSK------------------------CQLEQISWGVFDTLHRLQLLNMSH 506
Query: 408 NHFSGEIPSSLGNLSSLYEVFFNNNNLSGVIPFSLGNLKRLAFLEMSGNELS 459
N+ S L SL + + N + K LAF ++ N ++
Sbjct: 507 NNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVA 558
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 254 bits (650), Expect = 7e-77
Identities = 102/334 (30%), Positives = 156/334 (46%), Gaps = 37/334 (11%)
Query: 658 PSRLPSRPMMRKALPKMSYKSLLKATNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVI 717
L S ++ ++ L +ATN F LIG G FG VYKG L DG VA+K
Sbjct: 13 NDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRR 71
Query: 718 NLQCEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWL 777
+ + F E + L RH +LV +I C + ++Y+YM NG+L++ L
Sbjct: 72 TPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDE-----RNEMILIYKYMENGNLKRHL 126
Query: 778 HPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLS 837
+ +P + ++ QR+ I I A L YLH I+H D+K NILLD +
Sbjct: 127 YGSDLPT------MSMSWEQRLEICIGAARGLHYLH---TRAIIHRDVKSINILLDENFV 177
Query: 838 GHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMV 897
I DFG+++ E+ + LS+ VKGT+GY PEY + ++ DVYS+G++L E++
Sbjct: 178 PKITDFGISKKGTELDQTHLST--VVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVL 235
Query: 898 TAKKPTDVMF-EGDLNLHNFARMALPN-QVMDIVDPILRNDEEILASTDKCRRMQTGINS 955
A+ +NL +A + N Q+ IVDP + I
Sbjct: 236 CARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDP----------------NLADKIRP 279
Query: 956 RLECLISMVKIGVACSMESPQDRMNMTNVVHELQ 989
E L V C S +DR +M +V+ +L+
Sbjct: 280 --ESLRKFGDTAVKCLALSSEDRPSMGDVLWKLE 311
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 230 bits (590), Expect = 1e-68
Identities = 86/329 (26%), Positives = 141/329 (42%), Gaps = 52/329 (15%)
Query: 675 SYKSLLKATNGFSS------THLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGAS--- 725
S+ L TN F + +G G FG VYKG ++ VA+K + + +
Sbjct: 16 SFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN--NTTVAVKKLAAMVDITTEEL 73
Query: 726 -KSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPK 784
+ F E K + +H NLV+++ S D +VY YMPNGSL L
Sbjct: 74 KQQFDQEIKVMAKCQHENLVELLGFSSD-----GDDLCLVYVYMPNGSLLDRLS------ 122
Query: 785 RDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFG 844
+ L+ R IA A+ +++LH + +H D+K +NILLD + I DFG
Sbjct: 123 -CLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFG 178
Query: 845 LARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTD 904
LAR ++ + + ++S + GT Y APE G E++ D+YS+G++LLE++T D
Sbjct: 179 LARASEKFAQTVMTSR--IVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVD 235
Query: 905 VMFEGDLNLHNFARMALPNQ--VMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLIS 962
E L + + + D +D + + + + +
Sbjct: 236 EHREPQ-LLLDIKEEIEDEEKTIEDYIDKKMNDADS-------------------TSVEA 275
Query: 963 MVKIGVACSMESPQDRMNMTNVVHELQSV 991
M + C E R ++ V LQ +
Sbjct: 276 MYSVASQCLHEKKNKRPDIKKVQQLLQEM 304
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 210 bits (537), Expect = 3e-61
Identities = 65/335 (19%), Positives = 123/335 (36%), Gaps = 49/335 (14%)
Query: 674 MSYKSLLKATNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECK 733
+ ++L + + G FGCV+K L VA+K+ +Q + S E
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQ-DKQSWQNEYEVY 70
Query: 734 ALKNIRHRNLVKVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKL 793
+L ++H N+++ I + D ++ + GSL +L + +
Sbjct: 71 SLPGMKHENILQFIGAEKRGTSVDVDL-WLITAFHEKGSLSDFLKAN-----------VV 118
Query: 794 TLLQRISIAIDVASALDYLHHHCQE-------PILHCDLKPSNILLDNDLSGHIGDFGLA 846
+ + IA +A L YLH I H D+K N+LL N+L+ I DFGLA
Sbjct: 119 SWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLA 178
Query: 847 RFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNG------DVYSYGILLLEMVTAK 900
+ + + + G GT Y APE L ++ D+Y+ G++L E+ +
Sbjct: 179 LKFE--AGKSAGDTHGQVGTRRYMAPEV-LEGAINFQRDAFLRIDMYAMGLVLWELASRC 235
Query: 901 KPTDVMFEGDLNLHNFARMALPN----QVMDIVDPILRNDEEILASTDKCRRMQTGINSR 956
D + + F + + ++V + + K
Sbjct: 236 TAADGPVDE--YMLPFEEEIGQHPSLEDMQEVVVHKKK-RPVLRDYWQKH---------- 282
Query: 957 LECLISMVKIGVACSMESPQDRMNMTNVVHELQSV 991
+ + + C + R++ V + +
Sbjct: 283 -AGMAMLCETIEECWDHDAEARLSAGCVGERITQM 316
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 202 bits (516), Expect = 1e-56
Identities = 114/481 (23%), Positives = 192/481 (39%), Gaps = 45/481 (9%)
Query: 56 VTALDLMSKSLSGSLSPHLGNLSFLREINLSNNTIQGEIPPEFGRLFRLEALFLSNNSLV 115
L +++ ++S +L + + I+ L L + SNN L
Sbjct: 26 KMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK--SIDGVEYLNNLTQINFSNNQLT 81
Query: 116 GKIPANLSYCSRLTVLCIEYNKLQGRIPLEFVSLSKLKDLSLAKNKLTGGIPPFLGNLTS 175
P L ++L + + N++ PL +L+ L L+L N++T L NLT+
Sbjct: 82 DITP--LKNLTKLVDILMNNNQIADITPLA--NLTNLTGLTLFNNQITD--IDPLKNLTN 135
Query: 176 LEVLSLAGNSFGRNIPDSLGQLKQLKILAIGGNNLSGPIPPSIYNLSFLVVFSVSHNQIH 235
L L L+ N+ + +L L L+ L+ GN ++ P + NL+ L +S N++
Sbjct: 136 LNRLELSSNTI--SDISALSGLTSLQQLSF-GNQVTDLKP--LANLTTLERLDISSNKVS 190
Query: 236 GSLPPSLGLLLPNLKFFQIHHNFFSGSIPISLSNASKLEHIEIANNNFSGKLSVNFGGMK 295
L L NL+ +N S P L + L+ + + N + +
Sbjct: 191 D--ISVLA-KLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLK-DIG-TLASLT 243
Query: 296 NLSLLNLQFSNLGSGESDEMGFMNSLTNCSKLRVLSLGGNQFRGALPHSIANLSSQLQIL 355
NL+ L+L + + + + L+ +KL L LG NQ P +A L + L L
Sbjct: 244 NLTDLDLANNQISN--------LAPLSGLTKLTELKLGANQISNISP--LAGL-TALTNL 292
Query: 356 ILSSNQFYGSIPLGIGNLVDLYLLGMVENQFTGAIPKEMGKLQKLQGLDFSGNHFSGEIP 415
L+ NQ P I NL +L L + N + P + L KLQ L F N S
Sbjct: 293 ELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSD--V 346
Query: 416 SSLGNLSSLYEVFFNNNNLSGVIPFSLGNLKRLAFLEMSGNELSGTIPEDIFNISYLSNS 475
SSL NL+++ + +N +S + P L NL R+ L ++ + N+S +
Sbjct: 347 SSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNAPVNYKANVSIPNTV 404
Query: 476 LNLARNHLVGIIPPRIGNLRALRSFDVSNNDLSGEIPIELGHCSSLEEIYLAGNLFHGSI 535
N+ I P I + + D++ N L S I F G++
Sbjct: 405 KNVTGAL---IAPATISDGGSYTEPDITWN-LPSYTNEVSYTFSQPVTIGKGTTTFSGTV 460
Query: 536 P 536
Sbjct: 461 T 461
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 199 bits (507), Expect = 2e-55
Identities = 113/494 (22%), Positives = 177/494 (35%), Gaps = 49/494 (9%)
Query: 74 LGNLSFLREINLSNNTIQGEIPPEFGRLFRLEALFLSNNSLVGKIPANLSYCSRLTVLCI 133
L+ + L + + L ++ L + K + Y + LT +
Sbjct: 20 DTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGI--KSIDGVEYLNNLTQINF 75
Query: 134 EYNKLQGRIPLEFVSLSKLKDLSLAKNKLTGGIPPFLGNLTSLEVLSLAGNSFGRNIPDS 193
N+L PL+ +L+KL D+ + N++ I P L NLT+L L+L N D
Sbjct: 76 SNNQLTDITPLK--NLTKLVDILMNNNQIA-DITP-LANLTNLTGLTLFNNQI--TDIDP 129
Query: 194 LGQLKQLKILAIGGNNLSGPIPPSIYNLSFLVVFSVSHNQIHGSLPPSLGLLLPNLKFFQ 253
L L L L + N +S ++ L+ L S + L L L+
Sbjct: 130 LKNLTNLNRLELSSNTISD--ISALSGLTSLQQLSFGNQVTD---LKPLA-NLTTLERLD 183
Query: 254 IHHNFFSGSIPISLSNASKLEHIEIANNNFSGKLSVNFGGMKNLSLLNLQFSNLGSGESD 313
I N S L+ + LE + NN S G + NL L+L + L
Sbjct: 184 ISSNKVSD--ISVLAKLTNLESLIATNNQISD--ITPLGILTNLDELSLNGNQLKD---- 235
Query: 314 EMGFMNSLTNCSKLRVLSLGGNQFRGALPHSIANLSSQLQILILSSNQFYGSIPLGIGNL 373
+ +L + + L L L NQ P ++ L+ L L L +NQ PL L
Sbjct: 236 ----IGTLASLTNLTDLDLANNQISNLAP--LSGLTK-LTELKLGANQISNISPL--AGL 286
Query: 374 VDLYLLGMVENQFTGAIPKEMGKLQKLQGLDFSGNHFSGEIPSSLGNLSSLYEVFFNNNN 433
L L + ENQ P + L+ L L N+ S P + +L+ L +FF NN
Sbjct: 287 TALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNK 342
Query: 434 LSGVIPFSLGNLKRLAFLEMSGNELSGTIPEDIFNISYLSN--SLNLARNHLVGIIPPRI 491
+S V L NL + +L N++S D+ ++ L+ L L
Sbjct: 343 VSDVSS--LANLTNINWLSAGHNQIS-----DLTPLANLTRITQLGLNDQAWTNAPVNYK 395
Query: 492 GNLRALRSFDVSNNDLSGEIPIELGHCSSLEEIYLAGNLFHGSIPSFFNALKGVQKIDLS 551
N+ + L P + S E + NL I
Sbjct: 396 ANVSIPNTVKNVTGALI--APATISDGGSYTEPDITWNLPS-YTNEVSYTFSQPVTIGKG 452
Query: 552 RNNLSGQIPIFLEA 565
SG + L+A
Sbjct: 453 TTTFSGTVTQPLKA 466
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 193 bits (492), Expect = 2e-53
Identities = 84/476 (17%), Positives = 175/476 (36%), Gaps = 48/476 (10%)
Query: 103 RLEALFLSNNSLVGKIPANLSYCSRLTVLCIEYNKLQGRIPLEFVSLSKLKDLSLAKNKL 162
L + ++ ++ + +I + + + + + L ++ L + +
Sbjct: 2 PLGSATITQDTPINQIF-TDTALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGI 58
Query: 163 TGGIPPFLGNLTSLEVLSLAGNSFGRNIPDSLGQLKQLKILAIGGNNLSGPIPPSIYNLS 222
+ L +L ++ + N +I L L +L + + N ++ P + NL+
Sbjct: 59 K--SIDGVEYLNNLTQINFSNNQL-TDIT-PLKNLTKLVDILMNNNQIADITP--LANLT 112
Query: 223 FLVVFSVSHNQIHGSLPPSLGLLLPNLKFFQIHHNFFSGSIPISLSNASKLEHIEIANNN 282
L ++ +NQI + P L NL ++ N S +LS + L+ + N
Sbjct: 113 NLTGLTLFNNQIT-DIDPLKNL--TNLNRLELSSNTISD--ISALSGLTSLQQLSFGNQV 167
Query: 283 FSGKLSVNFGGMKNLSLLNLQFSNLGSGESDEMGFMNSLTNCSKLRVLSLGGNQFRGALP 342
+ L L++ + + ++ L + L L NQ P
Sbjct: 168 TD---LKPLANLTTLERLDISSNKVSD--------ISVLAKLTNLESLIATNNQISDITP 216
Query: 343 HSIANLSSQLQILILSSNQFYGSIPLGIGNLVDLYLLGMVENQFTGAIPKEMGKLQKLQG 402
+ L++ L L L+ NQ I + +L +L L + NQ + P + L KL
Sbjct: 217 --LGILTN-LDELSLNGNQL-KDIG-TLASLTNLTDLDLANNQISNLAP--LSGLTKLTE 269
Query: 403 LDFSGNHFSGEIPSSLGNLSSLYEVFFNNNNLSGVIPFSLGNLKRLAFLEMSGNELSGTI 462
L N S P L L++L + N N L + P + NLK L +L + N +S
Sbjct: 270 LKLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDIS 325
Query: 463 PEDIFNISYLSN--SLNLARNHLVGIIPPRIGNLRALRSFDVSNNDLSGEIPIELGHCSS 520
P +S L+ L N + + + NL + +N +S P+ + +
Sbjct: 326 P-----VSSLTKLQRLFFYNNKVSDVSS--LANLTNINWLSAGHNQISDLTPL--ANLTR 376
Query: 521 LEEIYLAGNLFHGSIPSFFNALKGVQKIDLSRNNLSGQIPIFLEALSLEYLNLSFN 576
+ ++ L + + ++ + + + + S ++++N
Sbjct: 377 ITQLGLNDQAWTNAPVNYKANVS-IPNTVKNVTGALIAPATISDGGSYTEPDITWN 431
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 180 bits (460), Expect = 3e-49
Identities = 95/438 (21%), Positives = 170/438 (38%), Gaps = 69/438 (15%)
Query: 148 SLSKLKDLSLAKNKLTGGIPPFLGNLTSLEVLSLAGNSFGRNIPDSLGQLKQLKILAIGG 207
+L++ L K +T + +L + L D + L L +
Sbjct: 22 ALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGI--KSIDGVEYLNNLTQINFSN 77
Query: 208 NNLSGPIPPSIYNLSFLVVFSVSHNQIHGSLPPSLGLLLPNLKFFQIHHNFFSGSIPISL 267
N L+ P + NL+ LV +++NQI L
Sbjct: 78 NQLTDITP--LKNLTKLVDILMNNNQIAD---------------------------ITPL 108
Query: 268 SNASKLEHIEIANNNFSGKLSVNFGGMKNLSLLNLQFSNLGSGESDEMGFMNSLTNCSKL 327
+N + L + + NN + + NL+ L L + + +++L+ + L
Sbjct: 109 ANLTNLTGLTLFNNQITD--IDPLKNLTNLNRLELSSNTISD--------ISALSGLTSL 158
Query: 328 RVLSLGGNQFRGALPHSIANLSSQLQILILSSNQFYGSIPLGIGNLVDLYLLGMVENQFT 387
+ LS G NQ P +ANL++ L+ L +SSN+ S + L +L L NQ +
Sbjct: 159 QQLSFG-NQVTDLKP--LANLTT-LERLDISSNKV--SDISVLAKLTNLESLIATNNQIS 212
Query: 388 GAIPKEMGKLQKLQGLDFSGNHFSGEIPSSLGNLSSLYEVFFNNNNLSGVIPFSLGNLKR 447
P +G L L L +GN +L +L++L ++ NN +S + P L L +
Sbjct: 213 DITP--LGILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTK 266
Query: 448 LAFLEMSGNELSGTIPEDIFNISYLSN--SLNLARNHLVGIIPPRIGNLRALRSFDVSNN 505
L L++ N++S +I ++ L+ +L L N L I P I NL+ L + N
Sbjct: 267 LTELKLGANQIS-----NISPLAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFN 319
Query: 506 DLSGEIPIELGHCSSLEEIYLAGNLFHGSIPSFFNALKGVQKIDLSRNNLSGQIPIFLEA 565
++S P + + L+ ++ N S S L + + N +S P+
Sbjct: 320 NISDISP--VSSLTKLQRLFFYNNKV--SDVSSLANLTNINWLSAGHNQISDLTPLA-NL 374
Query: 566 LSLEYLNLSFNDFEGKIP 583
+ L L+ +
Sbjct: 375 TRITQLGLNDQAWTNAPV 392
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 5e-44
Identities = 84/415 (20%), Positives = 157/415 (37%), Gaps = 47/415 (11%)
Query: 171 GNLTSLEVLSLAGNSFGRNIPDSLGQLKQLKILAIGGNNLSGPIPPSIYNLSFLVVFSVS 230
G L S + + D+ L + +G N++ + + +L +
Sbjct: 1 GPLGSATITQ--DTPINQIFTDT--ALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQAD 54
Query: 231 HNQIHGSLPPSLGLLLPNLKFFQIHHNFFSGSIPISLSNASKLEHIEIANNNFSGKLSVN 290
I + L NL +N + P L N +KL I + NN +
Sbjct: 55 RLGIKS--IDGVEYL-NNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIAD--ITP 107
Query: 291 FGGMKNLSLLNLQFSNLGSGESDEMGFMNSLTNCSKLRVLSLGGNQFRGALPHSIANLSS 350
+ NL+ L L + + ++ L N + L L L N +++ L+S
Sbjct: 108 LANLTNLTGLTLFNNQITD--------IDPLKNLTNLNRLELSSNTISD--ISALSGLTS 157
Query: 351 QLQILILSSNQFYGSIPLGIGNLVDLYLLGMVENQFTGAIPKEMGKLQKLQGLDFSGNHF 410
LQ L + + + NL L L + N+ + + KL L+ L + N
Sbjct: 158 -LQQLSFGNQV---TDLKPLANLTTLERLDISSNKVSD--ISVLAKLTNLESLIATNNQI 211
Query: 411 SGEIPSSLGNLSSLYEVFFNNNNLSGVIPFSLGNLKRLAFLEMSGNELSGTIPEDIFNIS 470
S P LG L++L E+ N N L + + +L L L+++ N++S ++ +S
Sbjct: 212 SDITP--LGILTNLDELSLNGNQLKDIGTLA--SLTNLTDLDLANNQIS-----NLAPLS 262
Query: 471 YLSN--SLNLARNHLVGIIPPRIGNLRALRSFDVSNNDLSGEIPIELGHCSSLEEIYLAG 528
L+ L L N + I P + L AL + +++ N L + + +L + L
Sbjct: 263 GLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLED--ISPISNLKNLTYLTLYF 318
Query: 529 NLFHGSIPSFFNALKGVQKIDLSRNNLSGQIPIFLEALSLEYLNLSFNDFEGKIP 583
N P ++L +Q++ N +S + ++ +L+ N P
Sbjct: 319 NNISDISP--VSSLTKLQRLFFYNNKVSD-VSSLANLTNINWLSAGHNQISDLTP 370
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 203 bits (518), Expect = 5e-56
Identities = 91/512 (17%), Positives = 179/512 (34%), Gaps = 24/512 (4%)
Query: 80 LREINLSNNTIQGEIPPEFGRLFRLEALFLSNNSLVGKIPANLSYCSRLTVLCIEYNKLQ 139
+ ++LS N ++ F L+ L LS + S L+ L + N +Q
Sbjct: 30 TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ 89
Query: 140 GRIPLEFVSLSKLKDLSLAKNKLTGGIPPFLGNLTSLEVLSLAGNSFGR-NIPDSLGQLK 198
F LS L+ L + L +G+L +L+ L++A N +P+ L
Sbjct: 90 SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLT 149
Query: 199 QLKILAIGGNNLSGPIPPSIYNLSFLVVFSV----SHNQIHGSLPPSLGLLLPNLKFFQI 254
L+ L + N + + L + + ++ S N ++ + P + L +
Sbjct: 150 NLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEI-RLHKLTL 207
Query: 255 HHNFFSGSIP----ISLSNASKLEHIEIANNNFSGKLSVNFGGMKNLSLLNLQFSNLGSG 310
+NF S ++ L+ + N + ++ L L ++ L
Sbjct: 208 RNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYL 267
Query: 311 ESDEMGFMNSLTNCSKLRVLSLGGNQFRGALPHSIANLSSQLQILILSSNQFYGSIPLGI 370
+ ++ + + SL S + Q L L + +F L +
Sbjct: 268 DYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFS---YNFGWQHLELVNCKFGQFPTLKL 324
Query: 371 GNLVDLYLLGMVENQFTGAIPKEMGKLQKLQGLDFSGN--HFSGEIPSSLGNLSSLYEVF 428
+L L N+ A + L L+ LD S N F G S +SL +
Sbjct: 325 KSLKRLTFTS---NKGGNAFSEV--DLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLD 379
Query: 429 FNNNNLSGVIPFSLGNLKRLAFLEMSGNELSGTIPEDIFNISYLSNSLNLARNHLVGIIP 488
+ N + + + L++L L+ + L +F L+++ H
Sbjct: 380 LSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFN 438
Query: 489 PRIGNLRALRSFDVSNNDLSGEIPIE-LGHCSSLEEIYLAGNLFHGSIPSFFNALKGVQK 547
L +L ++ N + +L + L+ P+ FN+L +Q
Sbjct: 439 GIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQV 498
Query: 548 IDLSRNNLSGQIPIFLEAL-SLEYLNLSFNDF 578
++++ N L + L SL+ + L N +
Sbjct: 499 LNMASNQLKSVPDGIFDRLTSLQKIWLHTNPW 530
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 199 bits (508), Expect = 1e-54
Identities = 111/521 (21%), Positives = 187/521 (35%), Gaps = 39/521 (7%)
Query: 56 VTALDLMSKSLSGSLSPHLGNLSFLREINLSNNTIQGEIPPEFGRLFRLEALFLSNNSLV 115
LDL L S + L+ ++LS IQ + L L L L+ N +
Sbjct: 30 TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ 89
Query: 116 GKIPANLSYCSRLTVLCIEYNKLQGRIPLEFVSLSKLKDLSLAKNKLT-GGIPPFLGNLT 174
S S L L L L LK+L++A N + +P + NLT
Sbjct: 90 SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLT 149
Query: 175 SLEVLSLAGNSFGRNIPDSLGQLKQLKI----LAIGGNNLSGPIPPSIYNLSFLVVFSVS 230
+LE L L+ N L L Q+ + L + N ++ I P + L ++
Sbjct: 150 NLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAFKEIRLHKLTLR 208
Query: 231 HNQIHGSLPPSLGLLLPNLKFFQIHHNFFSGSIPISLSNAS--------KLEHIEIANNN 282
+N ++ + L L+ ++ F + + S +E +A +
Sbjct: 209 NNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLD 268
Query: 283 FSGKLSVN-FGGMKNLSLLNLQFSNLGSGESDEMGFMNSLTNCSKLRVLSLGGNQFRGAL 341
+ ++ F + N+S +L + + + + L L +F
Sbjct: 269 YYLDDIIDLFNCLTNVSSFSLVSVTIER--------VKDFSYNFGWQHLELVNCKFGQFP 320
Query: 342 PHSIANLSSQLQILILSSNQFYGSIPLGIGNLVDLYLLGMVENQFT--GAIPKEMGKLQK 399
+ +L L +SN+ + +L L L + N + G +
Sbjct: 321 TLKLKSLKR----LTFTSNKGGNAFSEV--DLPSLEFLDLSRNGLSFKGCCSQSDFGTTS 374
Query: 400 LQGLDFSGNHFSGEIPSSLGNLSSLYEVFFNNNNLSGVIPFS-LGNLKRLAFLEMSGNEL 458
L+ LD S N + S+ L L + F ++NL + FS +L+ L +L++S
Sbjct: 375 LKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHT 433
Query: 459 SGTIPEDIFNISYLSN--SLNLARNHLVGIIPPRI-GNLRALRSFDVSNNDLSGEIPIEL 515
IF + LS+ L +A N P I LR L D+S L P
Sbjct: 434 R-VAFNGIF--NGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAF 490
Query: 516 GHCSSLEEIYLAGNLFHGSIPSFFNALKGVQKIDLSRNNLS 556
SSL+ + +A N F+ L +QKI L N
Sbjct: 491 NSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWD 531
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 176 bits (447), Expect = 1e-46
Identities = 103/508 (20%), Positives = 172/508 (33%), Gaps = 53/508 (10%)
Query: 109 LSNNSLVGKIPANLSYCSRLTVLCIEYNKLQGRIPLEFVSLSKLKDLSLAKNKLTGGIPP 168
+ KIP NL L + +N L+ F S +L+ L L++ ++
Sbjct: 14 CMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDG 70
Query: 169 FLGNLTSLEVLSLAGNSFGRNIPDSLGQLKQLKILAIGGNNLSGPIPPSIYNLSFLVVFS 228
+L+ L L L GN + L L+ L NL+ I +L L +
Sbjct: 71 AYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELN 130
Query: 229 VSHNQIHGSLPPSLGLLLPNLKFFQIHHNFFSGSIPISLSNAS----------------- 271
V+HN I P L NL+ + N L
Sbjct: 131 VAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN 190
Query: 272 ----------KLEHIEIANNNFSGKLSVN-FGGMKNLSLLNLQFSNLGSGESDEMGFMNS 320
+L + + NN S + G+ L + L + + E ++
Sbjct: 191 FIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSA 250
Query: 321 LTNCSKLRVLSLGGNQ---FRGALPHSIANLSSQLQILILSSNQFYGSIPL-GIGNLVDL 376
L L + + + L++ + L S L
Sbjct: 251 LEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTN-VSSFSLVSVTIERVKDFSYNFGWQHL 309
Query: 377 YLLGMVENQFTGAIPKEMGKLQKLQGLDFSGNHFSGEIPSSLGNLSSLYEVFFNNNNLS- 435
L+ QF KL+ L+ L F+ N S +L SL + + N LS
Sbjct: 310 ELVNCKFGQFPT------LKLKSLKRLTFTSNKGGN--AFSEVDLPSLEFLDLSRNGLSF 361
Query: 436 -GVIPFSLGNLKRLAFLEMSGNELSGTIPEDIFNISYLSNSLNLARNHLVGIIPPRI-GN 493
G S L +L++S N + T+ + + L L+ ++L + + +
Sbjct: 362 KGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLE-HLDFQHSNLKQMSEFSVFLS 419
Query: 494 LRALRSFDVSNNDLSGEIPIELGHCSSLEEIYLAGNLFHGSIPS-FFNALKGVQKIDLSR 552
LR L D+S+ SSLE + +AGN F + F L+ + +DLS+
Sbjct: 420 LRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQ 479
Query: 553 NNLSGQIP--IFLEALSLEYLNLSFNDF 578
L Q+ F SL+ LN++ N
Sbjct: 480 CQLE-QLSPTAFNSLSSLQVLNMASNQL 506
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 4e-43
Identities = 89/495 (17%), Positives = 151/495 (30%), Gaps = 64/495 (12%)
Query: 104 LEALFLSNNSLVGKIPANLSYCSRLTVLCIEYNKLQGRIPLEFVSLSKLKDLSLAKNKLT 163
+ L LS N L + L VL + ++Q + SLS L L L N +
Sbjct: 30 TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ 89
Query: 164 GGIPPFLGNLTSLEVLSLAGNSFGRNIPDSLGQLKQLKILAIGGNNL-SGPIPPSIYNLS 222
L+SL+ L + +G LK LK L + N + S +P NL+
Sbjct: 90 SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLT 149
Query: 223 FLVVFSVSHNQIHGSLPPSLGLLLPNLKFFQIH----HNFFSGSIPISLSNASKLEHIEI 278
L +S N+I S+ + +L + + N + I +L + +
Sbjct: 150 NLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLHKLTL 207
Query: 279 ANNNFSGKLSVN-FGGMKNLSLLNLQFSNLGSGESDEMGFMNSLTNCSKLRVLSLGGNQF 337
NN S + G+ L + L + + E ++L L +
Sbjct: 208 RNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYL 267
Query: 338 RGALPHSIANLSSQLQILILSSNQFYGSIPLGIGNLVDLYLLGMVENQFTGAIPKEMGKL 397
+ + I L ++ +V +
Sbjct: 268 ----------------------DYYLDDIIDLFNCLTNVSSFSLVSVTIER-VKDFSY-N 303
Query: 398 QKLQGLDFSGNHFSGEIPSSLGNLSSLYEVFFNNNNLSGVIPFSLGNLKRLAFLEMSGNE 457
Q L+ F L +L L F +N +L L FL++S N
Sbjct: 304 FGWQHLELVNCKFGQFPTLKLKSLKRLT---FTSNKGGNAFSEV--DLPSLEFLDLSRNG 358
Query: 458 LSGTIPEDIFNISYLSNSLNLARNHLVGIIPPRIGNLRALRSFDVSNNDLSGEIPIELGH 517
LS G +L+ D+S N + +
Sbjct: 359 LS-----------------------FKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLG 394
Query: 518 CSSLEEIYLAGNLFHGSIP-SFFNALKGVQKIDLSRNNLSGQIPIFLEAL-SLEYLNLSF 575
LE + + S F +L+ + +D+S + L SLE L ++
Sbjct: 395 LEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAG 454
Query: 576 NDFEGKIPAKGIFAN 590
N F+ IF
Sbjct: 455 NSFQENFLP-DIFTE 468
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 1e-38
Identities = 94/455 (20%), Positives = 159/455 (34%), Gaps = 46/455 (10%)
Query: 57 TALDLMSKSLSGSLSPHLGNLSFLREINLSNNTIQ-GEIPPEFGRLFRLEALFLSNNSLV 115
L + +L+ + +G+L L+E+N+++N IQ ++P F L LE L LS+N +
Sbjct: 103 QKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ 162
Query: 116 GKIPANLSYCSRLTVLCIE----YNKLQGRIPLEFVSLSKLKDLSLAKNKLTGGIPP-FL 170
+L ++ +L + N + I +L L+L N + + +
Sbjct: 163 SIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLHKLTLRNNFDSLNVMKTCI 221
Query: 171 GNLTSLEVLSLAGNSFGRNI------PDSLGQLKQLKILAIGGNNLSG---PIPPSIYNL 221
L LEV L F +L L L I L I L
Sbjct: 222 QGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCL 281
Query: 222 SFLVVFSVSHNQIHGSLPPSLGLLLPNLKFFQIHHNFFSGSIPISL-------------- 267
+ + FS+ I S +L+ F SL
Sbjct: 282 TNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAF 341
Query: 268 --SNASKLEHIEIANN--NFSGKLSVNFGGMKNLSLLNLQFSNLGSGESDEMGFMNSLTN 323
+ LE ++++ N +F G S + G +L L+L F+ + + ++
Sbjct: 342 SEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-------MSSNFLG 394
Query: 324 CSKLRVLSLGGNQFRGALPHSIANLSSQLQILILSSNQFYGSIPLGIGNLVDLYLLGMVE 383
+L L + + S+ L L +S + L L +L M
Sbjct: 395 LEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAG 454
Query: 384 NQFTGAIPKEM-GKLQKLQGLDFSGNHFSGEIPSSLGNLSSLYEVFFNNNNLSGVIPFSL 442
N F ++ +L+ L LD S P++ +LSSL + +N L V
Sbjct: 455 NSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIF 514
Query: 443 GNLKRLAFLEMSGNELSGTIPEDIFNISYLSNSLN 477
L L + + N + P I YLS LN
Sbjct: 515 DRLTSLQKIWLHTNPWDCSCP----RIDYLSRWLN 545
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 2e-26
Identities = 72/436 (16%), Positives = 133/436 (30%), Gaps = 78/436 (17%)
Query: 160 NKLTGGIPPFLGNLTSLEVLSLAGNSFGRNIPDSLGQLKQLKILAIGGNNLSGPIPPSIY 219
IP L S + L L+ N S +L++L + + +
Sbjct: 17 LNFYK-IPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQ 73
Query: 220 NLSFLVVFSVSHNQIHGSLPPSLGLLLPNLKFFQIHHNFFSGSIPISLSNASKLEHIEIA 279
+LS L ++ N I SL L +L+ + + + L+ + +A
Sbjct: 74 SLSHLSTLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVA 132
Query: 280 NNNF-SGKLSVNFGGMKNLSLLNLQFSNLGSGESDEMGFMNSLTNCSKLRVLSLGGNQFR 338
+N S KL F + NL L+L + + S ++ ++ + L L N
Sbjct: 133 HNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPL--LNLSLDLSLNPMN 190
Query: 339 GALPHSIANLSSQLQILILSSNQFYGSIPLGIGNLVDLYLLGMVENQFTGAIPKEMGKLQ 398
P + + L L L +N ++ + L
Sbjct: 191 FIQPGAFKEIR--LHKLTLRNNFDSLNVM-----------------------KTCIQGLA 225
Query: 399 KLQGLDFSGNHFSGEIPSSLGNLSSLYEVFFNNNNLSGVIPFSLGNLKRLAFLEMSGNEL 458
L+ F N NL +L L L E
Sbjct: 226 GLEVHRLVLGEF------------------RNEGNLEKFDKSALEGLCNLTIEE------ 261
Query: 459 SGTIPEDIFNISYLSNSLNLARNHLVGIIPPRIGNLRALRSFDVSNNDLSGEIPIELGHC 518
F ++YL L+ I L + SF + + + + + +
Sbjct: 262 --------FRLAYLDYYLDD--------IIDLFNCLTNVSSFSLVSVTIE-RVK-DFSYN 303
Query: 519 SSLEEIYLAGNLFHGSIPSFFNALKGVQKIDLSRNNLSGQIPIFLEALSLEYLNLSFNDF 578
+ + L N G P LK ++++ + N ++ SLE+L+LS N
Sbjct: 304 FGWQHLEL-VNCKFGQFP--TLKLKSLKRLTFTSNKGGN-AFSEVDLPSLEFLDLSRNGL 359
Query: 579 EGKIPAKGIFANASAI 594
K +++
Sbjct: 360 SFKGCCSQSDFGTTSL 375
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 194 bits (495), Expect = 2e-55
Identities = 76/342 (22%), Positives = 123/342 (35%), Gaps = 44/342 (12%)
Query: 674 MSYKSLLKATNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECK 733
+ + LIG G +G VYKG+LD VA+KV + ++F+ E
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSLD--ERPVAVKVFSFANR---QNFINEKN 57
Query: 734 --ALKNIRHRNLVKVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEI 791
+ + H N+ + I + G +V EY PNGSL K+L H
Sbjct: 58 IYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH----------- 106
Query: 792 KLTLLQRISIAIDVASALDYLH------HHCQEPILHCDLKPSNILLDNDLSGHIGDFGL 845
+ +A V L YLH H + I H DL N+L+ ND + I DFGL
Sbjct: 107 TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGL 166
Query: 846 ARFHQ----EVSNSTLSSSVGVKGTIGYTAPEY-------GLGSEVSTNGDVYSYGILLL 894
+ ++++ GTI Y APE D+Y+ G++
Sbjct: 167 SMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYW 226
Query: 895 EMVTAKKPTDVMFEGDLNLHNFARMALPNQVMDIVDPILRNDEEILASTDKCR-RMQTGI 953
E+ TD+ + + Q P D ++L S +K R +
Sbjct: 227 EIFMRC--TDLFPGESVP-----EYQMAFQTEVGNHPTF-EDMQVLVSREKQRPKFPEAW 278
Query: 954 NSRLECLISMVKIGVACSMESPQDRMNMTNVVHELQSVKNIL 995
+ S+ + C + + R+ + + I
Sbjct: 279 KENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIW 320
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 193 bits (492), Expect = 4e-55
Identities = 71/215 (33%), Positives = 109/215 (50%), Gaps = 21/215 (9%)
Query: 690 HLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGAS--KSFMAECKALKNIRHRNLVKVI 747
IG GSFG V++ G VA+K++ Q A F+ E +K +RH N+V +
Sbjct: 43 EKIGAGSFGTVHRAEWH--GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFM 100
Query: 748 TSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVAS 807
+ + Q + +IV EY+ GSL + LH +L +R+S+A DVA
Sbjct: 101 GAVT----QPPNL-SIVTEYLSRGSLYRLLH-------KSGAREQLDERRRLSMAYDVAK 148
Query: 808 ALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTI 867
++YLH+ PI+H +LK N+L+D + + DFGL+R ST SS GT
Sbjct: 149 GMNYLHN-RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKA----STFLSSKSAAGTP 203
Query: 868 GYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKP 902
+ APE + DVYS+G++L E+ T ++P
Sbjct: 204 EWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQP 238
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 188 bits (480), Expect = 1e-53
Identities = 68/214 (31%), Positives = 97/214 (45%), Gaps = 26/214 (12%)
Query: 690 HLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITS 749
++G G+FG V K VAIK I + E K+F+ E + L + H N+VK+ +
Sbjct: 14 EVVGRGAFGVVCKAKWR--AKDVAIKQIESESE--RKAFIVELRQLSRVNHPNIVKLYGA 69
Query: 750 CSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASAL 809
C N +V EY GSL LH E T +S + + +
Sbjct: 70 CL------NPV-CLVMEYAEGGSLYNVLH-------GAEPLPYYTAAHAMSWCLQCSQGV 115
Query: 810 DYLHHHCQEPILHCDLKPSNILLD-NDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIG 868
YLH + ++H DLKP N+LL I DFG A Q + KG+
Sbjct: 116 AYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQ-------THMTNNKGSAA 168
Query: 869 YTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKP 902
+ APE GS S DV+S+GI+L E++T +KP
Sbjct: 169 WMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKP 202
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 186 bits (474), Expect = 5e-53
Identities = 79/306 (25%), Positives = 124/306 (40%), Gaps = 55/306 (17%)
Query: 690 HLIGVGSFGCVYKGALDEDGIVVAIKVINLQC--EGASKSFMAECKALKNIRHRNLVKVI 747
IG GSFG VYKG D VA+K++N+ ++F E L+ RH N++ +
Sbjct: 30 QRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 86
Query: 748 TSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVAS 807
++ AIV ++ SL LH E K + + I IA A
Sbjct: 87 GYSTAPQL------AIVTQWCEGSSLYHHLHAS---------ETKFEMKKLIDIARQTAR 131
Query: 808 ALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTI 867
+DYLH I+H DLK +NI L D + IGDFGLA S S + G+I
Sbjct: 132 GMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGS--HQFEQLSGSI 186
Query: 868 GYTAPE---YGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMALPNQ 924
+ APE + S DVY++GI+L E++T + P +
Sbjct: 187 LWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLP----YSN--------------- 227
Query: 925 VMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNV 984
+ N ++I+ + R C M ++ C + +R + +
Sbjct: 228 --------INNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRI 279
Query: 985 VHELQS 990
+ E++
Sbjct: 280 LAEIEE 285
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 198 bits (504), Expect = 1e-52
Identities = 99/521 (19%), Positives = 190/521 (36%), Gaps = 44/521 (8%)
Query: 76 NLSFLREINLSNNTIQGEIPPE-FGRLFRLEALFLSNNSLVGKIPAN-LSYCSRLTVLCI 133
L+ + LS N I+ + F L +L+ L L + I L +L +
Sbjct: 22 VLNTTERLLLSFNYIR-TVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDL 80
Query: 134 EYNKLQGRIPLEFVSLSKLKDLSLAKNKLTGGIPP--FLGNLTSLEVLSLAGNSFGR-NI 190
+K+ P F L L +L L L+ + + NL +L L L+ N +
Sbjct: 81 GSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYL 140
Query: 191 PDSLGQLKQLKILAIGGNNLSGPIPPSIYNLSF--LVVFSVSHNQIHGSLPPSLGLLLPN 248
S G+L LK + N + + L L FS++ N ++ + G +
Sbjct: 141 HPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNP 200
Query: 249 LKFFQIHHNFFSGSIPISLSNASKLEHIEIANNNFSGKLSVNFGGMKNLSLLNLQFSNLG 308
+ + SG N ++ +N S + + ++ F N+
Sbjct: 201 FRNMVLEILDVSG-------NGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIK 253
Query: 309 SGESDEMGFMNSLTNCSKLRVLSLGGNQFRGALPHSIANLSSQLQILILSSNQFYGSIPL 368
+ + + + +R L L L L++L L+ N+ I
Sbjct: 254 DPDQNTFAGLARSS----VRHLDLSHGFVFSLNSRVFETLKD-LKVLNLAYNKI-NKIAD 307
Query: 369 GI-GNLVDLYLLGMVENQFTGAIPKEMGKLQKLQGLDFSGNHFSGEIPSSLGNLSSLYEV 427
L +L +L + N L K+ +D NH + + L L +
Sbjct: 308 EAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTL 367
Query: 428 FFNNNNLSGVIPFSLGNLKRLAFLEMSGNELSGTIPEDIFNISYLSNSLNLARNHLVGI- 486
+N L+ ++ + + + +SGN+L T+P+ +N ++L+ N L +
Sbjct: 368 DLRDNALT-----TIHFIPSIPDIFLSGNKLV-TLPKINLT----ANLIHLSENRLENLD 417
Query: 487 IPPRIGNLRALRSFDVSNNDLSGEIPIE--LGHCSSLEEIYLAGNLFHGSI-----PSFF 539
I + + L+ ++ N S + SLE+++L N+ + F
Sbjct: 418 ILYFLLRVPHLQILILNQNRFS-SCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVF 476
Query: 540 NALKGVQKIDLSRNNLSGQIP--IFLEALSLEYLNLSFNDF 578
L +Q + L+ N L+ +P +F +L L+L+ N
Sbjct: 477 EGLSHLQVLYLNHNYLN-SLPPGVFSHLTALRGLSLNSNRL 516
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 5e-37
Identities = 74/425 (17%), Positives = 144/425 (33%), Gaps = 51/425 (12%)
Query: 160 NKLTGGIPPFLGNLTSLEVLSLAGNSFGRNIPDSLGQLKQLKILAIGGNNLSGPIPP-SI 218
LT +P L + E L L+ N S L+QL++L +G I +
Sbjct: 14 CNLTQ-VPQ---VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAF 69
Query: 219 YNLSFLVVFSVSHNQIHGSLPPSLGLLLPNLKFFQIHHNFFSGSI--PISLSNASKLEHI 276
NL L + + ++I+ L P L +L +++ S ++ N L +
Sbjct: 70 RNLPNLRILDLGSSKIY-FLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRL 128
Query: 277 EIANNNFSG-KLSVNFGGMKNLSLLNLQFSNLGSGESDEMGFMNSLTNCSKLRVLSLGGN 335
+++ N L +FG + +L ++ + + E+ L + L SL N
Sbjct: 129 DLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHEL---EPLQGKT-LSFFSLAAN 184
Query: 336 QFRGALPHSIANLSSQLQILILSSNQFYGSIPLGIGNLVDLYLLGMVENQFTGAIPKEMG 395
+ + + ++L G N + + G N + + +
Sbjct: 185 SLYSRVSVDWGKCMNPFRNMVLEILDVSG-------NGWTVDITGNFSNAISKSQAFSLI 237
Query: 396 KLQKLQGLDFSGNHFSGEIPSSLGNL--SSLYEVFFNNNNLSGVIPFSLGNLKRLAFLEM 453
+ G F ++ ++ L SS+ + ++ + + LK L L +
Sbjct: 238 LAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNL 297
Query: 454 SGNELSGTIPEDIFNISYLSNSLNLARNHLVGIIPPRIGNLRALRSFDVSNNDLSGEIPI 513
+ N+++ I ++ F L L+ ++S N L
Sbjct: 298 AYNKIN-KIADEAFY------------------------GLDNLQVLNLSYNLLGELYSS 332
Query: 514 ELGHCSSLEEIYLAGNLFHGSIPSFFNALKGVQKIDLSRNNLSGQIPIFLEALSLEYLNL 573
+ I L N F L+ +Q +DL N L+ I S+ + L
Sbjct: 333 NFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALT-TIHFI---PSIPDIFL 388
Query: 574 SFNDF 578
S N
Sbjct: 389 SGNKL 393
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 1e-28
Identities = 73/447 (16%), Positives = 150/447 (33%), Gaps = 52/447 (11%)
Query: 75 GNLSFLREINLSNNTIQGEIPPEFGRLFRLEALFLSNNSLVGKIPANLS--YCSRLTVLC 132
GN + +N I + +++ + S + L
Sbjct: 213 GNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLD 272
Query: 133 IEYNKLQGRIPLEFVSLSKLKDLSLAKNKLTGGIPPFLGNLTSLEVLSLAGNSFGRNIPD 192
+ + + F +L LK L+LA NK+ L +L+VL+L+ N G
Sbjct: 273 LSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSS 332
Query: 193 SLGQLKQLKILAIGGNNLSGPIPPSIYNLSFLVVFSVSHNQIHGSLPPSLGLLLPNLKFF 252
+ L ++ + + N+++ + L L + N + ++ +P++
Sbjct: 333 NFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALT-TIH-----FIPSIPDI 386
Query: 253 QIHHNFFSGSIPISLSNASKLEHIEIANNNFSG-KLSVNFGGMKNLSLLNLQFSNLGSGE 311
+ N I+L+ I ++ N + + +L +L L + S
Sbjct: 387 FLSGNKLVTLPKINLT----ANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCS 442
Query: 312 SDEMGFMNSLTNCSKLRVLSLGGNQFRGALPHSIANLS----SQLQILILSSNQFYGSIP 367
D + + L L LG N + A + S LQ+L L+ N S+P
Sbjct: 443 GD-----QTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLN-SLP 496
Query: 368 LGIGNLVDLYLLGMVENQFTGAIPKEMGKLQKLQGLDFSGNHFSGEIPSSLGNLSSLYEV 427
G+ F+ L L+GL + N + + + ++L +
Sbjct: 497 PGV---------------FSH--------LTALRGLSLNSNRLT-VLSHND-LPANLEIL 531
Query: 428 FFNNNNLSGVIPFSLGNLKRLAFLEMSGNELSGTIPEDIFNISYLSNSLNLARNHLVGII 487
+ N L P +L L+++ N+ F I++L+++ I
Sbjct: 532 DISRNQLLAPNPDVFVSLSV---LDITHNKFICECELSTF-INWLNHTNVTIAGPPADIY 587
Query: 488 PPRIGNLRALRSFDVSNNDLSGEIPIE 514
+ + F +S E ++
Sbjct: 588 CVYPDSFSGVSLFSLSTEGCDEEEVLK 614
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 1e-24
Identities = 63/325 (19%), Positives = 111/325 (34%), Gaps = 27/325 (8%)
Query: 50 GRRHRRVTALDLMSKSLSGSLSPHLGNLSFLREINLSNNTIQGEIPPEFGRLFRLEALFL 109
G V LDL + S L L+ +NL+ N I F L L+ L L
Sbjct: 262 GLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNL 321
Query: 110 SNNSLVGKIPANLSYCSRLTVLCIEYNKLQGRIPLEFVSLSKLKDLSLAKNKLTGGIPPF 169
S N L +N ++ + ++ N + F L KL+ L L N LT
Sbjct: 322 SYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALT-----T 376
Query: 170 LGNLTSLEVLSLAGNSFGRNIPDSLGQLKQLKILAIGGNNLSG-PIPPSIYNLSFLVVFS 228
+ + S+ + L+GN +P + + N L I + + L +
Sbjct: 377 IHFIPSIPDIFLSGNKL-VTLPKINLTANLIHLS---ENRLENLDILYFLLRVPHLQILI 432
Query: 229 VSHNQIHGSLPPSLGLLLPNLKFFQIHHNFFSGSIPISL-----SNASKLEHIEIANNNF 283
++ N+ P+L+ + N + L S L+ + + +N
Sbjct: 433 LNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYL 492
Query: 284 SGKLSVNFGGMKNLSLLNLQFSNLGSGESDEMGFMNSLTNCSKLRVLSLGGNQFRGALPH 343
+ F + L L+L + L ++ + L +L + NQ P
Sbjct: 493 NSLPPGVFSHLTALRGLSLNSNRLTV--------LSHNDLPANLEILDISRNQLLAPNPD 544
Query: 344 SIANLSSQLQILILSSNQFYGSIPL 368
+LS ++ N+F L
Sbjct: 545 VFVSLSVLD----ITHNKFICECEL 565
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 182 bits (465), Expect = 5e-52
Identities = 59/225 (26%), Positives = 96/225 (42%), Gaps = 36/225 (16%)
Query: 690 HLIGVGSFGCVYKGALDEDGIVVAIKVINLQCE----GASKSFMAECKALKNIRHRNLVK 745
+IG+G FG VY+ G VA+K + ++ E K ++H N++
Sbjct: 13 EIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIA 70
Query: 746 VITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDV 805
+ C + + +V E+ G L + L ++ ++ A+ +
Sbjct: 71 LRGVCL----KEPNL-CLVMEFARGGPLNRVLSGK-----------RIPPDILVNWAVQI 114
Query: 806 ASALDYLHHHCQEPILHCDLKPSNILLDNDLSGH--------IGDFGLARFHQEVSNSTL 857
A ++YLH PI+H DLK SNIL+ + I DFGLAR
Sbjct: 115 ARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHR------ 168
Query: 858 SSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKP 902
++ + G + APE S S DV+SYG+LL E++T + P
Sbjct: 169 TTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVP 213
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 182 bits (463), Expect = 9e-52
Identities = 63/314 (20%), Positives = 114/314 (36%), Gaps = 69/314 (21%)
Query: 690 HLIGVGSFGCVYKGALDEDGIVVAIKVINLQC--EGASKSFMAECKALKNIRHRNLVKVI 747
+ G ++KG G + +KV+ ++ S+ F EC L+ H N++ V+
Sbjct: 16 TKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVL 73
Query: 748 TSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVAS 807
+C S ++ +MP GSL LH + + Q + A+D+A
Sbjct: 74 GACQS---PPAPHPTLITHWMPYGSLYNVLH--------EGTNFVVDQSQAVKFALDMAR 122
Query: 808 ALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTI 867
+ +LH + I L ++++D D++ I + Q S G
Sbjct: 123 GMAFLHT-LEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ---------SPGRMYAP 172
Query: 868 GYTAPE------YGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMAL 921
+ APE + D++S+ +LL E+VT + P F L N
Sbjct: 173 AWVAPEALQKKPEDTNRRSA---DMWSFAVLLWELVTREVP----FAD---LSN------ 216
Query: 922 PNQVMDIVDPILRNDEEILASTDKCRRMQ--TGINSRLECLISMVKIGVACSMESPQDRM 979
M+I + R GI+ + L+ + C E P R
Sbjct: 217 ----MEIGMKVALEG----------LRPTIPPGISPHVSKLMKI------CMNEDPAKRP 256
Query: 980 NMTNVVHELQSVKN 993
+V L+ +++
Sbjct: 257 KFDMIVPILEKMQD 270
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 180 bits (460), Expect = 3e-51
Identities = 66/319 (20%), Positives = 118/319 (36%), Gaps = 75/319 (23%)
Query: 690 HLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGAS-------KSFMAECKALKNIRHRN 742
IG G FG V+KG L +D VVAIK + L + F E + N+ H N
Sbjct: 25 KQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPN 84
Query: 743 LVKVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIA 802
+VK+ + +V E++P G L L + ++ +
Sbjct: 85 IVKLYGLMHNP-------PRMVMEFVPCGDLYHRLLDK---------AHPIKWSVKLRLM 128
Query: 803 IDVASALDYLHHHCQEPILHCDLKPSNILLDN-----DLSGHIGDFGLARFHQEVSNSTL 857
+D+A ++Y+ + PI+H DL+ NI L + + + DFGL++
Sbjct: 129 LDIALGIEYM-QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVH------ 181
Query: 858 SSSVGVKGTIGYTAPE--YGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHN 915
S G+ G + APE + D YS+ ++L ++T + P F+ ++
Sbjct: 182 -SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGP----FDE----YS 232
Query: 916 FARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLE----CLISMVKIGVACS 971
+ ++ N + + R C + + C
Sbjct: 233 YGKIKFINMIRE-------------------------EGLRPTIPEDCPPRLRNVIELCW 267
Query: 972 MESPQDRMNMTNVVHELQS 990
P+ R + + +V EL
Sbjct: 268 SGDPKKRPHFSYIVKELSE 286
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 182 bits (463), Expect = 1e-49
Identities = 97/518 (18%), Positives = 170/518 (32%), Gaps = 98/518 (18%)
Query: 70 LSPHLGNLSFLREINLSNNTIQGEIPPEFGRLFRLEALFLSNNSLVGKIPANLSYCSRLT 129
++P + +FL+E ++ + E+P E + + + + P +
Sbjct: 3 INPRNVSNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMA 61
Query: 130 VLCIEYNKLQGRIPLEFVSLSKLKDLSLAKNKLTGGIPPFLGNLTSLEVLSLAGNSFGRN 189
V + + + +L L L+ +P +L S L + NS
Sbjct: 62 VSRLRDCLDR-----------QAHELELNNLGLS-SLPELPPHLES---LVASCNSL-TE 105
Query: 190 IPDSLGQLKQLKILAIGGNNLSGPIP---------------PSIYNLSFLVVFSVSHNQI 234
+P+ LK L + LS P P + N SFL + V +N +
Sbjct: 106 LPELPQSLKSLLVDNNNLKALSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSL 165
Query: 235 HGSLPPSLGLLLPNLKFFQIHHNFFSGSIPISLSNASKLEHIEIANNNFSGKLSVNFGGM 294
LP P+L+F +N +P L N L I NN+ KL +
Sbjct: 166 K-KLPDL----PPSLEFIAAGNNQLE-ELP-ELQNLPFLTAIYADNNSLK-KLPDLPLSL 217
Query: 295 KNLSLLNLQFSNLGSGESDEMGFMNSLTNCSKLRVLSLGGNQFRGALPHSIANLSS---- 350
+++ N L L N L + N + LP +L +
Sbjct: 218 ESIVAGNNILEEL-----------PELQNLPFLTTIYADNNLLK-TLPDLPPSLEALNVR 265
Query: 351 ------------QLQILILSSNQFYGSIPLGIGNLVDLYLLGMVENQFTGAIPKEMGKLQ 398
L L +S N F + NL L N+ ++ L+
Sbjct: 266 DNYLTDLPELPQSLTFLDVSENIF-SGLSELPPNLYYLNASS---NEIR-SLCDLPPSLE 320
Query: 399 KLQGLDFSGNHFSGEIPSSLGNLSSLYEVFFNNNNLSGVIPFSLGNLKRLAFLEMSGNEL 458
+ L+ S N E+P+ L L + N+L+ +P NLK+ L + N L
Sbjct: 321 E---LNVSNNKLI-ELPALPPRLERLI---ASFNHLA-EVPELPQNLKQ---LHVEYNPL 369
Query: 459 SGTIPEDIFNISYLSNSLNLARNHLVGIIPPRIGNLRALRSFDVSNNDLSGEIPIELGHC 518
P+ ++ L + +LA +P NL+ L V N L E P
Sbjct: 370 R-EFPDIPESVEDLRMNSHLAE------VPELPQNLKQL---HVETNPLR-EFPDIPE-- 416
Query: 519 SSLEEIYLAGNLFHGSIPSFFNALKGVQKIDLSRNNLS 556
S+E++ + ++ ++
Sbjct: 417 -SVEDLRMNSERVVDPYEFAHETTDKLEDDVFEHHHHH 453
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 1e-37
Identities = 79/406 (19%), Positives = 141/406 (34%), Gaps = 73/406 (17%)
Query: 57 TALDLMSKSLSGSLSPHLGNLSFLREINLSNNTIQGEIPPEFGRLFRLEALFLSNNSLVG 116
+L SL+ L +L L N + + ++PP LE L +SNN L
Sbjct: 94 ESLVASCNSLT-ELPELPQSLKSLLVDNNNLKALS-DLPPL------LEYLGVSNNQLE- 144
Query: 117 KIPANLSYCSRLTVLCIEYNKLQGRIPLEFVSLSKLKDLSLAKNKLTGGIPPFLGNLTSL 176
K+P L S L ++ ++ N L+ ++P L+ ++ N+L P L NL L
Sbjct: 145 KLP-ELQNSSFLKIIDVDNNSLK-KLP---DLPPSLEFIAAGNNQLE--ELPELQNLPFL 197
Query: 177 EVLSLAGNSFGRNIPDSLGQLKQLKILAIGGNNLSGPIPPSIYNLSFLVVFSVSHNQIHG 236
+ NS + +PD L+ + G N L P + NL FL +N +
Sbjct: 198 TAIYADNNSL-KKLPDLPLSLESIVA---GNNILE--ELPELQNLPFLTTIYADNNLLK- 250
Query: 237 SLPPSLGLLLPNLKFFQIHHNFFSGSIPISLSNASKLEHIEIANNNFSGKLSVNFGGMKN 296
+LP +L+ + N+ + +P + L ++++ N FS LS +
Sbjct: 251 TLPDLPP----SLEALNVRDNYLT-DLPELPQS---LTFLDVSENIFS-GLSELPPNLYY 301
Query: 297 LSLLNLQFSNLGSGESDEMGFM-------NSLT----NCSKLRVLSLGGNQFRGALPHSI 345
L+ + + +L D + N L +L L N +P
Sbjct: 302 LNASSNEIRSL----CDLPPSLEELNVSNNKLIELPALPPRLERLIASFNHLA-EVPELP 356
Query: 346 ANLSSQLQILILSSNQFYGSIPLGIGNLVDLYL----------------LGMVENQFTGA 389
NL + L + N P ++ DL + L + N
Sbjct: 357 QNL----KQLHVEYNPLR-EFPDIPESVEDLRMNSHLAEVPELPQNLKQLHVETNPLR-E 410
Query: 390 IPKEMGKLQKLQGLDFSGNHFSGEIPSSLGNLSSLYEVFFNNNNLS 435
P ++ L + + L + F +++
Sbjct: 411 FPDIPESVEDL---RMNSERVVDPYEFAHETTDKLEDDVFEHHHHH 453
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 2e-18
Identities = 40/202 (19%), Positives = 76/202 (37%), Gaps = 33/202 (16%)
Query: 391 PKEMGKLQKLQGLDFSGNHFSGEIPSSLGNLSSLYEVFFNNNNLSGVIPFSLGNLKRLAF 450
P+ + LQ ++ + E+P N+ S E + + P G + +A
Sbjct: 5 PRNVSNTF-LQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAV 62
Query: 451 LEM-------------SGNELSGTIPEDIFNISYLSNSLNLARNHLVGIIPPRIGNLRAL 497
+ + LS ++PE ++ SL + N L +P +L++L
Sbjct: 63 SRLRDCLDRQAHELELNNLGLS-SLPELPPHL----ESLVASCNSLT-ELPELPQSLKSL 116
Query: 498 RSFDVSNNDLSGEIPIELGHCSSLEEIYLAGNLFHGSIPSFFNALKGVQKIDLSRNNLSG 557
+ + LS P LE + ++ N +P N ++ ID+ N+L
Sbjct: 117 LVDNNNLKALSDLPP-------LLEYLGVSNNQLE-KLPELQN-SSFLKIIDVDNNSLK- 166
Query: 558 QIPIFLEALSLEYLNLSFNDFE 579
++P SLE++ N E
Sbjct: 167 KLPDLPP--SLEFIAAGNNQLE 186
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 3e-05
Identities = 22/103 (21%), Positives = 40/103 (38%), Gaps = 17/103 (16%)
Query: 487 IPPRIGNLRALRSFDVSNNDLSGEIPIELGHCSSLEEIYLAGNLFHGSIPSFF------- 539
I PR + L+ +++L+ E+P+E + S E Y A + + + P
Sbjct: 3 INPRNVSNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMA 61
Query: 540 ------NALKGVQKIDLSRNNLSGQIPIFLEALSLEYLNLSFN 576
+ +++L+ LS +P LE L S N
Sbjct: 62 VSRLRDCLDRQAHELELNNLGLS-SLPELPP--HLESLVASCN 101
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 174 bits (444), Expect = 7e-49
Identities = 68/314 (21%), Positives = 117/314 (37%), Gaps = 41/314 (13%)
Query: 690 HLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECK--ALKNIRHRNLVKVI 747
+G G +G V++G+ G VA+K+ + + E KS+ E + +RH N++ I
Sbjct: 14 ECVGKGRYGEVWRGSWQ--GENVAVKIFSSRDE---KSWFRETELYNTVMLRHENILGFI 68
Query: 748 TSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVAS 807
S + ++ Y GSL +L L + + I + +AS
Sbjct: 69 ASDMTSRHSSTQL-WLITHYHEMGSLYDYLQLT-----------TLDTVSCLRIVLSIAS 116
Query: 808 ALDYLH-----HHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVG 862
L +LH + I H DLK NIL+ + I D GLA H + +N +
Sbjct: 117 GLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNP 176
Query: 863 VKGTIGYTAPE------YGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNF 916
GT Y APE + D++++G++L E+ ++ +
Sbjct: 177 RVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVED-------- 228
Query: 917 ARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQ 976
P + DP D + D+ R L S+ K+ C ++P
Sbjct: 229 --YKPPFYDVVPNDPSF-EDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPS 285
Query: 977 DRMNMTNVVHELQS 990
R+ + L
Sbjct: 286 ARLTALRIKKTLTK 299
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 181 bits (462), Expect = 8e-49
Identities = 98/533 (18%), Positives = 189/533 (35%), Gaps = 46/533 (8%)
Query: 59 LDLMSKSLSGSLSPHLGNLSFLREINLSNNTIQGEIPPE-FGRLFRLEALFLSNNSLVGK 117
D S+S + S+ L + ++ ++LS N I I L+ L L ++ +
Sbjct: 10 CDGRSRSFT-SIPSGL--TAAMKSLDLSFNKIT-YIGHGDLRACANLQVLILKSSRI-NT 64
Query: 118 IPAN-LSYCSRLTVLCIEYNKLQGRIPLEFVSLSKLKDLSLAKNKLTG-GIPPFLGNLTS 175
I + L L + N L F LS LK L+L N G+ NLT+
Sbjct: 65 IEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTN 124
Query: 176 LEVLSLAGNSFGRNIP-DSLGQLKQLKILAIGGNNLSGPIPPSIYNLSFLVVFSVSHNQI 234
L+ L + I L L L I +L S+ ++ + ++ ++
Sbjct: 125 LQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSES 184
Query: 235 HGSLPPSLGLLLPNLKFFQIHHNFFSGSIPISLSNASKLEHIEIANNNFSGKLSVNFGGM 294
L +L ++++ ++ + L ++ S +F +
Sbjct: 185 A-FLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNEL 243
Query: 295 KNLSLLNLQFSNLGSGESDEMGFMNSLTNCSKLRVLSLGGNQFRGALPHSIANLSSQLQI 354
L L+ S + +C+ + ++ + + ++
Sbjct: 244 LKLLRYILELSEV------------EFDDCTLNGLGDFNPSES-DVVSELGKVETVTIRR 290
Query: 355 LILSSNQFYGSIPLGIGNLVDLYLLGMVENQFTGAIPKEMGK-LQKLQGLDFSGNHFSGE 413
L + + + L + + + ++ +P + L+ L+ LD S N E
Sbjct: 291 LHIPQFYLFYDLSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEE 349
Query: 414 I---PSSLGNLSSLYEVFFNNNNLS--GVIPFSLGNLKRLAFLEMSGNELSGTIPEDIFN 468
+ G SL + + N+L L LK L L++S N +P+
Sbjct: 350 YLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQW 408
Query: 469 ISYLSNSLNLARNHLVGIIPPRIGNLRALRSFDVSNNDLSGEIPIELGHCSSLEEIYLAG 528
+ LNL+ + ++ + L DVSNN+L + L L+E+Y++
Sbjct: 409 PEKMR-FLNLSSTGIR-VVKT--CIPQTLEVLDVSNNNLD-SFSLFL---PRLQELYISR 460
Query: 529 NLFHGSIPS--FFNALKGVQKIDLSRNNLSGQIPIFLEAL-SLEYLNLSFNDF 578
N ++P F L + +SRN L + L SL+ + L N +
Sbjct: 461 NKLK-TLPDASLFPVL---LVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPW 509
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 176 bits (449), Expect = 4e-47
Identities = 91/523 (17%), Positives = 191/523 (36%), Gaps = 40/523 (7%)
Query: 84 NLSNNTIQGEIPPEFGRLFRLEALFLSNNSLVGKIPANLSYCSRLTVLCIEYNKLQGRIP 143
+ + + IP +++L LS N + +L C+ L VL ++ +++ I
Sbjct: 11 DGRSRSFT-SIPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRIN-TIE 66
Query: 144 LE-FVSLSKLKDLSLAKNKLTGGIPPFLGNLTSLEVLSLAGNSFGR-NIPDSLGQLKQLK 201
+ F SL L+ L L+ N L+ + G L+SL+ L+L GN + + L L+
Sbjct: 67 GDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQ 126
Query: 202 ILAIGGNNLSGPIPP-SIYNLSFLVVFSVSHNQIHGSLPPSLGLLLPNLKFFQIHHNFFS 260
L IG I L+ L + + + + ++ +H + +
Sbjct: 127 TLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLR-NYQSQSLKSIRDIHHLTLHLSESA 185
Query: 261 GSIPISLSNASKLEHIEIANNNFSG-KLSVNFGGMKNLSLLNLQFSNLGSGESDEMGFMN 319
+ I S + ++E+ + N + + S + + L F + +
Sbjct: 186 FLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLK 245
Query: 320 SLTNCSKLRVLSLGGNQFRGALPHSIANLSSQLQILILSSNQFYGSIPLGIGNLVDLYLL 379
L +L + + + ++ LG V + L
Sbjct: 246 LLRYILELSEVEFDDCTL--------------NGLGDFNPSESDVVSELGKVETVTIRRL 291
Query: 380 GMVENQFTGAIPKEMGKLQKLQGLDFSGNHFSGEIPSSLGNLSSLYEVFFNNNNLSGVIP 439
+ + + L+K++ + + S +L SL + + N +
Sbjct: 292 HIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYL 351
Query: 440 FS---LGNLKRLAFLEMSGNELSGTIPEDIFNISYLSN--SLNLARNHLVGIIPPRIGNL 494
+ G L L +S N L ++ + + L N SL+++RN +P
Sbjct: 352 KNSACKGAWPSLQTLVLSQNHLR-SMQKTGEILLTLKNLTSLDISRNTF-HPMPDSCQWP 409
Query: 495 RALRSFDVSNNDLSGEIPIELGHCSSLEEIYLAGNLFHGSIPSFFNALKGVQKIDLSRNN 554
+R ++S+ + ++ +LE + ++ N ++ SF L +Q++ +SRN
Sbjct: 410 EKMRFLNLSSTGIRV---VKTCIPQTLEVLDVSNN----NLDSFSLFLPRLQELYISRNK 462
Query: 555 LSGQIPIFLEALSLEYLNLSFNDFEGKIPAKGIFANASAISVV 597
L +P L + +S N K GIF +++ +
Sbjct: 463 LK-TLPDASLFPVLLVMKISRNQL--KSVPDGIFDRLTSLQKI 502
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 1e-30
Identities = 61/431 (14%), Positives = 128/431 (29%), Gaps = 53/431 (12%)
Query: 59 LDLMSKSLSGSLSPH-LGNLSFLREINLSNNTIQGEIPPEFGRLFRLEALFLSNNSLVGK 117
L + + + L+ L E+ + +++ + + L L +
Sbjct: 128 LRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSES-AF 186
Query: 118 IPANLSYCSRLTVLCIEYNKLQGRIPLEFVSLSKLKDLSLAKNKLTGGIPPFLGNLTSLE 177
+ LS ++ L L L L
Sbjct: 187 LLEIF-----------------------ADILSSVRYLELRDTNLARFQFSPLPVDEVSS 223
Query: 178 VLSLAGNSFGRNIPDSLGQLKQLKILAIGGNNLSGPIPPSIYNLSFLVVFSVSHNQIHGS 237
+ +S +L +L + + + + + + + ++
Sbjct: 224 PMKKLAFRGSVLTDESFNELLKLLRYILELSEV------EFDDCTLNGLGDFNPSESD-V 276
Query: 238 LPPSLGLLLPNLKFFQIHHNFFSGSIPISLSNASKLEHIEIANNNFSGKLSVNFGGMKNL 297
+ + ++ I + + S K++ I + N+ +K+L
Sbjct: 277 VSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSL 336
Query: 298 SLLNLQFSNLGSGESDEMGFMNSLTNCSKLRVLSLGGNQFR--GALPHSIANLSSQLQIL 355
L+L + + + + L+ L L N R + L + L L
Sbjct: 337 EFLDLSENLMVEEYLKNSACKGAWPS---LQTLVLSQNHLRSMQKTGEILLTLKN-LTSL 392
Query: 356 ILSSNQFYGSIPLGIGNLVDLYLLGMVENQFTGAIPKEMGKLQKLQGLDFSGNHFSGEIP 415
+S N F +P + L + + Q L+ LD S N+
Sbjct: 393 DISRNTF-HPMPDSCQWPEKMRFLNLSSTGIR-VVKT--CIPQTLEVLDVSNNNLD-SFS 447
Query: 416 SSLGNLSSLYEVFFNNNNLSGVIPFSLGNLKRLAFLEMSGNELSGTIPEDIFNISYLSN- 474
L L LY + N L + SL L +++S N+L ++P+ IF L++
Sbjct: 448 LFLPRLQELY---ISRNKLKTLPDASL--FPVLLVMKISRNQLK-SVPDGIF--DRLTSL 499
Query: 475 -SLNLARNHLV 484
+ L N
Sbjct: 500 QKIWLHTNPWD 510
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 176 bits (448), Expect = 8e-49
Identities = 75/380 (19%), Positives = 145/380 (38%), Gaps = 35/380 (9%)
Query: 80 LREINLSNNTIQGEIPPEFGRLFRLEALFLSNNSLVGKIPANLSYCSRLTVLCIEYNKLQ 139
+ I +I P L L S+ + +T L + K+
Sbjct: 2 AATLATLPAPI-NQIFP-DADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVA 57
Query: 140 GRIPLEFVSLSKLKDLSLAKNKLTGGIPPFLGNLTSLEVLSLAGNSFGRNIPDSLGQLKQ 199
+E+ L+ L+ L+L N++T I P L NL L L + N +L L
Sbjct: 58 SIQGIEY--LTNLEYLNLNGNQITD-ISP-LSNLVKLTNLYIGTNKI--TDISALQNLTN 111
Query: 200 LKILAIGGNNLSGPIPPSIYNLSFLVVFSVSHNQIHGSLPPSLGLLLPNLKFFQIHHNFF 259
L+ L + +N+S P + NL+ + ++ N S L + L + + +
Sbjct: 112 LRELYLNEDNISDISP--LANLTKMYSLNLGANHNL-SDLSPLSNM-TGLNYLTVTESKV 167
Query: 260 SGSIPISLSNASKLEHIEIANNNFSGKLSVNFGGMKNLSLLNLQFSNLGSGESDEMGFMN 319
PI+ N + L + + N + +L + + +
Sbjct: 168 KDVTPIA--NLTDLYSLSLNYNQIED--ISPLASLTSLHYFTAYVNQITD--------IT 215
Query: 320 SLTNCSKLRVLSLGGNQFRGALPHSIANLSSQLQILILSSNQFYGSIPLGIGNLVDLYLL 379
+ N ++L L +G N+ P +ANLS L L + +NQ I + +L L +L
Sbjct: 216 PVANMTRLNSLKIGNNKITDLSP--LANLSQ-LTWLEIGTNQI-SDIN-AVKDLTKLKML 270
Query: 380 GMVENQFTGAIPKEMGKLQKLQGLDFSGNHFSGEIPSSLGNLSSLYEVFFNNNNLSGVIP 439
+ NQ + + L +L L + N E +G L++L +F + N+++ + P
Sbjct: 271 NVGSNQISD--ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP 328
Query: 440 FSLGNLKRLAFLEMSGNELS 459
+ +L ++ + + +
Sbjct: 329 LA--SLSKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 175 bits (445), Expect = 2e-48
Identities = 87/381 (22%), Positives = 155/381 (40%), Gaps = 36/381 (9%)
Query: 128 LTVLCIEYNKLQGRIPLEFVSLSKLKDLSLAKNKLTGGIPPFLGNLTSLEVLSLAGNSFG 187
L + P L++ L K +T L S+ L +AG
Sbjct: 2 AATLATLPAPINQIFPDA--DLAEGIRAVLQKASVTD--VVTQEELESITKLVVAGEKV- 56
Query: 188 RNIPDSLGQLKQLKILAIGGNNLSGPIPPSIYNLSFLVVFSVSHNQIHGSLPPSLGLLLP 247
+I + L L+ L + GN ++ P + NL L + N+I + +L L
Sbjct: 57 ASIQG-IEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKI--TDISALQNL-T 110
Query: 248 NLKFFQIHHNFFSGSIPISLSNASKLEHIEIANNNFSGKLSVNFGGMKNLSLLNLQFSNL 307
NL+ ++ + S P L+N +K+ + + N+ LS M L+ L + S +
Sbjct: 111 NLRELYLNEDNISDISP--LANLTKMYSLNLGANHNLSDLS-PLSNMTGLNYLTVTESKV 167
Query: 308 GSGESDEMGFMNSLTNCSKLRVLSLGGNQFRGALPHSIANLSSQLQILILSSNQFYGSIP 367
+ + N + L LSL NQ P +A+L+ L NQ P
Sbjct: 168 KD--------VTPIANLTDLYSLSLNYNQIEDISP--LASLT-SLHYFTAYVNQITDITP 216
Query: 368 LGIGNLVDLYLLGMVENQFTGAIPKEMGKLQKLQGLDFSGNHFSGEIPSSLGNLSSLYEV 427
+ N+ L L + N+ T P + L +L L+ N S +++ +L+ L +
Sbjct: 217 VA--NMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISD--INAVKDLTKLKML 270
Query: 428 FFNNNNLSGVIPFSLGNLKRLAFLEMSGNELSGTIPEDIFNISYLSNSLNLARNHLVGII 487
+N +S + + NL +L L ++ N+L E I ++ L +L L++NH+ I
Sbjct: 271 NVGSNQISDISVLN--NLSQLNSLFLNNNQLGNEDMEVIGGLTNL-TTLFLSQNHITDIR 327
Query: 488 PPRIGNLRALRSFDVSNNDLS 508
P + +L + S D +N +
Sbjct: 328 P--LASLSKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 6e-45
Identities = 84/382 (21%), Positives = 146/382 (38%), Gaps = 40/382 (10%)
Query: 104 LEALFLSNNSLVGKIPANLSYCSRLTVLCIEYNKLQGRIPLEFVSLSKLKDLSLAKNKLT 163
L + +I + + ++ + + E L + L +A K+
Sbjct: 2 AATLATLPAPI-NQIF-PDADLAEGIRAVLQKASVTDVVTQE--ELESITKLVVAGEKVA 57
Query: 164 GGIPPFLGNLTSLEVLSLAGNSFGRNIPDSLGQLKQLKILAIGGNNLSGPIPPSIYNLSF 223
+ LT+LE L+L GN P L L +L L IG N ++ ++ NL+
Sbjct: 58 S--IQGIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKIT--DISALQNLTN 111
Query: 224 LVVFSVSHNQIHGSLPPSLGLLLPNLKFFQIHHNFFSGSIPISLSNASKLEHIEIANNNF 283
L ++ + I L L + + N + LSN + L ++ + +
Sbjct: 112 LRELYLNEDNISD--ISPLANL-TKMYSLNLGANHNLSDLS-PLSNMTGLNYLTVTESKV 167
Query: 284 SGKLSVNFGGMKNLSLLNLQFSNLGSGESDEMGFMNSLTNCSKLRVLSLGGNQFRGALPH 343
+ +L L+L ++ + ++ L + + L + NQ P
Sbjct: 168 KD--VTPIANLTDLYSLSLNYNQIED--------ISPLASLTSLHYFTAYVNQITDITP- 216
Query: 344 SIANLSSQLQILILSSNQFYGSIPLGIGNLVDLYLLGMVENQFTGAIPKEMGKLQKLQGL 403
+AN++ L L + +N+ PL NL L L + NQ + + L KL+ L
Sbjct: 217 -VANMTR-LNSLKIGNNKITDLSPLA--NLSQLTWLEIGTNQISD--INAVKDLTKLKML 270
Query: 404 DFSGNHFSGEIPSSLGNLSSLYEVFFNNNNLSGVIPFSLGNLKRLAFLEMSGNELSGTIP 463
+ N S S L NLS L +F NNN L +G L L L +S N ++
Sbjct: 271 NVGSNQISD--ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHIT---- 324
Query: 464 EDIFNISYLSN--SLNLARNHL 483
DI ++ LS S + A +
Sbjct: 325 -DIRPLASLSKMDSADFANQVI 345
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 161 bits (411), Expect = 6e-44
Identities = 72/403 (17%), Positives = 149/403 (36%), Gaps = 63/403 (15%)
Query: 176 LEVLSLAGNSFGRNIPDSLGQLKQLKILAIGGNNLSGPIPPSIYNLSFLVVFSVSHNQIH 235
L+ + PD+ L + + +++ + L + V+ ++
Sbjct: 2 AATLATLPAPINQIFPDA--DLAEGIRAVLQKASVTDVVTQE--ELESITKLVVAGEKVA 57
Query: 236 GSLPPSLGLLLPNLKFFQIHHNFFSGSIPISLSNASKLEHIEIANNNFSGKLSVNFGGMK 295
+ L NL++ ++ N + P LSN KL ++ I N + +S +
Sbjct: 58 S--IQGIEYL-TNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKIT-DIS-ALQNLT 110
Query: 296 NLSLLNLQFSNLGSGESDEMGFMNSLTNCSKLRVLSLGGNQFRGALPHSIANLSSQLQIL 355
NL L L N+ ++ L N +K+ L+LG N ++N++ L L
Sbjct: 111 NLRELYLNEDNISD--------ISPLANLTKMYSLNLGANHNLS-DLSPLSNMTG-LNYL 160
Query: 356 ILSSNQFYGSIPLGIGNLVDLYLLGMVENQFTGAIPKEMGKLQKLQGLDFSGNHFSGEIP 415
++ ++ P+ L L L + N P
Sbjct: 161 TVTESKVKDVTPIA--------------------------NLTDLYSLSLNYNQIEDISP 194
Query: 416 SSLGNLSSLYEVFFNNNNLSGVIPFSLGNLKRLAFLEMSGNELSGTIPEDIFNISYLSN- 474
L +L+SL+ N ++ + P + N+ RL L++ N+++ D+ ++ LS
Sbjct: 195 --LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKIT-----DLSPLANLSQL 245
Query: 475 -SLNLARNHLVGIIPPRIGNLRALRSFDVSNNDLSGEIPIELGHCSSLEEIYLAGNLFHG 533
L + N + I + +L L+ +V +N +S L + S L ++L N
Sbjct: 246 TWLEIGTNQISDINA--VKDLTKLKMLNVGSNQISD--ISVLNNLSQLNSLFLNNNQLGN 301
Query: 534 SIPSFFNALKGVQKIDLSRNNLSGQIPIFLEALSLEYLNLSFN 576
L + + LS+N+++ I ++ + +
Sbjct: 302 EDMEVIGGLTNLTTLFLSQNHITD-IRPLASLSKMDSADFANQ 343
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 144 bits (367), Expect = 4e-38
Identities = 62/321 (19%), Positives = 127/321 (39%), Gaps = 34/321 (10%)
Query: 265 ISLSNASKLEHIEIANNNFSGKLSVNFGGMKNLSLLNLQFSNLGSGESDEMGFMNSLTNC 324
++ ++ + + + V +++++ L + + S + +
Sbjct: 16 FPDADLAEGIRAVLQKASVTD--VVTQEELESITKLVVAGEKVAS--------IQGIEYL 65
Query: 325 SKLRVLSLGGNQFRGALPHSIANLSSQLQILILSSNQFYGSIPLGIGNLVDLYLLGMVEN 384
+ L L+L GNQ P ++NL +L L + +N+ + + NL +L L + E+
Sbjct: 66 TNLEYLNLNGNQITDISP--LSNLV-KLTNLYIGTNKI--TDISALQNLTNLRELYLNED 120
Query: 385 QFTGAIPKEMGKLQKLQGLDFSGNHFSGEIPSSLGNLSSLYEVFFNNNNLSGVIPFSLGN 444
+ P + L K+ L+ NH S L N++ L + + + V P N
Sbjct: 121 NISDISP--LANLTKMYSLNLGANHNLS-DLSPLSNMTGLNYLTVTESKVKDVTPI--AN 175
Query: 445 LKRLAFLEMSGNELSGTIPEDIFNISYLSN--SLNLARNHLVGIIPPRIGNLRALRSFDV 502
L L L ++ N++ DI ++ L++ N + I P + N+ L S +
Sbjct: 176 LTDLYSLSLNYNQIE-----DISPLASLTSLHYFTAYVNQITDITP--VANMTRLNSLKI 228
Query: 503 SNNDLSGEIPIELGHCSSLEEIYLAGNLFHGSIPSFFNALKGVQKIDLSRNNLSGQIPIF 562
NN ++ P L + S L + + N S + L ++ +++ N +S I +
Sbjct: 229 GNNKITDLSP--LANLSQLTWLEIGTNQI--SDINAVKDLTKLKMLNVGSNQISD-ISVL 283
Query: 563 LEALSLEYLNLSFNDFEGKIP 583
L L L+ N +
Sbjct: 284 NNLSQLNSLFLNNNQLGNEDM 304
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 87.2 bits (217), Expect = 2e-18
Identities = 35/186 (18%), Positives = 70/186 (37%), Gaps = 17/186 (9%)
Query: 400 LQGLDFSGNHFSGEIPSSLGNLSSLYEVFFNNNNLSGVIPFSLGNLKRLAFLEMSGNELS 459
L + P +L+ +++ V+ L+ + L ++G +++
Sbjct: 2 AATLATLPAPINQIFP--DADLAEGIRAVLQKASVTDVVTQE--ELESITKLVVAGEKVA 57
Query: 460 GTIPEDIFNISYLSN--SLNLARNHLVGIIPPRIGNLRALRSFDVSNNDLSGEIPIELGH 517
I I YL+N LNL N + I P + NL L + + N ++ L +
Sbjct: 58 -----SIQGIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKIT--DISALQN 108
Query: 518 CSSLEEIYLAGNLFHGSIPSFFNALKGVQKIDLSRNNLSGQIPIFLEALSLEYLNLSFND 577
++L E+YL + P L + ++L N+ + L YL ++ +
Sbjct: 109 LTNLRELYLNEDNISDISP--LANLTKMYSLNLGANHNLSDLSPLSNMTGLNYLTVTESK 166
Query: 578 FEGKIP 583
+ P
Sbjct: 167 VKDVTP 172
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 174 bits (442), Expect = 1e-48
Identities = 60/247 (24%), Positives = 97/247 (39%), Gaps = 31/247 (12%)
Query: 690 HLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITS 749
++G G FG K E G V+ +K + E ++F+ E K ++ + H N++K I
Sbjct: 16 EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGV 75
Query: 750 CSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASAL 809
+ + EY+ G+L + + + QR+S A D+AS +
Sbjct: 76 LY----KDKRL-NFITEYIKGGTLRGIIKSM---------DSQYPWSQRVSFAKDIASGM 121
Query: 810 DYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNS----------TLSS 859
YLH I+H DL N L+ + + + DFGLAR +
Sbjct: 122 AYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKK 178
Query: 860 SVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMF----EGDLNLHN 915
V G + APE G DV+S+GI+L E++ + LN+
Sbjct: 179 RYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRG 238
Query: 916 FARMALP 922
F P
Sbjct: 239 FLDRYCP 245
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 174 bits (444), Expect = 2e-48
Identities = 75/313 (23%), Positives = 108/313 (34%), Gaps = 39/313 (12%)
Query: 690 HLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITS 749
IG G +G V+ G G VA+KV E AS E +RH N++ I +
Sbjct: 43 KQIGKGRYGEVWMGKWR--GEKVAVKVFFTTEE-ASWFRETEIYQTVLMRHENILGFIAA 99
Query: 750 CSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASAL 809
++ +Y NGSL +L L + +A S L
Sbjct: 100 DIKGTGSWTQL-YLITDYHENGSLYDYLKST-----------TLDAKSMLKLAYSSVSGL 147
Query: 810 DYLH-----HHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVK 864
+LH + I H DLK NIL+ + + I D GLA +N
Sbjct: 148 CHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRV 207
Query: 865 GTIGYTAPEYGLGSEVSTNG------DVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFAR 918
GT Y PE S + D+YS+G++L E+ ++ E
Sbjct: 208 GTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEE---------- 257
Query: 919 MALPNQVMDIVDPILRNDEEILASTDKCRRMQTGIN-SRLECLISMVKIGVACSMESPQD 977
LP + DP ++ K R S ECL M K+ C +P
Sbjct: 258 YQLPYHDLVPSDPSY--EDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPAS 315
Query: 978 RMNMTNVVHELQS 990
R+ V L
Sbjct: 316 RLTALRVKKTLAK 328
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 174 bits (442), Expect = 4e-48
Identities = 73/319 (22%), Positives = 125/319 (39%), Gaps = 47/319 (14%)
Query: 690 HLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECK--ALKNIRHRNLVKVI 747
IG G FG V++G G VA+K+ + + E +S+ E + +RH N++ I
Sbjct: 48 ESIGKGRFGEVWRGKWR--GEEVAVKIFSSREE---RSWFREAEIYQTVMLRHENILGFI 102
Query: 748 TSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVAS 807
+ + + +V +Y +GSL +L+ + +T+ I +A+ AS
Sbjct: 103 AADNKDNGTWTQL-WLVSDYHEHGSLFDYLNRY-----------TVTVEGMIKLALSTAS 150
Query: 808 ALDYLH-----HHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVG 862
L +LH + I H DLK NIL+ + + I D GLA H +++ +
Sbjct: 151 GLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNH 210
Query: 863 VKGTIGYTAPEYGLGSEVSTNG------DVYSYGILLLEMVTAKKPTDVMFEGDLNLHNF 916
GT Y APE S + D+Y+ G++ E+ + +
Sbjct: 211 RVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHED-------- 262
Query: 917 ARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRL---ECLISMVKIGVACSME 973
LP + DP + +E ++ R I +R E L M KI C
Sbjct: 263 --YQLPYYDLVPSDPSV--EEMRKVVCEQKLRPN--IPNRWQSCEALRVMAKIMRECWYA 316
Query: 974 SPQDRMNMTNVVHELQSVK 992
+ R+ + L +
Sbjct: 317 NGAARLTALRIKKTLSQLS 335
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 172 bits (439), Expect = 5e-48
Identities = 58/225 (25%), Positives = 90/225 (40%), Gaps = 33/225 (14%)
Query: 690 HLIGVGSFGCVYKGALDEDGIVVAIKVINLQ--CEGASKSFMAECKALKNIRHRNLVKVI 747
LIG G FG VY G + VAI++I+++ E K+F E A + RH N+V +
Sbjct: 39 ELIGKGRFGQVYHGRWHGE---VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFM 95
Query: 748 TSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVAS 807
+C S AI+ +L + +I L + + IA ++
Sbjct: 96 GACMS-----PPHLAIITSLCKGRTLYSVVRDA---------KIVLDVNKTRQIAQEIVK 141
Query: 808 ALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSV-GVKGT 866
+ YLH + ILH DLK N+ DN I DFGL + + G
Sbjct: 142 GMGYLH---AKGILHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGW 197
Query: 867 IGYTAPE---------YGLGSEVSTNGDVYSYGILLLEMVTAKKP 902
+ + APE S + DV++ G + E+ + P
Sbjct: 198 LCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWP 242
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 4e-43
Identities = 65/381 (17%), Positives = 117/381 (30%), Gaps = 62/381 (16%)
Query: 68 GSLSPHLGNLSFLREINLSNNTIQGEIPPEFGRLFRLEALFLSNNSLVGKIPANLSYCSR 127
GS H + S + +T + R + + N +
Sbjct: 2 GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQA-NS---NN 57
Query: 128 LTVLCIEYNKLQGRIP-LEFVSLSKLKDLSLAKNKLTGGIPPFLGNLTSLEVLSLAGNSF 186
+ L+ LE + L L L P L+ L+ +++
Sbjct: 58 PQIETRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGL 116
Query: 187 GRNIPDSLGQLKQLKILAIGGNNLSGPIPPSIYNLSFLVVFSVSHNQIHGSLPPSLGLLL 246
+PD++ Q L+ L + N L +P SI +L+ L S+ LP L
Sbjct: 117 -MELPDTMQQFAGLETLTLARNPLRA-LPASIASLNRLRELSIRACPELTELPEPLAST- 173
Query: 247 PNLKFFQIHHNFFSGSIPISLSNASKLEHIEIANNNFSGKLSVNFGGMKNLSLLNLQFSN 306
S G+ NL L L+++
Sbjct: 174 ---------------------------------------DASGEHQGLVNLQSLRLEWTG 194
Query: 307 LGSGESDEMGFMNSLTNCSKLRVLSLGGNQFRGALPHSIANLSSQLQILILSSNQFYGSI 366
+ S S+ N L+ L + + AL +I +L L+ L L +
Sbjct: 195 IRS-------LPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPK-LEELDLRGCTALRNY 245
Query: 367 PLGIGNLVDLYLLGMVE-NQFTGAIPKEMGKLQKLQGLDFSGNHFSGEIPSSLGNLSSLY 425
P G L L + + + +P ++ +L +L+ LD G +PS + L +
Sbjct: 246 PPIFGGRAPLKRLILKDCSNLL-TLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANC 304
Query: 426 EVFFNNN---NLSGVIPFSLG 443
+ + L P +
Sbjct: 305 IILVPPHLQAQLDQHRPVARP 325
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 9e-42
Identities = 59/343 (17%), Positives = 110/343 (32%), Gaps = 26/343 (7%)
Query: 164 GGIPPFLGNLTSLEVLSLAGNSFGRNIPDSLGQLKQLKILAIGGNNLSGPIPPSIYNLSF 223
G + + E L G++ R D L Q ++ + + N +
Sbjct: 2 GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQA----NSNN 57
Query: 224 LVVFSVSHNQIHGSLPPSLGLL-LPNLKFFQIHHNFFSGSIPISLSNASKLEHIEIANNN 282
+ + + + + L P ++ P S L+H+ I
Sbjct: 58 PQIETRTGRALK-ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAG 115
Query: 283 FSGKLSVNFGGMKNLSLLNLQFSNLGSGESDEMGFMNSLTNCSKLRVLSLGGNQFRGALP 342
+L L L L + L + S+ + ++LR LS+ LP
Sbjct: 116 LM-ELPDTMQQFAGLETLTLARNPLRA-------LPASIASLNRLRELSIRACPELTELP 167
Query: 343 HSIANLS--------SQLQILILSSNQFYGSIPLGIGNLVDLYLLGMVENQFTGAIPKEM 394
+A+ LQ L L S+P I NL +L L + + + A+ +
Sbjct: 168 EPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAI 225
Query: 395 GKLQKLQGLDFSGNHFSGEIPSSLGNLSSLYEVFFNNNNLSGVIPFSLGNLKRLAFLEMS 454
L KL+ LD G P G + L + + + +P + L +L L++
Sbjct: 226 HHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLR 285
Query: 455 GNELSGTIPEDIFNISYLSNSLNLARNHLVGIIPPRIGNLRAL 497
G +P I + + + + + R A
Sbjct: 286 GCVNLSRLPSLIAQLPANC-IILVPPHLQAQLDQHRPVARPAE 327
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 5e-40
Identities = 51/327 (15%), Positives = 107/327 (32%), Gaps = 28/327 (8%)
Query: 261 GSIPISLSNASKLEHIEIANNNFSGKLSVNFGGMKNLSLLNLQFSNLGSGESDEMGFMNS 320
GS ++S E++ + + + +
Sbjct: 2 GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAW----------R 51
Query: 321 LTNCSKLRVLSLGGNQFRGALPHSIANLSS-QLQILILSSNQFYGSIPLGIGNLVDLYLL 379
N + ++ + G + A + + + L L S P L L +
Sbjct: 52 QANSNNPQIETRTGRALK-ATADLLEDATQPGRVALELRSVPL-PQFPDQAFRLSHLQHM 109
Query: 380 GMVENQFTGAIPKEMGKLQKLQGLDFSGNHFSGEIPSSLGNLSSLYEVFFNNNNLSGVIP 439
+ +P M + L+ L + N +P+S+ +L+ L E+ +P
Sbjct: 110 TIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELP 167
Query: 440 FSLGN---------LKRLAFLEMSGNELSGTIPEDIFNISYLSNSLNLARNHLVGIIPPR 490
L + L L L + + ++P I N+ L SL + + L + P
Sbjct: 168 EPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLK-SLKIRNSPLSAL-GPA 224
Query: 491 IGNLRALRSFDVSNNDLSGEIPIELGHCSSLEEIYLAGNLFHGSIPSFFNALKGVQKIDL 550
I +L L D+ P G + L+ + L ++P + L ++K+DL
Sbjct: 225 IHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDL 284
Query: 551 SRNNLSGQIPIFLEAL-SLEYLNLSFN 576
++P + L + + + +
Sbjct: 285 RGCVNLSRLPSLIAQLPANCIILVPPH 311
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 1e-39
Identities = 60/315 (19%), Positives = 109/315 (34%), Gaps = 31/315 (9%)
Query: 59 LDLMSKSLSGSLSPHLGNLSFLREINLSNNTIQGEIPPEFGRLFRLEALFLSNNSLVGKI 118
L + L + + + + +L
Sbjct: 17 LYFQGSTALRPYHDVLSQWQRHYNADRNRW----HSAWRQANSNNPQIETRTGRALK-AT 71
Query: 119 PANLSYCSR--LTVLCIEYNKLQGRIPLEFVSLSKLKDLSLAKNKLTGGIPPFLGNLTSL 176
L ++ L + L + P + LS L+ +++ L +P + L
Sbjct: 72 ADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGL 129
Query: 177 EVLSLAGNSFGRNIPDSLGQLKQLKILAIGGNNLSGPIPPSIYNLSF---------LVVF 227
E L+LA N R +P S+ L +L+ L+I +P + + L
Sbjct: 130 ETLTLARNPL-RALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSL 188
Query: 228 SVSHNQIHGSLPPSLGLLLPNLKFFQIHHNFFSGSIPISLSNASKLEHIEIANNNFSGKL 287
+ I SLP S+ L NLK +I ++ S ++ ++ + KLE +++
Sbjct: 189 RLEWTGIR-SLPASIA-NLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNY 245
Query: 288 SVNFGGMKNLSLLNLQ-FSNLGSGESDEMGFMNSLTNCSKLRVLSLGGNQFRGALPHSIA 346
FGG L L L+ SNL + + ++L L L G LP IA
Sbjct: 246 PPIFGGRAPLKRLILKDCSNLLT-------LPLDIHRLTQLEKLDLRGCVNLSRLPSLIA 298
Query: 347 NLSSQLQILILSSNQ 361
L + I+++ +
Sbjct: 299 QLPA-NCIILVPPHL 312
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 3e-38
Identities = 54/332 (16%), Positives = 104/332 (31%), Gaps = 29/332 (8%)
Query: 246 LPNLKFFQIHHNFFSGSIPISLSNASKLEHIEIANNNFSGKLSVNFGGMKNLSLLNLQFS 305
+ + LS + A+ N N +
Sbjct: 11 SSGRENLYFQGSTALRPYHDVLSQ---WQRHYNADRNRWHSAW-RQANSNNPQIETRTGR 66
Query: 306 NLGSGESDEMGFMNSLTNCS--KLRVLSLGGNQFRGALPHSIANLSSQLQILILSSNQFY 363
L + + L + + L L P LS LQ + + +
Sbjct: 67 ALKA-------TADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSH-LQHMTIDAAGL- 116
Query: 364 GSIPLGIGNLVDLYLLGMVENQFTGAIPKEMGKLQKLQGLDFSGNHFSGEIPSSLGN--- 420
+P + L L + N A+P + L +L+ L E+P L +
Sbjct: 117 MELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDA 175
Query: 421 ------LSSLYEVFFNNNNLSGVIPFSLGNLKRLAFLEMSGNELSGTIPEDIFNISYLSN 474
L +L + + +P S+ NL+ L L++ + LS + I ++ L
Sbjct: 176 SGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLE- 232
Query: 475 SLNLARNHLVGIIPPRIGNLRALRSFDVSNNDLSGEIPIELGHCSSLEEIYLAGNLFHGS 534
L+L + PP G L+ + + +P+++ + LE++ L G +
Sbjct: 233 ELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSR 292
Query: 535 IPSFFNALKGVQKIDLSRNNLSGQIPIFLEAL 566
+PS L I + + + A
Sbjct: 293 LPSLIAQLPANCIILVPPHLQAQLDQHRPVAR 324
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 4e-37
Identities = 46/240 (19%), Positives = 87/240 (36%), Gaps = 17/240 (7%)
Query: 52 RHRRVTALDLMSKSLSGSLSPHLGNLSFLREINLSNNTIQGEIPPEFGRLFRLEALFLSN 111
AL+L S L LS L+ + + + E+P + LE L L+
Sbjct: 79 TQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLAR 136
Query: 112 NSLVGKIPANLSYCSRLTVLCIEY-NKL--------QGRIPLEFVSLSKLKDLSLAKNKL 162
N L +PA+++ +RL L I +L E L L+ L L +
Sbjct: 137 NPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGI 195
Query: 163 TGGIPPFLGNLTSLEVLSLAGNSFGRNIPDSLGQLKQLKILAIGGNNLSGPIPPSIYNLS 222
+P + NL +L+ L + + + ++ L +L+ L + G PP +
Sbjct: 196 R-SLPASIANLQNLKSLKIRNSPL-SALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRA 253
Query: 223 FLVVFSVSH-NQIHGSLPPSLGLLLPNLKFFQIHHNFFSGSIPISLSNASKLEHIEIANN 281
L + + + +LP + L L+ + +P ++ I + +
Sbjct: 254 PLKRLILKDCSNLL-TLPLDIH-RLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPH 311
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 1e-26
Identities = 44/198 (22%), Positives = 73/198 (36%), Gaps = 13/198 (6%)
Query: 59 LDLMSKSLSGSLSPHLGNLSFLREINLSNNTIQGEIPPEFGR---------LFRLEALFL 109
L L L +L + +L+ LRE+++ E+P L L++L L
Sbjct: 132 LTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRL 190
Query: 110 SNNSLVGKIPANLSYCSRLTVLCIEYNKLQGRIPLEFVSLSKLKDLSLAKNKLTGGIPPF 169
+ +PA+++ L L I + L + L KL++L L PP
Sbjct: 191 EWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCTALRNYPPI 248
Query: 170 LGNLTSLEVLSLAGNSFGRNIPDSLGQLKQLKILAIGGNNLSGPIPPSIYNLSFLVVFSV 229
G L+ L L S +P + +L QL+ L + G +P I L + V
Sbjct: 249 FGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILV 308
Query: 230 SHNQIHGSLPPSLGLLLP 247
+ L + P
Sbjct: 309 PPHLQ-AQLDQHRPVARP 325
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 6e-13
Identities = 24/120 (20%), Positives = 46/120 (38%), Gaps = 1/120 (0%)
Query: 57 TALDLMSKSLSGSLSPHLGNLSFLREINLSNNTIQGEIPPEFGRLFRLEALFLSNNSLVG 116
+L + + LS +L P + +L L E++L T PP FG L+ L L + S +
Sbjct: 209 KSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLL 267
Query: 117 KIPANLSYCSRLTVLCIEYNKLQGRIPLEFVSLSKLKDLSLAKNKLTGGIPPFLGNLTSL 176
+P ++ ++L L + R+P L + + + +
Sbjct: 268 TLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLDQHRPVARPAE 327
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 7e-08
Identities = 24/193 (12%), Positives = 42/193 (21%), Gaps = 55/193 (28%)
Query: 388 GAIPKEMGKLQKLQGLDFSGNHFSGEIPSSLGNLSSLYEVFFNNNNLSGVIPFSLGNLKR 447
G+ + L F G+ L Y N + + N
Sbjct: 2 GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHY----NADRNRWHSAWRQANSNN 57
Query: 448 LAFLEMSGNELSGTIPEDIFNISYLS-NSLNLARNHLVGIIPPRIGNLRALRSFDVSNND 506
+G L + + + + +L L L P + L L+ +
Sbjct: 58 PQIETRTGRALK-ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAG 115
Query: 507 LSGEIPIELGHCSSLEEIYLAGNLFHGSIPSFFNALKGVQKIDLSRNNLSGQIPIFLEAL 566
L E+P + + LE
Sbjct: 116 LM-ELPDTMQQFAGLET------------------------------------------- 131
Query: 567 SLEYLNLSFNDFE 579
L L+ N
Sbjct: 132 ----LTLARNPLR 140
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 159 bits (403), Expect = 1e-41
Identities = 62/442 (14%), Positives = 139/442 (31%), Gaps = 27/442 (6%)
Query: 142 IPLEFVSLSKLKDLSLAKNKLTGGIPPFLGNLTSLEVLSLAGNSFGRNIPDSLGQLKQLK 201
I + ++ K + + L + + +++ L L+GN + L +L+
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 202 ILAIGGNNLSGPIPPSIYNLSFLVVFSVSHNQIHGSLPPSLGLLLPNLKFFQIHHNFFSG 261
+L + N L + +LS L +++N + L P+++ +N S
Sbjct: 62 LLNLSSNVLYE--TLDLESLSTLRTLDLNNNYVQ-ELLV-----GPSIETLHAANNNISR 113
Query: 262 SIPISLSNASKLEHIEIANNNFSGKLSVNFGGMKNLSLLNLQFSNLGSGESDEMGFMNSL 321
+S S ++I +ANN + ++ G + L+L+ + + + E+
Sbjct: 114 ---VSCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAEL-----A 165
Query: 322 TNCSKLRVLSLGGNQFRGALPHSIANLSSQLQILILSSNQFYGSIPLGIGNLVDLYLLGM 381
+ L L+L N + + + ++L+ L LSSN+ + + + + +
Sbjct: 166 ASSDTLEHLNLQYNFIY-DVKGQV--VFAKLKTLDLSSNKL-AFMGPEFQSAAGVTWISL 221
Query: 382 VENQFTGAIPKEMGKLQKLQGLDFSGNHFS-GEIPSSLGNLSSLYEVFFNNNNLSGVIPF 440
N+ I K + Q L+ D GN F G + + V + +
Sbjct: 222 RNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTV--AKQTVKKLTGQ 278
Query: 441 SLGNLKRLAFLEMSGN---ELSGTIPEDIFNISYLSNSLNLARNHLVGIIPPRIGNLRAL 497
+ +L + + + ++L + + N
Sbjct: 279 NEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQ 338
Query: 498 RSFDVSNNDLSGEIPIELGHCSSLEEIYLAGNLFHGSIPSFFNALKGVQKIDLSRNNLSG 557
R D I + + + + A +
Sbjct: 339 REIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQIE 398
Query: 558 QIPIFLEALSLEYLNLSFNDFE 579
E L+ L +E
Sbjct: 399 LQHATEEQSPLQLLRAIVKRYE 420
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 3e-39
Identities = 71/488 (14%), Positives = 150/488 (30%), Gaps = 29/488 (5%)
Query: 75 GNLSFLREINLSNNTIQGEIPPEFGRLFRLEALFLSNNSLVGKIPANLSYCSRLTVLCIE 134
N + + +++++++ + + ++ L LS N L A+L+ ++L +L +
Sbjct: 7 QNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLS 66
Query: 135 YNKLQGRIPLEFVSLSKLKDLSLAKNKLTGGIPPFLGNLTSLEVLSLAGNSFGRNIPDSL 194
N L L+ SLS L+ L L N + L S+E L A N+ + S
Sbjct: 67 SNVLYE--TLDLESLSTLRTLDLNNNYVQE-----LLVGPSIETLHAANNNI-SRVSCSR 118
Query: 195 GQLKQLKILAIGGNNLSGPIPPSIYNLSFLVVFSVSHNQIHGSLPPSLGLLLPNLKFFQI 254
GQ K + + N ++ S + + N+I L L+ +
Sbjct: 119 GQ--GKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNL 176
Query: 255 HHNFFSGSIPISLSNASKLEHIEIANNNFSGKLSVNFGGMKNLSLLNLQFSNLGSGESDE 314
+NF + +KL+ +++++N + + F ++ ++L+ + L
Sbjct: 177 QYNFIY-DVK-GQVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLVL----- 228
Query: 315 MGFMNSLTNCSKLRVLSLGGNQFRGALPHSIANLSSQLQILILSSNQFYGSIPLGIGNLV 374
+L L L GN F S ++ ++
Sbjct: 229 --IEKALRFSQNLEHFDLRGNGFHCGTLRDF--FSKNQRVQTVAKQTVKKLTGQNEEECT 284
Query: 375 DLYLLGMVENQFTGAIPKEMGKLQKLQGLDFSGNHFSG----EIPSSLGNLSSLYEVFFN 430
L +L L+ + + G + N + E+
Sbjct: 285 VPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDAL 344
Query: 431 NNNLSGVIPFSLGNLKRLAFLEMSGNELSGTIPEDIFNISYLSNSLNLARNHLVGI--IP 488
VI + LE L + + + +
Sbjct: 345 KEQYRTVIDQVTLRKQAKITLEQKKKALD-EQVSNGRRAHAELDGTLQQAVGQIELQHAT 403
Query: 489 PRIGNLRALRSFDVSNNDLSGEIPIELGHCSSLEEIYLAGNLFHGSIPSFFNALKGVQKI 548
L+ LR+ ++ E + ++Y + L G +
Sbjct: 404 EEQSPLQLLRAIVKRYEEMYVEQQSVQNNAIRDWDMYQHKETQLAEENARLKKLNGEADL 463
Query: 549 DLSRNNLS 556
L+ N +
Sbjct: 464 ALASANAT 471
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 151 bits (382), Expect = 7e-39
Identities = 64/476 (13%), Positives = 142/476 (29%), Gaps = 30/476 (6%)
Query: 55 RVTALDLMSKSLSGSLSPHLGNLSFLREINLSNNTIQGEIPPEFGRLFRLEALFLSNNSL 114
R + SL +L+ + ++E++LS N + + +LE L LS+N L
Sbjct: 11 RYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVL 70
Query: 115 VGKIPANLSYCSRLTVLCIEYNKLQGRIPLEFVSLSKLKDLSLAKNKLTGGIPPFLGNLT 174
+L S L L + N +Q E + ++ L A N ++ +
Sbjct: 71 YE--TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-RVSC--SRGQ 120
Query: 175 SLEVLSLAGNSFGRNIPDSLGQLKQLKILAIGGNNLSG-PIPPSIYNLSFLVVFSVSHNQ 233
+ + LA N G +++ L + N + + L ++ +N
Sbjct: 121 GKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNF 180
Query: 234 IHGSLPPSLGLLLPNLKFFQIHHNFFSGSIPISLSNASKLEHIEIANNNFSGKLSVNFGG 293
I+ + ++ LK + N + + +A+ + I + NN +
Sbjct: 181 IY-DVKG--QVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRF 235
Query: 294 MKNLSLLNLQFSNLGSGESDEMGFMNSLTNCSKLRVLSLGGNQFRGALPHSIANLSSQLQ 353
+NL +L+ N + F + RV ++ + L +
Sbjct: 236 SQNLEHFDLR-GNGFHCGTLRDFFSKN------QRVQTVAKQTVKK-LTGQNEEECTVPT 287
Query: 354 ILILSSNQFYGSIPLGIGNLVDLYLLGM----VENQFTGAIPKEMGKLQKLQGLDFSGNH 409
+ + L+ L + T + E + + +D
Sbjct: 288 LGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALKEQ 347
Query: 410 FSGEIPSSLGNLSSLYEVFFNNNNLSGVIPFSLGNLKRLAFLEMSGNELSGTIPEDIFNI 469
+ I + + L + L +
Sbjct: 348 YRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQ-IELQHATEEQ 406
Query: 470 SYLSNSLNLARNHLVGIIPPRIGNLRALRSFDVSNNDLSGEIPIELGHCSSLEEIY 525
S L + + + + + A+R +D+ + + ++ E L
Sbjct: 407 SPLQLLRAIVKRYEEMYVEQQSVQNNAIRDWDMYQHKET-QLAEENARLKKLNGEA 461
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 8e-39
Identities = 58/408 (14%), Positives = 122/408 (29%), Gaps = 29/408 (7%)
Query: 165 GIPPFLGNLTSLEVLSLAGNSFGRNIPDSLGQLKQLKILAIGGNNLSGPIPPSIYNLSFL 224
I N ++ + +S + + +K L + GN LS + + L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 225 VVFSVSHNQIHGSLPPSLGLLLPNLKFFQIHHNFFSGSIPISLSNASKLEHIEIANNNFS 284
+ ++S N ++ L L+ +++N+ L +E + ANNN S
Sbjct: 61 ELLNLSSNVLY-ETLDLES--LSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS 112
Query: 285 GKLSVNFGGMKNLSLLNLQFSNLGSGESDEMGFMNSLTNCSKLRVLSLGGNQFRGALPHS 344
V+ + + L + + S+++ L L N+
Sbjct: 113 ---RVSCSRGQGKKNIYLANNKITMLRD------LDEGCRSRVQYLDLKLNEIDTVNFAE 163
Query: 345 IANLSSQLQILILSSNQFYGSIPLGIGNLVDLYLLGMVENQFTGAIPKEMGKLQKLQGLD 404
+A S L+ L L N Y + + L L + N+ + E + +
Sbjct: 164 LAASSDTLEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWIS 220
Query: 405 FSGNHFSGEIPSSLGNLSSLYEVFFNNNNLS-GVIPFSLGNLKRLAFLEMSGNELSGTIP 463
N I +L +L N G + +R+ + + +
Sbjct: 221 LRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVK---KLT 276
Query: 464 EDIFNISYLSNSLNLARNHLVGIIPPRIGNLRALRSFDVSNNDLSG----EIPIELGHCS 519
+ + + P L AL+ + + G + E + +
Sbjct: 277 GQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQA 336
Query: 520 SLEEIYLAGNLFHGSIPSFFNALKGVQKIDLSRNNLSGQIPIFLEALS 567
EI + I + ++ + L Q+ A +
Sbjct: 337 RQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHA 384
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 2e-38
Identities = 83/499 (16%), Positives = 175/499 (35%), Gaps = 67/499 (13%)
Query: 74 LGNLSFLREINLSNNTIQGEIPPEFGRLFRLEALFLSNNSLVGKIPAN-LSYCSRLTVLC 132
L ++++ T E L + + N+++ K+PA L ++ +L
Sbjct: 23 LQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQVELLN 81
Query: 133 IEYNKLQGRIPLE-FVSLSKLKDLSLAKNKLTGGIPPFLGNLTSLEVLSLAGNSFGRNIP 191
+ +++ I F ++ L + N + P N+ L VL L N
Sbjct: 82 LNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPR 140
Query: 192 DSLGQLKQLKILAIGGNNLSGPIPPSI-YNLSFLVVFSVSHNQIHGSLPPSLGLLLPNLK 250
+L L++ NNL I + L +S N++ + S L+P+L
Sbjct: 141 GIFHNTPKLTTLSMSNNNLER-IEDDTFQATTSLQNLQLSSNRLT-HVDLS---LIPSLF 195
Query: 251 FFQIHHNFFSGSIPISLSNASKLEHIEIANNNFSGKLSVNFGGMKNLSLLNLQFSNLGSG 310
+ +N S +L+ +E ++ ++N+ + V L++L LQ +NL
Sbjct: 196 HANVSYNLLS-----TLAIPIAVEELDASHNSIN---VVRGPVNVELTILKLQHNNLTD- 246
Query: 311 ESDEMGFMNSLTNCSKLRVLSLGGNQFRGALPHSIANLSSQLQILILSSNQFYGSIPLGI 370
L N L + L N+ + H + +L+ L +S+N+
Sbjct: 247 -------TAWLLNYPGLVEVDLSYNELEKIMYHPFVKM-QRLERLYISNNRL-------- 290
Query: 371 GNLVDLYLLGMVENQFTGAIPKEMGKLQKLQGLDFSGNHFSGEIPSSLGNLSSLYEVFFN 430
A+ + L+ LD S NH + + L ++ +
Sbjct: 291 -----------------VALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLD 332
Query: 431 NNNLSGVIPFSLGNLKRLAFLEMSGNELSGT----IPEDIFNISYLSNSLNLA-----RN 481
+N++ + L L L +S N+ + ++ + + +
Sbjct: 333 HNSIVTL---KLSTHHTLKNLTLSHNDWDCNSLRALFRNVARPAVDDADQHCKIDYQLEH 389
Query: 482 HLVGIIPPRIGNLRALRSFDVSNNDLSGEIPIELGHCSSLEEIYLAGNLFHGSIPSFFNA 541
L + R L+ ++ + ++ G CS+ + I +L H
Sbjct: 390 GLCCKESDKPYLDRLLQ--YIALTSVVEKVQRAQGRCSATDTINSVQSLSHYITQQGGVP 447
Query: 542 LKGVQKIDLSRNNLSGQIP 560
L+G ++++ N L ++
Sbjct: 448 LQGNEQLEAEVNELRAEVQ 466
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 9e-36
Identities = 78/464 (16%), Positives = 167/464 (35%), Gaps = 36/464 (7%)
Query: 118 IPANLSYCSRLTVLCIEYNKLQGRIPLEFVSLSKLKDLSLAKNKLTGGIPP-FLGNLTSL 176
I +NL Y + I+ E ++L+ K ++ + + +P L + +
Sbjct: 19 IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQV 77
Query: 177 EVLSLAGNSFGRNIPDSLGQLKQLKILAIGGNNLSGPIPPSI-YNLSFLVVFSVSHNQIH 235
E+L+L + ++ L +G N + +PP + N+ L V + N +
Sbjct: 78 ELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRY-LPPHVFQNVPLLTVLVLERNDLS 136
Query: 236 GSLPPSLGLLLPNLKFFQIHHNFFSGSIPISLSNASKLEHIEIANNNFSGKLSVNFGGMK 295
SLP + P L + +N + + L+++++++N + V+ +
Sbjct: 137 -SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT---HVDLSLIP 192
Query: 296 NLSLLNLQFSNLGSGESDEMGFMNSLTNCSKLRVLSLGGNQFRGALPHSIANLSSQLQIL 355
+L N+ ++ L ++L + L N + ++ +L IL
Sbjct: 193 SLFHANVSYNLL-----------STLAIPIAVEELDASHNSIN-VVR---GPVNVELTIL 237
Query: 356 ILSSNQFYGSIPLGIGNLVDLYLLGMVENQFTGAIPKEMGKLQKLQGLDFSGNHFSGEIP 415
L N + N L + + N+ + K+Q+L+ L S N +
Sbjct: 238 KLQHNNL-TDTA-WLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALN 294
Query: 416 SSLGNLSSLYEVFFNNNNLSGVIPFSLGNLKRLAFLEMSGNELSGTIPEDIFNISYLSNS 475
+ +L + ++N+L + + RL L + N + T+ L N
Sbjct: 295 LYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLKLSTH--HTLKN- 349
Query: 476 LNLARNHLVGIIPPRIGNLRALRSFDVSNNDLSGEIPIELGH---CSSLEEIYLAGNLFH 532
L L+ N R + V + D +I +L H C ++ YL L +
Sbjct: 350 LTLSHNDWDCN--SLRALFRNVARPAVDDADQHCKIDYQLEHGLCCKESDKPYLDRLLQY 407
Query: 533 GSIPSFFNALKGVQKIDLSRNNLSGQIPIFLEALSLEYLNLSFN 576
++ S ++ Q + + ++ + + L N
Sbjct: 408 IALTSVVEKVQRAQGRCSATDTINSVQSLSHYITQQGGVPLQGN 451
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 125 bits (314), Expect = 9e-30
Identities = 68/390 (17%), Positives = 141/390 (36%), Gaps = 36/390 (9%)
Query: 220 NLSFLVVFSVSH-NQIHGSLPPSLGLL-LPNLKFFQIHHNFFSGSIPISLSNASKLEHIE 277
NL + VF H + + + L N K ++ L + ++E +
Sbjct: 22 NLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLN 81
Query: 278 IANNNFSGKLSVNFGGMKNLSLLNLQFSNLGSGESDEMGFMNSLTNCSKLRVLSLGGNQF 337
+ + + F + L + F+ + N L VL L N
Sbjct: 82 LNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPH------VFQNVPLLTVLVLERNDL 135
Query: 338 RGALPHSIANLSSQLQILILSSNQFYGSIPLGI-GNLVDLYLLGMVENQFTGAIPKEMGK 396
+LP I + + +L L +S+N I L L + N+ T + +
Sbjct: 136 S-SLPRGIFHNTPKLTTLSMSNNNL-ERIEDDTFQATTSLQNLQLSSNRLT-HVD--LSL 190
Query: 397 LQKLQGLDFSGNHFSGEIPSSLGNLSSLYEVFFNNNNLSGVIPFSLGNLKRLAFLEMSGN 456
+ L + S N S +L ++ E+ ++N+++ V L L ++ N
Sbjct: 191 IPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSINVVRGPVNVELTIL---KLQHN 242
Query: 457 ELSGTIPEDIFNISYLSN--SLNLARNHLVGIIPPRIGNLRALRSFDVSNNDLSGEIPIE 514
L+ D + ++L+ N L I+ ++ L +SNN L + +
Sbjct: 243 NLT-----DTAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLY 296
Query: 515 LGHCSSLEEIYLAGNLFHGSIPSFFNALKGVQKIDLSRNNLSGQIPIFLEAL-SLEYLNL 573
+L+ + L+ N + ++ + L N++ + + +L+ L L
Sbjct: 297 GQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLKL--STHHTLKNLTL 352
Query: 574 SFNDFEGKIPAKGIFANASAISVVGCNRLC 603
S ND++ + +F N + +V ++ C
Sbjct: 353 SHNDWDC-NSLRALFRNVARPAVDDADQHC 381
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 92.3 bits (229), Expect = 2e-19
Identities = 38/232 (16%), Positives = 81/232 (34%), Gaps = 14/232 (6%)
Query: 348 LSSQLQILILSSNQFYGSIPLGIGNLVDLYLLGMVENQFTGAIPKEMGKLQKLQGLDFSG 407
+ Q + + Y I + Y + + E L + + F
Sbjct: 1 VGGQQRYNVKPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKN 60
Query: 408 NHFSGEIPSSLGNLSSLYEVFFNNNNLSGVIPFSLGNLKRLAFLEMSGNELSGTIPEDIF 467
+ + L + + + N+ + + ++ + L M N + +P +F
Sbjct: 61 STMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVF 119
Query: 468 NISYLSN--SLNLARNHLVGIIPPRIGNLRALRSFDVSNNDLSGEIPIE-LGHCSSLEEI 524
+ L L RN L + N L + +SNN+L I + +SL+ +
Sbjct: 120 --QNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNL 176
Query: 525 YLAGNLFHGSIPSFFNALKGVQKIDLSRNNLSGQIPIFLEALSLEYLNLSFN 576
L+ N + + + + ++S N LS + +++E L+ S N
Sbjct: 177 QLSSNRLT-HVD--LSLIPSLFHANVSYNLLS-TLA---IPIAVEELDASHN 221
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 89.6 bits (222), Expect = 2e-18
Identities = 61/434 (14%), Positives = 131/434 (30%), Gaps = 25/434 (5%)
Query: 73 HLGNLSFLREINLSNNTIQGEIPPEFGRLFRLEALFLSNNSLVGKIPANLSYCSRLTVLC 132
L + L N+S N + +E L S+NS+ + + LT+L
Sbjct: 187 DLSLIPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSIN-VVRGPV--NVELTILK 238
Query: 133 IEYNKLQGRIPLEFVSLSKLKDLSLAKNKLTGGIPPFLGNLTSLEVLSLAGNSFGRNIPD 192
+++N L ++ L ++ L+ N+L + + LE L ++ N +
Sbjct: 239 LQHNNLT-DTA-WLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRL-VALNL 295
Query: 193 SLGQLKQLKILAIGGNNLSGPIPPSIYNLSFLVVFSVSHNQIHGSLPPSLGLLLPNLKFF 252
+ LK+L + N+L + + L + HN I +L S LK
Sbjct: 296 YGQPIPTLKVLDLSHNHLLH-VERNQPQFDRLENLYLDHNSIV-TLKLS---THHTLKNL 350
Query: 253 QIHHNFFSGSIPISLSNASKLEHIEIANNNFSGKLSVNFGGMKNLSLLNLQFSNLGSGES 312
+ HN + + +L + + + + K+ L +
Sbjct: 351 TLSHNDWDCNSLRALF--RNVARPAVDDADQHCKIDYQLEH----GLCCKESDKPYLDRL 404
Query: 313 DEMGFMNSLTNCSKLRVLSLGGNQFRGALPHSIANLSSQLQILILSSNQFYGSIPLGIGN 372
+ + S+ + ++ ++ Q + + + Q +
Sbjct: 405 LQYIALTSVVEKVQRAQGRCSATDTINSVQSLSHYITQQGGVPLQGNEQLEAEVNELRAE 464
Query: 373 LVDLYLLGMVENQFTGAIPKEMGKLQKLQGLDFSG-NHFSGEIPSSLGNLSSLYEVFFNN 431
+ L + + Q + E+ + L G S + +L F
Sbjct: 465 VQQLTNEQIQQEQLLQGLHAEIDTNLRRYRLPKDGLARSSDNLNKVFTHLKERQA--FKL 522
Query: 432 NNLSGVIPFSLGNLKRLAFLEMSGNELSGTIPEDIFNISYLSNSLNLARNHLVGIIPPRI 491
+ K LE L + + L +L R + + +
Sbjct: 523 RETQARRTEADAKQKETEDLEQENIALEKQLDNKRAKQAELRQETSLKRQKVKQLEAKKN 582
Query: 492 GNLRALRSFDVSNN 505
N R ++
Sbjct: 583 RNPDTRRVSHHHHH 596
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 77.7 bits (191), Expect = 9e-15
Identities = 54/322 (16%), Positives = 98/322 (30%), Gaps = 32/322 (9%)
Query: 72 PHLGNLSFLREINLSNNTIQGEIPPE-FGRLFRLEALFLSNNSLVGKIPANLSYCSRLTV 130
L N L E++LS N ++ +I F ++ RLE L++SNN LV + L V
Sbjct: 248 AWLLNYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKV 305
Query: 131 LCIEYNKLQGRIPLEFVSLSKLKDLSLAKNKLTGGIPPFLGNLTSLEVLSLAGNSFGRNI 190
L + +N L + +L++L L N + + +L+ L+L+ N + N
Sbjct: 306 LDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLKL--STHHTLKNLTLSHNDWDCN- 360
Query: 191 PDSLGQLKQLKILAIGGNNLSGPIPPSIYNLSFLVVFSVSHNQIHGSLPPSLGLLLPNLK 250
+ + A+ + I + + S P L LL +
Sbjct: 361 -SLRALFRNVARPAVDDADQHCKIDYQLEHGL----------CCKESDKPYLDRLLQYIA 409
Query: 251 FFQIHHNFFSGSIPISLSNASKLEHIEI----------ANNNFSGKLSVNFGGMKNLSLL 300
+ S ++ N + VN + L
Sbjct: 410 LTSVVEKVQRAQGRCSATDTINSVQSLSHYITQQGGVPLQGNEQLEAEVNELRAEVQQLT 469
Query: 301 NLQFSNLGSGESDEMGFMNSLTNCSKLRVLSLGGNQFRGALPHSIANLSSQLQILILSSN 360
N Q + TN + R+ G + L +L + + +
Sbjct: 470 NEQIQQEQLLQGLH---AEIDTNLRRYRLPKDGLARSSDNLNKVFTHLKERQAFKLRETQ 526
Query: 361 QFYGSIPLGIGNLVDLYLLGMV 382
DL +
Sbjct: 527 ARRTEADAKQKETEDLEQENIA 548
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 46.5 bits (110), Expect = 4e-05
Identities = 35/250 (14%), Positives = 80/250 (32%), Gaps = 9/250 (3%)
Query: 69 SLSPHLGNLSFLREINLSNNTIQGEIPPEFGRLFRLEALFLSNNSLVGKIPANLSYCSRL 128
+L+ + + L+ ++LS+N + + + RLE L+L +NS+V + + L
Sbjct: 292 ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLKLST--HHTL 347
Query: 129 TVLCIEYNKLQGRIPLEFVSLSKLKDLSLAKNKLTGGIPPFLGN-LTSLEVLSLAGNSFG 187
L + +N + ++ I L + L E +
Sbjct: 348 KNLTLSHNDWDCNSLRAL--FRNVARPAVDDADQHCKIDYQLEHGLCCKESDKPYLDRLL 405
Query: 188 RNIPDS-LGQLKQLKILAIGGNNLSGPIPPSIYNLSFLVVFSVSHNQIHGSLPPSLGLLL 246
+ I + + + Q + + + ++ + N+ + L +
Sbjct: 406 QYIALTSVVEKVQRAQGRCSATDTINSVQSLSHYITQQGGVPLQGNEQLEAEVNELRAEV 465
Query: 247 PNLKFFQIHHNFFSGSIPIS-LSNASKLEHIEIANNNFSGKLSVNFGGMKNLSLLNLQFS 305
L QI + +N + + S L+ F +K L+ +
Sbjct: 466 QQLTNEQIQQEQLLQGLHAEIDTNLRRYRLPKDGLARSSDNLNKVFTHLKERQAFKLRET 525
Query: 306 NLGSGESDEM 315
E+D
Sbjct: 526 QARRTEADAK 535
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 2e-38
Identities = 71/403 (17%), Positives = 146/403 (36%), Gaps = 35/403 (8%)
Query: 118 IPANLSYCSRLTVLCIEYNKLQGRIPLEFVSLSKLKDLSLAKNKLTGGIPP-FLGNLTSL 176
I +NL Y + I+ E ++L+ K ++ + + +P L + +
Sbjct: 13 IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQV 71
Query: 177 EVLSLAGNSFGRNIPDSLGQLKQLKILAIGGNNLSGPIPPSI-YNLSFLVVFSVSHNQIH 235
E+L+L + ++ L +G N + +PP + N+ L V + N +
Sbjct: 72 ELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRY-LPPHVFQNVPLLTVLVLERNDLS 130
Query: 236 GSLPPSLGLLLPNLKFFQIHHNFFSGSIPISLSNASKLEHIEIANNNFSGKLSVNFGGMK 295
SLP + P L + +N + + L+++++++N + V+ +
Sbjct: 131 -SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT---HVDLSLIP 186
Query: 296 NLSLLNLQFSNLGSGESDEMGFMNSLTNCSKLRVLSLGGNQFRGALPHSIANLSSQLQIL 355
+L N+ ++ L ++L + L N + ++ +L IL
Sbjct: 187 SLFHANVSYNLL-----------STLAIPIAVEELDASHNSIN-VVR---GPVNVELTIL 231
Query: 356 ILSSNQFYGSIPLGIGNLVDLYLLGMVENQFTGAIPKEM-GKLQKLQGLDFSGNHFSGEI 414
L N + N L + + N+ I K+Q+L+ L S N +
Sbjct: 232 KLQHNNL-TDTA-WLLNYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLV-AL 287
Query: 415 PSSLGNLSSLYEVFFNNNNLSGVIPFSLGNLKRLAFLEMSGNELSGTIPEDIFNISYLSN 474
+ +L + ++N+L + + RL L + N + T+ L N
Sbjct: 288 NLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLKLSTH--HTLKN 343
Query: 475 SLNLARNHLVGIIPPRIGNLRALRSFDVSNNDLSGEIPIELGH 517
L L+ N R + V + D +I +L H
Sbjct: 344 -LTLSHNDWDCN--SLRALFRNVARPAVDDADQHCKIDYQLEH 383
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 2e-38
Identities = 69/383 (18%), Positives = 143/383 (37%), Gaps = 33/383 (8%)
Query: 74 LGNLSFLREINLSNNTIQGEIPPEFGRLFRLEALFLSNNSLVGKIPAN-LSYCSRLTVLC 132
L ++++ T E L + + N+++ K+PA L ++ +L
Sbjct: 17 LQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQVELLN 75
Query: 133 IEYNKLQGRIPLE-FVSLSKLKDLSLAKNKLTGGIPPFLGNLTSLEVLSLAGNSFGRNIP 191
+ +++ I F ++ L + N + P N+ L VL L N
Sbjct: 76 LNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPR 134
Query: 192 DSLGQLKQLKILAIGGNNLSGPIPPSI-YNLSFLVVFSVSHNQIHGSLPPSLGLLLPNLK 250
+L L++ NNL I + L +S N++ + S L+P+L
Sbjct: 135 GIFHNTPKLTTLSMSNNNLER-IEDDTFQATTSLQNLQLSSNRLT-HVDLS---LIPSLF 189
Query: 251 FFQIHHNFFSGSIPISLSNASKLEHIEIANNNFSGKLSVNFGGMKNLSLLNLQFSNLGSG 310
+ +N S +L+ +E ++ ++N+ + V L++L LQ +NL
Sbjct: 190 HANVSYNLLS-----TLAIPIAVEELDASHNSIN---VVRGPVNVELTILKLQHNNLTD- 240
Query: 311 ESDEMGFMNSLTNCSKLRVLSLGGNQFRGALPHSIANLSSQLQILILSSNQFYGSIPLGI 370
L N L + L N+ + H + +L+ L +S+N+ ++ L
Sbjct: 241 -------TAWLLNYPGLVEVDLSYNELEKIMYHPFVKM-QRLERLYISNNRL-VALNLYG 291
Query: 371 GNLVDLYLLGMVENQFTGAIPKEMGKLQKLQGLDFSGNHFSGEIPSSLGNLSSLYEVFFN 430
+ L +L + N + + + +L+ L N + L +L + +
Sbjct: 292 QPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLK--LSTHHTLKNLTLS 347
Query: 431 NNNLSGV-IPFSLGNLKRLAFLE 452
+N+ + N+ R A +
Sbjct: 348 HNDWDCNSLRALFRNVARPAVDD 370
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 4e-33
Identities = 71/340 (20%), Positives = 126/340 (37%), Gaps = 33/340 (9%)
Query: 244 LLLPNLKFFQIHHNFFSGSIPISLSNASKLEHIEIANNNFSGKLSVNFGGMKNLSLLNLQ 303
+ ++ + + G I+L+N + + N+ + + + LLNL
Sbjct: 21 CVFYDVHIDMQTQDVYFGFEDITLNN---QKIVTFKNSTMRKLPAALLDSFRQVELLNLN 77
Query: 304 FSNLGSGESDEMGFMNSLTNCSKLRVLSLGGNQFRGALPHSIANLSSQLQILILSSNQFY 363
+ ++ + ++ L +G N R PH N+ L +L+L N
Sbjct: 78 DLQIEEIDT------YAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPL-LTVLVLERNDL- 129
Query: 364 GSIPLGI-GNLVDLYLLGMVENQFTGAIPKEM-GKLQKLQGLDFSGNHFSGEIPSSLGNL 421
S+P GI N L L M N I + LQ L S N + + L +
Sbjct: 130 SSLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLT-HVD--LSLI 185
Query: 422 SSLYEVFFNNNNLSGVIPFSLGNLKRLAFLEMSGNELSGTIPEDIFNISYLSNSLNLARN 481
SL+ + N LS +L + L+ S N ++ + + L+ L L N
Sbjct: 186 PSLFHANVSYNLLS-----TLAIPIAVEELDASHNSIN-VVRGPVN--VELT-ILKLQHN 236
Query: 482 HLVGIIPPRIGNLRALRSFDVSNNDLSGEIPIE-LGHCSSLEEIYLAGNLFHGSIPSFFN 540
+L + N L D+S N+L +I LE +Y++ N ++ +
Sbjct: 237 NLTDT--AWLLNYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLV-ALNLYGQ 292
Query: 541 ALKGVQKIDLSRNNLSGQIPIFLEAL-SLEYLNLSFNDFE 579
+ ++ +DLS N+L + LE L L N
Sbjct: 293 PIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV 331
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 2e-32
Identities = 70/426 (16%), Positives = 145/426 (34%), Gaps = 53/426 (12%)
Query: 190 IPDSLGQLKQLKILAIGGNNLSGPIPPSIYNLSFLVVFSVSHNQIHGSLPPSLGLLLPNL 249
I +L + I L+ + + ++ + LP +L +
Sbjct: 13 IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQV 71
Query: 250 KFFQIHHNFFSGSIPISLSNASKLEHIEIANNNFSGKLSVNFGGMKNLSLLNLQFSNLGS 309
+ ++ + + A ++ + + N F + L++L L+ ++L S
Sbjct: 72 ELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSS 131
Query: 310 GESDEMGFMNSLTNCSKLRVLSLGGNQFRGALPHSIANLSSQLQILILSSNQFYGSIPLG 369
N KL LS+ N + +S LQ L LSSN+ + L
Sbjct: 132 LPR------GIFHNTPKLTTLSMSNNNLERIEDDTFQATTS-LQNLQLSSNRL-THVDLS 183
Query: 370 IGNLVDLYLLGMVENQFTGAIPKEMGKLQKLQGLDFSGNHFSGEIPSSLGNLSSLYEVFF 429
+ L+ + N + + ++ LD S N + + + L +
Sbjct: 184 --LIPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSIN-VVRGPV--NVELTILKL 233
Query: 430 NNNNLSGVIPFSLGNLKRLAFLEMSGNELSGTIPEDIFNISYLSNSLNLARNHLVGIIPP 489
+NNL+ N L +++S NEL I F
Sbjct: 234 QHNNLTDTAWLL--NYPGLVEVDLSYNELE-KIMYHPFV--------------------- 269
Query: 490 RIGNLRALRSFDVSNNDLSGEIPIELGHCSSLEEIYLAGNLFHGSIPSFFNALKGVQKID 549
++ L +SNN L + + +L+ + L+ N + ++ +
Sbjct: 270 ---KMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLY 324
Query: 550 LSRNNLSGQIPIFLEAL-SLEYLNLSFNDFEGKIPAKGIFANASAISVVGCNRLCGGIPE 608
L N++ + + +L+ L LS ND++ + +F N + +V ++ C +
Sbjct: 325 LDHNSIV-TLKL--STHHTLKNLTLSHNDWDC-NSLRALFRNVARPAVDDADQHCKIDYQ 380
Query: 609 LQLPKC 614
L+ C
Sbjct: 381 LEHGLC 386
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 3e-20
Identities = 37/221 (16%), Positives = 76/221 (34%), Gaps = 14/221 (6%)
Query: 359 SNQFYGSIPLGIGNLVDLYLLGMVENQFTGAIPKEMGKLQKLQGLDFSGNHFSGEIPSSL 418
Y I + Y + + E L + + F + + L
Sbjct: 6 RQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALL 65
Query: 419 GNLSSLYEVFFNNNNLSGVIPFSLGNLKRLAFLEMSGNELSGTIPEDIFNISYLSN--SL 476
+ + + N+ + + ++ + L M N + +P +F + L
Sbjct: 66 DSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVF--QNVPLLTVL 122
Query: 477 NLARNHLVGIIPPRIGNLRALRSFDVSNNDLSGEIPIE-LGHCSSLEEIYLAGNLFHGSI 535
L RN L + N L + +SNN+L I + +SL+ + L+ N +
Sbjct: 123 VLERNDLSSLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLT-HV 180
Query: 536 PSFFNALKGVQKIDLSRNNLSGQIPIFLEALSLEYLNLSFN 576
+ + + ++S N LS +++E L+ S N
Sbjct: 181 D--LSLIPSLFHANVSYNLLS----TLAIPIAVEELDASHN 215
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 2e-19
Identities = 38/188 (20%), Positives = 71/188 (37%), Gaps = 16/188 (8%)
Query: 73 HLGNLSFLREINLSNNTIQGEIPPEFGRLFRLEALFLSNNSLVGKIPANLSYCSRLTVLC 132
L + L N+S N + +E L S+NS+ + + LT+L
Sbjct: 181 DLSLIPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSIN-VVRGPV--NVELTILK 232
Query: 133 IEYNKLQGRIPLEFVSLSKLKDLSLAKNKLTGGIPPFLGNLTSLEVLSLAGNSFGRNIPD 192
+++N L ++ L ++ L+ N+L + + LE L ++ N +
Sbjct: 233 LQHNNLT-DTA-WLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRL-VALNL 289
Query: 193 SLGQLKQLKILAIGGNNLSGPIPPSIYNLSFLVVFSVSHNQIHGSLPPSLGLLLPNLKFF 252
+ LK+L + N+L + + L + HN I +L S LK
Sbjct: 290 YGQPIPTLKVLDLSHNHLLH-VERNQPQFDRLENLYLDHNSIV-TLKLS---THHTLKNL 344
Query: 253 QIHHNFFS 260
+ HN +
Sbjct: 345 TLSHNDWD 352
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 2e-14
Identities = 33/141 (23%), Positives = 60/141 (42%), Gaps = 9/141 (6%)
Query: 72 PHLGNLSFLREINLSNNTIQGEIPPE-FGRLFRLEALFLSNNSLVGKIPANLSYCSRLTV 130
L N L E++LS N ++ +I F ++ RLE L++SNN LV + L V
Sbjct: 242 AWLLNYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKV 299
Query: 131 LCIEYNKLQGRIPLEFVSLSKLKDLSLAKNKLTGGIPPFLGNLTSLEVLSLAGNSFGRNI 190
L + +N L + +L++L L N + + +L+ L+L+ N + N
Sbjct: 300 LDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLKL--STHHTLKNLTLSHNDWDCN- 354
Query: 191 PDSLGQLKQLKILAIGGNNLS 211
+ + A+ +
Sbjct: 355 -SLRALFRNVARPAVDDADQH 374
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 3e-05
Identities = 16/71 (22%), Positives = 34/71 (47%), Gaps = 4/71 (5%)
Query: 69 SLSPHLGNLSFLREINLSNNTIQGEIPPEFGRLFRLEALFLSNNSLVGKIPANLSYCSRL 128
+L+ + + L+ ++LS+N + + + RLE L+L +NS+V + + L
Sbjct: 286 ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLKLST--HHTL 341
Query: 129 TVLCIEYNKLQ 139
L + +N
Sbjct: 342 KNLTLSHNDWD 352
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 4e-38
Identities = 64/216 (29%), Positives = 95/216 (43%), Gaps = 24/216 (11%)
Query: 691 LIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGAS--KSFMAECKALKNIRHRNLVKVIT 748
IG GSF VYKG E + VA + + S + F E + LK ++H N+V+
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 749 SCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASA 808
S S +V E M +G+L+ +L K K ++ S +
Sbjct: 93 SWESTVKGKKCI-VLVTELMTSGTLKTYLKRF---KVMKIKVLR-------SWCRQILKG 141
Query: 809 LDYLHHHCQEPILHCDLKPSNILLDNDLSGH--IGDFGLARFHQEVSNSTLSSSVGVKGT 866
L +LH PI+H DLK NI + +G IGD GLA + V GT
Sbjct: 142 LQFLHTR-TPPIIHRDLKCDNIFITGP-TGSVKIGDLGLATLKRASFAKA------VIGT 193
Query: 867 IGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKP 902
+ APE + + DVY++G+ +LEM T++ P
Sbjct: 194 PEFMAPEMY-EEKYDESVDVYAFGMCMLEMATSEYP 228
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 148 bits (374), Expect = 1e-37
Identities = 98/510 (19%), Positives = 180/510 (35%), Gaps = 43/510 (8%)
Query: 57 TALDLMSKSLSGSLSPHLGNLSFLREINLSNNTIQGEIPPEFGRLFRLEALFLSNNSLVG 116
+D L + L +N+S N I + L +L L +S+N +
Sbjct: 3 FLVDRSKNGLI-HVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQY 59
Query: 117 KIPANLSYCSRLTVLCIEYNKLQGRIPLEFVSLSKLKDLSLAKNKLTG-GIPPFLGNLTS 175
+ + L L + +NKL + LK L L+ N I GN++
Sbjct: 60 LDISVFKFNQELEYLDLSHNKLVK---ISCHPTVNLKHLDLSFNAFDALPICKEFGNMSQ 116
Query: 176 LEVLSLAGNSFGRNIPDSLGQLKQLKILAIGGNNLSGPIPPSIYNLSFLVVFSVSHNQIH 235
L+ L L+ ++ + L K+L + G P L F+ I
Sbjct: 117 LKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDP-----EGLQDFNTESLHI- 170
Query: 236 GSLPPSLGLLLPNLKFFQIHHNFFSGSIPISLSNASKLEHIEIANNNFSGKLSVNFGG-M 294
+ N +F I + LSN + + S + +
Sbjct: 171 --------VFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKL 222
Query: 295 KNLSLLNLQFSNLGSGESDEMGFMNSLTNCSKLRVLSLGGNQFRGALPHSIANLSS---- 350
NL+L N++ + + + L + + S+ + +G L + S
Sbjct: 223 SNLTLNNIETT------WNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLK 276
Query: 351 QLQILILSSNQFYGSIPLGIGNLVDLYLLGMVENQFTGAIPKEMGKLQKLQGLDFSGNHF 410
L I + S+ F ++ + + K+ LDFS N
Sbjct: 277 ALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLL 336
Query: 411 SGEIPSSLGNLSSLYEVFFNNNNLSGV--IPFSLGNLKRLAFLEMSGNELSGTIPEDIFN 468
+ + + G+L+ L + N L + I +K L L++S N +S +
Sbjct: 337 TDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDC- 395
Query: 469 ISYLSN--SLNLARNHLVGIIPPRIGNLRALRSFDVSNNDLSGEIPIELGHCSSLEEIYL 526
S+ + SLN++ N L I + ++ D+ +N + IP ++ +L+E+ +
Sbjct: 396 -SWTKSLLSLNMSSNILTDTIFRCL--PPRIKVLDLHSNKIK-SIPKQVVKLEALQELNV 451
Query: 527 AGNLFHGSIP-SFFNALKGVQKIDLSRNNL 555
A N S+P F+ L +QKI L N
Sbjct: 452 ASNQLK-SVPDGIFDRLTSLQKIWLHTNPW 480
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 9e-32
Identities = 90/482 (18%), Positives = 172/482 (35%), Gaps = 48/482 (9%)
Query: 109 LSNNSLVGKIPANLSYCSRLTVLCIEYNKLQGRIPLEFVSLSKLKDLSLAKNKLTGGIPP 168
S N L+ +P +LS + T+L I N + + +SLSKL+ L ++ N++
Sbjct: 7 RSKNGLI-HVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDIS 63
Query: 169 FLGNLTSLEVLSLAGNSFGRNIPDSLGQLKQLKILAIGGNNL-SGPIPPSIYNLSFLVVF 227
LE L L+ N I LK L + N + PI N+S L
Sbjct: 64 VFKFNQELEYLDLSHNKL-VKIS--CHPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFL 120
Query: 228 SVSHNQIHGSLPPSLGLLLPNLKFFQIHHNFFSGSIPISLSN--ASKLEHIEIANNNFSG 285
+S + S + L + + + P L + L + N F
Sbjct: 121 GLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHF 180
Query: 286 KLSVNFGGMKNLSLLNLQFSNLGSGESDEMGFMNSLTNCSKLRVLSLGGNQFRGALPHSI 345
L V+ + NL L N++ + S + + L KL L+L + I
Sbjct: 181 ILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRI 240
Query: 346 ANL--SSQLQILILSSNQFYGSIPLGIGNLVD-----LYLLGMVENQFTGAIPKEMGKLQ 398
L + + +S+ + G + + L + +V + F
Sbjct: 241 LQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFS 300
Query: 399 KLQGLDFSGNHFSGEIPSSLGNLSSLYEVFFNNNNLSGVIPFSLGNLKRLAFLEMSGNEL 458
+ +F+ + +S + F+NN L+ + + G+L L L + N+L
Sbjct: 301 NMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQL 360
Query: 459 SGTIPEDIFNISYLSN--SLNLARNHLVGIIPPRI-GNLRALRSFDVSNNDLSGEIPIEL 515
+ + + + + L++++N + ++L S ++S+N L+ I
Sbjct: 361 K-ELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTI---- 415
Query: 516 GHCSSLEEIYLAGNLFHGSIPSFFNALKGVQKIDLSRNNLSGQIPIFLEAL-SLEYLNLS 574
F ++ +DL N + IP + L +L+ LN++
Sbjct: 416 ----------------------FRCLPPRIKVLDLHSNKIK-SIPKQVVKLEALQELNVA 452
Query: 575 FN 576
N
Sbjct: 453 SN 454
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 91.8 bits (228), Expect = 2e-19
Identities = 67/393 (17%), Positives = 133/393 (33%), Gaps = 34/393 (8%)
Query: 214 IPPSIYNLSFLVVFSVSHNQIHGSLPPSLGLLLPNLKFFQIHHNFFSGSIPISLSNASKL 273
+ L+ S N I L S L L L+ I HN +L
Sbjct: 19 LSQKTTILNI------SQNYIS-ELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQEL 71
Query: 274 EHIEIANNNFSGKLSVNFGGMKNLSLLNLQFSNLGSGESDEMGFMNSLTNCSKLRVLSLG 333
E++++++N ++ NL L+L F+ D + N S+L+ L L
Sbjct: 72 EYLDLSHNKLV---KISCHPTVNLKHLDLSFNAF-----DALPICKEFGNMSQLKFLGLS 123
Query: 334 GNQFRGALPHSIANLSSQLQILILSSNQFYGSIPLGIGNLV--DLYLLGMVENQFTGAIP 391
+ IA+L+ +L+L P G+ + L+++ +F +
Sbjct: 124 TTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILD 183
Query: 392 KEMGKLQKLQGLDFSGNHFSGEIPSSLGNLSSLYEVF------FNNNNLSGVIPFSLGNL 445
+ + L+ + + L L+ L NN + + L
Sbjct: 184 VSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQL 243
Query: 446 ---KRLAFLEMSGNELSGTIPEDIFNISYLS-NSLNLARNHLVGIIPPRIGNLRALRSFD 501
+ + +S +L G + F+ S S +L++ + P+ + +
Sbjct: 244 VWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMN 303
Query: 502 VSNNDLSGEIPIELG---HCSSLEEIYLAGNLFHGSIPSFFNALKGVQKIDLSRNNLS-- 556
+ N +SG + + S + + NL ++ L ++ + L N L
Sbjct: 304 IKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKEL 363
Query: 557 -GQIPIFLEALSLEYLNLSFNDFEGKIPAKGIF 588
+ + SL+ L++S N KG
Sbjct: 364 SKIAEMTTQMKSLQQLDISQNSVS-YDEKKGDC 395
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 52.9 bits (127), Expect = 4e-07
Identities = 31/190 (16%), Positives = 67/190 (35%), Gaps = 34/190 (17%)
Query: 403 LDFSGNHFSGEIPSSLGNLSSLYEVFFNNNNLSGVIPFSLGNLKRLAFLEMSGNELSGTI 462
+D S N +P L + + N +S + + +L +L L +S N + +
Sbjct: 5 VDRSKNGLI-HVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQ-YL 60
Query: 463 PEDIFNISYLSNSLNLARNHLVGIIPPRIGNLRALRSFDVSNNDLSGEIPIELGHCSSLE 522
+F + L D+S+N L +I +L+
Sbjct: 61 DISVFK------------------------FNQELEYLDLSHNKLV-KISC--HPTVNLK 93
Query: 523 EIYLAGNLFHGSIP--SFFNALKGVQKIDLSRNNLSGQIPIFLEALSLEYLNLSFNDFEG 580
+ L+ N F ++P F + ++ + LS +L + + L++ + L + G
Sbjct: 94 HLDLSFNAFD-ALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYG 152
Query: 581 KIPAKGIFAN 590
+ +
Sbjct: 153 EKEDPEGLQD 162
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 44.1 bits (104), Expect = 2e-04
Identities = 27/121 (22%), Positives = 54/121 (44%), Gaps = 12/121 (9%)
Query: 473 SNSLNLARNHLVGI---IPPRIGNLRALRSFDVSNNDLSGEIPIELGHCSSLEEIYLAGN 529
++ ++N L+ + + + L ++S N +S ++ S L + ++ N
Sbjct: 2 EFLVDRSKNGLIHVPKDLSQKTTIL------NISQNYISELWTSDILSLSKLRILIISHN 55
Query: 530 LFHGSIPSFFNALKGVQKIDLSRNNLSGQIPIFLEALSLEYLNLSFNDFEGKIPAKGIFA 589
S F + ++ +DLS N L I ++L++L+LSFN F+ +P F
Sbjct: 56 RIQYLDISVFKFNQELEYLDLSHNKLVK-IS-CHPTVNLKHLDLSFNAFD-ALPICKEFG 112
Query: 590 N 590
N
Sbjct: 113 N 113
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 2e-37
Identities = 89/447 (19%), Positives = 151/447 (33%), Gaps = 88/447 (19%)
Query: 124 YCSRLTVLCIEYNKLQGRIPLEFVSLSKLKDLSLAKNKLTGGIPPFLGNLTSLEVLSLAG 183
+ VL + + L +P + + L + N LT +P L +LE ++G
Sbjct: 38 LNNGNAVLNVGESGLT-TLPDCL--PAHITTLVIPDNNLT-SLPALPPELRTLE---VSG 90
Query: 184 NSFGRNIPDSLGQLKQLKILAIGGNNLSGPIPPSIYNLSFLVVFSVSHNQIHGSLPPSLG 243
N ++P L +L I + +L P L L + NQ+ SLP
Sbjct: 91 NQL-TSLPVLPPGLLELSIFSNPLTHL----PALPSGLCKL---WIFGNQLT-SLPVLPP 141
Query: 244 LLLPNLKFFQIHHNFFSGSIPISLSNASKLEHIEIANNNFSGKLSVNFGGMKNLSLLNLQ 303
L+ + N + S+P S + L N Q
Sbjct: 142 ----GLQELSVSDNQLA-SLPALPSE------------------------LCKLWAYNNQ 172
Query: 304 FSNLGSGESDEMGFMNSLTNCSKLRVLSLGGNQFRGALPHSIANLSSQLQILILSSNQFY 363
++L + L+ LS+ NQ +LP S+L L +N+
Sbjct: 173 LTSLP----------MLPSG---LQELSVSDNQLA-SLPTLP----SELYKLWAYNNRLT 214
Query: 364 GSIPLGIGNLVDLYLLGMVENQFTGAIPKEMGKLQKLQGLDFSGNHFSGEIPSSLGNLSS 423
S+P L +L + G N+ T ++P +L++ L SGN + +P L S
Sbjct: 215 -SLPALPSGLKELIVSG---NRLT-SLPVLPSELKE---LMVSGNRLT-SLPMLPSGLLS 265
Query: 424 LYEVFFNNNNLSGVIPFSLGNLKRLAFLEMSGNELSGTIPEDIFNISYLSNSLN-LARNH 482
L N L+ +P SL +L + + GN LS + + I+ + R
Sbjct: 266 LS---VYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREITSAPGYSGPIIRFD 321
Query: 483 LVGIIPPRIGNLRALRSFDVSNNDLSGEIPIELGHCSSLEEIYLAGNLFHGSIPSFFNAL 542
+ G PR L + + L E N +F L
Sbjct: 322 MAGASAPRETRALHL----AAADWLVPAREGEPAPADRWHMFGQEDNA-----DAFSLFL 372
Query: 543 KGVQKIDLSRNN--LSGQIPIFLEALS 567
+ + + + QI +L L+
Sbjct: 373 DRLSETENFIKDAGFKAQISSWLAQLA 399
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 7e-37
Identities = 76/345 (22%), Positives = 133/345 (38%), Gaps = 53/345 (15%)
Query: 104 LEALFLSNNSLVGKIPANLSYCSRLTVLCIEYNKLQGRIPLEFVSLSKLKDLSLAKNKLT 163
L + + L +P L + +T L I N L +P +L+ L ++ N+LT
Sbjct: 42 NAVLNVGESGL-TTLPDCL--PAHITTLVIPDNNLT-SLP---ALPPELRTLEVSGNQLT 94
Query: 164 GGIPPFLGNLTSLEVLSLAGNSFGRNIPDSLGQLKQLKILAIGGNNLSGPIPPSIYNLSF 223
+P L L + S +P L +L I GN L+ +P L
Sbjct: 95 S-LPVLPPGLLELSIFSNPLTH----LPALPSGLCKLWI---FGNQLTS-LPVLPPGLQE 145
Query: 224 LVVFSVSHNQIHGSLPPSLGLLLPNLKFFQIHHNFFSGSIPISLSNASKLEHIEIANNNF 283
L SVS NQ+ SLP L ++N + S+P+ S L+ + +++N
Sbjct: 146 L---SVSDNQL-ASLPALPS----ELCKLWAYNNQLT-SLPMLPSG---LQELSVSDNQL 193
Query: 284 SGKLSVNFGGMKNLSLLNLQFSNLGSGESDEMGFMNSLTNCSKLRVLSLGGNQFRGALPH 343
+ L + L N + ++L + S L+ L + GN+ +LP
Sbjct: 194 A-SLPTLPSELYKLWAYNNRLTSLPA-------------LPSGLKELIVSGNRLT-SLPV 238
Query: 344 SIANLSSQLQILILSSNQFYGSIPLGIGNLVDLYLLGMVENQFTGAIPKEMGKLQKLQGL 403
S+L+ L++S N+ S+P+ L+ L + NQ T +P+ + L +
Sbjct: 239 LP----SELKELMVSGNRL-TSLPMLPSGLLSLSVYR---NQLT-RLPESLIHLSSETTV 289
Query: 404 DFSGNHFSGEIPSSLGNLSSLYEVFFNNNNLSGVIPFSLGNLKRL 448
+ GN S +L ++S + + S R
Sbjct: 290 NLEGNPLSERTLQALREITSA-PGYSGPIIRFDMAGASAPRETRA 333
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 141 bits (356), Expect = 7e-35
Identities = 79/349 (22%), Positives = 124/349 (35%), Gaps = 79/349 (22%)
Query: 224 LVVFSVSHNQIHGSLPPSLGLLLPNLKFFQIHHNFFSGSIPISLSNASKLEHIEIANNNF 283
V +V + + +LP L ++ I N + S+P L +E++ N
Sbjct: 42 NAVLNVGESGLT-TLPDCLP---AHITTLVIPDNNLT-SLPALPPE---LRTLEVSGNQL 93
Query: 284 SGKLSVNFGGMKNLSLLNLQFSNLGSGESDEMGFMNSLTN-CSKLRVLSLGGNQFRGALP 342
+ L V G+ LS+ + L S L L + GNQ +LP
Sbjct: 94 T-SLPVLPPGLLELSIFSNPL--------------THLPALPSGLCKLWIFGNQLT-SLP 137
Query: 343 HSIANLSSQLQILILSSNQFYGSIPLGIGNLVDLYLLGMVENQFTGAIPKEMGKLQKLQG 402
L Q L +S NQ S+P L L+ NQ T ++P LQ+L
Sbjct: 138 VLPPGL----QELSVSDNQL-ASLPALPSELCKLWAYN---NQLT-SLPMLPSGLQEL-- 186
Query: 403 LDFSGNHFSGEIPSSLGNLSSLYEVFFNNNNLSGVIPFSLGNLKRLAFLEMSGNELSGTI 462
S N + +P+ L L+ NN L+ +P LK L +SGN L+ ++
Sbjct: 187 -SVSDNQLA-SLPTLPSELYKLWA---YNNRLT-SLPALPSGLKEL---IVSGNRLT-SL 236
Query: 463 PEDIFNISYLSNSLNLARNHLVGIIPPRIGNLRALRSFDVSNNDLSGEIPIELGHCSSLE 522
P + L ++ N L +P L +L V N L+ +P L H SS
Sbjct: 237 PVLPSEL----KELMVSGNRLT-SLPMLPSGLLSL---SVYRNQLT-RLPESLIHLSSET 287
Query: 523 EIYLAGNLFHGSIPSFFNALKGVQKIDLSRNNLSGQIPIFLEALSLEYL 571
+ +L N LS + L ++
Sbjct: 288 TV------------------------NLEGNPLSERTLQALREITSAPG 312
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 7e-29
Identities = 67/349 (19%), Positives = 118/349 (33%), Gaps = 51/349 (14%)
Query: 56 VTALDLMSKSLSGSLSPHLGNLSFLREINLSNNTIQGEIPPEFGRLFRLEALFLSNNSLV 115
+T L + +L+ SL L R + +S N + +P L L L
Sbjct: 63 ITTLVIPDNNLT-SLPALPPEL---RTLEVSGNQLT-SLPVLPPGLLELSIFSNPLTHLP 117
Query: 116 GKIPANLSYCSRLTVLCIEYNKLQGRIPLEFVSLSKLKDLSLAKNKLTGGIPPFLGNLTS 175
+P+ L L I N+L +P V L++LS++ N+L +P L
Sbjct: 118 -ALPSG------LCKLWIFGNQLT-SLP---VLPPGLQELSVSDNQLA-SLPALPSELCK 165
Query: 176 LEVLSLAGNSFGRNIPDSLGQLKQLKILAIGGNNLSGPIPPSIYNLSFLVVFSVSHNQIH 235
L N ++P L++L + N L+ +P L L +N++
Sbjct: 166 LWAY---NNQL-TSLPMLPSGLQELS---VSDNQLAS-LPTLPSELYKL---WAYNNRLT 214
Query: 236 GSLPPSLGLLLPNLKFFQIHHNFFSGSIPISLSNASKLEHIEIANNNFSGKLSVNFGGMK 295
SLP LK + N + S+P+ S L+ + ++ N + L + G+
Sbjct: 215 -SLPALPS----GLKELIVSGNRLT-SLPVLPSE---LKELMVSGNRLT-SLPMLPSGLL 264
Query: 296 NLSLLNLQFSNLGSGESDEMGFMNSLTNCSKLRVLSLGGNQFRGALPHSIANLSSQLQIL 355
+LS+ Q + L SL + S ++L GN +
Sbjct: 265 SLSVYRNQLTRLP----------ESLIHLSSETTVNLEGNPLS-ERTLQALREITSAPGY 313
Query: 356 ILSSNQFYGSIPLGIGNLVDLYLLGMVENQFTGAIPKEMGKLQKLQGLD 404
+F + L+L + A E +
Sbjct: 314 SGPIIRFDMAGASAPRETRALHLA--AADWLVPAREGEPAPADRWHMFG 360
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 7e-23
Identities = 47/230 (20%), Positives = 92/230 (40%), Gaps = 37/230 (16%)
Query: 348 LSSQLQILILSSNQFYGSIPLGIG-NLVDLYLLGMVENQFTGAIPKEMGKLQKLQGLDFS 406
L++ +L + + ++P + ++ L + N T ++P +L+ L+ S
Sbjct: 38 LNNGNAVLNVGESGL-TTLPDCLPAHITTLVIPD---NNLT-SLPALPPELRT---LEVS 89
Query: 407 GNHFSGEIPSSLGNLSSLYEVFFNNNNLSGVIPFSLGNLKRLAFLEMSGNELSGTIPEDI 466
GN + +P L L +L P L + L + GN+L+ ++P
Sbjct: 90 GNQLT-SLPVLPPGLLELSIFSNPLTHL----PALPSGLCK---LWIFGNQLT-SLPVLP 140
Query: 467 FNISYLSNSLNLARNHLVGIIPPRIGNLRALRSFDVSNNDLSGEIPIELGHCSSLEEIYL 526
+ L+++ N L +P L L NN L+ +P+ L+E+ +
Sbjct: 141 PGLQ----ELSVSDNQL-ASLPALPSELCKL---WAYNNQLT-SLPMLPS---GLQELSV 188
Query: 527 AGNLFHGSIPSFFNALKGVQKIDLSRNNLSGQIPIFLEALSLEYLNLSFN 576
+ N S+P+ + L K+ N L+ +P L+ L +S N
Sbjct: 189 SDNQLA-SLPTLPSEL---YKLWAYNNRLT-SLPALPS--GLKELIVSGN 231
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 89.2 bits (221), Expect = 2e-18
Identities = 49/228 (21%), Positives = 88/228 (38%), Gaps = 28/228 (12%)
Query: 57 TALDLMSKSLSGSLSPHLGNLSFLREINLSNNTIQGEIPPEFGRLFRLEALFLSNNSLVG 116
L + L+ SL L +E+++S+N + +P L++L NN L
Sbjct: 164 CKLWAYNNQLT-SLPMLPSGL---QELSVSDNQLA-SLPTLPSELYKLW---AYNNRLT- 214
Query: 117 KIPANLSYCSRLTVLCIEYNKLQGRIPLEFVSLSKLKDLSLAKNKLTGGIPPFLGNLTSL 176
+PA S L L + N+L +P V S+LK+L ++ N+LT +P L SL
Sbjct: 215 SLPALPS---GLKELIVSGNRLT-SLP---VLPSELKELMVSGNRLTS-LPMLPSGLLSL 266
Query: 177 EVLSLAGNSFGRNIPDSLGQLKQLKILAIGGNNLSGPIPPSIYNLSFLVVFSVSHNQIHG 236
S+ N +P+SL L + + GN LS ++ ++ +S +
Sbjct: 267 ---SVYRNQL-TRLPESLIHLSSETTVNLEGNPLSERTLQALREITSAPGYSGPIIRFDM 322
Query: 237 SLP--PSLGLLLPNLKFFQIHHNFFSGSIPISLSNASKLEHIEIANNN 282
+ P L ++ + + A + +N
Sbjct: 323 AGASAPRETRALHLAAA-----DWLVPAREGEPAPADRWHMFGQEDNA 365
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 2e-35
Identities = 56/209 (26%), Positives = 106/209 (50%), Gaps = 24/209 (11%)
Query: 692 IGVGSFGCVYKGALDEDGIVVAIKVINLQCEGAS--KSFMAECKALKNIRHRNLVKVITS 749
+G G +G VY+G + + VA+K + E + F+ E +K I+H NLV+++
Sbjct: 228 LGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 284
Query: 750 CSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASAL 809
C+ + F I+ E+M G+L +L + +++ +++ + + +A ++SA+
Sbjct: 285 CT----REPPFY-IITEFMTYGNLLDYLR-----ECNRQ---EVSAVVLLYMATQISSAM 331
Query: 810 DYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGY 869
+YL +H +L N L+ + + DFGL+R T ++ G K I +
Sbjct: 332 EYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTG---DTYTAHAGAKFPIKW 385
Query: 870 TAPEYGLGSEVSTNGDVYSYGILLLEMVT 898
TAPE ++ S DV+++G+LL E+ T
Sbjct: 386 TAPESLAYNKFSIKSDVWAFGVLLWEIAT 414
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 3e-35
Identities = 66/256 (25%), Positives = 109/256 (42%), Gaps = 33/256 (12%)
Query: 658 PSRLPSRPMMRKALPKMSYKSLLKATNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVI 717
P P + + P M Y +L F IG G F VY+ A DG+ VA+K +
Sbjct: 14 PQFQPQKALR----PDMGYNTL----ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKV 65
Query: 718 NLQCEGASK---SFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKAIVYEYMPNGSLE 774
+ +K + E LK + H N++K S F ++ IV E G L
Sbjct: 66 QIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYAS-----FIEDNELNIVLELADAGDLS 120
Query: 775 KWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDN 834
+ + K K+ + + + + SAL+++H ++H D+KP+N+ +
Sbjct: 121 RMI------KHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITA 171
Query: 835 DLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLL 894
+GD GL R +S +++ + GT Y +PE + + D++S G LL
Sbjct: 172 TGVVKLGDLGLGR----FFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLY 227
Query: 895 EMVTAKKPTDVMFEGD 910
EM + P F GD
Sbjct: 228 EMAALQSP----FYGD 239
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 9e-35
Identities = 62/216 (28%), Positives = 98/216 (45%), Gaps = 24/216 (11%)
Query: 691 LIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSC 750
++G G++G VY G + + +AIK I + S+ E K+++H+N+V+ + S
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGS- 87
Query: 751 SSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALD 810
F N F I E +P GSL L P +D E I Q + L
Sbjct: 88 ----FSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQ-------ILEGLK 136
Query: 811 YLHHHCQEPILHCDLKPSNILLDNDLSGHI--GDFGLARFHQEVSNSTLSSSVGVKGTIG 868
YLH + I+H D+K N+L++ SG + DFG ++ ++ T + GT+
Sbjct: 137 YLHDNQ---IVHRDIKGDNVLINTY-SGVLKISDFGTSKRLAGINPCTET----FTGTLQ 188
Query: 869 YTAPE--YGLGSEVSTNGDVYSYGILLLEMVTAKKP 902
Y APE D++S G ++EM T K P
Sbjct: 189 YMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPP 224
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 4e-34
Identities = 79/443 (17%), Positives = 155/443 (34%), Gaps = 55/443 (12%)
Query: 74 LGNLSFLREINLSNNTIQGEIPPEFGRLFRLEALFLSNNSLVGKIPANLSYCSRLTVLCI 133
L+ L ++ N++I +L L L ++N++ + LS + LT L
Sbjct: 38 EEQLATLTSLDCHNSSITD--MTGIEKLTGLTKLICTSNNIT-TLD--LSQNTNLTYLAC 92
Query: 134 EYNKLQGRIPLEFVSLSKLKDLSLAKNKLTGGIPPFLGNLTSLEVLSLAGNSFGRNIPDS 193
+ NKL L+ L+KL L+ NKLT + + L L+ A N+ I
Sbjct: 93 DSNKLTN---LDVTPLTKLTYLNCDTNKLT-KLD--VSQNPLLTYLNCARNTL-TEID-- 143
Query: 194 LGQLKQLKILAIGGNNLSGPIPPSIYNLSFLVVFSVSHNQIHGSLPPSLGLLLPNLKFFQ 253
+ QL L N + + + L S N+I L S L
Sbjct: 144 VSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFNKIT-ELDVS---QNKLLNRLN 197
Query: 254 IHHNFFSGSIPISLSNASKLEHIEIANNNFSGKLSVNFGGMKNLSLLNLQFSNLGSGESD 313
N + + L+ +L ++ ++N + ++ + L+ + + L
Sbjct: 198 CDTNNITK---LDLNQNIQLTFLDCSSNKLT---EIDVTPLTQLTYFDCSVNPLTE---- 247
Query: 314 EMGFMNSLTNCSKLRVLSLGGNQFRGALPHSIANLSSQLQILILSSNQFYGSIPLGIGNL 373
++ SKL L I +L+ Q++ + L + +
Sbjct: 248 -----LDVSTLSKLTTLHCIQTDL-----LEI-DLTHNTQLIYFQAEGCRKIKELDVTHN 296
Query: 374 VDLYLLGMVENQFTGAIPKEMGKLQKLQGLDFSGNHFSGEIPSSLGNLSSLYEVFFNNNN 433
LYLL T ++ + KL L + + E+ + + + L + N +
Sbjct: 297 TQLYLLDCQAAGIT---ELDLSQNPKLVYLYLNNTELT-ELD--VSHNTKLKSLSCVNAH 350
Query: 434 LSGVIPFSLGNLKRLAFLEMSGNELSGTIPEDIFN----ISYLSNSLNLARNHLVGIIPP 489
+ +G + L + + E + N I+ + L+ N + I P
Sbjct: 351 IQDFSS--VGKIPALNNNFEAEGQTITMPKETLTNNSLTIAVSPDLLDQFGNPM--NIEP 406
Query: 490 RIGNLRALRSFDVSNNDLSGEIP 512
G + + ++ +LS + P
Sbjct: 407 GDGGVYDQATNTITWENLSTDNP 429
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 2e-32
Identities = 60/401 (14%), Positives = 125/401 (31%), Gaps = 49/401 (12%)
Query: 176 LEVLSLAGNSFGRNIPDSLGQLKQLKILAIGGNNLSGPIPPSIYNLSFLVVFSVSHNQIH 235
A S QL L L ++++ I L+ L + N I
Sbjct: 20 FASEVAAAFEMQATDTISEEQLATLTSLDCHNSSITDM--TGIEKLTGLTKLICTSNNIT 77
Query: 236 GSLPPSLGLLLPNLKFFQIHHNFFSGSIPISLSNASKLEHIEIANNNFSGKLSVNFGGMK 295
+L S NL + N + + ++ +KL ++ N + ++
Sbjct: 78 -TLDLSQ---NTNLTYLACDSNKLTN---LDVTPLTKLTYLNCDTNKLT---KLDVSQNP 127
Query: 296 NLSLLNLQFSNLGSGESDEMGFMNSLTNCSKLRVLSLGGNQFRGALPHSIANLSSQLQIL 355
L+ LN + L +++ ++L L N+ L + + QL L
Sbjct: 128 LLTYLNCARNTLTE---------IDVSHNTQLTELDCHLNKKITKLD--VTPQT-QLTTL 175
Query: 356 ILSSNQFYGSIPLGIGNLVDLYLLGMVENQFTGAIPKEMGKLQKLQGLDFSGNHFSGEIP 415
S N+ L + L L N T + + + +L LD S N + EI
Sbjct: 176 DCSFNKITE---LDVSQNKLLNRLNCDTNNIT-KLD--LNQNIQLTFLDCSSNKLT-EID 228
Query: 416 SSLGNLSSLYEVFFNNNNLSGVIPFSLGNLKRLAFLEMSGNELSGTIPEDIFNISYLSNS 475
+ L+ L + N L+ + L +L L +L ++++ +
Sbjct: 229 --VTPLTQLTYFDCSVNPLT---ELDVSTLSKLTTLHCIQTDLL------EIDLTHNTQL 277
Query: 476 LNLARNHLVGIIPPRIGNLRALRSFDVSNNDLSGEIPIELGHCSSLEEIYLAGNLFHGSI 535
+ I + + L D ++ ++L L +YL +
Sbjct: 278 IYFQAEGCRKIKELDVTHNTQLYLLDCQAAGIT---ELDLSQNPKLVYLYLNNTELT-EL 333
Query: 536 PSFFNALKGVQKIDLSRNNLSGQIPIFLEALSLEYLNLSFN 576
+ ++ + ++ + +L +
Sbjct: 334 D--VSHNTKLKSLSCVNAHIQ-DFSSVGKIPALNNNFEAEG 371
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 1e-31
Identities = 74/465 (15%), Positives = 151/465 (32%), Gaps = 63/465 (13%)
Query: 104 LEALFLSNNSLVGKIPANLSYCSRLTVLCIEYNKLQGRIPLEFVSLSKLKDLSLAKNKLT 163
+ + + + + LT L + + + L+ L L N +T
Sbjct: 20 FASEVAAAFEMQATDTISEEQLATLTSLDCHNSSITD-MT-GIEKLTGLTKLICTSNNIT 77
Query: 164 GGIPPFLGNLTSLEVLSLAGNSFGRNIPDSLGQLKQLKILAIGGNNLSGPIPPSIYNLSF 223
+ L T+L L+ N N+ + L +L L N L+ + S
Sbjct: 78 -TLD--LSQNTNLTYLACDSNKL-TNLD--VTPLTKLTYLNCDTNKLT-KLDVS--QNPL 128
Query: 224 LVVFSVSHNQIHGSLPPSLGLLLPNLKFFQIHHNFFSGSIPISLSNASKLEHIEIANNNF 283
L + + N + + S L H N + + + ++L ++ + N
Sbjct: 129 LTYLNCARNTLT-EIDVS---HNTQLTELDCHLNKKITKLDV--TPQTQLTTLDCSFNKI 182
Query: 284 SGKLSVNFGGMKNLSLLNLQFSNLGSGESDEMGFMNSLTNCSKLRVLSLGGNQFRGALPH 343
+ ++ K L+ LN +N+ + L +L L N+ +
Sbjct: 183 T---ELDVSQNKLLNRLNCDTNNITKLD---------LNQNIQLTFLDCSSNKLT-EID- 228
Query: 344 SIANLSSQLQILILSSNQFYGSIPLGIGNLVDLYLLGMVENQFTGAIPKEMGKLQKLQGL 403
+ L+ L S N L + L L L ++ I + +L
Sbjct: 229 -VTPLTQ-LTYFDCSVNPL---TELDVSTLSKLTTLHCIQTDLL-EID--LTHNTQLIYF 280
Query: 404 DFSGNHFSGEIPSSLGNLSSLYEVFFNNNNLSGVIPFSLGNLKRLAFLEMSGNELSGTIP 463
G E+ + + + LY + ++ L +L +L ++ EL+
Sbjct: 281 QAEGCRKIKELD--VTHNTQLYLLDCQAAGIT---ELDLSQNPKLVYLYLNNTELT---- 331
Query: 464 EDIFNISYLSN--SLNLARNHLVGIIPPRIGNLRALRSFDVSNNDLSGEIPIELGHCSSL 521
++S+ + SL+ H+ +G + AL + + +P E +SL
Sbjct: 332 --ELDVSHNTKLKSLSCVNAHIQDF--SSVGKIPALNNNFEAEGQTI-TMPKETLTNNSL 386
Query: 522 ------EEIYLAGNLFHGSIPSFFNALKGVQKIDLSRNNLSGQIP 560
+ + GN +I + ++ NLS P
Sbjct: 387 TIAVSPDLLDQFGNPM--NIEPGDGGVYDQATNTITWENLSTDNP 429
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 9e-34
Identities = 60/220 (27%), Positives = 94/220 (42%), Gaps = 35/220 (15%)
Query: 692 IGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKS----FMAECKALKNIRHRNLVK-- 745
IG G+FG V+ G L D +VA+K E F+ E + LK H N+V+
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCR---ETLPPDLKAKFLQEARILKQYSHPNIVRLI 178
Query: 746 -VITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAID 804
V T I IV E + G +L +L + + + D
Sbjct: 179 GVCTQKQPI--------YIVMELVQGGDFLTFLR-----TEGA----RLRVKTLLQMVGD 221
Query: 805 VASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVK 864
A+ ++YL + +H DL N L+ I DFG++R E ++ ++S G++
Sbjct: 222 AAAGMEYLE---SKCCIHRDLAARNCLVTEKNVLKISDFGMSR---EEADGVYAASGGLR 275
Query: 865 GT-IGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT-AKKP 902
+ +TAPE S+ DV+S+GILL E + P
Sbjct: 276 QVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASP 315
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 9e-34
Identities = 58/207 (28%), Positives = 98/207 (47%), Gaps = 22/207 (10%)
Query: 692 IGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSCS 751
+G G FG V+ + VA+K + + ++F+AE +K ++H LVK+ +
Sbjct: 196 LGAGQFGEVWMATYN-KHTKVAVKTMK-PGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT 253
Query: 752 SIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDY 811
+ I+ E+M GSL +L + K L + I + +A + +
Sbjct: 254 ------KEPIYIITEFMAKGSLLDFLK-----SDEGS---KQPLPKLIDFSAQIAEGMAF 299
Query: 812 LHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTA 871
+ +H DL+ +NIL+ L I DFGLAR + ++ ++ G K I +TA
Sbjct: 300 IEQRN---YIHRDLRAANILVSASLVCKIADFGLARV---IEDNEYTAREGAKFPIKWTA 353
Query: 872 PEYGLGSEVSTNGDVYSYGILLLEMVT 898
PE + DV+S+GILL+E+VT
Sbjct: 354 PEAINFGSFTIKSDVWSFGILLMEIVT 380
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 1e-33
Identities = 59/212 (27%), Positives = 109/212 (51%), Gaps = 26/212 (12%)
Query: 690 HLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGAS--KSFMAECKALKNIRHRNLVKVI 747
H +G G +G VY+G + + VA+K + E + F+ E +K I+H NLV+++
Sbjct: 19 HKLGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLL 75
Query: 748 TSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVAS 807
C+ + F I+ E+M G+L +L R+ + +++ + + +A ++S
Sbjct: 76 GVCT----REPPF-YIITEFMTYGNLLDYL-------RECNRQ-EVSAVVLLYMATQISS 122
Query: 808 ALDYL-HHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGT 866
A++YL + +H DL N L+ + + DFGL+R ++ T ++ G K
Sbjct: 123 AMEYLEKKNF----IHRDLAARNCLVGENHLVKVADFGLSRL---MTGDTYTAHAGAKFP 175
Query: 867 IGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT 898
I +TAPE ++ S DV+++G+LL E+ T
Sbjct: 176 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 2e-33
Identities = 57/339 (16%), Positives = 122/339 (35%), Gaps = 24/339 (7%)
Query: 69 SLSPHLGNLSFLREINLSNNTIQGEIPPEFGRLFRLEALFLSNNSLVGKIPANLSYCSRL 128
++ N + + +++++++ + + ++ L LS N L A+L+ ++L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 129 TVLCIEYNKLQGRIPLEFVSLSKLKDLSLAKNKLTGGIPPFLGNLTSLEVLSLAGNSFGR 188
+L + N L L+ SLS L+ L L N + L S+E L A N+
Sbjct: 61 ELLNLSSNVLYE--TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNI-S 112
Query: 189 NIPDSLGQLKQLKILAIGGNNLSGPIPPSIYNLSFLVVFSVSHNQIHGSLPPSLGLLLPN 248
+ S GQ K + + N ++ S + + N+I L
Sbjct: 113 RVSCSRGQ--GKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDT 170
Query: 249 LKFFQIHHNFFSGSIPISLSNASKLEHIEIANNNFSGKLSVNFGGMKNLSLLNLQFSNLG 308
L+ + +NF + +KL+ +++++N + + F ++ ++L+ + L
Sbjct: 171 LEHLNLQYNFIY-DVK-GQVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV 227
Query: 309 SGESDEMGFMNSLTNCSKLRVLSLGGNQFRGALPHSIANLSSQLQILILSSNQFYGSIPL 368
E +L L L GN F + + ++Q + + + +
Sbjct: 228 LIE-------KALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVK---KLTG 277
Query: 369 GIGNLVDLYLLGMVENQFTGAIPKEMG-KLQKLQGLDFS 406
+ LG +P +L L
Sbjct: 278 QNEEECTVPTLGHYGAYCCEDLPAPFADRLIALGHHHHH 316
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 1e-32
Identities = 60/369 (16%), Positives = 119/369 (32%), Gaps = 61/369 (16%)
Query: 118 IPANLSYCSRLTVLCIEYNKLQGRIPLEFVSLSKLKDLSLAKNKLTGGIPPFLGNLTSLE 177
I N + R + + + L+ + S +K+L L+ N L+ L T LE
Sbjct: 5 IKQNGN---RYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 178 VLSLAGNSFGRNIPDSLGQLKQLKILAIGGNNLSGPIPPSIYNLSFLVVFSVSHNQIHGS 237
+L+L+ N D L L L+ L + N + + + ++N I
Sbjct: 62 LLNLSSNVL-YETLD-LESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-R 113
Query: 238 LPPSLGLLLPNLKFFQIHHNFFSGSIPISLSNASKLEHIEIANNNFSG-KLSVNFGGMKN 296
+ S K + +N + + S+++++++ N +
Sbjct: 114 VSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDT 170
Query: 297 LSLLNLQFSNLGSGESDEMGFMNSLTNCSKLRVLSLGGNQFRGALPHSIANLSSQLQILI 356
L LNLQ++ + + +KL+ L L N+ + + + + +
Sbjct: 171 LEHLNLQYNFIYD--------VKGQVVFAKLKTLDLSSNKLA-FMGPEFQSAAG-VTWIS 220
Query: 357 LSSNQFYGSIPLGIGNLVDLYLLGMVENQFTGAIPKEMGKLQKLQGLDFSGNHFSGEIPS 416
L +N+ I K + Q L+ D GN F
Sbjct: 221 LRNNKL-------------------------VLIEKALRFSQNLEHFDLRGNGFH----- 250
Query: 417 SLGNLSSLYEVFFNNNNLSGVIPFSLGNLKRLAFLEMSGNELS--GTIPEDIFNISYLSN 474
+L + F N + V ++ L E + L G + +
Sbjct: 251 ----CGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADR 306
Query: 475 SLNLARNHL 483
+ L +H
Sbjct: 307 LIALGHHHH 315
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 1e-31
Identities = 49/291 (16%), Positives = 103/291 (35%), Gaps = 25/291 (8%)
Query: 291 FGGMKNLSLLNLQFSNLGSGESDEMGFMNSLTNCSKLRVLSLGGNQFRGALPHSIANLSS 350
+ + S+L + + + ++ L L GN +A +
Sbjct: 6 KQNGNRYKIEKVTDSSLKQALA------SLRQSAWNVKELDLSGNPLSQISAADLAPFTK 59
Query: 351 QLQILILSSNQFYGSIPLGIGNLVDLYLLGMVENQFTGAIPKEMGKLQKLQGLDFSGNHF 410
L++L LSSN Y ++ + +L L L + N E+ ++ L + N+
Sbjct: 60 -LELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNI 111
Query: 411 SGEIPSSLGNLSSLYEVFFNNNNLSGVIPFSLGNLKRLAFLEMSGNELSGTIPEDIFNIS 470
S S ++Y NN ++ + G R+ +L++ NE+ T+ +
Sbjct: 112 SRVSCSRGQGKKNIY---LANNKITMLRDLDEGCRSRVQYLDLKLNEID-TVNFAEL-AA 166
Query: 471 YLSN--SLNLARNHLVGIIPPRIGNLRALRSFDVSNNDLSGEIPIELGHCSSLEEIYLAG 528
LNL N + + ++ L++ D+S+N L+ + E + + I L
Sbjct: 167 SSDTLEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRN 223
Query: 529 NLFHGSIPSFFNALKGVQKIDLSRNNLSGQIPIFLEALSLEYLNLSFNDFE 579
N I + ++ DL N + + ++ +
Sbjct: 224 NKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVK 273
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 1e-30
Identities = 49/317 (15%), Positives = 98/317 (30%), Gaps = 26/317 (8%)
Query: 165 GIPPFLGNLTSLEVLSLAGNSFGRNIPDSLGQLKQLKILAIGGNNLSGPIPPSIYNLSFL 224
I N ++ + +S + + +K L + GN LS + + L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 225 VVFSVSHNQIHGSLPPSLGLLLPNLKFFQIHHNFFSGSIPISLSNASKLEHIEIANNNFS 284
+ ++S N ++ L L+ +++N+ L +E + ANNN S
Sbjct: 61 ELLNLSSNVLY-ETLDLES--LSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS 112
Query: 285 GKLSVNFGGMKNLSLLNLQFSNLGSGESDEMGFMNSLTNCSKLRVLSLGGNQFRGALPHS 344
V+ + + L + + S+++ L L N+
Sbjct: 113 ---RVSCSRGQGKKNIYLANNKITMLRD------LDEGCRSRVQYLDLKLNEIDTVNFAE 163
Query: 345 IANLSSQLQILILSSNQFYGSIPLGIG--NLVDLYLLGMVENQFTGAIPKEMGKLQKLQG 402
+A S L+ L L N Y + + L L L N+ + E +
Sbjct: 164 LAASSDTLEHLNLQYNFIY-DVKGQVVFAKLKTLDLSS---NKLA-FMGPEFQSAAGVTW 218
Query: 403 LDFSGNHFSGEIPSSLGNLSSLYEVFFNNNNLS-GVIPFSLGNLKRLAFLEMSGNELSGT 461
+ N I +L +L N G + +R+ + +
Sbjct: 219 ISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTG 277
Query: 462 IPEDIFNISYLSNSLNL 478
E+ + L +
Sbjct: 278 QNEEECTVPTLGHYGAY 294
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 1e-29
Identities = 49/299 (16%), Positives = 103/299 (34%), Gaps = 31/299 (10%)
Query: 54 RRVTALDLMSKSLSGSLSPHLGNLSFLREINLSNNTIQGEIPPEFGRLFRLEALFLSNNS 113
R + SL +L+ + ++E++LS N + + +LE L LS+N
Sbjct: 10 NRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNV 69
Query: 114 LVGKIPANLSYCSRLTVLCIEYNKLQGRIPLEFVSLSKLKDLSLAKNKLTGGIPPFLGNL 173
L +L S L L + N +Q E + ++ L A N ++ +
Sbjct: 70 LYE--TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-RVSC--SRG 119
Query: 174 TSLEVLSLAGNSFGRNIPDSLGQLKQLKILAIGGNNLSG-PIPPSIYNLSFLVVFSVSHN 232
+ + LA N G +++ L + N + + L ++ +N
Sbjct: 120 QGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYN 179
Query: 233 QIHGSLPPSLGLLLPNLKFFQIHHNFFSGSIPISLSNASKLEHIEIANNNFSGKLSVNFG 292
I+ + ++ LK + N + + +A+ + I + NN +
Sbjct: 180 FIY-DVKG--QVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALR 234
Query: 293 GMKNLSLLNLQFSNLGSGESDEMGFMNSLTNCSKLRVLSLGGNQFRGALPHSIANLSSQ 351
+NL +L+ + +C LR + + ++ L+ Q
Sbjct: 235 FSQNLEHFDLRGNGF---------------HCGTLRDFFSKNQRVQTVAKQTVKKLTGQ 278
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 1e-27
Identities = 41/241 (17%), Positives = 87/241 (36%), Gaps = 15/241 (6%)
Query: 340 ALPHSIANLSSQLQILILSSNQFYGSIPLGIGNLVDLYLLGMVENQFTGAIPKEMGKLQK 399
A+ N + +I ++ + ++ + ++ L + N + ++ K
Sbjct: 1 AIHEIKQNGNR-YKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTK 59
Query: 400 LQGLDFSGNHFSGEIPSSLGNLSSLYEVFFNNNNLSGVIPFSLGNLKRLAFLEMSGNELS 459
L+ L+ S N L +LS+L + NNN + L + L + N +S
Sbjct: 60 LELLNLSSNVLYE--TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS 112
Query: 460 GTIPEDIFNISYLSNSLNLARNHLVGIIPPRIGNLRALRSFDVSNNDLSG-EIPIELGHC 518
+ ++ LA N + + G ++ D+ N++
Sbjct: 113 -RVSCSRGQ---GKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASS 168
Query: 519 SSLEEIYLAGNLFHGSIPSFFNALKGVQKIDLSRNNLSGQIPIFLEALSLEYLNLSFNDF 578
+LE + L N + + ++ +DLS N L+ P F A + +++L N
Sbjct: 169 DTLEHLNLQYNFIY-DVKGQVV-FAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKL 226
Query: 579 E 579
Sbjct: 227 V 227
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 2e-33
Identities = 65/227 (28%), Positives = 115/227 (50%), Gaps = 44/227 (19%)
Query: 692 IGVGSFGCVYKGAL----DEDGIVVAIKVINLQCEGAS----KSFMAECKALKNIRHRNL 743
IG G FG VYKG L + + VAIK + G + F+ E + H N+
Sbjct: 52 IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLK---AGYTEKQRVDFLGEAGIMGQFSHHNI 108
Query: 744 VK---VITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRIS 800
++ VI+ + I+ EYM NG+L+K+L + + ++LQ +
Sbjct: 109 IRLEGVISKYKPM--------MIITEYMENGALDKFLREK---------DGEFSVLQLVG 151
Query: 801 IAIDVASALDYL-HHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSS 859
+ +A+ + YL + + +H DL NIL++++L + DFGL+R ++ +T ++
Sbjct: 152 MLRGIAAGMKYLANMNY----VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTT 207
Query: 860 SVGVKGTIGYTAPE---YGLGSEVSTNGDVYSYGILLLEMVT-AKKP 902
S G K I +TAPE Y + ++ DV+S+GI++ E++T ++P
Sbjct: 208 S-GGKIPIRWTAPEAISYR---KFTSASDVWSFGIVMWEVMTYGERP 250
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 3e-33
Identities = 64/212 (30%), Positives = 107/212 (50%), Gaps = 28/212 (13%)
Query: 690 HLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGAS--KSFMAECKALKNIRHRNLVKVI 747
+G G FG V+ G VA+K + +G+ +F+AE +K ++H+ LV++
Sbjct: 19 ERLGAGQFGEVWMGYY-NGHTKVAVKSLK---QGSMSPDAFLAEANLMKQLQHQRLVRLY 74
Query: 748 TSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVAS 807
+ + I+ EYM NGSL +L + IKLT+ + + +A +A
Sbjct: 75 AVVT------QEPIYIITEYMENGSLVDFL-------KTPS-GIKLTINKLLDMAAQIAE 120
Query: 808 ALDYL-HHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGT 866
+ ++ + +H DL+ +NIL+ + LS I DFGLAR + ++ ++ G K
Sbjct: 121 GMAFIEERNY----IHRDLRAANILVSDTLSCKIADFGLARL---IEDNEYTAREGAKFP 173
Query: 867 IGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT 898
I +TAPE + DV+S+GILL E+VT
Sbjct: 174 IKWTAPEAINYGTFTIKSDVWSFGILLTEIVT 205
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 3e-33
Identities = 63/210 (30%), Positives = 95/210 (45%), Gaps = 28/210 (13%)
Query: 690 HLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGAS-KSFMAECKALKNIRHRNLVKVIT 748
IG G FG V G G VA+K I A+ ++F+AE + +RH NLV+++
Sbjct: 199 QTIGKGEFGDVMLGDYR--GNKVAVKCIK---NDATAQAFLAEASVMTQLRHSNLVQLLG 253
Query: 749 SCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASA 808
+ IV EYM GSL +L R + L + ++DV A
Sbjct: 254 VIV----EEKGGLYIVTEYMAKGSLVDYLR-----SRGRS---VLGGDCLLKFSLDVCEA 301
Query: 809 LDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIG 868
++YL + +H DL N+L+ D + DFGL + S+ K +
Sbjct: 302 MEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTK-------EASSTQDTGKLPVK 351
Query: 869 YTAPEYGLGSEVSTNGDVYSYGILLLEMVT 898
+TAPE + ST DV+S+GILL E+ +
Sbjct: 352 WTAPEALREKKFSTKSDVWSFGILLWEIYS 381
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 4e-33
Identities = 59/261 (22%), Positives = 102/261 (39%), Gaps = 38/261 (14%)
Query: 691 LIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSC 750
LIG G FG V+K DG IK + E A + E KAL + H N+V
Sbjct: 18 LIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAER----EVKALAKLDHVNIVHYNGCW 73
Query: 751 SSIDFQGNDFKA-----------IVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRI 799
D+ I E+ G+LE+W+ ++ ++ +
Sbjct: 74 DGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR-GEKLDKVLA-------L 125
Query: 800 SIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSS 859
+ + +DY+H +++ DLKPSNI L + IGDFGL + ++ +
Sbjct: 126 ELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQVKIGDFGLVTSLK--NDGKRTR 180
Query: 860 SVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARM 919
S GT+ Y +PE + D+Y+ G++L E++ FE +
Sbjct: 181 SK---GTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDT---AFETSKFFTDLRDG 234
Query: 920 ALPN----QVMDIVDPILRND 936
+ + + ++ +L
Sbjct: 235 IISDIFDKKEKTLLQKLLSKK 255
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 4e-33
Identities = 63/226 (27%), Positives = 102/226 (45%), Gaps = 34/226 (15%)
Query: 691 LIGVGSFGCVYKGALDED-GIVVAIKVINLQC---EGASKSFMAECKALKNIRHRNLVKV 746
+G G VY A D I VAIK I + E K F E + H+N+V +
Sbjct: 18 KLGGGGMSTVYL-AEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSM 76
Query: 747 ITSCSSIDFQGNDFKA--IVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAID 804
I D + +V EY+ +L +++ H L++ I+
Sbjct: 77 I------D-VDEEDDCYYLVMEYIEGPTLSEYIESHG----------PLSVDTAINFTNQ 119
Query: 805 VASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVK 864
+ + + H I+H D+KP NIL+D++ + I DFG+A+ +S ++L+ + V
Sbjct: 120 ILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKA---LSETSLTQTNHVL 173
Query: 865 GTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGD 910
GT+ Y +PE G D+YS GI+L EM+ + P F G+
Sbjct: 174 GTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPP----FNGE 215
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 4e-33
Identities = 62/225 (27%), Positives = 108/225 (48%), Gaps = 41/225 (18%)
Query: 692 IGVGSFGCVYKGALDEDG---IVVAIKVINLQCEGAS----KSFMAECKALKNIRHRNLV 744
IG G G V G L G + VAIK + G + + F++E + H N++
Sbjct: 57 IGSGDSGEVCYGRLRVPGQRDVPVAIKALK---AGYTERQRRDFLSEASIMGQFDHPNII 113
Query: 745 K---VITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISI 801
+ V+T IV EYM NGSL+ +L H + + T++Q + +
Sbjct: 114 RLEGVVTRGRLA--------MIVTEYMENGSLDTFLRTH---------DGQFTIMQLVGM 156
Query: 802 AIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSV 861
V + + YL +H DL N+L+D++L + DFGL+R ++ ++ +++
Sbjct: 157 LRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTG 213
Query: 862 GVKGTIGYTAPE---YGLGSEVSTNGDVYSYGILLLEMVT-AKKP 902
G K I +TAPE + S S DV+S+G+++ E++ ++P
Sbjct: 214 G-KIPIRWTAPEAIAFRTFSSAS---DVWSFGVVMWEVLAYGERP 254
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 5e-33
Identities = 49/220 (22%), Positives = 100/220 (45%), Gaps = 26/220 (11%)
Query: 690 HLIGVGSFGCVYKGAL---DEDGIVVAIKVINLQCEGASKS----FMAECKALKNIRHRN 742
++G G FG V +G L D + VA+K ++ + +S+ F++E +K+ H N
Sbjct: 40 KILGEGEFGSVMEGNLKQEDGTSLKVAVKT--MKLDNSSQREIEEFLSEAACMKDFSHPN 97
Query: 743 LVKVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIA 802
+++++ C + QG ++ +M G L +L R + + L +
Sbjct: 98 VIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYS----RLETGPKHIPLQTLLKFM 153
Query: 803 IDVASALDYL-HHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSV 861
+D+A ++YL + + LH DL N +L +D++ + DFGL++
Sbjct: 154 VDIALGMEYLSNRNF----LHRDLAARNCMLRDDMTVCVADFGLSKKIYS--GDYYRQGR 207
Query: 862 GVKGTIGYTAPE---YGLGSEVSTNGDVYSYGILLLEMVT 898
K + + A E + ++ DV+++G+ + E+ T
Sbjct: 208 IAKMPVKWIAIESLADRV---YTSKSDVWAFGVTMWEIAT 244
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 7e-33
Identities = 61/268 (22%), Positives = 100/268 (37%), Gaps = 45/268 (16%)
Query: 649 LYWHKWRR-GPSRLPSRPMMRKALPKMSYKSLLKATNG---FSSTHLIGVGSFGCVYKGA 704
LY+ + P R+ R + L Y + F +G GS+G V+K
Sbjct: 18 LYFQSMHQLQPRRVSFRGEASETLQSPGYDPSRPESFFQQSFQRLSRLGHGSYGEVFKVR 77
Query: 705 LDEDGIVVAIKVINLQCEGAS--KSFMAECKALKNI-RHRNLVKVITSCSSIDFQGNDFK 761
EDG + A+K G +AE + + + +H V++ + ++
Sbjct: 78 SKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQA-----WEEGGIL 132
Query: 762 AIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPIL 821
+ E SL++ A E ++ D AL +LH ++
Sbjct: 133 YLQTELC-GPSLQQHCE--AWGASLPEAQVW-------GYLRDTLLALAHLHSQ---GLV 179
Query: 822 HCDLKPSNILLDNDLSGHI--GDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPE-----Y 874
H D+KP+NI L G GDFGL E+ + +G Y APE Y
Sbjct: 180 HLDVKPANIFLGPR--GRCKLGDFGLLV---ELGTAGAGEV--QEGDPRYMAPELLQGSY 232
Query: 875 GLGSEVSTNGDVYSYGILLLEMVTAKKP 902
G + DV+S G+ +LE+ +
Sbjct: 233 GTAA------DVFSLGLTILEVACNMEL 254
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 7e-33
Identities = 55/255 (21%), Positives = 94/255 (36%), Gaps = 29/255 (11%)
Query: 652 HKWRRGPSRLPSRPMMRKALPKMSYKSLLKATNGFSSTHLIGVGSFGCVYKGALDEDGIV 711
R GP + ++ K + + + +G GSFG V++ + G
Sbjct: 26 KLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQ 85
Query: 712 VAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKAIVYEYMPNG 771
A+K + L+ + E A + +V + + + + I E + G
Sbjct: 86 CAVKKVRLEV-----FRVEELVACAGLSSPRIVPLYGA-----VREGPWVNIFMELLEGG 135
Query: 772 SLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNIL 831
SL + + E L Q L+YLH ILH D+K N+L
Sbjct: 136 SLGQLIKQM---GCLPEDRALYYLGQ-------ALEGLEYLH---TRRILHGDVKADNVL 182
Query: 832 LDNDLSGH---IGDFGLA-RFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVY 887
L +D G + DFG A + +L + + GT + APE +G D++
Sbjct: 183 LSSD--GSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIW 240
Query: 888 SYGILLLEMVTAKKP 902
S ++L M+ P
Sbjct: 241 SSCCMMLHMLNGCHP 255
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 8e-33
Identities = 63/211 (29%), Positives = 96/211 (45%), Gaps = 30/211 (14%)
Query: 690 HLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGAS-KSFMAECKALKNIRHRNLVKVIT 748
IG G FG V G G VA+K I A+ ++F+AE + +RH NLV+++
Sbjct: 27 QTIGKGEFGDVMLGDYR--GNKVAVKCIK---NDATAQAFLAEASVMTQLRHSNLVQLLG 81
Query: 749 SCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASA 808
+ IV EYM GSL +L R + L + ++DV A
Sbjct: 82 VIV----EEKGGLYIVTEYMAKGSLVDYLR-----SRGRS---VLGGDCLLKFSLDVCEA 129
Query: 809 LDYL-HHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTI 867
++YL ++ +H DL N+L+ D + DFGL + S+ K +
Sbjct: 130 MEYLEGNNF----VHRDLAARNVLVSEDNVAKVSDFGLTK-------EASSTQDTGKLPV 178
Query: 868 GYTAPEYGLGSEVSTNGDVYSYGILLLEMVT 898
+TAPE + ST DV+S+GILL E+ +
Sbjct: 179 KWTAPEALREKKFSTKSDVWSFGILLWEIYS 209
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 1e-32
Identities = 65/217 (29%), Positives = 96/217 (44%), Gaps = 29/217 (13%)
Query: 690 HLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGAS--KSFMAECKALKNIRHRNLVKVI 747
+G G FG V G VA+K+I EG+ F E + + + H LVK
Sbjct: 14 KELGSGQFGVVKLGKWK-GQYDVAVKMIK---EGSMSEDEFFQEAQTMMKLSHPKLVKFY 69
Query: 748 TSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVAS 807
CS + IV EY+ NG L +L H L Q + + DV
Sbjct: 70 GVCS----KEYPI-YIVTEYISNGCLLNYLRSH---------GKGLEPSQLLEMCYDVCE 115
Query: 808 ALDYL-HHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGT 866
+ +L H +H DL N L+D DL + DFG+ R+ V + SSVG K
Sbjct: 116 GMAFLESHQF----IHRDLAARNCLVDRDLCVKVSDFGMTRY---VLDDQYVSSVGTKFP 168
Query: 867 IGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT-AKKP 902
+ ++APE + S+ DV+++GIL+ E+ + K P
Sbjct: 169 VKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMP 205
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 1e-32
Identities = 59/212 (27%), Positives = 96/212 (45%), Gaps = 22/212 (10%)
Query: 692 IGVGSFGCVYKGAL----DEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVI 747
+G G+FG V D G VVA+K + E + F E + LK+++H N+VK
Sbjct: 18 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 748 TSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVAS 807
C S G ++ EY+P GSL +L H + ++ ++ + +
Sbjct: 78 GVCYS---AGRRNLKLIMEYLPYGSLRDYLQKH---------KERIDHIKLLQYTSQICK 125
Query: 808 ALDYLH-HHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGT 866
++YL +H DL NIL++N+ IGDFGL + + +
Sbjct: 126 GMEYLGTKRY----IHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEFFKVKEPGESP 180
Query: 867 IGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT 898
I + APE S+ S DV+S+G++L E+ T
Sbjct: 181 IFWYAPESLTESKFSVASDVWSFGVVLYELFT 212
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 1e-32
Identities = 60/212 (28%), Positives = 98/212 (46%), Gaps = 28/212 (13%)
Query: 690 HLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGAS--KSFMAECKALKNIRHRNLVKVI 747
+G G FG V G VAIK+I EG+ F+ E K + N+ H LV++
Sbjct: 30 KELGTGQFGVVKYGKW-RGQYDVAIKMIK---EGSMSEDEFIEEAKVMMNLSHEKLVQLY 85
Query: 748 TSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVAS 807
C+ I+ EYM NG L +L + Q + + DV
Sbjct: 86 GVCTK-----QRPIFIITEYMANGCLLNYLREM---------RHRFQTQQLLEMCKDVCE 131
Query: 808 ALDYL-HHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGT 866
A++YL LH DL N L+++ + DFGL+R+ V + +SSVG K
Sbjct: 132 AMEYLESKQF----LHRDLAARNCLVNDQGVVKVSDFGLSRY---VLDDEYTSSVGSKFP 184
Query: 867 IGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT 898
+ ++ PE + S+ S+ D++++G+L+ E+ +
Sbjct: 185 VRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYS 216
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 2e-32
Identities = 58/225 (25%), Positives = 91/225 (40%), Gaps = 26/225 (11%)
Query: 691 LIGVGSFGCVYKGALDEDGIVVAIKVINL-QCEGASKSFMAECKALKNIRHRNLVKVITS 749
+G G FG V++ D AIK I L E A + M E KAL + H +V+ +
Sbjct: 12 CLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNA 71
Query: 750 -------CSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIA 802
+ I + +L+ W++ +E E + L I
Sbjct: 72 WLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGR---CTIEERERSVCL----HIF 124
Query: 803 IDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARF--------HQEVSN 854
+ +A A+++LH ++H DLKPSNI D +GDFGL
Sbjct: 125 LQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPM 181
Query: 855 STLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTA 899
+ G GT Y +PE G+ S D++S G++L E++
Sbjct: 182 PAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYP 226
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 2e-32
Identities = 58/216 (26%), Positives = 84/216 (38%), Gaps = 31/216 (14%)
Query: 692 IGVGSFGCVYKGAL---DEDGIVVAIKVIN---LQCEGASKSFMAECKALKNIRHRNLVK 745
+G GSFG V +G + VA+K + L A F+ E A+ ++ HRNL++
Sbjct: 26 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 746 VITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDV 805
+ + + +V E P GSL L H + L A+ V
Sbjct: 86 LYGVVLTPPMK------MVTELAPLGSLLDRLRKH---------QGHFLLGTLSRYAVQV 130
Query: 806 ASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKG 865
A + YL +H DL N+LL IGDFGL R ++ K
Sbjct: 131 AEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRA-LPQNDDHYVMQEHRKV 186
Query: 866 TIGYTAPE---YGLGSEVSTNGDVYSYGILLLEMVT 898
+ APE S S D + +G+ L EM T
Sbjct: 187 PFAWCAPESLKTRTFSHAS---DTWMFGVTLWEMFT 219
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 2e-32
Identities = 63/220 (28%), Positives = 108/220 (49%), Gaps = 31/220 (14%)
Query: 692 IGVGSFGCVYKGAL---DEDGIVVAIKVINLQC-EGASKSFMAECKALKNIRHRNLVK-- 745
+G G FG V G L + I VAIK + + E + F+ E + H N+++
Sbjct: 53 VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 746 -VITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAID 804
V+T + IV EYM NGSL+ +L H + + T++Q + +
Sbjct: 113 GVVTKSKPV--------MIVTEYMENGSLDSFLRKH---------DAQFTVIQLVGMLRG 155
Query: 805 VASALDYL-HHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGV 863
+AS + YL +H DL NIL++++L + DFGL R ++ + ++ G
Sbjct: 156 IASGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTR-GG 210
Query: 864 KGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT-AKKP 902
K I +T+PE + ++ DV+SYGI+L E+++ ++P
Sbjct: 211 KIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 2e-32
Identities = 52/223 (23%), Positives = 98/223 (43%), Gaps = 40/223 (17%)
Query: 692 IGVGSFGCVYKGAL---DEDGIVVAIKVINLQCEGASKS----FMAECKALKNIRHRNLV 744
+G G FG VY+G + I VA+K + + FM+E +KN+ H ++V
Sbjct: 20 LGEGFFGEVYEGVYTNHKGEKINVAVKTCK---KDCTLDNKEKFMSEAVIMKNLDHPHIV 76
Query: 745 KVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAID 804
K+I I+ E P G L +L + + L +L + ++
Sbjct: 77 KLIGIIEEEPTW------IIMELYPYGELGHYLERN---------KNSLKVLTLVLYSLQ 121
Query: 805 VASALDYL-HHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGV 863
+ A+ YL +C +H D+ NIL+ + +GDFGL+R+ + + +
Sbjct: 122 ICKAMAYLESINC----VHRDIAVRNILVASPECVKLGDFGLSRY---IEDEDYYKASVT 174
Query: 864 KGTIGYTAPE---YGLGSEVSTNGDVYSYGILLLEMVT-AKKP 902
+ I + +PE + +T DV+ + + + E+++ K+P
Sbjct: 175 RLPIKWMSPESINFR---RFTTASDVWMFAVCMWEILSFGKQP 214
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 2e-32
Identities = 53/223 (23%), Positives = 94/223 (42%), Gaps = 35/223 (15%)
Query: 692 IGVGSFGCVYKGAL---DEDGIVVAIKVINLQCEGAS----KSFMAECKALKNIRHRNLV 744
IG G FG VY G ++ I AIK ++ ++F+ E ++ + H N++
Sbjct: 29 IGKGHFGVVYHGEYIDQAQNRIQCAIKSLS---RITEMQQVEAFLREGLLMRGLNHPNVL 85
Query: 745 KVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAID 804
+I ++ YM +G L +++ + + T+ IS +
Sbjct: 86 ALIGIML----PPEGLPHVLLPYMCHGDLLQFI---------RSPQRNPTVKDLISFGLQ 132
Query: 805 VASALDYL-HHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGV 863
VA ++YL +H DL N +LD + + DFGLAR + ++
Sbjct: 133 VARGMEYLAEQKF----VHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHA 188
Query: 864 KGTIGYTAPE---YGLGSEVSTNGDVYSYGILLLEMVT-AKKP 902
+ + +TA E +T DV+S+G+LL E++T P
Sbjct: 189 RLPVKWTALESLQTYR---FTTKSDVWSFGVLLWELLTRGAPP 228
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 2e-32
Identities = 56/212 (26%), Positives = 90/212 (42%), Gaps = 28/212 (13%)
Query: 690 HLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGAS--KSFMAECKALKNIRHRNLVKVI 747
IG G FG V+ G + VAIK I EGA + F+ E + + + H LV++
Sbjct: 14 QEIGSGQFGLVHLGYW-LNKDKVAIKTIR---EGAMSEEDFIEEAEVMMKLSHPKLVQLY 69
Query: 748 TSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVAS 807
C +V E+M +G L +L + + +DV
Sbjct: 70 GVCLE-----QAPICLVTEFMEHGCLSDYLRTQ---------RGLFAAETLLGMCLDVCE 115
Query: 808 ALDYL-HHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGT 866
+ YL +H DL N L+ + + DFG+ RF V + +SS G K
Sbjct: 116 GMAYLEEACV----IHRDLAARNCLVGENQVIKVSDFGMTRF---VLDDQYTSSTGTKFP 168
Query: 867 IGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT 898
+ + +PE S S+ DV+S+G+L+ E+ +
Sbjct: 169 VKWASPEVFSFSRYSSKSDVWSFGVLMWEVFS 200
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 3e-32
Identities = 64/209 (30%), Positives = 99/209 (47%), Gaps = 22/209 (10%)
Query: 690 HLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITS 749
+G G FG V+ G VAIK + + ++F+ E + +K +RH LV++
Sbjct: 190 VKLGQGCFGEVWMGTW-NGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 247
Query: 750 CSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASAL 809
S IV EYM GSL +L + L L Q + +A +AS +
Sbjct: 248 VSEEPIY------IVTEYMSKGSLLDFLK-----GETGK---YLRLPQLVDMAAQIASGM 293
Query: 810 DYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGY 869
Y+ +H DL+ +NIL+ +L + DFGLAR + ++ ++ G K I +
Sbjct: 294 AYVERMN---YVHRDLRAANILVGENLVCKVADFGLAR---LIEDNEYTARQGAKFPIKW 347
Query: 870 TAPEYGLGSEVSTNGDVYSYGILLLEMVT 898
TAPE L + DV+S+GILL E+ T
Sbjct: 348 TAPEAALYGRFTIKSDVWSFGILLTELTT 376
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 4e-32
Identities = 59/212 (27%), Positives = 96/212 (45%), Gaps = 22/212 (10%)
Query: 692 IGVGSFGCVYKGAL----DEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVI 747
+G G+FG V D G VVA+K + E + F E + LK+++H N+VK
Sbjct: 49 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 108
Query: 748 TSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVAS 807
C S G ++ EY+P GSL +L H + ++ ++ + +
Sbjct: 109 GVCYS---AGRRNLKLIMEYLPYGSLRDYLQKH---------KERIDHIKLLQYTSQICK 156
Query: 808 ALDYLH-HHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGT 866
++YL +H DL NIL++N+ IGDFGL + + +
Sbjct: 157 GMEYLGTKRY----IHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEYYKVKEPGESP 211
Query: 867 IGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT 898
I + APE S+ S DV+S+G++L E+ T
Sbjct: 212 IFWYAPESLTESKFSVASDVWSFGVVLYELFT 243
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 4e-32
Identities = 55/223 (24%), Positives = 93/223 (41%), Gaps = 40/223 (17%)
Query: 692 IGVGSFGCVYKGALDEDG---IVVAIKVINLQCEGAS----KSFMAECKALKNIRHRNLV 744
IG G FG V++G + VAIK S + F+ E ++ H ++V
Sbjct: 23 IGEGQFGDVHQGIYMSPENPALAVAIKTCK---NCTSDSVREKFLQEALTMRQFDHPHIV 79
Query: 745 KVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAID 804
K+I + I+ E G L +L + L L I A
Sbjct: 80 KLIGVITENPVW------IIMELCTLGELRSFLQVR---------KYSLDLASLILYAYQ 124
Query: 805 VASALDYL-HHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGV 863
+++AL YL +H D+ N+L+ ++ +GDFGL+R+ + +ST +
Sbjct: 125 LSTALAYLESKRF----VHRDIAARNVLVSSNDCVKLGDFGLSRY---MEDSTYYKASKG 177
Query: 864 KGTIGYTAPE---YGLGSEVSTNGDVYSYGILLLEMVT-AKKP 902
K I + APE + + S DV+ +G+ + E++ KP
Sbjct: 178 KLPIKWMAPESINFRRFTSAS---DVWMFGVCMWEILMHGVKP 217
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 4e-32
Identities = 53/214 (24%), Positives = 89/214 (41%), Gaps = 30/214 (14%)
Query: 692 IGVGSFGCVYKGALDEDG--IVVAIKVINLQCEGASKS-FMAECKALKNIRHRNLVKVIT 748
+G G+FG V +G I VAIKV+ E A M E + + + + +V++I
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 749 SCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASA 808
C + +V E G L K+L ++ + + V+
Sbjct: 78 VCQAEALM------LVMEMAGGGPLHKFLVGK---------REEIPVSNVAELLHQVSMG 122
Query: 809 LDYL-HHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTI 867
+ YL + +H DL N+LL N I DFGL++ +S ++ K +
Sbjct: 123 MKYLEEKNF----VHRDLAARNVLLVNRHYAKISDFGLSKALGA-DDSYYTARSAGKWPL 177
Query: 868 GYTAPE---YGLGSEVSTNGDVYSYGILLLEMVT 898
+ APE + S S DV+SYG+ + E ++
Sbjct: 178 KWYAPECINFRKFSSRS---DVWSYGVTMWEALS 208
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 8e-32
Identities = 49/216 (22%), Positives = 92/216 (42%), Gaps = 33/216 (15%)
Query: 692 IGVGSFGCVYKGALDEDG----IVVAIKVINLQCEGASKS-FMAECKALKNIRHRNLVKV 746
+G G+FG VYKG +G I VAIK + + + E + ++ + ++ ++
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 747 ITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVA 806
+ C + Q ++ + MP G L ++ H + + ++ + +A
Sbjct: 83 LGICLTSTVQ------LITQLMPFGCLLDYVREH---------KDNIGSQYLLNWCVQIA 127
Query: 807 SALDYL-HHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKG 865
++YL +H DL N+L+ I DFGLA+ + G K
Sbjct: 128 KGMNYLEDRRL----VHRDLAARNVLVKTPQHVKITDFGLAKLLGA--EEKEYHAEGGKV 181
Query: 866 TIGYTAPE---YGLGSEVSTNGDVYSYGILLLEMVT 898
I + A E + + + S DV+SYG+ + E++T
Sbjct: 182 PIKWMALESILHRIYTHQS---DVWSYGVTVWELMT 214
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 9e-32
Identities = 59/225 (26%), Positives = 94/225 (41%), Gaps = 35/225 (15%)
Query: 690 HLIGVGSFGCVYKGAL---DEDGIVVAIKVINLQCEGASKS----FMAECKALKNIRHRN 742
+IG G FGCVY G L D I A+K +N F+ E +K+ H N
Sbjct: 31 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN---RITDIGEVSQFLTEGIIMKDFSHPN 87
Query: 743 LVKVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIA 802
++ ++ C +G+ +V YM +G L ++ T+ I
Sbjct: 88 VLSLLGICL--RSEGSPL--VVLPYMKHGDLRNFIRNE---------THNPTVKDLIGFG 134
Query: 803 IDVASALDYLH-HHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSV 861
+ VA + YL +H DL N +LD + + DFGLAR + ++ +
Sbjct: 135 LQVAKGMKYLASKKF----VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKT 190
Query: 862 GVKGTIGYTAPE---YGLGSEVSTNGDVYSYGILLLEMVT-AKKP 902
G K + + A E + S DV+S+G+LL E++T P
Sbjct: 191 GAKLPVKWMALESLQTQKFTTKS---DVWSFGVLLWELMTRGAPP 232
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 1e-31
Identities = 64/209 (30%), Positives = 100/209 (47%), Gaps = 22/209 (10%)
Query: 690 HLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITS 749
+G G FG V+ G + VAIK + + ++F+ E + +K +RH LV++
Sbjct: 273 VKLGQGCFGEVWMGTWN-GTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 330
Query: 750 CSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASAL 809
S IV EYM GSL +L + L L Q + +A +AS +
Sbjct: 331 VSEEPIY------IVTEYMSKGSLLDFLK-----GETGK---YLRLPQLVDMAAQIASGM 376
Query: 810 DYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGY 869
Y+ +H DL+ +NIL+ +L + DFGLAR + ++ ++ G K I +
Sbjct: 377 AYVERMN---YVHRDLRAANILVGENLVCKVADFGLAR---LIEDNEYTARQGAKFPIKW 430
Query: 870 TAPEYGLGSEVSTNGDVYSYGILLLEMVT 898
TAPE L + DV+S+GILL E+ T
Sbjct: 431 TAPEAALYGRFTIKSDVWSFGILLTELTT 459
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 1e-31
Identities = 55/213 (25%), Positives = 98/213 (46%), Gaps = 23/213 (10%)
Query: 692 IGVGSFGCVYKGAL----DEDGIVVAIKVINLQC-EGASKSFMAECKALKNIRHRNLVKV 746
+G G FG V D G VA+K + + E + L+N+ H N+VK
Sbjct: 29 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 747 ITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVA 806
C+ G + ++ E++P+GSL+++L + + K+ L Q++ A+ +
Sbjct: 89 KGICTE---DGGNGIKLIMEFLPSGSLKEYLPKN---------KNKINLKQQLKYAVQIC 136
Query: 807 SALDYLH-HHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKG 865
+DYL +H DL N+L++++ IGDFGL + E +
Sbjct: 137 KGMDYLGSRQY----VHRDLAARNVLVESEHQVKIGDFGLTKA-IETDKEYYTVKDDRDS 191
Query: 866 TIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT 898
+ + APE + S+ DV+S+G+ L E++T
Sbjct: 192 PVFWYAPECLMQSKFYIASDVWSFGVTLHELLT 224
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 1e-31
Identities = 73/398 (18%), Positives = 129/398 (32%), Gaps = 41/398 (10%)
Query: 56 VTALDLMSKSLSGSLSPH-LGNLSFLREINLSNNTIQGEIPPE-FGRLFRLEALFLSNNS 113
V +DL S++ L+ L L+ + + T I F L L L L N
Sbjct: 32 VNYVDLSLNSIA-ELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQ 90
Query: 114 LVGKIPAN-LSYCSRLTVLCIEYNKLQG-RIPLE-FVSLSKLKDLSLAKNKLTGGIPP-- 168
+ ++ + + L VL + L G + F L+ L+ L L N + I P
Sbjct: 91 FL-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIK-KIQPAS 148
Query: 169 FLGNLTSLEVLSLAGNSFG---RNIPDSLGQ-------LKQLKILAIGGNNLSGPIPPSI 218
F N+ VL L N + L + + + L +
Sbjct: 149 FFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNP 208
Query: 219 YNLSFLVVFSVSHNQIHGSLPPSLGLLLPNLKFFQIHHNFFSGSIPISLSNASKLEHIEI 278
+ + + +S N S+ + K + + K +
Sbjct: 209 FKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFK----DP 264
Query: 279 ANNNFSGKLSVNFGGMKNLSLLNLQFSNLGSGESDEMGFMNSLTNCSKLRVLSLGGNQFR 338
N F G + +L S + + + ++ + L L+L N+
Sbjct: 265 DNFTFKGL------EASGVKTCDLSKSKIFALLK------SVFSHFTDLEQLTLAQNEIN 312
Query: 339 GALPHSIANLSSQLQILILSSNQFYGSIPLGI-GNLVDLYLLGMVENQFTGAIPKEM-GK 396
++ L + L L LS N GSI + NL L +L + N A+ +
Sbjct: 313 KIDDNAFWGL-THLLKLNLSQNFL-GSIDSRMFENLDKLEVLDLSYNHIR-ALGDQSFLG 369
Query: 397 LQKLQGLDFSGNHFSGEIPSSLGNLSSLYEVFFNNNNL 434
L L+ L N L+SL +++ + N
Sbjct: 370 LPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPW 407
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 2e-30
Identities = 81/396 (20%), Positives = 146/396 (36%), Gaps = 41/396 (10%)
Query: 80 LREINLSNNTIQGEIPPE-FGRLFRLEALFLSNNSLVGKIPANL-SYCSRLTVLCIEYNK 137
+ ++LS N+I E+ F RL L+ L + + I N S L +L ++YN+
Sbjct: 32 VNYVDLSLNSIA-ELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQ 90
Query: 138 LQGRIPLE-FVSLSKLKDLSLAKNKLTGGIPP--FLGNLTSLEVLSLAGNSFGRNIPDSL 194
++ F L+ L+ L+L + L G + F LTSLE+L L N+ + P S
Sbjct: 91 FL-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASF 149
Query: 195 -GQLKQLKILAIGGNNLSGPIPPSI-YNLSFLVVFSVSHNQIHGSLPPSLGLLLPNLKFF 252
+++ +L + N + I N L L ++
Sbjct: 150 FLNMRRFHVLDLTFNKVKS-ICEEDLLNFQGKHF---------------TLLRLSSITLQ 193
Query: 253 QIHHNFFSGSIPISLSNASKLEHIEIANNNFSGKLSVNFGGMKNLSLLNLQFSNLGSGES 312
++ + + + + ++++ N F ++ F + + +
Sbjct: 194 DMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMG 253
Query: 313 DEMGFMN--SLTNC-------SKLRVLSLGGNQFRGALPHSIANLSSQLQILILSSNQFY 363
G N N S ++ L ++ AL S+ + + L+ L L+ N+
Sbjct: 254 SSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIF-ALLKSVFSHFTDLEQLTLAQNEI- 311
Query: 364 GSIPLGI-GNLVDLYLLGMVENQFTGAIPKEM-GKLQKLQGLDFSGNHFSGEIPS-SLGN 420
I L L L + +N +I M L KL+ LD S NH + S
Sbjct: 312 NKIDDNAFWGLTHLLKLNLSQNFLG-SIDSRMFENLDKLEVLDLSYNHIR-ALGDQSFLG 369
Query: 421 LSSLYEVFFNNNNLSGVIPFSLGNLKRLAFLEMSGN 456
L +L E+ + N L V L L + + N
Sbjct: 370 LPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 405
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-26
Identities = 71/423 (16%), Positives = 140/423 (33%), Gaps = 50/423 (11%)
Query: 118 IPANLSYCSRLTVLCIEYNKLQGRIPLEFVSLSKLKDLSLAKNKLTGGIPP-FLGNLTSL 176
+PA++ + + N + F L L+ L + + I L+SL
Sbjct: 28 LPAHV------NYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSL 81
Query: 177 EVLSLAGNSFGRNIPDS-LGQLKQLKILAIGGNNL-SGPIPPSIY-NLSFLVVFSVSHNQ 233
+L L N F + L L++L + NL + + + L+ L + + N
Sbjct: 82 IILKLDYNQF-LQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNN 140
Query: 234 IHGSLPPSLGLLLPNLKFFQIHHNFFSGSIPISLSNASKLEHIEIANNNFSGKLSVNFGG 293
I P S L + + N + I + +F
Sbjct: 141 IKKIQPASFFLNMRRFHVLDLTFN------KVK----------SICEEDLLNFQGKHF-- 182
Query: 294 MKNLSLLNLQFSNLGSGESDEMGFMNSLTNCSKLRVLSLGGNQFRGALPHSIANLSSQLQ 353
L L ++ ++ N + + L L GN F+ ++ + + +
Sbjct: 183 -TLLRLSSITLQDMNEYWLGWEKCGN-PFKNTSITTLDLSGNGFKESMAKRFFDAIAGTK 240
Query: 354 ILILSSNQFYGSIPLGIGNLVDLYLLGMVENQFTGAIPKEMGKLQKLQGLDFSGNHFSGE 413
I L + Y + F G + ++ D S +
Sbjct: 241 IQSLILSNSYNM----GSSFGHTNFKDPDNFTFKGL------EASGVKTCDLSKSKIFAL 290
Query: 414 IPSSLGNLSSLYEVFFNNNNLSGVIPFSLGNLKRLAFLEMSGNELSGTIPEDIFNISYLS 473
+ S + + L ++ N ++ + + L L L +S N L +I +F L
Sbjct: 291 LKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLG-SIDSRMF--ENLD 347
Query: 474 N--SLNLARNHLVGIIPPRI-GNLRALRSFDVSNNDLSGEIPIE-LGHCSSLEEIYLAGN 529
L+L+ NH+ + + L L+ + N L +P +SL++I+L N
Sbjct: 348 KLEVLDLSYNHI-RALGDQSFLGLPNLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 405
Query: 530 LFH 532
+
Sbjct: 406 PWD 408
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 7e-25
Identities = 70/418 (16%), Positives = 139/418 (33%), Gaps = 69/418 (16%)
Query: 200 LKILAIGGNNLSGPIPPSIYNLSFLVVFSVSHNQIHGSLPPSLGLLLPNLKFFQIHHNFF 259
+ + + N+++ S L L V + + L +L ++ +N F
Sbjct: 32 VNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQF 91
Query: 260 SGSIPISLSNASKLEHIEIANNNFSGKLSVNFGGMKNLSLLNLQFSNLGSGESDEMGFMN 319
+ F G+ NL +L L NL F
Sbjct: 92 L-QLETGA-----------------------FNGLANLEVLTLTQCNLDGAVLSGNFFKP 127
Query: 320 SLTNCSKLRVLSLGGNQFRGALPHSIANLSSQLQILILSSNQ--------FYG--SIPLG 369
LT+ L +L L N + P S + +L L+ N+
Sbjct: 128 -LTS---LEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFT 183
Query: 370 IGNLVDLYLLGMVENQFTGAIPKEMGKLQKLQGLDFSGNHF----SGEIPSSLGNLSSLY 425
+ L + L M E K + LD SGN F + ++
Sbjct: 184 LLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQS 243
Query: 426 EVFFNNNNLSGVIPFS-LGNLKRLAFLEMSGNELSGTIPEDIFNISYLSNSLNLARNHLV 484
+ N+ N+ + + F + + + + +L+++ +
Sbjct: 244 LILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVK---------------TCDLSKSKI- 287
Query: 485 GIIPPRI-GNLRALRSFDVSNNDLSGEIPIE-LGHCSSLEEIYLAGNLFHGSIPSF-FNA 541
+ + + L ++ N+++ +I + L ++ L+ N GSI S F
Sbjct: 288 FALLKSVFSHFTDLEQLTLAQNEIN-KIDDNAFWGLTHLLKLNLSQNFL-GSIDSRMFEN 345
Query: 542 LKGVQKIDLSRNNLSGQIP--IFLEALSLEYLNLSFNDFEGKIPAKGIFANASAISVV 597
L ++ +DLS N++ + FL +L+ L L N + +P GIF +++ +
Sbjct: 346 LDKLEVLDLSYNHIR-ALGDQSFLGLPNLKELALDTNQLK-SVP-DGIFDRLTSLQKI 400
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 2e-31
Identities = 53/212 (25%), Positives = 88/212 (41%), Gaps = 22/212 (10%)
Query: 692 IGVGSFGCVYKGAL----DEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVI 747
+G G+FG V D G +VA+K + + F E + LK + +VK
Sbjct: 31 LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 90
Query: 748 TSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVAS 807
G +V EY+P+G L +L H +L + + + +
Sbjct: 91 GVSYG---PGRQSLRLVMEYLPSGCLRDFLQRH---------RARLDASRLLLYSSQICK 138
Query: 808 ALDYLH-HHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGT 866
++YL C +H DL NIL++++ I DFGLA+ + +
Sbjct: 139 GMEYLGSRRC----VHRDLAARNILVESEAHVKIADFGLAKL-LPLDKDYYVVREPGQSP 193
Query: 867 IGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT 898
I + APE + S DV+S+G++L E+ T
Sbjct: 194 IFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 225
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 2e-31
Identities = 88/489 (17%), Positives = 173/489 (35%), Gaps = 48/489 (9%)
Query: 80 LREINLSNNTIQGEIPPEFGRLFRLEALFLSNNSLVGKIPANLSYCSRLTVLCIEYNKLQ 139
+ ++LS N+I P+ L L L LS+N + + ++
Sbjct: 54 TKALSLSQNSISELRMPDISFLSELRVLRLSHNRI-RSLDFHV----------------- 95
Query: 140 GRIPLEFVSLSKLKDLSLAKNKLTGGIPPFLGNLTSLEVLSLAGNSFGRNIPDS--LGQL 197
F+ L+ L ++ N+L I + SL L L+ N F +P G L
Sbjct: 96 ------FLFNQDLEYLDVSHNRLQ-NISC--CPMASLRHLDLSFNDF-DVLPVCKEFGNL 145
Query: 198 KQLKILAIGGNNL-SGPIPPSIYNLSFLVVFSVSHNQIHGSLPPSLGLL-LPNLKFFQIH 255
+L L + + P + ++ + I G SL + L
Sbjct: 146 TKLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHP 205
Query: 256 HNFFSGSIPISLSNASKLE--HIEIANNNFSGKLSVNFGGMKNLSLLNLQFSNLGSGESD 313
++ FS + +S++ L+ +I++ + N ++ + +LLN+ ++ +
Sbjct: 206 NSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKC 265
Query: 314 EMGFMNSLTNCSKLRVLSLGGNQFRGALPHSIANLSS----QLQILILSSNQFYGSIPLG 369
+ + L++ + S L I + + F S
Sbjct: 266 SVKLFQFF-WPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEAL 324
Query: 370 IGNLVDLYLLGMVENQFTGAIPKEMGKLQKLQGLDFSGNHFSGEIPSSLGNLSSLYEVFF 429
++ + + + L+F+ N F+ + L L +
Sbjct: 325 YSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLIL 384
Query: 430 NNNNLSGV--IPFSLGNLKRLAFLEMSGNELSGTIPEDIFNISYLSNSLNLARNHLVGII 487
N L + N+ L L++S N L+ + + LNL+ N L G +
Sbjct: 385 QRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSV 444
Query: 488 PPRI-GNLRALRSFDVSNNDLSGEIPIELGHCSSLEEIYLAGNLFHGSIP-SFFNALKGV 545
+ ++ L D+ NN + IP ++ H +L+E+ +A N S+P F+ L +
Sbjct: 445 FRCLPPKVKVL---DLHNNRIM-SIPKDVTHLQALQELNVASNQLK-SVPDGVFDRLTSL 499
Query: 546 QKIDLSRNN 554
Q I L N
Sbjct: 500 QYIWLHDNP 508
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 121 bits (304), Expect = 1e-28
Identities = 84/464 (18%), Positives = 167/464 (35%), Gaps = 42/464 (9%)
Query: 104 LEALFLSNNSLVGKIPANLSYCSRLTVLCIEYNKLQGRIPLE-FVSLSKLKDLSLAKNKL 162
+AL LS NS+ ++S+ S L VL + +N+++ + F+ L+ L ++ N+L
Sbjct: 54 TKALSLSQNSISELRMPDISFLSELRVLRLSHNRIR-SLDFHVFLFNQDLEYLDVSHNRL 112
Query: 163 TGGIPPFLGNLTSLEVLSLAGNSFGRNIPDS--LGQLKQLKILAIGGNNL-SGPIPPSIY 219
I + SL L L+ N F +P G L +L L + + P +
Sbjct: 113 QN-ISC--CPMASLRHLDLSFNDF-DVLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAH 168
Query: 220 NLSFLVVFSVSHNQIHGSLPPSLGLL-LPNLKFFQIHHNFFSGSIPISLSNASKLE--HI 276
++ + I G SL + L ++ FS + +S++ L+ +I
Sbjct: 169 LHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNI 228
Query: 277 EIANNNFSGKLSVNFGGMKNLSLLNLQFSNLGSGESDEMGFMNSLTNCSKLRVLSLGGNQ 336
++ + N ++ + +LLN+ ++ + + + L++
Sbjct: 229 KLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFF-WPRPVEYLNIYNLT 287
Query: 337 FRGALPHSIANLSS----QLQILILSSNQFYGSIPLGIGNLVDLYLLGMVENQFTGAIPK 392
+ S L I + + F S ++ + + +
Sbjct: 288 ITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMV 347
Query: 393 EMGKLQKLQGLDFSGNHFSGEIPSSLGNLSSLYEVFFNNNNLSGV--IPFSLGNLKRLAF 450
L+F+ N F+ + L L + N L + N+ L
Sbjct: 348 CPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLET 407
Query: 451 LEMSGNELSGTIPEDIFNISYLSNSLNLARNHLVGI---------------------IPP 489
L++S N L+ + + LNL+ N L G IP
Sbjct: 408 LDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLPPKVKVLDLHNNRIMSIPK 467
Query: 490 RIGNLRALRSFDVSNNDLSGEIPIE-LGHCSSLEEIYLAGNLFH 532
+ +L+AL+ +V++N L +P +SL+ I+L N +
Sbjct: 468 DVTHLQALQELNVASNQLK-SVPDGVFDRLTSLQYIWLHDNPWD 510
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 85.7 bits (212), Expect = 3e-17
Identities = 66/382 (17%), Positives = 123/382 (32%), Gaps = 33/382 (8%)
Query: 214 IPPSIYNLSFLVVFSVSHNQIHGSLPPSLGLLLPNLKFFQIHHNFFSGSIPISL-SNASK 272
+PP LS S N I L L L+ ++ HN S+ +
Sbjct: 50 LPPRTKALSL------SQNSIS-ELRMPDISFLSELRVLRLSHNRIR-SLDFHVFLFNQD 101
Query: 273 LEHIEIANNNFSGKLSVNFGGMKNLSLLNLQFSNLGSGESDEMGFMNSLTNCSKLRVLSL 332
LE++++++N +++ M +L L+L F++ D + N +KL L L
Sbjct: 102 LEYLDVSHNRLQ---NISCCPMASLRHLDLSFNDF-----DVLPVCKEFGNLTKLTFLGL 153
Query: 333 GGNQFRGALPHSIANLSSQLQILILSSNQFYGSIPLGIGNLVDLYL-LGMVENQ------ 385
+FR +A+L +L L S G + L L N
Sbjct: 154 SAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQV 213
Query: 386 FTGAIPKEMGKLQKLQGLDFSGNHFSGEIPSSLGNLSSLYEVFFNNNNLSGVIP--FSLG 443
+L ++ D + + + L + F
Sbjct: 214 NMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFF 273
Query: 444 NLKRLAFLEMSGNELSGTIPEDIFNISYLSNS----LNLARNHLVGIIPPRIGNLRALRS 499
+ + +L + ++ I + F S + ++ + +
Sbjct: 274 WPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNI 333
Query: 500 FDVSNNDLSGEIPIELGHCSSLEEIYLAGNLFHGSIPSFFNALKGVQKIDLSRNNL---S 556
+S +D + SS + N+F S+ + LK +Q + L RN L
Sbjct: 334 KMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFF 393
Query: 557 GQIPIFLEALSLEYLNLSFNDF 578
+ SLE L++S N
Sbjct: 394 KVALMTKNMSSLETLDVSLNSL 415
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 77.6 bits (191), Expect = 9e-15
Identities = 42/279 (15%), Positives = 95/279 (34%), Gaps = 19/279 (6%)
Query: 69 SLSPHLGNLSFLREINLSNNTIQGEIPPEFGRLF---RLEALFLSNNSLVGKIP-ANLSY 124
+ L L + L + + + + F +E L + N ++ +I +Y
Sbjct: 240 TFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTY 299
Query: 125 CSR----LTVLCIEYNKLQGRIPLEFVSLSKLKDLSLAKNKLTGGIPPFLGNLTSLEVLS 180
L + ++ + +++ L+ + + +S L+
Sbjct: 300 SETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLN 359
Query: 181 LAGNSFGRNIPDSLGQLKQLKILAIGGNNLS--GPIPPSIYNLSFLVVFSVSHNQIHGSL 238
N F ++ LK+L+ L + N L + N+S L VS N ++
Sbjct: 360 FTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHA 419
Query: 239 PPSLGLLLPNLKFFQIHHNFFSGSIPISLSNASKLEHIEIANNNFSGKLSVNFGGMKNLS 298
++ + N +GS+ L K++ +++ NN + + ++ L
Sbjct: 420 YDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQ 476
Query: 299 LLNLQFSNLGSGESDEMGFMNSLTNCSKLRVLSLGGNQF 337
LN+ + L S + L+ + L N +
Sbjct: 477 ELNVASNQLKSVPD------GVFDRLTSLQYIWLHDNPW 509
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 69.5 bits (170), Expect = 3e-12
Identities = 47/252 (18%), Positives = 94/252 (37%), Gaps = 20/252 (7%)
Query: 346 ANLSSQLQILILSSNQFYGSIPLG-IGNLVDLYLLGMVENQFTGAIPKEM-GKLQKLQGL 403
+L + + L LS N + + I L +L +L + N+ ++ + Q L+ L
Sbjct: 48 KDLPPRTKALSLSQNSI-SELRMPDISFLSELRVLRLSHNRIR-SLDFHVFLFNQDLEYL 105
Query: 404 DFSGNHFSGEIPSSLGNLSSLYEVFFNNNNLSGVIPFS--LGNLKRLAFLEMSGNELSGT 461
D S N I ++SL + + N+ V+P GNL +L FL +S +
Sbjct: 106 DVSHNRLQ-NISC--CPMASLRHLDLSFNDFD-VLPVCKEFGNLTKLTFLGLSAAKFRQL 161
Query: 462 IPEDIFNISYLSNSLNLARNHLVGIIPPRI--GNLRALRSFDVSNNDLSGEIPIELGHCS 519
+ ++ L+L H+ G + N L N+ S ++ + +
Sbjct: 162 DLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALG 221
Query: 520 SLE--EIYLAGNLFHGSIPSFFNALKGVQKIDLSRNNLSG------QIPIFLEALSLEYL 571
L+ I L + +G ++++ ++ ++ F +EYL
Sbjct: 222 HLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYL 281
Query: 572 NLSFNDFEGKIP 583
N+ +I
Sbjct: 282 NIYNLTITERID 293
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 2e-31
Identities = 64/222 (28%), Positives = 93/222 (41%), Gaps = 26/222 (11%)
Query: 691 LIGVGSFGCVYKGALDEDGIVVAIKVINLQC--EGASKSFMAECKALKNIRHRNLVKVIT 748
IG GSFG EDG IK IN+ + E L N++H N+V+
Sbjct: 31 KIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRE 90
Query: 749 SCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASA 808
S F+ N IV +Y G L K + K + + + + + A
Sbjct: 91 S-----FEENGSLYIVMDYCEGGDLFKRI------NAQKGVLFQEDQILDW--FVQICLA 137
Query: 809 LDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIG 868
L ++H ILH D+K NI L D + +GDFG+AR V NST+ + GT
Sbjct: 138 LKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIAR----VLNSTVELARACIGTPY 190
Query: 869 YTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGD 910
Y +PE + D+++ G +L E+ T K FE
Sbjct: 191 YLSPEICENKPYNNKSDIWALGCVLYELCTLKHA----FEAG 228
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 2e-31
Identities = 53/228 (23%), Positives = 87/228 (38%), Gaps = 35/228 (15%)
Query: 691 LIGVGSFGCVYKGALDE--DGIVVAIKVINLQC-EGASKSFMAECKALKNIRHRNLVKVI 747
I G G +Y ALD +G V +K + A MAE + L + H ++V++
Sbjct: 87 CIAHGGLGWIYL-ALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIF 145
Query: 748 TSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVAS 807
D G+ IV EY+ SL++ L + + I+ +++
Sbjct: 146 NFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK------------LPVAEAIAYLLEILP 193
Query: 808 ALDYLHHHCQEPILHCDLKPSNILLDNDLSG-HIGDFGLARFHQEVSNSTLSSSVGVKGT 866
AL YLH +++ DLKP NI+L + + D G ++S + GT
Sbjct: 194 ALSYLHSI---GLVYNDLKPENIMLTEE--QLKLIDLGAVS--------RINSFGYLYGT 240
Query: 867 IGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLH 914
G+ APE + D+Y+ G L + G
Sbjct: 241 PGFQAPEIVRT-GPTVATDIYTVGRTLAALTLDLPT----RNGRYVDG 283
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 3e-31
Identities = 68/318 (21%), Positives = 131/318 (41%), Gaps = 26/318 (8%)
Query: 78 SFLREINLSNNTIQGEIPPE-FGRLFRLEALFLSNNSLVGKIPAN-LSYCSRLTVLCIEY 135
+ R ++L N I+ + + F LE L L+ N + + + L L +
Sbjct: 32 TETRLLDLGKNRIK-TLNQDEFASFPHLEELELNENIV-SAVEPGAFNNLFNLRTLGLRS 89
Query: 136 NKLQGRIPLE-FVSLSKLKDLSLAKNKLTGGIPPFL-GNLTSLEVLSLAGNSFGRNIPDS 193
N+L+ IPL F LS L L +++NK+ + ++ +L +L+ L + N +
Sbjct: 90 NRLK-LIPLGVFTGLSNLTKLDISENKIV-ILLDYMFQDLYNLKSLEVGDNDLVYISHRA 147
Query: 194 LGQLKQLKILAIGGNNLSGPIPP-SIYNLSFLVVFSVSHNQIHGSLPPSLGLLLPNLKFF 252
L L+ L + NL+ IP ++ +L L+V + H I+ ++ L LK
Sbjct: 148 FSGLNSLEQLTLEKCNLTS-IPTEALSHLHGLIVLRLRHLNIN-AIRDYSFKRLYRLKVL 205
Query: 253 QIHHNFFSGSIPISLSNASKLEHIEIANNNFSGKLSVNFGGMKNLSLLNL---QFSNLGS 309
+I H + ++ + L + I + N + + + L LNL S +
Sbjct: 206 EISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEG 265
Query: 310 GESDEMGFMNSLTNCSKLRVLSLGGNQFRGALPHSIANLSSQLQILILSSNQFYGSIPLG 369
L +L+ + L G Q P++ L+ L++L +S NQ ++
Sbjct: 266 S---------MLHELLRLQEIQLVGGQLAVVEPYAFRGLNY-LRVLNVSGNQL-TTLEES 314
Query: 370 I-GNLVDLYLLGMVENQF 386
+ ++ +L L + N
Sbjct: 315 VFHSVGNLETLILDSNPL 332
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 4e-30
Identities = 65/331 (19%), Positives = 124/331 (37%), Gaps = 22/331 (6%)
Query: 207 GNNLSGPIPPSIYNLSFLVVFSVSHNQIHGSLPPSLGLLLPNLKFFQIHHNFFSGSIPIS 266
+P I + + + N+I +L P+L+ +++ N S P +
Sbjct: 20 RKRFVA-VPEGI--PTETRLLDLGKNRIK-TLNQDEFASFPHLEELELNENIVSAVEPGA 75
Query: 267 LSNASKLEHIEIANNNFSGKLSVN-FGGMKNLSLLNLQFSNLGSGESDEMGFMNSLTNCS 325
+N L + + +N + + F G+ NL+ L++ + + +
Sbjct: 76 FNNLFNLRTLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKIVILLDY------MFQDLY 128
Query: 326 KLRVLSLGGNQFRGALPHSIANLSSQLQILILSSNQFYGSIPLGI-GNLVDLYLLGMVEN 384
L+ L +G N + + L+S L+ L L SIP +L L +L +
Sbjct: 129 NLKSLEVGDNDLVYISHRAFSGLNS-LEQLTLEKCNL-TSIPTEALSHLHGLIVLRLRHL 186
Query: 385 QFTGAIPKEMGKLQKLQGLDFSGNHFSGEIPSSLGNLSSLYEVFFNNNNLSGVIPFSLGN 444
+L +L+ L+ S + + + +L + + NL+ V ++ +
Sbjct: 187 NINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRH 246
Query: 445 LKRLAFLEMSGNELSGTIPEDIFNISYLSN--SLNLARNHLVGIIPPRIGNLRALRSFDV 502
L L FL +S N +S TI + L + L L + P L LR +V
Sbjct: 247 LVYLRFLNLSYNPIS-TIEGSML--HELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNV 303
Query: 503 SNNDLSGEIPIEL-GHCSSLEEIYLAGNLFH 532
S N L+ + + +LE + L N
Sbjct: 304 SGNQLT-TLEESVFHSVGNLETLILDSNPLA 333
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 2e-28
Identities = 60/342 (17%), Positives = 118/342 (34%), Gaps = 47/342 (13%)
Query: 262 SIPISLSNASKLEHIEIANNNFSGKLSVNFGGMKNLSLLNLQFSNLGSGESDEMGFMNSL 321
++P + ++ +++ N F +L L L + + + E +
Sbjct: 25 AVPEGIP--TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPG------AF 76
Query: 322 TNCSKLRVLSLGGNQFRGALPHSIANLSSQLQILILSSNQFYGSIPLGIGNLVDLYLLGM 381
N LR L L N+ + LS+ L L +S N+ +
Sbjct: 77 NNLFNLRTLGLRSNRLKLIPLGVFTGLSN-LTKLDISENKI-VILL-------------- 120
Query: 382 VENQFTGAIPKEMGKLQKLQGLDFSGNHFSGEIPS-SLGNLSSLYEVFFNNNNLSGVIPF 440
+ F L L+ L+ N I + L+SL ++ NL+ +
Sbjct: 121 -DYMFQD--------LYNLKSLEVGDNDLV-YISHRAFSGLNSLEQLTLEKCNLTSIPTE 170
Query: 441 SLGNLKRLAFLEMSGNELSGTIPEDIFNISYLSN--SLNLARNHLVGIIPPRIGNLRALR 498
+L +L L L + ++ I + F L L ++ + + P L
Sbjct: 171 ALSHLHGLIVLRLRHLNIN-AIRDYSF--KRLYRLKVLEISHWPYLDTMTPNCLYGLNLT 227
Query: 499 SFDVSNNDLSGEIPIE-LGHCSSLEEIYLAGNLFHGSIPSFFNALKGVQKIDLSRNNLSG 557
S +++ +L+ +P + H L + L+ N S + L +Q+I L L+
Sbjct: 228 SLSITHCNLT-AVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLA- 285
Query: 558 QIP--IFLEALSLEYLNLSFNDFEGKIPAKGIFANASAISVV 597
+ F L LN+S N + +F + + +
Sbjct: 286 VVEPYAFRGLNYLRVLNVSGNQLT-TLEE-SVFHSVGNLETL 325
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 6e-24
Identities = 54/235 (22%), Positives = 97/235 (41%), Gaps = 11/235 (4%)
Query: 74 LGNLSFLREINLSNNTIQGEIPPE-FGRLFRLEALFLSNNSLVGKIPAN-LSYCSRLTVL 131
LS L ++++S N I + F L+ L++L + +N LV I S + L L
Sbjct: 100 FTGLSNLTKLDISENKIV-ILLDYMFQDLYNLKSLEVGDNDLV-YISHRAFSGLNSLEQL 157
Query: 132 CIEYNKLQGRIPLE-FVSLSKLKDLSLAKNKLTGGIPPFLGNLTSLEVLSLAGNSFGRNI 190
+E L IP E L L L L + L L+VL ++ + +
Sbjct: 158 TLEKCNLT-SIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTM 216
Query: 191 PDSLGQLKQLKILAIGGNNLSGPIPP-SIYNLSFLVVFSVSHNQIHGSLPPSLGLLLPNL 249
+ L L+I NL+ +P ++ +L +L ++S+N I ++ S+ L L
Sbjct: 217 TPNCLYGLNLTSLSITHCNLTA-VPYLAVRHLVYLRFLNLSYNPIS-TIEGSMLHELLRL 274
Query: 250 KFFQIHHNFFSGSIPISLSNASKLEHIEIANNNFSGKLSVN-FGGMKNLSLLNLQ 303
+ Q+ + P + + L + ++ N + L + F + NL L L
Sbjct: 275 QEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLT-TLEESVFHSVGNLETLILD 328
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 3e-23
Identities = 53/247 (21%), Positives = 96/247 (38%), Gaps = 15/247 (6%)
Query: 349 SSQLQILILSSNQFYGSIPLGI-GNLVDLYLLGMVENQFTGAIPKEMGKLQKLQGLDFSG 407
S+Q + ++ +F ++P GI L L N+ E L+ L+ +
Sbjct: 10 SAQDRAVLCHRKRF-VAVPEGIPTETRLLDLGK---NRIKTLNQDEFASFPHLEELELNE 65
Query: 408 NHFSGEIPSSLGNLSSLYEVFFNNNNLSGVIPFSLGNLKRLAFLEMSGNELSGTIPEDIF 467
N S P + NL +L + +N L + L L L++S N++ + + +F
Sbjct: 66 NIVSAVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIV-ILLDYMF 124
Query: 468 NISYLSN--SLNLARNHLVGIIPPRIGNLRALRSFDVSNNDLSGEIPIE-LGHCSSLEEI 524
L N SL + N LV I L +L + +L+ IP E L H L +
Sbjct: 125 --QDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLT-SIPTEALSHLHGLIVL 181
Query: 525 YLAGNLFHGSIPSFFNALKGVQKIDLSRNNLSGQI-PIFLEALSLEYLNLSFNDFEGKIP 583
L + F L ++ +++S + P L L+L L+++ + +P
Sbjct: 182 RLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVP 240
Query: 584 AKGIFAN 590
+
Sbjct: 241 Y-LAVRH 246
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 3e-31
Identities = 53/242 (21%), Positives = 94/242 (38%), Gaps = 31/242 (12%)
Query: 691 LIGVGSFGCVYKGALDEDGIVVAIKVIN-LQCEGASKSFMAECKALKNIRHRNLVKVITS 749
++G G+ V++G + G + AIKV N + M E + LK + H+N+VK+
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLF-- 73
Query: 750 CSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASAL 809
+ + K ++ E+ P GSL L + E E + L V +
Sbjct: 74 -AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRD-------VVGGM 125
Query: 810 DYLHHHCQEPILHCDLKPSNILLDNDLSGH----IGDFGLARFHQEVSNSTLSSSVGVKG 865
++L + I+H ++KP NI+ G + DFG AR ++ + S G
Sbjct: 126 NHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED--DEQFVSLY---G 177
Query: 866 TIGYTAPEYGLGSEVSTNG--------DVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFA 917
T Y P+ + + + D++S G+ T P N
Sbjct: 178 TEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMY 237
Query: 918 RM 919
++
Sbjct: 238 KI 239
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 3e-31
Identities = 60/233 (25%), Positives = 92/233 (39%), Gaps = 44/233 (18%)
Query: 691 LIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSC 750
++G G+FG V K D AIK I E + ++E L ++ H+ +V+ +
Sbjct: 13 VLGQGAFGQVVKARNALDSRYYAIKKIRH-TEEKLSTILSEVMLLASLNHQYVVRYYAAW 71
Query: 751 SSIDFQGNDFKA--------IVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIA 802
A I EY NG+L +H +++ + L ++I
Sbjct: 72 LERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSE---NLNQQRDEYWRLFRQI--- 125
Query: 803 IDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVG 862
AL Y+H I+H DLKP NI +D + IGDFGLA+ + S
Sbjct: 126 ---LEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQN 179
Query: 863 VK----------GTIGYTAPE-------YGLGSEVSTNGDVYSYGILLLEMVT 898
+ GT Y A E Y ++ D+YS GI+ EM+
Sbjct: 180 LPGSSDNLTSAIGTAMYVATEVLDGTGHY--NEKI----DMYSLGIIFFEMIY 226
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 3e-31
Identities = 50/219 (22%), Positives = 95/219 (43%), Gaps = 27/219 (12%)
Query: 692 IGVGSFGCVYKGAL---DEDGIVVAIKVINLQC--EGASKSFMAECKALKNIRHRNLVKV 746
+G G FG V + L D + VA+K++ + F+ E +K H ++ K+
Sbjct: 31 LGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKL 90
Query: 747 ITSCSSIDFQGNDFKA-IVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDV 805
+ +G ++ +M +G L +L R E L L + +D+
Sbjct: 91 VGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLAS----RIGENPFNLPLQTLVRFMVDI 146
Query: 806 ASALDYL-HHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLAR--FHQEVSNSTLSSSVG 862
A ++YL + +H DL N +L D++ + DFGL+R + + +S +
Sbjct: 147 ACGMEYLSSRNF----IHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLP 202
Query: 863 VKGTIGYTAPE---YGLGSEVSTNGDVYSYGILLLEMVT 898
VK + A E L + + DV+++G+ + E++T
Sbjct: 203 VK----WLALESLADNL---YTVHSDVWAFGVTMWEIMT 234
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 3e-31
Identities = 60/230 (26%), Positives = 91/230 (39%), Gaps = 33/230 (14%)
Query: 691 LIGVGSFGCVYKGALDEDGIVVAIKVINLQC--EGASKSFMAECKALKNIRHRNLVKVIT 748
IG GS+G K DG ++ K ++ E + ++E L+ ++H N+V+
Sbjct: 13 TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY- 71
Query: 749 SCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASA 808
I + N IV EY G L + + + L + + + A
Sbjct: 72 --DRIIDRTNTTLYIVMEYCEGGDLASVI------TKGTKERQYLDEEFVLRVMTQLTLA 123
Query: 809 LDYLH--HHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGT 866
L H +LH DLKP+N+ LD + +GDFGLAR + N S + GT
Sbjct: 124 LKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR----ILNHDTSFAKTFVGT 179
Query: 867 IGYTAPE------YGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGD 910
Y +PE Y S D++S G LL E+ P F
Sbjct: 180 PYYMSPEQMNRMSYNEKS------DIWSLGCLLYELCALMPP----FTAF 219
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 4e-31
Identities = 58/225 (25%), Positives = 94/225 (41%), Gaps = 35/225 (15%)
Query: 690 HLIGVGSFGCVYKGAL---DEDGIVVAIKVINLQCEGASKS----FMAECKALKNIRHRN 742
+IG G FGCVY G L D I A+K +N F+ E +K+ H N
Sbjct: 95 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN---RITDIGEVSQFLTEGIIMKDFSHPN 151
Query: 743 LVKVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIA 802
++ ++ C +G+ +V YM +G L ++ T+ I
Sbjct: 152 VLSLLGICL--RSEGSPL--VVLPYMKHGDLRNFIRNE---------THNPTVKDLIGFG 198
Query: 803 IDVASALDYL-HHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSV 861
+ VA + +L +H DL N +LD + + DFGLAR + ++ +
Sbjct: 199 LQVAKGMKFLASKKF----VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKT 254
Query: 862 GVKGTIGYTAPE---YGLGSEVSTNGDVYSYGILLLEMVT-AKKP 902
G K + + A E +T DV+S+G+LL E++T P
Sbjct: 255 GAKLPVKWMALESLQTQK---FTTKSDVWSFGVLLWELMTRGAPP 296
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 6e-31
Identities = 52/212 (24%), Positives = 89/212 (41%), Gaps = 25/212 (11%)
Query: 692 IGVGSFGCVYKGALDEDG----IVVAIKVINLQCEGASKS-FMAECKALKNIRHRNLVKV 746
+G G FG V+KG +G I V IKVI + S A+ ++ H ++V++
Sbjct: 21 LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 80
Query: 747 ITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVA 806
+ C Q +V +Y+P GSL + H L ++ + +A
Sbjct: 81 LGLCPGSSLQ------LVTQYLPLGSLLDHVRQH---------RGALGPQLLLNWGVQIA 125
Query: 807 SALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGT 866
+ YL H ++H +L N+LL + + DFG+A + K
Sbjct: 126 KGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPP--DDKQLLYSEAKTP 180
Query: 867 IGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT 898
I + A E + + DV+SYG+ + E++T
Sbjct: 181 IKWMALESIHFGKYTHQSDVWSYGVTVWELMT 212
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 6e-31
Identities = 57/229 (24%), Positives = 89/229 (38%), Gaps = 42/229 (18%)
Query: 691 LIGVGSFGCVYKGALDEDGIVVAIKVINLQC--EGASKSFMAECKALKNIRHRNL--VKV 746
IG G V++ L+E + AIK +NL+ S+ E L ++ + +++
Sbjct: 35 QIGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93
Query: 747 ITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVA 806
+ + +V E N L WL K E K +
Sbjct: 94 YDY-----EITDQYIYMVMECG-NIDLNSWLKKK---KSIDPWERKSYWKN-------ML 137
Query: 807 SALDYLHHHCQEPILHCDLKPSNILLDNDLSGH--IGDFGLARFHQEVSNSTLSSSVGVK 864
A+ +H H I+H DLKP+N L+ + G + DFG+A Q + S + S
Sbjct: 138 EAVHTIHQHG---IVHSDLKPANFLIVD---GMLKLIDFGIANQMQPDTTSVVKDS--QV 189
Query: 865 GTIGYTAPE-----------YGLGSEVSTNGDVYSYGILLLEMVTAKKP 902
GT+ Y PE S++S DV+S G +L M K P
Sbjct: 190 GTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 238
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 8e-31
Identities = 53/227 (23%), Positives = 89/227 (39%), Gaps = 36/227 (15%)
Query: 691 LIGVGSFGCVYKGALDED-GIVVAIKVINLQC---EGASKSFMAECKALKNIRHRNLVKV 746
L+G G G VY+ A D +VA+K+++ E + ++ ++V +
Sbjct: 41 LVGRGGMGDVYE-AEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPI 99
Query: 747 ITSCSSIDF---QGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAI 803
DF G + + + L L L + ++I
Sbjct: 100 H------DFGEIDGQLY--VDMRLINGVDLAAMLRRQG----------PLAPPRAVAIVR 141
Query: 804 DVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGV 863
+ SALD H H D+KP NIL+ D ++ DFG+A ++ L+
Sbjct: 142 QIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIAS---ATTDEKLTQLGNT 195
Query: 864 KGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGD 910
GT+ Y APE S + D+Y+ +L E +T P ++GD
Sbjct: 196 VGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPP----YQGD 238
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 9e-31
Identities = 57/229 (24%), Positives = 89/229 (38%), Gaps = 42/229 (18%)
Query: 691 LIGVGSFGCVYKGALDEDGIVVAIKVINLQC--EGASKSFMAECKALKNIRHRNL--VKV 746
IG G V++ L+E + AIK +NL+ S+ E L ++ + +++
Sbjct: 16 QIGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74
Query: 747 ITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVA 806
+ + +V E N L WL K E K +
Sbjct: 75 YDY-----EITDQYIYMVMEC-GNIDLNSWLKKK---KSIDPWERKSYWKN-------ML 118
Query: 807 SALDYLHHHCQEPILHCDLKPSNILLDNDLSGH--IGDFGLARFHQEVSNSTLSSSVGVK 864
A+ +H H I+H DLKP+N L+ + G + DFG+A Q + S + S
Sbjct: 119 EAVHTIHQHG---IVHSDLKPANFLIVD---GMLKLIDFGIANQMQPDTTSVVKDS--QV 170
Query: 865 GTIGYTAPE-----------YGLGSEVSTNGDVYSYGILLLEMVTAKKP 902
GT+ Y PE S++S DV+S G +L M K P
Sbjct: 171 GTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 219
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 1e-30
Identities = 60/232 (25%), Positives = 96/232 (41%), Gaps = 40/232 (17%)
Query: 691 LIGVGSFGCVYKGA---LDEDGIVVAIKVINLQC---EGASKSFMAECKALKNIRHRNLV 744
++G G V+ D VA+KV+ F E + + H +V
Sbjct: 19 ILGFGGMSEVHLARDLRDHRD---VAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIV 75
Query: 745 KVITSCSSIDFQGNDFKA------IVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQR 798
V D G IV EY+ +L +H +T +
Sbjct: 76 AVY------D-TGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG----------PMTPKRA 118
Query: 799 ISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLS 858
I + D AL++ H + I+H D+KP+NI++ + + DFG+AR + S ++++
Sbjct: 119 IEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIAD-SGNSVT 174
Query: 859 SSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGD 910
+ V GT Y +PE G V DVYS G +L E++T + P F GD
Sbjct: 175 QTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP----FTGD 222
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 1e-30
Identities = 61/331 (18%), Positives = 116/331 (35%), Gaps = 41/331 (12%)
Query: 691 LIGVGSFGCVYKGALDEDGIVVAIKVIN-LQCEGASKSFMAECKALKNIRHRNLVKVITS 749
++G G+ V++G + G + AIKV N + M E + LK + H+N+VK+
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLF-- 73
Query: 750 CSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASAL 809
+ + K ++ E+ P GSL L + E E + L V +
Sbjct: 74 -AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRD-------VVGGM 125
Query: 810 DYLHHHCQEPILHCDLKPSNILLDNDLSGH----IGDFGLARFHQEVSNSTLSSSVGVKG 865
++L + I+H ++KP NI+ G + DFG AR ++ + S G
Sbjct: 126 NHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED--DEQFVSLY---G 177
Query: 866 TIGYTAPEYGLGSEVSTNG--------DVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFA 917
T Y P+ + + + D++S G+ T P N
Sbjct: 178 TEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMY 237
Query: 918 RM--ALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESP 975
++ P+ + V + + G+ L +++ +
Sbjct: 238 KIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILE------ADQ 291
Query: 976 QDRMNMTNVVHELQSVKNILLELETVFNKQT 1006
+ E + + + VF+ Q
Sbjct: 292 EKCWGFDQFFAETSDILH--RMVIHVFSLQQ 320
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 2e-30
Identities = 60/314 (19%), Positives = 113/314 (35%), Gaps = 54/314 (17%)
Query: 691 LIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSC 750
+G G F V DG A+K I + + E + H N+++++ C
Sbjct: 36 KLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYC 95
Query: 751 SSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALD 810
++ ++ + G+L + +R K+ LT Q + + + + L+
Sbjct: 96 LRERGAKHEAW-LLLPFFKRGTLWNEI------ERLKDKGNFLTEDQILWLLLGICRGLE 148
Query: 811 YLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNS-----TLSSSVGVKG 865
+H H DLKP+NILL ++ + D G TL +
Sbjct: 149 AIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRC 205
Query: 866 TIGYTAPE------YGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARM 919
TI Y APE + + E + DV+S G +L M+ + P ++
Sbjct: 206 TISYRAPELFSVQSHCVIDERT---DVWSLGCVLYAMMFGEGP----YDMV--------- 249
Query: 920 ALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRM 979
Q D V ++N I +S L L++ P R
Sbjct: 250 ---FQKGDSVALAVQNQLSI--------PQSPRHSSALWQLLNS------MMTVDPHQRP 292
Query: 980 NMTNVVHELQSVKN 993
++ ++ +L++++
Sbjct: 293 HIPLLLSQLEALQP 306
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 2e-30
Identities = 58/213 (27%), Positives = 87/213 (40%), Gaps = 25/213 (11%)
Query: 692 IGVGSFGCVYKGAL----DEDGIVVAIKVINLQC-EGASKSFMAECKALKNIRHRNLVKV 746
+G G FG V D G +VA+K + + E L+ + H +++K
Sbjct: 39 LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98
Query: 747 ITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVA 806
C +V EY+P GSL +L H + L Q + A +
Sbjct: 99 KGCCEDAGAASL---QLVMEYVPLGSLRDYLPRH-----------SIGLAQLLLFAQQIC 144
Query: 807 SALDYLH-HHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKG 865
+ YLH H +H DL N+LLDND IGDFGLA+ E +
Sbjct: 145 EGMAYLHAQHY----IHRDLAARNVLLDNDRLVKIGDFGLAKAVPE-GHEYYRVREDGDS 199
Query: 866 TIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT 898
+ + APE + DV+S+G+ L E++T
Sbjct: 200 PVFWYAPECLKEYKFYYASDVWSFGVTLYELLT 232
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 2e-30
Identities = 62/225 (27%), Positives = 100/225 (44%), Gaps = 40/225 (17%)
Query: 692 IGVGSFGCVYKGAL-----DEDGIVVAIKVINLQCEGASKS----FMAECKALKNIRHRN 742
+G GSFG VY+G DE VAIK +N E AS F+ E +K +
Sbjct: 33 LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN---EAASMRERIEFLNEASVMKEFNCHH 89
Query: 743 LVKVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIA 802
+V+++ S QG ++ E M G L+ +L + + +L + I +A
Sbjct: 90 VVRLLGVVS----QGQPT-LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 144
Query: 803 IDVASALDYLH-HHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSV 861
++A + YL+ + +H DL N ++ D + IGDFG+ R E +
Sbjct: 145 GEIADGMAYLNANKF----VHRDLAARNCMVAEDFTVKIGDFGMTRDIYE-------TDY 193
Query: 862 GVKGTIGY-----TAPE---YGLGSEVSTNGDVYSYGILLLEMVT 898
KG G +PE G+ +T DV+S+G++L E+ T
Sbjct: 194 YRKGGKGLLPVRWMSPESLKDGV---FTTYSDVWSFGVVLWEIAT 235
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 123 bits (309), Expect = 3e-30
Identities = 56/229 (24%), Positives = 88/229 (38%), Gaps = 42/229 (18%)
Query: 691 LIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGAS--KSFMAECKALKNIRHRNL--VKV 746
IG G V++ L+E + AIK +NL+ S+ E L ++ + +++
Sbjct: 63 QIGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121
Query: 747 ITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVA 806
+ + +V E N L WL K E K +
Sbjct: 122 YDY-----EITDQYIYMVMEC-GNIDLNSWLKKK---KSIDPWERKSYWKN-------ML 165
Query: 807 SALDYLHHHCQEPILHCDLKPSNILLDNDLSGH--IGDFGLARFHQEVSNSTLSSSVGVK 864
A+ +H H I+H DLKP+N L+ + G + DFG+A Q + S + S
Sbjct: 166 EAVHTIHQHG---IVHSDLKPANFLIVD---GMLKLIDFGIANQMQPDTTSVVKDS--QV 217
Query: 865 GTIGYTAPE-----------YGLGSEVSTNGDVYSYGILLLEMVTAKKP 902
G + Y PE S++S DV+S G +L M K P
Sbjct: 218 GAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 266
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 4e-30
Identities = 51/211 (24%), Positives = 89/211 (42%), Gaps = 24/211 (11%)
Query: 692 IGVGSFGCVYKGALDEDG--IVVAIKVINLQCEGASKS-FMAECKALKNIRHRNLVKVIT 748
+G G+FG V +G I VAIKV+ E A M E + + + + +V++I
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403
Query: 749 SCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASA 808
C + +V E G L K+L ++ + + V+
Sbjct: 404 VCQAEALM------LVMEMAGGGPLHKFLVGK---------REEIPVSNVAELLHQVSMG 448
Query: 809 LDYL-HHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTI 867
+ YL + +H +L N+LL N I DFGL++ +S ++ K +
Sbjct: 449 MKYLEEKNF----VHRNLAARNVLLVNRHYAKISDFGLSKALGA-DDSYYTARSAGKWPL 503
Query: 868 GYTAPEYGLGSEVSTNGDVYSYGILLLEMVT 898
+ APE + S+ DV+SYG+ + E ++
Sbjct: 504 KWYAPECINFRKFSSRSDVWSYGVTMWEALS 534
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 5e-30
Identities = 48/215 (22%), Positives = 86/215 (40%), Gaps = 32/215 (14%)
Query: 692 IGVGSFGCVYKGALDEDG--IVVAIKVI--NLQCEGASKSFMAECKALKNIRHRNLVKVI 747
+G G+FG V KG VA+K++ +AE ++ + + +V++I
Sbjct: 25 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84
Query: 748 TSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVAS 807
C + + +V E G L K+L + + I + V+
Sbjct: 85 GICEAESWM------LVMEMAELGPLNKYLQQNR----------HVKDKNIIELVHQVSM 128
Query: 808 ALDYL-HHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGT 866
+ YL + +H DL N+LL I DFGL++ + + K
Sbjct: 129 GMKYLEESNF----VHRDLAARNVLLVTQHYAKISDFGLSKA-LRADENYYKAQTHGKWP 183
Query: 867 IGYTAPE---YGLGSEVSTNGDVYSYGILLLEMVT 898
+ + APE Y + S+ DV+S+G+L+ E +
Sbjct: 184 VKWYAPECINYY---KFSSKSDVWSFGVLMWEAFS 215
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 6e-30
Identities = 51/212 (24%), Positives = 93/212 (43%), Gaps = 25/212 (11%)
Query: 692 IGVGSFGCVYKGALDEDG----IVVAIKVINLQC-EGASKSFMAECKALKNIRHRNLVKV 746
+G G+FG VYKG +G I VAIK + A+K + E + ++ + ++ ++
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 747 ITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVA 806
+ C + Q ++ + MP G L ++ H + + ++ + +A
Sbjct: 83 LGICLTSTVQ------LITQLMPFGCLLDYVREH---------KDNIGSQYLLNWCVQIA 127
Query: 807 SALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGT 866
++YL ++H DL N+L+ I DFGLA+ + G K
Sbjct: 128 KGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGA--EEKEYHAEGGKVP 182
Query: 867 IGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT 898
I + A E L + DV+SYG+ + E++T
Sbjct: 183 IKWMALESILHRIYTHQSDVWSYGVTVWELMT 214
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 7e-30
Identities = 55/220 (25%), Positives = 92/220 (41%), Gaps = 34/220 (15%)
Query: 692 IGVGSFGCVYKGAL---DEDGIVVAIKVINLQCEGASKS----FMAECKALKNIRHRNLV 744
IG G FG V++G + + VAIK S S F+ E ++ H ++V
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCK---NCTSDSVREKFLQEALTMRQFDHPHIV 454
Query: 745 KVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAID 804
K+I + I+ E G L +L + L L I A
Sbjct: 455 KLIGVITENPVW------IIMELCTLGELRSFLQVR---------KFSLDLASLILYAYQ 499
Query: 805 VASALDYLH-HHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGV 863
+++AL YL +H D+ N+L+ ++ +GDFGL+R + +ST +
Sbjct: 500 LSTALAYLESKRF----VHRDIAARNVLVSSNDCVKLGDFGLSR---YMEDSTYYKASKG 552
Query: 864 KGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT-AKKP 902
K I + APE ++ DV+ +G+ + E++ KP
Sbjct: 553 KLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP 592
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 1e-29
Identities = 44/229 (19%), Positives = 90/229 (39%), Gaps = 44/229 (19%)
Query: 692 IGVGSFGCVYKGAL-------DEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLV 744
+G G+F ++KG V +KV++ S+SF + + H++LV
Sbjct: 16 LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 745 KVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAID 804
C D +V E++ GSL+ +L + + + +L ++ +A
Sbjct: 76 LNYGVCVC-----GDENILVQEFVKFGSLDTYLKKN---------KNCINILWKLEVAKQ 121
Query: 805 VASALDYL-HHHCQEPILHCDLKPSNILLDNDLSGH--------IGDFGLARFHQEVSNS 855
+A+A+ +L + +H ++ NILL + + D G++
Sbjct: 122 LAAAMHFLEENTL----IHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISIT------- 170
Query: 856 TLSSSVGVKGTIGYTAPE-YGLGSEVSTNGDVYSYGILLLEMVT-AKKP 902
+ ++ I + PE ++ D +S+G L E+ + KP
Sbjct: 171 -VLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKP 218
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 6e-29
Identities = 71/228 (31%), Positives = 104/228 (45%), Gaps = 41/228 (17%)
Query: 690 HLIGVGSFGCVYKGALDEDG--IVVAIKVINLQCEGASKS----FMAECKALKNI-RHRN 742
+IG G+FG V K + +DG + AIK + E ASK F E + L + H N
Sbjct: 31 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMK---EYASKDDHRDFAGELEVLCKLGHHPN 87
Query: 743 LVKVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEI------KLTLL 796
++ ++ +C + + EY P+G+L +L V + D I L+
Sbjct: 88 IINLLGACEH-----RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 142
Query: 797 QRISIAIDVASALDYL-HHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNS 855
Q + A DVA +DYL +H DL NIL+ + I DFGL+R
Sbjct: 143 QLLHFAADVARGMDYLSQKQF----IHRDLAARNILVGENYVAKIADFGLSR-------- 190
Query: 856 TLSSSVGVKGTIG-----YTAPEYGLGSEVSTNGDVYSYGILLLEMVT 898
V VK T+G + A E S +TN DV+SYG+LL E+V+
Sbjct: 191 --GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 7e-29
Identities = 62/227 (27%), Positives = 106/227 (46%), Gaps = 38/227 (16%)
Query: 692 IGVGSFGCVYKGALDEDGIVVAIKVINLQC--EGASKSFMAECKALKNIRHRNLVK---V 746
IG G++G V+K E +VA+K + L EG S + E LK ++H+N+V+ V
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 747 ITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVA 806
+ S + +V+E+ L+K+ +K L Q +
Sbjct: 70 LHSDKKL--------TLVFEFCDQ-DLKKYFDSCNGDL--DPEIVKSFLFQ-------LL 111
Query: 807 SALDYLHHHCQEPILHCDLKPSNILLDNDLSGH--IGDFGLARFHQEVSNSTLSSSVGVK 864
L + H +LH DLKP N+L++ + G + +FGLAR + S+ V V
Sbjct: 112 KGLGFCHSRN---VLHRDLKPQNLLINRN--GELKLANFGLARAFG-IPVRCYSAEV-V- 163
Query: 865 GTIGYTAPEYGLGSEV-STNGDVYSYGILLLEMVTAKKPTDVMFEGD 910
T+ Y P+ G+++ ST+ D++S G + E+ A +P +F G+
Sbjct: 164 -TLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP---LFPGN 206
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 7e-29
Identities = 54/247 (21%), Positives = 90/247 (36%), Gaps = 59/247 (23%)
Query: 686 FSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGAS--KSFMAECKALKNI-RHRN 742
F IG G FG V+K DG + AIK G+ ++ + E A + +H +
Sbjct: 13 FHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSH 72
Query: 743 LVKVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRD-KEIEIKLTLLQRISI 801
+V+ ++ + +D I EY GSL + + KE E+K LLQ
Sbjct: 73 VVRYFSA-----WAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQ---- 123
Query: 802 AIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGH-------------------IGD 842
V L Y+H ++H D+KPSNI + + IGD
Sbjct: 124 ---VGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGD 177
Query: 843 FGLARFHQEVSNSTLSSSVGVKGTIGYTAPE-------YGLGSEVSTNGDVYSYGILLLE 895
G +SS +G + A E + + D+++ + ++
Sbjct: 178 LGHVT--------RISSPQVEEGDSRFLANEVLQENYTHLPKA------DIFALALTVVC 223
Query: 896 MVTAKKP 902
A+
Sbjct: 224 AAGAEPL 230
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 9e-29
Identities = 61/218 (27%), Positives = 91/218 (41%), Gaps = 24/218 (11%)
Query: 692 IGVGSFGCVYKGALDEDGIVVAIKVINLQ-CEGASKSFMAECKALKNIRHRNLVK---VI 747
+G G FG V + + G VAIK + + + E + +K + H N+V V
Sbjct: 22 LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVP 81
Query: 748 TSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVAS 807
+ ND + EY G L K+L+ KE I+ L ++S
Sbjct: 82 DGLQKL--APNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSD-------ISS 132
Query: 808 ALDYLHHHCQEPILHCDLKPSNILLDNDLSGH---IGDFGLARFHQEVSNSTLSSSVGVK 864
AL YLH + I+H DLKP NI+L I D G A+ + + V
Sbjct: 133 ALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQ--GELCTEFV--- 184
Query: 865 GTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKP 902
GT+ Y APE + + D +S+G L E +T +P
Sbjct: 185 GTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRP 222
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 9e-29
Identities = 55/231 (23%), Positives = 95/231 (41%), Gaps = 37/231 (16%)
Query: 692 IGVGSFGCVYKGAL-----DEDGIVVAIKVINLQCEGASKS----FMAECKALKNIRHRN 742
+G FG VYKG L E VAIK + + A F E ++H N
Sbjct: 17 LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLK---DKAEGPLREEFRHEAMLRARLQHPN 73
Query: 743 LVKVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPH------AVPKRDKEIEIKLTLL 796
+V ++ + + ++++ Y +G L ++L D+ ++ L
Sbjct: 74 VVCLLGVVT----KDQPL-SMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPP 128
Query: 797 QRISIAIDVASALDYL-HHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNS 855
+ + +A+ ++YL HH +H DL N+L+ + L+ I D GL R
Sbjct: 129 DFVHLVAQIAAGMEYLSSHHV----VHKDLATRNVLVYDKLNVKISDLGLFREVYA--AD 182
Query: 856 TLSSSVGVKGTIGYTAPE---YGLGSEVSTNGDVYSYGILLLEMVT-AKKP 902
I + APE YG S + D++SYG++L E+ + +P
Sbjct: 183 YYKLLGNSLLPIRWMAPEAIMYGK---FSIDSDIWSYGVVLWEVFSYGLQP 230
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 1e-28
Identities = 59/228 (25%), Positives = 93/228 (40%), Gaps = 46/228 (20%)
Query: 692 IGVGSFGCVYKGAL-----DEDGIVVAIKVINLQCEGASKS----FMAECKALKNIRHRN 742
+G G+FG VY+G + D + VA+K + E S+ F+ E + H+N
Sbjct: 38 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP---EVCSEQDELDFLMEALIISKFNHQN 94
Query: 743 LVKVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIA 802
+V+ I Q I+ E M G L+ +L + L +L + +A
Sbjct: 95 IVRCIGVSL----QSLPR-FILMELMAGGDLKSFLRET---RPRPSQPSSLAMLDLLHVA 146
Query: 803 IDVASALDYL-HHHCQEPILHCDLKPSNILLDNDLSGH---IGDFGLARFHQEVSNSTLS 858
D+A YL +H +H D+ N LL G IGDFG+AR
Sbjct: 147 RDIACGCQYLEENHF----IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYR------- 195
Query: 859 SSVGVKGTIGY-----TAPE---YGLGSEVSTNGDVYSYGILLLEMVT 898
+S KG PE G+ ++ D +S+G+LL E+ +
Sbjct: 196 ASYYRKGGCAMLPVKWMPPEAFMEGI---FTSKTDTWSFGVLLWEIFS 240
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 1e-28
Identities = 68/226 (30%), Positives = 105/226 (46%), Gaps = 38/226 (16%)
Query: 692 IGVGSFGCVYKGALDEDGIVVAIKVINLQC-EGASKSFMAECKALKNIRHRNLVK---VI 747
+G G++ VYKG +VA+K I L+ EGA + + E LK+++H N+V +I
Sbjct: 10 LGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII 69
Query: 748 TSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVAS 807
+ S+ +V+EY+ L+++L +KL L Q +
Sbjct: 70 HTEKSL--------TLVFEYLDK-DLKQYLDDCGNII--NMHNVKLFLFQLL-------R 111
Query: 808 ALDYLHHHCQEPILHCDLKPSNILLDNDLSGH--IGDFGLARFHQEVSNSTLSSSVGVKG 865
L Y H +LH DLKP N+L++ G + DFGLAR + T + V V
Sbjct: 112 GLAYCHRQK---VLHRDLKPQNLLINER--GELKLADFGLARAKS-IPTKTYDNEV-V-- 162
Query: 866 TIGYTAPEYGLGSEV-STNGDVYSYGILLLEMVTAKKPTDVMFEGD 910
T+ Y P+ LGS ST D++ G + EM T +P +F G
Sbjct: 163 TLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMAT-GRP---LFPGS 204
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 3e-28
Identities = 64/227 (28%), Positives = 103/227 (45%), Gaps = 39/227 (17%)
Query: 692 IGVGSFGCVYKGAL-----DEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKV 746
+G G+FG V+ +D ++VA+K + A K F E + L N++H ++VK
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 747 ITSCSSIDFQGNDFKAIVYEYMPNGSLEKWL------HPHAVPKRDKEIEIKLTLLQRIS 800
C G+ +V+EYM +G L K+L V + ++ + +L L Q +
Sbjct: 83 YGVCG----DGDPL-IMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLH 137
Query: 801 IAIDVASALDYL-HHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSS 859
IA +AS + YL H +H DL N L+ +L IGDFG++R S+
Sbjct: 138 IASQIASGMVYLASQHF----VHRDLATRNCLVGANLLVKIGDFGMSR-------DVYST 186
Query: 860 SVGVKGTIG-----YTAPE---YGLGSEVSTNGDVYSYGILLLEMVT 898
G + PE Y +T DV+S+G++L E+ T
Sbjct: 187 DYYRVGGHTMLPIRWMPPESIMYRK---FTTESDVWSFGVILWEIFT 230
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 5e-28
Identities = 58/228 (25%), Positives = 92/228 (40%), Gaps = 46/228 (20%)
Query: 692 IGVGSFGCVYKGAL-----DEDGIVVAIKVINLQCEGASKS----FMAECKALKNIRHRN 742
+G G+FG VY+G + D + VA+K + E S+ F+ E + H+N
Sbjct: 79 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP---EVCSEQDELDFLMEALIISKFNHQN 135
Query: 743 LVKVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIA 802
+V+ I Q I+ E M G L+ +L + L +L + +A
Sbjct: 136 IVRCIGVSL----QSLPR-FILLELMAGGDLKSFLRET---RPRPSQPSSLAMLDLLHVA 187
Query: 803 IDVASALDYL-HHHCQEPILHCDLKPSNILLDNDLSGH---IGDFGLARFHQEVSNSTLS 858
D+A YL +H +H D+ N LL G IGDFG+AR
Sbjct: 188 RDIACGCQYLEENHF----IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYR------- 236
Query: 859 SSVGVKGTIGY-----TAPE---YGLGSEVSTNGDVYSYGILLLEMVT 898
+ KG PE G+ ++ D +S+G+LL E+ +
Sbjct: 237 AGYYRKGGCAMLPVKWMPPEAFMEGI---FTSKTDTWSFGVLLWEIFS 281
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 6e-28
Identities = 69/227 (30%), Positives = 107/227 (47%), Gaps = 40/227 (17%)
Query: 692 IGVGSFGCVYKGALDEDGIVVAIKVINLQC--EGASKSFMAECKALKNIRHRNLVK---V 746
IG G++G VYK A + G A+K I L+ EG + + E LK ++H N+VK V
Sbjct: 10 IGEGTYGVVYK-AQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 747 ITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVA 806
I + + +V+E++ L+K L + + K LLQ ++
Sbjct: 69 IHTKKRL--------VLVFEHLDQ-DLKKLLDVCEGGL--ESVTAKSFLLQLLN------ 111
Query: 807 SALDYLHHHCQEPILHCDLKPSNILLDNDLSGH--IGDFGLARFHQEVSNSTLSSSVGVK 864
+ Y H +LH DLKP N+L++ + G I DFGLAR + + + V
Sbjct: 112 -GIAYCHDRR---VLHRDLKPQNLLINRE--GELKIADFGLARAFG-IPVRKYTHEI-V- 162
Query: 865 GTIGYTAPEYGLGSEV-STNGDVYSYGILLLEMVTAKKPTDVMFEGD 910
T+ Y AP+ +GS+ ST D++S G + EMV P +F G
Sbjct: 163 -TLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVN-GTP---LFPGV 204
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 6e-28
Identities = 74/227 (32%), Positives = 114/227 (50%), Gaps = 40/227 (17%)
Query: 692 IGVGSFGCVYKGALDEDGIVVAIKVINLQC--EGASKSFMAECKALKNIRHRNLVK---V 746
+G G++G VYK A D G +VA+K I L EG + + E LK + H N+V V
Sbjct: 29 VGEGTYGVVYK-AKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDV 87
Query: 747 ITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVA 806
I S + +V+E+M L+K L + ++ +IK+ L Q +
Sbjct: 88 IHSERCL--------TLVFEFMEK-DLKKVLDENKTGL--QDSQIKIYLYQ-------LL 129
Query: 807 SALDYLHHHCQEPILHCDLKPSNILLDNDLSGH--IGDFGLARFHQEVSNSTLSSSVGVK 864
+ + H H ILH DLKP N+L+++D G + DFGLAR + + + V V
Sbjct: 130 RGVAHCHQHR---ILHRDLKPQNLLINSD--GALKLADFGLARAFG-IPVRSYTHEV-V- 181
Query: 865 GTIGYTAPEYGLGSEV-STNGDVYSYGILLLEMVTAKKPTDVMFEGD 910
T+ Y AP+ +GS+ ST+ D++S G + EM+T KP +F G
Sbjct: 182 -TLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMIT-GKP---LFPGV 223
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 7e-28
Identities = 72/229 (31%), Positives = 115/229 (50%), Gaps = 39/229 (17%)
Query: 692 IGVGSFGCVYKGALDEDGIVVAIKVINLQCE-GASKSFMAECKALKNIRHRNLVK---VI 747
+G G++ VYKG G+ VA+K + L E G + + E +K ++H N+V+ VI
Sbjct: 13 LGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVI 72
Query: 748 TSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEI---EIKLTLLQRISIAID 804
+ + + +V+E+M N L+K++ V + + +K Q
Sbjct: 73 HTENKL--------TLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQ------- 116
Query: 805 VASALDYLHHHCQEPILHCDLKPSNILLDNDLSGH--IGDFGLARFHQEVSNSTLSSSVG 862
+ L + H + ILH DLKP N+L++ G +GDFGLAR + +T SS V
Sbjct: 117 LLQGLAFCHENK---ILHRDLKPQNLLINKR--GQLKLGDFGLARAFG-IPVNTFSSEV- 169
Query: 863 VKGTIGYTAPEYGLGSEV-STNGDVYSYGILLLEMVTAKKPTDVMFEGD 910
V T+ Y AP+ +GS ST+ D++S G +L EM+T KP +F G
Sbjct: 170 V--TLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMIT-GKP---LFPGT 212
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 9e-28
Identities = 61/231 (26%), Positives = 105/231 (45%), Gaps = 39/231 (16%)
Query: 692 IGVGSFGCVYKGAL-----DEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKV 746
+G G+FG V+ ++D ++VA+K + E A + F E + L ++H+++V+
Sbjct: 49 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 747 ITSCSSIDFQGNDFKAIVYEYMPNGSLEKWL-----HPHAVPKRDKEIEIKLTLLQRISI 801
C+ +G +V+EYM +G L ++L + + L L Q +++
Sbjct: 109 FGVCT----EGRPL-LMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAV 163
Query: 802 AIDVASALDYL-HHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSS 860
A VA+ + YL H +H DL N L+ L IGDFG++R S+
Sbjct: 164 ASQVAAGMVYLAGLHF----VHRDLATRNCLVGQGLVVKIGDFGMSR-------DIYSTD 212
Query: 861 VGVKGTIG-----YTAPE---YGLGSEVSTNGDVYSYGILLLEMVT-AKKP 902
G + PE Y +T DV+S+G++L E+ T K+P
Sbjct: 213 YYRVGGRTMLPIRWMPPESILYRK---FTTESDVWSFGVVLWEIFTYGKQP 260
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 9e-28
Identities = 63/239 (26%), Positives = 93/239 (38%), Gaps = 54/239 (22%)
Query: 692 IGVGSFGCVYKGAL-----DEDGIVVAIKVINLQCEGASKS----FMAECKALKNIRHRN 742
+G G FG V K VA+K++ E AS S ++E LK + H +
Sbjct: 31 LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLK---ENASPSELRDLLSEFNVLKQVNHPH 87
Query: 743 LVKVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWL--------------HPHAVPKRDKE 788
++K+ +CS Q ++ EY GSL +L D
Sbjct: 88 VIKLYGACS----QDGPL-LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142
Query: 789 IEIKLTLLQRISIAIDVASALDYL-HHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLAR 847
E LT+ IS A ++ + YL +H DL NIL+ I DFGL+R
Sbjct: 143 DERALTMGDLISFAWQISQGMQYLAEMKL----VHRDLAARNILVAEGRKMKISDFGLSR 198
Query: 848 FHQEVSNSTLSSSVGVKGTIG-----YTAPE---YGLGSEVSTNGDVYSYGILLLEMVT 898
VK + G + A E + +T DV+S+G+LL E+VT
Sbjct: 199 -------DVYEEDSYVKRSQGRIPVKWMAIESLFDHI---YTTQSDVWSFGVLLWEIVT 247
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 1e-27
Identities = 59/231 (25%), Positives = 94/231 (40%), Gaps = 43/231 (18%)
Query: 692 IGVGSFGCVYKGAL-----DEDGIVVAIKVINLQCEGASKS----FMAECKALKNI-RHR 741
+G G+FG V + + + VA+K++ A + M+E K L + H
Sbjct: 31 LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLK---PSAHLTEREALMSELKVLSYLGNHM 87
Query: 742 NLVKVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWL--------HPHAVPKRDKEIEIKL 793
N+V ++ +C+ G ++ EY G L +L P ++ E+ L
Sbjct: 88 NIVNLLGACT----IGGPT-LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 794 TLLQRISIAIDVASALDYLH-HHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEV 852
L +S + VA + +L +C +H DL NILL + I DFGLAR +
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASKNC----IHRDLAARNILLTHGRITKICDFGLARDIKN- 197
Query: 853 SNSTLSSSVGVKGTIG-----YTAPEYGLGSEVSTNGDVYSYGILLLEMVT 898
S V + APE + DV+SYGI L E+ +
Sbjct: 198 ------DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-27
Identities = 58/229 (25%), Positives = 94/229 (41%), Gaps = 40/229 (17%)
Query: 692 IGVGSFGCVYKGAL-----DEDGIVVAIKVINLQCEGASKS----FMAECKALKNI-RHR 741
+G G+FG V + VA+K++ EGA+ S M+E K L +I H
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLK---EGATHSEHRALMSELKILIHIGHHL 91
Query: 742 NLVKVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEI------KLTL 795
N+V ++ +C+ + ++ E+ G+L +L ++ LTL
Sbjct: 92 NVVNLLGACT----KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTL 147
Query: 796 LQRISIAIDVASALDYL-HHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSN 854
I + VA +++L C +H DL NILL I DFGLAR +
Sbjct: 148 EHLICYSFQVAKGMEFLASRKC----IHRDLAARNILLSEKNVVKICDFGLARDIYK--- 200
Query: 855 STLSSSVGVKGTIG-----YTAPEYGLGSEVSTNGDVYSYGILLLEMVT 898
V+ + APE + DV+S+G+LL E+ +
Sbjct: 201 ----DPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 113 bits (283), Expect = 3e-27
Identities = 56/267 (20%), Positives = 89/267 (33%), Gaps = 57/267 (21%)
Query: 690 HLIGVGSFGCVYKGALDEDGIVVAIKVINL-QCEGASKSFMAECKALKNIRHRNLVKVIT 748
+G G FG V++ D AIK I L E A + M E KAL + H +V+
Sbjct: 12 QCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFN 71
Query: 749 SCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEI----------------- 791
+ + + + P + +I
Sbjct: 72 AWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSS 131
Query: 792 -------------KLTLLQRIS---------------IAIDVASALDYLHHHCQEPILHC 823
K L ++ I I +A A+++LH ++H
Sbjct: 132 PKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKG---LMHR 188
Query: 824 DLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVK--------GTIGYTAPEYG 875
DLKPSNI D +GDFGL + + GT Y +PE
Sbjct: 189 DLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQI 248
Query: 876 LGSEVSTNGDVYSYGILLLEMVTAKKP 902
G+ S D++S G++L E++ +
Sbjct: 249 HGNNYSHKVDIFSLGLILFELLYSFST 275
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 3e-27
Identities = 47/239 (19%), Positives = 88/239 (36%), Gaps = 28/239 (11%)
Query: 690 HLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIR-HRNLVKVIT 748
++ G F VY+ G A+K + E +++ + E +K + H N+V+ +
Sbjct: 34 RVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCS 93
Query: 749 SCSSIDFQGNDFKAIVY--EYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVA 806
+ S + + +A + G L ++L + + I
Sbjct: 94 AASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTV-------LKIFYQTC 146
Query: 807 SALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARF--------HQEVSNSTLS 858
A+ ++H + PI+H DLK N+LL N + + DFG A + +
Sbjct: 147 RAVQHMHRQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVE 205
Query: 859 SSVGVKGTIGYTAPE----YGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNL 913
+ T Y PE Y + D+++ G +L + + P FE L
Sbjct: 206 EEITRNTTPMYRTPEIIDLYS-NFPIGEKQDIWALGCILYLLCFRQHP----FEDGAKL 259
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 3e-27
Identities = 54/222 (24%), Positives = 94/222 (42%), Gaps = 29/222 (13%)
Query: 692 IGVGSFGCVYKGAL-----DEDGIVVAIKVINLQCEGASKS----FMAECKALKNI-RHR 741
+G G+FG V + ++ + VA+K++ A M+E K + ++ +H
Sbjct: 54 LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLK---STAHADEKEALMSELKIMSHLGQHE 110
Query: 742 NLVKVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIK----LTLLQ 797
N+V ++ +C+ G ++ EY G L +L + +
Sbjct: 111 NIVNLLGACT----HGGPV-LVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRD 165
Query: 798 RISIAIDVASALDYL-HHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNST 856
+ + VA + +L +C +H D+ N+LL N IGDFGLAR SN
Sbjct: 166 LLHFSSQVAQGMAFLASKNC----IHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYI 221
Query: 857 LSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT 898
+ + + + APE + DV+SYGILL E+ +
Sbjct: 222 VKG--NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 3e-27
Identities = 52/303 (17%), Positives = 97/303 (32%), Gaps = 47/303 (15%)
Query: 264 PISLSNASKLEHIEIANNNFSGKLSVNFGGMKNLSLLNLQFSNLGSGESDEMGFMNSLTN 323
SLS S I ++ + +L + S L
Sbjct: 10 NFSLSQNSFYNTISGTYADYFSAWD----KWEKQALPGENRNEAVS----------LLKE 55
Query: 324 C--SKLRVLSLGGNQFRGALPHSIANLSSQLQILILSSNQFYGSIPLGIGNLVDLYLLGM 381
C ++ L L +LP ++ Q+ +L ++ N S+P +L L
Sbjct: 56 CLINQFSELQLNRLNLS-SLPDNLP---PQITVLEITQNAL-ISLPELPASLEYLDACD- 109
Query: 382 VENQFTGAIPKEMGKLQKLQGLDFSGNHFSGEIPSSLGNLSSLYEVFFNNNNLSGVIPFS 441
N+ + +P+ L+ L D N + +P L + +NN L+ ++P
Sbjct: 110 --NRLS-TLPELPASLKHL---DVDNNQLT-MLPELPALLEYIN---ADNNQLT-MLPEL 158
Query: 442 LGNLKRLAFLEMSGNELSGTIPEDIFNISYLSNSLNLARNHLVGIIPPRIGNLRALRS-- 499
+L+ L + N+L+ +PE ++ +L+++ N L + P
Sbjct: 159 PTSLEVL---SVRNNQLT-FLPELPESLE----ALDVSTNLLESL-PAVPVRNHHSEETE 209
Query: 500 --FDVSNNDLSGEIPIELGHCSSLEEIYLAGNLFHGSIPSFFNALKGVQKIDLSRNNLSG 557
F N ++ IP + I L N I + R S
Sbjct: 210 IFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSM 268
Query: 558 QIP 560
Sbjct: 269 SDG 271
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 4e-27
Identities = 56/307 (18%), Positives = 111/307 (36%), Gaps = 48/307 (15%)
Query: 242 LGLLLPNLKFFQIHHNFFSGSIPISLSNA----SKLEHIEIANNNFSGKLSVNFGGMKNL 297
+ ++LP F + N F +I + ++ K E + N + +S+ +K
Sbjct: 1 MSIMLPINNNFSLSQNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSL----LKEC 56
Query: 298 SLLNLQFSNLGSGESDEMGFMNSLTN-----CSKLRVLSLGGNQFRGALPHSIANLSSQL 352
+ L +L++ ++ VL + N +LP A+L
Sbjct: 57 LINQFSELQLNR---------LNLSSLPDNLPPQITVLEITQNALI-SLPELPASL---- 102
Query: 353 QILILSSNQFYGSIPLGIGNLVDLYLLGMVENQFTGAIPKEMGKLQKLQGLDFSGNHFSG 412
+ L N+ ++P +L L + NQ T +P+ L+ + + N +
Sbjct: 103 EYLDACDNRL-STLPELPASLKHLDVDN---NQLT-MLPELPALLEYI---NADNNQLT- 153
Query: 413 EIPSSLGNLSSLYEVFFNNNNLSGVIPFSLGNLKRLAFLEMSGNELSGTIPEDIFNISYL 472
+P +L L NN L+ +P +L+ L ++S N L ++P +
Sbjct: 154 MLPELPTSLEVLS---VRNNQLT-FLPELPESLEAL---DVSTNLLE-SLPAVPVRNHHS 205
Query: 473 SNS---LNLARNHLVGIIPPRIGNLRALRSFDVSNNDLSGEIPIELGHCSSLEEIYLAGN 529
+ N + I P I +L + + +N LS I L ++ + +
Sbjct: 206 EETEIFFRCRENRITHI-PENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRI 264
Query: 530 LFHGSIP 536
F S
Sbjct: 265 YFSMSDG 271
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 3e-24
Identities = 61/340 (17%), Positives = 105/340 (30%), Gaps = 70/340 (20%)
Query: 135 YNKLQGRIPLEFVS----LSKLKDLSLAKNKLTGGIPPFLGNLTSLEVLSLAGNSFGRNI 190
YN + ++ S K +N+ + L + L L + ++
Sbjct: 19 YNTIS-GTYADYFSAWDKWEKQALPGENRNEAVSLLKECL--INQFSELQLNRLNL-SSL 74
Query: 191 PDSLGQLKQLKILAIGGNNLSGPIPPSIYNLSFLVVFSVSHNQIHGSLPPSLGLLLPNLK 250
PD+L Q+ +L I N L +P +L +L N++ +LP +LK
Sbjct: 75 PDNLPP--QITVLEITQNALI-SLPELPASLEYL---DACDNRLS-TLPELPA----SLK 123
Query: 251 FFQIHHNFFSGSIPISLSNASKLEHIEIANNNFSGKLSVNFGGMKNLSLLNLQFSNLGSG 310
+ +N + +P + LE+I NN + L L
Sbjct: 124 HLDVDNNQLT-MLPELPAL---LEYINADNNQLT-------------MLPEL-------- 158
Query: 311 ESDEMGFMNSLTNCSKLRVLSLGGNQFRGALPHSIANLSSQLQILILSSNQFYGSIPLGI 370
+ L VLS+ NQ LP +L + L +S+N S+P
Sbjct: 159 -------------PTSLEVLSVRNNQLT-FLPELPESL----EALDVSTNLL-ESLPAVP 199
Query: 371 GNLVDLYLLGMV----ENQFTGAIPKEMGKLQKLQGLDFSGNHFSGEIPSSLGNLSSLYE 426
+ EN+ T IP+ + L + N S I SL ++ +
Sbjct: 200 VRNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPD 258
Query: 427 VFFNNNNLSGVIPFSLGNLKRLAFLEMSGNELSGTIPEDI 466
S N + D+
Sbjct: 259 YHGPRIYFSMSDGQQ--NTLHRPLADAVTAWFPENKQSDV 296
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 98.9 bits (246), Expect = 2e-21
Identities = 49/327 (14%), Positives = 99/327 (30%), Gaps = 39/327 (11%)
Query: 99 GRLFRLEALFLSNNSLVGKIPANLSYC----SRLTVLCIEYNKLQGRIPLEFVSLSKLKD 154
F L N A+ + + N+ + +++ +
Sbjct: 8 NNNFSLSQNSFYNTIS--GTYADYFSAWDKWEKQALPGENRNEAVSLLKE--CLINQFSE 63
Query: 155 LSLAKNKLTGGIPPFLGNLTSLEVLSLAGNSFGRNIPDSLGQLKQLKILAIGGNNLSGPI 214
L L + L+ +P L + VL + N+ ++P+ L+ L N LS +
Sbjct: 64 LQLNRLNLS-SLPDNLP--PQITVLEITQNAL-ISLPELPASLEYLDAC---DNRLST-L 115
Query: 215 PPSIYNLSFLVVFSVSHNQIHGSLPPSLGLLLPNLKFFQIHHNFFSGSIPISLSNASKLE 274
P +L L V +NQ+ LP L++ +N + +P ++ LE
Sbjct: 116 PELPASLKHL---DVDNNQLT-MLPELPA----LLEYINADNNQLT-MLPELPTS---LE 163
Query: 275 HIEIANNNFSGKLSVNFGGMKNLSLLNLQFSNLGSGESDEMGFMNSLTNCSKLRVLSLGG 334
+ + NN + L ++ L + +L +
Sbjct: 164 VLSVRNNQLT-FLPELPESLEALDVSTNLLESL----PAVPVRNHHSE--ETEIFFRCRE 216
Query: 335 NQFRGALPHSIANLSSQLQILILSSNQFYGSIPLGIGNLVDLYLLGMVENQFTGAIPKEM 394
N+ +P +I +L +IL N I + F+ + ++
Sbjct: 217 NRIT-HIPENILSLDP-TCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQN 274
Query: 395 GKLQKLQGLDFSGNHFSGEIPSSLGNL 421
D F S + +
Sbjct: 275 --TLHRPLADAVTAWFPENKQSDVSQI 299
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 97.3 bits (242), Expect = 5e-21
Identities = 54/342 (15%), Positives = 98/342 (28%), Gaps = 60/342 (17%)
Query: 190 IPDSLGQLKQLKILAIGGNNLSGPIPPSIY----NLSFLVVFSVSHNQIHGSLPPSLGLL 245
+ L + N + + + N+ L L
Sbjct: 1 MSIMLPINNNFSLSQNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECL--- 57
Query: 246 LPNLKFFQIHHNFFSGSIPISLSNASKLEHIEIANNNFSGKLSVNFGGMKNLSLLNLQFS 305
+ Q++ S S+P +L ++ +EI N L ++ L + + S
Sbjct: 58 INQFSELQLNRLNLS-SLPDNL--PPQITVLEITQNALI-SLPELPASLEYLDACDNRLS 113
Query: 306 NLGSGESDEMGFMNSLTNCSKLRVLSLGGNQFRGALPHSIANLSSQLQILILSSNQFYGS 365
L + L+ L + NQ LP A L + + +NQ
Sbjct: 114 TL----PELPA---------SLKHLDVDNNQLT-MLPELPALL----EYINADNNQL-TM 154
Query: 366 IPLGIGNLVDLYLLGMVENQFTGAIPKEMGKLQKLQGLDFSGNHFSGEIPSSLGNLSSLY 425
+P +L L + NQ T +P+ L+ L D S N +P+
Sbjct: 155 LPELPTSLEVLSVRN---NQLT-FLPELPESLEAL---DVSTNLLE-SLPAVPVRNHHS- 205
Query: 426 EVFFNNNNLSGVIPFSLGNLKRLAFLEMSGNELSGTIPEDIFNISYLSNSLNLARNHLVG 485
+ F N ++ IPE+I ++ ++ L N L
Sbjct: 206 -------------------EETEIFFRCRENRIT-HIPENILSLDPTC-TIILEDNPLSS 244
Query: 486 IIPPRIGNLRALRSFDVSNNDLSGEIPIELGHCSSLEEIYLA 527
I + A + S + L + A
Sbjct: 245 RIRESLSQQTAQPDYHGPRIYFSMSDGQQNTLHRPLADAVTA 286
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 80.8 bits (199), Expect = 9e-16
Identities = 54/215 (25%), Positives = 86/215 (40%), Gaps = 29/215 (13%)
Query: 365 SIPLGIGNLVDLYLLGMVENQFTGAIPKEMGK-LQKLQGLDFSGNHFSGEIPSSL--GNL 421
SI L I N L N + + K + G + E S L +
Sbjct: 2 SIMLPINNNFSLSQN-SFYNTIS-GTYADYFSAWDKWEKQALPGENR-NEAVSLLKECLI 58
Query: 422 SSLYEVFFNNNNLSGVIPFSLGNLKRLAFLEMSGNELSGTIPEDIFNISYLSNSLNLARN 481
+ E+ N NLS +P +L ++ LE++ N L ++PE ++ YL + N
Sbjct: 59 NQFSELQLNRLNLS-SLPDNLP--PQITVLEITQNALI-SLPELPASLEYL----DACDN 110
Query: 482 HLVGIIPPRIGNLRALRSFDVSNNDLSGEIPIELGHCSSLEEIYLAGNLFHGSIPSFFNA 541
L +P +L+ L DV NN L+ +P LE I N +P +
Sbjct: 111 RLS-TLPELPASLKHL---DVDNNQLT-MLPELPA---LLEYINADNNQLT-MLPELPTS 161
Query: 542 LKGVQKIDLSRNNLSGQIPIFLEALSLEYLNLSFN 576
L + + + N L+ +P E SLE L++S N
Sbjct: 162 L---EVLSVRNNQLT-FLPELPE--SLEALDVSTN 190
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 58.8 bits (142), Expect = 7e-09
Identities = 27/134 (20%), Positives = 45/134 (33%), Gaps = 14/134 (10%)
Query: 57 TALDLMSKSLSGSLSPHLGNLSFLREINLSNNTIQGEIPPEFGRLFRLEALFLSNNSLVG 116
++ + L+ L +L +++ NN + +P LEAL +S N L
Sbjct: 143 EYINADNNQLT-MLPELPTSL---EVLSVRNNQLT-FLPEL---PESLEALDVSTNLLES 194
Query: 117 KIPANLSYCSRLT----VLCIEYNKLQGRIPLEFVSLSKLKDLSLAKNKLTGGIPPFLGN 172
+PA N++ IP +SL + L N L+ I L
Sbjct: 195 -LPAVPVRNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQ 252
Query: 173 LTSLEVLSLAGNSF 186
T+ F
Sbjct: 253 QTAQPDYHGPRIYF 266
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 51.9 bits (124), Expect = 9e-07
Identities = 21/134 (15%), Positives = 39/134 (29%), Gaps = 11/134 (8%)
Query: 68 GSLSPHLGNLSFLREINLSNNTIQGEIPPEFGRLFRLE----ALFLSNNSLVGKIPANLS 123
L +L +++S N ++ +P R E N + IP N+
Sbjct: 173 TFLPELPESL---EALDVSTNLLE-SLPAVPVRNHHSEETEIFFRCRENRIT-HIPENIL 227
Query: 124 YCSRLTVLCIEYNKLQGRIPLEFVSLSKLKDLSLAKNKLTGGIPPFLGNLTSLEVLSLAG 183
+ +E N L RI + D + + + N +
Sbjct: 228 SLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFS--MSDGQQNTLHRPLADAVT 285
Query: 184 NSFGRNIPDSLGQL 197
F N + Q+
Sbjct: 286 AWFPENKQSDVSQI 299
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 8e-27
Identities = 58/227 (25%), Positives = 98/227 (43%), Gaps = 34/227 (14%)
Query: 690 HLIGVGSFGCVYKGALDEDGIVVAIKVIN---LQCEGASKSFMAECKALKNIRHRNLVK- 745
+L+G GSF VY+ G+ VAIK+I+ + G + E K ++H ++++
Sbjct: 17 NLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILEL 76
Query: 746 --VITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAI 803
+ + +V E NG + ++L K E E + + Q
Sbjct: 77 YNYFEDSNYV--------YLVLEMCHNGEMNRYLKNR--VKPFSENEARHFMHQ------ 120
Query: 804 DVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGV 863
+ + + YLH H ILH DL SN+LL +++ I DFGLA ++ + +
Sbjct: 121 -IITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLAT-QLKMPHEKHYTLC-- 173
Query: 864 KGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGD 910
GT Y +PE S DV+S G + ++ + P F+ D
Sbjct: 174 -GTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPP----FDTD 215
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 8e-27
Identities = 29/274 (10%), Positives = 60/274 (21%), Gaps = 42/274 (15%)
Query: 691 LIGVGSFGCVYKGALDEDGIVVAIKVIN---LQCEGASKSFMAECKALKNIRHRNLVKVI 747
+ VG V+ E A+KV + A + + +
Sbjct: 69 PLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEAR 128
Query: 748 TSC------------------SSIDFQGNDFKAIVYEYMP--NGSLEKWLHPHAVPKRDK 787
Q + A MP + LE
Sbjct: 129 DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTL---DFVY 185
Query: 788 EIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLAR 847
+L + + L ++H P N+ + D +GD
Sbjct: 186 VFRGDEGILALHILTAQLIRLAANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSALW 242
Query: 848 FHQEVSNSTLSSSVGVKGTIGYTAPEY--GLGSEVSTNGDVYSYGILLLEMVTAKKPTDV 905
T + + Y E+ + + + + G+ + + P
Sbjct: 243 -----KVGTRGPASS--VPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLP--- 292
Query: 906 MFEGDLNLHNFARMALPNQVMDIVDPILRNDEEI 939
F + +V + +
Sbjct: 293 -FGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPL 325
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 8e-27
Identities = 71/266 (26%), Positives = 114/266 (42%), Gaps = 43/266 (16%)
Query: 658 PSRLPSRPMMRKALPKMSYKSLLKATN--GFSSTHLIGVGSFGCVYKGALDEDGIVVAIK 715
+ + + MS + AT+ + +G G++G VYK VAIK
Sbjct: 6 HHHMGTLEAQTQGPGSMSVSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIK 65
Query: 716 VINLQC--EGASKSFMAECKALKNIRHRNLVK---VITSCSSIDFQGNDFKAIVYEYMPN 770
I L+ EG + + E LK ++HRN+++ VI + +++EY N
Sbjct: 66 RIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRL--------HLIFEYAEN 117
Query: 771 GSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNI 830
L+K++ + IK L Q + + +++ H LH DLKP N+
Sbjct: 118 -DLKKYMDKN---PDVSMRVIKSFLYQ-------LINGVNFCHSRR---CLHRDLKPQNL 163
Query: 831 LLDNDLSGH-----IGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEV-STNG 884
LL + IGDFGLAR + + + + T+ Y PE LGS ST+
Sbjct: 164 LLSVSDASETPVLKIGDFGLARAFG-IPIRQFTHEI-I--TLWYRPPEILLGSRHYSTSV 219
Query: 885 DVYSYGILLLEMVTAKKPTDVMFEGD 910
D++S + EM+ K P +F GD
Sbjct: 220 DIWSIACIWAEMLM-KTP---LFPGD 241
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 1e-26
Identities = 53/231 (22%), Positives = 100/231 (43%), Gaps = 43/231 (18%)
Query: 692 IGVGSFGCVYKGAL-------DEDGIVVAIKVINLQCEGASKS----FMAECKALKNI-R 739
+G G+FG V ++ + VA+K++ + A++ ++E + +K I +
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLK---DDATEKDLSDLVSEMEMMKMIGK 99
Query: 740 HRNLVKVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWL------HPHAVPKRDKEIEIKL 793
H+N++ ++ +C+ Q ++ EY G+L ++L ++ E ++
Sbjct: 100 HKNIINLLGACT----QDGPL-YVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 794 TLLQRISIAIDVASALDYL-HHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEV 852
T +S +A ++YL C +H DL N+L+ + I DFGLAR
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLARDINN- 209
Query: 853 SNSTLSSSVGVKGTIG-----YTAPEYGLGSEVSTNGDVYSYGILLLEMVT 898
K T G + APE + DV+S+G+L+ E+ T
Sbjct: 210 ------IDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 1e-26
Identities = 66/230 (28%), Positives = 100/230 (43%), Gaps = 42/230 (18%)
Query: 692 IGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKS---FMA--ECKALKNIRHRNLVK- 745
+G G F VYK +VAIK I L +K A E K L+ + H N++
Sbjct: 18 LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 77
Query: 746 --VITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAI 803
S+I ++V+++M LE + +++ IK +L
Sbjct: 78 LDAFGHKSNI--------SLVFDFMET-DLEVIIKDNSLVL--TPSHIKAYMLM------ 120
Query: 804 DVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGH--IGDFGLARFHQEVSNSTLSSSV 861
L+YLH H ILH DLKP+N+LLD + G + DFGLA+ N + V
Sbjct: 121 -TLQGLEYLHQHW---ILHRDLKPNNLLLDEN--GVLKLADFGLAKSFG-SPNRAYTHQV 173
Query: 862 GVKGTIGYTAPEYGLGSEV-STNGDVYSYGILLLEMVTAKKPTDVMFEGD 910
V T Y APE G+ + D+++ G +L E++ + P GD
Sbjct: 174 -V--TRWYRAPELLFGARMYGVGVDMWAVGCILAELLL-RVP---FLPGD 216
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 1e-26
Identities = 59/233 (25%), Positives = 95/233 (40%), Gaps = 43/233 (18%)
Query: 690 HLIGVGSFGCVYKGAL-------DEDGIVVAIKVINLQCEGASKS----FMAECKALKNI 738
+G G+FG V VA+K++ A++ ++E + +K I
Sbjct: 75 KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLK---SDATEKDLSDLISEMEMMKMI 131
Query: 739 -RHRNLVKVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIK----- 792
+H+N++ ++ +C+ Q IV EY G+L ++L P +
Sbjct: 132 GKHKNIINLLGACT----QDGPLYVIV-EYASKGNLREYLQARRPPGLEYSYNPSHNPEE 186
Query: 793 -LTLLQRISIAIDVASALDYL-HHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQ 850
L+ +S A VA ++YL C +H DL N+L+ D I DFGLAR
Sbjct: 187 QLSSKDLVSCAYQVARGMEYLASKKC----IHRDLAARNVLVTEDNVMKIADFGLARDIH 242
Query: 851 EVSNSTLSSSVGVKGTIG-----YTAPEYGLGSEVSTNGDVYSYGILLLEMVT 898
K T G + APE + DV+S+G+LL E+ T
Sbjct: 243 H-------IDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 2e-26
Identities = 69/336 (20%), Positives = 118/336 (35%), Gaps = 54/336 (16%)
Query: 42 CEWEGITCGRRH---------RRVTALDLMSKSLSGSLSPH-LGNLSFLREINLSNNTIQ 91
C + C LDL + ++ + NL L + L NN I
Sbjct: 31 CHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKIT-EIKDGDFKNLKNLHTLILINNKIS 89
Query: 92 GEIPPE-FGRLFRLEALFLSNNSLVGKIPANLSYCSRLTVLCIEYNKLQGRIPLE-FVSL 149
+I P F L +LE L+LS N L ++P + L L + N++ ++ F L
Sbjct: 90 -KISPGAFAPLVKLERLYLSKNQLK-ELPEKMP--KTLQELRVHENEIT-KVRKSVFNGL 144
Query: 150 SKLKDLSLAKNKLT-GGIPP--FLGNLTSLEVLSLAGNSFGRNIPDSLGQLKQLKILAIG 206
+++ + L N L GI F G + L + +A + IP L
Sbjct: 145 NQMIVVELGTNPLKSSGIENGAFQG-MKKLSYIRIADTNI-TTIPQGL------------ 190
Query: 207 GNNLSGPIPPSIYNLSFLVVFSVSHNQIHGSLPPSLGLLLPNLKFFQIHHNFFSGSIPIS 266
PPS+ L N+I + + L NL + N S S
Sbjct: 191 --------PPSLTELHL------DGNKIT-KVDAASLKGLNNLAKLGLSFNSISAVDNGS 235
Query: 267 LSNASKLEHIEIANNNFSGKLSVNFGGMKNLSLLNLQFSNLGSGESDEMGFMNSLTNCSK 326
L+N L + + NN K+ K + ++ L +N+ + S++ T +
Sbjct: 236 LANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKAS 294
Query: 327 LRVLSLGGNQFRGAL--PHSIANLSSQLQILILSSN 360
+SL N + P + + + L +
Sbjct: 295 YSGVSLFSNPVQYWEIQPSTFRCVYV-RAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-25
Identities = 62/305 (20%), Positives = 112/305 (36%), Gaps = 33/305 (10%)
Query: 262 SIPISLSNASKLEHIEIANNNFSGKLSVNFGGMKNLSLLNLQFSNLGSGESDEMGFMNSL 321
+P L +++ NN + +F +KNL L L + + +
Sbjct: 45 KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISP------GAF 96
Query: 322 TNCSKLRVLSLGGNQFRGALPHSIANLSSQLQILILSSNQFYGSIPLGI-GNLVDLYLLG 380
KL L L NQ + LP + LQ L + N+ + + L + ++
Sbjct: 97 APLVKLERLYLSKNQLK-ELP---EKMPKTLQELRVHENEIT-KVRKSVFNGLNQMIVVE 151
Query: 381 MVENQFT-GAIPKEM-GKLQKLQGLDFSGNHFSGEIPSSLGNLSSLYEVFFNNNNLSGVI 438
+ N I ++KL + + + + IP L SL E+ + N ++ V
Sbjct: 152 LGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVD 208
Query: 439 PFSLGNLKRLAFLEMSGNELSGTIPEDIF-NISYLSNSLNLARNHLVGIIPPRIGNLRAL 497
SL L LA L +S N +S + N +L L+L N LV +P + + + +
Sbjct: 209 AASLKGLNNLAKLGLSFNSIS-AVDNGSLANTPHLR-ELHLNNNKLV-KVPGGLADHKYI 265
Query: 498 RSFDVSNNDLSGEIPIE-------LGHCSSLEEIYLAGN-LFHGSIPSF-FNALKGVQKI 548
+ + NN++S I +S + L N + + I F + +
Sbjct: 266 QVVYLHNNNIS-AIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAV 324
Query: 549 DLSRN 553
L
Sbjct: 325 QLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 3e-22
Identities = 62/281 (22%), Positives = 107/281 (38%), Gaps = 20/281 (7%)
Query: 327 LRVLSLGGNQFRGALPHSIANLSSQLQILILSSNQFYGSIPLGI-GNLVDLYLLGMVENQ 385
+L L N+ NL L LIL +N+ I G LV L L + +NQ
Sbjct: 54 TALLDLQNNKITEIKDGDFKNLK-NLHTLILINNKI-SKISPGAFAPLVKLERLYLSKNQ 111
Query: 386 FTGAIPKEMGKLQKLQGLDFSGNHFSGEIPSSLGNLSSLYEVFFNNNNL--SGVIPFSLG 443
+P++M + LQ L N + S L+ + V N L SG+ +
Sbjct: 112 LK-ELPEKM--PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQ 168
Query: 444 NLKRLAFLEMSGNELSGTIPEDIFNISYLSNSLNLARNHLVGIIPPRIGNLRALRSFDVS 503
+K+L+++ ++ ++ TIP+ + L+ L+L N + + + L L +S
Sbjct: 169 GMKKLSYIRIADTNIT-TIPQGLP--PSLT-ELHLDGNKITKVDAASLKGLNNLAKLGLS 224
Query: 504 NNDLSGEIPIELGHCSSLEEIYLAGNLFHGSIPSFFNALKGVQKIDLSRNNLS------- 556
N +S L + L E++L N +P K +Q + L NN+S
Sbjct: 225 FNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDF 283
Query: 557 GQIPIFLEALSLEYLNLSFNDFEGKIPAKGIFANASAISVV 597
+ S ++L N + F + V
Sbjct: 284 CPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAV 324
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 8e-22
Identities = 65/319 (20%), Positives = 109/319 (34%), Gaps = 31/319 (9%)
Query: 125 CSRLTVLCIEYNKLQGRIPLEFVSLSKLKDLSLAKNKLTGGIPPF-LGNLTSLEVLSLAG 183
C V C L+ ++P + L L NK+T I NL +L L L
Sbjct: 31 CHLRVVQC-SDLGLE-KVPKDL--PPDTALLDLQNNKITE-IKDGDFKNLKNLHTLILIN 85
Query: 184 NSFGRNIPDSLGQLKQLKILAIGGNNLSGPIPPSIYNLSFLVVFSVSHNQIHGSLPPSLG 243
N + P + L +L+ L + N L +P + L V N+I + S+
Sbjct: 86 NKISKISPGAFAPLVKLERLYLSKNQLKE-LPEKM--PKTLQELRVHENEIT-KVRKSVF 141
Query: 244 LLLPNLKFFQIHHNFFSGSI--PISLSNASKLEHIEIANNNFSGKLSVNFGGMKNLSLLN 301
L + ++ N S + KL +I IA+ N + + L L
Sbjct: 142 NGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGLPPSLTELHLDG 201
Query: 302 LQFSNLGSGESDEMGFMNSLTNCSKLRVLSLGGNQFRGALPHSIANLSSQLQILILSSNQ 361
+ + + + SL + L L L N S+AN L+ L L++N+
Sbjct: 202 NKITKVDAA---------SLKGLNNLAKLGLSFNSISAVDNGSLANTPH-LRELHLNNNK 251
Query: 362 FYGSIPLGIGNLVDLYLLGMVENQFTG------AIPKEMGKLQKLQGLDFSGNHFS-GEI 414
+P G+ + + ++ + N + P K G+ N EI
Sbjct: 252 LV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEI 310
Query: 415 PSSL-GNLSSLYEVFFNNN 432
S + V N
Sbjct: 311 QPSTFRCVYVRAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 7e-18
Identities = 46/234 (19%), Positives = 89/234 (38%), Gaps = 23/234 (9%)
Query: 351 QLQILILSSNQFYGSIPLGI-GNLVDLYLLGMVENQFTGAIPKEMGKLQKLQGLDFSGNH 409
L+++ S +P + + L L N+ T + L+ L L N
Sbjct: 32 HLRVVQCSDLGL-EKVPKDLPPDTALLDLQN---NKITEIKDGDFKNLKNLHTLILINNK 87
Query: 410 FSGEIPSSLGNLSSLYEVFFNNNNLSGVIPFSLGNLKRLAFLEMSGNELSGTIPEDIFNI 469
S P + L L ++ + N L + L+ L + NE++ + + +F
Sbjct: 88 ISKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQE---LRVHENEIT-KVRKSVF-- 141
Query: 470 SYLSN--SLNLARNHL-VGIIPPRI-GNLRALRSFDVSNNDLSGEIPIELGHCSSLEEIY 525
+ L+ + L N L I ++ L +++ +++ I G SL E++
Sbjct: 142 NGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITT---IPQGLPPSLTELH 198
Query: 526 LAGNLFHGSIPS-FFNALKGVQKIDLSRNNLSGQIP--IFLEALSLEYLNLSFN 576
L GN + + L + K+ LS N++S + L L+L+ N
Sbjct: 199 LDGNKIT-KVDAASLKGLNNLAKLGLSFNSIS-AVDNGSLANTPHLRELHLNNN 250
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 8e-08
Identities = 24/115 (20%), Positives = 48/115 (41%), Gaps = 13/115 (11%)
Query: 57 TALDLMSKSLSGSLSPH-LGNLSFLREINLSNNTIQGEIPPEFGRLFRLEALFLSNNSLV 115
L L S+S ++ L N LRE++L+NN + ++P ++ ++L NN++
Sbjct: 219 AKLGLSFNSIS-AVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNIS 276
Query: 116 GKIPAN-------LSYCSRLTVLCIEYNKLQ-GRIPLE-FVSLSKLKDLSLAKNK 161
I +N + + + + + N +Q I F + + L K
Sbjct: 277 -AIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 2e-26
Identities = 53/231 (22%), Positives = 99/231 (42%), Gaps = 43/231 (18%)
Query: 692 IGVGSFGCVYKGAL-------DEDGIVVAIKVINLQCEGASKS----FMAECKALKNI-R 739
+G G FG V ++ + VA+K++ + A++ ++E + +K I +
Sbjct: 89 LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLK---DDATEKDLSDLVSEMEMMKMIGK 145
Query: 740 HRNLVKVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWL------HPHAVPKRDKEIEIKL 793
H+N++ ++ +C+ Q ++ EY G+L ++L ++ E ++
Sbjct: 146 HKNIINLLGACT----QDGPL-YVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 200
Query: 794 TLLQRISIAIDVASALDYL-HHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEV 852
T +S +A ++YL C +H DL N+L+ + I DFGLAR
Sbjct: 201 TFKDLVSCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLARDINN- 255
Query: 853 SNSTLSSSVGVKGTIG-----YTAPEYGLGSEVSTNGDVYSYGILLLEMVT 898
K T G + APE + DV+S+G+L+ E+ T
Sbjct: 256 ------IDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-26
Identities = 55/236 (23%), Positives = 86/236 (36%), Gaps = 53/236 (22%)
Query: 690 HLIGVGSFGCVYKGALDEDGIVVAIKVIN---LQCEGASKSFMAECKALKNIRHRNLVK- 745
+G G F ++ + + V A K++ L + E +++ H+++V
Sbjct: 21 RFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 80
Query: 746 --VITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAI 803
+ +V E SL + K E E + L Q
Sbjct: 81 HGFFEDNDFV--------FVVLELCRRRSLLELHKRR---KALTEPEARYYLRQ------ 123
Query: 804 DVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGV 863
+ YLH + ++H DLK N+ L+ DL IGDFGL +T G
Sbjct: 124 -IVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGL---------ATKVEYDGE 170
Query: 864 K-----GTIGYTAPE----YGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGD 910
+ GT Y APE G EV DV+S G ++ ++ K P FE
Sbjct: 171 RKKVLCGTPNYIAPEVLSKKGHSFEV----DVWSIGCIMYTLLVGKPP----FETS 218
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 5e-26
Identities = 55/239 (23%), Positives = 94/239 (39%), Gaps = 54/239 (22%)
Query: 692 IGVGSFGCVYKGAL-----DEDGIVVAIKVINLQCEGASKS----FMAECKALKNIRHRN 742
IG G+FG V++ E +VA+K++ E AS F E + + N
Sbjct: 55 IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLK---EEASADMQADFQREAALMAEFDNPN 111
Query: 743 LVKVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPH--------------AVPKRDKE 788
+VK++ C+ G +++EYM G L ++L +
Sbjct: 112 IVKLLGVCA----VGKPM-CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 166
Query: 789 IEIKLTLLQRISIAIDVASALDYLH-HHCQEPILHCDLKPSNILLDNDLSGHIGDFGLAR 847
L+ +++ IA VA+ + YL +H DL N L+ ++ I DFGL+R
Sbjct: 167 GPPPLSCAEQLCIARQVAAGMAYLSERKF----VHRDLATRNCLVGENMVVKIADFGLSR 222
Query: 848 FHQEVSNSTLSSSVGVKGTIGY-----TAPE---YGLGSEVSTNGDVYSYGILLLEMVT 898
+ S+ PE Y +T DV++YG++L E+ +
Sbjct: 223 -------NIYSADYYKADGNDAIPIRWMPPESIFYNR---YTTESDVWAYGVVLWEIFS 271
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 5e-26
Identities = 55/236 (23%), Positives = 86/236 (36%), Gaps = 53/236 (22%)
Query: 690 HLIGVGSFGCVYKGALDEDGIVVAIKVIN---LQCEGASKSFMAECKALKNIRHRNLVK- 745
+G G F ++ + + V A K++ L + E +++ H+++V
Sbjct: 47 RFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 106
Query: 746 --VITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAI 803
+ +V E SL + K E E + L Q
Sbjct: 107 HGFFEDNDFV--------FVVLELCRRRSLLELHKRR---KALTEPEARYYLRQ------ 149
Query: 804 DVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGV 863
+ YLH + ++H DLK N+ L+ DL IGDFGL +T G
Sbjct: 150 -IVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGL---------ATKVEYDGE 196
Query: 864 K-----GTIGYTAPEY----GLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGD 910
+ GT Y APE G EV DV+S G ++ ++ K P FE
Sbjct: 197 RKKVLCGTPNYIAPEVLSKKGHSFEV----DVWSIGCIMYTLLVGKPP----FETS 244
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 7e-26
Identities = 54/224 (24%), Positives = 91/224 (40%), Gaps = 31/224 (13%)
Query: 690 HLIGVGSFGCVYKGALDEDGIVVAIKVIN---LQCEGASKSFMAECKALKNIRHRNLVKV 746
+G G FG VY + ++A+KV+ L+ G E + ++RH N++++
Sbjct: 15 RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74
Query: 747 ITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVA 806
F ++ EY P G++ + L + E + + +A
Sbjct: 75 YGY-----FHDATRVYLILEYAPLGTVYRELQKL---SKFDEQRTATYITE-------LA 119
Query: 807 SALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGT 866
+AL Y H ++H D+KP N+LL + I DFG + + L GT
Sbjct: 120 NALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC------GT 170
Query: 867 IGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGD 910
+ Y PE G D++S G+L E + K P FE +
Sbjct: 171 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP----FEAN 210
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 8e-26
Identities = 39/290 (13%), Positives = 82/290 (28%), Gaps = 66/290 (22%)
Query: 691 LIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKS----------------------- 727
++G + E G + V S +
Sbjct: 80 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139
Query: 728 -----FMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAV 782
F+ +K+ + + +++V + + F + + L H+
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLD-ERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 198
Query: 783 PKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGD 842
+ L R+ + + V L LHH+ ++H L+P +I+LD +
Sbjct: 199 THK------SLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTG 249
Query: 843 FGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNG-----------DVYSYGI 891
F S+ + G+ PE + D ++ G+
Sbjct: 250 FEHLVRDGARVVSS--------VSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL 301
Query: 892 LLLEMVTAKKPTDVMFEGDLNLHNFAR-----MALPNQVMDIVDPILRND 936
++ + A P D L +P V +++ LR
Sbjct: 302 VIYWIWCADLP----ITKDAALGGSEWIFRSCKNIPQPVRALLEGFLRYP 347
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 8e-26
Identities = 59/236 (25%), Positives = 92/236 (38%), Gaps = 48/236 (20%)
Query: 692 IGVGSFGCVYKGAL-----DEDGIVVAIKVINLQCEGAS----KSFMAECKALKNI-RHR 741
+G G+FG V I VA+K++ E A ++ M+E K + + H
Sbjct: 53 LGSGAFGKVMNATAYGISKTGVSIQVAVKMLK---EKADSSEREALMSELKMMTQLGSHE 109
Query: 742 NLVKVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEI---------- 791
N+V ++ +C+ +++EY G L +L + EIE
Sbjct: 110 NIVNLLGACT----LSGPI-YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 164
Query: 792 ---KLTLLQRISIAIDVASALDYL-HHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLAR 847
LT + A VA +++L C +H DL N+L+ + I DFGLAR
Sbjct: 165 DLNVLTFEDLLCFAYQVAKGMEFLEFKSC----VHRDLAARNVLVTHGKVVKICDFGLAR 220
Query: 848 FHQEVSNSTLSSSVGVKGTIG-----YTAPEYGLGSEVSTNGDVYSYGILLLEMVT 898
S V + APE + DV+SYGILL E+ +
Sbjct: 221 DIMS-------DSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 8e-26
Identities = 62/230 (26%), Positives = 103/230 (44%), Gaps = 33/230 (14%)
Query: 692 IGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMA--ECKALKNIRHRNLVK---V 746
IG G+FG V+K + G VA+K + ++ E A E K L+ ++H N+V +
Sbjct: 25 IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 84
Query: 747 ITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVA 806
+ +S + +V+++ + L L V EIK + +
Sbjct: 85 CRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKF--TLSEIKRVMQM-------LL 134
Query: 807 SALDYLHHHCQEPILHCDLKPSNILLDNDLSGH--IGDFGLARFHQEVSNST---LSSSV 861
+ L Y+H + ILH D+K +N+L+ D G + DFGLAR NS ++ V
Sbjct: 135 NGLYYIHRNK---ILHRDMKAANVLITRD--GVLKLADFGLARAFSLAKNSQPNRYTNRV 189
Query: 862 GVKGTIGYTAPEYGLGSEV-STNGDVYSYGILLLEMVTAKKPTDVMFEGD 910
V T+ Y PE LG D++ G ++ EM T + P + +G+
Sbjct: 190 -V--TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT-RSP---IMQGN 232
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 9e-26
Identities = 61/248 (24%), Positives = 105/248 (42%), Gaps = 30/248 (12%)
Query: 692 IGVGSFGCVYKG--ALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVK---V 746
+G G++G VYK +D A+K I G S S E L+ ++H N++ V
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQIEG--TGISMSACREIALLRELKHPNVISLQKV 86
Query: 747 ITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVA 806
S + ++++Y + L + H K +K+ ++L S+ +
Sbjct: 87 FLSHADRKV------WLLFDYAEH-DLWHIIKFHRASKANKK-PVQLPRGMVKSLLYQIL 138
Query: 807 SALDYLHHHCQEPILHCDLKPSNILLDNDLSGH----IGDFGLAR-FHQEVSNSTLSSSV 861
+ YLH + +LH DLKP+NIL+ + I D G AR F+ + V
Sbjct: 139 DGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPV 195
Query: 862 GVKGTIGYTAPEYGLGSEV-STNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMA 920
V T Y APE LG+ + D+++ G + E++T +P +F +
Sbjct: 196 VV--TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEP---IFHCRQEDIKTSNPY 249
Query: 921 LPNQVMDI 928
+Q+ I
Sbjct: 250 HHDQLDRI 257
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 1e-25
Identities = 55/247 (22%), Positives = 97/247 (39%), Gaps = 48/247 (19%)
Query: 692 IGVGSFGCVYKGALDEDGIVVAIKVIN-----------------LQCEGASKSFMAECKA 734
+ G F + ++D A+K + + F E +
Sbjct: 39 LNQGKFNKIILC--EKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQI 96
Query: 735 LKNIRHRNLVK---VITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEI 791
+ +I++ + +IT+ + + I+YEYM N S+ K+ DK
Sbjct: 97 ITDIKNEYCLTCEGIITNYDEV------Y--IIYEYMENDSILKFDEYFF--VLDKNYTC 146
Query: 792 KLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQE 851
+ + I V ++ Y+H+ I H D+KPSNIL+D + + DFG + +
Sbjct: 147 FIPIQVIKCIIKSVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFGES---EY 201
Query: 852 VSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNG---DVYSYGILLLEMVTAKKPTDVMFE 908
+ + + S GT + PE+ +E S NG D++S GI L M P F
Sbjct: 202 MVDKKIKGSR---GTYEFMPPEF-FSNESSYNGAKVDIWSLGICLYVMFYNVVP----FS 253
Query: 909 GDLNLHN 915
++L
Sbjct: 254 LKISLVE 260
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-25
Identities = 72/229 (31%), Positives = 110/229 (48%), Gaps = 35/229 (15%)
Query: 692 IGVGSFGCVYKGALD--EDGIVVAIKVINLQC--EGASKSFMAECKALKNIR---HRNLV 744
IG G++G V+K A D G VA+K + +Q EG S + E L+++ H N+V
Sbjct: 19 IGEGAYGKVFK-ARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 77
Query: 745 KVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAID 804
++ C+ +V+E++ L +L P E IK + Q
Sbjct: 78 RLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTE-TIKDMMFQ------- 128
Query: 805 VASALDYLHHHCQEPILHCDLKPSNILLDNDLSGH--IGDFGLAR-FHQEVSNSTLSSSV 861
+ LD+LH H ++H DLKP NIL+ + G + DFGLAR + ++ L+S V
Sbjct: 129 LLRGLDFLHSHR---VVHRDLKPQNILVTSS--GQIKLADFGLARIYSFQM---ALTSVV 180
Query: 862 GVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGD 910
V T+ Y APE L S +T D++S G + EM +KP +F G
Sbjct: 181 -V--TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKP---LFRGS 222
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 1e-25
Identities = 42/280 (15%), Positives = 79/280 (28%), Gaps = 47/280 (16%)
Query: 691 LIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGAS---KSFMAECKALKNIRH------- 740
++G + E G + V S K E L+ +R
Sbjct: 85 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144
Query: 741 ---------RNLVKVITSCSSIDFQGNDFKAIVYEY-----MPNGSLEKWLHPHAVPKRD 786
+LVK I + ++ V +L+ +
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204
Query: 787 KEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLA 846
+ L R+ + + V L LHH+ ++H L+P +I+LD + F
Sbjct: 205 HK---SLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHL 258
Query: 847 RFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNG-----DVYSYGILLLEMVTAKK 901
+ S + TA + D ++ G+ + + A
Sbjct: 259 VRDGASAVSPIGRGF---APPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADL 315
Query: 902 PTDVMFEGDLNLHNFARM-----ALPNQVMDIVDPILRND 936
P D L + +P V +++ LR
Sbjct: 316 P----NTDDAALGGSEWIFRSCKNIPQPVRALLEGFLRYP 351
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-25
Identities = 60/261 (22%), Positives = 106/261 (40%), Gaps = 17/261 (6%)
Query: 107 LFLSNNSLVGKIPANLSYCSRLTVLCIEYNKLQGRIPLEFVSLSKLKDLSLAKNKLT-GG 165
+ ++ L +P + S T L +E NKLQ F L++L LSL+ N L+ G
Sbjct: 12 IRCNSKGLT-SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKG 68
Query: 166 IPPF-LGNLTSLEVLSLAGNSFGRNIPDSLGQLKQLKILAIGGNNLSGPIPPSI-YNLSF 223
TSL+ L L+ N + + L+QL+ L +NL S+ +L
Sbjct: 69 CCSQSDFGTTSLKYLDLSFNGV-ITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRN 127
Query: 224 LVVFSVSHNQIHGSLPPSLGLLLPNLKFFQIHHNFFSGSI-PISLSNASKLEHIEIANNN 282
L+ +SH + L +L+ ++ N F + P + L ++++
Sbjct: 128 LIYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQ 186
Query: 283 FSGKLSVN-FGGMKNLSLLNLQFSNLGSGESDEMGFMNSLTNCSKLRVLSLGGNQFRGAL 341
+LS F + +L +LN+ +N S ++ + L+VL N +
Sbjct: 187 LE-QLSPTAFNSLSSLQVLNMSHNNFFSLDT------FPYKCLNSLQVLDYSLNHIMTSK 239
Query: 342 PHSIANLSSQLQILILSSNQF 362
+ + S L L L+ N F
Sbjct: 240 KQELQHFPSSLAFLNLTQNDF 260
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 1e-22
Identities = 48/231 (20%), Positives = 88/231 (38%), Gaps = 11/231 (4%)
Query: 80 LREINLSNNTIQGEIPP-EFGRLFRLEALFLSNNSL--VGKIPANLSYCSRLTVLCIEYN 136
+ L +N +Q +P F +L +L L LS+N L G + + L L + +N
Sbjct: 30 ATRLELESNKLQ-SLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFN 88
Query: 137 KLQGRIPLEFVSLSKLKDLSLAKNKLTGGIPP--FLGNLTSLEVLSLAGNSFGRNIPDSL 194
+ + F+ L +L+ L + L + +L +L L ++
Sbjct: 89 GVI-TMSSNFLGLEQLEHLDFQHSNLK-QMSEFSVFLSLRNLIYLDISHTHTRVAFNGIF 146
Query: 195 GQLKQLKILAIGGNNLSGPIPPSI-YNLSFLVVFSVSHNQIHGSLPPSLGLLLPNLKFFQ 253
L L++L + GN+ P I L L +S Q+ L P+ L +L+
Sbjct: 147 NGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLN 205
Query: 254 IHHNFFSGSIPISLSNASKLEHIEIANNNFSGKLSVNFGGM-KNLSLLNLQ 303
+ HN F + L+ ++ + N+ +L+ LNL
Sbjct: 206 MSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLT 256
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 4e-22
Identities = 61/292 (20%), Positives = 105/292 (35%), Gaps = 28/292 (9%)
Query: 296 NLSLLNLQFSNLGSGESDEMGFMNSLTNCSKLRVLSLGGNQ--FRGALPHSIANLSSQLQ 353
+ + L L+ + L S ++L LSL N F+G S + L+
Sbjct: 29 SATRLELESNKLQSLPH------GVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTT-SLK 81
Query: 354 ILILSSNQFYGSIPLGIGNLVDLYLLGMVENQFTGAIPKEM-GKLQKLQGLDFSGNHFSG 412
L LS N ++ L L L + + L+ L LD S H
Sbjct: 82 YLDLSFNGV-ITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTR- 139
Query: 413 EIPS----SLGNLSSLYEVFFNNNNLSGVIPFSLGNLKRLAFLEMSGNELSGTIPEDIFN 468
+ L +L L N+ +P L+ L FL++S +L + FN
Sbjct: 140 VAFNGIFNGLSSLEVLK--MAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFN 196
Query: 469 ISYLSN--SLNLARNHLVGIIPPRIGNLRALRSFDVSNNDLSGEIPIEL--GHCSSLEEI 524
LS+ LN++ N+ + L +L+ D S N + + SSL +
Sbjct: 197 --SLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIM-TSKKQELQHFPSSLAFL 253
Query: 525 YLAGNLFH--GSIPSFFNALKGVQKIDLSRNNLSGQIPIFLEALSLEYLNLS 574
L N F SF +K +++ + + P + + + LN++
Sbjct: 254 NLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDKQGMPVLSLNIT 305
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 6e-19
Identities = 53/286 (18%), Positives = 96/286 (33%), Gaps = 39/286 (13%)
Query: 175 SLEVLSLAGNSFGRNIPDSLGQLKQLKILAIGGNNLSGPIPPSI-YNLSFLVVFSVSHNQ 233
S + ++P + L + N L +P + L+ L S+S N
Sbjct: 8 SGTEIRCNSKGL-TSVPTGI--PSSATRLELESNKLQS-LPHGVFDKLTQLTKLSLSSNG 63
Query: 234 I-HGSLPPSLGLLLPNLKFFQIHHNFFSGSIPISLSNASKLEHIEIANNNFSGKLSVN-F 291
+ +LK+ + N ++ + +LEH++ ++N + F
Sbjct: 64 LSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVF 122
Query: 292 GGMKNLSLLNLQFSNLGSGESDEMGFMNSLTNCSKLRVLSLGGNQFRGALPHSIANLSSQ 351
++NL L++ ++ + S L VL + GN F+ I
Sbjct: 123 LSLRNLIYLDISHTHTRVAFN------GIFNGLSSLEVLKMAGNSFQENFLPDIFTELRN 176
Query: 352 LQILILSSNQFYGSIPLGIGNLVDLYLLGMVENQFTGAIPKEMGKLQKLQGLDFSGNHFS 411
L L LS Q + F L LQ L+ S N+F
Sbjct: 177 LTFLDLSQCQL-EQLS---------------PTAFNS--------LSSLQVLNMSHNNFF 212
Query: 412 GEIPSSLGNLSSLYEVFFNNNNLSGVIPFSLGNL-KRLAFLEMSGN 456
L+SL + ++ N++ L + LAFL ++ N
Sbjct: 213 SLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQN 258
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 2e-15
Identities = 30/141 (21%), Positives = 54/141 (38%), Gaps = 8/141 (5%)
Query: 76 NLSFLREINLSNNTIQGEIPPE-FGRLFRLEALFLSNNSLVGKIPAN-LSYCSRLTVLCI 133
+L L +++S+ + F L LE L ++ NS + + LT L +
Sbjct: 124 SLRNLIYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDL 182
Query: 134 EYNKLQGRIPLE-FVSLSKLKDLSLAKNKLTGGIPPFLGNLTSLEVLSLAGNSFGRNIPD 192
+L+ ++ F SLS L+ L+++ N L SL+VL + N
Sbjct: 183 SQCQLE-QLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHI-MTSKK 240
Query: 193 SL--GQLKQLKILAIGGNNLS 211
L L + N+ +
Sbjct: 241 QELQHFPSSLAFLNLTQNDFA 261
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 3e-13
Identities = 42/203 (20%), Positives = 74/203 (36%), Gaps = 34/203 (16%)
Query: 403 LDFSGNHFSGEIPSSLGNLSSLYEVFFNNNNLSGVIPFSLGNLKRLAFLEMSGNELS-GT 461
+ + + +P+ + SS + +N L + L +L L +S N LS
Sbjct: 12 IRCNSKGLT-SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKG 68
Query: 462 IPEDIF--------------NISYLSN---------SLNLARNHLVGIIPPRI-GNLRAL 497
+ +S+ L+ ++L + + +LR L
Sbjct: 69 CCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNL 128
Query: 498 RSFDVSNNDLSGEIPIE-LGHCSSLEEIYLAGNLFHGSIPS-FFNALKGVQKIDLSRNNL 555
D+S+ SSLE + +AGN F + F L+ + +DLS+ L
Sbjct: 129 IYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQL 187
Query: 556 SGQIP--IFLEALSLEYLNLSFN 576
Q+ F SL+ LN+S N
Sbjct: 188 E-QLSPTAFNSLSSLQVLNMSHN 209
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 2e-25
Identities = 69/229 (30%), Positives = 105/229 (45%), Gaps = 33/229 (14%)
Query: 692 IGVGSFGCVYKGALDEDGIVVAIKVINLQCE-GASKSF----MAECKALKNIR---HRNL 743
IGVG++G VYK G VA+K + + G + E L+ + H N+
Sbjct: 17 IGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNV 76
Query: 744 VKVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAI 803
V+++ C++ +V+E++ L +L P E IK + Q
Sbjct: 77 VRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAE-TIKDLMRQ------ 128
Query: 804 DVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGH--IGDFGLARFHQEVSNSTLSSSV 861
LD+LH +C I+H DLKP NIL+ + G + DFGLAR + L+ V
Sbjct: 129 -FLRGLDFLHANC---IVHRDLKPENILVTSG--GTVKLADFGLARIYS--YQMALTPVV 180
Query: 862 GVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGD 910
V T+ Y APE L S +T D++S G + EM +KP +F G+
Sbjct: 181 -V--TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKP---LFCGN 222
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-25
Identities = 69/337 (20%), Positives = 118/337 (35%), Gaps = 53/337 (15%)
Query: 41 FCEWEGITCGRRH---------RRVTALDLMSKSLSGSLSPH-LGNLSFLREINLSNNTI 90
C + C T LDL + +S L L L + L NN I
Sbjct: 32 HCHLRVVQCSDLGLKAVPKEISPDTTLLDLQNNDIS-ELRKDDFKGLQHLYALVLVNNKI 90
Query: 91 QGEIPPE-FGRLFRLEALFLSNNSLVGKIPANLSYCSRLTVLCIEYNKLQGRIPLE-FVS 148
+I + F L +L+ L++S N LV +IP NL S L L I N+++ ++P F
Sbjct: 91 S-KIHEKAFSPLRKLQKLYISKNHLV-EIPPNLP--SSLVELRIHDNRIR-KVPKGVFSG 145
Query: 149 LSKLKDLSLAKNKLT-GGIPPFLGNLTSLEVLSLAGNSFGRNIPDSLGQLKQLKILAIGG 207
L + + + N L G P + L L ++ IP L + L L +
Sbjct: 146 LRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKL-TGIPKDL--PETLNELHLDH 202
Query: 208 NNLSGPIPP-SIYNLSFLVVFSVSHNQIHGSLPPSLGLLLPNLKFFQIHHNFFSGSIPIS 266
N + I + S L + HNQI + S
Sbjct: 203 NKIQA-IELEDLLRYSKLYRLGLGHNQIR-MIENG------------------------S 236
Query: 267 LSNASKLEHIEIANNNFSGKLSVNFGGMKNLSLLNLQFSNLGSGESDEMGFMNSLTNCSK 326
LS L + + NN S ++ +K L ++ L +N+ ++ + +
Sbjct: 237 LSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAY 295
Query: 327 LRVLSLGGNQ--FRGALPHSIANLSSQLQILILSSNQ 361
+SL N + P + ++ + + +
Sbjct: 296 YNGISLFNNPVPYWEVQPATFRCVTD-RLAIQFGNYK 331
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 3e-23
Identities = 64/334 (19%), Positives = 112/334 (33%), Gaps = 43/334 (12%)
Query: 104 LEALFLSNNSLVGKIPANLSYCSRLTVLCIEYNKLQGRIPLEFVSLSKLKDLSLAKNKLT 163
L + S+ L +P +S T+L ++ N + +F L L L L NK++
Sbjct: 35 LRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKIS 91
Query: 164 GGIPPF-LGNLTSLEVLSLAGNSFGRNIPDSLGQLKQLKILAIGGNNLSGPIPPSI-YNL 221
I L L+ L ++ N IP +L L L I N + +P + L
Sbjct: 92 -KIHEKAFSPLRKLQKLYISKNHL-VEIPPNL--PSSLVELRIHDNRIRK-VPKGVFSGL 146
Query: 222 SFLVVFSVSHNQIHGSLPPSLGLLLPNLKFFQIHHNFFSGSIPISLSNASKLEHIEIANN 281
+ + N + S L + +I + IP L L + + +N
Sbjct: 147 RNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLT-GIPKDL--PETLNELHLDHN 203
Query: 282 NFSGKLSVN-FGGMKNLSLLNLQFSNLGSGESDEMGFMNSLTNCSKLRVLSLGGNQFRGA 340
+ + L L L + + E+ SL+ LR L L N+
Sbjct: 204 KIQ-AIELEDLLRYSKLYRLGLGHNQIRMIEN------GSLSFLPTLRELHLDNNKLS-R 255
Query: 341 LPHSIANLSSQLQILILSSNQFYGSIPLGIGNLVDLYLLGMVENQFTGAIPKEMGKLQKL 400
+P + +L LQ++ L +N + N F K
Sbjct: 256 VPAGLPDLKL-LQVVYLHTNNI-TKVG---------------VNDFCP--VGFGVKRAYY 296
Query: 401 QGLDFSGNHFS-GEI-PSSLGNLSSLYEVFFNNN 432
G+ N E+ P++ ++ + F N
Sbjct: 297 NGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNY 330
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 2e-21
Identities = 57/275 (20%), Positives = 94/275 (34%), Gaps = 23/275 (8%)
Query: 327 LRVLSLGGNQFRGALPHSIANLSSQLQILILSSNQFYGSIPLGI-GNLVDLYLLGMVENQ 385
+L L N L L L+L +N+ I L L L + +N
Sbjct: 56 TTLLDLQNNDISELRKDDFKGLQ-HLYALVLVNNKI-SKIHEKAFSPLRKLQKLYISKNH 113
Query: 386 FTGAIPKEMGKLQKLQGLDFSGNHFSGEIPSSLGNLSSLYEVFFNNNNL--SGVIPFSLG 443
IP + L L N L ++ + N L SG P +
Sbjct: 114 LV-EIPPNL--PSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFD 170
Query: 444 NLKRLAFLEMSGNELSGTIPEDIFNISYLSNSLNLARNHLVGIIPPRIGNLRALRSFDVS 503
LK L +L +S +L+ IP+D+ L N L+L N + I + L +
Sbjct: 171 GLK-LNYLRISEAKLT-GIPKDLP--ETL-NELHLDHNKIQAIELEDLLRYSKLYRLGLG 225
Query: 504 NNDLSGEIPIE-LGHCSSLEEIYLAGNLFHGSIPSFFNALKGVQKIDLSRNNLS------ 556
+N + I L +L E++L N +P+ LK +Q + L NN++
Sbjct: 226 HNQIR-MIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVND 283
Query: 557 -GQIPIFLEALSLEYLNLSFNDFEGKIPAKGIFAN 590
+ ++ ++L N F
Sbjct: 284 FCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRC 318
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 3e-21
Identities = 54/312 (17%), Positives = 102/312 (32%), Gaps = 40/312 (12%)
Query: 247 PNLKFFQIHHNFFSGSIPISLSNASKLEHIEIANNNFSGKLSVN-FGGMKNLSLLNLQFS 305
P+ + +N S L + + NN S K+ F ++ L L + +
Sbjct: 54 PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKIS-KIHEKAFSPLRKLQKLYISKN 112
Query: 306 NLGSGESDEMGFMNSLTNCSKLRVLSLGGNQFRGALPHSIANLSSQLQILILSSNQFY-G 364
+L N ++ L L + N+ R + L + + + + N
Sbjct: 113 HLVEIPP------NLPSS---LVELRIHDNRIRKVPKGVFSGLRN-MNCIEMGGNPLENS 162
Query: 365 SIPLGIGNLVDLYLLGMVENQFTGAIPKEMGKLQKLQGLDFSGNHFSGEIPS-SLGNLSS 423
G + + L L + E + T IPK++ + L L N I L S
Sbjct: 163 GFEPGAFDGLKLNYLRISEAKLT-GIPKDL--PETLNELHLDHNKIQ-AIELEDLLRYSK 218
Query: 424 LYEVFFNNNNLSGVIPFSLGNLKRLAFLEMSGNELSGTIPEDIFNISYLSNSLNLARNHL 483
LY + +N + + SL L L L + N+LS +P + ++ L + L N++
Sbjct: 219 LYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLL-QVVYLHTNNI 276
Query: 484 VGIIPPRIGNLRALRSFDVSNNDLSGEIPIELGHCSSLEEIYLAGN-LFHGSI-PSFFNA 541
+ + + I L N + + + P+ F
Sbjct: 277 TKVGVNDFCPVGFGVKR------------------AYYNGISLFNNPVPYWEVQPATFRC 318
Query: 542 LKGVQKIDLSRN 553
+ I
Sbjct: 319 VTDRLAIQFGNY 330
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 4e-19
Identities = 62/340 (18%), Positives = 113/340 (33%), Gaps = 54/340 (15%)
Query: 152 LKDLSLAKNKLTGGIPPFLGNLTSLEVLSLAGNSFGRNIPDSLGQLKQLKILAIGGNNLS 211
L+ + + L +P + +L L N D L+ L L + N +S
Sbjct: 35 LRVVQCSDLGLKA-VPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKIS 91
Query: 212 GPIPP-SIYNLSFLVVFSVSHNQIHGSLPPSLGLLLPNLKFFQIHHNFFSGSIPISLSNA 270
I + L L +S N + +PP+ L +L +IH N
Sbjct: 92 K-IHEKAFSPLRKLQKLYISKNHLV-EIPPN---LPSSLVELRIHDNRIR---------- 136
Query: 271 SKLEHIEIANNNFSGKLSVNFGGMKNLSLLNLQFSNLGSGESDEMGFMNSLTNCSKLRVL 330
++ FS G++N++ + + + L + + F KL L
Sbjct: 137 ------KVPKGVFS--------GLRNMNCIEMGGNPLENSGFEPGAFDG-----LKLNYL 177
Query: 331 SLGGNQFRGALPHSIANLSSQLQILILSSNQFYGSIPLGI-GNLVDLYLLGMVENQFTGA 389
+ + +P +L L L L N+ +I L LY LG+ NQ
Sbjct: 178 RISEAKLT-GIP---KDLPETLNELHLDHNKI-QAIELEDLLRYSKLYRLGLGHNQIRMI 232
Query: 390 IPKEMGKLQKLQGLDFSGNHFSGEIPSSLGNLSSLYEVFFNNNNLSGVIPFS------LG 443
+ L L+ L N S +P+ L +L L V+ + NN++ V
Sbjct: 233 ENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGV 291
Query: 444 NLKRLAFLEMSGNELS-GTIPEDIF-NISYLSNSLNLARN 481
+ + N + + F ++ ++
Sbjct: 292 KRAYYNGISLFNNPVPYWEVQPATFRCVTDRL-AIQFGNY 330
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 3e-25
Identities = 54/238 (22%), Positives = 86/238 (36%), Gaps = 37/238 (15%)
Query: 686 FSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKAL-KNIRHRNLV 744
S ++G GS G V G VA+K + + + E K L ++ H N++
Sbjct: 17 VVSEKILGYGSSGTVVF-QGSFQGRPVAVKRMLIDFC---DIALMEIKLLTESDDHPNVI 72
Query: 745 KVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAID 804
+ S + F I E N +L+ + E IS+
Sbjct: 73 RYYCS-----ETTDRFLYIALELC-NLNLQDLV---ESKNVSDENLKLQKEYNPISLLRQ 123
Query: 805 VASALDYLHHHCQEPILHCDLKPSNILLDNDLSGH-------------IGDFGLARFHQE 851
+AS + +LH I+H DLKP NIL+ I DFGL +
Sbjct: 124 IASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDS 180
Query: 852 VSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNG-------DVYSYGILLLEMVTAKKP 902
+S ++ GT G+ APE S D++S G + +++ K
Sbjct: 181 GQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKH 238
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 4e-25
Identities = 53/227 (23%), Positives = 89/227 (39%), Gaps = 34/227 (14%)
Query: 686 FSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC-EGASKSFMAECKALKNI-RHRNL 743
F ++G G+ G + + D VA+K I +C A + E + L+ H N+
Sbjct: 26 FCPKDVLGHGAEGTIVYRGM-FDNRDVAVKRILPECFSFADR----EVQLLRESDEHPNV 80
Query: 744 VKVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAI 803
++ + + F+ I E +L++++ +E L Q
Sbjct: 81 IRYFCT-----EKDRQFQYIAIELCA-ATLQEYVEQKD--FAHLGLEPITLLQQ------ 126
Query: 804 DVASALDYLHHHCQEPILHCDLKPSNILLDN-----DLSGHIGDFGLARFHQEVSNSTLS 858
S L +LH I+H DLKP NIL+ + I DFGL + V + S
Sbjct: 127 -TTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCK-KLAVGRHSFS 181
Query: 859 SSVGVKGTIGYTAPEY---GLGSEVSTNGDVYSYGILLLEMVTAKKP 902
GV GT G+ APE + D++S G + +++
Sbjct: 182 RRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSH 228
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 6e-25
Identities = 52/312 (16%), Positives = 100/312 (32%), Gaps = 36/312 (11%)
Query: 658 PSRLPSRPMMRKALPKMSYKSLLKATNG-FSSTHLIGVGSFGCVYKG-----ALDEDGIV 711
S P+ + LP + K+ + + HL+G G+F VY+ ++
Sbjct: 38 VSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQK 97
Query: 712 VAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKAIVYEYMPNG 771
+KV + LK +K ++ + +V E G
Sbjct: 98 FVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSA-----HLFQNGSVLVGELYSYG 152
Query: 772 SLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNIL 831
+L ++ E + IS A+ + ++ +H I+H D+KP N +
Sbjct: 153 TLLNAIN-----LYKNTPEKVMPQGLVISFAMRMLYMIEQVH---DCEIIHGDIKPDNFI 204
Query: 832 L---------DNDLSGHIG--DFGLARF-HQEVSNSTLSSSVGVKGTIGYTAPEYGLGSE 879
L ++DLS + D G + + ++ T G+ E
Sbjct: 205 LGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKC---ETSGFQCVEMLSNKP 261
Query: 880 VSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLH-NFARMALPNQVMDIVDPILR-NDE 937
+ D + + M+ G+ F R+ + + +L D
Sbjct: 262 WNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDC 321
Query: 938 EILASTDKCRRM 949
L S D R+
Sbjct: 322 HHLPSLDLLRQK 333
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 7e-25
Identities = 61/218 (27%), Positives = 98/218 (44%), Gaps = 36/218 (16%)
Query: 692 IGVGSFGCVYKGALDEDGIVVAIKVINL-QCEGASKSFMAECKALKNIRHRNLVKVITSC 750
+G G+ G V+K + G+V+A K+I+L + E + L +V
Sbjct: 41 LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVG----- 95
Query: 751 SSIDFQGNDFKA----IVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVA 806
F G + I E+M GSL++ L R E + ++I V
Sbjct: 96 ----FYGAFYSDGEISICMEHMDGGSLDQVLK---KAGRIPEQILG-------KVSIAVI 141
Query: 807 SALDYLHHHCQEPILHCDLKPSNILLDNDLSGHI--GDFGLARFHQEVSNSTLSSSVGVK 864
L YL + I+H D+KPSNIL+++ G I DFG++ ++ +S +S V
Sbjct: 142 KGLTYLREKHK--IMHRDVKPSNILVNS--RGEIKLCDFGVSG---QLIDSMANSFV--- 191
Query: 865 GTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKP 902
GT Y +PE G+ S D++S G+ L+EM + P
Sbjct: 192 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 229
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 54/223 (24%), Positives = 89/223 (39%), Gaps = 31/223 (13%)
Query: 691 LIGVGSFGCVYKGALDEDGIVVAIKVIN---LQCEGASKSFMAECKALKNIRHRNLVKVI 747
+G G FG VY ++ ++A+KV+ L+ EG E + ++RH N++++
Sbjct: 21 PLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMY 80
Query: 748 TSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVAS 807
F ++ E+ P G L K L H R E + + +A
Sbjct: 81 NY-----FHDRKRIYLMLEFAPRGELYKELQKH---GRFDEQRSATFMEE-------LAD 125
Query: 808 ALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTI 867
AL Y H ++H D+KP N+L+ I DFG + + T+ GT+
Sbjct: 126 ALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMC------GTL 176
Query: 868 GYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGD 910
Y PE G D++ G+L E + P F+
Sbjct: 177 DYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPP----FDSP 215
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-24
Identities = 54/221 (24%), Positives = 94/221 (42%), Gaps = 31/221 (14%)
Query: 686 FSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVK 745
++ IG G+ G VY G VAI+ +NLQ + + + E ++ ++ N+V
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 746 VITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDV 805
+ S + D +V EY+ GSL + + E +I ++ +
Sbjct: 82 YLDS-----YLVGDELWVVMEYLAGGSLTDVVTETCM----DEGQIA-------AVCREC 125
Query: 806 ASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKG 865
AL++LH ++H D+K NILL D S + DFG + ++ +
Sbjct: 126 LQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFC--------AQITPEQSKRS 174
Query: 866 TIGYT----APEYGLGSEVSTNGDVYSYGILLLEMVTAKKP 902
T+ T APE D++S GI+ +EM+ + P
Sbjct: 175 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 4e-24
Identities = 63/227 (27%), Positives = 97/227 (42%), Gaps = 27/227 (11%)
Query: 686 FSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINL-QCEGASKSFMAECKALKNIRHRNLV 744
+ +IG G+ V VAIK INL +C+ + + E +A+ H N+V
Sbjct: 17 YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIV 76
Query: 745 KVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAI- 803
TS F D +V + + GS+ + + E K +L +IA
Sbjct: 77 SYYTS-----FVVKDELWLVMKLLSGGSVL-----DIIKHIVAKGEHKSGVLDESTIATI 126
Query: 804 --DVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSV 861
+V L+YLH + Q +H D+K NILL D S I DFG++ F + T +
Sbjct: 127 LREVLEGLEYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVR 183
Query: 862 G-VKGTIGYTAPE-----YGLGSEVSTNGDVYSYGILLLEMVTAKKP 902
GT + APE G + D++S+GI +E+ T P
Sbjct: 184 KTFVGTPCWMAPEVMEQVRGYDFKA----DIWSFGITAIELATGAAP 226
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 5e-24
Identities = 57/225 (25%), Positives = 94/225 (41%), Gaps = 35/225 (15%)
Query: 692 IGVGSFGCVYKGALDEDGIVVAIKVINLQ--CEGASKSFMAECKALKNIRHRNLVKVITS 749
IG GS+G V+K + G +VAIK K + E + LK ++H NLV ++
Sbjct: 11 IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLL-- 68
Query: 750 CSSID-FQGNDFKAIVYEYMPNGSLEKWL--HPHAVPKRDKEIEIKLTLLQRISIAIDVA 806
+ F+ +V+EY + ++ L + VP E +K Q
Sbjct: 69 ----EVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVP----EHLVKSITWQ-------TL 112
Query: 807 SALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGT 866
A+++ H H +H D+KP NIL+ + DFG AR + V T
Sbjct: 113 QAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLT-GPSDYYDDEV---AT 165
Query: 867 IGYTAPEYGLGSEV-STNGDVYSYGILLLEMVTAKKPTDVMFEGD 910
Y +PE +G DV++ G + E+++ P ++ G
Sbjct: 166 RWYRSPELLVGDTQYGPPVDVWAIGCVFAELLS-GVP---LWPGK 206
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 5e-24
Identities = 52/227 (22%), Positives = 100/227 (44%), Gaps = 36/227 (15%)
Query: 686 FSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVK 745
+ +G G+FG VYK E G + A KVI + E + ++ E + L H +VK
Sbjct: 21 WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80
Query: 746 VITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDV 805
++ + + + I+ E+ P G+++ + + +I++ + +
Sbjct: 81 LLGA-----YYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQV---------VCRQM 126
Query: 806 ASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKG 865
AL++LH + I+H DLK N+L+ + + DFG++ + ++ +
Sbjct: 127 LEALNFLH---SKRIIHRDLKAGNVLMTLEGDIRLADFGVS--------AKNLKTLQKRD 175
Query: 866 T-IGYT----APEYGLGSEVSTNG-----DVYSYGILLLEMVTAKKP 902
+ IG T APE + + D++S GI L+EM + P
Sbjct: 176 SFIG-TPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPP 221
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 8e-24
Identities = 61/222 (27%), Positives = 94/222 (42%), Gaps = 32/222 (14%)
Query: 686 FSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINL-QCEGASKSFMAECKALKNIRHRNLV 744
F+ IG GSFG V+KG + VVAIK+I+L + E + E L +
Sbjct: 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 745 KVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAID 804
K S + + I+ EY+ GS L P E +I +I +
Sbjct: 84 KYYGS-----YLKDTKLWIIMEYLGGGSALDLLE----PGPLDETQIA-------TILRE 127
Query: 805 VASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVK 864
+ LDYLH E +H D+K +N+LL + DFG+A L+ + +
Sbjct: 128 ILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVA--------GQLTDTQIKR 176
Query: 865 GT-IG---YTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKP 902
T +G + APE S + D++S GI +E+ + P
Sbjct: 177 NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPP 218
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 8e-24
Identities = 55/221 (24%), Positives = 98/221 (44%), Gaps = 31/221 (14%)
Query: 686 FSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVK 745
S IG GS G V G VA+K+++L+ + + E +++ +H N+V+
Sbjct: 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVE 106
Query: 746 VITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDV 805
+ S + + ++ E++ G+L + R E +I ++ V
Sbjct: 107 MYKS-----YLVGEELWVLMEFLQGGALTDIVS----QVRLNEEQIA-------TVCEAV 150
Query: 806 ASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKG 865
AL YLH + ++H D+K +ILL D + DFG + +S V +
Sbjct: 151 LQALAYLH---AQGVIHRDIKSDSILLTLDGRVKLSDFGFC--------AQISKDVPKRK 199
Query: 866 TIGYT----APEYGLGSEVSTNGDVYSYGILLLEMVTAKKP 902
++ T APE S +T D++S GI+++EMV + P
Sbjct: 200 SLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPP 240
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 9e-24
Identities = 57/306 (18%), Positives = 95/306 (31%), Gaps = 20/306 (6%)
Query: 241 SLGLLLPNLKFFQIHHNFFSGSIPISLSNASKLEHIEIANNNFSGKLSVNFGGMKNLSLL 300
S P + + + + + S ++ + + +K+LSL
Sbjct: 14 SCNFSDPKPDWSSAFNCLGAADVELYGGGRSLEYLLKRVDTEADLGQFTDI--IKSLSLK 71
Query: 301 NLQFSNLGSGESDEMGFMNSLTNCSKLRVLSLGGNQFRGALPHSIANLS-SQLQILILSS 359
L G + L S L+ L+L + G P + + L IL L +
Sbjct: 72 RLTVRAARIPSRILFGALRVL-GISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRN 130
Query: 360 NQFYG--SIPLGIGNLVDLYL--LGMVENQFTGAIPKEMGKLQKLQGLDFSGNHFSGEIP 415
+ + + + L L + + +++ L LD S N GE
Sbjct: 131 VSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERG 190
Query: 416 SS----LGNLSSLYEVFFNNNN---LSGVIPFSLGNLKRLAFLEMSGNELSGTIPEDIFN 468
+L + N SGV +L L++S N L +
Sbjct: 191 LISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCD 250
Query: 469 ISYLSNSLNLARNHLVGIIPPRIGNLRALRSFDVSNNDLSGEIPIELGHCSSLEEIYLAG 528
NSLNL+ L + L L D+S N L P + + L G
Sbjct: 251 WPSQLNSLNLSFTGLKQVPKGLPAKLSVL---DLSYNRLD-RNPSPD-ELPQVGNLSLKG 305
Query: 529 NLFHGS 534
N F S
Sbjct: 306 NPFLDS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 93.4 bits (232), Expect = 1e-20
Identities = 43/244 (17%), Positives = 74/244 (30%), Gaps = 21/244 (8%)
Query: 80 LREINLSNNTIQGEIPPEFGRLF---RLEALFLSNNSLVGKIPANLS--YCSRLTVLCIE 134
L+ + + I I R+ L+ L L N + G P L L +L +
Sbjct: 70 LKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLR 129
Query: 135 YNKLQGRIP----LEFVSLSKLKDLSLAKNKLTGGIPPFLGNLTSLEVLSLAGNSFGRNI 190
R L+ LK LS+A+ + +L L L+ N
Sbjct: 130 NVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGER 189
Query: 191 -------PDSLGQLKQLKILAIGGNNLSGPIPPSIYNLSFLVVFSVSHNQIHGSLPPSLG 243
P L+ L + G SG L +SHN + +
Sbjct: 190 GLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSC 249
Query: 244 LLLPNLKFFQIHHNFFSGSIPISLSNASKLEHIEIANNNFSGKLSVNFGGMKNLSLLNLQ 303
L + +P L +KL ++++ N S + + L+L+
Sbjct: 250 DWPSQLNSLNLSFTGLK-QVPKGLP--AKLSVLDLSYNRLDRNPS--PDELPQVGNLSLK 304
Query: 304 FSNL 307
+
Sbjct: 305 GNPF 308
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 93.0 bits (231), Expect = 1e-20
Identities = 55/260 (21%), Positives = 94/260 (36%), Gaps = 20/260 (7%)
Query: 371 GNLVDLYLLGMVENQFTGAIPKEMGKLQKLQGLDFSGNHFSGEIPSS---LGNLSSLYEV 427
G YLL V+ + ++ K L+ L I + +S L E+
Sbjct: 41 GGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQEL 100
Query: 428 FFNNNNLSGVIPFSLGNL--KRLAFLEMSGNELSG--TIPEDIFNISYLS-NSLNLARNH 482
N ++G P L L L + + ++ L++A+ H
Sbjct: 101 TLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAH 160
Query: 483 LVGIIPPRIGNLRALRSFDVSNNDLSGEIPIELGHC----SSLEEIYLAGNLFH---GSI 535
+ ++ AL + D+S+N GE + C +L+ + L G
Sbjct: 161 SLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVC 220
Query: 536 PSFFNALKGVQKIDLSRNNLSGQIP--IFLEALSLEYLNLSFNDFEGKIPAKGIFANASA 593
+ A +Q +DLS N+L L LNLSF + ++P KG+ A S
Sbjct: 221 SALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVP-KGLPAKLSV 278
Query: 594 ISVVGCNRLCGGIPELQLPK 613
+ + NRL +LP+
Sbjct: 279 LD-LSYNRLDRNPSPDELPQ 297
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 91.5 bits (227), Expect = 4e-20
Identities = 58/309 (18%), Positives = 103/309 (33%), Gaps = 52/309 (16%)
Query: 73 HLGNLSFLREINLSNNTIQGEIPPEFGRLFRLEALFLSNNSLVGKIPANLSYCSRLTVLC 132
+ G S + + + + L+ L + + +I
Sbjct: 39 YGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGA---------- 88
Query: 133 IEYNKLQGRIPLEFVSLSKLKDLSLAKNKLTGGIPPFLGNLT--SLEVLSLAGNSFGRNI 190
L + +S L++L+L ++TG PP L T L +L+L S+
Sbjct: 89 -----------LRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWA-TR 136
Query: 191 PDSLGQLKQ-----LKILAIGGNNLSGPIPPSIYNLSFLVVFSVSHNQIHGSLPPSLGLL 245
L +L+Q LK+L+I + + L +S N G L
Sbjct: 137 DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALC 196
Query: 246 ---LPNLKFFQIHHNFF---SGSIPISLSNASKLEHIEIANNNFSGKLSV-NFGGMKNLS 298
P L+ + + SG + +L+ +++++N+ + L+
Sbjct: 197 PLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLN 256
Query: 299 LLNLQFSNLGSGESDEMGFMNSLTNC--SKLRVLSLGGNQFRGALPHSIANLSSQLQILI 356
LNL F+ L + +KL VL L N+ P S L + L
Sbjct: 257 SLNLSFTGL-----------KQVPKGLPAKLSVLDLSYNRLDR-NP-SPDELPQ-VGNLS 302
Query: 357 LSSNQFYGS 365
L N F S
Sbjct: 303 LKGNPFLDS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 73.0 bits (179), Expect = 6e-14
Identities = 35/169 (20%), Positives = 58/169 (34%), Gaps = 13/169 (7%)
Query: 53 HRRVTALDLMSKSLSGSLSPHLGNLSFLREINLSNNTIQGEIPPE----FGRLFRLEALF 108
+ L + + L ++LS+N GE + L+ L
Sbjct: 148 KPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLA 207
Query: 109 LSNN---SLVGKIPANLSYCSRLTVLCIEYNKLQGRIPLE-FVSLSKLKDLSLAKNKLTG 164
L N + G A + +L L + +N L+ S+L L+L+ L
Sbjct: 208 LRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQ 267
Query: 165 GIPPFLGNLTSLEVLSLAGNSFGRNIPDSLGQLKQLKILAIGGNNLSGP 213
+P L L VL L+ N P +L Q+ L++ GN
Sbjct: 268 -VPKGL--PAKLSVLDLSYNRL-DRNPSPD-ELPQVGNLSLKGNPFLDS 311
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-23
Identities = 61/225 (27%), Positives = 95/225 (42%), Gaps = 35/225 (15%)
Query: 692 IGVGSFGCVYKGALDEDGIVVAIKVINL--QCEGASKSFMAECKALKNIRHRNLVKVITS 749
+G GS+G V K + G +VAIK + K M E K LK +RH NLV ++
Sbjct: 33 VGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLL-- 90
Query: 750 CSSID-FQGNDFKAIVYEYMPNGSLEKWL--HPHAVPKRDKEIEIKLTLLQRISIAIDVA 806
+ + +V+E++ + ++ L P+ + ++ L Q I+
Sbjct: 91 ----EVCKKKKRWYLVFEFVDH-TILDDLELFPNGLD----YQVVQKYLFQIIN------ 135
Query: 807 SALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGT 866
+ + H H I+H D+KP NIL+ + DFG AR V T
Sbjct: 136 -GIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLA-APGEVYDDEV---AT 187
Query: 867 IGYTAPEYGLGSEV-STNGDVYSYGILLLEMVTAKKPTDVMFEGD 910
Y APE +G DV++ G L+ EM +P +F GD
Sbjct: 188 RWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFM-GEP---LFPGD 228
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 103 bits (257), Expect = 1e-23
Identities = 52/264 (19%), Positives = 81/264 (30%), Gaps = 43/264 (16%)
Query: 652 HKWRRGPSRLPSRPMMRKALPKMSYKSLLKATNGFSSTHLIGVG--SFGCVYKGALDEDG 709
H L + M Y+ L +IG G V G
Sbjct: 3 HHHHHHMENLYFQGMSSFLPEGGCYELL----------TVIGKGFEDLMTVNLARYKPTG 52
Query: 710 IVVAIKVINL--QCEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKAIVYEY 767
V ++ INL E K H N+V + F ++ +V +
Sbjct: 53 EYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRAT-----FIADNELWVVTSF 107
Query: 768 MPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKP 827
M GS + + H E+ I I V ALDY+HH +H +K
Sbjct: 108 MAYGSAKDLICTH-FMDGMNELAIA-------YILQGVLKALDYIHHMGY---VHRSVKA 156
Query: 828 SNILLDNDLSGHIGDFGLARF---HQEVSNSTLSSSVGVKGTIGYTAPE------YGLGS 878
S+IL+ D ++ H + + + +PE G +
Sbjct: 157 SHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDA 216
Query: 879 EVSTNGDVYSYGILLLEMVTAKKP 902
+ D+YS GI E+ P
Sbjct: 217 KS----DIYSVGITACELANGHVP 236
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 3e-23
Identities = 60/210 (28%), Positives = 89/210 (42%), Gaps = 14/210 (6%)
Query: 54 RRVTALDLMSKSLSGSLSPH-LGNLSFLREINLSNNTIQGEIPPE-FGRLFRLEALFLSN 111
+ L L S+ + L+ L + L +N + IP F L +L L+L N
Sbjct: 99 HHLEVLQLGRNSIR-QIEVGAFNGLASLNTLELFDNWLT-VIPSGAFEYLSKLRELWLRN 156
Query: 112 NSLVGKIPAN-LSYCSRLTVLCI-EYNKLQGRIPLE-FVSLSKLKDLSLAKNKLTGGIPP 168
N + IP+ + L L + E KL+ I F L LK L+L + +P
Sbjct: 157 NPIE-SIPSYAFNRVPSLMRLDLGELKKLE-YISEGAFEGLFNLKYLNLGMCNIKD-MPN 213
Query: 169 FLGNLTSLEVLSLAGNSFGRNIPDSLGQLKQLKILAIGGNNLSGPIPP-SIYNLSFLVVF 227
L LE L ++GN F P S L LK L + + +S I + L+ LV
Sbjct: 214 LT-PLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSL-IERNAFDGLASLVEL 271
Query: 228 SVSHNQIHGSLPPSLGLLLPNLKFFQIHHN 257
+++HN + SLP L L L +HHN
Sbjct: 272 NLAHNNLS-SLPHDLFTPLRYLVELHLHHN 300
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 4e-22
Identities = 63/229 (27%), Positives = 95/229 (41%), Gaps = 14/229 (6%)
Query: 80 LREINLSNNTIQGEIPPE-FGRLFRLEALFLSNNSLVGKIPAN-LSYCSRLTVLCIEYNK 137
R +NL N IQ I + F L LE L L NS+ +I + + L L + N
Sbjct: 77 TRYLNLMENNIQ-MIQADTFRHLHHLEVLQLGRNSI-RQIEVGAFNGLASLNTLELFDNW 134
Query: 138 LQGRIPLE-FVSLSKLKDLSLAKNKLTGGIPPF-LGNLTSLEVLSLAGNSFGRNIP-DSL 194
L IP F LSKL++L L N + IP + + SL L L I +
Sbjct: 135 LT-VIPSGAFEYLSKLRELWLRNNPIE-SIPSYAFNRVPSLMRLDLGELKKLEYISEGAF 192
Query: 195 GQLKQLKILAIGGNNLSGPIPPSIYNLSFLVVFSVSHNQIHGSLPPSLGLLLPNLKFFQI 254
L LK L +G N+ P++ L L +S N + P L +LK +
Sbjct: 193 EGLFNLKYLNLGMCNIKD--MPNLTPLVGLEELEMSGNHFP-EIRPGSFHGLSSLKKLWV 249
Query: 255 HHNFFSGSIPISLSNASKLEHIEIANNNFSGKLSVN-FGGMKNLSLLNL 302
++ S + + L + +A+NN S L + F ++ L L+L
Sbjct: 250 MNSQVSLIERNAFDGLASLVELNLAHNNLS-SLPHDLFTPLRYLVELHL 297
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 97.5 bits (243), Expect = 2e-21
Identities = 53/277 (19%), Positives = 103/277 (37%), Gaps = 47/277 (16%)
Query: 262 SIPISLSNASKLEHIEIANNNFSGKLSVNFGGMKNLSLLNLQFSNLGSGESDEMGFMNSL 321
+P + S ++ + NN + F + +L +L L +++ E +
Sbjct: 68 EVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEV------GAF 119
Query: 322 TNCSKLRVLSLGGNQFRGALPHSIANLSSQLQILILSSNQFYGSIPLGI----GNLVDLY 377
+ L L L N + LS L+ L L +N SIP +L+ L
Sbjct: 120 NGLASLNTLELFDNWLTVIPSGAFEYLSK-LRELWLRNNPI-ESIPSYAFNRVPSLMRLD 177
Query: 378 LLGMVENQFTGAIPKEM-GKLQKLQGLDFSGNHFSGEIPSSLGNLSSLYEVFFNNNNLSG 436
L + + I + L L+ L+ + ++P+ L L L E+ + N+
Sbjct: 178 LGEL--KKLE-YISEGAFEGLFNLKYLNLGMCNIK-DMPN-LTPLVGLEELEMSGNHFPE 232
Query: 437 VIPFSLGNLKRLAFLEMSGNELSGTIPEDIFNISYLSNSLNLARNHLVGIIPPRIGNLRA 496
+ P S L L L + +++S I + F+ L +
Sbjct: 233 IRPGSFHGLSSLKKLWVMNSQVS-LIERNAFD------------------------GLAS 267
Query: 497 LRSFDVSNNDLSGEIPIE-LGHCSSLEEIYLAGNLFH 532
L ++++N+LS +P + L E++L N ++
Sbjct: 268 LVELNLAHNNLS-SLPHDLFTPLRYLVELHLHHNPWN 303
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 92.9 bits (231), Expect = 7e-20
Identities = 53/256 (20%), Positives = 99/256 (38%), Gaps = 20/256 (7%)
Query: 349 SSQLQILILSSNQFYGSIPLGI-GNLVDLYLLGMVENQFTGAIPKEMGKLQKLQGLDFSG 407
S+Q ++ + +P GI N L L+ N L L+ L
Sbjct: 53 SNQFSKVVCTRRGL-SEVPQGIPSNTRYLNLME---NNIQMIQADTFRHLHHLEVLQLGR 108
Query: 408 NHFSGEIPSSLGNLSSLYEVFFNNNNLSGVIPFSLGNLKRLAFLEMSGNELSGTIPEDIF 467
N + L+SL + +N L+ + + L +L L + N + +IP F
Sbjct: 109 NSIRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIE-SIPSYAF 167
Query: 468 NISYLSN--SLNLARNHLVGIIPPRI-GNLRALRSFDVSNNDLSGEIPIELGHCSSLEEI 524
+ + + L+L + I L L+ ++ ++ ++P L LEE+
Sbjct: 168 --NRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMP-NLTPLVGLEEL 223
Query: 525 YLAGNLFHGSIPSF-FNALKGVQKIDLSRNNLSGQIP--IFLEALSLEYLNLSFNDFEGK 581
++GN F I F+ L ++K+ + + +S I F SL LNL+ N+
Sbjct: 224 EMSGNHFP-EIRPGSFHGLSSLKKLWVMNSQVS-LIERNAFDGLASLVELNLAHNNLS-S 280
Query: 582 IPAKGIFANASAISVV 597
+P +F + +
Sbjct: 281 LPH-DLFTPLRYLVEL 295
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 92.9 bits (231), Expect = 8e-20
Identities = 62/291 (21%), Positives = 103/291 (35%), Gaps = 48/291 (16%)
Query: 150 SKLKDLSLAKNKLT---GGIPPFLGNLTSLEVLSLAGNSFGRNIPDSLGQLKQLKILAIG 206
++ + + L+ GIP + L+L N+ D+ L L++L +G
Sbjct: 54 NQFSKVVCTRRGLSEVPQGIPS------NTRYLNLMENNIQMIQADTFRHLHHLEVLQLG 107
Query: 207 GNNLSGPIPPSI-YNLSFLVVFSVSHNQIHGSLPPSLGLLLPNLKFFQIHHNFFSGSIPI 265
N++ I L+ L + N + +P L L+ + +N SIP
Sbjct: 108 RNSIRQ-IEVGAFNGLASLNTLELFDNWLT-VIPSGAFEYLSKLRELWLRNNPIE-SIPS 164
Query: 266 -SLSNASKLEHIEIANNNFSGKLSVN-FGGMKNLSLLNLQFSNLGSGESDEMGFMNSLTN 323
+ + L +++ +S F G+ NL LNL N+ M +LT
Sbjct: 165 YAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKD--------MPNLTP 216
Query: 324 CSKLRVLSLGGNQFRGALPHSIANLSSQLQILILSSNQFYGSIPLGIGNLVDLYLLGMVE 383
L L + GN F P S LSS L+ L + ++Q I
Sbjct: 217 LVGLEELEMSGNHFPEIRPGSFHGLSS-LKKLWVMNSQV-SLIERNA------------- 261
Query: 384 NQFTGAIPKEMGKLQKLQGLDFSGNHFSGEIPSSLGNLSSLYEVFFNNNNL 434
F G L L L+ + N+ S L L E+ ++N
Sbjct: 262 --FDG--------LASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPW 302
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 87.5 bits (217), Expect = 3e-18
Identities = 58/247 (23%), Positives = 99/247 (40%), Gaps = 16/247 (6%)
Query: 237 SLPPSLGLLLPNLKFFQIHHNFFSGSIPISLSNASKLEHIEIANNNFSGKLSVN-FGGMK 295
+P + N ++ + N + + LE +++ N+ ++ V F G+
Sbjct: 68 EVPQGI---PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIR-QIEVGAFNGLA 123
Query: 296 NLSLLNLQFSNLGSGESDEMGFMNSLTNCSKLRVLSLGGNQFRGALPHSIANLSSQLQIL 355
+L+ L L + L S + SKLR L L N ++ + L L
Sbjct: 124 SLNTLELFDNWLTVIPSG------AFEYLSKLRELWLRNNPIESIPSYAFNRVP-SLMRL 176
Query: 356 ILSSNQFYGSIPLGI-GNLVDLYLLGMVENQFTGAIPKEMGKLQKLQGLDFSGNHFSGEI 414
L + I G L +L L + +P + L L+ L+ SGNHF
Sbjct: 177 DLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMP-NLTPLVGLEELEMSGNHFPEIR 234
Query: 415 PSSLGNLSSLYEVFFNNNNLSGVIPFSLGNLKRLAFLEMSGNELSGTIPEDIFNISYLSN 474
P S LSSL +++ N+ +S + + L L L ++ N LS ++P D+F
Sbjct: 235 PGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLS-SLPHDLFTPLRYLV 293
Query: 475 SLNLARN 481
L+L N
Sbjct: 294 ELHLHHN 300
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 3e-23
Identities = 46/206 (22%), Positives = 80/206 (38%), Gaps = 10/206 (4%)
Query: 57 TALDLMSKSLSGSLSPHLGNLSFLREINLSNNTIQGEIPPE-FGRLFRLEALFLSNNSLV 115
+ L +S + L + L +N + I F L LE L LS+N+ +
Sbjct: 35 QRIFLHGNRISHVPAASFRACRNLTILWLHSNVLA-RIDAAAFTGLALLEQLDLSDNAQL 93
Query: 116 GKIPAN-LSYCSRLTVLCIEYNKLQGRIPLE-FVSLSKLKDLSLAKNKLTGGIPP-FLGN 172
+ RL L ++ LQ + F L+ L+ L L N L +P +
Sbjct: 94 RSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQ-ALPDDTFRD 151
Query: 173 LTSLEVLSLAGNSFGRNIPDSLGQLKQLKILAIGGNNLSGPIPPSIY-NLSFLVVFSVSH 231
L +L L L GN + L L L + N ++ + P + +L L+ +
Sbjct: 152 LGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAH-VHPHAFRDLGRLMTLYLFA 210
Query: 232 NQIHGSLPPSLGLLLPNLKFFQIHHN 257
N + +LP L L++ +++ N
Sbjct: 211 NNLS-ALPTEALAPLRALQYLRLNDN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 4e-19
Identities = 48/210 (22%), Positives = 83/210 (39%), Gaps = 12/210 (5%)
Query: 80 LREINLSNNTIQGEIPPE-FGRLFRLEALFLSNNSLVGKIPAN-LSYCSRLTVLCIEYNK 137
+ I L N I +P F L L+L +N L +I A + + L L + N
Sbjct: 34 SQRIFLHGNRIS-HVPAASFRACRNLTILWLHSNVL-ARIDAAAFTGLALLEQLDLSDNA 91
Query: 138 LQGRIPLE-FVSLSKLKDLSLAKNKLTGGIPP-FLGNLTSLEVLSLAGNSFGRNIPD-SL 194
+ F L +L L L + L + P L +L+ L L N+ + +PD +
Sbjct: 92 QLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNAL-QALPDDTF 149
Query: 195 GQLKQLKILAIGGNNLSGPIPPSIYNLSFLVVFSVSHNQIHGSLPPSLGLLLPNLKFFQI 254
L L L + GN +S + L L + N++ + P L L +
Sbjct: 150 RDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVA-HVHPHAFRDLGRLMTLYL 208
Query: 255 HHNFFSGSIPIS-LSNASKLEHIEIANNNF 283
N S ++P L+ L+++ + +N +
Sbjct: 209 FANNLS-ALPTEALAPLRALQYLRLNDNPW 237
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 4e-19
Identities = 44/205 (21%), Positives = 83/205 (40%), Gaps = 15/205 (7%)
Query: 400 LQGLDFSGNHFSGEIPSSLGNLSSLYEVFFNNNNLSGVIPFSLGNLKRLAFLEMSGNELS 459
Q + GN S +S +L ++ ++N L+ + + L L L++S N
Sbjct: 34 SQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQL 93
Query: 460 GTIPEDIFNISYLSN--SLNLARNHLVGIIPPRI-GNLRALRSFDVSNNDLSGEIPIE-L 515
++ F L +L+L R L + P + L AL+ + +N L +P +
Sbjct: 94 RSVDPATF--HGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQ-ALPDDTF 149
Query: 516 GHCSSLEEIYLAGNLFHGSIPSF-FNALKGVQKIDLSRNNLSGQIP--IFLEALSLEYLN 572
+L ++L GN S+P F L + ++ L +N ++ + F + L L
Sbjct: 150 RDLGNLTHLFLHGNRIS-SVPERAFRGLHSLDRLLLHQNRVA-HVHPHAFRDLGRLMTLY 207
Query: 573 LSFNDFEGKIPAKGIFANASAISVV 597
L N+ +P A A+ +
Sbjct: 208 LFANNLS-ALPT-EALAPLRALQYL 230
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 1e-18
Identities = 45/231 (19%), Positives = 80/231 (34%), Gaps = 13/231 (5%)
Query: 110 SNNSLVGKIPANLSYCSRLTVLCIEYNKLQGRIPLEFVSLSKLKDLSLAKNKLTGGIPPF 169
L +P + + + + N++ F + L L L N L
Sbjct: 19 PQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAA 75
Query: 170 LGNLTSLEVLSLAGNSFGRNIP-DSLGQLKQLKILAIGGNNLSGPIPPSI-YNLSFLVVF 227
L LE L L+ N+ R++ + L +L L + L + P + L+ L
Sbjct: 76 FTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQE-LGPGLFRGLAALQYL 134
Query: 228 SVSHNQIHGSLPPSLGLLLPNLKFFQIHHNFFSGSIPISLSNASKLEHIEIANNNFSGKL 287
+ N + +LP L NL +H N S + L+ + + N +
Sbjct: 135 YLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVH 193
Query: 288 SVNFGGMKNLSLLNLQFSNLGSGESDEMGFMNSLTNCSKLRVLSLGGNQFR 338
F + L L L +NL + ++ +L L+ L L N +
Sbjct: 194 PHAFRDLGRLMTLYLFANNLSALPTE------ALAPLRALQYLRLNDNPWV 238
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 1e-17
Identities = 47/239 (19%), Positives = 86/239 (35%), Gaps = 15/239 (6%)
Query: 126 SRLTVLCIEYNKLQGRIPLEFVSLSKLKDLSLAKNKLTGGIPPFLGNLTSLEVLSLAGNS 185
++T C LQ +P+ + + + L N+++ +L +L L N
Sbjct: 12 PKVTTSC-PQQGLQ-AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNV 67
Query: 186 FGRNIPDSLGQLKQLKILAIGGNNLSGPIPPSI-YNLSFLVVFSVSHNQIHGSLPPSLGL 244
R + L L+ L + N + P+ + L L + + L P L
Sbjct: 68 LARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFR 126
Query: 245 LLPNLKFFQIHHNFFSGSIPI-SLSNASKLEHIEIANNNFSGKLSVNFGGMKNLSLLNLQ 303
L L++ + N ++P + + L H+ + N S F G+ +L L L
Sbjct: 127 GLAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLH 185
Query: 304 FSNLGSGESDEMGFMNSLTNCSKLRVLSLGGNQFRGALPHSIANLSSQLQILILSSNQF 362
+ + ++ + +L L L N ALP LQ L L+ N +
Sbjct: 186 QNRVAHVHP------HAFRDLGRLMTLYLFANNLS-ALPTEALAPLRALQYLRLNDNPW 237
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 2e-17
Identities = 49/223 (21%), Positives = 86/223 (38%), Gaps = 15/223 (6%)
Query: 262 SIPISLSNASKLEHIEIANNNFSGKLSVNFGGMKNLSLLNLQFSNLGSGESDEMGFMNSL 321
++P+ + + + I + N S + +F +NL++L L + L ++ +
Sbjct: 25 AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDA------AAF 76
Query: 322 TNCSKLRVLSLGGNQFRGALPHSI-ANLSSQLQILILSSNQFYGSIPLGI-GNLVDLYLL 379
T + L L L N ++ + L +L L L + G+ L L L
Sbjct: 77 TGLALLEQLDLSDNAQLRSVDPATFHGLG-RLHTLHLDRCGL-QELGPGLFRGLAALQYL 134
Query: 380 GMVENQFTGAIPKEM-GKLQKLQGLDFSGNHFSGEIPSSLGNLSSLYEVFFNNNNLSGVI 438
+ +N A+P + L L L GN S + L SL + + N ++ V
Sbjct: 135 YLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVH 193
Query: 439 PFSLGNLKRLAFLEMSGNELSGTIPEDIFNISYLSNSLNLARN 481
P + +L RL L + N LS +P + L L N
Sbjct: 194 PHAFRDLGRLMTLYLFANNLS-ALPTEALAPLRALQYLRLNDN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 6e-17
Identities = 42/216 (19%), Positives = 76/216 (35%), Gaps = 12/216 (5%)
Query: 346 ANLSSQLQILILSSNQFYGSIPLGI-GNLVDLYLLGMVENQFTGAIPKEMGKLQKLQGLD 404
+ + Q + L N+ +P +L +L + N L L+ LD
Sbjct: 28 VGIPAASQRIFLHGNRI-SHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLD 86
Query: 405 FSGNHFSGEIPSS-LGNLSSLYEVFFNNNNLSGVIPFSLGNLKRLAFLEMSGNELSGTIP 463
S N + + L L+ + + L + P L L +L + N L +P
Sbjct: 87 LSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQ-ALP 145
Query: 464 EDIFNISYLSN--SLNLARNHLVGIIPPRIGNLRALRSFDVSNNDLSGEIPIE-LGHCSS 520
+D F L N L L N + + L +L + N ++ +
Sbjct: 146 DDTF--RDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVA-HVHPHAFRDLGR 202
Query: 521 LEEIYLAGNLFHGSIPS-FFNALKGVQKIDLSRNNL 555
L +YL N ++P+ L+ +Q + L+ N
Sbjct: 203 LMTLYLFANNLS-ALPTEALAPLRALQYLRLNDNPW 237
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 2e-15
Identities = 45/227 (19%), Positives = 81/227 (35%), Gaps = 25/227 (11%)
Query: 214 IPPSIYNLSFLVVFSVSHNQIHGSLPPSLGLLLPNLKFFQIHHNFFSGSIPISLSNASKL 273
IP + + + N+I +P + NL +H N + + + + L
Sbjct: 30 IPAASQRIF------LHGNRIS-HVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALL 82
Query: 274 EHIEIANNNFSGKLSVN-FGGMKNLSLLNL---QFSNLGSGESDEMGFMNSLTNCSKLRV 329
E +++++N + F G+ L L+L LG G + L+
Sbjct: 83 EQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPG---------LFRGLAALQY 133
Query: 330 LSLGGNQFRGALPHSIANLSSQLQILILSSNQFYGSIPLGI-GNLVDLYLLGMVENQFTG 388
L L N + + +L L L L N+ S+P L L L + +N+
Sbjct: 134 LYLQDNALQALPDDTFRDLG-NLTHLFLHGNRI-SSVPERAFRGLHSLDRLLLHQNRVA- 190
Query: 389 AIPKEM-GKLQKLQGLDFSGNHFSGEIPSSLGNLSSLYEVFFNNNNL 434
+ L +L L N+ S +L L +L + N+N
Sbjct: 191 HVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPW 237
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 4e-12
Identities = 37/138 (26%), Positives = 57/138 (41%), Gaps = 10/138 (7%)
Query: 54 RRVTALDLMSKSLSGSLSPH-LGNLSFLREINLSNNTIQGEIPPE-FGRLFRLEALFLSN 111
R+ L L L L P L+ L+ + L +N +Q +P + F L L LFL
Sbjct: 105 GRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHG 162
Query: 112 NSLVGKIPAN-LSYCSRLTVLCIEYNKLQGRIPLE-FVSLSKLKDLSLAKNKLTGGIPP- 168
N + +P L L + N++ + F L +L L L N L+ +P
Sbjct: 163 NRIS-SVPERAFRGLHSLDRLLLHQNRVA-HVHPHAFRDLGRLMTLYLFANNLS-ALPTE 219
Query: 169 FLGNLTSLEVLSLAGNSF 186
L L +L+ L L N +
Sbjct: 220 ALAPLRALQYLRLNDNPW 237
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 5e-06
Identities = 29/141 (20%), Positives = 52/141 (36%), Gaps = 12/141 (8%)
Query: 454 SGNELSGTIPEDIFNISYLSNSLNLARNHLVGIIPPRIGNLRALRSFDVSNNDLSGEIPI 513
L +P I S + L N + + R L + +N L+ I
Sbjct: 19 PQQGLQ-AVPV---GIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLA-RIDA 73
Query: 514 E-LGHCSSLEEIYLAGNLFHGSIPS-FFNALKGVQKIDLSRNNLSGQIP--IFLEALSLE 569
+ LE++ L+ N S+ F+ L + + L R L ++ +F +L+
Sbjct: 74 AAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQ 132
Query: 570 YLNLSFNDFEGKIPAKGIFAN 590
YL L N + +P F +
Sbjct: 133 YLYLQDNALQ-ALPD-DTFRD 151
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 4e-23
Identities = 63/252 (25%), Positives = 103/252 (40%), Gaps = 33/252 (13%)
Query: 663 SRPMMRKALPKMSYKSLLKATNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCE 722
+ ++L ++ +L F L+G G++G VYKG + G + AIKV+++
Sbjct: 3 ASDSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-G 61
Query: 723 GASKSFMAECKALKNI-RHRNLVKVITSCSSIDFQGNDFKA-IVYEYMPNGSLEKWLHPH 780
+ E LK HRN+ + + G D + +V E+ GS+ +
Sbjct: 62 DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNT 121
Query: 781 AVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHI 840
KE I I ++ L +LH H ++H D+K N+LL + +
Sbjct: 122 K-GNTLKEEWIAY-------ICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKL 170
Query: 841 GDFGLARFHQEVSNSTLSSSVGVKGT-IGYT----APEYGLGSEVSTNG-----DVYSYG 890
DFG++ + L +VG + T IG T APE E D++S G
Sbjct: 171 VDFGVS--------AQLDRTVGRRNTFIG-TPYWMAPEVIACDENPDATYDFKSDLWSLG 221
Query: 891 ILLLEMVTAKKP 902
I +EM P
Sbjct: 222 ITAIEMAEGAPP 233
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 4e-23
Identities = 56/235 (23%), Positives = 93/235 (39%), Gaps = 45/235 (19%)
Query: 691 LIGVGSFGCVYKGALDEDGIVVAIKVIN----LQCEGASKSFMAECKALKNIRHRNLVK- 745
L+G GS+G V + E A+K++ + + E + L+ +RH+N+++
Sbjct: 12 LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71
Query: 746 --VITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAI 803
V+ + +V EY G E + KR + Q I
Sbjct: 72 VDVLYNEEKQKM------YMVMEYCVCGMQE--MLDSVPEKRFPVCQAHGYFCQLID--- 120
Query: 804 DVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGL-ARFHQEVSNSTLSSSVG 862
L+YLH I+H D+KP N+LL + I G+ H ++ T +S
Sbjct: 121 ----GLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQ- 172
Query: 863 VKGTIGYTAPE-------YGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGD 910
G+ + PE + G +V D++S G+ L + T P FEGD
Sbjct: 173 --GSPAFQPPEIANGLDTF-SGFKV----DIWSAGVTLYNITTGLYP----FEGD 216
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 6e-23
Identities = 59/210 (28%), Positives = 91/210 (43%), Gaps = 14/210 (6%)
Query: 54 RRVTALDLMSKSLSGSLSPH-LGNLSFLREINLSNNTIQGEIPPE-FGRLFRLEALFLSN 111
R + L L + ++ L+ L + L +N + IP F L +L+ L+L N
Sbjct: 88 RHLEILQLSRNHIR-TIEIGAFNGLANLNTLELFDNRLT-TIPNGAFVYLSKLKELWLRN 145
Query: 112 NSLVGKIPANL-SYCSRLTVLCI-EYNKLQGRIPLE-FVSLSKLKDLSLAKNKLTGGIPP 168
N + IP+ + L L + E +L I F LS L+ L+LA L IP
Sbjct: 146 NPIE-SIPSYAFNRIPSLRRLDLGELKRLS-YISEGAFEGLSNLRYLNLAMCNLRE-IPN 202
Query: 169 FLGNLTSLEVLSLAGNSFGRNIPDSLGQLKQLKILAIGGNNLSGPIPP-SIYNLSFLVVF 227
L L+ L L+GN P S L L+ L + + + I + NL LV
Sbjct: 203 LT-PLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQV-IERNAFDNLQSLVEI 260
Query: 228 SVSHNQIHGSLPPSLGLLLPNLKFFQIHHN 257
+++HN + LP L L +L+ +HHN
Sbjct: 261 NLAHNNLT-LLPHDLFTPLHHLERIHLHHN 289
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-22
Identities = 62/230 (26%), Positives = 94/230 (40%), Gaps = 14/230 (6%)
Query: 80 LREINLSNNTIQGEIPPE-FGRLFRLEALFLSNNSLVGKIPAN-LSYCSRLTVLCIEYNK 137
R +NL N IQ I F L LE L LS N + I + + L L + N+
Sbjct: 66 TRLLNLHENQIQ-IIKVNSFKHLRHLEILQLSRNHI-RTIEIGAFNGLANLNTLELFDNR 123
Query: 138 LQGRIPLE-FVSLSKLKDLSLAKNKLTGGIPPFL-GNLTSLEVLSLAGNSFGRNIP-DSL 194
L IP FV LSKLK+L L N + IP + + SL L L I +
Sbjct: 124 LT-TIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELKRLSYISEGAF 181
Query: 195 GQLKQLKILAIGGNNLSGPIPPSIYNLSFLVVFSVSHNQIHGSLPPSLGLLLPNLKFFQI 254
L L+ L + NL P++ L L +S N + ++ P L +L+ +
Sbjct: 182 EGLSNLRYLNLAMCNLRE--IPNLTPLIKLDELDLSGNHLS-AIRPGSFQGLMHLQKLWM 238
Query: 255 HHNFFSGSIPISLSNASKLEHIEIANNNFSGKLSVN-FGGMKNLSLLNLQ 303
+ + N L I +A+NN + L + F + +L ++L
Sbjct: 239 IQSQIQVIERNAFDNLQSLVEINLAHNNLT-LLPHDLFTPLHHLERIHLH 287
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 1e-20
Identities = 57/277 (20%), Positives = 109/277 (39%), Gaps = 47/277 (16%)
Query: 262 SIPISLSNASKLEHIEIANNNFSGKLSVNFGGMKNLSLLNLQFSNLGSGESDEMGFMNSL 321
+P +S + + + N +F +++L +L L +++ + E +
Sbjct: 57 EVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEI------GAF 108
Query: 322 TNCSKLRVLSLGGNQFRGALPHSIANLSSQLQILILSSNQFYGSIPLGI----GNLVDLY 377
+ L L L N+ + LS L+ L L +N SIP +L L
Sbjct: 109 NGLANLNTLELFDNRLTTIPNGAFVYLSK-LKELWLRNNPI-ESIPSYAFNRIPSLRRLD 166
Query: 378 LLGMVENQFTGAIPKEM-GKLQKLQGLDFSGNHFSGEIPSSLGNLSSLYEVFFNNNNLSG 436
L + + + I + L L+ L+ + + EIP+ L L L E+ + N+LS
Sbjct: 167 LGEL--KRLS-YISEGAFEGLSNLRYLNLAMCNLR-EIPN-LTPLIKLDELDLSGNHLSA 221
Query: 437 VIPFSLGNLKRLAFLEMSGNELSGTIPEDIFNISYLSNSLNLARNHLVGIIPPRIGNLRA 496
+ P S L L L M +++ I + F+ NL++
Sbjct: 222 IRPGSFQGLMHLQKLWMIQSQIQ-VIERNAFD------------------------NLQS 256
Query: 497 LRSFDVSNNDLSGEIPIE-LGHCSSLEEIYLAGNLFH 532
L ++++N+L+ +P + LE I+L N ++
Sbjct: 257 LVEINLAHNNLT-LLPHDLFTPLHHLERIHLHHNPWN 292
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 93.3 bits (232), Expect = 5e-20
Identities = 59/297 (19%), Positives = 100/297 (33%), Gaps = 46/297 (15%)
Query: 143 PLEFVSLSKLKDLSLAKNKLT---GGIPPFLGNLTSLEVLSLAGNSFGRNIPDSLGQLKQ 199
P ++ + + L GI + +L+L N +S L+
Sbjct: 36 PSVCSCSNQFSKVICVRKNLREVPDGIST------NTRLLNLHENQIQIIKVNSFKHLRH 89
Query: 200 LKILAIGGNNLSGPIPPSIYNLSFLVVFSVSHNQIHGSLPPSLGLLLPNLKFFQIHHNFF 259
L+IL + N++ + L+ L + N++ ++P + L LK + +N
Sbjct: 90 LEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPI 148
Query: 260 SGSIPISL-SNASKLEHIEIANNNFSGKLSVN-FGGMKNLSLLNLQFSNLGSGESDEMGF 317
SIP + L +++ +S F G+ NL LNL NL
Sbjct: 149 E-SIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLRE-------- 199
Query: 318 MNSLTNCSKLRVLSLGGNQFRGALPHSIANLSSQLQILILSSNQFYGSIPLGIGNLVDLY 377
+ +LT KL L L GN P S L LQ L + +Q I
Sbjct: 200 IPNLTPLIKLDELDLSGNHLSAIRPGSFQGLMH-LQKLWMIQSQI-QVIERNA------- 250
Query: 378 LLGMVENQFTGAIPKEMGKLQKLQGLDFSGNHFSGEIPSSLGNLSSLYEVFFNNNNL 434
F LQ L ++ + N+ + L L + ++N
Sbjct: 251 --------FDN--------LQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPW 291
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 91.0 bits (226), Expect = 2e-19
Identities = 58/255 (22%), Positives = 100/255 (39%), Gaps = 18/255 (7%)
Query: 349 SSQLQILILSSNQFYGSIPLGI-GNLVDLYLLGMVENQFTGAIPKEMGKLQKLQGLDFSG 407
S+Q +I +P GI N L L NQ L+ L+ L S
Sbjct: 42 SNQFSKVICVRKNL-REVPDGISTNTRLLNLHE---NQIQIIKVNSFKHLRHLEILQLSR 97
Query: 408 NHFSGEIPSSLGNLSSLYEVFFNNNNLSGVIPFSLGNLKRLAFLEMSGNELSGTIPEDIF 467
NH + L++L + +N L+ + + L +L L + N + +IP F
Sbjct: 98 NHIRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIE-SIPSYAF 156
Query: 468 NISYLSN--SLNLARNHLVGIIPPRI-GNLRALRSFDVSNNDLSGEIPIELGHCSSLEEI 524
+ + + L+L + I L LR +++ +L EIP L L+E+
Sbjct: 157 --NRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDEL 212
Query: 525 YLAGNLFHGSIPSFFNALKGVQKIDLSRNNLSGQIP--IFLEALSLEYLNLSFNDFEGKI 582
L+GN P F L +QK+ + ++ + I F SL +NL+ N+ +
Sbjct: 213 DLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQ-VIERNAFDNLQSLVEINLAHNNLT-LL 270
Query: 583 PAKGIFANASAISVV 597
P +F + +
Sbjct: 271 PH-DLFTPLHHLERI 284
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 4e-17
Identities = 55/236 (23%), Positives = 95/236 (40%), Gaps = 11/236 (4%)
Query: 247 PNLKFFQIHHNFFSGSIPISLSNASKLEHIEIANNNFSGKLSVNFGGMKNLSLLNLQFSN 306
N + +H N S + LE ++++ N+ F G+ NL+ L L +
Sbjct: 64 TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNR 123
Query: 307 LGSGESDEMGFMNSLTNCSKLRVLSLGGNQFRGALPHSIANLSSQLQILILSSNQFYGSI 366
L + + + SKL+ L L N ++ + S L+ L L + I
Sbjct: 124 LTTIPNG------AFVYLSKLKELWLRNNPIESIPSYAFNRIPS-LRRLDLGELKRLSYI 176
Query: 367 PLGI-GNLVDLYLLGMVENQFTGAIPKEMGKLQKLQGLDFSGNHFSGEIPSSLGNLSSLY 425
G L +L L + IP + L KL LD SGNH S P S L L
Sbjct: 177 SEGAFEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQ 234
Query: 426 EVFFNNNNLSGVIPFSLGNLKRLAFLEMSGNELSGTIPEDIFNISYLSNSLNLARN 481
+++ + + + + NL+ L + ++ N L+ +P D+F + ++L N
Sbjct: 235 KLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLT-LLPHDLFTPLHHLERIHLHHN 289
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 6e-12
Identities = 39/137 (28%), Positives = 58/137 (42%), Gaps = 9/137 (6%)
Query: 54 RRVTALDLMSKSLSGSLSPH-LGNLSFLREINLSNNTIQGEIPPEFGRLFRLEALFLSNN 112
+ LDL +S LS LR +NL+ ++ EIP L +L+ L LS N
Sbjct: 160 PSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGN 217
Query: 113 SLVGKIPAN-LSYCSRLTVLCIEYNKLQGRIPLE-FVSLSKLKDLSLAKNKLTGGIPP-F 169
L I L L + +++Q I F +L L +++LA N LT +P
Sbjct: 218 HLS-AIRPGSFQGLMHLQKLWMIQSQIQ-VIERNAFDNLQSLVEINLAHNNLTL-LPHDL 274
Query: 170 LGNLTSLEVLSLAGNSF 186
L LE + L N +
Sbjct: 275 FTPLHHLERIHLHHNPW 291
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 7e-23
Identities = 59/221 (26%), Positives = 90/221 (40%), Gaps = 31/221 (14%)
Query: 686 FSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVK 745
F +G GS+G VYK E G +VAIK + + E + + E ++ ++VK
Sbjct: 31 FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPV--ESDLQEIIKEISIMQQCDSPHVVK 88
Query: 746 VITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDV 805
S + N IV EY GS+ + + EI I
Sbjct: 89 YYGS-----YFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIAT---------ILQST 134
Query: 806 ASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKG 865
L+YLH +H D+K NILL+ + + DFG+A L+ ++ +
Sbjct: 135 LKGLEYLH---FMRKIHRDIKAGNILLNTEGHAKLADFGVA--------GQLTDTMAKRN 183
Query: 866 T-IG---YTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKP 902
T IG + APE + D++S GI +EM K P
Sbjct: 184 TVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPP 224
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 1e-22
Identities = 56/287 (19%), Positives = 100/287 (34%), Gaps = 35/287 (12%)
Query: 80 LREINLSNNTIQGEIPPE-FGRLFRLEALFLSNNSLVGKIPANL-SYCSRLTVLCIEYNK 137
++ ++LSNN I I R L+AL L++N + I + S L L + YN
Sbjct: 54 VKSLDLSNNRIT-YISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLGSLEHLDLSYNY 111
Query: 138 LQGRIPLE-FVSLSKLKDLSLAKNKLTGGIPP--FLGNLTSLEVLSLAGNSFGRNIPD-S 193
L + F LS L L+L N + +LT L++L + I
Sbjct: 112 LS-NLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQILRVGNMDTFTKIQRKD 169
Query: 194 LGQLKQLKILAIGGNNLSGPIPPSIYNLSFLVVFSVSHNQIHGSLPPSLGLLLPNLKFFQ 253
L L+ L I ++L P S+ ++ + + Q L + +++ +
Sbjct: 170 FAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI-LLLEIFVDVTSSVECLE 228
Query: 254 IHHNFFSGSIPISLSNASKLEHIEIANNNFSGKLSVNFGGMKNLSLLNLQFSNLGSGESD 313
+ + + S+L E + + + +L
Sbjct: 229 LRDT------DLDTFHFSELSTGETN----------SLIKKFTFRNVKITDESLFQVM-- 270
Query: 314 EMGFMNSLTNCSKLRVLSLGGNQFRGALPHSIANLSSQLQILILSSN 360
L S L L NQ + +P I + + LQ + L +N
Sbjct: 271 -----KLLNQISGLLELEFSRNQLKS-VPDGIFDRLTSLQKIWLHTN 311
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 2e-21
Identities = 58/280 (20%), Positives = 103/280 (36%), Gaps = 19/280 (6%)
Query: 109 LSNNSLVGKIPANLSYCSRLTVLCIEYNKLQGRIPLEFVSLSKLKDLSLAKNKLTGGIPP 168
S+ SL IP+ L+ + L + N++ + L+ L L N + I
Sbjct: 38 GSSGSL-NSIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGIN-TIEE 93
Query: 169 -FLGNLTSLEVLSLAGNSFGRNIP-DSLGQLKQLKILAIGGNNLSGPIPPSI--YNLSFL 224
+L SLE L L+ N N+ L L L + GN + + +L+ L
Sbjct: 94 DSFSSLGSLEHLDLSYNYL-SNLSSSWFKPLSSLTFLNLLGNPYKT-LGETSLFSHLTKL 151
Query: 225 VVFSVSHNQIHGSLPPSLGLLLPNLKFFQIHHNFFSGSIPISLSNASKLEHIEIANNNFS 284
+ V + + L L+ +I + P SL + + H+ +
Sbjct: 152 QILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI 211
Query: 285 GKLSVNFGGMKNLSLLNLQFSNLGSGESDEM--GFMNSLTNCSKLRVLSLGGNQFRGALP 342
L + ++ L L+ ++L + E+ G NSL R + + +
Sbjct: 212 LLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVM 270
Query: 343 HSIANLSSQLQILILSSNQFYGSIPLGI----GNLVDLYL 378
+ + S L L S NQ S+P GI +L ++L
Sbjct: 271 KLLNQI-SGLLELEFSRNQLK-SVPDGIFDRLTSLQKIWL 308
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 2e-19
Identities = 51/321 (15%), Positives = 106/321 (33%), Gaps = 21/321 (6%)
Query: 221 LSFLVVFSVSHNQIHGSLPPSLGLLLPNLKFFQIHHNFFSGSIPISLSNASKLEHIEIAN 280
V+ + S + L + + SIP L+ ++ ++++N
Sbjct: 6 WMVWVLGVIISLSKEESSNQA-SLSCDRNGICKGSSGSLN-SIPSGLT--EAVKSLDLSN 61
Query: 281 NNFSGKLSVNFGGMKNLSLLNLQFSNLGSGESDEMGFMNSLTNCSKLRVLSLGGNQFRGA 340
N + + + NL L L + + + E +S ++ L L L N
Sbjct: 62 NRITYISNSDLQRCVNLQALVLTSNGINTIEE------DSFSSLGSLEHLDLSYNYLS-N 114
Query: 341 LPHSI-ANLSSQLQILILSSNQFYGSIPLGI-GNLVDLYLLGMVENQFTGAIPKEM-GKL 397
L S LSS L L L N + + +L L +L + I ++ L
Sbjct: 115 LSSSWFKPLSS-LTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGL 173
Query: 398 QKLQGLDFSGNHFSGEIPSSLGNLSSLYEVFFNNNNLSGVIPFSLGNLKRLAFLEMSGNE 457
L+ L+ + P SL ++ ++ + + ++ + + LE+ +
Sbjct: 174 TFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTD 233
Query: 458 LSGTIPEDIFNISY--LSNSLNLARNHLVGI----IPPRIGNLRALRSFDVSNNDLSGEI 511
L ++ L + + + + L + S N L
Sbjct: 234 LDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLKSVP 293
Query: 512 PIELGHCSSLEEIYLAGNLFH 532
+SL++I+L N +
Sbjct: 294 DGIFDRLTSLQKIWLHTNPWD 314
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 82.1 bits (203), Expect = 8e-17
Identities = 53/280 (18%), Positives = 102/280 (36%), Gaps = 23/280 (8%)
Query: 324 CSKLRVLSLGGNQFRGALPHSIANLSSQLQILILSSNQFYGSIPLGI-GNLVDLYLLGMV 382
C + + ++P + L+ ++ L LS+N+ I V+L L +
Sbjct: 30 CDRNGICKGSSGSLN-SIP---SGLTEAVKSLDLSNNRI-TYISNSDLQRCVNLQALVLT 84
Query: 383 ENQFTGAIPKEM-GKLQKLQGLDFSGNHFSGEIPSSLGNLSSLYEVFFNNNNLSGVIPFS 441
N I ++ L L+ LD S N+ S S LSSL + N + S
Sbjct: 85 SNGIN-TIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETS 143
Query: 442 L-GNLKRLAFLEMSGNELSGTIPEDIFNISYLSN--SLNLARNHLVGIIPPRIGNLRALR 498
L +L +L L + + I F + L+ L + + L P + +++ +
Sbjct: 144 LFSHLTKLQILRVGNMDTFTKIQRKDF--AGLTFLEELEIDASDLQSYEPKSLKSIQNVS 201
Query: 499 SFDVSNNDLSGEIPIELGHCSSLEEIYLAGNLFHG----SIPS-FFNALKGV---QKIDL 550
+ + I + SS+E + L + + N+L + + +
Sbjct: 202 HLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKI 261
Query: 551 SRNNLSGQIPIFLEALSLEYLNLSFNDFEGKIPAKGIFAN 590
+ +L + + + L L S N + +P GIF
Sbjct: 262 TDESLFQVMKLLNQISGLLELEFSRNQLKS-VPD-GIFDR 299
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 82.1 bits (203), Expect = 9e-17
Identities = 39/244 (15%), Positives = 83/244 (34%), Gaps = 20/244 (8%)
Query: 54 RRVTALDLMSKSLSGSLSPHL-GNLSFLREINLSNNTIQGEIPPE-FGRLFRLEALFLSN 111
+ AL L S ++ ++ +L L ++LS N + + F L L L L
Sbjct: 76 VNLQALVLTSNGIN-TIEEDSFSSLGSLEHLDLSYNYLS-NLSSSWFKPLSSLTFLNLLG 133
Query: 112 NSLVGKIPANL-SYCSRLTVLCIEYNKLQGRIPLE-FVSLSKLKDLSLAKNKLTGGIPPF 169
N +L S+ ++L +L + +I + F L+ L++L + + L P
Sbjct: 134 NPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQS-YEPK 192
Query: 170 -LGNLTSLEVLSLAGNSFGRNIPDSLGQLKQLKILAIGGNNLSGPIPPSIYNLSF----- 223
L ++ ++ L L + + ++ L + +L +
Sbjct: 193 SLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIK 252
Query: 224 ---LVVFSVSHNQIHGSLPPSLGLLLPNLKFFQIHHNFFSGSIPIS-LSNASKLEHIEIA 279
++ + L + L + N S+P + L+ I +
Sbjct: 253 KFTFRNVKITDESL--FQVMKLLNQISGLLELEFSRNQLK-SVPDGIFDRLTSLQKIWLH 309
Query: 280 NNNF 283
N +
Sbjct: 310 TNPW 313
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 5e-22
Identities = 60/257 (23%), Positives = 107/257 (41%), Gaps = 30/257 (11%)
Query: 666 MMRKALPKMSYKSLLKATNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGAS 725
MM + + K + F + G G+FG V G G+ VAIK + +
Sbjct: 5 MMSLNAAAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRN 64
Query: 726 KSFMAECKALKNIRHRNLVK---VITSCSSIDFQGND-FKAIVYEYMPNGSLEKWLHPHA 781
+ + L + H N+V+ + D D + +V EY+P+ +L + +
Sbjct: 65 RELQ-IMQDLAVLHHPNIVQLQSYFYTLGERDR--RDIYLNVVMEYVPD-TLHRCCRNYY 120
Query: 782 VPKRD-KEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGH- 839
+ I IK+ L Q + ++ LH + H D+KP N+L+ N+ G
Sbjct: 121 RRQVAPPPILIKVFLFQ-------LIRSIGCLHLPSVN-VCHRDIKPHNVLV-NEADGTL 171
Query: 840 -IGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGS-EVSTNGDVYSYGILLLEMV 897
+ DFG A+ + + + + + Y APE G+ +T D++S G + EM+
Sbjct: 172 KLCDFGSAK--KLSPSEPNVAYI---CSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMM 226
Query: 898 TAKKPTDVMFEGDLNLH 914
+P +F GD +
Sbjct: 227 L-GEP---IFRGDNSAG 239
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 8e-22
Identities = 58/224 (25%), Positives = 90/224 (40%), Gaps = 38/224 (16%)
Query: 692 IGVGSFGCVYKGALDEDGIVVAIKVINL-QCEGASKSFMAECK-ALKNIRHRNLVKVITS 749
IG G++G V K G ++A+K I E K + + +++ +V+ +
Sbjct: 30 IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGA 89
Query: 750 CSSIDFQGNDFKAIVYEYMPNGSLEKWLH--PHAVPKRDKEIEIKLTLLQRISIAIDVAS 807
F+ D I E M + S +K+ + E + I +
Sbjct: 90 L----FREGDCW-ICMELM-STSFDKFYKYVYSVLDDVIPEEILG-------KITLATVK 136
Query: 808 ALDYLHHHCQEPILHCDLKPSNILLDNDLSGHI--GDFGLARFHQEVSNSTLSSSVGVKG 865
AL++L + + I+H D+KPSNILLD G+I DFG +S L S+
Sbjct: 137 ALNHLKENLK--IIHRDIKPSNILLDRS--GNIKLCDFG-------IS-GQLVDSIAKTR 184
Query: 866 TIG---YTAPE----YGLGSEVSTNGDVYSYGILLLEMVTAKKP 902
G Y APE DV+S GI L E+ T + P
Sbjct: 185 DAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFP 228
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 9e-22
Identities = 50/220 (22%), Positives = 89/220 (40%), Gaps = 31/220 (14%)
Query: 692 IGVGSFGCVYKGALDEDGIVVAIKVINLQCEGAS-KSFMAECK-ALKNIRHRNLVKVITS 749
+G G++G V K G ++A+K I K + + +++ + V +
Sbjct: 15 LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 74
Query: 750 CSSIDFQGNDFKAIVYEYMPNGSLEKWL-HPHAVPKRDKEIEIKLTLLQRISIAIDVASA 808
F+ D I E M + SL+K+ + E + IA+ + A
Sbjct: 75 L----FREGDVW-ICMELM-DTSLDKFYKQVIDKGQTIPEDILG-------KIAVSIVKA 121
Query: 809 LDYLHHHCQEPILHCDLKPSNILLDNDLSGHI--GDFGLARFHQEVSNSTLSSSVGVKGT 866
L++LH ++H D+KPSN+L++ G + DFG++ V + G
Sbjct: 122 LEHLHSKLS--VIHRDVKPSNVLINAL--GQVKMCDFGISG--YLVDDVAKDIDA---GC 172
Query: 867 IGYTAPE----YGLGSEVSTNGDVYSYGILLLEMVTAKKP 902
Y APE S D++S GI ++E+ + P
Sbjct: 173 KPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFP 212
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 2e-21
Identities = 69/231 (29%), Positives = 98/231 (42%), Gaps = 48/231 (20%)
Query: 692 IGVGSFGCVYKGALDEDGIVVAIKVIN---LQCEGASKSFMAECKALKNIRHRNLVK--- 745
IG G+F V G VAIK+I+ L K F E + +K + H N+VK
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFR-EVRIMKILNHPNIVKLFE 81
Query: 746 VITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDV 805
VI + ++ ++ EY G + +L H R KE E + Q +
Sbjct: 82 VIETEKTL--------YLIMEYASGGEVFDYLVAH---GRMKEKEARSKFRQ-------I 123
Query: 806 ASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKG 865
SA+ Y H I+H DLK N+LLD D++ I DFG + L + G
Sbjct: 124 VSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTV--GGKLDAFC---G 175
Query: 866 TIGYTAPE------YGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGD 910
Y APE Y G EV DV+S G++L +V+ P F+G
Sbjct: 176 APPYAAPELFQGKKY-DGPEV----DVWSLGVILYTLVSGSLP----FDGQ 217
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 95.6 bits (238), Expect = 3e-21
Identities = 63/258 (24%), Positives = 98/258 (37%), Gaps = 39/258 (15%)
Query: 657 GPSRLPSRPMMRKALPKMSYKSLLKATNG------FSSTHLIGVGSFGCVYKGALDEDGI 710
+ P +A + + + FS IG GSFG VY +
Sbjct: 22 FQGAMDPMPAGGRA-GSLKDPDVAELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSE 80
Query: 711 VVAIKVINLQCEGAS---KSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKAIVYEY 767
VVAIK ++ + ++ + + E + L+ +RH N ++ + +V EY
Sbjct: 81 VVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGC-----YLREHTAWLVMEY 135
Query: 768 MPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKP 827
GS L H P ++ EI + L YLH ++H D+K
Sbjct: 136 CL-GSASDLLEVHKKPLQEVEIAA---------VTHGALQGLAYLH---SHNMIHRDVKA 182
Query: 828 SNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNG--- 884
NILL +GDFG A S ++ + GT + APE L +
Sbjct: 183 GNILLSEPGLVKLGDFGSA--------SIMAPANSFVGTPYWMAPEVILAMDEGQYDGKV 234
Query: 885 DVYSYGILLLEMVTAKKP 902
DV+S GI +E+ K P
Sbjct: 235 DVWSLGITCIELAERKPP 252
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 3e-21
Identities = 61/281 (21%), Positives = 100/281 (35%), Gaps = 72/281 (25%)
Query: 686 FSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSF----------MAECKAL 735
F ++G GSF V AIK++ K E +
Sbjct: 32 FKFGKILGEGSFSTVVLARELATSREYAIKIL-------EKRHIIKENKVPYVTRERDVM 84
Query: 736 KNIRHRNLVKVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTL 795
+ H VK+ + FQ ++ Y NG L L
Sbjct: 85 SRLDHPFFVKLYFT-----FQDDEKLYFGLSYAKNGEL-------------------LKY 120
Query: 796 LQRISI---------AIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHI--GDFG 844
+++I ++ SAL+YLH I+H DLKP NILL+ D HI DFG
Sbjct: 121 IRKIGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNED--MHIQITDFG 175
Query: 845 LARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKP-- 902
A+ S ++S GT Y +PE + D+++ G ++ ++V P
Sbjct: 176 TAKVLSPESKQARANSFV--GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFR 233
Query: 903 ---TDVMFE----GDLNLHNFARMALPNQVMDIVDPILRND 936
++F+ + + + D+V+ +L D
Sbjct: 234 AGNEYLIFQKIIKLEYDFPEK----FFPKARDLVEKLLVLD 270
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 93.4 bits (233), Expect = 7e-21
Identities = 57/226 (25%), Positives = 84/226 (37%), Gaps = 63/226 (27%)
Query: 691 LIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSC 750
++G G+F V+ G + A+K I S E LK I+H N+V +
Sbjct: 16 VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDI- 74
Query: 751 SSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRI----------- 799
++ +V + + G E L RI
Sbjct: 75 ----YESTTHYYLVMQLVSGG------------------E----LFDRILERGVYTEKDA 108
Query: 800 -SIAIDVASALDYLHHHCQEPILHCDLKPSNILL---DNDLSGHIGDFGLARFHQEVSNS 855
+ V SA+ YLH + I+H DLKP N+L + + I DFGL++ N
Sbjct: 109 SLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKM---EQNG 162
Query: 856 TLSSSVGVKGTIGYTAPE----YGLGSEVSTNGDVYSYG----ILL 893
+S++ GT GY APE V D +S G ILL
Sbjct: 163 IMSTAC---GTPGYVAPEVLAQKPYSKAV----DCWSIGVITYILL 201
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 8e-21
Identities = 52/237 (21%), Positives = 100/237 (42%), Gaps = 43/237 (18%)
Query: 692 IGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIR-HRNLVK---VI 747
+G G + V++ + V +K++ + K E K L+N+R N++ ++
Sbjct: 44 LGRGKYSEVFEAINITNNEKVVVKILKPVKK---KKIKREIKILENLRGGPNIITLADIV 100
Query: 748 TSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVAS 807
S A+V+E++ N ++ + +I+ + + +
Sbjct: 101 KDPVS----RTP--ALVFEHVNNTDFKQLYQTL------TDYDIRFYMYE-------ILK 141
Query: 808 ALDYLHHHCQEPILHCDLKPSNILLDN---DLSGHIGDFGLARFHQEVSNSTLSSSVGVK 864
ALDY H I+H D+KP N+++D+ L + D+GLA F+ V V
Sbjct: 142 ALDYCHSMG---IMHRDVKPHNVMIDHEHRKLR--LIDWGLAEFYHPGQEYN----VRV- 191
Query: 865 GTIGYTAPEYGLGSEV-STNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMA 920
+ + PE + ++ + D++S G +L M+ K+P F G N R+A
Sbjct: 192 ASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP---FFHGHDNYDQLVRIA 245
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 9e-21
Identities = 55/210 (26%), Positives = 90/210 (42%), Gaps = 32/210 (15%)
Query: 692 IGVGSFGCVYKGALDEDGIVVAIKVIN-LQCEGASKSFMAECKALKNIRHRNLVKVITSC 750
+G G+FG V+ G+ IK IN + + + AE + LK++ H N++K+
Sbjct: 30 LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEV- 88
Query: 751 SSIDFQGNDFKAIVYEYMPNGSL-EKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASAL 809
F+ IV E G L E+ + A K E + + Q + +AL
Sbjct: 89 ----FEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQ-------MMNAL 137
Query: 810 DYLHHHCQEPILHCDLKPSNILLDN---DLSGHIGDFGLARFHQEVSNSTLSSSVGVKGT 866
Y H ++H DLKP NIL + I DFGLA + + +++ GT
Sbjct: 138 AYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKS--DEHSTNAA---GT 189
Query: 867 IGYTAPE---YGLGSEVSTNGDVYSYGILL 893
Y APE + + D++S G+++
Sbjct: 190 ALYMAPEVFKRDVTFKC----DIWSAGVVM 215
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 1e-20
Identities = 67/232 (28%), Positives = 107/232 (46%), Gaps = 47/232 (20%)
Query: 691 LIGVGSFGCVYKGALDEDGIVVAIKVIN---LQCEGASKSFMAECKALKNIRHRNLVK-- 745
+GVG+FG V G G VA+K++N ++ E + LK RH +++K
Sbjct: 18 TLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLY 77
Query: 746 -VITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAID 804
VI++ + +V EY+ G L ++ H R +E+E + Q +S
Sbjct: 78 QVISTPTDF--------FMVMEYVSGGELFDYICKH---GRVEEMEARRLFQQILS---- 122
Query: 805 VASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVK 864
A+DY H H ++H DLKP N+LLD ++ I DFGL+ + L +S
Sbjct: 123 ---AVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD--GEFLRTSC--- 171
Query: 865 GTIGYTAPE------YGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGD 910
G+ Y APE Y G EV D++S G++L ++ P F+ +
Sbjct: 172 GSPNYAAPEVISGRLY-AGPEV----DIWSCGVILYALLCGTLP----FDDE 214
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 1e-20
Identities = 66/286 (23%), Positives = 103/286 (36%), Gaps = 64/286 (22%)
Query: 691 LIGVGSFGCVYKGALDEDGIVVAIKVIN---LQCEGASKSFMAECKALKNIRHRNLVKVI 747
+IG G+F V + + G V A+K++N + G F E L N R + ++
Sbjct: 68 VIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLH 127
Query: 748 TSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAID--- 804
+ FQ ++ +V EY G L LTLL + I
Sbjct: 128 FA-----FQDENYLYLVMEYYVGGDL-------------------LTLLSKFGERIPAEM 163
Query: 805 -------VASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHI--GDFGLARFHQEVSNS 855
+ A+D +H +H D+KP NILLD GHI DFG + ++
Sbjct: 164 ARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRC--GHIRLADFGSCL--KLRADG 216
Query: 856 TLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVY-------SYGILLLEMVTAKKP-----T 903
T+ S V V GT Y +PE Y + G+ EM + P T
Sbjct: 217 TVRSLVAV-GTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADST 275
Query: 904 DVMFEGDLNLHNFARM-----ALPNQVMDIVDPILRNDEEILASTD 944
+ ++ + +P + D + +L E L
Sbjct: 276 AETYGKIVHYKEHLSLPLVDEGVPEEARDFIQRLLCPPETRLGRGG 321
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 1e-20
Identities = 63/237 (26%), Positives = 107/237 (45%), Gaps = 38/237 (16%)
Query: 686 FSSTHLIGVGSFGCVYKGALD-EDGIVVAIKVIN--LQCEGASKSFMAECKALKNIRHRN 742
+ + IG G+ G V A D VAIK ++ Q + +K E +K + H+N
Sbjct: 27 YQNLKPIGSGAQGIVCA-AYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 85
Query: 743 LVK---VITSCSSIDFQGNDFKAI--VYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQ 797
++ V T S++ +F+ + V E M + L + I+++L +
Sbjct: 86 IIGLLNVFTPQKSLE----EFQDVYIVMELM-----DANLC--------QVIQMELDHER 128
Query: 798 RISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTL 857
+ + + +LH I+H DLKPSNI++ +D + I DFGLAR ++ +
Sbjct: 129 MSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMM 183
Query: 858 SSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLH 914
+ V T Y APE LG N D++S G ++ EM+ V+F G ++
Sbjct: 184 TPYV---VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG----VLFPGTDHID 233
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 1e-20
Identities = 51/227 (22%), Positives = 88/227 (38%), Gaps = 57/227 (25%)
Query: 692 IGVGSFGCVYKGALDEDGIVVAIKVIN---------LQCEGASKSFMAECKALKNI-RHR 741
+G G V + A+K+I+ + + ++ + E L+ + H
Sbjct: 25 LGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHP 84
Query: 742 NLVKVITSCSSIDFQGNDFKAIVYEYMPNGSL-----EKWLHPHAVPKRDKEIEIKLTLL 796
N++++ + ++ N F +V++ M G L EK E E + +
Sbjct: 85 NIIQLKDT-----YETNTFFFLVFDLMKKGELFDYLTEK--------VTLSEKETRKIMR 131
Query: 797 QRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNST 856
+ + LH I+H DLKP NILLD+D++ + DFG +
Sbjct: 132 A-------LLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDP--GEK 179
Query: 857 LSSSVGVKGTIGYTAPE----------YGLGSEVSTNGDVYSYGILL 893
L GT Y APE G G EV D++S G+++
Sbjct: 180 LREVC---GTPSYLAPEIIECSMNDNHPGYGKEV----DMWSTGVIM 219
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 2e-20
Identities = 54/234 (23%), Positives = 88/234 (37%), Gaps = 44/234 (18%)
Query: 691 LIGVGSFGCVYKGALDEDGIVVAIKVINL-QCEGASKSFMAECKALKNIRHRNLVK---V 746
+G G++G V VA+K++++ + ++ E K + H N+VK
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 747 ITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVA 806
+ + EY G L + P E + + Q ++
Sbjct: 74 RREGNIQ--------YLFLEYCSGGELFDRIEPD---IGMPEPDAQRFFHQLMA------ 116
Query: 807 SALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGL-ARFHQEVSNSTLSSSVGVKG 865
+ YLH I H D+KP N+LLD + I DFGL F L+ G
Sbjct: 117 -GVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC---G 169
Query: 866 TIGYTAPE------YGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNL 913
T+ Y APE + V DV+S GI+L M+ + P ++ +
Sbjct: 170 TLPYVAPELLKRREF-HAEPV----DVWSCGIVLTAMLAGELP----WDQPSDS 214
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 2e-20
Identities = 61/225 (27%), Positives = 88/225 (39%), Gaps = 56/225 (24%)
Query: 692 IGVGSFGCVYKGALDEDGIVVAIKVIN--------LQCEGASKSFMAECKALKNIRHRNL 743
+G G+ G V + VAIK+I+ + + + E + LK + H +
Sbjct: 18 LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77
Query: 744 VKVITSCSSIDFQGNDFKAIVYEYMPNGSL-----EKWLHPHAVPKRDKEIEIKLTLLQR 798
+K+ F D+ IV E M G L KR KE KL Q
Sbjct: 78 IKIKNF-----FDAEDY-YIVLELMEGGELFDKVVGN--------KRLKEATCKLYFYQ- 122
Query: 799 ISIAIDVASALDYLHHHCQEPILHCDLKPSNILL---DNDLSGHIGDFGLARFHQEVSNS 855
+ A+ YLH + I+H DLKP N+LL + D I DFG ++ E S
Sbjct: 123 ------MLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE--TS 171
Query: 856 TLSSSVGVKGTIGYTAPE-------YGLGSEVSTNGDVYSYGILL 893
+ + GT Y APE G V D +S G++L
Sbjct: 172 LMRTLC---GTPTYLAPEVLVSVGTAGYNRAV----DCWSLGVIL 209
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 3e-20
Identities = 64/269 (23%), Positives = 99/269 (36%), Gaps = 56/269 (20%)
Query: 659 SRLPSRPMMRKALPKMSYKSLLKATNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVIN 718
+ + + P+ + +K IG G+FG +VA+K I
Sbjct: 4 APVTTGPLDMPIMHDSDRYDFVK---------DIGSGNFGVARLMRDKLTKELVAVKYIE 54
Query: 719 LQCEGASKSFMAECKALKNIRHRNLVK---VITSCSSIDFQGNDFKAIVYEYMPNGSLEK 775
++ E +++RH N+V+ VI + + + AI+ EY G L +
Sbjct: 55 RG-AAIDENVQREIINHRSLRHPNIVRFKEVILTPTHL--------AIIMEYASGGELYE 105
Query: 776 WLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDND 835
+ R E E + Q +S + Y H I H DLK N LLD
Sbjct: 106 RICNA---GRFSEDEARFFFQQLLS-------GVSYCHSMQ---ICHRDLKLENTLLDGS 152
Query: 836 LSGH--IGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPE------YGLGSEVSTNGDVY 887
+ I DFG ++ +S S+V GT Y APE Y G DV+
Sbjct: 153 PAPRLKICDFGYSKSSVL--HSQPKSTV---GTPAYIAPEVLLRQEYD-GKIA----DVW 202
Query: 888 SYGILLLEMVTAKKPTDVMFEGDLNLHNF 916
S G+ L M+ P FE ++
Sbjct: 203 SCGVTLYVMLVGAYP----FEDPEEPRDY 227
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 92.6 bits (230), Expect = 3e-20
Identities = 52/262 (19%), Positives = 92/262 (35%), Gaps = 59/262 (22%)
Query: 692 IGVGSFGCVYKGALDEDGIVVAIKVIN-----LQCEGASKSFMAECKALKNIRHRNLVKV 746
IG GS+G V ++ + AIK++N + E + +K + H N+ ++
Sbjct: 34 IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93
Query: 747 ITSCSSIDFQGNDFKAIVYEYMPNGSL------------------------------EKW 776
++ + +V E G L +
Sbjct: 94 YEV-----YEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEE 148
Query: 777 LHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDL 836
++ + ++ +I + SAL YLH+ I H D+KP N L +
Sbjct: 149 AINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHRDIKPENFLFSTNK 205
Query: 837 SGH--IGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPE------YGLGSEVSTNGDVYS 888
S + DFGL++ +++N GT + APE G + D +S
Sbjct: 206 SFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC----DAWS 261
Query: 889 YGILLLEMVTAKKPTDVMFEGD 910
G+LL ++ P F G
Sbjct: 262 AGVLLHLLLMGAVP----FPGV 279
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 3e-20
Identities = 64/236 (27%), Positives = 114/236 (48%), Gaps = 34/236 (14%)
Query: 686 FSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVK 745
++ T +IG GSFG VY+ L + G +VAIK + ++ E + ++ + H N+V+
Sbjct: 56 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIVR 111
Query: 746 ---VITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRD-KEIEIKLTLLQRISI 801
SS + + + +V +Y+P ++ + ++ K+ I +KL + Q
Sbjct: 112 LRYFFY--SSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQ---- 164
Query: 802 AIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGH--IGDFGLARFHQEVSNSTLSS 859
+ +L Y+H I H D+KP N+LLD D + + DFG A+ Q V S
Sbjct: 165 ---LFRSLAYIHSFG---ICHRDIKPQNLLLDPD-TAVLKLCDFGSAK--QLVRGEPNVS 215
Query: 860 SVGVKGTIGYTAPEYGLGSEV-STNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLH 914
+ + Y APE G+ +++ DV+S G +L E++ +P +F GD +
Sbjct: 216 YI---CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLL-GQP---IFPGDSGVD 264
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 3e-20
Identities = 59/222 (26%), Positives = 90/222 (40%), Gaps = 46/222 (20%)
Query: 690 HLIGVGSFGCVYKGALDEDGIVVAIKVIN--------LQCEGASKSFMAECKALKNIRHR 741
+G G+ G V + VAI++I+ + + + E + LK + H
Sbjct: 141 KTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHP 200
Query: 742 NLVKVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISI 801
++K+ + D+ IV E M G L + + KR KE KL Q
Sbjct: 201 CIIKIKNFFDAEDYY------IVLELMEGGELFDKVVGN---KRLKEATCKLYFYQ---- 247
Query: 802 AIDVASALDYLHHHCQEPILHCDLKPSNILL---DNDLSGHIGDFGLARFHQEVSNSTLS 858
+ A+ YLH + I+H DLKP N+LL + D I DFG ++ E S +
Sbjct: 248 ---MLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE--TSLMR 299
Query: 859 SSVGVKGTIGYTAPE-------YGLGSEVSTNGDVYSYGILL 893
+ GT Y APE G V D +S G++L
Sbjct: 300 TLC---GTPTYLAPEVLVSVGTAGYNRAV----DCWSLGVIL 334
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 4e-20
Identities = 52/272 (19%), Positives = 104/272 (38%), Gaps = 26/272 (9%)
Query: 321 LTNCSKLRVLSLGGNQFRGALPHSIANLSSQLQILILSSNQFYGSIPLGIGNLVDLYLLG 380
+ ++ G + + A+L + L +I G+ L +L L
Sbjct: 15 DPALANAIKIAAGKSNVTD--TVTQADLD-GITTLSAFGTGV-TTIE-GVQYLNNLIGLE 69
Query: 381 MVENQFTGAIPKEMGKLQKLQGLDFSGNHFSGEIPSSLGNLSSLYEVFFNNNNLSGVIPF 440
+ +NQ T P + L K+ L+ SGN S++ L S+ + + ++ V P
Sbjct: 70 LKDNQITDLAP--LKNLTKITELELSGNPLK--NVSAIAGLQSIKTLDLTSTQITDVTPL 125
Query: 441 SLGNLKRLAFLEMSGNELSGTIPEDIFNISYLSN--SLNLARNHLVGIIPPRIGNLRALR 498
+ L L L + N+++ +I ++ L+N L++ + + P + NL L
Sbjct: 126 A--GLSNLQVLYLDLNQIT-----NISPLAGLTNLQYLSIGNAQVSDLTP--LANLSKLT 176
Query: 499 SFDVSNNDLSGEIPIELGHCSSLEEIYLAGNLFHGSIPSFFNALKGVQKIDLSRNNLSGQ 558
+ +N +S +I L +L E++L N + N + + L+ ++ Q
Sbjct: 177 TLKADDNKIS-DIS-PLASLPNLIEVHLKNNQIS-DVSPLAN-TSNLFIVTLTNQTITNQ 232
Query: 559 IPIFLEALSLEYLNLSFNDFEGKIPAKGIFAN 590
+ +L N+ I I N
Sbjct: 233 PVFYNN--NLVVPNVVKGPSGAPIAPATISDN 262
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 4e-19
Identities = 58/254 (22%), Positives = 103/254 (40%), Gaps = 22/254 (8%)
Query: 56 VTALDLMSKSLSGSLSPHLGNLSFLREINLSNNTIQGEIPPEFGRLFRLEALFLSNNSLV 115
+ +++ +++ +L + ++ + I L L L L +N +
Sbjct: 21 AIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TIEG-VQYLNNLIGLELKDNQIT 76
Query: 116 GKIPANLSYCSRLTVLCIEYNKLQGRIPLEFVSLSKLKDLSLAKNKLTGGIPPFLGNLTS 175
+ L +++T L + N L+ + L +K L L ++T + P L L++
Sbjct: 77 -DLA-PLKNLTKITELELSGNPLKNVSAIA--GLQSIKTLDLTSTQIT-DVTP-LAGLSN 130
Query: 176 LEVLSLAGNSFGRNIPDSLGQLKQLKILAIGGNNLSGPIPPSIYNLSFLVVFSVSHNQIH 235
L+VL L N NI L L L+ L+IG +S + P + NLS L N+I
Sbjct: 131 LQVLYLDLNQI-TNIS-PLAGLTNLQYLSIGNAQVSD-LTP-LANLSKLTTLKADDNKIS 186
Query: 236 GSLPPSLGLLLPNLKFFQIHHNFFSGSIPISLSNASKLEHIEIANNNFSGKLSVNFGGMK 295
+ P LPNL + +N S P L+N S L + + N + +
Sbjct: 187 -DISPLAS--LPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTIT---NQPVFYNN 238
Query: 296 NLSLLNLQFSNLGS 309
NL + N+ G+
Sbjct: 239 NLVVPNVVKGPSGA 252
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 1e-18
Identities = 57/311 (18%), Positives = 110/311 (35%), Gaps = 43/311 (13%)
Query: 265 ISLSNASKLEHIEIANNNFSGKLSVNFGGMKNLSLLNLQFSNLGSGESDEMGFMNSLTNC 324
+ I +N + +V + ++ L+ + + + + +
Sbjct: 13 FPDPALANAIKIAAGKSNVTD--TVTQADLDGITTLSAFGTGVTT--------IEGVQYL 62
Query: 325 SKLRVLSLGGNQFRGALPHSIANLS--SQLQILILSSNQFYGSIPLGIGNLVDLYLLGMV 382
+ L L L NQ +A L +++ L LS N I L + L +
Sbjct: 63 NNLIGLELKDNQIT-----DLAPLKNLTKITELELSGNPL--KNVSAIAGLQSIKTLDLT 115
Query: 383 ENQFTGAIPKEMGKLQKLQGLDFSGNHFSGEIPSSLGNLSSLYEVFFNNNNLSGVIPFSL 442
Q T P + L LQ L N + I S L L++L + N +S + P L
Sbjct: 116 STQITDVTP--LAGLSNLQVLYLDLNQIT-NI-SPLAGLTNLQYLSIGNAQVSDLTP--L 169
Query: 443 GNLKRLAFLEMSGNELSGTIPEDIFNISYLSN--SLNLARNHLVGIIPPRIGNLRALRSF 500
NL +L L+ N++S DI ++ L N ++L N + + P + N L
Sbjct: 170 ANLSKLTTLKADDNKIS-----DISPLASLPNLIEVHLKNNQISDVSP--LANTSNLFIV 222
Query: 501 DVSNNDLSGEIPIELGHCSSLEEIY-LAGNLFHGSIPSFFNALKGVQKIDLSRNNLSGQI 559
++N ++ + + + +G + S + NL+ +
Sbjct: 223 TLTNQTITNQPVFYNNNLVVPNVVKGPSGAPIAPATISD--------NGTYASPNLTWNL 274
Query: 560 PIFLEALSLEY 570
F+ +S +
Sbjct: 275 TSFINNVSYTF 285
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 4e-18
Identities = 58/254 (22%), Positives = 104/254 (40%), Gaps = 25/254 (9%)
Query: 57 TALDLMSKSLSGSLSPHLGNLSFLREINLSNNTIQGEIPPEFGRLFRLEALFLSNNSLVG 116
L+L ++ L+P L NL+ + E+ LS N ++ + L ++ L L++ +
Sbjct: 66 IGLELKDNQIT-DLAP-LKNLTKITELELSGNPLK-NVSA-IAGLQSIKTLDLTSTQITD 121
Query: 117 KIPANLSYCSRLTVLCIEYNKLQGRIPLEFVSLSKLKDLSLAKNKLTGGIPPFLGNLTSL 176
P L+ S L VL ++ N++ PL L+ L+ LS+ +++ + P L NL+ L
Sbjct: 122 VTP--LAGLSNLQVLYLDLNQITNISPLA--GLTNLQYLSIGNAQVS-DLTP-LANLSKL 175
Query: 177 EVLSLAGNSFGRNIPD--SLGQLKQLKILAIGGNNLSGPIPPSIYNLSFLVVFSVSHNQI 234
L N I D L L L + + N +S P + N S L + ++++ I
Sbjct: 176 TTLKADDN----KISDISPLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTI 229
Query: 235 HGSLPPSLGLLLPNLKFFQIHHNFFSGSI-PISLSNASKLEHIEIANN--NFSGKLSVNF 291
+ P NL + I P ++S+ + N +F +S F
Sbjct: 230 T-NQPV---FYNNNLVVPNVVKGPSGAPIAPATISDNGTYASPNLTWNLTSFINNVSYTF 285
Query: 292 GGMKNLSLLNLQFS 305
+ FS
Sbjct: 286 NQSVTFKNTTVPFS 299
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 4e-18
Identities = 53/255 (20%), Positives = 102/255 (40%), Gaps = 19/255 (7%)
Query: 55 RVTALDLMSKSLSGSLSPHLGNLSFLREINLSNNTIQGEIPPEFGRLFRLEALFLSNNSL 114
+T L ++ ++ + L+ L + L +N I ++ P L ++ L LS N L
Sbjct: 42 GITTLSAFGTGVT-TIEG-VQYLNNLIGLELKDNQIT-DLAP-LKNLTKITELELSGNPL 97
Query: 115 VGKIPANLSYCSRLTVLCIEYNKLQGRIPLEFVSLSKLKDLSLAKNKLTGGIPPFLGNLT 174
K + ++ + L + ++ PL LS L+ L L N++T I P L LT
Sbjct: 98 --KNVSAIAGLQSIKTLDLTSTQITDVTPLA--GLSNLQVLYLDLNQIT-NISP-LAGLT 151
Query: 175 SLEVLSLAGNSFGRNIPDSLGQLKQLKILAIGGNNLSGPIPPSIYNLSFLVVFSVSHNQI 234
+L+ LS+ ++ L L +L L N +S I P + +L L+ + +NQI
Sbjct: 152 NLQYLSIGNAQV-SDL-TPLANLSKLTTLKADDNKISD-ISP-LASLPNLIEVHLKNNQI 207
Query: 235 HGSLPPSLGLLLPNLKFFQIHHNFFSGSIPISLSNASKLEHIEIANNNFSGKLSVNFGGM 294
+ P NL + + + +N ++ + +++ G
Sbjct: 208 S-DVSPLAN--TSNLFIVTLTNQTITNQPVFYNNNLVVPNVVKGPSGAPIAPATISDNG- 263
Query: 295 KNLSLLNLQFSNLGS 309
+ NL ++
Sbjct: 264 -TYASPNLTWNLTSF 277
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 5e-18
Identities = 62/323 (19%), Positives = 120/323 (37%), Gaps = 42/323 (13%)
Query: 194 LGQLKQLKILAIGGNNLSGPIPPSIYNLSFLVVFSVSHNQIHGSLPPSLGLLLPNLKFFQ 253
L +A G +N++ + +L + S + ++ L NL +
Sbjct: 15 DPALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TIEGVQYL--NNLIGLE 69
Query: 254 IHHNFFSGSIPISLSNASKLEHIEIANNNFSGKLSVNFGGMKNLSLLNLQFSNLGSGESD 313
+ N + + L N +K+ +E++ N +S G++++ L+L + +
Sbjct: 70 LKDNQIT-DLA-PLKNLTKITELELSGNPLK-NVS-AIAGLQSIKTLDLTSTQITD---- 121
Query: 314 EMGFMNSLTNCSKLRVLSLGGNQFRGALPHSIANLS--SQLQILILSSNQFYGSIPLGIG 371
+ L S L+VL L NQ +I+ L+ + LQ L + + Q + +
Sbjct: 122 ----VTPLAGLSNLQVLYLDLNQIT-----NISPLAGLTNLQYLSIGNAQVS-DLT-PLA 170
Query: 372 NLVDLYLLGMVENQFTGAIPKEMGKLQKLQGLDFSGNHFSGEIPSSLGNLSSLYEVFFNN 431
NL L L +N+ + P + L L + N S S L N S+L+ V N
Sbjct: 171 NLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDV--SPLANTSNLFIVTLTN 226
Query: 432 NNLSGVIPFSLGNLKRLAFLEMSGNELSGTIPEDIFNISYLSNSLNLARNHLVGIIPPRI 491
++ F NL N + G I + +S++ A +L + I
Sbjct: 227 QTITNQPVFYNNNLVVP-------NVVKGPSGAPI-APATISDNGTYASPNLTWNLTSFI 278
Query: 492 GNLRALRSFDVSNNDLSGEIPIE 514
N+ S+ + + +
Sbjct: 279 NNV----SYTFNQSVTFKNTTVP 297
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 6e-17
Identities = 55/257 (21%), Positives = 105/257 (40%), Gaps = 25/257 (9%)
Query: 104 LEALFLSNNSLVGKIPANLSYCSRLTVLCIEYNKLQGRIPLEFVSLSKLKDLSLAKNKLT 163
+ +++ + + +T L + ++ L+ L L L N++T
Sbjct: 21 AIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTTIEGVQ--YLNNLIGLELKDNQIT 76
Query: 164 GGIPPFLGNLTSLEVLSLAGNSFGRNIPDSLGQLKQLKILAIGGNNLSGPIPPSIYNLSF 223
+ P L NLT + L L+GN +N+ ++ L+ +K L + ++ P + LS
Sbjct: 77 D-LAP-LKNLTKITELELSGNPL-KNV-SAIAGLQSIKTLDLTSTQITDVTP--LAGLSN 130
Query: 224 LVVFSVSHNQIHGSLPPSLGLLLPNLKFFQIHHNFFSGSIPISLSNASKLEHIEIANNNF 283
L V + NQI ++ P G L NL++ I + S + L+N SKL ++ +N
Sbjct: 131 LQVLYLDLNQIT-NISPLAG--LTNLQYLSIGNAQVS-DLT-PLANLSKLTTLKADDNKI 185
Query: 284 SGKLSVNFGGMKNLSLLNLQFSNLGSGESDEMGFMNSLTNCSKLRVLSLGGNQFRGALPH 343
S +S + NL ++L+ + + ++ L N S L +++L
Sbjct: 186 S-DIS-PLASLPNLIEVHLKNNQISD--------VSPLANTSNLFIVTLTNQTITNQPVF 235
Query: 344 SIANLSSQLQILILSSN 360
NL + S
Sbjct: 236 YNNNLVVPNVVKGPSGA 252
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 4e-20
Identities = 52/231 (22%), Positives = 85/231 (36%), Gaps = 49/231 (21%)
Query: 692 IGVGSFGCVYKGALDEDGIVVAIKVIN---LQCEGASKSFMA-----ECKALKNIRHRNL 743
+G G+FG V+ E V +K I + + + E L + H N+
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 744 VK---VITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPK-RDKEIEIKLTLLQRI 799
+K + + +V E +G L+ L R E Q
Sbjct: 92 IKVLDIFENQGFF--------QLVMEKHGSG-LD--LFAFIDRHPRLDEPLASYIFRQ-- 138
Query: 800 SIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSS 859
+ SA+ YL I+H D+K NI++ D + + DFG A + + +
Sbjct: 139 -----LVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLER--GKLFYT 188
Query: 860 SVGVKGTIGYTAPE------YGLGSEVSTNGDVYSYGILLLEMVTAKKPTD 904
GTI Y APE Y G E+ +++S G+ L +V + P
Sbjct: 189 FC---GTIEYCAPEVLMGNPY-RGPEL----EMWSLGVTLYTLVFEENPFC 231
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 93.3 bits (232), Expect = 5e-20
Identities = 58/248 (23%), Positives = 90/248 (36%), Gaps = 57/248 (22%)
Query: 686 FSSTHLIGVGSFGCVYKGALDEDGIVVAIKVIN---LQCEGASKSFMAECKALKNIRHRN 742
F +IG G+FG V L V A+K++N + + F E L N +
Sbjct: 76 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKW 135
Query: 743 LVKVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIA 802
+ + + FQ ++ +V +Y G L LTLL +
Sbjct: 136 ITTLHYA-----FQDDNNLYLVMDYYVGGDL-------------------LTLLSKFEDR 171
Query: 803 ID----------VASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHI--GDFGLARFHQ 850
+ + A+D +H +H D+KP NIL+D + GHI DFG
Sbjct: 172 LPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMN--GHIRLADFGSCLKLM 226
Query: 851 EVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNG-----DVYSYGILLLEMVTAKKP--- 902
E S +V GT Y +PE E D +S G+ + EM+ + P
Sbjct: 227 EDGTVQSSVAV---GTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYA 283
Query: 903 --TDVMFE 908
+
Sbjct: 284 ESLVETYG 291
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 94.1 bits (234), Expect = 6e-20
Identities = 61/230 (26%), Positives = 96/230 (41%), Gaps = 29/230 (12%)
Query: 686 FSSTHLIGVGSFGCVYKGALDEDGIVVAIKVIN---LQCEGASKSFMAECKALKNIRHRN 742
F ++G G FG V+ + G + A K +N L+ + M E K L + R
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRF 246
Query: 743 LVKVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIA 802
+V + F+ +V M G + H + V + + + A
Sbjct: 247 IVS-LAYA----FETKTDLCLVMTIMNGGDI--RYHIYNVDEDNPGFQEPRA---IFYTA 296
Query: 803 IDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHI--GDFGLARFHQEVSNSTLSSS 860
+ S L++LH I++ DLKP N+LLD+D G++ D GLA + T
Sbjct: 297 -QIVSGLEHLHQRN---IIYRDLKPENVLLDDD--GNVRISDLGLAVELKAGQTKT-KGY 349
Query: 861 VGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGD 910
GT G+ APE LG E + D ++ G+ L EM+ A+ P F
Sbjct: 350 A---GTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGP----FRAR 392
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 6e-20
Identities = 54/223 (24%), Positives = 86/223 (38%), Gaps = 39/223 (17%)
Query: 692 IGVGSFGCVYKGALDEDGIVVAIKVINL-QCEGASKSFMAECKAL-KNIRHRNLVKVITS 749
+G G+ G V+K + G V+A+K + + +K + + + K+ +V+ +
Sbjct: 33 MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGT 92
Query: 750 CSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASAL 809
D I E M EK + E + + + + AL
Sbjct: 93 F----ITNTDVF-IAMELM-GTCAEKLK--KRMQGPIPERILG-------KMTVAIVKAL 137
Query: 810 DYLHHHCQEPILHCDLKPSNILLDNDLSGHI--GDFGLARFHQEVSNSTLSSSVGVKGTI 867
YL + ++H D+KPSNILLD G I DFG +S L +
Sbjct: 138 YYLKE--KHGVIHRDVKPSNILLDER--GQIKLCDFG-------IS-GRLVDDKAKDRSA 185
Query: 868 G---YTAPE-----YGLGSEVSTNGDVYSYGILLLEMVTAKKP 902
G Y APE + DV+S GI L+E+ T + P
Sbjct: 186 GCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFP 228
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 9e-20
Identities = 67/267 (25%), Positives = 122/267 (45%), Gaps = 38/267 (14%)
Query: 655 RRGPSRLPSRPMMRKALPKMSYKSLLKATNGFSSTHLIGVGSFGCVYKGALDEDGIVVAI 714
+ P P++ + A K+ + +++ +IG GSFG V++ L E V AI
Sbjct: 14 KLNPLDDPNKVIKVLASD---GKTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDEV-AI 69
Query: 715 KVINLQCEGASKSFMAECKALKNIRHRNLVK---VITSCSSIDFQGNDFKAIVYEYMPNG 771
K + ++ E + ++ ++H N+V S + D + F +V EY+P
Sbjct: 70 KKVLQDKRFKNR----ELQIMRIVKHPNVVDLKAFFYS--NGDKKDEVFLNLVLEYVPE- 122
Query: 772 SLEKWLHPHAVPKRD-KEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNI 830
++ + +A K+ + IKL + Q + +L Y+H I H D+KP N+
Sbjct: 123 TVYRASRHYAKLKQTMPMLLIKLYMYQ-------LLRSLAYIHSIG---ICHRDIKPQNL 172
Query: 831 LLDNDLSGH--IGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEV-STNGDVY 887
LLD SG + DFG A+ ++ S + + Y APE G+ +TN D++
Sbjct: 173 LLDPP-SGVLKLIDFGSAK--ILIAGEPNVSYI---CSRYYRAPELIFGATNYTTNIDIW 226
Query: 888 SYGILLLEMVTAKKPTDVMFEGDLNLH 914
S G ++ E++ +P +F G+ +
Sbjct: 227 STGCVMAELMQ-GQP---LFPGESGID 249
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 1e-19
Identities = 54/234 (23%), Positives = 88/234 (37%), Gaps = 44/234 (18%)
Query: 691 LIGVGSFGCVYKGALDEDGIVVAIKVINL-QCEGASKSFMAECKALKNIRHRNLVK---V 746
+G G++G V VA+K++++ + ++ E K + H N+VK
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 747 ITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVA 806
+ + EY G L + P E + + Q ++
Sbjct: 74 RREGNIQ--------YLFLEYCSGGELFDRIEPD---IGMPEPDAQRFFHQLMA------ 116
Query: 807 SALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGL-ARFHQEVSNSTLSSSVGVKG 865
+ YLH I H D+KP N+LLD + I DFGL F L+ G
Sbjct: 117 -GVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC---G 169
Query: 866 TIGYTAPE------YGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNL 913
T+ Y APE + V DV+S GI+L M+ + P ++ +
Sbjct: 170 TLPYVAPELLKRREF-HAEPV----DVWSCGIVLTAMLAGELP----WDQPSDS 214
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 1e-19
Identities = 54/211 (25%), Positives = 85/211 (40%), Gaps = 17/211 (8%)
Query: 57 TALDLMSKSLSGSLSPH-LGNLSFLREINLSNNTIQGEIPPE-FGRLFRLEALFLSNNSL 114
LDL L L + + L+ ++LS IQ I + L L L L+ N +
Sbjct: 31 KNLDLSFNPLR-HLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPI 88
Query: 115 VGKIPANL-SYCSRLTVLCIEYNKLQGRIPLEFVSLSKLKDLSLAKNKLTGGIPP--FLG 171
+ S S L L L L LK+L++A N + P F
Sbjct: 89 -QSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFS- 146
Query: 172 NLTSLEVLSLAGNSFGRNIP----DSLGQLKQLKI-LAIGGNNLSGPIPPSIYNLSFLVV 226
NLT+LE L L+ N ++I L Q+ L + L + N ++ I P + L
Sbjct: 147 NLTNLEHLDLSSNKI-QSIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAFKEIRLKE 204
Query: 227 FSVSHNQIHGSLPPSLGLLLPNLKFFQIHHN 257
++ NQ+ S+P + L +L+ +H N
Sbjct: 205 LALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 5e-15
Identities = 46/213 (21%), Positives = 85/213 (39%), Gaps = 19/213 (8%)
Query: 80 LREINLSNNTIQGEIPPE-FGRLFRLEALFLSNNSLVGKIPANL-SYCSRLTVLCIEYNK 137
+ ++LS N ++ + F L+ L LS + I S L+ L + N
Sbjct: 30 TKNLDLSFNPLR-HLGSYSFFSFPELQVLDLSRCEI-QTIEDGAYQSLSHLSTLILTGNP 87
Query: 138 LQGRIPLE-FVSLSKLKDLSLAKNKLTGGIPPFL-GNLTSLEVLSLAGNSFGR-NIPDSL 194
+Q + L F LS L+ L + L + F G+L +L+ L++A N +P+
Sbjct: 88 IQ-SLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQSFKLPEYF 145
Query: 195 GQLKQLKILAIGGNNLSGPIPPSIY-NLSFLVVFSV----SHNQIHGSLPPSLGLLLPNL 249
L L+ L + N + I + L + + ++ S N ++ + P + L
Sbjct: 146 SNLTNLEHLDLSSNKIQS-IYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEI-RL 202
Query: 250 KFFQIHHNFFSGSIPI-SLSNASKLEHIEIANN 281
K + N S+P + L+ I + N
Sbjct: 203 KELALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 2e-12
Identities = 51/250 (20%), Positives = 85/250 (34%), Gaps = 46/250 (18%)
Query: 165 GIPPFLGNLTSLEVLSLAGNSFGRNIPDSLGQLKQLKILAIGGNNLSGPIPPSIY-NLSF 223
+P S + L L+ N S +L++L + + I Y +LS
Sbjct: 25 NLP------FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQT-IEDGAYQSLSH 77
Query: 224 LVVFSVSHNQIHGSLPPSLGLLLPNLKFFQIHHNFFSGSIPISLSNASKLEHIEIANNNF 283
L ++ N I SL L +L+ L +E
Sbjct: 78 LSTLILTGNPIQ-SLALGAFSGLSSLQKLVAVET--------------NLASLE------ 116
Query: 284 SGKLSVNFGGMKNLSLLNLQFSNLGSGESDEMGFMNSLTNCSKLRVLSLGGNQFRGALPH 343
+ G +K L LN+ + + S + E F ++LTN L L L N+ + ++
Sbjct: 117 ----NFPIGHLKTLKELNVAHNLIQSFKLPEY-F-SNLTN---LEHLDLSSNKIQ-SIYC 166
Query: 344 SI----ANLSSQLQILILSSNQFYGSIPLGIGNLVDLYLLGMVENQFTGAIPKE-MGKLQ 398
+ + L LS N I G + L L + NQ ++P +L
Sbjct: 167 TDLRVLHQMPLLNLSLDLSLNPM-NFIQPGAFKEIRLKELALDTNQLK-SVPDGIFDRLT 224
Query: 399 KLQGLDFSGN 408
LQ + N
Sbjct: 225 SLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 3e-12
Identities = 53/219 (24%), Positives = 85/219 (38%), Gaps = 19/219 (8%)
Query: 346 ANLSSQLQILILSSNQFYGSIPLGI-GNLVDLYLLGMVENQFTGAIPKEM-GKLQKLQGL 403
NL + L LS N + + +L +L + + I L L L
Sbjct: 24 DNLPFSTKNLDLSFNPL-RHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTL 81
Query: 404 DFSGNHFSGEIPSSL-GNLSSLYEVFFNNNNLSGVIPFSLGNLKRLAFLEMSGNELSGTI 462
+GN + LSSL ++ NL+ + F +G+LK L L ++ N +
Sbjct: 82 ILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFK 140
Query: 463 PEDIFNISYLSN--SLNLARNHLVGIIPPRI-GNLRALRSF----DVSNNDLSGEIPIEL 515
+ F S L+N L+L+ N + I L + D+S N ++ I
Sbjct: 141 LPEYF--SNLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGA 196
Query: 516 GHCSSLEEIYLAGNLFHGSIPS-FFNALKGVQKIDLSRN 553
L+E+ L N S+P F+ L +QKI L N
Sbjct: 197 FKEIRLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 3e-11
Identities = 57/281 (20%), Positives = 92/281 (32%), Gaps = 76/281 (27%)
Query: 110 SNNSLVGKIPANLSYCSRLTVLCIEYNKLQGRIPLEFVSLSKLKDLSLAKNKLTGGIPP- 168
+ KIP NL L + +N L+ F S +L+ L L++ ++ I
Sbjct: 15 MELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDG 70
Query: 169 -FLGNLTSLEVLSLAGN---SFGRNIPDSLGQLKQLKILAIGGNNLSGPIPPSIYNLSFL 224
+ L+ L L L GN S L L++L
Sbjct: 71 AYQS-LSHLSTLILTGNPIQSLALGAFSGLSSLQKL------------------------ 105
Query: 225 VVFSVSHNQIHGSLPPSLGLLLPNLKFFQIHHNFFSGSIPIS--LSNASKLEHIEIANNN 282
+ SL L LK + HN S + SN + LEH+++++N
Sbjct: 106 ---VAVETNLA-SLENFPIGHLKTLKELNVAHNLIQ-SFKLPEYFSNLTNLEHLDLSSNK 160
Query: 283 FSGKLSVN-FGGMKNLSLLNLQFSNLGSGESDEMGFMNSLTNCSKLRVLSLGGNQFRGAL 341
+ + + LLNL L L N
Sbjct: 161 IQ-SIYCTDLRVLHQMPLLNLS--------------------------LDLSLNPMNFIQ 193
Query: 342 PHSIANLSSQLQILILSSNQFYGSIPLGI----GNLVDLYL 378
P + + +L+ L L +NQ S+P GI +L ++L
Sbjct: 194 PGAFKEI--RLKELALDTNQL-KSVPDGIFDRLTSLQKIWL 231
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 1e-08
Identities = 45/190 (23%), Positives = 77/190 (40%), Gaps = 29/190 (15%)
Query: 414 IPSSLGNLSSLYEVFFNNNNLSGVIPFSLGNLKRLAFLEMSGNELSGTIPEDIFNISYLS 473
+P S NL + N L + +S + L L++S E+ TI + + LS
Sbjct: 26 LPFSTKNL------DLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAY--QSLS 76
Query: 474 N--SLNLARNHLVGIIPPRI-GNLRALRSFDVSNNDLSGEIPIEL-GHCSSLEEIYLAGN 529
+ +L L N + + L +L+ +L+ + GH +L+E+ +A N
Sbjct: 77 HLSTLILTGNPIQSL-ALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHN 134
Query: 530 LFHGSIPS--FFNALKGVQKIDLSRNNLSGQIP--IF-----LEALSLEYLNLSFNDFEG 580
L S +F+ L ++ +DLS N + I + L+L L+LS N
Sbjct: 135 LIQ-SFKLPEYFSNLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLS-LDLSLNPMN- 190
Query: 581 KIPAKGIFAN 590
I G F
Sbjct: 191 FIQP-GAFKE 199
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 92.2 bits (229), Expect = 1e-19
Identities = 68/232 (29%), Positives = 106/232 (45%), Gaps = 47/232 (20%)
Query: 691 LIGVGSFGCVYKGALDEDGIVVAIKVIN---LQCEGASKSFMAECKALKNIRHRNLVK-- 745
+GVG+FG V G + G VA+K++N ++ E + LK RH +++K
Sbjct: 23 TLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLY 82
Query: 746 -VITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAID 804
VI++ S I +V EY+ G L ++ + R E E + Q +S
Sbjct: 83 QVISTPSDI--------FMVMEYVSGGELFDYICKN---GRLDEKESRRLFQQILS---- 127
Query: 805 VASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVK 864
+DY H H ++H DLKP N+LLD ++ I DFGL+ + L +S
Sbjct: 128 ---GVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD--GEFLRTSC--- 176
Query: 865 GTIGYTAPE------YGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGD 910
G+ Y APE Y G EV D++S G++L ++ P F+ D
Sbjct: 177 GSPNYAAPEVISGRLY-AGPEV----DIWSSGVILYALLCGTLP----FDDD 219
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 92.5 bits (229), Expect = 2e-19
Identities = 60/270 (22%), Positives = 101/270 (37%), Gaps = 21/270 (7%)
Query: 56 VTALDLMSKSLSGSLSPHLGNLSFLREINLSNNTIQGEIPPEFGRLFRLEALFLSNNSLV 115
+L KS++ L+ + +I +N+ I+ + L + LFL+ N L
Sbjct: 23 TIKDNLKKKSVT-DAVT-QNELNSIDQIIANNSDIK-SVQG-IQYLPNVTKLFLNGNKLT 78
Query: 116 GKIPANLSYCSRLTVLCIEYNKLQGRIPLEFVSLSKLKDLSLAKNKLTGGIPPFLGNLTS 175
I L+ L L ++ NK++ L+ L KLK LSL N ++ I L +L
Sbjct: 79 -DIK-PLTNLKNLGWLFLDENKIKDLSSLK--DLKKLKSLSLEHNGIS-DING-LVHLPQ 132
Query: 176 LEVLSLAGNSFGRNIPD--SLGQLKQLKILAIGGNNLSGPIPPSIYNLSFLVVFSVSHNQ 233
LE L L N I D L +L +L L++ N +S I P + L+ L +S N
Sbjct: 133 LESLYLGNN----KITDITVLSRLTKLDTLSLEDNQISD-IVP-LAGLTKLQNLYLSKNH 186
Query: 234 IHGSLPPSLGLLLPNLKFFQIHHNFFSGSIPISLSNASKLEHIEIANNNFSGKLSVNFGG 293
I L G L NL ++ SN ++ + + ++ G
Sbjct: 187 IS-DLRALAG--LKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEIISDDG 243
Query: 294 MKNLSLLNLQFSNLGSGESDEMGFMNSLTN 323
+ + S ++
Sbjct: 244 DYEKPNVKWHLPEFTNEVSFIFYQPVTIGK 273
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 87.9 bits (217), Expect = 5e-18
Identities = 44/238 (18%), Positives = 85/238 (35%), Gaps = 24/238 (10%)
Query: 344 SIANLSS--QLQILILSSNQFYGSIPLGIGNLVDLYLLGMVENQFTGAIPKEMGKLQKLQ 401
I + + L ++ L + + + + + L +
Sbjct: 13 QIFPDDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSV--QGIQYLPNVT 68
Query: 402 GLDFSGNHFSGEIPSSLGNLSSLYEVFFNNNNLSGVIPFSLGNLKRLAFLEMSGNELSGT 461
L +GN + +I L NL +L +F + N + + L +LK+L L + N +S
Sbjct: 69 KLFLNGNKLT-DI-KPLTNLKNLGWLFLDENKIKDLSS--LKDLKKLKSLSLEHNGIS-- 122
Query: 462 IPEDIFNISYLSN--SLNLARNHLVGIIPPRIGNLRALRSFDVSNNDLSGEIPIELGHCS 519
DI + +L SL L N + I + L L + + +N +S +I L +
Sbjct: 123 ---DINGLVHLPQLESLYLGNNKITDITV--LSRLTKLDTLSLEDNQIS-DIV-PLAGLT 175
Query: 520 SLEEIYLAGNLFHGSIPSFFNALKGVQKIDLSRNNLSGQIPIFLEALS-LEYLNLSFN 576
L+ +YL+ N S LK + ++L + L + +
Sbjct: 176 KLQNLYLSKNHI--SDLRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDG 231
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 85.9 bits (212), Expect = 2e-17
Identities = 49/255 (19%), Positives = 91/255 (35%), Gaps = 34/255 (13%)
Query: 136 NKLQGRIPLEFVSLSKLKDLSLAKNKLTGGIPPFLGNLTSLEVLSLAGNSFGRNIPD--S 193
++ P + + ++ +L K +T L S++ + + +I
Sbjct: 9 TPIKQIFPDD--AFAETIKDNLKKKSVTD--AVTQNELNSIDQIIANNS----DIKSVQG 60
Query: 194 LGQLKQLKILAIGGNNLSGPIPPSIYNLSFLVVFSVSHNQIHGSLPPSLGLLLPNLKFFQ 253
+ L + L + GN L+ I P + NL L + N+I L L LK
Sbjct: 61 IQYLPNVTKLFLNGNKLTD-IKP-LTNLKNLGWLFLDENKIK-DLSSLKD--LKKLKSLS 115
Query: 254 IHHNFFSGSIPISLSNASKLEHIEIANNNFSGKLSVNFGGMKNLSLLNLQFSNLGSGESD 313
+ HN S I L + +LE + + NN + ++ + L L+L+ + +
Sbjct: 116 LEHNGIS-DIN-GLVHLPQLESLYLGNNKIT-DIT-VLSRLTKLDTLSLEDNQISD---- 167
Query: 314 EMGFMNSLTNCSKLRVLSLGGNQFRGALPHSIANLS--SQLQILILSSNQFYGSIPLGIG 371
+ L +KL+ L L N + L+ L +L L S +
Sbjct: 168 ----IVPLAGLTKLQNLYLSKNHIS-----DLRALAGLKNLDVLELFSQECLNKPINHQS 218
Query: 372 NLVDLYLLGMVENQF 386
NLV + +
Sbjct: 219 NLVVPNTVKNTDGSL 233
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 84.8 bits (209), Expect = 5e-17
Identities = 56/244 (22%), Positives = 93/244 (38%), Gaps = 20/244 (8%)
Query: 57 TALDLMSKSLSGSLSPHLGNLSFLREINLSNNTIQGEIPPEFGRLFRLEALFLSNNSLVG 116
T L L L+ + P L NL L + L N I+ ++ L +L++L L +N +
Sbjct: 68 TKLFLNGNKLT-DIKP-LTNLKNLGWLFLDENKIK-DLSS-LKDLKKLKSLSLEHNGIS- 122
Query: 117 KIPANLSYCSRLTVLCIEYNKLQGRIPLEFVSLSKLKDLSLAKNKLTGGIPPFLGNLTSL 176
I L + +L L + NK+ L L+KL LSL N+++ I P L LT L
Sbjct: 123 DIN-GLVHLPQLESLYLGNNKITDITVLS--RLTKLDTLSLEDNQIS-DIVP-LAGLTKL 177
Query: 177 EVLSLAGNSFGRNIPD--SLGQLKQLKILAIGGNNLSGPIPPSIYNLSFLVVFSVSHNQI 234
+ L L+ N +I D +L LK L +L + NL + +
Sbjct: 178 QNLYLSKN----HISDLRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSL 233
Query: 235 HGSLPPSLGLLLPNLKFFQIHHNFFSGSIPISLSNASKLEHIEIANNNFSGKLSVNFGGM 294
S + + + +S + I A F G+++ +
Sbjct: 234 VTPEIISDDGDYEKPN---VKWHLPEFTNEVSFIFYQPV-TIGKAKARFHGRVTQPLKEV 289
Query: 295 KNLS 298
+S
Sbjct: 290 YTVS 293
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 84.4 bits (208), Expect = 6e-17
Identities = 51/321 (15%), Positives = 99/321 (30%), Gaps = 58/321 (18%)
Query: 152 LKDLSLAKNKLTGGIPPFLGNLTSLEVLSLAGNSFGRNIPDSLGQLKQLKILAIGGNNLS 211
+ + + I P +L S + +L + + +++
Sbjct: 1 MGETITVSTPIKQ-IFP-DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK 56
Query: 212 GPIPPSIYNLSFLVVFSVSHNQIHGSLPPSLGLLLPNLKFFQIHHNFFSGSIPISLSNAS 271
+ I L + ++ N++ + P L+N
Sbjct: 57 S-VQG-IQYLPNVTKLFLNGNKLT-DIKP--------------------------LTNLK 87
Query: 272 KLEHIEIANNNFSGKLSVNFGGMKNLSLLNLQFSNLGSGESDEMGFMNSLTNCSKLRVLS 331
L + + N LS + +K L L+L+ + + +N L + +L L
Sbjct: 88 NLGWLFLDENKIK-DLS-SLKDLKKLKSLSLEHNGISD--------INGLVHLPQLESLY 137
Query: 332 LGGNQFRGALPHSIANLS--SQLQILILSSNQFYGSIPLGIGNLVDLYLLGMVENQFTGA 389
LG N+ I LS ++L L L NQ I + L L L + +N +
Sbjct: 138 LGNNKI-----TDITVLSRLTKLDTLSLEDNQIS-DIV-PLAGLTKLQNLYLSKNHIS-- 188
Query: 390 IPKEMGKLQKLQGLDFSGNHFSGEIPSSLGNLSSLYEVFFNNNNLSGVIPFS----LGNL 445
+ + L+ L L+ + + NL V + +L S
Sbjct: 189 DLRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEIISDDGDYEKP 248
Query: 446 KRLAFLEMSGNELSGTIPEDI 466
L NE+S + +
Sbjct: 249 NVKWHLPEFTNEVSFIFYQPV 269
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 83.6 bits (206), Expect = 1e-16
Identities = 46/235 (19%), Positives = 86/235 (36%), Gaps = 27/235 (11%)
Query: 246 LPNLKFFQIHHNFFSGSIPISLSNASKLEHIEIANNNFSGKLSVNFGGMKNLSLLNLQFS 305
+ + ++ + + ++ I N++ + + N++ L L +
Sbjct: 20 FAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQ-GIQYLPNVTKLFLNGN 75
Query: 306 NLGSGESDEMGFMNSLTNCSKLRVLSLGGNQFRGALPHSIANLSS--QLQILILSSNQFY 363
L + LTN L L L N+ + +++L +L+ L L N
Sbjct: 76 KLTD--------IKPLTNLKNLGWLFLDENKIK-----DLSSLKDLKKLKSLSLEHNGI- 121
Query: 364 GSIPLGIGNLVDLYLLGMVENQFTGAIPKEMGKLQKLQGLDFSGNHFSGEIPSSLGNLSS 423
I G+ +L L L + N+ T + +L KL L N S +I L L+
Sbjct: 122 SDIN-GLVHLPQLESLYLGNNKITDITV--LSRLTKLDTLSLEDNQIS-DI-VPLAGLTK 176
Query: 424 LYEVFFNNNNLSGVIPFSLGNLKRLAFLEMSGNELSGTIPEDIFNISYLSNSLNL 478
L ++ + N++S + L LK L LE+ E N+ + N
Sbjct: 177 LQNLYLSKNHISDLRA--LAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNT 229
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 2e-19
Identities = 54/219 (24%), Positives = 80/219 (36%), Gaps = 51/219 (23%)
Query: 692 IGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSCS 751
IG GS+G V I A K I F E + +K++ H N++++ +
Sbjct: 17 IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYET-- 74
Query: 752 SIDFQGNDFKAIVYEYMPNGSL-----EKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVA 806
F+ N +V E G L K + +E + + V
Sbjct: 75 ---FEDNTDIYLVMELCTGGELFERVVHK--------RVFRESDAARIMKD-------VL 116
Query: 807 SALDYLHHHCQEPILHCDLKPSNILLDN---DLSGHIGDFGLARFHQEVSNSTLSSSVGV 863
SA+ Y H + H DLKP N L D + DFGLA + + + V
Sbjct: 117 SAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP--GKMMRTKV-- 169
Query: 864 KGTIGYTAPE-----YGLGSEVSTNGDVYSYG----ILL 893
GT Y +P+ YG E D +S G +LL
Sbjct: 170 -GTPYYVSPQVLEGLYGP--EC----DEWSAGVMMYVLL 201
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 90.2 bits (224), Expect = 2e-19
Identities = 50/261 (19%), Positives = 106/261 (40%), Gaps = 45/261 (17%)
Query: 691 LIGVGSFGCVYKGALD-EDGIVVAIKVINLQCEGASKSFMAECKALKNIR--------HR 741
+G G F V+ A D + VA+K++ +++ E K L+ +
Sbjct: 26 KLGWGHFSTVWL-AKDMVNNTHVAMKIVRGDKVY-TEAAEDEIKLLQRVNDADNTKEDSM 83
Query: 742 NLVKVITSCSSIDFQGNDFK--AIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRI 799
++ + +G + +V+E + +L + K+ + I L +++I
Sbjct: 84 GANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALI------KKYEHRGIPLIYVKQI 136
Query: 800 SIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGH------IGDFGLARFHQEVS 853
+ + LDY+H C I+H D+KP N+L++ S I D G A ++ E
Sbjct: 137 --SKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHY 192
Query: 854 NSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKK--PTDVMFEGDL 911
+++ + Y +PE LG+ D++S L+ E++T D
Sbjct: 193 TNSIQTRE-------YRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTK 245
Query: 912 NLHNFARMALPNQVMDIVDPI 932
+ + A++ ++++ +
Sbjct: 246 DDDHIAQI------IELLGEL 260
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 2e-19
Identities = 49/227 (21%), Positives = 83/227 (36%), Gaps = 64/227 (28%)
Query: 692 IGVGSFGCVYKGALDEDGIVVAIKVINLQ--CEGASKSFMAECKALKNIRHRNLVKVITS 749
+G G+F V + G+ A K+IN + + E + + ++H N+V++ S
Sbjct: 14 LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 73
Query: 750 CSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRI---------- 799
Q F +V++ + G E L + I
Sbjct: 74 -----IQEESFHYLVFDLVTGG------------------E----LFEDIVAREFYSEAD 106
Query: 800 --SIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGH---IGDFGLARFHQEVSN 854
+ ++ Y H + I+H +LKP N+LL + G + DFGLA + +
Sbjct: 107 ASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND--S 161
Query: 855 STLSSSVGVKGTIGYTAPE----YGLGSEVSTNGDVYSYG----ILL 893
GT GY +PE V D+++ G ILL
Sbjct: 162 EAWHGFA---GTPGYLSPEVLKKDPYSKPV----DIWACGVILYILL 201
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 2e-19
Identities = 54/244 (22%), Positives = 88/244 (36%), Gaps = 41/244 (16%)
Query: 686 FSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMA-----------ECKA 734
++ I GS+G V +D +GI VAIK + + E +
Sbjct: 24 YTVQRFISSGSYGAVCA-GVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRL 82
Query: 735 LKNIRHRNLVK---VITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEI 791
L + H N++ + + +V E M L + +H + I
Sbjct: 83 LNHFHHPNILGLRDIFVHFEEPAM--HKL-YLVTELMRT-DLAQVIHDQRIVISP--QHI 136
Query: 792 KLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQE 851
+ + + L LH + ++H DL P NILL ++ I DF LAR
Sbjct: 137 QYFMYH-------ILLGLHVLH---EAGVVHRDLHPGNILLADNNDITICDFNLAREDTA 186
Query: 852 VSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNG-DVYSYGILLLEMVTAKKPTDVMFEGD 910
+N T Y APE + + T D++S G ++ EM K +F G
Sbjct: 187 DANKT-----HYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK----ALFRGS 237
Query: 911 LNLH 914
+
Sbjct: 238 TFYN 241
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 91.4 bits (227), Expect = 3e-19
Identities = 63/237 (26%), Positives = 107/237 (45%), Gaps = 38/237 (16%)
Query: 686 FSSTHLIGVGSFGCVYKGALD-EDGIVVAIKVIN--LQCEGASKSFMAECKALKNIRHRN 742
+ + IG G+ G V A D VAIK ++ Q + +K E +K + H+N
Sbjct: 64 YQNLKPIGSGAQGIVCA-AYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 122
Query: 743 LVK---VITSCSSIDFQGNDFKAI--VYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQ 797
++ V T +++ +F+ + V E M + L + I+++L +
Sbjct: 123 IISLLNVFTPQKTLE----EFQDVYLVMELM-----DANLC--------QVIQMELDHER 165
Query: 798 RISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTL 857
+ + + +LH I+H DLKPSNI++ +D + I DFGLAR ++ +
Sbjct: 166 MSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMM 220
Query: 858 SSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLH 914
+ V T Y APE LG N D++S G ++ EMV K ++F G +
Sbjct: 221 TPYV---VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK----ILFPGRDYID 270
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 91.8 bits (228), Expect = 3e-19
Identities = 57/231 (24%), Positives = 95/231 (41%), Gaps = 34/231 (14%)
Query: 686 FSSTHLIGVGSFGCVYKGALDEDGIVVAIKVIN---LQCEGASKSFMAECKALKNIRHRN 742
F ++G G FG V + G + A K + ++ + E + L+ + R
Sbjct: 186 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 245
Query: 743 LVKVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIA 802
+V + + ++ D +V M G L+ ++ + + + A
Sbjct: 246 VVSLAYA-----YETKDALCLVLTLMNGGDLKFHIY--------HMGQAGFPEARAVFYA 292
Query: 803 IDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHI--GDFGLARFHQEVS-NSTLSS 859
++ L+ LH I++ DLKP NILLD+ GHI D GLA V T+
Sbjct: 293 AEICCGLEDLHRER---IVYRDLKPENILLDDH--GHIRISDLGLAV---HVPEGQTIKG 344
Query: 860 SVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGD 910
V GT+GY APE + + D ++ G LL EM+ + P F+
Sbjct: 345 RV---GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP----FQQR 388
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 3e-19
Identities = 54/245 (22%), Positives = 88/245 (35%), Gaps = 54/245 (22%)
Query: 686 FSSTHLIGVGSFGCVYKGALDEDGIVVAIKVIN---LQCEGASKSFMAECKALKNIRHRN 742
+ +IG G+FG V V A+K+++ + S F E +
Sbjct: 71 YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPW 130
Query: 743 LVKVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIA 802
+V++ + FQ + + +V EYMP G L + L+ +
Sbjct: 131 VVQLFYA-----FQDDRYLYMVMEYMPGGDL-------------------VNLMSNYDVP 166
Query: 803 IDVA--------SALDYLHHHCQEPILHCDLKPSNILLDNDLSGHI--GDFGLARFHQEV 852
A ALD +H +H D+KP N+LLD GH+ DFG +
Sbjct: 167 EKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKS--GHLKLADFGTCMKMNKE 221
Query: 853 SNSTLSSSVGVKGTIGYTAPE--YGLGSEVSTNGDV--YSYGILLLEMVTAKKP-----T 903
++V GT Y +PE G + + +S G+ L EM+ P
Sbjct: 222 GMVRCDTAV---GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL 278
Query: 904 DVMFE 908
+
Sbjct: 279 VGTYS 283
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 4e-19
Identities = 58/249 (23%), Positives = 99/249 (39%), Gaps = 54/249 (21%)
Query: 691 LIGVGSFGCVYKGALDEDGIVVAIKVIN----------------------LQCEGASKSF 728
IG GS+G V + D A+KV++ +
Sbjct: 20 EIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGP 79
Query: 729 MA----ECKALKNIRHRNLVKVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPK 784
+ E LK + H N+VK++ +D D +V+E + G +
Sbjct: 80 IEQVYQEIAILKKLDHPNVVKLVE---VLDDPNEDHLYMVFELVNQGPV----------- 125
Query: 785 RDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFG 844
+ L+ Q D+ ++YLH+ I+H D+KPSN+L+ D I DFG
Sbjct: 126 MEVPTLKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIKPSNLLVGEDGHIKIADFG 182
Query: 845 LARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNG---DVYSYGILLLEMVTAKK 901
++ + S++ LS++V GT + APE + +G DV++ G+ L V +
Sbjct: 183 VSNEFKG-SDALLSNTV---GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQC 238
Query: 902 PTDVMFEGD 910
P F +
Sbjct: 239 P----FMDE 243
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 5e-19
Identities = 57/220 (25%), Positives = 98/220 (44%), Gaps = 36/220 (16%)
Query: 692 IGVGSFGCVYKGALDEDGIVVAIKVIN---LQCEGASKSFMAECKALKNIRHRNLVKVIT 748
+G GSFG V G A+KVI+ ++ + +S + E + LK + H N++K+
Sbjct: 34 LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYE 93
Query: 749 SCSSIDFQGNDFKAIVYEYMPNGSL-EKWLHPHAVPKRDK--EIEIKLTLLQRISIAIDV 805
F+ + +V E G L ++ + R + E++ + Q V
Sbjct: 94 F-----FEDKGYFYLVGEVYTGGELFDE------IISRKRFSEVDAARIIRQ-------V 135
Query: 806 ASALDYLHHHCQEPILHCDLKPSNILLDNDLSGH---IGDFGLARFHQEVSNSTLSSSVG 862
S + Y+H + I+H DLKP N+LL++ I DFGL+ + + + +
Sbjct: 136 LSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA--SKKMKDKI- 189
Query: 863 VKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKP 902
GT Y APE L DV+S G++L +++ P
Sbjct: 190 --GTAYYIAPEV-LHGTYDEKCDVWSTGVILYILLSGCPP 226
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 5e-19
Identities = 63/275 (22%), Positives = 97/275 (35%), Gaps = 59/275 (21%)
Query: 656 RGPSRLPSRPMMRKALPKMSYKSLLKATNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIK 715
RG P + L K L++ + L+G G FG VY G D + VAIK
Sbjct: 17 RGSHMAPCNDLHATKLAPGKEKEPLESQ--YQVGPLLGSGGFGSVYSGIRVSDNLPVAIK 74
Query: 716 VIN---LQCEGASKSFMA---ECKALKNIRHR--NLVK---VITSCSSIDFQGNDFKAIV 764
+ + G + E LK + +++ S ++
Sbjct: 75 HVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSF--------VLI 126
Query: 765 YEY-MPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHC 823
E P L ++ +E + Q V A+ + H+ +LH
Sbjct: 127 LERPEPVQDLFDFITER---GALQEELARSFFWQ-------VLEAVRHCHNCG---VLHR 173
Query: 824 DLKPSNILLDNDLSGH--IGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPE------YG 875
D+K NIL+D + G + DFG + ++ + GT Y+ PE Y
Sbjct: 174 DIKDENILIDLN-RGELKLIDFGSGALLK---DTVYTDFD---GTRVYSPPEWIRYHRY- 225
Query: 876 LGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGD 910
G V+S GILL +MV P FE D
Sbjct: 226 HGRSA----AVWSLGILLYDMVCGDIP----FEHD 252
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 5e-19
Identities = 45/208 (21%), Positives = 80/208 (38%), Gaps = 32/208 (15%)
Query: 692 IGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSCS 751
+G G+FG V++ G V K IN + E + + H L+ + +
Sbjct: 59 LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDA-- 116
Query: 752 SIDFQGNDFKAIVYEYMPNGSL-EKWLHPHAVPKRDK---EIEIKLTLLQRISIAIDVAS 807
F+ ++ E++ G L ++ + D E E+ + Q
Sbjct: 117 ---FEDKYEMVLILEFLSGGELFDR------IAAEDYKMSEAEVINYMRQ-------ACE 160
Query: 808 ALDYLHHHCQEPILHCDLKPSNILLDNDLSGH--IGDFGLARFHQEVSNSTLSSSVGVKG 865
L ++H H I+H D+KP NI+ + + I DFGLA + + +
Sbjct: 161 GLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP--DEIVKVTT---A 212
Query: 866 TIGYTAPEYGLGSEVSTNGDVYSYGILL 893
T + APE V D+++ G+L
Sbjct: 213 TAEFAAPEIVDREPVGFYTDMWAIGVLG 240
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 7e-19
Identities = 58/216 (26%), Positives = 91/216 (42%), Gaps = 32/216 (14%)
Query: 686 FSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVK 745
S T ++G G FG V+K G+ +A K+I + + E + + H NL++
Sbjct: 91 VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQ 150
Query: 746 VITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQR--ISIAI 803
+ + F+ + +V EY+ G L D+ I+ L + I
Sbjct: 151 LYDA-----FESKNDIVLVMEYVDGGEL-----------FDRIIDESYNLTELDTILFMK 194
Query: 804 DVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHI--GDFGLARFHQEVSNSTLSSSV 861
+ + ++H ILH DLKP NIL N + I DFGLAR ++ L +
Sbjct: 195 QICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKP--REKLKVNF 249
Query: 862 GVKGTIGYTAPEYGLGSEVSTNGDVYSYG----ILL 893
GT + APE VS D++S G +LL
Sbjct: 250 ---GTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLL 282
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 8e-19
Identities = 55/237 (23%), Positives = 89/237 (37%), Gaps = 74/237 (31%)
Query: 692 IGVGSFGCVYKGALDEDGIVVAIKVINL--------QCEGASKSFMAECKALKNIR-HRN 742
IG G V + G A+K++ + Q E ++ E L+ + H +
Sbjct: 102 IGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPH 161
Query: 743 LVKVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRI--- 799
++ +I S ++ + F +V++ M G E L +
Sbjct: 162 IITLIDS-----YESSSFMFLVFDLMRKG------------------E----LFDYLTEK 194
Query: 800 ---------SIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQ 850
SI + A+ +LH + I+H DLKP NILLD+++ + DFG + +
Sbjct: 195 VALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFSCHLE 251
Query: 851 EVSNSTLSSSVGVKGTIGYTAPE----------YGLGSEVSTNGDVYSYG----ILL 893
L GT GY APE G G EV D+++ G LL
Sbjct: 252 P--GEKLRELC---GTPGYLAPEILKCSMDETHPGYGKEV----DLWACGVILFTLL 299
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 8e-19
Identities = 64/222 (28%), Positives = 93/222 (41%), Gaps = 55/222 (24%)
Query: 692 IGVGSFGCVYKGALDEDGIVVAIKVIN---LQCEGASKSFMAECKALKNIRHRNLVKVIT 748
+G GSFG V K A+KVIN + + + + + E + LK + H N++K+
Sbjct: 30 LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK-DTSTILREVELLKKLDHPNIMKLFE 88
Query: 749 SCSSIDFQGNDFKAIVYEYMPNGSL-----EKWLHPHAVPKRDKEIEIKLTLLQRISIAI 803
+ + IV E G L ++ KR E + + Q
Sbjct: 89 I-----LEDSSSFYIVGELYTGGELFDEIIKR--------KRFSEHDAARIIKQ------ 129
Query: 804 DVASALDYLHHHCQEPILHCDLKPSNILL---DNDLSGHIGDFGLARFHQEVSNSTLSSS 860
V S + Y+H H I+H DLKP NILL + D I DFGL+ Q+ N+ +
Sbjct: 130 -VFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ--NTKMKDR 183
Query: 861 VGVKGTIGYTAPE-----YGLGSEVSTNGDVYSYG----ILL 893
+ GT Y APE Y + DV+S G ILL
Sbjct: 184 I---GTAYYIAPEVLRGTYDE--KC----DVWSAGVILYILL 216
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 1e-18
Identities = 54/228 (23%), Positives = 83/228 (36%), Gaps = 53/228 (23%)
Query: 692 IGVGSFGCVYKGALDEDGIVVAIKVINLQ--CEGASKSFMAECKALKNIRHRNLVKVITS 749
+G G++G V + AIK+I ++ + E LK + H N++K+
Sbjct: 45 LGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDF 104
Query: 750 CSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRI---------- 799
F+ +V E G L I
Sbjct: 105 -----FEDKRNYYLVMECYKGG----------------------ELFDEIIHRMKFNEVD 137
Query: 800 --SIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGH---IGDFGLARFHQEVSN 854
I V S + YLH H I+H DLKP N+LL++ I DFGL+ +
Sbjct: 138 AAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFEN--Q 192
Query: 855 STLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKP 902
+ + GT Y APE L + DV+S G++L ++ P
Sbjct: 193 KKMKERL---GTAYYIAPEV-LRKKYDEKCDVWSIGVILFILLAGYPP 236
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 1e-18
Identities = 62/237 (26%), Positives = 102/237 (43%), Gaps = 39/237 (16%)
Query: 686 FSSTHLIGVGSFGCVYKGALDEDGIVVAIKVIN--LQCEGASKSFMAECKALKNIRHRNL 743
+ S +G G++G V G VAIK ++ Q E +K E LK+++H N+
Sbjct: 26 YVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENV 85
Query: 744 VK---VITSCSSIDFQGNDFKAI--VYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQR 798
+ V T SS+ +F V +M + L K + +K + +
Sbjct: 86 IGLLDVFTPASSLR----NFYDFYLVMPFM-----QTDLQ--------KIMGLKFSEEKI 128
Query: 799 ISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLS 858
+ + L Y+H ++H DLKP N+ ++ D I DFGLAR +++ ++
Sbjct: 129 QYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLAR----HADAEMT 181
Query: 859 SSVGVKGTIGYTAPEYGLGSEVSTNG-DVYSYGILLLEMVTAKKPTDVMFEGDLNLH 914
V T Y APE L D++S G ++ EM+T K +F+G L
Sbjct: 182 GYV---VTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK----TLFKGKDYLD 231
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 2e-18
Identities = 55/243 (22%), Positives = 83/243 (34%), Gaps = 61/243 (25%)
Query: 691 LIGVGSFGCVYKGALDEDGIVVAIKVIN-------LQCEGASKSFMAECKALKNIR---- 739
L+G G FG V+ G D + VAIKVI + + E L +
Sbjct: 38 LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPL-EVALLWKVGAGGG 96
Query: 740 HRNLVK---VITSCSSIDFQGNDFKAIVYEY-MPNGSLEKWLHPHAVPKRDKEIEIKLTL 795
H +++ + +V E +P L ++ E +
Sbjct: 97 HPGVIRLLDWFETQEGF--------MLVLERPLPAQDLFDYITEK---GPLGEGPSRCFF 145
Query: 796 LQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGH--IGDFGLARFHQEVS 853
Q V +A+ + H ++H D+K NIL+D G + DFG
Sbjct: 146 GQ-------VVAAIQHCHSRG---VVHRDIKDENILIDLR-RGCAKLIDFGSGALLH--- 191
Query: 854 NSTLSSSVGVKGTIGYTAPE------YGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMF 907
+ + GT Y+ PE Y V+S GILL +MV P F
Sbjct: 192 DEPYTDFD---GTRVYSPPEWISRHQY-HALPA----TVWSLGILLYDMVCGDIP----F 239
Query: 908 EGD 910
E D
Sbjct: 240 ERD 242
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 86.0 bits (213), Expect = 2e-18
Identities = 33/268 (12%), Positives = 65/268 (24%), Gaps = 72/268 (26%)
Query: 691 LIGVGSFGCVYKGALDED-GIVVAIKVINLQC---EGASKSFMAECKALKNIRHRNLVKV 746
G ++ ALD VA+ ++ Q + + ++ L I + +V
Sbjct: 38 FHGGVPPLQFWQ-ALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARV 96
Query: 747 ITSCSSIDF-QGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDV 805
+ D +V E++ GSL++ P I +
Sbjct: 97 L------DVVHTRAGGLVVAEWIRGGSLQEVADTSPSPVG------------AIRAMQSL 138
Query: 806 ASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKG 865
A+A D H + PS + + D G + V
Sbjct: 139 AAAADAAHRA---GVALSIDHPSRVRVSID--GDV----------------------VLA 171
Query: 866 TIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGD--------LNLHNFA 917
+ D+ G L ++ + P
Sbjct: 172 YPATMPD-------ANPQDDIRGIGASLYALLVNRWP----LPEAGVRSGLAPAERDTAG 220
Query: 918 RMALPNQVMDIVDPILRNDEEILASTDK 945
+ P + + + S
Sbjct: 221 QPIEPADIDRDIPFQI--SAVAARSVQG 246
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 2e-18
Identities = 28/160 (17%), Positives = 53/160 (33%), Gaps = 7/160 (4%)
Query: 75 GNLSFLREINLSNNTIQGEIPPEFGRLFRLEALFLSNNSLVGKIPANLSYCSRLTVLCIE 134
++ L I L+N + ++ ++ L ++N +S S L L I
Sbjct: 41 AQMNSLTYITLANINVT-DLTG-IEYAHNIKDLTINNIHA--TNYNPISGLSNLERLRIM 96
Query: 135 YNKLQGRIPLEFVSLSKLKDLSLAKNKLTGGIPPFLGNLTSLEVLSLAGNSFGRNIPDSL 194
+ L+ L L ++ + I + L + + L+ N +I L
Sbjct: 97 GKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDI-MPL 155
Query: 195 GQLKQLKILAIGGNNLSGPIPPSIYNLSFLVVFSVSHNQI 234
L +LK L I + + I + L I
Sbjct: 156 KTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQTI 193
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 8e-18
Identities = 31/182 (17%), Positives = 61/182 (33%), Gaps = 11/182 (6%)
Query: 76 NLSFLREINLSNNTIQGEIPPEFGRLFRLEALFLSNNSLVGKIPANLSYCSRLTVLCIEY 135
L ++ ++ L + L+N + V + + Y + L I
Sbjct: 21 TFKAYLNGLLGQSSTA---NITEAQMNSLTYITLANIN-VTDLT-GIEYAHNIKDLTINN 75
Query: 136 NKLQGRIPLEFVSLSKLKDLSLAKNKLTGGIPPFLGNLTSLEVLSLAGNSFGRNIPDSLG 195
P+ LS L+ L + +T P L LTSL +L ++ ++ +I +
Sbjct: 76 IHATNYNPIS--GLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKIN 133
Query: 196 QLKQLKILAIGGNNLSGPIPPSIYNLSFLVVFSVSHNQIHGSLPPSLGLLLPNLKFFQIH 255
L ++ + + N I P + L L ++ + +H P L
Sbjct: 134 TLPKVNSIDLSYNGAITDIMP-LKTLPELKSLNIQFDGVH-DYRGIED--FPKLNQLYAF 189
Query: 256 HN 257
Sbjct: 190 SQ 191
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 8e-18
Identities = 31/159 (19%), Positives = 64/159 (40%), Gaps = 11/159 (6%)
Query: 56 VTALDLMSKSLSGSLSPHLGNLSFLREINLSNNTIQGEIPPEFGRLFRLEALFLSNNSLV 115
+T + L + +++ L+ + ++++ ++N P L LE L + +
Sbjct: 46 LTYITLANINVT-DLTG-IEYAHNIKDLTINNIHAT-NYNP-ISGLSNLERLRIMGKDVT 101
Query: 116 GKIPANLSYCSRLTVLCIEYNKLQGRIPLEFVSLSKLKDLSLAKNKLTGGIPPFLGNLTS 175
NLS + LT+L I ++ I + +L K+ + L+ N I P L L
Sbjct: 102 SDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMP-LKTLPE 160
Query: 176 LEVLSLAGNSFGRNIPD--SLGQLKQLKILAIGGNNLSG 212
L+ L++ + + D + +L L + G
Sbjct: 161 LKSLNIQFD----GVHDYRGIEDFPKLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 5e-16
Identities = 28/180 (15%), Positives = 66/180 (36%), Gaps = 8/180 (4%)
Query: 350 SQLQILILSSNQFYGSIPLGIGNLVDLYLLGMVENQFTGAIPKEMGKLQKLQGLDFSGNH 409
S + + + + + L + + T + ++ L + H
Sbjct: 20 STFKAYLNGLLGQSSTANITEAQMNSLTYITLANINVTDL--TGIEYAHNIKDLTINNIH 77
Query: 410 FSGEIPSSLGNLSSLYEVFFNNNNLSGVIPFSLGNLKRLAFLEMSGNELSGTIPEDIFNI 469
+ + + LS+L + +++ +L L L L++S + +I I +
Sbjct: 78 ATN--YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTL 135
Query: 470 SYLSNSLNLARNHLVGIIPPRIGNLRALRSFDVSNNDLSGEIPIELGHCSSLEEIYLAGN 529
+ NS++L+ N + I P + L L+S ++ + + IE L ++Y
Sbjct: 136 PKV-NSIDLSYNGAITDIMP-LKTLPELKSLNIQFDGVHDYRGIE--DFPKLNQLYAFSQ 191
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 7e-16
Identities = 30/169 (17%), Positives = 64/169 (37%), Gaps = 13/169 (7%)
Query: 344 SIANLSSQLQILILSSNQFYGSIPLGIGNLVDLYLLGMVENQFTGAIPKEMGKLQKLQGL 403
+ A ++S L + L++ + GI ++ L + T P + L L+ L
Sbjct: 39 TEAQMNS-LTYITLANINV-TDLT-GIEYAHNIKDLTINNIHATNYNP--ISGLSNLERL 93
Query: 404 DFSGNHFSGEIPSSLGNLSSLYEVFFNNNNLSGVIPFSLGNLKRLAFLEMSGNELSGTIP 463
G + + +L L+SL + +++ I + L ++ +++S N
Sbjct: 94 RIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAI---- 149
Query: 464 EDIFNISYLSN--SLNLARNHLVGIIPPRIGNLRALRSFDVSNNDLSGE 510
DI + L SLN+ + + I + L + + G+
Sbjct: 150 TDIMPLKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQTIGGK 196
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 7e-15
Identities = 32/157 (20%), Positives = 56/157 (35%), Gaps = 9/157 (5%)
Query: 422 SSLYEVFFNNNNLSGVIPFSLGNLKRLAFLEMSGNELSGTIPEDIFNISYLSN--SLNLA 479
S+ S + + L ++ ++ ++ D+ I Y N L +
Sbjct: 20 STFKAYLNGLLGQSSTANITEAQMNSLTYITLANINVT-----DLTGIEYAHNIKDLTIN 74
Query: 480 RNHLVGIIPPRIGNLRALRSFDVSNNDLSGEIPIELGHCSSLEEIYLAGNLFHGSIPSFF 539
H P I L L + D++ + L +SL + ++ + SI +
Sbjct: 75 NIHATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKI 132
Query: 540 NALKGVQKIDLSRNNLSGQIPIFLEALSLEYLNLSFN 576
N L V IDLS N I L+ LN+ F+
Sbjct: 133 NTLPKVNSIDLSYNGAITDIMPLKTLPELKSLNIQFD 169
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 2e-13
Identities = 22/165 (13%), Positives = 63/165 (38%), Gaps = 8/165 (4%)
Query: 393 EMGKLQKLQGLDFSGNHFSGEIPSSLGNLSSLYEVFFNNNNLSGVIPFSLGNLKRLAFLE 452
++ L + + + + ++ + + ++ ++ NN + + P + L L L
Sbjct: 39 TEAQMNSLTYITLANINVT-DL-TGIEYAHNIKDLTINNIHATNYNP--ISGLSNLERLR 94
Query: 453 MSGNELSGTIPEDIFNISYLSNSLNLARNHLVGIIPPRIGNLRALRSFDVSNNDLSGEIP 512
+ G +++ ++ ++ L L+++ + I +I L + S D+S N +I
Sbjct: 95 IMGKDVTSDKIPNLSGLTSL-TLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIM 153
Query: 513 IELGHCSSLEEIYLAGNLFHGSIPSFFNALKGVQKIDLSRNNLSG 557
L L+ + + + H + ++ + G
Sbjct: 154 -PLKTLPELKSLNIQFDGVHDY--RGIEDFPKLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 2e-12
Identities = 27/216 (12%), Positives = 68/216 (31%), Gaps = 46/216 (21%)
Query: 148 SLSKLKDLSLAKNKLTGGIPPFLGNLTSLEVLSLAGNSFGRNIPD--SLGQLKQLKILAI 205
+ + L ++ + SL ++LA N+ D + +K L I
Sbjct: 21 TFKAYLNGLLGQSSTA---NITEAQMNSLTYITLANI----NVTDLTGIEYAHNIKDLTI 73
Query: 206 GGNNLSGPIPPSIYNLSFLVVFSVSHNQIHGSLPPSLGLLLPNLKFFQIHHNFFSGSIPI 265
+ + + +S L NL+ +I +
Sbjct: 74 NNIHAT-----NYNPIS----------------------GLSNLERLRIMGKDVTSDKIP 106
Query: 266 SLSNASKLEHIEIANNNFSGKLSVNFGGMKNLSLLNLQFSNLGSGESDEMGFMNSLTNCS 325
+LS + L ++I+++ + + ++ ++L ++ + + L
Sbjct: 107 NLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITD-------IMPLKTLP 159
Query: 326 KLRVLSLGGNQFRGALPHSIANLSSQLQILILSSNQ 361
+L+ L++ + I + +L L S
Sbjct: 160 ELKSLNIQFDGVHDYRG--IEDF-PKLNQLYAFSQT 192
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 3e-18
Identities = 50/252 (19%), Positives = 95/252 (37%), Gaps = 20/252 (7%)
Query: 56 VTALDLMSKSLSGSLSPHLGNLSFLREINLSNNTIQGEIPPEFGRLFRLEALFLSNNSLV 115
+L +S++ L LS ++ N N+ IQ + L+ L LS+N +
Sbjct: 21 AVKQNLGKQSVT-DLVS-QKELSGVQNFNGDNSNIQ-SLAG-MQFFTNLKELHLSHNQIS 76
Query: 116 GKIPANLSYCSRLTVLCIEYNKLQGRIPLEFVSLSKLKDLSLAKNKLTGGIPPFLGNLTS 175
+ L ++L L + N+L+ L + + L L L N+L L +L +
Sbjct: 77 -DLS-PLKDLTKLEELSVNRNRLKN---LNGIPSACLSRLFLDNNELRD--TDSLIHLKN 129
Query: 176 LEVLSLAGNSFGRNIPDSLGQLKQLKILAIGGNNLSGPIPPSIYNLSFLVVFSVSHNQIH 235
LE+LS+ N ++I LG L +L++L + GN ++ + L + ++ +
Sbjct: 130 LEILSIRNNKL-KSI-VMLGFLSKLEVLDLHGNEITNTGG--LTRLKKVNWIDLTGQKCV 185
Query: 236 GSLPPSLGLLLPNLKFFQIHHNFFSGSIPISLSNASKLEHIEIANNN--FSGKLSVNFGG 293
L + S P +SN + ++ ++S F
Sbjct: 186 NEPVKYQPELYITNTVKDPDGRWIS---PYYISNGGSYVDGCVLWELPVYTDEVSYKFSE 242
Query: 294 MKNLSLLNLQFS 305
N+ F
Sbjct: 243 YINVGETEAIFD 254
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 2e-11
Identities = 36/201 (17%), Positives = 76/201 (37%), Gaps = 24/201 (11%)
Query: 136 NKLQGRIPLEFVSLSKLKDLSLAKNKLTGGIPPFLGNLTSLEVLSLAGNSFGRNIPDSLG 195
+ P L+ +L K +T + L+ ++ + ++ +++ +
Sbjct: 7 TPINQVFPDP--GLANAVKQNLGKQSVT-DLVS-QKELSGVQNFNGDNSNI-QSL-AGMQ 60
Query: 196 QLKQLKILAIGGNNLSGPIPPSIYNLSFLVVFSVSHNQIHGSLPPSLGLLLPNLKFFQIH 255
LK L + N +S + P + +L+ L SV+ N++ +L + L +
Sbjct: 61 FFTNLKELHLSHNQISD-LSP-LKDLTKLEELSVNRNRLK-NLNG---IPSACLSRLFLD 114
Query: 256 HNFFSGSIPISLSNASKLEHIEIANNNFSGKLSVNFGGMKNLSLLNLQFSNLGSGESDEM 315
+N SL + LE + I NN + G + L +L+L + + +
Sbjct: 115 NNELR-DTD-SLIHLKNLEILSIRNNKLK-SIV-MLGFLSKLEVLDLHGNEITN------ 164
Query: 316 GFMNSLTNCSKLRVLSLGGNQ 336
LT K+ + L G +
Sbjct: 165 --TGGLTRLKKVNWIDLTGQK 183
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 3e-11
Identities = 25/163 (15%), Positives = 57/163 (34%), Gaps = 17/163 (10%)
Query: 416 SSLGNLSSLYEVFFNNNNLSGVIPFSLGNLKRLAFLEMSGNELSGTIPEDIFNISYLSN- 474
L++ + +++ ++ L + + + + + + +N
Sbjct: 13 FPDPGLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNIQ-----SLAGMQFFTNL 65
Query: 475 -SLNLARNHLVGIIPPRIGNLRALRSFDVSNNDLSGEIPIELGHCSSLEEIYLAGNLFHG 533
L+L+ N + + P + +L L V+ N L + + L ++L N
Sbjct: 66 KELHLSHNQISDLSP--LKDLTKLEELSVNRNRLKN---LNGIPSACLSRLFLDNNEL-- 118
Query: 534 SIPSFFNALKGVQKIDLSRNNLSGQIPIFLEALSLEYLNLSFN 576
LK ++ + + N L I + LE L+L N
Sbjct: 119 RDTDSLIHLKNLEILSIRNNKLK-SIVMLGFLSKLEVLDLHGN 160
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 1e-10
Identities = 37/182 (20%), Positives = 63/182 (34%), Gaps = 20/182 (10%)
Query: 350 SQLQILILSSNQFYGSIPLGIGNLVDLYLLGMVENQFTGAIPKEMGKLQKLQGLDFSGNH 409
+ L + + L + + M L+ L S N
Sbjct: 19 ANAVKQNLGKQSV--TDLVSQKELSGVQNFNGDNSNIQ--SLAGMQFFTNLKELHLSHNQ 74
Query: 410 FSGEIPSSLGNLSSLYEVFFNNNNLSGVIPFSLGNLKRLAFLEMSGNELSGTIPEDIFNI 469
S ++ S L +L+ L E+ N N L + L R L + NEL D ++
Sbjct: 75 IS-DL-SPLKDLTKLEELSVNRNRLKNLNGIPSACLSR---LFLDNNELR-----DTDSL 124
Query: 470 SYLSN--SLNLARNHLVGIIPPRIGNLRALRSFDVSNNDLSGEIPIELGHCSSLEEIYLA 527
+L N L++ N L I+ +G L L D+ N+++ + + I L
Sbjct: 125 IHLKNLEILSIRNNKLKSIVM--LGFLSKLEVLDLHGNEITNTGGLT--RLKKVNWIDLT 180
Query: 528 GN 529
G
Sbjct: 181 GQ 182
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 2e-10
Identities = 46/264 (17%), Positives = 89/264 (33%), Gaps = 51/264 (19%)
Query: 246 LPNLKFFQIHHNFFSGSIPISLSNASKLEHIEIANNNFSGKLSVNFGGMKNLSLLNLQFS 305
L N + S + +S S +++ N+N L+ NL L+L +
Sbjct: 18 LANAVKQNLGKQ--SVTDLVSQKELSGVQNFNGDNSNIQ-SLA-GMQFFTNLKELHLSHN 73
Query: 306 NLGSGESDEMGFMNSLTNCSKLRVLSLGGNQFRGALPHSIANLSS-QLQILILSSNQFYG 364
+ ++ L + +KL LS+ N+ + ++ + S L L L +N+
Sbjct: 74 QISD--------LSPLKDLTKLEELSVNRNRLK-----NLNGIPSACLSRLFLDNNE--- 117
Query: 365 SIPLGIGNLVDLYLLGMVENQFTGAIPKEMGKLQKLQGLDFSGNHFSGEIPSSLGNLSSL 424
+ + L L+ L+ L N I LG LS L
Sbjct: 118 -----LRDTDSL------------------IHLKNLEILSIRNNKLK-SI-VMLGFLSKL 152
Query: 425 YEVFFNNNNLSGVIPFSLGNLKRLAFLEMSGNELSGTIPEDIFNISYLSNSLNLARNHLV 484
+ + N ++ L LK++ +++++G + E + L + +
Sbjct: 153 EVLDLHGNEITNTGG--LTRLKKVNWIDLTGQKCV---NEPVKYQPELYITNTVKDPDGR 207
Query: 485 GIIPPRIGNLRALRSFDVSNNDLS 508
I P I N + V
Sbjct: 208 WISPYYISNGGSYVDGCVLWELPV 231
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 3e-18
Identities = 72/232 (31%), Positives = 105/232 (45%), Gaps = 48/232 (20%)
Query: 691 LIGVGSFGCVYKGALDEDGIVVAIKVIN---LQCEGASKSFMAECKALKNIRHRNLVK-- 745
+G GSFG V + VA+K I+ L+ E LK +RH +++K
Sbjct: 16 TLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLY 75
Query: 746 -VITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAID 804
VIT+ + I +V EY G L ++ KR E E + Q I
Sbjct: 76 DVITTPTDI--------VMVIEYA-GGELFDYIVEK---KRMTEDEGRRFFQQIIC---- 119
Query: 805 VASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVK 864
A++Y H H I+H DLKP N+LLD++L+ I DFGL+ + + L +S
Sbjct: 120 ---AIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTD--GNFLKTSC--- 168
Query: 865 GTIGYTAPE------YGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGD 910
G+ Y APE Y G EV DV+S GI+L M+ + P F+ +
Sbjct: 169 GSPNYAAPEVINGKLY-AGPEV----DVWSCGIVLYVMLVGRLP----FDDE 211
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 4e-18
Identities = 49/215 (22%), Positives = 83/215 (38%), Gaps = 36/215 (16%)
Query: 692 IGVGSFGCVYKGALDEDGIVVAIKVIN----LQCEGASK-SFMAECKALKNIRHRNLVKV 746
IG G F V + E G A+K+++ G S E ++H ++V++
Sbjct: 32 IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91
Query: 747 ITSCSSIDFQGNDFKAIVYEYMPNGSL-EKWLHPHAVPKRDKEIEIKLTLLQRISIAIDV 805
+ + + + +V+E+M L + + E + Q +
Sbjct: 92 LET-----YSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQ-------I 139
Query: 806 ASALDYLHHHCQEPILHCDLKPSNILLDNDLSGH---IGDFGLARFHQEVSNSTLSSSVG 862
AL Y H + I+H D+KP +LL + + +G FG+A E S V
Sbjct: 140 LEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGE-SGLVAGGRV- 194
Query: 863 VKGTIGYTAPE----YGLGSEVSTNGDVYSYGILL 893
GT + APE G V DV+ G++L
Sbjct: 195 --GTPHFMAPEVVKREPYGKPV----DVWGCGVIL 223
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 4e-18
Identities = 59/249 (23%), Positives = 92/249 (36%), Gaps = 69/249 (27%)
Query: 686 FSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSF----------MAECKAL 735
F +G GSFG V E G A+K++ K + E + L
Sbjct: 43 FDRIKTLGTGSFGRVMLVKHKESGNHYAMKIL-------DKQKVVKLKQIEHTLNEKRIL 95
Query: 736 KNIRHRNLVKVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTL 795
+ + LVK+ S F+ N +V EY+ G + +
Sbjct: 96 QAVNFPFLVKLEFS-----FKDNSNLYMVMEYVAGGEM-------------------FSH 131
Query: 796 LQRISI---------AIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHI--GDFG 844
L+RI A + +YLH +++ DLKP N+L+D G+I DFG
Sbjct: 132 LRRIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQ--GYIQVTDFG 186
Query: 845 LARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKP-- 902
A+ + + TL GT APE L + D ++ G+L+ EM P
Sbjct: 187 FAKRVKGRTW-TLC------GTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFF 239
Query: 903 ---TDVMFE 908
++E
Sbjct: 240 ADQPIQIYE 248
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 88.0 bits (218), Expect = 5e-18
Identities = 50/206 (24%), Positives = 86/206 (41%), Gaps = 28/206 (13%)
Query: 692 IGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSCS 751
+G G+FG V++ G A K + E ++ E + + +RH LV + +
Sbjct: 165 LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDA-- 222
Query: 752 SIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDK--EIEIKLTLLQRISIAIDVASAL 809
F+ ++ ++YE+M G L + + + +K E E + Q V L
Sbjct: 223 ---FEDDNEMVMIYEFMSGGELFEKV----ADEHNKMSEDEAVEYMRQ-------VCKGL 268
Query: 810 DYLHHHCQEPILHCDLKPSNILLDNDLSGHI--GDFGLARFHQEVSNSTLSSSVGVKGTI 867
++H + +H DLKP NI+ S + DFGL ++ + GT
Sbjct: 269 CHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP--KQSVKVTT---GTA 320
Query: 868 GYTAPEYGLGSEVSTNGDVYSYGILL 893
+ APE G V D++S G+L
Sbjct: 321 EFAAPEVAEGKPVGYYTDMWSVGVLS 346
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 5e-18
Identities = 61/215 (28%), Positives = 93/215 (43%), Gaps = 45/215 (20%)
Query: 692 IGVGSFGCVYKGALDEDGIVVAIKVINLQ--CEGASKSFMAECKALKNIRHRNLVKVITS 749
+G GSFG V K A+KVIN + + + E + LK + H N++K+
Sbjct: 30 LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 750 CSSIDFQGNDFKAIVYEYMPNGSL-EKWLHPHAVPKRDK--EIEIKLTLLQRISIAIDVA 806
+ + IV E G L ++ + KR + E + + Q V
Sbjct: 90 -----LEDSSSFYIVGELYTGGELFDE------IIKRKRFSEHDAARIIKQ-------VF 131
Query: 807 SALDYLHHHCQEPILHCDLKPSNILLDNDLSGH---IGDFGLARFHQEVSNSTLSSSVGV 863
S + Y+H H I+H DLKP NILL++ I DFGL+ Q+ N+ + +
Sbjct: 132 SGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ--NTKMKDRI-- 184
Query: 864 KGTIGYTAPE-----YGLGSEVSTNGDVYSYGILL 893
GT Y APE Y + DV+S G++L
Sbjct: 185 -GTAYYIAPEVLRGTY--DEKC----DVWSAGVIL 212
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 5e-18
Identities = 55/266 (20%), Positives = 95/266 (35%), Gaps = 71/266 (26%)
Query: 657 GPSRLPSRPMMRKALPKMSYKSLLKATNGFSST----HLIGVGSFGCVYKGALDEDGIVV 712
GP + S ++ + ++ A+ FS +G G+F V + G+
Sbjct: 1 GPH-MASMTGGQQMGRGSEF--MMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEF 57
Query: 713 AIKVIN--LQCEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKAIVYEYMPN 770
A K+IN + E + + ++H N+V++ S Q F +V++ +
Sbjct: 58 AAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS-----IQEESFHYLVFDLVTG 112
Query: 771 GSLEKWLHPHAVPKRDKEIEIKLTLLQRI------------SIAIDVASALDYLHHHCQE 818
G E L + I + ++ Y H +
Sbjct: 113 G------------------E----LFEDIVAREFYSEADASHCIQQILESIAYCHSNG-- 148
Query: 819 PILHCDLKPSNILLDNDLSGH---IGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPE-- 873
I+H +LKP N+LL + G + DFGLA + + GT GY +PE
Sbjct: 149 -IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND--SEAWHGFA---GTPGYLSPEVL 202
Query: 874 --YGLGSEVSTNGDVYSYG----ILL 893
V D+++ G ILL
Sbjct: 203 KKDPYSKPV----DIWACGVILYILL 224
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 7e-18
Identities = 57/238 (23%), Positives = 91/238 (38%), Gaps = 59/238 (24%)
Query: 686 FSSTHLIGVGSFGCVYKGALDEDGIVVAIKVIN---LQCEGASKSFMAECKALKNIRHRN 742
F IG GSFG V ++ + A+K +N ++ E + ++ + H
Sbjct: 17 FEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPF 76
Query: 743 LVKVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISI- 801
LV + S FQ + +V + + G L LQ+
Sbjct: 77 LVNLWYS-----FQDEEDMFMVVDLLLGGDL-------------------RYHLQQNVHF 112
Query: 802 --------AIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIG--DFGLARFHQE 851
++ ALDYL + I+H D+KP NILLD GH+ DF +A
Sbjct: 113 KEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEH--GHVHITDFNIAA---M 164
Query: 852 VSNSTLSSSVGVKGTIGYTAPE-------YGLGSEVSTNGDVYSYGILLLEMVTAKKP 902
+ T +++ GT Y APE G V D +S G+ E++ ++P
Sbjct: 165 LPRETQITTMA--GTKPYMAPEMFSSRKGAGYSFAV----DWWSLGVTAYELLRGRRP 216
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 7e-18
Identities = 66/255 (25%), Positives = 106/255 (41%), Gaps = 39/255 (15%)
Query: 674 MSYKSLLKATNGFSSTHLIGVGSFGCVYKGALD-EDGIVVAIKVIN-LQCEGASKSFMAE 731
M + + ++ F L+G G++G V A G +VAIK I + + E
Sbjct: 1 MPKRIVYNISSDFQLKSLLGEGAYGVVCS-ATHKPTGEIVAIKKIEPFDKPLFALRTLRE 59
Query: 732 CKALKNIRHRNLVK---VITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDK- 787
K LK+ +H N++ + S +F N+ I+ E M + LH V
Sbjct: 60 IKILKHFKHENIITIFNIQRPDSFENF--NEV-YIIQELM-----QTDLH--RVISTQML 109
Query: 788 -EIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLA 846
+ I+ + Q + A+ LH ++H DLKPSN+L++++ + DFGLA
Sbjct: 110 SDDHIQYFIYQTLR-------AVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLA 159
Query: 847 RFHQEVSNSTLSSSVGVKG------TIGYTAPEYGLGSEVSTNG-DVYSYGILLLEMVTA 899
R E + + G T Y APE L S + DV+S G +L E+
Sbjct: 160 RIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLR 219
Query: 900 KKPTDVMFEGDLNLH 914
+ +F G H
Sbjct: 220 R----PIFPGRDYRH 230
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 8e-18
Identities = 47/229 (20%), Positives = 79/229 (34%), Gaps = 67/229 (29%)
Query: 692 IGVGSFGCVYKGALDEDGIVVAIKVIN--LQCEGASKSFMAECKALKNIRHRNLVKVITS 749
+G G+F V + G A +IN + E + + ++H N+V++ S
Sbjct: 19 LGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 78
Query: 750 CSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRI---------- 799
++++ + G E L + I
Sbjct: 79 -----ISEEGHHYLIFDLVTGG------------------E----LFEDIVAREYYSEAD 111
Query: 800 --SIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGH---IGDFGLARFHQEVSN 854
+ A+ + H ++H +LKP N+LL + L G + DFGLA +
Sbjct: 112 ASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEG-EQ 167
Query: 855 STLSSSVGVKGTIGYTAPE------YGLGSEVSTNGDVYSYG----ILL 893
GT GY +PE YG V D+++ G ILL
Sbjct: 168 QAWFGFA---GTPGYLSPEVLRKDPYGK--PV----DLWACGVILYILL 207
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 9e-18
Identities = 66/239 (27%), Positives = 100/239 (41%), Gaps = 41/239 (17%)
Query: 692 IGVGSFGCVYKGALD-EDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVI--- 747
+G G G V+ A+D + VAIK I L + K + E K ++ + H N+VKV
Sbjct: 19 LGCGGNGLVFS-AVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEIL 77
Query: 748 ----TSCSSIDFQGNDFKAI--VYEYMPNGSLEKWLHPHAVPKRDK--EIEIKLTLLQRI 799
+ + + ++ V EYM E L V ++ E +L + Q
Sbjct: 78 GPSGSQLTDDVGSLTELNSVYIVQEYM-----ETDLA--NVLEQGPLLEEHARLFMYQ-- 128
Query: 800 SIAIDVASALDYLHHHCQEPILHCDLKPSNILLD-NDLSGHIGDFGLAR--FHQEVSNST 856
+ L Y+H +LH DLKP+N+ ++ DL IGDFGLAR
Sbjct: 129 -----LLRGLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGH 180
Query: 857 LSSSVGVKGTIGYTAPEYGLGSEVSTNG-DVYSYGILLLEMVTAKKPTDVMFEGDLNLH 914
LS + T Y +P L T D+++ G + EM+T K +F G L
Sbjct: 181 LSEGL---VTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK----TLFAGAHELE 232
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 9e-18
Identities = 50/202 (24%), Positives = 75/202 (37%), Gaps = 49/202 (24%)
Query: 691 LIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIR-HRNLVKVITS 749
++G G+ V A+K+I Q E + L + HRN++++I
Sbjct: 20 VLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEF 79
Query: 750 CSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRI---------- 799
F+ D +V+E M GS+ L I
Sbjct: 80 -----FEEEDRFYLVFEKMRGGSI----------------------LSHIHKRRHFNELE 112
Query: 800 --SIAIDVASALDYLHHHCQEPILHCDLKPSNILL---DNDLSGHIGDFGLARFHQEVSN 854
+ DVASALD+LH+ I H DLKP NIL + I DF L + +
Sbjct: 113 ASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGD 169
Query: 855 STLSSSVGVK---GTIGYTAPE 873
+ S+ + G+ Y APE
Sbjct: 170 CSPISTPELLTPCGSAEYMAPE 191
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 84.5 bits (210), Expect = 1e-17
Identities = 65/249 (26%), Positives = 99/249 (39%), Gaps = 69/249 (27%)
Query: 686 FSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSF----------MAECKAL 735
F +G GSFG V+ +G A+KV+ K E L
Sbjct: 8 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVL-------KKEIVVRLKQVEHTNDERLML 60
Query: 736 KNIRHRNLVKVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTL 795
+ H ++++ + FQ ++ +Y+ G L +L
Sbjct: 61 SIVTHPFIIRMWGT-----FQDAQQIFMIMDYIEGGEL-------------------FSL 96
Query: 796 LQRISI---------AIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHI--GDFG 844
L++ A +V AL+YLH I++ DLKP NILLD + GHI DFG
Sbjct: 97 LRKSQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKN--GHIKITDFG 151
Query: 845 LARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKP-- 902
A++ +V+ TL GT Y APE + + D +S+GIL+ EM+ P
Sbjct: 152 FAKYVPDVTY-TLC------GTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFY 204
Query: 903 ---TDVMFE 908
T +E
Sbjct: 205 DSNTMKTYE 213
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 1e-17
Identities = 70/234 (29%), Positives = 106/234 (45%), Gaps = 44/234 (18%)
Query: 692 IGVGSFGCVYKGALD-EDGIVVAIKVIN--LQCEGASKSFMAECKALKNIRHRNLVK--- 745
+G G++G V A+D G VAIK + Q E +K E + LK++RH N++
Sbjct: 33 VGSGAYGAVCS-AVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLD 91
Query: 746 VITSCSSIDFQGNDFKAI--VYEYMPNGSLEKWLHPHAVPKRDK--EIEIKLTLLQRISI 801
V T ++D DF V +M L + K +K E I+ + Q +
Sbjct: 92 VFTPDETLD----DFTDFYLVMPFM-----GTDLG--KLMKHEKLGEDRIQFLVYQMLK- 139
Query: 802 AIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSV 861
L Y+H I+H DLKP N+ ++ D I DFGLAR ++S ++ V
Sbjct: 140 ------GLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR----QADSEMTGYV 186
Query: 862 GVKGTIGYTAPEYGLGSEVSTNG-DVYSYGILLLEMVTAKKPTDVMFEGDLNLH 914
T Y APE L T D++S G ++ EM+T K +F+G +L
Sbjct: 187 ---VTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK----TLFKGSDHLD 233
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 85.6 bits (212), Expect = 2e-17
Identities = 62/228 (27%), Positives = 99/228 (43%), Gaps = 33/228 (14%)
Query: 691 LIGVGSFGCVYKGALDEDGIVVAIKVI---NLQCEGASKSFMAECKALKNIRHRNLVKVI 747
L+G G+FG V G A+K++ + + + E + L+N RH L +
Sbjct: 155 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 214
Query: 748 TSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVAS 807
S FQ +D V EY G L L R++ R A ++ S
Sbjct: 215 YS-----FQTHDRLCFVMEYANGGELFFHLS------RERVFSEDRA---RFYGA-EIVS 259
Query: 808 ALDYLHHHCQEPILHCDLKPSNILLDNDLSGHI--GDFGLARFHQEVSNSTLSSSVGVKG 865
ALDYLH ++ +++ DLK N++LD D GHI DFGL + + + + G
Sbjct: 260 ALDYLHS--EKNVVYRDLKLENLMLDKD--GHIKITDFGLCKEGIKDGATMKTFC----G 311
Query: 866 TIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKP-----TDVMFE 908
T Y APE ++ D + G+++ EM+ + P + +FE
Sbjct: 312 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFE 359
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 3e-17
Identities = 57/224 (25%), Positives = 87/224 (38%), Gaps = 52/224 (23%)
Query: 692 IGVGSFGCVYKGALDEDGIVVAIKVIN-------------LQCEGASKSFMAECKALKNI 738
+G G++G V AIKVI E + E LK++
Sbjct: 44 LGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL 103
Query: 739 RHRNLVKVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIK-LTLLQ 797
H N++K+ F+ + +V E+ G L ++ I
Sbjct: 104 DHPNIIKLFDV-----FEDKKYFYLVTEFYEGGEL-----------FEQIINRHKFDECD 147
Query: 798 RISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGH---IGDFGLARFHQEVSN 854
+I + S + YLH H I+H D+KP NILL+N S I DFGL+ F + +
Sbjct: 148 AANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSK--D 202
Query: 855 STLSSSVGVKGTIGYTAPE-----YGLGSEVSTNGDVYSYGILL 893
L + GT Y APE Y + DV+S G+++
Sbjct: 203 YKLRDRL---GTAYYIAPEVLKKKY--NEKC----DVWSCGVIM 237
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 3e-17
Identities = 56/237 (23%), Positives = 103/237 (43%), Gaps = 38/237 (16%)
Query: 686 FSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINL--QCEGASKSFMAECKALKNIRHRNL 743
+ + +G G++G V + G+ VA+K ++ Q +K E + LK+++H N+
Sbjct: 31 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 90
Query: 744 VK---VITSCSSIDFQGNDFKAI--VYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQR 798
+ V T S++ +F + V M L+ ++ + ++ + Q
Sbjct: 91 IGLLDVFTPARSLE----EFNDVYLVTHLM-----GADLNNIVKCQKLTDDHVQFLIYQI 141
Query: 799 ISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLS 858
+ L Y+H I+H DLKPSN+ ++ D I DFGLAR + ++
Sbjct: 142 LR-------GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTADEMT 187
Query: 859 SSVGVKGTIGYTAPEYGLGSEVSTNG-DVYSYGILLLEMVTAKKPTDVMFEGDLNLH 914
V T Y APE L D++S G ++ E++T + +F G ++
Sbjct: 188 GYV---ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR----TLFPGTDHID 237
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 3e-17
Identities = 64/239 (26%), Positives = 106/239 (44%), Gaps = 41/239 (17%)
Query: 691 LIGVGSFGCVYKGALD-EDGIVVAIKVINLQCEGASKSF----MAECKALKNIRHR---N 742
+IG GSFG V K A D + VA+K++ K F E + L+++R + N
Sbjct: 104 VIGKGSFGQVVK-AYDHKVHQHVALKMVR-----NEKRFHRQAAEEIRILEHLRKQDKDN 157
Query: 743 LVKVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIA 802
+ VI + F+ + + +E + + +L + + K++K L L+++ A
Sbjct: 158 TMNVIHMLENFTFRNHIC--MTFELL-SMNLYELI------KKNKFQGFSLPLVRKF--A 206
Query: 803 IDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHI--GDFGLARFHQEVSNSTLSSS 860
+ LD LH + I+HCDLKP NILL I DFG + + + + + S
Sbjct: 207 HSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQSR 263
Query: 861 VGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARM 919
Y APE LG+ D++S G +L E++T + G+ A M
Sbjct: 264 F-------YRAPEVILGARYGMPIDMWSLGCILAELLTGY----PLLPGEDEGDQLACM 311
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 4e-17
Identities = 55/228 (24%), Positives = 81/228 (35%), Gaps = 73/228 (32%)
Query: 692 IGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMA----ECKALKNIR-HRNLVKV 746
+G GSF K + A+K+I+ K A E ALK H N+VK+
Sbjct: 19 LGEGSFSICRKCVHKKSNQAFAVKIIS-------KRMEANTQKEITALKLCEGHPNIVKL 71
Query: 747 ITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRI------- 799
F +V E + G L +RI
Sbjct: 72 HEV-----FHDQLHTFLVMELLNGGEL----------------------FERIKKKKHFS 104
Query: 800 -----SIAIDVASALDYLHHHCQEPILHCDLKPSNILL---DNDLSGHIGDFGLARFHQE 851
I + SA+ ++H ++H DLKP N+L +++L I DFG AR
Sbjct: 105 ETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPP 161
Query: 852 VSNSTLSSSVGVKGTIGYTAPE------YGLGSEVSTNGDVYSYGILL 893
N L + T+ Y APE Y D++S G++L
Sbjct: 162 -DNQPLKTPC---FTLHYAAPELLNQNGYDE--SC----DLWSLGVIL 199
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 83.3 bits (206), Expect = 4e-17
Identities = 41/235 (17%), Positives = 77/235 (32%), Gaps = 15/235 (6%)
Query: 54 RRVTALDLMSKSLSGSLSPH-LGNLSFLREINLSNNTIQGEIPPE-FGRLFRLEALFLSN 111
R L + L + L +I +S N + I + F L +L + +
Sbjct: 30 RNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK 88
Query: 112 NSLVGKIPAN-LSYCSRLTVLCIEYNKLQGRIP-LEFVSLSKLKDLSLAKNKLTGGIPP- 168
+ + I L L I ++ +P + + + L + N I
Sbjct: 89 ANNLLYINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDNINIHTIERN 147
Query: 169 -FLGNLTSLEVLSLAGNSFGRNIPDSLGQLKQLKILAIGGNNLSGPIPPSI-YNLSFLVV 226
F+G +L L N + + ++ NNL +P + + S V+
Sbjct: 148 SFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDELNLSDNNNLEE-LPNDVFHGASGPVI 206
Query: 227 FSVSHNQIHGSLPPSLGLLLPNLKFFQIHHNFFSGSIPISLSNASKLEHIEIANN 281
+S +IH SLP L L+ ++ +P +L L +
Sbjct: 207 LDISRTRIH-SLPSYGLENLKKLRARSTYNLK---KLP-TLEKLVALMEASLTYP 256
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 76.0 bits (187), Expect = 9e-15
Identities = 45/254 (17%), Positives = 89/254 (35%), Gaps = 33/254 (12%)
Query: 327 LRVLSLGGNQFRGALPHSIANLSSQLQILILSSNQFYGSIPLGIGNLVDLYLLGMVENQF 386
L + R + + L+ + +S N I + F
Sbjct: 32 AIELRFVLTKLRVIQKGAFSGFG-DLEKIEISQNDVLEVIEADV---------------F 75
Query: 387 TGAIPKEMGKLQKLQGLDFS-GNHFSGEIPSSLGNLSSLYEVFFNNNNLSGVIPFSLGNL 445
+ L KL + N+ P + NL +L + +N + + +
Sbjct: 76 SN--------LPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHS 127
Query: 446 KRLAFLEMSGNELSGTIPEDIF-NISYLSNSLNLARNHLVGIIPPRIGNLRALRSFDVSN 504
+ L++ N TI + F +S+ S L L +N + I + N
Sbjct: 128 LQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDELNLSDN 187
Query: 505 NDLSGEIPIE-LGHCSSLEEIYLAGNLFHGSIPSFFNALKGVQK-IDLSRNNLSGQIPIF 562
N+L E+P + S + ++ H S+PS L+ ++K S NL ++P
Sbjct: 188 NNLE-ELPNDVFHGASGPVILDISRTRIH-SLPS--YGLENLKKLRARSTYNLK-KLPTL 242
Query: 563 LEALSLEYLNLSFN 576
+ ++L +L++
Sbjct: 243 EKLVALMEASLTYP 256
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 74.9 bits (184), Expect = 2e-14
Identities = 47/264 (17%), Positives = 84/264 (31%), Gaps = 38/264 (14%)
Query: 245 LLPNLKFFQIHHNFFSGSIPISLSNASKLEHIEIANNNFSGKLSVN-FGGMKNLSLLNLQ 303
L N + + S LE IEI+ N+ + + F + L + ++
Sbjct: 28 LPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIE 87
Query: 304 FSNLGSGESDEMGFMNSLTNCSKLRVLSLGGNQFRGALPHSIANLSSQLQILILSSNQFY 363
+N + E N L+ L + + LP S Q +L + N
Sbjct: 88 KANNLLYINPEA-----FQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDNINI 141
Query: 364 GSIPLGIGNLVDLYLLGMVENQFTGAIPKEMGKLQKLQGLDFSGNHFSGEIPSSLGNLSS 423
+I N F G + L + N EI +S N +
Sbjct: 142 HTIE---------------RNSFVGLSF-------ESVILWLNKNGIQ-EIHNSAFNGTQ 178
Query: 424 LYEVFF-NNNNLSGVIPFSLGNLKRLAFLEMSGNELSGTIPEDIF-NISYLSNSLNLARN 481
L E+ +NNNL + L++S + ++P N+ L + +
Sbjct: 179 LDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIH-SLPSYGLENLKKLR-ARSTYNL 236
Query: 482 HLVGIIPPRIGNLRALRSFDVSNN 505
+ P + L AL ++
Sbjct: 237 KKL----PTLEKLVALMEASLTYP 256
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 74.5 bits (183), Expect = 3e-14
Identities = 49/262 (18%), Positives = 95/262 (36%), Gaps = 23/262 (8%)
Query: 105 EALFLSNNSLVGKIPANLSYCSRLTVLCIEYNKLQGRIPLEFVSLSKLKDLSLAKNKLTG 164
+ + +IP++L L KL+ F L+ + +++N +
Sbjct: 12 RVFLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLE 68
Query: 165 GIPPF-LGNLTSLEVLSLAGNSFGRNIP-DSLGQLKQLKILAIGGNNLSGPIPPSIY-NL 221
I NL L + + + I ++ L L+ L I + +P +
Sbjct: 69 VIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKH-LPDVHKIHS 127
Query: 222 SFLVVFSVSHN-QIHGSLPP-SLGLLLPNLKFFQIHHNFFSGSIPISLSNASKLEHIEIA 279
V+ + N IH ++ S L ++ N I S N ++L+ + ++
Sbjct: 128 LQKVLLDIQDNINIH-TIERNSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLS 185
Query: 280 NNNFSGKLSVN-FGGMKNLSLLNLQFSNLGSGESDEMGFMNSLTNCSKLRVLSLGGNQFR 338
+NN +L + F G +L++ + + S S L N KLR S +
Sbjct: 186 DNNNLEELPNDVFHGASGPVILDISRTRIHSLPS------YGLENLKKLRARSTYNLK-- 237
Query: 339 GALPHSIANLSSQLQILILSSN 360
LP ++ L + L L+
Sbjct: 238 -KLP-TLEKLVA-LMEASLTYP 256
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 61.8 bits (150), Expect = 3e-10
Identities = 45/203 (22%), Positives = 79/203 (38%), Gaps = 9/203 (4%)
Query: 403 LDFSGNHFSGEIPSSLGNLSSLYEVFFNNNNLSGVIPFSLGNLKRLAFLEMSGNELSGTI 462
+ + EIPS L + E+ F L + + L +E+S N++ I
Sbjct: 14 FLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVI 70
Query: 463 PEDIF-NISYLSNSLNLARNHLVGIIPPRIGNLRALRSFDVSNNDLSGEIPIEL-GHCSS 520
D+F N+ L N+L+ I P NL L+ +SN + +P H
Sbjct: 71 EADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQ 129
Query: 521 LEEIYLAGNLFHGSIP--SFFNALKGVQKIDLSRNNLSGQIPIFLEALSLEYLNLSFNDF 578
+ + N+ +I SF + L++N + L+ LNLS N+
Sbjct: 130 KVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDELNLSDNNN 189
Query: 579 EGKIPAKGIFANASAISVVGCNR 601
++P +F AS ++ +R
Sbjct: 190 LEELPN-DVFHGASGPVILDISR 211
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 5e-17
Identities = 62/269 (23%), Positives = 104/269 (38%), Gaps = 23/269 (8%)
Query: 56 VTALDLMSKSLSGSLSPHLGNLSFLREINLSNNTIQGEIPPEFGRLFRLEALFLSNNSLV 115
+L KS++ L+ + +I +N+ I+ + L + LFL+ N L
Sbjct: 26 TIKDNLKKKSVT-DAVT-QNELNSIDQIIANNSDIK-SVQG-IQYLPNVTKLFLNGNKLT 81
Query: 116 GKIPANLSYCSRLTVLCIEYNKLQGRIPLEFVSLSKLKDLSLAKNKLTGGIPPFLGNLTS 175
I L+ L L ++ NK++ L+ L KLK LSL N ++ I L +L
Sbjct: 82 -DIK-PLANLKNLGWLFLDENKVKDLSSLK--DLKKLKSLSLEHNGIS-DING-LVHLPQ 135
Query: 176 LEVLSLAGNSFGRNIPD--SLGQLKQLKILAIGGNNLSGPIPPSIYNLSFLVVFSVSHNQ 233
LE L L N I D L +L +L L++ N +S I P + L+ L +S N
Sbjct: 136 LESLYLGNN----KITDITVLSRLTKLDTLSLEDNQISD-IVP-LAGLTKLQNLYLSKNH 189
Query: 234 IHGSLPPSLGLLLPNLKFFQIHHNFFSGSIPISLSNASKLEHIEIANNNFSGKLSVNFGG 293
I L G L NL ++ SN ++ + + ++ G
Sbjct: 190 IS-DLRALAG--LKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEIISDDG 246
Query: 294 MKNLSLLNLQFSNLGSGESDEMGFMNSLT 322
+ N+++ F +T
Sbjct: 247 --DYEKPNVKWHLPEFTNEVSFIFYQPVT 273
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 9e-16
Identities = 51/258 (19%), Positives = 106/258 (41%), Gaps = 23/258 (8%)
Query: 321 LTNCSKLRVLSLGGNQFRGALPHSIANLSSQLQILILSSNQFYGSIPLGIGNLVDLYLLG 380
++ +L A+ L+S + +I +++ S+ GI L ++ L
Sbjct: 20 DDAFAETIKDNLKKKSVTDAVT--QNELNS-IDQIIANNSDI-KSVQ-GIQYLPNVTKLF 74
Query: 381 MVENQFTGAIPKEMGKLQKLQGLDFSGNHFSGEIPSSLGNLSSLYEVFFNNNNLSGVIPF 440
+ N+ T P + L+ L L N ++ SSL +L L + +N +S +
Sbjct: 75 LNGNKLTDIKP--LANLKNLGWLFLDENKVK-DL-SSLKDLKKLKSLSLEHNGISDING- 129
Query: 441 SLGNLKRLAFLEMSGNELSGTIPEDIFNISYLSN--SLNLARNHLVGIIPPRIGNLRALR 498
L +L +L L + N+++ DI +S L+ +L+L N + I+P + L L+
Sbjct: 130 -LVHLPQLESLYLGNNKIT-----DITVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQ 181
Query: 499 SFDVSNNDLSGEIPIELGHCSSLEEIYLAGNLFHGSIPSFFNALKGVQKIDLSRNNLSGQ 558
+ +S N +S ++ L +L+ + L + + L + + +L
Sbjct: 182 NLYLSKNHIS-DLR-ALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTP 239
Query: 559 IPIFLEALSLEYLNLSFN 576
I + E N+ ++
Sbjct: 240 EIIS-DDGDYEKPNVKWH 256
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 7e-15
Identities = 47/256 (18%), Positives = 90/256 (35%), Gaps = 34/256 (13%)
Query: 136 NKLQGRIPLEFVSLSKLKDLSLAKNKLTGGIPPFLGNLTSLEVLSLAGNSFGRNIPD--S 193
++ + + ++ +L K +T L S++ + + +I
Sbjct: 12 TPIKQIFSDD--AFAETIKDNLKKKSVTD--AVTQNELNSIDQIIANNS----DIKSVQG 63
Query: 194 LGQLKQLKILAIGGNNLSGPIPPSIYNLSFLVVFSVSHNQIHGSLPPSLGLLLPNLKFFQ 253
+ L + L + GN L+ I P + NL L + N++ L L LK
Sbjct: 64 IQYLPNVTKLFLNGNKLTD-IKP-LANLKNLGWLFLDENKVK-DLSSLKD--LKKLKSLS 118
Query: 254 IHHNFFSGSIPISLSNASKLEHIEIANNNFSGKLSVNFGGMKNLSLLNLQFSNLGSGESD 313
+ HN S I L + +LE + + NN + ++ + L L+L+ + +
Sbjct: 119 LEHNGIS-DIN-GLVHLPQLESLYLGNNKIT-DIT-VLSRLTKLDTLSLEDNQISD---- 170
Query: 314 EMGFMNSLTNCSKLRVLSLGGNQFRGALPHSIANLS--SQLQILILSSNQFYGSIPLGIG 371
+ L +KL+ L L N + L+ L +L L S +
Sbjct: 171 ----IVPLAGLTKLQNLYLSKNHIS-----DLRALAGLKNLDVLELFSQECLNKPINHQS 221
Query: 372 NLVDLYLLGMVENQFT 387
NLV + +
Sbjct: 222 NLVVPNTVKNTDGSLV 237
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 9e-15
Identities = 49/262 (18%), Positives = 93/262 (35%), Gaps = 30/262 (11%)
Query: 246 LPNLKFFQIHHNFFSGSIPISLSNASKLEHIEIANNNFSGKLSVNFGGMKNLSLLNLQFS 305
+ + ++ + + ++ I N++ + + N++ L L +
Sbjct: 23 FAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQ-GIQYLPNVTKLFLNGN 78
Query: 306 NLGSGESDEMGFMNSLTNCSKLRVLSLGGNQFRGALPHSIANLSS--QLQILILSSNQFY 363
L + L N L L L N+ + +++L +L+ L L N
Sbjct: 79 KLTD--------IKPLANLKNLGWLFLDENKVK-----DLSSLKDLKKLKSLSLEHNGI- 124
Query: 364 GSIPLGIGNLVDLYLLGMVENQFTGAIPKEMGKLQKLQGLDFSGNHFSGEIPSSLGNLSS 423
I G+ +L L L + N+ T + +L KL L N S +I L L+
Sbjct: 125 SDIN-GLVHLPQLESLYLGNNKITDITV--LSRLTKLDTLSLEDNQIS-DI-VPLAGLTK 179
Query: 424 LYEVFFNNNNLSGVIPFSLGNLKRLAFLEMSGNELSGTIPEDIFNISYLSNSLNLARNHL 483
L ++ + N++S + L LK L LE+ E N+ N++ L
Sbjct: 180 LQNLYLSKNHISDLRA--LAGLKNLDVLELFSQECLNKPINHQSNLVVP-NTVKNTDGSL 236
Query: 484 VGIIPPRIGNLRALRSFDVSNN 505
V I + +V +
Sbjct: 237 VTPEI--ISDDGDYEKPNVKWH 256
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 1e-07
Identities = 28/170 (16%), Positives = 53/170 (31%), Gaps = 28/170 (16%)
Query: 426 EVFFNNNNLSGVIPFSLGNLKRLAFLEMSGNELSGTIP-----------------EDIFN 468
E + + + ++ + + +
Sbjct: 6 ETITVPTPIKQIFS--DDAFAETIKDNLKKKSVTDAVTQNELNSIDQIIANNSDIKSVQG 63
Query: 469 ISYLSN--SLNLARNHLVGIIPPRIGNLRALRSFDVSNNDLSGEIPIELGHCSSLEEIYL 526
I YL N L L N L I P + NL+ L + N + ++ L L+ + L
Sbjct: 64 IQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVK-DLS-SLKDLKKLKSLSL 119
Query: 527 AGNLFHGSIPSFFNALKGVQKIDLSRNNLSGQIPIFLEALSLEYLNLSFN 576
N S + L ++ + L N ++ I + L+ L+L N
Sbjct: 120 EHNGI--SDINGLVHLPQLESLYLGNNKIT-DITVLSRLTKLDTLSLEDN 166
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 5e-17
Identities = 66/232 (28%), Positives = 100/232 (43%), Gaps = 34/232 (14%)
Query: 686 FSSTHLIGVGSFGCVYKGALD-EDGIVVAIKVIN-LQCEGASKSFMAECKALKNIRHRNL 743
+++ IG G++G V A D + + VAIK I+ + + + + E K L RH N+
Sbjct: 29 YTNLSYIGEGAYGMVCS-AYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 87
Query: 744 VK---VITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRIS 800
+ +I + + D IV + M E L+ + I L Q
Sbjct: 88 IGINDIIRAPTIEQM--KDV-YIVQDLM-----ETDLYKLLKTQHLSNDHICYFLYQ--- 136
Query: 801 IAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLAR--FHQEVSNSTLS 858
+ L Y+H +LH DLKPSN+LL+ I DFGLAR L+
Sbjct: 137 ----ILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT 189
Query: 859 SSVGVKGTIGYTAPEYGLGSEVSTNG-DVYSYGILLLEMVTAKKPTDVMFEG 909
V T Y APE L S+ T D++S G +L EM++ + +F G
Sbjct: 190 EYV---ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR----PIFPG 234
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 6e-17
Identities = 49/206 (23%), Positives = 79/206 (38%), Gaps = 29/206 (14%)
Query: 692 IGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMA-ECKALKNIRHRNLVKVITSC 750
+G G FG V++ K + +G + + E L RHRN++ + S
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFVK--VKGTDQVLVKKEISILNIARHRNILHLHES- 69
Query: 751 SSIDFQGNDFKAIVYEYMPNGSL-EKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASAL 809
F+ + +++E++ + E R +L + +S V AL
Sbjct: 70 ----FESMEELVMIFEFISGLDIFE----------RINTSAFELNEREIVSYVHQVCEAL 115
Query: 810 DYLHHHCQEPILHCDLKPSNILLDNDLSGH--IGDFGLARFHQEVSNSTLSSSVGVKGTI 867
+LH H I H D++P NI+ S I +FG AR +
Sbjct: 116 QFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP--GDNFRLLF---TAP 167
Query: 868 GYTAPEYGLGSEVSTNGDVYSYGILL 893
Y APE VST D++S G L+
Sbjct: 168 EYYAPEVHQHDVVSTATDMWSLGTLV 193
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 82.9 bits (205), Expect = 6e-17
Identities = 47/257 (18%), Positives = 98/257 (38%), Gaps = 44/257 (17%)
Query: 686 FSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVK 745
+S +G GSFG V + E G A+K + ++ E +K + H N++K
Sbjct: 9 YSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNR----ELDIMKVLDHVNIIK 64
Query: 746 ---VITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTL------L 796
+ + + + + H + + + + + L
Sbjct: 65 LVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTL 124
Query: 797 QRISIAIDVAS-----------------ALDYLHHHCQEPILHCDLKPSNILLD-NDLSG 838
++ + + A+ ++H I H D+KP N+L++ D +
Sbjct: 125 HKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL---GICHRDIKPQNLLVNSKDNTL 181
Query: 839 HIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNG-DVYSYGILLLEMV 897
+ DFG A+ + + + + + + Y APE LG+ T D++S G + E++
Sbjct: 182 KLCDFGSAK--KLIPSEPSVAYI---CSRFYRAPELMLGATEYTPSIDLWSIGCVFGELI 236
Query: 898 TAKKPTDVMFEGDLNLH 914
KP +F G+ ++
Sbjct: 237 L-GKP---LFSGETSID 249
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 7e-17
Identities = 50/204 (24%), Positives = 85/204 (41%), Gaps = 14/204 (6%)
Query: 57 TALDLMSKSLSGSLSPHLGNLSFLREINLSNNTIQGEIPPEFGRLFRLEALFLSNNSLVG 116
++ ++L+ +L P L ++LS N + RL L L L
Sbjct: 13 LEVNCDKRNLT-ALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAEL-T 68
Query: 117 KIPANLSYCSRLTVLCIEYNKLQGRIPLEFVSLSKLKDLSLAKNKLTGGIPP-FLGNLTS 175
K+ L L + +N+LQ +PL +L L L ++ N+LT +P L L
Sbjct: 69 KLQV-DGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGE 125
Query: 176 LEVLSLAGNSFGRNIPDSL-GQLKQLKILAIGGNNLSGPIPPSIY-NLSFLVVFSVSHNQ 233
L+ L L GN + +P L +L+ L++ NNL+ +P + L L + N
Sbjct: 126 LQELYLKGNEL-KTLPPGLLTPTPKLEKLSLANNNLTE-LPAGLLNGLENLDTLLLQENS 183
Query: 234 IHGSLPPSLGLLLPNLKFFQIHHN 257
++ ++P L F +H N
Sbjct: 184 LY-TIPKGF-FGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 3e-14
Identities = 41/205 (20%), Positives = 79/205 (38%), Gaps = 14/205 (6%)
Query: 104 LEALFLSNNSLVGKIPANLSYCSRLTVLCIEYNKLQGRIPLEFVSLSKLKDLSLAKNKLT 163
+ +L +P +L T+L + N L + ++L L+L + +LT
Sbjct: 12 HLEVNCDKRNL-TALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT 68
Query: 164 GGIPPFLGNLTSLEVLSLAGNSFGRNIPDSLGQLKQLKILAIGGNNLSGPIPPSIY-NLS 222
+ G L L L L+ N +++P L L +L + N L+ +P L
Sbjct: 69 -KLQVD-GTLPVLGTLDLSHNQL-QSLPLLGQTLPALTVLDVSFNRLTS-LPLGALRGLG 124
Query: 223 FLVVFSVSHNQIHGSLPPSLGLLLPNLKFFQIHHNFFSGSIPISL-SNASKLEHIEIANN 281
L + N++ +LPP L P L+ + +N + +P L + L+ + + N
Sbjct: 125 ELQELYLKGNELK-TLPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQEN 182
Query: 282 NFSGKLSVNFGGMKNLSLLNLQFSN 306
+ ++ G + L
Sbjct: 183 SLY---TIPKGFFGSHLLPFAFLHG 204
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 1e-13
Identities = 51/214 (23%), Positives = 79/214 (36%), Gaps = 17/214 (7%)
Query: 320 SLTNCSKLRVLSLGGNQFRGALPHSIANLSSQLQILILSSNQFYGSIPLGI-GNLVDLYL 378
++ + ++ ALP +L IL LS N + L L
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALP---PDLPKDTTILHLSENLL-YTFSLATLMPYTRLTQ 59
Query: 379 LGMVENQFTGAIPKEMGKLQKLQGLDFSGNHFSGEIPSSLGNLSSLYEVFFNNNNLSGVI 438
L + + T + G L L LD S N +P L +L + + N L+ +
Sbjct: 60 LNLDRAELT-KLQ-VDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLP 116
Query: 439 PFSLGNLKRLAFLEMSGNELSGTIPEDIFNISYLSN--SLNLARNHLVGIIPPRI-GNLR 495
+L L L L + GNEL T+P + + L+LA N+L +P + L
Sbjct: 117 LGALRGLGELQELYLKGNELK-TLPPGLL--TPTPKLEKLSLANNNLTE-LPAGLLNGLE 172
Query: 496 ALRSFDVSNNDLSGEIPIELGHCSSLEEIYLAGN 529
L + + N L IP L +L GN
Sbjct: 173 NLDTLLLQENSLYT-IPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 1e-11
Identities = 48/189 (25%), Positives = 69/189 (36%), Gaps = 19/189 (10%)
Query: 295 KNLSLLNLQFSNLGSGESDEMGFMNSLTNCSKLRVLSLGGNQFRGALPHSIANLSSQLQI 354
L L +L ++L L+L + L + L
Sbjct: 34 TILHLSENLLYTFSLA---------TLMPYTRLTQLNLDRAELT-KLQ--VDGTLPVLGT 81
Query: 355 LILSSNQFYGSIPLGIGNLVDLYLLGMVENQFTGAIPKEM-GKLQKLQGLDFSGNHFSGE 413
L LS NQ S+PL L L +L + N+ T ++P L +LQ L GN
Sbjct: 82 LDLSHNQL-QSLPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNELK-T 138
Query: 414 IPSSL-GNLSSLYEVFFNNNNLSGVIPFSLGNLKRLAFLEMSGNELSGTIPEDIFNISYL 472
+P L L ++ NNNL+ + L L+ L L + N L TIP+ F L
Sbjct: 139 LPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLL 197
Query: 473 SNSLNLARN 481
L N
Sbjct: 198 PF-AFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 58.6 bits (142), Expect = 2e-09
Identities = 47/185 (25%), Positives = 76/185 (41%), Gaps = 23/185 (12%)
Query: 414 IPSSLGNLSSLYEVFFNNNNLSGVIPFSLGNLKRLAFLEMSGNELSGTIPEDIFNISYLS 473
+P L + N L +L RL L + EL+ + + +
Sbjct: 29 LPKDTTIL------HLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQ--VDGTLPVL 79
Query: 474 NSLNLARNHLVGIIPPRIGNLRALRSFDVSNNDLSGEIPIELG---HCSSLEEIYLAGNL 530
+L+L+ N L + P L AL DVS N L+ + LG L+E+YL GN
Sbjct: 80 GTLDLSHNQLQSL-PLLGQTLPALTVLDVSFNRLTS---LPLGALRGLGELQELYLKGNE 135
Query: 531 FHGSIPS-FFNALKGVQKIDLSRNNLSGQIP--IFLEALSLEYLNLSFNDFEGKIPAKGI 587
++P ++K+ L+ NNL+ ++P + +L+ L L N IP KG
Sbjct: 136 LK-TLPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQENSLYT-IP-KGF 191
Query: 588 FANAS 592
F +
Sbjct: 192 FGSHL 196
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 4e-06
Identities = 27/139 (19%), Positives = 55/139 (39%), Gaps = 12/139 (8%)
Query: 454 SGNELSGTIPEDIFNISYLSNSLNLARNHLVGIIPPRIGNLRALRSFDVSNNDLSGEIPI 513
L+ +P D+ + L+L+ N L + L ++ +L+ ++ +
Sbjct: 18 DKRNLT-ALPPDLP--KDTTI-LHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQV 72
Query: 514 ELGHCSSLEEIYLAGNLFHGSIPSFFNALKGVQKIDLSRNNLSGQIP--IFLEALSLEYL 571
+ G L + L+ N S+P L + +D+S N L+ +P L+ L
Sbjct: 73 D-GTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQEL 129
Query: 572 NLSFNDFEGKIPAKGIFAN 590
L N+ + +P G+
Sbjct: 130 YLKGNELK-TLPP-GLLTP 146
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 83.8 bits (207), Expect = 1e-16
Identities = 58/230 (25%), Positives = 92/230 (40%), Gaps = 43/230 (18%)
Query: 686 FSSTHLIGVGSFGCVYKGALDEDGIVVAIKVIN---LQCEGASKSFMAECKAL---KNIR 739
FS +IG G FG VY + G + A+K ++ ++ + + E L
Sbjct: 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 250
Query: 740 HRNLVKVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRI 799
+V + + F D + + + M G L L H V R
Sbjct: 251 CPFIVCMSYA-----FHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADM---------RF 296
Query: 800 SIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHI--GDFGLARFHQEVSNSTL 857
A ++ L+++H+ +++ DLKP+NILLD GH+ D GLA + S
Sbjct: 297 YAA-EIILGLEHMHNRF---VVYRDLKPANILLDEH--GHVRISDLGLAC---DFSKKKP 347
Query: 858 SSSVGVKGTIGYTAPE-----YGLGSEVSTNGDVYSYGILLLEMVTAKKP 902
+SV GT GY APE S D +S G +L +++ P
Sbjct: 348 HASV---GTHGYMAPEVLQKGVAYDSSA----DWFSLGCMLFKLLRGHSP 390
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 82.6 bits (204), Expect = 1e-16
Identities = 62/256 (24%), Positives = 94/256 (36%), Gaps = 52/256 (20%)
Query: 686 FSSTHLIGVGSFGCVYKGALD-EDGIVVAIKVINL--QCEGASKSFMAECKALKNIRHRN 742
+ HLIG GS+G V + A D + VVAIK I + K + E L + H +
Sbjct: 55 YEIRHLIGTGSYGHVCE-AYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDH 113
Query: 743 LVK---VITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIE--IKLTLLQ 797
+VK ++ F ++ +V E + K + LT L
Sbjct: 114 VVKVLDIVIPKDVEKF--DEL-YVVLEIA-----DSDFK--------KLFRTPVYLTELH 157
Query: 798 RISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTL 857
++ ++ + Y+H ILH DLKP+N L++ D S + DFGLAR N
Sbjct: 158 IKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNS 214
Query: 858 SSSVGVKGTIG-----------------------YTAPEYGLGSEVSTNG-DVYSYGILL 893
+ + Y APE L E T DV+S G +
Sbjct: 215 QLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIF 274
Query: 894 LEMVTAKKPTDVMFEG 909
E++ K
Sbjct: 275 AELLNMIKENVAYHAD 290
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 1e-16
Identities = 46/211 (21%), Positives = 81/211 (38%), Gaps = 33/211 (15%)
Query: 692 IGVGSFGCVYKGALDEDGIVVAIKVINLQCEGAS--KSFMAECKALKNIRHR-NLVKVIT 748
+G G F V + G A K + + G + E L+ + ++ +
Sbjct: 37 LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96
Query: 749 SCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDK---EIEIKLTLLQRISIAIDV 805
++ ++ EY G E + +P+ + E ++ + Q +
Sbjct: 97 V-----YENTSEIILILEYAAGG--E--IFSLCLPELAEMVSENDVIRLIKQ-------I 140
Query: 806 ASALDYLHHHCQEPILHCDLKPSNILLDNDLSGH---IGDFGLARFHQEVSNSTLSSSVG 862
+ YLH + I+H DLKP NILL + I DFG++R L +
Sbjct: 141 LEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGH--ACELREIM- 194
Query: 863 VKGTIGYTAPEYGLGSEVSTNGDVYSYGILL 893
GT Y APE ++T D+++ GI+
Sbjct: 195 --GTPEYLAPEILNYDPITTATDMWNIGIIA 223
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 2e-16
Identities = 54/226 (23%), Positives = 80/226 (35%), Gaps = 64/226 (28%)
Query: 691 LIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSC 750
+G G+ VY+ A+KV+ + K E L + H N++K+
Sbjct: 60 ELGRGATSIVYRCKQKGTQKPYALKVLKKTVD--KKIVRTEIGVLLRLSHPNIIKLKEI- 116
Query: 751 SSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRI----------- 799
F+ ++V E + G L RI
Sbjct: 117 ----FETPTEISLVLELVTGGEL----------------------FDRIVEKGYYSERDA 150
Query: 800 -SIAIDVASALDYLHHHCQEPILHCDLKPSNILL---DNDLSGHIGDFGLARFHQEVSNS 855
+ A+ YLH + I+H DLKP N+L D I DFGL++ +
Sbjct: 151 ADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH--QV 205
Query: 856 TLSSSVGVKGTIGYTAPE----YGLGSEVSTNGDVYSYG----ILL 893
+ + GT GY APE G EV D++S G ILL
Sbjct: 206 LMKTVC---GTPGYCAPEILRGCAYGPEV----DMWSVGIITYILL 244
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 2e-16
Identities = 59/254 (23%), Positives = 103/254 (40%), Gaps = 65/254 (25%)
Query: 691 LIGVGSFGCVY---KGALDEDGIVVAIKVIN----LQCEGASKSFMAECKALKNIRHRN- 742
++G G++G V+ K + + G + A+KV+ +Q ++ E + L++IR
Sbjct: 61 VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 120
Query: 743 LVKVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISI- 801
LV + + FQ ++ +Y+ G L T L +
Sbjct: 121 LVTLHYA-----FQTETKLHLILDYINGGEL-------------------FTHLSQRERF 156
Query: 802 --------AIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHI--GDFGLARFHQE 851
++ AL++LH I++ D+K NILLD++ GH+ DFGL++
Sbjct: 157 TEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSN--GHVVLTDFGLSKEFVA 211
Query: 852 VSNSTLSSSVGVKGTIGYTAPE------YGLGSEVSTNGDVYSYGILLLEMVTAKKPTDV 905
GTI Y AP+ G V D +S G+L+ E++T P
Sbjct: 212 DETERAYDFC---GTIEYMAPDIVRGGDSGHDKAV----DWWSLGVLMYELLTGASP--- 261
Query: 906 MFEGDLNLHNFARM 919
F D ++ A +
Sbjct: 262 -FTVDGEKNSQAEI 274
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 2e-16
Identities = 45/213 (21%), Positives = 81/213 (38%), Gaps = 35/213 (16%)
Query: 692 IGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKS------FMAECKALKNIRHRNLVK 745
+G G F V K G+ A K I + AS+ E L+ + H N++
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 746 VITSCSSIDFQGNDFKAIVYEYMPNGSL-EKWLHPHAVPKRDKEIEIKLTLLQRISIAID 804
+ ++ ++ E + G L + + +++ E + T +
Sbjct: 80 LHDV-----YENRTDVVLILELVSGGELFDF------LAQKESLSEEEATSFIK-----Q 123
Query: 805 VASALDYLHHHCQEPILHCDLKPSNILLDNDLSGH----IGDFGLARFHQEVSNSTLSSS 860
+ ++YLH I H DLKP NI+L + + DFGLA ++ +
Sbjct: 124 ILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED--GVEFKNI 178
Query: 861 VGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILL 893
GT + APE + D++S G++
Sbjct: 179 F---GTPEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 2e-16
Identities = 51/254 (20%), Positives = 90/254 (35%), Gaps = 71/254 (27%)
Query: 667 MRKALPKMSYKSLLKATNGFSST----HLIGVGSFGCVYKGALDEDGIVVAIKVINLQCE 722
M+ + L + + F+ IGVGS+ + + A+K+I+
Sbjct: 1 MQTVGVHSIVQQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR 60
Query: 723 GASKSFMAECKAL-KNIRHRNLVKVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHA 781
++ E + L + +H N++ + + + +V E M G L
Sbjct: 61 DPTE----EIEILLRYGQHPNIITLKDV-----YDDGKYVYVVTELMKGGEL-------- 103
Query: 782 VPKRDKEIEIKLTLLQRI------------SIAIDVASALDYLHHHCQEPILHCDLKPSN 829
L +I ++ + ++YLH ++H DLKPSN
Sbjct: 104 --------------LDKILRQKFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSN 146
Query: 830 ILLDNDLSGH----IGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPE------YGLGSE 879
IL ++ I DFG A+ + N L + T + APE Y
Sbjct: 147 ILYVDESGNPESIRICDFGFAKQLRA-ENGLLMTPC---YTANFVAPEVLERQGYDA--A 200
Query: 880 VSTNGDVYSYGILL 893
D++S G+LL
Sbjct: 201 C----DIWSLGVLL 210
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 2e-16
Identities = 58/232 (25%), Positives = 103/232 (44%), Gaps = 38/232 (16%)
Query: 691 LIGVGSFGCVY---KGALDEDGIVVAIKVIN----LQCEGASKSFMAECKALKNIRHRNL 743
++G G +G V+ K G + A+KV+ ++ + AE L+ ++H +
Sbjct: 24 VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFI 83
Query: 744 VKVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAI 803
V +I + FQ ++ EY+ G L L R+ +A
Sbjct: 84 VDLIYA-----FQTGGKLYLILEYLSGGELFMQLE------REGIFMEDTA---CFYLA- 128
Query: 804 DVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHI--GDFGLARFHQEVSNSTLSSSV 861
+++ AL +LH I++ DLKP NI+L++ GH+ DFGL + + + + T++ +
Sbjct: 129 EISMALGHLHQK---GIIYRDLKPENIMLNHQ--GHVKLTDFGLCK--ESIHDGTVTHTF 181
Query: 862 GVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKP-----TDVMFE 908
GTI Y APE + S + D +S G L+ +M+T P +
Sbjct: 182 C--GTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTID 231
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 2e-16
Identities = 44/215 (20%), Positives = 79/215 (36%), Gaps = 39/215 (18%)
Query: 692 IGVGSFGCVYKGALDEDGIVVAIKVIN------LQCEGASKSFMAECKALKNIRHRNLVK 745
+G G F V K G+ A K I + + E L+ + H N++
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79
Query: 746 VITSCSSIDFQGNDFKAIVYEYMPNGSL-EKWLHPHAVPKRDK--EIEIKLTLLQRISIA 802
+ ++ ++ E + G L + + +++ E E + Q
Sbjct: 80 LHDV-----YENRTDVVLILELVSGGELFDF------LAQKESLSEEEATSFIKQ----- 123
Query: 803 IDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGH----IGDFGLARFHQEVSNSTLS 858
+ ++YLH I H DLKP NI+L + + DFGLA ++
Sbjct: 124 --ILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED--GVEFK 176
Query: 859 SSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILL 893
+ GT + APE + D++S G++
Sbjct: 177 NIF---GTPEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 3e-16
Identities = 44/225 (19%), Positives = 76/225 (33%), Gaps = 63/225 (28%)
Query: 691 LIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKAL-KNIRHRNLVKVITS 749
++G+G G V + G A+K++ S E + ++V ++
Sbjct: 36 VLGLGVNGKVLECFHRRTGQKCALKLLY-----DSPKARQEVDHHWQASGGPHIVCILDV 90
Query: 750 CSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRI---------- 799
++ I+ E M G L RI
Sbjct: 91 YENMHHGKRCL-LIIMECMEGGEL----------------------FSRIQERGDQAFTE 127
Query: 800 ----SIAIDVASALDYLHHHCQEPILHCDLKPSNILL---DNDLSGHIGDFGLARFHQEV 852
I D+ +A+ +LH H I H D+KP N+L + D + DFG A+
Sbjct: 128 REAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKE---T 181
Query: 853 SNSTLSSSVGVKGTIGYTAPE----YGLGSEVSTNGDVYSYGILL 893
+ + L + T Y APE D++S G+++
Sbjct: 182 TQNALQTPC---YTPYYVAPEVLGPEKYDKSC----DMWSLGVIM 219
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 79.9 bits (198), Expect = 3e-16
Identities = 60/237 (25%), Positives = 103/237 (43%), Gaps = 50/237 (21%)
Query: 691 LIGVGSFGCVY---KGALDEDGIVVAIKVINLQCEGASKSF---------MAECKALKNI 738
++G GSFG V+ K + + + A+KV+ K+ E L +
Sbjct: 31 VLGQGSFGKVFLVKKISGSDARQLYAMKVL-------KKATLKVRDRVRTKMERDILVEV 83
Query: 739 RHRNLVKVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQR 798
H +VK+ + FQ ++ +++ G L L ++ + +
Sbjct: 84 NHPFIVKLHYA-----FQTEGKLYLILDFLRGGDLFTRLS------KEVMFTEEDV---K 129
Query: 799 ISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHI--GDFGLARFHQEVSNST 856
+A ++A ALD+LH I++ DLKP NILLD + GHI DFGL++ + + +
Sbjct: 130 FYLA-ELALALDHLHSLG---IIYRDLKPENILLDEE--GHIKLTDFGLSK--ESIDHEK 181
Query: 857 LSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKP-----TDVMFE 908
+ S GT+ Y APE + + D +S+G+L+ EM+T P
Sbjct: 182 KAYSFC--GTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMT 236
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 4e-16
Identities = 62/239 (25%), Positives = 99/239 (41%), Gaps = 39/239 (16%)
Query: 691 LIGVGSFGCVYKGALD-EDGIVVAIKVINLQCEGASKSF----MAECKALKNIRHR---N 742
LIG GSFG V K A D + VAIK+I K+F E + L+ +
Sbjct: 61 LIGKGSFGQVVK-AYDRVEQEWVAIKIIK-----NKKAFLNQAQIEVRLLELMNKHDTEM 114
Query: 743 LVKVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIA 802
++ F+ + +V+E + + +L L + + L L ++ A
Sbjct: 115 KYYIVHLKRHFMFRNHLC--LVFEML-SYNLYDLL------RNTNFRGVSLNLTRKF--A 163
Query: 803 IDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIG--DFGLARFHQEVSNSTLSSS 860
+ +AL +L + I+HCDLKP NILL N I DFG + + + S
Sbjct: 164 QQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSR 222
Query: 861 VGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARM 919
Y +PE LG D++S G +L+EM T + +F G + ++
Sbjct: 223 F-------YRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE----PLFSGANEVDQMNKI 270
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 80.0 bits (197), Expect = 5e-16
Identities = 57/271 (21%), Positives = 96/271 (35%), Gaps = 70/271 (25%)
Query: 690 HLIGVGSFGCVYKGAL-----DEDGIVVAIKVINLQCEGAS----KSFMAECKALKNI-R 739
+G G+FG V + VA+K++ EGA+ ++ M+E K L +I
Sbjct: 28 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLK---EGATHSEHRALMSELKILIHIGH 84
Query: 740 HRNLVKVITSCSSIDF------------------------------------QGNDFKAI 763
H N+V ++ +C+ QG D+
Sbjct: 85 HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGA 144
Query: 764 VYEYMPNGS---------------LEKWLHPHAVPKRDKEIEIK-LTLLQRISIAIDVAS 807
+ + EK L + +++ LTL I + VA
Sbjct: 145 IPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAK 204
Query: 808 ALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTI 867
+++L +H DL NILL I DFGLAR + + + +
Sbjct: 205 GMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYK--DPDYVRKGDARLPL 259
Query: 868 GYTAPEYGLGSEVSTNGDVYSYGILLLEMVT 898
+ APE + DV+S+G+LL E+ +
Sbjct: 260 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 6e-16
Identities = 60/228 (26%), Positives = 100/228 (43%), Gaps = 34/228 (14%)
Query: 691 LIGVGSFGCVYKGALDEDGIVVAIKVI---NLQCEGASKSFMAECKALKNIRHRNLVKVI 747
L+G G+FG V G A+K++ + + + E + L+N RH L +
Sbjct: 12 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 71
Query: 748 TSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVAS 807
+ FQ +D V EY G L L R++ + R A ++ S
Sbjct: 72 YA-----FQTHDRLCFVMEYANGGELFFHLS------RERVFTEERA---RFYGA-EIVS 116
Query: 808 ALDYLHHHCQEPILHCDLKPSNILLDNDLSGHI--GDFGLARFHQEVSNSTLSSSVGVKG 865
AL+YLH +++ D+K N++LD D GHI DFGL + + +S+ + G
Sbjct: 117 ALEYLHSR---DVVYRDIKLENLMLDKD--GHIKITDFGLCK--EGISDGATMKTFC--G 167
Query: 866 TIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKP-----TDVMFE 908
T Y APE ++ D + G+++ EM+ + P + +FE
Sbjct: 168 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFE 215
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 7e-16
Identities = 51/218 (23%), Positives = 81/218 (37%), Gaps = 41/218 (18%)
Query: 692 IGVGSFGCVYKGALDEDGIVVAIKVIN------LQCEGASKSFMAECKALKNIRHRNLVK 745
+G G F V K G A K I + + + E L+ IRH N++
Sbjct: 13 LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72
Query: 746 VITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDK--EIEIKLTLLQRISIAI 803
+ F+ ++ E + G L + +++ E E L Q
Sbjct: 73 LHDI-----FENKTDVVLILELVSGGELF-----DFLAEKESLTEDEATQFLKQ------ 116
Query: 804 DVASALDYLHHHCQEPILHCDLKPSNILL-DNDLSGH---IGDFGLARFHQEVSNSTLSS 859
+ + YLH I H DLKP NI+L D ++ + DFG+A + + +
Sbjct: 117 -ILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEA--GNEFKN 170
Query: 860 SVGVKGTIGYTAPEYGLGSEVSTNGDVYSYG----ILL 893
GT + APE + D++S G ILL
Sbjct: 171 IF---GTPEFVAPEIVNYEPLGLEADMWSIGVITYILL 205
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 79.8 bits (197), Expect = 9e-16
Identities = 60/249 (24%), Positives = 98/249 (39%), Gaps = 43/249 (17%)
Query: 686 FSSTHLIGVGSFGCVYKGALD-EDGIVVAIKVIN--LQCEGASKSFMAECKALKNIRHRN 742
+ HLIG GS+G VY A D VAIK +N + K + E L ++
Sbjct: 28 YIIKHLIGRGSYGYVYL-AYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDY 86
Query: 743 LVK---VITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRI 799
+++ +I + F ++ IV E + L + K I LT
Sbjct: 87 IIRLYDLIIPDDLLKF--DEL-YIVLEIA-----DSDLK--KLFKTP----IFLTEEHIK 132
Query: 800 SIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSS 859
+I ++ +++H + I+H DLKP+N LL+ D S + DFGLAR ++ + +
Sbjct: 133 TILYNLLLGENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVN 189
Query: 860 SVGVKGTIG------------------YTAPEYGLGSEVSTNG-DVYSYGILLLEMVTAK 900
+ G Y APE L E T D++S G + E++
Sbjct: 190 DLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNML 249
Query: 901 KPTDVMFEG 909
+
Sbjct: 250 QSHINDPTN 258
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 2e-15
Identities = 50/215 (23%), Positives = 83/215 (38%), Gaps = 39/215 (18%)
Query: 692 IGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKS------FMAECKALKNIRHRNLVK 745
+G G F V K G+ A K I + +S+ E LK I+H N++
Sbjct: 19 LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 746 VITSCSSIDFQGNDFKAIVYEYMPNGSL-EKWLHPHAVPKRDK--EIEIKLTLLQRISIA 802
+ ++ ++ E + G L + + +++ E E L Q
Sbjct: 79 LHEV-----YENKTDVILILELVAGGELFDF------LAEKESLTEEEATEFLKQ----- 122
Query: 803 IDVASALDYLHHHCQEPILHCDLKPSNILL-DNDLSGH---IGDFGLARFHQEVSNSTLS 858
+ + + YLH I H DLKP NI+L D ++ I DFGLA +
Sbjct: 123 --ILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF--GNEFK 175
Query: 859 SSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILL 893
+ GT + APE + D++S G++
Sbjct: 176 NIF---GTPEFVAPEIVNYEPLGLEADMWSIGVIT 207
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 77.6 bits (191), Expect = 3e-15
Identities = 41/168 (24%), Positives = 66/168 (39%), Gaps = 16/168 (9%)
Query: 54 RRVTALDLMSKSLSGSLSPH--LGNLSFLREINLSNNTIQGEIPPE-FGRLFRLEALFLS 110
LDL +LS L L+ L + LS+N + I E F + L L LS
Sbjct: 39 SYTALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLS 96
Query: 111 NNSLVGKIPAN-LSYCSRLTVLCIEYNKLQGRIPLE-FVSLSKLKDLSLAKNKLTGGIPP 168
+N L + S L VL + N + + F +++L+ L L++N+++ P
Sbjct: 97 SNHLH-TLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQISR-FPV 153
Query: 169 ----FLGNLTSLEVLSLAGNSFGRNIPDSLGQLKQLK--ILAIGGNNL 210
L L +L L+ N + L +L L + N L
Sbjct: 154 ELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPL 201
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 69.9 bits (171), Expect = 1e-12
Identities = 32/192 (16%), Positives = 65/192 (33%), Gaps = 21/192 (10%)
Query: 125 CSRLTVLCIEYNKLQ---GRIPLEFVSLSKLKDLSLAKNKLTGGIPP--FLGNLTSLEVL 179
C+ + C +L +P L L+ N L+ + LT+L L
Sbjct: 18 CASNILSCS-KQQLPNVPQSLPSY------TALLDLSHNNLSR-LRAEWTPTRLTNLHSL 69
Query: 180 SLAGNSFGRNIPDSLGQLKQLKILAIGGNNLSGPIPPSI-YNLSFLVVFSVSHNQIHGSL 238
L+ N ++ + L+ L + N+L + + +L L V + +N I +
Sbjct: 70 LLSHNHLNFISSEAFVPVPNLRYLDLSSNHLHT-LDEFLFSDLQALEVLLLYNNHIV-VV 127
Query: 239 PPSLGLLLPNLKFFQIHHNFFSGSIP----ISLSNASKLEHIEIANNNFSGKLSVNFGGM 294
+ + L+ + N S P + KL +++++N + +
Sbjct: 128 DRNAFEDMAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKL 186
Query: 295 KNLSLLNLQFSN 306
L N
Sbjct: 187 PAWVKNGLYLHN 198
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 66.0 bits (161), Expect = 2e-11
Identities = 36/168 (21%), Positives = 68/168 (40%), Gaps = 11/168 (6%)
Query: 346 ANLSSQLQILILSSNQFYGSIPLGI--GNLVDLYLLGMVENQFTGAIPKEM-GKLQKLQG 402
+L S +L LS N + L +L+ L + N I E + L+
Sbjct: 35 QSLPSYTALLDLSHNNL-SRLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPNLRY 92
Query: 403 LDFSGNHFSGEIPS-SLGNLSSLYEVFFNNNNLSGVIPFSLGNLKRLAFLEMSGNELSGT 461
LD S NH + +L +L + NN++ V + ++ +L L +S N++S
Sbjct: 93 LDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQIS-R 150
Query: 462 IPEDIF-NISYLSN--SLNLARNHLVGIIPPRIGNLRALRSFDVSNND 506
P ++ + + L L+L+ N L + + L A + ++
Sbjct: 151 FPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHN 198
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 52.5 bits (126), Expect = 3e-07
Identities = 39/171 (22%), Positives = 63/171 (36%), Gaps = 42/171 (24%)
Query: 414 IPSSLGNLSSLYEVFFNNNNLSGVIP-FSLGNLKRLAFLEMSGNELSGTIPEDIFNISYL 472
+PS L ++NNLS + ++ L L L +S N L+ I + F
Sbjct: 37 LPSYTALL------DLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFV---- 85
Query: 473 SNSLNLARNHLVGIIPPRIGNLRALRSFDVSNNDLSGEIPIE-LGHCSSLEEIYLAGNLF 531
+ LR D+S+N L + +LE + L N
Sbjct: 86 --------------------PVPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHI 124
Query: 532 HGSIPSF-FNALKGVQKIDLSRNNLSGQIP--IF--LEAL-SLEYLNLSFN 576
+ F + +QK+ LS+N +S + P + L L L+LS N
Sbjct: 125 V-VVDRNAFEDMAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSN 173
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 49.5 bits (118), Expect = 3e-06
Identities = 39/193 (20%), Positives = 72/193 (37%), Gaps = 35/193 (18%)
Query: 247 PNLKFFQIHHNFFSGSIP--ISLSNASKLEHIEIANNNFSGKLSVN-FGGMKNLSLLNLQ 303
+ HN S + + + + L + +++N+ + +S F + NL L+L
Sbjct: 39 SYTALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLS 96
Query: 304 FSNLGSGESDEMGFMNSLTNCSKLRVLSLGGNQFRGALPHSIANLSSQLQILILSSNQFY 363
++L + + ++ L VL L N ++ ++ +QLQ L LS NQ
Sbjct: 97 SNHLHTLDEF------LFSDLQALEVLLLYNNHIVVVDRNAFEDM-AQLQKLYLSQNQIS 149
Query: 364 GSIPLGIGNLVDLYLLGMVENQFTGAIPKEMGKLQKLQGLDFSGNHFSGEIPSSLGNLSS 423
P+ + KL KL LD S N + L L +
Sbjct: 150 -RFPVEL---------------IKD-----GNKLPKLMLLDLSSNKLKKLPLTDLQKLPA 188
Query: 424 LYE--VFFNNNNL 434
+ ++ +NN L
Sbjct: 189 WVKNGLYLHNNPL 201
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 4e-15
Identities = 62/234 (26%), Positives = 96/234 (41%), Gaps = 35/234 (14%)
Query: 686 FSSTHLIGVGSFGCVYKGALDEDGIVVAIKVI---NLQCEGASKSFMAECKAL-KNIRHR 741
F ++G GSFG V+ + AIK + + + + M E + L H
Sbjct: 19 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 78
Query: 742 NLVKVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISI 801
L + + FQ + V EY+ G L + K L +
Sbjct: 79 FLTHMFCT-----FQTKENLFFVMEYLNGGDLMYHIQS----------CHKFDLSRATFY 123
Query: 802 AIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHI--GDFGLARFHQEVSNSTLSS 859
A ++ L +LH I++ DLK NILLD D GHI DFG+ + + T +
Sbjct: 124 AAEIILGLQFLHSK---GIVYRDLKLDNILLDKD--GHIKIADFGMCKENMLGDAKTNT- 177
Query: 860 SVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKP-----TDVMFE 908
GT Y APE LG + + + D +S+G+LL EM+ + P + +F
Sbjct: 178 ---FCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFH 228
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 5e-15
Identities = 55/185 (29%), Positives = 91/185 (49%), Gaps = 15/185 (8%)
Query: 80 LREINLSNNTIQGEIPPE-FGRLFRLEALFLSNNSLVGKIPANL-SYCSRLTVLCIEYNK 137
++++L +N + +P + F RL +L L+L++N L +PA + L L + NK
Sbjct: 39 TKKLDLQSNKLS-SLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNK 96
Query: 138 LQGRIPLE-FVSLSKLKDLSLAKNKLTGGIPP--FLGNLTSLEVLSLAGNSFGRNIPDSL 194
LQ +P+ F L L +L L +N+L +PP F +LT L LSL N +++P +
Sbjct: 97 LQ-ALPIGVFDQLVNLAELRLDRNQLK-SLPPRVF-DSLTKLTYLSLGYNEL-QSLPKGV 152
Query: 195 -GQLKQLKILAIGGNNLSGPIPPSIY-NLSFLVVFSVSHNQIHGSLPPSLGLLLPNLKFF 252
+L LK L + N L +P + L+ L + +NQ+ +P L LK
Sbjct: 153 FDKLTSLKELRLYNNQLKR-VPEGAFDKLTELKTLKLDNNQLK-RVPEGAFDSLEKLKML 210
Query: 253 QIHHN 257
Q+ N
Sbjct: 211 QLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 2e-11
Identities = 52/191 (27%), Positives = 89/191 (46%), Gaps = 17/191 (8%)
Query: 118 IPANLSYCSRLTVLCIEYNKLQGRIPLEFVSLSKLKDLSLAKNKLTGGIPP--FLGNLTS 175
IPA+ L ++ NKL F L+KL+ L L NKL +P F L +
Sbjct: 35 IPADT------KKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKE-LKN 86
Query: 176 LEVLSLAGNSFGRNIPDSL-GQLKQLKILAIGGNNLSGPIPPSIY-NLSFLVVFSVSHNQ 233
LE L + N + +P + QL L L + N L +PP ++ +L+ L S+ +N+
Sbjct: 87 LETLWVTDNKL-QALPIGVFDQLVNLAELRLDRNQLKS-LPPRVFDSLTKLTYLSLGYNE 144
Query: 234 IHGSLPPSLGLLLPNLKFFQIHHNFFSGSIPISL-SNASKLEHIEIANNNFSGKLSVNFG 292
+ SLP + L +LK ++++N +P ++L+ +++ NN F
Sbjct: 145 LQ-SLPKGVFDKLTSLKELRLYNNQLK-RVPEGAFDKLTELKTLKLDNNQLKRVPEGAFD 202
Query: 293 GMKNLSLLNLQ 303
++ L +L LQ
Sbjct: 203 SLEKLKMLQLQ 213
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 2e-10
Identities = 51/209 (24%), Positives = 84/209 (40%), Gaps = 17/209 (8%)
Query: 280 NNNFSGKLSVN-FGGMKNLSLLNLQFSNLGSGESDEMGFMNSLTNCSKLRVLSLGGNQFR 338
+N S L F + L LL L + L + + G L N L L + N+ +
Sbjct: 46 SNKLS-SLPSKAFHRLTKLRLLYLNDNKLQTLPA---GIFKELKN---LETLWVTDNKLQ 98
Query: 339 GALPHSIANLSSQLQILILSSNQFYGSIPLGI-GNLVDLYLLGMVENQFTGAIPKEM-GK 396
ALP + + L L L NQ S+P + +L L L + N+ ++PK + K
Sbjct: 99 -ALPIGVFDQLVNLAELRLDRNQL-KSLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVFDK 155
Query: 397 LQKLQGLDFSGNHFSGEIPSSLGNLSSLYEVFFNNNNLSGVIPFSLGNLKRLAFLEMSGN 456
L L+ L N + L+ L + +NN L V + +L++L L++ N
Sbjct: 156 LTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215
Query: 457 ELSGTIPEDIFNISYLSNSLNLARNHLVG 485
T I Y++ L + +G
Sbjct: 216 PWDCTCNG----IIYMAKWLKKKADEGLG 240
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 7e-10
Identities = 38/135 (28%), Positives = 58/135 (42%), Gaps = 14/135 (10%)
Query: 57 TALDLMSKSLSGSLSPHL-GNLSFLREINLSNNTIQGEIPPE-FGRLFRLEALFLSNNSL 114
L + L +L + L L E+ L N ++ +PP F L +L L L N L
Sbjct: 88 ETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNEL 145
Query: 115 VGKIPAN----LSYCSRLTVLCIEYNKLQGRIPLE-FVSLSKLKDLSLAKNKLTGGIPPF 169
+P L+ L L + N+L+ R+P F L++LK L L N+L
Sbjct: 146 Q-SLPKGVFDKLT---SLKELRLYNNQLK-RVPEGAFDKLTELKTLKLDNNQLKRVPEGA 200
Query: 170 LGNLTSLEVLSLAGN 184
+L L++L L N
Sbjct: 201 FDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 4e-09
Identities = 45/189 (23%), Positives = 83/189 (43%), Gaps = 11/189 (5%)
Query: 346 ANLSSQLQILILSSNQFYGSIPLGI-GNLVDLYLLGMVENQFTGAIPKEM-GKLQKLQGL 403
+N+ + + L L SN+ S+P L L LL + +N+ +P + +L+ L+ L
Sbjct: 33 SNIPADTKKLDLQSNKL-SSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETL 90
Query: 404 DFSGNHFSGEIPSSL-GNLSSLYEVFFNNNNLSGVIPFSLGNLKRLAFLEMSGNELSGTI 462
+ N +P + L +L E+ + N L + P +L +L +L + NEL ++
Sbjct: 91 WVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQ-SL 148
Query: 463 PEDIFNISYLSN--SLNLARNHLVGIIPPRIGNLRALRSFDVSNNDLSGEIPIELGHCSS 520
P+ +F+ L++ L L N L + L L++ + NN L
Sbjct: 149 PKGVFD--KLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEK 206
Query: 521 LEEIYLAGN 529
L+ + L N
Sbjct: 207 LKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 1e-08
Identities = 49/184 (26%), Positives = 79/184 (42%), Gaps = 14/184 (7%)
Query: 400 LQGLDFSGNHFSGEIPSSLGNLSSLYEVFFNNNNLSGVIPFSLGNLKRLAFLEMSGNELS 459
+ LD N S + L+ L ++ N+N L + LK L L ++ N+L
Sbjct: 39 TKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQ 98
Query: 460 GTIPEDIFNISYLSN--SLNLARNHLVGIIPPRI-GNLRALRSFDVSNNDLSGEIPIEL- 515
+P +F L N L L RN L + PPR+ +L L + N+L +P +
Sbjct: 99 -ALPIGVF--DQLVNLAELRLDRNQLKSL-PPRVFDSLTKLTYLSLGYNELQ-SLPKGVF 153
Query: 516 GHCSSLEEIYLAGNLFHGSIPSF-FNALKGVQKIDLSRNNLSGQIP--IFLEALSLEYLN 572
+SL+E+ L N +P F+ L ++ + L N L ++P F L+ L
Sbjct: 154 DKLTSLKELRLYNNQLK-RVPEGAFDKLTELKTLKLDNNQLK-RVPEGAFDSLEKLKMLQ 211
Query: 573 LSFN 576
L N
Sbjct: 212 LQEN 215
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 9e-15
Identities = 71/236 (30%), Positives = 102/236 (43%), Gaps = 49/236 (20%)
Query: 691 LIGVGSFGCVYKGALDEDGIVVAIKVI---NLQCEGASKSFMAECKAL-KNIRHRNLVKV 746
+IG GSFG V + + A+KV+ + + K M+E L KN++H LV +
Sbjct: 45 VIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 104
Query: 747 ITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLH-------PHAVPKRDKEIEIKLTLLQRI 799
S FQ D V +Y+ G L L P A R
Sbjct: 105 HFS-----FQTADKLYFVLDYINGGELFYHLQRERCFLEPRA----------------RF 143
Query: 800 SIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHI--GDFGLARFHQEVSNSTL 857
A ++ASAL YLH I++ DLKP NILLD+ GHI DFGL + + + +++
Sbjct: 144 YAA-EIASALGYLHSL---NIVYRDLKPENILLDSQ--GHIVLTDFGLCK--ENIEHNST 195
Query: 858 SSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKP-----TDVMFE 908
+S+ GT Y APE D + G +L EM+ P T M++
Sbjct: 196 TSTFC--GTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYD 249
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 76.6 bits (188), Expect = 2e-14
Identities = 56/234 (23%), Positives = 97/234 (41%), Gaps = 35/234 (14%)
Query: 686 FSSTHLIGVGSFGCVYKGALDEDGIVVAIKVI---NLQCEGASKSFMAECKALKNI-RHR 741
F+ ++G GSFG V + A+K++ + + + M E + L +
Sbjct: 343 FNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPP 402
Query: 742 NLVKVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISI 801
L + + SC FQ D V EY+ G L + + +
Sbjct: 403 FLTQ-LHSC----FQTMDRLYFVMEYVNGGDLMYHIQQ----------VGRFKEPHAVFY 447
Query: 802 AIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHI--GDFGLARFHQEVSNSTLSS 859
A ++A L +L I++ DLK N++LD++ GHI DFG+ + + +T +
Sbjct: 448 AAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSE--GHIKIADFGMCKENIWDGVTTKT- 501
Query: 860 SVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKP-----TDVMFE 908
GT Y APE + D +++G+LL EM+ + P D +F+
Sbjct: 502 ---FCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQ 552
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 75.2 bits (185), Expect = 2e-14
Identities = 46/266 (17%), Positives = 87/266 (32%), Gaps = 70/266 (26%)
Query: 656 RGPSRLPSRPMMRKALPKMSYKSLLKATNGFS----STHLIGVGSFGCVYKGALDEDGIV 711
P++ P P + + +K ++ ++G+G G V +
Sbjct: 30 HPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEK 89
Query: 712 VAIKVINLQCEGASKSFMAECKALKNI-RHRNLVKVITSCSSIDFQGNDFKAIVYEYMPN 770
A+K++ E + + ++V+++ + + G IV E +
Sbjct: 90 FALKMLQ-----DCPKARREVELHWRASQCPHIVRIVDVYEN-LYAGRKCLLIVMECLDG 143
Query: 771 GSLEKWLHPHAVPKRDKEIEIKLTLLQRI--------------SIAIDVASALDYLHHHC 816
G L RI I + A+ YLH
Sbjct: 144 GEL----------------------FSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN 181
Query: 817 QEPILHCDLKPSNILL---DNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPE 873
I H D+KP N+L + + DFG A+ +++L++ T Y APE
Sbjct: 182 ---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS--HNSLTTPC---YTPYYVAPE 233
Query: 874 ------YGLGSEVSTNGDVYSYGILL 893
Y D++S G+++
Sbjct: 234 VLGPEKYDK--SC----DMWSLGVIM 253
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 3e-14
Identities = 40/212 (18%), Positives = 69/212 (32%), Gaps = 16/212 (7%)
Query: 56 VTALDLMSKSLSGSLSPH-LGNLSFLREINLSNNTIQGEIPPE-FGRLFRLEALFLSNNS 113
L L+ L ++ H NL + I +S + ++ F L ++ + + N
Sbjct: 33 TQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTR 91
Query: 114 LVGKIPAN-LSYCSRLTVLCIEYNKLQGRIP--LEFVSLSKLKDLSLAKNKLTGGIPP-- 168
+ I + L L L I L+ P + S L + N IP
Sbjct: 92 NLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVNA 150
Query: 169 FLGNLTSLEVLSLAGNSFGRNIPDSLGQLKQLKILAIGGNNLSGPIPPSIYN--LSFLVV 226
F G L L N F ++ +L + + N I + S +
Sbjct: 151 FQGLCNETLTLKLYNNGF-TSVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSL 209
Query: 227 FSVSHNQIHGSLPPSLGLLLPNLKFFQIHHNF 258
VS + +LP L +LK + +
Sbjct: 210 LDVSQTSVT-ALPSK---GLEHLKELIARNTW 237
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 4e-14
Identities = 35/231 (15%), Positives = 79/231 (34%), Gaps = 35/231 (15%)
Query: 80 LREINLSNNTIQGEIPPE-FGRLFRLEALFLSNNSLVGKIPANL-SYCSRLTVLCIEYNK 137
+ + L ++ IP F L + +++S + + ++ ++ S++T + I +
Sbjct: 33 TQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTR 91
Query: 138 LQGRIPLE-FVSLSKLKDLSLAKNKLTGGIPP--FLGNLTSLEVLSLAGNSFGRNIPDSL 194
I + L LK L + L P + + +L + N + +IP +
Sbjct: 92 NLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVNA 150
Query: 195 --GQLKQLKILAIGGNNLSGPIPPSIYNLSFLVVFSVSHNQIHGSLPPSLGLLLPNLKFF 252
G + L + N + + +N + L ++ N+ L
Sbjct: 151 FQGLCNETLTLKLYNNGFTS-VQGYAFNGTKLDAVYLNKNK--------------YLT-- 193
Query: 253 QIHHNFFSGSIPISLSNASKLEHIEIANNNFSGKLSVN-FGGMKNLSLLNL 302
I + F G S ++++ + + L +K L N
Sbjct: 194 VIDKDAFGG-------VYSGPSLLDVSQTSVT-ALPSKGLEHLKELIARNT 236
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 2e-11
Identities = 40/242 (16%), Positives = 79/242 (32%), Gaps = 42/242 (17%)
Query: 324 CSKLRVLSLGGNQFRGALPHSIANLSSQLQILILSSNQFYGSIPLGIGNLVDLYLLGMVE 383
C + + + I +L Q L L +IP
Sbjct: 10 CHQEEDFRVTCKDIQ-----RIPSLPPSTQTLKLIETHL-RTIP---------------S 48
Query: 384 NQFTGAIPKEMGKLQKLQGLDFSGNHFSGEIP----SSLGNLSSLYEVFFNNNNLSGVIP 439
+ F+ L + + S + ++ +L ++ + N NL+ + P
Sbjct: 49 HAFSN--------LPNISRIYVSIDVTLQQLESHSFYNLSKVTHIE--IRNTRNLTYIDP 98
Query: 440 FSLGNLKRLAFLEMSGNELSGTIPEDIFNISYLSN-SLNLARNHLVGIIPPRI--GNLRA 496
+L L L FL + L P+ S L + N + IP G
Sbjct: 99 DALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNE 157
Query: 497 LRSFDVSNNDLSGEIPIELGHCSSLEEIYLAGNLFHGSIP--SFFNALKGVQKIDLSRNN 554
+ + NN + + + + L+ +YL N + I +F G +D+S+ +
Sbjct: 158 TLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTS 216
Query: 555 LS 556
++
Sbjct: 217 VT 218
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 1e-09
Identities = 33/217 (15%), Positives = 76/217 (35%), Gaps = 21/217 (9%)
Query: 245 LLPNLKFFQIHHNFFSGSIPI-SLSNASKLEHIEIANNNFSGKLSVN-FGGMKNLSLLNL 302
L P+ + ++ +IP + SN + I ++ + +L + F + ++ + +
Sbjct: 29 LPPSTQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEI 87
Query: 303 ----QFSNLGSGESDEMGFMNSLTNCSKLRVLSLGGNQFRGALPHSIANLSSQLQILILS 358
+ + +L L+ L + + + + IL ++
Sbjct: 88 RNTRNLTYIDPD---------ALKELPLLKFLGIFNTGLKMFPDLTKVYSTDIFFILEIT 138
Query: 359 SNQFYGSIPLGI--GNLVDLYLLGMVENQFTGAIPKEMGKLQKLQGLDFSGNHFSGEIPS 416
N + SIP+ G + L + N FT ++ KL + + N + I
Sbjct: 139 DNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDK 197
Query: 417 SL--GNLSSLYEVFFNNNNLSGVIPFSLGNLKRLAFL 451
G S + + +++ + L +LK L
Sbjct: 198 DAFGGVYSGPSLLDVSQTSVTALPSKGLEHLKELIAR 234
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 74.8 bits (183), Expect = 7e-14
Identities = 38/146 (26%), Positives = 58/146 (39%), Gaps = 7/146 (4%)
Query: 32 LNSWNDSRHFCEWEGITCGRRHRRVTALDLMSKSLSGSLSPHLGNLSFLREINLSNNTIQ 91
+D R E + V L L K L+ L HL L + ++LS+N ++
Sbjct: 419 AAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLT-VL-CHLEQLLLVTHLDLSHNRLR 476
Query: 92 GEIPPEFGRLFRLEALFLSNNSLVGKIPANLSYCSRLTVLCIEYNKLQG-RIPLEFVSLS 150
+PP L LE L S+N+L + ++ RL L + N+LQ VS
Sbjct: 477 -ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCP 533
Query: 151 KLKDLSLAKNKLTGGIPPFLGNLTSL 176
+L L+L N L L +
Sbjct: 534 RLVLLNLQGNSLC-QEEGIQERLAEM 558
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 71.7 bits (175), Expect = 5e-13
Identities = 58/362 (16%), Positives = 115/362 (31%), Gaps = 57/362 (15%)
Query: 7 AALEDGDRAALQAFKSMIAHEPQGILNSWNDSRHFCEWEGITCGRRHRRVTALDLMSKSL 66
+ E+ + + + +L +++ EW R V DL + SL
Sbjct: 250 VSREEACLSVCFSRPLTVGSRMGTLLLMVDEAPLSVEWRTPDGRNRPSHVWLCDLPAASL 309
Query: 67 SGSLS-----PHLGNLSFLREINLSNNTIQGEIPPEFGRLFRLEALFLSNNSLVGKIPAN 121
+ L +E L + + + +L LS + +
Sbjct: 310 NDQLPQHTFRVIWTGSDSQKECVLLKDRPECW-CRDSATDEQLFRCELSVEKST-VLQSE 367
Query: 122 LSYCSRLTVLCIEYNKLQGRIPLEFVSLSKLKDLSLAKNKLTGGIPPFLGNLTSLEVLSL 181
L C L L E I L + L L K L + L +++ +
Sbjct: 368 LESCKELQELEPENKWCLLTIILL---MRALDPLLYEKETLQ-----YFSTLKAVDPMRA 419
Query: 182 AGNSFGR-----NIPDSLGQLKQLKILAIGGNNLSGPIPPSIYNLSFLVVFSVSHNQIHG 236
A R + +++L + +L+ + + L + +SHN++
Sbjct: 420 AYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLR- 476
Query: 237 SLPPSLGLLLPNLKFFQIHHNFFSGSIPISLSNASKLEHIEIANNNFSGKLSVNFGGMKN 296
+LPP+L L L+ Q N LE+++ +
Sbjct: 477 ALPPALAAL-RCLEVLQASDN--------------ALENVD------------GVANLPR 509
Query: 297 LSLLNLQFSNLGSGESDEMGFMNSLTNCSKLRVLSLGGNQFRGA--LPHSIANLSSQLQI 354
L L L + L + + L +C +L +L+L GN + +A + +
Sbjct: 510 LQELLLCNNRLQQSAAIQ-----PLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSS 564
Query: 355 LI 356
++
Sbjct: 565 IL 566
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 64.4 bits (156), Expect = 1e-10
Identities = 32/186 (17%), Positives = 65/186 (34%), Gaps = 9/186 (4%)
Query: 391 PKEMGKLQKLQGLDFSGNHFSGEIPSSLGNLSSLYEVFFNNNNLSGVIPFSLGNLKRLAF 450
++ ++L + S S + S L + L E+ N I + L L +
Sbjct: 342 CRDSATDEQLFRCELSVEK-STVLQSELESCKELQELEPENKWCLLTIILLMRALDPLLY 400
Query: 451 LEMSGNELSGTIPEDIFNISYLSNSLNLARNHLVGIIPPRIGNLRALRSFDVSNNDLSGE 510
+ + S D +YL + R+ + +R +++ DL+
Sbjct: 401 EKETLQYFSTLKAVDPMRAAYLDDL----RSKFLLENSVLKMEYADVRVLHLAHKDLT-V 455
Query: 511 IPIELGHCSSLEEIYLAGNLFHGSIPSFFNALKGVQKIDLSRNNLSGQIPIFLEALSLEY 570
+ L + + L+ N ++P AL+ ++ + S N L + L+
Sbjct: 456 LC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVDGVANLPRLQE 512
Query: 571 LNLSFN 576
L L N
Sbjct: 513 LLLCNN 518
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 61.7 bits (149), Expect = 7e-10
Identities = 35/212 (16%), Positives = 71/212 (33%), Gaps = 21/212 (9%)
Query: 351 QLQILILSSNQFYGSIPLGIGNLVDLYLLGMVENQFTGAIPKEMGKLQKLQGLDFSGNHF 410
QL LS + + + + +L L I M L L + +F
Sbjct: 350 QLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYF 408
Query: 411 SGEIPSSLGNLSSL--YEVFFNNNNLSGVIPFSLGNLKRLAFLEMSGNELSGTIPEDIFN 468
S +L + + + + + L ++ +L+ + +
Sbjct: 409 S-----TLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLT-----VLCH 458
Query: 469 ISYLSN--SLNLARNHLVGIIPPRIGNLRALRSFDVSNNDLSGEIPIELGHCSSLEEIYL 526
+ L L+L+ N L + PP + LR L S+N L + + + L+E+ L
Sbjct: 459 LEQLLLVTHLDLSHNRLRAL-PPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLL 515
Query: 527 AGNLFHGSIPSF--FNALKGVQKIDLSRNNLS 556
N + + + ++L N+L
Sbjct: 516 CNNRL-QQSAAIQPLVSCPRLVLLNLQGNSLC 546
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 9e-14
Identities = 56/241 (23%), Positives = 98/241 (40%), Gaps = 49/241 (20%)
Query: 686 FSSTHLIGVGSFGCVYKGALDEDGIVVAIKVI---NLQCEGASKSFMAECKAL-KNIRHR 741
F+ ++G GSFG V + A+K++ + + + M E + L +
Sbjct: 22 FNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPP 81
Query: 742 NLVKVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLH-------PHAVPKRDKEIEIKLT 794
L ++ + FQ D V EY+ G L + PHA
Sbjct: 82 FLTQLHSC-----FQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHA------------- 123
Query: 795 LLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHI--GDFGLARFHQEV 852
A ++A L +L I++ DLK N++LD++ GHI DFG+ + + +
Sbjct: 124 ---VFYAA-EIAIGLFFLQSK---GIIYRDLKLDNVMLDSE--GHIKIADFGMCK--ENI 172
Query: 853 SNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKP-----TDVMF 907
+ + + GT Y APE + D +++G+LL EM+ + P D +F
Sbjct: 173 WDGVTTKTFC--GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELF 230
Query: 908 E 908
+
Sbjct: 231 Q 231
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 1e-13
Identities = 58/366 (15%), Positives = 114/366 (31%), Gaps = 68/366 (18%)
Query: 54 RRVTALDLMSKSLS----GSLSPHLGNLSFLREINLSNNTIQGEIPPEFGRLFR-----L 104
++ + L L+ +S L L E+NL +N + + + +
Sbjct: 28 QQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKI 87
Query: 105 EALFLSNNSL----VGKIPANLSYCSRLTVLCIEYNKLQGRIPLEFVSLS--------KL 152
+ L L N L G + + L L L + N L L +L
Sbjct: 88 QKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDA---GLQLLCEGLLDPQCRL 144
Query: 153 KDLSLAKNKLT----GGIPPFLGNLTSLEVLSLAGNSFG----RNIPDSLGQLK-QLKIL 203
+ L L L+ + L + L+++ N R + L QL+ L
Sbjct: 145 EKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEAL 204
Query: 204 AIGGNNLS----GPIPPSIYNLSFLVVFSVSHNQIH--GSLPPSLGLLLPN--LKFFQIH 255
+ ++ + + + + L ++ N++ G GLL P+ L+ I
Sbjct: 205 KLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIW 264
Query: 256 HNFFS----GSIPISLSNASKLEHIEIANNNFSGKLSVNFGGMKNLSL-----------L 300
+ G + L L+ + +A N + G + L L
Sbjct: 265 ECGITAKGCGDLCRVLRAKESLKELSLAGNELGDE------GARLLCETLLEPGCQLESL 318
Query: 301 NLQFSNLGSGESDEMGFMNSLTNCSKLRVLSLGGNQFRG----ALPHSIANLSSQLQILI 356
++ + + + L L L + N+ L + S L++L
Sbjct: 319 WVKSCSFTAACCSHFS--SVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLW 376
Query: 357 LSSNQF 362
L+
Sbjct: 377 LADCDV 382
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 3e-13
Identities = 63/459 (13%), Positives = 142/459 (30%), Gaps = 60/459 (13%)
Query: 174 TSLEVLSLAGNSFG-RNIPDSLGQLKQLKILAIGGNNLS----GPIPPSIYNLSFLVVFS 228
++ L + + L L+Q +++ + L+ I ++ L +
Sbjct: 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 62
Query: 229 VSHNQIHGSLPPSL--GLLLPN--LKFFQIHHNFFS----GSIPISLSNASKLEHIEIAN 280
+ N++ + GL P+ ++ + + + G + +L L+ + +++
Sbjct: 63 LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSD 122
Query: 281 NNFSGKLSVNFGGM---KNLSLLNLQFSNLGSGESDEMGFMNSLTNCSKLRVLSLGGNQF 337
N L LQ + + L + L++ N
Sbjct: 123 NLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDI 182
Query: 338 RG----ALPHSIANLSSQLQILILSSNQF----YGSIPLGIGNLVDLYLLGMVENQFTGA 389
L + + QL+ L L S + + + L L + N+
Sbjct: 183 NEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDV 242
Query: 390 IPKEMGK-----LQKLQGLDFSGNHFSGE----IPSSLGNLSSLYEVFFNNNNL--SGVI 438
E+ +L+ L + + + L SL E+ N L G
Sbjct: 243 GMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGAR 302
Query: 439 PFSLG---NLKRLAFLEMSGNELSGTIPEDIFN-ISYLSN--SLNLARNHLVGIIPPRIG 492
+L L + + + ++ L ++ N L +
Sbjct: 303 LLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELC 362
Query: 493 -----NLRALRSFDVSNNDLSGE----IPIELGHCSSLEEIYLAGNLFHGS-IPSFFNAL 542
LR +++ D+S + L SL E+ L+ N + I ++
Sbjct: 363 QGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESV 422
Query: 543 K----GVQKIDLSRNNLSGQIPIFLEAL-----SLEYLN 572
+ ++++ L S ++ L+AL SL ++
Sbjct: 423 RQPGCLLEQLVLYDIYWSEEMEDRLQALEKDKPSLRVIS 461
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 2e-11
Identities = 68/364 (18%), Positives = 116/364 (31%), Gaps = 62/364 (17%)
Query: 53 HRRVTALDLMSKSLS----GSLSPHLGNLSFLREINLSNNTIQGEIPPEFGRLFR----- 103
++ L L + L+ G LS L L L+E++LS+N +
Sbjct: 84 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCR 143
Query: 104 LEALFLSNNSL----VGKIPANLSYCSRLTVLCIEYNKLQGR-----IPLEFVSLSKLKD 154
LE L L SL + + L L + N + S +L+
Sbjct: 144 LEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEA 203
Query: 155 LSLAKNKLT----GGIPPFLGNLTSLEVLSLAGNSFGRN-----IPDSLGQLKQLKILAI 205
L L +T + + + SL L+L N G P L +L+ L I
Sbjct: 204 LKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWI 263
Query: 206 GGNNLSGP----IPPSIYNLSFLVVFSVSHNQIHGS----LPPSLGLLLPNLKFFQIHHN 257
++ + + L S++ N++ L +L L+ +
Sbjct: 264 WECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSC 323
Query: 258 FFS--GSIPIS--LSNASKLEHIEIANNNFSGKLSVNFGGMKNLSL-----------LNL 302
F+ S L+ L ++I+NN G++ L L L
Sbjct: 324 SFTAACCSHFSSVLAQNRFLLELQISNNRLEDA------GVRELCQGLGQPGSVLRVLWL 377
Query: 303 QFSNLGSGESDEMGFMNSLTNCSKLRVLSLGGNQF--RGA--LPHSIANLSSQLQILILS 358
++ +S +L LR L L N G L S+ L+ L+L
Sbjct: 378 ADCDV--SDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLY 435
Query: 359 SNQF 362
+
Sbjct: 436 DIYW 439
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 3e-11
Identities = 74/495 (14%), Positives = 146/495 (29%), Gaps = 103/495 (20%)
Query: 80 LREINLSNNTIQGEIPPEFGRLFR-LEALFLSNNSL----VGKIPANLSYCSRLTVLCIE 134
++ +++ + E L + + + L + L I + L L L +
Sbjct: 5 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 64
Query: 135 YNKLQGRIPLEFVSLSKLKDLSLAKNKLTGGIPPFLGNLTSLEVLSLAGNSFG----RNI 190
N+L + + ++ LSL +
Sbjct: 65 SNELGD---------VGVHCVLQG----------LQTPSCKIQKLSLQNCCLTGAGCGVL 105
Query: 191 PDSLGQLKQLKILAIGGNNLSGPIPPSI-----YNLSFLVVFSVSHNQIHGSLPPSLGLL 245
+L L L+ L + N L + L + + + + L +
Sbjct: 106 SSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASV 165
Query: 246 L---PNLKFFQIHHNFFSGSIPISLS-----NASKLEHIEIANNNFSGK----LSVNFGG 293
L P+ K + +N + + L + +LE +++ + + L
Sbjct: 166 LRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVAS 225
Query: 294 MKNLSLLNLQFSNLGSGESDEMGFMNSLTNCSKLRVLSLGGNQFRGALPHSIANL---SS 350
+L L L + LG E+ + LR L + + +
Sbjct: 226 KASLRELALGSNKLGDVGMAELCPGLLHPSSR-LRTLWIWECGITAKGCGDLCRVLRAKE 284
Query: 351 QLQILILSSNQFYGSIPLGIGNLVDLYLLGMVENQFTGAIPKEMGKLQKLQGLDFSGNHF 410
L+ L L+ N+ +G+ L + +L+ L F
Sbjct: 285 SLKELSLAGNE--------LGDEGARLLCETLLEPGC-----------QLESLWVKSCSF 325
Query: 411 SGE----IPSSLGNLSSLYEVFFNNNNL--SGVIPFSLG---NLKRLAFLEMSGNELSGT 461
+ S L L E+ +NN L +GV G L L ++ ++S
Sbjct: 326 TAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVS-- 383
Query: 462 IPEDIFNISYLSNSLNLARNHLVGIIPPRIGNLRALRSFDVSNNDLSGEIPIELG----- 516
+++ L NH +LR D+SNN L ++L
Sbjct: 384 -DSSCSSLAAT-----LLANH-------------SLRELDLSNNCLGDAGILQLVESVRQ 424
Query: 517 HCSSLEEIYLAGNLF 531
LE++ L +
Sbjct: 425 PGCLLEQLVLYDIYW 439
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 2e-13
Identities = 60/234 (25%), Positives = 97/234 (41%), Gaps = 35/234 (14%)
Query: 686 FSSTHLIGVGSFGCVYKGALDEDGIVVAIKVI---NLQCEGASKSFMAECKALKNI-RHR 741
F ++G GSFG V + E G + A+KV+ + + + M E + L H
Sbjct: 25 FEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHP 84
Query: 742 NLVKVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISI 801
L ++ FQ D V E++ G L + + +
Sbjct: 85 FLTQLFCC-----FQTPDRLFFVMEFVNGGDLMFHIQK----------SRRFDEARARFY 129
Query: 802 AIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHI--GDFGLARFHQEVSNSTLSS 859
A ++ SAL +LH I++ DLK N+LLD++ GH DFG+ + + + N ++
Sbjct: 130 AAEIISALMFLHDK---GIIYRDLKLDNVLLDHE--GHCKLADFGMCK--EGICNGVTTA 182
Query: 860 SVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKP-----TDVMFE 908
+ GT Y APE D ++ G+LL EM+ P D +FE
Sbjct: 183 TFC--GTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFE 234
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 2e-13
Identities = 65/248 (26%), Positives = 106/248 (42%), Gaps = 49/248 (19%)
Query: 686 FSSTHLIGVGSFGCVYKGALD-EDGIVVAIKVIN--LQCEGASKSFMAECKALKNIR-HR 741
+ +G G++G V+K ++D G VVA+K I Q ++ E L + H
Sbjct: 11 YELVKKLGKGAYGIVWK-SIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHE 69
Query: 742 NLVKVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDK--EIEIKLTLLQRI 799
N+V ++ + + D +V++YM E LH AV + + + + + Q I
Sbjct: 70 NIVNLLNVLRADND--RDV-YLVFDYM-----ETDLH--AVIRANILEPVHKQYVVYQLI 119
Query: 800 SIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSS 859
+ YLH +LH D+KPSNILL+ + + DFGL+R + T +
Sbjct: 120 K-------VIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNI 169
Query: 860 SVGVKGTIG-----------------YTAPEYGLGSEVSTNG-DVYSYGILLLEMVTAKK 901
+ + Y APE LGS T G D++S G +L E++ K
Sbjct: 170 PLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK- 228
Query: 902 PTDVMFEG 909
+F G
Sbjct: 229 ---PIFPG 233
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 3e-13
Identities = 59/270 (21%), Positives = 95/270 (35%), Gaps = 65/270 (24%)
Query: 691 LIGVGSFGCVYKGALD--EDGIVVAIKVINLQCEGASKSF----MAECKALKNIRHR--- 741
+G G+FG V + LD VA+K+I + E LK I+ +
Sbjct: 26 NLGEGTFGKVVE-CLDHARGKSQVALKIIR-----NVGKYREAARLEINVLKKIKEKDKE 79
Query: 742 NLVKVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISI 801
N + +F G+ I +E + + ++L K + L ++ +
Sbjct: 80 NKFLCVLMSDWFNFHGHMC--IAFELL-GKNTFEFL------KENNFQPYPLPHVRHM-- 128
Query: 802 AIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIG-------------------D 842
A + AL +LH + + H DLKP NIL N + D
Sbjct: 129 AYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVAD 185
Query: 843 FGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKP 902
FG A F E + +++ Y PE L + DV+S G +L E
Sbjct: 186 FGSATFDHEHHTTIVATRH-------YRPPEVILELGWAQPCDVWSIGCILFEYYRGF-- 236
Query: 903 TDVMFEGDLNLHNFARMALPNQVMDIVDPI 932
+F+ N + M I+ PI
Sbjct: 237 --TLFQTHENREHLVMM------EKILGPI 258
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 1e-12
Identities = 56/225 (24%), Positives = 93/225 (41%), Gaps = 44/225 (19%)
Query: 691 LIGVGSFGCVYKGALDEDGIVVAIKVI---NLQCEGASKSFMAECKAL-KNIRHRNLVKV 746
+IG GS+ V L + + A+KV+ + + E + H LV +
Sbjct: 16 VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 75
Query: 747 ITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLH-------PHAVPKRDKEIEIKLTLLQRI 799
+ FQ V EY+ G L + HA R
Sbjct: 76 HSC-----FQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHA----------------RF 114
Query: 800 SIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHI--GDFGLARFHQEVSNSTL 857
A +++ AL+YLH I++ DLK N+LLD++ GHI D+G+ + + +
Sbjct: 115 YSA-EISLALNYLHER---GIIYRDLKLDNVLLDSE--GHIKLTDYGMCK--EGLRPGDT 166
Query: 858 SSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKP 902
+S+ GT Y APE G + + D ++ G+L+ EM+ + P
Sbjct: 167 TSTFC--GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 209
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 69.4 bits (170), Expect = 1e-12
Identities = 55/340 (16%), Positives = 104/340 (30%), Gaps = 69/340 (20%)
Query: 294 MKNLSLLNLQFSNLGSGESDEMGFMNSLTNCSKLRVLSLGGNQF--RGALPHSIANL--- 348
M S+ DE L ++ + L GN A ++
Sbjct: 1 MARFSIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAA--RWLSENIAS 58
Query: 349 SSQLQILILSSNQFYGSIPLGIGNLVDLYLLGMVENQFTGAIPKEMGKLQKLQGLDFSGN 408
L+I S G + D + + + + K KL + S N
Sbjct: 59 KKDLEIAEFSDIF--------TGRVKDEIPEAL------RLLLQALLKCPKLHTVRLSDN 104
Query: 409 HFSGE----IPSSLGNLSSLYEVFFNNNNLSGVIPFSLGNLKRLAFLEMSGNELSGTIPE 464
F + L + L ++ +NN L +G +++ + E
Sbjct: 105 AFGPTAQEPLIDFLSKHTPLEHLYLHNNGLG----------------PQAGAKIARALQE 148
Query: 465 DIFNISYLSN----SLNLARNHL----VGIIPPRIGNLRALRSFDVSNNDLSGE-----I 511
N + S+ RN L + + R L + + N + E +
Sbjct: 149 LAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLL 208
Query: 512 PIELGHCSSLEEIYLAGNLFHGS-IPSFFNALKG---VQKIDLSRNNLSGQ-IPIFLEAL 566
L +C L+ + L N F + ALK ++++ L+ LS + ++A
Sbjct: 209 LEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAF 268
Query: 567 ------SLEYLNLSFNDFEGKIPAKGIFANASAISVVGCN 600
L+ L L +N+ I + + I +
Sbjct: 269 SKLENIGLQTLRLQYNE----IELDAVRTLKTVIDEKMPD 304
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 1e-08
Identities = 59/341 (17%), Positives = 106/341 (31%), Gaps = 55/341 (16%)
Query: 74 LGNLSFLREINLSNNTIQGEIPPEFGRLFR----LEALFLSNNSL----VGKIPANLSYC 125
+ S + +L + I E + ++ + LS N++ + N++
Sbjct: 1 MARFS-IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASK 59
Query: 126 SRLTVL---CIEYNKLQGRIPLEFVSLSK-------LKDLSLAKNKLTG----GIPPFLG 171
L + I +++ IP L + L + L+ N + FL
Sbjct: 60 KDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLS 119
Query: 172 NLTSLEVLSLAGNSFG----RNIPDSLGQL---------KQLKILAIGGNNLSGP----I 214
T LE L L N G I +L +L L+ + G N L
Sbjct: 120 KHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEW 179
Query: 215 PPSIYNLSFLVVFSVSHNQIHGS-LPPSLGLLL---PNLKFFQIHHNFFS--GSIPIS-- 266
+ + L + N I + L L LK + N F+ GS ++
Sbjct: 180 AKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIA 239
Query: 267 LSNASKLEHIEIANNNFSGK----LSVNFGGMKNLSLLNLQFSNLGSGESDEMGFMNSL- 321
L + L + + + S + + F ++N+ L L+ +
Sbjct: 240 LKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVID 299
Query: 322 TNCSKLRVLSLGGNQFR--GALPHSIANLSSQLQILILSSN 360
L L L GN+F + I + S L
Sbjct: 300 EKMPDLLFLELNGNRFSEEDDVVDEIREVFSTRGRGELDEL 340
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 6e-08
Identities = 45/233 (19%), Positives = 74/233 (31%), Gaps = 42/233 (18%)
Query: 69 SLSPHLGNLSFLREINLSNNTIQGEIPPEFGRLFR----LEALFLSNNSL---------- 114
L L L + LS+N LE L+L NN L
Sbjct: 85 LLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIAR 144
Query: 115 ---VGKIPANLSYCSRLTVLCIEYNKLQGR----IPLEFVSLSKLKDLSLAKNKLTG-GI 166
+ L + N+L+ F S L + + +N + GI
Sbjct: 145 ALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGI 204
Query: 167 PPFLGNL----TSLEVLSLAGNSFG----RNIPDSLGQLKQLKILAIGGNNLS------- 211
L L+VL L N+F + +L L+ L + LS
Sbjct: 205 EHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAV 264
Query: 212 GPIPPSIYNLSFLVVFSVSHNQIHG----SLPPSLGLLLPNLKFFQIHHNFFS 260
+ N+ L + +N+I +L + +P+L F +++ N FS
Sbjct: 265 VDAFSKLENIG-LQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS 316
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 5e-07
Identities = 54/338 (15%), Positives = 93/338 (27%), Gaps = 77/338 (22%)
Query: 51 RRHRRVTALDLMSKSLSG----SLSPHLGNLSFLREINLSNNTIQGEIPPEFGRLFRLEA 106
V + L ++ LS ++ + L S+ R++
Sbjct: 29 LEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTG-----------RVKD 77
Query: 107 LFLSNNSLVGKIPANLSYCSRLTVLCIEYNKL--QGRIPLEFVSLSKLKDLSLAKNKLTG 164
L+ + L C +L + + N + PL
Sbjct: 78 EIPEALRLLLQA---LLKCPKLHTVRLSDNAFGPTAQEPLI------------------- 115
Query: 165 GIPPFLGNLTSLEVLSLAGNSFG----RNIPDSLGQLKQLKILAIGGNNLSGPIPPSIYN 220
FL T LE L L N G I +L +L K N
Sbjct: 116 ---DFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAK---------------N 157
Query: 221 LSFLVVFSVSHNQIHGSLPPSLGLLL---PNLKFFQIHHNFF-----SGSIPISLSNASK 272
L N++ L ++ N + L+ +
Sbjct: 158 APPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQE 217
Query: 273 LEHIEIANNNFSGK----LSVNFGGMKNLSLLNLQFSNLGSGESDEMGFMNSLTNCSKLR 328
L+ +++ +N F+ L++ NL L L L + + + S L+
Sbjct: 218 LKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQ 277
Query: 329 VLSLGGNQFRG----ALPHSIANLSSQLQILILSSNQF 362
L L N+ L I L L L+ N+F
Sbjct: 278 TLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRF 315
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 2e-12
Identities = 36/137 (26%), Positives = 58/137 (42%), Gaps = 11/137 (8%)
Query: 56 VTALDLMSKSLSGSLSPH--LGNLSFLREINLSNNTIQGEIPPE-FGRLFRLEALFLSNN 112
L L + + L L LR+IN SNN I +I F + + L++N
Sbjct: 34 TAELRLNNNEFT-VLEATGIFKKLPQLRKINFSNNKIT-DIEEGAFEGASGVNEILLTSN 91
Query: 113 SLVGKIPANL-SYCSRLTVLCIEYNKLQGRIPLE-FVSLSKLKDLSLAKNKLTGGIPP-F 169
L + + L L + N++ + + F+ LS ++ LSL N++T + P
Sbjct: 92 RLEN-VQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQIT-TVAPGA 148
Query: 170 LGNLTSLEVLSLAGNSF 186
L SL L+L N F
Sbjct: 149 FDTLHSLSTLNLLANPF 165
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 5e-08
Identities = 27/118 (22%), Positives = 46/118 (38%), Gaps = 8/118 (6%)
Query: 105 EALFLSNNSLVGKIPAN--LSYCSRLTVLCIEYNKLQGRIPLEFVSLSKLKDLSLAKNKL 162
L L+NN + A +L + NK+ F S + ++ L N+L
Sbjct: 35 AELRLNNNEFT-VLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRL 93
Query: 163 TGGIPP--FLGNLTSLEVLSLAGNSFGRNIPDSLGQLKQLKILAIGGNNLSGPIPPSI 218
+ F G L SL+ L L N DS L +++L++ N ++ + P
Sbjct: 94 E-NVQHKMFKG-LESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQIT-TVAPGA 148
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 6e-07
Identities = 27/140 (19%), Positives = 52/140 (37%), Gaps = 8/140 (5%)
Query: 346 ANLSSQLQILILSSNQFYGSIPLGI-GNLVDLYLLGMVENQFTGAIPKEMGKLQKLQGLD 404
++ L L++N+F GI L L + N+ T + +
Sbjct: 28 EHIPQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEIL 87
Query: 405 FSGNHFSGEIPSSL-GNLSSLYEVFFNNNNLSGVIPFSLGNLKRLAFLEMSGNELSGTIP 463
+ N + + L SL + +N ++ V S L + L + N+++ T+
Sbjct: 88 LTSNRLE-NVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQIT-TVA 145
Query: 464 EDIFNISYLSN--SLNLARN 481
F+ L + +LNL N
Sbjct: 146 PGAFD--TLHSLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 1e-06
Identities = 28/131 (21%), Positives = 50/131 (38%), Gaps = 4/131 (3%)
Query: 328 RVLSLGGNQFRGALPHSIANLSSQLQILILSSNQFYGSIPLGI-GNLVDLYLLGMVENQF 386
L L N+F I QL+ + S+N+ I G + + + N+
Sbjct: 35 AELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKI-TDIEEGAFEGASGVNEILLTSNRL 93
Query: 387 TGAIPKEM-GKLQKLQGLDFSGNHFSGEIPSSLGNLSSLYEVFFNNNNLSGVIPFSLGNL 445
+ +M L+ L+ L N + S LSS+ + +N ++ V P + L
Sbjct: 94 E-NVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTL 152
Query: 446 KRLAFLEMSGN 456
L+ L + N
Sbjct: 153 HSLSTLNLLAN 163
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 2e-12
Identities = 55/225 (24%), Positives = 93/225 (41%), Gaps = 44/225 (19%)
Query: 691 LIGVGSFGCVYKGALDEDGIVVAIKVI---NLQCEGASKSFMAECKAL-KNIRHRNLVKV 746
+IG GS+ V L + + A++V+ + + E + H LV +
Sbjct: 59 VIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 118
Query: 747 ITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLH-------PHAVPKRDKEIEIKLTLLQRI 799
+ FQ V EY+ G L + HA R
Sbjct: 119 HSC-----FQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHA----------------RF 157
Query: 800 SIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHI--GDFGLARFHQEVSNSTL 857
A +++ AL+YLH I++ DLK N+LLD++ GHI D+G+ + + +
Sbjct: 158 YSA-EISLALNYLHER---GIIYRDLKLDNVLLDSE--GHIKLTDYGMCK--EGLRPGDT 209
Query: 858 SSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKP 902
+S+ GT Y APE G + + D ++ G+L+ EM+ + P
Sbjct: 210 TSTFC--GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 252
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 2e-12
Identities = 39/135 (28%), Positives = 62/135 (45%), Gaps = 8/135 (5%)
Query: 56 VTALDLMSKSLSGSLSPH-LGNLSFLREINLSNNTIQGEIPPE-FGRLFRLEALFLSNNS 113
+T + L ++ + P LR I+LSNN I E+ P+ F L L +L L N
Sbjct: 34 ITEIRLEQNTIK-VIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNK 91
Query: 114 LVGKIPANL-SYCSRLTVLCIEYNKLQGRIPLE-FVSLSKLKDLSLAKNKLTGGIPPFLG 171
+ ++P +L L +L + NK+ + ++ F L L LSL NKL
Sbjct: 92 IT-ELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFS 149
Query: 172 NLTSLEVLSLAGNSF 186
L +++ + LA N F
Sbjct: 150 PLRAIQTMHLAQNPF 164
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 2e-11
Identities = 36/164 (21%), Positives = 63/164 (38%), Gaps = 15/164 (9%)
Query: 125 CSRLTVLCIEYNKLQ---GRIPLEFVSLSKLKDLSLAKNKLTGGIPPF-LGNLTSLEVLS 180
CS V C L +P + ++ L +N + IPP L +
Sbjct: 11 CSNNIVDC-RGKGLTEIPTNLPET------ITEIRLEQNTIKV-IPPGAFSPYKKLRRID 62
Query: 181 LAGNSFGRNIPDSLGQLKQLKILAIGGNNLSGPIPPSI-YNLSFLVVFSVSHNQIHGSLP 239
L+ N PD+ L+ L L + GN ++ +P S+ L L + ++ N+I+ L
Sbjct: 63 LSNNQISELAPDAFQGLRSLNSLVLYGNKITE-LPKSLFEGLFSLQLLLLNANKIN-CLR 120
Query: 240 PSLGLLLPNLKFFQIHHNFFSGSIPISLSNASKLEHIEIANNNF 283
L NL ++ N + S ++ + +A N F
Sbjct: 121 VDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPF 164
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 7e-07
Identities = 24/135 (17%), Positives = 43/135 (31%), Gaps = 11/135 (8%)
Query: 300 LNLQFSNLGSGESDEMGFMNSLTNCSKLRVLSLGGNQFRGALPHSIANLSSQLQILILSS 359
+ L+ + + + + KLR + L NQ L L L+L
Sbjct: 37 IRLEQNTIKVIPP------GAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYG 89
Query: 360 NQFYGSIPLGI-GNLVDLYLLGMVENQFTGAIPKEM-GKLQKLQGLDFSGNHFSGEIPSS 417
N+ +P + L L LL + N+ + + L L L N +
Sbjct: 90 NKI-TELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQTIAKGT 147
Query: 418 LGNLSSLYEVFFNNN 432
L ++ + N
Sbjct: 148 FSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 7e-07
Identities = 26/135 (19%), Positives = 52/135 (38%), Gaps = 7/135 (5%)
Query: 401 QGLDFSGNHFSGEIPSSLGNLSSLYEVFFNNNNLSGVIPFSLGNLKRLAFLEMSGNELSG 460
+ N P + L + +NN +S + P + L+ L L + GN+++
Sbjct: 35 TEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKIT- 93
Query: 461 TIPEDIFNISYLSN--SLNLARNHLVGIIPPRI-GNLRALRSFDVSNNDLSGEIPIELGH 517
+P+ +F L + L L N + + +L L + +N L
Sbjct: 94 ELPKSLFE--GLFSLQLLLLNANKINC-LRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSP 150
Query: 518 CSSLEEIYLAGNLFH 532
+++ ++LA N F
Sbjct: 151 LRAIQTMHLAQNPFI 165
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 4e-12
Identities = 53/270 (19%), Positives = 102/270 (37%), Gaps = 65/270 (24%)
Query: 691 LIGVGSFGCVYKGALD--EDGIVVAIKVINLQCEGASKSF----MAECKALKNIRHR--- 741
+G G+FG V + +D G VA+K++ + +E + L+++
Sbjct: 21 TLGEGAFGKVVE-CIDHKAGGRHVAVKIVK-----NVDRYCEAARSEIQVLEHLNTTDPN 74
Query: 742 NLVKVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISI 801
+ + + + G+ IV+E + S ++ K + + +L ++++
Sbjct: 75 STFRCVQMLEWFEHHGHIC--IVFELL-GLSTYDFI------KENGFLPFRLDHIRKM-- 123
Query: 802 AIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIG-------------------D 842
A + ++++LH + + H DLKP NIL D
Sbjct: 124 AYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVD 180
Query: 843 FGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKP 902
FG A + E ++ +S+ Y APE L S DV+S G +L+E
Sbjct: 181 FGSATYDDEHHSTLVSTRH-------YRAPEVILALGWSQPCDVWSIGCILIEYYLGF-- 231
Query: 903 TDVMFEGDLNLHNFARMALPNQVMDIVDPI 932
+F + + A M I+ P+
Sbjct: 232 --TVFPTHDSKEHLAMM------ERILGPL 253
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 9e-12
Identities = 58/277 (20%), Positives = 101/277 (36%), Gaps = 75/277 (27%)
Query: 691 LIGVGSFGCVYKGALD-EDGIVVAIKVINLQCEGASKSF----MAECKALKNIRHR---- 741
+G G+FG V ++ A+KV+ K + E LK I++
Sbjct: 42 KMGDGTFGRVLL-CQHIDNKKYYAVKVVR-----NIKKYTRSAKIEADILKKIQNDDINN 95
Query: 742 -NLVKVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRIS 800
N+VK + + +++E + SL + + R+ + ++
Sbjct: 96 NNIVKYH---GKFMYYDHMC--LIFEPL-GPSLYEII------TRNNYNGFHIEDIK--L 141
Query: 801 IAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIG------------------- 841
I++ AL+YL + H DLKP NILLD+
Sbjct: 142 YCIEILKALNYLRKMS---LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKS 198
Query: 842 ------DFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLE 895
DFG A F + S +++ Y APE L + D++S+G +L E
Sbjct: 199 TGIKLIDFGCATFKSDYHGSIINTRQ-------YRAPEVILNLGWDVSSDMWSFGCVLAE 251
Query: 896 MVTAKKPTDVMFEGDLNLHNFARMALPNQVMDIVDPI 932
+ T ++F ++ + A M I+ PI
Sbjct: 252 LYTG----SLLFRTHEHMEHLAMM------ESIIQPI 278
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 64.8 bits (158), Expect = 4e-11
Identities = 33/174 (18%), Positives = 66/174 (37%), Gaps = 33/174 (18%)
Query: 691 LIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITS- 749
IG G FG +Y A V+ ++ + F E K + + ++ +K
Sbjct: 44 KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFS-ELKFYQRVAKKDCIKKWIER 102
Query: 750 -------------CSSIDFQGNDFKAIVYEYMPNG-SLEKWLHPHAVPKRDKEIEIKLTL 795
+F+G ++ +V E + G L+K ++ + L
Sbjct: 103 KQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL--GIDLQKIS------GQNGTFKKSTVL 154
Query: 796 LQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSG--HIGDFGLAR 847
+ I + L+Y+H + +H D+K +N+LL ++ D+GL+
Sbjct: 155 Q----LGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSY 201
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 2e-10
Identities = 33/173 (19%), Positives = 55/173 (31%), Gaps = 49/173 (28%)
Query: 692 IGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNI-RHRNLVKVITSC 750
+G+G G V + A+K++ E + + ++V+++
Sbjct: 26 LGLGINGKVLQIFNKRTQEKFALKMLQ-----DCPKARREVELHWRASQCPHIVRIVDVY 80
Query: 751 SSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRI----------- 799
+ + G IV E + G E L RI
Sbjct: 81 EN-LYAGRKCLLIVMECLDGG------------------E----LFSRIQDRGDQAFTER 117
Query: 800 ---SIAIDVASALDYLHHHCQEPILHCDLKPSNILL---DNDLSGHIGDFGLA 846
I + A+ YLH I H D+KP N+L + + DFG A
Sbjct: 118 EASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA 167
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 3e-10
Identities = 44/161 (27%), Positives = 66/161 (40%), Gaps = 11/161 (6%)
Query: 274 EHIEIANNNFSGKLSVNFGGMKNLSLLNLQFSNLGSGESDEMGFMNSLTNCSKLRVLSLG 333
E +++ + + F G+ L+ LNL ++ L + + G + LT L L L
Sbjct: 38 EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSA---GVFDDLTE---LGTLGLA 91
Query: 334 GNQFRGALPHSIANLSSQLQILILSSNQFYGSIPLGI-GNLVDLYLLGMVENQFTGAIPK 392
NQ +LP + + +QL L L NQ S+P G+ L L L + NQ +IP
Sbjct: 92 NNQLA-SLPLGVFDHLTQLDKLYLGGNQL-KSLPSGVFDRLTKLKELRLNTNQLQ-SIPA 148
Query: 393 EM-GKLQKLQGLDFSGNHFSGEIPSSLGNLSSLYEVFFNNN 432
KL LQ L S N + L L + N
Sbjct: 149 GAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 58.6 bits (142), Expect = 2e-09
Identities = 49/152 (32%), Positives = 73/152 (48%), Gaps = 13/152 (8%)
Query: 57 TALDLMSKSLSGSLSPHLGNLSFLREINLSNNTIQGEIPPE-FGRLFRLEALFLSNNSLV 115
LDL S L+ L+ L +NL N +Q + F L L L L+NN L
Sbjct: 38 EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQT-LSAGVFDDLTELGTLGLANNQLA 96
Query: 116 GKIPANL-SYCSRLTVLCIEYNKLQGRIPLE-FVSLSKLKDLSLAKNKLTGGIPP--FLG 171
+P + + ++L L + N+L+ +P F L+KLK+L L N+L IP F
Sbjct: 97 -SLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQ-SIPAGAF-D 152
Query: 172 NLTSLEVLSLAGN---SFGRNIPDSLGQLKQL 200
LT+L+ LSL+ N S D LG+L+ +
Sbjct: 153 KLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTI 184
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 2e-08
Identities = 49/173 (28%), Positives = 73/173 (42%), Gaps = 21/173 (12%)
Query: 118 IPANLSYCSRLTVLCIEYNKLQGRIPLEFVSLSKLKDLSLAKNKLTGGIPP--FLGNLTS 175
IPA+ L ++ L F L+KL L+L N+L + F LT
Sbjct: 33 IPADT------EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDD-LTE 84
Query: 176 LEVLSLAGN---SFGRNIPDSLGQLKQLKILAIGGNNLSGPIPPSIY-NLSFLVVFSVSH 231
L L LA N S + D L QL +L +GGN L +P ++ L+ L ++
Sbjct: 85 LGTLGLANNQLASLPLGVFDHLTQLDKLY---LGGNQLKS-LPSGVFDRLTKLKELRLNT 140
Query: 232 NQIHGSLPPSLGLLLPNLKFFQIHHNFFSGSIPI-SLSNASKLEHIEIANNNF 283
NQ+ S+P L NL+ + N S+P + KL+ I + N F
Sbjct: 141 NQLQ-SIPAGAFDKLTNLQTLSLSTNQLQ-SVPHGAFDRLGKLQTITLFGNQF 191
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 8e-08
Identities = 50/159 (31%), Positives = 73/159 (45%), Gaps = 13/159 (8%)
Query: 105 EALFLSNNSLVGKIPANLSYCSRLTVLCIEYNKLQGRIPLEFVSLSKLKDLSLAKNKLTG 164
E L L + L A ++LT L ++YN+LQ F L++L L LA N+L
Sbjct: 38 EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLA- 96
Query: 165 GIPP--FLGNLTSLEVLSLAGN---SFGRNIPDSLGQLKQLKILAIGGNNLSGPIPPSIY 219
+P F LT L+ L L GN S + D L +LK+ L + N L IP +
Sbjct: 97 SLPLGVFDH-LTQLDKLYLGGNQLKSLPSGVFDRLTKLKE---LRLNTNQLQS-IPAGAF 151
Query: 220 N-LSFLVVFSVSHNQIHGSLPPSLGLLLPNLKFFQIHHN 257
+ L+ L S+S NQ+ S+P L L+ + N
Sbjct: 152 DKLTNLQTLSLSTNQLQ-SVPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 2e-04
Identities = 41/170 (24%), Positives = 69/170 (40%), Gaps = 20/170 (11%)
Query: 414 IPSSLGNLSSLYEVFFNNNNLSGVIPFSLGNLKRLAFLEMSGNELSGTIPEDIFNISYLS 473
IP+ L + L+ + + L +L +L + N+L T+ +F+
Sbjct: 33 IPADTEKL------DLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTEL 85
Query: 474 NSLNLARNHLVGIIPPRI-GNLRALRSFDVSNNDLSGEIPIELG---HCSSLEEIYLAGN 529
+L LA N L +P + +L L + N L + G + L+E+ L N
Sbjct: 86 GTLGLANNQLAS-LPLGVFDHLTQLDKLYLGGNQLKS---LPSGVFDRLTKLKELRLNTN 141
Query: 530 LFHGSIPS-FFNALKGVQKIDLSRNNLSGQIP--IFLEALSLEYLNLSFN 576
SIP+ F+ L +Q + LS N L +P F L+ + L N
Sbjct: 142 QLQ-SIPAGAFDKLTNLQTLSLSTNQLQS-VPHGAFDRLGKLQTITLFGN 189
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 1e-09
Identities = 33/139 (23%), Positives = 45/139 (32%), Gaps = 28/139 (20%)
Query: 71 SPHLGNLSFLREINLSNNTIQGEIPPEFGRLFRLEALFLSNNSLVGKIPANLSYCSRLTV 130
+ N RE++L I I L + +A+ S+N +
Sbjct: 12 AAQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEI---------------- 54
Query: 131 LCIEYNKLQGRIPLEFVSLSKLKDLSLAKNKLTGGIPPFLGNLTSLEVLSLAGNSFGR-N 189
KL G F L +LK L + N++ L L L L NS
Sbjct: 55 -----RKLDG-----FPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELG 104
Query: 190 IPDSLGQLKQLKILAIGGN 208
D L LK L L I N
Sbjct: 105 DLDPLASLKSLTYLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 6e-08
Identities = 21/117 (17%), Positives = 38/117 (32%), Gaps = 9/117 (7%)
Query: 416 SSLGNLSSLYEVFFNNNNLSGVIPFSLGNLKRLAFLEMSGNELSGTIPEDIFNISYLSN- 474
+ N E+ + VI L + ++ S NE+ + L
Sbjct: 13 AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-----KLDGFPLLRRL 66
Query: 475 -SLNLARNHLVGIIPPRIGNLRALRSFDVSNNDLSGEIPIE-LGHCSSLEEIYLAGN 529
+L + N + I L L ++NN L ++ L SL + + N
Sbjct: 67 KTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 1e-05
Identities = 22/115 (19%), Positives = 43/115 (37%), Gaps = 7/115 (6%)
Query: 145 EFVSLSKLKDLSLAKNKLTGGIPPFLGNLTSLEVLSLAGNSFGRNIPDSLGQLKQLKILA 204
++ + + ++L L K+ I L + + + N R + D L++LK L
Sbjct: 14 QYTNAVRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEI-RKL-DGFPLLRRLKTLL 70
Query: 205 IGGNNLSGPIPPSIYNLSFLVVFSVSHNQIHGSLPPSLGLL--LPNLKFFQIHHN 257
+ N + L L +++N + L L L +L + I N
Sbjct: 71 VNNNRICRIGEGLDQALPDLTELILTNNSL--VELGDLDPLASLKSLTYLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 2e-05
Identities = 20/107 (18%), Positives = 37/107 (34%), Gaps = 9/107 (8%)
Query: 107 LFLSNNSLVGKIPANLSYCSRLTVLCIEYNKLQGRIPLEFVSLSKLKDLSLAKNKLT--G 164
+ L+ L+ + + R L + K+ I +L + + + N++
Sbjct: 2 VKLTAE-LIEQAA-QYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKLD 58
Query: 165 GIPPFLGNLTSLEVLSLAGNSFGRNIPDSLGQLKQLKILAIGGNNLS 211
G P L L+ L + N R L L L + N+L
Sbjct: 59 GFP----LLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV 101
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 4e-05
Identities = 31/146 (21%), Positives = 48/146 (32%), Gaps = 39/146 (26%)
Query: 320 SLTNCSKLRVLSLGGNQFRGALPHSIANLSS---QLQILILSSNQFYGSIPLGIGNLVDL 376
TN + R L L G + I NL + Q + S N+ I L
Sbjct: 14 QYTNAVRDRELDLRGYKI-----PVIENLGATLDQFDAIDFSDNE--------IRKLDGF 60
Query: 377 YLLGMVENQFTGAIPKEMGKLQKLQGLDFSGNHFSGEIPSSLGNLSSLYEVFFNNNN--- 433
L++L+ L + N L L E+ NN+
Sbjct: 61 ------------------PLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVE 102
Query: 434 LSGVIPFSLGNLKRLAFLEMSGNELS 459
L + P L +LK L +L + N ++
Sbjct: 103 LGDLDP--LASLKSLTYLCILRNPVT 126
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 5e-05
Identities = 28/104 (26%), Positives = 43/104 (41%), Gaps = 7/104 (6%)
Query: 65 SLSGSLSPHLGNL----SFLREINLSNNTIQGEIPPEFGRLFRLEALFLSNNSLVGKIPA 120
L G P + NL I+ S+N I+ ++ F L RL+ L ++NN +
Sbjct: 25 DLRGYKIPVIENLGATLDQFDAIDFSDNEIR-KLDG-FPLLRRLKTLLVNNNRICRIGEG 82
Query: 121 NLSYCSRLTVLCIEYNKLQGRIPLEF-VSLSKLKDLSLAKNKLT 163
LT L + N L L+ SL L L + +N +T
Sbjct: 83 LDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVT 126
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 40.4 bits (95), Expect = 8e-04
Identities = 19/121 (15%), Positives = 38/121 (31%), Gaps = 11/121 (9%)
Query: 216 PSIYNLSFLVVFSVSHNQIHGSLPPSLGLLLPNLKFFQIHHNFFSGSIPIS-LSNASKLE 274
N + +I + +LG L N + +L+
Sbjct: 13 AQYTNAVRDRELDLRGYKI--PVIENLGATLDQFDAIDFSDN---EIRKLDGFPLLRRLK 67
Query: 275 HIEIANNNFSGKLSVNFGGMKNLSLLNLQFSNLGSGESDEMGFMNSLTNCSKLRVLSLGG 334
+ + NN + +L+ L L ++L E+G ++ L + L L +
Sbjct: 68 TLLVNNNRICRIGEGLDQALPDLTELILTNNSL-----VELGDLDPLASLKSLTYLCILR 122
Query: 335 N 335
N
Sbjct: 123 N 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 3e-09
Identities = 28/107 (26%), Positives = 46/107 (42%), Gaps = 4/107 (3%)
Query: 104 LEALFLSNNSL-VGKIPANLSYCSRLTVLCIEYNKLQGRIPLEFVSLSKLKDLSLAKNKL 162
++ L L N+ GK+ L L L I L+KLK L L+ N++
Sbjct: 19 VKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SIA-NLPKLNKLKKLELSDNRV 76
Query: 163 TGGIPPFLGNLTSLEVLSLAGNSFGR-NIPDSLGQLKQLKILAIGGN 208
+GG+ +L L+L+GN + + L +L+ LK L +
Sbjct: 77 SGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 2e-05
Identities = 36/159 (22%), Positives = 52/159 (32%), Gaps = 31/159 (19%)
Query: 50 GRRHRRVTALDL-MSKSLSGSLSPHLGNLSFLREINLSNNTIQGEIPPEFGRLFRLEALF 108
R V L L S+S G L L ++ N + I +L +L+ L
Sbjct: 13 NRTPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SIAN-LPKLNKLKKLE 70
Query: 109 LSNNSLVGKIPANLSYCSRLTVLCIEYNKLQGRIPLEFVSLSKLKDLSLAKNKLTGGIPP 168
LS+N + G + C LT L + NK + L +
Sbjct: 71 LSDNRVSGGLEVLAEKCPNLTHLNLSGNK-----------IKDLSTIE------------ 107
Query: 169 FLGNLTSLEVLSLAGNSFGRNIPD----SLGQLKQLKIL 203
L L +L+ L L N+ D L QL L
Sbjct: 108 PLKKLENLKSLDLFNCEVT-NLNDYRENVFKLLPQLTYL 145
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 5e-04
Identities = 20/101 (19%), Positives = 39/101 (38%), Gaps = 3/101 (2%)
Query: 37 DSRHFCEWEGITCGRRHRRVTALDLMSKSLSGSLSPHLGNLSFLREINLSNNTIQGEIPP 96
D+ E + + L ++ L+ S++ +L L+ L+++ LS+N + G +
Sbjct: 25 DNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SIA-NLPKLNKLKKLELSDNRVSGGLEV 82
Query: 97 EFGRLFRLEALFLSNNSLVG-KIPANLSYCSRLTVLCIEYN 136
+ L L LS N + L L L +
Sbjct: 83 LAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 5e-04
Identities = 24/112 (21%), Positives = 48/112 (42%), Gaps = 8/112 (7%)
Query: 372 NLVDLYLLGMVENQFTGAIPKEMGKLQKLQGLDFSGNHFSGEIPSSLGNLSSLYEVFFNN 431
++ +L L N+ G + + ++L+ L + I ++L L+ L ++ ++
Sbjct: 18 DVKELVLDNSRSNE--GKLEGLTDEFEELEFLSTINVGLT-SI-ANLPKLNKLKKLELSD 73
Query: 432 NNLSGVIPFSLGNLKRLAFLEMSGNELSGTIPEDIFNISYLSN--SLNLARN 481
N +SG + L L +SGN++ I + L N SL+L
Sbjct: 74 NRVSGGLEVLAEKCPNLTHLNLSGNKIKD--LSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 40.0 bits (94), Expect = 7e-04
Identities = 18/90 (20%), Positives = 34/90 (37%), Gaps = 7/90 (7%)
Query: 125 CSRLTVLCIEYNKLQ-GRIPLEFVSLSKLKDLSLAKNKLT--GGIPPFLGNLTSLEVLSL 181
S + L ++ ++ G++ +L+ LS LT +P L L+ L L
Sbjct: 16 PSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSIANLP----KLNKLKKLEL 71
Query: 182 AGNSFGRNIPDSLGQLKQLKILAIGGNNLS 211
+ N + + L L + GN +
Sbjct: 72 SDNRVSGGLEVLAEKCPNLTHLNLSGNKIK 101
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 59.0 bits (143), Expect = 3e-09
Identities = 37/177 (20%), Positives = 67/177 (37%), Gaps = 34/177 (19%)
Query: 690 HLIGVGSFGCVYKGALDEDGIV-----VAIKVIN-----LQCEG------ASKSFMAECK 733
IG G FGC+Y ++ V +KV L E A + +
Sbjct: 41 LPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWI 100
Query: 734 ALKNIRHRNLVKVITSCSSIDFQGNDFKAIVYEYMPNG-SLEKWLHPHAVPKRDKEIEIK 792
+ +++ + K D G ++ ++ + G L+K K K
Sbjct: 101 RTRKLKYLGVPKYW-GSGLHDKNGKSYRFMIMDRF--GSDLQKIYE-----ANAKRFSRK 152
Query: 793 LTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSG--HIGDFGLAR 847
L +++ + L+Y+H H +H D+K SN+LL+ ++ D+GLA
Sbjct: 153 TVLQ----LSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 3e-09
Identities = 32/152 (21%), Positives = 64/152 (42%), Gaps = 17/152 (11%)
Query: 73 HLGNLSFLREINLSN--NTIQGEIPPEFGRLFRLEALFLSNNSLVGKIPANLSYCSRLTV 130
+ ++ L I+ ++ L + L LS N++ KI ++LS L +
Sbjct: 18 KSVVATEAEKVELHGMIPPIE-KMDATLSTLKACKHLALSTNNIE-KI-SSLSGMENLRI 74
Query: 131 LCIEYNKLQGRIPLEFVSLSKLKDLSLAKNKLTGGIPPFLGNLTSLEVLSLAGNSFGRNI 190
L + N ++ L+ V L++L ++ N++ + + L +L VL ++ N I
Sbjct: 75 LSLGRNLIKKIENLDAV-ADTLEELWISYNQIA-SLSG-IEKLVNLRVLYMSNN----KI 127
Query: 191 PD-----SLGQLKQLKILAIGGNNLSGPIPPS 217
+ L L +L+ L + GN L +
Sbjct: 128 TNWGEIDKLAALDKLEDLLLAGNPLYNDYKEN 159
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 1e-08
Identities = 40/146 (27%), Positives = 60/146 (41%), Gaps = 18/146 (12%)
Query: 70 LSPHLGNLSFLREINLSNNTIQGEIPPEFGRLFRLEALFLSNNSLVGKIPANLSYCSRLT 129
+ L L + + LS N I+ +I + L L L N + KI + L
Sbjct: 40 MDATLSTLKACKHLALSTNNIE-KISS-LSGMENLRILSLGRNLIK-KIENLDAVADTLE 96
Query: 130 VLCIEYNKLQGRIPLEFVSLSKLKDLSLAKNKLT--GGIPPFLGNLTSLEVLSLAGNSFG 187
L I YN++ +E L L+ L ++ NK+T G I L L LE L LAGN
Sbjct: 97 ELWISYNQIASLSGIE--KLVNLRVLYMSNNKITNWGEIDK-LAALDKLEDLLLAGNPLY 153
Query: 188 RNIPDS----------LGQLKQLKIL 203
+ ++ + +L LK L
Sbjct: 154 NDYKENNATSEYRIEVVKRLPNLKKL 179
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 3e-08
Identities = 30/155 (19%), Positives = 57/155 (36%), Gaps = 16/155 (10%)
Query: 107 LFLSNNSLVGKIPANLSYCSRLTVLCIEYNKLQGRIPLEFVSLSKLKDLSLAKNKLTGGI 166
L + K+ A LS L + N ++ L + L+ LSL +N + I
Sbjct: 30 LHGMIPPIE-KMDATLSTLKACKHLALSTNNIEKISSLS--GMENLRILSLGRNLIK-KI 85
Query: 167 PPFLGNLTSLEVLSLAGNSFGRNIPDSLGQLKQLKILAIGGNNLSGPIP-PSIYNLSFLV 225
+LE L ++ N ++ + +L L++L + N ++ + L L
Sbjct: 86 ENLDAVADTLEELWISYNQI-ASL-SGIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLE 143
Query: 226 VFSVSHNQIHGSLPPSLG---------LLLPNLKF 251
++ N ++ + LPNLK
Sbjct: 144 DLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKK 178
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 7e-08
Identities = 28/131 (21%), Positives = 56/131 (42%), Gaps = 14/131 (10%)
Query: 403 LDFSGNHFSGEIPSSLGNLSSLYEVFFNNNNLSGVIPFSLGNLKRLAFLEMSGNELSGTI 462
L ++ ++L L + + + NN+ + L ++ L L + N +
Sbjct: 30 LHGMIPPIE-KMDATLSTLKACKHLALSTNNIEKISS--LSGMENLRILSLGRNLIK--- 83
Query: 463 PEDIFNISYLSNS---LNLARNHLVGIIPPRIGNLRALRSFDVSNNDLSGEIPIE-LGHC 518
I N+ ++++ L ++ N + + I L LR +SNN ++ I+ L
Sbjct: 84 --KIENLDAVADTLEELWISYNQIASLSG--IEKLVNLRVLYMSNNKITNWGEIDKLAAL 139
Query: 519 SSLEEIYLAGN 529
LE++ LAGN
Sbjct: 140 DKLEDLLLAGN 150
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 2e-06
Identities = 31/204 (15%), Positives = 67/204 (32%), Gaps = 62/204 (30%)
Query: 136 NKLQGRIPLEFVSLSKLK--DLSLAKNKLTGGIPPFLGNLTSLEVLSLAGNSFGRNIPDS 193
+ ++ + V ++ + +L + + L L + + L+L+ N+ + I S
Sbjct: 9 DAIRIFEERKSVVATEAEKVELHGMIPPIEK-MDATLSTLKACKHLALSTNNIEK-I-SS 65
Query: 194 LGQLKQLKILAIGGNNLSGPIPPSIYNLSFLVVFSVSHNQIHGSLPPSLGLLLPNLKFFQ 253
L ++ L+IL++G N + I NL + L+
Sbjct: 66 LSGMENLRILSLGRNLIK-----KIENLDAV---------------------ADTLEELW 99
Query: 254 IHHNFFSGSIPISLSNASKLEHIEIANNNFSGKLSVNFGGMKNLSLLNLQFSNLGSGESD 313
I +N ++ + + NL +L + + + +
Sbjct: 100 ISYN--------------QIASLS------------GIEKLVNLRVLYMSNNKITNWGE- 132
Query: 314 EMGFMNSLTNCSKLRVLSLGGNQF 337
++ L KL L L GN
Sbjct: 133 ----IDKLAALDKLEDLLLAGNPL 152
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 58.6 bits (142), Expect = 4e-09
Identities = 27/173 (15%), Positives = 59/173 (34%), Gaps = 30/173 (17%)
Query: 692 IGVGSFGCVYKGALDEDGIV--------VAIKV--INLQCEGASKSFMAECKALKNIRHR 741
+ G +Y+ A ++K+ + + F K L+ + +
Sbjct: 50 QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109
Query: 742 NLVKV----ITSCSSIDFQGNDFKAIVYEYMPNG-SLEKWLHPHAVPKRDKEIEIKLTLL 796
L I +C + ++ +V + G SL+ L + + L
Sbjct: 110 KLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQSALDVSP----KHVLSERSVLQ 163
Query: 797 QRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSG--HIGDFGLAR 847
+A + AL++LH + +H ++ NI +D + + +G A
Sbjct: 164 ----VACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 6e-09
Identities = 30/107 (28%), Positives = 46/107 (42%), Gaps = 4/107 (3%)
Query: 104 LEALFLSNNSL-VGKIPANLSYCSRLTVLCIEYNKLQGRIPLEFVSLSKLKDLSLAKNKL 162
+ L L N GKI + L L + L L L KLK L L++N++
Sbjct: 26 VRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISVSNLP--KLPKLKKLELSENRI 83
Query: 163 TGGIPPFLGNLTSLEVLSLAGNSFGR-NIPDSLGQLKQLKILAIGGN 208
GG+ L +L L+L+GN + + L +L+ LK L +
Sbjct: 84 FGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNC 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 3e-06
Identities = 35/159 (22%), Positives = 49/159 (30%), Gaps = 31/159 (19%)
Query: 50 GRRHRRVTALDL-MSKSLSGSLSPHLGNLSFLREINLSNNTIQGEIPPEFGRLFRLEALF 108
R V L L KS G + L ++L N + + +L +L+ L
Sbjct: 20 NRTPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SVSN-LPKLPKLKKLE 77
Query: 109 LSNNSLVGKIPANLSYCSRLTVLCIEYNKLQGRIPLEFVSLSKLKDLSLAKNKLTGGIPP 168
LS N + G + LT L + NK L + L
Sbjct: 78 LSENRIFGGLDMLAEKLPNLTHLNLSGNK-----------LKDISTLE------------ 114
Query: 169 FLGNLTSLEVLSLAGNSFGRNIPD----SLGQLKQLKIL 203
L L L+ L L N+ D L QL L
Sbjct: 115 PLKKLECLKSLDLFNCEV-TNLNDYRESVFKLLPQLTYL 152
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 58.0 bits (139), Expect = 6e-09
Identities = 33/201 (16%), Positives = 58/201 (28%), Gaps = 35/201 (17%)
Query: 678 SLLKATNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVI--------NLQCEGASKSFM 729
S T IG G FG V++ D VAIK+I N + + +
Sbjct: 14 SHCLPTEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEIL 71
Query: 730 AE---CKALKNIRHRNLVKVITSCSSIDF---QGNDFKAIVYEYMPNGSLEKWLHPHAVP 783
E K L + + QG+ ++ + S + +
Sbjct: 72 PEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDF 131
Query: 784 KRDKEIEI-----------------KLTLLQRISIAIDVASALDYLHHHCQEPILHCDLK 826
+D ++ I +L SI + ++L + H DL
Sbjct: 132 FKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLR--FEHRDLH 189
Query: 827 PSNILLDNDLSGHIGDFGLAR 847
N+LL + +
Sbjct: 190 WGNVLLKKTSLKKLHYTLNGK 210
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 56.8 bits (137), Expect = 2e-08
Identities = 70/451 (15%), Positives = 146/451 (32%), Gaps = 53/451 (11%)
Query: 54 RRVTALDLMSKSLSGSLSPHLGNLS----FLREINLSNNTIQGEIPPEFGRLF-RLEALF 108
+L+ G + P + +S +L EI L + + + F + L
Sbjct: 77 PHFADFNLVPDGWGGYVYPWIEAMSSSYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLV 136
Query: 109 LSNNSLVGK--IPANLSYCSRLTVLCIEYNKLQGRIPLEFVSLSK----LKDLSLA--KN 160
LS+ + A + C L L + + + L L+++ +
Sbjct: 137 LSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISCLAS 196
Query: 161 KLT-GGIPPFLGNLTSLEVLSLAGNSFGRNIPDSLGQLKQLKILAIGG------NNLSGP 213
+++ + + +L+ L L + L + QL+ L GG ++
Sbjct: 197 EVSFSALERLVTRCPNLKSLKLNRAVPLEKLATLLQRAPQLEELGTGGYTAEVRPDVYSG 256
Query: 214 IPPSIYNLSFLVVFSVSHNQIHGSLPPSLGLLLPNLKFFQIHHNFFS--GSIPISLSNAS 271
+ ++ L S + + L P++ + L + + + + L
Sbjct: 257 LSVALSGCKELRCLSGFWDAVPAYL-PAVYSVCSRLTTLNLSYATVQSYDLVKL-LCQCP 314
Query: 272 KLEHIEIANNNFSGKLSVNFGGMKNLSLLNLQFSNLGSGESD----EMGFMNSLTNCSKL 327
KL+ + + + L V K+L L + S E + E G ++ C KL
Sbjct: 315 KLQRLWVLDYIEDAGLEVLASTCKDLRELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKL 374
Query: 328 RVLSLGGNQFRGALPHSIANLSSQLQILILSSNQFYGSIPLGIG--------------NL 373
+ Q A +IA + L + L + +L
Sbjct: 375 ESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDL 434
Query: 374 VDLYLLGMVENQFTGAIPKEMGK-LQKLQGLDFSGNHFSGE----IPSSLGNLSSLYEVF 428
L L G++ T + + +G +K++ L + S + S +L L
Sbjct: 435 RRLSLSGLL----TDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKL--EI 488
Query: 429 FNNNNLSGVIPFSLGNLKRLAFLEMSGNELS 459
+ + + L+ + L MS +S
Sbjct: 489 RDCPFGDKALLANASKLETMRSLWMSSCSVS 519
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 54.1 bits (130), Expect = 2e-07
Identities = 65/514 (12%), Positives = 158/514 (30%), Gaps = 52/514 (10%)
Query: 100 RLFRLEALFLSNNSLVGKIPA----NLSYCSRLT----VLCIEYNKLQGRIPLEFVSLSK 151
++F +S +++ + P L V + I S +
Sbjct: 47 KVFIGNCYAVSPATVIRRFPKVRSVELKGKPHFADFNLVPDGWGGYVYPWIEAMSSSYTW 106
Query: 152 LKDLSLAKNKLT-GGIPPFLGNLTSLEVLSLAGNSFGRNIPDS-----LGQLKQLKILAI 205
L+++ L + +T + + + +VL L+ + LK L +
Sbjct: 107 LEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCE---GFSTDGLAAIAATCRNLKELDL 163
Query: 206 GGNNLSGPIPPSIYNLSFL------VVFSVSHNQIHGSLPPSLGLLLPNLKFFQIHHNFF 259
+++ + + + S +++ S L PNLK +++
Sbjct: 164 RESDVDDVSGHWLSHFPDTYTSLVSLNISCLASEVSFSALERLVTRCPNLKSLKLNRAVP 223
Query: 260 SGSIPISLSNASKLEHIEIANNNFSGKLSVNFGGMKNLSLLNLQFSNLGSGESDEMGFMN 319
+ L A +LE + + V G LS G ++
Sbjct: 224 LEKLATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALSGCKELRCLSGFWDAVPAYLPA 283
Query: 320 SLTNCSKLRVLSLGGNQFRGALPHSIANLSSQLQILILS---SNQFYGSIPLGIGNLVDL 376
+ CS+L L+L + + +LQ L + + + +L +L
Sbjct: 284 VYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDYIEDAGLEVLASTCKDLREL 343
Query: 377 YLLGMVE------NQFTGAIPKEMGK-LQKLQGLDFSGNHFSGEIPSSLGNLSSLYEVFF 429
+ T + KL+ + + + +L +
Sbjct: 344 RVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNA---------ALITIAR 394
Query: 430 NNNNLSGVIPFSLGNLKRLAFLEMSGNELSGTIPEDIFNISYLSNSLNLARNHLVGIIPP 489
N N++ F L ++ A ++ L + + L L+L+ +
Sbjct: 395 NRPNMTR---FRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLR-RLSLSGLLTDKVFEY 450
Query: 490 RIGNLRALRSFDVSNNDLSGEIPIELG-HCSSLEEIYLAG-NLFHGSIPSFFNALKGVQK 547
+ + V+ S + C SL ++ + ++ + + L+ ++
Sbjct: 451 IGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRS 510
Query: 548 IDLSRNNLSGQ-IPIFLEA---LSLEYLNLSFND 577
+ +S ++S + + L++E ++
Sbjct: 511 LWMSSCSVSFGACKLLGQKMPKLNVEVIDERGAP 544
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 55.9 bits (134), Expect = 3e-08
Identities = 19/97 (19%), Positives = 30/97 (30%), Gaps = 3/97 (3%)
Query: 389 AIPKEMGKLQKLQGLDFSGNHFSGEIPS-SLGNLSSLYEVFFNNNNLSGVIPFSLGNLKR 447
+ + L L + L L L + + L V P + R
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPR 81
Query: 448 LAFLEMSGNELSGTIPEDIFNISYLSNSLNLARNHLV 484
L+ L +S N L ++ L L L+ N L
Sbjct: 82 LSRLNLSFNALE-SLSWKTVQGLSLQE-LVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 52.4 bits (125), Expect = 4e-07
Identities = 23/109 (21%), Positives = 41/109 (37%), Gaps = 5/109 (4%)
Query: 57 TALDLMSKSLSGSLSPHLGNLSFLREINLSNNTIQGEIPPE-FGRLFRLEALFLSNNSLV 115
+ L SL HL L E+ + N + L L L + + L
Sbjct: 11 SGLRCTRDGALDSL-HHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR 69
Query: 116 GKIPAN-LSYCSRLTVLCIEYNKLQGRIPLEFVSLSKLKDLSLAKNKLT 163
+ + + RL+ L + +N L+ + + V L++L L+ N L
Sbjct: 70 -FVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 51.7 bits (123), Expect = 7e-07
Identities = 22/121 (18%), Positives = 38/121 (31%), Gaps = 27/121 (22%)
Query: 413 EIPSSLGNLSSLYEVFFNNNNLSGVIP-FSLGNLKRLAFLEMSGNELSGTIPEDIFNISY 471
+ L +L E++ N + L L L L + + L + D F+
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDAFH--- 77
Query: 472 LSNSLNLARNHLVGIIPPRIGNLRALRSFDVSNNDLSGEIPIELGHCSSLEEIYLAGNLF 531
L ++S N L + + SL+E+ L+GN
Sbjct: 78 ---------------------FTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115
Query: 532 H 532
H
Sbjct: 116 H 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 51.7 bits (123), Expect = 7e-07
Identities = 13/96 (13%), Positives = 28/96 (29%), Gaps = 3/96 (3%)
Query: 189 NIPDSLGQLKQLKILAIGGNNLSGPIPP-SIYNLSFLVVFSVSHNQIHGSLPPSLGLLLP 247
+ L + L L I + + L L ++ + + + P P
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDAFHFTP 80
Query: 248 NLKFFQIHHNFFSGSIPISLSNASKLEHIEIANNNF 283
L + N S+ L+ + ++ N
Sbjct: 81 RLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 49.4 bits (117), Expect = 3e-06
Identities = 18/113 (15%), Positives = 33/113 (29%), Gaps = 5/113 (4%)
Query: 125 CSRLT-VLCIEYNKLQGRIPLEFVSLSKLKDLSLAKNKLTGGIPPF-LGNLTSLEVLSLA 182
+ + C L L +L + + + L L L L++
Sbjct: 7 PHGSSGLRCTRDGAL--DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIV 64
Query: 183 GNSFGRNIPDSLGQLKQLKILAIGGNNLSGPIPPSIYNLSFLVVFSVSHNQIH 235
+ PD+ +L L + N L + L +S N +H
Sbjct: 65 KSGLRFVAPDAFHFTPRLSRLNLSFNALES-LSWKTVQGLSLQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 49.4 bits (117), Expect = 4e-06
Identities = 16/94 (17%), Positives = 32/94 (34%), Gaps = 3/94 (3%)
Query: 487 IPPRIGNLRALRSFDVSNNDLSGEIPIE-LGHCSSLEEIYLAGNLFHGSIPSF-FNALKG 544
+ L + N + + L L + + + + F+
Sbjct: 23 SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDAFHFTPR 81
Query: 545 VQKIDLSRNNLSGQIPIFLEALSLEYLNLSFNDF 578
+ +++LS N L ++ LSL+ L LS N
Sbjct: 82 LSRLNLSFNALESLSWKTVQGLSLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 48.6 bits (115), Expect = 6e-06
Identities = 17/96 (17%), Positives = 34/96 (35%), Gaps = 5/96 (5%)
Query: 166 IPPFLGNLTSLEVLSLAGNSFGRNIPD-SLGQLKQLKILAIGGNNLSGPIPPSI-YNLSF 223
L +L L + +++ L L +L+ L I + L + P +
Sbjct: 23 SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDAFHFTPR 81
Query: 224 LVVFSVSHNQIHGSLPPSLGLLLPNLKFFQIHHNFF 259
L ++S N + SL + +L+ + N
Sbjct: 82 LSRLNLSFNALE-SLSWKT-VQGLSLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 47.0 bits (111), Expect = 2e-05
Identities = 24/102 (23%), Positives = 34/102 (33%), Gaps = 9/102 (8%)
Query: 262 SIPISLSNASKLEHIEIANNNFSGKL-SVNFGGMKNLSLLNLQFSNLGSGESDEMGFMNS 320
L A L + I N L + G+ L L + S L D +
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPD------A 75
Query: 321 LTNCSKLRVLSLGGNQFRGALPHSIANLSSQLQILILSSNQF 362
+L L+L N ++ LS LQ L+LS N
Sbjct: 76 FHFTPRLSRLNLSFNALESLSWKTVQGLS--LQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 44.7 bits (105), Expect = 1e-04
Identities = 18/97 (18%), Positives = 34/97 (35%), Gaps = 5/97 (5%)
Query: 340 ALPHSIANLSSQLQILILSSNQFYGSIPLG-IGNLVDLYLLGMVENQFTGAIPKEM-GKL 397
H + L L + + Q + L + L +L L +V++ + +
Sbjct: 22 DSLHHLPGAE-NLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDAFHFT 79
Query: 398 QKLQGLDFSGNHFSGEIPSSLGNLSSLYEVFFNNNNL 434
+L L+ S N + SL E+ + N L
Sbjct: 80 PRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 4e-08
Identities = 40/166 (24%), Positives = 66/166 (39%), Gaps = 28/166 (16%)
Query: 689 THLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRH-RNLVKVI 747
IG G+FG + G VAIK+ + + E + K + + +V
Sbjct: 14 GKKIGCGNFGELRLGKNLYTNEYVAIKL--EPMKSRAPQLHLEYRFYKQLGSGDGIPQVY 71
Query: 748 TSCSSIDFQGNDFKAIVYEYMPNG-SLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVA 806
+ A+V E + G SLE D+ +K L+ IAI +
Sbjct: 72 YFG-----PCGKYNAMVLELL--GPSLEDLFD-----LCDRTFSLKTVLM----IAIQLI 115
Query: 807 SALDYLHHHCQEPILHCDLKPSNILLDNDLSG-----HIGDFGLAR 847
S ++Y+H +++ D+KP N L+ + HI DF LA+
Sbjct: 116 SRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 1e-07
Identities = 37/112 (33%), Positives = 56/112 (50%), Gaps = 11/112 (9%)
Query: 81 REINLSNNTIQGEIPPE--FGRLFRLEALFLSNNSLVGKIPANL-SYCSRLTVLCIEYNK 137
E+ L++N + I + FGRL L L L N L I N S + L + NK
Sbjct: 32 TELLLNDNELG-RISSDGLFGRLPHLVKLELKRNQLT-GIEPNAFEGASHIQELQLGENK 89
Query: 138 LQGRIPLE-FVSLSKLKDLSLAKNKLTGGIPP--FLGNLTSLEVLSLAGNSF 186
++ I + F+ L +LK L+L N+++ + P F +L SL L+LA N F
Sbjct: 90 IK-EISNKMFLGLHQLKTLNLYDNQISC-VMPGSF-EHLNSLTSLNLASNPF 138
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 6e-05
Identities = 25/107 (23%), Positives = 39/107 (36%), Gaps = 4/107 (3%)
Query: 328 RVLSLGGNQFRGALPHSIANLSSQLQILILSSNQFYGSIPLGI-GNLVDLYLLGMVENQF 386
L L N+ + L L L NQ I + L + EN+
Sbjct: 32 TELLLNDNELGRISSDGLFGRLPHLVKLELKRNQL-TGIEPNAFEGASHIQELQLGENKI 90
Query: 387 TGAIPKEM-GKLQKLQGLDFSGNHFSGEIPSSLGNLSSLYEVFFNNN 432
I +M L +L+ L+ N S +P S +L+SL + +N
Sbjct: 91 K-EISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASN 136
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 1e-07
Identities = 51/229 (22%), Positives = 85/229 (37%), Gaps = 39/229 (17%)
Query: 57 TALDLMSKSLSGSLSPHLGNLSFLREINLSNNTIQGEIPPEFGRLFRLEALFLSNNSLVG 116
+L KS++ L+ + +I +N+ I+ L + L L N L
Sbjct: 22 IKANLKKKSVT-DAVTQNE-LNSIDQIIANNSDIKSV--QGIQYLPNVRYLALGGNKLH- 76
Query: 117 KIPANLSYCSRLTVLCIEYNKLQGRIPLEFVSLSKLKDLSLAKNKLTGGIPP--FLGNLT 174
I A L+ L L L N+L +P F LT
Sbjct: 77 DISA-------------------------LKELTNLTYLILTGNQLQ-SLPNGVFDK-LT 109
Query: 175 SLEVLSLAGNSFGRNIPDSLGQLKQLKILAIGGNNLSGPIPPSIY-NLSFLVVFSVSHNQ 233
+L+ L L N +L L L + N L +P ++ L+ L +S+NQ
Sbjct: 110 NLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQS-LPKGVFDKLTNLTELDLSYNQ 168
Query: 234 IHGSLPPSLGLLLPNLKFFQIHHNFFSGSIPI-SLSNASKLEHIEIANN 281
+ SLP + L LK +++ N S+P + L++I + +N
Sbjct: 169 LQ-SLPEGVFDKLTQLKDLRLYQNQLK-SVPDGVFDRLTSLQYIWLHDN 215
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 4e-07
Identities = 42/164 (25%), Positives = 75/164 (45%), Gaps = 15/164 (9%)
Query: 272 KLEHIEIANNNFSGKLSVNFGGMKNLSLLNLQFSNLGSGESDEMGFMNSLTNCSKLRVLS 331
+ ++ + N +S + NL+ L L + L S + G + LT L+ L
Sbjct: 64 NVRYLALGGNKLH-DISA-LKELTNLTYLILTGNQLQSLPN---GVFDKLT---NLKELV 115
Query: 332 LGGNQFRGALPHSIANLSSQLQILILSSNQFYGSIPLGI-GNLVDLYLLGMVENQFTGAI 390
L NQ + +LP + + + L L L+ NQ S+P G+ L +L L + NQ ++
Sbjct: 116 LVENQLQ-SLPDGVFDKLTNLTYLNLAHNQL-QSLPKGVFDKLTNLTELDLSYNQLQ-SL 172
Query: 391 PKEM-GKLQKLQGLDFSGNHFSGEIPS-SLGNLSSLYEVFFNNN 432
P+ + KL +L+ L N +P L+SL ++ ++N
Sbjct: 173 PEGVFDKLTQLKDLRLYQNQLKS-VPDGVFDRLTSLQYIWLHDN 215
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 4e-04
Identities = 44/219 (20%), Positives = 75/219 (34%), Gaps = 29/219 (13%)
Query: 346 ANLSSQLQILILSSNQFYGSIPLGIGNLVDLYLLGMVENQFT--GAIPKEMGKLQKLQGL 403
+ ++ L L + + + I L ++ L
Sbjct: 15 DDAFAETIKANLKKKSV-TDAVTQNE-LNSIDQIIANNSDIKSVQGIQY----LPNVRYL 68
Query: 404 DFSGNHFSGEIPSSLG---NLSSLYEVFFNNNNLSGVIPFSLGNLKRLAFLEMSGNELSG 460
GN + L++L + N L + L L L + N+L
Sbjct: 69 ALGGNKLH-----DISALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQ- 122
Query: 461 TIPEDIFNISYLSNSLNLARNHLVGIIPPRI-GNLRALRSFDVSNNDLSGEIPI----EL 515
++P+ +F+ LNLA N L +P + L L D+S N L +P +L
Sbjct: 123 SLPDGVFDKLTNLTYLNLAHNQLQS-LPKGVFDKLTNLTELDLSYNQLQ-SLPEGVFDKL 180
Query: 516 GHCSSLEEIYLAGNLFHGSIPS-FFNALKGVQKIDLSRN 553
L+++ L N S+P F+ L +Q I L N
Sbjct: 181 TQ---LKDLRLYQNQLK-SVPDGVFDRLTSLQYIWLHDN 215
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 | Back alignment and structure |
|---|
Score = 54.2 bits (130), Expect = 1e-07
Identities = 51/308 (16%), Positives = 89/308 (28%), Gaps = 35/308 (11%)
Query: 69 SLSPHLGNLSFLREINLSNNTIQGEIPPEFGRLFRLEALFLSNNSLVGKIPANLSYCSRL 128
NL +L+ + E +L L LS +P + +++
Sbjct: 237 GFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGPNE-MPILFPFAAQI 295
Query: 129 TVLCIEYNKLQGRIPLEFVS-LSKLKDLSLAKNKLTGGIPPFLGNLTSLEVLSLAGNSFG 187
L + Y L+ + L+ L G+ L+ L + +
Sbjct: 296 RKLDLLYALLETEDHCTLIQKCPNLEVLETRNVIGDRGLEVLAQYCKQLKRLRIERGADE 355
Query: 188 RNIPDSLGQLKQLKILAIGGNNLSGPIPPSIYNLSFLVVFSVSHNQIHGSLPPSLGLLLP 247
+ + D G + Q ++A+ L +V + I S+G L
Sbjct: 356 QGMEDEEGLVSQRGLIALA------------QGCQELEYMAVYVSDITNESLESIGTYLK 403
Query: 248 NLKFFQ---------IHHNFFSGSIPISLSNASKLEHIEIANNNFSGKLS----VNFG-G 293
NL F+ I + L KL G L+ G
Sbjct: 404 NLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLR--QGGLTDLGLSYIGQY 461
Query: 294 MKNLSLLNLQFSNLGSGESDEMGFMNSLTNCSKLRVLSLGGNQFRGALPHSIANLSSQLQ 353
N+ + L + SDE G M C L+ L + G F + L+
Sbjct: 462 SPNVRWMLLGYVGE----SDE-GLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLR 516
Query: 354 ILILSSNQ 361
L + +
Sbjct: 517 YLWVQGYR 524
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 53.0 bits (127), Expect = 3e-07
Identities = 56/271 (20%), Positives = 93/271 (34%), Gaps = 69/271 (25%)
Query: 690 HLIGVGSFGCVYKGALD-EDGIVVAIKVINLQCEGASKSFMAECKALKNIR-----HRNL 743
+G G F V+ + D + VA+KV+ + + E + LK++R N
Sbjct: 43 RKLGWGHFSTVWL-SWDIQGKKFVAMKVVKSAEHYTETA-LDEIRLLKSVRNSDPNDPNR 100
Query: 744 VKVITSCSSIDFQGNDFK--AIVYEYMPNG-SLEKWLHPHAVPKRDKEIEIKLTLLQRIS 800
V+ G + +V+E + G L KW+ + + L +++I
Sbjct: 101 EMVVQLLDDFKISGVNGTHICMVFEVL--GHHLLKWI------IKSNYQGLPLPCVKKI- 151
Query: 801 IAIDVASALDYLHHHCQEPILHCDLKPSNILL---------------------------- 832
V LDYLH C+ I+H D+KP NILL
Sbjct: 152 -IQQVLQGLDYLHTKCR--IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGS 208
Query: 833 DNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKG--------------TIGYTAPEYGLGS 878
+ L + + L + G T Y + E +GS
Sbjct: 209 AVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLIGS 268
Query: 879 EVSTNGDVYSYGILLLEMVTAKKPTDVMFEG 909
+T D++S + E+ T D +FE
Sbjct: 269 GYNTPADIWSTACMAFELATG----DYLFEP 295
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 3e-07
Identities = 38/130 (29%), Positives = 54/130 (41%), Gaps = 9/130 (6%)
Query: 280 NNNFSGKLSVN-FGGMKNLSLLNLQFSNLGSGESDEMGFMNSLTNCSKLRVLSLGGNQFR 338
++N KL F + NL L L + LG+ G +SLT L VL LG NQ
Sbjct: 48 HDNQITKLEPGVFDSLINLKELYLGSNQLGALPV---GVFDSLTQ---LTVLDLGTNQLT 101
Query: 339 GALPHSIANLSSQLQILILSSNQFYGSIPLGIGNLVDLYLLGMVENQFTGAIPKEMGKLQ 398
LP ++ + L+ L + N+ +P GI L L L + +NQ +L
Sbjct: 102 -VLPSAVFDRLVHLKELFMCCNKL-TELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLS 159
Query: 399 KLQGLDFSGN 408
L GN
Sbjct: 160 SLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 6e-07
Identities = 38/137 (27%), Positives = 53/137 (38%), Gaps = 19/137 (13%)
Query: 57 TALDLMSKSLSGSLSP----HLGNLSFLREINLSNNTIQGEIPPE-FGRLFRLEALFLSN 111
L L ++ L P L NL L L +N + +P F L +L L L
Sbjct: 43 QILYLHDNQIT-KLEPGVFDSLINLKEL---YLGSNQLG-ALPVGVFDSLTQLTVLDLGT 97
Query: 112 NSLVGKIPA----NLSYCSRLTVLCIEYNKLQGRIPLEFVSLSKLKDLSLAKNKLTGGIP 167
N L +P+ L L L + NKL +P L+ L L+L +N+L
Sbjct: 98 NQLT-VLPSAVFDRL---VHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPH 152
Query: 168 PFLGNLTSLEVLSLAGN 184
L+SL L GN
Sbjct: 153 GAFDRLSSLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 2e-06
Identities = 34/130 (26%), Positives = 57/130 (43%), Gaps = 4/130 (3%)
Query: 328 RVLSLGGNQFRGALPHSIANLSSQLQILILSSNQFYGSIPLGI-GNLVDLYLLGMVENQF 386
++L L NQ L + + L+ L L SNQ G++P+G+ +L L +L + NQ
Sbjct: 43 QILYLHDNQIT-KLEPGVFDSLINLKELYLGSNQL-GALPVGVFDSLTQLTVLDLGTNQL 100
Query: 387 TGAIPKEMGKLQKLQGLDFSGNHFSGEIPSSLGNLSSLYEVFFNNNNLSGVIPFSLGNLK 446
T +L L+ L N + E+P + L+ L + + N L + + L
Sbjct: 101 TVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLS 159
Query: 447 RLAFLEMSGN 456
L + GN
Sbjct: 160 SLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 3e-06
Identities = 30/108 (27%), Positives = 46/108 (42%), Gaps = 5/108 (4%)
Query: 105 EALFLSNNSLVGKIPANLSYCSRLTVLCIEYNKLQGRIPLEFVSLSKLKDLSLAKNKLTG 164
+ L+L +N + P L L + N+L F SL++L L L N+LT
Sbjct: 43 QILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLT- 101
Query: 165 GIPP--FLGNLTSLEVLSLAGNSFGRNIPDSLGQLKQLKILAIGGNNL 210
+P F L L+ L + N +P + +L L LA+ N L
Sbjct: 102 VLPSAVF-DRLVHLKELFMCCNKL-TELPRGIERLTHLTHLALDQNQL 147
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 2e-05
Identities = 36/122 (29%), Positives = 52/122 (42%), Gaps = 19/122 (15%)
Query: 118 IPANLSYCSRLTVLCIEYNKLQGRIPLEFVSLSKLKDLSLAKNKLT---GGIPPFLGNLT 174
IP N +L + N++ P F SL LK+L L N+L G+ +LT
Sbjct: 38 IPTNA------QILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVF---DSLT 88
Query: 175 SLEVLSLAGN---SFGRNIPDSLGQLKQLKILAIGGNNLSGPIPPSIYNLSFLVVFSVSH 231
L VL L N + D L LK+ L + N L+ +P I L+ L ++
Sbjct: 89 QLTVLDLGTNQLTVLPSAVFDRLVHLKE---LFMCCNKLTE-LPRGIERLTHLTHLALDQ 144
Query: 232 NQ 233
NQ
Sbjct: 145 NQ 146
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 4e-07
Identities = 30/107 (28%), Positives = 49/107 (45%), Gaps = 7/107 (6%)
Query: 81 REINLSNNTIQGEIPPEFGRLFRLEALFLSNNSLVGKIPANL-SYCSRLTVLCIEYNKLQ 139
E+ L N +P E L + LSNN + + S ++L L + YN+L+
Sbjct: 34 TELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQLLTLILSYNRLR 91
Query: 140 GRIPLEFVSLSKLKDLSLAKNKLTGGIP--PFLGNLTSLEVLSLAGN 184
P F L L+ LSL N ++ +P F +L++L L++ N
Sbjct: 92 CIPPRTFDGLKSLRLLSLHGNDIS-VVPEGAF-NDLSALSHLAIGAN 136
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 6e-06
Identities = 26/96 (27%), Positives = 47/96 (48%), Gaps = 11/96 (11%)
Query: 118 IPANLSYCSRLTVLCIEYNKLQGRIPLEFVSLSKLKDLSLAKNKLTGGIPPFL-GNLTSL 176
IP ++ T L ++ N+ +P E + L + L+ N+++ + N+T L
Sbjct: 29 IPRDV------TELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQL 80
Query: 177 EVLSLAGNSFGRNIPDSL-GQLKQLKILAIGGNNLS 211
L L+ N R IP LK L++L++ GN++S
Sbjct: 81 LTLILSYNRL-RCIPPRTFDGLKSLRLLSLHGNDIS 115
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 4e-05
Identities = 36/109 (33%), Positives = 55/109 (50%), Gaps = 14/109 (12%)
Query: 365 SIPLGI-GNLVDLYLLGMVENQFTGAIPKEMGKLQKLQGLDFSGNHFSGEIP----SSLG 419
+P GI ++ +LYL G NQFT +PKE+ + L +D S N S + S++
Sbjct: 24 VLPKGIPRDVTELYLDG---NQFT-LVPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMT 78
Query: 420 NLSSLYEVFFNNNNLSGVIPFSLGNLKRLAFLEMSGNELSGTIPEDIFN 468
L +L + N L + P + LK L L + GN++S +PE FN
Sbjct: 79 QLLTLI---LSYNRLRCIPPRTFDGLKSLRLLSLHGNDIS-VVPEGAFN 123
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 4e-07
Identities = 43/161 (26%), Positives = 69/161 (42%), Gaps = 26/161 (16%)
Query: 692 IGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRH-RNLVKVITSC 750
IG GSFG +Y G G VAIK+ ++ + E K K ++ + +
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCG 74
Query: 751 SSIDFQGNDFKAIVYEYMPNG-SLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASAL 809
D+ +V E + G SLE + ++ +K LL +A + S +
Sbjct: 75 -----AEGDYNVMVMELL--GPSLEDLFN-----FCSRKFSLKTVLL----LADQMISRI 118
Query: 810 DYLHHHCQEPILHCDLKPSNILLDNDLSGH---IGDFGLAR 847
+Y+H +H D+KP N L+ G+ I DFGLA+
Sbjct: 119 EYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 7e-07
Identities = 34/163 (20%), Positives = 63/163 (38%), Gaps = 28/163 (17%)
Query: 692 IGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSCS 751
IG GSFG +++G + VAIK + + + E + K L +
Sbjct: 18 IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYK-----LLAGCTGIPN 70
Query: 752 SIDF-QGNDFKAIVYEYMPNG-SLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASAL 809
F Q +V + + G SLE L ++ +K + A + + +
Sbjct: 71 VYYFGQEGLHNVLVIDLL--GPSLEDLLD-----LCGRKFSVKTVAM----AAKQMLARV 119
Query: 810 DYLHHHCQEPILHCDLKPSNILLDNDLSG-----HIGDFGLAR 847
+H +++ D+KP N L+ S ++ DFG+ +
Sbjct: 120 QSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 50.6 bits (120), Expect = 2e-06
Identities = 50/302 (16%), Positives = 104/302 (34%), Gaps = 81/302 (26%)
Query: 22 SMIAHEPQGILNSWNDSRHFCEWEGITCGRRHRRVTALDLMSKSLSGSLSPHLGNLSFLR 81
S+IA + L +W+ W+ + C D ++ + SL+ L
Sbjct: 331 SIIAESIRDGLATWD------NWKHVNC----------DKLTTIIESSLN----VLE--- 367
Query: 82 EINLSNNTIQGEIPPEFGRLFRLEALFLSNNSLVGKIPANLSYCSRLTVLCIEYNKLQGR 141
P E+ ++F ++F + IP +L + + +
Sbjct: 368 -------------PAEYRKMFDRLSVFPPS---A-HIPTI--------LLSLIWFDVIKS 402
Query: 142 IPLEFVSLSKLKDLSLAK---NKLTGGIPPFLGNLTSLEVLSLAGNSFG--RNIPDSLGQ 196
+ V +KL SL + + T IP LE+ N + R+I D
Sbjct: 403 DVMVVV--NKLHKYSLVEKQPKESTISIPSIY-----LELKVKLENEYALHRSIVDHYNI 455
Query: 197 LKQLKILAIGGNNLSGPIPPSIYNLSFLVVFSVSH--NQIHGSLPPSLGLLLPNLKFFQ- 253
K ++L P Y S + H N H ++ + +F +
Sbjct: 456 PKTFD-----SDDLI-PPYLDQYFYSHI----GHHLKNIEHPERMTLFRMVFLDFRFLEQ 505
Query: 254 -IHHNFFSGSIPISLSNA-SKLE----HIEIANNNFSGKLS--VNFGGMKNLSLLNLQFS 305
I H+ + + S+ N +L+ +I + + ++ ++F +L+ +++
Sbjct: 506 KIRHDSTAWNASGSILNTLQQLKFYKPYICDNDPKYERLVNAILDFLPKIEENLICSKYT 565
Query: 306 NL 307
+L
Sbjct: 566 DL 567
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 45.2 bits (106), Expect = 1e-04
Identities = 72/552 (13%), Positives = 140/552 (25%), Gaps = 185/552 (33%)
Query: 167 PPFLGNLTSLEVLSLAGNSFGR-------NIPDSLGQLKQL-KILAIGGNN-----LSGP 213
F+ N +V + + + D++ +L L +
Sbjct: 27 DAFVDNFDCKDVQDMPKSILSKEEIDHIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEV 86
Query: 214 IPPSIYNLSFLV-VFSVSHNQIHGSLPPSLGLLLPNLKFFQIHHNFFSGSIPISLSNASK 272
+ N FL+ Q PS+ + + ++ + + N S+
Sbjct: 87 LRI---NYKFLMSPIKTEQRQ------PSM----MTRMYIEQRDRLYNDNQVFAKYNVSR 133
Query: 273 LEHIEIANNNFSGKLSVNFG----GMKNLSLLNLQFSNLGSGESDEMGFMNSLTN--CSK 326
L+ +L G+ GSG++ + C
Sbjct: 134 LQPYLKLRQALL-ELRPAKNVLIDGVL------------GSGKT-------WVALDVCLS 173
Query: 327 LRV----------LSLGGNQFRGALPHSIANLSSQLQILILSSNQFYGSIPLGIGNLVDL 376
+V L+L + + L Q+ S + +I L I ++
Sbjct: 174 YKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAE 233
Query: 377 YLLGMVENQFTGAIPKEMGKLQKLQGLD--FSGNH---FSG-----------EIPSSLGN 420
+ + L L + F+ ++ L
Sbjct: 234 LRRLLKSKPYENC----------LLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSA 283
Query: 421 LSSLYEVFFNNNNLSGVIPFSLGNLKRL--AFLEMSGNELSGTIPEDIFNISYLSNSL-- 476
++ + +++++ + +K L +L+ +L P ++ + S+
Sbjct: 284 ATT-THISLDHHSM----TLTPDEVKSLLLKYLDCRPQDL----PREVLTTNPRRLSIIA 334
Query: 477 NLARNHLVGIIPPRIGNLRAL------RSFDVSNNDLSGE-----------------IPI 513
R+ N + + + S N L IP
Sbjct: 335 ESIRDG-----LATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPT 389
Query: 514 --------------------ELGHCSSLEE------------IYL-----AGNLF--HGS 534
+L H SL E IYL N + H S
Sbjct: 390 ILLSLIWFDVIKSDVMVVVNKL-HKYSLVEKQPKESTISIPSIYLELKVKLENEYALHRS 448
Query: 535 IPSFFNALKGVQKIDLSRNNLSGQIPIFL-------------EALSLEYLNLSFNDFEGK 581
I +N K DL L + + +L+ F E K
Sbjct: 449 IVDHYNIPKTFDSDDLIPPYLDQYFYSHIGHHLKNIEHPERMTLFRMVFLDFRF--LEQK 506
Query: 582 IPAKGIFANASA 593
I NAS
Sbjct: 507 IRHDSTAWNASG 518
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 4e-06
Identities = 45/136 (33%), Positives = 66/136 (48%), Gaps = 16/136 (11%)
Query: 57 TALDLMSKSLSGSLSPHLGNLSFLREINLSNNTIQGEIPPE-FGRLFRLEALFLSNNSLV 115
T LDL + SL + L+ L ++ L N +Q +P F +L L L LS N L
Sbjct: 31 TYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTSLTYLNLSTNQLQ 89
Query: 116 GKIPA----NLSYCSRLTVLCIEYNKLQGRIPLE-FVSLSKLKDLSLAKNKLTGGIPP-- 168
+P L+ +L L + N+LQ +P F L++LKDL L +N+L +P
Sbjct: 90 -SLPNGVFDKLT---QLKELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQNQLK-SVPDGV 143
Query: 169 FLGNLTSLEVLSLAGN 184
F LTSL+ + L N
Sbjct: 144 F-DRLTSLQYIWLHDN 158
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 4e-06
Identities = 40/141 (28%), Positives = 65/141 (46%), Gaps = 16/141 (11%)
Query: 295 KNLSLLNLQFSNLGSGESDEMGFMNSLTNCSKLRVLSLGGNQFRGALPHSIANLSSQLQI 354
L L +L +G DE+ + L L LGGN+ + +LP+ + N + L
Sbjct: 31 TYLDLETNSLKSLPNGVFDEL---------TSLTQLYLGGNKLQ-SLPNGVFNKLTSLTY 80
Query: 355 LILSSNQFYGSIPLGI-GNLVDLYLLGMVENQFTGAIPKEM-GKLQKLQGLDFSGNHFSG 412
L LS+NQ S+P G+ L L L + NQ ++P + KL +L+ L N
Sbjct: 81 LNLSTNQL-QSLPNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQNQLKS 138
Query: 413 EIPS-SLGNLSSLYEVFFNNN 432
+P L+SL ++ ++N
Sbjct: 139 -VPDGVFDRLTSLQYIWLHDN 158
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 1e-05
Identities = 34/102 (33%), Positives = 44/102 (43%), Gaps = 9/102 (8%)
Query: 105 EALFLSNNSLVGKIPANLSYCSRLTVLCIEYNKLQGRIPLEFVSLSKLKDLSLAKNKLTG 164
L L NSL + LT L + NKLQ F L+ L L+L+ N+L
Sbjct: 31 TYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQ- 89
Query: 165 GIPP--FLGNLTSLEVLSLAGNSFGRNIP----DSLGQLKQL 200
+P F LT L+ L+L N +P D L QLK L
Sbjct: 90 SLPNGVF-DKLTQLKELALNTNQLQS-LPDGVFDKLTQLKDL 129
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 4e-04
Identities = 41/157 (26%), Positives = 62/157 (39%), Gaps = 33/157 (21%)
Query: 129 TVLCIEYNKLQGRIPLEFVSLSKLKDLSLAKNKLTGGIPPFLGNLTSLEVLSLAGN---S 185
T L +E N L+ F L+ L L L NKL LTSL L+L+ N S
Sbjct: 31 TYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQS 90
Query: 186 FGRNIPDSLGQLKQLKILAIGGNNLSGPIPPSIYNLSFLVVFSVSHNQIHGSLPPSLGLL 245
+ D L QLK+L +++ NQ+ SLP +
Sbjct: 91 LPNGVFDKLTQLKEL---------------------------ALNTNQLQ-SLPDGVFDK 122
Query: 246 LPNLKFFQIHHNFFSGSIPI-SLSNASKLEHIEIANN 281
L LK +++ N S+P + L++I + +N
Sbjct: 123 LTQLKDLRLYQNQLK-SVPDGVFDRLTSLQYIWLHDN 158
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 4e-06
Identities = 53/329 (16%), Positives = 103/329 (31%), Gaps = 65/329 (19%)
Query: 74 LGNLSFLREINLSNNTIQGEIPPEFGRLFR-----LEALFLSNNSL----VGKIPANL-S 123
+ ++LS N + E + F + +L LS NSL ++ L +
Sbjct: 18 TSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAA 77
Query: 124 YCSRLTVLCIEYNKLQGRIPLEFVSL-----SKLKDLSLAKNKLTGGIPPFLGNL----- 173
+ +T L + N L + E V + L L N +
Sbjct: 78 IPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLP 137
Query: 174 TSLEVLSLAGNSFGRNIPDSLGQL-----KQLKILAIGGNNLSGPIPPSIYNLSF----- 223
S+ L+L GN G D L Q+ + L + GNNL+ + L+
Sbjct: 138 ASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLA---SKNCAELAKFLASI 194
Query: 224 ---LVVFSVSHNQIHGSLPPSLGLLLPNLKFFQIHHNFFSGSIPISLSNASKLEHIEIAN 280
+ +S N + L + S + + + +
Sbjct: 195 PASVTSLDLSANLLGLKSYAELAYIF--------------------SSIPNHVVSLNLCL 234
Query: 281 NNFSGK----LSVNFGGMKNLSLLNLQFSNLGS-GESDEMGFMNSLTNCSKLRVLSLGGN 335
N G L + +K+L + L + + + + + N K+ ++ G
Sbjct: 235 NCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGK 294
Query: 336 QFRG----ALPHSIANLSSQLQILILSSN 360
+ + + I LS + + L +
Sbjct: 295 EIHPSHSIPISNLIRELSGKADVPSLLNQ 323
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 1e-04
Identities = 50/346 (14%), Positives = 94/346 (27%), Gaps = 76/346 (21%)
Query: 268 SNASKLEHIEIANNNFSGKLSVNFGGM-----KNLSLLNLQFSNLGSGESDEMGFMNSLT 322
+ + + + ++ N+ K S + N++ LNL + L SDE+ +
Sbjct: 48 NTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVKTLAAI 107
Query: 323 NCSKLRVLSLGGNQFRG----ALPHSIANLSSQLQILILSSNQFY--GSIPLGIG----- 371
+ + VL LG N F + +NL + + L L N S L
Sbjct: 108 PFT-ITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIP 166
Query: 372 -NLVDLYLLGMVENQFTGAIPKEMGKL-----QKLQGLDFSGNHFSGEIPSSLG-----N 420
N+ L L N E+ K + LD S N + + L
Sbjct: 167 ANVNSLNL---RGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSI 223
Query: 421 LSSLYEVFFNNNNLSGV----IPFSLGNLKRLAFLEMSGNELSGTIPEDIFNISYLSNSL 476
+ + + N L G + +LK L + + + + E +
Sbjct: 224 PNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALG------ 277
Query: 477 NLARNHLVGIIPPRIGNLRALRSFDVSNNDLSGEIPIELG-----HCSSLEEIYLAGNLF 531
N++ + D + ++ I + + L
Sbjct: 278 ------------AAFPNIQKIILVDKNGKEIHPSHSIPISNLIRELSGKADVPSLLNQ-- 323
Query: 532 HGSIPSFFNALKGVQKIDLSRNNLSGQIPIFLEALSLEYLNLSFND 577
A K I+ L +
Sbjct: 324 -----CLIFAQKHQTNIEDLNIP-----------DELRESIQTCKP 353
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 48.1 bits (114), Expect = 1e-05
Identities = 39/161 (24%), Positives = 72/161 (44%), Gaps = 26/161 (16%)
Query: 692 IGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSCS 751
IG GSFG +Y G + VAIK+ N++ + + E K + ++ + +
Sbjct: 15 IGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGI-----PN 67
Query: 752 SIDF-QGNDFKAIVYEYMPNG-SLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASAL 809
F D+ +V + + G SLE + +++ +K L+ +A + + +
Sbjct: 68 VRWFGVEGDYNVLVMDLL--GPSLEDLFN-----FCSRKLSLKTVLM----LADQMINRV 116
Query: 810 DYLHHHCQEPILHCDLKPSNILLDNDLSGH---IGDFGLAR 847
+++H LH D+KP N L+ + I DFGLA+
Sbjct: 117 EFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 46.9 bits (110), Expect = 2e-05
Identities = 24/164 (14%), Positives = 50/164 (30%), Gaps = 15/164 (9%)
Query: 63 SKSLSGSLSPHLGNLSFLREINLSNNTIQGEIPPEFGRL--FRLEALFLSNNSLVGKIPA 120
S LSP L + L + + L + + L ++ + + +
Sbjct: 157 SWIEQVDLSPVLDAMPLLNNLKIKGTNNLSIGKKPRPNLKSLEIISGGLPDSVVEDILGS 216
Query: 121 NLSYCSRLTVLCIEYNKLQGRIP------LEFVSLSKLKDLSLAKNKLTGGIPPFLGN-- 172
+L +L + + LK L + + +
Sbjct: 217 DLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESD 276
Query: 173 -LTSLEVLSLAGNSFG----RNIPDSLGQLKQLKILAIGGNNLS 211
L LE + ++ R + D + ++K LK + + N LS
Sbjct: 277 ILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLS 320
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 45.3 bits (106), Expect = 7e-05
Identities = 18/133 (13%), Positives = 41/133 (30%), Gaps = 19/133 (14%)
Query: 396 KLQKLQGLDFSGNHFSGEIPSSLG-----NLSSLYEVFFNNNNLSGVIP-------FSLG 443
L+ L+ + + NL L ++ + FS
Sbjct: 191 PRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKL-VLYVGVEDYGFDGDMNVFRPLFSKD 249
Query: 444 NLKRLAFLEMSGNELSGTIPEDIFNISYLSN--SLNLARNHL----VGIIPPRIGNLRAL 497
L +L + E + E L +++++ L ++ + ++ L
Sbjct: 250 RFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHL 309
Query: 498 RSFDVSNNDLSGE 510
+ ++ N LS E
Sbjct: 310 KFINMKYNYLSDE 322
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 41.9 bits (97), Expect = 9e-04
Identities = 27/204 (13%), Positives = 60/204 (29%), Gaps = 27/204 (13%)
Query: 222 SFLVVFSVSHNQIHGSLPPSLGLLLPNLKFFQIHHNFFSGSIPISLSNASKLEHIEIANN 281
F +I L +L + + ++ I L+ +EI +
Sbjct: 144 LFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNLSIGKKPRPNLKSLEIISG 203
Query: 282 NFS--GKLSVNFGGMKNLSLLNLQFSNLGSGESDEMGFMNSL---TNCSKLRVLSLGGNQ 336
+ + NL L L G +M L L+ L + +
Sbjct: 204 GLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAE 263
Query: 337 FRGALPHSIAN--LSSQLQILILSSNQFYGSIPLGIGNLVDLYLLGMVENQFTGAIPKEM 394
+ + + QL+ + +S+ + + G + +
Sbjct: 264 EQNVVVEMFLESDILPQLETMDISAGV--------LTDE------GAR------LLLDHV 303
Query: 395 GKLQKLQGLDFSGNHFSGEIPSSL 418
K++ L+ ++ N+ S E+ L
Sbjct: 304 DKIKHLKFINMKYNYLSDEMKKEL 327
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 43.0 bits (102), Expect = 1e-04
Identities = 34/109 (31%), Positives = 53/109 (48%), Gaps = 10/109 (9%)
Query: 81 REINLSNNTIQGEIPPEFGRLFRLEALFLSNNSLVGKIPA----NLSYCSRLTVLCIEYN 136
+ L +N +Q F +L +L L LS N + +P L ++LT+L + N
Sbjct: 31 TRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDKL---TKLTILYLHEN 86
Query: 137 KLQGRIPLE-FVSLSKLKDLSLAKNKLTGGIPPFLGNLTSLEVLSLAGN 184
KLQ +P F L++LK+L+L N+L LTSL+ + L N
Sbjct: 87 KLQ-SLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 134
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 43.0 bits (102), Expect = 1e-04
Identities = 31/88 (35%), Positives = 44/88 (50%), Gaps = 13/88 (14%)
Query: 118 IPANLSYCSRLTVLCIEYNKLQGRIPLEFVSLSKLKDLSLAKNKLTGGIPP--FLGNLTS 175
IP++ T L +E NKLQ F L++L LSL++N++ +P F LT
Sbjct: 26 IPSSA------TRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVF-DKLTK 77
Query: 176 LEVLSLAGN---SFGRNIPDSLGQLKQL 200
L +L L N S + D L QLK+L
Sbjct: 78 LTILYLHENKLQSLPNGVFDKLTQLKEL 105
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 2e-04
Identities = 32/115 (27%), Positives = 47/115 (40%), Gaps = 12/115 (10%)
Query: 295 KNLSLLNLQFSNLGSGESDEMGFMNSLTNCSKLRVLSLGGNQFRGALPHSIANLSSQLQI 354
L L + + +L G D LT L LSL NQ + +LP + + ++L I
Sbjct: 31 TRLELESNKLQSLPHGVFD------KLTQ---LTKLSLSQNQIQ-SLPDGVFDKLTKLTI 80
Query: 355 LILSSNQFYGSIPLGI-GNLVDLYLLGMVENQFTGAIPKEMGKLQKLQGLDFSGN 408
L L N+ S+P G+ L L L + NQ +L LQ + N
Sbjct: 81 LYLHENKL-QSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 134
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174 | Back alignment and structure |
|---|
Score = 40.7 bits (96), Expect = 6e-04
Identities = 27/88 (30%), Positives = 34/88 (38%), Gaps = 13/88 (14%)
Query: 118 IPANLSYCSRLTVLCIEYNKLQGRIPLEFVSLSKLKDLSLAKNKLTGGIPP--FLGNLTS 175
IP + L + N++ P F L L+ L NKLT IP F LT
Sbjct: 31 IPTDK------QRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLT-AIPTGVF-DKLTQ 82
Query: 176 LEVLSLAGN---SFGRNIPDSLGQLKQL 200
L L L N S R D+L L +
Sbjct: 83 LTQLDLNDNHLKSIPRGAFDNLKSLTHI 110
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170 | Back alignment and structure |
|---|
Score = 40.7 bits (96), Expect = 6e-04
Identities = 28/88 (31%), Positives = 37/88 (42%), Gaps = 13/88 (14%)
Query: 118 IPANLSYCSRLTVLCIEYNKLQGRIPLEFVSLSKLKDLSLAKNKLTGGIPP--FLGNLTS 175
IP VL + N++ P F L++L L L N+LT +P F LT
Sbjct: 28 IPTTT------QVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLT-VLPAGVF-DKLTQ 79
Query: 176 LEVLSLAGN---SFGRNIPDSLGQLKQL 200
L LSL N S R D+L L +
Sbjct: 80 LTQLSLNDNQLKSIPRGAFDNLKSLTHI 107
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 1008 | |||
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 100.0 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 100.0 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 100.0 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 100.0 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 100.0 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 100.0 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 100.0 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 100.0 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 100.0 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 100.0 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 100.0 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 100.0 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 100.0 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 100.0 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 100.0 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 100.0 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 100.0 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 100.0 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 100.0 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 100.0 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.98 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.97 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.97 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.97 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.97 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.97 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.97 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.96 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.96 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.96 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.96 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.95 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.95 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.95 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.95 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.95 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.95 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.95 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.95 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.95 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.94 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.94 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.94 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.94 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.94 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.94 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.94 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.94 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.93 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.93 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.92 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.92 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.92 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.91 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.91 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.91 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.91 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.9 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.9 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.9 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.9 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.9 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.89 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.89 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.88 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.88 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.88 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.88 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.87 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.87 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.87 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.87 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.87 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.86 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.86 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.86 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.86 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.85 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.84 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.83 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.83 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.81 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.8 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.79 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.78 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.78 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.78 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.78 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.78 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.78 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.78 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.77 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.76 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.76 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.76 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.75 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.74 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.74 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.73 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.73 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.73 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.73 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.69 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.67 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.67 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.64 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.63 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.63 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.62 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.61 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.61 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.6 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.59 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.59 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.57 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.56 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.56 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.55 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.53 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.51 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 99.5 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 99.5 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.41 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.4 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.4 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.37 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.28 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 99.27 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 99.25 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.24 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.22 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.19 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.18 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.96 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.86 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.86 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 98.85 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.85 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 98.84 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.81 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.76 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.48 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.37 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.34 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.34 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.27 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.24 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.2 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.15 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.94 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.83 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.8 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.78 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.72 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.53 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.45 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.35 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.18 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.1 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.96 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.88 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.82 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.78 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.77 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 96.58 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 96.55 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.4 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.33 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.33 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.13 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 95.94 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.83 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 94.58 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 90.21 |
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-81 Score=772.71 Aligned_cols=594 Identities=30% Similarity=0.462 Sum_probs=438.7
Q ss_pred ccCChhhHHHHHHHHHhhccCCCCCCCCCCCCCCCCcccceEEcCCCCeEEEEeccccCCCCc---cC------------
Q 045798 7 AALEDGDRAALQAFKSMIAHEPQGILNSWNDSRHFCEWEGITCGRRHRRVTALDLMSKSLSGS---LS------------ 71 (1008)
Q Consensus 7 ~~~~~~~~~~l~~~k~~~~~~~~~~~~~w~~~~~~c~w~gv~c~~~~~~v~~l~l~~~~l~~~---l~------------ 71 (1008)
+++.++|++||++||+++. ||. .+++|+.+++||.|.||+|+ .++|+.|||+++++.|. ++
T Consensus 7 ~~~~~~~~~all~~k~~~~-~~~-~l~~W~~~~~~C~w~gv~C~--~~~v~~L~L~~~~l~g~~~~l~~~l~~L~~L~~l 82 (768)
T 3rgz_A 7 SQSLYREIHQLISFKDVLP-DKN-LLPDWSSNKNPCTFDGVTCR--DDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESL 82 (768)
T ss_dssp -CCHHHHHHHHHHHHTTCS-CTT-SSTTCCTTSCGGGSTTEEEE--TTEEEEEECTTSCCCEEHHHHHHHTTTCTTCCEE
T ss_pred ccCCHHHHHHHHHHHhhCC-Ccc-cccCCCCCCCCcCCcceEEC--CCcEEEEECCCCCcCCccCccChhHhccCccccc
Confidence 4557889999999999997 777 89999988999999999998 58999999999998886 44
Q ss_pred -----------cCccCCccCCeeeecCCCCCCCCCc--cccCCCCCCEEEccCCCCCCccCccc-ccCcCcceEeeeccc
Q 045798 72 -----------PHLGNLSFLREINLSNNTIQGEIPP--EFGRLFRLEALFLSNNSLVGKIPANL-SYCSRLTVLCIEYNK 137 (1008)
Q Consensus 72 -----------~~l~~l~~L~~L~L~~n~~~~~~p~--~~~~l~~L~~L~Ls~n~l~~~~p~~l-~~l~~L~~L~Ls~n~ 137 (1008)
+.++.+++|++|+|++|.+++.+|. .|+++++|++|+|++|.+++.+|..+ .++++|++|+|++|+
T Consensus 83 ~~~~~~~~~l~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~n~ 162 (768)
T 3rgz_A 83 FLSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANS 162 (768)
T ss_dssp ECTTSCEEECCCCCCCCTTCCEEECCSSEEEEEGGGGGGGGGCTTCCEEECCSSEEECCSSCCSCCCCTTCSEEECCSSC
T ss_pred CCcCCCcCCCchhhccCCCCCEEECCCCcCCCcCCChHHHhCCCCCCEEECcCCccCCcCCHHHhccCCCCCEEECCCCc
Confidence 4677888888888888888888887 88888888888888888887777665 667777777777777
Q ss_pred cccCCCcc---c----------------------cccCCCCeeecccccCCCCCCCCCccccccchhhcccccCCCCCCc
Q 045798 138 LQGRIPLE---F----------------------VSLSKLKDLSLAKNKLTGGIPPFLGNLTSLEVLSLAGNSFGRNIPD 192 (1008)
Q Consensus 138 l~~~~p~~---~----------------------~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~ 192 (1008)
+++..|.. + ..+++|++|+|++|++++.+|. ++++++|++|++++|++++..|.
T Consensus 163 l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~l~~L~~L~Ls~n~l~~~~~~-l~~l~~L~~L~Ls~n~l~~~~~~ 241 (768)
T 3rgz_A 163 ISGANVVGWVLSDGCGELKHLAISGNKISGDVDVSRCVNLEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNKLSGDFSR 241 (768)
T ss_dssp CEEETHHHHHHTTCCTTCCEEECCSSEEESCCBCTTCTTCCEEECCSSCCCSCCCB-CTTCCSCCEEECCSSCCCSCHHH
T ss_pred cCCcCChhhhhhccCCCCCEEECCCCcccccCCcccCCcCCEEECcCCcCCCCCcc-cccCCCCCEEECcCCcCCCcccH
Confidence 76655544 3 3455566666666666655554 66777777777777777666677
Q ss_pred cccCCCCCcEEEecCCcccccCCccccCCCCcceeccccccccccCChhhhhcCCCCcEEEeccccCCCCCCcccccCCC
Q 045798 193 SLGQLKQLKILAIGGNNLSGPIPPSIYNLSFLVVFSVSHNQIHGSLPPSLGLLLPNLKFFQIHHNFFSGSIPISLSNASK 272 (1008)
Q Consensus 193 ~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~ 272 (1008)
+|+.+++|++|++++|.+++.+|.. .+++|++|++++|++++.+|..++..+++|++|+|++|.+.+.+|..+.++++
T Consensus 242 ~l~~l~~L~~L~Ls~n~l~~~~~~~--~l~~L~~L~L~~n~l~~~ip~~~~~~~~~L~~L~Ls~n~l~~~~p~~~~~l~~ 319 (768)
T 3rgz_A 242 AISTCTELKLLNISSNQFVGPIPPL--PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSL 319 (768)
T ss_dssp HTTTCSSCCEEECCSSCCEESCCCC--CCTTCCEEECCSSEEEESCCCCSCTTCTTCSEEECCSSEEEECCCGGGGGCTT
T ss_pred HHhcCCCCCEEECCCCcccCccCcc--ccCCCCEEECcCCccCCccCHHHHhhcCcCCEEECcCCcCCCccchHHhcCCC
Confidence 7777777777777777776655544 56666777777777766777777665678888888888887777888888888
Q ss_pred Cceeeccccccccccccc-ccCCCcccccccccccCCC-CCCCcc-----------------------------------
Q 045798 273 LEHIEIANNNFSGKLSVN-FGGMKNLSLLNLQFSNLGS-GESDEM----------------------------------- 315 (1008)
Q Consensus 273 L~~L~L~~N~l~~~~~~~-~~~l~~L~~L~L~~n~l~~-~~~~~~----------------------------------- 315 (1008)
|++|++++|++.+..|.. |..+++|+.|++++|++.. ......
T Consensus 320 L~~L~L~~n~l~~~ip~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L 399 (768)
T 3rgz_A 320 LESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQEL 399 (768)
T ss_dssp CCEEECCSSEEEEECCHHHHTTCTTCCEEECCSSEEEECCCTTHHHHTTTCSEEECCSSEEEEECCTTTTCSTTCCCCEE
T ss_pred ccEEECCCCcccCcCCHHHHhcCCCCCEEeCcCCccCccccHHHHhhhcCCcEEEccCCCcCCCcChhhhhcccCCccEE
Confidence 888888888877655544 7777777777777776641 111000
Q ss_pred ---------cccccccccCCCcEEEecCCcCCccCChhhhhhcccceeeeeccccccCCCCCccccccccceEEecCccc
Q 045798 316 ---------GFMNSLTNCSKLRVLSLGGNQFRGALPHSIANLSSQLQILILSSNQFYGSIPLGIGNLVDLYLLGMVENQF 386 (1008)
Q Consensus 316 ---------~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l 386 (1008)
..+..+..+++|+.|++++|++++.+|..+..+. +|++|++++|.+++.+|..+..+++|+.|++++|++
T Consensus 400 ~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~-~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l 478 (768)
T 3rgz_A 400 YLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLS-KLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDL 478 (768)
T ss_dssp ECCSSEEEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCT-TCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCC
T ss_pred ECCCCccccccCHHHhcCCCCCEEECcCCcccCcccHHHhcCC-CCCEEECCCCcccCcCCHHHcCCCCceEEEecCCcc
Confidence 1222344555555555555555555555555554 356666666666555666666666666666666666
Q ss_pred cCCcchhccCCCCCceEEccCCcccccccccccCCCCcceeeccccccccccCCCCcCCCcccEeecccccccCCcchhh
Q 045798 387 TGAIPKEMGKLQKLQGLDFSGNHFSGEIPSSLGNLSSLYEVFFNNNNLSGVIPFSLGNLKRLAFLEMSGNELSGTIPEDI 466 (1008)
Q Consensus 387 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~lp~~~ 466 (1008)
++.+|..+..+++|++|+|++|++++.+|.+++.+++|++|+|++|++++.+|..++++++|++|+|++|+++|.+|..+
T Consensus 479 ~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~ 558 (768)
T 3rgz_A 479 TGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAM 558 (768)
T ss_dssp CSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEEECCGGGGGCTTCCEEECCSSEEESBCCGGG
T ss_pred cCcCCHHHhcCCCCCEEEccCCccCCcCChHHhcCCCCCEEECCCCcccCcCCHHHcCCCCCCEEECCCCccCCcCChHH
Confidence 66666666666666666666666666666666666666666666666666666666666666666666666666666655
Q ss_pred hhhhhh---------------------------------------------hhhhcccCccccCCCcccccccccccccc
Q 045798 467 FNISYL---------------------------------------------SNSLNLARNHLVGIIPPRIGNLRALRSFD 501 (1008)
Q Consensus 467 ~~~~~~---------------------------------------------~~~L~L~~N~l~~~~p~~~~~l~~L~~Ld 501 (1008)
+..... .+.++++.|.+.|.+|..++.+++|+.||
T Consensus 559 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~Ld 638 (768)
T 3rgz_A 559 FKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLD 638 (768)
T ss_dssp GTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCEEE
T ss_pred hcccchhhhhccccccccccccccccccccccccccccccccchhhhccccccccccccceecccCchhhhccccccEEE
Confidence 442211 11233444666666666777788999999
Q ss_pred cccccccCCCCcccccccccceeeccCcccccchhhhhhccccccEEecCCCcccccccCc-ccccccceeecccCcccc
Q 045798 502 VSNNDLSGEIPIELGHCSSLEEIYLAGNLFHGSIPSFFNALKGVQKIDLSRNNLSGQIPIF-LEALSLEYLNLSFNDFEG 580 (1008)
Q Consensus 502 ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~-~~~~~L~~L~l~~N~l~g 580 (1008)
||+|+++|.+|.+++.+++|+.|+|++|+|+|.+|..|+.+++|+.||||+|+++|.+|.. ..+.+|++||+++|+|+|
T Consensus 639 Ls~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g 718 (768)
T 3rgz_A 639 MSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSG 718 (768)
T ss_dssp CCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSSEEEE
T ss_pred CcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcCCcccc
Confidence 9999999999999999999999999999999999999999999999999999999999988 678899999999999999
Q ss_pred cCCCCcccCCcccceeccCCccCCCCCC
Q 045798 581 KIPAKGIFANASAISVVGCNRLCGGIPE 608 (1008)
Q Consensus 581 ~~p~~~~~~~~~~~~~~~n~~l~g~~~~ 608 (1008)
.||..++|.++...+|.||+++||.+..
T Consensus 719 ~iP~~~~~~~~~~~~~~gN~~Lcg~~l~ 746 (768)
T 3rgz_A 719 PIPEMGQFETFPPAKFLNNPGLCGYPLP 746 (768)
T ss_dssp ECCSSSSGGGSCGGGGCSCTEEESTTSC
T ss_pred cCCCchhhccCCHHHhcCCchhcCCCCc
Confidence 9999999999999999999999997643
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-63 Score=612.59 Aligned_cols=514 Identities=33% Similarity=0.486 Sum_probs=433.6
Q ss_pred eEEEEeccccCCCCccCcCccCCccCCeeeecCCCCCCCCCccccCCCCCCEEEccCCCCCCccCcccccCcCcceEeee
Q 045798 55 RVTALDLMSKSLSGSLSPHLGNLSFLREINLSNNTIQGEIPPEFGRLFRLEALFLSNNSLVGKIPANLSYCSRLTVLCIE 134 (1008)
Q Consensus 55 ~v~~l~l~~~~l~~~l~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls 134 (1008)
.++.|++++|.+++.++. ..+++|++|+|++|++++.+|. |+++++|++|+|++|.+++.+|..++.+++|++|+|+
T Consensus 179 ~L~~L~Ls~n~l~~~~~~--~~l~~L~~L~Ls~n~l~~~~~~-l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~Ls 255 (768)
T 3rgz_A 179 ELKHLAISGNKISGDVDV--SRCVNLEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNIS 255 (768)
T ss_dssp TCCEEECCSSEEESCCBC--TTCTTCCEEECCSSCCCSCCCB-CTTCCSCCEEECCSSCCCSCHHHHTTTCSSCCEEECC
T ss_pred CCCEEECCCCcccccCCc--ccCCcCCEEECcCCcCCCCCcc-cccCCCCCEEECcCCcCCCcccHHHhcCCCCCEEECC
Confidence 344555555555543332 5677777777777777766665 7777777777777777777777777777777777777
Q ss_pred ccccccCCCccccccCCCCeeecccccCCCCCCCCCccc-cccchhhcccccCCCCCCccccCCCCCcEEEecCCccccc
Q 045798 135 YNKLQGRIPLEFVSLSKLKDLSLAKNKLTGGIPPFLGNL-TSLEVLSLAGNSFGRNIPDSLGQLKQLKILAIGGNNLSGP 213 (1008)
Q Consensus 135 ~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l-~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~ 213 (1008)
+|++.+.+|.. .+++|++|++++|++++.+|..+..+ ++|++|+|++|++++..|..|+.+++|++|++++|.+++.
T Consensus 256 ~n~l~~~~~~~--~l~~L~~L~L~~n~l~~~ip~~~~~~~~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~ 333 (768)
T 3rgz_A 256 SNQFVGPIPPL--PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGE 333 (768)
T ss_dssp SSCCEESCCCC--CCTTCCEEECCSSEEEESCCCCSCTTCTTCSEEECCSSEEEECCCGGGGGCTTCCEEECCSSEEEEE
T ss_pred CCcccCccCcc--ccCCCCEEECcCCccCCccCHHHHhhcCcCCEEECcCCcCCCccchHHhcCCCccEEECCCCcccCc
Confidence 77777666654 67777778888887777777777665 7888888888888777888888888888888888888777
Q ss_pred CCcc-ccCCCCcceeccccccccccCChhhhhcCCCCcEEEeccccCCCCCCccccc--CCCCceeeccccccccccccc
Q 045798 214 IPPS-IYNLSFLVVFSVSHNQIHGSLPPSLGLLLPNLKFFQIHHNFFSGSIPISLSN--ASKLEHIEIANNNFSGKLSVN 290 (1008)
Q Consensus 214 ~~~~-~~~l~~L~~L~ls~N~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~--l~~L~~L~L~~N~l~~~~~~~ 290 (1008)
+|.. +.++++|++|++++|++++.+|..+....++|++|+|++|.+.+.+|..+.. +++|++|++++|++++..|..
T Consensus 334 ip~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~ 413 (768)
T 3rgz_A 334 LPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPT 413 (768)
T ss_dssp CCHHHHTTCTTCCEEECCSSEEEECCCTTHHHHTTTCSEEECCSSEEEEECCTTTTCSTTCCCCEEECCSSEEEEECCGG
T ss_pred CCHHHHhcCCCCCEEeCcCCccCccccHHHHhhhcCCcEEEccCCCcCCCcChhhhhcccCCccEEECCCCccccccCHH
Confidence 7765 7888888888888888887888777664458888888888888777777776 788999999999999899999
Q ss_pred ccCCCcccccccccccCCCCCCCcccccccccccCCCcEEEecCCcCCccCChhhhhhcccceeeeeccccccCCCCCcc
Q 045798 291 FGGMKNLSLLNLQFSNLGSGESDEMGFMNSLTNCSKLRVLSLGGNQFRGALPHSIANLSSQLQILILSSNQFYGSIPLGI 370 (1008)
Q Consensus 291 ~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~Ls~N~l~~~~p~~~ 370 (1008)
|..+++|+.|++++|+++... +..+..+++|+.|++++|++.+.+|..+..+. +|++|+|++|++++.+|..+
T Consensus 414 l~~l~~L~~L~Ls~N~l~~~~------p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~-~L~~L~L~~N~l~~~~p~~l 486 (768)
T 3rgz_A 414 LSNCSELVSLHLSFNYLSGTI------PSSLGSLSKLRDLKLWLNMLEGEIPQELMYVK-TLETLILDFNDLTGEIPSGL 486 (768)
T ss_dssp GGGCTTCCEEECCSSEEESCC------CGGGGGCTTCCEEECCSSCCCSCCCGGGGGCT-TCCEEECCSSCCCSCCCGGG
T ss_pred HhcCCCCCEEECcCCcccCcc------cHHHhcCCCCCEEECCCCcccCcCCHHHcCCC-CceEEEecCCcccCcCCHHH
Confidence 999999999999999887533 34688999999999999999999999999886 59999999999999999999
Q ss_pred ccccccceEEecCccccCCcchhccCCCCCceEEccCCcccccccccccCCCCcceeeccccccccccCCCCcCCCccc-
Q 045798 371 GNLVDLYLLGMVENQFTGAIPKEMGKLQKLQGLDFSGNHFSGEIPSSLGNLSSLYEVFFNNNNLSGVIPFSLGNLKRLA- 449 (1008)
Q Consensus 371 ~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~- 449 (1008)
.++++|+.|++++|++++.+|.+++.+++|++|+|++|++++.+|..+..+++|+.|++++|.++|.+|..+..+..+.
T Consensus 487 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~~~ 566 (768)
T 3rgz_A 487 SNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIA 566 (768)
T ss_dssp GGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEEECCGGGGGCTTCCEEECCSSEEESBCCGGGGTTTTCBC
T ss_pred hcCCCCCEEEccCCccCCcCChHHhcCCCCCEEECCCCcccCcCCHHHcCCCCCCEEECCCCccCCcCChHHhcccchhh
Confidence 9999999999999999999999999999999999999999999999999999999999999999999998776654433
Q ss_pred ---------------------------------------------EeecccccccCCcchhhhhhhhhhhhhcccCcccc
Q 045798 450 ---------------------------------------------FLEMSGNELSGTIPEDIFNISYLSNSLNLARNHLV 484 (1008)
Q Consensus 450 ---------------------------------------------~L~Ls~N~l~~~lp~~~~~~~~~~~~L~L~~N~l~ 484 (1008)
.++++.|.++|.+|..+..... ++.|+|++|+++
T Consensus 567 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~-L~~LdLs~N~l~ 645 (768)
T 3rgz_A 567 ANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGS-MMFLDMSYNMLS 645 (768)
T ss_dssp CSTTCSCEEEEEECCSCCTTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBC-CCEEECCSSCCB
T ss_pred hhccccccccccccccccccccccccccccccccchhhhccccccccccccceecccCchhhhcccc-ccEEECcCCccc
Confidence 3445557788888877655444 478999999999
Q ss_pred CCCcccccccccccccccccccccCCCCcccccccccceeeccCcccccchhhhhhccccccEEecCCCcccccccCccc
Q 045798 485 GIIPPRIGNLRALRSFDVSNNDLSGEIPIELGHCSSLEEIYLAGNLFHGSIPSFFNALKGVQKIDLSRNNLSGQIPIFLE 564 (1008)
Q Consensus 485 ~~~p~~~~~l~~L~~Ldls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~ 564 (1008)
|.+|..|+.+++|+.|||++|+++|.+|..|+.+++|++|||++|+++|.+|..++.++.|+.||||+|+++|.||....
T Consensus 646 g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g~iP~~~~ 725 (768)
T 3rgz_A 646 GYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQ 725 (768)
T ss_dssp SCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSSEEEEECCSSSS
T ss_pred ccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcCCcccccCCCchh
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999998877
Q ss_pred ccccceeecccCc-cccc
Q 045798 565 ALSLEYLNLSFND-FEGK 581 (1008)
Q Consensus 565 ~~~L~~L~l~~N~-l~g~ 581 (1008)
..++..+.+.+|. +.|.
T Consensus 726 ~~~~~~~~~~gN~~Lcg~ 743 (768)
T 3rgz_A 726 FETFPPAKFLNNPGLCGY 743 (768)
T ss_dssp GGGSCGGGGCSCTEEEST
T ss_pred hccCCHHHhcCCchhcCC
Confidence 7788888888885 6664
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-58 Score=569.45 Aligned_cols=563 Identities=21% Similarity=0.204 Sum_probs=473.7
Q ss_pred CCcccceEEcCC---------CCeEEEEeccccCCCCccCcCccCCccCCeeeecCCCCCCCCCccccCCCCCCEEEccC
Q 045798 41 FCEWEGITCGRR---------HRRVTALDLMSKSLSGSLSPHLGNLSFLREINLSNNTIQGEIPPEFGRLFRLEALFLSN 111 (1008)
Q Consensus 41 ~c~w~gv~c~~~---------~~~v~~l~l~~~~l~~~l~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~ 111 (1008)
.|.++.+.|... ..+++.|||++|.+++..+..+..+++|++|+|++|.+++..|..|.++++|++|+|++
T Consensus 3 ~~~~~~~~cs~~~L~~ip~~~~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~ 82 (680)
T 1ziw_A 3 TVSHEVADCSHLKLTQVPDDLPTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQH 82 (680)
T ss_dssp -CBSSEEECCSSCCSSCCSCSCTTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCS
T ss_pred eeECCeeECCCCCccccccccCCCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCC
Confidence 355555666531 35799999999999987777899999999999999999999999999999999999999
Q ss_pred CCCCCccCcccccCcCcceEeeeccccccCCCccccccCCCCeeecccccCCCCCCCCCccccccchhhcccccCCCCCC
Q 045798 112 NSLVGKIPANLSYCSRLTVLCIEYNKLQGRIPLEFVSLSKLKDLSLAKNKLTGGIPPFLGNLTSLEVLSLAGNSFGRNIP 191 (1008)
Q Consensus 112 n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~ 191 (1008)
|.+++..+..|+++++|++|+|++|++++..|..|+++++|++|+|++|.+++..|..++++++|++|++++|.+++..+
T Consensus 83 n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~ 162 (680)
T 1ziw_A 83 NELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKS 162 (680)
T ss_dssp SCCCCCCTTTTTTCTTCSEEECCSSCCCCCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCCCBCH
T ss_pred CccCccChhhhccCCCCCEEECCCCccCccChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEccCCcccccCH
Confidence 99996666689999999999999999998888899999999999999999998889999999999999999999988877
Q ss_pred cccc--CCCCCcEEEecCCcccccCCccccCC---------------------------CCcceeccccccccccCChhh
Q 045798 192 DSLG--QLKQLKILAIGGNNLSGPIPPSIYNL---------------------------SFLVVFSVSHNQIHGSLPPSL 242 (1008)
Q Consensus 192 ~~~~--~l~~L~~L~L~~n~l~~~~~~~~~~l---------------------------~~L~~L~ls~N~l~~~lp~~~ 242 (1008)
..+. .+++|+.|++++|.+++..|..+..+ ++|+.|++++|.+.+..|..+
T Consensus 163 ~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~~~l~~~~~~~~~~~l~~~~L~~L~L~~n~l~~~~~~~~ 242 (680)
T 1ziw_A 163 EELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTF 242 (680)
T ss_dssp HHHGGGTTCEESEEECTTCCCCCBCTTGGGGSSEECEEECTTCCCHHHHHHHHHHHHTTSCCCEEECTTSCCCEECTTTT
T ss_pred HHhhccccccccEEECCCCcccccChhhhhhhhhhhhhhccccccChhhHHHHHHHhhhccccEEEccCCcccccChhHh
Confidence 7765 56899999999999998888877765 456677777777776555554
Q ss_pred hhc-CCCCcEEEeccccCCCCCCcccccCCCCceeecccccccccccccccCCCcccccccccccCCCCCCCccccc---
Q 045798 243 GLL-LPNLKFFQIHHNFFSGSIPISLSNASKLEHIEIANNNFSGKLSVNFGGMKNLSLLNLQFSNLGSGESDEMGFM--- 318 (1008)
Q Consensus 243 ~~~-l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~--- 318 (1008)
... .++|+.|+|++|.+.+..|..+..+++|++|++++|++.+..+..|.++++|+.|+++.|.....- ....++
T Consensus 243 ~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~~~~~~~~-~~~~lp~i~ 321 (680)
T 1ziw_A 243 LGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSI-SLASLPKID 321 (680)
T ss_dssp GGGGGSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSCCBSEECTTTTTTCTTCCEEECTTCBCCC-------CCEEC
T ss_pred hccCcCCCCEEECCCCCcCccCcccccCcccccEeeCCCCccCccChhhhcCCCCccEEeccchhhhccc-ccccccccC
Confidence 431 145999999999988888888888999999999999998888888889999999998876443110 000111
Q ss_pred -ccccccCCCcEEEecCCcCCccCChhhhhhcccceeeeeccccccCC--CCCccccc--cccceEEecCccccCCcchh
Q 045798 319 -NSLTNCSKLRVLSLGGNQFRGALPHSIANLSSQLQILILSSNQFYGS--IPLGIGNL--VDLYLLGMVENQFTGAIPKE 393 (1008)
Q Consensus 319 -~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~Ls~N~l~~~--~p~~~~~l--~~L~~L~L~~n~l~~~~~~~ 393 (1008)
..+..+++|+.|++++|++.+..+..+..+. +|++|++++|.+... .+..+..+ ++|+.|++++|++++..|..
T Consensus 322 ~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~-~L~~L~Ls~n~~~~~~l~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~ 400 (680)
T 1ziw_A 322 DFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLI-NLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDA 400 (680)
T ss_dssp TTTTTTCTTCCEEECCSCCBCCCCTTTTTTCT-TCCEEECTTCBSCCCEECTTTTGGGTTSCCCEEECTTSCCCEECTTT
T ss_pred hhhcccCCCCCEEECCCCccCCCChhHhcccc-CCcEEECCCCchhhhhcchhhhcccccCcCceEECCCCCCCeEChhh
Confidence 1567889999999999999987787888876 599999999986422 22234333 58999999999999999999
Q ss_pred ccCCCCCceEEccCCccccccc-ccccCCCCcceeeccccccccccCCCCcCCCcccEeeccccccc--CCcchhhhhhh
Q 045798 394 MGKLQKLQGLDFSGNHFSGEIP-SSLGNLSSLYEVFFNNNNLSGVIPFSLGNLKRLAFLEMSGNELS--GTIPEDIFNIS 470 (1008)
Q Consensus 394 ~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~--~~lp~~~~~~~ 470 (1008)
|..+++|+.|+|++|++.+.+| ..|.++++|++|++++|++.+..+..|..+++|+.|++++|.++ +.+|..+....
T Consensus 401 ~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~~~l~ 480 (680)
T 1ziw_A 401 FSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLR 480 (680)
T ss_dssp TTTCTTCCEEECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCBCTTCSSCTTTTCT
T ss_pred hhCCCCCCEEeCCCCcCccccCcccccCcccccEEecCCCCcceeChhhhhcCcccccchhccccccccccCCcccccCC
Confidence 9999999999999999987666 68999999999999999999999999999999999999999987 56777666554
Q ss_pred hhhhhhcccCccccCCCcccccccccccccccccccccCCC--------CcccccccccceeeccCcccccchhhhhhcc
Q 045798 471 YLSNSLNLARNHLVGIIPPRIGNLRALRSFDVSNNDLSGEI--------PIELGHCSSLEEIYLAGNLFHGSIPSFFNAL 542 (1008)
Q Consensus 471 ~~~~~L~L~~N~l~~~~p~~~~~l~~L~~Ldls~N~l~~~~--------p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l 542 (1008)
. ++.|+|++|++++..|..|+.+++|+.|+|++|.+++.. +..+..+++|++|+|++|+++...+..|..+
T Consensus 481 ~-L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l 559 (680)
T 1ziw_A 481 N-LTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDL 559 (680)
T ss_dssp T-CCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCCCCCTTTTTTC
T ss_pred C-CCEEECCCCCCCcCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCCCCCHHHcccc
Confidence 4 578999999999988888999999999999999998532 2347899999999999999996555679999
Q ss_pred ccccEEecCCCcccccccCc-ccccccceeecccCcccccCCCCc--ccCCcccceeccCCccCCCC
Q 045798 543 KGVQKIDLSRNNLSGQIPIF-LEALSLEYLNLSFNDFEGKIPAKG--IFANASAISVVGCNRLCGGI 606 (1008)
Q Consensus 543 ~~L~~L~ls~N~l~~~~p~~-~~~~~L~~L~l~~N~l~g~~p~~~--~~~~~~~~~~~~n~~l~g~~ 606 (1008)
++|+.|||++|++++..+.. ..+.+|+.|+|++|.|++.+|... .+.++..+.+.||++.|+|.
T Consensus 560 ~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N~~~c~c~ 626 (680)
T 1ziw_A 560 FELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCE 626 (680)
T ss_dssp TTCCEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCCCBCCHHHHHHHHTTCSEEECTTCCCCBCCC
T ss_pred cCcceeECCCCCCCcCCHhHhCCCCCCCEEECCCCcCCccChhHhcccccccCEEEccCCCcccCCc
Confidence 99999999999999766655 578899999999999999877542 46778888999999999975
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-58 Score=556.71 Aligned_cols=511 Identities=19% Similarity=0.231 Sum_probs=335.7
Q ss_pred hhccCChhhHHHHHHHHHhhccCCCCC-------CCCCCCCCCCCcc---cceEEcCCCCeEEEEeccccCCCCccCcCc
Q 045798 5 QVAALEDGDRAALQAFKSMIAHEPQGI-------LNSWNDSRHFCEW---EGITCGRRHRRVTALDLMSKSLSGSLSPHL 74 (1008)
Q Consensus 5 ~~~~~~~~~~~~l~~~k~~~~~~~~~~-------~~~w~~~~~~c~w---~gv~c~~~~~~v~~l~l~~~~l~~~l~~~l 74 (1008)
.+++....|+.||.+|+.++..+.+.. ..+|+.+++||.| .||+|+.. ++|+.|+|+++++.|.+|+++
T Consensus 23 ~~~~~~~~d~~aL~~~~~~~~~~~w~~~~~~~~~~~~W~~~~~~c~w~~~~GV~C~~~-~~V~~L~L~~~~l~g~lp~~l 101 (636)
T 4eco_A 23 SRTAEYIKDYLALKEIWDALNGKNWSQQGFGTQPGANWNFNKELDMWGAQPGVSLNSN-GRVTGLSLEGFGASGRVPDAI 101 (636)
T ss_dssp CCCCHHHHHHHHHHHHHHHTTGGGCCCCC------CCCCCSSCGGGTTCCTTEEECTT-CCEEEEECTTSCCEEEECGGG
T ss_pred hhhhhHHHHHHHHHHHHHHcCCCCcccCCcCCccCCCCCCCCCcccccCCCCeEEcCC-CCEEEEEecCcccCCcCChHH
Confidence 345666789999999999986544332 2389999999999 99999865 899999999999999999999
Q ss_pred cCCccCCeeeecCCCCC------C------CCCccccCCCCCCEEEccCCCCCCccCccccc-CcCcceEeeeccccccC
Q 045798 75 GNLSFLREINLSNNTIQ------G------EIPPEFGRLFRLEALFLSNNSLVGKIPANLSY-CSRLTVLCIEYNKLQGR 141 (1008)
Q Consensus 75 ~~l~~L~~L~L~~n~~~------~------~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~-l~~L~~L~Ls~n~l~~~ 141 (1008)
+.+++|++|+|++|.+. + .+|... +..|+ +++++|.+.+.+|..++. +..+..+++....+..
T Consensus 102 ~~L~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~--~~~l~-l~l~~~~l~~~~~~~~~~~~~~l~~~~l~~~~~~~- 177 (636)
T 4eco_A 102 GQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQ--KQKMR-MHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKK- 177 (636)
T ss_dssp GGCTTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHH--HHHHH-THHHHHHTCCCGGGGSCHHHHHHHHHCTTSCCCCC-
T ss_pred hcCccceEEECcCCccccCCccccccccccCchHHH--HHHHH-hhHHHhhhccCchhhHHHHHHHHhhcCcccccccc-
Confidence 99999999999999762 2 334333 45566 777778777777766663 2334444444332221
Q ss_pred CCccccccCCCCeeecc--cccCCCCCCCCCccccccchhhcccccCCCC-----------------CCcccc--CCCCC
Q 045798 142 IPLEFVSLSKLKDLSLA--KNKLTGGIPPFLGNLTSLEVLSLAGNSFGRN-----------------IPDSLG--QLKQL 200 (1008)
Q Consensus 142 ~p~~~~~l~~L~~L~L~--~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~-----------------~~~~~~--~l~~L 200 (1008)
.....++.+.+. +|++++ +|..|+++++|++|+|++|++++. +|..++ ++++|
T Consensus 178 -----~~~~~l~~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L 251 (636)
T 4eco_A 178 -----SSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDL 251 (636)
T ss_dssp -----CCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTC
T ss_pred -----ccccchhhhhhccccCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCC
Confidence 112233333333 567776 777777777777777777777664 788877 88888
Q ss_pred cEEEecCCcccccCCccccCCCCcceecccccc-ccc-cCChhhhhc-----CCCCcEEEeccccCCCCCCc--ccccCC
Q 045798 201 KILAIGGNNLSGPIPPSIYNLSFLVVFSVSHNQ-IHG-SLPPSLGLL-----LPNLKFFQIHHNFFSGSIPI--SLSNAS 271 (1008)
Q Consensus 201 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~ls~N~-l~~-~lp~~~~~~-----l~~L~~L~L~~N~l~~~~p~--~l~~l~ 271 (1008)
++|+|++|.+.+.+|..|+++++|++|++++|+ ++| .+|..++.. +++|++|+|++|.++ .+|. .+.+++
T Consensus 252 ~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~ 330 (636)
T 4eco_A 252 TDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMK 330 (636)
T ss_dssp CEEEEECCTTCSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCT
T ss_pred CEEEecCCcCCccChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhhccCC
Confidence 888888888888888888888888888888887 887 788777652 478899999999888 7887 888888
Q ss_pred CCceeecccccccccccccccCCCcccccccccccCCCCCCCcccccccccccCC-CcEEEecCCcCCccCChhhhhhc-
Q 045798 272 KLEHIEIANNNFSGKLSVNFGGMKNLSLLNLQFSNLGSGESDEMGFMNSLTNCSK-LRVLSLGGNQFRGALPHSIANLS- 349 (1008)
Q Consensus 272 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~l~~-L~~L~Ls~N~l~~~~p~~~~~l~- 349 (1008)
+|++|++++|++.+..| .|..+++|+.|++++|+++.+ +..+..+++ |+.|++++|+++ .+|..+....
T Consensus 331 ~L~~L~L~~N~l~g~ip-~~~~l~~L~~L~L~~N~l~~l-------p~~l~~l~~~L~~L~Ls~N~l~-~lp~~~~~~~l 401 (636)
T 4eco_A 331 KLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQITEI-------PANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSV 401 (636)
T ss_dssp TCCEEECCSCCCEEECC-CCEEEEEESEEECCSSEEEEC-------CTTSEEECTTCCEEECCSSCCS-SCCSCCCTTCS
T ss_pred CCCEEeCcCCcCccchh-hhCCCCCCCEEECCCCccccc-------cHhhhhhcccCcEEEccCCcCc-ccchhhhhccc
Confidence 99999999988886666 666666666666655555421 223445555 555555555555 4554443321
Q ss_pred ccceeeeeccccccCCCCCccc-------cccccceEEecCccccCCcchhccCCCCCceEEccCCcccccccccccCCC
Q 045798 350 SQLQILILSSNQFYGSIPLGIG-------NLVDLYLLGMVENQFTGAIPKEMGKLQKLQGLDFSGNHFSGEIPSSLGNLS 422 (1008)
Q Consensus 350 ~~L~~L~Ls~N~l~~~~p~~~~-------~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 422 (1008)
.+|++|++++|.+++.+|..+. .+.+|+.|+|++|++++..+..+..+++|+.|+|++|+++ .+|.......
T Consensus 402 ~~L~~L~Ls~N~l~~~~p~~l~~~~~~~~~~~~L~~L~Ls~N~l~~lp~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~~~ 480 (636)
T 4eco_A 402 SVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLT-EIPKNSLKDE 480 (636)
T ss_dssp SCEEEEECCSSCTTTTTTCSSCTTCSSCCCCCCEEEEECCSSCCCSCCTHHHHTTCCCSEEECCSSCCS-BCCSSSSEET
T ss_pred CccCEEECcCCcCCCcchhhhcccccccccCCCCCEEECcCCccCcCCHHHHccCCCCCEEECCCCCCC-CcCHHHhccc
Confidence 1355555555555555555554 4444555555555554322233334444555555555444 3332211100
Q ss_pred CcceeeccccccccccCCCCcCCCcccEeecccccccCCcchhhhhhhhhhhhhcccCccccCCCccccc--cccccccc
Q 045798 423 SLYEVFFNNNNLSGVIPFSLGNLKRLAFLEMSGNELSGTIPEDIFNISYLSNSLNLARNHLVGIIPPRIG--NLRALRSF 500 (1008)
Q Consensus 423 ~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~lp~~~~~~~~~~~~L~L~~N~l~~~~p~~~~--~l~~L~~L 500 (1008)
+..+.++++|+.|+|++|+++ . +|..+. .+++|+.|
T Consensus 481 ----------------~~~~~~l~~L~~L~Ls~N~l~-~-------------------------lp~~~~~~~l~~L~~L 518 (636)
T 4eco_A 481 ----------------NENFKNTYLLTSIDLRFNKLT-K-------------------------LSDDFRATTLPYLVGI 518 (636)
T ss_dssp ----------------TEECTTGGGCCEEECCSSCCC-B-------------------------CCGGGSTTTCTTCCEE
T ss_pred ----------------cccccccCCccEEECcCCcCC-c-------------------------cChhhhhccCCCcCEE
Confidence 000112235666666666665 2 333343 45566666
Q ss_pred ccccccccCCCCcccccccccceeec------cCcccccchhhhhhccccccEEecCCCcccccccCcccccccceeecc
Q 045798 501 DVSNNDLSGEIPIELGHCSSLEEIYL------AGNLFHGSIPSFFNALKGVQKIDLSRNNLSGQIPIFLEALSLEYLNLS 574 (1008)
Q Consensus 501 dls~N~l~~~~p~~~~~l~~L~~L~L------~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~L~~L~l~ 574 (1008)
+|++|++++ +|..++.+++|++|+| ++|++.+.+|..|+.+++|+.|+|++|++ +.+|.... .+|+.|+++
T Consensus 519 ~Ls~N~l~~-ip~~~~~l~~L~~L~Ls~N~~ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l-~~ip~~~~-~~L~~L~Ls 595 (636)
T 4eco_A 519 DLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDI-RKVNEKIT-PNISVLDIK 595 (636)
T ss_dssp ECCSSCCSS-CCCGGGGCSSCCEEECCSCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCCC-TTCCEEECC
T ss_pred ECCCCCCCC-cChhhhcCCCCCEEECCCCcccccCcccccChHHHhcCCCCCEEECCCCcC-CccCHhHh-CcCCEEECc
Confidence 666666654 5666666666666666 56777777888888888888888888888 56666533 578888888
Q ss_pred cCcccccC
Q 045798 575 FNDFEGKI 582 (1008)
Q Consensus 575 ~N~l~g~~ 582 (1008)
+|++....
T Consensus 596 ~N~l~~~~ 603 (636)
T 4eco_A 596 DNPNISID 603 (636)
T ss_dssp SCTTCEEE
T ss_pred CCCCcccc
Confidence 88666543
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-56 Score=538.21 Aligned_cols=514 Identities=20% Similarity=0.173 Sum_probs=335.4
Q ss_pred eEEEEeccccCCCCccCcCccCCccCCeeeecCCCCCCCCCccccCCCCCCEEEccCCCCCCccCcccccCcCcceEeee
Q 045798 55 RVTALDLMSKSLSGSLSPHLGNLSFLREINLSNNTIQGEIPPEFGRLFRLEALFLSNNSLVGKIPANLSYCSRLTVLCIE 134 (1008)
Q Consensus 55 ~v~~l~l~~~~l~~~l~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls 134 (1008)
.++.|||++|.+++..|..++.+++|++|+|++|++++..|.+|.++++|++|+|++|++++..|..|+++++|++|+++
T Consensus 34 ~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~ 113 (606)
T 3t6q_A 34 STECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFI 113 (606)
T ss_dssp TCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCSEECTTTTSSCTTCCEEECT
T ss_pred cCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCcccccChhhhcccccccEeecc
Confidence 35555555555554445555555555555555555555555555555555555555555555555555555555555555
Q ss_pred ccccccCCCccccccCCCCeeecccccCCCCCCCCCccccccchhhcccccCCCCCCccccCCCCCc--EEEecCCcccc
Q 045798 135 YNKLQGRIPLEFVSLSKLKDLSLAKNKLTGGIPPFLGNLTSLEVLSLAGNSFGRNIPDSLGQLKQLK--ILAIGGNNLSG 212 (1008)
Q Consensus 135 ~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~--~L~L~~n~l~~ 212 (1008)
+|++++..|..|+++++|++|++++|++++..++.+..+++|++|++++|.+++..+..|+.+++|+ .|++++|.+++
T Consensus 114 ~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~l~L~l~~n~l~~ 193 (606)
T 3t6q_A 114 QTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAG 193 (606)
T ss_dssp TSCCSCGGGSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCCCEECHHHHHTTTTCCSEEEECTTCCCCE
T ss_pred ccCcccCCcchhccCCcccEEECCCCcccccCcccccCCcccCEEEcccCcccccChhhhhhhcccceeEEecCCCccCc
Confidence 5555544455555555555555555555543323333355555555555555555555555555555 55555555555
Q ss_pred cCCccccCCCCcceeccccccccccCChhhhhcCCCCcEEEeccccCC-----CCCCcccccCC--CCceeecccccccc
Q 045798 213 PIPPSIYNLSFLVVFSVSHNQIHGSLPPSLGLLLPNLKFFQIHHNFFS-----GSIPISLSNAS--KLEHIEIANNNFSG 285 (1008)
Q Consensus 213 ~~~~~~~~l~~L~~L~ls~N~l~~~lp~~~~~~l~~L~~L~L~~N~l~-----~~~p~~l~~l~--~L~~L~L~~N~l~~ 285 (1008)
..|..+.. .+|+.|++++|... +. .+..+.++....+.-+.+. ...+..+..+. +|+.|++++|.+.+
T Consensus 194 ~~~~~~~~-~~L~~L~l~~~~~~---~~-~~~~l~~~~l~~l~~~~~~~~~~~~i~~~~~~~l~~~~L~~L~l~~n~l~~ 268 (606)
T 3t6q_A 194 IEPGAFDS-AVFQSLNFGGTQNL---LV-IFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFN 268 (606)
T ss_dssp ECTTTTTT-CEEEEEECTTCSCH---HH-HHHHTTTCEEEEEECCCCTTSCCCCCCGGGGGGGGGSEEEEEECTTCCCSS
T ss_pred cChhHhhh-ccccccccCCchhH---HH-HhhhccccchhheechhhccccccccChhHhchhhcCceeEEEeecCccCc
Confidence 44444333 34555555555411 11 1112233322222222111 11122233332 67888888888888
Q ss_pred cccccccCCCcccccccccccCCCCCCCcccccccccccCCCcEEEecCCcCCccCChhhhhhcccceeeeeccccccCC
Q 045798 286 KLSVNFGGMKNLSLLNLQFSNLGSGESDEMGFMNSLTNCSKLRVLSLGGNQFRGALPHSIANLSSQLQILILSSNQFYGS 365 (1008)
Q Consensus 286 ~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~Ls~N~l~~~ 365 (1008)
..+..|..+++|+.|++++|+++.++ ..+..+++|++|++++|++.+..|..+..+. +|++|++++|.+.+.
T Consensus 269 ~~~~~~~~l~~L~~L~l~~n~l~~lp-------~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~-~L~~L~l~~n~~~~~ 340 (606)
T 3t6q_A 269 ISSNTFHCFSGLQELDLTATHLSELP-------SGLVGLSTLKKLVLSANKFENLCQISASNFP-SLTHLSIKGNTKRLE 340 (606)
T ss_dssp CCTTTTTTCTTCSEEECTTSCCSCCC-------SSCCSCTTCCEEECTTCCCSBGGGGCGGGCT-TCSEEECCSCSSCCB
T ss_pred cCHHHhccccCCCEEeccCCccCCCC-------hhhcccccCCEEECccCCcCcCchhhhhccC-cCCEEECCCCCcccc
Confidence 77777888888888888888776543 3466778888888888888866676777765 488888888887766
Q ss_pred CCCc-cccccccceEEecCccccCCc--chhccCCCCCceEEccCCcccccccccccCCCCcceeeccccccccccCCC-
Q 045798 366 IPLG-IGNLVDLYLLGMVENQFTGAI--PKEMGKLQKLQGLDFSGNHFSGEIPSSLGNLSSLYEVFFNNNNLSGVIPFS- 441 (1008)
Q Consensus 366 ~p~~-~~~l~~L~~L~L~~n~l~~~~--~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~- 441 (1008)
+|.. +..+++|+.|++++|.+.+.. +..+..+++|++|+|++|++.+..|..|..+++|++|++++|.+.+..|..
T Consensus 341 ~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~ 420 (606)
T 3t6q_A 341 LGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSP 420 (606)
T ss_dssp CCSSTTTTCTTCCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSEEECTTCCEECCTTCCT
T ss_pred cchhhhhccCcCCEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCccCCeEECCCCcCCCcccchh
Confidence 6554 778888888888888887665 667788888888888888887777778888888888888888887765543
Q ss_pred CcCCCcccEeecccccccCCcchhhhhhhhhhhhhcccCccccCC---CcccccccccccccccccccccCCCCcccccc
Q 045798 442 LGNLKRLAFLEMSGNELSGTIPEDIFNISYLSNSLNLARNHLVGI---IPPRIGNLRALRSFDVSNNDLSGEIPIELGHC 518 (1008)
Q Consensus 442 ~~~l~~L~~L~Ls~N~l~~~lp~~~~~~~~~~~~L~L~~N~l~~~---~p~~~~~l~~L~~Ldls~N~l~~~~p~~~~~l 518 (1008)
|.++++|+.|++++|.+++..|..+.. ...++.|+|++|++++. .+..+..+++|+.|+|++|.+++..|..|+.+
T Consensus 421 ~~~l~~L~~L~l~~n~l~~~~~~~~~~-l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l 499 (606)
T 3t6q_A 421 FQNLHLLKVLNLSHSLLDISSEQLFDG-LPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSL 499 (606)
T ss_dssp TTTCTTCCEEECTTCCCBTTCTTTTTT-CTTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEECTTTTTTC
T ss_pred hhCcccCCEEECCCCccCCcCHHHHhC-CCCCCEEECCCCCCCccccccchhhccCCCccEEECCCCccCccChhhhccc
Confidence 778888888888888887544544433 34456788888887762 33567788888888888888887778888888
Q ss_pred cccceeeccCcccccchhhhhhccccccEEecCCCcccccccCc-ccccccceeecccCcccccCC
Q 045798 519 SSLEEIYLAGNLFHGSIPSFFNALKGVQKIDLSRNNLSGQIPIF-LEALSLEYLNLSFNDFEGKIP 583 (1008)
Q Consensus 519 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~-~~~~~L~~L~l~~N~l~g~~p 583 (1008)
++|++|+|++|++++.+|..|..++.| .|+|++|++++.+|.. ..+.+|+.|++++|++.+..+
T Consensus 500 ~~L~~L~Ls~N~l~~~~~~~l~~l~~L-~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 564 (606)
T 3t6q_A 500 KMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDCTCS 564 (606)
T ss_dssp TTCCEEECCSSCCCGGGGGGGTTCCSC-EEECCSSCCCCCCGGGHHHHHTSSEEECTTCCEECSGG
T ss_pred cCCCEEECCCCccCcCChhHhCccccc-EEECcCCcccccCHhhcccCCCCCEEeCCCCCccccCC
Confidence 888888888888888888888888888 8888888888777765 556778888888888887665
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-56 Score=544.31 Aligned_cols=531 Identities=20% Similarity=0.165 Sum_probs=459.3
Q ss_pred EeccccCCCCccCcCccCCccCCeeeecCCCCCCCCCccccCCCCCCEEEccCCCCCCccCcccccCcCcceEeeecccc
Q 045798 59 LDLMSKSLSGSLSPHLGNLSFLREINLSNNTIQGEIPPEFGRLFRLEALFLSNNSLVGKIPANLSYCSRLTVLCIEYNKL 138 (1008)
Q Consensus 59 l~l~~~~l~~~l~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l 138 (1008)
+|..+.+++ .+|..+.. .+++|+|++|.+++..|.+|.++++|++|+|++|++++..|..|+++++|++|+|++|++
T Consensus 17 ~~c~~~~l~-~iP~~l~~--~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l 93 (606)
T 3t6q_A 17 YNCENLGLN-EIPGTLPN--STECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPL 93 (606)
T ss_dssp EECTTSCCS-SCCTTSCT--TCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCC
T ss_pred EECCCCCcc-cCcCCCCC--cCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCcc
Confidence 334445555 56766654 689999999999988899999999999999999999988899999999999999999999
Q ss_pred ccCCCccccccCCCCeeecccccCCCCCCCCCccccccchhhcccccCCCCCCccccCCCCCcEEEecCCcccccCCccc
Q 045798 139 QGRIPLEFVSLSKLKDLSLAKNKLTGGIPPFLGNLTSLEVLSLAGNSFGRNIPDSLGQLKQLKILAIGGNNLSGPIPPSI 218 (1008)
Q Consensus 139 ~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~ 218 (1008)
++..|..|+++++|++|++++|++++..+..++++++|++|++++|++.+.....+..+++|++|++++|.+++..+..|
T Consensus 94 ~~~~~~~~~~l~~L~~L~L~~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~ 173 (606)
T 3t6q_A 94 IFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDM 173 (606)
T ss_dssp SEECTTTTSSCTTCCEEECTTSCCSCGGGSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCCCEECHHHH
T ss_pred cccChhhhcccccccEeeccccCcccCCcchhccCCcccEEECCCCcccccCcccccCCcccCEEEcccCcccccChhhh
Confidence 98899999999999999999999997778889999999999999999987655556669999999999999998889999
Q ss_pred cCCCCcc--eeccccccccccCChhhhhcCCCCcEEEeccccCCCCCCcccccCCCCceeeccccc-----ccccccccc
Q 045798 219 YNLSFLV--VFSVSHNQIHGSLPPSLGLLLPNLKFFQIHHNFFSGSIPISLSNASKLEHIEIANNN-----FSGKLSVNF 291 (1008)
Q Consensus 219 ~~l~~L~--~L~ls~N~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~-----l~~~~~~~~ 291 (1008)
..+++|+ .|++++|.+.+..|.. +. ..+|+.|++++|. ..+..+..+.++....+.-+. ...+.+..|
T Consensus 174 ~~l~~L~~l~L~l~~n~l~~~~~~~-~~-~~~L~~L~l~~~~---~~~~~~~~l~~~~l~~l~~~~~~~~~~~~i~~~~~ 248 (606)
T 3t6q_A 174 SSLQQATNLSLNLNGNDIAGIEPGA-FD-SAVFQSLNFGGTQ---NLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVF 248 (606)
T ss_dssp HTTTTCCSEEEECTTCCCCEECTTT-TT-TCEEEEEECTTCS---CHHHHHHHTTTCEEEEEECCCCTTSCCCCCCGGGG
T ss_pred hhhcccceeEEecCCCccCccChhH-hh-hccccccccCCch---hHHHHhhhccccchhheechhhccccccccChhHh
Confidence 9999999 8999999999655544 43 4689999999987 234445555544433333222 223334445
Q ss_pred cCCC--cccccccccccCCCCCCCcccccccccccCCCcEEEecCCcCCccCChhhhhhcccceeeeeccccccCCCCCc
Q 045798 292 GGMK--NLSLLNLQFSNLGSGESDEMGFMNSLTNCSKLRVLSLGGNQFRGALPHSIANLSSQLQILILSSNQFYGSIPLG 369 (1008)
Q Consensus 292 ~~l~--~L~~L~L~~n~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~Ls~N~l~~~~p~~ 369 (1008)
.++. +|+.|++++|+++.+... .+..+++|++|++++|+++ .+|..+..+. +|++|++++|.+++..|..
T Consensus 249 ~~l~~~~L~~L~l~~n~l~~~~~~------~~~~l~~L~~L~l~~n~l~-~lp~~l~~l~-~L~~L~l~~n~l~~~~~~~ 320 (606)
T 3t6q_A 249 EGLCEMSVESINLQKHYFFNISSN------TFHCFSGLQELDLTATHLS-ELPSGLVGLS-TLKKLVLSANKFENLCQIS 320 (606)
T ss_dssp GGGGGSEEEEEECTTCCCSSCCTT------TTTTCTTCSEEECTTSCCS-CCCSSCCSCT-TCCEEECTTCCCSBGGGGC
T ss_pred chhhcCceeEEEeecCccCccCHH------HhccccCCCEEeccCCccC-CCChhhcccc-cCCEEECccCCcCcCchhh
Confidence 5554 799999999999876643 5788999999999999999 7888888876 5999999999999888899
Q ss_pred cccccccceEEecCccccCCcch-hccCCCCCceEEccCCcccccc--cccccCCCCcceeeccccccccccCCCCcCCC
Q 045798 370 IGNLVDLYLLGMVENQFTGAIPK-EMGKLQKLQGLDFSGNHFSGEI--PSSLGNLSSLYEVFFNNNNLSGVIPFSLGNLK 446 (1008)
Q Consensus 370 ~~~l~~L~~L~L~~n~l~~~~~~-~~~~l~~L~~L~Ls~N~l~~~~--p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~ 446 (1008)
+..+++|+.|++++|.+.+.+|. .+..+++|++|+|++|.+++.. +..+..+++|++|++++|.+.+..|..|..++
T Consensus 321 ~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~ 400 (606)
T 3t6q_A 321 ASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECP 400 (606)
T ss_dssp GGGCTTCSEEECCSCSSCCBCCSSTTTTCTTCCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCT
T ss_pred hhccCcCCEEECCCCCcccccchhhhhccCcCCEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCc
Confidence 99999999999999999976665 4999999999999999999766 78899999999999999999999999999999
Q ss_pred cccEeecccccccCCcchhhhhhhhhhhhhcccCccccCCCcccccccccccccccccccccC---CCCcccccccccce
Q 045798 447 RLAFLEMSGNELSGTIPEDIFNISYLSNSLNLARNHLVGIIPPRIGNLRALRSFDVSNNDLSG---EIPIELGHCSSLEE 523 (1008)
Q Consensus 447 ~L~~L~Ls~N~l~~~lp~~~~~~~~~~~~L~L~~N~l~~~~p~~~~~l~~L~~Ldls~N~l~~---~~p~~~~~l~~L~~ 523 (1008)
+|+.|++++|++++..|...+.....++.|+|++|.+.+..|..++.+++|+.|++++|.+++ ..+..+..+++|++
T Consensus 401 ~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~ 480 (606)
T 3t6q_A 401 QLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEI 480 (606)
T ss_dssp TCSEEECTTCCEECCTTCCTTTTCTTCCEEECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCCE
T ss_pred cCCeEECCCCcCCCcccchhhhCcccCCEEECCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccCCCccE
Confidence 999999999999987777766666777899999999999999999999999999999999986 23467999999999
Q ss_pred eeccCcccccchhhhhhccccccEEecCCCcccccccCc-ccccccceeecccCcccccCCCC-cccCCcccceeccCCc
Q 045798 524 IYLAGNLFHGSIPSFFNALKGVQKIDLSRNNLSGQIPIF-LEALSLEYLNLSFNDFEGKIPAK-GIFANASAISVVGCNR 601 (1008)
Q Consensus 524 L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~-~~~~~L~~L~l~~N~l~g~~p~~-~~~~~~~~~~~~~n~~ 601 (1008)
|+|++|++++.+|..|+.+++|+.|||++|++++.+|.. ..+..| .|++++|.+++.+|.. ..+.++..+.+.||++
T Consensus 481 L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L-~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~ 559 (606)
T 3t6q_A 481 LVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPL 559 (606)
T ss_dssp EECTTSCCCEECTTTTTTCTTCCEEECCSSCCCGGGGGGGTTCCSC-EEECCSSCCCCCCGGGHHHHHTSSEEECTTCCE
T ss_pred EECCCCccCccChhhhccccCCCEEECCCCccCcCChhHhCccccc-EEECcCCcccccCHhhcccCCCCCEEeCCCCCc
Confidence 999999999999999999999999999999999998877 667789 9999999999988864 3466778888999999
Q ss_pred cCCCC
Q 045798 602 LCGGI 606 (1008)
Q Consensus 602 l~g~~ 606 (1008)
.|.+.
T Consensus 560 ~c~c~ 564 (606)
T 3t6q_A 560 DCTCS 564 (606)
T ss_dssp ECSGG
T ss_pred cccCC
Confidence 98753
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-55 Score=552.41 Aligned_cols=509 Identities=22% Similarity=0.209 Sum_probs=291.2
Q ss_pred ccCCeeeecCCCCCCCCCccccCCCCCCEEEccCCCCCCcc-CcccccCcCcceEeeeccccccCCCccccccCCCCeee
Q 045798 78 SFLREINLSNNTIQGEIPPEFGRLFRLEALFLSNNSLVGKI-PANLSYCSRLTVLCIEYNKLQGRIPLEFVSLSKLKDLS 156 (1008)
Q Consensus 78 ~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~-p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~ 156 (1008)
++|++|+|++|.+++..|.+|.++++|++|+|++|.+.+.+ |..|+++++|++|+|++|.+++..|..|.++++|++|+
T Consensus 24 ~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 103 (844)
T 3j0a_A 24 NTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELR 103 (844)
T ss_dssp TTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTTSSCSCSSCCCEE
T ss_pred CCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHhHccCCcccCEee
Confidence 45566666666666555556666666666666666444344 55566666666666666666655566666666666666
Q ss_pred cccccCCCCCCCC--CccccccchhhcccccCCCCCC-ccccCCCCCcEEEecCCcccccCCccccCC--CCcceecccc
Q 045798 157 LAKNKLTGGIPPF--LGNLTSLEVLSLAGNSFGRNIP-DSLGQLKQLKILAIGGNNLSGPIPPSIYNL--SFLVVFSVSH 231 (1008)
Q Consensus 157 L~~n~l~~~~~~~--~~~l~~L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l--~~L~~L~ls~ 231 (1008)
|++|.+++.+|.. |+++++|++|+|++|.+.+..+ ..|+.+++|++|+|++|.+++..+..+..+ ++|+.|+++.
T Consensus 104 Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~~~l~~l~~~~L~~L~L~~ 183 (844)
T 3j0a_A 104 LYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAA 183 (844)
T ss_dssp CTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCCSGGGHHHHHCSSCCCEECC
T ss_pred CcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCeeCHHHcccccCCccceEECCC
Confidence 6666665544433 5566666666666666654433 345666666666666666665555555555 5566666666
Q ss_pred ccccccCChhhhhc-----CCCCcEEEeccccCCCCCCcccccC---CCCceeecc---------cccccccccccccCC
Q 045798 232 NQIHGSLPPSLGLL-----LPNLKFFQIHHNFFSGSIPISLSNA---SKLEHIEIA---------NNNFSGKLSVNFGGM 294 (1008)
Q Consensus 232 N~l~~~lp~~~~~~-----l~~L~~L~L~~N~l~~~~p~~l~~l---~~L~~L~L~---------~N~l~~~~~~~~~~l 294 (1008)
|.+.+..|..+... ..+|+.|++++|.+.+..+..+... ++++.|.++ .+.+.+.....|.++
T Consensus 184 n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~~~~~~~~~~l~~~~~~~f~~l 263 (844)
T 3j0a_A 184 NSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGL 263 (844)
T ss_dssp SBSCCCCCCCCCSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSCCBCSSSCSSSTTGGGTTTTTT
T ss_pred CccccccccchhhcCCccccCceeEEecCCCcCchhHHHHHHhhcCcccccceecccccccccccccccCCCChhhhhcc
Confidence 66655444432210 1135666666666555555544332 344444444 233333344444443
Q ss_pred --CcccccccccccCCCCCCCcccccccccccCCCcEEEecCCcCCccCChhhhhhcccceeeeeccccccCCCCCcccc
Q 045798 295 --KNLSLLNLQFSNLGSGESDEMGFMNSLTNCSKLRVLSLGGNQFRGALPHSIANLSSQLQILILSSNQFYGSIPLGIGN 372 (1008)
Q Consensus 295 --~~L~~L~L~~n~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~Ls~N~l~~~~p~~~~~ 372 (1008)
++|+.|++++|.+..... ..+..+++|+.|+|++|++.+..|..+..+. +|++|+|++|.+++..|..+..
T Consensus 264 ~~~~L~~L~Ls~n~l~~~~~------~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~-~L~~L~Ls~N~l~~~~~~~~~~ 336 (844)
T 3j0a_A 264 ARSSVRHLDLSHGFVFSLNS------RVFETLKDLKVLNLAYNKINKIADEAFYGLD-NLQVLNLSYNLLGELYSSNFYG 336 (844)
T ss_dssp TTSCCCEEECTTCCCCEECS------CCSSSCCCCCEEEEESCCCCEECTTTTTTCS-SCCEEEEESCCCSCCCSCSCSS
T ss_pred ccCCccEEECCCCcccccCh------hhhhcCCCCCEEECCCCcCCCCChHHhcCCC-CCCEEECCCCCCCccCHHHhcC
Confidence 456666666666554322 2455566666666666666655555555554 4666666666666555666666
Q ss_pred ccccceEEecCccccCCcchhccCCCCCceEEccCCcccccccccccCCCCcceeeccccccccccCCCCcCCCcccEee
Q 045798 373 LVDLYLLGMVENQFTGAIPKEMGKLQKLQGLDFSGNHFSGEIPSSLGNLSSLYEVFFNNNNLSGVIPFSLGNLKRLAFLE 452 (1008)
Q Consensus 373 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ 452 (1008)
+++|+.|++++|.+.+..+..|..+++|+.|+|++|.+++ ++ .+++|+.|++++|++. .+|.. ..+++.|+
T Consensus 337 l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~-i~----~~~~L~~L~l~~N~l~-~l~~~---~~~l~~L~ 407 (844)
T 3j0a_A 337 LPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTT-IH----FIPSIPDIFLSGNKLV-TLPKI---NLTANLIH 407 (844)
T ss_dssp CTTCCEEECCSCCCCCCCSSCSCSCCCCCEEEEETCCSCC-CS----SCCSCSEEEEESCCCC-CCCCC---CTTCCEEE
T ss_pred CCCCCEEECCCCCCCccChhhhcCCCCCCEEECCCCCCCc-cc----CCCCcchhccCCCCcc-ccccc---ccccceee
Confidence 6666666666666665555566666666666666666652 22 2556666666666666 33332 34566666
Q ss_pred cccccccCCcchhh-hhhhhhhhhhcccCccccCCCcc-ccccccccccccccccccc-----CCCCcccccccccceee
Q 045798 453 MSGNELSGTIPEDI-FNISYLSNSLNLARNHLVGIIPP-RIGNLRALRSFDVSNNDLS-----GEIPIELGHCSSLEEIY 525 (1008)
Q Consensus 453 Ls~N~l~~~lp~~~-~~~~~~~~~L~L~~N~l~~~~p~-~~~~l~~L~~Ldls~N~l~-----~~~p~~~~~l~~L~~L~ 525 (1008)
+++|++++ ++... ......++.|+|++|++++..+. .+..+++|+.|+|++|.++ +..|..|..+++|++|+
T Consensus 408 ls~N~l~~-l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~ 486 (844)
T 3j0a_A 408 LSENRLEN-LDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLY 486 (844)
T ss_dssp CCSCCCCS-STTHHHHTTCTTCCEEEEESCCCCCCCSSSSSCSCTTCCBCEEESCCCSSSCCSCCCSSCSSCBCCEECCC
T ss_pred cccCcccc-CchhhhhhcCCccceeeCCCCcccccccccccccCCccccccCCCCccccccccccchhhhcCcccccEEE
Confidence 66666653 32211 11223345666666666654332 2444566666666666665 33344566666666666
Q ss_pred ccCcccccchhhhhhccccccEEecCCCcccccccCcccccccceeecccCcccccCCCCcccCCcccceeccCCccCCC
Q 045798 526 LAGNLFHGSIPSFFNALKGVQKIDLSRNNLSGQIPIFLEALSLEYLNLSFNDFEGKIPAKGIFANASAISVVGCNRLCGG 605 (1008)
Q Consensus 526 L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~L~~L~l~~N~l~g~~p~~~~~~~~~~~~~~~n~~l~g~ 605 (1008)
|++|+|++.+|..|..+++|+.|+|++|+|++..|.... .+|+.|+|++|.|+|.+|.. |.++..+.+.||++.|+|
T Consensus 487 Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~-~~L~~L~Ls~N~l~~~~~~~--~~~L~~l~l~~Np~~C~c 563 (844)
T 3j0a_A 487 LNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLP-ANLEILDISRNQLLAPNPDV--FVSLSVLDITHNKFICEC 563 (844)
T ss_dssp CCHHHHTTCCTTSSSSCCSCSEEEEESCCCSSCCCCCCC-SCCCEEEEEEECCCCCCSCC--CSSCCEEEEEEECCCCSS
T ss_pred CCCCcccccChhHccchhhhheeECCCCCCCccChhhhh-ccccEEECCCCcCCCCChhH--hCCcCEEEecCCCccccc
Confidence 666666666666666666666666666666665544433 55666666666666666643 445556666666666655
Q ss_pred C
Q 045798 606 I 606 (1008)
Q Consensus 606 ~ 606 (1008)
.
T Consensus 564 ~ 564 (844)
T 3j0a_A 564 E 564 (844)
T ss_dssp S
T ss_pred c
Confidence 3
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-55 Score=539.61 Aligned_cols=523 Identities=20% Similarity=0.223 Sum_probs=456.7
Q ss_pred CeEEEEeccccCCCCccCcCccCCccCCeeeecCCCCCCCCCccccCCCCCCEEEccCCCCCCccCcccccCcCcceEee
Q 045798 54 RRVTALDLMSKSLSGSLSPHLGNLSFLREINLSNNTIQGEIPPEFGRLFRLEALFLSNNSLVGKIPANLSYCSRLTVLCI 133 (1008)
Q Consensus 54 ~~v~~l~l~~~~l~~~l~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L 133 (1008)
..++.|||++|.+++..|..++.+++|++|+|++|++++..+.+|.++++|++|+|++|++++..|..|+++++|++|+|
T Consensus 49 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 128 (680)
T 1ziw_A 49 SQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDL 128 (680)
T ss_dssp TTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCSCTTTTCTTCCEEEC
T ss_pred CcCcEEECCCCccCccCHHHHhcccCcCEEECCCCccCccChhhhccCCCCCEEECCCCccCccChhHccccCCCCEEEC
Confidence 46899999999999888889999999999999999999666668999999999999999999888889999999999999
Q ss_pred eccccccCCCccccccCCCCeeecccccCCCCCCCCCc--cccccchhhcccccCCCCCCccccCC--------------
Q 045798 134 EYNKLQGRIPLEFVSLSKLKDLSLAKNKLTGGIPPFLG--NLTSLEVLSLAGNSFGRNIPDSLGQL-------------- 197 (1008)
Q Consensus 134 s~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~--~l~~L~~L~L~~n~l~~~~~~~~~~l-------------- 197 (1008)
++|.+++..|..+.++++|++|++++|++++..+..+. .+++|++|++++|++++..|..|..+
T Consensus 129 s~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~~~l~ 208 (680)
T 1ziw_A 129 SHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLG 208 (680)
T ss_dssp CSSCCSCCCCCSSSCCTTCCEEECCSSCCCCBCHHHHGGGTTCEESEEECTTCCCCCBCTTGGGGSSEECEEECTTCCCH
T ss_pred CCCcccccCchhhcccccCCEEEccCCcccccCHHHhhccccccccEEECCCCcccccChhhhhhhhhhhhhhccccccC
Confidence 99999999999999999999999999999976666554 45899999999999998888877654
Q ss_pred -------------CCCcEEEecCCcccccCCccccCCCC--cceeccccccccccCChhhhhcCCCCcEEEeccccCCCC
Q 045798 198 -------------KQLKILAIGGNNLSGPIPPSIYNLSF--LVVFSVSHNQIHGSLPPSLGLLLPNLKFFQIHHNFFSGS 262 (1008)
Q Consensus 198 -------------~~L~~L~L~~n~l~~~~~~~~~~l~~--L~~L~ls~N~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~ 262 (1008)
++|+.|++++|.+++..|.+|.+++. |+.|++++|++++..|. .+..+++|++|+|++|.+.+.
T Consensus 209 ~~~~~~~~~~l~~~~L~~L~L~~n~l~~~~~~~~~~l~~~~L~~L~Ls~n~l~~~~~~-~~~~l~~L~~L~L~~n~l~~~ 287 (680)
T 1ziw_A 209 PSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGND-SFAWLPQLEYFFLEYNNIQHL 287 (680)
T ss_dssp HHHHHHHHHHHTTSCCCEEECTTSCCCEECTTTTGGGGGSCCCEEECTTSCCCEECTT-TTTTCTTCCEEECCSCCBSEE
T ss_pred hhhHHHHHHHhhhccccEEEccCCcccccChhHhhccCcCCCCEEECCCCCcCccCcc-cccCcccccEeeCCCCccCcc
Confidence 56788899999999999999998866 99999999999854444 455689999999999999999
Q ss_pred CCcccccCCCCceeecccccccc---------cccccccCCCcccccccccccCCCCCCCcccccccccccCCCcEEEec
Q 045798 263 IPISLSNASKLEHIEIANNNFSG---------KLSVNFGGMKNLSLLNLQFSNLGSGESDEMGFMNSLTNCSKLRVLSLG 333 (1008)
Q Consensus 263 ~p~~l~~l~~L~~L~L~~N~l~~---------~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~l~~L~~L~Ls 333 (1008)
.|..+..+++|++|++++|...+ +....|..+++|+.|++++|++...... .+..+++|++|+++
T Consensus 288 ~~~~~~~l~~L~~L~L~~~~~~~~~~~~~lp~i~~~~~~~l~~L~~L~l~~n~l~~~~~~------~~~~l~~L~~L~Ls 361 (680)
T 1ziw_A 288 FSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSN------MFTGLINLKYLSLS 361 (680)
T ss_dssp CTTTTTTCTTCCEEECTTCBCCC------CCEECTTTTTTCTTCCEEECCSCCBCCCCTT------TTTTCTTCCEEECT
T ss_pred ChhhhcCCCCccEEeccchhhhcccccccccccChhhcccCCCCCEEECCCCccCCCChh------HhccccCCcEEECC
Confidence 99999999999999999886543 2234788999999999999999876543 57889999999999
Q ss_pred CCcCCcc-CC-hhhhhhc-ccceeeeeccccccCCCCCccccccccceEEecCccccCCcc-hhccCCCCCceEEccCCc
Q 045798 334 GNQFRGA-LP-HSIANLS-SQLQILILSSNQFYGSIPLGIGNLVDLYLLGMVENQFTGAIP-KEMGKLQKLQGLDFSGNH 409 (1008)
Q Consensus 334 ~N~l~~~-~p-~~~~~l~-~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~Ls~N~ 409 (1008)
+|.+... ++ ..+..+. +.|+.|++++|++++..|..+..+++|+.|++++|.+.+.+| ..|..+++|++|+|++|+
T Consensus 362 ~n~~~~~~l~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~ 441 (680)
T 1ziw_A 362 NSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNK 441 (680)
T ss_dssp TCBSCCCEECTTTTGGGTTSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCEEECCSGGGTTCTTCCEEECCSCS
T ss_pred CCchhhhhcchhhhcccccCcCceEECCCCCCCeEChhhhhCCCCCCEEeCCCCcCccccCcccccCcccccEEecCCCC
Confidence 9985422 22 2233322 369999999999999999999999999999999999987665 789999999999999999
Q ss_pred ccccccccccCCCCcceeeccccccc--cccCCCCcCCCcccEeecccccccCCcchhhhhhhhhhhhhcccCccccCCC
Q 045798 410 FSGEIPSSLGNLSSLYEVFFNNNNLS--GVIPFSLGNLKRLAFLEMSGNELSGTIPEDIFNISYLSNSLNLARNHLVGII 487 (1008)
Q Consensus 410 l~~~~p~~~~~l~~L~~L~l~~N~l~--~~~p~~~~~l~~L~~L~Ls~N~l~~~lp~~~~~~~~~~~~L~L~~N~l~~~~ 487 (1008)
+.+..+..|..+++|+.|++++|.+. +..|..|.++++|+.|+|++|+++ .+|...+.....++.|+|++|++++..
T Consensus 442 l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~~l~~L~~L~Ls~N~l~~~~ 520 (680)
T 1ziw_A 442 YLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIA-NINDDMLEGLEKLEILDLQHNNLARLW 520 (680)
T ss_dssp EEECCTTTTTTCTTCCEEECTTSCCBCTTCSSCTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCGGGG
T ss_pred cceeChhhhhcCcccccchhccccccccccCCcccccCCCCCEEECCCCCCC-cCChhhhccccccCEEeCCCCCccccc
Confidence 99888999999999999999999987 568999999999999999999999 577776666677789999999998642
Q ss_pred c--------ccccccccccccccccccccCCCCcccccccccceeeccCcccccchhhhhhccccccEEecCCCcccccc
Q 045798 488 P--------PRIGNLRALRSFDVSNNDLSGEIPIELGHCSSLEEIYLAGNLFHGSIPSFFNALKGVQKIDLSRNNLSGQI 559 (1008)
Q Consensus 488 p--------~~~~~l~~L~~Ldls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~ 559 (1008)
+ ..|+++++|+.|+|++|.++...+..|..+++|++|+|++|+|++..+..|..+++|+.|+|++|++++..
T Consensus 521 ~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~ 600 (680)
T 1ziw_A 521 KHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVE 600 (680)
T ss_dssp STTSTTSCCCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCCCBCC
T ss_pred hhhccCCcchhhcCCCCCCEEECCCCCCCCCCHHHcccccCcceeECCCCCCCcCCHhHhCCCCCCCEEECCCCcCCccC
Confidence 2 24789999999999999999444446899999999999999999877788999999999999999999988
Q ss_pred cCcc--cccccceeecccCcccccCCC
Q 045798 560 PIFL--EALSLEYLNLSFNDFEGKIPA 584 (1008)
Q Consensus 560 p~~~--~~~~L~~L~l~~N~l~g~~p~ 584 (1008)
|... .+.+|+.|++++|++.+..+.
T Consensus 601 ~~~~~~~~~~L~~l~l~~N~~~c~c~~ 627 (680)
T 1ziw_A 601 KKVFGPAFRNLTELDMRFNPFDCTCES 627 (680)
T ss_dssp HHHHHHHHTTCSEEECTTCCCCBCCCC
T ss_pred hhHhcccccccCEEEccCCCcccCCcc
Confidence 7653 577899999999999998764
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-55 Score=530.92 Aligned_cols=527 Identities=19% Similarity=0.156 Sum_probs=287.7
Q ss_pred EeccccCCCCccCcCccCCccCCeeeecCCCCCCCCCccccCCCCCCEEEccCCCCCCccCcccccCcCcceEeeecccc
Q 045798 59 LDLMSKSLSGSLSPHLGNLSFLREINLSNNTIQGEIPPEFGRLFRLEALFLSNNSLVGKIPANLSYCSRLTVLCIEYNKL 138 (1008)
Q Consensus 59 l~l~~~~l~~~l~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l 138 (1008)
+|.++++++ .+|..+. ++|++|+|++|++++..+..|.++++|++|+|++|++++..|..|+++++|++|+|++|++
T Consensus 16 ~~c~~~~l~-~ip~~~~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l 92 (606)
T 3vq2_A 16 YQCMDQKLS-KVPDDIP--SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPI 92 (606)
T ss_dssp EECTTSCCS-SCCTTSC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCC
T ss_pred eEccCCCcc-cCCCCCC--CCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcc
Confidence 445555555 4555544 5677777777777766666777777777777777777766677777777777777777777
Q ss_pred ccCCCccccccCCCCeeecccccCCCCCCCCCccccccchhhcccccCCC-CCCccccCCCCCcEEEecCCcccccCCcc
Q 045798 139 QGRIPLEFVSLSKLKDLSLAKNKLTGGIPPFLGNLTSLEVLSLAGNSFGR-NIPDSLGQLKQLKILAIGGNNLSGPIPPS 217 (1008)
Q Consensus 139 ~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~ 217 (1008)
++..|..|+++++|++|+|++|++++..+..++++++|++|++++|.+.+ .+|..|+++++|++|++++|++++..+..
T Consensus 93 ~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~~~~~ 172 (606)
T 3vq2_A 93 QSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVND 172 (606)
T ss_dssp CCCCTTSSTTCTTCCEEECTTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEECTTT
T ss_pred cccChhhcCCcccCCEEEccCCccccccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCcceecChhh
Confidence 76667777777777777777777776655667777777777777777754 45777777777777777777777766666
Q ss_pred ccCCCCcc----eeccccccccccCChhhhhcCCCCcEEEeccccCC-CCCCcccccCCCCceeeccccccccc------
Q 045798 218 IYNLSFLV----VFSVSHNQIHGSLPPSLGLLLPNLKFFQIHHNFFS-GSIPISLSNASKLEHIEIANNNFSGK------ 286 (1008)
Q Consensus 218 ~~~l~~L~----~L~ls~N~l~~~lp~~~~~~l~~L~~L~L~~N~l~-~~~p~~l~~l~~L~~L~L~~N~l~~~------ 286 (1008)
|..+++|+ +|++++|.++ .++...+... +|+.|++++|.+. +..|..+.++++|+.+++..+.+.+.
T Consensus 173 ~~~l~~L~~~l~~L~l~~n~l~-~~~~~~~~~~-~L~~L~L~~n~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~l~~~ 250 (606)
T 3vq2_A 173 LQFLRENPQVNLSLDMSLNPID-FIQDQAFQGI-KLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIF 250 (606)
T ss_dssp THHHHHCTTCCCEEECTTCCCC-EECTTTTTTC-EEEEEEEESCCSCHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCC
T ss_pred hhhhhccccccceeeccCCCcc-eeCcccccCc-eeeeeeccCCccchhHHHHHhccccccccccccccccccCCccccc
Confidence 66666554 6777777776 5555555433 6777777777765 34555666666666666543333211
Q ss_pred ccccccCCCc--cccccc-ccccCCCCCCCcccccccccccCCCcEEEecCCcCCccCChhhhhhcccceeeeecccccc
Q 045798 287 LSVNFGGMKN--LSLLNL-QFSNLGSGESDEMGFMNSLTNCSKLRVLSLGGNQFRGALPHSIANLSSQLQILILSSNQFY 363 (1008)
Q Consensus 287 ~~~~~~~l~~--L~~L~L-~~n~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~Ls~N~l~ 363 (1008)
....+.++.. ++.+++ ..|.+.. ..+ .+..+++|+.|++++|.+. .+| .+..+. +|++|++++|.+
T Consensus 251 ~~~~~~~l~~l~l~~l~l~~~~~~~~------~~~-~~~~l~~L~~L~l~~~~~~-~l~-~l~~~~-~L~~L~l~~n~l- 319 (606)
T 3vq2_A 251 EPSIMEGLCDVTIDEFRLTYTNDFSD------DIV-KFHCLANVSAMSLAGVSIK-YLE-DVPKHF-KWQSLSIIRCQL- 319 (606)
T ss_dssp CGGGGTTGGGSEEEEEEECCCTTCCG------GGG-SCGGGTTCSEEEEESCCCC-CCC-CCCTTC-CCSEEEEESCCC-
T ss_pred ChHHhhhhhhccHhheeccccccccc------ccc-ccccCCCCCEEEecCccch-hhh-hccccc-cCCEEEcccccC-
Confidence 1111111111 111111 1111111 111 1444455555555555554 333 333332 355555555555
Q ss_pred CCCCCccccccccceEEecCccccCCcchhccCCCCCceEEccCCccccc--ccccccCCCCcceeeccccccccccCCC
Q 045798 364 GSIPLGIGNLVDLYLLGMVENQFTGAIPKEMGKLQKLQGLDFSGNHFSGE--IPSSLGNLSSLYEVFFNNNNLSGVIPFS 441 (1008)
Q Consensus 364 ~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~--~p~~~~~l~~L~~L~l~~N~l~~~~p~~ 441 (1008)
+.+| .+ .+++|+.|++++|+..+.. .+..+++|++|+|++|++++. +|..+..+++|++|++++|.+.+ +|..
T Consensus 320 ~~lp-~~-~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~-~~~~ 394 (606)
T 3vq2_A 320 KQFP-TL-DLPFLKSLTLTMNKGSISF--KKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAII-MSAN 394 (606)
T ss_dssp SSCC-CC-CCSSCCEEEEESCSSCEEC--CCCCCTTCCEEECCSSCEEEEEECCHHHHCCSCCCEEECCSCSEEE-ECCC
T ss_pred cccc-cC-CCCccceeeccCCcCccch--hhccCCCCCEEECcCCccCCCcchhhhhccCCcccEeECCCCcccc-chhh
Confidence 3444 22 4555555555555333222 344455555555555555433 24444455555555555555442 3344
Q ss_pred CcCCCcccEeecccccccCCcchhhhhhhhhhhhhcccCccccCCCcccccccccccccccccccccC-CCCcccccccc
Q 045798 442 LGNLKRLAFLEMSGNELSGTIPEDIFNISYLSNSLNLARNHLVGIIPPRIGNLRALRSFDVSNNDLSG-EIPIELGHCSS 520 (1008)
Q Consensus 442 ~~~l~~L~~L~Ls~N~l~~~lp~~~~~~~~~~~~L~L~~N~l~~~~p~~~~~l~~L~~Ldls~N~l~~-~~p~~~~~l~~ 520 (1008)
|..+++|+.|++++|++++..|...+.....++.|++++|.+.+..|..++.+++|+.|++++|.+++ .+|..++.+++
T Consensus 395 ~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~ 474 (606)
T 3vq2_A 395 FMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTN 474 (606)
T ss_dssp CTTCTTCCEEECTTSEEESTTTTTTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTT
T ss_pred ccCCCCCCeeECCCCccCCccChhhhhccccCCEEECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhccCCC
Confidence 55555555555555555443332333333334455555555555555555555555555555555554 24555555555
Q ss_pred cceeeccCcccccchhhhhhccccccEEecCCCcccccccCc-ccccccceeecccCcccccCCCCcccC-Ccccceecc
Q 045798 521 LEEIYLAGNLFHGSIPSFFNALKGVQKIDLSRNNLSGQIPIF-LEALSLEYLNLSFNDFEGKIPAKGIFA-NASAISVVG 598 (1008)
Q Consensus 521 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~-~~~~~L~~L~l~~N~l~g~~p~~~~~~-~~~~~~~~~ 598 (1008)
|++|+|++|++++.+|..|..+++|+.|+|++|++++.+|.. ..+.+|++|++++|+++..++....+. ++..+.+.+
T Consensus 475 L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~p~~~~~l~~~L~~l~l~~ 554 (606)
T 3vq2_A 475 LTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTN 554 (606)
T ss_dssp CCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCCEEECTTSCCCCEESCGGGSCTTCCEEECCS
T ss_pred CCEEECCCCcCCccChhhhcccccCCEEECCCCcCCCcCHHHccCCCcCCEEECCCCcCcccCHhHhhhcccCcEEEccC
Confidence 555555555555555555555555555555555555554443 334455555555555553222222222 244444555
Q ss_pred CCccCCCC
Q 045798 599 CNRLCGGI 606 (1008)
Q Consensus 599 n~~l~g~~ 606 (1008)
|++.|++.
T Consensus 555 N~~~c~c~ 562 (606)
T 3vq2_A 555 NSVACICE 562 (606)
T ss_dssp CCCCCSST
T ss_pred CCcccCCc
Confidence 55555443
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-55 Score=536.03 Aligned_cols=507 Identities=18% Similarity=0.186 Sum_probs=344.9
Q ss_pred hhccCChhhHHHHHHHHHhhccCCCCCCCCCCCCC-----CC--Ccc------------cceEEcCCCCeEEEEeccccC
Q 045798 5 QVAALEDGDRAALQAFKSMIAHEPQGILNSWNDSR-----HF--CEW------------EGITCGRRHRRVTALDLMSKS 65 (1008)
Q Consensus 5 ~~~~~~~~~~~~l~~~k~~~~~~~~~~~~~w~~~~-----~~--c~w------------~gv~c~~~~~~v~~l~l~~~~ 65 (1008)
.++++..+|++||++||+++. +| +|+.+. ++ |.| .||+|+. .++|+.|+|++++
T Consensus 262 ~~~~~~~~d~~ALl~~k~~l~-~~-----~W~~~~~~~~~~~~~C~W~~~~~~~~w~~~~GV~C~~-~~~V~~L~Ls~~~ 334 (876)
T 4ecn_A 262 KETAEYIKDYKALKAIWEALD-GK-----NWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDN-NGRVTGLSLAGFG 334 (876)
T ss_dssp CCCCHHHHHHHHHHHHHHHTT-GG-----GCCCCCSSCSSCCCCCSCCCSSCGGGTTCCTTEEECT-TSCEEEEECTTTC
T ss_pred cccccchHHHHHHHHHHHHcC-CC-----CCCcCCCcccccCCccccccccccccccCcCceEecC-CCCEEEEECccCC
Confidence 355677889999999999995 55 676543 44 999 9999986 5899999999999
Q ss_pred CCCccCcCccCCccCCeeee-cCCCCCCCCCccccCCC-CCCE--------------EE-ccCCCCCC-----------c
Q 045798 66 LSGSLSPHLGNLSFLREINL-SNNTIQGEIPPEFGRLF-RLEA--------------LF-LSNNSLVG-----------K 117 (1008)
Q Consensus 66 l~~~l~~~l~~l~~L~~L~L-~~n~~~~~~p~~~~~l~-~L~~--------------L~-Ls~n~l~~-----------~ 117 (1008)
+.|.+|++++.|++|++|+| ++|.++|..|....... .+.. ++ .....+.+ .
T Consensus 335 L~G~ip~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~l~~~~l~~~~~~ 414 (876)
T 4ecn_A 335 AKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEM 414 (876)
T ss_dssp CEEEECGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHTCTTS
T ss_pred CCCcCchHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhHHHHHHhhhCccc
Confidence 99999999999999999999 88888776442211110 0000 00 00000000 0
Q ss_pred cCcccccCcCcceEeeec--cccccCCCccccccCCCCeeecccccCCC-----------------CCCCCCc--ccccc
Q 045798 118 IPANLSYCSRLTVLCIEY--NKLQGRIPLEFVSLSKLKDLSLAKNKLTG-----------------GIPPFLG--NLTSL 176 (1008)
Q Consensus 118 ~p~~l~~l~~L~~L~Ls~--n~l~~~~p~~~~~l~~L~~L~L~~n~l~~-----------------~~~~~~~--~l~~L 176 (1008)
.+........++.+.+.. |++++ +|..|+++++|++|+|++|++++ .+|..++ ++++|
T Consensus 415 ~~i~~~~~l~l~~l~l~~~~N~L~~-IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L 493 (876)
T 4ecn_A 415 KPIKKDSRISLKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDL 493 (876)
T ss_dssp CCCCCCCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTC
T ss_pred cccccccccchhhceeccccCcccc-hhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCC
Confidence 000011112222222222 44554 45555555555555555555554 2566655 66666
Q ss_pred chhhcccccCCCCCCccccCCCCCcEEEecCCc-ccc-cCCccccCCC-------CcceeccccccccccCCh-hhhhcC
Q 045798 177 EVLSLAGNSFGRNIPDSLGQLKQLKILAIGGNN-LSG-PIPPSIYNLS-------FLVVFSVSHNQIHGSLPP-SLGLLL 246 (1008)
Q Consensus 177 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~-l~~-~~~~~~~~l~-------~L~~L~ls~N~l~~~lp~-~~~~~l 246 (1008)
++|+|++|++.+.+|..|+.+++|+.|+|++|+ +++ .+|..+..++ +|+.|+|++|+++ .+|. ..+..+
T Consensus 494 ~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L 572 (876)
T 4ecn_A 494 TDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKM 572 (876)
T ss_dssp CEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTTC
T ss_pred CEEECcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhhhcC
Confidence 666666666666666666666666666666665 665 5555444443 6666666666666 6665 223336
Q ss_pred CCCcEEEeccccCCCCCCcccccCCCCceeecccccccccccccccCCCc-ccccccccccCCCCCCCccccccccccc-
Q 045798 247 PNLKFFQIHHNFFSGSIPISLSNASKLEHIEIANNNFSGKLSVNFGGMKN-LSLLNLQFSNLGSGESDEMGFMNSLTNC- 324 (1008)
Q Consensus 247 ~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~-L~~L~L~~n~l~~~~~~~~~~~~~l~~l- 324 (1008)
++|+.|+|++|.+. .+| .+.++++|+.|++++|++. ..|..+.++++ |+.|+|++|+++.++ ..+..+
T Consensus 573 ~~L~~L~Ls~N~l~-~lp-~~~~L~~L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~~lp-------~~~~~~~ 642 (876)
T 4ecn_A 573 VKLGLLDCVHNKVR-HLE-AFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLKYIP-------NIFNAKS 642 (876)
T ss_dssp TTCCEEECTTSCCC-BCC-CCCTTSEESEEECCSSCCS-CCCTTSCEECTTCCEEECCSSCCCSCC-------SCCCTTC
T ss_pred CCCCEEECCCCCcc-cch-hhcCCCcceEEECcCCccc-cchHHHhhccccCCEEECcCCCCCcCc-------hhhhccc
Confidence 66666666666666 555 6666667777777777666 45555666666 777777776665432 123333
Q ss_pred -CCCcEEEecCCcCCccCChhh---hhhc-ccceeeeeccccccCCCCCcc-ccccccceEEecCccccCCcchhccC--
Q 045798 325 -SKLRVLSLGGNQFRGALPHSI---ANLS-SQLQILILSSNQFYGSIPLGI-GNLVDLYLLGMVENQFTGAIPKEMGK-- 396 (1008)
Q Consensus 325 -~~L~~L~Ls~N~l~~~~p~~~---~~l~-~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~L~L~~n~l~~~~~~~~~~-- 396 (1008)
++|+.|+|++|++.+.+|... ..+. .+|+.|+|++|.++ .+|..+ ..+++|+.|+|++|+++ .+|..+..
T Consensus 643 ~~~L~~L~Ls~N~l~g~ip~l~~~l~~~~~~~L~~L~Ls~N~L~-~lp~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~~~~ 720 (876)
T 4ecn_A 643 VYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQ-KFPTELFATGSPISTIILSNNLMT-SIPENSLKPK 720 (876)
T ss_dssp SSCEEEEECCSSCTTTTSSSCSSCTTTCCCCCEEEEECCSSCCC-SCCHHHHHTTCCCSEEECCSCCCS-CCCTTSSSCT
T ss_pred cCCCCEEECcCCcCCCccccchhhhccccCCCcCEEEccCCcCC-ccCHHHHccCCCCCEEECCCCcCC-ccChHHhccc
Confidence 347788888888776555322 1111 25888888888888 556554 47788888888888888 55554433
Q ss_pred ------CCCCceEEccCCccccccccccc--CCCCcceeeccccccccccCCCCcCCCcccEeecccccccCCcchhhhh
Q 045798 397 ------LQKLQGLDFSGNHFSGEIPSSLG--NLSSLYEVFFNNNNLSGVIPFSLGNLKRLAFLEMSGNELSGTIPEDIFN 468 (1008)
Q Consensus 397 ------l~~L~~L~Ls~N~l~~~~p~~~~--~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~lp~~~~~ 468 (1008)
+++|+.|+|++|+++ .+|..+. .+++|+.|+|++|.+++ +|..+.++++|+.|+|++|+
T Consensus 721 ~~~l~nl~~L~~L~Ls~N~L~-~lp~~l~~~~l~~L~~L~Ls~N~L~~-lp~~l~~L~~L~~L~Ls~N~----------- 787 (876)
T 4ecn_A 721 DGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQR----------- 787 (876)
T ss_dssp TSCCTTGGGCCEEECCSSCCC-CCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCTTCCEEECCCCB-----------
T ss_pred cccccccCCccEEECCCCCCc-cchHHhhhccCCCcCEEEeCCCCCCc-cchhhhcCCCCCEEECCCCC-----------
Confidence 238999999999998 7888887 89999999999999997 78889999999999999987
Q ss_pred hhhhhhhhcccCccccCCCcccccccccccccccccccccCCCCcccccccccceeeccCcccccchhhhhhccccccEE
Q 045798 469 ISYLSNSLNLARNHLVGIIPPRIGNLRALRSFDVSNNDLSGEIPIELGHCSSLEEIYLAGNLFHGSIPSFFNALKGVQKI 548 (1008)
Q Consensus 469 ~~~~~~~L~L~~N~l~~~~p~~~~~l~~L~~Ldls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 548 (1008)
++++|++.+.+|..|+.+++|+.|+|++|++ +.+|..+. ++|+.|+|++|++...-+..+.....+..+
T Consensus 788 --------~ls~N~l~~~ip~~l~~L~~L~~L~Ls~N~L-~~Ip~~l~--~~L~~LdLs~N~l~~i~~~~~~~~~~~~~~ 856 (876)
T 4ecn_A 788 --------DAEGNRILRQWPTGITTCPSLIQLQIGSNDI-RKVDEKLT--PQLYILDIADNPNISIDVTSVCPYIEAGMY 856 (876)
T ss_dssp --------CTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCCC--SSSCEEECCSCTTCEEECGGGHHHHHTTCC
T ss_pred --------CcccccccccChHHHhcCCCCCEEECCCCCC-CccCHhhc--CCCCEEECCCCCCCccChHHccccccchhe
Confidence 4577888888999999999999999999999 58888876 689999999998887667777777777777
Q ss_pred ecCCCccc
Q 045798 549 DLSRNNLS 556 (1008)
Q Consensus 549 ~ls~N~l~ 556 (1008)
.|++|++.
T Consensus 857 ~L~~n~~~ 864 (876)
T 4ecn_A 857 VLLYDKTQ 864 (876)
T ss_dssp EEECCTTS
T ss_pred eecCCCcc
Confidence 88777665
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-54 Score=537.87 Aligned_cols=521 Identities=19% Similarity=0.201 Sum_probs=453.0
Q ss_pred CcccceEEcCCCCeEEEEeccccCCCCccCcCccCCccCCeeeecCCCCCCCC-CccccCCCCCCEEEccCCCCCCccCc
Q 045798 42 CEWEGITCGRRHRRVTALDLMSKSLSGSLSPHLGNLSFLREINLSNNTIQGEI-PPEFGRLFRLEALFLSNNSLVGKIPA 120 (1008)
Q Consensus 42 c~w~gv~c~~~~~~v~~l~l~~~~l~~~l~~~l~~l~~L~~L~L~~n~~~~~~-p~~~~~l~~L~~L~Ls~n~l~~~~p~ 120 (1008)
|.|..|.+ -...++.|||++|.+++..+..+..+++|++|+|++|.+.+.+ |.+|.++++|++|+|++|.+++..|.
T Consensus 14 ~~L~~vP~--lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~ 91 (844)
T 3j0a_A 14 CNLTQVPQ--VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPD 91 (844)
T ss_dssp CCSSCCCS--SCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTT
T ss_pred CCCCCCCC--CCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHh
Confidence 45666665 4568999999999999888999999999999999999666565 78999999999999999999988899
Q ss_pred ccccCcCcceEeeeccccccCCCcc--ccccCCCCeeecccccCCCCCC-CCCccccccchhhcccccCCCCCCccccCC
Q 045798 121 NLSYCSRLTVLCIEYNKLQGRIPLE--FVSLSKLKDLSLAKNKLTGGIP-PFLGNLTSLEVLSLAGNSFGRNIPDSLGQL 197 (1008)
Q Consensus 121 ~l~~l~~L~~L~Ls~n~l~~~~p~~--~~~l~~L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l 197 (1008)
.|+++++|++|+|++|.+++.+|.. |.++++|++|+|++|.+++..+ ..|+++++|++|+|++|.+++..+..|..+
T Consensus 92 ~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~~~l~~l 171 (844)
T 3j0a_A 92 AFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPL 171 (844)
T ss_dssp SSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCCSGGGHHH
T ss_pred HccCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCeeCHHHcccc
Confidence 9999999999999999999866665 9999999999999999997655 579999999999999999999999999988
Q ss_pred --CCCcEEEecCCcccccCCccccCCCC------cceeccccccccccCChhhhhcC--CCCcEEEeccc---------c
Q 045798 198 --KQLKILAIGGNNLSGPIPPSIYNLSF------LVVFSVSHNQIHGSLPPSLGLLL--PNLKFFQIHHN---------F 258 (1008)
Q Consensus 198 --~~L~~L~L~~n~l~~~~~~~~~~l~~------L~~L~ls~N~l~~~lp~~~~~~l--~~L~~L~L~~N---------~ 258 (1008)
++|+.|++++|.+.+..|..+..+++ |+.|++++|.+.+.++..+...+ .+++.|.++++ .
T Consensus 172 ~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~~~~~~~~~~ 251 (844)
T 3j0a_A 172 QGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHN 251 (844)
T ss_dssp HHCSSCCCEECCSBSCCCCCCCCCSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSCCBCSSSCSS
T ss_pred cCCccceEECCCCccccccccchhhcCCccccCceeEEecCCCcCchhHHHHHHhhcCcccccceecccccccccccccc
Confidence 89999999999999988888877766 99999999999988888776643 57888888743 3
Q ss_pred CCCCCCcccccC--CCCceeecccccccccccccccCCCcccccccccccCCCCCCCcccccccccccCCCcEEEecCCc
Q 045798 259 FSGSIPISLSNA--SKLEHIEIANNNFSGKLSVNFGGMKNLSLLNLQFSNLGSGESDEMGFMNSLTNCSKLRVLSLGGNQ 336 (1008)
Q Consensus 259 l~~~~p~~l~~l--~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~ 336 (1008)
+.+..+..+..+ ++|+.|++++|.+.+..+..|..+++|+.|+|++|++..... ..+..+++|++|+|++|+
T Consensus 252 l~~~~~~~f~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~------~~~~~l~~L~~L~Ls~N~ 325 (844)
T 3j0a_A 252 IKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIAD------EAFYGLDNLQVLNLSYNL 325 (844)
T ss_dssp STTGGGTTTTTTTTSCCCEEECTTCCCCEECSCCSSSCCCCCEEEEESCCCCEECT------TTTTTCSSCCEEEEESCC
T ss_pred cCCCChhhhhccccCCccEEECCCCcccccChhhhhcCCCCCEEECCCCcCCCCCh------HHhcCCCCCCEEECCCCC
Confidence 333344455544 789999999999999999999999999999999999986543 367889999999999999
Q ss_pred CCccCChhhhhhcccceeeeeccccccCCCCCccccccccceEEecCccccCCcchhccCCCCCceEEccCCcccccccc
Q 045798 337 FRGALPHSIANLSSQLQILILSSNQFYGSIPLGIGNLVDLYLLGMVENQFTGAIPKEMGKLQKLQGLDFSGNHFSGEIPS 416 (1008)
Q Consensus 337 l~~~~p~~~~~l~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~ 416 (1008)
+++..|..+..+. +|++|+|++|.+.+..+..|..+++|+.|+|++|.+++. ..+++|+.|++++|+++ .+|.
T Consensus 326 l~~~~~~~~~~l~-~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~i-----~~~~~L~~L~l~~N~l~-~l~~ 398 (844)
T 3j0a_A 326 LGELYSSNFYGLP-KVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTI-----HFIPSIPDIFLSGNKLV-TLPK 398 (844)
T ss_dssp CSCCCSCSCSSCT-TCCEEECCSCCCCCCCSSCSCSCCCCCEEEEETCCSCCC-----SSCCSCSEEEEESCCCC-CCCC
T ss_pred CCccCHHHhcCCC-CCCEEECCCCCCCccChhhhcCCCCCCEEECCCCCCCcc-----cCCCCcchhccCCCCcc-cccc
Confidence 9988888888886 599999999999988888899999999999999999853 33889999999999998 5665
Q ss_pred cccCCCCcceeeccccccccccC-CCCcCCCcccEeecccccccCCcchhhhhhhhhhhhhcccCcccc-----CCCccc
Q 045798 417 SLGNLSSLYEVFFNNNNLSGVIP-FSLGNLKRLAFLEMSGNELSGTIPEDIFNISYLSNSLNLARNHLV-----GIIPPR 490 (1008)
Q Consensus 417 ~~~~l~~L~~L~l~~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~lp~~~~~~~~~~~~L~L~~N~l~-----~~~p~~ 490 (1008)
. ..+++.|++++|++.+... ..+.++++|+.|+|++|++++..+...+.....++.|+|++|.++ +..|..
T Consensus 399 ~---~~~l~~L~ls~N~l~~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~~ 475 (844)
T 3j0a_A 399 I---NLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDV 475 (844)
T ss_dssp C---CTTCCEEECCSCCCCSSTTHHHHTTCTTCCEEEEESCCCCCCCSSSSSCSCTTCCBCEEESCCCSSSCCSCCCSSC
T ss_pred c---ccccceeecccCccccCchhhhhhcCCccceeeCCCCcccccccccccccCCccccccCCCCccccccccccchhh
Confidence 4 4678999999999996422 235689999999999999996555545555667789999999997 455677
Q ss_pred ccccccccccccccccccCCCCcccccccccceeeccCcccccchhhhhhccccccEEecCCCcccccccCcccccccce
Q 045798 491 IGNLRALRSFDVSNNDLSGEIPIELGHCSSLEEIYLAGNLFHGSIPSFFNALKGVQKIDLSRNNLSGQIPIFLEALSLEY 570 (1008)
Q Consensus 491 ~~~l~~L~~Ldls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~L~~ 570 (1008)
|..+++|+.|||++|.+++..|..|..+++|++|+|++|+|++.+|..+. ++|+.|||++|+|++.+|... .+|+.
T Consensus 476 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~--~~L~~L~Ls~N~l~~~~~~~~--~~L~~ 551 (844)
T 3j0a_A 476 FEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLP--ANLEILDISRNQLLAPNPDVF--VSLSV 551 (844)
T ss_dssp SSCBCCEECCCCCHHHHTTCCTTSSSSCCSCSEEEEESCCCSSCCCCCCC--SCCCEEEEEEECCCCCCSCCC--SSCCE
T ss_pred hcCcccccEEECCCCcccccChhHccchhhhheeECCCCCCCccChhhhh--ccccEEECCCCcCCCCChhHh--CCcCE
Confidence 99999999999999999998899999999999999999999987777776 899999999999999988764 47999
Q ss_pred eecccCcccccCCC
Q 045798 571 LNLSFNDFEGKIPA 584 (1008)
Q Consensus 571 L~l~~N~l~g~~p~ 584 (1008)
|++++|++.+..+.
T Consensus 552 l~l~~Np~~C~c~~ 565 (844)
T 3j0a_A 552 LDITHNKFICECEL 565 (844)
T ss_dssp EEEEEECCCCSSSC
T ss_pred EEecCCCccccccc
Confidence 99999999998764
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-54 Score=518.37 Aligned_cols=507 Identities=19% Similarity=0.169 Sum_probs=433.5
Q ss_pred CCeeeecCCCCCCCCCccccCCCCCCEEEccCCCCCCccCcccccCcCcceEeeeccccccCCCccccccCCCCeeeccc
Q 045798 80 LREINLSNNTIQGEIPPEFGRLFRLEALFLSNNSLVGKIPANLSYCSRLTVLCIEYNKLQGRIPLEFVSLSKLKDLSLAK 159 (1008)
Q Consensus 80 L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~ 159 (1008)
.++++.++++++ .+|..+. ++|++|+|++|++++..+..|+++++|++|+|++|++++..|..|.++++|++|+|++
T Consensus 13 ~~~~~c~~~~l~-~ip~~~~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~ 89 (606)
T 3vq2_A 13 NITYQCMDQKLS-KVPDDIP--SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTG 89 (606)
T ss_dssp TTEEECTTSCCS-SCCTTSC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTT
T ss_pred CCceEccCCCcc-cCCCCCC--CCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCC
Confidence 468999999999 7777665 8999999999999988888999999999999999999988899999999999999999
Q ss_pred ccCCCCCCCCCccccccchhhcccccCCCCCCccccCCCCCcEEEecCCcccc-cCCccccCCCCcceeccccccccccC
Q 045798 160 NKLTGGIPPFLGNLTSLEVLSLAGNSFGRNIPDSLGQLKQLKILAIGGNNLSG-PIPPSIYNLSFLVVFSVSHNQIHGSL 238 (1008)
Q Consensus 160 n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~~l~~L~~L~ls~N~l~~~l 238 (1008)
|++++..|..|+++++|++|+|++|++++..+..|+.+++|++|++++|.+++ .+|..|.++++|++|++++|++++..
T Consensus 90 n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~~ 169 (606)
T 3vq2_A 90 NPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTIT 169 (606)
T ss_dssp CCCCCCCTTSSTTCTTCCEEECTTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEEC
T ss_pred CcccccChhhcCCcccCCEEEccCCccccccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCcceecC
Confidence 99998889999999999999999999988888999999999999999999986 56999999999999999999999655
Q ss_pred ChhhhhcCCC----CcEEEeccccCCCCCCcccccCCCCceeeccccccc-ccccccccCCCcccccccccccCCCCCCC
Q 045798 239 PPSLGLLLPN----LKFFQIHHNFFSGSIPISLSNASKLEHIEIANNNFS-GKLSVNFGGMKNLSLLNLQFSNLGSGESD 313 (1008)
Q Consensus 239 p~~~~~~l~~----L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~~ 313 (1008)
|..+.. +++ +.+|++++|.+.+..+..+... +|+.|++++|.+. +..+..+..+++|+.+++..+.+......
T Consensus 170 ~~~~~~-l~~L~~~l~~L~l~~n~l~~~~~~~~~~~-~L~~L~L~~n~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~l 247 (606)
T 3vq2_A 170 VNDLQF-LRENPQVNLSLDMSLNPIDFIQDQAFQGI-KLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNL 247 (606)
T ss_dssp TTTTHH-HHHCTTCCCEEECTTCCCCEECTTTTTTC-EEEEEEEESCCSCHHHHHHHHHTTTTCEEEEEEEECCTTSCCC
T ss_pred hhhhhh-hhccccccceeeccCCCcceeCcccccCc-eeeeeeccCCccchhHHHHHhccccccccccccccccccCCcc
Confidence 544432 333 5589999999996655555544 9999999999987 56777889999999999877665443221
Q ss_pred c---ccccccccccCCCcEEEe-cCCcCCccCChhhhhhcccceeeeeccccccCCCCCccccccccceEEecCccccCC
Q 045798 314 E---MGFMNSLTNCSKLRVLSL-GGNQFRGALPHSIANLSSQLQILILSSNQFYGSIPLGIGNLVDLYLLGMVENQFTGA 389 (1008)
Q Consensus 314 ~---~~~~~~l~~l~~L~~L~L-s~N~l~~~~p~~~~~l~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~ 389 (1008)
. ...+..+..+ .++.+++ ..|.+.+.+|. +..+. +|+.|++++|.+. .+| .+..+++|+.|++++|.+ +.
T Consensus 248 ~~~~~~~~~~l~~l-~l~~l~l~~~~~~~~~~~~-~~~l~-~L~~L~l~~~~~~-~l~-~l~~~~~L~~L~l~~n~l-~~ 321 (606)
T 3vq2_A 248 EIFEPSIMEGLCDV-TIDEFRLTYTNDFSDDIVK-FHCLA-NVSAMSLAGVSIK-YLE-DVPKHFKWQSLSIIRCQL-KQ 321 (606)
T ss_dssp SCCCGGGGTTGGGS-EEEEEEECCCTTCCGGGGS-CGGGT-TCSEEEEESCCCC-CCC-CCCTTCCCSEEEEESCCC-SS
T ss_pred cccChHHhhhhhhc-cHhheeccccccccccccc-cccCC-CCCEEEecCccch-hhh-hccccccCCEEEcccccC-cc
Confidence 1 1222233333 5677777 78888888877 66665 6999999999997 667 899999999999999999 57
Q ss_pred cchhccCCCCCceEEccCCcccccccccccCCCCcceeeccccccccc--cCCCCcCCCcccEeecccccccCCcchhhh
Q 045798 390 IPKEMGKLQKLQGLDFSGNHFSGEIPSSLGNLSSLYEVFFNNNNLSGV--IPFSLGNLKRLAFLEMSGNELSGTIPEDIF 467 (1008)
Q Consensus 390 ~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~--~p~~~~~l~~L~~L~Ls~N~l~~~lp~~~~ 467 (1008)
+| .+ .+++|+.|++++|+..+.+ .+..+++|++|++++|.+++. .|..+..+++|+.|++++|.++ .+|..+.
T Consensus 322 lp-~~-~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~-~~~~~~~ 396 (606)
T 3vq2_A 322 FP-TL-DLPFLKSLTLTMNKGSISF--KKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFM 396 (606)
T ss_dssp CC-CC-CCSSCCEEEEESCSSCEEC--CCCCCTTCCEEECCSSCEEEEEECCHHHHCCSCCCEEECCSCSEE-EECCCCT
T ss_pred cc-cC-CCCccceeeccCCcCccch--hhccCCCCCEEECcCCccCCCcchhhhhccCCcccEeECCCCccc-cchhhcc
Confidence 88 45 9999999999999765444 678999999999999999976 3888999999999999999998 5885554
Q ss_pred hhhhhhhhhcccCccccCCCc-ccccccccccccccccccccCCCCcccccccccceeeccCccccc-chhhhhhccccc
Q 045798 468 NISYLSNSLNLARNHLVGIIP-PRIGNLRALRSFDVSNNDLSGEIPIELGHCSSLEEIYLAGNLFHG-SIPSFFNALKGV 545 (1008)
Q Consensus 468 ~~~~~~~~L~L~~N~l~~~~p-~~~~~l~~L~~Ldls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L 545 (1008)
.. ..++.|++++|++.+..| ..+..+++|+.|++++|.+++..|..++.+++|++|+|++|++++ .+|..|+.+++|
T Consensus 397 ~l-~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L 475 (606)
T 3vq2_A 397 GL-EELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNL 475 (606)
T ss_dssp TC-TTCCEEECTTSEEESTTTTTTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTC
T ss_pred CC-CCCCeeECCCCccCCccChhhhhccccCCEEECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhccCCCC
Confidence 44 456899999999999888 789999999999999999999999999999999999999999998 489999999999
Q ss_pred cEEecCCCcccccccCc-ccccccceeecccCcccccCCCC-cccCCcccceeccCCccCC
Q 045798 546 QKIDLSRNNLSGQIPIF-LEALSLEYLNLSFNDFEGKIPAK-GIFANASAISVVGCNRLCG 604 (1008)
Q Consensus 546 ~~L~ls~N~l~~~~p~~-~~~~~L~~L~l~~N~l~g~~p~~-~~~~~~~~~~~~~n~~l~g 604 (1008)
+.|+|++|++++.+|.. ..+.+|++|++++|++++.+|.. ..+.++..+.+.+|. +.+
T Consensus 476 ~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~-l~~ 535 (606)
T 3vq2_A 476 TFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNR-IET 535 (606)
T ss_dssp CEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCCEEECTTSC-CCC
T ss_pred CEEECCCCcCCccChhhhcccccCCEEECCCCcCCCcCHHHccCCCcCCEEECCCCc-Ccc
Confidence 99999999999988876 67889999999999999998864 345666677666664 443
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-52 Score=500.37 Aligned_cols=492 Identities=18% Similarity=0.209 Sum_probs=375.9
Q ss_pred CCCcccceEEcCCCCeEEEEeccccCCCCccCcCccCCccCCeeeecCCCCCCCCCccccCCCCCCEEEccCCCCCCccC
Q 045798 40 HFCEWEGITCGRRHRRVTALDLMSKSLSGSLSPHLGNLSFLREINLSNNTIQGEIPPEFGRLFRLEALFLSNNSLVGKIP 119 (1008)
Q Consensus 40 ~~c~w~gv~c~~~~~~v~~l~l~~~~l~~~l~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p 119 (1008)
..|.|.|+ |+. ++++++ .+|+.+. ++|++|+|++|++++..|.+|.++++|++|+|++|++++..|
T Consensus 2 ~~C~~~~~-c~~----------~~~~l~-~ip~~~~--~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~ 67 (549)
T 2z81_A 2 LSCDASGV-CDG----------RSRSFT-SIPSGLT--AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEG 67 (549)
T ss_dssp CEECTTSE-EEC----------TTSCCS-SCCSCCC--TTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECT
T ss_pred ccCCCCce-EEC----------CCCccc-cccccCC--CCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccCh
Confidence 46999998 854 345566 6777665 789999999999998889999999999999999999998888
Q ss_pred cccccCcCcceEeeeccccccCCCccccccCCCCeeecccccCCC-CCCCCCccccccchhhccccc-CCCCCCccccCC
Q 045798 120 ANLSYCSRLTVLCIEYNKLQGRIPLEFVSLSKLKDLSLAKNKLTG-GIPPFLGNLTSLEVLSLAGNS-FGRNIPDSLGQL 197 (1008)
Q Consensus 120 ~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~-~~~~~~~~l~~L~~L~L~~n~-l~~~~~~~~~~l 197 (1008)
..|+.+++|++|+|++|++++..|..|+++++|++|++++|++++ ..|..++++++|++|++++|. +....+..|..+
T Consensus 68 ~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l 147 (549)
T 2z81_A 68 DAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGL 147 (549)
T ss_dssp TTTTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTC
T ss_pred hhccccccCCEEECCCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcc
Confidence 999999999999999999998888889999999999999999996 357889999999999999999 444445789999
Q ss_pred CCCcEEEecCCcccccCCccccCCCCcceeccccccccccCChhhhhcCCCCcEEEeccccCCCCC--C-cccccCCCCc
Q 045798 198 KQLKILAIGGNNLSGPIPPSIYNLSFLVVFSVSHNQIHGSLPPSLGLLLPNLKFFQIHHNFFSGSI--P-ISLSNASKLE 274 (1008)
Q Consensus 198 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~--p-~~l~~l~~L~ 274 (1008)
++|++|++++|.+++..|..+..+++|+.|+++.|.+. .+|..++..+++|++|++++|.+.+.. | .....+++|+
T Consensus 148 ~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~~~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~~L~ 226 (549)
T 2z81_A 148 TSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESA-FLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMK 226 (549)
T ss_dssp CEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSBST-THHHHHHHSTTTBSEEEEESCBCTTCCCCCCSSCCCCCCCC
T ss_pred cccCeeeccCCcccccChhhhhccccCceEecccCccc-ccchhhHhhcccccEEEccCCccccccccccchhhhhhccc
Confidence 99999999999999999999999999999999999987 788888778999999999999998642 2 2335678999
Q ss_pred eeeccccccccccccc----ccCCCcccccccccccCCCCCCCcccccccccccCCCcEEEecCCcCCcc-----CChhh
Q 045798 275 HIEIANNNFSGKLSVN----FGGMKNLSLLNLQFSNLGSGESDEMGFMNSLTNCSKLRVLSLGGNQFRGA-----LPHSI 345 (1008)
Q Consensus 275 ~L~L~~N~l~~~~~~~----~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~-----~p~~~ 345 (1008)
.|++++|.+.+..+.. +..+++|+.+++++|.+.............+..+.+|+.|++.++.+... ++..
T Consensus 227 ~L~l~~n~l~~~~~~~l~~~~~~~~~L~~l~l~~~~~~~~~~~~~~~~~~~~~l~~L~~L~l~~~~i~~~~~~~~l~~~- 305 (549)
T 2z81_A 227 KLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTV- 305 (549)
T ss_dssp EEEEESCEEEHHHHHHHHGGGGGCTTCCEEEEESCEEECCSCCCCCTTTCCCCCTTCCEEEEESCBCSCGGGSCCCCHH-
T ss_pred ceeccccccchhHHHHHHHHhhhhccccccccccccccccccccccchhhhhhhcccccccccccccchhhhcccchhh-
Confidence 9999999998755433 45678999999999887665432222234567788999999999987632 1222
Q ss_pred hhhcccceeeeeccccccCCCCCcc-ccccccceEEecCccccCCcch---hccCCCCCceEEccCCccccccc--cccc
Q 045798 346 ANLSSQLQILILSSNQFYGSIPLGI-GNLVDLYLLGMVENQFTGAIPK---EMGKLQKLQGLDFSGNHFSGEIP--SSLG 419 (1008)
Q Consensus 346 ~~l~~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~L~L~~n~l~~~~~~---~~~~l~~L~~L~Ls~N~l~~~~p--~~~~ 419 (1008)
.....+|+.|++++|.+. .+|..+ ..+++|+.|++++|++.+..|. .+..+++|++|+|++|++++..+ ..+.
T Consensus 306 ~~~~~~L~~L~l~~n~l~-~ip~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~ 384 (549)
T 2z81_A 306 YSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILL 384 (549)
T ss_dssp HHHSTTCCEEEEESSCCC-CCCHHHHHHCTTCCEEECCSSCCCHHHHHHHTCTTSSTTCCEEECTTSCCCCHHHHHHHGG
T ss_pred hhhcccceEEEeccCccc-cCCHHHHhcCccccEEEccCCccccccccchhhhhccccCcEEEccCCcccccccchhhhh
Confidence 223346999999999987 677766 5799999999999999887654 37788999999999999985433 4588
Q ss_pred CCCCcceeeccccccccccCCCCcCCCcccEeecccccccCCcchhhhhhhhhhhhhcccCccccCCCcccccccccccc
Q 045798 420 NLSSLYEVFFNNNNLSGVIPFSLGNLKRLAFLEMSGNELSGTIPEDIFNISYLSNSLNLARNHLVGIIPPRIGNLRALRS 499 (1008)
Q Consensus 420 ~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~lp~~~~~~~~~~~~L~L~~N~l~~~~p~~~~~l~~L~~ 499 (1008)
.+++|++|++++|+++ .+|..+..+++|++|++++|+++ .+|..+. ..++.|+|++|++++.+ +.+++|+.
T Consensus 385 ~l~~L~~L~Ls~N~l~-~lp~~~~~~~~L~~L~Ls~N~l~-~l~~~~~---~~L~~L~Ls~N~l~~~~----~~l~~L~~ 455 (549)
T 2z81_A 385 TLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR-VVKTCIP---QTLEVLDVSNNNLDSFS----LFLPRLQE 455 (549)
T ss_dssp GCTTCCEEECTTCCCC-CCCSCCCCCTTCCEEECTTSCCS-CCCTTSC---TTCSEEECCSSCCSCCC----CCCTTCCE
T ss_pred cCCCCCEEECCCCCCc-cCChhhcccccccEEECCCCCcc-cccchhc---CCceEEECCCCChhhhc----ccCChhcE
Confidence 8999999999999998 67888899999999999999987 4554332 22344444444444321 23444444
Q ss_pred cccccccccCCCCcccccccccceeeccCcccccchhhhhhccccccEEecCCCcccccc
Q 045798 500 FDVSNNDLSGEIPIELGHCSSLEEIYLAGNLFHGSIPSFFNALKGVQKIDLSRNNLSGQI 559 (1008)
Q Consensus 500 Ldls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~ 559 (1008)
|||++|+++ .+|. ...+++|++|+|++|+|++.+|..|..+++|+.|+|++|++++..
T Consensus 456 L~Ls~N~l~-~ip~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~ 513 (549)
T 2z81_A 456 LYISRNKLK-TLPD-ASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSC 513 (549)
T ss_dssp EECCSSCCS-SCCC-GGGCTTCCEEECCSSCCCCCCTTGGGGCTTCCEEECCSSCBCCCH
T ss_pred EECCCCccC-cCCC-cccCccCCEEecCCCccCCcCHHHHhcCcccCEEEecCCCccCCC
Confidence 444444444 3443 233444444444444444444444444444444444444444433
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-50 Score=485.43 Aligned_cols=503 Identities=19% Similarity=0.169 Sum_probs=384.5
Q ss_pred ccCCCCccCcCccCCccCCeeeecCCCCCCCCCccccCCCCCCEEEccCCCCCCccCcccccCcCcceEeeeccccccCC
Q 045798 63 SKSLSGSLSPHLGNLSFLREINLSNNTIQGEIPPEFGRLFRLEALFLSNNSLVGKIPANLSYCSRLTVLCIEYNKLQGRI 142 (1008)
Q Consensus 63 ~~~l~~~l~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~ 142 (1008)
+.+++ .+|..+. +.+++|+|++|++++..+.+|.++++|++|+|++|++++..|..|+++++|++|+|++|++++..
T Consensus 16 ~~~l~-~ip~~l~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~ 92 (570)
T 2z63_A 16 ELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLA 92 (570)
T ss_dssp SSCCS-SCCSSSC--SSCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEEC
T ss_pred CCCcc-ccCCCcc--ccccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccC
Confidence 33444 4555443 46888888888888777778888888888888888888777778888888888888888888777
Q ss_pred CccccccCCCCeeecccccCCCCCCCCCccccccchhhcccccCCC-CCCccccCCCCCcEEEecCCcccccCCccccCC
Q 045798 143 PLEFVSLSKLKDLSLAKNKLTGGIPPFLGNLTSLEVLSLAGNSFGR-NIPDSLGQLKQLKILAIGGNNLSGPIPPSIYNL 221 (1008)
Q Consensus 143 p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l 221 (1008)
|..|.++++|++|++++|++++..+..++++++|++|++++|.+.+ .+|..|+++++|++|++++|.+++..+..+..+
T Consensus 93 ~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l 172 (570)
T 2z63_A 93 LGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVL 172 (570)
T ss_dssp TTTTTTCTTCCEEECTTSCCCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEECGGGGHHH
T ss_pred HhhhcCccccccccccccccccCCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCccceecHHHccch
Confidence 7888888888888888888886555568888888888888888866 358888888888888888888887777788888
Q ss_pred CCc----ceeccccccccccCChhhhhcCCCCcEEEeccccCCC-CCCcccccCCCCceeecccccc------ccccccc
Q 045798 222 SFL----VVFSVSHNQIHGSLPPSLGLLLPNLKFFQIHHNFFSG-SIPISLSNASKLEHIEIANNNF------SGKLSVN 290 (1008)
Q Consensus 222 ~~L----~~L~ls~N~l~~~lp~~~~~~l~~L~~L~L~~N~l~~-~~p~~l~~l~~L~~L~L~~N~l------~~~~~~~ 290 (1008)
++| +.|++++|.+.+. +...+... +|+.|++++|.... .++..+..++.++.+.+..+.+ .......
T Consensus 173 ~~L~~~~~~L~l~~n~l~~~-~~~~~~~~-~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~ 250 (570)
T 2z63_A 173 HQMPLLNLSLDLSLNPMNFI-QPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSA 250 (570)
T ss_dssp HTCTTCCCEEECTTCCCCEE-CTTTTTTC-EEEEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEECCCCSSCEECCTTT
T ss_pred hccchhhhhcccCCCCceec-CHHHhccC-cceeEecccccccccchhhhhcCccccceeeeccccccCchhhhhcchhh
Confidence 877 7888888888744 44444433 78888888875432 3344555666666555543322 2222333
Q ss_pred ccCCCcc--cccccccc-cCCCCCCCcccccccccccCCCcEEEecCCcCCccCChhhhhhcccceeeeeccccccCCCC
Q 045798 291 FGGMKNL--SLLNLQFS-NLGSGESDEMGFMNSLTNCSKLRVLSLGGNQFRGALPHSIANLSSQLQILILSSNQFYGSIP 367 (1008)
Q Consensus 291 ~~~l~~L--~~L~L~~n-~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~Ls~N~l~~~~p 367 (1008)
|.++.++ +.++++.+ .+.. ..+..+..+++|+.|++++|.+. .+|..+..+ +|++|++++|.+. .+|
T Consensus 251 ~~~l~~l~l~~l~l~~~~~~~~------~~~~~~~~l~~L~~L~l~~~~l~-~l~~~~~~~--~L~~L~l~~n~~~-~l~ 320 (570)
T 2z63_A 251 LEGLCNLTIEEFRLAYLDYYLD------DIIDLFNCLTNVSSFSLVSVTIE-RVKDFSYNF--GWQHLELVNCKFG-QFP 320 (570)
T ss_dssp TGGGGGSEEEEEEEEETTEEES------CSTTTTGGGTTCSEEEEESCEEC-SCCBCCSCC--CCSEEEEESCBCS-SCC
T ss_pred hccccccchhhhhhhcchhhhh------hchhhhcCcCcccEEEecCccch-hhhhhhccC--CccEEeeccCccc-ccC
Confidence 4443333 33333333 2211 12335667788888888888887 577777666 5888888888887 565
Q ss_pred CccccccccceEEecCccccCCcchhccCCCCCceEEccCCcccccc--cccccCCCCcceeeccccccccccCCCCcCC
Q 045798 368 LGIGNLVDLYLLGMVENQFTGAIPKEMGKLQKLQGLDFSGNHFSGEI--PSSLGNLSSLYEVFFNNNNLSGVIPFSLGNL 445 (1008)
Q Consensus 368 ~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~--p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l 445 (1008)
. ..+++|+.|++++|.+.+..+. ..+++|+.|+|++|++++.. |..+.++++|++|++++|.+.+..+. +..+
T Consensus 321 ~--~~l~~L~~L~l~~n~~~~~~~~--~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~-~~~l 395 (570)
T 2z63_A 321 T--LKLKSLKRLTFTSNKGGNAFSE--VDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSN-FLGL 395 (570)
T ss_dssp B--CBCSSCCEEEEESCBSCCBCCC--CBCTTCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEEEEEEE-EETC
T ss_pred c--ccccccCEEeCcCCcccccccc--ccCCCCCEEeCcCCccCccccccccccccCccCEEECCCCcccccccc-cccc
Confidence 5 4677888888888888766554 67788888888888887543 66777888888888888888865554 8888
Q ss_pred CcccEeecccccccCCcchhhhhhhhhhhhhcccCccccCCCccccccccccccccccccccc-CCCCccccccccccee
Q 045798 446 KRLAFLEMSGNELSGTIPEDIFNISYLSNSLNLARNHLVGIIPPRIGNLRALRSFDVSNNDLS-GEIPIELGHCSSLEEI 524 (1008)
Q Consensus 446 ~~L~~L~Ls~N~l~~~lp~~~~~~~~~~~~L~L~~N~l~~~~p~~~~~l~~L~~Ldls~N~l~-~~~p~~~~~l~~L~~L 524 (1008)
++|+.|++++|++++..|...+.....+++|++++|.+.+..|..+..+++|+.|+|++|.++ +.+|..+..+++|++|
T Consensus 396 ~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L 475 (570)
T 2z63_A 396 EQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFL 475 (570)
T ss_dssp TTCCEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEE
T ss_pred CCCCEEEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEE
Confidence 888888888888886666555555566678888888888888999999999999999999998 6799999999999999
Q ss_pred eccCcccccchhhhhhccccccEEecCCCcccccccCc-ccccccceeecccCcccccCCCC
Q 045798 525 YLAGNLFHGSIPSFFNALKGVQKIDLSRNNLSGQIPIF-LEALSLEYLNLSFNDFEGKIPAK 585 (1008)
Q Consensus 525 ~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~-~~~~~L~~L~l~~N~l~g~~p~~ 585 (1008)
+|++|++++..|..|..+++|+.|+|++|++++.+|.. ..+.+|+.|++++|+++|.+|..
T Consensus 476 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~~ 537 (570)
T 2z63_A 476 DLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRI 537 (570)
T ss_dssp ECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTTT
T ss_pred ECCCCccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCCcccCCCcch
Confidence 99999999888999999999999999999999988765 67889999999999999999865
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-51 Score=441.94 Aligned_cols=269 Identities=27% Similarity=0.412 Sum_probs=211.0
Q ss_pred cCCCCCceEeeccCeeEEEEEEc-----CCCeEEEEEEeccccchhhHHHHHHHHHHhhcCCCCceeeeeccccccccCC
Q 045798 684 NGFSSTHLIGVGSFGCVYKGALD-----EDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGN 758 (1008)
Q Consensus 684 ~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 758 (1008)
++|.+.+.||+|+||+||+|++. .+++.||||+++.......++|.+|+++|++++|||||+++|+| .++
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~-----~~~ 87 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVC-----VEG 87 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-----CSS
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEE-----eeC
Confidence 46788899999999999999874 35789999999877667778899999999999999999999996 445
Q ss_pred ceEEEEEeccCCCChhcccccCCCCC---CCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCC
Q 045798 759 DFKAIVYEYMPNGSLEKWLHPHAVPK---RDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDND 835 (1008)
Q Consensus 759 ~~~~lv~e~~~~gsL~~~l~~~~~~~---~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~ 835 (1008)
+..++|||||++|+|.++++..+... ........+++.+++.|+.|||.||+|||++ +||||||||+|||++++
T Consensus 88 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~ 164 (299)
T 4asz_A 88 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGEN 164 (299)
T ss_dssp SSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGG
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCC
Confidence 67999999999999999997653100 0001122799999999999999999999997 99999999999999999
Q ss_pred CCeEEcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCccccCCccHH
Q 045798 836 LSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT-AKKPTDVMFEGDLNLH 914 (1008)
Q Consensus 836 ~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-G~~pf~~~~~~~~~~~ 914 (1008)
+.+||+|||+|+......... ......||+.|||||++.+..|+.++|||||||++|||+| |+.||...... ...
T Consensus 165 ~~~Ki~DFGla~~~~~~~~~~--~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~--~~~ 240 (299)
T 4asz_A 165 LLVKIGDFGMSRDVYSTDYYR--VGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN--EVI 240 (299)
T ss_dssp GCEEECCCSCHHHHTGGGCEE--ETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH--HHH
T ss_pred CcEEECCcccceecCCCCcee--ecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH--HHH
Confidence 999999999998654432221 1233458999999999999999999999999999999999 89998643111 000
Q ss_pred HHHHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHHHHHHHH
Q 045798 915 NFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHELQSVKNI 994 (1008)
Q Consensus 915 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~i~~~ 994 (1008)
.... . ..+.+ ....++.++.+++.+||+.||++||||+||++.|+++.+.
T Consensus 241 ~~i~-----------~---------------~~~~~----~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~ 290 (299)
T 4asz_A 241 ECIT-----------Q---------------GRVLQ----RPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA 290 (299)
T ss_dssp HHHH-----------H---------------TCCCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHH-----------c---------------CCCCC----CCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 0000 0 00000 0113556789999999999999999999999999887654
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-51 Score=437.27 Aligned_cols=262 Identities=30% Similarity=0.442 Sum_probs=202.2
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEecccc--chhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCce
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC--EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDF 760 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 760 (1008)
.++|++.++||+|+||+||+|++. ..||||+++... ....+.|.+|++++++++|||||+++|+|. ++.
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~------~~~ 105 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMT------KDN 105 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC------SSS
T ss_pred HHHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE------CCe
Confidence 457888999999999999999874 259999997432 344578999999999999999999999863 234
Q ss_pred EEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEE
Q 045798 761 KAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHI 840 (1008)
Q Consensus 761 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 840 (1008)
.++|||||++|+|.++++.... ++++.++..|+.|||.||+|||++ +||||||||+|||+++++.+||
T Consensus 106 ~~iVmEy~~gGsL~~~l~~~~~---------~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki 173 (307)
T 3omv_A 106 LAIVTQWCEGSSLYKHLHVQET---------KFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKI 173 (307)
T ss_dssp CEEEEECCSSCBHHHHHHTSCC---------CCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEE
T ss_pred EEEEEEcCCCCCHHHHHhhcCC---------CCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEE
Confidence 7999999999999999975432 689999999999999999999997 9999999999999999999999
Q ss_pred cccCcccccccccCccccccccccccccccCccccCC---CCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHH
Q 045798 841 GDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLG---SEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFA 917 (1008)
Q Consensus 841 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~ 917 (1008)
+|||+|+......... ......||+.|||||++.+ +.|+.++|||||||++|||+||+.||........ .....
T Consensus 174 ~DFGla~~~~~~~~~~--~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~-~~~~~ 250 (307)
T 3omv_A 174 GDFGLATVKSRWSGSQ--QVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQ-IIFMV 250 (307)
T ss_dssp CCCSSCBC--------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH-HHHHH
T ss_pred eeccCceecccCCcce--eecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHH-HHHHH
Confidence 9999998664432221 2234569999999999854 4689999999999999999999999964321110 11111
Q ss_pred HhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHHHHHHHH
Q 045798 918 RMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHELQSVKNI 994 (1008)
Q Consensus 918 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~i~~~ 994 (1008)
.... ..+.+. .....++.++.+++.+||+.||++||||.||++.|+.++..
T Consensus 251 ~~~~-------~~p~~~-------------------~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~ 301 (307)
T 3omv_A 251 GRGY-------ASPDLS-------------------KLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHS 301 (307)
T ss_dssp HTTC-------CCCCST-------------------TSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTT
T ss_pred hcCC-------CCCCcc-------------------cccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcc
Confidence 0000 000000 01123566789999999999999999999999999887654
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-50 Score=443.38 Aligned_cols=269 Identities=26% Similarity=0.404 Sum_probs=206.2
Q ss_pred cCCCCCceEeeccCeeEEEEEEc-----CCCeEEEEEEeccccchhhHHHHHHHHHHhhcCCCCceeeeeccccccccCC
Q 045798 684 NGFSSTHLIGVGSFGCVYKGALD-----EDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGN 758 (1008)
Q Consensus 684 ~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 758 (1008)
++|.+.++||+|+||+||+|++. .+++.||||+++.......++|.+|+++|++++|||||+++|+|. ++
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~-----~~ 115 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCT-----EG 115 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-----SS
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----EC
Confidence 45677899999999999999874 357899999998776677788999999999999999999999964 45
Q ss_pred ceEEEEEeccCCCChhcccccCCCCCC-----CcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeec
Q 045798 759 DFKAIVYEYMPNGSLEKWLHPHAVPKR-----DKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLD 833 (1008)
Q Consensus 759 ~~~~lv~e~~~~gsL~~~l~~~~~~~~-----~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~ 833 (1008)
+..++|||||++|+|.++++....... ......++++.+++.|+.|||.||+|||+. +||||||||+|||++
T Consensus 116 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~ 192 (329)
T 4aoj_A 116 RPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVG 192 (329)
T ss_dssp SSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEE
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEEC
Confidence 669999999999999999987543211 011123699999999999999999999997 999999999999999
Q ss_pred CCCCeEEcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCccccCCcc
Q 045798 834 NDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT-AKKPTDVMFEGDLN 912 (1008)
Q Consensus 834 ~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-G~~pf~~~~~~~~~ 912 (1008)
+++.+||+|||+|+......... ......||+.|||||++.+..|+.++|||||||++|||+| |+.||......+
T Consensus 193 ~~~~~Ki~DFGla~~~~~~~~~~--~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~-- 268 (329)
T 4aoj_A 193 QGLVVKIGDFGMSRDIYSTDYYR--VGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTE-- 268 (329)
T ss_dssp TTTEEEECCCC------------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHH--
T ss_pred CCCcEEEcccccceeccCCCcce--ecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHH--
Confidence 99999999999998664432221 1234569999999999999999999999999999999999 899986431110
Q ss_pred HHHHHHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHHHHHH
Q 045798 913 LHNFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHELQSVK 992 (1008)
Q Consensus 913 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~i~ 992 (1008)
....... ..+.+ ....++.++.+++.+||+.||++||||+||++.|+.+.
T Consensus 269 ~~~~i~~--------------------------g~~~~----~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~ 318 (329)
T 4aoj_A 269 AIDCITQ--------------------------GRELE----RPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALA 318 (329)
T ss_dssp HHHHHHH--------------------------TCCCC----CCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHH
T ss_pred HHHHHHc--------------------------CCCCC----CcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHh
Confidence 0000000 00000 01135567899999999999999999999999999886
Q ss_pred HH
Q 045798 993 NI 994 (1008)
Q Consensus 993 ~~ 994 (1008)
+.
T Consensus 319 ~~ 320 (329)
T 4aoj_A 319 QA 320 (329)
T ss_dssp HS
T ss_pred hC
Confidence 54
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-49 Score=478.52 Aligned_cols=492 Identities=21% Similarity=0.193 Sum_probs=405.4
Q ss_pred CeEEEEeccccCCCCccCcCccCCccCCeeeecCCCCCCCCCccccCCCCCCEEEccCCCCCCccCcccccCcCcceEee
Q 045798 54 RRVTALDLMSKSLSGSLSPHLGNLSFLREINLSNNTIQGEIPPEFGRLFRLEALFLSNNSLVGKIPANLSYCSRLTVLCI 133 (1008)
Q Consensus 54 ~~v~~l~l~~~~l~~~l~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L 133 (1008)
..++.|||++|.+++..+..+..+++|++|+|++|++++..|..|.++++|++|+|++|.+++..|..|+++++|++|++
T Consensus 28 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 107 (570)
T 2z63_A 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA 107 (570)
T ss_dssp SSCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEEC
T ss_pred ccccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhhcCccccccccc
Confidence 46899999999999877889999999999999999999888889999999999999999999888899999999999999
Q ss_pred eccccccCCCccccccCCCCeeecccccCCC-CCCCCCccccccchhhcccccCCCCCCccccCCCCC----cEEEecCC
Q 045798 134 EYNKLQGRIPLEFVSLSKLKDLSLAKNKLTG-GIPPFLGNLTSLEVLSLAGNSFGRNIPDSLGQLKQL----KILAIGGN 208 (1008)
Q Consensus 134 s~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L----~~L~L~~n 208 (1008)
++|++++..+..|+++++|++|++++|.+++ .+|..|+++++|++|++++|++++..+..|+.+++| +.|++++|
T Consensus 108 ~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~~~~~L~l~~n 187 (570)
T 2z63_A 108 VETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLN 187 (570)
T ss_dssp TTSCCCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEECGGGGHHHHTCTTCCCEEECTTC
T ss_pred cccccccCCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCccceecHHHccchhccchhhhhcccCCC
Confidence 9999997777789999999999999999996 469999999999999999999998888899999988 89999999
Q ss_pred cccccCCccccCCCCcceeccccccccccCChhhhhcCCCCcEEEeccccCCC------CCCcccccCC--CCceeeccc
Q 045798 209 NLSGPIPPSIYNLSFLVVFSVSHNQIHGSLPPSLGLLLPNLKFFQIHHNFFSG------SIPISLSNAS--KLEHIEIAN 280 (1008)
Q Consensus 209 ~l~~~~~~~~~~l~~L~~L~ls~N~l~~~lp~~~~~~l~~L~~L~L~~N~l~~------~~p~~l~~l~--~L~~L~L~~ 280 (1008)
.+++..+..+..+ +|+.|++++|.............+++++.+.+..+.+.. .....+..+. .++.+++++
T Consensus 188 ~l~~~~~~~~~~~-~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~~ 266 (570)
T 2z63_A 188 PMNFIQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAY 266 (570)
T ss_dssp CCCEECTTTTTTC-EEEEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEECCCCSSCEECCTTTTGGGGGSEEEEEEEEE
T ss_pred CceecCHHHhccC-cceeEecccccccccchhhhhcCccccceeeeccccccCchhhhhcchhhhccccccchhhhhhhc
Confidence 9999888888877 899999999965433223344456777766665433221 1122223332 356677777
Q ss_pred c-cccccccccccCCCcccccccccccCCCCCCCcccccccccccCCCcEEEecCCcCCccCChhhhhhcccceeeeecc
Q 045798 281 N-NFSGKLSVNFGGMKNLSLLNLQFSNLGSGESDEMGFMNSLTNCSKLRVLSLGGNQFRGALPHSIANLSSQLQILILSS 359 (1008)
Q Consensus 281 N-~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~Ls~ 359 (1008)
| .+.+..+..|..+++|+.|++++|.+..+. ..+..+ +|+.|++++|.+. .+|.. .+. +|+.|++++
T Consensus 267 ~~~~~~~~~~~~~~l~~L~~L~l~~~~l~~l~-------~~~~~~-~L~~L~l~~n~~~-~l~~~--~l~-~L~~L~l~~ 334 (570)
T 2z63_A 267 LDYYLDDIIDLFNCLTNVSSFSLVSVTIERVK-------DFSYNF-GWQHLELVNCKFG-QFPTL--KLK-SLKRLTFTS 334 (570)
T ss_dssp TTEEESCSTTTTGGGTTCSEEEEESCEECSCC-------BCCSCC-CCSEEEEESCBCS-SCCBC--BCS-SCCEEEEES
T ss_pred chhhhhhchhhhcCcCcccEEEecCccchhhh-------hhhccC-CccEEeeccCccc-ccCcc--ccc-ccCEEeCcC
Confidence 7 677777788888888888888888776543 235556 8888888888887 56652 333 588888888
Q ss_pred ccccCCCCCccccccccceEEecCccccCCc--chhccCCCCCceEEccCCcccccccccccCCCCcceeeccccccccc
Q 045798 360 NQFYGSIPLGIGNLVDLYLLGMVENQFTGAI--PKEMGKLQKLQGLDFSGNHFSGEIPSSLGNLSSLYEVFFNNNNLSGV 437 (1008)
Q Consensus 360 N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~--~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ 437 (1008)
|.+.+..+. ..+++|+.|++++|++++.. +..+..+++|++|+|++|.+.+..+ .+..+++|++|++++|.+.+.
T Consensus 335 n~~~~~~~~--~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~-~~~~l~~L~~L~l~~n~l~~~ 411 (570)
T 2z63_A 335 NKGGNAFSE--VDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSS-NFLGLEQLEHLDFQHSNLKQM 411 (570)
T ss_dssp CBSCCBCCC--CBCTTCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEEEEEE-EEETCTTCCEEECTTSEEESC
T ss_pred Ccccccccc--ccCCCCCEEeCcCCccCccccccccccccCccCEEECCCCccccccc-cccccCCCCEEEccCCccccc
Confidence 888766654 67888888888888887654 6778888888888888888885444 488888888888888888876
Q ss_pred cC-CCCcCCCcccEeecccccccCCcchhhhhhhhhhhhhcccCcccc-CCCcccccccccccccccccccccCCCCccc
Q 045798 438 IP-FSLGNLKRLAFLEMSGNELSGTIPEDIFNISYLSNSLNLARNHLV-GIIPPRIGNLRALRSFDVSNNDLSGEIPIEL 515 (1008)
Q Consensus 438 ~p-~~~~~l~~L~~L~Ls~N~l~~~lp~~~~~~~~~~~~L~L~~N~l~-~~~p~~~~~l~~L~~Ldls~N~l~~~~p~~~ 515 (1008)
.| ..+.++++|++|++++|++++..|..+.. ...++.|+|++|.++ +.+|..++.+++|+.|+|++|.+++..|..+
T Consensus 412 ~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~-l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~ 490 (570)
T 2z63_A 412 SEFSVFLSLRNLIYLDISHTHTRVAFNGIFNG-LSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAF 490 (570)
T ss_dssp TTSCTTTTCTTCCEEECTTSCCEECCTTTTTT-CTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTT
T ss_pred cchhhhhcCCCCCEEeCcCCcccccchhhhhc-CCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhh
Confidence 65 56888888888888888888655554443 345578888888887 5789999999999999999999998889999
Q ss_pred ccccccceeeccCcccccchhhhhhccccccEEecCCCcccccccCc
Q 045798 516 GHCSSLEEIYLAGNLFHGSIPSFFNALKGVQKIDLSRNNLSGQIPIF 562 (1008)
Q Consensus 516 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~ 562 (1008)
..+++|++|+|++|++++.+|..|..+++|+.|++++|++++..|..
T Consensus 491 ~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~~ 537 (570)
T 2z63_A 491 NSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRI 537 (570)
T ss_dssp TTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTTT
T ss_pred hcccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCCcccCCCcch
Confidence 99999999999999999988899999999999999999999988754
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-50 Score=439.93 Aligned_cols=250 Identities=23% Similarity=0.319 Sum_probs=208.1
Q ss_pred cCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccchhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceEEE
Q 045798 684 NGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKAI 763 (1008)
Q Consensus 684 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 763 (1008)
+.|++.++||+|+||+||+|+++.+|+.||||+++.......+.+.+|+++|++++|||||+++++ +.+++..|+
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~-----~~~~~~~~i 148 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNS-----YLVGDELWV 148 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEE-----EEETTEEEE
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEE-----EEECCEEEE
Confidence 468999999999999999999999999999999986666666789999999999999999999999 456778999
Q ss_pred EEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEccc
Q 045798 764 VYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDF 843 (1008)
Q Consensus 764 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 843 (1008)
|||||++|+|.+++... ++++.+++.|+.||+.||+|||++ +||||||||+|||++.++.+||+||
T Consensus 149 vmEy~~gg~L~~~l~~~-----------~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DF 214 (346)
T 4fih_A 149 VMEFLEGGALTDIVTHT-----------RMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDF 214 (346)
T ss_dssp EECCCTTEEHHHHHHHS-----------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCC
T ss_pred EEeCCCCCcHHHHHHcC-----------CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecC
Confidence 99999999999999753 689999999999999999999998 9999999999999999999999999
Q ss_pred CcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCc
Q 045798 844 GLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMALPN 923 (1008)
Q Consensus 844 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~~~~~ 923 (1008)
|+|+........ ....+||+.|||||++.+..|+.++||||+||++|||++|+.||..... ...........+.
T Consensus 215 Gla~~~~~~~~~----~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~--~~~~~~i~~~~~~ 288 (346)
T 4fih_A 215 GFCAQVSKEVPR----RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP--LKAMKMIRDNLPP 288 (346)
T ss_dssp TTCEECCSSSCC----BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--HHHHHHHHHSSCC
T ss_pred cCceecCCCCCc----ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH--HHHHHHHHcCCCC
Confidence 999876543222 2346799999999999999999999999999999999999999864211 0010111111000
Q ss_pred chhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 924 QVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 924 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
........+.++.+++.+||+.||++|||++|+++
T Consensus 289 ----------------------------~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 289 ----------------------------RLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp ----------------------------CCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ----------------------------CCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 01111234556899999999999999999999875
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-50 Score=442.59 Aligned_cols=252 Identities=25% Similarity=0.336 Sum_probs=201.5
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEecccc--chhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCce
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC--EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDF 760 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 760 (1008)
.++|++++.||+|+||+||+|++..+|+.||||+++... ....+.+.+|++++++++|||||+++++ +.+++.
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~-----~~~~~~ 97 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRES-----FEENGS 97 (350)
T ss_dssp CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEE-----EEETTE
T ss_pred ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEE-----EEECCE
Confidence 368999999999999999999999999999999997542 3445789999999999999999999999 456778
Q ss_pred EEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEE
Q 045798 761 KAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHI 840 (1008)
Q Consensus 761 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 840 (1008)
.|+|||||+||+|.+++...+.. .+++.+++.|+.||+.||+|||++ +||||||||+|||+++++.+||
T Consensus 98 ~yiVmEy~~gg~L~~~i~~~~~~--------~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl 166 (350)
T 4b9d_A 98 LYIVMDYCEGGDLFKRINAQKGV--------LFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQL 166 (350)
T ss_dssp EEEEEECCTTCBHHHHHHHTTTC--------CCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEE
T ss_pred EEEEEeCCCCCcHHHHHHHcCCC--------CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEE
Confidence 99999999999999999754322 678999999999999999999998 9999999999999999999999
Q ss_pred cccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHhh
Q 045798 841 GDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMA 920 (1008)
Q Consensus 841 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~~ 920 (1008)
+|||+|+....... .....+||+.|||||++.+..|+.++|||||||++|||++|+.||......+ .+.......
T Consensus 167 ~DFGla~~~~~~~~----~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~-~~~~i~~~~ 241 (350)
T 4b9d_A 167 GDFGIARVLNSTVE----LARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKN-LVLKIISGS 241 (350)
T ss_dssp CSTTEESCCCHHHH----HHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHTC
T ss_pred cccccceeecCCcc----cccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH-HHHHHHcCC
Confidence 99999987654321 1223569999999999999999999999999999999999999996421110 001111100
Q ss_pred CCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 921 LPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 921 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
.+. .....+.++.+++.+||+.||++|||++|+++
T Consensus 242 ~~~-------------------------------~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 242 FPP-------------------------------VSLHYSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp CCC-------------------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCC-------------------------------CCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000 00123456899999999999999999999976
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-50 Score=439.31 Aligned_cols=266 Identities=22% Similarity=0.273 Sum_probs=210.6
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccchhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceEE
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKA 762 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 762 (1008)
.+.|++.++||+|+||+||+|+++.+|+.||||+++... ...+|++++++++|||||++++++ .+++..|
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~-----~~~~E~~il~~l~HpnIV~l~~~~-----~~~~~~~ 126 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEV-----FRVEELVACAGLSSPRIVPLYGAV-----REGPWVN 126 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT-----CCTHHHHTTTTCCCTTBCCEEEEE-----EETTEEE
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHH-----hHHHHHHHHHhCCCCCCCcEEEEE-----EECCEEE
Confidence 356888899999999999999999999999999997542 235799999999999999999994 5667799
Q ss_pred EEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCC-CeEEc
Q 045798 763 IVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDL-SGHIG 841 (1008)
Q Consensus 763 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kL~ 841 (1008)
+|||||+||+|.++++..+ .+++.+++.|+.||+.||+|||++ +||||||||+|||++.++ .+||+
T Consensus 127 ivmEy~~gg~L~~~l~~~~----------~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~ 193 (336)
T 4g3f_A 127 IFMELLEGGSLGQLIKQMG----------CLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALC 193 (336)
T ss_dssp EEECCCTTCBHHHHHHHHS----------SCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEEC
T ss_pred EEEeccCCCcHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEe
Confidence 9999999999999997654 799999999999999999999998 999999999999999987 69999
Q ss_pred ccCcccccccccCcc-ccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHhh
Q 045798 842 DFGLARFHQEVSNST-LSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMA 920 (1008)
Q Consensus 842 Dfg~a~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~~ 920 (1008)
|||+|+......... .......+||+.|||||++.+..|+.++|||||||++|||++|+.||........ ........
T Consensus 194 DFGla~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~-~~~i~~~~ 272 (336)
T 4g3f_A 194 DFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPL-CLKIASEP 272 (336)
T ss_dssp CCTTCEEC------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCC-HHHHHHSC
T ss_pred eCCCCeEccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH-HHHHHcCC
Confidence 999998765433221 1122345799999999999999999999999999999999999999975432221 11111100
Q ss_pred CCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHHHHHHHHHHHHHH
Q 045798 921 LPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHELQSVKNILLELET 1000 (1008)
Q Consensus 921 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~i~~~~~~~~~ 1000 (1008)
... ..+ ...++..+.+++.+||+.||++|||+.|+++.|.........++.
T Consensus 273 --~~~---------------------~~~------~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~h 323 (336)
T 4g3f_A 273 --PPI---------------------REI------PPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKS 323 (336)
T ss_dssp --CGG---------------------GGS------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCS
T ss_pred --CCc---------------------hhc------CccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccC
Confidence 000 000 112456688999999999999999999999998887766554443
Q ss_pred h
Q 045798 1001 V 1001 (1008)
Q Consensus 1001 ~ 1001 (1008)
+
T Consensus 324 P 324 (336)
T 4g3f_A 324 P 324 (336)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-50 Score=436.27 Aligned_cols=266 Identities=22% Similarity=0.342 Sum_probs=208.3
Q ss_pred CCCCCceEeeccCeeEEEEEEc-----CCCeEEEEEEeccccc-hhhHHHHHHHHHHhhcCCCCceeeeeccccccccCC
Q 045798 685 GFSSTHLIGVGSFGCVYKGALD-----EDGIVVAIKVINLQCE-GASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGN 758 (1008)
Q Consensus 685 ~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 758 (1008)
++++.+.||+|+||+||+|++. .+++.||||+++.... ...+.|.+|+.++++++|||||+++|+|. .+
T Consensus 27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~-----~~ 101 (308)
T 4gt4_A 27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVT-----KD 101 (308)
T ss_dssp GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEEC-----SS
T ss_pred HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEE-----EC
Confidence 4667899999999999999973 3578999999975433 34578999999999999999999999964 45
Q ss_pred ceEEEEEeccCCCChhcccccCCCCCC------CcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeee
Q 045798 759 DFKAIVYEYMPNGSLEKWLHPHAVPKR------DKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILL 832 (1008)
Q Consensus 759 ~~~~lv~e~~~~gsL~~~l~~~~~~~~------~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll 832 (1008)
+..++|||||++|+|.+++........ .......+++.+++.|+.|||.||+|||+. +||||||||+|||+
T Consensus 102 ~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl 178 (308)
T 4gt4_A 102 QPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLV 178 (308)
T ss_dssp SSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEE
T ss_pred CEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEE
Confidence 568999999999999999975432111 111233699999999999999999999998 99999999999999
Q ss_pred cCCCCeEEcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCccccCCc
Q 045798 833 DNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT-AKKPTDVMFEGDL 911 (1008)
Q Consensus 833 ~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-G~~pf~~~~~~~~ 911 (1008)
++++.+||+|||+|+......... ......||+.|||||++.++.|+.++|||||||++|||+| |+.||......
T Consensus 179 ~~~~~~Ki~DFGlar~~~~~~~~~--~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~-- 254 (308)
T 4gt4_A 179 YDKLNVKISDLGLFREVYAADYYK--LLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ-- 254 (308)
T ss_dssp CGGGCEEECCSCCBCGGGGGGCBC--SSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHH--
T ss_pred CCCCCEEECCcccceeccCCCcee--EecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHH--
Confidence 999999999999998664432221 2234569999999999999999999999999999999998 89998643211
Q ss_pred cHHHHHHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHHHHH
Q 045798 912 NLHNFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHELQSV 991 (1008)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~i 991 (1008)
.... .+.. ..+.+ ....++.++.++|.+||+.||++||||+||++.|+++
T Consensus 255 ---~~~~---------~i~~--------------~~~~~----~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 255 ---DVVE---------MIRN--------------RQVLP----CPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp ---HHHH---------HHHT--------------TCCCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred ---HHHH---------HHHc--------------CCCCC----CcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 1110 0000 00000 1123566789999999999999999999999999875
Q ss_pred H
Q 045798 992 K 992 (1008)
Q Consensus 992 ~ 992 (1008)
.
T Consensus 305 ~ 305 (308)
T 4gt4_A 305 G 305 (308)
T ss_dssp C
T ss_pred c
Confidence 4
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-49 Score=429.49 Aligned_cols=282 Identities=24% Similarity=0.296 Sum_probs=205.7
Q ss_pred cCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccchhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceEEE
Q 045798 684 NGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKAI 763 (1008)
Q Consensus 684 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 763 (1008)
++|.+.++||+|+||+||+|++ +|+.||||+++... .....+..|+..+.+++|||||+++++|...+ ......|+
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~-~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~-~~~~~~~l 78 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE-ERSWFREAEIYQTVMLRHENILGFIAADNKDN-GTWTQLWL 78 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SSSEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc-hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecC-CCceEEEE
Confidence 4577889999999999999998 68999999997542 22233445666677889999999999986421 12236899
Q ss_pred EEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhC-----CCCCceeccCCCCCeeecCCCCe
Q 045798 764 VYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHH-----CQEPILHCDLKPSNILLDNDLSG 838 (1008)
Q Consensus 764 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~-----~~~~ivH~Dlkp~NIll~~~~~~ 838 (1008)
|||||++|+|.++++.. ++++..+.+++.|++.||+|||++ ..++||||||||+|||++.++.+
T Consensus 79 V~Ey~~~gsL~~~l~~~-----------~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~ 147 (303)
T 3hmm_A 79 VSDYHEHGSLFDYLNRY-----------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTC 147 (303)
T ss_dssp EEECCTTCBHHHHHHHC-----------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCE
T ss_pred EecCCCCCcHHHHHHhC-----------CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCE
Confidence 99999999999999754 689999999999999999999975 23589999999999999999999
Q ss_pred EEcccCcccccccccCccccccccccccccccCccccCCC------CCCcccchhhHHHHHHHHHhCCCCCCccccCCcc
Q 045798 839 HIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGS------EVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLN 912 (1008)
Q Consensus 839 kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~ 912 (1008)
||+|||+|+................+||+.|||||++.+. .++.++|||||||++|||+||++||.........
T Consensus 148 Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p 227 (303)
T 3hmm_A 148 CIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP 227 (303)
T ss_dssp EECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCT
T ss_pred EEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCcccccccc
Confidence 9999999987655443333333446799999999998764 4678999999999999999999887543222111
Q ss_pred HHHHHHhhCCcchhhhhcccccCchHHhhhhhhhhhccccch---hHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHHH
Q 045798 913 LHNFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGIN---SRLECLISMVKIGVACSMESPQDRMNMTNVVHELQ 989 (1008)
Q Consensus 913 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 989 (1008)
+..... .......+...... ...++..+ ...+++..+.+++.+||+.||++||||.||++.|+
T Consensus 228 ~~~~~~--~~~~~~~~~~~~~~------------~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 293 (303)
T 3hmm_A 228 YYDLVP--SDPSVEEMRKVVCE------------QKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 293 (303)
T ss_dssp TTTTSC--SSCCHHHHHHHHTT------------SCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHH
T ss_pred chhccc--ccchHHHHHHHHhc------------ccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHH
Confidence 110000 00000000000000 01111111 12356778999999999999999999999999999
Q ss_pred HHHHH
Q 045798 990 SVKNI 994 (1008)
Q Consensus 990 ~i~~~ 994 (1008)
++.+.
T Consensus 294 ~l~~~ 298 (303)
T 3hmm_A 294 QLSQQ 298 (303)
T ss_dssp HHHHC
T ss_pred HHHHH
Confidence 88654
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-49 Score=423.09 Aligned_cols=251 Identities=26% Similarity=0.387 Sum_probs=197.5
Q ss_pred CCCceEeeccCeeEEEEEEcCCCeEEEEEEeccc--cchhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceEEEE
Q 045798 687 SSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQ--CEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKAIV 764 (1008)
Q Consensus 687 ~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 764 (1008)
++.+.||+|+||+||+|.+..+++.||+|++... .....+.|.+|++++++++|||||++++++... ...+...|+|
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~-~~~~~~~~lv 107 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWEST-VKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEE-ETTEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeec-cCCCcEEEEE
Confidence 5667899999999999999999999999999643 234457899999999999999999999986432 1234568999
Q ss_pred EeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecC-CCCeEEccc
Q 045798 765 YEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDN-DLSGHIGDF 843 (1008)
Q Consensus 765 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kL~Df 843 (1008)
||||++|+|.+++.... .+++..++.|+.||+.||+|||++ .++||||||||+|||++. ++.+||+||
T Consensus 108 mEy~~gg~L~~~l~~~~----------~l~~~~~~~~~~qi~~aL~ylH~~-~~~IiHRDlKp~NILl~~~~g~vKl~DF 176 (290)
T 3fpq_A 108 TELMTSGTLKTYLKRFK----------VMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDL 176 (290)
T ss_dssp EECCCSCBHHHHHHHHS----------SCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCCCCCGGGEEESSTTSCEEECCT
T ss_pred EeCCCCCCHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHHC-CCCEEecccChhheeEECCCCCEEEEeC
Confidence 99999999999997654 789999999999999999999997 123999999999999974 799999999
Q ss_pred CcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCc
Q 045798 844 GLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMALPN 923 (1008)
Q Consensus 844 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~~~~~ 923 (1008)
|+|+...... ....+||+.|||||++.+ .|+.++|||||||++|||+||+.||..... ...........
T Consensus 177 Gla~~~~~~~------~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~----~~~~~~~i~~~ 245 (290)
T 3fpq_A 177 GLATLKRASF------AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN----AAQIYRRVTSG 245 (290)
T ss_dssp TGGGGCCTTS------BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS----HHHHHHHHTTT
T ss_pred cCCEeCCCCc------cCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCc----HHHHHHHHHcC
Confidence 9998543221 223579999999999865 699999999999999999999999863211 11111100000
Q ss_pred chhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 924 QVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 924 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
. . + .......++++.+++.+||+.||++|||++|+++
T Consensus 246 ~---------~--~---------------~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 246 V---------K--P---------------ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp C---------C--C---------------GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred C---------C--C---------------CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 0 0 0000112345789999999999999999999875
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-50 Score=430.95 Aligned_cols=249 Identities=23% Similarity=0.326 Sum_probs=206.2
Q ss_pred cCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccc---cchhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCce
Q 045798 684 NGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQ---CEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDF 760 (1008)
Q Consensus 684 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 760 (1008)
++|++.+.||+|+||+||+|++..+++.||||+++.. .....+.+.+|++++++++|||||+++++ +++++.
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~-----~~~~~~ 106 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFT-----FQDDEK 106 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEE-----EECSSE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEE-----EEeCCE
Confidence 5799999999999999999999999999999999743 23445789999999999999999999999 567788
Q ss_pred EEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEE
Q 045798 761 KAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHI 840 (1008)
Q Consensus 761 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 840 (1008)
.|+|||||+||+|.+++...+ .+++.+++.++.||+.||+|||++ +||||||||+|||++.++.+||
T Consensus 107 ~yivmEy~~gG~L~~~i~~~~----------~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl 173 (311)
T 4aw0_A 107 LYFGLSYAKNGELLKYIRKIG----------SFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQI 173 (311)
T ss_dssp EEEEECCCTTEEHHHHHHHHS----------SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEE
T ss_pred EEEEEecCCCCCHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEE
Confidence 999999999999999997654 799999999999999999999998 9999999999999999999999
Q ss_pred cccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHhh
Q 045798 841 GDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMA 920 (1008)
Q Consensus 841 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~~ 920 (1008)
+|||+|+......... .....+||+.|||||++.+..|+.++||||+||++|||++|+.||...... ........
T Consensus 174 ~DFGla~~~~~~~~~~--~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~-~~~~~i~~-- 248 (311)
T 4aw0_A 174 TDFGTAKVLSPESKQA--RANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEG-LIFAKIIK-- 248 (311)
T ss_dssp CCCTTCEECCTTTTCC--CBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHH--
T ss_pred EEcCCceecCCCCCcc--cccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHc--
Confidence 9999998765432221 233467999999999999999999999999999999999999999642110 00001100
Q ss_pred CCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHH
Q 045798 921 LPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVV 985 (1008)
Q Consensus 921 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl 985 (1008)
... .++. ..+.++.+++.+||+.||++|||++|++
T Consensus 249 --------------~~~----------~~p~------~~s~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 249 --------------LEY----------DFPE------KFFPKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp --------------TCC----------CCCT------TCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred --------------CCC----------CCCc------ccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence 000 0111 1234578999999999999999999874
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-49 Score=441.32 Aligned_cols=250 Identities=23% Similarity=0.309 Sum_probs=208.2
Q ss_pred cCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccchhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceEEE
Q 045798 684 NGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKAI 763 (1008)
Q Consensus 684 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 763 (1008)
+.|++.+.||+|+||.||+|+++.+|+.||||++........+.+.+|+++|++++|||||++++++ .+++..|+
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~-----~~~~~~~i 225 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY-----LVGDELWV 225 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEE-----EETTEEEE
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEE-----EECCEEEE
Confidence 5699999999999999999999999999999999876666677899999999999999999999994 56678999
Q ss_pred EEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEccc
Q 045798 764 VYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDF 843 (1008)
Q Consensus 764 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 843 (1008)
|||||+||+|.++++.. ++++.++..|+.||+.||+|||++ +||||||||+|||++.+|.+||+||
T Consensus 226 VmEy~~gG~L~~~i~~~-----------~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DF 291 (423)
T 4fie_A 226 VMEFLEGGALTDIVTHT-----------RMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDF 291 (423)
T ss_dssp EEECCTTEEHHHHHHHS-----------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCC
T ss_pred EEeCCCCCcHHHHHhcc-----------CCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecC
Confidence 99999999999998643 689999999999999999999998 9999999999999999999999999
Q ss_pred CcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCc
Q 045798 844 GLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMALPN 923 (1008)
Q Consensus 844 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~~~~~ 923 (1008)
|+|+........ ....+||+.|||||++.+..|+.++|||||||++|||++|+.||..... ......+....+.
T Consensus 292 Gla~~~~~~~~~----~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~--~~~~~~i~~~~~~ 365 (423)
T 4fie_A 292 GFCAQVSKEVPR----RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP--LKAMKMIRDNLPP 365 (423)
T ss_dssp TTCEECCSSCCC----BCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--HHHHHHHHHSCCC
T ss_pred ccceECCCCCcc----ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH--HHHHHHHHcCCCC
Confidence 999876543222 2346799999999999999999999999999999999999999863211 0011111111100
Q ss_pred chhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 924 QVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 924 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
. .......+.++.+++.+||+.||++|||++|+++
T Consensus 366 --------~--------------------~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 366 --------R--------------------LKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp --------C--------------------CSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred --------C--------------------CcccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0 0011123456789999999999999999999876
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-49 Score=468.17 Aligned_cols=454 Identities=20% Similarity=0.218 Sum_probs=249.2
Q ss_pred EEeccccCCCCccCcCccCCccCCeeeecCCCCCCCCCccccCCCCCCEEEccCCCCCCccCcccccCcCcceEeeeccc
Q 045798 58 ALDLMSKSLSGSLSPHLGNLSFLREINLSNNTIQGEIPPEFGRLFRLEALFLSNNSLVGKIPANLSYCSRLTVLCIEYNK 137 (1008)
Q Consensus 58 ~l~l~~~~l~~~l~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~ 137 (1008)
.+|+++++++ .+|..+. ++|++|+|++|++++..|..|.++++|++|+|++|++++..|..|+++++|++|+|++|+
T Consensus 4 ~l~ls~n~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~ 80 (520)
T 2z7x_B 4 LVDRSKNGLI-HVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNK 80 (520)
T ss_dssp EEECTTSCCS-SCCCSCC--TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSC
T ss_pred eEecCCCCcc-ccccccc--ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCCc
Confidence 5677777777 5666555 677777777777776666677777777777777777776667777777777777777777
Q ss_pred cccCCCccccccCCCCeeecccccCCC-CCCCCCccccccchhhcccccCCCCCCccccCCCCC--cEEEecCCcc--cc
Q 045798 138 LQGRIPLEFVSLSKLKDLSLAKNKLTG-GIPPFLGNLTSLEVLSLAGNSFGRNIPDSLGQLKQL--KILAIGGNNL--SG 212 (1008)
Q Consensus 138 l~~~~p~~~~~l~~L~~L~L~~n~l~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L--~~L~L~~n~l--~~ 212 (1008)
|+ .+|.. .+++|++|+|++|++++ .+|..|+++++|++|++++|++++ ..|..+++| +.|++++|.+ .+
T Consensus 81 l~-~lp~~--~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~---~~~~~l~~L~L~~L~l~~n~l~~~~ 154 (520)
T 2z7x_B 81 LV-KISCH--PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEK---SSVLPIAHLNISKVLLVLGETYGEK 154 (520)
T ss_dssp CC-EEECC--CCCCCSEEECCSSCCSSCCCCGGGGGCTTCCEEEEEESSCCG---GGGGGGTTSCEEEEEEEECTTTTSS
T ss_pred ee-ecCcc--ccCCccEEeccCCccccccchhhhccCCcceEEEecCcccch---hhccccccceeeEEEeecccccccc
Confidence 77 34444 56777777777777765 356667777777777777777654 345566666 7777777776 55
Q ss_pred cCCccccCCC-CcceeccccccccccCChhhhhcCCCCcEEEecccc-------CCCCCCcccccCCCCceeeccccccc
Q 045798 213 PIPPSIYNLS-FLVVFSVSHNQIHGSLPPSLGLLLPNLKFFQIHHNF-------FSGSIPISLSNASKLEHIEIANNNFS 284 (1008)
Q Consensus 213 ~~~~~~~~l~-~L~~L~ls~N~l~~~lp~~~~~~l~~L~~L~L~~N~-------l~~~~p~~l~~l~~L~~L~L~~N~l~ 284 (1008)
..|..+..+. ....+++++|.+.+.++...+..+++|+.|++++|. +.+.+| .+..+++|+.|++++|.+.
T Consensus 155 ~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~-~l~~l~~L~~L~l~~~~l~ 233 (520)
T 2z7x_B 155 EDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILA-KLQTNPKLSNLTLNNIETT 233 (520)
T ss_dssp CCTTTTTTCCEEEEEEECCSSSCCCCCCCCCCTTCSEEEECCEEECCSTTTTHHHHHHHH-GGGGCTTCCEEEEEEEEEE
T ss_pred cccccccccccceEEEEeccCcchhhhhhhhhhcccceeeccccccccccccceeecchh-hhccccchhhccccccccC
Confidence 5666665554 233445555555544444444444444444444443 222222 3333334444444333333
Q ss_pred ccccccccCCCcccccccccccCCCCCCCcccccccccccCCCcEEEecCCcCCccCChhhhhh--cccceeeeeccccc
Q 045798 285 GKLSVNFGGMKNLSLLNLQFSNLGSGESDEMGFMNSLTNCSKLRVLSLGGNQFRGALPHSIANL--SSQLQILILSSNQF 362 (1008)
Q Consensus 285 ~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l--~~~L~~L~Ls~N~l 362 (1008)
+ ..+..+... ..+|++|++++|++
T Consensus 234 ~------------------------------------------------------~~~~~~~~~~~~~~L~~L~l~~n~l 259 (520)
T 2z7x_B 234 W------------------------------------------------------NSFIRILQLVWHTTVWYFSISNVKL 259 (520)
T ss_dssp H------------------------------------------------------HHHHHHHHHHHTSSCSEEEEEEEEE
T ss_pred H------------------------------------------------------HHHHHHHHHhhhCcccEEEeecccc
Confidence 2 111111100 01344444444444
Q ss_pred cCCCCCcc-----ccccccceEEecCccccCCcc-hhccCC---CCCceEEccCCcccccccccccCCCCcceeeccccc
Q 045798 363 YGSIPLGI-----GNLVDLYLLGMVENQFTGAIP-KEMGKL---QKLQGLDFSGNHFSGEIPSSLGNLSSLYEVFFNNNN 433 (1008)
Q Consensus 363 ~~~~p~~~-----~~l~~L~~L~L~~n~l~~~~~-~~~~~l---~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~ 433 (1008)
++.+|..+ ..+++|+.+++++|.+ .+| ..+..+ .+|+.|++++|.+.... .+..+++|++|++++|.
T Consensus 260 ~~~~p~~~~~~~~~~l~~L~~l~l~~n~~--~~p~~~~~~~~~~~~L~~L~l~~n~l~~~~--~~~~l~~L~~L~Ls~n~ 335 (520)
T 2z7x_B 260 QGQLDFRDFDYSGTSLKALSIHQVVSDVF--GFPQSYIYEIFSNMNIKNFTVSGTRMVHML--CPSKISPFLHLDFSNNL 335 (520)
T ss_dssp ESCCCCCCCCCCSCCCCEEEEEEEEECCC--CSCTHHHHHHHHTCCCSEEEEESSCCCCCC--CCSSCCCCCEEECCSSC
T ss_pred cCccccchhhcccccCceeEeccccccce--ecchhhhhcccccCceeEEEcCCCcccccc--chhhCCcccEEEeECCc
Confidence 44444444 4444444444444444 222 333332 34455555554443211 11344444455555555
Q ss_pred cccccCCCCcCCCcccEeecccccccC--CcchhhhhhhhhhhhhcccCccccCCCcc-cccccccccccccccccccCC
Q 045798 434 LSGVIPFSLGNLKRLAFLEMSGNELSG--TIPEDIFNISYLSNSLNLARNHLVGIIPP-RIGNLRALRSFDVSNNDLSGE 510 (1008)
Q Consensus 434 l~~~~p~~~~~l~~L~~L~Ls~N~l~~--~lp~~~~~~~~~~~~L~L~~N~l~~~~p~-~~~~l~~L~~Ldls~N~l~~~ 510 (1008)
+++..|..++++++|++|+|++|++++ .+|..+.. ...++.|+|++|++++.+|. .+..+++|+.|++++|.+++.
T Consensus 336 l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~-l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~~~ 414 (520)
T 2z7x_B 336 LTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQ-MKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDT 414 (520)
T ss_dssp CCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTT-CTTCCEEECCSSCCBCCGGGCSCCCCTTCCEEECCSSCCCGG
T ss_pred cChhhhhhhccCCCCCEEEccCCccCccccchHHHhh-CCCCCEEECCCCcCCcccccchhccCccCCEEECcCCCCCcc
Confidence 544444444445555555555555442 12222222 22234455555555443443 255566666777777766666
Q ss_pred CCcccccccccceeeccCcccccchhhhhhccccccEEecCCCcccccccC-cccccccceeecccCcccccCC
Q 045798 511 IPIELGHCSSLEEIYLAGNLFHGSIPSFFNALKGVQKIDLSRNNLSGQIPI-FLEALSLEYLNLSFNDFEGKIP 583 (1008)
Q Consensus 511 ~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~-~~~~~~L~~L~l~~N~l~g~~p 583 (1008)
+|..+. ++|++|+|++|+|+ .+|..+..+++|+.|+|++|++++..+. ...+.+|++|++++|++++..+
T Consensus 415 ~~~~l~--~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~N~~~c~c~ 485 (520)
T 2z7x_B 415 IFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 485 (520)
T ss_dssp GGGSCC--TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred hhhhhc--ccCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCCccCHHHhccCCcccEEECcCCCCcccCC
Confidence 665553 56677777777776 5666666677777777777777643322 2445567777777777766544
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-49 Score=416.25 Aligned_cols=247 Identities=25% Similarity=0.354 Sum_probs=190.3
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEecccc---chhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCc
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC---EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGND 759 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 759 (1008)
.++|++.+.||+|+||+||+|++..+|+.||||+++... ....+.+.+|++++++++|||||+++++ +.+++
T Consensus 12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~-----~~~~~ 86 (275)
T 3hyh_A 12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDV-----IKSKD 86 (275)
T ss_dssp --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEE-----EECSS
T ss_pred eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEE-----EEECC
Confidence 368999999999999999999999999999999997432 2345679999999999999999999999 56677
Q ss_pred eEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeE
Q 045798 760 FKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGH 839 (1008)
Q Consensus 760 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 839 (1008)
..|+||||| +|+|.+++...+ ++++.+++.++.||+.||+|||++ +|+||||||+|||+++++.+|
T Consensus 87 ~~~ivmEy~-~g~L~~~l~~~~----------~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vk 152 (275)
T 3hyh_A 87 EIIMVIEYA-GNELFDYIVQRD----------KMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVK 152 (275)
T ss_dssp EEEEEEECC-CEEHHHHHHHSC----------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEE
T ss_pred EEEEEEeCC-CCCHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEE
Confidence 899999999 789999997654 799999999999999999999998 999999999999999999999
Q ss_pred EcccCcccccccccCccccccccccccccccCccccCCCCC-CcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHH
Q 045798 840 IGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEV-STNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFAR 918 (1008)
Q Consensus 840 L~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~ 918 (1008)
|+|||+|+....... ....+||+.|||||++.+..+ +.++||||+||++|||++|+.||..... .....
T Consensus 153 l~DFGla~~~~~~~~-----~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~-----~~~~~ 222 (275)
T 3hyh_A 153 IADFGLSNIMTDGNF-----LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESI-----PVLFK 222 (275)
T ss_dssp ECCSSCC--------------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHH
T ss_pred EeecCCCeecCCCCc-----cCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCH-----HHHHH
Confidence 999999986543321 223569999999999998876 5799999999999999999999964211 11100
Q ss_pred hhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 919 MALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 919 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
. +.... ..++ ...+.++.+++.+||+.||++|||++|+++
T Consensus 223 ~--------i~~~~--------------~~~p------~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 223 N--------ISNGV--------------YTLP------KFLSPGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp H--------HHHTC--------------CCCC------TTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred H--------HHcCC--------------CCCC------CCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 0 00000 0000 013456789999999999999999999976
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-48 Score=461.02 Aligned_cols=483 Identities=20% Similarity=0.219 Sum_probs=288.8
Q ss_pred CeeeecCCCCCCCCCccccCCCCCCEEEccCCCCCCccCcccccCcCcceEeeeccccccCCCccccccCCCCeeecccc
Q 045798 81 REINLSNNTIQGEIPPEFGRLFRLEALFLSNNSLVGKIPANLSYCSRLTVLCIEYNKLQGRIPLEFVSLSKLKDLSLAKN 160 (1008)
Q Consensus 81 ~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n 160 (1008)
...++++++++ .+|..+. ++|++|+|++|++++..|..|+++++|++|+|++|++++..|..|.++++|++|+|++|
T Consensus 8 ~~c~~~~~~l~-~ip~~~~--~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n 84 (549)
T 2z81_A 8 GVCDGRSRSFT-SIPSGLT--AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDN 84 (549)
T ss_dssp SEEECTTSCCS-SCCSCCC--TTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTS
T ss_pred ceEECCCCccc-cccccCC--CCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEECCCC
Confidence 34577788888 6776654 78888888888888777888888888888888888888777788888888888888888
Q ss_pred cCCCCCCCCCccccccchhhcccccCCC-CCCccccCCCCCcEEEecCCc-ccccCCccccCCCCcceeccccccccccC
Q 045798 161 KLTGGIPPFLGNLTSLEVLSLAGNSFGR-NIPDSLGQLKQLKILAIGGNN-LSGPIPPSIYNLSFLVVFSVSHNQIHGSL 238 (1008)
Q Consensus 161 ~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~~l~~L~~L~L~~n~-l~~~~~~~~~~l~~L~~L~ls~N~l~~~l 238 (1008)
++++..|..|+++++|++|++++|++++ ..|..|+.+++|++|++++|. +....+..|.++++|++|++++|++++.+
T Consensus 85 ~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~ 164 (549)
T 2z81_A 85 HLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQ 164 (549)
T ss_dssp CCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEEC
T ss_pred ccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCcccccC
Confidence 8886666668888888888888888865 356678888888888888887 44343467888888888888888887666
Q ss_pred ChhhhhcCCCCcEEEeccccCCCCCCcc-cccCCCCceeecccccccccc---cccccCCCcccccccccccCCCCCCCc
Q 045798 239 PPSLGLLLPNLKFFQIHHNFFSGSIPIS-LSNASKLEHIEIANNNFSGKL---SVNFGGMKNLSLLNLQFSNLGSGESDE 314 (1008)
Q Consensus 239 p~~~~~~l~~L~~L~L~~N~l~~~~p~~-l~~l~~L~~L~L~~N~l~~~~---~~~~~~l~~L~~L~L~~n~l~~~~~~~ 314 (1008)
|..+.. +++|++|++++|.+.. +|.. +..+++|++|++++|++.+.. ......+++|+.|++++|.+.....
T Consensus 165 ~~~l~~-l~~L~~L~l~~n~~~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~-- 240 (549)
T 2z81_A 165 SQSLKS-IRDIHHLTLHLSESAF-LLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESF-- 240 (549)
T ss_dssp TTTTTT-CSEEEEEEEECSBSTT-HHHHHHHSTTTBSEEEEESCBCTTCCCCCCSSCCCCCCCCEEEEESCEEEHHHH--
T ss_pred hhhhhc-cccCceEecccCcccc-cchhhHhhcccccEEEccCCccccccccccchhhhhhcccceeccccccchhHH--
Confidence 655543 6777777777777663 3333 345677777777777776542 1122345566666666655432211
Q ss_pred ccccccccccCCCcEEEecCCcCCccCC------hhhhhhcccceeeeeccccccCC-----CCCccccccccceEEecC
Q 045798 315 MGFMNSLTNCSKLRVLSLGGNQFRGALP------HSIANLSSQLQILILSSNQFYGS-----IPLGIGNLVDLYLLGMVE 383 (1008)
Q Consensus 315 ~~~~~~l~~l~~L~~L~Ls~N~l~~~~p------~~~~~l~~~L~~L~Ls~N~l~~~-----~p~~~~~l~~L~~L~L~~ 383 (1008)
..+...+..+++|+.+++++|.+.+... ..+..+ .+|+.|+++++.+... ++..+..+.+|+.|++++
T Consensus 241 ~~l~~~~~~~~~L~~l~l~~~~~~~~~~~~~~~~~~~~~l-~~L~~L~l~~~~i~~~~~~~~l~~~~~~~~~L~~L~l~~ 319 (549)
T 2z81_A 241 NELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSEL-GKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVEN 319 (549)
T ss_dssp HHHHGGGGGCTTCCEEEEESCEEECCSCCCCCTTTCCCCC-TTCCEEEEESCBCSCGGGSCCCCHHHHHSTTCCEEEEES
T ss_pred HHHHHHhhhhccccccccccccccccccccccchhhhhhh-cccccccccccccchhhhcccchhhhhhcccceEEEecc
Confidence 1122233455566666666665543210 111122 2355566555554321 111122234566666666
Q ss_pred ccccCCcchhc-cCCCCCceEEccCCccccccc---ccccCCCCcceeeccccccccccC--CCCcCCCcccEeeccccc
Q 045798 384 NQFTGAIPKEM-GKLQKLQGLDFSGNHFSGEIP---SSLGNLSSLYEVFFNNNNLSGVIP--FSLGNLKRLAFLEMSGNE 457 (1008)
Q Consensus 384 n~l~~~~~~~~-~~l~~L~~L~Ls~N~l~~~~p---~~~~~l~~L~~L~l~~N~l~~~~p--~~~~~l~~L~~L~Ls~N~ 457 (1008)
|++. .+|..+ ..+++|++|+|++|++++.+| ..+..+++|+.|++++|++++..+ ..+..+++|++|+|++|+
T Consensus 320 n~l~-~ip~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~ 398 (549)
T 2z81_A 320 SKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNT 398 (549)
T ss_dssp SCCC-CCCHHHHHHCTTCCEEECCSSCCCHHHHHHHTCTTSSTTCCEEECTTSCCCCHHHHHHHGGGCTTCCEEECTTCC
T ss_pred Cccc-cCCHHHHhcCccccEEEccCCccccccccchhhhhccccCcEEEccCCcccccccchhhhhcCCCCCEEECCCCC
Confidence 6655 344433 355666666666666655443 234555666666666666654322 335556666666666666
Q ss_pred ccCCcchhhhhhhhhhhhhcccCccccCCCcccccccccccccccccccccCCCCcccccccccceeeccCcccccchhh
Q 045798 458 LSGTIPEDIFNISYLSNSLNLARNHLVGIIPPRIGNLRALRSFDVSNNDLSGEIPIELGHCSSLEEIYLAGNLFHGSIPS 537 (1008)
Q Consensus 458 l~~~lp~~~~~~~~~~~~L~L~~N~l~~~~p~~~~~l~~L~~Ldls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~ 537 (1008)
++ .+|..+... ..++.|+|++|.+++ +|..+ .++|+.|||++|++++.+ ..+++|++|+|++|+|+ .+|.
T Consensus 399 l~-~lp~~~~~~-~~L~~L~Ls~N~l~~-l~~~~--~~~L~~L~Ls~N~l~~~~----~~l~~L~~L~Ls~N~l~-~ip~ 468 (549)
T 2z81_A 399 FH-PMPDSCQWP-EKMRFLNLSSTGIRV-VKTCI--PQTLEVLDVSNNNLDSFS----LFLPRLQELYISRNKLK-TLPD 468 (549)
T ss_dssp CC-CCCSCCCCC-TTCCEEECTTSCCSC-CCTTS--CTTCSEEECCSSCCSCCC----CCCTTCCEEECCSSCCS-SCCC
T ss_pred Cc-cCChhhccc-ccccEEECCCCCccc-ccchh--cCCceEEECCCCChhhhc----ccCChhcEEECCCCccC-cCCC
Confidence 65 455443332 223455555555542 23222 135555555555555321 34455555555555555 3444
Q ss_pred hhhccccccEEecCCCcccccccCc-ccccccceeecccCcccccCC
Q 045798 538 FFNALKGVQKIDLSRNNLSGQIPIF-LEALSLEYLNLSFNDFEGKIP 583 (1008)
Q Consensus 538 ~~~~l~~L~~L~ls~N~l~~~~p~~-~~~~~L~~L~l~~N~l~g~~p 583 (1008)
...+++|+.|||++|++++.+|.. ..+.+|+.|++++|++.+..|
T Consensus 469 -~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 514 (549)
T 2z81_A 469 -ASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 514 (549)
T ss_dssp -GGGCTTCCEEECCSSCCCCCCTTGGGGCTTCCEEECCSSCBCCCHH
T ss_pred -cccCccCCEEecCCCccCCcCHHHHhcCcccCEEEecCCCccCCCc
Confidence 244555555555555555555443 344455555555555555544
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-49 Score=432.73 Aligned_cols=276 Identities=22% Similarity=0.303 Sum_probs=214.0
Q ss_pred HHHHhcCCCCCceEeeccCeeEEEEEEcCC-----CeEEEEEEeccccc-hhhHHHHHHHHHHhhcCC-CCceeeeeccc
Q 045798 679 LLKATNGFSSTHLIGVGSFGCVYKGALDED-----GIVVAIKVINLQCE-GASKSFMAECKALKNIRH-RNLVKVITSCS 751 (1008)
Q Consensus 679 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~-----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h-~niv~~~~~~~ 751 (1008)
.+...++|++.+.||+|+||+||+|.+... ++.||||+++.... ...+.|.+|+++|.++.| ||||+++|+|.
T Consensus 59 wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~ 138 (353)
T 4ase_A 59 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACT 138 (353)
T ss_dssp HBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEE
Confidence 334457899999999999999999998543 36899999975433 445679999999999965 89999999974
Q ss_pred cccccCCceEEEEEeccCCCChhcccccCCCCC------CCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccC
Q 045798 752 SIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPK------RDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDL 825 (1008)
Q Consensus 752 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~------~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dl 825 (1008)
..++..++|||||++|+|.++++...... ........+++.+++.|+.|||+||+|||++ +||||||
T Consensus 139 ----~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRDL 211 (353)
T 4ase_A 139 ----KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDL 211 (353)
T ss_dssp ----CTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCC
T ss_pred ----ecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecCcc
Confidence 34456899999999999999997643210 0011123689999999999999999999998 9999999
Q ss_pred CCCCeeecCCCCeEEcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCC
Q 045798 826 KPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT-AKKPTD 904 (1008)
Q Consensus 826 kp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-G~~pf~ 904 (1008)
||+|||+++++.+||+|||+|+......... ......||+.|||||++.+..|+.++|||||||++|||+| |+.||.
T Consensus 212 K~~NILl~~~~~vKi~DFGlar~~~~~~~~~--~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~ 289 (353)
T 4ase_A 212 AARNILLSEKNVVKICDFGLARDIYKDPDYV--RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 289 (353)
T ss_dssp SGGGEEECGGGCEEECCCGGGSCTTTCTTSE--EETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred CccceeeCCCCCEEECcchhhhhcccCCCce--eeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCC
Confidence 9999999999999999999998665433222 2334568999999999999999999999999999999998 999986
Q ss_pred ccccCCccHHHHHHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHH
Q 045798 905 VMFEGDLNLHNFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNV 984 (1008)
Q Consensus 905 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev 984 (1008)
...... .+....... .+++. ...++.++.++|.+||+.||++||||+||
T Consensus 290 ~~~~~~-~~~~~i~~g--------------------------~~~~~----p~~~~~~~~~li~~c~~~dP~~RPt~~ei 338 (353)
T 4ase_A 290 GVKIDE-EFCRRLKEG--------------------------TRMRA----PDYTTPEMYQTMLDCWHGEPSQRPTFSEL 338 (353)
T ss_dssp TCCCSH-HHHHHHHHT--------------------------CCCCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred CCCHHH-HHHHHHHcC--------------------------CCCCC----CccCCHHHHHHHHHHcCcChhHCcCHHHH
Confidence 432111 111111100 00000 01245678999999999999999999999
Q ss_pred HHHHHHHHHH
Q 045798 985 VHELQSVKNI 994 (1008)
Q Consensus 985 l~~L~~i~~~ 994 (1008)
++.|+.+.++
T Consensus 339 l~~L~~llq~ 348 (353)
T 4ase_A 339 VEHLGNLLQA 348 (353)
T ss_dssp HHHHHHHHHH
T ss_pred HHHHHHHHHH
Confidence 9999988654
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-47 Score=461.97 Aligned_cols=555 Identities=18% Similarity=0.141 Sum_probs=415.9
Q ss_pred CCCCCCCCCCCCcccceEEcCCCCeEEEEeccccCCCCccCcCccCCccCCeeeecCCCCCCCCCccccCCCCCCEEEcc
Q 045798 31 ILNSWNDSRHFCEWEGITCGRRHRRVTALDLMSKSLSGSLSPHLGNLSFLREINLSNNTIQGEIPPEFGRLFRLEALFLS 110 (1008)
Q Consensus 31 ~~~~w~~~~~~c~w~gv~c~~~~~~v~~l~l~~~~l~~~l~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls 110 (1008)
.+++|..+.+ ..|+...|......| |=++.+++ .+|..+. +++++|||++|+|++..+.+|.++++|++|+|+
T Consensus 12 ~~~~~~~~~p-~~~~~c~~~~~~~~~---~c~~~~l~-~vP~~lp--~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls 84 (635)
T 4g8a_A 12 KLAAANSSIP-ESWEPCVEVVPNITY---QCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLS 84 (635)
T ss_dssp --------------CCSEEEETTTEE---ECTTSCCS-SCCSSSC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECT
T ss_pred hhhcccCCCC-CCCCCccccCCCCEE---ECCCCCcC-ccCCCCC--cCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECC
Confidence 3455544322 235444443322222 22334555 5676554 478999999999997778899999999999999
Q ss_pred CCCCCCccCcccccCcCcceEeeeccccccCCCccccccCCCCeeecccccCCCCCCCCCccccccchhhcccccCCC-C
Q 045798 111 NNSLVGKIPANLSYCSRLTVLCIEYNKLQGRIPLEFVSLSKLKDLSLAKNKLTGGIPPFLGNLTSLEVLSLAGNSFGR-N 189 (1008)
Q Consensus 111 ~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~ 189 (1008)
+|+|++..|.+|+++++|++|+|++|+|++..+..|.++++|++|+|++|++++..+..|+++++|++|+|++|+++. .
T Consensus 85 ~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~ 164 (635)
T 4g8a_A 85 RCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFK 164 (635)
T ss_dssp TCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCC
T ss_pred CCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEECCCCcCCCCChhhhhcCcccCeeccccCccccCC
Confidence 999997778889999999999999999998777889999999999999999997777789999999999999999965 4
Q ss_pred CCccccCCCCCcEEEecCCcccccCCccccCCCCcc----eeccccccccccCChhhhhcCCCCcEEEeccccCCCC-CC
Q 045798 190 IPDSLGQLKQLKILAIGGNNLSGPIPPSIYNLSFLV----VFSVSHNQIHGSLPPSLGLLLPNLKFFQIHHNFFSGS-IP 264 (1008)
Q Consensus 190 ~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~----~L~ls~N~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~-~p 264 (1008)
.|..++.+++|++|++++|++++..+..|..+.+++ .++++.|.+. .++...+. ...+..+++.+|..... .+
T Consensus 165 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~l~~~~~~~~ls~n~l~-~i~~~~~~-~~~~~~l~l~~n~~~~~~~~ 242 (635)
T 4g8a_A 165 LPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFK-EIRLHKLTLRNNFDSLNVMK 242 (635)
T ss_dssp CCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCCEEECTTCCCC-EECTTTTT-TCEEEEEEEESCCSSHHHHH
T ss_pred CchhhccchhhhhhcccCccccccccccccchhhhhhhhhhhhcccCccc-ccCccccc-chhhhhhhhhcccccccccc
Confidence 578889999999999999999988888887766554 6888999987 55555554 34677888888876532 33
Q ss_pred cccccCCCCceeeccccc------ccccccccccCCCcccccccccccCCCCCCCcccccccccccCCCcEEEecCCcCC
Q 045798 265 ISLSNASKLEHIEIANNN------FSGKLSVNFGGMKNLSLLNLQFSNLGSGESDEMGFMNSLTNCSKLRVLSLGGNQFR 338 (1008)
Q Consensus 265 ~~l~~l~~L~~L~L~~N~------l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~ 338 (1008)
..+..+..++...+..+. +.......+..+..+..+.+..+...... ......+..+.+++.+.+.+|.+.
T Consensus 243 ~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~~l~~~~~~~~~---~~~~~~~~~~~~l~~l~~~~~~~~ 319 (635)
T 4g8a_A 243 TCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYL---DGIIDLFNCLTNVSSFSLVSVTIE 319 (635)
T ss_dssp HHHHTTTTCEEEEEEEECCTTSCCCSCCCTTTTGGGGGSEEEEEEEECCCSCE---EECTTTTGGGTTCSEEEEESCEEE
T ss_pred hhhcCCcccccccccccccccccccccccccccccccchhhhhhhhhhhcccc---cchhhhhhhhcccccccccccccc
Confidence 455667777766654433 22333444555566666665554433221 122234566778888898888877
Q ss_pred ccCChhhhhhcccceeeeeccccccCCCCCccccccccceEEecCccccCCcchhccCCCCCceEEccCCcccc--cccc
Q 045798 339 GALPHSIANLSSQLQILILSSNQFYGSIPLGIGNLVDLYLLGMVENQFTGAIPKEMGKLQKLQGLDFSGNHFSG--EIPS 416 (1008)
Q Consensus 339 ~~~p~~~~~l~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~--~~p~ 416 (1008)
...+ +... ..|+.|++++|.+.+..+ ..+..|+.+++.+|.+... .....+++|+.|++++|.+.. ..+.
T Consensus 320 ~~~~--~~~~-~~L~~L~l~~~~~~~~~~---~~l~~L~~l~l~~n~~~~~--~~~~~l~~L~~L~ls~n~l~~~~~~~~ 391 (635)
T 4g8a_A 320 RVKD--FSYN-FGWQHLELVNCKFGQFPT---LKLKSLKRLTFTSNKGGNA--FSEVDLPSLEFLDLSRNGLSFKGCCSQ 391 (635)
T ss_dssp ECGG--GGSC-CCCSEEEEESCEESSCCC---CBCTTCCEEEEESCCSCCB--CCCCBCTTCCEEECCSSCCBEEEECCH
T ss_pred cccc--cccc-hhhhhhhcccccccCcCc---ccchhhhhcccccccCCCC--cccccccccccchhhcccccccccccc
Confidence 4322 2333 358899999998875443 3466788888888887643 334578899999999998853 3455
Q ss_pred cccCCCCcceeeccccccccccCCCCcCCCcccEeecccccccCCcchhhhhhhhhhhhhcccCccccCCCccccccccc
Q 045798 417 SLGNLSSLYEVFFNNNNLSGVIPFSLGNLKRLAFLEMSGNELSGTIPEDIFNISYLSNSLNLARNHLVGIIPPRIGNLRA 496 (1008)
Q Consensus 417 ~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~lp~~~~~~~~~~~~L~L~~N~l~~~~p~~~~~l~~ 496 (1008)
.+..+.+|+.+++..|.+.. .+..+..+++|+.+++++|...+..+...+.....++.++++.|.+.+..|..+..+++
T Consensus 392 ~~~~~~~L~~L~~~~~~~~~-~~~~~~~l~~L~~l~l~~~~~~~~~~~~~~~~l~~l~~l~ls~n~l~~~~~~~~~~~~~ 470 (635)
T 4g8a_A 392 SDFGTISLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSS 470 (635)
T ss_dssp HHHSCSCCCEEECCSCSEEE-ECSCCTTCTTCCEEECTTSEEESTTSSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTT
T ss_pred chhhhhhhhhhhcccccccc-ccccccccccccchhhhhccccccccccccccccccccccccccccccccccccccchh
Confidence 66778889999999998874 56678889999999999888887777777777777788999999999888888999999
Q ss_pred cccccccccccc-CCCCcccccccccceeeccCcccccchhhhhhccccccEEecCCCcccccccCc-ccccccceeecc
Q 045798 497 LRSFDVSNNDLS-GEIPIELGHCSSLEEIYLAGNLFHGSIPSFFNALKGVQKIDLSRNNLSGQIPIF-LEALSLEYLNLS 574 (1008)
Q Consensus 497 L~~Ldls~N~l~-~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~-~~~~~L~~L~l~ 574 (1008)
|+.|+|++|.+. +..|..|..+++|++|+|++|+|++.+|..|..+++|+.|+|++|+|++..|.. ..+.+|++|+|+
T Consensus 471 L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls 550 (635)
T 4g8a_A 471 LEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYS 550 (635)
T ss_dssp CCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCEEECT
T ss_pred hhhhhhhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCCCCEEECC
Confidence 999999998744 457888899999999999999999888999999999999999999999887765 567789999999
Q ss_pred cCcccccCCCCc-cc-CCcccceeccCCccCCCC
Q 045798 575 FNDFEGKIPAKG-IF-ANASAISVVGCNRLCGGI 606 (1008)
Q Consensus 575 ~N~l~g~~p~~~-~~-~~~~~~~~~~n~~l~g~~ 606 (1008)
+|+|++.+|..- .+ .++..+.+.+||+.|.|.
T Consensus 551 ~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~C~ 584 (635)
T 4g8a_A 551 LNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCE 584 (635)
T ss_dssp TSCCCBCCSSCTTCCCTTCCEEECTTCCBCCSGG
T ss_pred CCcCCCCCHHHHHhhhCcCCEEEeeCCCCcccCC
Confidence 999999888652 23 466777888999998863
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=455.16 Aligned_cols=460 Identities=19% Similarity=0.215 Sum_probs=345.1
Q ss_pred CeeeecCCCCCCCCCccccCCCCCCEEEccCCCCCCccCcccccCcCcceEeeeccccccCCCccccccCCCCeeecccc
Q 045798 81 REINLSNNTIQGEIPPEFGRLFRLEALFLSNNSLVGKIPANLSYCSRLTVLCIEYNKLQGRIPLEFVSLSKLKDLSLAKN 160 (1008)
Q Consensus 81 ~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n 160 (1008)
++|++++|+++ .+|..+. ++|++|+|++|.+++..|..|+++++|++|+|++|++++..|..|.++++|++|+|++|
T Consensus 3 ~~l~ls~n~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N 79 (520)
T 2z7x_B 3 FLVDRSKNGLI-HVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHN 79 (520)
T ss_dssp CEEECTTSCCS-SCCCSCC--TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSS
T ss_pred ceEecCCCCcc-ccccccc--ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCC
Confidence 57899999998 6777666 88999999999998777788899999999999999998877888888999999999999
Q ss_pred cCCCCCCCCCccccccchhhcccccCCC-CCCccccCCCCCcEEEecCCcccccCCccccCCCCc--ceeccccccc--c
Q 045798 161 KLTGGIPPFLGNLTSLEVLSLAGNSFGR-NIPDSLGQLKQLKILAIGGNNLSGPIPPSIYNLSFL--VVFSVSHNQI--H 235 (1008)
Q Consensus 161 ~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L--~~L~ls~N~l--~ 235 (1008)
+++ .+|.. .+++|++|+|++|++++ ..|..|+.+++|++|++++|.+++ ..+..+++| +.|++++|.+ .
T Consensus 80 ~l~-~lp~~--~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~---~~~~~l~~L~L~~L~l~~n~l~~~ 153 (520)
T 2z7x_B 80 KLV-KISCH--PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEK---SSVLPIAHLNISKVLLVLGETYGE 153 (520)
T ss_dssp CCC-EEECC--CCCCCSEEECCSSCCSSCCCCGGGGGCTTCCEEEEEESSCCG---GGGGGGTTSCEEEEEEEECTTTTS
T ss_pred cee-ecCcc--ccCCccEEeccCCccccccchhhhccCCcceEEEecCcccch---hhccccccceeeEEEeeccccccc
Confidence 888 56655 78888888888888876 467788888888888888888774 345555555 6666666665 4
Q ss_pred ccCChhhhhcCCCCcEEEeccccCCCCCCcccccCC-CCceeeccccccccccc-ccccCCCcccccccccccCCCCCCC
Q 045798 236 GSLPPSLGLLLPNLKFFQIHHNFFSGSIPISLSNAS-KLEHIEIANNNFSGKLS-VNFGGMKNLSLLNLQFSNLGSGESD 313 (1008)
Q Consensus 236 ~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~-~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~n~l~~~~~~ 313 (1008)
+..| ..+..+. +...+++++|++.+..+ ..+..+++|+.|+++.|.......
T Consensus 154 ~~~~-------------------------~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~- 207 (520)
T 2z7x_B 154 KEDP-------------------------EGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCS- 207 (520)
T ss_dssp SCCT-------------------------TTTTTCCEEEEEEECCSSSCCCCCCCCCCTTCSEEEECCEEECCSTTTTH-
T ss_pred cccc-------------------------ccccccccceEEEEeccCcchhhhhhhhhhcccceeeccccccccccccc-
Confidence 3333 3333333 22334555555543222 223333444444333332100000
Q ss_pred cccccccccccCCCcEEEecCCcCCccCChhhhhhcccceeeeeccccccCCCCCccc---cccccceEEecCccccCCc
Q 045798 314 EMGFMNSLTNCSKLRVLSLGGNQFRGALPHSIANLSSQLQILILSSNQFYGSIPLGIG---NLVDLYLLGMVENQFTGAI 390 (1008)
Q Consensus 314 ~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~Ls~N~l~~~~p~~~~---~l~~L~~L~L~~n~l~~~~ 390 (1008)
.+.+.+| .+..+. +|+.|++++|.+++..+..+. ..++|+.|++++|++.|.+
T Consensus 208 ----------------------~~~~~~~-~l~~l~-~L~~L~l~~~~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~ 263 (520)
T 2z7x_B 208 ----------------------YFLSILA-KLQTNP-KLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQL 263 (520)
T ss_dssp ----------------------HHHHHHH-GGGGCT-TCCEEEEEEEEEEHHHHHHHHHHHHTSSCSEEEEEEEEEESCC
T ss_pred ----------------------eeecchh-hhcccc-chhhccccccccCHHHHHHHHHHhhhCcccEEEeecccccCcc
Confidence 0232333 444444 477888887777643322221 2358999999999999999
Q ss_pred chhc-----cCCCCCceEEccCCccccccc-ccccCC---CCcceeeccccccccccCCCCcCCCcccEeecccccccCC
Q 045798 391 PKEM-----GKLQKLQGLDFSGNHFSGEIP-SSLGNL---SSLYEVFFNNNNLSGVIPFSLGNLKRLAFLEMSGNELSGT 461 (1008)
Q Consensus 391 ~~~~-----~~l~~L~~L~Ls~N~l~~~~p-~~~~~l---~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 461 (1008)
|..+ ..+++|+.+++++|.+ .+| ..+..+ .+|+.|++++|.+.... .+..+++|++|++++|++++.
T Consensus 264 p~~~~~~~~~~l~~L~~l~l~~n~~--~~p~~~~~~~~~~~~L~~L~l~~n~l~~~~--~~~~l~~L~~L~Ls~n~l~~~ 339 (520)
T 2z7x_B 264 DFRDFDYSGTSLKALSIHQVVSDVF--GFPQSYIYEIFSNMNIKNFTVSGTRMVHML--CPSKISPFLHLDFSNNLLTDT 339 (520)
T ss_dssp CCCCCCCCSCCCCEEEEEEEEECCC--CSCTHHHHHHHHTCCCSEEEEESSCCCCCC--CCSSCCCCCEEECCSSCCCTT
T ss_pred ccchhhcccccCceeEeccccccce--ecchhhhhcccccCceeEEEcCCCcccccc--chhhCCcccEEEeECCccChh
Confidence 9998 9999999999999999 455 455555 67999999999987432 237899999999999999988
Q ss_pred cchhhhhhhhhhhhhcccCccccC--CCcccccccccccccccccccccCCCCcc-cccccccceeeccCcccccchhhh
Q 045798 462 IPEDIFNISYLSNSLNLARNHLVG--IIPPRIGNLRALRSFDVSNNDLSGEIPIE-LGHCSSLEEIYLAGNLFHGSIPSF 538 (1008)
Q Consensus 462 lp~~~~~~~~~~~~L~L~~N~l~~--~~p~~~~~l~~L~~Ldls~N~l~~~~p~~-~~~l~~L~~L~L~~N~l~~~~p~~ 538 (1008)
+|..+.... .++.|+|++|++++ .+|..++.+++|++|||++|.+++.+|.. +..+++|++|+|++|++++.+|..
T Consensus 340 ~~~~~~~l~-~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~ 418 (520)
T 2z7x_B 340 VFENCGHLT-ELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRC 418 (520)
T ss_dssp TTTTCCCCS-SCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCEEECCSSCCCGGGGGS
T ss_pred hhhhhccCC-CCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccCCEEECcCCCCCcchhhh
Confidence 888776554 45899999999997 66788999999999999999999767765 888999999999999999988887
Q ss_pred hhccccccEEecCCCcccccccCc-ccccccceeecccCcccccCCC-CcccCCcccceeccCCccCCCCC
Q 045798 539 FNALKGVQKIDLSRNNLSGQIPIF-LEALSLEYLNLSFNDFEGKIPA-KGIFANASAISVVGCNRLCGGIP 607 (1008)
Q Consensus 539 ~~~l~~L~~L~ls~N~l~~~~p~~-~~~~~L~~L~l~~N~l~g~~p~-~~~~~~~~~~~~~~n~~l~g~~~ 607 (1008)
+. ++|+.|||++|+++ .+|.. ..+.+|++|++++|++++.++. ...+.++..+.+.+|++.|.|..
T Consensus 419 l~--~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~N~~~c~c~~ 486 (520)
T 2z7x_B 419 LP--PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 486 (520)
T ss_dssp CC--TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCCCHHH
T ss_pred hc--ccCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCCccCHHHhccCCcccEEECcCCCCcccCCc
Confidence 75 79999999999999 56654 7788999999999999964443 34566778888899999887643
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-48 Score=416.40 Aligned_cols=259 Identities=24% Similarity=0.364 Sum_probs=191.6
Q ss_pred cCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEecccc-chhhHHHHHHHHHHhhcCCCCceeeeeccccccc-------
Q 045798 684 NGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC-EGASKSFMAECKALKNIRHRNLVKVITSCSSIDF------- 755 (1008)
Q Consensus 684 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~------- 755 (1008)
++|++++.||+|+||+||+|+++.+|+.||||+++... +...+.+.+|++++++++|||||++++++...+.
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 45899999999999999999999999999999997543 3445789999999999999999999998754321
Q ss_pred cCCceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCC
Q 045798 756 QGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDND 835 (1008)
Q Consensus 756 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~ 835 (1008)
....+.|+|||||++|+|.+++....... ..++..++.|+.||+.||+|||++ +||||||||+|||++.+
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~-------~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~ 154 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIE-------ERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMD 154 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGG-------GSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTT
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCC-------hhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCC
Confidence 23345799999999999999997654211 456778899999999999999998 99999999999999999
Q ss_pred CCeEEcccCcccccccccCcc--------ccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccc
Q 045798 836 LSGHIGDFGLARFHQEVSNST--------LSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMF 907 (1008)
Q Consensus 836 ~~~kL~Dfg~a~~~~~~~~~~--------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~ 907 (1008)
+.+||+|||+|+......... .......+||+.|||||++.+..|+.++|||||||++|||++ ||....
T Consensus 155 ~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~ 231 (299)
T 4g31_A 155 DVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM 231 (299)
T ss_dssp CCEEECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH
T ss_pred CcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc
Confidence 999999999998765433211 112234579999999999999999999999999999999996 765321
Q ss_pred cCCccHHHHHHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 908 EGDLNLHNFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 908 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
+............ ++ +...+..+...+++.+||+.||++|||+.|+++
T Consensus 232 ~~~~~~~~~~~~~----------------------------~p---~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 232 ERVRTLTDVRNLK----------------------------FP---PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp HHHHHHHHHHTTC----------------------------CC---HHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHHHHHhcCC----------------------------CC---CCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1000000000000 00 011223445678999999999999999999986
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=463.81 Aligned_cols=506 Identities=19% Similarity=0.257 Sum_probs=335.9
Q ss_pred ChhhHHHHHHHHHhhccCCCCCCCCCCCCC----CCCcccceEEcCCC---CeEEEEeccccCCCCccCcCccCCccCCe
Q 045798 10 EDGDRAALQAFKSMIAHEPQGILNSWNDSR----HFCEWEGITCGRRH---RRVTALDLMSKSLSGSLSPHLGNLSFLRE 82 (1008)
Q Consensus 10 ~~~~~~~l~~~k~~~~~~~~~~~~~w~~~~----~~c~w~gv~c~~~~---~~v~~l~l~~~~l~~~l~~~l~~l~~L~~ 82 (1008)
.+++...-.|++.....-. -.+|.... ..|.|..-+..+.+ ..|++- .. ..++.
T Consensus 25 ~~~~~~d~~aL~~~~~~~~---~~~w~~~~~~~~~~~~W~~~~~~c~w~~~~GV~C~------------~~----~~V~~ 85 (636)
T 4eco_A 25 TAEYIKDYLALKEIWDALN---GKNWSQQGFGTQPGANWNFNKELDMWGAQPGVSLN------------SN----GRVTG 85 (636)
T ss_dssp CCHHHHHHHHHHHHHHHTT---GGGCCCCC------CCCCCSSCGGGTTCCTTEEEC------------TT----CCEEE
T ss_pred hhhHHHHHHHHHHHHHHcC---CCCcccCCcCCccCCCCCCCCCcccccCCCCeEEc------------CC----CCEEE
Confidence 3445566677776664321 24787443 23479632211233 345541 00 46899
Q ss_pred eeecCCCCCCCCCccccCCCCCCEEEccCCCC------CC------ccCcccccCcCcceEeeeccccccCCCccccc-c
Q 045798 83 INLSNNTIQGEIPPEFGRLFRLEALFLSNNSL------VG------KIPANLSYCSRLTVLCIEYNKLQGRIPLEFVS-L 149 (1008)
Q Consensus 83 L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l------~~------~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~-l 149 (1008)
|+|++|+++|.+|++|++|++|++|+|++|.+ .+ .+|... +..|+ +++++|.+.+.+|..+.. +
T Consensus 86 L~L~~~~l~g~lp~~l~~L~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~--~~~l~-l~l~~~~l~~~~~~~~~~~~ 162 (636)
T 4eco_A 86 LSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQ--KQKMR-MHYQKTFVDYDPREDFSDLI 162 (636)
T ss_dssp EECTTSCCEEEECGGGGGCTTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHH--HHHHH-THHHHHHTCCCGGGGSCHHH
T ss_pred EEecCcccCCcCChHHhcCccceEEECcCCccccCCccccccccccCchHHH--HHHHH-hhHHHhhhccCchhhHHHHH
Confidence 99999999999999999999999999999976 22 334333 56777 899999998888877764 3
Q ss_pred CCCCeeecccccCCCCCCCCCccccccchhhcc--cccCCCCCCccccCCCCCcEEEecCCccccc--------------
Q 045798 150 SKLKDLSLAKNKLTGGIPPFLGNLTSLEVLSLA--GNSFGRNIPDSLGQLKQLKILAIGGNNLSGP-------------- 213 (1008)
Q Consensus 150 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~--~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~-------------- 213 (1008)
..+..+++....+.. .....++.+++. +|++++ +|.+|+++++|++|+|++|.+++.
T Consensus 163 ~~l~~~~l~~~~~~~------~~~~~l~~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~ 235 (636)
T 4eco_A 163 KDCINSDPQQKSIKK------SSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYA 235 (636)
T ss_dssp HHHHHHCTTSCCCCC------CCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHH
T ss_pred HHHhhcCcccccccc------ccccchhhhhhccccCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchh
Confidence 445555555444431 222445555555 588988 899999999999999999999986
Q ss_pred ---CCcccc--CCCCcceeccccccccccCChhhhhcCCCCcEEEecccc-CCC-CCCcccccCCCCceeeccccccccc
Q 045798 214 ---IPPSIY--NLSFLVVFSVSHNQIHGSLPPSLGLLLPNLKFFQIHHNF-FSG-SIPISLSNASKLEHIEIANNNFSGK 286 (1008)
Q Consensus 214 ---~~~~~~--~l~~L~~L~ls~N~l~~~lp~~~~~~l~~L~~L~L~~N~-l~~-~~p~~l~~l~~L~~L~L~~N~l~~~ 286 (1008)
+|..++ ++++|++|++++|.+.+.+|..+.. +++|++|+|++|. +++ .+|..+.++
T Consensus 236 ~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~-l~~L~~L~Ls~n~~l~~~~lp~~~~~L---------------- 298 (636)
T 4eco_A 236 QQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKA-LPEMQLINVACNRGISGEQLKDDWQAL---------------- 298 (636)
T ss_dssp HHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTT-CSSCCEEECTTCTTSCHHHHHHHHHHH----------------
T ss_pred cccCchhhhhcccCCCCEEEecCCcCCccChHHHhc-CCCCCEEECcCCCCCccccchHHHHhh----------------
Confidence 899999 9999999999999998777755433 5555555555555 544 444444333
Q ss_pred ccccccCCCcccccccccccCCCCCCCcccccccccccCCCcEEEecCCcCCccCCh--hhhhhcccceeeeeccccccC
Q 045798 287 LSVNFGGMKNLSLLNLQFSNLGSGESDEMGFMNSLTNCSKLRVLSLGGNQFRGALPH--SIANLSSQLQILILSSNQFYG 364 (1008)
Q Consensus 287 ~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~--~~~~l~~~L~~L~Ls~N~l~~ 364 (1008)
. .+..+++|++|++++|+++ .+|. .+..+. +|++|++++|+++|
T Consensus 299 --------~------------------------~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~-~L~~L~L~~N~l~g 344 (636)
T 4eco_A 299 --------A------------------------DAPVGEKIQIIYIGYNNLK-TFPVETSLQKMK-KLGMLECLYNQLEG 344 (636)
T ss_dssp --------H------------------------HSGGGGTCCEEECCSSCCS-SCCCHHHHTTCT-TCCEEECCSCCCEE
T ss_pred --------h------------------------ccccCCCCCEEECCCCcCC-ccCchhhhccCC-CCCEEeCcCCcCcc
Confidence 0 0112234444444444444 4444 444443 35555555555554
Q ss_pred CCCCccccccccceEEecCccccCCcchhccCCCC-CceEEccCCcccccccccccCCC--CcceeeccccccccccCCC
Q 045798 365 SIPLGIGNLVDLYLLGMVENQFTGAIPKEMGKLQK-LQGLDFSGNHFSGEIPSSLGNLS--SLYEVFFNNNNLSGVIPFS 441 (1008)
Q Consensus 365 ~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~-L~~L~Ls~N~l~~~~p~~~~~l~--~L~~L~l~~N~l~~~~p~~ 441 (1008)
.+| .+..+++|+.|++++|+++ .+|..+..+++ |+.|+|++|+++ .+|..+..++ +|+.|++++|.+.+..|..
T Consensus 345 ~ip-~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~~~p~~ 421 (636)
T 4eco_A 345 KLP-AFGSEIKLASLNLAYNQIT-EIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKN 421 (636)
T ss_dssp ECC-CCEEEEEESEEECCSSEEE-ECCTTSEEECTTCCEEECCSSCCS-SCCSCCCTTCSSCEEEEECCSSCTTTTTTCS
T ss_pred chh-hhCCCCCCCEEECCCCccc-cccHhhhhhcccCcEEEccCCcCc-ccchhhhhcccCccCEEECcCCcCCCcchhh
Confidence 455 4555555555555555555 44555555555 555555555555 4454444433 5555555555555555555
Q ss_pred Cc-------CCCcccEeecccccccCCcchhhhhhhhhhhhhcccCccccCCCcccc--------ccccccccccccccc
Q 045798 442 LG-------NLKRLAFLEMSGNELSGTIPEDIFNISYLSNSLNLARNHLVGIIPPRI--------GNLRALRSFDVSNND 506 (1008)
Q Consensus 442 ~~-------~l~~L~~L~Ls~N~l~~~lp~~~~~~~~~~~~L~L~~N~l~~~~p~~~--------~~l~~L~~Ldls~N~ 506 (1008)
|. .+++|+.|+|++|+++ .+|..++.....++.|+|++|+++ .+|..+ .++++|+.|+|++|.
T Consensus 422 l~~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~~~~~~~~~l~~L~~L~Ls~N~ 499 (636)
T 4eco_A 422 FDPLDPTPFKGINVSSINLSNNQIS-KFPKELFSTGSPLSSINLMGNMLT-EIPKNSLKDENENFKNTYLLTSIDLRFNK 499 (636)
T ss_dssp SCTTCSSCCCCCCEEEEECCSSCCC-SCCTHHHHTTCCCSEEECCSSCCS-BCCSSSSEETTEECTTGGGCCEEECCSSC
T ss_pred hcccccccccCCCCCEEECcCCccC-cCCHHHHccCCCCCEEECCCCCCC-CcCHHHhccccccccccCCccEEECcCCc
Confidence 55 4555555555555555 455555544444455555555555 333332 234499999999999
Q ss_pred ccCCCCcccc--cccccceeeccCcccccchhhhhhccccccEEec------CCCcccccccCc-ccccccceeecccCc
Q 045798 507 LSGEIPIELG--HCSSLEEIYLAGNLFHGSIPSFFNALKGVQKIDL------SRNNLSGQIPIF-LEALSLEYLNLSFND 577 (1008)
Q Consensus 507 l~~~~p~~~~--~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l------s~N~l~~~~p~~-~~~~~L~~L~l~~N~ 577 (1008)
++ .+|..+. .+++|++|+|++|+|++ +|..+..+++|+.|+| ++|++.+.+|.. ..+.+|++|+|++|.
T Consensus 500 l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~-ip~~~~~l~~L~~L~Ls~N~~ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~ 577 (636)
T 4eco_A 500 LT-KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSND 577 (636)
T ss_dssp CC-BCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCSSCCEEECCSCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSC
T ss_pred CC-ccChhhhhccCCCcCEEECCCCCCCC-cChhhhcCCCCCEEECCCCcccccCcccccChHHHhcCCCCCEEECCCCc
Confidence 99 8999997 99999999999999997 9999999999999999 568899999977 678899999999999
Q ss_pred ccccCCCCcccCCcccceeccCCccCC
Q 045798 578 FEGKIPAKGIFANASAISVVGCNRLCG 604 (1008)
Q Consensus 578 l~g~~p~~~~~~~~~~~~~~~n~~l~g 604 (1008)
+ +.+|.. .+.++..+.+.+|+..|-
T Consensus 578 l-~~ip~~-~~~~L~~L~Ls~N~l~~~ 602 (636)
T 4eco_A 578 I-RKVNEK-ITPNISVLDIKDNPNISI 602 (636)
T ss_dssp C-CBCCSC-CCTTCCEEECCSCTTCEE
T ss_pred C-CccCHh-HhCcCCEEECcCCCCccc
Confidence 9 778875 336777777888876653
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-48 Score=418.91 Aligned_cols=243 Identities=24% Similarity=0.296 Sum_probs=191.1
Q ss_pred cCCCCCceEeeccCeeEEEEEEc---CCCeEEEEEEecccc--chhhHHHHHHHHHHhhcCCCCceeeeeccccccccCC
Q 045798 684 NGFSSTHLIGVGSFGCVYKGALD---EDGIVVAIKVINLQC--EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGN 758 (1008)
Q Consensus 684 ~~y~~~~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 758 (1008)
++|++.+.||+|+||+||+|++. .+++.||||+++... .....++.+|++++++++|||||+++++ +.++
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~-----~~~~ 98 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYA-----FQTE 98 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEE-----EEET
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEE-----EEEC
Confidence 57999999999999999999873 367899999997432 2334578999999999999999999999 4567
Q ss_pred ceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCe
Q 045798 759 DFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSG 838 (1008)
Q Consensus 759 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 838 (1008)
+..|+|||||+||+|.+++...+ .+++.+++.++.||+.||+|||++ +||||||||+|||+++++.+
T Consensus 99 ~~~~ivmEy~~gg~L~~~l~~~~----------~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~v 165 (304)
T 3ubd_A 99 GKLYLILDFLRGGDLFTRLSKEV----------MFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHI 165 (304)
T ss_dssp TEEEEEECCCTTCEEHHHHHHHC----------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCE
T ss_pred CEEEEEEEcCCCCCHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCE
Confidence 78999999999999999997654 789999999999999999999998 99999999999999999999
Q ss_pred EEcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHH
Q 045798 839 HIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFAR 918 (1008)
Q Consensus 839 kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~ 918 (1008)
||+|||+|+........ ....+||+.|||||++.+..|+.++||||+||++|||++|+.||......+ .......
T Consensus 166 Kl~DFGla~~~~~~~~~----~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~-~~~~i~~ 240 (304)
T 3ubd_A 166 KLTDFGLSKESIDHEKK----AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKE-TMTMILK 240 (304)
T ss_dssp EEESSEEEEC-----CC----CCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHH
T ss_pred EecccccceeccCCCcc----ccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHH-HHHHHHc
Confidence 99999999865433221 234579999999999999999999999999999999999999996421110 0000000
Q ss_pred hhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCH
Q 045798 919 MALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNM 981 (1008)
Q Consensus 919 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~ 981 (1008)
... .++ ...+.++.+++.+||+.||++|||+
T Consensus 241 ------------~~~--------------~~p------~~~s~~~~~li~~~L~~dP~~R~ta 271 (304)
T 3ubd_A 241 ------------AKL--------------GMP------QFLSPEAQSLLRMLFKRNPANRLGA 271 (304)
T ss_dssp ------------CCC--------------CCC------TTSCHHHHHHHHHHTCSSGGGSTTC
T ss_pred ------------CCC--------------CCC------CcCCHHHHHHHHHHcccCHHHCCCC
Confidence 000 000 1234567899999999999999996
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-46 Score=454.37 Aligned_cols=513 Identities=22% Similarity=0.182 Sum_probs=423.5
Q ss_pred CeEEEEeccccCCCCccCcCccCCccCCeeeecCCCCCCCCCccccCCCCCCEEEccCCCCCCccCcccccCcCcceEee
Q 045798 54 RRVTALDLMSKSLSGSLSPHLGNLSFLREINLSNNTIQGEIPPEFGRLFRLEALFLSNNSLVGKIPANLSYCSRLTVLCI 133 (1008)
Q Consensus 54 ~~v~~l~l~~~~l~~~l~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L 133 (1008)
..++.|||++|.+++..+.+|..+++|++|+|++|+|+++.|.+|.++++|++|+|++|+|++..+..|+++++|++|+|
T Consensus 52 ~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~L 131 (635)
T 4g8a_A 52 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA 131 (635)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEEC
T ss_pred cCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEEC
Confidence 46899999999999666678999999999999999999888889999999999999999999777788999999999999
Q ss_pred eccccccCCCccccccCCCCeeecccccCCC-CCCCCCccccccchhhcccccCCCCCCccccCCCCC----cEEEecCC
Q 045798 134 EYNKLQGRIPLEFVSLSKLKDLSLAKNKLTG-GIPPFLGNLTSLEVLSLAGNSFGRNIPDSLGQLKQL----KILAIGGN 208 (1008)
Q Consensus 134 s~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L----~~L~L~~n 208 (1008)
++|++++..+..|+++++|++|+|++|++++ ..|..++.+++|++|+|++|++++..+..|..+.++ ..++++.|
T Consensus 132 s~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~l~~~~~~~~ls~n 211 (635)
T 4g8a_A 132 VETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLN 211 (635)
T ss_dssp TTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCCEEECTTC
T ss_pred CCCcCCCCChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCccccccccccccchhhhhhhhhhhhcccC
Confidence 9999998888889999999999999999985 357888999999999999999999888888776654 47899999
Q ss_pred cccccCCccccCCCCcceeccccccccccCChhhhhcCCCCcEEEeccccCC------CCCCcccccCCCCceeeccccc
Q 045798 209 NLSGPIPPSIYNLSFLVVFSVSHNQIHGSLPPSLGLLLPNLKFFQIHHNFFS------GSIPISLSNASKLEHIEIANNN 282 (1008)
Q Consensus 209 ~l~~~~~~~~~~l~~L~~L~ls~N~l~~~lp~~~~~~l~~L~~L~L~~N~l~------~~~p~~l~~l~~L~~L~L~~N~ 282 (1008)
.++...+..+.. ..+..+++++|.....++...+..+..++...+..+... ......+..+..+...++..+.
T Consensus 212 ~l~~i~~~~~~~-~~~~~l~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~~l~~~~ 290 (635)
T 4g8a_A 212 PMNFIQPGAFKE-IRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAY 290 (635)
T ss_dssp CCCEECTTTTTT-CEEEEEEEESCCSSHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCTTTTGGGGGSEEEEEEEEC
T ss_pred cccccCcccccc-hhhhhhhhhcccccccccchhhcCCcccccccccccccccccccccccccccccccchhhhhhhhhh
Confidence 999766655544 567889999998776677777777888888777654432 2334455566666666666554
Q ss_pred cccc---ccccccCCCcccccccccccCCCCCCCcccccccccccCCCcEEEecCCcCCccCChhhhhhcccceeeeecc
Q 045798 283 FSGK---LSVNFGGMKNLSLLNLQFSNLGSGESDEMGFMNSLTNCSKLRVLSLGGNQFRGALPHSIANLSSQLQILILSS 359 (1008)
Q Consensus 283 l~~~---~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~Ls~ 359 (1008)
.... ....+..+.+++.+.+..+.+.... .+.....|+.|++++|.+.+..+..+ ..|+.+++++
T Consensus 291 ~~~~~~~~~~~~~~~~~l~~l~~~~~~~~~~~--------~~~~~~~L~~L~l~~~~~~~~~~~~l----~~L~~l~l~~ 358 (635)
T 4g8a_A 291 LDYYLDGIIDLFNCLTNVSSFSLVSVTIERVK--------DFSYNFGWQHLELVNCKFGQFPTLKL----KSLKRLTFTS 358 (635)
T ss_dssp CCSCEEECTTTTGGGTTCSEEEEESCEEEECG--------GGGSCCCCSEEEEESCEESSCCCCBC----TTCCEEEEES
T ss_pred hcccccchhhhhhhhccccccccccccccccc--------ccccchhhhhhhcccccccCcCcccc----hhhhhccccc
Confidence 4322 2344666778888888777665432 35566789999999999885444322 2588999999
Q ss_pred ccccCCCCCccccccccceEEecCccccC--CcchhccCCCCCceEEccCCcccccccccccCCCCcceeeccccccccc
Q 045798 360 NQFYGSIPLGIGNLVDLYLLGMVENQFTG--AIPKEMGKLQKLQGLDFSGNHFSGEIPSSLGNLSSLYEVFFNNNNLSGV 437 (1008)
Q Consensus 360 N~l~~~~p~~~~~l~~L~~L~L~~n~l~~--~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ 437 (1008)
|.+... .....+++|+.|++++|.+.. ..+..+..+.+|+.|+++.|.+. ..+..+..+++|+.+++.+|.....
T Consensus 359 n~~~~~--~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~~~~~~~~-~~~~~~~~l~~L~~l~l~~~~~~~~ 435 (635)
T 4g8a_A 359 NKGGNA--FSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTISLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQM 435 (635)
T ss_dssp CCSCCB--CCCCBCTTCCEEECCSSCCBEEEECCHHHHSCSCCCEEECCSCSEE-EECSCCTTCTTCCEEECTTSEEEST
T ss_pred ccCCCC--cccccccccccchhhccccccccccccchhhhhhhhhhhccccccc-cccccccccccccchhhhhcccccc
Confidence 988643 345678999999999998863 45677888999999999999998 5667788999999999998887765
Q ss_pred cC-CCCcCCCcccEeecccccccCCcchhhhhhhhhhhhhcccCcccc-CCCcccccccccccccccccccccCCCCccc
Q 045798 438 IP-FSLGNLKRLAFLEMSGNELSGTIPEDIFNISYLSNSLNLARNHLV-GIIPPRIGNLRALRSFDVSNNDLSGEIPIEL 515 (1008)
Q Consensus 438 ~p-~~~~~l~~L~~L~Ls~N~l~~~lp~~~~~~~~~~~~L~L~~N~l~-~~~p~~~~~l~~L~~Ldls~N~l~~~~p~~~ 515 (1008)
.+ ..|..+++++.+++++|.+++ ++...+.....++.|+|++|.+. +..|..|..+++|+.|||++|++++..|..|
T Consensus 436 ~~~~~~~~l~~l~~l~ls~n~l~~-~~~~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f 514 (635)
T 4g8a_A 436 SEFSVFLSLRNLIYLDISHTHTRV-AFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAF 514 (635)
T ss_dssp TSSCTTTTCTTCCEEECTTSCCEE-CCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTT
T ss_pred cccccccccccccccccccccccc-ccccccccchhhhhhhhhhcccccccCchhhhhccccCEEECCCCccCCcChHHH
Confidence 54 568889999999999999984 55555666666789999999854 4678899999999999999999999899999
Q ss_pred ccccccceeeccCcccccchhhhhhccccccEEecCCCcccccccCc-ccc-cccceeecccCcccccCC
Q 045798 516 GHCSSLEEIYLAGNLFHGSIPSFFNALKGVQKIDLSRNNLSGQIPIF-LEA-LSLEYLNLSFNDFEGKIP 583 (1008)
Q Consensus 516 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~-~~~-~~L~~L~l~~N~l~g~~p 583 (1008)
+.+++|++|+|++|+|++..|..|..+++|+.|||++|+|++.+|.. ..+ .+|++|+|++|++...-.
T Consensus 515 ~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~C~ 584 (635)
T 4g8a_A 515 NSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCE 584 (635)
T ss_dssp TTCTTCCEEECTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCCSGG
T ss_pred cCCCCCCEEECCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCcccCC
Confidence 99999999999999999989999999999999999999999999987 444 579999999999998643
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=460.98 Aligned_cols=450 Identities=18% Similarity=0.216 Sum_probs=255.2
Q ss_pred ccCCeeeecCCCCCCCCCccccCCCCCCEEEc-cCCCCCCccCcccccC----cCc--ceEee----------ecccccc
Q 045798 78 SFLREINLSNNTIQGEIPPEFGRLFRLEALFL-SNNSLVGKIPANLSYC----SRL--TVLCI----------EYNKLQG 140 (1008)
Q Consensus 78 ~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L-s~n~l~~~~p~~l~~l----~~L--~~L~L----------s~n~l~~ 140 (1008)
..++.|+|++|+++|.+|++|++|++|++|+| ++|.++|..|-..... ..+ +.+.. ....+.+
T Consensus 323 ~~V~~L~Ls~~~L~G~ip~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~ 402 (876)
T 4ecn_A 323 GRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSD 402 (876)
T ss_dssp SCEEEEECTTTCCEEEECGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCH
T ss_pred CCEEEEECccCCCCCcCchHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhH
Confidence 46888999999999999999999999999999 8888876644221111 000 00000 0001110
Q ss_pred C-----------CCccccccCCCCeeeccc--ccCCCCCCCCCccccccchhhcccccCCC-----------------CC
Q 045798 141 R-----------IPLEFVSLSKLKDLSLAK--NKLTGGIPPFLGNLTSLEVLSLAGNSFGR-----------------NI 190 (1008)
Q Consensus 141 ~-----------~p~~~~~l~~L~~L~L~~--n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-----------------~~ 190 (1008)
. .+........++.+.+.. |++++ +|..|+++++|++|+|++|++++ .+
T Consensus 403 l~~~~l~~~~~~~~i~~~~~l~l~~l~l~~~~N~L~~-IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~i 481 (876)
T 4ecn_A 403 LLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYE 481 (876)
T ss_dssp HHHHHHHTCTTSCCCCCCCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHT
T ss_pred HHHHHhhhCccccccccccccchhhceeccccCcccc-hhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccC
Confidence 1 111112233445555544 77776 77788888888888888888876 37
Q ss_pred Ccccc--CCCCCcEEEecCCcccccCCccccCCCCcceecccccc-ccc-cCChhhhh------cCCCCcEEEeccccCC
Q 045798 191 PDSLG--QLKQLKILAIGGNNLSGPIPPSIYNLSFLVVFSVSHNQ-IHG-SLPPSLGL------LLPNLKFFQIHHNFFS 260 (1008)
Q Consensus 191 ~~~~~--~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ls~N~-l~~-~lp~~~~~------~l~~L~~L~L~~N~l~ 260 (1008)
|..++ .+++|++|+|++|.+.+.+|..|.++++|+.|+|++|+ ++| .+|..+.. .+++|++|+|++|.++
T Consensus 482 P~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~ 561 (876)
T 4ecn_A 482 NEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE 561 (876)
T ss_dssp TSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC
T ss_pred ChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC
Confidence 77766 88888888888888877888888888888888888887 776 67766543 2357777777777777
Q ss_pred CCCCc--ccccCCCCceeecccccccccccccccCCCcccccccccccCCCCCCCcccccccccccCC-CcEEEecCCcC
Q 045798 261 GSIPI--SLSNASKLEHIEIANNNFSGKLSVNFGGMKNLSLLNLQFSNLGSGESDEMGFMNSLTNCSK-LRVLSLGGNQF 337 (1008)
Q Consensus 261 ~~~p~--~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~l~~-L~~L~Ls~N~l 337 (1008)
.+|. .+.++++|++|+|++|++. .+| .|..+++|+.|+|++|++..++ ..+..+++ |+.|+|++|++
T Consensus 562 -~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp-~~~~L~~L~~L~Ls~N~l~~lp-------~~l~~l~~~L~~L~Ls~N~L 631 (876)
T 4ecn_A 562 -EFPASASLQKMVKLGLLDCVHNKVR-HLE-AFGTNVKLTDLKLDYNQIEEIP-------EDFCAFTDQVEGLGFSHNKL 631 (876)
T ss_dssp -BCCCHHHHTTCTTCCEEECTTSCCC-BCC-CCCTTSEESEEECCSSCCSCCC-------TTSCEECTTCCEEECCSSCC
T ss_pred -ccCChhhhhcCCCCCEEECCCCCcc-cch-hhcCCCcceEEECcCCccccch-------HHHhhccccCCEEECcCCCC
Confidence 6666 7777777777777777777 444 6666666666666666655322 23455555 66666666666
Q ss_pred CccCChhhhhhc-ccceeeeeccccccCCCCCcc---c--cccccceEEecCccccCCcchhccCCCCCceEEccCCccc
Q 045798 338 RGALPHSIANLS-SQLQILILSSNQFYGSIPLGI---G--NLVDLYLLGMVENQFTGAIPKEMGKLQKLQGLDFSGNHFS 411 (1008)
Q Consensus 338 ~~~~p~~~~~l~-~~L~~L~Ls~N~l~~~~p~~~---~--~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 411 (1008)
+ .+|..+.... .+|+.|+|++|++++.+|... . .+.+|+.|+|++|+++...+..+..+++|+.|+|++|+++
T Consensus 632 ~-~lp~~~~~~~~~~L~~L~Ls~N~l~g~ip~l~~~l~~~~~~~L~~L~Ls~N~L~~lp~~~~~~l~~L~~L~Ls~N~L~ 710 (876)
T 4ecn_A 632 K-YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMT 710 (876)
T ss_dssp C-SCCSCCCTTCSSCEEEEECCSSCTTTTSSSCSSCTTTCCCCCEEEEECCSSCCCSCCHHHHHTTCCCSEEECCSCCCS
T ss_pred C-cCchhhhccccCCCCEEECcCCcCCCccccchhhhccccCCCcCEEEccCCcCCccCHHHHccCCCCCEEECCCCcCC
Confidence 5 4554444332 125566666666555443211 1 1224555555555555222222234455555555555554
Q ss_pred ccccccccCCCCcceeeccccccccccCCCCcCCCcccEeecccccccCCcchhhhhhhhhhhhhcccCccccCCCcccc
Q 045798 412 GEIPSSLGNLSSLYEVFFNNNNLSGVIPFSLGNLKRLAFLEMSGNELSGTIPEDIFNISYLSNSLNLARNHLVGIIPPRI 491 (1008)
Q Consensus 412 ~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~lp~~~~~~~~~~~~L~L~~N~l~~~~p~~~ 491 (1008)
.+|..+.... +..+.++++|+.|+|++|+++ .+|..++.
T Consensus 711 -~ip~~~~~~~----------------~~~l~nl~~L~~L~Ls~N~L~-~lp~~l~~----------------------- 749 (876)
T 4ecn_A 711 -SIPENSLKPK----------------DGNYKNTYLLTTIDLRFNKLT-SLSDDFRA----------------------- 749 (876)
T ss_dssp -CCCTTSSSCT----------------TSCCTTGGGCCEEECCSSCCC-CCCGGGST-----------------------
T ss_pred -ccChHHhccc----------------cccccccCCccEEECCCCCCc-cchHHhhh-----------------------
Confidence 3333222111 000112336666666666665 33333220
Q ss_pred cccccccccccccccccCCCCcccccccccceeecc------CcccccchhhhhhccccccEEecCCCcccccccCcccc
Q 045798 492 GNLRALRSFDVSNNDLSGEIPIELGHCSSLEEIYLA------GNLFHGSIPSFFNALKGVQKIDLSRNNLSGQIPIFLEA 565 (1008)
Q Consensus 492 ~~l~~L~~Ldls~N~l~~~~p~~~~~l~~L~~L~L~------~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~ 565 (1008)
..+++|+.|+|++|.+++ +|..++.+++|+.|+|+ +|++.+.+|..|..+++|+.|+|++|++ +.+|....
T Consensus 750 ~~l~~L~~L~Ls~N~L~~-lp~~l~~L~~L~~L~Ls~N~~ls~N~l~~~ip~~l~~L~~L~~L~Ls~N~L-~~Ip~~l~- 826 (876)
T 4ecn_A 750 TTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDI-RKVDEKLT- 826 (876)
T ss_dssp TTCTTCCEEECCSSCCSS-CCCGGGGCTTCCEEECCCCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCCC-
T ss_pred ccCCCcCEEEeCCCCCCc-cchhhhcCCCCCEEECCCCCCcccccccccChHHHhcCCCCCEEECCCCCC-CccCHhhc-
Confidence 033344444444444442 34444444444444443 3555556666666666666666666666 45555422
Q ss_pred cccceeecccCcccccCC
Q 045798 566 LSLEYLNLSFNDFEGKIP 583 (1008)
Q Consensus 566 ~~L~~L~l~~N~l~g~~p 583 (1008)
.+|+.|+|++|++....+
T Consensus 827 ~~L~~LdLs~N~l~~i~~ 844 (876)
T 4ecn_A 827 PQLYILDIADNPNISIDV 844 (876)
T ss_dssp SSSCEEECCSCTTCEEEC
T ss_pred CCCCEEECCCCCCCccCh
Confidence 356666666666555443
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-46 Score=418.68 Aligned_cols=283 Identities=20% Similarity=0.219 Sum_probs=207.8
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEecccc--chhhHHHHHHHHHHhhcCCCCceeeeeccccc-cccCCc
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC--EGASKSFMAECKALKNIRHRNLVKVITSCSSI-DFQGND 759 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~~~~ 759 (1008)
.++|++++.||+|+||+||+|++..+|+.||||+++... ....+.+.+|+++|++++|||||++++++... .+.+.+
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 367999999999999999999999999999999997443 33456789999999999999999999987643 244567
Q ss_pred eEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeE
Q 045798 760 FKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGH 839 (1008)
Q Consensus 760 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 839 (1008)
..|+|||||+ |+|.+++...+ ++++..++.++.||+.||+|||++ +||||||||+|||++.++.+|
T Consensus 133 ~~~ivmE~~~-g~L~~~i~~~~----------~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~K 198 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIHSSQ----------PLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELK 198 (398)
T ss_dssp CEEEEEECCS-EEHHHHHTSSS----------CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEE
T ss_pred EEEEEEeCCC-CCHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEE
Confidence 8999999995 78999997654 799999999999999999999998 999999999999999999999
Q ss_pred EcccCcccccccccCccccccccccccccccCccccCCC-CCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHH
Q 045798 840 IGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGS-EVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFAR 918 (1008)
Q Consensus 840 L~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~ 918 (1008)
|+|||+|+................+||+.|||||++.+. .++.++||||+||++|||++|++||......+ .+.....
T Consensus 199 i~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~-~l~~I~~ 277 (398)
T 4b99_A 199 IGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVH-QLQLIMM 277 (398)
T ss_dssp ECCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHH-HHHHHHH
T ss_pred EeecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHH-HHHHHHH
Confidence 999999987654433333334456799999999998875 46899999999999999999999996432111 1111111
Q ss_pred hhCCcchhhhhcccccCchHHhhhhhhhhhccccchh-----HHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 919 MALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINS-----RLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 919 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
......... ......... ......++...+. ....+.++.+|+.+||+.||++||||+|+++
T Consensus 278 ~~g~p~~~~-~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 344 (398)
T 4b99_A 278 VLGTPSPAV-IQAVGAERV-----RAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR 344 (398)
T ss_dssp HHCCCCGGG-TC-----CH-----HHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred hcCCCChHH-hhhhhhhhh-----hhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 111111000 000000000 0000000000000 0123456789999999999999999999976
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-46 Score=445.26 Aligned_cols=219 Identities=20% Similarity=0.196 Sum_probs=161.1
Q ss_pred EEEeccccCCCCccCcCccCCccCCeeeecCCCCCCCCCccccCCCCCCEEEccCCCCCCccCcccccCcCcceEeeecc
Q 045798 57 TALDLMSKSLSGSLSPHLGNLSFLREINLSNNTIQGEIPPEFGRLFRLEALFLSNNSLVGKIPANLSYCSRLTVLCIEYN 136 (1008)
Q Consensus 57 ~~l~l~~~~l~~~l~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n 136 (1008)
..+|+++++++ .+|..+. ++|++|+|++|.+++..|.+|.++++|++|+|++|++++..|..|+++++|++|+|++|
T Consensus 34 ~~l~ls~~~L~-~ip~~~~--~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N 110 (562)
T 3a79_B 34 SMVDYSNRNLT-HVPKDLP--PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHN 110 (562)
T ss_dssp CEEECTTSCCC-SCCTTSC--TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTS
T ss_pred cEEEcCCCCCc-cCCCCCC--CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCC
Confidence 67899999998 4777665 78999999999999777788999999999999999999888888999999999999999
Q ss_pred ccccCCCccccccCCCCeeecccccCCCC-CCCCCccccccchhhcccccCCCCCCccccCCCCC--cEEEecCCcc--c
Q 045798 137 KLQGRIPLEFVSLSKLKDLSLAKNKLTGG-IPPFLGNLTSLEVLSLAGNSFGRNIPDSLGQLKQL--KILAIGGNNL--S 211 (1008)
Q Consensus 137 ~l~~~~p~~~~~l~~L~~L~L~~n~l~~~-~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L--~~L~L~~n~l--~ 211 (1008)
+|+ .+|.. .+++|++|+|++|++++. +|..|+++++|++|++++|+++.. .+..+++| +.|++++|.+ +
T Consensus 111 ~l~-~lp~~--~l~~L~~L~Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~---~~~~l~~L~L~~L~L~~n~l~~~ 184 (562)
T 3a79_B 111 RLQ-NISCC--PMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQL---DLLPVAHLHLSCILLDLVSYHIK 184 (562)
T ss_dssp CCC-EECSC--CCTTCSEEECCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCTT---TTGGGTTSCEEEEEEEESSCCCC
T ss_pred cCC-ccCcc--ccccCCEEECCCCCccccCchHhhcccCcccEEecCCCccccC---chhhhhhceeeEEEeeccccccc
Confidence 998 45655 788999999999998853 457888889999999999888653 45555555 8889988888 7
Q ss_pred ccCCccccCCC-CcceeccccccccccCChhhhhcCCCCcEEEeccccCC----CCCCcccccCCCCceeeccccccc
Q 045798 212 GPIPPSIYNLS-FLVVFSVSHNQIHGSLPPSLGLLLPNLKFFQIHHNFFS----GSIPISLSNASKLEHIEIANNNFS 284 (1008)
Q Consensus 212 ~~~~~~~~~l~-~L~~L~ls~N~l~~~lp~~~~~~l~~L~~L~L~~N~l~----~~~p~~l~~l~~L~~L~L~~N~l~ 284 (1008)
+..|..+..+. ..-.+++++|.+.+.++...+..+++|+.|++++|... ...+..+..+++|+.|+++++.+.
T Consensus 185 ~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~l~~~~~~l~~l~~L~~L~L~~~~l~ 262 (562)
T 3a79_B 185 GGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETT 262 (562)
T ss_dssp SSSCCEEEECCEEEEEEEECSSSCCCCCCEEEESSEEEEEEEEEECCSTTHHHHHHHHHHHHSCSSCEEEEEEEEEEC
T ss_pred ccCcccccccCcceEEEEecCccchhhhhhhcccccceEEEecccccccccchHHHHHHHHhccCcceEEEecCCcCc
Confidence 77777777755 12245777777776666555555566666666665311 011123344445555555444443
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=431.51 Aligned_cols=463 Identities=20% Similarity=0.209 Sum_probs=325.4
Q ss_pred cCCeeeecCCCCCCCCCccccCCCCCCEEEccCCCCCCccCcccccCcCcceEeeeccccccCCCccccccCCCCeeecc
Q 045798 79 FLREINLSNNTIQGEIPPEFGRLFRLEALFLSNNSLVGKIPANLSYCSRLTVLCIEYNKLQGRIPLEFVSLSKLKDLSLA 158 (1008)
Q Consensus 79 ~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~ 158 (1008)
..+++++++|+++ .+|..+. ++|++|+|++|.+++..|..|+++++|++|+|++|++++..|..|.++++|++|+|+
T Consensus 32 ~~~~l~ls~~~L~-~ip~~~~--~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls 108 (562)
T 3a79_B 32 LESMVDYSNRNLT-HVPKDLP--PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVS 108 (562)
T ss_dssp -CCEEECTTSCCC-SCCTTSC--TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECT
T ss_pred CCcEEEcCCCCCc-cCCCCCC--CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECC
Confidence 3489999999999 5777664 899999999999998888899999999999999999998889999999999999999
Q ss_pred cccCCCCCCCCCccccccchhhcccccCCCC-CCccccCCCCCcEEEecCCcccccCCccccCCCCc--ceeccccccc-
Q 045798 159 KNKLTGGIPPFLGNLTSLEVLSLAGNSFGRN-IPDSLGQLKQLKILAIGGNNLSGPIPPSIYNLSFL--VVFSVSHNQI- 234 (1008)
Q Consensus 159 ~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~-~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L--~~L~ls~N~l- 234 (1008)
+|+++ .+|.. .+++|++|+|++|++++. .|..|+++++|++|++++|.+++. .+..+++| +.|++++|.+
T Consensus 109 ~N~l~-~lp~~--~l~~L~~L~Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~---~~~~l~~L~L~~L~L~~n~l~ 182 (562)
T 3a79_B 109 HNRLQ-NISCC--PMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQL---DLLPVAHLHLSCILLDLVSYH 182 (562)
T ss_dssp TSCCC-EECSC--CCTTCSEEECCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCTT---TTGGGTTSCEEEEEEEESSCC
T ss_pred CCcCC-ccCcc--ccccCCEEECCCCCccccCchHhhcccCcccEEecCCCccccC---chhhhhhceeeEEEeeccccc
Confidence 99999 66766 789999999999999763 468899999999999999998853 34444444 8888888877
Q ss_pred -cccCChhhhhcCCCCcEEEeccccCCCCCCc-ccccCCCCceeecccccccccccccccCCCcccccccccccCCCCCC
Q 045798 235 -HGSLPPSLGLLLPNLKFFQIHHNFFSGSIPI-SLSNASKLEHIEIANNNFSGKLSVNFGGMKNLSLLNLQFSNLGSGES 312 (1008)
Q Consensus 235 -~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~-~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~ 312 (1008)
++..|..+...-...-.+++++|.+.+.++. .+..+++|+.|++++|+.. ..
T Consensus 183 ~~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~------------------------~~-- 236 (562)
T 3a79_B 183 IKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDEN------------------------CQ-- 236 (562)
T ss_dssp CCSSSCCEEEECCEEEEEEEECSSSCCCCCCEEEESSEEEEEEEEEECCSTT------------------------HH--
T ss_pred ccccCcccccccCcceEEEEecCccchhhhhhhcccccceEEEecccccccc------------------------cc--
Confidence 6555554432111122456666666554433 3445566666666665311 00
Q ss_pred CcccccccccccCCCcEEEecCCcCCccCChhhhhh--cccceeeeeccccccCCCCCcc-----ccccccceEEecCcc
Q 045798 313 DEMGFMNSLTNCSKLRVLSLGGNQFRGALPHSIANL--SSQLQILILSSNQFYGSIPLGI-----GNLVDLYLLGMVENQ 385 (1008)
Q Consensus 313 ~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l--~~~L~~L~Ls~N~l~~~~p~~~-----~~l~~L~~L~L~~n~ 385 (1008)
........+..+++|+.|+++++.+.+.....+... ..+|++|++++|.+++.+|..+ ..+..|..+++..|.
T Consensus 237 ~l~~~~~~l~~l~~L~~L~L~~~~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~ip~~~~~~~~~~L~~L~~~~~~~~~ 316 (562)
T 3a79_B 237 RLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQV 316 (562)
T ss_dssp HHHHHHHHHHSCSSCEEEEEEEEEECHHHHHHHHHHHTTSSEEEEEEEEEEECSCCCCCCCCCCSCSCCEEEEEEEEECC
T ss_pred hHHHHHHHHhccCcceEEEecCCcCcHHHHHHHHHhhhcccccEEEEeccEeeccccchhhhcccccchheehhhcccce
Confidence 000112234455566666666555543211111110 1258888888888887777776 677777777777776
Q ss_pred ccCCcc-hhccCC---CCCceEEccCCcccccccccccCCCCcceeeccccccccccCCCCcCCCcccEeecccccccCC
Q 045798 386 FTGAIP-KEMGKL---QKLQGLDFSGNHFSGEIPSSLGNLSSLYEVFFNNNNLSGVIPFSLGNLKRLAFLEMSGNELSGT 461 (1008)
Q Consensus 386 l~~~~~-~~~~~l---~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 461 (1008)
+ .+| ..+..+ .+|+.|++++|.+.... ....+++|++|++++|.+++..|..++++++|+.|+|++|++++
T Consensus 317 ~--~~p~~~~~~~~~~~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~- 391 (562)
T 3a79_B 317 F--LFSKEALYSVFAEMNIKMLSISDTPFIHMV--CPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKN- 391 (562)
T ss_dssp C--SSCHHHHHHHHHTCCCSEEEEESSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCB-
T ss_pred e--ecChhhhhhhhccCcceEEEccCCCccccc--CccCCCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCC-
Confidence 6 333 333322 56888888888775221 12567778888888888887777788888888888888888873
Q ss_pred cch--hhhhhhhhhhhhcccCccccCCCcc-cccccccccccccccccccCCCCcccccccccceeeccCcccccchhhh
Q 045798 462 IPE--DIFNISYLSNSLNLARNHLVGIIPP-RIGNLRALRSFDVSNNDLSGEIPIELGHCSSLEEIYLAGNLFHGSIPSF 538 (1008)
Q Consensus 462 lp~--~~~~~~~~~~~L~L~~N~l~~~~p~-~~~~l~~L~~Ldls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~ 538 (1008)
+|. ..+.....++.|+|++|++++.+|. .+..+++|+.|+|++|.+++.+|..+. ++|++|+|++|+|+ .+|..
T Consensus 392 ~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~-~ip~~ 468 (562)
T 3a79_B 392 FFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKD 468 (562)
T ss_dssp TTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTCCEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCC-CCCTT
T ss_pred cccchhhhcCCCCCCEEECCCCcCCCccChhhhcCcccCCEEECCCCCCCcchhhhhc--CcCCEEECCCCcCc-ccChh
Confidence 432 2223334456777777777774554 477788888888888888877776654 68888888888888 67777
Q ss_pred hhccccccEEecCCCcccccccC-cccccccceeecccCcccccCCC
Q 045798 539 FNALKGVQKIDLSRNNLSGQIPI-FLEALSLEYLNLSFNDFEGKIPA 584 (1008)
Q Consensus 539 ~~~l~~L~~L~ls~N~l~~~~p~-~~~~~~L~~L~l~~N~l~g~~p~ 584 (1008)
+..+++|+.|+|++|++++..+. ...+.+|+.|++++|++++..|.
T Consensus 469 ~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~N~~~c~c~~ 515 (562)
T 3a79_B 469 VTHLQALQELNVASNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCPG 515 (562)
T ss_dssp TTSSCCCSEEECCSSCCCCCCTTSTTTCTTCCCEECCSCCBCCCHHH
T ss_pred hcCCCCCCEEECCCCCCCCCCHHHHhcCCCCCEEEecCCCcCCCcch
Confidence 77888888888888888854443 35667788888888888887663
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-45 Score=404.73 Aligned_cols=202 Identities=25% Similarity=0.350 Sum_probs=170.6
Q ss_pred HHhcCCCCCceEeeccCeeEEEEEEc---CCCeEEEEEEeccccchhhHHHHHHHHHHhhc-CCCCceeeeecccccccc
Q 045798 681 KATNGFSSTHLIGVGSFGCVYKGALD---EDGIVVAIKVINLQCEGASKSFMAECKALKNI-RHRNLVKVITSCSSIDFQ 756 (1008)
Q Consensus 681 ~~~~~y~~~~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 756 (1008)
...++|++.+.||+|+||+||+|+++ .+++.||+|++... ....++.+|+++++.+ +||||++++++ +.
T Consensus 18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~--~~~~~~~~E~~~l~~~~~h~nIv~l~~~-----~~ 90 (361)
T 4f9c_A 18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT--SHPIRIAAELQCLTVAGGQDNVMGVKYC-----FR 90 (361)
T ss_dssp GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT--SCHHHHHHHHHHHHHTCSBTTBCCCSEE-----EE
T ss_pred CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc--cCHHHHHHHHHHHHHhcCCCCCceEEEE-----EE
Confidence 34678999999999999999999874 35789999998654 2345688999999998 79999999998 56
Q ss_pred CCceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCC-
Q 045798 757 GNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDND- 835 (1008)
Q Consensus 757 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~- 835 (1008)
++++.|+||||+++|+|.+++. .+++.+++.++.||+.||+|||++ |||||||||+|||++.+
T Consensus 91 ~~~~~~lvmE~~~g~~L~~~~~-------------~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~ 154 (361)
T 4f9c_A 91 KNDHVVIAMPYLEHESFLDILN-------------SLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRL 154 (361)
T ss_dssp ETTEEEEEEECCCCCCHHHHHT-------------TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTT
T ss_pred ECCEEEEEEeCCCcccHHHHHc-------------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCC
Confidence 6788999999999999999984 588999999999999999999998 99999999999999876
Q ss_pred CCeEEcccCcccccccccCcc------------------------ccccccccccccccCccccCCC-CCCcccchhhHH
Q 045798 836 LSGHIGDFGLARFHQEVSNST------------------------LSSSVGVKGTIGYTAPEYGLGS-EVSTNGDVYSYG 890 (1008)
Q Consensus 836 ~~~kL~Dfg~a~~~~~~~~~~------------------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG 890 (1008)
+.+||+|||+|+......... .......+||+.|+|||++.+. .|+.++||||+|
T Consensus 155 ~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG 234 (361)
T 4f9c_A 155 KKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAG 234 (361)
T ss_dssp TEEEECCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHH
T ss_pred CeEEECcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhH
Confidence 799999999998654322110 0112235699999999998876 489999999999
Q ss_pred HHHHHHHhCCCCCCc
Q 045798 891 ILLLEMVTAKKPTDV 905 (1008)
Q Consensus 891 ~vl~elltG~~pf~~ 905 (1008)
|++|||++|+.||..
T Consensus 235 ~il~ell~G~~Pf~~ 249 (361)
T 4f9c_A 235 VIFLSLLSGRYPFYK 249 (361)
T ss_dssp HHHHHHHHTCSSSSC
T ss_pred HHHHHHHHCCCCCCC
Confidence 999999999999964
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=411.88 Aligned_cols=250 Identities=22% Similarity=0.281 Sum_probs=198.5
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEecccc---chhhHHH---HHHHHHHhhcCCCCceeeeecccccccc
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC---EGASKSF---MAECKALKNIRHRNLVKVITSCSSIDFQ 756 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~---~~E~~~l~~l~h~niv~~~~~~~~~~~~ 756 (1008)
.++|++.+.||+|+||+||+|+++.+|+.||||+++... ......+ ..++.+++.++|||||+++++ ++
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~-----f~ 262 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYA-----FH 262 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEE-----EE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEE-----EE
Confidence 467999999999999999999999999999999996321 1222233 344667777899999999999 57
Q ss_pred CCceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCC
Q 045798 757 GNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDL 836 (1008)
Q Consensus 757 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 836 (1008)
+++..|+|||||+||+|.+++...+ .+++..++.++.||+.||+|||++ +||||||||+|||++.+|
T Consensus 263 ~~~~lylVmEy~~GGdL~~~l~~~~----------~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G 329 (689)
T 3v5w_A 263 TPDKLSFILDLMNGGDLHYHLSQHG----------VFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHG 329 (689)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHHC----------CCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTS
T ss_pred ECCEEEEEEecCCCCcHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCC
Confidence 7788999999999999999997654 799999999999999999999998 999999999999999999
Q ss_pred CeEEcccCcccccccccCccccccccccccccccCccccCC-CCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHH
Q 045798 837 SGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLG-SEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHN 915 (1008)
Q Consensus 837 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~ 915 (1008)
++||+|||+|+...... ....+||+.|||||++.+ ..|+.++||||+||++|||++|++||......+. ..
T Consensus 330 ~vKL~DFGlA~~~~~~~------~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~--~~ 401 (689)
T 3v5w_A 330 HVRISDLGLACDFSKKK------PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK--HE 401 (689)
T ss_dssp CEEECCCTTCEECSSCC------CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCH--HH
T ss_pred CEEecccceeeecCCCC------CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH--HH
Confidence 99999999998664432 234579999999999864 5799999999999999999999999974322111 11
Q ss_pred HHHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCC-----HHHHHH
Q 045798 916 FARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMN-----MTNVVH 986 (1008)
Q Consensus 916 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~ 986 (1008)
..... .... ..++ ...+.++.+++.+||+.||.+|++ ++||++
T Consensus 402 i~~~i--------~~~~--------------~~~p------~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 402 IDRMT--------LTMA--------------VELP------DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp HHHHH--------HHCC--------------CCCC------TTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred HHHhh--------cCCC--------------CCCC------ccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 10000 0000 0000 123456789999999999999998 677654
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-43 Score=413.56 Aligned_cols=253 Identities=21% Similarity=0.295 Sum_probs=207.7
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccchhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceEE
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKA 762 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 762 (1008)
.++|++.+.||+|+||.||+|+++.+|+.||+|++........+.+.+|+++|+.++|||||+++++ +.+++..|
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~-----~~~~~~~~ 230 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDA-----FEDDNEMV 230 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEE-----EECSSEEE
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEE-----EEECCEEE
Confidence 4689999999999999999999999999999999987666667789999999999999999999999 56778899
Q ss_pred EEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCC--CCeEE
Q 045798 763 IVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDND--LSGHI 840 (1008)
Q Consensus 763 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~--~~~kL 840 (1008)
+|||||+||+|.+++..... .+++.++..++.||+.||+|||++ +|+||||||+|||++.+ +.+||
T Consensus 231 iv~E~~~gg~L~~~i~~~~~---------~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl 298 (573)
T 3uto_A 231 MIYEFMSGGELFEKVADEHN---------KMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKL 298 (573)
T ss_dssp EEEECCCCCBHHHHHTCTTS---------CEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEE
T ss_pred EEEeecCCCcHHHHHHHhCC---------CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEE
Confidence 99999999999999865421 689999999999999999999998 99999999999999854 89999
Q ss_pred cccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHhh
Q 045798 841 GDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMA 920 (1008)
Q Consensus 841 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~~ 920 (1008)
+|||+|+....... ....+||+.|||||++.+..|+.++||||+||++|||++|+.||......+ .+.......
T Consensus 299 ~DFG~a~~~~~~~~-----~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~-~~~~i~~~~ 372 (573)
T 3uto_A 299 IDFGLTAHLDPKQS-----VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE-TLRNVKSCD 372 (573)
T ss_dssp CCCSSCEECCTTSE-----EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH-HHHHHHTTC
T ss_pred eeccceeEccCCCc-----eeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH-HHHHHHhCC
Confidence 99999987654322 123469999999999999999999999999999999999999986432110 000000000
Q ss_pred CCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 921 LPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 921 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
. .. ........+.++.+|+.+||+.||.+|||++|+++
T Consensus 373 ~------------~~----------------~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 373 W------------NM----------------DDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp C------------CC----------------CSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred C------------CC----------------CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 00 00001123456789999999999999999999986
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=379.69 Aligned_cols=294 Identities=24% Similarity=0.450 Sum_probs=275.0
Q ss_pred ccCChhhHHHHHHHHHhhccCCCCCCCCCCCCCCCCc--ccceEEcCCC--CeEEEEeccccCCCC--ccCcCccCCccC
Q 045798 7 AALEDGDRAALQAFKSMIAHEPQGILNSWNDSRHFCE--WEGITCGRRH--RRVTALDLMSKSLSG--SLSPHLGNLSFL 80 (1008)
Q Consensus 7 ~~~~~~~~~~l~~~k~~~~~~~~~~~~~w~~~~~~c~--w~gv~c~~~~--~~v~~l~l~~~~l~~--~l~~~l~~l~~L 80 (1008)
+.|.++|++||++||+++. ||. .+++|+.+++||. |.||+|+... ++|+.|+|+++.++| .+|+.+..+++|
T Consensus 1 ~~c~~~~~~aL~~~k~~~~-~~~-~l~~W~~~~~~C~~~w~gv~C~~~~~~~~l~~L~L~~~~l~~~~~~~~~l~~l~~L 78 (313)
T 1ogq_A 1 ELCNPQDKQALLQIKKDLG-NPT-TLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYL 78 (313)
T ss_dssp CCSCHHHHHHHHHHHHHTT-CCG-GGTTCCTTSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTC
T ss_pred CCCCHHHHHHHHHHHHhcC-Ccc-cccCCCCCCCCCcCCCcceEeCCCCCCceEEEEECCCCCccCCcccChhHhCCCCC
Confidence 3589999999999999995 665 6899998889998 9999998654 799999999999999 899999999999
Q ss_pred CeeeecC-CCCCCCCCccccCCCCCCEEEccCCCCCCccCcccccCcCcceEeeeccccccCCCccccccCCCCeeeccc
Q 045798 81 REINLSN-NTIQGEIPPEFGRLFRLEALFLSNNSLVGKIPANLSYCSRLTVLCIEYNKLQGRIPLEFVSLSKLKDLSLAK 159 (1008)
Q Consensus 81 ~~L~L~~-n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~ 159 (1008)
++|+|++ |++.+.+|..|.++++|++|+|++|++++.+|..|+.+++|++|+|++|.+++.+|..|..+++|++|+|++
T Consensus 79 ~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~ 158 (313)
T 1ogq_A 79 NFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDG 158 (313)
T ss_dssp SEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCS
T ss_pred CeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCccCCcCChHHhcCCCCCeEECcC
Confidence 9999995 999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccCCCCCCCCCcccc-ccchhhcccccCCCCCCccccCCCCCcEEEecCCcccccCCccccCCCCcceeccccccccccC
Q 045798 160 NKLTGGIPPFLGNLT-SLEVLSLAGNSFGRNIPDSLGQLKQLKILAIGGNNLSGPIPPSIYNLSFLVVFSVSHNQIHGSL 238 (1008)
Q Consensus 160 n~l~~~~~~~~~~l~-~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~~~l 238 (1008)
|++++.+|..++.++ +|++|++++|++++..|..|..++ |+.|++++|.+++..|..|..+++|+.|++++|++++.+
T Consensus 159 N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 237 (313)
T 1ogq_A 159 NRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDL 237 (313)
T ss_dssp SCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBG
T ss_pred CcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-ccEEECcCCcccCcCCHHHhcCCCCCEEECCCCceeeec
Confidence 999999999999998 999999999999989999999998 999999999999999999999999999999999998666
Q ss_pred ChhhhhcCCCCcEEEeccccCCCCCCcccccCCCCceeecccccccccccccccCCCccccccccccc
Q 045798 239 PPSLGLLLPNLKFFQIHHNFFSGSIPISLSNASKLEHIEIANNNFSGKLSVNFGGMKNLSLLNLQFSN 306 (1008)
Q Consensus 239 p~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~ 306 (1008)
|. +..+++|++|+|++|.+++.+|..+..+++|++|++++|++++..|.. ..+++|+.|++++|.
T Consensus 238 ~~--~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~-~~l~~L~~l~l~~N~ 302 (313)
T 1ogq_A 238 GK--VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG-GNLQRFDVSAYANNK 302 (313)
T ss_dssp GG--CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCS-TTGGGSCGGGTCSSS
T ss_pred Cc--ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCCCC-ccccccChHHhcCCC
Confidence 65 455899999999999999999999999999999999999999888876 778888888888876
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=396.70 Aligned_cols=392 Identities=20% Similarity=0.204 Sum_probs=252.8
Q ss_pred CeeeecCCCCCCCCCccccCCCCCCEEEccCCCCCCccCcccccCcCcceEeeeccccccCC-CccccccCCCCeeeccc
Q 045798 81 REINLSNNTIQGEIPPEFGRLFRLEALFLSNNSLVGKIPANLSYCSRLTVLCIEYNKLQGRI-PLEFVSLSKLKDLSLAK 159 (1008)
Q Consensus 81 ~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~-p~~~~~l~~L~~L~L~~ 159 (1008)
+.++.++++++ .+|. + .++|++|+|++|.+++..|..|+++++|++|+|++|.+.+.+ +..|.++++|++|+|++
T Consensus 13 ~~~~c~~~~l~-~lp~-l--~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~ 88 (455)
T 3v47_A 13 YNAICINRGLH-QVPE-L--PAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDY 88 (455)
T ss_dssp TEEECCSSCCS-SCCC-C--CTTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTT
T ss_pred cccCcCCCCcc-cCCC-C--CCccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEeCCC
Confidence 45677777776 5554 2 267777777777777666777777777777777777775333 45566666666666666
Q ss_pred ccCCCCCCCCCccccccchhhcccccCCCCCCcc--ccCCCCCcEEEecCCcccccCCccccCCCCcceecccccccccc
Q 045798 160 NKLTGGIPPFLGNLTSLEVLSLAGNSFGRNIPDS--LGQLKQLKILAIGGNNLSGPIPPSIYNLSFLVVFSVSHNQIHGS 237 (1008)
Q Consensus 160 n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~--~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~~~ 237 (1008)
|++++..|..|+++++|++|+|++|++++..+.. |..+++|++|+|++|.+++..|.
T Consensus 89 n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~--------------------- 147 (455)
T 3v47_A 89 NQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPA--------------------- 147 (455)
T ss_dssp CTTCEECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCC---------------------
T ss_pred CccCccChhhccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCccCcc---------------------
Confidence 6666555666666666666666666665433332 55555555555555555544443
Q ss_pred CChhhhhcCCCCcEEEeccccCCCCCCcccccC--CCCceeecccccccccccccccCCCcccccccccccCCCCCCCcc
Q 045798 238 LPPSLGLLLPNLKFFQIHHNFFSGSIPISLSNA--SKLEHIEIANNNFSGKLSVNFGGMKNLSLLNLQFSNLGSGESDEM 315 (1008)
Q Consensus 238 lp~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l--~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~ 315 (1008)
.++..+++|++|+|++|.+.+..|..+..+ .+|+.|++++|.+.+..+..+..
T Consensus 148 ---~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~~~L~~L~l~~n~l~~~~~~~~~~---------------------- 202 (455)
T 3v47_A 148 ---SFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGW---------------------- 202 (455)
T ss_dssp ---GGGGGCTTCCEEECTTCCBSCCCTTTSGGGTTCEEEEEECTTCBCTTCSTTCTTH----------------------
T ss_pred ---cccCCCCcccEEeCCCCcccccChhhhhccccccccccccccCcccccchhhccc----------------------
Confidence 333334444444444444444444444444 46666666666666544332210
Q ss_pred cccccccccCCCcEEEecCCcCCccCChhhhhhc--ccceeeeeccccccCCCCCccccccccceEEecCccccCCcchh
Q 045798 316 GFMNSLTNCSKLRVLSLGGNQFRGALPHSIANLS--SQLQILILSSNQFYGSIPLGIGNLVDLYLLGMVENQFTGAIPKE 393 (1008)
Q Consensus 316 ~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~--~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~ 393 (1008)
.....+..+++|+.|++++|++.+..|..+.... .+|+.|++++|.+.+... ..+.+.+..+..
T Consensus 203 ~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~--------------~~~~~~~~~~~~ 268 (455)
T 3v47_A 203 EKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSF--------------GHTNFKDPDNFT 268 (455)
T ss_dssp HHHCCTTTTCEEEEEECTTSCCCHHHHHHHHHHTTTCCEEEEECTTCTTTSCCT--------------TCCSSCCCCTTT
T ss_pred cccccccccceeeeEecCCCcccccchhhhhccccccceeeEeecccccccccc--------------chhhhccCcccc
Confidence 0111234567888899999998887887776652 358888888887664211 122233233333
Q ss_pred ccC--CCCCceEEccCCcccccccccccCCCCcceeeccccccccccCCCCcCCCcccEeecccccccCCcchhhhhhhh
Q 045798 394 MGK--LQKLQGLDFSGNHFSGEIPSSLGNLSSLYEVFFNNNNLSGVIPFSLGNLKRLAFLEMSGNELSGTIPEDIFNISY 471 (1008)
Q Consensus 394 ~~~--l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~lp~~~~~~~~ 471 (1008)
+.. .++|+.|+|++|.+.+..|..+..+++|++|++++|.+.+..|..|.++++|++|+|++|++++
T Consensus 269 ~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~----------- 337 (455)
T 3v47_A 269 FKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGS----------- 337 (455)
T ss_dssp TGGGTTSCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCE-----------
T ss_pred cccccccCceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCC-----------
Confidence 333 3578888888888887777778888888888888888887777778888888888888777763
Q ss_pred hhhhhcccCccccCCCcccccccccccccccccccccCCCCcccccccccceeeccCcccccchhhhhhccccccEEecC
Q 045798 472 LSNSLNLARNHLVGIIPPRIGNLRALRSFDVSNNDLSGEIPIELGHCSSLEEIYLAGNLFHGSIPSFFNALKGVQKIDLS 551 (1008)
Q Consensus 472 ~~~~L~L~~N~l~~~~p~~~~~l~~L~~Ldls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls 551 (1008)
..|..|+.+++|+.|||++|.+++..|..+..+++|++|+|++|+|++..+..|..+++|+.|+|+
T Consensus 338 --------------~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~ 403 (455)
T 3v47_A 338 --------------IDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLH 403 (455)
T ss_dssp --------------ECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECC
T ss_pred --------------cChhHhcCcccCCEEECCCCcccccChhhccccccccEEECCCCccccCCHhHhccCCcccEEEcc
Confidence 345556677777777777777776667777777777777777777776566666777777777777
Q ss_pred CCcccccccC
Q 045798 552 RNNLSGQIPI 561 (1008)
Q Consensus 552 ~N~l~~~~p~ 561 (1008)
+|++++..|.
T Consensus 404 ~N~l~~~~~~ 413 (455)
T 3v47_A 404 TNPWDCSCPR 413 (455)
T ss_dssp SSCBCCCTTT
T ss_pred CCCcccCCCc
Confidence 7777776663
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=400.65 Aligned_cols=402 Identities=22% Similarity=0.268 Sum_probs=196.4
Q ss_pred ccCCccCCeeeecCCCCCCCCCccccCCCCCCEEEccCCCCCCccCcccccCcCcceEeeeccccccCCCccccccCCCC
Q 045798 74 LGNLSFLREINLSNNTIQGEIPPEFGRLFRLEALFLSNNSLVGKIPANLSYCSRLTVLCIEYNKLQGRIPLEFVSLSKLK 153 (1008)
Q Consensus 74 l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~ 153 (1008)
-...++|++|++++|++ +.+|++|+++++|++|++++|.+++.+|..++++++|+.+++++|.. .+|+
T Consensus 7 ~~~~~~L~~L~l~~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~-----------~~l~ 74 (454)
T 1jl5_A 7 NVSNTFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLD-----------RQAH 74 (454)
T ss_dssp ----------------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHH-----------HTCS
T ss_pred ccccccchhhhcccCch-hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhc-----------cCCC
Confidence 33456777777777777 47777777777777777777777777777777777776666665542 4567
Q ss_pred eeecccccCCCCCCCCCccccccchhhcccccCCCCCCccccCCCCCcEEEecCCcccccCCccccCCCCcceecccccc
Q 045798 154 DLSLAKNKLTGGIPPFLGNLTSLEVLSLAGNSFGRNIPDSLGQLKQLKILAIGGNNLSGPIPPSIYNLSFLVVFSVSHNQ 233 (1008)
Q Consensus 154 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ls~N~ 233 (1008)
+|++++|.+++ +|.. .++|++|++++|++++ +|.. +++|++|++++|++++. +.. .++|++|++++|+
T Consensus 75 ~L~l~~~~l~~-lp~~---~~~L~~L~l~~n~l~~-lp~~---~~~L~~L~l~~n~l~~l-~~~---~~~L~~L~L~~n~ 142 (454)
T 1jl5_A 75 ELELNNLGLSS-LPEL---PPHLESLVASCNSLTE-LPEL---PQSLKSLLVDNNNLKAL-SDL---PPLLEYLGVSNNQ 142 (454)
T ss_dssp EEECTTSCCSC-CCSC---CTTCSEEECCSSCCSS-CCCC---CTTCCEEECCSSCCSCC-CSC---CTTCCEEECCSSC
T ss_pred EEEecCCcccc-CCCC---cCCCCEEEccCCcCCc-cccc---cCCCcEEECCCCccCcc-cCC---CCCCCEEECcCCC
Confidence 78888888774 4442 2567777777777765 4432 36677777777777642 211 1466666666666
Q ss_pred ccccCChhhhhcCCCCcEEEeccccCCCCCCcccccCCCCceeecccccccccccccccCCCcccccccccccCCCCCCC
Q 045798 234 IHGSLPPSLGLLLPNLKFFQIHHNFFSGSIPISLSNASKLEHIEIANNNFSGKLSVNFGGMKNLSLLNLQFSNLGSGESD 313 (1008)
Q Consensus 234 l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~ 313 (1008)
++ .+|. +..+++|++|++++|++++ +|..+ .+|++|++++|++++. + .|.+++
T Consensus 143 l~-~lp~--~~~l~~L~~L~l~~N~l~~-lp~~~---~~L~~L~L~~n~l~~l-~-~~~~l~------------------ 195 (454)
T 1jl5_A 143 LE-KLPE--LQNSSFLKIIDVDNNSLKK-LPDLP---PSLEFIAAGNNQLEEL-P-ELQNLP------------------ 195 (454)
T ss_dssp CS-SCCC--CTTCTTCCEEECCSSCCSC-CCCCC---TTCCEEECCSSCCSSC-C-CCTTCT------------------
T ss_pred CC-CCcc--cCCCCCCCEEECCCCcCcc-cCCCc---ccccEEECcCCcCCcC-c-cccCCC------------------
Confidence 66 3552 3445666666666666653 34322 3566666666665542 2 344444
Q ss_pred cccccccccccCCCcEEEecCCcCCccCChhhhhhcccceeeeeccccccCCCCCccccccccceEEecCccccCCcchh
Q 045798 314 EMGFMNSLTNCSKLRVLSLGGNQFRGALPHSIANLSSQLQILILSSNQFYGSIPLGIGNLVDLYLLGMVENQFTGAIPKE 393 (1008)
Q Consensus 314 ~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~ 393 (1008)
+|+.|++++|++++ +|... .+|++|++++|.++ .+|. +..+++|+.|++++|++++ +|..
T Consensus 196 ------------~L~~L~l~~N~l~~-l~~~~----~~L~~L~l~~n~l~-~lp~-~~~l~~L~~L~l~~N~l~~-l~~~ 255 (454)
T 1jl5_A 196 ------------FLTAIYADNNSLKK-LPDLP----LSLESIVAGNNILE-ELPE-LQNLPFLTTIYADNNLLKT-LPDL 255 (454)
T ss_dssp ------------TCCEEECCSSCCSS-CCCCC----TTCCEEECCSSCCS-SCCC-CTTCTTCCEEECCSSCCSS-CCSC
T ss_pred ------------CCCEEECCCCcCCc-CCCCc----CcccEEECcCCcCC-cccc-cCCCCCCCEEECCCCcCCc-cccc
Confidence 45555555555542 22211 13555555555555 4442 5555555555555555553 2321
Q ss_pred ccCCCCCceEEccCCcccccccccccCCCCcceeeccccccccccCCCCcCCCcccEeecccccccCCcchhhhhhhhhh
Q 045798 394 MGKLQKLQGLDFSGNHFSGEIPSSLGNLSSLYEVFFNNNNLSGVIPFSLGNLKRLAFLEMSGNELSGTIPEDIFNISYLS 473 (1008)
Q Consensus 394 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~lp~~~~~~~~~~ 473 (1008)
+++|+.|++++|++++ +|.. +++|++|++++|.+++. |.. .++|+.|++++|++++ +|. ....+
T Consensus 256 ---~~~L~~L~l~~N~l~~-l~~~---~~~L~~L~ls~N~l~~l-~~~---~~~L~~L~l~~N~l~~-i~~----~~~~L 319 (454)
T 1jl5_A 256 ---PPSLEALNVRDNYLTD-LPEL---PQSLTFLDVSENIFSGL-SEL---PPNLYYLNASSNEIRS-LCD----LPPSL 319 (454)
T ss_dssp ---CTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSEE-SCC---CTTCCEEECCSSCCSE-ECC----CCTTC
T ss_pred ---ccccCEEECCCCcccc-cCcc---cCcCCEEECcCCccCcc-cCc---CCcCCEEECcCCcCCc-ccC----CcCcC
Confidence 2455666666666553 3332 24555666666665542 211 1455666666666552 221 11233
Q ss_pred hhhcccCccccCCCcccccccccccccccccccccCCCCcccccccccceeeccCccccc--chhhhhhccccccEEecC
Q 045798 474 NSLNLARNHLVGIIPPRIGNLRALRSFDVSNNDLSGEIPIELGHCSSLEEIYLAGNLFHG--SIPSFFNALKGVQKIDLS 551 (1008)
Q Consensus 474 ~~L~L~~N~l~~~~p~~~~~l~~L~~Ldls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~ls 551 (1008)
+.|++++|++++ +|.. +++|+.|++++|.++ .+|. .+++|++|+|++|++++ .+|.+++.+ +
T Consensus 320 ~~L~Ls~N~l~~-lp~~---~~~L~~L~L~~N~l~-~lp~---~l~~L~~L~L~~N~l~~l~~ip~~l~~L--------~ 383 (454)
T 1jl5_A 320 EELNVSNNKLIE-LPAL---PPRLERLIASFNHLA-EVPE---LPQNLKQLHVEYNPLREFPDIPESVEDL--------R 383 (454)
T ss_dssp CEEECCSSCCSC-CCCC---CTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCSSCCCCCTTCCEE--------E
T ss_pred CEEECCCCcccc-cccc---CCcCCEEECCCCccc-cccc---hhhhccEEECCCCCCCcCCCChHHHHhh--------h
Confidence 455555555554 4433 356677777777776 4555 35667777777777776 566655443 2
Q ss_pred CCcccccccCcccccccceeecccCcccc
Q 045798 552 RNNLSGQIPIFLEALSLEYLNLSFNDFEG 580 (1008)
Q Consensus 552 ~N~l~~~~p~~~~~~~L~~L~l~~N~l~g 580 (1008)
.|.+.|.+|.. ..+|+.|++++|+++|
T Consensus 384 ~n~~~~~i~~~--~~~L~~L~ls~N~l~~ 410 (454)
T 1jl5_A 384 MNSHLAEVPEL--PQNLKQLHVETNPLRE 410 (454)
T ss_dssp CCC--------------------------
T ss_pred hcccccccccc--cCcCCEEECCCCcCCc
Confidence 34455555442 2356666666666665
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=396.64 Aligned_cols=376 Identities=20% Similarity=0.237 Sum_probs=303.1
Q ss_pred CCCCccCcCccCCccCCeeeecCCCCCCCCCccccCCCCCCEEEccCCCCCCcc-CcccccCcCcceEeeeccccccCCC
Q 045798 65 SLSGSLSPHLGNLSFLREINLSNNTIQGEIPPEFGRLFRLEALFLSNNSLVGKI-PANLSYCSRLTVLCIEYNKLQGRIP 143 (1008)
Q Consensus 65 ~l~~~l~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~-p~~l~~l~~L~~L~Ls~n~l~~~~p 143 (1008)
+++ .+|. +. ++|++|+|++|++++..|..|.++++|++|+|++|.+.+.+ |..|..+++|++|+|++|++++..|
T Consensus 21 ~l~-~lp~-l~--~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~n~l~~~~~ 96 (455)
T 3v47_A 21 GLH-QVPE-LP--AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQLET 96 (455)
T ss_dssp CCS-SCCC-CC--TTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTTCTTCEECT
T ss_pred Ccc-cCCC-CC--CccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEeCCCCccCccCh
Confidence 444 4555 32 78999999999999888899999999999999999997555 5679999999999999999998889
Q ss_pred ccccccCCCCeeecccccCCCCCCCC--CccccccchhhcccccCCCCCCcc-ccCCCCCcEEEecCCcccccCCccccC
Q 045798 144 LEFVSLSKLKDLSLAKNKLTGGIPPF--LGNLTSLEVLSLAGNSFGRNIPDS-LGQLKQLKILAIGGNNLSGPIPPSIYN 220 (1008)
Q Consensus 144 ~~~~~l~~L~~L~L~~n~l~~~~~~~--~~~l~~L~~L~L~~n~l~~~~~~~-~~~l~~L~~L~L~~n~l~~~~~~~~~~ 220 (1008)
..|.++++|++|+|++|++++..+.. |+++++|++|+|++|++++..|.. |..+++|++|++++|.+++..+..+..
T Consensus 97 ~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~ 176 (455)
T 3v47_A 97 GAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLN 176 (455)
T ss_dssp TTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCCBSCCCTTTSGG
T ss_pred hhccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCcccccChhhhhc
Confidence 99999999999999999998755444 889999999999999998887776 889999999999999999888888887
Q ss_pred C--CCcceeccccccccccCChhhh--------hcCCCCcEEEeccccCCCCCCcccccC---CCCceeecccccccccc
Q 045798 221 L--SFLVVFSVSHNQIHGSLPPSLG--------LLLPNLKFFQIHHNFFSGSIPISLSNA---SKLEHIEIANNNFSGKL 287 (1008)
Q Consensus 221 l--~~L~~L~ls~N~l~~~lp~~~~--------~~l~~L~~L~L~~N~l~~~~p~~l~~l---~~L~~L~L~~N~l~~~~ 287 (1008)
+ .+|+.|++++|.+.+ ++.... ..+++|++|+|++|.+.+..|..+... ++|+.|++++|.+.+..
T Consensus 177 l~~~~L~~L~l~~n~l~~-~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~ 255 (455)
T 3v47_A 177 FQGKHFTLLRLSSITLQD-MNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSS 255 (455)
T ss_dssp GTTCEEEEEECTTCBCTT-CSTTCTTHHHHCCTTTTCEEEEEECTTSCCCHHHHHHHHHHTTTCCEEEEECTTCTTTSCC
T ss_pred cccccccccccccCcccc-cchhhccccccccccccceeeeEecCCCcccccchhhhhccccccceeeEeeccccccccc
Confidence 6 688999999999874 333221 124678888888888877676666544 77788888877665431
Q ss_pred cccccCCCcccccccccccCCCCCCCcccccccccccCCCcEEEecCCcCCccCChhhhhhcccceeeeeccccccCCCC
Q 045798 288 SVNFGGMKNLSLLNLQFSNLGSGESDEMGFMNSLTNCSKLRVLSLGGNQFRGALPHSIANLSSQLQILILSSNQFYGSIP 367 (1008)
Q Consensus 288 ~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~Ls~N~l~~~~p 367 (1008)
. ..+.+.......+ .-...++|+.|++++|++.+..|..+..+. +|++|+|++|++++..|
T Consensus 256 ~--------------~~~~~~~~~~~~~----~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~-~L~~L~Ls~n~l~~~~~ 316 (455)
T 3v47_A 256 F--------------GHTNFKDPDNFTF----KGLEASGVKTCDLSKSKIFALLKSVFSHFT-DLEQLTLAQNEINKIDD 316 (455)
T ss_dssp T--------------TCCSSCCCCTTTT----GGGTTSCCCEEECCSSCCCEECTTTTTTCT-TCCEEECTTSCCCEECT
T ss_pred c--------------chhhhccCccccc----ccccccCceEEEecCccccccchhhcccCC-CCCEEECCCCcccccCh
Confidence 1 1111111111100 011236899999999999988888888876 59999999999998888
Q ss_pred CccccccccceEEecCccccCCcchhccCCCCCceEEccCCcccccccccccCCCCcceeeccccccccccCCCCcCCCc
Q 045798 368 LGIGNLVDLYLLGMVENQFTGAIPKEMGKLQKLQGLDFSGNHFSGEIPSSLGNLSSLYEVFFNNNNLSGVIPFSLGNLKR 447 (1008)
Q Consensus 368 ~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~ 447 (1008)
..|..+++|+.|+|++|++++..|..|..+++|++|+|++|++++..|..|.++++|++|++++|++++..+..|..+++
T Consensus 317 ~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~ 396 (455)
T 3v47_A 317 NAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTS 396 (455)
T ss_dssp TTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTT
T ss_pred hHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEECCCCcccccChhhccccccccEEECCCCccccCCHhHhccCCc
Confidence 88999999999999999998888888999999999999999999888889999999999999999999877778889999
Q ss_pred ccEeecccccccCCcch
Q 045798 448 LAFLEMSGNELSGTIPE 464 (1008)
Q Consensus 448 L~~L~Ls~N~l~~~lp~ 464 (1008)
|+.|+|++|++++..|.
T Consensus 397 L~~L~l~~N~l~~~~~~ 413 (455)
T 3v47_A 397 LQKIWLHTNPWDCSCPR 413 (455)
T ss_dssp CCEEECCSSCBCCCTTT
T ss_pred ccEEEccCCCcccCCCc
Confidence 99999999999987773
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=376.55 Aligned_cols=286 Identities=35% Similarity=0.557 Sum_probs=225.1
Q ss_pred CCHHHHHHHhcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccchhhHHHHHHHHHHhhcCCCCceeeeeccccc
Q 045798 674 MSYKSLLKATNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSCSSI 753 (1008)
Q Consensus 674 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 753 (1008)
+++.++..++++|++.+.||+|+||.||+|.+. +++.||||++........+.+.+|++++++++||||++++++|
T Consensus 29 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~--- 104 (321)
T 2qkw_B 29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFC--- 104 (321)
T ss_dssp -CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEEC---
T ss_pred ecHHHHHHHHhccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEE---
Confidence 344455667899999999999999999999975 7899999999876666778899999999999999999999995
Q ss_pred cccCCceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeec
Q 045798 754 DFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLD 833 (1008)
Q Consensus 754 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~ 833 (1008)
..++..++||||+++|+|.+++...... ...+++.+++.++.|++.||+|||+. +|+||||||+||+++
T Consensus 105 --~~~~~~~lv~e~~~~~~L~~~l~~~~~~------~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~ 173 (321)
T 2qkw_B 105 --DERNEMILIYKYMENGNLKRHLYGSDLP------TMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLD 173 (321)
T ss_dssp --CCTTCCEEEEECCTTCBTGGGSSSSCCC------SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEEC
T ss_pred --cCCCeEEEEEEcCCCCcHHHHHhccCCC------ccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEEC
Confidence 4566789999999999999999765422 12689999999999999999999998 999999999999999
Q ss_pred CCCCeEEcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCC-cc
Q 045798 834 NDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGD-LN 912 (1008)
Q Consensus 834 ~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~-~~ 912 (1008)
.++.+||+|||+++......... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+ ..
T Consensus 174 ~~~~~kl~Dfg~~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~ 251 (321)
T 2qkw_B 174 ENFVPKITDFGISKKGTELDQTH--LSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVN 251 (321)
T ss_dssp TTCCEEECCCTTCEECSSSSCCC--CBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCC
T ss_pred CCCCEEEeecccccccccccccc--cccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHH
Confidence 99999999999998654322211 1223458999999999988899999999999999999999999997543222 12
Q ss_pred HHHHHHh-hCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHHHHH
Q 045798 913 LHNFARM-ALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHELQSV 991 (1008)
Q Consensus 913 ~~~~~~~-~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~i 991 (1008)
...+... .........+++.+.. ....+++..+.+++.+||+.||++|||+.||++.|+.+
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~------------------~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 313 (321)
T 2qkw_B 252 LAEWAVESHNNGQLEQIVDPNLAD------------------KIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYA 313 (321)
T ss_dssp HHHHTHHHHTTTCCCSSSSSSCTT------------------CSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHhhhccccccHHHhcChhhcc------------------ccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 2222111 1111111222221110 11235778899999999999999999999999999987
Q ss_pred HHH
Q 045798 992 KNI 994 (1008)
Q Consensus 992 ~~~ 994 (1008)
...
T Consensus 314 l~~ 316 (321)
T 2qkw_B 314 LRL 316 (321)
T ss_dssp HHS
T ss_pred hhc
Confidence 653
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=391.11 Aligned_cols=421 Identities=23% Similarity=0.257 Sum_probs=198.7
Q ss_pred CeEEEEeccccCCCCccCcCccCCccCCeeeecCCCCCCCCCccccCCCCCCEEEccCCCCCCccCcccccCcCcceEee
Q 045798 54 RRVTALDLMSKSLSGSLSPHLGNLSFLREINLSNNTIQGEIPPEFGRLFRLEALFLSNNSLVGKIPANLSYCSRLTVLCI 133 (1008)
Q Consensus 54 ~~v~~l~l~~~~l~~~l~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L 133 (1008)
.+++.++++++.+ |.+|++++.+++|++|++++|.++|.+|.+++++.+|+.+++++|.. .++++|++
T Consensus 11 ~~L~~L~l~~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~-----------~~l~~L~l 78 (454)
T 1jl5_A 11 TFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLD-----------RQAHELEL 78 (454)
T ss_dssp ------------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHH-----------HTCSEEEC
T ss_pred ccchhhhcccCch-hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhc-----------cCCCEEEe
Confidence 4788999999999 79999999999999999999999999999999999874444444321 33444555
Q ss_pred eccccccCCCccccccCCCCeeecccccCCCCCCCCCccccccchhhcccccCCCCCCccccCCCCCcEEEecCCccccc
Q 045798 134 EYNKLQGRIPLEFVSLSKLKDLSLAKNKLTGGIPPFLGNLTSLEVLSLAGNSFGRNIPDSLGQLKQLKILAIGGNNLSGP 213 (1008)
Q Consensus 134 s~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~ 213 (1008)
++|.+++ +|.. .++|++|++++|++++ +|..+ ++|++|++++|++++ ++.. .++|++|++++|++++
T Consensus 79 ~~~~l~~-lp~~---~~~L~~L~l~~n~l~~-lp~~~---~~L~~L~l~~n~l~~-l~~~---~~~L~~L~L~~n~l~~- 145 (454)
T 1jl5_A 79 NNLGLSS-LPEL---PPHLESLVASCNSLTE-LPELP---QSLKSLLVDNNNLKA-LSDL---PPLLEYLGVSNNQLEK- 145 (454)
T ss_dssp TTSCCSC-CCSC---CTTCSEEECCSSCCSS-CCCCC---TTCCEEECCSSCCSC-CCSC---CTTCCEEECCSSCCSS-
T ss_pred cCCcccc-CCCC---cCCCCEEEccCCcCCc-ccccc---CCCcEEECCCCccCc-ccCC---CCCCCEEECcCCCCCC-
Confidence 5555443 2221 1345555555555553 33322 445555555555533 1111 1455555555555554
Q ss_pred CCccccCCCCcceeccccccccccCChhhhhcCCCCcEEEeccccCCCCCCcccccCCCCceeecccccccccccccccC
Q 045798 214 IPPSIYNLSFLVVFSVSHNQIHGSLPPSLGLLLPNLKFFQIHHNFFSGSIPISLSNASKLEHIEIANNNFSGKLSVNFGG 293 (1008)
Q Consensus 214 ~~~~~~~l~~L~~L~ls~N~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~ 293 (1008)
+| .|.++++|++|++++|+++ .+|.. .++|++|++++|.+++ +| .+.++++|++|++++|++++... .
T Consensus 146 lp-~~~~l~~L~~L~l~~N~l~-~lp~~----~~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~~N~l~~l~~-~--- 213 (454)
T 1jl5_A 146 LP-ELQNSSFLKIIDVDNNSLK-KLPDL----PPSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYADNNSLKKLPD-L--- 213 (454)
T ss_dssp CC-CCTTCTTCCEEECCSSCCS-CCCCC----CTTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSSCCC-C---
T ss_pred Cc-ccCCCCCCCEEECCCCcCc-ccCCC----cccccEEECcCCcCCc-Cc-cccCCCCCCEEECCCCcCCcCCC-C---
Confidence 34 3555566666666666555 34432 2466666666666664 44 46666677777777776665321 1
Q ss_pred CCcccccccccccCCCCCCCcccccccccccCCCcEEEecCCcCCccCChhhhhhcccceeeeeccccccCCCCCccccc
Q 045798 294 MKNLSLLNLQFSNLGSGESDEMGFMNSLTNCSKLRVLSLGGNQFRGALPHSIANLSSQLQILILSSNQFYGSIPLGIGNL 373 (1008)
Q Consensus 294 l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~Ls~N~l~~~~p~~~~~l 373 (1008)
.++|+.|++++|+++.++ .+..+++|++|++++|++++ +|..+ .+|++|++++|++++ +|.. +
T Consensus 214 ~~~L~~L~l~~n~l~~lp--------~~~~l~~L~~L~l~~N~l~~-l~~~~----~~L~~L~l~~N~l~~-l~~~---~ 276 (454)
T 1jl5_A 214 PLSLESIVAGNNILEELP--------ELQNLPFLTTIYADNNLLKT-LPDLP----PSLEALNVRDNYLTD-LPEL---P 276 (454)
T ss_dssp CTTCCEEECCSSCCSSCC--------CCTTCTTCCEEECCSSCCSS-CCSCC----TTCCEEECCSSCCSC-CCCC---C
T ss_pred cCcccEEECcCCcCCccc--------ccCCCCCCCEEECCCCcCCc-ccccc----cccCEEECCCCcccc-cCcc---c
Confidence 135555566555554322 24456666666666666663 34321 246666666666663 4432 2
Q ss_pred cccceEEecCccccCCcchhccCCCCCceEEccCCcccccccccccCCCCcceeeccccccccccCCCCcCCCcccEeec
Q 045798 374 VDLYLLGMVENQFTGAIPKEMGKLQKLQGLDFSGNHFSGEIPSSLGNLSSLYEVFFNNNNLSGVIPFSLGNLKRLAFLEM 453 (1008)
Q Consensus 374 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L 453 (1008)
++|+.|++++|++++. |.. .++|+.|++++|++++ ++.. .++|++|++++|++++ +|.. +++|+.|++
T Consensus 277 ~~L~~L~ls~N~l~~l-~~~---~~~L~~L~l~~N~l~~-i~~~---~~~L~~L~Ls~N~l~~-lp~~---~~~L~~L~L 344 (454)
T 1jl5_A 277 QSLTFLDVSENIFSGL-SEL---PPNLYYLNASSNEIRS-LCDL---PPSLEELNVSNNKLIE-LPAL---PPRLERLIA 344 (454)
T ss_dssp TTCCEEECCSSCCSEE-SCC---CTTCCEEECCSSCCSE-ECCC---CTTCCEEECCSSCCSC-CCCC---CTTCCEEEC
T ss_pred CcCCEEECcCCccCcc-cCc---CCcCCEEECcCCcCCc-ccCC---cCcCCEEECCCCcccc-cccc---CCcCCEEEC
Confidence 5566666666666541 110 1456666666666653 2211 1356666666666664 3432 355666666
Q ss_pred ccccccCCcchhhhhhhhhhhhhcccCccccCCCcccccccccccccccccccccC--CCCcccccccccceeeccCccc
Q 045798 454 SGNELSGTIPEDIFNISYLSNSLNLARNHLVGIIPPRIGNLRALRSFDVSNNDLSG--EIPIELGHCSSLEEIYLAGNLF 531 (1008)
Q Consensus 454 s~N~l~~~lp~~~~~~~~~~~~L~L~~N~l~~~~p~~~~~l~~L~~Ldls~N~l~~--~~p~~~~~l~~L~~L~L~~N~l 531 (1008)
++|+++ .+|. .+++|++|++++|++++ .+|.+++. |+.|.+
T Consensus 345 ~~N~l~--------------------------~lp~---~l~~L~~L~L~~N~l~~l~~ip~~l~~--------L~~n~~ 387 (454)
T 1jl5_A 345 SFNHLA--------------------------EVPE---LPQNLKQLHVEYNPLREFPDIPESVED--------LRMNSH 387 (454)
T ss_dssp CSSCCS--------------------------CCCC---CCTTCCEEECCSSCCSSCCCCCTTCCE--------EECCC-
T ss_pred CCCccc--------------------------cccc---hhhhccEEECCCCCCCcCCCChHHHHh--------hhhccc
Confidence 666665 3444 35788888888888887 67766653 345777
Q ss_pred ccchhhhhhccccccEEecCCCcccc--cccCcccccccceeecccCcccccCCCC
Q 045798 532 HGSIPSFFNALKGVQKIDLSRNNLSG--QIPIFLEALSLEYLNLSFNDFEGKIPAK 585 (1008)
Q Consensus 532 ~~~~p~~~~~l~~L~~L~ls~N~l~~--~~p~~~~~~~L~~L~l~~N~l~g~~p~~ 585 (1008)
.|.+|.. +++|+.||+++|++++ .+|. +++.|.+.+|.+.+++|..
T Consensus 388 ~~~i~~~---~~~L~~L~ls~N~l~~~~~iP~-----sl~~L~~~~~~~~~~~~~~ 435 (454)
T 1jl5_A 388 LAEVPEL---PQNLKQLHVETNPLREFPDIPE-----SVEDLRMNSERVVDPYEFA 435 (454)
T ss_dssp --------------------------------------------------------
T ss_pred ccccccc---cCcCCEEECCCCcCCccccchh-----hHhheeCcCcccCCccccC
Confidence 7788874 5788899999999987 6664 4677888999999888754
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=373.34 Aligned_cols=267 Identities=25% Similarity=0.388 Sum_probs=214.7
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccchhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceEE
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKA 762 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 762 (1008)
.++|.+.+.||+|+||+||+|.+..+++.||+|++........+.+.+|++++++++||||+++++++ .+++..+
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~~~ 83 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVL-----YKDKRLN 83 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-----EETTEEE
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEE-----ecCCeeE
Confidence 46789999999999999999999989999999998766667778899999999999999999999995 4566799
Q ss_pred EEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEcc
Q 045798 763 IVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGD 842 (1008)
Q Consensus 763 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 842 (1008)
+||||+++|+|.+++..... .+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|
T Consensus 84 lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~D 151 (310)
T 3s95_A 84 FITEYIKGGTLRGIIKSMDS---------QYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVAD 151 (310)
T ss_dssp EEEECCTTCBHHHHHHHCCT---------TSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECC
T ss_pred EEEEecCCCcHHHHHHhccC---------CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEee
Confidence 99999999999999976432 689999999999999999999998 999999999999999999999999
Q ss_pred cCcccccccccCccc----------cccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCcc
Q 045798 843 FGLARFHQEVSNSTL----------SSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLN 912 (1008)
Q Consensus 843 fg~a~~~~~~~~~~~----------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~ 912 (1008)
||.++.......... .......||+.|+|||++.+..++.++|||||||++|||++|..||.........
T Consensus 152 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~ 231 (310)
T 3s95_A 152 FGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMD 231 (310)
T ss_dssp CTTCEECC--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTT
T ss_pred cccceecccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHH
Confidence 999986644332211 0112456999999999999999999999999999999999999998643221111
Q ss_pred HHHHHHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHHHHHH
Q 045798 913 LHNFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHELQSVK 992 (1008)
Q Consensus 913 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~i~ 992 (1008)
.. .......+... ...++..+.+++.+||+.||++|||++|+++.|++++
T Consensus 232 ~~--------~~~~~~~~~~~----------------------~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~ 281 (310)
T 3s95_A 232 FG--------LNVRGFLDRYC----------------------PPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLR 281 (310)
T ss_dssp SS--------BCHHHHHHHTC----------------------CTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred Hh--------hhhhccccccC----------------------CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 00 00000010000 0123345789999999999999999999999999998
Q ss_pred HHHH
Q 045798 993 NILL 996 (1008)
Q Consensus 993 ~~~~ 996 (1008)
....
T Consensus 282 ~~~~ 285 (310)
T 3s95_A 282 MHLA 285 (310)
T ss_dssp HHHH
T ss_pred Hhcc
Confidence 7643
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=368.99 Aligned_cols=251 Identities=23% Similarity=0.287 Sum_probs=206.8
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccchhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceEE
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKA 762 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 762 (1008)
.++|++.+.||+|+||+||+|.+..+++.||||++........+.+.+|+.++++++||||+++++++ ..++..+
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~~~ 93 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY-----LVGDELW 93 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEE-----EETTEEE
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEE-----EECCEEE
Confidence 46899999999999999999999889999999999866666677899999999999999999999985 4566799
Q ss_pred EEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEcc
Q 045798 763 IVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGD 842 (1008)
Q Consensus 763 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 842 (1008)
+||||+++|+|.+++... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|
T Consensus 94 lv~e~~~~~~L~~~~~~~-----------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~D 159 (297)
T 3fxz_A 94 VVMEYLAGGSLTDVVTET-----------CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTD 159 (297)
T ss_dssp EEEECCTTCBHHHHHHHS-----------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECC
T ss_pred EEEECCCCCCHHHHHhhc-----------CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEee
Confidence 999999999999999754 588999999999999999999998 999999999999999999999999
Q ss_pred cCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHhhCC
Q 045798 843 FGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMALP 922 (1008)
Q Consensus 843 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~~~~ 922 (1008)
||++......... .....||+.|+|||++.+..++.++|||||||++|||++|+.||........ .........+
T Consensus 160 fg~~~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-~~~~~~~~~~ 234 (297)
T 3fxz_A 160 FGFCAQITPEQSK----RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA-LYLIATNGTP 234 (297)
T ss_dssp CTTCEECCSTTCC----BCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-HHHHHHHCSC
T ss_pred CCCceecCCcccc----cCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHhCCCC
Confidence 9999865443222 2235699999999999999999999999999999999999999864311100 0000000000
Q ss_pred cchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 923 NQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 923 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
........+..+.+++.+||+.||++|||++|+++
T Consensus 235 -----------------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 235 -----------------------------ELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp -----------------------------CCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -----------------------------CCCCccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 00001123456789999999999999999999986
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-41 Score=368.67 Aligned_cols=268 Identities=25% Similarity=0.372 Sum_probs=207.5
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccchhhHHHHHHHHHHhh--cCCCCceeeeeccccccccCCce
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKN--IRHRNLVKVITSCSSIDFQGNDF 760 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~~~~~~~~~~~~~~~~ 760 (1008)
.++|++.+.||+|+||+||+|.+ +++.||||++... ....+.+|.+++.. ++||||+++++++... ......
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~-~~~~~~ 80 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTS-RHSSTQ 80 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEE-ETTEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccc-cCCCce
Confidence 56899999999999999999998 6899999998643 34556667777766 7999999999986542 234566
Q ss_pred EEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHh--------hCCCCCceeccCCCCCeee
Q 045798 761 KAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLH--------HHCQEPILHCDLKPSNILL 832 (1008)
Q Consensus 761 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH--------~~~~~~ivH~Dlkp~NIll 832 (1008)
.++||||+++|+|.++++.. .+++..++.++.||+.||+||| +. +|+||||||+||++
T Consensus 81 ~~lv~e~~~~g~L~~~l~~~-----------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill 146 (301)
T 3q4u_A 81 LWLITHYHEMGSLYDYLQLT-----------TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILV 146 (301)
T ss_dssp EEEEECCCTTCBHHHHHTTC-----------CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEE
T ss_pred eEEehhhccCCCHHHHHhhc-----------ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEE
Confidence 89999999999999999643 6899999999999999999999 65 99999999999999
Q ss_pred cCCCCeEEcccCcccccccccCccccccccccccccccCccccCCC------CCCcccchhhHHHHHHHHHhC-------
Q 045798 833 DNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGS------EVSTNGDVYSYGILLLEMVTA------- 899 (1008)
Q Consensus 833 ~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~sDvwslG~vl~elltG------- 899 (1008)
+.++.+||+|||+|+.................||+.|+|||++.+. .+++++|||||||++|||++|
T Consensus 147 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~ 226 (301)
T 3q4u_A 147 KKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIV 226 (301)
T ss_dssp CTTSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBC
T ss_pred cCCCCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccc
Confidence 9999999999999986655443332223345699999999998876 556799999999999999999
Q ss_pred ---CCCCCccccCCccHHHHHHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCC
Q 045798 900 ---KKPTDVMFEGDLNLHNFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQ 976 (1008)
Q Consensus 900 ---~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~ 976 (1008)
+.||...................... .+. .+.......++.++.+++.+||+.||+
T Consensus 227 ~~~~~pf~~~~~~~~~~~~~~~~~~~~~~----~~~-----------------~~~~~~~~~~~~~l~~li~~cl~~dP~ 285 (301)
T 3q4u_A 227 EDYKPPFYDVVPNDPSFEDMRKVVCVDQQ----RPN-----------------IPNRWFSDPTLTSLAKLMKECWYQNPS 285 (301)
T ss_dssp CCCCCTTTTTSCSSCCHHHHHHHHTTSCC----CCC-----------------CCGGGGGSHHHHHHHHHHHHHCCSSGG
T ss_pred ccccccccccCCCCcchhhhhHHHhccCC----CCC-----------------CChhhccCccHHHHHHHHHHHhhcChh
Confidence 77775443333332222221111000 000 000001234677899999999999999
Q ss_pred CCCCHHHHHHHHHHH
Q 045798 977 DRMNMTNVVHELQSV 991 (1008)
Q Consensus 977 ~RPt~~evl~~L~~i 991 (1008)
+|||++||++.|+++
T Consensus 286 ~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 286 ARLTALRIKKTLTKI 300 (301)
T ss_dssp GSCCHHHHHHHHHHH
T ss_pred hCCCHHHHHHHHhcc
Confidence 999999999999886
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=376.15 Aligned_cols=288 Identities=34% Similarity=0.591 Sum_probs=227.2
Q ss_pred cCCCCCHHHHHHHhcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccc-hhhHHHHHHHHHHhhcCCCCceeeee
Q 045798 670 ALPKMSYKSLLKATNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCE-GASKSFMAECKALKNIRHRNLVKVIT 748 (1008)
Q Consensus 670 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~ 748 (1008)
....+++.++..+.++|++.+.||+|+||.||+|... +++.||||+++.... .....+.+|++++++++||||+++++
T Consensus 16 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~ 94 (326)
T 3uim_A 16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRG 94 (326)
T ss_dssp CCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCE
T ss_pred ccceecHHHHHHHhhccccceeEecCCCcEEEEEEec-CCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEE
Confidence 3557889999999999999999999999999999864 789999999975432 23347999999999999999999999
Q ss_pred ccccccccCCceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCC
Q 045798 749 SCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPS 828 (1008)
Q Consensus 749 ~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~ 828 (1008)
+| ..++..++||||+++|+|.+++....... ..+++..+..++.|++.||+|||+.+.++|+||||||+
T Consensus 95 ~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~ 163 (326)
T 3uim_A 95 FC-----MTPTERLLVYPYMANGSVASCLRERPESQ------PPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAA 163 (326)
T ss_dssp EE-----CCSSCCEEEEECCTTCBHHHHHHCCSTTC------CCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGG
T ss_pred EE-----ecCCceEEEEEeccCCCHHHHHHhccccC------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchh
Confidence 95 45566899999999999999998654321 15899999999999999999999975569999999999
Q ss_pred CeeecCCCCeEEcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccc-
Q 045798 829 NILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMF- 907 (1008)
Q Consensus 829 NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~- 907 (1008)
||+++.++.+||+|||+++......... .....||+.|+|||++.+..++.++|||||||++|||++|+.||+...
T Consensus 164 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 240 (326)
T 3uim_A 164 NILLDEEFEAVVGDFGLAKLMDYKDTHV---TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARL 240 (326)
T ss_dssp GEEECTTCCEEECCCSSCEECCSSSSCE---ECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHH
T ss_pred hEEECCCCCEEeccCccccccCcccccc---cccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCccccccc
Confidence 9999999999999999998664433222 223458999999999988889999999999999999999999996321
Q ss_pred --cCCccHHHHHHhhCCcc-hhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHH
Q 045798 908 --EGDLNLHNFARMALPNQ-VMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNV 984 (1008)
Q Consensus 908 --~~~~~~~~~~~~~~~~~-~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev 984 (1008)
..+.....+........ .....+..+.. ....+.+..+.+++.+||+.||.+|||+.||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------------~~~~~~~~~l~~li~~cl~~dP~~Rps~~el 302 (326)
T 3uim_A 241 ANDDDVMLLDWVKGLLKEKKLEALVDVDLQG------------------NYKDEEVEQLIQVALLCTQSSPMERPKMSEV 302 (326)
T ss_dssp TTTSCSBHHHHHTTTTSSCCSTTSSCTTCTT------------------SCCHHHHHHHHHHHHHHTCSCGGGSCCHHHH
T ss_pred ccccchhHHHHHHHHhhchhhhhhcChhhcc------------------ccCHHHHHHHHHHHHHHhCcCCccCCCHHHH
Confidence 12222333332222211 12222211111 1124567889999999999999999999999
Q ss_pred HHHHHH
Q 045798 985 VHELQS 990 (1008)
Q Consensus 985 l~~L~~ 990 (1008)
++.|++
T Consensus 303 l~~L~~ 308 (326)
T 3uim_A 303 VRMLEG 308 (326)
T ss_dssp HHHHHT
T ss_pred HHHhcC
Confidence 999975
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-41 Score=370.52 Aligned_cols=285 Identities=22% Similarity=0.307 Sum_probs=211.3
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccchhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceEE
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKA 762 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 762 (1008)
.++|++.+.||+|+||+||+|++ .++.||||+++.. ......+.+|+.++++++||||+++++++.... ......+
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-~~~~~~~ 98 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQL--LNEYVAVKIFPIQ-DKQSWQNEYEVYSLPGMKHENILQFIGAEKRGT-SVDVDLW 98 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEE--TTEEEEEEEECGG-GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SSSEEEE
T ss_pred hhhchhhheecccCceEEEEEEE--CCCEEEEEEeecC-chHHHHHHHHHHHHhcCCCCCchhhcceeccCC-CCCceEE
Confidence 56899999999999999999998 4899999999754 333456677999999999999999999976422 1234579
Q ss_pred EEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhC-------CCCCceeccCCCCCeeecCC
Q 045798 763 IVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHH-------CQEPILHCDLKPSNILLDND 835 (1008)
Q Consensus 763 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~-------~~~~ivH~Dlkp~NIll~~~ 835 (1008)
+||||+++|+|.++++.. .+++..++.++.|++.||+|||+. ..++|+||||||+||+++.+
T Consensus 99 lv~e~~~~g~L~~~l~~~-----------~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~ 167 (322)
T 3soc_A 99 LITAFHEKGSLSDFLKAN-----------VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNN 167 (322)
T ss_dssp EEEECCTTCBHHHHHHHC-----------CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTT
T ss_pred EEEecCCCCCHHHHHHhc-----------CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCC
Confidence 999999999999999653 689999999999999999999984 12389999999999999999
Q ss_pred CCeEEcccCcccccccccCccccccccccccccccCccccCCC-----CCCcccchhhHHHHHHHHHhCCCCCCccccCC
Q 045798 836 LSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGS-----EVSTNGDVYSYGILLLEMVTAKKPTDVMFEGD 910 (1008)
Q Consensus 836 ~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~sDvwslG~vl~elltG~~pf~~~~~~~ 910 (1008)
+.+||+|||+++......... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||.......
T Consensus 168 ~~~kL~DFg~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~ 245 (322)
T 3soc_A 168 LTACIADFGLALKFEAGKSAG--DTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEY 245 (322)
T ss_dssp CCEEECCCTTCEEECTTSCCC--CCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCC
T ss_pred CeEEEccCCcccccccccCcc--ccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchh
Confidence 999999999998665433221 12335699999999998863 56678999999999999999999997543321
Q ss_pred ccHHHHHHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHHHH
Q 045798 911 LNLHNFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHELQS 990 (1008)
Q Consensus 911 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 990 (1008)
........ .......++.+....... ............++.++.+++.+||+.||++|||+.||++.|++
T Consensus 246 ~~~~~~~~-~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 315 (322)
T 3soc_A 246 MLPFEEEI-GQHPSLEDMQEVVVHKKK---------RPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQ 315 (322)
T ss_dssp CCTTHHHH-CSSCCHHHHHHHHTTSCC---------CCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ccchhhhh-ccCCchhhhhhhhhcccC---------CCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 11100000 000111111110000000 00000001122466779999999999999999999999999999
Q ss_pred HHHH
Q 045798 991 VKNI 994 (1008)
Q Consensus 991 i~~~ 994 (1008)
+++.
T Consensus 316 l~~~ 319 (322)
T 3soc_A 316 MQRL 319 (322)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 8764
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-40 Score=360.51 Aligned_cols=284 Identities=30% Similarity=0.479 Sum_probs=224.4
Q ss_pred cCCCCCHHHHHHHhcCCCCC------ceEeeccCeeEEEEEEcCCCeEEEEEEeccc----cchhhHHHHHHHHHHhhcC
Q 045798 670 ALPKMSYKSLLKATNGFSST------HLIGVGSFGCVYKGALDEDGIVVAIKVINLQ----CEGASKSFMAECKALKNIR 739 (1008)
Q Consensus 670 ~~~~~~~~~~~~~~~~y~~~------~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~ 739 (1008)
....+++.++..++++|... +.||+|+||.||+|.. +++.||||++... .....+.+.+|++++++++
T Consensus 11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 88 (307)
T 2nru_A 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQ 88 (307)
T ss_dssp CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCC
T ss_pred CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcC
Confidence 45678999999999998877 8999999999999987 6889999998643 2344578999999999999
Q ss_pred CCCceeeeeccccccccCCceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCC
Q 045798 740 HRNLVKVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEP 819 (1008)
Q Consensus 740 h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ 819 (1008)
||||+++++++ ..++..++||||+++++|.+++...... ..+++..++.++.|++.||+|||+. +
T Consensus 89 h~~i~~~~~~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~-------~~~~~~~~~~i~~~i~~~l~~lH~~---~ 153 (307)
T 2nru_A 89 HENLVELLGFS-----SDGDDLCLVYVYMPNGSLLDRLSCLDGT-------PPLSWHMRCKIAQGAANGINFLHEN---H 153 (307)
T ss_dssp CTTBCCEEEEE-----CSSSSCEEEEECCTTCBHHHHHHTGGGC-------CCCCHHHHHHHHHHHHHHHHHHHHT---T
T ss_pred CCCeEEEEEEE-----ecCCceEEEEEecCCCcHHHHHHhccCC-------CCCCHHHHHHHHHHHHHHHHHHhcC---C
Confidence 99999999995 4556789999999999999998643211 1689999999999999999999998 9
Q ss_pred ceeccCCCCCeeecCCCCeEEcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhC
Q 045798 820 ILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTA 899 (1008)
Q Consensus 820 ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG 899 (1008)
|+||||||+||+++.++.+||+|||.+.......... ......||+.|+|||.+.+ .++.++||||||+++|+|++|
T Consensus 154 i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g 230 (307)
T 2nru_A 154 HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTV--MTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITG 230 (307)
T ss_dssp EECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCE--ECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHC
T ss_pred eecCCCCHHHEEEcCCCcEEEeecccccccccccccc--cccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHC
Confidence 9999999999999999999999999998654432221 1223468999999998765 588999999999999999999
Q ss_pred CCCCCccccCCccHHHHHHh--hCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCC
Q 045798 900 KKPTDVMFEGDLNLHNFARM--ALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQD 977 (1008)
Q Consensus 900 ~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~ 977 (1008)
..||......... ..+... .......+.+++.+.. .....+..+.+++.+||+.||.+
T Consensus 231 ~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~-------------------~~~~~~~~l~~li~~cl~~~p~~ 290 (307)
T 2nru_A 231 LPAVDEHREPQLL-LDIKEEIEDEEKTIEDYIDKKMND-------------------ADSTSVEAMYSVASQCLHEKKNK 290 (307)
T ss_dssp CCSBCTTBSSSBT-THHHHHHHTTSCCHHHHSCSSCSC-------------------CCHHHHHHHHHHHHHHTCSSTTT
T ss_pred CCCcccCcchHHH-HHHHHHhhhhhhhhhhhccccccc-------------------cchHHHHHHHHHHHHHcCCCccc
Confidence 9999754332211 111111 1112233333332221 12346778999999999999999
Q ss_pred CCCHHHHHHHHHHHHH
Q 045798 978 RMNMTNVVHELQSVKN 993 (1008)
Q Consensus 978 RPt~~evl~~L~~i~~ 993 (1008)
|||++||++.|+++..
T Consensus 291 Rps~~~l~~~L~~l~~ 306 (307)
T 2nru_A 291 RPDIKKVQQLLQEMTA 306 (307)
T ss_dssp SCCHHHHHHHHHHHC-
T ss_pred CcCHHHHHHHHHHHhc
Confidence 9999999999998754
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=364.80 Aligned_cols=263 Identities=23% Similarity=0.272 Sum_probs=213.0
Q ss_pred CCCCHHHHHHHhcC----------CCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccchhhHHHHHHHHHHhhcCCC
Q 045798 672 PKMSYKSLLKATNG----------FSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHR 741 (1008)
Q Consensus 672 ~~~~~~~~~~~~~~----------y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ 741 (1008)
+.++++++..+++. |...+.||+|+||.||+|++..+|+.||||++........+.+.+|+.++++++||
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ 102 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF 102 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence 56788888888764 67778999999999999999889999999999876666677899999999999999
Q ss_pred CceeeeeccccccccCCceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCce
Q 045798 742 NLVKVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPIL 821 (1008)
Q Consensus 742 niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iv 821 (1008)
||+++++++ ..++..++||||+++++|.+++... .+++..+..++.|++.||+|||+. +|+
T Consensus 103 niv~~~~~~-----~~~~~~~lv~e~~~~~~L~~~l~~~-----------~l~~~~~~~i~~qi~~~L~~LH~~---~iv 163 (321)
T 2c30_A 103 NVVEMYKSY-----LVGEELWVLMEFLQGGALTDIVSQV-----------RLNEEQIATVCEAVLQALAYLHAQ---GVI 163 (321)
T ss_dssp TBCCEEEEE-----EETTEEEEEECCCCSCBHHHHHTTC-----------CCCHHHHHHHHHHHHHHHHHHHHT---TEE
T ss_pred CcceEEEEE-----EECCEEEEEEecCCCCCHHHHHHhc-----------CCCHHHHHHHHHHHHHHHHHHHHC---Cee
Confidence 999999995 4456799999999999999998643 689999999999999999999998 999
Q ss_pred eccCCCCCeeecCCCCeEEcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCC
Q 045798 822 HCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKK 901 (1008)
Q Consensus 822 H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~ 901 (1008)
||||||+||+++.++.+||+|||++......... .....||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus 164 H~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~ 239 (321)
T 2c30_A 164 HRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK----RKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEP 239 (321)
T ss_dssp CCCCSGGGEEECTTCCEEECCCTTCEECCSSSCC----BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSC
T ss_pred cCCCCHHHEEECCCCcEEEeeeeeeeecccCccc----cccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCC
Confidence 9999999999999999999999999865443221 223469999999999999999999999999999999999999
Q ss_pred CCCccccCCccHHHHHHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCH
Q 045798 902 PTDVMFEGDLNLHNFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNM 981 (1008)
Q Consensus 902 pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~ 981 (1008)
||...... .......... .+.+ ......+..+.+++.+||+.||++|||+
T Consensus 240 pf~~~~~~--~~~~~~~~~~--------~~~~--------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~ 289 (321)
T 2c30_A 240 PYFSDSPV--QAMKRLRDSP--------PPKL--------------------KNSHKVSPVLRDFLERMLVRDPQERATA 289 (321)
T ss_dssp TTTTSCHH--HHHHHHHHSS--------CCCC--------------------TTGGGSCHHHHHHHHHHSCSSTTTSCCH
T ss_pred CCCCCCHH--HHHHHHhcCC--------CCCc--------------------CccccCCHHHHHHHHHHccCChhhCcCH
Confidence 98642110 0000000000 0000 0011234567899999999999999999
Q ss_pred HHHHHH
Q 045798 982 TNVVHE 987 (1008)
Q Consensus 982 ~evl~~ 987 (1008)
+|+++.
T Consensus 290 ~ell~h 295 (321)
T 2c30_A 290 QELLDH 295 (321)
T ss_dssp HHHHTS
T ss_pred HHHhcC
Confidence 999873
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-41 Score=369.93 Aligned_cols=248 Identities=24% Similarity=0.347 Sum_probs=203.1
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccc--cchhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCce
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQ--CEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDF 760 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 760 (1008)
.++|++.+.||+|+||.||+|++..+|+.||||++... .....+.+.+|+++++.++||||+++++++ ...+.
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~-----~~~~~ 88 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVI-----ETEKT 88 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECSSE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----EECCE
Confidence 56899999999999999999999889999999999754 234456789999999999999999999994 55677
Q ss_pred EEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEE
Q 045798 761 KAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHI 840 (1008)
Q Consensus 761 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 840 (1008)
.++||||+++|+|.+++...+ ++++..++.++.||+.||+|||+. +|+||||||+||+++.++.+||
T Consensus 89 ~~lv~e~~~~~~L~~~l~~~~----------~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl 155 (328)
T 3fe3_A 89 LYLIMEYASGGEVFDYLVAHG----------RMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKI 155 (328)
T ss_dssp EEEEECCCTTCBHHHHHHHHC----------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEE
T ss_pred EEEEEECCCCCcHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEE
Confidence 999999999999999997653 689999999999999999999998 9999999999999999999999
Q ss_pred cccCcccccccccCccccccccccccccccCccccCCCCCC-cccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHh
Q 045798 841 GDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVS-TNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARM 919 (1008)
Q Consensus 841 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~ 919 (1008)
+|||++........ .....||+.|+|||++.+..++ +++||||+||++|||++|+.||..... .....
T Consensus 156 ~DFG~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-----~~~~~- 224 (328)
T 3fe3_A 156 ADFGFSNEFTVGGK-----LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNL-----KELRE- 224 (328)
T ss_dssp CSTTCCGGGSSSCG-----GGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHH-
T ss_pred eeccCceecCCCCc-----cccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCH-----HHHHH-
Confidence 99999986543321 2235699999999999888765 799999999999999999999864311 01100
Q ss_pred hCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 920 ALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 920 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
...... ...+ ...+.++.+++.+||+.||.+|||++|+++
T Consensus 225 -----------~i~~~~----------~~~p------~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 264 (328)
T 3fe3_A 225 -----------RVLRGK----------YRIP------FYMSTDCENLLKRFLVLNPIKRGTLEQIMK 264 (328)
T ss_dssp -----------HHHHCC----------CCCC------TTSCHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred -----------HHHhCC----------CCCC------CCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 000000 0000 013445789999999999999999999975
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=365.42 Aligned_cols=261 Identities=28% Similarity=0.405 Sum_probs=200.6
Q ss_pred HhcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEecccc--chhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCc
Q 045798 682 ATNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC--EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGND 759 (1008)
Q Consensus 682 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 759 (1008)
..++|++.+.||+|+||+||+|++ +++.||||++.... ....+.+.+|++++++++||||+++++++ ...+
T Consensus 35 ~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~ 107 (309)
T 3p86_A 35 PWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV-----TQPP 107 (309)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----CSTT
T ss_pred ChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----EECC
Confidence 356899999999999999999988 68899999997543 33446799999999999999999999995 4556
Q ss_pred eEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCC--ceeccCCCCCeeecCCCC
Q 045798 760 FKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEP--ILHCDLKPSNILLDNDLS 837 (1008)
Q Consensus 760 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~--ivH~Dlkp~NIll~~~~~ 837 (1008)
..++||||+++|+|.+++..... ...+++..++.++.|++.||+|||+. + |+||||||+||+++.++.
T Consensus 108 ~~~lv~e~~~~~~L~~~l~~~~~-------~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~ 177 (309)
T 3p86_A 108 NLSIVTEYLSRGSLYRLLHKSGA-------REQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYT 177 (309)
T ss_dssp CCEEEEECCTTCBHHHHHHSTTH-------HHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCC
T ss_pred ceEEEEecCCCCcHHHHHhhcCC-------CCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCc
Confidence 68999999999999999976531 11489999999999999999999997 7 999999999999999999
Q ss_pred eEEcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHH
Q 045798 838 GHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFA 917 (1008)
Q Consensus 838 ~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~ 917 (1008)
+||+|||+++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+ .....
T Consensus 178 ~kL~Dfg~a~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~--~~~~~ 251 (309)
T 3p86_A 178 VKVCDFGLSRLKASTFL----SSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQ--VVAAV 251 (309)
T ss_dssp EEECCCC---------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHH--HHHHH
T ss_pred EEECCCCCCcccccccc----ccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHH
Confidence 99999999975443221 1223458999999999999999999999999999999999999986431110 00000
Q ss_pred HhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHHHHHHHH
Q 045798 918 RMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHELQSVKNI 994 (1008)
Q Consensus 918 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~i~~~ 994 (1008)
..... .. . .....+.++.+++.+||+.||++|||++|+++.|+.+.+.
T Consensus 252 ~~~~~---------~~--------------~------~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~ 299 (309)
T 3p86_A 252 GFKCK---------RL--------------E------IPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS 299 (309)
T ss_dssp HHSCC---------CC--------------C------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred HhcCC---------CC--------------C------CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 00000 00 0 0012345689999999999999999999999999988654
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-41 Score=367.45 Aligned_cols=280 Identities=24% Similarity=0.373 Sum_probs=210.5
Q ss_pred hcCCCCCceEeeccCeeEEEEE----EcCCCeEEEEEEeccccchhhHHHHHHHHHHhhcCCCCceeeeeccccccccCC
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGA----LDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGN 758 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~----~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 758 (1008)
.++|++.+.||+|+||+||+|+ ...+++.||||+++.......+.+.+|++++++++||||++++++|.. .+.
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---~~~ 85 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYS---AGR 85 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECH---HHH
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec---CCC
Confidence 4679999999999999999998 456889999999987666667889999999999999999999998643 233
Q ss_pred ceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCe
Q 045798 759 DFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSG 838 (1008)
Q Consensus 759 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 838 (1008)
...++||||+++|+|.+++..... .+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+
T Consensus 86 ~~~~lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~ 153 (295)
T 3ugc_A 86 RNLKLIMEYLPYGSLRDYLQKHKE---------RIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRV 153 (295)
T ss_dssp TSCEEEEECCTTCBHHHHHHHCGG---------GCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEE
T ss_pred CceEEEEEeCCCCCHHHHHHhccc---------ccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeE
Confidence 457999999999999999976531 589999999999999999999998 99999999999999999999
Q ss_pred EEcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHH
Q 045798 839 HIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFAR 918 (1008)
Q Consensus 839 kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~ 918 (1008)
||+|||+++......... .......++..|+|||++.+..++.++||||||+++|||++|..||...... +..
T Consensus 154 kl~Dfg~~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~------~~~ 226 (295)
T 3ugc_A 154 KIGDFGLTKVLPQDKEFF-KVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE------FMR 226 (295)
T ss_dssp EECCCCSCC--------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHH------HHH
T ss_pred EEccCcccccccCCccee-eeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHH------HHh
Confidence 999999998765433221 1122344778899999999889999999999999999999999998643211 111
Q ss_pred hhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHHHHHHHH
Q 045798 919 MALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHELQSVKNI 994 (1008)
Q Consensus 919 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~i~~~ 994 (1008)
............. ..........+. +....++.++.+++.+||+.||++|||++|+++.|+++.+.
T Consensus 227 ~~~~~~~~~~~~~------~~~~~~~~~~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~ 292 (295)
T 3ugc_A 227 MIGNDKQGQMIVF------HLIELLKNNGRL----PRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN 292 (295)
T ss_dssp HHCTTCCTHHHHH------HHHHHHHTTCCC----CCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred hhcCccccchhHH------HHHHHHhccCcC----CCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence 1000000000000 000000000000 11123566789999999999999999999999999998764
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-41 Score=371.80 Aligned_cols=266 Identities=26% Similarity=0.434 Sum_probs=208.5
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCC---eEEEEEEeccc-cchhhHHHHHHHHHHhhcCCCCceeeeeccccccccCC
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDG---IVVAIKVINLQ-CEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGN 758 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 758 (1008)
.++|++.+.||+|+||.||+|.+..++ ..||||+++.. .....+.+.+|++++++++||||+++++++ ..+
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~ 122 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVV-----TRG 122 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-----CGG
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EeC
Confidence 357889999999999999999997444 46999999754 334457899999999999999999999995 455
Q ss_pred ceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCe
Q 045798 759 DFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSG 838 (1008)
Q Consensus 759 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 838 (1008)
+..++||||+++|+|.+++..... .+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+
T Consensus 123 ~~~~lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~ 190 (325)
T 3kul_A 123 RLAMIVTEYMENGSLDTFLRTHDG---------QFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVC 190 (325)
T ss_dssp GCCEEEEECCTTCBHHHHHHTTTT---------CSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCE
T ss_pred CccEEEeeCCCCCcHHHHHHhccc---------CCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCE
Confidence 668999999999999999965431 689999999999999999999998 99999999999999999999
Q ss_pred EEcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCccccCCccHHHHH
Q 045798 839 HIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT-AKKPTDVMFEGDLNLHNFA 917 (1008)
Q Consensus 839 kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-G~~pf~~~~~~~~~~~~~~ 917 (1008)
||+|||+++.......... ......+|+.|+|||++.+..++.++|||||||++|||++ |..||......+ .....
T Consensus 191 kl~Dfg~a~~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~--~~~~~ 267 (325)
T 3kul_A 191 KVSDFGLSRVLEDDPDAAY-TTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRD--VISSV 267 (325)
T ss_dssp EECCCSSCEECC----CCE-ECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH--HHHHH
T ss_pred EECCCCcccccccCcccee-eccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHH--HHHHH
Confidence 9999999987654432221 1223346788999999988899999999999999999999 999986431110 00000
Q ss_pred HhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHHHHHHHHHHH
Q 045798 918 RMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHELQSVKNILLE 997 (1008)
Q Consensus 918 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~i~~~~~~ 997 (1008)
. ... ..+ ....++..+.+++.+||+.||++|||+.||++.|+.+......
T Consensus 268 ~------------~~~--------------~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~~ 317 (325)
T 3kul_A 268 E------------EGY--------------RLP----APMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPES 317 (325)
T ss_dssp H------------TTC--------------CCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC-
T ss_pred H------------cCC--------------CCC----CCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCccc
Confidence 0 000 000 0112455689999999999999999999999999998766444
Q ss_pred H
Q 045798 998 L 998 (1008)
Q Consensus 998 ~ 998 (1008)
.
T Consensus 318 ~ 318 (325)
T 3kul_A 318 L 318 (325)
T ss_dssp -
T ss_pred c
Confidence 3
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=364.89 Aligned_cols=254 Identities=22% Similarity=0.300 Sum_probs=203.1
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccc-hhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceE
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCE-GASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFK 761 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 761 (1008)
.++|++.+.||+|+||.||+|++..+++.||||++..... ...+.+.+|+.+++.++||||+++++++ ..++..
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~-----~~~~~~ 80 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR-----REGNIQ 80 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEE-----ECSSEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEE-----ecCCeE
Confidence 4689999999999999999999998999999999964432 3346789999999999999999999994 556778
Q ss_pred EEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEc
Q 045798 762 AIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIG 841 (1008)
Q Consensus 762 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 841 (1008)
++||||+++|+|.+++.... .+++..++.++.||+.||+|||+. +|+||||||+||+++.++.+||+
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~----------~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~ 147 (323)
T 3tki_A 81 YLFLEYCSGGELFDRIEPDI----------GMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKIS 147 (323)
T ss_dssp EEEEECCTTEEGGGGSBTTT----------BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEEC
T ss_pred EEEEEcCCCCcHHHHHhhcC----------CCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEE
Confidence 99999999999999997654 689999999999999999999998 99999999999999999999999
Q ss_pred ccCcccccccccCccccccccccccccccCccccCCCCC-CcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHhh
Q 045798 842 DFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEV-STNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMA 920 (1008)
Q Consensus 842 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~~ 920 (1008)
|||+++......... ......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||............+....
T Consensus 148 Dfg~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~ 225 (323)
T 3tki_A 148 DFGLATVFRYNNRER--LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK 225 (323)
T ss_dssp CCTTCEECEETTEEC--CBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTC
T ss_pred EeeccceeccCCccc--ccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhccc
Confidence 999998654332211 1223569999999999887765 7799999999999999999999975433222222211110
Q ss_pred CCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 921 LPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 921 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
... ......+..+.+++.+||+.||.+|||++|+++
T Consensus 226 ~~~------------------------------~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~ 261 (323)
T 3tki_A 226 TYL------------------------------NPWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (323)
T ss_dssp TTS------------------------------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ccC------------------------------CccccCCHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 000 001123455789999999999999999999976
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-40 Score=366.55 Aligned_cols=252 Identities=20% Similarity=0.259 Sum_probs=204.5
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccch------hhHHHHHHHHHHhhcCCCCceeeeecccccccc
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEG------ASKSFMAECKALKNIRHRNLVKVITSCSSIDFQ 756 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 756 (1008)
.++|++.+.||+|+||.||+|++..+|+.||+|+++..... ..+.+.+|+.++++++||||+++++++ .
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~-----~ 85 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVY-----E 85 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEE-----E
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEE-----E
Confidence 56799999999999999999999989999999999754321 346799999999999999999999994 5
Q ss_pred CCceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCC
Q 045798 757 GNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDL 836 (1008)
Q Consensus 757 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 836 (1008)
++...++||||+++|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+||+++.++
T Consensus 86 ~~~~~~lv~e~~~gg~L~~~l~~~~----------~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~ 152 (361)
T 2yab_A 86 NRTDVVLILELVSGGELFDFLAQKE----------SLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKN 152 (361)
T ss_dssp CSSEEEEEEECCCSCBHHHHHTTCS----------CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTT
T ss_pred eCCEEEEEEEcCCCCcHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCC
Confidence 6678999999999999999997653 689999999999999999999998 999999999999998776
Q ss_pred ----CeEEcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCcc
Q 045798 837 ----SGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLN 912 (1008)
Q Consensus 837 ----~~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~ 912 (1008)
.+||+|||++........ .....||+.|+|||++.+..++.++||||+||++|+|++|..||......+ .
T Consensus 153 ~~~~~vkl~DFG~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~-~ 226 (361)
T 2yab_A 153 IPIPHIKLIDFGLAHEIEDGVE-----FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE-T 226 (361)
T ss_dssp SSSCCEEECCCSSCEECCTTCC-----CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH-H
T ss_pred CCccCEEEEecCCceEcCCCCc-----cccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH-H
Confidence 799999999986654321 223469999999999999899999999999999999999999986421110 0
Q ss_pred HHHHHHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 913 LHNFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 913 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
...... ....... ......+..+.+++.+||..||.+|||+.|+++
T Consensus 227 ~~~i~~------------~~~~~~~----------------~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 227 LANITA------------VSYDFDE----------------EFFSQTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp HHHHHT------------TCCCCCH----------------HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHHHh------------cCCCCCc----------------hhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 000000 0000000 001123456789999999999999999999985
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-40 Score=362.61 Aligned_cols=252 Identities=21% Similarity=0.267 Sum_probs=205.0
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccchhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceEE
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKA 762 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 762 (1008)
.++|++.+.||+|+||.||+|.+..+++.||+|+++.. ......+.+|+++++.++||||+++++++ .+.+..+
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~-----~~~~~~~ 77 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESF-----ESMEELV 77 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEE-----EETTEEE
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEE-----ecCCEEE
Confidence 46899999999999999999999999999999999754 34456789999999999999999999995 5566799
Q ss_pred EEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecC--CCCeEE
Q 045798 763 IVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDN--DLSGHI 840 (1008)
Q Consensus 763 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~--~~~~kL 840 (1008)
+||||+++|+|.+++..... .+++.+++.++.||+.||+|||+. +|+||||||+||+++. ++.+||
T Consensus 78 lv~e~~~g~~L~~~l~~~~~---------~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl 145 (321)
T 1tki_A 78 MIFEFISGLDIFERINTSAF---------ELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKI 145 (321)
T ss_dssp EEECCCCCCBHHHHHTSSSC---------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEE
T ss_pred EEEEeCCCCCHHHHHHhcCC---------CCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEE
Confidence 99999999999999975431 689999999999999999999998 9999999999999987 789999
Q ss_pred cccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHhh
Q 045798 841 GDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMA 920 (1008)
Q Consensus 841 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~~ 920 (1008)
+|||++........ .....||+.|+|||++.+..++.++||||+||++|+|++|..||...... ........
T Consensus 146 ~Dfg~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~~i~~-- 217 (321)
T 1tki_A 146 IEFGQARQLKPGDN-----FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ-QIIENIMN-- 217 (321)
T ss_dssp CCCTTCEECCTTCE-----EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH-HHHHHHHH--
T ss_pred EECCCCeECCCCCc-----cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHH-HHHHHHHc--
Confidence 99999987644322 12245899999999999988999999999999999999999998642111 00011111
Q ss_pred CCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 921 LPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 921 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
....... ......+.++.+++.+||+.||.+|||+.|+++
T Consensus 218 ----------~~~~~~~----------------~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 257 (321)
T 1tki_A 218 ----------AEYTFDE----------------EAFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp ----------TCCCCCH----------------HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ----------CCCCCCh----------------hhhccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0000000 011134556899999999999999999999987
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=371.07 Aligned_cols=271 Identities=21% Similarity=0.396 Sum_probs=211.3
Q ss_pred hcCCCCCceEeeccCeeEEEEEEc-------CCCeEEEEEEecccc-chhhHHHHHHHHHHhhc-CCCCceeeeeccccc
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALD-------EDGIVVAIKVINLQC-EGASKSFMAECKALKNI-RHRNLVKVITSCSSI 753 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~-------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~ 753 (1008)
.++|++.+.||+|+||.||+|++. .++..||||+++... ....+.+.+|+++++++ +||||++++++|
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~--- 156 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC--- 156 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEE---
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEE---
Confidence 467999999999999999999874 345689999997543 34456899999999999 899999999995
Q ss_pred cccCCceEEEEEeccCCCChhcccccCCCCCCC------cccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCC
Q 045798 754 DFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRD------KEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKP 827 (1008)
Q Consensus 754 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~------~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp 827 (1008)
..++..|+||||+++|+|.+++......... ......+++.+++.++.||+.||+|||+. +|+||||||
T Consensus 157 --~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp 231 (370)
T 2psq_A 157 --TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAA 231 (370)
T ss_dssp --CSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCG
T ss_pred --ccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---Ceeccccch
Confidence 4556789999999999999999865432100 00112689999999999999999999998 999999999
Q ss_pred CCeeecCCCCeEEcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCcc
Q 045798 828 SNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT-AKKPTDVM 906 (1008)
Q Consensus 828 ~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-G~~pf~~~ 906 (1008)
+||+++.++.+||+|||+++......... ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||...
T Consensus 232 ~NIll~~~~~~kl~DFG~a~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~ 309 (370)
T 2psq_A 232 RNVLVTENNVMKIADFGLARDINNIDYYK--KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI 309 (370)
T ss_dssp GGEEECTTCCEEECCCSSCEETTCCCTTC--TTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred hhEEECCCCCEEEccccCCcccCccccee--cccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCC
Confidence 99999999999999999998654432211 1223457889999999999999999999999999999999 99998643
Q ss_pred ccCCccHHHHHHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 907 FEGDLNLHNFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 907 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
... .......... . .. ....++.++.+++.+||+.||++|||+.|+++
T Consensus 310 ~~~--~~~~~~~~~~------------~----------------~~--~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 357 (370)
T 2psq_A 310 PVE--ELFKLLKEGH------------R----------------MD--KPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 357 (370)
T ss_dssp CGG--GHHHHHHTTC------------C----------------CC--CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CHH--HHHHHHhcCC------------C----------------CC--CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 111 0000000000 0 00 00124556899999999999999999999999
Q ss_pred HHHHHHHHH
Q 045798 987 ELQSVKNIL 995 (1008)
Q Consensus 987 ~L~~i~~~~ 995 (1008)
.|+++....
T Consensus 358 ~L~~il~~~ 366 (370)
T 2psq_A 358 DLDRILTLT 366 (370)
T ss_dssp HHHHHHHHH
T ss_pred HHHHHHHHh
Confidence 999987653
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-40 Score=364.75 Aligned_cols=249 Identities=24% Similarity=0.304 Sum_probs=203.1
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccc---cchhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCc
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQ---CEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGND 759 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 759 (1008)
.++|++.+.||+|+||.||+|+...+++.||+|+++.. .......+.+|+++++.++||||++++++ +...+
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~-----~~~~~ 78 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYA-----FQTHD 78 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEE-----EECSS
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEE-----EEeCC
Confidence 46799999999999999999999989999999999743 23345678999999999999999999998 45667
Q ss_pred eEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeE
Q 045798 760 FKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGH 839 (1008)
Q Consensus 760 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 839 (1008)
..|+||||+++|+|.+++.... .+++..++.++.||+.||+|||++ +|+||||||+||+++.++.+|
T Consensus 79 ~~~lv~E~~~gg~L~~~l~~~~----------~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vk 145 (337)
T 1o6l_A 79 RLCFVMEYANGGELFFHLSRER----------VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIK 145 (337)
T ss_dssp EEEEEEECCTTCBHHHHHHHHS----------CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEE
T ss_pred EEEEEEeCCCCCcHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEE
Confidence 8999999999999999987543 689999999999999999999998 999999999999999999999
Q ss_pred EcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHh
Q 045798 840 IGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARM 919 (1008)
Q Consensus 840 L~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~ 919 (1008)
|+|||+++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..... .....
T Consensus 146 L~DFG~a~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~-----~~~~~- 215 (337)
T 1o6l_A 146 ITDFGLCKEGISDGA----TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-----ERLFE- 215 (337)
T ss_dssp ECCCTTCBCSCCTTC----CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHH-
T ss_pred EeeccchhhcccCCC----cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCH-----HHHHH-
Confidence 999999985432221 12335699999999999999999999999999999999999999863211 00000
Q ss_pred hCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCC-----CHHHHHH
Q 045798 920 ALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRM-----NMTNVVH 986 (1008)
Q Consensus 920 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~ 986 (1008)
.+..... .++ ...+.++.+++.+||+.||++|| +++|+++
T Consensus 216 -------~i~~~~~--------------~~p------~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~ 260 (337)
T 1o6l_A 216 -------LILMEEI--------------RFP------RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp -------HHHHCCC--------------CCC------TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred -------HHHcCCC--------------CCC------CCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence 0000000 001 01345678999999999999999 8998876
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=360.57 Aligned_cols=262 Identities=25% Similarity=0.363 Sum_probs=205.5
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEecccc---chhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCc
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC---EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGND 759 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 759 (1008)
.++|++.+.||+|+||.||+|++..+++.||+|++.... ....+.+.+|+.++++++||||+++++++ ..++
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~-----~~~~ 84 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVD-----EEDD 84 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEE-----ECSS
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEee-----eeCC
Confidence 467999999999999999999998899999999986432 33456899999999999999999999994 5667
Q ss_pred eEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeE
Q 045798 760 FKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGH 839 (1008)
Q Consensus 760 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 839 (1008)
..++||||+++++|.+++.... ++++..++.++.|++.||+|||+. +|+||||||+||+++.++.+|
T Consensus 85 ~~~lv~e~~~g~~L~~~l~~~~----------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~k 151 (294)
T 4eqm_A 85 CYYLVMEYIEGPTLSEYIESHG----------PLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLK 151 (294)
T ss_dssp EEEEEEECCCSCBHHHHHHHHC----------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEE
T ss_pred eEEEEEeCCCCCCHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEE
Confidence 7999999999999999997543 689999999999999999999998 999999999999999999999
Q ss_pred EcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHh
Q 045798 840 IGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARM 919 (1008)
Q Consensus 840 L~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~ 919 (1008)
|+|||+++........ ......||+.|+|||++.+..++.++||||+|+++|||++|+.||....... .....
T Consensus 152 l~Dfg~~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~----~~~~~ 224 (294)
T 4eqm_A 152 IFDFGIAKALSETSLT---QTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVS----IAIKH 224 (294)
T ss_dssp ECCCSSSTTC----------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHH----HHHHH
T ss_pred EEeCCCcccccccccc---ccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH----HHHHH
Confidence 9999999866433221 1223458999999999999999999999999999999999999986432110 00000
Q ss_pred hCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCC-CHHHHHHHHHHHHH
Q 045798 920 ALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRM-NMTNVVHELQSVKN 993 (1008)
Q Consensus 920 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-t~~evl~~L~~i~~ 993 (1008)
. ........ .. .....+..+.+++.+||+.||++|| +++++.+.|+++..
T Consensus 225 ~---------~~~~~~~~---------~~------~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~ 275 (294)
T 4eqm_A 225 I---------QDSVPNVT---------TD------VRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLH 275 (294)
T ss_dssp H---------SSCCCCHH---------HH------SCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSS
T ss_pred h---------hccCCCcc---------hh------cccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHh
Confidence 0 00000000 00 0112456689999999999999998 89999999887643
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=372.63 Aligned_cols=262 Identities=27% Similarity=0.481 Sum_probs=197.7
Q ss_pred hcCCCCCceEeeccCeeEEEEEEc---CCCeEEEEEEecccc-chhhHHHHHHHHHHhhcCCCCceeeeeccccccccCC
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALD---EDGIVVAIKVINLQC-EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGN 758 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 758 (1008)
.++|++.+.||+|+||.||+|++. .++..||||+++... ....+.+.+|++++++++||||++++++| ..+
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-----~~~ 118 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVV-----TKS 118 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-----CSS
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----eeC
Confidence 457999999999999999999986 457789999997543 34456899999999999999999999995 445
Q ss_pred ceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCe
Q 045798 759 DFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSG 838 (1008)
Q Consensus 759 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 838 (1008)
+..++||||+++|+|.+++..... .+++.+++.++.||+.||+|||+. +|+||||||+||+++.++.+
T Consensus 119 ~~~~lv~e~~~~~sL~~~l~~~~~---------~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~ 186 (373)
T 2qol_A 119 KPVMIVTEYMENGSLDSFLRKHDA---------QFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVC 186 (373)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTT---------CSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCE
T ss_pred CceEEEEeCCCCCcHHHHHHhCCC---------CCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCE
Confidence 678999999999999999976432 689999999999999999999998 99999999999999999999
Q ss_pred EEcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCccccCCccHHHHH
Q 045798 839 HIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT-AKKPTDVMFEGDLNLHNFA 917 (1008)
Q Consensus 839 kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-G~~pf~~~~~~~~~~~~~~ 917 (1008)
||+|||+++.......... ......+++.|+|||++.+..++.++|||||||++|||++ |+.||...... ..
T Consensus 187 kl~Dfg~a~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~-----~~- 259 (373)
T 2qol_A 187 KVSDFGLGRVLEDDPEAAY-TTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ-----DV- 259 (373)
T ss_dssp EECCC-----------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHH-----HH-
T ss_pred EECcCccccccccCCccce-eccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHH-----HH-
Confidence 9999999987654332211 1122335788999999998899999999999999999998 99998643110 00
Q ss_pred HhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHHHHHHHH
Q 045798 918 RMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHELQSVKNI 994 (1008)
Q Consensus 918 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~i~~~ 994 (1008)
...+..... .+ ....++..+.+++.+||+.||++||++.||++.|+++...
T Consensus 260 --------~~~i~~~~~--------------~~----~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 310 (373)
T 2qol_A 260 --------IKAVDEGYR--------------LP----PPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310 (373)
T ss_dssp --------HHHHHTTEE--------------CC----CCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred --------HHHHHcCCC--------------CC----CCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhC
Confidence 000100000 00 0112456689999999999999999999999999988654
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=372.33 Aligned_cols=281 Identities=21% Similarity=0.281 Sum_probs=216.3
Q ss_pred CCHHHHHHHhcCCCCCceEeeccCeeEEEEEE-----cCCCeEEEEEEeccccc-hhhHHHHHHHHHHhhc-CCCCceee
Q 045798 674 MSYKSLLKATNGFSSTHLIGVGSFGCVYKGAL-----DEDGIVVAIKVINLQCE-GASKSFMAECKALKNI-RHRNLVKV 746 (1008)
Q Consensus 674 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-----~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~ 746 (1008)
+...+.....++|++.+.||+|+||.||+|++ ..+++.||||+++.... ...+.+.+|++++.++ +||||+++
T Consensus 12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~ 91 (359)
T 3vhe_A 12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 91 (359)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeee
Confidence 34455555678999999999999999999984 45678999999975433 3456799999999999 89999999
Q ss_pred eeccccccccCCceEEEEEeccCCCChhcccccCCCCCCC----------------------------------------
Q 045798 747 ITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRD---------------------------------------- 786 (1008)
Q Consensus 747 ~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~---------------------------------------- 786 (1008)
+++|. ..+...++||||+++|+|.+++.........
T Consensus 92 ~~~~~----~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (359)
T 3vhe_A 92 LGACT----KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGF 167 (359)
T ss_dssp EEEEC----STTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC--------------------------------------
T ss_pred eeeee----cCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccc
Confidence 99964 3345589999999999999999765421000
Q ss_pred ----------------cccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEcccCcccccc
Q 045798 787 ----------------KEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQ 850 (1008)
Q Consensus 787 ----------------~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~ 850 (1008)
......+++..++.++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~ 244 (359)
T 3vhe_A 168 VEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIY 244 (359)
T ss_dssp ----------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTT
T ss_pred ccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeec
Confidence 00011389999999999999999999998 99999999999999999999999999998664
Q ss_pred cccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCccccCCccHHHHHHhhCCcchhhhh
Q 045798 851 EVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT-AKKPTDVMFEGDLNLHNFARMALPNQVMDIV 929 (1008)
Q Consensus 851 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 929 (1008)
...... ......||+.|+|||++.+..++.++|||||||++|||++ |+.||........ ............
T Consensus 245 ~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~-~~~~~~~~~~~~----- 316 (359)
T 3vhe_A 245 KDPDYV--RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE-FCRRLKEGTRMR----- 316 (359)
T ss_dssp SCTTCE--EC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH-HHHHHHHTCCCC-----
T ss_pred ccccch--hccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHH-HHHHHHcCCCCC-----
Confidence 433221 2233558999999999988899999999999999999998 9999864322111 111111000000
Q ss_pred cccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHHHHHHHH
Q 045798 930 DPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHELQSVKNI 994 (1008)
Q Consensus 930 d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~i~~~ 994 (1008)
. ....+.++.+++.+||+.||.+|||++|+++.|+++.+.
T Consensus 317 -------------------~------~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 356 (359)
T 3vhe_A 317 -------------------A------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 356 (359)
T ss_dssp -------------------C------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -------------------C------CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHH
Confidence 0 011345678999999999999999999999999998765
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-39 Score=370.91 Aligned_cols=320 Identities=20% Similarity=0.196 Sum_probs=211.7
Q ss_pred ccCcCccCCccCCeeeecCCCCCCCCCccccCCCCCCEEEccCCCCCCccCcccccCcCcceEeeeccccccCCCccccc
Q 045798 69 SLSPHLGNLSFLREINLSNNTIQGEIPPEFGRLFRLEALFLSNNSLVGKIPANLSYCSRLTVLCIEYNKLQGRIPLEFVS 148 (1008)
Q Consensus 69 ~l~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~ 148 (1008)
..+..++.+++|++|+|++|.+++. | .|..+++|++|+|++|++++. | ++.+++|++|++++|++++. + +++
T Consensus 33 ~~~~~~~~l~~L~~L~Ls~n~l~~~-~-~l~~l~~L~~L~Ls~n~l~~~-~--~~~l~~L~~L~Ls~N~l~~~-~--~~~ 104 (457)
T 3bz5_A 33 TDTISEEQLATLTSLDCHNSSITDM-T-GIEKLTGLTKLICTSNNITTL-D--LSQNTNLTYLACDSNKLTNL-D--VTP 104 (457)
T ss_dssp TSEEEHHHHTTCCEEECCSSCCCCC-T-TGGGCTTCSEEECCSSCCSCC-C--CTTCTTCSEEECCSSCCSCC-C--CTT
T ss_pred ccccChhHcCCCCEEEccCCCcccC-h-hhcccCCCCEEEccCCcCCeE-c--cccCCCCCEEECcCCCCcee-e--cCC
Confidence 3444566777788888888887753 4 577788888888888887753 3 77778888888888887753 3 777
Q ss_pred cCCCCeeecccccCCCCCCCCCccccccchhhcccccCCCCCCccccCCCCCcEEEecCCcccccCCccccCCCCcceec
Q 045798 149 LSKLKDLSLAKNKLTGGIPPFLGNLTSLEVLSLAGNSFGRNIPDSLGQLKQLKILAIGGNNLSGPIPPSIYNLSFLVVFS 228 (1008)
Q Consensus 149 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 228 (1008)
+++|++|++++|++++ ++ ++.+++|++|++++|++++. .++.+++|++|++++|...+.+ .+..+++|+.|+
T Consensus 105 l~~L~~L~L~~N~l~~-l~--~~~l~~L~~L~l~~N~l~~l---~l~~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ 176 (457)
T 3bz5_A 105 LTKLTYLNCDTNKLTK-LD--VSQNPLLTYLNCARNTLTEI---DVSHNTQLTELDCHLNKKITKL--DVTPQTQLTTLD 176 (457)
T ss_dssp CTTCCEEECCSSCCSC-CC--CTTCTTCCEEECTTSCCSCC---CCTTCTTCCEEECTTCSCCCCC--CCTTCTTCCEEE
T ss_pred CCcCCEEECCCCcCCe-ec--CCCCCcCCEEECCCCcccee---ccccCCcCCEEECCCCCccccc--ccccCCcCCEEE
Confidence 7788888888887775 33 77777788888888877663 2677777888888777544443 466777777777
Q ss_pred cccccccccCChhhhhcCCCCcEEEeccccCCCCCCcccccCCCCceeecccccccccccccccCCCcccccccccccCC
Q 045798 229 VSHNQIHGSLPPSLGLLLPNLKFFQIHHNFFSGSIPISLSNASKLEHIEIANNNFSGKLSVNFGGMKNLSLLNLQFSNLG 308 (1008)
Q Consensus 229 ls~N~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~ 308 (1008)
+++|+++ .+| +..+++|+.|++++|.+++. .+..+++|++|++++|+++++ | +..+++|+.|++++|+++
T Consensus 177 ls~n~l~-~l~---l~~l~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~i-p--~~~l~~L~~L~l~~N~l~ 246 (457)
T 3bz5_A 177 CSFNKIT-ELD---VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTEI-D--VTPLTQLTYFDCSVNPLT 246 (457)
T ss_dssp CCSSCCC-CCC---CTTCTTCCEEECCSSCCSCC---CCTTCTTCSEEECCSSCCSCC-C--CTTCTTCSEEECCSSCCS
T ss_pred CCCCccc-eec---cccCCCCCEEECcCCcCCee---ccccCCCCCEEECcCCccccc-C--ccccCCCCEEEeeCCcCC
Confidence 7777777 355 33467777777777777753 366777777777777777763 2 566666666666666665
Q ss_pred CCCCCcccccccccccCCCcEEEecCCcCCccCChhhhhhcccceeeeeccccccCCCCCccccccccceEEecCccccC
Q 045798 309 SGESDEMGFMNSLTNCSKLRVLSLGGNQFRGALPHSIANLSSQLQILILSSNQFYGSIPLGIGNLVDLYLLGMVENQFTG 388 (1008)
Q Consensus 309 ~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~ 388 (1008)
... +..+++|+.|++++|+ |+.|++++|.+.+.+| ++.+++|+.|++++|.+.+
T Consensus 247 ~~~---------~~~l~~L~~L~l~~n~---------------L~~L~l~~n~~~~~~~--~~~l~~L~~L~Ls~n~~l~ 300 (457)
T 3bz5_A 247 ELD---------VSTLSKLTTLHCIQTD---------------LLEIDLTHNTQLIYFQ--AEGCRKIKELDVTHNTQLY 300 (457)
T ss_dssp CCC---------CTTCTTCCEEECTTCC---------------CSCCCCTTCTTCCEEE--CTTCTTCCCCCCTTCTTCC
T ss_pred CcC---------HHHCCCCCEEeccCCC---------------CCEEECCCCccCCccc--ccccccCCEEECCCCcccc
Confidence 532 2345566666665542 4456666666665555 3455666666666666555
Q ss_pred CcchhccCCCCCceEEccCCcccccccccccCCCCcceeeccccccccccCCCCcCCCcccEeeccccccc
Q 045798 389 AIPKEMGKLQKLQGLDFSGNHFSGEIPSSLGNLSSLYEVFFNNNNLSGVIPFSLGNLKRLAFLEMSGNELS 459 (1008)
Q Consensus 389 ~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 459 (1008)
.+|. ...+|+.|++++| ++|++|++++|++++. + ++++++|+.|++++|+++
T Consensus 301 ~l~~---~~~~L~~L~l~~~-------------~~L~~L~L~~N~l~~l-~--l~~l~~L~~L~l~~N~l~ 352 (457)
T 3bz5_A 301 LLDC---QAAGITELDLSQN-------------PKLVYLYLNNTELTEL-D--VSHNTKLKSLSCVNAHIQ 352 (457)
T ss_dssp EEEC---TTCCCSCCCCTTC-------------TTCCEEECTTCCCSCC-C--CTTCTTCSEEECCSSCCC
T ss_pred eecc---CCCcceEechhhc-------------ccCCEEECCCCccccc-c--cccCCcCcEEECCCCCCC
Confidence 5553 2344555555444 4566666666666653 2 666666666666666665
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=375.78 Aligned_cols=261 Identities=26% Similarity=0.389 Sum_probs=209.0
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEecccc-chhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceE
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC-EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFK 761 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 761 (1008)
.++|.+.+.||+|+||.||+|.+..+++.||||+++... ....+.+.+|++++++++||||++++++| ..++..
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~-----~~~~~~ 187 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC-----TQKQPI 187 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEE-----CSSSSC
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-----ecCCCc
Confidence 467899999999999999999998889999999987543 23445789999999999999999999995 445668
Q ss_pred EEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEc
Q 045798 762 AIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIG 841 (1008)
Q Consensus 762 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 841 (1008)
++||||+++|+|.+++.... ..+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+
T Consensus 188 ~lv~e~~~~g~L~~~l~~~~---------~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~ 255 (377)
T 3cbl_A 188 YIVMELVQGGDFLTFLRTEG---------ARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKIS 255 (377)
T ss_dssp EEEEECCTTCBHHHHHHHHG---------GGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEEC
T ss_pred EEEEEcCCCCCHHHHHHhcC---------CCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEEC
Confidence 99999999999999997542 1689999999999999999999998 99999999999999999999999
Q ss_pred ccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCccccCCccHHHHHHhh
Q 045798 842 DFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT-AKKPTDVMFEGDLNLHNFARMA 920 (1008)
Q Consensus 842 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-G~~pf~~~~~~~~~~~~~~~~~ 920 (1008)
|||+++....... ........++..|+|||++.+..++.++|||||||++|||++ |..||...... .....
T Consensus 256 DfG~s~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~--~~~~~---- 327 (377)
T 3cbl_A 256 DFGMSREEADGVY--AASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQ--QTREF---- 327 (377)
T ss_dssp CGGGCEECTTSEE--ECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHH--HHHHH----
T ss_pred cCCCceecCCCce--eecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHH----
Confidence 9999985433211 111112236788999999988889999999999999999998 99998643111 00001
Q ss_pred CCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHHHHHHHH
Q 045798 921 LPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHELQSVKNI 994 (1008)
Q Consensus 921 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~i~~~ 994 (1008)
+... .+++ ....++.++.+++.+||+.||++|||++++++.|+++++.
T Consensus 328 --------~~~~--------------~~~~----~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~ 375 (377)
T 3cbl_A 328 --------VEKG--------------GRLP----CPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375 (377)
T ss_dssp --------HHTT--------------CCCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --------HHcC--------------CCCC----CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence 1000 0000 0112455689999999999999999999999999998764
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-40 Score=352.27 Aligned_cols=258 Identities=24% Similarity=0.371 Sum_probs=207.7
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccchhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceEE
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKA 762 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 762 (1008)
.++|++.+.||+|+||.||+|.+. +++.||+|+++... ...+.+.+|++++++++||||+++++++ .++...+
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~~ 81 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVC-----LEQAPIC 81 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEE-----CSSSSEE
T ss_pred hhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEE-----ecCCceE
Confidence 357899999999999999999996 68889999997543 3346799999999999999999999995 4556689
Q ss_pred EEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEcc
Q 045798 763 IVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGD 842 (1008)
Q Consensus 763 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 842 (1008)
+||||+++++|.+++..... .+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|
T Consensus 82 lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~D 149 (269)
T 4hcu_A 82 LVFEFMEHGCLSDYLRTQRG---------LFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSD 149 (269)
T ss_dssp EEEECCTTCBHHHHHHTTTT---------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECC
T ss_pred EEEEeCCCCcHHHHHHhcCc---------ccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEecc
Confidence 99999999999999965432 689999999999999999999998 999999999999999999999999
Q ss_pred cCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCccccCCccHHHHHHhhC
Q 045798 843 FGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT-AKKPTDVMFEGDLNLHNFARMAL 921 (1008)
Q Consensus 843 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-G~~pf~~~~~~~~~~~~~~~~~~ 921 (1008)
||.++....... .......+|+.|+|||++.+..++.++||||+|+++|+|++ |+.||...... ..........
T Consensus 150 fg~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~--~~~~~~~~~~ 224 (269)
T 4hcu_A 150 FGMTRFVLDDQY---TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS--EVVEDISTGF 224 (269)
T ss_dssp TTGGGGBCCHHH---HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHHHHHTTC
T ss_pred cccccccccccc---ccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHH--HHHHHHhcCc
Confidence 999986543321 12233457888999999988899999999999999999999 99998642111 0000000000
Q ss_pred CcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHHHHHHHH
Q 045798 922 PNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHELQSVKNI 994 (1008)
Q Consensus 922 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~i~~~ 994 (1008)
.. . .....+..+.+++.+||+.||++|||++|+++.|+++.+.
T Consensus 225 ~~----------------------------~--~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~ 267 (269)
T 4hcu_A 225 RL----------------------------Y--KPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 267 (269)
T ss_dssp CC----------------------------C--CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred cC----------------------------C--CCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence 00 0 0011245578999999999999999999999999998763
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=365.01 Aligned_cols=253 Identities=19% Similarity=0.269 Sum_probs=203.8
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEecccc--chhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCce
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC--EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDF 760 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 760 (1008)
.++|++.+.||+|+||.||+|.+..+++.||+|+++... ....+.+.+|++++++++||||+++++++ .+++.
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~-----~~~~~ 102 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI-----QEESF 102 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECSSE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----EeCCE
Confidence 467999999999999999999999899999999997542 33456789999999999999999999994 56677
Q ss_pred EEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCC---CC
Q 045798 761 KAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDND---LS 837 (1008)
Q Consensus 761 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~---~~ 837 (1008)
.++||||+++|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+||+++.+ +.
T Consensus 103 ~~lv~e~~~gg~L~~~l~~~~----------~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~ 169 (362)
T 2bdw_A 103 HYLVFDLVTGGELFEDIVARE----------FYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAA 169 (362)
T ss_dssp EEEEECCCCSCBHHHHHTTCS----------CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCC
T ss_pred EEEEEecCCCCCHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCC
Confidence 999999999999999987653 689999999999999999999998 99999999999999765 45
Q ss_pred eEEcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHH
Q 045798 838 GHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFA 917 (1008)
Q Consensus 838 ~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~ 917 (1008)
+||+|||++........ .....||+.|+|||++.+..++.++|||||||++|+|++|..||...... .......
T Consensus 170 ~kl~DfG~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~-~~~~~i~ 243 (362)
T 2bdw_A 170 VKLADFGLAIEVNDSEA-----WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH-RLYAQIK 243 (362)
T ss_dssp EEECCCTTCBCCTTCCS-----CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHH
T ss_pred EEEeecCcceEecCCcc-----cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH-HHHHHHH
Confidence 99999999986653321 22356999999999999999999999999999999999999998642110 0000000
Q ss_pred HhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 045798 918 RMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHE 987 (1008)
Q Consensus 918 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 987 (1008)
..... .+.+.....+.++.+++.+||+.||++|||+.|+++.
T Consensus 244 ~~~~~----------------------------~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 244 AGAYD----------------------------YPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp HTCCC----------------------------CCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hCCCC----------------------------CCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00000 0000111235567899999999999999999998763
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=360.00 Aligned_cols=252 Identities=21% Similarity=0.275 Sum_probs=203.6
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccch------hhHHHHHHHHHHhhcCCCCceeeeecccccccc
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEG------ASKSFMAECKALKNIRHRNLVKVITSCSSIDFQ 756 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 756 (1008)
.++|.+.+.||+|+||.||+|.+..+++.||+|+++..... ..+.+.+|+.++++++||||+++++++ .
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~ 84 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVY-----E 84 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEE-----E
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEE-----E
Confidence 35699999999999999999999989999999999754321 356799999999999999999999994 5
Q ss_pred CCceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCC
Q 045798 757 GNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDL 836 (1008)
Q Consensus 757 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 836 (1008)
.+...++||||+++++|.+++.... .+++..++.++.||+.||+|||+. +|+||||||+||+++.++
T Consensus 85 ~~~~~~lv~e~~~~~~L~~~l~~~~----------~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~ 151 (326)
T 2y0a_A 85 NKTDVILILELVAGGELFDFLAEKE----------SLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRN 151 (326)
T ss_dssp CSSEEEEEEECCCSCBHHHHHTTSS----------CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSS
T ss_pred eCCEEEEEEEcCCCCCHHHHHHhcC----------CcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCC
Confidence 5677999999999999999997543 689999999999999999999998 999999999999998887
Q ss_pred ----CeEEcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCcc
Q 045798 837 ----SGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLN 912 (1008)
Q Consensus 837 ----~~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~ 912 (1008)
.+||+|||+++....... .....||+.|+|||++.+..++.++|||||||++|+|++|..||....... .
T Consensus 152 ~~~~~~kl~Dfg~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~ 225 (326)
T 2y0a_A 152 VPKPRIKIIDFGLAHKIDFGNE-----FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE-T 225 (326)
T ss_dssp SSSCCEEECCCTTCEECCTTSC-----CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH-H
T ss_pred CCCCCEEEEECCCCeECCCCCc-----cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH-H
Confidence 899999999986643321 123459999999999998999999999999999999999999986421110 0
Q ss_pred HHHHHHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 913 LHNFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 913 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
......... .... ......+..+.+++.+||+.||++|||+.|+++
T Consensus 226 ~~~~~~~~~------------~~~~----------------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 226 LANVSAVNY------------EFED----------------EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp HHHHHHTCC------------CCCH----------------HHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHHhcCC------------CcCc----------------cccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 000000000 0000 001123456789999999999999999999987
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=360.04 Aligned_cols=284 Identities=20% Similarity=0.249 Sum_probs=213.4
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEecccc-chhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceE
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC-EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFK 761 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 761 (1008)
.++|++.+.||+|+||+||+|++..+++.||||+++... ....+.+.+|++++++++||||+++++++.. ......
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---~~~~~~ 84 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEE---TTTRHK 84 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEEC---TTTCCE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeec---CCCceE
Confidence 357999999999999999999999889999999997543 3345678899999999999999999998642 334478
Q ss_pred EEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeee----cCCCC
Q 045798 762 AIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILL----DNDLS 837 (1008)
Q Consensus 762 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll----~~~~~ 837 (1008)
++||||+++++|.+++...... ..+++..++.++.||+.||+|||+. +|+||||||+||++ +.++.
T Consensus 85 ~lv~e~~~~~~L~~~l~~~~~~-------~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~ 154 (319)
T 4euu_A 85 VLIMEFCPCGSLYTVLEEPSNA-------YGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSV 154 (319)
T ss_dssp EEEEECCTTCBHHHHHHSGGGT-------TCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEE
T ss_pred EEEEeCCCCCCHHHHHHHhccc-------cCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCce
Confidence 9999999999999999765321 1489999999999999999999998 99999999999999 77888
Q ss_pred eEEcccCcccccccccCccccccccccccccccCccccC--------CCCCCcccchhhHHHHHHHHHhCCCCCCccccC
Q 045798 838 GHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGL--------GSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEG 909 (1008)
Q Consensus 838 ~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~ 909 (1008)
+||+|||+++........ ....||+.|+|||++. +..++.++|||||||++|||++|+.||......
T Consensus 155 ~kL~Dfg~a~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~ 229 (319)
T 4euu_A 155 YKLTDFGAARELEDDEQF-----VSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGP 229 (319)
T ss_dssp EEECCCTTCEECCTTCCB-----CCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCG
T ss_pred EEEccCCCceecCCCCce-----eecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcc
Confidence 999999999866543221 2345899999999875 567899999999999999999999999643322
Q ss_pred CccHHHHH--HhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 045798 910 DLNLHNFA--RMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHE 987 (1008)
Q Consensus 910 ~~~~~~~~--~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 987 (1008)
........ ....+......+...... .......++.........+..+.+++.+||+.||++|||++|+++.
T Consensus 230 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h 303 (319)
T 4euu_A 230 RRNKEVMYKIITGKPSGAISGVQKAENG------PIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE 303 (319)
T ss_dssp GGCHHHHHHHHHHCCTTCCEEEECSTTC------CEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHH
T ss_pred chhHHHHHHHhcCCCcccchhhhcccCC------ccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhc
Confidence 22111111 111111100000000000 0000011122222335677889999999999999999999999988
Q ss_pred HHH
Q 045798 988 LQS 990 (1008)
Q Consensus 988 L~~ 990 (1008)
...
T Consensus 304 ~~d 306 (319)
T 4euu_A 304 TSD 306 (319)
T ss_dssp HHH
T ss_pred cHH
Confidence 764
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=368.05 Aligned_cols=294 Identities=23% Similarity=0.324 Sum_probs=209.0
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccchhhHHHHHHHHH--HhhcCCCCceeeeeccccccccCCce
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKA--LKNIRHRNLVKVITSCSSIDFQGNDF 760 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~--l~~l~h~niv~~~~~~~~~~~~~~~~ 760 (1008)
.++|++.+.||+|+||.||+|+. +++.||||+++.. ....+..|.++ +..++||||+++++.+......+...
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 86 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFA---NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRME 86 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEE
T ss_pred hHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeecc---chhhHHHHHHHHHHHhccCcchhhheecccccccCCCce
Confidence 46899999999999999999987 6899999999743 22344444444 44589999999998766555666677
Q ss_pred EEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCC------CCCceeccCCCCCeeecC
Q 045798 761 KAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHC------QEPILHCDLKPSNILLDN 834 (1008)
Q Consensus 761 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~------~~~ivH~Dlkp~NIll~~ 834 (1008)
.++||||+++|+|.+++... ..++..++.++.||+.||+|||+.. .++|+||||||+||+++.
T Consensus 87 ~~lv~e~~~~g~L~~~l~~~-----------~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~ 155 (336)
T 3g2f_A 87 YLLVMEYYPNGSLXKYLSLH-----------TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKN 155 (336)
T ss_dssp EEEEECCCTTCBHHHHHHHC-----------CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECT
T ss_pred EEEEEecCCCCcHHHHHhhc-----------ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcC
Confidence 89999999999999999654 4588999999999999999999852 228999999999999999
Q ss_pred CCCeEEcccCcccccccccCc----cccccccccccccccCccccCC-------CCCCcccchhhHHHHHHHHHhCCCCC
Q 045798 835 DLSGHIGDFGLARFHQEVSNS----TLSSSVGVKGTIGYTAPEYGLG-------SEVSTNGDVYSYGILLLEMVTAKKPT 903 (1008)
Q Consensus 835 ~~~~kL~Dfg~a~~~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~sDvwslG~vl~elltG~~pf 903 (1008)
++.+||+|||+++........ .........||+.|+|||++.+ ..++.++|||||||++|||++|..||
T Consensus 156 ~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~ 235 (336)
T 3g2f_A 156 DGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDL 235 (336)
T ss_dssp TSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGG
T ss_pred CCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcC
Confidence 999999999999866543211 1111223469999999999887 45678999999999999999998876
Q ss_pred CccccCCccHHHHHH-hhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHH
Q 045798 904 DVMFEGDLNLHNFAR-MALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMT 982 (1008)
Q Consensus 904 ~~~~~~~~~~~~~~~-~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ 982 (1008)
............+.. ........+. ..... .......++........++.++.+++.+||+.||++|||++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~-------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ 307 (336)
T 3g2f_A 236 FPGESVPEYQMAFQTEVGNHPTFEDM-QVLVS-------REKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQ 307 (336)
T ss_dssp STTSCCCCCCCTTHHHHCSSCCHHHH-HHHHT-------TSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHH
T ss_pred CCccchhHHHHhhhcccCCCchHHHH-Hhhhc-------ccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchH
Confidence 432221111111110 0000000000 00000 00001112222222335677899999999999999999999
Q ss_pred HHHHHHHHHHHHHHHHHH
Q 045798 983 NVVHELQSVKNILLELET 1000 (1008)
Q Consensus 983 evl~~L~~i~~~~~~~~~ 1000 (1008)
|+++.|+++...+.+-++
T Consensus 308 e~l~~L~~ll~~~~~~~~ 325 (336)
T 3g2f_A 308 XAEERMAELMMIWERNKS 325 (336)
T ss_dssp HHHHHHHHHHHCCCC---
T ss_pred HHHHHHHHHHHHHHhccc
Confidence 999999998876554443
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=356.32 Aligned_cols=252 Identities=23% Similarity=0.303 Sum_probs=196.6
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccc--------------------------hhhHHHHHHHHHHh
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCE--------------------------GASKSFMAECKALK 736 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--------------------------~~~~~~~~E~~~l~ 736 (1008)
.++|++.+.||+|+||.||+|.+..+++.||||++..... ...+.+.+|+++++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 4689999999999999999999998999999999864321 12356899999999
Q ss_pred hcCCCCceeeeeccccccccCCceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCC
Q 045798 737 NIRHRNLVKVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHC 816 (1008)
Q Consensus 737 ~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ 816 (1008)
+++||||+++++++.. ...+..++||||+++++|.+++... .+++.+++.++.||+.||+|||+.
T Consensus 92 ~l~h~~iv~~~~~~~~---~~~~~~~lv~e~~~~~~l~~~~~~~-----------~~~~~~~~~~~~qi~~~l~~lH~~- 156 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDD---PNEDHLYMVFELVNQGPVMEVPTLK-----------PLSEDQARFYFQDLIKGIEYLHYQ- 156 (298)
T ss_dssp TCCCTTBCCEEEEEEC---SSSSEEEEEEECCTTCBSCCSSCSS-----------CCCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred hCCCCCCCeEEEEEEc---CCCCEEEEEEecCCCCcHHHHhhcC-----------CCCHHHHHHHHHHHHHHHHHHHHC-
Confidence 9999999999999643 2356789999999999999876432 689999999999999999999998
Q ss_pred CCCceeccCCCCCeeecCCCCeEEcccCcccccccccCccccccccccccccccCccccCCCC---CCcccchhhHHHHH
Q 045798 817 QEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSE---VSTNGDVYSYGILL 893 (1008)
Q Consensus 817 ~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~sDvwslG~vl 893 (1008)
+|+||||||+||+++.++.+||+|||+++........ .....||+.|+|||++.+.. ++.++|||||||++
T Consensus 157 --~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l 230 (298)
T 2zv2_A 157 --KIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDAL----LSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTL 230 (298)
T ss_dssp --TEECCCCCGGGEEECTTSCEEECCCTTCEECSSSSCE----ECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHH
T ss_pred --CeeccCCCHHHEEECCCCCEEEecCCCcccccccccc----ccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHH
Confidence 9999999999999999999999999999866443221 12346899999999987765 47889999999999
Q ss_pred HHHHhCCCCCCccccCCccHHHHHHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCc
Q 045798 894 LEMVTAKKPTDVMFEGDLNLHNFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSME 973 (1008)
Q Consensus 894 ~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 973 (1008)
|||++|+.||..... ........ ..... . +.....+.++.+++.+||+.
T Consensus 231 ~~l~~g~~pf~~~~~--~~~~~~~~-----------~~~~~--------------~----~~~~~~~~~l~~li~~~l~~ 279 (298)
T 2zv2_A 231 YCFVFGQCPFMDERI--MCLHSKIK-----------SQALE--------------F----PDQPDIAEDLKDLITRMLDK 279 (298)
T ss_dssp HHHHHSSCSSCCSSH--HHHHHHHH-----------HCCCC--------------C----CSSSCCCHHHHHHHHHHTCS
T ss_pred HHHHHCCCCCCCccH--HHHHHHHh-----------cccCC--------------C----CCccccCHHHHHHHHHHhhc
Confidence 999999999863211 00000000 00000 0 00012345689999999999
Q ss_pred CCCCCCCHHHHHH
Q 045798 974 SPQDRMNMTNVVH 986 (1008)
Q Consensus 974 dP~~RPt~~evl~ 986 (1008)
||++|||+.|+++
T Consensus 280 dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 280 NPESRIVVPEIKL 292 (298)
T ss_dssp CTTTSCCHHHHTT
T ss_pred ChhhCCCHHHHhc
Confidence 9999999999875
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=372.06 Aligned_cols=254 Identities=17% Similarity=0.202 Sum_probs=203.7
Q ss_pred HhcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEecccc--chhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCc
Q 045798 682 ATNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC--EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGND 759 (1008)
Q Consensus 682 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 759 (1008)
..++|++.+.||+|+||.||+|.+..+|+.||+|++.... ....+.+.+|++++++++||||+++++++ .+++
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~-----~~~~ 83 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSI-----SEEG 83 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEE-----ECSS
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEE-----EECC
Confidence 3567999999999999999999999999999999997543 23456789999999999999999999994 5677
Q ss_pred eEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeec---CCC
Q 045798 760 FKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLD---NDL 836 (1008)
Q Consensus 760 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~---~~~ 836 (1008)
..++||||+++|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+||+++ .++
T Consensus 84 ~~~lv~E~~~gg~L~~~i~~~~----------~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~ 150 (444)
T 3soa_A 84 HHYLIFDLVTGGELFEDIVARE----------YYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGA 150 (444)
T ss_dssp EEEEEECCCBCCBHHHHHHHCS----------CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTC
T ss_pred EEEEEEEeCCCCCHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCC
Confidence 8999999999999999987654 689999999999999999999998 999999999999998 568
Q ss_pred CeEEcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHH
Q 045798 837 SGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNF 916 (1008)
Q Consensus 837 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~ 916 (1008)
.+||+|||++......... .....||+.|+|||++.+..++.++||||+||++|+|++|..||...... ......
T Consensus 151 ~vkL~DFG~a~~~~~~~~~----~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~-~~~~~i 225 (444)
T 3soa_A 151 AVKLADFGLAIEVEGEQQA----WFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQH-RLYQQI 225 (444)
T ss_dssp CEEECCCSSCBCCCTTCCB----CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHH
T ss_pred cEEEccCceeEEecCCCce----eecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHH-HHHHHH
Confidence 8999999999866543221 22356999999999999999999999999999999999999998642110 000011
Q ss_pred HHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 917 ARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 917 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
...... .+.+.....+.++.+++.+||+.||++|||+.|+++
T Consensus 226 ~~~~~~----------------------------~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 226 KAGAYD----------------------------FPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALK 267 (444)
T ss_dssp HHTCCC----------------------------CCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HhCCCC----------------------------CCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 000000 000011123456789999999999999999999987
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-40 Score=362.76 Aligned_cols=247 Identities=26% Similarity=0.322 Sum_probs=200.8
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEecccc---chhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCc
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC---EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGND 759 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 759 (1008)
.++|.+.+.||+|+||.||+|.+..+++.||+|++.... ......+.+|+++++.++||||+++++++ ..++
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~-----~~~~ 82 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVI-----TTPT 82 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSS
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEE-----EeCC
Confidence 468999999999999999999998899999999986432 22345789999999999999999999995 4566
Q ss_pred eEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeE
Q 045798 760 FKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGH 839 (1008)
Q Consensus 760 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 839 (1008)
..++||||+ +|+|.+++.... .+++.+++.++.||+.||+|||+. +|+||||||+||+++.++.+|
T Consensus 83 ~~~lv~E~~-~g~l~~~l~~~~----------~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~k 148 (336)
T 3h4j_B 83 DIVMVIEYA-GGELFDYIVEKK----------RMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVK 148 (336)
T ss_dssp EEEEEECCC-CEEHHHHHHHHC----------SCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEE
T ss_pred EEEEEEECC-CCcHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEE
Confidence 799999999 789999886543 689999999999999999999998 999999999999999999999
Q ss_pred EcccCcccccccccCccccccccccccccccCccccCCCCC-CcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHH
Q 045798 840 IGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEV-STNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFAR 918 (1008)
Q Consensus 840 L~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~ 918 (1008)
|+|||++........ .....||+.|+|||++.+..+ ++++||||+||++|+|++|+.||........
T Consensus 149 l~DFG~s~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~------- 216 (336)
T 3h4j_B 149 IADFGLSNIMTDGNF-----LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL------- 216 (336)
T ss_dssp ECCSSCTBTTTTSBT-----TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC-------
T ss_pred EEEeccceeccCCcc-----cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHH-------
Confidence 999999986544322 123459999999999988776 6899999999999999999999964321110
Q ss_pred hhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 919 MALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 919 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
........ ..++ ...+..+.+++.+||+.||.+|||++|+++
T Consensus 217 ----------~~~i~~~~----------~~~p------~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 258 (336)
T 3h4j_B 217 ----------FKKVNSCV----------YVMP------DFLSPGAQSLIRRMIVADPMQRITIQEIRR 258 (336)
T ss_dssp ----------BCCCCSSC----------CCCC------TTSCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred ----------HHHHHcCC----------CCCc------ccCCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 00000000 0000 113445789999999999999999999976
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=364.60 Aligned_cols=253 Identities=20% Similarity=0.251 Sum_probs=205.4
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccchhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceEE
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKA 762 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 762 (1008)
.++|++.+.||+|+||.||+|.+..+++.||+|++..........+.+|++++++++||||+++++++ .++...+
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~-----~~~~~~~ 124 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF-----EDKYEMV 124 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEE-----ECSSEEE
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEE-----EeCCEEE
Confidence 46899999999999999999999989999999999866555667899999999999999999999994 5567799
Q ss_pred EEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecC--CCCeEE
Q 045798 763 IVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDN--DLSGHI 840 (1008)
Q Consensus 763 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~--~~~~kL 840 (1008)
+||||+++|+|.+++..... .+++..++.++.||+.||+|||+. +|+||||||+||+++. ++.+||
T Consensus 125 lv~E~~~gg~L~~~l~~~~~---------~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL 192 (387)
T 1kob_A 125 LILEFLSGGELFDRIAAEDY---------KMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKI 192 (387)
T ss_dssp EEEECCCCCBHHHHTTCTTC---------CBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEE
T ss_pred EEEEcCCCCcHHHHHHhhcC---------CCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEE
Confidence 99999999999999875431 689999999999999999999998 9999999999999974 578999
Q ss_pred cccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHhh
Q 045798 841 GDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMA 920 (1008)
Q Consensus 841 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~~ 920 (1008)
+|||+++........ ....||+.|+|||++.+..++.++|||||||++|||++|..||...... ..........
T Consensus 193 ~DFG~a~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~-~~~~~i~~~~ 266 (387)
T 1kob_A 193 IDFGLATKLNPDEIV-----KVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL-ETLQNVKRCD 266 (387)
T ss_dssp CCCTTCEECCTTSCE-----EEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH-HHHHHHHHCC
T ss_pred EecccceecCCCcce-----eeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHH-HHHHHHHhCC
Confidence 999999866443221 1235899999999999999999999999999999999999998642110 0001110000
Q ss_pred CCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 921 LPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 921 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
.. .. .......+.++.+++.+||+.||++|||+.|+++
T Consensus 267 ~~------------~~----------------~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 304 (387)
T 1kob_A 267 WE------------FD----------------EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 304 (387)
T ss_dssp CC------------CC----------------SSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred CC------------CC----------------ccccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 00 00 0001123456799999999999999999999987
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-40 Score=368.79 Aligned_cols=276 Identities=17% Similarity=0.236 Sum_probs=209.2
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCC-----CeEEEEEEeccccchh-----------hHHHHHHHHHHhhcCCCCceee
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDED-----GIVVAIKVINLQCEGA-----------SKSFMAECKALKNIRHRNLVKV 746 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~-----~~~vavK~~~~~~~~~-----------~~~~~~E~~~l~~l~h~niv~~ 746 (1008)
.++|++.+.||+|+||.||+|.+..+ ++.||||++....... ...+..|+..++.++||||+++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~ 113 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY 113 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence 45899999999999999999998654 5789999987543211 1234456667778889999999
Q ss_pred eeccccccccCCceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCC
Q 045798 747 ITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLK 826 (1008)
Q Consensus 747 ~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlk 826 (1008)
++++... ..+..+.++||||+ +++|.+++..... .+++..++.|+.||+.||+|||+. +|+|||||
T Consensus 114 ~~~~~~~-~~~~~~~~lv~e~~-g~~L~~~~~~~~~---------~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlk 179 (364)
T 3op5_A 114 WGSGLHD-KNGKSYRFMIMDRF-GSDLQKIYEANAK---------RFSRKTVLQLSLRILDILEYIHEH---EYVHGDIK 179 (364)
T ss_dssp EEEEEEE-ETTEEEEEEEEECE-EEEHHHHHHHTTS---------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCC
T ss_pred Eeeeeec-cCCcceEEEEEeCC-CCCHHHHHHhccC---------CCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCC
Confidence 9997542 12335689999999 9999999976421 689999999999999999999998 99999999
Q ss_pred CCCeeec--CCCCeEEcccCcccccccccCccc---cccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCC
Q 045798 827 PSNILLD--NDLSGHIGDFGLARFHQEVSNSTL---SSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKK 901 (1008)
Q Consensus 827 p~NIll~--~~~~~kL~Dfg~a~~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~ 901 (1008)
|+|||++ .++.+||+|||+++.......... .......||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus 180 p~Nill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~ 259 (364)
T 3op5_A 180 ASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHL 259 (364)
T ss_dssp GGGEEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCC
T ss_pred HHHEEEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCC
Confidence 9999999 889999999999987654332211 11233459999999999999999999999999999999999999
Q ss_pred CCCccccCCccHHHHHHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCH
Q 045798 902 PTDVMFEGDLNLHNFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNM 981 (1008)
Q Consensus 902 pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~ 981 (1008)
||...... .................++++.+.. ..++.++.+++..||+.||.+||++
T Consensus 260 Pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~li~~cl~~~p~~RP~~ 317 (364)
T 3op5_A 260 PWEDNLKD-PKYVRDSKIRYRENIASLMDKCFPA---------------------ANAPGEIAKYMETVKLLDYTEKPLY 317 (364)
T ss_dssp TTGGGTTC-HHHHHHHHHHHHHCHHHHHHHHSCT---------------------TCCCHHHHHHHHHHHTCCTTCCCCH
T ss_pred CccccccC-HHHHHHHHHHhhhhHHHHHHHhccc---------------------ccCHHHHHHHHHHHhcCCCCCCCCH
Confidence 99743221 1111111111112222222222110 1235678999999999999999999
Q ss_pred HHHHHHHHHHHHH
Q 045798 982 TNVVHELQSVKNI 994 (1008)
Q Consensus 982 ~evl~~L~~i~~~ 994 (1008)
++|++.|+.+.+.
T Consensus 318 ~~l~~~l~~~~~~ 330 (364)
T 3op5_A 318 ENLRDILLQGLKA 330 (364)
T ss_dssp HHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHH
Confidence 9999999987764
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=355.60 Aligned_cols=276 Identities=21% Similarity=0.288 Sum_probs=201.6
Q ss_pred cCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEecccc--chhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceE
Q 045798 684 NGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC--EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFK 761 (1008)
Q Consensus 684 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 761 (1008)
++|++.+.||+|+||+||+|.+..+++.||+|+++... ....+.+.+|++++++++||||+++++++ ..++..
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~ 76 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVL-----HSDKKL 76 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEE-----EETTEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEE-----EeCCEE
Confidence 57999999999999999999999899999999997543 33457789999999999999999999994 456779
Q ss_pred EEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEc
Q 045798 762 AIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIG 841 (1008)
Q Consensus 762 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 841 (1008)
++||||+++ ++.+++..... .+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+
T Consensus 77 ~lv~e~~~~-~l~~~~~~~~~---------~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~ 143 (292)
T 3o0g_A 77 TLVFEFCDQ-DLKKYFDSCNG---------DLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLA 143 (292)
T ss_dssp EEEEECCSE-EHHHHHHHTTT---------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEEC
T ss_pred EEEEecCCC-CHHHHHHhCCC---------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEe
Confidence 999999965 66666544321 689999999999999999999998 99999999999999999999999
Q ss_pred ccCcccccccccCccccccccccccccccCccccCCCC-CCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHhh
Q 045798 842 DFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSE-VSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMA 920 (1008)
Q Consensus 842 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~~ 920 (1008)
|||.++........ .....||+.|+|||++.+.. ++.++||||+||++|||++|..||.................
T Consensus 144 Dfg~~~~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~ 219 (292)
T 3o0g_A 144 NFGLARAFGIPVRC----YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLL 219 (292)
T ss_dssp CCTTCEECCSCCSC----CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHH
T ss_pred ecccceecCCcccc----ccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHh
Confidence 99999865432221 22345899999999988766 79999999999999999999988643322222222222211
Q ss_pred CCcchhh--hhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 921 LPNQVMD--IVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 921 ~~~~~~~--~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
....... .....-...+ .... .............+.++.+++.+||+.||++|||++|+++
T Consensus 220 ~~~~~~~~~~~~~~~~~~~--~~~~---~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 220 GTPTEEQWPSMTKLPDYKP--YPMY---PATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp CCCCTTTCTTGGGSTTCCC--CCCC---CTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCCChhhhhhhcccccccc--cccc---cCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 1111000 0000000000 0000 0000000011124556789999999999999999999975
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-39 Score=357.10 Aligned_cols=277 Identities=25% Similarity=0.325 Sum_probs=203.5
Q ss_pred HHHhcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccchhhHHHHHHHHHHhhc--CCCCceeeeeccccccccC
Q 045798 680 LKATNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNI--RHRNLVKVITSCSSIDFQG 757 (1008)
Q Consensus 680 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~~~~~~~~~~~~~ 757 (1008)
....++|++.+.||+|+||.||+|++ .++.||||++... ....+.+|.+++... +||||+++++++.... ..
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~-~~ 106 (337)
T 3mdy_A 33 RTIAKQIQMVKQIGKGRYGEVWMGKW--RGEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGT-GS 106 (337)
T ss_dssp TTHHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESC-GG
T ss_pred cccccceEEEeEeecCCCeEEEEEEE--CCceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCC-CC
Confidence 33457899999999999999999998 4899999998643 234455566666555 9999999999865321 12
Q ss_pred CceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCC-----CCCceeccCCCCCeee
Q 045798 758 NDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHC-----QEPILHCDLKPSNILL 832 (1008)
Q Consensus 758 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~-----~~~ivH~Dlkp~NIll 832 (1008)
....++||||+++|+|.++++.. .+++..++.++.|++.||+|||+.. .++|+||||||+||++
T Consensus 107 ~~~~~lv~e~~~~g~L~~~l~~~-----------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill 175 (337)
T 3mdy_A 107 WTQLYLITDYHENGSLYDYLKST-----------TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILV 175 (337)
T ss_dssp GCEEEEEECCCTTCBHHHHHHHC-----------CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEE
T ss_pred CCceEEEEeccCCCcHHHHhhcc-----------CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEE
Confidence 25789999999999999999643 6899999999999999999999741 2389999999999999
Q ss_pred cCCCCeEEcccCcccccccccCccccccccccccccccCccccCCCCCCcc------cchhhHHHHHHHHHhCCC-----
Q 045798 833 DNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTN------GDVYSYGILLLEMVTAKK----- 901 (1008)
Q Consensus 833 ~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~------sDvwslG~vl~elltG~~----- 901 (1008)
+.++.+||+|||+++.................||+.|+|||++.+..++.+ +|||||||++|||++|..
T Consensus 176 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~ 255 (337)
T 3mdy_A 176 KKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIV 255 (337)
T ss_dssp CTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBC
T ss_pred CCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccc
Confidence 999999999999998665443332222334569999999999988766655 999999999999999954
Q ss_pred -----CCCccccCCccHHHHHHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCC
Q 045798 902 -----PTDVMFEGDLNLHNFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQ 976 (1008)
Q Consensus 902 -----pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~ 976 (1008)
||..................... .... .+......+++.++.+++.+||+.||+
T Consensus 256 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~--------~~~~-------------~~~~~~~~~~~~~l~~li~~~l~~dP~ 314 (337)
T 3mdy_A 256 EEYQLPYHDLVPSDPSYEDMREIVCIKK--------LRPS-------------FPNRWSSDECLRQMGKLMTECWAHNPA 314 (337)
T ss_dssp CCCCCTTTTTSCSSCCHHHHHHHHTTSC--------CCCC-------------CCGGGGGSHHHHHHHHHHHHHSCSSGG
T ss_pred ccccccHhhhcCCCCchhhhHHHHhhhc--------cCcc-------------ccccchhhHHHHHHHHHHHHhhhhChh
Confidence 44332222222111111110000 0000 000011236788899999999999999
Q ss_pred CCCCHHHHHHHHHHHHHH
Q 045798 977 DRMNMTNVVHELQSVKNI 994 (1008)
Q Consensus 977 ~RPt~~evl~~L~~i~~~ 994 (1008)
+|||+.||++.|+++.+.
T Consensus 315 ~Rps~~ell~~L~~l~~~ 332 (337)
T 3mdy_A 315 SRLTALRVKKTLAKMSES 332 (337)
T ss_dssp GSCCHHHHHHHHHHHHHT
T ss_pred hCCCHHHHHHHHHHHHhh
Confidence 999999999999998764
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=367.45 Aligned_cols=249 Identities=24% Similarity=0.302 Sum_probs=198.6
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccc---cchhhHHHHHHHHHHhhc-CCCCceeeeeccccccccCC
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQ---CEGASKSFMAECKALKNI-RHRNLVKVITSCSSIDFQGN 758 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~ 758 (1008)
.++|++.+.||+|+||.||+|++..+++.||||+++.. .....+.+.+|.++++.+ +||||++++++ +...
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~-----~~~~ 96 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCC-----FQTP 96 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEE-----EECS
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEE-----EEeC
Confidence 57899999999999999999999989999999999743 233456788999999988 79999999999 4567
Q ss_pred ceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCe
Q 045798 759 DFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSG 838 (1008)
Q Consensus 759 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 838 (1008)
+..|+||||+++|+|.+++.... .+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+
T Consensus 97 ~~~~lv~E~~~gg~L~~~l~~~~----------~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~i 163 (353)
T 3txo_A 97 DRLFFVMEFVNGGDLMFHIQKSR----------RFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHC 163 (353)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHS----------SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCE
T ss_pred CEEEEEEeCCCCCcHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCE
Confidence 78999999999999999997654 789999999999999999999998 99999999999999999999
Q ss_pred EEcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHH
Q 045798 839 HIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFAR 918 (1008)
Q Consensus 839 kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~ 918 (1008)
||+|||+|+....... ......||+.|+|||++.+..++.++||||+||++|||++|+.||......+ ......
T Consensus 164 kL~DFG~a~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~-~~~~i~- 237 (353)
T 3txo_A 164 KLADFGMCKEGICNGV----TTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDD-LFEAIL- 237 (353)
T ss_dssp EECCCTTCBCSCC-------------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHH-
T ss_pred EEccccceeecccCCc----cccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHH-HHHHHH-
Confidence 9999999985332221 1233569999999999988889999999999999999999999986431110 000000
Q ss_pred hhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCH------HHHHH
Q 045798 919 MALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNM------TNVVH 986 (1008)
Q Consensus 919 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~------~evl~ 986 (1008)
.... .++ ...+..+.+++.+||+.||++||++ +|+++
T Consensus 238 -----------~~~~--------------~~p------~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 238 -----------NDEV--------------VYP------TWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp -----------HCCC--------------CCC------TTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred -----------cCCC--------------CCC------CCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 0000 000 0123457899999999999999998 66654
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-40 Score=353.97 Aligned_cols=258 Identities=26% Similarity=0.425 Sum_probs=207.0
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccchhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceEE
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKA 762 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 762 (1008)
.++|++.+.||+|+||.||+|.+. ++..||+|+++... ...+.+.+|++++++++||||+++++++ ..+...+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~~ 79 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVC-----SKEYPIY 79 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTT-BCHHHHHHHHHHHHHCCCTTBCCEEEEE-----CSSSSEE
T ss_pred hhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCC-CcHHHHHHHHHHHHhCCCCCEeeEEEEE-----ccCCceE
Confidence 467999999999999999999886 67889999997553 3346799999999999999999999995 5566789
Q ss_pred EEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEcc
Q 045798 763 IVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGD 842 (1008)
Q Consensus 763 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 842 (1008)
+||||+++++|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|
T Consensus 80 lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~D 147 (268)
T 3sxs_A 80 IVTEYISNGCLLNYLRSHG---------KGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSD 147 (268)
T ss_dssp EEEECCTTCBHHHHHHHHG---------GGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECC
T ss_pred EEEEccCCCcHHHHHHHcC---------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEcc
Confidence 9999999999999997542 1589999999999999999999998 999999999999999999999999
Q ss_pred cCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCccccCCccHHHHHHhhC
Q 045798 843 FGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT-AKKPTDVMFEGDLNLHNFARMAL 921 (1008)
Q Consensus 843 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-G~~pf~~~~~~~~~~~~~~~~~~ 921 (1008)
||.+......... ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||....... .......
T Consensus 148 fg~~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~----~~~~~~~ 220 (268)
T 3sxs_A 148 FGMTRYVLDDQYV---SSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSE----VVLKVSQ 220 (268)
T ss_dssp TTCEEECCTTCEE---ECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHH----HHHHHHT
T ss_pred Cccceecchhhhh---cccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHH----HHHHHHc
Confidence 9999865443221 1223446788999999988889999999999999999999 999986432110 0000000
Q ss_pred CcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHHHHHHHH
Q 045798 922 PNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHELQSVKNI 994 (1008)
Q Consensus 922 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~i~~~ 994 (1008)
. . ... .....+..+.+++.+||+.||.+|||+.|+++.|+++++.
T Consensus 221 ~---------~---------------~~~----~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (268)
T 3sxs_A 221 G---------H---------------RLY----RPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK 265 (268)
T ss_dssp T---------C---------------CCC----CCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred C---------C---------------CCC----CCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence 0 0 000 0001234578999999999999999999999999987654
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=367.09 Aligned_cols=253 Identities=23% Similarity=0.322 Sum_probs=198.1
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEecccc---chhhHHHHHHHHHHhhc-CCCCceeeeeccccccccCC
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC---EGASKSFMAECKALKNI-RHRNLVKVITSCSSIDFQGN 758 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~ 758 (1008)
.++|++.+.||+|+||.||+|++..+++.||+|+++... ....+.+.+|..++.++ +||||++++++ +..+
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~-----~~~~ 125 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSC-----FQTE 125 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEE-----EECS
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEE-----EEEC
Confidence 467999999999999999999999999999999997542 23345688999999887 89999999998 4567
Q ss_pred ceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCe
Q 045798 759 DFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSG 838 (1008)
Q Consensus 759 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 838 (1008)
+..++||||+++|+|..++.... .+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+
T Consensus 126 ~~~~lV~E~~~gg~L~~~l~~~~----------~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~i 192 (396)
T 4dc2_A 126 SRLFFVIEYVNGGDLMFHMQRQR----------KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHI 192 (396)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHS----------SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCE
T ss_pred CEEEEEEEcCCCCcHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCE
Confidence 78999999999999999987643 789999999999999999999998 99999999999999999999
Q ss_pred EEcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHH
Q 045798 839 HIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFAR 918 (1008)
Q Consensus 839 kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~ 918 (1008)
||+|||+|+....... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||......+....
T Consensus 193 kL~DFGla~~~~~~~~----~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~---- 264 (396)
T 4dc2_A 193 KLTDYGMCKEGLRPGD----TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ---- 264 (396)
T ss_dssp EECCCTTCBCCCCTTC----CBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC----------
T ss_pred EEeecceeeecccCCC----ccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccch----
Confidence 9999999985322221 12345699999999999999999999999999999999999999964321110000
Q ss_pred hhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCH
Q 045798 919 MALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNM 981 (1008)
Q Consensus 919 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~ 981 (1008)
.....+....... ...++ ...+.++.+++.+||+.||.+||++
T Consensus 265 ----~~~~~~~~~i~~~----------~~~~p------~~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 265 ----NTEDYLFQVILEK----------QIRIP------RSLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp ----CCHHHHHHHHHHC----------CCCCC------TTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred ----hhHHHHHHHHhcc----------ccCCC------CcCCHHHHHHHHHHhcCCHhHcCCC
Confidence 0000000000000 00011 1234567899999999999999997
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-40 Score=369.64 Aligned_cols=272 Identities=23% Similarity=0.351 Sum_probs=209.9
Q ss_pred hcCCCCCceEeeccCeeEEEEEE-----cCCCeEEEEEEeccc-cchhhHHHHHHHHHHhhcCCCCceeeeecccccccc
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGAL-----DEDGIVVAIKVINLQ-CEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQ 756 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~-----~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 756 (1008)
.++|++.+.||+|+||.||+|.+ ..+++.||||+++.. .......+.+|+.++++++||||+++++++ .
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~-----~ 144 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVS-----L 144 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----C
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEE-----e
Confidence 35789999999999999999994 446789999999744 234456799999999999999999999995 4
Q ss_pred CCceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCC
Q 045798 757 GNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDL 836 (1008)
Q Consensus 757 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 836 (1008)
.+...++||||+++|+|.+++........ ....+++.+++.++.||+.||+|||+. +|+||||||+|||++.++
T Consensus 145 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~ 218 (367)
T 3l9p_A 145 QSLPRFILLELMAGGDLKSFLRETRPRPS---QPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPG 218 (367)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHHSCCSS---SCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSS
T ss_pred cCCCCEEEEEeCCCCCHHHHHHhhccccC---ccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCC
Confidence 55668999999999999999976542111 112689999999999999999999998 999999999999999554
Q ss_pred ---CeEEcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCccccCCcc
Q 045798 837 ---SGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT-AKKPTDVMFEGDLN 912 (1008)
Q Consensus 837 ---~~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-G~~pf~~~~~~~~~ 912 (1008)
.+||+|||+|+......... ......+|+.|+|||++.+..++.++|||||||++|||++ |..||...... .
T Consensus 219 ~~~~~kL~DFG~a~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~--~ 294 (367)
T 3l9p_A 219 PGRVAKIGDFGMARDIYRAGYYR--KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ--E 294 (367)
T ss_dssp TTCCEEECCCHHHHHHHHHSSCT--TCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--H
T ss_pred CCceEEECCCccccccccccccc--cCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH--H
Confidence 59999999998554332211 1223457899999999988899999999999999999998 99998643111 0
Q ss_pred HHHHHHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHHHHHH
Q 045798 913 LHNFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHELQSVK 992 (1008)
Q Consensus 913 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~i~ 992 (1008)
......... . .. ....++..+.+++.+||+.||++|||+.||++.|+.+.
T Consensus 295 ~~~~i~~~~------------~--------------~~----~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~ 344 (367)
T 3l9p_A 295 VLEFVTSGG------------R--------------MD----PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 344 (367)
T ss_dssp HHHHHHTTC------------C--------------CC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHcCC------------C--------------CC----CCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 000000000 0 00 01123456889999999999999999999999999987
Q ss_pred HHHHHHH
Q 045798 993 NILLELE 999 (1008)
Q Consensus 993 ~~~~~~~ 999 (1008)
...+...
T Consensus 345 ~~~~~~~ 351 (367)
T 3l9p_A 345 QDPDVIN 351 (367)
T ss_dssp HCHHHHT
T ss_pred hChhhcc
Confidence 7655443
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=353.14 Aligned_cols=265 Identities=17% Similarity=0.186 Sum_probs=210.7
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccchhhHHHHHHHHHHhhc-CCCCceeeeeccccccccCCceE
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNI-RHRNLVKVITSCSSIDFQGNDFK 761 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~ 761 (1008)
.++|++.+.||+|+||.||+|.+..+++.||||++... ...+.+.+|+++++++ +|++++++++++ ..+...
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~e~~~~~~l~~~~~i~~~~~~~-----~~~~~~ 81 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR--SDAPQLRDEYRTYKLLAGCTGIPNVYYFG-----QEGLHN 81 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECC--TTSCCHHHHHHHHHHTTTCTTCCCEEEEE-----EETTEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccC--CccHHHHHHHHHHHHHhcCCCCCeEEeec-----CCCcee
Confidence 46799999999999999999999889999999998643 2335688999999999 899999999984 556778
Q ss_pred EEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCC----
Q 045798 762 AIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLS---- 837 (1008)
Q Consensus 762 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~---- 837 (1008)
++||||+ +++|.+++..... ++++..++.++.||+.||+|||+. +|+||||||+||+++.++.
T Consensus 82 ~lv~e~~-~~~L~~~l~~~~~---------~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~ 148 (298)
T 1csn_A 82 VLVIDLL-GPSLEDLLDLCGR---------KFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNAN 148 (298)
T ss_dssp EEEEECC-CCBHHHHHHHTTT---------CCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTT
T ss_pred EEEEEec-CCCHHHHHHHhcc---------CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCC
Confidence 9999999 9999999976431 589999999999999999999997 9999999999999987776
Q ss_pred -eEEcccCcccccccccCccc---cccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCcc-
Q 045798 838 -GHIGDFGLARFHQEVSNSTL---SSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLN- 912 (1008)
Q Consensus 838 -~kL~Dfg~a~~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~- 912 (1008)
+||+|||+++.......... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.........
T Consensus 149 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~ 228 (298)
T 1csn_A 149 MIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQ 228 (298)
T ss_dssp CEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHH
T ss_pred eEEEEECccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHH
Confidence 99999999987654432211 1223456999999999999999999999999999999999999999753221110
Q ss_pred -HHHHHHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHHHHH
Q 045798 913 -LHNFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHELQSV 991 (1008)
Q Consensus 913 -~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~i 991 (1008)
.............. .....++.++.+++.+||+.||++|||+++|++.|+++
T Consensus 229 ~~~~~~~~~~~~~~~---------------------------~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~ 281 (298)
T 1csn_A 229 KYERIGEKKQSTPLR---------------------------ELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKV 281 (298)
T ss_dssp HHHHHHHHHHHSCHH---------------------------HHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred HHHHHHhhccCccHH---------------------------HHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHH
Confidence 00000000000000 00012456789999999999999999999999999988
Q ss_pred HHH
Q 045798 992 KNI 994 (1008)
Q Consensus 992 ~~~ 994 (1008)
.+.
T Consensus 282 ~~~ 284 (298)
T 1csn_A 282 LER 284 (298)
T ss_dssp HHH
T ss_pred HHh
Confidence 765
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=360.70 Aligned_cols=264 Identities=19% Similarity=0.220 Sum_probs=208.7
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccchhhHHHHHHHHHHhhc-CCCCceeeeeccccccccCCceE
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNI-RHRNLVKVITSCSSIDFQGNDFK 761 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~ 761 (1008)
.++|++.+.||+|+||.||+|.+..+++.||||++.... ..+.+.+|+++++++ +||||+++++++ ..++..
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~-----~~~~~~ 80 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS--RAPQLHLEYRFYKQLGSGDGIPQVYYFG-----PCGKYN 80 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC--SSCCHHHHHHHHHHHCSCTTSCCEEEEE-----EETTEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc--chHHHHHHHHHHHHhhCCCCCCEEEEEE-----ecCCcc
Confidence 467999999999999999999998899999999987542 234688999999999 999999999984 456678
Q ss_pred EEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCC----
Q 045798 762 AIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLS---- 837 (1008)
Q Consensus 762 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~---- 837 (1008)
++||||+ +++|.+++..... .+++..++.++.|++.||+|||+. +|+||||||+||+++.++.
T Consensus 81 ~lv~e~~-~~~L~~~~~~~~~---------~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~ 147 (330)
T 2izr_A 81 AMVLELL-GPSLEDLFDLCDR---------TFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQ 147 (330)
T ss_dssp EEEEECC-CCBHHHHHHHTTT---------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTT
T ss_pred EEEEEeC-CCCHHHHHHHcCC---------CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCc
Confidence 9999999 9999999976421 689999999999999999999998 9999999999999998887
Q ss_pred -eEEcccCcccccccccCccc---cccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCcc-
Q 045798 838 -GHIGDFGLARFHQEVSNSTL---SSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLN- 912 (1008)
Q Consensus 838 -~kL~Dfg~a~~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~- 912 (1008)
+||+|||+++.......... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.........
T Consensus 148 ~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~ 227 (330)
T 2izr_A 148 VIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKE 227 (330)
T ss_dssp SEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHH
T ss_pred eEEEEEcccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHH
Confidence 99999999987654332211 1123456999999999999999999999999999999999999999753211110
Q ss_pred -HHHHHHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHHHHH
Q 045798 913 -LHNFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHELQSV 991 (1008)
Q Consensus 913 -~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~i 991 (1008)
.........+.. .+ ......+ ++.+++..||+.||.+||++++|.+.|+++
T Consensus 228 ~~~~i~~~~~~~~------------~~---------------~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~ 279 (330)
T 2izr_A 228 RYQKIGDTKRATP------------IE---------------VLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDL 279 (330)
T ss_dssp HHHHHHHHHHHSC------------HH---------------HHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred HHHHHHhhhccCC------------HH---------------HHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHH
Confidence 000000000000 00 0000123 789999999999999999999999999877
Q ss_pred HHH
Q 045798 992 KNI 994 (1008)
Q Consensus 992 ~~~ 994 (1008)
.+.
T Consensus 280 ~~~ 282 (330)
T 2izr_A 280 FDR 282 (330)
T ss_dssp HHH
T ss_pred HHH
Confidence 654
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=362.27 Aligned_cols=251 Identities=24% Similarity=0.319 Sum_probs=201.3
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEecccc---chhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCc
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC---EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGND 759 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 759 (1008)
.++|++.+.||+|+||.||+|++..+++.||+|++.... ....+.+.+|+++++.++||||+++++++ .+.+
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~-----~~~~ 88 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSF-----QDEE 88 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECSS
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EeCC
Confidence 367999999999999999999999999999999986432 23456789999999999999999999994 5667
Q ss_pred eEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeE
Q 045798 760 FKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGH 839 (1008)
Q Consensus 760 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 839 (1008)
..|+||||+++|+|.+++.... .+++..++.++.||+.||+|||+. +|+||||||+||+++.++.+|
T Consensus 89 ~~~lv~e~~~gg~L~~~l~~~~----------~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vk 155 (384)
T 4fr4_A 89 DMFMVVDLLLGGDLRYHLQQNV----------HFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVH 155 (384)
T ss_dssp EEEEEECCCTTEEHHHHHHTTC----------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEE
T ss_pred EEEEEEecCCCCcHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEE
Confidence 7999999999999999997654 689999999999999999999998 999999999999999999999
Q ss_pred EcccCcccccccccCccccccccccccccccCccccCC---CCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHH
Q 045798 840 IGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLG---SEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNF 916 (1008)
Q Consensus 840 L~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~ 916 (1008)
|+|||+|+....... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... ....
T Consensus 156 L~DFG~a~~~~~~~~-----~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~--~~~~ 228 (384)
T 4fr4_A 156 ITDFNIAAMLPRETQ-----ITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTS--SKEI 228 (384)
T ss_dssp ECCCTTCEECCTTCC-----BCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSC--HHHH
T ss_pred EeccceeeeccCCCc-----eeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCcc--HHHH
Confidence 999999986543221 233569999999999864 458999999999999999999999996432211 1111
Q ss_pred HHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCC-HHHHHH
Q 045798 917 ARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMN-MTNVVH 986 (1008)
Q Consensus 917 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-~~evl~ 986 (1008)
.... ..... .++ ...+..+.+++.+||+.||.+||+ ++++.+
T Consensus 229 ~~~~--------~~~~~--------------~~p------~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 229 VHTF--------ETTVV--------------TYP------SAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp HHHH--------HHCCC--------------CCC------TTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred HHHH--------hhccc--------------CCC------CcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 0000 00000 000 123456789999999999999998 665543
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=352.18 Aligned_cols=254 Identities=27% Similarity=0.425 Sum_probs=201.1
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccchh-------hHHHHHHHHHHhhcCCCCceeeeeccccccc
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGA-------SKSFMAECKALKNIRHRNLVKVITSCSSIDF 755 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 755 (1008)
.++|++.+.||+|+||.||+|++..+++.||+|++....... .+.+.+|++++++++||||+++++++..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--- 94 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHN--- 94 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETT---
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecC---
Confidence 468999999999999999999998899999999986433211 1678999999999999999999998532
Q ss_pred cCCceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCC--ceeccCCCCCeeec
Q 045798 756 QGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEP--ILHCDLKPSNILLD 833 (1008)
Q Consensus 756 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~--ivH~Dlkp~NIll~ 833 (1008)
. .++||||+++|+|.+++..... .+++..++.++.|++.||+|||++ + |+||||||+||+++
T Consensus 95 --~--~~lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~ 158 (287)
T 4f0f_A 95 --P--PRMVMEFVPCGDLYHRLLDKAH---------PIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQ 158 (287)
T ss_dssp --T--TEEEEECCTTCBHHHHHHCTTS---------CCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEES
T ss_pred --C--CeEEEEecCCCCHHHHHhcccC---------CccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEe
Confidence 2 2699999999999988865432 689999999999999999999998 7 99999999999998
Q ss_pred CCCC-----eEEcccCcccccccccCccccccccccccccccCccccC--CCCCCcccchhhHHHHHHHHHhCCCCCCcc
Q 045798 834 NDLS-----GHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGL--GSEVSTNGDVYSYGILLLEMVTAKKPTDVM 906 (1008)
Q Consensus 834 ~~~~-----~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~sDvwslG~vl~elltG~~pf~~~ 906 (1008)
.++. +||+|||+++..... .....||+.|+|||++. ...++.++|||||||++|||++|+.||...
T Consensus 159 ~~~~~~~~~~kl~Dfg~~~~~~~~-------~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 231 (287)
T 4f0f_A 159 SLDENAPVCAKVADFGLSQQSVHS-------VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEY 231 (287)
T ss_dssp CCCTTCSCCEEECCCTTCBCCSSC-------EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred ccCCCCceeEEeCCCCcccccccc-------ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccc
Confidence 8776 999999999744321 12345899999999984 456789999999999999999999999743
Q ss_pred ccCCccHHHHHHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 907 FEGDLNLHNFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 907 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
............... . ... ....++..+.+++.+||+.||++|||++|+++
T Consensus 232 ~~~~~~~~~~~~~~~-----------~----------------~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 282 (287)
T 4f0f_A 232 SYGKIKFINMIREEG-----------L----------------RPT--IPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK 282 (287)
T ss_dssp CCCHHHHHHHHHHSC-----------C----------------CCC--CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cccHHHHHHHHhccC-----------C----------------CCC--CCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 222111111111000 0 000 00123556899999999999999999999999
Q ss_pred HHHHH
Q 045798 987 ELQSV 991 (1008)
Q Consensus 987 ~L~~i 991 (1008)
.|+++
T Consensus 283 ~L~~l 287 (287)
T 4f0f_A 283 ELSEL 287 (287)
T ss_dssp HHHTC
T ss_pred HHHhC
Confidence 99763
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=356.37 Aligned_cols=246 Identities=25% Similarity=0.323 Sum_probs=202.3
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEecccc---chhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCc
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC---EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGND 759 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 759 (1008)
.++|++.+.||+|+||.||+|+...+|+.||+|+++... ....+.+.+|+.+++.++||||+++++++ .+.+
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~-----~~~~ 79 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTF-----QDAQ 79 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEE-----ECSS
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEE-----EeCC
Confidence 467999999999999999999999899999999997432 23456788999999999999999999994 5667
Q ss_pred eEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeE
Q 045798 760 FKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGH 839 (1008)
Q Consensus 760 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 839 (1008)
..|+||||+++|+|.+++.... .+++..++.++.||+.||+|||++ +|+||||||+||+++.++.+|
T Consensus 80 ~~~lv~e~~~gg~L~~~l~~~~----------~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~k 146 (318)
T 1fot_A 80 QIFMIMDYIEGGELFSLLRKSQ----------RFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIK 146 (318)
T ss_dssp EEEEEECCCCSCBHHHHHHHTS----------SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEE
T ss_pred EEEEEEeCCCCCCHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEE
Confidence 8999999999999999997654 689999999999999999999998 999999999999999999999
Q ss_pred EcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHh
Q 045798 840 IGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARM 919 (1008)
Q Consensus 840 L~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~ 919 (1008)
|+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ...+
T Consensus 147 L~Dfg~a~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~----~~~~--- 212 (318)
T 1fot_A 147 ITDFGFAKYVPDV-------TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT----MKTY--- 212 (318)
T ss_dssp ECCCSSCEECSSC-------BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH----HHHH---
T ss_pred EeecCcceecCCc-------cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH----HHHH---
Confidence 9999999865432 1234699999999999999999999999999999999999999864211 0000
Q ss_pred hCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCC-----CHHHHHH
Q 045798 920 ALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRM-----NMTNVVH 986 (1008)
Q Consensus 920 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~ 986 (1008)
..+..... .++. ..+.++.+++.+|++.||++|| +++|+++
T Consensus 213 ------~~i~~~~~--------------~~p~------~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 213 ------EKILNAEL--------------RFPP------FFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp ------HHHHHCCC--------------CCCT------TSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred ------HHHHhCCC--------------CCCC------CCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 00000000 0010 1234578999999999999999 8888875
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=374.56 Aligned_cols=254 Identities=26% Similarity=0.387 Sum_probs=205.2
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccchhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceEE
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKA 762 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 762 (1008)
.++|++.+.||+|+||.||+|.+ .++.||||+++... ..+.+.+|++++++++||||++++++|. ......+
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~--~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~----~~~~~~~ 263 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIV----EEKGGLY 263 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEE----CTTSCEE
T ss_pred hHHeEEEeeecCcCCeeEEEEEe--cCCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEE----cCCCceE
Confidence 46788999999999999999998 47899999997543 4578999999999999999999999864 3344689
Q ss_pred EEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEcc
Q 045798 763 IVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGD 842 (1008)
Q Consensus 763 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 842 (1008)
+||||+++|+|.+++...... .+++..++.++.||+.||+|||+. +|+||||||+||+++.++.+||+|
T Consensus 264 iv~e~~~~g~L~~~l~~~~~~--------~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~D 332 (450)
T 1k9a_A 264 IVTEYMAKGSLVDYLRSRGRS--------VLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSD 332 (450)
T ss_dssp EEEECCTTCBHHHHHHHHCTT--------TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECC
T ss_pred EEEEecCCCcHHHHHHhcCCC--------CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEee
Confidence 999999999999999764321 478999999999999999999998 999999999999999999999999
Q ss_pred cCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCccccCCccHHHHHHhhC
Q 045798 843 FGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT-AKKPTDVMFEGDLNLHNFARMAL 921 (1008)
Q Consensus 843 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-G~~pf~~~~~~~~~~~~~~~~~~ 921 (1008)
||+++...... ....++..|+|||++.+..++.++|||||||++|||++ |+.||......+ ......
T Consensus 333 fG~a~~~~~~~-------~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~--~~~~i~--- 400 (450)
T 1k9a_A 333 FGLTKEASSTQ-------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--VVPRVE--- 400 (450)
T ss_dssp CTTCEECC-------------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT--HHHHHH---
T ss_pred CCCcccccccc-------cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHH---
Confidence 99998543221 11247889999999999999999999999999999998 999986432111 000000
Q ss_pred CcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHHHHHHHH
Q 045798 922 PNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHELQSVKNI 994 (1008)
Q Consensus 922 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~i~~~ 994 (1008)
... +++ ....++.++.++|.+||+.||++|||+.|+++.|+.+...
T Consensus 401 ---------~~~--------------~~~----~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 401 ---------KGY--------------KMD----APDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446 (450)
T ss_dssp ---------TTC--------------CCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred ---------cCC--------------CCC----CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence 000 000 0113456789999999999999999999999999998754
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=361.10 Aligned_cols=252 Identities=21% Similarity=0.265 Sum_probs=189.2
Q ss_pred HhcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccchhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceE
Q 045798 682 ATNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFK 761 (1008)
Q Consensus 682 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 761 (1008)
..++|++.+.||+|+||.||+|.+..+++.||||+++... ..+.+.+|++++++++||||+++++++ ..++..
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~-----~~~~~~ 123 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIF-----ETPTEI 123 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEE-----ECSSEE
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeE-----ecCCeE
Confidence 3568999999999999999999999889999999997542 346788999999999999999999995 456679
Q ss_pred EEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecC---CCCe
Q 045798 762 AIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDN---DLSG 838 (1008)
Q Consensus 762 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~ 838 (1008)
++||||+++|+|.+++.... .+++.+++.++.||+.||+|||+. +|+||||||+||+++. ++.+
T Consensus 124 ~lv~e~~~~~~L~~~l~~~~----------~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~ 190 (349)
T 2w4o_A 124 SLVLELVTGGELFDRIVEKG----------YYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPL 190 (349)
T ss_dssp EEEECCCCSCBHHHHHTTCS----------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCE
T ss_pred EEEEEeCCCCCHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCE
Confidence 99999999999999997654 689999999999999999999998 9999999999999975 8899
Q ss_pred EEcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHH
Q 045798 839 HIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFAR 918 (1008)
Q Consensus 839 kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~ 918 (1008)
||+|||+++....... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...............
T Consensus 191 kl~Dfg~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~ 265 (349)
T 2w4o_A 191 KIADFGLSKIVEHQVL-----MKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILN 265 (349)
T ss_dssp EECCCC---------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHT
T ss_pred EEccCccccccCcccc-----cccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHh
Confidence 9999999986543221 12345899999999999999999999999999999999999998643221111111110
Q ss_pred hhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 919 MALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 919 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
.... .. .+.....+.++.+++.+||+.||++|||+.|+++
T Consensus 266 ~~~~-----~~-----------------------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 266 CEYY-----FI-----------------------SPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp TCCC-----CC-----------------------TTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CCCc-----cC-----------------------CchhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0000 00 0001123456789999999999999999999986
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-39 Score=370.25 Aligned_cols=282 Identities=20% Similarity=0.154 Sum_probs=201.5
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccc--cchhhHHHHHHHHHHhhcCCCCceeeeeccccccc-cCCc
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQ--CEGASKSFMAECKALKNIRHRNLVKVITSCSSIDF-QGND 759 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~ 759 (1008)
.++|++.+.||+|+||.||+|.+..+++.||||++... .....+++.+|+.+++.++||||+++++++..... ....
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 57899999999999999999999999999999999743 33446788999999999999999999999754321 3446
Q ss_pred eEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeE
Q 045798 760 FKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGH 839 (1008)
Q Consensus 760 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 839 (1008)
..|+||||+++ ++.+.+.. .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+|
T Consensus 141 ~~~lv~E~~~~-~l~~~~~~------------~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~k 204 (464)
T 3ttj_A 141 DVYLVMELMDA-NLCQVIQM------------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLK 204 (464)
T ss_dssp EEEEEEECCSE-EHHHHHTS------------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEE
T ss_pred eEEEEEeCCCC-CHHHHHhh------------cCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEE
Confidence 78999999965 56666632 578899999999999999999998 999999999999999999999
Q ss_pred EcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHh
Q 045798 840 IGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARM 919 (1008)
Q Consensus 840 L~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~ 919 (1008)
|+|||+|+....... .....||+.|+|||++.+..++.++||||+||++|||++|+.||...... ..+......
T Consensus 205 l~DFG~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~-~~~~~i~~~ 278 (464)
T 3ttj_A 205 ILDFGLARTAGTSFM-----MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYI-DQWNKVIEQ 278 (464)
T ss_dssp ECCCCCC-----CCC-----C----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHH
T ss_pred EEEEEeeeecCCCcc-----cCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHh
Confidence 999999986543221 22356899999999999999999999999999999999999999643211 111111111
Q ss_pred hCCcc----------hhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 920 ALPNQ----------VMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 920 ~~~~~----------~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
...+. ....+...-...............++.........+.++.+++.+||+.||++|||++|+++
T Consensus 279 lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 355 (464)
T 3ttj_A 279 LGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 355 (464)
T ss_dssp HCSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cCCCCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 11110 00000000000000000000000011111122334677899999999999999999999986
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-40 Score=362.81 Aligned_cols=284 Identities=22% Similarity=0.299 Sum_probs=213.7
Q ss_pred hcCCCCCceEeeccCeeEEEEE----EcCCCeEEEEEEeccccchhhHHHHHHHHHHhhcCCCCceeeeeccccccccCC
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGA----LDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGN 758 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~----~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 758 (1008)
.++|++.+.||+|+||.||+|+ ...+++.||||++........+.+.+|++++++++||||+++++++.. .+.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~ 98 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYG---PGR 98 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC---SSS
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEec---CCC
Confidence 3679999999999999999999 456889999999987766667789999999999999999999998642 456
Q ss_pred ceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCe
Q 045798 759 DFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSG 838 (1008)
Q Consensus 759 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 838 (1008)
...++||||+++++|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~ 166 (327)
T 3lxl_A 99 QSLRLVMEYLPSGCLRDFLQRHR---------ARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHV 166 (327)
T ss_dssp CEEEEEEECCTTCBHHHHHHHHG---------GGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEE
T ss_pred ceEEEEEeecCCCCHHHHHHhcc---------cCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCE
Confidence 67899999999999999997532 1689999999999999999999998 99999999999999999999
Q ss_pred EEcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHH
Q 045798 839 HIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFAR 918 (1008)
Q Consensus 839 kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~ 918 (1008)
||+|||.++......... .......+|..|+|||++.+..++.++|||||||++|+|++|+.||....... ...+..
T Consensus 167 kl~Dfg~~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~--~~~~~~ 243 (327)
T 3lxl_A 167 KIADFGLAKLLPLDKDYY-VVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEF--LRMMGC 243 (327)
T ss_dssp EECCGGGCEECCTTCSEE-ECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHH--HHHCC-
T ss_pred EEcccccceecccCCccc-eeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchh--hhhccc
Confidence 999999998765433222 12233458889999999988889999999999999999999999976421110 000000
Q ss_pred hhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHHHHHHHHHHHH
Q 045798 919 MALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHELQSVKNILLEL 998 (1008)
Q Consensus 919 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~i~~~~~~~ 998 (1008)
...........+. ...... .+....++..+.+++.+||+.||++|||++|+++.|+.+.......
T Consensus 244 ~~~~~~~~~~~~~-----------~~~~~~----~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~ 308 (327)
T 3lxl_A 244 ERDVPALSRLLEL-----------LEEGQR----LPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGC 308 (327)
T ss_dssp ---CCHHHHHHHH-----------HHTTCC----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC-------
T ss_pred ccccccHHHHHHH-----------hhcccC----CCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhcCc
Confidence 0000000010000 000000 0011234567899999999999999999999999999987665444
Q ss_pred H
Q 045798 999 E 999 (1008)
Q Consensus 999 ~ 999 (1008)
.
T Consensus 309 ~ 309 (327)
T 3lxl_A 309 E 309 (327)
T ss_dssp -
T ss_pred c
Confidence 3
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=363.07 Aligned_cols=256 Identities=19% Similarity=0.263 Sum_probs=202.3
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEecccc-----chhhHHHHHHHHHHhhcCCCCceeeeeccccccccC
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC-----EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQG 757 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 757 (1008)
.++|++.+.||+|+||.||+|.+..+++.||||+++... ....+.+.+|+++++.++||||+++++++ ..
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~-----~~ 97 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETY-----SS 97 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEE-----EE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEE-----Ee
Confidence 357999999999999999999999899999999986321 12357799999999999999999999984 45
Q ss_pred CceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCC
Q 045798 758 NDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLS 837 (1008)
Q Consensus 758 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 837 (1008)
++..|+||||+++++|.+++...... ...+++..+..++.||+.||+|||+. +|+||||||+||+++.++.
T Consensus 98 ~~~~~lv~e~~~g~~L~~~l~~~~~~------~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~ 168 (351)
T 3c0i_A 98 DGMLYMVFEFMDGADLCFEIVKRADA------GFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKEN 168 (351)
T ss_dssp TTEEEEEEECCSSCBHHHHHHHHHHT------TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSST
T ss_pred CCEEEEEEeCCCCCCHHHHHHHhccc------CCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCC
Confidence 67799999999999998887543211 11589999999999999999999998 9999999999999986654
Q ss_pred ---eEEcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHH
Q 045798 838 ---GHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLH 914 (1008)
Q Consensus 838 ---~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~ 914 (1008)
+||+|||++......... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||....+ ....
T Consensus 169 ~~~vkl~Dfg~a~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--~~~~ 242 (351)
T 3c0i_A 169 SAPVKLGGFGVAIQLGESGLV----AGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE--RLFE 242 (351)
T ss_dssp TCCEEECCCTTCEECCTTSCB----CCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH--HHHH
T ss_pred CCcEEEecCcceeEecCCCee----ecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH--HHHH
Confidence 999999999866543211 2234699999999999999999999999999999999999999864211 0000
Q ss_pred HHHHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 915 NFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 915 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
.... ......+ ......+.++.+++.+||+.||++|||+.|+++
T Consensus 243 ~i~~------------~~~~~~~----------------~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 243 GIIK------------GKYKMNP----------------RQWSHISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp HHHH------------TCCCCCH----------------HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHc------------CCCCCCc----------------cccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 1100 0000000 001123556899999999999999999999986
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-39 Score=353.46 Aligned_cols=278 Identities=24% Similarity=0.304 Sum_probs=200.7
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEecccc--chhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCce
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC--EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDF 760 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 760 (1008)
.++|++.+.||+|+||+||+|++. +++.||+|+++... ....+.+.+|++++++++||||+++++++ ..++.
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~ 93 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVI-----HSERC 93 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEE-----CCSSC
T ss_pred HhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEE-----ccCCE
Confidence 578999999999999999999995 68999999997442 23346789999999999999999999994 55677
Q ss_pred EEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEE
Q 045798 761 KAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHI 840 (1008)
Q Consensus 761 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 840 (1008)
.++||||++ ++|.+++..... .+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||
T Consensus 94 ~~lv~e~~~-~~l~~~~~~~~~---------~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl 160 (311)
T 3niz_A 94 LTLVFEFME-KDLKKVLDENKT---------GLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKL 160 (311)
T ss_dssp EEEEEECCS-EEHHHHHHTCTT---------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEE
T ss_pred EEEEEcCCC-CCHHHHHHhccC---------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEE
Confidence 999999996 588888765432 589999999999999999999998 9999999999999999999999
Q ss_pred cccCcccccccccCccccccccccccccccCccccCC-CCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHh
Q 045798 841 GDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLG-SEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARM 919 (1008)
Q Consensus 841 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~ 919 (1008)
+|||+++........ .....||+.|+|||++.+ ..++.++||||+||++|+|++|+.||......+. .......
T Consensus 161 ~Dfg~a~~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~i~~~ 235 (311)
T 3niz_A 161 ADFGLARAFGIPVRS----YTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQ-LPKIFSI 235 (311)
T ss_dssp CCCTTCEETTSCCC-------CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTH-HHHHHHH
T ss_pred ccCcCceecCCCccc----ccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHH
Confidence 999999865433221 223458999999999876 5689999999999999999999999975433222 2222211
Q ss_pred hCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 920 ALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 920 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
........+.. ....+......................+.++.+++.+||+.||++|||++|+++
T Consensus 236 ~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 236 LGTPNPREWPQ--VQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp HCCCCTTTSGG--GTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HCCCChHHhhh--hhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 11111000000 000000000000000000000001123456789999999999999999999986
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=363.98 Aligned_cols=211 Identities=27% Similarity=0.354 Sum_probs=182.0
Q ss_pred cCCCCCHHHHHHHhcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccchhhHHHHHHHHHHhhcC-----CCCce
Q 045798 670 ALPKMSYKSLLKATNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIR-----HRNLV 744 (1008)
Q Consensus 670 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h~niv 744 (1008)
....+++.+.....++|++.++||+|+||.||+|++..+++.||||+++.. ....+.+..|+++++.+. ||||+
T Consensus 21 ~~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv 99 (360)
T 3llt_A 21 EIVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIV 99 (360)
T ss_dssp GGGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBC
T ss_pred cceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCee
Confidence 344566666666678999999999999999999999889999999999743 344567888999999996 99999
Q ss_pred eeeeccccccccCCceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceecc
Q 045798 745 KVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCD 824 (1008)
Q Consensus 745 ~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~D 824 (1008)
++++++ ...+..++||||+ +++|.+++...... .+++..++.++.||+.||+|||+. +|+|||
T Consensus 100 ~~~~~~-----~~~~~~~lv~e~~-~~~L~~~~~~~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrD 162 (360)
T 3llt_A 100 KYHGKF-----MYYDHMCLIFEPL-GPSLYEIITRNNYN--------GFHIEDIKLYCIEILKALNYLRKM---SLTHTD 162 (360)
T ss_dssp CEEEEE-----EETTEEEEEECCC-CCBHHHHHHHTTTC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSC
T ss_pred ccccee-----eECCeeEEEEcCC-CCCHHHHHHhcCCC--------CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCC
Confidence 999985 4556799999999 99999999765422 589999999999999999999998 999999
Q ss_pred CCCCCeeecC-------------------------CCCeEEcccCcccccccccCccccccccccccccccCccccCCCC
Q 045798 825 LKPSNILLDN-------------------------DLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSE 879 (1008)
Q Consensus 825 lkp~NIll~~-------------------------~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 879 (1008)
|||+|||++. ++.+||+|||+|+...... ....||+.|+|||++.+..
T Consensus 163 lkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~-------~~~~gt~~y~aPE~~~~~~ 235 (360)
T 3llt_A 163 LKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH-------GSIINTRQYRAPEVILNLG 235 (360)
T ss_dssp CSGGGEEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCC-------CSCCSCGGGCCHHHHTTCC
T ss_pred CCcccEEEccccccccccchhcccccccccccccCCCCEEEEeccCceecCCCC-------cCccCcccccCcHHHcCCC
Confidence 9999999975 7899999999998543322 2345899999999999999
Q ss_pred CCcccchhhHHHHHHHHHhCCCCCCc
Q 045798 880 VSTNGDVYSYGILLLEMVTAKKPTDV 905 (1008)
Q Consensus 880 ~~~~sDvwslG~vl~elltG~~pf~~ 905 (1008)
++.++|||||||++|||++|+.||..
T Consensus 236 ~~~~~DiwslG~il~ell~g~~pf~~ 261 (360)
T 3llt_A 236 WDVSSDMWSFGCVLAELYTGSLLFRT 261 (360)
T ss_dssp CCTTHHHHHHHHHHHHHHHSSCSCCC
T ss_pred CCCccchHHHHHHHHHHHHCCCCCCC
Confidence 99999999999999999999999964
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=362.41 Aligned_cols=250 Identities=26% Similarity=0.354 Sum_probs=201.5
Q ss_pred HHhcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEecccc---chhhHHHHHHHHHHhhc-CCCCceeeeecccccccc
Q 045798 681 KATNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC---EGASKSFMAECKALKNI-RHRNLVKVITSCSSIDFQ 756 (1008)
Q Consensus 681 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 756 (1008)
...++|.+.+.||+|+||.||+|+++.+++.||+|+++... ....+.+..|.+++..+ +||||++++++ +.
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~-----~~ 88 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCT-----FQ 88 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEE-----EE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEE-----EE
Confidence 35678999999999999999999999899999999997432 23456788999999887 99999999998 45
Q ss_pred CCceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCC
Q 045798 757 GNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDL 836 (1008)
Q Consensus 757 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 836 (1008)
+.+..|+||||+++|+|.+++.... .+++..++.++.||+.||+|||++ +|+||||||+||+++.++
T Consensus 89 ~~~~~~lv~E~~~gg~L~~~l~~~~----------~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g 155 (345)
T 1xjd_A 89 TKENLFFVMEYLNGGDLMYHIQSCH----------KFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDG 155 (345)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHHS----------SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTS
T ss_pred eCCEEEEEEeCCCCCcHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCC
Confidence 6678999999999999999997543 689999999999999999999998 999999999999999999
Q ss_pred CeEEcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHH
Q 045798 837 SGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNF 916 (1008)
Q Consensus 837 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~ 916 (1008)
.+||+|||+++....... ......||+.|+|||++.+..++.++||||+||++|||++|+.||...... .....
T Consensus 156 ~vkL~DFG~a~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~--~~~~~ 229 (345)
T 1xjd_A 156 HIKIADFGMCKENMLGDA----KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE--ELFHS 229 (345)
T ss_dssp CEEECCCTTCBCCCCTTC----CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHH
T ss_pred CEEEeEChhhhhcccCCC----cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHH--HHHHH
Confidence 999999999985432221 123456999999999999999999999999999999999999998642110 00000
Q ss_pred HHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHH-HHH
Q 045798 917 ARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMT-NVV 985 (1008)
Q Consensus 917 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~-evl 985 (1008)
.... . ..++ ...+.++.+++.+||+.||++||++. |++
T Consensus 230 i~~~---------------~----------~~~p------~~~s~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 230 IRMD---------------N----------PFYP------RWLEKEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp HHHC---------------C----------CCCC------TTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred HHhC---------------C----------CCCC------cccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 0000 0 0000 01234578999999999999999997 664
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-39 Score=356.33 Aligned_cols=260 Identities=24% Similarity=0.329 Sum_probs=201.2
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEecccc-chhhHHHHHHHHHHhhcCCCCceeeeeccccccc------
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC-EGASKSFMAECKALKNIRHRNLVKVITSCSSIDF------ 755 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~------ 755 (1008)
.++|++.+.||+|+||.||+|++..+++.||||+++... +...+.+.+|++++++++||||+++++++.....
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 457999999999999999999998899999999997543 3456789999999999999999999998743211
Q ss_pred ----------------------------------------------cCCceEEEEEeccCCCChhcccccCCCCCCCccc
Q 045798 756 ----------------------------------------------QGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEI 789 (1008)
Q Consensus 756 ----------------------------------------------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~ 789 (1008)
....+.++||||+++++|.+++......
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~------ 158 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSL------ 158 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSG------
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCc------
Confidence 1223489999999999999999865432
Q ss_pred ccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEcccCcccccccccCcc--------ccccc
Q 045798 790 EIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNST--------LSSSV 861 (1008)
Q Consensus 790 ~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~--------~~~~~ 861 (1008)
...++..++.++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++......... .....
T Consensus 159 -~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~ 234 (332)
T 3qd2_B 159 -EDREHGVCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHT 234 (332)
T ss_dssp -GGSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCC
T ss_pred -cchhhHHHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhcccccccccccccc
Confidence 1567778999999999999999998 99999999999999999999999999998765442211 11223
Q ss_pred cccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCcchhhhhcccccCchHHhh
Q 045798 862 GVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMALPNQVMDIVDPILRNDEEILA 941 (1008)
Q Consensus 862 ~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 941 (1008)
...||+.|+|||++.+..++.++|||||||++|||++|..|+..... ... .......
T Consensus 235 ~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~~-------~~~--------~~~~~~~-------- 291 (332)
T 3qd2_B 235 GQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERVR-------IIT--------DVRNLKF-------- 291 (332)
T ss_dssp SCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHHH-------HHH--------HHHTTCC--------
T ss_pred ccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHHH-------HHH--------HhhccCC--------
Confidence 45699999999999999999999999999999999998777421100 000 0000000
Q ss_pred hhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 942 STDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 942 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
.......+.++.+++.+||+.||++|||++|+++
T Consensus 292 -----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 292 -----------PLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIE 325 (332)
T ss_dssp -----------CHHHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHH
T ss_pred -----------CcccccCChhHHHHHHHHccCCCCcCCCHHHHhh
Confidence 0011234556789999999999999999999986
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=354.18 Aligned_cols=258 Identities=28% Similarity=0.377 Sum_probs=199.0
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccchhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceEE
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKA 762 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 762 (1008)
.++|++.+.||+|+||.||+|.+ .++.||+|++... ...+.+.+|++++++++||||+++++++. +..+
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-------~~~~ 75 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKW--RAKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACL-------NPVC 75 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCT-------TTTE
T ss_pred HhHeeeeeEeecCCCceEEEEEE--CCeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEc-------CCcE
Confidence 35788999999999999999998 4789999998643 44578999999999999999999999854 2368
Q ss_pred EEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCC-eEEc
Q 045798 763 IVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLS-GHIG 841 (1008)
Q Consensus 763 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~-~kL~ 841 (1008)
+||||+++|+|.+++...... ..+++..++.++.|+++||+|||+...++|+||||||+||+++.++. +||+
T Consensus 76 lv~e~~~~~~L~~~l~~~~~~-------~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~ 148 (307)
T 2eva_A 76 LVMEYAEGGSLYNVLHGAEPL-------PYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKIC 148 (307)
T ss_dssp EEEECCTTCBHHHHHHCSSSE-------ECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEEC
T ss_pred EEEEcCCCCCHHHHHhccCCC-------CccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEc
Confidence 999999999999999765321 14788999999999999999999943349999999999999998886 7999
Q ss_pred ccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHhhC
Q 045798 842 DFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMAL 921 (1008)
Q Consensus 842 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~~~ 921 (1008)
|||.+....... ....||+.|+|||++.+..++.++|||||||++|||++|+.||..................
T Consensus 149 Dfg~~~~~~~~~-------~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~ 221 (307)
T 2eva_A 149 DFGTACDIQTHM-------TNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGT 221 (307)
T ss_dssp CCCC-------------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTC
T ss_pred cccccccccccc-------ccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCC
Confidence 999997553321 1234899999999999999999999999999999999999998643221111100000000
Q ss_pred CcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHHHHHHHHH
Q 045798 922 PNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHELQSVKNIL 995 (1008)
Q Consensus 922 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~i~~~~ 995 (1008)
.. . ....++..+.+++.+||+.||++|||++|+++.|+.+....
T Consensus 222 ~~----------------------------~--~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 265 (307)
T 2eva_A 222 RP----------------------------P--LIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYF 265 (307)
T ss_dssp CC----------------------------C--CBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGC
T ss_pred CC----------------------------C--cccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhc
Confidence 00 0 00123456789999999999999999999999999876543
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=356.46 Aligned_cols=282 Identities=25% Similarity=0.283 Sum_probs=203.7
Q ss_pred HhcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEecccc-----chhhHHHHHHHHHHhhc---CCCCceeeeeccccc
Q 045798 682 ATNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC-----EGASKSFMAECKALKNI---RHRNLVKVITSCSSI 753 (1008)
Q Consensus 682 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~~ 753 (1008)
..++|++.+.||+|+||+||+|++..+++.||||+++... ......+.+|+++++++ +||||++++++|...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 3678999999999999999999998899999999987432 12235677888887777 499999999997654
Q ss_pred cccCCceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeec
Q 045798 754 DFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLD 833 (1008)
Q Consensus 754 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~ 833 (1008)
........++||||++ ++|.+++...... .+++..++.++.||+.||+|||+. +|+||||||+||+++
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~--------~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~ 154 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAPPP--------GLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVT 154 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCCTT--------CSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEEC
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhccCC--------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEc
Confidence 4333446899999995 6999999765422 489999999999999999999998 999999999999999
Q ss_pred CCCCeEEcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccH
Q 045798 834 NDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNL 913 (1008)
Q Consensus 834 ~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~ 913 (1008)
.++.+||+|||.++........ ....||+.|+|||++.+..++.++|||||||++|||++|+.||......+. .
T Consensus 155 ~~~~~kl~Dfg~a~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~-~ 228 (308)
T 3g33_A 155 SGGTVKLADFGLARIYSYQMAL-----TPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQ-L 228 (308)
T ss_dssp TTSCEEECSCSCTTTSTTCCCS-----GGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHH-H
T ss_pred CCCCEEEeeCccccccCCCccc-----CCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH-H
Confidence 9999999999999865433221 234589999999999999999999999999999999999999864322211 1
Q ss_pred HHHHHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 914 HNFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 914 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
..............+.. ....... ... ............+.+.++.+++.+||+.||++|||+.|+++
T Consensus 229 ~~i~~~~~~~~~~~~~~-~~~~~~~---~~~-~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 229 GKIFDLIGLPPEDDWPR-DVSLPRG---AFP-PRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp HHHHHHHCCCCTTTSCS-SCSSCGG---GSC-CCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHHhCCCChhhccc-hhhcccc---ccC-CCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 11111111000000000 0000000 000 00000000001134566899999999999999999999986
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=360.96 Aligned_cols=271 Identities=20% Similarity=0.260 Sum_probs=204.0
Q ss_pred HHHHhcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccc-----cchhhHHHHHHHHHHhhcCCCCceeeeeccccc
Q 045798 679 LLKATNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQ-----CEGASKSFMAECKALKNIRHRNLVKVITSCSSI 753 (1008)
Q Consensus 679 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 753 (1008)
+....++|++.+.||+|+||.||+|.+..+++.||+|++... .....+.+.+|++++++++||||+++++++
T Consensus 21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~--- 97 (345)
T 3hko_A 21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVY--- 97 (345)
T ss_dssp HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEE---
T ss_pred hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhh---
Confidence 445577899999999999999999999989999999998643 234557899999999999999999999995
Q ss_pred cccCCceEEEEEeccCCCChhcccccCCCCCC------------------------------CcccccccCHHHHHHHHH
Q 045798 754 DFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKR------------------------------DKEIEIKLTLLQRISIAI 803 (1008)
Q Consensus 754 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~------------------------------~~~~~~~l~~~~~~~i~~ 803 (1008)
.+++..++||||+++|+|.+++........ .......+++..++.++.
T Consensus 98 --~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 175 (345)
T 3hko_A 98 --EDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMR 175 (345)
T ss_dssp --ECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHH
T ss_pred --ccCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHH
Confidence 556779999999999999999863211100 000122457888999999
Q ss_pred HHHHHHHHHhhCCCCCceeccCCCCCeeecCCC--CeEEcccCcccccccccCccccccccccccccccCccccCC--CC
Q 045798 804 DVASALDYLHHHCQEPILHCDLKPSNILLDNDL--SGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLG--SE 879 (1008)
Q Consensus 804 qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~--~~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~ 879 (1008)
||+.||+|||+. +|+||||||+||+++.++ .+||+|||+++.................||+.|+|||++.+ ..
T Consensus 176 qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 252 (345)
T 3hko_A 176 QIFSALHYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNES 252 (345)
T ss_dssp HHHHHHHHHHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSC
T ss_pred HHHHHHHHHHHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCC
Confidence 999999999998 999999999999998776 89999999998665433333223344569999999999875 67
Q ss_pred CCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHH
Q 045798 880 VSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLEC 959 (1008)
Q Consensus 880 ~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 959 (1008)
++.++|||||||++|||++|+.||......+. ... ........ ..+.....
T Consensus 253 ~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-~~~------------~~~~~~~~----------------~~~~~~~~ 303 (345)
T 3hko_A 253 YGPKCDAWSAGVLLHLLLMGAVPFPGVNDADT-ISQ------------VLNKKLCF----------------ENPNYNVL 303 (345)
T ss_dssp CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHH------------HHHCCCCT----------------TSGGGGGS
T ss_pred CCcHHHHHHHHHHHHHHHHCCCCCCCCChHHH-HHH------------HHhccccc----------------CCcccccC
Confidence 89999999999999999999999864321110 000 01100000 00011123
Q ss_pred HHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 960 LISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 960 ~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
+..+.+++.+||+.||.+|||+.|+++
T Consensus 304 ~~~~~~li~~~l~~~p~~Rps~~~~l~ 330 (345)
T 3hko_A 304 SPLARDLLSNLLNRNVDERFDAMRALQ 330 (345)
T ss_dssp CHHHHHHHHHHSCSCTTTSCCHHHHHH
T ss_pred CHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 456889999999999999999999986
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=355.82 Aligned_cols=275 Identities=25% Similarity=0.343 Sum_probs=210.4
Q ss_pred HHHHhcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccchhhHHHHHHHHHHhh--cCCCCceeeeecccccccc
Q 045798 679 LLKATNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKN--IRHRNLVKVITSCSSIDFQ 756 (1008)
Q Consensus 679 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~~~~~~~~~~~~ 756 (1008)
-....++|++.+.||+|+||.||+|.+ +++.||||+++.. ....+.+|++++.. ++||||+++++++.... .
T Consensus 37 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~-~ 110 (342)
T 1b6c_B 37 QRTIARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDN-G 110 (342)
T ss_dssp HHHHHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCC-S
T ss_pred cccccccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccC-C
Confidence 344567899999999999999999998 5899999999643 34667889999887 69999999999964321 1
Q ss_pred CCceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHh--------hCCCCCceeccCCCC
Q 045798 757 GNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLH--------HHCQEPILHCDLKPS 828 (1008)
Q Consensus 757 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH--------~~~~~~ivH~Dlkp~ 828 (1008)
.....++||||+++|+|.+++... .+++.+++.++.|++.||+||| +. +|+||||||+
T Consensus 111 ~~~~~~lv~e~~~~g~L~~~l~~~-----------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~ 176 (342)
T 1b6c_B 111 TWTQLWLVSDYHEHGSLFDYLNRY-----------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSK 176 (342)
T ss_dssp SCCCEEEEECCCTTCBHHHHHHHC-----------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGG
T ss_pred ccceeEEEEeecCCCcHHHHHhcc-----------CccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHH
Confidence 113689999999999999999653 6899999999999999999999 65 9999999999
Q ss_pred CeeecCCCCeEEcccCcccccccccCccccccccccccccccCccccCCC------CCCcccchhhHHHHHHHHHhC---
Q 045798 829 NILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGS------EVSTNGDVYSYGILLLEMVTA--- 899 (1008)
Q Consensus 829 NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~sDvwslG~vl~elltG--- 899 (1008)
||+++.++.+||+|||++..................||+.|+|||++.+. .++.++|||||||++|||++|
T Consensus 177 NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~ 256 (342)
T 1b6c_B 177 NILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSI 256 (342)
T ss_dssp GEEECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCB
T ss_pred HEEECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCc
Confidence 99999999999999999986654433222223345699999999998775 344789999999999999999
Q ss_pred -------CCCCCccccCCccHHHHHHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccC
Q 045798 900 -------KKPTDVMFEGDLNLHNFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSM 972 (1008)
Q Consensus 900 -------~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 972 (1008)
..||......+.....+....... .+.... + ......+++..+.+++.+||+
T Consensus 257 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~--------~~~~~~------------~-~~~~~~~~~~~l~~li~~cl~ 315 (342)
T 1b6c_B 257 GGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQ--------KLRPNI------------P-NRWQSCEALRVMAKIMRECWY 315 (342)
T ss_dssp TTBCCCCCCTTTTTSCSSCCHHHHHHHHTTS--------CCCCCC------------C-GGGGTSHHHHHHHHHHHHHCC
T ss_pred CCcccccccCccccCcCcccHHHHHHHHHHH--------HhCCCC------------c-ccccchhHHHHHHHHHHHHhc
Confidence 667654333322222222211110 000000 0 000123567789999999999
Q ss_pred cCCCCCCCHHHHHHHHHHHHHH
Q 045798 973 ESPQDRMNMTNVVHELQSVKNI 994 (1008)
Q Consensus 973 ~dP~~RPt~~evl~~L~~i~~~ 994 (1008)
.||++|||+.||++.|+++.+.
T Consensus 316 ~dp~~Rps~~~i~~~L~~i~~~ 337 (342)
T 1b6c_B 316 ANGAARLTALRIKKTLSQLSQQ 337 (342)
T ss_dssp SSGGGSCCHHHHHHHHHHHHHT
T ss_pred cChhhCCCHHHHHHHHHHHHHH
Confidence 9999999999999999998654
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-39 Score=351.44 Aligned_cols=264 Identities=23% Similarity=0.372 Sum_probs=204.5
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCC---CeEEEEEEecccc-chhhHHHHHHHHHHhhcCCCCceeeeeccccccccCC
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDED---GIVVAIKVINLQC-EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGN 758 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 758 (1008)
..+|++.+.||+|+||.||+|.+..+ +..||+|+++... ....+.+.+|++++++++||||++++++|. ..+
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~----~~~ 99 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICL----RSE 99 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEC----CSS
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEE----cCC
Confidence 34688899999999999999997433 3468999987533 344578999999999999999999999863 445
Q ss_pred ceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCe
Q 045798 759 DFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSG 838 (1008)
Q Consensus 759 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 838 (1008)
+..++||||+++|+|.+++..... .+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+
T Consensus 100 ~~~~~v~e~~~~~~L~~~l~~~~~---------~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~ 167 (298)
T 3f66_A 100 GSPLVVLPYMKHGDLRNFIRNETH---------NPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTV 167 (298)
T ss_dssp SCCEEEEECCTTCBHHHHHHCTTC---------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCE
T ss_pred CceEEEEeCCCCCCHHHHHHhccc---------CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCE
Confidence 668999999999999999975432 678999999999999999999998 99999999999999999999
Q ss_pred EEcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCC-CCCCccccCCccHHHHH
Q 045798 839 HIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAK-KPTDVMFEGDLNLHNFA 917 (1008)
Q Consensus 839 kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~-~pf~~~~~~~~~~~~~~ 917 (1008)
||+|||.++.................+|+.|+|||.+.+..++.++||||+|+++|||++|. +||...... .......
T Consensus 168 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~-~~~~~~~ 246 (298)
T 3f66_A 168 KVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF-DITVYLL 246 (298)
T ss_dssp EECSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTT-THHHHHH
T ss_pred EECcccccccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHH-HHHHHHh
Confidence 99999999876554433333334456788999999998889999999999999999999954 555432111 1111110
Q ss_pred HhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHHHHHHHH
Q 045798 918 RMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHELQSVKNI 994 (1008)
Q Consensus 918 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~i~~~ 994 (1008)
..... . ....++..+.+++.+||+.||++|||++|+++.|+++...
T Consensus 247 ~~~~~------------~-------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 292 (298)
T 3f66_A 247 QGRRL------------L-------------------QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 292 (298)
T ss_dssp TTCCC------------C-------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred cCCCC------------C-------------------CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 00000 0 0011344688999999999999999999999999988664
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=350.13 Aligned_cols=254 Identities=27% Similarity=0.415 Sum_probs=192.1
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccc----hhhHHHHHHHHHHhhcCCCCceeeeeccccccccCC
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCE----GASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGN 758 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 758 (1008)
.++|++.+.||+|+||.||+|.+ .++.||||+++.... ...+.+.+|+++++.++||||+++++++ ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~ 78 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFW--IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVC-----LKE 78 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEE--TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEE-----CCC
T ss_pred hhheeeeeeeccCCCeEEEEEEE--cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEE-----ecC
Confidence 46799999999999999999998 488999999875432 2346789999999999999999999995 455
Q ss_pred ceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecC----
Q 045798 759 DFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDN---- 834 (1008)
Q Consensus 759 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~---- 834 (1008)
+..++||||+++++|.+++... ++++..++.++.|++.||+|||+....+|+||||||+||+++.
T Consensus 79 ~~~~lv~e~~~~~~L~~~~~~~-----------~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~ 147 (271)
T 3dtc_A 79 PNLCLVMEFARGGPLNRVLSGK-----------RIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVEN 147 (271)
T ss_dssp --CEEEEECCTTEEHHHHHTSS-----------CCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSS
T ss_pred CceEEEEEcCCCCCHHHHhhcC-----------CCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEeccccc
Confidence 6689999999999999998643 6899999999999999999999981112999999999999986
Q ss_pred ----CCCeEEcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCC
Q 045798 835 ----DLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGD 910 (1008)
Q Consensus 835 ----~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~ 910 (1008)
++.+||+|||.+......... ...||+.|+|||.+.+..++.++||||||+++|+|++|+.||.......
T Consensus 148 ~~~~~~~~kl~Dfg~~~~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~ 221 (271)
T 3dtc_A 148 GDLSNKILKITDFGLAREWHRTTKM------SAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLA 221 (271)
T ss_dssp SCCSSCCEEECCCCC-------------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHH
T ss_pred ccccCcceEEccCCccccccccccc------CCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 778999999999865433221 2458999999999988889999999999999999999999986432110
Q ss_pred ccHHHHHHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHHHH
Q 045798 911 LNLHNFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHELQS 990 (1008)
Q Consensus 911 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 990 (1008)
....... .... .+....++..+.+++.+||+.||.+|||+.|+++.|++
T Consensus 222 ----~~~~~~~---------~~~~------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~ 270 (271)
T 3dtc_A 222 ----VAYGVAM---------NKLA------------------LPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT 270 (271)
T ss_dssp ----HHHHHHT---------SCCC------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred ----HHHhhhc---------CCCC------------------CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence 0000000 0000 00011234568999999999999999999999999976
Q ss_pred H
Q 045798 991 V 991 (1008)
Q Consensus 991 i 991 (1008)
+
T Consensus 271 l 271 (271)
T 3dtc_A 271 I 271 (271)
T ss_dssp -
T ss_pred C
Confidence 4
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=351.22 Aligned_cols=260 Identities=22% Similarity=0.334 Sum_probs=197.6
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcC---CCeEEEEEEecccc-chhhHHHHHHHHHHhhcCCCCceeeeeccccccccCC
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDE---DGIVVAIKVINLQC-EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGN 758 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 758 (1008)
.++|++.+.||+|+||.||+|.+.. .+..||+|+++... ....+.+.+|+.++++++||||+++++++. +
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~------~ 87 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT------E 87 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC------S
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc------c
Confidence 5689999999999999999999854 35679999987543 344568999999999999999999999852 3
Q ss_pred ceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCe
Q 045798 759 DFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSG 838 (1008)
Q Consensus 759 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 838 (1008)
+..++||||+++++|.+++..... .+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~ 155 (281)
T 1mp8_A 88 NPVWIIMELCTLGELRSFLQVRKY---------SLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCV 155 (281)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTT---------TSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEE
T ss_pred CccEEEEecCCCCCHHHHHHhcCC---------CCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCE
Confidence 457999999999999999975431 689999999999999999999998 99999999999999999999
Q ss_pred EEcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCccccCCccHHHHH
Q 045798 839 HIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT-AKKPTDVMFEGDLNLHNFA 917 (1008)
Q Consensus 839 kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-G~~pf~~~~~~~~~~~~~~ 917 (1008)
||+|||+++......... .....+|+.|+|||++.+..++.++|||||||++|||++ |..||......+ .....
T Consensus 156 kl~Dfg~~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~--~~~~i 230 (281)
T 1mp8_A 156 KLGDFGLSRYMEDSTYYK---ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND--VIGRI 230 (281)
T ss_dssp EECC----------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--HHHHH
T ss_pred EECccccccccCcccccc---cccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHH--HHHHH
Confidence 999999998664432211 122346789999999988889999999999999999997 999986432211 00000
Q ss_pred HhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHHHHHHHHH
Q 045798 918 RMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHELQSVKNIL 995 (1008)
Q Consensus 918 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~i~~~~ 995 (1008)
..... . . ....++..+.+++.+||+.||++|||+.|+++.|+++.+..
T Consensus 231 ~~~~~-----------~-------------~------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 278 (281)
T 1mp8_A 231 ENGER-----------L-------------P------MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 278 (281)
T ss_dssp HTTCC-----------C-------------C------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HcCCC-----------C-------------C------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 00000 0 0 00123456889999999999999999999999999987654
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-40 Score=356.79 Aligned_cols=253 Identities=20% Similarity=0.343 Sum_probs=202.3
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCC-------eEEEEEEeccccchhhHHHHHHHHHHhhcCCCCceeeeeccccccc
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDG-------IVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSCSSIDF 755 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~-------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 755 (1008)
.++|++.+.||+|+||.||+|.+..++ ..||+|++........+.+.+|++++++++||||+++++++
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~----- 81 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVC----- 81 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEE-----
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEE-----
Confidence 457899999999999999999997666 57999999876666778899999999999999999999995
Q ss_pred cCCceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCC
Q 045798 756 QGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDND 835 (1008)
Q Consensus 756 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~ 835 (1008)
..++..++||||+++|+|.+++..... .+++..++.++.||+.||+|||+. +|+||||||+||+++.+
T Consensus 82 ~~~~~~~lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~ 149 (289)
T 4fvq_A 82 VCGDENILVQEFVKFGSLDTYLKKNKN---------CINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIRE 149 (289)
T ss_dssp CCTTCCEEEEECCTTCBHHHHHHHTGG---------GCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEEC
T ss_pred EeCCCCEEEEECCCCCCHHHHHHhCCC---------CCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecC
Confidence 445668999999999999999976531 489999999999999999999998 99999999999999988
Q ss_pred CC--------eEEcccCcccccccccCccccccccccccccccCccccCC-CCCCcccchhhHHHHHHHHHhCCCCCCcc
Q 045798 836 LS--------GHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLG-SEVSTNGDVYSYGILLLEMVTAKKPTDVM 906 (1008)
Q Consensus 836 ~~--------~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltG~~pf~~~ 906 (1008)
+. +||+|||.+....... ...+|+.|+|||++.+ ..++.++|||||||++|||++|..|+...
T Consensus 150 ~~~~~~~~~~~kl~Dfg~~~~~~~~~--------~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~ 221 (289)
T 4fvq_A 150 EDRKTGNPPFIKLSDPGISITVLPKD--------ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSA 221 (289)
T ss_dssp CBGGGTBCCEEEECCCCSCTTTSCHH--------HHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred CcccccccceeeeccCcccccccCcc--------ccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccc
Confidence 87 9999999997543221 1347889999999887 67899999999999999999966554322
Q ss_pred ccCCccHHHHHHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 907 FEGDLNLHNFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 907 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
....... .... .. ...+. ..+.++.+++.+||+.||++|||++|+++
T Consensus 222 ~~~~~~~-~~~~--~~------------------------~~~~~------~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 268 (289)
T 4fvq_A 222 LDSQRKL-QFYE--DR------------------------HQLPA------PKAAELANLINNCMDYEPDHRPSFRAIIR 268 (289)
T ss_dssp SCHHHHH-HHHH--TT------------------------CCCCC------CSSCTTHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred cchHHHH-HHhh--cc------------------------CCCCC------CCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 1111000 0000 00 00000 01234689999999999999999999999
Q ss_pred HHHHHHH
Q 045798 987 ELQSVKN 993 (1008)
Q Consensus 987 ~L~~i~~ 993 (1008)
.|+++..
T Consensus 269 ~l~~l~~ 275 (289)
T 4fvq_A 269 DLNSLFT 275 (289)
T ss_dssp HHHTCC-
T ss_pred HHHHhcC
Confidence 9988754
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=352.02 Aligned_cols=260 Identities=30% Similarity=0.451 Sum_probs=194.9
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEecccc--chhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCce
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC--EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDF 760 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 760 (1008)
.++|++.+.||+|+||.||+|.+. ..||+|+++... ....+.+.+|++++++++||||+++++++ ....
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~------~~~~ 93 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS------TAPQ 93 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESS---SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE------CSSS
T ss_pred ccceeeeeEecCCCCeEEEEEEEc---CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec------cCCc
Confidence 568999999999999999999874 359999997543 34457899999999999999999999973 3345
Q ss_pred EEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEE
Q 045798 761 KAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHI 840 (1008)
Q Consensus 761 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 840 (1008)
.++||||+++++|.+++..... .+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||
T Consensus 94 ~~lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl 161 (289)
T 3og7_A 94 LAIVTQWCEGSSLYHHLHASET---------KFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKI 161 (289)
T ss_dssp CEEEEECCCEEEHHHHHTTC------------CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEE
T ss_pred cEEEEEecCCCcHHHHHhhccC---------CCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEE
Confidence 7999999999999999965432 689999999999999999999998 9999999999999999999999
Q ss_pred cccCcccccccccCccccccccccccccccCccccC---CCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHH
Q 045798 841 GDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGL---GSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFA 917 (1008)
Q Consensus 841 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~ 917 (1008)
+|||++.......... ......||+.|+|||++. +..++.++||||||+++|||++|+.||......+.......
T Consensus 162 ~Dfg~~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~ 239 (289)
T 3og7_A 162 GDFGLATEKSRWSGSH--QFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVG 239 (289)
T ss_dssp CCCC--------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHH
T ss_pred ccceeccccccccccc--cccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhc
Confidence 9999998654322211 122345899999999986 56788899999999999999999999964322111111111
Q ss_pred HhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHHHHHH
Q 045798 918 RMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHELQSVK 992 (1008)
Q Consensus 918 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~i~ 992 (1008)
.......... ....++.++.+++.+||+.||.+|||++|+++.|+++.
T Consensus 240 ~~~~~~~~~~---------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~ 287 (289)
T 3og7_A 240 RGSLSPDLSK---------------------------VRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287 (289)
T ss_dssp HTSCCCCTTS---------------------------SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred ccccCcchhh---------------------------ccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence 1111110000 01134567899999999999999999999999999864
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-39 Score=349.79 Aligned_cols=259 Identities=25% Similarity=0.398 Sum_probs=205.4
Q ss_pred HhcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccchhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceE
Q 045798 682 ATNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFK 761 (1008)
Q Consensus 682 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 761 (1008)
..++|++.+.||+|+||.||+|.+. ++..||+|+++... ...+.+.+|++++++++||||+++++++ ..++..
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~ 94 (283)
T 3gen_A 22 DPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVC-----TKQRPI 94 (283)
T ss_dssp CGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEE-----CSSSSE
T ss_pred CHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCC-CCHHHHHHHHHHHhcCCCCCEeeEEEEE-----ecCCCe
Confidence 3568999999999999999999986 78899999997553 2346799999999999999999999995 456678
Q ss_pred EEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEc
Q 045798 762 AIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIG 841 (1008)
Q Consensus 762 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 841 (1008)
++||||+++++|.+++.... ..+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||+
T Consensus 95 ~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~ 162 (283)
T 3gen_A 95 FIITEYMANGCLLNYLREMR---------HRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVS 162 (283)
T ss_dssp EEEECCCTTCBHHHHHHCGG---------GCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEEC
T ss_pred EEEEeccCCCcHHHHHHHhc---------cCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEc
Confidence 99999999999999997532 1689999999999999999999998 99999999999999999999999
Q ss_pred ccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCccccCCccHHHHHHhh
Q 045798 842 DFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT-AKKPTDVMFEGDLNLHNFARMA 920 (1008)
Q Consensus 842 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-G~~pf~~~~~~~~~~~~~~~~~ 920 (1008)
|||.++....... .......+|+.|+|||++.+..++.++||||+|+++|||++ |+.||....... ......
T Consensus 163 Dfg~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~--~~~~~~-- 235 (283)
T 3gen_A 163 DFGLSRYVLDDEY---TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE--TAEHIA-- 235 (283)
T ss_dssp STTGGGGBCCHHH---HSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH--HHHHHH--
T ss_pred ccccccccccccc---ccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhH--HHHHHh--
Confidence 9999986543321 12223447888999999988889999999999999999998 999986432110 000000
Q ss_pred CCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHHHHHHHH
Q 045798 921 LPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHELQSVKNI 994 (1008)
Q Consensus 921 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~i~~~ 994 (1008)
...... .....+..+.+++.+||+.||.+|||++|+++.|+++.+.
T Consensus 236 ----------~~~~~~------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~ 281 (283)
T 3gen_A 236 ----------QGLRLY------------------RPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE 281 (283)
T ss_dssp ----------TTCCCC------------------CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----------cccCCC------------------CCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence 000000 0001234678999999999999999999999999988754
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=369.51 Aligned_cols=259 Identities=20% Similarity=0.236 Sum_probs=204.7
Q ss_pred HHHHHHhcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEecccc---chhhHHHHHHHHHHhhcCCCCceeeeeccccc
Q 045798 677 KSLLKATNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC---EGASKSFMAECKALKNIRHRNLVKVITSCSSI 753 (1008)
Q Consensus 677 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 753 (1008)
.++....++|++.+.||+|+||.||+|++..+++.||+|+++... ....+.+.+|+.+++.++||||+++++++
T Consensus 62 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~--- 138 (410)
T 3v8s_A 62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAF--- 138 (410)
T ss_dssp HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEE---
T ss_pred HhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEE---
Confidence 344445689999999999999999999999899999999996421 22335688999999999999999999994
Q ss_pred cccCCceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeec
Q 045798 754 DFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLD 833 (1008)
Q Consensus 754 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~ 833 (1008)
.+++..|+||||+++|+|.+++... .+++..++.++.||+.||+|||+. +|+||||||+|||++
T Consensus 139 --~~~~~~~lV~E~~~gg~L~~~l~~~-----------~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~ 202 (410)
T 3v8s_A 139 --QDDRYLYMVMEYMPGGDLVNLMSNY-----------DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLD 202 (410)
T ss_dssp --ECSSEEEEEECCCTTEEHHHHHHHC-----------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEC
T ss_pred --EECCEEEEEEeCCCCCcHHHHHHcC-----------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeEC
Confidence 5677899999999999999998643 588999999999999999999998 999999999999999
Q ss_pred CCCCeEEcccCcccccccccCccccccccccccccccCccccCCCC----CCcccchhhHHHHHHHHHhCCCCCCccccC
Q 045798 834 NDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSE----VSTNGDVYSYGILLLEMVTAKKPTDVMFEG 909 (1008)
Q Consensus 834 ~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDvwslG~vl~elltG~~pf~~~~~~ 909 (1008)
.++.+||+|||+|+........ ......||+.|+|||++.+.. ++.++|||||||++|||++|+.||......
T Consensus 203 ~~g~ikL~DFG~a~~~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~ 279 (410)
T 3v8s_A 203 KSGHLKLADFGTCMKMNKEGMV---RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV 279 (410)
T ss_dssp TTSCEEECCCTTCEECCTTSEE---ECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHH
T ss_pred CCCCEEEeccceeEeeccCCcc---cccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChh
Confidence 9999999999999865433211 123456999999999987655 889999999999999999999998632110
Q ss_pred CccHHHHHHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCC--CCCHHHHHH
Q 045798 910 DLNLHNFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQD--RMNMTNVVH 986 (1008)
Q Consensus 910 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~evl~ 986 (1008)
. ....... ... ...+ +.....+.++.+++.+||+.+|.+ ||+++||++
T Consensus 280 ~-~~~~i~~----------------~~~--------~~~~----p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~ 329 (410)
T 3v8s_A 280 G-TYSKIMN----------------HKN--------SLTF----PDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKR 329 (410)
T ss_dssp H-HHHHHHT----------------HHH--------HCCC----CTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHT
T ss_pred h-HHHHHHh----------------ccc--------cccC----CCcccccHHHHHHHHHHccChhhhCCCCCHHHHhc
Confidence 0 0000000 000 0000 000123456789999999999998 999999986
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=364.46 Aligned_cols=374 Identities=18% Similarity=0.173 Sum_probs=252.1
Q ss_pred CCeeeecCCCCCCCCCccccCCCCCCEEEccCCCCCCccCcccccCcCcceEeeeccccccCCCccccccCCCCeeeccc
Q 045798 80 LREINLSNNTIQGEIPPEFGRLFRLEALFLSNNSLVGKIPANLSYCSRLTVLCIEYNKLQGRIPLEFVSLSKLKDLSLAK 159 (1008)
Q Consensus 80 L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~ 159 (1008)
++..........+..+..++++++|++|++++|.+++. | .++.+++|++|+|++|++++. | ++.+++|++|++++
T Consensus 20 l~~~~~~~~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~-~-~l~~l~~L~~L~Ls~n~l~~~-~--~~~l~~L~~L~Ls~ 94 (457)
T 3bz5_A 20 FASEVAAAFEMQATDTISEEQLATLTSLDCHNSSITDM-T-GIEKLTGLTKLICTSNNITTL-D--LSQNTNLTYLACDS 94 (457)
T ss_dssp HHHHHHHHTTCCTTSEEEHHHHTTCCEEECCSSCCCCC-T-TGGGCTTCSEEECCSSCCSCC-C--CTTCTTCSEEECCS
T ss_pred HHHHHHHhcCcCcccccChhHcCCCCEEEccCCCcccC-h-hhcccCCCCEEEccCCcCCeE-c--cccCCCCCEEECcC
Confidence 34444444555666677889999999999999999964 5 689999999999999999964 4 88899999999999
Q ss_pred ccCCCCCCCCCccccccchhhcccccCCCCCCccccCCCCCcEEEecCCcccccCCccccCCCCcceeccccccccccCC
Q 045798 160 NKLTGGIPPFLGNLTSLEVLSLAGNSFGRNIPDSLGQLKQLKILAIGGNNLSGPIPPSIYNLSFLVVFSVSHNQIHGSLP 239 (1008)
Q Consensus 160 n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~~~lp 239 (1008)
|++++. + ++++++|++|++++|++++. + ++.+++|++|++++|++++. .++.+++|++|++++|+..+.++
T Consensus 95 N~l~~~-~--~~~l~~L~~L~L~~N~l~~l-~--~~~l~~L~~L~l~~N~l~~l---~l~~l~~L~~L~l~~n~~~~~~~ 165 (457)
T 3bz5_A 95 NKLTNL-D--VTPLTKLTYLNCDTNKLTKL-D--VSQNPLLTYLNCARNTLTEI---DVSHNTQLTELDCHLNKKITKLD 165 (457)
T ss_dssp SCCSCC-C--CTTCTTCCEEECCSSCCSCC-C--CTTCTTCCEEECTTSCCSCC---CCTTCTTCCEEECTTCSCCCCCC
T ss_pred CCCcee-e--cCCCCcCCEEECCCCcCCee-c--CCCCCcCCEEECCCCcccee---ccccCCcCCEEECCCCCcccccc
Confidence 999864 3 88899999999999998763 3 88889999999999998864 27778888888888886544552
Q ss_pred hhhhhcCCCCcEEEeccccCCCCCCcccccCCCCceeecccccccccccccccCCCcccccccccccCCCCCCCcccccc
Q 045798 240 PSLGLLLPNLKFFQIHHNFFSGSIPISLSNASKLEHIEIANNNFSGKLSVNFGGMKNLSLLNLQFSNLGSGESDEMGFMN 319 (1008)
Q Consensus 240 ~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~ 319 (1008)
+..+++|++|++++|.+++ +| +..+++|+.|++++|++++. .
T Consensus 166 ---~~~l~~L~~L~ls~n~l~~-l~--l~~l~~L~~L~l~~N~l~~~---~----------------------------- 207 (457)
T 3bz5_A 166 ---VTPQTQLTTLDCSFNKITE-LD--VSQNKLLNRLNCDTNNITKL---D----------------------------- 207 (457)
T ss_dssp ---CTTCTTCCEEECCSSCCCC-CC--CTTCTTCCEEECCSSCCSCC---C-----------------------------
T ss_pred ---cccCCcCCEEECCCCccce-ec--cccCCCCCEEECcCCcCCee---c-----------------------------
Confidence 2335666666666666664 33 55566666666666665543 1
Q ss_pred cccccCCCcEEEecCCcCCccCChhhhhhcccceeeeeccccccCCCCCccccccccceEEecCccccCCcchhccCCCC
Q 045798 320 SLTNCSKLRVLSLGGNQFRGALPHSIANLSSQLQILILSSNQFYGSIPLGIGNLVDLYLLGMVENQFTGAIPKEMGKLQK 399 (1008)
Q Consensus 320 ~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~ 399 (1008)
+..+++|+.|++++|++++ +| +..+. +|++|++++|++++.. +..+++|+.|++++| +
T Consensus 208 -l~~l~~L~~L~Ls~N~l~~-ip--~~~l~-~L~~L~l~~N~l~~~~---~~~l~~L~~L~l~~n--------------~ 265 (457)
T 3bz5_A 208 -LNQNIQLTFLDCSSNKLTE-ID--VTPLT-QLTYFDCSVNPLTELD---VSTLSKLTTLHCIQT--------------D 265 (457)
T ss_dssp -CTTCTTCSEEECCSSCCSC-CC--CTTCT-TCSEEECCSSCCSCCC---CTTCTTCCEEECTTC--------------C
T ss_pred -cccCCCCCEEECcCCcccc-cC--ccccC-CCCEEEeeCCcCCCcC---HHHCCCCCEEeccCC--------------C
Confidence 3345566666666776664 44 44443 4777777777777532 445667777776654 4
Q ss_pred CceEEccCCcccccccccccCCCCcceeeccccccccccCCCCcCCCcccEeecccccccCCcchhhhhhhhhhhhhccc
Q 045798 400 LQGLDFSGNHFSGEIPSSLGNLSSLYEVFFNNNNLSGVIPFSLGNLKRLAFLEMSGNELSGTIPEDIFNISYLSNSLNLA 479 (1008)
Q Consensus 400 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~lp~~~~~~~~~~~~L~L~ 479 (1008)
|+.|++++|.+.+.+| ++.+++|+.|++++|.+.+.+|. ...+|+.|++++|
T Consensus 266 L~~L~l~~n~~~~~~~--~~~l~~L~~L~Ls~n~~l~~l~~---~~~~L~~L~l~~~----------------------- 317 (457)
T 3bz5_A 266 LLEIDLTHNTQLIYFQ--AEGCRKIKELDVTHNTQLYLLDC---QAAGITELDLSQN----------------------- 317 (457)
T ss_dssp CSCCCCTTCTTCCEEE--CTTCTTCCCCCCTTCTTCCEEEC---TTCCCSCCCCTTC-----------------------
T ss_pred CCEEECCCCccCCccc--ccccccCCEEECCCCcccceecc---CCCcceEechhhc-----------------------
Confidence 5677888888776666 45666777777777766655553 2234444444333
Q ss_pred CccccCCCcccccccccccccccccccccCCCCcccccccccceeeccCcccccchhhhhhccccccEEecCCCcccccc
Q 045798 480 RNHLVGIIPPRIGNLRALRSFDVSNNDLSGEIPIELGHCSSLEEIYLAGNLFHGSIPSFFNALKGVQKIDLSRNNLSGQI 559 (1008)
Q Consensus 480 ~N~l~~~~p~~~~~l~~L~~Ldls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~ 559 (1008)
++|+.|++++|++++ ++ ++.+++|+.|++++|+|++ ++.|..|++++|.++|.
T Consensus 318 ---------------~~L~~L~L~~N~l~~-l~--l~~l~~L~~L~l~~N~l~~--------l~~L~~L~l~~n~l~g~- 370 (457)
T 3bz5_A 318 ---------------PKLVYLYLNNTELTE-LD--VSHNTKLKSLSCVNAHIQD--------FSSVGKIPALNNNFEAE- 370 (457)
T ss_dssp ---------------TTCCEEECTTCCCSC-CC--CTTCTTCSEEECCSSCCCB--------CTTGGGSSGGGTSEEEE-
T ss_pred ---------------ccCCEEECCCCcccc-cc--cccCCcCcEEECCCCCCCC--------ccccccccccCCcEEec-
Confidence 345556666666654 22 5556666666666666654 23445556666666654
Q ss_pred cCcccccccceeecccCcccccCCCC
Q 045798 560 PIFLEALSLEYLNLSFNDFEGKIPAK 585 (1008)
Q Consensus 560 p~~~~~~~L~~L~l~~N~l~g~~p~~ 585 (1008)
..+..|..+++++|+|+|.||..
T Consensus 371 ---~~~~~l~~l~l~~N~l~g~ip~~ 393 (457)
T 3bz5_A 371 ---GQTITMPKETLTNNSLTIAVSPD 393 (457)
T ss_dssp ---EEEEECCCBCCBTTBEEEECCTT
T ss_pred ---ceeeecCccccccCcEEEEcChh
Confidence 23445666677777777777653
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=360.69 Aligned_cols=260 Identities=24% Similarity=0.398 Sum_probs=200.2
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeE----EEEEEeccc-cchhhHHHHHHHHHHhhcCCCCceeeeeccccccccC
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIV----VAIKVINLQ-CEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQG 757 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~----vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 757 (1008)
.++|++.+.||+|+||+||+|++..+++. ||+|+++.. .....+.+.+|+.++++++||||++++++|..
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----- 88 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT----- 88 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEES-----
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEec-----
Confidence 35799999999999999999998766654 588877533 23445789999999999999999999999643
Q ss_pred CceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCC
Q 045798 758 NDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLS 837 (1008)
Q Consensus 758 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 837 (1008)
...++|+||+++|+|.+++..... .+++..++.|+.||+.||+|||+. +|+||||||+||+++.++.
T Consensus 89 -~~~~~v~e~~~~g~L~~~l~~~~~---------~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~ 155 (327)
T 3poz_A 89 -STVQLITQLMPFGCLLDYVREHKD---------NIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQH 155 (327)
T ss_dssp -SSEEEEEECCTTCBHHHHHHHSTT---------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTE
T ss_pred -CCeEEEEEecCCCcHHHHHHhcCC---------CCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCC
Confidence 237899999999999999976432 689999999999999999999998 9999999999999999999
Q ss_pred eEEcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCccccCCccHHHH
Q 045798 838 GHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT-AKKPTDVMFEGDLNLHNF 916 (1008)
Q Consensus 838 ~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-G~~pf~~~~~~~~~~~~~ 916 (1008)
+||+|||+|+......... ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||....... ....
T Consensus 156 ~kl~Dfg~a~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--~~~~ 231 (327)
T 3poz_A 156 VKITDFGLAKLLGAEEKEY--HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--ISSI 231 (327)
T ss_dssp EEECCTTHHHHHTTTCC---------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--HHHH
T ss_pred EEEccCcceeEccCCcccc--cccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHH--HHHH
Confidence 9999999998665433221 1223447889999999999999999999999999999999 999986432111 1111
Q ss_pred HHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHHHHHHHH
Q 045798 917 ARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHELQSVKNI 994 (1008)
Q Consensus 917 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~i~~~ 994 (1008)
.. .... .+ ....++..+.+++.+||+.||++|||+.|+++.|+.+...
T Consensus 232 ~~------------~~~~--------------~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~ 279 (327)
T 3poz_A 232 LE------------KGER--------------LP----QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp HH------------TTCC--------------CC----CCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred HH------------cCCC--------------CC----CCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence 11 0000 00 0012345678999999999999999999999999988654
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=350.88 Aligned_cols=263 Identities=24% Similarity=0.398 Sum_probs=214.2
Q ss_pred HhcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccchhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceE
Q 045798 682 ATNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFK 761 (1008)
Q Consensus 682 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 761 (1008)
..++|++.+.||+|+||.||+|.+..+++.||+|+++.. ....+.+.+|++++++++||||+++++++ ..++..
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~ 84 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVC-----TREPPF 84 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEE-----CSSSSE
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----ccCCCE
Confidence 467899999999999999999999988999999999754 44567899999999999999999999995 456678
Q ss_pred EEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEc
Q 045798 762 AIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIG 841 (1008)
Q Consensus 762 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 841 (1008)
++||||+++++|.+++...... .+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+
T Consensus 85 ~~v~e~~~~~~L~~~~~~~~~~--------~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~ 153 (288)
T 3kfa_A 85 YIITEFMTYGNLLDYLRECNRQ--------EVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVA 153 (288)
T ss_dssp EEEEECCTTEEHHHHHHHCCTT--------TSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEEC
T ss_pred EEEEEcCCCCcHHHHHHhcccC--------CccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEc
Confidence 9999999999999999764322 689999999999999999999998 99999999999999999999999
Q ss_pred ccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCccccCCccHHHHHHhh
Q 045798 842 DFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT-AKKPTDVMFEGDLNLHNFARMA 920 (1008)
Q Consensus 842 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-G~~pf~~~~~~~~~~~~~~~~~ 920 (1008)
|||.+......... ......+|+.|+|||++.+..++.++||||||+++|+|++ |..||...... .......
T Consensus 154 Dfg~~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~--~~~~~~~-- 226 (288)
T 3kfa_A 154 DFGLSRLMTGDTYT---AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS--QVYELLE-- 226 (288)
T ss_dssp CCCGGGTSCSSSSE---EETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG--GHHHHHH--
T ss_pred cCccceeccCCccc---cccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHh--
Confidence 99999866543222 1223457889999999988899999999999999999999 99998643211 0111110
Q ss_pred CCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHHHHHHHHHH
Q 045798 921 LPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHELQSVKNILL 996 (1008)
Q Consensus 921 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~i~~~~~ 996 (1008)
..... .....++..+.+++.+||+.||.+|||++|+++.|+++.....
T Consensus 227 ----------~~~~~------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~~ 274 (288)
T 3kfa_A 227 ----------KDYRM------------------ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESS 274 (288)
T ss_dssp ----------TTCCC------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred ----------ccCCC------------------CCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhcc
Confidence 00000 0001234568999999999999999999999999999877644
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=363.18 Aligned_cols=254 Identities=22% Similarity=0.257 Sum_probs=194.0
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccchhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceEE
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKA 762 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 762 (1008)
.++|++.+.||+|+||.||+|++..+++.||||++... ....+.+.+|+.++++++||||+++++++ ..++..+
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~-----~~~~~~~ 92 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERG-AAIDENVQREIINHRSLRHPNIVRFKEVI-----LTPTHLA 92 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESS-TTSCHHHHHHHHHHHHCCCTTBCCEEEEE-----ECSSEEE
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecC-ccccHHHHHHHHHHHhCCCCCCCcEEEEE-----eeCCEEE
Confidence 56899999999999999999999989999999999754 23346789999999999999999999994 4567799
Q ss_pred EEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCC--eEE
Q 045798 763 IVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLS--GHI 840 (1008)
Q Consensus 763 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~--~kL 840 (1008)
+||||+++|+|.+++...+ ++++..++.++.|++.||+|||++ +|+||||||+||+++.++. +||
T Consensus 93 lv~e~~~~~~L~~~l~~~~----------~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl 159 (361)
T 3uc3_A 93 IIMEYASGGELYERICNAG----------RFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKI 159 (361)
T ss_dssp EEEECCCSCBHHHHHHHHS----------SCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEE
T ss_pred EEEEeCCCCCHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEE
Confidence 9999999999999986543 689999999999999999999998 9999999999999987765 999
Q ss_pred cccCcccccccccCccccccccccccccccCccccCCCCCCcc-cchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHh
Q 045798 841 GDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTN-GDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARM 919 (1008)
Q Consensus 841 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~ 919 (1008)
+|||+++....... .....||+.|+|||++.+..++.+ +||||+||++|+|++|+.||........ .......
T Consensus 160 ~Dfg~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~-~~~~~~~ 233 (361)
T 3uc3_A 160 CDFGYSKSSVLHSQ-----PKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRD-YRKTIQR 233 (361)
T ss_dssp CCCCCC--------------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCC-HHHHHHH
T ss_pred eecCccccccccCC-----CCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHH-HHHHHHH
Confidence 99999974332211 123459999999999988877655 8999999999999999999975322211 1111110
Q ss_pred hCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 045798 920 ALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHE 987 (1008)
Q Consensus 920 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 987 (1008)
. ..... ..+.....+.++.+++.+||+.||++|||+.|+++.
T Consensus 234 ~--------~~~~~------------------~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 234 I--------LSVKY------------------SIPDDIRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp H--------HTTCC------------------CCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred H--------hcCCC------------------CCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 0 00000 000011234567899999999999999999999863
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=363.14 Aligned_cols=262 Identities=24% Similarity=0.412 Sum_probs=195.1
Q ss_pred CCCCCceEeeccCeeEEEEEEcCC---CeEEEEEEeccc-cchhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCce
Q 045798 685 GFSSTHLIGVGSFGCVYKGALDED---GIVVAIKVINLQ-CEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDF 760 (1008)
Q Consensus 685 ~y~~~~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 760 (1008)
.|.+.+.||+|+||.||+|.+..+ +..||+|+++.. .....+.+.+|+.++++++||||++++++|. ..++.
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~----~~~~~ 165 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICL----RSEGS 165 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEEC----CCSSC
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEE----cCCCC
Confidence 466778999999999999997533 246899998743 3355678999999999999999999999863 34456
Q ss_pred EEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEE
Q 045798 761 KAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHI 840 (1008)
Q Consensus 761 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 840 (1008)
.++||||+++|+|.+++..... .+++..++.++.||+.||+|||+. +|+||||||+||+++.++.+||
T Consensus 166 ~~lv~e~~~~g~L~~~l~~~~~---------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL 233 (373)
T 3c1x_A 166 PLVVLPYMKHGDLRNFIRNETH---------NPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKV 233 (373)
T ss_dssp CEEEEECCTTCBHHHHHHCTTC---------CCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEE
T ss_pred eEEEEECCCCCCHHHHHhhccc---------CCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEE
Confidence 7999999999999999975432 578899999999999999999998 9999999999999999999999
Q ss_pred cccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCccccCCccHHHHHHh
Q 045798 841 GDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT-AKKPTDVMFEGDLNLHNFARM 919 (1008)
Q Consensus 841 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-G~~pf~~~~~~~~~~~~~~~~ 919 (1008)
+|||+++.................+|+.|+|||++.+..++.++|||||||++|||++ |.+||......+ .......
T Consensus 234 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~--~~~~~~~ 311 (373)
T 3c1x_A 234 ADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD--ITVYLLQ 311 (373)
T ss_dssp CCC---------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSC--HHHHHHT
T ss_pred eeccccccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHH--HHHHHHc
Confidence 9999998664433222222233457889999999998899999999999999999999 666765332111 1111100
Q ss_pred hCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHHHHHHHH
Q 045798 920 ALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHELQSVKNI 994 (1008)
Q Consensus 920 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~i~~~ 994 (1008)
.. +.. ....++..+.+++.+||+.||++|||+.|+++.|+++...
T Consensus 312 ~~--------------------------~~~----~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~ 356 (373)
T 3c1x_A 312 GR--------------------------RLL----QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 356 (373)
T ss_dssp TC--------------------------CCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CC--------------------------CCC----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 00 000 0012345689999999999999999999999999988654
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=358.63 Aligned_cols=265 Identities=23% Similarity=0.333 Sum_probs=197.9
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEecccc---chhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCc
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC---EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGND 759 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 759 (1008)
.++|++.+.||+|+||.||+|++..+++.||||+++... ......+.+|++++++++||||+++++++.... ..+.
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~~ 89 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET-PAGP 89 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEE-TTEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccC-CCCc
Confidence 468999999999999999999998899999999997542 233467899999999999999999999865422 1223
Q ss_pred eEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeE
Q 045798 760 FKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGH 839 (1008)
Q Consensus 760 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 839 (1008)
..|+||||+++++|.+++.... .+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+|
T Consensus 90 ~~~lv~e~~~g~~L~~~l~~~~----------~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~k 156 (311)
T 3ork_A 90 LPYIVMEYVDGVTLRDIVHTEG----------PMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVK 156 (311)
T ss_dssp EEEEEEECCCEEEHHHHHHHHC----------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEE
T ss_pred ccEEEEecCCCCCHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEE
Confidence 4599999999999999997543 689999999999999999999998 999999999999999999999
Q ss_pred EcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHh
Q 045798 840 IGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARM 919 (1008)
Q Consensus 840 L~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~ 919 (1008)
|+|||+++......... .......||+.|+|||++.+..++.++|||||||++|||++|+.||............ ...
T Consensus 157 l~Dfg~a~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~-~~~ 234 (311)
T 3ork_A 157 VMDFGIARAIADSGNSV-TQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQH-VRE 234 (311)
T ss_dssp ECCCSCC-------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH-HHC
T ss_pred EeeccCccccccccccc-ccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH-hcC
Confidence 99999998665432221 1223356899999999999999999999999999999999999998643211100000 000
Q ss_pred hCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHH-HHHHHH
Q 045798 920 ALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVV-HELQSV 991 (1008)
Q Consensus 920 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl-~~L~~i 991 (1008)
.. .. + .......+.++.+++.+||+.||++||++.+++ +.+.++
T Consensus 235 ~~------------~~-~---------------~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 279 (311)
T 3ork_A 235 DP------------IP-P---------------SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 279 (311)
T ss_dssp CC------------CC-H---------------HHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred CC------------CC-c---------------ccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence 00 00 0 000112455689999999999999999766655 444443
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-39 Score=365.42 Aligned_cols=287 Identities=17% Similarity=0.186 Sum_probs=205.6
Q ss_pred hcCCCCCceEeec--cCeeEEEEEEcCCCeEEEEEEecccc--chhhHHHHHHHHHHhhcCCCCceeeeeccccccccCC
Q 045798 683 TNGFSSTHLIGVG--SFGCVYKGALDEDGIVVAIKVINLQC--EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGN 758 (1008)
Q Consensus 683 ~~~y~~~~~lg~G--~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 758 (1008)
.++|++.+.||+| +||.||+|++..+++.||||+++... ....+.+.+|++++++++||||+++++++ ..+
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-----~~~ 98 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATF-----IAD 98 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----EET
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEE-----EEC
Confidence 5689999999999 99999999999899999999997543 34456788999999999999999999995 456
Q ss_pred ceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCe
Q 045798 759 DFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSG 838 (1008)
Q Consensus 759 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 838 (1008)
+..++||||+++|+|.+++...... .+++..++.++.||+.||+|||+. +|+||||||+||+++.++.+
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~~~~--------~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~ 167 (389)
T 3gni_B 99 NELWVVTSFMAYGSAKDLICTHFMD--------GMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKV 167 (389)
T ss_dssp TEEEEEEECCTTCBHHHHHHHTCTT--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCE
T ss_pred CEEEEEEEccCCCCHHHHHhhhccc--------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCE
Confidence 6799999999999999999765322 689999999999999999999998 99999999999999999999
Q ss_pred EEcccCcccccccccCc---cccccccccccccccCccccCC--CCCCcccchhhHHHHHHHHHhCCCCCCccccCCccH
Q 045798 839 HIGDFGLARFHQEVSNS---TLSSSVGVKGTIGYTAPEYGLG--SEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNL 913 (1008)
Q Consensus 839 kL~Dfg~a~~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~ 913 (1008)
||+|||.+......... .........||+.|+|||++.+ ..++.++|||||||++|||++|+.||..........
T Consensus 168 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~ 247 (389)
T 3gni_B 168 YLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLL 247 (389)
T ss_dssp EECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHH
T ss_pred EEcccccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHH
Confidence 99999998754332211 1111222468999999999887 578999999999999999999999997532222111
Q ss_pred HHHHHhhCCcchh-------hh--------hcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCC
Q 045798 914 HNFARMALPNQVM-------DI--------VDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDR 978 (1008)
Q Consensus 914 ~~~~~~~~~~~~~-------~~--------~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R 978 (1008)
. ......+.... .. ....+........ ...........+.....+..+.+++.+||+.||++|
T Consensus 248 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R 325 (389)
T 3gni_B 248 E-KLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTST-PRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDAR 325 (389)
T ss_dssp H-C---------------------------------------------------------CCHHHHHHHHHHTCSCTTTS
T ss_pred H-HhcCCCCccccccccccccccccccccccccccccccccCc-cccccCCCCCCccccccCHHHHHHHHHHhhcCcccC
Confidence 1 11000000000 00 0000000000000 000000000111123456678999999999999999
Q ss_pred CCHHHHHHH
Q 045798 979 MNMTNVVHE 987 (1008)
Q Consensus 979 Pt~~evl~~ 987 (1008)
||++|+++.
T Consensus 326 pta~ell~h 334 (389)
T 3gni_B 326 PSASTLLNH 334 (389)
T ss_dssp CCHHHHTTS
T ss_pred CCHHHHhcC
Confidence 999999853
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-39 Score=373.90 Aligned_cols=204 Identities=30% Similarity=0.367 Sum_probs=162.4
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccc--cchhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCce
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQ--CEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDF 760 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 760 (1008)
.++|++.+.||+|+||.||+|++..+++.||||++... .....+++.+|++++++++||||+++++++..........
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 46899999999999999999999989999999998643 2344578999999999999999999999987655566678
Q ss_pred EEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEE
Q 045798 761 KAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHI 840 (1008)
Q Consensus 761 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 840 (1008)
.|+||||+ +++|.+++.... .+++..++.++.||+.||+|||+. +||||||||+|||++.++.+||
T Consensus 132 ~~lv~e~~-~~~L~~~~~~~~----------~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl 197 (458)
T 3rp9_A 132 LYVVLEIA-DSDFKKLFRTPV----------YLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKV 197 (458)
T ss_dssp EEEEECCC-SEEHHHHHHSSC----------CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEE
T ss_pred EEEEEecc-ccchhhhcccCC----------CCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEee
Confidence 99999998 679999987553 689999999999999999999998 9999999999999999999999
Q ss_pred cccCcccccccccCcc-----------------------ccccccccccccccCcccc-CCCCCCcccchhhHHHHHHHH
Q 045798 841 GDFGLARFHQEVSNST-----------------------LSSSVGVKGTIGYTAPEYG-LGSEVSTNGDVYSYGILLLEM 896 (1008)
Q Consensus 841 ~Dfg~a~~~~~~~~~~-----------------------~~~~~~~~gt~~y~aPE~~-~~~~~~~~sDvwslG~vl~el 896 (1008)
+|||+|+......... .......+||+.|+|||++ .+..++.++|||||||++|||
T Consensus 198 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~el 277 (458)
T 3rp9_A 198 CDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAEL 277 (458)
T ss_dssp CCCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHH
T ss_pred cccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHH
Confidence 9999998764322110 0122345689999999976 556799999999999999999
Q ss_pred HhCC
Q 045798 897 VTAK 900 (1008)
Q Consensus 897 ltG~ 900 (1008)
++|.
T Consensus 278 ltg~ 281 (458)
T 3rp9_A 278 LNMI 281 (458)
T ss_dssp HTTS
T ss_pred HHhc
Confidence 9943
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=348.99 Aligned_cols=263 Identities=24% Similarity=0.360 Sum_probs=205.4
Q ss_pred CCCCCceEeeccCeeEEEEEEcCCC---eEEEEEEeccccc-hhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCce
Q 045798 685 GFSSTHLIGVGSFGCVYKGALDEDG---IVVAIKVINLQCE-GASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDF 760 (1008)
Q Consensus 685 ~y~~~~~lg~G~~g~Vy~~~~~~~~---~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 760 (1008)
.|.+.+.||+|+||+||+|.+..++ ..||+|+++.... ...+.+.+|++++++++||||+++++++. ..+..
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~----~~~~~ 97 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIML----PPEGL 97 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEC----CSSSC
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEe----cCCCC
Confidence 4566789999999999999975444 3799999975433 44578999999999999999999999964 23344
Q ss_pred EEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEE
Q 045798 761 KAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHI 840 (1008)
Q Consensus 761 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 840 (1008)
.++||||+.+|+|.+++..... .+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||
T Consensus 98 ~~~v~e~~~~~~L~~~~~~~~~---------~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl 165 (298)
T 3pls_A 98 PHVLLPYMCHGDLLQFIRSPQR---------NPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKV 165 (298)
T ss_dssp CEEEECCCTTCBHHHHHHCTTC---------CCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEE
T ss_pred cEEEEecccCCCHHHHHhcccc---------CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEe
Confidence 5899999999999999976432 688999999999999999999998 9999999999999999999999
Q ss_pred cccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHhh
Q 045798 841 GDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMA 920 (1008)
Q Consensus 841 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~~ 920 (1008)
+|||+++.................+|+.|+|||.+.+..++.++||||||+++|+|++|..|+........ ........
T Consensus 166 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~-~~~~~~~~ 244 (298)
T 3pls_A 166 ADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFD-LTHFLAQG 244 (298)
T ss_dssp CCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGG-HHHHHHTT
T ss_pred CcCCCcccccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHH-HHHHhhcC
Confidence 99999986654432222233345688999999999999999999999999999999997666532211111 11111100
Q ss_pred CCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHHHHHHHH
Q 045798 921 LPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHELQSVKNI 994 (1008)
Q Consensus 921 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~i~~~ 994 (1008)
... + .....+..+.+++.+||+.||.+|||++|+++.|+++.+.
T Consensus 245 ~~~--------------------------~----~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~ 288 (298)
T 3pls_A 245 RRL--------------------------P----QPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSA 288 (298)
T ss_dssp CCC--------------------------C----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCC--------------------------C----CCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 000 0 0012345688999999999999999999999999998765
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=359.76 Aligned_cols=246 Identities=22% Similarity=0.264 Sum_probs=202.3
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEecccc---chhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCc
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC---EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGND 759 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 759 (1008)
.++|++.+.||+|+||.||+|++..+|+.||+|+++... ....+.+.+|+++++.++||||++++++ +.+++
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~-----~~~~~ 114 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFS-----FKDNS 114 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEE-----EECSS
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEE-----EEcCC
Confidence 467999999999999999999999899999999996432 2345678999999999999999999998 45667
Q ss_pred eEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeE
Q 045798 760 FKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGH 839 (1008)
Q Consensus 760 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 839 (1008)
..|+||||+++|+|.+++.... .+++..++.++.||+.||+|||++ +|+||||||+||+++.++.+|
T Consensus 115 ~~~lv~e~~~gg~L~~~l~~~~----------~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~k 181 (350)
T 1rdq_E 115 NLYMVMEYVAGGEMFSHLRRIG----------RFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQ 181 (350)
T ss_dssp EEEEEEECCTTCBHHHHHHHHC----------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEE
T ss_pred EEEEEEcCCCCCcHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEE
Confidence 8999999999999999997643 689999999999999999999998 999999999999999999999
Q ss_pred EcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHh
Q 045798 840 IGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARM 919 (1008)
Q Consensus 840 L~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~ 919 (1008)
|+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...... ........
T Consensus 182 L~DFg~a~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~-~~~~~i~~- 252 (350)
T 1rdq_E 182 VTDFGFAKRVKGR-------TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKIVS- 252 (350)
T ss_dssp ECCCTTCEECSSC-------BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHH-
T ss_pred EcccccceeccCC-------cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHH-HHHHHHHc-
Confidence 9999999865432 12346999999999999999999999999999999999999998642110 00000000
Q ss_pred hCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCC-----HHHHHH
Q 045798 920 ALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMN-----MTNVVH 986 (1008)
Q Consensus 920 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~ 986 (1008)
... .++ ...+.++.+++.+||+.||.+||+ ++||++
T Consensus 253 -----------~~~--------------~~p------~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 253 -----------GKV--------------RFP------SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp -----------CCC--------------CCC------TTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred -----------CCC--------------CCC------CCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 000 000 113456789999999999999998 777765
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-39 Score=354.64 Aligned_cols=269 Identities=24% Similarity=0.353 Sum_probs=210.1
Q ss_pred hcCCCCCceEeeccCeeEEEEEEc-----CCCeEEEEEEecccc-chhhHHHHHHHHHHhhcCCCCceeeeecccccccc
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALD-----EDGIVVAIKVINLQC-EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQ 756 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 756 (1008)
.++|.+.+.||+|+||.||+|.+. .+++.||+|+++... ....+.+.+|++++++++||||+++++++ .
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~ 96 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGAC-----S 96 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-----C
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEE-----e
Confidence 567999999999999999999983 456899999997543 34457899999999999999999999995 4
Q ss_pred CCceEEEEEeccCCCChhcccccCCCCCC--------------CcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCcee
Q 045798 757 GNDFKAIVYEYMPNGSLEKWLHPHAVPKR--------------DKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILH 822 (1008)
Q Consensus 757 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~--------------~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH 822 (1008)
.++..++||||+++++|.+++........ .......+++.+++.++.||+.||+|||+. +|+|
T Consensus 97 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH 173 (314)
T 2ivs_A 97 QDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVH 173 (314)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEEC
T ss_pred cCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCcc
Confidence 55678999999999999999976542100 000112589999999999999999999998 9999
Q ss_pred ccCCCCCeeecCCCCeEEcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHh-CCC
Q 045798 823 CDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT-AKK 901 (1008)
Q Consensus 823 ~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-G~~ 901 (1008)
|||||+||+++.++.+||+|||+++......... ......+|+.|+|||.+.+..++.++|||||||++|||++ |+.
T Consensus 174 ~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~ 251 (314)
T 2ivs_A 174 RDLAARNILVAEGRKMKISDFGLSRDVYEEDSYV--KRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGN 251 (314)
T ss_dssp CCCSGGGEEEETTTEEEECCCTTCEECTTTSCEE--CSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCC
T ss_pred cccchheEEEcCCCCEEEccccccccccccccce--eccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCC
Confidence 9999999999999999999999998664432221 1223447889999999988889999999999999999999 999
Q ss_pred CCCccccCCccHHHHHHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCH
Q 045798 902 PTDVMFEGDLNLHNFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNM 981 (1008)
Q Consensus 902 pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~ 981 (1008)
||...... ............ .....++..+.+++.+||+.||++|||+
T Consensus 252 p~~~~~~~--~~~~~~~~~~~~------------------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~ 299 (314)
T 2ivs_A 252 PYPGIPPE--RLFNLLKTGHRM------------------------------ERPDNCSEEMYRLMLQCWKQEPDKRPVF 299 (314)
T ss_dssp SSTTCCGG--GHHHHHHTTCCC------------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred CCCCCCHH--HHHHHhhcCCcC------------------------------CCCccCCHHHHHHHHHHccCChhhCcCH
Confidence 98643211 111111000000 0001234568999999999999999999
Q ss_pred HHHHHHHHHHHH
Q 045798 982 TNVVHELQSVKN 993 (1008)
Q Consensus 982 ~evl~~L~~i~~ 993 (1008)
.|+++.|+++..
T Consensus 300 ~~l~~~l~~~~~ 311 (314)
T 2ivs_A 300 ADISKDLEKMMV 311 (314)
T ss_dssp HHHHHHHHHHHH
T ss_pred HHHHHHHHHHHh
Confidence 999999998765
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=356.66 Aligned_cols=284 Identities=25% Similarity=0.375 Sum_probs=190.5
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEecccc-chhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceE
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC-EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFK 761 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 761 (1008)
.++|++.+.||+|+||.||+|.+..+++.||+|+++... ....+.+.+|++++++++||||+++++++ ..++..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~~ 78 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVI-----HTENKL 78 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEE-----CCTTEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEE-----EECCeE
Confidence 468999999999999999999998899999999997543 23456789999999999999999999994 556779
Q ss_pred EEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEc
Q 045798 762 AIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIG 841 (1008)
Q Consensus 762 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 841 (1008)
++||||++ |+|.+++........ ...+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+
T Consensus 79 ~lv~e~~~-~~L~~~l~~~~~~~~----~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~ 150 (317)
T 2pmi_A 79 TLVFEFMD-NDLKKYMDSRTVGNT----PRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLG 150 (317)
T ss_dssp EEEEECCC-CBHHHHHHHHHSSSC----CCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEEC
T ss_pred EEEEEecC-CCHHHHHHhcccccc----ccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEEC
Confidence 99999996 699998865321110 11589999999999999999999998 99999999999999999999999
Q ss_pred ccCcccccccccCccccccccccccccccCccccCCC-CCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHhh
Q 045798 842 DFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGS-EVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMA 920 (1008)
Q Consensus 842 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~~ 920 (1008)
|||+++........ .....||+.|+|||++.+. .++.++|||||||++|||++|+.||......+ .........
T Consensus 151 Dfg~~~~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~i~~~~ 225 (317)
T 2pmi_A 151 DFGLARAFGIPVNT----FSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEE-QLKLIFDIM 225 (317)
T ss_dssp CCSSCEETTSCCCC----CCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHH
T ss_pred cCccceecCCCccc----CCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHh
Confidence 99999865432221 1234589999999998764 68999999999999999999999997432211 111111111
Q ss_pred C-C-cchhhhhcccccCchHHh--hhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 921 L-P-NQVMDIVDPILRNDEEIL--ASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 921 ~-~-~~~~~~~d~~l~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
. + ......+...-...+... ........+.+. .....+.++.+++.+||+.||++|||++|+++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 226 GTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPH--TKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp CSCCTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGG--CSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred CCCChhHhhhhhhhhhcccccccccchhHHHhhccc--ccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 0 0 000000000000000000 000000000000 00123456899999999999999999999875
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-39 Score=356.63 Aligned_cols=253 Identities=23% Similarity=0.313 Sum_probs=198.7
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEecccc---chhhHHHHHHHHHHhhc-CCCCceeeeeccccccccCC
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC---EGASKSFMAECKALKNI-RHRNLVKVITSCSSIDFQGN 758 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~ 758 (1008)
.++|++.+.||+|+||.||+|++..+++.||+|+++... ....+.+.+|+.+++++ +||||+++++++ ...
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~-----~~~ 82 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCF-----QTE 82 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEE-----ECS
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEE-----EeC
Confidence 357999999999999999999999899999999997542 33456788999999988 899999999994 566
Q ss_pred ceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCe
Q 045798 759 DFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSG 838 (1008)
Q Consensus 759 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 838 (1008)
+..|+||||+++|+|.+++.... .+++..++.++.||+.||+|||+. +|+||||||+||+++.++.+
T Consensus 83 ~~~~lv~e~~~gg~L~~~l~~~~----------~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~ 149 (345)
T 3a8x_A 83 SRLFFVIEYVNGGDLMFHMQRQR----------KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHI 149 (345)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHS----------SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCE
T ss_pred CEEEEEEeCCCCCcHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCE
Confidence 78999999999999999997543 689999999999999999999998 99999999999999999999
Q ss_pred EEcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHH
Q 045798 839 HIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFAR 918 (1008)
Q Consensus 839 kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~ 918 (1008)
||+|||+++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+....
T Consensus 150 kL~DFG~a~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~---- 221 (345)
T 3a8x_A 150 KLTDYGMCKEGLRPGD----TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ---- 221 (345)
T ss_dssp EECCGGGCBCSCCTTC----CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC----------
T ss_pred EEEeccccccccCCCC----cccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCccccccccc----
Confidence 9999999985332221 12335699999999999999999999999999999999999999964211110000
Q ss_pred hhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCH
Q 045798 919 MALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNM 981 (1008)
Q Consensus 919 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~ 981 (1008)
............. ...++ ...+.++.+++.+||+.||.+||++
T Consensus 222 ----~~~~~~~~~i~~~----------~~~~p------~~~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 222 ----NTEDYLFQVILEK----------QIRIP------RSLSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp -----CHHHHHHHHHHC----------CCCCC------TTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred ----ccHHHHHHHHHcC----------CCCCC------CCCCHHHHHHHHHHhcCCHhHCCCC
Confidence 0000000000000 00011 1234567899999999999999996
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=358.19 Aligned_cols=273 Identities=20% Similarity=0.362 Sum_probs=194.9
Q ss_pred HhcCCCCCceEeeccCeeEEEEEEcCCCe---EEEEEEeccc--cchhhHHHHHHHHHHhhcCCCCceeeeecccccccc
Q 045798 682 ATNGFSSTHLIGVGSFGCVYKGALDEDGI---VVAIKVINLQ--CEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQ 756 (1008)
Q Consensus 682 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~---~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 756 (1008)
..++|++.+.||+|+||.||+|.+..++. .||||+++.. .....+.+.+|++++++++||||+++++++......
T Consensus 21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 100 (323)
T 3qup_A 21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAK 100 (323)
T ss_dssp C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC---
T ss_pred ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccc
Confidence 35689999999999999999999876654 8999999754 345567899999999999999999999996532211
Q ss_pred -CCceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCC
Q 045798 757 -GNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDND 835 (1008)
Q Consensus 757 -~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~ 835 (1008)
.....++||||+++|+|.+++....... ....+++..++.++.|++.||+|||+. +|+||||||+||+++++
T Consensus 101 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~----~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~ 173 (323)
T 3qup_A 101 GRLPIPMVILPFMKHGDLHAFLLASRIGE----NPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAED 173 (323)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHHHC-------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTT
T ss_pred cCCCccEEEEEeccCCcHHHHHHhhhccc----cccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCC
Confidence 1112489999999999999986543211 112589999999999999999999998 99999999999999999
Q ss_pred CCeEEcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCccccCCccHH
Q 045798 836 LSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT-AKKPTDVMFEGDLNLH 914 (1008)
Q Consensus 836 ~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-G~~pf~~~~~~~~~~~ 914 (1008)
+.+||+|||+++......... ......+++.|+|||.+.+..++.++|||||||++|||++ |..||......+ ...
T Consensus 174 ~~~kl~Dfg~a~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~-~~~ 250 (323)
T 3qup_A 174 MTVCVADFGLSRKIYSGDYYR--QGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE-IYN 250 (323)
T ss_dssp SCEEECCCCC-------------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG-HHH
T ss_pred CCEEEeecccccccccccccc--ccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHH-HHH
Confidence 999999999998664432211 1223347889999999998899999999999999999999 899986432211 000
Q ss_pred HHHHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHHHHHHHH
Q 045798 915 NFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHELQSVKNI 994 (1008)
Q Consensus 915 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~i~~~ 994 (1008)
....... .. .....+.++.+++.+||+.||++|||+.|+++.|+++...
T Consensus 251 ~~~~~~~-----------~~--------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~ 299 (323)
T 3qup_A 251 YLIGGNR-----------LK--------------------QPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGH 299 (323)
T ss_dssp HHHTTCC-----------CC--------------------CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHhcCCC-----------CC--------------------CCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 0000000 00 0012345689999999999999999999999999998765
Q ss_pred H
Q 045798 995 L 995 (1008)
Q Consensus 995 ~ 995 (1008)
.
T Consensus 300 ~ 300 (323)
T 3qup_A 300 L 300 (323)
T ss_dssp -
T ss_pred h
Confidence 3
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=367.32 Aligned_cols=287 Identities=20% Similarity=0.258 Sum_probs=215.4
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEecccc-chhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceE
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC-EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFK 761 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 761 (1008)
.++|++.+.||+|+||.||+|++..+++.||||+++... ....+.+.+|++++++++||||+++++++.. ......
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~---~~~~~~ 84 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEE---TTTRHK 84 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEEC---TTTCCE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeecc---CCCCee
Confidence 457999999999999999999999889999999997543 2345678899999999999999999998643 334468
Q ss_pred EEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeee----cCCCC
Q 045798 762 AIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILL----DNDLS 837 (1008)
Q Consensus 762 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll----~~~~~ 837 (1008)
++||||+++|+|.+++...... ..+++..++.++.||+.||+|||+. +|+||||||+||++ +.++.
T Consensus 85 ~lv~e~~~~g~L~~~l~~~~~~-------~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~ 154 (396)
T 4eut_A 85 VLIMEFCPCGSLYTVLEEPSNA-------YGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSV 154 (396)
T ss_dssp EEEECCCTTEEHHHHTTSGGGT-------TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEE
T ss_pred EEEEecCCCCCHHHHHHhhhcc-------cCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCcee
Confidence 9999999999999999764321 1489999999999999999999998 99999999999999 77788
Q ss_pred eEEcccCcccccccccCccccccccccccccccCccccCC--------CCCCcccchhhHHHHHHHHHhCCCCCCccccC
Q 045798 838 GHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLG--------SEVSTNGDVYSYGILLLEMVTAKKPTDVMFEG 909 (1008)
Q Consensus 838 ~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~sDvwslG~vl~elltG~~pf~~~~~~ 909 (1008)
+||+|||.++....... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||......
T Consensus 155 ~kL~DFG~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~ 229 (396)
T 4eut_A 155 YKLTDFGAARELEDDEQ-----FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGP 229 (396)
T ss_dssp EEECCGGGCEECCCGGG-----SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCT
T ss_pred EEEecCCCceEccCCCc-----cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcc
Confidence 99999999986644322 223458999999998764 46788999999999999999999999754332
Q ss_pred CccHHHHHHh--hCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 045798 910 DLNLHNFARM--ALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHE 987 (1008)
Q Consensus 910 ~~~~~~~~~~--~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 987 (1008)
.......... ..+......+....... .......+.........+..+.+++.+||+.||++|||++|+++.
T Consensus 230 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~------~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~ 303 (396)
T 4eut_A 230 RRNKEVMYKIITGKPSGAISGVQKAENGP------IDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE 303 (396)
T ss_dssp TTCHHHHHHHHHSCCTTCCEEEECSTTCC------EEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHH
T ss_pred cchHHHHHHHhcCCCcccchhheeccCCC------cccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHH
Confidence 2222221111 11111100000000000 000011111222235677889999999999999999999999999
Q ss_pred HHHHHH
Q 045798 988 LQSVKN 993 (1008)
Q Consensus 988 L~~i~~ 993 (1008)
++.+..
T Consensus 304 l~~il~ 309 (396)
T 4eut_A 304 TSDILH 309 (396)
T ss_dssp HHHHHT
T ss_pred HHHHhh
Confidence 988754
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=347.91 Aligned_cols=255 Identities=23% Similarity=0.332 Sum_probs=203.0
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEecccc--chhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCce
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC--EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDF 760 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 760 (1008)
.++|++.+.||+|+||.||+|++ .++.||||+++... ....+.+.+|+.++++++||||+++++++.. .....
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---~~~~~ 83 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRW--QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQS---PPAPH 83 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECT---TTSSS
T ss_pred HHHhHHHHHhcCCCcceEEEEEE--CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEcc---CCCCC
Confidence 45799999999999999999998 48899999997543 3445679999999999999999999999643 22367
Q ss_pred EEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCC--ceeccCCCCCeeecCCCCe
Q 045798 761 KAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEP--ILHCDLKPSNILLDNDLSG 838 (1008)
Q Consensus 761 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~--ivH~Dlkp~NIll~~~~~~ 838 (1008)
.++||||+++|+|.+++...... .+++..++.++.|++.||+|||+. + |+||||||+||+++.++.+
T Consensus 84 ~~lv~e~~~~~~L~~~l~~~~~~--------~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~ 152 (271)
T 3kmu_A 84 PTLITHWMPYGSLYNVLHEGTNF--------VVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTA 152 (271)
T ss_dssp CEEEEECCTTCBHHHHHHSCSSC--------CCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCE
T ss_pred eEeeecccCCCcHHHHHhhcccC--------CCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcce
Confidence 89999999999999999865421 589999999999999999999997 7 9999999999999999999
Q ss_pred EEcccCcccccccccCccccccccccccccccCccccCCCCCCc---ccchhhHHHHHHHHHhCCCCCCccccCCccHHH
Q 045798 839 HIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVST---NGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHN 915 (1008)
Q Consensus 839 kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~ 915 (1008)
+++|||++..... ....||+.|+|||++.+..++. ++|||||||++|||++|+.||......+. ...
T Consensus 153 ~l~~~~~~~~~~~---------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~~ 222 (271)
T 3kmu_A 153 RISMADVKFSFQS---------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEI-GMK 222 (271)
T ss_dssp EEEGGGSCCTTSC---------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHH-HHH
T ss_pred eEEeccceeeecc---------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHH-HHH
Confidence 9999988764322 1234899999999988765544 79999999999999999999864321110 000
Q ss_pred HHHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHHHHHHH
Q 045798 916 FARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHELQSVKN 993 (1008)
Q Consensus 916 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~i~~ 993 (1008)
........ .. ....+..+.+++.+||+.||++|||++|+++.|+++.+
T Consensus 223 ~~~~~~~~----------------------------~~--~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 223 VALEGLRP----------------------------TI--PPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp HHHSCCCC----------------------------CC--CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred HHhcCCCC----------------------------CC--CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 00000000 00 01234568999999999999999999999999998753
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-39 Score=360.42 Aligned_cols=273 Identities=22% Similarity=0.314 Sum_probs=207.8
Q ss_pred HhcCCCCCceEeeccCeeEEEEEE-----cCCCeEEEEEEecccc-chhhHHHHHHHHHHhhc-CCCCceeeeecccccc
Q 045798 682 ATNGFSSTHLIGVGSFGCVYKGAL-----DEDGIVVAIKVINLQC-EGASKSFMAECKALKNI-RHRNLVKVITSCSSID 754 (1008)
Q Consensus 682 ~~~~y~~~~~lg~G~~g~Vy~~~~-----~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~ 754 (1008)
..++|.+.+.||+|+||.||+|.+ ..+++.||+|+++... ....+.+.+|+++++++ +||||+++++++
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~---- 118 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGAC---- 118 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEE----
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE----
Confidence 357899999999999999999997 2356789999997542 34457899999999999 999999999995
Q ss_pred ccCCceEEEEEeccCCCChhcccccCCCCCCC-------------cccccccCHHHHHHHHHHHHHHHHHHhhCCCCCce
Q 045798 755 FQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRD-------------KEIEIKLTLLQRISIAIDVASALDYLHHHCQEPIL 821 (1008)
Q Consensus 755 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~-------------~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iv 821 (1008)
..++..++||||+++|+|.+++......... ......+++..++.++.||+.||+|||+. +|+
T Consensus 119 -~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~iv 194 (344)
T 1rjb_A 119 -TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCV 194 (344)
T ss_dssp -CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEE
T ss_pred -eeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---Ccc
Confidence 4456689999999999999999765421000 00112589999999999999999999998 999
Q ss_pred eccCCCCCeeecCCCCeEEcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHh-CC
Q 045798 822 HCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT-AK 900 (1008)
Q Consensus 822 H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-G~ 900 (1008)
||||||+||+++.++.+||+|||++.......... ......+|+.|+|||++.+..++.++|||||||++|||++ |.
T Consensus 195 H~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~ 272 (344)
T 1rjb_A 195 HRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYV--VRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGV 272 (344)
T ss_dssp ETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSE--EETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSC
T ss_pred cCCCChhhEEEcCCCcEEeCCCccCcccccCccce--eccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCC
Confidence 99999999999999999999999998665433221 1223457889999999988899999999999999999998 99
Q ss_pred CCCCccccCCccHHHHHHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCC
Q 045798 901 KPTDVMFEGDLNLHNFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMN 980 (1008)
Q Consensus 901 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt 980 (1008)
.||....... ............ . ....++.++.+++.+||+.||.+|||
T Consensus 273 ~p~~~~~~~~-~~~~~~~~~~~~----------------------------~--~~~~~~~~l~~li~~~l~~dp~~Rps 321 (344)
T 1rjb_A 273 NPYPGIPVDA-NFYKLIQNGFKM----------------------------D--QPFYATEEIYIIMQSCWAFDSRKRPS 321 (344)
T ss_dssp CSSTTCCCSH-HHHHHHHTTCCC----------------------------C--CCTTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred CCcccCCcHH-HHHHHHhcCCCC----------------------------C--CCCCCCHHHHHHHHHHcCCCchhCcC
Confidence 9986432111 111111100000 0 00123456899999999999999999
Q ss_pred HHHHHHHHHHHHHHH
Q 045798 981 MTNVVHELQSVKNIL 995 (1008)
Q Consensus 981 ~~evl~~L~~i~~~~ 995 (1008)
+.|+++.|+.+.+..
T Consensus 322 ~~~l~~~l~~~~~~~ 336 (344)
T 1rjb_A 322 FPNLTSFLGCQLADA 336 (344)
T ss_dssp HHHHHHHHHHHC---
T ss_pred HHHHHHHHHHHHHHH
Confidence 999999999886653
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=371.49 Aligned_cols=263 Identities=20% Similarity=0.209 Sum_probs=206.0
Q ss_pred HHHHHHHhcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEecccc---chhhHHHHHHHHHHhhcCCCCceeeeecccc
Q 045798 676 YKSLLKATNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC---EGASKSFMAECKALKNIRHRNLVKVITSCSS 752 (1008)
Q Consensus 676 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 752 (1008)
+.++....++|++.++||+|+||+||+|++..+++.||+|+++... ......+.+|+.++..++||||++++++|
T Consensus 66 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~-- 143 (437)
T 4aw2_A 66 VKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAF-- 143 (437)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEE--
T ss_pred hhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEE--
Confidence 3445556789999999999999999999999899999999996421 22234589999999999999999999994
Q ss_pred ccccCCceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeee
Q 045798 753 IDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILL 832 (1008)
Q Consensus 753 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll 832 (1008)
.+++..|+||||+++|+|.+++..... .+++..++.++.||+.||+|||+. +||||||||+|||+
T Consensus 144 ---~~~~~~~lV~Ey~~gg~L~~~l~~~~~---------~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl 208 (437)
T 4aw2_A 144 ---QDDNNLYLVMDYYVGGDLLTLLSKFED---------RLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILM 208 (437)
T ss_dssp ---ECSSEEEEEECCCTTCBHHHHHHTTTT---------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEE
T ss_pred ---eeCCEEEEEEecCCCCcHHHHHHHccC---------CCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeE
Confidence 566779999999999999999976321 689999999999999999999998 99999999999999
Q ss_pred cCCCCeEEcccCcccccccccCccccccccccccccccCccccC-----CCCCCcccchhhHHHHHHHHHhCCCCCCccc
Q 045798 833 DNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGL-----GSEVSTNGDVYSYGILLLEMVTAKKPTDVMF 907 (1008)
Q Consensus 833 ~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwslG~vl~elltG~~pf~~~~ 907 (1008)
+.++.+||+|||+|+........ .....+||+.|+|||++. ...++.++|||||||++|||++|+.||....
T Consensus 209 ~~~g~vkL~DFGla~~~~~~~~~---~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~ 285 (437)
T 4aw2_A 209 DMNGHIRLADFGSCLKLMEDGTV---QSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAES 285 (437)
T ss_dssp CTTSCEEECCCTTCEECCTTSCE---ECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred cCCCCEEEcchhhhhhcccCCCc---ccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999765433221 122356999999999986 5678999999999999999999999986421
Q ss_pred cCCccHHHHHHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCC--CCCHHHHH
Q 045798 908 EGDLNLHNFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQD--RMNMTNVV 985 (1008)
Q Consensus 908 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~evl 985 (1008)
..+ ....... .. ....++... ...+.++.+++.+|+..+|++ ||+++|++
T Consensus 286 ~~~-~~~~i~~------------~~------------~~~~~p~~~---~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil 337 (437)
T 4aw2_A 286 LVE-TYGKIMN------------HK------------ERFQFPTQV---TDVSENAKDLIRRLICSREHRLGQNGIEDFK 337 (437)
T ss_dssp HHH-HHHHHHT------------HH------------HHCCCCSSC---CCSCHHHHHHHHTTSSCGGGCTTTTTTHHHH
T ss_pred hhH-HHHhhhh------------cc------------ccccCCccc---ccCCHHHHHHHHHHhcccccccCCCCHHHHh
Confidence 110 0000000 00 000000000 013455789999999988888 99999987
Q ss_pred H
Q 045798 986 H 986 (1008)
Q Consensus 986 ~ 986 (1008)
+
T Consensus 338 ~ 338 (437)
T 4aw2_A 338 K 338 (437)
T ss_dssp T
T ss_pred C
Confidence 6
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-39 Score=345.84 Aligned_cols=251 Identities=21% Similarity=0.236 Sum_probs=204.0
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccchhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceEE
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKA 762 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 762 (1008)
.++|++.+.||+|+||.||+|.+..+++.||+|++........+.+.+|++++++++||||+++++++ ..+...+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~~ 82 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETF-----EDNTDIY 82 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECSSEEE
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEE-----ecCCeEE
Confidence 46799999999999999999999989999999999866556678899999999999999999999995 5567799
Q ss_pred EEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeee---cCCCCeE
Q 045798 763 IVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILL---DNDLSGH 839 (1008)
Q Consensus 763 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~k 839 (1008)
+||||+++++|.+++.... .+++..++.++.|++.||+|||+. +|+||||||+||++ +.++.+|
T Consensus 83 lv~e~~~~~~L~~~~~~~~----------~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~ 149 (277)
T 3f3z_A 83 LVMELCTGGELFERVVHKR----------VFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLK 149 (277)
T ss_dssp EEEECCCSCBHHHHHHHHC----------SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEE
T ss_pred EEEeccCCCcHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEE
Confidence 9999999999999887543 689999999999999999999998 99999999999999 7889999
Q ss_pred EcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHh
Q 045798 840 IGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARM 919 (1008)
Q Consensus 840 L~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~ 919 (1008)
|+|||.+........ .....||+.|+|||++.+. ++.++||||||+++|||++|+.||......+ ........
T Consensus 150 l~Dfg~~~~~~~~~~-----~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~ 222 (277)
T 3f3z_A 150 LIDFGLAARFKPGKM-----MRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSE-VMLKIREG 222 (277)
T ss_dssp ECCCTTCEECCTTSC-----BCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHC
T ss_pred EEecccceeccCccc-----hhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHH-HHHHHHhC
Confidence 999999986543322 1234589999999998664 8999999999999999999999986432110 00000000
Q ss_pred hCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 920 ALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 920 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
.. .. +.......+..+.+++.+||+.||++|||+.|+++
T Consensus 223 ~~------------~~----------------~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 223 TF------------TF----------------PEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp CC------------CC----------------CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred CC------------CC----------------CchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00 00 00001123556899999999999999999999986
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-39 Score=354.26 Aligned_cols=271 Identities=24% Similarity=0.350 Sum_probs=211.2
Q ss_pred hcCCCCCceEeeccCeeEEEEEE-----cCCCeEEEEEEeccccc-hhhHHHHHHHHHHhhc-CCCCceeeeeccccccc
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGAL-----DEDGIVVAIKVINLQCE-GASKSFMAECKALKNI-RHRNLVKVITSCSSIDF 755 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~-----~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 755 (1008)
.++|++.+.||+|+||.||+|.+ ..+++.||+|+++.... ...+.+.+|+++++++ +||||+++++++
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~----- 96 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGAC----- 96 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEE-----
Confidence 46899999999999999999985 34678999999975433 4457899999999999 999999999995
Q ss_pred cCCceEEEEEeccCCCChhcccccCCCCCC--------CcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCC
Q 045798 756 QGNDFKAIVYEYMPNGSLEKWLHPHAVPKR--------DKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKP 827 (1008)
Q Consensus 756 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~--------~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp 827 (1008)
..++..++||||+++|+|.+++........ .......+++..++.++.||+.||+|||+. +|+||||||
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp 173 (313)
T 1t46_A 97 TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAA 173 (313)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSG
T ss_pred ecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCcc
Confidence 445668999999999999999976542100 001122589999999999999999999998 999999999
Q ss_pred CCeeecCCCCeEEcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCcc
Q 045798 828 SNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT-AKKPTDVM 906 (1008)
Q Consensus 828 ~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-G~~pf~~~ 906 (1008)
+||+++.++.+||+|||.+.......... ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||...
T Consensus 174 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~ 251 (313)
T 1t46_A 174 RNILLTHGRITKICDFGLARDIKNDSNYV--VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM 251 (313)
T ss_dssp GGEEEETTTEEEECCCGGGSCTTSCTTSE--ECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred ceEEEcCCCCEEEccccccccccccccce--eccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcc
Confidence 99999999999999999998765443221 1223457889999999988899999999999999999999 99998643
Q ss_pred ccCCccHHHHHHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 907 FEGDLNLHNFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 907 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
.... ............ . .....+..+.+++.+||+.||.+|||+.|+++
T Consensus 252 ~~~~-~~~~~~~~~~~~--------~----------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 300 (313)
T 1t46_A 252 PVDS-KFYKMIKEGFRM--------L----------------------SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (313)
T ss_dssp CSSH-HHHHHHHHTCCC--------C----------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cchh-HHHHHhccCCCC--------C----------------------CcccCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 2211 111111100000 0 00123456899999999999999999999999
Q ss_pred HHHHHHHH
Q 045798 987 ELQSVKNI 994 (1008)
Q Consensus 987 ~L~~i~~~ 994 (1008)
.|+++...
T Consensus 301 ~L~~~~~~ 308 (313)
T 1t46_A 301 LIEKQISE 308 (313)
T ss_dssp HHHHHHHH
T ss_pred HHHHHHHH
Confidence 99887653
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-39 Score=358.98 Aligned_cols=250 Identities=22% Similarity=0.278 Sum_probs=201.1
Q ss_pred HhcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEecccc---chhhHHHHHHHHHHhhc-CCCCceeeeeccccccccC
Q 045798 682 ATNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC---EGASKSFMAECKALKNI-RHRNLVKVITSCSSIDFQG 757 (1008)
Q Consensus 682 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~ 757 (1008)
..++|++.+.||+|+||.||+|++..+++.||+|+++... ....+.+.+|.+++..+ +||+|++++++ +..
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~-----~~~ 92 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSC-----FQT 92 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEE-----EEC
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEE-----EEc
Confidence 3578999999999999999999998889999999997432 23456788999999988 89999999998 456
Q ss_pred CceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCC
Q 045798 758 NDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLS 837 (1008)
Q Consensus 758 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 837 (1008)
.+..|+||||+++|+|.+++.... .+++..++.++.||+.||+|||+. +|+||||||+||+++.++.
T Consensus 93 ~~~~~lv~E~~~gg~L~~~l~~~~----------~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ 159 (353)
T 2i0e_A 93 MDRLYFVMEYVNGGDLMYHIQQVG----------RFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGH 159 (353)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHHS----------SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSC
T ss_pred CCEEEEEEeCCCCCcHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCc
Confidence 678999999999999999997543 689999999999999999999998 9999999999999999999
Q ss_pred eEEcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHH
Q 045798 838 GHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFA 917 (1008)
Q Consensus 838 ~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~ 917 (1008)
+||+|||+++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ......
T Consensus 160 vkL~DFG~a~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~-~~~~~i- 233 (353)
T 2i0e_A 160 IKIADFGMCKENIWDGV----TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED-ELFQSI- 233 (353)
T ss_dssp EEECCCTTCBCCCCTTC----CBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHH-
T ss_pred EEEEeCCcccccccCCc----ccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHH-HHHHHH-
Confidence 99999999985332221 123456999999999999999999999999999999999999998642110 000000
Q ss_pred HhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCH-----HHHHH
Q 045798 918 RMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNM-----TNVVH 986 (1008)
Q Consensus 918 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~-----~evl~ 986 (1008)
..... .++ ...+.++.+++.+||+.||.+||++ +|+++
T Consensus 234 -----------~~~~~--------------~~p------~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 234 -----------MEHNV--------------AYP------KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp -----------HHCCC--------------CCC------TTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred -----------HhCCC--------------CCC------CCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 00000 000 1234567899999999999999964 56554
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-39 Score=348.87 Aligned_cols=264 Identities=23% Similarity=0.381 Sum_probs=207.3
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcC---CCeEEEEEEecccc-chhhHHHHHHHHHHhhcCCCCceeeeeccccccccCC
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDE---DGIVVAIKVINLQC-EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGN 758 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 758 (1008)
.++|.+.+.||+|+||.||+|.+.. ++..||+|+++... ....+.+.+|++++++++||||+++++++. .
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~------~ 84 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIE------E 84 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEEC------S
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEc------C
Confidence 5689999999999999999998753 34569999997543 345678999999999999999999999853 2
Q ss_pred ceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCe
Q 045798 759 DFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSG 838 (1008)
Q Consensus 759 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 838 (1008)
+..++||||+++++|.+++..... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+
T Consensus 85 ~~~~~v~e~~~~~~L~~~l~~~~~---------~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~ 152 (281)
T 3cc6_A 85 EPTWIIMELYPYGELGHYLERNKN---------SLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECV 152 (281)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHTT---------TCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEE
T ss_pred CCCEEEEecCCCCCHHHHHHhccc---------cCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcE
Confidence 346899999999999999975431 589999999999999999999998 99999999999999999999
Q ss_pred EEcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCccccCCccHHHHH
Q 045798 839 HIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT-AKKPTDVMFEGDLNLHNFA 917 (1008)
Q Consensus 839 kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-G~~pf~~~~~~~~~~~~~~ 917 (1008)
||+|||.+.......... .....+++.|+|||++.+..++.++||||||+++|||++ |+.||......+ .....
T Consensus 153 kl~Dfg~~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~--~~~~~ 227 (281)
T 3cc6_A 153 KLGDFGLSRYIEDEDYYK---ASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD--VIGVL 227 (281)
T ss_dssp EECCCCGGGCC------------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGG--HHHHH
T ss_pred EeCccCCCcccccccccc---cccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHH--HHHHH
Confidence 999999998665432211 222347889999999988889999999999999999998 999986432211 11110
Q ss_pred HhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHHHHHHHHHHH
Q 045798 918 RMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHELQSVKNILLE 997 (1008)
Q Consensus 918 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~i~~~~~~ 997 (1008)
..... .+ ....++..+.+++.+||+.||++|||+.|+++.|+++.....+
T Consensus 228 ~~~~~--------------------------~~----~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~~ 277 (281)
T 3cc6_A 228 EKGDR--------------------------LP----KPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQMEKD 277 (281)
T ss_dssp HHTCC--------------------------CC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHH
T ss_pred hcCCC--------------------------CC----CCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHhhhh
Confidence 00000 00 0011345688999999999999999999999999999887766
Q ss_pred HH
Q 045798 998 LE 999 (1008)
Q Consensus 998 ~~ 999 (1008)
+.
T Consensus 278 i~ 279 (281)
T 3cc6_A 278 IA 279 (281)
T ss_dssp HH
T ss_pred hh
Confidence 53
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=361.06 Aligned_cols=272 Identities=22% Similarity=0.349 Sum_probs=209.6
Q ss_pred HhcCCCCCceEeeccCeeEEEEEEc-----CCCeEEEEEEecccc-chhhHHHHHHHHHHhhcCCCCceeeeeccccccc
Q 045798 682 ATNGFSSTHLIGVGSFGCVYKGALD-----EDGIVVAIKVINLQC-EGASKSFMAECKALKNIRHRNLVKVITSCSSIDF 755 (1008)
Q Consensus 682 ~~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 755 (1008)
..++|++.+.||+|+||.||+|++. .+++.||||+++... ....+.+.+|++++++++||||++++++|
T Consensus 45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~----- 119 (343)
T 1luf_A 45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC----- 119 (343)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-----
T ss_pred cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-----
Confidence 4678999999999999999999996 345899999997543 34457899999999999999999999995
Q ss_pred cCCceEEEEEeccCCCChhcccccCCCCCC--------------CcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCce
Q 045798 756 QGNDFKAIVYEYMPNGSLEKWLHPHAVPKR--------------DKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPIL 821 (1008)
Q Consensus 756 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~--------------~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iv 821 (1008)
..++..++||||+++|+|.+++........ .......+++.+++.++.||+.||+|||++ +|+
T Consensus 120 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~iv 196 (343)
T 1luf_A 120 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFV 196 (343)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCC
T ss_pred ccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---Cee
Confidence 445678999999999999999976432100 000013789999999999999999999998 999
Q ss_pred eccCCCCCeeecCCCCeEEcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHh-CC
Q 045798 822 HCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT-AK 900 (1008)
Q Consensus 822 H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-G~ 900 (1008)
||||||+||+++.++.+||+|||+++......... ......+|+.|+|||++.+..++.++|||||||++|||++ |.
T Consensus 197 H~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~ 274 (343)
T 1luf_A 197 HRDLATRNCLVGENMVVKIADFGLSRNIYSADYYK--ADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL 274 (343)
T ss_dssp CSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC------CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTC
T ss_pred cCCCCcceEEECCCCeEEEeecCCCcccccCcccc--ccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCC
Confidence 99999999999999999999999998654332111 1223457899999999988889999999999999999999 99
Q ss_pred CCCCccccCCccHHHHHHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCC
Q 045798 901 KPTDVMFEGDLNLHNFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMN 980 (1008)
Q Consensus 901 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt 980 (1008)
.||...... ..... +.+..... . ...++.++.+++.+||+.||.+|||
T Consensus 275 ~p~~~~~~~-----~~~~~--------~~~~~~~~-------------~------~~~~~~~l~~li~~~l~~~p~~Rps 322 (343)
T 1luf_A 275 QPYYGMAHE-----EVIYY--------VRDGNILA-------------C------PENCPLELYNLMRLCWSKLPADRPS 322 (343)
T ss_dssp CTTTTSCHH-----HHHHH--------HHTTCCCC-------------C------CTTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred CcCCCCChH-----HHHHH--------HhCCCcCC-------------C------CCCCCHHHHHHHHHHcccCcccCCC
Confidence 998642110 01000 00000000 0 0123456899999999999999999
Q ss_pred HHHHHHHHHHHHHHH
Q 045798 981 MTNVVHELQSVKNIL 995 (1008)
Q Consensus 981 ~~evl~~L~~i~~~~ 995 (1008)
+.|+++.|+++....
T Consensus 323 ~~~~~~~L~~~~~~~ 337 (343)
T 1luf_A 323 FCSIHRILQRMCERA 337 (343)
T ss_dssp HHHHHHHHHHTTC--
T ss_pred HHHHHHHHHHHHhhh
Confidence 999999999876543
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=361.61 Aligned_cols=271 Identities=23% Similarity=0.382 Sum_probs=211.7
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcC-------CCeEEEEEEecccc-chhhHHHHHHHHHHhhc-CCCCceeeeeccccc
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDE-------DGIVVAIKVINLQC-EGASKSFMAECKALKNI-RHRNLVKVITSCSSI 753 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~ 753 (1008)
.++|.+.+.||+|+||.||+|++.. .+..||||+++... ....+.+.+|+++++++ +||||++++++|
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~--- 144 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC--- 144 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE---
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeee---
Confidence 4689999999999999999999742 34689999997543 34457899999999999 999999999995
Q ss_pred cccCCceEEEEEeccCCCChhcccccCCCCCCC------cccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCC
Q 045798 754 DFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRD------KEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKP 827 (1008)
Q Consensus 754 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~------~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp 827 (1008)
..++..++||||+++|+|.+++......... ......+++.+++.++.||+.||+|||+. +|+||||||
T Consensus 145 --~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp 219 (382)
T 3tt0_A 145 --TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAA 219 (382)
T ss_dssp --CSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCG
T ss_pred --ccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCc
Confidence 4556689999999999999999765421100 01122699999999999999999999998 999999999
Q ss_pred CCeeecCCCCeEEcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCcc
Q 045798 828 SNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT-AKKPTDVM 906 (1008)
Q Consensus 828 ~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-G~~pf~~~ 906 (1008)
+||+++.++.+||+|||+++......... ......+|+.|+|||++.+..++.++|||||||++|||++ |..||...
T Consensus 220 ~NIll~~~~~~kL~DFG~a~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~ 297 (382)
T 3tt0_A 220 RNVLVTEDNVMKIADFGLARDIHHIDYYK--KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV 297 (382)
T ss_dssp GGEEECTTCCEEECSCSCCCCSSCCCTTC--CCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred ceEEEcCCCcEEEcccCcccccccccccc--cccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999998665432211 1223457889999999999999999999999999999999 99998632
Q ss_pred ccCCccHHHHHHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 907 FEGDLNLHNFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 907 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
.. ..... .+..... .. ....++.++.+++.+||+.||++|||++||++
T Consensus 298 ~~-----~~~~~---------~~~~~~~--------------~~----~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 345 (382)
T 3tt0_A 298 PV-----EELFK---------LLKEGHR--------------MD----KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 345 (382)
T ss_dssp CH-----HHHHH---------HHHTTCC--------------CC----CCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CH-----HHHHH---------HHHcCCC--------------CC----CCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 11 01100 0000000 00 00123456899999999999999999999999
Q ss_pred HHHHHHHHH
Q 045798 987 ELQSVKNIL 995 (1008)
Q Consensus 987 ~L~~i~~~~ 995 (1008)
.|+++....
T Consensus 346 ~L~~~~~~~ 354 (382)
T 3tt0_A 346 DLDRIVALT 354 (382)
T ss_dssp HHHHHHHHS
T ss_pred HHHHHHHHH
Confidence 999987663
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=353.92 Aligned_cols=277 Identities=23% Similarity=0.385 Sum_probs=207.9
Q ss_pred hcCCCCCceEeeccCeeEEEEE----EcCCCeEEEEEEecccc-chhhHHHHHHHHHHhhcCCCCceeeeeccccccccC
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGA----LDEDGIVVAIKVINLQC-EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQG 757 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~----~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 757 (1008)
.+.|++.+.||+|+||.||+|+ ...+++.||+|+++... ....+.+.+|++++++++||||+++++++.. ..
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~ 96 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTE---DG 96 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-----
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEec---CC
Confidence 3468999999999999999999 45688999999997443 3345789999999999999999999999653 33
Q ss_pred CceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCC
Q 045798 758 NDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLS 837 (1008)
Q Consensus 758 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 837 (1008)
....++||||+++|+|.+++..... .+++..++.++.|++.||+|||+. +|+||||||+||+++.++.
T Consensus 97 ~~~~~lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~ 164 (302)
T 4e5w_A 97 GNGIKLIMEFLPSGSLKEYLPKNKN---------KINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQ 164 (302)
T ss_dssp -CCEEEEEECCTTCBHHHHHHHHTT---------TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTE
T ss_pred CceEEEEEEeCCCCcHHHHHHhccc---------cCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCC
Confidence 3568999999999999999954431 689999999999999999999998 9999999999999999999
Q ss_pred eEEcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHH
Q 045798 838 GHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFA 917 (1008)
Q Consensus 838 ~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~ 917 (1008)
+||+|||.+.......... .......+|..|+|||++.+..++.++||||+|+++|||++|+.|+..... .+.
T Consensus 165 ~kl~Dfg~~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~ 237 (302)
T 4e5w_A 165 VKIGDFGLTKAIETDKEYY-TVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMA------LFL 237 (302)
T ss_dssp EEECCCTTCEECCTTCCEE-ECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHH------HHH
T ss_pred EEECcccccccccCCCcce-eccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhh------HHh
Confidence 9999999998765443221 222334588899999999888999999999999999999999998643211 111
Q ss_pred HhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHHHHHH
Q 045798 918 RMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHELQSVK 992 (1008)
Q Consensus 918 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~i~ 992 (1008)
....+........ ............ +....++..+.+++.+||+.||.+|||+.|+++.|+++.
T Consensus 238 ~~~~~~~~~~~~~-------~~~~~~~~~~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 238 KMIGPTHGQMTVT-------RLVNTLKEGKRL----PCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp HHHCSCCGGGHHH-------HHHHHHHTTCCC----CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred hccCCcccccCHH-------HHHHHHhccCCC----CCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 1111110000000 000000000000 011234567899999999999999999999999999874
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-39 Score=359.70 Aligned_cols=247 Identities=23% Similarity=0.260 Sum_probs=195.5
Q ss_pred CceEeeccCeeEEEEEEcCCCeEEEEEEeccccchhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceEEEEEecc
Q 045798 689 THLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKAIVYEYM 768 (1008)
Q Consensus 689 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 768 (1008)
.+.||+|+||.||+|.+..+|+.||+|+++.......+.+.+|++++++++||||+++++++ ...+..++||||+
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~-----~~~~~~~lv~E~~ 168 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAF-----ESKNDIVLVMEYV 168 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSSEEEEEEECC
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEE-----EECCEEEEEEeCC
Confidence 56899999999999999889999999999876556677899999999999999999999995 4566799999999
Q ss_pred CCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeee--cCCCCeEEcccCcc
Q 045798 769 PNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILL--DNDLSGHIGDFGLA 846 (1008)
Q Consensus 769 ~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll--~~~~~~kL~Dfg~a 846 (1008)
++++|.+++.... ..+++..++.++.||+.||+|||+. +|+||||||+||++ +.++.+||+|||++
T Consensus 169 ~~~~L~~~l~~~~---------~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a 236 (373)
T 2x4f_A 169 DGGELFDRIIDES---------YNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLA 236 (373)
T ss_dssp TTCEEHHHHHHTG---------GGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSC
T ss_pred CCCcHHHHHHhcC---------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCc
Confidence 9999999886542 1689999999999999999999998 99999999999999 56789999999999
Q ss_pred cccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCcchh
Q 045798 847 RFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMALPNQVM 926 (1008)
Q Consensus 847 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 926 (1008)
+........ ....||+.|+|||++.+..++.++|||||||++|||++|+.||...... ..........+.
T Consensus 237 ~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~-~~~~~i~~~~~~---- 306 (373)
T 2x4f_A 237 RRYKPREKL-----KVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDA-ETLNNILACRWD---- 306 (373)
T ss_dssp EECCTTCBC-----CCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHH-HHHHHHHHTCCC----
T ss_pred eecCCcccc-----ccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhccCC----
Confidence 866443221 2245899999999999989999999999999999999999998643211 011111111000
Q ss_pred hhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 927 DIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 927 ~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
.. .......+.++.+++.+||+.||.+|||++|+++
T Consensus 307 --------~~----------------~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 307 --------LE----------------DEEFQDISEEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp --------SC----------------SGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred --------CC----------------hhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00 0001123456899999999999999999999987
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=345.83 Aligned_cols=252 Identities=19% Similarity=0.273 Sum_probs=203.0
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEecccc--chhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCce
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC--EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDF 760 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 760 (1008)
.++|++.+.||+|+||.||+|.+..+++.||+|++.... ....+.+.+|++++++++||||+++++++ ..++.
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~ 79 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI-----QEESF 79 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECSSE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEE-----EcCCE
Confidence 578999999999999999999999899999999997542 33456789999999999999999999994 55667
Q ss_pred EEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCC---
Q 045798 761 KAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLS--- 837 (1008)
Q Consensus 761 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~--- 837 (1008)
.++||||+++++|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.
T Consensus 80 ~~~v~e~~~~~~l~~~~~~~~----------~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~ 146 (284)
T 3kk8_A 80 HYLVFDLVTGGELFEDIVARE----------FYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAA 146 (284)
T ss_dssp EEEEECCCCSCBHHHHHHHHS----------SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCC
T ss_pred EEEEEecCCCCCHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCc
Confidence 899999999999998886543 689999999999999999999998 9999999999999976655
Q ss_pred eEEcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHH
Q 045798 838 GHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFA 917 (1008)
Q Consensus 838 ~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~ 917 (1008)
+||+|||.+........ .....||+.|+|||++.+..++.++||||+|+++|+|++|+.||....... ......
T Consensus 147 ~kl~Dfg~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-~~~~~~ 220 (284)
T 3kk8_A 147 VKLADFGLAIEVNDSEA-----WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR-LYAQIK 220 (284)
T ss_dssp EEECCCTTCEECCSSCB-----CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHH
T ss_pred EEEeeceeeEEcccCcc-----ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhH-HHHHHH
Confidence 99999999976543322 123458999999999999999999999999999999999999986421110 000000
Q ss_pred HhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 918 RMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 918 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
..... .+.+.....+.++.+++.+||+.||++|||++|+++
T Consensus 221 ~~~~~----------------------------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 221 AGAYD----------------------------YPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp HTCCC----------------------------CCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred hcccc----------------------------CCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 00000 000001123456789999999999999999999987
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-39 Score=355.03 Aligned_cols=278 Identities=24% Similarity=0.358 Sum_probs=210.0
Q ss_pred CCCCceEeeccCeeEEEEEE----cCCCeEEEEEEecccc-chhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCce
Q 045798 686 FSSTHLIGVGSFGCVYKGAL----DEDGIVVAIKVINLQC-EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDF 760 (1008)
Q Consensus 686 y~~~~~lg~G~~g~Vy~~~~----~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 760 (1008)
|++.+.||+|+||+||+|.. ..+++.||||+++... ....+.+.+|++++++++||||+++++++.. .+...
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---~~~~~ 109 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCED---AGAAS 109 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE---TTTTE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEec---CCCce
Confidence 48999999999999988765 3478999999998543 3445779999999999999999999999653 33567
Q ss_pred EEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEE
Q 045798 761 KAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHI 840 (1008)
Q Consensus 761 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 840 (1008)
.++||||+++|+|.+++... .+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||
T Consensus 110 ~~lv~e~~~~~~L~~~l~~~-----------~~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl 175 (318)
T 3lxp_A 110 LQLVMEYVPLGSLRDYLPRH-----------SIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKI 175 (318)
T ss_dssp EEEEECCCTTCBHHHHGGGS-----------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEE
T ss_pred EEEEEecccCCcHHHHHhhC-----------CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEE
Confidence 89999999999999999754 588999999999999999999998 9999999999999999999999
Q ss_pred cccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHhh
Q 045798 841 GDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMA 920 (1008)
Q Consensus 841 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~~ 920 (1008)
+|||.+.......... .......+|..|+|||++.+..++.++||||||+++|||++|+.||........ ....
T Consensus 176 ~Dfg~a~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~-----~~~~ 249 (318)
T 3lxp_A 176 GDFGLAKAVPEGHEYY-RVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFL-----ELIG 249 (318)
T ss_dssp CCGGGCEECCTTCSEE-EC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHH-----HHHC
T ss_pred CCcccccccccccccc-ccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhh-----hhhc
Confidence 9999998765433221 122334588899999999988999999999999999999999999864321100 0000
Q ss_pred CCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHHHHHHHHHHHH
Q 045798 921 LPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHELQSVKNILLEL 998 (1008)
Q Consensus 921 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~i~~~~~~~ 998 (1008)
......... ........... .+....++.++.+++.+||+.||++|||++|+++.|+++.+.+...
T Consensus 250 ~~~~~~~~~--------~~~~~~~~~~~----~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~~ 315 (318)
T 3lxp_A 250 IAQGQMTVL--------RLTELLERGER----LPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQGQ 315 (318)
T ss_dssp SCCHHHHHH--------HHHHHHHTTCC----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHC-
T ss_pred ccccchhHH--------HHHHHHhcccC----CCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhccC
Confidence 000000000 00000000000 0011234567899999999999999999999999999998876543
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=347.71 Aligned_cols=268 Identities=22% Similarity=0.275 Sum_probs=207.9
Q ss_pred HhcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccchhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceE
Q 045798 682 ATNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFK 761 (1008)
Q Consensus 682 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 761 (1008)
..++|++.+.||+|+||.||+|++..+++.||||++.... ..+.+.+|+++++.++|++++..++.+. ..++..
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~----~~~~~~ 80 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCG----AEGDYN 80 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEE----EETTEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc--cchHHHHHHHHHHHhcCCCCCCeeeeec----CCCCce
Confidence 4578999999999999999999998899999999876432 2346889999999999988888777753 456778
Q ss_pred EEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeee---cCCCCe
Q 045798 762 AIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILL---DNDLSG 838 (1008)
Q Consensus 762 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~ 838 (1008)
++||||+ +++|.+++..... .+++..++.++.||+.||+|||++ +|+||||||+||++ +.++.+
T Consensus 81 ~lv~e~~-~~~L~~~~~~~~~---------~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~ 147 (296)
T 4hgt_A 81 VMVMELL-GPSLEDLFNFCSR---------KFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLV 147 (296)
T ss_dssp EEEEECC-CCBHHHHHHHTTS---------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCE
T ss_pred EEEEEcc-CCCHHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeE
Confidence 9999999 9999999874321 689999999999999999999998 99999999999999 788999
Q ss_pred EEcccCcccccccccCcc---ccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCc--cH
Q 045798 839 HIGDFGLARFHQEVSNST---LSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDL--NL 913 (1008)
Q Consensus 839 kL~Dfg~a~~~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~--~~ 913 (1008)
||+|||.++......... ........||+.|+|||++.+..++.++|||||||++|||++|+.||........ ..
T Consensus 148 kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~ 227 (296)
T 4hgt_A 148 YIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKY 227 (296)
T ss_dssp EECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHH
T ss_pred EEecCccceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhh
Confidence 999999998765443211 1122345699999999999999999999999999999999999999975322211 11
Q ss_pred HHHHHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHHHHHHH
Q 045798 914 HNFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHELQSVKN 993 (1008)
Q Consensus 914 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~i~~ 993 (1008)
........+.. .+ ......+.++.+++.+||+.||++|||++||++.|+++..
T Consensus 228 ~~~~~~~~~~~------------~~---------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~ 280 (296)
T 4hgt_A 228 ERISEKKMSTP------------IE---------------VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 280 (296)
T ss_dssp HHHHHHHHHSC------------HH---------------HHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHH
T ss_pred hhhhcccccch------------hh---------------hhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHH
Confidence 11111000000 00 0001235578999999999999999999999999998876
Q ss_pred HH
Q 045798 994 IL 995 (1008)
Q Consensus 994 ~~ 995 (1008)
..
T Consensus 281 ~~ 282 (296)
T 4hgt_A 281 RQ 282 (296)
T ss_dssp HH
T ss_pred Hh
Confidence 54
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=346.42 Aligned_cols=267 Identities=22% Similarity=0.274 Sum_probs=210.4
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccchhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceEE
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKA 762 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 762 (1008)
.++|++.+.||+|+||.||+|++..+++.||||++.... ..+.+.+|+++++.++|++++..+..+. ..++..+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~----~~~~~~~ 81 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCG----AEGDYNV 81 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS--SCCHHHHHHHHHHHHTTSTTCCCEEEEE----EETTEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc--chhHHHHHHHHHHHhhcCCCCCcccccc----CCCCceE
Confidence 578999999999999999999998899999999986542 2356899999999999988877776653 4566789
Q ss_pred EEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeee---cCCCCeE
Q 045798 763 IVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILL---DNDLSGH 839 (1008)
Q Consensus 763 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~k 839 (1008)
+||||+ +++|.+++..... .+++..++.++.|++.||+|||++ +|+||||||+||++ +.++.+|
T Consensus 82 lv~e~~-~~~L~~~~~~~~~---------~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~k 148 (296)
T 3uzp_A 82 MVMELL-GPSLEDLFNFCSR---------KFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVY 148 (296)
T ss_dssp EEEECC-CCBHHHHHHHTTT---------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEE
T ss_pred EEEEec-CCCHHHHHHhhcc---------CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEE
Confidence 999999 9999999974321 689999999999999999999998 99999999999999 4888999
Q ss_pred EcccCcccccccccCccc---cccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCC--ccHH
Q 045798 840 IGDFGLARFHQEVSNSTL---SSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGD--LNLH 914 (1008)
Q Consensus 840 L~Dfg~a~~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~--~~~~ 914 (1008)
|+|||.+........... .......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ....
T Consensus 149 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~ 228 (296)
T 3uzp_A 149 IIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYE 228 (296)
T ss_dssp ECCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHH
T ss_pred EeeCCCcccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhh
Confidence 999999987654432111 11234569999999999999999999999999999999999999997532211 1111
Q ss_pred HHHHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHHHHHHHH
Q 045798 915 NFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHELQSVKNI 994 (1008)
Q Consensus 915 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~i~~~ 994 (1008)
.......... .+ ......+.++.+++.+||+.||.+|||++||++.|+++...
T Consensus 229 ~~~~~~~~~~------------~~---------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 281 (296)
T 3uzp_A 229 RISEKKMSTP------------IE---------------VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 281 (296)
T ss_dssp HHHHHHHHSC------------HH---------------HHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHH
T ss_pred hhcccccCCc------------hH---------------HHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHh
Confidence 1111000000 00 00012346689999999999999999999999999988665
Q ss_pred H
Q 045798 995 L 995 (1008)
Q Consensus 995 ~ 995 (1008)
.
T Consensus 282 ~ 282 (296)
T 3uzp_A 282 Q 282 (296)
T ss_dssp T
T ss_pred c
Confidence 3
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=365.88 Aligned_cols=208 Identities=26% Similarity=0.317 Sum_probs=173.1
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccc--cchhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCce
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQ--CEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDF 760 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 760 (1008)
.++|++.+.||+|+||.||+|.+..+++.||||+++.. .....+++.+|++++++++||||+++++++..........
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 56899999999999999999999999999999999743 2344578999999999999999999999976554444477
Q ss_pred EEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEE
Q 045798 761 KAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHI 840 (1008)
Q Consensus 761 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 840 (1008)
.|+||||++ ++|.+++.... .+++..++.++.||+.||+|||+. +|+||||||+||+++.++.+||
T Consensus 105 ~~lv~e~~~-~~L~~~~~~~~----------~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL 170 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKTPI----------FLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKV 170 (432)
T ss_dssp EEEEEECCS-EEHHHHHHSSC----------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEE
T ss_pred EEEEEecCC-cCHHHHHhccC----------CCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEE
Confidence 999999994 69999997643 689999999999999999999998 9999999999999999999999
Q ss_pred cccCcccccccccCcc------------------ccccccccccccccCcccc-CCCCCCcccchhhHHHHHHHHHhCCC
Q 045798 841 GDFGLARFHQEVSNST------------------LSSSVGVKGTIGYTAPEYG-LGSEVSTNGDVYSYGILLLEMVTAKK 901 (1008)
Q Consensus 841 ~Dfg~a~~~~~~~~~~------------------~~~~~~~~gt~~y~aPE~~-~~~~~~~~sDvwslG~vl~elltG~~ 901 (1008)
+|||+|+......... .......+||+.|+|||++ .+..++.++||||+||++|||++|..
T Consensus 171 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~ 250 (432)
T 3n9x_A 171 CDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQ 250 (432)
T ss_dssp CCCTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCT
T ss_pred ccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccc
Confidence 9999998765432210 0112446799999999985 55679999999999999999999766
Q ss_pred CCC
Q 045798 902 PTD 904 (1008)
Q Consensus 902 pf~ 904 (1008)
||.
T Consensus 251 p~~ 253 (432)
T 3n9x_A 251 SHI 253 (432)
T ss_dssp TTC
T ss_pred ccc
Confidence 654
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=350.95 Aligned_cols=252 Identities=20% Similarity=0.261 Sum_probs=203.8
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccch------hhHHHHHHHHHHhhcCCCCceeeeecccccccc
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEG------ASKSFMAECKALKNIRHRNLVKVITSCSSIDFQ 756 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 756 (1008)
.++|++.+.||+|+||.||+|.+..+++.||+|+++..... ..+.+.+|++++++++||||+++++++ .
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~ 85 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVY-----E 85 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEE-----E
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEE-----e
Confidence 45799999999999999999999989999999999754321 356799999999999999999999994 5
Q ss_pred CCceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCC
Q 045798 757 GNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDL 836 (1008)
Q Consensus 757 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 836 (1008)
.++..++||||+++++|.+++.... .+++..++.++.|++.||+|||+. +|+||||||+||+++.++
T Consensus 86 ~~~~~~lv~e~~~~~~L~~~l~~~~----------~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~ 152 (321)
T 2a2a_A 86 NRTDVVLILELVSGGELFDFLAQKE----------SLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKN 152 (321)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHTCS----------CEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTT
T ss_pred cCCEEEEEEEcCCCCcHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCC
Confidence 5677999999999999999997643 689999999999999999999998 999999999999999887
Q ss_pred ----CeEEcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCcc
Q 045798 837 ----SGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLN 912 (1008)
Q Consensus 837 ----~~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~ 912 (1008)
.+||+|||.+........ .....||+.|+|||++.+..++.++|||||||++|+|++|+.||......
T Consensus 153 ~~~~~~kl~Dfg~~~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--- 224 (321)
T 2a2a_A 153 IPIPHIKLIDFGLAHEIEDGVE-----FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ--- 224 (321)
T ss_dssp SSSCCEEECCCTTCEECCTTCC-----CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH---
T ss_pred CCcCCEEEccCccceecCcccc-----ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHH---
Confidence 799999999986654321 12345899999999999999999999999999999999999998642111
Q ss_pred HHHHHHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 913 LHNFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 913 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
..... +.........+ .....+..+.+++.+||+.||++|||++|+++
T Consensus 225 -~~~~~---------i~~~~~~~~~~----------------~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 225 -ETLAN---------ITSVSYDFDEE----------------FFSHTSELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp -HHHHH---------HHTTCCCCCHH----------------HHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred -HHHHH---------HHhcccccChh----------------hhcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 00000 00000000000 00123456789999999999999999999987
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=379.18 Aligned_cols=258 Identities=24% Similarity=0.432 Sum_probs=209.2
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccchhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceEE
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKA 762 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 762 (1008)
.++|++.+.||+|+||.||+|.+..++..||||+++... ...+.|.+|++++++++||||++++++| ...+..+
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~-----~~~~~~~ 292 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVC-----TREPPFY 292 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEE-----CSSSSCE
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEE-----ecCCcEE
Confidence 456888999999999999999998889999999997543 3457899999999999999999999996 4456689
Q ss_pred EEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEcc
Q 045798 763 IVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGD 842 (1008)
Q Consensus 763 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 842 (1008)
+||||+++|+|.+++...... .+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|
T Consensus 293 lv~E~~~~g~L~~~l~~~~~~--------~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~D 361 (495)
T 1opk_A 293 IITEFMTYGNLLDYLRECNRQ--------EVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVAD 361 (495)
T ss_dssp EEEECCTTCBHHHHHHHSCTT--------TSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECC
T ss_pred EEEEccCCCCHHHHHHhcCcC--------CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEee
Confidence 999999999999999764321 689999999999999999999998 999999999999999999999999
Q ss_pred cCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCccccCCccHHHHHHhhC
Q 045798 843 FGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT-AKKPTDVMFEGDLNLHNFARMAL 921 (1008)
Q Consensus 843 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-G~~pf~~~~~~~~~~~~~~~~~~ 921 (1008)
||+++....... .......++..|+|||++.+..++.++|||||||++|||++ |..||...... ..
T Consensus 362 FG~a~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~--~~-------- 428 (495)
T 1opk_A 362 FGLSRLMTGDTY---TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS--QV-------- 428 (495)
T ss_dssp TTCEECCTTCCE---ECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG--GH--------
T ss_pred cccceeccCCce---eecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHH--HH--------
Confidence 999986643221 11223446789999999988899999999999999999999 99998643211 00
Q ss_pred CcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHHHHHH
Q 045798 922 PNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHELQSVK 992 (1008)
Q Consensus 922 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~i~ 992 (1008)
...+..... +. ....++..+.+++.+||+.||++|||+.||++.|+.+.
T Consensus 429 ----~~~~~~~~~--------------~~----~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~ 477 (495)
T 1opk_A 429 ----YELLEKDYR--------------ME----RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 477 (495)
T ss_dssp ----HHHHHTTCC--------------CC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred ----HHHHHcCCC--------------CC----CCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 011110000 00 01124567899999999999999999999999998873
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=342.58 Aligned_cols=254 Identities=22% Similarity=0.305 Sum_probs=204.9
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEecccc-chhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceE
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC-EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFK 761 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 761 (1008)
.++|++.+.||+|+||.||+|.+..+++.||+|+++... ....+.+.+|+.+++.++||||+++++++ ..++..
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~ 80 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR-----REGNIQ 80 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEE-----EETTEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEE-----EcCCEE
Confidence 467999999999999999999998899999999997443 34457899999999999999999999985 456678
Q ss_pred EEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEc
Q 045798 762 AIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIG 841 (1008)
Q Consensus 762 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 841 (1008)
++||||+++++|.+++.... .+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~----------~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~ 147 (276)
T 2yex_A 81 YLFLEYCSGGELFDRIEPDI----------GMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKIS 147 (276)
T ss_dssp EEEEECCTTEEGGGGSBTTT----------BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEEC
T ss_pred EEEEEecCCCcHHHHHhhcc----------CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEe
Confidence 99999999999999997543 689999999999999999999998 99999999999999999999999
Q ss_pred ccCcccccccccCccccccccccccccccCccccCCCCC-CcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHhh
Q 045798 842 DFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEV-STNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMA 920 (1008)
Q Consensus 842 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~~ 920 (1008)
|||.+......... .......||+.|+|||++.+..+ +.++||||||+++|||++|+.||............+....
T Consensus 148 dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~ 225 (276)
T 2yex_A 148 DFGLATVFRYNNRE--RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK 225 (276)
T ss_dssp CCTTCEECEETTEE--CCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTC
T ss_pred eCCCccccCCCcch--hcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcc
Confidence 99999865433211 11223468999999999988765 7799999999999999999999975433222222211100
Q ss_pred CCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 921 LPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 921 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
.. .......+..+.+++.+||+.||.+|||++|+++
T Consensus 226 ~~------------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 226 TY------------------------------LNPWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp TT------------------------------STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred cc------------------------------cCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 00 0001123456789999999999999999999975
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-39 Score=353.38 Aligned_cols=277 Identities=21% Similarity=0.258 Sum_probs=199.2
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccc--hhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCce
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCE--GASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDF 760 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 760 (1008)
.++|++.+.||+|+||.||+|.+..+++.||+|++..... ...+.+.+|++++++++||||+++++++ ..++.
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~ 76 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVF-----RRKRR 76 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----EETTE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhhee-----ecCCe
Confidence 3679999999999999999999998899999999865432 3356788999999999999999999995 45667
Q ss_pred EEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEE
Q 045798 761 KAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHI 840 (1008)
Q Consensus 761 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 840 (1008)
.++||||+++++|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||
T Consensus 77 ~~lv~e~~~~~~l~~~~~~~~----------~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl 143 (311)
T 4agu_A 77 LHLVFEYCDHTVLHELDRYQR----------GVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKL 143 (311)
T ss_dssp EEEEEECCSEEHHHHHHHTSS----------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEE
T ss_pred EEEEEEeCCCchHHHHHhhhc----------CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEE
Confidence 999999999999999876543 689999999999999999999998 9999999999999999999999
Q ss_pred cccCcccccccccCccccccccccccccccCccccCC-CCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHh
Q 045798 841 GDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLG-SEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARM 919 (1008)
Q Consensus 841 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~ 919 (1008)
+|||.+......... .....||..|+|||++.+ ..++.++||||+||++|+|++|+.||......+.. ......
T Consensus 144 ~Dfg~~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-~~~~~~ 218 (311)
T 4agu_A 144 CDFGFARLLTGPSDY----YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQL-YLIRKT 218 (311)
T ss_dssp CCCTTCEECC----------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH-HHHHHH
T ss_pred eeCCCchhccCcccc----cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHHH
Confidence 999999866533221 123458999999999876 56899999999999999999999998643221111 111000
Q ss_pred h--CCcchhhhhc-ccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 920 A--LPNQVMDIVD-PILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 920 ~--~~~~~~~~~d-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
. ..+....... ........ .................+..+.+++.+||+.||.+|||++|+++
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 284 (311)
T 4agu_A 219 LGDLIPRHQQVFSTNQYFSGVK----IPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH 284 (311)
T ss_dssp HCSCCHHHHHHHHTCGGGTTCC----CCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred hcccccccccccccccccccCc----CCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 0 0000000000 00000000 00000000000001134556899999999999999999999986
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-39 Score=355.01 Aligned_cols=260 Identities=23% Similarity=0.352 Sum_probs=203.1
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeE----EEEEEecccc-chhhHHHHHHHHHHhhcCCCCceeeeeccccccccC
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIV----VAIKVINLQC-EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQG 757 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~----vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 757 (1008)
.++|++.+.||+|+||.||+|.+..+++. ||+|++.... ......+.+|+.++++++||||++++++|.
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~------ 85 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP------ 85 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC------
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc------
Confidence 35789999999999999999999777764 7788775332 233456889999999999999999999853
Q ss_pred CceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCC
Q 045798 758 NDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLS 837 (1008)
Q Consensus 758 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 837 (1008)
++..++||||+++|+|.+++..... .+++..++.++.||+.||+|||+. +|+||||||+||+++.++.
T Consensus 86 ~~~~~~v~e~~~~~~L~~~l~~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~ 153 (325)
T 3kex_A 86 GSSLQLVTQYLPLGSLLDHVRQHRG---------ALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQ 153 (325)
T ss_dssp BSSEEEEEECCTTCBSHHHHHSSGG---------GSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSC
T ss_pred CCccEEEEEeCCCCCHHHHHHHccc---------cCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCe
Confidence 3458999999999999999976421 688899999999999999999998 9999999999999999999
Q ss_pred eEEcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCccccCCccHHHH
Q 045798 838 GHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT-AKKPTDVMFEGDLNLHNF 916 (1008)
Q Consensus 838 ~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-G~~pf~~~~~~~~~~~~~ 916 (1008)
+||+|||+++.......... .....+|..|+|||++.+..++.++|||||||++|||++ |+.||...... .....
T Consensus 154 ~kl~Dfg~a~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~~~~ 229 (325)
T 3kex_A 154 VQVADFGVADLLPPDDKQLL--YSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLA--EVPDL 229 (325)
T ss_dssp EEECSCSGGGGSCCCTTCCC-------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTT--HHHHH
T ss_pred EEECCCCcccccCccccccc--ccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHH--HHHHH
Confidence 99999999987654432221 223457889999999998899999999999999999999 99998743211 11111
Q ss_pred HHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHHHHHHHH
Q 045798 917 ARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHELQSVKNI 994 (1008)
Q Consensus 917 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~i~~~ 994 (1008)
...... .. ....++.++.+++.+||+.||.+|||+.|+++.|+++...
T Consensus 230 ~~~~~~----------~~--------------------~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~ 277 (325)
T 3kex_A 230 LEKGER----------LA--------------------QPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARD 277 (325)
T ss_dssp HHTTCB----------CC--------------------CCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTS
T ss_pred HHcCCC----------CC--------------------CCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 110000 00 0001233468899999999999999999999999887543
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=368.45 Aligned_cols=248 Identities=25% Similarity=0.362 Sum_probs=202.6
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEecccc---chhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCc
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC---EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGND 759 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 759 (1008)
.++|.+.+.||+|+||.||+|++..+|+.||||+++... ....+.+.+|+++++.++||||+++++++ ...+
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~-----~~~~ 89 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVI-----STPS 89 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSS
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EECC
Confidence 467999999999999999999998899999999996432 23346789999999999999999999994 4566
Q ss_pred eEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeE
Q 045798 760 FKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGH 839 (1008)
Q Consensus 760 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 839 (1008)
..++||||+++|+|.+++...+ .+++..++.++.||+.||+|||+. +|+||||||+||+++.++.+|
T Consensus 90 ~~~lv~E~~~gg~L~~~l~~~~----------~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vk 156 (476)
T 2y94_A 90 DIFMVMEYVSGGELFDYICKNG----------RLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAK 156 (476)
T ss_dssp EEEEEEECCSSEEHHHHTTSSS----------SCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEE
T ss_pred EEEEEEeCCCCCcHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeE
Confidence 7999999999999999997654 689999999999999999999998 999999999999999999999
Q ss_pred EcccCcccccccccCccccccccccccccccCccccCCCCC-CcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHH
Q 045798 840 IGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEV-STNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFAR 918 (1008)
Q Consensus 840 L~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~ 918 (1008)
|+|||++........ .....||+.|+|||++.+..+ +.++||||+||++|||++|+.||...... ....
T Consensus 157 L~DFG~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~-----~~~~ 226 (476)
T 2y94_A 157 IADFGLSNMMSDGEF-----LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVP-----TLFK 226 (476)
T ss_dssp ECCCSSCEECCTTCC-----BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSH-----HHHH
T ss_pred EEeccchhhcccccc-----ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHH-----HHHH
Confidence 999999986644221 123469999999999988765 68999999999999999999998642110 0000
Q ss_pred hhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 919 MALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 919 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
.+.+.... .+ ...+.++.+++.+||+.||.+|||++|+++
T Consensus 227 --------~i~~~~~~--------------~p------~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 227 --------KICDGIFY--------------TP------QYLNPSVISLLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp --------HHHTTCCC--------------CC------TTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred --------HHhcCCcC--------------CC------ccCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence 00000000 00 012345789999999999999999999987
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=362.10 Aligned_cols=253 Identities=21% Similarity=0.231 Sum_probs=193.6
Q ss_pred HhcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEecccc--------chhhHHHHHHHHHHhhcCCCCceeeeeccccc
Q 045798 682 ATNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC--------EGASKSFMAECKALKNIRHRNLVKVITSCSSI 753 (1008)
Q Consensus 682 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 753 (1008)
..++|.+.+.||+|+||.||+|.+..+++.||||++.... ......+.+|++++++++||||+++++++.
T Consensus 133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-- 210 (419)
T 3i6u_A 133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-- 210 (419)
T ss_dssp HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE--
T ss_pred hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe--
Confidence 4678999999999999999999999999999999986432 112235889999999999999999999842
Q ss_pred cccCCceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeec
Q 045798 754 DFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLD 833 (1008)
Q Consensus 754 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~ 833 (1008)
.+..++||||+++|+|.+++.... .+++..++.++.|++.||+|||+. +|+||||||+||+++
T Consensus 211 ----~~~~~lv~e~~~~g~L~~~l~~~~----------~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~ 273 (419)
T 3i6u_A 211 ----AEDYYIVLELMEGGELFDKVVGNK----------RLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLS 273 (419)
T ss_dssp ----SSEEEEEEECCTTCBGGGGTSSSC----------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEES
T ss_pred ----cCceEEEEEcCCCCcHHHHHhccC----------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEe
Confidence 334799999999999999987654 789999999999999999999998 999999999999997
Q ss_pred CC---CCeEEcccCcccccccccCccccccccccccccccCccccCC---CCCCcccchhhHHHHHHHHHhCCCCCCccc
Q 045798 834 ND---LSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLG---SEVSTNGDVYSYGILLLEMVTAKKPTDVMF 907 (1008)
Q Consensus 834 ~~---~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwslG~vl~elltG~~pf~~~~ 907 (1008)
.+ +.+||+|||+|+....... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||....
T Consensus 274 ~~~~~~~~kl~DFG~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~ 348 (419)
T 3i6u_A 274 SQEEDCLIKITDFGHSKILGETSL-----MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHR 348 (419)
T ss_dssp SSSSSCCEEECCSSTTTSCC----------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCS
T ss_pred cCCCcceEEEeecccceecCCCcc-----ccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCc
Confidence 54 4599999999987643321 223568999999999864 568889999999999999999999997432
Q ss_pred cCCccHHHHHHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 908 EGDLNLHNFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 908 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
............... ..++ .....+..+.+++.+||+.||++|||++|+++
T Consensus 349 ~~~~~~~~i~~~~~~------------~~~~----------------~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 349 TQVSLKDQITSGKYN------------FIPE----------------VWAEVSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp SSCCHHHHHHTTCCC------------CCHH----------------HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred chHHHHHHHhcCCCC------------CCch----------------hhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 221111111110000 0000 01123556899999999999999999999987
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-39 Score=346.86 Aligned_cols=249 Identities=22% Similarity=0.350 Sum_probs=200.4
Q ss_pred HhcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEecccc---chhhHHHHHHHHHHhhcCCCCceeeeeccccccccCC
Q 045798 682 ATNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC---EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGN 758 (1008)
Q Consensus 682 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 758 (1008)
+.++|++.+.||+|+||.||+|.+..+++.||+|++.... ......+.+|+.++++++||||+++++++ .+.
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~ 81 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF-----HDA 81 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECS
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheE-----ecC
Confidence 3568999999999999999999999899999999986432 22346789999999999999999999995 556
Q ss_pred ceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCe
Q 045798 759 DFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSG 838 (1008)
Q Consensus 759 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 838 (1008)
+..++||||+++++|.+++.... .+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+
T Consensus 82 ~~~~lv~e~~~~~~l~~~l~~~~----------~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~ 148 (279)
T 3fdn_A 82 TRVYLILEYAPLGTVYRELQKLS----------KFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGEL 148 (279)
T ss_dssp SEEEEEECCCTTEEHHHHHHHHS----------SCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCE
T ss_pred CEEEEEEecCCCCcHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCE
Confidence 77999999999999999987543 689999999999999999999997 99999999999999999999
Q ss_pred EEcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHH
Q 045798 839 HIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFAR 918 (1008)
Q Consensus 839 kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~ 918 (1008)
||+|||++........ ....|++.|+|||.+.+..++.++||||||+++|+|++|+.||......+ .......
T Consensus 149 ~l~Dfg~~~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~ 221 (279)
T 3fdn_A 149 KIADFGWSVHAPSSRR------TDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE-TYKRISR 221 (279)
T ss_dssp EECSCCEESCC--------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHHHHHH
T ss_pred EEEeccccccCCcccc------cccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHH-HHHHHHh
Confidence 9999999865433221 23458999999999999999999999999999999999999986321100 0000000
Q ss_pred hhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 045798 919 MALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHE 987 (1008)
Q Consensus 919 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 987 (1008)
... .++ ...+..+.+++.+||+.||.+|||++|+++.
T Consensus 222 ~~~--------------------------~~~------~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 222 VEF--------------------------TFP------DFVTEGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp TCC--------------------------CCC------TTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred CCC--------------------------CCC------CcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 000 000 1134457899999999999999999999874
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-39 Score=353.96 Aligned_cols=251 Identities=22% Similarity=0.270 Sum_probs=180.0
Q ss_pred CceEeeccCeeEEEEEEcCCCeEEEEEEeccccchhhHHHHHHHHHHhhcC-CCCceeeeeccccccccCCceEEEEEec
Q 045798 689 THLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIR-HRNLVKVITSCSSIDFQGNDFKAIVYEY 767 (1008)
Q Consensus 689 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~lv~e~ 767 (1008)
.+.||+|+||.||+|.+..+++.||||++... ....+.+|+.+++.+. ||||+++++++ .++...++||||
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~-----~~~~~~~lv~e~ 87 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVF-----HDQLHTFLVMEL 87 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEE-----ECSSEEEEEECC
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEE-----EcCCEEEEEEEc
Confidence 47899999999999999989999999999643 4467889999999996 99999999994 566779999999
Q ss_pred cCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCC---CeEEcccC
Q 045798 768 MPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDL---SGHIGDFG 844 (1008)
Q Consensus 768 ~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~kL~Dfg 844 (1008)
+++|+|.+++.... .+++.++..++.||+.||+|||+. +|+||||||+||+++.++ .+||+|||
T Consensus 88 ~~~~~L~~~l~~~~----------~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg 154 (325)
T 3kn6_A 88 LNGGELFERIKKKK----------HFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFG 154 (325)
T ss_dssp CCSCBHHHHHHHCS----------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCT
T ss_pred cCCCcHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccc
Confidence 99999999997654 789999999999999999999998 999999999999997765 89999999
Q ss_pred cccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCcc
Q 045798 845 LARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMALPNQ 924 (1008)
Q Consensus 845 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~~~~~~ 924 (1008)
+++........ .....||+.|+|||++.+..++.++|||||||++|+|++|+.||........ ...
T Consensus 155 ~a~~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~----------~~~ 220 (325)
T 3kn6_A 155 FARLKPPDNQP----LKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLT----------CTS 220 (325)
T ss_dssp TCEECCC--------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-----------------CCC
T ss_pred cceecCCCCCc----ccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccc----------ccc
Confidence 99865433221 2234589999999999999999999999999999999999999974322100 000
Q ss_pred hhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 925 VMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 925 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
..+......... ...........+.++.+++.+||+.||.+|||++|+++
T Consensus 221 ~~~~~~~i~~~~------------~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 270 (325)
T 3kn6_A 221 AVEIMKKIKKGD------------FSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY 270 (325)
T ss_dssp HHHHHHHHTTTC------------CCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred HHHHHHHHHcCC------------CCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence 011111111000 00011112234567899999999999999999999873
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=350.80 Aligned_cols=275 Identities=21% Similarity=0.368 Sum_probs=201.1
Q ss_pred HHhcCCCCCceEeeccCeeEEEEEEcC---CCeEEEEEEecccc--chhhHHHHHHHHHHhhcCCCCceeeeeccccccc
Q 045798 681 KATNGFSSTHLIGVGSFGCVYKGALDE---DGIVVAIKVINLQC--EGASKSFMAECKALKNIRHRNLVKVITSCSSIDF 755 (1008)
Q Consensus 681 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 755 (1008)
...++|.+.+.||+|+||.||+|.+.. +++.||+|+++... ....+.+.+|++++++++||||+++++++.....
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 110 (313)
T 3brb_A 31 IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSS 110 (313)
T ss_dssp CCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC---
T ss_pred cCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccc
Confidence 345789999999999999999998854 45689999997542 3445679999999999999999999999765443
Q ss_pred cCCceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCC
Q 045798 756 QGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDND 835 (1008)
Q Consensus 756 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~ 835 (1008)
......++||||+++|+|.+++....... ....+++..++.++.||+.||+|||+. +|+||||||+||+++.+
T Consensus 111 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~----~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~ 183 (313)
T 3brb_A 111 QGIPKPMVILPFMKYGDLHTYLLYSRLET----GPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDD 183 (313)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHTTBTT----SCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTT
T ss_pred cCCcccEEEEecccCCCHHHHHHHhhhhc----CCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCC
Confidence 33345799999999999999985432111 012689999999999999999999998 99999999999999999
Q ss_pred CCeEEcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCccccCCccHH
Q 045798 836 LSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT-AKKPTDVMFEGDLNLH 914 (1008)
Q Consensus 836 ~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-G~~pf~~~~~~~~~~~ 914 (1008)
+.+||+|||++.......... ......+++.|+|||.+.+..++.++||||||+++|||++ |..||....... ..
T Consensus 184 ~~~kl~Dfg~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--~~ 259 (313)
T 3brb_A 184 MTVCVADFGLSKKIYSGDYYR--QGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE--MY 259 (313)
T ss_dssp SCEEECSCSCC------------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG--HH
T ss_pred CcEEEeecCcceecccccccC--cccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHH--HH
Confidence 999999999998654432111 1223347889999999999999999999999999999999 888886432111 10
Q ss_pred HHHHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHHHHHHHH
Q 045798 915 NFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHELQSVKNI 994 (1008)
Q Consensus 915 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~i~~~ 994 (1008)
......... . ....++..+.+++.+||+.||.+|||+.++++.|+++.+.
T Consensus 260 ~~~~~~~~~------------------------~------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~ 309 (313)
T 3brb_A 260 DYLLHGHRL------------------------K------QPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLES 309 (313)
T ss_dssp HHHHTTCCC------------------------C------CBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHcCCCC------------------------C------CCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 000000000 0 0012345689999999999999999999999999998876
Q ss_pred HH
Q 045798 995 LL 996 (1008)
Q Consensus 995 ~~ 996 (1008)
..
T Consensus 310 lp 311 (313)
T 3brb_A 310 LP 311 (313)
T ss_dssp C-
T ss_pred cC
Confidence 44
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-39 Score=354.00 Aligned_cols=281 Identities=21% Similarity=0.279 Sum_probs=215.2
Q ss_pred CHHHHHHHhcCCCCCceEeeccCeeEEEEEE-----cCCCeEEEEEEeccccc-hhhHHHHHHHHHHhhc-CCCCceeee
Q 045798 675 SYKSLLKATNGFSSTHLIGVGSFGCVYKGAL-----DEDGIVVAIKVINLQCE-GASKSFMAECKALKNI-RHRNLVKVI 747 (1008)
Q Consensus 675 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-----~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~ 747 (1008)
.........++|++.+.||+|+||.||+|.+ ..+++.||||+++.... ...+.+.+|+++++++ +||||++++
T Consensus 18 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 97 (316)
T 2xir_A 18 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 97 (316)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEE
Confidence 4444455578999999999999999999985 34678999999975433 3456799999999999 799999999
Q ss_pred eccccccccCCceEEEEEeccCCCChhcccccCCCCCCC------cccccccCHHHHHHHHHHHHHHHHHHhhCCCCCce
Q 045798 748 TSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRD------KEIEIKLTLLQRISIAIDVASALDYLHHHCQEPIL 821 (1008)
Q Consensus 748 ~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~------~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iv 821 (1008)
+++. ..+...++||||+++|+|.+++......... ......+++..++.++.|++.||+|||+. +|+
T Consensus 98 ~~~~----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~ 170 (316)
T 2xir_A 98 GACT----KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCI 170 (316)
T ss_dssp EEEC----CTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCC
T ss_pred EEEe----cCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---Ccc
Confidence 9864 3345589999999999999999765421000 00011389999999999999999999998 999
Q ss_pred eccCCCCCeeecCCCCeEEcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHh-CC
Q 045798 822 HCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT-AK 900 (1008)
Q Consensus 822 H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-G~ 900 (1008)
||||||+||+++.++.+||+|||.++......... ......+|+.|+|||++.+..++.++|||||||++|||++ |.
T Consensus 171 H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~ 248 (316)
T 2xir_A 171 HRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV--RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA 248 (316)
T ss_dssp CSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSE--EETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred cccCccceEEECCCCCEEECCCccccccccCccce--eccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCC
Confidence 99999999999999999999999998664432221 1223457889999999988899999999999999999998 99
Q ss_pred CCCCccccCCccHHHHHHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCC
Q 045798 901 KPTDVMFEGDLNLHNFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMN 980 (1008)
Q Consensus 901 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt 980 (1008)
.||............... ..... . ....+.++.+++.+||+.||.+|||
T Consensus 249 ~p~~~~~~~~~~~~~~~~-~~~~~------------------------~------~~~~~~~l~~li~~~l~~dp~~Rps 297 (316)
T 2xir_A 249 SPYPGVKIDEEFCRRLKE-GTRMR------------------------A------PDYTTPEMYQTMLDCWHGEPSQRPT 297 (316)
T ss_dssp CSSTTCCCSHHHHHHHHH-TCCCC------------------------C------CTTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred CCCcccchhHHHHHHhcc-CccCC------------------------C------CCCCCHHHHHHHHHHcCCChhhCcC
Confidence 998643211111111100 00000 0 0113446789999999999999999
Q ss_pred HHHHHHHHHHHHHHH
Q 045798 981 MTNVVHELQSVKNIL 995 (1008)
Q Consensus 981 ~~evl~~L~~i~~~~ 995 (1008)
+.|+++.|+.+....
T Consensus 298 ~~ell~~L~~~~~~~ 312 (316)
T 2xir_A 298 FSELVEHLGNLLQAN 312 (316)
T ss_dssp HHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHhhh
Confidence 999999999987653
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=359.89 Aligned_cols=270 Identities=19% Similarity=0.252 Sum_probs=202.9
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcC---CCeEEEEEEeccccch-----------hhHHHHHHHHHHhhcCCCCceeeee
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDE---DGIVVAIKVINLQCEG-----------ASKSFMAECKALKNIRHRNLVKVIT 748 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~h~niv~~~~ 748 (1008)
.++|++.+.||+|+||.||+|.+.. ++..||+|++...... ....+.+|+..++.++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 4679999999999999999999976 7789999998754321 1234678889999999999999999
Q ss_pred ccccccccCCceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCC
Q 045798 749 SCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPS 828 (1008)
Q Consensus 749 ~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~ 828 (1008)
++... +.+....++||||+ +++|.+++.... .+++.+++.++.||+.||+|||+. +|+||||||+
T Consensus 116 ~~~~~-~~~~~~~~lv~e~~-~~~L~~~l~~~~----------~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~ 180 (345)
T 2v62_A 116 SGLTE-FKGRSYRFMVMERL-GIDLQKISGQNG----------TFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAA 180 (345)
T ss_dssp EEEEE-SSSCEEEEEEEECE-EEEHHHHCBGGG----------BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGG
T ss_pred ccccc-cCCCcEEEEEEecc-CCCHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHH
Confidence 96542 23467899999999 999999997653 689999999999999999999998 9999999999
Q ss_pred CeeecCCC--CeEEcccCcccccccccCcc---ccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCC
Q 045798 829 NILLDNDL--SGHIGDFGLARFHQEVSNST---LSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPT 903 (1008)
Q Consensus 829 NIll~~~~--~~kL~Dfg~a~~~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf 903 (1008)
||+++.++ .+||+|||+++......... ........||+.|+|||++.+..++.++|||||||++|||++|+.||
T Consensus 181 NIll~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf 260 (345)
T 2v62_A 181 NLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPW 260 (345)
T ss_dssp GEEEESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred HEEEccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCc
Confidence 99999887 99999999998765432211 11123456999999999999999999999999999999999999999
Q ss_pred CccccCCccHHHHHHh---hCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCC
Q 045798 904 DVMFEGDLNLHNFARM---ALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMN 980 (1008)
Q Consensus 904 ~~~~~~~~~~~~~~~~---~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt 980 (1008)
................ ..+....... .....+.++.+++.+||+.||++|||
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~l~~li~~~l~~dp~~Rps 315 (345)
T 2v62_A 261 EQNLKDPVAVQTAKTNLLDELPQSVLKWA-------------------------PSGSSCCEIAQFLVCAHSLAYDEKPN 315 (345)
T ss_dssp GGGTTCHHHHHHHHHHHHHTTTHHHHHHS-------------------------CTTSCCHHHHHHHHHHHTCCTTCCCC
T ss_pred cccccccHHHHHHHHhhcccccHHHHhhc-------------------------cccccHHHHHHHHHHHhhcCcccCCC
Confidence 6432221111111100 0010000000 00024557899999999999999999
Q ss_pred HHHHHHHHHHHH
Q 045798 981 MTNVVHELQSVK 992 (1008)
Q Consensus 981 ~~evl~~L~~i~ 992 (1008)
+++|++.|+++.
T Consensus 316 ~~~l~~~L~~~~ 327 (345)
T 2v62_A 316 YQALKKILNPHG 327 (345)
T ss_dssp HHHHHHHHCTTC
T ss_pred HHHHHHHHhccC
Confidence 999999998653
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=362.92 Aligned_cols=207 Identities=25% Similarity=0.382 Sum_probs=166.3
Q ss_pred HhcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccc--cchhhHHHHHHHHHHhhcC-CCCceeeeeccccccccCC
Q 045798 682 ATNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQ--CEGASKSFMAECKALKNIR-HRNLVKVITSCSSIDFQGN 758 (1008)
Q Consensus 682 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~ 758 (1008)
..++|++.+.||+|+||.||+|.+..+++.||||++... .......+.+|+.+++++. ||||+++++++.. .+.
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~---~~~ 83 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRA---DND 83 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC---TTS
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEec---CCC
Confidence 467899999999999999999999999999999998643 2345567889999999996 9999999999653 344
Q ss_pred ceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCe
Q 045798 759 DFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSG 838 (1008)
Q Consensus 759 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 838 (1008)
...|+||||++ ++|.+++... .+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+
T Consensus 84 ~~~~lv~e~~~-~~L~~~~~~~-----------~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~ 148 (388)
T 3oz6_A 84 RDVYLVFDYME-TDLHAVIRAN-----------ILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHV 148 (388)
T ss_dssp SCEEEEEECCS-EEHHHHHHHT-----------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCE
T ss_pred CEEEEEecccC-cCHHHHHHcC-----------CCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCE
Confidence 56899999996 6999988653 688999999999999999999998 99999999999999999999
Q ss_pred EEcccCcccccccccCc-----------------cccccccccccccccCccccCC-CCCCcccchhhHHHHHHHHHhCC
Q 045798 839 HIGDFGLARFHQEVSNS-----------------TLSSSVGVKGTIGYTAPEYGLG-SEVSTNGDVYSYGILLLEMVTAK 900 (1008)
Q Consensus 839 kL~Dfg~a~~~~~~~~~-----------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltG~ 900 (1008)
||+|||+|+........ ........+||+.|+|||++.+ ..++.++||||+||++|||++|+
T Consensus 149 kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~ 228 (388)
T 3oz6_A 149 KVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228 (388)
T ss_dssp EECCCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSS
T ss_pred EecCCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCC
Confidence 99999999865431110 0111233569999999999876 67899999999999999999999
Q ss_pred CCCCcc
Q 045798 901 KPTDVM 906 (1008)
Q Consensus 901 ~pf~~~ 906 (1008)
+||...
T Consensus 229 ~pf~~~ 234 (388)
T 3oz6_A 229 PIFPGS 234 (388)
T ss_dssp CSCCCS
T ss_pred CCCCCC
Confidence 999643
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=374.73 Aligned_cols=257 Identities=26% Similarity=0.422 Sum_probs=206.3
Q ss_pred HhcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccchhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceE
Q 045798 682 ATNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFK 761 (1008)
Q Consensus 682 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 761 (1008)
..++|++.+.||+|+||.||+|.+. ++..||||+++... ...+.+.+|++++++++||||+++++++. .+..
T Consensus 186 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~------~~~~ 257 (454)
T 1qcf_A 186 PRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT------KEPI 257 (454)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC------SSSC
T ss_pred chHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe------CCcc
Confidence 3567889999999999999999996 67889999998643 34678999999999999999999999853 3457
Q ss_pred EEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEc
Q 045798 762 AIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIG 841 (1008)
Q Consensus 762 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 841 (1008)
++||||+++|+|.+++.... ...+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+
T Consensus 258 ~lv~e~~~~g~L~~~l~~~~--------~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~ 326 (454)
T 1qcf_A 258 YIITEFMAKGSLLDFLKSDE--------GSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIA 326 (454)
T ss_dssp EEEECCCTTCBHHHHHHSHH--------HHTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEEC
T ss_pred EEEEeecCCCcHHHHHHhcc--------CCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEe
Confidence 99999999999999997542 12578899999999999999999998 99999999999999999999999
Q ss_pred ccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCccccCCccHHHHHHhh
Q 045798 842 DFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT-AKKPTDVMFEGDLNLHNFARMA 920 (1008)
Q Consensus 842 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-G~~pf~~~~~~~~~~~~~~~~~ 920 (1008)
|||+++...... ........++..|+|||++.+..++.++|||||||++|||++ |+.||......+ ......
T Consensus 327 DFG~a~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~--~~~~i~-- 399 (454)
T 1qcf_A 327 DFGLARVIEDNE---YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE--VIRALE-- 399 (454)
T ss_dssp STTGGGGBCCHH---HHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH--HHHHHH--
T ss_pred eCCCceEcCCCc---eeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHH--HHHHHH--
Confidence 999998654321 111223346789999999988899999999999999999999 999986421110 000000
Q ss_pred CCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHHHHHH
Q 045798 921 LPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHELQSVK 992 (1008)
Q Consensus 921 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~i~ 992 (1008)
.. .+++. ...++.++.+++.+||+.||++|||+++|++.|+.+.
T Consensus 400 ----------~~--------------~~~~~----~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~ 443 (454)
T 1qcf_A 400 ----------RG--------------YRMPR----PENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFY 443 (454)
T ss_dssp ----------HT--------------CCCCC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred ----------cC--------------CCCCC----CCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHH
Confidence 00 00000 1134567899999999999999999999999998764
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-39 Score=356.75 Aligned_cols=243 Identities=23% Similarity=0.348 Sum_probs=201.6
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccc--------hhhHHHHHHHHHHhhcCCCCceeeeecccccc
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCE--------GASKSFMAECKALKNIRHRNLVKVITSCSSID 754 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 754 (1008)
.++|++.+.||+|+||.||+|++..+++.||||+++.... ...+.+.+|++++++++||||+++++++
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~---- 98 (335)
T 3dls_A 23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIF---- 98 (335)
T ss_dssp HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEE----
T ss_pred ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEE----
Confidence 5689999999999999999999999999999999975421 1334678899999999999999999994
Q ss_pred ccCCceEEEEEeccCCC-ChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeec
Q 045798 755 FQGNDFKAIVYEYMPNG-SLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLD 833 (1008)
Q Consensus 755 ~~~~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~ 833 (1008)
...+..++||||+.+| +|.+++.... .+++..++.++.||+.||+|||+. +|+||||||+||+++
T Consensus 99 -~~~~~~~lv~e~~~~g~~l~~~~~~~~----------~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~ 164 (335)
T 3dls_A 99 -ENQGFFQLVMEKHGSGLDLFAFIDRHP----------RLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIA 164 (335)
T ss_dssp -ECSSEEEEEEECCTTSCBHHHHHHTCC----------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC
T ss_pred -eeCCEEEEEEEeCCCCccHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEc
Confidence 5667799999999777 9999997654 689999999999999999999998 999999999999999
Q ss_pred CCCCeEEcccCcccccccccCccccccccccccccccCccccCCCCC-CcccchhhHHHHHHHHHhCCCCCCccccCCcc
Q 045798 834 NDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEV-STNGDVYSYGILLLEMVTAKKPTDVMFEGDLN 912 (1008)
Q Consensus 834 ~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwslG~vl~elltG~~pf~~~~~~~~~ 912 (1008)
.++.+||+|||+++........ ....||+.|+|||++.+..+ +.++|||||||++|||++|+.||....+.
T Consensus 165 ~~~~~kL~Dfg~a~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--- 236 (335)
T 3dls_A 165 EDFTIKLIDFGSAAYLERGKLF-----YTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET--- 236 (335)
T ss_dssp TTSCEEECCCTTCEECCTTCCB-----CEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG---
T ss_pred CCCcEEEeecccceECCCCCce-----eccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH---
Confidence 9999999999999866543221 23458999999999988876 78999999999999999999998642110
Q ss_pred HHHHHHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 045798 913 LHNFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHE 987 (1008)
Q Consensus 913 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 987 (1008)
....... ....+.++.+++.+||+.||++|||++|+++.
T Consensus 237 ----------------~~~~~~~--------------------~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 237 ----------------VEAAIHP--------------------PYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp ----------------TTTCCCC--------------------SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred ----------------HhhccCC--------------------CcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000000 00123457899999999999999999999874
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=354.12 Aligned_cols=281 Identities=24% Similarity=0.381 Sum_probs=213.0
Q ss_pred hcCCCCCceEeeccCeeEEEEEE----cCCCeEEEEEEeccccchhhHHHHHHHHHHhhcCCCCceeeeeccccccccCC
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGAL----DEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGN 758 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~----~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 758 (1008)
.++|++.+.||+|+||.||+|+. ..+++.||||++........+.+.+|++++++++||||+++++++.. .+.
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---~~~ 116 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYS---AGR 116 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC------
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEe---cCC
Confidence 45689999999999999999984 55789999999987666677889999999999999999999998643 233
Q ss_pred ceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCe
Q 045798 759 DFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSG 838 (1008)
Q Consensus 759 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 838 (1008)
...++||||+++++|.+++..... .+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+
T Consensus 117 ~~~~lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~ 184 (326)
T 2w1i_A 117 RNLKLIMEYLPYGSLRDYLQKHKE---------RIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRV 184 (326)
T ss_dssp -CCEEEECCCTTCBHHHHHHHSTT---------SSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEE
T ss_pred CceEEEEECCCCCCHHHHHHhccc---------CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcE
Confidence 468999999999999999976531 589999999999999999999998 99999999999999999999
Q ss_pred EEcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHH
Q 045798 839 HIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFAR 918 (1008)
Q Consensus 839 kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~ 918 (1008)
||+|||++.......... .......++..|+|||.+.+..++.++||||||+++|||++|..||..... .+..
T Consensus 185 kL~Dfg~~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~------~~~~ 257 (326)
T 2w1i_A 185 KIGDFGLTKVLPQDKEYY-KVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPA------EFMR 257 (326)
T ss_dssp EECCCTTCEECCSSCSEE-ECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHH------HHHH
T ss_pred EEecCcchhhcccccccc-ccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHH------HHHH
Confidence 999999998765443221 112234477889999999888899999999999999999999999753211 1111
Q ss_pred hhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHHHHHHHHH
Q 045798 919 MALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHELQSVKNIL 995 (1008)
Q Consensus 919 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~i~~~~ 995 (1008)
............. ..........+. +....++.++.+++.+||+.||++|||+.||++.|+++++..
T Consensus 258 ~~~~~~~~~~~~~------~~~~~~~~~~~~----~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~l 324 (326)
T 2w1i_A 258 MIGNDKQGQMIVF------HLIELLKNNGRL----PRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQM 324 (326)
T ss_dssp HHCTTCCTHHHHH------HHHHHHHTTCCC----CCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred hhccccchhhhHH------HHHHHhhcCCCC----CCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence 0000000000000 000000000000 011234567899999999999999999999999999998764
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-39 Score=353.49 Aligned_cols=270 Identities=19% Similarity=0.229 Sum_probs=208.8
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccchhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceEE
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKA 762 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 762 (1008)
.++|++.+.||+|+||.||+|.+..+++.||||++........+.+.+|++++++++||||+++++++... .......+
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~~~~~ 106 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRE-RGAKHEAW 106 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEE-ETTEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEec-cCCCceeE
Confidence 46799999999999999999999889999999999766666678899999999999999999999986531 12345789
Q ss_pred EEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEcc
Q 045798 763 IVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGD 842 (1008)
Q Consensus 763 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 842 (1008)
+||||+++|+|.+++...... ...+++.+++.++.||+.||+|||+. +|+||||||+||+++.++.+||+|
T Consensus 107 lv~e~~~~~~L~~~l~~~~~~------~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~d 177 (317)
T 2buj_A 107 LLLPFFKRGTLWNEIERLKDK------GNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMD 177 (317)
T ss_dssp EEEECCTTCBHHHHHHHHHTT------TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECC
T ss_pred EEEEeCCCCcHHHHHHHHHhc------CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEe
Confidence 999999999999998753211 11689999999999999999999998 999999999999999999999999
Q ss_pred cCcccccccccCcc-----ccccccccccccccCccccCCCC---CCcccchhhHHHHHHHHHhCCCCCCccccCCccHH
Q 045798 843 FGLARFHQEVSNST-----LSSSVGVKGTIGYTAPEYGLGSE---VSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLH 914 (1008)
Q Consensus 843 fg~a~~~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~---~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~ 914 (1008)
||.+.......... ........||+.|+|||++.+.. ++.++|||||||++|||++|+.||...........
T Consensus 178 fg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~ 257 (317)
T 2buj_A 178 LGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVA 257 (317)
T ss_dssp CSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHH
T ss_pred cCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhh
Confidence 99987553321110 00112234799999999987654 68899999999999999999999864322211111
Q ss_pred HHHHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHHHHHH
Q 045798 915 NFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHELQSVK 992 (1008)
Q Consensus 915 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~i~ 992 (1008)
...... .. . +.....+..+.+++.+||+.||.+|||++|+++.|+.+.
T Consensus 258 ~~~~~~------------~~--------------~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~ 305 (317)
T 2buj_A 258 LAVQNQ------------LS--------------I----PQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQ 305 (317)
T ss_dssp HHHHCC----------------------------C----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTC
T ss_pred HHhhcc------------CC--------------C----CccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcC
Confidence 111100 00 0 000123456899999999999999999999999998764
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=360.68 Aligned_cols=256 Identities=19% Similarity=0.230 Sum_probs=194.4
Q ss_pred hcCCCCC-ceEeeccCeeEEEEEEcCCCeEEEEEEeccccchhhHHHHHHHHHHhhc-CCCCceeeeeccccccccCCce
Q 045798 683 TNGFSST-HLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNI-RHRNLVKVITSCSSIDFQGNDF 760 (1008)
Q Consensus 683 ~~~y~~~-~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~ 760 (1008)
.++|.+. +.||+|+||+||+|.+..+++.||||+++.. ..+.+|++++.+. +||||+++++++... +.+...
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~-~~~~~~ 133 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENL-YAGRKC 133 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEE-ETTEEE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeec-ccCCcE
Confidence 4567776 6899999999999999989999999998632 4577888887554 899999999986431 234567
Q ss_pred EEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecC---CCC
Q 045798 761 KAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDN---DLS 837 (1008)
Q Consensus 761 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~~ 837 (1008)
.|+||||+++|+|.+++...... .+++..++.|+.||+.||+|||+. +|+||||||+|||++. ++.
T Consensus 134 ~~lv~E~~~gg~L~~~l~~~~~~--------~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~ 202 (400)
T 1nxk_A 134 LLIVMECLDGGELFSRIQDRGDQ--------AFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAI 202 (400)
T ss_dssp EEEEEECCCSEEHHHHHHCC-----------CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCC
T ss_pred EEEEEEeCCCCcHHHHHHHhCCC--------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCcc
Confidence 89999999999999999765321 689999999999999999999998 9999999999999987 789
Q ss_pred eEEcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCcc--HHH
Q 045798 838 GHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLN--LHN 915 (1008)
Q Consensus 838 ~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~--~~~ 915 (1008)
+||+|||+++....... .....||+.|+|||++.+..++.++|||||||++|||++|+.||......... ...
T Consensus 203 ~kl~DFG~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~ 277 (400)
T 1nxk_A 203 LKLTDFGFAKETTSHNS-----LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT 277 (400)
T ss_dssp EEECCCTTCEECC----------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHH
T ss_pred EEEEecccccccCCCCc-----cccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHH
Confidence 99999999986543221 22346899999999999999999999999999999999999999753221110 100
Q ss_pred HHHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 045798 916 FARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHE 987 (1008)
Q Consensus 916 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 987 (1008)
..... .. ....+....++.++.+++.+||+.||++|||++|+++.
T Consensus 278 ~i~~~-----------~~----------------~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 278 RIRMG-----------QY----------------EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp HHHHT-----------CC----------------CCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred HHHcC-----------cc----------------cCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 00000 00 00000111245568999999999999999999999873
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=346.94 Aligned_cols=274 Identities=25% Similarity=0.312 Sum_probs=197.4
Q ss_pred cCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccc--hhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceE
Q 045798 684 NGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCE--GASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFK 761 (1008)
Q Consensus 684 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 761 (1008)
++|++.+.||+|+||.||+|++ .+++.||+|+++.... ...+.+.+|++++++++||||+++++++ ..++..
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~ 75 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI-----HTKKRL 75 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEE-----ECSSCE
T ss_pred ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEE-----ccCCeE
Confidence 5799999999999999999998 5789999999975432 2346789999999999999999999995 456679
Q ss_pred EEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEc
Q 045798 762 AIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIG 841 (1008)
Q Consensus 762 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 841 (1008)
++||||++ ++|.+++..... .+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+
T Consensus 76 ~lv~e~~~-~~l~~~~~~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~ 142 (288)
T 1ob3_A 76 VLVFEHLD-QDLKKLLDVCEG---------GLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIA 142 (288)
T ss_dssp EEEEECCS-EEHHHHHHTSTT---------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEEC
T ss_pred EEEEEecC-CCHHHHHHhccc---------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEe
Confidence 99999996 499998875431 688999999999999999999998 99999999999999999999999
Q ss_pred ccCcccccccccCccccccccccccccccCccccCCC-CCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHhh
Q 045798 842 DFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGS-EVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMA 920 (1008)
Q Consensus 842 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~~ 920 (1008)
|||.++........ .....||+.|+|||++.+. .++.++||||+||++|||++|+.||......+. ........
T Consensus 143 Dfg~~~~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~-~~~~~~~~ 217 (288)
T 1ob3_A 143 DFGLARAFGIPVRK----YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ-LMRIFRIL 217 (288)
T ss_dssp CTTHHHHHCC-------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHH
T ss_pred ECccccccCccccc----cccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHH
Confidence 99999865432211 1234589999999998764 589999999999999999999999874322111 11111111
Q ss_pred CCcchhh--hhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 921 LPNQVMD--IVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 921 ~~~~~~~--~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
....... .....-...+. ....... +........+.++.+++.+||+.||++|||++|+++
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~----~~~~~~~-~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 218 GTPNSKNWPNVTELPKYDPN----FTVYEPL-PWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp CCCCTTTSTTGGGSTTCCTT----CCCCCCC-CGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCCChhhchhhhcccccccc----cccccCc-cHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 1000000 00000000000 0000000 000001123456789999999999999999999875
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-39 Score=356.23 Aligned_cols=267 Identities=26% Similarity=0.455 Sum_probs=203.1
Q ss_pred cCCCCCceEeeccCeeEEEEEEcCC----CeEEEEEEecccc-chhhHHHHHHHHHHhhcCCCCceeeeeccccccccCC
Q 045798 684 NGFSSTHLIGVGSFGCVYKGALDED----GIVVAIKVINLQC-EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGN 758 (1008)
Q Consensus 684 ~~y~~~~~lg~G~~g~Vy~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 758 (1008)
++|++.+.||+|+||.||+|.+..+ +..||||+++... ......+.+|++++++++||||+++++++ ...
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~ 118 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVI-----SKY 118 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-----CSS
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE-----ecC
Confidence 5677889999999999999998644 3469999997543 33456799999999999999999999995 456
Q ss_pred ceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCe
Q 045798 759 DFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSG 838 (1008)
Q Consensus 759 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 838 (1008)
+..++||||+++|+|.+++..... .+++.+++.++.||+.||+|||+. +|+||||||+||+++.++.+
T Consensus 119 ~~~~lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~ 186 (333)
T 1mqb_A 119 KPMMIITEYMENGALDKFLREKDG---------EFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVC 186 (333)
T ss_dssp SSEEEEEECCTTEEHHHHHHHTTT---------CSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCE
T ss_pred CCcEEEEeCCCCCcHHHHHHhCCC---------CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcE
Confidence 679999999999999999975421 689999999999999999999998 99999999999999999999
Q ss_pred EEcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCccccCCccHHHHH
Q 045798 839 HIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT-AKKPTDVMFEGDLNLHNFA 917 (1008)
Q Consensus 839 kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-G~~pf~~~~~~~~~~~~~~ 917 (1008)
||+|||.++.......... ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||...... ...
T Consensus 187 kl~Dfg~~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~-----~~~ 260 (333)
T 1mqb_A 187 KVSDFGLSRVLEDDPEATY-TTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH-----EVM 260 (333)
T ss_dssp EECCCCC------------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-----HHH
T ss_pred EECCCCcchhhcccccccc-ccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHH-----HHH
Confidence 9999999987654322211 1222346789999999998899999999999999999999 99998632110 000
Q ss_pred HhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHHHHHHHHHHH
Q 045798 918 RMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHELQSVKNILLE 997 (1008)
Q Consensus 918 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~i~~~~~~ 997 (1008)
. .+.... +.+ ....++..+.+++.+||+.||++||++.|+++.|+++......
T Consensus 261 ~---------~~~~~~--------------~~~----~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~~ 313 (333)
T 1mqb_A 261 K---------AINDGF--------------RLP----TPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDS 313 (333)
T ss_dssp H---------HHHTTC--------------CCC----CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGGG
T ss_pred H---------HHHCCC--------------cCC----CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcchh
Confidence 0 000000 000 0012345689999999999999999999999999998876554
Q ss_pred HHH
Q 045798 998 LET 1000 (1008)
Q Consensus 998 ~~~ 1000 (1008)
.++
T Consensus 314 ~~~ 316 (333)
T 1mqb_A 314 LKT 316 (333)
T ss_dssp GGS
T ss_pred hhh
Confidence 443
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=349.70 Aligned_cols=263 Identities=19% Similarity=0.227 Sum_probs=199.3
Q ss_pred HhcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccc---hhhHHHHHHHHHHhhcCCCCceeeeeccccccccCC
Q 045798 682 ATNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCE---GASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGN 758 (1008)
Q Consensus 682 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 758 (1008)
..++|++.+.||+|+||.||+|.+..+++.||+|+++.... ...+.+.+|+.++++++||||+++++++ ..+
T Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~-----~~~ 106 (309)
T 2h34_A 32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFG-----EID 106 (309)
T ss_dssp --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-----EET
T ss_pred EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEE-----eeC
Confidence 35789999999999999999999988999999999975422 2346799999999999999999999995 446
Q ss_pred ceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCe
Q 045798 759 DFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSG 838 (1008)
Q Consensus 759 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 838 (1008)
+..++||||+++++|.+++.... .+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+
T Consensus 107 ~~~~lv~e~~~~~~L~~~l~~~~----------~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~ 173 (309)
T 2h34_A 107 GQLYVDMRLINGVDLAAMLRRQG----------PLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFA 173 (309)
T ss_dssp TEEEEEEECCCCEEHHHHHHHHC----------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCE
T ss_pred CeEEEEEEecCCCCHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCE
Confidence 67999999999999999997543 689999999999999999999998 99999999999999999999
Q ss_pred EEcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHH
Q 045798 839 HIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFAR 918 (1008)
Q Consensus 839 kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~ 918 (1008)
||+|||++......... ......|++.|+|||++.+..++.++||||||+++|||++|+.||...... .......
T Consensus 174 kl~Dfg~~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~~~ 248 (309)
T 2h34_A 174 YLVDFGIASATTDEKLT---QLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS--VMGAHIN 248 (309)
T ss_dssp EECSCCC-------------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH--HHHHHHH
T ss_pred EEecCccCccccccccc---cccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH--HHHHHhc
Confidence 99999999865443211 122345899999999999999999999999999999999999998643111 0000000
Q ss_pred hhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCC-CHHHHHHHHHHHHHHH
Q 045798 919 MALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRM-NMTNVVHELQSVKNIL 995 (1008)
Q Consensus 919 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-t~~evl~~L~~i~~~~ 995 (1008)
...+. ........+.++.+++.+||+.||++|| +++++++.|+.+....
T Consensus 249 ~~~~~----------------------------~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~ 298 (309)
T 2h34_A 249 QAIPR----------------------------PSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATA 298 (309)
T ss_dssp SCCCC----------------------------GGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC--
T ss_pred cCCCC----------------------------ccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhh
Confidence 00000 0000112345678999999999999999 9999999998875443
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=342.17 Aligned_cols=257 Identities=24% Similarity=0.371 Sum_probs=206.8
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccchhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceEE
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKA 762 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 762 (1008)
.++|++.+.||+|+||.||+|.+. +++.||+|+++.... ..+.+.+|++++++++||||+++++++ ..++..+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~ 79 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVC-----LEQAPIC 79 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEE-----CSSSSCE
T ss_pred hhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEE-----ccCCCeE
Confidence 457899999999999999999996 788999999976533 346799999999999999999999995 4456689
Q ss_pred EEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEcc
Q 045798 763 IVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGD 842 (1008)
Q Consensus 763 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 842 (1008)
+||||+++++|.+++..... .+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|
T Consensus 80 lv~e~~~~~~L~~~~~~~~~---------~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~d 147 (267)
T 3t9t_A 80 LVTEFMEHGCLSDYLRTQRG---------LFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSD 147 (267)
T ss_dssp EEECCCTTCBHHHHHHHTTT---------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECC
T ss_pred EEEeCCCCCcHHHHHhhCcc---------cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEcc
Confidence 99999999999999976431 589999999999999999999998 999999999999999999999999
Q ss_pred cCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCccccCCccHHHHHHhhC
Q 045798 843 FGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT-AKKPTDVMFEGDLNLHNFARMAL 921 (1008)
Q Consensus 843 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-G~~pf~~~~~~~~~~~~~~~~~~ 921 (1008)
||.+....... ........++..|+|||++.+..++.++||||||+++|+|++ |+.||...... ..........
T Consensus 148 fg~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~~~~i~~~~ 222 (267)
T 3t9t_A 148 FGMTRFVLDDQ---YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS--EVVEDISTGF 222 (267)
T ss_dssp TTGGGGBCCHH---HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHHHHHTTC
T ss_pred ccccccccccc---ccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHH--HHHHHHhcCC
Confidence 99998654321 111223457889999999988889999999999999999999 89998642110 0000000000
Q ss_pred CcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHHHHHHH
Q 045798 922 PNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHELQSVKN 993 (1008)
Q Consensus 922 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~i~~ 993 (1008)
. . . .....+..+.+++.+||+.||++|||+.|+++.|+++.+
T Consensus 223 ~--------~--------------------~--~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (267)
T 3t9t_A 223 R--------L--------------------Y--KPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 264 (267)
T ss_dssp C--------C--------------------C--CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred c--------C--------------------C--CCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 0 0 0 000124567899999999999999999999999999875
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=356.63 Aligned_cols=282 Identities=22% Similarity=0.231 Sum_probs=208.8
Q ss_pred HhcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEecccc-chhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCce
Q 045798 682 ATNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC-EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDF 760 (1008)
Q Consensus 682 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 760 (1008)
..++|++.+.||+|+||.||+|.+..+++.||||++.... ....+.+.+|++++++++||||+++++++..........
T Consensus 25 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 104 (364)
T 3qyz_A 25 VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 104 (364)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred ccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence 3568999999999999999999999899999999997433 334578999999999999999999999987655555667
Q ss_pred EEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEE
Q 045798 761 KAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHI 840 (1008)
Q Consensus 761 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 840 (1008)
.++||||++ |+|.+++... .+++..++.++.||+.||+|||+. +|+||||||+||+++.++.+||
T Consensus 105 ~~iv~e~~~-~~L~~~l~~~-----------~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl 169 (364)
T 3qyz_A 105 VYIVQDLME-TDLYKLLKTQ-----------HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKI 169 (364)
T ss_dssp EEEEEECCS-EEHHHHHHHC-----------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEE
T ss_pred EEEEEcccC-cCHHHHHHhC-----------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEE
Confidence 999999995 6999988643 689999999999999999999998 9999999999999999999999
Q ss_pred cccCcccccccccCccccccccccccccccCccccCC-CCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHh
Q 045798 841 GDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLG-SEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARM 919 (1008)
Q Consensus 841 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~ 919 (1008)
+|||.++.......... ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||......+ ........
T Consensus 170 ~Dfg~a~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~~~~i~~~ 247 (364)
T 3qyz_A 170 CDFGLARVADPDHDHTG-FLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLD-QLNHILGI 247 (364)
T ss_dssp CCCTTCEECCGGGCBCC-TTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGG-HHHHHHHH
T ss_pred EeCcceEecCCCCCccc-cccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHH-HHHHHHHH
Confidence 99999986654332211 1233569999999998654 458999999999999999999999996532221 11111111
Q ss_pred hCCcchhhhhcccccCchHHhhhhhhhhhccc--cc---hhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 920 ALPNQVMDIVDPILRNDEEILASTDKCRRMQT--GI---NSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 920 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~--~~---~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
...... +.+........ .. .....+. .. ......+.++.+++.+||+.||.+|||++|+++
T Consensus 248 ~~~~~~-~~~~~~~~~~~--~~---~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 313 (364)
T 3qyz_A 248 LGSPSQ-EDLNCIINLKA--RN---YLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313 (364)
T ss_dssp HCSCCH-HHHHTCCCHHH--HH---HHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hCCCCH-HHHHHhhhhhH--HH---HHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 111111 10100000000 00 0000000 00 000123456899999999999999999999986
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-39 Score=363.34 Aligned_cols=262 Identities=21% Similarity=0.245 Sum_probs=203.8
Q ss_pred HHHHHHHhcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEecccc---chhhHHHHHHHHHHhhcCCCCceeeeecccc
Q 045798 676 YKSLLKATNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC---EGASKSFMAECKALKNIRHRNLVKVITSCSS 752 (1008)
Q Consensus 676 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 752 (1008)
+.+.....++|++.+.||+|+||.||+|+.+.+++.||+|+++... ....+.+.+|.+++..++||||++++++
T Consensus 53 ~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~--- 129 (412)
T 2vd5_A 53 LKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFA--- 129 (412)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEE---
T ss_pred hhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEE---
Confidence 3344445689999999999999999999999899999999996431 2234568899999999999999999998
Q ss_pred ccccCCceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeee
Q 045798 753 IDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILL 832 (1008)
Q Consensus 753 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll 832 (1008)
+.+++..|+||||+++|+|.+++...+. .+++..++.++.||+.||+|||+. +|+||||||+|||+
T Consensus 130 --~~~~~~~~lVmE~~~gg~L~~~l~~~~~---------~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl 195 (412)
T 2vd5_A 130 --FQDENYLYLVMEYYVGGDLLTLLSKFGE---------RIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILL 195 (412)
T ss_dssp --EECSSEEEEEECCCCSCBHHHHHHHHSS---------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEE
T ss_pred --EeeCCEEEEEEcCCCCCcHHHHHHhcCC---------CCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeee
Confidence 4567789999999999999999975421 689999999999999999999998 99999999999999
Q ss_pred cCCCCeEEcccCcccccccccCccccccccccccccccCccccC-------CCCCCcccchhhHHHHHHHHHhCCCCCCc
Q 045798 833 DNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGL-------GSEVSTNGDVYSYGILLLEMVTAKKPTDV 905 (1008)
Q Consensus 833 ~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~sDvwslG~vl~elltG~~pf~~ 905 (1008)
+.++++||+|||+++........ ......||+.|+|||++. +..++.++|||||||++|||++|+.||..
T Consensus 196 d~~g~vkL~DFGla~~~~~~~~~---~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~ 272 (412)
T 2vd5_A 196 DRCGHIRLADFGSCLKLRADGTV---RSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYA 272 (412)
T ss_dssp CTTSCEEECCCTTCEECCTTSCE---ECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred cCCCCEEEeechhheeccCCCcc---ccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCC
Confidence 99999999999999866443221 122356999999999986 45789999999999999999999999864
Q ss_pred cccCCccHHHHHHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCC---CCHH
Q 045798 906 MFEGDLNLHNFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDR---MNMT 982 (1008)
Q Consensus 906 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R---Pt~~ 982 (1008)
....+ .+....... ..+ .++. .....+.++.+++.+||. +|.+| |+++
T Consensus 273 ~~~~~-~~~~i~~~~----------~~~--------------~~p~---~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ 323 (412)
T 2vd5_A 273 DSTAE-TYGKIVHYK----------EHL--------------SLPL---VDEGVPEEARDFIQRLLC-PPETRLGRGGAG 323 (412)
T ss_dssp SSHHH-HHHHHHTHH----------HHC--------------CCC-------CCCHHHHHHHHTTSS-CGGGCTTTTTHH
T ss_pred CCHHH-HHHHHHhcc----------cCc--------------CCCc---cccCCCHHHHHHHHHHcC-ChhhcCCCCCHH
Confidence 21110 000000000 000 0000 001234567999999999 99998 5888
Q ss_pred HHHH
Q 045798 983 NVVH 986 (1008)
Q Consensus 983 evl~ 986 (1008)
|+++
T Consensus 324 ei~~ 327 (412)
T 2vd5_A 324 DFRT 327 (412)
T ss_dssp HHHT
T ss_pred HHhc
Confidence 8865
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=350.58 Aligned_cols=266 Identities=23% Similarity=0.313 Sum_probs=200.3
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccc---cchhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCc
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQ---CEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGND 759 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 759 (1008)
.++|++.+.||+|+||.||+|.+..+++.||+|+++.. .....+.+.+|++++++++||||+++++++ ..++
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~ 105 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASF-----IEDN 105 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-----EETT
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----EcCC
Confidence 46799999999999999999999889999999999743 234456799999999999999999999995 4456
Q ss_pred eEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeE
Q 045798 760 FKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGH 839 (1008)
Q Consensus 760 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 839 (1008)
..++||||+++++|.+++...... ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+|
T Consensus 106 ~~~lv~e~~~~~~L~~~l~~~~~~------~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~k 176 (310)
T 2wqm_A 106 ELNIVLELADAGDLSRMIKHFKKQ------KRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVK 176 (310)
T ss_dssp EEEEEEECCCSCBHHHHHHHHHHT------TCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEE
T ss_pred cEEEEEecCCCCCHHHHHHHhccc------ccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEE
Confidence 799999999999999998642111 11689999999999999999999998 999999999999999999999
Q ss_pred EcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHh
Q 045798 840 IGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARM 919 (1008)
Q Consensus 840 L~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~ 919 (1008)
|+|||++......... .....|++.|+|||++.+..++.++||||||+++|+|++|+.||................
T Consensus 177 l~Dfg~~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~ 252 (310)
T 2wqm_A 177 LGDLGLGRFFSSKTTA----AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQ 252 (310)
T ss_dssp ECCC----------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHT
T ss_pred EEeccceeeecCCCcc----ccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhc
Confidence 9999999865433221 123458999999999999999999999999999999999999986321111111100000
Q ss_pred -hCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHHHHHHHHHH
Q 045798 920 -ALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHELQSVKNILL 996 (1008)
Q Consensus 920 -~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~i~~~~~ 996 (1008)
..+. . .....+.++.+++.+||+.||.+|||+.||++.|+++++...
T Consensus 253 ~~~~~---------~---------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~ 300 (310)
T 2wqm_A 253 CDYPP---------L---------------------PSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTA 300 (310)
T ss_dssp TCSCC---------C---------------------CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred ccCCC---------C---------------------cccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhh
Confidence 0000 0 001234568999999999999999999999999999987654
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-39 Score=354.29 Aligned_cols=260 Identities=23% Similarity=0.396 Sum_probs=200.1
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeE----EEEEEeccc-cchhhHHHHHHHHHHhhcCCCCceeeeeccccccccC
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIV----VAIKVINLQ-CEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQG 757 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~----vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 757 (1008)
.++|++.+.||+|+||.||+|.+..+++. ||+|.++.. .....+.+.+|+.++++++||||++++++|..
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~----- 88 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT----- 88 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEES-----
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEec-----
Confidence 46799999999999999999999777764 577776533 33456789999999999999999999999642
Q ss_pred CceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCC
Q 045798 758 NDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLS 837 (1008)
Q Consensus 758 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 837 (1008)
...++|+||+++|+|.+++..... .+++..++.|+.||+.||+|||++ +|+||||||+||+++.++.
T Consensus 89 -~~~~~v~~~~~~g~L~~~l~~~~~---------~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~ 155 (327)
T 3lzb_A 89 -STVQLITQLMPFGCLLDYVREHKD---------NIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQH 155 (327)
T ss_dssp -SSEEEEECCCSSCBHHHHHHHTTT---------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTE
T ss_pred -CCceEEEEecCCCcHHHHHHhcCC---------CCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCC
Confidence 237899999999999999976532 689999999999999999999998 9999999999999999999
Q ss_pred eEEcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCccccCCccHHHH
Q 045798 838 GHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT-AKKPTDVMFEGDLNLHNF 916 (1008)
Q Consensus 838 ~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-G~~pf~~~~~~~~~~~~~ 916 (1008)
+||+|||+++......... ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||....... ....
T Consensus 156 ~kL~DfG~a~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~--~~~~ 231 (327)
T 3lzb_A 156 VKITDFGLAKLLGAEEKEY--HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--ISSI 231 (327)
T ss_dssp EEECCTTC------------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--HHHH
T ss_pred EEEccCcceeEccCccccc--cccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH--HHHH
Confidence 9999999998764433221 1223447889999999999999999999999999999999 999986432211 1111
Q ss_pred HHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHHHHHHHH
Q 045798 917 ARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHELQSVKNI 994 (1008)
Q Consensus 917 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~i~~~ 994 (1008)
..... . .+ ....++.++.+++.+||+.||.+|||+.|+++.|+++...
T Consensus 232 ~~~~~------------~--------------~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 279 (327)
T 3lzb_A 232 LEKGE------------R--------------LP----QPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp HHTTC------------C--------------CC----CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred HHcCC------------C--------------CC----CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 10000 0 00 0012344678999999999999999999999999998754
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-39 Score=360.13 Aligned_cols=251 Identities=27% Similarity=0.331 Sum_probs=192.5
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEecccc---chhhHHHHHHHHH-HhhcCCCCceeeeeccccccccCC
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC---EGASKSFMAECKA-LKNIRHRNLVKVITSCSSIDFQGN 758 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~-l~~l~h~niv~~~~~~~~~~~~~~ 758 (1008)
.++|++.+.||+|+||.||+|+++.+++.||+|+++... ......+.+|..+ ++.++||||++++++ +...
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~-----~~~~ 111 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFS-----FQTA 111 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEE-----EECS
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEE-----EEeC
Confidence 467999999999999999999999899999999997543 2334556777776 567899999999998 4567
Q ss_pred ceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCe
Q 045798 759 DFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSG 838 (1008)
Q Consensus 759 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 838 (1008)
+..|+||||+++|+|.+++.... .+++..++.++.||+.||+|||++ +|+||||||+||+++.++.+
T Consensus 112 ~~~~lv~E~~~gg~L~~~l~~~~----------~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~i 178 (373)
T 2r5t_A 112 DKLYFVLDYINGGELFYHLQRER----------CFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHI 178 (373)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHS----------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCE
T ss_pred CEEEEEEeCCCCCcHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCE
Confidence 78999999999999999997543 688999999999999999999998 99999999999999999999
Q ss_pred EEcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHH
Q 045798 839 HIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFAR 918 (1008)
Q Consensus 839 kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~ 918 (1008)
||+|||+++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ...
T Consensus 179 kL~DFG~a~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~-----~~~- 248 (373)
T 2r5t_A 179 VLTDFGLCKENIEHNS----TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA-----EMY- 248 (373)
T ss_dssp EECCCCBCGGGBCCCC----CCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHH-----HHH-
T ss_pred EEeeCccccccccCCC----ccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH-----HHH-
Confidence 9999999985332221 123456999999999999999999999999999999999999998642110 000
Q ss_pred hhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHH
Q 045798 919 MALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHEL 988 (1008)
Q Consensus 919 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 988 (1008)
..++...+ .++. ..+..+.+++.+||+.||.+||++.+.++.+
T Consensus 249 -------~~i~~~~~--------------~~~~------~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i 291 (373)
T 2r5t_A 249 -------DNILNKPL--------------QLKP------NITNSARHLLEGLLQKDRTKRLGAKDDFMEI 291 (373)
T ss_dssp -------HHHHHSCC--------------CCCS------SSCHHHHHHHHHHTCSSGGGSTTTTTTHHHH
T ss_pred -------HHHHhccc--------------CCCC------CCCHHHHHHHHHHcccCHHhCCCCCCCHHHH
Confidence 00010000 0011 1234578999999999999999986544433
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=354.18 Aligned_cols=276 Identities=22% Similarity=0.307 Sum_probs=211.9
Q ss_pred HHHhcCCCCCceEeeccCeeEEEEEEcCCC-----eEEEEEEecccc-chhhHHHHHHHHHHhhc-CCCCceeeeecccc
Q 045798 680 LKATNGFSSTHLIGVGSFGCVYKGALDEDG-----IVVAIKVINLQC-EGASKSFMAECKALKNI-RHRNLVKVITSCSS 752 (1008)
Q Consensus 680 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~-----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~ 752 (1008)
....++|++.+.||+|+||.||+|.+..++ +.||+|+++... ....+.+.+|+++++++ +||||++++++|
T Consensus 42 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~-- 119 (333)
T 2i1m_A 42 EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGAC-- 119 (333)
T ss_dssp BCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE--
T ss_pred cCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEE--
Confidence 334578999999999999999999986555 489999997543 34457799999999999 899999999995
Q ss_pred ccccCCceEEEEEeccCCCChhcccccCCCC----CCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCC
Q 045798 753 IDFQGNDFKAIVYEYMPNGSLEKWLHPHAVP----KRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPS 828 (1008)
Q Consensus 753 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~----~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~ 828 (1008)
..++..++||||+++|+|.+++...... .........+++..++.++.||+.||+|||+. +|+||||||+
T Consensus 120 ---~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~ 193 (333)
T 2i1m_A 120 ---THGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAAR 193 (333)
T ss_dssp ---CSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGG
T ss_pred ---ecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccc
Confidence 4556689999999999999998753210 00000012579999999999999999999998 9999999999
Q ss_pred CeeecCCCCeEEcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCccc
Q 045798 829 NILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT-AKKPTDVMF 907 (1008)
Q Consensus 829 NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-G~~pf~~~~ 907 (1008)
||+++.++.+||+|||++.......... ......+|+.|+|||++.+..++.++|||||||++|||++ |..||....
T Consensus 194 NIl~~~~~~~kl~Dfg~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 271 (333)
T 2i1m_A 194 NVLLTNGHVAKIGDFGLARDIMNDSNYI--VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGIL 271 (333)
T ss_dssp GCEEEGGGEEEBCCCGGGCCGGGCTTSE--ECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred eEEECCCCeEEECcccccccccccccee--ecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccc
Confidence 9999999999999999998664433221 1223457889999999988889999999999999999998 899986432
Q ss_pred cCCccHHHHHHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 045798 908 EGDLNLHNFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHE 987 (1008)
Q Consensus 908 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 987 (1008)
... ............. ....++..+.+++.+||+.||.+|||+.||++.
T Consensus 272 ~~~-~~~~~~~~~~~~~------------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 320 (333)
T 2i1m_A 272 VNS-KFYKLVKDGYQMA------------------------------QPAFAPKNIYSIMQACWALEPTHRPTFQQICSF 320 (333)
T ss_dssp SSH-HHHHHHHHTCCCC------------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hhH-HHHHHHhcCCCCC------------------------------CCCCCCHHHHHHHHHHhccChhhCcCHHHHHHH
Confidence 211 1111111100000 000124567899999999999999999999999
Q ss_pred HHHHHHHHH
Q 045798 988 LQSVKNILL 996 (1008)
Q Consensus 988 L~~i~~~~~ 996 (1008)
|+++.....
T Consensus 321 L~~~~~~~~ 329 (333)
T 2i1m_A 321 LQEQAQEDR 329 (333)
T ss_dssp HHHHHHHHH
T ss_pred HHHHHHhhh
Confidence 998876543
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=352.17 Aligned_cols=249 Identities=22% Similarity=0.277 Sum_probs=191.0
Q ss_pred hcCCCCCceEeeccCeeEEEEEEc---CCCeEEEEEEecccc----chhhHHHHHHHHHHhhcCCCCceeeeeccccccc
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALD---EDGIVVAIKVINLQC----EGASKSFMAECKALKNIRHRNLVKVITSCSSIDF 755 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 755 (1008)
.++|++.+.||+|+||.||+|+.. .+++.||+|+++... ......+.+|++++++++||||+++++++
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~----- 90 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAF----- 90 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEE-----
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEE-----
Confidence 467999999999999999999984 578999999997542 23345688999999999999999999994
Q ss_pred cCCceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCC
Q 045798 756 QGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDND 835 (1008)
Q Consensus 756 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~ 835 (1008)
..++..|+||||+++++|.+++.... .+++..++.++.||+.||+|||+. +|+||||||+||+++.+
T Consensus 91 ~~~~~~~lv~e~~~~~~L~~~l~~~~----------~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~ 157 (327)
T 3a62_A 91 QTGGKLYLILEYLSGGELFMQLEREG----------IFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQ 157 (327)
T ss_dssp ECSSCEEEEEECCTTEEHHHHHHHHS----------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTT
T ss_pred EcCCEEEEEEeCCCCCcHHHHHHhCC----------CCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCC
Confidence 55677999999999999999997543 688999999999999999999998 99999999999999999
Q ss_pred CCeEEcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHH
Q 045798 836 LSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHN 915 (1008)
Q Consensus 836 ~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~ 915 (1008)
+.+||+|||+++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ....
T Consensus 158 ~~~kl~Dfg~~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~ 232 (327)
T 3a62_A 158 GHVKLTDFGLCKESIHDGT----VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKK-TIDK 232 (327)
T ss_dssp SCEEECCCSCC--------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHH
T ss_pred CcEEEEeCCcccccccCCc----cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHH-HHHH
Confidence 9999999999975432221 1223468999999999999899999999999999999999999986431110 0000
Q ss_pred HHHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCC-----CHHHHHH
Q 045798 916 FARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRM-----NMTNVVH 986 (1008)
Q Consensus 916 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~ 986 (1008)
... ... .++ ...+.++.+++.+||+.||++|| +++|+++
T Consensus 233 i~~------------~~~--------------~~p------~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 233 ILK------------CKL--------------NLP------PYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp HHH------------TCC--------------CCC------TTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred HHh------------CCC--------------CCC------CCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 000 000 000 01345678999999999999999 6777765
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=352.00 Aligned_cols=272 Identities=22% Similarity=0.256 Sum_probs=199.6
Q ss_pred hcCCCCC-ceEeeccCeeEEEEEEcCCCeEEEEEEeccccchhhHHHHHHHHHHhhc-CCCCceeeeeccccccccCCce
Q 045798 683 TNGFSST-HLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNI-RHRNLVKVITSCSSIDFQGNDF 760 (1008)
Q Consensus 683 ~~~y~~~-~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~ 760 (1008)
.+.|++. +.||+|+||.||+|.+..+++.||||+++.......+.+.+|++++.++ +||||+++++++ ..++.
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~-----~~~~~ 85 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFF-----EEEDR 85 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEE-----EETTE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEE-----eeCCE
Confidence 3568875 7899999999999999889999999999866556677899999999985 799999999995 45677
Q ss_pred EEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCC---
Q 045798 761 KAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLS--- 837 (1008)
Q Consensus 761 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~--- 837 (1008)
.++||||+++|+|.+++.... .+++..++.++.||+.||+|||+. +|+||||||+||+++.++.
T Consensus 86 ~~lv~e~~~~~~L~~~l~~~~----------~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~ 152 (316)
T 2ac3_A 86 FYLVFEKMRGGSILSHIHKRR----------HFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSP 152 (316)
T ss_dssp EEEEEECCTTCBHHHHHHHHS----------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCS
T ss_pred EEEEEEcCCCCcHHHHHhccC----------CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCc
Confidence 999999999999999997643 689999999999999999999998 9999999999999988766
Q ss_pred eEEcccCcccccccccCc---cccccccccccccccCccccCC-----CCCCcccchhhHHHHHHHHHhCCCCCCccccC
Q 045798 838 GHIGDFGLARFHQEVSNS---TLSSSVGVKGTIGYTAPEYGLG-----SEVSTNGDVYSYGILLLEMVTAKKPTDVMFEG 909 (1008)
Q Consensus 838 ~kL~Dfg~a~~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwslG~vl~elltG~~pf~~~~~~ 909 (1008)
+||+|||++......... .........||+.|+|||++.+ ..++.++|||||||++|||++|+.||......
T Consensus 153 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~ 232 (316)
T 2ac3_A 153 VKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGS 232 (316)
T ss_dssp EEECCTTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCS
T ss_pred eEEEEccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccc
Confidence 999999999865432211 1111223458999999999865 45889999999999999999999999754332
Q ss_pred CccHHHHHHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 910 DLNLHNFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 910 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
+..+.... ..+.....+...... .....+.......+.++.+++.+||+.||++|||++|+++
T Consensus 233 ~~~~~~~~--~~~~~~~~~~~~i~~------------~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 295 (316)
T 2ac3_A 233 DCGWDRGE--ACPACQNMLFESIQE------------GKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ 295 (316)
T ss_dssp CSCC------CCHHHHHHHHHHHHH------------CCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred cccccccc--cchhHHHHHHHHHhc------------cCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 21110000 000000000000000 0000000011124567899999999999999999999987
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=352.00 Aligned_cols=272 Identities=21% Similarity=0.394 Sum_probs=209.9
Q ss_pred hcCCCCCceEeeccCeeEEEEEEc-------CCCeEEEEEEecccc-chhhHHHHHHHHHHhhc-CCCCceeeeeccccc
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALD-------EDGIVVAIKVINLQC-EGASKSFMAECKALKNI-RHRNLVKVITSCSSI 753 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~-------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~ 753 (1008)
.++|++.+.||+|+||.||+|.+. .+++.||+|+++... ....+.+.+|+++++++ +||||+++++++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~--- 110 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC--- 110 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE---
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEE---
Confidence 578999999999999999999974 356789999997543 34456799999999999 999999999995
Q ss_pred cccCCceEEEEEeccCCCChhcccccCCCCCCC------cccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCC
Q 045798 754 DFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRD------KEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKP 827 (1008)
Q Consensus 754 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~------~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp 827 (1008)
..++..++||||+++|+|.+++......... ......+++..++.++.||+.||+|||+. +|+||||||
T Consensus 111 --~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp 185 (334)
T 2pvf_A 111 --TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAA 185 (334)
T ss_dssp --CSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSG
T ss_pred --ccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCcc
Confidence 4556789999999999999999865432110 00122589999999999999999999998 999999999
Q ss_pred CCeeecCCCCeEEcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCcc
Q 045798 828 SNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT-AKKPTDVM 906 (1008)
Q Consensus 828 ~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-G~~pf~~~ 906 (1008)
+||+++.++.+||+|||+++......... ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||...
T Consensus 186 ~NIll~~~~~~kL~Dfg~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~ 263 (334)
T 2pvf_A 186 RNVLVTENNVMKIADFGLARDINNIDYYK--KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI 263 (334)
T ss_dssp GGEEECTTCCEEECCCTTCEECTTTSSEE--CCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred ceEEEcCCCCEEEcccccccccccccccc--ccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcC
Confidence 99999999999999999998665432211 1223447889999999988889999999999999999999 99998642
Q ss_pred ccCCccHHHHHHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 907 FEGDLNLHNFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 907 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
... ........... .. ....++.++.+++.+||+.||.+|||+.|+++
T Consensus 264 ~~~--~~~~~~~~~~~--------------------------~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 311 (334)
T 2pvf_A 264 PVE--ELFKLLKEGHR--------------------------MD----KPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 311 (334)
T ss_dssp CHH--HHHHHHHHTCC--------------------------CC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CHH--HHHHHHhcCCC--------------------------CC----CCccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 110 00000000000 00 00123456899999999999999999999999
Q ss_pred HHHHHHHHHH
Q 045798 987 ELQSVKNILL 996 (1008)
Q Consensus 987 ~L~~i~~~~~ 996 (1008)
.|+++.....
T Consensus 312 ~L~~l~~~~~ 321 (334)
T 2pvf_A 312 DLDRILTLTT 321 (334)
T ss_dssp HHHHHHHHHC
T ss_pred HHHHHHhccc
Confidence 9999977643
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=343.37 Aligned_cols=252 Identities=26% Similarity=0.368 Sum_probs=199.6
Q ss_pred cCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEecccc--chhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceE
Q 045798 684 NGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC--EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFK 761 (1008)
Q Consensus 684 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 761 (1008)
..|++.+.||+|+||.||+|.+..++..||+|++.... ....+.+.+|+.++++++||||+++++++... ..+....
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~~~~~ 104 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWEST-VKGKKCI 104 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEE-SSSCEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccc-cCCCceE
Confidence 34788889999999999999999899999999987432 34457799999999999999999999986532 2345678
Q ss_pred EEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCC--ceeccCCCCCeeec-CCCCe
Q 045798 762 AIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEP--ILHCDLKPSNILLD-NDLSG 838 (1008)
Q Consensus 762 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~--ivH~Dlkp~NIll~-~~~~~ 838 (1008)
++||||+++++|.+++.... .+++..++.++.||+.||+|||+. + |+||||||+||+++ .++.+
T Consensus 105 ~lv~e~~~~~~L~~~l~~~~----------~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~ 171 (290)
T 1t4h_A 105 VLVTELMTSGTLKTYLKRFK----------VMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSV 171 (290)
T ss_dssp EEEEECCCSCBHHHHHHHHS----------SCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCE
T ss_pred EEEEEecCCCCHHHHHHHcc----------CCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCE
Confidence 99999999999999997543 689999999999999999999997 7 99999999999997 78999
Q ss_pred EEcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHH
Q 045798 839 HIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFAR 918 (1008)
Q Consensus 839 kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~ 918 (1008)
||+|||++........ ....||+.|+|||++.+ .++.++||||+||++|+|++|+.||....... ....
T Consensus 172 kl~Dfg~~~~~~~~~~------~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~----~~~~ 240 (290)
T 1t4h_A 172 KIGDLGLATLKRASFA------KAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA----QIYR 240 (290)
T ss_dssp EECCTTGGGGCCTTSB------EESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH----HHHH
T ss_pred EEeeCCCccccccccc------ccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHH----HHHH
Confidence 9999999975433221 22458999999998764 58999999999999999999999986432111 1111
Q ss_pred hhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 919 MALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 919 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
...... .. .......+.++.+++.+||+.||.+|||++|+++
T Consensus 241 ~~~~~~---------~~-----------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 241 RVTSGV---------KP-----------------ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp HHTTTC---------CC-----------------GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHhccC---------Cc-----------------cccCCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 000000 00 0000112345789999999999999999999985
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=347.29 Aligned_cols=251 Identities=23% Similarity=0.265 Sum_probs=200.4
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccchhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceEE
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKA 762 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 762 (1008)
.++|.+.+.||+|+||.||+|++..+|+.||+|+++.......+.+.+|++++++++||||+++++++ ..++..+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~ 82 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIY-----ESTTHYY 82 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEE-----ECSSEEE
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhc-----ccCCEEE
Confidence 45799999999999999999999889999999999865555556789999999999999999999984 5567799
Q ss_pred EEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeee---cCCCCeE
Q 045798 763 IVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILL---DNDLSGH 839 (1008)
Q Consensus 763 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~k 839 (1008)
+||||+++++|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||++ +.++.+|
T Consensus 83 lv~e~~~~~~L~~~l~~~~----------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~k 149 (304)
T 2jam_A 83 LVMQLVSGGELFDRILERG----------VYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIM 149 (304)
T ss_dssp EEECCCCSCBHHHHHHHHS----------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEE
T ss_pred EEEEcCCCccHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEE
Confidence 9999999999999986543 689999999999999999999998 99999999999999 7889999
Q ss_pred EcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHh
Q 045798 840 IGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARM 919 (1008)
Q Consensus 840 L~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~ 919 (1008)
|+|||.+....... .....||+.|+|||++.+..++.++||||+||++|||++|+.||....... ........
T Consensus 150 l~Dfg~~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~i~~~ 222 (304)
T 2jam_A 150 ITDFGLSKMEQNGI------MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESK-LFEKIKEG 222 (304)
T ss_dssp BCSCSTTCCCCCBT------THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHH-HHHHHHHC
T ss_pred EccCCcceecCCCc------cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH-HHHHHHcC
Confidence 99999997543321 112358999999999999999999999999999999999999986431110 00000000
Q ss_pred hCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 920 ALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 920 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
. .. + ..+.....+.++.+++.+||+.||.+|||++|+++
T Consensus 223 ~------------~~--------------~--~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (304)
T 2jam_A 223 Y------------YE--------------F--ESPFWDDISESAKDFICHLLEKDPNERYTCEKALS 261 (304)
T ss_dssp C------------CC--------------C--CTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred C------------CC--------------C--CccccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0 00 0 00001123456899999999999999999999986
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-39 Score=348.30 Aligned_cols=263 Identities=22% Similarity=0.310 Sum_probs=206.6
Q ss_pred HhcCCCCCc-eEeeccCeeEEEEEE--cCCCeEEEEEEecccc--chhhHHHHHHHHHHhhcCCCCceeeeecccccccc
Q 045798 682 ATNGFSSTH-LIGVGSFGCVYKGAL--DEDGIVVAIKVINLQC--EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQ 756 (1008)
Q Consensus 682 ~~~~y~~~~-~lg~G~~g~Vy~~~~--~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 756 (1008)
..++|.+.+ .||+|+||.||+|.+ ..+++.||||+++... ....+.+.+|+++++.++||||+++++++
T Consensus 14 ~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~------ 87 (291)
T 1xbb_A 14 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC------ 87 (291)
T ss_dssp CGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE------
T ss_pred cchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE------
Confidence 356788888 999999999999954 5567899999997543 23357899999999999999999999985
Q ss_pred CCceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCC
Q 045798 757 GNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDL 836 (1008)
Q Consensus 757 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 836 (1008)
..+..++||||+++++|.+++.... .+++..++.++.|++.||+|||+. +|+||||||+||+++.++
T Consensus 88 ~~~~~~lv~e~~~~~~L~~~l~~~~----------~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~ 154 (291)
T 1xbb_A 88 EAESWMLVMEMAELGPLNKYLQQNR----------HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQH 154 (291)
T ss_dssp ESSSEEEEEECCTTEEHHHHHHHCT----------TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETT
T ss_pred CCCCcEEEEEeCCCCCHHHHHHhCc----------CCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCC
Confidence 2345799999999999999997653 689999999999999999999998 999999999999999999
Q ss_pred CeEEcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCccccCCccHHH
Q 045798 837 SGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT-AKKPTDVMFEGDLNLHN 915 (1008)
Q Consensus 837 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-G~~pf~~~~~~~~~~~~ 915 (1008)
.+||+|||++........... ......+++.|+|||++.+..++.++||||||+++|||++ |+.||...... ....
T Consensus 155 ~~kl~Dfg~~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~~~ 231 (291)
T 1xbb_A 155 YAKISDFGLSKALRADENYYK-AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS--EVTA 231 (291)
T ss_dssp EEEECCCTTCEECCTTCSEEE-C----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HHHH
T ss_pred cEEEccCCcceeeccCCCccc-ccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHH--HHHH
Confidence 999999999986654332211 1222346789999999988889999999999999999999 99998643211 0001
Q ss_pred HHHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHHHHHHHHH
Q 045798 916 FARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHELQSVKNIL 995 (1008)
Q Consensus 916 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~i~~~~ 995 (1008)
....... . . ....++..+.+++.+||+.||++|||+.|+++.|+++....
T Consensus 232 ~~~~~~~--------~----------------~------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~ 281 (291)
T 1xbb_A 232 MLEKGER--------M----------------G------CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 281 (291)
T ss_dssp HHHTTCC--------C----------------C------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred HHHcCCC--------C----------------C------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHH
Confidence 1000000 0 0 00123556899999999999999999999999999987654
Q ss_pred H
Q 045798 996 L 996 (1008)
Q Consensus 996 ~ 996 (1008)
.
T Consensus 282 ~ 282 (291)
T 1xbb_A 282 V 282 (291)
T ss_dssp H
T ss_pred h
Confidence 3
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=344.59 Aligned_cols=254 Identities=26% Similarity=0.388 Sum_probs=198.2
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccchhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceEE
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKA 762 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 762 (1008)
.++|++.+.||+|+||.||+|.+ .++.||||+++.. ...+.+.+|++++++++||||+++++++. ...+..+
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~----~~~~~~~ 91 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIV----EEKGGLY 91 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEEC----CC--CCE
T ss_pred hhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecch--hHHHHHHHHHHHHHhCCCCCEeeEEEEEE----cCCCceE
Confidence 46799999999999999999988 5889999999744 34578999999999999999999999853 3345689
Q ss_pred EEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEcc
Q 045798 763 IVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGD 842 (1008)
Q Consensus 763 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 842 (1008)
+||||+++++|.+++.... ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|
T Consensus 92 lv~e~~~~~~L~~~l~~~~--------~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~D 160 (278)
T 1byg_A 92 IVTEYMAKGSLVDYLRSRG--------RSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSD 160 (278)
T ss_dssp EEECCCTTEEHHHHHHHHH--------HHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECC
T ss_pred EEEecCCCCCHHHHHHhcc--------cccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEee
Confidence 9999999999999997542 11478999999999999999999998 999999999999999999999999
Q ss_pred cCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCccccCCccHHHHHHhhC
Q 045798 843 FGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT-AKKPTDVMFEGDLNLHNFARMAL 921 (1008)
Q Consensus 843 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-G~~pf~~~~~~~~~~~~~~~~~~ 921 (1008)
||.+........ ...+++.|+|||++.+..++.++||||||+++|||++ |+.||......+ .....
T Consensus 161 fg~~~~~~~~~~-------~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~--~~~~~---- 227 (278)
T 1byg_A 161 FGLTKEASSTQD-------TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--VVPRV---- 227 (278)
T ss_dssp CCC-------------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG--HHHHH----
T ss_pred cccccccccccc-------CCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHH----
Confidence 999975543221 2247889999999988889999999999999999998 999986432110 00000
Q ss_pred CcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHHHHHHHH
Q 045798 922 PNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHELQSVKNI 994 (1008)
Q Consensus 922 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~i~~~ 994 (1008)
...... .....++..+.+++.+||+.||++|||+.|+++.|++++..
T Consensus 228 --------~~~~~~------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~ 274 (278)
T 1byg_A 228 --------EKGYKM------------------DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 274 (278)
T ss_dssp --------TTTCCC------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --------hcCCCC------------------CCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhh
Confidence 000000 00012345689999999999999999999999999998765
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=350.11 Aligned_cols=266 Identities=19% Similarity=0.236 Sum_probs=207.5
Q ss_pred CCCCCHHHHHHHhcCCCCC-ceEeeccCeeEEEEEEcCCCeEEEEEEecccc--chhhHHHHHHHHHHhhc-CCCCceee
Q 045798 671 LPKMSYKSLLKATNGFSST-HLIGVGSFGCVYKGALDEDGIVVAIKVINLQC--EGASKSFMAECKALKNI-RHRNLVKV 746 (1008)
Q Consensus 671 ~~~~~~~~~~~~~~~y~~~-~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~~ 746 (1008)
.+.+.+.......++|.+. +.||+|+||.||+|.+..+++.||+|+++... ......+.+|+.+++++ +||||+++
T Consensus 15 ~~n~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~ 94 (327)
T 3lm5_A 15 TENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINL 94 (327)
T ss_dssp -CCCCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCE
T ss_pred chhhHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEE
Confidence 4455666666677788888 89999999999999999899999999997543 23357899999999999 57999999
Q ss_pred eeccccccccCCceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCC
Q 045798 747 ITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLK 826 (1008)
Q Consensus 747 ~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlk 826 (1008)
++++ ..++..++||||+++|+|.+++...... .+++..++.++.|++.||+|||+. +|+|||||
T Consensus 95 ~~~~-----~~~~~~~lv~e~~~~~~L~~~~~~~~~~--------~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dik 158 (327)
T 3lm5_A 95 HEVY-----ENTSEIILILEYAAGGEIFSLCLPELAE--------MVSENDVIRLIKQILEGVYYLHQN---NIVHLDLK 158 (327)
T ss_dssp EEEE-----ECSSEEEEEEECCTTEEGGGGGSSCC-C--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCC
T ss_pred EEEE-----EeCCeEEEEEEecCCCcHHHHHHHhccc--------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCC
Confidence 9994 5667799999999999999998654321 689999999999999999999998 99999999
Q ss_pred CCCeeecC---CCCeEEcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCC
Q 045798 827 PSNILLDN---DLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPT 903 (1008)
Q Consensus 827 p~NIll~~---~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf 903 (1008)
|+||+++. ++.+||+|||+++....... .....||+.|+|||++.+..++.++|||||||++|||++|+.||
T Consensus 159 p~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf 233 (327)
T 3lm5_A 159 PQNILLSSIYPLGDIKIVDFGMSRKIGHACE-----LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPF 233 (327)
T ss_dssp GGGEEESCBTTBCCEEECCGGGCEEC--------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred hHHEEEecCCCCCcEEEeeCccccccCCccc-----cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence 99999987 78999999999986643322 12345899999999999999999999999999999999999998
Q ss_pred CccccCCccHHHHHHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHH
Q 045798 904 DVMFEGDLNLHNFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTN 983 (1008)
Q Consensus 904 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 983 (1008)
......+ ............ ........+..+.+++.+||+.||++|||++|
T Consensus 234 ~~~~~~~-~~~~i~~~~~~~----------------------------~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ 284 (327)
T 3lm5_A 234 VGEDNQE-TYLNISQVNVDY----------------------------SEETFSSVSQLATDFIQSLLVKNPEKRPTAEI 284 (327)
T ss_dssp CCSSHHH-HHHHHHHTCCCC----------------------------CTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred CCCCchH-HHHHHHhccccc----------------------------CchhhcccCHHHHHHHHHHcCCChhhCcCHHH
Confidence 6432110 000000000000 00001123456789999999999999999999
Q ss_pred HHH
Q 045798 984 VVH 986 (1008)
Q Consensus 984 vl~ 986 (1008)
+++
T Consensus 285 ll~ 287 (327)
T 3lm5_A 285 CLS 287 (327)
T ss_dssp HTT
T ss_pred HhC
Confidence 976
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-39 Score=355.87 Aligned_cols=278 Identities=24% Similarity=0.310 Sum_probs=195.3
Q ss_pred HHHhcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccc--hhhHHHHHHHHHHhhcCCCCceeeeeccccccccC
Q 045798 680 LKATNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCE--GASKSFMAECKALKNIRHRNLVKVITSCSSIDFQG 757 (1008)
Q Consensus 680 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 757 (1008)
....++|++.+.||+|+||+||+|++..+++.||||+++.... ...+.+.+|++++++++||||+++++++ ..
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~ 104 (329)
T 3gbz_A 30 ATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVI-----HH 104 (329)
T ss_dssp --CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEE-----EE
T ss_pred ccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEE-----ec
Confidence 3456789999999999999999999999999999999975432 2345688999999999999999999994 55
Q ss_pred CceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeec----
Q 045798 758 NDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLD---- 833 (1008)
Q Consensus 758 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~---- 833 (1008)
++..++||||++ |+|.+++.... .+++..++.++.||+.||+|||+. +|+||||||+||+++
T Consensus 105 ~~~~~lv~e~~~-~~L~~~~~~~~----------~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~ 170 (329)
T 3gbz_A 105 NHRLHLIFEYAE-NDLKKYMDKNP----------DVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDA 170 (329)
T ss_dssp TTEEEEEEECCS-EEHHHHHHHCT----------TCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC---
T ss_pred CCEEEEEEecCC-CCHHHHHhhcC----------CCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCC
Confidence 677999999996 59999997654 689999999999999999999998 999999999999994
Q ss_pred -CCCCeEEcccCcccccccccCccccccccccccccccCccccCCC-CCCcccchhhHHHHHHHHHhCCCCCCccccCCc
Q 045798 834 -NDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGS-EVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDL 911 (1008)
Q Consensus 834 -~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~ 911 (1008)
.++.+||+|||+++........ .....||+.|+|||++.+. .++.++|||||||++|||++|+.||......+.
T Consensus 171 ~~~~~~kl~Dfg~a~~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~ 246 (329)
T 3gbz_A 171 SETPVLKIGDFGLARAFGIPIRQ----FTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQ 246 (329)
T ss_dssp --CCEEEECCTTHHHHHC---------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred CccceEEECcCCCccccCCcccc----cCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHH
Confidence 4556999999999865432211 2234589999999998875 489999999999999999999999864322211
Q ss_pred cHHHHHHhhCCcc-hhhhhcc--cccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 912 NLHNFARMALPNQ-VMDIVDP--ILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 912 ~~~~~~~~~~~~~-~~~~~d~--~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
..........+.. ....... ...... ... ....... ......+.++.+++.+||+.||++|||++|+++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~-~~~~~~~--~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 247 LFKIFEVLGLPDDTTWPGVTALPDWKQSF---PKF-RGKTLKR--VLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp HHHHHHHHCCCCTTTSTTGGGSTTCCTTC---CCC-CCCCHHH--HHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHHHhCCCchhhhhhhhhhhhhhhhh---hhh-ccccHhh--hcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 1111111111110 0000000 000000 000 0000000 000113456799999999999999999999975
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=356.19 Aligned_cols=278 Identities=22% Similarity=0.274 Sum_probs=198.4
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccc--cchhhHHHHHHHHHHhhcCCCCceeeeecccccc-ccCCc
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQ--CEGASKSFMAECKALKNIRHRNLVKVITSCSSID-FQGND 759 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~~~ 759 (1008)
.++|++.+.||+|+||.||+|.+..+|+.||||++... .....+++.+|+++++.++||||+++++++.... .....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 46899999999999999999999989999999998643 2344567899999999999999999999975432 12234
Q ss_pred eEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeE
Q 045798 760 FKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGH 839 (1008)
Q Consensus 760 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 839 (1008)
..|+||||+ +++|.+++... .+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+|
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~~-----------~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~k 168 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKHE-----------KLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELK 168 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHHC-----------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEE
T ss_pred eEEEEEecC-CCCHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEE
Confidence 579999999 88999998753 688999999999999999999998 999999999999999999999
Q ss_pred EcccCcccccccccCccccccccccccccccCccccCC-CCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHH
Q 045798 840 IGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLG-SEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFAR 918 (1008)
Q Consensus 840 L~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~ 918 (1008)
|+|||+++..... .....+|+.|+|||++.+ ..++.++||||+||++|||++|+.||......+ .+.....
T Consensus 169 l~Dfg~a~~~~~~-------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~l~~i~~ 240 (367)
T 1cm8_A 169 ILDFGLARQADSE-------MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLD-QLKEIMK 240 (367)
T ss_dssp ECCCTTCEECCSS-------CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHH
T ss_pred EEeeecccccccc-------cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHH
Confidence 9999999865432 223458999999999877 679999999999999999999999986432111 1111111
Q ss_pred hhCCcchhhhhcccccCchHHhhhhhhhhhc-cccc-hhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 919 MALPNQVMDIVDPILRNDEEILASTDKCRRM-QTGI-NSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 919 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~-~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
..... ..+++... .... ........... .... ......+..+.+++.+||+.||.+|||++|+++
T Consensus 241 ~~g~~-~~~~~~~~-~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~ 307 (367)
T 1cm8_A 241 VTGTP-PAEFVQRL-QSDE-AKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 307 (367)
T ss_dssp HHCCC-CHHHHHTC-SCHH-HHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred hcCCC-CHHHHHHh-hhHH-HHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence 11111 01111100 0000 00000000000 0000 001123556899999999999999999999987
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=351.05 Aligned_cols=277 Identities=19% Similarity=0.234 Sum_probs=204.4
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccchhhHHHHHHHHHHhhcC-CCCceeeeeccccccccCCceE
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIR-HRNLVKVITSCSSIDFQGNDFK 761 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~ 761 (1008)
.++|++.+.||+|+||.||+|++..+++.||||+++.. ..+.+.+|++++++++ ||||+++++++.. ......
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~---~~~~~~ 108 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKD---PVSRTP 108 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEEC---TTTCCE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeecc---CCCCce
Confidence 36799999999999999999999889999999999743 3467899999999996 9999999999653 235678
Q ss_pred EEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCC-CeEE
Q 045798 762 AIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDL-SGHI 840 (1008)
Q Consensus 762 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kL 840 (1008)
++||||+++++|.+++. .+++..++.++.||+.||+|||+. +|+||||||+||+++.++ .+||
T Consensus 109 ~lv~e~~~~~~l~~~~~-------------~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl 172 (330)
T 3nsz_A 109 ALVFEHVNNTDFKQLYQ-------------TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRL 172 (330)
T ss_dssp EEEEECCCCCCHHHHGG-------------GCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEE
T ss_pred EEEEeccCchhHHHHHH-------------hCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEE
Confidence 99999999999999884 578899999999999999999998 999999999999999776 8999
Q ss_pred cccCcccccccccCccccccccccccccccCccccCC-CCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHh
Q 045798 841 GDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLG-SEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARM 919 (1008)
Q Consensus 841 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~ 919 (1008)
+|||+++........ ....++..|+|||++.+ ..++.++|||||||++|||++|+.||................
T Consensus 173 ~Dfg~a~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~ 247 (330)
T 3nsz_A 173 IDWGLAEFYHPGQEY-----NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKV 247 (330)
T ss_dssp CCCTTCEECCTTCCC-----CSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHH
T ss_pred EeCCCceEcCCCCcc-----ccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHh
Confidence 999999865443221 23458999999999877 678999999999999999999999985433222222222222
Q ss_pred hCCcchhhhhccccc-CchHHhhhhhh--hhhccc--cchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 920 ALPNQVMDIVDPILR-NDEEILASTDK--CRRMQT--GINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 920 ~~~~~~~~~~d~~l~-~~~~~~~~~~~--~~~~~~--~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
.......+.++..-. ..+........ ...+.. ........+.++.+++.+||+.||++|||++|+++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 248 LGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp HCHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred cCCchhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 211111111111100 00000000000 000000 00011124567899999999999999999999986
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=348.33 Aligned_cols=245 Identities=22% Similarity=0.250 Sum_probs=192.2
Q ss_pred cCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEecccc--chhhHHHHHHHHHHhhc-CCCCceeeeeccccccccCCce
Q 045798 684 NGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC--EGASKSFMAECKALKNI-RHRNLVKVITSCSSIDFQGNDF 760 (1008)
Q Consensus 684 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~ 760 (1008)
++|++.++||+|+||+||+|++..+++.||||++.... ......+..|+..+.++ +||||++++++| ..++.
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~-----~~~~~ 131 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAW-----EEGGI 131 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----EETTE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEE-----EeCCE
Confidence 57999999999999999999999899999999986432 23334556666666665 999999999995 45677
Q ss_pred EEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEE
Q 045798 761 KAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHI 840 (1008)
Q Consensus 761 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 840 (1008)
.++||||+ +++|.+++..... .+++..++.++.||+.||+|||+. +|+||||||+||+++.++.+||
T Consensus 132 ~~lv~e~~-~~~L~~~~~~~~~---------~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl 198 (311)
T 3p1a_A 132 LYLQTELC-GPSLQQHCEAWGA---------SLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKL 198 (311)
T ss_dssp EEEEEECC-CCBHHHHHHHHCS---------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEE
T ss_pred EEEEEecc-CCCHHHHHHhcCC---------CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEE
Confidence 99999999 7799998865431 689999999999999999999998 9999999999999999999999
Q ss_pred cccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHhh
Q 045798 841 GDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMA 920 (1008)
Q Consensus 841 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~~ 920 (1008)
+|||++........ .....||+.|+|||++.+ .++.++|||||||++|||++|..|+.... ......
T Consensus 199 ~DFG~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~----~~~~~~--- 265 (311)
T 3p1a_A 199 GDFGLLVELGTAGA-----GEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE----GWQQLR--- 265 (311)
T ss_dssp CCCTTCEECC-----------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH----HHHHHT---
T ss_pred ccceeeeecccCCC-----CcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc----HHHHHh---
Confidence 99999986543321 223458999999999876 78999999999999999999977654210 011000
Q ss_pred CCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 921 LPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 921 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
..... + ......+.++.+++.+||+.||++|||++|+++
T Consensus 266 ---------~~~~~--~----------------~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 266 ---------QGYLP--P----------------EFTAGLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp ---------TTCCC--H----------------HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ---------ccCCC--c----------------ccccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 00000 0 001123456899999999999999999999985
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=343.93 Aligned_cols=250 Identities=24% Similarity=0.389 Sum_probs=182.6
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEecccc---chhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCc
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC---EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGND 759 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 759 (1008)
.++|++.+.||+|+||.||+|.+..+++.||+|++.... ....+.+.+|++++++++||||+++++++ .+.+
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~ 84 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYF-----EDSN 84 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEE-----ECSS
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEE-----ccCC
Confidence 467999999999999999999998899999999996432 22346799999999999999999999994 5567
Q ss_pred eEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeE
Q 045798 760 FKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGH 839 (1008)
Q Consensus 760 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 839 (1008)
..++||||+++++|.+++..... .+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+|
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~k 152 (278)
T 3cok_A 85 YVYLVLEMCHNGEMNRYLKNRVK---------PFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIK 152 (278)
T ss_dssp EEEEEEECCTTEEHHHHHHTCSS---------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEE
T ss_pred eEEEEEecCCCCcHHHHHhhccC---------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEE
Confidence 79999999999999999975431 689999999999999999999998 999999999999999999999
Q ss_pred EcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHh
Q 045798 840 IGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARM 919 (1008)
Q Consensus 840 L~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~ 919 (1008)
|+|||.+......... .....||+.|+|||++.+..++.++||||||+++|||++|+.||........ .
T Consensus 153 l~dfg~~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-----~-- 221 (278)
T 3cok_A 153 IADFGLATQLKMPHEK----HYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT-----L-- 221 (278)
T ss_dssp ECCCTTCEECC--------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC----------
T ss_pred EEeecceeeccCCCCc----ceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH-----H--
Confidence 9999999865432221 1234589999999999988899999999999999999999999864321100 0
Q ss_pred hCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 920 ALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 920 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
........ ..+ ...+.++.+++.+||+.||++|||++|+++
T Consensus 222 ----------~~~~~~~~----------~~~------~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 222 ----------NKVVLADY----------EMP------SFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp ------------CCSSCC----------CCC------TTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred ----------HHHhhccc----------CCc------cccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 00000000 000 012345789999999999999999999986
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=354.97 Aligned_cols=284 Identities=23% Similarity=0.317 Sum_probs=204.8
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEecccc--chhhHHHHHHHHHHhhcCCCCceeeeeccccccc---cC
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC--EGASKSFMAECKALKNIRHRNLVKVITSCSSIDF---QG 757 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~---~~ 757 (1008)
.++|++.+.||+|+||.||+|++..+++.||+|++.... ......+.+|++++++++||||+++++++..... ..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 468999999999999999999998899999999986443 2334678899999999999999999999764321 12
Q ss_pred CceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCC
Q 045798 758 NDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLS 837 (1008)
Q Consensus 758 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 837 (1008)
.+..++||||++ ++|.+.+..... .+++.+++.++.||+.||+|||+. +|+||||||+||+++.++.
T Consensus 96 ~~~~~lv~e~~~-~~l~~~l~~~~~---------~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~ 162 (351)
T 3mi9_A 96 KGSIYLVFDFCE-HDLAGLLSNVLV---------KFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGV 162 (351)
T ss_dssp -CEEEEEEECCS-EEHHHHHHCTTS---------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSC
T ss_pred CceEEEEEeccC-CCHHHHHhhccC---------CCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCC
Confidence 457899999996 577777754421 689999999999999999999998 9999999999999999999
Q ss_pred eEEcccCcccccccccCccccccccccccccccCccccCC-CCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHH
Q 045798 838 GHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLG-SEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNF 916 (1008)
Q Consensus 838 ~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~ 916 (1008)
+||+|||+++.................||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... .....
T Consensus 163 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~~~~i 241 (351)
T 3mi9_A 163 LKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQH-QLALI 241 (351)
T ss_dssp EEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHH
T ss_pred EEEccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHH
Confidence 9999999998765443333333344568999999998876 458999999999999999999999987532211 11111
Q ss_pred HHhh--CCcchhhhhccc-ccCchHHhhhhhhhhhccccchh---HHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 917 ARMA--LPNQVMDIVDPI-LRNDEEILASTDKCRRMQTGINS---RLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 917 ~~~~--~~~~~~~~~d~~-l~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
.... .+.......+.. .... ............. ....+..+.+++.+||+.||++|||++|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 311 (351)
T 3mi9_A 242 SQLCGSITPEVWPNVDNYELYEK------LELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 311 (351)
T ss_dssp HHHHCCCCTTTSTTGGGCGGGTS------SCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHhCCCChhhccccccchhhcc------cccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence 1111 111110000000 0000 0000000000000 0112456889999999999999999999986
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=369.14 Aligned_cols=254 Identities=23% Similarity=0.310 Sum_probs=204.2
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEecccc---chhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCc
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC---EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGND 759 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 759 (1008)
.++|++.+.||+|+||.||+|++..+|+.||+|++.... ......+.+|++++++++||||+++++++ .+.+
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~-----~~~~ 257 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAY-----ETKD 257 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECSS
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEE-----eeCC
Confidence 467999999999999999999999899999999996431 23346789999999999999999999984 5667
Q ss_pred eEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeE
Q 045798 760 FKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGH 839 (1008)
Q Consensus 760 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 839 (1008)
..|+||||+++|+|.+++...... .+++..++.++.||+.||+|||++ +||||||||+||+++.++.+|
T Consensus 258 ~l~lVmEy~~gg~L~~~l~~~~~~--------~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vK 326 (576)
T 2acx_A 258 ALCLVLTLMNGGDLKFHIYHMGQA--------GFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIR 326 (576)
T ss_dssp EEEEEECCCCSCBHHHHHHSSSSC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEE
T ss_pred EEEEEEEcCCCCcHHHHHHhcCCC--------CCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeE
Confidence 899999999999999998765421 589999999999999999999998 999999999999999999999
Q ss_pred EcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHh
Q 045798 840 IGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARM 919 (1008)
Q Consensus 840 L~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~ 919 (1008)
|+|||+|+....... .....||+.|+|||++.+..++.++|||||||++|||++|+.||......... ......
T Consensus 327 L~DFGla~~~~~~~~-----~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~-~~i~~~ 400 (576)
T 2acx_A 327 ISDLGLAVHVPEGQT-----IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR-EEVERL 400 (576)
T ss_dssp ECCCTTCEECCTTCC-----EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCH-HHHHHH
T ss_pred EEecccceecccCcc-----ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhH-HHHHHH
Confidence 999999986643321 12346999999999999999999999999999999999999999753221111 001000
Q ss_pred hCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCC-----CHHHHHH
Q 045798 920 ALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRM-----NMTNVVH 986 (1008)
Q Consensus 920 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~ 986 (1008)
+.. .+... ....+.++.+++.+||+.||.+|| +++||++
T Consensus 401 ---------i~~-----------------~~~~~--p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 401 ---------VKE-----------------VPEEY--SERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp ---------HHH-----------------CCCCC--CTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred ---------hhc-----------------ccccC--CccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 000 00000 012345678999999999999999 7788875
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=359.25 Aligned_cols=200 Identities=27% Similarity=0.401 Sum_probs=175.1
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEecccc-chhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceE
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC-EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFK 761 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 761 (1008)
.++|++.+.||+|+||.||+|.+..+++.||+|+++... ....+.+.+|++++++++||||+++++++ ..++..
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~ 106 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF-----YSDGEI 106 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEE-----EETTEE
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEE-----EECCEE
Confidence 357999999999999999999999899999999997553 34457899999999999999999999985 456679
Q ss_pred EEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEc
Q 045798 762 AIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIG 841 (1008)
Q Consensus 762 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 841 (1008)
++||||+++++|.+++.... .+++..+..++.|++.||+|||+. .+|+||||||+||+++.++.+||+
T Consensus 107 ~lv~e~~~~~~L~~~l~~~~----------~~~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~ 174 (360)
T 3eqc_A 107 SICMEHMDGGSLDQVLKKAG----------RIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLC 174 (360)
T ss_dssp EEEECCCTTCBHHHHHHHHS----------SCCHHHHHHHHHHHHHHHHHHHHH--HCCCCSCCSGGGEEECTTCCEEEC
T ss_pred EEEEECCCCCCHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHHh--CCEEcCCccHHHEEECCCCCEEEE
Confidence 99999999999999997643 689999999999999999999983 189999999999999999999999
Q ss_pred ccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCc
Q 045798 842 DFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDV 905 (1008)
Q Consensus 842 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~ 905 (1008)
|||++....... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||..
T Consensus 175 Dfg~~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 232 (360)
T 3eqc_A 175 DFGVSGQLIDSM------ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPP 232 (360)
T ss_dssp CCCCCHHHHHHC----------CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSC
T ss_pred ECCCCccccccc------ccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 999997553321 1234589999999999999999999999999999999999999974
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=354.38 Aligned_cols=247 Identities=28% Similarity=0.341 Sum_probs=197.0
Q ss_pred cCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEecccc---chhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCce
Q 045798 684 NGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC---EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDF 760 (1008)
Q Consensus 684 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 760 (1008)
+.|+..+.||+|+||.||+|++..+++.||||++.... ....+.+.+|++++++++||||+++++++ ..++.
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~-----~~~~~ 128 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCY-----LREHT 128 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----EETTE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----EECCe
Confidence 45889999999999999999998899999999997542 23346789999999999999999999995 44567
Q ss_pred EEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEE
Q 045798 761 KAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHI 840 (1008)
Q Consensus 761 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 840 (1008)
.++||||++ |+|.+++..... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||
T Consensus 129 ~~lv~e~~~-g~l~~~l~~~~~---------~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL 195 (348)
T 1u5q_A 129 AWLVMEYCL-GSASDLLEVHKK---------PLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKL 195 (348)
T ss_dssp EEEEEECCS-EEHHHHHHHHTS---------CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEE
T ss_pred EEEEEecCC-CCHHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEE
Confidence 999999996 688888754321 689999999999999999999998 9999999999999999999999
Q ss_pred cccCcccccccccCccccccccccccccccCccccC---CCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHH
Q 045798 841 GDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGL---GSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFA 917 (1008)
Q Consensus 841 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~ 917 (1008)
+|||++...... ....||+.|+|||++. +..++.++|||||||++|||++|+.||....... ......
T Consensus 196 ~DfG~a~~~~~~--------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~-~~~~~~ 266 (348)
T 1u5q_A 196 GDFGSASIMAPA--------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-ALYHIA 266 (348)
T ss_dssp CCCTTCBSSSSB--------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-HHHHHH
T ss_pred eeccCceecCCC--------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHH
Confidence 999999865432 1245899999999874 5678999999999999999999999986421110 000000
Q ss_pred HhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 045798 918 RMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHE 987 (1008)
Q Consensus 918 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 987 (1008)
.... +... ....+..+.+++.+||+.||++|||++|+++.
T Consensus 267 ~~~~---------~~~~---------------------~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 267 QNES---------PALQ---------------------SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 306 (348)
T ss_dssp HSCC---------CCCC---------------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred hcCC---------CCCC---------------------CCCCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 0000 0000 01234557899999999999999999999863
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-38 Score=342.22 Aligned_cols=263 Identities=23% Similarity=0.353 Sum_probs=207.7
Q ss_pred hcCCCCCc-eEeeccCeeEEEEEEc--CCCeEEEEEEecccc-chhhHHHHHHHHHHhhcCCCCceeeeeccccccccCC
Q 045798 683 TNGFSSTH-LIGVGSFGCVYKGALD--EDGIVVAIKVINLQC-EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGN 758 (1008)
Q Consensus 683 ~~~y~~~~-~lg~G~~g~Vy~~~~~--~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 758 (1008)
.++|.+.+ .||+|+||.||+|.+. .+++.||+|+++... ....+.+.+|++++++++||||+++++++. .
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~------~ 81 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ------A 81 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE------S
T ss_pred HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEec------C
Confidence 34566666 9999999999999863 467899999998643 345678999999999999999999999852 3
Q ss_pred ceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCe
Q 045798 759 DFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSG 838 (1008)
Q Consensus 759 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 838 (1008)
+..++||||+++++|.+++..... .+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+
T Consensus 82 ~~~~lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~ 149 (287)
T 1u59_A 82 EALMLVMEMAGGGPLHKFLVGKRE---------EIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYA 149 (287)
T ss_dssp SSEEEEEECCTTEEHHHHHTTCTT---------TSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEE
T ss_pred CCcEEEEEeCCCCCHHHHHHhCCc---------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCE
Confidence 458999999999999999965431 689999999999999999999998 99999999999999999999
Q ss_pred EEcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCccccCCccHHHHH
Q 045798 839 HIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT-AKKPTDVMFEGDLNLHNFA 917 (1008)
Q Consensus 839 kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-G~~pf~~~~~~~~~~~~~~ 917 (1008)
||+|||.+.......... .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||...... ......
T Consensus 150 kl~Dfg~~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--~~~~~i 226 (287)
T 1u59_A 150 KISDFGLSKALGADDSYY-TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP--EVMAFI 226 (287)
T ss_dssp EECCCTTCEECTTCSCEE-CCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH--HHHHHH
T ss_pred EECcccceeeeccCccee-eccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH--HHHHHH
Confidence 999999998765433221 11223347899999999988889999999999999999998 99998643211 111111
Q ss_pred HhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHHHHHHHHHH
Q 045798 918 RMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHELQSVKNILL 996 (1008)
Q Consensus 918 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~i~~~~~ 996 (1008)
..... .. ....++.++.+++.+||+.||.+||++.|+++.|+++..+..
T Consensus 227 ~~~~~----------------------------~~--~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~ 275 (287)
T 1u59_A 227 EQGKR----------------------------ME--CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA 275 (287)
T ss_dssp HTTCC----------------------------CC--CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred hcCCc----------------------------CC--CCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence 00000 00 001245568999999999999999999999999999877643
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-38 Score=340.88 Aligned_cols=256 Identities=21% Similarity=0.275 Sum_probs=202.1
Q ss_pred cCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccc------hhhHHHHHHHHHHhhcCCCCceeeeeccccccccC
Q 045798 684 NGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCE------GASKSFMAECKALKNIRHRNLVKVITSCSSIDFQG 757 (1008)
Q Consensus 684 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 757 (1008)
++|++.+.||+|+||.||+|.+..+++.||+|+++.... ...+.+.+|++++++++||||+++++++ ..
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~ 79 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIF-----EN 79 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEE-----EC
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhhee-----cC
Confidence 568999999999999999999988999999999874421 1357899999999999999999999995 45
Q ss_pred CceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCC-
Q 045798 758 NDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDL- 836 (1008)
Q Consensus 758 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~- 836 (1008)
+...++||||+++++|.+++.... .+++..++.++.||+.||+|||+. +|+||||||+||+++.++
T Consensus 80 ~~~~~lv~e~~~~~~L~~~l~~~~----------~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~ 146 (283)
T 3bhy_A 80 KTDVVLILELVSGGELFDFLAEKE----------SLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNV 146 (283)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHHS----------SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSS
T ss_pred CCeEEEEEeecCCCcHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCC
Confidence 667999999999999999996543 689999999999999999999998 999999999999998877
Q ss_pred ---CeEEcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccH
Q 045798 837 ---SGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNL 913 (1008)
Q Consensus 837 ---~~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~ 913 (1008)
.+||+|||.+........ .....|++.|+|||++.+..++.++||||||+++|+|++|+.||......+ ..
T Consensus 147 ~~~~~kl~dfg~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~ 220 (283)
T 3bhy_A 147 PNPRIKLIDFGIAHKIEAGNE-----FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQE-TL 220 (283)
T ss_dssp SSCCEEECCCTTCEECC-------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH-HH
T ss_pred CCCceEEEecccceeccCCCc-----ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHH-HH
Confidence 899999999986543321 123458999999999999999999999999999999999999986432110 00
Q ss_pred HHHHHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH--HHHHH
Q 045798 914 HNFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH--ELQSV 991 (1008)
Q Consensus 914 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~--~L~~i 991 (1008)
....... ..... ......+..+.+++.+||+.||.+|||+.|+++ .++.+
T Consensus 221 ~~~~~~~------------~~~~~----------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 272 (283)
T 3bhy_A 221 TNISAVN------------YDFDE----------------EYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAI 272 (283)
T ss_dssp HHHHTTC------------CCCCH----------------HHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHH
T ss_pred HHhHhcc------------cCCcc----------------hhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHH
Confidence 0000000 00000 001123456789999999999999999999987 34444
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-39 Score=370.52 Aligned_cols=249 Identities=24% Similarity=0.297 Sum_probs=192.9
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccc---cchhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCc
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQ---CEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGND 759 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 759 (1008)
.++|++.+.||+|+||.||+|.+..+++.||||+++.. .......+.+|+++++.++||||+++++++ ...+
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~-----~~~~ 221 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSF-----QTHD 221 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEE-----EETT
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEE-----eeCC
Confidence 46799999999999999999999999999999999743 233446788999999999999999999995 4566
Q ss_pred eEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhh-CCCCCceeccCCCCCeeecCCCCe
Q 045798 760 FKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHH-HCQEPILHCDLKPSNILLDNDLSG 838 (1008)
Q Consensus 760 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~ 838 (1008)
..++||||+++|+|.+++.... .+++..+..++.||+.||+|||+ . +|+||||||+|||++.++.+
T Consensus 222 ~~~lv~e~~~~~~L~~~l~~~~----------~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~ 288 (446)
T 4ejn_A 222 RLCFVMEYANGGELFFHLSRER----------VFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHI 288 (446)
T ss_dssp EEEEEECCCSSCBHHHHHHHHS----------CCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCE
T ss_pred EEEEEEeeCCCCcHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCE
Confidence 7999999999999999987543 68999999999999999999998 6 99999999999999999999
Q ss_pred EEcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHH
Q 045798 839 HIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFAR 918 (1008)
Q Consensus 839 kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~ 918 (1008)
||+|||+|+....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ......
T Consensus 289 kl~DFG~a~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~--~~~~~i- 361 (446)
T 4ejn_A 289 KITDFGLCKEGIKDGA----TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--KLFELI- 361 (446)
T ss_dssp EECCCCCCCTTCC---------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHH-
T ss_pred EEccCCCceeccCCCc----ccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH--HHHHHH-
Confidence 9999999985432221 123356999999999999999999999999999999999999998642110 000000
Q ss_pred hhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCC-----CHHHHHH
Q 045798 919 MALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRM-----NMTNVVH 986 (1008)
Q Consensus 919 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~ 986 (1008)
..... .++ ...+.++.+++.+||+.||.+|| |++|+++
T Consensus 362 ----------~~~~~--------------~~p------~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 362 ----------LMEEI--------------RFP------RTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp ----------HHCCC--------------CCC------TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred ----------HhCCC--------------CCC------ccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 00000 000 11345678999999999999999 9999986
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=342.34 Aligned_cols=259 Identities=29% Similarity=0.446 Sum_probs=206.5
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccchhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceEE
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKA 762 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 762 (1008)
.++|++.+.||+|+||.||+|.+. +++.||+|+++... ...+.+.+|++++++++||||+++++++. .+..+
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~------~~~~~ 83 (279)
T 1qpc_A 12 RETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT------QEPIY 83 (279)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC------SSSCE
T ss_pred HHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEc------CCCcE
Confidence 467999999999999999999985 67889999997543 34578999999999999999999999853 33479
Q ss_pred EEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEcc
Q 045798 763 IVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGD 842 (1008)
Q Consensus 763 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 842 (1008)
+||||+++++|.+++.... ...+++..++.++.|++.||+|||+. +|+||||||+||++++++.+||+|
T Consensus 84 ~v~e~~~~~~L~~~l~~~~--------~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~D 152 (279)
T 1qpc_A 84 IITEYMENGSLVDFLKTPS--------GIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIAD 152 (279)
T ss_dssp EEEECCTTCBHHHHTTSHH--------HHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECC
T ss_pred EEEecCCCCCHHHHHhcCC--------CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECC
Confidence 9999999999999996532 12589999999999999999999998 999999999999999999999999
Q ss_pred cCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCccccCCccHHHHHHhhC
Q 045798 843 FGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT-AKKPTDVMFEGDLNLHNFARMAL 921 (1008)
Q Consensus 843 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-G~~pf~~~~~~~~~~~~~~~~~~ 921 (1008)
||.+......... ......++..|+|||++.+..++.++||||||+++|||++ |+.||...... .........
T Consensus 153 fg~~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--~~~~~~~~~- 226 (279)
T 1qpc_A 153 FGLARLIEDNEYT---AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP--EVIQNLERG- 226 (279)
T ss_dssp CTTCEECSSSCEE---CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HHHHHHHTT-
T ss_pred CcccccccCcccc---cccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHH--HHHHHHhcc-
Confidence 9999866443211 1223447889999999988889999999999999999999 89998642111 000000000
Q ss_pred CcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHHHHHHHHH
Q 045798 922 PNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHELQSVKNIL 995 (1008)
Q Consensus 922 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~i~~~~ 995 (1008)
.. .. ....++.++.+++.+||+.||++|||++++++.|+.+....
T Consensus 227 -----------~~--------------~~----~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 271 (279)
T 1qpc_A 227 -----------YR--------------MV----RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTAT 271 (279)
T ss_dssp -----------CC--------------CC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred -----------cC--------------CC----CcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhc
Confidence 00 00 00123456899999999999999999999999999886653
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=353.62 Aligned_cols=252 Identities=21% Similarity=0.261 Sum_probs=198.0
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccchhhHHHHHHHHHHhhc-CCCCceeeeeccccccccCCceE
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNI-RHRNLVKVITSCSSIDFQGNDFK 761 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~ 761 (1008)
.++|++.+.||+|+||.||+|.+..+++.||+|+++.... ...+|++++.++ +||||+++++++ .+++..
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~-----~~~~~~ 91 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVY-----DDGKYV 91 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEE-----ECSSEE
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEE-----EcCCEE
Confidence 5679999999999999999999998999999999975432 345788888888 799999999994 567789
Q ss_pred EEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCC----CC
Q 045798 762 AIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDND----LS 837 (1008)
Q Consensus 762 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~----~~ 837 (1008)
|+||||+++|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+||++..+ +.
T Consensus 92 ~lv~E~~~gg~L~~~i~~~~----------~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~ 158 (342)
T 2qr7_A 92 YVVTELMKGGELLDKILRQK----------FFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPES 158 (342)
T ss_dssp EEEECCCCSCBHHHHHHTCT----------TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGG
T ss_pred EEEEeCCCCCcHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCe
Confidence 99999999999999997654 689999999999999999999998 99999999999998543 35
Q ss_pred eEEcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHH
Q 045798 838 GHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFA 917 (1008)
Q Consensus 838 ~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~ 917 (1008)
+||+|||+++........ .....||+.|+|||++.+..++.++|||||||++|||++|..||...... ......
T Consensus 159 ~kl~Dfg~a~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~--~~~~~~ 232 (342)
T 2qr7_A 159 IRICDFGFAKQLRAENGL----LMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDD--TPEEIL 232 (342)
T ss_dssp EEECCCTTCEECBCTTCC----BCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTS--CHHHHH
T ss_pred EEEEECCCcccCcCCCCc----eeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcC--CHHHHH
Confidence 999999999865443221 22346899999999998888999999999999999999999999642211 111111
Q ss_pred HhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 918 RMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 918 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
... ..... ..........+.++.+++.+||+.||++|||+.|+++
T Consensus 233 ~~i--------~~~~~----------------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 233 ARI--------GSGKF----------------SLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp HHH--------HHCCC----------------CCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred HHH--------ccCCc----------------ccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 000 00000 0000001123456789999999999999999999986
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=355.23 Aligned_cols=278 Identities=21% Similarity=0.265 Sum_probs=188.4
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccc--cchhhHHHHHHHHHHhhcCCCCceeeeeccccc-cccCCc
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQ--CEGASKSFMAECKALKNIRHRNLVKVITSCSSI-DFQGND 759 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~~~~ 759 (1008)
.++|++.+.||+|+||.||+|.+..+|+.||||++... .....+.+.+|+++++.++||||+++++++... ......
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 47899999999999999999999989999999999643 234456789999999999999999999986542 123345
Q ss_pred eEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeE
Q 045798 760 FKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGH 839 (1008)
Q Consensus 760 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 839 (1008)
..++|+|++ +++|.+++... .+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+|
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~~-----------~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~k 172 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKCQ-----------KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELK 172 (367)
T ss_dssp CCEEEEECC-CEECC-----C-----------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEE
T ss_pred eEEEEeccc-CCCHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEE
Confidence 689999999 78999988642 689999999999999999999998 999999999999999999999
Q ss_pred EcccCcccccccccCccccccccccccccccCccccCC-CCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHH
Q 045798 840 IGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLG-SEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFAR 918 (1008)
Q Consensus 840 L~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~ 918 (1008)
|+|||+++..... .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||...... ..+.....
T Consensus 173 L~DFG~a~~~~~~-------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-~~l~~i~~ 244 (367)
T 2fst_X 173 ILDFGLARHTADE-------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI-DQLKLILR 244 (367)
T ss_dssp ECC----------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHH
T ss_pred Eeecccccccccc-------CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHH
Confidence 9999999865432 123458999999999877 67899999999999999999999998643211 11111111
Q ss_pred hhCCcchhhhhcccccCchHHhhhhhhhhhccc-cch-hHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 919 MALPNQVMDIVDPILRNDEEILASTDKCRRMQT-GIN-SRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 919 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~-~~~-~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
....+. .+.+...-.... ..........+. ... .....+..+.+++.+||+.||.+|||++|+++
T Consensus 245 ~~g~p~-~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~ 311 (367)
T 2fst_X 245 LVGTPG-AELLKKISSESA--RNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 311 (367)
T ss_dssp HHCSCC-HHHHTTCCCHHH--HHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HhCCCC-HHHHHHhhhHHH--HHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence 111111 111111000000 000000000000 000 00123456899999999999999999999986
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-37 Score=355.78 Aligned_cols=345 Identities=29% Similarity=0.396 Sum_probs=200.4
Q ss_pred CccCCeeeecCCCCCCCCCccccCCCCCCEEEccCCCCCCccCcccccCcCcceEeeeccccccCCCccccccCCCCeee
Q 045798 77 LSFLREINLSNNTIQGEIPPEFGRLFRLEALFLSNNSLVGKIPANLSYCSRLTVLCIEYNKLQGRIPLEFVSLSKLKDLS 156 (1008)
Q Consensus 77 l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~ 156 (1008)
+++|++|+++++.++ .+| .+..+++|++|+|++|.+++..| ++.+++|++|++++|.+++..+ +.++++|++|+
T Consensus 45 l~~l~~L~l~~~~i~-~l~-~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~ 118 (466)
T 1o6v_A 45 LDQVTTLQADRLGIK-SID-GVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLT 118 (466)
T ss_dssp HHTCCEEECCSSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GTTCTTCCEEE
T ss_pred hccccEEecCCCCCc-cCc-chhhhcCCCEEECCCCccCCchh--hhccccCCEEECCCCccccChh--hcCCCCCCEEE
Confidence 445555566555555 333 25555666666666666553332 5555666666666666554333 55556666666
Q ss_pred cccccCCCCCCCCCccccccchhhcccccCCCCCCccccCCCCCcEEEecCCcccccCCccccCCCCcceeccccccccc
Q 045798 157 LAKNKLTGGIPPFLGNLTSLEVLSLAGNSFGRNIPDSLGQLKQLKILAIGGNNLSGPIPPSIYNLSFLVVFSVSHNQIHG 236 (1008)
Q Consensus 157 L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~~ 236 (1008)
+++|++++..+ +.++++|++|++++|.+.+ ++ .++.+++|+.|+++ |.+.+.. .+.++++|+.|++++|.+.
T Consensus 119 L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~-~~-~~~~l~~L~~L~l~-~~~~~~~--~~~~l~~L~~L~l~~n~l~- 190 (466)
T 1o6v_A 119 LFNNQITDIDP--LKNLTNLNRLELSSNTISD-IS-ALSGLTSLQQLSFG-NQVTDLK--PLANLTTLERLDISSNKVS- 190 (466)
T ss_dssp CCSSCCCCCGG--GTTCTTCSEEEEEEEEECC-CG-GGTTCTTCSEEEEE-ESCCCCG--GGTTCTTCCEEECCSSCCC-
T ss_pred CCCCCCCCChH--HcCCCCCCEEECCCCccCC-Ch-hhccCCcccEeecC-CcccCch--hhccCCCCCEEECcCCcCC-
Confidence 66666553322 5555666666666665543 22 35556666666664 3333221 2555666666666666655
Q ss_pred cCChhhhhcCCCCcEEEeccccCCCCCCcccccCCCCceeecccccccccccccccCCCcccccccccccCCCCCCCccc
Q 045798 237 SLPPSLGLLLPNLKFFQIHHNFFSGSIPISLSNASKLEHIEIANNNFSGKLSVNFGGMKNLSLLNLQFSNLGSGESDEMG 316 (1008)
Q Consensus 237 ~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~ 316 (1008)
.++. +..+++|++|++++|.+.+..| +..+++|++|++++|++.+. ..+..+++|+.|++++|++....
T Consensus 191 ~~~~--l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~----- 259 (466)
T 1o6v_A 191 DISV--LAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLA----- 259 (466)
T ss_dssp CCGG--GGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCG-----
T ss_pred CChh--hccCCCCCEEEecCCccccccc--ccccCCCCEEECCCCCcccc--hhhhcCCCCCEEECCCCccccch-----
Confidence 2322 2335566666666666654433 45566666666666666543 23455555555555555554322
Q ss_pred ccccccccCCCcEEEecCCcCCccCChhhhhhcccceeeeeccccccCCCCCccccccccceEEecCccccCCcchhccC
Q 045798 317 FMNSLTNCSKLRVLSLGGNQFRGALPHSIANLSSQLQILILSSNQFYGSIPLGIGNLVDLYLLGMVENQFTGAIPKEMGK 396 (1008)
Q Consensus 317 ~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~ 396 (1008)
.+..+++|+.|++++|++++..+ +..+. +|+.|++++|++++..+ +..+++|+.|++++|++++..| +..
T Consensus 260 ---~~~~l~~L~~L~l~~n~l~~~~~--~~~l~-~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~ 329 (466)
T 1o6v_A 260 ---PLSGLTKLTELKLGANQISNISP--LAGLT-ALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSS 329 (466)
T ss_dssp ---GGTTCTTCSEEECCSSCCCCCGG--GTTCT-TCSEEECCSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGG--GGG
T ss_pred ---hhhcCCCCCEEECCCCccCcccc--ccCCC-ccCeEEcCCCcccCchh--hcCCCCCCEEECcCCcCCCchh--hcc
Confidence 24556666666666666664322 44443 47777777777664433 6667777777777777776554 566
Q ss_pred CCCCceEEccCCcccccccccccCCCCcceeeccccccccccCCCCcCCCcccEeecccccccC
Q 045798 397 LQKLQGLDFSGNHFSGEIPSSLGNLSSLYEVFFNNNNLSGVIPFSLGNLKRLAFLEMSGNELSG 460 (1008)
Q Consensus 397 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 460 (1008)
+++|+.|++++|++++. ..+.++++|+.|++++|++++..| +..+++|+.|++++|++++
T Consensus 330 l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~~~~ 389 (466)
T 1o6v_A 330 LTKLQRLFFYNNKVSDV--SSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTN 389 (466)
T ss_dssp CTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCBCGG--GTTCTTCCEEECCCEEEEC
T ss_pred CccCCEeECCCCccCCc--hhhccCCCCCEEeCCCCccCccch--hhcCCCCCEEeccCCcccC
Confidence 77777777777777643 356677777777777777776665 6677777777777777763
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=352.13 Aligned_cols=267 Identities=20% Similarity=0.243 Sum_probs=194.5
Q ss_pred HhcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccchhhHHHHHHHHHHhhcC-CCCceeeeecccccc---ccC
Q 045798 682 ATNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIR-HRNLVKVITSCSSID---FQG 757 (1008)
Q Consensus 682 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~---~~~ 757 (1008)
...+|++.+.||+|+||.||+|++..+++.||||++........+.+.+|+.+++++. ||||+++++++.... ...
T Consensus 26 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~ 105 (337)
T 3ll6_A 26 GELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTG 105 (337)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTS
T ss_pred cCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccC
Confidence 3457999999999999999999998899999999997666666778999999999995 999999999874321 245
Q ss_pred CceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCC--ceeccCCCCCeeecCC
Q 045798 758 NDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEP--ILHCDLKPSNILLDND 835 (1008)
Q Consensus 758 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~--ivH~Dlkp~NIll~~~ 835 (1008)
....++||||+ +|+|.+++...... ..+++..++.++.||+.||+|||+. + |+||||||+||+++.+
T Consensus 106 ~~~~~lv~e~~-~g~L~~~l~~~~~~-------~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~ 174 (337)
T 3ll6_A 106 QAEFLLLTELC-KGQLVEFLKKMESR-------GPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQ 174 (337)
T ss_dssp SEEEEEEEECC-SEEHHHHHHHHHTT-------CSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTT
T ss_pred CceEEEEEEec-CCCHHHHHHHhhcc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCC
Confidence 56689999999 57999988652211 1689999999999999999999997 7 9999999999999999
Q ss_pred CCeEEcccCcccccccccCccc--------cccccccccccccCcccc---CCCCCCcccchhhHHHHHHHHHhCCCCCC
Q 045798 836 LSGHIGDFGLARFHQEVSNSTL--------SSSVGVKGTIGYTAPEYG---LGSEVSTNGDVYSYGILLLEMVTAKKPTD 904 (1008)
Q Consensus 836 ~~~kL~Dfg~a~~~~~~~~~~~--------~~~~~~~gt~~y~aPE~~---~~~~~~~~sDvwslG~vl~elltG~~pf~ 904 (1008)
+.+||+|||+++.......... .......||+.|+|||++ .+..++.++|||||||++|||++|+.||.
T Consensus 175 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~ 254 (337)
T 3ll6_A 175 GTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFE 254 (337)
T ss_dssp SCEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-
T ss_pred CCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCc
Confidence 9999999999987654332111 011134589999999998 56678999999999999999999999986
Q ss_pred ccccCCccHHHHHHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHH
Q 045798 905 VMFEGDLNLHNFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNV 984 (1008)
Q Consensus 905 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev 984 (1008)
...... . ......... ....+..+.+++.+||+.||.+|||+.|+
T Consensus 255 ~~~~~~-----~------------~~~~~~~~~------------------~~~~~~~~~~li~~~l~~~p~~Rps~~e~ 299 (337)
T 3ll6_A 255 DGAKLR-----I------------VNGKYSIPP------------------HDTQYTVFHSLIRAMLQVNPEERLSIAEV 299 (337)
T ss_dssp ----------------------------CCCCT------------------TCCSSGGGHHHHHHHSCSSGGGSCCHHHH
T ss_pred chhHHH-----h------------hcCcccCCc------------------ccccchHHHHHHHHHccCChhhCcCHHHH
Confidence 321110 0 000000000 00112236789999999999999999999
Q ss_pred HHHHHHHHHH
Q 045798 985 VHELQSVKNI 994 (1008)
Q Consensus 985 l~~L~~i~~~ 994 (1008)
++.|+.+...
T Consensus 300 l~~l~~~~~~ 309 (337)
T 3ll6_A 300 VHQLQEIAAA 309 (337)
T ss_dssp HHHHHHHHHH
T ss_pred HHHHHHHHhc
Confidence 9999998764
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=346.16 Aligned_cols=258 Identities=26% Similarity=0.382 Sum_probs=206.2
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccchhhHHHHHHHHHHhhcCCCCceeeeeccccccc-------
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSCSSIDF------- 755 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~------- 755 (1008)
.++|++.+.||+|+||.||+|.+..+++.||+|+++... +.+.+|++++++++||||+++++++....+
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 85 (284)
T 2a19_B 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSK 85 (284)
T ss_dssp HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC------
T ss_pred ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccc
Confidence 457999999999999999999998899999999997542 356789999999999999999998654221
Q ss_pred ----cCCceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCee
Q 045798 756 ----QGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNIL 831 (1008)
Q Consensus 756 ----~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIl 831 (1008)
......++||||+++++|.+++..... ..+++..++.++.||+.||+|||+. +|+||||||+||+
T Consensus 86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil 154 (284)
T 2a19_B 86 NSSRSKTKCLFIQMEFCDKGTLEQWIEKRRG--------EKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIF 154 (284)
T ss_dssp ---CCEEEEEEEEECCCCSCBHHHHHHHGGG--------SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEE
T ss_pred cccccCcceEEEEEeccCCCCHHHHHhhccC--------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEE
Confidence 224568999999999999999975421 1689999999999999999999998 9999999999999
Q ss_pred ecCCCCeEEcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCc
Q 045798 832 LDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDL 911 (1008)
Q Consensus 832 l~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~ 911 (1008)
++.++.+||+|||.+........ .....||+.|+|||++.+..++.++||||||+++|||++|..|+....
T Consensus 155 ~~~~~~~kl~Dfg~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~---- 225 (284)
T 2a19_B 155 LVDTKQVKIGDFGLVTSLKNDGK-----RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETS---- 225 (284)
T ss_dssp EEETTEEEECCCTTCEESSCCSC-----CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHH----
T ss_pred EcCCCCEEECcchhheecccccc-----ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHH----
Confidence 99999999999999986654322 123458999999999999899999999999999999999998863210
Q ss_pred cHHHHHHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHHHHH
Q 045798 912 NLHNFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHELQSV 991 (1008)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~i 991 (1008)
.... ...+..+. ...+..+.+++.+||+.||.+|||+.|+++.|+.+
T Consensus 226 ---~~~~--------~~~~~~~~----------------------~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~ 272 (284)
T 2a19_B 226 ---KFFT--------DLRDGIIS----------------------DIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVW 272 (284)
T ss_dssp ---HHHH--------HHHTTCCC----------------------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---HHHH--------Hhhccccc----------------------ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 0000 00000000 01234578999999999999999999999999988
Q ss_pred HHHHHH
Q 045798 992 KNILLE 997 (1008)
Q Consensus 992 ~~~~~~ 997 (1008)
++....
T Consensus 273 ~~~~~~ 278 (284)
T 2a19_B 273 KKSPEK 278 (284)
T ss_dssp TC----
T ss_pred hhCCCc
Confidence 766443
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-37 Score=357.12 Aligned_cols=347 Identities=26% Similarity=0.359 Sum_probs=222.9
Q ss_pred cCCCCCCEEEccCCCCCCccCcccccCcCcceEeeeccccccCCCccccccCCCCeeecccccCCCCCCCCCccccccch
Q 045798 99 GRLFRLEALFLSNNSLVGKIPANLSYCSRLTVLCIEYNKLQGRIPLEFVSLSKLKDLSLAKNKLTGGIPPFLGNLTSLEV 178 (1008)
Q Consensus 99 ~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~ 178 (1008)
..+.+|+.|++++|.+. .+|. +..+++|++|+|++|.+++..+ +.++++|++|++++|++++..+ ++++++|++
T Consensus 43 ~~l~~l~~L~l~~~~i~-~l~~-~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~ 116 (466)
T 1o6v_A 43 TDLDQVTTLQADRLGIK-SIDG-VEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTG 116 (466)
T ss_dssp HHHHTCCEEECCSSCCC-CCTT-GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GTTCTTCCE
T ss_pred hHhccccEEecCCCCCc-cCcc-hhhhcCCCEEECCCCccCCchh--hhccccCCEEECCCCccccChh--hcCCCCCCE
Confidence 45788999999999998 4664 8889999999999999996544 8899999999999999985544 888999999
Q ss_pred hhcccccCCCCCCccccCCCCCcEEEecCCcccccCCccccCCCCcceeccccccccccCChhhhhcCCCCcEEEecccc
Q 045798 179 LSLAGNSFGRNIPDSLGQLKQLKILAIGGNNLSGPIPPSIYNLSFLVVFSVSHNQIHGSLPPSLGLLLPNLKFFQIHHNF 258 (1008)
Q Consensus 179 L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~~~lp~~~~~~l~~L~~L~L~~N~ 258 (1008)
|++++|.+++..+ +..+++|++|++++|.+++. ..+..+++|+.|+++ |.+. .++. +..+++|+.|++++|.
T Consensus 117 L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~l~-~~~~-~~~~--~~~l~~L~~L~l~~n~ 188 (466)
T 1o6v_A 117 LTLFNNQITDIDP--LKNLTNLNRLELSSNTISDI--SALSGLTSLQQLSFG-NQVT-DLKP--LANLTTLERLDISSNK 188 (466)
T ss_dssp EECCSSCCCCCGG--GTTCTTCSEEEEEEEEECCC--GGGTTCTTCSEEEEE-ESCC-CCGG--GTTCTTCCEEECCSSC
T ss_pred EECCCCCCCCChH--HcCCCCCCEEECCCCccCCC--hhhccCCcccEeecC-Cccc-Cchh--hccCCCCCEEECcCCc
Confidence 9999999876543 88899999999999988853 347888888888886 4454 2322 4456777777777777
Q ss_pred CCCCCCcccccCCCCceeecccccccccccccccCCCcccccccccccCCCCCCCcccccccccccCCCcEEEecCCcCC
Q 045798 259 FSGSIPISLSNASKLEHIEIANNNFSGKLSVNFGGMKNLSLLNLQFSNLGSGESDEMGFMNSLTNCSKLRVLSLGGNQFR 338 (1008)
Q Consensus 259 l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~ 338 (1008)
+.+. ..+..+++|++|++++|.+.+..+ +..+++|+.|++++|++... ..+..+++
T Consensus 189 l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--------~~l~~l~~------------ 244 (466)
T 1o6v_A 189 VSDI--SVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--------GTLASLTN------------ 244 (466)
T ss_dssp CCCC--GGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC--------GGGGGCTT------------
T ss_pred CCCC--hhhccCCCCCEEEecCCccccccc--ccccCCCCEEECCCCCcccc--------hhhhcCCC------------
Confidence 7643 236677777777777777765544 44455555555555554432 12334444
Q ss_pred ccCChhhhhhcccceeeeeccccccCCCCCccccccccceEEecCccccCCcchhccCCCCCceEEccCCcccccccccc
Q 045798 339 GALPHSIANLSSQLQILILSSNQFYGSIPLGIGNLVDLYLLGMVENQFTGAIPKEMGKLQKLQGLDFSGNHFSGEIPSSL 418 (1008)
Q Consensus 339 ~~~p~~~~~l~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 418 (1008)
|++|++++|.+++..| +..+++|+.|++++|++++..+ +..+++|+.|+|++|++.+..+ +
T Consensus 245 -------------L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~ 305 (466)
T 1o6v_A 245 -------------LTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP--I 305 (466)
T ss_dssp -------------CSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCSCCGG--G
T ss_pred -------------CCEEECCCCccccchh--hhcCCCCCEEECCCCccCcccc--ccCCCccCeEEcCCCcccCchh--h
Confidence 4455555554443322 4455555555555555554333 5555666666666666654332 5
Q ss_pred cCCCCcceeeccccccccccCCCCcCCCcccEeecccccccCCcchhhhhhhhhhhhhcccCccccCCCccccccccccc
Q 045798 419 GNLSSLYEVFFNNNNLSGVIPFSLGNLKRLAFLEMSGNELSGTIPEDIFNISYLSNSLNLARNHLVGIIPPRIGNLRALR 498 (1008)
Q Consensus 419 ~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~lp~~~~~~~~~~~~L~L~~N~l~~~~p~~~~~l~~L~ 498 (1008)
..+++|+.|++++|.+++..| +..+++|+.|++++|++++ + ..++.+++|+
T Consensus 306 ~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~-~--------------------------~~l~~l~~L~ 356 (466)
T 1o6v_A 306 SNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSD-V--------------------------SSLANLTNIN 356 (466)
T ss_dssp GGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECCSSCCCC-C--------------------------GGGTTCTTCC
T ss_pred cCCCCCCEEECcCCcCCCchh--hccCccCCEeECCCCccCC-c--------------------------hhhccCCCCC
Confidence 555666666666666665444 4556666666666666652 1 1234445555
Q ss_pred ccccccccccCCCCcccccccccceeeccCccccc
Q 045798 499 SFDVSNNDLSGEIPIELGHCSSLEEIYLAGNLFHG 533 (1008)
Q Consensus 499 ~Ldls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 533 (1008)
.|++++|++++..| +..+++|+.|++++|++++
T Consensus 357 ~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~~~~ 389 (466)
T 1o6v_A 357 WLSAGHNQISDLTP--LANLTRITQLGLNDQAWTN 389 (466)
T ss_dssp EEECCSSCCCBCGG--GTTCTTCCEEECCCEEEEC
T ss_pred EEeCCCCccCccch--hhcCCCCCEEeccCCcccC
Confidence 55555555554443 4455555555555555553
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=353.47 Aligned_cols=278 Identities=23% Similarity=0.313 Sum_probs=195.9
Q ss_pred cCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccc-hhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceEE
Q 045798 684 NGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCE-GASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKA 762 (1008)
Q Consensus 684 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 762 (1008)
++|++.+.||+|+||+||+|.+..+++.||+|+++.... .....+.+|++++++++||||+++++++ ..++..+
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~~ 76 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII-----HTEKSLT 76 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEE-----ECSSCEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEE-----eeCCEEE
Confidence 579999999999999999999988999999999975432 2223566899999999999999999995 4566799
Q ss_pred EEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEcc
Q 045798 763 IVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGD 842 (1008)
Q Consensus 763 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 842 (1008)
+||||++ |+|.+++..... .+++..++.++.||+.||+|||+. +|+||||||+||+++.++.+||+|
T Consensus 77 lv~e~~~-~~l~~~~~~~~~---------~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~D 143 (324)
T 3mtl_A 77 LVFEYLD-KDLKQYLDDCGN---------IINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLAD 143 (324)
T ss_dssp EEEECCS-EEHHHHHHHTTT---------CCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECS
T ss_pred EEecccc-cCHHHHHHhcCC---------CCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEcc
Confidence 9999996 699998876532 589999999999999999999998 999999999999999999999999
Q ss_pred cCcccccccccCccccccccccccccccCccccCC-CCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHhhC
Q 045798 843 FGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLG-SEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMAL 921 (1008)
Q Consensus 843 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~~~ 921 (1008)
||+++........ .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||......+ ..........
T Consensus 144 fg~a~~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~i~~~~~ 218 (324)
T 3mtl_A 144 FGLARAKSIPTKT----YDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEE-QLHFIFRILG 218 (324)
T ss_dssp SSEEECC----------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHC
T ss_pred CcccccccCCccc----cccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhC
Confidence 9999855432221 223458999999999876 568999999999999999999999997532211 1111111111
Q ss_pred CcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 922 PNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 922 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
... ............ .....................+.++.+++.+||+.||++|||++|+++
T Consensus 219 ~~~-~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 281 (324)
T 3mtl_A 219 TPT-EETWPGILSNEE-FKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK 281 (324)
T ss_dssp CCC-TTTSTTGGGCHH-HHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred CCC-hHhchhhhcchh-hcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 110 000000000000 000000000000000011124556789999999999999999999986
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-38 Score=351.71 Aligned_cols=257 Identities=21% Similarity=0.319 Sum_probs=203.2
Q ss_pred HHHHHhcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccc--------hhhHHHHHHHHHHhhc-CCCCceeeee
Q 045798 678 SLLKATNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCE--------GASKSFMAECKALKNI-RHRNLVKVIT 748 (1008)
Q Consensus 678 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l-~h~niv~~~~ 748 (1008)
......++|++.+.||+|+||.||+|.+..+|+.||||+++.... ...+.+.+|+++++++ +||||+++++
T Consensus 88 ~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 167 (365)
T 2y7j_A 88 AAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLID 167 (365)
T ss_dssp HHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEE
T ss_pred hhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEE
Confidence 334456789999999999999999999988899999999875431 1245688999999999 8999999999
Q ss_pred ccccccccCCceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCC
Q 045798 749 SCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPS 828 (1008)
Q Consensus 749 ~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~ 828 (1008)
++ ......++||||+++++|.+++.... .+++..+..++.||+.||+|||+. ||+||||||+
T Consensus 168 ~~-----~~~~~~~lv~e~~~g~~L~~~l~~~~----------~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~ 229 (365)
T 2y7j_A 168 SY-----ESSSFMFLVFDLMRKGELFDYLTEKV----------ALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPE 229 (365)
T ss_dssp EE-----EBSSEEEEEECCCTTCBHHHHHHHHS----------SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGG
T ss_pred EE-----eeCCEEEEEEEeCCCCcHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHH
Confidence 84 45677999999999999999987543 689999999999999999999998 9999999999
Q ss_pred CeeecCCCCeEEcccCcccccccccCccccccccccccccccCccccCC------CCCCcccchhhHHHHHHHHHhCCCC
Q 045798 829 NILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLG------SEVSTNGDVYSYGILLLEMVTAKKP 902 (1008)
Q Consensus 829 NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~sDvwslG~vl~elltG~~p 902 (1008)
||+++.++.+||+|||++........ .....||+.|+|||++.+ ..++.++|||||||++|||++|+.|
T Consensus 230 NIl~~~~~~ikl~DfG~~~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~p 304 (365)
T 2y7j_A 230 NILLDDNMQIRLSDFGFSCHLEPGEK-----LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPP 304 (365)
T ss_dssp GEEECTTCCEEECCCTTCEECCTTCC-----BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCS
T ss_pred HEEECCCCCEEEEecCcccccCCCcc-----cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCC
Confidence 99999999999999999986654322 123568999999998753 3588999999999999999999999
Q ss_pred CCccccCCccHHHHHHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHH
Q 045798 903 TDVMFEGDLNLHNFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMT 982 (1008)
Q Consensus 903 f~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ 982 (1008)
|...... ........ ..... ..+.....+..+.+++.+||+.||++|||++
T Consensus 305 f~~~~~~-~~~~~i~~------------~~~~~----------------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ 355 (365)
T 2y7j_A 305 FWHRRQI-LMLRMIME------------GQYQF----------------SSPEWDDRSSTVKDLISRLLQVDPEARLTAE 355 (365)
T ss_dssp SCCSSHH-HHHHHHHH------------TCCCC----------------CHHHHSSSCHHHHHHHHHHSCSSTTTSCCHH
T ss_pred CCCCCHH-HHHHHHHh------------CCCCC----------------CCcccccCCHHHHHHHHHHcCCChhHCcCHH
Confidence 8642110 00000000 00000 0001112345689999999999999999999
Q ss_pred HHHH
Q 045798 983 NVVH 986 (1008)
Q Consensus 983 evl~ 986 (1008)
|+++
T Consensus 356 ell~ 359 (365)
T 2y7j_A 356 QALQ 359 (365)
T ss_dssp HHHH
T ss_pred HHhc
Confidence 9986
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=351.15 Aligned_cols=282 Identities=20% Similarity=0.183 Sum_probs=197.8
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccc--cchhhHHHHHHHHHHhhcCCCCceeeeecccccc-ccCCc
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQ--CEGASKSFMAECKALKNIRHRNLVKVITSCSSID-FQGND 759 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~~~ 759 (1008)
.++|++.+.||+|+||.||+|.+..+++.||||++... .....+.+.+|+.+++.++||||+++++++.... .....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 46899999999999999999999989999999999753 2344567899999999999999999999965432 23334
Q ss_pred eEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeE
Q 045798 760 FKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGH 839 (1008)
Q Consensus 760 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 839 (1008)
..++||||++ ++|.+++.. .+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+|
T Consensus 104 ~~~lv~e~~~-~~l~~~~~~------------~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~k 167 (371)
T 2xrw_A 104 DVYIVMELMD-ANLCQVIQM------------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLK 167 (371)
T ss_dssp EEEEEEECCS-EEHHHHHHS------------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEE
T ss_pred ceEEEEEcCC-CCHHHHHhh------------ccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEE
Confidence 7899999995 578888742 578899999999999999999998 999999999999999999999
Q ss_pred EcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHh
Q 045798 840 IGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARM 919 (1008)
Q Consensus 840 L~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~ 919 (1008)
|+|||+++....... .....||+.|+|||++.+..++.++|||||||++|||++|+.||......+ .+......
T Consensus 168 l~Dfg~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~i~~~ 241 (371)
T 2xrw_A 168 ILDFGLARTAGTSFM-----MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHID-QWNKVIEQ 241 (371)
T ss_dssp ECCCCC---------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHC-
T ss_pred EEEeecccccccccc-----cCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHH
Confidence 999999986543211 123458999999999999999999999999999999999999986432111 11111110
Q ss_pred hCCcchhhhhccc---c----cCchH----HhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 045798 920 ALPNQVMDIVDPI---L----RNDEE----ILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHE 987 (1008)
Q Consensus 920 ~~~~~~~~~~d~~---l----~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 987 (1008)
......+..... . ...+. ..........++.........+.++.+++.+||+.||++|||++|+++.
T Consensus 242 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 319 (371)
T 2xrw_A 242 -LGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 319 (371)
T ss_dssp -CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred -hCCCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence 000000000000 0 00000 0000000000111111223457789999999999999999999999873
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-38 Score=342.23 Aligned_cols=254 Identities=24% Similarity=0.283 Sum_probs=196.2
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEecccc-chhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceE
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC-EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFK 761 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 761 (1008)
.++|.+.+.||+|+||.||+|.+..+++.||+|++.... ....+.+.+|++++++++||||+++++++ .+....
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~~ 95 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF-----EDYHNM 95 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECSSEE
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHhe-----ecCCeE
Confidence 357999999999999999999999899999999997543 33457899999999999999999999995 456679
Q ss_pred EEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeee---cCCCCe
Q 045798 762 AIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILL---DNDLSG 838 (1008)
Q Consensus 762 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~ 838 (1008)
++||||+++|+|.+++..... ....+++..++.++.|++.||+|||+. +|+||||||+||++ +.++.+
T Consensus 96 ~lv~e~~~~~~L~~~l~~~~~------~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~ 166 (285)
T 3is5_A 96 YIVMETCEGGELLERIVSAQA------RGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPI 166 (285)
T ss_dssp EEEECCCSCCBHHHHHHHHHH------HTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCE
T ss_pred EEEEEeCCCCcHHHHHHhhhh------cccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCE
Confidence 999999999999998854311 012689999999999999999999998 99999999999999 456889
Q ss_pred EEcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHH
Q 045798 839 HIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFAR 918 (1008)
Q Consensus 839 kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~ 918 (1008)
||+|||++........ .....||+.|+|||++. ..++.++||||||+++|||++|+.||......+ ......
T Consensus 167 kl~Dfg~a~~~~~~~~-----~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~--~~~~~~ 238 (285)
T 3is5_A 167 KIIDFGLAELFKSDEH-----STNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEE--VQQKAT 238 (285)
T ss_dssp EECCCCCCCC---------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHH
T ss_pred EEEeeecceecCCccc-----CcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHH--HHhhhc
Confidence 9999999986544322 12345899999999875 568999999999999999999999986432110 000000
Q ss_pred hhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 919 MALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 919 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
...+ .... .....+.++.+++.+||+.||++|||+.|+++
T Consensus 239 ~~~~---------~~~~-------------------~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 239 YKEP---------NYAV-------------------ECRPLTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp HCCC---------CCCC---------------------CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred cCCc---------cccc-------------------ccCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0000 0000 00012345789999999999999999999985
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=356.32 Aligned_cols=274 Identities=14% Similarity=0.150 Sum_probs=205.8
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcC--------CCeEEEEEEeccccchhhHHHHHHHHHHhhcCCCCceeeeecccc--
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDE--------DGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSCSS-- 752 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-- 752 (1008)
.++|++.+.||+|+||.||+|++.. .++.||+|++... +.+.+|++++++++||||+++++....
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 3689999999999999999999976 4889999998643 468899999999999999984332111
Q ss_pred ---------ccccCCceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceec
Q 045798 753 ---------IDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHC 823 (1008)
Q Consensus 753 ---------~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~ 823 (1008)
.....+...++||||+ +++|.+++..... ..+++..++.++.||+.||+|||+. +|+||
T Consensus 116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~--------~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~ 183 (352)
T 2jii_A 116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPK--------HVLSERSVLQVACRLLDALEFLHEN---EYVHG 183 (352)
T ss_dssp TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGG--------GCCCHHHHHHHHHHHHHHHHHHHHT---TCBCS
T ss_pred ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCc--------CCCCHHHHHHHHHHHHHHHHHHHhC---CccCC
Confidence 0122367789999999 9999999976521 2789999999999999999999998 99999
Q ss_pred cCCCCCeeecCCC--CeEEcccCcccccccccCccc---cccccccccccccCccccCCCCCCcccchhhHHHHHHHHHh
Q 045798 824 DLKPSNILLDNDL--SGHIGDFGLARFHQEVSNSTL---SSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT 898 (1008)
Q Consensus 824 Dlkp~NIll~~~~--~~kL~Dfg~a~~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt 898 (1008)
||||+||+++.++ .+||+|||+++.......... .......||+.|+|||++.+..++.++|||||||++|||++
T Consensus 184 Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~ 263 (352)
T 2jii_A 184 NVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLY 263 (352)
T ss_dssp CCCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred CCCHHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHh
Confidence 9999999999998 899999999987654332111 11233469999999999999999999999999999999999
Q ss_pred CCCCCCccccCCccHHHHHHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCC
Q 045798 899 AKKPTDVMFEGDLNLHNFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDR 978 (1008)
Q Consensus 899 G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R 978 (1008)
|+.||................. ......+.+. .......+.++.+++.+||+.||++|
T Consensus 264 g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~---------------------~~~~~~~~~~l~~li~~~l~~dp~~R 321 (352)
T 2jii_A 264 GFLPWTNCLPNTEDIMKQKQKF-VDKPGPFVGP---------------------CGHWIRPSETLQKYLKVVMALTYEEK 321 (352)
T ss_dssp SCCTTGGGTTCHHHHHHHHHHH-HHSCCCEECT---------------------TSCEECCCHHHHHHHHHHHTCCTTCC
T ss_pred CCCCcccCCcCHHHHHHHHHhc-cCChhhhhhh---------------------ccccCCCcHHHHHHHHHHHhCChhhC
Confidence 9999975432211111111100 0000000000 00001134568999999999999999
Q ss_pred CCHHHHHHHHHHHHHHH
Q 045798 979 MNMTNVVHELQSVKNIL 995 (1008)
Q Consensus 979 Pt~~evl~~L~~i~~~~ 995 (1008)
||++||++.|+++.+..
T Consensus 322 ps~~~l~~~L~~~~~~~ 338 (352)
T 2jii_A 322 PPYAMLRNNLEALLQDL 338 (352)
T ss_dssp CCHHHHHHHHHHHHHHT
T ss_pred CCHHHHHHHHHHHHHhc
Confidence 99999999999887653
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=369.16 Aligned_cols=256 Identities=30% Similarity=0.453 Sum_probs=199.9
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccchhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceEE
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKA 762 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 762 (1008)
.++|++.+.||+|+||.||+|.+. .+..||||+++... ...+.+.+|++++++++||||+++++++.. +..+
T Consensus 183 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~------~~~~ 254 (452)
T 1fmk_A 183 RESLRLEVKLGQGCFGEVWMGTWN-GTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EPIY 254 (452)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS------SSCE
T ss_pred hhHceeeeeecCCCCeEEEEEEEC-CCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC------CceE
Confidence 467889999999999999999996 56789999998543 335689999999999999999999998632 4579
Q ss_pred EEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEcc
Q 045798 763 IVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGD 842 (1008)
Q Consensus 763 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 842 (1008)
+||||+++|+|.+++.... ...+++.++..++.||+.||+|||+. +|+||||||+||++++++.+||+|
T Consensus 255 iv~e~~~~gsL~~~l~~~~--------~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~D 323 (452)
T 1fmk_A 255 IVTEYMSKGSLLDFLKGET--------GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVAD 323 (452)
T ss_dssp EEECCCTTCBHHHHHSHHH--------HTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECC
T ss_pred EEehhhcCCCHHHHHHhcC--------CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECC
Confidence 9999999999999997432 11589999999999999999999998 999999999999999999999999
Q ss_pred cCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCccccCCccHHHHHHhhC
Q 045798 843 FGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT-AKKPTDVMFEGDLNLHNFARMAL 921 (1008)
Q Consensus 843 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-G~~pf~~~~~~~~~~~~~~~~~~ 921 (1008)
||+++........ ......++..|+|||++.+..++.++|||||||++|||++ |+.||...... ....
T Consensus 324 fG~a~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~-----~~~~--- 392 (452)
T 1fmk_A 324 FGLARLIEDNEYT---ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR-----EVLD--- 392 (452)
T ss_dssp CCTTC-----------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-----HHHH---
T ss_pred CccceecCCCcee---cccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHH-----HHHH---
Confidence 9999866432211 1223347889999999988899999999999999999999 99998642111 0000
Q ss_pred CcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHHHHHH
Q 045798 922 PNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHELQSVK 992 (1008)
Q Consensus 922 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~i~ 992 (1008)
.+... .+++ ....++..+.+++.+||+.||++|||++++++.|+.+.
T Consensus 393 ------~i~~~--------------~~~~----~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~ 439 (452)
T 1fmk_A 393 ------QVERG--------------YRMP----CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 439 (452)
T ss_dssp ------HHHTT--------------CCCC----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred ------HHHcC--------------CCCC----CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 00000 0000 01134567899999999999999999999999998754
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=342.23 Aligned_cols=247 Identities=23% Similarity=0.361 Sum_probs=202.0
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEecccc---chhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCc
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC---EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGND 759 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 759 (1008)
.++|++.+.||+|+||.||+|.+..+++.||+|++.... ....+.+.+|++++++++||||+++++++ ..++
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~ 87 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYF-----HDRK 87 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECSS
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEE-----EcCC
Confidence 467999999999999999999998899999999986432 23346799999999999999999999994 4567
Q ss_pred eEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeE
Q 045798 760 FKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGH 839 (1008)
Q Consensus 760 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 839 (1008)
..++||||+++++|.+++.... .+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+|
T Consensus 88 ~~~lv~e~~~~~~L~~~l~~~~----------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~k 154 (284)
T 2vgo_A 88 RIYLMLEFAPRGELYKELQKHG----------RFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELK 154 (284)
T ss_dssp EEEEEECCCTTEEHHHHHHHHS----------SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEE
T ss_pred EEEEEEEeCCCCcHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEE
Confidence 7999999999999999997543 689999999999999999999997 999999999999999999999
Q ss_pred EcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHh
Q 045798 840 IGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARM 919 (1008)
Q Consensus 840 L~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~ 919 (1008)
|+|||.+....... .....|++.|+|||++.+..++.++||||||+++|+|++|+.||......+ ...
T Consensus 155 l~Dfg~~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-----~~~- 222 (284)
T 2vgo_A 155 IADFGWSVHAPSLR------RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTE-----THR- 222 (284)
T ss_dssp ECCCTTCEECSSSC------BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH-----HHH-
T ss_pred EecccccccCcccc------cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhH-----HHH-
Confidence 99999997544321 123458999999999999999999999999999999999999986431110 000
Q ss_pred hCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 920 ALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 920 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
.+..... .++ ...+..+.+++.+||+.||.+|||++|+++
T Consensus 223 -------~~~~~~~--------------~~~------~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 223 -------RIVNVDL--------------KFP------PFLSDGSKDLISKLLRYHPPQRLPLKGVME 262 (284)
T ss_dssp -------HHHTTCC--------------CCC------TTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred -------HHhcccc--------------CCC------CcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence 0000000 000 012445789999999999999999999986
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-39 Score=356.42 Aligned_cols=276 Identities=22% Similarity=0.347 Sum_probs=211.1
Q ss_pred HHHHHHHhcCCCCCceEeeccCeeEEEEEEc-----CCCeEEEEEEeccccc-hhhHHHHHHHHHHhhcCCCCceeeeec
Q 045798 676 YKSLLKATNGFSSTHLIGVGSFGCVYKGALD-----EDGIVVAIKVINLQCE-GASKSFMAECKALKNIRHRNLVKVITS 749 (1008)
Q Consensus 676 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~ 749 (1008)
.++.....++|++.+.||+|+||.||+|.+. .+++.||+|++..... .....+.+|++++++++||||++++++
T Consensus 17 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~ 96 (322)
T 1p4o_A 17 PDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGV 96 (322)
T ss_dssp CCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEE
T ss_pred hhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEE
Confidence 3344456788999999999999999999875 3578899999975432 345679999999999999999999999
Q ss_pred cccccccCCceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCC
Q 045798 750 CSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSN 829 (1008)
Q Consensus 750 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~N 829 (1008)
+ ..++..++||||+++|+|.+++...............+++..++.++.||+.||+|||+. +|+||||||+|
T Consensus 97 ~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~N 168 (322)
T 1p4o_A 97 V-----SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARN 168 (322)
T ss_dssp E-----CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGG
T ss_pred E-----ccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccce
Confidence 5 455678999999999999999875321000000012578999999999999999999998 99999999999
Q ss_pred eeecCCCCeEEcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCcccc
Q 045798 830 ILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT-AKKPTDVMFE 908 (1008)
Q Consensus 830 Ill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-G~~pf~~~~~ 908 (1008)
|+++.++.+||+|||+++......... ......+|+.|+|||++.+..++.++|||||||++|||++ |..||.....
T Consensus 169 Ili~~~~~~kl~Dfg~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~ 246 (322)
T 1p4o_A 169 CMVAEDFTVKIGDFGMTRDIYETDYYR--KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN 246 (322)
T ss_dssp EEECTTCCEEECCTTCCCGGGGGGCEE--GGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH
T ss_pred EEEcCCCeEEECcCccccccccccccc--cccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCH
Confidence 999999999999999998654432211 1223457889999999988889999999999999999999 8888864211
Q ss_pred CCccHHHHHHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHH
Q 045798 909 GDLNLHNFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHEL 988 (1008)
Q Consensus 909 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 988 (1008)
. ...... ....... ....++..+.+++.+||+.||.+|||+.|+++.|
T Consensus 247 ~-----~~~~~~--------~~~~~~~-------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L 294 (322)
T 1p4o_A 247 E-----QVLRFV--------MEGGLLD-------------------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSI 294 (322)
T ss_dssp H-----HHHHHH--------HTTCCCC-------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred H-----HHHHHH--------HcCCcCC-------------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 1 010000 0000000 0012345688999999999999999999999999
Q ss_pred HHHHH
Q 045798 989 QSVKN 993 (1008)
Q Consensus 989 ~~i~~ 993 (1008)
+++..
T Consensus 295 ~~~~~ 299 (322)
T 1p4o_A 295 KEEME 299 (322)
T ss_dssp GGGSC
T ss_pred HHhhc
Confidence 87643
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=353.81 Aligned_cols=252 Identities=25% Similarity=0.353 Sum_probs=192.5
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEecccc--chhhHHHHHHHHHHhhcCC--CCceeeeeccccccccCC
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC--EGASKSFMAECKALKNIRH--RNLVKVITSCSSIDFQGN 758 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~~~ 758 (1008)
.++|++.+.||+|+||.||+|.+. +++.||||++.... ....+.+.+|++++++++| |||+++++++ ..+
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~-----~~~ 81 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE-----ITD 81 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEE-----ECS
T ss_pred cCEEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeE-----eeC
Confidence 467999999999999999999985 78999999987543 3345779999999999976 9999999994 456
Q ss_pred ceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCe
Q 045798 759 DFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSG 838 (1008)
Q Consensus 759 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 838 (1008)
...++|||+ .+++|.+++.... .+++.++..++.||+.||+|||+. +|+||||||+||+++ ++.+
T Consensus 82 ~~~~lv~e~-~~~~L~~~l~~~~----------~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~ 146 (343)
T 3dbq_A 82 QYIYMVMEC-GNIDLNSWLKKKK----------SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGML 146 (343)
T ss_dssp SEEEEEECC-CSEEHHHHHHHSC----------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEE
T ss_pred CEEEEEEeC-CCCCHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcE
Confidence 679999995 5889999997654 689999999999999999999998 999999999999997 5789
Q ss_pred EEcccCcccccccccCccccccccccccccccCccccCC-----------CCCCcccchhhHHHHHHHHHhCCCCCCccc
Q 045798 839 HIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLG-----------SEVSTNGDVYSYGILLLEMVTAKKPTDVMF 907 (1008)
Q Consensus 839 kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDvwslG~vl~elltG~~pf~~~~ 907 (1008)
||+|||+++......... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||....
T Consensus 147 kl~DFG~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 224 (343)
T 3dbq_A 147 KLIDFGIANQMQPDTTSV--VKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII 224 (343)
T ss_dssp EECCCSSSCCC--------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred EEeecccccccCcccccc--cCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhh
Confidence 999999998665432221 1223569999999999754 678899999999999999999999986432
Q ss_pred cCCccHHHHHHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 045798 908 EGDLNLHNFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHE 987 (1008)
Q Consensus 908 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 987 (1008)
....... ..+++..... ++ ...+.++.+++.+||+.||.+|||+.|+++.
T Consensus 225 ~~~~~~~------------~~~~~~~~~~------------~~------~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 225 NQISKLH------------AIIDPNHEIE------------FP------DIPEKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp SHHHHHH------------HHHCTTSCCC------------CC------CCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hHHHHHH------------HHhcCCcccC------------Cc------ccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 2111111 1111100000 00 0123457899999999999999999999864
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-39 Score=363.74 Aligned_cols=261 Identities=16% Similarity=0.136 Sum_probs=194.8
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEecc---ccchhhHHHHHHHH---HHhhcCCCCceeeeecccccc--
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINL---QCEGASKSFMAECK---ALKNIRHRNLVKVITSCSSID-- 754 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~---~~~~~~~~~~~E~~---~l~~l~h~niv~~~~~~~~~~-- 754 (1008)
.++|++.+.||+|+||.||+|.+..+|+.||||+++. ......+.+.+|++ ++++++||||+++++.+....
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 4678999999999999999999988899999999973 23445678999994 555558999999985433110
Q ss_pred ccCC------------c-----eEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCC
Q 045798 755 FQGN------------D-----FKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQ 817 (1008)
Q Consensus 755 ~~~~------------~-----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ 817 (1008)
+..+ + ..|+||||+ +|+|.+++....... +....+++..++.|+.||+.||+|||+.
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~---~~~~~l~~~~~~~i~~qi~~aL~~LH~~-- 225 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHS---STHKSLVHHARLQLTLQVIRLLASLHHY-- 225 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTT---TTTHHHHHHHHHHHHHHHHHHHHHHHHT--
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccc---cccccccHHHHHHHHHHHHHHHHHHHhC--
Confidence 1111 1 378999999 689999997542110 0112456788999999999999999998
Q ss_pred CCceeccCCCCCeeecCCCCeEEcccCcccccccccCccccccccccccccccCccccCCC-----------CCCcccch
Q 045798 818 EPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGS-----------EVSTNGDV 886 (1008)
Q Consensus 818 ~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~sDv 886 (1008)
+|+||||||+|||++.++.+||+|||+|+..... .....| +.|+|||++.+. .++.++||
T Consensus 226 -~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~-------~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Dv 296 (377)
T 3byv_A 226 -GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAR-------VVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDA 296 (377)
T ss_dssp -TEECSCCCGGGEEECTTCCEEECCGGGCEETTCE-------EECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHH
T ss_pred -CeecCCCCHHHEEEcCCCCEEEEechhheecCCc-------ccCCCC-cCccChhhhcccccccccccccccCChhhhH
Confidence 9999999999999999999999999999853321 123457 999999998877 89999999
Q ss_pred hhHHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHH
Q 045798 887 YSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKI 966 (1008)
Q Consensus 887 wslG~vl~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 966 (1008)
|||||++|||++|+.||........ ...... .. ...+.++.++
T Consensus 297 wSlG~il~elltg~~Pf~~~~~~~~-------------~~~~~~-~~-----------------------~~~~~~~~~l 339 (377)
T 3byv_A 297 WALGLVIYWIWCADLPITKDAALGG-------------SEWIFR-SC-----------------------KNIPQPVRAL 339 (377)
T ss_dssp HHHHHHHHHHHHSSCCC------CC-------------SGGGGS-SC-----------------------CCCCHHHHHH
T ss_pred HHHHHHHHHHHHCCCCCcccccccc-------------hhhhhh-hc-----------------------cCCCHHHHHH
Confidence 9999999999999999864321110 000000 00 0124567899
Q ss_pred HhcccCcCCCCCCCHHHHHH--HHHHHHHHH
Q 045798 967 GVACSMESPQDRMNMTNVVH--ELQSVKNIL 995 (1008)
Q Consensus 967 i~~cl~~dP~~RPt~~evl~--~L~~i~~~~ 995 (1008)
+.+||+.||++|||+.|+++ .++++.+..
T Consensus 340 i~~~L~~dp~~Rpt~~e~l~hp~f~~~~~~~ 370 (377)
T 3byv_A 340 LEGFLRYPKEDRLLPLQAMETPEYEQLRTEL 370 (377)
T ss_dssp HHHHTCSSGGGCCCHHHHHTSHHHHHHHHHH
T ss_pred HHHHcCCCchhCCCHHHHhhChHHHHHHHHH
Confidence 99999999999999999997 455555443
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-38 Score=343.59 Aligned_cols=250 Identities=21% Similarity=0.270 Sum_probs=203.6
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEecccc---chhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCc
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC---EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGND 759 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 759 (1008)
.++|.+.+.||+|+||.||+|.+..+++.||+|++.... ....+.+.+|+.+++.++||||+++++++ ..++
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~~ 88 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFF-----EDND 88 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECSS
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeee-----ccCC
Confidence 467999999999999999999999899999999986432 34456789999999999999999999995 4566
Q ss_pred eEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeE
Q 045798 760 FKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGH 839 (1008)
Q Consensus 760 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 839 (1008)
..++||||+++++|.+++.... .+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+|
T Consensus 89 ~~~lv~e~~~~~~L~~~~~~~~----------~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~k 155 (294)
T 2rku_A 89 FVFVVLELCRRRSLLELHKRRK----------ALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVK 155 (294)
T ss_dssp EEEEEEECCTTCBHHHHHHHHC----------SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEE
T ss_pred EEEEEEecCCCCCHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEE
Confidence 7999999999999999886543 689999999999999999999998 999999999999999999999
Q ss_pred EcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHh
Q 045798 840 IGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARM 919 (1008)
Q Consensus 840 L~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~ 919 (1008)
|+|||.+......... .....||+.|+|||++.+..++.++||||||+++|+|++|+.||...... ..+...
T Consensus 156 l~dfg~~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~----~~~~~~ 227 (294)
T 2rku_A 156 IGDFGLATKVEYDGER----KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK----ETYLRI 227 (294)
T ss_dssp ECCCTTCEECCSTTCC----BCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH----HHHHHH
T ss_pred EEeccCceecccCccc----cccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHH
Confidence 9999999865432221 12345899999999999988999999999999999999999998643211 001000
Q ss_pred hCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 045798 920 ALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHE 987 (1008)
Q Consensus 920 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 987 (1008)
. .... ..+ ...+..+.+++.+||+.||++|||++|+++.
T Consensus 228 ~---------~~~~--------------~~~------~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 228 K---------KNEY--------------SIP------KHINPVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp H---------TTCC--------------CCC------TTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred h---------hccC--------------CCc------cccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 0 0000 000 0123457899999999999999999999863
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-38 Score=365.79 Aligned_cols=251 Identities=26% Similarity=0.298 Sum_probs=200.9
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccc--cchhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCce
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQ--CEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDF 760 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 760 (1008)
.++|++.+.||+|+||+||+|.+..+++.||||++... .......+.+|++++++++||||+++++++ .....
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~-----~~~~~ 95 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEIL-----EDSSS 95 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECSSE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEE-----EcCCE
Confidence 46799999999999999999999989999999998633 233457899999999999999999999994 55677
Q ss_pred EEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeec---CCCC
Q 045798 761 KAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLD---NDLS 837 (1008)
Q Consensus 761 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~---~~~~ 837 (1008)
.++||||+++|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+||+++ .++.
T Consensus 96 ~~lv~e~~~~~~L~~~~~~~~----------~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~ 162 (486)
T 3mwu_A 96 FYIVGELYTGGELFDEIIKRK----------RFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCD 162 (486)
T ss_dssp EEEEECCCCSCBHHHHHHHHS----------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCC
T ss_pred EEEEEEcCCCCcHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCC
Confidence 999999999999999886543 789999999999999999999998 999999999999995 5567
Q ss_pred eEEcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHH
Q 045798 838 GHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFA 917 (1008)
Q Consensus 838 ~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~ 917 (1008)
+||+|||+++....... .....||+.|+|||++.+ .++.++||||+||++|+|++|+.||......+ ......
T Consensus 163 ~kl~Dfg~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~i~ 235 (486)
T 3mwu_A 163 IKIIDFGLSTCFQQNTK-----MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD-ILKRVE 235 (486)
T ss_dssp EEECSCSCTTTBCCC---------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHH
T ss_pred EEEEECCcCeECCCCCc-----cCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHH
Confidence 99999999986543321 223469999999999876 58999999999999999999999986431110 000110
Q ss_pred HhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 918 RMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 918 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
.... ....+.....+.++.+++.+||+.||.+|||+.|+++
T Consensus 236 ~~~~----------------------------~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~ 276 (486)
T 3mwu_A 236 TGKY----------------------------AFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (486)
T ss_dssp HTCC----------------------------CSCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred hCCC----------------------------CCCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 0000 0001111234556789999999999999999999987
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=352.83 Aligned_cols=279 Identities=22% Similarity=0.271 Sum_probs=200.7
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccc--hhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCce
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCE--GASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDF 760 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 760 (1008)
.++|++.+.||+|+||.||+|++..+++.||+|++..... ...+.+.+|++++++++||||+++++++ ...+.
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~ 98 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVC-----KKKKR 98 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----EETTE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEe-----ecCCE
Confidence 4679999999999999999999998899999999864432 3346688999999999999999999995 45667
Q ss_pred EEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEE
Q 045798 761 KAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHI 840 (1008)
Q Consensus 761 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 840 (1008)
.++||||+++++|.++..... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||
T Consensus 99 ~~lv~e~~~~~~l~~~~~~~~----------~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl 165 (331)
T 4aaa_A 99 WYLVFEFVDHTILDDLELFPN----------GLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKL 165 (331)
T ss_dssp EEEEEECCSEEHHHHHHHSTT----------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEE
T ss_pred EEEEEecCCcchHHHHHhhcc----------CCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEE
Confidence 899999999999988865443 689999999999999999999998 9999999999999999999999
Q ss_pred cccCcccccccccCccccccccccccccccCccccCCC-CCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHh
Q 045798 841 GDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGS-EVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARM 919 (1008)
Q Consensus 841 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~ 919 (1008)
+|||.++........ .....||+.|+|||++.+. .++.++||||+||++|+|++|+.||......+. .......
T Consensus 166 ~Dfg~~~~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~~~~~ 240 (331)
T 4aaa_A 166 CDFGFARTLAAPGEV----YDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQ-LYHIMMC 240 (331)
T ss_dssp CCCTTC----------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHH
T ss_pred EeCCCceeecCCccc----cCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHH-HHHHHHH
Confidence 999999865433221 1234589999999998775 789999999999999999999999864322111 1111111
Q ss_pred h--CCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 045798 920 A--LPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHE 987 (1008)
Q Consensus 920 ~--~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 987 (1008)
. ..+.........-..... .........+........+..+.+++.+||+.||++|||++|+++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 307 (331)
T 4aaa_A 241 LGNLIPRHQELFNKNPVFAGV---RLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH 307 (331)
T ss_dssp HCSCCHHHHHHHHHCGGGTTC---CCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred hCCCChhhhhHhhhccccccc---cCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0 000000000000000000 0000000000000011345678999999999999999999999873
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-38 Score=363.94 Aligned_cols=252 Identities=25% Similarity=0.337 Sum_probs=201.2
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEecccc---chhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCc
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC---EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGND 759 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 759 (1008)
.++|.+.+.||+|+||.||+|++..+|+.||+|++.... ....+.+.+|++++++++||||++++++ +...+
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~-----~~~~~ 258 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYA-----FETKT 258 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEE-----EECSS
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEE-----EeeCC
Confidence 467999999999999999999998899999999996432 2334678999999999999999999998 45667
Q ss_pred eEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeE
Q 045798 760 FKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGH 839 (1008)
Q Consensus 760 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 839 (1008)
..|+||||+++|+|.+++...... ...+++..++.++.||+.||+|||++ +|+||||||+||+++.++.+|
T Consensus 259 ~l~lVmE~~~gg~L~~~l~~~~~~------~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vk 329 (543)
T 3c4z_A 259 DLCLVMTIMNGGDIRYHIYNVDED------NPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVR 329 (543)
T ss_dssp EEEEEECCCTTCBHHHHHHTSSTT------SCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEE
T ss_pred EEEEEEEeccCCCHHHHHHHhhcc------cccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEE
Confidence 799999999999999998754321 11689999999999999999999998 999999999999999999999
Q ss_pred EcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHh
Q 045798 840 IGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARM 919 (1008)
Q Consensus 840 L~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~ 919 (1008)
|+|||+++........ .....||+.|+|||++.+..++.++|||||||++|||++|+.||....+.... ......
T Consensus 330 L~DFGla~~~~~~~~~----~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~-~~~~~~ 404 (543)
T 3c4z_A 330 ISDLGLAVELKAGQTK----TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN-KELKQR 404 (543)
T ss_dssp ECCCTTCEECCTTCCC----BCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCH-HHHHHH
T ss_pred EeecceeeeccCCCcc----cccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhH-HHHHHH
Confidence 9999999865443221 22346999999999999999999999999999999999999999753221111 111100
Q ss_pred hCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCH
Q 045798 920 ALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNM 981 (1008)
Q Consensus 920 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~ 981 (1008)
+..... .++ ...+..+.+++.+||+.||.+||++
T Consensus 405 --------i~~~~~--------------~~p------~~~s~~~~~li~~lL~~dP~~R~~~ 438 (543)
T 3c4z_A 405 --------VLEQAV--------------TYP------DKFSPASKDFCEALLQKDPEKRLGF 438 (543)
T ss_dssp --------HHHCCC--------------CCC------TTSCHHHHHHHHHHSCSSGGGSCCC
T ss_pred --------Hhhccc--------------CCC------cccCHHHHHHHHHhccCCHhHCCCC
Confidence 000000 000 1234567899999999999999975
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-38 Score=349.97 Aligned_cols=249 Identities=21% Similarity=0.264 Sum_probs=203.2
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccc---cchhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCc
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQ---CEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGND 759 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 759 (1008)
.++|.+.+.||+|+||.||+|.+..+++.||+|++... .....+.+.+|+.+++.++||||+++++++ .+.+
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~ 114 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFF-----EDND 114 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECSS
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----ecCC
Confidence 46799999999999999999999989999999998643 234557789999999999999999999995 4566
Q ss_pred eEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeE
Q 045798 760 FKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGH 839 (1008)
Q Consensus 760 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 839 (1008)
..++||||+++++|.+++.... .+++.+++.++.||+.||+|||+. +|+||||||+||+++.++.+|
T Consensus 115 ~~~lv~e~~~~~~L~~~~~~~~----------~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~k 181 (335)
T 2owb_A 115 FVFVVLELCRRRSLLELHKRRK----------ALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVK 181 (335)
T ss_dssp EEEEEECCCTTCBHHHHHHHHC----------SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEE
T ss_pred eEEEEEecCCCCCHHHHHhccC----------CCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEE
Confidence 7999999999999999886543 689999999999999999999998 999999999999999999999
Q ss_pred EcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHh
Q 045798 840 IGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARM 919 (1008)
Q Consensus 840 L~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~ 919 (1008)
|+|||++......... .....||..|+|||++.+..++.++||||||+++|||++|+.||...... ..+...
T Consensus 182 l~Dfg~~~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~----~~~~~~ 253 (335)
T 2owb_A 182 IGDFGLATKVEYDGER----KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK----ETYLRI 253 (335)
T ss_dssp ECCCTTCEECCSTTCC----BCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH----HHHHHH
T ss_pred EeeccCceecccCccc----ccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHH----HHHHHH
Confidence 9999999865432221 12345899999999999888999999999999999999999998642111 000000
Q ss_pred hCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 920 ALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 920 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
..... .++ ...+..+.+++.+||+.||++|||++|+++
T Consensus 254 ---------~~~~~--------------~~~------~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 291 (335)
T 2owb_A 254 ---------KKNEY--------------SIP------KHINPVAASLIQKMLQTDPTARPTINELLN 291 (335)
T ss_dssp ---------HHTCC--------------CCC------TTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred ---------hcCCC--------------CCC------ccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00000 000 012345789999999999999999999986
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=340.73 Aligned_cols=254 Identities=24% Similarity=0.341 Sum_probs=197.9
Q ss_pred cCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccchhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceEEE
Q 045798 684 NGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKAI 763 (1008)
Q Consensus 684 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 763 (1008)
++|.....||+|+||.||+|.+..+++.||+|+++.......+.+.+|+.+++.++||||+++++++ ...+..++
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~~~~~l 96 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF-----SENGFIKI 96 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEE-----EETTEEEE
T ss_pred cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEE-----EeCCcEEE
Confidence 3455666999999999999999889999999999876666678899999999999999999999995 45567899
Q ss_pred EEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecC-CCCeEEcc
Q 045798 764 VYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDN-DLSGHIGD 842 (1008)
Q Consensus 764 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kL~D 842 (1008)
||||+++++|.+++...... ..+++..+..++.|++.||+|||+. +|+||||||+||+++. ++.+||+|
T Consensus 97 v~e~~~~~~L~~~l~~~~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~D 166 (295)
T 2clq_A 97 FMEQVPGGSLSALLRSKWGP-------LKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISD 166 (295)
T ss_dssp EEECCSEEEHHHHHHHTTCC-------CTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECC
T ss_pred EEEeCCCCCHHHHHHhhccC-------CCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEee
Confidence 99999999999999765321 1567889999999999999999998 9999999999999987 89999999
Q ss_pred cCcccccccccCccccccccccccccccCccccCCCC--CCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHhh
Q 045798 843 FGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSE--VSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMA 920 (1008)
Q Consensus 843 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~~ 920 (1008)
||.+......... .....|++.|+|||++.+.. ++.++||||||+++|+|++|+.||.................
T Consensus 167 fg~~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 242 (295)
T 2clq_A 167 FGTSKRLAGINPC----TETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFK 242 (295)
T ss_dssp TTTCEESCC---------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHC
T ss_pred cccccccCCCCCc----ccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhcccc
Confidence 9999865432211 22345899999999987643 78999999999999999999999864211110000000000
Q ss_pred CCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 921 LPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 921 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
. .+.. ....+.++.+++.+||+.||++|||++|+++
T Consensus 243 ~----------------------------~~~~--~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 243 V----------------------------HPEI--PESMSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp C----------------------------CCCC--CTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred c----------------------------cccc--cccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0 0000 0123456789999999999999999999986
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-38 Score=352.64 Aligned_cols=280 Identities=21% Similarity=0.223 Sum_probs=203.2
Q ss_pred HHHHHHHhcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccc-----------hhhHHHHHHHHHHhhcCCCCce
Q 045798 676 YKSLLKATNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCE-----------GASKSFMAECKALKNIRHRNLV 744 (1008)
Q Consensus 676 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-----------~~~~~~~~E~~~l~~l~h~niv 744 (1008)
.+++....++|++.+.||+|+||.||+|.+. +++.||||++..... ...+.+.+|++++++++||||+
T Consensus 14 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 92 (362)
T 3pg1_A 14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL 92 (362)
T ss_dssp HHHHHHTTCSCEEEEEEEEETTEEEEEEECT-TSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred HHHHHHhccceEEeEEeccCCCEEEEEEECC-CCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence 4677788899999999999999999999986 599999999864321 1236899999999999999999
Q ss_pred eeeeccccccccCCceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceecc
Q 045798 745 KVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCD 824 (1008)
Q Consensus 745 ~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~D 824 (1008)
++++++...........++||||++ |+|.+++..... .+++..+..++.||+.||+|||+. +|+|||
T Consensus 93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~D 159 (362)
T 3pg1_A 93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRI---------VISPQHIQYFMYHILLGLHVLHEA---GVVHRD 159 (362)
T ss_dssp CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTS---------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCC
T ss_pred ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhccc---------CCCHHHHHHHHHHHHHHHHHHHHC---cCEecC
Confidence 9999976544455667899999996 688888875431 689999999999999999999998 999999
Q ss_pred CCCCCeeecCCCCeEEcccCcccccccccCccccccccccccccccCccccCC-CCCCcccchhhHHHHHHHHHhCCCCC
Q 045798 825 LKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLG-SEVSTNGDVYSYGILLLEMVTAKKPT 903 (1008)
Q Consensus 825 lkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltG~~pf 903 (1008)
|||+||+++.++.+||+|||.++....... .....||+.|+|||++.+ ..++.++||||+||++|+|++|+.||
T Consensus 160 lkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf 234 (362)
T 3pg1_A 160 LHPGNILLADNNDITICDFNLAREDTADAN-----KTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALF 234 (362)
T ss_dssp CCGGGEEECTTCCEEECCTTC--------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred CChHHEEEcCCCCEEEEecCcccccccccc-----cceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCC
Confidence 999999999999999999999975433222 223458999999999877 67899999999999999999999998
Q ss_pred CccccCCccHHHHHHhhCCcchh-----------hhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccC
Q 045798 904 DVMFEGDLNLHNFARMALPNQVM-----------DIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSM 972 (1008)
Q Consensus 904 ~~~~~~~~~~~~~~~~~~~~~~~-----------~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 972 (1008)
......+ ............... +.+.......+. ..........+..+.+++.+||+
T Consensus 235 ~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~li~~~L~ 302 (362)
T 3pg1_A 235 RGSTFYN-QLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPA-----------RAWTAVVPTADPVALDLIAKMLE 302 (362)
T ss_dssp CCSSHHH-HHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCC-----------CCHHHHSTTSCHHHHHHHHHHTC
T ss_pred CCCCHHH-HHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCCh-----------hhHHhhCCCCCHHHHHHHHHHhc
Confidence 7432111 111111111111111 111111110000 00000011235568999999999
Q ss_pred cCCCCCCCHHHHHH
Q 045798 973 ESPQDRMNMTNVVH 986 (1008)
Q Consensus 973 ~dP~~RPt~~evl~ 986 (1008)
.||.+|||+.|+++
T Consensus 303 ~dP~~Rpt~~ell~ 316 (362)
T 3pg1_A 303 FNPQRRISTEQALR 316 (362)
T ss_dssp SSGGGSCCHHHHHT
T ss_pred CChhhCCCHHHHHc
Confidence 99999999999986
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-38 Score=367.64 Aligned_cols=251 Identities=24% Similarity=0.325 Sum_probs=202.9
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEecccc---chhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCc
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC---EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGND 759 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 759 (1008)
.++|++.+.||+|+||.||+|.+..+++.||||++.... ....+.+.+|++++++++||||+++++++ ....
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~-----~~~~ 99 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFF-----EDKG 99 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSS
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EeCC
Confidence 457999999999999999999999899999999986432 34467899999999999999999999994 5567
Q ss_pred eEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeee---cCCC
Q 045798 760 FKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILL---DNDL 836 (1008)
Q Consensus 760 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll---~~~~ 836 (1008)
..++||||+++|+|.+++.... .+++..++.++.||+.||+|||++ +|+||||||+||++ +.++
T Consensus 100 ~~~lv~e~~~~~~L~~~~~~~~----------~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~ 166 (484)
T 3nyv_A 100 YFYLVGEVYTGGELFDEIISRK----------RFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDA 166 (484)
T ss_dssp EEEEEECCCCSCBHHHHHHTCS----------CCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTC
T ss_pred EEEEEEecCCCCCHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCC
Confidence 7999999999999999987654 689999999999999999999998 99999999999999 5678
Q ss_pred CeEEcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHH
Q 045798 837 SGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNF 916 (1008)
Q Consensus 837 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~ 916 (1008)
.+||+|||+++........ ....||+.|+|||++.+ .++.++||||+||++|+|++|+.||......+ .....
T Consensus 167 ~~kl~Dfg~a~~~~~~~~~-----~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~i 239 (484)
T 3nyv_A 167 NIRIIDFGLSTHFEASKKM-----KDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYD-ILKKV 239 (484)
T ss_dssp CEEECCTTHHHHBCCCCSH-----HHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHH
T ss_pred cEEEEeeeeeEEccccccc-----ccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHH-HHHHH
Confidence 9999999999866443221 22458999999999876 68999999999999999999999986431110 00011
Q ss_pred HHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 917 ARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 917 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
..... ....+.....+..+.+++.+||+.||.+|||+.|+++
T Consensus 240 ~~~~~----------------------------~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 240 EKGKY----------------------------TFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp HHCCC----------------------------CCCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HcCCC----------------------------CCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence 00000 0001111234556899999999999999999999986
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=349.67 Aligned_cols=272 Identities=23% Similarity=0.343 Sum_probs=205.2
Q ss_pred hcCCCCCceEeeccCeeEEEEE-----EcCCCeEEEEEEeccc-cchhhHHHHHHHHHHhhcCCCCceeeeecccccccc
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGA-----LDEDGIVVAIKVINLQ-CEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQ 756 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~-----~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 756 (1008)
.++|++.+.||+|+||.||+|. ...+++.||||++... .......+.+|+.++++++||||+++++++ .
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~ 103 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVS-----L 103 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----C
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEE-----c
Confidence 4689999999999999999999 4457789999999744 234556899999999999999999999995 4
Q ss_pred CCceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecC--
Q 045798 757 GNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDN-- 834 (1008)
Q Consensus 757 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~-- 834 (1008)
..+..++||||+++++|.+++........ ....+++..++.++.||+.||+|||+. +|+||||||+||+++.
T Consensus 104 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~---~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~ 177 (327)
T 2yfx_A 104 QSLPRFILMELMAGGDLKSFLRETRPRPS---QPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPG 177 (327)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHTSCCSS---STTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSS
T ss_pred CCCCcEEEEecCCCCcHHHHHHhhccccc---ccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCC
Confidence 45668999999999999999986543211 112689999999999999999999998 9999999999999984
Q ss_pred -CCCeEEcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCccccCCcc
Q 045798 835 -DLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT-AKKPTDVMFEGDLN 912 (1008)
Q Consensus 835 -~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-G~~pf~~~~~~~~~ 912 (1008)
+..+||+|||.+.......... ......+|+.|+|||++.+..++.++||||||+++|||++ |..||...... .
T Consensus 178 ~~~~~kl~Dfg~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--~ 253 (327)
T 2yfx_A 178 PGRVAKIGDFGMARDIYRASYYR--KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ--E 253 (327)
T ss_dssp TTCCEEECCCHHHHHHHC--------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--H
T ss_pred CcceEEECccccccccccccccc--cCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHH--H
Confidence 4569999999997553322111 1223457899999999988889999999999999999998 99998642110 0
Q ss_pred HHHHHHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHHHHHH
Q 045798 913 LHNFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHELQSVK 992 (1008)
Q Consensus 913 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~i~ 992 (1008)
......... .. . ....++..+.+++.+||+.||.+|||+.|+++.|+.+.
T Consensus 254 ~~~~~~~~~------------~~--------------~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~ 303 (327)
T 2yfx_A 254 VLEFVTSGG------------RM--------------D----PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 303 (327)
T ss_dssp HHHHHHTTC------------CC--------------C----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHhcCC------------CC--------------C----CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHh
Confidence 001100000 00 0 00123456889999999999999999999999999887
Q ss_pred HHHHHHH
Q 045798 993 NILLELE 999 (1008)
Q Consensus 993 ~~~~~~~ 999 (1008)
.......
T Consensus 304 ~~~~~~~ 310 (327)
T 2yfx_A 304 QDPDVIN 310 (327)
T ss_dssp HCHHHHT
T ss_pred cCHHHhc
Confidence 7654443
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=359.01 Aligned_cols=268 Identities=22% Similarity=0.287 Sum_probs=206.8
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccchhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceEE
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKA 762 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 762 (1008)
.++|++.++||+|+||.||+|.+..+++.||||++..... ...+.+|+++++.+.|++.+..+.++ ....+..+
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~----~~~~~~~~ 79 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWF----GVEGDYNV 79 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEE----EEETTEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEE----EeeCCEEE
Confidence 4689999999999999999999988999999999865432 34588999999999775544444433 24566789
Q ss_pred EEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeee---cCCCCeE
Q 045798 763 IVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILL---DNDLSGH 839 (1008)
Q Consensus 763 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~k 839 (1008)
+||||+ +++|.+++..... .+++..++.|+.||+.||+|||+. +||||||||+|||+ +.++.+|
T Consensus 80 lvme~~-g~sL~~ll~~~~~---------~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vk 146 (483)
T 3sv0_A 80 LVMDLL-GPSLEDLFNFCSR---------KLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVY 146 (483)
T ss_dssp EEEECC-CCBHHHHHHHTTT---------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEE
T ss_pred EEEECC-CCCHHHHHHhhcC---------CCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEE
Confidence 999999 9999999975321 689999999999999999999998 99999999999999 6889999
Q ss_pred EcccCcccccccccCcc---ccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHH
Q 045798 840 IGDFGLARFHQEVSNST---LSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNF 916 (1008)
Q Consensus 840 L~Dfg~a~~~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~ 916 (1008)
|+|||+++......... ........||+.|+|||++.+..++.++|||||||++|||++|+.||......... ..+
T Consensus 147 L~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~-~~~ 225 (483)
T 3sv0_A 147 IIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKK-QKY 225 (483)
T ss_dssp ECCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHH-HHH
T ss_pred EEeCCcceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHH-HHH
Confidence 99999998765543221 11223456999999999999999999999999999999999999999753221110 000
Q ss_pred HHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHHHHHHHH
Q 045798 917 ARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHELQSVKNI 994 (1008)
Q Consensus 917 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~i~~~ 994 (1008)
. .+....+....+ .....++.++.+++..||+.||++||++++|++.|+.+...
T Consensus 226 ~---------~i~~~~~~~~~~---------------~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~ 279 (483)
T 3sv0_A 226 E---------KISEKKVATSIE---------------ALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIR 279 (483)
T ss_dssp H---------HHHHHHHHSCHH---------------HHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred H---------HHhhccccccHH---------------HHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHH
Confidence 0 000000000000 00012356789999999999999999999999999988654
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-38 Score=356.33 Aligned_cols=251 Identities=24% Similarity=0.344 Sum_probs=192.3
Q ss_pred cCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEecccc--chhhHHHHHHHHHHhhcC--CCCceeeeeccccccccCCc
Q 045798 684 NGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC--EGASKSFMAECKALKNIR--HRNLVKVITSCSSIDFQGND 759 (1008)
Q Consensus 684 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~~~~~ 759 (1008)
++|++.+.||+|+||.||+|.+. +++.||||++.... ....+.+.+|+++++++. ||||+++++++ ..++
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~-----~~~~ 129 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE-----ITDQ 129 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEE-----ECSS
T ss_pred CceEEEEEEccCCCeEEEEEEcC-CCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEE-----ecCC
Confidence 45999999999999999999986 58999999997542 344578999999999996 59999999985 4556
Q ss_pred eEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeE
Q 045798 760 FKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGH 839 (1008)
Q Consensus 760 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 839 (1008)
..++||| +.+++|.+++.... .+++.+++.++.||+.||+|||+. +|+||||||+|||++ ++.+|
T Consensus 130 ~~~lv~E-~~~~~L~~~l~~~~----------~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~k 194 (390)
T 2zmd_A 130 YIYMVME-CGNIDLNSWLKKKK----------SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLK 194 (390)
T ss_dssp EEEEEEE-CCSEEHHHHHHHCS----------SCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEE
T ss_pred EEEEEEe-cCCCCHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEE
Confidence 6999999 55889999997654 688899999999999999999998 999999999999995 57999
Q ss_pred EcccCcccccccccCccccccccccccccccCccccCC-----------CCCCcccchhhHHHHHHHHHhCCCCCCcccc
Q 045798 840 IGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLG-----------SEVSTNGDVYSYGILLLEMVTAKKPTDVMFE 908 (1008)
Q Consensus 840 L~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDvwslG~vl~elltG~~pf~~~~~ 908 (1008)
|+|||+++......... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.....
T Consensus 195 l~DFG~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~ 272 (390)
T 2zmd_A 195 LIDFGIANQMQPDTTSV--VKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN 272 (390)
T ss_dssp ECCCSSSCCC-----------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCC
T ss_pred EEecCccccccCCCccc--cCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhH
Confidence 99999998765432211 1223569999999999765 3688999999999999999999999864321
Q ss_pred CCccHHHHHHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 045798 909 GDLNLHNFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHE 987 (1008)
Q Consensus 909 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 987 (1008)
... .. ..++++..... ++. ..+.++.+++.+||+.||.+|||+.|+++.
T Consensus 273 ~~~---~~---------~~~~~~~~~~~------------~~~------~~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 273 QIS---KL---------HAIIDPNHEIE------------FPD------IPEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp HHH---HH---------HHHHCTTSCCC------------CCC------CSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHH---HH---------HHHhCccccCC------------CCc------cchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 111 11 11111110000 000 113457899999999999999999999863
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=365.66 Aligned_cols=251 Identities=22% Similarity=0.282 Sum_probs=197.2
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEecccc--chhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCce
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC--EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDF 760 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 760 (1008)
.++|++.+.||+|+||+||+|++..+++.||+|+++... ......+.+|+.+++.++||||++++++| .....
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~-----~~~~~ 110 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFF-----EDKRN 110 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSSE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEE-----EeCCE
Confidence 456999999999999999999999899999999997542 33457799999999999999999999995 55677
Q ss_pred EEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecC---CCC
Q 045798 761 KAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDN---DLS 837 (1008)
Q Consensus 761 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~~ 837 (1008)
.++||||+++|+|.+++.... .+++..++.++.||+.||+|||+. +|+||||||+||+++. ++.
T Consensus 111 ~~lv~e~~~~g~L~~~~~~~~----------~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~ 177 (494)
T 3lij_A 111 YYLVMECYKGGELFDEIIHRM----------KFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDAL 177 (494)
T ss_dssp EEEEEECCCSCBHHHHHHHHS----------SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCC
T ss_pred EEEEEecCCCCcHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCc
Confidence 999999999999999886543 689999999999999999999998 9999999999999976 455
Q ss_pred eEEcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHH
Q 045798 838 GHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFA 917 (1008)
Q Consensus 838 ~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~ 917 (1008)
+||+|||+|........ .....||+.|+|||++. ..++.++||||+||++|+|++|..||......+ ......
T Consensus 178 ~kl~DfG~a~~~~~~~~-----~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~i~ 250 (494)
T 3lij_A 178 IKIVDFGLSAVFENQKK-----MKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQE-ILRKVE 250 (494)
T ss_dssp EEECCCTTCEECBTTBC-----BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHH
T ss_pred EEEEECCCCeECCCCcc-----ccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHH
Confidence 99999999986654322 22346999999999976 469999999999999999999999986432110 000110
Q ss_pred HhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 918 RMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 918 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
..... ...+.....+..+.+++.+||+.||.+|||+.|+++
T Consensus 251 ~~~~~----------------------------~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 251 KGKYT----------------------------FDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALE 291 (494)
T ss_dssp HTCCC----------------------------CCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hCCCC----------------------------CCchhcccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence 00000 000011123456789999999999999999999986
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-38 Score=352.35 Aligned_cols=258 Identities=16% Similarity=0.129 Sum_probs=201.8
Q ss_pred HhcCCCCCceEeeccCeeEEEEE-----EcCCCeEEEEEEeccccchhhHHHHHHHHHHhhcC---CCCceeeeeccccc
Q 045798 682 ATNGFSSTHLIGVGSFGCVYKGA-----LDEDGIVVAIKVINLQCEGASKSFMAECKALKNIR---HRNLVKVITSCSSI 753 (1008)
Q Consensus 682 ~~~~y~~~~~lg~G~~g~Vy~~~-----~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~ 753 (1008)
..++|.+.+.||+|+||.||+|. ...+++.||||+++.. ....+.+|++++++++ |+||+++++++
T Consensus 63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~--- 136 (365)
T 3e7e_A 63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAH--- 136 (365)
T ss_dssp SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEE---
T ss_pred CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheee---
Confidence 45789999999999999999994 5568899999999744 3456788888888886 99999999995
Q ss_pred cccCCceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeec
Q 045798 754 DFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLD 833 (1008)
Q Consensus 754 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~ 833 (1008)
..++..++||||+++|+|.+++....... ...+++..++.|+.||+.||+|||+. +||||||||+|||++
T Consensus 137 --~~~~~~~lv~e~~~~g~L~~~l~~~~~~~-----~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~ 206 (365)
T 3e7e_A 137 --LFQNGSVLVGELYSYGTLLNAINLYKNTP-----EKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILG 206 (365)
T ss_dssp --ECSSCEEEEECCCCSCBHHHHHHHHHTST-----TCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEEC
T ss_pred --ecCCCcEEEEeccCCCcHHHHHHHhhccc-----ccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEec
Confidence 45567899999999999999997432110 11699999999999999999999997 999999999999999
Q ss_pred C-----------CCCeEEcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCC
Q 045798 834 N-----------DLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKP 902 (1008)
Q Consensus 834 ~-----------~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~p 902 (1008)
. ++.+||+|||+|+......... ......||+.|+|||++.+..++.++|||||||++|||++|+.|
T Consensus 207 ~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p 284 (365)
T 3e7e_A 207 NGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGT--IFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYM 284 (365)
T ss_dssp GGGTCC------CTTEEECCCTTCEEGGGSCTTE--EECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCC
T ss_pred ccccCccccccccCCEEEeeCchhhhhhccCCCc--eeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCc
Confidence 8 8999999999997554322211 22345699999999999999999999999999999999999999
Q ss_pred CCccccCCccHHHHHHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCC-CCH
Q 045798 903 TDVMFEGDLNLHNFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDR-MNM 981 (1008)
Q Consensus 903 f~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R-Pt~ 981 (1008)
|......... ....+... .....+.+++..|++.+|.+| |++
T Consensus 285 f~~~~~~~~~----------------~~~~~~~~---------------------~~~~~~~~~~~~~l~~~p~~r~~~~ 327 (365)
T 3e7e_A 285 KVKNEGGECK----------------PEGLFRRL---------------------PHLDMWNEFFHVMLNIPDCHHLPSL 327 (365)
T ss_dssp CEEEETTEEE----------------ECSCCTTC---------------------SSHHHHHHHHHHHHCCCCTTCCCCH
T ss_pred cccCCCCcee----------------echhcccc---------------------CcHHHHHHHHHHHcCCCCCCcchHH
Confidence 8643221100 00000000 013346788999999999998 678
Q ss_pred HHHHHHHHHHHHH
Q 045798 982 TNVVHELQSVKNI 994 (1008)
Q Consensus 982 ~evl~~L~~i~~~ 994 (1008)
+++.+.|+++...
T Consensus 328 ~~l~~~l~~~l~~ 340 (365)
T 3e7e_A 328 DLLRQKLKKVFQQ 340 (365)
T ss_dssp HHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHH
Confidence 8888888877554
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=340.45 Aligned_cols=250 Identities=26% Similarity=0.344 Sum_probs=204.2
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEecccc-chhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceE
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC-EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFK 761 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 761 (1008)
.+.|++.+.||+|+||.||+|.+..+++.||+|+++... ....+.+.+|+.++++++||||+++++++ ..+...
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~ 95 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY-----LKDTKL 95 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEE-----EETTEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEE-----ecCCeE
Confidence 457999999999999999999998899999999997543 34567899999999999999999999985 445678
Q ss_pred EEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEc
Q 045798 762 AIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIG 841 (1008)
Q Consensus 762 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 841 (1008)
++||||+++++|.+++... ++++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+
T Consensus 96 ~lv~e~~~~~~L~~~~~~~-----------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~ 161 (303)
T 3a7i_A 96 WIIMEYLGGGSALDLLEPG-----------PLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLA 161 (303)
T ss_dssp EEEEECCTTEEHHHHHTTS-----------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEEC
T ss_pred EEEEEeCCCCcHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEe
Confidence 9999999999999998643 689999999999999999999998 99999999999999999999999
Q ss_pred ccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHhhC
Q 045798 842 DFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMAL 921 (1008)
Q Consensus 842 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~~~ 921 (1008)
|||.+......... .....||+.|+|||++.+..++.++||||||+++|+|++|+.||....... .........
T Consensus 162 Dfg~~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~~~~~~~ 235 (303)
T 3a7i_A 162 DFGVAGQLTDTQIK----RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMK--VLFLIPKNN 235 (303)
T ss_dssp CCTTCEECBTTBCC----BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH--HHHHHHHSC
T ss_pred ecccceecCccccc----cCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHH--HHHHhhcCC
Confidence 99999865443211 223458999999999999999999999999999999999999986431110 000000000
Q ss_pred CcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 045798 922 PNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHE 987 (1008)
Q Consensus 922 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 987 (1008)
+ +.+ ....+..+.+++.+||+.||.+|||+.|+++.
T Consensus 236 ~--------~~~----------------------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 236 P--------PTL----------------------EGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp C--------CCC----------------------CSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred C--------CCC----------------------ccccCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 0 000 01134457899999999999999999999874
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=372.05 Aligned_cols=259 Identities=23% Similarity=0.368 Sum_probs=200.3
Q ss_pred CCCCCc-eEeeccCeeEEEEEEc--CCCeEEEEEEecccc-chhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCce
Q 045798 685 GFSSTH-LIGVGSFGCVYKGALD--EDGIVVAIKVINLQC-EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDF 760 (1008)
Q Consensus 685 ~y~~~~-~lg~G~~g~Vy~~~~~--~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 760 (1008)
++.+.+ .||+|+||.||+|.+. .++..||||+++... ....+.+.+|++++++++||||++++++|.. +.
T Consensus 336 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~------~~ 409 (613)
T 2ozo_A 336 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA------EA 409 (613)
T ss_dssp SEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES------SS
T ss_pred ceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc------CC
Confidence 334444 7999999999999875 356789999998643 3456789999999999999999999999642 34
Q ss_pred EEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEE
Q 045798 761 KAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHI 840 (1008)
Q Consensus 761 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 840 (1008)
.++||||+++|+|.+++..... .+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||
T Consensus 410 ~~lv~E~~~~g~L~~~l~~~~~---------~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL 477 (613)
T 2ozo_A 410 LMLVMEMAGGGPLHKFLVGKRE---------EIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKI 477 (613)
T ss_dssp EEEEEECCTTCBHHHHHTTCTT---------TSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEE
T ss_pred eEEEEEeCCCCcHHHHHhhccC---------CCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEE
Confidence 8999999999999999975431 689999999999999999999998 9999999999999999999999
Q ss_pred cccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCccccCCccHHHHHHh
Q 045798 841 GDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT-AKKPTDVMFEGDLNLHNFARM 919 (1008)
Q Consensus 841 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-G~~pf~~~~~~~~~~~~~~~~ 919 (1008)
+|||+++......... .......+++.|+|||++.+..++.++|||||||++|||++ |+.||...... .......
T Consensus 478 ~DFGla~~~~~~~~~~-~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~--~~~~~i~- 553 (613)
T 2ozo_A 478 SDFGLSKALGADDSYY-TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP--EVMAFIE- 553 (613)
T ss_dssp CCCSTTTTCC---------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSH--HHHHHHH-
T ss_pred eeccCcccccCCCcee-eeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHH--HHHHHHH-
Confidence 9999998764432211 11222336789999999988899999999999999999998 99998643211 0111100
Q ss_pred hCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHHHHHHHH
Q 045798 920 ALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHELQSVKNI 994 (1008)
Q Consensus 920 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~i~~~ 994 (1008)
.. .++. ....++.++.++|.+||+.||++||++.+|++.|+.+...
T Consensus 554 -----------~~--------------~~~~----~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~ 599 (613)
T 2ozo_A 554 -----------QG--------------KRME----CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 599 (613)
T ss_dssp -----------TT--------------CCCC----CCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred -----------cC--------------CCCC----CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence 00 0000 0113456789999999999999999999999999987554
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=342.48 Aligned_cols=258 Identities=23% Similarity=0.321 Sum_probs=202.6
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEecccc--chhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCce
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC--EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDF 760 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 760 (1008)
.++|++.+.||+|+||.||+|.+..+++.||+|++.... ....+.+.+|++++++++||||+++++++.. ..+..
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~~~ 81 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIID---RTNTT 81 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE---GGGTE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEec---CCCce
Confidence 468999999999999999999999899999999997542 3445679999999999999999999998542 34567
Q ss_pred EEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCC-----ceeccCCCCCeeecCC
Q 045798 761 KAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEP-----ILHCDLKPSNILLDND 835 (1008)
Q Consensus 761 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~-----ivH~Dlkp~NIll~~~ 835 (1008)
.++||||+++++|.+++...... ...+++..++.++.|++.||+|||+. + |+||||||+||+++.+
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~------~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~ 152 (279)
T 2w5a_A 82 LYIVMEYCEGGDLASVITKGTKE------RQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGK 152 (279)
T ss_dssp EEEEEECCTTEEHHHHHHHHHHT------TCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSS
T ss_pred EEEEEeCCCCCCHHHHHHhhccc------CCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCC
Confidence 89999999999999999754211 11589999999999999999999997 7 9999999999999999
Q ss_pred CCeEEcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHH
Q 045798 836 LSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHN 915 (1008)
Q Consensus 836 ~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~ 915 (1008)
+.+||+|||.++........ .....|++.|+|||++.+..++.++||||||+++|+|++|+.||...... ....
T Consensus 153 ~~~kl~dfg~~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~ 226 (279)
T 2w5a_A 153 QNVKLGDFGLARILNHDTSF----AKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK--ELAG 226 (279)
T ss_dssp SCEEECCCCHHHHC---CHH----HHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHH
T ss_pred CCEEEecCchheeecccccc----ccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHH--HHHH
Confidence 99999999999865433211 11235899999999999889999999999999999999999998643110 0000
Q ss_pred HHHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHH
Q 045798 916 FARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHEL 988 (1008)
Q Consensus 916 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 988 (1008)
...... .. .+ ....+.++.+++.+||+.||++|||++||++.+
T Consensus 227 ~i~~~~-----------~~-------------~~------~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~ 269 (279)
T 2w5a_A 227 KIREGK-----------FR-------------RI------PYRYSDELNEIITRMLNLKDYHRPSVEEILENP 269 (279)
T ss_dssp HHHHTC-----------CC-------------CC------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTST
T ss_pred HHhhcc-----------cc-------------cC------CcccCHHHHHHHHHHcCCCcccCCCHHHHHhCh
Confidence 000000 00 00 012345689999999999999999999999764
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-38 Score=348.62 Aligned_cols=266 Identities=27% Similarity=0.431 Sum_probs=204.1
Q ss_pred cCCCCCceEeeccCeeEEEEEEcCCCeEE--EEEEeccc-cchhhHHHHHHHHHHhhc-CCCCceeeeeccccccccCCc
Q 045798 684 NGFSSTHLIGVGSFGCVYKGALDEDGIVV--AIKVINLQ-CEGASKSFMAECKALKNI-RHRNLVKVITSCSSIDFQGND 759 (1008)
Q Consensus 684 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~v--avK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~ 759 (1008)
++|++.+.||+|+||.||+|++..++..+ |+|+++.. .....+.+.+|+++++++ +||||+++++++ ...+
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~-----~~~~ 99 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGAC-----EHRG 99 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEE-----EETT
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceee-----eeCC
Confidence 57999999999999999999998888755 99988743 234456799999999999 999999999995 4566
Q ss_pred eEEEEEeccCCCChhcccccCCCCCCC------cccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeec
Q 045798 760 FKAIVYEYMPNGSLEKWLHPHAVPKRD------KEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLD 833 (1008)
Q Consensus 760 ~~~lv~e~~~~gsL~~~l~~~~~~~~~------~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~ 833 (1008)
..++||||+++|+|.+++......... ......+++.+++.++.||+.||+|||+. +|+||||||+||+++
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~ 176 (327)
T 1fvr_A 100 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVG 176 (327)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC
T ss_pred ceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEc
Confidence 799999999999999999765310000 00012689999999999999999999998 999999999999999
Q ss_pred CCCCeEEcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCccccCCcc
Q 045798 834 NDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT-AKKPTDVMFEGDLN 912 (1008)
Q Consensus 834 ~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-G~~pf~~~~~~~~~ 912 (1008)
.++.+||+|||+++....... .....+++.|+|||++.+..++.++|||||||++|||++ |+.||......
T Consensus 177 ~~~~~kL~Dfg~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~--- 248 (327)
T 1fvr_A 177 ENYVAKIADFGLSRGQEVYVK-----KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA--- 248 (327)
T ss_dssp GGGCEEECCTTCEESSCEECC-----C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---
T ss_pred CCCeEEEcccCcCcccccccc-----ccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHH---
Confidence 999999999999974332211 122347889999999988889999999999999999998 99998643110
Q ss_pred HHHHHHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHHHHHH
Q 045798 913 LHNFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHELQSVK 992 (1008)
Q Consensus 913 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~i~ 992 (1008)
..... +..... .. ....++..+.+++.+||+.||.+|||++|+++.|+++.
T Consensus 249 --~~~~~---------~~~~~~--------------~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 299 (327)
T 1fvr_A 249 --ELYEK---------LPQGYR--------------LE----KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 299 (327)
T ss_dssp --HHHHH---------GGGTCC--------------CC----CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --HHHHH---------hhcCCC--------------CC----CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 01000 000000 00 00123456899999999999999999999999999876
Q ss_pred HH
Q 045798 993 NI 994 (1008)
Q Consensus 993 ~~ 994 (1008)
+.
T Consensus 300 ~~ 301 (327)
T 1fvr_A 300 EE 301 (327)
T ss_dssp HS
T ss_pred Hh
Confidence 64
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=350.21 Aligned_cols=286 Identities=21% Similarity=0.219 Sum_probs=205.7
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEecccc-chhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceE
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC-EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFK 761 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 761 (1008)
.++|++.+.||+|+||.||+|.+..+|+.||||+++... ......+.+|++++++++||||+++++++....+......
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 568999999999999999999998899999999997433 3345678899999999999999999999776555666789
Q ss_pred EEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEc
Q 045798 762 AIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIG 841 (1008)
Q Consensus 762 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 841 (1008)
++||||++ ++|.+++... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+
T Consensus 90 ~lv~e~~~-~~L~~~~~~~-----------~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~ 154 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVISTQ-----------MLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVC 154 (353)
T ss_dssp EEEECCCS-EEHHHHHHHC-----------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEEC
T ss_pred EEEEeccC-ccHHHHHhhc-----------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEE
Confidence 99999995 6999988653 689999999999999999999998 99999999999999999999999
Q ss_pred ccCcccccccccCccc------cccccccccccccCccccCC-CCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHH
Q 045798 842 DFGLARFHQEVSNSTL------SSSVGVKGTIGYTAPEYGLG-SEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLH 914 (1008)
Q Consensus 842 Dfg~a~~~~~~~~~~~------~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~ 914 (1008)
|||+++.......... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+. ..
T Consensus 155 Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~ 233 (353)
T 2b9h_A 155 DFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQ-LL 233 (353)
T ss_dssp CCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HH
T ss_pred ecccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHH-HH
Confidence 9999986654322111 11223468999999998654 6789999999999999999999999874321111 11
Q ss_pred HHHHhhCCcchhhhhcccccCchHHhhhhhhhhhcccc--chhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 915 NFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTG--INSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 915 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
................. . ...............+.. .......+.++.+++.+||+.||++|||++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~-~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (353)
T 2b9h_A 234 LIFGIIGTPHSDNDLRC-I-ESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE 305 (353)
T ss_dssp HHHHHHCCCCSTTTTTT-C-CCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHhCCCchhccccc-c-ccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 11111000000000000 0 000000000000000000 0001134567899999999999999999999986
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=348.94 Aligned_cols=280 Identities=22% Similarity=0.278 Sum_probs=196.5
Q ss_pred HHHhcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccc-----hhhHHHHHHHHHHhhcCCCCceeeeecccccc
Q 045798 680 LKATNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCE-----GASKSFMAECKALKNIRHRNLVKVITSCSSID 754 (1008)
Q Consensus 680 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 754 (1008)
....++|++.+.||+|+||.||+|.+..+|+.||||+++.... ...+.+.+|++++++++||||+++++++
T Consensus 6 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~---- 81 (346)
T 1ua2_A 6 KSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAF---- 81 (346)
T ss_dssp -------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEE----
T ss_pred HHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEE----
Confidence 3446789999999999999999999988899999999974322 1235788999999999999999999995
Q ss_pred ccCCceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecC
Q 045798 755 FQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDN 834 (1008)
Q Consensus 755 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~ 834 (1008)
...+..++||||+++ +|.+++..... .+++..+..++.|++.||+|||+. +|+||||||+||+++.
T Consensus 82 -~~~~~~~lv~e~~~~-~l~~~~~~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~ 147 (346)
T 1ua2_A 82 -GHKSNISLVFDFMET-DLEVIIKDNSL---------VLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDE 147 (346)
T ss_dssp -CCTTCCEEEEECCSE-EHHHHHTTCCS---------SCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECT
T ss_pred -eeCCceEEEEEcCCC-CHHHHHHhcCc---------CCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcC
Confidence 456678999999965 89888875431 578889999999999999999998 9999999999999999
Q ss_pred CCCeEEcccCcccccccccCccccccccccccccccCccccCCC-CCCcccchhhHHHHHHHHHhCCCCCCccccCCccH
Q 045798 835 DLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGS-EVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNL 913 (1008)
Q Consensus 835 ~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~ 913 (1008)
++.+||+|||+++........ .....||+.|+|||++.+. .++.++|||||||++|||++|.+||......+ ..
T Consensus 148 ~~~~kl~Dfg~a~~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~-~~ 222 (346)
T 1ua2_A 148 NGVLKLADFGLAKSFGSPNRA----YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD-QL 222 (346)
T ss_dssp TCCEEECCCGGGSTTTSCCCC----CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HH
T ss_pred CCCEEEEecccceeccCCccc----CCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH-HH
Confidence 999999999999866433221 2234589999999998764 58899999999999999999999986432211 11
Q ss_pred HHHHHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 914 HNFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 914 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
..............+.+. ...++.. ........+ ........+.++.+++.+||+.||++|||++|+++
T Consensus 223 ~~i~~~~~~~~~~~~~~~--~~~~~~~-~~~~~~~~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 291 (346)
T 1ua2_A 223 TRIFETLGTPTEEQWPDM--CSLPDYV-TFKSFPGIP-LHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 291 (346)
T ss_dssp HHHHHHHCCCCTTTSSST--TSSTTCC-CCCCCCCCC-HHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred HHHHHHcCCCChhhhhhh--ccCcccc-cccccCCCC-hHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhc
Confidence 111111111000000000 0000000 000000000 00001123467899999999999999999999986
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=343.43 Aligned_cols=252 Identities=22% Similarity=0.232 Sum_probs=196.2
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEecccc--------chhhHHHHHHHHHHhhcCCCCceeeeecccccc
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC--------EGASKSFMAECKALKNIRHRNLVKVITSCSSID 754 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 754 (1008)
.++|++.+.||+|+||.||+|.+..+++.||||++.... ......+.+|++++++++||||+++++++.
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~--- 85 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD--- 85 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEE---
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEc---
Confidence 467999999999999999999999899999999986432 122345889999999999999999999853
Q ss_pred ccCCceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecC
Q 045798 755 FQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDN 834 (1008)
Q Consensus 755 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~ 834 (1008)
.+ ..++||||+++++|.+++.... .+++..++.++.||+.||+|||+. +|+||||||+||+++.
T Consensus 86 --~~-~~~lv~e~~~~~~L~~~~~~~~----------~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~ 149 (322)
T 2ycf_A 86 --AE-DYYIVLELMEGGELFDKVVGNK----------RLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSS 149 (322)
T ss_dssp --SS-SEEEEEECCTTEETHHHHSTTC----------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESS
T ss_pred --CC-ceEEEEecCCCCcHHHHHhccC----------CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEec
Confidence 22 3799999999999999987543 689999999999999999999998 9999999999999987
Q ss_pred CCC---eEEcccCcccccccccCccccccccccccccccCccccC---CCCCCcccchhhHHHHHHHHHhCCCCCCcccc
Q 045798 835 DLS---GHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGL---GSEVSTNGDVYSYGILLLEMVTAKKPTDVMFE 908 (1008)
Q Consensus 835 ~~~---~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwslG~vl~elltG~~pf~~~~~ 908 (1008)
++. +||+|||+++....... .....||+.|+|||++. ...++.++|||||||++|+|++|..||.....
T Consensus 150 ~~~~~~~kl~Dfg~~~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 224 (322)
T 2ycf_A 150 QEEDCLIKITDFGHSKILGETSL-----MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT 224 (322)
T ss_dssp SSSSCCEEECCCTTCEECCCCHH-----HHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTC
T ss_pred CCCCCeEEEccCccceecccccc-----cccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccch
Confidence 654 99999999986543221 11245899999999863 56789999999999999999999999964322
Q ss_pred CCccHHHHHHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 909 GDLNLHNFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 909 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
.............. ..++ .....+..+.+++.+||+.||++|||++|+++
T Consensus 225 ~~~~~~~~~~~~~~------------~~~~----------------~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 225 QVSLKDQITSGKYN------------FIPE----------------VWAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp SSCHHHHHHHTCCC------------CCHH----------------HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHHHHHHHhCccc------------cCch----------------hhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 21111111110000 0000 01123456899999999999999999999986
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=356.15 Aligned_cols=199 Identities=24% Similarity=0.338 Sum_probs=171.9
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccchhhHHHHHHHHHHhhc------CCCCceeeeecccccccc
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNI------RHRNLVKVITSCSSIDFQ 756 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l------~h~niv~~~~~~~~~~~~ 756 (1008)
..+|++.+.||+|+||.||+|.+..+++.||||+++.. ....+.+.+|+++++.+ +|+||+++++++ .
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~-----~ 169 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENF-----T 169 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEE-----E
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeec-----c
Confidence 45799999999999999999999989999999999754 33446778888888887 577999999984 4
Q ss_pred CCceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCC
Q 045798 757 GNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDL 836 (1008)
Q Consensus 757 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 836 (1008)
.....++||||+ +++|.+++...... .+++..++.++.||+.||+|||+. +|+||||||+|||++.++
T Consensus 170 ~~~~~~lv~e~~-~~~L~~~l~~~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~ 237 (429)
T 3kvw_A 170 FRNHICMTFELL-SMNLYELIKKNKFQ--------GFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQG 237 (429)
T ss_dssp ETTEEEEEECCC-CCBHHHHHHHTTTC--------CCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTT
T ss_pred cCCeEEEEEecc-CCCHHHHHHhccCC--------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCC
Confidence 567799999999 57999998765422 589999999999999999999998 999999999999999988
Q ss_pred C--eEEcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCcc
Q 045798 837 S--GHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVM 906 (1008)
Q Consensus 837 ~--~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~ 906 (1008)
. +||+|||+|+..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 238 ~~~vkL~DFG~a~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~ 302 (429)
T 3kvw_A 238 RSGIKVIDFGSSCYEHQR-------VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGE 302 (429)
T ss_dssp SCCEEECCCTTCEETTCC-------CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CcceEEeecccceecCCc-------ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCC
Confidence 7 999999999754322 12345899999999999999999999999999999999999998754
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=364.63 Aligned_cols=251 Identities=22% Similarity=0.277 Sum_probs=199.3
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccc-------------hhhHHHHHHHHHHhhcCCCCceeeeec
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCE-------------GASKSFMAECKALKNIRHRNLVKVITS 749 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~l~h~niv~~~~~ 749 (1008)
.++|++.+.||+|+||+||+|.+..+++.||+|+++.... ...+.+.+|++++++++||||++++++
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 114 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV 114 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 5789999999999999999999998999999999974321 234678999999999999999999999
Q ss_pred cccccccCCceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCC
Q 045798 750 CSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSN 829 (1008)
Q Consensus 750 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~N 829 (1008)
+ .++...++|||||++|+|.+++.... .+++..++.++.||+.||+|||+. +|+||||||+|
T Consensus 115 ~-----~~~~~~~lv~e~~~gg~L~~~l~~~~----------~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~N 176 (504)
T 3q5i_A 115 F-----EDKKYFYLVTEFYEGGELFEQIINRH----------KFDECDAANIMKQILSGICYLHKH---NIVHRDIKPEN 176 (504)
T ss_dssp E-----ECSSEEEEEEECCTTCBHHHHHHHHS----------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGG
T ss_pred E-----EcCCEEEEEEecCCCCcHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHH
Confidence 4 56677999999999999999986543 689999999999999999999998 99999999999
Q ss_pred eeecCCC---CeEEcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCcc
Q 045798 830 ILLDNDL---SGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVM 906 (1008)
Q Consensus 830 Ill~~~~---~~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~ 906 (1008)
|+++.++ .+||+|||++........ .....||+.|+|||++. ..++.++||||+||++|+|++|..||...
T Consensus 177 il~~~~~~~~~~kl~Dfg~a~~~~~~~~-----~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~ 250 (504)
T 3q5i_A 177 ILLENKNSLLNIKIVDFGLSSFFSKDYK-----LRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQ 250 (504)
T ss_dssp EEESSTTCCSSEEECCCTTCEECCTTSC-----BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred EEEecCCCCccEEEEECCCCEEcCCCCc-----cccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCC
Confidence 9998775 699999999986654322 22345999999999976 46899999999999999999999998643
Q ss_pred ccCCccHHHHHHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 907 FEGDLNLHNFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 907 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
...+ ....... ..... ..+.....+.++.+++.+||+.||.+|||++|+++
T Consensus 251 ~~~~-~~~~i~~------------~~~~~----------------~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~ 301 (504)
T 3q5i_A 251 NDQD-IIKKVEK------------GKYYF----------------DFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALN 301 (504)
T ss_dssp SHHH-HHHHHHH------------CCCCC----------------CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CHHH-HHHHHHc------------CCCCC----------------CccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 2110 0000000 00000 00011124556899999999999999999999975
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=337.28 Aligned_cols=248 Identities=25% Similarity=0.356 Sum_probs=194.0
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEecccc---chhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCc
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC---EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGND 759 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 759 (1008)
.++|++.+.||+|+||.||+|.+..+++.||||++.... ....+.+.+|+++++.++||||+++++++ ..++
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~ 84 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVI-----STPT 84 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECSS
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEE-----ecCC
Confidence 468999999999999999999998899999999996432 23346789999999999999999999994 4566
Q ss_pred eEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeE
Q 045798 760 FKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGH 839 (1008)
Q Consensus 760 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 839 (1008)
..++||||+++++|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+|
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~~~----------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~ 151 (276)
T 2h6d_A 85 DFFMVMEYVSGGELFDYICKHG----------RVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAK 151 (276)
T ss_dssp EEEEEEECCCSCBHHHHHHHHC----------SCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEE
T ss_pred eEEEEEeccCCCcHHHHHhccC----------CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEE
Confidence 7999999999999999997543 689999999999999999999998 999999999999999999999
Q ss_pred EcccCcccccccccCccccccccccccccccCccccCCCCC-CcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHH
Q 045798 840 IGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEV-STNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFAR 918 (1008)
Q Consensus 840 L~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~ 918 (1008)
|+|||.+........ .....+++.|+|||.+.+..+ +.++||||||+++|+|++|+.||...... .......
T Consensus 152 l~dfg~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~~~~~~ 224 (276)
T 2h6d_A 152 IADFGLSNMMSDGEF-----LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVP--TLFKKIR 224 (276)
T ss_dssp ECCCCGGGCCCC------------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHH
T ss_pred EeecccccccCCCcc-----eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHH--HHHHHhh
Confidence 999999986543321 122458999999999988765 68999999999999999999998642110 0000000
Q ss_pred hhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 919 MALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 919 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
... . ..+ ...+..+.+++.+||+.||.+|||++|+++
T Consensus 225 ~~~------------~-------------~~~------~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 261 (276)
T 2h6d_A 225 GGV------------F-------------YIP------EYLNRSVATLLMHMLQVDPLKRATIKDIRE 261 (276)
T ss_dssp HCC------------C-------------CCC------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cCc------------c-------------cCc------hhcCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 000 0 000 012345789999999999999999999987
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-38 Score=349.48 Aligned_cols=267 Identities=22% Similarity=0.301 Sum_probs=201.2
Q ss_pred CCCHHHHHHHhcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccchhhHHHHHHHHHHhhc-CCCCceeeeeccc
Q 045798 673 KMSYKSLLKATNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNI-RHRNLVKVITSCS 751 (1008)
Q Consensus 673 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~ 751 (1008)
.+.+.++....++|++.+.||+|+||.||+|.+..+++.||||++... ....+.+.+|+.+++++ +||||+++++++.
T Consensus 13 ~~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 91 (326)
T 2x7f_A 13 EIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-GDEEEEIKQEINMLKKYSHHRNIATYYGAFI 91 (326)
T ss_dssp ---CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-SSTTHHHHHHHHHHHHHCCSTTBCCEEEEEE
T ss_pred hccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecC-cccHHHHHHHHHHHHhccCCCCeeeeeeEEe
Confidence 344445555678999999999999999999999889999999999754 33457899999999999 8999999999975
Q ss_pred cccc-cCCceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCe
Q 045798 752 SIDF-QGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNI 830 (1008)
Q Consensus 752 ~~~~-~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NI 830 (1008)
.... ...+..++||||+++|+|.+++..... ..+++..++.++.||+.||+|||+. +|+||||||+||
T Consensus 92 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NI 160 (326)
T 2x7f_A 92 KKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKG--------NTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNV 160 (326)
T ss_dssp ECC--CCCCEEEEEEECCTTEEHHHHHHHSGG--------GCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGE
T ss_pred eccCccccceEEEEEEcCCCCcHHHHHHhccc--------CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHE
Confidence 4221 114678999999999999999976431 2689999999999999999999998 999999999999
Q ss_pred eecCCCCeEEcccCcccccccccCccccccccccccccccCccccC-----CCCCCcccchhhHHHHHHHHHhCCCCCCc
Q 045798 831 LLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGL-----GSEVSTNGDVYSYGILLLEMVTAKKPTDV 905 (1008)
Q Consensus 831 ll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwslG~vl~elltG~~pf~~ 905 (1008)
+++.++.+||+|||++......... .....||+.|+|||++. +..++.++|||||||++|+|++|+.||..
T Consensus 161 l~~~~~~~kl~Dfg~~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 236 (326)
T 2x7f_A 161 LLTENAEVKLVDFGVSAQLDRTVGR----RNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCD 236 (326)
T ss_dssp EECTTCCEEECCCTTTC-----------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTT
T ss_pred EEcCCCCEEEeeCcCceecCcCccc----cccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999865432211 12345899999999987 56789999999999999999999999864
Q ss_pred cccCCccHHHHHHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHH
Q 045798 906 MFEGDLNLHNFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVV 985 (1008)
Q Consensus 906 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl 985 (1008)
..... ..........+ .. .....+..+.+++.+||+.||.+|||++|++
T Consensus 237 ~~~~~-~~~~~~~~~~~---------~~---------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll 285 (326)
T 2x7f_A 237 MHPMR-ALFLIPRNPAP---------RL---------------------KSKKWSKKFQSFIESCLVKNHSQRPATEQLM 285 (326)
T ss_dssp SCHHH-HHHHHHHSCCC---------CC---------------------SCSCSCHHHHHHHHHHCCSSGGGSCCHHHHH
T ss_pred CcHHH-HHHHhhcCccc---------cC---------------------CccccCHHHHHHHHHHhccChhhCCCHHHHh
Confidence 32110 00000000000 00 0011345678999999999999999999998
Q ss_pred H
Q 045798 986 H 986 (1008)
Q Consensus 986 ~ 986 (1008)
+
T Consensus 286 ~ 286 (326)
T 2x7f_A 286 K 286 (326)
T ss_dssp T
T ss_pred h
Confidence 7
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-38 Score=343.78 Aligned_cols=253 Identities=23% Similarity=0.325 Sum_probs=198.2
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccchhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceEE
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKA 762 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 762 (1008)
.++|++.+.||+|+||.||+|.+..+++.||+|++........+.+.+|++++++++||||+++++++ ..++..+
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~ 92 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAY-----YHDGKLW 92 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECC-CEE
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeee-----eeCCeEE
Confidence 56899999999999999999999888999999999876666678899999999999999999999995 4456789
Q ss_pred EEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEcc
Q 045798 763 IVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGD 842 (1008)
Q Consensus 763 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 842 (1008)
+||||+++++|.+++..... .+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|
T Consensus 93 lv~e~~~~~~l~~~~~~~~~---------~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~D 160 (302)
T 2j7t_A 93 IMIEFCPGGAVDAIMLELDR---------GLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLAD 160 (302)
T ss_dssp EEEECCTTEEHHHHHHHHTS---------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECC
T ss_pred EEEEeCCCCcHHHHHHhhcc---------CCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEE
Confidence 99999999999998865321 689999999999999999999998 999999999999999999999999
Q ss_pred cCcccccccccCccccccccccccccccCcccc-----CCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHH
Q 045798 843 FGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYG-----LGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFA 917 (1008)
Q Consensus 843 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~ 917 (1008)
||++........ ......||+.|+|||++ .+..++.++||||||+++|+|++|+.||....... ......
T Consensus 161 fg~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~~ 235 (302)
T 2j7t_A 161 FGVSAKNLKTLQ----KRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR-VLLKIA 235 (302)
T ss_dssp CHHHHHHHHHHH----C-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-HHHHHH
T ss_pred CCCCcccccccc----ccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHH-HHHHHh
Confidence 999864322111 11234589999999987 46678999999999999999999999986432110 000000
Q ss_pred HhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 918 RMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 918 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
....+ ........+..+.+++.+||+.||++|||+.|+++
T Consensus 236 ~~~~~-----------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 236 KSDPP-----------------------------TLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp HSCCC-----------------------------CCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred ccCCc-----------------------------ccCCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 00000 00001123456889999999999999999999986
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=338.38 Aligned_cols=254 Identities=21% Similarity=0.286 Sum_probs=202.1
Q ss_pred HHhcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEecccc---------chhhHHHHHHHHHHhhcC-CCCceeeeecc
Q 045798 681 KATNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC---------EGASKSFMAECKALKNIR-HRNLVKVITSC 750 (1008)
Q Consensus 681 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---------~~~~~~~~~E~~~l~~l~-h~niv~~~~~~ 750 (1008)
...++|++.+.||+|+||.||+|.+..+++.||||+++... ....+.+.+|+++++++. ||||+++++++
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (298)
T 1phk_A 14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY 93 (298)
T ss_dssp -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence 34578999999999999999999999899999999997542 122457889999999995 99999999994
Q ss_pred ccccccCCceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCe
Q 045798 751 SSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNI 830 (1008)
Q Consensus 751 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NI 830 (1008)
..+...++||||+++++|.+++.... .+++..++.++.||+.||+|||+. +|+||||||+||
T Consensus 94 -----~~~~~~~lv~e~~~~~~L~~~l~~~~----------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Ni 155 (298)
T 1phk_A 94 -----ETNTFFFLVFDLMKKGELFDYLTEKV----------TLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENI 155 (298)
T ss_dssp -----ECSSEEEEEEECCTTCBHHHHHHHHS----------SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGE
T ss_pred -----ccCCeEEEEEeccCCCcHHHHHhccC----------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceE
Confidence 55677999999999999999997543 689999999999999999999998 999999999999
Q ss_pred eecCCCCeEEcccCcccccccccCccccccccccccccccCccccC------CCCCCcccchhhHHHHHHHHHhCCCCCC
Q 045798 831 LLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGL------GSEVSTNGDVYSYGILLLEMVTAKKPTD 904 (1008)
Q Consensus 831 ll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~sDvwslG~vl~elltG~~pf~ 904 (1008)
+++.++.+||+|||.+........ .....|++.|+|||++. ...++.++||||||+++|+|++|+.||.
T Consensus 156 l~~~~~~~kl~dfg~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~ 230 (298)
T 1phk_A 156 LLDDDMNIKLTDFGFSCQLDPGEK-----LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFW 230 (298)
T ss_dssp EECTTCCEEECCCTTCEECCTTCC-----BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred EEcCCCcEEEecccchhhcCCCcc-----cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCc
Confidence 999999999999999986543321 12345899999999874 4568899999999999999999999986
Q ss_pred ccccCCccHHHHHHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHH
Q 045798 905 VMFEGDLNLHNFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNV 984 (1008)
Q Consensus 905 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev 984 (1008)
..... ........... . ...+.....+..+.+++.+||+.||++|||+.|+
T Consensus 231 ~~~~~-~~~~~~~~~~~------------~----------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l 281 (298)
T 1phk_A 231 HRKQM-LMLRMIMSGNY------------Q----------------FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEA 281 (298)
T ss_dssp CSSHH-HHHHHHHHTCC------------C----------------CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHH
T ss_pred CccHH-HHHHHHhcCCc------------c----------------cCcccccccCHHHHHHHHHHccCCcccCCCHHHH
Confidence 42110 00000000000 0 0000111345568999999999999999999999
Q ss_pred HH
Q 045798 985 VH 986 (1008)
Q Consensus 985 l~ 986 (1008)
++
T Consensus 282 l~ 283 (298)
T 1phk_A 282 LA 283 (298)
T ss_dssp TT
T ss_pred Hh
Confidence 75
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=373.30 Aligned_cols=253 Identities=23% Similarity=0.346 Sum_probs=197.8
Q ss_pred ceEeeccCeeEEEEEE--cCCCeEEEEEEecccc--chhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceEEEEE
Q 045798 690 HLIGVGSFGCVYKGAL--DEDGIVVAIKVINLQC--EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKAIVY 765 (1008)
Q Consensus 690 ~~lg~G~~g~Vy~~~~--~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 765 (1008)
+.||+|+||.||+|.+ ..+++.||||+++... ....+.+.+|++++++++||||++++++|. .+..++||
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~------~~~~~lv~ 448 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE------AESWMLVM 448 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE------SSSEEEEE
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe------cCCEEEEE
Confidence 4799999999999965 4467899999997543 234578999999999999999999999863 23478999
Q ss_pred eccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEcccCc
Q 045798 766 EYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGL 845 (1008)
Q Consensus 766 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~ 845 (1008)
||+++|+|.+++.... .+++..++.|+.||+.||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 449 E~~~~g~L~~~l~~~~----------~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGl 515 (635)
T 4fl3_A 449 EMAELGPLNKYLQQNR----------HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGL 515 (635)
T ss_dssp ECCTTEEHHHHHHHCT----------TCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTH
T ss_pred EccCCCCHHHHHhhCC----------CCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCC
Confidence 9999999999997553 689999999999999999999998 999999999999999999999999999
Q ss_pred ccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCccccCCccHHHHHHhhCCcc
Q 045798 846 ARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT-AKKPTDVMFEGDLNLHNFARMALPNQ 924 (1008)
Q Consensus 846 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~ 924 (1008)
|+......... .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||......+ ....
T Consensus 516 a~~~~~~~~~~-~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~--~~~~-------- 584 (635)
T 4fl3_A 516 SKALRADENYY-KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE--VTAM-------- 584 (635)
T ss_dssp HHHTTC--------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--HHHH--------
T ss_pred ccccccCcccc-ccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHH--------
Confidence 98765433221 11223347889999999998899999999999999999998 999986432110 0000
Q ss_pred hhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHHHHHHHH
Q 045798 925 VMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHELQSVKNI 994 (1008)
Q Consensus 925 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~i~~~ 994 (1008)
+.... ++. ....++.++.+++..||+.||++|||+++|++.|+++...
T Consensus 585 ----i~~~~--------------~~~----~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~ 632 (635)
T 4fl3_A 585 ----LEKGE--------------RMG----CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 632 (635)
T ss_dssp ----HHTTC--------------CCC----CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred ----HHcCC--------------CCC----CCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 00000 000 0112456789999999999999999999999999987543
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=337.80 Aligned_cols=247 Identities=21% Similarity=0.271 Sum_probs=196.6
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccc--cchhhHHHHHHHHHHhhc-CCCCceeeeeccccccccCCc
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQ--CEGASKSFMAECKALKNI-RHRNLVKVITSCSSIDFQGND 759 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~ 759 (1008)
.++|++.+.||+|+||.||+|.+..+++.||+|+++.. .......+.+|+..+.++ +||||+++++++ ..++
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~-----~~~~ 84 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAW-----AEDD 84 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEE-----EETT
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeee-----ecCC
Confidence 46799999999999999999999889999999999753 234456789999999999 999999999995 4566
Q ss_pred eEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCC----
Q 045798 760 FKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDND---- 835 (1008)
Q Consensus 760 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~---- 835 (1008)
..++||||+++++|.+++...... ...+++..++.++.||+.||+|||++ +|+||||||+||+++.+
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~~~~~------~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~ 155 (289)
T 1x8b_A 85 HMLIQNEYCNGGSLADAISENYRI------MSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPN 155 (289)
T ss_dssp EEEEEEECCTTCBHHHHHHHHHHH------TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC------
T ss_pred eEEEEEEecCCCcHHHHHHhhccc------ccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCc
Confidence 799999999999999999754210 01689999999999999999999998 99999999999999844
Q ss_pred ---------------CCeEEcccCcccccccccCccccccccccccccccCccccCCC-CCCcccchhhHHHHHHHHHhC
Q 045798 836 ---------------LSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGS-EVSTNGDVYSYGILLLEMVTA 899 (1008)
Q Consensus 836 ---------------~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltG 899 (1008)
..+||+|||.+....... ...||+.|+|||++.+. .+++++|||||||++|+|++|
T Consensus 156 ~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~--------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~ 227 (289)
T 1x8b_A 156 AASEEGDEDDWASNKVMFKIGDLGHVTRISSPQ--------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGA 227 (289)
T ss_dssp --------------CCCEEECCCTTCEETTCSC--------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTC
T ss_pred ccccccccccccCCceEEEEcccccccccCCcc--------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcC
Confidence 479999999998654322 13489999999998776 567899999999999999999
Q ss_pred CCCCCccccCCccHHHHHHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCC
Q 045798 900 KKPTDVMFEGDLNLHNFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRM 979 (1008)
Q Consensus 900 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP 979 (1008)
.+|+... ...........+ ..+ ...+..+.+++.+||+.||++||
T Consensus 228 ~~~~~~~----~~~~~~~~~~~~-------------------------~~~------~~~~~~~~~li~~~l~~dp~~Rp 272 (289)
T 1x8b_A 228 EPLPRNG----DQWHEIRQGRLP-------------------------RIP------QVLSQEFTELLKVMIHPDPERRP 272 (289)
T ss_dssp CCCCSSS----HHHHHHHTTCCC-------------------------CCS------SCCCHHHHHHHHHHTCSSGGGSC
T ss_pred CCCCcch----hHHHHHHcCCCC-------------------------CCC------cccCHHHHHHHHHHhCCCcccCC
Confidence 9875421 111111110000 000 01345678999999999999999
Q ss_pred CHHHHHH
Q 045798 980 NMTNVVH 986 (1008)
Q Consensus 980 t~~evl~ 986 (1008)
|+.|+++
T Consensus 273 s~~~ll~ 279 (289)
T 1x8b_A 273 SAMALVK 279 (289)
T ss_dssp CHHHHHT
T ss_pred CHHHHhh
Confidence 9999976
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=342.18 Aligned_cols=285 Identities=23% Similarity=0.251 Sum_probs=199.1
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccchhhHHHHHHHHHHhhcCCCCceeeeecccccc--------
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSCSSID-------- 754 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-------- 754 (1008)
.++|++.+.||+|+||.||+|.+..+++.||+|++........+.+.+|++++++++||||+++++++....
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 468999999999999999999998889999999998766666788999999999999999999999864321
Q ss_pred -ccCCceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeec
Q 045798 755 -FQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLD 833 (1008)
Q Consensus 755 -~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~ 833 (1008)
.......++||||++ |+|.+++... ++++..++.++.|++.||+|||++ +|+||||||+||+++
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~~~-----------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~ 154 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLEQG-----------PLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFIN 154 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHTTC-----------CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEE
T ss_pred cccccCceeEEeeccC-CCHHHHhhcC-----------CccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEc
Confidence 245577899999996 6999998643 688999999999999999999998 999999999999997
Q ss_pred -CCCCeEEcccCcccccccccCccccccccccccccccCccccCC-CCCCcccchhhHHHHHHHHHhCCCCCCccccCCc
Q 045798 834 -NDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLG-SEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDL 911 (1008)
Q Consensus 834 -~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~ 911 (1008)
+++.+||+|||.++......... .......+|..|+|||.+.+ ..++.++|||||||++|||++|+.||.......
T Consensus 155 ~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~- 232 (320)
T 2i6l_A 155 TEDLVLKIGDFGLARIMDPHYSHK-GHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELE- 232 (320)
T ss_dssp TTTTEEEECCCTTCBCC---------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-
T ss_pred CCCCeEEEccCccccccCCCcccc-cccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHH-
Confidence 56799999999998664322111 11223457899999998765 678999999999999999999999987432211
Q ss_pred cHHHHHHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 912 NLHNFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
...... ...+..............+..... .......+........+.++.+++.+||+.||++|||++|+++
T Consensus 233 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 233 QMQLIL-ESIPVVHEEDRQELLSVIPVYIRN-DMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS 305 (320)
T ss_dssp HHHHHH-HHSCCCCHHHHHHHHTTSCHHHHH-HTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred HHHHHH-HhcCCCchhhhhhhhhcCcccccc-cccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence 111111 111111000000000000000000 0000000000001134567899999999999999999999986
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=352.23 Aligned_cols=289 Identities=21% Similarity=0.225 Sum_probs=200.8
Q ss_pred HHHhcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccchhhHHHHHHHHHHhhcCCCCceeeeeccccccc----
Q 045798 680 LKATNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSCSSIDF---- 755 (1008)
Q Consensus 680 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~---- 755 (1008)
....++|++.+.||+|+||.||+|.+..+|+.||||++..... ...+|+++++.++||||+++++++.....
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 78 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK 78 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence 3456789999999999999999999998999999999864422 23479999999999999999998754321
Q ss_pred -----------------------------cCCceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHH
Q 045798 756 -----------------------------QGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVA 806 (1008)
Q Consensus 756 -----------------------------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~ 806 (1008)
....+.++||||++ |+|.+.+...... ...+++..++.++.||+
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~------~~~l~~~~~~~i~~qi~ 151 (383)
T 3eb0_A 79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRS------GRSIPMNLISIYIYQLF 151 (383)
T ss_dssp -------------------------------CCEEEEEECCCS-EEHHHHHHHHHHT------TCCCCHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhc------CCCCCHHHHHHHHHHHH
Confidence 34456889999996 5877776532110 11789999999999999
Q ss_pred HHHHHHhhCCCCCceeccCCCCCeeec-CCCCeEEcccCcccccccccCccccccccccccccccCccccCCC-CCCccc
Q 045798 807 SALDYLHHHCQEPILHCDLKPSNILLD-NDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGS-EVSTNG 884 (1008)
Q Consensus 807 ~~L~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~s 884 (1008)
.||+|||+. +|+||||||+||+++ .++.+||+|||.|+........ ....+|+.|+|||++.+. .++.++
T Consensus 152 ~aL~~LH~~---gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~ 223 (383)
T 3eb0_A 152 RAVGFIHSL---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPS-----VAYICSRFYRAPELMLGATEYTPSI 223 (383)
T ss_dssp HHHHHHHTT---TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCC-----CCCCCCSSCCCHHHHTTCSSCCTHH
T ss_pred HHHHHHHHC---cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCC-----cCcccCCCccCHHHhcCCCCCCcch
Confidence 999999997 999999999999997 6889999999999865443221 234589999999998775 489999
Q ss_pred chhhHHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCcchhhhh--cccccCchHHhhhhhhhhhccccchhHHHHHHH
Q 045798 885 DVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMALPNQVMDIV--DPILRNDEEILASTDKCRRMQTGINSRLECLIS 962 (1008)
Q Consensus 885 DvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~--d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 962 (1008)
||||+||++|||++|+.||......+ ...........+....+. ++..... .........+... .....+.+
T Consensus 224 DiwslG~il~ell~g~~pf~~~~~~~-~~~~i~~~~g~p~~~~~~~~~~~~~~~---~~~~~~~~~~~~~--~~~~~~~~ 297 (383)
T 3eb0_A 224 DLWSIGCVFGELILGKPLFSGETSID-QLVRIIQIMGTPTKEQMIRMNPHYTEV---RFPTLKAKDWRKI--LPEGTPSL 297 (383)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHCCCCHHHHHHHCTTC--C---CCCCCCCCCHHHH--SCTTCCHH
T ss_pred hhhhHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCCHHHHHHhCcccccc---cCCccCcccHHhh--CCCCCCHH
Confidence 99999999999999999987432211 112222211111111110 0000000 0000000000000 01124556
Q ss_pred HHHHHhcccCcCCCCCCCHHHHHH--HHHHHHH
Q 045798 963 MVKIGVACSMESPQDRMNMTNVVH--ELQSVKN 993 (1008)
Q Consensus 963 l~~li~~cl~~dP~~RPt~~evl~--~L~~i~~ 993 (1008)
+.+++.+||+.||.+|||+.|+++ .++.+++
T Consensus 298 ~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 330 (383)
T 3eb0_A 298 AIDLLEQILRYEPDLRINPYEAMAHPFFDHLRN 330 (383)
T ss_dssp HHHHHHHHCCSSGGGSCCHHHHHTSGGGHHHHH
T ss_pred HHHHHHHHccCChhhCCCHHHHhcCHHHHHHHh
Confidence 899999999999999999999985 3444443
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-37 Score=342.92 Aligned_cols=278 Identities=19% Similarity=0.273 Sum_probs=204.2
Q ss_pred hcCCCCCceEeeccCeeEEEEEE-cCCCeEEEEEEeccccchhhHHHHHHHHHHhhcCCC------Cceeeeeccccccc
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGAL-DEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHR------NLVKVITSCSSIDF 755 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~------niv~~~~~~~~~~~ 755 (1008)
.++|++.+.||+|+||.||+|.+ ..+++.||||+++.. ....+.+.+|+++++.++|+ +++++++++
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~----- 86 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWF----- 86 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEE-----
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeeccc-----
Confidence 46899999999999999999998 557899999999754 34457789999999998665 489999984
Q ss_pred cCCceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecC-
Q 045798 756 QGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDN- 834 (1008)
Q Consensus 756 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~- 834 (1008)
...+..++||||+ +++|.+++...... ++++..++.++.||+.||+|||++ +|+||||||+||+++.
T Consensus 87 ~~~~~~~lv~e~~-~~~l~~~l~~~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~ 154 (339)
T 1z57_A 87 EHHGHICIVFELL-GLSTYDFIKENGFL--------PFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQS 154 (339)
T ss_dssp EETTEEEEEEECC-CCBHHHHHHHTTTC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCC
T ss_pred ccCCcEEEEEcCC-CCCHHHHHHhcCCC--------CCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEecc
Confidence 4566799999999 89999999765422 688999999999999999999998 9999999999999987
Q ss_pred ------------------CCCeEEcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHH
Q 045798 835 ------------------DLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEM 896 (1008)
Q Consensus 835 ------------------~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~el 896 (1008)
++.+||+|||.++...... ....||+.|+|||++.+..++.++|||||||++|||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~-------~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el 227 (339)
T 1z57_A 155 DYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEHH-------STLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEY 227 (339)
T ss_dssp CEEEEEC----CEEEEESCCCEEECCCSSCEETTSCC-------CSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHH
T ss_pred ccccccCCccccccccccCCCceEeeCcccccCcccc-------ccccCCccccChHHhhCCCCCcchhhHHHHHHHHHH
Confidence 6689999999998643321 234589999999999999999999999999999999
Q ss_pred HhCCCCCCccccCCccHHHHHHh--hCCcchhhhhcc---------cccCc-hHHhhhhhhhhhccccchhHHHHHHHHH
Q 045798 897 VTAKKPTDVMFEGDLNLHNFARM--ALPNQVMDIVDP---------ILRND-EEILASTDKCRRMQTGINSRLECLISMV 964 (1008)
Q Consensus 897 ltG~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~~d~---------~l~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 964 (1008)
++|+.||......+ ........ ..+......... ..... .........+............++.++.
T Consensus 228 ~~g~~pf~~~~~~~-~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 306 (339)
T 1z57_A 228 YLGFTVFPTHDSKE-HLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLF 306 (339)
T ss_dssp HHSSCSCCCSCHHH-HHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHH
T ss_pred HhCCCCCCCCChHH-HHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHH
Confidence 99999997432211 11111111 111111000000 00000 0000000111111111122335677899
Q ss_pred HHHhcccCcCCCCCCCHHHHHH
Q 045798 965 KIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 965 ~li~~cl~~dP~~RPt~~evl~ 986 (1008)
+++.+||+.||.+|||++|+++
T Consensus 307 ~li~~~L~~dP~~Rpt~~ell~ 328 (339)
T 1z57_A 307 DLIQKMLEYDPAKRITLREALK 328 (339)
T ss_dssp HHHHHHTCSSTTTSCCHHHHTT
T ss_pred HHHHHHhCcCcccccCHHHHhc
Confidence 9999999999999999999975
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-37 Score=347.94 Aligned_cols=277 Identities=20% Similarity=0.224 Sum_probs=198.1
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEecccc--chhhHHHHHHHHHHhhcCCCCceeeeeccccccc-cCCc
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC--EGASKSFMAECKALKNIRHRNLVKVITSCSSIDF-QGND 759 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~ 759 (1008)
.++|.+.+.||+|+||.||+|.+..+|+.||||++.... ....+.+.+|+.+++.++||||+++++++..... ....
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 468999999999999999999999899999999997532 3345788999999999999999999999654321 1112
Q ss_pred eEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeE
Q 045798 760 FKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGH 839 (1008)
Q Consensus 760 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 839 (1008)
..++||||++ ++|.+++.. .+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+|
T Consensus 121 ~~~lv~e~~~-~~l~~~~~~------------~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~k 184 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMGM------------EFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELK 184 (371)
T ss_dssp CCEEEEECCC-EEHHHHTTS------------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEE
T ss_pred eEEEEEcccc-ccHHHHhhc------------CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEE
Confidence 3499999995 688887732 589999999999999999999998 999999999999999999999
Q ss_pred EcccCcccccccccCccccccccccccccccCccccCC-CCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHH
Q 045798 840 IGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLG-SEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFAR 918 (1008)
Q Consensus 840 L~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~ 918 (1008)
|+|||.++..... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||......+ .......
T Consensus 185 L~Dfg~a~~~~~~-------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~i~~ 256 (371)
T 4exu_A 185 ILDFGLARHADAE-------MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD-QLTQILK 256 (371)
T ss_dssp ECSTTCC---------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHH
T ss_pred EEecCcccccccC-------cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHH
Confidence 9999999855432 123458999999999887 678999999999999999999999997432111 1111111
Q ss_pred hhCCcchhhhhcccccCchHHhhhhhhhhhccc-cc-hhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 919 MALPNQVMDIVDPILRNDEEILASTDKCRRMQT-GI-NSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 919 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~-~~-~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
..... ..++....-. .. ...........+. .. ......+..+.+++.+||+.||++|||++|+++
T Consensus 257 ~~~~~-~~~~~~~~~~-~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 323 (371)
T 4exu_A 257 VTGVP-GTEFVQKLND-KA-AKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 323 (371)
T ss_dssp HHCCC-CHHHHTTCSC-HH-HHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HhCCC-cHHHHHHhhh-hh-hhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence 11110 0111110000 00 0000000000000 00 001123567899999999999999999999986
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-37 Score=340.51 Aligned_cols=252 Identities=25% Similarity=0.327 Sum_probs=197.7
Q ss_pred HhcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccchhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceE
Q 045798 682 ATNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFK 761 (1008)
Q Consensus 682 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 761 (1008)
..++|++.+.||+|+||.||+|.+..+|+.||+|++... ...+.+.+|++++++++||||+++++++ ...+..
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~ 99 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPHVVKYYGSY-----FKNTDL 99 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETT--SCCHHHHHHHHHHHTCCCTTBCCEEEEE-----EETTEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCch--HHHHHHHHHHHHHHhCCCCCCccEEEEE-----EeCCEE
Confidence 456899999999999999999999888999999999754 2346789999999999999999999985 445678
Q ss_pred EEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEc
Q 045798 762 AIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIG 841 (1008)
Q Consensus 762 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 841 (1008)
++||||+++++|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+
T Consensus 100 ~lv~e~~~~~~L~~~~~~~~---------~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~ 167 (314)
T 3com_A 100 WIVMEYCGAGSVSDIIRLRN---------KTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLA 167 (314)
T ss_dssp EEEEECCTTEEHHHHHHHHT---------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEEC
T ss_pred EEEeecCCCCCHHHHHHhcC---------CCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEe
Confidence 99999999999999986322 1689999999999999999999998 99999999999999999999999
Q ss_pred ccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHhhC
Q 045798 842 DFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMAL 921 (1008)
Q Consensus 842 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~~~ 921 (1008)
|||.+......... .....|++.|+|||++.+..++.++||||||+++|+|++|+.||....... .........
T Consensus 168 dfg~~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~~~~~~~ 241 (314)
T 3com_A 168 DFGVAGQLTDTMAK----RNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMR--AIFMIPTNP 241 (314)
T ss_dssp CCTTCEECBTTBSC----BCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH--HHHHHHHSC
T ss_pred ecccchhhhhhccc----cCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHhcCC
Confidence 99999865443221 223458999999999999899999999999999999999999986421110 000000000
Q ss_pred CcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 922 PNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 922 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
+ +. .......+..+.+++.+||+.||.+|||+.|+++
T Consensus 242 ~--------~~--------------------~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 242 P--------PT--------------------FRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp C--------CC--------------------CSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred C--------cc--------------------cCCcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 0 00 0001123456889999999999999999999986
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-38 Score=371.59 Aligned_cols=256 Identities=30% Similarity=0.461 Sum_probs=204.4
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccchhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceEE
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKA 762 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 762 (1008)
.++|++.+.||+|+||.||+|.+. .+..||||+++... ...+.|.+|+++|++++||||++++++|.. +..+
T Consensus 266 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~------~~~~ 337 (535)
T 2h8h_A 266 RESLRLEVKLGQGCFGEVWMGTWN-GTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EPIY 337 (535)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET-TTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS------SSCE
T ss_pred hhhhhhheecccCCCeEEEEEEEC-CCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee------ccce
Confidence 467889999999999999999996 56789999998543 335689999999999999999999998632 4579
Q ss_pred EEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEcc
Q 045798 763 IVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGD 842 (1008)
Q Consensus 763 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 842 (1008)
+||||+++|+|.+++.... ...+++.+++.|+.||+.||+|||+. +|+||||||+|||++.++.+||+|
T Consensus 338 lv~e~~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~D 406 (535)
T 2h8h_A 338 IVTEYMSKGSLLDFLKGET--------GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVAD 406 (535)
T ss_dssp EEECCCTTEEHHHHHSHHH--------HTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECC
T ss_pred EeeehhcCCcHHHHHhhcC--------CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEcc
Confidence 9999999999999997432 11589999999999999999999998 999999999999999999999999
Q ss_pred cCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCccccCCccHHHHHHhhC
Q 045798 843 FGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT-AKKPTDVMFEGDLNLHNFARMAL 921 (1008)
Q Consensus 843 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-G~~pf~~~~~~~~~~~~~~~~~~ 921 (1008)
||+++...... ........++..|+|||++.+..++.++|||||||++|||++ |+.||...... ...
T Consensus 407 FG~a~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~-----~~~---- 474 (535)
T 2h8h_A 407 FGLARLIEDNE---YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR-----EVL---- 474 (535)
T ss_dssp TTSTTTCCCHH---HHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHH-----HHH----
T ss_pred cccceecCCCc---eecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-----HHH----
Confidence 99998664321 111223347789999999988899999999999999999999 89998643111 000
Q ss_pred CcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHHHHHH
Q 045798 922 PNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHELQSVK 992 (1008)
Q Consensus 922 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~i~ 992 (1008)
..+... .+++ ....++..+.++|.+||+.||++|||+++|++.|+.+.
T Consensus 475 -----~~i~~~--------------~~~~----~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~ 522 (535)
T 2h8h_A 475 -----DQVERG--------------YRMP----CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 522 (535)
T ss_dssp -----HHHHTT--------------CCCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred -----HHHHcC--------------CCCC----CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 000000 0000 01134567899999999999999999999999998753
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-38 Score=344.79 Aligned_cols=271 Identities=24% Similarity=0.273 Sum_probs=183.8
Q ss_pred HhcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEecccc-chhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCce
Q 045798 682 ATNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC-EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDF 760 (1008)
Q Consensus 682 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 760 (1008)
..++|++.+.||+|+||.||+|.+..+++.||||++.... ....+.+.+|++++++++||||+++++++ ...+.
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~ 87 (303)
T 2vwi_A 13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSF-----VVKDE 87 (303)
T ss_dssp CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEE-----ESSSC
T ss_pred chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEE-----eecCC
Confidence 4578999999999999999999998889999999987543 33456789999999999999999999985 44566
Q ss_pred EEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEE
Q 045798 761 KAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHI 840 (1008)
Q Consensus 761 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 840 (1008)
.++||||+++++|.+++........ .....+++..++.++.||+.||+|||+. +|+||||||+||+++.++.+||
T Consensus 88 ~~lv~e~~~~~~L~~~l~~~~~~~~--~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl 162 (303)
T 2vwi_A 88 LWLVMKLLSGGSVLDIIKHIVAKGE--HKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQI 162 (303)
T ss_dssp EEEEEECCTTCBHHHHHHHHHHTTT--TTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEE
T ss_pred cEEEehhccCCchHHHHHHHhhccc--cccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEE
Confidence 8999999999999999864210000 0011689999999999999999999998 9999999999999999999999
Q ss_pred cccCcccccccccCcc-ccccccccccccccCccccCC-CCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHH
Q 045798 841 GDFGLARFHQEVSNST-LSSSVGVKGTIGYTAPEYGLG-SEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFAR 918 (1008)
Q Consensus 841 ~Dfg~a~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~ 918 (1008)
+|||.+.......... ........||+.|+|||++.+ ..++.++||||||+++|||++|+.||......... ....
T Consensus 163 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~--~~~~ 240 (303)
T 2vwi_A 163 ADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVL--MLTL 240 (303)
T ss_dssp CCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHH--HHHH
T ss_pred EeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHH--HHHh
Confidence 9999997654332111 111223458999999999865 46899999999999999999999998753221110 0000
Q ss_pred hhCCcchhh-hhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 919 MALPNQVMD-IVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 919 ~~~~~~~~~-~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
...+..... ..++. . ....+.++.+++.+||+.||.+|||+.|+++
T Consensus 241 ~~~~~~~~~~~~~~~----------------~------~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 241 QNDPPSLETGVQDKE----------------M------LKKYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp TSSCCCTTC-----C----------------C------CCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred ccCCCccccccccch----------------h------hhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 000000000 00000 0 0113456789999999999999999999987
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=348.73 Aligned_cols=255 Identities=23% Similarity=0.310 Sum_probs=199.4
Q ss_pred hcCCCCCceEeeccCeeEEEEEEc---CCCeEEEEEEecccc----chhhHHHHHHHHHHhhc-CCCCceeeeecccccc
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALD---EDGIVVAIKVINLQC----EGASKSFMAECKALKNI-RHRNLVKVITSCSSID 754 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~ 754 (1008)
.++|++.+.||+|+||.||+|+.. .+++.||||+++... ....+.+.+|+++++++ +||||+++++++
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~---- 128 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF---- 128 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEE----
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEE----
Confidence 467999999999999999999984 478999999987432 23446678899999999 799999999984
Q ss_pred ccCCceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecC
Q 045798 755 FQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDN 834 (1008)
Q Consensus 755 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~ 834 (1008)
..++..++||||+++|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+||+++.
T Consensus 129 -~~~~~~~lv~e~~~~~~L~~~l~~~~----------~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~ 194 (355)
T 1vzo_A 129 -QTETKLHLILDYINGGELFTHLSQRE----------RFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDS 194 (355)
T ss_dssp -EETTEEEEEECCCCSCBHHHHHHHHS----------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECT
T ss_pred -eeCceEEEEeecCCCCCHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECC
Confidence 45667999999999999999997543 689999999999999999999998 9999999999999999
Q ss_pred CCCeEEcccCcccccccccCccccccccccccccccCccccCC--CCCCcccchhhHHHHHHHHHhCCCCCCccccCCcc
Q 045798 835 DLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLG--SEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLN 912 (1008)
Q Consensus 835 ~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~ 912 (1008)
++.+||+|||+++........ ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||........
T Consensus 195 ~~~~kl~DfG~a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~- 270 (355)
T 1vzo_A 195 NGHVVLTDFGLSKEFVADETE---RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS- 270 (355)
T ss_dssp TSCEEESCSSEEEECCGGGGG---GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC-
T ss_pred CCcEEEeeCCCCeecccCCCC---cccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccch-
Confidence 999999999999865433221 1223569999999999886 3478999999999999999999999964322211
Q ss_pred HHHHHHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCC-----CHHHHHHH
Q 045798 913 LHNFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRM-----NMTNVVHE 987 (1008)
Q Consensus 913 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~ 987 (1008)
........ ....+ .. ....+..+.+++.+||+.||.+|| |++|+++.
T Consensus 271 ~~~~~~~~------------~~~~~----------~~------~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h 322 (355)
T 1vzo_A 271 QAEISRRI------------LKSEP----------PY------PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 322 (355)
T ss_dssp HHHHHHHH------------HHCCC----------CC------CTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred HHHHHHHH------------hccCC----------CC------CcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcC
Confidence 11111100 00000 00 012344578999999999999999 99999874
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=373.68 Aligned_cols=245 Identities=22% Similarity=0.285 Sum_probs=200.3
Q ss_pred HhcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccc---cchhhHHHHHHHHHHhhc-CCCCceeeeeccccccccC
Q 045798 682 ATNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQ---CEGASKSFMAECKALKNI-RHRNLVKVITSCSSIDFQG 757 (1008)
Q Consensus 682 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~ 757 (1008)
..++|++.+.||+|+||.||+|++..+++.||||+++.. .....+.+..|.+++..+ +||+|++++++ +++
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~-----~~~ 413 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSC-----FQT 413 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEE-----CBC
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEE-----EEe
Confidence 356899999999999999999999999999999999743 234456788999999988 79999999998 566
Q ss_pred CceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCC
Q 045798 758 NDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLS 837 (1008)
Q Consensus 758 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 837 (1008)
.+..|+||||+++|+|.+++.... .+++..++.++.||+.||+|||+. +||||||||+|||++.++.
T Consensus 414 ~~~~~lV~E~~~gg~L~~~l~~~~----------~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ 480 (674)
T 3pfq_A 414 MDRLYFVMEYVNGGDLMYHIQQVG----------RFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGH 480 (674)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHHS----------SCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSC
T ss_pred CCEEEEEEeCcCCCcHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCc
Confidence 778999999999999999997654 789999999999999999999998 9999999999999999999
Q ss_pred eEEcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHH
Q 045798 838 GHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFA 917 (1008)
Q Consensus 838 ~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~ 917 (1008)
+||+|||+|+....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ...
T Consensus 481 ikL~DFGla~~~~~~~~----~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~-----~~~ 551 (674)
T 3pfq_A 481 IKIADFGMCKENIWDGV----TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED-----ELF 551 (674)
T ss_dssp EEECCCTTCEECCCTTC----CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH-----HHH
T ss_pred EEEeecceeeccccCCc----ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHH-----HHH
Confidence 99999999985432221 123456999999999999999999999999999999999999998643110 010
Q ss_pred HhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCH
Q 045798 918 RMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNM 981 (1008)
Q Consensus 918 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~ 981 (1008)
. .+....+ .++ ...+.++.+++.+||+.||++||++
T Consensus 552 ~--------~i~~~~~--------------~~p------~~~s~~~~~li~~lL~~dP~~R~~~ 587 (674)
T 3pfq_A 552 Q--------SIMEHNV--------------AYP------KSMSKEAVAICKGLMTKHPGKRLGC 587 (674)
T ss_dssp H--------HHHSSCC--------------CCC------TTSCHHHHHHHHHHSCSSSTTCTTC
T ss_pred H--------HHHhCCC--------------CCC------ccCCHHHHHHHHHHccCCHHHCCCC
Confidence 0 0000000 001 1234567899999999999999998
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-37 Score=349.23 Aligned_cols=284 Identities=19% Similarity=0.245 Sum_probs=204.2
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccchhhHHHHHHHHHHhhcC--------CCCceeeeecccccc
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIR--------HRNLVKVITSCSSID 754 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--------h~niv~~~~~~~~~~ 754 (1008)
.++|++.+.||+|+||+||+|++..+++.||||+++.. ....+.+.+|++++++++ |+||+++++++....
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~ 114 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence 36899999999999999999999889999999999744 344577899999999985 788999999864321
Q ss_pred ccCCceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecC
Q 045798 755 FQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDN 834 (1008)
Q Consensus 755 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~ 834 (1008)
..+...++||||+ ++++.+++...... .+++..++.++.||+.||+|||++ .+|+||||||+|||++.
T Consensus 115 -~~~~~~~lv~e~~-~~~l~~~~~~~~~~--------~~~~~~~~~i~~qi~~aL~~lH~~--~givHrDikp~NIll~~ 182 (397)
T 1wak_A 115 -VNGTHICMVFEVL-GHHLLKWIIKSNYQ--------GLPLPCVKKIIQQVLQGLDYLHTK--CRIIHTDIKPENILLSV 182 (397)
T ss_dssp -TTEEEEEEEECCC-CCBHHHHHHHTTTS--------CCCHHHHHHHHHHHHHHHHHHHHT--TCEECCCCSGGGEEECC
T ss_pred -CCCceEEEEEecc-CccHHHHHHhcccC--------CCCHHHHHHHHHHHHHHHHHHHHh--CCEecCCCCHHHeeEec
Confidence 2456789999999 66777776544211 689999999999999999999984 28999999999999987
Q ss_pred CC-------------------------------------------------CeEEcccCcccccccccCccccccccccc
Q 045798 835 DL-------------------------------------------------SGHIGDFGLARFHQEVSNSTLSSSVGVKG 865 (1008)
Q Consensus 835 ~~-------------------------------------------------~~kL~Dfg~a~~~~~~~~~~~~~~~~~~g 865 (1008)
++ .+||+|||.++..... .....|
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-------~~~~~g 255 (397)
T 1wak_A 183 NEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-------FTEDIQ 255 (397)
T ss_dssp CHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-------SCSCCS
T ss_pred cchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-------CccCCC
Confidence 75 7999999999865432 122458
Q ss_pred cccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCcc-----HHHHHHhhC--Ccchhh---hhcccccC
Q 045798 866 TIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLN-----LHNFARMAL--PNQVMD---IVDPILRN 935 (1008)
Q Consensus 866 t~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~-----~~~~~~~~~--~~~~~~---~~d~~l~~ 935 (1008)
|+.|+|||++.+..++.++|||||||++|||++|+.||......... ......... +..... ........
T Consensus 256 t~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~ 335 (397)
T 1wak_A 256 TRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTK 335 (397)
T ss_dssp CGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCT
T ss_pred CCcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCC
Confidence 99999999999999999999999999999999999999754322211 111111110 100000 00000000
Q ss_pred chHHhh-----hhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 936 DEEILA-----STDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 936 ~~~~~~-----~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
...... ................+.+..+.+++.+||+.||++|||++|+++
T Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 336 KGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp TSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred ccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 000000 000000000111123466788999999999999999999999985
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-37 Score=340.86 Aligned_cols=282 Identities=23% Similarity=0.293 Sum_probs=204.6
Q ss_pred HhcCCCCCceEeeccCeeEEEEEEc-CCCeEEEEEEeccccc--hhhHHHHHHHHHHhhc---CCCCceeeeeccccccc
Q 045798 682 ATNGFSSTHLIGVGSFGCVYKGALD-EDGIVVAIKVINLQCE--GASKSFMAECKALKNI---RHRNLVKVITSCSSIDF 755 (1008)
Q Consensus 682 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~~~~ 755 (1008)
+.++|++.+.||+|+||.||+|++. .+++.||+|+++.... .....+.+|+.+++.+ +||||++++++|.....
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 4678999999999999999999994 6789999999874322 2234677888887776 89999999999764333
Q ss_pred cCCceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCC
Q 045798 756 QGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDND 835 (1008)
Q Consensus 756 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~ 835 (1008)
......++||||++ |+|.+++...... .+++..++.++.||+.||+|||+. +|+||||||+||+++.+
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~ 156 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVPEP--------GVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSS 156 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSCTT--------CSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTT
T ss_pred CCCceEEEEEecCC-CCHHHHHHhcccC--------CCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCC
Confidence 45677899999996 6999998765421 589999999999999999999998 99999999999999999
Q ss_pred CCeEEcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHH
Q 045798 836 LSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHN 915 (1008)
Q Consensus 836 ~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~ 915 (1008)
+.+||+|||.++...... ......||..|+|||++.+..++.++|||||||++|||++|+.||......+ ....
T Consensus 157 ~~~kl~Dfg~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~ 230 (326)
T 1blx_A 157 GQIKLADFGLARIYSFQM-----ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD-QLGK 230 (326)
T ss_dssp CCEEECSCCSCCCCCGGG-----GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHH
T ss_pred CCEEEecCcccccccCCC-----CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHH-HHHH
Confidence 999999999998654322 1223458999999999999999999999999999999999999987432211 1111
Q ss_pred HHHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 916 FARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 916 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
............+......... ... ..............+..+.+++.+||+.||++|||+.|+++
T Consensus 231 i~~~~~~~~~~~~~~~~~~~~~----~~~-~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 231 ILDVIGLPGEEDWPRDVALPRQ----AFH-SKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp HHHHHCCCCGGGSCTTCSSCGG----GSC-CCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHHcCCCCcccCccccccchh----hhc-ccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 1111110000000000000000 000 00000000001124556889999999999999999999985
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-37 Score=335.81 Aligned_cols=255 Identities=19% Similarity=0.290 Sum_probs=198.0
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEecccc----chhhHHHHHHHHHHhhcCCCCceeeeeccccccccCC
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC----EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGN 758 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 758 (1008)
.++|++.+.||+|+||.||+|.+..+++.||+|+++... ....+.+.+|++++++++||||+++++++.. ...
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~ 80 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYN---EEK 80 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEC---C--
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEc---CCC
Confidence 578999999999999999999998899999999997432 2345789999999999999999999998632 445
Q ss_pred ceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCe
Q 045798 759 DFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSG 838 (1008)
Q Consensus 759 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 838 (1008)
...++||||++++ |.+++...... .+++..++.++.||+.||+|||+. +|+||||||+||+++.++.+
T Consensus 81 ~~~~lv~e~~~~~-l~~~~~~~~~~--------~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~ 148 (305)
T 2wtk_C 81 QKMYMVMEYCVCG-MQEMLDSVPEK--------RFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTL 148 (305)
T ss_dssp -CEEEEEECCSEE-HHHHHHHSTTC--------SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCE
T ss_pred CeEEEEehhccCC-HHHHHHhCccc--------ccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcE
Confidence 6789999999765 77777654321 689999999999999999999998 99999999999999999999
Q ss_pred EEcccCcccccccccCccccccccccccccccCccccCCCC--CCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHH
Q 045798 839 HIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSE--VSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNF 916 (1008)
Q Consensus 839 kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~ 916 (1008)
||+|||.+.......... ......||+.|+|||++.+.. ++.++||||||+++|||++|+.||..... ...
T Consensus 149 kl~dfg~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~~ 221 (305)
T 2wtk_C 149 KISALGVAEALHPFAADD--TCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNI-----YKL 221 (305)
T ss_dssp EECCCTTCEECCTTCSSC--EECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSH-----HHH
T ss_pred EeeccccccccCcccccc--ccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchH-----HHH
Confidence 999999998654322211 122345899999999987644 47799999999999999999999864211 000
Q ss_pred HHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 045798 917 ARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHE 987 (1008)
Q Consensus 917 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 987 (1008)
... +..... ..+ ..++..+.+++.+||+.||.+|||++|+++.
T Consensus 222 ~~~--------i~~~~~--------------~~~------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 222 FEN--------IGKGSY--------------AIP------GDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp HHH--------HHHCCC--------------CCC------SSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred HHH--------HhcCCC--------------CCC------CccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 000 000000 000 1234567899999999999999999999863
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-38 Score=341.35 Aligned_cols=262 Identities=26% Similarity=0.351 Sum_probs=195.7
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcC-CC--eEEEEEEeccc---cchhhHHHHHHHHHHhhcCCCCceeeeecccccccc
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDE-DG--IVVAIKVINLQ---CEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQ 756 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~-~~--~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 756 (1008)
.++|++.+.||+|+||.||+|.+.. ++ ..||+|+++.. .....+.+.+|++++++++||||+++++++..
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---- 92 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT---- 92 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS----
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcc----
Confidence 4679999999999999999998643 33 36999998743 23456789999999999999999999999542
Q ss_pred CCceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCC
Q 045798 757 GNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDL 836 (1008)
Q Consensus 757 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 836 (1008)
+ ..++||||+++++|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++
T Consensus 93 -~-~~~~v~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~ 158 (291)
T 1u46_A 93 -P-PMKMVTELAPLGSLLDRLRKHQ---------GHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRD 158 (291)
T ss_dssp -S-SCEEEEECCTTCBHHHHHHHHG---------GGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETT
T ss_pred -C-CceeeEecccCCCHHHHHHhcc---------CCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCC
Confidence 2 3789999999999999987542 1689999999999999999999998 999999999999999999
Q ss_pred CeEEcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCccccCCccHHH
Q 045798 837 SGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT-AKKPTDVMFEGDLNLHN 915 (1008)
Q Consensus 837 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-G~~pf~~~~~~~~~~~~ 915 (1008)
.+||+|||++.......... .......+|..|+|||++.+..++.++||||||+++|+|++ |+.||...... .
T Consensus 159 ~~kl~Dfg~~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-----~ 232 (291)
T 1u46_A 159 LVKIGDFGLMRALPQNDDHY-VMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS-----Q 232 (291)
T ss_dssp EEEECCCTTCEECCC-CCEE-EC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-----H
T ss_pred CEEEccccccccccccccch-hhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHH-----H
Confidence 99999999998765433221 11223457889999999988889999999999999999999 99998643211 0
Q ss_pred HHHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHHHHHHHH
Q 045798 916 FARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHELQSVKNI 994 (1008)
Q Consensus 916 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~i~~~ 994 (1008)
..... ..... . .+....++.++.+++.+||+.||++|||+.++++.|+++...
T Consensus 233 ~~~~~--------~~~~~--------------~----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 285 (291)
T 1u46_A 233 ILHKI--------DKEGE--------------R----LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPT 285 (291)
T ss_dssp HHHHH--------HTSCC--------------C----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred HHHHH--------HccCC--------------C----CCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCcc
Confidence 00000 00000 0 000112455689999999999999999999999999887654
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=337.81 Aligned_cols=255 Identities=20% Similarity=0.242 Sum_probs=185.4
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccc--hhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCce
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCE--GASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDF 760 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 760 (1008)
.++|++.+.||+|+||.||+|++..+++.||+|+++.... ...+.+.++...++.++||||+++++++ ..++.
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~-----~~~~~ 80 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGAL-----FREGD 80 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSSS
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeee-----eccCC
Confidence 5689999999999999999999988999999999975422 2233455555668888999999999995 45567
Q ss_pred EEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEE
Q 045798 761 KAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHI 840 (1008)
Q Consensus 761 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 840 (1008)
.++||||++ |+|.+++...... ...+++..++.++.|++.||+|||+. .+|+||||||+||+++.++.+||
T Consensus 81 ~~lv~e~~~-~~l~~~l~~~~~~------~~~~~~~~~~~i~~qi~~~l~~lH~~--~~i~H~dlkp~Nil~~~~~~~kl 151 (290)
T 3fme_A 81 VWICMELMD-TSLDKFYKQVIDK------GQTIPEDILGKIAVSIVKALEHLHSK--LSVIHRDVKPSNVLINALGQVKM 151 (290)
T ss_dssp EEEEEECCS-EEHHHHHHHHHHT------TCCCCHHHHHHHHHHHHHHHHHHHHH--SCCCCCCCSGGGCEECTTCCEEB
T ss_pred EEEEEehhc-cchHHHHHHHHhc------CCCCCHHHHHHHHHHHHHHHHHHhhc--CCeecCCCCHHHEEECCCCCEEE
Confidence 899999996 5888877542110 11689999999999999999999983 28999999999999999999999
Q ss_pred cccCcccccccccCccccccccccccccccCcccc----CCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHH
Q 045798 841 GDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYG----LGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNF 916 (1008)
Q Consensus 841 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~ 916 (1008)
+|||.+......... ....||+.|+|||++ .+..++.++||||+||++|||++|+.||.............
T Consensus 152 ~Dfg~~~~~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~ 226 (290)
T 3fme_A 152 CDFGISGYLVDDVAK-----DIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQV 226 (290)
T ss_dssp CCC--------------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHH
T ss_pred eecCCcccccccccc-----cccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHH
Confidence 999999865443221 123589999999995 56678999999999999999999999986422111111111
Q ss_pred HHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 917 ARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 917 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
.....+.. .....+.++.+++.+||+.||++|||++|+++
T Consensus 227 ~~~~~~~~------------------------------~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 227 VEEPSPQL------------------------------PADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp HHSCCCCC------------------------------CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred hccCCCCc------------------------------ccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 11100000 00123456799999999999999999999987
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-37 Score=345.33 Aligned_cols=291 Identities=20% Similarity=0.246 Sum_probs=194.2
Q ss_pred HHHHHHHhcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccchhhHHHHHHHHHHhhcCCCCceeeeeccccccc
Q 045798 676 YKSLLKATNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSCSSIDF 755 (1008)
Q Consensus 676 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 755 (1008)
..+.....++|++.+.||+|+||.||+|.+..+++.||||++... ......+.+|++.++.++||||+++++++.....
T Consensus 15 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~ 93 (360)
T 3e3p_A 15 DERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQD-PRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGE 93 (360)
T ss_dssp SHHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECC-TTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECS
T ss_pred hhhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecC-ccccHHHHHHHHHHHhcCCCCcccHHHhhhcccc
Confidence 345667789999999999999999999999889999999998644 3334567788888999999999999999754332
Q ss_pred --cCCceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHh--hCCCCCceeccCCCCCee
Q 045798 756 --QGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLH--HHCQEPILHCDLKPSNIL 831 (1008)
Q Consensus 756 --~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH--~~~~~~ivH~Dlkp~NIl 831 (1008)
....+.++||||+++ +|.+.+...... ...+++..+..++.|++.||+||| +. +|+||||||+||+
T Consensus 94 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~------~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIl 163 (360)
T 3e3p_A 94 RDRRDIYLNVVMEYVPD-TLHRCCRNYYRR------QVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVL 163 (360)
T ss_dssp SCTTCEEEEEEEECCSC-BHHHHHHHHHTT------TCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEE
T ss_pred ccccceeEEEEeecccc-cHHHHHHHHhhc------ccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEE
Confidence 223347899999965 554443321000 116889999999999999999999 76 9999999999999
Q ss_pred ecC-CCCeEEcccCcccccccccCccccccccccccccccCccccCCCC-CCcccchhhHHHHHHHHHhCCCCCCccccC
Q 045798 832 LDN-DLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSE-VSTNGDVYSYGILLLEMVTAKKPTDVMFEG 909 (1008)
Q Consensus 832 l~~-~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwslG~vl~elltG~~pf~~~~~~ 909 (1008)
++. ++.+||+|||+++....... .....||+.|+|||++.+.. ++.++|||||||++|||++|+.||......
T Consensus 164 l~~~~~~~kl~Dfg~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~ 238 (360)
T 3e3p_A 164 VNEADGTLKLCDFGSAKKLSPSEP-----NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSA 238 (360)
T ss_dssp EETTTTEEEECCCTTCBCCCTTSC-----CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred EeCCCCcEEEeeCCCceecCCCCC-----cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChH
Confidence 996 89999999999986654322 12345899999999987654 899999999999999999999998753221
Q ss_pred CccHHHHHHhhCCc--chhhhhcccccCchHH-hhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 910 DLNLHNFARMALPN--QVMDIVDPILRNDEEI-LASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 910 ~~~~~~~~~~~~~~--~~~~~~d~~l~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
.......+..... .....+++........ .........+.. .....+.++.+++.+||+.||.+|||+.|+++
T Consensus 239 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 314 (360)
T 3e3p_A 239 -GQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSD---HSLKDAKEAYDLLSALLQYLPEERMKPYEALC 314 (360)
T ss_dssp -HHHHHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTT---CCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred -HHHHHHHHHcCCCCHHHHHhcccchhhccccccccCCcccccch---hhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence 1111221111111 1111111110000000 000000000000 00124567899999999999999999999986
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-38 Score=354.21 Aligned_cols=267 Identities=11% Similarity=0.035 Sum_probs=184.5
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccc---hhhHHHHHHHHHHhhc--CCCCceeeeeccc------
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCE---GASKSFMAECKALKNI--RHRNLVKVITSCS------ 751 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l--~h~niv~~~~~~~------ 751 (1008)
...|++.+.||+|+||.||+|.+..+++.||||+++.... ...+.+.+|+++++.+ +||||++++..+.
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 3458899999999999999999988999999999986432 3455678886555555 6999888553321
Q ss_pred -cccc------------cCCceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHH------HHHHHHHHHHHHHH
Q 045798 752 -SIDF------------QGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQR------ISIAIDVASALDYL 812 (1008)
Q Consensus 752 -~~~~------------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~------~~i~~qi~~~L~~L 812 (1008)
.... ......|+||||++ |+|.+++..... .+.+..+ ..++.||+.||+||
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~---------~~~~~~~~~~~vk~~i~~qi~~aL~~L 210 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF---------VYVFRGDEGILALHILTAQLIRLAANL 210 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH---------SCCCCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc---------ccchhhhhhhhhHHHHHHHHHHHHHHH
Confidence 1000 00145899999997 899999976421 2344444 67889999999999
Q ss_pred hhCCCCCceeccCCCCCeeecCCCCeEEcccCcccccccccCccccccccccccccccCccccCC--CCCCcccchhhHH
Q 045798 813 HHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLG--SEVSTNGDVYSYG 890 (1008)
Q Consensus 813 H~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwslG 890 (1008)
|++ +|+||||||+|||++.++.+||+|||+|+....... ...+|+.|+|||++.+ ..++.++||||||
T Consensus 211 H~~---~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~~-------~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG 280 (371)
T 3q60_A 211 QSK---GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRGP-------ASSVPVTYAPREFLNASTATFTHALNAWQLG 280 (371)
T ss_dssp HHT---TEEETTCSGGGEEECTTSCEEECCGGGEEETTCEEE-------GGGSCGGGCCHHHHTCSEEECCHHHHHHHHH
T ss_pred HHC---CCccCcCCHHHEEECCCCCEEEEecceeeecCCCcc-------CccCCcCCcChhhccCCCCCcCccccHHHHH
Confidence 998 999999999999999999999999999986543211 2346799999999987 6799999999999
Q ss_pred HHHHHHHhCCCCCCccccCCccHHHHHHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcc
Q 045798 891 ILLLEMVTAKKPTDVMFEGDLNLHNFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVAC 970 (1008)
Q Consensus 891 ~vl~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 970 (1008)
|++|||++|+.||......... .+..... ...... ....+.....+..+.+++.+|
T Consensus 281 ~il~elltg~~Pf~~~~~~~~~--~~~~~~~----~~~~~~------------------~~~~~~~~~~~~~~~~li~~~ 336 (371)
T 3q60_A 281 LSIYRVWCLFLPFGLVTPGIKG--SWKRPSL----RVPGTD------------------SLAFGSCTPLPDFVKTLIGRF 336 (371)
T ss_dssp HHHHHHHHSSCSTTBCCTTCTT--CCCBCCT----TSCCCC------------------SCCCTTSSCCCHHHHHHHHHH
T ss_pred HHHHHHHhCCCCCCCcCccccc--chhhhhh----hhcccc------------------ccchhhccCCCHHHHHHHHHH
Confidence 9999999999999754221100 0000000 000000 000000112355689999999
Q ss_pred cCcCCCCCCCHHHHHH--HHHHHHH
Q 045798 971 SMESPQDRMNMTNVVH--ELQSVKN 993 (1008)
Q Consensus 971 l~~dP~~RPt~~evl~--~L~~i~~ 993 (1008)
|+.||++|||+.|+++ .++.+.+
T Consensus 337 L~~dP~~Rpt~~e~l~hp~f~~~~~ 361 (371)
T 3q60_A 337 LNFDRRRRLLPLEAMETPEFLQLQN 361 (371)
T ss_dssp TCSSTTTCCCHHHHTTSHHHHHHHH
T ss_pred cCCChhhCCCHHHHhcCHHHHHHHH
Confidence 9999999999999986 3444443
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=341.60 Aligned_cols=265 Identities=20% Similarity=0.271 Sum_probs=201.2
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccchh-----------------hHHHHHHHHHHhhcCCCCcee
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGA-----------------SKSFMAECKALKNIRHRNLVK 745 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-----------------~~~~~~E~~~l~~l~h~niv~ 745 (1008)
.++|++.+.||+|+||.||+|.+ +++.||+|++....... .+.+.+|++++++++||||++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~ 107 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT 107 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence 46899999999999999999999 89999999997432111 178999999999999999999
Q ss_pred eeeccccccccCCceEEEEEeccCCCChhcc------cccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhh-CCCC
Q 045798 746 VITSCSSIDFQGNDFKAIVYEYMPNGSLEKW------LHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHH-HCQE 818 (1008)
Q Consensus 746 ~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~------l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~ 818 (1008)
+++++ ...+..++||||+++|+|.++ +..... ..+++..++.++.|++.||+|||+ .
T Consensus 108 ~~~~~-----~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~--------~~~~~~~~~~i~~qi~~~l~~lH~~~--- 171 (348)
T 2pml_X 108 CEGII-----TNYDEVYIIYEYMENDSILKFDEYFFVLDKNYT--------CFIPIQVIKCIIKSVLNSFSYIHNEK--- 171 (348)
T ss_dssp CSEEE-----ESSSEEEEEEECCTTCBSSEESSSEESSCSSSC--------CCCCHHHHHHHHHHHHHHHHHHHHTS---
T ss_pred EEEEE-----eeCCeEEEEEeccCCCcHHHHHHHhhhhhhccc--------cCCCHHHHHHHHHHHHHHHHHHhccC---
Confidence 99995 456679999999999999999 543211 278999999999999999999998 7
Q ss_pred CceeccCCCCCeeecCCCCeEEcccCcccccccccCccccccccccccccccCccccCCC-CCCc-ccchhhHHHHHHHH
Q 045798 819 PILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGS-EVST-NGDVYSYGILLLEM 896 (1008)
Q Consensus 819 ~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~sDvwslG~vl~el 896 (1008)
+|+||||||+||+++.++.+||+|||.+...... ......|+..|+|||++.+. .++. ++|||||||++|||
T Consensus 172 ~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l 245 (348)
T 2pml_X 172 NICHRDVKPSNILMDKNGRVKLSDFGESEYMVDK------KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVM 245 (348)
T ss_dssp CEECCCCCGGGEEECTTSCEEECCCTTCEECBTT------EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHH
T ss_pred CEeecCCChHhEEEcCCCcEEEeccccccccccc------cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHH
Confidence 9999999999999999999999999999865433 12234589999999999887 6666 99999999999999
Q ss_pred HhCCCCCCccccCCccHHHHHHhh--CCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcC
Q 045798 897 VTAKKPTDVMFEGDLNLHNFARMA--LPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMES 974 (1008)
Q Consensus 897 ltG~~pf~~~~~~~~~~~~~~~~~--~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d 974 (1008)
++|+.||................. .+........+..... ........+.++.+++.+||+.|
T Consensus 246 ~~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~~l~~li~~~L~~d 310 (348)
T 2pml_X 246 FYNVVPFSLKISLVELFNNIRTKNIEYPLDRNHFLYPLTNKK---------------STCSNNFLSNEDIDFLKLFLRKN 310 (348)
T ss_dssp HHSSCSSCCSSCSHHHHHHHTSCCCCCCCSSSSSTTTTCC-----------------------CCCHHHHHHHHHHCCSS
T ss_pred HhCCCCCCCCCcHHHHHHHHhccCcCCccchhhhhccccccc---------------cccchhhcCHHHHHHHHHHccCC
Confidence 999999874322111111111100 0100000000000000 00001234567899999999999
Q ss_pred CCCCCCHHHHHH
Q 045798 975 PQDRMNMTNVVH 986 (1008)
Q Consensus 975 P~~RPt~~evl~ 986 (1008)
|.+|||++|+++
T Consensus 311 P~~Rps~~e~l~ 322 (348)
T 2pml_X 311 PAERITSEDALK 322 (348)
T ss_dssp GGGSCCHHHHHT
T ss_pred hhhCCCHHHHhc
Confidence 999999999998
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-37 Score=332.46 Aligned_cols=252 Identities=25% Similarity=0.292 Sum_probs=200.4
Q ss_pred HhcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEecccc--chhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCc
Q 045798 682 ATNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC--EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGND 759 (1008)
Q Consensus 682 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 759 (1008)
..++|++.+.||+|+||.||+|.+..+++.||+|++.... ....+.+.+|++++++++||||+++++++ ...+
T Consensus 20 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~ 94 (287)
T 2wei_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEIL-----EDSS 94 (287)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECSS
T ss_pred HhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEE-----eCCC
Confidence 3468999999999999999999998899999999986432 33457899999999999999999999995 4566
Q ss_pred eEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCC---C
Q 045798 760 FKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDND---L 836 (1008)
Q Consensus 760 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~---~ 836 (1008)
..++||||+++++|.+++.... .+++.+++.++.||+.||+|||+. +|+||||||+||+++.+ +
T Consensus 95 ~~~lv~e~~~~~~L~~~l~~~~----------~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~ 161 (287)
T 2wei_A 95 SFYIVGELYTGGELFDEIIKRK----------RFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDC 161 (287)
T ss_dssp EEEEEECCCCSCBHHHHHHHHS----------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTC
T ss_pred eEEEEEEccCCCCHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcc
Confidence 7999999999999999886543 689999999999999999999998 99999999999999754 4
Q ss_pred CeEEcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHH
Q 045798 837 SGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNF 916 (1008)
Q Consensus 837 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~ 916 (1008)
.+||+|||.+......... ....+|+.|+|||.+.+ .++.++||||||+++|+|++|+.||......+ .....
T Consensus 162 ~~kL~Dfg~~~~~~~~~~~-----~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-~~~~~ 234 (287)
T 2wei_A 162 DIKIIDFGLSTCFQQNTKM-----KDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD-ILKRV 234 (287)
T ss_dssp CEEECSTTGGGTBCCCSSC-----SCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHH
T ss_pred cEEEeccCcceeecCCCcc-----ccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHH-HHHHH
Confidence 7999999999865433221 22348999999999876 48999999999999999999999986431110 00000
Q ss_pred HHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 917 ARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 917 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
..... ....+.....+.++.+++.+||+.||++|||+.|+++
T Consensus 235 ~~~~~----------------------------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 235 ETGKY----------------------------AFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp HHCCC----------------------------CCCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HcCCC----------------------------CCCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 00000 0000111123456899999999999999999999987
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-36 Score=360.76 Aligned_cols=176 Identities=16% Similarity=0.205 Sum_probs=98.5
Q ss_pred CCCCCCCCCCCCCCCc----ccceEEcCCCCeEEEEeccccCCCCccCcCccCCccCCeeeecCCCCCCCCCccccCCCC
Q 045798 28 PQGILNSWNDSRHFCE----WEGITCGRRHRRVTALDLMSKSLSGSLSPHLGNLSFLREINLSNNTIQGEIPPEFGRLFR 103 (1008)
Q Consensus 28 ~~~~~~~w~~~~~~c~----w~gv~c~~~~~~v~~l~l~~~~l~~~l~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~ 103 (1008)
....+++|.++.+||. |.++.|. .++ +-...... ....-..+.+++.|++++|.++...+..|..+++
T Consensus 5 ~~~~l~~~~~~~~C~~~~~~~~c~~~~---~~i---~~~~~~~~--~~~~~l~l~~l~~l~l~~~~l~~lp~~~~~~l~~ 76 (597)
T 3oja_B 5 QRYNVKPRQPEYKCIDSNLQYDCVFYD---VHI---DMQTQDVY--FGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQ 76 (597)
T ss_dssp ------CCCSEECCCCC--CCSEEECS---CEE---CSSCCCCE--ESCSSGGGCCCSEEEESSCEESEECTHHHHHCCC
T ss_pred ccccccCCCCCCcCcccCcCceeEecC---cee---cccccccc--cCcccccCCCceEEEeeCCCCCCcCHHHHccCCC
Confidence 3445789998887774 5544442 111 11111111 1111223566777777777777555555666777
Q ss_pred CCEEEccCCCCCCccCcccccCcCcceEeeeccccccCCCccccccCCCCeeecccccCCCCCCCCCccccccchhhccc
Q 045798 104 LEALFLSNNSLVGKIPANLSYCSRLTVLCIEYNKLQGRIPLEFVSLSKLKDLSLAKNKLTGGIPPFLGNLTSLEVLSLAG 183 (1008)
Q Consensus 104 L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~ 183 (1008)
|++|+|++|.+++..|..|+.+++|++|+|++|.+++..|..|+++++|++|+|++|.+++..+..|+++++|++|+|++
T Consensus 77 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~Ls~ 156 (597)
T 3oja_B 77 VELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSN 156 (597)
T ss_dssp CSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCCHHHhccCCCCCEEEeeC
Confidence 77777777777766666667777777777776666666666666666666666666666644334445555555555555
Q ss_pred ccCCCCCCccccCCCCCcEEEecCCccc
Q 045798 184 NSFGRNIPDSLGQLKQLKILAIGGNNLS 211 (1008)
Q Consensus 184 n~l~~~~~~~~~~l~~L~~L~L~~n~l~ 211 (1008)
|.+++..|..|+.+++|++|+|++|.++
T Consensus 157 N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 184 (597)
T 3oja_B 157 NNLERIEDDTFQATTSLQNLQLSSNRLT 184 (597)
T ss_dssp SCCCBCCTTTTTTCTTCCEEECTTSCCS
T ss_pred CcCCCCChhhhhcCCcCcEEECcCCCCC
Confidence 5555554545555555555555555444
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=341.30 Aligned_cols=277 Identities=21% Similarity=0.226 Sum_probs=198.2
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEecccc--chhhHHHHHHHHHHhhcCCCCceeeeeccccccc-cCCc
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC--EGASKSFMAECKALKNIRHRNLVKVITSCSSIDF-QGND 759 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~ 759 (1008)
.++|.+.+.||+|+||.||+|.+..+|+.||||++.... ....+.+.+|+.++++++||||+++++++..... ....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 467999999999999999999999899999999997532 3345678999999999999999999998653221 1112
Q ss_pred eEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeE
Q 045798 760 FKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGH 839 (1008)
Q Consensus 760 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 839 (1008)
..++||||++ ++|.+++.. .+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+|
T Consensus 103 ~~~lv~e~~~-~~l~~~~~~------------~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~k 166 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMGL------------KFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELK 166 (353)
T ss_dssp CCEEEEECCS-EEGGGTTTS------------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEE
T ss_pred eEEEEecccc-CCHHHHhcC------------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEE
Confidence 4599999995 688887742 588999999999999999999998 999999999999999999999
Q ss_pred EcccCcccccccccCccccccccccccccccCccccCC-CCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHH
Q 045798 840 IGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLG-SEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFAR 918 (1008)
Q Consensus 840 L~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~ 918 (1008)
|+|||.++..... .....+|+.|+|||++.+ ..++.++|||||||++|||++|+.||......+ .......
T Consensus 167 l~Dfg~~~~~~~~-------~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~-~~~~i~~ 238 (353)
T 3coi_A 167 ILDFGLARHADAE-------MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD-QLTQILK 238 (353)
T ss_dssp ECSTTCTTC---------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHH-HHHHHHH
T ss_pred EeecccccCCCCC-------ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHH
Confidence 9999999864332 123458999999999877 678999999999999999999999986432111 1111111
Q ss_pred hhCCcchhhhhcccccCchHHhhhhhhhh-hccccc-hhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 919 MALPNQVMDIVDPILRNDEEILASTDKCR-RMQTGI-NSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 919 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~-~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
.... ...++......... ........ ...... ......+.++.+++.+||+.||++|||++|+++
T Consensus 239 ~~~~-~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 305 (353)
T 3coi_A 239 VTGV-PGTEFVQKLNDKAA--KSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 305 (353)
T ss_dssp HHCB-CCHHHHTTCSCHHH--HHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HhCC-CCHHHHHHHhhHHH--HHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 1100 00111110000000 00000000 000000 001134567899999999999999999999986
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=345.33 Aligned_cols=202 Identities=27% Similarity=0.298 Sum_probs=170.6
Q ss_pred HhcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccchhhHHHHHHHHHHhhcC-CC-----Cceeeeeccccccc
Q 045798 682 ATNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIR-HR-----NLVKVITSCSSIDF 755 (1008)
Q Consensus 682 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~-----niv~~~~~~~~~~~ 755 (1008)
..++|++.+.||+|+||+||+|.+..+++.||||+++.. ......+.+|+++++.++ |+ +|+++++++
T Consensus 52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~----- 125 (382)
T 2vx3_A 52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHF----- 125 (382)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEE-----
T ss_pred eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeee-----
Confidence 467899999999999999999999989999999999743 334567888999988884 55 488888884
Q ss_pred cCCceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeec--
Q 045798 756 QGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLD-- 833 (1008)
Q Consensus 756 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~-- 833 (1008)
...+..++||||++ ++|.+++...... .+++..++.++.|++.||+|||++ ..+|+||||||+||+++
T Consensus 126 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~--------~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~ 195 (382)
T 2vx3_A 126 MFRNHLCLVFEMLS-YNLYDLLRNTNFR--------GVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNP 195 (382)
T ss_dssp EETTEEEEEEECCC-CBHHHHHHHTTTS--------CCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESST
T ss_pred ccCCceEEEEecCC-CCHHHHHhhcCcC--------CCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecC
Confidence 45577999999995 6999999765321 589999999999999999999953 24999999999999995
Q ss_pred CCCCeEEcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCcc
Q 045798 834 NDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVM 906 (1008)
Q Consensus 834 ~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~ 906 (1008)
.++.+||+|||+|+..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 196 ~~~~~kL~DFG~a~~~~~~-------~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~ 261 (382)
T 2vx3_A 196 KRSAIKIVDFGSSCQLGQR-------IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGA 261 (382)
T ss_dssp TSCCEEECCCTTCEETTCC-------CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CCCcEEEEeccCceecccc-------cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 4788999999999865432 12345899999999999999999999999999999999999999743
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-36 Score=353.66 Aligned_cols=320 Identities=19% Similarity=0.148 Sum_probs=208.2
Q ss_pred eeccccccccccCChhhhhcCCCCcEEEeccccCCCCCCcccccCCCCceeecccccccccccccccCCCcccccccccc
Q 045798 226 VFSVSHNQIHGSLPPSLGLLLPNLKFFQIHHNFFSGSIPISLSNASKLEHIEIANNNFSGKLSVNFGGMKNLSLLNLQFS 305 (1008)
Q Consensus 226 ~L~ls~N~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n 305 (1008)
.++.+++.++ .+|..+ .++++.|+|++|.+++..+..|.++++|++|+|++|.+.+..+..|.++++|+.|+|++|
T Consensus 15 ~v~c~~~~l~-~ip~~~---~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n 90 (477)
T 2id5_A 15 AVLCHRKRFV-AVPEGI---PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSN 90 (477)
T ss_dssp EEECCSCCCS-SCCSCC---CTTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred EEEeCCCCcC-cCCCCC---CCCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCC
Confidence 4555555554 555543 246667777777776666667777777777777777777776777777777777777777
Q ss_pred cCCCCCCCcccccccccccCCCcEEEecCCcCCccCChhhhhhcccceeeeeccccccCCCCCccccccccceEEecCcc
Q 045798 306 NLGSGESDEMGFMNSLTNCSKLRVLSLGGNQFRGALPHSIANLSSQLQILILSSNQFYGSIPLGIGNLVDLYLLGMVENQ 385 (1008)
Q Consensus 306 ~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~ 385 (1008)
+++.+... .|.++++|++|+|++|++.+..|..+..+. +|++|+|++|.+++..|..|..+++|+.|++++|+
T Consensus 91 ~l~~~~~~------~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~-~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~ 163 (477)
T 2id5_A 91 RLKLIPLG------VFTGLSNLTKLDISENKIVILLDYMFQDLY-NLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCN 163 (477)
T ss_dssp CCCSCCTT------SSTTCTTCCEEECTTSCCCEECTTTTTTCT-TCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCC
T ss_pred cCCccCcc------cccCCCCCCEEECCCCccccCChhHccccc-cCCEEECCCCccceeChhhccCCCCCCEEECCCCc
Confidence 66654432 355677777777777777766666666665 47777777777776667777777788888888887
Q ss_pred ccCCcchhccCCCCCceEEccCCcccccccccccCCCCcceeeccccccccccCCCCcCCCcccEeecccccccCCcchh
Q 045798 386 FTGAIPKEMGKLQKLQGLDFSGNHFSGEIPSSLGNLSSLYEVFFNNNNLSGVIPFSLGNLKRLAFLEMSGNELSGTIPED 465 (1008)
Q Consensus 386 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~lp~~ 465 (1008)
+++..+..|..+++|+.|+|++|.+.+..+..|..+++|+.|++++|.+.+.+|..+....+|+.|+|++|+++ .+|..
T Consensus 164 l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~-~~~~~ 242 (477)
T 2id5_A 164 LTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYL 242 (477)
T ss_dssp CSSCCHHHHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTCCEECTTTTTTCCCSEEEEESSCCC-SCCHH
T ss_pred CcccChhHhcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCccccccCcccccCccccEEECcCCccc-ccCHH
Confidence 77766667777778888888888777666667777777777777777776666666666667777777777776 44443
Q ss_pred hhhhhhhhhhhcccCccccCCCcccccccccccccccccccccCCCCcccccccccceeeccCcccccchhhhhhccccc
Q 045798 466 IFNISYLSNSLNLARNHLVGIIPPRIGNLRALRSFDVSNNDLSGEIPIELGHCSSLEEIYLAGNLFHGSIPSFFNALKGV 545 (1008)
Q Consensus 466 ~~~~~~~~~~L~L~~N~l~~~~p~~~~~l~~L~~Ldls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L 545 (1008)
.|..+++|+.|+|++|.+++..+..|..+++|++|+|++|++++..|..|..+++|
T Consensus 243 ------------------------~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L 298 (477)
T 2id5_A 243 ------------------------AVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYL 298 (477)
T ss_dssp ------------------------HHTTCTTCCEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTC
T ss_pred ------------------------HhcCccccCeeECCCCcCCccChhhccccccCCEEECCCCccceECHHHhcCcccC
Confidence 34445555555555555554444445555555555555555555555555555555
Q ss_pred cEEecCCCcccccccCc-ccccccceeecccCccccc
Q 045798 546 QKIDLSRNNLSGQIPIF-LEALSLEYLNLSFNDFEGK 581 (1008)
Q Consensus 546 ~~L~ls~N~l~~~~p~~-~~~~~L~~L~l~~N~l~g~ 581 (1008)
+.|+|++|++++..+.. ..+.+|++|+|++|++.+.
T Consensus 299 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~c~ 335 (477)
T 2id5_A 299 RVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLACD 335 (477)
T ss_dssp CEEECCSSCCSCCCGGGBSCGGGCCEEECCSSCEECS
T ss_pred CEEECCCCcCceeCHhHcCCCcccCEEEccCCCccCc
Confidence 55555555555444333 3344555555555555544
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-37 Score=335.73 Aligned_cols=260 Identities=25% Similarity=0.328 Sum_probs=194.2
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccchhhHHHHHHHHHHhhcCCCCceeeeecccccc--------
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSCSSID-------- 754 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-------- 754 (1008)
.++|++.+.||+|+||.||+|++..+++.||||+++.. ....+.+.+|++++++++||||+++++++....
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA 83 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence 46799999999999999999999889999999999643 344578999999999999999999999865321
Q ss_pred ccCCceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecC
Q 045798 755 FQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDN 834 (1008)
Q Consensus 755 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~ 834 (1008)
.......++||||+++|+|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+||+++.
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~ 151 (303)
T 1zy4_A 84 VKKKSTLFIQMEYCENGTLYDLIHSEN---------LNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDE 151 (303)
T ss_dssp --CEEEEEEEEECCCSCBHHHHHHHSC---------GGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECT
T ss_pred cccCCceEEEEecCCCCCHHHhhhccc---------cccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcC
Confidence 133567899999999999999997542 1678899999999999999999998 9999999999999999
Q ss_pred CCCeEEcccCcccccccccCc----------cccccccccccccccCccccCCC-CCCcccchhhHHHHHHHHHhCCCCC
Q 045798 835 DLSGHIGDFGLARFHQEVSNS----------TLSSSVGVKGTIGYTAPEYGLGS-EVSTNGDVYSYGILLLEMVTAKKPT 903 (1008)
Q Consensus 835 ~~~~kL~Dfg~a~~~~~~~~~----------~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltG~~pf 903 (1008)
++.+||+|||.+......... .........||+.|+|||++.+. .++.++|||||||++|||++ ||
T Consensus 152 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~ 228 (303)
T 1zy4_A 152 SRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PF 228 (303)
T ss_dssp TSCEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CC
T ss_pred CCCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---cc
Confidence 999999999999865432110 01112234589999999998764 68999999999999999998 54
Q ss_pred CccccCCccHHHHHHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHH
Q 045798 904 DVMFEGDLNLHNFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTN 983 (1008)
Q Consensus 904 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 983 (1008)
............. . .... .++.. .....+..+.+++.+||+.||.+|||++|
T Consensus 229 ~~~~~~~~~~~~~-~-----------~~~~--------------~~~~~--~~~~~~~~~~~li~~~l~~dp~~Rps~~~ 280 (303)
T 1zy4_A 229 STGMERVNILKKL-R-----------SVSI--------------EFPPD--FDDNKMKVEKKIIRLLIDHDPNKRPGART 280 (303)
T ss_dssp SSHHHHHHHHHHH-H-----------STTC--------------CCCTT--CCTTTSHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred CCchhHHHHHHhc-c-----------cccc--------------ccCcc--ccccchHHHHHHHHHHHhcCcccCcCHHH
Confidence 3211100000000 0 0000 00000 01123456789999999999999999999
Q ss_pred HHH
Q 045798 984 VVH 986 (1008)
Q Consensus 984 vl~ 986 (1008)
+++
T Consensus 281 ll~ 283 (303)
T 1zy4_A 281 LLN 283 (303)
T ss_dssp HHH
T ss_pred HhC
Confidence 987
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=340.55 Aligned_cols=278 Identities=20% Similarity=0.295 Sum_probs=202.1
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCC-eEEEEEEeccccchhhHHHHHHHHHHhhcCCCC------ceeeeeccccccc
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDG-IVVAIKVINLQCEGASKSFMAECKALKNIRHRN------LVKVITSCSSIDF 755 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~~~~~~~~~~~ 755 (1008)
.++|++.+.||+|+||.||+|.+..++ +.||+|+++.. ....+.+.+|++++++++|++ ++.++++ +
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~-----~ 91 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDW-----F 91 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEE-----E
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeee-----e
Confidence 468999999999999999999997666 79999999744 344567889999999997665 8888887 3
Q ss_pred cCCceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeee---
Q 045798 756 QGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILL--- 832 (1008)
Q Consensus 756 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll--- 832 (1008)
...+..++||||+ ++++.+++...... .+++.+++.++.||+.||+|||+. +|+||||||+||++
T Consensus 92 ~~~~~~~lv~e~~-~~~l~~~l~~~~~~--------~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~ 159 (355)
T 2eu9_A 92 NFHGHMCIAFELL-GKNTFEFLKENNFQ--------PYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNS 159 (355)
T ss_dssp EETTEEEEEEECC-CCBHHHHHHHTTTC--------CCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCC
T ss_pred eeCCeEEEEEecc-CCChHHHHHhccCC--------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecc
Confidence 5566799999999 77787777654321 689999999999999999999997 99999999999999
Q ss_pred ----------------cCCCCeEEcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHH
Q 045798 833 ----------------DNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEM 896 (1008)
Q Consensus 833 ----------------~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~el 896 (1008)
+.++.+||+|||.++...... ....||+.|+|||++.+..++.++|||||||++|||
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~-------~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el 232 (355)
T 2eu9_A 160 EFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEHH-------TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEY 232 (355)
T ss_dssp CEEEEECCC-CCCEEEESCCCEEECCCTTCEETTSCC-------CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccCCCcEEEeecCccccccccc-------cCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHH
Confidence 567899999999998543321 234589999999999999999999999999999999
Q ss_pred HhCCCCCCccccCCccHHHHHHh--hCCcchhhhhcc---------cccC-chHHhhhhhhhhhccccchhHHHHHHHHH
Q 045798 897 VTAKKPTDVMFEGDLNLHNFARM--ALPNQVMDIVDP---------ILRN-DEEILASTDKCRRMQTGINSRLECLISMV 964 (1008)
Q Consensus 897 ltG~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~~d~---------~l~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 964 (1008)
++|+.||......+ ........ ..+......... .... ..........+.............+.++.
T Consensus 233 ~~g~~pf~~~~~~~-~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 311 (355)
T 2eu9_A 233 YRGFTLFQTHENRE-HLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLF 311 (355)
T ss_dssp HHSSCSCCCSSHHH-HHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHH
T ss_pred HhCCCCCCCCCHHH-HHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHH
Confidence 99999997432211 11111111 111111000000 0000 00000011111111111122234567899
Q ss_pred HHHhcccCcCCCCCCCHHHHHH
Q 045798 965 KIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 965 ~li~~cl~~dP~~RPt~~evl~ 986 (1008)
+++.+||+.||++|||++|+++
T Consensus 312 ~li~~~L~~dP~~Rpt~~e~l~ 333 (355)
T 2eu9_A 312 DLMRRMLEFDPAQRITLAEALL 333 (355)
T ss_dssp HHHHHHTCSSTTTSCCHHHHTT
T ss_pred HHHHHHhcCChhhCcCHHHHhc
Confidence 9999999999999999999985
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-37 Score=352.55 Aligned_cols=279 Identities=21% Similarity=0.250 Sum_probs=195.8
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccchhhHHHHHHHHHHhhcCCCCceeeeeccccccc-cCCceE
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSCSSIDF-QGNDFK 761 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~~~ 761 (1008)
..+|++.+.||+|+||.||+|++..+++.||||++.... ....+|++++++++||||+++++++..... .+..+.
T Consensus 53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~ 128 (420)
T 1j1b_A 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 128 (420)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEE
T ss_pred cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeE
Confidence 346899999999999999999998899999999986432 224579999999999999999998754322 233456
Q ss_pred EEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCC-CCeEE
Q 045798 762 AIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDND-LSGHI 840 (1008)
Q Consensus 762 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kL 840 (1008)
++||||+++ ++.+++...... ...+++..++.++.||+.||+|||+. +|+||||||+|||++.+ +.+||
T Consensus 129 ~lv~e~~~~-~l~~~~~~~~~~------~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl 198 (420)
T 1j1b_A 129 NLVLDYVPE-TVYRVARHYSRA------KQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKL 198 (420)
T ss_dssp EEEEECCCE-EHHHHHHHHHHT------TCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEE
T ss_pred Eeehhcccc-cHHHHHHHHhhc------cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEe
Confidence 799999964 666655421100 11689999999999999999999997 99999999999999965 56899
Q ss_pred cccCcccccccccCccccccccccccccccCccccCCC-CCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHh
Q 045798 841 GDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGS-EVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARM 919 (1008)
Q Consensus 841 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~ 919 (1008)
+|||+++....... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||...... ..+......
T Consensus 199 ~DFG~a~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~-~~l~~i~~~ 272 (420)
T 1j1b_A 199 CDFGSAKQLVRGEP-----NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV-DQLVEIIKV 272 (420)
T ss_dssp CCCTTCEECCTTCC-----CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHH
T ss_pred ccchhhhhcccCCC-----ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHH
Confidence 99999986543322 1234689999999998765 7899999999999999999999998743221 112222221
Q ss_pred hCCcchhhh--hcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 920 ALPNQVMDI--VDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 920 ~~~~~~~~~--~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
........+ ..+...... .......++........+.++.+++.+||+.||++|||+.|+++
T Consensus 273 lg~p~~~~~~~~~~~~~~~~-----~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~ 336 (420)
T 1j1b_A 273 LGTPTREQIREMNPNYTEFK-----FPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 336 (420)
T ss_dssp HCSCCHHHHHHHCSCCCCCC-----CCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hCCCCHHHHHhhChhhhhhc-----cCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence 111111000 011000000 00000000000000123466899999999999999999999985
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-36 Score=349.21 Aligned_cols=315 Identities=21% Similarity=0.234 Sum_probs=195.8
Q ss_pred cccCCCCccCcCccCCccCCeeeecCCCCCCCCCccccCCCCCCEEEccCCCCCCccCcccccCcCcceEeeeccccccC
Q 045798 62 MSKSLSGSLSPHLGNLSFLREINLSNNTIQGEIPPEFGRLFRLEALFLSNNSLVGKIPANLSYCSRLTVLCIEYNKLQGR 141 (1008)
Q Consensus 62 ~~~~l~~~l~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~ 141 (1008)
.+++++ .+|..+. ++|++|+|++|++++..+..|.++++|++|+|++|.+++..|..|+++++|++|+|++|++++.
T Consensus 19 ~~~~l~-~ip~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~ 95 (477)
T 2id5_A 19 HRKRFV-AVPEGIP--TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKLI 95 (477)
T ss_dssp CSCCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCSC
T ss_pred CCCCcC-cCCCCCC--CCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCcCCcc
Confidence 344555 4565543 4678888888888877777788888888888888887776677777777777777777777755
Q ss_pred CCccccccCCCCeeecccccCCCCCCCCCccccccchhhcccccCCCCCCccccCCCCCcEEEecCCcccccCCccccCC
Q 045798 142 IPLEFVSLSKLKDLSLAKNKLTGGIPPFLGNLTSLEVLSLAGNSFGRNIPDSLGQLKQLKILAIGGNNLSGPIPPSIYNL 221 (1008)
Q Consensus 142 ~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l 221 (1008)
.+..|.++++|++|+|++|++++..+..|.++++|++|+|++|.+.+..+..|..+++|+.|++++|.+++..+..|.++
T Consensus 96 ~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l 175 (477)
T 2id5_A 96 PLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHL 175 (477)
T ss_dssp CTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCCHHHHTTC
T ss_pred CcccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCCCcCcccChhHhccc
Confidence 55566677777777777777766656666666666666666666655555556666666666666665554433444444
Q ss_pred CCcceeccccccccccCChhhhhcCCCCcEEEeccccCCCCCCcccccCCCCceeecccccccccccccccCCCcccccc
Q 045798 222 SFLVVFSVSHNQIHGSLPPSLGLLLPNLKFFQIHHNFFSGSIPISLSNASKLEHIEIANNNFSGKLSVNFGGMKNLSLLN 301 (1008)
Q Consensus 222 ~~L~~L~ls~N~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 301 (1008)
+ +|+.|+|++|.+.+..+..+..+++|++|++++|.+.+..+..+..
T Consensus 176 ~-------------------------~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~-------- 222 (477)
T 2id5_A 176 H-------------------------GLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLY-------- 222 (477)
T ss_dssp T-------------------------TCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTCCEECTTTTT--------
T ss_pred C-------------------------CCcEEeCCCCcCcEeChhhcccCcccceeeCCCCccccccCccccc--------
Confidence 4 4444444444444444445555666666666665544333322211
Q ss_pred cccccCCCCCCCcccccccccccCCCcEEEecCCcCCccCC-hhhhhhcccceeeeeccccccCCCCCccccccccceEE
Q 045798 302 LQFSNLGSGESDEMGFMNSLTNCSKLRVLSLGGNQFRGALP-HSIANLSSQLQILILSSNQFYGSIPLGIGNLVDLYLLG 380 (1008)
Q Consensus 302 L~~n~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 380 (1008)
..+|+.|++++|+++ .+| ..+..+. +|++|+|++|.+++..+..+..+++|+.|+
T Consensus 223 ----------------------~~~L~~L~l~~n~l~-~~~~~~~~~l~-~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~ 278 (477)
T 2id5_A 223 ----------------------GLNLTSLSITHCNLT-AVPYLAVRHLV-YLRFLNLSYNPISTIEGSMLHELLRLQEIQ 278 (477)
T ss_dssp ----------------------TCCCSEEEEESSCCC-SCCHHHHTTCT-TCCEEECCSSCCCEECTTSCTTCTTCCEEE
T ss_pred ----------------------CccccEEECcCCccc-ccCHHHhcCcc-ccCeeECCCCcCCccChhhccccccCCEEE
Confidence 124555555555555 233 3344443 466666666666655555566666666666
Q ss_pred ecCccccCCcchhccCCCCCceEEccCCcccccccccccCCCCcceeecccccccc
Q 045798 381 MVENQFTGAIPKEMGKLQKLQGLDFSGNHFSGEIPSSLGNLSSLYEVFFNNNNLSG 436 (1008)
Q Consensus 381 L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~ 436 (1008)
|++|++++..|..|..+++|+.|+|++|++++..+..|..+++|+.|+|++|.+..
T Consensus 279 L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~c 334 (477)
T 2id5_A 279 LVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLAC 334 (477)
T ss_dssp CCSSCCSEECTTTBTTCTTCCEEECCSSCCSCCCGGGBSCGGGCCEEECCSSCEEC
T ss_pred CCCCccceECHHHhcCcccCCEEECCCCcCceeCHhHcCCCcccCEEEccCCCccC
Confidence 66666666666666667777777777777765555566666777777777776653
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-37 Score=349.02 Aligned_cols=278 Identities=22% Similarity=0.246 Sum_probs=192.6
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccchhhHHHHHHHHHHhhcCCCCceeeeeccccccc-cCCceE
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSCSSIDF-QGNDFK 761 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~~~ 761 (1008)
..+|++.+.||+|+||.||+|++..+++ ||+|++..... ...+|+++++.++||||+++++++..... .+..+.
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 113 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFL 113 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEE
Confidence 3579999999999999999999975554 88887753322 23479999999999999999999754332 344457
Q ss_pred EEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeec-CCCCeEE
Q 045798 762 AIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLD-NDLSGHI 840 (1008)
Q Consensus 762 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~kL 840 (1008)
++||||++++.+......... ...+++..++.++.||+.||+|||+. +|+||||||+||+++ .++.+||
T Consensus 114 ~lv~e~~~~~l~~~~~~~~~~-------~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL 183 (394)
T 4e7w_A 114 NLVLEYVPETVYRASRHYAKL-------KQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKL 183 (394)
T ss_dssp EEEEECCSEEHHHHHHHHHHT-------TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEE
T ss_pred EEEeeccCccHHHHHHHHHhh-------cCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEE
Confidence 899999976433332211110 11689999999999999999999998 999999999999999 7999999
Q ss_pred cccCcccccccccCccccccccccccccccCccccCCC-CCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHh
Q 045798 841 GDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGS-EVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARM 919 (1008)
Q Consensus 841 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~ 919 (1008)
+|||+|+....... .....||+.|+|||++.+. .++.++||||+||++|||++|+.||......+ ........
T Consensus 184 ~DFG~a~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~-~l~~i~~~ 257 (394)
T 4e7w_A 184 IDFGSAKILIAGEP-----NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGID-QLVEIIKV 257 (394)
T ss_dssp CCCTTCEECCTTCC-----CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHH
T ss_pred eeCCCcccccCCCC-----CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHH
Confidence 99999986543322 1234589999999998765 58999999999999999999999987432211 11122211
Q ss_pred hCCcchh--hhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 920 ALPNQVM--DIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 920 ~~~~~~~--~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
....... ....+...... .......+.........+.++.+++.+||+.||.+|||+.|+++
T Consensus 258 ~g~p~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 321 (394)
T 4e7w_A 258 LGTPSREQIKTMNPNYMEHK-----FPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC 321 (394)
T ss_dssp HCCCCHHHHHHHCGGGSSSC-----CCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred hCCCCHHHHHhhChhhhhhc-----cccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhc
Confidence 1111100 00000000000 00000000000001124567899999999999999999999986
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=366.75 Aligned_cols=260 Identities=23% Similarity=0.348 Sum_probs=204.1
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcC---CCeEEEEEEecccc-chhhHHHHHHHHHHhhcCCCCceeeeeccccccccCC
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDE---DGIVVAIKVINLQC-EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGN 758 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 758 (1008)
.++|++.+.||+|+||.||+|.+.. .+..||+|+++... ....+.+.+|+.++++++||||+++++++. +
T Consensus 389 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~------~ 462 (656)
T 2j0j_A 389 RERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT------E 462 (656)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC------S
T ss_pred cccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe------c
Confidence 4678899999999999999999853 35689999987543 344578999999999999999999999852 2
Q ss_pred ceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCe
Q 045798 759 DFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSG 838 (1008)
Q Consensus 759 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 838 (1008)
+..++||||+++|+|.+++..... .+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+
T Consensus 463 ~~~~lv~E~~~~g~L~~~l~~~~~---------~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~v 530 (656)
T 2j0j_A 463 NPVWIIMELCTLGELRSFLQVRKF---------SLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCV 530 (656)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTTT---------TCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEE
T ss_pred CceEEEEEcCCCCcHHHHHHhccC---------CCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCE
Confidence 457999999999999999975431 689999999999999999999998 99999999999999999999
Q ss_pred EEcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCccccCCccHHHHH
Q 045798 839 HIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT-AKKPTDVMFEGDLNLHNFA 917 (1008)
Q Consensus 839 kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-G~~pf~~~~~~~~~~~~~~ 917 (1008)
||+|||+++......... .....+|+.|+|||++.+..++.++|||||||++|||++ |..||......+ .....
T Consensus 531 kL~DFG~a~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~--~~~~i 605 (656)
T 2j0j_A 531 KLGDFGLSRYMEDSTYYK---ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND--VIGRI 605 (656)
T ss_dssp EECCCCCCCSCCC-------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--HHHHH
T ss_pred EEEecCCCeecCCCccee---ccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHH--HHHHH
Confidence 999999998664432211 222347789999999988899999999999999999997 999986432110 00000
Q ss_pred HhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHHHHHHHHH
Q 045798 918 RMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHELQSVKNIL 995 (1008)
Q Consensus 918 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~i~~~~ 995 (1008)
.... .. . ....++..+.+++.+||+.||++|||+.|+++.|+++.+..
T Consensus 606 ~~~~--------------------------~~--~--~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~~ 653 (656)
T 2j0j_A 606 ENGE--------------------------RL--P--MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 653 (656)
T ss_dssp HHTC--------------------------CC--C--CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HcCC--------------------------CC--C--CCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHh
Confidence 0000 00 0 00123456899999999999999999999999999987653
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-37 Score=359.34 Aligned_cols=278 Identities=22% Similarity=0.243 Sum_probs=201.7
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccc-cchhhHHHHHHHHHHhhcCCCCceeeeecccccc-ccCCce
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQ-CEGASKSFMAECKALKNIRHRNLVKVITSCSSID-FQGNDF 760 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~~~~ 760 (1008)
.++|++.+.||+|+||.||+|.+..+|+.||||+++.. .....+.+.+|++++++++||||+++++++.... +..++.
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 47899999999999999999999889999999998754 3344677999999999999999999999965422 233677
Q ss_pred EEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCC---
Q 045798 761 KAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLS--- 837 (1008)
Q Consensus 761 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~--- 837 (1008)
.++||||+++|+|.+++....... .+++..++.++.|++.||+|||+. +|+||||||+||+++.++.
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~~~~-------~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~ 162 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFENCC-------GLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLI 162 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSSCTT-------CCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCE
T ss_pred EEEEEEeCCCCCHHHHHHhcccCC-------CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCcee
Confidence 899999999999999997654221 578889999999999999999998 9999999999999997765
Q ss_pred eEEcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHH
Q 045798 838 GHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFA 917 (1008)
Q Consensus 838 ~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~ 917 (1008)
+||+|||.+........ .....||+.|+|||++.+..++.++|||||||++|+|++|..||..... ...|.
T Consensus 163 vKL~DFG~a~~~~~~~~-----~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~----~~~~~ 233 (676)
T 3qa8_A 163 HKIIDLGYAKELDQGEL-----CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQ----PVQWH 233 (676)
T ss_dssp EEECSCCCCCBTTSCCC-----CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCH----HHHSS
T ss_pred EEEcccccccccccccc-----cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccc----hhhhh
Confidence 89999999986644322 1234689999999999999999999999999999999999999864211 01111
Q ss_pred HhhCCcchh-hhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHH
Q 045798 918 RMALPNQVM-DIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVV 985 (1008)
Q Consensus 918 ~~~~~~~~~-~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl 985 (1008)
......... ........... ......+.+.......+..+.+++.+||+.||++|||++|++
T Consensus 234 ~~i~~~~~~~~~~~~~l~g~~------~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL 296 (676)
T 3qa8_A 234 GKVREKSNEHIVVYDDLTGAV------KFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNP 296 (676)
T ss_dssp TTCC------CCSCCCCSSSC------CCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCC
T ss_pred hhhhcccchhhhhhhhhcccc------ccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHh
Confidence 000000000 00000000000 000011111111224567889999999999999999998843
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=347.62 Aligned_cols=212 Identities=26% Similarity=0.361 Sum_probs=157.1
Q ss_pred cCCCC-CceEeeccCeeEEEEEEc--CCCeEEEEEEeccccchhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCce
Q 045798 684 NGFSS-THLIGVGSFGCVYKGALD--EDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDF 760 (1008)
Q Consensus 684 ~~y~~-~~~lg~G~~g~Vy~~~~~--~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 760 (1008)
+.|.+ .++||+|+||.||+|++. .+++.||||++... .....+.+|++++++++||||+++++++.. ..+..
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~---~~~~~ 94 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGT--GISMSACREIALLRELKHPNVISLQKVFLS---HADRK 94 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSS--SCCHHHHHHHHHHHHCCCTTBCCCCEEEEE---TTTTE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCC--CCCHHHHHHHHHHHhcCCCCeeeEeeEEec---CCCCe
Confidence 34665 458999999999999975 46889999999743 234578899999999999999999999642 45667
Q ss_pred EEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeee----cCCC
Q 045798 761 KAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILL----DNDL 836 (1008)
Q Consensus 761 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll----~~~~ 836 (1008)
.++||||++ ++|.+++........ ......+++..++.|+.||+.||+|||+. +|+||||||+|||+ +.++
T Consensus 95 ~~lv~e~~~-~~l~~~~~~~~~~~~-~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~ 169 (405)
T 3rgf_A 95 VWLLFDYAE-HDLWHIIKFHRASKA-NKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERG 169 (405)
T ss_dssp EEEEEECCS-EEHHHHHHHHHHHC--------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTT
T ss_pred EEEEEeCCC-CCHHHHHHHhccccc-cccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCC
Confidence 999999995 688888753221000 00112589999999999999999999998 99999999999999 6789
Q ss_pred CeEEcccCcccccccccCccccccccccccccccCccccCCC-CCCcccchhhHHHHHHHHHhCCCCCCcc
Q 045798 837 SGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGS-EVSTNGDVYSYGILLLEMVTAKKPTDVM 906 (1008)
Q Consensus 837 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltG~~pf~~~ 906 (1008)
.+||+|||+|+........ ........||+.|+|||++.+. .++.++|||||||++|||++|+.||...
T Consensus 170 ~~kl~Dfg~a~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 239 (405)
T 3rgf_A 170 RVKIADMGFARLFNSPLKP-LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 239 (405)
T ss_dssp CEEECCTTCCC-----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCC
T ss_pred cEEEEECCCceecCCCCcc-cccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCc
Confidence 9999999999876543211 1122345689999999998874 5899999999999999999999999653
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-36 Score=339.02 Aligned_cols=350 Identities=17% Similarity=0.177 Sum_probs=226.4
Q ss_pred CCCCCCCCCCCc-ccceEEcCCCCeEEEEeccccCCCCccCcCccCCccCCeeeecCCCCCCCCCccccCCCCCCEEEcc
Q 045798 32 LNSWNDSRHFCE-WEGITCGRRHRRVTALDLMSKSLSGSLSPHLGNLSFLREINLSNNTIQGEIPPEFGRLFRLEALFLS 110 (1008)
Q Consensus 32 ~~~w~~~~~~c~-w~gv~c~~~~~~v~~l~l~~~~l~~~l~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls 110 (1008)
+++|..+.+||. |.+..|.....++ ............-..+.+|++|++++|.++...+..|..+++|++|+|+
T Consensus 3 ~~~~~~~~~C~~~~~~~~c~~~~~~i-----~~~~~~~~~~~~~~~l~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~ 77 (390)
T 3o6n_A 3 VKPRQPEYKCIDSNLQYDCVFYDVHI-----DMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLN 77 (390)
T ss_dssp ----CCEECBCC------EEEESCEE-----CSSCCCCEESCSSGGGCCCSEEEEESCEESEECTHHHHHCCCCSEEECT
T ss_pred cCCCCCccceehhhhhhccceeeeee-----ecccccccccccccccCCceEEEecCCchhhCChhHhcccccCcEEECC
Confidence 578988777764 6666664322222 1111111222233456788999999988885555557888889999999
Q ss_pred CCCCCCccCcccccCcCcceEeeeccccccCCCccccccCCCCeeecccccCCCCCCCCCccccccchhhcccccCCCCC
Q 045798 111 NNSLVGKIPANLSYCSRLTVLCIEYNKLQGRIPLEFVSLSKLKDLSLAKNKLTGGIPPFLGNLTSLEVLSLAGNSFGRNI 190 (1008)
Q Consensus 111 ~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~ 190 (1008)
+|.+++..+..|+.+++|++|+|++|.+++..|..|.++++|++|+|++|+++...+..|+++++|++|++++|++.+..
T Consensus 78 ~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~ 157 (390)
T 3o6n_A 78 DLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIE 157 (390)
T ss_dssp TSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCC
T ss_pred CCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccCcCCHHHhcCCCCCcEEECCCCccCccC
Confidence 98888777778888888888888888888777777888888888888888888444444677888888888888887777
Q ss_pred CccccCCCCCcEEEecCCcccccCCccccCCCCcceeccccccccccCChhhhhcCCCCcEEEeccccCCCCCCcccccC
Q 045798 191 PDSLGQLKQLKILAIGGNNLSGPIPPSIYNLSFLVVFSVSHNQIHGSLPPSLGLLLPNLKFFQIHHNFFSGSIPISLSNA 270 (1008)
Q Consensus 191 ~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l 270 (1008)
+..|..+++|++|++++|.+++. .+..+++|+.|++++|.+.+ +...
T Consensus 158 ~~~~~~l~~L~~L~l~~n~l~~~---~~~~l~~L~~L~l~~n~l~~------------------------------~~~~ 204 (390)
T 3o6n_A 158 DDTFQATTSLQNLQLSSNRLTHV---DLSLIPSLFHANVSYNLLST------------------------------LAIP 204 (390)
T ss_dssp TTTTSSCTTCCEEECCSSCCSBC---CGGGCTTCSEEECCSSCCSE------------------------------EECC
T ss_pred hhhccCCCCCCEEECCCCcCCcc---ccccccccceeecccccccc------------------------------cCCC
Confidence 77777777777777777777643 23444555555555555441 1122
Q ss_pred CCCceeecccccccccccccccCCCcccccccccccCCCCCCCcccccccccccCCCcEEEecCCcCCccCChhhhhhcc
Q 045798 271 SKLEHIEIANNNFSGKLSVNFGGMKNLSLLNLQFSNLGSGESDEMGFMNSLTNCSKLRVLSLGGNQFRGALPHSIANLSS 350 (1008)
Q Consensus 271 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 350 (1008)
++|++|++++|.+...... ..++|+.|++++|++++. ..+..+.
T Consensus 205 ~~L~~L~l~~n~l~~~~~~---------------------------------~~~~L~~L~l~~n~l~~~--~~l~~l~- 248 (390)
T 3o6n_A 205 IAVEELDASHNSINVVRGP---------------------------------VNVELTILKLQHNNLTDT--AWLLNYP- 248 (390)
T ss_dssp SSCSEEECCSSCCCEEECC---------------------------------CCSSCCEEECCSSCCCCC--GGGGGCT-
T ss_pred CcceEEECCCCeeeecccc---------------------------------ccccccEEECCCCCCccc--HHHcCCC-
Confidence 3455555555555433111 113444555555555421 2344443
Q ss_pred cceeeeeccccccCCCCCccccccccceEEecCccccCCcchhccCCCCCceEEccCCcccccccccccCCCCcceeecc
Q 045798 351 QLQILILSSNQFYGSIPLGIGNLVDLYLLGMVENQFTGAIPKEMGKLQKLQGLDFSGNHFSGEIPSSLGNLSSLYEVFFN 430 (1008)
Q Consensus 351 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~ 430 (1008)
+|++|+|++|.+++..|..+..+++|+.|+|++|++++ +|..+..+++|+.|+|++|+++ .+|..+..+++|+.|+++
T Consensus 249 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L~L~ 326 (390)
T 3o6n_A 249 GLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLD 326 (390)
T ss_dssp TCSEEECCSSCCCEEESGGGTTCSSCCEEECCSSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECC
T ss_pred CccEEECCCCcCCCcChhHccccccCCEEECCCCcCcc-cCcccCCCCCCCEEECCCCcce-ecCccccccCcCCEEECC
Confidence 36666666666665556666667777777777777764 4555667778888888888887 566667778888888888
Q ss_pred ccccccccCCCCcCCCcccEeecccccccC
Q 045798 431 NNNLSGVIPFSLGNLKRLAFLEMSGNELSG 460 (1008)
Q Consensus 431 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 460 (1008)
+|.++.. | +..+++|+.|++++|.+++
T Consensus 327 ~N~i~~~-~--~~~~~~L~~L~l~~N~~~~ 353 (390)
T 3o6n_A 327 HNSIVTL-K--LSTHHTLKNLTLSHNDWDC 353 (390)
T ss_dssp SSCCCCC-C--CCTTCCCSEEECCSSCEEH
T ss_pred CCcccee-C--chhhccCCEEEcCCCCccc
Confidence 8888743 3 6778888999999998874
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=338.34 Aligned_cols=257 Identities=19% Similarity=0.222 Sum_probs=175.2
Q ss_pred hcCCCCCc-eEeeccCeeEEEEEEcCCCeEEEEEEeccccchhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceE
Q 045798 683 TNGFSSTH-LIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFK 761 (1008)
Q Consensus 683 ~~~y~~~~-~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 761 (1008)
.++|.+.+ .||+|+||.||+|.+..+++.||||++... . ....+....++.++||||+++++++.... ..+...
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~---~~~~e~~~~~~~~~h~~i~~~~~~~~~~~-~~~~~~ 101 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-P---KARQEVDHHWQASGGPHIVCILDVYENMH-HGKRCL 101 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS-H---HHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TTEEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc-H---HHHHHHHHHHHhcCCCChHHHHHHHhhcc-CCCceE
Confidence 57899855 699999999999999989999999998643 1 12222333456679999999999865321 235568
Q ss_pred EEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecC---CCCe
Q 045798 762 AIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDN---DLSG 838 (1008)
Q Consensus 762 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~ 838 (1008)
++||||+++|+|.+++...... .+++.+++.++.||+.||+|||+. +|+||||||+||+++. ++.+
T Consensus 102 ~lv~e~~~gg~L~~~l~~~~~~--------~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~ 170 (336)
T 3fhr_A 102 LIIMECMEGGELFSRIQERGDQ--------AFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVL 170 (336)
T ss_dssp EEEEECCTTEEHHHHHHTC-CC--------CCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCE
T ss_pred EEEEeccCCCCHHHHHHhcCCC--------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceE
Confidence 9999999999999999865421 689999999999999999999998 9999999999999976 4559
Q ss_pred EEcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHH
Q 045798 839 HIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFAR 918 (1008)
Q Consensus 839 kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~ 918 (1008)
||+|||+++...... .....+|+.|+|||++.+..++.++|||||||++|+|++|+.||...............
T Consensus 171 kl~Dfg~~~~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~ 244 (336)
T 3fhr_A 171 KLTDFGFAKETTQNA------LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRR 244 (336)
T ss_dssp EECCCTTCEEC----------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------
T ss_pred EEeccccceeccccc------cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHh
Confidence 999999998654322 12245899999999998889999999999999999999999998643221110000000
Q ss_pred hhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 919 MALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 919 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
. .... .....+.....+.++.+++.+||+.||.+|||++|+++
T Consensus 245 --~-------~~~~----------------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 287 (336)
T 3fhr_A 245 --I-------RLGQ----------------YGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN 287 (336)
T ss_dssp -------------------------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred --h-------hccc----------------cccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0 0000 00000001124556899999999999999999999987
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-37 Score=339.19 Aligned_cols=263 Identities=24% Similarity=0.341 Sum_probs=196.0
Q ss_pred CCCCHHHHHHHhcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEecccc--chhhHHHHHHHHHHhhcC--CCCceeee
Q 045798 672 PKMSYKSLLKATNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC--EGASKSFMAECKALKNIR--HRNLVKVI 747 (1008)
Q Consensus 672 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~--h~niv~~~ 747 (1008)
..+.++.+....++|++.+.||+|+||.||+|.+. +++.||||++.... ....+.+.+|++++++++ ||||++++
T Consensus 16 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~ 94 (313)
T 3cek_A 16 ENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 94 (313)
T ss_dssp ----CCEEEETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEE
T ss_pred CCCCeeeeeeccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEE
Confidence 34444445555678999999999999999999985 68999999997442 344578999999999996 59999999
Q ss_pred eccccccccCCceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCC
Q 045798 748 TSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKP 827 (1008)
Q Consensus 748 ~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp 827 (1008)
+++ ..++..++||| +.+++|.+++.... .+++..++.++.|++.||+|||+. +|+||||||
T Consensus 95 ~~~-----~~~~~~~lv~e-~~~~~L~~~l~~~~----------~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp 155 (313)
T 3cek_A 95 DYE-----ITDQYIYMVME-CGNIDLNSWLKKKK----------SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKP 155 (313)
T ss_dssp EEE-----ECSSEEEEEEC-CCSEEHHHHHHHCS----------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCG
T ss_pred EEe-----ecCCEEEEEEe-cCCCcHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCc
Confidence 985 45667999999 55889999997654 689999999999999999999998 999999999
Q ss_pred CCeeecCCCCeEEcccCcccccccccCccccccccccccccccCccccCC-----------CCCCcccchhhHHHHHHHH
Q 045798 828 SNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLG-----------SEVSTNGDVYSYGILLLEM 896 (1008)
Q Consensus 828 ~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDvwslG~vl~el 896 (1008)
+||++++ +.+||+|||++.......... ......||+.|+|||++.+ ..++.++|||||||++|||
T Consensus 156 ~NIl~~~-~~~kL~Dfg~~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el 232 (313)
T 3cek_A 156 ANFLIVD-GMLKLIDFGIANQMQPDTTSV--VKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYM 232 (313)
T ss_dssp GGEEEET-TEEEECCCSSSCC----------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHH
T ss_pred ccEEEEC-CeEEEeeccccccccCccccc--cccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHH
Confidence 9999965 799999999998664432211 1223458999999999875 4688899999999999999
Q ss_pred HhCCCCCCccccCCccHHHHHHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCC
Q 045798 897 VTAKKPTDVMFEGDLNLHNFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQ 976 (1008)
Q Consensus 897 ltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~ 976 (1008)
++|+.||........... ...++.... .++ ...+.++.+++.+||+.||.
T Consensus 233 ~~g~~pf~~~~~~~~~~~------------~~~~~~~~~------------~~~------~~~~~~l~~li~~~l~~dp~ 282 (313)
T 3cek_A 233 TYGKTPFQQIINQISKLH------------AIIDPNHEI------------EFP------DIPEKDLQDVLKCCLKRDPK 282 (313)
T ss_dssp HHSSCTTTTCCSHHHHHH------------HHHCTTSCC------------CCC------CCSCHHHHHHHHHHTCSSTT
T ss_pred HhCCCchhhHHHHHHHHH------------HHHhccccc------------CCc------ccchHHHHHHHHHHccCCcc
Confidence 999999864322111111 111110000 000 01234578999999999999
Q ss_pred CCCCHHHHHHH
Q 045798 977 DRMNMTNVVHE 987 (1008)
Q Consensus 977 ~RPt~~evl~~ 987 (1008)
+|||++|+++.
T Consensus 283 ~Rps~~ell~h 293 (313)
T 3cek_A 283 QRISIPELLAH 293 (313)
T ss_dssp TSCCHHHHHTS
T ss_pred cCcCHHHHhcC
Confidence 99999999874
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-37 Score=337.08 Aligned_cols=246 Identities=22% Similarity=0.298 Sum_probs=191.2
Q ss_pred HHHHHhcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccc------hhhHHHHHHHHHHhhc----CCCCceeee
Q 045798 678 SLLKATNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCE------GASKSFMAECKALKNI----RHRNLVKVI 747 (1008)
Q Consensus 678 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l----~h~niv~~~ 747 (1008)
+.....++|++.+.||+|+||.||+|.+..+++.||||+++.... .....+.+|+.++.++ +||||++++
T Consensus 25 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~ 104 (312)
T 2iwi_A 25 DREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLL 104 (312)
T ss_dssp --------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEE
T ss_pred chhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEE
Confidence 344456789999999999999999999988999999999975432 1234567799999998 899999999
Q ss_pred eccccccccCCceEEEEEec-cCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCC
Q 045798 748 TSCSSIDFQGNDFKAIVYEY-MPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLK 826 (1008)
Q Consensus 748 ~~~~~~~~~~~~~~~lv~e~-~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlk 826 (1008)
+++ ...+..++|||| +.+++|.+++.... .+++..++.++.||+.||+|||+. +|+|||||
T Consensus 105 ~~~-----~~~~~~~~v~e~~~~~~~L~~~l~~~~----------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlk 166 (312)
T 2iwi_A 105 DWF-----ETQEGFMLVLERPLPAQDLFDYITEKG----------PLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIK 166 (312)
T ss_dssp EEC----------CEEEEECCSSEEEHHHHHHHHC----------SCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCS
T ss_pred EEE-----ecCCeEEEEEEecCCCCCHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCC
Confidence 994 455668999999 78999999997643 689999999999999999999998 99999999
Q ss_pred CCCeeec-CCCCeEEcccCcccccccccCccccccccccccccccCccccCCCCC-CcccchhhHHHHHHHHHhCCCCCC
Q 045798 827 PSNILLD-NDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEV-STNGDVYSYGILLLEMVTAKKPTD 904 (1008)
Q Consensus 827 p~NIll~-~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwslG~vl~elltG~~pf~ 904 (1008)
|+||+++ .++.+||+|||.+....... .....|+..|+|||++.+..+ +.++|||||||++|||++|+.||.
T Consensus 167 p~Nil~~~~~~~~kl~dfg~~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 240 (312)
T 2iwi_A 167 DENILIDLRRGCAKLIDFGSGALLHDEP------YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFE 240 (312)
T ss_dssp GGGEEEETTTTEEEECCCSSCEECCSSC------BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCC
T ss_pred hhhEEEeCCCCeEEEEEcchhhhcccCc------ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCC
Confidence 9999999 88999999999998665432 123458999999999876665 458999999999999999999986
Q ss_pred ccccCCccHHHHHHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHH
Q 045798 905 VMFEGDLNLHNFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNV 984 (1008)
Q Consensus 905 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev 984 (1008)
...+ ... .... ++ ...+..+.+++.+||+.||++|||++|+
T Consensus 241 ~~~~-------~~~------------~~~~--------------~~------~~~~~~~~~li~~~l~~~p~~Rps~~e~ 281 (312)
T 2iwi_A 241 RDQE-------ILE------------AELH--------------FP------AHVSPDCCALIRRCLAPKPSSRPSLEEI 281 (312)
T ss_dssp SHHH-------HHH------------TCCC--------------CC------TTSCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred ChHH-------Hhh------------hccC--------------Cc------ccCCHHHHHHHHHHccCChhhCcCHHHH
Confidence 3210 000 0000 00 0123457899999999999999999999
Q ss_pred HH
Q 045798 985 VH 986 (1008)
Q Consensus 985 l~ 986 (1008)
++
T Consensus 282 l~ 283 (312)
T 2iwi_A 282 LL 283 (312)
T ss_dssp HH
T ss_pred hc
Confidence 87
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-37 Score=340.96 Aligned_cols=265 Identities=23% Similarity=0.305 Sum_probs=196.6
Q ss_pred HHhcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEecccc--chhhHHHHHHHHHHhhcCCCCceeeeeccccccccCC
Q 045798 681 KATNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC--EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGN 758 (1008)
Q Consensus 681 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 758 (1008)
...++|++.+.||+|+||.||+|.+.. .||+|+++... ....+.+.+|+.++++++||||+++++++ ..+
T Consensus 30 i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~ 101 (319)
T 2y4i_B 30 IPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGAC-----MSP 101 (319)
T ss_dssp SCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEE-----ECS
T ss_pred CCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEE-----ecC
Confidence 346789999999999999999999853 49999987432 23345688999999999999999999995 445
Q ss_pred ceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCe
Q 045798 759 DFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSG 838 (1008)
Q Consensus 759 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 838 (1008)
+..++||||+++++|.+++..... .+++..++.++.||+.||+|||+. +|+||||||+||+++ ++.+
T Consensus 102 ~~~~iv~e~~~~~~L~~~l~~~~~---------~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~ 168 (319)
T 2y4i_B 102 PHLAIITSLCKGRTLYSVVRDAKI---------VLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKV 168 (319)
T ss_dssp SCEEEECBCCCSEEHHHHTTSSCC---------CCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CC
T ss_pred CceEEEeecccCCcHHHHHHhcCC---------CCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCE
Confidence 669999999999999999976431 588999999999999999999998 999999999999998 6799
Q ss_pred EEcccCcccccccccCc-cccccccccccccccCccccCC---------CCCCcccchhhHHHHHHHHHhCCCCCCcccc
Q 045798 839 HIGDFGLARFHQEVSNS-TLSSSVGVKGTIGYTAPEYGLG---------SEVSTNGDVYSYGILLLEMVTAKKPTDVMFE 908 (1008)
Q Consensus 839 kL~Dfg~a~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~---------~~~~~~sDvwslG~vl~elltG~~pf~~~~~ 908 (1008)
||+|||++......... .........|++.|+|||++.+ ..++.++|||||||++|||++|+.||.....
T Consensus 169 ~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~ 248 (319)
T 2y4i_B 169 VITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPA 248 (319)
T ss_dssp EECCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCH
T ss_pred EEeecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 99999998755322111 1111223458999999999864 3578899999999999999999999864321
Q ss_pred CCccHHHHHHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHH
Q 045798 909 GDLNLHNFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHEL 988 (1008)
Q Consensus 909 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 988 (1008)
.. ......... .+... ....+.++.+++.+||+.||++|||+.|+++.|
T Consensus 249 ~~--~~~~~~~~~--------~~~~~---------------------~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l 297 (319)
T 2y4i_B 249 EA--IIWQMGTGM--------KPNLS---------------------QIGMGKEISDILLFCWAFEQEERPTFTKLMDML 297 (319)
T ss_dssp HH--HHHHHHTTC--------CCCCC---------------------CSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHH
T ss_pred HH--HHHHhccCC--------CCCCC---------------------cCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHH
Confidence 10 000000000 00000 001234578999999999999999999999999
Q ss_pred HHHHHHHHH
Q 045798 989 QSVKNILLE 997 (1008)
Q Consensus 989 ~~i~~~~~~ 997 (1008)
+++.+....
T Consensus 298 ~~l~~~~~~ 306 (319)
T 2y4i_B 298 EKLPKRNRR 306 (319)
T ss_dssp TTC------
T ss_pred HHHHHhhcc
Confidence 998776544
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-37 Score=338.73 Aligned_cols=242 Identities=23% Similarity=0.290 Sum_probs=197.4
Q ss_pred HhcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccc------hhhHHHHHHHHHHhhcC--CCCceeeeeccccc
Q 045798 682 ATNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCE------GASKSFMAECKALKNIR--HRNLVKVITSCSSI 753 (1008)
Q Consensus 682 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~ 753 (1008)
..++|++.+.||+|+||.||+|.+..+++.||||+++.... ...+.+.+|+.+++++. |+||+++++++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~--- 117 (320)
T 3a99_A 41 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF--- 117 (320)
T ss_dssp CTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE---
T ss_pred ccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEE---
Confidence 45789999999999999999999988999999999975422 12356788999999995 59999999994
Q ss_pred cccCCceEEEEEeccCC-CChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeee
Q 045798 754 DFQGNDFKAIVYEYMPN-GSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILL 832 (1008)
Q Consensus 754 ~~~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll 832 (1008)
..++..++|||++.+ ++|.+++.... .+++..++.++.||+.||+|||+. +|+||||||+||++
T Consensus 118 --~~~~~~~lv~e~~~~~~~L~~~l~~~~----------~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll 182 (320)
T 3a99_A 118 --ERPDSFVLILERPEPVQDLFDFITERG----------ALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILI 182 (320)
T ss_dssp --ECSSEEEEEEECCSSEEEHHHHHHHHC----------SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEE
T ss_pred --ecCCcEEEEEEcCCCCccHHHHHhccC----------CCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEE
Confidence 556779999999976 89999987543 689999999999999999999998 99999999999999
Q ss_pred c-CCCCeEEcccCcccccccccCccccccccccccccccCccccCCCCC-CcccchhhHHHHHHHHHhCCCCCCccccCC
Q 045798 833 D-NDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEV-STNGDVYSYGILLLEMVTAKKPTDVMFEGD 910 (1008)
Q Consensus 833 ~-~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwslG~vl~elltG~~pf~~~~~~~ 910 (1008)
+ +++.+||+|||+++...... .....||+.|+|||++.+..+ +.++|||||||++|||++|+.||....+
T Consensus 183 ~~~~~~~kL~Dfg~~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~-- 254 (320)
T 3a99_A 183 DLNRGELKLIDFGSGALLKDTV------YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE-- 254 (320)
T ss_dssp ETTTTEEEECCCTTCEECCSSC------BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH--
T ss_pred eCCCCCEEEeeCcccccccccc------ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh--
Confidence 9 78999999999998664322 123458999999999877665 6789999999999999999999863210
Q ss_pred ccHHHHHHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 911 LNLHNFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 911 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
.... ... .+ ...+.++.+++.+||+.||++|||++|+++
T Consensus 255 -----~~~~------------~~~--------------~~------~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 255 -----IIRG------------QVF--------------FR------QRVSSECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp -----HHHC------------CCC--------------CS------SCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -----hhcc------------ccc--------------cc------ccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0000 000 00 012346789999999999999999999987
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=343.78 Aligned_cols=283 Identities=18% Similarity=0.251 Sum_probs=201.7
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccchhhHHHHHHHHHHhhcC-----------CCCceeeeeccc
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIR-----------HRNLVKVITSCS 751 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~~~~~~~ 751 (1008)
.++|++.+.||+|+||.||+|.+..+++.||||+++.. ....+.+.+|+++++++. ||||+++++++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 46899999999999999999999889999999999743 334567889999999886 899999999865
Q ss_pred cccccCCceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCee
Q 045798 752 SIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNIL 831 (1008)
Q Consensus 752 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIl 831 (1008)
... ......++||||+ +++|.+++...... .+++..++.++.||+.||+|||++ .+|+||||||+||+
T Consensus 97 ~~~-~~~~~~~lv~e~~-~~~L~~~~~~~~~~--------~~~~~~~~~i~~qi~~aL~~lH~~--~~ivH~Dikp~NIl 164 (373)
T 1q8y_A 97 HKG-PNGVHVVMVFEVL-GENLLALIKKYEHR--------GIPLIYVKQISKQLLLGLDYMHRR--CGIIHTDIKPENVL 164 (373)
T ss_dssp EEE-TTEEEEEEEECCC-CEEHHHHHHHTTTS--------CCCHHHHHHHHHHHHHHHHHHHHT--TCEECSCCSGGGEE
T ss_pred ccC-CCCceEEEEEecC-CCCHHHHHHHhhcc--------CCcHHHHHHHHHHHHHHHHHHHhc--CCEEecCCChHHeE
Confidence 321 2334789999999 99999999764321 589999999999999999999983 28999999999999
Q ss_pred ec------CCCCeEEcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCc
Q 045798 832 LD------NDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDV 905 (1008)
Q Consensus 832 l~------~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~ 905 (1008)
++ ..+.+||+|||+++...... ....||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 165 l~~~~~~~~~~~~kl~Dfg~a~~~~~~~-------~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 237 (373)
T 1q8y_A 165 MEIVDSPENLIQIKIADLGNACWYDEHY-------TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEP 237 (373)
T ss_dssp EEEEETTTTEEEEEECCCTTCEETTBCC-------CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC--
T ss_pred EeccCCCcCcceEEEcccccccccCCCC-------CCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 94 44589999999998654321 223589999999999999999999999999999999999999975
Q ss_pred cccCCc-----cHHHHHHhhC--Ccchhh-------hhcc--cccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhc
Q 045798 906 MFEGDL-----NLHNFARMAL--PNQVMD-------IVDP--ILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVA 969 (1008)
Q Consensus 906 ~~~~~~-----~~~~~~~~~~--~~~~~~-------~~d~--~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 969 (1008)
...... .......... +..... +... .+..... ....................+.++.+++.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 316 (373)
T 1q8y_A 238 DEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISK-LKFWPLEDVLTEKYKFSKDEAKEISDFLSP 316 (373)
T ss_dssp -------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCC-CCBCCHHHHHHHTTCCCHHHHHHHHHHHGG
T ss_pred CcccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhccccc-ccccchhhhhhhcccCCcchHHHHHHHHHH
Confidence 322110 1111111110 100000 0000 0000000 000000000001111224677889999999
Q ss_pred ccCcCCCCCCCHHHHHH
Q 045798 970 CSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 970 cl~~dP~~RPt~~evl~ 986 (1008)
||+.||++|||++|+++
T Consensus 317 ~L~~dP~~Rpt~~ell~ 333 (373)
T 1q8y_A 317 MLQLDPRKRADAGGLVN 333 (373)
T ss_dssp GGCSSTTTCBCHHHHHT
T ss_pred HhccCccccCCHHHHhh
Confidence 99999999999999986
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-36 Score=346.14 Aligned_cols=259 Identities=23% Similarity=0.271 Sum_probs=184.3
Q ss_pred cCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccchhhHHHHHHHHHHhhc-CCCCceeeeeccccccccCCceEE
Q 045798 684 NGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNI-RHRNLVKVITSCSSIDFQGNDFKA 762 (1008)
Q Consensus 684 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~ 762 (1008)
+.|.+.+.||+|+||+||.+.. .+|+.||||++... ..+.+.+|+++++++ +||||++++++ +..++..+
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~-~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~-----~~~~~~~~ 85 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGS-FQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCS-----ETTDRFLY 85 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEE-SSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEE-----EECSSEEE
T ss_pred heeeccCeEeeCCCeEEEEEEE-ECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEE-----EecCCeEE
Confidence 3455678899999999987654 47999999998643 345678999999887 89999999998 45667799
Q ss_pred EEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCC-------
Q 045798 763 IVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDND------- 835 (1008)
Q Consensus 763 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~------- 835 (1008)
+||||++ |+|.+++......... ....++..++.++.||+.||+|||+. +|+||||||+||+++.+
T Consensus 86 lv~E~~~-gsL~~~l~~~~~~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~ 158 (434)
T 2rio_A 86 IALELCN-LNLQDLVESKNVSDEN---LKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQ 158 (434)
T ss_dssp EEECCCS-EEHHHHHHTC---------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCC
T ss_pred EEEecCC-CCHHHHHhccCCCchh---hhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCccccccc
Confidence 9999995 6999999765422110 00123445678999999999999998 99999999999999754
Q ss_pred ------CCeEEcccCcccccccccCccccccccccccccccCccccCC-------CCCCcccchhhHHHHHHHHHh-CCC
Q 045798 836 ------LSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLG-------SEVSTNGDVYSYGILLLEMVT-AKK 901 (1008)
Q Consensus 836 ------~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~sDvwslG~vl~ellt-G~~ 901 (1008)
+.+||+|||+++.................||+.|+|||++.+ ..++.++|||||||++|||++ |+.
T Consensus 159 ~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~ 238 (434)
T 2rio_A 159 QTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKH 238 (434)
T ss_dssp TTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCC
T ss_pred ccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCC
Confidence 489999999998765443222212234569999999999876 578999999999999999999 999
Q ss_pred CCCccccCCccHHHHHHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCH
Q 045798 902 PTDVMFEGDLNLHNFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNM 981 (1008)
Q Consensus 902 pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~ 981 (1008)
||....... ............ . ........+.++.+++.+||+.||.+|||+
T Consensus 239 Pf~~~~~~~---~~i~~~~~~~~~-------~------------------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~ 290 (434)
T 2rio_A 239 PFGDKYSRE---SNIIRGIFSLDE-------M------------------KCLHDRSLIAEATDLISQMIDHDPLKRPTA 290 (434)
T ss_dssp TTCSTTTHH---HHHHHTCCCCCC-------C------------------TTCCCHHHHHHHHHHHHHHTCSSGGGSCCH
T ss_pred CCCCchhhH---HHHhcCCCCccc-------c------------------cccccccchHHHHHHHHHHhhCChhhCCCH
Confidence 986432111 111111100000 0 000112456778999999999999999999
Q ss_pred HHHHH
Q 045798 982 TNVVH 986 (1008)
Q Consensus 982 ~evl~ 986 (1008)
.||++
T Consensus 291 ~eil~ 295 (434)
T 2rio_A 291 MKVLR 295 (434)
T ss_dssp HHHHT
T ss_pred HHHHh
Confidence 99986
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-36 Score=334.92 Aligned_cols=259 Identities=21% Similarity=0.260 Sum_probs=177.1
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccc-hhhHHHHHHHH-HHhhcCCCCceeeeeccccccccCCce
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCE-GASKSFMAECK-ALKNIRHRNLVKVITSCSSIDFQGNDF 760 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~~~~ 760 (1008)
.++|++.+.||+|+||.||+|.+..+++.||||+++.... .....+..|+. +++.++||||+++++++ ..++.
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~-----~~~~~ 95 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGAL-----FREGD 95 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEE-----ECSSE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEE-----EeCCc
Confidence 4689999999999999999999988999999999975432 33445666666 67778999999999995 45567
Q ss_pred EEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEE
Q 045798 761 KAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHI 840 (1008)
Q Consensus 761 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 840 (1008)
.++||||++ ++|.+++...... ....+++..+..++.|++.||.|||+. .+|+||||||+||+++.++.+||
T Consensus 96 ~~lv~e~~~-~~l~~~~~~~~~~-----~~~~~~~~~~~~i~~~i~~~l~~lH~~--~~ivH~dlkp~NIll~~~~~~kl 167 (327)
T 3aln_A 96 CWICMELMS-TSFDKFYKYVYSV-----LDDVIPEEILGKITLATVKALNHLKEN--LKIIHRDIKPSNILLDRSGNIKL 167 (327)
T ss_dssp EEEEECCCS-EEHHHHHHHHHHT-----TCCCCCHHHHHHHHHHHHHHHHHHHHH--HSCCCSCCCGGGEEEETTTEEEE
T ss_pred eEEEEeecC-CChHHHHHHHHhh-----hcccCcHHHHHHHHHHHHHHHHHHhcc--CCEeECCCCHHHEEEcCCCCEEE
Confidence 899999996 5888777531100 011689999999999999999999984 38999999999999999999999
Q ss_pred cccCcccccccccCccccccccccccccccCcccc----CCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHH
Q 045798 841 GDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYG----LGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNF 916 (1008)
Q Consensus 841 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~ 916 (1008)
+|||+++....... .....||+.|+|||++ .+..++.++|||||||++|||++|+.||.........
T Consensus 168 ~Dfg~~~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~---- 238 (327)
T 3aln_A 168 CDFGISGQLVDSIA-----KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQ---- 238 (327)
T ss_dssp CCCSSSCC-----------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC----------
T ss_pred ccCCCceecccccc-----cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHH----
Confidence 99999986543321 1223589999999998 4567899999999999999999999998643211000
Q ss_pred HHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 917 ARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 917 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
+......... .+.. ......+..+.+++.+||+.||++|||+.|+++
T Consensus 239 ------------~~~~~~~~~~---------~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 239 ------------LTQVVKGDPP---------QLSN--SEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp -------------CCCCCSCCC---------CCCC--CSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred ------------HHHHhcCCCC---------CCCC--cccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 0000000000 0000 000123456899999999999999999999987
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-35 Score=324.50 Aligned_cols=275 Identities=19% Similarity=0.245 Sum_probs=220.7
Q ss_pred hhhccCChhhHHHHHHHHHhhccCCCCCCCCC----CCCCCCCcccceEEcC--------CCCeEEEEeccccCCCCccC
Q 045798 4 FQVAALEDGDRAALQAFKSMIAHEPQGILNSW----NDSRHFCEWEGITCGR--------RHRRVTALDLMSKSLSGSLS 71 (1008)
Q Consensus 4 ~~~~~~~~~~~~~l~~~k~~~~~~~~~~~~~w----~~~~~~c~w~gv~c~~--------~~~~v~~l~l~~~~l~~~l~ 71 (1008)
.|..++..+|++||++||+++..||.+.+.+| ....++|.|.|+.|.. ...+|+.|+|+++.++ .+|
T Consensus 19 ~~~~~~~~~~~~aLl~~k~~~~~~~~~~~~~w~~~~~~~~~~~~~~g~~~~~~~~~l~~~~~~~l~~L~L~~n~l~-~lp 97 (328)
T 4fcg_A 19 FQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIETRTGRALKATADLLEDATQPGRVALELRSVPLP-QFP 97 (328)
T ss_dssp CC--CCCCCHHHHHHHHHHHHHHCCTTHHHHHHHHTTTCTTSCCSHHHHHHHHHHHHHHHTSTTCCEEEEESSCCS-SCC
T ss_pred eeccccCchHHHHHHHHHHhccCCchhhhhhhcccccccccccccCCcchhhhHHHHhcccccceeEEEccCCCch-hcC
Confidence 45667888999999999999988888888899 5677899999999952 3467899999999988 788
Q ss_pred cCccCCccCCeeeecCCCCCCCCCccccCCCCCCEEEccCCCCCCccCcccccCcCcceEeeeccccccCCCccccc---
Q 045798 72 PHLGNLSFLREINLSNNTIQGEIPPEFGRLFRLEALFLSNNSLVGKIPANLSYCSRLTVLCIEYNKLQGRIPLEFVS--- 148 (1008)
Q Consensus 72 ~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~--- 148 (1008)
+.++.+++|++|+|++|.++ .+|..|+++++|++|+|++|.++ .+|..++.+++|++|+|++|++.+.+|..+..
T Consensus 98 ~~l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~~~~ 175 (328)
T 4fcg_A 98 DQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDA 175 (328)
T ss_dssp SCGGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEETTCCCCCSCSEEEC-
T ss_pred hhhhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECCCCCCccccChhHhhccc
Confidence 88888999999999999998 88888999999999999999998 78888999999999999998888888887764
Q ss_pred ------cCCCCeeecccccCCCCCCCCCccccccchhhcccccCCCCCCccccCCCCCcEEEecCCcccccCCccccCCC
Q 045798 149 ------LSKLKDLSLAKNKLTGGIPPFLGNLTSLEVLSLAGNSFGRNIPDSLGQLKQLKILAIGGNNLSGPIPPSIYNLS 222 (1008)
Q Consensus 149 ------l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~ 222 (1008)
+++|++|+|++|+++ .+|..++++++|++|+|++|++++ +|..|..+++|++|+|++|.+.+.+|..+.+++
T Consensus 176 ~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~-l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~ 253 (328)
T 4fcg_A 176 SGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRA 253 (328)
T ss_dssp CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCC-CCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCC
T ss_pred hhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCCc-CchhhccCCCCCEEECcCCcchhhhHHHhcCCC
Confidence 778888888888887 677777778888888888888764 555677788888888888777777777777777
Q ss_pred CcceeccccccccccCChhhhhcCCCCcEEEeccccCCCCCCcccccCCCCceeeccccccc
Q 045798 223 FLVVFSVSHNQIHGSLPPSLGLLLPNLKFFQIHHNFFSGSIPISLSNASKLEHIEIANNNFS 284 (1008)
Q Consensus 223 ~L~~L~ls~N~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~ 284 (1008)
+|+.|++++|.+.+.+|..+. .+++|++|+|++|.+.+.+|..+.++++|+.+++..+.+.
T Consensus 254 ~L~~L~L~~n~~~~~~p~~~~-~l~~L~~L~L~~n~~~~~iP~~l~~L~~L~~l~l~~~~~~ 314 (328)
T 4fcg_A 254 PLKRLILKDCSNLLTLPLDIH-RLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQA 314 (328)
T ss_dssp CCCEEECTTCTTCCBCCTTGG-GCTTCCEEECTTCTTCCCCCGGGGGSCTTCEEECCGGGSC
T ss_pred CCCEEECCCCCchhhcchhhh-cCCCCCEEeCCCCCchhhccHHHhhccCceEEeCCHHHHH
Confidence 777777777777767776643 3677777777777777777777777777777776665554
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=328.74 Aligned_cols=252 Identities=22% Similarity=0.251 Sum_probs=178.6
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccch--hhHHHHHHHHHHhhcCCCCceeeeeccccccccCCce
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEG--ASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDF 760 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 760 (1008)
.++|++.+.||+|+||.||+|.+..+++.||||++...... ..+.+.++..+++.++||||+++++++ ..++.
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~-----~~~~~ 98 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTF-----ITNTD 98 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEE-----ECSSE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEE-----ecCCc
Confidence 46789999999999999999999889999999999754322 223445555678888999999999995 45667
Q ss_pred EEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhh-CCCCCceeccCCCCCeeecCCCCeE
Q 045798 761 KAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHH-HCQEPILHCDLKPSNILLDNDLSGH 839 (1008)
Q Consensus 761 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~k 839 (1008)
.++||||+ ++.+..+..... ..+++..++.++.|++.||+|||+ . +|+||||||+||+++.++.+|
T Consensus 99 ~~lv~e~~-~~~~~~l~~~~~---------~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~k 165 (318)
T 2dyl_A 99 VFIAMELM-GTCAEKLKKRMQ---------GPIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGQIK 165 (318)
T ss_dssp EEEEECCC-SEEHHHHHHHHT---------SCCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECTTSCEE
T ss_pred EEEEEecc-CCcHHHHHHHhc---------cCCCHHHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECCCCCEE
Confidence 99999999 555655544321 168999999999999999999998 4 899999999999999999999
Q ss_pred EcccCcccccccccCccccccccccccccccCccccC-----CCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHH
Q 045798 840 IGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGL-----GSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLH 914 (1008)
Q Consensus 840 L~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~ 914 (1008)
|+|||.+........ .....+|+.|+|||++. +..++.++|||||||++|||++|+.||...........
T Consensus 166 l~dfg~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~ 240 (318)
T 2dyl_A 166 LCDFGISGRLVDDKA-----KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLT 240 (318)
T ss_dssp ECCCTTC-------------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHH
T ss_pred EEECCCchhccCCcc-----ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHH
Confidence 999999976543221 12245899999999984 45688999999999999999999999864211111111
Q ss_pred HHHHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 915 NFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 915 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
.......+ ..+.....+.++.+++.+||+.||.+|||++|+++
T Consensus 241 ~~~~~~~~-----------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 241 KVLQEEPP-----------------------------LLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp HHHHSCCC-----------------------------CCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred HHhccCCC-----------------------------CCCccCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 11110000 00000123456789999999999999999999987
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=338.90 Aligned_cols=268 Identities=15% Similarity=0.135 Sum_probs=192.5
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccc---hhhHHHHHHHHHHhhcCC-CCceeeeec---------
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCE---GASKSFMAECKALKNIRH-RNLVKVITS--------- 749 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h-~niv~~~~~--------- 749 (1008)
...|...+.||+|+||.||+|.+..+|+.||||+++.... ...+.+.+|+.+++.+.| ++......+
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 156 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 156 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence 3457788999999999999999988999999999974322 335789999999999977 322111111
Q ss_pred ------------cccccccCCceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCC
Q 045798 750 ------------CSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQ 817 (1008)
Q Consensus 750 ------------~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ 817 (1008)
+...........+++|+++ +++|.+++....... .....+++..++.++.||+.||+|||+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~---~~~~~l~~~~~~~i~~qi~~aL~~LH~~-- 230 (413)
T 3dzo_A 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHS---STHKSLVHHARLQLTLQVIRLLASLHHY-- 230 (413)
T ss_dssp EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHT---TTSHHHHHHHHHHHHHHHHHHHHHHHHT--
T ss_pred cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhccc---ccCCCCCHHHHHHHHHHHHHHHHHHHhC--
Confidence 0000001123467788877 789999884211000 0012688999999999999999999998
Q ss_pred CCceeccCCCCCeeecCCCCeEEcccCcccccccccCccccccccccccccccCcccc----------CCCCCCcccchh
Q 045798 818 EPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYG----------LGSEVSTNGDVY 887 (1008)
Q Consensus 818 ~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~sDvw 887 (1008)
+|+||||||+|||++.++.+||+|||+++..... .....| +.|+|||++ .+..++.++|||
T Consensus 231 -~iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-------~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~Dvw 301 (413)
T 3dzo_A 231 -GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-------AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTW 301 (413)
T ss_dssp -TEECSCCCGGGEEECTTCCEEECCGGGCEETTEE-------ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHH
T ss_pred -CcccCCcccceEEEecCCeEEEEeccceeecCCc-------cccCCC-CceeCchhhhccccccccccCcCCCchhhHH
Confidence 9999999999999999999999999999865433 223457 999999998 666788999999
Q ss_pred hHHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHH
Q 045798 888 SYGILLLEMVTAKKPTDVMFEGDLNLHNFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIG 967 (1008)
Q Consensus 888 slG~vl~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 967 (1008)
||||++|||++|+.||........ .+..+... . ..+.++.+++
T Consensus 302 SlGvil~elltg~~Pf~~~~~~~~-----------------~~~~~~~~----------~----------~~~~~~~~li 344 (413)
T 3dzo_A 302 TLGLAIYWIWCADLPNTDDAALGG-----------------SEWIFRSC----------K----------NIPQPVRALL 344 (413)
T ss_dssp HHHHHHHHHHHSSCCCCTTGGGSC-----------------SGGGGSSC----------C----------CCCHHHHHHH
T ss_pred HHHHHHHHHHHCCCCCCCcchhhh-----------------HHHHHhhc----------c----------cCCHHHHHHH
Confidence 999999999999999864321110 00001000 0 1235689999
Q ss_pred hcccCcCCCCCCCHHHHHHH--HHHHHHHHHHHHHhh
Q 045798 968 VACSMESPQDRMNMTNVVHE--LQSVKNILLELETVF 1002 (1008)
Q Consensus 968 ~~cl~~dP~~RPt~~evl~~--L~~i~~~~~~~~~~~ 1002 (1008)
.+||+.||++|||+.|+++. ++.+.+........+
T Consensus 345 ~~~l~~dP~~Rpt~~~~l~~~~~~~~~~~~~~~~~~~ 381 (413)
T 3dzo_A 345 EGFLRYPKEDRLLPLQAMETPEYEQLRTELSAALPLY 381 (413)
T ss_dssp HHHTCSSGGGSCCHHHHTTSHHHHHHHHHHHHHGGGG
T ss_pred HHHccCChhhCcCHHHHHhCHHHHHHHHHHHHHhhhh
Confidence 99999999999999999874 556655555444333
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-35 Score=316.66 Aligned_cols=236 Identities=11% Similarity=0.062 Sum_probs=183.6
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEecccc---chhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCc
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC---EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGND 759 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 759 (1008)
.++|++.+.||+|+||.||+|.+..+++.||||+++... ....+.+.+|+.++++++||||+++++++ ..++
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~-----~~~~ 104 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVV-----HTRA 104 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-----EETT
T ss_pred cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEE-----EECC
Confidence 367999999999999999999998889999999997543 23347899999999999999999999995 4566
Q ss_pred eEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeE
Q 045798 760 FKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGH 839 (1008)
Q Consensus 760 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 839 (1008)
..|+||||+++++|.+++... ....++..|+.|++.||+|||++ +|+||||||+||+++.++.+|
T Consensus 105 ~~~lv~e~~~g~~L~~~l~~~------------~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~k 169 (286)
T 3uqc_A 105 GGLVVAEWIRGGSLQEVADTS------------PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVV 169 (286)
T ss_dssp EEEEEEECCCEEEHHHHHTTC------------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEE
T ss_pred cEEEEEEecCCCCHHHHHhcC------------CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEE
Confidence 799999999999999998532 24457888999999999999998 999999999999999999999
Q ss_pred EcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHh
Q 045798 840 IGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARM 919 (1008)
Q Consensus 840 L~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~ 919 (1008)
|+++| |++ .++.++|||||||++|||++|+.||............
T Consensus 170 l~~~~------------------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~---- 214 (286)
T 3uqc_A 170 LAYPA------------------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPA---- 214 (286)
T ss_dssp ECSCC------------------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEEC----
T ss_pred EEecc------------------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHH----
Confidence 97443 333 2688999999999999999999999753221100000
Q ss_pred hCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHHHHHHHHHH
Q 045798 920 ALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHELQSVKNILL 996 (1008)
Q Consensus 920 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~i~~~~~ 996 (1008)
........ ..........+.++.+++.+||+.||++| |+.|+++.|+++.....
T Consensus 215 ----------~~~~~~~~------------~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~~ 268 (286)
T 3uqc_A 215 ----------ERDTAGQP------------IEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVAD 268 (286)
T ss_dssp ----------CBCTTSCB------------CCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC---
T ss_pred ----------HHHhccCC------------CChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccCC
Confidence 00000000 00000011245568999999999999999 99999999999876543
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-35 Score=337.59 Aligned_cols=251 Identities=24% Similarity=0.322 Sum_probs=182.3
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccchhhHHHHHHHHHHhhc-CCCCceeeeeccccccccCCceE
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNI-RHRNLVKVITSCSSIDFQGNDFK 761 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~ 761 (1008)
..+|.+.+.||+|+||+||.... .+++.||||++..... ..+.+|+++++++ +||||+++++++ .+....
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~~~~-~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~-----~~~~~~ 93 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVYRGM-FDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTE-----KDRQFQ 93 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEEEEE-SSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEE-----EETTEE
T ss_pred cEEEecCCeeecCcCEEEEEEEE-eCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEE-----ecCCEE
Confidence 45688899999999999764333 4789999999864322 3467899999999 899999999984 556678
Q ss_pred EEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecC-----CC
Q 045798 762 AIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDN-----DL 836 (1008)
Q Consensus 762 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~-----~~ 836 (1008)
|+||||++ |+|.+++..... ...+..++.++.||+.||+|||+. +|+||||||+||+++. ..
T Consensus 94 ~lv~E~~~-g~L~~~l~~~~~---------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~ 160 (432)
T 3p23_A 94 YIAIELCA-ATLQEYVEQKDF---------AHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKI 160 (432)
T ss_dssp EEEEECCS-EEHHHHHHSSSC---------CCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBC
T ss_pred EEEEECCC-CCHHHHHHhcCC---------CccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCce
Confidence 99999995 699999976542 234445678999999999999998 9999999999999953 34
Q ss_pred CeEEcccCcccccccccCccccccccccccccccCccccC---CCCCCcccchhhHHHHHHHHHh-CCCCCCccccCCcc
Q 045798 837 SGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGL---GSEVSTNGDVYSYGILLLEMVT-AKKPTDVMFEGDLN 912 (1008)
Q Consensus 837 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwslG~vl~ellt-G~~pf~~~~~~~~~ 912 (1008)
.+||+|||+|+......... .......||+.|+|||++. ...++.++|||||||++|||++ |..||......
T Consensus 161 ~~kL~DFG~a~~~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~--- 236 (432)
T 3p23_A 161 KAMISDFGLCKKLAVGRHSF-SRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQR--- 236 (432)
T ss_dssp CEEECCTTEEECC-------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTH---
T ss_pred eEEEecccceeeccCCCcce-eeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHH---
Confidence 68899999998765432211 1223456999999999987 4567889999999999999999 89998532111
Q ss_pred HHHHHHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 913 LHNFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 913 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
............. ..........+.+++.+||+.||.+|||++||++
T Consensus 237 ---~~~~~~~~~~~~~------------------------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 237 ---QANILLGACSLDC------------------------LHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp ---HHHHHTTCCCCTT------------------------SCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ---HHHHHhccCCccc------------------------cCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 0000000000000 0001123455789999999999999999999994
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-35 Score=353.80 Aligned_cols=249 Identities=23% Similarity=0.320 Sum_probs=197.9
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcC-CCeEEEEEEecccc-chhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCce
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDE-DGIVVAIKVINLQC-EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDF 760 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 760 (1008)
.++|++.+.||+|+||.||+|.+.. +++.||||++.... ....+.+.+|++++++++||||+++++++......+...
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 3689999999999999999999975 78999999986433 344567899999999999999999999976543333334
Q ss_pred EEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEE
Q 045798 761 KAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHI 840 (1008)
Q Consensus 761 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 840 (1008)
.|+||||+++++|.+++.. .+++.+++.|+.||+.||+|||++ +||||||||+||+++.+ .+||
T Consensus 159 ~~lv~E~~~g~~L~~~~~~------------~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl 222 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKGQ------------KLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKL 222 (681)
T ss_dssp EEEEEECCCCEECC----C------------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEE
T ss_pred eEEEEEeCCCCcHHHHHhC------------CCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEE
Confidence 7999999999999987642 589999999999999999999998 99999999999999986 9999
Q ss_pred cccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHhh
Q 045798 841 GDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMA 920 (1008)
Q Consensus 841 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~~ 920 (1008)
+|||+++..... ....||+.|+|||++.+. ++.++|||||||++|+|++|..||........
T Consensus 223 ~DFG~a~~~~~~--------~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~--------- 284 (681)
T 2pzi_A 223 IDLGAVSRINSF--------GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDGL--------- 284 (681)
T ss_dssp CCCTTCEETTCC--------SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSSC---------
T ss_pred EecccchhcccC--------CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCcccccccc---------
Confidence 999999865432 234589999999998765 48899999999999999999988753211100
Q ss_pred CCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCC-CHHHHHHHHHHHHHHH
Q 045798 921 LPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRM-NMTNVVHELQSVKNIL 995 (1008)
Q Consensus 921 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-t~~evl~~L~~i~~~~ 995 (1008)
+ ... .....+..+.+++.+||+.||.+|| +++++.+.|..+....
T Consensus 285 -~-----------~~~------------------~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~~ 330 (681)
T 2pzi_A 285 -P-----------EDD------------------PVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLREV 330 (681)
T ss_dssp -C-----------TTC------------------HHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHHHH
T ss_pred -c-----------ccc------------------cccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHHHHh
Confidence 0 000 0112345688999999999999999 5677777787776544
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-35 Score=321.63 Aligned_cols=256 Identities=32% Similarity=0.502 Sum_probs=183.0
Q ss_pred CCCcEEEecCCcCCc--cCChhhhhhcccceeeeecc-ccccCCCCCccccccccceEEecCccccCCcchhccCCCCCc
Q 045798 325 SKLRVLSLGGNQFRG--ALPHSIANLSSQLQILILSS-NQFYGSIPLGIGNLVDLYLLGMVENQFTGAIPKEMGKLQKLQ 401 (1008)
Q Consensus 325 ~~L~~L~Ls~N~l~~--~~p~~~~~l~~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~ 401 (1008)
.+++.|+|++|.+.+ .+|..+..+. +|++|+|++ |.+.+.+|..+.++++|++|+|++|++++.+|..|..+++|+
T Consensus 50 ~~l~~L~L~~~~l~~~~~~~~~l~~l~-~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~ 128 (313)
T 1ogq_A 50 YRVNNLDLSGLNLPKPYPIPSSLANLP-YLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLV 128 (313)
T ss_dssp CCEEEEEEECCCCSSCEECCGGGGGCT-TCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCC
T ss_pred ceEEEEECCCCCccCCcccChhHhCCC-CCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCC
Confidence 356777777777776 6677666665 477777774 677767777777777777777777777766777777777777
Q ss_pred eEEccCCcccccccccccCCCCcceeeccccccccccCCCCcCCC-cccEeecccccccCCcchhhhhhhhhhhhhcccC
Q 045798 402 GLDFSGNHFSGEIPSSLGNLSSLYEVFFNNNNLSGVIPFSLGNLK-RLAFLEMSGNELSGTIPEDIFNISYLSNSLNLAR 480 (1008)
Q Consensus 402 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~-~L~~L~Ls~N~l~~~lp~~~~~~~~~~~~L~L~~ 480 (1008)
+|+|++|++++.+|..+..+++|++|++++|.+++.+|..+..++ +|+.|+|++|++++
T Consensus 129 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~-------------------- 188 (313)
T 1ogq_A 129 TLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTG-------------------- 188 (313)
T ss_dssp EEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEE--------------------
T ss_pred EEeCCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeec--------------------
Confidence 777777777766676677777777777777777666666666666 66666666666664
Q ss_pred ccccCCCcccccccccccccccccccccCCCCcccccccccceeeccCcccccchhhhhhccccccEEecCCCccccccc
Q 045798 481 NHLVGIIPPRIGNLRALRSFDVSNNDLSGEIPIELGHCSSLEEIYLAGNLFHGSIPSFFNALKGVQKIDLSRNNLSGQIP 560 (1008)
Q Consensus 481 N~l~~~~p~~~~~l~~L~~Ldls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p 560 (1008)
.+|..++.+. |+.|+|++|.+++.+|..+..+++|++|+|++|++++.+|. +..+++|+.|+|++|++++.+|
T Consensus 189 -----~~~~~~~~l~-L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p 261 (313)
T 1ogq_A 189 -----KIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLP 261 (313)
T ss_dssp -----ECCGGGGGCC-CSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECCSSCCEECCC
T ss_pred -----cCChHHhCCc-ccEEECcCCcccCcCCHHHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEECcCCcccCcCC
Confidence 5555566665 77777777777777777777777777777777777766655 6677777777777777777777
Q ss_pred Cc-ccccccceeecccCcccccCCCCcccCCcccceeccCCccCCCCCC
Q 045798 561 IF-LEALSLEYLNLSFNDFEGKIPAKGIFANASAISVVGCNRLCGGIPE 608 (1008)
Q Consensus 561 ~~-~~~~~L~~L~l~~N~l~g~~p~~~~~~~~~~~~~~~n~~l~g~~~~ 608 (1008)
.. ..+.+|+.|+|++|+++|.+|....+.++..+.+.+|+++||.|.+
T Consensus 262 ~~l~~l~~L~~L~Ls~N~l~~~ip~~~~l~~L~~l~l~~N~~lc~~p~~ 310 (313)
T 1ogq_A 262 QGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSPLP 310 (313)
T ss_dssp GGGGGCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSSSEEESTTSS
T ss_pred hHHhcCcCCCEEECcCCcccccCCCCccccccChHHhcCCCCccCCCCC
Confidence 65 5566777777777778777877766777777778888888886543
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-34 Score=325.53 Aligned_cols=265 Identities=15% Similarity=0.138 Sum_probs=136.1
Q ss_pred CcCcceEeeeccccccCCCccccccCCCCeeecccccCCCCCCCCCccccccchhhcccccCCCCCCccccCCCCCcEEE
Q 045798 125 CSRLTVLCIEYNKLQGRIPLEFVSLSKLKDLSLAKNKLTGGIPPFLGNLTSLEVLSLAGNSFGRNIPDSLGQLKQLKILA 204 (1008)
Q Consensus 125 l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 204 (1008)
++++++|++++|.++...+..|..+++|++|+|++|.+++..+..|.++++|++|+|++|++++..|..|+.+++|++|+
T Consensus 44 l~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 123 (390)
T 3o6n_A 44 LNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLV 123 (390)
T ss_dssp GCCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred cCCceEEEecCCchhhCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEE
Confidence 46666666666666644444456666666666666666655555566666666666666666555555555555555555
Q ss_pred ecCCcccccCCccccCCCCcceeccccccccccCChhhhhcCCCCcEEEeccccCCCCCCcccccCCCCceeeccccccc
Q 045798 205 IGGNNLSGPIPPSIYNLSFLVVFSVSHNQIHGSLPPSLGLLLPNLKFFQIHHNFFSGSIPISLSNASKLEHIEIANNNFS 284 (1008)
Q Consensus 205 L~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~ 284 (1008)
+++|.++...+..|.+++ +|++|+|++|.+.+..|..+..+++|++|++++|+++
T Consensus 124 L~~n~l~~l~~~~~~~l~-------------------------~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~ 178 (390)
T 3o6n_A 124 LERNDLSSLPRGIFHNTP-------------------------KLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT 178 (390)
T ss_dssp CCSSCCCCCCTTTTTTCT-------------------------TCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCS
T ss_pred CCCCccCcCCHHHhcCCC-------------------------CCcEEECCCCccCccChhhccCCCCCCEEECCCCcCC
Confidence 555555533333334444 4444444444444444444555555566666555554
Q ss_pred ccccccccCCCcccccccccccCCCCCCCcccccccccccCCCcEEEecCCcCCccCChhhhhhcccceeeeeccccccC
Q 045798 285 GKLSVNFGGMKNLSLLNLQFSNLGSGESDEMGFMNSLTNCSKLRVLSLGGNQFRGALPHSIANLSSQLQILILSSNQFYG 364 (1008)
Q Consensus 285 ~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~Ls~N~l~~ 364 (1008)
+.. +. .+++|+.|++++|.+.+. + ....|+.|++++|.+..
T Consensus 179 ~~~---~~------------------------------~l~~L~~L~l~~n~l~~~-~-----~~~~L~~L~l~~n~l~~ 219 (390)
T 3o6n_A 179 HVD---LS------------------------------LIPSLFHANVSYNLLSTL-A-----IPIAVEELDASHNSINV 219 (390)
T ss_dssp BCC---GG------------------------------GCTTCSEEECCSSCCSEE-E-----CCSSCSEEECCSSCCCE
T ss_pred ccc---cc------------------------------cccccceeeccccccccc-C-----CCCcceEEECCCCeeee
Confidence 321 12 233444444444444421 0 01135555555555542
Q ss_pred CCCCccccccccceEEecCccccCCcchhccCCCCCceEEccCCcccccccccccCCCCcceeeccccccccccCCCCcC
Q 045798 365 SIPLGIGNLVDLYLLGMVENQFTGAIPKEMGKLQKLQGLDFSGNHFSGEIPSSLGNLSSLYEVFFNNNNLSGVIPFSLGN 444 (1008)
Q Consensus 365 ~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~ 444 (1008)
. |.. ..++|+.|++++|.+++. ..+..+++|+.|+|++|.+++..|..|..+++|++|+|++|++++ +|..+..
T Consensus 220 ~-~~~--~~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~ 293 (390)
T 3o6n_A 220 V-RGP--VNVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQP 293 (390)
T ss_dssp E-ECC--CCSSCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECCSSCCCE-EECSSSC
T ss_pred c-ccc--ccccccEEECCCCCCccc--HHHcCCCCccEEECCCCcCCCcChhHccccccCCEEECCCCcCcc-cCcccCC
Confidence 1 211 123455555555555432 345555555555555555555555555555555555555555553 3334444
Q ss_pred CCcccEeeccccccc
Q 045798 445 LKRLAFLEMSGNELS 459 (1008)
Q Consensus 445 l~~L~~L~Ls~N~l~ 459 (1008)
+++|+.|+|++|+++
T Consensus 294 l~~L~~L~L~~n~l~ 308 (390)
T 3o6n_A 294 IPTLKVLDLSHNHLL 308 (390)
T ss_dssp CTTCCEEECCSSCCC
T ss_pred CCCCCEEECCCCcce
Confidence 555555555555554
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-34 Score=313.90 Aligned_cols=236 Identities=18% Similarity=0.260 Sum_probs=181.0
Q ss_pred hcCCCCC-ceEeeccCeeEEEEEEcCCCeEEEEEEeccccchhhHHHHHHHHHH-hhcCCCCceeeeeccccccccCCce
Q 045798 683 TNGFSST-HLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKAL-KNIRHRNLVKVITSCSSIDFQGNDF 760 (1008)
Q Consensus 683 ~~~y~~~-~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l-~~l~h~niv~~~~~~~~~~~~~~~~ 760 (1008)
.++|.+. +.||+|+||.||+|.+..+++.||+|+++.. ..+.+|+.++ +..+||||+++++++... ......
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~-~~~~~~ 89 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENL-YAGRKC 89 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEE-ETTEEE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhh-cCCCce
Confidence 4567777 7899999999999999889999999998632 4677888888 555999999999986432 233567
Q ss_pred EEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecC---CCC
Q 045798 761 KAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDN---DLS 837 (1008)
Q Consensus 761 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~~ 837 (1008)
.++||||+++|+|.+++...... .+++..++.++.|++.||+|||+. +|+||||||+||+++. ++.
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~~~--------~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~ 158 (299)
T 3m2w_A 90 LLIVMECLDGGELFSRIQDRGDQ--------AFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAI 158 (299)
T ss_dssp EEEEECCCCSCBHHHHHHHCTTC--------CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCC
T ss_pred EEEEEeecCCCcHHHHHHhccCC--------CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCc
Confidence 89999999999999999865421 689999999999999999999998 9999999999999998 789
Q ss_pred eEEcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHH
Q 045798 838 GHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFA 917 (1008)
Q Consensus 838 ~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~ 917 (1008)
+||+|||++.... +..++.++|||||||++|||++|+.||........
T Consensus 159 ~kl~Dfg~a~~~~--------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~------ 206 (299)
T 3m2w_A 159 LKLTDFGFAKETT--------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI------ 206 (299)
T ss_dssp EEECCCTTCEECT--------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC------------
T ss_pred EEEeccccccccc--------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhh------
Confidence 9999999986322 23467899999999999999999999864321100
Q ss_pred HhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 918 RMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 918 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
.... ....... ......+.....+.++.+++.+||+.||.+|||++|+++
T Consensus 207 ----~~~~---~~~~~~~------------~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~ 256 (299)
T 3m2w_A 207 ----SPGM---KTRIRMG------------QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 256 (299)
T ss_dssp -----CCS---CCSSCTT------------CCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ----hHHH---HHHHhhc------------cccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 0000 0000000 000000011234567899999999999999999999987
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-33 Score=338.91 Aligned_cols=136 Identities=13% Similarity=0.153 Sum_probs=92.9
Q ss_pred CcCcceEeeeccccccCCCccccccCCCCeeecccccCCCCCCCCCccccccchhhcccccCCCCCCccccCCCCCcEEE
Q 045798 125 CSRLTVLCIEYNKLQGRIPLEFVSLSKLKDLSLAKNKLTGGIPPFLGNLTSLEVLSLAGNSFGRNIPDSLGQLKQLKILA 204 (1008)
Q Consensus 125 l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 204 (1008)
+++++.|++++|.+....+..|.++++|++|+|++|.+++..|..|+++++|++|+|++|.+++..|..|+.+++|++|+
T Consensus 50 l~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 129 (597)
T 3oja_B 50 LNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLV 129 (597)
T ss_dssp GCCCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEE
Confidence 56788888888888866666677788888888888888876667777778888888887777776677777777777777
Q ss_pred ecCCcccccCCccccCCCCcceeccccccccccCChhhhhcCCCCcEEEeccccCCCCCCcccccCCCCceeeccccccc
Q 045798 205 IGGNNLSGPIPPSIYNLSFLVVFSVSHNQIHGSLPPSLGLLLPNLKFFQIHHNFFSGSIPISLSNASKLEHIEIANNNFS 284 (1008)
Q Consensus 205 L~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~ 284 (1008)
|++|.+++..+..|.++++|++|+|++|.++ +..|..+..+++|++|++++|.++
T Consensus 130 L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~-------------------------~~~~~~~~~l~~L~~L~L~~N~l~ 184 (597)
T 3oja_B 130 LERNDLSSLPRGIFHNTPKLTTLSMSNNNLE-------------------------RIEDDTFQATTSLQNLQLSSNRLT 184 (597)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-------------------------BCCTTTTTTCTTCCEEECTTSCCS
T ss_pred eeCCCCCCCCHHHhccCCCCCEEEeeCCcCC-------------------------CCChhhhhcCCcCcEEECcCCCCC
Confidence 7777776544444555555555555555544 344444555555555555555554
Q ss_pred c
Q 045798 285 G 285 (1008)
Q Consensus 285 ~ 285 (1008)
+
T Consensus 185 ~ 185 (597)
T 3oja_B 185 H 185 (597)
T ss_dssp B
T ss_pred C
Confidence 3
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-33 Score=310.30 Aligned_cols=307 Identities=28% Similarity=0.392 Sum_probs=199.3
Q ss_pred ccCCccCCeeeecCCCCCCCCCccccCCCCCCEEEccCCCCCCccCcccccCcCcceEeeeccccccCCCccccccCCCC
Q 045798 74 LGNLSFLREINLSNNTIQGEIPPEFGRLFRLEALFLSNNSLVGKIPANLSYCSRLTVLCIEYNKLQGRIPLEFVSLSKLK 153 (1008)
Q Consensus 74 l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~ 153 (1008)
+..+++|++|++++|.++ .++ .+..+++|++|++++|++++..+ +..+++|++|++++|.+++ ++ .+..+++|+
T Consensus 40 ~~~l~~L~~L~l~~~~i~-~~~-~~~~~~~L~~L~l~~n~i~~~~~--~~~l~~L~~L~L~~n~i~~-~~-~~~~l~~L~ 113 (347)
T 4fmz_A 40 QEELESITKLVVAGEKVA-SIQ-GIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKITD-IS-ALQNLTNLR 113 (347)
T ss_dssp HHHHTTCSEEECCSSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-CG-GGTTCTTCS
T ss_pred chhcccccEEEEeCCccc-cch-hhhhcCCccEEEccCCccccchh--hhcCCcCCEEEccCCcccC-ch-HHcCCCcCC
Confidence 345667777777777776 344 37777778888888777774333 7777777777777777774 33 577777777
Q ss_pred eeecccccCCCCCCCCCccccccchhhcccccCCCCCCccccCCCCCcEEEecCCcccccCCccccCCCCcceecccccc
Q 045798 154 DLSLAKNKLTGGIPPFLGNLTSLEVLSLAGNSFGRNIPDSLGQLKQLKILAIGGNNLSGPIPPSIYNLSFLVVFSVSHNQ 233 (1008)
Q Consensus 154 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ls~N~ 233 (1008)
+|++++|++++. +. +..+++|++|++++|......+ .+..+++|++|++++|.+.+..+ +..+++|+.|++++|.
T Consensus 114 ~L~l~~n~i~~~-~~-~~~l~~L~~L~l~~n~~~~~~~-~~~~l~~L~~L~l~~~~~~~~~~--~~~l~~L~~L~l~~n~ 188 (347)
T 4fmz_A 114 ELYLNEDNISDI-SP-LANLTKMYSLNLGANHNLSDLS-PLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQ 188 (347)
T ss_dssp EEECTTSCCCCC-GG-GTTCTTCCEEECTTCTTCCCCG-GGTTCTTCCEEECCSSCCCCCGG--GGGCTTCSEEECTTSC
T ss_pred EEECcCCcccCc-hh-hccCCceeEEECCCCCCccccc-chhhCCCCcEEEecCCCcCCchh--hccCCCCCEEEccCCc
Confidence 777777777743 33 6677777777777775544333 37777777777777777764333 6666777777777776
Q ss_pred ccccCChhhhhcCCCCcEEEeccccCCCCCCcccccCCCCceeecccccccccccccccCCCcccccccccccCCCCCCC
Q 045798 234 IHGSLPPSLGLLLPNLKFFQIHHNFFSGSIPISLSNASKLEHIEIANNNFSGKLSVNFGGMKNLSLLNLQFSNLGSGESD 313 (1008)
Q Consensus 234 l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~ 313 (1008)
+. .++. +..+++|+.|++++|.+.+..+ +..+++|++|++++|++++..+ +.
T Consensus 189 l~-~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~~~~--~~--------------------- 240 (347)
T 4fmz_A 189 IE-DISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP--LA--------------------- 240 (347)
T ss_dssp CC-CCGG--GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GT---------------------
T ss_pred cc-cccc--ccCCCccceeecccCCCCCCch--hhcCCcCCEEEccCCccCCCcc--hh---------------------
Confidence 65 3333 3345666666666666664333 5566666666666666654333 33
Q ss_pred cccccccccccCCCcEEEecCCcCCccCChhhhhhcccceeeeeccccccCCCCCccccccccceEEecCccccCCcchh
Q 045798 314 EMGFMNSLTNCSKLRVLSLGGNQFRGALPHSIANLSSQLQILILSSNQFYGSIPLGIGNLVDLYLLGMVENQFTGAIPKE 393 (1008)
Q Consensus 314 ~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~ 393 (1008)
.+++|++|++++|.+++ + ..+..+. +|++|++++|.+++. ..+..+++|+.|++++|++++..+..
T Consensus 241 ---------~l~~L~~L~l~~n~l~~-~-~~~~~l~-~L~~L~l~~n~l~~~--~~~~~l~~L~~L~L~~n~l~~~~~~~ 306 (347)
T 4fmz_A 241 ---------NLSQLTWLEIGTNQISD-I-NAVKDLT-KLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEV 306 (347)
T ss_dssp ---------TCTTCCEEECCSSCCCC-C-GGGTTCT-TCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCGGGHHH
T ss_pred ---------cCCCCCEEECCCCccCC-C-hhHhcCC-CcCEEEccCCccCCC--hhhcCCCCCCEEECcCCcCCCcChhH
Confidence 44445555555555542 2 2333333 366666666666532 34667777788888888877777777
Q ss_pred ccCCCCCceEEccCCcccccccccccCCCCcceeeccccccc
Q 045798 394 MGKLQKLQGLDFSGNHFSGEIPSSLGNLSSLYEVFFNNNNLS 435 (1008)
Q Consensus 394 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~ 435 (1008)
+..+++|+.|+|++|++++..| +..+++|++|++++|.|+
T Consensus 307 l~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~N~i~ 346 (347)
T 4fmz_A 307 IGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346 (347)
T ss_dssp HHTCTTCSEEECCSSSCCCCGG--GGGCTTCSEESSSCC---
T ss_pred hhccccCCEEEccCCccccccC--hhhhhccceeehhhhccc
Confidence 8888888888888888876555 777888888888888775
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-32 Score=305.73 Aligned_cols=308 Identities=24% Similarity=0.374 Sum_probs=231.2
Q ss_pred cccCCCCCCEEEccCCCCCCccCcccccCcCcceEeeeccccccCCCccccccCCCCeeecccccCCCCCCCCCcccccc
Q 045798 97 EFGRLFRLEALFLSNNSLVGKIPANLSYCSRLTVLCIEYNKLQGRIPLEFVSLSKLKDLSLAKNKLTGGIPPFLGNLTSL 176 (1008)
Q Consensus 97 ~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L 176 (1008)
.+..+++|++|++++|.+. .+| .+..+++|++|++++|++++..+ +..+++|++|++++|.++. + +.+.++++|
T Consensus 39 ~~~~l~~L~~L~l~~~~i~-~~~-~~~~~~~L~~L~l~~n~i~~~~~--~~~l~~L~~L~L~~n~i~~-~-~~~~~l~~L 112 (347)
T 4fmz_A 39 TQEELESITKLVVAGEKVA-SIQ-GIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKITD-I-SALQNLTNL 112 (347)
T ss_dssp CHHHHTTCSEEECCSSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-C-GGGTTCTTC
T ss_pred cchhcccccEEEEeCCccc-cch-hhhhcCCccEEEccCCccccchh--hhcCCcCCEEEccCCcccC-c-hHHcCCCcC
Confidence 4567889999999999988 445 38888999999999998885433 8888888888888888884 3 357788888
Q ss_pred chhhcccccCCCCCCccccCCCCCcEEEecCCcccccCCccccCCCCcceeccccccccccCChhhhhcCCCCcEEEecc
Q 045798 177 EVLSLAGNSFGRNIPDSLGQLKQLKILAIGGNNLSGPIPPSIYNLSFLVVFSVSHNQIHGSLPPSLGLLLPNLKFFQIHH 256 (1008)
Q Consensus 177 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~~~lp~~~~~~l~~L~~L~L~~ 256 (1008)
++|++++|.+.+..+ +..+++|+.|++++|..... +..+..+++|++|++++|.+. .++. +..+++|+.|++++
T Consensus 113 ~~L~l~~n~i~~~~~--~~~l~~L~~L~l~~n~~~~~-~~~~~~l~~L~~L~l~~~~~~-~~~~--~~~l~~L~~L~l~~ 186 (347)
T 4fmz_A 113 RELYLNEDNISDISP--LANLTKMYSLNLGANHNLSD-LSPLSNMTGLNYLTVTESKVK-DVTP--IANLTDLYSLSLNY 186 (347)
T ss_dssp SEEECTTSCCCCCGG--GTTCTTCCEEECTTCTTCCC-CGGGTTCTTCCEEECCSSCCC-CCGG--GGGCTTCSEEECTT
T ss_pred CEEECcCCcccCchh--hccCCceeEEECCCCCCccc-ccchhhCCCCcEEEecCCCcC-Cchh--hccCCCCCEEEccC
Confidence 888888888865433 77788888888888755433 333667777777777777665 2322 23355555555555
Q ss_pred ccCCCCCCcccccCCCCceeecccccccccccccccCCCcccccccccccCCCCCCCcccccccccccCCCcEEEecCCc
Q 045798 257 NFFSGSIPISLSNASKLEHIEIANNNFSGKLSVNFGGMKNLSLLNLQFSNLGSGESDEMGFMNSLTNCSKLRVLSLGGNQ 336 (1008)
Q Consensus 257 N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~ 336 (1008)
|.+.+..+ +..+++|+.|++++| .+.... .+..+++|++|++++|+
T Consensus 187 n~l~~~~~--~~~l~~L~~L~l~~n------------------------~l~~~~--------~~~~~~~L~~L~l~~n~ 232 (347)
T 4fmz_A 187 NQIEDISP--LASLTSLHYFTAYVN------------------------QITDIT--------PVANMTRLNSLKIGNNK 232 (347)
T ss_dssp SCCCCCGG--GGGCTTCCEEECCSS------------------------CCCCCG--------GGGGCTTCCEEECCSSC
T ss_pred Cccccccc--ccCCCccceeecccC------------------------CCCCCc--------hhhcCCcCCEEEccCCc
Confidence 55543222 444444555554444 443322 25567788899999999
Q ss_pred CCccCChhhhhhcccceeeeeccccccCCCCCccccccccceEEecCccccCCcchhccCCCCCceEEccCCcccccccc
Q 045798 337 FRGALPHSIANLSSQLQILILSSNQFYGSIPLGIGNLVDLYLLGMVENQFTGAIPKEMGKLQKLQGLDFSGNHFSGEIPS 416 (1008)
Q Consensus 337 l~~~~p~~~~~l~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~ 416 (1008)
+++ ++. +..+. +|++|++++|.+++. ..+..+++|+.|++++|++++. +.+..+++|+.|+|++|++++..|.
T Consensus 233 l~~-~~~-~~~l~-~L~~L~l~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~L~~n~l~~~~~~ 305 (347)
T 4fmz_A 233 ITD-LSP-LANLS-QLTWLEIGTNQISDI--NAVKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDME 305 (347)
T ss_dssp CCC-CGG-GTTCT-TCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCGGGHH
T ss_pred cCC-Ccc-hhcCC-CCCEEECCCCccCCC--hhHhcCCCcCEEEccCCccCCC--hhhcCCCCCCEEECcCCcCCCcChh
Confidence 884 343 66665 699999999999853 5689999999999999999975 5689999999999999999988999
Q ss_pred cccCCCCcceeeccccccccccCCCCcCCCcccEeeccccccc
Q 045798 417 SLGNLSSLYEVFFNNNNLSGVIPFSLGNLKRLAFLEMSGNELS 459 (1008)
Q Consensus 417 ~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 459 (1008)
.+..+++|++|++++|.+++..| +..+++|+.|++++|.++
T Consensus 306 ~l~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~N~i~ 346 (347)
T 4fmz_A 306 VIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346 (347)
T ss_dssp HHHTCTTCSEEECCSSSCCCCGG--GGGCTTCSEESSSCC---
T ss_pred HhhccccCCEEEccCCccccccC--hhhhhccceeehhhhccc
Confidence 99999999999999999998777 889999999999999986
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-34 Score=317.63 Aligned_cols=196 Identities=21% Similarity=0.190 Sum_probs=160.0
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEecccc--------chhhHHHHHHHHHHhhcC---------CCCcee
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC--------EGASKSFMAECKALKNIR---------HRNLVK 745 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~---------h~niv~ 745 (1008)
.++|++.+.||+|+||+||+|++ +|+.||||+++... ....+.+.+|++++++++ ||||++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred cccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 46789999999999999999998 68999999997542 223377899999999886 666666
Q ss_pred eeecc-----------------cc--------ccccCCceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHH
Q 045798 746 VITSC-----------------SS--------IDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRIS 800 (1008)
Q Consensus 746 ~~~~~-----------------~~--------~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~ 800 (1008)
+.+++ .. .++.+++..|+||||+++|++.+.+... .+++..++.
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~~-----------~~~~~~~~~ 165 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTK-----------LSSLATAKS 165 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTTT-----------CCCHHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHhc-----------CCCHHHHHH
Confidence 55542 21 0012367899999999999777766432 679999999
Q ss_pred HHHHHHHHHHHHh-hCCCCCceeccCCCCCeeecCCC--------------------CeEEcccCcccccccccCccccc
Q 045798 801 IAIDVASALDYLH-HHCQEPILHCDLKPSNILLDNDL--------------------SGHIGDFGLARFHQEVSNSTLSS 859 (1008)
Q Consensus 801 i~~qi~~~L~~LH-~~~~~~ivH~Dlkp~NIll~~~~--------------------~~kL~Dfg~a~~~~~~~~~~~~~ 859 (1008)
++.||+.||+||| +. +|+||||||+|||++.++ .+||+|||+|+.....
T Consensus 166 i~~qi~~aL~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------- 235 (336)
T 2vuw_A 166 ILHQLTASLAVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------- 235 (336)
T ss_dssp HHHHHHHHHHHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------
T ss_pred HHHHHHHHHHHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------
Confidence 9999999999999 87 999999999999999887 8999999999865432
Q ss_pred cccccccccccCccccCCCCCCcccchhhHHHH-HHHHHhCCCCCC
Q 045798 860 SVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGIL-LLEMVTAKKPTD 904 (1008)
Q Consensus 860 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~v-l~elltG~~pf~ 904 (1008)
...||+.|+|||++.+.. +.++||||+|++ .+++++|..||.
T Consensus 236 --~~~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~ 278 (336)
T 2vuw_A 236 --IVVFCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYS 278 (336)
T ss_dssp --EEECCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHH
T ss_pred --cEEEeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCc
Confidence 235899999999998766 889999998777 788888999974
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.98 E-value=3.5e-31 Score=294.23 Aligned_cols=293 Identities=23% Similarity=0.283 Sum_probs=179.6
Q ss_pred cCCeeeecCCCCCCCCCccccCCCCCCEEEccCCCCCCccCcccccCcCcceEeeeccccccCCCccccccCCCCeeecc
Q 045798 79 FLREINLSNNTIQGEIPPEFGRLFRLEALFLSNNSLVGKIPANLSYCSRLTVLCIEYNKLQGRIPLEFVSLSKLKDLSLA 158 (1008)
Q Consensus 79 ~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~ 158 (1008)
+|+.++++++.++ .+|..+. ++|++|+|++|.+++..|..|+++++|++|+|++|++++..|..|.++++|++|+++
T Consensus 34 ~l~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 110 (332)
T 2ft3_A 34 HLRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYIS 110 (332)
T ss_dssp ETTEEECCSSCCS-SCCSCCC--TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECC
T ss_pred cCCEEECCCCCcc-ccCCCCC--CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECC
Confidence 4667777777776 5665553 577777777777776666677777777777777777777667777778888888888
Q ss_pred cccCCCCCCCCCccccccchhhcccccCCCCCCccccCCCCCcEEEecCCccc--ccCCccccCCCCcceeccccccccc
Q 045798 159 KNKLTGGIPPFLGNLTSLEVLSLAGNSFGRNIPDSLGQLKQLKILAIGGNNLS--GPIPPSIYNLSFLVVFSVSHNQIHG 236 (1008)
Q Consensus 159 ~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~--~~~~~~~~~l~~L~~L~ls~N~l~~ 236 (1008)
+|+++ .+|..+. ++|++|++++|++....+..|..+++|+.|++++|.++ +..+..+..+ +|+.|++++|+++
T Consensus 111 ~n~l~-~l~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l~- 185 (332)
T 2ft3_A 111 KNHLV-EIPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLT- 185 (332)
T ss_dssp SSCCC-SCCSSCC--TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBCS-
T ss_pred CCcCC-ccCcccc--ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECcCCCCC-
Confidence 88877 5555554 67888888888887766677888888888888888885 3667777777 8888888888887
Q ss_pred cCChhhhhcCCCCcEEEeccccCCCCCCcccccCCCCceeecccccccccccccccCCCcccccccccccCCCCCCCccc
Q 045798 237 SLPPSLGLLLPNLKFFQIHHNFFSGSIPISLSNASKLEHIEIANNNFSGKLSVNFGGMKNLSLLNLQFSNLGSGESDEMG 316 (1008)
Q Consensus 237 ~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~ 316 (1008)
.+|..++ ++|++|++++|.+++..+..+..+++|++|++++|++.+..+..
T Consensus 186 ~l~~~~~---~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~-------------------------- 236 (332)
T 2ft3_A 186 GIPKDLP---ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGS-------------------------- 236 (332)
T ss_dssp SCCSSSC---SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTG--------------------------
T ss_pred ccCcccc---CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhH--------------------------
Confidence 4555432 45555555555555444455555555555555555555443333
Q ss_pred ccccccccCCCcEEEecCCcCCccCChhhhhhcccceeeeeccccccCCCCCccccccccceEEecCccccCCcchhccC
Q 045798 317 FMNSLTNCSKLRVLSLGGNQFRGALPHSIANLSSQLQILILSSNQFYGSIPLGIGNLVDLYLLGMVENQFTGAIPKEMGK 396 (1008)
Q Consensus 317 ~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~ 396 (1008)
+..+++|+.|++++|+++ .+|..+..+. +|++|++++|++++..+..|....- -..
T Consensus 237 ----~~~l~~L~~L~L~~N~l~-~lp~~l~~l~-~L~~L~l~~N~l~~~~~~~~~~~~~------------------~~~ 292 (332)
T 2ft3_A 237 ----LSFLPTLRELHLDNNKLS-RVPAGLPDLK-LLQVVYLHTNNITKVGVNDFCPVGF------------------GVK 292 (332)
T ss_dssp ----GGGCTTCCEEECCSSCCC-BCCTTGGGCT-TCCEEECCSSCCCBCCTTSSSCSSC------------------CSS
T ss_pred ----hhCCCCCCEEECCCCcCe-ecChhhhcCc-cCCEEECCCCCCCccChhHcccccc------------------ccc
Confidence 334444555555555554 4444444443 3555555555554333333322100 001
Q ss_pred CCCCceEEccCCccc--ccccccccCCCCcceeecccc
Q 045798 397 LQKLQGLDFSGNHFS--GEIPSSLGNLSSLYEVFFNNN 432 (1008)
Q Consensus 397 l~~L~~L~Ls~N~l~--~~~p~~~~~l~~L~~L~l~~N 432 (1008)
..+|+.|++++|.+. +..|..|..+++|+.+++++|
T Consensus 293 ~~~l~~L~l~~N~~~~~~~~~~~~~~l~~L~~l~l~~n 330 (332)
T 2ft3_A 293 RAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNY 330 (332)
T ss_dssp SCCBSEEECCSSSSCGGGSCGGGGTTBCCSTTEEC---
T ss_pred cccccceEeecCcccccccCcccccccchhhhhhcccc
Confidence 234555555555554 344555555555666655555
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3e-31 Score=294.60 Aligned_cols=289 Identities=20% Similarity=0.233 Sum_probs=173.6
Q ss_pred CcceeccccccccccCChhhhhcCCCCcEEEeccccCCCCCCcccccCCCCceeecccccccccccccccCCCccccccc
Q 045798 223 FLVVFSVSHNQIHGSLPPSLGLLLPNLKFFQIHHNFFSGSIPISLSNASKLEHIEIANNNFSGKLSVNFGGMKNLSLLNL 302 (1008)
Q Consensus 223 ~L~~L~ls~N~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 302 (1008)
+++.++++++.++ .+|..+ .++|++|+|++|.+++..+..+.++++|++|++++|++++..+..|.++++|+.|++
T Consensus 32 ~l~~l~~~~~~l~-~lp~~~---~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 107 (330)
T 1xku_A 32 HLRVVQCSDLGLE-KVPKDL---PPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYL 107 (330)
T ss_dssp ETTEEECTTSCCC-SCCCSC---CTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEEC
T ss_pred CCeEEEecCCCcc-ccCccC---CCCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEEC
Confidence 4555666666655 555443 246677777777777655566777777777777777777766666766666666666
Q ss_pred ccccCCCCCCCcccccccccccCCCcEEEecCCcCCccCChhhhhhcccceeeeeccccccC--CCCCccccccccceEE
Q 045798 303 QFSNLGSGESDEMGFMNSLTNCSKLRVLSLGGNQFRGALPHSIANLSSQLQILILSSNQFYG--SIPLGIGNLVDLYLLG 380 (1008)
Q Consensus 303 ~~n~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~ 380 (1008)
++|+++.++.. + .++|++|++++|++++..+..+..+. +|++|++++|.+.. ..+..+..+++|+.|+
T Consensus 108 s~n~l~~l~~~-------~--~~~L~~L~l~~n~l~~~~~~~~~~l~-~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~ 177 (330)
T 1xku_A 108 SKNQLKELPEK-------M--PKTLQELRVHENEITKVRKSVFNGLN-QMIVVELGTNPLKSSGIENGAFQGMKKLSYIR 177 (330)
T ss_dssp CSSCCSBCCSS-------C--CTTCCEEECCSSCCCBBCHHHHTTCT-TCCEEECCSSCCCGGGBCTTGGGGCTTCCEEE
T ss_pred CCCcCCccChh-------h--cccccEEECCCCcccccCHhHhcCCc-cccEEECCCCcCCccCcChhhccCCCCcCEEE
Confidence 66666544322 1 14667777777777654444555554 47777777776642 4555566666666666
Q ss_pred ecCccccCCcchhccCCCCCceEEccCCcccccccccccCCCCcceeeccccccccccCCCCcCCCcccEeecccccccC
Q 045798 381 MVENQFTGAIPKEMGKLQKLQGLDFSGNHFSGEIPSSLGNLSSLYEVFFNNNNLSGVIPFSLGNLKRLAFLEMSGNELSG 460 (1008)
Q Consensus 381 L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 460 (1008)
+++|+++. +|..+. ++|+.|+|++|++++..|..+..+++|+.|++++|.+++..+..|..+++|+.|+|++|+++
T Consensus 178 l~~n~l~~-l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~- 253 (330)
T 1xku_A 178 IADTNITT-IPQGLP--PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV- 253 (330)
T ss_dssp CCSSCCCS-CCSSCC--TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-
T ss_pred CCCCcccc-CCcccc--ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCc-
Confidence 66666663 333332 56666666666666555566666666666666666666555556666666666666666665
Q ss_pred CcchhhhhhhhhhhhhcccCccccCCCcccccccccccccccccccccCCCCccccc------ccccceeeccCccccc-
Q 045798 461 TIPEDIFNISYLSNSLNLARNHLVGIIPPRIGNLRALRSFDVSNNDLSGEIPIELGH------CSSLEEIYLAGNLFHG- 533 (1008)
Q Consensus 461 ~lp~~~~~~~~~~~~L~L~~N~l~~~~p~~~~~l~~L~~Ldls~N~l~~~~p~~~~~------l~~L~~L~L~~N~l~~- 533 (1008)
.+|..+..+++|+.|++++|.+++..+..|.. ...|+.|++++|++..
T Consensus 254 -------------------------~lp~~l~~l~~L~~L~l~~N~i~~~~~~~f~~~~~~~~~~~l~~l~l~~N~~~~~ 308 (330)
T 1xku_A 254 -------------------------KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYW 308 (330)
T ss_dssp -------------------------SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGG
T ss_pred -------------------------cCChhhccCCCcCEEECCCCcCCccChhhcCCcccccccccccceEeecCccccc
Confidence 34445555666666666666666444444432 2556666666666642
Q ss_pred -chhhhhhccccccEEecCCCc
Q 045798 534 -SIPSFFNALKGVQKIDLSRNN 554 (1008)
Q Consensus 534 -~~p~~~~~l~~L~~L~ls~N~ 554 (1008)
..|..|..+..|+.++|++|+
T Consensus 309 ~i~~~~f~~~~~l~~l~L~~N~ 330 (330)
T 1xku_A 309 EIQPSTFRCVYVRAAVQLGNYK 330 (330)
T ss_dssp GSCGGGGTTCCCGGGEEC----
T ss_pred ccCccccccccceeEEEecccC
Confidence 345566666666666666663
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.97 E-value=4.4e-35 Score=342.06 Aligned_cols=386 Identities=17% Similarity=0.139 Sum_probs=236.7
Q ss_pred cccchhhcccccCCCCCCcc-ccCCCCCcEEEecCCcccc----cCCccccCCCCcceeccccccccccCChhhhhcCC-
Q 045798 174 TSLEVLSLAGNSFGRNIPDS-LGQLKQLKILAIGGNNLSG----PIPPSIYNLSFLVVFSVSHNQIHGSLPPSLGLLLP- 247 (1008)
Q Consensus 174 ~~L~~L~L~~n~l~~~~~~~-~~~l~~L~~L~L~~n~l~~----~~~~~~~~l~~L~~L~ls~N~l~~~lp~~~~~~l~- 247 (1008)
++|++|+|++|+++...... +..+++|++|++++|.+++ .++..+..+++|++|++++|.+.+..+..++..++
T Consensus 3 ~~l~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~ 82 (461)
T 1z7x_W 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQT 82 (461)
T ss_dssp EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCS
T ss_pred ccceehhhhhcccCchhHHHHHhhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHhh
Confidence 45566666666654333222 5566666677777666653 23455666677777777777766444455555555
Q ss_pred ---CCcEEEeccccCCC----CCCcccccCCCCceeeccccccccccccccc-----CCCcccccccccccCCCCCCCcc
Q 045798 248 ---NLKFFQIHHNFFSG----SIPISLSNASKLEHIEIANNNFSGKLSVNFG-----GMKNLSLLNLQFSNLGSGESDEM 315 (1008)
Q Consensus 248 ---~L~~L~L~~N~l~~----~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~-----~l~~L~~L~L~~n~l~~~~~~~~ 315 (1008)
+|++|+|++|.+.. .++..+..+++|++|++++|.+.+..+..+. ..++|+.|++++|+++.... .
T Consensus 83 ~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~--~ 160 (461)
T 1z7x_W 83 PSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASC--E 160 (461)
T ss_dssp TTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGH--H
T ss_pred CCCceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHH--H
Confidence 57777777777763 4467777788888888888887655443332 24456666666666554221 1
Q ss_pred cccccccccCCCcEEEecCCcCCccCChhhhhh----cccceeeeeccccccCC----CCCccccccccceEEecCcccc
Q 045798 316 GFMNSLTNCSKLRVLSLGGNQFRGALPHSIANL----SSQLQILILSSNQFYGS----IPLGIGNLVDLYLLGMVENQFT 387 (1008)
Q Consensus 316 ~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l----~~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~L~~n~l~ 387 (1008)
.+...+..+++|+.|++++|.+....+..+... ..+|++|++++|.+++. ++..+..+++|+.|++++|.+.
T Consensus 161 ~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~ 240 (461)
T 1z7x_W 161 PLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLG 240 (461)
T ss_dssp HHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCH
T ss_pred HHHHHHhhCCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCcCC
Confidence 223345566777777777777764444433321 12577777777766642 3445555666666666666665
Q ss_pred CCc-----chhccCCCCCceEEccCCccccc----ccccccCCCCcceeeccccccccccCCCCcC-----CCcccEeec
Q 045798 388 GAI-----PKEMGKLQKLQGLDFSGNHFSGE----IPSSLGNLSSLYEVFFNNNNLSGVIPFSLGN-----LKRLAFLEM 453 (1008)
Q Consensus 388 ~~~-----~~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~-----l~~L~~L~L 453 (1008)
+.. +..+..+++|+.|+|++|++++. ++..+..+++|++|++++|.+....+..+.. .++|+.|+|
T Consensus 241 ~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L 320 (461)
T 1z7x_W 241 DVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWV 320 (461)
T ss_dssp HHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEEC
T ss_pred hHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHHHhccCCccceeeEc
Confidence 432 22223456666666666666542 4455555666666666666665433322222 245666666
Q ss_pred ccccccCCcchhhhhhhhhhhhhcccCccccCCCcccccccccccccccccccccCCCCccccc-----ccccceeeccC
Q 045798 454 SGNELSGTIPEDIFNISYLSNSLNLARNHLVGIIPPRIGNLRALRSFDVSNNDLSGEIPIELGH-----CSSLEEIYLAG 528 (1008)
Q Consensus 454 s~N~l~~~lp~~~~~~~~~~~~L~L~~N~l~~~~p~~~~~l~~L~~Ldls~N~l~~~~p~~~~~-----l~~L~~L~L~~ 528 (1008)
++|.+++.... .++..+..+++|+.|||++|.+++..+..+.. .++|++|+|++
T Consensus 321 ~~n~l~~~~~~---------------------~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~ 379 (461)
T 1z7x_W 321 KSCSFTAACCS---------------------HFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLAD 379 (461)
T ss_dssp TTSCCBGGGHH---------------------HHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTT
T ss_pred CCCCCchHHHH---------------------HHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCC
Confidence 66665521000 24566777889999999999988665555543 67999999999
Q ss_pred ccccc----chhhhhhccccccEEecCCCcccccccCc------ccccccceeecccCcccccC
Q 045798 529 NLFHG----SIPSFFNALKGVQKIDLSRNNLSGQIPIF------LEALSLEYLNLSFNDFEGKI 582 (1008)
Q Consensus 529 N~l~~----~~p~~~~~l~~L~~L~ls~N~l~~~~p~~------~~~~~L~~L~l~~N~l~g~~ 582 (1008)
|++++ .+|..+..+++|+.|||++|++++.-... .....|+.|++.+|.+....
T Consensus 380 n~i~~~~~~~l~~~l~~~~~L~~L~l~~N~i~~~~~~~l~~~l~~~~~~L~~L~~~~~~~~~~~ 443 (461)
T 1z7x_W 380 CDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEM 443 (461)
T ss_dssp SCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCCCHHH
T ss_pred CCCChhhHHHHHHHHHhCCCccEEECCCCCCCHHHHHHHHHHhccCCcchhheeecccccCHHH
Confidence 99986 78899999999999999999988642111 11235777777777665543
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.3e-31 Score=293.32 Aligned_cols=179 Identities=22% Similarity=0.290 Sum_probs=100.7
Q ss_pred CCCEEEccCCCCCCccCcccccCcCcceEeeeccccccCCCccccccCCCCeeecccccCCCCCCCCCccccccchhhcc
Q 045798 103 RLEALFLSNNSLVGKIPANLSYCSRLTVLCIEYNKLQGRIPLEFVSLSKLKDLSLAKNKLTGGIPPFLGNLTSLEVLSLA 182 (1008)
Q Consensus 103 ~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 182 (1008)
+|++|+|++|++++..+..|+++++|++|+|++|++++..|..|.++++|++|++++|+++ .+|..+. ++|++|+++
T Consensus 53 ~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~--~~L~~L~l~ 129 (330)
T 1xku_A 53 DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-ELPEKMP--KTLQELRVH 129 (330)
T ss_dssp TCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCS-BCCSSCC--TTCCEEECC
T ss_pred CCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECCCCcCC-ccChhhc--ccccEEECC
Confidence 4444444444444433334444444444444444444444445555555555555555555 3343333 456666666
Q ss_pred cccCCCCCCccccCCCCCcEEEecCCcccc--cCCccccCCCCcceeccccccccccCChhhhhcCCCCcEEEeccccCC
Q 045798 183 GNSFGRNIPDSLGQLKQLKILAIGGNNLSG--PIPPSIYNLSFLVVFSVSHNQIHGSLPPSLGLLLPNLKFFQIHHNFFS 260 (1008)
Q Consensus 183 ~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~--~~~~~~~~l~~L~~L~ls~N~l~~~lp~~~~~~l~~L~~L~L~~N~l~ 260 (1008)
+|++++..+..|..+++|+.|++++|.++. ..+..+.++++|++|++++|.++ .+|..++ ++|++|++++|.++
T Consensus 130 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~-~l~~~~~---~~L~~L~l~~n~l~ 205 (330)
T 1xku_A 130 ENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGLP---PSLTELHLDGNKIT 205 (330)
T ss_dssp SSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCC-SCCSSCC---TTCSEEECTTSCCC
T ss_pred CCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCccc-cCCcccc---ccCCEEECCCCcCC
Confidence 666655555566666777777777776642 55566666677777777777666 4554432 46666666666666
Q ss_pred CCCCcccccCCCCceeeccccccccccc
Q 045798 261 GSIPISLSNASKLEHIEIANNNFSGKLS 288 (1008)
Q Consensus 261 ~~~p~~l~~l~~L~~L~L~~N~l~~~~~ 288 (1008)
+..|..+..+++|++|++++|++++..+
T Consensus 206 ~~~~~~~~~l~~L~~L~Ls~n~l~~~~~ 233 (330)
T 1xku_A 206 KVDAASLKGLNNLAKLGLSFNSISAVDN 233 (330)
T ss_dssp EECTGGGTTCTTCCEEECCSSCCCEECT
T ss_pred ccCHHHhcCCCCCCEEECCCCcCceeCh
Confidence 5555556666666666666666554443
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.4e-31 Score=295.52 Aligned_cols=288 Identities=20% Similarity=0.221 Sum_probs=178.8
Q ss_pred CCCeeecccccCCCCCCCCCccccccchhhcccccCCCCCCccccCCCCCcEEEecCCcccccCCccccCCCCcceeccc
Q 045798 151 KLKDLSLAKNKLTGGIPPFLGNLTSLEVLSLAGNSFGRNIPDSLGQLKQLKILAIGGNNLSGPIPPSIYNLSFLVVFSVS 230 (1008)
Q Consensus 151 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ls 230 (1008)
+|+.+++++|.++ .+|..+. ++|+.|++++|.+.+..+..|..+++|++|++++|.+++..|..|.++++|++|+++
T Consensus 34 ~l~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 110 (332)
T 2ft3_A 34 HLRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYIS 110 (332)
T ss_dssp ETTEEECCSSCCS-SCCSCCC--TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECC
T ss_pred cCCEEECCCCCcc-ccCCCCC--CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECC
Confidence 4555566655555 4444443 456666666666655555566666666666666666666556666666666666666
Q ss_pred cccccccCChhhhhcCCCCcEEEeccccCCCCCCcccccCCCCceeecccccccc--cccccccCCCcccccccccccCC
Q 045798 231 HNQIHGSLPPSLGLLLPNLKFFQIHHNFFSGSIPISLSNASKLEHIEIANNNFSG--KLSVNFGGMKNLSLLNLQFSNLG 308 (1008)
Q Consensus 231 ~N~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~--~~~~~~~~l~~L~~L~L~~n~l~ 308 (1008)
+|+++ .+|..++ ++|++|++++|.+.+..+..+.++++|++|++++|.+.. ..+..|..+ +|+.|++++|+++
T Consensus 111 ~n~l~-~l~~~~~---~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l~ 185 (332)
T 2ft3_A 111 KNHLV-EIPPNLP---SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLT 185 (332)
T ss_dssp SSCCC-SCCSSCC---TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBCS
T ss_pred CCcCC-ccCcccc---ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECcCCCCC
Confidence 66665 5555543 567777777777765555566777777777777777753 555556665 6666666666665
Q ss_pred CCCCCcccccccccccCCCcEEEecCCcCCccCChhhhhhcccceeeeeccccccCCCCCccccccccceEEecCccccC
Q 045798 309 SGESDEMGFMNSLTNCSKLRVLSLGGNQFRGALPHSIANLSSQLQILILSSNQFYGSIPLGIGNLVDLYLLGMVENQFTG 388 (1008)
Q Consensus 309 ~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~ 388 (1008)
.++.. + .++|+.|++++|++++..+..+..+. +|++|+|++|++++..+..+..+++|+.|++++|+++
T Consensus 186 ~l~~~-------~--~~~L~~L~l~~n~i~~~~~~~l~~l~-~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~- 254 (332)
T 2ft3_A 186 GIPKD-------L--PETLNELHLDHNKIQAIELEDLLRYS-KLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS- 254 (332)
T ss_dssp SCCSS-------S--CSSCSCCBCCSSCCCCCCTTSSTTCT-TCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-
T ss_pred ccCcc-------c--cCCCCEEECCCCcCCccCHHHhcCCC-CCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-
Confidence 54322 1 14566666666666655555565554 4777777777776665666667777777777777776
Q ss_pred CcchhccCCCCCceEEccCCcccccccccccCC------CCcceeeccccccc--cccCCCCcCCCcccEeeccccc
Q 045798 389 AIPKEMGKLQKLQGLDFSGNHFSGEIPSSLGNL------SSLYEVFFNNNNLS--GVIPFSLGNLKRLAFLEMSGNE 457 (1008)
Q Consensus 389 ~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l------~~L~~L~l~~N~l~--~~~p~~~~~l~~L~~L~Ls~N~ 457 (1008)
.+|..+..+++|+.|+|++|++++..+..|... .+|+.|++++|.+. +..|..|..+++|+.|++++|+
T Consensus 255 ~lp~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~l~~L~l~~N~~~~~~~~~~~~~~l~~L~~l~l~~n~ 331 (332)
T 2ft3_A 255 RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331 (332)
T ss_dssp BCCTTGGGCTTCCEEECCSSCCCBCCTTSSSCSSCCSSSCCBSEEECCSSSSCGGGSCGGGGTTBCCSTTEEC----
T ss_pred ecChhhhcCccCCEEECCCCCCCccChhHccccccccccccccceEeecCcccccccCcccccccchhhhhhccccc
Confidence 566667777777777777777765555555432 45667777777665 4556666667777777776664
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.97 E-value=4.8e-35 Score=341.74 Aligned_cols=356 Identities=19% Similarity=0.157 Sum_probs=210.2
Q ss_pred cCCeeeecCCCCCCCCCcc-ccCCCCCCEEEccCCCCCC----ccCcccccCcCcceEeeeccccccCCCcccc-ccC--
Q 045798 79 FLREINLSNNTIQGEIPPE-FGRLFRLEALFLSNNSLVG----KIPANLSYCSRLTVLCIEYNKLQGRIPLEFV-SLS-- 150 (1008)
Q Consensus 79 ~L~~L~L~~n~~~~~~p~~-~~~l~~L~~L~Ls~n~l~~----~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~-~l~-- 150 (1008)
.|++|+|++|+++...... +..+++|++|+|++|++++ .++..+..+++|++|+|++|.+.+..+..+. .++
T Consensus 4 ~l~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~ 83 (461)
T 1z7x_W 4 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP 83 (461)
T ss_dssp EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCST
T ss_pred cceehhhhhcccCchhHHHHHhhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHhhC
Confidence 4555555555554322222 4455555555555555552 2344455555566666666555543333322 233
Q ss_pred --CCCeeecccccCCC----CCCCCCccccccchhhcccccCCCCCCcccc-----CCCCCcEEEecCCcccccC----C
Q 045798 151 --KLKDLSLAKNKLTG----GIPPFLGNLTSLEVLSLAGNSFGRNIPDSLG-----QLKQLKILAIGGNNLSGPI----P 215 (1008)
Q Consensus 151 --~L~~L~L~~n~l~~----~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~-----~l~~L~~L~L~~n~l~~~~----~ 215 (1008)
+|++|+|++|+++. .++..+..+++|++|+|++|.++...+..+. ..++|++|++++|.+++.. +
T Consensus 84 ~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~ 163 (461)
T 1z7x_W 84 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLA 163 (461)
T ss_dssp TCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHH
T ss_pred CCceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHHHHH
Confidence 46666666666552 2355555666666666666665433232222 2456777777777776532 4
Q ss_pred ccccCCCCcceeccccccccccCChhhhh----cCCCCcEEEeccccCCCC----CCcccccCCCCceeecccccccccc
Q 045798 216 PSIYNLSFLVVFSVSHNQIHGSLPPSLGL----LLPNLKFFQIHHNFFSGS----IPISLSNASKLEHIEIANNNFSGKL 287 (1008)
Q Consensus 216 ~~~~~l~~L~~L~ls~N~l~~~lp~~~~~----~l~~L~~L~L~~N~l~~~----~p~~l~~l~~L~~L~L~~N~l~~~~ 287 (1008)
..+..+++|++|++++|.+.+..+..+.. ..++|++|+|++|.+++. ++..+..+++|++|++++|++.+..
T Consensus 164 ~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~ 243 (461)
T 1z7x_W 164 SVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVG 243 (461)
T ss_dssp HHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHH
T ss_pred HHHhhCCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCcCChHH
Confidence 45556677777777777766433333322 345788888888877753 4666677788888888888877543
Q ss_pred -----cccccCCCcccccccccccCCCCCCCcccccccccccCCCcEEEecCCcCCccCChhhhhhc----ccceeeeec
Q 045798 288 -----SVNFGGMKNLSLLNLQFSNLGSGESDEMGFMNSLTNCSKLRVLSLGGNQFRGALPHSIANLS----SQLQILILS 358 (1008)
Q Consensus 288 -----~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~----~~L~~L~Ls 358 (1008)
+..+..+++|+.|++++|+++..+.. .++..+..+++|++|++++|.+.+..+..+.... .+|++|+|+
T Consensus 244 ~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~--~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~ 321 (461)
T 1z7x_W 244 MAELCPGLLHPSSRLRTLWIWECGITAKGCG--DLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVK 321 (461)
T ss_dssp HHHHHHHHTSTTCCCCEEECTTSCCCHHHHH--HHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECT
T ss_pred HHHHHHHHhcCCCCceEEECcCCCCCHHHHH--HHHHHHhhCCCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcC
Confidence 22233567777777777766542211 1334556677888888888877654444444331 257777777
Q ss_pred cccccCC----CCCccccccccceEEecCccccCCcchhccC-----CCCCceEEccCCcccc----cccccccCCCCcc
Q 045798 359 SNQFYGS----IPLGIGNLVDLYLLGMVENQFTGAIPKEMGK-----LQKLQGLDFSGNHFSG----EIPSSLGNLSSLY 425 (1008)
Q Consensus 359 ~N~l~~~----~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~-----l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~ 425 (1008)
+|.+++. ++..+..+++|+.|++++|++++..+..+.. .++|+.|+|++|++++ .+|..+..+++|+
T Consensus 322 ~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~ 401 (461)
T 1z7x_W 322 SCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLR 401 (461)
T ss_dssp TSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCC
T ss_pred CCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCCChhhHHHHHHHHHhCCCcc
Confidence 7777644 3445556677777777777776554444432 5577777777777764 5666666677777
Q ss_pred eeecccccccc
Q 045798 426 EVFFNNNNLSG 436 (1008)
Q Consensus 426 ~L~l~~N~l~~ 436 (1008)
+|++++|.+++
T Consensus 402 ~L~l~~N~i~~ 412 (461)
T 1z7x_W 402 ELDLSNNCLGD 412 (461)
T ss_dssp EEECCSSSCCH
T ss_pred EEECCCCCCCH
Confidence 77777777664
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.8e-30 Score=291.07 Aligned_cols=261 Identities=21% Similarity=0.233 Sum_probs=208.0
Q ss_pred CCCCCCCCCCcccceEEcCCCCeEEEEeccccCCCCccCcCccCCccCCeeeecCCCCCCCCCccccCCCCCCEEEccCC
Q 045798 33 NSWNDSRHFCEWEGITCGRRHRRVTALDLMSKSLSGSLSPHLGNLSFLREINLSNNTIQGEIPPEFGRLFRLEALFLSNN 112 (1008)
Q Consensus 33 ~~w~~~~~~c~w~gv~c~~~~~~v~~l~l~~~~l~~~l~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n 112 (1008)
..|....+.|.|.|+ |+ .++++++ .+|..+. ++|++|+|++|++++..+..|.++++|++|+|++|
T Consensus 21 ~~~~~~~~~C~~~~~-c~----------~~~~~l~-~iP~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n 86 (353)
T 2z80_A 21 ESSNQASLSCDRNGI-CK----------GSSGSLN-SIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSN 86 (353)
T ss_dssp ------CCEECTTSE-EE----------CCSTTCS-SCCTTCC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTS
T ss_pred cCCCccCCCCCCCeE-ee----------CCCCCcc-ccccccc--ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCC
Confidence 356667788999887 64 3456666 6777665 48999999999999777779999999999999999
Q ss_pred CCCCccCcccccCcCcceEeeeccccccCCCccccccCCCCeeecccccCCCCCC-CCCccccccchhhcccc-cCCCCC
Q 045798 113 SLVGKIPANLSYCSRLTVLCIEYNKLQGRIPLEFVSLSKLKDLSLAKNKLTGGIP-PFLGNLTSLEVLSLAGN-SFGRNI 190 (1008)
Q Consensus 113 ~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~L~~n-~l~~~~ 190 (1008)
++++..|..|+++++|++|+|++|++++..+..|.++++|++|++++|++++..+ ..+.++++|++|++++| .+....
T Consensus 87 ~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~ 166 (353)
T 2z80_A 87 GINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQ 166 (353)
T ss_dssp CCCEECTTTTTTCTTCCEEECCSSCCSSCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEEC
T ss_pred ccCccCHhhcCCCCCCCEEECCCCcCCcCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCccccccC
Confidence 9998888999999999999999999997666669999999999999999995433 48999999999999999 577777
Q ss_pred CccccCCCCCcEEEecCCcccccCCccccCCCCcceeccccccccccCChhhhhcCCCCcEEEeccccCCCCCCcccc--
Q 045798 191 PDSLGQLKQLKILAIGGNNLSGPIPPSIYNLSFLVVFSVSHNQIHGSLPPSLGLLLPNLKFFQIHHNFFSGSIPISLS-- 268 (1008)
Q Consensus 191 ~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~l~-- 268 (1008)
+..|..+++|++|++++|.+++..|..+..+++|++|++++|++. .+|..++..+++|+.|++++|.+++..+..+.
T Consensus 167 ~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~-~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~ 245 (353)
T 2z80_A 167 RKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI-LLLEIFVDVTSSVECLELRDTDLDTFHFSELSTG 245 (353)
T ss_dssp TTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSCST-THHHHHHHHTTTEEEEEEESCBCTTCCCC-----
T ss_pred HHHccCCCCCCEEECCCCCcCccCHHHHhccccCCeecCCCCccc-cchhhhhhhcccccEEECCCCccccccccccccc
Confidence 889999999999999999999999999999999999999999996 78888887789999999999999976555443
Q ss_pred -cCCCCceeeccccccccc----ccccccCCCcccccccccccCC
Q 045798 269 -NASKLEHIEIANNNFSGK----LSVNFGGMKNLSLLNLQFSNLG 308 (1008)
Q Consensus 269 -~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~L~~n~l~ 308 (1008)
....++.++++++.+.+. .+..+..+++|+.|++++|+++
T Consensus 246 ~~~~~l~~l~L~~~~l~~~~l~~l~~~l~~l~~L~~L~Ls~N~l~ 290 (353)
T 2z80_A 246 ETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLK 290 (353)
T ss_dssp -CCCCCCEEEEESCBCCHHHHHHHHHHHHTCTTCCEEECCSSCCC
T ss_pred cccchhhccccccccccCcchhhhHHHHhcccCCCEEECCCCCCC
Confidence 345666677777666542 2333444444444444444444
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.96 E-value=3.3e-29 Score=274.91 Aligned_cols=240 Identities=21% Similarity=0.261 Sum_probs=191.3
Q ss_pred CCCCCcccceEEcCCCCeEEEEeccccCCCCccCcCccCCccCCeeeecCCCCCCCCCccccCCCCCCEEEccCCCCCCc
Q 045798 38 SRHFCEWEGITCGRRHRRVTALDLMSKSLSGSLSPHLGNLSFLREINLSNNTIQGEIPPEFGRLFRLEALFLSNNSLVGK 117 (1008)
Q Consensus 38 ~~~~c~w~gv~c~~~~~~v~~l~l~~~~l~~~l~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~ 117 (1008)
..+.|.|.++.|.. ++++ .+|..+. ++|++|+|++|+++...+..|.++++|++|+|++|.++..
T Consensus 3 ~~C~C~~~~l~c~~------------~~l~-~ip~~~~--~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~ 67 (306)
T 2z66_A 3 SRCSCSGTEIRCNS------------KGLT-SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFK 67 (306)
T ss_dssp TTCEEETTEEECCS------------SCCS-SCCSCCC--TTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEE
T ss_pred CCCeeCCCEEEcCC------------CCcc-cCCCCCC--CCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcc
Confidence 34668898888854 2344 4565543 6899999999999955555689999999999999999833
Q ss_pred --cCcccccCcCcceEeeeccccccCCCccccccCCCCeeecccccCCCCCC-CCCccccccchhhcccccCCCCCCccc
Q 045798 118 --IPANLSYCSRLTVLCIEYNKLQGRIPLEFVSLSKLKDLSLAKNKLTGGIP-PFLGNLTSLEVLSLAGNSFGRNIPDSL 194 (1008)
Q Consensus 118 --~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~L~~n~l~~~~~~~~ 194 (1008)
.|..+..+++|++|+|++|.+. .+|..+..+++|++|++++|++++..+ ..+..+++|++|++++|.+.+..+..|
T Consensus 68 ~~~~~~~~~~~~L~~L~Ls~n~i~-~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~ 146 (306)
T 2z66_A 68 GCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIF 146 (306)
T ss_dssp EEEEHHHHSCSCCCEEECCSCSEE-EEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTT
T ss_pred cCcccccccccccCEEECCCCccc-cChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhc
Confidence 3677888999999999999998 577789999999999999999996554 578899999999999999988888889
Q ss_pred cCCCCCcEEEecCCcccc-cCCccccCCCCcceeccccccccccCChhhhhcCCCCcEEEeccccCCCCCCcccccCCCC
Q 045798 195 GQLKQLKILAIGGNNLSG-PIPPSIYNLSFLVVFSVSHNQIHGSLPPSLGLLLPNLKFFQIHHNFFSGSIPISLSNASKL 273 (1008)
Q Consensus 195 ~~l~~L~~L~L~~n~l~~-~~~~~~~~l~~L~~L~ls~N~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L 273 (1008)
..+++|++|++++|.+++ ..|..+..+++|++|++++|++++..|. .+..+++|++|+|++|.+++..+..+..+++|
T Consensus 147 ~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~-~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L 225 (306)
T 2z66_A 147 NGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPT-AFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSL 225 (306)
T ss_dssp TTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTT-TTTTCTTCCEEECTTSCCSBCCSGGGTTCTTC
T ss_pred ccCcCCCEEECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHH-HhcCCCCCCEEECCCCccCccChhhccCcccC
Confidence 999999999999999986 5788888888888888888888744343 33447778888888887776666667777777
Q ss_pred ceeecccccccccccccccCC
Q 045798 274 EHIEIANNNFSGKLSVNFGGM 294 (1008)
Q Consensus 274 ~~L~L~~N~l~~~~~~~~~~l 294 (1008)
++|++++|++.+..+..+..+
T Consensus 226 ~~L~L~~N~l~~~~~~~~~~~ 246 (306)
T 2z66_A 226 QVLDYSLNHIMTSKKQELQHF 246 (306)
T ss_dssp CEEECTTSCCCBCSSSSCCCC
T ss_pred CEeECCCCCCcccCHHHHHhh
Confidence 777777777776665555443
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.3e-31 Score=323.36 Aligned_cols=435 Identities=15% Similarity=0.134 Sum_probs=213.8
Q ss_pred CCcccceEEcCCCCeEEEEeccccCCCCccCcCccCCccCCeeeecCCCC---CCCCCcccc------------CCCCCC
Q 045798 41 FCEWEGITCGRRHRRVTALDLMSKSLSGSLSPHLGNLSFLREINLSNNTI---QGEIPPEFG------------RLFRLE 105 (1008)
Q Consensus 41 ~c~w~gv~c~~~~~~v~~l~l~~~~l~~~l~~~l~~l~~L~~L~L~~n~~---~~~~p~~~~------------~l~~L~ 105 (1008)
|++|.++.+... .++ .+.. ......+..+..+++|++|+|+++.. .+.+|..++ .+++|+
T Consensus 41 ck~W~~~~~~~~-~~l---~~~~-~~~~~~~~~~~~~~~L~~L~L~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~L~ 115 (592)
T 3ogk_B 41 CRRWFKIDSETR-EHV---TMAL-CYTATPDRLSRRFPNLRSLKLKGKPRAAMFNLIPENWGGYVTPWVTEISNNLRQLK 115 (592)
T ss_dssp CHHHHHHHHHHC-CEE---EESC-GGGSCHHHHHHHCTTCSEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCC
T ss_pred hHHHHHhhhccc-cEE---EEee-ccccChHHHHHhCCCCeEEEecCCcchhhcccccccccccchHHHHHHHhhCCCCC
Confidence 458998854322 122 2221 12223344556778889999877532 124444333 566677
Q ss_pred EEEccCCCCCCccCcccccC--cCcceEeeeccc-ccc-CCCccccccCCCCeeecccccCCCCCCCCCccccccchhhc
Q 045798 106 ALFLSNNSLVGKIPANLSYC--SRLTVLCIEYNK-LQG-RIPLEFVSLSKLKDLSLAKNKLTGGIPPFLGNLTSLEVLSL 181 (1008)
Q Consensus 106 ~L~Ls~n~l~~~~p~~l~~l--~~L~~L~Ls~n~-l~~-~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 181 (1008)
+|+|++|.+++..+..++.. .+|++|+|++|. ++. .++....++++|++|+|++|.+++....+
T Consensus 116 ~L~L~~~~i~~~~~~~l~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~------------ 183 (592)
T 3ogk_B 116 SVHFRRMIVSDLDLDRLAKARADDLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKW------------ 183 (592)
T ss_dssp EEEEESCBCCHHHHHHHHHHHGGGCCEEEEESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHH------------
T ss_pred eEEeeccEecHHHHHHHHHhccccCcEEECcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhH------------
Confidence 77777766665555555543 336666666665 211 11122234556666666666554331110
Q ss_pred ccccCCCCCCccccCCCCCcEEEecCCccc----ccCCccccCCCCcceeccccccccccCChhhhhcCCCCcEEEeccc
Q 045798 182 AGNSFGRNIPDSLGQLKQLKILAIGGNNLS----GPIPPSIYNLSFLVVFSVSHNQIHGSLPPSLGLLLPNLKFFQIHHN 257 (1008)
Q Consensus 182 ~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~----~~~~~~~~~l~~L~~L~ls~N~l~~~lp~~~~~~l~~L~~L~L~~N 257 (1008)
++..+..+++|+.|++++|.++ +.++..+.++++|+.|++++|.+. .+|. .+..+++|+.|+++++
T Consensus 184 --------l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~-~l~~-~~~~~~~L~~L~l~~~ 253 (592)
T 3ogk_B 184 --------LHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEIL-ELVG-FFKAAANLEEFCGGSL 253 (592)
T ss_dssp --------HHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGG-GGHH-HHHHCTTCCEEEECBC
T ss_pred --------HHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHH-HHHH-HHhhhhHHHhhccccc
Confidence 1112233444444444444443 122223334445555555555444 2332 2223455555555432
Q ss_pred cCC---CCCCcccccCCCCceeecccccccccccccccCCCcccccccccccCCCCCCCcccccccccccCCCcEEEecC
Q 045798 258 FFS---GSIPISLSNASKLEHIEIANNNFSGKLSVNFGGMKNLSLLNLQFSNLGSGESDEMGFMNSLTNCSKLRVLSLGG 334 (1008)
Q Consensus 258 ~l~---~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~ 334 (1008)
... ...+..+..+++|+.|+++++... ..+..+..+++|+.|+|++|.++... +...+..+++|+.|+++
T Consensus 254 ~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~-~l~~~~~~~~~L~~L~Ls~~~l~~~~-----~~~~~~~~~~L~~L~L~- 326 (592)
T 3ogk_B 254 NEDIGMPEKYMNLVFPRKLCRLGLSYMGPN-EMPILFPFAAQIRKLDLLYALLETED-----HCTLIQKCPNLEVLETR- 326 (592)
T ss_dssp CCCTTCTTSSSCCCCCTTCCEEEETTCCTT-TGGGGGGGGGGCCEEEETTCCCCHHH-----HHHHHTTCTTCCEEEEE-
T ss_pred ccccchHHHHHHhhccccccccCccccchh-HHHHHHhhcCCCcEEecCCCcCCHHH-----HHHHHHhCcCCCEEecc-
Confidence 211 122334455555665555553221 22333333334444444433321110 11112344444444444
Q ss_pred CcCCccCChhhhhhcccceeeeeccccccCCCCCccccccccceEEecC-----------ccccCC-cchhccCCCCCce
Q 045798 335 NQFRGALPHSIANLSSQLQILILSSNQFYGSIPLGIGNLVDLYLLGMVE-----------NQFTGA-IPKEMGKLQKLQG 402 (1008)
Q Consensus 335 N~l~~~~p~~~~~l~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~-----------n~l~~~-~~~~~~~l~~L~~ 402 (1008)
+.+. .+.++..+..+++|+.|++++ |.+++. ++..+..+++|++
T Consensus 327 ~~~~------------------------~~~l~~~~~~~~~L~~L~L~~g~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~ 382 (592)
T 3ogk_B 327 NVIG------------------------DRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEY 382 (592)
T ss_dssp GGGH------------------------HHHHHHHHHHCTTCCEEEEECCCCSSTTSSTTCCCCHHHHHHHHHHCTTCSE
T ss_pred CccC------------------------HHHHHHHHHhCCCCCEEEeecCccccccccccCccCHHHHHHHHhhCccCeE
Confidence 2222 111122223334444444441 333322 1122334566666
Q ss_pred EEccCCcccccccccccC-CCCcceeecc----ccccccc-----cCCCCcCCCcccEeeccccc--ccCCcchhhhhhh
Q 045798 403 LDFSGNHFSGEIPSSLGN-LSSLYEVFFN----NNNLSGV-----IPFSLGNLKRLAFLEMSGNE--LSGTIPEDIFNIS 470 (1008)
Q Consensus 403 L~Ls~N~l~~~~p~~~~~-l~~L~~L~l~----~N~l~~~-----~p~~~~~l~~L~~L~Ls~N~--l~~~lp~~~~~~~ 470 (1008)
|+|+.|.+++..+..+.. +++|+.|+++ .|.+++. ++..+.++++|+.|++++|. +++
T Consensus 383 L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~---------- 452 (592)
T 3ogk_B 383 MAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTD---------- 452 (592)
T ss_dssp EEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCSSCCCHHHHHHHHHHCTTCCEEEEECCGGGCCH----------
T ss_pred EEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccccCchHHHHHHHHHHhCCCCCEEEEecCCCCccH----------
Confidence 666666665554444443 5566666664 4455432 22234556777777776432 432
Q ss_pred hhhhhhcccCccccCCCccccc-ccccccccccccccccC-CCCcccccccccceeeccCcccccc-hhhhhhccccccE
Q 045798 471 YLSNSLNLARNHLVGIIPPRIG-NLRALRSFDVSNNDLSG-EIPIELGHCSSLEEIYLAGNLFHGS-IPSFFNALKGVQK 547 (1008)
Q Consensus 471 ~~~~~L~L~~N~l~~~~p~~~~-~l~~L~~Ldls~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~ 547 (1008)
..+..++ .+++|+.|+|++|.+++ .++..+..+++|++|+|++|.+++. ++..+..+++|+.
T Consensus 453 ---------------~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~ 517 (592)
T 3ogk_B 453 ---------------LGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRY 517 (592)
T ss_dssp ---------------HHHHHHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBHHHHHHHHHHCSSCCE
T ss_pred ---------------HHHHHHHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcHHHHHHHHHhcCccCe
Confidence 1122222 26678888888888775 3455556778888888888888755 4555677888999
Q ss_pred EecCCCccccc
Q 045798 548 IDLSRNNLSGQ 558 (1008)
Q Consensus 548 L~ls~N~l~~~ 558 (1008)
|+|++|++++.
T Consensus 518 L~ls~n~it~~ 528 (592)
T 3ogk_B 518 LWVQGYRASMT 528 (592)
T ss_dssp EEEESCBCCTT
T ss_pred eECcCCcCCHH
Confidence 99999988764
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.96 E-value=1e-30 Score=288.80 Aligned_cols=277 Identities=18% Similarity=0.272 Sum_probs=221.7
Q ss_pred cCCCCCCCCCCC--CCCCCcccceEEcCCCCeEEEEeccccCCCCccCcCc--cCCccCCeeeecCCCCCCCCCccccCC
Q 045798 26 HEPQGILNSWND--SRHFCEWEGITCGRRHRRVTALDLMSKSLSGSLSPHL--GNLSFLREINLSNNTIQGEIPPEFGRL 101 (1008)
Q Consensus 26 ~~~~~~~~~w~~--~~~~c~w~gv~c~~~~~~v~~l~l~~~~l~~~l~~~l--~~l~~L~~L~L~~n~~~~~~p~~~~~l 101 (1008)
.|+..++..|.. ..++|.|.+.-|.............+.... .++..+ .....+++|+|++|+++ .+|..+.++
T Consensus 26 ~~~~~aLl~~k~~~~~~~~~~~~~w~~~~~~~~~~~~~~g~~~~-~~~~~l~~~~~~~l~~L~L~~n~l~-~lp~~l~~l 103 (328)
T 4fcg_A 26 RPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIETRTGRALK-ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRL 103 (328)
T ss_dssp CCHHHHHHHHHHHHHHCCTTHHHHHHHHTTTCTTSCCSHHHHHH-HHHHHHHHHTSTTCCEEEEESSCCS-SCCSCGGGG
T ss_pred chHHHHHHHHHHhccCCchhhhhhhcccccccccccccCCcchh-hhHHHHhcccccceeEEEccCCCch-hcChhhhhC
Confidence 455556777865 357889988776321110000001111000 111111 23578999999999999 889999999
Q ss_pred CCCCEEEccCCCCCCccCcccccCcCcceEeeeccccccCCCccccccCCCCeeecccccCCCCCCCCCcc---------
Q 045798 102 FRLEALFLSNNSLVGKIPANLSYCSRLTVLCIEYNKLQGRIPLEFVSLSKLKDLSLAKNKLTGGIPPFLGN--------- 172 (1008)
Q Consensus 102 ~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~--------- 172 (1008)
++|++|+|++|.++ .+|..++.+++|++|+|++|+++ .+|..|.++++|++|+|++|++.+.+|..++.
T Consensus 104 ~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~~~~~~~~~~ 181 (328)
T 4fcg_A 104 SHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQG 181 (328)
T ss_dssp TTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEETTCCCCCSCSEEEC-CCCEEE
T ss_pred CCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECCCCCCccccChhHhhccchhhhcc
Confidence 99999999999999 89999999999999999999999 78999999999999999999988899988765
Q ss_pred ccccchhhcccccCCCCCCccccCCCCCcEEEecCCcccccCCccccCCCCcceeccccccccccCChhhhhcCCCCcEE
Q 045798 173 LTSLEVLSLAGNSFGRNIPDSLGQLKQLKILAIGGNNLSGPIPPSIYNLSFLVVFSVSHNQIHGSLPPSLGLLLPNLKFF 252 (1008)
Q Consensus 173 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~~~lp~~~~~~l~~L~~L 252 (1008)
+++|++|+|++|+++ .+|..++.+++|++|+|++|.+++ +|..+..+++|++|++++|.+.+.+|..+. .+++|++|
T Consensus 182 l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~-l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~-~l~~L~~L 258 (328)
T 4fcg_A 182 LVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCTALRNYPPIFG-GRAPLKRL 258 (328)
T ss_dssp STTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCC-CCGGGGGCTTCCEEECTTCTTCCBCCCCTT-CCCCCCEE
T ss_pred CCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCCc-CchhhccCCCCCEEECcCCcchhhhHHHhc-CCCCCCEE
Confidence 889999999999996 778889999999999999999985 566788899999999999988888877654 47889999
Q ss_pred EeccccCCCCCCcccccCCCCceeecccccccccccccccCCCcccccccccccCCC
Q 045798 253 QIHHNFFSGSIPISLSNASKLEHIEIANNNFSGKLSVNFGGMKNLSLLNLQFSNLGS 309 (1008)
Q Consensus 253 ~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~ 309 (1008)
+|++|.+.+.+|..+.++++|++|++++|++.+..|..+..+++|+.+++..+.+..
T Consensus 259 ~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~~L~~L~~l~l~~~~~~~ 315 (328)
T 4fcg_A 259 ILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQ 315 (328)
T ss_dssp ECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCCGGGGGSCTTCEEECCGGGSCC
T ss_pred ECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhccHHHhhccCceEEeCCHHHHHH
Confidence 999988888888888899999999999998888888888888888888877665543
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.2e-28 Score=270.42 Aligned_cols=250 Identities=20% Similarity=0.212 Sum_probs=122.1
Q ss_pred ceeccccccccccCChhhhhcCCCCcEEEeccccCCCCCCcccccCCCCceeecccccccccccccccCCCccccccccc
Q 045798 225 VVFSVSHNQIHGSLPPSLGLLLPNLKFFQIHHNFFSGSIPISLSNASKLEHIEIANNNFSGKLSVNFGGMKNLSLLNLQF 304 (1008)
Q Consensus 225 ~~L~ls~N~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~ 304 (1008)
+.++++++.++ .+|..+. ++|++|+|++|.++...+..+.++++|++|++++|++.....
T Consensus 10 ~~l~c~~~~l~-~ip~~~~---~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~---------------- 69 (306)
T 2z66_A 10 TEIRCNSKGLT-SVPTGIP---SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGC---------------- 69 (306)
T ss_dssp TEEECCSSCCS-SCCSCCC---TTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEE----------------
T ss_pred CEEEcCCCCcc-cCCCCCC---CCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccC----------------
Confidence 34566666665 5554332 355555555555553333334445555555555554432110
Q ss_pred ccCCCCCCCcccccccccccCCCcEEEecCCcCCccCChhhhhhcccceeeeeccccccCCCC-CccccccccceEEecC
Q 045798 305 SNLGSGESDEMGFMNSLTNCSKLRVLSLGGNQFRGALPHSIANLSSQLQILILSSNQFYGSIP-LGIGNLVDLYLLGMVE 383 (1008)
Q Consensus 305 n~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~L~~ 383 (1008)
.+..+..+++|++|++++|.+. .+|..+..+. +|++|++++|.+++..+ ..+..+++|++|++++
T Consensus 70 ------------~~~~~~~~~~L~~L~Ls~n~i~-~l~~~~~~l~-~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~ 135 (306)
T 2z66_A 70 ------------CSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLE-QLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISH 135 (306)
T ss_dssp ------------EEHHHHSCSCCCEEECCSCSEE-EEEEEEETCT-TCCEEECTTSEEESSTTTTTTTTCTTCCEEECTT
T ss_pred ------------cccccccccccCEEECCCCccc-cChhhcCCCC-CCCEEECCCCcccccccchhhhhccCCCEEECCC
Confidence 0112233445555555555554 3333344333 35555555555553332 3455555555555555
Q ss_pred ccccCCcchhccCCCCCceEEccCCcccc-cccccccCCCCcceeeccccccccccCCCCcCCCcccEeecccccccCCc
Q 045798 384 NQFTGAIPKEMGKLQKLQGLDFSGNHFSG-EIPSSLGNLSSLYEVFFNNNNLSGVIPFSLGNLKRLAFLEMSGNELSGTI 462 (1008)
Q Consensus 384 n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~l 462 (1008)
|.+.+..+..+..+++|++|+|++|.+++ .+|..+..+++|++|++++|.+++..|..|..+++|+.|+|++|++++
T Consensus 136 n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~-- 213 (306)
T 2z66_A 136 THTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFS-- 213 (306)
T ss_dssp SCCEECSTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSB--
T ss_pred CcCCccchhhcccCcCCCEEECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCc--
Confidence 55555555555555555555555555543 344455555555555555555554445555555555555555555442
Q ss_pred chhhhhhhhhhhhhcccCccccCCCcccccccccccccccccccccCCCCcccccc-cccceeeccCccccc
Q 045798 463 PEDIFNISYLSNSLNLARNHLVGIIPPRIGNLRALRSFDVSNNDLSGEIPIELGHC-SSLEEIYLAGNLFHG 533 (1008)
Q Consensus 463 p~~~~~~~~~~~~L~L~~N~l~~~~p~~~~~l~~L~~Ldls~N~l~~~~p~~~~~l-~~L~~L~L~~N~l~~ 533 (1008)
..+..+..+++|+.|||++|.+++..|..+..+ ++|++|+|++|++++
T Consensus 214 -----------------------~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~ 262 (306)
T 2z66_A 214 -----------------------LDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFAC 262 (306)
T ss_dssp -----------------------CCSGGGTTCTTCCEEECTTSCCCBCSSSSCCCCCTTCCEEECTTCCEEC
T ss_pred -----------------------cChhhccCcccCCEeECCCCCCcccCHHHHHhhhccCCEEEccCCCeec
Confidence 222234445555555555555555555555554 255555555555554
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.1e-31 Score=321.36 Aligned_cols=398 Identities=14% Similarity=0.099 Sum_probs=272.8
Q ss_pred CeEEEEeccccCC---CCccCcCcc------------CCccCCeeeecCCCCCCCCCccccCC--CCCCEEEccCCC-CC
Q 045798 54 RRVTALDLMSKSL---SGSLSPHLG------------NLSFLREINLSNNTIQGEIPPEFGRL--FRLEALFLSNNS-LV 115 (1008)
Q Consensus 54 ~~v~~l~l~~~~l---~~~l~~~l~------------~l~~L~~L~L~~n~~~~~~p~~~~~l--~~L~~L~Ls~n~-l~ 115 (1008)
.+++.|+|.++.. .+.+|..++ .+++|++|+|++|.+++..+..+... .+|++|+|++|. ++
T Consensus 73 ~~L~~L~L~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~L~~L~L~~~~~~~ 152 (592)
T 3ogk_B 73 PNLRSLKLKGKPRAAMFNLIPENWGGYVTPWVTEISNNLRQLKSVHFRRMIVSDLDLDRLAKARADDLETLKLDKCSGFT 152 (592)
T ss_dssp TTCSEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCCEEEEESCBCCHHHHHHHHHHHGGGCCEEEEESCEEEE
T ss_pred CCCeEEEecCCcchhhcccccccccccchHHHHHHHhhCCCCCeEEeeccEecHHHHHHHHHhccccCcEEECcCCCCcC
Confidence 4588999977532 133443333 78999999999999887766667663 449999999997 32
Q ss_pred C-ccCcccccCcCcceEeeeccccccC----CCccccccCCCCeeecccccCCC----CCCCCCccccccchhhcccccC
Q 045798 116 G-KIPANLSYCSRLTVLCIEYNKLQGR----IPLEFVSLSKLKDLSLAKNKLTG----GIPPFLGNLTSLEVLSLAGNSF 186 (1008)
Q Consensus 116 ~-~~p~~l~~l~~L~~L~Ls~n~l~~~----~p~~~~~l~~L~~L~L~~n~l~~----~~~~~~~~l~~L~~L~L~~n~l 186 (1008)
. .++..+..+++|++|+|++|.+++. ++..+..+++|++|++++|.+++ .++..+.++++|++|++++|.+
T Consensus 153 ~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~ 232 (592)
T 3ogk_B 153 TDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEI 232 (592)
T ss_dssp HHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBG
T ss_pred HHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccH
Confidence 1 2233345889999999999999866 44456678999999999999973 3344456789999999999998
Q ss_pred CCCCCccccCCCCCcEEEecCCccc---ccCCccccCCCCcceeccccccccccCChhhhhcCCCCcEEEeccccCCCCC
Q 045798 187 GRNIPDSLGQLKQLKILAIGGNNLS---GPIPPSIYNLSFLVVFSVSHNQIHGSLPPSLGLLLPNLKFFQIHHNFFSGSI 263 (1008)
Q Consensus 187 ~~~~~~~~~~l~~L~~L~L~~n~l~---~~~~~~~~~l~~L~~L~ls~N~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~ 263 (1008)
.+ ++..+..+++|+.|+++.+... ...+..+..+++|+.|+++++... .+|.. +..+++|++|+|++|.+++..
T Consensus 233 ~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~-~l~~~-~~~~~~L~~L~Ls~~~l~~~~ 309 (592)
T 3ogk_B 233 LE-LVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGPN-EMPIL-FPFAAQIRKLDLLYALLETED 309 (592)
T ss_dssp GG-GHHHHHHCTTCCEEEECBCCCCTTCTTSSSCCCCCTTCCEEEETTCCTT-TGGGG-GGGGGGCCEEEETTCCCCHHH
T ss_pred HH-HHHHHhhhhHHHhhcccccccccchHHHHHHhhccccccccCccccchh-HHHHH-HhhcCCCcEEecCCCcCCHHH
Confidence 65 7788999999999999864333 344567788889999999886543 45543 344788999999999876543
Q ss_pred C-cccccCCCCceeecccccccc-cccccccCCCccccccccc-----------ccCCCCCCCcccccccccccCCCcEE
Q 045798 264 P-ISLSNASKLEHIEIANNNFSG-KLSVNFGGMKNLSLLNLQF-----------SNLGSGESDEMGFMNSLTNCSKLRVL 330 (1008)
Q Consensus 264 p-~~l~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~L~~-----------n~l~~~~~~~~~~~~~l~~l~~L~~L 330 (1008)
. ..+..+++|++|+++ +.+.+ ..+..+..+++|+.|++++ |.++.. ++......+++|+.|
T Consensus 310 ~~~~~~~~~~L~~L~L~-~~~~~~~l~~~~~~~~~L~~L~L~~g~~~~~~~~~~~~~~~~-----~~~~l~~~~~~L~~L 383 (592)
T 3ogk_B 310 HCTLIQKCPNLEVLETR-NVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQR-----GLIALAQGCQELEYM 383 (592)
T ss_dssp HHHHHTTCTTCCEEEEE-GGGHHHHHHHHHHHCTTCCEEEEECCCCSSTTSSTTCCCCHH-----HHHHHHHHCTTCSEE
T ss_pred HHHHHHhCcCCCEEecc-CccCHHHHHHHHHhCCCCCEEEeecCccccccccccCccCHH-----HHHHHHhhCccCeEE
Confidence 3 335788899999998 44433 3333345678888888883 344321 111223457788888
Q ss_pred EecCCcCCccCChhhhhhcccceeeeec----cccccCC-----CCCccccccccceEEecCcc--ccCCcchhcc-CCC
Q 045798 331 SLGGNQFRGALPHSIANLSSQLQILILS----SNQFYGS-----IPLGIGNLVDLYLLGMVENQ--FTGAIPKEMG-KLQ 398 (1008)
Q Consensus 331 ~Ls~N~l~~~~p~~~~~l~~~L~~L~Ls----~N~l~~~-----~p~~~~~l~~L~~L~L~~n~--l~~~~~~~~~-~l~ 398 (1008)
+++.|.+++..+..+....++|+.|+++ .|.+++. ++..+..+++|+.|++++|. +++..+..+. .++
T Consensus 384 ~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~~~~~~~~~~~ 463 (592)
T 3ogk_B 384 AVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSP 463 (592)
T ss_dssp EEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCSSCCCHHHHHHHHHHCTTCCEEEEECCGGGCCHHHHHHHHHSCT
T ss_pred EeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccccCchHHHHHHHHHHhCCCCCEEEEecCCCCccHHHHHHHHHhCc
Confidence 8888888766666666533468888885 5566642 22235567777777776433 5544444443 367
Q ss_pred CCceEEccCCcccc-cccccccCCCCcceeeccccccccc-cCCCCcCCCcccEeecccccccC
Q 045798 399 KLQGLDFSGNHFSG-EIPSSLGNLSSLYEVFFNNNNLSGV-IPFSLGNLKRLAFLEMSGNELSG 460 (1008)
Q Consensus 399 ~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~l~~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~ 460 (1008)
+|+.|+|++|++++ .++..+.++++|++|++++|.+++. ++..+..+++|++|+|++|++++
T Consensus 464 ~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ls~n~it~ 527 (592)
T 3ogk_B 464 NVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRASM 527 (592)
T ss_dssp TCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBHHHHHHHHHHCSSCCEEEEESCBCCT
T ss_pred cceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcHHHHHHHHHhcCccCeeECcCCcCCH
Confidence 77777777777765 3344456667777777777776543 33334556777777777777663
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.3e-28 Score=290.10 Aligned_cols=292 Identities=25% Similarity=0.349 Sum_probs=181.3
Q ss_pred CCCCCCCCCCCCcccceEE------cCCCCeEEEEeccccCCCCccCcCccCCccCCeeeecCCCCCCCCCccccCCCCC
Q 045798 31 ILNSWNDSRHFCEWEGITC------GRRHRRVTALDLMSKSLSGSLSPHLGNLSFLREINLSNNTIQGEIPPEFGRLFRL 104 (1008)
Q Consensus 31 ~~~~w~~~~~~c~w~gv~c------~~~~~~v~~l~l~~~~l~~~l~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L 104 (1008)
..+.|....+||.|+|..| .+....++.|++++++++ .+|..+. ++|++|+|++|+++ .+|. .+++|
T Consensus 11 ~w~~W~~~~~~~~~~~r~~~~~~~~~c~~~~l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~-~lp~---~l~~L 83 (622)
T 3g06_A 11 VWSAWRRAAPAEESRGRAAVVQKMRACLNNGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPA---LPPEL 83 (622)
T ss_dssp HHHHHHHTCCGGGHHHHHHHHHHHHHHHHHCCCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCS-CCCC---CCTTC
T ss_pred HHHHHHhcCCcchhccccccCcccccccCCCCcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCC-CCCC---cCCCC
Confidence 3456877889999977432 112234677777777777 6666665 67777777777777 4554 46777
Q ss_pred CEEEccCCCCCCccCcccccCcCcceEeeeccccccCCCccccccCCCCeeecccccCCCCCCCCCccccccchhhcccc
Q 045798 105 EALFLSNNSLVGKIPANLSYCSRLTVLCIEYNKLQGRIPLEFVSLSKLKDLSLAKNKLTGGIPPFLGNLTSLEVLSLAGN 184 (1008)
Q Consensus 105 ~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n 184 (1008)
++|+|++|+|+ .+|. .+++|++|+|++|++++ +|. .+++|+.|++++|+|+ .+|.. +++|++|+|++|
T Consensus 84 ~~L~Ls~N~l~-~lp~---~l~~L~~L~Ls~N~l~~-l~~---~l~~L~~L~L~~N~l~-~lp~~---l~~L~~L~Ls~N 151 (622)
T 3g06_A 84 RTLEVSGNQLT-SLPV---LPPGLLELSIFSNPLTH-LPA---LPSGLCKLWIFGNQLT-SLPVL---PPGLQELSVSDN 151 (622)
T ss_dssp CEEEECSCCCS-CCCC---CCTTCCEEEECSCCCCC-CCC---CCTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSS
T ss_pred CEEEcCCCcCC-cCCC---CCCCCCEEECcCCcCCC-CCC---CCCCcCEEECCCCCCC-cCCCC---CCCCCEEECcCC
Confidence 77777777777 4554 56777777777777764 333 3566677777777766 34443 255666666666
Q ss_pred cCCCCCCccccCCCCCcEEEecCCcccccCCccccCCCCcceeccccccccccCChhhhhcCCCCcEEEeccccCCCCCC
Q 045798 185 SFGRNIPDSLGQLKQLKILAIGGNNLSGPIPPSIYNLSFLVVFSVSHNQIHGSLPPSLGLLLPNLKFFQIHHNFFSGSIP 264 (1008)
Q Consensus 185 ~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p 264 (1008)
++++ +|. .+++|+.|++++|.+++ +| ..+++|+.|+|++|.+++ +|
T Consensus 152 ~l~~-l~~---~~~~L~~L~L~~N~l~~-------------------------l~----~~~~~L~~L~Ls~N~l~~-l~ 197 (622)
T 3g06_A 152 QLAS-LPA---LPSELCKLWAYNNQLTS-------------------------LP----MLPSGLQELSVSDNQLAS-LP 197 (622)
T ss_dssp CCSC-CCC---CCTTCCEEECCSSCCSC-------------------------CC----CCCTTCCEEECCSSCCSC-CC
T ss_pred cCCC-cCC---ccCCCCEEECCCCCCCC-------------------------Cc----ccCCCCcEEECCCCCCCC-CC
Confidence 6543 222 23445555555555543 33 123455555555555552 23
Q ss_pred cccccCCCCceeecccccccccccccccCCCcccccccccccCCCCCCCcccccccccccCCCcEEEecCCcCCccCChh
Q 045798 265 ISLSNASKLEHIEIANNNFSGKLSVNFGGMKNLSLLNLQFSNLGSGESDEMGFMNSLTNCSKLRVLSLGGNQFRGALPHS 344 (1008)
Q Consensus 265 ~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~ 344 (1008)
.. +++|+.|++++|.++.+.. .+++|+.|++++|++++ +|..
T Consensus 198 ~~---~~~L~~L~L~~N~l~~l~~----------------------------------~~~~L~~L~Ls~N~L~~-lp~~ 239 (622)
T 3g06_A 198 TL---PSELYKLWAYNNRLTSLPA----------------------------------LPSGLKELIVSGNRLTS-LPVL 239 (622)
T ss_dssp CC---CTTCCEEECCSSCCSSCCC----------------------------------CCTTCCEEECCSSCCSC-CCCC
T ss_pred Cc---cchhhEEECcCCcccccCC----------------------------------CCCCCCEEEccCCccCc-CCCC
Confidence 21 2455666666665553211 11345566666666653 4411
Q ss_pred hhhhcccceeeeeccccccCCCCCccccccccceEEecCccccCCcchhccCCCCCceEEccCCcccccccccccCCC
Q 045798 345 IANLSSQLQILILSSNQFYGSIPLGIGNLVDLYLLGMVENQFTGAIPKEMGKLQKLQGLDFSGNHFSGEIPSSLGNLS 422 (1008)
Q Consensus 345 ~~~l~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 422 (1008)
.++|++|+|++|+|+ .+|. .+++|+.|+|++|+|+ .+|..+..+++|+.|+|++|.+++..|..+..++
T Consensus 240 ----l~~L~~L~Ls~N~L~-~lp~---~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L~~N~l~~~~~~~l~~L~ 308 (622)
T 3g06_A 240 ----PSELKELMVSGNRLT-SLPM---LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREIT 308 (622)
T ss_dssp ----CTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEECCSCCCCHHHHHHHHHHH
T ss_pred ----CCcCcEEECCCCCCC-cCCc---ccccCcEEeCCCCCCC-cCCHHHhhccccCEEEecCCCCCCcCHHHHHhcc
Confidence 135777777777777 4554 5677888888888888 6688888899999999999999888887766554
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.95 E-value=4.9e-30 Score=281.86 Aligned_cols=248 Identities=19% Similarity=0.234 Sum_probs=142.5
Q ss_pred CCccCCeeeecCCCCCCCCCccccCCCCCCEEEccCCCCC-CccCcccc-------cCcCcceEeeeccccccCCCccc-
Q 045798 76 NLSFLREINLSNNTIQGEIPPEFGRLFRLEALFLSNNSLV-GKIPANLS-------YCSRLTVLCIEYNKLQGRIPLEF- 146 (1008)
Q Consensus 76 ~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~-~~~p~~l~-------~l~~L~~L~Ls~n~l~~~~p~~~- 146 (1008)
..++|++|++++|.+ .+|..+... |++|+|++|.++ ..+|..+. ++++|++|+|++|++++.+|..+
T Consensus 41 ~~~~L~~l~l~~n~l--~~p~~~~~~--L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~ 116 (312)
T 1wwl_A 41 GGRSLEYLLKRVDTE--ADLGQFTDI--IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLL 116 (312)
T ss_dssp EEEECTTHHHHCCTT--CCCHHHHHH--HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCCCSS
T ss_pred cCCCceeEeeccccc--ccHHHHHHH--HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHHHHH
Confidence 344555555555555 445444433 555555555552 33444443 45556666666666655555544
Q ss_pred -cccCCCCeeecccccCCCCCCCCCccc-----cccchhhcccccCCCCCCccccCCCCCcEEEecCCccccc--CCccc
Q 045798 147 -VSLSKLKDLSLAKNKLTGGIPPFLGNL-----TSLEVLSLAGNSFGRNIPDSLGQLKQLKILAIGGNNLSGP--IPPSI 218 (1008)
Q Consensus 147 -~~l~~L~~L~L~~n~l~~~~~~~~~~l-----~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~--~~~~~ 218 (1008)
..+++|++|+|++|++++. |..++.+ ++|++|+|++|++.+..+..|+.+++|++|++++|++.+. .+..+
T Consensus 117 ~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~ 195 (312)
T 1wwl_A 117 EATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISAL 195 (312)
T ss_dssp SCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHHHS
T ss_pred HhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHHHH
Confidence 5555666666666665544 5555554 5666666666666555555666666666666666665443 22222
Q ss_pred --cCCCCcceeccccccccc--cCChhhhhcCCCCcEEEeccccCCCCCC-cccccCCCCceeecccccccccccccccC
Q 045798 219 --YNLSFLVVFSVSHNQIHG--SLPPSLGLLLPNLKFFQIHHNFFSGSIP-ISLSNASKLEHIEIANNNFSGKLSVNFGG 293 (1008)
Q Consensus 219 --~~l~~L~~L~ls~N~l~~--~lp~~~~~~l~~L~~L~L~~N~l~~~~p-~~l~~l~~L~~L~L~~N~l~~~~~~~~~~ 293 (1008)
..+++|++|++++|++++ .++..++..+++|++|+|++|.+.+..| ..+..+++|++|++++|+++. .|..+.
T Consensus 196 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~-ip~~~~- 273 (312)
T 1wwl_A 196 CPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQ-VPKGLP- 273 (312)
T ss_dssp CTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCSS-CCSSCC-
T ss_pred HhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccCh-hhhhcc-
Confidence 556666666666666652 3334444456666677777776665554 344556677777777777663 333333
Q ss_pred CCcccccccccccCCCCCCCcccccccccccCCCcEEEecCCcCCc
Q 045798 294 MKNLSLLNLQFSNLGSGESDEMGFMNSLTNCSKLRVLSLGGNQFRG 339 (1008)
Q Consensus 294 l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~ 339 (1008)
++|+.|+|++|+++..+ .+..+++|++|++++|++++
T Consensus 274 -~~L~~L~Ls~N~l~~~p--------~~~~l~~L~~L~L~~N~l~~ 310 (312)
T 1wwl_A 274 -AKLSVLDLSYNRLDRNP--------SPDELPQVGNLSLKGNPFLD 310 (312)
T ss_dssp -SEEEEEECCSSCCCSCC--------CTTTSCEEEEEECTTCTTTC
T ss_pred -CCceEEECCCCCCCCCh--------hHhhCCCCCEEeccCCCCCC
Confidence 66777777777766542 24566777778888877764
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.3e-27 Score=267.84 Aligned_cols=284 Identities=22% Similarity=0.235 Sum_probs=148.1
Q ss_pred CcCcceEeeeccccccCCCccccccCCCCeeecccccCCCCCCCCCccccccchhhcccccCCCCCCccccCCCCCcEEE
Q 045798 125 CSRLTVLCIEYNKLQGRIPLEFVSLSKLKDLSLAKNKLTGGIPPFLGNLTSLEVLSLAGNSFGRNIPDSLGQLKQLKILA 204 (1008)
Q Consensus 125 l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 204 (1008)
++.....++++|.++ .+|..+. ++|++|++++|++++..+..|.++++|++|++++|++++..+.+|..+++|++|+
T Consensus 30 C~~~~~c~~~~~~l~-~iP~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 106 (353)
T 2z80_A 30 CDRNGICKGSSGSLN-SIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLD 106 (353)
T ss_dssp ECTTSEEECCSTTCS-SCCTTCC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEE
T ss_pred CCCCeEeeCCCCCcc-ccccccc--ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEE
Confidence 344444555555555 3444333 3555555555555543333455555555555555555444444555555555555
Q ss_pred ecCCcccccCCccccCCCCcceeccccccccccCChhhhhcCCCCcEEEeccccCCCCCCcccccCCCCceeecccc-cc
Q 045798 205 IGGNNLSGPIPPSIYNLSFLVVFSVSHNQIHGSLPPSLGLLLPNLKFFQIHHNFFSGSIPISLSNASKLEHIEIANN-NF 283 (1008)
Q Consensus 205 L~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N-~l 283 (1008)
+++|.+++..+..|.++++|++|++++|+++ .+|.. ..+.++++|++|++++| .+
T Consensus 107 Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~-----------------------~~~~~l~~L~~L~l~~n~~~ 162 (353)
T 2z80_A 107 LSYNYLSNLSSSWFKPLSSLTFLNLLGNPYK-TLGET-----------------------SLFSHLTKLQILRVGNMDTF 162 (353)
T ss_dssp CCSSCCSSCCHHHHTTCTTCSEEECTTCCCS-SSCSS-----------------------CSCTTCTTCCEEEEEESSSC
T ss_pred CCCCcCCcCCHhHhCCCccCCEEECCCCCCc-ccCch-----------------------hhhccCCCCcEEECCCCccc
Confidence 5555555333333444444444444444444 33330 24455555555555555 24
Q ss_pred cccccccccCCCcccccccccccCCCCCCCcccccccccccCCCcEEEecCCcCCccCChhhhhhcccceeeeecccccc
Q 045798 284 SGKLSVNFGGMKNLSLLNLQFSNLGSGESDEMGFMNSLTNCSKLRVLSLGGNQFRGALPHSIANLSSQLQILILSSNQFY 363 (1008)
Q Consensus 284 ~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~Ls~N~l~ 363 (1008)
....+..|.++++|+.|++++|++.... +..+..+++|++|++++|++. .+|..+....++|++|++++|.++
T Consensus 163 ~~~~~~~~~~l~~L~~L~l~~n~l~~~~------~~~l~~l~~L~~L~l~~n~l~-~~~~~~~~~~~~L~~L~L~~n~l~ 235 (353)
T 2z80_A 163 TKIQRKDFAGLTFLEELEIDASDLQSYE------PKSLKSIQNVSHLILHMKQHI-LLLEIFVDVTSSVECLELRDTDLD 235 (353)
T ss_dssp CEECTTTTTTCCEEEEEEEEETTCCEEC------TTTTTTCSEEEEEEEECSCST-THHHHHHHHTTTEEEEEEESCBCT
T ss_pred cccCHHHccCCCCCCEEECCCCCcCccC------HHHHhccccCCeecCCCCccc-cchhhhhhhcccccEEECCCCccc
Confidence 4444444555555555555544443321 123455566667777777765 445444433345777777777776
Q ss_pred CCCCCccccccccceEEecCccccCCcchhccCCCCCceEEccCCcccc----cccccccCCCCcceeeccccccccccC
Q 045798 364 GSIPLGIGNLVDLYLLGMVENQFTGAIPKEMGKLQKLQGLDFSGNHFSG----EIPSSLGNLSSLYEVFFNNNNLSGVIP 439 (1008)
Q Consensus 364 ~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~l~~N~l~~~~p 439 (1008)
+..+..+.. ......++.++|++|.+.+ .+|..+..+++|++|++++|+++...+
T Consensus 236 ~~~~~~l~~---------------------~~~~~~l~~l~L~~~~l~~~~l~~l~~~l~~l~~L~~L~Ls~N~l~~i~~ 294 (353)
T 2z80_A 236 TFHFSELST---------------------GETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLKSVPD 294 (353)
T ss_dssp TCCCC---------------------------CCCCCCEEEEESCBCCHHHHHHHHHHHHTCTTCCEEECCSSCCCCCCT
T ss_pred ccccccccc---------------------ccccchhhccccccccccCcchhhhHHHHhcccCCCEEECCCCCCCccCH
Confidence 544332221 1122344455555555443 355666667777777777777774333
Q ss_pred CCCcCCCcccEeecccccccCCcc
Q 045798 440 FSLGNLKRLAFLEMSGNELSGTIP 463 (1008)
Q Consensus 440 ~~~~~l~~L~~L~Ls~N~l~~~lp 463 (1008)
..|.++++|++|+|++|.+++..|
T Consensus 295 ~~~~~l~~L~~L~L~~N~~~~~~~ 318 (353)
T 2z80_A 295 GIFDRLTSLQKIWLHTNPWDCSCP 318 (353)
T ss_dssp TTTTTCTTCCEEECCSSCBCCCHH
T ss_pred HHHhcCCCCCEEEeeCCCccCcCC
Confidence 335777888888888888876554
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=5.7e-28 Score=262.07 Aligned_cols=253 Identities=19% Similarity=0.199 Sum_probs=179.3
Q ss_pred cEEEecCCcCCccCChhhhhhcccceeeeeccccccCCCCCccccccccceEEecCccccCCcchhccCCCCCceEEccC
Q 045798 328 RVLSLGGNQFRGALPHSIANLSSQLQILILSSNQFYGSIPLGIGNLVDLYLLGMVENQFTGAIPKEMGKLQKLQGLDFSG 407 (1008)
Q Consensus 328 ~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~ 407 (1008)
++++.+++.++ .+|..+. .+|++|++++|.+++..+..|..+++|++|++++|.+++..|..|..+++|++|+|++
T Consensus 14 ~~~~c~~~~l~-~ip~~~~---~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 89 (285)
T 1ozn_A 14 VTTSCPQQGLQ-AVPVGIP---AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSD 89 (285)
T ss_dssp CEEECCSSCCS-SCCTTCC---TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred eEEEcCcCCcc-cCCcCCC---CCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCC
Confidence 45566666665 4454332 2466666666666655555666666666666666666666666666666667777766
Q ss_pred Cc-ccccccccccCCCCcceeeccccccccccCCCCcCCCcccEeecccccccCCcchhhhhhhhhhhhhcccCccccCC
Q 045798 408 NH-FSGEIPSSLGNLSSLYEVFFNNNNLSGVIPFSLGNLKRLAFLEMSGNELSGTIPEDIFNISYLSNSLNLARNHLVGI 486 (1008)
Q Consensus 408 N~-l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~lp~~~~~~~~~~~~L~L~~N~l~~~ 486 (1008)
|+ +....|..+..+++|++|++++|.+.+..|..|.++++|++|++++|+++ .+|...+.....++.|+|++|++++.
T Consensus 90 n~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~~~~~~~~~l~~L~~L~l~~n~l~~~ 168 (285)
T 1ozn_A 90 NAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRISSV 168 (285)
T ss_dssp CTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCEE
T ss_pred CCCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCccc-ccCHhHhccCCCccEEECCCCccccc
Confidence 65 55444666666666667777766666666666666666777777766666 44444444444455666666666655
Q ss_pred CcccccccccccccccccccccCCCCcccccccccceeeccCcccccchhhhhhccccccEEecCCCcccccccCccccc
Q 045798 487 IPPRIGNLRALRSFDVSNNDLSGEIPIELGHCSSLEEIYLAGNLFHGSIPSFFNALKGVQKIDLSRNNLSGQIPIFLEAL 566 (1008)
Q Consensus 487 ~p~~~~~l~~L~~Ldls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~ 566 (1008)
.+..|..+++|+.|+|++|.+++..|..+..+++|++|+|++|++++..+..|..+++|+.|+|++|++++..+...-..
T Consensus 169 ~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~~~~~~~~ 248 (285)
T 1ozn_A 169 PERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWA 248 (285)
T ss_dssp CTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGGHHHHH
T ss_pred CHHHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCCcCCHHHcccCcccCEEeccCCCccCCCCcHHHHH
Confidence 56678889999999999999998889999999999999999999998778889999999999999999987665442233
Q ss_pred ccceeecccCcccccCCCC
Q 045798 567 SLEYLNLSFNDFEGKIPAK 585 (1008)
Q Consensus 567 ~L~~L~l~~N~l~g~~p~~ 585 (1008)
.++.+..+.|.+.+..|+.
T Consensus 249 ~l~~~~~~~~~~~c~~p~~ 267 (285)
T 1ozn_A 249 WLQKFRGSSSEVPCSLPQR 267 (285)
T ss_dssp HHHHCCSEECCCBEEESGG
T ss_pred HHHhcccccCccccCCchH
Confidence 4777778888888888864
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.95 E-value=4.5e-29 Score=274.19 Aligned_cols=254 Identities=20% Similarity=0.216 Sum_probs=160.4
Q ss_pred cccCCCcccccccccccCCCCCCCcccccccccccCCCcEEEecCCcCC-ccCChhhh-------hhcccceeeeecccc
Q 045798 290 NFGGMKNLSLLNLQFSNLGSGESDEMGFMNSLTNCSKLRVLSLGGNQFR-GALPHSIA-------NLSSQLQILILSSNQ 361 (1008)
Q Consensus 290 ~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~-~~~p~~~~-------~l~~~L~~L~Ls~N~ 361 (1008)
.+++.++|+.|++++|.+ .+. ..+... |+.|+|++|++. ..+|..+. .+. +|++|+|++|.
T Consensus 38 ~~~~~~~L~~l~l~~n~l-~~p-------~~~~~~--L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~-~L~~L~L~~n~ 106 (312)
T 1wwl_A 38 LYGGGRSLEYLLKRVDTE-ADL-------GQFTDI--IKSLSLKRLTVRAARIPSRILFGALRVLGIS-GLQELTLENLE 106 (312)
T ss_dssp EEEEEEECTTHHHHCCTT-CCC-------HHHHHH--HHHCCCCEEEEEEEECBHHHHHHHHHHHTTS-CCCEEEEEEEB
T ss_pred EEccCCCceeEeeccccc-ccH-------HHHHHH--HhhcccccccccCCCcCHHHHHHHHHhcCcC-CccEEEccCCc
Confidence 455666777777777776 222 122222 666677777763 34555443 343 47777777777
Q ss_pred ccCCCCCcc--ccccccceEEecCccccCCcchhccCC-----CCCceEEccCCcccccccccccCCCCcceeecccccc
Q 045798 362 FYGSIPLGI--GNLVDLYLLGMVENQFTGAIPKEMGKL-----QKLQGLDFSGNHFSGEIPSSLGNLSSLYEVFFNNNNL 434 (1008)
Q Consensus 362 l~~~~p~~~--~~l~~L~~L~L~~n~l~~~~~~~~~~l-----~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l 434 (1008)
+++.+|..+ ..+++|++|+|++|++++. |..+..+ ++|++|+|++|++.+..|..|+.+++|++|++++|++
T Consensus 107 l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l 185 (312)
T 1wwl_A 107 VTGTAPPPLLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPE 185 (312)
T ss_dssp CBSCCCCCSSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTT
T ss_pred ccchhHHHHHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCc
Confidence 776666665 6677777777777777765 6666665 6777777777777766666677777777777777776
Q ss_pred ccc--cCCCC--cCCCcccEeecccccccCCcchhhhhhhhhhhhhcccCccccCCCcccccccccccccccccccccCC
Q 045798 435 SGV--IPFSL--GNLKRLAFLEMSGNELSGTIPEDIFNISYLSNSLNLARNHLVGIIPPRIGNLRALRSFDVSNNDLSGE 510 (1008)
Q Consensus 435 ~~~--~p~~~--~~l~~L~~L~Ls~N~l~~~lp~~~~~~~~~~~~L~L~~N~l~~~~p~~~~~l~~L~~Ldls~N~l~~~ 510 (1008)
.+. .|..+ ..+++|++|+|++|++++ +|. .....+..+++|+.|||++|.+++.
T Consensus 186 ~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~-~~~---------------------~~~~~~~~l~~L~~L~Ls~N~l~~~ 243 (312)
T 1wwl_A 186 LGERGLISALCPLKFPTLQVLALRNAGMET-PSG---------------------VCSALAAARVQLQGLDLSHNSLRDA 243 (312)
T ss_dssp CHHHHHHHHSCTTSCTTCCEEECTTSCCCC-HHH---------------------HHHHHHHTTCCCSEEECTTSCCCSS
T ss_pred CcchHHHHHHHhccCCCCCEEECCCCcCcc-hHH---------------------HHHHHHhcCCCCCEEECCCCcCCcc
Confidence 554 22222 666777777777777652 211 1112234556777777777777765
Q ss_pred CC-cccccccccceeeccCcccccchhhhhhccccccEEecCCCcccccccCcccccccceeecccCccccc
Q 045798 511 IP-IELGHCSSLEEIYLAGNLFHGSIPSFFNALKGVQKIDLSRNNLSGQIPIFLEALSLEYLNLSFNDFEGK 581 (1008)
Q Consensus 511 ~p-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~L~~L~l~~N~l~g~ 581 (1008)
.| ..+..+++|++|+|++|+|+ .+|..+. ++|+.|||++|+|++. |....+.+|++|++++|++++.
T Consensus 244 ~~~~~~~~l~~L~~L~Ls~N~l~-~ip~~~~--~~L~~L~Ls~N~l~~~-p~~~~l~~L~~L~L~~N~l~~~ 311 (312)
T 1wwl_A 244 AGAPSCDWPSQLNSLNLSFTGLK-QVPKGLP--AKLSVLDLSYNRLDRN-PSPDELPQVGNLSLKGNPFLDS 311 (312)
T ss_dssp CCCSCCCCCTTCCEEECTTSCCS-SCCSSCC--SEEEEEECCSSCCCSC-CCTTTSCEEEEEECTTCTTTCC
T ss_pred cchhhhhhcCCCCEEECCCCccC-hhhhhcc--CCceEEECCCCCCCCC-hhHhhCCCCCEEeccCCCCCCC
Confidence 54 34555677777777777777 5666655 6777777777777765 5555666777777777777663
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.95 E-value=1.7e-27 Score=276.30 Aligned_cols=238 Identities=24% Similarity=0.199 Sum_probs=138.3
Q ss_pred cccCCCCccCcCccCCccCCeeeecCCCCCCCCCccccCCCCCCEEEccCCCCCCccCcccccCcCcceEeeeccccccC
Q 045798 62 MSKSLSGSLSPHLGNLSFLREINLSNNTIQGEIPPEFGRLFRLEALFLSNNSLVGKIPANLSYCSRLTVLCIEYNKLQGR 141 (1008)
Q Consensus 62 ~~~~l~~~l~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~ 141 (1008)
.+.+++ .+|..+. ++|++|+|++|++++..|..|.++++|++|+|++|++++..|..|.++++|++|+|++|++++.
T Consensus 62 ~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~ 138 (452)
T 3zyi_A 62 TRRGLS-EVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLTVI 138 (452)
T ss_dssp CSSCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSBC
T ss_pred CCCCcC-ccCCCCC--CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCCcCCcc
Confidence 344444 4555443 4667777777777766666677777777777777777766666677777777777777777655
Q ss_pred CCccccccCCCCeeecccccCCCCCCCCCccccccchhhccc-ccCCCCCCccccCCCCCcEEEecCCcccccCCccccC
Q 045798 142 IPLEFVSLSKLKDLSLAKNKLTGGIPPFLGNLTSLEVLSLAG-NSFGRNIPDSLGQLKQLKILAIGGNNLSGPIPPSIYN 220 (1008)
Q Consensus 142 ~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~-n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~ 220 (1008)
.+..|..+++|++|+|++|+++...+..|.++++|+.|++++ |.+....+..|..+++|++|+|++|++++. | .+..
T Consensus 139 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~-~-~~~~ 216 (452)
T 3zyi_A 139 PSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKDM-P-NLTP 216 (452)
T ss_dssp CTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSSC-C-CCTT
T ss_pred ChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCccccc-c-cccc
Confidence 555666667777777777776655555666666666666666 334333344566666666666666666632 2 3555
Q ss_pred CCCcceeccccccccccCChhhhhcCCCCcEEEeccccCCCCCCcccccCCCCceeecccccccccccccccCCCccccc
Q 045798 221 LSFLVVFSVSHNQIHGSLPPSLGLLLPNLKFFQIHHNFFSGSIPISLSNASKLEHIEIANNNFSGKLSVNFGGMKNLSLL 300 (1008)
Q Consensus 221 l~~L~~L~ls~N~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 300 (1008)
+++|+.|+|++|++++ ++...+..+++|+.|+|++|.+.+..|..+..+++|++|+|++|++++..+..|..+++|+.|
T Consensus 217 l~~L~~L~Ls~N~l~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 295 (452)
T 3zyi_A 217 LVGLEELEMSGNHFPE-IRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVEL 295 (452)
T ss_dssp CTTCCEEECTTSCCSE-ECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSSTTCTTCCEE
T ss_pred cccccEEECcCCcCcc-cCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHHhccccCCCEE
Confidence 5555555555555553 222233334555555555555554445555555555555555555554444444444333333
Q ss_pred ccccc
Q 045798 301 NLQFS 305 (1008)
Q Consensus 301 ~L~~n 305 (1008)
+|++|
T Consensus 296 ~L~~N 300 (452)
T 3zyi_A 296 HLHHN 300 (452)
T ss_dssp ECCSS
T ss_pred EccCC
Confidence 33333
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.3e-28 Score=271.28 Aligned_cols=257 Identities=21% Similarity=0.219 Sum_probs=148.2
Q ss_pred cceeccccccccccCChhhhhcCCCCcEEEeccccCCCCCCcccccCCCCceeecccccccccccccccCCCcccccccc
Q 045798 224 LVVFSVSHNQIHGSLPPSLGLLLPNLKFFQIHHNFFSGSIPISLSNASKLEHIEIANNNFSGKLSVNFGGMKNLSLLNLQ 303 (1008)
Q Consensus 224 L~~L~ls~N~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~ 303 (1008)
++.++++.+.+. ..+..++..+++|++|+|++|.+++..|..+..+++|++|++++|++.+..+ |..++
T Consensus 12 l~i~~ls~~~l~-~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~-------- 80 (317)
T 3o53_A 12 YKIEKVTDSSLK-QALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLS-------- 80 (317)
T ss_dssp EEEESCCTTTHH-HHHHHHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCT--------
T ss_pred eeEeeccccchh-hhHHHHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcC--------
Confidence 445566666665 4555555556677777777777776666677777777777777777765433 44444
Q ss_pred cccCCCCCCCcccccccccccCCCcEEEecCCcCCccCChhhhhhcccceeeeeccccccCCCCCccccccccceEEecC
Q 045798 304 FSNLGSGESDEMGFMNSLTNCSKLRVLSLGGNQFRGALPHSIANLSSQLQILILSSNQFYGSIPLGIGNLVDLYLLGMVE 383 (1008)
Q Consensus 304 ~n~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~ 383 (1008)
+|++|++++|++++ ++. . .+|++|++++|++++..+. .+++|+.|++++
T Consensus 81 ----------------------~L~~L~Ls~n~l~~-l~~----~-~~L~~L~l~~n~l~~~~~~---~~~~L~~L~l~~ 129 (317)
T 3o53_A 81 ----------------------TLRTLDLNNNYVQE-LLV----G-PSIETLHAANNNISRVSCS---RGQGKKNIYLAN 129 (317)
T ss_dssp ----------------------TCCEEECCSSEEEE-EEE----C-TTCCEEECCSSCCSEEEEC---CCSSCEEEECCS
T ss_pred ----------------------CCCEEECcCCcccc-ccC----C-CCcCEEECCCCccCCcCcc---ccCCCCEEECCC
Confidence 44444444444442 111 0 1355555555555433222 234455555555
Q ss_pred ccccCCcchhccCCCCCceEEccCCccccccccccc-CCCCcceeeccccccccccCCCCcCCCcccEeecccccccCCc
Q 045798 384 NQFTGAIPKEMGKLQKLQGLDFSGNHFSGEIPSSLG-NLSSLYEVFFNNNNLSGVIPFSLGNLKRLAFLEMSGNELSGTI 462 (1008)
Q Consensus 384 n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~l 462 (1008)
|++++..+..+..+++|++|+|++|.+++..+..+. .+++|++|+|++|.+++..+ ...+++|+.|+|++|+++
T Consensus 130 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~--~~~l~~L~~L~Ls~N~l~--- 204 (317)
T 3o53_A 130 NKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVKG--QVVFAKLKTLDLSSNKLA--- 204 (317)
T ss_dssp SCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEEEC--CCCCTTCCEEECCSSCCC---
T ss_pred CCCCCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCccccc--ccccccCCEEECCCCcCC---
Confidence 555555555555556666666666666554444442 45555566666655554321 223566666666666665
Q ss_pred chhhhhhhhhhhhhcccCccccCCCcccccccccccccccccccccCCCCcccccccccceeeccCcccc-cchhhhhhc
Q 045798 463 PEDIFNISYLSNSLNLARNHLVGIIPPRIGNLRALRSFDVSNNDLSGEIPIELGHCSSLEEIYLAGNLFH-GSIPSFFNA 541 (1008)
Q Consensus 463 p~~~~~~~~~~~~L~L~~N~l~~~~p~~~~~l~~L~~Ldls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~-~~~p~~~~~ 541 (1008)
.+|..+..+++|+.|+|++|.++ .+|..+..+++|+.|+|++|++. +.+|.++..
T Consensus 205 -----------------------~l~~~~~~l~~L~~L~L~~N~l~-~l~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~ 260 (317)
T 3o53_A 205 -----------------------FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSK 260 (317)
T ss_dssp -----------------------EECGGGGGGTTCSEEECTTSCCC-EECTTCCCCTTCCEEECTTCCCBHHHHHHHHHT
T ss_pred -----------------------cchhhhcccCcccEEECcCCccc-chhhHhhcCCCCCEEEccCCCccCcCHHHHHhc
Confidence 23333555666667777777666 45666666666777777777666 556666666
Q ss_pred cccccEEecC
Q 045798 542 LKGVQKIDLS 551 (1008)
Q Consensus 542 l~~L~~L~ls 551 (1008)
+++|+.|+++
T Consensus 261 ~~~L~~l~l~ 270 (317)
T 3o53_A 261 NQRVQTVAKQ 270 (317)
T ss_dssp CHHHHHHHHH
T ss_pred cccceEEECC
Confidence 6666666666
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.95 E-value=2.5e-27 Score=274.89 Aligned_cols=249 Identities=19% Similarity=0.228 Sum_probs=161.1
Q ss_pred CcEEEecCCcCCccCChhhhhhcccceeeeeccccccCCCCCccccccccceEEecCccccCCcchhccCCCCCceEEcc
Q 045798 327 LRVLSLGGNQFRGALPHSIANLSSQLQILILSSNQFYGSIPLGIGNLVDLYLLGMVENQFTGAIPKEMGKLQKLQGLDFS 406 (1008)
Q Consensus 327 L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls 406 (1008)
...++.+++.++ .+|..+. +.+++|+|++|+|++..|..|.++++|+.|+|++|+|++..+..|.++++|++|+|+
T Consensus 56 ~~~v~c~~~~l~-~iP~~~~---~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~ 131 (452)
T 3zyi_A 56 FSKVVCTRRGLS-EVPQGIP---SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELF 131 (452)
T ss_dssp SCEEECCSSCCS-SCCSCCC---TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECC
T ss_pred CcEEEECCCCcC-ccCCCCC---CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECC
Confidence 345666666666 5565443 357777777777776667777777777777777777777767777777777777777
Q ss_pred CCcccccccccccCCCCcceeeccccccccccCCCCcCCCcccEeecccccccCCcchhhhhhhhhhhhhcccCccccCC
Q 045798 407 GNHFSGEIPSSLGNLSSLYEVFFNNNNLSGVIPFSLGNLKRLAFLEMSGNELSGTIPEDIFNISYLSNSLNLARNHLVGI 486 (1008)
Q Consensus 407 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~lp~~~~~~~~~~~~L~L~~N~l~~~ 486 (1008)
+|++++..+..|..+++|++|+|++|.+....+..|.++++|+.|+|++|...+.+|...+.....++.|+|++|++++.
T Consensus 132 ~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~ 211 (452)
T 3zyi_A 132 DNWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKDM 211 (452)
T ss_dssp SSCCSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSSC
T ss_pred CCcCCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCccccc
Confidence 77777655566777777777777777777666667777777777777774444455555444444445555555555532
Q ss_pred CcccccccccccccccccccccCCCCcccccccccceeeccCcccccchhhhhhccccccEEecCCCcccccccCc-ccc
Q 045798 487 IPPRIGNLRALRSFDVSNNDLSGEIPIELGHCSSLEEIYLAGNLFHGSIPSFFNALKGVQKIDLSRNNLSGQIPIF-LEA 565 (1008)
Q Consensus 487 ~p~~~~~l~~L~~Ldls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~-~~~ 565 (1008)
| .+..+++|+.|+|++|.+++..|..|..+++|++|+|++|++++..|..|..+++|+.|||++|+|++..+.. ..+
T Consensus 212 -~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l 289 (452)
T 3zyi_A 212 -P-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPL 289 (452)
T ss_dssp -C-CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSSTTC
T ss_pred -c-cccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHHhccc
Confidence 2 3555666666666666666555666666666666666666666656666666666666666666666544443 345
Q ss_pred cccceeecccCccccc
Q 045798 566 LSLEYLNLSFNDFEGK 581 (1008)
Q Consensus 566 ~~L~~L~l~~N~l~g~ 581 (1008)
.+|+.|+|++|++...
T Consensus 290 ~~L~~L~L~~Np~~Cd 305 (452)
T 3zyi_A 290 RYLVELHLHHNPWNCD 305 (452)
T ss_dssp TTCCEEECCSSCEECS
T ss_pred cCCCEEEccCCCcCCC
Confidence 5566666666655543
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=7.4e-27 Score=269.90 Aligned_cols=243 Identities=23% Similarity=0.200 Sum_probs=169.0
Q ss_pred EeccccCCCCccCcCccCCccCCeeeecCCCCCCCCCccccCCCCCCEEEccCCCCCCccCcccccCcCcceEeeecccc
Q 045798 59 LDLMSKSLSGSLSPHLGNLSFLREINLSNNTIQGEIPPEFGRLFRLEALFLSNNSLVGKIPANLSYCSRLTVLCIEYNKL 138 (1008)
Q Consensus 59 l~l~~~~l~~~l~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l 138 (1008)
++..+.+++ .+|..+. ++++.|+|++|++++..+..|.++++|++|+|++|++++..+..|.++++|++|+|++|+|
T Consensus 48 v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l 124 (440)
T 3zyj_A 48 VICVRKNLR-EVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRL 124 (440)
T ss_dssp EECCSCCCS-SCCSCCC--TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSSCC
T ss_pred EEeCCCCcC-cCCCCCC--CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCCcC
Confidence 444555666 5676655 5788888888888877778888888888888888888877778888888888888888888
Q ss_pred ccCCCccccccCCCCeeecccccCCCCCCCCCccccccchhhcccc-cCCCCCCccccCCCCCcEEEecCCcccccCCcc
Q 045798 139 QGRIPLEFVSLSKLKDLSLAKNKLTGGIPPFLGNLTSLEVLSLAGN-SFGRNIPDSLGQLKQLKILAIGGNNLSGPIPPS 217 (1008)
Q Consensus 139 ~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n-~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~ 217 (1008)
++..+..|..+++|++|+|++|+++...+..|.++++|++|+|++| .+....+..|..+++|++|+|++|.++. +| .
T Consensus 125 ~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~-~~-~ 202 (440)
T 3zyj_A 125 TTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLRE-IP-N 202 (440)
T ss_dssp SSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCSS-CC-C
T ss_pred CeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCcc-cc-c
Confidence 8666667888888888888888888666667888888888888874 4444445567777888888888887773 33 3
Q ss_pred ccCCCCcceeccccccccccCChhhhhcCCCCcEEEeccccCCCCCCcccccCCCCceeecccccccccccccccCCCcc
Q 045798 218 IYNLSFLVVFSVSHNQIHGSLPPSLGLLLPNLKFFQIHHNFFSGSIPISLSNASKLEHIEIANNNFSGKLSVNFGGMKNL 297 (1008)
Q Consensus 218 ~~~l~~L~~L~ls~N~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L 297 (1008)
+..+++|+.|+|++|++++ ++...+..+++|+.|+|++|.+++..+..|.++++|++|+|++|+++...+..|..+++|
T Consensus 203 ~~~l~~L~~L~Ls~N~l~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L 281 (440)
T 3zyj_A 203 LTPLIKLDELDLSGNHLSA-IRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHL 281 (440)
T ss_dssp CTTCSSCCEEECTTSCCCE-ECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTTSSCTTC
T ss_pred cCCCcccCEEECCCCccCc-cChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChhHhccccCC
Confidence 6666667777777776663 333333445666666666666665555566666666666666666665555545444444
Q ss_pred cccccccccC
Q 045798 298 SLLNLQFSNL 307 (1008)
Q Consensus 298 ~~L~L~~n~l 307 (1008)
+.|+|++|.+
T Consensus 282 ~~L~L~~Np~ 291 (440)
T 3zyj_A 282 ERIHLHHNPW 291 (440)
T ss_dssp CEEECCSSCE
T ss_pred CEEEcCCCCc
Confidence 4444444443
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.94 E-value=2.5e-29 Score=292.99 Aligned_cols=217 Identities=20% Similarity=0.198 Sum_probs=118.0
Q ss_pred cceeeeeccccccCCCCCccccccccceEEecCccccCCcchhccCCCCCceEEccCCcccccccccccCCCCcceeecc
Q 045798 351 QLQILILSSNQFYGSIPLGIGNLVDLYLLGMVENQFTGAIPKEMGKLQKLQGLDFSGNHFSGEIPSSLGNLSSLYEVFFN 430 (1008)
Q Consensus 351 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~ 430 (1008)
+|++|+|++|.+++..|..|..+++|++|+|++|.+++..| +..+++|++|+|++|.|++..+ .++|+.|+++
T Consensus 35 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~~-----~~~L~~L~L~ 107 (487)
T 3oja_A 35 NVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLV-----GPSIETLHAA 107 (487)
T ss_dssp GCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEEE-----CTTCCEEECC
T ss_pred CccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCCC-----CCCcCEEECc
Confidence 46777777777766556666666677777777766665544 6666666677777666663322 2566666666
Q ss_pred ccccccccCCCCcCCCcccEeecccccccCCcchhhhhhhhhhhhhcccCccccCCCcccccccccccccccccccccCC
Q 045798 431 NNNLSGVIPFSLGNLKRLAFLEMSGNELSGTIPEDIFNISYLSNSLNLARNHLVGIIPPRIGNLRALRSFDVSNNDLSGE 510 (1008)
Q Consensus 431 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~lp~~~~~~~~~~~~L~L~~N~l~~~~p~~~~~l~~L~~Ldls~N~l~~~ 510 (1008)
+|.+++..+.. +++|+.|+|++|.+++ ..|..|+.+++|+.|||++|.+++.
T Consensus 108 ~N~l~~~~~~~---l~~L~~L~L~~N~l~~-------------------------~~~~~~~~l~~L~~L~Ls~N~l~~~ 159 (487)
T 3oja_A 108 NNNISRVSCSR---GQGKKNIYLANNKITM-------------------------LRDLDEGCRSRVQYLDLKLNEIDTV 159 (487)
T ss_dssp SSCCCCEEECC---CSSCEEEECCSSCCCS-------------------------GGGBCGGGGSSEEEEECTTSCCCEE
T ss_pred CCcCCCCCccc---cCCCCEEECCCCCCCC-------------------------CCchhhcCCCCCCEEECCCCCCCCc
Confidence 66666554432 3556666666666664 3444444455555555555555544
Q ss_pred CCcccc-cccccceeeccCcccccchhhhhhccccccEEecCCCcccccccCcccccccceeecccCcccccCCCCcccC
Q 045798 511 IPIELG-HCSSLEEIYLAGNLFHGSIPSFFNALKGVQKIDLSRNNLSGQIPIFLEALSLEYLNLSFNDFEGKIPAKGIFA 589 (1008)
Q Consensus 511 ~p~~~~-~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~L~~L~l~~N~l~g~~p~~~~~~ 589 (1008)
.|..+. .+++|++|+|++|.|++..+ +..+++|+.|+|++|++++.+|....+.+|+.|+|++|.|++.++....+.
T Consensus 160 ~~~~l~~~l~~L~~L~Ls~N~l~~~~~--~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~lp~~l~~l~ 237 (487)
T 3oja_A 160 NFAELAASSDTLEHLNLQYNFIYDVKG--QVVFAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKLVLIEKALRFSQ 237 (487)
T ss_dssp EGGGGGGGTTTCCEEECTTSCCCEEEC--CCCCTTCCEEECCSSCCCEECGGGGGGTTCSEEECTTSCCCEECTTCCCCT
T ss_pred ChHHHhhhCCcccEEecCCCccccccc--cccCCCCCEEECCCCCCCCCCHhHcCCCCccEEEecCCcCcccchhhccCC
Confidence 444443 44555555555555553311 123455555555555555444443444445555555555554333223334
Q ss_pred CcccceeccCCccCC
Q 045798 590 NASAISVVGCNRLCG 604 (1008)
Q Consensus 590 ~~~~~~~~~n~~l~g 604 (1008)
++..+.+.+|+..|+
T Consensus 238 ~L~~L~l~~N~l~c~ 252 (487)
T 3oja_A 238 NLEHFDLRGNGFHCG 252 (487)
T ss_dssp TCCEEECTTCCBCHH
T ss_pred CCCEEEcCCCCCcCc
Confidence 444444455555444
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=3.4e-27 Score=255.91 Aligned_cols=221 Identities=21% Similarity=0.214 Sum_probs=146.7
Q ss_pred EEEeccccCCCCccCcCccCCccCCeeeecCCCCCCCCCccccCCCCCCEEEccCCCCCCccCcccccCcCcceEeeecc
Q 045798 57 TALDLMSKSLSGSLSPHLGNLSFLREINLSNNTIQGEIPPEFGRLFRLEALFLSNNSLVGKIPANLSYCSRLTVLCIEYN 136 (1008)
Q Consensus 57 ~~l~l~~~~l~~~l~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n 136 (1008)
+.++.++++++ .+|..+ .++|++|+|++|++++..+..|..+++|++|+|++|.+++..|..|+.+++|++|+|++|
T Consensus 14 ~~~~c~~~~l~-~ip~~~--~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n 90 (285)
T 1ozn_A 14 VTTSCPQQGLQ-AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDN 90 (285)
T ss_dssp CEEECCSSCCS-SCCTTC--CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSC
T ss_pred eEEEcCcCCcc-cCCcCC--CCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCC
Confidence 45666677776 455544 357888888888888777777888888888888888888777888888888888888888
Q ss_pred c-cccCCCccccccCCCCeeecccccCCCCCCCCCccccccchhhcccccCCCCCCccccCCCCCcEEEecCCcccccCC
Q 045798 137 K-LQGRIPLEFVSLSKLKDLSLAKNKLTGGIPPFLGNLTSLEVLSLAGNSFGRNIPDSLGQLKQLKILAIGGNNLSGPIP 215 (1008)
Q Consensus 137 ~-l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~ 215 (1008)
. +....|..|..+++|++|++++|++++..|..|.++++|++|++++|++++..+..|+.+++|++|++++|.+++..+
T Consensus 91 ~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~ 170 (285)
T 1ozn_A 91 AQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPE 170 (285)
T ss_dssp TTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECT
T ss_pred CCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccCH
Confidence 6 776667777778888888888888876667777777777777777777766666667777777777777777775555
Q ss_pred ccccCCCCcceeccccccccccCChhhhhcCCCCcEEEeccccCCCCCCcccccCCCCceeecccc
Q 045798 216 PSIYNLSFLVVFSVSHNQIHGSLPPSLGLLLPNLKFFQIHHNFFSGSIPISLSNASKLEHIEIANN 281 (1008)
Q Consensus 216 ~~~~~l~~L~~L~ls~N~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N 281 (1008)
..|..+++|+.|++++|.+++..|..+ ..+++|+.|+|++|.+++..+..+..+++|++|++++|
T Consensus 171 ~~~~~l~~L~~L~l~~n~l~~~~~~~~-~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N 235 (285)
T 1ozn_A 171 RAFRGLHSLDRLLLHQNRVAHVHPHAF-RDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDN 235 (285)
T ss_dssp TTTTTCTTCCEEECCSSCCCEECTTTT-TTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSS
T ss_pred HHhcCccccCEEECCCCcccccCHhHc-cCcccccEeeCCCCcCCcCCHHHcccCcccCEEeccCC
Confidence 556666666666666666553323222 22334444444444443322233333333333333333
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=9.3e-27 Score=269.06 Aligned_cols=225 Identities=19% Similarity=0.187 Sum_probs=183.7
Q ss_pred CCeeeecCCCCCCCCCccccCCCCCCEEEccCCCCCCccCcccccCcCcceEeeeccccccCCCccccccCCCCeeeccc
Q 045798 80 LREINLSNNTIQGEIPPEFGRLFRLEALFLSNNSLVGKIPANLSYCSRLTVLCIEYNKLQGRIPLEFVSLSKLKDLSLAK 159 (1008)
Q Consensus 80 L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~ 159 (1008)
.+.++.++++++ .+|..+. +++++|+|++|++++..+..|.++++|++|+|++|+|++..+..|.++++|++|+|++
T Consensus 45 ~~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~ 121 (440)
T 3zyj_A 45 FSKVICVRKNLR-EVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFD 121 (440)
T ss_dssp SCEEECCSCCCS-SCCSCCC--TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCS
T ss_pred CCEEEeCCCCcC-cCCCCCC--CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCC
Confidence 467888999998 7787665 7899999999999988889999999999999999999988888999999999999999
Q ss_pred ccCCCCCCCCCccccccchhhcccccCCCCCCccccCCCCCcEEEecC-CcccccCCccccCCCCcceeccccccccccC
Q 045798 160 NKLTGGIPPFLGNLTSLEVLSLAGNSFGRNIPDSLGQLKQLKILAIGG-NNLSGPIPPSIYNLSFLVVFSVSHNQIHGSL 238 (1008)
Q Consensus 160 n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~-n~l~~~~~~~~~~l~~L~~L~ls~N~l~~~l 238 (1008)
|+++...+..|.++++|++|+|++|++....+..|..+++|++|++++ |.+....+..|.++++|++|++++|+++ .+
T Consensus 122 n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~-~~ 200 (440)
T 3zyj_A 122 NRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EI 200 (440)
T ss_dssp SCCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCS-SC
T ss_pred CcCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCc-cc
Confidence 999977677899999999999999999887788899999999999998 4555555667888899999999999887 66
Q ss_pred ChhhhhcCCCCcEEEeccccCCCCCCcccccCCCCceeecccccccccccccccCCCcccccccccccCCCC
Q 045798 239 PPSLGLLLPNLKFFQIHHNFFSGSIPISLSNASKLEHIEIANNNFSGKLSVNFGGMKNLSLLNLQFSNLGSG 310 (1008)
Q Consensus 239 p~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~ 310 (1008)
|. +..+++|+.|+|++|.+++..|..|.++++|+.|++++|++.+..+..|.++++|+.|+|++|+++.+
T Consensus 201 ~~--~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 270 (440)
T 3zyj_A 201 PN--LTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLL 270 (440)
T ss_dssp CC--CTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCC
T ss_pred cc--cCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCcc
Confidence 64 34467777777777777777777777777777777777777776666666665555555555555543
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.94 E-value=2.4e-26 Score=272.69 Aligned_cols=141 Identities=29% Similarity=0.380 Sum_probs=70.9
Q ss_pred ccceEEecCccccCCcchhccCCCCCceEEccCCcccccccccccCCCCcceeeccccccccccCCCCcCCCcccEeecc
Q 045798 375 DLYLLGMVENQFTGAIPKEMGKLQKLQGLDFSGNHFSGEIPSSLGNLSSLYEVFFNNNNLSGVIPFSLGNLKRLAFLEMS 454 (1008)
Q Consensus 375 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls 454 (1008)
+|+.|++++|.+++ +| ..+++|+.|+|++|++++ +|.. +++|+.|++++|.++. +|.. +++|+.|+|+
T Consensus 162 ~L~~L~L~~N~l~~-l~---~~~~~L~~L~Ls~N~l~~-l~~~---~~~L~~L~L~~N~l~~-l~~~---~~~L~~L~Ls 229 (622)
T 3g06_A 162 ELCKLWAYNNQLTS-LP---MLPSGLQELSVSDNQLAS-LPTL---PSELYKLWAYNNRLTS-LPAL---PSGLKELIVS 229 (622)
T ss_dssp TCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSS-CCCC---CTTCCEEECC
T ss_pred CCCEEECCCCCCCC-Cc---ccCCCCcEEECCCCCCCC-CCCc---cchhhEEECcCCcccc-cCCC---CCCCCEEEcc
Confidence 44444555555443 22 234555566666665552 3332 2455556666666552 3322 3556666666
Q ss_pred cccccCCcchhhhhhhhhhhhhcccCccccCCCcccccccccccccccccccccCCCCcccccccccceeeccCcccccc
Q 045798 455 GNELSGTIPEDIFNISYLSNSLNLARNHLVGIIPPRIGNLRALRSFDVSNNDLSGEIPIELGHCSSLEEIYLAGNLFHGS 534 (1008)
Q Consensus 455 ~N~l~~~lp~~~~~~~~~~~~L~L~~N~l~~~~p~~~~~l~~L~~Ldls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 534 (1008)
+|++++ +| ..+++|+.|+|++|.|+ .+|. .+++|+.|+|++|+|+ .
T Consensus 230 ~N~L~~-lp----------------------------~~l~~L~~L~Ls~N~L~-~lp~---~~~~L~~L~Ls~N~L~-~ 275 (622)
T 3g06_A 230 GNRLTS-LP----------------------------VLPSELKELMVSGNRLT-SLPM---LPSGLLSLSVYRNQLT-R 275 (622)
T ss_dssp SSCCSC-CC----------------------------CCCTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCC-S
T ss_pred CCccCc-CC----------------------------CCCCcCcEEECCCCCCC-cCCc---ccccCcEEeCCCCCCC-c
Confidence 666652 22 12244555555555555 3443 3445555555555555 4
Q ss_pred hhhhhhccccccEEecCCCcccccccC
Q 045798 535 IPSFFNALKGVQKIDLSRNNLSGQIPI 561 (1008)
Q Consensus 535 ~p~~~~~l~~L~~L~ls~N~l~~~~p~ 561 (1008)
+|..|..+++|+.|+|++|++++.+|.
T Consensus 276 lp~~l~~l~~L~~L~L~~N~l~~~~~~ 302 (622)
T 3g06_A 276 LPESLIHLSSETTVNLEGNPLSERTLQ 302 (622)
T ss_dssp CCGGGGGSCTTCEEECCSCCCCHHHHH
T ss_pred CCHHHhhccccCEEEecCCCCCCcCHH
Confidence 455555555555555555555554443
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.94 E-value=2.2e-26 Score=247.07 Aligned_cols=217 Identities=25% Similarity=0.319 Sum_probs=176.0
Q ss_pred CCCCcccceEEcCCCCeEEEEeccccCCCCccCcCccCCccCCeeeecCCCCCCCCCccccCCCCCCEEEccCCCCCCcc
Q 045798 39 RHFCEWEGITCGRRHRRVTALDLMSKSLSGSLSPHLGNLSFLREINLSNNTIQGEIPPEFGRLFRLEALFLSNNSLVGKI 118 (1008)
Q Consensus 39 ~~~c~w~gv~c~~~~~~v~~l~l~~~~l~~~l~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~ 118 (1008)
.++|.|.|+.|... ..++.+|++++.++ .+|..+. ++|++|+|++|++++..+..|.++++|++|+|++|.++...
T Consensus 2 ~~~C~~~~~~C~c~-~~~~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~ 77 (270)
T 2o6q_A 2 EALCKKDGGVCSCN-NNKNSVDCSSKKLT-AIPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLP 77 (270)
T ss_dssp CCCBGGGTCSBEEE-TTTTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCC
T ss_pred CccCCCCCCCCEeC-CCCCEEEccCCCCC-ccCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeC
Confidence 48999999988643 23567889999888 5776665 67899999999999777778999999999999999998666
Q ss_pred CcccccCcCcceEeeeccccccCCCccccccCCCCeeecccccCCCCCCCCCccccccchhhcccccCCCCCCccccCCC
Q 045798 119 PANLSYCSRLTVLCIEYNKLQGRIPLEFVSLSKLKDLSLAKNKLTGGIPPFLGNLTSLEVLSLAGNSFGRNIPDSLGQLK 198 (1008)
Q Consensus 119 p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~ 198 (1008)
+..|..+++|++|+|++|++++..+..|..+++|++|++++|++++..+..|+++++|++|+|++|++++..+..|..++
T Consensus 78 ~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~ 157 (270)
T 2o6q_A 78 AGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLT 157 (270)
T ss_dssp TTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCT
T ss_pred hhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCc
Confidence 66678899999999999999877777788889999999999999877777788888888888888888777777788888
Q ss_pred CCcEEEecCCcccccCCccccCCCCcceeccccccccccCChhhhhcCCCCcEEEeccccCC
Q 045798 199 QLKILAIGGNNLSGPIPPSIYNLSFLVVFSVSHNQIHGSLPPSLGLLLPNLKFFQIHHNFFS 260 (1008)
Q Consensus 199 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~~~lp~~~~~~l~~L~~L~L~~N~l~ 260 (1008)
+|+.|+|++|.+++..+..|.++++|+.|++++|+++ .+|...+..+++|+.|+|++|.+.
T Consensus 158 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~l~~N~~~ 218 (270)
T 2o6q_A 158 SLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLK-RVPEGAFDSLEKLKMLQLQENPWD 218 (270)
T ss_dssp TCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCS-CCCTTTTTTCTTCCEEECCSSCBC
T ss_pred ccceeEecCCcCcEeChhHhccCCCcCEEECCCCcCC-cCCHHHhccccCCCEEEecCCCee
Confidence 8888888888888777777888888888888888877 566655555667777777777665
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=3.6e-28 Score=286.75 Aligned_cols=185 Identities=15% Similarity=0.044 Sum_probs=130.3
Q ss_pred EeeccCeeEEEEEEcCCCeEEEEEEecccc----------chhhHHHHHHHHHHhhc-CCCCceeeeeccccccccCCce
Q 045798 692 IGVGSFGCVYKGALDEDGIVVAIKVINLQC----------EGASKSFMAECKALKNI-RHRNLVKVITSCSSIDFQGNDF 760 (1008)
Q Consensus 692 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----------~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~ 760 (1008)
.+.|++|.+..++..-.|+.||+|++.... +...++|.+|+++|+++ .|+||++++++ ++++..
T Consensus 242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~-----~ed~~~ 316 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAH-----GENAQS 316 (569)
T ss_dssp -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEE-----EECSSE
T ss_pred cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEE-----EEECCE
Confidence 556667777666665578899999996432 22335799999999999 79999999999 577888
Q ss_pred EEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEE
Q 045798 761 KAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHI 840 (1008)
Q Consensus 761 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 840 (1008)
.||||||++|++|.+++...+ +++.. +|+.||+.||+|+|++ |||||||||+|||++++|.+||
T Consensus 317 ~yLVMEyv~G~~L~d~i~~~~----------~l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL 380 (569)
T 4azs_A 317 GWLVMEKLPGRLLSDMLAAGE----------EIDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARL 380 (569)
T ss_dssp EEEEEECCCSEEHHHHHHTTC----------CCCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEE
T ss_pred EEEEEecCCCCcHHHHHHhCC----------CCCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEE
Confidence 999999999999999998664 45554 4899999999999998 9999999999999999999999
Q ss_pred cccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCC
Q 045798 841 GDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKP 902 (1008)
Q Consensus 841 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~p 902 (1008)
+|||+|+........ ....+||++|+|||++.+ .+..++|+||+|++++++.+|..+
T Consensus 381 ~DFGlAr~~~~~~~~----~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 381 IDFGSIVTTPQDCSW----PTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp CCCTTEESCC---CC----SHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred eecccCeeCCCCCcc----ccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence 999999866543222 233569999999999876 467789999999998887666544
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.94 E-value=9.3e-28 Score=264.31 Aligned_cols=248 Identities=19% Similarity=0.260 Sum_probs=171.5
Q ss_pred ccCCCcEEEecCCcCCccCChhhhhhcccceeeeeccccccCCCCCccccccccceEEecCccccCCcchhccCCCCCce
Q 045798 323 NCSKLRVLSLGGNQFRGALPHSIANLSSQLQILILSSNQFYGSIPLGIGNLVDLYLLGMVENQFTGAIPKEMGKLQKLQG 402 (1008)
Q Consensus 323 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~ 402 (1008)
.+++|+.|+|++|++++..|..+..+. +|++|+|++|.+++..+ +..+++|++|++++|++++.. ..++|+.
T Consensus 32 ~~~~L~~L~L~~n~l~~~~~~~~~~l~-~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls~n~l~~l~-----~~~~L~~ 103 (317)
T 3o53_A 32 SAWNVKELDLSGNPLSQISAADLAPFT-KLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELL-----VGPSIET 103 (317)
T ss_dssp TGGGCSEEECTTSCCCCCCHHHHTTCT-TCCEEECTTSCCEEEEE--ETTCTTCCEEECCSSEEEEEE-----ECTTCCE
T ss_pred cCCCCCEEECcCCccCcCCHHHhhCCC-cCCEEECCCCcCCcchh--hhhcCCCCEEECcCCcccccc-----CCCCcCE
Confidence 344566666666666655455555554 46666666666664433 666666677777666666422 2366777
Q ss_pred EEccCCcccccccccccCCCCcceeeccccccccccCCCCcCCCcccEeecccccccCCcchhhhhhhhhhhhhcccCcc
Q 045798 403 LDFSGNHFSGEIPSSLGNLSSLYEVFFNNNNLSGVIPFSLGNLKRLAFLEMSGNELSGTIPEDIFNISYLSNSLNLARNH 482 (1008)
Q Consensus 403 L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~lp~~~~~~~~~~~~L~L~~N~ 482 (1008)
|++++|++++..+.. +++|++|++++|.+++..|..+..+++|++|+|++|++++..|..++.....++.|+|++|.
T Consensus 104 L~l~~n~l~~~~~~~---~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~ 180 (317)
T 3o53_A 104 LHAANNNISRVSCSR---GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNF 180 (317)
T ss_dssp EECCSSCCSEEEECC---CSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSC
T ss_pred EECCCCccCCcCccc---cCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCc
Confidence 777777776544333 45566777777777766666666677777777777777644444444334445666666666
Q ss_pred ccCCCcccccccccccccccccccccCCCCcccccccccceeeccCcccccchhhhhhccccccEEecCCCccc-ccccC
Q 045798 483 LVGIIPPRIGNLRALRSFDVSNNDLSGEIPIELGHCSSLEEIYLAGNLFHGSIPSFFNALKGVQKIDLSRNNLS-GQIPI 561 (1008)
Q Consensus 483 l~~~~p~~~~~l~~L~~Ldls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~-~~~p~ 561 (1008)
+++. | ....+++|+.|+|++|.++ .+|..+..+++|++|+|++|+|+ .+|..+..+++|+.|+|++|+++ +.+|.
T Consensus 181 l~~~-~-~~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~L~~N~l~-~l~~~~~~l~~L~~L~l~~N~~~~~~~~~ 256 (317)
T 3o53_A 181 IYDV-K-GQVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRD 256 (317)
T ss_dssp CCEE-E-CCCCCTTCCEEECCSSCCC-EECGGGGGGTTCSEEECTTSCCC-EECTTCCCCTTCCEEECTTCCCBHHHHHH
T ss_pred Cccc-c-cccccccCCEEECCCCcCC-cchhhhcccCcccEEECcCCccc-chhhHhhcCCCCCEEEccCCCccCcCHHH
Confidence 6644 3 2335889999999999998 56667899999999999999999 57888999999999999999998 66666
Q ss_pred c-ccccccceeecc-cCcccccCCCC
Q 045798 562 F-LEALSLEYLNLS-FNDFEGKIPAK 585 (1008)
Q Consensus 562 ~-~~~~~L~~L~l~-~N~l~g~~p~~ 585 (1008)
+ ..+..|+.|+++ .+.++|..|..
T Consensus 257 ~~~~~~~L~~l~l~~~~~l~~~~~~~ 282 (317)
T 3o53_A 257 FFSKNQRVQTVAKQTVKKLTGQNEEE 282 (317)
T ss_dssp HHHTCHHHHHHHHHHHHHHHSSSSCC
T ss_pred HHhccccceEEECCCchhccCCchhc
Confidence 6 567789999998 66788877754
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.93 E-value=8.3e-27 Score=271.70 Aligned_cols=237 Identities=20% Similarity=0.254 Sum_probs=167.1
Q ss_pred ccCCCcEEEecCCcCCccCChhhhhhcccceeeeeccccccCCCCCccccccccceEEecCccccCCcchhccCCCCCce
Q 045798 323 NCSKLRVLSLGGNQFRGALPHSIANLSSQLQILILSSNQFYGSIPLGIGNLVDLYLLGMVENQFTGAIPKEMGKLQKLQG 402 (1008)
Q Consensus 323 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~ 402 (1008)
.+++|+.|+|++|.+++..|..+..+. +|++|+|++|.+++..| +..+++|++|+|++|.|++..+ .++|+.
T Consensus 32 ~~~~L~~L~Ls~n~l~~~~~~~~~~l~-~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~~-----~~~L~~ 103 (487)
T 3oja_A 32 SAWNVKELDLSGNPLSQISAADLAPFT-KLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLV-----GPSIET 103 (487)
T ss_dssp TGGGCCEEECCSSCCCCCCGGGGTTCT-TCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEEE-----CTTCCE
T ss_pred cCCCccEEEeeCCcCCCCCHHHHhCCC-CCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCCC-----CCCcCE
Confidence 345889999999999877777887776 59999999999986665 8889999999999999885433 388999
Q ss_pred EEccCCcccccccccccCCCCcceeeccccccccccCCCCcCCCcccEeecccccccCCcchhhhhhhhhhhhhcccCcc
Q 045798 403 LDFSGNHFSGEIPSSLGNLSSLYEVFFNNNNLSGVIPFSLGNLKRLAFLEMSGNELSGTIPEDIFNISYLSNSLNLARNH 482 (1008)
Q Consensus 403 L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~lp~~~~~~~~~~~~L~L~~N~ 482 (1008)
|+|++|.+++..+.. +++|+.|+|++|.+++..|..|+.+++|+.|+|++|.+++..|..+......++.|+|++|.
T Consensus 104 L~L~~N~l~~~~~~~---l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~ 180 (487)
T 3oja_A 104 LHAANNNISRVSCSR---GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNF 180 (487)
T ss_dssp EECCSSCCCCEEECC---CSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSC
T ss_pred EECcCCcCCCCCccc---cCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCc
Confidence 999999998766543 57889999999999988888899999999999999999865555554333444556666666
Q ss_pred ccCCCcccccccccccccccccccccCCCCcccccccccceeeccCcccccchhhhhhccccccEEecCCCccc-ccccC
Q 045798 483 LVGIIPPRIGNLRALRSFDVSNNDLSGEIPIELGHCSSLEEIYLAGNLFHGSIPSFFNALKGVQKIDLSRNNLS-GQIPI 561 (1008)
Q Consensus 483 l~~~~p~~~~~l~~L~~Ldls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~-~~~p~ 561 (1008)
+++. | .+..+++|+.|||++|.+++ +|..++.+++|+.|+|++|.|++ +|..+..+++|+.|+|++|+++ +.+|.
T Consensus 181 l~~~-~-~~~~l~~L~~L~Ls~N~l~~-~~~~~~~l~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~l~~N~l~c~~~~~ 256 (487)
T 3oja_A 181 IYDV-K-GQVVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRD 256 (487)
T ss_dssp CCEE-E-CCCCCTTCCEEECCSSCCCE-ECGGGGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCBCHHHHHH
T ss_pred cccc-c-ccccCCCCCEEECCCCCCCC-CCHhHcCCCCccEEEecCCcCcc-cchhhccCCCCCEEEcCCCCCcCcchHH
Confidence 5544 2 23346666666666666663 44446666666666666666663 5555666666666666666666 34444
Q ss_pred c-ccccccceeecc
Q 045798 562 F-LEALSLEYLNLS 574 (1008)
Q Consensus 562 ~-~~~~~L~~L~l~ 574 (1008)
+ ..+..|+.|+++
T Consensus 257 ~~~~l~~L~~l~~~ 270 (487)
T 3oja_A 257 FFSKNQRVQTVAKQ 270 (487)
T ss_dssp HHTTCHHHHHHHHH
T ss_pred HHHhCCCCcEEecc
Confidence 3 334445555554
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.93 E-value=9.2e-29 Score=298.49 Aligned_cols=442 Identities=15% Similarity=0.103 Sum_probs=218.0
Q ss_pred CeeeecCCCCCCCCCccccCCCCCCEEEccCCCCC---CccCcc------------cccCcCcceEeeeccccccCCCcc
Q 045798 81 REINLSNNTIQGEIPPEFGRLFRLEALFLSNNSLV---GKIPAN------------LSYCSRLTVLCIEYNKLQGRIPLE 145 (1008)
Q Consensus 81 ~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~---~~~p~~------------l~~l~~L~~L~Ls~n~l~~~~p~~ 145 (1008)
+.++++++... .....+..+++|++|+|++|... +..|.. ...+++|++|+|++|.+++..+..
T Consensus 46 ~~l~~~~~~~~-~~~~~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~~~~~~ 124 (594)
T 2p1m_B 46 RKVFIGNCYAV-SPATVIRRFPKVRSVELKGKPHFADFNLVPDGWGGYVYPWIEAMSSSYTWLEEIRLKRMVVTDDCLEL 124 (594)
T ss_dssp CEEEESSTTSS-CHHHHHHHCTTCCEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCCEEEEESCBCCHHHHHH
T ss_pred eEEeecccccc-CHHHHHhhCCCceEEeccCCCchhhcccccccccchhhHHHHHHHHhCCCCCeEEeeCcEEcHHHHHH
Confidence 45666554332 22335677899999999998632 122221 235677888888888777666666
Q ss_pred cc-ccCCCCeeecccc-cCCCC-CCCCCccccccchhhcccccCCCCCCcccc----CCCCCcEEEecCCc--ccc-cCC
Q 045798 146 FV-SLSKLKDLSLAKN-KLTGG-IPPFLGNLTSLEVLSLAGNSFGRNIPDSLG----QLKQLKILAIGGNN--LSG-PIP 215 (1008)
Q Consensus 146 ~~-~l~~L~~L~L~~n-~l~~~-~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~----~l~~L~~L~L~~n~--l~~-~~~ 215 (1008)
+. .+++|++|+|++| .++.. ++..+.++++|++|+|++|.+++..+.++. .+++|+.|++++|. ++. .+.
T Consensus 125 l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~~L~~L~l~~~~~~~~~~~l~ 204 (594)
T 2p1m_B 125 IAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISCLASEVSFSALE 204 (594)
T ss_dssp HHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCCCCCEEECTTCCSCCCHHHHH
T ss_pred HHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCCcCcEEEecccCCcCCHHHHH
Confidence 65 5777888888777 44421 233334566677777777666544433333 44466666666654 110 011
Q ss_pred ccccCCCCcceeccccc-cccccCChhhhhcCCCCcEEEeccccCCCCCCcccccCCCCceeecccccccccccccccCC
Q 045798 216 PSIYNLSFLVVFSVSHN-QIHGSLPPSLGLLLPNLKFFQIHHNFFSGSIPISLSNASKLEHIEIANNNFSGKLSVNFGGM 294 (1008)
Q Consensus 216 ~~~~~l~~L~~L~ls~N-~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l 294 (1008)
..+.++++|+.|++++| .+. .++..+ ..+++|+.|+++.+... ++.|.+.+.. ..+.++
T Consensus 205 ~l~~~~~~L~~L~L~~~~~~~-~l~~~~-~~~~~L~~L~l~~~~~~-----------------~~~~~~~~l~-~~l~~~ 264 (594)
T 2p1m_B 205 RLVTRCPNLKSLKLNRAVPLE-KLATLL-QRAPQLEELGTGGYTAE-----------------VRPDVYSGLS-VALSGC 264 (594)
T ss_dssp HHHHHCTTCCEEECCTTSCHH-HHHHHH-HHCTTCSEEECSBCCCC-----------------CCHHHHHHHH-HHHHTC
T ss_pred HHHHhCCCCcEEecCCCCcHH-HHHHHH-hcCCcceEcccccccCc-----------------cchhhHHHHH-HHHhcC
Confidence 11223355555555554 222 222222 22444444443322110 2222233221 234444
Q ss_pred Cccccc-ccccccCCCCCCCcccccccccccCCCcEEEecCCcCCccCChhhhhhcccceeeeeccccccC-CCCCcccc
Q 045798 295 KNLSLL-NLQFSNLGSGESDEMGFMNSLTNCSKLRVLSLGGNQFRGALPHSIANLSSQLQILILSSNQFYG-SIPLGIGN 372 (1008)
Q Consensus 295 ~~L~~L-~L~~n~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~Ls~N~l~~-~~p~~~~~ 372 (1008)
++|+.| .+.... ...++..+..+++|+.|++++|.+++.....+....++|++|++++| +.. .++.....
T Consensus 265 ~~L~~Ls~~~~~~-------~~~l~~~~~~~~~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~-~~~~~l~~l~~~ 336 (594)
T 2p1m_B 265 KELRCLSGFWDAV-------PAYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY-IEDAGLEVLAST 336 (594)
T ss_dssp TTCCEEECCBTCC-------GGGGGGGHHHHTTCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG-GHHHHHHHHHHH
T ss_pred CCcccccCCcccc-------hhhHHHHHHhhCCCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc-cCHHHHHHHHHh
Confidence 444444 121100 01112222345556666666665443222221111124555555555 221 11111223
Q ss_pred ccccceEEec---------CccccCCcchhcc-CCCCCceEEccCCccccccccccc-CCCCcceeecc--c----cccc
Q 045798 373 LVDLYLLGMV---------ENQFTGAIPKEMG-KLQKLQGLDFSGNHFSGEIPSSLG-NLSSLYEVFFN--N----NNLS 435 (1008)
Q Consensus 373 l~~L~~L~L~---------~n~l~~~~~~~~~-~l~~L~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~l~--~----N~l~ 435 (1008)
+++|+.|++. .+.+++.....+. .+++|+.|+++.|.+++..+..+. .+++|+.|+++ + |.++
T Consensus 337 ~~~L~~L~L~~~~~~g~~~~~~l~~~~l~~l~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~ 416 (594)
T 2p1m_B 337 CKDLRELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLT 416 (594)
T ss_dssp CTTCCEEEEECSCTTCSSCSSCCCHHHHHHHHHHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTT
T ss_pred CCCCCEEEEecCcccccccCCCCCHHHHHHHHHhchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCccccc
Confidence 4555555552 2333322222222 255666666666666544444333 35556666665 2 3333
Q ss_pred c-----ccCCCCcCCCcccEeecccccccCCcchhhhhhhhhhhhhcccCccccCCCcccccc-cccccccccccccccC
Q 045798 436 G-----VIPFSLGNLKRLAFLEMSGNELSGTIPEDIFNISYLSNSLNLARNHLVGIIPPRIGN-LRALRSFDVSNNDLSG 509 (1008)
Q Consensus 436 ~-----~~p~~~~~l~~L~~L~Ls~N~l~~~lp~~~~~~~~~~~~L~L~~N~l~~~~p~~~~~-l~~L~~Ldls~N~l~~ 509 (1008)
. .++..+..+++|+.|+|++ .++ +..+..++. +++|+.|+|++|.+++
T Consensus 417 ~~~~~~~~~~l~~~~~~L~~L~L~~-~l~-------------------------~~~~~~l~~~~~~L~~L~L~~~~i~~ 470 (594)
T 2p1m_B 417 LEPLDIGFGAIVEHCKDLRRLSLSG-LLT-------------------------DKVFEYIGTYAKKMEMLSVAFAGDSD 470 (594)
T ss_dssp CCCTHHHHHHHHHHCTTCCEEECCS-SCC-------------------------HHHHHHHHHHCTTCCEEEEESCCSSH
T ss_pred CCchhhHHHHHHhhCCCccEEeecC-ccc-------------------------HHHHHHHHHhchhccEeeccCCCCcH
Confidence 1 1111234455666666654 333 222333333 6778888888888765
Q ss_pred CCCccc-ccccccceeeccCcccccchhh-hhhccccccEEecCCCcccccccCc--ccccccceeecccCc
Q 045798 510 EIPIEL-GHCSSLEEIYLAGNLFHGSIPS-FFNALKGVQKIDLSRNNLSGQIPIF--LEALSLEYLNLSFND 577 (1008)
Q Consensus 510 ~~p~~~-~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~ls~N~l~~~~p~~--~~~~~L~~L~l~~N~ 577 (1008)
..+..+ ..+++|++|+|++|++++..+. .+..+++|+.|++++|+++..-... ..+..|+...+..+.
T Consensus 471 ~~~~~l~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~l~~~lp~l~i~~~~~~~ 542 (594)
T 2p1m_B 471 LGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLWMSSCSVSFGACKLLGQKMPKLNVEVIDERG 542 (594)
T ss_dssp HHHHHHHHHCTTCCEEEEESCSCCHHHHHHTGGGGGGSSEEEEESSCCBHHHHHHHHHHCTTEEEEEECSSS
T ss_pred HHHHHHHhcCCCcCEEECcCCCCcHHHHHHHHHhCCCCCEEeeeCCCCCHHHHHHHHHhCCCCEEEEecCCC
Confidence 544444 5578888888888888655443 4455788888888888875322211 123345444555443
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.92 E-value=6.9e-29 Score=299.60 Aligned_cols=451 Identities=14% Similarity=0.094 Sum_probs=280.6
Q ss_pred CCCcccceEEcCCCCeEEEEeccccCCCCccCcCccCCccCCeeeecCCCCC---CCCCcc------------ccCCCCC
Q 045798 40 HFCEWEGITCGRRHRRVTALDLMSKSLSGSLSPHLGNLSFLREINLSNNTIQ---GEIPPE------------FGRLFRL 104 (1008)
Q Consensus 40 ~~c~w~gv~c~~~~~~v~~l~l~~~~l~~~l~~~l~~l~~L~~L~L~~n~~~---~~~p~~------------~~~l~~L 104 (1008)
-|++|.++... ....+++...... .....+..+++|++|+|+++... +..|.. +..+++|
T Consensus 33 vck~W~~~~~~----~~~~l~~~~~~~~-~~~~~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~~l~~l~~~~~~L 107 (594)
T 2p1m_B 33 VCKSWYEIERW----CRRKVFIGNCYAV-SPATVIRRFPKVRSVELKGKPHFADFNLVPDGWGGYVYPWIEAMSSSYTWL 107 (594)
T ss_dssp SCHHHHHHHHH----HCCEEEESSTTSS-CHHHHHHHCTTCCEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTC
T ss_pred HHHHHHHhhhh----hceEEeecccccc-CHHHHHhhCCCceEEeccCCCchhhcccccccccchhhHHHHHHHHhCCCC
Confidence 35579888221 1234455433222 12234567889999999987532 122222 2467899
Q ss_pred CEEEccCCCCCCccCcccc-cCcCcceEeeecc-ccccC-CCccccccCCCCeeecccccCCCCCCCCC----ccccccc
Q 045798 105 EALFLSNNSLVGKIPANLS-YCSRLTVLCIEYN-KLQGR-IPLEFVSLSKLKDLSLAKNKLTGGIPPFL----GNLTSLE 177 (1008)
Q Consensus 105 ~~L~Ls~n~l~~~~p~~l~-~l~~L~~L~Ls~n-~l~~~-~p~~~~~l~~L~~L~L~~n~l~~~~~~~~----~~l~~L~ 177 (1008)
++|+|++|.+++..+..+. .+++|++|+|++| .++.. ++..+.++++|++|+|++|.+++..+..+ ..+++|+
T Consensus 108 ~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~~L~ 187 (594)
T 2p1m_B 108 EEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLV 187 (594)
T ss_dssp CEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCCCCC
T ss_pred CeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCCcCc
Confidence 9999999999987777776 7899999999999 55532 44455579999999999999886554444 3667999
Q ss_pred hhhcccccCCCCCCcc----ccCCCCCcEEEecCC-cccccCCccccCCCCcceeccccc-------cccccCChhhhhc
Q 045798 178 VLSLAGNSFGRNIPDS----LGQLKQLKILAIGGN-NLSGPIPPSIYNLSFLVVFSVSHN-------QIHGSLPPSLGLL 245 (1008)
Q Consensus 178 ~L~L~~n~l~~~~~~~----~~~l~~L~~L~L~~n-~l~~~~~~~~~~l~~L~~L~ls~N-------~l~~~lp~~~~~~ 245 (1008)
+|++++|. ....... +..+++|++|++++| .+++ ++..+..+++|+.|+++.+ .+. .++..+ ..
T Consensus 188 ~L~l~~~~-~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~-~l~~~l-~~ 263 (594)
T 2p1m_B 188 SLNISCLA-SEVSFSALERLVTRCPNLKSLKLNRAVPLEK-LATLLQRAPQLEELGTGGYTAEVRPDVYS-GLSVAL-SG 263 (594)
T ss_dssp EEECTTCC-SCCCHHHHHHHHHHCTTCCEEECCTTSCHHH-HHHHHHHCTTCSEEECSBCCCCCCHHHHH-HHHHHH-HT
T ss_pred EEEecccC-CcCCHHHHHHHHHhCCCCcEEecCCCCcHHH-HHHHHhcCCcceEcccccccCccchhhHH-HHHHHH-hc
Confidence 99999997 2222222 345799999999998 4444 7788889999999995544 444 344433 45
Q ss_pred CCCCcEE-EeccccCCCCCCcccccCCCCceeecccccccccccc-cccCCCcccccccccccCCCCCCCcccccccccc
Q 045798 246 LPNLKFF-QIHHNFFSGSIPISLSNASKLEHIEIANNNFSGKLSV-NFGGMKNLSLLNLQFSNLGSGESDEMGFMNSLTN 323 (1008)
Q Consensus 246 l~~L~~L-~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~-~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~ 323 (1008)
+++|+.| .+.+... ..++..+..+++|++|++++|.+.+.... .+..+++|+.|++++| +.. ..+......
T Consensus 264 ~~~L~~Ls~~~~~~~-~~l~~~~~~~~~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~-~~~-----~~l~~l~~~ 336 (594)
T 2p1m_B 264 CKELRCLSGFWDAVP-AYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY-IED-----AGLEVLAST 336 (594)
T ss_dssp CTTCCEEECCBTCCG-GGGGGGHHHHTTCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG-GHH-----HHHHHHHHH
T ss_pred CCCcccccCCcccch-hhHHHHHHhhCCCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc-cCH-----HHHHHHHHh
Confidence 7888888 4443332 24455555778888899888886644322 2456778888888766 321 111112234
Q ss_pred cCCCcEEEecC---------CcCCccCChhhhhhcccceeeeeccccccCCCCCccc-cccccceEEec--C----cccc
Q 045798 324 CSKLRVLSLGG---------NQFRGALPHSIANLSSQLQILILSSNQFYGSIPLGIG-NLVDLYLLGMV--E----NQFT 387 (1008)
Q Consensus 324 l~~L~~L~Ls~---------N~l~~~~p~~~~~l~~~L~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~L~--~----n~l~ 387 (1008)
+++|+.|++++ +.+++.....+....++|+.|+++.|.+++..+..+. .+++|+.|+++ + |.++
T Consensus 337 ~~~L~~L~L~~~~~~g~~~~~~l~~~~l~~l~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~ 416 (594)
T 2p1m_B 337 CKDLRELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLT 416 (594)
T ss_dssp CTTCCEEEEECSCTTCSSCSSCCCHHHHHHHHHHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTT
T ss_pred CCCCCEEEEecCcccccccCCCCCHHHHHHHHHhchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCccccc
Confidence 67788887733 4444332233332223577777777776644444443 46677777776 3 4444
Q ss_pred CC-----cchhccCCCCCceEEccCCcccccccccccC-CCCcceeeccccccccccCCCC-cCCCcccEeecccccccC
Q 045798 388 GA-----IPKEMGKLQKLQGLDFSGNHFSGEIPSSLGN-LSSLYEVFFNNNNLSGVIPFSL-GNLKRLAFLEMSGNELSG 460 (1008)
Q Consensus 388 ~~-----~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-l~~L~~L~l~~N~l~~~~p~~~-~~l~~L~~L~Ls~N~l~~ 460 (1008)
+. ++..+..+++|+.|+|++ .+++..+..+.. +++|+.|+|++|.+++..+..+ ..+++|+.|+|++|.+++
T Consensus 417 ~~~~~~~~~~l~~~~~~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~ 495 (594)
T 2p1m_B 417 LEPLDIGFGAIVEHCKDLRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGD 495 (594)
T ss_dssp CCCTHHHHHHHHHHCTTCCEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCH
T ss_pred CCchhhHHHHHHhhCCCccEEeecC-cccHHHHHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcH
Confidence 21 122255566777777766 555444444443 5667777777776654433333 446667777777666642
Q ss_pred CcchhhhhhhhhhhhhcccCccccCCCc-ccccccccccccccccccccCCCCccc-ccccccceeeccCcccc
Q 045798 461 TIPEDIFNISYLSNSLNLARNHLVGIIP-PRIGNLRALRSFDVSNNDLSGEIPIEL-GHCSSLEEIYLAGNLFH 532 (1008)
Q Consensus 461 ~lp~~~~~~~~~~~~L~L~~N~l~~~~p-~~~~~l~~L~~Ldls~N~l~~~~p~~~-~~l~~L~~L~L~~N~l~ 532 (1008)
..+ ..+..+++|+.|++++|.++......+ ..++.|+...+..+.-.
T Consensus 496 -------------------------~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~l~~~lp~l~i~~~~~~~~~ 544 (594)
T 2p1m_B 496 -------------------------KALLANASKLETMRSLWMSSCSVSFGACKLLGQKMPKLNVEVIDERGAP 544 (594)
T ss_dssp -------------------------HHHHHTGGGGGGSSEEEEESSCCBHHHHHHHHHHCTTEEEEEECSSSCG
T ss_pred -------------------------HHHHHHHHhCCCCCEEeeeCCCCCHHHHHHHHHhCCCCEEEEecCCCcc
Confidence 111 233457889999999998854333333 34677777777666443
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.7e-24 Score=233.43 Aligned_cols=213 Identities=19% Similarity=0.179 Sum_probs=172.5
Q ss_pred ccCcCccCCccCCeeeecCCCCCCCCCccccCCCCCCEEEccCCCCCCccCcccccCcCcceEeeeccccccCCCccccc
Q 045798 69 SLSPHLGNLSFLREINLSNNTIQGEIPPEFGRLFRLEALFLSNNSLVGKIPANLSYCSRLTVLCIEYNKLQGRIPLEFVS 148 (1008)
Q Consensus 69 ~l~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~ 148 (1008)
.+|..+. ++|++|+|++|++++..+..|.++++|++|+|++|++++..+..|+.+++|++|+|++|++++..+..|.+
T Consensus 21 ~ip~~l~--~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~ 98 (276)
T 2z62_A 21 KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSG 98 (276)
T ss_dssp SCCSSSC--TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTT
T ss_pred ccCCCCC--CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcC
Confidence 4666554 47999999999999777778999999999999999999777778999999999999999999888888999
Q ss_pred cCCCCeeecccccCCCCCCCCCccccccchhhcccccCCCC-CCccccCCCCCcEEEecCCcccccCCccccCCCCcc--
Q 045798 149 LSKLKDLSLAKNKLTGGIPPFLGNLTSLEVLSLAGNSFGRN-IPDSLGQLKQLKILAIGGNNLSGPIPPSIYNLSFLV-- 225 (1008)
Q Consensus 149 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~-~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~-- 225 (1008)
+++|++|++++|++++..+..++++++|++|++++|++.+. +|..|..+++|++|++++|++++..+..+..+++|+
T Consensus 99 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l 178 (276)
T 2z62_A 99 LSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLL 178 (276)
T ss_dssp CTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTC
T ss_pred CccccEEECCCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHhhhhhhcccc
Confidence 99999999999999977776889999999999999998764 588899999999999999999887777777777776
Q ss_pred --eeccccccccccCChhhhhcCCCCcEEEeccccCCCCCCcccccCCCCceeecccccccc
Q 045798 226 --VFSVSHNQIHGSLPPSLGLLLPNLKFFQIHHNFFSGSIPISLSNASKLEHIEIANNNFSG 285 (1008)
Q Consensus 226 --~L~ls~N~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~ 285 (1008)
.|++++|.++ .++...+. ..+|+.|+|++|.+++..+..+..+++|++|++++|++..
T Consensus 179 ~l~L~ls~n~l~-~~~~~~~~-~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c 238 (276)
T 2z62_A 179 NLSLDLSLNPMN-FIQPGAFK-EIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDC 238 (276)
T ss_dssp CEEEECCSSCCC-EECTTSSC-SCCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBCC
T ss_pred ceeeecCCCccc-ccCccccC-CCcccEEECCCCceeecCHhHhcccccccEEEccCCcccc
Confidence 7788888887 44444443 2367777777777775555556667777777777776653
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=3e-24 Score=231.57 Aligned_cols=228 Identities=20% Similarity=0.210 Sum_probs=180.8
Q ss_pred EEEecCCcCCccCChhhhhhcccceeeeeccccccCCCCCccccccccceEEecCccccCCcchhccCCCCCceEEccCC
Q 045798 329 VLSLGGNQFRGALPHSIANLSSQLQILILSSNQFYGSIPLGIGNLVDLYLLGMVENQFTGAIPKEMGKLQKLQGLDFSGN 408 (1008)
Q Consensus 329 ~L~Ls~N~l~~~~p~~~~~l~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N 408 (1008)
..+..+..+. .+|..+. ..|++|++++|.+++..+..+.++++|++|++++|++++..+..|..+++|++|+|++|
T Consensus 11 ~~~c~~~~l~-~ip~~l~---~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n 86 (276)
T 2z62_A 11 TYQCMELNFY-KIPDNLP---FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGN 86 (276)
T ss_dssp EEECTTSCCS-SCCSSSC---TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTC
T ss_pred eEEecCCCcc-ccCCCCC---CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCC
Confidence 4566677776 5666543 35888888888888666667888888888888888888777778888888888888888
Q ss_pred cccccccccccCCCCcceeeccccccccccCCCCcCCCcccEeecccccccCCcchhhhhhhhhhhhhcccCccccCCCc
Q 045798 409 HFSGEIPSSLGNLSSLYEVFFNNNNLSGVIPFSLGNLKRLAFLEMSGNELSGTIPEDIFNISYLSNSLNLARNHLVGIIP 488 (1008)
Q Consensus 409 ~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~lp~~~~~~~~~~~~L~L~~N~l~~~~p 488 (1008)
++++..+..|.++++|++|++++|.+.+..+..+..+++|++|++++|++++ ..+|
T Consensus 87 ~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~------------------------~~l~ 142 (276)
T 2z62_A 87 PIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQS------------------------FKLP 142 (276)
T ss_dssp CCCEECTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCC------------------------CCCC
T ss_pred ccCccChhhhcCCccccEEECCCCCccccCchhcccCCCCCEEECcCCccce------------------------ecCc
Confidence 8887777788888888888888888887777678888888888888888763 0257
Q ss_pred ccccccccccccccccccccCCCCcccccccccc----eeeccCcccccchhhhhhccccccEEecCCCcccccccCc-c
Q 045798 489 PRIGNLRALRSFDVSNNDLSGEIPIELGHCSSLE----EIYLAGNLFHGSIPSFFNALKGVQKIDLSRNNLSGQIPIF-L 563 (1008)
Q Consensus 489 ~~~~~l~~L~~Ldls~N~l~~~~p~~~~~l~~L~----~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~-~ 563 (1008)
..++.+++|+.|+|++|.+++..+..+..+++|+ +|++++|++++..+..+. ..+|+.|+|++|++++..+.. .
T Consensus 143 ~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l~L~ls~n~l~~~~~~~~~-~~~L~~L~L~~n~l~~~~~~~~~ 221 (276)
T 2z62_A 143 EYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFK-EIRLKELALDTNQLKSVPDGIFD 221 (276)
T ss_dssp GGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCEEEECCSSCCCEECTTSSC-SCCEEEEECCSSCCSCCCTTTTT
T ss_pred hhhccCCCCCEEECCCCCCCcCCHHHhhhhhhccccceeeecCCCcccccCccccC-CCcccEEECCCCceeecCHhHhc
Confidence 7788889999999999999877777888888887 889999999865555554 447999999999998776655 5
Q ss_pred cccccceeecccCcccccCCCC
Q 045798 564 EALSLEYLNLSFNDFEGKIPAK 585 (1008)
Q Consensus 564 ~~~~L~~L~l~~N~l~g~~p~~ 585 (1008)
.+.+|+.|++++|++++..|..
T Consensus 222 ~l~~L~~L~l~~N~~~c~c~~l 243 (276)
T 2z62_A 222 RLTSLQKIWLHTNPWDCSCPRI 243 (276)
T ss_dssp TCCSCCEEECCSSCBCCCTTTT
T ss_pred ccccccEEEccCCcccccCCch
Confidence 6778999999999999887754
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.91 E-value=9.4e-25 Score=234.56 Aligned_cols=200 Identities=21% Similarity=0.304 Sum_probs=153.6
Q ss_pred cceeeeeccccccCCCCCccccccccceEEecCccccCCcchhccCCCCCceEEccCCcccccccccccCCCCcceeecc
Q 045798 351 QLQILILSSNQFYGSIPLGIGNLVDLYLLGMVENQFTGAIPKEMGKLQKLQGLDFSGNHFSGEIPSSLGNLSSLYEVFFN 430 (1008)
Q Consensus 351 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~ 430 (1008)
+|+.|++++|.++ .+ ..+..+++|++|++++|++++. ..+..+++|++|+|++|.+++..+..|.++++|++|+++
T Consensus 42 ~L~~L~l~~~~i~-~~-~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 117 (272)
T 3rfs_A 42 SIDQIIANNSDIK-SV-QGIQYLPNVRYLALGGNKLHDI--SALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLV 117 (272)
T ss_dssp TCCEEECTTSCCC-CC-TTGGGCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECT
T ss_pred ceeeeeeCCCCcc-cc-cccccCCCCcEEECCCCCCCCc--hhhcCCCCCCEEECCCCccCccChhHhcCCcCCCEEECC
Confidence 3666666666655 22 2356666777777777776642 356777777777777777776666667777777777777
Q ss_pred ccccccccCCCCcCCCcccEeecccccccCCcchhhhhhhhhhhhhcccCccccCCCcccccccccccccccccccccCC
Q 045798 431 NNNLSGVIPFSLGNLKRLAFLEMSGNELSGTIPEDIFNISYLSNSLNLARNHLVGIIPPRIGNLRALRSFDVSNNDLSGE 510 (1008)
Q Consensus 431 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~lp~~~~~~~~~~~~L~L~~N~l~~~~p~~~~~l~~L~~Ldls~N~l~~~ 510 (1008)
+|.+++..+..|+.+++|++|+|++|++++ ..+..++.+++|+.|++++|.+++.
T Consensus 118 ~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-------------------------~~~~~~~~l~~L~~L~l~~n~l~~~ 172 (272)
T 3rfs_A 118 ENQLQSLPDGVFDKLTNLTYLNLAHNQLQS-------------------------LPKGVFDKLTNLTELDLSYNQLQSL 172 (272)
T ss_dssp TSCCCCCCTTTTTTCTTCCEEECCSSCCCC-------------------------CCTTTTTTCTTCCEEECCSSCCCCC
T ss_pred CCcCCccCHHHhccCCCCCEEECCCCccCc-------------------------cCHHHhccCccCCEEECCCCCcCcc
Confidence 777776666667777777777777777763 4445567788899999999999877
Q ss_pred CCcccccccccceeeccCcccccchhhhhhccccccEEecCCCcccccccCcccccccceeecccCcccccCCCC
Q 045798 511 IPIELGHCSSLEEIYLAGNLFHGSIPSFFNALKGVQKIDLSRNNLSGQIPIFLEALSLEYLNLSFNDFEGKIPAK 585 (1008)
Q Consensus 511 ~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~L~~L~l~~N~l~g~~p~~ 585 (1008)
.|..++.+++|++|+|++|++++.+|..|..+++|+.|+|++|++.+..| .|+.|+++.|.++|.+|..
T Consensus 173 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~------~l~~l~~~~n~~~g~ip~~ 241 (272)
T 3rfs_A 173 PEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCP------GIRYLSEWINKHSGVVRNS 241 (272)
T ss_dssp CTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT------TTHHHHHHHHHTGGGBBCT
T ss_pred CHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCccccCc------HHHHHHHHHHhCCCcccCc
Confidence 77778889999999999999998888888999999999999999887655 5888999999999999975
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.91 E-value=5.8e-24 Score=225.54 Aligned_cols=192 Identities=22% Similarity=0.220 Sum_probs=163.2
Q ss_pred CCCcccceEEcCCCCeEEEEeccccCCCCccCcCccCCccCCeeeecCCCCCCCCCccccCCCCCCEEEccCCCCCCccC
Q 045798 40 HFCEWEGITCGRRHRRVTALDLMSKSLSGSLSPHLGNLSFLREINLSNNTIQGEIPPEFGRLFRLEALFLSNNSLVGKIP 119 (1008)
Q Consensus 40 ~~c~w~gv~c~~~~~~v~~l~l~~~~l~~~l~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p 119 (1008)
+||.|.|++|... .+.+|+++++++ .+|..+. +.|++|+|++|++++..+..|.++++|++|+|++|++++..|
T Consensus 3 ~Cp~~~gC~C~~~---~~~l~~~~~~l~-~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~ 76 (251)
T 3m19_A 3 TCETVTGCTCNEG---KKEVDCQGKSLD-SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSA 76 (251)
T ss_dssp -CHHHHSSEEEGG---GTEEECTTCCCS-SCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCT
T ss_pred cCCCCCceEcCCC---CeEEecCCCCcc-ccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCH
Confidence 6889999999643 346788888888 6777665 589999999999998888889999999999999999998888
Q ss_pred cccccCcCcceEeeeccccccCCCccccccCCCCeeecccccCCCCCCCCCccccccchhhcccccCCCCCCccccCCCC
Q 045798 120 ANLSYCSRLTVLCIEYNKLQGRIPLEFVSLSKLKDLSLAKNKLTGGIPPFLGNLTSLEVLSLAGNSFGRNIPDSLGQLKQ 199 (1008)
Q Consensus 120 ~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~ 199 (1008)
..|..+++|++|+|++|++++..+..|..+++|++|+|++|+|++..+..|.++++|++|+|++|++++..+..|..+++
T Consensus 77 ~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~ 156 (251)
T 3m19_A 77 GVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTN 156 (251)
T ss_dssp TTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTT
T ss_pred hHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcC
Confidence 88999999999999999999777788888999999999999998766667888889999999999988777778888888
Q ss_pred CcEEEecCCcccccCCccccCCCCcceecccccccccc
Q 045798 200 LKILAIGGNNLSGPIPPSIYNLSFLVVFSVSHNQIHGS 237 (1008)
Q Consensus 200 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~~~ 237 (1008)
|++|+|++|++++..+..|..+++|+.|++++|.+...
T Consensus 157 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 194 (251)
T 3m19_A 157 LQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDCS 194 (251)
T ss_dssp CCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCTT
T ss_pred CCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeCC
Confidence 99999999988877777888888888888888887643
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.91 E-value=2.2e-23 Score=223.67 Aligned_cols=202 Identities=22% Similarity=0.247 Sum_probs=150.4
Q ss_pred cCCeeeecCCCCCCCCCccccCCCCCCEEEccCCCCCCccCcccccCcCcceEeeeccccccCCCccccccCCCCeeecc
Q 045798 79 FLREINLSNNTIQGEIPPEFGRLFRLEALFLSNNSLVGKIPANLSYCSRLTVLCIEYNKLQGRIPLEFVSLSKLKDLSLA 158 (1008)
Q Consensus 79 ~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~ 158 (1008)
.++++++++++++ .+|..+. ++|++|+|++|++++..+..|+.+++|++|+|++|+++...+..|.++++|++|+|+
T Consensus 17 ~~~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~ 93 (270)
T 2o6q_A 17 NKNSVDCSSKKLT-AIPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVT 93 (270)
T ss_dssp TTTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECC
T ss_pred CCCEEEccCCCCC-ccCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECC
Confidence 4678888888888 5676554 678888888888887667788888888888888888886666667788888888888
Q ss_pred cccCCCCCCCCCccccccchhhcccccCCCCCCccccCCCCCcEEEecCCcccccCCccccCCCCcceeccccccccccC
Q 045798 159 KNKLTGGIPPFLGNLTSLEVLSLAGNSFGRNIPDSLGQLKQLKILAIGGNNLSGPIPPSIYNLSFLVVFSVSHNQIHGSL 238 (1008)
Q Consensus 159 ~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~~~l 238 (1008)
+|++++..+..|.++++|++|++++|++++..+..|..+++|++|+|++|.+++..+..|..+++|+.|++++|+++ .+
T Consensus 94 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~~ 172 (270)
T 2o6q_A 94 DNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLK-RV 172 (270)
T ss_dssp SSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCS-CC
T ss_pred CCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCc-Ee
Confidence 88888666667788888888888888887777777888888888888888887666666777777777777777776 45
Q ss_pred ChhhhhcCCCCcEEEeccccCCCCCCcccccCCCCceeeccccccc
Q 045798 239 PPSLGLLLPNLKFFQIHHNFFSGSIPISLSNASKLEHIEIANNNFS 284 (1008)
Q Consensus 239 p~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~ 284 (1008)
+...+..+++|++|+|++|.+++..+..+..+++|+.|++++|.+.
T Consensus 173 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~ 218 (270)
T 2o6q_A 173 PEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWD 218 (270)
T ss_dssp CTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBC
T ss_pred ChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCee
Confidence 5554445666666666666666544445555666666666666554
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.91 E-value=1.2e-23 Score=227.69 Aligned_cols=203 Identities=25% Similarity=0.269 Sum_probs=151.2
Q ss_pred ccCCccCCeeeecCCCCCCCCCccccCCCCCCEEEccCCCCCCccCcccccCcCcceEeeeccccccCCCccccccCCCC
Q 045798 74 LGNLSFLREINLSNNTIQGEIPPEFGRLFRLEALFLSNNSLVGKIPANLSYCSRLTVLCIEYNKLQGRIPLEFVSLSKLK 153 (1008)
Q Consensus 74 l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~ 153 (1008)
+..+++|+++++++|+++ .+|..+. +++++|+|++|.+++..|..|..+++|++|+|++|.|++..+. ..+++|+
T Consensus 6 ~~~l~~l~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~--~~l~~L~ 80 (290)
T 1p9a_G 6 VSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVD--GTLPVLG 80 (290)
T ss_dssp EECSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEECC--SCCTTCC
T ss_pred ccccCCccEEECCCCCCC-cCCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccCC--CCCCcCC
Confidence 556677777888877777 5565553 5777888888888776677777788888888888887754332 6677788
Q ss_pred eeecccccCCCCCCCCCccccccchhhcccccCCCCCCccccCCCCCcEEEecCCcccccCCccccCCCCcceecccccc
Q 045798 154 DLSLAKNKLTGGIPPFLGNLTSLEVLSLAGNSFGRNIPDSLGQLKQLKILAIGGNNLSGPIPPSIYNLSFLVVFSVSHNQ 233 (1008)
Q Consensus 154 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ls~N~ 233 (1008)
+|+|++|+++ .+|..+..+++|++|+|++|++++..+..|..+++|++|+|++|++++..+..|..+++|+.|+|++|+
T Consensus 81 ~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~ 159 (290)
T 1p9a_G 81 TLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNN 159 (290)
T ss_dssp EEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSC
T ss_pred EEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCc
Confidence 8888888877 667777777888888888888877667778888888888888888877666677777778888888887
Q ss_pred ccccCChhhhhcCCCCcEEEeccccCCCCCCcccccCCCCceeeccccccc
Q 045798 234 IHGSLPPSLGLLLPNLKFFQIHHNFFSGSIPISLSNASKLEHIEIANNNFS 284 (1008)
Q Consensus 234 l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~ 284 (1008)
++ .+|..++..+++|++|+|++|+++ .+|..+..+.+|+.|++++|.+.
T Consensus 160 l~-~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~~ 208 (290)
T 1p9a_G 160 LT-ELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWL 208 (290)
T ss_dssp CS-CCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBC
T ss_pred CC-ccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCCcc
Confidence 77 677766666777777777777777 56666666777777777777765
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=7.5e-25 Score=257.07 Aligned_cols=192 Identities=18% Similarity=0.146 Sum_probs=142.6
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccc--------hhhHHHHHHHHHHhhcCCCCceeeeecccccc
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCE--------GASKSFMAECKALKNIRHRNLVKVITSCSSID 754 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 754 (1008)
...+...+.||+|+||.||+|.. .++.+|+|+...... ...+++.+|++++++++||||+++..++.
T Consensus 335 ~~~~~~~~~LG~G~fg~Vy~~~~--~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~--- 409 (540)
T 3en9_A 335 KKRKIPEHLIGKGAEADIKRDSY--LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDV--- 409 (540)
T ss_dssp -------------CCEEEEEEEC--SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEE---
T ss_pred cccCCCCCEEeeCCCEEEEEEEE--CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEE---
Confidence 33345567999999999999955 678899998643211 12346899999999999999995444432
Q ss_pred ccCCceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecC
Q 045798 755 FQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDN 834 (1008)
Q Consensus 755 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~ 834 (1008)
..+..|+||||+++++|.+++.. +..++.|+++||+|||++ +|+||||||+|||++.
T Consensus 410 --~~~~~~lVmE~~~ggsL~~~l~~------------------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~ 466 (540)
T 3en9_A 410 --DLDNKRIMMSYINGKLAKDVIED------------------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK 466 (540)
T ss_dssp --ETTTTEEEEECCCSEEHHHHSTT------------------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS
T ss_pred --eCCccEEEEECCCCCCHHHHHHH------------------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC
Confidence 23446999999999999999863 457999999999999998 9999999999999998
Q ss_pred CCCeEEcccCcccccccccCcccc---ccccccccccccCccccCC--CCCCcccchhhHHHHHHHHHhCCCCCC
Q 045798 835 DLSGHIGDFGLARFHQEVSNSTLS---SSVGVKGTIGYTAPEYGLG--SEVSTNGDVYSYGILLLEMVTAKKPTD 904 (1008)
Q Consensus 835 ~~~~kL~Dfg~a~~~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwslG~vl~elltG~~pf~ 904 (1008)
.+||+|||+|+........... ......||+.|+|||++.. ..|+..+|+|+..+-..+-+.++.+|.
T Consensus 467 --~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 467 --DLYIIDFGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp --SEEECCCTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred --eEEEEECccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 9999999999977543221100 1124569999999999876 567888999999999999888887763
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.90 E-value=9.1e-24 Score=231.72 Aligned_cols=229 Identities=18% Similarity=0.176 Sum_probs=165.1
Q ss_pred CCCcEEEecCCcCCccCChh---hhhhcccceeeeeccccccCCCCCcc--ccccccceEEecCccccCCcc----hhcc
Q 045798 325 SKLRVLSLGGNQFRGALPHS---IANLSSQLQILILSSNQFYGSIPLGI--GNLVDLYLLGMVENQFTGAIP----KEMG 395 (1008)
Q Consensus 325 ~~L~~L~Ls~N~l~~~~p~~---~~~l~~~L~~L~Ls~N~l~~~~p~~~--~~l~~L~~L~L~~n~l~~~~~----~~~~ 395 (1008)
..++.+.+.++.+....-.. +... ++|++|++++|.+++..|..+ ..+++|+.|+|++|++++..+ ..+.
T Consensus 64 ~~l~~l~l~~~~~~~~~~~~~~~~~~~-~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~ 142 (310)
T 4glp_A 64 LRVRRLTVGAAQVPAQLLVGALRVLAY-SRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQW 142 (310)
T ss_dssp CCCCEEEECSCCCBHHHHHHHHHHHHH-SCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTT
T ss_pred cceeEEEEeCCcCCHHHHHHHHHhccc-CceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhh
Confidence 35677788877765221111 1122 259999999999999999888 899999999999999997655 4556
Q ss_pred CCCCCceEEccCCcccccccccccCCCCcceeeccccccccc--c--CCCCcCCCcccEeecccccccCCcchhhhhhhh
Q 045798 396 KLQKLQGLDFSGNHFSGEIPSSLGNLSSLYEVFFNNNNLSGV--I--PFSLGNLKRLAFLEMSGNELSGTIPEDIFNISY 471 (1008)
Q Consensus 396 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~--~--p~~~~~l~~L~~L~Ls~N~l~~~lp~~~~~~~~ 471 (1008)
.+++|++|+|++|++.+..|..|..+++|++|+|++|++.+. + +..+..+++|++|+|++|+++ .+|....
T Consensus 143 ~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~l~~~~~---- 217 (310)
T 4glp_A 143 LKPGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGME-TPTGVCA---- 217 (310)
T ss_dssp BCSCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCC-CHHHHHH----
T ss_pred hccCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCC-chHHHHH----
Confidence 789999999999999988888999999999999999998752 2 333578899999999999997 3333211
Q ss_pred hhhhhcccCccccCCCcccccccccccccccccccccCCCCcccccc---cccceeeccCcccccchhhhhhccccccEE
Q 045798 472 LSNSLNLARNHLVGIIPPRIGNLRALRSFDVSNNDLSGEIPIELGHC---SSLEEIYLAGNLFHGSIPSFFNALKGVQKI 548 (1008)
Q Consensus 472 ~~~~L~L~~N~l~~~~p~~~~~l~~L~~Ldls~N~l~~~~p~~~~~l---~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 548 (1008)
..++.+++|++|||++|.+++..|..+..+ ++|++|+|++|+|+ .+|..+. ++|+.|
T Consensus 218 -----------------~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L 277 (310)
T 4glp_A 218 -----------------ALAAAGVQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLP--AKLRVL 277 (310)
T ss_dssp -----------------HHHHHTCCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCC--SCCSCE
T ss_pred -----------------HHHhcCCCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhc--CCCCEE
Confidence 013455667777777777776666666665 47777777777777 5565553 677777
Q ss_pred ecCCCcccccccCcccccccceeecccCcccc
Q 045798 549 DLSRNNLSGQIPIFLEALSLEYLNLSFNDFEG 580 (1008)
Q Consensus 549 ~ls~N~l~~~~p~~~~~~~L~~L~l~~N~l~g 580 (1008)
||++|++++. |....+..|+.|+|++|+|+.
T Consensus 278 ~Ls~N~l~~~-~~~~~l~~L~~L~L~~N~l~~ 308 (310)
T 4glp_A 278 DLSSNRLNRA-PQPDELPEVDNLTLDGNPFLV 308 (310)
T ss_dssp ECCSCCCCSC-CCTTSCCCCSCEECSSTTTSC
T ss_pred ECCCCcCCCC-chhhhCCCccEEECcCCCCCC
Confidence 7777777753 334455667777777777654
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.90 E-value=1.5e-23 Score=226.90 Aligned_cols=204 Identities=23% Similarity=0.214 Sum_probs=149.4
Q ss_pred ccccCCCcEEEecCCcCCccCChhhhhhcccceeeeeccccccCCCCCccccccccceEEecCccccCCcchhccCCCCC
Q 045798 321 LTNCSKLRVLSLGGNQFRGALPHSIANLSSQLQILILSSNQFYGSIPLGIGNLVDLYLLGMVENQFTGAIPKEMGKLQKL 400 (1008)
Q Consensus 321 l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L 400 (1008)
+.++++++.+++++|.++ .+|..+. ..++.|+|++|.+++..|..|..+++|+.|+|++|.|++..+. ..+++|
T Consensus 6 ~~~l~~l~~l~~~~~~l~-~ip~~~~---~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~--~~l~~L 79 (290)
T 1p9a_G 6 VSKVASHLEVNCDKRNLT-ALPPDLP---KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVD--GTLPVL 79 (290)
T ss_dssp EECSTTCCEEECTTSCCS-SCCSCCC---TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEECC--SCCTTC
T ss_pred ccccCCccEEECCCCCCC-cCCCCCC---CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccCC--CCCCcC
Confidence 456777888888888887 5665543 3588888888888877777788888888888888888754332 677888
Q ss_pred ceEEccCCcccccccccccCCCCcceeeccccccccccCCCCcCCCcccEeecccccccCCcchhhhhhhhhhhhhcccC
Q 045798 401 QGLDFSGNHFSGEIPSSLGNLSSLYEVFFNNNNLSGVIPFSLGNLKRLAFLEMSGNELSGTIPEDIFNISYLSNSLNLAR 480 (1008)
Q Consensus 401 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~lp~~~~~~~~~~~~L~L~~ 480 (1008)
++|+|++|+++ .+|..+..+++|+.|++++|+|++..|..|.++++|+.|+|++|++++
T Consensus 80 ~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~-------------------- 138 (290)
T 1p9a_G 80 GTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKT-------------------- 138 (290)
T ss_dssp CEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCC--------------------
T ss_pred CEEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCc--------------------
Confidence 88888888887 667777788888888888888887777778888888888888887762
Q ss_pred ccccCCCcccccccccccccccccccccCCCCcccccccccceeeccCcccccchhhhhhccccccEEecCCCcccc
Q 045798 481 NHLVGIIPPRIGNLRALRSFDVSNNDLSGEIPIELGHCSSLEEIYLAGNLFHGSIPSFFNALKGVQKIDLSRNNLSG 557 (1008)
Q Consensus 481 N~l~~~~p~~~~~l~~L~~Ldls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~ 557 (1008)
..+..|..+++|+.|+|++|++++..+..+..+++|+.|+|++|+|+ .+|..+..+.+|+.|+|++|++..
T Consensus 139 -----~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~~C 209 (290)
T 1p9a_G 139 -----LPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLC 209 (290)
T ss_dssp -----CCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCC
T ss_pred -----cChhhcccccCCCEEECCCCcCCccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCCccC
Confidence 23344556677777777777777444445566777777777777777 566666667777777777777664
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.90 E-value=2e-23 Score=224.24 Aligned_cols=211 Identities=24% Similarity=0.256 Sum_probs=158.7
Q ss_pred ccCCccCCeeeecCCCCCCCCCccccCCCCCCEEEccCCCCCCccCcccccCcCcceEeeeccccccCCCccccccCCCC
Q 045798 74 LGNLSFLREINLSNNTIQGEIPPEFGRLFRLEALFLSNNSLVGKIPANLSYCSRLTVLCIEYNKLQGRIPLEFVSLSKLK 153 (1008)
Q Consensus 74 l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~ 153 (1008)
+..+++|+.|++++|.++ .++ .+..+++|++|+|++|.+++ + ..++.+++|++|+|++|.+++..+..|.++++|+
T Consensus 37 ~~~l~~L~~L~l~~~~i~-~~~-~l~~l~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~ 112 (272)
T 3rfs_A 37 QNELNSIDQIIANNSDIK-SVQ-GIQYLPNVRYLALGGNKLHD-I-SALKELTNLTYLILTGNQLQSLPNGVFDKLTNLK 112 (272)
T ss_dssp HHHHTTCCEEECTTSCCC-CCT-TGGGCTTCCEEECTTSCCCC-C-GGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCC
T ss_pred cccccceeeeeeCCCCcc-ccc-ccccCCCCcEEECCCCCCCC-c-hhhcCCCCCCEEECCCCccCccChhHhcCCcCCC
Confidence 456677788888887776 333 47778888888888888774 2 3677788888888888888876666777788888
Q ss_pred eeecccccCCCCCCCCCccccccchhhcccccCCCCCCccccCCCCCcEEEecCCcccccCCccccCCCCcceecccccc
Q 045798 154 DLSLAKNKLTGGIPPFLGNLTSLEVLSLAGNSFGRNIPDSLGQLKQLKILAIGGNNLSGPIPPSIYNLSFLVVFSVSHNQ 233 (1008)
Q Consensus 154 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ls~N~ 233 (1008)
+|+|++|++++..+..|+++++|++|++++|++++..+..|..+++|+.|++++|++++..+..+..+++|+.|++++|+
T Consensus 113 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~ 192 (272)
T 3rfs_A 113 ELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQ 192 (272)
T ss_dssp EEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred EEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCc
Confidence 88888888886666667778888888888888877777777788888888888888887767777788888888888888
Q ss_pred ccccCChhhhhcCCCCcEEEeccccCCCCCCcccccCCCCceeecccccccccccccccCCCc
Q 045798 234 IHGSLPPSLGLLLPNLKFFQIHHNFFSGSIPISLSNASKLEHIEIANNNFSGKLSVNFGGMKN 296 (1008)
Q Consensus 234 l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~ 296 (1008)
++ .++...+..+++|++|+|++|.+.+ .+++|+.|++..|.+++..|..++.+..
T Consensus 193 l~-~~~~~~~~~l~~L~~L~l~~N~~~~-------~~~~l~~l~~~~n~~~g~ip~~~~~~~~ 247 (272)
T 3rfs_A 193 LK-SVPDGVFDRLTSLQYIWLHDNPWDC-------TCPGIRYLSEWINKHSGVVRNSAGSVAP 247 (272)
T ss_dssp CS-CCCTTTTTTCTTCCEEECCSSCBCC-------CTTTTHHHHHHHHHTGGGBBCTTSCBCG
T ss_pred CC-ccCHHHHhCCcCCCEEEccCCCccc-------cCcHHHHHHHHHHhCCCcccCcccccCC
Confidence 87 4555555567888888888887763 3556888888888888888877765544
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.90 E-value=2.5e-23 Score=218.93 Aligned_cols=203 Identities=14% Similarity=0.150 Sum_probs=150.2
Q ss_pred ccCcCccCCccCCeeeecCCCCCCCCCccccCCCCCCEEEccCCC-CCCccCcccccCcCcceEeeec-cccccCCCccc
Q 045798 69 SLSPHLGNLSFLREINLSNNTIQGEIPPEFGRLFRLEALFLSNNS-LVGKIPANLSYCSRLTVLCIEY-NKLQGRIPLEF 146 (1008)
Q Consensus 69 ~l~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~-l~~~~p~~l~~l~~L~~L~Ls~-n~l~~~~p~~~ 146 (1008)
.+|. +. .+|++|+|++|++++..+..|.++++|++|++++|. +++..+..|+.+++|++|++++ |++++..+..|
T Consensus 25 ~ip~-~~--~~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f 101 (239)
T 2xwt_C 25 RIPS-LP--PSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDAL 101 (239)
T ss_dssp SCCC-CC--TTCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSE
T ss_pred ccCC-CC--CcccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHh
Confidence 4665 43 389999999999997777789999999999999997 8866667899999999999998 99997777888
Q ss_pred cccCCCCeeecccccCCCCCCCCCccccccc---hhhcccc-cCCCCCCccccCCCCCc-EEEecCCcccccCCccccCC
Q 045798 147 VSLSKLKDLSLAKNKLTGGIPPFLGNLTSLE---VLSLAGN-SFGRNIPDSLGQLKQLK-ILAIGGNNLSGPIPPSIYNL 221 (1008)
Q Consensus 147 ~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~---~L~L~~n-~l~~~~~~~~~~l~~L~-~L~L~~n~l~~~~~~~~~~l 221 (1008)
.++++|++|++++|++++ +|. |..+++|+ +|++++| ++++..+..|..+++|+ .|++++|+++.+.+..|..
T Consensus 102 ~~l~~L~~L~l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~~i~~~~~~~- 178 (239)
T 2xwt_C 102 KELPLLKFLGIFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTSVQGYAFNG- 178 (239)
T ss_dssp ECCTTCCEEEEEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCCEECTTTTTT-
T ss_pred CCCCCCCEEeCCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCcccCHhhcCC-
Confidence 889999999999999885 665 77777777 8888888 77766666777777777 7777777777444444444
Q ss_pred CCcceecccccc-ccccCChhhhhcC-CCCcEEEeccccCCCCCCcccccCCCCceeecccc
Q 045798 222 SFLVVFSVSHNQ-IHGSLPPSLGLLL-PNLKFFQIHHNFFSGSIPISLSNASKLEHIEIANN 281 (1008)
Q Consensus 222 ~~L~~L~ls~N~-l~~~lp~~~~~~l-~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N 281 (1008)
++|+.|++++|+ ++ .+|...+..+ ++|+.|+|++|.+++ +|.. .+++|+.|+++++
T Consensus 179 ~~L~~L~L~~n~~l~-~i~~~~~~~l~~~L~~L~l~~N~l~~-l~~~--~~~~L~~L~l~~~ 236 (239)
T 2xwt_C 179 TKLDAVYLNKNKYLT-VIDKDAFGGVYSGPSLLDVSQTSVTA-LPSK--GLEHLKELIARNT 236 (239)
T ss_dssp CEEEEEECTTCTTCC-EECTTTTTTCSBCCSEEECTTCCCCC-CCCT--TCTTCSEEECTTC
T ss_pred CCCCEEEcCCCCCcc-cCCHHHhhccccCCcEEECCCCcccc-CChh--HhccCceeeccCc
Confidence 677777777774 65 5555555555 666666666666663 3322 4455555555544
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.89 E-value=1.4e-24 Score=243.74 Aligned_cols=122 Identities=14% Similarity=0.161 Sum_probs=60.2
Q ss_pred ccceEEecCccccCCcchhcc----CC-CCCceEEccCCccccc----ccccccC-CCCcceeeccccccccccC----C
Q 045798 375 DLYLLGMVENQFTGAIPKEMG----KL-QKLQGLDFSGNHFSGE----IPSSLGN-LSSLYEVFFNNNNLSGVIP----F 440 (1008)
Q Consensus 375 ~L~~L~L~~n~l~~~~~~~~~----~l-~~L~~L~Ls~N~l~~~----~p~~~~~-l~~L~~L~l~~N~l~~~~p----~ 440 (1008)
+|+.|+|++|++++..+..+. .+ ++|+.|||++|.|++. ++..+.. .++|++|+|++|.+++..+ .
T Consensus 168 ~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~ 247 (362)
T 3goz_A 168 NVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKL 247 (362)
T ss_dssp TCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHHSCTTCCEEECCSSCCCCCCHHHHHH
T ss_pred cccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHHHHHHHhcCCCCceEEECcCCCCCcHHHHHHHH
Confidence 444555555554444433222 22 3555555555555531 3333333 2355555555555554322 3
Q ss_pred CCcCCCcccEeecccccccCCcchhhhhhhhhhhhhcccCccccCCCcccccccccccccccccccccCCCCcc
Q 045798 441 SLGNLKRLAFLEMSGNELSGTIPEDIFNISYLSNSLNLARNHLVGIIPPRIGNLRALRSFDVSNNDLSGEIPIE 514 (1008)
Q Consensus 441 ~~~~l~~L~~L~Ls~N~l~~~lp~~~~~~~~~~~~L~L~~N~l~~~~p~~~~~l~~L~~Ldls~N~l~~~~p~~ 514 (1008)
.+..+++|+.|+|++|.+.+..+..+. .++..+..+++|+.||+++|.+.+..|..
T Consensus 248 ~~~~l~~L~~L~L~~n~l~~i~~~~~~------------------~l~~~~~~l~~L~~LdL~~N~l~~~~~~~ 303 (362)
T 3goz_A 248 LKDSLKHLQTVYLDYDIVKNMSKEQCK------------------ALGAAFPNIQKIILVDKNGKEIHPSHSIP 303 (362)
T ss_dssp TTTTTTTCSEEEEEHHHHTTCCHHHHH------------------HHHTTSTTCCEEEEECTTSCBCCGGGCHH
T ss_pred HHhcCCCccEEEeccCCccccCHHHHH------------------HHHHHhccCCceEEEecCCCcCCCcchHH
Confidence 345566677777777765521111111 22334555666777777777766544433
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.89 E-value=4.8e-23 Score=218.43 Aligned_cols=179 Identities=20% Similarity=0.228 Sum_probs=118.4
Q ss_pred ceeeeeccccccCCCCCccccccccceEEecCccccCCcchhccCCCCCceEEccCCcccccccccccCCCCcceeeccc
Q 045798 352 LQILILSSNQFYGSIPLGIGNLVDLYLLGMVENQFTGAIPKEMGKLQKLQGLDFSGNHFSGEIPSSLGNLSSLYEVFFNN 431 (1008)
Q Consensus 352 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~ 431 (1008)
.+.++++++.++ .+|..+. ++++.|+|++|++.+..+..|..+++|++|+|++|++++..+..|..+++|++|+|++
T Consensus 16 ~~~l~~~~~~l~-~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~ 92 (251)
T 3m19_A 16 KKEVDCQGKSLD-SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLAN 92 (251)
T ss_dssp GTEEECTTCCCS-SCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTT
T ss_pred CeEEecCCCCcc-ccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECCC
Confidence 455566666655 4554443 4566666666666666666666666777777777777666666666666777777777
Q ss_pred cccccccCCCCcCCCcccEeecccccccCCcchhhhhhhhhhhhhcccCccccCCCcccccccccccccccccccccCCC
Q 045798 432 NNLSGVIPFSLGNLKRLAFLEMSGNELSGTIPEDIFNISYLSNSLNLARNHLVGIIPPRIGNLRALRSFDVSNNDLSGEI 511 (1008)
Q Consensus 432 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~lp~~~~~~~~~~~~L~L~~N~l~~~~p~~~~~l~~L~~Ldls~N~l~~~~ 511 (1008)
|.+++..+..|..+++|++|+|++|++++ ..+..|..+++|+.|+|++|.+++..
T Consensus 93 n~l~~~~~~~~~~l~~L~~L~L~~N~l~~-------------------------~~~~~~~~l~~L~~L~Ls~N~l~~~~ 147 (251)
T 3m19_A 93 NQLASLPLGVFDHLTQLDKLYLGGNQLKS-------------------------LPSGVFDRLTKLKELRLNTNQLQSIP 147 (251)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCCC-------------------------CCTTTTTTCTTCCEEECCSSCCCCCC
T ss_pred CcccccChhHhcccCCCCEEEcCCCcCCC-------------------------cChhHhccCCcccEEECcCCcCCccC
Confidence 77766666666777777777777777662 22334556667777777777777555
Q ss_pred CcccccccccceeeccCcccccchhhhhhccccccEEecCCCccccc
Q 045798 512 PIELGHCSSLEEIYLAGNLFHGSIPSFFNALKGVQKIDLSRNNLSGQ 558 (1008)
Q Consensus 512 p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~ 558 (1008)
|..|+.+++|++|+|++|+|++..|..|..+++|+.|+|++|++++.
T Consensus 148 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 194 (251)
T 3m19_A 148 AGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDCS 194 (251)
T ss_dssp TTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCTT
T ss_pred HHHcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeCC
Confidence 55677777777777777777766666777777777777777777765
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.88 E-value=1.1e-22 Score=213.92 Aligned_cols=214 Identities=20% Similarity=0.185 Sum_probs=183.4
Q ss_pred CCCCCcc-cce--EEcC------CCCeEEEEeccccCCCCccCcCccCCccCCeeeecCCC-CCCCCCccccCCCCCCEE
Q 045798 38 SRHFCEW-EGI--TCGR------RHRRVTALDLMSKSLSGSLSPHLGNLSFLREINLSNNT-IQGEIPPEFGRLFRLEAL 107 (1008)
Q Consensus 38 ~~~~c~w-~gv--~c~~------~~~~v~~l~l~~~~l~~~l~~~l~~l~~L~~L~L~~n~-~~~~~p~~~~~l~~L~~L 107 (1008)
..+.|.+ .++ .|.. -...++.|+|++|.+++..+..+..+++|++|+|++|+ ++...+..|.++++|++|
T Consensus 6 ~~C~C~~~~~~~v~c~~l~~ip~~~~~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L 85 (239)
T 2xwt_C 6 PPCECHQEEDFRVTCKDIQRIPSLPPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHI 85 (239)
T ss_dssp SSCSEEECSTTEEEECSCSSCCCCCTTCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEE
T ss_pred CCCeeCCCCcceeEccCccccCCCCCcccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEE
Confidence 3455654 554 4853 23468999999999996666689999999999999997 887777799999999999
Q ss_pred EccC-CCCCCccCcccccCcCcceEeeeccccccCCCccccccCCCC---eeecccc-cCCCCCCCCCccccccc-hhhc
Q 045798 108 FLSN-NSLVGKIPANLSYCSRLTVLCIEYNKLQGRIPLEFVSLSKLK---DLSLAKN-KLTGGIPPFLGNLTSLE-VLSL 181 (1008)
Q Consensus 108 ~Ls~-n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~---~L~L~~n-~l~~~~~~~~~~l~~L~-~L~L 181 (1008)
+|++ |++++..+..|.++++|++|++++|++++ +|. |..+++|+ +|++++| ++++..+..|.++++|+ +|++
T Consensus 86 ~l~~~n~l~~i~~~~f~~l~~L~~L~l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l 163 (239)
T 2xwt_C 86 EIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKL 163 (239)
T ss_dssp EEEEETTCCEECTTSEECCTTCCEEEEEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEEC
T ss_pred ECCCCCCeeEcCHHHhCCCCCCCEEeCCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEc
Confidence 9999 99997777899999999999999999996 665 88888898 9999999 99977777899999999 9999
Q ss_pred ccccCCCCCCccccCCCCCcEEEecCCc-ccccCCccccCC-CCcceeccccccccccCChhhhhcCCCCcEEEecccc
Q 045798 182 AGNSFGRNIPDSLGQLKQLKILAIGGNN-LSGPIPPSIYNL-SFLVVFSVSHNQIHGSLPPSLGLLLPNLKFFQIHHNF 258 (1008)
Q Consensus 182 ~~n~l~~~~~~~~~~l~~L~~L~L~~n~-l~~~~~~~~~~l-~~L~~L~ls~N~l~~~lp~~~~~~l~~L~~L~L~~N~ 258 (1008)
++|+++...+..|.. ++|+.|++++|+ +++..+..|.++ ++|+.|++++|+++ .+|.. .+++|+.|+++++.
T Consensus 164 ~~n~l~~i~~~~~~~-~~L~~L~L~~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~-~l~~~---~~~~L~~L~l~~~~ 237 (239)
T 2xwt_C 164 YNNGFTSVQGYAFNG-TKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT-ALPSK---GLEHLKELIARNTW 237 (239)
T ss_dssp CSCCCCEECTTTTTT-CEEEEEECTTCTTCCEECTTTTTTCSBCCSEEECTTCCCC-CCCCT---TCTTCSEEECTTC-
T ss_pred CCCCCcccCHhhcCC-CCCCEEEcCCCCCcccCCHHHhhccccCCcEEECCCCccc-cCChh---HhccCceeeccCcc
Confidence 999998555555666 899999999995 998888899999 99999999999998 77766 37899999998864
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.88 E-value=1.4e-24 Score=246.39 Aligned_cols=142 Identities=15% Similarity=0.204 Sum_probs=73.9
Q ss_pred CCCceEEccCCccc-cccc---ccccCCCCcceeeccccccc--c---ccCCCCcCCCcccEeecccccccCCcchhhhh
Q 045798 398 QKLQGLDFSGNHFS-GEIP---SSLGNLSSLYEVFFNNNNLS--G---VIPFSLGNLKRLAFLEMSGNELSGTIPEDIFN 468 (1008)
Q Consensus 398 ~~L~~L~Ls~N~l~-~~~p---~~~~~l~~L~~L~l~~N~l~--~---~~p~~~~~l~~L~~L~Ls~N~l~~~lp~~~~~ 468 (1008)
++|++|+|++|+++ +.++ ..+..+++|+.|++++|.++ | ..|..+..+++|+.|+|++|.++.. .
T Consensus 159 ~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~---g--- 232 (386)
T 2ca6_A 159 PPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHL---G--- 232 (386)
T ss_dssp CCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHH---H---
T ss_pred CCCcEEECCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcH---H---
Confidence 55666666666554 2233 23444555555555555554 1 2333555555666666666655310 0
Q ss_pred hhhhhhhhcccCccccCCCcccccccccccccccccccccCC----CCccc--ccccccceeeccCccccc----chhhh
Q 045798 469 ISYLSNSLNLARNHLVGIIPPRIGNLRALRSFDVSNNDLSGE----IPIEL--GHCSSLEEIYLAGNLFHG----SIPSF 538 (1008)
Q Consensus 469 ~~~~~~~L~L~~N~l~~~~p~~~~~l~~L~~Ldls~N~l~~~----~p~~~--~~l~~L~~L~L~~N~l~~----~~p~~ 538 (1008)
.+.+|..+..+++|+.|+|++|.+++. +|..+ +.+++|++|+|++|.+++ .+|..
T Consensus 233 ---------------~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~ 297 (386)
T 2ca6_A 233 ---------------SSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTV 297 (386)
T ss_dssp ---------------HHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHH
T ss_pred ---------------HHHHHHHHccCCCcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHH
Confidence 002344455555566666666665543 34444 225666666666666665 35555
Q ss_pred h-hccccccEEecCCCccccccc
Q 045798 539 F-NALKGVQKIDLSRNNLSGQIP 560 (1008)
Q Consensus 539 ~-~~l~~L~~L~ls~N~l~~~~p 560 (1008)
+ .++++|+.|+|++|++++..|
T Consensus 298 l~~~l~~L~~L~l~~N~l~~~~~ 320 (386)
T 2ca6_A 298 IDEKMPDLLFLELNGNRFSEEDD 320 (386)
T ss_dssp HHHHCTTCCEEECTTSBSCTTSH
T ss_pred HHhcCCCceEEEccCCcCCcchh
Confidence 5 445666666666666665443
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.88 E-value=3e-24 Score=240.99 Aligned_cols=267 Identities=18% Similarity=0.172 Sum_probs=169.9
Q ss_pred EeccccCCCCccCcCccCCccCCeeeecCCCCCCCCC----ccccCCC-CCCEEEccCCCCCCccCcccccC-----cCc
Q 045798 59 LDLMSKSLSGSLSPHLGNLSFLREINLSNNTIQGEIP----PEFGRLF-RLEALFLSNNSLVGKIPANLSYC-----SRL 128 (1008)
Q Consensus 59 l~l~~~~l~~~l~~~l~~l~~L~~L~L~~n~~~~~~p----~~~~~l~-~L~~L~Ls~n~l~~~~p~~l~~l-----~~L 128 (1008)
.+|+.++++|.+|..+...++|++|+|++|.+++..+ ..|..++ +|++|+|++|.+++..+..+..+ ++|
T Consensus 3 ~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L 82 (362)
T 3goz_A 3 YKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANV 82 (362)
T ss_dssp EECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTC
T ss_pred cccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCc
Confidence 4677777887777776666778888888888876555 6677777 78888888888887767776665 788
Q ss_pred ceEeeeccccccCCCcccccc-----CCCCeeecccccCCCCCCCCCc----c-ccccchhhcccccCCCCC----Cccc
Q 045798 129 TVLCIEYNKLQGRIPLEFVSL-----SKLKDLSLAKNKLTGGIPPFLG----N-LTSLEVLSLAGNSFGRNI----PDSL 194 (1008)
Q Consensus 129 ~~L~Ls~n~l~~~~p~~~~~l-----~~L~~L~L~~n~l~~~~~~~~~----~-l~~L~~L~L~~n~l~~~~----~~~~ 194 (1008)
++|+|++|++++..+..+... ++|++|+|++|++++..+..+. . .++|++|+|++|+++... +..+
T Consensus 83 ~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l 162 (362)
T 3goz_A 83 TSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQIL 162 (362)
T ss_dssp CEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHHH
T ss_pred cEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHHH
Confidence 888888888876666655443 6788888888887755444332 2 247777777777775433 3334
Q ss_pred cCCC-CCcEEEecCCcccccCCcccc----CC-CCcceecccccccccc----CChhhhhcCCCCcEEEeccccCCCCCC
Q 045798 195 GQLK-QLKILAIGGNNLSGPIPPSIY----NL-SFLVVFSVSHNQIHGS----LPPSLGLLLPNLKFFQIHHNFFSGSIP 264 (1008)
Q Consensus 195 ~~l~-~L~~L~L~~n~l~~~~~~~~~----~l-~~L~~L~ls~N~l~~~----lp~~~~~~l~~L~~L~L~~N~l~~~~p 264 (1008)
..++ +|++|+|++|++++..+..+. .+ ++|+.|+|++|.+.+. ++..+....++|++|+|++|.+.+..+
T Consensus 163 ~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~ 242 (362)
T 3goz_A 163 AAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSL 242 (362)
T ss_dssp HTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHHSCTTCCEEECCSSCCCCCCH
T ss_pred hcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHHHHHHHhcCCCCceEEECcCCCCCcHHH
Confidence 4454 777777777777655544333 33 4677777777776632 333333333466666666666654333
Q ss_pred ----cccccCCCCceeecccccccccccccccCCCcccccccccccCCCCCCCcccccccccccCCCcEEEecCCcCCcc
Q 045798 265 ----ISLSNASKLEHIEIANNNFSGKLSVNFGGMKNLSLLNLQFSNLGSGESDEMGFMNSLTNCSKLRVLSLGGNQFRGA 340 (1008)
Q Consensus 265 ----~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~ 340 (1008)
..+..+++|++|++++|.+.+..+..+ ..+...+..+++|+.|++++|++...
T Consensus 243 ~~l~~~~~~l~~L~~L~L~~n~l~~i~~~~~-----------------------~~l~~~~~~l~~L~~LdL~~N~l~~~ 299 (362)
T 3goz_A 243 ENLKLLKDSLKHLQTVYLDYDIVKNMSKEQC-----------------------KALGAAFPNIQKIILVDKNGKEIHPS 299 (362)
T ss_dssp HHHHHTTTTTTTCSEEEEEHHHHTTCCHHHH-----------------------HHHHTTSTTCCEEEEECTTSCBCCGG
T ss_pred HHHHHHHhcCCCccEEEeccCCccccCHHHH-----------------------HHHHHHhccCCceEEEecCCCcCCCc
Confidence 223444556666666665443322211 12233566778888999999998876
Q ss_pred CChhhhhh
Q 045798 341 LPHSIANL 348 (1008)
Q Consensus 341 ~p~~~~~l 348 (1008)
.+..+.+.
T Consensus 300 ~~~~~~~~ 307 (362)
T 3goz_A 300 HSIPISNL 307 (362)
T ss_dssp GCHHHHHH
T ss_pred chHHHHHH
Confidence 66655543
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.88 E-value=1.1e-22 Score=223.11 Aligned_cols=226 Identities=15% Similarity=0.145 Sum_probs=175.4
Q ss_pred ccCCeeeecCCCCCCCCCc---cccCCCCCCEEEccCCCCCCccCccc--ccCcCcceEeeeccccccCCC----ccccc
Q 045798 78 SFLREINLSNNTIQGEIPP---EFGRLFRLEALFLSNNSLVGKIPANL--SYCSRLTVLCIEYNKLQGRIP----LEFVS 148 (1008)
Q Consensus 78 ~~L~~L~L~~n~~~~~~p~---~~~~l~~L~~L~Ls~n~l~~~~p~~l--~~l~~L~~L~Ls~n~l~~~~p----~~~~~ 148 (1008)
..++.|.+.++.++...-. .+..+++|++|+|++|.+++..|..+ +.+++|++|+|++|.+++..+ ..+..
T Consensus 64 ~~l~~l~l~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~ 143 (310)
T 4glp_A 64 LRVRRLTVGAAQVPAQLLVGALRVLAYSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWL 143 (310)
T ss_dssp CCCCEEEECSCCCBHHHHHHHHHHHHHSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTB
T ss_pred cceeEEEEeCCcCCHHHHHHHHHhcccCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhh
Confidence 3467788888776521111 12345679999999999988888888 889999999999999987555 44557
Q ss_pred cCCCCeeecccccCCCCCCCCCccccccchhhcccccCCCC--C--CccccCCCCCcEEEecCCcccccCCc----cccC
Q 045798 149 LSKLKDLSLAKNKLTGGIPPFLGNLTSLEVLSLAGNSFGRN--I--PDSLGQLKQLKILAIGGNNLSGPIPP----SIYN 220 (1008)
Q Consensus 149 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~--~--~~~~~~l~~L~~L~L~~n~l~~~~~~----~~~~ 220 (1008)
+++|++|+|++|++++..+..|+++++|++|+|++|++.+. . +..+..+++|++|+|++|+++.. +. .+..
T Consensus 144 ~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~l-~~~~~~l~~~ 222 (310)
T 4glp_A 144 KPGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMETP-TGVCAALAAA 222 (310)
T ss_dssp CSCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCCH-HHHHHHHHHH
T ss_pred ccCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCch-HHHHHHHHhc
Confidence 88999999999999877788888999999999999987542 1 23347888999999999998732 22 3577
Q ss_pred CCCcceeccccccccccCChhhhhc--CCCCcEEEeccccCCCCCCcccccCCCCceeecccccccccccccccCCCccc
Q 045798 221 LSFLVVFSVSHNQIHGSLPPSLGLL--LPNLKFFQIHHNFFSGSIPISLSNASKLEHIEIANNNFSGKLSVNFGGMKNLS 298 (1008)
Q Consensus 221 l~~L~~L~ls~N~l~~~lp~~~~~~--l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~ 298 (1008)
+++|++|+|++|++++.+|..++.. +++|++|+|++|+++ .+|..+. ++|++|++++|++++... +..+++|+
T Consensus 223 l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N~l~~~~~--~~~l~~L~ 297 (310)
T 4glp_A 223 GVQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLP--AKLRVLDLSSNRLNRAPQ--PDELPEVD 297 (310)
T ss_dssp TCCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCC--SCCSCEECCSCCCCSCCC--TTSCCCCS
T ss_pred CCCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhc--CCCCEEECCCCcCCCCch--hhhCCCcc
Confidence 8899999999999987667666553 379999999999998 6677664 789999999999987622 67889999
Q ss_pred ccccccccCCC
Q 045798 299 LLNLQFSNLGS 309 (1008)
Q Consensus 299 ~L~L~~n~l~~ 309 (1008)
.|+|++|+++.
T Consensus 298 ~L~L~~N~l~~ 308 (310)
T 4glp_A 298 NLTLDGNPFLV 308 (310)
T ss_dssp CEECSSTTTSC
T ss_pred EEECcCCCCCC
Confidence 99999998865
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.87 E-value=1.6e-22 Score=221.04 Aligned_cols=194 Identities=22% Similarity=0.387 Sum_probs=124.3
Q ss_pred cccCCCcEEEecCCcCCccCChhhhhhcccceeeeeccccccCCCCCccccccccceEEecCccccCCcchhccCCCCCc
Q 045798 322 TNCSKLRVLSLGGNQFRGALPHSIANLSSQLQILILSSNQFYGSIPLGIGNLVDLYLLGMVENQFTGAIPKEMGKLQKLQ 401 (1008)
Q Consensus 322 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~ 401 (1008)
..+++|+.|++++|.+. .+| .+..+. +|++|+|++|.+++..+ +..+++|++|++++|++++. ..+..+++|+
T Consensus 38 ~~l~~L~~L~l~~~~i~-~l~-~~~~l~-~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~n~l~~~--~~~~~l~~L~ 110 (308)
T 1h6u_A 38 ADLDGITTLSAFGTGVT-TIE-GVQYLN-NLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKNV--SAIAGLQSIK 110 (308)
T ss_dssp HHHHTCCEEECTTSCCC-CCT-TGGGCT-TCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSCC--GGGTTCTTCC
T ss_pred HHcCCcCEEEeeCCCcc-Cch-hhhccC-CCCEEEccCCcCCCChh--HccCCCCCEEEccCCcCCCc--hhhcCCCCCC
Confidence 34556666666666665 333 344443 46666666666663332 66666666666666666643 2466666677
Q ss_pred eEEccCCcccccccccccCCCCcceeeccccccccccCCCCcCCCcccEeecccccccCCcchhhhhhhhhhhhhcccCc
Q 045798 402 GLDFSGNHFSGEIPSSLGNLSSLYEVFFNNNNLSGVIPFSLGNLKRLAFLEMSGNELSGTIPEDIFNISYLSNSLNLARN 481 (1008)
Q Consensus 402 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~lp~~~~~~~~~~~~L~L~~N 481 (1008)
.|+|++|++++ ++. +..+++|++|++++|.+++..+ +..+++|+.|+|++|++++
T Consensus 111 ~L~l~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~--------------------- 165 (308)
T 1h6u_A 111 TLDLTSTQITD-VTP-LAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSD--------------------- 165 (308)
T ss_dssp EEECTTSCCCC-CGG-GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCC---------------------
T ss_pred EEECCCCCCCC-chh-hcCCCCCCEEECCCCccCcCcc--ccCCCCccEEEccCCcCCC---------------------
Confidence 77777776664 232 6666666666666666665433 6666666666666666652
Q ss_pred cccCCCcccccccccccccccccccccCCCCcccccccccceeeccCcccccchhhhhhccccccEEecCCCcccc
Q 045798 482 HLVGIIPPRIGNLRALRSFDVSNNDLSGEIPIELGHCSSLEEIYLAGNLFHGSIPSFFNALKGVQKIDLSRNNLSG 557 (1008)
Q Consensus 482 ~l~~~~p~~~~~l~~L~~Ldls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~ 557 (1008)
++. +..+++|+.|++++|.+++. |. +..+++|++|+|++|++++..| +..+++|+.|+|++|++++
T Consensus 166 -----~~~-l~~l~~L~~L~l~~n~l~~~-~~-l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~l~~N~i~~ 231 (308)
T 1h6u_A 166 -----LTP-LANLSKLTTLKADDNKISDI-SP-LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITN 231 (308)
T ss_dssp -----CGG-GTTCTTCCEEECCSSCCCCC-GG-GGGCTTCCEEECTTSCCCBCGG--GTTCTTCCEEEEEEEEEEC
T ss_pred -----Chh-hcCCCCCCEEECCCCccCcC-hh-hcCCCCCCEEEccCCccCcccc--ccCCCCCCEEEccCCeeec
Confidence 222 66677788888888877743 33 6777788888888888875543 6777888888888888775
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.87 E-value=8.3e-24 Score=235.36 Aligned_cols=271 Identities=18% Similarity=0.213 Sum_probs=154.3
Q ss_pred CCCCcccceEEcCCCCeEEEEeccccCCCCccCcCccCC--ccCCeeeecCCCCCCCCCccccCCCCCCEEEccCCCCCC
Q 045798 39 RHFCEWEGITCGRRHRRVTALDLMSKSLSGSLSPHLGNL--SFLREINLSNNTIQGEIPPEFGRLFRLEALFLSNNSLVG 116 (1008)
Q Consensus 39 ~~~c~w~gv~c~~~~~~v~~l~l~~~~l~~~l~~~l~~l--~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~ 116 (1008)
.-|..|.++.|+.. .++.+|++++.+. +..+..+ +.++.|++++|.+++..+. +..+++|++|+|++|.+++
T Consensus 34 ~vc~~W~~~~~~~~--~~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~ 107 (336)
T 2ast_B 34 GVCKRWYRLASDES--LWQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEV 107 (336)
T ss_dssp SSCHHHHHHHTCST--TSSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECH
T ss_pred HHHHHHHHHhcCch--hheeeccccccCC---HHHHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCH
Confidence 34568999887532 3556777766655 3344555 6677777777777655443 4456667777777666664
Q ss_pred c-cCcccccCcCcceEeeeccccccCCCccccccCCCCeeecccc-cCCCCCCCCCccccccchhhcccccCCCCCCccc
Q 045798 117 K-IPANLSYCSRLTVLCIEYNKLQGRIPLEFVSLSKLKDLSLAKN-KLTGGIPPFLGNLTSLEVLSLAGNSFGRNIPDSL 194 (1008)
Q Consensus 117 ~-~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n-~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~ 194 (1008)
. +|..+..+++|++|+|++|.+++..+..++.+++|++|++++| .+++. .++..+
T Consensus 108 ~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~-----------------------~l~~~~ 164 (336)
T 2ast_B 108 STLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEF-----------------------ALQTLL 164 (336)
T ss_dssp HHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHH-----------------------HHHHHH
T ss_pred HHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHH-----------------------HHHHHH
Confidence 4 5556666666666666666666555555555666666666655 34421 123334
Q ss_pred cCCCCCcEEEecCC-ccccc-CCccccCCC-Ccceecccccc--cc-ccCChhhhhcCCCCcEEEecccc-CCCCCCccc
Q 045798 195 GQLKQLKILAIGGN-NLSGP-IPPSIYNLS-FLVVFSVSHNQ--IH-GSLPPSLGLLLPNLKFFQIHHNF-FSGSIPISL 267 (1008)
Q Consensus 195 ~~l~~L~~L~L~~n-~l~~~-~~~~~~~l~-~L~~L~ls~N~--l~-~~lp~~~~~~l~~L~~L~L~~N~-l~~~~p~~l 267 (1008)
..+++|++|++++| .+++. ++..+..++ +|++|++++|. ++ +.+|.. +..+++|++|+|++|. +++..+..+
T Consensus 165 ~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~~~~~~~~~~l~~~-~~~~~~L~~L~l~~~~~l~~~~~~~l 243 (336)
T 2ast_B 165 SSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTL-VRRCPNLVHLDLSDSVMLKNDCFQEF 243 (336)
T ss_dssp HHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHH-HHHCTTCSEEECTTCTTCCGGGGGGG
T ss_pred hcCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeCCCcccCCHHHHHHH-HhhCCCCCEEeCCCCCcCCHHHHHHH
Confidence 44455555555555 44432 334445555 55555555552 22 123332 2235666666666666 444555566
Q ss_pred ccCCCCceeecccccccccccccccCCCcccccccccccCCCCCCCcccccccccccCCCcEEEecCCcCCccCChhhhh
Q 045798 268 SNASKLEHIEIANNNFSGKLSVNFGGMKNLSLLNLQFSNLGSGESDEMGFMNSLTNCSKLRVLSLGGNQFRGALPHSIAN 347 (1008)
Q Consensus 268 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~ 347 (1008)
..+++|++|++++|. ...+.. ...+..+++|+.|++++| +. ...+..
T Consensus 244 ~~l~~L~~L~l~~~~--~~~~~~---------------------------~~~l~~~~~L~~L~l~~~-i~---~~~~~~ 290 (336)
T 2ast_B 244 FQLNYLQHLSLSRCY--DIIPET---------------------------LLELGEIPTLKTLQVFGI-VP---DGTLQL 290 (336)
T ss_dssp GGCTTCCEEECTTCT--TCCGGG---------------------------GGGGGGCTTCCEEECTTS-SC---TTCHHH
T ss_pred hCCCCCCEeeCCCCC--CCCHHH---------------------------HHHHhcCCCCCEEeccCc-cC---HHHHHH
Confidence 666666666666664 111111 123456777888888877 33 223444
Q ss_pred hcccceeeeeccccccCCCCCcccc
Q 045798 348 LSSQLQILILSSNQFYGSIPLGIGN 372 (1008)
Q Consensus 348 l~~~L~~L~Ls~N~l~~~~p~~~~~ 372 (1008)
+...+..|++++|++++..|..+++
T Consensus 291 l~~~l~~L~l~~n~l~~~~~~~~~~ 315 (336)
T 2ast_B 291 LKEALPHLQINCSHFTTIARPTIGN 315 (336)
T ss_dssp HHHHSTTSEESCCCSCCTTCSSCSS
T ss_pred HHhhCcceEEecccCccccCCcccc
Confidence 4345777888888888777766654
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.87 E-value=3.5e-24 Score=243.07 Aligned_cols=246 Identities=19% Similarity=0.272 Sum_probs=163.8
Q ss_pred ccccccccCCCcEEEecCCcCCccCChhh----hhhcccceeeeeccc---cccCCCCCcc-------ccccccceEEec
Q 045798 317 FMNSLTNCSKLRVLSLGGNQFRGALPHSI----ANLSSQLQILILSSN---QFYGSIPLGI-------GNLVDLYLLGMV 382 (1008)
Q Consensus 317 ~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~----~~l~~~L~~L~Ls~N---~l~~~~p~~~-------~~l~~L~~L~L~ 382 (1008)
+...+..+++|+.|+|++|++....+..+ ..+. +|++|+|++| ++++.+|..+ ..+++|++|+|+
T Consensus 24 l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~-~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls 102 (386)
T 2ca6_A 24 VFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKK-DLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLS 102 (386)
T ss_dssp TSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCT-TCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECC
T ss_pred HHHHHhcCCCccEEECCCCCCCHHHHHHHHHHHHhCC-CccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECC
Confidence 34456677778888888887775544433 2333 4777777775 3334444443 455666666666
Q ss_pred CccccC----CcchhccCCCCCceEEccCCccccccccccc----CC---------CCcceeeccccccc-cccC---CC
Q 045798 383 ENQFTG----AIPKEMGKLQKLQGLDFSGNHFSGEIPSSLG----NL---------SSLYEVFFNNNNLS-GVIP---FS 441 (1008)
Q Consensus 383 ~n~l~~----~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~----~l---------~~L~~L~l~~N~l~-~~~p---~~ 441 (1008)
+|.+.+ .+|..+..+++|++|+|++|.+++..+..+. .+ ++|++|+|++|.++ +.+| ..
T Consensus 103 ~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~ 182 (386)
T 2ca6_A 103 DNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKT 182 (386)
T ss_dssp SCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHH
T ss_pred CCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHH
Confidence 666665 3555666666666666666666533332222 22 55566666666554 2223 23
Q ss_pred CcCCCcccEeecccccccCCcchhhhhhhhhhhhhcccCccccCCCccccccccccccccccccccc----CCCCccccc
Q 045798 442 LGNLKRLAFLEMSGNELSGTIPEDIFNISYLSNSLNLARNHLVGIIPPRIGNLRALRSFDVSNNDLS----GEIPIELGH 517 (1008)
Q Consensus 442 ~~~l~~L~~L~Ls~N~l~~~lp~~~~~~~~~~~~L~L~~N~l~~~~p~~~~~l~~L~~Ldls~N~l~----~~~p~~~~~ 517 (1008)
+..+++|+.|+|++|+++. ..+ ....|..+..+++|+.|+|++|.++ +.+|..+..
T Consensus 183 l~~~~~L~~L~L~~n~l~~---~g~-----------------~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~ 242 (386)
T 2ca6_A 183 FQSHRLLHTVKMVQNGIRP---EGI-----------------EHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKS 242 (386)
T ss_dssp HHHCTTCCEEECCSSCCCH---HHH-----------------HHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGG
T ss_pred HHhCCCcCEEECcCCCCCH---hHH-----------------HHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHcc
Confidence 4455555555555555541 000 0023447888999999999999996 578889999
Q ss_pred ccccceeeccCcccccc----hhhhhhc--cccccEEecCCCcccc----cccCcc--cccccceeecccCcccccCC
Q 045798 518 CSSLEEIYLAGNLFHGS----IPSFFNA--LKGVQKIDLSRNNLSG----QIPIFL--EALSLEYLNLSFNDFEGKIP 583 (1008)
Q Consensus 518 l~~L~~L~L~~N~l~~~----~p~~~~~--l~~L~~L~ls~N~l~~----~~p~~~--~~~~L~~L~l~~N~l~g~~p 583 (1008)
+++|++|+|++|++++. +|..+.. +++|+.|+|++|++++ .+|... .+.+|++|++++|.+++..|
T Consensus 243 ~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~~~~ 320 (386)
T 2ca6_A 243 WPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDD 320 (386)
T ss_dssp CTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTTSH
T ss_pred CCCcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCcchh
Confidence 99999999999999976 6777744 9999999999999998 477653 46889999999999998765
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.87 E-value=7.1e-22 Score=220.42 Aligned_cols=205 Identities=16% Similarity=0.116 Sum_probs=146.6
Q ss_pred CCCcccceEEcCCCCeEEEEeccccCCCCccCcCccCCccCCeeeecCCCCCCCCCccccCCCCCCEEEccCCCCCCccC
Q 045798 40 HFCEWEGITCGRRHRRVTALDLMSKSLSGSLSPHLGNLSFLREINLSNNTIQGEIPPEFGRLFRLEALFLSNNSLVGKIP 119 (1008)
Q Consensus 40 ~~c~w~gv~c~~~~~~v~~l~l~~~~l~~~l~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p 119 (1008)
+.|+|..|.|. +++++ .+|..+. +++++|+|++|+|+...+.+|.++++|++|+|++|++.+.+|
T Consensus 7 C~C~~~~v~C~------------~~~Lt-~iP~~l~--~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~ 71 (350)
T 4ay9_X 7 CHCSNRVFLCQ------------ESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIE 71 (350)
T ss_dssp SEEETTEEEEE------------STTCC-SCCTTCC--TTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEEC
T ss_pred cEeeCCEEEec------------CCCCC-ccCcCcC--CCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccC
Confidence 44677777774 34555 5776663 578999999999996556689999999999999999876665
Q ss_pred -cccccCcCcce-EeeeccccccCCCccccccCCCCeeecccccCCCCCCCCCccccccchhhccc-ccCCCCCCccccC
Q 045798 120 -ANLSYCSRLTV-LCIEYNKLQGRIPLEFVSLSKLKDLSLAKNKLTGGIPPFLGNLTSLEVLSLAG-NSFGRNIPDSLGQ 196 (1008)
Q Consensus 120 -~~l~~l~~L~~-L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~-n~l~~~~~~~~~~ 196 (1008)
.+|.++++|+. +.++.|+++...|..|..+++|++|++++|+++...+..+....++..|++.+ |++....+..|..
T Consensus 72 ~~~f~~L~~l~~~l~~~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~ 151 (350)
T 4ay9_X 72 ADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVG 151 (350)
T ss_dssp TTSBCSCTTCCEEEEEEETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTT
T ss_pred hhHhhcchhhhhhhcccCCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccccccccchhh
Confidence 46788888765 56677888877788888899999999999998866666666677777788755 5666656666766
Q ss_pred CC-CCcEEEecCCcccccCCccccCCCCcceecccc-ccccccCChhhhhcCCCCcEEEeccccCCC
Q 045798 197 LK-QLKILAIGGNNLSGPIPPSIYNLSFLVVFSVSH-NQIHGSLPPSLGLLLPNLKFFQIHHNFFSG 261 (1008)
Q Consensus 197 l~-~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ls~-N~l~~~lp~~~~~~l~~L~~L~L~~N~l~~ 261 (1008)
+. .++.|+|++|+|+.+.+..| ...+|+.|++++ |.++ .+|...+..+++|++|+|++|+|+.
T Consensus 152 ~~~~l~~L~L~~N~i~~i~~~~f-~~~~L~~l~l~~~n~l~-~i~~~~f~~l~~L~~LdLs~N~l~~ 216 (350)
T 4ay9_X 152 LSFESVILWLNKNGIQEIHNSAF-NGTQLDELNLSDNNNLE-ELPNDVFHGASGPVILDISRTRIHS 216 (350)
T ss_dssp SBSSCEEEECCSSCCCEECTTSS-TTEEEEEEECTTCTTCC-CCCTTTTTTEECCSEEECTTSCCCC
T ss_pred cchhhhhhccccccccCCChhhc-cccchhHHhhccCCccc-CCCHHHhccCcccchhhcCCCCcCc
Confidence 64 57778888888775444333 445677777764 4444 6666655555666666666666553
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.87 E-value=5.8e-23 Score=228.54 Aligned_cols=251 Identities=15% Similarity=0.153 Sum_probs=192.7
Q ss_pred CCcEEEecCCcCCccCChhhhhh-cccceeeeeccccccCCCCCccccccccceEEecCccccCC-cchhccCCCCCceE
Q 045798 326 KLRVLSLGGNQFRGALPHSIANL-SSQLQILILSSNQFYGSIPLGIGNLVDLYLLGMVENQFTGA-IPKEMGKLQKLQGL 403 (1008)
Q Consensus 326 ~L~~L~Ls~N~l~~~~p~~~~~l-~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~-~~~~~~~l~~L~~L 403 (1008)
.++.+++++|.+. +..+..+ ...++.|++++|.+.+..+. +..+++|++|++++|.+++. ++..+..+++|++|
T Consensus 48 ~~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L 123 (336)
T 2ast_B 48 LWQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNL 123 (336)
T ss_dssp TSSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEE
T ss_pred hheeeccccccCC---HHHHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEE
Confidence 3667888888776 4445544 13588888888888866555 55788888888888888765 77788888888888
Q ss_pred EccCCcccccccccccCCCCcceeecccc-ccccc-cCCCCcCCCcccEeecccc-cccCC-cchhhhhhhhhhhhhccc
Q 045798 404 DFSGNHFSGEIPSSLGNLSSLYEVFFNNN-NLSGV-IPFSLGNLKRLAFLEMSGN-ELSGT-IPEDIFNISYLSNSLNLA 479 (1008)
Q Consensus 404 ~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N-~l~~~-~p~~~~~l~~L~~L~Ls~N-~l~~~-lp~~~~~~~~~~~~L~L~ 479 (1008)
+|++|.+++..+..++.+++|++|++++| .+++. ++..+.++++|+.|++++| .+++. +|..+......++.|+|+
T Consensus 124 ~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~ 203 (336)
T 2ast_B 124 SLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLS 203 (336)
T ss_dssp ECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECC
T ss_pred eCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeC
Confidence 88888888778888888888888888888 67653 5666778888888888888 88743 444444444256788888
Q ss_pred Cc--ccc-CCCccccccccccccccccccc-ccCCCCcccccccccceeeccCcc-cccchhhhhhccccccEEecCCCc
Q 045798 480 RN--HLV-GIIPPRIGNLRALRSFDVSNND-LSGEIPIELGHCSSLEEIYLAGNL-FHGSIPSFFNALKGVQKIDLSRNN 554 (1008)
Q Consensus 480 ~N--~l~-~~~p~~~~~l~~L~~Ldls~N~-l~~~~p~~~~~l~~L~~L~L~~N~-l~~~~p~~~~~l~~L~~L~ls~N~ 554 (1008)
+| .++ +.+|..+..+++|+.|++++|. +++..+..+..+++|++|+|++|. +.......++.+++|+.|+|++|
T Consensus 204 ~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l~~L~~L~l~~~~~~~~~~~~~l~~~~~L~~L~l~~~- 282 (336)
T 2ast_B 204 GYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI- 282 (336)
T ss_dssp SCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS-
T ss_pred CCcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhCCCCCCEeeCCCCCCCCHHHHHHHhcCCCCCEEeccCc-
Confidence 88 454 4567778889999999999999 777888899999999999999995 33222236888999999999999
Q ss_pred ccccccCc--ccc-cccceeecccCcccccCCCC
Q 045798 555 LSGQIPIF--LEA-LSLEYLNLSFNDFEGKIPAK 585 (1008)
Q Consensus 555 l~~~~p~~--~~~-~~L~~L~l~~N~l~g~~p~~ 585 (1008)
++.. ..+ ..+..|++++|.++|..|..
T Consensus 283 ----i~~~~~~~l~~~l~~L~l~~n~l~~~~~~~ 312 (336)
T 2ast_B 283 ----VPDGTLQLLKEALPHLQINCSHFTTIARPT 312 (336)
T ss_dssp ----SCTTCHHHHHHHSTTSEESCCCSCCTTCSS
T ss_pred ----cCHHHHHHHHhhCcceEEecccCccccCCc
Confidence 3332 233 24889999999999998864
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=2.7e-22 Score=215.41 Aligned_cols=162 Identities=19% Similarity=0.128 Sum_probs=125.1
Q ss_pred HHHHhcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccc------------------hhhHHHHHHHHHHhhcCC
Q 045798 679 LLKATNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCE------------------GASKSFMAECKALKNIRH 740 (1008)
Q Consensus 679 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~h 740 (1008)
+......|.+.+.||+|+||.||+|.+ .+|+.||+|+++.... .....+.+|++++++++|
T Consensus 85 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~ 163 (282)
T 1zar_A 85 LVRSGKVDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG 163 (282)
T ss_dssp HHHTTSCSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTT
T ss_pred HHhCCeEEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccC
Confidence 344455677789999999999999999 7899999999964321 134578999999999984
Q ss_pred CCceeeeeccccccccCCceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCc
Q 045798 741 RNLVKVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPI 820 (1008)
Q Consensus 741 ~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i 820 (1008)
+++.+++. .+..++||||+++++|.+ +... ....++.|++.||+|||+. +|
T Consensus 164 ---~~v~~~~~------~~~~~lvmE~~~g~~L~~-l~~~----------------~~~~i~~qi~~~l~~lH~~---gi 214 (282)
T 1zar_A 164 ---LAVPKVYA------WEGNAVLMELIDAKELYR-VRVE----------------NPDEVLDMILEEVAKFYHR---GI 214 (282)
T ss_dssp ---SSSCCEEE------EETTEEEEECCCCEEGGG-CCCS----------------CHHHHHHHHHHHHHHHHHT---TE
T ss_pred ---CCcCeEEe------ccceEEEEEecCCCcHHH-cchh----------------hHHHHHHHHHHHHHHHHHC---CC
Confidence 55555421 134699999999999998 4211 2346999999999999998 99
Q ss_pred eeccCCCCCeeecCCCCeEEcccCcccccccccCccccccccccccccccCccccCC----------CCCCcccchhh
Q 045798 821 LHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLG----------SEVSTNGDVYS 888 (1008)
Q Consensus 821 vH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----------~~~~~~sDvws 888 (1008)
+||||||+|||++ ++.+||+|||+|+ .+..|+|||++.. ..+...+|+|.
T Consensus 215 iHrDlkp~NILl~-~~~vkl~DFG~a~-----------------~~~~~~a~e~l~rdv~~i~~~f~~~~~~~~~~~~ 274 (282)
T 1zar_A 215 VHGDLSQYNVLVS-EEGIWIIDFPQSV-----------------EVGEEGWREILERDVRNIITYFSRTYRTEKDINS 274 (282)
T ss_dssp ECSCCSTTSEEEE-TTEEEECCCTTCE-----------------ETTSTTHHHHHHHHHHHHHHHHHHHHCCCCCHHH
T ss_pred EeCCCCHHHEEEE-CCcEEEEECCCCe-----------------ECCCCCHHHHHHHHHHHHHHHHHHhcCCCCChHH
Confidence 9999999999999 9999999999996 3445788887643 23455556654
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.86 E-value=1.3e-21 Score=200.90 Aligned_cols=184 Identities=23% Similarity=0.238 Sum_probs=143.8
Q ss_pred CCCCCcccceEEcCCCCeEEEEeccccCCCCccCcCccCCccCCeeeecCCCCCCCCCccccCCCCCCEEEccCCCCCCc
Q 045798 38 SRHFCEWEGITCGRRHRRVTALDLMSKSLSGSLSPHLGNLSFLREINLSNNTIQGEIPPEFGRLFRLEALFLSNNSLVGK 117 (1008)
Q Consensus 38 ~~~~c~w~gv~c~~~~~~v~~l~l~~~~l~~~l~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~ 117 (1008)
..+.|.|.+|.|... +++ .+|..+ .++|++|+|++|++++..+..|..+++|++|+|++|++++.
T Consensus 3 ~~C~C~~~~v~c~~~------------~l~-~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~ 67 (208)
T 2o6s_A 3 SRCSCSGTTVECYSQ------------GRT-SVPTGI--PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSL 67 (208)
T ss_dssp TTCEEETTEEECCSS------------CCS-SCCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCC
T ss_pred CCCEECCCEEEecCC------------Ccc-CCCCCC--CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCcc
Confidence 356789999999642 333 345444 35889999999999977777788999999999999999976
Q ss_pred cCcccccCcCcceEeeeccccccCCCccccccCCCCeeecccccCCCCCCCCCccccccchhhcccccCCCCCCccccCC
Q 045798 118 IPANLSYCSRLTVLCIEYNKLQGRIPLEFVSLSKLKDLSLAKNKLTGGIPPFLGNLTSLEVLSLAGNSFGRNIPDSLGQL 197 (1008)
Q Consensus 118 ~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l 197 (1008)
.+..|..+++|++|+|++|++++..+..|..+++|++|+|++|++++..+..|.++++|++|++++|++++..+..|..+
T Consensus 68 ~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l 147 (208)
T 2o6s_A 68 PNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRL 147 (208)
T ss_dssp CTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTC
T ss_pred ChhhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccC
Confidence 66778889999999999999987767778888889999998888886666667888888888888888877666678888
Q ss_pred CCCcEEEecCCcccccCCccccCCCCcceeccccccccccCChhhh
Q 045798 198 KQLKILAIGGNNLSGPIPPSIYNLSFLVVFSVSHNQIHGSLPPSLG 243 (1008)
Q Consensus 198 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~~~lp~~~~ 243 (1008)
++|+.|++++|.+.+ .+++|+.|+++.|+++|.+|..+.
T Consensus 148 ~~L~~L~l~~N~~~~-------~~~~l~~L~~~~n~~~g~ip~~~~ 186 (208)
T 2o6s_A 148 TSLQYIWLHDNPWDC-------TCPGIRYLSEWINKHSGVVRNSAG 186 (208)
T ss_dssp TTCCEEECCSCCBCC-------CTTTTHHHHHHHHHCTTTBBCTTS
T ss_pred CCccEEEecCCCeec-------CCCCHHHHHHHHHhCCceeeccCc
Confidence 888888888887653 345677777777777776666543
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.86 E-value=1.4e-21 Score=213.51 Aligned_cols=195 Identities=27% Similarity=0.351 Sum_probs=141.0
Q ss_pred ccCCccCCeeeecCCCCCCCCCccccCCCCCCEEEccCCCCCCccCcccccCcCcceEeeeccccccCCCccccccCCCC
Q 045798 74 LGNLSFLREINLSNNTIQGEIPPEFGRLFRLEALFLSNNSLVGKIPANLSYCSRLTVLCIEYNKLQGRIPLEFVSLSKLK 153 (1008)
Q Consensus 74 l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~ 153 (1008)
...+++|++|++++|.++ .+| .+..+++|++|+|++|.+++..+ +..+++|++|+|++|++++. + .+..+++|+
T Consensus 37 ~~~l~~L~~L~l~~~~i~-~l~-~~~~l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~n~l~~~-~-~~~~l~~L~ 110 (308)
T 1h6u_A 37 QADLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKNV-S-AIAGLQSIK 110 (308)
T ss_dssp HHHHHTCCEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSCC-G-GGTTCTTCC
T ss_pred HHHcCCcCEEEeeCCCcc-Cch-hhhccCCCCEEEccCCcCCCChh--HccCCCCCEEEccCCcCCCc-h-hhcCCCCCC
Confidence 345677888888888877 344 57778888888888888875444 77888888888888888753 3 577788888
Q ss_pred eeecccccCCCCCCCCCccccccchhhcccccCCCCCCccccCCCCCcEEEecCCcccccCCccccCCCCcceecccccc
Q 045798 154 DLSLAKNKLTGGIPPFLGNLTSLEVLSLAGNSFGRNIPDSLGQLKQLKILAIGGNNLSGPIPPSIYNLSFLVVFSVSHNQ 233 (1008)
Q Consensus 154 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ls~N~ 233 (1008)
+|++++|++++. + .+..+++|++|++++|++++..+ +..+++|+.|++++|.+++..+ +..+++|+.|++++|+
T Consensus 111 ~L~l~~n~l~~~-~-~l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~ 184 (308)
T 1h6u_A 111 TLDLTSTQITDV-T-PLAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADDNK 184 (308)
T ss_dssp EEECTTSCCCCC-G-GGTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSC
T ss_pred EEECCCCCCCCc-h-hhcCCCCCCEEECCCCccCcCcc--ccCCCCccEEEccCCcCCCChh--hcCCCCCCEEECCCCc
Confidence 888888888743 3 27777888888888888765443 7778888888888888875433 7777778888888887
Q ss_pred ccccCChhhhhcCCCCcEEEeccccCCCCCCcccccCCCCceeecccccccc
Q 045798 234 IHGSLPPSLGLLLPNLKFFQIHHNFFSGSIPISLSNASKLEHIEIANNNFSG 285 (1008)
Q Consensus 234 l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~ 285 (1008)
++ .++. +..+++|++|+|++|.+.+.. .+..+++|+.|++++|++++
T Consensus 185 l~-~~~~--l~~l~~L~~L~L~~N~l~~~~--~l~~l~~L~~L~l~~N~i~~ 231 (308)
T 1h6u_A 185 IS-DISP--LASLPNLIEVHLKNNQISDVS--PLANTSNLFIVTLTNQTITN 231 (308)
T ss_dssp CC-CCGG--GGGCTTCCEEECTTSCCCBCG--GGTTCTTCCEEEEEEEEEEC
T ss_pred cC-cChh--hcCCCCCCEEEccCCccCccc--cccCCCCCCEEEccCCeeec
Confidence 76 4443 344677777777777777544 26677777777777777764
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.86 E-value=1.8e-21 Score=217.22 Aligned_cols=240 Identities=20% Similarity=0.089 Sum_probs=190.7
Q ss_pred CeeeecCCCCCCCCCccccCCCCCCEEEccCCCCCCccCcccccCcCcceEeeeccccccCCC-ccccccCCCCe-eecc
Q 045798 81 REINLSNNTIQGEIPPEFGRLFRLEALFLSNNSLVGKIPANLSYCSRLTVLCIEYNKLQGRIP-LEFVSLSKLKD-LSLA 158 (1008)
Q Consensus 81 ~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p-~~~~~l~~L~~-L~L~ 158 (1008)
++++.++++++ .+|..+ .+++++|+|++|+|+...+.+|+++++|++|+|++|++.+.+| ..|.++++|++ +.++
T Consensus 12 ~~v~C~~~~Lt-~iP~~l--~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~ 88 (350)
T 4ay9_X 12 RVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK 88 (350)
T ss_dssp TEEEEESTTCC-SCCTTC--CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEE
T ss_pred CEEEecCCCCC-ccCcCc--CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhccc
Confidence 56888999999 788766 3689999999999995555689999999999999999876555 57888988876 6667
Q ss_pred cccCCCCCCCCCccccccchhhcccccCCCCCCccccCCCCCcEEEecC-CcccccCCccccCCC-Ccceeccccccccc
Q 045798 159 KNKLTGGIPPFLGNLTSLEVLSLAGNSFGRNIPDSLGQLKQLKILAIGG-NNLSGPIPPSIYNLS-FLVVFSVSHNQIHG 236 (1008)
Q Consensus 159 ~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~-n~l~~~~~~~~~~l~-~L~~L~ls~N~l~~ 236 (1008)
+|+|+...|..|.++++|++|++++|++....+..+....++..|++.+ |.+..+.+..|..+. .++.|+|++|+|+
T Consensus 89 ~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i~- 167 (350)
T 4ay9_X 89 ANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ- 167 (350)
T ss_dssp ETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCC-
T ss_pred CCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccccccccchhhcchhhhhhcccccccc-
Confidence 8999977788999999999999999999887777888888899999976 678777777788775 5889999999998
Q ss_pred cCChhhhhcCCCCcEEEecc-ccCCCCCCcccccCCCCceeecccccccccccccccCCCcccccccccccCCCCCCCcc
Q 045798 237 SLPPSLGLLLPNLKFFQIHH-NFFSGSIPISLSNASKLEHIEIANNNFSGKLSVNFGGMKNLSLLNLQFSNLGSGESDEM 315 (1008)
Q Consensus 237 ~lp~~~~~~l~~L~~L~L~~-N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~ 315 (1008)
.+|..++. ..+|+.|++.+ |.++...+..|..+++|++|++++|+|+.+.+..|.++++|+.+++. ++..++
T Consensus 168 ~i~~~~f~-~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~~lp~~~~~~L~~L~~l~~~--~l~~lP---- 240 (350)
T 4ay9_X 168 EIHNSAFN-GTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTY--NLKKLP---- 240 (350)
T ss_dssp EECTTSST-TEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCCCCCSSSCTTCCEEECTTCT--TCCCCC----
T ss_pred CCChhhcc-ccchhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcCccChhhhccchHhhhccCC--CcCcCC----
Confidence 78877765 46788899875 66665445678889999999999999988877777777777766653 333322
Q ss_pred cccccccccCCCcEEEecCC
Q 045798 316 GFMNSLTNCSKLRVLSLGGN 335 (1008)
Q Consensus 316 ~~~~~l~~l~~L~~L~Ls~N 335 (1008)
++..+++|+.++++++
T Consensus 241 ----~l~~l~~L~~l~l~~~ 256 (350)
T 4ay9_X 241 ----TLEKLVALMEASLTYP 256 (350)
T ss_dssp ----CTTTCCSCCEEECSCH
T ss_pred ----CchhCcChhhCcCCCC
Confidence 3556667777776543
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.85 E-value=4.8e-22 Score=232.74 Aligned_cols=214 Identities=23% Similarity=0.306 Sum_probs=140.3
Q ss_pred CCCCCCCCCCC-----cccce-EEcCCCCeEEEEeccccCCCCccCcCccCCccCCeeeecCCCCCCCCCccccCCCCCC
Q 045798 32 LNSWNDSRHFC-----EWEGI-TCGRRHRRVTALDLMSKSLSGSLSPHLGNLSFLREINLSNNTIQGEIPPEFGRLFRLE 105 (1008)
Q Consensus 32 ~~~w~~~~~~c-----~w~gv-~c~~~~~~v~~l~l~~~~l~~~l~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~ 105 (1008)
+.+|..+.+.| .|.|+ .|.. .+++.|+|+++++++ +|..+. ++|++|+|++|+|+ .+| ..+++|+
T Consensus 33 l~~W~~~~~~~~~~~~~~~~l~~C~~--~~L~~L~Ls~n~L~~-lp~~l~--~~L~~L~Ls~N~l~-~ip---~~l~~L~ 103 (571)
T 3cvr_A 33 WDKWEKQALPGENRNEAVSLLKECLI--NQFSELQLNRLNLSS-LPDNLP--PQITVLEITQNALI-SLP---ELPASLE 103 (571)
T ss_dssp HHHHHTTCCTTCCHHHHHHHHHHHHH--TTCSEEECCSSCCSC-CCSCCC--TTCSEEECCSSCCS-CCC---CCCTTCC
T ss_pred HHHHhccCCccccccchhhhcccccc--CCccEEEeCCCCCCc-cCHhHc--CCCCEEECcCCCCc-ccc---cccCCCC
Confidence 45676666777 79999 6854 368888888888886 777664 77888888888888 666 4578888
Q ss_pred EEEccCCCCCCccCcccccCcCcceEeeeccccccCCCccccccCCCCeeecccccCCCCCCCCCccccccchhhccccc
Q 045798 106 ALFLSNNSLVGKIPANLSYCSRLTVLCIEYNKLQGRIPLEFVSLSKLKDLSLAKNKLTGGIPPFLGNLTSLEVLSLAGNS 185 (1008)
Q Consensus 106 ~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~ 185 (1008)
+|+|++|+|++ +|. +.. +|++|+|++|+|++ +|. .+++|++|+|++|+|++ +|. .+++|++|+|++|+
T Consensus 104 ~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~ 171 (571)
T 3cvr_A 104 YLDACDNRLST-LPE-LPA--SLKHLDVDNNQLTM-LPE---LPALLEYINADNNQLTM-LPE---LPTSLEVLSVRNNQ 171 (571)
T ss_dssp EEECCSSCCSC-CCC-CCT--TCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSC
T ss_pred EEEccCCCCCC-cch-hhc--CCCEEECCCCcCCC-CCC---cCccccEEeCCCCccCc-CCC---cCCCcCEEECCCCC
Confidence 88888888885 666 554 88888888888885 554 56788888888888874 554 45677777777777
Q ss_pred CCCCCCccccCCCCCcEEEecCCcccccCCccccCCCCcceeccccccccccCChhhhhcCCCCcEEEeccccCCCCCCc
Q 045798 186 FGRNIPDSLGQLKQLKILAIGGNNLSGPIPPSIYNLSFLVVFSVSHNQIHGSLPPSLGLLLPNLKFFQIHHNFFSGSIPI 265 (1008)
Q Consensus 186 l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~ 265 (1008)
+++ +|. |. ++|+.|+|++|+|+ .+|. |.. +| +...+.|+.|+|++|.|+ .+|.
T Consensus 172 L~~-lp~-l~--~~L~~L~Ls~N~L~-~lp~-~~~--~L------------------~~~~~~L~~L~Ls~N~l~-~lp~ 224 (571)
T 3cvr_A 172 LTF-LPE-LP--ESLEALDVSTNLLE-SLPA-VPV--RN------------------HHSEETEIFFRCRENRIT-HIPE 224 (571)
T ss_dssp CSC-CCC-CC--TTCCEEECCSSCCS-SCCC-CC----------------------------CCEEEECCSSCCC-CCCG
T ss_pred CCC-cch-hh--CCCCEEECcCCCCC-chhh-HHH--hh------------------hcccccceEEecCCCcce-ecCH
Confidence 755 555 54 67777777777776 3444 433 44 000112244444444444 3444
Q ss_pred ccccCCCCceeecccccccccccccccC
Q 045798 266 SLSNASKLEHIEIANNNFSGKLSVNFGG 293 (1008)
Q Consensus 266 ~l~~l~~L~~L~L~~N~l~~~~~~~~~~ 293 (1008)
.+..+++|+.|+|++|++++..|..|..
T Consensus 225 ~l~~l~~L~~L~L~~N~l~~~~p~~l~~ 252 (571)
T 3cvr_A 225 NILSLDPTCTIILEDNPLSSRIRESLSQ 252 (571)
T ss_dssp GGGGSCTTEEEECCSSSCCHHHHHHHHH
T ss_pred HHhcCCCCCEEEeeCCcCCCcCHHHHHH
Confidence 4445555555555555555555554444
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.84 E-value=8e-21 Score=222.43 Aligned_cols=188 Identities=22% Similarity=0.320 Sum_probs=93.3
Q ss_pred CCcEEEecCCcCCccCChhhhhhcccceeeeeccccccCCCCCccccccccceEEecCccccCCcchhccCCCCCceEEc
Q 045798 326 KLRVLSLGGNQFRGALPHSIANLSSQLQILILSSNQFYGSIPLGIGNLVDLYLLGMVENQFTGAIPKEMGKLQKLQGLDF 405 (1008)
Q Consensus 326 ~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 405 (1008)
+|+.|+|++|.+++ +|..+. ++|++|+|++|+|+ .+| ..+++|+.|+|++|+|++ +|. +.. +|+.|+|
T Consensus 60 ~L~~L~Ls~n~L~~-lp~~l~---~~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~L 127 (571)
T 3cvr_A 60 QFSELQLNRLNLSS-LPDNLP---PQITVLEITQNALI-SLP---ELPASLEYLDACDNRLST-LPE-LPA--SLKHLDV 127 (571)
T ss_dssp TCSEEECCSSCCSC-CCSCCC---TTCSEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSC-CCC-CCT--TCCEEEC
T ss_pred CccEEEeCCCCCCc-cCHhHc---CCCCEEECcCCCCc-ccc---cccCCCCEEEccCCCCCC-cch-hhc--CCCEEEC
Confidence 45555555555553 444332 23555555555555 444 234555555555555554 333 333 5555555
Q ss_pred cCCcccccccccccCCCCcceeeccccccccccCCCCcCCCcccEeecccccccCCcchhhhhhhhhhhhhcccCccccC
Q 045798 406 SGNHFSGEIPSSLGNLSSLYEVFFNNNNLSGVIPFSLGNLKRLAFLEMSGNELSGTIPEDIFNISYLSNSLNLARNHLVG 485 (1008)
Q Consensus 406 s~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~lp~~~~~~~~~~~~L~L~~N~l~~ 485 (1008)
++|+|++ +|. .+++|+.|+|++|.|++ +|. .+++|+.|+|++|+|++ +|. +. ..++.|+|++|+|+
T Consensus 128 s~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~L~~-lp~-l~---~~L~~L~Ls~N~L~- 193 (571)
T 3cvr_A 128 DNNQLTM-LPE---LPALLEYINADNNQLTM-LPE---LPTSLEVLSVRNNQLTF-LPE-LP---ESLEALDVSTNLLE- 193 (571)
T ss_dssp CSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC-CC---TTCCEEECCSSCCS-
T ss_pred CCCcCCC-CCC---cCccccEEeCCCCccCc-CCC---cCCCcCEEECCCCCCCC-cch-hh---CCCCEEECcCCCCC-
Confidence 5555553 343 34555555555555554 333 34555555555555552 333 11 22233333333333
Q ss_pred CCcccccccccc-------cccccccccccCCCCcccccccccceeeccCcccccchhhhhhccc
Q 045798 486 IIPPRIGNLRAL-------RSFDVSNNDLSGEIPIELGHCSSLEEIYLAGNLFHGSIPSFFNALK 543 (1008)
Q Consensus 486 ~~p~~~~~l~~L-------~~Ldls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~ 543 (1008)
.+|. |.. +| +.|+|++|.|+ .+|..+..+++|+.|+|++|+|++.+|..|..++
T Consensus 194 ~lp~-~~~--~L~~~~~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~ 254 (571)
T 3cvr_A 194 SLPA-VPV--RNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQT 254 (571)
T ss_dssp SCCC-CC----------CCEEEECCSSCCC-CCCGGGGGSCTTEEEECCSSSCCHHHHHHHHHHH
T ss_pred chhh-HHH--hhhcccccceEEecCCCcce-ecCHHHhcCCCCCEEEeeCCcCCCcCHHHHHHhh
Confidence 2333 222 33 55666666665 4555555556666666666666555555555544
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.83 E-value=2.3e-20 Score=191.71 Aligned_cols=181 Identities=23% Similarity=0.189 Sum_probs=144.9
Q ss_pred CeeeecCCCCCCCCCccccCCCCCCEEEccCCCCCCccCcccccCcCcceEeeeccccccCCCccccccCCCCeeecccc
Q 045798 81 REINLSNNTIQGEIPPEFGRLFRLEALFLSNNSLVGKIPANLSYCSRLTVLCIEYNKLQGRIPLEFVSLSKLKDLSLAKN 160 (1008)
Q Consensus 81 ~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n 160 (1008)
+.++++++.++ .+|..+ .++|++|+|++|++++..+..++.+++|++|+|++|++++..+..|..+++|++|+|++|
T Consensus 10 ~~v~c~~~~l~-~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n 86 (208)
T 2o6s_A 10 TTVECYSQGRT-SVPTGI--PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTN 86 (208)
T ss_dssp TEEECCSSCCS-SCCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEecCCCcc-CCCCCC--CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCC
Confidence 46778888887 566544 468999999999999777777889999999999999999776777888999999999999
Q ss_pred cCCCCCCCCCccccccchhhcccccCCCCCCccccCCCCCcEEEecCCcccccCCccccCCCCcceeccccccccccCCh
Q 045798 161 KLTGGIPPFLGNLTSLEVLSLAGNSFGRNIPDSLGQLKQLKILAIGGNNLSGPIPPSIYNLSFLVVFSVSHNQIHGSLPP 240 (1008)
Q Consensus 161 ~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~~~lp~ 240 (1008)
++++..+..|.++++|++|++++|++++..+..|..+++|++|++++|++++..+..|..+++|+.|++++|.+.+.
T Consensus 87 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~--- 163 (208)
T 2o6s_A 87 QLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCT--- 163 (208)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCCC---
T ss_pred cCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCeecC---
Confidence 99866666788888999999999998877777788888899999988888877676788888888888888877632
Q ss_pred hhhhcCCCCcEEEeccccCCCCCCcccccCCC
Q 045798 241 SLGLLLPNLKFFQIHHNFFSGSIPISLSNASK 272 (1008)
Q Consensus 241 ~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~ 272 (1008)
+++|++|+++.|.++|.+|..++.++.
T Consensus 164 -----~~~l~~L~~~~n~~~g~ip~~~~~l~~ 190 (208)
T 2o6s_A 164 -----CPGIRYLSEWINKHSGVVRNSAGSVAP 190 (208)
T ss_dssp -----TTTTHHHHHHHHHCTTTBBCTTSSBCT
T ss_pred -----CCCHHHHHHHHHhCCceeeccCccccC
Confidence 356677777777777777766665544
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.83 E-value=3.8e-20 Score=192.77 Aligned_cols=164 Identities=25% Similarity=0.277 Sum_probs=133.0
Q ss_pred CCCCCCCCCCcccceEEcCCCCeEEEEeccccCCCCccCcCccCCccCCeeeecCCCCCCCCCccccCCCCCCEEEccCC
Q 045798 33 NSWNDSRHFCEWEGITCGRRHRRVTALDLMSKSLSGSLSPHLGNLSFLREINLSNNTIQGEIPPEFGRLFRLEALFLSNN 112 (1008)
Q Consensus 33 ~~w~~~~~~c~w~gv~c~~~~~~v~~l~l~~~~l~~~l~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n 112 (1008)
.-|..+++.|+|++|.|... .++ .+|..+. ++|++|+|++|++++..|..|..+++|++|+|++|
T Consensus 10 ~~~~~~~~~Cs~~~v~c~~~------------~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N 74 (229)
T 3e6j_A 10 SAACPSQCSCSGTTVDCRSK------------RHA-SVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSN 74 (229)
T ss_dssp -CCCCTTCEEETTEEECTTS------------CCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred hccCCCCCEEeCCEeEccCC------------CcC-ccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCC
Confidence 44667789999999999642 233 5666554 78999999999999888888999999999999999
Q ss_pred CCCCccCcccccCcCcceEeeeccccccCCCccccccCCCCeeecccccCCCCCCCCCccccccchhhcccccCCCCCCc
Q 045798 113 SLVGKIPANLSYCSRLTVLCIEYNKLQGRIPLEFVSLSKLKDLSLAKNKLTGGIPPFLGNLTSLEVLSLAGNSFGRNIPD 192 (1008)
Q Consensus 113 ~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~ 192 (1008)
+|+...+..|..+++|++|+|++|+|++..+..|..+++|++|+|++|+|+ .+|..+..+++|++|+|++|++++..+.
T Consensus 75 ~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~ 153 (229)
T 3e6j_A 75 QLGALPVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHG 153 (229)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTT
T ss_pred CCCCcChhhcccCCCcCEEECCCCcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHH
Confidence 998666677888999999999999998777777888888888888888888 6777888888888888888888776667
Q ss_pred cccCCCCCcEEEecCCcccc
Q 045798 193 SLGQLKQLKILAIGGNNLSG 212 (1008)
Q Consensus 193 ~~~~l~~L~~L~L~~n~l~~ 212 (1008)
.|..+++|+.|+|++|.+..
T Consensus 154 ~~~~l~~L~~L~l~~N~~~c 173 (229)
T 3e6j_A 154 AFDRLSSLTHAYLFGNPWDC 173 (229)
T ss_dssp TTTTCTTCCEEECTTSCBCT
T ss_pred HHhCCCCCCEEEeeCCCccC
Confidence 77788888888888887763
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.81 E-value=6e-21 Score=232.39 Aligned_cols=235 Identities=23% Similarity=0.243 Sum_probs=130.7
Q ss_pred cCChhhHHHHHHHHHhhccCCCCCCCCCC-CCCCCCcccceEEcCCCCeEEEEeccccCCCCccCcCccCCccCCeee--
Q 045798 8 ALEDGDRAALQAFKSMIAHEPQGILNSWN-DSRHFCEWEGITCGRRHRRVTALDLMSKSLSGSLSPHLGNLSFLREIN-- 84 (1008)
Q Consensus 8 ~~~~~~~~~l~~~k~~~~~~~~~~~~~w~-~~~~~c~w~gv~c~~~~~~v~~l~l~~~~l~~~l~~~l~~l~~L~~L~-- 84 (1008)
.....++++|.++..+........-.+|. ..+..+.|.++.+.. .+++.|+|.++.+.. .+..+.....|..+.
T Consensus 128 s~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~--~~~~~l~L~~n~~~~-~~~~~l~~l~Ls~~~i~ 204 (727)
T 4b8c_D 128 SLVDCTKQALMEMADTLTDSKTAKKQQPTGDSTPSGTATNSAVST--PLTPKIELFANGKDE-ANQALLQHKKLSQYSID 204 (727)
T ss_dssp ----CCCHHHHHHHHHHHHHHTTC--------------------------------------------------------
T ss_pred hccccchhhhhhhhhhcccccCcccCCCcCCCCccccCCCceecC--CccceEEeeCCCCCc-chhhHhhcCccCccccc
Confidence 34567889999999877544444445674 345677898888854 579999999988875 444443333333333
Q ss_pred ---ecCCCCCCCCCccccCCCCCCEEEccCCCCCCccCcccccCcCcceEeeeccccccCCCccccccCCCCeeeccccc
Q 045798 85 ---LSNNTIQGEIPPEFGRLFRLEALFLSNNSLVGKIPANLSYCSRLTVLCIEYNKLQGRIPLEFVSLSKLKDLSLAKNK 161 (1008)
Q Consensus 85 ---L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~ 161 (1008)
++.|.+. ..++.|..+.+|++|+|++|.+. .+|..+..+++|++|+|++|.|+ .+|..|+++++|++|+|++|+
T Consensus 205 ~~~~~~n~~~-~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~ 281 (727)
T 4b8c_D 205 EDDDIENRMV-MPKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNR 281 (727)
T ss_dssp ------------------CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSC
T ss_pred Ccccccccee-cChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCc
Confidence 2334444 56778888999999999999988 78888888999999999999998 788888999999999999999
Q ss_pred CCCCCCCCCccccccchhhcccccCCCCCCccccCCCCCcEEEecCCcccccCCccccCCCC-cceeccccccccccCCh
Q 045798 162 LTGGIPPFLGNLTSLEVLSLAGNSFGRNIPDSLGQLKQLKILAIGGNNLSGPIPPSIYNLSF-LVVFSVSHNQIHGSLPP 240 (1008)
Q Consensus 162 l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~-L~~L~ls~N~l~~~lp~ 240 (1008)
|+ .+|..|++|++|++|+|++|.++ .+|..|+.+++|+.|+|++|.+++.+|..+..+.. +..|+|++|.+++.+|.
T Consensus 282 l~-~lp~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~ 359 (727)
T 4b8c_D 282 LT-SLPAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPH 359 (727)
T ss_dssp CS-SCCSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCC
T ss_pred CC-ccChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCcc
Confidence 98 77888999999999999999885 66777889999999999999998888877766533 23477888888876654
Q ss_pred hhhhcCCCCcEEEeccc
Q 045798 241 SLGLLLPNLKFFQIHHN 257 (1008)
Q Consensus 241 ~~~~~l~~L~~L~L~~N 257 (1008)
.|+.|++++|
T Consensus 360 -------~l~~l~l~~n 369 (727)
T 4b8c_D 360 -------ERRFIEINTD 369 (727)
T ss_dssp -------C---------
T ss_pred -------ccceeEeecc
Confidence 4556666666
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.80 E-value=1.8e-19 Score=186.22 Aligned_cols=149 Identities=25% Similarity=0.272 Sum_probs=115.8
Q ss_pred eccccCCCCccCcCccCCccCCeeeecCCCCCCCCCccccCCCCCCEEEccCCCCCCccCcccccCcCcceEeeeccccc
Q 045798 60 DLMSKSLSGSLSPHLGNLSFLREINLSNNTIQGEIPPEFGRLFRLEALFLSNNSLVGKIPANLSYCSRLTVLCIEYNKLQ 139 (1008)
Q Consensus 60 ~l~~~~l~~~l~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~ 139 (1008)
++++++++ .+|..+. +.|++|+|++|+|++..+..|..+++|++|+|++|++++..|..|..+++|++|+|++|+|+
T Consensus 17 ~c~~~~l~-~iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~ 93 (220)
T 2v9t_B 17 DCRGKGLT-EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKIT 93 (220)
T ss_dssp ECTTSCCS-SCCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSCCC
T ss_pred EcCCCCcC-cCCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCcCC
Confidence 33445555 5666554 67888999998888777778888888888888888888777888888888888888888888
Q ss_pred cCCCccccccCCCCeeecccccCCCCCCCCCccccccchhhcccccCCCCCCccccCCCCCcEEEecCCccc
Q 045798 140 GRIPLEFVSLSKLKDLSLAKNKLTGGIPPFLGNLTSLEVLSLAGNSFGRNIPDSLGQLKQLKILAIGGNNLS 211 (1008)
Q Consensus 140 ~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~ 211 (1008)
...+..|..+++|++|+|++|+|++..|..|.++++|++|+|++|++++..+..|..+++|+.|+|++|.+.
T Consensus 94 ~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~ 165 (220)
T 2v9t_B 94 ELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFI 165 (220)
T ss_dssp CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEE
T ss_pred ccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcC
Confidence 666666777888888888888888777777777777888888887777766667777777777777777765
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.79 E-value=1.1e-19 Score=196.54 Aligned_cols=172 Identities=26% Similarity=0.365 Sum_probs=85.8
Q ss_pred CCCCCCEEEccCCCCCCccCcccccCcCcceEeeeccccccCCCccccccCCCCeeecccccCCCCCCCCCccccccchh
Q 045798 100 RLFRLEALFLSNNSLVGKIPANLSYCSRLTVLCIEYNKLQGRIPLEFVSLSKLKDLSLAKNKLTGGIPPFLGNLTSLEVL 179 (1008)
Q Consensus 100 ~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 179 (1008)
.+++|++|++++|.++. ++ .++.+++|++|+|++|++++..+ +.++++|++|++++|++++ ++ .+..+++|++|
T Consensus 44 ~l~~L~~L~l~~~~i~~-~~-~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~-~~-~l~~l~~L~~L 117 (291)
T 1h6t_A 44 ELNSIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSL 117 (291)
T ss_dssp HHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEE
T ss_pred hcCcccEEEccCCCccc-Ch-hHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCCC-Ch-hhccCCCCCEE
Confidence 44445555555554442 22 24444555555555555543322 4445555555555555542 22 24445555555
Q ss_pred hcccccCCCCCCccccCCCCCcEEEecCCcccccCCccccCCCCcceeccccccccccCChhhhhcCCCCcEEEeccccC
Q 045798 180 SLAGNSFGRNIPDSLGQLKQLKILAIGGNNLSGPIPPSIYNLSFLVVFSVSHNQIHGSLPPSLGLLLPNLKFFQIHHNFF 259 (1008)
Q Consensus 180 ~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~~~lp~~~~~~l~~L~~L~L~~N~l 259 (1008)
++++|++++. ..+..+++|+.|++++|.+++. ..+..+++|+.|++++|++++ ++. +..+++|++|+|++|.+
T Consensus 118 ~L~~n~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~-~~~--l~~l~~L~~L~L~~N~i 190 (291)
T 1h6t_A 118 SLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISD-IVP--LAGLTKLQNLYLSKNHI 190 (291)
T ss_dssp ECTTSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCC-CGG--GTTCTTCCEEECCSSCC
T ss_pred ECCCCcCCCC--hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCcccc-chh--hcCCCccCEEECCCCcC
Confidence 5555555332 2355555555555555555533 345555555555555555552 222 33355555555555555
Q ss_pred CCCCCcccccCCCCceeeccccccccc
Q 045798 260 SGSIPISLSNASKLEHIEIANNNFSGK 286 (1008)
Q Consensus 260 ~~~~p~~l~~l~~L~~L~L~~N~l~~~ 286 (1008)
++ ++ .+..+++|+.|++++|++...
T Consensus 191 ~~-l~-~l~~l~~L~~L~l~~n~i~~~ 215 (291)
T 1h6t_A 191 SD-LR-ALAGLKNLDVLELFSQECLNK 215 (291)
T ss_dssp CB-CG-GGTTCTTCSEEEEEEEEEECC
T ss_pred CC-Ch-hhccCCCCCEEECcCCcccCC
Confidence 53 22 356666666666666666543
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.78 E-value=1.9e-19 Score=213.46 Aligned_cols=197 Identities=23% Similarity=0.305 Sum_probs=131.8
Q ss_pred ccCCeeeecCCCCCCCCCccccCCCCCCEEEccCCCCCCccCcccccCcCcceEeeeccccccCCCccccccCCCCeeec
Q 045798 78 SFLREINLSNNTIQGEIPPEFGRLFRLEALFLSNNSLVGKIPANLSYCSRLTVLCIEYNKLQGRIPLEFVSLSKLKDLSL 157 (1008)
Q Consensus 78 ~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L 157 (1008)
..+..+.++.+.+...++ +..|.+|++|++++|.+. .+| .++.+++|+.|+|++|+|++..| +..+++|+.|+|
T Consensus 21 ~~l~~l~l~~~~i~~~~~--~~~L~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~L 94 (605)
T 1m9s_A 21 AETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQ-GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFL 94 (605)
T ss_dssp HHHHHHHTTCSCTTSEEC--HHHHTTCCCCBCTTCCCC-CCT-TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEEC
T ss_pred HHHHHHhccCCCcccccc--hhcCCCCCEEECcCCCCC-CCh-HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEEC
Confidence 344555666666654333 456677777777777776 333 46677777777777777775444 667777777777
Q ss_pred ccccCCCCCCCCCccccccchhhcccccCCCCCCccccCCCCCcEEEecCCcccccCCccccCCCCcceecccccccccc
Q 045798 158 AKNKLTGGIPPFLGNLTSLEVLSLAGNSFGRNIPDSLGQLKQLKILAIGGNNLSGPIPPSIYNLSFLVVFSVSHNQIHGS 237 (1008)
Q Consensus 158 ~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~~~ 237 (1008)
++|+|++ ++ .+..+++|+.|+|++|++.+. ..+..+++|+.|+|++|.+++. ..+..+++|+.|+|++|.+.+.
T Consensus 95 s~N~l~~-l~-~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~ 168 (605)
T 1m9s_A 95 DENKIKD-LS-SLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDI 168 (605)
T ss_dssp CSSCCCC-CT-TSTTCTTCCEEECTTSCCCCC--GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCCC
T ss_pred cCCCCCC-Ch-hhccCCCCCEEEecCCCCCCC--ccccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCCc
Confidence 7777763 33 567777777777777777542 3477777777777777777754 5677777777777777777743
Q ss_pred CChhhhhcCCCCcEEEeccccCCCCCCcccccCCCCceeecccccccccccccc
Q 045798 238 LPPSLGLLLPNLKFFQIHHNFFSGSIPISLSNASKLEHIEIANNNFSGKLSVNF 291 (1008)
Q Consensus 238 lp~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~ 291 (1008)
.| +..+++|+.|+|++|.+++. ..+..+++|+.|+|++|++.+.....+
T Consensus 169 ~~---l~~l~~L~~L~Ls~N~i~~l--~~l~~l~~L~~L~L~~N~l~~~p~~~~ 217 (605)
T 1m9s_A 169 VP---LAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFSQECLNKPINHQ 217 (605)
T ss_dssp GG---GTTCTTCCEEECCSSCCCBC--GGGTTCTTCSEEECCSEEEECCCCCCC
T ss_pred hh---hccCCCCCEEECcCCCCCCC--hHHccCCCCCEEEccCCcCcCCccccc
Confidence 33 44467777777777777753 357777888888888888776544333
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.78 E-value=7.7e-19 Score=181.50 Aligned_cols=151 Identities=23% Similarity=0.287 Sum_probs=113.2
Q ss_pred EEeccccCCCCccCcCccCCccCCeeeecCCCCCCCCC-ccccCCCCCCEEEccCCCCCCccCcccccCcCcceEeeecc
Q 045798 58 ALDLMSKSLSGSLSPHLGNLSFLREINLSNNTIQGEIP-PEFGRLFRLEALFLSNNSLVGKIPANLSYCSRLTVLCIEYN 136 (1008)
Q Consensus 58 ~l~l~~~~l~~~l~~~l~~l~~L~~L~L~~n~~~~~~p-~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n 136 (1008)
.++++++.++ .+|..+.. .+++|+|++|++++..+ ..|..+++|++|+|++|+|++..+..|+.+++|++|+|++|
T Consensus 15 ~l~~s~n~l~-~iP~~~~~--~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N 91 (220)
T 2v70_A 15 TVDCSNQKLN-KIPEHIPQ--YTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSN 91 (220)
T ss_dssp EEECCSSCCS-SCCSCCCT--TCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred EeEeCCCCcc-cCccCCCC--CCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCC
Confidence 4566667776 46665543 46788888888886644 45778888888888888888766777888888888888888
Q ss_pred ccccCCCccccccCCCCeeecccccCCCCCCCCCccccccchhhcccccCCCCCCccccCCCCCcEEEecCCccc
Q 045798 137 KLQGRIPLEFVSLSKLKDLSLAKNKLTGGIPPFLGNLTSLEVLSLAGNSFGRNIPDSLGQLKQLKILAIGGNNLS 211 (1008)
Q Consensus 137 ~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~ 211 (1008)
+|++..+..|..+++|++|+|++|+|++..|..|.++++|++|+|++|++++..|..|..+++|+.|+|++|.+.
T Consensus 92 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 166 (220)
T 2v70_A 92 RLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFN 166 (220)
T ss_dssp CCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEE
T ss_pred ccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCc
Confidence 888777777777888888888888887766777777777777777777777666777777777777777777665
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.78 E-value=2.8e-21 Score=227.84 Aligned_cols=204 Identities=19% Similarity=0.215 Sum_probs=107.0
Q ss_pred cccCCCcEEEecCCcCCccCChhhhhhcccceeeeeccccccCCCCCccccccccceEEecCccccCCcchhccCCCCCc
Q 045798 322 TNCSKLRVLSLGGNQFRGALPHSIANLSSQLQILILSSNQFYGSIPLGIGNLVDLYLLGMVENQFTGAIPKEMGKLQKLQ 401 (1008)
Q Consensus 322 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~ 401 (1008)
..+++|+.|+|++|+++ .+|..+..+. +|+.|++++|......|. .+..+.+.+..|..++.+++|+
T Consensus 346 ~~~~~L~~L~Ls~n~L~-~Lp~~i~~l~-~L~~L~l~~n~~l~~l~~-----------ll~~~~~~~~~~~~l~~l~~L~ 412 (567)
T 1dce_A 346 ATDEQLFRCELSVEKST-VLQSELESCK-ELQELEPENKWCLLTIIL-----------LMRALDPLLYEKETLQYFSTLK 412 (567)
T ss_dssp STTTTSSSCCCCHHHHH-HHHHHHHHHH-HHHHHCTTCHHHHHHHHH-----------HHHHHCTGGGHHHHHHHHHHHH
T ss_pred ccCccceeccCChhhHH-hhHHHHHHHH-HHHHhccccchhhhhHHH-----------HHHhcccccCCHHHHHHHHhcc
Confidence 45667777777777776 6777777775 477777766642101110 0111223345555666666666
Q ss_pred eEE-ccCCcccccccccccCCCCcceeeccccccccccCCCCcCCCcccEeecccccccCCcchhhhhhhhhhhhhcccC
Q 045798 402 GLD-FSGNHFSGEIPSSLGNLSSLYEVFFNNNNLSGVIPFSLGNLKRLAFLEMSGNELSGTIPEDIFNISYLSNSLNLAR 480 (1008)
Q Consensus 402 ~L~-Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~lp~~~~~~~~~~~~L~L~~ 480 (1008)
.|+ ++.|.+. .|..+.+++|.+....+ ..|+.|+|++|+|++ +|. + .....++.|+|++
T Consensus 413 ~L~~l~~n~~~-----------~L~~l~l~~n~i~~l~~------~~L~~L~Ls~n~l~~-lp~-~-~~l~~L~~L~Ls~ 472 (567)
T 1dce_A 413 AVDPMRAAYLD-----------DLRSKFLLENSVLKMEY------ADVRVLHLAHKDLTV-LCH-L-EQLLLVTHLDLSH 472 (567)
T ss_dssp HHCGGGHHHHH-----------HHHHHHHHHHHHHHHHH------TTCSEEECTTSCCSS-CCC-G-GGGTTCCEEECCS
T ss_pred cCcchhhcccc-----------hhhhhhhhcccccccCc------cCceEEEecCCCCCC-CcC-c-cccccCcEeecCc
Confidence 666 5555432 34444555555543222 125555555555542 332 1 1111222333333
Q ss_pred ccccCCCcccccccccccccccccccccCCCCcccccccccceeeccCcccccch-hhhhhccccccEEecCCCcccccc
Q 045798 481 NHLVGIIPPRIGNLRALRSFDVSNNDLSGEIPIELGHCSSLEEIYLAGNLFHGSI-PSFFNALKGVQKIDLSRNNLSGQI 559 (1008)
Q Consensus 481 N~l~~~~p~~~~~l~~L~~Ldls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~ls~N~l~~~~ 559 (1008)
|+|+ .+|..|+.+++|+.|+|++|.|++ +| .++.+++|++|+|++|+|++.+ |..|+.+++|+.|+|++|++++.+
T Consensus 473 N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~ 549 (567)
T 1dce_A 473 NRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEE 549 (567)
T ss_dssp SCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSS
T ss_pred cccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCc
Confidence 3333 445555556666666666666653 44 5566666666666666666554 566666666666666666666554
Q ss_pred cC
Q 045798 560 PI 561 (1008)
Q Consensus 560 p~ 561 (1008)
|.
T Consensus 550 ~~ 551 (567)
T 1dce_A 550 GI 551 (567)
T ss_dssp SC
T ss_pred cH
Confidence 43
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.78 E-value=3.4e-19 Score=199.47 Aligned_cols=128 Identities=23% Similarity=0.232 Sum_probs=81.3
Q ss_pred cEEEecCCcCCccCChhhhhhcccceeeeeccccccCCCCCccc-cccccceEEecCccccCCcchhccCCCCCceEEcc
Q 045798 328 RVLSLGGNQFRGALPHSIANLSSQLQILILSSNQFYGSIPLGIG-NLVDLYLLGMVENQFTGAIPKEMGKLQKLQGLDFS 406 (1008)
Q Consensus 328 ~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls 406 (1008)
+.+++++|.++ .+|..+.. .++.|+|++|+|++..+..+. .+++|+.|+|++|+|++..+..|..+++|++|+|+
T Consensus 21 ~~l~c~~~~l~-~iP~~~~~---~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls 96 (361)
T 2xot_A 21 NILSCSKQQLP-NVPQSLPS---YTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLS 96 (361)
T ss_dssp TEEECCSSCCS-SCCSSCCT---TCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECC
T ss_pred CEEEeCCCCcC-ccCccCCC---CCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECC
Confidence 56777777776 45654432 366777777777655555555 66666666666666666555666666666666666
Q ss_pred CCcccccccccccCCCCcceeeccccccccccCCCCcCCCcccEeeccccccc
Q 045798 407 GNHFSGEIPSSLGNLSSLYEVFFNNNNLSGVIPFSLGNLKRLAFLEMSGNELS 459 (1008)
Q Consensus 407 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 459 (1008)
+|+|++..+..|.++++|+.|+|++|+|.+..|..|.++++|+.|+|++|+|+
T Consensus 97 ~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~ 149 (361)
T 2xot_A 97 SNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQIS 149 (361)
T ss_dssp SSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCC
T ss_pred CCcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCC
Confidence 66666555555666666666666666666555666666666666666666665
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.78 E-value=4.5e-19 Score=191.89 Aligned_cols=173 Identities=27% Similarity=0.341 Sum_probs=134.9
Q ss_pred ccCCccCCeeeecCCCCCCCCCccccCCCCCCEEEccCCCCCCccCcccccCcCcceEeeeccccccCCCccccccCCCC
Q 045798 74 LGNLSFLREINLSNNTIQGEIPPEFGRLFRLEALFLSNNSLVGKIPANLSYCSRLTVLCIEYNKLQGRIPLEFVSLSKLK 153 (1008)
Q Consensus 74 l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~ 153 (1008)
+..+++|++|++++|.++. ++ .+..+++|++|+|++|++++..+ ++.+++|++|+|++|++++ +| .+..+++|+
T Consensus 42 ~~~l~~L~~L~l~~~~i~~-~~-~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~-~~-~l~~l~~L~ 115 (291)
T 1h6t_A 42 QNELNSIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKD-LS-SLKDLKKLK 115 (291)
T ss_dssp HHHHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-GG-GGTTCTTCC
T ss_pred hhhcCcccEEEccCCCccc-Ch-hHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCCC-Ch-hhccCCCCC
Confidence 3467778888888888873 33 47788888888888888885544 8888888888888888875 33 477888888
Q ss_pred eeecccccCCCCCCCCCccccccchhhcccccCCCCCCccccCCCCCcEEEecCCcccccCCccccCCCCcceecccccc
Q 045798 154 DLSLAKNKLTGGIPPFLGNLTSLEVLSLAGNSFGRNIPDSLGQLKQLKILAIGGNNLSGPIPPSIYNLSFLVVFSVSHNQ 233 (1008)
Q Consensus 154 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ls~N~ 233 (1008)
+|++++|++++. +.+..+++|++|++++|++++. ..+..+++|+.|++++|++++..+ +..+++|+.|++++|.
T Consensus 116 ~L~L~~n~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~L~~N~ 189 (291)
T 1h6t_A 116 SLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNH 189 (291)
T ss_dssp EEECTTSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSC
T ss_pred EEECCCCcCCCC--hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCccccchh--hcCCCccCEEECCCCc
Confidence 888888888853 4677888888888888888654 568888888888888888886544 8888888888888888
Q ss_pred ccccCChhhhhcCCCCcEEEeccccCCC
Q 045798 234 IHGSLPPSLGLLLPNLKFFQIHHNFFSG 261 (1008)
Q Consensus 234 l~~~lp~~~~~~l~~L~~L~L~~N~l~~ 261 (1008)
++ .++. +..+++|+.|++++|.+..
T Consensus 190 i~-~l~~--l~~l~~L~~L~l~~n~i~~ 214 (291)
T 1h6t_A 190 IS-DLRA--LAGLKNLDVLELFSQECLN 214 (291)
T ss_dssp CC-BCGG--GTTCTTCSEEEEEEEEEEC
T ss_pred CC-CChh--hccCCCCCEEECcCCcccC
Confidence 87 4553 4558888899998888874
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.78 E-value=3.5e-19 Score=199.45 Aligned_cols=175 Identities=21% Similarity=0.204 Sum_probs=119.9
Q ss_pred EEeccccCCCCccCcCccCCccCCeeeecCCCCCCCCCcccc-CCCCCCEEEccCCCCCCccCcccccCcCcceEeeecc
Q 045798 58 ALDLMSKSLSGSLSPHLGNLSFLREINLSNNTIQGEIPPEFG-RLFRLEALFLSNNSLVGKIPANLSYCSRLTVLCIEYN 136 (1008)
Q Consensus 58 ~l~l~~~~l~~~l~~~l~~l~~L~~L~L~~n~~~~~~p~~~~-~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n 136 (1008)
.+++++++++ .+|..+. ..++.|+|++|+|++..+..|. .+++|++|+|++|+|++..+..|..+++|++|+|++|
T Consensus 22 ~l~c~~~~l~-~iP~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N 98 (361)
T 2xot_A 22 ILSCSKQQLP-NVPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSN 98 (361)
T ss_dssp EEECCSSCCS-SCCSSCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred EEEeCCCCcC-ccCccCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCCC
Confidence 4566667776 4666554 3478888888888876676776 7888888888888888666677888888888888888
Q ss_pred ccccCCCccccccCCCCeeecccccCCCCCCCCCccccccchhhcccccCCCCCCccc---cCCCCCcEEEecCCccccc
Q 045798 137 KLQGRIPLEFVSLSKLKDLSLAKNKLTGGIPPFLGNLTSLEVLSLAGNSFGRNIPDSL---GQLKQLKILAIGGNNLSGP 213 (1008)
Q Consensus 137 ~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~---~~l~~L~~L~L~~n~l~~~ 213 (1008)
+|++..+..|..+++|++|+|++|+|++..|..|.++++|+.|+|++|+++...+..| ..+++|+.|+|++|+|++.
T Consensus 99 ~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~~l 178 (361)
T 2xot_A 99 HLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKKL 178 (361)
T ss_dssp CCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCCCC
T ss_pred cCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCCcc
Confidence 8876666677777777777777777776666777777777777777777765444444 4566666666666666644
Q ss_pred CCccccCCCC--cceecccccccc
Q 045798 214 IPPSIYNLSF--LVVFSVSHNQIH 235 (1008)
Q Consensus 214 ~~~~~~~l~~--L~~L~ls~N~l~ 235 (1008)
.+..+..++. |+.|+|++|.+.
T Consensus 179 ~~~~~~~l~~~~l~~l~l~~N~~~ 202 (361)
T 2xot_A 179 PLTDLQKLPAWVKNGLYLHNNPLE 202 (361)
T ss_dssp CHHHHHHSCHHHHTTEECCSSCEE
T ss_pred CHHHhhhccHhhcceEEecCCCcc
Confidence 4445555544 244555555443
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.78 E-value=1.2e-18 Score=180.18 Aligned_cols=152 Identities=21% Similarity=0.269 Sum_probs=131.6
Q ss_pred CeeeecCCCCCCCCCccccCCCCCCEEEccCCCCCCccCcccccCcCcceEeeeccccccCCCccccccCCCCeeecccc
Q 045798 81 REINLSNNTIQGEIPPEFGRLFRLEALFLSNNSLVGKIPANLSYCSRLTVLCIEYNKLQGRIPLEFVSLSKLKDLSLAKN 160 (1008)
Q Consensus 81 ~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n 160 (1008)
+.+++++++++ .+|..+. ++|++|+|++|+|++..+..|..+++|++|+|++|+|++..|..|.++++|++|+|++|
T Consensus 14 ~~v~c~~~~l~-~iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N 90 (220)
T 2v9t_B 14 NIVDCRGKGLT-EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGN 90 (220)
T ss_dssp TEEECTTSCCS-SCCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSS
T ss_pred CEEEcCCCCcC-cCCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCC
Confidence 57889999998 6776664 78999999999999777778999999999999999999888899999999999999999
Q ss_pred cCCCCCCCCCccccccchhhcccccCCCCCCccccCCCCCcEEEecCCcccccCCccccCCCCcceecccccccc
Q 045798 161 KLTGGIPPFLGNLTSLEVLSLAGNSFGRNIPDSLGQLKQLKILAIGGNNLSGPIPPSIYNLSFLVVFSVSHNQIH 235 (1008)
Q Consensus 161 ~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~ 235 (1008)
+|+...+..|.++++|++|+|++|++++..+..|..+++|+.|+|++|.+++..+..|..+++|+.|+|++|.+.
T Consensus 91 ~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~ 165 (220)
T 2v9t_B 91 KITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFI 165 (220)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEE
T ss_pred cCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcC
Confidence 999666666788999999999999998888888999999999999999998877777888888888888888775
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.77 E-value=1.4e-18 Score=179.49 Aligned_cols=156 Identities=20% Similarity=0.213 Sum_probs=133.3
Q ss_pred CeeeecCCCCCCCCCccccCCCCCCEEEccCCCCCCccC-cccccCcCcceEeeeccccccCCCccccccCCCCeeeccc
Q 045798 81 REINLSNNTIQGEIPPEFGRLFRLEALFLSNNSLVGKIP-ANLSYCSRLTVLCIEYNKLQGRIPLEFVSLSKLKDLSLAK 159 (1008)
Q Consensus 81 ~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p-~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~ 159 (1008)
+++++++|+++ .+|..+. ..+++|+|++|++++..| ..|..+++|++|+|++|+|++..+..|.++++|++|+|++
T Consensus 14 ~~l~~s~n~l~-~iP~~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~ 90 (220)
T 2v70_A 14 TTVDCSNQKLN-KIPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTS 90 (220)
T ss_dssp TEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CEeEeCCCCcc-cCccCCC--CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCC
Confidence 58999999998 5776654 456899999999996654 4588999999999999999987788899999999999999
Q ss_pred ccCCCCCCCCCccccccchhhcccccCCCCCCccccCCCCCcEEEecCCcccccCCccccCCCCcceeccccccccccCC
Q 045798 160 NKLTGGIPPFLGNLTSLEVLSLAGNSFGRNIPDSLGQLKQLKILAIGGNNLSGPIPPSIYNLSFLVVFSVSHNQIHGSLP 239 (1008)
Q Consensus 160 n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~~~lp 239 (1008)
|++++..+..|.++++|++|+|++|++++..|..|..+++|++|+|++|++++..|..|..+++|+.|++++|.+....+
T Consensus 91 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~ 170 (220)
T 2v70_A 91 NRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCNCY 170 (220)
T ss_dssp SCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECSGG
T ss_pred CccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCCCc
Confidence 99997777778889999999999999988888889999999999999999998888888888888888888888875443
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.76 E-value=1.4e-18 Score=205.89 Aligned_cols=181 Identities=28% Similarity=0.337 Sum_probs=140.3
Q ss_pred ccCCccCCeeeecCCCCCCCCCccccCCCCCCEEEccCCCCCCccCcccccCcCcceEeeeccccccCCCccccccCCCC
Q 045798 74 LGNLSFLREINLSNNTIQGEIPPEFGRLFRLEALFLSNNSLVGKIPANLSYCSRLTVLCIEYNKLQGRIPLEFVSLSKLK 153 (1008)
Q Consensus 74 l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~ 153 (1008)
+..+++|+.|+|++|.+. .++ .|..+++|++|+|++|++++..| +..+++|++|+|++|.|++ +| .+..+++|+
T Consensus 39 ~~~L~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~-l~-~l~~l~~L~ 112 (605)
T 1m9s_A 39 QNELNSIDQIIANNSDIK-SVQ-GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIKD-LS-SLKDLKKLK 112 (605)
T ss_dssp HHHHTTCCCCBCTTCCCC-CCT-TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCC-CT-TSTTCTTCC
T ss_pred hhcCCCCCEEECcCCCCC-CCh-HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEECcCCCCCC-Ch-hhccCCCCC
Confidence 456778888888888887 444 58888888888888888886554 8888888888888888885 33 678888888
Q ss_pred eeecccccCCCCCCCCCccccccchhhcccccCCCCCCccccCCCCCcEEEecCCcccccCCccccCCCCcceecccccc
Q 045798 154 DLSLAKNKLTGGIPPFLGNLTSLEVLSLAGNSFGRNIPDSLGQLKQLKILAIGGNNLSGPIPPSIYNLSFLVVFSVSHNQ 233 (1008)
Q Consensus 154 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ls~N~ 233 (1008)
+|+|++|++++ + +.+..+++|+.|+|++|++++. ..|..+++|+.|+|++|.+++..| +..+++|+.|+|++|+
T Consensus 113 ~L~Ls~N~l~~-l-~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~ 186 (605)
T 1m9s_A 113 SLSLEHNGISD-I-NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNH 186 (605)
T ss_dssp EEECTTSCCCC-C-GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSC
T ss_pred EEEecCCCCCC-C-ccccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCCchh--hccCCCCCEEECcCCC
Confidence 88888888884 3 4578888888888888888664 668888888888888888887655 8888888888888888
Q ss_pred ccccCChhhhhcCCCCcEEEeccccCCCCCCccccc
Q 045798 234 IHGSLPPSLGLLLPNLKFFQIHHNFFSGSIPISLSN 269 (1008)
Q Consensus 234 l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~ 269 (1008)
+. .+|. +..+++|+.|+|++|.+.+.....+..
T Consensus 187 i~-~l~~--l~~l~~L~~L~L~~N~l~~~p~~~~~~ 219 (605)
T 1m9s_A 187 IS-DLRA--LAGLKNLDVLELFSQECLNKPINHQSN 219 (605)
T ss_dssp CC-BCGG--GTTCTTCSEEECCSEEEECCCCCCCSS
T ss_pred CC-CChH--HccCCCCCEEEccCCcCcCCccccccc
Confidence 87 4442 445788888888888887543333333
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.76 E-value=2.8e-18 Score=178.53 Aligned_cols=136 Identities=20% Similarity=0.266 Sum_probs=67.0
Q ss_pred CCceEEccCCcccccccccccCCCCcceeeccccccccccCCCCcCCCcccEeecccccccCCcchhhhhhhhhhhhhcc
Q 045798 399 KLQGLDFSGNHFSGEIPSSLGNLSSLYEVFFNNNNLSGVIPFSLGNLKRLAFLEMSGNELSGTIPEDIFNISYLSNSLNL 478 (1008)
Q Consensus 399 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~lp~~~~~~~~~~~~L~L 478 (1008)
+|++|+|++|+|++..|..|.++++|+.|+|++|+|....+..|..+++|+.|+|++|+|++
T Consensus 41 ~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~------------------ 102 (229)
T 3e6j_A 41 NAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLTV------------------ 102 (229)
T ss_dssp TCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCC------------------
T ss_pred CCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCCCcCCc------------------
Confidence 34444444444443334444444444444444444443333444455555555555555541
Q ss_pred cCccccCCCcccccccccccccccccccccCCCCcccccccccceeeccCcccccchhhhhhccccccEEecCCCccccc
Q 045798 479 ARNHLVGIIPPRIGNLRALRSFDVSNNDLSGEIPIELGHCSSLEEIYLAGNLFHGSIPSFFNALKGVQKIDLSRNNLSGQ 558 (1008)
Q Consensus 479 ~~N~l~~~~p~~~~~l~~L~~Ldls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~ 558 (1008)
..+..|..+++|+.|+|++|.++ .+|..+..+++|++|+|++|+|++..+..|..+++|+.|+|++|++++.
T Consensus 103 -------l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 174 (229)
T 3e6j_A 103 -------LPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDCE 174 (229)
T ss_dssp -------CCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCTT
T ss_pred -------cChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCccCC
Confidence 12223344455555555555555 4555555555555555555555544445555566666666666666554
Q ss_pred cc
Q 045798 559 IP 560 (1008)
Q Consensus 559 ~p 560 (1008)
.+
T Consensus 175 c~ 176 (229)
T 3e6j_A 175 CR 176 (229)
T ss_dssp BG
T ss_pred cc
Confidence 43
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.76 E-value=3.4e-21 Score=227.16 Aligned_cols=207 Identities=20% Similarity=0.199 Sum_probs=137.4
Q ss_pred cCCCCCCEEEccCCCCCCccCcccccCcCcceEeeeccc-------------cccCCCccccccCCCCeee-cccccCCC
Q 045798 99 GRLFRLEALFLSNNSLVGKIPANLSYCSRLTVLCIEYNK-------------LQGRIPLEFVSLSKLKDLS-LAKNKLTG 164 (1008)
Q Consensus 99 ~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~-------------l~~~~p~~~~~l~~L~~L~-L~~n~l~~ 164 (1008)
..+++|+.|+|++|+++ .+|..+++|++|+.|++++|. +.+.+|..++.+++|+.|+ ++.|.+
T Consensus 346 ~~~~~L~~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~l~~ll~~~~~~~~~~~~l~~l~~L~~L~~l~~n~~-- 422 (567)
T 1dce_A 346 ATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYL-- 422 (567)
T ss_dssp STTTTSSSCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHCTGGGHHHHHHHHHHHHHHCGGGHHHH--
T ss_pred ccCccceeccCChhhHH-hhHHHHHHHHHHHHhccccchhhhhHHHHHHhcccccCCHHHHHHHHhcccCcchhhccc--
Confidence 45777778888888877 777778888888888876664 4556677777788888877 566543
Q ss_pred CCCCCCccccccchhhcccccCCCCCCccccCCCCCcEEEecCCcccccCCccccCCCCcceeccccccccccCChhhhh
Q 045798 165 GIPPFLGNLTSLEVLSLAGNSFGRNIPDSLGQLKQLKILAIGGNNLSGPIPPSIYNLSFLVVFSVSHNQIHGSLPPSLGL 244 (1008)
Q Consensus 165 ~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~~~lp~~~~~ 244 (1008)
.+|+.+.+++|.++...+ ..|+.|+|++|.+++ +|. |..+++|+.|+|++|+++ .+|..+.
T Consensus 423 ---------~~L~~l~l~~n~i~~l~~------~~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~- 483 (567)
T 1dce_A 423 ---------DDLRSKFLLENSVLKMEY------ADVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPALA- 483 (567)
T ss_dssp ---------HHHHHHHHHHHHHHHHHH------TTCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGGG-
T ss_pred ---------chhhhhhhhcccccccCc------cCceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchhhh-
Confidence 355666666666543222 136677777777765 444 677777777777777776 6666544
Q ss_pred cCCCCcEEEeccccCCCCCCcccccCCCCceeecccccccccc-cccccCCCcccccccccccCCCCCCCcccccccccc
Q 045798 245 LLPNLKFFQIHHNFFSGSIPISLSNASKLEHIEIANNNFSGKL-SVNFGGMKNLSLLNLQFSNLGSGESDEMGFMNSLTN 323 (1008)
Q Consensus 245 ~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~-~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~ 323 (1008)
.+++|++|+|++|.+++ +| .+.++++|++|+|++|+|++.. |..|..+++|+.|+|++|+++...... ...+..
T Consensus 484 ~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~---~~l~~~ 558 (567)
T 1dce_A 484 ALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQ---ERLAEM 558 (567)
T ss_dssp GCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCT---THHHHH
T ss_pred cCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccHH---HHHHHH
Confidence 36777777777777774 45 6677777777777777777665 667777777777777777766543321 112344
Q ss_pred cCCCcEEEe
Q 045798 324 CSKLRVLSL 332 (1008)
Q Consensus 324 l~~L~~L~L 332 (1008)
+++|+.|++
T Consensus 559 lp~L~~L~l 567 (567)
T 1dce_A 559 LPSVSSILT 567 (567)
T ss_dssp CTTCSEEEC
T ss_pred CcccCccCC
Confidence 677777764
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.75 E-value=6.2e-19 Score=214.67 Aligned_cols=200 Identities=24% Similarity=0.245 Sum_probs=117.5
Q ss_pred EEecCCcCCccCChhhhhhcccceeeeeccccccCCCCCccccccccceEEecCccccCCcchhccCCCCCceEEccCCc
Q 045798 330 LSLGGNQFRGALPHSIANLSSQLQILILSSNQFYGSIPLGIGNLVDLYLLGMVENQFTGAIPKEMGKLQKLQGLDFSGNH 409 (1008)
Q Consensus 330 L~Ls~N~l~~~~p~~~~~l~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~ 409 (1008)
++++.|++. ..+..+..+. .|+.|+|++|.+. .+|..+..+++|++|+|++|.|+ .+|..|..+++|++|+|++|.
T Consensus 206 ~~~~~n~~~-~~~~~~~~l~-~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~ 281 (727)
T 4b8c_D 206 DDDIENRMV-MPKDSKYDDQ-LWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNR 281 (727)
T ss_dssp -----------------CCC-CCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSC
T ss_pred cccccccee-cChhhhccCC-CCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCc
Confidence 344555555 4555666654 4888888888887 67777778888888888888888 788888999999999999999
Q ss_pred ccccccccccCCCCcceeeccccccccccCCCCcCCCcccEeecccccccCCcchhhhhhhhhhhhhcccCccccCCCcc
Q 045798 410 FSGEIPSSLGNLSSLYEVFFNNNNLSGVIPFSLGNLKRLAFLEMSGNELSGTIPEDIFNISYLSNSLNLARNHLVGIIPP 489 (1008)
Q Consensus 410 l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~lp~~~~~~~~~~~~L~L~~N~l~~~~p~ 489 (1008)
|+ .+|..|.+|++|++|+|++|.|+ .+|..|+++++|+.|+|++|+|++.+|..+.........|+|++|.+++.+|.
T Consensus 282 l~-~lp~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~ 359 (727)
T 4b8c_D 282 LT-SLPAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPH 359 (727)
T ss_dssp CS-SCCSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCC
T ss_pred CC-ccChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCcc
Confidence 98 77888999999999999999997 67888999999999999999999888877766555545577777777777665
Q ss_pred cccccccccccccccccccCCCCcccccccccceeeccCcccccchhhhhhccccccEEecCCCcccc
Q 045798 490 RIGNLRALRSFDVSNNDLSGEIPIELGHCSSLEEIYLAGNLFHGSIPSFFNALKGVQKIDLSRNNLSG 557 (1008)
Q Consensus 490 ~~~~l~~L~~Ldls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~ 557 (1008)
. |+.|++++|... -.. .+.|.+.++..+..+..+....+++|-+.+
T Consensus 360 ~------l~~l~l~~n~~~---~~~-------------~~~l~~~~~~~~~~l~~~~~~~ls~Nil~~ 405 (727)
T 4b8c_D 360 E------RRFIEINTDGEP---QRE-------------YDSLQQSTEHLATDLAKRTFTVLSYNTLCQ 405 (727)
T ss_dssp C---------------------------------------------------------------CCCG
T ss_pred c------cceeEeeccccc---ccc-------------cCCccccccchhhcccccceeeeecccccc
Confidence 3 455666666100 000 112333334444555566666666666653
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.74 E-value=1.8e-18 Score=183.49 Aligned_cols=137 Identities=19% Similarity=0.166 Sum_probs=105.9
Q ss_pred CCCCceEeeccCeeEEEEEEcCCCeE--EEEEEeccccch------------------------hhHHHHHHHHHHhhcC
Q 045798 686 FSSTHLIGVGSFGCVYKGALDEDGIV--VAIKVINLQCEG------------------------ASKSFMAECKALKNIR 739 (1008)
Q Consensus 686 y~~~~~lg~G~~g~Vy~~~~~~~~~~--vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l~ 739 (1008)
|.+.+.||+|+||.||+|.+..+|+. ||||+++..... ....+.+|++++.++.
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 66789999999999999999668888 999997543111 1136889999999998
Q ss_pred CCCc--eeeeeccccccccCCceEEEEEeccCC-C----ChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHH
Q 045798 740 HRNL--VKVITSCSSIDFQGNDFKAIVYEYMPN-G----SLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYL 812 (1008)
Q Consensus 740 h~ni--v~~~~~~~~~~~~~~~~~~lv~e~~~~-g----sL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~L 812 (1008)
|+++ ..+++. +..++||||+.+ | +|.++.. ..++..+..++.|++.||+||
T Consensus 129 ~~~i~~p~~~~~---------~~~~lVmE~~g~~g~~~~~L~~~~~-------------~~~~~~~~~i~~qi~~~l~~l 186 (258)
T 1zth_A 129 EAGVSVPQPYTY---------MKNVLLMEFIGEDELPAPTLVELGR-------------ELKELDVEGIFNDVVENVKRL 186 (258)
T ss_dssp HTTCCCCCEEEE---------ETTEEEEECCEETTEECCBHHHHGG-------------GGGGSCHHHHHHHHHHHHHHH
T ss_pred hCCCCCCeEEEc---------CCCEEEEEecCCCCCccccHHHHhh-------------ccChHHHHHHHHHHHHHHHHH
Confidence 8754 333332 236899999942 4 5555432 122446778999999999999
Q ss_pred h-hCCCCCceeccCCCCCeeecCCCCeEEcccCccccc
Q 045798 813 H-HHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFH 849 (1008)
Q Consensus 813 H-~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~ 849 (1008)
| +. +|+||||||+|||++. .++|+|||+|...
T Consensus 187 H~~~---givHrDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 187 YQEA---ELVHADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp HHTS---CEECSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred HHHC---CEEeCCCCHHHEEEcC--cEEEEECcccccC
Confidence 9 87 9999999999999998 9999999999754
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.74 E-value=4.6e-18 Score=172.61 Aligned_cols=156 Identities=15% Similarity=0.198 Sum_probs=103.8
Q ss_pred cccccccceEEecCccccCCcchhccCCCCCceEEccCCcccccccccccCCCCcceeeccccccccccCCCCcCCCccc
Q 045798 370 IGNLVDLYLLGMVENQFTGAIPKEMGKLQKLQGLDFSGNHFSGEIPSSLGNLSSLYEVFFNNNNLSGVIPFSLGNLKRLA 449 (1008)
Q Consensus 370 ~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~ 449 (1008)
...+++|+.|++++|.++ .+| .+..+++|++|++++|.+. .+..+..+++|++|++++|.+++..|..|+.+++|+
T Consensus 40 ~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~--~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~ 115 (197)
T 4ezg_A 40 EAQMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHAT--NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLT 115 (197)
T ss_dssp HHHHHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCS--CCGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCC
T ss_pred hhhcCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCC--cchhhhcCCCCCEEEeECCccCcccChhhcCCCCCC
Confidence 356667777777777776 444 5677777777777777664 234567777777777777777766677777777777
Q ss_pred EeecccccccCCcchhhhhhhhhhhhhcccCccccCCCcccccccccccccccccccccCCCCcccccccccceeeccCc
Q 045798 450 FLEMSGNELSGTIPEDIFNISYLSNSLNLARNHLVGIIPPRIGNLRALRSFDVSNNDLSGEIPIELGHCSSLEEIYLAGN 529 (1008)
Q Consensus 450 ~L~Ls~N~l~~~lp~~~~~~~~~~~~L~L~~N~l~~~~p~~~~~l~~L~~Ldls~N~l~~~~p~~~~~l~~L~~L~L~~N 529 (1008)
+|+|++|++++ ..|..++.+++|+.|++++|.+.+.+| .+..+++|++|++++|
T Consensus 116 ~L~Ls~n~i~~-------------------------~~~~~l~~l~~L~~L~L~~n~~i~~~~-~l~~l~~L~~L~l~~n 169 (197)
T 4ezg_A 116 LLDISHSAHDD-------------------------SILTKINTLPKVNSIDLSYNGAITDIM-PLKTLPELKSLNIQFD 169 (197)
T ss_dssp EEECCSSBCBG-------------------------GGHHHHTTCSSCCEEECCSCTBCCCCG-GGGGCSSCCEEECTTB
T ss_pred EEEecCCccCc-------------------------HhHHHHhhCCCCCEEEccCCCCccccH-hhcCCCCCCEEECCCC
Confidence 77777777763 334556666777777777776222555 5677777777777777
Q ss_pred ccccchhhhhhccccccEEecCCCcccc
Q 045798 530 LFHGSIPSFFNALKGVQKIDLSRNNLSG 557 (1008)
Q Consensus 530 ~l~~~~p~~~~~l~~L~~L~ls~N~l~~ 557 (1008)
++++ ++ .+..+++|+.|++++|++.+
T Consensus 170 ~i~~-~~-~l~~l~~L~~L~l~~N~i~~ 195 (197)
T 4ezg_A 170 GVHD-YR-GIEDFPKLNQLYAFSQTIGG 195 (197)
T ss_dssp CCCC-CT-TGGGCSSCCEEEECBC----
T ss_pred CCcC-hH-HhccCCCCCEEEeeCcccCC
Confidence 7774 33 56677777777777777653
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.73 E-value=3e-18 Score=182.26 Aligned_cols=169 Identities=22% Similarity=0.298 Sum_probs=108.4
Q ss_pred CCccCCeeeecCCCCCCCCCccccCCCCCCEEEccCCCCCCccCcccccCcCcceEeeeccccccCCCccccccCCCCee
Q 045798 76 NLSFLREINLSNNTIQGEIPPEFGRLFRLEALFLSNNSLVGKIPANLSYCSRLTVLCIEYNKLQGRIPLEFVSLSKLKDL 155 (1008)
Q Consensus 76 ~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L 155 (1008)
.+.++..+++++|.+++ ++ .+..+++|++|++++|+++ .+| .++.+++|++|+|++|+|++..+ +..+++|++|
T Consensus 17 ~l~~l~~l~l~~~~i~~-~~-~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L 90 (263)
T 1xeu_A 17 GLANAVKQNLGKQSVTD-LV-SQKELSGVQNFNGDNSNIQ-SLA-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEEL 90 (263)
T ss_dssp HHHHHHHHHHTCSCTTS-EE-CHHHHTTCSEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEE
T ss_pred HHHHHHHHHhcCCCccc-cc-chhhcCcCcEEECcCCCcc-cch-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEE
Confidence 45566677777777763 33 5677777777777777777 445 57777777777777777775444 7777777777
Q ss_pred ecccccCCCCCCCCCccccccchhhcccccCCCCCCccccCCCCCcEEEecCCcccccCCccccCCCCcceecccccccc
Q 045798 156 SLAKNKLTGGIPPFLGNLTSLEVLSLAGNSFGRNIPDSLGQLKQLKILAIGGNNLSGPIPPSIYNLSFLVVFSVSHNQIH 235 (1008)
Q Consensus 156 ~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~ 235 (1008)
+|++|++++ +|... . ++|++|+|++|++++. ..+..+++|+.|++++|++++. + .+..+++|+.|++++|+++
T Consensus 91 ~L~~N~l~~-l~~~~-~-~~L~~L~L~~N~l~~~--~~l~~l~~L~~L~Ls~N~i~~~-~-~l~~l~~L~~L~L~~N~i~ 163 (263)
T 1xeu_A 91 SVNRNRLKN-LNGIP-S-ACLSRLFLDNNELRDT--DSLIHLKNLEILSIRNNKLKSI-V-MLGFLSKLEVLDLHGNEIT 163 (263)
T ss_dssp ECCSSCCSC-CTTCC-C-SSCCEEECCSSCCSBS--GGGTTCTTCCEEECTTSCCCBC-G-GGGGCTTCCEEECTTSCCC
T ss_pred ECCCCccCC-cCccc-c-CcccEEEccCCccCCC--hhhcCcccccEEECCCCcCCCC-h-HHccCCCCCEEECCCCcCc
Confidence 777777774 33322 2 6777777777777543 2466777777777777777643 2 5666666666666666665
Q ss_pred ccCChhhhhcCCCCcEEEeccccCC
Q 045798 236 GSLPPSLGLLLPNLKFFQIHHNFFS 260 (1008)
Q Consensus 236 ~~lp~~~~~~l~~L~~L~L~~N~l~ 260 (1008)
+. ..+..+++|+.|++++|.+.
T Consensus 164 ~~---~~l~~l~~L~~L~l~~N~~~ 185 (263)
T 1xeu_A 164 NT---GGLTRLKKVNWIDLTGQKCV 185 (263)
T ss_dssp BC---TTSTTCCCCCEEEEEEEEEE
T ss_pred ch---HHhccCCCCCEEeCCCCccc
Confidence 32 22233555555555555555
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.73 E-value=2.4e-18 Score=183.09 Aligned_cols=168 Identities=24% Similarity=0.263 Sum_probs=99.8
Q ss_pred cceeeeeccccccCCCCCccccccccceEEecCccccCCcchhccCCCCCceEEccCCcccccccccccCCCCcceeecc
Q 045798 351 QLQILILSSNQFYGSIPLGIGNLVDLYLLGMVENQFTGAIPKEMGKLQKLQGLDFSGNHFSGEIPSSLGNLSSLYEVFFN 430 (1008)
Q Consensus 351 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~ 430 (1008)
.+..+++++|.+++ ++ .+..+++|+.|++++|+++. ++ .+..+++|+.|+|++|++++..+ +..+++|+.|+++
T Consensus 20 ~l~~l~l~~~~i~~-~~-~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L~L~ 93 (263)
T 1xeu_A 20 NAVKQNLGKQSVTD-LV-SQKELSGVQNFNGDNSNIQS-LA-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEELSVN 93 (263)
T ss_dssp HHHHHHHTCSCTTS-EE-CHHHHTTCSEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEEECC
T ss_pred HHHHHHhcCCCccc-cc-chhhcCcCcEEECcCCCccc-ch-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEEECC
Confidence 36667777777763 33 45666667777777766663 33 56666666666666666664333 5666666666666
Q ss_pred ccccccccCCCCcCCCcccEeecccccccCCcchhhhhhhhhhhhhcccCccccCCCcccccccccccccccccccccCC
Q 045798 431 NNNLSGVIPFSLGNLKRLAFLEMSGNELSGTIPEDIFNISYLSNSLNLARNHLVGIIPPRIGNLRALRSFDVSNNDLSGE 510 (1008)
Q Consensus 431 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~lp~~~~~~~~~~~~L~L~~N~l~~~~p~~~~~l~~L~~Ldls~N~l~~~ 510 (1008)
+|++++. |.. .. ++|+.|+|++|++++ ++ .++.+++|+.|+|++|++++
T Consensus 94 ~N~l~~l-~~~-~~-~~L~~L~L~~N~l~~--------------------------~~-~l~~l~~L~~L~Ls~N~i~~- 142 (263)
T 1xeu_A 94 RNRLKNL-NGI-PS-ACLSRLFLDNNELRD--------------------------TD-SLIHLKNLEILSIRNNKLKS- 142 (263)
T ss_dssp SSCCSCC-TTC-CC-SSCCEEECCSSCCSB--------------------------SG-GGTTCTTCCEEECTTSCCCB-
T ss_pred CCccCCc-Ccc-cc-CcccEEEccCCccCC--------------------------Ch-hhcCcccccEEECCCCcCCC-
Confidence 6666542 221 11 555666665555541 12 35556666666666666663
Q ss_pred CCcccccccccceeeccCcccccchhhhhhccccccEEecCCCccccc
Q 045798 511 IPIELGHCSSLEEIYLAGNLFHGSIPSFFNALKGVQKIDLSRNNLSGQ 558 (1008)
Q Consensus 511 ~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~ 558 (1008)
+| .++.+++|++|+|++|++++. ..+..+++|+.|+|++|++++.
T Consensus 143 ~~-~l~~l~~L~~L~L~~N~i~~~--~~l~~l~~L~~L~l~~N~~~~~ 187 (263)
T 1xeu_A 143 IV-MLGFLSKLEVLDLHGNEITNT--GGLTRLKKVNWIDLTGQKCVNE 187 (263)
T ss_dssp CG-GGGGCTTCCEEECTTSCCCBC--TTSTTCCCCCEEEEEEEEEECC
T ss_pred Ch-HHccCCCCCEEECCCCcCcch--HHhccCCCCCEEeCCCCcccCC
Confidence 33 466666666666666666644 4556666666666666666544
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.73 E-value=8.5e-18 Score=169.65 Aligned_cols=132 Identities=21% Similarity=0.339 Sum_probs=79.8
Q ss_pred ceEEccCCcccccccccccCCCCcceeeccccccccccCC-CCcCCCcccEeecccccccCCcchhhhhhhhhhhhhccc
Q 045798 401 QGLDFSGNHFSGEIPSSLGNLSSLYEVFFNNNNLSGVIPF-SLGNLKRLAFLEMSGNELSGTIPEDIFNISYLSNSLNLA 479 (1008)
Q Consensus 401 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~lp~~~~~~~~~~~~L~L~ 479 (1008)
+++++++|.++ .+|..+.. +|++|++++|.|++..+. .|..+++|++|+|++|++++
T Consensus 11 ~~l~~s~~~l~-~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~------------------- 68 (192)
T 1w8a_A 11 TTVDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTG------------------- 68 (192)
T ss_dssp TEEECTTSCCS-SCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCC-------------------
T ss_pred CEEEcCCCCcC-cCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCC-------------------
Confidence 45555555554 44443332 555555555555544443 35566666666666666553
Q ss_pred CccccCCCcccccccccccccccccccccCCCCcccccccccceeeccCcccccchhhhhhccccccEEecCCCcccccc
Q 045798 480 RNHLVGIIPPRIGNLRALRSFDVSNNDLSGEIPIELGHCSSLEEIYLAGNLFHGSIPSFFNALKGVQKIDLSRNNLSGQI 559 (1008)
Q Consensus 480 ~N~l~~~~p~~~~~l~~L~~Ldls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~ 559 (1008)
..|..|..+++|+.|+|++|++++..|..|..+++|++|+|++|+|++.+|..|..+++|+.|+|++|++++..
T Consensus 69 ------~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c 142 (192)
T 1w8a_A 69 ------IEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNC 142 (192)
T ss_dssp ------BCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSG
T ss_pred ------cCHhHcCCcccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcC
Confidence 34455566666666666666666555555666666777777777777666667777777777777777777655
Q ss_pred c
Q 045798 560 P 560 (1008)
Q Consensus 560 p 560 (1008)
+
T Consensus 143 ~ 143 (192)
T 1w8a_A 143 H 143 (192)
T ss_dssp G
T ss_pred c
Confidence 4
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.73 E-value=5.2e-18 Score=172.23 Aligned_cols=151 Identities=18% Similarity=0.251 Sum_probs=62.3
Q ss_pred CCCCCEEEccCCCCCCccCcccccCcCcceEeeeccccccCCCccccccCCCCeeecccccCCCCCCCCCccccccchhh
Q 045798 101 LFRLEALFLSNNSLVGKIPANLSYCSRLTVLCIEYNKLQGRIPLEFVSLSKLKDLSLAKNKLTGGIPPFLGNLTSLEVLS 180 (1008)
Q Consensus 101 l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 180 (1008)
+++|++|++++|.++ .+| .+..+++|++|++++|.++. +..+..+++|++|++++|++++..+..++.+++|++|+
T Consensus 43 l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~~--~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~ 118 (197)
T 4ezg_A 43 MNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHATN--YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLD 118 (197)
T ss_dssp HHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCSC--CGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEE
T ss_pred cCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCCc--chhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEE
Confidence 333444444444433 222 23334444444444443321 12333444444444444444433344444444444444
Q ss_pred cccccCCCCCCccccCCCCCcEEEecCCc-ccccCCccccCCCCcceeccccccccccCChhhhhcCCCCcEEEeccccC
Q 045798 181 LAGNSFGRNIPDSLGQLKQLKILAIGGNN-LSGPIPPSIYNLSFLVVFSVSHNQIHGSLPPSLGLLLPNLKFFQIHHNFF 259 (1008)
Q Consensus 181 L~~n~l~~~~~~~~~~l~~L~~L~L~~n~-l~~~~~~~~~~l~~L~~L~ls~N~l~~~lp~~~~~~l~~L~~L~L~~N~l 259 (1008)
+++|++++..+..|+.+++|++|++++|. ++. ++ .+..+++|+.|++++|+++ .++ .+..+++|++|++++|++
T Consensus 119 Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~~-~~-~l~~l~~L~~L~l~~n~i~-~~~--~l~~l~~L~~L~l~~N~i 193 (197)
T 4ezg_A 119 ISHSAHDDSILTKINTLPKVNSIDLSYNGAITD-IM-PLKTLPELKSLNIQFDGVH-DYR--GIEDFPKLNQLYAFSQTI 193 (197)
T ss_dssp CCSSBCBGGGHHHHTTCSSCCEEECCSCTBCCC-CG-GGGGCSSCCEEECTTBCCC-CCT--TGGGCSSCCEEEECBC--
T ss_pred ecCCccCcHhHHHHhhCCCCCEEEccCCCCccc-cH-hhcCCCCCCEEECCCCCCc-ChH--HhccCCCCCEEEeeCccc
Confidence 44444443344444444444444444444 332 22 3444444455555555444 232 222345555555555554
Q ss_pred C
Q 045798 260 S 260 (1008)
Q Consensus 260 ~ 260 (1008)
.
T Consensus 194 ~ 194 (197)
T 4ezg_A 194 G 194 (197)
T ss_dssp -
T ss_pred C
Confidence 3
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.69 E-value=1.2e-16 Score=161.10 Aligned_cols=133 Identities=22% Similarity=0.280 Sum_probs=121.1
Q ss_pred cEEEecCCcCCccCChhhhhhcccceeeeeccccccCCCCC-ccccccccceEEecCccccCCcchhccCCCCCceEEcc
Q 045798 328 RVLSLGGNQFRGALPHSIANLSSQLQILILSSNQFYGSIPL-GIGNLVDLYLLGMVENQFTGAIPKEMGKLQKLQGLDFS 406 (1008)
Q Consensus 328 ~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls 406 (1008)
+.+++++|+++ .+|..+.. .|++|+|++|++++..+. .+..+++|++|+|++|+|++..|..|..+++|++|+|+
T Consensus 11 ~~l~~s~~~l~-~ip~~~~~---~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls 86 (192)
T 1w8a_A 11 TTVDCTGRGLK-EIPRDIPL---HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLG 86 (192)
T ss_dssp TEEECTTSCCS-SCCSCCCT---TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred CEEEcCCCCcC-cCccCCCC---CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECC
Confidence 68899999997 77876544 699999999999966664 48999999999999999999999999999999999999
Q ss_pred CCcccccccccccCCCCcceeeccccccccccCCCCcCCCcccEeecccccccCCcch
Q 045798 407 GNHFSGEIPSSLGNLSSLYEVFFNNNNLSGVIPFSLGNLKRLAFLEMSGNELSGTIPE 464 (1008)
Q Consensus 407 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~lp~ 464 (1008)
+|+|++..+..|.++++|++|+|++|+|++..|..|..+++|+.|+|++|.+++..+.
T Consensus 87 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l 144 (192)
T 1w8a_A 87 ENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHL 144 (192)
T ss_dssp SCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGG
T ss_pred CCcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCcc
Confidence 9999988888899999999999999999999999999999999999999999987653
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.67 E-value=5.6e-17 Score=179.13 Aligned_cols=287 Identities=14% Similarity=0.086 Sum_probs=135.9
Q ss_pred cCCCCeeecccccCCCCCCCCCcc-ccccchhhcccccCC--CCCCccccCCCCCcEEEecCCcccccCCccccC-----
Q 045798 149 LSKLKDLSLAKNKLTGGIPPFLGN-LTSLEVLSLAGNSFG--RNIPDSLGQLKQLKILAIGGNNLSGPIPPSIYN----- 220 (1008)
Q Consensus 149 l~~L~~L~L~~n~l~~~~~~~~~~-l~~L~~L~L~~n~l~--~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~----- 220 (1008)
+.++++|.++++- .......+.. +++|+.|+|++|++. ......+ +.++.+.+..|.| ...+|.+
T Consensus 24 ~~~l~~L~l~g~i-~~~~~~~l~~~l~~L~~LdLs~n~i~~~~~~~~~~---~~~~~~~~~~~~I---~~~aF~~~~~~~ 96 (329)
T 3sb4_A 24 ANSITHLTLTGKL-NAEDFRHLRDEFPSLKVLDISNAEIKMYSGKAGTY---PNGKFYIYMANFV---PAYAFSNVVNGV 96 (329)
T ss_dssp HHHCSEEEEEEEE-CHHHHHHHHHSCTTCCEEEEEEEEECCEEESSSSS---GGGCCEEECTTEE---CTTTTEEEETTE
T ss_pred hCceeEEEEeccc-cHHHHHHHHHhhccCeEEecCcceeEEecCccccc---ccccccccccccc---CHHHhccccccc
Confidence 5677778777642 1111112222 556777777777764 1111112 2234444444432 2345555
Q ss_pred ---CCCcceeccccccccccCChhhhhcCCCCcEEEeccccCCCCCCcccccCCCCceeeccccc----ccccccccccC
Q 045798 221 ---LSFLVVFSVSHNQIHGSLPPSLGLLLPNLKFFQIHHNFFSGSIPISLSNASKLEHIEIANNN----FSGKLSVNFGG 293 (1008)
Q Consensus 221 ---l~~L~~L~ls~N~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~----l~~~~~~~~~~ 293 (1008)
+++|+.|+|++ .++ .|+...|..+++|+.|++++|.+....+.+|..+.++..+.+..+. ........|.+
T Consensus 97 ~~g~~~L~~l~L~~-~i~-~I~~~aF~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~~~f~~ 174 (329)
T 3sb4_A 97 TKGKQTLEKVILSE-KIK-NIEDAAFKGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRWEHFAFIE 174 (329)
T ss_dssp EEECTTCCC-CBCT-TCC-EECTTTTTTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTTTTSCEEE
T ss_pred ccccCCCcEEECCc-ccc-chhHHHhhcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhcccccccccccc
Confidence 66666666666 555 5666666666666666666666655555556555555555544421 12222333333
Q ss_pred CCccc-ccccccccCCCCCCCcccccccccccCCCcEEEecCCcCCccCChhhhhhcccceeeeeccccccCCCCCcccc
Q 045798 294 MKNLS-LLNLQFSNLGSGESDEMGFMNSLTNCSKLRVLSLGGNQFRGALPHSIANLSSQLQILILSSNQFYGSIPLGIGN 372 (1008)
Q Consensus 294 l~~L~-~L~L~~n~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~Ls~N~l~~~~p~~~~~ 372 (1008)
+.+|+ .+.+... ..+. ......-....++..+.+.++-.. .....+.....+|+.|+|++|+++...+..|.+
T Consensus 175 ~~~L~~~i~~~~~--~~l~---~~~~~~~~~~~~~~~l~~~~~l~~-~~~~~l~~~~~~L~~l~L~~n~i~~I~~~aF~~ 248 (329)
T 3sb4_A 175 GEPLETTIQVGAM--GKLE---DEIMKAGLQPRDINFLTIEGKLDN-ADFKLIRDYMPNLVSLDISKTNATTIPDFTFAQ 248 (329)
T ss_dssp SCCCEEEEEECTT--CCHH---HHHHHTTCCGGGCSEEEEEECCCH-HHHHHHHHHCTTCCEEECTTBCCCEECTTTTTT
T ss_pred ccccceeEEecCC--CcHH---HHHhhcccCccccceEEEeeeecH-HHHHHHHHhcCCCeEEECCCCCcceecHhhhhC
Confidence 33333 1111100 0000 000000011233344444433111 111112221234666666665555444445555
Q ss_pred ccccceEEecCccccCCcchhccCCCCCc-eEEccCCcccccccccccCCCCcceeeccccccccccCCCCcCCCcccEe
Q 045798 373 LVDLYLLGMVENQFTGAIPKEMGKLQKLQ-GLDFSGNHFSGEIPSSLGNLSSLYEVFFNNNNLSGVIPFSLGNLKRLAFL 451 (1008)
Q Consensus 373 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~-~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L 451 (1008)
+.+|+.|+|.+| ++.+.+..|.++++|+ .|+|.+ .++...+..|.++++|+.|++++|.+..+.+.+|.++++|+.|
T Consensus 249 ~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I~~~aF~~~~~L~~l 326 (329)
T 3sb4_A 249 KKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKITTLGDELFGNGVPSKLI 326 (329)
T ss_dssp CTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSSCCCEECTTTTCTTCCCCEE
T ss_pred CCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEeCCCccCccchhhhcCCcchhhh
Confidence 666666666555 5544555555566665 666655 4443444555556666666665555555555555555555555
Q ss_pred e
Q 045798 452 E 452 (1008)
Q Consensus 452 ~ 452 (1008)
+
T Consensus 327 y 327 (329)
T 3sb4_A 327 Y 327 (329)
T ss_dssp E
T ss_pred c
Confidence 4
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.67 E-value=1.8e-17 Score=183.10 Aligned_cols=293 Identities=13% Similarity=0.110 Sum_probs=151.2
Q ss_pred CccCcCccC--CccCCeeeecCCCCCCCCCccccC-CCCCCEEEccCCCCC--CccCcccccCcCcceEeeeccccccCC
Q 045798 68 GSLSPHLGN--LSFLREINLSNNTIQGEIPPEFGR-LFRLEALFLSNNSLV--GKIPANLSYCSRLTVLCIEYNKLQGRI 142 (1008)
Q Consensus 68 ~~l~~~l~~--l~~L~~L~L~~n~~~~~~p~~~~~-l~~L~~L~Ls~n~l~--~~~p~~l~~l~~L~~L~Ls~n~l~~~~ 142 (1008)
|.+...+.. +.++++|.++++ +....-..+.. +++|++|||++|++. ...+. .++.+..+.+..|.| .
T Consensus 13 g~l~~~l~~~~~~~l~~L~l~g~-i~~~~~~~l~~~l~~L~~LdLs~n~i~~~~~~~~---~~~~~~~~~~~~~~I---~ 85 (329)
T 3sb4_A 13 GTLISMMTEEEANSITHLTLTGK-LNAEDFRHLRDEFPSLKVLDISNAEIKMYSGKAG---TYPNGKFYIYMANFV---P 85 (329)
T ss_dssp TCGGGGSCHHHHHHCSEEEEEEE-ECHHHHHHHHHSCTTCCEEEEEEEEECCEEESSS---SSGGGCCEEECTTEE---C
T ss_pred CcHHhhccchhhCceeEEEEecc-ccHHHHHHHHHhhccCeEEecCcceeEEecCccc---ccccccccccccccc---C
Confidence 344444433 667788887763 22111112233 667777777777776 22222 222244445544432 2
Q ss_pred Cccccc--------cCCCCeeecccccCCCCCCCCCccccccchhhcccccCCCCCCccccCCCCCcEEEecCCc----c
Q 045798 143 PLEFVS--------LSKLKDLSLAKNKLTGGIPPFLGNLTSLEVLSLAGNSFGRNIPDSLGQLKQLKILAIGGNN----L 210 (1008)
Q Consensus 143 p~~~~~--------l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~----l 210 (1008)
+.+|.+ +++|+.|+|.+ .++.+.+..|.++++|+.|++++|.+....+.+|..+.++..+.+..+. .
T Consensus 86 ~~aF~~~~~~~~~g~~~L~~l~L~~-~i~~I~~~aF~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~ 164 (329)
T 3sb4_A 86 AYAFSNVVNGVTKGKQTLEKVILSE-KIKNIEDAAFKGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFK 164 (329)
T ss_dssp TTTTEEEETTEEEECTTCCC-CBCT-TCCEECTTTTTTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTS
T ss_pred HHHhcccccccccccCCCcEEECCc-cccchhHHHhhcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhcc
Confidence 345555 67777777766 6665555667777777777777776666666667666666655555422 1
Q ss_pred cccCCccccCCCCcc-eeccccccccccCChhhhhc---CCCCcEEEeccccCCCCCCccc-ccCCCCceeecccccccc
Q 045798 211 SGPIPPSIYNLSFLV-VFSVSHNQIHGSLPPSLGLL---LPNLKFFQIHHNFFSGSIPISL-SNASKLEHIEIANNNFSG 285 (1008)
Q Consensus 211 ~~~~~~~~~~l~~L~-~L~ls~N~l~~~lp~~~~~~---l~~L~~L~L~~N~l~~~~p~~l-~~l~~L~~L~L~~N~l~~ 285 (1008)
......+|.++..|+ .+.+... +.++..++.. ..+++.+.+.++-.. .....+ ..+++|+.|+|++|+++.
T Consensus 165 ~~i~~~~f~~~~~L~~~i~~~~~---~~l~~~~~~~~~~~~~~~~l~~~~~l~~-~~~~~l~~~~~~L~~l~L~~n~i~~ 240 (329)
T 3sb4_A 165 NRWEHFAFIEGEPLETTIQVGAM---GKLEDEIMKAGLQPRDINFLTIEGKLDN-ADFKLIRDYMPNLVSLDISKTNATT 240 (329)
T ss_dssp TTTTTSCEEESCCCEEEEEECTT---CCHHHHHHHTTCCGGGCSEEEEEECCCH-HHHHHHHHHCTTCCEEECTTBCCCE
T ss_pred ccccccccccccccceeEEecCC---CcHHHHHhhcccCccccceEEEeeeecH-HHHHHHHHhcCCCeEEECCCCCcce
Confidence 223344455555555 3333322 1233333321 334455555544221 111111 125566666666666666
Q ss_pred cccccccCCCcccccccccccCCCCCCCcccccccccccCCCcEEEecCCcCCccCChhhhhhcccceeeeeccccccCC
Q 045798 286 KLSVNFGGMKNLSLLNLQFSNLGSGESDEMGFMNSLTNCSKLRVLSLGGNQFRGALPHSIANLSSQLQILILSSNQFYGS 365 (1008)
Q Consensus 286 ~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~Ls~N~l~~~ 365 (1008)
+...+|.++.+|+.++|+.| +..++.. +|.++++|+ ..+++.+ .++..
T Consensus 241 I~~~aF~~~~~L~~l~l~~n-i~~I~~~------aF~~~~~L~------------------------~~l~l~~-~l~~I 288 (329)
T 3sb4_A 241 IPDFTFAQKKYLLKIKLPHN-LKTIGQR------VFSNCGRLA------------------------GTLELPA-SVTAI 288 (329)
T ss_dssp ECTTTTTTCTTCCEEECCTT-CCEECTT------TTTTCTTCC------------------------EEEEECT-TCCEE
T ss_pred ecHhhhhCCCCCCEEECCcc-cceehHH------HhhCChhcc------------------------EEEEEcc-cceEE
Confidence 55555555555555555544 3333222 344444444 0444444 33333
Q ss_pred CCCccccccccceEEecCccccCCcchhccCCCCCceEE
Q 045798 366 IPLGIGNLVDLYLLGMVENQFTGAIPKEMGKLQKLQGLD 404 (1008)
Q Consensus 366 ~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 404 (1008)
-+..|.++++|+.+++++|+++.+.+..|.++++|+.|+
T Consensus 289 ~~~aF~~c~~L~~l~l~~n~i~~I~~~aF~~~~~L~~ly 327 (329)
T 3sb4_A 289 EFGAFMGCDNLRYVLATGDKITTLGDELFGNGVPSKLIY 327 (329)
T ss_dssp CTTTTTTCTTEEEEEECSSCCCEECTTTTCTTCCCCEEE
T ss_pred chhhhhCCccCCEEEeCCCccCccchhhhcCCcchhhhc
Confidence 445566666666666666666656666677777777665
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.64 E-value=3.1e-16 Score=154.69 Aligned_cols=84 Identities=30% Similarity=0.366 Sum_probs=42.8
Q ss_pred ccCCeeeecCCCCC-CCCCccccCCCCCCEEEccCCCCCCccCcccccCcCcceEeeeccccccCCCccccccCCCCeee
Q 045798 78 SFLREINLSNNTIQ-GEIPPEFGRLFRLEALFLSNNSLVGKIPANLSYCSRLTVLCIEYNKLQGRIPLEFVSLSKLKDLS 156 (1008)
Q Consensus 78 ~~L~~L~L~~n~~~-~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~ 156 (1008)
++|++|+|++|.++ +.+|..+..+++|++|+|++|.+++. ..++.+++|++|+|++|++++.+|..+..+++|++|+
T Consensus 24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 101 (168)
T 2ell_A 24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLN 101 (168)
T ss_dssp TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEE
T ss_pred ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEe
Confidence 44555555555554 44455555555555555555555533 4445555555555555555544444444445555555
Q ss_pred cccccCC
Q 045798 157 LAKNKLT 163 (1008)
Q Consensus 157 L~~n~l~ 163 (1008)
|++|+++
T Consensus 102 Ls~N~l~ 108 (168)
T 2ell_A 102 LSGNKLK 108 (168)
T ss_dssp CBSSSCC
T ss_pred ccCCccC
Confidence 5554444
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.63 E-value=8.7e-16 Score=152.85 Aligned_cols=134 Identities=29% Similarity=0.356 Sum_probs=84.3
Q ss_pred CCCCcccceEEcCCCCeEEEEeccccCCCCccCcCccCCccCCeeeecCCCCCCCCCccccCCCCCCEEEccCCCCCCcc
Q 045798 39 RHFCEWEGITCGRRHRRVTALDLMSKSLSGSLSPHLGNLSFLREINLSNNTIQGEIPPEFGRLFRLEALFLSNNSLVGKI 118 (1008)
Q Consensus 39 ~~~c~w~gv~c~~~~~~v~~l~l~~~~l~~~l~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~ 118 (1008)
.+.|+|.++.|.. ++++ .+|..+. ++|++|++++|++++..+..|..+++|++|+|++|++++..
T Consensus 4 ~C~C~~~~l~~~~------------~~l~-~~p~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~ 68 (177)
T 2o6r_A 4 RCSCSGTEIRCNS------------KGLT-SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLP 68 (177)
T ss_dssp TCEEETTEEECCS------------SCCS-SCCTTCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCC
T ss_pred CCEeCCCEEEecC------------CCCc-cCCCCCC--CCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeC
Confidence 4567888777753 3333 3444332 57778888888877666666777777777777777777555
Q ss_pred CcccccCcCcceEeeeccccccCCCccccccCCCCeeecccccCCCCCCCCCccccccchhhcccccCC
Q 045798 119 PANLSYCSRLTVLCIEYNKLQGRIPLEFVSLSKLKDLSLAKNKLTGGIPPFLGNLTSLEVLSLAGNSFG 187 (1008)
Q Consensus 119 p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~ 187 (1008)
+..++.+++|++|+|++|+|++..+..|..+++|++|++++|++++..+..+..+++|++|++++|.+.
T Consensus 69 ~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~ 137 (177)
T 2o6r_A 69 DGVFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWD 137 (177)
T ss_dssp TTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBC
T ss_pred hhHccCCCccCEEECCCCCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCee
Confidence 555666677777777766666555555566666666666666666443334455555555555555554
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.63 E-value=4.1e-16 Score=153.76 Aligned_cols=136 Identities=24% Similarity=0.248 Sum_probs=94.6
Q ss_pred CCCCEEEccCCCCC-CccCcccccCcCcceEeeeccccccCCCccccccCCCCeeecccccCCCCCCCCCccccccchhh
Q 045798 102 FRLEALFLSNNSLV-GKIPANLSYCSRLTVLCIEYNKLQGRIPLEFVSLSKLKDLSLAKNKLTGGIPPFLGNLTSLEVLS 180 (1008)
Q Consensus 102 ~~L~~L~Ls~n~l~-~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 180 (1008)
++|++|+|++|.++ +.+|..+..+++|++|+|++|.+++. ..+..+++|++|+|++|++++.+|..+.++++|++|+
T Consensus 24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 101 (168)
T 2ell_A 24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLN 101 (168)
T ss_dssp TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEE
T ss_pred ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEe
Confidence 66777777777776 56677777777777777777777754 6667777777777777777755666666677777777
Q ss_pred cccccCCCCC-CccccCCCCCcEEEecCCcccccCC---ccccCCCCcceeccccccccccCCh
Q 045798 181 LAGNSFGRNI-PDSLGQLKQLKILAIGGNNLSGPIP---PSIYNLSFLVVFSVSHNQIHGSLPP 240 (1008)
Q Consensus 181 L~~n~l~~~~-~~~~~~l~~L~~L~L~~n~l~~~~~---~~~~~l~~L~~L~ls~N~l~~~lp~ 240 (1008)
+++|++++.. +..+..+++|+.|++++|.+++..+ ..+..+++|+.|++++|.+. .+|.
T Consensus 102 Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~-~~~~ 164 (168)
T 2ell_A 102 LSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQ-EAPD 164 (168)
T ss_dssp CBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSC-BCCS
T ss_pred ccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChh-hccc
Confidence 7777775532 2567777777777777777775444 36777777777777777766 4543
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.62 E-value=4.4e-16 Score=150.14 Aligned_cols=128 Identities=18% Similarity=0.181 Sum_probs=81.0
Q ss_pred CCCceEEccCCccc-ccccccccCCCCcceeeccccccccccCCCCcCCCcccEeecccccccCCcchhhhhhhhhhhhh
Q 045798 398 QKLQGLDFSGNHFS-GEIPSSLGNLSSLYEVFFNNNNLSGVIPFSLGNLKRLAFLEMSGNELSGTIPEDIFNISYLSNSL 476 (1008)
Q Consensus 398 ~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~lp~~~~~~~~~~~~L 476 (1008)
++|+.|++++|.++ +.+|..+..+++|+.|++++|.+.+. ..++.+++|++|+|++|++++
T Consensus 17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~---------------- 78 (149)
T 2je0_A 17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSG---------------- 78 (149)
T ss_dssp GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCS----------------
T ss_pred ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccc----------------
Confidence 45666666666665 55565566666666666666666644 556666677777777776663
Q ss_pred cccCccccCCCcccccccccccccccccccccCC-CCcccccccccceeeccCcccccchh---hhhhccccccEEecCC
Q 045798 477 NLARNHLVGIIPPRIGNLRALRSFDVSNNDLSGE-IPIELGHCSSLEEIYLAGNLFHGSIP---SFFNALKGVQKIDLSR 552 (1008)
Q Consensus 477 ~L~~N~l~~~~p~~~~~l~~L~~Ldls~N~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~p---~~~~~l~~L~~L~ls~ 552 (1008)
.+|..++.+++|++|++++|.+++. .|..++.+++|++|++++|++++..+ ..++.+++|+.||+++
T Consensus 79 ---------~~~~~~~~l~~L~~L~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~d 149 (149)
T 2je0_A 79 ---------GLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGYD 149 (149)
T ss_dssp ---------CTHHHHHHCTTCCEEECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTBC
T ss_pred ---------hHHHHhhhCCCCCEEECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCCC
Confidence 2444455566677777777776642 23566667777777777777775544 4677777777777653
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.61 E-value=7e-16 Score=168.77 Aligned_cols=138 Identities=19% Similarity=0.190 Sum_probs=99.0
Q ss_pred cCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccc--------------hhhHHH--------HHHHHHHhhcCCC
Q 045798 684 NGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCE--------------GASKSF--------MAECKALKNIRHR 741 (1008)
Q Consensus 684 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--------------~~~~~~--------~~E~~~l~~l~h~ 741 (1008)
.-|.+.+.||+|++|.||+|.+. +|+.||||+++.... ...... .+|...+.++.+.
T Consensus 95 ~iY~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~ 173 (397)
T 4gyi_A 95 DVYSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEE 173 (397)
T ss_dssp SCSEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred CEEEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhc
Confidence 34889999999999999999985 799999999763210 001122 3455555555333
Q ss_pred Cce--eeeeccccccccCCceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCC
Q 045798 742 NLV--KVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEP 819 (1008)
Q Consensus 742 niv--~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ 819 (1008)
++. ..+++ ...++||||++|++|.++... .....++.|++.+|.|||+. |
T Consensus 174 gv~vp~p~~~---------~~~~LVME~i~G~~L~~l~~~----------------~~~~~l~~qll~~l~~lH~~---g 225 (397)
T 4gyi_A 174 GFPVPEPIAQ---------SRHTIVMSLVDALPMRQVSSV----------------PDPASLYADLIALILRLAKH---G 225 (397)
T ss_dssp TCSCCCEEEE---------ETTEEEEECCSCEEGGGCCCC----------------SCHHHHHHHHHHHHHHHHHT---T
T ss_pred CCCCCeeeec---------cCceEEEEecCCccHhhhccc----------------HHHHHHHHHHHHHHHHHHHC---C
Confidence 321 11111 123799999999888776431 12356889999999999998 9
Q ss_pred ceeccCCCCCeeecCCC----------CeEEcccCcccccc
Q 045798 820 ILHCDLKPSNILLDNDL----------SGHIGDFGLARFHQ 850 (1008)
Q Consensus 820 ivH~Dlkp~NIll~~~~----------~~kL~Dfg~a~~~~ 850 (1008)
||||||||.|||+++++ .+.|+||+.+....
T Consensus 226 IVHrDLKp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~~~ 266 (397)
T 4gyi_A 226 LIHGDFNEFNILIREEKDAEDPSSITLTPIIIXFPQMVSMD 266 (397)
T ss_dssp EECSCCSTTSEEEEEEECSSCTTSEEEEEEECCCTTCEETT
T ss_pred CcCCCCCHHHEEEeCCCCcccccccccceEEEEeCCcccCC
Confidence 99999999999998776 38999999887543
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.61 E-value=2.2e-15 Score=151.87 Aligned_cols=108 Identities=30% Similarity=0.417 Sum_probs=48.8
Q ss_pred CCCEEEccCCCCCCccCcccccCcCcceEeeeccccccCCCccccccCCCCeeecccccCCCCCCCCCccccccchhhcc
Q 045798 103 RLEALFLSNNSLVGKIPANLSYCSRLTVLCIEYNKLQGRIPLEFVSLSKLKDLSLAKNKLTGGIPPFLGNLTSLEVLSLA 182 (1008)
Q Consensus 103 ~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 182 (1008)
+|++|+|++|+|+ .+|..|..+++|++|+|++|+|++..+..|.++++|++|+|++|+|++..+..|.++++|++|+|+
T Consensus 32 ~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~L~ 110 (193)
T 2wfh_A 32 DVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRCIPPRTFDGLKSLRLLSLH 110 (193)
T ss_dssp TCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECC
T ss_pred CCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCccCEeCHHHhCCCCCCCEEECC
Confidence 3444444444443 333344444444444444444443333444444444444444444444334444444444444444
Q ss_pred cccCCCCCCccccCCCCCcEEEecCCccc
Q 045798 183 GNSFGRNIPDSLGQLKQLKILAIGGNNLS 211 (1008)
Q Consensus 183 ~n~l~~~~~~~~~~l~~L~~L~L~~n~l~ 211 (1008)
+|+++...+..|..+++|+.|+|++|.+.
T Consensus 111 ~N~l~~~~~~~~~~l~~L~~L~L~~N~~~ 139 (193)
T 2wfh_A 111 GNDISVVPEGAFNDLSALSHLAIGANPLY 139 (193)
T ss_dssp SSCCCBCCTTTTTTCTTCCEEECCSSCEE
T ss_pred CCCCCeeChhhhhcCccccEEEeCCCCee
Confidence 44444433344555555555555555554
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.60 E-value=8.5e-15 Score=164.90 Aligned_cols=264 Identities=15% Similarity=0.095 Sum_probs=136.1
Q ss_pred ccCCeeeecCCCCCCCCCccccCCCCCCEEEccCCCCCCccCcccccCcCcceEeeeccccccCCCccccccCCCCeeec
Q 045798 78 SFLREINLSNNTIQGEIPPEFGRLFRLEALFLSNNSLVGKIPANLSYCSRLTVLCIEYNKLQGRIPLEFVSLSKLKDLSL 157 (1008)
Q Consensus 78 ~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L 157 (1008)
..++.+.+.+ .++.+-..+|.++ +|+.+.+.++ ++.....+|.++ +|+.+.+.. .++.+.+.+|.++++|+.+++
T Consensus 113 ~~l~~i~ip~-~i~~I~~~aF~~~-~L~~i~l~~~-i~~I~~~aF~~~-~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l 187 (401)
T 4fdw_A 113 KGYNEIILPN-SVKSIPKDAFRNS-QIAKVVLNEG-LKSIGDMAFFNS-TVQEIVFPS-TLEQLKEDIFYYCYNLKKADL 187 (401)
T ss_dssp SSCSEEECCT-TCCEECTTTTTTC-CCSEEECCTT-CCEECTTTTTTC-CCCEEECCT-TCCEECSSTTTTCTTCCEEEC
T ss_pred CCccEEEECC-ccCEehHhhcccC-CccEEEeCCC-ccEECHHhcCCC-CceEEEeCC-CccEehHHHhhCcccCCeeec
Confidence 4555555544 3443445556554 5666666555 554445555553 466666654 455455556666666666666
Q ss_pred ccccCCCCCCCCCccccccchhhcccccCCCCCCccccCCCCCcEEEecCCcccccCCccccCCCCcceecccccccccc
Q 045798 158 AKNKLTGGIPPFLGNLTSLEVLSLAGNSFGRNIPDSLGQLKQLKILAIGGNNLSGPIPPSIYNLSFLVVFSVSHNQIHGS 237 (1008)
Q Consensus 158 ~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~~~ 237 (1008)
.+|+++......|. ..+|+.+.|..+ +......+|.++++|+.+++..| ++.+...+|.+ .+|+.+.+. +.++ .
T Consensus 188 ~~n~l~~I~~~aF~-~~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~lp-~~i~-~ 261 (401)
T 4fdw_A 188 SKTKITKLPASTFV-YAGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGITTVKLP-NGVT-N 261 (401)
T ss_dssp TTSCCSEECTTTTT-TCCCSEEECCTT-CCEECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCSEEEEE-TTCC-E
T ss_pred CCCcceEechhhEe-ecccCEEEeCCc-hheehhhHhhCCCCCCEEecCCC-ccCcccccccc-CCccEEEeC-CCcc-E
Confidence 66666643334444 356666666533 54555555666666666666553 44444555555 455555552 3343 4
Q ss_pred CChhhhhcCCCCcEEEeccccCC-----CCCCcccccCCCCceeecccccccccccccccCCCcccccccccccCCCCCC
Q 045798 238 LPPSLGLLLPNLKFFQIHHNFFS-----GSIPISLSNASKLEHIEIANNNFSGKLSVNFGGMKNLSLLNLQFSNLGSGES 312 (1008)
Q Consensus 238 lp~~~~~~l~~L~~L~L~~N~l~-----~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~ 312 (1008)
++...|..+++|+.+++.+|.+. ...+.+|.++++|+.+++. +.+..+...+|.
T Consensus 262 I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~-------------------- 320 (401)
T 4fdw_A 262 IASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIP-ESIRILGQGLLG-------------------- 320 (401)
T ss_dssp ECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCC-TTCCEECTTTTT--------------------
T ss_pred EChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeC-CceEEEhhhhhc--------------------
Confidence 55555555555555555555443 2333444455555555554 234444444444
Q ss_pred CcccccccccccCCCcEEEecCCcCCccCChhhhhhcccceeeeeccccccCCCCCcccccc-ccceEEecCccc
Q 045798 313 DEMGFMNSLTNCSKLRVLSLGGNQFRGALPHSIANLSSQLQILILSSNQFYGSIPLGIGNLV-DLYLLGMVENQF 386 (1008)
Q Consensus 313 ~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~L~L~~n~l 386 (1008)
++++|+.+.|..| ++..-...|.++ +|+.+++++|.+....+..|.+++ ++..|++..+.+
T Consensus 321 ----------~c~~L~~l~lp~~-l~~I~~~aF~~~--~L~~l~l~~n~~~~l~~~~F~~~~~~l~~l~vp~~~~ 382 (401)
T 4fdw_A 321 ----------GNRKVTQLTIPAN-VTQINFSAFNNT--GIKEVKVEGTTPPQVFEKVWYGFPDDITVIRVPAESV 382 (401)
T ss_dssp ----------TCCSCCEEEECTT-CCEECTTSSSSS--CCCEEEECCSSCCBCCCSSCCCSCTTCCEEEECGGGH
T ss_pred ----------CCCCccEEEECcc-ccEEcHHhCCCC--CCCEEEEcCCCCcccccccccCCCCCccEEEeCHHHH
Confidence 4445555555332 332223333333 355555555555444444455553 555666655544
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.59 E-value=6.8e-16 Score=148.82 Aligned_cols=127 Identities=24% Similarity=0.208 Sum_probs=76.9
Q ss_pred CccCCeeeecCCCCC-CCCCccccCCCCCCEEEccCCCCCCccCcccccCcCcceEeeeccccccCCCccccccCCCCee
Q 045798 77 LSFLREINLSNNTIQ-GEIPPEFGRLFRLEALFLSNNSLVGKIPANLSYCSRLTVLCIEYNKLQGRIPLEFVSLSKLKDL 155 (1008)
Q Consensus 77 l~~L~~L~L~~n~~~-~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L 155 (1008)
.++|++|++++|.++ +.+|..+..+++|++|++++|.+++. ..++.+++|++|++++|.+++.+|..+..+++|++|
T Consensus 16 ~~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L 93 (149)
T 2je0_A 16 PSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHL 93 (149)
T ss_dssp GGGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEE
T ss_pred CccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEE
Confidence 356777777777776 56666667777777777777777644 556666777777777777765566666666666666
Q ss_pred ecccccCCCC-CCCCCccccccchhhcccccCCCCCC---ccccCCCCCcEEEe
Q 045798 156 SLAKNKLTGG-IPPFLGNLTSLEVLSLAGNSFGRNIP---DSLGQLKQLKILAI 205 (1008)
Q Consensus 156 ~L~~n~l~~~-~~~~~~~l~~L~~L~L~~n~l~~~~~---~~~~~l~~L~~L~L 205 (1008)
++++|++++. .+..++.+++|++|++++|.+++..+ ..+..+++|+.|++
T Consensus 94 ~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l 147 (149)
T 2je0_A 94 NLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDG 147 (149)
T ss_dssp ECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETT
T ss_pred ECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccC
Confidence 6666666632 12445555555555555555543333 23444444444444
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.59 E-value=4.6e-15 Score=149.43 Aligned_cols=127 Identities=24% Similarity=0.333 Sum_probs=101.7
Q ss_pred CEEEccCCCCCCccCcccccCcCcceEeeeccccccCCCccccccCCCCeeecccccCCCCCCCCCccccccchhhcccc
Q 045798 105 EALFLSNNSLVGKIPANLSYCSRLTVLCIEYNKLQGRIPLEFVSLSKLKDLSLAKNKLTGGIPPFLGNLTSLEVLSLAGN 184 (1008)
Q Consensus 105 ~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n 184 (1008)
+++++++|+++ .+|..+. ++|++|+|++|+|+ .+|..|.++++|++|+|++|+|++..+..|.++++|++|+|++|
T Consensus 13 ~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N 88 (193)
T 2wfh_A 13 TVVRCSNKGLK-VLPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYN 88 (193)
T ss_dssp TEEECTTSCCS-SCCSCCC--TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEcCCCCCC-cCCCCCC--CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCC
Confidence 46777777777 5665543 57888899999888 67788888888888888888888777778888888888888888
Q ss_pred cCCCCCCccccCCCCCcEEEecCCcccccCCccccCCCCcceecccccccc
Q 045798 185 SFGRNIPDSLGQLKQLKILAIGGNNLSGPIPPSIYNLSFLVVFSVSHNQIH 235 (1008)
Q Consensus 185 ~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~ 235 (1008)
++++..+..|..+++|+.|+|++|.++...+..|..+++|+.|+|++|.+.
T Consensus 89 ~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~ 139 (193)
T 2wfh_A 89 RLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLY 139 (193)
T ss_dssp CCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEE
T ss_pred ccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCee
Confidence 888877778888888888888888888666667777777777777777775
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.57 E-value=8.2e-15 Score=145.77 Aligned_cols=129 Identities=23% Similarity=0.207 Sum_probs=80.5
Q ss_pred CCeeeecCCCCCCCCCccccCCCCCCEEEccCCCCCCccCcccccCcCcceEeeeccccccCCCccccccCCCCeeeccc
Q 045798 80 LREINLSNNTIQGEIPPEFGRLFRLEALFLSNNSLVGKIPANLSYCSRLTVLCIEYNKLQGRIPLEFVSLSKLKDLSLAK 159 (1008)
Q Consensus 80 L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~ 159 (1008)
.+.+++++|+++ .+|..+ .++|++|++++|++++..+..++.+++|++|++++|++++..+..|..+++|++|+|++
T Consensus 9 ~~~l~~~~~~l~-~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 85 (177)
T 2o6r_A 9 GTEIRCNSKGLT-SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHE 85 (177)
T ss_dssp TTEEECCSSCCS-SCCTTC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEEEecCCCCc-cCCCCC--CCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCC
Confidence 356777777776 455433 25677777777777755555666677777777777777655555566666666666666
Q ss_pred ccCCCCCCCCCccccccchhhcccccCCCCCCccccCCCCCcEEEecCCccc
Q 045798 160 NKLTGGIPPFLGNLTSLEVLSLAGNSFGRNIPDSLGQLKQLKILAIGGNNLS 211 (1008)
Q Consensus 160 n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~ 211 (1008)
|++++..+..+.++++|++|++++|++++..+..|..+++|++|++++|.++
T Consensus 86 N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~ 137 (177)
T 2o6r_A 86 NKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWD 137 (177)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBC
T ss_pred CCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCee
Confidence 6666555555566666666666666665544444555556666666655555
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.56 E-value=9e-17 Score=163.18 Aligned_cols=135 Identities=19% Similarity=0.268 Sum_probs=68.9
Q ss_pred CCCCCceEEccCCcccccccc------cccCCCCcceeeccccccccccCCCCcCCCcccEeecccccccCCcchhhhhh
Q 045798 396 KLQKLQGLDFSGNHFSGEIPS------SLGNLSSLYEVFFNNNNLSGVIPFSLGNLKRLAFLEMSGNELSGTIPEDIFNI 469 (1008)
Q Consensus 396 ~l~~L~~L~Ls~N~l~~~~p~------~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~lp~~~~~~ 469 (1008)
....++.+++++|.+.+.+|. .+..+++|++|++++|.+++ +| .+..+++|++|++++|+++ .+
T Consensus 16 ~~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l------- 85 (198)
T 1ds9_A 16 ERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KI------- 85 (198)
T ss_dssp HTTCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SC-------
T ss_pred hcccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cc-------
Confidence 334445555555555544444 55555556666666665554 44 5555666666666666665 22
Q ss_pred hhhhhhhcccCccccCCCcccccccccccccccccccccCCCCcccccccccceeeccCcccccchh-hhhhccccccEE
Q 045798 470 SYLSNSLNLARNHLVGIIPPRIGNLRALRSFDVSNNDLSGEIPIELGHCSSLEEIYLAGNLFHGSIP-SFFNALKGVQKI 548 (1008)
Q Consensus 470 ~~~~~~L~L~~N~l~~~~p~~~~~l~~L~~Ldls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L 548 (1008)
|..+..+++|+.|+|++|.+++ +| .++.+++|++|+|++|++++..+ ..+..+++|+.|
T Consensus 86 ------------------~~~~~~~~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L 145 (198)
T 1ds9_A 86 ------------------ENLDAVADTLEELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDL 145 (198)
T ss_dssp ------------------SSHHHHHHHCSEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEE
T ss_pred ------------------cchhhcCCcCCEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEE
Confidence 2333334455555555555542 33 34455555555555555553221 345555555555
Q ss_pred ecCCCccccccc
Q 045798 549 DLSRNNLSGQIP 560 (1008)
Q Consensus 549 ~ls~N~l~~~~p 560 (1008)
++++|++++.+|
T Consensus 146 ~l~~N~l~~~~~ 157 (198)
T 1ds9_A 146 LLAGNPLYNDYK 157 (198)
T ss_dssp EECSCHHHHHHH
T ss_pred EecCCccccccc
Confidence 555555555444
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.56 E-value=7.9e-17 Score=163.63 Aligned_cols=156 Identities=22% Similarity=0.254 Sum_probs=112.3
Q ss_pred cceeeeeccccccCCCCCccccccccceEEecCccccCCcchhccCCCCCceEEccCCcccccccccccCCCCcceeecc
Q 045798 351 QLQILILSSNQFYGSIPLGIGNLVDLYLLGMVENQFTGAIPKEMGKLQKLQGLDFSGNHFSGEIPSSLGNLSSLYEVFFN 430 (1008)
Q Consensus 351 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~ 430 (1008)
.++.++++.|.+++.+|. ++ .+|..+..+++|++|+|++|++++ +| .+..+++|+.|+++
T Consensus 19 ~l~~l~l~~~~l~~~~~~-----------------l~-~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~ 78 (198)
T 1ds9_A 19 SVVATEAEKVELHGMIPP-----------------IE-KMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLG 78 (198)
T ss_dssp CCCCTTCSEEECCBCCTT-----------------CC-CCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEE
T ss_pred cccCcchheeEeccccCc-----------------Hh-hhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECC
Confidence 466666666666654442 11 233467777777777777777774 55 67777778888888
Q ss_pred ccccccccCCCCcCCCcccEeecccccccCCcchhhhhhhhhhhhhcccCccccCCCcccccccccccccccccccccCC
Q 045798 431 NNNLSGVIPFSLGNLKRLAFLEMSGNELSGTIPEDIFNISYLSNSLNLARNHLVGIIPPRIGNLRALRSFDVSNNDLSGE 510 (1008)
Q Consensus 431 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~lp~~~~~~~~~~~~L~L~~N~l~~~~p~~~~~l~~L~~Ldls~N~l~~~ 510 (1008)
+|.++ .+|..+..+++|++|+|++|++++ +| .++.+++|+.|++++|.+++
T Consensus 79 ~n~l~-~l~~~~~~~~~L~~L~L~~N~l~~--------------------------l~-~~~~l~~L~~L~l~~N~i~~- 129 (198)
T 1ds9_A 79 RNLIK-KIENLDAVADTLEELWISYNQIAS--------------------------LS-GIEKLVNLRVLYMSNNKITN- 129 (198)
T ss_dssp EEEEC-SCSSHHHHHHHCSEEEEEEEECCC--------------------------HH-HHHHHHHSSEEEESEEECCC-
T ss_pred CCCcc-cccchhhcCCcCCEEECcCCcCCc--------------------------CC-ccccCCCCCEEECCCCcCCc-
Confidence 88777 566667777888888888888873 22 35667788888888888873
Q ss_pred CC--cccccccccceeeccCcccccchhh----------hhhccccccEEecCCCcccc
Q 045798 511 IP--IELGHCSSLEEIYLAGNLFHGSIPS----------FFNALKGVQKIDLSRNNLSG 557 (1008)
Q Consensus 511 ~p--~~~~~l~~L~~L~L~~N~l~~~~p~----------~~~~l~~L~~L~ls~N~l~~ 557 (1008)
+| ..+..+++|++|++++|++.+.+|. .+..+++|+.|| +|.++.
T Consensus 130 ~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~l~~L~~Ld--~~~i~~ 186 (198)
T 1ds9_A 130 WGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD--GMPVDV 186 (198)
T ss_dssp HHHHHHHTTTTTCSEEEECSCHHHHHHHTTTTHHHHHHHHHHHCSSCSEEC--CGGGTT
T ss_pred hhHHHHHhcCCCCCEEEecCCccccccccccchHHHHHHHHHhCCCcEEEC--CcccCH
Confidence 33 3678888899999999998877665 388899999887 666653
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.55 E-value=5.6e-14 Score=158.21 Aligned_cols=247 Identities=12% Similarity=0.111 Sum_probs=200.0
Q ss_pred CccCCccCCeeeecCCCCCCCCCccccCCCCCCEEEccCCCCCCccCcccccCcCcceEeeeccccccCCCccccccCCC
Q 045798 73 HLGNLSFLREINLSNNTIQGEIPPEFGRLFRLEALFLSNNSLVGKIPANLSYCSRLTVLCIEYNKLQGRIPLEFVSLSKL 152 (1008)
Q Consensus 73 ~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L 152 (1008)
.+.. .+|+.+.|.++ ++.+-..+|.++ +|+.+.+.+ .++...+.+|.+|++|+.++++.|+++.+....|. ..+|
T Consensus 131 aF~~-~~L~~i~l~~~-i~~I~~~aF~~~-~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l~~n~l~~I~~~aF~-~~~L 205 (401)
T 4fdw_A 131 AFRN-SQIAKVVLNEG-LKSIGDMAFFNS-TVQEIVFPS-TLEQLKEDIFYYCYNLKKADLSKTKITKLPASTFV-YAGI 205 (401)
T ss_dssp TTTT-CCCSEEECCTT-CCEECTTTTTTC-CCCEEECCT-TCCEECSSTTTTCTTCCEEECTTSCCSEECTTTTT-TCCC
T ss_pred hccc-CCccEEEeCCC-ccEECHHhcCCC-CceEEEeCC-CccEehHHHhhCcccCCeeecCCCcceEechhhEe-eccc
Confidence 4555 47999999876 776667788885 799999986 77767778999999999999999999966666776 6899
Q ss_pred CeeecccccCCCCCCCCCccccccchhhcccccCCCCCCccccCCCCCcEEEecCCcccccCCccccCCCCcceeccccc
Q 045798 153 KDLSLAKNKLTGGIPPFLGNLTSLEVLSLAGNSFGRNIPDSLGQLKQLKILAIGGNNLSGPIPPSIYNLSFLVVFSVSHN 232 (1008)
Q Consensus 153 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ls~N 232 (1008)
+.+.|.++ ++.+....|.++++|+.+++..| ++.....+|.+ .+|+.+.+ .+.++.+...+|.++++|+.+++.+|
T Consensus 206 ~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~l-p~~i~~I~~~aF~~c~~L~~l~l~~~ 281 (401)
T 4fdw_A 206 EEVLLPVT-LKEIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGITTVKL-PNGVTNIASRAFYYCPELAEVTTYGS 281 (401)
T ss_dssp SEEECCTT-CCEECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCSEEEE-ETTCCEECTTTTTTCTTCCEEEEESS
T ss_pred CEEEeCCc-hheehhhHhhCCCCCCEEecCCC-ccCcccccccc-CCccEEEe-CCCccEEChhHhhCCCCCCEEEeCCc
Confidence 99999855 77677889999999999999975 66777788888 89999999 45677788899999999999999998
Q ss_pred ccc----ccCChhhhhcCCCCcEEEeccccCCCCCCcccccCCCCceeecccccccccccccccCCCcccccccccccCC
Q 045798 233 QIH----GSLPPSLGLLLPNLKFFQIHHNFFSGSIPISLSNASKLEHIEIANNNFSGKLSVNFGGMKNLSLLNLQFSNLG 308 (1008)
Q Consensus 233 ~l~----~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~ 308 (1008)
.+. ..++...|..+++|+.++|.+ .++.+...+|.++++|+.+++..| ++.+...+|.++ +|+.+++..|.+.
T Consensus 282 ~~~~~~~~~I~~~aF~~c~~L~~l~l~~-~i~~I~~~aF~~c~~L~~l~lp~~-l~~I~~~aF~~~-~L~~l~l~~n~~~ 358 (401)
T 4fdw_A 282 TFNDDPEAMIHPYCLEGCPKLARFEIPE-SIRILGQGLLGGNRKVTQLTIPAN-VTQINFSAFNNT-GIKEVKVEGTTPP 358 (401)
T ss_dssp CCCCCTTCEECTTTTTTCTTCCEECCCT-TCCEECTTTTTTCCSCCEEEECTT-CCEECTTSSSSS-CCCEEEECCSSCC
T ss_pred cccCCcccEECHHHhhCCccCCeEEeCC-ceEEEhhhhhcCCCCccEEEECcc-ccEEcHHhCCCC-CCCEEEEcCCCCc
Confidence 764 248888999999999999994 577677889999999999999665 777788888888 8888888887776
Q ss_pred CCCCCcccccccccccC-CCcEEEecCCcC
Q 045798 309 SGESDEMGFMNSLTNCS-KLRVLSLGGNQF 337 (1008)
Q Consensus 309 ~~~~~~~~~~~~l~~l~-~L~~L~Ls~N~l 337 (1008)
.+... .|.+++ .+..|++..+.+
T Consensus 359 ~l~~~------~F~~~~~~l~~l~vp~~~~ 382 (401)
T 4fdw_A 359 QVFEK------VWYGFPDDITVIRVPAESV 382 (401)
T ss_dssp BCCCS------SCCCSCTTCCEEEECGGGH
T ss_pred ccccc------cccCCCCCccEEEeCHHHH
Confidence 65433 344442 566666655544
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.53 E-value=6.8e-15 Score=146.13 Aligned_cols=133 Identities=20% Similarity=0.238 Sum_probs=72.3
Q ss_pred ccCCCCCceEEccCCcccccccccccCCC-CcceeeccccccccccCCCCcCCCcccEeecccccccCCcchhhhhhhhh
Q 045798 394 MGKLQKLQGLDFSGNHFSGEIPSSLGNLS-SLYEVFFNNNNLSGVIPFSLGNLKRLAFLEMSGNELSGTIPEDIFNISYL 472 (1008)
Q Consensus 394 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~lp~~~~~~~~~ 472 (1008)
+..+.+|+.|+|++|+++ .+|. +..+. +|+.|++++|.+++. ..|..+++|++|+|++|++++ +|
T Consensus 15 ~~~~~~L~~L~l~~n~l~-~i~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~-~~--------- 80 (176)
T 1a9n_A 15 YTNAVRDRELDLRGYKIP-VIEN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICR-IG--------- 80 (176)
T ss_dssp EECTTSCEEEECTTSCCC-SCCC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCE-EC---------
T ss_pred cCCcCCceEEEeeCCCCc-hhHH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccc-cC---------
Confidence 334455555555555555 2332 33332 555555555555543 355556666666666666651 11
Q ss_pred hhhhcccCccccCCCcccccccccccccccccccccCCCCc--ccccccccceeeccCcccccchhh----hhhcccccc
Q 045798 473 SNSLNLARNHLVGIIPPRIGNLRALRSFDVSNNDLSGEIPI--ELGHCSSLEEIYLAGNLFHGSIPS----FFNALKGVQ 546 (1008)
Q Consensus 473 ~~~L~L~~N~l~~~~p~~~~~l~~L~~Ldls~N~l~~~~p~--~~~~l~~L~~L~L~~N~l~~~~p~----~~~~l~~L~ 546 (1008)
+..++.+++|+.|+|++|.++ .+|. .+..+++|+.|++++|+++ .+|. .+..+++|+
T Consensus 81 ---------------~~~~~~l~~L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~-~~~~~~~~~~~~l~~L~ 143 (176)
T 1a9n_A 81 ---------------EGLDQALPDLTELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVR 143 (176)
T ss_dssp ---------------SCHHHHCTTCCEEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCS
T ss_pred ---------------cchhhcCCCCCEEECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCC-CcHhHHHHHHHHCCccc
Confidence 122344555666666666654 4444 5556666666666666665 3444 366666777
Q ss_pred EEecCCCcccc
Q 045798 547 KIDLSRNNLSG 557 (1008)
Q Consensus 547 ~L~ls~N~l~~ 557 (1008)
.||+++|.+..
T Consensus 144 ~Ld~~~n~~~~ 154 (176)
T 1a9n_A 144 VLDFQKVKLKE 154 (176)
T ss_dssp EETTEECCHHH
T ss_pred eeCCCcCCHHH
Confidence 77776666553
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.51 E-value=9.4e-15 Score=145.10 Aligned_cols=135 Identities=16% Similarity=0.165 Sum_probs=101.8
Q ss_pred cccccccceEEecCccccCCcchhccCCC-CCceEEccCCcccccccccccCCCCcceeeccccccccccCCCCcCCCcc
Q 045798 370 IGNLVDLYLLGMVENQFTGAIPKEMGKLQ-KLQGLDFSGNHFSGEIPSSLGNLSSLYEVFFNNNNLSGVIPFSLGNLKRL 448 (1008)
Q Consensus 370 ~~~l~~L~~L~L~~n~l~~~~~~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L 448 (1008)
+.++.+|+.|++++|+++. +|. +..+. +|+.|+|++|.+++. ..+..+++|+.|++++|.|++..+..|..+++|
T Consensus 15 ~~~~~~L~~L~l~~n~l~~-i~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L 90 (176)
T 1a9n_A 15 YTNAVRDRELDLRGYKIPV-IEN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDL 90 (176)
T ss_dssp EECTTSCEEEECTTSCCCS-CCC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTC
T ss_pred cCCcCCceEEEeeCCCCch-hHH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCC
Confidence 4556677777777777774 344 44444 888888888888854 678888888888888888886655556888899
Q ss_pred cEeecccccccCCcchhhhhhhhhhhhhcccCccccCCCcccccccccccccccccccccCCCCcc----ccccccccee
Q 045798 449 AFLEMSGNELSGTIPEDIFNISYLSNSLNLARNHLVGIIPPRIGNLRALRSFDVSNNDLSGEIPIE----LGHCSSLEEI 524 (1008)
Q Consensus 449 ~~L~Ls~N~l~~~lp~~~~~~~~~~~~L~L~~N~l~~~~p~~~~~l~~L~~Ldls~N~l~~~~p~~----~~~l~~L~~L 524 (1008)
++|+|++|+++ .+|. ...++.+++|+.|++++|.++ .+|.. ++.+++|+.|
T Consensus 91 ~~L~L~~N~i~-~~~~-----------------------~~~l~~l~~L~~L~l~~N~i~-~~~~~~~~~~~~l~~L~~L 145 (176)
T 1a9n_A 91 TELILTNNSLV-ELGD-----------------------LDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVL 145 (176)
T ss_dssp CEEECCSCCCC-CGGG-----------------------GGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEE
T ss_pred CEEECCCCcCC-cchh-----------------------hHhhhcCCCCCEEEecCCCCC-CcHhHHHHHHHHCCcccee
Confidence 99999999886 2221 015677888889999999887 56764 8888999999
Q ss_pred eccCccccc
Q 045798 525 YLAGNLFHG 533 (1008)
Q Consensus 525 ~L~~N~l~~ 533 (1008)
|+++|.+..
T Consensus 146 d~~~n~~~~ 154 (176)
T 1a9n_A 146 DFQKVKLKE 154 (176)
T ss_dssp TTEECCHHH
T ss_pred CCCcCCHHH
Confidence 999998874
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=99.50 E-value=1.9e-13 Score=154.79 Aligned_cols=313 Identities=12% Similarity=0.050 Sum_probs=148.1
Q ss_pred CccccCCCCCCEEEccCCCCCCccCcccccCcCcceEeeeccccccCCCccccccCCCCeeecccccCCCCCCCCCcccc
Q 045798 95 PPEFGRLFRLEALFLSNNSLVGKIPANLSYCSRLTVLCIEYNKLQGRIPLEFVSLSKLKDLSLAKNKLTGGIPPFLGNLT 174 (1008)
Q Consensus 95 p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~ 174 (1008)
..+|.++.+|+.+.|..+ ++.....+|.++++|+.++|..+ ++.+...+|.++.+|+.+.+..+ +.......|.++.
T Consensus 64 ~~AF~~c~~L~~i~lp~~-i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~-l~~i~~~aF~~~~ 140 (394)
T 4fs7_A 64 YAAFQGCRKVTEIKIPST-VREIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPLM-LKSIGVEAFKGCD 140 (394)
T ss_dssp TTTTTTCTTEEEEECCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECTTTTTTCC
T ss_pred HHHhhCCCCceEEEeCCC-ccCcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhcccCc-eeeecceeeeccc
Confidence 445556666666666432 44344455566666666666533 44344455555566665555433 2223344454443
Q ss_pred ccchhhcccccCCCCCCccccCCCCCcEEEecCCcccccCCccccCCCCcceeccccccccccCChhhhhcCCCCcEEEe
Q 045798 175 SLEVLSLAGNSFGRNIPDSLGQLKQLKILAIGGNNLSGPIPPSIYNLSFLVVFSVSHNQIHGSLPPSLGLLLPNLKFFQI 254 (1008)
Q Consensus 175 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~~~lp~~~~~~l~~L~~L~L 254 (1008)
.++....... ......+|..+++|+.+.+.++. ..+...+|.++.+|+.+++..| ++ .++...+.....|+.+.+
T Consensus 141 ~~~~~~~~~~--~~i~~~aF~~c~~L~~i~l~~~~-~~I~~~~F~~c~~L~~i~l~~~-~~-~I~~~~F~~~~~L~~i~~ 215 (394)
T 4fs7_A 141 FKEITIPEGV--TVIGDEAFATCESLEYVSLPDSM-ETLHNGLFSGCGKLKSIKLPRN-LK-IIRDYCFAECILLENMEF 215 (394)
T ss_dssp CSEEECCTTC--CEECTTTTTTCTTCCEEECCTTC-CEECTTTTTTCTTCCBCCCCTT-CC-EECTTTTTTCTTCCBCCC
T ss_pred ccccccCccc--cccchhhhcccCCCcEEecCCcc-ceeccccccCCCCceEEEcCCC-ce-EeCchhhccccccceeec
Confidence 3332222221 12334456666666666665443 2244555666666666666554 33 444444444555555544
Q ss_pred ccccCCCCCCcccccCCCCceeecccccccccccccccCCCcccccccccccCCCCCCCcccccccccccCCCcEEEecC
Q 045798 255 HHNFFSGSIPISLSNASKLEHIEIANNNFSGKLSVNFGGMKNLSLLNLQFSNLGSGESDEMGFMNSLTNCSKLRVLSLGG 334 (1008)
Q Consensus 255 ~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~ 334 (1008)
..+... +........+|+.+.+..+ +..+....|.+...|+.+.+ ..
T Consensus 216 ~~~~~~--i~~~~~~~~~l~~i~ip~~-~~~i~~~~f~~~~~l~~~~~------------------------------~~ 262 (394)
T 4fs7_A 216 PNSLYY--LGDFALSKTGVKNIIIPDS-FTELGKSVFYGCTDLESISI------------------------------QN 262 (394)
T ss_dssp CTTCCE--ECTTTTTTCCCCEEEECTT-CCEECSSTTTTCSSCCEEEE------------------------------CC
T ss_pred CCCceE--eehhhcccCCCceEEECCC-ceecccccccccccceeEEc------------------------------CC
Confidence 443322 1222223344555544322 22233334444444444444 33
Q ss_pred CcCCccCChhhhhhcccceeeeeccccccCCCCCccccccccceEEecCccccCCcchhccCCCCCceEEccCCcccccc
Q 045798 335 NQFRGALPHSIANLSSQLQILILSSNQFYGSIPLGIGNLVDLYLLGMVENQFTGAIPKEMGKLQKLQGLDFSGNHFSGEI 414 (1008)
Q Consensus 335 N~l~~~~p~~~~~l~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 414 (1008)
+... .....+.... .++.+.+..+.+. ...|..+.+|+.+.+.++ ++.+....|.++.+|+.++|..+ ++..-
T Consensus 263 ~~~~-i~~~~F~~~~-~l~~~~~~~~~i~---~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~ 335 (394)
T 4fs7_A 263 NKLR-IGGSLFYNCS-GLKKVIYGSVIVP---EKTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VEEIG 335 (394)
T ss_dssp TTCE-ECSCTTTTCT-TCCEEEECSSEEC---TTTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CCEEC
T ss_pred Ccce-eecccccccc-ccceeccCceeec---cccccccccccccccccc-cceechhhhcCCCCCCEEEeCCc-ccEEh
Confidence 3222 1122222221 2444444333221 123445555555555433 44344455666666666666533 44334
Q ss_pred cccccCCCCcceeeccccccccccCCCCcCCCcccEeecccc
Q 045798 415 PSSLGNLSSLYEVFFNNNNLSGVIPFSLGNLKRLAFLEMSGN 456 (1008)
Q Consensus 415 p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N 456 (1008)
..+|.++++|+.+.+..| +..+-..+|.++++|+.+++..+
T Consensus 336 ~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~lp~~ 376 (394)
T 4fs7_A 336 KRSFRGCTSLSNINFPLS-LRKIGANAFQGCINLKKVELPKR 376 (394)
T ss_dssp TTTTTTCTTCCEECCCTT-CCEECTTTBTTCTTCCEEEEEGG
T ss_pred HHhccCCCCCCEEEECcc-ccEehHHHhhCCCCCCEEEECCC
Confidence 455666666666666554 44455556666666666666543
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=99.50 E-value=4e-13 Score=152.13 Aligned_cols=334 Identities=12% Similarity=0.028 Sum_probs=215.9
Q ss_pred CCCccCcccccCcCcceEeeeccccccCCCccccccCCCCeeecccccCCCCCCCCCccccccchhhcccccCCCCCCcc
Q 045798 114 LVGKIPANLSYCSRLTVLCIEYNKLQGRIPLEFVSLSKLKDLSLAKNKLTGGIPPFLGNLTSLEVLSLAGNSFGRNIPDS 193 (1008)
Q Consensus 114 l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~ 193 (1008)
++.+...+|.++.+|+.+.|.. .++.+-..+|.++++|+.+++.++ ++......|.++.+|+.+.+..+ +......+
T Consensus 59 VtsIg~~AF~~c~~L~~i~lp~-~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~-l~~i~~~a 135 (394)
T 4fs7_A 59 VVSIGYAAFQGCRKVTEIKIPS-TVREIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPLM-LKSIGVEA 135 (394)
T ss_dssp EEEECTTTTTTCTTEEEEECCT-TCCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECTTT
T ss_pred EeEhHHHHhhCCCCceEEEeCC-CccCcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhcccCc-eeeeccee
Confidence 4545566788888888888864 466566677888888888888654 55455667777778877776544 43445556
Q ss_pred ccCCCCCcEEEecCCcccccCCccccCCCCcceeccccccccccCChhhhhcCCCCcEEEeccccCCCCCCcccccCCCC
Q 045798 194 LGQLKQLKILAIGGNNLSGPIPPSIYNLSFLVVFSVSHNQIHGSLPPSLGLLLPNLKFFQIHHNFFSGSIPISLSNASKL 273 (1008)
Q Consensus 194 ~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L 273 (1008)
|..+..+....... +..+...+|.++++|+.+.+.++.. .++.. +|.++.+|
T Consensus 136 F~~~~~~~~~~~~~--~~~i~~~aF~~c~~L~~i~l~~~~~--~I~~~------------------------~F~~c~~L 187 (394)
T 4fs7_A 136 FKGCDFKEITIPEG--VTVIGDEAFATCESLEYVSLPDSME--TLHNG------------------------LFSGCGKL 187 (394)
T ss_dssp TTTCCCSEEECCTT--CCEECTTTTTTCTTCCEEECCTTCC--EECTT------------------------TTTTCTTC
T ss_pred eecccccccccCcc--ccccchhhhcccCCCcEEecCCccc--eeccc------------------------cccCCCCc
Confidence 66665433332222 2223345566666666666554322 34444 44555555
Q ss_pred ceeecccccccccccccccCCCcccccccccccCCCCCCCcccccccccccCCCcEEEecCCcCCccCChhhhhhcccce
Q 045798 274 EHIEIANNNFSGKLSVNFGGMKNLSLLNLQFSNLGSGESDEMGFMNSLTNCSKLRVLSLGGNQFRGALPHSIANLSSQLQ 353 (1008)
Q Consensus 274 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~ 353 (1008)
+.+++..| +..+....|.+...|+.+.+..+..... .......+|+.+.+..+ ++......+.... .|+
T Consensus 188 ~~i~l~~~-~~~I~~~~F~~~~~L~~i~~~~~~~~i~--------~~~~~~~~l~~i~ip~~-~~~i~~~~f~~~~-~l~ 256 (394)
T 4fs7_A 188 KSIKLPRN-LKIIRDYCFAECILLENMEFPNSLYYLG--------DFALSKTGVKNIIIPDS-FTELGKSVFYGCT-DLE 256 (394)
T ss_dssp CBCCCCTT-CCEECTTTTTTCTTCCBCCCCTTCCEEC--------TTTTTTCCCCEEEECTT-CCEECSSTTTTCS-SCC
T ss_pred eEEEcCCC-ceEeCchhhccccccceeecCCCceEee--------hhhcccCCCceEEECCC-ceecccccccccc-cce
Confidence 55555544 4444555566666666665544322111 12233456777777543 3322233444443 699
Q ss_pred eeeeccccccCCCCCccccccccceEEecCccccCCcchhccCCCCCceEEccCCcccccccccccCCCCcceeeccccc
Q 045798 354 ILILSSNQFYGSIPLGIGNLVDLYLLGMVENQFTGAIPKEMGKLQKLQGLDFSGNHFSGEIPSSLGNLSSLYEVFFNNNN 433 (1008)
Q Consensus 354 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~ 433 (1008)
.+.+..+... .....|.....++.+....+.+. ...|..+.+|+.+.+..+ ++.....+|.++.+|+.+.|.++
T Consensus 257 ~~~~~~~~~~-i~~~~F~~~~~l~~~~~~~~~i~---~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~- 330 (394)
T 4fs7_A 257 SISIQNNKLR-IGGSLFYNCSGLKKVIYGSVIVP---EKTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL- 330 (394)
T ss_dssp EEEECCTTCE-ECSCTTTTCTTCCEEEECSSEEC---TTTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-
T ss_pred eEEcCCCcce-eeccccccccccceeccCceeec---cccccccccccccccccc-cceechhhhcCCCCCCEEEeCCc-
Confidence 9999887655 56677889999999988776543 456888999999999876 66466678999999999999755
Q ss_pred cccccCCCCcCCCcccEeecccccccCCcchhhhhhhhhhhhhcccCccccCCCcccccccccccc
Q 045798 434 LSGVIPFSLGNLKRLAFLEMSGNELSGTIPEDIFNISYLSNSLNLARNHLVGIIPPRIGNLRALRS 499 (1008)
Q Consensus 434 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~lp~~~~~~~~~~~~L~L~~N~l~~~~p~~~~~l~~L~~ 499 (1008)
+..+-..+|.++++|+.+++..| ++ .|+...|..-..++.+++..+ ++ .+..+|.++++|+.
T Consensus 331 v~~I~~~aF~~c~~L~~i~lp~~-l~-~I~~~aF~~C~~L~~i~lp~~-~~-~~~~~F~~c~~L~~ 392 (394)
T 4fs7_A 331 VEEIGKRSFRGCTSLSNINFPLS-LR-KIGANAFQGCINLKKVELPKR-LE-QYRYDFEDTTKFKW 392 (394)
T ss_dssp CCEECTTTTTTCTTCCEECCCTT-CC-EECTTTBTTCTTCCEEEEEGG-GG-GGGGGBCTTCEEEE
T ss_pred ccEEhHHhccCCCCCCEEEECcc-cc-EehHHHhhCCCCCCEEEECCC-CE-EhhheecCCCCCcE
Confidence 77677889999999999999877 76 788888877666677777644 22 22345555555554
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.41 E-value=6.5e-13 Score=130.65 Aligned_cols=107 Identities=23% Similarity=0.297 Sum_probs=86.3
Q ss_pred ceeeeeccccccCCCCCccccccccceEEecCccccCCcchhccCCCCCceEEccCCcccccccccccCCCCcceeeccc
Q 045798 352 LQILILSSNQFYGSIPLGIGNLVDLYLLGMVENQFTGAIPKEMGKLQKLQGLDFSGNHFSGEIPSSLGNLSSLYEVFFNN 431 (1008)
Q Consensus 352 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~ 431 (1008)
.+.+++++|.++ .+|..+. ++|+.|+|++|+|++..|..|..+++|++|+|++|+|++..+..|.++++|++|+|++
T Consensus 11 ~~~l~~s~n~l~-~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~ 87 (170)
T 3g39_A 11 GTTVDCSGKSLA-SVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLND 87 (170)
T ss_dssp TTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEEEeCCCCcC-ccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCC
Confidence 456777777776 4665553 6778888888888877788888888888888888888877677778888899999999
Q ss_pred cccccccCCCCcCCCcccEeecccccccCC
Q 045798 432 NNLSGVIPFSLGNLKRLAFLEMSGNELSGT 461 (1008)
Q Consensus 432 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 461 (1008)
|+|++..+..|..+++|+.|+|++|.+++.
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~ 117 (170)
T 3g39_A 88 NQLKSIPRGAFDNLKSLTHIWLLNNPWDCA 117 (170)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCBCTT
T ss_pred CccCEeCHHHhcCCCCCCEEEeCCCCCCCC
Confidence 999877777889999999999999999843
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.40 E-value=6.7e-13 Score=130.56 Aligned_cols=103 Identities=27% Similarity=0.276 Sum_probs=60.9
Q ss_pred EEeccccCCCCccCcCccCCccCCeeeecCCCCCCCCCccccCCCCCCEEEccCCCCCCccCcccccCcCcceEeeeccc
Q 045798 58 ALDLMSKSLSGSLSPHLGNLSFLREINLSNNTIQGEIPPEFGRLFRLEALFLSNNSLVGKIPANLSYCSRLTVLCIEYNK 137 (1008)
Q Consensus 58 ~l~l~~~~l~~~l~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~ 137 (1008)
.+|++++.++ .+|..+. +.|++|+|++|+|++..|..|..+++|++|+|++|+|++..+..|..+++|++|+|++|+
T Consensus 13 ~l~~s~n~l~-~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~ 89 (170)
T 3g39_A 13 TVDCSGKSLA-SVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDNQ 89 (170)
T ss_dssp EEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred EEEeCCCCcC-ccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCCc
Confidence 3444555555 3555443 566666666666665556666666666666666666665555555666666666666666
Q ss_pred cccCCCccccccCCCCeeecccccCC
Q 045798 138 LQGRIPLEFVSLSKLKDLSLAKNKLT 163 (1008)
Q Consensus 138 l~~~~p~~~~~l~~L~~L~L~~n~l~ 163 (1008)
|++..+..|..+++|++|+|++|.++
T Consensus 90 l~~~~~~~~~~l~~L~~L~L~~N~~~ 115 (170)
T 3g39_A 90 LKSIPRGAFDNLKSLTHIWLLNNPWD 115 (170)
T ss_dssp CCCCCTTTTTTCTTCCEEECCSSCBC
T ss_pred cCEeCHHHhcCCCCCCEEEeCCCCCC
Confidence 66544445555666666666666555
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.40 E-value=9.9e-13 Score=129.77 Aligned_cols=110 Identities=25% Similarity=0.308 Sum_probs=83.4
Q ss_pred eeeeeccccccCCCCCccccccccceEEecCccccCCcchhccCCCCCceEEccCCcccccccccccCCCCcceeecccc
Q 045798 353 QILILSSNQFYGSIPLGIGNLVDLYLLGMVENQFTGAIPKEMGKLQKLQGLDFSGNHFSGEIPSSLGNLSSLYEVFFNNN 432 (1008)
Q Consensus 353 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N 432 (1008)
+.+++++|.++ .+|..+. ++|+.|+|++|+|++..|..|..+++|++|+|++|+|++..+..|.++++|+.|+|++|
T Consensus 15 ~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N 91 (174)
T 2r9u_A 15 TLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN 91 (174)
T ss_dssp SEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred cEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence 45666666665 5565553 67777777777777777777888888888888888888665566788888888888888
Q ss_pred ccccccCCCCcCCCcccEeecccccccCCcchhh
Q 045798 433 NLSGVIPFSLGNLKRLAFLEMSGNELSGTIPEDI 466 (1008)
Q Consensus 433 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~lp~~~ 466 (1008)
+|++..+..|..+++|+.|+|++|.+. ..|..+
T Consensus 92 ~l~~l~~~~~~~l~~L~~L~L~~N~~~-c~~~~~ 124 (174)
T 2r9u_A 92 HLKSIPRGAFDNLKSLTHIYLYNNPWD-CECRDI 124 (174)
T ss_dssp CCCCCCTTTTTTCTTCSEEECCSSCBC-TTBGGG
T ss_pred ccceeCHHHhccccCCCEEEeCCCCcc-cccccH
Confidence 888766667888999999999999987 444433
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.37 E-value=1.3e-12 Score=129.01 Aligned_cols=104 Identities=23% Similarity=0.264 Sum_probs=63.0
Q ss_pred EEEeccccCCCCccCcCccCCccCCeeeecCCCCCCCCCccccCCCCCCEEEccCCCCCCccCcccccCcCcceEeeecc
Q 045798 57 TALDLMSKSLSGSLSPHLGNLSFLREINLSNNTIQGEIPPEFGRLFRLEALFLSNNSLVGKIPANLSYCSRLTVLCIEYN 136 (1008)
Q Consensus 57 ~~l~l~~~~l~~~l~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n 136 (1008)
+.++++++.++ .+|..+. ++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..|..+++|++|+|++|
T Consensus 15 ~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N 91 (174)
T 2r9u_A 15 TLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN 91 (174)
T ss_dssp SEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred cEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence 35666666664 5555553 56666666666666666666666666666666666666544444556666666666666
Q ss_pred ccccCCCccccccCCCCeeecccccCC
Q 045798 137 KLQGRIPLEFVSLSKLKDLSLAKNKLT 163 (1008)
Q Consensus 137 ~l~~~~p~~~~~l~~L~~L~L~~n~l~ 163 (1008)
+|++..+..|..+++|++|+|++|.+.
T Consensus 92 ~l~~l~~~~~~~l~~L~~L~L~~N~~~ 118 (174)
T 2r9u_A 92 HLKSIPRGAFDNLKSLTHIYLYNNPWD 118 (174)
T ss_dssp CCCCCCTTTTTTCTTCSEEECCSSCBC
T ss_pred ccceeCHHHhccccCCCEEEeCCCCcc
Confidence 666444444555666666666666555
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.28 E-value=9.2e-14 Score=154.89 Aligned_cols=140 Identities=14% Similarity=0.161 Sum_probs=74.2
Q ss_pred CCCceEEccCCccccccccccc-CCCCcceeeccccccccccCCCC-----cCCCcccEeecccccccCCcchhhhhhhh
Q 045798 398 QKLQGLDFSGNHFSGEIPSSLG-NLSSLYEVFFNNNNLSGVIPFSL-----GNLKRLAFLEMSGNELSGTIPEDIFNISY 471 (1008)
Q Consensus 398 ~~L~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~l~~N~l~~~~p~~~-----~~l~~L~~L~Ls~N~l~~~lp~~~~~~~~ 471 (1008)
++|+.|+|++|.++......+. .+++|+.|+|++|.++......+ ...++|+.|+|++|.|+.. ...
T Consensus 101 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~~~~~~L~~L~Ls~n~l~~~---~~~---- 173 (372)
T 3un9_A 101 HALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAA---GVA---- 173 (372)
T ss_dssp SCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHHSTTCCCCEEECCSSCCHHH---HHH----
T ss_pred CCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHHhcCCccceeeCCCCCCChH---HHH----
Confidence 4555555655555432222221 23445555555555543222222 1235566666666666410 000
Q ss_pred hhhhhcccCccccCCCcccccccccccccccccccccCC----CCcccccccccceeeccCcccccc----hhhhhhccc
Q 045798 472 LSNSLNLARNHLVGIIPPRIGNLRALRSFDVSNNDLSGE----IPIELGHCSSLEEIYLAGNLFHGS----IPSFFNALK 543 (1008)
Q Consensus 472 ~~~~L~L~~N~l~~~~p~~~~~l~~L~~Ldls~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~ 543 (1008)
.++..+..+++|++|||++|.+++. ++..+..+++|++|+|++|.|+.. ++..+...+
T Consensus 174 --------------~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l~~~L~~~~ 239 (372)
T 3un9_A 174 --------------VLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHP 239 (372)
T ss_dssp --------------HHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHHHHHHHHCS
T ss_pred --------------HHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHHHHHHHhCC
Confidence 1233344556677777777776532 244455566777777777777643 334455567
Q ss_pred cccEEecCCCccccc
Q 045798 544 GVQKIDLSRNNLSGQ 558 (1008)
Q Consensus 544 ~L~~L~ls~N~l~~~ 558 (1008)
+|+.|||++|.|+..
T Consensus 240 ~L~~L~Ls~N~i~~~ 254 (372)
T 3un9_A 240 SLELLHLYFNELSSE 254 (372)
T ss_dssp SCCEEECTTSSCCHH
T ss_pred CCCEEeccCCCCCHH
Confidence 777777777777643
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=99.27 E-value=8.8e-11 Score=132.79 Aligned_cols=133 Identities=11% Similarity=0.200 Sum_probs=63.3
Q ss_pred cchhccCCCCCceEEccCCcccccccccccCCCCcceeeccccccccccCCCCcCCCcccEeecccccccCCcchhhhhh
Q 045798 390 IPKEMGKLQKLQGLDFSGNHFSGEIPSSLGNLSSLYEVFFNNNNLSGVIPFSLGNLKRLAFLEMSGNELSGTIPEDIFNI 469 (1008)
Q Consensus 390 ~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~lp~~~~~~ 469 (1008)
....|.++.+|+.+.+..+... .....|.+++.|+.+.+. +.+..+...+|.++.+|+.++|..+ ++ .
T Consensus 257 ~~~aF~~c~~L~~i~lp~~~~~-I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~-~-------- 324 (394)
T 4gt6_A 257 ETHAFDSCAYLASVKMPDSVVS-IGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-IT-Q-------- 324 (394)
T ss_dssp CTTTTTTCSSCCEEECCTTCCE-ECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CC-E--------
T ss_pred ccceeeecccccEEecccccce-ecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-cc-E--------
Confidence 3445556666666666554433 344455566666666664 3344344555666666666655432 22 1
Q ss_pred hhhhhhhcccCccccCCCcccccccccccccccccccccCCCCcccccccccceeeccCcccccchhhhhhccccccEEe
Q 045798 470 SYLSNSLNLARNHLVGIIPPRIGNLRALRSFDVSNNDLSGEIPIELGHCSSLEEIYLAGNLFHGSIPSFFNALKGVQKID 549 (1008)
Q Consensus 470 ~~~~~~L~L~~N~l~~~~p~~~~~l~~L~~Ldls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 549 (1008)
+-..+|.++.+|+.+.+..+ ++..-...|.+|++|+.+++.+|... + ..|....+|+.+.
T Consensus 325 ----------------I~~~aF~~C~~L~~i~ip~s-v~~I~~~aF~~C~~L~~i~~~~~~~~--~-~~~~~~~~L~~i~ 384 (394)
T 4gt6_A 325 ----------------ILDDAFAGCEQLERIAIPSS-VTKIPESAFSNCTALNNIEYSGSRSQ--W-NAISTDSGLQNLP 384 (394)
T ss_dssp ----------------ECTTTTTTCTTCCEEEECTT-CCBCCGGGGTTCTTCCEEEESSCHHH--H-HTCBCCCCC----
T ss_pred ----------------ehHhHhhCCCCCCEEEECcc-cCEEhHhHhhCCCCCCEEEECCceee--h-hhhhccCCCCEEE
Confidence 22234555556666666433 43233345555666666666555432 1 3444555555555
Q ss_pred cCCCc
Q 045798 550 LSRNN 554 (1008)
Q Consensus 550 ls~N~ 554 (1008)
+..|.
T Consensus 385 i~~~~ 389 (394)
T 4gt6_A 385 VAPGS 389 (394)
T ss_dssp -----
T ss_pred eCCCC
Confidence 55443
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=99.25 E-value=1.6e-10 Score=130.63 Aligned_cols=84 Identities=12% Similarity=0.143 Sum_probs=43.7
Q ss_pred ccccccccceEEecCccccCCcchhccCCCCCceEEccCCcccccccccccCCCCcceeeccccccccccCCCCcCCCcc
Q 045798 369 GIGNLVDLYLLGMVENQFTGAIPKEMGKLQKLQGLDFSGNHFSGEIPSSLGNLSSLYEVFFNNNNLSGVIPFSLGNLKRL 448 (1008)
Q Consensus 369 ~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L 448 (1008)
.|.++..|+.+.+.++... +....|.++++|+.+.+. +.++......|.++.+|+.+.|..+ ++.+-..+|.++.+|
T Consensus 260 aF~~c~~L~~i~lp~~~~~-I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L 336 (394)
T 4gt6_A 260 AFDSCAYLASVKMPDSVVS-IGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQL 336 (394)
T ss_dssp TTTTCSSCCEEECCTTCCE-ECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTC
T ss_pred eeeecccccEEecccccce-ecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCC
Confidence 3444555555555433222 344455555666666664 3344333445556666666666543 443445566666666
Q ss_pred cEeeccc
Q 045798 449 AFLEMSG 455 (1008)
Q Consensus 449 ~~L~Ls~ 455 (1008)
+.+.+..
T Consensus 337 ~~i~ip~ 343 (394)
T 4gt6_A 337 ERIAIPS 343 (394)
T ss_dssp CEEEECT
T ss_pred CEEEECc
Confidence 6666543
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.24 E-value=1.4e-11 Score=136.91 Aligned_cols=108 Identities=25% Similarity=0.296 Sum_probs=85.1
Q ss_pred CCcccceEEcCCCCeEEEEecccc-CCCCccCcCccCCccCCeeeecC-CCCCCCCCccccCCCCCCEEEccCCCCCCcc
Q 045798 41 FCEWEGITCGRRHRRVTALDLMSK-SLSGSLSPHLGNLSFLREINLSN-NTIQGEIPPEFGRLFRLEALFLSNNSLVGKI 118 (1008)
Q Consensus 41 ~c~w~gv~c~~~~~~v~~l~l~~~-~l~~~l~~~l~~l~~L~~L~L~~-n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~ 118 (1008)
.|.|.+|.|. ++ +++ .+|. +..+++|++|+|++ |.|++..+..|.+|++|++|+|++|+|++..
T Consensus 7 ~C~~~~v~~~------------~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~ 72 (347)
T 2ifg_A 7 PHGSSGLRCT------------RDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVA 72 (347)
T ss_dssp CSSSSCEECC------------SSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEEC
T ss_pred cccCCEEEcC------------CCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeC
Confidence 4888777774 33 566 4777 88888899999986 8888777788888888888888888888888
Q ss_pred CcccccCcCcceEeeeccccccCCCccccccCCCCeeecccccCC
Q 045798 119 PANLSYCSRLTVLCIEYNKLQGRIPLEFVSLSKLKDLSLAKNKLT 163 (1008)
Q Consensus 119 p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~ 163 (1008)
|..|++|++|++|+|++|+|++..+..|..++ |+.|+|++|.+.
T Consensus 73 ~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~-L~~l~l~~N~~~ 116 (347)
T 2ifg_A 73 PDAFHFTPRLSRLNLSFNALESLSWKTVQGLS-LQELVLSGNPLH 116 (347)
T ss_dssp TTGGGSCSCCCEEECCSSCCSCCCSTTTCSCC-CCEEECCSSCCC
T ss_pred HHHhcCCcCCCEEeCCCCccceeCHHHcccCC-ceEEEeeCCCcc
Confidence 88888888888888888888866555665555 888888888776
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.22 E-value=1e-13 Score=154.55 Aligned_cols=134 Identities=14% Similarity=0.091 Sum_probs=64.6
Q ss_pred CCCCEEEccCCCCCCccCcccccC-----cCcceEeeeccccccCCCcccc-ccCCCCeeecccccCCCCCCCCC-----
Q 045798 102 FRLEALFLSNNSLVGKIPANLSYC-----SRLTVLCIEYNKLQGRIPLEFV-SLSKLKDLSLAKNKLTGGIPPFL----- 170 (1008)
Q Consensus 102 ~~L~~L~Ls~n~l~~~~p~~l~~l-----~~L~~L~Ls~n~l~~~~p~~~~-~l~~L~~L~L~~n~l~~~~~~~~----- 170 (1008)
++|++|+|++|.++......+..+ ++|++|+|++|.++......+. .+++|++|+|++|.|+......+
T Consensus 72 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~ 151 (372)
T 3un9_A 72 SSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLL 151 (372)
T ss_dssp TTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHH
T ss_pred hhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHH
Confidence 456666666666654333333322 4566666666665433222222 24455666666665543222222
Q ss_pred ccccccchhhcccccCCC----CCCccccCCCCCcEEEecCCccccc----CCccccCCCCcceecccccccc
Q 045798 171 GNLTSLEVLSLAGNSFGR----NIPDSLGQLKQLKILAIGGNNLSGP----IPPSIYNLSFLVVFSVSHNQIH 235 (1008)
Q Consensus 171 ~~l~~L~~L~L~~n~l~~----~~~~~~~~l~~L~~L~L~~n~l~~~----~~~~~~~l~~L~~L~ls~N~l~ 235 (1008)
...++|++|+|++|.++. .++..+..+++|++|+|++|.|++. +...+...++|+.|+|++|.|+
T Consensus 152 ~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~ 224 (372)
T 3un9_A 152 HDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAG 224 (372)
T ss_dssp STTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCC
T ss_pred hcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCC
Confidence 123445555555555532 1223334555566666666655432 1334444455555555555554
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.19 E-value=5.2e-11 Score=132.30 Aligned_cols=104 Identities=17% Similarity=0.138 Sum_probs=87.3
Q ss_pred eeeeccc-cccCCCCCccccccccceEEecC-ccccCCcchhccCCCCCceEEccCCcccccccccccCCCCcceeeccc
Q 045798 354 ILILSSN-QFYGSIPLGIGNLVDLYLLGMVE-NQFTGAIPKEMGKLQKLQGLDFSGNHFSGEIPSSLGNLSSLYEVFFNN 431 (1008)
Q Consensus 354 ~L~Ls~N-~l~~~~p~~~~~l~~L~~L~L~~-n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~ 431 (1008)
.++++++ .++ .+|. +..+.+|+.|+|++ |+|++..+..|..+++|+.|+|++|+|++..|..|.+|++|+.|+|++
T Consensus 12 ~v~~~~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~ 89 (347)
T 2ifg_A 12 GLRCTRDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSF 89 (347)
T ss_dssp CEECCSSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCS
T ss_pred EEEcCCCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCC
Confidence 4577777 777 5777 88888888888886 888888788899999999999999999988888889999999999999
Q ss_pred cccccccCCCCcCCCcccEeecccccccC
Q 045798 432 NNLSGVIPFSLGNLKRLAFLEMSGNELSG 460 (1008)
Q Consensus 432 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 460 (1008)
|+|++..+..|..++ |+.|+|++|.+..
T Consensus 90 N~l~~~~~~~~~~~~-L~~l~l~~N~~~c 117 (347)
T 2ifg_A 90 NALESLSWKTVQGLS-LQELVLSGNPLHC 117 (347)
T ss_dssp SCCSCCCSTTTCSCC-CCEEECCSSCCCC
T ss_pred CccceeCHHHcccCC-ceEEEeeCCCccC
Confidence 999877777777666 9999999999874
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.18 E-value=4.1e-11 Score=127.38 Aligned_cols=147 Identities=15% Similarity=0.077 Sum_probs=113.0
Q ss_pred HHHHhcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccchhhHHHHHHHHHHhhc-CCCCceeeeeccccccccC
Q 045798 679 LLKATNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNI-RHRNLVKVITSCSSIDFQG 757 (1008)
Q Consensus 679 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~ 757 (1008)
+.....+|++...++.|+.+.||++.. .++.+++|+...........+.+|+++++.+ .+..+.++++++ ..
T Consensus 9 l~~~l~~~~~~~~~~g~s~~~v~~~~~--~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~-----~~ 81 (263)
T 3tm0_A 9 LKKLIEKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFE-----RH 81 (263)
T ss_dssp HHHHHTTSEEEECCSCCSSSEEEEEEC--SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEE-----EE
T ss_pred HHHHhccceeEeeccCCCCCeEEEEEC--CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEE-----ec
Confidence 344567898889999999999999976 4689999998753223345689999999998 467788888874 34
Q ss_pred CceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCC---------------------
Q 045798 758 NDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHC--------------------- 816 (1008)
Q Consensus 758 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--------------------- 816 (1008)
.+..|+||||++|.+|.+..... .....++.+++++++.||+..
T Consensus 82 ~~~~~lv~e~i~G~~l~~~~~~~---------------~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~ 146 (263)
T 3tm0_A 82 DGWSNLLMSEADGVLCSEEYEDE---------------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLL 146 (263)
T ss_dssp TTEEEEEEECCSSEEHHHHCCTT---------------TCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHH
T ss_pred CCceEEEEEecCCeehhhccCCc---------------ccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHH
Confidence 56689999999999998764211 123468899999999999821
Q ss_pred -----------------------------------CCCceeccCCCCCeeecCCCCeEEcccCccc
Q 045798 817 -----------------------------------QEPILHCDLKPSNILLDNDLSGHIGDFGLAR 847 (1008)
Q Consensus 817 -----------------------------------~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~ 847 (1008)
+..++|||++|.||+++++..+.|+||+.+.
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 147 NNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp HTTCSCCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred hccccccccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 1358999999999999876566799999875
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.96 E-value=6.6e-10 Score=117.97 Aligned_cols=138 Identities=17% Similarity=0.082 Sum_probs=97.5
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccchhhHHHHHHHHHHhhcCCCC--ceeeeeccccccccCCce
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRN--LVKVITSCSSIDFQGNDF 760 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~~~~~~~~~~~~~~~~ 760 (1008)
..+|.+....+.|..+.||++.. .+|+.+++|+.... ....+.+|+++++.+.+.+ +.++++++ ..++.
T Consensus 19 ~~~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~-----~~~~~ 89 (264)
T 1nd4_A 19 LFGYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVV-----TEAGR 89 (264)
T ss_dssp TTTCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEE-----ECSSC
T ss_pred cCCCceEecccCCCCceEEEEec-CCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEec-----cCCCC
Confidence 34455433334556699999975 46788999997643 2356789999999985444 45577763 33456
Q ss_pred EEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCC------------------------
Q 045798 761 KAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHC------------------------ 816 (1008)
Q Consensus 761 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~------------------------ 816 (1008)
.++||||++|.++. ... .. ...++.+++..++.||+..
T Consensus 90 ~~~v~e~i~G~~l~--~~~-------------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~ 151 (264)
T 1nd4_A 90 DWLLLGEVPGQDLL--SSH-------------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAG 151 (264)
T ss_dssp EEEEEECCSSEETT--TSC-------------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTT
T ss_pred CEEEEEecCCcccC--cCc-------------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcC
Confidence 89999999998884 211 11 1256778888888888742
Q ss_pred -------------------------------CCCceeccCCCCCeeecCCCCeEEcccCccc
Q 045798 817 -------------------------------QEPILHCDLKPSNILLDNDLSGHIGDFGLAR 847 (1008)
Q Consensus 817 -------------------------------~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~ 847 (1008)
+..++|||++|.||++++++.+.|+|||.+.
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 152 LVDQDDLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp CCCTTSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred CccchhhhhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 1129999999999999877667799999875
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.86 E-value=6.8e-09 Score=115.64 Aligned_cols=147 Identities=13% Similarity=0.144 Sum_probs=106.9
Q ss_pred CCCceEeeccCeeEEEEEEcCCCeEEEEEEec--cccc-hhhHHHHHHHHHHhhcC--CCCceeeeeccccccccCCceE
Q 045798 687 SSTHLIGVGSFGCVYKGALDEDGIVVAIKVIN--LQCE-GASKSFMAECKALKNIR--HRNLVKVITSCSSIDFQGNDFK 761 (1008)
Q Consensus 687 ~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~--~~~~-~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~~~~~~~ 761 (1008)
..++.++.|.++.||++... +..+++|+.. .... .....+.+|+++++.+. +..+.+++.++.... ..+..
T Consensus 41 ~~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~--~~g~~ 116 (359)
T 3dxp_A 41 LSVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDES--VIGRA 116 (359)
T ss_dssp CEEEECCC-CCSCEEEEECS--SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTT--TTSSC
T ss_pred ceEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCC--ccCCe
Confidence 34678999999999998873 4678899875 3221 22357889999999996 455778888764321 12457
Q ss_pred EEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCC-------------------------
Q 045798 762 AIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHC------------------------- 816 (1008)
Q Consensus 762 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~------------------------- 816 (1008)
++||||++|..+.+.... .++..++..++.+++.+|+.||+..
T Consensus 117 ~~vme~v~G~~l~~~~~~------------~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 184 (359)
T 3dxp_A 117 FYIMEFVSGRVLWDQSLP------------GMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTK 184 (359)
T ss_dssp EEEEECCCCBCCCCTTCT------------TCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHH
T ss_pred EEEEEecCCeecCCCccc------------cCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHH
Confidence 899999998877542110 4677888999999999999999731
Q ss_pred ------------------------------CCCceeccCCCCCeeecCCCC--eEEcccCccccc
Q 045798 817 ------------------------------QEPILHCDLKPSNILLDNDLS--GHIGDFGLARFH 849 (1008)
Q Consensus 817 ------------------------------~~~ivH~Dlkp~NIll~~~~~--~kL~Dfg~a~~~ 849 (1008)
...++|||++|.||+++.++. +.|+||+.+..-
T Consensus 185 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g 249 (359)
T 3dxp_A 185 QYKLSETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG 249 (359)
T ss_dssp HHHHHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred HHHhcCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence 247999999999999987753 689999998743
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.86 E-value=8.9e-10 Score=121.46 Aligned_cols=165 Identities=13% Similarity=0.130 Sum_probs=92.9
Q ss_pred cchhccCCCCCceEEccCCcccccccccccCCCCcceeeccccccccccCCCCc--CCCcccEeeccc--ccccCCcchh
Q 045798 390 IPKEMGKLQKLQGLDFSGNHFSGEIPSSLGNLSSLYEVFFNNNNLSGVIPFSLG--NLKRLAFLEMSG--NELSGTIPED 465 (1008)
Q Consensus 390 ~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~--~l~~L~~L~Ls~--N~l~~~lp~~ 465 (1008)
+...+..+++|+.|+|++|.-. .++. + .+++|+.|+|..|.+.......+. .+++|+.|+|+. |...|.. .
T Consensus 164 L~~ll~~~P~L~~L~L~g~~~l-~l~~-~-~~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~--~ 238 (362)
T 2ra8_A 164 LSPVLDAMPLLNNLKIKGTNNL-SIGK-K-PRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDG--D 238 (362)
T ss_dssp CHHHHHTCTTCCEEEEECCBTC-BCCS-C-BCTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCS--C
T ss_pred HHHHHhcCCCCcEEEEeCCCCc-eecc-c-cCCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccch--h
Confidence 4455667778888888777311 2233 3 267777888777776543333333 567788887753 2221110 0
Q ss_pred hhhhhhhhhhhcccCccccCCCcccc--cccccccccccccccccCCCCcccc---cccccceeeccCcccccc----hh
Q 045798 466 IFNISYLSNSLNLARNHLVGIIPPRI--GNLRALRSFDVSNNDLSGEIPIELG---HCSSLEEIYLAGNLFHGS----IP 536 (1008)
Q Consensus 466 ~~~~~~~~~~L~L~~N~l~~~~p~~~--~~l~~L~~Ldls~N~l~~~~p~~~~---~l~~L~~L~L~~N~l~~~----~p 536 (1008)
+.. +...+ ..+++|++|+|++|.+.+..+..+. .+++|++|+|+.|.|.+. ++
T Consensus 239 ~~~------------------l~~~l~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~ 300 (362)
T 2ra8_A 239 MNV------------------FRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLL 300 (362)
T ss_dssp GGG------------------TGGGSCTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHH
T ss_pred HHH------------------HHHHHhcCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHH
Confidence 000 00111 2467788888888777643333332 467888888888888753 34
Q ss_pred hhhhccccccEEecCCCcccccccCcccccccceeecccCc
Q 045798 537 SFFNALKGVQKIDLSRNNLSGQIPIFLEALSLEYLNLSFND 577 (1008)
Q Consensus 537 ~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~L~~L~l~~N~ 577 (1008)
..+..+++|+.|+|++|.++...-....-.-...+++++|.
T Consensus 301 ~~L~~l~~L~~L~L~~n~i~d~~~~~l~~alg~~~~~~~~~ 341 (362)
T 2ra8_A 301 DHVDKIKHLKFINMKYNYLSDEMKKELQKSLPMKIDVSDSQ 341 (362)
T ss_dssp TTHHHHTTCSEEECCSBBCCHHHHHHHHHHCCSEEECCSBC
T ss_pred hhcccCCcceEEECCCCcCCHHHHHHHHHHcCCEEEecCCc
Confidence 44456788888888888776432111110012456777665
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=98.85 E-value=4.5e-08 Score=109.91 Aligned_cols=304 Identities=10% Similarity=0.060 Sum_probs=143.3
Q ss_pred CCCccccccchhhcccccCCCCCCccccCCCCCcEEEecCCcccccCCccccCCCCcceeccccccccccCChhhhhcCC
Q 045798 168 PFLGNLTSLEVLSLAGNSFGRNIPDSLGQLKQLKILAIGGNNLSGPIPPSIYNLSFLVVFSVSHNQIHGSLPPSLGLLLP 247 (1008)
Q Consensus 168 ~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~~~lp~~~~~~l~ 247 (1008)
+++....+|+.+.+.. .++.....+|.++.+|+.+.|..+ ++.+...+|.++ +|+.+.+..+ ++ .++...|.. .
T Consensus 40 ~~~~~~~~i~~v~ip~-~vt~Ig~~aF~~C~~L~~I~lp~~-v~~Ig~~aF~~c-~l~~i~~~~~-l~-~I~~~aF~~-~ 113 (379)
T 4h09_A 40 PWYKDRDRISEVRVNS-GITSIGEANFNSCYNMTKVTVAST-VTSIGDGAFADT-KLQSYTGMER-VK-KFGDYVFQG-T 113 (379)
T ss_dssp TTGGGGGGCSEEEECT-TEEEECTTTTTTCTTCCEEEECTT-CCEECTTTTTTC-CCCEEEECTT-CC-EECTTTTTT-C
T ss_pred cccccccCCEEEEeCC-CccChHHHHhhCCCCCCEEEeCCc-ceEechhhhcCC-CCceEECCce-ee-Eeccceecc-C
Confidence 3455566777777754 355555667777777877777644 555666667665 4666555433 33 444444443 2
Q ss_pred CCcEEEeccccCCCCCCcccccCCCCceeecccccccccccccccCCCcccccccccccCCCCCCCcccccccccccCCC
Q 045798 248 NLKFFQIHHNFFSGSIPISLSNASKLEHIEIANNNFSGKLSVNFGGMKNLSLLNLQFSNLGSGESDEMGFMNSLTNCSKL 327 (1008)
Q Consensus 248 ~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~l~~L 327 (1008)
+|+.+.+..+... ....+|.+. +|+.+.+..+ +..+.... +..+..+
T Consensus 114 ~L~~i~lp~~~~~-i~~~~F~~~-~l~~~~~~~~-v~~i~~~~------------------------------f~~~~~l 160 (379)
T 4h09_A 114 DLDDFEFPGATTE-IGNYIFYNS-SVKRIVIPKS-VTTIKDGI------------------------------GYKAENL 160 (379)
T ss_dssp CCSEEECCTTCCE-ECTTTTTTC-CCCEEEECTT-CCEECSCT------------------------------TTTCTTC
T ss_pred CcccccCCCcccc-ccccccccc-eeeeeeccce-eeccccch------------------------------hcccccc
Confidence 5555555543221 222222222 3333333221 22222223 3344444
Q ss_pred cEEEecCCcCCccCChhhhhhcccceeeeeccccccCCCCCccccccccceEEecCccccCCcchhccCCCCCceEEccC
Q 045798 328 RVLSLGGNQFRGALPHSIANLSSQLQILILSSNQFYGSIPLGIGNLVDLYLLGMVENQFTGAIPKEMGKLQKLQGLDFSG 407 (1008)
Q Consensus 328 ~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~ 407 (1008)
+.+.+..+...... ..... .+... .....+.....+..+.+.... .......+....+|+.+.+..
T Consensus 161 ~~~~~~~~~~~~~~-~~~~~-----------~~~~~-~~~~~~~~~~~~~~~~~~~~~-~~i~~~~f~~~~~l~~i~~~~ 226 (379)
T 4h09_A 161 EKIEVSSNNKNYVA-ENYVL-----------YNKNK-TILESYPAAKTGTEFTIPSTV-KTVTAYGFSYGKNLKKITITS 226 (379)
T ss_dssp CEEEECTTCSSEEE-ETTEE-----------EETTS-SEEEECCTTCCCSEEECCTTC-CEECTTTTTTCSSCSEEECCT
T ss_pred cccccccccceeec-cccee-----------ccccc-ceeccccccccccccccccce-eEEeecccccccccceeeecc
Confidence 44444433222000 00000 00000 011112222223333222211 112334444555566665544
Q ss_pred CcccccccccccCCCCcceeeccccccccccCCCCcCCCcccEeecccccccCCcchhhhhhhhhhhhhcccCccccCCC
Q 045798 408 NHFSGEIPSSLGNLSSLYEVFFNNNNLSGVIPFSLGNLKRLAFLEMSGNELSGTIPEDIFNISYLSNSLNLARNHLVGII 487 (1008)
Q Consensus 408 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~lp~~~~~~~~~~~~L~L~~N~l~~~~ 487 (1008)
+ +.......|.+...|+.+.+..+ ++.+-..+|.++.+|+.+.+..+ ++ .+ -
T Consensus 227 ~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~-~i------------------------~ 278 (379)
T 4h09_A 227 G-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VK-TV------------------------P 278 (379)
T ss_dssp T-CCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CS-EE------------------------C
T ss_pred c-eeEEccccccCCccceEEEcCCC-ccEeCccccceeehhcccccccc-ce-ec------------------------c
Confidence 4 22233445555666666666544 44344555666666666665432 22 12 2
Q ss_pred cccccccccccccccccccccCCCCcccccccccceeeccCcccccchhhhhhccccccEEecCCC
Q 045798 488 PPRIGNLRALRSFDVSNNDLSGEIPIELGHCSSLEEIYLAGNLFHGSIPSFFNALKGVQKIDLSRN 553 (1008)
Q Consensus 488 p~~~~~l~~L~~Ldls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N 553 (1008)
...|.++.+|+.+++.++.++..-...|.+|.+|+.+.|..+ ++..-...|.++++|+.+.+..+
T Consensus 279 ~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~ip~~ 343 (379)
T 4h09_A 279 YLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKALSTISYPKS 343 (379)
T ss_dssp TTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCCCCCCTT
T ss_pred ccccccccccccccccccccceehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCCCEEEECCc
Confidence 234555666666666666555334455666666666666544 44333456666677776666544
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.85 E-value=4.1e-10 Score=124.11 Aligned_cols=206 Identities=14% Similarity=0.167 Sum_probs=113.9
Q ss_pred CeEEEEeccccCCCC-c-------cCcCccCCccCCeeeecCCCCC---------CCCCccccCCCCCCEEEccCCCCCC
Q 045798 54 RRVTALDLMSKSLSG-S-------LSPHLGNLSFLREINLSNNTIQ---------GEIPPEFGRLFRLEALFLSNNSLVG 116 (1008)
Q Consensus 54 ~~v~~l~l~~~~l~~-~-------l~~~l~~l~~L~~L~L~~n~~~---------~~~p~~~~~l~~L~~L~Ls~n~l~~ 116 (1008)
.+|+.|.+......| . +..++..+++|+.|.+.++... +.+...+..+++|+.|+|++|.-.
T Consensus 107 ~~v~~L~lg~~~~~~~~~~~~~~~L~~s~~~l~~L~~L~l~~~~~e~~~is~~~~~~L~~ll~~~P~L~~L~L~g~~~l- 185 (362)
T 2ra8_A 107 PSLKQITIGXWGYEGEDCSDIADGIVENKEKFAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNL- 185 (362)
T ss_dssp GGCSEEEECCCCSSSCCSHHHHHHHHTTHHHHTTCSEEEECCCCTTTCCGGGCBCCBCHHHHHTCTTCCEEEEECCBTC-
T ss_pred hhcceEEEcccccCCCcHHHHHHHHHHhhhhcchhhheeecCcchhhcccccccccCHHHHHhcCCCCcEEEEeCCCCc-
Confidence 457777776554442 1 2344566788888888664331 123334456677777777776311
Q ss_pred ccCcccccCcCcceEeeeccccccCCCcccc--ccCCCCeeeccc--ccCCCCCCCCCccccccchhhcccccCCCCCCc
Q 045798 117 KIPANLSYCSRLTVLCIEYNKLQGRIPLEFV--SLSKLKDLSLAK--NKLTGGIPPFLGNLTSLEVLSLAGNSFGRNIPD 192 (1008)
Q Consensus 117 ~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~--~l~~L~~L~L~~--n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~ 192 (1008)
.++. +. +++|++|+|..|.+.......+. .+++|++|+|+. |...+. ..+ ..|. .
T Consensus 186 ~l~~-~~-~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~--~~~---~~l~--------------~ 244 (362)
T 2ra8_A 186 SIGK-KP-RPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFD--GDM---NVFR--------------P 244 (362)
T ss_dssp BCCS-CB-CTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCC--SCG---GGTG--------------G
T ss_pred eecc-cc-CCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccc--hhH---HHHH--------------H
Confidence 2222 32 66777777777766543333333 466777776642 111110 001 0111 0
Q ss_pred cc--cCCCCCcEEEecCCcccccCCcccc---CCCCcceeccccccccccCChhhh---hcCCCCcEEEeccccCCCCCC
Q 045798 193 SL--GQLKQLKILAIGGNNLSGPIPPSIY---NLSFLVVFSVSHNQIHGSLPPSLG---LLLPNLKFFQIHHNFFSGSIP 264 (1008)
Q Consensus 193 ~~--~~l~~L~~L~L~~n~l~~~~~~~~~---~l~~L~~L~ls~N~l~~~lp~~~~---~~l~~L~~L~L~~N~l~~~~p 264 (1008)
.+ ..+++|+.|+|++|.+....+..+. .+++|++|+|+.|.+.+.....+. ..+++|+.|+|++|.++...-
T Consensus 245 ~l~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~d~~~ 324 (362)
T 2ra8_A 245 LFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMK 324 (362)
T ss_dssp GSCTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCCHHHH
T ss_pred HHhcCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCCHHHH
Confidence 11 2467788888888777643322222 467888888888887753332332 236788888888888775433
Q ss_pred cccccCCCCceeeccccc
Q 045798 265 ISLSNASKLEHIEIANNN 282 (1008)
Q Consensus 265 ~~l~~l~~L~~L~L~~N~ 282 (1008)
..+...- ...++++.++
T Consensus 325 ~~l~~al-g~~~~~~~~~ 341 (362)
T 2ra8_A 325 KELQKSL-PMKIDVSDSQ 341 (362)
T ss_dssp HHHHHHC-CSEEECCSBC
T ss_pred HHHHHHc-CCEEEecCCc
Confidence 3333311 3557888776
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=98.84 E-value=1.1e-07 Score=106.70 Aligned_cols=128 Identities=9% Similarity=0.060 Sum_probs=72.4
Q ss_pred CccCCccCCeeeecCCCCCCCCCccccCCCCCCEEEccCCCCCCccCcccccCcCcceEeeeccccccCCCccccccCCC
Q 045798 73 HLGNLSFLREINLSNNTIQGEIPPEFGRLFRLEALFLSNNSLVGKIPANLSYCSRLTVLCIEYNKLQGRIPLEFVSLSKL 152 (1008)
Q Consensus 73 ~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L 152 (1008)
++....+|+.+.+.. .++.+-..+|.++.+|+.++|..+ ++.....+|.++ +|+.+.+..+ ++.+...+|.. .+|
T Consensus 41 ~~~~~~~i~~v~ip~-~vt~Ig~~aF~~C~~L~~I~lp~~-v~~Ig~~aF~~c-~l~~i~~~~~-l~~I~~~aF~~-~~L 115 (379)
T 4h09_A 41 WYKDRDRISEVRVNS-GITSIGEANFNSCYNMTKVTVAST-VTSIGDGAFADT-KLQSYTGMER-VKKFGDYVFQG-TDL 115 (379)
T ss_dssp TGGGGGGCSEEEECT-TEEEECTTTTTTCTTCCEEEECTT-CCEECTTTTTTC-CCCEEEECTT-CCEECTTTTTT-CCC
T ss_pred ccccccCCEEEEeCC-CccChHHHHhhCCCCCCEEEeCCc-ceEechhhhcCC-CCceEECCce-eeEeccceecc-CCc
Confidence 445566788888865 455455667888888888888654 654556667776 5777766543 44344445544 367
Q ss_pred CeeecccccCCCCCCCCCccccccchhhcccccCCCCCCccccCCCCCcEEEecCC
Q 045798 153 KDLSLAKNKLTGGIPPFLGNLTSLEVLSLAGNSFGRNIPDSLGQLKQLKILAIGGN 208 (1008)
Q Consensus 153 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n 208 (1008)
+.+.+..+- +......|.+. +|+.+.+..+ ++.....+|..+..++.+.+..+
T Consensus 116 ~~i~lp~~~-~~i~~~~F~~~-~l~~~~~~~~-v~~i~~~~f~~~~~l~~~~~~~~ 168 (379)
T 4h09_A 116 DDFEFPGAT-TEIGNYIFYNS-SVKRIVIPKS-VTTIKDGIGYKAENLEKIEVSSN 168 (379)
T ss_dssp SEEECCTTC-CEECTTTTTTC-CCCEEEECTT-CCEECSCTTTTCTTCCEEEECTT
T ss_pred ccccCCCcc-ccccccccccc-eeeeeeccce-eeccccchhcccccccccccccc
Confidence 777776542 21333344432 3444443322 33334445555556655555543
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.81 E-value=1.7e-09 Score=117.47 Aligned_cols=192 Identities=16% Similarity=0.111 Sum_probs=122.4
Q ss_pred CceEeeccCeeEEEEEEcCCCeEEEEEEeccccchhhHHHHHHHHHHhhc-CCCC--ceeeeeccccccccCCceEEEEE
Q 045798 689 THLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNI-RHRN--LVKVITSCSSIDFQGNDFKAIVY 765 (1008)
Q Consensus 689 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~n--iv~~~~~~~~~~~~~~~~~~lv~ 765 (1008)
++.++.|.+..||++. ..+++|+.... .....+.+|+++++.+ .+.. +.+++..+.. ...-...|+||
T Consensus 25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~--~~~~~~~~~vm 95 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN-----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMP--SETYQMSFAGF 95 (304)
T ss_dssp CCEEEECSSEEEEEST-----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCC--CSSCSCSCEEE
T ss_pred eEecCCCCcceEEEEC-----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCC--CCCCCcceEEE
Confidence 4679999999999863 45889986432 3456789999999888 3332 3444444221 11112357899
Q ss_pred eccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCC-----------------------------
Q 045798 766 EYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHC----------------------------- 816 (1008)
Q Consensus 766 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~----------------------------- 816 (1008)
|+++|.++.+... ..++..++..++.+++..++.||+..
T Consensus 96 ~~i~G~~l~~~~~------------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (304)
T 3sg8_A 96 TKIKGVPLTPLLL------------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSR 163 (304)
T ss_dssp ECCCCEECCHHHH------------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTT
T ss_pred cccCCeECCcccc------------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcc
Confidence 9999988765321 14677788888888888888888621
Q ss_pred --------------------------CCCceeccCCCCCeeecC--CCCeEEcccCcccccccccCcccccc--------
Q 045798 817 --------------------------QEPILHCDLKPSNILLDN--DLSGHIGDFGLARFHQEVSNSTLSSS-------- 860 (1008)
Q Consensus 817 --------------------------~~~ivH~Dlkp~NIll~~--~~~~kL~Dfg~a~~~~~~~~~~~~~~-------- 860 (1008)
...++|+|++|.||++++ +..+.++||+.+..-....+......
T Consensus 164 ~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~ 243 (304)
T 3sg8_A 164 ELKGPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGME 243 (304)
T ss_dssp TSCHHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHH
T ss_pred cCCcccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHH
Confidence 135799999999999998 45678999999875332111100000
Q ss_pred --ccccccccccC-ccccCCCCCCcccchhhHHHHHHHHHhCCCCC
Q 045798 861 --VGVKGTIGYTA-PEYGLGSEVSTNGDVYSYGILLLEMVTAKKPT 903 (1008)
Q Consensus 861 --~~~~gt~~y~a-PE~~~~~~~~~~sDvwslG~vl~elltG~~pf 903 (1008)
.......++.. |+.... .....+.|++|.++|.+.+|..+|
T Consensus 244 ~~~~~l~~Y~~~~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 244 FVSKILNHYKHKDIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHHHHHHHTCSCHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HHHHHHHHcCCCCcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHHH
Confidence 00000111111 222111 112258999999999999999875
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.76 E-value=3.9e-11 Score=125.12 Aligned_cols=120 Identities=18% Similarity=0.133 Sum_probs=55.8
Q ss_pred CCcccceEEcCCCCeEEEEeccc---cCCCCccCc-CccCCccCCeeeecCCCCCCCCCc-cccCCCCCCE--EEccCCC
Q 045798 41 FCEWEGITCGRRHRRVTALDLMS---KSLSGSLSP-HLGNLSFLREINLSNNTIQGEIPP-EFGRLFRLEA--LFLSNNS 113 (1008)
Q Consensus 41 ~c~w~gv~c~~~~~~v~~l~l~~---~~l~~~l~~-~l~~l~~L~~L~L~~n~~~~~~p~-~~~~l~~L~~--L~Ls~n~ 113 (1008)
.|.|.|+.|+....+|+.+...+ ..+.+.+++ .+..++. .|...+|.-++.+.- .|...+.|.. ++++.|.
T Consensus 77 l~~~~g~i~~~~~~ki~~~v~~~~~~~~~~~~l~~~~~~~Lk~--~l~~ryn~~~~~LdLs~l~~dp~L~~~~l~l~~N~ 154 (267)
T 3rw6_A 77 LKAVNYKILDRENRRISIIINSSAPPHTILNELKPEQVEQLKL--IMSKRYDGSQQALDLKGLRSDPDLVAQNIDVVLNR 154 (267)
T ss_dssp HHHTTSSCBCTTSCBCCCEEEECCCCHHHHTSCCHHHHHHHHH--HHHHTEETTTTEEECTTGGGCHHHHHTTCCCCTTS
T ss_pred HHhcCcEEECCCCCEEEEEEecCCCcccccccCCHHHHHHHHH--HHHhccchhccccCHHHcCCCcchhhcCccccCCH
Confidence 48999999987766776655544 223333332 2222222 222333333322211 1333334443 4455553
Q ss_pred CCCccCc----ccccCcCcceEeeecccccc--CCCccccccCCCCeeecccccCC
Q 045798 114 LVGKIPA----NLSYCSRLTVLCIEYNKLQG--RIPLEFVSLSKLKDLSLAKNKLT 163 (1008)
Q Consensus 114 l~~~~p~----~l~~l~~L~~L~Ls~n~l~~--~~p~~~~~l~~L~~L~L~~n~l~ 163 (1008)
.. .++. ...++++|++|+|++|+|++ .+|..+..+++|+.|+|++|+|+
T Consensus 155 ~~-~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~ 209 (267)
T 3rw6_A 155 RS-CMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELK 209 (267)
T ss_dssp HH-HHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCC
T ss_pred HH-HHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccC
Confidence 32 1111 11344555555555555554 22344445555555555555555
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.37 E-value=6.7e-08 Score=100.68 Aligned_cols=66 Identities=20% Similarity=0.195 Sum_probs=40.5
Q ss_pred cccccceeeccCccccc--chhhhhhccccccEEecCCCcccccccCccccc--ccceeecccCcccccCC
Q 045798 517 HCSSLEEIYLAGNLFHG--SIPSFFNALKGVQKIDLSRNNLSGQIPIFLEAL--SLEYLNLSFNDFEGKIP 583 (1008)
Q Consensus 517 ~l~~L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~--~L~~L~l~~N~l~g~~p 583 (1008)
++++|++|+|++|+|++ .+|..+..+++|+.|||++|+|++. .....+. .|++|+|++|.+++.+|
T Consensus 168 ~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~-~~l~~l~~l~L~~L~L~~Npl~~~~~ 237 (267)
T 3rw6_A 168 NIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE-RELDKIKGLKLEELWLDGNSLCDTFR 237 (267)
T ss_dssp HCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG-GGGGGGTTSCCSEEECTTSTTGGGCS
T ss_pred hCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc-hhhhhcccCCcceEEccCCcCccccC
Confidence 45666666666666665 3456666677777777777777654 1111122 67777777777776665
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.34 E-value=1e-08 Score=101.85 Aligned_cols=122 Identities=17% Similarity=0.136 Sum_probs=63.3
Q ss_pred cCcCccCCccCCeeeecCC-CCCCC----CCccccCCCCCCEEEccCCCCCCcc----CcccccCcCcceEeeecccccc
Q 045798 70 LSPHLGNLSFLREINLSNN-TIQGE----IPPEFGRLFRLEALFLSNNSLVGKI----PANLSYCSRLTVLCIEYNKLQG 140 (1008)
Q Consensus 70 l~~~l~~l~~L~~L~L~~n-~~~~~----~p~~~~~l~~L~~L~Ls~n~l~~~~----p~~l~~l~~L~~L~Ls~n~l~~ 140 (1008)
+...+...+.|++|+|++| .++.. +...+...++|++|+|++|.|.... ...+...++|++|+|++|.|..
T Consensus 28 l~~~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~ 107 (185)
T 1io0_A 28 LKRIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISG 107 (185)
T ss_dssp HHHHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCH
T ss_pred HHHHHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCH
Confidence 3344556667777777777 66532 2334455666777777777766322 2233344556666666666553
Q ss_pred C----CCccccccCCCCeeec--ccccCCCCCCCCCccccccchhhcccccCCCCCCccccCCCCCcEEEecCCccc
Q 045798 141 R----IPLEFVSLSKLKDLSL--AKNKLTGGIPPFLGNLTSLEVLSLAGNSFGRNIPDSLGQLKQLKILAIGGNNLS 211 (1008)
Q Consensus 141 ~----~p~~~~~l~~L~~L~L--~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~ 211 (1008)
. +...+...++|++|+| ++|.|+..... .+...+...++|++|+|++|.+.
T Consensus 108 ~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~--------------------~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 108 SGILALVEALQSNTSLIELRIDNQSQPLGNNVEM--------------------EIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp HHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHH--------------------HHHHHHHHCSSCCEEECCCSSHH
T ss_pred HHHHHHHHHHHhCCCceEEEecCCCCCCCHHHHH--------------------HHHHHHHhCCCcCEEeccCCCCC
Confidence 2 2223333344444444 34444311100 12234445567777777777765
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.34 E-value=1.4e-06 Score=92.70 Aligned_cols=142 Identities=16% Similarity=0.074 Sum_probs=99.4
Q ss_pred hcCCCCCceEeeccCe-eEEEEEEcCCCeEEEEEEeccccchhhHHHHHHHHHHhhcC-CCCceeeeeccccccccCCce
Q 045798 683 TNGFSSTHLIGVGSFG-CVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIR-HRNLVKVITSCSSIDFQGNDF 760 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g-~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~ 760 (1008)
..+|+. +.+..|..| .||+.....++..+++|+-.. .....+.+|+.+++.+. +--+.++++++. +++.
T Consensus 24 l~g~~~-~~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~---~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~-----~~~~ 94 (272)
T 4gkh_A 24 LYGYRW-ARDNVGQSGATIYRLYGKPNAPELFLKHGKG---SVANDVTDEMVRLNWLTAFMPLPTIKHFIR-----TPDD 94 (272)
T ss_dssp HTTCEE-EEEECSSSSCEEEEEECCTTCCCEEEEEEET---HHHHHHHHHHHHHHHHTTTSCCCCEEEEEE-----ETTE
T ss_pred ccCCeE-EEccCCCcCCeEEEEEecCCCeEEEEEECCC---CCHhHHHHHHHHHHHhccCCCcCeEEEEEE-----ECCe
Confidence 344543 456667666 699988776778899998653 34567889999998883 334667777643 3456
Q ss_pred EEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCC------------------------
Q 045798 761 KAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHC------------------------ 816 (1008)
Q Consensus 761 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~------------------------ 816 (1008)
.++|||+++|.++.+..... ......++.+++..++.||...
T Consensus 95 ~~lvme~l~G~~~~~~~~~~--------------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (272)
T 4gkh_A 95 AWLLTTAIPGKTAFQVLEEY--------------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNG 160 (272)
T ss_dssp EEEEEECCCSEEHHHHHHHC--------------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTT
T ss_pred EEEEEEeeCCccccccccCC--------------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHh
Confidence 89999999998877654321 1223456666777777777421
Q ss_pred -------------------------------CCCceeccCCCCCeeecCCCCeEEcccCccc
Q 045798 817 -------------------------------QEPILHCDLKPSNILLDNDLSGHIGDFGLAR 847 (1008)
Q Consensus 817 -------------------------------~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~ 847 (1008)
...++|+|+.+.||++++++.+-|+||+.+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 161 LVDASDFDDERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp CCCGGGCCGGGTTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred hhhhhhccccccchHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 1237899999999999987777799999886
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.24 E-value=6.9e-08 Score=95.88 Aligned_cols=121 Identities=17% Similarity=0.094 Sum_probs=75.3
Q ss_pred CccccCCCCCCEEEccCC-CCCCc----cCcccccCcCcceEeeeccccccCC----CccccccCCCCeeecccccCCCC
Q 045798 95 PPEFGRLFRLEALFLSNN-SLVGK----IPANLSYCSRLTVLCIEYNKLQGRI----PLEFVSLSKLKDLSLAKNKLTGG 165 (1008)
Q Consensus 95 p~~~~~l~~L~~L~Ls~n-~l~~~----~p~~l~~l~~L~~L~Ls~n~l~~~~----p~~~~~l~~L~~L~L~~n~l~~~ 165 (1008)
...+...+.|++|+|++| .+... +...+...++|++|+|++|.|...- ...+...++|++|+|++|.|+..
T Consensus 29 ~~~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~ 108 (185)
T 1io0_A 29 KRIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGS 108 (185)
T ss_dssp HHHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHH
T ss_pred HHHHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHH
Confidence 345566778888888888 77643 2334455567777777777765322 22233334555555555555421
Q ss_pred CCCCCccccccchhhcccccCCCCCCccccCCCCCcEEEe--cCCccccc----CCccccCCCCcceecccccccc
Q 045798 166 IPPFLGNLTSLEVLSLAGNSFGRNIPDSLGQLKQLKILAI--GGNNLSGP----IPPSIYNLSFLVVFSVSHNQIH 235 (1008)
Q Consensus 166 ~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L--~~n~l~~~----~~~~~~~l~~L~~L~ls~N~l~ 235 (1008)
.. ..+..++...++|++|+| ++|.+... +...+...++|++|+|++|.+.
T Consensus 109 g~--------------------~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 109 GI--------------------LALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp HH--------------------HHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred HH--------------------HHHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence 10 012345566677888888 77888743 3445666789999999999986
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.20 E-value=5.2e-06 Score=89.69 Aligned_cols=137 Identities=15% Similarity=0.109 Sum_probs=94.1
Q ss_pred CceEeeccCeeEEEEEEcCCCeEEEEEEeccccchhhHHHHHHHHHHhhcCCC---CceeeeeccccccccCCceEEEEE
Q 045798 689 THLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHR---NLVKVITSCSSIDFQGNDFKAIVY 765 (1008)
Q Consensus 689 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~~~~~~~~~~~~~~~~~~lv~ 765 (1008)
++.++.|....||+. +..+++|+.. .......+.+|+++++.+.+. .+.+++.++. ...+..++||
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~----~~~g~~~~v~ 92 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGK----RSDGNPFVGY 92 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEE----CTTSCEEEEE
T ss_pred eeecCCCcceeEEEE-----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecc----cCCCceEEEE
Confidence 467888999999987 4568888853 233456899999999999642 3455555532 2345578999
Q ss_pred eccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhC------------------------------
Q 045798 766 EYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHH------------------------------ 815 (1008)
Q Consensus 766 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~------------------------------ 815 (1008)
||++|.++.+.... .++..+...++.+++..|+.||+.
T Consensus 93 e~i~G~~l~~~~~~------------~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~ 160 (306)
T 3tdw_A 93 RKVQGQILGEDGMA------------VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQV 160 (306)
T ss_dssp ECCCSEECHHHHHT------------TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHT
T ss_pred eccCCeECchhhhh------------hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhc
Confidence 99999888653211 234445555555666655555542
Q ss_pred ---------------------------CCCCceeccCCCCCeeecC---CCCe-EEcccCcccc
Q 045798 816 ---------------------------CQEPILHCDLKPSNILLDN---DLSG-HIGDFGLARF 848 (1008)
Q Consensus 816 ---------------------------~~~~ivH~Dlkp~NIll~~---~~~~-kL~Dfg~a~~ 848 (1008)
.+..++|+|++|.||+++. ++.+ .|+||+.+..
T Consensus 161 ~~~l~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 161 FPLLDESLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp GGGSCHHHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred ccccchhhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 1235699999999999987 4554 8999998863
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.94 E-value=1.7e-05 Score=87.83 Aligned_cols=86 Identities=6% Similarity=-0.099 Sum_probs=56.6
Q ss_pred CceE-eeccCeeEEEEEEc--C----CCeEEEEEEecccc---chhhHHHHHHHHHHhhcC-C--CCceeeeeccccccc
Q 045798 689 THLI-GVGSFGCVYKGALD--E----DGIVVAIKVINLQC---EGASKSFMAECKALKNIR-H--RNLVKVITSCSSIDF 755 (1008)
Q Consensus 689 ~~~l-g~G~~g~Vy~~~~~--~----~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h--~niv~~~~~~~~~~~ 755 (1008)
.+.| +.|....+|+.... . +++.+++|+..... ......+.+|+.+++.+. + -.+.+++.++.....
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 3567 78888999998763 1 16789999875432 111256788999888883 2 356677776433211
Q ss_pred cCCceEEEEEeccCCCChhcc
Q 045798 756 QGNDFKAIVYEYMPNGSLEKW 776 (1008)
Q Consensus 756 ~~~~~~~lv~e~~~~gsL~~~ 776 (1008)
....++||||++|..+.+.
T Consensus 105 --~g~~~~v~e~l~G~~l~~~ 123 (357)
T 3ats_A 105 --LGTPFFLMDYVEGVVPPDV 123 (357)
T ss_dssp --TSSCEEEEECCCCBCCCBT
T ss_pred --cCCceEEEEecCCCChhhc
Confidence 1346899999998887653
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.83 E-value=2.1e-06 Score=82.69 Aligned_cols=82 Identities=15% Similarity=0.066 Sum_probs=36.4
Q ss_pred cCCeeeecCCCCCCCCCccccCCCCCCEEEccCCC-CCCccCcccccC----cCcceEeeeccc-cccCCCccccccCCC
Q 045798 79 FLREINLSNNTIQGEIPPEFGRLFRLEALFLSNNS-LVGKIPANLSYC----SRLTVLCIEYNK-LQGRIPLEFVSLSKL 152 (1008)
Q Consensus 79 ~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~-l~~~~p~~l~~l----~~L~~L~Ls~n~-l~~~~p~~~~~l~~L 152 (1008)
.|++|||+++.++..--..+..+++|++|+|++|. |++..-..++.+ ++|++|+|++|. |+..--..+.++++|
T Consensus 62 ~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~L 141 (176)
T 3e4g_A 62 KIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRNL 141 (176)
T ss_dssp CEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTTC
T ss_pred eEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCCC
Confidence 45555555555543333344455555555555552 443333333332 244555555442 433222233344444
Q ss_pred Ceeecccc
Q 045798 153 KDLSLAKN 160 (1008)
Q Consensus 153 ~~L~L~~n 160 (1008)
++|+|+++
T Consensus 142 ~~L~L~~c 149 (176)
T 3e4g_A 142 KYLFLSDL 149 (176)
T ss_dssp CEEEEESC
T ss_pred CEEECCCC
Confidence 44444443
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.80 E-value=6.3e-06 Score=79.31 Aligned_cols=84 Identities=8% Similarity=0.079 Sum_probs=45.6
Q ss_pred CCCCEEEccCCCCCCccCcccccCcCcceEeeeccc-cccCCCcccccc----CCCCeeeccccc-CCCCCCCCCccccc
Q 045798 102 FRLEALFLSNNSLVGKIPANLSYCSRLTVLCIEYNK-LQGRIPLEFVSL----SKLKDLSLAKNK-LTGGIPPFLGNLTS 175 (1008)
Q Consensus 102 ~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~-l~~~~p~~~~~l----~~L~~L~L~~n~-l~~~~~~~~~~l~~ 175 (1008)
.+|++|||++|.|+...-..+..+++|++|+|++|. |++.--..++.+ ++|++|+|++|. |+...-..+..+++
T Consensus 61 ~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~ 140 (176)
T 3e4g_A 61 YKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRN 140 (176)
T ss_dssp CCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTT
T ss_pred ceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCC
Confidence 356666666666665555555666666666666663 443333333332 246666666653 55433334555666
Q ss_pred cchhhccccc
Q 045798 176 LEVLSLAGNS 185 (1008)
Q Consensus 176 L~~L~L~~n~ 185 (1008)
|++|+|++|.
T Consensus 141 L~~L~L~~c~ 150 (176)
T 3e4g_A 141 LKYLFLSDLP 150 (176)
T ss_dssp CCEEEEESCT
T ss_pred CCEEECCCCC
Confidence 6666666654
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.78 E-value=3.8e-05 Score=86.45 Aligned_cols=76 Identities=18% Similarity=0.111 Sum_probs=49.3
Q ss_pred CceEeeccCeeEEEEEEcCCCeEEEEEEeccccc-------hhhHHHHHHHHHHhhcCC--C-CceeeeeccccccccCC
Q 045798 689 THLIGVGSFGCVYKGALDEDGIVVAIKVINLQCE-------GASKSFMAECKALKNIRH--R-NLVKVITSCSSIDFQGN 758 (1008)
Q Consensus 689 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~h--~-niv~~~~~~~~~~~~~~ 758 (1008)
.+.+|.|.++.||++....+++.|+||....... ...+++..|+++++.+.. + .+.+++.+ +.
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~-------d~ 107 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS-------DT 107 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE-------ET
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE-------cC
Confidence 4679999999999997655678899998653211 123567889999988732 3 34455543 12
Q ss_pred ceEEEEEeccCCC
Q 045798 759 DFKAIVYEYMPNG 771 (1008)
Q Consensus 759 ~~~~lv~e~~~~g 771 (1008)
+..++|||++++.
T Consensus 108 ~~~~lvmE~l~g~ 120 (397)
T 2olc_A 108 EMAVTVMEDLSHL 120 (397)
T ss_dssp TTTEEEECCCTTS
T ss_pred CccEEEEEeCCCc
Confidence 2358999999763
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.72 E-value=0.0002 Score=78.74 Aligned_cols=152 Identities=17% Similarity=0.124 Sum_probs=80.9
Q ss_pred ceEeeccCeeEEEEEEcCCCeEEEEEEeccccchhhHHHHHHHHHHhhcCC--CCceeeeecccccc-ccCCceEEEEEe
Q 045798 690 HLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRH--RNLVKVITSCSSID-FQGNDFKAIVYE 766 (1008)
Q Consensus 690 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~-~~~~~~~~lv~e 766 (1008)
+.|+.|..+.||++... +..+++|+.... ...+..|+.+++.+.. -.+.+++....... ...++..++|||
T Consensus 38 ~~l~gG~~n~~~~v~~~--~~~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~ 111 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTD--SGAVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYD 111 (346)
T ss_dssp EECC----CEEEEEEET--TEEEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEE
T ss_pred eeccccccCcEEEEEeC--CCCEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEE
Confidence 45666778999998873 345999998642 2334456666665521 13344443211000 123456789999
Q ss_pred ccCCCChhc--------------ccccCCC----CCCCcccccccCHHH-------------------------------
Q 045798 767 YMPNGSLEK--------------WLHPHAV----PKRDKEIEIKLTLLQ------------------------------- 797 (1008)
Q Consensus 767 ~~~~gsL~~--------------~l~~~~~----~~~~~~~~~~l~~~~------------------------------- 797 (1008)
|++|..+.. .++.... +.........-.|..
T Consensus 112 ~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 191 (346)
T 2q83_A 112 WIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQE 191 (346)
T ss_dssp CCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHH
T ss_pred eecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHH
Confidence 998866531 0111000 000000000011111
Q ss_pred HHHHHHHHHHHHHHHhh----------CCCCCceeccCCCCCeeecCCCCeEEcccCccc
Q 045798 798 RISIAIDVASALDYLHH----------HCQEPILHCDLKPSNILLDNDLSGHIGDFGLAR 847 (1008)
Q Consensus 798 ~~~i~~qi~~~L~~LH~----------~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~ 847 (1008)
...+..++..++++|++ ..+..++|||+++.||+++.++.+.++||+.+.
T Consensus 192 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 192 IDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 11122234456667763 023589999999999999888899999999875
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.53 E-value=0.00024 Score=75.78 Aligned_cols=79 Identities=15% Similarity=0.136 Sum_probs=57.5
Q ss_pred CCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccchhhHHHHHHHHHHhhcCC---CCceeeeeccccccccCCceE
Q 045798 685 GFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRH---RNLVKVITSCSSIDFQGNDFK 761 (1008)
Q Consensus 685 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h---~niv~~~~~~~~~~~~~~~~~ 761 (1008)
...-++.+|.|..+.||+.... +|+.|++|+...........|..|++.|+.+.- -.+.+++++. ..
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~-DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~---------~~ 85 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELA-DGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD---------DR 85 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEET-TSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE---------TT
T ss_pred CeEEEEecCCCCCeEEEEEEEC-CCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc---------Cc
Confidence 3445678999999999999984 889999998765444445678899999998832 2345555542 13
Q ss_pred EEEEeccCCCCh
Q 045798 762 AIVYEYMPNGSL 773 (1008)
Q Consensus 762 ~lv~e~~~~gsL 773 (1008)
++||||++++..
T Consensus 86 ~lv~e~l~~~~~ 97 (288)
T 3f7w_A 86 TLAMEWVDERPP 97 (288)
T ss_dssp EEEEECCCCCCC
T ss_pred eEEEEeecccCC
Confidence 789999977654
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.45 E-value=0.00065 Score=72.75 Aligned_cols=75 Identities=13% Similarity=0.076 Sum_probs=57.6
Q ss_pred CceEeeccCeeEEEEEEcCCCeEEEEEEeccccchhhHHHHHHHHHHhhcC---CCCceeeeeccccccccCCceEEEEE
Q 045798 689 THLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIR---HRNLVKVITSCSSIDFQGNDFKAIVY 765 (1008)
Q Consensus 689 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~~~~~~lv~ 765 (1008)
.+.|+.|....+|+... ++..+++|+.... ....+..|++.++.+. ...+.+++.++. .++..++||
T Consensus 41 ~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~-----~~g~~~lvm 110 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLIND--EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGN-----SQGHSFLLL 110 (312)
T ss_dssp EEEECCSSSSEEEEEES--SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEE-----CSSEEEEEE
T ss_pred eEEeCCccceeeeEEEE--CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEee-----cCCceEEEE
Confidence 46799999999999876 4678889987532 3567889999998883 356777877743 235689999
Q ss_pred eccCCCCh
Q 045798 766 EYMPNGSL 773 (1008)
Q Consensus 766 e~~~~gsL 773 (1008)
||+++..+
T Consensus 111 e~l~G~~~ 118 (312)
T 3jr1_A 111 EALNKSKN 118 (312)
T ss_dssp ECCCCCCC
T ss_pred EeccCCCC
Confidence 99998765
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.35 E-value=0.0011 Score=72.06 Aligned_cols=172 Identities=11% Similarity=0.055 Sum_probs=91.9
Q ss_pred CCCCHHHHHHHhcCCCCC-----ceEeeccCeeEEEEEEcCCCeEEEEEEeccccchhhHHHHHHHHHHhhcCCCC--ce
Q 045798 672 PKMSYKSLLKATNGFSST-----HLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRN--LV 744 (1008)
Q Consensus 672 ~~~~~~~~~~~~~~y~~~-----~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv 744 (1008)
..++.+++......|.+. +.|+.|....+|++... +| .+++|+.... ...+.+..|+.+++.+.... +.
T Consensus 5 ~~~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~-~g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP 80 (322)
T 2ppq_A 5 TDITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTT-KD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCP 80 (322)
T ss_dssp CCCCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEES-SC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCC
T ss_pred ccCCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeC-Cc-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCC
Confidence 346677777777777652 34667888999998874 34 6889988642 12345667888887773222 33
Q ss_pred eeeecccccc-ccCCceEEEEEeccCCCChhcc--------------cccCCC--CCCCcccccccCHHHHHH-------
Q 045798 745 KVITSCSSID-FQGNDFKAIVYEYMPNGSLEKW--------------LHPHAV--PKRDKEIEIKLTLLQRIS------- 800 (1008)
Q Consensus 745 ~~~~~~~~~~-~~~~~~~~lv~e~~~~gsL~~~--------------l~~~~~--~~~~~~~~~~l~~~~~~~------- 800 (1008)
+++....... ....+..++||+|++|..+... ++.... ............|.....
T Consensus 81 ~~~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~ 160 (322)
T 2ppq_A 81 LPLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERAD 160 (322)
T ss_dssp CBCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGG
T ss_pred cccCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHH
Confidence 3332210000 0123457899999988665321 111000 000000000001111000
Q ss_pred -----HHHHHHHHHHHHhhC----CCCCceeccCCCCCeeecCCCCeEEcccCccc
Q 045798 801 -----IAIDVASALDYLHHH----CQEPILHCDLKPSNILLDNDLSGHIGDFGLAR 847 (1008)
Q Consensus 801 -----i~~qi~~~L~~LH~~----~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~ 847 (1008)
+...+...++++++. .+.+++|+|+.+.||+++++..+.++||+.+.
T Consensus 161 ~~~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 161 EVEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp GTSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhhhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 011234445555532 23479999999999999987656899999875
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.18 E-value=0.0012 Score=74.69 Aligned_cols=79 Identities=8% Similarity=0.028 Sum_probs=49.5
Q ss_pred CCceeccCCCCCeeecCCCCeEEcccCcccccccccCccccccccccccccccCccccCCC---CCCcccchhhHHHHHH
Q 045798 818 EPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGS---EVSTNGDVYSYGILLL 894 (1008)
Q Consensus 818 ~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDvwslG~vl~ 894 (1008)
..++|||++|.||+++.++ ++++||+.+..-....+..... ..-...|.+|+..... ......++.+.+..+|
T Consensus 232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (420)
T 2pyw_A 232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYL---GNLILAFFAQDGHATQENDRKEYKQWILRTIEQTW 307 (420)
T ss_dssp CEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHH---HHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHH
T ss_pred CeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHH---HHHHHHHHhcccccccccchHHHHHHHHHHHHHHH
Confidence 5899999999999998876 9999999997543222111100 0012346666654311 1122355668888888
Q ss_pred HHHhCC
Q 045798 895 EMVTAK 900 (1008)
Q Consensus 895 elltG~ 900 (1008)
+.+++.
T Consensus 308 ~~y~~~ 313 (420)
T 2pyw_A 308 NLFNKR 313 (420)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 887754
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.10 E-value=0.0019 Score=70.27 Aligned_cols=99 Identities=8% Similarity=0.054 Sum_probs=60.6
Q ss_pred CCCCCHHHHHHHhcCCCC-----CceEeeccCeeEEEEEEcCCCeEEEEEEeccccchhhHHHHHHHHHHhhcCCC--Cc
Q 045798 671 LPKMSYKSLLKATNGFSS-----THLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHR--NL 743 (1008)
Q Consensus 671 ~~~~~~~~~~~~~~~y~~-----~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--ni 743 (1008)
....+.+.+......|.+ ++.++ |....||++... +|+.+++|+..... .....+..|..+++.+... .+
T Consensus 8 ~~~l~~~~i~~~l~~~g~~~~~~~~~l~-g~~n~~y~v~~~-~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~v 84 (328)
T 1zyl_A 8 FQTLHPDTIMDALFEHGIRVDSGLTPLN-SYENRVYQFQDE-DRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPV 84 (328)
T ss_dssp CCCCCHHHHHHHHHHTTCCCCSCCEEEC-CSSSEEEEECCT-TCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSB
T ss_pred CCCCCHHHHHHHHHHcCCCCCceEEeec-CcccceEEEEcC-CCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCee
Confidence 455666666666555533 34576 888899987763 56789999986331 2345677788888877322 23
Q ss_pred eeeeeccccc-cccCCceEEEEEeccCCCCh
Q 045798 744 VKVITSCSSI-DFQGNDFKAIVYEYMPNGSL 773 (1008)
Q Consensus 744 v~~~~~~~~~-~~~~~~~~~lv~e~~~~gsL 773 (1008)
++++.. ... -...++..++|||+++|..+
T Consensus 85 p~~~~~-~g~~~~~~~g~~~~l~~~i~G~~~ 114 (328)
T 1zyl_A 85 AAPVAF-NGQTLLNHQGFYFAVFPSVGGRQF 114 (328)
T ss_dssp CCCCCB-TTBSCEEETTEEEEEEECCCCEEC
T ss_pred cceeec-CCcEEEEECCEEEEEEEecCCCCC
Confidence 444432 100 01124567899999987554
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.96 E-value=0.0017 Score=69.69 Aligned_cols=73 Identities=11% Similarity=0.067 Sum_probs=45.5
Q ss_pred CCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccchhhHHHHHHHHHHhhcCCCCc-eeeeeccccccccCCceEEEEE
Q 045798 687 SSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNL-VKVITSCSSIDFQGNDFKAIVY 765 (1008)
Q Consensus 687 ~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~~~~~~lv~ 765 (1008)
.-++.|+.|....+|++ ..+++|+....... .....+|+.+++.+....+ .++++.+ ++..++|+
T Consensus 21 ~~i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~~-------~~~~~~v~ 86 (301)
T 3dxq_A 21 TGPLERLGGLTNLVFRA------GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHVD-------PATGVMVT 86 (301)
T ss_dssp CSCEEEESCSSEEEEEE------TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEEC-------TTTCCEEE
T ss_pred cceeEcCCcccccccee------eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEEE-------CCCCEEEE
Confidence 33788999999999998 45889987643221 1234568887777732222 4555542 22246899
Q ss_pred ecc-CCCCh
Q 045798 766 EYM-PNGSL 773 (1008)
Q Consensus 766 e~~-~~gsL 773 (1008)
||+ ++.++
T Consensus 87 e~i~~g~~l 95 (301)
T 3dxq_A 87 RYIAGAQTM 95 (301)
T ss_dssp ECCTTCEEC
T ss_pred eecCCCccC
Confidence 999 66555
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.88 E-value=0.0022 Score=70.62 Aligned_cols=144 Identities=15% Similarity=0.157 Sum_probs=83.7
Q ss_pred CceEeeccCeeEEEEEEcC-------CCeEEEEEEeccccchhhHHHHHHHHHHhhcC-CCCceeeeeccccccccCCce
Q 045798 689 THLIGVGSFGCVYKGALDE-------DGIVVAIKVINLQCEGASKSFMAECKALKNIR-HRNLVKVITSCSSIDFQGNDF 760 (1008)
Q Consensus 689 ~~~lg~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~ 760 (1008)
++.+..|-...+|++.... +++.|++|+.... ........+|.++++.+. +.-..++++.+. +
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~-----~--- 125 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFP-----E--- 125 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEET-----T---
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcC-----C---
Confidence 4668778889999988742 3578999986432 223456678999998883 333356666532 2
Q ss_pred EEEEEeccCCCChhcc-c----------------ccCCCCCCCccccccc--CHHHHHHHHHHHHH--------------
Q 045798 761 KAIVYEYMPNGSLEKW-L----------------HPHAVPKRDKEIEIKL--TLLQRISIAIDVAS-------------- 807 (1008)
Q Consensus 761 ~~lv~e~~~~gsL~~~-l----------------~~~~~~~~~~~~~~~l--~~~~~~~i~~qi~~-------------- 807 (1008)
.+||||++|.++..- + +....+ ..... -+.++.++..++..
T Consensus 126 -g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~-----~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~ 199 (379)
T 3feg_A 126 -GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMP-----FTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEM 199 (379)
T ss_dssp -EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCS-----SCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHH
T ss_pred -ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCC-----CCCCcccHHHHHHHHHHHHHhccCcccchhhhhhh
Confidence 289999988665421 0 111000 00011 24455555544422
Q ss_pred -----HHHHHh----hC-CCCCceeccCCCCCeeecCC----CCeEEcccCccc
Q 045798 808 -----ALDYLH----HH-CQEPILHCDLKPSNILLDND----LSGHIGDFGLAR 847 (1008)
Q Consensus 808 -----~L~~LH----~~-~~~~ivH~Dlkp~NIll~~~----~~~kL~Dfg~a~ 847 (1008)
.++.|. .. .+..++|+|+.+.||+++.+ +.+.++||..|.
T Consensus 200 ~~l~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 200 YSLKDEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp TTHHHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 223332 21 13468999999999999876 789999999886
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.82 E-value=0.0045 Score=70.10 Aligned_cols=76 Identities=16% Similarity=0.081 Sum_probs=48.9
Q ss_pred CceEeeccCeeEEEEEEcCCCeEEEEEEeccccchhhHHHHHHHHHHhhcCCCCc-eeeeeccccccccCCceEEEEEec
Q 045798 689 THLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNL-VKVITSCSSIDFQGNDFKAIVYEY 767 (1008)
Q Consensus 689 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~~~~~~lv~e~ 767 (1008)
++.|+.|-...+|++.....+..|++|+........ -+..+|..+++.+...++ .++++++ . + ..||||
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~-idR~~E~~vl~~L~~~gl~P~ll~~~-----~-~---G~v~e~ 182 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEI-INREREKKISCILYNKNIAKKIYVFF-----T-N---GRIEEF 182 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSC-SCHHHHHHHHHHHTTSSSBCCEEEEE-----T-T---EEEEEC
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhh-cCHHHHHHHHHHHHhcCCCCCEEEEe-----C-C---eEEEEe
Confidence 467888999999999885335889999875432211 123689999998854444 4566653 1 1 359999
Q ss_pred cCCCChh
Q 045798 768 MPNGSLE 774 (1008)
Q Consensus 768 ~~~gsL~ 774 (1008)
++|.++.
T Consensus 183 I~G~~l~ 189 (458)
T 2qg7_A 183 MDGYALS 189 (458)
T ss_dssp CCSEECC
T ss_pred eCCccCC
Confidence 9875553
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.78 E-value=0.0028 Score=71.43 Aligned_cols=74 Identities=20% Similarity=0.222 Sum_probs=49.8
Q ss_pred CceEeeccCeeEEEEEEcC-------CCeEEEEEEeccccchhhHHHHHHHHHHhhcCCCC-ceeeeeccccccccCCce
Q 045798 689 THLIGVGSFGCVYKGALDE-------DGIVVAIKVINLQCEGASKSFMAECKALKNIRHRN-LVKVITSCSSIDFQGNDF 760 (1008)
Q Consensus 689 ~~~lg~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~~~~~~~~~~~~~~~~ 760 (1008)
++.|+.|....||++.... +++.|++|+.... ...+.+.+|..+++.+...+ ..++++.+ .+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~-----~~--- 147 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIF-----SG--- 147 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEE-----TT---
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEe-----CC---
Confidence 4678889899999998742 2578999998432 11245668999998884333 35666652 21
Q ss_pred EEEEEeccCCCCh
Q 045798 761 KAIVYEYMPNGSL 773 (1008)
Q Consensus 761 ~~lv~e~~~~gsL 773 (1008)
.+|+||++|.++
T Consensus 148 -g~v~e~l~G~~l 159 (429)
T 1nw1_A 148 -GRLEEYIPSRPL 159 (429)
T ss_dssp -EEEECCCCEEEC
T ss_pred -CEEEEEeCCccc
Confidence 389999986554
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.77 E-value=0.0027 Score=69.12 Aligned_cols=32 Identities=22% Similarity=0.267 Sum_probs=27.7
Q ss_pred CCCceeccCCCCCeeecCC----CCeEEcccCcccc
Q 045798 817 QEPILHCDLKPSNILLDND----LSGHIGDFGLARF 848 (1008)
Q Consensus 817 ~~~ivH~Dlkp~NIll~~~----~~~kL~Dfg~a~~ 848 (1008)
+..++|||+.+.||+++.+ +.+.++||+.+..
T Consensus 182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 3579999999999999874 6789999998864
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=96.58 E-value=0.00023 Score=69.74 Aligned_cols=41 Identities=17% Similarity=0.225 Sum_probs=20.0
Q ss_pred cCCccCCeeeecCC-CCCC----CCCccccCCCCCCEEEccCCCCC
Q 045798 75 GNLSFLREINLSNN-TIQG----EIPPEFGRLFRLEALFLSNNSLV 115 (1008)
Q Consensus 75 ~~l~~L~~L~L~~n-~~~~----~~p~~~~~l~~L~~L~Ls~n~l~ 115 (1008)
..-+.|++|+|++| .|.. .+-+.+..-..|++|+|++|+|.
T Consensus 38 ~~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~ig 83 (197)
T 1pgv_A 38 EDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAIS 83 (197)
T ss_dssp TTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCB
T ss_pred hcCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCC
Confidence 34455666666553 4432 12233444455555555555555
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=96.55 E-value=0.00034 Score=68.55 Aligned_cols=40 Identities=20% Similarity=0.234 Sum_probs=18.7
Q ss_pred CCCCCcEEEecCC-cccc----cCCccccCCCCcceecccccccc
Q 045798 196 QLKQLKILAIGGN-NLSG----PIPPSIYNLSFLVVFSVSHNQIH 235 (1008)
Q Consensus 196 ~l~~L~~L~L~~n-~l~~----~~~~~~~~l~~L~~L~ls~N~l~ 235 (1008)
.-+.|+.|+|++| +|.. .+.+++..-+.|+.|+|++|+|.
T Consensus 39 ~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~ig 83 (197)
T 1pgv_A 39 DDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAIS 83 (197)
T ss_dssp TCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCB
T ss_pred cCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCC
Confidence 3445666666653 5432 12233344444555555555443
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.40 E-value=0.0028 Score=57.98 Aligned_cols=56 Identities=21% Similarity=0.373 Sum_probs=36.2
Q ss_pred cccccccccc-CCCCcccccccccceeeccCcccccchhhhhhccccccEEecCCCccc
Q 045798 499 SFDVSNNDLS-GEIPIELGHCSSLEEIYLAGNLFHGSIPSFFNALKGVQKIDLSRNNLS 556 (1008)
Q Consensus 499 ~Ldls~N~l~-~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~ 556 (1008)
.+|-+++.++ ..+|..+. .+|++|+|++|+|+...+..|..+++|+.|+|++|.+.
T Consensus 12 ~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR 68 (130)
T ss_dssp EEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred EEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence 4566666664 24554432 45777777777777555566777777777777777665
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.33 E-value=0.011 Score=64.40 Aligned_cols=31 Identities=26% Similarity=0.318 Sum_probs=27.7
Q ss_pred CCceeccCCCCCeeecCCCCeEEcccCcccc
Q 045798 818 EPILHCDLKPSNILLDNDLSGHIGDFGLARF 848 (1008)
Q Consensus 818 ~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~ 848 (1008)
..++|+|+.+.||++++++.+.++||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 4799999999999999888899999988764
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.33 E-value=0.0075 Score=66.65 Aligned_cols=75 Identities=12% Similarity=0.166 Sum_probs=44.7
Q ss_pred CceEeeccCeeEEEEEEcC--------CCeEEEEEEeccccchhhHHHHHHHHHHhhcCCCC-ceeeeeccccccccCCc
Q 045798 689 THLIGVGSFGCVYKGALDE--------DGIVVAIKVINLQCEGASKSFMAECKALKNIRHRN-LVKVITSCSSIDFQGND 759 (1008)
Q Consensus 689 ~~~lg~G~~g~Vy~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~~~~~~~~~~~~~~~ 759 (1008)
.+.++.|....+|++.... .++.+++|+...... .......|.++++.+...+ +.++++.. .
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~~~~E~~~l~~L~~~g~~P~~~~~~-----~--- 108 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD-ELYNTISEFEVYKTMSKYKIAPQLLNTF-----N--- 108 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG-GTSCHHHHHHHHHHHHHTTSSCCEEEEE-----T---
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc-ceecHHHHHHHHHHHHhcCCCCceEEec-----C---
Confidence 3567888889999998742 126889998754322 1123467888888774323 44565541 1
Q ss_pred eEEEEEeccCCCCh
Q 045798 760 FKAIVYEYMPNGSL 773 (1008)
Q Consensus 760 ~~~lv~e~~~~gsL 773 (1008)
.++||||++|..+
T Consensus 109 -~~~v~e~i~G~~l 121 (369)
T 3c5i_A 109 -GGRIEEWLYGDPL 121 (369)
T ss_dssp -TEEEEECCCSEEC
T ss_pred -CcEEEEEecCCcC
Confidence 2689999987554
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.13 E-value=0.0059 Score=55.82 Aligned_cols=56 Identities=23% Similarity=0.327 Sum_probs=34.2
Q ss_pred eeecccccCC-CCCCCCCccccccchhhcccccCCCCCCccccCCCCCcEEEecCCccc
Q 045798 154 DLSLAKNKLT-GGIPPFLGNLTSLEVLSLAGNSFGRNIPDSLGQLKQLKILAIGGNNLS 211 (1008)
Q Consensus 154 ~L~L~~n~l~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~ 211 (1008)
.++.+++.++ ..+|..+. ++|++|+|++|+|+...++.|..+++|+.|+|++|.+.
T Consensus 12 ~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR 68 (130)
T ss_dssp EEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred EEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence 4566666664 24454433 35666677777666666666666777777777776654
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=95.94 E-value=0.023 Score=55.84 Aligned_cols=103 Identities=16% Similarity=0.078 Sum_probs=65.8
Q ss_pred CChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEcccCcccccc
Q 045798 771 GSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQ 850 (1008)
Q Consensus 771 gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~ 850 (1008)
.+|.+.+...+ .+++++++|.++.|.+.+|.-+-.. +.-..+=+.|..|++..+|.+...+ +.+.
T Consensus 33 vSL~eIL~~~~---------~PlsEEqaWALc~Qc~~~L~~~~~~--~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~--- 97 (229)
T 2yle_A 33 LSLEEILRLYN---------QPINEEQAWAVCYQCCGSLRAAARR--RQPRHRVRSAAQIRVWRDGAVTLAP-AADD--- 97 (229)
T ss_dssp EEHHHHHHHHT---------SCCCHHHHHHHHHHHHHHHHHHHHT--TCCCCCCCSGGGEEEETTSCEEECC-C------
T ss_pred ccHHHHHHHcC---------CCcCHHHHHHHHHHHHHHHHhhhhc--ccCCceecCCcceEEecCCceeccc-cccc---
Confidence 36777776543 2899999999999999998776221 0111233456889999999988764 1111
Q ss_pred cccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCC
Q 045798 851 EVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKP 902 (1008)
Q Consensus 851 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~p 902 (1008)
.....+.|||... ...+.+.=|||+|+++|..+--..|
T Consensus 98 -------------~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 98 -------------AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp ----------------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred -------------ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 0223466888753 3456788999999999999875554
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=94.58 E-value=0.059 Score=60.04 Aligned_cols=75 Identities=8% Similarity=0.084 Sum_probs=48.8
Q ss_pred CceEeeccCeeEEEEEEcCC-------CeEEEEEEeccccchhhHHHHHHHHHHhhcC-CCCceeeeeccccccccCCce
Q 045798 689 THLIGVGSFGCVYKGALDED-------GIVVAIKVINLQCEGASKSFMAECKALKNIR-HRNLVKVITSCSSIDFQGNDF 760 (1008)
Q Consensus 689 ~~~lg~G~~g~Vy~~~~~~~-------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~ 760 (1008)
++.+..|-...+|+...... ++.|++|+.....+ ..-+..+|.++++.+. +.-..++++.+ .
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~-~~idR~~E~~~l~~L~~~gi~P~l~~~~-----~---- 144 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVG-KFYDSKVELDVFRYLSNINIAPNIIADF-----P---- 144 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEE-----T----
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcc-hhcCHHHHHHHHHHHHhcCCCCCEEEEc-----C----
Confidence 46677788899999987421 57899998754322 1223467888888873 32244555432 1
Q ss_pred EEEEEeccCCCCh
Q 045798 761 KAIVYEYMPNGSL 773 (1008)
Q Consensus 761 ~~lv~e~~~~gsL 773 (1008)
.+.||||++|..|
T Consensus 145 ~~~I~efI~G~~l 157 (424)
T 3mes_A 145 EGRIEEFIDGEPL 157 (424)
T ss_dssp TEEEEECCCSEEC
T ss_pred CCEEEEEeCCccC
Confidence 2689999988664
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=90.21 E-value=0.12 Score=57.39 Aligned_cols=28 Identities=29% Similarity=0.345 Sum_probs=24.3
Q ss_pred ceeccCCCCCeee------cCCCCeEEcccCccc
Q 045798 820 ILHCDLKPSNILL------DNDLSGHIGDFGLAR 847 (1008)
Q Consensus 820 ivH~Dlkp~NIll------~~~~~~kL~Dfg~a~ 847 (1008)
++|+|+.+.||++ +++..++++||.+|.
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~ 279 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS 279 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence 5799999999999 456779999999886
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 1008 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-57 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-53 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 7e-52 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 7e-51 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-50 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 9e-49 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-48 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-48 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-48 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 6e-48 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-47 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 3e-47 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-46 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 3e-46 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 3e-46 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 6e-46 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 6e-46 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 6e-46 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-45 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-45 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 3e-45 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 4e-45 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-44 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 4e-44 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-43 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 3e-43 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 5e-43 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 8e-43 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-42 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-42 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-41 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 4e-41 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 3e-40 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-39 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 3e-39 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 4e-38 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-37 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 3e-37 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 3e-37 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 4e-36 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-35 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-35 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 3e-35 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 6e-35 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-34 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 1e-34 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 7e-34 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-33 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-33 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-32 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 3e-31 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 5e-31 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 5e-31 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-30 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-30 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-30 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-29 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 6e-29 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 1e-28 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 3e-28 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 8e-28 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-27 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 5e-26 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 1e-17 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 3e-16 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 3e-15 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 1e-09 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 4e-08 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 6e-05 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 6e-04 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 7e-25 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-24 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 6e-20 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 8e-12 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-09 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 6e-09 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 3e-20 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 6e-20 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 1e-17 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 8e-17 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 3e-11 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 1e-05 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 4e-20 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 5e-15 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 1e-14 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 7e-14 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 2e-11 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 6e-18 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 3e-11 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 1e-09 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 6e-08 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 8e-07 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 1e-04 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-08 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-08 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 1e-07 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-07 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 2e-08 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 8e-07 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 3e-06 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 2e-05 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 6e-05 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 8e-05 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 0.001 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-08 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 8e-08 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 1e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 9e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 8e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 5e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 6e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 6e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.001 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.001 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.001 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.001 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.003 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 5e-06 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 6e-05 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 1e-05 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 1e-05 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 3e-05 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 3e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.001 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.002 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 2e-05 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 2e-05 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 2e-05 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 4e-05 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 2e-04 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 3e-04 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 0.003 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 3e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.002 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.002 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.004 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (501), Expect = 2e-57
Identities = 80/308 (25%), Positives = 126/308 (40%), Gaps = 55/308 (17%)
Query: 690 HLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGAS--KSFMAECKALKNIRHRNLVKVI 747
IG GSFG VYKG D VA+K++N+ ++F E L+ RH N++ +
Sbjct: 14 QRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 70
Query: 748 TSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVAS 807
+ AIV ++ SL LH IE K +++ I IA A
Sbjct: 71 ------GYSTAPQLAIVTQWCEGSSLYHHLH---------IIETKFEMIKLIDIARQTAQ 115
Query: 808 ALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTI 867
+DYLH I+H DLK +NI L DL+ IGDFGLA S S + G+I
Sbjct: 116 GMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQ--LSGSI 170
Query: 868 GYTAPEYGLGSE---VSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMALPNQ 924
+ APE + S DVY++GI+L E++T + P +
Sbjct: 171 LWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP----YSN--------------- 211
Query: 925 VMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNV 984
+ N ++I+ + R C +M ++ C + +R +
Sbjct: 212 --------INNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQI 263
Query: 985 VHELQSVK 992
+ ++ +
Sbjct: 264 LASIELLA 271
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 186 bits (473), Expect = 2e-53
Identities = 70/331 (21%), Positives = 142/331 (42%), Gaps = 62/331 (18%)
Query: 675 SYKSLLKATNGFSST---------HLIGVGSFGCVYKGALDEDG---IVVAIKVINLQ-C 721
+++ +A F+ +IG G FG V G L G I VAIK +
Sbjct: 8 TFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYT 67
Query: 722 EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHA 781
E + F++E + H N++ + + + I+ E+M NGSL+ +L +
Sbjct: 68 EKQRRDFLSEASIMGQFDHPNVIHLEGVVTK-----STPVMIITEFMENGSLDSFLRQND 122
Query: 782 VPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIG 841
T++Q + + +A+ + YL +H DL NIL++++L +
Sbjct: 123 GQF---------TVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVS 170
Query: 842 DFGLARF-HQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAK 900
DFGL+RF + S+ T +S++G K I +TAPE + ++ DV+SYGI++ E+++
Sbjct: 171 DFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYG 230
Query: 901 KPTDVMFEGDLNLHNFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECL 960
+ + +++++ + ++ R+ ++C
Sbjct: 231 ER---PYWDM------------------------TNQDVINAIEQDYRLP----PPMDCP 259
Query: 961 ISMVKIGVACSMESPQDRMNMTNVVHELQSV 991
++ ++ + C + R +V+ L +
Sbjct: 260 SALHQLMLDCWQKDRNHRPKFGQIVNTLDKM 290
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (462), Expect = 7e-52
Identities = 72/313 (23%), Positives = 118/313 (37%), Gaps = 37/313 (11%)
Query: 692 IGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSCS 751
IG G FG V++G G VA+K+ + + E S AE +RH N++ I + +
Sbjct: 11 IGKGRFGEVWRGKWR--GEEVAVKIFSSR-EERSWFREAEIYQTVMLRHENILGFIAADN 67
Query: 752 SIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDY 811
+ +V +Y +GSL +L+ + +T+ I +A+ AS L +
Sbjct: 68 KDNGTWTQL-WLVSDYHEHGSLFDYLNRY-----------TVTVEGMIKLALSTASGLAH 115
Query: 812 LHHHC-----QEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGT 866
LH + I H DLK NIL+ + + I D GLA H +++ + GT
Sbjct: 116 LHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGT 175
Query: 867 IGYTAPEYGLGS------EVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMA 920
Y APE S E D+Y+ G++ E+ + + L ++
Sbjct: 176 KRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235
Query: 921 LPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMN 980
+ M V + I C E L M KI C + R+
Sbjct: 236 PSVEEMRKVVCEQKLRPNIPNRWQSC-----------EALRVMAKIMRECWYANGAARLT 284
Query: 981 MTNVVHELQSVKN 993
+ L +
Sbjct: 285 ALRIKKTLSQLSQ 297
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (456), Expect = 7e-51
Identities = 57/222 (25%), Positives = 98/222 (44%), Gaps = 24/222 (10%)
Query: 682 ATNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQ-CEGASKSFMAECKALKNIRH 740
+ F +G G+ G V+K + G+V+A K+I+L+ + E + L
Sbjct: 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 63
Query: 741 RNLVKVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRIS 800
+V + S + +I E+M GSL++ L ++
Sbjct: 64 PYIVGFYGAFYS-----DGEISICMEHMDGGSLDQVLKKAG----------RIPEQILGK 108
Query: 801 IAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSS 860
++I V L YL I+H D+KPSNIL+++ + DFG++ + +S +S
Sbjct: 109 VSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQ---LIDSMANSF 163
Query: 861 VGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKP 902
VG T Y +PE G+ S D++S G+ L+EM + P
Sbjct: 164 VG---TRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 202
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (449), Expect = 2e-50
Identities = 76/300 (25%), Positives = 131/300 (43%), Gaps = 53/300 (17%)
Query: 690 HLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITS 749
+G G FG V+ G VA+K + Q + +F+AE +K ++H+ LV++
Sbjct: 19 ERLGAGQFGEVWMG-YYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAV 76
Query: 750 CSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASAL 809
+ + I+ EYM NGSL +L + IKLT+ + + +A +A +
Sbjct: 77 VT------QEPIYIITEYMENGSLVDFLKTPS--------GIKLTINKLLDMAAQIAEGM 122
Query: 810 DYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGY 869
++ +H DL+ +NIL+ + LS I DFGLAR + ++ ++ G K I +
Sbjct: 123 AFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARL---IEDNEYTAREGAKFPIKW 176
Query: 870 TAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMALPNQVMDIV 929
TAPE + DV+S+GILL E+VT + + G
Sbjct: 177 TAPEAINYGTFTIKSDVWSFGILLTEIVTHGRI---PYPGM------------------- 214
Query: 930 DPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHELQ 989
+ E++ + ++ RM N C + ++ C E P+DR + L+
Sbjct: 215 -----TNPEVIQNLERGYRMVRPDN----CPEELYQLMRLCWKERPEDRPTFDYLRSVLE 265
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (437), Expect = 9e-49
Identities = 60/302 (19%), Positives = 117/302 (38%), Gaps = 53/302 (17%)
Query: 692 IGVGSFGCVYKGAL--DEDGIVVAIKVINLQ-CEGASKSFMAECKALKNIRHRNLVKVIT 748
+G G+FG V +G + I VAIKV+ + ++ M E + + + + +V++I
Sbjct: 17 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 76
Query: 749 SCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASA 808
C + +V E G L K+L ++ + + V+
Sbjct: 77 VCQAEAL------MLVMEMAGGGPLHKFLVGK---------REEIPVSNVAELLHQVSMG 121
Query: 809 LDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIG 868
+ YL +H DL N+LL N I DFGL++ +S ++ K +
Sbjct: 122 MKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGA-DDSYYTARSAGKWPLK 177
Query: 869 YTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMALPNQVMDI 928
+ APE + S+ DV+SYG+ + E ++ + ++
Sbjct: 178 WYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKP---YKKM------------------ 216
Query: 929 VDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHEL 988
E++A ++ +RM+ EC + + C + +DR + V +
Sbjct: 217 ------KGPEVMAFIEQGKRMEC----PPECPPELYALMSDCWIYKWEDRPDFLTVEQRM 266
Query: 989 QS 990
++
Sbjct: 267 RA 268
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (434), Expect = 2e-48
Identities = 70/304 (23%), Positives = 115/304 (37%), Gaps = 57/304 (18%)
Query: 690 HLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITS 749
IG G FG V G D G VA+K I + +++F+AE + +RH NLV+++
Sbjct: 13 QTIGKGEFGDVMLG--DYRGNKVAVKCIKN--DATAQAFLAEASVMTQLRHSNLVQLLGV 68
Query: 750 CSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASAL 809
+ IV EYM GSL +L L + ++DV A+
Sbjct: 69 I----VEEKGGLYIVTEYMAKGSLVDYLRSRGRSV--------LGGDCLLKFSLDVCEAM 116
Query: 810 DYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGY 869
+YL + +H DL N+L+ D + DFGL + ++ K + +
Sbjct: 117 EYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT-------GKLPVKW 166
Query: 870 TAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMALPNQVMDIV 929
TAPE + ST DV+S+GILL E+ + + + L + MD
Sbjct: 167 TAPEALREKKFSTKSDVWSFGILLWEIYSFGRV----PYPRIPLKDVVPRVEKGYKMDAP 222
Query: 930 DPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHELQ 989
D C ++ ++ C R + + +L+
Sbjct: 223 D---------------------------GCPPAVYEVMKNCWHLDAAMRPSFLQLREQLE 255
Query: 990 SVKN 993
+K
Sbjct: 256 HIKT 259
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (437), Expect = 2e-48
Identities = 65/310 (20%), Positives = 121/310 (39%), Gaps = 51/310 (16%)
Query: 691 LIGVGSFGCVYKGALDED---GIVVAIKVIN-LQCEGASKSFMAECKALKNIRHRNLVKV 746
+IG G FGCVY G L ++ I A+K +N + G F+ E +K+ H N++ +
Sbjct: 34 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 93
Query: 747 ITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVA 806
+ C + +V YM +G L ++ T+ I + VA
Sbjct: 94 LGIC----LRSEGSPLVVLPYMKHGDLRNFIRNE---------THNPTVKDLIGFGLQVA 140
Query: 807 SALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGT 866
+ + +H DL N +LD + + DFGLAR + ++ + G K
Sbjct: 141 KGM---KFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLP 197
Query: 867 IGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMALPNQVM 926
+ + A E + +T DV+S+G+LL E++T P D+N
Sbjct: 198 VKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP----PYPDVNT------------F 241
Query: 927 DIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986
DI +L+ + C + ++ + C + R + + +V
Sbjct: 242 DITVYLLQGRRLLQPE---------------YCPDPLYEVMLKCWHPKAEMRPSFSELVS 286
Query: 987 ELQSVKNILL 996
+ ++ + +
Sbjct: 287 RISAIFSTFI 296
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (433), Expect = 2e-48
Identities = 64/248 (25%), Positives = 100/248 (40%), Gaps = 24/248 (9%)
Query: 692 IGVGSFGCVYKGALDEDGIVVAIKVINLQ--CEGASKSFMAECKALKNIRHRNLVKVITS 749
IG GSF VYKG E + VA + + + + F E + LK ++H N+V+ S
Sbjct: 17 IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDS 76
Query: 750 CSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASAL 809
S +G +V E M +G+L+ +L + + S + L
Sbjct: 77 WES-TVKGKKCIVLVTELMTSGTLKTYLKRFK----------VMKIKVLRSWCRQILKGL 125
Query: 810 DYLHHHCQEPILHCDLKPSNILLDNDLSGH--IGDFGLARFHQEVSNSTLSSSVGVKGTI 867
+LH PI+H DLK NI + +G IGD GLA + V GT
Sbjct: 126 QFLHTRTP-PIIHRDLKCDNIFITGP-TGSVKIGDLGLATLKRASFAKA------VIGTP 177
Query: 868 GYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMALPNQVMD 927
+ APE + + DVY++G+ +LEM T++ P P
Sbjct: 178 EFMAPEM-YEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDK 236
Query: 928 IVDPILRN 935
+ P ++
Sbjct: 237 VAIPEVKE 244
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (430), Expect = 6e-48
Identities = 60/250 (24%), Positives = 99/250 (39%), Gaps = 19/250 (7%)
Query: 691 LIGVGSFGCVYKGALDEDGIVVAIKVINLQC--EGASKSFMAECKALKNIRHRNLVKVIT 748
IG GS+G K DG ++ K ++ E + ++E L+ ++H N+V+
Sbjct: 11 TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 70
Query: 749 SCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASA 808
+ N IV EY G L + ++ L + + + A
Sbjct: 71 RIID---RTNTTLYIVMEYCEGGDLASVITKGTKERQ------YLDEEFVLRVMTQLTLA 121
Query: 809 LDYLHHH--CQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGT 866
L H +LH DLKP+N+ LD + +GDFGLAR N S + GT
Sbjct: 122 LKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI----LNHDTSFAKAFVGT 177
Query: 867 IGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDL--NLHNFARMALPNQ 924
Y +PE + D++S G LL E+ P + +L + +P +
Sbjct: 178 PYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYR 237
Query: 925 VMDIVDPILR 934
D ++ I+
Sbjct: 238 YSDELNEIIT 247
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (427), Expect = 2e-47
Identities = 74/301 (24%), Positives = 121/301 (40%), Gaps = 53/301 (17%)
Query: 690 HLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITS 749
+G G FG V+ G VAIK + ++F+ E + +K +RH LV++
Sbjct: 23 VKLGQGCFGEVWMG-TWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAV 80
Query: 750 CSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASAL 809
S + IV EYM GSL +L Q + +A +AS +
Sbjct: 81 VS------EEPIYIVTEYMSKGSLLDFLKGETGKYLRLP--------QLVDMAAQIASGM 126
Query: 810 DYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGY 869
Y+ +H DL+ +NIL+ +L + DFGLAR + ++ ++ G K I +
Sbjct: 127 AYVERMN---YVHRDLRAANILVGENLVCKVADFGLARL---IEDNEYTARQGAKFPIKW 180
Query: 870 TAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMALPNQVMDIV 929
TAPE L + DV+S+GILL E+ T + + G
Sbjct: 181 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRV---PYPGM------------------- 218
Query: 930 DPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHELQ 989
+ E+L ++ RM EC S+ + C + P++R + L+
Sbjct: 219 -----VNREVLDQVERGYRMP----CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 269
Query: 990 S 990
Sbjct: 270 D 270
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (429), Expect = 3e-47
Identities = 63/321 (19%), Positives = 117/321 (36%), Gaps = 60/321 (18%)
Query: 690 HLIGVGSFGCVYKGAL-----DEDGIVVAIKVINLQC-EGASKSFMAECKALKNI-RHRN 742
++G G+FG V I VA+K++ + ++ M+E K + + H N
Sbjct: 43 KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHEN 102
Query: 743 LVKVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIK---------- 792
+V ++ +C+ + +++EY G L +L + EIE +
Sbjct: 103 IVNLLGACTL-----SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEED 157
Query: 793 ---LTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFH 849
LT + A VA +++L +H DL N+L+ + I DFGLAR
Sbjct: 158 LNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARDI 214
Query: 850 QEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEG 909
SN + + + + APE + DV+SYGILL E+ +
Sbjct: 215 MSDSNYVVRGNAR--LPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP------ 266
Query: 910 DLNLHNFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVA 969
+ + + ++ + D+ A+ + + I +
Sbjct: 267 ------YPGIPVDANFYKLIQNGFKMDQPFYATEE------------------IYIIMQS 302
Query: 970 CSMESPQDRMNMTNVVHELQS 990
C + R + N+ L
Sbjct: 303 CWAFDSRKRPSFPNLTSFLGC 323
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 166 bits (421), Expect = 2e-46
Identities = 66/306 (21%), Positives = 129/306 (42%), Gaps = 51/306 (16%)
Query: 686 FSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVK 745
+ H +G G +G VY+G + + VA+K + + F+ E +K I+H NLV+
Sbjct: 19 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQ 77
Query: 746 VITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDV 805
++ C+ I+ E+M G+L +L +++ + + +A +
Sbjct: 78 LLGVCTR-----EPPFYIITEFMTYGNLLDYLRECN--------RQEVSAVVLLYMATQI 124
Query: 806 ASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKG 865
+SA++YL +H DL N L+ + + DFGL+R ++ T ++ G K
Sbjct: 125 SSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRL---MTGDTYTAHAGAKF 178
Query: 866 TIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMALPNQV 925
I +TAPE ++ S DV+++G+LL E+ T + G +QV
Sbjct: 179 PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMS---PYPGI----------DLSQV 225
Query: 926 MDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVV 985
++++ R + C + ++ AC +P DR + +
Sbjct: 226 YELLEKDYRMERPE------------------GCPEKVYELMRACWQWNPSDRPSFAEIH 267
Query: 986 HELQSV 991
+++
Sbjct: 268 QAFETM 273
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (418), Expect = 3e-46
Identities = 59/303 (19%), Positives = 107/303 (35%), Gaps = 55/303 (18%)
Query: 692 IGVGSFGCVYKGAL--DEDGIVVAIKVINLQC--EGASKSFMAECKALKNIRHRNLVKVI 747
+G G+FG V KG + VA+K++ + +AE ++ + + +V++I
Sbjct: 15 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 74
Query: 748 TSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVAS 807
C + +V E G L K+L + + I + V+
Sbjct: 75 GICE------AESWMLVMEMAELGPLNKYLQQN----------RHVKDKNIIELVHQVSM 118
Query: 808 ALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTI 867
+ YL +H DL N+LL I DFGL++ + + + K +
Sbjct: 119 GMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRA-DENYYKAQTHGKWPV 174
Query: 868 GYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMALPNQVMD 927
+ APE + S+ DV+S+G+L+ E + + + G
Sbjct: 175 KWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQK---PYRGM----------------- 214
Query: 928 IVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHE 987
E+ A +K RM C M + C ++R V
Sbjct: 215 -------KGSEVTAMLEKGERMGCPAG----CPREMYDLMNLCWTYDVENRPGFAAVELR 263
Query: 988 LQS 990
L++
Sbjct: 264 LRN 266
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (417), Expect = 3e-46
Identities = 68/300 (22%), Positives = 119/300 (39%), Gaps = 53/300 (17%)
Query: 692 IGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSCS 751
IG G FG V+ G + VAIK I + F+ E + + + H LV++ C
Sbjct: 13 IGSGQFGLVHLG-YWLNKDKVAIKTIREGAMS-EEDFIEEAEVMMKLSHPKLVQLYGVCL 70
Query: 752 SIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDY 811
+V+E+M +G L +L + + + +DV + Y
Sbjct: 71 E-----QAPICLVFEFMEHGCLSDYLRTQRGLFAAE---------TLLGMCLDVCEGMAY 116
Query: 812 LHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTA 871
L C ++H DL N L+ + + DFG+ RF V + +SS G K + + +
Sbjct: 117 LEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRF---VLDDQYTSSTGTKFPVKWAS 170
Query: 872 PEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMALPNQVMDIVDP 931
PE S S+ DV+S+G+L+ E+ + K ++V++ +
Sbjct: 171 PEVFSFSRYSSKSDVWSFGVLMWEVFSEGKI-------------PYENRSNSEVVEDIST 217
Query: 932 ILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHELQSV 991
R + LAST + +I C E P+DR + ++ +L +
Sbjct: 218 GFRLYKPRLASTH------------------VYQIMNHCWKERPEDRPAFSRLLRQLAEI 259
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (414), Expect = 6e-46
Identities = 67/300 (22%), Positives = 114/300 (38%), Gaps = 53/300 (17%)
Query: 692 IGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSCS 751
+G G FG V G VAIK+I F+ E K + N+ H LV++ C+
Sbjct: 12 LGTGQFGVVKYG-KWRGQYDVAIKMIKEGSMS-EDEFIEEAKVMMNLSHEKLVQLYGVCT 69
Query: 752 SIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDY 811
I+ EYM NG L +L + Q + + DV A++Y
Sbjct: 70 K-----QRPIFIITEYMANGCLLNYLREM---------RHRFQTQQLLEMCKDVCEAMEY 115
Query: 812 LHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTA 871
L LH DL N L+++ + DFGL+R+ V + +SSVG K + ++
Sbjct: 116 LESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRY---VLDDEYTSSVGSKFPVRWSP 169
Query: 872 PEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMALPNQVMDIVDP 931
PE + S+ S+ D++++G+L+ E+ + K +E
Sbjct: 170 PEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMP---YERF--------------------- 205
Query: 932 ILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHELQSV 991
+ E + R+ + I +C E +R ++ + V
Sbjct: 206 ---TNSETAEHIAQGLRLYRPHL----ASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (418), Expect = 6e-46
Identities = 65/316 (20%), Positives = 113/316 (35%), Gaps = 55/316 (17%)
Query: 690 HLIGVGSFGCVYKGAL-----DEDGIVVAIKVINL-QCEGASKSFMAECKALKNI-RHRN 742
+G G+FG V + + + VA+K++ ++ M+E K L + H N
Sbjct: 29 KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 88
Query: 743 LVKVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPH--------AVPKRDKEIEIKLT 794
+V ++ +C+ ++ EY G L +L P ++ E+ L
Sbjct: 89 IVNLLGACTI-----GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALD 143
Query: 795 LLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSN 854
L +S + VA + +L +H DL NILL + I DFGLAR + SN
Sbjct: 144 LEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKNDSN 200
Query: 855 STLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLH 914
+ + + + APE + DV+SYGI L E+ +
Sbjct: 201 YVVKGNAR--LPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS------------ 246
Query: 915 NFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMES 974
+ M + ++ ++ R A + M I C
Sbjct: 247 PYPGMPVDSKFYKMIKEGFRMLSPEHAPAE------------------MYDIMKTCWDAD 288
Query: 975 PQDRMNMTNVVHELQS 990
P R +V ++
Sbjct: 289 PLKRPTFKQIVQLIEK 304
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (416), Expect = 6e-46
Identities = 71/321 (22%), Positives = 137/321 (42%), Gaps = 54/321 (16%)
Query: 686 FSSTHLIGVGSFGCVYKGALDEDG----IVVAIKVINLQC-EGASKSFMAECKALKNIRH 740
+ +IG G FG VYKG L + VAIK + E F+ E + H
Sbjct: 9 VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSH 68
Query: 741 RNLVKVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRIS 800
N++++ S I+ EYM NG+L+K+L + + ++LQ +
Sbjct: 69 HNIIRLEGVISK-----YKPMMIITEYMENGALDKFLREK---------DGEFSVLQLVG 114
Query: 801 IAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSS 860
+ +A+ + YL + +H DL NIL++++L + DFGL+R ++ +T ++
Sbjct: 115 MLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAT-YTT 170
Query: 861 VGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMA 920
G K I +TAPE + ++ DV+S+GI++ E++T +
Sbjct: 171 SGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS------------ 218
Query: 921 LPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMN 980
++VM ++ R + + ++C ++ ++ + C + R
Sbjct: 219 -NHEVMKAINDGFR------------------LPTPMDCPSAIYQLMMQCWQQERARRPK 259
Query: 981 MTNVVHELQSVKNILLELETV 1001
++V L + L+T+
Sbjct: 260 FADIVSILDKLIRAPDSLKTL 280
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 164 bits (416), Expect = 1e-45
Identities = 61/318 (19%), Positives = 113/318 (35%), Gaps = 61/318 (19%)
Query: 692 IGVGSFGCVYKGAL-----DEDGIVVAIKVINLQC-EGASKSFMAECKALKNIRHRNLVK 745
IG G+FG V++ E +VA+K++ + F E + + N+VK
Sbjct: 21 IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 80
Query: 746 VITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLH--------------PHAVPKRDKEIEI 791
++ C+ +++EYM G L ++L +
Sbjct: 81 LLGVCAV-----GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPP 135
Query: 792 KLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQE 851
L+ +++ IA VA+ + YL +H DL N L+ ++ I DFGL+R
Sbjct: 136 PLSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRNIYS 192
Query: 852 VSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDL 911
+ I + PE + +T DV++YG++L E+ +
Sbjct: 193 ADYYKADGNDA--IPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP-------- 242
Query: 912 NLHNFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACS 971
+ MA + + D + E C + + + C
Sbjct: 243 ----YYGMAHEEVIYYVRDGNILACPE-------------------NCPLELYNLMRLCW 279
Query: 972 MESPQDRMNMTNVVHELQ 989
+ P DR + ++ LQ
Sbjct: 280 SKLPADRPSFCSIHRILQ 297
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (416), Expect = 1e-45
Identities = 78/330 (23%), Positives = 131/330 (39%), Gaps = 57/330 (17%)
Query: 684 NGFSSTHLIGVGSFGCVYKGALDEDG--IVVAIKVIN-LQCEGASKSFMAECKALKNI-R 739
N +IG G+FG V K + +DG + AIK + + + F E + L +
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 740 HRNLVKVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEI------KL 793
H N++ ++ +C + + + EY P+G+L +L V + D I L
Sbjct: 70 HPNIINLLGAC-----EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTL 124
Query: 794 TLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVS 853
+ Q + A DVA +DYL +H DL NIL+ + I DFGL+R +
Sbjct: 125 SSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV 181
Query: 854 NSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNL 913
T+ + + + A E S +TN DV+SYG+LL E+V+ + G
Sbjct: 182 KKTM-----GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT---PYCGM--- 230
Query: 914 HNFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSME 973
E+ + R++ +N C + + C E
Sbjct: 231 ---------------------TCAELYEKLPQGYRLEKPLN----CDDEVYDLMRQCWRE 265
Query: 974 SPQDRMNMTNVVHELQSVKNILLELETVFN 1003
P +R + ++ L +L E +T N
Sbjct: 266 KPYERPSFAQILVSLN---RMLEERKTYVN 292
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (410), Expect = 3e-45
Identities = 56/260 (21%), Positives = 104/260 (40%), Gaps = 40/260 (15%)
Query: 691 LIGVGSFGCVYKGALDEDGIVVAIKVIN---LQCEGASKSFMAECKALKNIRHRNLVKVI 747
+G G FG VY + ++A+KV+ L+ G E + ++RH N++++
Sbjct: 13 PLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 72
Query: 748 TSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVAS 807
++ EY P G++ + L + K + + ++A+
Sbjct: 73 GYFHD-----ATRVYLILEYAPLGTVYRELQKLS----------KFDEQRTATYITELAN 117
Query: 808 ALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTI 867
AL Y H ++H D+KP N+LL + I DFG + S + GT+
Sbjct: 118 ALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPS------SRRTTLCGTL 168
Query: 868 GYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMA------- 920
Y PE G D++S G+L E + K P FE + + R++
Sbjct: 169 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP----FEANTYQETYKRISRVEFTFP 224
Query: 921 --LPNQVMDIVDPILRNDEE 938
+ D++ +L+++
Sbjct: 225 DFVTEGARDLISRLLKHNPS 244
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (409), Expect = 4e-45
Identities = 55/247 (22%), Positives = 93/247 (37%), Gaps = 22/247 (8%)
Query: 691 LIGVGSFGCVYKGALDEDGIVVAIKVINL-QCEGASKSFMAECKALKNIRHRNLVKVITS 749
+G G++G V VA+K++++ + ++ E K + H N+VK
Sbjct: 12 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 71
Query: 750 CSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASAL 809
+ + + + EY G L + P I + + + +
Sbjct: 72 R-----REGNIQYLFLEYCSGGELFDRIEPD----------IGMPEPDAQRFFHQLMAGV 116
Query: 810 DYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGY 869
YLH I H D+KP N+LLD + I DFGLA + + L + + GT+ Y
Sbjct: 117 VYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK--MCGTLPY 171
Query: 870 TAPEYGLGSEVSTNG-DVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMALPNQVMDI 928
APE E DV+S GI+L M+ + P D + ++
Sbjct: 172 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKK 231
Query: 929 VDPILRN 935
+D
Sbjct: 232 IDSAPLA 238
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (406), Expect = 2e-44
Identities = 60/216 (27%), Positives = 94/216 (43%), Gaps = 26/216 (12%)
Query: 692 IGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSCS 751
+G G+FG VYK E ++ A KVI+ + E + +M E L + H N+VK++ +
Sbjct: 20 LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 79
Query: 752 SIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDY 811
+ I+ E+ G+++ + E+E LT Q + AL+Y
Sbjct: 80 Y-----ENNLWILIEFCAGGAVDAVML---------ELERPLTESQIQVVCKQTLDALNY 125
Query: 812 LHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTA 871
LH + I+H DLK NIL D + DFG++ + T+ GT + A
Sbjct: 126 LHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAK----NTRTIQRRDSFIGTPYWMA 178
Query: 872 PEY-----GLGSEVSTNGDVYSYGILLLEMVTAKKP 902
PE DV+S GI L+EM + P
Sbjct: 179 PEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPP 214
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 160 bits (405), Expect = 4e-44
Identities = 62/256 (24%), Positives = 94/256 (36%), Gaps = 33/256 (12%)
Query: 686 FSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINL---QCEGASKSFMAECKALKNIRHRN 742
FS IG GSFG VY + VVAIK ++ Q + + E + L+ +RH N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 743 LVKVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIA 802
++ +V EY + + L ++ ++
Sbjct: 77 TIQYRGCY-----LREHTAWLVMEYCLGSASDLLEVHKK----------PLQEVEIAAVT 121
Query: 803 IDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVG 862
L YLH H ++H D+K NILL +GDFG A ++ +
Sbjct: 122 HGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASI--------MAPANS 170
Query: 863 VKGTIGYTAPEYGLGSEVSTNG---DVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARM 919
GT + APE L + DV+S GI +E+ K P M L++ A+
Sbjct: 171 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-LYHIAQN 229
Query: 920 ALPNQVMDIVDPILRN 935
P RN
Sbjct: 230 ESPALQSGHWSEYFRN 245
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 159 bits (403), Expect = 2e-43
Identities = 55/259 (21%), Positives = 97/259 (37%), Gaps = 33/259 (12%)
Query: 691 LIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSC 750
+G G+FG V++ G A K + E ++ E + + +RH LV + +
Sbjct: 33 ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDA- 91
Query: 751 SSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALD 810
F+ ++ ++YE+M G L + + K++ + + V L
Sbjct: 92 ----FEDDNEMVMIYEFMSGGELFEKVADE---------HNKMSEDEAVEYMRQVCKGLC 138
Query: 811 YLHHHCQEPILHCDLKPSNILLDNDLSGHI--GDFGLARFHQEVSNSTLSSSVGVKGTIG 868
++H + +H DLKP NI+ S + DFGL S GT
Sbjct: 139 HMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK-----QSVKVTTGTAE 190
Query: 869 YTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVM---------FEGDLNLHNFARM 919
+ APE G V D++S G+L +++ P D N+ + A
Sbjct: 191 FAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFS 250
Query: 920 ALPNQVMDIVDPILRNDEE 938
+ D + +L D
Sbjct: 251 GISEDGKDFIRKLLLADPN 269
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (395), Expect = 3e-43
Identities = 70/307 (22%), Positives = 107/307 (34%), Gaps = 55/307 (17%)
Query: 692 IGVGSFGCVYKGALDED---GIVVAIKVIN---LQCEGASKSFMAECKALKNIRHRNLVK 745
+G GSFG V +G D + VA+K + L A F+ E A+ ++ HRNL++
Sbjct: 16 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 746 VITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDV 805
+ + + +V E P GSL L H + L A+ V
Sbjct: 76 LYGVVLTPPMK------MVTELAPLGSLLDRLRKH---------QGHFLLGTLSRYAVQV 120
Query: 806 ASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKG 865
A + YL +H DL N+LL IGDFGL R + + + K
Sbjct: 121 AEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE-HRKV 176
Query: 866 TIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMALPNQV 925
+ APE S D + +G+ L EM T + + G
Sbjct: 177 PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQE---PWIGL-------------NG 220
Query: 926 MDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVV 985
I+ I + E + D C + + V C P+DR +
Sbjct: 221 SQILHKIDKEGERLPRPED--------------CPQDIYNVMVQCWAHKPEDRPTFVALR 266
Query: 986 HELQSVK 992
L +
Sbjct: 267 DFLLEAQ 273
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (396), Expect = 5e-43
Identities = 61/307 (19%), Positives = 116/307 (37%), Gaps = 47/307 (15%)
Query: 690 HLIGVGSFGCVYKGAL-----DEDGIVVAIKVINL-QCEGASKSFMAECKALKNIRHRNL 743
+G GSFG VY+G DE VAIK +N F+ E +K ++
Sbjct: 26 RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 85
Query: 744 VKVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAI 803
V+++ ++ E M G L+ +L + + +L + I +A
Sbjct: 86 VRLLGVV-----SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAG 140
Query: 804 DVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGV 863
++A + YL+ + +H DL N ++ D + IGDFG+ R E
Sbjct: 141 EIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE--TDYYRKGGKG 195
Query: 864 KGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMALPN 923
+ + +PE +T DV+S+G++L E+ T + ++G L+ R +
Sbjct: 196 LLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP---YQG-LSNEQVLRFVMEG 251
Query: 924 QVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTN 983
++D D C + ++ C +P+ R +
Sbjct: 252 GLLDKPD---------------------------NCPDMLFELMRMCWQYNPKMRPSFLE 284
Query: 984 VVHELQS 990
++ ++
Sbjct: 285 IISSIKE 291
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (393), Expect = 8e-43
Identities = 53/215 (24%), Positives = 84/215 (39%), Gaps = 23/215 (10%)
Query: 691 LIGVGSFGCVYKGALDEDGIVVAIKVIN---LQCEGASKSFMAECKALKNIRHRNLVKVI 747
++G GSF V AIK++ + E E + + H VK+
Sbjct: 15 ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY 74
Query: 748 TSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVAS 807
+ FQ ++ Y NG L K++ ++ S
Sbjct: 75 FT-----FQDDEKLYFGLSYAKNGELLKYIRKIG----------SFDETCTRFYTAEIVS 119
Query: 808 ALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTI 867
AL+YLH I+H DLKP NILL+ D+ I DFG A+ S ++S GT
Sbjct: 120 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANS--FVGTA 174
Query: 868 GYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKP 902
Y +PE + D+++ G ++ ++V P
Sbjct: 175 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 209
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (393), Expect = 1e-42
Identities = 53/212 (25%), Positives = 90/212 (42%), Gaps = 23/212 (10%)
Query: 691 LIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSC 750
IG G+ G VY G VAI+ +NLQ + + + E ++ ++ N+V + S
Sbjct: 27 KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86
Query: 751 SSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALD 810
D +V EY+ GSL + + + Q ++ + AL+
Sbjct: 87 -----LVGDELWVVMEYLAGGSLTDVVTETCMDEG-----------QIAAVCRECLQALE 130
Query: 811 YLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYT 870
+LH + ++H D+K NILL D S + DFG + + + GT +
Sbjct: 131 FLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST----MVGTPYWM 183
Query: 871 APEYGLGSEVSTNGDVYSYGILLLEMVTAKKP 902
APE D++S GI+ +EM+ + P
Sbjct: 184 APEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (393), Expect = 2e-42
Identities = 68/320 (21%), Positives = 122/320 (38%), Gaps = 57/320 (17%)
Query: 679 LLKATNGFSSTHLIGVGSFGCVYKGALDEDG----IVVAIKVINL-QCEGASKSFMAECK 733
+LK T F ++G G+FG VYKG +G I VAIK + A+K + E
Sbjct: 5 ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 63
Query: 734 ALKNIRHRNLVKVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKL 793
+ ++ + ++ +++ C + Q ++ + MP G L ++ H + +
Sbjct: 64 VMASVDNPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREH---------KDNI 108
Query: 794 TLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVS 853
++ + +A ++YL ++H DL N+L+ I DFGLA+ +
Sbjct: 109 GSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLG--A 163
Query: 854 NSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNL 913
+ G K I + A E L + DV+SYG+ + E++T ++G
Sbjct: 164 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK---PYDGI--- 217
Query: 914 HNFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSME 973
EI + +K R+ C I + I V C M
Sbjct: 218 ---------------------PASEISSILEKGERLPQPPI----CTIDVYMIMVKCWMI 252
Query: 974 SPQDRMNMTNVVHELQSVKN 993
R ++ E +
Sbjct: 253 DADSRPKFRELIIEFSKMAR 272
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 151 bits (382), Expect = 2e-41
Identities = 66/307 (21%), Positives = 124/307 (40%), Gaps = 48/307 (15%)
Query: 691 LIGVGSFGCVYKGALDEDGIVVAIKVIN---LQCEGASKSFMAECKALKNIRHRNLVKVI 747
++G G V+ VA+KV+ + F E + + H +V V
Sbjct: 14 ILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 73
Query: 748 TSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVAS 807
+ + + IV EY+ +L +H +T + I + D
Sbjct: 74 DTGEA-ETPAGPLPYIVMEYVDGVTLRDIVHTEG----------PMTPKRAIEVIADACQ 122
Query: 808 ALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTI 867
AL++ H + I+H D+KP+NI++ + + DFG+AR + S ++++ + V GT
Sbjct: 123 ALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIAD-SGNSVTQTAAVIGTA 178
Query: 868 GYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMALPNQVMD 927
Y +PE G V DVYS G +L E++T + P F GD +
Sbjct: 179 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP----FTGD-------------SPVS 221
Query: 928 IVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRM-NMTNVVH 986
+ +R D ++ + G+++ L+ ++ ++P++R +
Sbjct: 222 VAYQHVREDPIPPSARHE------GLSADLDAVVLK------ALAKNPENRYQTAAEMRA 269
Query: 987 ELQSVKN 993
+L V N
Sbjct: 270 DLVRVHN 276
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 152 bits (386), Expect = 4e-41
Identities = 47/259 (18%), Positives = 92/259 (35%), Gaps = 33/259 (12%)
Query: 691 LIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSC 750
+G G+FG V++ G V K IN + E + + H L+ + +
Sbjct: 36 ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDA- 94
Query: 751 SSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALD 810
F+ ++ E++ G L + + K++ + I+ L
Sbjct: 95 ----FEDKYEMVLILEFLSGGELFDRIAAE---------DYKMSEAEVINYMRQACEGLK 141
Query: 811 YLHHHCQEPILHCDLKPSNILLDNDLSGHI--GDFGLARFHQEVSNSTLSSSVGVKGTIG 868
++H H I+H D+KP NI+ + + + DFGLA T
Sbjct: 142 HMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD-----EIVKVTTATAE 193
Query: 869 YTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKP---------TDVMFEGDLNLHNFARM 919
+ APE V D+++ G+L +++ P + D A
Sbjct: 194 FAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFS 253
Query: 920 ALPNQVMDIVDPILRNDEE 938
++ + D + +L+ +
Sbjct: 254 SVSPEAKDFIKNLLQKEPR 272
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (373), Expect = 3e-40
Identities = 62/307 (20%), Positives = 116/307 (37%), Gaps = 60/307 (19%)
Query: 691 LIGVGSFGCVYKG---ALDEDGIVVAIKVI-NLQCEGASKSFMAECKALKNIRHRNLVKV 746
IG G FG V++G + + + VAIK N + + F+ E ++ H ++VK+
Sbjct: 14 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73
Query: 747 ITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVA 806
I + + I+ E G L +L L L I A ++
Sbjct: 74 IGVIT------ENPVWIIMELCTLGELRSFLQVRKYS---------LDLASLILYAYQLS 118
Query: 807 SALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGT 866
+AL YL +H D+ N+L+ ++ +GDFGL+R+ + +ST + K
Sbjct: 119 TALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRY---MEDSTYYKASKGKLP 172
Query: 867 IGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMALPNQVM 926
I + APE ++ DV+ +G+ + E++ P Q +
Sbjct: 173 IKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVK-------------------PFQGV 213
Query: 927 DIVDPILRNDEEILASTDKCRRMQ--TGINSRLECLISMVKIGVACSMESPQDRMNMTNV 984
+ +++ + R+ L L++ C P R T +
Sbjct: 214 --------KNNDVIGRIENGERLPMPPNCPPTLYSLMTK------CWAYDPSRRPRFTEL 259
Query: 985 VHELQSV 991
+L ++
Sbjct: 260 KAQLSTI 266
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (369), Expect = 1e-39
Identities = 61/314 (19%), Positives = 104/314 (33%), Gaps = 50/314 (15%)
Query: 690 HLIGVGSFGCVYKGAL-----DEDGIVVAIKVINL-QCEGASKSFMAECKALKNIRHRNL 743
+G G+FG V + VA+K++ ++ M+E K L +I H
Sbjct: 19 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 78
Query: 744 VKVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEI------EIKLTLLQ 797
V + + ++ E+ G+L +L ++ + LTL
Sbjct: 79 VVNLLGAC---TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 135
Query: 798 RISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTL 857
I + VA +++L +H DL NILL I DFGLAR + +
Sbjct: 136 LICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 192
Query: 858 SSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFA 917
+ + + APE + DV+S+G+LL E+ + + G F
Sbjct: 193 KGD--ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS---PYPGVKIDEEFC 247
Query: 918 RMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQD 977
R M D M + + C P
Sbjct: 248 RRLKEGTRMRAPD---------------------------YTTPEMYQTMLDCWHGEPSQ 280
Query: 978 RMNMTNVVHELQSV 991
R + +V L ++
Sbjct: 281 RPTFSELVEHLGNL 294
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (367), Expect = 3e-39
Identities = 65/317 (20%), Positives = 114/317 (35%), Gaps = 56/317 (17%)
Query: 690 HLIGVGSFGCVYKGAL-------DEDGIVVAIKVINLQ-CEGASKSFMAECKALKNI-RH 740
+G G+FG V VA+K++ E ++E + +K I +H
Sbjct: 19 KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 78
Query: 741 RNLVKVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEI------EIKLT 794
+N++ ++ +C+ + ++ EY G+L ++L P + E +L+
Sbjct: 79 KNIINLLGACTQ-----DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLS 133
Query: 795 LLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSN 854
+S A VA ++YL +H DL N+L+ D I DFGLAR
Sbjct: 134 SKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHH--I 188
Query: 855 STLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLH 914
+ + + + APE + DV+S+G+LL E+ T + G
Sbjct: 189 DYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS---PYPG----- 240
Query: 915 NFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMES 974
EE+ + RM N C + + C
Sbjct: 241 -------------------VPVEELFKLLKEGHRMDKPSN----CTNELYMMMRDCWHAV 277
Query: 975 PQDRMNMTNVVHELQSV 991
P R +V +L +
Sbjct: 278 PSQRPTFKQLVEDLDRI 294
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (361), Expect = 4e-38
Identities = 66/323 (20%), Positives = 116/323 (35%), Gaps = 45/323 (13%)
Query: 691 LIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSC 750
+G G FG V++ K + ++ E L RHRN++ + S
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHES- 69
Query: 751 SSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALD 810
F+ + +++E++ + + ++ A L + +S V AL
Sbjct: 70 ----FESMEELVMIFEFISGLDIFERINTSAFE---------LNEREIVSYVHQVCEALQ 116
Query: 811 YLHHHCQEPILHCDLKPSNILLDNDLSGH--IGDFGLARFHQEVSNSTLSSSVGVKGTIG 868
+LH H I H D++P NI+ S I +FG AR + N L +
Sbjct: 117 FLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL-----LFTAPE 168
Query: 869 YTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKP---------TDVMFEGDLNLHNFARM 919
Y APE VST D++S G L+ +++ P + + + A
Sbjct: 169 YYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFK 228
Query: 920 ALPNQVMDIVDPILRND-------EEILAS---TDKCRRMQTGINSRLECLISMVK-IGV 968
+ + MD VD +L + E L K R+ T + L+ I
Sbjct: 229 EISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKIERVSTKVIRTLKHRRYYHTLIKK 288
Query: 969 ACSMESPQDRMNMTNVVHELQSV 991
+M R++ + + V
Sbjct: 289 DLNMVVSAARISCGGAIRSQKGV 311
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 142 bits (358), Expect = 2e-37
Identities = 65/284 (22%), Positives = 106/284 (37%), Gaps = 31/284 (10%)
Query: 684 NGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINL------QCEGASKSFMAECKALKN 737
N FS +IG G FG VY + G + A+K ++ Q E + + +
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 738 IRHRNLVKVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQ 797
+V + + F D + + + M G L L H V
Sbjct: 64 GDCPFIVCMSYA-----FHTPDKLSFILDLMNGGDLHYHLSQHGVFSEA----------D 108
Query: 798 RISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTL 857
A ++ L+++H+ +++ DLKP+NILLD I D GLA +
Sbjct: 109 MRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSK------ 159
Query: 858 SSSVGVKGTIGYTAPEYGL-GSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNF 916
GT GY APE G ++ D +S G +L +++ P D + +
Sbjct: 160 KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR 219
Query: 917 ARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECL 960
+ + ++ D P LR+ E L D RR+ E
Sbjct: 220 MTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVK 263
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 140 bits (354), Expect = 3e-37
Identities = 52/258 (20%), Positives = 88/258 (34%), Gaps = 30/258 (11%)
Query: 691 LIGVGSFGCVYKGALDEDGIVVAIKVINLQ-CEGASKSFMAECKALKNIRHRNLVKVITS 749
++G G+F V +VAIK I + EG S E L I+H N+V +
Sbjct: 16 VLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDI 75
Query: 750 CSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASAL 809
++ ++ + + G L + T + V A+
Sbjct: 76 -----YESGGHLYLIMQLVSGGELFDRIVEKG----------FYTERDASRLIFQVLDAV 120
Query: 810 DYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGY 869
YLH LD D I DFGL++ S LS++ GT GY
Sbjct: 121 KYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP--GSVLSTAC---GTPGY 175
Query: 870 TAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPT---------DVMFEGDLNLHNFARMA 920
APE S D +S G++ ++ P + + + + +
Sbjct: 176 VAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDD 235
Query: 921 LPNQVMDIVDPILRNDEE 938
+ + D + ++ D E
Sbjct: 236 ISDSAKDFIRHLMEKDPE 253
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 139 bits (350), Expect = 3e-37
Identities = 57/288 (19%), Positives = 107/288 (37%), Gaps = 55/288 (19%)
Query: 686 FSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINL---------QCEGASKSFMAECKALK 736
+ ++G G V + A+K+I++ + + ++ + E L+
Sbjct: 5 YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 64
Query: 737 NIR-HRNLVKVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTL 795
+ H N++++ ++ N F +V++ M G L +L + L+
Sbjct: 65 KVSGHPNIIQLKD-----TYETNTFFFLVFDLMKKGELFDYLTEK----------VTLSE 109
Query: 796 LQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNS 855
+ I + + LH I+H DLKP NILLD+D++ + DFG +
Sbjct: 110 KETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL 166
Query: 856 TLSSSVGVKGTIGYTAPEYGLGSEVSTNG------DVYSYGILLLEMVTAKKP------- 902
V GT Y APE S + D++S G+++ ++ P
Sbjct: 167 R-----EVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM 221
Query: 903 --TDVMFEGDLNLHNFARMALPNQVMDIVDPILRND-------EEILA 941
++ G+ + + V D+V L EE LA
Sbjct: 222 LMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (345), Expect = 4e-36
Identities = 61/258 (23%), Positives = 102/258 (39%), Gaps = 31/258 (12%)
Query: 690 HLIGVGSFGCVYKGALDEDGIVVAIKVIN---LQCEGASKSFMAECKAL-KNIRHRNLVK 745
++G GSFG V+ + AIK + + + + M E + L H L
Sbjct: 8 KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 67
Query: 746 VITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDV 805
+ + Q + V EY+ G L + K L + A ++
Sbjct: 68 MFCTF-----QTKENLFFVMEYLNGGDLMYHIQSCH----------KFDLSRATFYAAEI 112
Query: 806 ASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKG 865
L +LH I++ DLK NILLD D I DFG+ + + + + G
Sbjct: 113 ILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENM----LGDAKTNTFCG 165
Query: 866 TIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKP-----TDVMFEGDLNLHNFARMA 920
T Y APE LG + + + D +S+G+LL EM+ + P + +F + F
Sbjct: 166 TPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRW 225
Query: 921 LPNQVMDIVDPILRNDEE 938
L + D++ + + E
Sbjct: 226 LEKEAKDLLVKLFVREPE 243
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (339), Expect = 2e-35
Identities = 73/299 (24%), Positives = 116/299 (38%), Gaps = 29/299 (9%)
Query: 692 IGVGSFGCVYKG-ALDEDGIVVAIKVINLQC--EGASKSFMAE---CKALKNIRHRNLVK 745
IG G++G V+K L G VA+K + +Q EG S + E + L+ H N+V+
Sbjct: 15 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 74
Query: 746 VITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDV 805
+ C+ +V+E++ DK E + + +
Sbjct: 75 LFDVCTVSRTDRETKLTLVFEHVDQDLTTYL---------DKVPEPGVPTETIKDMMFQL 125
Query: 806 ASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKG 865
LD+LH H ++H DLKP NIL+ + + DFGLAR + T V
Sbjct: 126 LRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALT-----SVVV 177
Query: 866 TIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMALPNQV 925
T+ Y APE L S +T D++S G + EM K + D + LP +
Sbjct: 178 TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE 237
Query: 926 MDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNV 984
D L S + T I+ + L+ C +P R++ +
Sbjct: 238 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLL------KCLTFNPAKRISAYSA 290
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (342), Expect = 2e-35
Identities = 63/307 (20%), Positives = 112/307 (36%), Gaps = 22/307 (7%)
Query: 678 SLLKATNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVIN-LQCEGASKSFMAECKALK 736
+ +++ IG G++G V + + + VAIK I+ + + + + E K L
Sbjct: 2 QVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILL 61
Query: 737 NIRHRNLVKVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLL 796
RH N++ + + + + ++ L K L L+
Sbjct: 62 RFRHENIIGINDIIRAPTIEQMK-DVYLVTHLMGADLYKLLKTQ-----------HLSND 109
Query: 797 QRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNST 856
+ L Y+H +LH DLKPSN+LL+ I DFGLAR +
Sbjct: 110 HICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADP-DHDH 165
Query: 857 LSSSVGVKGTIGYTAPEYGLGSEVSTN-GDVYSYGILLLEMVTAKKPTDVMFEGDLNLHN 915
T Y APE L S+ T D++S G +L EM++ + D H
Sbjct: 166 TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI 225
Query: 916 FARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRL-ECLISMVKIGVACSMES 974
+ P+Q L+ +L+ K + + + ++ +
Sbjct: 226 LGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLD---KMLTFN 282
Query: 975 PQDRMNM 981
P R+ +
Sbjct: 283 PHKRIEV 289
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (338), Expect = 3e-35
Identities = 59/234 (25%), Positives = 103/234 (44%), Gaps = 23/234 (9%)
Query: 692 IGVGSFGCVYKGALDEDGIVVAIKVINLQC--EGASKSFMAECKALKNIRHRNLVKVITS 749
IG G+FG V+K + G VA+K + ++ EG + + E K L+ ++H N+V +I
Sbjct: 18 IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 77
Query: 750 CSSIDFQGNDFKA---IVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVA 806
C + N K +V+++ + + +K TL + + +
Sbjct: 78 CRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVL----------VKFTLSEIKRVMQML- 126
Query: 807 SALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGT 866
L+ L++ + ILH D+K +N+L+ D + DFGLAR NS + T
Sbjct: 127 --LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVT 184
Query: 867 IGYTAPEYGLGS-EVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARM 919
+ Y PE LG + D++ G ++ EM T +G+ H A +
Sbjct: 185 LWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPI----MQGNTEQHQLALI 234
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (339), Expect = 6e-35
Identities = 60/237 (25%), Positives = 103/237 (43%), Gaps = 26/237 (10%)
Query: 686 FSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVK 745
++ T +IG GSFG VY+ L + G +VAIK + + E + ++ + H N+V+
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD----KRFKNRELQIMRKLDHCNIVR 77
Query: 746 VITSC-SSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAID 804
+ SS + + + +V +Y+P H + L ++
Sbjct: 78 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-------YSRAKQTLPVIYVKLYMYQ 130
Query: 805 VASALDYLHHHCQEPILHCDLKPSNILLDNDLSGH-IGDFGLARFHQEVSNSTLSSSVGV 863
+ +L Y+H I H D+KP N+LLD D + + DFG A+ V S +
Sbjct: 131 LFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGEPNVSYICS 185
Query: 864 KGTIGYTAPEYGLGSEVSTNG-DVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARM 919
+ Y APE G+ T+ DV+S G +L E++ + F GD + +
Sbjct: 186 R---YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPI----FPGDSGVDQLVEI 235
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 132 bits (334), Expect = 1e-34
Identities = 51/215 (23%), Positives = 87/215 (40%), Gaps = 28/215 (13%)
Query: 691 LIGVGSFGCVYKGALDEDGIVVAIKVIN---LQCEGASKSFMAECKALKNIRHRNLVKVI 747
+G GSFG V+ +G A+KV+ + + E L + H ++++
Sbjct: 11 TLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMW 70
Query: 748 TSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVAS 807
+ Q ++ +Y+ G L L +R K +
Sbjct: 71 GTF-----QDAQQIFMIMDYIEGGELFSLLRKS---QRFPNPVAKFYAAE---------- 112
Query: 808 ALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTI 867
L + + I++ DLKP NILLD + I DFG A++ +V+ + + GT
Sbjct: 113 VCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYT-------LCGTP 165
Query: 868 GYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKP 902
Y APE + + D +S+GIL+ EM+ P
Sbjct: 166 DYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTP 200
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 132 bits (332), Expect = 1e-34
Identities = 57/266 (21%), Positives = 97/266 (36%), Gaps = 26/266 (9%)
Query: 691 LIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSC 750
IG GSFG +Y G G VAIK+ + + E K K ++ + I C
Sbjct: 14 KIGSGSFGDIYLGTDIAAGEEVAIKLECV--KTKHPQLHIESKIYKMMQGGVGIPTIRWC 71
Query: 751 SSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALD 810
D+ +V E + + + K +L + +A + S ++
Sbjct: 72 ----GAEGDYNVMVMELLGPSLEDLFNFCSR----------KFSLKTVLLLADQMISRIE 117
Query: 811 YLHHHCQEPILHCDLKPSNILLDNDLSG---HIGDFGLARFHQEVSNST---LSSSVGVK 864
Y+H +H D+KP N L+ G +I DFGLA+ +++ + +
Sbjct: 118 YIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLT 174
Query: 865 GTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMALPNQ 924
GT Y + LG E S D+ S G +L+ P + + R++
Sbjct: 175 GTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATK-RQKYERISEKKM 233
Query: 925 VMDIVDPILRNDEEILASTDKCRRMQ 950
I E + CR ++
Sbjct: 234 STPIEVLCKGYPSEFATYLNFCRSLR 259
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (327), Expect = 7e-34
Identities = 58/235 (24%), Positives = 97/235 (41%), Gaps = 32/235 (13%)
Query: 691 LIGVGSFGCVYKGALDEDGIVVAIKVINLQC-----EGASKSFMAECKALKNIRHRNLVK 745
+G G F VYK +VAIK I L +G +++ + E K L+ + H N++
Sbjct: 5 FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 64
Query: 746 VITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDV 805
++ + ++V+++M + LT + +
Sbjct: 65 LLDAF-----GHKSNISLVFDFMETDLEVIIKDNS----------LVLTPSHIKAYMLMT 109
Query: 806 ASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKG 865
L+YLH H ILH DLKP+N+LLD + + DFGLA+ S +
Sbjct: 110 LQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSF----GSPNRAYTHQVV 162
Query: 866 TIGYTAPEYGLGSEV-STNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARM 919
T Y APE G+ + D+++ G +L E++ GD +L R+
Sbjct: 163 TRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPF----LPGDSDLDQLTRI 213
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (327), Expect = 1e-33
Identities = 46/251 (18%), Positives = 87/251 (34%), Gaps = 30/251 (11%)
Query: 691 LIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNI-RHRNLVKVITS 749
++G+G G V + A+K++ E + + ++V+++
Sbjct: 19 VLGLGINGKVLQIFNKRTQEKFALKMLQ-----DCPKARREVELHWRASQCPHIVRIVDV 73
Query: 750 CSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASAL 809
++ + G IV E + G L + + T + I + A+
Sbjct: 74 YENL-YAGRKCLLIVMECLDGGELFSRIQ--------DRGDQAFTEREASEIMKSIGEAI 124
Query: 810 DYLHHHCQEPILHCDLKPSNILLD---NDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGT 866
YLH I H D+KP N+L + + DFG A+ +S T
Sbjct: 125 QYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS-----HNSLTTPCYT 176
Query: 867 IGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMALPNQVM 926
Y APE + + D++S G+++ ++ P F + L M ++
Sbjct: 177 PYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP----FYSNHGLAISPGMKTRIRMG 232
Query: 927 DIVDPILRNDE 937
P E
Sbjct: 233 QYEFPNPEWSE 243
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 128 bits (322), Expect = 2e-33
Identities = 44/268 (16%), Positives = 89/268 (33%), Gaps = 28/268 (10%)
Query: 691 LIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSC 750
IG GSFG +++G + VAIK + + + E + K + + +
Sbjct: 12 RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYF 69
Query: 751 SSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALD 810
Q +V + + + K ++ A + + +
Sbjct: 70 ----GQEGLHNVLVIDLLGPSLEDLLDLCGR----------KFSVKTVAMAAKQMLARVQ 115
Query: 811 YLHHHCQEPILHCDLKPSNILLDNDLSGHIG-----DFGLARFHQEVSNSTLS---SSVG 862
+H +++ D+KP N L+ S + DFG+ +F+++
Sbjct: 116 SIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKN 172
Query: 863 VKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMALP 922
+ GT Y + LG E S D+ + G + + + P + N + R+
Sbjct: 173 LSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAAT-NKQKYERIGEK 231
Query: 923 NQVMDIVDPILRNDEEILASTDKCRRMQ 950
Q + + EE R +
Sbjct: 232 KQSTPLRELCAGFPEEFYKYMHYARNLA 259
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (317), Expect = 1e-32
Identities = 49/260 (18%), Positives = 91/260 (35%), Gaps = 42/260 (16%)
Query: 691 LIGVGSFGCVYKGALDEDGIVVAIKVINL------QCEGASKSFMAECKALKNIRHRNLV 744
+G G F V K G+ A K I + + + E LK I+H N++
Sbjct: 17 ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76
Query: 745 KVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAID 804
+ ++ ++ E + G L +L ++ E
Sbjct: 77 TLHEV-----YENKTDVILILELVAGGELFDFLAEKESLTEEEATEF------------- 118
Query: 805 VASALDYLHHHCQEPILHCDLKPSNILLDNDLSG----HIGDFGLARFHQEVSNSTLSSS 860
+ L+ +++ I H DLKP NI+L + I DFGLA +
Sbjct: 119 LKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK---- 174
Query: 861 VGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMA 920
+ GT + APE + D++S G++ +++ P F GD A ++
Sbjct: 175 -NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP----FLGDTKQETLANVS 229
Query: 921 -----LPNQVMDIVDPILRN 935
++ + ++
Sbjct: 230 AVNYEFEDEYFSNTSALAKD 249
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (306), Expect = 3e-31
Identities = 66/237 (27%), Positives = 101/237 (42%), Gaps = 28/237 (11%)
Query: 686 FSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC--EGASKSFMAECKALKNIRHRNL 743
F IG G++G VYK G VVA+K I L EG + + E LK + H N+
Sbjct: 4 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 744 VKVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAI 803
VK++ + +V+E++ + D + L S
Sbjct: 64 VKLLDVI-----HTENKLYLVFEFLHQDLKKFM---------DASALTGIPLPLIKSYLF 109
Query: 804 DVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGV 863
+ L + H H +LH DLKP N+L++ + + + DFGLAR + +
Sbjct: 110 QLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAF----GVPVRTYTHE 162
Query: 864 KGTIGYTAPEYGLGSE-VSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARM 919
T+ Y APE LG + ST D++S G + EMVT + F GD + R+
Sbjct: 163 VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRAL----FPGDSEIDQLFRI 215
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (304), Expect = 5e-31
Identities = 55/261 (21%), Positives = 86/261 (32%), Gaps = 40/261 (15%)
Query: 691 LIGVGSFGCVYKGALDEDGIVVAIKVINLQC------EGASKSFMAECKALKNIR--HRN 742
L+G G FG VY G D + VAIK + E LK +
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 743 LVKVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIA 802
+++++ D ++ E L S
Sbjct: 71 VIRLLDWFER-----PDSFVLILERPEPVQDLFDFITERGA---------LQEELARSFF 116
Query: 803 IDVASALDYLHHHCQEPILHCDLKPSNILLD-NDLSGHIGDFGLARFHQEVSNSTLSSSV 861
V A+ + H+ +LH D+K NIL+D N + DFG ++ +
Sbjct: 117 WQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTD----- 168
Query: 862 GVKGTIGYTAPEYGLGSEVSTNG-DVYSYGILLLEMVTAKKPTDVMFEGD---LNLHNFA 917
GT Y+ PE+ V+S GILL +MV P FE D + F
Sbjct: 169 -FDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP----FEHDEEIIRGQVFF 223
Query: 918 RMALPNQVMDIVDPILRNDEE 938
R + ++ ++ L
Sbjct: 224 RQRVSSECQHLIRWCLALRPS 244
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (304), Expect = 5e-31
Identities = 58/301 (19%), Positives = 107/301 (35%), Gaps = 38/301 (12%)
Query: 692 IGVGSFGCVYKGALDEDGIVVAIKVINLQC--EGASKSFMAECKALKNIRHRNLVKVITS 749
IG G++G V+K E +VA+K + L EG S + E LK ++H+N+V++
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 750 CSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASAL 809
S + +V+E+ + + + + S + L
Sbjct: 70 LHS-----DKKLTLVFEFCDQDLKKYFDSCNGDLDPE----------IVKSFLFQLLKGL 114
Query: 810 DYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGY 869
+ H +LH DLKP N+L++ + + +FGLAR S V
Sbjct: 115 GFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARA---FGIPVRCYSAEVVTLWYR 168
Query: 870 TAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMA------LPN 923
ST+ D++S G + E+ A +P +F G+ R+
Sbjct: 169 PPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP---LFPGNDVDDQLKRIFRLLGTPTEE 225
Query: 924 QVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTN 983
Q + + +T + +N+ L+ +P R++
Sbjct: 226 QWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQ------NLLKCNPVQRISAEE 279
Query: 984 V 984
Sbjct: 280 A 280
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 121 bits (305), Expect = 1e-30
Identities = 64/319 (20%), Positives = 111/319 (34%), Gaps = 46/319 (14%)
Query: 655 RRGPSRLPSRPMMRKALPKMSYKSLLKATNG-----FSSTHLIGVGSFGCVYKGALDEDG 709
++G + + + KA K + N F +G GSFG V E G
Sbjct: 7 KKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESG 66
Query: 710 IVVAIKVIN---LQCEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKAIVYE 766
A+K+++ + + + E + L+ + LVK+ S V E
Sbjct: 67 NHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM-----VME 121
Query: 767 YMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLK 826
Y+ G + L + + A + +YLH +++ DLK
Sbjct: 122 YVAGGEMFSHLRRIG----------RFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLK 168
Query: 827 PSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDV 886
P N+L+D + DFG A+ + + + + GT APE L + D
Sbjct: 169 PENLLIDQQGYIQVTDFGFAKRVKGRTWT-------LCGTPEALAPEIILSKGYNKAVDW 221
Query: 887 YSYGILLLEMVTAKKPTDVMFEGD-----LNLHNFARMALPNQVMDIVDPILRNDEEILA 941
++ G+L+ EM P F D ++ P+ + +LRN L
Sbjct: 222 WALGVLIYEMAAGYPP----FFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRN----LL 273
Query: 942 STDKCRRMQTGINSRLECL 960
D +R N +
Sbjct: 274 QVDLTKRFGNLKNGVNDIK 292
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 119 bits (299), Expect = 2e-30
Identities = 68/298 (22%), Positives = 115/298 (38%), Gaps = 34/298 (11%)
Query: 692 IGVGSFGCVYKGALDEDGIVVAIKVINLQC--EGASKSFMAECKALKNIRHRNLVKVITS 749
IG G++G VYK A + G A+K I L+ EG + + E LK ++H N+VK+
Sbjct: 10 IGEGTYGVVYK-AQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 750 CSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASAL 809
+ +V+E++ + + + K LLQ L
Sbjct: 69 IHT-----KKRLVLVFEHLDQDLKKLLDVCE---GGLESVTAKSFLLQ----------LL 110
Query: 810 DYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGY 869
+ + + +LH DLKP N+L++ + I DFGLAR + T+ Y
Sbjct: 111 NGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAF----GIPVRKYTHEIVTLWY 166
Query: 870 TAPEYGLGSE-VSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMALPNQVM-- 926
AP+ +GS+ ST D++S G + EMV + E D + F + PN
Sbjct: 167 RAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWP 226
Query: 927 DIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNV 984
++ + + + G++ L+S P R+
Sbjct: 227 NVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLS------KMLKLDPNQRITAKQA 278
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (303), Expect = 2e-30
Identities = 60/289 (20%), Positives = 105/289 (36%), Gaps = 46/289 (15%)
Query: 684 NGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC---EGASKSFMAECKALKNIRH 740
N F L+G G+FG V G A+K++ + + + E + L+N RH
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 741 RNLVKVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRIS 800
L + + Q +D V EY G L L T +
Sbjct: 65 PFLTALKYAF-----QTHDRLCFVMEYANGGELFFHLSRE----------RVFTEERARF 109
Query: 801 IAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSS 860
++ SAL + +++ D+K N++LD D I DFGL + S ++
Sbjct: 110 YGAEIVSAL---EYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKE----GISDGATM 162
Query: 861 VGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGD-----LNLHN 915
GT Y APE ++ D + G+++ EM+ + P F L
Sbjct: 163 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP----FYNQDHERLFELIL 218
Query: 916 FARMALPNQV----MDIVDPILRNDEEILASTDKCRRMQTGINSRLECL 960
+ P + ++ +L+ D + +R+ G + E +
Sbjct: 219 MEEIRFPRTLSPEAKSLLAGLLKKDPK--------QRLGGGPSDAKEVM 259
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (297), Expect = 2e-29
Identities = 55/216 (25%), Positives = 90/216 (41%), Gaps = 26/216 (12%)
Query: 691 LIGVGSFGCVYKGALDEDGIVVAIKVIN--LQCEGASKSFMAECKALKNIRHRNLVKVIT 748
+G G++G V G VAIK + Q E +K E + LK++RH N++ ++
Sbjct: 25 PVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLD 84
Query: 749 SCSSIDFQGNDFK-AIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVAS 807
+ + + +V +M + H KL + + +
Sbjct: 85 VFTPDETLDDFTDFYLVMPFMGTDLGKLMKHE------------KLGEDRIQFLVYQMLK 132
Query: 808 ALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTI 867
L Y+H H DLKP N+ ++ D I DFGLAR ++S ++ V T
Sbjct: 133 GLRYIHAAGII---HRDLKPGNLAVNEDCELKILDFGLARQ----ADSEMTGYV---VTR 182
Query: 868 GYTAPEYGLGSE-VSTNGDVYSYGILLLEMVTAKKP 902
Y APE L + D++S G ++ EM+T K
Sbjct: 183 WYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTL 218
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (293), Expect = 6e-29
Identities = 54/232 (23%), Positives = 87/232 (37%), Gaps = 28/232 (12%)
Query: 691 LIGVGSFGCVYKGALDEDGIVVAIKVIN--LQCEGASKSFMAECKALKNIRHRNLVKVIT 748
IG G+ G V VAIK ++ Q + +K E +K + H+N++ ++
Sbjct: 24 PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83
Query: 749 SCSSID-FQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVAS 807
+ + +V E M + + + +
Sbjct: 84 VFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL-------------DHERMSYLLYQMLC 130
Query: 808 ALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTI 867
+ +LH H DLKPSNI++ +D + I DFGLAR T T
Sbjct: 131 GIKHLHSAGII---HRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMT-----PYVVTR 182
Query: 868 GYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARM 919
Y APE LG N D++S G ++ EMV K F G + + ++
Sbjct: 183 YYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKIL----FPGRDYIDQWNKV 230
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 116 bits (290), Expect = 1e-28
Identities = 53/252 (21%), Positives = 100/252 (39%), Gaps = 33/252 (13%)
Query: 691 LIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIR-HRNLVKVITS 749
+G G + V++ + V +K++ K E K L+N+R N++ +
Sbjct: 42 KLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADI 98
Query: 750 CSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASAL 809
+ A+V+E++ N ++ LT ++ AL
Sbjct: 99 VKDPV---SRTPALVFEHVNNTDFKQLYQT-------------LTDYDIRFYMYEILKAL 142
Query: 810 DYLHHHCQEPILHCDLKPSNILLDND-LSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIG 868
DY H I+H D+KP N+++D++ + D+GLA F+ +
Sbjct: 143 DYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYN-----VRVASRY 194
Query: 869 YTAPEYGLGSE-VSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMALPNQVMD 927
+ PE + + + D++S G +L M+ K+P F G N R+A D
Sbjct: 195 FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP---FFHGHDNYDQLVRIAKVLGTED 251
Query: 928 IVDPILRNDEEI 939
+ D I + + E+
Sbjct: 252 LYDYIDKYNIEL 263
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (287), Expect = 3e-28
Identities = 50/232 (21%), Positives = 90/232 (38%), Gaps = 28/232 (12%)
Query: 691 LIGVGSFGCVYKGALDEDGIVVAIKVIN--LQCEGASKSFMAECKALKNIRHRNLVKVIT 748
+G G++G V + G+ VA+K ++ Q +K E + LK+++H N++ ++
Sbjct: 25 PVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 84
Query: 749 SCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASA 808
+ + ++ L + KLT + +
Sbjct: 85 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ-----------KLTDDHVQFLIYQILRG 133
Query: 809 LDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIG 868
L Y+H H DLKPSN+ ++ D I DFGLAR + T
Sbjct: 134 LKYIHSADII---HRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY-------VATRW 183
Query: 869 YTAPEYGLGSE-VSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARM 919
Y APE L + D++S G ++ E++T + F G ++ +
Sbjct: 184 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTL----FPGTDHIDQLKLI 231
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 113 bits (284), Expect = 8e-28
Identities = 45/245 (18%), Positives = 94/245 (38%), Gaps = 11/245 (4%)
Query: 690 HLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITS 749
+G G F V+ + VA+K++ + +++ E K L+ + + K +
Sbjct: 19 RKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSM 77
Query: 750 CSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRI-SIAIDVASA 808
++ + D + + + + K+ E + L + I+ +
Sbjct: 78 GANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLG 137
Query: 809 LDYLHHHCQEPILHCDLKPSNILLD-NDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTI 867
LDY+H C I+H D+KP N+L++ D ++ +A + T
Sbjct: 138 LDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGN--ACWYDEHYTNSIQTR 193
Query: 868 GYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMALPNQVMD 927
Y +PE LG+ D++S L+ E++T FE D Q+++
Sbjct: 194 EYRSPEVLLGAPWGCGADIWSTACLIFELITGDFL----FEPDEGHSYTKDDDHIAQIIE 249
Query: 928 IVDPI 932
++ +
Sbjct: 250 LLGEL 254
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (280), Expect = 2e-27
Identities = 52/239 (21%), Positives = 98/239 (41%), Gaps = 33/239 (13%)
Query: 691 LIGVGSFGCVYKG---ALDEDGIVVAIKVIN----LQCEGASKSFMAECKALKNIRHRNL 743
++G G++G V+ + + G + A+KV+ +Q ++ E + L++IR
Sbjct: 31 VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 90
Query: 744 VKVITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAI 803
+ + FQ ++ +Y+ G L L + I
Sbjct: 91 LVTLHYA----FQTETKLHLILDYINGGELFTHLSQR-------------ERFTEHEVQI 133
Query: 804 DVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGV 863
V + L H + I++ D+K NILLD++ + DFGL++ +
Sbjct: 134 YVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETER---AYDF 190
Query: 864 KGTIGYTAPEYGLGSEVSTNG--DVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMA 920
GTI Y AP+ G + + D +S G+L+ E++T P F D ++ A ++
Sbjct: 191 CGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP----FTVDGEKNSQAEIS 245
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 107 bits (267), Expect = 5e-26
Identities = 66/306 (21%), Positives = 120/306 (39%), Gaps = 14/306 (4%)
Query: 13 DRAALQAFKSMIAHEPQGILNSWNDSRHFCE--WEGITC--GRRHRRVTALDLMSKSLSG 68
D+ AL K + + L+SW + C W G+ C + RV LDL +L
Sbjct: 7 DKQALLQIKKDLGN--PTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPK 64
Query: 69 --SLSPHLGNLSFLREINLSNNT-IQGEIPPEFGRLFRLEALFLSNNSLVGKIPANLSYC 125
+ L NL +L + + + G IPP +L +L L++++ ++ G IP LS
Sbjct: 65 PYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQI 124
Query: 126 SRLTVLCIEYNKLQGRIPLEFVSLSKLKDLSLAKNKLTGGIPPFLGNLTSLEV-LSLAGN 184
L L YN L G +P SL L ++ N+++G IP G+ + L ++++ N
Sbjct: 125 KTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRN 184
Query: 185 SFGRNIPDSLGQLKQLKILAIGGNNLSGPIPPSIYNLSFLVVFSVSHNQIHGSLPPSLGL 244
IP + L + + + + ++ L
Sbjct: 185 RLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLS- 243
Query: 245 LLPNLKFFQIHHNFFSGSIPISLSNASKLEHIEIANNNFSGKLSVNFGGMKNLSLLNLQF 304
NL + +N G++P L+ L + ++ NN G++ G ++ +
Sbjct: 244 --KNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYAN 300
Query: 305 SNLGSG 310
+ G
Sbjct: 301 NKCLCG 306
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 82.5 bits (202), Expect = 1e-17
Identities = 63/274 (22%), Positives = 98/274 (35%), Gaps = 11/274 (4%)
Query: 192 DSLGQLKQLKILAIGGNNLSG--PIPPSIYNLSFLVVFSVSHNQIHGSLPPSLGLLLPNL 249
D+ Q ++ L + G NL PIP S+ NL +L + P L L
Sbjct: 44 DTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQL 103
Query: 250 KFFQIHHNFFSGSIPISLSNASKLEHIEIANNNFSGKLSVNFGGMKNLSLLNLQFSNLGS 309
+ I H SG+IP LS L ++ + N SG L + + NL + + +
Sbjct: 104 HYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISG 163
Query: 310 GESDEMGFMNSLTNCSKLRVLSLGGNQFRGALPHSIANLSSQLQILILSSNQFYGSIPLG 369
D G + L + N+ G +P + AN + S
Sbjct: 164 AIPDSYGSFSKLFTSMTIS-----RNRLTGKIPPTFAN---LNLAFVDLSRNMLEGDASV 215
Query: 370 IGNLVDLYLLGMVENQFTGAIPKEMGKLQKLQGLDFSGNHFSGEIPSSLGNLSSLYEVFF 429
+ + ++G + L GLD N G +P L L L+ +
Sbjct: 216 LFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNV 275
Query: 430 NNNNLSGVIPFSLGNLKRLAFLEMSGNELSGTIP 463
+ NNL G IP GNL+R + N+ P
Sbjct: 276 SFNNLCGEIP-QGGNLQRFDVSAYANNKCLCGSP 308
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 78.6 bits (192), Expect = 3e-16
Identities = 70/271 (25%), Positives = 108/271 (39%), Gaps = 13/271 (4%)
Query: 148 SLSKLKDLSLAKNKLTGG--IPPFLGNLTSLEVLSLAGN-SFGRNIPDSLGQLKQLKILA 204
++ +L L+ L IP L NL L L + G + IP ++ +L QL L
Sbjct: 48 QTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLY 107
Query: 205 IGGNNLSGPIPPSIYNLSFLVVFSVSHNQIHGSLPPSLGLLLPNLKFFQIHHNFFSGSIP 264
I N+SG IP + + LV S+N + G+LPPS+ LPNL N SG+IP
Sbjct: 108 ITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSIS-SLPNLVGITFDGNRISGAIP 166
Query: 265 ISLSNASKLEHIEIANNNFSGKLSVNFGGMKNLSLLNLQFSNLGSGESDEMGFMNSLTNC 324
S + SKL + N G + NL + + + G + L
Sbjct: 167 DSYGSFSKLFTSMTISRN-------RLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGS 219
Query: 325 SKLRVLSLGGNQFRGALPHSIANLSSQLQILILSSNQFYGSIPLGIGNLVDLYLLGMVEN 384
K + + + L +N+ YG++P G+ L L+ L + N
Sbjct: 220 DKNTQKIHLAKNSLAFDLGKVGLSKNLNGLD-LRNNRIYGTLPQGLTQLKFLHSLNVSFN 278
Query: 385 QFTGAIPKEMGKLQKLQGLDFSGNHFSGEIP 415
G IP + G LQ+ ++ N P
Sbjct: 279 NLCGEIP-QGGNLQRFDVSAYANNKCLCGSP 308
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 75.6 bits (184), Expect = 3e-15
Identities = 74/300 (24%), Positives = 120/300 (40%), Gaps = 33/300 (11%)
Query: 319 NSLTNCSKLRVLSLGGNQFRGA--LPHSIANLSSQLQILILSSNQFYGSIPLGIGNLVDL 376
++ T ++ L L G +P S+ANL + I N G IP I L L
Sbjct: 44 DTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQL 103
Query: 377 YLLGMVENQFTGAIPKEMGKLQKLQGLDFSGNHFSGEIPSSLGNLSSLYEVFFNNNNLSG 436
+ L + +GAIP + +++ L LDFS N SG +P S+ +L +L + F+ N +SG
Sbjct: 104 HYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISG 163
Query: 437 VIPFSLGNLKRLAF-LEMSGNELSGTIPEDIFNISYLSNSLNLARNHLVGIIPPRIGNLR 495
IP S G+ +L + +S N L+G IP N++ L+ +
Sbjct: 164 AIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNT 223
Query: 496 ALRSFDVSNNDLSGEIPIELGHCSSLEEIYLAGNLFHGSIPSFFNALKGVQKIDLSRNNL 555
++ ++G +L + L N +G++P LK + +++S NNL
Sbjct: 224 QKIHLAKNSLA---FDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNL 280
Query: 556 SGQIPIFLEALSLEYLNLSFNDFEGKIPAKGIFANASAISVVGCNRLCGGIPELQLPKCT 615
G+IP + + N LCG LP CT
Sbjct: 281 CGEIPQGGNLQRFDVSAYANN-----------------------KCLCGS----PLPACT 313
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 58.6 bits (140), Expect = 1e-09
Identities = 27/125 (21%), Positives = 44/125 (35%), Gaps = 1/125 (0%)
Query: 20 FKSMIAHEPQGILNSWNDSRHFCEWEGITCGRRHRRVTALDLMSKSLSGSLSPHLGNLSF 79
I + ++ D + + T ++K+ +G
Sbjct: 186 LTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKN 245
Query: 80 LREINLSNNTIQGEIPPEFGRLFRLEALFLSNNSLVGKIPANLSYCSRLTVLCIEYNKLQ 139
L ++L NN I G +P +L L +L +S N+L G+IP R V NK
Sbjct: 246 LNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNKCL 304
Query: 140 GRIPL 144
PL
Sbjct: 305 CGSPL 309
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 54.0 bits (128), Expect = 4e-08
Identities = 51/209 (24%), Positives = 74/209 (35%), Gaps = 4/209 (1%)
Query: 32 LNSWNDSRHFCEWEGITCGRRHRRVTALDLMSKSLSGSLSPHLGNLSFLREINLSNNTIQ 91
L+ + + + + LD +LSG+L P + +L L I N I
Sbjct: 103 LHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRIS 162
Query: 92 GEIPPEFGRLFRLEA-LFLSNNSLVGKIPANLSYCSRLTVLCIEYNKLQGRIPLEFVSLS 150
G IP +G +L + +S N L GKIP + + V L
Sbjct: 163 GAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSD-- 220
Query: 151 KLKDLSLAKNKLTGGIPPFLGNLTSLEVLSLAGNSFGRNIPDSLGQLKQLKILAIGGNNL 210
K +G +L L L N +P L QLK L L + NNL
Sbjct: 221 KNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNL 280
Query: 211 SGPIPPSIYNLSFLVVFSVSHNQIHGSLP 239
G I P NL V + ++N+ P
Sbjct: 281 CGEI-PQGGNLQRFDVSAYANNKCLCGSP 308
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 44.0 bits (102), Expect = 6e-05
Identities = 39/132 (29%), Positives = 62/132 (46%), Gaps = 2/132 (1%)
Query: 431 NNNLSGVIPFSLGNLKRLAFLEMSGNELSG--TIPEDIFNISYLSNSLNLARNHLVGIIP 488
N GV+ + R+ L++SG L IP + N+ YL+ N+LVG IP
Sbjct: 35 NRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIP 94
Query: 489 PRIGNLRALRSFDVSNNDLSGEIPIELGHCSSLEEIYLAGNLFHGSIPSFFNALKGVQKI 548
P I L L +++ ++SG IP L +L + + N G++P ++L + I
Sbjct: 95 PAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGI 154
Query: 549 DLSRNNLSGQIP 560
N +SG IP
Sbjct: 155 TFDGNRISGAIP 166
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 40.9 bits (94), Expect = 6e-04
Identities = 39/154 (25%), Positives = 62/154 (40%), Gaps = 4/154 (2%)
Query: 404 DFSGNHFSGEIPSSLGNLSSLYEVFFNNNNLSGV--IPFSLGNLKRLAFLEMSGNE-LSG 460
D + G + + + + + NL IP SL NL L FL + G L G
Sbjct: 32 DCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVG 91
Query: 461 TIPEDIFNISYLSNSLNLARNHLVGIIPPRIGNLRALRSFDVSNNDLSGEIPIELGHCSS 520
IP I ++ L + ++ G IP + ++ L + D S N LSG +P + +
Sbjct: 92 PIPPAIAKLTQLHYL-YITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPN 150
Query: 521 LEEIYLAGNLFHGSIPSFFNALKGVQKIDLSRNN 554
L I GN G+IP + + + N
Sbjct: 151 LVGITFDGNRISGAIPDSYGSFSKLFTSMTISRN 184
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 105 bits (263), Expect = 7e-25
Identities = 79/390 (20%), Positives = 137/390 (35%), Gaps = 34/390 (8%)
Query: 148 SLSKLKDLSLAKNKLTGGIPPFLGNLTSLEVLSLAGNSFGRNIPDSLGQLKQLKILAIGG 207
+L++ L K +T + +L + L ++I D + L L +
Sbjct: 20 ALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGI-KSI-DGVEYLNNLTQINFSN 75
Query: 208 NNLSGPIPPSIYNLSFLVVFSVSHNQIHGSLPPSLGLLLPNLKFFQIHHNFFSGSIPISL 267
N L+ P + NL+ LV +++NQI P + L L F ++
Sbjct: 76 NQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTN 133
Query: 268 SNASKLEHIEIANNNFSGKLSVNFGGMKN------LSLLNLQFSNLGSGESDEMGFMNSL 321
N +L I++ + L+ L NL S+++ ++ L
Sbjct: 134 LNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVL 193
Query: 322 TNCSKLRVLSLGGNQFRGALPHSIANLSSQLQILILSSNQFYGSIPLGIGNLVDLYLLGM 381
+ L L NQ P I + L L L+ NQ + +L +L L +
Sbjct: 194 AKLTNLESLIATNNQISDITPLGI---LTNLDELSLNGNQLKD--IGTLASLTNLTDLDL 248
Query: 382 VENQFTGAIPKEMGKLQKLQGLDFSGNHFSGEIPSSLGNLSSLYEVFFNNNNLSGVIPFS 441
NQ + P + L KL L N S P + + E+ N
Sbjct: 249 ANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLE----DISP 302
Query: 442 LGNLKRLAFLEMSGNELSGTIPEDIFNISYLSN--SLNLARNHLVGIIPPRIGNLRALRS 499
+ NLK L +L + N +S P +S L+ L A N + + NL +
Sbjct: 303 ISNLKNLTYLTLYFNNISDISP-----VSSLTKLQRLFFANNKVSD--VSSLANLTNINW 355
Query: 500 FDVSNNDLSGEIPIELGHCSSLEEIYLAGN 529
+N +S P L + + + ++ L
Sbjct: 356 LSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 104 bits (259), Expect = 2e-24
Identities = 69/394 (17%), Positives = 133/394 (33%), Gaps = 33/394 (8%)
Query: 190 IPDSLGQLKQLKILAIGGNNLSGPIPPSIYNLSFLVVFSVSHNQIHGSLPPSLGL-LLPN 248
D+ L + +G N++ + + +L + I S+ G+ L N
Sbjct: 16 FTDT--ALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIK-SID---GVEYLNN 67
Query: 249 LKFFQIHHNFFSGSIPISLSNASKLEHIEIANNNFSGKLSVNFGGMKNLSLLNLQFSNLG 308
L +N + P L N +KL I + NN + + L
Sbjct: 68 LTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDI 125
Query: 309 SGESDEMGFMNSLTNCSKLRVLSLGGNQFRGALPHSIANLSSQLQILILSSNQFYGSIPL 368
+ + + + +S ++ + L++ +
Sbjct: 126 DPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSN 185
Query: 369 GI------GNLVDLYLLGMVENQFTGAIPKEMGKLQKLQGLDFSGNHFSGEIPSSLGNLS 422
+ L +L L NQ + P + L L +GN +L +L+
Sbjct: 186 KVSDISVLAKLTNLESLIATNNQISDITPLGILT--NLDELSLNGNQLKD--IGTLASLT 241
Query: 423 SLYEVFFNNNNLSGVIPFSLGNLKRLAFLEMSGNELSGTIPEDIFNISYLSNSLNLARNH 482
+L ++ NN +S + P S L +L L++ N++S P ++ L+ NL N
Sbjct: 242 NLTDLDLANNQISNLAPLS--GLTKLTELKLGANQISNISP-----LAGLTALTNLELNE 294
Query: 483 LVGIIPPRIGNLRALRSFDVSNNDLSGEIPIELGHCSSLEEIYLAGNLFHGSIPSFFNAL 542
I NL+ L + N++S P+ + L+ ++ A N S S L
Sbjct: 295 NQLEDISPISNLKNLTYLTLYFNNISDISPV--SSLTKLQRLFFANNKV--SDVSSLANL 350
Query: 543 KGVQKIDLSRNNLSGQIPIFLEALSLEYLNLSFN 576
+ + N +S P+ + L L+
Sbjct: 351 TNINWLSAGHNQISDLTPLA-NLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 90.8 bits (224), Expect = 6e-20
Identities = 77/393 (19%), Positives = 141/393 (35%), Gaps = 41/393 (10%)
Query: 76 NLSFLREINLSNNTIQGEIPPEFGRLFRLEALFLSNNSLVGKIPANLSYCSRLTVLCIEY 135
L+ + L + + L ++ L + K + Y + LT +
Sbjct: 20 ALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGI--KSIDGVEYLNNLTQINFSN 75
Query: 136 NKLQGRIPLEFVSLSKLKDLSLAKNKLTGGIPPFLGNLTSLEVLSLAGNSFGRNIPD--- 192
N+L PL+ +L+KL D+ + N++ P + L + + +
Sbjct: 76 NQLTDITPLK--NLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTN 133
Query: 193 ---------SLGQLKQLKILAIGGNNLSGPIPPSIYNLSFLVVFSVSHNQIHGSLPPSLG 243
++ + L L G + L+ L + S+
Sbjct: 134 LNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVL 193
Query: 244 LLLPNLKFFQIHHNFFSGSIPISLSNASKLEHIEIANNNFSGKLSVNFGGMKNLSLLNLQ 303
L NL+ +N S P+ + L+ + + N + + NL+ L+L
Sbjct: 194 AKLTNLESLIATNNQISDITPL--GILTNLDELSLNGNQLKDIGT--LASLTNLTDLDLA 249
Query: 304 FSNLGSGESDEMGFMNSLTNCSKLRVLSLGGNQFRGALPHSIANLSSQLQILILSSNQFY 363
+ + + + L+ +KL L LG NQ P L+ + L N+
Sbjct: 250 NNQISN--------LAPLSGLTKLTELKLGANQISNISP-----LAGLTALTNLELNENQ 296
Query: 364 GSIPLGIGNLVDLYLLGMVENQFTGAIPKEMGKLQKLQGLDFSGNHFSGEIPSSLGNLSS 423
I NL +L L + N + P + L KLQ L F+ N S SSL NL++
Sbjct: 297 LEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTN 352
Query: 424 LYEVFFNNNNLSGVIPFSLGNLKRLAFLEMSGN 456
+ + +N +S + P L NL R+ L ++
Sbjct: 353 INWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 65.8 bits (159), Expect = 8e-12
Identities = 36/165 (21%), Positives = 57/165 (34%), Gaps = 28/165 (16%)
Query: 40 HFCEWEGITCGRRHRRVTALDLMSKSLSGSLSPHLGNLSFLREINLSNNTIQGEIP---- 95
+ + + I +T LDL + +S L L+ L E+ L N I P
Sbjct: 227 NGNQLKDIGTLASLTNLTDLDLANNQISNL--APLSGLTKLTELKLGANQISNISPLAGL 284
Query: 96 ----------------PEFGRLFRLEALFLSNNSLVGKIPANLSYCSRLTVLCIEYNKLQ 139
L L L L N++ P +S ++L L NK+
Sbjct: 285 TALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVS 342
Query: 140 GRIPLEFVSLSKLKDLSLAKNKLTGGIPPFLGNLTSLEVLSLAGN 184
+L+ + LS N+++ P L NLT + L L
Sbjct: 343 D--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 59.2 bits (142), Expect = 1e-09
Identities = 22/120 (18%), Positives = 45/120 (37%), Gaps = 6/120 (5%)
Query: 17 LQAFKSMIAHEPQGILNSWNDSRHFCEWEGITCGRRHRRVTALDLMSKSLSGSLSPHLGN 76
L A + G+ N + + E I+ + +T L L ++S + +
Sbjct: 270 LGANQISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDI--SPVSS 327
Query: 77 LSFLREINLSNNTIQGEIPPEFGRLFRLEALFLSNNSLVGKIPANLSYCSRLTVLCIEYN 136
L+ L+ + +NN + L + L +N + P L+ +R+T L +
Sbjct: 328 LTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 56.9 bits (136), Expect = 6e-09
Identities = 56/331 (16%), Positives = 105/331 (31%), Gaps = 40/331 (12%)
Query: 268 SNASKLEHIEIANNNFSGKLSVNFGGMKNLSLLNLQFSNLGSGESDEMGFMNSLTNCSKL 327
+ ++ + N + +S + ++ L + S ++ + + L
Sbjct: 19 TALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKS--------IDGVEYLNNL 68
Query: 328 RVLSLGGNQFRGALPHSIANLSSQLQILILSSNQFYGSIPLGIGNLVDLYLLGMVENQFT 387
++ NQ P + NL+ L +++++NQ PL + L +
Sbjct: 69 TQINFSNNQLTDITP--LKNLTK-LVDILMNNNQIADITPLANLTNLTGLTLFNNQITDI 125
Query: 388 GAIPKEMGKLQKLQGL---------------DFSGNHFSGEIPSSLGNLSSLYEVFFNNN 432
+ + L NL++L + ++N
Sbjct: 126 DPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSN 185
Query: 433 NLSGVIPFSLGNLKRLAFLEMSGNELSGTIPEDIFNISYLSNSLNLARNHLVGIIPPRIG 492
+S + + L L L + N++S P I + L+L N L I +
Sbjct: 186 KVSDISVLA--KLTNLESLIATNNQISDITPLGILTNL---DELSLNGNQLKDI--GTLA 238
Query: 493 NLRALRSFDVSNNDLSGEIPIELGHCSSLEEIYLAGNLFHGSIPSFFNALKGVQKIDLSR 552
+L L D++NN +S P L + L E+ L N P
Sbjct: 239 SLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTA---LTNLELN 293
Query: 553 NNLSGQIPIFLEALSLEYLNLSFNDFEGKIP 583
N I +L YL L FN+ P
Sbjct: 294 ENQLEDISPISNLKNLTYLTLYFNNISDISP 324
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 90.5 bits (223), Expect = 3e-20
Identities = 58/297 (19%), Positives = 112/297 (37%), Gaps = 23/297 (7%)
Query: 262 SIPISLSNASKLEHIEIANNNFSGKLSVNFGGMKNLSLLNLQFSNLGSGESDEMGFMNSL 321
+P L +++ NN + +F +KNL L L + + +
Sbjct: 24 KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPG------AF 75
Query: 322 TNCSKLRVLSLGGNQFRGALPHSIANLSSQLQILILSSNQFYGSIPLGIGNLVDLYLLGM 381
KL L L NQ + LP + +L++ + S+ G+ ++ + L
Sbjct: 76 APLVKLERLYLSKNQLKE-LPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTN 134
Query: 382 VENQFTGAIPKEMGKLQKLQGLDFSGNHFSGEIPSSLGNLSSLYEVFFNNNNLSGVIPFS 441
+ +G ++KL + + + + IP L SL E+ + N ++ V S
Sbjct: 135 -PLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAAS 190
Query: 442 LGNLKRLAFLEMSGNELSGTIPEDIFNISYLSNSLNLARNHLVGIIPPRIGNLRALRSFD 501
L L LA L +S N +S + N +L N+ + +P + + + ++
Sbjct: 191 LKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHL--NNNKLVKVPGGLADHKYIQVVY 248
Query: 502 VSNNDLSG------EIPIELGHCSSLEEIYLAGN-LFHGSI-PSFFNALKGVQKIDL 550
+ NN++S P +S + L N + + I PS F + + L
Sbjct: 249 LHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQL 305
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 89.7 bits (221), Expect = 6e-20
Identities = 52/259 (20%), Positives = 92/259 (35%), Gaps = 6/259 (2%)
Query: 80 LREINLSNNTIQGEIPPEFGRLFRLEALFLSNNSLVGKIPANLSYCSRLTVLCIEYNKLQ 139
++L NN I +F L L L L NN + P + +L L + N+L+
Sbjct: 33 TALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK 92
Query: 140 GRIPLEFVSLSKLKDLSLAKNKLTGGIPPFLGNLTSLEVLSLAGNSFGRNIPDSLGQLKQ 199
+L +L+ K+ + L + +E L + +K+
Sbjct: 93 ELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVE-LGTNPLKSSGIENGAFQGMKK 151
Query: 200 LKILAIGGNNLSGPIPPSIYNLSFLVVFSVSHNQIHGSLPPSLGLLLPNLKFFQIHHNFF 259
L + I N++ IP + L + N+I SL L NL + N
Sbjct: 152 LSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAASLK-GLNNLAKLGLSFNSI 207
Query: 260 SGSIPISLSNASKLEHIEIANNNFSGKLSVNFGGMKNLSLLNLQFSNLGSGESDEMGFMN 319
S SL+N L + + NN K + ++ L +N+ + S++
Sbjct: 208 SAVDNGSLANTPHLRELHLNNNKLVKVP-GGLADHKYIQVVYLHNNNISAIGSNDFCPPG 266
Query: 320 SLTNCSKLRVLSLGGNQFR 338
T + +SL N +
Sbjct: 267 YNTKKASYSGVSLFSNPVQ 285
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 82.8 bits (203), Expect = 1e-17
Identities = 41/235 (17%), Positives = 81/235 (34%), Gaps = 5/235 (2%)
Query: 346 ANLSSQLQILILSSNQFYGSIPLGIGNLVDLYLLGMVENQFTGAIPKEMGKLQKLQGLDF 405
+L +L L +N+ NL +L+ L ++ N+ + P L KL+ L
Sbjct: 27 KDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYL 86
Query: 406 SGNHFSGEIPSSLGNLSSLYEVFFNNNNLSGVIPFSLGNLKRLAFLEMSGNELSGTIPED 465
S N E+P + V N F+ N + L + + SG
Sbjct: 87 SKNQLK-ELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGA 145
Query: 466 IFNISYLSNSLNLARNHLVGIIPPRIGNLRALRSFDVSNNDLSGEIPIELGHCSSLEEIY 525
+ LS +A ++ I G +L + N ++ L ++L ++
Sbjct: 146 FQGMKKLSYI-RIADTNITTIPQ---GLPPSLTELHLDGNKITKVDAASLKGLNNLAKLG 201
Query: 526 LAGNLFHGSIPSFFNALKGVQKIDLSRNNLSGQIPIFLEALSLEYLNLSFNDFEG 580
L+ N ++++ L+ N L + ++ + L N+
Sbjct: 202 LSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNNNISA 256
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 80.1 bits (196), Expect = 8e-17
Identities = 49/273 (17%), Positives = 96/273 (35%), Gaps = 17/273 (6%)
Query: 214 IPPSIYNLSFLVVFSVSHNQIHGSLPPSLGLLLPNLKFFQIHHNFFSGSIPISLSNASKL 273
+P + + + +N+I + L NL + +N S P + + KL
Sbjct: 25 VPKDLP--PDTALLDLQNNKITE-IKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 81
Query: 274 EHIEIANNNFSGKLSVNFGGMKNLSLLNLQFSNLGSGESDEMGFMNSLTNCSKLRVLSLG 333
E + ++ N ++ L + + + + + + M + +
Sbjct: 82 ERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTN------- 134
Query: 334 GNQFRGALPHSIANLSSQLQILILSSNQFYGSIPLGIG-NLVDLYLLGMVENQFTGAIPK 392
+ G + + L + ++ +IP G+ +L +L+L G N+ T
Sbjct: 135 PLKSSGIENGAFQGMKK-LSYIRIADTNI-TTIPQGLPPSLTELHLDG---NKITKVDAA 189
Query: 393 EMGKLQKLQGLDFSGNHFSGEIPSSLGNLSSLYEVFFNNNNLSGVIPFSLGNLKRLAFLE 452
+ L L L S N S SL N L E+ NNN L +P L + K + +
Sbjct: 190 SLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVY 248
Query: 453 MSGNELSGTIPEDIFNISYLSNSLNLARNHLVG 485
+ N +S D Y + + + L
Sbjct: 249 LHNNNISAIGSNDFCPPGYNTKKASYSGVSLFS 281
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 63.5 bits (153), Expect = 3e-11
Identities = 34/184 (18%), Positives = 62/184 (33%), Gaps = 7/184 (3%)
Query: 400 LQGLDFSGNHFSGEIPSSLGNLSSLYEVFFNNNNLSGVIPFSLGNLKRLAFLEMSGNELS 459
L+ + S ++P L + NN ++ + NLK L L + N++S
Sbjct: 12 LRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKIS 68
Query: 460 GTIPEDIFNISYLSNSLNLARNHLVGIIPPRIGNLRALRSFDVSNNDLSGEIPIELGHCS 519
P + L L L++N L + L+ LR + + + L
Sbjct: 69 KISPGAFAPLVKL-ERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMI 127
Query: 520 SLEEIYLAGNLFHGSIPSFFNALKGVQKIDLSRNNLSGQIPIFLEALSLEYLNLSFNDFE 579
+E + G F +K + I ++ N++ SL L+L N
Sbjct: 128 VVE-LGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGLPP--SLTELHLDGNKIT 184
Query: 580 GKIP 583
Sbjct: 185 KVDA 188
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 45.8 bits (107), Expect = 1e-05
Identities = 27/158 (17%), Positives = 52/158 (32%), Gaps = 1/158 (0%)
Query: 468 NISYLSNSLNLARNHLVGIIPPRIGNLRALRSFDVSNNDLSGEIPIELGHCSSLEEIYLA 527
++ + L+L N + I NL+ L + + NN +S P LE +YL+
Sbjct: 28 DLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLS 87
Query: 528 GNLFHGSIPSFFNALKGVQKIDLSRNNLSGQIPIFLEALSLEYLNLSFNDFEGKIPAKGI 587
N L+ ++ + + + L + + L + G
Sbjct: 88 KNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQ 147
Query: 588 FANASAISVVGCNRLCGGIPELQLPKCTESKSSSQKIS 625
+ + + IP+ P TE KI+
Sbjct: 148 GMKKLSYIRIADTNIT-TIPQGLPPSLTELHLDGNKIT 184
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 89.5 bits (220), Expect = 4e-20
Identities = 46/254 (18%), Positives = 84/254 (33%), Gaps = 4/254 (1%)
Query: 327 LRVLSLGGNQFRGALPHSIANLSSQLQILILSSNQFYGSIPLGIGNLVDLYLLGMVENQF 386
+ + L GN+ S + + + S+ G + L Q
Sbjct: 34 SQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQL 93
Query: 387 TGAIPKEMGKLQKLQGLDFSGNHFSGEIPSSLGNLSSLYEVFFNNNNLSGVIPFSLGNLK 446
P L +L L P L++L ++ +N L + + +L
Sbjct: 94 RSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLG 153
Query: 447 RLAFLEMSGNELSGTIPEDIFNISYLSNSLNLARNHLVGIIPPRIGNLRALRSFDVSNND 506
L L + GN +S + L L +N + + P +L L + + N+
Sbjct: 154 NLTHLFLHGNRISSVPERAFRGLHSLDRL-LLHQNRVAHVHPHAFRDLGRLMTLYLFANN 212
Query: 507 LSGEIPIELGHCSSLEEIYLAGNLFHGSIPSFFNALKGVQKIDLSRNNLSGQIPIFLEAL 566
LS L +L+ + L N + + +QK S + + +P L
Sbjct: 213 LSALPTEALAPLRALQYLRLNDNPWVCDCRARPL-WAWLQKFRGSSSEVPCSLPQRLAGR 271
Query: 567 SLEYLNLSFNDFEG 580
L L+ ND +G
Sbjct: 272 DL--KRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 74.5 bits (181), Expect = 5e-15
Identities = 48/231 (20%), Positives = 80/231 (34%), Gaps = 6/231 (2%)
Query: 32 LNSWNDSRHFCEWEGITCGRRHRRVTALDLMSKSLSGSLSP-HLGNLSFLREINLSNNTI 90
L + + LDL + S+ P L L ++L +
Sbjct: 58 LTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGL 117
Query: 91 QGEIPPEFGRLFRLEALFLSNNSLVGKIPANLSYCSRLTVLCIEYNKLQGRIPLEFVSLS 150
Q P F L L+ L+L +N+L LT L + N++ F L
Sbjct: 118 QELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLH 177
Query: 151 KLKDLSLAKNKLTGGIPPFLGNLTSLEVLSLAGNSFGRNIPDSLGQLKQLKILAIGGNNL 210
L L L +N++ P +L L L L N+ ++L L+ L+ L + N
Sbjct: 178 SLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPW 237
Query: 211 SGPIPPSIYNLSFLVVFSVSHNQIHGSLPPSLGLLLPNLKFFQIHHNFFSG 261
+ ++L F S +++ SLP L ++ N G
Sbjct: 238 VCDC-RARPLWAWLQKFRGSSSEVPCSLPQRLA----GRDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 73.7 bits (179), Expect = 1e-14
Identities = 46/196 (23%), Positives = 69/196 (35%), Gaps = 5/196 (2%)
Query: 90 IQGEIPPEFGRLFRLEALFLSNNSLVGKIPANLSYCSRLTVLCIEYNKLQGRIPLEFVSL 149
++ P F L RL L L L P + L L ++ N LQ F L
Sbjct: 93 LRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDL 152
Query: 150 SKLKDLSLAKNKLTGGIPPFLGNLTSLEVLSLAGNSFGRNIPDSLGQLKQLKILAIGGNN 209
L L L N+++ L SL+ L L N P + L +L L + NN
Sbjct: 153 GNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANN 212
Query: 210 LSGPIPPSIYNLSFLVVFSVSHNQIHGSLPPSLGLLLPNLKFFQIHHNFFSGSIPISLSN 269
LS ++ L L ++ N L L+ F+ + S+P L+
Sbjct: 213 LSALPTEALAPLRALQYLRLNDNPWVCD--CRARPLWAWLQKFRGSSSEVPCSLPQRLAG 270
Query: 270 ASKLEHIEIANNNFSG 285
+A N+ G
Sbjct: 271 RDLK---RLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 71.0 bits (172), Expect = 7e-14
Identities = 48/295 (16%), Positives = 95/295 (32%), Gaps = 37/295 (12%)
Query: 166 IPPFLGNLTSLEVLSLAGNSFGRNIPDSLGQLKQLKILAIGGNNLSGPIPPSIYNLSFLV 225
+P + + + + L GN S + L IL + N L+ + L+ L
Sbjct: 26 VPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLE 83
Query: 226 VFSVSHNQIHGSLPPSLGLLLPNLKFFQIHHNFFSGSIPISLSNASKLEHIEIANNNFSG 285
+S N S+ P+ L L + P + L+++ + +N
Sbjct: 84 QLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQA 143
Query: 286 KLSVNFGGMKNLSLLNLQFSNLGSGESDEMGFMNSLTNCSKLRVLSLGGNQFRGALPHSI 345
++ + L L L GN+ +
Sbjct: 144 LPD------------------------------DTFRDLGNLTHLFLHGNRISSVPERAF 173
Query: 346 ANLSSQLQILILSSNQFYGSIPLGIGNLVDLYLLGMVENQFTGAIPKEMGKLQKLQGLDF 405
L S L L+L N+ P +L L L + N + + + L+ LQ L
Sbjct: 174 RGLHS-LDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRL 232
Query: 406 SGNHFSGEIPSSLGNLSSLYEVFFNNNNLSGVIPFSLGNLKRLAFLEMSGNELSG 460
+ N + + + + L + +++ + +P L ++ N+L G
Sbjct: 233 NDNPWVCDCR-ARPLWAWLQKFRGSSSEVPCSLPQRLAGRD---LKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 63.7 bits (153), Expect = 2e-11
Identities = 45/247 (18%), Positives = 85/247 (34%), Gaps = 27/247 (10%)
Query: 389 AIPKEMGKLQKLQGLDFSGNHFSGEIPSSLGNLSSLYEVFFNNNNLSGVIPFSLGNLKRL 448
A+P + Q + GN S +S +L ++ ++N L+ + + L L
Sbjct: 25 AVPVGIPAA--SQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALL 82
Query: 449 AFLEMSGNELSGTIPEDIFNISYLSNSLNLARNHLVGIIPPRIGNLRALRSFDVSNNDLS 508
L++S N ++ F+ ++L+L R L + P L AL+ + +N L
Sbjct: 83 EQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQ 142
Query: 509 GEIPIELGHCSSLEEIYLAGNLFHGSIPSFFNALKGVQKIDLSRNNLSGQIPIFLEAL-- 566
+L ++L GN F L + ++ L +N ++ P L
Sbjct: 143 ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGR 202
Query: 567 -----------------------SLEYLNLSFNDFEGKIPAKGIFANASAISVVGCNRLC 603
+L+YL L+ N + A+ ++A C
Sbjct: 203 LMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQKFRGSSSEVPC 262
Query: 604 GGIPELQ 610
L
Sbjct: 263 SLPQRLA 269
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 81.0 bits (199), Expect = 6e-18
Identities = 25/169 (14%), Positives = 49/169 (28%), Gaps = 37/169 (21%)
Query: 691 LIGVGSFGCVYKGALDEDGIVVAIKVINL----------QCEGASKSFMAECKALKNIRH 740
L+G G V+ E +K + + + F
Sbjct: 7 LMGEGKESAVFN-CYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 741 RNLVKV--ITSCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQR 798
R L K+ + ++GN A++ E + L + +
Sbjct: 66 RALQKLQGLAVPKVYAWEGN---AVLMELIDAKELYRVRVEN-----------------P 105
Query: 799 ISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGLAR 847
+ + + +H I+H DL N+L+ + I DF +
Sbjct: 106 DEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVS-EEGIWIIDFPQSV 150
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 63.2 bits (152), Expect = 3e-11
Identities = 40/276 (14%), Positives = 90/276 (32%), Gaps = 12/276 (4%)
Query: 179 LSLAGNSFGRNIPDSLGQL--KQLKILAIGGNNLSGPIPPSIYNLSFLVVFSVSHNQIHG 236
L L G + PD G+L + + + + P+ + +S++ I
Sbjct: 5 LDLTGKNL---HPDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFR-VQHMDLSNSVIEV 60
Query: 237 SLPPSLGLLLPNLKFFQIHHNFFSGSIPISLSNASKLEHIEIANNNFSGKLSV--NFGGM 294
S + L+ + S I +L+ S L + ++ + + ++
Sbjct: 61 STLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSC 120
Query: 295 KNLSLLNLQFSNLGSGESDEMGFMNSLTNCSKLRVLSLGGNQFRGALPHSIANLSSQLQI 354
L LNL + + + ++ + ++L + N + L + + + +
Sbjct: 121 SRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHL 180
Query: 355 LILSSNQFYGSIPLGIGNLVDLYLLGMVE-NQFTGAIPKEMGKLQKLQGLDFSGNHFSGE 413
+ S L L L + E+G++ L+ L G G
Sbjct: 181 DLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGT 240
Query: 414 IPSSLGNLSSLYEVFFNNNNLSGVIPFSLGNLKRLA 449
+ L L N ++ + + ++GN K
Sbjct: 241 LQLLKEALPHLQ---INCSHFTTIARPTIGNKKNQE 273
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 58.2 bits (139), Expect = 1e-09
Identities = 43/262 (16%), Positives = 90/262 (34%), Gaps = 12/262 (4%)
Query: 57 TALDLMSKSLSGSLSPHLGNLSFLREINLSNNTIQGEIPPEFGRLFRLEALFLSNNSLVG 116
LDL K+L ++ L + + + + + F FR++ + LSN+ +
Sbjct: 3 QTLDLTGKNLHPDVTGRLLSQG-VIAFRCPRSFMDQPLAEHF-SPFRVQHMDLSNSVIEV 60
Query: 117 K-IPANLSYCSRLTVLCIEYNKLQGRIPLEFVSLSKLKDLSLA--KNKLTGGIPPFLGNL 173
+ LS CS+L L +E +L I S L L+L+ + L +
Sbjct: 61 STLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSC 120
Query: 174 TSLEVLSLAGNS------FGRNIPDSLGQLKQLKILAIGGNNLSGPIPPSIYNLSFLVVF 227
+ L+ L+L+ + + QL + N + + LV
Sbjct: 121 SRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHL 180
Query: 228 SVSHNQIHGSLPPSLGLLLPNLKFFQIHH-NFFSGSIPISLSNASKLEHIEIANNNFSGK 286
+S + + + L L+ + + L L+ +++ G
Sbjct: 181 DLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGT 240
Query: 287 LSVNFGGMKNLSLLNLQFSNLG 308
L + + +L + F+ +
Sbjct: 241 LQLLKEALPHLQINCSHFTTIA 262
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 52.8 bits (125), Expect = 6e-08
Identities = 33/245 (13%), Positives = 76/245 (31%), Gaps = 15/245 (6%)
Query: 326 KLRVLSLGGNQFRGALPHSIANLSSQLQILILSSNQFYG-SIPLGIGNLVDLYLLGMVEN 384
+ + L + ++Q + LS++ ++ + L L +
Sbjct: 24 GVIAFRCPRSFMDQPLAEHFSPF--RVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGL 81
Query: 385 QFTGAIPKEMGKLQKLQGLDFSGNHFSGEIPS--------SLGNLSSLYEVFFNNNNLSG 436
+ + I + K L L+ SG E L L+ + F ++
Sbjct: 82 RLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQV 141
Query: 437 VIPFSLGNLKRLAFLEMSGNELSGTIPEDIFNISYLSNSLNLARNHLVGIIPPRIGNLRA 496
+ + +L N + + L + L L
Sbjct: 142 AVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNY 201
Query: 497 LRSFDVSN-NDLSGEIPIELGHCSSLEEIYLAGNLFHGSIPSFFNALKGVQKIDLSRNNL 555
L+ +S D+ E +ELG +L+ + + G + G++ AL + ++ ++
Sbjct: 202 LQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLLKEAL---PHLQINCSHF 258
Query: 556 SGQIP 560
+
Sbjct: 259 TTIAR 263
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.7 bits (117), Expect = 8e-07
Identities = 47/296 (15%), Positives = 96/296 (32%), Gaps = 33/296 (11%)
Query: 203 LAIGGNNLSGPIPPSIYNLSFLVVFSVSHNQIHGSLPPSLGLLLPNLKFFQIHHNFFSG- 261
L + G NL + + + ++ F + + L ++ + ++
Sbjct: 5 LDLTGKNLHPDVTGRLLSQG-VIAFRCPRSFMDQPLAEHFSPF--RVQHMDLSNSVIEVS 61
Query: 262 SIPISLSNASKLEHIEIANNNFSGKLSVNFGGMKNLSLLNLQFSNLGSGESDEMGFMNSL 321
++ LS SKL+++ + S + NL LNL + S + + +
Sbjct: 62 TLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSS-- 119
Query: 322 TNCSKLRVLSLGGNQFRGALPHSIANLSSQLQILILSSNQFYGSIPLGIGNLVDLYLLGM 381
CS+L L+L + ++ + L L G
Sbjct: 120 --CSRLDELNLSWCFDF-------------------TEKHVQVAVAHVSETITQLNLSGY 158
Query: 382 VENQFTGAIPKEMGKLQKLQGLDFSGNH-FSGEIPSSLGNLSSLYEVFFNN-NNLSGVIP 439
+N + + + L LD S + + L+ L + + ++
Sbjct: 159 RKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETL 218
Query: 440 FSLGNLKRLAFLEMSGNELSGTIPEDIFNISYLSNSLNLARNHLVGIIPPRIGNLR 495
LG + L L++ G GT+ + L + +H I P IGN +
Sbjct: 219 LELGEIPTLKTLQVFGIVPDGTLQLLKEALP----HLQINCSHFTTIARPTIGNKK 270
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.4 bits (98), Expect = 1e-04
Identities = 17/102 (16%), Positives = 34/102 (33%), Gaps = 4/102 (3%)
Query: 401 QGLDFSGNHFSGEIPSSLGNLSSLYEVFFN-NNNLSGVIPFSLGNLKRLAFLEMSGNELS 459
Q LD +G + P G L S + F + + R+ +++S + +
Sbjct: 3 QTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIE 59
Query: 460 GTIPEDIFNISYLSNSLNLARNHLVGIIPPRIGNLRALRSFD 501
+ I + +L+L L I + L +
Sbjct: 60 VSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLN 101
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 54.3 bits (129), Expect = 2e-08
Identities = 36/191 (18%), Positives = 64/191 (33%), Gaps = 8/191 (4%)
Query: 389 AIPKEMGKLQKLQGLDFSGNHFSGEIPSSLGNLSSLYEVFFNNNNLSGVIPFSLGNLKRL 448
A+P ++ K L S N ++L + L ++ NL L L
Sbjct: 24 ALPPDLPKD--TTILHLSENLLYTFSLATLMPYTRLTQL-----NLDRAELTKLQVDGTL 76
Query: 449 AFL-EMSGNELSGTIPEDIFNISYLSNSLNLARNHLVGIIPPRIGNLRALRSFDVSNNDL 507
L + + + L+++ N L + + L L+ + N+L
Sbjct: 77 PVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNEL 136
Query: 508 SGEIPIELGHCSSLEEIYLAGNLFHGSIPSFFNALKGVQKIDLSRNNLSGQIPIFLEALS 567
P L LE++ LA N N L+ + + L N+L F +
Sbjct: 137 KTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLYTIPKGFFGSHL 196
Query: 568 LEYLNLSFNDF 578
L + L N +
Sbjct: 197 LPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 54.3 bits (129), Expect = 2e-08
Identities = 46/213 (21%), Positives = 77/213 (36%), Gaps = 9/213 (4%)
Query: 320 SLTNCSKLRVLSLGGNQFRGALPHSIANLSSQLQILILSSNQFYGSIPLGIGNLVDLYLL 379
++ + ++ ALP +L IL LS N Y + L L
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALP---PDLPKDTTILHLSENLLYTFSLATLMPYTRLTQL 60
Query: 380 GMVENQFTGAIPKEMGKLQKLQGLDFSGNHFSGEIPSSLGNLSSLYEVFFNNNNLSGVIP 439
+ + T + G L L ++ +P L +L + + N L+ +
Sbjct: 61 NLDRAELT--KLQVDGTLPVLG-TLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPL 117
Query: 440 FSLGNLKRLAFLEMSGNELSGTIPEDIFNISYLSNSLNLARNHLVGIIPPRIGNLRALRS 499
+L L L L + GNEL T+P + + L+LA N+L + + L L +
Sbjct: 118 GALRGLGELQELYLKGNELK-TLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDT 176
Query: 500 FDVSNNDLSGEIPIELGHCSSLEEIYLAGNLFH 532
+ N L IP L +L GN +
Sbjct: 177 LLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWL 208
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.6 bits (122), Expect = 1e-07
Identities = 32/218 (14%), Positives = 60/218 (27%), Gaps = 15/218 (6%)
Query: 217 SIYNLSFLVVFSVSHNQIHGSLPPSLGLLLPNLKFFQIHHNFFSGSIPISLSNASKLEHI 276
+ ++ + + + +LPP L + + N +L ++L +
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPPDLP---KDTTILHLSENLLYTFSLATLMPYTRLTQL 60
Query: 277 EIANNNFSGKLSVNFGGMKNLSLLNLQFSNLGSGESDEMGFMNSLTNCSKLRVLSLGGNQ 336
N L +L + +++ + L +
Sbjct: 61 -----NLDRAELTKLQVDGTLPVLGTLDLS-----HNQLQSLPLLGQTLPALTVLDVSFN 110
Query: 337 FRGALPHSIANLSSQLQILILSSNQFYGSIPLGIGNLVDLYLLGMVENQFTGAIPKEMGK 396
+LP +LQ L L N+ P + L L + N T +
Sbjct: 111 RLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNG 170
Query: 397 LQKLQGLDFSGNHFSGEIPSSLGNLSSLYEVFFNNNNL 434
L+ L L N IP L F + N
Sbjct: 171 LENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.6 bits (122), Expect = 2e-07
Identities = 41/212 (19%), Positives = 74/212 (34%), Gaps = 9/212 (4%)
Query: 48 TCGRRHRRVTALDLMSKSLSGSLSPHLGNLSFLREINLSNNTIQGEIPPEFGRLFRLEAL 107
+ + ++ ++L+ +L P L ++LS N + RL L
Sbjct: 5 EVSKVASHLE-VNCDKRNLT-ALPPDLPKD--TTILHLSENLLYTFSLATLMPYTRLTQL 60
Query: 108 FLSNNSLVGKIPANLSYCSRLTVLCIEYNKLQGRIPLEFVSLSKLKDLSLAKNKLTGGIP 167
L + + + +PL +L L L ++ N+LT
Sbjct: 61 NLDRAE---LTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPL 117
Query: 168 PFLGNLTSLEVLSLAGNSFGRNIPDSLGQLKQLKILAIGGNNLSGPIPPSIYNLSFLVVF 227
L L L+ L L GN P L +L+ L++ NNL+ + L L
Sbjct: 118 GALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTL 177
Query: 228 SVSHNQIHGSLPPSLGLLLPNLKFFQIHHNFF 259
+ N ++ ++P L F +H N +
Sbjct: 178 LLQENSLY-TIPKGFF-GSHLLPFAFLHGNPW 207
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 51.3 bits (122), Expect = 2e-08
Identities = 28/121 (23%), Positives = 49/121 (40%), Gaps = 7/121 (5%)
Query: 81 REINLSNNTIQGEIPPEFGRLFRLEALFLSNNSLVGKIPANLSYCSRLTVLCIEYNKLQG 140
R ++L++ + + +L + L LS+N L P L+ L VL N
Sbjct: 1 RVLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDN--AL 55
Query: 141 RIPLEFVSLSKLKDLSLAKNKLTGGIPP-FLGNLTSLEVLSLAGNSFGRNIPDSLGQLKQ 199
+L +L++L L N+L L + L +L+L GNS +L +
Sbjct: 56 ENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSL-CQEEGIQERLAE 114
Query: 200 L 200
+
Sbjct: 115 M 115
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 46.6 bits (110), Expect = 8e-07
Identities = 30/119 (25%), Positives = 49/119 (41%), Gaps = 7/119 (5%)
Query: 59 LDLMSKSLSGSLSPHLGNLSFLREINLSNNTIQGEIPPEFGRLFRLEALFLSNNSLVGKI 118
L L K L+ HL L + ++LS+N ++ +PP L LE L + +
Sbjct: 3 LHLAHKDLTVL--CHLEQLLLVTHLDLSHNRLRA-LPPALAALRCLE--VLQASDNALEN 57
Query: 119 PANLSYCSRLTVLCIEYNKLQGRIPLE-FVSLSKLKDLSLAKNKLTGGIPPFLGNLTSL 176
++ RL L + N+LQ ++ VS +L L+L N L L +
Sbjct: 58 VDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLC-QEEGIQERLAEM 115
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 45.1 bits (106), Expect = 3e-06
Identities = 28/123 (22%), Positives = 44/123 (35%), Gaps = 5/123 (4%)
Query: 155 LSLAKNKLTGGIPPFLGNLTSLEVLSLAGNSFGRNIPDSLGQLKQLKILAIGGNNLSGPI 214
L LA LT + L L + L L+ N R +P +L L+ L++L N
Sbjct: 3 LHLAHKDLT--VLCHLEQLLLVTHLDLSHNRL-RALPPALAALRCLEVLQASDNA--LEN 57
Query: 215 PPSIYNLSFLVVFSVSHNQIHGSLPPSLGLLLPNLKFFQIHHNFFSGSIPISLSNASKLE 274
+ NL L + +N++ S + P L + N I A L
Sbjct: 58 VDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLP 117
Query: 275 HIE 277
+
Sbjct: 118 SVS 120
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 42.8 bits (100), Expect = 2e-05
Identities = 21/128 (16%), Positives = 35/128 (27%), Gaps = 13/128 (10%)
Query: 328 RVLSLGGNQFRGALPHSIANLSSQLQILILSSNQFYGSIPLGIGNLVDLYLLGMVENQFT 387
RVL L + L + L LS N+ P + L L +L +N
Sbjct: 1 RVLHLAHKDLTV--LCHLEQLL-LVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALE 56
Query: 388 GAIPKEMGKLQKLQGLDFSGNHF-SGEIPSSLGNLSSLYEVFFNNNNLSGV------IPF 440
+ L N L + L + N+L +
Sbjct: 57 NVDGVANLPRLQE--LLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAE 114
Query: 441 SLGNLKRL 448
L ++ +
Sbjct: 115 MLPSVSSI 122
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 41.6 bits (97), Expect = 6e-05
Identities = 24/108 (22%), Positives = 37/108 (34%), Gaps = 7/108 (6%)
Query: 476 LNLARNHLVGIIPPRIGNLRALRSFDVSNNDLSGEIPIELGHCSSLEEIYLAGNLFHGSI 535
L+LA L + + L + D+S+N L P L LE + + N
Sbjct: 3 LHLAHKDLTVL--CHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALENVD 59
Query: 536 PSFFNALKGVQKIDLSRNNLSGQIPI--FLEALSLEYLNLSFNDFEGK 581
+Q++ L N L I + L LNL N +
Sbjct: 60 GVANL--PRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 105
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 41.2 bits (96), Expect = 8e-05
Identities = 21/125 (16%), Positives = 43/125 (34%), Gaps = 5/125 (4%)
Query: 353 QILILSSNQFYGSIPLGIGNLVDLYLLGMVENQFTGAIPKEMGKLQKLQGLDFSGNHFSG 412
++L L+ ++ + L+ + L + N+ P + L+ L+ L S N
Sbjct: 1 RVLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALE- 56
Query: 413 EIPSSLGNLSSLYEVFFNNNNLSGVIPFSLGNLKRLAFLEMSGNELSGTIPEDIFNISYL 472
+ + NN L + RL L + GN L ++ +
Sbjct: 57 NVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ-EEGIQERLAEM 115
Query: 473 SNSLN 477
S++
Sbjct: 116 LPSVS 120
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 37.8 bits (87), Expect = 0.001
Identities = 24/133 (18%), Positives = 51/133 (38%), Gaps = 13/133 (9%)
Query: 226 VFSVSHNQIHGSLPPSLGLLLPNLKFFQIHHNFFSGSIPISLSNASKLEHIEIANNNFSG 285
V ++H + ++ L L + + HN P +L+ LE ++ ++N
Sbjct: 2 VLHLAHKDL--TVLCHLEQL-LLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALEN 57
Query: 286 KLSVNFGGMKNLSLLNLQFSNLGSGESDEMGFMNSLTNCSKLRVLSLGGNQFRG--ALPH 343
V + L L L + L + + L +C +L +L+L GN +
Sbjct: 58 VDGVAN--LPRLQELLLCNNRLQQSAAIQ-----PLVSCPRLVLLNLQGNSLCQEEGIQE 110
Query: 344 SIANLSSQLQILI 356
+A + + ++
Sbjct: 111 RLAEMLPSVSSIL 123
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 54.8 bits (130), Expect = 2e-08
Identities = 55/326 (16%), Positives = 100/326 (30%), Gaps = 17/326 (5%)
Query: 150 SKLKDLSLAKNKLTGGIPPFLGNLTSLEVLSLAGNSFGRNIPDSLGQLKQLKILAIGGNN 209
+ +L L L+ +P +L SL + NS +P+ LK L +
Sbjct: 38 RQAHELELNNLGLSS-LPELPPHLESL---VASCNSL-TELPELPQSLKSLLVDNNNLKA 92
Query: 210 LSGPIPPSIYNLSFLVVFSVSHNQIHGSLPPSLGLLLPNLKFFQIHHNFFSGSIPISLSN 269
LS P Y + S + + +LK +
Sbjct: 93 LSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQL 152
Query: 270 ASKLEHIEIAN--NNFSGKLSVNFGGMKNLSLLNLQFSNLGSGESDEMGFMNSLTNCSKL 327
E + ++ S+ LSL ++ N E E+ + LT
Sbjct: 153 EELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTTIYAD 212
Query: 328 RVLSLGGNQFRGALPHSIANLSSQLQILILSSNQFYGSIPLGIGNLVDLYLLGMV-ENQF 386
L +L + + L + + + I + + + N
Sbjct: 213 NNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNAS 272
Query: 387 TGAIPKEMGKLQKLQGLDFSGNHFSGEIPSSLGNLSSLYEVFFNNNNLSGVIPFSLGNLK 446
+ I L+ L+ S N E+P+ L L + N+L+ +P NLK
Sbjct: 273 SNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLERLI---ASFNHLAE-VPELPQNLK 327
Query: 447 RLAFLEMSGNELSGTIPEDIFNISYL 472
+ L + N L P+ ++ L
Sbjct: 328 Q---LHVEYNPLR-EFPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 53.3 bits (126), Expect = 8e-08
Identities = 54/327 (16%), Positives = 102/327 (31%), Gaps = 18/327 (5%)
Query: 125 CSRLTVLCIEYNKLQGRIPLEFVSLSKLKDLSLAKNKLTGGIPPFLGNLTSLEVLSLAGN 184
+ L + L +P L+ L + N LT +P +L SL V +
Sbjct: 37 DRQAHELELNNLGLS-SLP---ELPPHLESLVASCNSLTE-LPELPQSLKSLLVDNNNLK 91
Query: 185 SFGRNIP--DSLGQLKQLKILAIGGNNLSGPIPPSIYNLSFLVVFSVSHNQIHGSLPPSL 242
+ P + LG N S + N S + + + + +
Sbjct: 92 ALSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQ 151
Query: 243 GLLLPNLKFFQIHHNFFSGSIPISLSNASKLEHIEIANNNFSGKLSVNFGGMKNLSLLNL 302
LP L+ ++ + + L I N + + L+ +
Sbjct: 152 LEELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTTIYA 211
Query: 303 QFSNLGSGESDEMGFMNS-LTNCSKLRVLSLGGNQFRGALPHSIANLSSQLQILILSSNQ 361
+ L + + + + L + + +I + S+L + N
Sbjct: 212 DNNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNA 271
Query: 362 FYGSIPLGIGNLVDLYLLGMVENQFTGAIPKEMGKLQKLQGLDFSGNHFSGEIPSSLGNL 421
I L L + N+ +P +L++L S NH + E+P NL
Sbjct: 272 SSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLERL---IASFNHLA-EVPELPQNL 326
Query: 422 SSLYEVFFNNNNLSGV--IPFSLGNLK 446
L+ N L IP S+ +L+
Sbjct: 327 KQLH---VEYNPLREFPDIPESVEDLR 350
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 49.4 bits (116), Expect = 1e-06
Identities = 21/95 (22%), Positives = 35/95 (36%), Gaps = 9/95 (9%)
Query: 108 FLSNNSLVGKIPANLSYCSRLTVLCIEYNKLQGRIPLEFVSLSKLKDLSLAKNKLTGGIP 167
N+ +I + L L + NKL +P +L+ L + N L +P
Sbjct: 266 LYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELP---ALPPRLERLIASFNHLAE-VP 320
Query: 168 PFLGNLTSLEVLSLAGNSFGRNIPDSLGQLKQLKI 202
NL L + N R PD ++ L++
Sbjct: 321 ELPQNLKQL---HVEYNPL-REFPDIPESVEDLRM 351
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 48.7 bits (114), Expect = 2e-06
Identities = 25/95 (26%), Positives = 35/95 (36%), Gaps = 9/95 (9%)
Query: 84 NLSNNTIQGEIPPEFGRLFRLEALFLSNNSLVGKIPANLSYCSRLTVLCIEYNKLQGRIP 143
N EI LE L +SNN L+ ++PA RL L +N L +P
Sbjct: 266 LYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALP---PRLERLIASFNHLA-EVP 320
Query: 144 LEFVSLSKLKDLSLAKNKLTGGIPPFLGNLTSLEV 178
LK L + N L P ++ L +
Sbjct: 321 ---ELPQNLKQLHVEYNPLR-EFPDIPESVEDLRM 351
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 45.2 bits (105), Expect = 2e-05
Identities = 23/94 (24%), Positives = 36/94 (38%), Gaps = 11/94 (11%)
Query: 481 NHLVGIIPPRIGNLRALRSFDVSNNDLSGEIPIELGHCSSLEEIYLAGNLFHGSIPSFFN 540
N I +L +VSNN L E+P LE + + N +P
Sbjct: 270 NASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPP---RLERLIASFNHL-AEVPELPQ 324
Query: 541 ALKGVQKIDLSRNNLSGQIPIFLEALSLEYLNLS 574
LK ++ + N L + P E S+E L ++
Sbjct: 325 NLK---QLHVEYNPLR-EFPDIPE--SVEDLRMN 352
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 40.2 bits (92), Expect = 9e-04
Identities = 17/94 (18%), Positives = 33/94 (35%), Gaps = 10/94 (10%)
Query: 208 NNLSGPIPPSIYNLSFLVVFSVSHNQIHGSLPPSLGLLLPNLKFFQIHHNFFSGSIPISL 267
N S I L +VS+N++ LP P L+ N + +P
Sbjct: 270 NASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALP----PRLERLIASFNHLA-EVPELP 323
Query: 268 SNASKLEHIEIANNNFSGKLSVNFGGMKNLSLLN 301
N L+ + + N + +++L + +
Sbjct: 324 QN---LKQLHVEYNPLR-EFPDIPESVEDLRMNS 353
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.4 bits (113), Expect = 4e-06
Identities = 13/96 (13%), Positives = 33/96 (34%), Gaps = 7/96 (7%)
Query: 273 LEHIEIANNNFSGK-LSVNFGGMKNLSLLNLQFSNLGSGESDEMGFMNSLTNCSKLRVLS 331
++ ++I S + ++ ++ L L ++ ++L L L+
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDIS--SALRVNPALAELN 61
Query: 332 LGGNQFRG----ALPHSIANLSSQLQILILSSNQFY 363
L N+ + + S ++Q L L +
Sbjct: 62 LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLT 97
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.0 bits (104), Expect = 4e-05
Identities = 16/88 (18%), Positives = 26/88 (29%), Gaps = 6/88 (6%)
Query: 290 NFGGMKNLSLLNLQFSNLGSGESDEMGFMNSLTNCSKLRVLSLGGNQFRG----ALPHSI 345
L +L L ++ S +L LR L L N L S+
Sbjct: 364 LGQPGSVLRVLWLADCDVSD--SSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESV 421
Query: 346 ANLSSQLQILILSSNQFYGSIPLGIGNL 373
L+ L+L + + + L
Sbjct: 422 RQPGCLLEQLVLYDIYWSEEMEDRLQAL 449
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.8 bits (101), Expect = 8e-05
Identities = 18/98 (18%), Positives = 33/98 (33%), Gaps = 13/98 (13%)
Query: 119 PANLSYCSRLTVLCIEYNKLQGR----IPLEFVSLSKLKDLSLAKNKLTGGIPPFLG--- 171
S L VL + + + ++ L++L L+ N L L
Sbjct: 362 QGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESV 421
Query: 172 --NLTSLEVLSLAGNSFGRNIPDSLGQLKQ----LKIL 203
LE L L + + D L L++ L+++
Sbjct: 422 RQPGCLLEQLVLYDIYWSEEMEDRLQALEKDKPSLRVI 459
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.4 bits (100), Expect = 1e-04
Identities = 19/90 (21%), Positives = 30/90 (33%), Gaps = 5/90 (5%)
Query: 128 LTVLCIEYNKLQGRIPLEFVS-LSKLKDLSLAKNKLTG----GIPPFLGNLTSLEVLSLA 182
+ L I+ +L E + L + + + L LT I L +L L+L
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 183 GNSFGRNIPDSLGQLKQLKILAIGGNNLSG 212
N G + Q Q I +L
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.3 bits (97), Expect = 3e-04
Identities = 16/88 (18%), Positives = 28/88 (31%), Gaps = 9/88 (10%)
Query: 398 QKLQGLDFSGNHFSGE----IPSSLGNLSSLYEVFFNNNNLSGVIPFSLG-----NLKRL 448
L+ L + S + ++L SL E+ +NN L L L
Sbjct: 369 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLL 428
Query: 449 AFLEMSGNELSGTIPEDIFNISYLSNSL 476
L + S + + + + SL
Sbjct: 429 EQLVLYDIYWSEEMEDRLQALEKDKPSL 456
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.5 bits (95), Expect = 4e-04
Identities = 9/79 (11%), Positives = 26/79 (32%), Gaps = 5/79 (6%)
Query: 175 SLEVLSLAGNSFG-RNIPDSLGQLKQLKILAIGGNNLSG----PIPPSIYNLSFLVVFSV 229
++ L + + L L+Q +++ + L+ I ++ L ++
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 230 SHNQIHGSLPPSLGLLLPN 248
N++ + L
Sbjct: 63 RSNELGDVGVHCVLQGLQT 81
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.5 bits (95), Expect = 5e-04
Identities = 18/105 (17%), Positives = 34/105 (32%), Gaps = 23/105 (21%)
Query: 474 NSLNLARNHL----VGIIPPRIGNLRALRSFDVSNNDLSGEIPIELGHCSSLEEIYLAGN 529
L LA + + + +LR D+SNN L ++L
Sbjct: 372 RVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVE------------ 419
Query: 530 LFHGSIPSFFNALKGVQKIDLSRNNLSGQIPIFLEALSLEYLNLS 574
S ++++ L S ++ L+AL + +L
Sbjct: 420 -------SVRQPGCLLEQLVLYDIYWSEEMEDRLQALEKDKPSLR 457
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.1 bits (94), Expect = 6e-04
Identities = 12/81 (14%), Positives = 26/81 (32%), Gaps = 9/81 (11%)
Query: 376 LYLLGMVENQFTG----AIPKEMGKLQKLQGLDFSGNHFSGEIPSSLG-----NLSSLYE 426
L +L + + + ++ + L+ LD S N L L +
Sbjct: 371 LRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQ 430
Query: 427 VFFNNNNLSGVIPFSLGNLKR 447
+ + S + L L++
Sbjct: 431 LVLYDIYWSEEMEDRLQALEK 451
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.1 bits (94), Expect = 6e-04
Identities = 18/98 (18%), Positives = 32/98 (32%), Gaps = 8/98 (8%)
Query: 310 GESDEMGFMNSLTNCSKLRVLSLGGNQFRGALPHSIANL---SSQLQILILSSNQFYGSI 366
S LRVL L + S+A + L+ L LS+N +
Sbjct: 354 DAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAG 413
Query: 367 PLGIG-----NLVDLYLLGMVENQFTGAIPKEMGKLQK 399
L + L L + + ++ + + L+K
Sbjct: 414 ILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQALEK 451
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.3 bits (92), Expect = 0.001
Identities = 24/155 (15%), Positives = 39/155 (25%), Gaps = 29/155 (18%)
Query: 35 WNDSRHFCEWEGITCGRRHRRVTALDLMSKSLSGSLSPHLGNLSFLREINLSNNTIQGEI 94
HF +++ L + S LR + L++ +
Sbjct: 326 AACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSS 385
Query: 95 PPEFGRLFRLEALFLSNNSLVGKIPANLSYCSRLTVLCIEYNKLQGRIPLEFVS-----L 149
+ A L L L + N L L+ V
Sbjct: 386 --------------------CSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPG 425
Query: 150 SKLKDLSLAKNKLTGGIPPFLGNL----TSLEVLS 180
L+ L L + + L L SL V+S
Sbjct: 426 CLLEQLVLYDIYWSEEMEDRLQALEKDKPSLRVIS 460
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.3 bits (92), Expect = 0.001
Identities = 13/81 (16%), Positives = 26/81 (32%), Gaps = 8/81 (9%)
Query: 296 NLSLLNLQFSNLGSGESDEMGFMNSLTNCSKLRVLSLGGNQFRGALPHSIANL---SSQL 352
++ L++Q L + L + +V+ L A I++ + L
Sbjct: 3 DIQSLDIQCEELSDA-----RWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPAL 57
Query: 353 QILILSSNQFYGSIPLGIGNL 373
L L SN+ +
Sbjct: 58 AELNLRSNELGDVGVHCVLQG 78
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.3 bits (92), Expect = 0.001
Identities = 12/93 (12%), Positives = 25/93 (26%), Gaps = 5/93 (5%)
Query: 475 SLNLARNHLVGIIPPRI-GNLRALRSFDVSNNDLSGE----IPIELGHCSSLEEIYLAGN 529
SL++ L + L+ + + + L+ I L +L E+ L N
Sbjct: 6 SLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSN 65
Query: 530 LFHGSIPSFFNALKGVQKIDLSRNNLSGQIPIF 562
+ + +L
Sbjct: 66 ELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTG 98
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.0 bits (91), Expect = 0.001
Identities = 12/91 (13%), Positives = 28/91 (30%), Gaps = 9/91 (9%)
Query: 451 LEMSGNELSGTIPEDIFNISYLSNSLNLARNHL----VGIIPPRIGNLRALRSFDVSNND 506
L++ ELS ++ + + L L I + AL ++ +N+
Sbjct: 7 LDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNE 66
Query: 507 LSGEIPIELGH-----CSSLEEIYLAGNLFH 532
L + ++++ L
Sbjct: 67 LGDVGVHCVLQGLQTPSCKIQKLSLQNCCLT 97
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.8 bits (88), Expect = 0.003
Identities = 12/70 (17%), Positives = 22/70 (31%), Gaps = 6/70 (8%)
Query: 520 SLEEIYLAGN-LFHGSIPSFFNALKGVQKIDLSRNNLSGQIPIFL-EAL----SLEYLNL 573
++ + + L L+ Q + L L+ + AL +L LNL
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 574 SFNDFEGKIP 583
N+
Sbjct: 63 RSNELGDVGV 72
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.3 bits (106), Expect = 5e-06
Identities = 29/137 (21%), Positives = 51/137 (37%), Gaps = 7/137 (5%)
Query: 71 SPHLGNLSFLREINLSNNTIQGEIPPEFGRLFRLEALFLSNNSLVGKIPANLSYCSRLTV 130
+ N RE++L I I L + +A+ S+N + + RL
Sbjct: 11 AAQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEI--RKLDGFPLLRRLKT 67
Query: 131 LCIEYNKLQGRIPLEFVSLSKLKDLSLAKNKLTG-GIPPFLGNLTSLEVLSLAGNSFGRN 189
L + N++ +L L +L L N L G L +L SL L + N
Sbjct: 68 LLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNK 127
Query: 190 I---PDSLGQLKQLKIL 203
+ ++ Q+++L
Sbjct: 128 KHYRLYVIYKVPQVRVL 144
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.2 bits (98), Expect = 6e-05
Identities = 26/139 (18%), Positives = 44/139 (31%), Gaps = 8/139 (5%)
Query: 320 SLTNCSKLRVLSLGGNQFRGALPHSIANLSSQLQILILSSNQFYGSIPLGIGNLVDLYLL 379
TN + R L L G + + + A L Q + S N+ + G L L L
Sbjct: 13 QYTNAVRDRELDLRGYKIP-VIENLGATL-DQFDAIDFSDNEIR-KLD-GFPLLRRLKTL 68
Query: 380 GMVENQFTGAIPKEMGKLQKLQGLDFSGNHFSG-EIPSSLGNLSSLYEVFFNNNN---LS 435
+ N+ L L L + N L +L SL + N
Sbjct: 69 LVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKK 128
Query: 436 GVIPFSLGNLKRLAFLEMS 454
+ + + ++ L+
Sbjct: 129 HYRLYVIYKVPQVRVLDFQ 147
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 45.2 bits (105), Expect = 1e-05
Identities = 33/178 (18%), Positives = 64/178 (35%), Gaps = 6/178 (3%)
Query: 401 QGLDFSGNHFSGEIPSSLGNLSSLYEVFFNNNNLSGVIPFSLGNLKRLAFLEMSGNELSG 460
+D +G EIP + E+ N+N L + L
Sbjct: 11 TTVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT 67
Query: 461 TIPEDIFNISYLSNSLNLARNHLVGIIPPRIGNLRALRSFDVSNNDLSGEIPIELGHCSS 520
I + F + L L N + I L L++ ++ +N +S +P H +S
Sbjct: 68 GIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNS 127
Query: 521 LEEIYLAGNLFHGSIPSFFNALKGVQKIDLSRNNLSGQIPIFLEALSLEYLNLSFNDF 578
L + LA N F+ + + + ++K L+ P + + + +L ++F
Sbjct: 128 LTSLNLASNPFNCNCHLAWF-AEWLRKKSLNGGAARCGAPSKVRDVQI--KDLPHSEF 182
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 46.4 bits (108), Expect = 1e-05
Identities = 43/338 (12%), Positives = 96/338 (28%), Gaps = 29/338 (8%)
Query: 140 GRIPLEFVSLSKLKDLSLAKNKLTGGIPPFLGNLTSLEVLSLAGNSFG----RNIPDSLG 195
R +E SL KL ++ K + L S++ + L+GN+ G R + +++
Sbjct: 1 ARFSIEGKSL-KLDAITTEDEK---SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIA 56
Query: 196 QLKQLKILAIGGN---NLSGPIPPSIYNLSFLVVFSVSHNQIHGSLPPSLGLLLPNLKFF 252
K L+I + IP ++ L ++ + + S L F
Sbjct: 57 SKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDF 116
Query: 253 QIHHNFFSGSI--PISLSNASKLEHIEIANNNFSGKLSVNFGGMKNLSLLNLQFSNLGSG 310
H L + + K + N ++++ + N
Sbjct: 117 LSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMK 176
Query: 311 ESDEMGFMN---SLTNCSKLRVLSLGGNQFRGALPHSIANLSSQLQILILSSNQFYGSIP 367
E + + + + G L ++ ++
Sbjct: 177 EWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALA 236
Query: 368 LGIGNLVDLYLLGMVENQFTGAIPKEMG------KLQKLQGLDFSGNHFSGEIPSSL--- 418
+ + + +L LG+ + + + + LQ L N + +L
Sbjct: 237 IALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTV 296
Query: 419 --GNLSSLYEVFFNNNNLS--GVIPFSLGNLKRLAFLE 452
+ L + N N S + + +
Sbjct: 297 IDEKMPDLLFLELNGNRFSEEDDVVDEIREVFSTRGRG 334
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 44.9 bits (104), Expect = 3e-05
Identities = 54/339 (15%), Positives = 102/339 (30%), Gaps = 33/339 (9%)
Query: 59 LDLMSKSLSGSLSPHLGNLSFLREINLSNNTIQGE----IPPEFGRLFRLEALFLSNNS- 113
LD ++ S+ L ++EI LS NTI E + LE S+
Sbjct: 12 LDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFT 71
Query: 114 --LVGKIPANLSYCSRLTVLCIEYNKLQGRIPLEFVSLSKLKDLSLAKNKLTGGIPPFLG 171
+ +IP L + + C + + ++ + + L+K+ +
Sbjct: 72 GRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNN 131
Query: 172 NLTSLEVLSLAGNSFGRNIPDSLGQLKQLKILAIGGNNLSGPIPPSIYNLSFLVVFSVSH 231
L +A + L+ + G N L + S
Sbjct: 132 GLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLE----------------NGSM 175
Query: 232 NQIHGSLPPSLGLLLPNLKFFQIHHNFFSGSIPISLSNASKLEHIEIANNNFS----GKL 287
+ + L + I + L+ +L+ +++ +N F+ L
Sbjct: 176 KEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSAL 235
Query: 288 SVNFGGMKNLSLLNLQFSNLGSGESDEMGFMNSLTNCSKLRVLSLGGNQFRG----ALPH 343
++ NL L L L + + + S L+ L L N+ L
Sbjct: 236 AIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKT 295
Query: 344 SIANLSSQLQILILSSNQFY--GSIPLGIGNLVDLYLLG 380
I L L L+ N+F + I + G
Sbjct: 296 VIDEKMPDLLFLELNGNRFSEEDDVVDEIREVFSTRGRG 334
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 42.2 bits (97), Expect = 3e-04
Identities = 43/313 (13%), Positives = 77/313 (24%), Gaps = 30/313 (9%)
Query: 297 LSLLNLQFSNLGSGESDEMGFMNSLTNCSKLRVLSLGGNQFRGALPHSIANL---SSQLQ 353
S+ DE L ++ + L GN ++ L+
Sbjct: 3 FSIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLE 62
Query: 354 ILILSSNQFY---GSIPLGIGNLVDLYLLGMVENQFTGAIPKEMGKLQKLQGLDFSGNHF 410
I S IP + L+ L + + Q+ S +
Sbjct: 63 IAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTP 122
Query: 411 SGEIPSSLGNLSSLYEVFFNNNNLSGVIPFSLGNLKRLAFLEMSGNELSGTIPEDIFNIS 470
+ L + N L + N L ++
Sbjct: 123 LEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTF 182
Query: 471 YLSNSLNLARNHLVGIIPPRIGN------------LRALRSFDVSNNDLSGEIPIELGHC 518
L+ + GI P I + + + S + I L
Sbjct: 183 QSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSW 242
Query: 519 SSLEEIYLAGNLFHGSIPSF------FNALKGVQKIDLSRNNLSGQIPIFLEAL------ 566
+L E+ L L + G+Q + L N + L+ +
Sbjct: 243 PNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMP 302
Query: 567 SLEYLNLSFNDFE 579
L +L L+ N F
Sbjct: 303 DLLFLELNGNRFS 315
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 39.5 bits (90), Expect = 0.001
Identities = 13/71 (18%), Positives = 24/71 (33%), Gaps = 6/71 (8%)
Query: 143 PLEFVSLSKLKDLSLAKNKLTGGIPPFL-----GNLTSLEVLSLAGNSFGRNIPDSLGQL 197
+ L+ L L N++ L + L L L GN F D + ++
Sbjct: 266 AFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS-EEDDVVDEI 324
Query: 198 KQLKILAIGGN 208
+++ G
Sbjct: 325 REVFSTRGRGE 335
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 39.1 bits (89), Expect = 0.002
Identities = 39/323 (12%), Positives = 79/323 (24%), Gaps = 33/323 (10%)
Query: 248 NLKFFQIHHNFFSGSIPISLSNASKLEHIEIANNNFSGK----LSVNFGGMKNLSLLNLQ 303
+LK I S+ L ++ I ++ N + LS N K+L +
Sbjct: 9 SLKLDAITTEDEK-SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFS 67
Query: 304 FSNLGSGESDEMGFMNSLTNCSKLRVLSLGGNQFRGALPHSIANLSSQLQILILSSNQFY 363
G + + + L ++ + + I LS +
Sbjct: 68 DIFTGRVKDEIPEALRLLLQALL----KCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPL 123
Query: 364 GSIPLGIGNLVDLYLLGMVENQFTGAIPKEMGKLQKLQGLDFSGNHFSGEIPSS------ 417
+ L L + A+ K+ L+ + N
Sbjct: 124 EHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQ 183
Query: 418 ------LGNLSSLYEVFFNNNNLSGVIPFSLGNLKRLAFLEMSGNELSGTIPEDIFNISY 471
+ +L LK L + + L +
Sbjct: 184 SHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWP 243
Query: 472 LSNSLNLARNHLVGIIPPRIGN------LRALRSFDVSNNDLSGEIPIEL-----GHCSS 520
L L L + + L++ + N++ + L
Sbjct: 244 NLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPD 303
Query: 521 LEEIYLAGNLFHGSIPSFFNALK 543
L + L GN F + ++
Sbjct: 304 LLFLELNGNRF-SEEDDVVDEIR 325
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 45.0 bits (105), Expect = 2e-05
Identities = 30/216 (13%), Positives = 72/216 (33%), Gaps = 22/216 (10%)
Query: 365 SIPLGIG------NLVDLYLLGMVENQFTGAIPKEMGKLQKLQGLDFSGNHFSGEIPSSL 418
++P I + + + T A+ + +L + + + + +
Sbjct: 9 TVPTPIKQIFSDDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQG--I 64
Query: 419 GNLSSLYEVFFNNNNLSGVIPFSLGNLKRLAFLEMSGNELSGTIPEDIFNISYLSNSLNL 478
L ++ ++F N N L+ + P + NLK L +L + N++ + +
Sbjct: 65 QYLPNVTKLFLNGNKLTDIKPLA--NLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHN 122
Query: 479 ARNHLVGIIPPRIGNLRALRSFDVSNNDLSGEIPIELGHCSSLEEIYLAGNLFHGSIPSF 538
+ + G++ + +N + L + I
Sbjct: 123 GISDINGLVHLPQLE----SLYLGNNKITDITVLSRLTKLD----TLSLEDNQISDIVPL 174
Query: 539 FNALKGVQKIDLSRNNLSGQIPIFLEALSLEYLNLS 574
L +Q + LS+N++S + +L+ L L
Sbjct: 175 AG-LTKLQNLYLSKNHISD-LRALAGLKNLDVLELF 208
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 44.6 bits (104), Expect = 2e-05
Identities = 19/61 (31%), Positives = 33/61 (54%), Gaps = 4/61 (6%)
Query: 121 NLSYCSRLTVLCIEYNKLQGRIPLEFVSLSKLKDLSLAKNKLTGGIPPFLGNLTSLEVLS 180
L+ S+LT L + NK+ PL SL L ++ L N+++ P L N ++L +++
Sbjct: 168 PLANLSKLTTLKADDNKISDISPLA--SLPNLIEVHLKNNQISDVSP--LANTSNLFIVT 223
Query: 181 L 181
L
Sbjct: 224 L 224
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 44.6 bits (104), Expect = 2e-05
Identities = 43/242 (17%), Positives = 77/242 (31%), Gaps = 28/242 (11%)
Query: 190 IPDSLGQLKQLKILAIGGNNLSGPIPPSIYNLSFLVVFSVSHNQIHGSLPPSLGLLLPNL 249
PD L +A G +N++ + + +L + S + ++ L NL
Sbjct: 13 FPDP--ALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVT-TIEGVQYL--NNL 65
Query: 250 KFFQIHHNFFSGSIPISLSNASKLEHIEIANNNFSGKLSVNFGGMKNLSLLNLQFSNLGS 309
++ N + P+ + ++
Sbjct: 66 IGLELKDNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTST-------- 117
Query: 310 GESDEMGFMNSLTNCSKLRVLSLGGNQFRGALPHSIANLSSQLQILILSSNQFYGSIPLG 369
++ + L S L+VL L NQ +I+ L+ + LS S
Sbjct: 118 ----QITDVTPLAGLSNLQVLYLDLNQI-----TNISPLAGLTNLQYLSIGNAQVSDLTP 168
Query: 370 IGNLVDLYLLGMVENQFTGAIPKEMGKLQKLQGLDFSGNHFSGEIPSSLGNLSSLYEVFF 429
+ NL L L +N+ + P + L L + N S P L N S+L+ V
Sbjct: 169 LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTL 224
Query: 430 NN 431
N
Sbjct: 225 TN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 43.9 bits (102), Expect = 4e-05
Identities = 30/198 (15%), Positives = 65/198 (32%), Gaps = 13/198 (6%)
Query: 264 PISLSNASKLEHIEIANNNFSGKLSVNFGGMKNLSLLNLQFSNLGSGESDEMGFMNSLTN 323
++ ++ + + + + + NL L L+ + + + +
Sbjct: 34 TVTQADLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLELKDNQITDLAPLKNLTKITELE 91
Query: 324 CSKLRVLSLGGNQFRGALPHSIANLSSQLQILILSSNQFYGSIPLGIGNLVDLYLLGMVE 383
S + ++ ++ + + L+ + L + + ++ L +
Sbjct: 92 LSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVLYLDLNQITNISPLAGLT 151
Query: 384 NQFTGAIPKEM-------GKLQKLQGLDFSGNHFSGEIPSSLGNLSSLYEVFFNNNNLSG 436
N +I L KL L N S P L +L +L EV NN +S
Sbjct: 152 NLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISD 209
Query: 437 VIPFSLGNLKRLAFLEMS 454
V P L N L + ++
Sbjct: 210 VSP--LANTSNLFIVTLT 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 41.6 bits (96), Expect = 2e-04
Identities = 26/216 (12%), Positives = 59/216 (27%), Gaps = 20/216 (9%)
Query: 372 NLVDLYLLGMVENQFTGAIPKEMGKLQKLQGLDFSGNHFSGEIPSSLGNLSSLYEVFFNN 431
L + + ++ T + + L + L G + + L++L + +
Sbjct: 17 ALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKD 72
Query: 432 NNLSGVIPFSLGNLKRLAFLEMSGNELSGTIPEDIFNISYLSNSLNLAR----------- 480
N ++ + P L + + I + S +
Sbjct: 73 NQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQ 132
Query: 481 --NHLVGIIPPRIGNLRALRSFDVSNNDLSGEIPIELGHCSSLEEIYLAGNLFHGSIPSF 538
+ I +S + L + S L + N P
Sbjct: 133 VLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP-- 190
Query: 539 FNALKGVQKIDLSRNNLSGQIPIFLEALSLEYLNLS 574
+L + ++ L N +S P +L + L+
Sbjct: 191 LASLPNLIEVHLKNNQISDVSP-LANTSNLFIVTLT 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 41.2 bits (95), Expect = 3e-04
Identities = 33/217 (15%), Positives = 69/217 (31%), Gaps = 22/217 (10%)
Query: 323 NCSKLRVLSLGGNQFRGALPHSIANLSSQLQILILSSNQFYGSIPLGIGNLVDLYLLGMV 382
+ ++ G + + + A+L + L +I G+ L +L L +
Sbjct: 17 ALANAIKIAAGKSNVTDTV--TQADLDG-ITTLSAFGTGVT-TIE-GVQYLNNLIGLELK 71
Query: 383 ENQFTGAIPKE--------MGKLQKLQGLDFSGNHFSGEIPSSLGNLSSLYEVFFNNNNL 434
+NQ T P + L+ + S + + +NL
Sbjct: 72 DNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNL 131
Query: 435 SGVIPFSLGNLKRLAFLEMSGNELSGTIPEDIFNISYLSNSLNL-----ARNHLVGIIPP 489
+ ++ + + +++ L+N L N + I P
Sbjct: 132 QVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP- 190
Query: 490 RIGNLRALRSFDVSNNDLSGEIPIELGHCSSLEEIYL 526
+ +L L + NN +S P L + S+L + L
Sbjct: 191 -LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTL 224
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 38.1 bits (87), Expect = 0.003
Identities = 17/77 (22%), Positives = 27/77 (35%), Gaps = 4/77 (5%)
Query: 35 WNDSRHFCEWEGITCGRRHRRVTALDLMSKSLSGSLSPHLGNLSFLREINLSNNTIQGEI 94
S + +T ++T L +S L +L L E++L NN I
Sbjct: 154 QYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDI--SPLASLPNLIEVHLKNNQISDVS 211
Query: 95 PPEFGRLFRLEALFLSN 111
P L + L+N
Sbjct: 212 P--LANTSNLFIVTLTN 226
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.2 bits (93), Expect = 3e-04
Identities = 21/98 (21%), Positives = 40/98 (40%), Gaps = 3/98 (3%)
Query: 72 PHLGNLSFLREINLSNNTIQGEIPPEFGRLFRLEALFLSNNSLVGK--IPANLSYCSRLT 129
P L + +N ++ + + L +L LSNN L + + + L
Sbjct: 36 PDLVAQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLK 94
Query: 130 VLCIEYNKLQGRIPLEFVSLSKLKDLSLAKNKLTGGIP 167
+L + N+L+ L+ + KL++L L N L+
Sbjct: 95 ILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFR 132
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.7 bits (88), Expect = 0.002
Identities = 29/237 (12%), Positives = 60/237 (25%), Gaps = 8/237 (3%)
Query: 125 CSRLTVLCIEYNKLQGRIPLEFVSLSKLKDLSLAKNKLTGGIPPFLGNLTSLEVLSLAGN 184
CS LC + +K+ IP + +L KL LE + ++ N
Sbjct: 8 CSNRVFLC-QESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQN 63
Query: 185 SFGRNIPDSLGQLKQLKILAIGGNNLSGPIPPSIYNLSFLVVFSVSHNQIHGSLPPSLGL 244
I + + + + + + P +
Sbjct: 64 DVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHK 123
Query: 245 LLPNLKFFQIHHNFFSGSIPISLSNASKLEHIEIANNNFSGKLSVNFGGMKNLSLLNLQF 304
+ K + + S I N +G ++ L L
Sbjct: 124 IHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNL 183
Query: 305 SNLGSGESDEMGFMNSLTNCSKLRVLSLGGNQFRGALPHSIANLSSQLQILILSSNQ 361
S + E + S +L + + + + NL L+ + +
Sbjct: 184 S---DNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKK-LRARSTYNLK 236
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.7 bits (88), Expect = 0.002
Identities = 32/229 (13%), Positives = 55/229 (24%), Gaps = 9/229 (3%)
Query: 207 GNNLSGPIPPSIYNLSFLVVFSVSHNQIHGSLPPSLGLLLPNLKFFQIHHNFFSGSIPIS 266
+ ++ IP + + ++ + +L+ +I N I
Sbjct: 17 ESKVTE-IPSDL--PRNAIELRFVLTKLRV-IQKGAFSGFGDLEKIEISQNDVLEVIEAD 72
Query: 267 LSNASKLEHIEIANNNFSGKLSVNFGGMKNLSLLNLQFSNLGSGESDEMGFMNSLTNCSK 326
+ + H + +L L SN G ++ ++SL
Sbjct: 73 VFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLL 132
Query: 327 LRVLSLGGNQFRGALPHSIANLSSQLQILILSSNQFYGSIPLGIGNLVDLYLLGMVENQF 386
+S LS + IL L+ N L N
Sbjct: 133 DIQ---DNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNL 189
Query: 387 TGAIPKEMGKLQKLQGLDFSGNHFSGEIPSSLGNLSSLYEVFFNNNNLS 435
LD S L NL L + NL
Sbjct: 190 EELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRA--RSTYNLK 236
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.0 bits (86), Expect = 0.004
Identities = 13/75 (17%), Positives = 25/75 (33%)
Query: 107 LFLSNNSLVGKIPANLSYCSRLTVLCIEYNKLQGRIPLEFVSLSKLKDLSLAKNKLTGGI 166
L+L+ N + + + + N L+ F S L +++ ++
Sbjct: 158 LWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLP 217
Query: 167 PPFLGNLTSLEVLSL 181
L NL L S
Sbjct: 218 SYGLENLKKLRARST 232
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 1008 | |||
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.98 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.96 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.95 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.93 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.93 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.92 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.91 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.88 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.88 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.85 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.84 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.81 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.78 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.77 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.76 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.74 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.74 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.73 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.73 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.73 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.7 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.69 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.69 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.68 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.51 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.49 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.48 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.48 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.46 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.46 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.42 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.41 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.35 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.35 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.24 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.23 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.51 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.41 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.41 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.8 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.53 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.3 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.21 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.17 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.66 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 96.46 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 96.17 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.1 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-49 Score=419.72 Aligned_cols=254 Identities=22% Similarity=0.305 Sum_probs=203.9
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEecccc-chhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceE
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC-EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFK 761 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 761 (1008)
.++|++.+.||+|+||+||+|+++.+|+.||||+++... ....+.+.+|++++++++||||+++++++ .+++..
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~-----~~~~~~ 78 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR-----REGNIQ 78 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEE-----EETTEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeee-----ccCcee
Confidence 357999999999999999999999899999999997543 23446799999999999999999999994 566789
Q ss_pred EEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEc
Q 045798 762 AIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIG 841 (1008)
Q Consensus 762 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 841 (1008)
|+|||||++|+|.+++.... .+++.+++.++.||+.||+|||++ +|+||||||+|||+++++.+||+
T Consensus 79 ~ivmEy~~gg~L~~~l~~~~----------~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~ 145 (271)
T d1nvra_ 79 YLFLEYCSGGELFDRIEPDI----------GMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKIS 145 (271)
T ss_dssp EEEEECCTTEEGGGGSBTTT----------BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEEC
T ss_pred EEEEeccCCCcHHHHHhcCC----------CCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEc
Confidence 99999999999999997654 799999999999999999999998 99999999999999999999999
Q ss_pred ccCcccccccccCccccccccccccccccCccccCCCCC-CcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHhh
Q 045798 842 DFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEV-STNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMA 920 (1008)
Q Consensus 842 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~~ 920 (1008)
|||+|+........ ......+||+.|+|||++.+..+ +.++||||+||++|||++|+.||.................
T Consensus 146 DFG~a~~~~~~~~~--~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~ 223 (271)
T d1nvra_ 146 DFGLATVFRYNNRE--RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK 223 (271)
T ss_dssp CCTTCEECEETTEE--CCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTC
T ss_pred cchhheeeccCCcc--ccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC
Confidence 99999876543221 12334679999999999988776 5789999999999999999999975432222111111100
Q ss_pred CCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 921 LPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 921 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
.. .......+.++.+++.+||+.||++|||++|+++
T Consensus 224 ~~------------------------------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 224 TY------------------------------LNPWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp TT------------------------------STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CC------------------------------CCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 00 0001123456789999999999999999999865
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-49 Score=419.38 Aligned_cols=262 Identities=30% Similarity=0.442 Sum_probs=203.0
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccc--cchhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCce
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQ--CEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDF 760 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 760 (1008)
.++|++.+.||+|+||+||+|+.. ..||||+++.. .....+.|.+|++++++++|||||++++++. ++.
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~------~~~ 77 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST------APQ 77 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC------SSS
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe------ccE
Confidence 467999999999999999999864 35999999744 3445678999999999999999999999853 234
Q ss_pred EEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEE
Q 045798 761 KAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHI 840 (1008)
Q Consensus 761 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 840 (1008)
.++|||||++|+|.+++..... ++++..+..|+.||++||+|||+. +||||||||+|||++.++.+||
T Consensus 78 ~~lv~Ey~~~g~L~~~l~~~~~---------~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl 145 (276)
T d1uwha_ 78 LAIVTQWCEGSSLYHHLHIIET---------KFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKI 145 (276)
T ss_dssp CEEEEECCCEEEHHHHHHTSCC---------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEE
T ss_pred EEEEEecCCCCCHHHHHhhccC---------CCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEE
Confidence 7999999999999999975432 689999999999999999999997 9999999999999999999999
Q ss_pred cccCcccccccccCccccccccccccccccCccccCC---CCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHH
Q 045798 841 GDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLG---SEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFA 917 (1008)
Q Consensus 841 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~ 917 (1008)
+|||+|+......... ......||+.|+|||++.+ ..|+.++|||||||++|||+||+.||..............
T Consensus 146 ~DFGla~~~~~~~~~~--~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~ 223 (276)
T d1uwha_ 146 GDFGLATVKSRWSGSH--QFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVG 223 (276)
T ss_dssp CCCCCSCC--------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHH
T ss_pred ccccceeeccccCCcc--cccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHh
Confidence 9999998665432221 2234569999999999864 3588999999999999999999999864321111111111
Q ss_pred HhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHHHHHHHH
Q 045798 918 RMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHELQSVKNI 994 (1008)
Q Consensus 918 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~i~~~ 994 (1008)
....++.. ......++.++.+++.+||+.||++||||+||++.|+.+++.
T Consensus 224 ~~~~~p~~---------------------------~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~ 273 (276)
T d1uwha_ 224 RGYLSPDL---------------------------SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARS 273 (276)
T ss_dssp HTSCCCCG---------------------------GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred cCCCCCcc---------------------------hhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHc
Confidence 10001000 001123456789999999999999999999999999988754
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-48 Score=418.74 Aligned_cols=250 Identities=23% Similarity=0.287 Sum_probs=206.9
Q ss_pred cCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccchhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceEEE
Q 045798 684 NGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKAI 763 (1008)
Q Consensus 684 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 763 (1008)
++|++.+.||+|+||+||+|++..+|+.||||+++.......+.+.+|++++++++||||+++++++ .+++..|+
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~-----~~~~~~~i 94 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY-----LVGDELWV 94 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEE-----EETTEEEE
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEE-----EECCEEEE
Confidence 4799999999999999999999989999999999876566667899999999999999999999994 55677999
Q ss_pred EEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEccc
Q 045798 764 VYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDF 843 (1008)
Q Consensus 764 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 843 (1008)
|||||++|+|.+++... .+++.+++.++.||+.||+|||++ +||||||||+|||++.++.+||+||
T Consensus 95 vmEy~~gg~L~~~~~~~-----------~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DF 160 (293)
T d1yhwa1 95 VMEYLAGGSLTDVVTET-----------CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDF 160 (293)
T ss_dssp EEECCTTCBHHHHHHHS-----------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCC
T ss_pred EEEecCCCcHHHHhhcc-----------CCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccc
Confidence 99999999999987643 689999999999999999999998 9999999999999999999999999
Q ss_pred CcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCc
Q 045798 844 GLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMALPN 923 (1008)
Q Consensus 844 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~~~~~ 923 (1008)
|+|+........ .....||+.|+|||++.+..++.++||||+||++|||++|+.||......+. .........+
T Consensus 161 G~a~~~~~~~~~----~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~-~~~~~~~~~~- 234 (293)
T d1yhwa1 161 GFCAQITPEQSK----RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA-LYLIATNGTP- 234 (293)
T ss_dssp TTCEECCSTTCC----BCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-HHHHHHHCSC-
T ss_pred hhheeecccccc----ccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHH-HHHHHhCCCC-
Confidence 999876443222 2335699999999999999999999999999999999999999864211100 0001000000
Q ss_pred chhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 924 QVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 924 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
........+.++.+++.+||+.||.+|||++|+++
T Consensus 235 ----------------------------~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 235 ----------------------------ELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp ----------------------------CCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred ----------------------------CCCCcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00011124556889999999999999999999975
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-48 Score=414.05 Aligned_cols=258 Identities=23% Similarity=0.358 Sum_probs=197.9
Q ss_pred cCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccchhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceEEE
Q 045798 684 NGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKAI 763 (1008)
Q Consensus 684 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 763 (1008)
++|++.+.||+|+||+||+|++. +++.||||+++.. ....++|.+|++++++++||||++++|+|. .++..++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~-----~~~~~~l 77 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCL-----EQAPICL 77 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-----SSSSCEE
T ss_pred HHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCC-cCcHHHHHHHHHHHHhcCCCCcccccceec-----cCCceEE
Confidence 57889999999999999999986 6789999999754 334578999999999999999999999964 4566899
Q ss_pred EEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEccc
Q 045798 764 VYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDF 843 (1008)
Q Consensus 764 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 843 (1008)
||||+++|+|.+++..... .+++..++.|+.|||.||+|||+. +|+||||||+||++++++.+||+||
T Consensus 78 v~E~~~~g~L~~~l~~~~~---------~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DF 145 (263)
T d1sm2a_ 78 VFEFMEHGCLSDYLRTQRG---------LFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDF 145 (263)
T ss_dssp EEECCTTCBHHHHHHTTTT---------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSC
T ss_pred EEEecCCCcHHHHhhcccc---------CCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEeccc
Confidence 9999999999999875532 689999999999999999999998 9999999999999999999999999
Q ss_pred CcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCc
Q 045798 844 GLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMALPN 923 (1008)
Q Consensus 844 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~~~~~ 923 (1008)
|+|+......... .....||+.|+|||++.+..++.++|||||||++|||+||..|+...... ............
T Consensus 146 Gla~~~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~-~~~~~~i~~~~~- 220 (263)
T d1sm2a_ 146 GMTRFVLDDQYTS---STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN-SEVVEDISTGFR- 220 (263)
T ss_dssp C---------------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCH-HHHHHHHHHTCC-
T ss_pred chheeccCCCcee---ecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCH-HHHHHHHHhcCC-
Confidence 9998665433221 22346899999999999999999999999999999999965554321111 001111100000
Q ss_pred chhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHHHHHHHH
Q 045798 924 QVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHELQSVKNI 994 (1008)
Q Consensus 924 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~i~~~ 994 (1008)
.. ....++.++.+++.+||+.||++||||+||++.|+++++.
T Consensus 221 -------------------------~~----~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~es 262 (263)
T d1sm2a_ 221 -------------------------LY----KPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262 (263)
T ss_dssp -------------------------CC----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -------------------------CC----CccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhC
Confidence 00 0012345689999999999999999999999999998763
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.8e-49 Score=413.27 Aligned_cols=246 Identities=22% Similarity=0.341 Sum_probs=204.2
Q ss_pred cCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccc---cchhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCce
Q 045798 684 NGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQ---CEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDF 760 (1008)
Q Consensus 684 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 760 (1008)
++|++.+.||+|+||+||+|+++.+++.||+|++... .....+.+.+|++++++++||||+++++++ .+++.
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~-----~~~~~ 80 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF-----HDATR 80 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECSSE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEE-----EECCE
Confidence 5799999999999999999999989999999998633 234456789999999999999999999994 56778
Q ss_pred EEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEE
Q 045798 761 KAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHI 840 (1008)
Q Consensus 761 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 840 (1008)
.|+|||||++|+|.+++.... .+++..++.++.||+.||+|||++ +||||||||+|||++.++.+||
T Consensus 81 ~~ivmEy~~~g~L~~~l~~~~----------~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl 147 (263)
T d2j4za1 81 VYLILEYAPLGTVYRELQKLS----------KFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKI 147 (263)
T ss_dssp EEEEEECCTTCBHHHHHHHHS----------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEE
T ss_pred EEEEEeecCCCcHHHHHhhcC----------CCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEee
Confidence 999999999999999997654 789999999999999999999998 9999999999999999999999
Q ss_pred cccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHhh
Q 045798 841 GDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMA 920 (1008)
Q Consensus 841 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~~ 920 (1008)
+|||+|+....... ....||+.|+|||++.+..++.++|||||||++|||++|+.||......+ .......
T Consensus 148 ~DFG~a~~~~~~~~------~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~-~~~~i~~-- 218 (263)
T d2j4za1 148 ADFGWSVHAPSSRR------TTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE-TYKRISR-- 218 (263)
T ss_dssp CCCCSCSCCCCCCC------EETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHHHHHT--
T ss_pred cccceeeecCCCcc------cccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHH-HHHHHHc--
Confidence 99999986543321 23469999999999999999999999999999999999999986421100 0000000
Q ss_pred CCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 921 LPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 921 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
... .++ ...+.++.+++.+||+.||++|||++|+++
T Consensus 219 --------------~~~----------~~p------~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 219 --------------VEF----------TFP------DFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp --------------TCC----------CCC------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --------------CCC----------CCC------ccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 000 000 123456789999999999999999999986
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5.4e-49 Score=421.87 Aligned_cols=260 Identities=24% Similarity=0.407 Sum_probs=210.9
Q ss_pred HhcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccchhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceE
Q 045798 682 ATNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFK 761 (1008)
Q Consensus 682 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 761 (1008)
..++|++.+.||+|+||+||+|++..+++.||||+++.. ....++|.+|++++++++|||||+++++| .+++..
T Consensus 15 ~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~-----~~~~~~ 88 (287)
T d1opja_ 15 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVC-----TREPPF 88 (287)
T ss_dssp CGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTT-CSCHHHHHHHHHHHHHCCCTTBCCEEEEE-----CSSSSC
T ss_pred cHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCc-cchHHHHHHHHHHHHhCCCCCEecCCccE-----eeCCee
Confidence 356789999999999999999999889999999999754 33457899999999999999999999995 456678
Q ss_pred EEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEc
Q 045798 762 AIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIG 841 (1008)
Q Consensus 762 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 841 (1008)
++|||||++|+|.+++...... .+++..++.|+.||+.||+|||+. +|+||||||+|||+++++.+||+
T Consensus 89 ~iv~E~~~~g~l~~~l~~~~~~--------~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~ 157 (287)
T d1opja_ 89 YIITEFMTYGNLLDYLRECNRQ--------EVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVA 157 (287)
T ss_dssp EEEEECCTTCBHHHHHHHSCTT--------TSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEEC
T ss_pred EEEeecccCcchHHHhhhcccc--------chHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEc
Confidence 9999999999999998754322 789999999999999999999997 99999999999999999999999
Q ss_pred ccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHhhC
Q 045798 842 DFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMAL 921 (1008)
Q Consensus 842 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~~~ 921 (1008)
|||+|+......... .....|++.|+|||++.+..++.++|||||||++|||++|..||...... ...
T Consensus 158 DFG~a~~~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~----~~~----- 225 (287)
T d1opja_ 158 DFGLSRLMTGDTYTA---HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL----SQV----- 225 (287)
T ss_dssp CCCCTTTCCSSSSEE---ETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCH----HHH-----
T ss_pred cccceeecCCCCcee---eccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchH----HHH-----
Confidence 999998765433222 23345899999999999999999999999999999999988776432111 111
Q ss_pred CcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHHHHHH
Q 045798 922 PNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHELQSVK 992 (1008)
Q Consensus 922 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~i~ 992 (1008)
.+.+..... .. ....++.++.+++.+||+.||++||||+||++.|+.+.
T Consensus 226 ----~~~i~~~~~----------------~~--~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~ 274 (287)
T d1opja_ 226 ----YELLEKDYR----------------ME--RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 274 (287)
T ss_dssp ----HHHHHTTCC----------------CC--CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred ----HHHHhcCCC----------------CC--CCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 011110000 00 01124566899999999999999999999999998764
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-48 Score=415.54 Aligned_cols=252 Identities=24% Similarity=0.326 Sum_probs=205.5
Q ss_pred cCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccchhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceEEE
Q 045798 684 NGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKAI 763 (1008)
Q Consensus 684 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 763 (1008)
+.|++.+.||+|+||+||+|++..+++.||||+++.......+.+.+|++++++++|||||++++++ .+++..++
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~-----~~~~~~~l 86 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF-----YYENNLWI 86 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEE-----EETTEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----eeCCeEEE
Confidence 4689999999999999999999999999999999877677778899999999999999999999994 55677999
Q ss_pred EEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEccc
Q 045798 764 VYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDF 843 (1008)
Q Consensus 764 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 843 (1008)
|||||++|+|.+++..... .+++.++..++.||+.||+|||++ +||||||||+|||++.++.+||+||
T Consensus 87 vmEy~~~g~L~~~~~~~~~---------~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DF 154 (288)
T d2jfla1 87 LIEFCAGGAVDAVMLELER---------PLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADF 154 (288)
T ss_dssp EEECCTTEEHHHHHHHHTS---------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCC
T ss_pred EEecCCCCcHHHHHHhcCC---------CCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEec
Confidence 9999999999999764321 689999999999999999999998 9999999999999999999999999
Q ss_pred CcccccccccCccccccccccccccccCccccC-----CCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHH
Q 045798 844 GLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGL-----GSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFAR 918 (1008)
Q Consensus 844 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~ 918 (1008)
|+|+....... ......||+.|+|||++. +..|+.++|||||||++|||++|+.||......+ .......
T Consensus 155 G~a~~~~~~~~----~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~-~~~~i~~ 229 (288)
T d2jfla1 155 GVSAKNTRTIQ----RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR-VLLKIAK 229 (288)
T ss_dssp TTCEECHHHHH----HHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGG-HHHHHHH
T ss_pred hhhhccCCCcc----cccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHH-HHHHHHc
Confidence 99975543221 122356999999999874 4568999999999999999999999986432111 1111111
Q ss_pred hhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 919 MALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 919 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
... +........+.++.+++.+||+.||++|||++|+++
T Consensus 230 ~~~-----------------------------~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 230 SEP-----------------------------PTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp SCC-----------------------------CCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCC-----------------------------CCCCccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000 000011124556899999999999999999999976
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5e-48 Score=416.94 Aligned_cols=261 Identities=26% Similarity=0.461 Sum_probs=196.2
Q ss_pred cCCCCCceEeeccCeeEEEEEEcCCCe---EEEEEEeccc-cchhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCc
Q 045798 684 NGFSSTHLIGVGSFGCVYKGALDEDGI---VVAIKVINLQ-CEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGND 759 (1008)
Q Consensus 684 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~---~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 759 (1008)
++|++.+.||+|+||+||+|+++.+++ .||||++... .....+.|.+|++++++++|||||+++|+| ..++
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~-----~~~~ 100 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVV-----TKST 100 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-----CSSS
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEE-----eeCC
Confidence 456778899999999999999875553 6899988654 334557899999999999999999999995 4456
Q ss_pred eEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeE
Q 045798 760 FKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGH 839 (1008)
Q Consensus 760 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 839 (1008)
..++|||||++|+|.+++..... .+++.+++.|+.||++||+|||+. +|+||||||+|||++.++.+|
T Consensus 101 ~~~iv~Ey~~~g~L~~~~~~~~~---------~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~K 168 (299)
T d1jpaa_ 101 PVMIITEFMENGSLDSFLRQNDG---------QFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCK 168 (299)
T ss_dssp SCEEEEECCTTEEHHHHHHTTTT---------CSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEE
T ss_pred EEEEEEEecCCCcceeeeccccC---------CCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEECCCCcEE
Confidence 68999999999999998876432 689999999999999999999997 999999999999999999999
Q ss_pred EcccCcccccccccCcc-ccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCccccCCccHHHHH
Q 045798 840 IGDFGLARFHQEVSNST-LSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT-AKKPTDVMFEGDLNLHNFA 917 (1008)
Q Consensus 840 L~Dfg~a~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-G~~pf~~~~~~~~~~~~~~ 917 (1008)
|+|||+|+......... ........||+.|+|||++.+..++.++|||||||++|||+| |+.||...... .....
T Consensus 169 l~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~--~~~~~- 245 (299)
T d1jpaa_ 169 VSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ--DVINA- 245 (299)
T ss_dssp ECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHHH-
T ss_pred ECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHH--HHHHH-
Confidence 99999998765443222 122233458999999999999999999999999999999998 89998643111 00000
Q ss_pred HhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHHHHHHH
Q 045798 918 RMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHELQSVKN 993 (1008)
Q Consensus 918 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~i~~ 993 (1008)
+... .+.+ ...+++.++.+++.+||+.||++||||+||++.|+++..
T Consensus 246 -----------i~~~--------------~~~~----~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~ 292 (299)
T d1jpaa_ 246 -----------IEQD--------------YRLP----PPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 292 (299)
T ss_dssp -----------HHTT--------------CCCC----CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred -----------HHcC--------------CCCC----CCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 0000 0000 112355678999999999999999999999999988754
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-48 Score=411.06 Aligned_cols=257 Identities=28% Similarity=0.434 Sum_probs=204.8
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccchhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceEE
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKA 762 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 762 (1008)
.++|++.+.||+|+||+||+|+++ +++.||||+++.. ....+.|.+|++++++++|||||+++++|.. +..+
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~------~~~~ 83 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ------EPIY 83 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS------SSCE
T ss_pred HHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccC-cCCHHHHHHHHHHHHhCCCCCEeEEEeeecc------CCeE
Confidence 457889999999999999999986 6789999999754 3345689999999999999999999998532 3468
Q ss_pred EEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEcc
Q 045798 763 IVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGD 842 (1008)
Q Consensus 763 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 842 (1008)
+||||+++|+|.+++.... ..++++..++.|+.||++||+|||++ +|+||||||+|||+++++.+||+|
T Consensus 84 iv~Ey~~~g~L~~~~~~~~--------~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~D 152 (272)
T d1qpca_ 84 IITEYMENGSLVDFLKTPS--------GIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIAD 152 (272)
T ss_dssp EEEECCTTCBHHHHTTSHH--------HHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECC
T ss_pred EEEEeCCCCcHHHHHhhcC--------CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeecc
Confidence 9999999999999876543 12689999999999999999999997 999999999999999999999999
Q ss_pred cCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHhhCC
Q 045798 843 FGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMALP 922 (1008)
Q Consensus 843 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~~~~ 922 (1008)
||+|+........ ......||+.|+|||++.+..++.++|||||||++|||+||..|+............. .
T Consensus 153 FGla~~~~~~~~~---~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i-~---- 224 (272)
T d1qpca_ 153 FGLARLIEDNEYT---AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL-E---- 224 (272)
T ss_dssp CTTCEECSSSCEE---CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHH-H----
T ss_pred ccceEEccCCccc---cccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHH-H----
Confidence 9999876543221 2233568999999999998899999999999999999999766654221111000000 0
Q ss_pred cchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHHHHHH
Q 045798 923 NQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHELQSVK 992 (1008)
Q Consensus 923 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~i~ 992 (1008)
... +. .. ...++.++.+++.+||+.||++||||+||++.|+.+-
T Consensus 225 --------~~~--------------~~--~~--p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~f 268 (272)
T d1qpca_ 225 --------RGY--------------RM--VR--PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268 (272)
T ss_dssp --------TTC--------------CC--CC--CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --------hcC--------------CC--CC--cccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhh
Confidence 000 00 00 0124556899999999999999999999999998764
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-48 Score=412.58 Aligned_cols=259 Identities=22% Similarity=0.314 Sum_probs=193.9
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEecccc--chhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCce
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC--EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDF 760 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 760 (1008)
.++|++.+.||+|+||+||+|+++.+|+.||||+++... +...+.+.+|++++++++||||+++++++.+ ..++.
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~---~~~~~ 79 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIID---RTNTT 79 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC-------C
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEe---CCCCE
Confidence 367999999999999999999999999999999997543 3445679999999999999999999998642 34456
Q ss_pred EEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCC--CCCceeccCCCCCeeecCCCCe
Q 045798 761 KAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHC--QEPILHCDLKPSNILLDNDLSG 838 (1008)
Q Consensus 761 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--~~~ivH~Dlkp~NIll~~~~~~ 838 (1008)
.|+|||||++|+|.+++...... ...+++..++.++.||+.||+|||+.. ..+||||||||+|||++.++.+
T Consensus 80 ~~ivmEy~~~g~L~~~i~~~~~~------~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~v 153 (269)
T d2java1 80 LYIVMEYCEGGDLASVITKGTKE------RQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNV 153 (269)
T ss_dssp EEEEEECCTTEEHHHHHHHHHHH------TCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCE
T ss_pred EEEEEecCCCCcHHHHHHhcccc------CCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcE
Confidence 89999999999999998643210 116899999999999999999999861 1249999999999999999999
Q ss_pred EEcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHH
Q 045798 839 HIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFAR 918 (1008)
Q Consensus 839 kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~ 918 (1008)
||+|||+|+........ .....||+.|+|||++.+..+++++|||||||++|||++|+.||......+ .......
T Consensus 154 kl~DFG~a~~~~~~~~~----~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~-~~~~i~~ 228 (269)
T d2java1 154 KLGDFGLARILNHDTSF----AKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE-LAGKIRE 228 (269)
T ss_dssp EECCHHHHHHC---------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHH
T ss_pred EEeeccceeecccCCCc----cccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHH-HHHHHHc
Confidence 99999999876543222 223569999999999999999999999999999999999999986431110 0000000
Q ss_pred hhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 919 MALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 919 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
... . .. ....+.++.+++.+||+.||++|||++|+++
T Consensus 229 ~~~------------~-------------~~------~~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 229 GKF------------R-------------RI------PYRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp TCC------------C-------------CC------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCC------------C-------------CC------CcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 000 0 00 0123456899999999999999999999875
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-47 Score=405.12 Aligned_cols=251 Identities=26% Similarity=0.386 Sum_probs=197.6
Q ss_pred CCCceEeeccCeeEEEEEEcCCCeEEEEEEeccc--cchhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceEEEE
Q 045798 687 SSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQ--CEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKAIV 764 (1008)
Q Consensus 687 ~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 764 (1008)
++.++||+|+||+||+|++..+++.||+|++... .....+.+.+|++++++++|||||++++++... ...+...|+|
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~-~~~~~~~~iv 90 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWEST-VKGKKCIVLV 90 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEE-SSSCEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeec-cccCCEEEEE
Confidence 5667899999999999999989999999998743 234456799999999999999999999986532 2345678999
Q ss_pred EeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeec-CCCCeEEccc
Q 045798 765 YEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLD-NDLSGHIGDF 843 (1008)
Q Consensus 765 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~kL~Df 843 (1008)
|||+++|+|.+++.... .+++..++.++.||+.||+|||++ .++|+||||||+|||++ +++.+||+||
T Consensus 91 mE~~~~g~L~~~l~~~~----------~~~~~~~~~~~~qi~~gl~yLH~~-~~~IiHrDiKp~NILl~~~~~~~Kl~DF 159 (270)
T d1t4ha_ 91 TELMTSGTLKTYLKRFK----------VMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDL 159 (270)
T ss_dssp EECCCSCBHHHHHHHHS----------SCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCSCCCGGGEEESSTTSCEEECCT
T ss_pred EeCCCCCcHHHHHhccc----------cccHHHHHHHHHHHHHHHHHHHHC-CCCEEeCCcChhhceeeCCCCCEEEeec
Confidence 99999999999997654 789999999999999999999997 12399999999999996 5789999999
Q ss_pred CcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCc
Q 045798 844 GLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMALPN 923 (1008)
Q Consensus 844 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~~~~~ 923 (1008)
|+|+...... .....||+.|+|||++.+ .++.++|||||||++|||++|+.||...... ..........
T Consensus 160 Gla~~~~~~~------~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~----~~~~~~i~~~ 228 (270)
T d1t4ha_ 160 GLATLKRASF------AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA----AQIYRRVTSG 228 (270)
T ss_dssp TGGGGCCTTS------BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH----HHHHHHHTTT
T ss_pred CcceeccCCc------cCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccH----HHHHHHHHcC
Confidence 9998543321 123569999999999865 5999999999999999999999998632111 1111100000
Q ss_pred chhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 924 QVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 924 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
. . +.......++++.+++.+||+.||++|||++|+++
T Consensus 229 ~---------~-----------------~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 229 V---------K-----------------PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp C---------C-----------------CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred C---------C-----------------CcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 0 0 00000112345789999999999999999999975
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-48 Score=423.51 Aligned_cols=199 Identities=27% Similarity=0.411 Sum_probs=177.5
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEecccc-chhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceE
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC-EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFK 761 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 761 (1008)
.++|++++.||+|+||+||+|++..+|+.||+|+++... +...+.+.+|++++++++|||||+++++| .+++..
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~-----~~~~~~ 79 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF-----YSDGEI 79 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEE-----ECSSEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EECCEE
Confidence 578999999999999999999999999999999997543 34457899999999999999999999994 566779
Q ss_pred EEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhh-CCCCCceeccCCCCCeeecCCCCeEE
Q 045798 762 AIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHH-HCQEPILHCDLKPSNILLDNDLSGHI 840 (1008)
Q Consensus 762 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kL 840 (1008)
|+|||||++|+|.+++.+.+ .+++..++.++.|++.||.|||+ + +|+||||||+|||++.++.+||
T Consensus 80 ~iVmEy~~gg~L~~~l~~~~----------~l~~~~~~~~~~qil~aL~yLH~~~---~IiHRDiKP~NILl~~~~~vkl 146 (322)
T d1s9ja_ 80 SICMEHMDGGSLDQVLKKAG----------RIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKL 146 (322)
T ss_dssp EEEEECCTTEEHHHHHHHHS----------SCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEE
T ss_pred EEEEEcCCCCcHHHHHhhcC----------CCCHHHHHHHHHHHHHHHHHHHHhC---CEEccccCHHHeeECCCCCEEE
Confidence 99999999999999997654 78999999999999999999996 4 8999999999999999999999
Q ss_pred cccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCc
Q 045798 841 GDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDV 905 (1008)
Q Consensus 841 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~ 905 (1008)
+|||+|+...... ....+||+.|+|||++.+..|++++||||+||++|||++|+.||..
T Consensus 147 ~DFGla~~~~~~~------~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~ 205 (322)
T d1s9ja_ 147 CDFGVSGQLIDSM------ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPP 205 (322)
T ss_dssp CCCCCCHHHHHHT------C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSC
T ss_pred eeCCCccccCCCc------cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 9999998654322 2235699999999999999999999999999999999999999965
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-47 Score=409.16 Aligned_cols=266 Identities=26% Similarity=0.441 Sum_probs=201.3
Q ss_pred cCCCCCceEeeccCeeEEEEEEcCCC----eEEEEEEecccc-chhhHHHHHHHHHHhhcCCCCceeeeeccccccccCC
Q 045798 684 NGFSSTHLIGVGSFGCVYKGALDEDG----IVVAIKVINLQC-EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGN 758 (1008)
Q Consensus 684 ~~y~~~~~lg~G~~g~Vy~~~~~~~~----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 758 (1008)
+.|++.++||+|+||+||+|.++.++ ..||||+++... +.....|.+|++++++++|||||+++|+| ...
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~-----~~~ 81 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVI-----SKY 81 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-----CSS
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEE-----ecC
Confidence 46888899999999999999986544 479999997543 34456799999999999999999999995 455
Q ss_pred ceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCe
Q 045798 759 DFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSG 838 (1008)
Q Consensus 759 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 838 (1008)
+..++||||+.++++.+++..... .+++.++..++.||+.||+|||+. +|+||||||+|||++.++.+
T Consensus 82 ~~~~~v~e~~~~~~l~~~~~~~~~---------~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~ 149 (283)
T d1mqba_ 82 KPMMIITEYMENGALDKFLREKDG---------EFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVC 149 (283)
T ss_dssp SSEEEEEECCTTEEHHHHHHHTTT---------CSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCE
T ss_pred CceEEEEEecccCcchhhhhcccc---------cccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeE
Confidence 668999999999999988765432 689999999999999999999998 99999999999999999999
Q ss_pred EEcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHH
Q 045798 839 HIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFAR 918 (1008)
Q Consensus 839 kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~ 918 (1008)
||+|||+|+......... .......||+.|+|||++.+..++.++|||||||++|||++|..|+...... ....
T Consensus 150 Kl~DFGla~~~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~----~~~~- 223 (283)
T d1mqba_ 150 KVSDFGLSRVLEDDPEAT-YTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN----HEVM- 223 (283)
T ss_dssp EECCCCC------------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH----HHHH-
T ss_pred EEcccchhhcccCCCccc-eEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCH----HHHH-
Confidence 999999998765433222 1223345899999999999999999999999999999999977665422111 1111
Q ss_pred hhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHHHHHHHHHHHH
Q 045798 919 MALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHELQSVKNILLEL 998 (1008)
Q Consensus 919 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~i~~~~~~~ 998 (1008)
..+....+ . + ....++.++.+++.+||+.||++||||.||++.|+++.+.-+.+
T Consensus 224 --------~~i~~~~~--------------~--~--~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~p~~l 277 (283)
T d1mqba_ 224 --------KAINDGFR--------------L--P--TPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSL 277 (283)
T ss_dssp --------HHHHTTCC--------------C--C--CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGGGG
T ss_pred --------HHHhccCC--------------C--C--CchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhCcccc
Confidence 11110000 0 0 01124567899999999999999999999999999887654333
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-47 Score=410.24 Aligned_cols=250 Identities=23% Similarity=0.314 Sum_probs=202.5
Q ss_pred cCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccc---cchhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCce
Q 045798 684 NGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQ---CEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDF 760 (1008)
Q Consensus 684 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 760 (1008)
++|++.+.||+|+||+||+|++..+++.||||+++.. .+...+.+.+|++++++++||||++++++ +.+++.
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~-----~~~~~~ 82 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFT-----FQDDEK 82 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEE-----EECSSE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEE-----EEECCE
Confidence 5799999999999999999999989999999999643 23445679999999999999999999999 456778
Q ss_pred EEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEE
Q 045798 761 KAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHI 840 (1008)
Q Consensus 761 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 840 (1008)
.|+|||||++|+|.+++...+ .+++..++.++.|++.||+|||+. +||||||||+|||+++++.+||
T Consensus 83 ~~ivmEy~~gg~L~~~~~~~~----------~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl 149 (288)
T d1uu3a_ 83 LYFGLSYAKNGELLKYIRKIG----------SFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQI 149 (288)
T ss_dssp EEEEECCCTTEEHHHHHHHHS----------SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEE
T ss_pred EEEEEEccCCCCHHHhhhccC----------CCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEe
Confidence 999999999999999987654 789999999999999999999998 9999999999999999999999
Q ss_pred cccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHhh
Q 045798 841 GDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMA 920 (1008)
Q Consensus 841 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~~ 920 (1008)
+|||+|+......... ......||+.|+|||++.+..++.++||||+||++|||++|+.||...... ... .
T Consensus 150 ~DFG~a~~~~~~~~~~--~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~----~~~-~-- 220 (288)
T d1uu3a_ 150 TDFGTAKVLSPESKQA--RANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEY----LIF-Q-- 220 (288)
T ss_dssp CCCTTCEECC------------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHH-H--
T ss_pred cccccceecccCCccc--ccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHH----HHH-H--
Confidence 9999998765432221 123356999999999999999999999999999999999999998642110 000 0
Q ss_pred CCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 921 LPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 921 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
....... .++ ...+.++.+++.+||+.||.+|||++|++.
T Consensus 221 ----------~i~~~~~----------~~p------~~~s~~~~~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 221 ----------KIIKLEY----------DFP------EKFFPKARDLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp ----------HHHTTCC----------CCC------TTCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred ----------HHHcCCC----------CCC------ccCCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence 0000000 001 123456789999999999999999999755
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.8e-47 Score=410.76 Aligned_cols=252 Identities=22% Similarity=0.277 Sum_probs=190.3
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEecccc-chhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceE
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC-EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFK 761 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 761 (1008)
.+.|++.+.||+|+||+||+|+++.+++.||||++.... ....+.+.+|++++++++||||++++++ +.+++..
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~-----~~~~~~~ 82 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDI-----YESGGHL 82 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEE-----EECSSEE
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEE-----EEECCEE
Confidence 467999999999999999999999899999999997543 2334678899999999999999999999 4667789
Q ss_pred EEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeec---CCCCe
Q 045798 762 AIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLD---NDLSG 838 (1008)
Q Consensus 762 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~---~~~~~ 838 (1008)
|+|||||+||+|.+++.... .+++.++..++.||+.||+|||+. +||||||||+||++. +++.+
T Consensus 83 ~lvmE~~~gg~L~~~l~~~~----------~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~v 149 (307)
T d1a06a_ 83 YLIMQLVSGGELFDRIVEKG----------FYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKI 149 (307)
T ss_dssp EEEECCCCSCBHHHHHHTCS----------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCE
T ss_pred EEEEeccCCCcHHHhhhccc----------CCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceE
Confidence 99999999999999997654 799999999999999999999998 999999999999994 57899
Q ss_pred EEcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHH
Q 045798 839 HIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFAR 918 (1008)
Q Consensus 839 kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~ 918 (1008)
||+|||+|+....... ....+||+.|+|||++.+..|++++||||+||++|||++|+.||....... .......
T Consensus 150 kl~DFG~a~~~~~~~~-----~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~-~~~~i~~ 223 (307)
T d1a06a_ 150 MISDFGLSKMEDPGSV-----LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAK-LFEQILK 223 (307)
T ss_dssp EECCC-----------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHT
T ss_pred EEeccceeEEccCCCe-----eeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHH-HHHHHhc
Confidence 9999999986543322 223569999999999999999999999999999999999999986421110 0000000
Q ss_pred hhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 919 MALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 919 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
.. .. ...+.....+.++.+++.+||+.||++|||++|+++
T Consensus 224 ~~------------~~----------------~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 224 AE------------YE----------------FDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263 (307)
T ss_dssp TC------------CC----------------CCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred cC------------CC----------------CCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 00 00 000011124556899999999999999999999987
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-47 Score=404.12 Aligned_cols=259 Identities=24% Similarity=0.382 Sum_probs=205.3
Q ss_pred cCCCCCce-EeeccCeeEEEEEEcC--CCeEEEEEEecccc-chhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCc
Q 045798 684 NGFSSTHL-IGVGSFGCVYKGALDE--DGIVVAIKVINLQC-EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGND 759 (1008)
Q Consensus 684 ~~y~~~~~-lg~G~~g~Vy~~~~~~--~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 759 (1008)
++|.+.+. ||+|+||+||+|.++. ++..||||+++... ....++|.+|++++++++|||||+++|+|.. +
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~------~ 81 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA------E 81 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES------S
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc------C
Confidence 45666674 9999999999998753 45689999997543 3446789999999999999999999998632 3
Q ss_pred eEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeE
Q 045798 760 FKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGH 839 (1008)
Q Consensus 760 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 839 (1008)
..|+|||||++|+|.+++..... .+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+|
T Consensus 82 ~~~lvmE~~~~g~L~~~l~~~~~---------~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~K 149 (285)
T d1u59a_ 82 ALMLVMEMAGGGPLHKFLVGKRE---------EIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAK 149 (285)
T ss_dssp SEEEEEECCTTEEHHHHHTTCTT---------TSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEE
T ss_pred eEEEEEEeCCCCcHHHHhhcccc---------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCcee
Confidence 47999999999999999865432 689999999999999999999997 999999999999999999999
Q ss_pred EcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCccccCCccHHHHHH
Q 045798 840 IGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT-AKKPTDVMFEGDLNLHNFAR 918 (1008)
Q Consensus 840 L~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-G~~pf~~~~~~~~~~~~~~~ 918 (1008)
|+|||+|+......... .......||+.|+|||++.+..++.++|||||||++|||+| |+.||...... .......
T Consensus 150 l~DFGla~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~--~~~~~i~ 226 (285)
T d1u59a_ 150 ISDFGLSKALGADDSYY-TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP--EVMAFIE 226 (285)
T ss_dssp ECCCTTCEECTTCSCEE-CCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH--HHHHHHH
T ss_pred eccchhhhccccccccc-ccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHH--HHHHHHH
Confidence 99999998765443222 22334568999999999998999999999999999999998 89998643211 1111110
Q ss_pred hhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHHHHHHH
Q 045798 919 MALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHELQSVKN 993 (1008)
Q Consensus 919 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~i~~ 993 (1008)
.. .+. . ....++.++.+++.+||+.||++||||.+|++.|+.+..
T Consensus 227 ~~--------------------------~~~--~--~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~ 271 (285)
T d1u59a_ 227 QG--------------------------KRM--E--CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 271 (285)
T ss_dssp TT--------------------------CCC--C--CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cC--------------------------CCC--C--CCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 00 000 0 011345678999999999999999999999999887643
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-47 Score=398.91 Aligned_cols=254 Identities=26% Similarity=0.419 Sum_probs=207.0
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccchhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceEE
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKA 762 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 762 (1008)
.++|++.++||+|+||+||+|+++ +++.||||+++.. ....+.|.+|+.++++++||||++++|+| .+++..+
T Consensus 3 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~-~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~-----~~~~~~~ 75 (258)
T d1k2pa_ 3 PKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLVQLYGVC-----TKQRPIF 75 (258)
T ss_dssp CCCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESS-SSCHHHHHHHHHHHHTCCCTTBCCEEEEE-----CCSSSEE
T ss_pred hHHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcC-cCCHHHHHHHHHHHHhcCCCceeeEEEEE-----eeCCceE
Confidence 368999999999999999999985 7889999999865 33457899999999999999999999995 4456799
Q ss_pred EEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEcc
Q 045798 763 IVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGD 842 (1008)
Q Consensus 763 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 842 (1008)
+||||+++|+|.+++..... .+++..++.++.||++||+|||+. +|+||||||+||++++++.+||+|
T Consensus 76 iv~Ey~~~g~l~~~~~~~~~---------~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~D 143 (258)
T d1k2pa_ 76 IITEYMANGCLLNYLREMRH---------RFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSD 143 (258)
T ss_dssp EEEECCTTEEHHHHHHSGGG---------CCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECC
T ss_pred EEEEccCCCcHHHhhhcccc---------CCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECc
Confidence 99999999999999765432 688999999999999999999997 999999999999999999999999
Q ss_pred cCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCccccCCccHHHHHHhhC
Q 045798 843 FGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT-AKKPTDVMFEGDLNLHNFARMAL 921 (1008)
Q Consensus 843 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-G~~pf~~~~~~~~~~~~~~~~~~ 921 (1008)
||+|+........ ......||+.|+|||.+.+..++.++|||||||++|||+| |+.||......+ ........
T Consensus 144 fG~a~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~--~~~~i~~~- 217 (258)
T d1k2pa_ 144 FGLSRYVLDDEYT---SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE--TAEHIAQG- 217 (258)
T ss_dssp CSSCCBCSSSSCC---CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH--HHHHHHTT-
T ss_pred chhheeccCCCce---eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHH--HHHHHHhC-
Confidence 9999866543222 2234568999999999999999999999999999999998 899986432111 11100000
Q ss_pred CcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHHHH
Q 045798 922 PNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHELQS 990 (1008)
Q Consensus 922 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 990 (1008)
. +.. ....++.++.+++.+||+.||++||||+||++.|..
T Consensus 218 -----------~--------------~~~----~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 218 -----------L--------------RLY----RPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp -----------C--------------CCC----CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred -----------C--------------CCC----CcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 0 000 001234568999999999999999999999998854
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.6e-46 Score=412.99 Aligned_cols=253 Identities=20% Similarity=0.276 Sum_probs=207.1
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccchhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceEE
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKA 762 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 762 (1008)
.++|++.+.||+|+||.||+|++..+|+.||||++........+.+.+|++++++++|||||++++++ .+++..|
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~-----~~~~~~~ 99 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF-----EDDNEMV 99 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEE-----EETTEEE
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEE-----EECCEEE
Confidence 46899999999999999999999989999999999876666678899999999999999999999994 5677899
Q ss_pred EEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeec--CCCCeEE
Q 045798 763 IVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLD--NDLSGHI 840 (1008)
Q Consensus 763 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~--~~~~~kL 840 (1008)
+|||||++|+|.+++..... ++++..++.|+.||+.||+|||++ +||||||||+|||++ .++.+||
T Consensus 100 ivmE~~~gg~L~~~l~~~~~---------~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL 167 (350)
T d1koaa2 100 MIYEFMSGGELFEKVADEHN---------KMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKL 167 (350)
T ss_dssp EEECCCCSCBHHHHHTCTTS---------CBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEE
T ss_pred EEEEcCCCCCHHHHHHhhcC---------CCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEE
Confidence 99999999999999864421 699999999999999999999998 999999999999995 4678999
Q ss_pred cccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHhh
Q 045798 841 GDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMA 920 (1008)
Q Consensus 841 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~~ 920 (1008)
+|||+|+........ ....||+.|+|||++.+..++.++||||+||++|||++|+.||...... ..+.......
T Consensus 168 ~DFG~a~~~~~~~~~-----~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~-~~~~~i~~~~ 241 (350)
T d1koaa2 168 IDFGLTAHLDPKQSV-----KVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD-ETLRNVKSCD 241 (350)
T ss_dssp CCCTTCEECCTTSCE-----EEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHTC
T ss_pred eecchheeccccccc-----ceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHH-HHHHHHHhCC
Confidence 999999876543322 2346899999999999999999999999999999999999998642111 0011111100
Q ss_pred CCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 921 LPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 921 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
.. . ........+.++.+++.+||+.||++|||++|+++
T Consensus 242 ~~------------~----------------~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 279 (350)
T d1koaa2 242 WN------------M----------------DDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE 279 (350)
T ss_dssp CC------------S----------------CCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred CC------------C----------------CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00 0 00001123456789999999999999999999987
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=2.6e-46 Score=411.62 Aligned_cols=253 Identities=20% Similarity=0.264 Sum_probs=207.2
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccchhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceEE
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKA 762 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 762 (1008)
.++|++.+.||+|+||.||+|++..+|+.||||+++.......+.+.+|++++++++|||||+++++ +.+++..|
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~-----~~~~~~~~ 102 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDA-----FEDKYEMV 102 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEE-----EECSSEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEE-----EEECCEEE
Confidence 4679999999999999999999998999999999987655666789999999999999999999999 56678899
Q ss_pred EEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeec--CCCCeEE
Q 045798 763 IVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLD--NDLSGHI 840 (1008)
Q Consensus 763 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~--~~~~~kL 840 (1008)
+|||||++|+|.+++..... ++++.+++.|+.||+.||+|||+. |||||||||+|||++ .++.+||
T Consensus 103 ivmE~~~gg~L~~~~~~~~~---------~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL 170 (352)
T d1koba_ 103 LILEFLSGGELFDRIAAEDY---------KMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKI 170 (352)
T ss_dssp EEEECCCCCBHHHHTTCTTC---------CBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEE
T ss_pred EEEEcCCCChHHHHHHhcCC---------CCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEE
Confidence 99999999999988765432 699999999999999999999998 999999999999997 6789999
Q ss_pred cccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHhh
Q 045798 841 GDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMA 920 (1008)
Q Consensus 841 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~~ 920 (1008)
+|||+|+........ ....||+.|+|||++.+..++.++||||+||++|||++|+.||......+ .........
T Consensus 171 ~DFGla~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~-~~~~i~~~~ 244 (352)
T d1koba_ 171 IDFGLATKLNPDEIV-----KVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE-TLQNVKRCD 244 (352)
T ss_dssp CCCTTCEECCTTSCE-----EEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH-HHHHHHHCC
T ss_pred eecccceecCCCCce-----eeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhCC
Confidence 999999876543222 23458999999999999999999999999999999999999986421110 011111100
Q ss_pred CCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 921 LPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 921 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
.. .+.......+.++.+++.+||+.||.+|||++|+++
T Consensus 245 ~~----------------------------~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 282 (352)
T d1koba_ 245 WE----------------------------FDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 282 (352)
T ss_dssp CC----------------------------CCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred CC----------------------------CCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00 000001123456789999999999999999999976
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.5e-47 Score=408.94 Aligned_cols=245 Identities=27% Similarity=0.315 Sum_probs=199.1
Q ss_pred CCCCCceEeeccCeeEEEEEEcCCCeEEEEEEecccc---chhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceE
Q 045798 685 GFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC---EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFK 761 (1008)
Q Consensus 685 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 761 (1008)
.|+..+.||+|+||+||+|++..+++.||||+++... ....+.+.+|++++++++|||||++++++ .+++..
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~-----~~~~~~ 90 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCY-----LREHTA 90 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-----EETTEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEE-----EECCEE
Confidence 4899999999999999999999999999999997543 23346789999999999999999999994 556779
Q ss_pred EEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEc
Q 045798 762 AIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIG 841 (1008)
Q Consensus 762 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 841 (1008)
|+|||||++|++..++.... ++++.+++.++.||+.||+|||++ +||||||||+|||++.++.+||+
T Consensus 91 ~iv~E~~~~g~l~~~~~~~~----------~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~ 157 (309)
T d1u5ra_ 91 WLVMEYCLGSASDLLEVHKK----------PLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLG 157 (309)
T ss_dssp EEEEECCSEEHHHHHHHHTS----------CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEEC
T ss_pred EEEEEecCCCchHHHHHhCC----------CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEe
Confidence 99999999999987765543 789999999999999999999998 99999999999999999999999
Q ss_pred ccCcccccccccCccccccccccccccccCccccCC---CCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHH
Q 045798 842 DFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLG---SEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFAR 918 (1008)
Q Consensus 842 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~ 918 (1008)
|||+|+..... ....||+.|+|||++.+ ..|+.++|||||||++|||++|+.||......+ .......
T Consensus 158 DFG~a~~~~~~--------~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~-~~~~i~~ 228 (309)
T d1u5ra_ 158 DFGSASIMAPA--------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-ALYHIAQ 228 (309)
T ss_dssp CCTTCBSSSSB--------CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-HHHHHHH
T ss_pred ecccccccCCC--------CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHH-HHHHHHh
Confidence 99999865432 23459999999999864 468999999999999999999999986321110 0000000
Q ss_pred hhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 919 MALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 919 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
...+ .. .....+.++.+++.+||+.||++|||++|+++
T Consensus 229 ~~~~---------~~---------------------~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 229 NESP---------AL---------------------QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp SCCC---------CC---------------------SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCC---------CC---------------------CCCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 0000 00 00123456899999999999999999999975
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-46 Score=399.20 Aligned_cols=250 Identities=24% Similarity=0.347 Sum_probs=198.0
Q ss_pred ceEeeccCeeEEEEEEc--CCCeEEEEEEeccc--cchhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceEEEEE
Q 045798 690 HLIGVGSFGCVYKGALD--EDGIVVAIKVINLQ--CEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKAIVY 765 (1008)
Q Consensus 690 ~~lg~G~~g~Vy~~~~~--~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 765 (1008)
++||+|+||+||+|.+. ..++.||||+++.. .+...+.|.+|++++++++|||||+++++|.. +..++||
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~------~~~~lvm 86 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA------ESWMLVM 86 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES------SSEEEEE
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc------CCEEEEE
Confidence 57999999999999874 34578999999743 23445789999999999999999999999632 3468999
Q ss_pred eccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEcccCc
Q 045798 766 EYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFGL 845 (1008)
Q Consensus 766 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~ 845 (1008)
||+++|+|.+++.... .+++..++.|+.||+.||+|||+. +||||||||+|||++.++.+||+|||+
T Consensus 87 E~~~~g~L~~~l~~~~----------~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGl 153 (277)
T d1xbba_ 87 EMAELGPLNKYLQQNR----------HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGL 153 (277)
T ss_dssp ECCTTEEHHHHHHHCT----------TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTT
T ss_pred EcCCCCcHHHHHhhcc----------CCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhh
Confidence 9999999999997654 789999999999999999999997 999999999999999999999999999
Q ss_pred ccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCccccCCccHHHHHHhhCCcc
Q 045798 846 ARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT-AKKPTDVMFEGDLNLHNFARMALPNQ 924 (1008)
Q Consensus 846 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~ 924 (1008)
|+.......... ......||+.|+|||++.+..++.++|||||||++|||++ |+.||...... .......
T Consensus 154 a~~~~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~--~~~~~i~------ 224 (277)
T d1xbba_ 154 SKALRADENYYK-AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS--EVTAMLE------ 224 (277)
T ss_dssp CEECCTTCSEEE-C----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HHHHHHH------
T ss_pred hhhccccccccc-cccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHH--HHHHHHH------
Confidence 987654433221 2234568999999999999999999999999999999998 89998643111 0111110
Q ss_pred hhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHHHHH
Q 045798 925 VMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHELQSV 991 (1008)
Q Consensus 925 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~i 991 (1008)
.. .+.+ . ...++.++.+++.+||+.||++|||++||++.|+..
T Consensus 225 ------~~--------------~~~~--~--p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~ 267 (277)
T d1xbba_ 225 ------KG--------------ERMG--C--PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 267 (277)
T ss_dssp ------TT--------------CCCC--C--CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred ------cC--------------CCCC--C--CcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCH
Confidence 00 0000 0 112456789999999999999999999999988775
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-46 Score=400.14 Aligned_cols=252 Identities=21% Similarity=0.278 Sum_probs=204.3
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEecccc------chhhHHHHHHHHHHhhcCCCCceeeeecccccccc
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC------EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQ 756 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 756 (1008)
.++|++.+.||+|+||+||+|+++.+|+.||||+++... ....+.+.+|++++++++|||||+++++ +.
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~-----~~ 83 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEV-----YE 83 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEE-----EE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEE-----EE
Confidence 467999999999999999999999899999999986432 1235689999999999999999999999 46
Q ss_pred CCceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCC
Q 045798 757 GNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDL 836 (1008)
Q Consensus 757 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 836 (1008)
+++..|+|||||++|+|.+++...+ .+++..++.++.||+.||+|||+. +||||||||+||+++.++
T Consensus 84 ~~~~~~iv~E~~~gg~L~~~i~~~~----------~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~ 150 (293)
T d1jksa_ 84 NKTDVILILELVAGGELFDFLAEKE----------SLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRN 150 (293)
T ss_dssp CSSEEEEEEECCCSCBHHHHHHHHS----------SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSS
T ss_pred ECCEEEEEEEcCCCccccchhcccc----------ccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCC
Confidence 6778999999999999999997653 799999999999999999999998 999999999999998776
Q ss_pred ----CeEEcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCcc
Q 045798 837 ----SGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLN 912 (1008)
Q Consensus 837 ----~~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~ 912 (1008)
.+|++|||+|+....... .....||+.|+|||++.+..++.++||||+||++|||++|+.||......+ .
T Consensus 151 ~~~~~vkl~DfG~a~~~~~~~~-----~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~-~ 224 (293)
T d1jksa_ 151 VPKPRIKIIDFGLAHKIDFGNE-----FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE-T 224 (293)
T ss_dssp SSSCCEEECCCTTCEECTTSCB-----CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-H
T ss_pred CcccceEecchhhhhhcCCCcc-----ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHH-H
Confidence 499999999986644322 223458999999999999999999999999999999999999986421110 0
Q ss_pred HHHHHHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 913 LHNFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 913 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
........ ..... ......+.++.+++.+||+.||++|||++|+++
T Consensus 225 ~~~i~~~~------------~~~~~----------------~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 225 LANVSAVN------------YEFED----------------EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp HHHHHTTC------------CCCCH----------------HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred HHHHHhcC------------CCCCc----------------hhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00000000 00000 001124556789999999999999999999976
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-46 Score=410.00 Aligned_cols=265 Identities=23% Similarity=0.337 Sum_probs=204.3
Q ss_pred cCCCCCceEeeccCeeEEEEEEcCCC-----eEEEEEEeccc-cchhhHHHHHHHHHHhhc-CCCCceeeeecccccccc
Q 045798 684 NGFSSTHLIGVGSFGCVYKGALDEDG-----IVVAIKVINLQ-CEGASKSFMAECKALKNI-RHRNLVKVITSCSSIDFQ 756 (1008)
Q Consensus 684 ~~y~~~~~lg~G~~g~Vy~~~~~~~~-----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 756 (1008)
++|++.+.||+|+||+||+|++...+ ..||+|++... .......+.+|+.++.++ +|||||+++++| .
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~-----~ 111 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGAC-----T 111 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEE-----C
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEE-----e
Confidence 57899999999999999999986543 37999998643 334456899999999998 899999999995 4
Q ss_pred CCceEEEEEeccCCCChhcccccCCCCCCC-------------cccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceec
Q 045798 757 GNDFKAIVYEYMPNGSLEKWLHPHAVPKRD-------------KEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHC 823 (1008)
Q Consensus 757 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~-------------~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~ 823 (1008)
+.+..++|||||++|+|.++++........ ......+++..++.++.||+.||+|||++ +||||
T Consensus 112 ~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHR 188 (325)
T d1rjba_ 112 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHR 188 (325)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEET
T ss_pred eCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---Ceeec
Confidence 566789999999999999999765421100 01123689999999999999999999998 99999
Q ss_pred cCCCCCeeecCCCCeEEcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCC
Q 045798 824 DLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT-AKKP 902 (1008)
Q Consensus 824 Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-G~~p 902 (1008)
||||+||+++.++.+||+|||+|+......... ......||+.|+|||++.+..++.++|||||||++|||+| |+.|
T Consensus 189 DlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~P 266 (325)
T d1rjba_ 189 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYV--VRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP 266 (325)
T ss_dssp TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSE--EETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCS
T ss_pred cCchhccccccCCeEEEeeccccccccCCCcee--eeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCC
Confidence 999999999999999999999998665443322 1234568999999999999999999999999999999998 8999
Q ss_pred CCccccCCccHHHHHHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHH
Q 045798 903 TDVMFEGDLNLHNFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMT 982 (1008)
Q Consensus 903 f~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ 982 (1008)
|...... ..+........ + ++ ....++.++.+++.+||+.||++||||+
T Consensus 267 f~~~~~~-~~~~~~~~~~~------------~--------------~~----~p~~~~~~l~~li~~cl~~dP~~RPt~~ 315 (325)
T d1rjba_ 267 YPGIPVD-ANFYKLIQNGF------------K--------------MD----QPFYATEEIYIIMQSCWAFDSRKRPSFP 315 (325)
T ss_dssp STTCCCS-HHHHHHHHTTC------------C--------------CC----CCTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred CCCCCHH-HHHHHHHhcCC------------C--------------CC----CCCcCCHHHHHHHHHHcCCChhHCcCHH
Confidence 8643221 11111111100 0 00 0112456789999999999999999999
Q ss_pred HHHHHHH
Q 045798 983 NVVHELQ 989 (1008)
Q Consensus 983 evl~~L~ 989 (1008)
||++.|.
T Consensus 316 ei~~~L~ 322 (325)
T d1rjba_ 316 NLTSFLG 322 (325)
T ss_dssp HHHHHHH
T ss_pred HHHHHHh
Confidence 9999985
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=5.9e-46 Score=397.86 Aligned_cols=266 Identities=23% Similarity=0.323 Sum_probs=204.6
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEecccc---chhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCc
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC---EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGND 759 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 759 (1008)
.++|++.+.||+|+||+||+|++..+|+.||||+++... ....+.+.+|++++++++||||+++++++...+ ....
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~-~~~~ 84 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET-PAGP 84 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEC-SSSE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeecc-CCCc
Confidence 467999999999999999999999899999999997442 334567999999999999999999999865421 2334
Q ss_pred eEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeE
Q 045798 760 FKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGH 839 (1008)
Q Consensus 760 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 839 (1008)
..|+||||+++++|.+++...+ ++++.+++.++.||+.||+|||++ +|+||||||+||+++.++..+
T Consensus 85 ~~~lvmE~~~g~~L~~~~~~~~----------~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~ 151 (277)
T d1o6ya_ 85 LPYIVMEYVDGVTLRDIVHTEG----------PMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVK 151 (277)
T ss_dssp EEEEEEECCCEEEHHHHHHHHC----------SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEE
T ss_pred eEEEEEECCCCCEehhhhcccC----------CCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccce
Confidence 5899999999999999887654 789999999999999999999998 999999999999999999999
Q ss_pred EcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHh
Q 045798 840 IGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARM 919 (1008)
Q Consensus 840 L~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~ 919 (1008)
++|||.+.......... .......||+.|+|||++.+..+++++||||+||++|||+||+.||...... ......
T Consensus 152 l~d~~~~~~~~~~~~~~-~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~----~~~~~~ 226 (277)
T d1o6ya_ 152 VMDFGIARAIADSGNSV-TQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV----SVAYQH 226 (277)
T ss_dssp ECCCTTCEECC-----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH----HHHHHH
T ss_pred eehhhhhhhhccccccc-cccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHH----HHHHHH
Confidence 99999987554433221 2233456999999999999999999999999999999999999998642111 100000
Q ss_pred hCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCC-CHHHHHHHHHHHH
Q 045798 920 ALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRM-NMTNVVHELQSVK 992 (1008)
Q Consensus 920 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-t~~evl~~L~~i~ 992 (1008)
+...+ ..+.......+.++.+++.+||+.||.+|| |++|+++.|.++.
T Consensus 227 -------------~~~~~------------~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 227 -------------VREDP------------IPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp -------------HHCCC------------CCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred -------------HhcCC------------CCCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 00000 000000112456689999999999999999 8999999998875
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-45 Score=398.85 Aligned_cols=282 Identities=24% Similarity=0.281 Sum_probs=205.7
Q ss_pred cCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccchhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceEEE
Q 045798 684 NGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKAI 763 (1008)
Q Consensus 684 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 763 (1008)
++|.+.+.||+|+||.||+|++ +|+.||||+++... ........|+..+..++||||++++++|...+ ......++
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~-~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~-~~~~~~~l 78 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE-ERSWFREAEIYQTVMLRHENILGFIAADNKDN-GTWTQLWL 78 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SSSEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc-hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCC-CcceEEEE
Confidence 4677889999999999999997 68999999996442 22223344555566789999999999986532 23346899
Q ss_pred EEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhC-----CCCCceeccCCCCCeeecCCCCe
Q 045798 764 VYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHH-----CQEPILHCDLKPSNILLDNDLSG 838 (1008)
Q Consensus 764 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~-----~~~~ivH~Dlkp~NIll~~~~~~ 838 (1008)
|||||++|+|.++++.. ++++..++.++.|+|.||+|+|+. ..++||||||||+|||++.++.+
T Consensus 79 v~Ey~~~g~L~~~l~~~-----------~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~ 147 (303)
T d1vjya_ 79 VSDYHEHGSLFDYLNRY-----------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTC 147 (303)
T ss_dssp EEECCTTCBHHHHHHHC-----------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCE
T ss_pred EEecccCCCHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCe
Confidence 99999999999999754 689999999999999999999973 13599999999999999999999
Q ss_pred EEcccCcccccccccCccccccccccccccccCccccCCC------CCCcccchhhHHHHHHHHHhCCCCCCccccCCcc
Q 045798 839 HIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGS------EVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLN 912 (1008)
Q Consensus 839 kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~ 912 (1008)
||+|||+++.................||+.|+|||++.+. .++.++|||||||++|||+||..||.........
T Consensus 148 Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~ 227 (303)
T d1vjya_ 148 CIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP 227 (303)
T ss_dssp EECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCT
T ss_pred EEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccc
Confidence 9999999987765544333334456799999999998764 2677999999999999999999887543222111
Q ss_pred HHHHHHhhCCcchhhhhcccccCchHHhhhhhhhhhcccc---chhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHHH
Q 045798 913 LHNFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTG---INSRLECLISMVKIGVACSMESPQDRMNMTNVVHELQ 989 (1008)
Q Consensus 913 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 989 (1008)
...... .........+... ...+++. .....+.+..+.+++.+||+.||++||||.||++.|+
T Consensus 228 ~~~~~~--~~~~~~~~~~~~~------------~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~ 293 (303)
T d1vjya_ 228 YYDLVP--SDPSVEEMRKVVC------------EQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 293 (303)
T ss_dssp TTTTSC--SSCCHHHHHHHHT------------TSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHH
T ss_pred hhhccc--ccchHHHHHHHHh------------ccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHH
Confidence 111000 0000000000000 0011111 1112356677999999999999999999999999999
Q ss_pred HHHHH
Q 045798 990 SVKNI 994 (1008)
Q Consensus 990 ~i~~~ 994 (1008)
++.+.
T Consensus 294 ~i~~~ 298 (303)
T d1vjya_ 294 QLSQQ 298 (303)
T ss_dssp HHHHH
T ss_pred HHHHh
Confidence 88754
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-46 Score=393.41 Aligned_cols=254 Identities=26% Similarity=0.383 Sum_probs=197.8
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccchhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceEE
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKA 762 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 762 (1008)
.++|++.+.||+|+||.||+|++ .|+.||||+++.. ...+.+.+|++++++++||||++++|+|. +..+..+
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~----~~~~~~~ 77 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIV----EEKGGLY 77 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEEC----CC--CCE
T ss_pred HHHeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEE----ecCCcEE
Confidence 35688899999999999999998 5789999999743 44578999999999999999999999863 3445579
Q ss_pred EEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEcc
Q 045798 763 IVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGD 842 (1008)
Q Consensus 763 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 842 (1008)
+||||+++|+|.+++.... ...+++..++.|+.||+.||+|||+. +|+||||||+||+++.++.+|++|
T Consensus 78 lv~ey~~~g~L~~~l~~~~--------~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~d 146 (262)
T d1byga_ 78 IVTEYMAKGSLVDYLRSRG--------RSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSD 146 (262)
T ss_dssp EEECCCTTEEHHHHHHHHH--------HHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECC
T ss_pred EEEeccCCCCHHHHHHhcC--------CCCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecc
Confidence 9999999999999996542 12589999999999999999999997 999999999999999999999999
Q ss_pred cCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCccccCCccHHHHHHhhC
Q 045798 843 FGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT-AKKPTDVMFEGDLNLHNFARMAL 921 (1008)
Q Consensus 843 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-G~~pf~~~~~~~~~~~~~~~~~~ 921 (1008)
||+++....... ...+|..|+|||++.+..+++++|||||||++|||+| |++||...... ..........
T Consensus 147 fg~s~~~~~~~~-------~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~--~~~~~i~~~~ 217 (262)
T d1byga_ 147 FGLTKEASSTQD-------TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--DVVPRVEKGY 217 (262)
T ss_dssp CCC-------------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG--GHHHHHTTTC
T ss_pred cccceecCCCCc-------cccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHH--HHHHHHHcCC
Confidence 999986543221 2347899999999998999999999999999999998 67776532111 1111110000
Q ss_pred CcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHHHHHHHH
Q 045798 922 PNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHELQSVKNI 994 (1008)
Q Consensus 922 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~i~~~ 994 (1008)
++.. ...++.++.+++.+||+.||++||||.|+++.|++++..
T Consensus 218 ----------------------------~~~~--~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~~ 260 (262)
T d1byga_ 218 ----------------------------KMDA--PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 260 (262)
T ss_dssp ----------------------------CCCC--CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----------------------------CCCC--CccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHhC
Confidence 0000 012345689999999999999999999999999998753
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-45 Score=402.91 Aligned_cols=249 Identities=24% Similarity=0.309 Sum_probs=205.0
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccc---cchhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCc
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQ---CEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGND 759 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 759 (1008)
.++|++++.||+|+||.||+|+++.+|+.||||+++.. .....+.+.+|+.++++++||||++++++ +.+++
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~-----~~~~~ 78 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYA-----FQTHD 78 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEE-----EECSS
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEee-----ecccc
Confidence 46799999999999999999999999999999999743 23345778999999999999999999999 56778
Q ss_pred eEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeE
Q 045798 760 FKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGH 839 (1008)
Q Consensus 760 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 839 (1008)
..|+|||||++|+|.+++...+ .+++..++.++.||+.||+|||++ +|+||||||+|||++++|.+|
T Consensus 79 ~~~iv~ey~~gg~L~~~~~~~~----------~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vk 145 (337)
T d1o6la_ 79 RLCFVMEYANGGELFFHLSRER----------VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIK 145 (337)
T ss_dssp EEEEEEECCTTCBHHHHHHHHS----------CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEE
T ss_pred ccccceeccCCCchhhhhhccc----------CCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEE
Confidence 8999999999999999998654 789999999999999999999998 999999999999999999999
Q ss_pred EcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHh
Q 045798 840 IGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARM 919 (1008)
Q Consensus 840 L~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~ 919 (1008)
|+|||+|+........ ....+||+.|+|||++.+..|+.++||||+||++|||++|++||...... ....
T Consensus 146 l~DFG~a~~~~~~~~~----~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~-----~~~~- 215 (337)
T d1o6la_ 146 ITDFGLCKEGISDGAT----MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-----RLFE- 215 (337)
T ss_dssp ECCCTTCBCSCCTTCC----BCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-----HHHH-
T ss_pred EeecccccccccCCcc----cccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHH-----HHHH-
Confidence 9999999865433221 23456999999999999999999999999999999999999998643111 0000
Q ss_pred hCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCC-----HHHHHH
Q 045798 920 ALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMN-----MTNVVH 986 (1008)
Q Consensus 920 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~ 986 (1008)
...... ..++ ...+.++.+++.+||+.||++||+ ++|+++
T Consensus 216 -----------~i~~~~----------~~~p------~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 216 -----------LILMEE----------IRFP------RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp -----------HHHHCC----------CCCC------TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred -----------HHhcCC----------CCCC------ccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 000000 0011 123455789999999999999995 777765
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-46 Score=397.65 Aligned_cols=257 Identities=28% Similarity=0.416 Sum_probs=199.2
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccchhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceEE
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKA 762 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 762 (1008)
.++|++.+.||+|+||+||+|+++ +++.||||+++.. ....+.|.+|+.++++++|||||+++++|. ++..+
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~-~~~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~------~~~~~ 87 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWN-GTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVS------EEPIY 87 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEEC------SSSCE
T ss_pred HHHEEEeeEEeeCCCeEEEEEEEC-CCCEEEEEEECcc-cCCHHHHHHHHHHHHhcccCCEeEEEEEEe------cCCeE
Confidence 467999999999999999999996 5578999999754 334578999999999999999999999863 23468
Q ss_pred EEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEcc
Q 045798 763 IVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGD 842 (1008)
Q Consensus 763 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 842 (1008)
+||||+++|+|..++..... ..+++.+++.++.||+.||+|||+. +|+||||||+|||+++++.+||+|
T Consensus 88 lv~Ey~~~g~l~~~~~~~~~--------~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~D 156 (285)
T d1fmka3 88 IVTEYMSKGSLLDFLKGETG--------KYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVAD 156 (285)
T ss_dssp EEECCCTTCBHHHHHSHHHH--------TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECC
T ss_pred EEEEecCCCchhhhhhhccc--------ccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcc
Confidence 99999999999998875421 1689999999999999999999998 999999999999999999999999
Q ss_pred cCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHhhCC
Q 045798 843 FGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMALP 922 (1008)
Q Consensus 843 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~~~~ 922 (1008)
||+|+........ ......||+.|+|||++.++.++.++|||||||++|||++|..||.......... ....
T Consensus 157 fGla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~-~~i~---- 228 (285)
T d1fmka3 157 FGLARLIEDNEYT---ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL-DQVE---- 228 (285)
T ss_dssp CCTTC-----------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH-HHHH----
T ss_pred cchhhhccCCCce---eeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHH-HHHH----
Confidence 9999866433222 2233458999999999999999999999999999999999877754321111101 1000
Q ss_pred cchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHHHHHH
Q 045798 923 NQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHELQSVK 992 (1008)
Q Consensus 923 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~i~ 992 (1008)
.... .+ ....+++++.+++.+||+.||++||||++|++.|+.+.
T Consensus 229 --------~~~~----------------~~--~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~ 272 (285)
T d1fmka3 229 --------RGYR----------------MP--CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 272 (285)
T ss_dssp --------TTCC----------------CC--CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred --------hcCC----------------CC--CCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhh
Confidence 0000 00 01134567899999999999999999999998887643
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-45 Score=396.52 Aligned_cols=259 Identities=24% Similarity=0.386 Sum_probs=205.3
Q ss_pred CceEeeccCeeEEEEEEcCCC---eEEEEEEeccc-cchhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceEEEE
Q 045798 689 THLIGVGSFGCVYKGALDEDG---IVVAIKVINLQ-CEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKAIV 764 (1008)
Q Consensus 689 ~~~lg~G~~g~Vy~~~~~~~~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 764 (1008)
.++||+|+||+||+|++..++ ..||||+++.. .....++|.+|++++++++||||++++|+|. ..+...++|
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~----~~~~~~~lv 107 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICL----RSEGSPLVV 107 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEE----ETTTEEEEE
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEE----ecCCceEEE
Confidence 468999999999999985433 46999999743 4455678999999999999999999999864 344568999
Q ss_pred EeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEcccC
Q 045798 765 YEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGDFG 844 (1008)
Q Consensus 765 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg 844 (1008)
||||++|+|.+++..... ..++..++.++.|++.||.|+|+. +|+||||||+|||+++++.+||+|||
T Consensus 108 ~E~~~~g~l~~~~~~~~~---------~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG 175 (311)
T d1r0pa_ 108 LPYMKHGDLRNFIRNETH---------NPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFG 175 (311)
T ss_dssp EECCTTCBHHHHHHCTTC---------CCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSG
T ss_pred EEEeecCchhhhhccccc---------cchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEeccc
Confidence 999999999999876542 577889999999999999999997 99999999999999999999999999
Q ss_pred cccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCcc
Q 045798 845 LARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMALPNQ 924 (1008)
Q Consensus 845 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~~~~~~ 924 (1008)
+++.................||+.|+|||.+.+..++.++||||||+++|||++|+.||..................+
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~-- 253 (311)
T d1r0pa_ 176 LARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRL-- 253 (311)
T ss_dssp GGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCC--
T ss_pred chhhccccccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCC--
Confidence 999776554443333445678999999999999999999999999999999999888876432211111111100000
Q ss_pred hhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHHHHHHHH
Q 045798 925 VMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHELQSVKNI 994 (1008)
Q Consensus 925 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~i~~~ 994 (1008)
. . ...++.++.+++.+||+.||++||||.||++.|+++.+.
T Consensus 254 -------------------------~--~--p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~ 294 (311)
T d1r0pa_ 254 -------------------------L--Q--PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 294 (311)
T ss_dssp -------------------------C--C--CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred -------------------------C--C--cccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 0 0 012345689999999999999999999999999988654
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.5e-46 Score=403.38 Aligned_cols=272 Identities=23% Similarity=0.369 Sum_probs=209.0
Q ss_pred HHHHhcCCCCCceEeeccCeeEEEEEEc-----CCCeEEEEEEeccccc-hhhHHHHHHHHHHhhcCCCCceeeeecccc
Q 045798 679 LLKATNGFSSTHLIGVGSFGCVYKGALD-----EDGIVVAIKVINLQCE-GASKSFMAECKALKNIRHRNLVKVITSCSS 752 (1008)
Q Consensus 679 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 752 (1008)
++...++|++.+.||+|+||+||+|+++ .+++.||||+++.... ...++|.+|++++++++||||++++++|
T Consensus 8 ~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~-- 85 (301)
T d1lufa_ 8 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC-- 85 (301)
T ss_dssp TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE--
T ss_pred ccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeee--
Confidence 3334578999999999999999999975 2568999999975433 3456799999999999999999999996
Q ss_pred ccccCCceEEEEEeccCCCChhcccccCCCCCC--------------CcccccccCHHHHHHHHHHHHHHHHHHhhCCCC
Q 045798 753 IDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKR--------------DKEIEIKLTLLQRISIAIDVASALDYLHHHCQE 818 (1008)
Q Consensus 753 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~--------------~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~ 818 (1008)
...+..++||||+++|+|.+++........ .......+++..++.|+.|++.||+|||+.
T Consensus 86 ---~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~--- 159 (301)
T d1lufa_ 86 ---AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER--- 159 (301)
T ss_dssp ---CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---
T ss_pred ---ccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---
Confidence 445668999999999999999965432100 011123589999999999999999999997
Q ss_pred CceeccCCCCCeeecCCCCeEEcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHh
Q 045798 819 PILHCDLKPSNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT 898 (1008)
Q Consensus 819 ~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt 898 (1008)
+||||||||+|||++.++.+||+|||+|+......... ......||+.|+|||.+.+..++.++|||||||++|||++
T Consensus 160 ~ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~ 237 (301)
T d1lufa_ 160 KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYK--ADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 237 (301)
T ss_dssp TCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC------CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred CeEeeEEcccceEECCCCcEEEccchhheeccCCcccc--ccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHc
Confidence 99999999999999999999999999998654433222 2234568899999999999999999999999999999999
Q ss_pred CC-CCCCccccCCccHHHHHHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCC
Q 045798 899 AK-KPTDVMFEGDLNLHNFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQD 977 (1008)
Q Consensus 899 G~-~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~ 977 (1008)
|. +||...... ....... +... . . ....++.++.+++.+||+.||++
T Consensus 238 ~~~~p~~~~~~~--e~~~~v~-----------~~~~---------------~--~--~p~~~~~~~~~li~~cl~~~P~~ 285 (301)
T d1lufa_ 238 YGLQPYYGMAHE--EVIYYVR-----------DGNI---------------L--A--CPENCPLELYNLMRLCWSKLPAD 285 (301)
T ss_dssp TTCCTTTTSCHH--HHHHHHH-----------TTCC---------------C--C--CCTTCCHHHHHHHHHHTCSSGGG
T ss_pred cCCCCCCCCCHH--HHHHHHH-----------cCCC---------------C--C--CCccchHHHHHHHHHHcCCChhH
Confidence 86 455432111 0000000 0000 0 0 01124557899999999999999
Q ss_pred CCCHHHHHHHHHHHH
Q 045798 978 RMNMTNVVHELQSVK 992 (1008)
Q Consensus 978 RPt~~evl~~L~~i~ 992 (1008)
||||.||+++|++|.
T Consensus 286 RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 286 RPSFCSIHRILQRMC 300 (301)
T ss_dssp SCCHHHHHHHHHHTT
T ss_pred CcCHHHHHHHHHHhc
Confidence 999999999999875
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-45 Score=391.64 Aligned_cols=259 Identities=23% Similarity=0.352 Sum_probs=197.4
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCC---CeEEEEEEecccc-chhhHHHHHHHHHHhhcCCCCceeeeeccccccccCC
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDED---GIVVAIKVINLQC-EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGN 758 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 758 (1008)
.++|++.+.||+|+||.||+|++..+ +..||||+++... ....+.+.+|++++++++||||++++++|. +
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~------~ 79 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT------E 79 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC------S
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe------c
Confidence 35789999999999999999998543 3578999987543 344567999999999999999999999853 2
Q ss_pred ceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCe
Q 045798 759 DFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSG 838 (1008)
Q Consensus 759 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 838 (1008)
+..++||||+++|+|.+++..... .+++..++.++.||++||+|||++ +|+||||||+||+++.++.+
T Consensus 80 ~~~~iv~E~~~~g~l~~~~~~~~~---------~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~ 147 (273)
T d1mp8a_ 80 NPVWIIMELCTLGELRSFLQVRKY---------SLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCV 147 (273)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTT---------TSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEE
T ss_pred CeEEEEEEeccCCcHHhhhhccCC---------CCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcE
Confidence 457999999999999998765432 689999999999999999999998 99999999999999999999
Q ss_pred EEcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCccccCCccHHHHH
Q 045798 839 HIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT-AKKPTDVMFEGDLNLHNFA 917 (1008)
Q Consensus 839 kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-G~~pf~~~~~~~~~~~~~~ 917 (1008)
||+|||+|+........ ......||+.|+|||++.+..++.++|||||||++|||++ |.+||......+ .....
T Consensus 148 Kl~DfG~a~~~~~~~~~---~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~--~~~~i 222 (273)
T d1mp8a_ 148 KLGDFGLSRYMEDSTYY---KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND--VIGRI 222 (273)
T ss_dssp EECC----------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--HHHHH
T ss_pred EEccchhheeccCCcce---eccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHH--HHHHH
Confidence 99999999866443222 1233458999999999999999999999999999999998 888886432211 11110
Q ss_pred HhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHHHHHHHH
Q 045798 918 RMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHELQSVKNI 994 (1008)
Q Consensus 918 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~i~~~ 994 (1008)
.... +. +....++.++.+++.+||+.||++||||+||++.|+++.+.
T Consensus 223 ~~~~--------------------------~~----~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 269 (273)
T d1mp8a_ 223 ENGE--------------------------RL----PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 269 (273)
T ss_dssp HTTC--------------------------CC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HcCC--------------------------CC----CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 0000 00 00113456789999999999999999999999999988765
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=4.9e-45 Score=388.01 Aligned_cols=251 Identities=21% Similarity=0.291 Sum_probs=202.8
Q ss_pred cCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccc---------hhhHHHHHHHHHHhhcC-CCCceeeeeccccc
Q 045798 684 NGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCE---------GASKSFMAECKALKNIR-HRNLVKVITSCSSI 753 (1008)
Q Consensus 684 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---------~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~ 753 (1008)
++|++.+.||+|+||+||+|++..+|+.||||+++.... ...+.+.+|+.++++++ ||||++++++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~---- 78 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDT---- 78 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE----
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEee----
Confidence 689999999999999999999998999999999874421 12346889999999996 9999999999
Q ss_pred cccCCceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeec
Q 045798 754 DFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLD 833 (1008)
Q Consensus 754 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~ 833 (1008)
+.+++..|+|||||++|+|.++++..+ .+++.+++.++.||+.||+|||+. +|+||||||+||+++
T Consensus 79 -~~~~~~~~ivmE~~~~g~L~~~l~~~~----------~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~ 144 (277)
T d1phka_ 79 -YETNTFFFLVFDLMKKGELFDYLTEKV----------TLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLD 144 (277)
T ss_dssp -EECSSEEEEEEECCTTCBHHHHHHHHS----------SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC
T ss_pred -cccCcceEEEEEcCCCchHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEc
Confidence 567788999999999999999997654 799999999999999999999997 999999999999999
Q ss_pred CCCCeEEcccCcccccccccCccccccccccccccccCccccCC------CCCCcccchhhHHHHHHHHHhCCCCCCccc
Q 045798 834 NDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLG------SEVSTNGDVYSYGILLLEMVTAKKPTDVMF 907 (1008)
Q Consensus 834 ~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~sDvwslG~vl~elltG~~pf~~~~ 907 (1008)
.++.+||+|||+|+....... .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||....
T Consensus 145 ~~~~~kl~DFG~a~~~~~~~~-----~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~ 219 (277)
T d1phka_ 145 DDMNIKLTDFGFSCQLDPGEK-----LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK 219 (277)
T ss_dssp TTCCEEECCCTTCEECCTTCC-----BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CCCCeEEccchheeEccCCCc-----eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCC
Confidence 999999999999987654322 123569999999998753 357889999999999999999999997432
Q ss_pred cCCccHHHHHHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 908 EGDLNLHNFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 908 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
... .......... ....+.....++++.+++.+||+.||++|||++||++
T Consensus 220 ~~~-~~~~i~~~~~----------------------------~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 220 QML-MLRMIMSGNY----------------------------QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp HHH-HHHHHHHTCC----------------------------CCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HHH-HHHHHHhCCC----------------------------CCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 111 0001111000 0001111234567899999999999999999999865
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-45 Score=400.48 Aligned_cols=259 Identities=24% Similarity=0.400 Sum_probs=201.8
Q ss_pred cCCCCCceEeeccCeeEEEEEEcCCCe----EEEEEEeccc-cchhhHHHHHHHHHHhhcCCCCceeeeeccccccccCC
Q 045798 684 NGFSSTHLIGVGSFGCVYKGALDEDGI----VVAIKVINLQ-CEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGN 758 (1008)
Q Consensus 684 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 758 (1008)
++|+++++||+|+||+||+|.+..+|+ +||+|+++.. .....+.|.+|++++++++|||||+++|+|..
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~------ 82 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT------ 82 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEES------
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec------
Confidence 469999999999999999999977765 6888888643 34456789999999999999999999999743
Q ss_pred ceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCe
Q 045798 759 DFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSG 838 (1008)
Q Consensus 759 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 838 (1008)
+..++++||+.+|+|.+++..... .+++..++.|+.||+.||+|||++ +||||||||+||+++.++.+
T Consensus 83 ~~~~~v~e~~~~~~l~~~~~~~~~---------~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~ 150 (317)
T d1xkka_ 83 STVQLITQLMPFGCLLDYVREHKD---------NIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHV 150 (317)
T ss_dssp SSEEEEEECCTTCBHHHHHHHTSS---------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEE
T ss_pred CCeeEEEEeccCCccccccccccc---------CCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCe
Confidence 236788999999999998876532 789999999999999999999998 99999999999999999999
Q ss_pred EEcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCccccCCccHHHHH
Q 045798 839 HIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT-AKKPTDVMFEGDLNLHNFA 917 (1008)
Q Consensus 839 kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-G~~pf~~~~~~~~~~~~~~ 917 (1008)
||+|||+|+.......... .....||+.|+|||++.++.++.++|||||||++|||+| |.+||+..... ......
T Consensus 151 kl~DFGla~~~~~~~~~~~--~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~--~~~~~i 226 (317)
T d1xkka_ 151 KITDFGLAKLLGAEEKEYH--AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--EISSIL 226 (317)
T ss_dssp EECCCSHHHHTTTTCC----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGG--GHHHHH
T ss_pred Eeeccccceeccccccccc--ccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHH--HHHHHH
Confidence 9999999987654332221 223458999999999999999999999999999999998 78887643211 111111
Q ss_pred HhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHHHHHHHH
Q 045798 918 RMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHELQSVKNI 994 (1008)
Q Consensus 918 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~i~~~ 994 (1008)
.... +.+ ....++.++.+++.+||+.||.+|||+.||++.|+++...
T Consensus 227 ~~~~--------------------------~~~----~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~~ 273 (317)
T d1xkka_ 227 EKGE--------------------------RLP----QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 273 (317)
T ss_dssp HHTC--------------------------CCC----CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred HcCC--------------------------CCC----CCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHhC
Confidence 1000 000 0112455689999999999999999999999999887643
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.8e-45 Score=397.78 Aligned_cols=245 Identities=25% Similarity=0.315 Sum_probs=203.1
Q ss_pred cCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccc---cchhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCce
Q 045798 684 NGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQ---CEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDF 760 (1008)
Q Consensus 684 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 760 (1008)
++|++.+.||+|+||+||+|+++.+|+.||||+++.. .....+.+.+|+.++++++||||++++++ +.+++.
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~-----~~~~~~ 78 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGT-----FQDAQQ 78 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEE-----EECSSE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeee-----EeeCCe
Confidence 5799999999999999999999989999999999643 23345789999999999999999999999 456778
Q ss_pred EEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEE
Q 045798 761 KAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHI 840 (1008)
Q Consensus 761 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 840 (1008)
.|+|||||+||+|..++.... .+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||
T Consensus 79 ~~ivmE~~~gg~l~~~~~~~~----------~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL 145 (316)
T d1fota_ 79 IFMIMDYIEGGELFSLLRKSQ----------RFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKI 145 (316)
T ss_dssp EEEEECCCCSCBHHHHHHHTS----------SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEE
T ss_pred eeeEeeecCCccccccccccc----------cccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEE
Confidence 999999999999999987665 678899999999999999999997 9999999999999999999999
Q ss_pred cccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHhh
Q 045798 841 GDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMA 920 (1008)
Q Consensus 841 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~~ 920 (1008)
+|||+|+...... ....||+.|+|||++.+..|+.++||||+||++|||++|+.||...... ..
T Consensus 146 ~DFG~a~~~~~~~-------~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~-----~~---- 209 (316)
T d1fota_ 146 TDFGFAKYVPDVT-------YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM-----KT---- 209 (316)
T ss_dssp CCCSSCEECSSCB-------CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH-----HH----
T ss_pred ecCccceEecccc-------ccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHH-----HH----
Confidence 9999998664322 2356999999999999999999999999999999999999998642110 00
Q ss_pred CCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCC-----CHHHHHH
Q 045798 921 LPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRM-----NMTNVVH 986 (1008)
Q Consensus 921 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~ 986 (1008)
....+... ..++ ...+.++.+++.+||+.||.+|| |++|+++
T Consensus 210 --------~~~i~~~~----------~~~p------~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 210 --------YEKILNAE----------LRFP------PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp --------HHHHHHCC----------CCCC------TTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred --------HHHHHcCC----------CCCC------CCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 00000000 0001 11344578999999999999996 8999876
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-45 Score=396.85 Aligned_cols=272 Identities=22% Similarity=0.301 Sum_probs=200.0
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcC-----CCeEEEEEEecccc-chhhHHHHHHHHHHhhc-CCCCceeeeeccccccc
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDE-----DGIVVAIKVINLQC-EGASKSFMAECKALKNI-RHRNLVKVITSCSSIDF 755 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 755 (1008)
.++|++.+.||+|+||.||+|.+.. +++.||||+++... ....+.+.+|+.++.++ +|+||+.+++++.
T Consensus 12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~---- 87 (299)
T d1ywna1 12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACT---- 87 (299)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC----
T ss_pred HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeec----
Confidence 4679999999999999999999753 44789999997543 34456788888888887 7899999999863
Q ss_pred cCCceEEEEEeccCCCChhcccccCCCCCC------CcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCC
Q 045798 756 QGNDFKAIVYEYMPNGSLEKWLHPHAVPKR------DKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSN 829 (1008)
Q Consensus 756 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~------~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~N 829 (1008)
..+...++|||||++|+|.++++....... .......+++.++..++.||++||+|||++ +||||||||+|
T Consensus 88 ~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlKp~N 164 (299)
T d1ywna1 88 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARN 164 (299)
T ss_dssp STTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGG
T ss_pred cCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcCCccc
Confidence 445568999999999999999975432100 001123689999999999999999999998 99999999999
Q ss_pred eeecCCCCeEEcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCC-CCCCcccc
Q 045798 830 ILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAK-KPTDVMFE 908 (1008)
Q Consensus 830 Ill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~-~pf~~~~~ 908 (1008)
||+++++.+||+|||+|+......... ......||+.|+|||++.+..++.++|||||||++|||++|. +||.....
T Consensus 165 ILl~~~~~~Kl~DFGla~~~~~~~~~~--~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~ 242 (299)
T d1ywna1 165 ILLSEKNVVKICDFGLARDIYKDPDYV--RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 242 (299)
T ss_dssp EEECGGGCEEECC------CCSCTTSC--CTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCC
T ss_pred eeECCCCcEEEccCcchhhcccccccc--ccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999998655433222 223456999999999999999999999999999999999975 46643211
Q ss_pred CCccHHHHHHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHH
Q 045798 909 GDLNLHNFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHEL 988 (1008)
Q Consensus 909 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 988 (1008)
...+........... ....++.++.+++.+||+.||++||||+||++.|
T Consensus 243 -~~~~~~~~~~~~~~~------------------------------~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L 291 (299)
T d1ywna1 243 -DEEFCRRLKEGTRMR------------------------------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 291 (299)
T ss_dssp -SHHHHHHHHHTCCCC------------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred -HHHHHHHHhcCCCCC------------------------------CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 111111111100000 0012345689999999999999999999999999
Q ss_pred HHHHHH
Q 045798 989 QSVKNI 994 (1008)
Q Consensus 989 ~~i~~~ 994 (1008)
+.+.++
T Consensus 292 ~~ilq~ 297 (299)
T d1ywna1 292 GNLLQA 297 (299)
T ss_dssp HHHHHH
T ss_pred HHHHhC
Confidence 988654
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-44 Score=394.44 Aligned_cols=252 Identities=21% Similarity=0.272 Sum_probs=204.2
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccchhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceEE
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKA 762 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 762 (1008)
.++|++.+.||+|+||+||+|.+..+++.||||+++... .....+.+|++++++++||||++++++ +.+++..|
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~-----~~~~~~~~ 77 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHES-----FESMEELV 77 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEE-----EEETTEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEE-----EEECCEEE
Confidence 468999999999999999999999899999999997653 334578899999999999999999999 46677899
Q ss_pred EEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCC--CCeEE
Q 045798 763 IVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDND--LSGHI 840 (1008)
Q Consensus 763 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~--~~~kL 840 (1008)
+|||||+||+|.+++...+. ++++.+++.|+.||+.||+|||+. +|+||||||+|||++.+ ..+||
T Consensus 78 lvmE~~~gg~L~~~i~~~~~---------~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl 145 (321)
T d1tkia_ 78 MIFEFISGLDIFERINTSAF---------ELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKI 145 (321)
T ss_dssp EEECCCCCCBHHHHHTSSSC---------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEE
T ss_pred EEEecCCCCcHHHHHHhcCC---------CCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEE
Confidence 99999999999999976532 689999999999999999999997 99999999999999854 58999
Q ss_pred cccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHhh
Q 045798 841 GDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMA 920 (1008)
Q Consensus 841 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~~ 920 (1008)
+|||+++....... .....+|+.|+|||...+..++.++||||+||++|+|++|+.||......+ .........
T Consensus 146 ~DFG~~~~~~~~~~-----~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~-~~~~i~~~~ 219 (321)
T d1tkia_ 146 IEFGQARQLKPGDN-----FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ-IIENIMNAE 219 (321)
T ss_dssp CCCTTCEECCTTCE-----EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHHHHHHTC
T ss_pred cccchhhccccCCc-----ccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhCC
Confidence 99999986543321 122458999999999999999999999999999999999999986432110 000110000
Q ss_pred CCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 921 LPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 921 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
.... .......+.++.+++.+||+.||.+|||++|+++
T Consensus 220 ------------~~~~----------------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 220 ------------YTFD----------------EEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp ------------CCCC----------------HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ------------CCCC----------------hhhccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000 0011123456789999999999999999999986
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=6.3e-45 Score=400.61 Aligned_cols=245 Identities=23% Similarity=0.299 Sum_probs=203.0
Q ss_pred cCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccc---cchhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCce
Q 045798 684 NGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQ---CEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDF 760 (1008)
Q Consensus 684 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 760 (1008)
++|++++.||+|+||.||+|+++.+|+.||||+++.. .....+.+.+|+++++.++||||++++++ +.....
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~-----~~~~~~ 115 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFS-----FKDNSN 115 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEE-----EECSSE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccc-----cccccc
Confidence 5799999999999999999999989999999998643 23345678999999999999999999999 456777
Q ss_pred EEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEE
Q 045798 761 KAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHI 840 (1008)
Q Consensus 761 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 840 (1008)
.++||||+.+|+|.+++...+ .+++..++.++.||+.||.|||++ +||||||||+|||++.++.+||
T Consensus 116 ~~~v~e~~~~g~l~~~l~~~~----------~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL 182 (350)
T d1rdqe_ 116 LYMVMEYVAGGEMFSHLRRIG----------RFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQV 182 (350)
T ss_dssp EEEEEECCTTCBHHHHHHHHC----------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEE
T ss_pred cccccccccccchhhhHhhcC----------CCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEe
Confidence 999999999999999997654 789999999999999999999998 9999999999999999999999
Q ss_pred cccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHhh
Q 045798 841 GDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMA 920 (1008)
Q Consensus 841 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~~ 920 (1008)
+|||+|+...... ....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......
T Consensus 183 ~DFG~a~~~~~~~-------~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~----~~~~~~-- 249 (350)
T d1rdqe_ 183 TDFGFAKRVKGRT-------WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP----IQIYEK-- 249 (350)
T ss_dssp CCCTTCEECSSCB-------CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHH--
T ss_pred eeceeeeeccccc-------ccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCH----HHHHHH--
Confidence 9999998664322 235699999999999999999999999999999999999999863211 000000
Q ss_pred CCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCC-----CHHHHHH
Q 045798 921 LPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRM-----NMTNVVH 986 (1008)
Q Consensus 921 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~ 986 (1008)
+..... ..+ ...+.++.+++.+||+.||.+|+ |++|+++
T Consensus 250 -------i~~~~~--------------~~p------~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 250 -------IVSGKV--------------RFP------SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp -------HHHCCC--------------CCC------TTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred -------HhcCCC--------------CCC------ccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 000000 000 12345678999999999999994 8999876
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.4e-44 Score=400.06 Aligned_cols=250 Identities=23% Similarity=0.290 Sum_probs=197.6
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEecccc---chhhHHHH---HHHHHHhhcCCCCceeeeecccccccc
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC---EGASKSFM---AECKALKNIRHRNLVKVITSCSSIDFQ 756 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~---~E~~~l~~l~h~niv~~~~~~~~~~~~ 756 (1008)
.++|++.+.||+|+||.||+|++..+|+.||||++.... ......+. +|+++++.++|||||+++++ +.
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~-----~~ 77 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYA-----FH 77 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEE-----EE
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEE-----EE
Confidence 368999999999999999999999999999999986321 12223344 44677777889999999999 45
Q ss_pred CCceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCC
Q 045798 757 GNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDL 836 (1008)
Q Consensus 757 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 836 (1008)
+++..|+|||||++|+|.+++.... .+++..++.++.||+.||+|||+. +||||||||+|||++.++
T Consensus 78 ~~~~~~ivmE~~~gg~L~~~l~~~~----------~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g 144 (364)
T d1omwa3 78 TPDKLSFILDLMNGGDLHYHLSQHG----------VFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHG 144 (364)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHHC----------SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSS
T ss_pred ECCEEEEEEEecCCCcHHHHHHhcc----------cccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCC
Confidence 6778999999999999999997654 689999999999999999999998 999999999999999999
Q ss_pred CeEEcccCcccccccccCccccccccccccccccCccccCC-CCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHH
Q 045798 837 SGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLG-SEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHN 915 (1008)
Q Consensus 837 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~ 915 (1008)
.+||+|||+|+...... .....||+.|+|||++.+ ..|+.++|||||||++|||++|+.||......+ ...
T Consensus 145 ~iKl~DFGla~~~~~~~------~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~--~~~ 216 (364)
T d1omwa3 145 HVRISDLGLACDFSKKK------PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD--KHE 216 (364)
T ss_dssp CEEECCCTTCEECSSSC------CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSC--HHH
T ss_pred cEEEeeeceeeecCCCc------ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHH--HHH
Confidence 99999999998664432 223469999999999865 568999999999999999999999997432211 111
Q ss_pred HHHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCC-----HHHHHH
Q 045798 916 FARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMN-----MTNVVH 986 (1008)
Q Consensus 916 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~ 986 (1008)
..+...... . .. ....+.++.+++.+||+.||++||| |+|+++
T Consensus 217 ~~~~~~~~~------------~----------~~------~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 217 IDRMTLTMA------------V----------EL------PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp HHHHSSSCC------------C----------CC------CSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred HHHhcccCC------------C----------CC------CCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 111111000 0 00 0123456789999999999999999 677765
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-44 Score=395.99 Aligned_cols=257 Identities=18% Similarity=0.216 Sum_probs=201.0
Q ss_pred hcCCCCCc-eEeeccCeeEEEEEEcCCCeEEEEEEeccccchhhHHHHHHHHHHhhc-CCCCceeeeeccccccccCCce
Q 045798 683 TNGFSSTH-LIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNI-RHRNLVKVITSCSSIDFQGNDF 760 (1008)
Q Consensus 683 ~~~y~~~~-~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~ 760 (1008)
.++|.+.+ .||+|+||+||+|++..+++.||||+++.. ..+.+|++++.++ +|||||++++++... ......
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~-~~~~~~ 83 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENL-YAGRKC 83 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEE-ETTEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeec-ccCCCE
Confidence 46798875 599999999999999889999999998632 5678899987665 899999999986432 233567
Q ss_pred EEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecC---CCC
Q 045798 761 KAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDN---DLS 837 (1008)
Q Consensus 761 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~~ 837 (1008)
.|+|||||+||+|.+++...+.. .+++.+++.|+.||+.||+|||+. +|+||||||+|||++. .+.
T Consensus 84 ~~ivmEy~~gg~L~~~i~~~~~~--------~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~ 152 (335)
T d2ozaa1 84 LLIVMECLDGGELFSRIQDRGDQ--------AFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAI 152 (335)
T ss_dssp EEEEEECCCSEEHHHHHHSCSCC--------CEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCC
T ss_pred EEEEEECCCCCcHHHHHHhcCCC--------CcCHHHHHHHHHHHHHHHHHHHHc---CCcccccccccccccccccccc
Confidence 89999999999999999764321 699999999999999999999998 9999999999999975 567
Q ss_pred eEEcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHH
Q 045798 838 GHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFA 917 (1008)
Q Consensus 838 ~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~ 917 (1008)
+||+|||+|+....... .....||+.|+|||++.+..|+.++|||||||++|+|+||+.||......... ...
T Consensus 153 ~Kl~DFG~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~-~~~- 225 (335)
T d2ozaa1 153 LKLTDFGFAKETTSHNS-----LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS-PGM- 225 (335)
T ss_dssp EEECCCTTCEECCCCCC-----CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------
T ss_pred ccccccceeeeccCCCc-----cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHH-HHH-
Confidence 99999999986654322 22356999999999999999999999999999999999999999643211100 000
Q ss_pred HhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 918 RMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 918 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
........ ...+.+.....+.++.+++.+||+.||++|||+.|+++
T Consensus 226 -----------~~~i~~~~------------~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 226 -----------KTRIRMGQ------------YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp -------------CCCSCS------------SSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred -----------HHHHhcCC------------CCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 00000000 00011122345667899999999999999999999976
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-45 Score=389.48 Aligned_cols=258 Identities=26% Similarity=0.370 Sum_probs=194.9
Q ss_pred cCCCCCceEeeccCeeEEEEEEcCC---CeEEEEEEeccc---cchhhHHHHHHHHHHhhcCCCCceeeeeccccccccC
Q 045798 684 NGFSSTHLIGVGSFGCVYKGALDED---GIVVAIKVINLQ---CEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQG 757 (1008)
Q Consensus 684 ~~y~~~~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 757 (1008)
++|++.+.||+|+||.||+|+.... ...||||+++.. .+...++|.+|++++++++||||++++|+|..
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~----- 82 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT----- 82 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-----
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-----
Confidence 5689999999999999999987432 247899998743 23445789999999999999999999999642
Q ss_pred CceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCC
Q 045798 758 NDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLS 837 (1008)
Q Consensus 758 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 837 (1008)
+..++||||+++|++.+++.... ..+++..++.++.||+.||+|||+. +|+||||||+||+++.++.
T Consensus 83 -~~~~lv~e~~~~~~l~~~~~~~~---------~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~ 149 (273)
T d1u46a_ 83 -PPMKMVTELAPLGSLLDRLRKHQ---------GHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDL 149 (273)
T ss_dssp -SSCEEEEECCTTCBHHHHHHHHG---------GGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTE
T ss_pred -cchheeeeeecCcchhhhhhccc---------CCCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccc
Confidence 24689999999999998876543 1699999999999999999999997 9999999999999999999
Q ss_pred eEEcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCccccCCccHHHH
Q 045798 838 GHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT-AKKPTDVMFEGDLNLHNF 916 (1008)
Q Consensus 838 ~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-G~~pf~~~~~~~~~~~~~ 916 (1008)
+||+|||+++......... .......|+..|+|||++.+..++.++|||||||++|||+| |+.||......+ .....
T Consensus 150 vkl~DfGl~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~-~~~~i 227 (273)
T d1u46a_ 150 VKIGDFGLMRALPQNDDHY-VMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ-ILHKI 227 (273)
T ss_dssp EEECCCTTCEECCC-CCEE-EC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-HHHHH
T ss_pred eeeccchhhhhcccCCCcc-eecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHH-HHHHH
Confidence 9999999999765443322 22333457889999999999999999999999999999998 899986331111 00000
Q ss_pred HHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHHHHH
Q 045798 917 ARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHELQSV 991 (1008)
Q Consensus 917 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~i 991 (1008)
.+.. . ++ +....++.++.+++.+||+.||++||||+||++.|++.
T Consensus 228 ~~~~------------~--------------~~----~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 228 DKEG------------E--------------RL----PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp HTSC------------C--------------CC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HhCC------------C--------------CC----CCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 0000 0 00 00112445689999999999999999999999988764
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-44 Score=394.09 Aligned_cols=248 Identities=26% Similarity=0.364 Sum_probs=200.8
Q ss_pred cCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccc---cchhhHHHHHHHHHHh-hcCCCCceeeeeccccccccCCc
Q 045798 684 NGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQ---CEGASKSFMAECKALK-NIRHRNLVKVITSCSSIDFQGND 759 (1008)
Q Consensus 684 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~-~l~h~niv~~~~~~~~~~~~~~~ 759 (1008)
++|.+.+.||+|+||+||+|++..+++.||||+++.. .....+.+..|+.++. .++||||++++++ +.+++
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~-----~~~~~ 76 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCT-----FQTKE 76 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEE-----EECSS
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEE-----EccCC
Confidence 5799999999999999999999999999999999743 2334456777777765 6799999999999 56677
Q ss_pred eEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeE
Q 045798 760 FKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGH 839 (1008)
Q Consensus 760 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 839 (1008)
..|+|||||++|+|.+++.... .+++.+++.++.||+.||+|||++ +|+||||||+|||+++++.+|
T Consensus 77 ~~yivmEy~~~g~L~~~i~~~~----------~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~k 143 (320)
T d1xjda_ 77 NLFFVMEYLNGGDLMYHIQSCH----------KFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIK 143 (320)
T ss_dssp EEEEEEECCTTCBHHHHHHHHS----------SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEE
T ss_pred ceeEEEeecCCCcHHHHhhccC----------CCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCcee
Confidence 8999999999999999997654 789999999999999999999998 999999999999999999999
Q ss_pred EcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHh
Q 045798 840 IGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARM 919 (1008)
Q Consensus 840 L~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~ 919 (1008)
|+|||+|+........ .....||+.|+|||++.+..++.++||||+||++|||++|+.||...... ........
T Consensus 144 l~DFG~a~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~--~~~~~i~~ 217 (320)
T d1xjda_ 144 IADFGMCKENMLGDAK----TNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE--ELFHSIRM 217 (320)
T ss_dssp ECCCTTCBCCCCTTCC----BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHH
T ss_pred ccccchhhhccccccc----ccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHH--HHHHHHHc
Confidence 9999999865433222 23356999999999999999999999999999999999999999642111 00000000
Q ss_pred hCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHH-HHHH
Q 045798 920 ALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMT-NVVH 986 (1008)
Q Consensus 920 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~-evl~ 986 (1008)
. .+ .++ ...+.++.+++.+||+.||++|||+. |+++
T Consensus 218 ~---------------~~----------~~p------~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 218 D---------------NP----------FYP------RWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp C---------------CC----------CCC------TTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred C---------------CC----------CCC------ccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 0 00 000 11345678999999999999999995 6753
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-44 Score=392.06 Aligned_cols=265 Identities=27% Similarity=0.420 Sum_probs=202.6
Q ss_pred cCCCCCceEeeccCeeEEEEEEcCCCe--EEEEEEeccc-cchhhHHHHHHHHHHhhc-CCCCceeeeeccccccccCCc
Q 045798 684 NGFSSTHLIGVGSFGCVYKGALDEDGI--VVAIKVINLQ-CEGASKSFMAECKALKNI-RHRNLVKVITSCSSIDFQGND 759 (1008)
Q Consensus 684 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~ 759 (1008)
++|++.+.||+|+||+||+|.++.++. .||||+++.. .....+.+.+|+++++++ +|||||+++++| ..++
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~-----~~~~ 84 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGAC-----EHRG 84 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEE-----EETT
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEE-----ecCC
Confidence 578899999999999999999987776 4677877533 334556899999999999 799999999996 4456
Q ss_pred eEEEEEeccCCCChhcccccCCCCCC------CcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeec
Q 045798 760 FKAIVYEYMPNGSLEKWLHPHAVPKR------DKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLD 833 (1008)
Q Consensus 760 ~~~lv~e~~~~gsL~~~l~~~~~~~~------~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~ 833 (1008)
..++||||+++|+|.++++....... .......+++.++..++.||+.||.|+|+. +|+||||||+|||++
T Consensus 85 ~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~ 161 (309)
T d1fvra_ 85 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVG 161 (309)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC
T ss_pred eeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEc
Confidence 79999999999999999976421000 000122799999999999999999999998 999999999999999
Q ss_pred CCCCeEEcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCC-CCCccccCCcc
Q 045798 834 NDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKK-PTDVMFEGDLN 912 (1008)
Q Consensus 834 ~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~-pf~~~~~~~~~ 912 (1008)
.++.+||+|||+|+........ ....||..|+|||.+.+..++.++|||||||++|||++|.. ||....
T Consensus 162 ~~~~~kl~DfG~a~~~~~~~~~-----~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~----- 231 (309)
T d1fvra_ 162 ENYVAKIADFGLSRGQEVYVKK-----TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT----- 231 (309)
T ss_dssp GGGCEEECCTTCEESSCEECCC---------CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC-----
T ss_pred CCCceEEccccccccccccccc-----cceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCC-----
Confidence 9999999999999865433222 22458999999999999999999999999999999999765 554221
Q ss_pred HHHHHHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHHHHHH
Q 045798 913 LHNFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHELQSVK 992 (1008)
Q Consensus 913 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~i~ 992 (1008)
...... .+... .+.. ....++.++.+++.+||+.||++||||+||++.|+++.
T Consensus 232 ~~~~~~---------~i~~~--------------~~~~----~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~ 284 (309)
T d1fvra_ 232 CAELYE---------KLPQG--------------YRLE----KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 284 (309)
T ss_dssp HHHHHH---------HGGGT--------------CCCC----CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHH---------HHHhc--------------CCCC----CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 111110 00000 0000 01124567899999999999999999999999999886
Q ss_pred H
Q 045798 993 N 993 (1008)
Q Consensus 993 ~ 993 (1008)
+
T Consensus 285 ~ 285 (309)
T d1fvra_ 285 E 285 (309)
T ss_dssp H
T ss_pred h
Confidence 4
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-44 Score=387.38 Aligned_cols=271 Identities=24% Similarity=0.318 Sum_probs=210.4
Q ss_pred hcCCCCCceEeeccCeeEEEEEEc-----CCCeEEEEEEecccc-chhhHHHHHHHHHHhhc-CCCCceeeeeccccccc
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALD-----EDGIVVAIKVINLQC-EGASKSFMAECKALKNI-RHRNLVKVITSCSSIDF 755 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 755 (1008)
.++|++.++||+|+||.||+|++. .+++.||||+++... ......+.+|+.+++++ +|||||+++++|
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~----- 96 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGAC----- 96 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEE-----
Confidence 367889999999999999999863 356799999997543 34456799999999999 799999999996
Q ss_pred cCCceEEEEEeccCCCChhcccccCCCCCCC--------cccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCC
Q 045798 756 QGNDFKAIVYEYMPNGSLEKWLHPHAVPKRD--------KEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKP 827 (1008)
Q Consensus 756 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~--------~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp 827 (1008)
..++..++|||||++|+|.++++........ ......+++..+..++.||+.||+|||++ ++|||||||
T Consensus 97 ~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp 173 (311)
T d1t46a_ 97 TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAA 173 (311)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSG
T ss_pred eeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeeccccc
Confidence 4456689999999999999999765422110 11223689999999999999999999998 999999999
Q ss_pred CCeeecCCCCeEEcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccc
Q 045798 828 SNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMF 907 (1008)
Q Consensus 828 ~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~ 907 (1008)
+||+++.++.+|++|||.++......... ......||+.|+|||++.+..++.++|||||||++|||+|++.|+....
T Consensus 174 ~NIl~~~~~~~ki~DfG~~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~ 251 (311)
T d1t46a_ 174 RNILLTHGRITKICDFGLARDIKNDSNYV--VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM 251 (311)
T ss_dssp GGEEEETTTEEEECCCGGGSCTTSCTTSE--ECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred ccccccccCcccccccchheeccCCCcce--EeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999999765443322 2344679999999999999999999999999999999999555543222
Q ss_pred cCCccHHHHHHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 045798 908 EGDLNLHNFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHE 987 (1008)
Q Consensus 908 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 987 (1008)
.....+.......... .. ....+.++.+++.+||+.||++||||+||+++
T Consensus 252 ~~~~~~~~~i~~~~~~----------------------------~~--~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~ 301 (311)
T d1t46a_ 252 PVDSKFYKMIKEGFRM----------------------------LS--PEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301 (311)
T ss_dssp CSSHHHHHHHHHTCCC----------------------------CC--CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHHhcCCCC----------------------------CC--cccccHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 2222222221111100 00 01234568999999999999999999999999
Q ss_pred HHHHHH
Q 045798 988 LQSVKN 993 (1008)
Q Consensus 988 L~~i~~ 993 (1008)
|+++..
T Consensus 302 L~~~i~ 307 (311)
T d1t46a_ 302 IEKQIS 307 (311)
T ss_dssp HHHHHH
T ss_pred HHHhhc
Confidence 987643
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.9e-44 Score=384.17 Aligned_cols=269 Identities=23% Similarity=0.372 Sum_probs=204.8
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCC-------eEEEEEEeccccc-hhhHHHHHHHHHHhhc-CCCCceeeeeccccc
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDG-------IVVAIKVINLQCE-GASKSFMAECKALKNI-RHRNLVKVITSCSSI 753 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~-------~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~ 753 (1008)
.++|.+.+.||+|+||.||+|+....+ ..||||+++.... .....+.+|+..+.++ +|||||+++++|
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~--- 88 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC--- 88 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE---
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEeccccc---
Confidence 457899999999999999999975433 4799999976543 4457889999999888 899999999996
Q ss_pred cccCCceEEEEEeccCCCChhcccccCCCCCC------CcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCC
Q 045798 754 DFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKR------DKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKP 827 (1008)
Q Consensus 754 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~------~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp 827 (1008)
.+++..++||||+++|+|.+++........ .......+++.+++.++.||+.||+|||+. +||||||||
T Consensus 89 --~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp 163 (299)
T d1fgka_ 89 --TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAA 163 (299)
T ss_dssp --CSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSG
T ss_pred --ccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeecc
Confidence 445678999999999999999976643211 011123689999999999999999999998 999999999
Q ss_pred CCeeecCCCCeEEcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHh-CCCCCCcc
Q 045798 828 SNILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVT-AKKPTDVM 906 (1008)
Q Consensus 828 ~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-G~~pf~~~ 906 (1008)
+|||++.++.+||+|||+++......... ......+|+.|+|||.+.++.|++++|||||||++|||++ |.+||...
T Consensus 164 ~NiLl~~~~~~kl~dfg~~~~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~ 241 (299)
T d1fgka_ 164 RNVLVTEDNVMKIADFGLARDIHHIDYYK--KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV 241 (299)
T ss_dssp GGEEECTTCCEEECSTTCCCCGGGCCTTC--CCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred cceeecCCCCeEeccchhhcccccccccc--ccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCC
Confidence 99999999999999999998765543322 2334568999999999999999999999999999999998 67777532
Q ss_pred ccCCccHHHHHHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 907 FEGDLNLHNFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 907 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
... ..... +..... . .. ...++.++.+++.+||+.||.+||||.||++
T Consensus 242 ~~~--~~~~~------------i~~~~~--------------~--~~--p~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 242 PVE--ELFKL------------LKEGHR--------------M--DK--PSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289 (299)
T ss_dssp CHH--HHHHH------------HHTTCC--------------C--CC--CSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CHH--HHHHH------------HHcCCC--------------C--CC--CccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 111 01111 100000 0 00 0123456899999999999999999999999
Q ss_pred HHHHHHH
Q 045798 987 ELQSVKN 993 (1008)
Q Consensus 987 ~L~~i~~ 993 (1008)
.|+++.+
T Consensus 290 ~L~~i~a 296 (299)
T d1fgka_ 290 DLDRIVA 296 (299)
T ss_dssp HHHHHHH
T ss_pred HHHHHhh
Confidence 9998854
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-44 Score=386.12 Aligned_cols=269 Identities=23% Similarity=0.279 Sum_probs=194.9
Q ss_pred CCceEeeccCeeEEEEEEcCCCeEEEEEEeccccc-----hhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceEE
Q 045798 688 STHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCE-----GASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKA 762 (1008)
Q Consensus 688 ~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 762 (1008)
.+++||+|+||+||+|++..+|+.||||+++.... ...+.+.+|++++++++|||||+++++ +..++..|
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~-----~~~~~~~~ 76 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDA-----FGHKSNIS 76 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEE-----ECCTTCCE
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEee-----eccCCcee
Confidence 35789999999999999998999999999864322 123578999999999999999999999 45667799
Q ss_pred EEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEcc
Q 045798 763 IVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIGD 842 (1008)
Q Consensus 763 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 842 (1008)
+||||++++++..+..... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|
T Consensus 77 ivmE~~~~~~~~~~~~~~~----------~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~D 143 (299)
T d1ua2a_ 77 LVFDFMETDLEVIIKDNSL----------VLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLAD 143 (299)
T ss_dssp EEEECCSEEHHHHHTTCCS----------SCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC
T ss_pred ehhhhhcchHHhhhhhccc----------CCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCcccccc
Confidence 9999998887777665443 688889999999999999999998 999999999999999999999999
Q ss_pred cCcccccccccCccccccccccccccccCccccCCC-CCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHhhC
Q 045798 843 FGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGS-EVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMAL 921 (1008)
Q Consensus 843 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~~~ 921 (1008)
||.|+........ ....+||+.|+|||++.+. .++.++||||+||++|||++|.+||....+.+ .+........
T Consensus 144 FG~a~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~-~l~~i~~~~~ 218 (299)
T d1ua2a_ 144 FGLAKSFGSPNRA----YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD-QLTRIFETLG 218 (299)
T ss_dssp CGGGSTTTSCCCC----CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHC
T ss_pred CccccccCCCccc----ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHH-HHHHHHHhcC
Confidence 9999865443222 2234699999999988654 57999999999999999999999986432211 1111111111
Q ss_pred CcchhhhhcccccCchHHhhhhhhhhhccccch---hHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 922 PNQVMDIVDPILRNDEEILASTDKCRRMQTGIN---SRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 922 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
......+.+..-.... ......+ ..+ .....+.++.+++.+||+.||++||||+|+++
T Consensus 219 ~~~~~~~~~~~~~~~~------~~~~~~~-~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 219 TPTEEQWPDMCSLPDY------VTFKSFP-GIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp CCCTTTSSSTTSSTTC------CCCCCCC-CCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred CCChhhccchhccchh------hhhccCC-CCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 1110000000000000 0000000 000 00123456899999999999999999999975
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.7e-44 Score=384.64 Aligned_cols=275 Identities=27% Similarity=0.349 Sum_probs=199.0
Q ss_pred cCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEecccc--chhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceE
Q 045798 684 NGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC--EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFK 761 (1008)
Q Consensus 684 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 761 (1008)
++|++++.||+|+||+||+|.+..+|+.||||+++... +...+++.+|++++++++||||++++++ +.+++..
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~-----~~~~~~~ 76 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV-----IHTENKL 76 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEE-----EEETTEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccc-----cccccce
Confidence 68999999999999999999999899999999997543 2335789999999999999999999999 4567789
Q ss_pred EEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEc
Q 045798 762 AIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIG 841 (1008)
Q Consensus 762 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 841 (1008)
|+||||+.+ ++.+++..... ..+++..++.++.||+.||+|||+. +||||||||+|||++.++.+||+
T Consensus 77 ~iv~e~~~~-~~~~~~~~~~~--------~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~ 144 (298)
T d1gz8a_ 77 YLVFEFLHQ-DLKKFMDASAL--------TGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLA 144 (298)
T ss_dssp EEEEECCSE-EHHHHHHHTTT--------TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEEC
T ss_pred eEEEeecCC-chhhhhhhhcc--------cCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceec
Confidence 999999955 55555433321 1689999999999999999999998 99999999999999999999999
Q ss_pred ccCcccccccccCccccccccccccccccCccccCCCC-CCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHhh
Q 045798 842 DFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSE-VSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMA 920 (1008)
Q Consensus 842 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~~ 920 (1008)
|||.|+........ .....||+.|+|||.+.... ++.++||||+||++|+|++|+.||......+. ........
T Consensus 145 DFG~a~~~~~~~~~----~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~-~~~i~~~~ 219 (298)
T d1gz8a_ 145 DFGLARAFGVPVRT----YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ-LFRIFRTL 219 (298)
T ss_dssp STTHHHHHCCCSBC----TTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHH
T ss_pred cCCcceeccCCccc----ceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHH-HHHHHHhc
Confidence 99999865433222 22346999999999877665 57899999999999999999999974322111 11111111
Q ss_pred CC-cc-hhhhhcccccCchHHhhhhhhhhhccccch-hHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 921 LP-NQ-VMDIVDPILRNDEEILASTDKCRRMQTGIN-SRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 921 ~~-~~-~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
.. .. ........-... .... ........ .....+.++.+++.+||+.||++|||++|+++
T Consensus 220 ~~~~~~~~~~~~~~~~~~----~~~~--~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~ 282 (298)
T d1gz8a_ 220 GTPDEVVWPGVTSMPDYK----PSFP--KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282 (298)
T ss_dssp CCCCTTTSTTGGGSTTCC----TTSC--CCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCCchhhccccccccccc----cccc--cccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 11 10 000000000000 0000 00000000 01123456789999999999999999999976
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-44 Score=389.89 Aligned_cols=269 Identities=21% Similarity=0.355 Sum_probs=207.8
Q ss_pred hcCCCCCceEeeccCeeEEEEEEc-----CCCeEEEEEEecccc-chhhHHHHHHHHHHhhcCCCCceeeeecccccccc
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALD-----EDGIVVAIKVINLQC-EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQ 756 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 756 (1008)
.++|++.+.||+|+||+||+|.+. .+++.||||+++... ......|.+|++++++++||||++++++| .
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~-----~ 93 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV-----S 93 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEE-----C
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEE-----e
Confidence 467889999999999999999884 235789999997543 34446799999999999999999999995 4
Q ss_pred CCceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCC
Q 045798 757 GNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDL 836 (1008)
Q Consensus 757 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 836 (1008)
.++..++||||+++|+|.+++...............+++..+..++.|+++||.|||+. +|+||||||+|||+++++
T Consensus 94 ~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~ 170 (308)
T d1p4oa_ 94 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDF 170 (308)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTC
T ss_pred cCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCCc
Confidence 45668999999999999999865321100011112578999999999999999999997 999999999999999999
Q ss_pred CeEEcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCC-CCCCccccCCccHHH
Q 045798 837 SGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAK-KPTDVMFEGDLNLHN 915 (1008)
Q Consensus 837 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~-~pf~~~~~~~~~~~~ 915 (1008)
++||+|||+|+......... ......||+.|+|||.+.+..++.++|||||||++|||+||. .||..... ..
T Consensus 171 ~~Kl~DFGla~~~~~~~~~~--~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~-----~~ 243 (308)
T d1p4oa_ 171 TVKIGDFGMTRDIYETDYYR--KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN-----EQ 243 (308)
T ss_dssp CEEECCTTCCCGGGGGGCEE--GGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH-----HH
T ss_pred eEEEeecccceeccCCccee--eccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCH-----HH
Confidence 99999999998765543322 223346899999999999999999999999999999999985 55542211 11
Q ss_pred HHHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHHHHHHH
Q 045798 916 FARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHELQSVKN 993 (1008)
Q Consensus 916 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~i~~ 993 (1008)
.... +.+.. ++. ....++..+.+++.+||+.||.+||||+||++.|++..+
T Consensus 244 ~~~~--------i~~~~---------------~~~----~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 244 VLRF--------VMEGG---------------LLD----KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp HHHH--------HHTTC---------------CCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred HHHH--------HHhCC---------------CCC----CcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 1100 00000 000 001234568999999999999999999999999987644
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-43 Score=386.04 Aligned_cols=281 Identities=22% Similarity=0.268 Sum_probs=202.9
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCC-CeEEEEEEecccc--chhhHHHHHHHHHHhhc---CCCCceeeeecccccccc
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDED-GIVVAIKVINLQC--EGASKSFMAECKALKNI---RHRNLVKVITSCSSIDFQ 756 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~~~~~ 756 (1008)
.++|++++.||+|+||+||+|++..+ ++.||||+++... +.....+.+|+.+++.+ +||||++++++|......
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 47899999999999999999999654 6789999987432 22344577888887766 799999999998765556
Q ss_pred CCceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCC
Q 045798 757 GNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDL 836 (1008)
Q Consensus 757 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 836 (1008)
.....+++|||++++.+........ ..+++..++.++.|++.||+|||++ +||||||||+|||++.++
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~ 153 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVPE---------PGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSG 153 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSCT---------TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTC
T ss_pred cCceEEEEEEeccCCchhhhhhccC---------CCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCC
Confidence 6678999999998876654443322 1689999999999999999999998 999999999999999999
Q ss_pred CeEEcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHH
Q 045798 837 SGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNF 916 (1008)
Q Consensus 837 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~ 916 (1008)
.+||+|||.++...... ......||+.|+|||++.+..|+.++||||+||++|||++|+.||......+ .+...
T Consensus 154 ~~kl~dfg~~~~~~~~~-----~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~-~~~~i 227 (305)
T d1blxa_ 154 QIKLADFGLARIYSFQM-----ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD-QLGKI 227 (305)
T ss_dssp CEEECSCCSCCCCCGGG-----GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHH
T ss_pred Ceeecchhhhhhhcccc-----cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHH-HHHHH
Confidence 99999999998654332 2234569999999999999999999999999999999999999997432211 11111
Q ss_pred HHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 917 ARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 917 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
...........+.... ....... ......+........+..+.+++.+||+.||++||||+|+++
T Consensus 228 ~~~~~~~~~~~~~~~~-~~~~~~~----~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~ 292 (305)
T d1blxa_ 228 LDVIGLPGEEDWPRDV-ALPRQAF----HSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292 (305)
T ss_dssp HHHHCCCCGGGSCTTC-SSCGGGS----CCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHhhCCCchhcccccc-cchhhhh----ccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 1111111111100000 0000000 000000000001123456789999999999999999999875
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-44 Score=381.67 Aligned_cols=241 Identities=23% Similarity=0.295 Sum_probs=195.0
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccc------hhhHHHHHHHHHHhhcC--CCCceeeeecccccc
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCE------GASKSFMAECKALKNIR--HRNLVKVITSCSSID 754 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~ 754 (1008)
.++|++.+.||+|+||+||+|++..+|+.||||+++.... ....++.+|+.++++++ ||||++++++
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~----- 77 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW----- 77 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEE-----
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEE-----
Confidence 3579999999999999999999998999999999864321 12244778999999996 8999999999
Q ss_pred ccCCceEEEEEeccCC-CChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeec
Q 045798 755 FQGNDFKAIVYEYMPN-GSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLD 833 (1008)
Q Consensus 755 ~~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~ 833 (1008)
+.+++..++||||+.+ +++.+++.... .+++.+++.++.||+.||+|||+. +|+||||||+|||++
T Consensus 78 ~~~~~~~~lv~e~~~~~~~l~~~~~~~~----------~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~ 144 (273)
T d1xwsa_ 78 FERPDSFVLILERPEPVQDLFDFITERG----------ALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILID 144 (273)
T ss_dssp EECSSEEEEEEECCSSEEEHHHHHHHHC----------SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEE
T ss_pred EeeCCeEEEEEEeccCcchHHHHHhccC----------CCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEe
Confidence 4667789999999976 57778776543 789999999999999999999998 999999999999998
Q ss_pred C-CCCeEEcccCcccccccccCccccccccccccccccCccccCCCCC-CcccchhhHHHHHHHHHhCCCCCCccccCCc
Q 045798 834 N-DLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEV-STNGDVYSYGILLLEMVTAKKPTDVMFEGDL 911 (1008)
Q Consensus 834 ~-~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwslG~vl~elltG~~pf~~~~~~~~ 911 (1008)
. ++.+||+|||+|+...... .....||+.|+|||++.+..+ +.++||||+||++|||++|+.||....
T Consensus 145 ~~~~~vkl~DFG~a~~~~~~~------~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~---- 214 (273)
T d1xwsa_ 145 LNRGELKLIDFGSGALLKDTV------YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE---- 214 (273)
T ss_dssp TTTTEEEECCCTTCEECCSSC------BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH----
T ss_pred cCCCeEEECccccceeccccc------ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch----
Confidence 5 4799999999998654322 223569999999999887665 577899999999999999999986321
Q ss_pred cHHHHHHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 912 NLHNFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
...+.. . .++. ..+.++.+++.+||+.||++|||++|+++
T Consensus 215 ---~i~~~~------------~--------------~~~~------~~s~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 215 ---EIIRGQ------------V--------------FFRQ------RVSSECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp ---HHHHCC------------C--------------CCSS------CCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ---HHhhcc------------c--------------CCCC------CCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 011000 0 0000 12456789999999999999999999976
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-42 Score=380.98 Aligned_cols=284 Identities=22% Similarity=0.282 Sum_probs=200.7
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccc--cchhhHHHHHHHHHHhhcCCCCceeeeecccccc---ccC
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQ--CEGASKSFMAECKALKNIRHRNLVKVITSCSSID---FQG 757 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~---~~~ 757 (1008)
.++|++++.||+|+||+||+|++..+|+.||||++... .+...+++.+|++++++++||||+++++++.... ...
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 47899999999999999999999989999999998643 2344577899999999999999999999875432 233
Q ss_pred CceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCC
Q 045798 758 NDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLS 837 (1008)
Q Consensus 758 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 837 (1008)
++..++||||++++.+..+..... .+++..++.++.||+.||+|||+. +|+||||||+|||++.++.
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~~~~----------~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~ 155 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSNVLV----------KFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGV 155 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTCTTC----------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSC
T ss_pred CceEEEEEeccCCCccchhhhccc----------ccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCc
Confidence 456899999998776665544332 688999999999999999999998 9999999999999999999
Q ss_pred eEEcccCcccccccccCccccccccccccccccCccccCCC-CCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHH
Q 045798 838 GHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGS-EVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNF 916 (1008)
Q Consensus 838 ~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~ 916 (1008)
+|++|||+|+.................||+.|+|||++.+. .+++++||||+||++|||++|+.||...... ......
T Consensus 156 ~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~-~~~~~i 234 (318)
T d3blha1 156 LKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQ-HQLALI 234 (318)
T ss_dssp EEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHH
T ss_pred EEeeecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHH-HHHHHH
Confidence 99999999986654433333333445799999999998765 6899999999999999999999998643211 111111
Q ss_pred HHhhC--Ccchhhhhc-ccccCchHHhhhhhhhhhccccch---hHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 917 ARMAL--PNQVMDIVD-PILRNDEEILASTDKCRRMQTGIN---SRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 917 ~~~~~--~~~~~~~~d-~~l~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
.+... +.......+ ..... ............. ........+.+++.+||+.||++||||+|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~ 304 (318)
T d3blha1 235 SQLCGSITPEVWPNVDNYELYE------KLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304 (318)
T ss_dssp HHHHCCCCTTTSTTCCCC-------------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHhcCCCChhhccccchhhhhh------hhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence 11111 111100000 00000 0000000011111 11123446789999999999999999999985
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=9.9e-43 Score=375.06 Aligned_cols=274 Identities=23% Similarity=0.282 Sum_probs=199.2
Q ss_pred cCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEecccc--chhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceE
Q 045798 684 NGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC--EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFK 761 (1008)
Q Consensus 684 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 761 (1008)
++|+++++||+|+||+||+|+++ +|+.||||+++... +...+++.+|+.++++++||||++++++ +..++..
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~-----~~~~~~~ 75 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV-----IHTKKRL 75 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEE-----EECSSCE
T ss_pred CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeee-----cccCCce
Confidence 68999999999999999999996 88999999997543 3335789999999999999999999999 4566779
Q ss_pred EEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEc
Q 045798 762 AIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIG 841 (1008)
Q Consensus 762 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 841 (1008)
++||||+.++.+..+..... .+++..++.++.||+.||+|||+. +||||||||+|||++.++.+|++
T Consensus 76 ~i~~e~~~~~~~~~~~~~~~----------~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~ 142 (286)
T d1ob3a_ 76 VLVFEHLDQDLKKLLDVCEG----------GLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIA 142 (286)
T ss_dssp EEEEECCSEEHHHHHHTSTT----------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEEC
T ss_pred eEEEEeehhhhHHHHHhhcC----------CcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEec
Confidence 99999998777777665443 799999999999999999999998 99999999999999999999999
Q ss_pred ccCcccccccccCccccccccccccccccCccccCCC-CCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHhh
Q 045798 842 DFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGS-EVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMA 920 (1008)
Q Consensus 842 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~~ 920 (1008)
|||.|......... .....+++.|+|||.+.+. .++.++||||+||++|||++|+.||....+.+. ........
T Consensus 143 DfG~a~~~~~~~~~----~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~-~~~i~~~~ 217 (286)
T d1ob3a_ 143 DFGLARAFGIPVRK----YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ-LMRIFRIL 217 (286)
T ss_dssp CTTHHHHHCC-------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHH
T ss_pred ccccceecccCccc----cceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHH-HHHHHHhh
Confidence 99999865433221 2234589999999998764 568999999999999999999999975432211 11111111
Q ss_pred CCcchhhhh--cccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 921 LPNQVMDIV--DPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 921 ~~~~~~~~~--d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
.......+. ........ ... .....+........+..+.+++.+||+.||++|||++|+++
T Consensus 218 ~~~~~~~~~~~~~~~~~~~----~~~-~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 218 GTPNSKNWPNVTELPKYDP----NFT-VYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp CCCCTTTSTTGGGSTTCCT----TCC-CCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCCChhhccchhhhhhccc----ccc-cccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111100000 00000000 000 00000000001123456789999999999999999999974
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-42 Score=382.62 Aligned_cols=285 Identities=21% Similarity=0.207 Sum_probs=202.9
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEecccc-chhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceE
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC-EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFK 761 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 761 (1008)
+++|++++.||+|+||+||+|.+..+|+.||||+++... ....+.+++|+++|++++||||+++++++....+......
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 467999999999999999999999999999999997543 3445689999999999999999999999876555555556
Q ss_pred EEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEc
Q 045798 762 AIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIG 841 (1008)
Q Consensus 762 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 841 (1008)
++|++ +.+|+|.+++... ++++..++.++.||+.||+|||++ +||||||||+|||++.++.+||+
T Consensus 87 ~l~~~-~~~g~L~~~l~~~-----------~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~ 151 (345)
T d1pmea_ 87 YLVTH-LMGADLYKLLKTQ-----------HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKIC 151 (345)
T ss_dssp EEEEE-CCCEEHHHHHHHC-----------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEEC
T ss_pred EEEEe-ecCCchhhhhhcC-----------CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEc
Confidence 66655 5599999999643 689999999999999999999998 99999999999999999999999
Q ss_pred ccCcccccccccCccccccccccccccccCccccCC-CCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHhh
Q 045798 842 DFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLG-SEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMA 920 (1008)
Q Consensus 842 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~~ 920 (1008)
|||+|+.......... .....+||+.|+|||++.. ..++.++||||+||++|||++|+.||......+... ......
T Consensus 152 DfG~a~~~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~-~~~~~~ 229 (345)
T d1pmea_ 152 DFGLARVADPDHDHTG-FLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLN-HILGIL 229 (345)
T ss_dssp CCTTCEECCGGGCBCC-TTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH-HHHHHH
T ss_pred ccCceeeccCCCccce-eeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHH-HHhhhc
Confidence 9999986654433221 2334569999999999754 467889999999999999999999996532211111 111111
Q ss_pred CCcchhhhhcccccCchHHhhhhhhhhhccccc-hhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 921 LPNQVMDIVDPILRNDEEILASTDKCRRMQTGI-NSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 921 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
........................ ..-.... ......+.++.+++.+||+.||++||||+|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~ 294 (345)
T d1pmea_ 230 GSPSQEDLNCIINLKARNYLLSLP--HKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294 (345)
T ss_dssp CSCCHHHHHTCCCHHHHHHHHTSC--CCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cCCChhhhhhhhhhhhhcccccCC--ccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111110000000000000000000 0000000 000122346789999999999999999999986
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=9.4e-42 Score=369.90 Aligned_cols=265 Identities=22% Similarity=0.268 Sum_probs=203.0
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccchhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceEE
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFKA 762 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 762 (1008)
.++|++.+.||+|+||.||+|++..+|+.||||++.... ..+++.+|+++++.++|++++..++.| ...++..+
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~i~~~l~~~~~i~~~~~~----~~~~~~~~ 79 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWC----GAEGDYNV 79 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT--TSCCHHHHHHHHHHSTTSTTCCCEEEE----EEETTEEE
T ss_pred CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc--cCHHHHHHHHHHHHccCCCcccEEEEE----EecCCEEE
Confidence 367999999999999999999998899999999987542 234588999999999888777666554 34567789
Q ss_pred EEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeec---CCCCeE
Q 045798 763 IVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLD---NDLSGH 839 (1008)
Q Consensus 763 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~---~~~~~k 839 (1008)
+||||+ ++++.+.+..... .+++..+..++.|++.||+|||++ +|+||||||+||+++ .+..+|
T Consensus 80 ivme~~-~~~l~~~~~~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vk 146 (299)
T d1ckia_ 80 MVMELL-GPSLEDLFNFCSR---------KFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVY 146 (299)
T ss_dssp EEEECC-CCBHHHHHHHTTT---------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEE
T ss_pred EEEEEc-CCchhhhhhhccC---------CCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceee
Confidence 999999 6677776654321 789999999999999999999998 999999999999985 456799
Q ss_pred EcccCcccccccccCcc---ccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHH--
Q 045798 840 IGDFGLARFHQEVSNST---LSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLH-- 914 (1008)
Q Consensus 840 L~Dfg~a~~~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~-- 914 (1008)
++|||+|+......... ........||+.|+|||++.+..+++++|||||||++|||++|+.||...........
T Consensus 147 l~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~ 226 (299)
T d1ckia_ 147 IIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYE 226 (299)
T ss_dssp ECCCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HH
T ss_pred eeccCcceeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHH
Confidence 99999999775543221 1223346799999999999999999999999999999999999999975322211110
Q ss_pred HHHHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHHHHHHH
Q 045798 915 NFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHELQSVKN 993 (1008)
Q Consensus 915 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~i~~ 993 (1008)
....... .... . .....++.++.+++..||+.||++||+++++.+.|+.+..
T Consensus 227 ~~~~~~~------------~~~~---------~------~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~ 278 (299)
T d1ckia_ 227 RISEKKM------------STPI---------E------VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 278 (299)
T ss_dssp HHHHHHH------------HSCH---------H------HHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHH
T ss_pred HhhcccC------------CCCh---------h------HhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHH
Confidence 0000000 0000 0 0011345678999999999999999999999998887643
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-42 Score=378.73 Aligned_cols=279 Identities=22% Similarity=0.274 Sum_probs=197.8
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccc--cchhhHHHHHHHHHHhhcCCCCceeeeecccccc-ccCCc
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQ--CEGASKSFMAECKALKNIRHRNLVKVITSCSSID-FQGND 759 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~~~ 759 (1008)
.++|++++.||+|+||+||+|.+..+|+.||||+++.. .+...+.+.+|+++|++++|||||+++++|...+ .....
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 46899999999999999999999989999999999743 2344568999999999999999999999976433 22344
Q ss_pred eEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeE
Q 045798 760 FKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGH 839 (1008)
Q Consensus 760 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 839 (1008)
+.|+||||+ +.+|..+.+.. ++++..++.++.||+.||+|||++ +|+||||||+|||++.++.+|
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~~-----------~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~k 161 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKHE-----------KLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELK 161 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHHC-----------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEE
T ss_pred eEEEEEecc-cccHHHHHHhc-----------cccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhcccccccc
Confidence 679999999 67888777543 689999999999999999999998 999999999999999999999
Q ss_pred EcccCcccccccccCccccccccccccccccCccccCCC-CCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHH
Q 045798 840 IGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGS-EVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFAR 918 (1008)
Q Consensus 840 L~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~ 918 (1008)
++|||.|+...... ....||+.|+|||++.+. .++.++||||+||++|||++|+.||......+ .+.....
T Consensus 162 l~Dfg~a~~~~~~~-------~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~-~~~~~~~ 233 (346)
T d1cm8a_ 162 ILDFGLARQADSEM-------TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLD-QLKEIMK 233 (346)
T ss_dssp ECCCTTCEECCSSC-------CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHH
T ss_pred cccccceeccCCcc-------ccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHH-HHHHHHh
Confidence 99999998654322 234699999999998764 56899999999999999999999986432111 1111111
Q ss_pred hhCCcchhhhhcccccCchHHhhhhhhhhhcc-ccc-hhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 045798 919 MALPNQVMDIVDPILRNDEEILASTDKCRRMQ-TGI-NSRLECLISMVKIGVACSMESPQDRMNMTNVVHE 987 (1008)
Q Consensus 919 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~-~~~-~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 987 (1008)
...... .+..... ...... .......... ... ......+..+.+++.+||+.||.+||||+|+++.
T Consensus 234 ~~~~~~-~~~~~~~-~~~~~~-~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~H 301 (346)
T d1cm8a_ 234 VTGTPP-AEFVQRL-QSDEAK-NYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 301 (346)
T ss_dssp HHCCCC-HHHHHTC-SCHHHH-HHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ccCCCc-HHHHhhh-cchhhh-hhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 111110 0000000 000000 0000000000 000 0011234567899999999999999999999873
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.6e-41 Score=373.20 Aligned_cols=276 Identities=19% Similarity=0.240 Sum_probs=200.4
Q ss_pred cCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccchhhHHHHHHHHHHhhcC-CCCceeeeeccccccccCCceEE
Q 045798 684 NGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIR-HRNLVKVITSCSSIDFQGNDFKA 762 (1008)
Q Consensus 684 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~ 762 (1008)
++|+++++||+|+||+||+|++..+|+.||||+++.. ..+++.+|+++|++++ ||||+++++++.. ......+
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~---~~~~~~~ 108 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKD---PVSRTPA 108 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEEC---TTTCSEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEe---cCCCcee
Confidence 5799999999999999999999989999999999743 3467899999999995 9999999998642 3456789
Q ss_pred EEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCC-CeEEc
Q 045798 763 IVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDL-SGHIG 841 (1008)
Q Consensus 763 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kL~ 841 (1008)
+|||||++++|..+.+ .+++..++.++.||+.||+|||++ +||||||||+|||++.++ .+||+
T Consensus 109 ~v~e~~~~~~L~~~~~-------------~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~ 172 (328)
T d3bqca1 109 LVFEHVNNTDFKQLYQ-------------TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLI 172 (328)
T ss_dssp EEEECCCSCBGGGTTT-------------SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEEC
T ss_pred EEEeecCCCcHHHHhc-------------CCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeec
Confidence 9999999999987643 689999999999999999999998 999999999999998655 58999
Q ss_pred ccCcccccccccCccccccccccccccccCccccCCC-CCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHhh
Q 045798 842 DFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGS-EVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMA 920 (1008)
Q Consensus 842 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~~ 920 (1008)
|||+|+....... .....+|+.|+|||.+.+. .++.++||||+||++|||++|+.||.................
T Consensus 173 DFG~a~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~ 247 (328)
T d3bqca1 173 DWGLAEFYHPGQE-----YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVL 247 (328)
T ss_dssp CGGGCEECCTTCC-----CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHH
T ss_pred ccccceeccCCCc-----ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHH
Confidence 9999986654322 2234589999999997765 479999999999999999999999864322111111111111
Q ss_pred CCcchhhhhccc-ccCchHHhhhhh--hhhhcc--ccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 921 LPNQVMDIVDPI-LRNDEEILASTD--KCRRMQ--TGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 921 ~~~~~~~~~d~~-l~~~~~~~~~~~--~~~~~~--~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
..+...+..... ............ ...... .........+.++.+++.+||+.||++|||++|+++
T Consensus 248 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 248 GTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp CHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCchhhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111111111000 000000000000 000000 000111234556789999999999999999999975
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-41 Score=368.42 Aligned_cols=276 Identities=21% Similarity=0.263 Sum_probs=205.3
Q ss_pred cCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEecccc--chhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCceE
Q 045798 684 NGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC--EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDFK 761 (1008)
Q Consensus 684 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 761 (1008)
++|++++.||+|+||+||+|++..+++.||||+++... +....++.+|+.+++.++||||+++++++ .+.+..
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~-----~~~~~~ 76 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVL-----HSDKKL 76 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSSEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeecccc-----ccccce
Confidence 58999999999999999999999999999999997443 34467899999999999999999999994 566779
Q ss_pred EEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEEc
Q 045798 762 AIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHIG 841 (1008)
Q Consensus 762 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 841 (1008)
++|+|++.++++..++...+ .+++..++.++.|++.||+|||++ +||||||||+|||++.++.+||+
T Consensus 77 ~iv~~~~~~~~l~~~~~~~~----------~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~ 143 (292)
T d1unla_ 77 TLVFEFCDQDLKKYFDSCNG----------DLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLA 143 (292)
T ss_dssp EEEEECCSEEHHHHHHHTTT----------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEEC
T ss_pred eEEeeecccccccccccccc----------ccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeee
Confidence 99999999999988877654 788999999999999999999998 99999999999999999999999
Q ss_pred ccCcccccccccCccccccccccccccccCccccCCCC-CCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHhh
Q 045798 842 DFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSE-VSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMA 920 (1008)
Q Consensus 842 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~~ 920 (1008)
|||.|+......... ....++..|+|||.+.+.. ++.++||||+||++|||++|+.||.................
T Consensus 144 DFG~a~~~~~~~~~~----~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~ 219 (292)
T d1unla_ 144 NFGLARAFGIPVRCY----SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLL 219 (292)
T ss_dssp CCTTCEECCSCCSCC----CSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHH
T ss_pred ecchhhcccCCCccc----eeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhc
Confidence 999998765433222 2244788999999987665 68999999999999999999999753222121222222211
Q ss_pred CCcc--hhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 921 LPNQ--VMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 921 ~~~~--~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
.+.. .............. ................+..+.+++.+|++.||.+||||+|+++
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 220 GTPTEEQWPSMTKLPDYKPY-----PMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp CCCCTTTCTTGGGSTTCCCC-----CCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred CCCChhhhhhhhhccccccc-----ccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1111 00000000000000 0000000000011123456789999999999999999999875
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=3.7e-41 Score=362.78 Aligned_cols=266 Identities=18% Similarity=0.204 Sum_probs=206.2
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccchhhHHHHHHHHHHhhcCC-CCceeeeeccccccccCCceE
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRH-RNLVKVITSCSSIDFQGNDFK 761 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~~~~~ 761 (1008)
.++|++.+.||+|+||+||+|++..+|+.||||+++... ..+.+.+|+++++.+.| +|++.+++++ ..+...
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~-----~~~~~~ 76 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFG-----QEGLHN 76 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEE-----EETTEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEe-----ecCCcc
Confidence 368999999999999999999999899999999986432 23457889999999965 8999999884 566778
Q ss_pred EEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecC-----CC
Q 045798 762 AIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDN-----DL 836 (1008)
Q Consensus 762 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~-----~~ 836 (1008)
++||||+ +++|.+++..... .+++..+..++.|++.||+|||+. +|+||||||+||+++. ++
T Consensus 77 ~~vme~~-~~~l~~~~~~~~~---------~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~ 143 (293)
T d1csna_ 77 VLVIDLL-GPSLEDLLDLCGR---------KFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNAN 143 (293)
T ss_dssp EEEEECC-CCBHHHHHHHTTT---------CCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTT
T ss_pred EEEEEec-CCCHHHHHHhhcc---------chhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCC
Confidence 9999999 7899999875532 689999999999999999999998 9999999999999974 57
Q ss_pred CeEEcccCcccccccccCcc---ccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccH
Q 045798 837 SGHIGDFGLARFHQEVSNST---LSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNL 913 (1008)
Q Consensus 837 ~~kL~Dfg~a~~~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~ 913 (1008)
.+||+|||+|+......... ........||+.|+|||++.+..+++++|||||||++|||++|+.||..........
T Consensus 144 ~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~ 223 (293)
T d1csna_ 144 MIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQ 223 (293)
T ss_dssp CEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHH
T ss_pred ceEEcccceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHH
Confidence 89999999998765432221 112334679999999999999999999999999999999999999997432221110
Q ss_pred HHHHHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHHHHHHH
Q 045798 914 HNFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVHELQSVKN 993 (1008)
Q Consensus 914 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~i~~ 993 (1008)
.... +......... ... ...+++++.+++..|++.+|++||+++.+.+.++++.+
T Consensus 224 -~~~~---------i~~~~~~~~~---------~~l------~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~ 278 (293)
T d1csna_ 224 -KYER---------IGEKKQSTPL---------REL------CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLE 278 (293)
T ss_dssp -HHHH---------HHHHHHHSCH---------HHH------TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred -HHHH---------HHhccCCCCh---------HHh------cCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHH
Confidence 0000 0000000000 000 01245678999999999999999999999888877654
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-41 Score=372.80 Aligned_cols=282 Identities=20% Similarity=0.162 Sum_probs=197.5
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEecccc--chhhHHHHHHHHHHhhcCCCCceeeeeccccccc-cCCc
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC--EGASKSFMAECKALKNIRHRNLVKVITSCSSIDF-QGND 759 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~ 759 (1008)
.++|+++++||+|+||+||+|++..+|+.||||+++... .....++.+|+.++++++||||+++++++...+. +...
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence 368999999999999999999999899999999997432 3445678999999999999999999999754332 3567
Q ss_pred eEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeE
Q 045798 760 FKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGH 839 (1008)
Q Consensus 760 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 839 (1008)
+.|+|||||.++.+. .+.. .+++..++.++.||+.||+|||+. ||+||||||+|||++.++.+|
T Consensus 96 ~~~iv~Ey~~~~l~~-~~~~------------~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~k 159 (355)
T d2b1pa1 96 DVYLVMELMDANLCQ-VIQM------------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLK 159 (355)
T ss_dssp EEEEEEECCSEEHHH-HHTS------------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEE
T ss_pred eeEEEEeccchHHHH-hhhc------------CCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCcccccccccccee
Confidence 899999999665444 4421 678999999999999999999998 999999999999999999999
Q ss_pred EcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHh
Q 045798 840 IGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARM 919 (1008)
Q Consensus 840 L~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~ 919 (1008)
++|||.++....... .....+|+.|+|||++.+..+++++||||+||++|||++|+.||....... ........
T Consensus 160 l~df~~~~~~~~~~~-----~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~-~~~~i~~~ 233 (355)
T d2b1pa1 160 ILDFGLARTAGTSFM-----MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID-QWNKVIEQ 233 (355)
T ss_dssp ECCCCC--------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHH
T ss_pred eechhhhhccccccc-----cccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHH-HHHHHHHh
Confidence 999999886544322 223458999999999999999999999999999999999999986432111 11111111
Q ss_pred hCCc----------chhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 920 ALPN----------QVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 920 ~~~~----------~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
.... ....................................+.++.+++.+|++.||++||||+|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~ 310 (355)
T d2b1pa1 234 LGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 310 (355)
T ss_dssp HCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ccCCCHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 1110 011111111000000000000000111112233456778999999999999999999999985
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-41 Score=375.79 Aligned_cols=279 Identities=22% Similarity=0.253 Sum_probs=194.5
Q ss_pred CCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccchhhHHHHHHHHHHhhcCCCCceeeeecccccc-ccCCceEEE
Q 045798 685 GFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRNLVKVITSCSSID-FQGNDFKAI 763 (1008)
Q Consensus 685 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~~~~~~l 763 (1008)
+|+..++||+|+||+||+|++..+|+.||||+++.... ...+|++++++++||||+++++++.... ..+..+.++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 58889999999999999999999999999999975422 2357999999999999999999975432 234556899
Q ss_pred EEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCC-CeEEcc
Q 045798 764 VYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDL-SGHIGD 842 (1008)
Q Consensus 764 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kL~D 842 (1008)
|||||+++.+..+...... ...+++.+++.|+.||+.||+|||++ +|+||||||+|||++.++ .+||+|
T Consensus 97 v~Ey~~~~~~~~l~~~~~~-------~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~D 166 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRA-------KQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCD 166 (350)
T ss_dssp EEECCSEEHHHHHHHHHHT-------TCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECC
T ss_pred EEeccCCccHHHHHhhhhc-------cCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEec
Confidence 9999976543333221110 11799999999999999999999997 999999999999999775 899999
Q ss_pred cCcccccccccCccccccccccccccccCccccCC-CCCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHhhC
Q 045798 843 FGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLG-SEVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARMAL 921 (1008)
Q Consensus 843 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~~~ 921 (1008)
||+|+....... .....||..|+|||.+.+ ..++.++||||+||++|||++|+.||......+ .+........
T Consensus 167 FG~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~-~l~~i~~~~g 240 (350)
T d1q5ka_ 167 FGSAKQLVRGEP-----NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD-QLVEIIKVLG 240 (350)
T ss_dssp CTTCEECCTTSC-----CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHH-HHHHHHHHHC
T ss_pred ccchhhccCCcc-----cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHH-HHHHHHHHhC
Confidence 999986644322 223469999999998765 568999999999999999999999996432211 1111111111
Q ss_pred CcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 922 PNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 922 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
.... +.+........... .......+.........+.++.+++.+||+.||++||||+|+++
T Consensus 241 ~~~~-~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 302 (350)
T d1q5ka_ 241 TPTR-EQIREMNPNYTEFK--FPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302 (350)
T ss_dssp CCCH-HHHHHHCC---CCC--CCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CChH-Hhhhhhccchhhcc--ccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1110 00000000000000 00000000000001123456789999999999999999999986
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-41 Score=373.92 Aligned_cols=279 Identities=20% Similarity=0.250 Sum_probs=198.5
Q ss_pred hcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEecccc--chhhHHHHHHHHHHhhcCCCCceeeeeccccccccCCce
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQC--EGASKSFMAECKALKNIRHRNLVKVITSCSSIDFQGNDF 760 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 760 (1008)
.++|++++.||+|+||+||+|++..+|+.||||+++... ....+++.+|++++++++||||+++++++......+...
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 578999999999999999999999899999999997543 234567899999999999999999999876443333344
Q ss_pred EEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecCCCCeEE
Q 045798 761 KAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDNDLSGHI 840 (1008)
Q Consensus 761 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 840 (1008)
.++|++|+.+|+|.+++... ++++.+++.++.||+.||+|||++ +|+||||||+|||++.++.+|+
T Consensus 97 ~~~i~~~~~gg~L~~~~~~~-----------~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl 162 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKCQ-----------KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKI 162 (348)
T ss_dssp CCEEEEECCSEEHHHHHTTC-----------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEE
T ss_pred eEEEEEeecCCchhhhcccc-----------cccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccc
Confidence 45666777799999998643 689999999999999999999998 9999999999999999999999
Q ss_pred cccCcccccccccCccccccccccccccccCccccCCC-CCCcccchhhHHHHHHHHHhCCCCCCccccCCccHHHHHHh
Q 045798 841 GDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGS-EVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLNLHNFARM 919 (1008)
Q Consensus 841 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~~~~~~~~ 919 (1008)
+|||.|...... .....||+.|+|||...+. .++.++||||+||++|+|++|+.||........ .......
T Consensus 163 ~dfg~a~~~~~~-------~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~-~~~i~~~ 234 (348)
T d2gfsa1 163 LDFGLARHTDDE-------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ-LKLILRL 234 (348)
T ss_dssp CCC----CCTGG-------GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHH
T ss_pred cccchhcccCcc-------cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHH-HHHHHHh
Confidence 999999755332 2234589999999987665 468899999999999999999999864321111 1111111
Q ss_pred hCCcchhhhhcccccCchHHhhhhhhhhhcccc-ch-hHHHHHHHHHHHHhcccCcCCCCCCCHHHHHH
Q 045798 920 ALPNQVMDIVDPILRNDEEILASTDKCRRMQTG-IN-SRLECLISMVKIGVACSMESPQDRMNMTNVVH 986 (1008)
Q Consensus 920 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~-~~-~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 986 (1008)
..... .+..... .. .............+.. .. .....+.++.+++.+|++.||++||||+|+++
T Consensus 235 ~~~~~-~~~~~~~-~~-~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~ 300 (348)
T d2gfsa1 235 VGTPG-AELLKKI-SS-ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300 (348)
T ss_dssp HCCCC-HHHHTTC-CC-HHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cCCCC-hHHhhhc-cc-hhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence 11100 0000000 00 0000000000000000 00 00123456789999999999999999999986
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=100.00 E-value=2.1e-40 Score=362.75 Aligned_cols=294 Identities=24% Similarity=0.439 Sum_probs=267.6
Q ss_pred cCChhhHHHHHHHHHhhccCCCCCCCCCCCCCCCC--cccceEEcCCC--CeEEEEeccccCCCC--ccCcCccCCccCC
Q 045798 8 ALEDGDRAALQAFKSMIAHEPQGILNSWNDSRHFC--EWEGITCGRRH--RRVTALDLMSKSLSG--SLSPHLGNLSFLR 81 (1008)
Q Consensus 8 ~~~~~~~~~l~~~k~~~~~~~~~~~~~w~~~~~~c--~w~gv~c~~~~--~~v~~l~l~~~~l~~--~l~~~l~~l~~L~ 81 (1008)
.|.|+||+||++||+++.+ |. .+++|+.++||| .|.||+|+... +||+.|||++++++| .+|+.++.|++|+
T Consensus 2 ~c~~~e~~aLl~~k~~~~~-~~-~l~sW~~~~d~C~~~w~gv~C~~~~~~~~v~~L~L~~~~l~g~~~lp~~l~~L~~L~ 79 (313)
T d1ogqa_ 2 LCNPQDKQALLQIKKDLGN-PT-TLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLN 79 (313)
T ss_dssp CSCHHHHHHHHHHHHHTTC-CG-GGTTCCTTSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTCS
T ss_pred CCCHHHHHHHHHHHHHCCC-CC-cCCCCCCCCCCCCCcCCCeEEeCCCCcEEEEEEECCCCCCCCCCCCChHHhcCcccc
Confidence 5899999999999999974 43 589999999999 59999998643 489999999999998 5889999999999
Q ss_pred eeeecC-CCCCCCCCccccCCCCCCEEEccCCCCCCccCcccccCcCcceEeeeccccccCCCccccccCCCCeeecccc
Q 045798 82 EINLSN-NTIQGEIPPEFGRLFRLEALFLSNNSLVGKIPANLSYCSRLTVLCIEYNKLQGRIPLEFVSLSKLKDLSLAKN 160 (1008)
Q Consensus 82 ~L~L~~-n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n 160 (1008)
+|+|++ |+++|.+|.+|+++++|++|+|++|++.+..+..+..+.+|+++++++|.+.+.+|..+.++++|+.+++++|
T Consensus 80 ~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n 159 (313)
T d1ogqa_ 80 FLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGN 159 (313)
T ss_dssp EEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSS
T ss_pred ccccccccccccccccccccccccchhhhccccccccccccccchhhhcccccccccccccCchhhccCcccceeecccc
Confidence 999997 8999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cCCCCCCCCCcccccc-chhhcccccCCCCCCccccCCCCCcEEEecCCcccccCCccccCCCCcceeccccccccccCC
Q 045798 161 KLTGGIPPFLGNLTSL-EVLSLAGNSFGRNIPDSLGQLKQLKILAIGGNNLSGPIPPSIYNLSFLVVFSVSHNQIHGSLP 239 (1008)
Q Consensus 161 ~l~~~~~~~~~~l~~L-~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~~~lp 239 (1008)
.+++.+|..+..+.++ +.+++++|++++..|..+..+..+ .++++++.+.+.+|..+..+++|+.+++++|.+.+.+|
T Consensus 160 ~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~-~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~ 238 (313)
T d1ogqa_ 160 RISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLA-FVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG 238 (313)
T ss_dssp CCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCS-EEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGG
T ss_pred ccccccccccccccccccccccccccccccccccccccccc-cccccccccccccccccccccccccccccccccccccc
Confidence 9999999999888886 889999999999999999888665 79999999999999999999999999999999987655
Q ss_pred hhhhhcCCCCcEEEeccccCCCCCCcccccCCCCceeecccccccccccccccCCCcccccccccccC
Q 045798 240 PSLGLLLPNLKFFQIHHNFFSGSIPISLSNASKLEHIEIANNNFSGKLSVNFGGMKNLSLLNLQFSNL 307 (1008)
Q Consensus 240 ~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l 307 (1008)
. ...+++|++|+|++|++++.+|..++++++|++|+|++|+++|.+|. ++.+++|+.+++++|+.
T Consensus 239 ~--~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~-~~~L~~L~~l~l~~N~~ 303 (313)
T d1ogqa_ 239 K--VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQRFDVSAYANNKC 303 (313)
T ss_dssp G--CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCC-STTGGGSCGGGTCSSSE
T ss_pred c--cccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCC-cccCCCCCHHHhCCCcc
Confidence 3 34478999999999999999999999999999999999999987774 57778888888887763
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-41 Score=366.27 Aligned_cols=254 Identities=24% Similarity=0.315 Sum_probs=199.8
Q ss_pred hcCCCCCceEeeccCeeEEEEEE---cCCCeEEEEEEecccc----chhhHHHHHHHHHHhhcCC-CCceeeeecccccc
Q 045798 683 TNGFSSTHLIGVGSFGCVYKGAL---DEDGIVVAIKVINLQC----EGASKSFMAECKALKNIRH-RNLVKVITSCSSID 754 (1008)
Q Consensus 683 ~~~y~~~~~lg~G~~g~Vy~~~~---~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~ 754 (1008)
.++|++++.||+|+||+||+|+. +.+|+.||||+++... ....+.+.+|++++++++| |||++++++
T Consensus 23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~----- 97 (322)
T d1vzoa_ 23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYA----- 97 (322)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEE-----
T ss_pred hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeee-----
Confidence 36799999999999999999987 3468999999986432 2345678999999999966 899999998
Q ss_pred ccCCceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeeecC
Q 045798 755 FQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILLDN 834 (1008)
Q Consensus 755 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~ 834 (1008)
+.+....++||||+.+|+|.+++.... .+++..++.++.||+.||+|+|+. +||||||||+||+++.
T Consensus 98 ~~~~~~~~~v~e~~~~~~L~~~i~~~~----------~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~ 164 (322)
T d1vzoa_ 98 FQTETKLHLILDYINGGELFTHLSQRE----------RFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDS 164 (322)
T ss_dssp EEETTEEEEEECCCCSCBHHHHHHHHS----------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECT
T ss_pred eccCCceeeeeecccccHHHHHHHhcc----------cccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecC
Confidence 456678999999999999999997665 678899999999999999999998 9999999999999999
Q ss_pred CCCeEEcccCcccccccccCccccccccccccccccCccccCCC--CCCcccchhhHHHHHHHHHhCCCCCCccccCCcc
Q 045798 835 DLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGS--EVSTNGDVYSYGILLLEMVTAKKPTDVMFEGDLN 912 (1008)
Q Consensus 835 ~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDvwslG~vl~elltG~~pf~~~~~~~~~ 912 (1008)
++.+||+|||+|+......... .....|++.|+|||.+.+. .++.++||||+||++|||++|+.||......+..
T Consensus 165 ~~~vkL~DFG~a~~~~~~~~~~---~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~ 241 (322)
T d1vzoa_ 165 NGHVVLTDFGLSKEFVADETER---AYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ 241 (322)
T ss_dssp TSCEEESCSSEEEECCGGGGGG---GCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCH
T ss_pred CCCEEEeeccchhhhccccccc---ccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 9999999999998664433221 2335699999999998765 4678999999999999999999999754332221
Q ss_pred HHHHHHhhCCcchhhhhcccccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcccCcCCCCCCC-----HHHHHH
Q 045798 913 LHNFARMALPNQVMDIVDPILRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVACSMESPQDRMN-----MTNVVH 986 (1008)
Q Consensus 913 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~ 986 (1008)
.... .... ...... ....+.++.+++.+||+.||++||| ++|+++
T Consensus 242 ~~i~-~~~~--------------------------~~~~~~--~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 242 AEIS-RRIL--------------------------KSEPPY--PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp HHHH-HHHH--------------------------HCCCCC--CTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred HHHH-Hhcc--------------------------cCCCCC--cccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 1111 1000 000000 0124566899999999999999994 788875
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.7e-36 Score=338.83 Aligned_cols=282 Identities=18% Similarity=0.217 Sum_probs=190.5
Q ss_pred cCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccchhhHHHHHHHHHHhhcC-----------CCCceeeeecccc
Q 045798 684 NGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIR-----------HRNLVKVITSCSS 752 (1008)
Q Consensus 684 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~~~~~~~~ 752 (1008)
++|+++++||+|+||+||+|++..+|+.||||+++.. ....+.+.+|++++++++ |+||+++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~-~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc-ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 3599999999999999999999999999999999754 334567889999988875 5789999888542
Q ss_pred ccccCCceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCCCeee
Q 045798 753 IDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPSNILL 832 (1008)
Q Consensus 753 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll 832 (1008)
......+++++++..+........... ...+++..+..++.||+.||+|||+. .+|+||||||+|||+
T Consensus 92 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~i~~i~~qil~al~~lh~~--~~IvHrDlKp~NIll 159 (362)
T d1q8ya_ 92 ---KGPNGVHVVMVFEVLGENLLALIKKYE-------HRGIPLIYVKQISKQLLLGLDYMHRR--CGIIHTDIKPENVLM 159 (362)
T ss_dssp ---EETTEEEEEEEECCCCEEHHHHHHHTT-------TSCCCHHHHHHHHHHHHHHHHHHHHT--TCEECSCCSGGGEEE
T ss_pred ---ccccceeeeeeeccccccccccccccc-------ccCCcHHHHHHHHHHHHHHHHHHhhh--cCcccccCChhHeee
Confidence 344556677776655433222221111 11788999999999999999999983 299999999999999
Q ss_pred cCCCC------eEEcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHHHHHHhCCCCCCcc
Q 045798 833 DNDLS------GHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILLLEMVTAKKPTDVM 906 (1008)
Q Consensus 833 ~~~~~------~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltG~~pf~~~ 906 (1008)
+.++. ++++|||.|....... ....||+.|+|||++.+..++.++||||+||++++|++|+.||...
T Consensus 160 ~~~~~~~~~~~~kl~dfg~s~~~~~~~-------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~ 232 (362)
T d1q8ya_ 160 EIVDSPENLIQIKIADLGNACWYDEHY-------TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPD 232 (362)
T ss_dssp EEEETTTTEEEEEECCCTTCEETTBCC-------CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---
T ss_pred eccCcccccceeeEeeccccccccccc-------ccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCC
Confidence 86653 8999999997543322 2345999999999999999999999999999999999999999743
Q ss_pred ccCCc-----cHHHHHHhhC--Ccchh-------hhhccc--ccCchHHhhhhhhhhhccccchhHHHHHHHHHHHHhcc
Q 045798 907 FEGDL-----NLHNFARMAL--PNQVM-------DIVDPI--LRNDEEILASTDKCRRMQTGINSRLECLISMVKIGVAC 970 (1008)
Q Consensus 907 ~~~~~-----~~~~~~~~~~--~~~~~-------~~~d~~--l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 970 (1008)
..... .......... +.... ...+.. ....... ...................+.++.+++.+|
T Consensus 233 ~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~dll~~m 311 (362)
T d1q8ya_ 233 EGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKL-KFWPLEDVLTEKYKFSKDEAKEISDFLSPM 311 (362)
T ss_dssp ------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCC-CBCCHHHHHHHTTCCCHHHHHHHHHHHGGG
T ss_pred ccccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccc-cCCchhhhcccccccCcccCHHHHHHHHHH
Confidence 22110 0111111111 00000 000000 0000000 000000000001112345677899999999
Q ss_pred cCcCCCCCCCHHHHHH
Q 045798 971 SMESPQDRMNMTNVVH 986 (1008)
Q Consensus 971 l~~dP~~RPt~~evl~ 986 (1008)
+..||.+||||+|+++
T Consensus 312 L~~dP~~Rpta~e~L~ 327 (362)
T d1q8ya_ 312 LQLDPRKRADAGGLVN 327 (362)
T ss_dssp GCSSTTTCBCHHHHHT
T ss_pred CCCChhHCcCHHHHhc
Confidence 9999999999999875
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.98 E-value=5.3e-33 Score=303.46 Aligned_cols=254 Identities=31% Similarity=0.446 Sum_probs=173.2
Q ss_pred ceeeeeccccccC--CCCCccccccccceEEecC-ccccCCcchhccCCCCCceEEccCCcccccccccccCCCCcceee
Q 045798 352 LQILILSSNQFYG--SIPLGIGNLVDLYLLGMVE-NQFTGAIPKEMGKLQKLQGLDFSGNHFSGEIPSSLGNLSSLYEVF 428 (1008)
Q Consensus 352 L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~L~~-n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 428 (1008)
++.|+|++|.+++ .+|..++++++|++|+|++ |++.|.+|..|+++++|++|+|++|++.+..+..+..+..|+.++
T Consensus 52 v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~ 131 (313)
T d1ogqa_ 52 VNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLD 131 (313)
T ss_dssp EEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEE
T ss_pred EEEEECCCCCCCCCCCCChHHhcCccccccccccccccccccccccccccccchhhhccccccccccccccchhhhcccc
Confidence 4455555555544 3455555555555555554 555555555566666666666666666555555555556666666
Q ss_pred ccccccccccCCCCcCCCcccEeecccccccCCcchhhhhhhhhhhhhcccCccccCCCccccccccccccccccccccc
Q 045798 429 FNNNNLSGVIPFSLGNLKRLAFLEMSGNELSGTIPEDIFNISYLSNSLNLARNHLVGIIPPRIGNLRALRSFDVSNNDLS 508 (1008)
Q Consensus 429 l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~lp~~~~~~~~~~~~L~L~~N~l~~~~p~~~~~l~~L~~Ldls~N~l~ 508 (1008)
+++|.+.+.+|..+.+++.|+.+++++|+++|.+|..+.....+.+.+++++|++++..|..++.+..+ .+++++|.+.
T Consensus 132 l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~-~l~l~~~~~~ 210 (313)
T d1ogqa_ 132 FSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLA-FVDLSRNMLE 210 (313)
T ss_dssp CCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCS-EEECCSSEEE
T ss_pred cccccccccCchhhccCcccceeeccccccccccccccccccccccccccccccccccccccccccccc-cccccccccc
Confidence 666665555566666666666666666666656666555555555556666666666677766666544 5788888888
Q ss_pred CCCCcccccccccceeeccCcccccchhhhhhccccccEEecCCCcccccccCc-ccccccceeecccCcccccCCCCcc
Q 045798 509 GEIPIELGHCSSLEEIYLAGNLFHGSIPSFFNALKGVQKIDLSRNNLSGQIPIF-LEALSLEYLNLSFNDFEGKIPAKGI 587 (1008)
Q Consensus 509 ~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~-~~~~~L~~L~l~~N~l~g~~p~~~~ 587 (1008)
|.+|..++.+++|+.+++++|.+.+.+| .++.+++|+.|||++|+++|.+|.. ..+.+|++|+|++|+|+|.+|+.+.
T Consensus 211 ~~~~~~~~~~~~l~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~~~ 289 (313)
T d1ogqa_ 211 GDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGN 289 (313)
T ss_dssp ECCGGGCCTTSCCSEEECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTT
T ss_pred cccccccccccccccccccccccccccc-ccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCCccc
Confidence 8888888888888888888888887655 5777888888888888888888876 5677788888888888888887777
Q ss_pred cCCcccceeccCCccCCCCC
Q 045798 588 FANASAISVVGCNRLCGGIP 607 (1008)
Q Consensus 588 ~~~~~~~~~~~n~~l~g~~~ 607 (1008)
+.++..+.+.||+++||.|+
T Consensus 290 L~~L~~l~l~~N~~l~g~pl 309 (313)
T d1ogqa_ 290 LQRFDVSAYANNKCLCGSPL 309 (313)
T ss_dssp GGGSCGGGTCSSSEEESTTS
T ss_pred CCCCCHHHhCCCccccCCCC
Confidence 77888888888889999754
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.96 E-value=3.2e-28 Score=273.94 Aligned_cols=185 Identities=26% Similarity=0.410 Sum_probs=85.3
Q ss_pred ceeeeeccccccCCCCCccccccccceEEecCccccCCcchhccCCCCCceEEccCCcccccccccccCCCCcceeeccc
Q 045798 352 LQILILSSNQFYGSIPLGIGNLVDLYLLGMVENQFTGAIPKEMGKLQKLQGLDFSGNHFSGEIPSSLGNLSSLYEVFFNN 431 (1008)
Q Consensus 352 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~ 431 (1008)
++.+++++|.+++..| +..+++|+.|++++|+++.. +.+..+++|+.|++++|++++..+ +..+++|+.|++++
T Consensus 199 ~~~l~l~~n~i~~~~~--~~~~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~ 272 (384)
T d2omza2 199 LESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGA 272 (384)
T ss_dssp CSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCS
T ss_pred cceeeccCCccCCCCc--ccccCCCCEEECCCCCCCCc--chhhcccccchhccccCccCCCCc--ccccccCCEeeccC
Confidence 4444444444443222 23334444444444444421 234455555555555555553222 44555555555555
Q ss_pred cccccccCCCCcCCCcccEeecccccccCCcchhhhhhhhhhhhhcccCccccCCCcccccccccccccccccccccCCC
Q 045798 432 NNLSGVIPFSLGNLKRLAFLEMSGNELSGTIPEDIFNISYLSNSLNLARNHLVGIIPPRIGNLRALRSFDVSNNDLSGEI 511 (1008)
Q Consensus 432 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~lp~~~~~~~~~~~~L~L~~N~l~~~~p~~~~~l~~L~~Ldls~N~l~~~~ 511 (1008)
|.+.+..+ +..++.++.++++.|++++ + ..+..+++++.|++++|++++..
T Consensus 273 ~~l~~~~~--~~~~~~l~~l~~~~n~l~~-~--------------------------~~~~~~~~l~~L~ls~n~l~~l~ 323 (384)
T d2omza2 273 NQISNISP--LAGLTALTNLELNENQLED-I--------------------------SPISNLKNLTYLTLYFNNISDIS 323 (384)
T ss_dssp SCCCCCGG--GTTCTTCSEEECCSSCCSC-C--------------------------GGGGGCTTCSEEECCSSCCSCCG
T ss_pred cccCCCCc--ccccccccccccccccccc-c--------------------------cccchhcccCeEECCCCCCCCCc
Confidence 55553322 4455555555555555542 1 11333444444555555544321
Q ss_pred CcccccccccceeeccCcccccchhhhhhccccccEEecCCCcccccccCcccccccceeecccC
Q 045798 512 PIELGHCSSLEEIYLAGNLFHGSIPSFFNALKGVQKIDLSRNNLSGQIPIFLEALSLEYLNLSFN 576 (1008)
Q Consensus 512 p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~L~~L~l~~N 576 (1008)
.+..+++|++|+|++|+|++ +| .|+.+++|+.|+|++|++++.+| ...+.+|+.|+|++|
T Consensus 324 --~l~~l~~L~~L~L~~n~l~~-l~-~l~~l~~L~~L~l~~N~l~~l~~-l~~l~~L~~L~L~~N 383 (384)
T d2omza2 324 --PVSSLTKLQRLFFANNKVSD-VS-SLANLTNINWLSAGHNQISDLTP-LANLTRITQLGLNDQ 383 (384)
T ss_dssp --GGGGCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECCSSCCCBCGG-GTTCTTCSEEECCCE
T ss_pred --ccccCCCCCEEECCCCCCCC-Ch-hHcCCCCCCEEECCCCcCCCChh-hccCCCCCEeeCCCC
Confidence 14444555555555555542 22 34455555555555555554333 333445555555554
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.95 E-value=1.7e-27 Score=267.95 Aligned_cols=341 Identities=26% Similarity=0.309 Sum_probs=167.2
Q ss_pred CccCCeeeecCCCCCCCCCccccCCCCCCEEEccCCCCCCccCcccccCcCcceEeeeccccccCCCccccccCCCCeee
Q 045798 77 LSFLREINLSNNTIQGEIPPEFGRLFRLEALFLSNNSLVGKIPANLSYCSRLTVLCIEYNKLQGRIPLEFVSLSKLKDLS 156 (1008)
Q Consensus 77 l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~ 156 (1008)
+.+|++|++++++|+. + +.+..+++|++|+|++|+|++. | .++++++|++|++++|++.+.. .++++++|+.|+
T Consensus 43 l~~l~~L~l~~~~I~~-l-~gl~~L~nL~~L~Ls~N~l~~l-~-~l~~L~~L~~L~L~~n~i~~i~--~l~~l~~L~~L~ 116 (384)
T d2omza2 43 LDQVTTLQADRLGIKS-I-DGVEYLNNLTQINFSNNQLTDI-T-PLKNLTKLVDILMNNNQIADIT--PLANLTNLTGLT 116 (384)
T ss_dssp HTTCCEEECCSSCCCC-C-TTGGGCTTCCEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCCCCG--GGTTCTTCCEEE
T ss_pred hCCCCEEECCCCCCCC-c-cccccCCCCCEEeCcCCcCCCC-c-cccCCccccccccccccccccc--cccccccccccc
Confidence 3445555555555542 2 2344555555555555555532 2 1555555555555555554322 244555555555
Q ss_pred cccccCCCCCCCCCccccccchhhcccccCCCCCCccccCCCCCcEEEecCCcccccCCccccCCCCcceeccccccccc
Q 045798 157 LAKNKLTGGIPPFLGNLTSLEVLSLAGNSFGRNIPDSLGQLKQLKILAIGGNNLSGPIPPSIYNLSFLVVFSVSHNQIHG 236 (1008)
Q Consensus 157 L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~~ 236 (1008)
+++|.+++..+ ......+..+....|.+....+.................. ...+...+.........|....
T Consensus 117 ~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~ 189 (384)
T d2omza2 117 LFNNQITDIDP--LKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTD-----LKPLANLTTLERLDISSNKVSD 189 (384)
T ss_dssp CCSSCCCCCGG--GTTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCCC-----CGGGTTCTTCCEEECCSSCCCC
T ss_pred ccccccccccc--ccccccccccccccccccccccccccccccccccccccch-----hhhhcccccccccccccccccc
Confidence 55555543221 1122333344444443322222111111111111111111 1112222222233333332220
Q ss_pred cCChhhhhcCCCCcEEEeccccCCCCCCcccccCCCCceeecccccccccccccccCCCcccccccccccCCCCCCCccc
Q 045798 237 SLPPSLGLLLPNLKFFQIHHNFFSGSIPISLSNASKLEHIEIANNNFSGKLSVNFGGMKNLSLLNLQFSNLGSGESDEMG 316 (1008)
Q Consensus 237 ~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~ 316 (1008)
......+++++.+++++|.+++..| +...++|++|++++|+++.. ..+..+++|+.|+++.|.++...
T Consensus 190 ---~~~~~~l~~~~~l~l~~n~i~~~~~--~~~~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~----- 257 (384)
T d2omza2 190 ---ISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLA----- 257 (384)
T ss_dssp ---CGGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCG-----
T ss_pred ---ccccccccccceeeccCCccCCCCc--ccccCCCCEEECCCCCCCCc--chhhcccccchhccccCccCCCC-----
Confidence 1111223444444444444443322 23344445555555544432 13444445555555555444321
Q ss_pred ccccccccCCCcEEEecCCcCCccCChhhhhhcccceeeeeccccccCCCCCccccccccceEEecCccccCCcchhccC
Q 045798 317 FMNSLTNCSKLRVLSLGGNQFRGALPHSIANLSSQLQILILSSNQFYGSIPLGIGNLVDLYLLGMVENQFTGAIPKEMGK 396 (1008)
Q Consensus 317 ~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~ 396 (1008)
.+..+++|++|++++|++++. + .+..+. .++.++++.|.+++ ...+..+++++.|++++|++++.. .+..
T Consensus 258 ---~~~~~~~L~~L~l~~~~l~~~-~-~~~~~~-~l~~l~~~~n~l~~--~~~~~~~~~l~~L~ls~n~l~~l~--~l~~ 327 (384)
T d2omza2 258 ---PLSGLTKLTELKLGANQISNI-S-PLAGLT-ALTNLELNENQLED--ISPISNLKNLTYLTLYFNNISDIS--PVSS 327 (384)
T ss_dssp ---GGTTCTTCSEEECCSSCCCCC-G-GGTTCT-TCSEEECCSSCCSC--CGGGGGCTTCSEEECCSSCCSCCG--GGGG
T ss_pred ---cccccccCCEeeccCcccCCC-C-cccccc-cccccccccccccc--ccccchhcccCeEECCCCCCCCCc--cccc
Confidence 244556666666666666532 2 233333 36667777776663 234666677777777777777543 2677
Q ss_pred CCCCceEEccCCcccccccccccCCCCcceeeccccccccccCCCCcCCCcccEeecccc
Q 045798 397 LQKLQGLDFSGNHFSGEIPSSLGNLSSLYEVFFNNNNLSGVIPFSLGNLKRLAFLEMSGN 456 (1008)
Q Consensus 397 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N 456 (1008)
+++|+.|+|++|+|++ ++ .+.++++|++|++++|++++..| +.++++|+.|+|++|
T Consensus 328 l~~L~~L~L~~n~l~~-l~-~l~~l~~L~~L~l~~N~l~~l~~--l~~l~~L~~L~L~~N 383 (384)
T d2omza2 328 LTKLQRLFFANNKVSD-VS-SLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383 (384)
T ss_dssp CTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECCSSCCCBCGG--GTTCTTCSEEECCCE
T ss_pred CCCCCEEECCCCCCCC-Ch-hHcCCCCCCEEECCCCcCCCChh--hccCCCCCEeeCCCC
Confidence 7788888888887763 33 57777888888888888876554 777888888888877
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.93 E-value=1.5e-25 Score=243.01 Aligned_cols=277 Identities=21% Similarity=0.252 Sum_probs=202.5
Q ss_pred CCCCcccceEEcCCCCeEEEEeccccCCCCccCcCccCCccCCeeeecCCCCCCCCCccccCCCCCCEEEccCCCCCCcc
Q 045798 39 RHFCEWEGITCGRRHRRVTALDLMSKSLSGSLSPHLGNLSFLREINLSNNTIQGEIPPEFGRLFRLEALFLSNNSLVGKI 118 (1008)
Q Consensus 39 ~~~c~w~gv~c~~~~~~v~~l~l~~~~l~~~l~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~ 118 (1008)
.+-|.|++|.|.. .+++ .+|..+. +++++|+|++|+|+...+.+|.++++|++|++++|.+....
T Consensus 7 ~c~c~~~~~~C~~------------~~L~-~lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~ 71 (305)
T d1xkua_ 7 RCQCHLRVVQCSD------------LGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKIS 71 (305)
T ss_dssp TCEEETTEEECTT------------SCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBC
T ss_pred CCEecCCEEEecC------------CCCC-ccCCCCC--CCCCEEECcCCcCCCcChhHhhccccccccccccccccccc
Confidence 4558888888854 3455 6777664 57999999999999555568999999999999999999777
Q ss_pred CcccccCcCcceEeeeccccccCCCccccccCCCCeeecccccCCCCCCCCCccccccchhhcccccCC--CCCCccccC
Q 045798 119 PANLSYCSRLTVLCIEYNKLQGRIPLEFVSLSKLKDLSLAKNKLTGGIPPFLGNLTSLEVLSLAGNSFG--RNIPDSLGQ 196 (1008)
Q Consensus 119 p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~--~~~~~~~~~ 196 (1008)
|..|.++++|++|++++|+++ .+|..+. ..|+.|++.+|.+.+..+..+.....+..++...|... ...+..|..
T Consensus 72 ~~~f~~l~~L~~L~l~~n~l~-~l~~~~~--~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~ 148 (305)
T d1xkua_ 72 PGAFAPLVKLERLYLSKNQLK-ELPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQG 148 (305)
T ss_dssp TTTTTTCTTCCEEECCSSCCS-BCCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGG
T ss_pred hhhhhCCCccCEecccCCccC-cCccchh--hhhhhhhccccchhhhhhhhhhccccccccccccccccccCCCcccccc
Confidence 888999999999999999998 4554433 57888888888888655555666667777777777542 344566778
Q ss_pred CCCCcEEEecCCcccccCCccccCCCCcceeccccccccccCChhhhhcCCCCcEEEeccccCCCCCCcccccCCCCcee
Q 045798 197 LKQLKILAIGGNNLSGPIPPSIYNLSFLVVFSVSHNQIHGSLPPSLGLLLPNLKFFQIHHNFFSGSIPISLSNASKLEHI 276 (1008)
Q Consensus 197 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L 276 (1008)
+++|+.+++++|.++. +|..+ .++|+.|++++|.+.+..+. .+..++.++.|++++|.+.+..+..+.++++|++|
T Consensus 149 l~~L~~l~l~~n~l~~-l~~~~--~~~L~~L~l~~n~~~~~~~~-~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L 224 (305)
T d1xkua_ 149 MKKLSYIRIADTNITT-IPQGL--PPSLTELHLDGNKITKVDAA-SLKGLNNLAKLGLSFNSISAVDNGSLANTPHLREL 224 (305)
T ss_dssp CTTCCEEECCSSCCCS-CCSSC--CTTCSEEECTTSCCCEECTG-GGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEE
T ss_pred ccccCccccccCCccc-cCccc--CCccCEEECCCCcCCCCChh-Hhhccccccccccccccccccccccccccccceee
Confidence 8888888888888774 34332 46778888888887755444 34456778888888888877777777778888888
Q ss_pred ecccccccccccccccCCCcccccccccccCCCCCCCcccccccccccCCCcEEEecCCcCC
Q 045798 277 EIANNNFSGKLSVNFGGMKNLSLLNLQFSNLGSGESDEMGFMNSLTNCSKLRVLSLGGNQFR 338 (1008)
Q Consensus 277 ~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~ 338 (1008)
+|++|+|+.+ |..|..+++|+.|+|++|+|+.++...+..+..+..+.+|+.|+|++|.+.
T Consensus 225 ~L~~N~L~~l-p~~l~~l~~L~~L~Ls~N~i~~i~~~~f~~~~~~~~~~~L~~L~L~~N~~~ 285 (305)
T d1xkua_ 225 HLNNNKLVKV-PGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQ 285 (305)
T ss_dssp ECCSSCCSSC-CTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSC
T ss_pred eccccccccc-ccccccccCCCEEECCCCccCccChhhccCcchhcccCCCCEEECCCCcCc
Confidence 8888877754 556777777777777777777766554444444455566666666666654
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.93 E-value=2.4e-25 Score=241.32 Aligned_cols=278 Identities=18% Similarity=0.252 Sum_probs=170.6
Q ss_pred CCCeeecccccCCCCCCCCCccccccchhhcccccCCCCCCccccCCCCCcEEEecCCcccccCCccccCCCCcceeccc
Q 045798 151 KLKDLSLAKNKLTGGIPPFLGNLTSLEVLSLAGNSFGRNIPDSLGQLKQLKILAIGGNNLSGPIPPSIYNLSFLVVFSVS 230 (1008)
Q Consensus 151 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ls 230 (1008)
.++.++.++++++ .+|..+. +++++|+|++|+++...+.+|.++++|++|++++|.++...|.+|.++++|+.|+++
T Consensus 11 ~~~~~~C~~~~L~-~lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~ 87 (305)
T d1xkua_ 11 HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLS 87 (305)
T ss_dssp ETTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred cCCEEEecCCCCC-ccCCCCC--CCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEeccc
Confidence 3445555555555 4455443 456666666666655444556666666666666666665555566666666666666
Q ss_pred cccccccCChhhhhcCCCCcEEEeccccCCCCCCcccccCCCCceeecccccccccccccccCCCcccccccccccCCCC
Q 045798 231 HNQIHGSLPPSLGLLLPNLKFFQIHHNFFSGSIPISLSNASKLEHIEIANNNFSGKLSVNFGGMKNLSLLNLQFSNLGSG 310 (1008)
Q Consensus 231 ~N~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~ 310 (1008)
+|+++ .+|... .+.+..|++.+|.+.+..+..+.....+..++...|.......
T Consensus 88 ~n~l~-~l~~~~---~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~---------------------- 141 (305)
T d1xkua_ 88 KNQLK-ELPEKM---PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGI---------------------- 141 (305)
T ss_dssp SSCCS-BCCSSC---CTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGB----------------------
T ss_pred CCccC-cCccch---hhhhhhhhccccchhhhhhhhhhccccccccccccccccccCC----------------------
Confidence 66665 455433 2355555666655554444444445555555555543321110
Q ss_pred CCCcccccccccccCCCcEEEecCCcCCccCChhhhhhcccceeeeeccccccCCCCCccccccccceEEecCccccCCc
Q 045798 311 ESDEMGFMNSLTNCSKLRVLSLGGNQFRGALPHSIANLSSQLQILILSSNQFYGSIPLGIGNLVDLYLLGMVENQFTGAI 390 (1008)
Q Consensus 311 ~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~ 390 (1008)
....+..+++|+.+++++|.+. .+|..+ ..+|+.|++++|.+++..+..+..++.++.|++++|.+.+..
T Consensus 142 ------~~~~~~~l~~L~~l~l~~n~l~-~l~~~~---~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~ 211 (305)
T d1xkua_ 142 ------ENGAFQGMKKLSYIRIADTNIT-TIPQGL---PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVD 211 (305)
T ss_dssp ------CTTGGGGCTTCCEEECCSSCCC-SCCSSC---CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEEC
T ss_pred ------CccccccccccCccccccCCcc-ccCccc---CCccCEEECCCCcCCCCChhHhhccccccccccccccccccc
Confidence 0123445556666666666665 344432 234777777777777677777777777777888888777777
Q ss_pred chhccCCCCCceEEccCCcccccccccccCCCCcceeeccccccccccCCC------CcCCCcccEeeccccccc-CCcc
Q 045798 391 PKEMGKLQKLQGLDFSGNHFSGEIPSSLGNLSSLYEVFFNNNNLSGVIPFS------LGNLKRLAFLEMSGNELS-GTIP 463 (1008)
Q Consensus 391 ~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~------~~~l~~L~~L~Ls~N~l~-~~lp 463 (1008)
+..+..+++|++|+|++|+|+ .+|.+|..+++|+.|+|++|+|+...... +..+.+|+.|+|++|.++ ..++
T Consensus 212 ~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~~i~~~~f~~~~~~~~~~~L~~L~L~~N~~~~~~~~ 290 (305)
T d1xkua_ 212 NGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQ 290 (305)
T ss_dssp TTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGGGSC
T ss_pred cccccccccceeeeccccccc-ccccccccccCCCEEECCCCccCccChhhccCcchhcccCCCCEEECCCCcCccCcCC
Confidence 777788888888888888887 56777788888888888888877543333 345678888999999885 3444
Q ss_pred hhhhh
Q 045798 464 EDIFN 468 (1008)
Q Consensus 464 ~~~~~ 468 (1008)
...|.
T Consensus 291 ~~~f~ 295 (305)
T d1xkua_ 291 PSTFR 295 (305)
T ss_dssp GGGGT
T ss_pred HhHhc
Confidence 44443
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.92 E-value=2.4e-25 Score=238.35 Aligned_cols=252 Identities=18% Similarity=0.200 Sum_probs=208.7
Q ss_pred EEEecCCcCCccCChhhhhhcccceeeeeccccccCCCCCccccccccceEEecCccccCCcchhccCCCCCceEEcc-C
Q 045798 329 VLSLGGNQFRGALPHSIANLSSQLQILILSSNQFYGSIPLGIGNLVDLYLLGMVENQFTGAIPKEMGKLQKLQGLDFS-G 407 (1008)
Q Consensus 329 ~L~Ls~N~l~~~~p~~~~~l~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls-~ 407 (1008)
.++.++++++ .+|..+. +.+++|+|++|+|++..+..|.++++|++|++++|++.+..+..+..+..+..++.+ .
T Consensus 15 ~v~c~~~~L~-~iP~~ip---~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~ 90 (284)
T d1ozna_ 15 TTSCPQQGLQ-AVPVGIP---AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDN 90 (284)
T ss_dssp EEECCSSCCS-SCCTTCC---TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSC
T ss_pred EEEcCCCCCC-ccCCCCC---CCCCEEECcCCcCCCCCHHHhhccccccccccccccccccccccccccccccccccccc
Confidence 4566777777 6776554 358889999999886666678888999999999999888888888888888888765 5
Q ss_pred CcccccccccccCCCCcceeeccccccccccCCCCcCCCcccEeecccccccCCcchhhhhhhhhhhhhcccCccccCCC
Q 045798 408 NHFSGEIPSSLGNLSSLYEVFFNNNNLSGVIPFSLGNLKRLAFLEMSGNELSGTIPEDIFNISYLSNSLNLARNHLVGII 487 (1008)
Q Consensus 408 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~lp~~~~~~~~~~~~L~L~~N~l~~~~ 487 (1008)
|.++...+..|.++++|++|++++|.+....+..+..+.+|+.+++++|+++ .+|...+.....++.|+|++|++++..
T Consensus 91 ~~~~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~-~i~~~~f~~~~~L~~L~l~~N~l~~l~ 169 (284)
T d1ozna_ 91 AQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRISSVP 169 (284)
T ss_dssp TTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCEEC
T ss_pred cccccccchhhcccccCCEEecCCcccccccccccchhcccchhhhcccccc-ccChhHhccccchhhcccccCcccccc
Confidence 6677666778888899999999999988777778888889999999999997 677777766666788889999888888
Q ss_pred cccccccccccccccccccccCCCCcccccccccceeeccCcccccchhhhhhccccccEEecCCCcccccccCcccccc
Q 045798 488 PPRIGNLRALRSFDVSNNDLSGEIPIELGHCSSLEEIYLAGNLFHGSIPSFFNALKGVQKIDLSRNNLSGQIPIFLEALS 567 (1008)
Q Consensus 488 p~~~~~l~~L~~Ldls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~ 567 (1008)
+..|.++++|+.+++++|++++..|..|..+++|++|++++|++.+..|..|+.+++|+.|+|++|++.+.-+...-...
T Consensus 170 ~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~~~~l~~~ 249 (284)
T d1ozna_ 170 ERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAW 249 (284)
T ss_dssp TTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGGHHHHHH
T ss_pred hhhhccccccchhhhhhccccccChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCCCccchHHHHH
Confidence 88999999999999999999988899999999999999999999998999999999999999999999976553322335
Q ss_pred cceeecccCcccccCCCC
Q 045798 568 LEYLNLSFNDFEGKIPAK 585 (1008)
Q Consensus 568 L~~L~l~~N~l~g~~p~~ 585 (1008)
++.+....+.+....|..
T Consensus 250 l~~~~~~~~~~~C~~p~~ 267 (284)
T d1ozna_ 250 LQKFRGSSSEVPCSLPQR 267 (284)
T ss_dssp HHHCCSEECCCBEEESGG
T ss_pred HHhCcCCCCceEeCCchH
Confidence 777888888888776654
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.91 E-value=1.2e-24 Score=232.76 Aligned_cols=221 Identities=21% Similarity=0.205 Sum_probs=150.7
Q ss_pred eccccCCCCccCcCccCCccCCeeeecCCCCCCCCCccccCCCCCCEEEccCCCCCCccCcccccCcCcceEeee-cccc
Q 045798 60 DLMSKSLSGSLSPHLGNLSFLREINLSNNTIQGEIPPEFGRLFRLEALFLSNNSLVGKIPANLSYCSRLTVLCIE-YNKL 138 (1008)
Q Consensus 60 ~l~~~~l~~~l~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls-~n~l 138 (1008)
+.++++++ .+|..+. +.+++|+|++|+|+...+.+|.++++|++|++++|++....+..+..+..++.++.. .|.+
T Consensus 17 ~c~~~~L~-~iP~~ip--~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~~ 93 (284)
T d1ozna_ 17 SCPQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQL 93 (284)
T ss_dssp ECCSSCCS-SCCTTCC--TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTC
T ss_pred EcCCCCCC-ccCCCCC--CCCCEEECcCCcCCCCCHHHhhcccccccccccccccccccccccccccccccccccccccc
Confidence 34555666 5666554 467888888888886666678888888888888888887777777777778777654 4566
Q ss_pred ccCCCccccccCCCCeeecccccCCCCCCCCCccccccchhhcccccCCCCCCccccCCCCCcEEEecCCcccccCCccc
Q 045798 139 QGRIPLEFVSLSKLKDLSLAKNKLTGGIPPFLGNLTSLEVLSLAGNSFGRNIPDSLGQLKQLKILAIGGNNLSGPIPPSI 218 (1008)
Q Consensus 139 ~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~ 218 (1008)
+...+..|.++++|++|++++|.+....+..+....+|+.+++++|++++..+.+|..+++|+.|++++|++++..+.+|
T Consensus 94 ~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f 173 (284)
T d1ozna_ 94 RSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAF 173 (284)
T ss_dssp CCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTT
T ss_pred ccccchhhcccccCCEEecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchhhh
Confidence 66667777777778888888777776666667777777777777777776666777777777777777777776666677
Q ss_pred cCCCCcceeccccccccccCChhhhhcCCCCcEEEeccccCCCCCCcccccCCCCceeeccccccc
Q 045798 219 YNLSFLVVFSVSHNQIHGSLPPSLGLLLPNLKFFQIHHNFFSGSIPISLSNASKLEHIEIANNNFS 284 (1008)
Q Consensus 219 ~~l~~L~~L~ls~N~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~ 284 (1008)
.++++|+.+++++|++++..| ..+..+++|++|++++|.+.+..+..|.++++|++|++++|++.
T Consensus 174 ~~l~~L~~l~l~~N~l~~i~~-~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~ 238 (284)
T d1ozna_ 174 RGLHSLDRLLLHQNRVAHVHP-HAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWV 238 (284)
T ss_dssp TTCTTCCEEECCSSCCCEECT-TTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEE
T ss_pred ccccccchhhhhhccccccCh-hHhhhhhhcccccccccccccccccccccccccCEEEecCCCCC
Confidence 777777777777776663333 23333555555555555555544455555555555555555544
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.88 E-value=1.8e-22 Score=213.12 Aligned_cols=195 Identities=25% Similarity=0.226 Sum_probs=149.1
Q ss_pred EEeccccCCCCccCcCccCCccCCeeeecCCCCCCCCCccccCCCCCCEEEccCCCCCCccCcccccCcCcceEeeeccc
Q 045798 58 ALDLMSKSLSGSLSPHLGNLSFLREINLSNNTIQGEIPPEFGRLFRLEALFLSNNSLVGKIPANLSYCSRLTVLCIEYNK 137 (1008)
Q Consensus 58 ~l~l~~~~l~~~l~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~ 137 (1008)
++|.++++++ .+|+.+. ++|++|+|++|+|++..+.+|.++++|++|+|++|+|+ .+| .++.+++|++|+|++|+
T Consensus 14 ~v~C~~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~-~l~-~~~~l~~L~~L~Ls~N~ 88 (266)
T d1p9ag_ 14 EVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQ-VDGTLPVLGTLDLSHNQ 88 (266)
T ss_dssp EEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCC-EEE-CCSCCTTCCEEECCSSC
T ss_pred EEEccCCCCC-eeCcCcC--cCCCEEECcCCcCCCcCHHHhhcccccccccccccccc-ccc-ccccccccccccccccc
Confidence 3467777777 5777664 57888888888888666677888888888888888887 444 35678888888888888
Q ss_pred cccCCCccccccCCCCeeecccccCCCCCCCCCccccccchhhcccccCCCCCCccccCCCCCcEEEecCCcccccCCcc
Q 045798 138 LQGRIPLEFVSLSKLKDLSLAKNKLTGGIPPFLGNLTSLEVLSLAGNSFGRNIPDSLGQLKQLKILAIGGNNLSGPIPPS 217 (1008)
Q Consensus 138 l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~ 217 (1008)
++ ..+..+..+++|+.|++++|.+....+..+..+.++++|++++|.+....+..+..+++|+.|++++|++++..+..
T Consensus 89 l~-~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~ 167 (266)
T d1p9ag_ 89 LQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGL 167 (266)
T ss_dssp CS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTT
T ss_pred cc-ccccccccccccccccccccccceeeccccccccccccccccccccceeccccccccccchhcccccccccccCccc
Confidence 87 45667777888888888888888767777777888888888888887777777777888888888888888777777
Q ss_pred ccCCCCcceeccccccccccCChhhhhcCCCCcEEEeccccCC
Q 045798 218 IYNLSFLVVFSVSHNQIHGSLPPSLGLLLPNLKFFQIHHNFFS 260 (1008)
Q Consensus 218 ~~~l~~L~~L~ls~N~l~~~lp~~~~~~l~~L~~L~L~~N~l~ 260 (1008)
|..+++|++|+|++|+|+ .+|..++. +++|++|+|++|.+.
T Consensus 168 ~~~l~~L~~L~Ls~N~L~-~lp~~~~~-~~~L~~L~L~~Np~~ 208 (266)
T d1p9ag_ 168 LNGLENLDTLLLQENSLY-TIPKGFFG-SHLLPFAFLHGNPWL 208 (266)
T ss_dssp TTTCTTCCEEECCSSCCC-CCCTTTTT-TCCCSEEECCSCCBC
T ss_pred cccccccceeecccCCCc-ccChhHCC-CCCCCEEEecCCCCC
Confidence 777788888888888777 67766654 566666666666654
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.88 E-value=2.6e-22 Score=211.95 Aligned_cols=201 Identities=25% Similarity=0.278 Sum_probs=160.3
Q ss_pred CCccCCeeeecCCCCCCCCCccccCCCCCCEEEccCCCCCCccCcccccCcCcceEeeeccccccCCCccccccCCCCee
Q 045798 76 NLSFLREINLSNNTIQGEIPPEFGRLFRLEALFLSNNSLVGKIPANLSYCSRLTVLCIEYNKLQGRIPLEFVSLSKLKDL 155 (1008)
Q Consensus 76 ~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L 155 (1008)
....+.+++.++++++ .+|+.+. ++|++|+|++|+|++..+..|.++++|++|+|++|+|+. +| .++.+++|++|
T Consensus 8 ~~~~~~~v~C~~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L 82 (266)
T d1p9ag_ 8 KVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTK-LQ-VDGTLPVLGTL 82 (266)
T ss_dssp CSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCE-EE-CCSCCTTCCEE
T ss_pred ccCCCeEEEccCCCCC-eeCcCcC--cCCCEEECcCCcCCCcCHHHhhccccccccccccccccc-cc-ccccccccccc
Confidence 3455677899999998 6777664 578999999999986666788999999999999999884 33 35678889999
Q ss_pred ecccccCCCCCCCCCccccccchhhcccccCCCCCCccccCCCCCcEEEecCCcccccCCccccCCCCcceecccccccc
Q 045798 156 SLAKNKLTGGIPPFLGNLTSLEVLSLAGNSFGRNIPDSLGQLKQLKILAIGGNNLSGPIPPSIYNLSFLVVFSVSHNQIH 235 (1008)
Q Consensus 156 ~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~ 235 (1008)
+|++|+++ ..+..+.++++|+.|++++|.+....+..+..+.++++|++++|.++...+..+..+++|+.|++++|+++
T Consensus 83 ~Ls~N~l~-~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~ 161 (266)
T d1p9ag_ 83 DLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLT 161 (266)
T ss_dssp ECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCS
T ss_pred cccccccc-ccccccccccccccccccccccceeeccccccccccccccccccccceeccccccccccchhccccccccc
Confidence 99999988 55777888888888888888888777888888888888888888888777777888888888888888887
Q ss_pred ccCChhhhhcCCCCcEEEeccccCCCCCCcccccCCCCceeeccccccc
Q 045798 236 GSLPPSLGLLLPNLKFFQIHHNFFSGSIPISLSNASKLEHIEIANNNFS 284 (1008)
Q Consensus 236 ~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~ 284 (1008)
.++...+..+++|++|+|++|+|+ .+|..+..+++|+.|+|++|.+.
T Consensus 162 -~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~ 208 (266)
T d1p9ag_ 162 -ELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWL 208 (266)
T ss_dssp -CCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBC
T ss_pred -ccCccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCCC
Confidence 566666666777888888888777 66777777777777777777664
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.85 E-value=3.3e-22 Score=199.43 Aligned_cols=169 Identities=18% Similarity=0.159 Sum_probs=119.9
Q ss_pred CCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccc------------------hhhHHHHHHHHHHhhcCCCCceeeee
Q 045798 687 SSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCE------------------GASKSFMAECKALKNIRHRNLVKVIT 748 (1008)
Q Consensus 687 ~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~h~niv~~~~ 748 (1008)
.+.++||+|+||+||+|.+. +|+.||||+++.... .......+|...+.++.|.+++..++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp EEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred hhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence 46789999999999999985 799999998753211 11234567889999999999998876
Q ss_pred ccccccccCCceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCCCCCceeccCCCC
Q 045798 749 SCSSIDFQGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHCQEPILHCDLKPS 828 (1008)
Q Consensus 749 ~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~ 828 (1008)
+.. .++||||+++..+.+ ++...+..++.|++.|++|||++ +|+||||||+
T Consensus 82 ~~~---------~~lvme~~~~~~~~~-----------------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~ 132 (191)
T d1zara2 82 WEG---------NAVLMELIDAKELYR-----------------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQY 132 (191)
T ss_dssp EET---------TEEEEECCCCEEGGG-----------------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTT
T ss_pred ecC---------CEEEEEeeccccccc-----------------hhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChh
Confidence 521 379999997755443 23334567999999999999998 9999999999
Q ss_pred CeeecCCCCeEEcccCcccccccccCccccccccccccccccCccccCCCCCCcccchhhHHHHH
Q 045798 829 NILLDNDLSGHIGDFGLARFHQEVSNSTLSSSVGVKGTIGYTAPEYGLGSEVSTNGDVYSYGILL 893 (1008)
Q Consensus 829 NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl 893 (1008)
|||++++ .++|+|||.|.............. ..... .|. ..+.|+.++|+||..--+
T Consensus 133 NILv~~~-~~~liDFG~a~~~~~~~~~~~l~r-d~~~~-----~~~-f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 133 NVLVSEE-GIWIIDFPQSVEVGEEGWREILER-DVRNI-----ITY-FSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp SEEEETT-EEEECCCTTCEETTSTTHHHHHHH-HHHHH-----HHH-HHHHHCCCCCHHHHHHHH
T ss_pred heeeeCC-CEEEEECCCcccCCCCCcHHHHHH-HHHHH-----HHH-HcCCCCCcccHHHHHHHH
Confidence 9999965 589999999975543221111000 00000 111 235678899999975433
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.84 E-value=2.6e-19 Score=197.61 Aligned_cols=136 Identities=26% Similarity=0.338 Sum_probs=67.1
Q ss_pred EEEEeccccCCCCccCcCccCCccCCeeeecCCCCCCCCCccccCCCCCCEEEccCCCCCCccCcccccCcCcceEeeec
Q 045798 56 VTALDLMSKSLSGSLSPHLGNLSFLREINLSNNTIQGEIPPEFGRLFRLEALFLSNNSLVGKIPANLSYCSRLTVLCIEY 135 (1008)
Q Consensus 56 v~~l~l~~~~l~~~l~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~ 135 (1008)
++.|||++++++ .+|+. .++|++|+|++|+|+ .+|+. +.+|+.|++++|+++ .++.. .+.|++|++++
T Consensus 40 l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~l~~n~l~-~l~~l---p~~L~~L~L~~ 107 (353)
T d1jl5a_ 40 AHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPEL---PQSLKSLLVDNNNLK-ALSDL---PPLLEYLGVSN 107 (353)
T ss_dssp CSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCC---CTTCCEEECCSSCCS-CCCSC---CTTCCEEECCS
T ss_pred CCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCc-ccccc---hhhhhhhhhhhcccc-hhhhh---ccccccccccc
Confidence 456666666665 45542 345666666666666 45543 235666666666665 22211 12456666666
Q ss_pred cccccCCCccccccCCCCeeecccccCCCCCCCCCccccccchhhcccccCCCCCCccccCCCCCcEEEecCCccc
Q 045798 136 NKLQGRIPLEFVSLSKLKDLSLAKNKLTGGIPPFLGNLTSLEVLSLAGNSFGRNIPDSLGQLKQLKILAIGGNNLS 211 (1008)
Q Consensus 136 n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~ 211 (1008)
|.+. .+|. ++.+++|++|++++|.+. ..+..+ ..+..+.+.++.. .....+..++.++.|++++|.+.
T Consensus 108 n~l~-~lp~-~~~l~~L~~L~l~~~~~~-~~~~~~---~~l~~l~~~~~~~--~~~~~l~~l~~l~~L~l~~n~~~ 175 (353)
T d1jl5a_ 108 NQLE-KLPE-LQNSSFLKIIDVDNNSLK-KLPDLP---PSLEFIAAGNNQL--EELPELQNLPFLTAIYADNNSLK 175 (353)
T ss_dssp SCCS-SCCC-CTTCTTCCEEECCSSCCS-CCCCCC---TTCCEEECCSSCC--SSCCCCTTCTTCCEEECCSSCCS
T ss_pred cccc-cccc-hhhhccceeecccccccc-cccccc---ccccchhhccccc--cccccccccccceeccccccccc
Confidence 6655 3332 345556666666655555 223222 2233333333332 12233444555555555555444
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.81 E-value=9e-19 Score=193.26 Aligned_cols=299 Identities=27% Similarity=0.364 Sum_probs=178.4
Q ss_pred ccCCeeeecCCCCCCCCCccccCCCCCCEEEccCCCCCCccCcccccCcCcceEeeeccccccCCCccccccCCCCeeec
Q 045798 78 SFLREINLSNNTIQGEIPPEFGRLFRLEALFLSNNSLVGKIPANLSYCSRLTVLCIEYNKLQGRIPLEFVSLSKLKDLSL 157 (1008)
Q Consensus 78 ~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L 157 (1008)
.+|++|+|++|+++ .+|+. +++|++|+|++|+|+ .+|..+ .+|+.|++++|+++ .++. + .+.|++|++
T Consensus 38 ~~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~-~l~~-l--p~~L~~L~L 105 (353)
T d1jl5a_ 38 RQAHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLK-ALSD-L--PPLLEYLGV 105 (353)
T ss_dssp HTCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCS-CCCS-C--CTTCCEEEC
T ss_pred cCCCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccc-hhhh-h--ccccccccc
Confidence 36889999999998 67754 578999999999999 778654 57889999999988 3332 1 146899999
Q ss_pred ccccCCCCCCCCCccccccchhhcccccCCCCCCccccCCCCCcEEEecCCcccccCCccccCCCCcceecccccccccc
Q 045798 158 AKNKLTGGIPPFLGNLTSLEVLSLAGNSFGRNIPDSLGQLKQLKILAIGGNNLSGPIPPSIYNLSFLVVFSVSHNQIHGS 237 (1008)
Q Consensus 158 ~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~~~ 237 (1008)
++|.++ .+|. ++.+++|+.|++++|.+... +. ....+..+.+..+... ....+..++.++.+++++|.+. .
T Consensus 106 ~~n~l~-~lp~-~~~l~~L~~L~l~~~~~~~~-~~---~~~~l~~l~~~~~~~~--~~~~l~~l~~l~~L~l~~n~~~-~ 176 (353)
T d1jl5a_ 106 SNNQLE-KLPE-LQNSSFLKIIDVDNNSLKKL-PD---LPPSLEFIAAGNNQLE--ELPELQNLPFLTAIYADNNSLK-K 176 (353)
T ss_dssp CSSCCS-SCCC-CTTCTTCCEEECCSSCCSCC-CC---CCTTCCEEECCSSCCS--SCCCCTTCTTCCEEECCSSCCS-S
T ss_pred cccccc-cccc-hhhhccceeecccccccccc-cc---ccccccchhhcccccc--ccccccccccceeccccccccc-c
Confidence 999988 5564 57888999999998888543 22 2456677777766654 3456777788888888888776 3
Q ss_pred CChhhhhcCCCCcEEEeccccCCCCCCcccccCCCCceeecccccccccccccccCCCcccccccccccCCCCCCCcccc
Q 045798 238 LPPSLGLLLPNLKFFQIHHNFFSGSIPISLSNASKLEHIEIANNNFSGKLSVNFGGMKNLSLLNLQFSNLGSGESDEMGF 317 (1008)
Q Consensus 238 lp~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~ 317 (1008)
++.. ....+.+...++.+. .++ .+..++.|+.+++++|...... ....
T Consensus 177 ~~~~----~~~~~~l~~~~~~~~-~~~-~~~~l~~L~~l~l~~n~~~~~~----~~~~---------------------- 224 (353)
T d1jl5a_ 177 LPDL----PLSLESIVAGNNILE-ELP-ELQNLPFLTTIYADNNLLKTLP----DLPP---------------------- 224 (353)
T ss_dssp CCCC----CTTCCEEECCSSCCS-SCC-CCTTCTTCCEEECCSSCCSSCC----SCCT----------------------
T ss_pred cccc----ccccccccccccccc-ccc-cccccccccccccccccccccc----cccc----------------------
Confidence 3322 223445555555444 222 2445666666666666544221 1122
Q ss_pred cccccccCCCcEEEecCCcCCccCChhhhhhcccceeeeeccccccCCCCCccccc-cccceEEecCccccCCcchhccC
Q 045798 318 MNSLTNCSKLRVLSLGGNQFRGALPHSIANLSSQLQILILSSNQFYGSIPLGIGNL-VDLYLLGMVENQFTGAIPKEMGK 396 (1008)
Q Consensus 318 ~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~Ls~N~l~~~~p~~~~~l-~~L~~L~L~~n~l~~~~~~~~~~ 396 (1008)
++..+.+.+|++.. .+.. ...+...++..+.+.+ +..+ ......++..+.+.+. ...
T Consensus 225 --------~l~~~~~~~~~~~~-~~~~----~~~l~~~~~~~~~~~~-----l~~l~~~~~~~~~~~~~~~~~----~~~ 282 (353)
T d1jl5a_ 225 --------SLEALNVRDNYLTD-LPEL----PQSLTFLDVSENIFSG-----LSELPPNLYYLNASSNEIRSL----CDL 282 (353)
T ss_dssp --------TCCEEECCSSCCSC-CCCC----CTTCCEEECCSSCCSE-----ESCCCTTCCEEECCSSCCSEE----CCC
T ss_pred --------cccccccccccccc-cccc----cccccccccccccccc-----cccccchhcccccccCccccc----ccc
Confidence 33344444444431 1111 1123344444433321 1111 1223344444444321 223
Q ss_pred CCCCceEEccCCcccccccccccCCCCcceeeccccccccccCCCCcCCCcccEeeccccccc
Q 045798 397 LQKLQGLDFSGNHFSGEIPSSLGNLSSLYEVFFNNNNLSGVIPFSLGNLKRLAFLEMSGNELS 459 (1008)
Q Consensus 397 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 459 (1008)
+++|++|+|++|+|+ .+|.. +++|+.|+|++|+|+ .+|.. +++|+.|++++|+++
T Consensus 283 ~~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~L~~N~L~-~l~~~---~~~L~~L~L~~N~L~ 337 (353)
T d1jl5a_ 283 PPSLEELNVSNNKLI-ELPAL---PPRLERLIASFNHLA-EVPEL---PQNLKQLHVEYNPLR 337 (353)
T ss_dssp CTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCS
T ss_pred CCCCCEEECCCCccC-ccccc---cCCCCEEECCCCcCC-ccccc---cCCCCEEECcCCcCC
Confidence 456777777777766 45543 355666677777766 34432 346677777777766
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.78 E-value=6.4e-19 Score=183.12 Aligned_cols=213 Identities=15% Similarity=0.095 Sum_probs=149.8
Q ss_pred cccCCCCccCcCccCCccCCeeeecCCCCCCCCCccccCCCCCCEEEccCCCCCCcc-CcccccCcCcceEeeec-cccc
Q 045798 62 MSKSLSGSLSPHLGNLSFLREINLSNNTIQGEIPPEFGRLFRLEALFLSNNSLVGKI-PANLSYCSRLTVLCIEY-NKLQ 139 (1008)
Q Consensus 62 ~~~~l~~~l~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~-p~~l~~l~~L~~L~Ls~-n~l~ 139 (1008)
++.+++ .+|+.+. +++++|+|++|+|+...+.+|.++++|++|+|++|.+...+ +..|.+++++++|.+.. |++.
T Consensus 16 ~~~~l~-~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~n~l~ 92 (242)
T d1xwdc1 16 QESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLL 92 (242)
T ss_dssp ESCSCS-SCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECCTTCC
T ss_pred eCCCCC-CcCCCCC--CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeecccccccccccccccccccccc
Confidence 345566 6777664 57899999999999666668999999999999999988655 45788899999998875 6787
Q ss_pred cCCCccccccCCCCeeecccccCCCCCC-CCCccccccchhhcccccCCCCCCccccCCC-CCcEEEecCCcccccCCcc
Q 045798 140 GRIPLEFVSLSKLKDLSLAKNKLTGGIP-PFLGNLTSLEVLSLAGNSFGRNIPDSLGQLK-QLKILAIGGNNLSGPIPPS 217 (1008)
Q Consensus 140 ~~~p~~~~~l~~L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~-~L~~L~L~~n~l~~~~~~~ 217 (1008)
...+..|.++++|++|++++|++....+ ..+..+..+..+..+++.+....+..|..++ .++.|++++|+++.+.+..
T Consensus 93 ~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~~i~~~~ 172 (242)
T d1xwdc1 93 YINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCA 172 (242)
T ss_dssp EECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCEECTTT
T ss_pred ccccccccccccccccccchhhhcccccccccccccccccccccccccccccccccccccccceeeeccccccccccccc
Confidence 7778889999999999999999874322 2344556666667777777666667777664 6777888888887655555
Q ss_pred ccCCCCcceeccccccccccCChhhhhcCCCCcEEEeccccCCCCCCcccccCCCCceeec
Q 045798 218 IYNLSFLVVFSVSHNQIHGSLPPSLGLLLPNLKFFQIHHNFFSGSIPISLSNASKLEHIEI 278 (1008)
Q Consensus 218 ~~~l~~L~~L~ls~N~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L 278 (1008)
+.....++.+++++|+++ .+|...+..+++|++|+|++|+++...+..|.++++|+.+++
T Consensus 173 ~~~~~l~~~~~l~~n~l~-~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~l~~ 232 (242)
T d1xwdc1 173 FNGTQLDELNLSDNNNLE-ELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST 232 (242)
T ss_dssp TTTCCEEEEECTTCTTCC-CCCTTTTTTSCCCSEEECTTSCCCCCCSSSCTTCCEEESSSE
T ss_pred ccchhhhccccccccccc-cccHHHhcCCCCCCEEECCCCcCCccCHHHHcCCcccccCcC
Confidence 444333344456666676 666666555666666666666665433444555555554444
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.77 E-value=1.9e-21 Score=223.52 Aligned_cols=385 Identities=16% Similarity=0.151 Sum_probs=197.6
Q ss_pred ccchhhcccccCCCCC-CccccCCCCCcEEEecCCcccc----cCCccccCCCCcceeccccccccccCChhhh----hc
Q 045798 175 SLEVLSLAGNSFGRNI-PDSLGQLKQLKILAIGGNNLSG----PIPPSIYNLSFLVVFSVSHNQIHGSLPPSLG----LL 245 (1008)
Q Consensus 175 ~L~~L~L~~n~l~~~~-~~~~~~l~~L~~L~L~~n~l~~----~~~~~~~~l~~L~~L~ls~N~l~~~lp~~~~----~~ 245 (1008)
+|+.||+++|+++... ...+..++++++|+|++|.++. .+..++..+++|++|||++|.|+..--..+. ..
T Consensus 3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~ 82 (460)
T d1z7xw1 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP 82 (460)
T ss_dssp EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCST
T ss_pred CCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcC
Confidence 3444444444443211 1223344455555555554442 1223344455555555555554311101111 11
Q ss_pred CCCCcEEEeccccCCCC----CCcccccCCCCceeecccccccccccccccC-----CCcccccccccccCCCCCCCccc
Q 045798 246 LPNLKFFQIHHNFFSGS----IPISLSNASKLEHIEIANNNFSGKLSVNFGG-----MKNLSLLNLQFSNLGSGESDEMG 316 (1008)
Q Consensus 246 l~~L~~L~L~~N~l~~~----~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~-----l~~L~~L~L~~n~l~~~~~~~~~ 316 (1008)
..+|++|+|++|.+++. ++..+..+++|++|++++|.+.......+.. .............+.. .....
T Consensus 83 ~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~--~~~~~ 160 (460)
T d1z7xw1 83 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSA--ASCEP 160 (460)
T ss_dssp TCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBG--GGHHH
T ss_pred CCCCCEEECCCCCccccccccccchhhccccccccccccccchhhhhhhhhhcccccccccccccccccccch--hhhcc
Confidence 23566666666666532 3345566677777777777766433222211 1111111111111111 00111
Q ss_pred ccccccccCCCcEEEecCCcCCccCCh----hhhhhcccceeeeeccccccCCC----CCccccccccceEEecCccccC
Q 045798 317 FMNSLTNCSKLRVLSLGGNQFRGALPH----SIANLSSQLQILILSSNQFYGSI----PLGIGNLVDLYLLGMVENQFTG 388 (1008)
Q Consensus 317 ~~~~l~~l~~L~~L~Ls~N~l~~~~p~----~~~~l~~~L~~L~Ls~N~l~~~~----p~~~~~l~~L~~L~L~~n~l~~ 388 (1008)
....+.....++.++++++.+....-. .+.........+++..+.+.... ...+.....++.+++++|.+..
T Consensus 161 ~~~~l~~~~~~~~~~ls~~~~~~~~~~~~~~~l~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~~l~~~~n~~~~ 240 (460)
T d1z7xw1 161 LASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGD 240 (460)
T ss_dssp HHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccchhhhcccccccccccccccchhhccccc
Confidence 122345566778888877765522111 11121223556666666554211 1123345667777777776542
Q ss_pred -----CcchhccCCCCCceEEccCCccccc----ccccccCCCCcceeeccccccccccCCC-----CcCCCcccEeecc
Q 045798 389 -----AIPKEMGKLQKLQGLDFSGNHFSGE----IPSSLGNLSSLYEVFFNNNNLSGVIPFS-----LGNLKRLAFLEMS 454 (1008)
Q Consensus 389 -----~~~~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~~p~~-----~~~l~~L~~L~Ls 454 (1008)
...........|+.|++++|.+... ....+...+.++.+++++|.+....... ......|+.++++
T Consensus 241 ~~~~~~~~~~~~~~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~l~~~l~~~~~~L~~l~l~ 320 (460)
T d1z7xw1 241 VGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVK 320 (460)
T ss_dssp HHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECT
T ss_pred cccchhhcccccccccccccccccccccccccccccccccccccccccccccccccccccchhhcccccccccccccccc
Confidence 1223344456777777777776532 2223445566777777777665321111 1123456677777
Q ss_pred cccccCCcchhhhhhhhhhhhhcccCccccCCCcccccccccccccccccccccCC----CCcccc-cccccceeeccCc
Q 045798 455 GNELSGTIPEDIFNISYLSNSLNLARNHLVGIIPPRIGNLRALRSFDVSNNDLSGE----IPIELG-HCSSLEEIYLAGN 529 (1008)
Q Consensus 455 ~N~l~~~lp~~~~~~~~~~~~L~L~~N~l~~~~p~~~~~l~~L~~Ldls~N~l~~~----~p~~~~-~l~~L~~L~L~~N 529 (1008)
+|.++..-.. .+...+...++|+.|||++|++++. ++..+. ..+.|++|+|++|
T Consensus 321 ~~~l~~~~~~---------------------~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n 379 (460)
T d1z7xw1 321 SCSFTAACCS---------------------HFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADC 379 (460)
T ss_dssp TSCCBGGGHH---------------------HHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTS
T ss_pred ccchhhhhhh---------------------hcccccccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCC
Confidence 7666521111 0112233456788889998888642 333333 3567899999999
Q ss_pred ccccc----hhhhhhccccccEEecCCCcccccccCc----c--cccccceeecccCcccccC
Q 045798 530 LFHGS----IPSFFNALKGVQKIDLSRNNLSGQIPIF----L--EALSLEYLNLSFNDFEGKI 582 (1008)
Q Consensus 530 ~l~~~----~p~~~~~l~~L~~L~ls~N~l~~~~p~~----~--~~~~L~~L~l~~N~l~g~~ 582 (1008)
.|+.. +++.+..+++|+.|||++|+++...... . ....|+.|++++|.+....
T Consensus 380 ~i~~~~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~l~l~~~~~~~~~ 442 (460)
T d1z7xw1 380 DVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEM 442 (460)
T ss_dssp CCCHHHHHHHHHHHHHCCCCCEEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCCCHHH
T ss_pred CCChHHHHHHHHHHhcCCCCCEEECCCCcCCHHHHHHHHHHHHhCCCccCEEECCCCCCCHHH
Confidence 98742 5566777889999999999987532221 1 2235889999998887643
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.76 E-value=1.8e-18 Score=179.71 Aligned_cols=218 Identities=17% Similarity=0.110 Sum_probs=171.6
Q ss_pred CeeeecCCCCCCCCCccccCCCCCCEEEccCCCCCCccCcccccCcCcceEeeeccccccCC-CccccccCCCCeeecc-
Q 045798 81 REINLSNNTIQGEIPPEFGRLFRLEALFLSNNSLVGKIPANLSYCSRLTVLCIEYNKLQGRI-PLEFVSLSKLKDLSLA- 158 (1008)
Q Consensus 81 ~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~-p~~~~~l~~L~~L~L~- 158 (1008)
+.++.++.+++ .+|+.+. +++++|+|++|+|+...+.+|.++++|++|++++|.+...+ +..|.+++++++|.+.
T Consensus 11 ~~i~c~~~~l~-~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~ 87 (242)
T d1xwdc1 11 RVFLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK 87 (242)
T ss_dssp SEEEEESCSCS-SCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEEC
T ss_pred CEEEEeCCCCC-CcCCCCC--CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccccc
Confidence 57888888888 7776653 58999999999999555667999999999999999987644 5578889999999876
Q ss_pred cccCCCCCCCCCccccccchhhcccccCCCCCCc-cccCCCCCcEEEecCCcccccCCccccCCC-Ccceeccccccccc
Q 045798 159 KNKLTGGIPPFLGNLTSLEVLSLAGNSFGRNIPD-SLGQLKQLKILAIGGNNLSGPIPPSIYNLS-FLVVFSVSHNQIHG 236 (1008)
Q Consensus 159 ~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~-~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~-~L~~L~ls~N~l~~ 236 (1008)
.|.+....+..|.++++|++|++++|++....+. .+..+..+..+...++.+....+..|.+++ .++.|++++|+++
T Consensus 88 ~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~- 166 (242)
T d1xwdc1 88 ANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ- 166 (242)
T ss_dssp CTTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCC-
T ss_pred cccccccccccccccccccccccchhhhcccccccccccccccccccccccccccccccccccccccceeeeccccccc-
Confidence 4678877788899999999999999998654332 344566777777788888877777887765 7888999999998
Q ss_pred cCChhhhhcCCCCcEE-EeccccCCCCCCcccccCCCCceeecccccccccccccccCCCcccccccc
Q 045798 237 SLPPSLGLLLPNLKFF-QIHHNFFSGSIPISLSNASKLEHIEIANNNFSGKLSVNFGGMKNLSLLNLQ 303 (1008)
Q Consensus 237 ~lp~~~~~~l~~L~~L-~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~ 303 (1008)
.++...+.. ++++.+ ++++|+++...+..|.++++|++|++++|+|+.+.+..|.++++|+.+++.
T Consensus 167 ~i~~~~~~~-~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~l~~~ 233 (242)
T d1xwdc1 167 EIHNCAFNG-TQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTY 233 (242)
T ss_dssp EECTTTTTT-CCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCCCCSSSCTTCCEEESSSEE
T ss_pred ccccccccc-hhhhccccccccccccccHHHhcCCCCCCEEECCCCcCCccCHHHHcCCcccccCcCC
Confidence 677766653 454444 567788885555668888889999999888887777778888888777664
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.74 E-value=2.5e-21 Score=222.52 Aligned_cols=109 Identities=21% Similarity=0.255 Sum_probs=67.2
Q ss_pred eEEEEeccccCCCCc-cCcCccCCccCCeeeecCCCCCC----CCCccccCCCCCCEEEccCCCCCCcc----Cccccc-
Q 045798 55 RVTALDLMSKSLSGS-LSPHLGNLSFLREINLSNNTIQG----EIPPEFGRLFRLEALFLSNNSLVGKI----PANLSY- 124 (1008)
Q Consensus 55 ~v~~l~l~~~~l~~~-l~~~l~~l~~L~~L~L~~n~~~~----~~p~~~~~l~~L~~L~Ls~n~l~~~~----p~~l~~- 124 (1008)
.++.||++++++++. +...+..+++|++|+|++|.++. .+...+..+++|++|||++|.|+... ...+..
T Consensus 3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~ 82 (460)
T d1z7xw1 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP 82 (460)
T ss_dssp EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCST
T ss_pred CCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcC
Confidence 467777777777653 23345566777777777777762 23444566777777777777775321 222221
Q ss_pred CcCcceEeeeccccccC----CCccccccCCCCeeecccccCC
Q 045798 125 CSRLTVLCIEYNKLQGR----IPLEFVSLSKLKDLSLAKNKLT 163 (1008)
Q Consensus 125 l~~L~~L~Ls~n~l~~~----~p~~~~~l~~L~~L~L~~n~l~ 163 (1008)
..+|++|+|++|++++. ++..+..+++|++|+|++|.++
T Consensus 83 ~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~ 125 (460)
T d1z7xw1 83 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLG 125 (460)
T ss_dssp TCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCH
T ss_pred CCCCCEEECCCCCccccccccccchhhccccccccccccccch
Confidence 24677777777777532 2344556667777777777665
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.74 E-value=1.6e-18 Score=172.40 Aligned_cols=129 Identities=22% Similarity=0.293 Sum_probs=80.4
Q ss_pred CcEEEecCCcCCccCChhhhhhcccceeeeeccccccCCC-CCccccccccceEEecCccccCCcchhccCCCCCceEEc
Q 045798 327 LRVLSLGGNQFRGALPHSIANLSSQLQILILSSNQFYGSI-PLGIGNLVDLYLLGMVENQFTGAIPKEMGKLQKLQGLDF 405 (1008)
Q Consensus 327 L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 405 (1008)
.++++.++++++ .+|..+. ..+++|+|++|+|++.+ +..|.++++|+.|+|++|++.+..+..|..+++|++|+|
T Consensus 10 ~~~v~Cs~~~L~-~iP~~lp---~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~L 85 (192)
T d1w8aa_ 10 GTTVDCTGRGLK-EIPRDIP---LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQL 85 (192)
T ss_dssp TTEEECTTSCCS-SCCSCCC---TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEEC
T ss_pred CCEEEEeCCCcC-ccCCCCC---CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeee
Confidence 346667777776 5665443 34666777777665433 344566666666666666666666666666666666666
Q ss_pred cCCcccccccccccCCCCcceeeccccccccccCCCCcCCCcccEeeccccccc
Q 045798 406 SGNHFSGEIPSSLGNLSSLYEVFFNNNNLSGVIPFSLGNLKRLAFLEMSGNELS 459 (1008)
Q Consensus 406 s~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 459 (1008)
++|+|+...|..|.++++|++|+|++|+|++..|.+|..+++|++|+|++|.+.
T Consensus 86 s~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~ 139 (192)
T d1w8aa_ 86 GENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFN 139 (192)
T ss_dssp CSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBC
T ss_pred ccccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccc
Confidence 666666555555666666666666666666655666666666666666666665
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.73 E-value=9.5e-18 Score=172.01 Aligned_cols=188 Identities=24% Similarity=0.339 Sum_probs=89.9
Q ss_pred cCCccCCeeeecCCCCCCCCCccccCCCCCCEEEccCCCCCCccCcccccCcCcceEeeeccccccCCCccccccCCCCe
Q 045798 75 GNLSFLREINLSNNTIQGEIPPEFGRLFRLEALFLSNNSLVGKIPANLSYCSRLTVLCIEYNKLQGRIPLEFVSLSKLKD 154 (1008)
Q Consensus 75 ~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~ 154 (1008)
..+.+|++|++.+|+|+ .++ .+..+++|++|++++|++++..| +..+++|++|++++|.++. + ..+..+++|+.
T Consensus 38 ~~l~~L~~L~l~~~~i~-~l~-~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~n~~~~-i-~~l~~l~~L~~ 111 (227)
T d1h6ua2 38 ADLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKN-V-SAIAGLQSIKT 111 (227)
T ss_dssp HHHHTCCEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSC-C-GGGTTCTTCCE
T ss_pred HHcCCcCEEECCCCCCC-cch-hHhcCCCCcEeecCCceeecccc--ccccccccccccccccccc-c-ccccccccccc
Confidence 34455555555555555 232 35555555555555555553322 5555555555555555542 2 13445555555
Q ss_pred eecccccCCCCCCCCCccccccchhhcccccCCCCCCccccCCCCCcEEEecCCcccccCCccccCCCCcceeccccccc
Q 045798 155 LSLAKNKLTGGIPPFLGNLTSLEVLSLAGNSFGRNIPDSLGQLKQLKILAIGGNNLSGPIPPSIYNLSFLVVFSVSHNQI 234 (1008)
Q Consensus 155 L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ls~N~l 234 (1008)
++++++...+. ..+...+.++.+.++++.+... ..+..+++|+.|++++|.++.. ..+.++++|+.|+|++|++
T Consensus 112 l~l~~~~~~~~--~~~~~~~~~~~l~~~~~~~~~~--~~~~~~~~L~~L~l~~n~~~~~--~~l~~l~~L~~L~Ls~n~l 185 (227)
T d1h6ua2 112 LDLTSTQITDV--TPLAGLSNLQVLYLDLNQITNI--SPLAGLTNLQYLSIGNAQVSDL--TPLANLSKLTTLKADDNKI 185 (227)
T ss_dssp EECTTSCCCCC--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCC
T ss_pred ccccccccccc--chhccccchhhhhchhhhhchh--hhhccccccccccccccccccc--hhhcccccceecccCCCcc
Confidence 55555554422 1233344455555555544321 2244445555555555544421 1244444444444444444
Q ss_pred cccCChhhhhcCCCCcEEEeccccCCCCCCcccccCCCCceeecccccccccccccccCCCcccccccc
Q 045798 235 HGSLPPSLGLLLPNLKFFQIHHNFFSGSIPISLSNASKLEHIEIANNNFSGKLSVNFGGMKNLSLLNLQ 303 (1008)
Q Consensus 235 ~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~ 303 (1008)
+ .++ .+.++++|++|++++|+++++.+ +.++++|+.|+++
T Consensus 186 ~-~l~--------------------------~l~~l~~L~~L~Ls~N~lt~i~~--l~~l~~L~~L~ls 225 (227)
T d1h6ua2 186 S-DIS--------------------------PLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225 (227)
T ss_dssp C-CCG--------------------------GGGGCTTCCEEECTTSCCCBCGG--GTTCTTCCEEEEE
T ss_pred C-CCh--------------------------hhcCCCCCCEEECcCCcCCCCcc--cccCCCCCEEEee
Confidence 4 222 24445555555555555554332 4455555555554
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.73 E-value=1.2e-17 Score=166.13 Aligned_cols=175 Identities=19% Similarity=0.176 Sum_probs=135.4
Q ss_pred ceeeeeccccccCCCCCccccccccceEEecCccccC-CcchhccCCCCCceEEccCCcccccccccccCCCCcceeecc
Q 045798 352 LQILILSSNQFYGSIPLGIGNLVDLYLLGMVENQFTG-AIPKEMGKLQKLQGLDFSGNHFSGEIPSSLGNLSSLYEVFFN 430 (1008)
Q Consensus 352 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~-~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~ 430 (1008)
.+.++.++++++ .+|..+. +++++|+|++|+|++ ..+..|.++++|+.|+|++|.+.+..+..|..+++|++|+|+
T Consensus 10 ~~~v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls 86 (192)
T d1w8aa_ 10 GTTVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLG 86 (192)
T ss_dssp TTEEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred CCEEEEeCCCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeec
Confidence 567888888888 6777664 678888888888876 445667888888888888888888888888888888888888
Q ss_pred ccccccccCCCCcCCCcccEeecccccccCCcchhhhhhhhhhhhhcccCccccCCCcccccccccccccccccccccCC
Q 045798 431 NNNLSGVIPFSLGNLKRLAFLEMSGNELSGTIPEDIFNISYLSNSLNLARNHLVGIIPPRIGNLRALRSFDVSNNDLSGE 510 (1008)
Q Consensus 431 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~lp~~~~~~~~~~~~L~L~~N~l~~~~p~~~~~l~~L~~Ldls~N~l~~~ 510 (1008)
+|+|.++.|.+|.++++|++|+|++|+|+ .+|.+.|.....+++|+|++|.+....+ ...-...++.+.++.|.++..
T Consensus 87 ~N~l~~l~~~~F~~l~~L~~L~L~~N~l~-~i~~~~f~~l~~L~~l~L~~N~~~~~~~-~~~~~~~l~~~~l~~~~~~c~ 164 (192)
T d1w8aa_ 87 ENKIKEISNKMFLGLHQLKTLNLYDNQIS-CVMPGSFEHLNSLTSLNLASNPFNCNCH-LAWFAEWLRKKSLNGGAARCG 164 (192)
T ss_dssp SCCCCEECSSSSTTCTTCCEEECCSSCCC-EECTTSSTTCTTCCEEECTTCCBCCSGG-GHHHHHHHHHHCCSGGGCBBC
T ss_pred cccccccCHHHHhCCCcccccccCCcccc-ccCHHHhcCCcccccccccccccccccc-hHHHhhhhhhhcccCCCeEeC
Confidence 88888888888888888888888888887 6887777767777888888888875432 222234577778888888766
Q ss_pred CCcccccccccceeeccCcccccc
Q 045798 511 IPIELGHCSSLEEIYLAGNLFHGS 534 (1008)
Q Consensus 511 ~p~~~~~l~~L~~L~L~~N~l~~~ 534 (1008)
.|.. +..++.++|+.|.|.-.
T Consensus 165 ~p~~---l~~~~l~~L~~n~l~C~ 185 (192)
T d1w8aa_ 165 APSK---VRDVQIKDLPHSEFKCS 185 (192)
T ss_dssp SSTT---TTTSBGGGSCTTTCCCC
T ss_pred CChh---hcCCEeeecCHhhCcCC
Confidence 7754 45667788888888743
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.73 E-value=4.1e-18 Score=174.83 Aligned_cols=209 Identities=23% Similarity=0.322 Sum_probs=137.2
Q ss_pred CccCCeeeecCCCCCCCCCccccCCCCCCEEEccCCCCCCccCcccccCcCcceEeeeccccccCCCccccccCCCCeee
Q 045798 77 LSFLREINLSNNTIQGEIPPEFGRLFRLEALFLSNNSLVGKIPANLSYCSRLTVLCIEYNKLQGRIPLEFVSLSKLKDLS 156 (1008)
Q Consensus 77 l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~ 156 (1008)
+.++..++++.+++++.+ .+..+.+|++|++++|+|+. ++ .+..+++|++|++++|++++..| +..+++|++++
T Consensus 18 l~~~~~~~l~~~~~~d~~--~~~~l~~L~~L~l~~~~i~~-l~-~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~ 91 (227)
T d1h6ua2 18 LANAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELE 91 (227)
T ss_dssp HHHHHHHHTTCSSTTSEE--CHHHHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEE
T ss_pred HHHHHHHHhCCCCcCCcC--CHHHcCCcCEEECCCCCCCc-ch-hHhcCCCCcEeecCCceeecccc--ccccccccccc
Confidence 344455667777776543 35667778888888887773 43 47777777777777777775433 66667777777
Q ss_pred cccccCCCCCCCCCccccccchhhcccccCCCCCCccccCCCCCcEEEecCCcccccCCccccCCCCcceeccccccccc
Q 045798 157 LAKNKLTGGIPPFLGNLTSLEVLSLAGNSFGRNIPDSLGQLKQLKILAIGGNNLSGPIPPSIYNLSFLVVFSVSHNQIHG 236 (1008)
Q Consensus 157 L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~~ 236 (1008)
+++|.++. ++ .+.++++|+.+++++|...+. ..+...+.++.+.+ +.+.+..
T Consensus 92 ~~~n~~~~-i~-~l~~l~~L~~l~l~~~~~~~~--~~~~~~~~~~~l~~------------------------~~~~~~~ 143 (227)
T d1h6ua2 92 LSGNPLKN-VS-AIAGLQSIKTLDLTSTQITDV--TPLAGLSNLQVLYL------------------------DLNQITN 143 (227)
T ss_dssp CCSCCCSC-CG-GGTTCTTCCEEECTTSCCCCC--GGGTTCTTCCEEEC------------------------CSSCCCC
T ss_pred cccccccc-cc-ccccccccccccccccccccc--chhccccchhhhhc------------------------hhhhhch
Confidence 77766652 22 345555566666555554321 22344444444444 4444431
Q ss_pred cCChhhhhcCCCCcEEEeccccCCCCCCcccccCCCCceeecccccccccccccccCCCcccccccccccCCCCCCCccc
Q 045798 237 SLPPSLGLLLPNLKFFQIHHNFFSGSIPISLSNASKLEHIEIANNNFSGKLSVNFGGMKNLSLLNLQFSNLGSGESDEMG 316 (1008)
Q Consensus 237 ~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~ 316 (1008)
..+ +...++|++|++++|.+.+. ..+.++++|+.|++++|+++++. .|.++++|+.|+|++|+++.+.
T Consensus 144 ~~~---~~~~~~L~~L~l~~n~~~~~--~~l~~l~~L~~L~Ls~n~l~~l~--~l~~l~~L~~L~Ls~N~lt~i~----- 211 (227)
T d1h6ua2 144 ISP---LAGLTNLQYLSIGNAQVSDL--TPLANLSKLTTLKADDNKISDIS--PLASLPNLIEVHLKNNQISDVS----- 211 (227)
T ss_dssp CGG---GGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCCCG--GGGGCTTCCEEECTTSCCCBCG-----
T ss_pred hhh---hccccccccccccccccccc--hhhcccccceecccCCCccCCCh--hhcCCCCCCEEECcCCcCCCCc-----
Confidence 111 22355667777777766533 23778899999999999998754 3889999999999999998653
Q ss_pred ccccccccCCCcEEEecC
Q 045798 317 FMNSLTNCSKLRVLSLGG 334 (1008)
Q Consensus 317 ~~~~l~~l~~L~~L~Ls~ 334 (1008)
.+.++++|+.|++++
T Consensus 212 ---~l~~l~~L~~L~lsn 226 (227)
T d1h6ua2 212 ---PLANTSNLFIVTLTN 226 (227)
T ss_dssp ---GGTTCTTCCEEEEEE
T ss_pred ---ccccCCCCCEEEeeC
Confidence 478999999999974
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.70 E-value=2.3e-17 Score=166.56 Aligned_cols=81 Identities=23% Similarity=0.335 Sum_probs=38.8
Q ss_pred ccccceEEecCccccCCcchhccCCCCCceEEccCCcccccccccccCCCCcceeeccccccccccCCCCcCCCcccEee
Q 045798 373 LVDLYLLGMVENQFTGAIPKEMGKLQKLQGLDFSGNHFSGEIPSSLGNLSSLYEVFFNNNNLSGVIPFSLGNLKRLAFLE 452 (1008)
Q Consensus 373 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ 452 (1008)
+.+|+.|++++|.++... .+..+++|++|+|++|+|++. + .++.+++|+.|++++|++++ +| .+.++++|+.|+
T Consensus 45 L~~L~~L~l~~~~i~~l~--~l~~l~~L~~L~L~~n~i~~l-~-~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~ 118 (210)
T d1h6ta2 45 LNSIDQIIANNSDIKSVQ--GIQYLPNVTKLFLNGNKLTDI-K-PLANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLS 118 (210)
T ss_dssp HHTCCEEECTTSCCCCCT--TGGGCTTCCEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEE
T ss_pred hcCccEEECcCCCCCCch--hHhhCCCCCEEeCCCccccCc-c-ccccCccccccccccccccc-cc-cccccccccccc
Confidence 444445555555444321 244455555555555555432 2 23445555555555555543 22 245555555555
Q ss_pred ccccccc
Q 045798 453 MSGNELS 459 (1008)
Q Consensus 453 Ls~N~l~ 459 (1008)
+++|.+.
T Consensus 119 l~~~~~~ 125 (210)
T d1h6ta2 119 LEHNGIS 125 (210)
T ss_dssp CTTSCCC
T ss_pred ccccccc
Confidence 5555543
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.69 E-value=3.9e-17 Score=164.79 Aligned_cols=165 Identities=25% Similarity=0.359 Sum_probs=85.5
Q ss_pred CCCCCEEEccCCCCCCccCcccccCcCcceEeeeccccccCCCccccccCCCCeeecccccCCCCCCCCCccccccchhh
Q 045798 101 LFRLEALFLSNNSLVGKIPANLSYCSRLTVLCIEYNKLQGRIPLEFVSLSKLKDLSLAKNKLTGGIPPFLGNLTSLEVLS 180 (1008)
Q Consensus 101 l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 180 (1008)
+.+|++|++++|.+++ ++ .+..+++|++|+|++|+|++.. .++.+++|++|++++|++++ ++ .+.++++|+.|+
T Consensus 45 L~~L~~L~l~~~~i~~-l~-~l~~l~~L~~L~L~~n~i~~l~--~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~ 118 (210)
T d1h6ta2 45 LNSIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTDIK--PLANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLS 118 (210)
T ss_dssp HHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEE
T ss_pred hcCccEEECcCCCCCC-ch-hHhhCCCCCEEeCCCccccCcc--ccccCccccccccccccccc-cc-cccccccccccc
Confidence 4445555555555542 22 2445555555555555555322 23445555555555555552 22 345555555555
Q ss_pred cccccCCCCCCccccCCCCCcEEEecCCcccccCCccccCCCCcceeccccccccccCChhhhhcCCCCcEEEeccccCC
Q 045798 181 LAGNSFGRNIPDSLGQLKQLKILAIGGNNLSGPIPPSIYNLSFLVVFSVSHNQIHGSLPPSLGLLLPNLKFFQIHHNFFS 260 (1008)
Q Consensus 181 L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~~~lp~~~~~~l~~L~~L~L~~N~l~ 260 (1008)
+++|.+.. ...+..+++|+.+++++|.+++ +..+..+++|+.+++++|+++ .++. +..+++|+.|+|++|+++
T Consensus 119 l~~~~~~~--~~~l~~l~~l~~l~~~~n~l~~--~~~~~~l~~L~~l~l~~n~l~-~i~~--l~~l~~L~~L~Ls~N~i~ 191 (210)
T d1h6ta2 119 LEHNGISD--INGLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQIS-DIVP--LAGLTKLQNLYLSKNHIS 191 (210)
T ss_dssp CTTSCCCC--CGGGGGCTTCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCC-CCGG--GTTCTTCCEEECCSSCCC
T ss_pred cccccccc--cccccccccccccccccccccc--ccccccccccccccccccccc-cccc--ccCCCCCCEEECCCCCCC
Confidence 55555432 2235555555555555555542 234455555666666666555 3332 233566666666666665
Q ss_pred CCCCcccccCCCCceeeccc
Q 045798 261 GSIPISLSNASKLEHIEIAN 280 (1008)
Q Consensus 261 ~~~p~~l~~l~~L~~L~L~~ 280 (1008)
. +| .+.++++|++|+|++
T Consensus 192 ~-l~-~l~~l~~L~~L~Ls~ 209 (210)
T d1h6ta2 192 D-LR-ALAGLKNLDVLELFS 209 (210)
T ss_dssp B-CG-GGTTCTTCSEEEEEE
T ss_pred C-Ch-hhcCCCCCCEEEccC
Confidence 3 33 466677777777653
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.69 E-value=3.3e-17 Score=163.89 Aligned_cols=177 Identities=24% Similarity=0.407 Sum_probs=100.4
Q ss_pred eeeccccccCCCCCccccccccceEEecCccccCCcchhccCCCCCceEEccCCcccccccccccCCCCcceeecccccc
Q 045798 355 LILSSNQFYGSIPLGIGNLVDLYLLGMVENQFTGAIPKEMGKLQKLQGLDFSGNHFSGEIPSSLGNLSSLYEVFFNNNNL 434 (1008)
Q Consensus 355 L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l 434 (1008)
+.++.+.+++.++ ...+.+++.|++++|.++.. +.+..+++|++|+|++|++++..| +.++++|++|++++|.+
T Consensus 23 ~~l~~~~~~~~~~--~~~l~~l~~L~l~~~~i~~l--~~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~ 96 (199)
T d2omxa2 23 TVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQI 96 (199)
T ss_dssp HHTTCSSTTSEEC--HHHHTTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCC
T ss_pred HHhCCCCCCCccC--HHHhcCCCEEECCCCCCCCc--cccccCCCcCcCccccccccCccc--ccCCccccccccccccc
Confidence 3455555543322 23455666666666666532 235566666666666666664322 66666666666666666
Q ss_pred ccccCCCCcCCCcccEeecccccccCCcchhhhhhhhhhhhhcccCccccCCCcccccccccccccccccccccCCCCcc
Q 045798 435 SGVIPFSLGNLKRLAFLEMSGNELSGTIPEDIFNISYLSNSLNLARNHLVGIIPPRIGNLRALRSFDVSNNDLSGEIPIE 514 (1008)
Q Consensus 435 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~lp~~~~~~~~~~~~L~L~~N~l~~~~p~~~~~l~~L~~Ldls~N~l~~~~p~~ 514 (1008)
... + .+.++++|+.|++++|.+.. + +.+..+++|+.|++++|++. .+| .
T Consensus 97 ~~~-~-~l~~l~~L~~L~l~~~~~~~--------------------------~-~~~~~l~~L~~L~l~~n~l~-~~~-~ 145 (199)
T d2omxa2 97 ADI-T-PLANLTNLTGLTLFNNQITD--------------------------I-DPLKNLTNLNRLELSSNTIS-DIS-A 145 (199)
T ss_dssp CCC-G-GGTTCTTCSEEECCSSCCCC--------------------------C-GGGTTCTTCSEEECCSSCCC-CCG-G
T ss_pred ccc-c-cccccccccccccccccccc--------------------------c-cccchhhhhHHhhhhhhhhc-ccc-c
Confidence 532 2 25666667777766666652 1 12445566666666666665 232 3
Q ss_pred cccccccceeeccCcccccchhhhhhccccccEEecCCCcccccccCccccccccee
Q 045798 515 LGHCSSLEEIYLAGNLFHGSIPSFFNALKGVQKIDLSRNNLSGQIPIFLEALSLEYL 571 (1008)
Q Consensus 515 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~L~~L 571 (1008)
+..+++|++|++++|++++. + .++.+++|+.|++++|++++ +|....+.+|++|
T Consensus 146 l~~~~~L~~L~l~~n~l~~l-~-~l~~l~~L~~L~ls~N~i~~-i~~l~~L~~L~~L 199 (199)
T d2omxa2 146 LSGLTSLQQLNFSSNQVTDL-K-PLANLTTLERLDISSNKVSD-ISVLAKLTNLESL 199 (199)
T ss_dssp GTTCTTCSEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCCC-CGGGGGCTTCSEE
T ss_pred ccccccccccccccccccCC-c-cccCCCCCCEEECCCCCCCC-CccccCCCCCCcC
Confidence 56666666666666666643 2 25666666666766666664 3333444445443
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.68 E-value=3.1e-17 Score=164.10 Aligned_cols=166 Identities=26% Similarity=0.331 Sum_probs=89.1
Q ss_pred CCeeeecCCCCCCCCCccccCCCCCCEEEccCCCCCCccCcccccCcCcceEeeeccccccCCCccccccCCCCeeeccc
Q 045798 80 LREINLSNNTIQGEIPPEFGRLFRLEALFLSNNSLVGKIPANLSYCSRLTVLCIEYNKLQGRIPLEFVSLSKLKDLSLAK 159 (1008)
Q Consensus 80 L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~ 159 (1008)
+..+.++.+++++.++ ...+.++++|++++|.++. ++ .++.+++|++|++++|++++..| ++++++|++|++++
T Consensus 20 ~i~~~l~~~~~~~~~~--~~~l~~l~~L~l~~~~i~~-l~-~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~ 93 (199)
T d2omxa2 20 KMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS-ID-GVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNN 93 (199)
T ss_dssp HHHHHTTCSSTTSEEC--HHHHTTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCS
T ss_pred HHHHHhCCCCCCCccC--HHHhcCCCEEECCCCCCCC-cc-ccccCCCcCcCccccccccCccc--ccCCcccccccccc
Confidence 3344555555554332 2345666666666666662 22 35666666666666666664332 56666666666666
Q ss_pred ccCCCCCCCCCccccccchhhcccccCCCCCCccccCCCCCcEEEecCCcccccCCccccCCCCcceeccccccccccCC
Q 045798 160 NKLTGGIPPFLGNLTSLEVLSLAGNSFGRNIPDSLGQLKQLKILAIGGNNLSGPIPPSIYNLSFLVVFSVSHNQIHGSLP 239 (1008)
Q Consensus 160 n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~~~lp 239 (1008)
|.+.. ++ .+.++++|+.|++++|.+... ..+..+++|+.|++++|++.. .+.+..+++|+.|++++|+++ .++
T Consensus 94 n~~~~-~~-~l~~l~~L~~L~l~~~~~~~~--~~~~~l~~L~~L~l~~n~l~~--~~~l~~~~~L~~L~l~~n~l~-~l~ 166 (199)
T d2omxa2 94 NQIAD-IT-PLANLTNLTGLTLFNNQITDI--DPLKNLTNLNRLELSSNTISD--ISALSGLTSLQQLNFSSNQVT-DLK 166 (199)
T ss_dssp SCCCC-CG-GGTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEECCSSCCCC--CGGGTTCTTCSEEECCSSCCC-CCG
T ss_pred ccccc-cc-ccccccccccccccccccccc--cccchhhhhHHhhhhhhhhcc--ccccccccccccccccccccc-CCc
Confidence 66652 22 255666666666666665332 235556666666666666552 223555555555555555554 222
Q ss_pred hhhhhcCCCCcEEEeccccCC
Q 045798 240 PSLGLLLPNLKFFQIHHNFFS 260 (1008)
Q Consensus 240 ~~~~~~l~~L~~L~L~~N~l~ 260 (1008)
. +..+++|++|++++|+++
T Consensus 167 ~--l~~l~~L~~L~ls~N~i~ 185 (199)
T d2omxa2 167 P--LANLTTLERLDISSNKVS 185 (199)
T ss_dssp G--GTTCTTCCEEECCSSCCC
T ss_pred c--ccCCCCCCEEECCCCCCC
Confidence 1 222444444444444444
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.51 E-value=1.8e-15 Score=160.03 Aligned_cols=248 Identities=15% Similarity=0.167 Sum_probs=161.3
Q ss_pred EEEecCCcCCccCChhhhhhcc-cceeeeeccccccCCCCCccccccccceEEecCccccCC-cchhccCCCCCceEEcc
Q 045798 329 VLSLGGNQFRGALPHSIANLSS-QLQILILSSNQFYGSIPLGIGNLVDLYLLGMVENQFTGA-IPKEMGKLQKLQGLDFS 406 (1008)
Q Consensus 329 ~L~Ls~N~l~~~~p~~~~~l~~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~-~~~~~~~l~~L~~L~Ls 406 (1008)
.+|++++.+. |+.+..+.. .+..+.++...+... ........+|++||+++|.++.. +...+..+++|++|+|+
T Consensus 4 ~lDLs~~~l~---~~~l~~l~~~~~~~lrl~~~~~~~~-~~~~~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~ 79 (284)
T d2astb2 4 TLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQP-LAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLE 79 (284)
T ss_dssp EEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSC-CCSCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECT
T ss_pred EEECCCCCCC---chHHHHHHhccceEeeccccccccc-hhhhccCCCCCEEECCCCccCHHHHHHHHHhCCCccccccc
Confidence 6777777765 333333221 245666666665532 23344556888888888887644 34557788888888888
Q ss_pred CCcccccccccccCCCCcceeecccc-ccccc-cCCCCcCCCcccEeecccc-cccC-CcchhhhhhhhhhhhhcccCcc
Q 045798 407 GNHFSGEIPSSLGNLSSLYEVFFNNN-NLSGV-IPFSLGNLKRLAFLEMSGN-ELSG-TIPEDIFNISYLSNSLNLARNH 482 (1008)
Q Consensus 407 ~N~l~~~~p~~~~~l~~L~~L~l~~N-~l~~~-~p~~~~~l~~L~~L~Ls~N-~l~~-~lp~~~~~~~~~~~~L~L~~N~ 482 (1008)
+|.+.+..+..++.+++|++|++++| .++.. +...+.++++|++|+++++ .++. .++..+......++.|+++++.
T Consensus 80 ~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~ 159 (284)
T d2astb2 80 GLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYR 159 (284)
T ss_dssp TCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCG
T ss_pred ccCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhccccccccccccccccchhhhcccccccchhhhcccc
Confidence 88888777788888888888888885 45421 2222456788899998885 3431 1222223333456677777642
Q ss_pred --ccCC-Ccccccccccccccccccc-cccCCCCcccccccccceeeccCc-ccccchhhhhhccccccEEecCCCccc-
Q 045798 483 --LVGI-IPPRIGNLRALRSFDVSNN-DLSGEIPIELGHCSSLEEIYLAGN-LFHGSIPSFFNALKGVQKIDLSRNNLS- 556 (1008)
Q Consensus 483 --l~~~-~p~~~~~l~~L~~Ldls~N-~l~~~~p~~~~~l~~L~~L~L~~N-~l~~~~p~~~~~l~~L~~L~ls~N~l~- 556 (1008)
++.. +...+.++++|++||+++| .+++..+..+.++++|++|+|++| .+++.....++++++|+.|+++++ ++
T Consensus 160 ~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~-~~d 238 (284)
T d2astb2 160 KNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI-VPD 238 (284)
T ss_dssp GGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS-SCT
T ss_pred cccccccccccccccccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCCCEEeeeCC-CCH
Confidence 3321 2233456788999999885 477777788888889999999985 677777777888899999998877 22
Q ss_pred ccccCcccccccceeecccCcccccCC
Q 045798 557 GQIPIFLEALSLEYLNLSFNDFEGKIP 583 (1008)
Q Consensus 557 ~~~p~~~~~~~L~~L~l~~N~l~g~~p 583 (1008)
+.++.. ...+..|.+..+++++..+
T Consensus 239 ~~l~~l--~~~lp~L~i~~~~ls~~~~ 263 (284)
T d2astb2 239 GTLQLL--KEALPHLQINCSHFTTIAR 263 (284)
T ss_dssp TCHHHH--HHHSTTSEESCCCSCCTTC
T ss_pred HHHHHH--HHhCccccccCccCCCCCC
Confidence 111111 1236666777777776654
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.49 E-value=7.7e-15 Score=140.19 Aligned_cols=109 Identities=23% Similarity=0.182 Sum_probs=42.4
Q ss_pred CCCCCCEEEccCCCCCCccCcccccCcCcceEeeeccccccCCCccccccCCCCeeecccccCCCCCCCCCccccccchh
Q 045798 100 RLFRLEALFLSNNSLVGKIPANLSYCSRLTVLCIEYNKLQGRIPLEFVSLSKLKDLSLAKNKLTGGIPPFLGNLTSLEVL 179 (1008)
Q Consensus 100 ~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 179 (1008)
++.+|++|+|++|+|+ .++..+..+++|++|+|++|+|+. + +.|..+++|++|++++|+++...+..+..+++|++|
T Consensus 16 n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~~-l-~~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~L 92 (162)
T d1a9na_ 16 NAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRK-L-DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTEL 92 (162)
T ss_dssp CTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCCE-E-CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEE
T ss_pred CcCcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCCc-c-CCcccCcchhhhhcccccccCCCccccccccccccc
Confidence 3334444444444443 223333334444444444444432 1 123334444444444444442222222334444444
Q ss_pred hcccccCCCCCC-ccccCCCCCcEEEecCCccc
Q 045798 180 SLAGNSFGRNIP-DSLGQLKQLKILAIGGNNLS 211 (1008)
Q Consensus 180 ~L~~n~l~~~~~-~~~~~l~~L~~L~L~~n~l~ 211 (1008)
++++|++..... ..+..+++|++|++++|.++
T Consensus 93 ~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~ 125 (162)
T d1a9na_ 93 ILTNNSLVELGDLDPLASLKSLTYLCILRNPVT 125 (162)
T ss_dssp ECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGG
T ss_pred eeccccccccccccccccccccchhhcCCCccc
Confidence 444444422111 23444445555555555444
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.48 E-value=5.7e-14 Score=127.26 Aligned_cols=101 Identities=26% Similarity=0.340 Sum_probs=43.7
Q ss_pred EEEccCCCCCCccCcccccCcCcceEeeeccccccCCCccccccCCCCeeecccccCCCCCCCCCccccccchhhccccc
Q 045798 106 ALFLSNNSLVGKIPANLSYCSRLTVLCIEYNKLQGRIPLEFVSLSKLKDLSLAKNKLTGGIPPFLGNLTSLEVLSLAGNS 185 (1008)
Q Consensus 106 ~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~ 185 (1008)
+|+|++|+++ .++ .++.+++|++|++++|+|+ .+|..|+.+++|+.|++++|+|++ +| .++++++|++|++++|+
T Consensus 2 ~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~l~~N~ 76 (124)
T d1dcea3 2 VLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNR 76 (124)
T ss_dssp EEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSC
T ss_pred EEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhcccccccccccccc-cC-ccccccccCeEECCCCc
Confidence 3444444444 222 2444444444444444444 233344444444444444444442 22 24444444444444444
Q ss_pred CCCCC-CccccCCCCCcEEEecCCccc
Q 045798 186 FGRNI-PDSLGQLKQLKILAIGGNNLS 211 (1008)
Q Consensus 186 l~~~~-~~~~~~l~~L~~L~L~~n~l~ 211 (1008)
++... ...+..+++|+.|++++|+++
T Consensus 77 i~~~~~~~~l~~~~~L~~L~l~~N~i~ 103 (124)
T d1dcea3 77 LQQSAAIQPLVSCPRLVLLNLQGNSLC 103 (124)
T ss_dssp CCSSSTTGGGGGCTTCCEEECTTSGGG
T ss_pred cCCCCCchhhcCCCCCCEEECCCCcCC
Confidence 43221 123444455555555555444
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.48 E-value=3.1e-14 Score=128.98 Aligned_cols=118 Identities=25% Similarity=0.318 Sum_probs=80.2
Q ss_pred CeeeecCCCCCCCCCccccCCCCCCEEEccCCCCCCccCcccccCcCcceEeeeccccccCCCccccccCCCCeeecccc
Q 045798 81 REINLSNNTIQGEIPPEFGRLFRLEALFLSNNSLVGKIPANLSYCSRLTVLCIEYNKLQGRIPLEFVSLSKLKDLSLAKN 160 (1008)
Q Consensus 81 ~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n 160 (1008)
|.|+|++|+++ .++ .+..+.+|++|++++|+|+ .+|..++.+++|++|++++|+|++ +| .++++++|++|++++|
T Consensus 1 R~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~l~~N 75 (124)
T d1dcea3 1 RVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNN 75 (124)
T ss_dssp SEEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSS
T ss_pred CEEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhcccccccccccccc-cC-ccccccccCeEECCCC
Confidence 46777777777 444 3777777888888888777 566677777888888888888774 33 4777788888888888
Q ss_pred cCCCCC-CCCCccccccchhhcccccCCCCC---CccccCCCCCcEE
Q 045798 161 KLTGGI-PPFLGNLTSLEVLSLAGNSFGRNI---PDSLGQLKQLKIL 203 (1008)
Q Consensus 161 ~l~~~~-~~~~~~l~~L~~L~L~~n~l~~~~---~~~~~~l~~L~~L 203 (1008)
+|+... ...++.+++|++|++++|+++... ...+..+++|+.|
T Consensus 76 ~i~~~~~~~~l~~~~~L~~L~l~~N~i~~~~~~~~~l~~~lp~L~~L 122 (124)
T d1dcea3 76 RLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSI 122 (124)
T ss_dssp CCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCTTHHHHHCTTCSEE
T ss_pred ccCCCCCchhhcCCCCCCEEECCCCcCCcCccHHHHHHHHCcCcceE
Confidence 877432 245677778888888888775321 2223345555544
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.46 E-value=3.3e-14 Score=135.76 Aligned_cols=111 Identities=17% Similarity=0.126 Sum_probs=77.0
Q ss_pred cccCcCcceEeeeccccccCCCccccccCCCCeeecccccCCCCCCCCCccccccchhhcccccCCCCCCccccCCCCCc
Q 045798 122 LSYCSRLTVLCIEYNKLQGRIPLEFVSLSKLKDLSLAKNKLTGGIPPFLGNLTSLEVLSLAGNSFGRNIPDSLGQLKQLK 201 (1008)
Q Consensus 122 l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~ 201 (1008)
+.++.+|++|+|++|+|+ .++..+..+++|++|+|++|+|+ .+ +.|..+++|++|++++|+++...+..+..+++|+
T Consensus 14 ~~n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~-~l-~~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~ 90 (162)
T d1a9na_ 14 YTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KL-DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLT 90 (162)
T ss_dssp EECTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCC-EE-CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCC
T ss_pred ccCcCcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCC-cc-CCcccCcchhhhhcccccccCCCccccccccccc
Confidence 556677788888888887 34555666777888888888777 33 3467777777777777777665555566777777
Q ss_pred EEEecCCcccccCC-ccccCCCCcceecccccccc
Q 045798 202 ILAIGGNNLSGPIP-PSIYNLSFLVVFSVSHNQIH 235 (1008)
Q Consensus 202 ~L~L~~n~l~~~~~-~~~~~l~~L~~L~ls~N~l~ 235 (1008)
.|++++|+++.... ..+..+++|++|++++|.++
T Consensus 91 ~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~ 125 (162)
T d1a9na_ 91 ELILTNNSLVELGDLDPLASLKSLTYLCILRNPVT 125 (162)
T ss_dssp EEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGG
T ss_pred cceeccccccccccccccccccccchhhcCCCccc
Confidence 77777777764321 35666666777777777665
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.46 E-value=1.2e-14 Score=153.77 Aligned_cols=61 Identities=15% Similarity=0.075 Sum_probs=35.8
Q ss_pred CCCcceeccccccccccCChhhhhcCCCCcEEEeccccCCCCCCcccccCCCCceeecccc
Q 045798 221 LSFLVVFSVSHNQIHGSLPPSLGLLLPNLKFFQIHHNFFSGSIPISLSNASKLEHIEIANN 281 (1008)
Q Consensus 221 l~~L~~L~ls~N~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N 281 (1008)
..+|++||+++|.+.......++..+++|++|+|++|.+.+..+..+..+++|++|++++|
T Consensus 45 ~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c 105 (284)
T d2astb2 45 PFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGC 105 (284)
T ss_dssp CBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTC
T ss_pred CCCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCcccccc
Confidence 3456666666665554333444455566666666666665555555666666666666664
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.42 E-value=1.1e-14 Score=159.09 Aligned_cols=63 Identities=14% Similarity=0.190 Sum_probs=29.7
Q ss_pred CCCCceEEccCCccccc----ccccccCCCCcceeecccccccc-----ccCCCCcCCCcccEeeccccccc
Q 045798 397 LQKLQGLDFSGNHFSGE----IPSSLGNLSSLYEVFFNNNNLSG-----VIPFSLGNLKRLAFLEMSGNELS 459 (1008)
Q Consensus 397 l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~~-----~~p~~~~~l~~L~~L~Ls~N~l~ 459 (1008)
.+.|+.|++++|++... +...+...+.|++|+|++|.+.. .+...+..+++|+.|+|++|.++
T Consensus 157 ~~~L~~l~l~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~ 228 (344)
T d2ca6a1 157 APPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFT 228 (344)
T ss_dssp CCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCH
T ss_pred Ccccceeecccccccccccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhccccccccccc
Confidence 44555666666555421 11223334445555555554432 12233445555666666655553
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.41 E-value=6e-15 Score=161.33 Aligned_cols=192 Identities=18% Similarity=0.220 Sum_probs=116.8
Q ss_pred cccccccceEEecCccccCC----cchhccCCCCCceEEccCCccccccccc-------------ccCCCCcceeecccc
Q 045798 370 IGNLVDLYLLGMVENQFTGA----IPKEMGKLQKLQGLDFSGNHFSGEIPSS-------------LGNLSSLYEVFFNNN 432 (1008)
Q Consensus 370 ~~~l~~L~~L~L~~n~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~~p~~-------------~~~l~~L~~L~l~~N 432 (1008)
+...++|+.|+|++|.+... +...+...++|+.|++++|.+....... ....+.|+.+.+++|
T Consensus 89 l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n 168 (344)
T d2ca6a1 89 LLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRN 168 (344)
T ss_dssp HTTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSS
T ss_pred HhhCCCcccccccccccccccccchhhhhcccccchheecccccccccccccccccccccccccccccCcccceeecccc
Confidence 33455677777777766543 2334445677777777777764211111 123445666666666
Q ss_pred ccccc----cCCCCcCCCcccEeecccccccCCcchhhhhhhhhhhhhcccCccccCCCccccccccccccccccccccc
Q 045798 433 NLSGV----IPFSLGNLKRLAFLEMSGNELSGTIPEDIFNISYLSNSLNLARNHLVGIIPPRIGNLRALRSFDVSNNDLS 508 (1008)
Q Consensus 433 ~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~lp~~~~~~~~~~~~L~L~~N~l~~~~p~~~~~l~~L~~Ldls~N~l~ 508 (1008)
.+... +...+...+.|+.|+|++|+++. +.+. ..+...+..+++|+.|+|++|.++
T Consensus 169 ~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~---~g~~-----------------~~l~~~l~~~~~L~~L~Ls~N~i~ 228 (344)
T d2ca6a1 169 RLENGSMKEWAKTFQSHRLLHTVKMVQNGIRP---EGIE-----------------HLLLEGLAYCQELKVLDLQDNTFT 228 (344)
T ss_dssp CCTGGGHHHHHHHHHHCTTCCEEECCSSCCCH---HHHH-----------------HHHHTTGGGCTTCCEEECCSSCCH
T ss_pred cccccccccccchhhhhhhhcccccccccccc---cccc-----------------cchhhhhcchhhhccccccccccc
Confidence 65421 22223445566666666666541 0000 012344667788999999999876
Q ss_pred CC----CCcccccccccceeeccCcccccchhhhh----hc--cccccEEecCCCcccccc----cCcc--cccccceee
Q 045798 509 GE----IPIELGHCSSLEEIYLAGNLFHGSIPSFF----NA--LKGVQKIDLSRNNLSGQI----PIFL--EALSLEYLN 572 (1008)
Q Consensus 509 ~~----~p~~~~~l~~L~~L~L~~N~l~~~~p~~~----~~--l~~L~~L~ls~N~l~~~~----p~~~--~~~~L~~L~ 572 (1008)
.. +...+..+++|++|+|++|.|++.-...+ .. .+.|+.|||++|+++..- .... +...|+.|+
T Consensus 229 ~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~ 308 (344)
T d2ca6a1 229 HLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLE 308 (344)
T ss_dssp HHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEE
T ss_pred ccccccccccccccccchhhhhhcCccCchhhHHHHHHhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEE
Confidence 32 44566778899999999999886533333 22 357899999999987532 2221 345799999
Q ss_pred cccCccccc
Q 045798 573 LSFNDFEGK 581 (1008)
Q Consensus 573 l~~N~l~g~ 581 (1008)
|++|.+...
T Consensus 309 l~~N~~~~~ 317 (344)
T d2ca6a1 309 LNGNRFSEE 317 (344)
T ss_dssp CTTSBSCTT
T ss_pred CCCCcCCCc
Confidence 999988653
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.35 E-value=1.7e-14 Score=142.98 Aligned_cols=41 Identities=34% Similarity=0.439 Sum_probs=21.1
Q ss_pred ccccccccccccccccccCCCC--cccccccccceeeccCcccc
Q 045798 491 IGNLRALRSFDVSNNDLSGEIP--IELGHCSSLEEIYLAGNLFH 532 (1008)
Q Consensus 491 ~~~l~~L~~Ldls~N~l~~~~p--~~~~~l~~L~~L~L~~N~l~ 532 (1008)
+..+++|+.|++++|+++ .++ ..+..+++|++|+|++|++.
T Consensus 111 ~~~l~~L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~L~~N~l~ 153 (198)
T d1m9la_ 111 IEKLVNLRVLYMSNNKIT-NWGEIDKLAALDKLEDLLLAGNPLY 153 (198)
T ss_dssp HHHHHHSSEEEESEEECC-CHHHHHHHTTTTTCSEEEECSSHHH
T ss_pred ccccccccccccccchhc-cccccccccCCCccceeecCCCccc
Confidence 344555555555555554 222 23455555555555555554
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.35 E-value=1.3e-14 Score=143.88 Aligned_cols=116 Identities=25% Similarity=0.315 Sum_probs=73.5
Q ss_pred CCCccccCCCCCCEEEccCCCCCCccCcccccCcCcceEeeeccccccCCCccccccCCCCeeecccccCCCCCCCCCcc
Q 045798 93 EIPPEFGRLFRLEALFLSNNSLVGKIPANLSYCSRLTVLCIEYNKLQGRIPLEFVSLSKLKDLSLAKNKLTGGIPPFLGN 172 (1008)
Q Consensus 93 ~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~ 172 (1008)
.++.++..+++|++|+|++|+|+ .++ .+..+++|++|+|++|+|+ .+|..+..+++|++|++++|+++. + +.+..
T Consensus 39 ~l~~sl~~L~~L~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~-l-~~~~~ 113 (198)
T d1m9la_ 39 KMDATLSTLKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-L-SGIEK 113 (198)
T ss_dssp CCHHHHHHTTTCCEEECSEEEES-CCC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCC-H-HHHHH
T ss_pred hhhhHHhcccccceeECcccCCC-Ccc-cccCCccccChhhcccccc-cccccccccccccccccccccccc-c-ccccc
Confidence 34455666677777777777766 333 4666777777777777776 345444555667777777777763 2 23566
Q ss_pred ccccchhhcccccCCCCCC-ccccCCCCCcEEEecCCccccc
Q 045798 173 LTSLEVLSLAGNSFGRNIP-DSLGQLKQLKILAIGGNNLSGP 213 (1008)
Q Consensus 173 l~~L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~L~~n~l~~~ 213 (1008)
+++|+.|++++|+++.... ..|..+++|+.|+|++|.++..
T Consensus 114 l~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~~ 155 (198)
T d1m9la_ 114 LVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYND 155 (198)
T ss_dssp HHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHHHH
T ss_pred cccccccccccchhccccccccccCCCccceeecCCCccccC
Confidence 6777777777777644321 3567777777777777776643
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.24 E-value=4.9e-12 Score=119.50 Aligned_cols=98 Identities=21% Similarity=0.205 Sum_probs=71.6
Q ss_pred cCCCCccCcCccCCccCCeeeecCC-CCCCCCCccccCCCCCCEEEccCCCCCCccCcccccCcCcceEeeeccccccCC
Q 045798 64 KSLSGSLSPHLGNLSFLREINLSNN-TIQGEIPPEFGRLFRLEALFLSNNSLVGKIPANLSYCSRLTVLCIEYNKLQGRI 142 (1008)
Q Consensus 64 ~~l~~~l~~~l~~l~~L~~L~L~~n-~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~ 142 (1008)
+++. ..|..+..+++|++|++++| .++...+++|.++++|+.|+|++|+|+...|.+|..+++|++|+|++|+|+...
T Consensus 18 ~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~~l~ 96 (156)
T d2ifga3 18 DGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLS 96 (156)
T ss_dssp SCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCSCCC
T ss_pred CCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceeccCCCCcccC
Confidence 3444 45667778888888888765 477666677888888888888888888666777888888888888888888444
Q ss_pred CccccccCCCCeeecccccCC
Q 045798 143 PLEFVSLSKLKDLSLAKNKLT 163 (1008)
Q Consensus 143 p~~~~~l~~L~~L~L~~n~l~ 163 (1008)
+..|. ..+|++|+|++|.+.
T Consensus 97 ~~~~~-~~~l~~L~L~~Np~~ 116 (156)
T d2ifga3 97 WKTVQ-GLSLQELVLSGNPLH 116 (156)
T ss_dssp STTTC-SCCCCEEECCSSCCC
T ss_pred hhhhc-cccccccccCCCccc
Confidence 44444 346778888887764
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.23 E-value=8.3e-12 Score=117.87 Aligned_cols=106 Identities=18% Similarity=0.091 Sum_probs=64.4
Q ss_pred CCeeecccccCCCCCCCCCccccccchhhcccc-cCCCCCCccccCCCCCcEEEecCCcccccCCccccCCCCcceeccc
Q 045798 152 LKDLSLAKNKLTGGIPPFLGNLTSLEVLSLAGN-SFGRNIPDSLGQLKQLKILAIGGNNLSGPIPPSIYNLSFLVVFSVS 230 (1008)
Q Consensus 152 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n-~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ls 230 (1008)
...++++++.+. ..|..+..+++|++|++++| .++...+++|.++++|+.|+|++|+|+.+.+.+|..+++|++|+|+
T Consensus 10 ~~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls 88 (156)
T d2ifga3 10 SSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLS 88 (156)
T ss_dssp SSCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECC
T ss_pred CCeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceecc
Confidence 344555555555 44555555666666666544 3555555566666666666666666666666666666666666666
Q ss_pred cccccccCChhhhhcCCCCcEEEeccccCC
Q 045798 231 HNQIHGSLPPSLGLLLPNLKFFQIHHNFFS 260 (1008)
Q Consensus 231 ~N~l~~~lp~~~~~~l~~L~~L~L~~N~l~ 260 (1008)
+|+|+ .+|..++..+ +|++|+|++|.+.
T Consensus 89 ~N~l~-~l~~~~~~~~-~l~~L~L~~Np~~ 116 (156)
T d2ifga3 89 FNALE-SLSWKTVQGL-SLQELVLSGNPLH 116 (156)
T ss_dssp SSCCS-CCCSTTTCSC-CCCEEECCSSCCC
T ss_pred CCCCc-ccChhhhccc-cccccccCCCccc
Confidence 66666 5666555433 5666666666654
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.51 E-value=3.9e-09 Score=99.90 Aligned_cols=59 Identities=20% Similarity=0.367 Sum_probs=29.3
Q ss_pred ccccccccccccccccccCCCCcccccccccceeeccCcccccchh-------hhhhccccccEEe
Q 045798 491 IGNLRALRSFDVSNNDLSGEIPIELGHCSSLEEIYLAGNLFHGSIP-------SFFNALKGVQKID 549 (1008)
Q Consensus 491 ~~~l~~L~~Ldls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-------~~~~~l~~L~~L~ 549 (1008)
+..+++|+.||||+|.++...+-.......|++|++++|++..... ..+..+++|+.||
T Consensus 87 ~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~y~~~i~~~~P~L~~LD 152 (162)
T d1koha1 87 VQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIRERFPKLLRLD 152 (162)
T ss_dssp HHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSSSSSHHHHHHHHHTTSTTCCEET
T ss_pred HhhCCcccccccccCccccchhhhhhhccccceeecCCCCcCcCcccchhHHHHHHHHCCCCCEEC
Confidence 4455666666666666652222122223445666666666654322 1234455555554
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.41 E-value=1.2e-08 Score=96.43 Aligned_cols=65 Identities=25% Similarity=0.291 Sum_probs=28.5
Q ss_pred cccCCCCeeecccccCCCCC--CCCCccccccchhhcccccCCCCCCccccCCCCCcEEEecCCccc
Q 045798 147 VSLSKLKDLSLAKNKLTGGI--PPFLGNLTSLEVLSLAGNSFGRNIPDSLGQLKQLKILAIGGNNLS 211 (1008)
Q Consensus 147 ~~l~~L~~L~L~~n~l~~~~--~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~ 211 (1008)
..+++|++|+|++|+|+..- +..+..+++|+.|+|++|.++...+-.+....+|+.|++++|.++
T Consensus 62 ~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~ 128 (162)
T d1koha1 62 ENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLS 128 (162)
T ss_dssp HHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTS
T ss_pred HhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccccceeecCCCCcC
Confidence 34455555555555554221 122334455555555555553322222223334444555555444
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.41 E-value=3.5e-07 Score=94.20 Aligned_cols=149 Identities=15% Similarity=0.081 Sum_probs=101.2
Q ss_pred HHHHHHhcCCCCCceEeeccCeeEEEEEEcCCCeEEEEEEeccccchhhHHHHHHHHHHhhcC-CCCceeeeeccccccc
Q 045798 677 KSLLKATNGFSSTHLIGVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIR-HRNLVKVITSCSSIDF 755 (1008)
Q Consensus 677 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~ 755 (1008)
.++.+....|++++..+.++.+.||+... +++.+++|+...........+.+|+..++.+. +--+.+++.++
T Consensus 7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~--~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~----- 79 (263)
T d1j7la_ 7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFE----- 79 (263)
T ss_dssp HHHHHHHTTSEEEECSCCCSSSEEEEEEC--SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEE-----
T ss_pred HHHHHhhhceEEEEcCCCCCCCcEEEEEe--CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEE-----
Confidence 35566667887777655555678998764 56778899887554555556788988888773 43455666652
Q ss_pred cCCceEEEEEeccCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhhCC-------------------
Q 045798 756 QGNDFKAIVYEYMPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHHHC------------------- 816 (1008)
Q Consensus 756 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~------------------- 816 (1008)
..++..++||++++|.++.+...... ....++.+++..++.||+..
T Consensus 80 ~~~~~~~lv~~~l~G~~~~~~~~~~~---------------~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~ 144 (263)
T d1j7la_ 80 RHDGWSNLLMSEADGVLCSEEYEDEQ---------------SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDY 144 (263)
T ss_dssp EETTEEEEEEECCSSEEHHHHTTTCS---------------CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHH
T ss_pred ecCCceEEEEEecccccccccccccc---------------cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHH
Confidence 34566899999999988765432111 12234555556666666321
Q ss_pred -------------------------------------CCCceeccCCCCCeeecCCCCeEEcccCccc
Q 045798 817 -------------------------------------QEPILHCDLKPSNILLDNDLSGHIGDFGLAR 847 (1008)
Q Consensus 817 -------------------------------------~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~ 847 (1008)
...++|+|+.|.||++++++.+-|+||+.+.
T Consensus 145 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 145 LLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp HHHTTCSCCCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHhhhhhhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 1237899999999999987666799999886
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.80 E-value=9.7e-06 Score=82.49 Aligned_cols=130 Identities=16% Similarity=0.090 Sum_probs=82.8
Q ss_pred eEeeccC-eeEEEEEEcCCCeEEEEEEeccccchhhHHHHHHHHHHhhcC--CCCceeeeeccccccccCCceEEEEEec
Q 045798 691 LIGVGSF-GCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIR--HRNLVKVITSCSSIDFQGNDFKAIVYEY 767 (1008)
Q Consensus 691 ~lg~G~~-g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~~~~~~~~lv~e~ 767 (1008)
.+..|.. +.||+.... ++..+++|..... ....+..|+..++.+. .-.+.++++++ .+++..++||++
T Consensus 17 ~~~~G~s~~~v~r~~~~-~~~~~vlK~~~~~---~~~~l~~E~~~l~~L~~~gvpvP~v~~~~-----~~~~~~~~v~~~ 87 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQ-GRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVV-----TEAGRDWLLLGE 87 (255)
T ss_dssp ECSCTTSSCEEEEEECT-TSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEE-----ECSSCEEEEEEC
T ss_pred EcCCcccCCeEEEEEeC-CCCEEEEEeCCcc---CHhHHHHHHHHHHHHHhcCCCCCceeeec-----ccccceEEEEEe
Confidence 4455554 689998874 6777889986543 2345777888887773 23355666653 344568999999
Q ss_pred cCCCChhcccccCCCCCCCcccccccCHHHHHHHHHHHHHHHHHHhh---------------------------------
Q 045798 768 MPNGSLEKWLHPHAVPKRDKEIEIKLTLLQRISIAIDVASALDYLHH--------------------------------- 814 (1008)
Q Consensus 768 ~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~--------------------------------- 814 (1008)
++|.++.+... .. ..++.+++..++-||+
T Consensus 88 i~G~~~~~~~~---------------~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 149 (255)
T d1nd4a_ 88 VPGQDLLSSHL---------------AP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDL 149 (255)
T ss_dssp CSSEETTTSCC---------------CH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSC
T ss_pred eeccccccccc---------------cH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccc
Confidence 98876654211 10 1122233333344442
Q ss_pred ------------------CC----CCCceeccCCCCCeeecCCCCeEEcccCccc
Q 045798 815 ------------------HC----QEPILHCDLKPSNILLDNDLSGHIGDFGLAR 847 (1008)
Q Consensus 815 ------------------~~----~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~ 847 (1008)
.. +..++|+|+.|.||+++++..+-|+||+.+.
T Consensus 150 ~~~~~~~~~~~~~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 150 DEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp CGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred cchhhhhHHHHHHHHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 10 1237999999999999987667899999875
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.53 E-value=6.2e-05 Score=81.42 Aligned_cols=78 Identities=19% Similarity=0.125 Sum_probs=49.8
Q ss_pred CceEeeccCeeEEEEEEcCCCeEEEEEEeccc----c---chhhHHHHHHHHHHhhc-CC--CCceeeeeccccccccCC
Q 045798 689 THLIGVGSFGCVYKGALDEDGIVVAIKVINLQ----C---EGASKSFMAECKALKNI-RH--RNLVKVITSCSSIDFQGN 758 (1008)
Q Consensus 689 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~----~---~~~~~~~~~E~~~l~~l-~h--~niv~~~~~~~~~~~~~~ 758 (1008)
.+.||.|....||++....+++.|+||.-... . +....+...|++.++.+ .+ ..+.+++.+. +
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d-------~ 103 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD-------T 103 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE-------T
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc-------C
Confidence 45789999999999988767889999975421 1 12234566788888776 22 3455666542 2
Q ss_pred ceEEEEEeccCCCCh
Q 045798 759 DFKAIVYEYMPNGSL 773 (1008)
Q Consensus 759 ~~~~lv~e~~~~gsL 773 (1008)
+..++|||++++..+
T Consensus 104 ~~~~lvmE~L~~~~~ 118 (392)
T d2pula1 104 EMAVTVMEDLSHLKI 118 (392)
T ss_dssp TTTEEEECCCTTSEE
T ss_pred CCCEEEEeccCCccc
Confidence 345799999976543
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.30 E-value=1.8e-05 Score=74.38 Aligned_cols=17 Identities=18% Similarity=0.217 Sum_probs=7.8
Q ss_pred cCCCCCCEEEccCCCCC
Q 045798 99 GRLFRLEALFLSNNSLV 115 (1008)
Q Consensus 99 ~~l~~L~~L~Ls~n~l~ 115 (1008)
...++|++|+|++|.+.
T Consensus 41 ~~n~~L~~L~Ls~n~l~ 57 (167)
T d1pgva_ 41 CNSKHIEKFSLANTAIS 57 (167)
T ss_dssp TTCSCCCEEECTTSCCB
T ss_pred hhCCccceeeccccccc
Confidence 33444444444444443
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.21 E-value=3.1e-05 Score=72.69 Aligned_cols=11 Identities=18% Similarity=0.422 Sum_probs=6.3
Q ss_pred cCCCCeeeccc
Q 045798 149 LSKLKDLSLAK 159 (1008)
Q Consensus 149 l~~L~~L~L~~ 159 (1008)
.++|++|+|++
T Consensus 14 ~~~L~~L~L~~ 24 (167)
T d1pgva_ 14 DTDLKEVNINN 24 (167)
T ss_dssp CSSCCEEECTT
T ss_pred CCCCcEEEeCC
Confidence 35566666654
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.17 E-value=0.0014 Score=68.38 Aligned_cols=172 Identities=13% Similarity=0.106 Sum_probs=90.4
Q ss_pred CCCCHHHHHHHhcCCC--C-CceEeecc-CeeEEEEEEcCCCeEEEEEEeccccchhhHHHHHHHHHHhhcCCCC--cee
Q 045798 672 PKMSYKSLLKATNGFS--S-THLIGVGS-FGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRN--LVK 745 (1008)
Q Consensus 672 ~~~~~~~~~~~~~~y~--~-~~~lg~G~-~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~ 745 (1008)
..++.+.+..+...+- . .+.+-=++ --.||++... +|+.||+|+.+.. ....+++..|.+.+..+.... ++.
T Consensus 6 ~~L~pd~i~~al~~~g~~~~~~~~~L~s~EN~vy~v~~~-dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~ 83 (325)
T d1zyla1 6 QTLHPDTIMDALFEHGIRVDSGLTPLNSYENRVYQFQDE-DRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAA 83 (325)
T ss_dssp CCCCHHHHHHHHHHTTCCCCSCCEEECCSSSEEEEECCT-TCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCC
T ss_pred cccCHHHHHHHHHHcCCCCCcCccccccccceeEEEEcC-CCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCC
Confidence 3455666655554331 1 12222233 3589999884 8899999998754 223466788888888874222 222
Q ss_pred eeeccccccccCCceEEEEEeccCCCChhcc--------------cc----cCCCCCCCc-cc-------------cccc
Q 045798 746 VITSCSSIDFQGNDFKAIVYEYMPNGSLEKW--------------LH----PHAVPKRDK-EI-------------EIKL 793 (1008)
Q Consensus 746 ~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~--------------l~----~~~~~~~~~-~~-------------~~~l 793 (1008)
.+.......+..+...+.|+++++|..+... ++ ......+.. .. ...+
T Consensus 84 p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~ 163 (325)
T d1zyla1 84 PVAFNGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLI 163 (325)
T ss_dssp CCCBTTBSCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSS
T ss_pred ceecCCCeeeeeeeEEEEEEeecCCcCCCCCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcC
Confidence 2222222223455678899999976444211 00 000000000 00 0011
Q ss_pred CHH---HHHHHHHHHHHHHHHHh-hCCCCCceeccCCCCCeeecCCCCeEEcccCccc
Q 045798 794 TLL---QRISIAIDVASALDYLH-HHCQEPILHCDLKPSNILLDNDLSGHIGDFGLAR 847 (1008)
Q Consensus 794 ~~~---~~~~i~~qi~~~L~~LH-~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~ 847 (1008)
+.. .....+.++...+.-.- +..+.++||+|+.+.|||++++ ..++||+-+.
T Consensus 164 ~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~liHgDlh~~NvL~~~~--~~~IDFdd~~ 219 (325)
T d1zyla1 164 PSGLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWRDG--PMFVDLDDAR 219 (325)
T ss_dssp CTTTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEESSS--EEECCCTTCC
T ss_pred CHHHHHHHHHHHHHHHHHHHHhccccCCceeecCCCCcccEEEeCC--ceEEechhcc
Confidence 111 12222333333332221 2224578999999999999744 4589999886
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.66 E-value=0.0042 Score=64.40 Aligned_cols=171 Identities=9% Similarity=-0.019 Sum_probs=86.9
Q ss_pred CCCHHHHHHHhcCCCCCceE-----eeccCeeEEEEEEcCCCeEEEEEEeccccchhhHHHHHHHHHHhhcCCCC--cee
Q 045798 673 KMSYKSLLKATNGFSSTHLI-----GVGSFGCVYKGALDEDGIVVAIKVINLQCEGASKSFMAECKALKNIRHRN--LVK 745 (1008)
Q Consensus 673 ~~~~~~~~~~~~~y~~~~~l-----g~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~ 745 (1008)
..+.+++.....+|.+.+.. ..|.--+.|+.... + ..+++|++... ...+.+..|++++..+...+ +..
T Consensus 2 ~ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~-~-g~yVLri~~~~--~~~~~l~~~~~~l~~L~~~g~pvp~ 77 (316)
T d2ppqa1 2 DITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTT-K-DPLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPL 77 (316)
T ss_dssp CCCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEES-S-CCEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCC
T ss_pred CCCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEEC-C-CcEEEEEcCCC--CCHHHHHHHHHHHHhhhhccccccc
Confidence 45678888888899876544 35555778998874 3 45899998643 12345556677777763222 111
Q ss_pred eeeccc-cccccCCceEEEEEeccCCCChhccccc------------------CCCCCCCccc-------------cccc
Q 045798 746 VITSCS-SIDFQGNDFKAIVYEYMPNGSLEKWLHP------------------HAVPKRDKEI-------------EIKL 793 (1008)
Q Consensus 746 ~~~~~~-~~~~~~~~~~~lv~e~~~~gsL~~~l~~------------------~~~~~~~~~~-------------~~~l 793 (1008)
.+.... ..........+.++.+..+......-.. .......... ....
T Consensus 78 pi~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (316)
T d2ppqa1 78 PLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADE 157 (316)
T ss_dssp BCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGG
T ss_pred cceecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhh
Confidence 111100 0001223345666777655433221100 0000000000 0000
Q ss_pred CHHHHHHHHHHHHHHHHHHhh-CCCCCceeccCCCCCeeecCCCCeEEcccCccc
Q 045798 794 TLLQRISIAIDVASALDYLHH-HCQEPILHCDLKPSNILLDNDLSGHIGDFGLAR 847 (1008)
Q Consensus 794 ~~~~~~~i~~qi~~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~ 847 (1008)
........+..+...+...+. ..++|+||+|+.++||+++++...-+.||+.+.
T Consensus 158 ~~~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 158 VEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp TSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cchhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 111112222222222232222 234689999999999999988777899999886
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=96.46 E-value=0.00014 Score=68.01 Aligned_cols=16 Identities=0% Similarity=-0.147 Sum_probs=7.8
Q ss_pred CCCCCCEEEccCCCCC
Q 045798 100 RLFRLEALFLSNNSLV 115 (1008)
Q Consensus 100 ~l~~L~~L~Ls~n~l~ 115 (1008)
..++|++|+|++|.++
T Consensus 44 ~n~~L~~L~Ls~n~l~ 59 (166)
T d1io0a_ 44 TNTYVKKFSIVGTRSN 59 (166)
T ss_dssp TCCSCCEEECTTSCCC
T ss_pred cCCccCeeeccCCccc
Confidence 4444555555555444
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=96.17 E-value=0.00053 Score=63.87 Aligned_cols=41 Identities=12% Similarity=0.233 Sum_probs=22.0
Q ss_pred cCCCCCcEEEecC-Cccccc----CCccccCCCCcceecccccccc
Q 045798 195 GQLKQLKILAIGG-NNLSGP----IPPSIYNLSFLVVFSVSHNQIH 235 (1008)
Q Consensus 195 ~~l~~L~~L~L~~-n~l~~~----~~~~~~~l~~L~~L~ls~N~l~ 235 (1008)
...++|++|+|++ +.++.. +..++...++|+.|++++|.+.
T Consensus 14 ~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~ 59 (166)
T d1io0a_ 14 NNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSN 59 (166)
T ss_dssp TTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCC
T ss_pred hcCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCccc
Confidence 3456677777765 345421 2223445556666666666554
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.10 E-value=0.0094 Score=63.81 Aligned_cols=75 Identities=20% Similarity=0.174 Sum_probs=50.4
Q ss_pred CceEeeccCeeEEEEEEcC-------CCeEEEEEEeccccchhhHHHHHHHHHHhhcC-CCCceeeeeccccccccCCce
Q 045798 689 THLIGVGSFGCVYKGALDE-------DGIVVAIKVINLQCEGASKSFMAECKALKNIR-HRNLVKVITSCSSIDFQGNDF 760 (1008)
Q Consensus 689 ~~~lg~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~ 760 (1008)
++.|+.|-.-.+|++.... ..+.|++++.. .... .....+|..+++.+. +.-..++++++.
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~~~~-~idr~~E~~i~~~ls~~gl~Pkll~~~~--------- 115 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-NPET-ESHLVAESVIFTLLSERHLGPKLYGIFS--------- 115 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-SCCC-HHHHHHHHHHHHHHHHTTSSSCEEEEET---------
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-Ccch-hhHHHHHHHHHHHHHhCCCCCeEEEEcC---------
Confidence 4678888899999998742 23567777765 2222 345668999998883 433456777642
Q ss_pred EEEEEeccCCCChh
Q 045798 761 KAIVYEYMPNGSLE 774 (1008)
Q Consensus 761 ~~lv~e~~~~gsL~ 774 (1008)
-.+|+||++|..+.
T Consensus 116 ~g~I~efi~g~~l~ 129 (395)
T d1nw1a_ 116 GGRLEEYIPSRPLS 129 (395)
T ss_dssp TEEEECCCCEEECC
T ss_pred CceEEEEeccccCC
Confidence 26899999775543
|